tic agents|mesh-ancestor
20266621|NCT00521430|Cyclosporine|cyclosporine|mesh-list
20266622|NCT00521430|Methylprednisolone|methylprednisolone|mesh-list
20266623|NCT00521430|Methotrexate|methotrexate|mesh-list
20266624|NCT00521430|Fludarabine phosphate|fludarabine phosphate|mesh-list
20266625|NCT00521430|Fludarabine|fludarabine|mesh-list
20266626|NCT00521430|Busulfan|busulfan|mesh-list
20266627|NCT00521430|Cyclosporins|cyclosporins|mesh-list
20266628|NCT00521430|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20266629|NCT00521430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20266630|NCT00521430|Abortifacient Agents|abortifacient agents|mesh-ancestor
20266631|NCT00521430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20266632|NCT00521430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266633|NCT00521430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20266634|NCT00521430|Antimetabolites|antimetabolites|mesh-ancestor
20266635|NCT00521430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266636|NCT00521430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20266637|NCT00521430|Dermatologic Agents|dermatologic agents|mesh-ancestor
20266638|NCT00521430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266639|NCT00521430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20266640|NCT00521430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20266641|NCT00521430|Immunologic Factors|immunologic factors|mesh-ancestor
20266642|NCT00521430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20266643|NCT00521430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20266644|NCT00521430|Antifungal Agents|antifungal agents|mesh-ancestor
20266645|NCT00521430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20266646|NCT00521430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20266647|NCT00521430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20266648|NCT00521430|Antiemetics|antiemetics|mesh-ancestor
20266649|NCT00521430|Autonomic Agents|autonomic agents|mesh-ancestor
20266650|NCT00521430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266651|NCT00521430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20266652|NCT00521430|Glucocorticoids|glucocorticoids|mesh-ancestor
20266653|NCT00521430|Hormones|hormones|mesh-ancestor
20266654|NCT00521430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20266655|NCT00521430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20266656|NCT00521430|Protective Agents|protective agents|mesh-ancestor
20266657|NCT00521430|Alkylating Agents|alkylating agents|mesh-ancestor
20266658|NCT00521430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20266659|NCT00521430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20287255|NCT05242874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19732824|NCT04569916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19732825|NCT04569916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19732826|NCT04569916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940757|NCT01464788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940758|NCT01464788|Antithrombins|antithrombins|mesh-ancestor
19940759|NCT01464788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20287256|NCT05242874|Glucocorticoids|glucocorticoids|mesh-ancestor
20287257|NCT05242874|Hormones|hormones|mesh-ancestor
20287258|NCT05242874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19732827|NCT04569916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287259|NCT05242874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20287260|NCT05242874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940760|NCT01464788|Protease Inhibitors|protease inhibitors|mesh-ancestor
19940761|NCT01464788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940762|NCT01464788|Anticoagulants|anticoagulants|mesh-ancestor
19940763|NCT01464788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19940764|NCT01464827|Ritonavir|ritonavir|mesh-list
19940765|NCT01464827|Ribavirin|ribavirin|mesh-list
19940766|NCT01464827|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19940767|NCT01464827|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19940768|NCT01464827|Protease Inhibitors|protease inhibitors|mesh-ancestor
19940769|NCT01464827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940770|NCT01464827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940771|NCT01464827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19940772|NCT01464827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19940773|NCT01464827|Antiviral Agents|antiviral agents|mesh-ancestor
19940774|NCT01464827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19940775|NCT01464827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19940776|NCT01464827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19940777|NCT01464827|Antimetabolites|antimetabolites|mesh-ancestor
19940778|NCT01464840|Azithromycin|azithromycin|mesh-list
20266660|NCT00521482|Thalidomide|thalidomide|mesh-list
20542807|NCT01865630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20542808|NCT01865630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20542809|NCT01865630|Immunologic Factors|immunologic factors|mesh-ancestor
20542810|NCT01865669|Oxytocin|oxytocin|mesh-list
20542811|NCT01865669|Oxytocics|oxytocics|mesh-ancestor
20542812|NCT01865669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20542813|NCT01865669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542814|NCT01865721|Entonox|entonox|mesh-list
20542815|NCT01865721|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20542816|NCT01865721|Anesthetics|anesthetics|mesh-ancestor
20542817|NCT01865721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19940779|NCT01464840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20266661|NCT00521482|Temozolomide|temozolomide|mesh-list
20266662|NCT00521482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20266663|NCT00521482|Alkylating Agents|alkylating agents|mesh-ancestor
20266664|NCT00521482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266665|NCT00521482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20266666|NCT00521482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20266667|NCT00521482|Immunologic Factors|immunologic factors|mesh-ancestor
20266668|NCT00521482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266669|NCT00521482|Leprostatic Agents|leprostatic agents|mesh-ancestor
20266670|NCT00521482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20266671|NCT00521482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20266672|NCT00521482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20266673|NCT00521482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20266674|NCT00521482|Growth Substances|growth substances|mesh-ancestor
20266675|NCT00521482|Growth Inhibitors|growth inhibitors|mesh-ancestor
20266676|NCT00521521|Docetaxel|docetaxel|mesh-list
20266677|NCT00521521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542818|NCT01865721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542819|NCT01865760|Octreotide|octreotide|mesh-list
20542820|NCT01865760|Somatostatin|somatostatin|mesh-list
20542821|NCT01865760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20542822|NCT01865760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20542823|NCT01865760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20542824|NCT01865760|Hormones|hormones|mesh-ancestor
20542825|NCT01865760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20542826|NCT01865760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542827|NCT01865916|Ascorbic Acid|ascorbic acid|mesh-list
20542828|NCT01865916|Bisacodyl|bisacodyl|mesh-list
20542829|NCT01865916|Antioxidants|antioxidants|mesh-ancestor
20542830|NCT01865916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542831|NCT01865916|Protective Agents|protective agents|mesh-ancestor
20542832|NCT01865916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542833|NCT01865916|Vitamins|vitamins|mesh-ancestor
20542834|NCT01865916|Micronutrients|micronutrients|mesh-ancestor
20542835|NCT01865916|Cathartics|cathartics|mesh-ancestor
20542836|NCT01865916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20542837|NCT01865916|Laxatives|laxatives|mesh-ancestor
20542838|NCT01865968|Vaccines|vaccines|mesh-list
20542839|NCT01865968|Immunologic Factors|immunologic factors|mesh-ancestor
20542840|NCT01865968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940780|NCT01464840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20542841|NCT01866007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20542842|NCT01866007|Immunologic Factors|immunologic factors|mesh-ancestor
20542843|NCT01866007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940781|NCT01464879|Testosterone|testosterone|mesh-list
19940782|NCT01464879|Androgens|androgens|mesh-ancestor
19940783|NCT01464879|Hormones|hormones|mesh-ancestor
19940784|NCT01464879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19940785|NCT01464879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940786|NCT01464931|Denosumab|denosumab|mesh-list
19940787|NCT01464931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19940788|NCT01464931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940789|NCT01465022|Estrogens|estrogens|mesh-list
19940790|NCT01465022|Progestins|progestins|mesh-list
19940791|NCT01465022|Hormones|hormones|mesh-ancestor
19940792|NCT01465022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19940793|NCT01465022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940794|NCT01465178|Cholecalciferol|cholecalciferol|mesh-list
19940795|NCT01465178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19940796|NCT01465178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940797|NCT01465178|Vitamins|vitamins|mesh-ancestor
19940798|NCT01465178|Micronutrients|micronutrients|mesh-ancestor
19940799|NCT01465178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19940800|NCT01465191|Morphine|morphine|mesh-list
19940801|NCT01465191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19940802|NCT01465191|Narcotics|narcotics|mesh-ancestor
19940803|NCT01465191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19940804|NCT01465191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940805|NCT01465191|Analgesics|analgesics|mesh-ancestor
19940806|NCT01465191|Sensory System Agents|sensory system agents|mesh-ancestor
19940807|NCT01465191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19940808|NCT01465334|Methylprednisolone|methylprednisolone|mesh-list
19940809|NCT01465334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19940810|NCT01465334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19940811|NCT01465334|Prednisolone|prednisolone|mesh-list
19940812|NCT01465334|Prednisolone acetate|prednisolone acetate|mesh-list
19940813|NCT01465334|Alemtuzumab|alemtuzumab|mesh-list
19940814|NCT01465334|Ofatumumab|ofatumumab|mesh-list
19940815|NCT01465334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19940816|NCT01465334|Prednisolone phosphate|prednisolone phosphate|mesh-list
19940817|NCT01465334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19940818|NCT01465334|Antiemetics|antiemetics|mesh-ancestor
19940819|NCT01465334|Autonomic Agents|autonomic agents|mesh-ancestor
19940820|NCT01465334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19940821|NCT01465334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940822|NCT01465334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19940823|NCT01465334|Glucocorticoids|glucocorticoids|mesh-ancestor
19940824|NCT01465334|Hormones|hormones|mesh-ancestor
19940825|NCT01465334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19940826|NCT01465334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19940827|NCT01465334|Protective Agents|protective agents|mesh-ancestor
19940828|NCT01465334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19940829|NCT01465334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940830|NCT01465334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19940831|NCT01465347|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
19940832|NCT01465347|Antioxidants|antioxidants|mesh-ancestor
19940833|NCT01465347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940834|NCT01465347|Protective Agents|protective agents|mesh-ancestor
19940835|NCT01465347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940836|NCT01465347|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19940837|NCT01465347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940838|NCT01465386|Bortezomib|bortezomib|mesh-list
19940839|NCT01465386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940840|NCT01465412|Adenosine|adenosine|mesh-list
19940841|NCT01465412|Analgesics|analgesics|mesh-ancestor
19940842|NCT01465412|Sensory System Agents|sensory system agents|mesh-ancestor
19940843|NCT01465412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19940844|NCT01465412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940845|NCT01465412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19940846|NCT01465412|Vasodilator Agents|vasodilator agents|mesh-ancestor
19940847|NCT01465412|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19940848|NCT01465412|Purinergic Agonists|purinergic agonists|mesh-ancestor
19940849|NCT01465412|Purinergic Agents|purinergic agents|mesh-ancestor
19940850|NCT01465412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20266678|NCT00521521|Tubulin Modulators|tubulin modulators|mesh-ancestor
19940851|NCT01465412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940852|NCT01465464|Orantinib|orantinib|mesh-list
19940853|NCT01465464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19940854|NCT01465464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266679|NCT00521521|Antimitotic Agents|antimitotic agents|mesh-ancestor
19940855|NCT01465464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940856|NCT01465659|Temozolomide|temozolomide|mesh-list
19940857|NCT01465659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19940858|NCT01465659|Alkylating Agents|alkylating agents|mesh-ancestor
19940859|NCT01465659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940860|NCT01465659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940861|NCT01465763|Tofacitinib|tofacitinib|mesh-list
19940862|NCT01465763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19940863|NCT01465763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940864|NCT01465763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940865|NCT01465802|Doxycycline|doxycycline|mesh-list
19940866|NCT01465802|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
19940867|NCT01465802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19940868|NCT01465802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19940869|NCT01465802|Antimalarials|antimalarials|mesh-ancestor
19940870|NCT01465802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19940871|NCT01465802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19940872|NCT01465802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19940873|NCT01465802|Glucocorticoids|glucocorticoids|mesh-ancestor
19940874|NCT01465802|Hormones|hormones|mesh-ancestor
19940875|NCT01465802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19940876|NCT01465802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940877|NCT01465958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19940878|NCT01465958|gamma-Globulins|gamma-globulins|mesh-list
19940879|NCT01465958|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19940880|NCT01465958|Immunoglobulin G|immunoglobulin g|mesh-list
19940881|NCT01465958|Immunologic Factors|immunologic factors|mesh-ancestor
19940882|NCT01465958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940883|NCT01465997|Lacosamide|lacosamide|mesh-list
19940884|NCT01465997|Carbamazepine|carbamazepine|mesh-list
19940885|NCT01465997|Anticonvulsants|anticonvulsants|mesh-ancestor
19940886|NCT01465997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19940887|NCT01465997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19940888|NCT01465997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19940889|NCT01465997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940890|NCT01465997|Antimanic Agents|antimanic agents|mesh-ancestor
19940891|NCT01465997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19940892|NCT01465997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19940893|NCT01465997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940894|NCT01465997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19940895|NCT01465997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19940896|NCT01465997|Analgesics|analgesics|mesh-ancestor
19940897|NCT01465997|Sensory System Agents|sensory system agents|mesh-ancestor
19940898|NCT01465997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19940899|NCT01465997|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19940900|NCT01465997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19940901|NCT01466062|Palivizumab|palivizumab|mesh-list
19940902|NCT01466062|Antiviral Agents|antiviral agents|mesh-ancestor
19940903|NCT01466062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19940904|NCT01466127|Oxytocin|oxytocin|mesh-list
19940905|NCT01466127|Oxytocics|oxytocics|mesh-ancestor
19940906|NCT01466127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19940907|NCT01466127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940908|NCT01466153|Rituximab|rituximab|mesh-list
19940909|NCT01466153|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19940910|NCT01466153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19940911|NCT01466153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940912|NCT01466153|Immunologic Factors|immunologic factors|mesh-ancestor
19940913|NCT01466153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940914|NCT01466153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19940915|NCT01466153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19940916|NCT01466153|Alkylating Agents|alkylating agents|mesh-ancestor
19940917|NCT01466153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940918|NCT01466179|Blinatumomab|blinatumomab|mesh-list
19940919|NCT01466179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940920|NCT01466192|Ribavirin|ribavirin|mesh-list
19940921|NCT01466192|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19940922|NCT01466192|Antimetabolites|antimetabolites|mesh-ancestor
19940923|NCT01466192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940924|NCT01466192|Antiviral Agents|antiviral agents|mesh-ancestor
19940925|NCT01466192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19940926|NCT01466270|Donepezil|donepezil|mesh-list
19940927|NCT01466270|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19940928|NCT01466270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266680|NCT00521521|Mitosis Modulators|mitosis modulators|mesh-ancestor
19940929|NCT01466270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940930|NCT01466270|Cholinergic Agents|cholinergic agents|mesh-ancestor
19940931|NCT01466270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19940932|NCT01466270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940933|NCT01466270|Nootropic Agents|nootropic agents|mesh-ancestor
19940934|NCT01466348|Acetaminophen|acetaminophen|mesh-list
19940935|NCT01466348|Caffeine|caffeine|mesh-list
19940936|NCT01466348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19940937|NCT01466348|Analgesics|analgesics|mesh-ancestor
19940938|NCT01466348|Sensory System Agents|sensory system agents|mesh-ancestor
19940939|NCT01466348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19940940|NCT01466348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940941|NCT01466348|Antipyretics|antipyretics|mesh-ancestor
19940942|NCT01466348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19940943|NCT01466348|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19940944|NCT01466348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940945|NCT01466348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940946|NCT01466348|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19940947|NCT01466348|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19940948|NCT01466348|Purinergic Agents|purinergic agents|mesh-ancestor
19940949|NCT01466348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19940950|NCT01466361|Nicotine|nicotine|mesh-list
19940951|NCT01466361|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19940952|NCT01466361|Autonomic Agents|autonomic agents|mesh-ancestor
19940953|NCT01466361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19940954|NCT01466361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940955|NCT01466361|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19940956|NCT01466361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19940957|NCT01466361|Cholinergic Agents|cholinergic agents|mesh-ancestor
19940958|NCT01466361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19940959|NCT01466361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940960|NCT01466387|Vaccines|vaccines|mesh-list
19940961|NCT01466387|Immunologic Factors|immunologic factors|mesh-ancestor
19940962|NCT01466387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940963|NCT01466491|Lidocaine|lidocaine|mesh-list
19940964|NCT01466491|Anesthetics, Local|anesthetics, local|mesh-ancestor
19940965|NCT01466491|Anesthetics|anesthetics|mesh-ancestor
19940966|NCT01466491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19940967|NCT01466491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940968|NCT01466491|Sensory System Agents|sensory system agents|mesh-ancestor
19940969|NCT01466491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19940970|NCT01466491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19940971|NCT01466491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19940972|NCT01466491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19940973|NCT01466491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19940974|NCT01466491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940975|NCT01466595|Rifaximin|rifaximin|mesh-list
19940976|NCT01466595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19940977|NCT01466595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19940978|NCT01466595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19940979|NCT01466660|Gefitinib|gefitinib|mesh-list
19940980|NCT01466660|Afatinib|afatinib|mesh-list
19940981|NCT01466660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19940982|NCT01466660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19940983|NCT01466660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19940984|NCT01466660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19940985|NCT01466673|Moxifloxacin|moxifloxacin|mesh-list
19940986|NCT01466673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19940987|NCT01466673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19940988|NCT01466673|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19940989|NCT01466673|Desogestrel|desogestrel|mesh-list
19940990|NCT01466673|Norgestimate|norgestimate|mesh-list
19940991|NCT01466673|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19940992|NCT01466673|Estradiol|estradiol|mesh-list
19940993|NCT01466673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19940994|NCT01466673|Estrogens|estrogens|mesh-ancestor
19940995|NCT01466673|Hormones|hormones|mesh-ancestor
19940996|NCT01466673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19940997|NCT01466673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19940998|NCT01466673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19940999|NCT01466673|Contraceptive Agents|contraceptive agents|mesh-ancestor
19941000|NCT01466673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19941001|NCT01466673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19941002|NCT01466673|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19941003|NCT01466673|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19941004|NCT01466673|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19941005|NCT01466673|Progestins|progestins|mesh-ancestor
19941006|NCT01466673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19941007|NCT01466673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20266681|NCT00521521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266682|NCT00521612|Sevoflurane|sevoflurane|mesh-list
20266683|NCT00521612|Isoflurane|isoflurane|mesh-list
20266684|NCT00521612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20266685|NCT00521612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20266686|NCT00521612|Anesthetics, General|anesthetics, general|mesh-ancestor
20266687|NCT00521612|Anesthetics|anesthetics|mesh-ancestor
20266688|NCT00521612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20266689|NCT00521612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266690|NCT00521690|Insulin Detemir|insulin detemir|mesh-list
20266691|NCT00521690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20266692|NCT00521690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266693|NCT00521703|Lidocaine|lidocaine|mesh-list
20266694|NCT00521703|Anesthetics, Local|anesthetics, local|mesh-ancestor
20266695|NCT00521703|Anesthetics|anesthetics|mesh-ancestor
20266696|NCT00521703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20266697|NCT00521703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266698|NCT00521703|Sensory System Agents|sensory system agents|mesh-ancestor
20266699|NCT00521703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266700|NCT00521703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20266701|NCT00521703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20266702|NCT00521703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20266703|NCT00521703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20266704|NCT00521703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266705|NCT00521742|Pioglitazone|pioglitazone|mesh-list
20266706|NCT00521742|Glyburide|glyburide|mesh-list
20266707|NCT00521742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20266708|NCT00521742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266709|NCT00521781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20266710|NCT00521781|Leuprolide|leuprolide|mesh-list
20266711|NCT00521781|Bicalutamide|bicalutamide|mesh-list
20266712|NCT00521781|Androgen Antagonists|androgen antagonists|mesh-list
20266713|NCT00521781|Androgens|androgens|mesh-list
20266714|NCT00521781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20266715|NCT00521781|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20266716|NCT00521781|Fertility Agents|fertility agents|mesh-ancestor
20266717|NCT00521781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20266718|NCT00521781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266719|NCT00521781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20266720|NCT00521781|Hormone Antagonists|hormone antagonists|mesh-ancestor
20266721|NCT00521781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20266722|NCT00521781|Hormones|hormones|mesh-ancestor
20266723|NCT00521820|Pioglitazone|pioglitazone|mesh-list
20266724|NCT00521820|Glyburide|glyburide|mesh-list
20266725|NCT00521820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20266726|NCT00521820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266727|NCT00521859|Vidarabine|vidarabine|mesh-list
20266728|NCT00521859|Fludarabine|fludarabine|mesh-list
20266729|NCT00521859|Fludarabine phosphate|fludarabine phosphate|mesh-list
20266730|NCT00521859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20266731|NCT00521859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20266732|NCT00521859|Antimetabolites|antimetabolites|mesh-ancestor
20266733|NCT00521859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266734|NCT00521859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19941008|NCT01466673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19941009|NCT01466673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19941010|NCT01466673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941011|NCT01466673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941012|NCT01466673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941013|NCT01466673|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19941014|NCT01466764|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19941015|NCT01466764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19941016|NCT01466790|Ribavirin|ribavirin|mesh-list
19941017|NCT01466790|Sofosbuvir|sofosbuvir|mesh-list
19941018|NCT01466790|Simeprevir|simeprevir|mesh-list
19941019|NCT01466790|Antimetabolites|antimetabolites|mesh-ancestor
19941020|NCT01466790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941021|NCT01466790|Antiviral Agents|antiviral agents|mesh-ancestor
20266735|NCT00521859|Immunologic Factors|immunologic factors|mesh-ancestor
20266736|NCT00521859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941022|NCT01466790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941023|NCT01466790|Protease Inhibitors|protease inhibitors|mesh-ancestor
19941024|NCT01466790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941025|NCT01467076|Alprostadil|alprostadil|mesh-list
19941026|NCT01467076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19941027|NCT01467076|Vasodilator Agents|vasodilator agents|mesh-ancestor
19941028|NCT01467076|Urological Agents|urological agents|mesh-ancestor
19941029|NCT01467466|Acetylcysteine|acetylcysteine|mesh-list
19941030|NCT01467466|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19941031|NCT01467466|Antiviral Agents|antiviral agents|mesh-ancestor
19941032|NCT01467466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941033|NCT01467466|Expectorants|expectorants|mesh-ancestor
19941034|NCT01467466|Respiratory System Agents|respiratory system agents|mesh-ancestor
19941035|NCT01467466|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19941036|NCT01467466|Antioxidants|antioxidants|mesh-ancestor
19941037|NCT01467466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941038|NCT01467466|Protective Agents|protective agents|mesh-ancestor
19941039|NCT01467466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941040|NCT01467466|Antidotes|antidotes|mesh-ancestor
19941041|NCT01467479|Interferons|interferons|mesh-list
19941042|NCT01467479|Ribavirin|ribavirin|mesh-list
20266737|NCT00521859|Antiviral Agents|antiviral agents|mesh-ancestor
20266738|NCT00521859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20266739|NCT00521950|Mercaptopurine|mercaptopurine|mesh-list
20266740|NCT00521950|Azathioprine|azathioprine|mesh-list
20266741|NCT00521950|Antimetabolites|antimetabolites|mesh-ancestor
20266742|NCT00521950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266743|NCT00521950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20266744|NCT00521950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20266745|NCT00521950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20266746|NCT00521950|Immunologic Factors|immunologic factors|mesh-ancestor
20266747|NCT00521950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266748|NCT00521950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20266749|NCT00521950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542844|NCT01866059|Methamphetamine|methamphetamine|mesh-list
20542845|NCT01866059|Calcium|calcium|mesh-list
20542846|NCT01866059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20542847|NCT01866059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542848|NCT01866059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20542849|NCT01866059|Sympathomimetics|sympathomimetics|mesh-ancestor
20542850|NCT01866059|Autonomic Agents|autonomic agents|mesh-ancestor
20542851|NCT01866059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20542852|NCT01866059|Dopamine Agents|dopamine agents|mesh-ancestor
20542853|NCT01866059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20542854|NCT01866059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542855|NCT01866059|Adrenergic Agents|adrenergic agents|mesh-ancestor
20542856|NCT01866059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20542857|NCT01866059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20542858|NCT01866059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20542859|NCT01866059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20542860|NCT01866241|Misoprostol|misoprostol|mesh-list
20542861|NCT01866241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20542862|NCT01866241|Abortifacient Agents|abortifacient agents|mesh-ancestor
20542863|NCT01866241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20542864|NCT01866241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941043|NCT01467479|Interferon-alpha|interferon-alpha|mesh-list
19941044|NCT01467479|Interferon alpha-2|interferon alpha-2|mesh-list
19941045|NCT01467479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19941046|NCT01467479|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19941047|NCT01467479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941048|NCT01467479|Antiviral Agents|antiviral agents|mesh-ancestor
19941049|NCT01467479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941050|NCT01467479|Antimetabolites|antimetabolites|mesh-ancestor
19941051|NCT01467479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941052|NCT01467479|Immunologic Factors|immunologic factors|mesh-ancestor
19941053|NCT01467479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941054|NCT01467492|Interferons|interferons|mesh-list
19941055|NCT01467492|Ribavirin|ribavirin|mesh-list
19941056|NCT01467492|Interferon-alpha|interferon-alpha|mesh-list
19941057|NCT01467492|Interferon alpha-2|interferon alpha-2|mesh-list
19941058|NCT01467492|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19941059|NCT01467492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941060|NCT01467492|Antiviral Agents|antiviral agents|mesh-ancestor
19941061|NCT01467492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941062|NCT01467492|Antimetabolites|antimetabolites|mesh-ancestor
19941063|NCT01467492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941064|NCT01467492|Immunologic Factors|immunologic factors|mesh-ancestor
19941065|NCT01467492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941066|NCT01467505|Interferons|interferons|mesh-list
19941067|NCT01467505|Ribavirin|ribavirin|mesh-list
19941068|NCT01467505|Interferon-alpha|interferon-alpha|mesh-list
19941069|NCT01467505|Interferon alpha-2|interferon alpha-2|mesh-list
19941070|NCT01467505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19941071|NCT01467505|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19941072|NCT01467505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941073|NCT01467505|Antiviral Agents|antiviral agents|mesh-ancestor
19941074|NCT01467505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941075|NCT01467505|Antimetabolites|antimetabolites|mesh-ancestor
19941076|NCT01467505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941077|NCT01467505|Immunologic Factors|immunologic factors|mesh-ancestor
19941078|NCT01467505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973788|NCT01828554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19973789|NCT01828554|Antimetabolites|antimetabolites|mesh-ancestor
19973790|NCT01828554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973791|NCT01828554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973792|NCT01828593|Immunoglobulins|immunoglobulins|mesh-list
19973793|NCT01828593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19973794|NCT01828593|Antibodies|antibodies|mesh-list
19973795|NCT01828593|Immunologic Factors|immunologic factors|mesh-ancestor
19973796|NCT01828593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973797|NCT01829217|Sunitinib|sunitinib|mesh-list
19973798|NCT01829217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973799|NCT01829217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19973800|NCT01829217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19973801|NCT01829217|Growth Substances|growth substances|mesh-ancestor
19973802|NCT01829217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973803|NCT01829217|Growth Inhibitors|growth inhibitors|mesh-ancestor
19973804|NCT01829217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19973805|NCT01829217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973806|NCT01829217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973807|NCT01829243|Milnacipran|milnacipran|mesh-list
19973808|NCT01829243|Levomilnacipran|levomilnacipran|mesh-list
19973809|NCT01829243|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19973810|NCT01829243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19973811|NCT01829243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19973812|NCT01829243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973813|NCT01829243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19973814|NCT01829243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973815|NCT01829243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19973816|NCT01829243|Analgesics|analgesics|mesh-ancestor
19973817|NCT01829243|Sensory System Agents|sensory system agents|mesh-ancestor
19973818|NCT01829243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19973819|NCT01829243|Antidepressive Agents|antidepressive agents|mesh-ancestor
19973820|NCT01829243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19973821|NCT01829295|Mycophenolic Acid|mycophenolic acid|mesh-list
19973822|NCT01829295|Prednisone|prednisone|mesh-list
19973823|NCT01829295|Methotrexate|methotrexate|mesh-list
19973824|NCT01829295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19973825|NCT01829295|Glucocorticoids|glucocorticoids|mesh-ancestor
19973826|NCT01829295|Hormones|hormones|mesh-ancestor
19973827|NCT01829295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19973828|NCT01829295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973829|NCT01829295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19973830|NCT01829295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973831|NCT01829295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19973832|NCT01829295|Abortifacient Agents|abortifacient agents|mesh-ancestor
19973833|NCT01829295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19973834|NCT01829295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19973835|NCT01829295|Antimetabolites|antimetabolites|mesh-ancestor
19973836|NCT01829295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973837|NCT01829295|Dermatologic Agents|dermatologic agents|mesh-ancestor
19973838|NCT01829295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973839|NCT01829295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19973840|NCT01829295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19973841|NCT01829295|Immunologic Factors|immunologic factors|mesh-ancestor
19973842|NCT01829295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19973843|NCT01829295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19973844|NCT01829295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19973845|NCT01829295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19973846|NCT01829295|Antitubercular Agents|antitubercular agents|mesh-ancestor
19941079|NCT01467583|PENTA|penta|mesh-list
19941080|NCT01467583|Fondaparinux|fondaparinux|mesh-list
19941081|NCT01467583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19941082|NCT01467583|Antithrombins|antithrombins|mesh-ancestor
19941083|NCT01467583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19941084|NCT01467583|Protease Inhibitors|protease inhibitors|mesh-ancestor
19941085|NCT01467583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941086|NCT01467583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941087|NCT01467583|Anticoagulants|anticoagulants|mesh-ancestor
19941088|NCT01467583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19941089|NCT01467583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19941090|NCT01467661|Anagrelide|anagrelide|mesh-list
19941091|NCT01467661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19941092|NCT01467661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19941093|NCT01467661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941094|NCT01467661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19941095|NCT01467882|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19941096|NCT01467882|Luteolytic Agents|luteolytic agents|mesh-ancestor
19941097|NCT01467882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19941098|NCT01467882|Contraceptive Agents|contraceptive agents|mesh-ancestor
19941099|NCT01467882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19941100|NCT01467882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941101|NCT01467882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19941102|NCT01467882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19941103|NCT01467882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941104|NCT01467947|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
19941105|NCT01467947|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19941106|NCT01467947|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19941107|NCT01467947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19941108|NCT01467947|Immunologic Factors|immunologic factors|mesh-ancestor
19941109|NCT01467947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941110|NCT01467999|Guanfacine|guanfacine|mesh-list
19941111|NCT01467999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19941112|NCT01467999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19941113|NCT01467999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19941114|NCT01467999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19941115|NCT01467999|Adrenergic Agents|adrenergic agents|mesh-ancestor
19941116|NCT01467999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19941117|NCT01467999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941118|NCT01467999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941119|NCT01468012|Levodopa|levodopa|mesh-list
19941120|NCT01468012|Carbidopa|carbidopa|mesh-list
19941121|NCT01468012|Entacapone|entacapone|mesh-list
19941122|NCT01468012|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19941123|NCT01468012|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19941124|NCT01468012|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19941125|NCT01468012|Dopamine Agents|dopamine agents|mesh-ancestor
19941126|NCT01468012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19941127|NCT01468012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941128|NCT01468012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941129|NCT01468012|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19941130|NCT01468012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941131|NCT01468012|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19941132|NCT01468012|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19941133|NCT01468012|Immunologic Factors|immunologic factors|mesh-ancestor
19941134|NCT01468012|Dopamine Agonists|dopamine agonists|mesh-ancestor
19941135|NCT01468181|Dulaglutide|dulaglutide|mesh-list
19941136|NCT01468181|Biguanides|biguanides|mesh-list
19941137|NCT01468181|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
19941138|NCT01468181|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
19941139|NCT01468181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19941140|NCT01468181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941141|NCT01468181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941142|NCT01468181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941143|NCT01468207|Adalimumab|adalimumab|mesh-list
19941144|NCT01468207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19941145|NCT01468207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19941146|NCT01468233|Adalimumab|adalimumab|mesh-list
19941147|NCT01468233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19941148|NCT01468233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19941149|NCT01468311|Daclizumab|daclizumab|mesh-list
19941150|NCT01468311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19941151|NCT01468311|Immunologic Factors|immunologic factors|mesh-ancestor
19941152|NCT01468311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941153|NCT01468337|Interferons|interferons|mesh-list
19941154|NCT01468337|Interferon-gamma|interferon-gamma|mesh-list
19941155|NCT01468337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941156|NCT01468337|Antiviral Agents|antiviral agents|mesh-ancestor
19941157|NCT01468337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941158|NCT01468350|4-Aminopyridine|4-aminopyridine|mesh-list
19941159|NCT01468350|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19941160|NCT01468350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19941161|NCT01468350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941162|NCT01468532|Prednisone|prednisone|mesh-list
19941163|NCT01468532|Docetaxel|docetaxel|mesh-list
19941164|NCT01468532|Pasireotide|pasireotide|mesh-list
19941165|NCT01468532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941166|NCT01468532|Tubulin Modulators|tubulin modulators|mesh-ancestor
19941167|NCT01468532|Antimitotic Agents|antimitotic agents|mesh-ancestor
19941168|NCT01468532|Mitosis Modulators|mitosis modulators|mesh-ancestor
19941169|NCT01468532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941170|NCT01468532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19941171|NCT01468532|Glucocorticoids|glucocorticoids|mesh-ancestor
19941172|NCT01468532|Hormones|hormones|mesh-ancestor
19941173|NCT01468532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19941174|NCT01468532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941175|NCT01468532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19941176|NCT01468558|Ketoconazole|ketoconazole|mesh-list
19941177|NCT01468558|Antifungal Agents|antifungal agents|mesh-ancestor
19941178|NCT01468558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941179|NCT01468558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19941180|NCT01468558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19941181|NCT01468558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941182|NCT01468558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941183|NCT01468558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19941184|NCT01468558|Hormone Antagonists|hormone antagonists|mesh-ancestor
19941185|NCT01468558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19941186|NCT01468558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941187|NCT01468558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19941188|NCT01468584|Ribavirin|ribavirin|mesh-list
19941189|NCT01468584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19941190|NCT01468584|Antimetabolites|antimetabolites|mesh-ancestor
19941191|NCT01468584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941192|NCT01468584|Antiviral Agents|antiviral agents|mesh-ancestor
19941193|NCT01468584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941194|NCT01468818|Cyclophosphamide|cyclophosphamide|mesh-list
19941195|NCT01468818|Fludarabine|fludarabine|mesh-list
19941196|NCT01468818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19941197|NCT01468818|Immunologic Factors|immunologic factors|mesh-ancestor
19941198|NCT01468818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941199|NCT01468818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19941200|NCT01468818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19941201|NCT01468818|Alkylating Agents|alkylating agents|mesh-ancestor
19941202|NCT01468818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941203|NCT01468818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941204|NCT01468818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19941205|NCT01468844|Minocycline|minocycline|mesh-list
19941206|NCT01468844|Bevacizumab|bevacizumab|mesh-list
19941207|NCT01468844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19941208|NCT01468844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941209|NCT01468844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19941210|NCT01468844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19941211|NCT01468844|Growth Substances|growth substances|mesh-ancestor
19941212|NCT01468844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941213|NCT01468844|Growth Inhibitors|growth inhibitors|mesh-ancestor
19941214|NCT01468844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19941215|NCT01468844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941216|NCT01468909|Paclitaxel|paclitaxel|mesh-list
19941217|NCT01468909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19941218|NCT01468909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19941219|NCT01468909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941220|NCT01468909|Tubulin Modulators|tubulin modulators|mesh-ancestor
19941221|NCT01468909|Antimitotic Agents|antimitotic agents|mesh-ancestor
19941222|NCT01468909|Mitosis Modulators|mitosis modulators|mesh-ancestor
19941223|NCT01468909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941224|NCT01468987|Insulin|insulin|mesh-list
19941225|NCT01468987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19941226|NCT01468987|Insulin Glargine|insulin glargine|mesh-list
19941227|NCT01468987|Insulin Lispro|insulin lispro|mesh-list
19941228|NCT01468987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19732828|NCT04569916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732829|NCT04569916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19732830|NCT04569890|Hydroxychloroquine|hydroxychloroquine|mesh-list
19941229|NCT01468987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941230|NCT01469000|Pemetrexed|pemetrexed|mesh-list
19941231|NCT01469000|Gefitinib|gefitinib|mesh-list
19941232|NCT01469000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941233|NCT01469000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266750|NCT00521950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19941234|NCT01469000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941235|NCT01469000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19941236|NCT01469000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19941237|NCT01469000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19941238|NCT01469013|Methotrexate|methotrexate|mesh-list
20266751|NCT00521963|Infliximab|infliximab|mesh-list
20266752|NCT00521963|Dermatologic Agents|dermatologic agents|mesh-ancestor
20266753|NCT00521963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20266754|NCT00521963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20266755|NCT00522015|Rivastigmine|rivastigmine|mesh-list
20266756|NCT00522015|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20266757|NCT00522015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266758|NCT00522015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266759|NCT00522015|Cholinergic Agents|cholinergic agents|mesh-ancestor
20266760|NCT00522015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20266761|NCT00522015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266762|NCT00522015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20266763|NCT00522015|Protective Agents|protective agents|mesh-ancestor
20266764|NCT00522132|Artesunate|artesunate|mesh-list
20266765|NCT00522132|Antimalarials|antimalarials|mesh-ancestor
20266766|NCT00522132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20266767|NCT00522132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20266768|NCT00522132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20266769|NCT00522132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20266770|NCT00522132|Antiviral Agents|antiviral agents|mesh-ancestor
20266771|NCT00522132|Schistosomicides|schistosomicides|mesh-ancestor
20266772|NCT00522132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20266773|NCT00522132|Anthelmintics|anthelmintics|mesh-ancestor
20266774|NCT00522158|Atorvastatin|atorvastatin|mesh-list
20266775|NCT00522158|Simvastatin|simvastatin|mesh-list
20266776|NCT00522158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20266777|NCT00522158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20266778|NCT00522158|Antimetabolites|antimetabolites|mesh-ancestor
20266779|NCT00522158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266780|NCT00522158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20266781|NCT00522158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20266782|NCT00522158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266783|NCT00522184|Etanercept|etanercept|mesh-list
20266784|NCT00522184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20266785|NCT00522184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20266786|NCT00522184|Analgesics|analgesics|mesh-ancestor
20266787|NCT00522184|Sensory System Agents|sensory system agents|mesh-ancestor
20266788|NCT00522184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266789|NCT00522184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266790|NCT00522184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20266791|NCT00522184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20266792|NCT00522184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20266793|NCT00522184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20266794|NCT00522184|Immunologic Factors|immunologic factors|mesh-ancestor
20266795|NCT00522210|Insulin|insulin|mesh-list
20266796|NCT00522210|Isophane Insulin, Human|isophane insulin, human|mesh-list
20266797|NCT00522210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20266798|NCT00522210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732831|NCT04569890|Prednisone|prednisone|mesh-list
19732832|NCT04569890|Certolizumab Pegol|certolizumab pegol|mesh-list
19732833|NCT04569890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19732834|NCT04569890|Glucocorticoids|glucocorticoids|mesh-ancestor
19732835|NCT04569890|Hormones|hormones|mesh-ancestor
19732836|NCT04569890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19732837|NCT04569890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732838|NCT04569890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19732839|NCT04569890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732840|NCT04569890|Antimalarials|antimalarials|mesh-ancestor
19732841|NCT04569890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19732842|NCT04569890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19732843|NCT04569890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19732844|NCT04569890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941239|NCT01469013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19941240|NCT01469013|Abortifacient Agents|abortifacient agents|mesh-ancestor
19941241|NCT01469013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19941242|NCT01469013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941243|NCT01469013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19941244|NCT01469013|Antimetabolites|antimetabolites|mesh-ancestor
19732845|NCT04569890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732846|NCT04569890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19732847|NCT04569890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19941245|NCT01469013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941246|NCT01469013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941247|NCT01469013|Dermatologic Agents|dermatologic agents|mesh-ancestor
19941248|NCT01469013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941249|NCT01469013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19941250|NCT01469013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19941251|NCT01469013|Immunologic Factors|immunologic factors|mesh-ancestor
19941252|NCT01469013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19941253|NCT01469013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19941254|NCT01469052|Axitinib|axitinib|mesh-list
19941255|NCT01469052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941256|NCT01469052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19941257|NCT01469052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941258|NCT01469052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941259|NCT01469065|Nicotinic Acids|nicotinic acids|mesh-list
19941260|NCT01469065|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
19941261|NCT01469065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266799|NCT00522249|Interferons|interferons|mesh-list
20266800|NCT00522249|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20266801|NCT00522249|Interferon-alpha|interferon-alpha|mesh-list
20266802|NCT00522249|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
20266803|NCT00522249|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20266804|NCT00522249|Sunitinib|sunitinib|mesh-list
20266805|NCT00522249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20266806|NCT00522249|Antiviral Agents|antiviral agents|mesh-ancestor
20266807|NCT00522249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20266808|NCT00522249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20266809|NCT00522249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266810|NCT00522249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266811|NCT00522249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20266812|NCT00522249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20266813|NCT00522249|Growth Substances|growth substances|mesh-ancestor
20266814|NCT00522249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266815|NCT00522249|Growth Inhibitors|growth inhibitors|mesh-ancestor
20266816|NCT00522249|Immunologic Factors|immunologic factors|mesh-ancestor
20266817|NCT00522444|Magnesium Sulfate|magnesium sulfate|mesh-list
20266818|NCT00522444|Analgesics|analgesics|mesh-ancestor
20266819|NCT00522444|Sensory System Agents|sensory system agents|mesh-ancestor
20266820|NCT00522444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266821|NCT00522444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266822|NCT00522444|Anesthetics|anesthetics|mesh-ancestor
20266823|NCT00522444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20266824|NCT00522444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20266825|NCT00522444|Anticonvulsants|anticonvulsants|mesh-ancestor
20266826|NCT00522444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20266827|NCT00522444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20266828|NCT00522444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266829|NCT00522444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20266830|NCT00522444|Tocolytic Agents|tocolytic agents|mesh-ancestor
20266831|NCT00522444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20266832|NCT00522470|Rosiglitazone|rosiglitazone|mesh-list
20266833|NCT00522470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20266834|NCT00522470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266835|NCT00522509|Floxuridine|floxuridine|mesh-list
20266836|NCT00522509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20266837|NCT00522509|Antimetabolites|antimetabolites|mesh-ancestor
19973847|NCT01829295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20266838|NCT00522509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732848|NCT04569890|Immunologic Factors|immunologic factors|mesh-ancestor
19732849|NCT04569994|Insulin|insulin|mesh-list
19732850|NCT04569994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19732851|NCT04569994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732852|NCT04569513|Parathyroid Hormone|parathyroid hormone|mesh-list
19732853|NCT04569513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19941262|NCT01469065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941263|NCT01469065|Vitamin B Complex|vitamin b complex|mesh-ancestor
19941264|NCT01469065|Vitamins|vitamins|mesh-ancestor
19941265|NCT01469065|Micronutrients|micronutrients|mesh-ancestor
19941266|NCT01469065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941267|NCT01469221|Apaziquone|apaziquone|mesh-list
19941268|NCT01469221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941269|NCT01469234|Loratadine|loratadine|mesh-list
19941270|NCT01469234|Fexofenadine|fexofenadine|mesh-list
19941271|NCT01469234|Terfenadine|terfenadine|mesh-list
19941272|NCT01469234|Antipruritics|antipruritics|mesh-ancestor
19941273|NCT01469234|Dermatologic Agents|dermatologic agents|mesh-ancestor
19941274|NCT01469234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19941275|NCT01469234|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19941276|NCT01469234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19941277|NCT01469234|Histamine Antagonists|histamine antagonists|mesh-ancestor
19941278|NCT01469234|Histamine Agents|histamine agents|mesh-ancestor
19941279|NCT01469234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19941280|NCT01469234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941281|NCT01469234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941282|NCT01469364|Aztreonam|aztreonam|mesh-list
19941283|NCT01469364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19941284|NCT01469364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941285|NCT01469377|Cariprazine|cariprazine|mesh-list
19941286|NCT01469377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19941287|NCT01469377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19941288|NCT01469377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19941289|NCT01469377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941290|NCT01469377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19941291|NCT01469546|Axitinib|axitinib|mesh-list
19941292|NCT01469546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941293|NCT01469546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19941294|NCT01469546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941295|NCT01469546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941296|NCT01469585|Doxycycline|doxycycline|mesh-list
19941297|NCT01469585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19941298|NCT01469585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941299|NCT01469585|Antimalarials|antimalarials|mesh-ancestor
19941300|NCT01469585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19941301|NCT01469585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19941302|NCT01469637|Sulfamethoxazole|sulfamethoxazole|mesh-list
19941303|NCT01469637|Mesalamine|mesalamine|mesh-list
19941304|NCT01469637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941305|NCT01469637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19941306|NCT01469637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19941307|NCT01469637|Analgesics|analgesics|mesh-ancestor
19941308|NCT01469637|Sensory System Agents|sensory system agents|mesh-ancestor
19941309|NCT01469637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19941310|NCT01469637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941311|NCT01469637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19941312|NCT01469637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19941313|NCT01469767|Fluocinonide|fluocinonide|mesh-list
19941314|NCT01469767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19941315|NCT01469767|Glucocorticoids|glucocorticoids|mesh-ancestor
19941316|NCT01469767|Hormones|hormones|mesh-ancestor
19941317|NCT01469767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19941318|NCT01469767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941319|NCT01469767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19941320|NCT01469819|Lubiprostone|lubiprostone|mesh-list
19941321|NCT01469819|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19941322|NCT01469819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19941323|NCT01469819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941324|NCT01470001|Solifenacin Succinate|solifenacin succinate|mesh-list
19941325|NCT01470001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19941326|NCT01470001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19941327|NCT01470001|Cholinergic Agents|cholinergic agents|mesh-ancestor
19941328|NCT01470001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19941329|NCT01470001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941330|NCT01470001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941331|NCT01470001|Urological Agents|urological agents|mesh-ancestor
19941332|NCT01470027|Acetylcysteine|acetylcysteine|mesh-list
19941333|NCT01470027|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19941334|NCT01470027|Antiviral Agents|antiviral agents|mesh-ancestor
19941335|NCT01470027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941336|NCT01470027|Expectorants|expectorants|mesh-ancestor
19941337|NCT01470027|Respiratory System Agents|respiratory system agents|mesh-ancestor
19941338|NCT01470027|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19941339|NCT01470027|Antioxidants|antioxidants|mesh-ancestor
19941340|NCT01470027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941341|NCT01470027|Protective Agents|protective agents|mesh-ancestor
19941342|NCT01470027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941343|NCT01470027|Antidotes|antidotes|mesh-ancestor
19941344|NCT01470118|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19941345|NCT01470118|Dextrans|dextrans|mesh-list
19941346|NCT01470118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19941347|NCT01470118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19941348|NCT01470118|Lubricant Eye Drops|lubricant eye drops|mesh-list
19941349|NCT01470118|Alcaftadine|alcaftadine|mesh-list
19941350|NCT01470118|Anticoagulants|anticoagulants|mesh-ancestor
19941351|NCT01470118|Plasma Substitutes|plasma substitutes|mesh-ancestor
19941352|NCT01470118|Blood Substitutes|blood substitutes|mesh-ancestor
19941353|NCT01470118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19941354|NCT01470118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19941355|NCT01470118|Analgesics|analgesics|mesh-ancestor
19941356|NCT01470118|Sensory System Agents|sensory system agents|mesh-ancestor
19941357|NCT01470118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19941358|NCT01470118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941359|NCT01470118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19941360|NCT01470118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19941361|NCT01470118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19941362|NCT01470118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19941363|NCT01470118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19941364|NCT01470118|Histamine Antagonists|histamine antagonists|mesh-ancestor
19941365|NCT01470118|Histamine Agents|histamine agents|mesh-ancestor
19941366|NCT01470118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19941367|NCT01470118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941368|NCT01470144|Epoprostenol|epoprostenol|mesh-list
19941369|NCT01470144|Tezosentan|tezosentan|mesh-list
19941370|NCT01470144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19941371|NCT01470144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19941372|NCT01470144|Vasodilator Agents|vasodilator agents|mesh-ancestor
19941373|NCT01470170|Alfentanil|alfentanil|mesh-list
19941374|NCT01470170|Propofol|propofol|mesh-list
19941375|NCT01470170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19941376|NCT01470170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19941377|NCT01470170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941378|NCT01470170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19941379|NCT01470170|Anesthetics, General|anesthetics, general|mesh-ancestor
19941380|NCT01470170|Anesthetics|anesthetics|mesh-ancestor
19941381|NCT01470170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19941382|NCT01470170|Narcotics|narcotics|mesh-ancestor
19941383|NCT01470170|Analgesics|analgesics|mesh-ancestor
19450224|NCT03430466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941384|NCT01470170|Sensory System Agents|sensory system agents|mesh-ancestor
19941385|NCT01470170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19941386|NCT01470196|Dexamethasone|dexamethasone|mesh-list
19941387|NCT01470196|Rituximab|rituximab|mesh-list
19941388|NCT01470196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19941389|NCT01470196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941390|NCT01470196|Immunologic Factors|immunologic factors|mesh-ancestor
19941391|NCT01470196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941392|NCT01470196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19941393|NCT01470196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19941394|NCT01470196|Antiemetics|antiemetics|mesh-ancestor
19941395|NCT01470196|Autonomic Agents|autonomic agents|mesh-ancestor
19941396|NCT01470196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19941397|NCT01470196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19941398|NCT01470196|Glucocorticoids|glucocorticoids|mesh-ancestor
19941399|NCT01470196|Hormones|hormones|mesh-ancestor
19941400|NCT01470196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19941401|NCT01470196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19941402|NCT01470248|Arsenic Trioxide|arsenic trioxide|mesh-list
19941403|NCT01470248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941404|NCT01470417|Gemcitabine|gemcitabine|mesh-list
19941405|NCT01470417|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19941406|NCT01470417|Paclitaxel|paclitaxel|mesh-list
19941407|NCT01470417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19941408|NCT01470417|Antimetabolites|antimetabolites|mesh-ancestor
19941409|NCT01470417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941410|NCT01470417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941411|NCT01470417|Antiviral Agents|antiviral agents|mesh-ancestor
19941412|NCT01470417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941413|NCT01470417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941414|NCT01470417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19941415|NCT01470417|Immunologic Factors|immunologic factors|mesh-ancestor
19941416|NCT01470417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941417|NCT01470417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19941418|NCT01470417|Tubulin Modulators|tubulin modulators|mesh-ancestor
19941419|NCT01470417|Antimitotic Agents|antimitotic agents|mesh-ancestor
19941420|NCT01470417|Mitosis Modulators|mitosis modulators|mesh-ancestor
19941421|NCT01470469|Guanfacine|guanfacine|mesh-list
19941422|NCT01470469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19941423|NCT01470469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19941424|NCT01470469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19941425|NCT01470469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19941426|NCT01470469|Adrenergic Agents|adrenergic agents|mesh-ancestor
19941427|NCT01470469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19941428|NCT01470469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941429|NCT01470469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941430|NCT01470599|Tofacitinib|tofacitinib|mesh-list
19941431|NCT01470599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19941432|NCT01470599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941433|NCT01470599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941434|NCT01470612|Tofacitinib|tofacitinib|mesh-list
19941435|NCT01470612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19941436|NCT01470612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941437|NCT01470612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941438|NCT01470651|Modafinil|modafinil|mesh-list
19941439|NCT01470651|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19941440|NCT01470651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941441|NCT01470651|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19941442|NCT01470651|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19941443|NCT01470651|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19941444|NCT01470651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941445|NCT01470859|Levodopa|levodopa|mesh-list
19941446|NCT01470859|Carbidopa|carbidopa|mesh-list
19941447|NCT01470859|Pramipexole|pramipexole|mesh-list
19941448|NCT01470859|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19941449|NCT01470859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19941450|NCT01470859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19941451|NCT01470859|Dopamine Agents|dopamine agents|mesh-ancestor
19941452|NCT01470859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19941453|NCT01470859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941454|NCT01470859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941455|NCT01470859|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19941456|NCT01470859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941457|NCT01470859|Antioxidants|antioxidants|mesh-ancestor
19941458|NCT01470859|Protective Agents|protective agents|mesh-ancestor
19941459|NCT01470859|Dopamine Agonists|dopamine agonists|mesh-ancestor
19941460|NCT01470859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19941461|NCT01470859|Immunologic Factors|immunologic factors|mesh-ancestor
19941462|NCT01470989|Triamcinolone|triamcinolone|mesh-list
19941463|NCT01470989|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19941464|NCT01470989|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19941465|NCT01470989|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19941466|NCT01470989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19941467|NCT01470989|Glucocorticoids|glucocorticoids|mesh-ancestor
19941468|NCT01470989|Hormones|hormones|mesh-ancestor
19941469|NCT01470989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19941470|NCT01470989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941471|NCT01470989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19941472|NCT01470989|Immunologic Factors|immunologic factors|mesh-ancestor
19941473|NCT01470989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941474|NCT01470989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941475|NCT01471015|Darbepoetin alfa|darbepoetin alfa|mesh-list
19941476|NCT01471015|Hematinics|hematinics|mesh-ancestor
19941477|NCT01471054|Dexamethasone|dexamethasone|mesh-list
19941478|NCT01471054|Bevacizumab|bevacizumab|mesh-list
19941479|NCT01471054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19941480|NCT01471054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941481|NCT01471054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19941482|NCT01471054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19941483|NCT01471054|Growth Substances|growth substances|mesh-ancestor
19941484|NCT01471054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941485|NCT01471054|Growth Inhibitors|growth inhibitors|mesh-ancestor
19941486|NCT01471054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19941487|NCT01471054|Antiemetics|antiemetics|mesh-ancestor
19941488|NCT01471054|Autonomic Agents|autonomic agents|mesh-ancestor
19941489|NCT01471054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19941490|NCT01471054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19941491|NCT01471054|Glucocorticoids|glucocorticoids|mesh-ancestor
19941492|NCT01471054|Hormones|hormones|mesh-ancestor
19941493|NCT01471054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19941494|NCT01471054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19941495|NCT01471093|Rebamipide|rebamipide|mesh-list
19941496|NCT01471093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19941497|NCT01471093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19941498|NCT01471093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19941499|NCT01471093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19941500|NCT01471093|Antioxidants|antioxidants|mesh-ancestor
19941501|NCT01471093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941502|NCT01471093|Protective Agents|protective agents|mesh-ancestor
19941503|NCT01471093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941504|NCT01471093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941505|NCT01471171|Bromides|bromides|mesh-list
19941506|NCT01471171|Anticonvulsants|anticonvulsants|mesh-ancestor
19941507|NCT01471197|Pemetrexed|pemetrexed|mesh-list
19941508|NCT01471197|Ipilimumab|ipilimumab|mesh-list
19941509|NCT01471197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941510|NCT01471197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941511|NCT01471197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941512|NCT01471197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19941513|NCT01471197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19941514|NCT01471197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19941515|NCT01471197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19941516|NCT01471353|Capecitabine|capecitabine|mesh-list
19941517|NCT01471353|Sorafenib|sorafenib|mesh-list
19941518|NCT01471353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19941519|NCT01471353|Antimetabolites|antimetabolites|mesh-ancestor
19941520|NCT01471353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941521|NCT01471353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941522|NCT01471353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19941523|NCT01471353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941524|NCT01471379|Milnacipran|milnacipran|mesh-list
19941525|NCT01471379|Levomilnacipran|levomilnacipran|mesh-list
19941526|NCT01471379|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19941527|NCT01471379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19941528|NCT01471379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19941529|NCT01471379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941530|NCT01471379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19941531|NCT01471379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941532|NCT01471379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20266839|NCT00522509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20266840|NCT00522587|Remifentanil|remifentanil|mesh-list
20266841|NCT00522587|Sevoflurane|sevoflurane|mesh-list
20266842|NCT00522587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20266843|NCT00522587|Narcotics|narcotics|mesh-ancestor
20266844|NCT00522587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20266845|NCT00522587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266846|NCT00522587|Analgesics|analgesics|mesh-ancestor
20266847|NCT00522587|Sensory System Agents|sensory system agents|mesh-ancestor
20266848|NCT00522587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266849|NCT00522587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20266850|NCT00522587|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20266851|NCT00522587|Anesthetics, General|anesthetics, general|mesh-ancestor
20266852|NCT00522587|Anesthetics|anesthetics|mesh-ancestor
20266853|NCT00522639|Deoxyglucose|deoxyglucose|mesh-list
20266854|NCT00522639|Antimetabolites|antimetabolites|mesh-ancestor
20266855|NCT00522639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266856|NCT00522639|Antiviral Agents|antiviral agents|mesh-ancestor
20266857|NCT00522639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20266858|NCT00522665|Irinotecan|irinotecan|mesh-list
20266859|NCT00522665|Cetuximab|cetuximab|mesh-list
20266860|NCT00522665|Everolimus|everolimus|mesh-list
20266861|NCT00522665|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20266862|NCT00522665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20266863|NCT00522665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266864|NCT00522665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542865|NCT01866241|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20542866|NCT01866241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19941533|NCT01471379|Analgesics|analgesics|mesh-ancestor
20266865|NCT00522665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941534|NCT01471379|Sensory System Agents|sensory system agents|mesh-ancestor
19941535|NCT01471379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19941536|NCT01471379|Antidepressive Agents|antidepressive agents|mesh-ancestor
20266866|NCT00522665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20266867|NCT00522665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20266868|NCT00522665|Immunologic Factors|immunologic factors|mesh-ancestor
20266869|NCT00522665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266870|NCT00522743|Hormones|hormones|mesh-list
20266871|NCT00522743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20266872|NCT00522743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266873|NCT00522782|Budesonide|budesonide|mesh-list
20266874|NCT00522782|Nitric Oxide|nitric oxide|mesh-list
20266875|NCT00522782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20266876|NCT00522782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20266877|NCT00522782|Autonomic Agents|autonomic agents|mesh-ancestor
20266878|NCT00522782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266879|NCT00522782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266880|NCT00522782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20266881|NCT00522782|Respiratory System Agents|respiratory system agents|mesh-ancestor
20266882|NCT00522782|Glucocorticoids|glucocorticoids|mesh-ancestor
20266883|NCT00522782|Hormones|hormones|mesh-ancestor
20266884|NCT00522782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20542867|NCT01866241|Oxytocics|oxytocics|mesh-ancestor
20542868|NCT01866254|Morphine|morphine|mesh-list
20542869|NCT01866254|Hydromorphone|hydromorphone|mesh-list
20542870|NCT01866254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20542871|NCT01866254|Narcotics|narcotics|mesh-ancestor
20542872|NCT01866254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20542873|NCT01866254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542874|NCT01866254|Analgesics|analgesics|mesh-ancestor
20542875|NCT01866254|Sensory System Agents|sensory system agents|mesh-ancestor
20542876|NCT01866254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20542877|NCT01866267|Maraviroc|maraviroc|mesh-list
20542878|NCT01866267|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20542879|NCT01866267|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20542880|NCT01866267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542881|NCT01866267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20542882|NCT01866267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20542883|NCT01866267|Antiviral Agents|antiviral agents|mesh-ancestor
20542884|NCT01866267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20542885|NCT01866267|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20542886|NCT01866397|Cidofovir|cidofovir|mesh-list
20542887|NCT01866397|Antiviral Agents|antiviral agents|mesh-ancestor
20542888|NCT01866397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20542889|NCT01866397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542890|NCT01866397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542891|NCT01866488|Misoprostol|misoprostol|mesh-list
20542892|NCT01866488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20542893|NCT01866488|Abortifacient Agents|abortifacient agents|mesh-ancestor
20542894|NCT01866488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20542895|NCT01866488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542896|NCT01866488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20542897|NCT01866488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20542898|NCT01866488|Oxytocics|oxytocics|mesh-ancestor
20542899|NCT01866514|Lidocaine|lidocaine|mesh-list
20542900|NCT01866514|Anesthetics, Local|anesthetics, local|mesh-ancestor
20542901|NCT01866514|Anesthetics|anesthetics|mesh-ancestor
20542902|NCT01866514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20542903|NCT01866514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542904|NCT01866514|Sensory System Agents|sensory system agents|mesh-ancestor
20542905|NCT01866514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20542906|NCT01866514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20542907|NCT01866514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20542908|NCT01866514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20542909|NCT01866514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20542910|NCT01866514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542911|NCT01866553|Interferons|interferons|mesh-list
20542912|NCT01866553|Interferon-alpha|interferon-alpha|mesh-list
20542913|NCT01866553|Interferon alpha-2|interferon alpha-2|mesh-list
20542914|NCT01866553|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20542915|NCT01866553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941537|NCT01471379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19941538|NCT01471574|Interferons|interferons|mesh-list
19941539|NCT01471574|Ribavirin|ribavirin|mesh-list
19941540|NCT01471574|Interferon-alpha|interferon-alpha|mesh-list
20542916|NCT01866553|Antiviral Agents|antiviral agents|mesh-ancestor
19941541|NCT01471574|Interferon alpha-2|interferon alpha-2|mesh-list
19941542|NCT01471574|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19941543|NCT01471574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941544|NCT01471574|Antiviral Agents|antiviral agents|mesh-ancestor
19941545|NCT01471574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941546|NCT01471574|Antimetabolites|antimetabolites|mesh-ancestor
19941547|NCT01471574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941548|NCT01471574|Immunologic Factors|immunologic factors|mesh-ancestor
19941549|NCT01471574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941550|NCT01471639|Ketorolac|ketorolac|mesh-list
19941551|NCT01471639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19941552|NCT01471639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19941553|NCT01471639|Analgesics|analgesics|mesh-ancestor
19941554|NCT01471639|Sensory System Agents|sensory system agents|mesh-ancestor
19941555|NCT01471639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19941556|NCT01471639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941557|NCT01471639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19941558|NCT01471639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19941559|NCT01471639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19941560|NCT01471639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941561|NCT01471639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941562|NCT01471691|Ranibizumab|ranibizumab|mesh-list
19941563|NCT01471691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19941564|NCT01471691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19941565|NCT01471691|Growth Substances|growth substances|mesh-ancestor
19941566|NCT01471691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941567|NCT01471691|Growth Inhibitors|growth inhibitors|mesh-ancestor
20266885|NCT00522782|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20266886|NCT00522782|Antioxidants|antioxidants|mesh-ancestor
20266887|NCT00522782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266888|NCT00522782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20266889|NCT00522782|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20266890|NCT00522782|Vasodilator Agents|vasodilator agents|mesh-ancestor
20266891|NCT00522782|Gasotransmitters|gasotransmitters|mesh-ancestor
20266892|NCT00522782|Protective Agents|protective agents|mesh-ancestor
20266893|NCT00522821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20266894|NCT00522821|Immunoglobulins|immunoglobulins|mesh-list
20266895|NCT00522821|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20266896|NCT00522821|Antibodies|antibodies|mesh-list
20266897|NCT00522821|gamma-Globulins|gamma-globulins|mesh-list
20266898|NCT00522821|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20266899|NCT00522821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20266900|NCT00522821|Immunologic Factors|immunologic factors|mesh-ancestor
20266901|NCT00522821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266902|NCT00522886|Cetuximab|cetuximab|mesh-list
20266903|NCT00522886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20266904|NCT00522886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20266905|NCT00522938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20266906|NCT00522938|Tosedostat|tosedostat|mesh-list
20266907|NCT00522938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20266908|NCT00522938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20266909|NCT00522938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266910|NCT00522938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266911|NCT00523055|Lidocaine|lidocaine|mesh-list
20266912|NCT00523055|Anesthetics, Local|anesthetics, local|mesh-ancestor
20266913|NCT00523055|Anesthetics|anesthetics|mesh-ancestor
20266914|NCT00523055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20266915|NCT00523055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266916|NCT00523055|Sensory System Agents|sensory system agents|mesh-ancestor
20266917|NCT00523055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266918|NCT00523055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20266919|NCT00523055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20266920|NCT00523055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20266921|NCT00523055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20266922|NCT00523055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266923|NCT00523068|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20266924|NCT00523068|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20266925|NCT00523068|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20266926|NCT00523068|Cholinergic Agents|cholinergic agents|mesh-ancestor
20266927|NCT00523068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20266928|NCT00523068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266929|NCT00523068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941568|NCT01471691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941569|NCT01471782|Blinatumomab|blinatumomab|mesh-list
19941570|NCT01471782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941571|NCT01472185|Ranolazine|ranolazine|mesh-list
19941572|NCT01472185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19941573|NCT01472185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19941574|NCT01472185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941575|NCT01472380|Efavirenz|efavirenz|mesh-list
19941576|NCT01472380|Fenofibric acid|fenofibric acid|mesh-list
19941577|NCT01472380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19941578|NCT01472380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19941579|NCT01472380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941580|NCT01472380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941581|NCT01472380|Antiviral Agents|antiviral agents|mesh-ancestor
19941582|NCT01472380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941583|NCT01472380|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19941584|NCT01472380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19941585|NCT01472380|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19941586|NCT01472380|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19941587|NCT01472380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19941588|NCT01472380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19941589|NCT01472380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19941590|NCT01472380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19941591|NCT01472380|Antimetabolites|antimetabolites|mesh-ancestor
19941592|NCT01472380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19941593|NCT01472432|Vildagliptin|vildagliptin|mesh-list
19941594|NCT01472432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19941595|NCT01472432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941596|NCT01472432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19941597|NCT01472432|Protease Inhibitors|protease inhibitors|mesh-ancestor
19941598|NCT01472432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941599|NCT01472432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941600|NCT01472445|Vitamin D|vitamin d|mesh-list
19941601|NCT01472445|Cholecalciferol|cholecalciferol|mesh-list
19941602|NCT01472445|Vitamins|vitamins|mesh-ancestor
19941603|NCT01472445|Micronutrients|micronutrients|mesh-ancestor
19941604|NCT01472445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941605|NCT01472445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19941606|NCT01472445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19941607|NCT01472549|Ethanol|ethanol|mesh-list
19941608|NCT01472549|Chlorhexidine|chlorhexidine|mesh-list
19941609|NCT01472549|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19941610|NCT01472549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941611|NCT01472549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19941612|NCT01472549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941613|NCT01472549|Disinfectants|disinfectants|mesh-ancestor
19941614|NCT01472835|Fentanyl|fentanyl|mesh-list
19941615|NCT01472835|Midazolam|midazolam|mesh-list
19941616|NCT01472835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19941617|NCT01472835|Narcotics|narcotics|mesh-ancestor
19941618|NCT01472835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19941619|NCT01472835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941620|NCT01472835|Analgesics|analgesics|mesh-ancestor
19941621|NCT01472835|Sensory System Agents|sensory system agents|mesh-ancestor
19941622|NCT01472835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19941623|NCT01472835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19941624|NCT01472835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19941625|NCT01472835|Anesthetics, General|anesthetics, general|mesh-ancestor
19941626|NCT01472835|Anesthetics|anesthetics|mesh-ancestor
19941627|NCT01472835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19941628|NCT01472835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19941629|NCT01472835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19941630|NCT01472835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19941631|NCT01472835|GABA Modulators|gaba modulators|mesh-ancestor
19941632|NCT01472835|GABA Agents|gaba agents|mesh-ancestor
20542917|NCT01866553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20542918|NCT01866553|Immunologic Factors|immunologic factors|mesh-ancestor
20542919|NCT01866553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542920|NCT01866605|Midazolam|midazolam|mesh-list
20542921|NCT01866605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20542922|NCT01866605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20542923|NCT01866605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20542924|NCT01866605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542925|NCT01866605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20542926|NCT01866605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19941633|NCT01472835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19973848|NCT01829295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20542927|NCT01866605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20542928|NCT01866605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20542929|NCT01866605|Anesthetics, General|anesthetics, general|mesh-ancestor
20542930|NCT01866605|Anesthetics|anesthetics|mesh-ancestor
20542931|NCT01866605|GABA Modulators|gaba modulators|mesh-ancestor
20542932|NCT01866605|GABA Agents|gaba agents|mesh-ancestor
20542933|NCT01866605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20542934|NCT01866605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542935|NCT01866644|Acetylcysteine|acetylcysteine|mesh-list
20542936|NCT01866644|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20542937|NCT01866644|Antiviral Agents|antiviral agents|mesh-ancestor
20542938|NCT01866644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941634|NCT01472835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941635|NCT01472874|Trientine|trientine|mesh-list
19941636|NCT01472874|Chelating Agents|chelating agents|mesh-ancestor
19941637|NCT01472874|Sequestering Agents|sequestering agents|mesh-ancestor
19941638|NCT01472874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941639|NCT01472965|Ethanol|ethanol|mesh-list
19941640|NCT01472965|Heparin|heparin|mesh-list
19941641|NCT01472965|Calcium heparin|calcium heparin|mesh-list
19941642|NCT01472965|Anticoagulants|anticoagulants|mesh-ancestor
19941643|NCT01472965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19941644|NCT01472965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19941645|NCT01472965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941646|NCT01472965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19941647|NCT01472965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941648|NCT01472965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19941649|NCT01472965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941650|NCT01473368|Amoxicillin|amoxicillin|mesh-list
19941651|NCT01473368|Clavulanic Acid|clavulanic acid|mesh-list
19941652|NCT01473368|Clavulanic Acids|clavulanic acids|mesh-list
19941653|NCT01473368|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19941654|NCT01473368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19941655|NCT01473368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941656|NCT01473368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19941657|NCT01473368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941658|NCT01473368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941659|NCT01473381|Dexetimide|dexetimide|mesh-list
19941660|NCT01473381|Citalopram|citalopram|mesh-list
19941661|NCT01473381|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
19941662|NCT01473381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19941663|NCT01473381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19941664|NCT01473381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19941665|NCT01473381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941666|NCT01473381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19941667|NCT01473381|Serotonin Agents|serotonin agents|mesh-ancestor
19941668|NCT01473381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941669|NCT01473381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19941670|NCT01473381|Antidepressive Agents|antidepressive agents|mesh-ancestor
19941671|NCT01473381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19941672|NCT01473381|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19941673|NCT01473381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19941674|NCT01473381|Parasympatholytics|parasympatholytics|mesh-ancestor
19941675|NCT01473381|Autonomic Agents|autonomic agents|mesh-ancestor
19941676|NCT01473381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19941677|NCT01473381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19941678|NCT01473381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19941679|NCT01473381|Cholinergic Agents|cholinergic agents|mesh-ancestor
19941680|NCT01473381|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19941681|NCT01473381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19941682|NCT01473394|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
19941683|NCT01473394|Antidepressive Agents|antidepressive agents|mesh-ancestor
19941684|NCT01473394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19941685|NCT01473394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19941686|NCT01473394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19941687|NCT01473394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19941688|NCT01473394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941689|NCT01473394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19941690|NCT01473394|Serotonin Agents|serotonin agents|mesh-ancestor
19941691|NCT01473394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941692|NCT01473394|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19941693|NCT01473394|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20542939|NCT01866644|Expectorants|expectorants|mesh-ancestor
19941694|NCT01473407|Epoetin Alfa|epoetin alfa|mesh-list
19941695|NCT01473407|Hematinics|hematinics|mesh-ancestor
19941696|NCT01473420|Epoetin Alfa|epoetin alfa|mesh-list
19941697|NCT01473420|Hematinics|hematinics|mesh-ancestor
19941698|NCT01473524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
19941699|NCT01473524|Cathartics|cathartics|mesh-ancestor
19941700|NCT01473524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19941701|NCT01473563|Pemetrexed|pemetrexed|mesh-list
19941702|NCT01473563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941703|NCT01473563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941704|NCT01473563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941705|NCT01473563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19941706|NCT01473563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19941707|NCT01473589|Vitamin D|vitamin d|mesh-list
19941708|NCT01473589|Teriparatide|teriparatide|mesh-list
19941709|NCT01473589|Calcium|calcium|mesh-list
19941710|NCT01473589|Vitamins|vitamins|mesh-ancestor
19941711|NCT01473589|Micronutrients|micronutrients|mesh-ancestor
19941712|NCT01473589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941713|NCT01473589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19941714|NCT01473589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19973849|NCT01829399|Epinephrine|epinephrine|mesh-list
19973850|NCT01829399|Bupivacaine|bupivacaine|mesh-list
19973851|NCT01829399|Anesthetics, Local|anesthetics, local|mesh-ancestor
19973852|NCT01829399|Anesthetics|anesthetics|mesh-ancestor
19973853|NCT01829399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19973854|NCT01829399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973855|NCT01829399|Sensory System Agents|sensory system agents|mesh-ancestor
19973856|NCT01829399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19973857|NCT01829399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19973858|NCT01829399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19973859|NCT01829399|Adrenergic Agents|adrenergic agents|mesh-ancestor
19973860|NCT01829399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19973861|NCT01829399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973862|NCT01829399|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19973863|NCT01829399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19973864|NCT01829399|Autonomic Agents|autonomic agents|mesh-ancestor
19973865|NCT01829399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19973866|NCT01829399|Respiratory System Agents|respiratory system agents|mesh-ancestor
19973867|NCT01829399|Mydriatics|mydriatics|mesh-ancestor
19973868|NCT01829399|Sympathomimetics|sympathomimetics|mesh-ancestor
19973869|NCT01829399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19973870|NCT01829425|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19973871|NCT01829425|Oxybutynin|oxybutynin|mesh-list
19973872|NCT01829425|Cholinergic Antagonists|cholinergic antagonists|mesh-list
19973873|NCT01829425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19973874|NCT01829425|Cholinergic Agents|cholinergic agents|mesh-ancestor
19973875|NCT01829425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19973876|NCT01829425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973877|NCT01829425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973878|NCT01829425|Urological Agents|urological agents|mesh-ancestor
19973879|NCT01829425|Parasympatholytics|parasympatholytics|mesh-ancestor
19973880|NCT01829425|Autonomic Agents|autonomic agents|mesh-ancestor
19973881|NCT01829425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19973882|NCT01829503|Cytarabine|cytarabine|mesh-list
19973883|NCT01829503|Decitabine|decitabine|mesh-list
19973884|NCT01829503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19973885|NCT01829503|Antimetabolites|antimetabolites|mesh-ancestor
19973886|NCT01829503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973887|NCT01829503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973888|NCT01829503|Antiviral Agents|antiviral agents|mesh-ancestor
19973889|NCT01829503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19973890|NCT01829503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19973891|NCT01829503|Immunologic Factors|immunologic factors|mesh-ancestor
19973892|NCT01829503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973893|NCT01829503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973894|NCT01829516|Oxytocin|oxytocin|mesh-list
19973895|NCT01829516|Oxytocics|oxytocics|mesh-ancestor
19973896|NCT01829516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19973897|NCT01829516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973898|NCT01829919|Paroxetine|paroxetine|mesh-list
20266930|NCT00523068|Urological Agents|urological agents|mesh-ancestor
20266931|NCT00523120|Diclofenac|diclofenac|mesh-list
19973899|NCT01829919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19973900|NCT01829919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19973901|NCT01829919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19973902|NCT01829919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941715|NCT01473602|Vitamin D|vitamin d|mesh-list
19941716|NCT01473602|Teriparatide|teriparatide|mesh-list
19941717|NCT01473602|Calcium|calcium|mesh-list
19941718|NCT01473602|Vitamins|vitamins|mesh-ancestor
19941719|NCT01473602|Micronutrients|micronutrients|mesh-ancestor
19941720|NCT01473602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941721|NCT01473602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19941722|NCT01473602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19941723|NCT01473745|Daminozide|daminozide|mesh-list
19941724|NCT01473745|Plant Growth Regulators|plant growth regulators|mesh-ancestor
19941725|NCT01473745|Growth Substances|growth substances|mesh-ancestor
19941726|NCT01473745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941727|NCT01473836|Metronidazole|metronidazole|mesh-list
19941728|NCT01473836|Ceftriaxone|ceftriaxone|mesh-list
19941729|NCT01473836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941730|NCT01473836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19941731|NCT01473836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19941732|NCT01473836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19941733|NCT01473940|Gemcitabine|gemcitabine|mesh-list
19941734|NCT01473940|Ipilimumab|ipilimumab|mesh-list
19941735|NCT01473940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19941736|NCT01473940|Antibodies|antibodies|mesh-list
19941737|NCT01473940|Immunoglobulins|immunoglobulins|mesh-list
19941738|NCT01473940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19941739|NCT01473940|Immunologic Factors|immunologic factors|mesh-ancestor
19941740|NCT01473940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941741|NCT01473940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19941742|NCT01473940|Antimetabolites|antimetabolites|mesh-ancestor
19941743|NCT01473940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941744|NCT01473940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941745|NCT01473940|Antiviral Agents|antiviral agents|mesh-ancestor
19941746|NCT01473940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941747|NCT01473940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941748|NCT01473940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19941749|NCT01473940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19941750|NCT01473953|Liraglutide|liraglutide|mesh-list
19941751|NCT01473953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19941752|NCT01473953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941753|NCT01473953|Incretins|incretins|mesh-ancestor
19941754|NCT01473953|Hormones|hormones|mesh-ancestor
19941755|NCT01473953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19941756|NCT01474018|Bromocriptine|bromocriptine|mesh-list
19941757|NCT01474018|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19941758|NCT01474018|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19941759|NCT01474018|Hormone Antagonists|hormone antagonists|mesh-ancestor
19941760|NCT01474018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19941761|NCT01474018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941762|NCT01474018|Dopamine Agonists|dopamine agonists|mesh-ancestor
19941763|NCT01474018|Dopamine Agents|dopamine agents|mesh-ancestor
19941764|NCT01474018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19941765|NCT01474018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941766|NCT01474109|Macitentan|macitentan|mesh-list
19941767|NCT01474109|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19941768|NCT01474109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19941769|NCT01474109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941770|NCT01474109|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19941771|NCT01474122|Macitentan|macitentan|mesh-list
19941772|NCT01474122|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19941773|NCT01474122|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19941774|NCT01474122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941775|NCT01474122|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19941776|NCT01474200|Furosemide|furosemide|mesh-list
19941777|NCT01474200|Diuretics|diuretics|mesh-list
19941778|NCT01474200|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
19941779|NCT01474200|Natriuretic Agents|natriuretic agents|mesh-ancestor
19941780|NCT01474200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554129|NCT01933516|Rituximab|rituximab|mesh-list
19732854|NCT04569513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732855|NCT04569630|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19732856|NCT04569630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732857|NCT04569214|PAZ320|paz320|mesh-list
19732858|NCT04569214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19732859|NCT04569214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732860|NCT04569279|Warfarin|warfarin|mesh-list
19732861|NCT04569279|Rivaroxaban|rivaroxaban|mesh-list
19732862|NCT04569279|Anticoagulants|anticoagulants|mesh-ancestor
19941781|NCT01474200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19941782|NCT01474200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941783|NCT01474213|Dexmedetomidine|dexmedetomidine|mesh-list
19941784|NCT01474213|Remifentanil|remifentanil|mesh-list
19941785|NCT01474213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19941786|NCT01474213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19941787|NCT01474213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941788|NCT01474213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19941789|NCT01474213|Analgesics|analgesics|mesh-ancestor
19941790|NCT01474213|Sensory System Agents|sensory system agents|mesh-ancestor
19941791|NCT01474213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732863|NCT04569279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19732864|NCT04569279|Antithrombins|antithrombins|mesh-ancestor
19732865|NCT04569279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19732866|NCT04569279|Protease Inhibitors|protease inhibitors|mesh-ancestor
19732867|NCT04569279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732868|NCT04569279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941792|NCT01474213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19941793|NCT01474213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19941794|NCT01474213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19941795|NCT01474213|Adrenergic Agents|adrenergic agents|mesh-ancestor
19941796|NCT01474213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19941797|NCT01474213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941798|NCT01474213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19941799|NCT01474213|Narcotics|narcotics|mesh-ancestor
19941800|NCT01474239|Bevacizumab|bevacizumab|mesh-list
19941801|NCT01474239|Fotemustine|fotemustine|mesh-list
19941802|NCT01474239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19941803|NCT01474239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941804|NCT01474239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19941805|NCT01474239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19941806|NCT01474239|Growth Substances|growth substances|mesh-ancestor
19941807|NCT01474239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941808|NCT01474239|Growth Inhibitors|growth inhibitors|mesh-ancestor
19941809|NCT01474486|Ergocalciferols|ergocalciferols|mesh-list
19941810|NCT01474486|Thiamine|thiamine|mesh-list
19941811|NCT01474486|Micronutrients|micronutrients|mesh-list
19941812|NCT01474486|Trace Elements|trace elements|mesh-list
19941813|NCT01474486|Vitamins|vitamins|mesh-ancestor
19941814|NCT01474486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941815|NCT01474486|Vitamin B Complex|vitamin b complex|mesh-ancestor
19941816|NCT01474486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19941817|NCT01474486|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19941818|NCT01474512|Ixekizumab|ixekizumab|mesh-list
19941819|NCT01474512|Dermatologic Agents|dermatologic agents|mesh-ancestor
19941820|NCT01474538|Insulin|insulin|mesh-list
19941821|NCT01474538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19941822|NCT01474538|Insulin Aspart|insulin aspart|mesh-list
19941823|NCT01474538|Insulin Lispro|insulin lispro|mesh-list
19941824|NCT01474538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19941825|NCT01474538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941826|NCT01474551|Vemurafenib|vemurafenib|mesh-list
19941827|NCT01474551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941828|NCT01474551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19941829|NCT01474551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941830|NCT01474551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941831|NCT01474590|Doxycycline|doxycycline|mesh-list
19941832|NCT01474590|Isotretinoin|isotretinoin|mesh-list
19941833|NCT01474590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19941834|NCT01474590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941835|NCT01474590|Antimalarials|antimalarials|mesh-ancestor
19941836|NCT01474590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19941837|NCT01474590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19941838|NCT01474590|Dermatologic Agents|dermatologic agents|mesh-ancestor
19941839|NCT01474746|Sertraline|sertraline|mesh-list
19941840|NCT01474746|Antidepressive Agents|antidepressive agents|mesh-ancestor
19941841|NCT01474746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19941842|NCT01474746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19941843|NCT01474746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19941844|NCT01474746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19941845|NCT01474746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732869|NCT04568863|Melatonin|melatonin|mesh-list
19732870|NCT04568863|Antioxidants|antioxidants|mesh-ancestor
19732871|NCT04568863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732872|NCT04568863|Protective Agents|protective agents|mesh-ancestor
19732873|NCT04568863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941846|NCT01474746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19941847|NCT01474746|Serotonin Agents|serotonin agents|mesh-ancestor
19941848|NCT01474746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941849|NCT01474772|Pregabalin|pregabalin|mesh-list
19941850|NCT01474772|Analgesics|analgesics|mesh-ancestor
19941851|NCT01474772|Sensory System Agents|sensory system agents|mesh-ancestor
19941852|NCT01474772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19941853|NCT01474772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941854|NCT01474772|Anticonvulsants|anticonvulsants|mesh-ancestor
19941855|NCT01474772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19941856|NCT01474772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19941857|NCT01474772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941858|NCT01474772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19941859|NCT01474772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19941860|NCT01474772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19941861|NCT01474772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19941862|NCT01474772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19941863|NCT01474915|Promethazine|promethazine|mesh-list
19941864|NCT01474915|Diphenhydramine|diphenhydramine|mesh-list
19941865|NCT01474915|Dexamethasone|dexamethasone|mesh-list
19941866|NCT01474915|Ondansetron|ondansetron|mesh-list
19941867|NCT01474915|Aprepitant|aprepitant|mesh-list
19941868|NCT01474915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19941869|NCT01474915|Antiemetics|antiemetics|mesh-ancestor
19941870|NCT01474915|Autonomic Agents|autonomic agents|mesh-ancestor
19941871|NCT01474915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19941872|NCT01474915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941873|NCT01474915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19941874|NCT01474915|Glucocorticoids|glucocorticoids|mesh-ancestor
19941875|NCT01474915|Hormones|hormones|mesh-ancestor
19941876|NCT01474915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19941877|NCT01474915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19941878|NCT01474915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941879|NCT01474915|Antipruritics|antipruritics|mesh-ancestor
19941880|NCT01474915|Dermatologic Agents|dermatologic agents|mesh-ancestor
19941881|NCT01474915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19941882|NCT01474915|Serotonin Agents|serotonin agents|mesh-ancestor
19941883|NCT01474915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19941884|NCT01474915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941885|NCT01474915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19941886|NCT01474915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19941887|NCT01474915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19941888|NCT01474915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19941889|NCT01474915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19941890|NCT01474915|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19941891|NCT01474915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19941892|NCT01474915|Histamine Antagonists|histamine antagonists|mesh-ancestor
19941893|NCT01474915|Histamine Agents|histamine agents|mesh-ancestor
19941894|NCT01474915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19941895|NCT01474915|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19941896|NCT01474915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19941897|NCT01474915|Anesthetics, Local|anesthetics, local|mesh-ancestor
19941898|NCT01474915|Anesthetics|anesthetics|mesh-ancestor
19941899|NCT01474915|Sensory System Agents|sensory system agents|mesh-ancestor
19941900|NCT01474993|Sulforaphane|sulforaphane|mesh-list
19941901|NCT01474993|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19941902|NCT01474993|Protective Agents|protective agents|mesh-ancestor
19941903|NCT01474993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941904|NCT01474993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941905|NCT01475071|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
19941906|NCT01475071|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19941907|NCT01475071|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19941908|NCT01475071|Dermatologic Agents|dermatologic agents|mesh-ancestor
19941909|NCT01475253|Lidocaine|lidocaine|mesh-list
19941910|NCT01475253|Anesthetics, Local|anesthetics, local|mesh-ancestor
19941911|NCT01475253|Anesthetics|anesthetics|mesh-ancestor
19941912|NCT01475253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19941913|NCT01475253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941914|NCT01475253|Sensory System Agents|sensory system agents|mesh-ancestor
19941915|NCT01475253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19941916|NCT01475253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19941917|NCT01475253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19941918|NCT01475253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19941919|NCT01475253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19941920|NCT01475253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941921|NCT01475331|Ethanol|ethanol|mesh-list
19941922|NCT01475331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19941923|NCT01475331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941924|NCT01475331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19941925|NCT01475331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941926|NCT01475461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19941927|NCT01475461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19941928|NCT01475461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941929|NCT01475461|Incretins|incretins|mesh-ancestor
19941930|NCT01475461|Hormones|hormones|mesh-ancestor
19941931|NCT01475461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19941932|NCT01475461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19941933|NCT01475461|Protease Inhibitors|protease inhibitors|mesh-ancestor
19941934|NCT01475461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941935|NCT01475461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941936|NCT01475513|Moxifloxacin|moxifloxacin|mesh-list
19941937|NCT01475513|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19941938|NCT01475513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19941939|NCT01475513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19941940|NCT01475513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19941941|NCT01475513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19941942|NCT01475513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19941943|NCT01475513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19941944|NCT01475513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941945|NCT01475513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19941946|NCT01475513|Contraceptive Agents|contraceptive agents|mesh-ancestor
19941947|NCT01475513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19941948|NCT01475513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941949|NCT01475513|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19941950|NCT01475513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19941951|NCT01475513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19941952|NCT01475643|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19941953|NCT01475643|Prednisolone|prednisolone|mesh-list
19941954|NCT01475643|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19941955|NCT01475643|Methylprednisolone|methylprednisolone|mesh-list
19941956|NCT01475643|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19941957|NCT01475643|Prednisolone acetate|prednisolone acetate|mesh-list
19941958|NCT01475643|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19941959|NCT01475643|Prednisolone phosphate|prednisolone phosphate|mesh-list
19941960|NCT01475643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19941961|NCT01475643|Glucocorticoids|glucocorticoids|mesh-ancestor
19941962|NCT01475643|Hormones|hormones|mesh-ancestor
19941963|NCT01475643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19941964|NCT01475643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941965|NCT01475643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19941966|NCT01475643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19941967|NCT01475643|Antiemetics|antiemetics|mesh-ancestor
19941968|NCT01475643|Autonomic Agents|autonomic agents|mesh-ancestor
19941969|NCT01475643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19941970|NCT01475643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20266932|NCT00523120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20266933|NCT00523120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20266934|NCT00523120|Analgesics|analgesics|mesh-ancestor
20266935|NCT00523120|Sensory System Agents|sensory system agents|mesh-ancestor
20266936|NCT00523120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266937|NCT00523120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266938|NCT00523120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20266939|NCT00523120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20266940|NCT00523120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20266941|NCT00523120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266942|NCT00523120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287261|NCT05242874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287262|NCT05242874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20287263|NCT05242874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20287264|NCT05242874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20287265|NCT05242874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20287266|NCT05242874|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20287267|NCT05242874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20287268|NCT05242874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20287269|NCT05242874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20287270|NCT05242874|Serotonin Agents|serotonin agents|mesh-ancestor
20287271|NCT05242874|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19941971|NCT01475643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19941972|NCT01475643|Protective Agents|protective agents|mesh-ancestor
19941973|NCT01475643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19941974|NCT01475721|Fluticasone|fluticasone|mesh-list
19941975|NCT01475721|Xhance|xhance|mesh-list
19941976|NCT01475721|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19941977|NCT01475721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19941978|NCT01475721|Autonomic Agents|autonomic agents|mesh-ancestor
19941979|NCT01475721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19941980|NCT01475721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941981|NCT01475721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19941982|NCT01475721|Respiratory System Agents|respiratory system agents|mesh-ancestor
19941983|NCT01475721|Glucocorticoids|glucocorticoids|mesh-ancestor
19941984|NCT01475721|Hormones|hormones|mesh-ancestor
20266943|NCT00523133|Naltrexone|naltrexone|mesh-list
20266944|NCT00523133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20266945|NCT00523133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20266946|NCT00523133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266947|NCT00523133|Sensory System Agents|sensory system agents|mesh-ancestor
20266948|NCT00523133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266949|NCT00523159|Sargramostim|sargramostim|mesh-list
20266950|NCT00523159|Immunologic Factors|immunologic factors|mesh-ancestor
20266951|NCT00523159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266952|NCT00523185|Diazepam|diazepam|mesh-list
20266953|NCT00523185|Lorazepam|lorazepam|mesh-list
20266954|NCT00523185|Anticonvulsants|anticonvulsants|mesh-ancestor
20266955|NCT00523185|Antiemetics|antiemetics|mesh-ancestor
20266956|NCT00523185|Autonomic Agents|autonomic agents|mesh-ancestor
20266957|NCT00523185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266958|NCT00523185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266959|NCT00523185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20266960|NCT00523185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20266961|NCT00523185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20266962|NCT00523185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20266963|NCT00523185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20266964|NCT00523185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20266965|NCT00523185|GABA Modulators|gaba modulators|mesh-ancestor
20266966|NCT00523185|GABA Agents|gaba agents|mesh-ancestor
20266967|NCT00523185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20266968|NCT00523185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266969|NCT00523185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20266970|NCT00523185|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20266971|NCT00523185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20266972|NCT00523185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20266973|NCT00523185|Anesthetics, General|anesthetics, general|mesh-ancestor
20266974|NCT00523185|Anesthetics|anesthetics|mesh-ancestor
20266975|NCT00523263|Heparin|heparin|mesh-list
20266976|NCT00523263|Anticoagulants|anticoagulants|mesh-ancestor
20266977|NCT00523263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20266978|NCT00523263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20266979|NCT00523263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20266980|NCT00523289|Bupivacaine|bupivacaine|mesh-list
20266981|NCT00523289|Ropivacaine|ropivacaine|mesh-list
20266982|NCT00523289|Anesthetics, Local|anesthetics, local|mesh-ancestor
20266983|NCT00523289|Anesthetics|anesthetics|mesh-ancestor
20266984|NCT00523289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20266985|NCT00523289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20266986|NCT00523289|Sensory System Agents|sensory system agents|mesh-ancestor
20266987|NCT00523289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20266988|NCT00523354|Infliximab|infliximab|mesh-list
20266989|NCT00523354|Dermatologic Agents|dermatologic agents|mesh-ancestor
20266990|NCT00523354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20266991|NCT00523354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20266992|NCT00523380|Doxorubicin|doxorubicin|mesh-list
20266993|NCT00523380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20266994|NCT00523380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20266995|NCT00523380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20266996|NCT00523380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20266997|NCT00523380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20542940|NCT01866644|Respiratory System Agents|respiratory system agents|mesh-ancestor
20542941|NCT01866644|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19941985|NCT01475721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19941986|NCT01475721|Sympathomimetics|sympathomimetics|mesh-ancestor
19941987|NCT01475721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20266998|NCT00523380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20266999|NCT00523380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267000|NCT00523393|Insulin|insulin|mesh-list
20542942|NCT01866644|Antioxidants|antioxidants|mesh-ancestor
19941988|NCT01475721|Dermatologic Agents|dermatologic agents|mesh-ancestor
19941989|NCT01475721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19941990|NCT01475734|rGLP-1 protein|rglp-1 protein|mesh-list
19941991|NCT01475734|Incretins|incretins|mesh-ancestor
19941992|NCT01475734|Hormones|hormones|mesh-ancestor
19941993|NCT01475734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19941994|NCT01475734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19941995|NCT01475825|Mipomersen|mipomersen|mesh-list
19941996|NCT01475825|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19941997|NCT01475825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19941998|NCT01475825|Antimetabolites|antimetabolites|mesh-ancestor
20267001|NCT00523393|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20267002|NCT00523393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20267003|NCT00523393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267004|NCT00523406|Triamcinolone|triamcinolone|mesh-list
20267005|NCT00523406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20267006|NCT00523406|Glucocorticoids|glucocorticoids|mesh-ancestor
20267007|NCT00523406|Hormones|hormones|mesh-ancestor
20267008|NCT00523406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20267009|NCT00523406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267010|NCT00523432|Sirolimus|sirolimus|mesh-list
20267011|NCT00523432|Topotecan|topotecan|mesh-list
20267012|NCT00523432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20267013|NCT00523432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20267014|NCT00523432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542943|NCT01866644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542944|NCT01866644|Protective Agents|protective agents|mesh-ancestor
20542945|NCT01866644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542946|NCT01866644|Antidotes|antidotes|mesh-ancestor
20542947|NCT01866657|Phenylephrine|phenylephrine|mesh-list
20542948|NCT01866657|Dopamine|dopamine|mesh-list
20542949|NCT01866657|Ephedrine|ephedrine|mesh-list
20542950|NCT01866657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
20542951|NCT01866657|Propofol|propofol|mesh-list
20542952|NCT01866657|Sevoflurane|sevoflurane|mesh-list
20542953|NCT01866657|Anesthetics|anesthetics|mesh-ancestor
20542954|NCT01866657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20542955|NCT01866657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542956|NCT01866657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20542957|NCT01866657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20542958|NCT01866657|Anesthetics, General|anesthetics, general|mesh-ancestor
20542959|NCT01866657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20542960|NCT01866657|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20542961|NCT01866657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20542962|NCT01866657|Mydriatics|mydriatics|mesh-ancestor
20542963|NCT01866657|Autonomic Agents|autonomic agents|mesh-ancestor
20542964|NCT01866657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20542965|NCT01866657|Sympathomimetics|sympathomimetics|mesh-ancestor
20542966|NCT01866657|Nasal Decongestants|nasal decongestants|mesh-ancestor
20542967|NCT01866657|Respiratory System Agents|respiratory system agents|mesh-ancestor
20542968|NCT01866657|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20542969|NCT01866657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20542970|NCT01866657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20542971|NCT01866657|Adrenergic Agents|adrenergic agents|mesh-ancestor
20542972|NCT01866657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20542973|NCT01866657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542974|NCT01866657|Protective Agents|protective agents|mesh-ancestor
20542975|NCT01866657|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20542976|NCT01866657|Dopamine Agents|dopamine agents|mesh-ancestor
20542977|NCT01867138|Vancomycin|vancomycin|mesh-list
20542978|NCT01867138|Cefazolin|cefazolin|mesh-list
20542979|NCT01867138|Amikacin|amikacin|mesh-list
20542980|NCT01867138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20542981|NCT01867138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20554130|NCT01933516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20554131|NCT01933516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554132|NCT01933516|Immunologic Factors|immunologic factors|mesh-ancestor
20554133|NCT01933516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554134|NCT01933516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20554135|NCT01933542|Morphine|morphine|mesh-list
20554136|NCT01933542|Chlorzoxazone|chlorzoxazone|mesh-list
20554137|NCT01933542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20554138|NCT01933542|Narcotics|narcotics|mesh-ancestor
19973903|NCT01829919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20554139|NCT01933542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20554140|NCT01933542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554141|NCT01933542|Analgesics|analgesics|mesh-ancestor
20554142|NCT01933542|Sensory System Agents|sensory system agents|mesh-ancestor
19941999|NCT01475825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942000|NCT01475825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19942001|NCT01475838|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19942002|NCT01475838|Antiviral Agents|antiviral agents|mesh-ancestor
19942003|NCT01475838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19942004|NCT01475838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19942005|NCT01475838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19942006|NCT01475955|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19942007|NCT01475955|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19942008|NCT01475955|Dermatologic Agents|dermatologic agents|mesh-ancestor
20267015|NCT00523432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267016|NCT00523432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267017|NCT00523432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20267018|NCT00523432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20267019|NCT00523432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20267020|NCT00523432|Antifungal Agents|antifungal agents|mesh-ancestor
20267021|NCT00523432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20267022|NCT00523432|Immunologic Factors|immunologic factors|mesh-ancestor
20267023|NCT00523432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267024|NCT00523445|Varenicline|varenicline|mesh-list
20267025|NCT00523445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20267026|NCT00523445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20267027|NCT00523445|Cholinergic Agents|cholinergic agents|mesh-ancestor
20267028|NCT00523445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20267029|NCT00523445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267030|NCT00523445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267031|NCT00523458|Efavirenz|efavirenz|mesh-list
20267032|NCT00523458|Nevirapine|nevirapine|mesh-list
20267033|NCT00523458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20267034|NCT00523458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20267035|NCT00523458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267036|NCT00523458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267037|NCT00523458|Antiviral Agents|antiviral agents|mesh-ancestor
20267038|NCT00523458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20267039|NCT00523458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20267040|NCT00523458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20267041|NCT00523458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20267042|NCT00523458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20267043|NCT00523458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20267044|NCT00523458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20267045|NCT00523458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20267046|NCT00523458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20267047|NCT00523666|Galantamine|galantamine|mesh-list
20267048|NCT00523666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20267049|NCT00523666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267050|NCT00523666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267051|NCT00523666|Cholinergic Agents|cholinergic agents|mesh-ancestor
20267052|NCT00523666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20267053|NCT00523666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267054|NCT00523666|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20267055|NCT00523666|Autonomic Agents|autonomic agents|mesh-ancestor
20267056|NCT00523666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20267057|NCT00523666|Nootropic Agents|nootropic agents|mesh-ancestor
20267058|NCT00523692|Etanercept|etanercept|mesh-list
20267059|NCT00523692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20267060|NCT00523692|Methotrexate|methotrexate|mesh-list
20267061|NCT00523692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20267062|NCT00523692|Abortifacient Agents|abortifacient agents|mesh-ancestor
20267063|NCT00523692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20267064|NCT00523692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267065|NCT00523692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20267066|NCT00523692|Antimetabolites|antimetabolites|mesh-ancestor
20267067|NCT00523692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267068|NCT00523692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267069|NCT00523692|Dermatologic Agents|dermatologic agents|mesh-ancestor
20267070|NCT00523692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267071|NCT00523692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20267072|NCT00523692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20267073|NCT00523692|Immunologic Factors|immunologic factors|mesh-ancestor
20267074|NCT00523692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20267075|NCT00523692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20287272|NCT05242874|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19942009|NCT01476202|Nicotine|nicotine|mesh-list
19942010|NCT01476202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19942011|NCT01476202|Autonomic Agents|autonomic agents|mesh-ancestor
19942012|NCT01476202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942013|NCT01476202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942014|NCT01476202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19942015|NCT01476202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19942016|NCT01476202|Cholinergic Agents|cholinergic agents|mesh-ancestor
19942017|NCT01476202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19942018|NCT01476202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942019|NCT01476267|Dalcetrapib|dalcetrapib|mesh-list
19942020|NCT01476267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19942021|NCT01476267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19942022|NCT01476267|Antimetabolites|antimetabolites|mesh-ancestor
19942023|NCT01476267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942024|NCT01476267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19732874|NCT04568863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19732875|NCT04568772|Atovaquone|atovaquone|mesh-list
19732876|NCT04568772|Proguanil|proguanil|mesh-list
19942025|NCT01476345|Insulin Glargine|insulin glargine|mesh-list
19942026|NCT01476345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19942027|NCT01476345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942028|NCT01476449|Ranibizumab|ranibizumab|mesh-list
19942029|NCT01476449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19942030|NCT01476449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19942031|NCT01476449|Growth Substances|growth substances|mesh-ancestor
19942032|NCT01476449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942033|NCT01476449|Growth Inhibitors|growth inhibitors|mesh-ancestor
19942034|NCT01476449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942035|NCT01476475|Insulin|insulin|mesh-list
19942036|NCT01476475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19942037|NCT01476475|Metformin|metformin|mesh-list
19942038|NCT01476475|Insulin Glargine|insulin glargine|mesh-list
19942039|NCT01476475|Lixisenatide|lixisenatide|mesh-list
19942040|NCT01476475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19942041|NCT01476475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942042|NCT01476696|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19942043|NCT01476696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19942044|NCT01477320|Pantoprazole|pantoprazole|mesh-list
19942045|NCT01477320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19942046|NCT01477320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19942047|NCT01477320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19942048|NCT01477320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942049|NCT01477320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942050|NCT01477333|Treprostinil|treprostinil|mesh-list
19942051|NCT01477333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19942052|NCT01477463|Vitamin D|vitamin d|mesh-list
19942053|NCT01477463|Ergocalciferols|ergocalciferols|mesh-list
19942054|NCT01477463|Cholecalciferol|cholecalciferol|mesh-list
19942055|NCT01477463|Vitamins|vitamins|mesh-list
19942056|NCT01477463|Micronutrients|micronutrients|mesh-ancestor
19942057|NCT01477463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942058|NCT01477463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19942059|NCT01477463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19942060|NCT01477762|Dexamethasone|dexamethasone|mesh-list
19942061|NCT01477762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19942062|NCT01477762|Antiemetics|antiemetics|mesh-ancestor
19942063|NCT01477762|Autonomic Agents|autonomic agents|mesh-ancestor
19942064|NCT01477762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942065|NCT01477762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942066|NCT01477762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19942067|NCT01477762|Glucocorticoids|glucocorticoids|mesh-ancestor
19942068|NCT01477762|Hormones|hormones|mesh-ancestor
19942069|NCT01477762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19942070|NCT01477762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19942071|NCT01477762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267076|NCT00523692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19732877|NCT04568772|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
19732878|NCT04568772|Esomeprazole|esomeprazole|mesh-list
19732879|NCT04568772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19732880|NCT04568772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19732881|NCT04568772|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19732882|NCT04568772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732883|NCT04568772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942072|NCT01477853|Metformin|metformin|mesh-list
19942073|NCT01477853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19942074|NCT01477853|Glimepiride|glimepiride|mesh-list
19942075|NCT01477853|Atorvastatin|atorvastatin|mesh-list
19942076|NCT01477853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19942077|NCT01477853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942078|NCT01477853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19942079|NCT01477853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19942080|NCT01477853|Antimetabolites|antimetabolites|mesh-ancestor
19942081|NCT01477853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942082|NCT01477853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19942083|NCT01477853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19942084|NCT01477853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942085|NCT01477853|Incretins|incretins|mesh-ancestor
19942086|NCT01477853|Hormones|hormones|mesh-ancestor
20267077|NCT00523692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20267078|NCT00523692|Analgesics|analgesics|mesh-ancestor
20267079|NCT00523692|Sensory System Agents|sensory system agents|mesh-ancestor
20267080|NCT00523692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20267081|NCT00523692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20267082|NCT00523692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20267083|NCT00523757|Spironolactone|spironolactone|mesh-list
20267084|NCT00523757|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20267085|NCT00523757|Hormone Antagonists|hormone antagonists|mesh-ancestor
20267086|NCT00523757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20267087|NCT00523757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267088|NCT00523757|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20267089|NCT00523757|Diuretics|diuretics|mesh-ancestor
20267090|NCT00523757|Natriuretic Agents|natriuretic agents|mesh-ancestor
20267091|NCT00523887|Fentanyl|fentanyl|mesh-list
20267092|NCT00523887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20267093|NCT00523887|Narcotics|narcotics|mesh-ancestor
20267094|NCT00523887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20267095|NCT00523887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267096|NCT00523887|Analgesics|analgesics|mesh-ancestor
20267097|NCT00523887|Sensory System Agents|sensory system agents|mesh-ancestor
20267098|NCT00523887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20267099|NCT00523887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20267100|NCT00523887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20267101|NCT00523887|Anesthetics, General|anesthetics, general|mesh-ancestor
20267102|NCT00523887|Anesthetics|anesthetics|mesh-ancestor
20267103|NCT00523913|Rosiglitazone|rosiglitazone|mesh-list
20267104|NCT00523913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20267105|NCT00523913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267106|NCT00523926|Bedaquiline|bedaquiline|mesh-list
20267107|NCT00523926|Antitubercular Agents|antitubercular agents|mesh-ancestor
20267108|NCT00523926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20267109|NCT00523926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20267110|NCT00523952|Tacrolimus|tacrolimus|mesh-list
20267111|NCT00523952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20267112|NCT00523952|Immunologic Factors|immunologic factors|mesh-ancestor
20267113|NCT00523952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267114|NCT00523952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20267115|NCT00523952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267116|NCT00523952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267117|NCT00523965|Amphotericin B|amphotericin b|mesh-list
20267118|NCT00523965|Paromomycin|paromomycin|mesh-list
20267119|NCT00523965|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20267120|NCT00523965|Miltefosine|miltefosine|mesh-list
20267121|NCT00523965|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
20267122|NCT00523965|Deoxycholic Acid|deoxycholic acid|mesh-list
20267123|NCT00523965|Amebicides|amebicides|mesh-ancestor
20267124|NCT00523965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20267125|NCT00523965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20267126|NCT00523965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20267127|NCT00523965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20267128|NCT00523965|Antifungal Agents|antifungal agents|mesh-ancestor
20267129|NCT00523965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267130|NCT00523965|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20267131|NCT00523965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20267132|NCT00524004|Immunoglobulin G|immunoglobulin g|mesh-list
20267133|NCT00524004|Immunologic Factors|immunologic factors|mesh-ancestor
20267134|NCT00524004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267135|NCT00524069|Gemcitabine|gemcitabine|mesh-list
20267136|NCT00524069|Bevacizumab|bevacizumab|mesh-list
20267137|NCT00524069|Capecitabine|capecitabine|mesh-list
19973904|NCT01829919|Serotonin Agents|serotonin agents|mesh-ancestor
20267138|NCT00524069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19942087|NCT01477853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19942088|NCT01477853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19942089|NCT01477853|Protease Inhibitors|protease inhibitors|mesh-ancestor
19942090|NCT01477853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19942091|NCT01477853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19942092|NCT01477853|Immunologic Factors|immunologic factors|mesh-ancestor
19942093|NCT01477892|Remifentanil|remifentanil|mesh-list
19942094|NCT01477892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19942095|NCT01477892|Narcotics|narcotics|mesh-ancestor
19942096|NCT01477892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19942097|NCT01477892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942098|NCT01477892|Analgesics|analgesics|mesh-ancestor
19942099|NCT01477892|Sensory System Agents|sensory system agents|mesh-ancestor
19942100|NCT01477892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942101|NCT01478048|Dexamethasone|dexamethasone|mesh-list
19942102|NCT01478048|Dexamethasone acetate|dexamethasone acetate|mesh-list
19942103|NCT01478048|Bortezomib|bortezomib|mesh-list
19942104|NCT01478048|Elotuzumab|elotuzumab|mesh-list
19942105|NCT01478048|BB 1101|bb 1101|mesh-list
19942106|NCT01478048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19942107|NCT01478048|Antiemetics|antiemetics|mesh-ancestor
19942108|NCT01478048|Autonomic Agents|autonomic agents|mesh-ancestor
19942109|NCT01478048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942110|NCT01478048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942111|NCT01478048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19942112|NCT01478048|Glucocorticoids|glucocorticoids|mesh-ancestor
19942113|NCT01478048|Hormones|hormones|mesh-ancestor
19942114|NCT01478048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19942115|NCT01478048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19942116|NCT01478048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942117|NCT01478048|Protease Inhibitors|protease inhibitors|mesh-ancestor
19942118|NCT01478048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942119|NCT01478048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942120|NCT01478256|Erythromycin|erythromycin|mesh-list
19942121|NCT01478256|Erythromycin Estolate|erythromycin estolate|mesh-list
19942122|NCT01478256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19942123|NCT01478256|Erythromycin stearate|erythromycin stearate|mesh-list
19942124|NCT01478256|Besifloxacin|besifloxacin|mesh-list
19942125|NCT01478256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19942126|NCT01478256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19942127|NCT01478256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19942128|NCT01478256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19942129|NCT01478256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942130|NCT01478256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942131|NCT01478256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19942132|NCT01478256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19942133|NCT01478256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942134|NCT01478321|Bevacizumab|bevacizumab|mesh-list
19942135|NCT01478321|Temozolomide|temozolomide|mesh-list
19942136|NCT01478321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19942137|NCT01478321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942138|NCT01478321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19942139|NCT01478321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19942140|NCT01478321|Growth Substances|growth substances|mesh-ancestor
19942141|NCT01478321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942142|NCT01478321|Growth Inhibitors|growth inhibitors|mesh-ancestor
19942143|NCT01478321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19942144|NCT01478321|Alkylating Agents|alkylating agents|mesh-ancestor
19942145|NCT01478321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942146|NCT01478581|Dexamethasone|dexamethasone|mesh-list
19942147|NCT01478581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19942148|NCT01478581|Antiemetics|antiemetics|mesh-ancestor
19942149|NCT01478581|Autonomic Agents|autonomic agents|mesh-ancestor
19942150|NCT01478581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942151|NCT01478581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942152|NCT01478581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19942153|NCT01478581|Glucocorticoids|glucocorticoids|mesh-ancestor
19942154|NCT01478581|Hormones|hormones|mesh-ancestor
19942155|NCT01478581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19942156|NCT01478581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19942157|NCT01478581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942158|NCT01478594|Bevacizumab|bevacizumab|mesh-list
19942159|NCT01478594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19942160|NCT01478594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942161|NCT01478594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19942162|NCT01478594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19942163|NCT01478594|Growth Substances|growth substances|mesh-ancestor
19942164|NCT01478594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942165|NCT01478594|Growth Inhibitors|growth inhibitors|mesh-ancestor
19942166|NCT01478828|Lovastatin|lovastatin|mesh-list
19942167|NCT01478828|L 647318|l 647318|mesh-list
19942168|NCT01478828|Dihydromevinolin|dihydromevinolin|mesh-list
19942169|NCT01478828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19942170|NCT01478828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19942171|NCT01478828|Antimetabolites|antimetabolites|mesh-ancestor
19942172|NCT01478828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942173|NCT01478828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19942174|NCT01478828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19942175|NCT01478828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942176|NCT01478971|Epoetin Alfa|epoetin alfa|mesh-list
19942177|NCT01478971|Hematinics|hematinics|mesh-ancestor
19942178|NCT01479127|Silicon|silicon|mesh-list
19942179|NCT01479127|Levodopa|levodopa|mesh-list
19942180|NCT01479127|Carbidopa|carbidopa|mesh-list
19942181|NCT01479127|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19942182|NCT01479127|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19942183|NCT01479127|Dopamine Agents|dopamine agents|mesh-ancestor
19942184|NCT01479127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19942185|NCT01479127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942186|NCT01479127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942187|NCT01479127|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20267139|NCT00524069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267140|NCT00524069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20267141|NCT00524069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20267142|NCT00524069|Growth Substances|growth substances|mesh-ancestor
20267143|NCT00524069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267144|NCT00524069|Growth Inhibitors|growth inhibitors|mesh-ancestor
20267145|NCT00524069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20267146|NCT00524069|Antimetabolites|antimetabolites|mesh-ancestor
20542982|NCT01867255|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20542983|NCT01867255|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20542984|NCT01867255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20542985|NCT01867255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20542986|NCT01867255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542987|NCT01867255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20542988|NCT01867255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20542989|NCT01867255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20542990|NCT01867255|Antidepressive Agents|antidepressive agents|mesh-ancestor
20542991|NCT01867255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20542992|NCT01867268|Acetazolamide|acetazolamide|mesh-list
19942188|NCT01479127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942189|NCT01479127|Trace Elements|trace elements|mesh-ancestor
19942190|NCT01479127|Micronutrients|micronutrients|mesh-ancestor
19942191|NCT01479270|Epinephrine|epinephrine|mesh-list
19942192|NCT01479270|Ropivacaine|ropivacaine|mesh-list
19942193|NCT01479270|Anesthetics, Local|anesthetics, local|mesh-ancestor
19942194|NCT01479270|Anesthetics|anesthetics|mesh-ancestor
19942195|NCT01479270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19942196|NCT01479270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942197|NCT01479270|Sensory System Agents|sensory system agents|mesh-ancestor
19942198|NCT01479270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942199|NCT01479270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20267147|NCT00524069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267148|NCT00524069|Antiviral Agents|antiviral agents|mesh-ancestor
20267149|NCT00524069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20267150|NCT00524069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267151|NCT00524069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20267152|NCT00524069|Immunologic Factors|immunologic factors|mesh-ancestor
20267153|NCT00524095|Fluticasone|fluticasone|mesh-list
20267154|NCT00524095|Xhance|xhance|mesh-list
20267155|NCT00524095|Azithromycin|azithromycin|mesh-list
20267156|NCT00524095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20267157|NCT00524095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20267158|NCT00524095|Autonomic Agents|autonomic agents|mesh-ancestor
20267159|NCT00524095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20267160|NCT00524095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267161|NCT00524095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20267162|NCT00524095|Respiratory System Agents|respiratory system agents|mesh-ancestor
20267163|NCT00524095|Dermatologic Agents|dermatologic agents|mesh-ancestor
20267164|NCT00524095|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20267165|NCT00524095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20267166|NCT00524095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20267167|NCT00524160|Fentanyl|fentanyl|mesh-list
20267168|NCT00524160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20267169|NCT00524160|Narcotics|narcotics|mesh-ancestor
20267170|NCT00524160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19942200|NCT01479270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19942201|NCT01479270|Adrenergic Agents|adrenergic agents|mesh-ancestor
19942202|NCT01479270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19942203|NCT01479270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942204|NCT01479270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19942205|NCT01479270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19942206|NCT01479270|Autonomic Agents|autonomic agents|mesh-ancestor
19942207|NCT01479270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19942208|NCT01479270|Respiratory System Agents|respiratory system agents|mesh-ancestor
20267171|NCT00524160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267172|NCT00524160|Analgesics|analgesics|mesh-ancestor
20267173|NCT00524160|Sensory System Agents|sensory system agents|mesh-ancestor
20267174|NCT00524160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20267175|NCT00524160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20267176|NCT00524160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20267177|NCT00524160|Anesthetics, General|anesthetics, general|mesh-ancestor
20267178|NCT00524160|Anesthetics|anesthetics|mesh-ancestor
20267179|NCT00524186|Leucovorin|leucovorin|mesh-list
20267180|NCT00524186|Fluorouracil|fluorouracil|mesh-list
20267181|NCT00524186|Irinotecan|irinotecan|mesh-list
20267182|NCT00524186|Sunitinib|sunitinib|mesh-list
20267183|NCT00524186|Calcium|calcium|mesh-list
20267184|NCT00524186|Levoleucovorin|levoleucovorin|mesh-list
20267185|NCT00524186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20267186|NCT00524186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267187|NCT00524186|Antimetabolites|antimetabolites|mesh-ancestor
20267188|NCT00524186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267189|NCT00524186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20267190|NCT00524186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267191|NCT00524186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20267192|NCT00524186|Immunologic Factors|immunologic factors|mesh-ancestor
20267193|NCT00524186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20267194|NCT00524186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20267195|NCT00524186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267196|NCT00524186|Antidotes|antidotes|mesh-ancestor
20267197|NCT00524186|Protective Agents|protective agents|mesh-ancestor
20267198|NCT00524186|Vitamin B Complex|vitamin b complex|mesh-ancestor
20267199|NCT00524186|Vitamins|vitamins|mesh-ancestor
20267200|NCT00524186|Micronutrients|micronutrients|mesh-ancestor
20542993|NCT01867268|Anticonvulsants|anticonvulsants|mesh-ancestor
19942209|NCT01479270|Mydriatics|mydriatics|mesh-ancestor
20267201|NCT00524186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20267202|NCT00524186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20267203|NCT00524186|Growth Substances|growth substances|mesh-ancestor
19942210|NCT01479270|Sympathomimetics|sympathomimetics|mesh-ancestor
19942211|NCT01479270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19942212|NCT01479348|Tetrahydrouridine|tetrahydrouridine|mesh-list
19942213|NCT01479348|Antimetabolites|antimetabolites|mesh-ancestor
19942214|NCT01479348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942215|NCT01479374|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19942216|NCT01479374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19942217|NCT01479374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19942218|NCT01479374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19942219|NCT01479374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19942220|NCT01479374|Analgesics|analgesics|mesh-ancestor
19942221|NCT01479374|Sensory System Agents|sensory system agents|mesh-ancestor
20267204|NCT00524186|Growth Inhibitors|growth inhibitors|mesh-ancestor
20267205|NCT00524186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20267206|NCT00524199|Mesna|mesna|mesh-list
20267207|NCT00524199|Protective Agents|protective agents|mesh-ancestor
20267208|NCT00524199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267209|NCT00524251|Esomeprazole|esomeprazole|mesh-list
20267210|NCT00524251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20267211|NCT00524251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20267212|NCT00524251|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20267213|NCT00524251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267214|NCT00524251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267215|NCT00524381|Etanercept|etanercept|mesh-list
20267216|NCT00524381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20542994|NCT01867268|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19942222|NCT01479374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20267217|NCT00524381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20542995|NCT01867268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20542996|NCT01867268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20542997|NCT01867268|Diuretics|diuretics|mesh-ancestor
20542998|NCT01867268|Natriuretic Agents|natriuretic agents|mesh-ancestor
20542999|NCT01867268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543000|NCT01867281|Aspirin|aspirin|mesh-list
20543001|NCT01867281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20543002|NCT01867281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20543003|NCT01867281|Analgesics|analgesics|mesh-ancestor
20543004|NCT01867281|Sensory System Agents|sensory system agents|mesh-ancestor
20543005|NCT01867281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543006|NCT01867281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543007|NCT01867281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20543008|NCT01867281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20543009|NCT01867281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20543010|NCT01867281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20543011|NCT01867281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543012|NCT01867281|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20543013|NCT01867281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20543014|NCT01867281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543015|NCT01867281|Antipyretics|antipyretics|mesh-ancestor
20543016|NCT01867463|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20543017|NCT01867463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20543018|NCT01867463|Immunologic Factors|immunologic factors|mesh-ancestor
20543019|NCT01867463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543020|NCT01867463|Antacids|antacids|mesh-ancestor
20543021|NCT01867463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543022|NCT01867463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20543023|NCT01867502|Metformin|metformin|mesh-list
20543024|NCT01867502|Vildagliptin|vildagliptin|mesh-list
20543025|NCT01867502|Glyburide|glyburide|mesh-list
20543026|NCT01867502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20543027|NCT01867502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543028|NCT01867502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20543029|NCT01867502|Protease Inhibitors|protease inhibitors|mesh-ancestor
20543030|NCT01867502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543031|NCT01867502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543032|NCT01867593|Carbon-11 methionine|carbon-11 methionine|mesh-list
20543033|NCT01867593|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20543034|NCT01867593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543035|NCT01867645|Immunoglobulins|immunoglobulins|mesh-list
20543036|NCT01867645|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20543037|NCT01867645|Antibodies|antibodies|mesh-list
20543038|NCT01867645|gamma-Globulins|gamma-globulins|mesh-list
20543039|NCT01867645|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19942223|NCT01479374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942224|NCT01479374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19942225|NCT01479374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19942226|NCT01479374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19942227|NCT01479374|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19942228|NCT01479374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19942229|NCT01479374|Histamine Antagonists|histamine antagonists|mesh-ancestor
19942230|NCT01479374|Histamine Agents|histamine agents|mesh-ancestor
19942231|NCT01479374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19942232|NCT01479374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942233|NCT01479439|Losartan|losartan|mesh-list
19942234|NCT01479439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19942235|NCT01479439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19942236|NCT01479439|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19942237|NCT01479439|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19942238|NCT01479439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942239|NCT01479465|Leucovorin|leucovorin|mesh-list
19942240|NCT01479465|Fluorouracil|fluorouracil|mesh-list
19942241|NCT01479465|Irinotecan|irinotecan|mesh-list
19942242|NCT01479465|Antimetabolites|antimetabolites|mesh-ancestor
19942243|NCT01479465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942244|NCT01479465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19942245|NCT01479465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942246|NCT01479465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19942247|NCT01479465|Immunologic Factors|immunologic factors|mesh-ancestor
19942248|NCT01479465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942249|NCT01479465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19942250|NCT01479465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19942251|NCT01479465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942252|NCT01479465|Antidotes|antidotes|mesh-ancestor
19942253|NCT01479465|Protective Agents|protective agents|mesh-ancestor
19942254|NCT01479465|Vitamin B Complex|vitamin b complex|mesh-ancestor
19942255|NCT01479465|Vitamins|vitamins|mesh-ancestor
19942256|NCT01479465|Micronutrients|micronutrients|mesh-ancestor
19942257|NCT01479517|Tetracaine|tetracaine|mesh-list
19942258|NCT01479517|Anesthetics, Local|anesthetics, local|mesh-ancestor
19942259|NCT01479517|Anesthetics|anesthetics|mesh-ancestor
19942260|NCT01479517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19942261|NCT01479517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942262|NCT01479517|Sensory System Agents|sensory system agents|mesh-ancestor
19942263|NCT01479517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942264|NCT01479530|Rasagiline|rasagiline|mesh-list
19942265|NCT01479530|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19942266|NCT01479530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942267|NCT01479530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942268|NCT01479530|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19942269|NCT01479530|Protective Agents|protective agents|mesh-ancestor
19942270|NCT01479530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942271|NCT01479621|Fluticasone|fluticasone|mesh-list
19942272|NCT01479621|Xhance|xhance|mesh-list
19942273|NCT01479621|Albuterol|albuterol|mesh-list
19942274|NCT01479621|Adrenergic Agonists|adrenergic agonists|mesh-list
19942275|NCT01479621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19942276|NCT01479621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19942277|NCT01479621|Autonomic Agents|autonomic agents|mesh-ancestor
19942278|NCT01479621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942279|NCT01479621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942280|NCT01479621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19942281|NCT01479621|Respiratory System Agents|respiratory system agents|mesh-ancestor
19942282|NCT01479621|Dermatologic Agents|dermatologic agents|mesh-ancestor
19942283|NCT01479621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19942284|NCT01479621|Tocolytic Agents|tocolytic agents|mesh-ancestor
19942285|NCT01479621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19942286|NCT01479621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19942287|NCT01479621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19942288|NCT01479621|Adrenergic Agents|adrenergic agents|mesh-ancestor
19942289|NCT01479621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19942290|NCT01479621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942291|NCT01479764|Glycopyrrolate|glycopyrrolate|mesh-list
19942292|NCT01479764|Neostigmine|neostigmine|mesh-list
19942293|NCT01479764|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19942294|NCT01479764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942295|NCT01479764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942296|NCT01479764|Cholinergic Agents|cholinergic agents|mesh-ancestor
19942297|NCT01479764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19942298|NCT01479764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942299|NCT01479764|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19942300|NCT01479764|Autonomic Agents|autonomic agents|mesh-ancestor
19942301|NCT01479764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942302|NCT01479764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19942303|NCT01479764|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19942304|NCT01479764|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19942305|NCT01479868|Interferons|interferons|mesh-list
19942306|NCT01479868|Ribavirin|ribavirin|mesh-list
19942307|NCT01479868|Interferon-alpha|interferon-alpha|mesh-list
19942308|NCT01479868|Interferon alpha-2|interferon alpha-2|mesh-list
19942309|NCT01479868|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19942310|NCT01479868|Simeprevir|simeprevir|mesh-list
19942311|NCT01479868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942312|NCT01479868|Antiviral Agents|antiviral agents|mesh-ancestor
19942313|NCT01479868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19942314|NCT01479868|Antimetabolites|antimetabolites|mesh-ancestor
19942315|NCT01479868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942316|NCT01479868|Immunologic Factors|immunologic factors|mesh-ancestor
19942317|NCT01479868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942318|NCT01479868|Protease Inhibitors|protease inhibitors|mesh-ancestor
19942319|NCT01479868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973905|NCT01829919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973906|NCT01829919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19973907|NCT01829919|Antidepressive Agents|antidepressive agents|mesh-ancestor
19973908|NCT01829919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19973909|NCT01829919|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19973910|NCT01829919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19973911|NCT01829919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973912|NCT01830127|Ribavirin|ribavirin|mesh-list
19973913|NCT01830127|Antimetabolites|antimetabolites|mesh-ancestor
19973914|NCT01830127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973915|NCT01830127|Antiviral Agents|antiviral agents|mesh-ancestor
19973916|NCT01830127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19973917|NCT01830140|Bimatoprost|bimatoprost|mesh-list
19973918|NCT01830140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20267218|NCT00524381|Analgesics|analgesics|mesh-ancestor
20267219|NCT00524381|Sensory System Agents|sensory system agents|mesh-ancestor
20267220|NCT00524381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20267221|NCT00524381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267222|NCT00524381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20267223|NCT00524381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20267224|NCT00524381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20267225|NCT00524381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20267226|NCT00524381|Immunologic Factors|immunologic factors|mesh-ancestor
20267227|NCT00524407|Epoetin Alfa|epoetin alfa|mesh-list
20267228|NCT00524407|Hematinics|hematinics|mesh-ancestor
20267229|NCT00524433|Tezosentan|tezosentan|mesh-list
20267230|NCT00524433|Vasodilator Agents|vasodilator agents|mesh-ancestor
20267231|NCT00524498|Cisplatin|cisplatin|mesh-list
20267232|NCT00524498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267233|NCT00524524|Beta-lapachone|beta-lapachone|mesh-list
20267234|NCT00524524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20267235|NCT00524524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20267236|NCT00524524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20267237|NCT00524524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267238|NCT00524524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267239|NCT00524524|Antiviral Agents|antiviral agents|mesh-ancestor
20267240|NCT00524615|Spironolactone|spironolactone|mesh-list
20267241|NCT00524615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20267242|NCT00524615|Hormone Antagonists|hormone antagonists|mesh-ancestor
20267243|NCT00524615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20267244|NCT00524615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267245|NCT00524615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20267246|NCT00524615|Diuretics|diuretics|mesh-ancestor
20267247|NCT00524615|Natriuretic Agents|natriuretic agents|mesh-ancestor
20267248|NCT00524667|Fludarabine|fludarabine|mesh-list
20267249|NCT00524667|Valproic Acid|valproic acid|mesh-list
20267250|NCT00524667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267251|NCT00524667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267252|NCT00524667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973919|NCT01830543|Aspirin|aspirin|mesh-list
19973920|NCT01830543|Vitamin K|vitamin k|mesh-list
19973921|NCT01830543|Rivaroxaban|rivaroxaban|mesh-list
19973922|NCT01830543|Clopidogrel|clopidogrel|mesh-list
20267253|NCT00524667|Anticonvulsants|anticonvulsants|mesh-ancestor
19942320|NCT01480076|4-Aminopyridine|4-aminopyridine|mesh-list
19942321|NCT01480076|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19942322|NCT01480076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19942323|NCT01480076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942324|NCT01480089|Ropivacaine|ropivacaine|mesh-list
19942325|NCT01480089|Anesthetics, Local|anesthetics, local|mesh-ancestor
19942326|NCT01480089|Anesthetics|anesthetics|mesh-ancestor
19942327|NCT01480089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19942328|NCT01480089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942329|NCT01480089|Sensory System Agents|sensory system agents|mesh-ancestor
19942330|NCT01480089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942331|NCT01480219|Voriconazole|voriconazole|mesh-list
19942332|NCT01480219|Antifungal Agents|antifungal agents|mesh-ancestor
19942333|NCT01480219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19942334|NCT01480219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19942335|NCT01480219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20267254|NCT00524667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267255|NCT00524667|GABA Agents|gaba agents|mesh-ancestor
20267256|NCT00524667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20267257|NCT00524667|Antimanic Agents|antimanic agents|mesh-ancestor
20267258|NCT00524667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20267259|NCT00524667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20267260|NCT00524667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20267261|NCT00524693|Montelukast|montelukast|mesh-list
20267262|NCT00524693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20267263|NCT00524693|Respiratory System Agents|respiratory system agents|mesh-ancestor
20267264|NCT00524693|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20267265|NCT00524693|Hormone Antagonists|hormone antagonists|mesh-ancestor
20267266|NCT00524693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20267267|NCT00524693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267268|NCT00524693|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20267269|NCT00524693|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20267270|NCT00524693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267271|NCT00524706|Leucovorin|leucovorin|mesh-list
20267272|NCT00524706|Oxaliplatin|oxaliplatin|mesh-list
20267273|NCT00524706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267274|NCT00524706|Antidotes|antidotes|mesh-ancestor
20267275|NCT00524706|Protective Agents|protective agents|mesh-ancestor
20267276|NCT00524706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267277|NCT00524706|Vitamin B Complex|vitamin b complex|mesh-ancestor
20267278|NCT00524706|Vitamins|vitamins|mesh-ancestor
20267279|NCT00524706|Micronutrients|micronutrients|mesh-ancestor
20267280|NCT00524810|Docetaxel|docetaxel|mesh-list
20267281|NCT00524810|Doxorubicin|doxorubicin|mesh-list
20267282|NCT00524810|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20267283|NCT00524810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267284|NCT00524810|Tubulin Modulators|tubulin modulators|mesh-ancestor
20267285|NCT00524810|Antimitotic Agents|antimitotic agents|mesh-ancestor
20267286|NCT00524810|Mitosis Modulators|mitosis modulators|mesh-ancestor
20267287|NCT00524810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267288|NCT00524810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20267289|NCT00524810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20267290|NCT00524810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20267291|NCT00524810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267292|NCT00524836|Levocetirizine|levocetirizine|mesh-list
20267293|NCT00524836|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20267294|NCT00524836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20267295|NCT00524836|Histamine Antagonists|histamine antagonists|mesh-ancestor
20267296|NCT00524836|Histamine Agents|histamine agents|mesh-ancestor
20267297|NCT00524836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20267298|NCT00524836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267299|NCT00524836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267300|NCT00524849|Zoledronic Acid|zoledronic acid|mesh-list
20267301|NCT00524849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20267302|NCT00524849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267303|NCT00524875|Bevacizumab|bevacizumab|mesh-list
20267304|NCT00524875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20267305|NCT00524875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267306|NCT00524875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20267307|NCT00524875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20267308|NCT00524875|Growth Substances|growth substances|mesh-ancestor
20267309|NCT00524875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267310|NCT00524875|Growth Inhibitors|growth inhibitors|mesh-ancestor
20543040|NCT01867645|Immunologic Factors|immunologic factors|mesh-ancestor
19942336|NCT01480219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942337|NCT01480219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942338|NCT01480219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19942339|NCT01480219|Hormone Antagonists|hormone antagonists|mesh-ancestor
19942340|NCT01480219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19942341|NCT01480219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942342|NCT01480219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19942343|NCT01480232|Nicotine|nicotine|mesh-list
19942344|NCT01480232|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19942345|NCT01480232|Autonomic Agents|autonomic agents|mesh-ancestor
19942346|NCT01480232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942347|NCT01480232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942348|NCT01480232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19942349|NCT01480232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19942350|NCT01480232|Cholinergic Agents|cholinergic agents|mesh-ancestor
19942351|NCT01480232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19942352|NCT01480232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942353|NCT01480258|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19942354|NCT01480258|Immunologic Factors|immunologic factors|mesh-ancestor
19942355|NCT01480258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942356|NCT01480297|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19942357|NCT01480297|Sodium Salicylate|sodium salicylate|mesh-list
19942358|NCT01480297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19942359|NCT01480297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19942360|NCT01480297|Analgesics|analgesics|mesh-ancestor
19942361|NCT01480297|Sensory System Agents|sensory system agents|mesh-ancestor
19942362|NCT01480297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942363|NCT01480297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942364|NCT01480297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19942365|NCT01480297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19942366|NCT01480297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19942367|NCT01480297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942368|NCT01480297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942369|NCT01480596|Belimumab|belimumab|mesh-list
19942370|NCT01480596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19942371|NCT01480596|Immunologic Factors|immunologic factors|mesh-ancestor
19942372|NCT01480596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942373|NCT01480674|Trastuzumab|trastuzumab|mesh-list
19942374|NCT01480674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19942375|NCT01480674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942376|NCT01480843|Insulin Glargine|insulin glargine|mesh-list
19942377|NCT01480843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19942378|NCT01480843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942379|NCT01481116|Glimepiride|glimepiride|mesh-list
19942380|NCT01481116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19942381|NCT01481116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19942382|NCT01481116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942383|NCT01481116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19942384|NCT01481116|Immunologic Factors|immunologic factors|mesh-ancestor
19942385|NCT01481545|Leucovorin|leucovorin|mesh-list
19942386|NCT01481545|Bevacizumab|bevacizumab|mesh-list
19942387|NCT01481545|Fluorouracil|fluorouracil|mesh-list
19942388|NCT01481545|Oxaliplatin|oxaliplatin|mesh-list
19942389|NCT01481545|Raltitrexed|raltitrexed|mesh-list
19942390|NCT01481545|Levoleucovorin|levoleucovorin|mesh-list
19942391|NCT01481545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19942392|NCT01481545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942393|NCT01481545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19942394|NCT01481545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19942395|NCT01481545|Growth Substances|growth substances|mesh-ancestor
19942396|NCT01481545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942397|NCT01481545|Growth Inhibitors|growth inhibitors|mesh-ancestor
19942398|NCT01481545|Antimetabolites|antimetabolites|mesh-ancestor
19942399|NCT01481545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942400|NCT01481545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19942401|NCT01481545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19942402|NCT01481545|Immunologic Factors|immunologic factors|mesh-ancestor
19942403|NCT01481545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19942404|NCT01481545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942405|NCT01481545|Antidotes|antidotes|mesh-ancestor
19942406|NCT01481545|Protective Agents|protective agents|mesh-ancestor
19942407|NCT01481545|Vitamin B Complex|vitamin b complex|mesh-ancestor
19942408|NCT01481545|Vitamins|vitamins|mesh-ancestor
19942409|NCT01481545|Micronutrients|micronutrients|mesh-ancestor
19942410|NCT01481740|Phenylephrine|phenylephrine|mesh-list
19942411|NCT01481740|Oxymetazoline|oxymetazoline|mesh-list
19942412|NCT01481740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19942413|NCT01481740|Mydriatics|mydriatics|mesh-ancestor
19942414|NCT01481740|Autonomic Agents|autonomic agents|mesh-ancestor
19942415|NCT01481740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942416|NCT01481740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942417|NCT01481740|Sympathomimetics|sympathomimetics|mesh-ancestor
19942418|NCT01481740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19942419|NCT01481740|Nasal Decongestants|nasal decongestants|mesh-ancestor
19942420|NCT01481740|Respiratory System Agents|respiratory system agents|mesh-ancestor
19942421|NCT01481740|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19942422|NCT01481740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19942423|NCT01481740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19942424|NCT01481740|Adrenergic Agents|adrenergic agents|mesh-ancestor
19942425|NCT01481740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19942426|NCT01481740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942427|NCT01481740|Protective Agents|protective agents|mesh-ancestor
19942428|NCT01481779|Insulin Lispro|insulin lispro|mesh-list
19942429|NCT01481779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19942430|NCT01481779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942431|NCT01482091|Fentanyl|fentanyl|mesh-list
19942432|NCT01482091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19942433|NCT01482091|Narcotics|narcotics|mesh-ancestor
19942434|NCT01482091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19942435|NCT01482091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942436|NCT01482091|Analgesics|analgesics|mesh-ancestor
19942437|NCT01482091|Sensory System Agents|sensory system agents|mesh-ancestor
19942438|NCT01482091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942439|NCT01482091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19942440|NCT01482091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19942441|NCT01482091|Anesthetics, General|anesthetics, general|mesh-ancestor
19942442|NCT01482091|Anesthetics|anesthetics|mesh-ancestor
19942443|NCT01482169|Adenosine|adenosine|mesh-list
19942444|NCT01482169|Regadenoson|regadenoson|mesh-list
19942445|NCT01482169|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19942446|NCT01482169|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19942447|NCT01482169|Purinergic Agonists|purinergic agonists|mesh-ancestor
19942448|NCT01482169|Purinergic Agents|purinergic agents|mesh-ancestor
19942449|NCT01482169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19942450|NCT01482169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942451|NCT01482169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942452|NCT01482169|Analgesics|analgesics|mesh-ancestor
19942453|NCT01482169|Sensory System Agents|sensory system agents|mesh-ancestor
20267311|NCT00524901|Epoetin Alfa|epoetin alfa|mesh-list
20267312|NCT00524901|Hematinics|hematinics|mesh-ancestor
20267313|NCT00524914|Apomorphine|apomorphine|mesh-list
20267314|NCT00524914|Emetics|emetics|mesh-ancestor
20267315|NCT00524914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267316|NCT00524914|Autonomic Agents|autonomic agents|mesh-ancestor
20267317|NCT00524914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20267318|NCT00524914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20267319|NCT00524914|Dopamine Agonists|dopamine agonists|mesh-ancestor
20267320|NCT00524914|Dopamine Agents|dopamine agents|mesh-ancestor
20267321|NCT00524914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20267322|NCT00524914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267323|NCT00524927|Methoxyflurane|methoxyflurane|mesh-list
20267324|NCT00524927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20267325|NCT00524927|Anesthetics, General|anesthetics, general|mesh-ancestor
20267326|NCT00524927|Anesthetics|anesthetics|mesh-ancestor
20267327|NCT00524927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20267328|NCT00524927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267329|NCT00524966|Hemostatics|hemostatics|mesh-list
20267330|NCT00524966|Coagulants|coagulants|mesh-ancestor
20267331|NCT00525005|Docetaxel|docetaxel|mesh-list
20543041|NCT01867645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543042|NCT01867697|Leucovorin|leucovorin|mesh-list
20543043|NCT01867697|Folic Acid|folic acid|mesh-list
20543044|NCT01867697|Oxaliplatin|oxaliplatin|mesh-list
20543045|NCT01867697|Irinotecan|irinotecan|mesh-list
20543046|NCT01867697|Cetuximab|cetuximab|mesh-list
20543047|NCT01867697|Calcium Carbonate|calcium carbonate|mesh-list
20543048|NCT01867697|Levoleucovorin|levoleucovorin|mesh-list
19942454|NCT01482169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20267332|NCT00525005|Oxaliplatin|oxaliplatin|mesh-list
20543049|NCT01867697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942455|NCT01482169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20267333|NCT00525005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543050|NCT01867697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942456|NCT01482169|Vasodilator Agents|vasodilator agents|mesh-ancestor
19942457|NCT01482715|Rucaparib|rucaparib|mesh-list
19942458|NCT01482715|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19942459|NCT01482715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942460|NCT01482715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942461|NCT01482715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942462|NCT01482767|Interferons|interferons|mesh-list
19942463|NCT01482767|Ribavirin|ribavirin|mesh-list
19942464|NCT01482767|Interferon-alpha|interferon-alpha|mesh-list
19942465|NCT01482767|Interferon alpha-2|interferon alpha-2|mesh-list
19942466|NCT01482767|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19942467|NCT01482767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942468|NCT01482767|Antiviral Agents|antiviral agents|mesh-ancestor
19942469|NCT01482767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19942470|NCT01482767|Antimetabolites|antimetabolites|mesh-ancestor
19942471|NCT01482767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942472|NCT01482767|Immunologic Factors|immunologic factors|mesh-ancestor
19942473|NCT01482767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942474|NCT01482910|Aflibercept|aflibercept|mesh-list
19942475|NCT01482910|Verteporfin|verteporfin|mesh-list
19942476|NCT01482910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19942477|NCT01482910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20267334|NCT00525005|Tubulin Modulators|tubulin modulators|mesh-ancestor
20267335|NCT00525005|Antimitotic Agents|antimitotic agents|mesh-ancestor
20267336|NCT00525005|Mitosis Modulators|mitosis modulators|mesh-ancestor
20267337|NCT00525005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267338|NCT00525096|Celecoxib|celecoxib|mesh-list
20267339|NCT00525096|Exemestane|exemestane|mesh-list
20267340|NCT00525096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20267341|NCT00525096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20267342|NCT00525096|Analgesics|analgesics|mesh-ancestor
20267343|NCT00525096|Sensory System Agents|sensory system agents|mesh-ancestor
20267344|NCT00525096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20267345|NCT00525096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267346|NCT00525096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20267347|NCT00525096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20267348|NCT00525096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20267349|NCT00525096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20267350|NCT00525096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267351|NCT00525096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267352|NCT00525096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267353|NCT00525096|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20267354|NCT00525096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20267355|NCT00525096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20267356|NCT00525096|Hormone Antagonists|hormone antagonists|mesh-ancestor
20267357|NCT00525096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20287273|NCT05242874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20287274|NCT05232344|Estradiol|estradiol|mesh-list
20287275|NCT05232344|Progesterone|progesterone|mesh-list
20287276|NCT05232344|Estrogens|estrogens|mesh-ancestor
20287277|NCT05232344|Hormones|hormones|mesh-ancestor
20287278|NCT05232344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20287279|NCT05232344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287280|NCT05232344|Progestins|progestins|mesh-ancestor
20287281|NCT05195034|Dexmedetomidine|dexmedetomidine|mesh-list
20287282|NCT05195034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20287283|NCT05195034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20287284|NCT05195034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287285|NCT05195034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20287286|NCT05195034|Analgesics|analgesics|mesh-ancestor
20287287|NCT05195034|Sensory System Agents|sensory system agents|mesh-ancestor
20287288|NCT05195034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287289|NCT05195034|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20287290|NCT05195034|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20287291|NCT05195034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20287292|NCT05195034|Adrenergic Agents|adrenergic agents|mesh-ancestor
20287293|NCT05195034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450225|NCT03430466|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19450226|NCT03430466|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19450227|NCT03430466|Hormone Antagonists|hormone antagonists|mesh-ancestor
19450228|NCT03430466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19942478|NCT01482910|Growth Substances|growth substances|mesh-ancestor
19942479|NCT01482910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942480|NCT01482910|Growth Inhibitors|growth inhibitors|mesh-ancestor
19942481|NCT01482910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942482|NCT01482910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19942483|NCT01482910|Dermatologic Agents|dermatologic agents|mesh-ancestor
19942484|NCT01482962|Gemcitabine|gemcitabine|mesh-list
19942485|NCT01482962|Romidepsin|romidepsin|mesh-list
19942486|NCT01482962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19942487|NCT01482962|Antimetabolites|antimetabolites|mesh-ancestor
19942488|NCT01482962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942489|NCT01482962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942490|NCT01482962|Antiviral Agents|antiviral agents|mesh-ancestor
19942491|NCT01482962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19942492|NCT01482962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942493|NCT01482962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19942494|NCT01482962|Immunologic Factors|immunologic factors|mesh-ancestor
19942495|NCT01482962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942496|NCT01482962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19942497|NCT01483144|Eflornithine|eflornithine|mesh-list
19942498|NCT01483144|Sulindac|sulindac|mesh-list
19942499|NCT01483144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942500|NCT01483144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19942501|NCT01483144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19942502|NCT01483144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19942503|NCT01483144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19942504|NCT01483144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
19942505|NCT01483144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942506|NCT01483144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942507|NCT01483144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19942508|NCT01483144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19942509|NCT01483144|Analgesics|analgesics|mesh-ancestor
19942510|NCT01483144|Sensory System Agents|sensory system agents|mesh-ancestor
19942511|NCT01483144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942512|NCT01483144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942513|NCT01483144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19942514|NCT01483144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19942515|NCT01483144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19942516|NCT01483560|Metformin|metformin|mesh-list
19942517|NCT01483560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19942518|NCT01483560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942519|NCT01483599|Adalimumab|adalimumab|mesh-list
19942520|NCT01483599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19942521|NCT01483599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19942522|NCT01483625|Tiotropium Bromide|tiotropium bromide|mesh-list
19942523|NCT01483625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19942524|NCT01483625|Autonomic Agents|autonomic agents|mesh-ancestor
19942525|NCT01483625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942526|NCT01483625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942527|NCT01483625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19450229|NCT03430466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267358|NCT00525200|Docetaxel|docetaxel|mesh-list
20267359|NCT00525200|Cisplatin|cisplatin|mesh-list
20267360|NCT00525200|Fluorouracil|fluorouracil|mesh-list
20267361|NCT00525200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267362|NCT00525200|Tubulin Modulators|tubulin modulators|mesh-ancestor
20267363|NCT00525200|Antimitotic Agents|antimitotic agents|mesh-ancestor
20267364|NCT00525200|Mitosis Modulators|mitosis modulators|mesh-ancestor
20267365|NCT00525200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267366|NCT00525200|Antimetabolites|antimetabolites|mesh-ancestor
20267367|NCT00525200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20267368|NCT00525200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20267369|NCT00525200|Immunologic Factors|immunologic factors|mesh-ancestor
20267370|NCT00525200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267371|NCT00525239|Ritonavir|ritonavir|mesh-list
20267372|NCT00525239|Lopinavir|lopinavir|mesh-list
20267373|NCT00525239|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20267374|NCT00525239|Efavirenz|efavirenz|mesh-list
20267375|NCT00525239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20267376|NCT00525239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20267377|NCT00525239|Protease Inhibitors|protease inhibitors|mesh-ancestor
20267378|NCT00525239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267379|NCT00525239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267380|NCT00525239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20267381|NCT00525239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20267382|NCT00525239|Antiviral Agents|antiviral agents|mesh-ancestor
19450230|NCT03430362|Scopolamine|scopolamine|mesh-list
20267383|NCT00525239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20267384|NCT00525239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20267385|NCT00525239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19942528|NCT01483625|Respiratory System Agents|respiratory system agents|mesh-ancestor
19942529|NCT01483625|Parasympatholytics|parasympatholytics|mesh-ancestor
19942530|NCT01483625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19942531|NCT01483625|Cholinergic Agents|cholinergic agents|mesh-ancestor
19942532|NCT01483625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19942533|NCT01483625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942534|NCT01483651|Insulin|insulin|mesh-list
19942535|NCT01483651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19942536|NCT01483651|Glucagon|glucagon|mesh-list
19942537|NCT01483651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19942538|NCT01483651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942539|NCT01483651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19942540|NCT01483651|Hormones|hormones|mesh-ancestor
19942541|NCT01483651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19942542|NCT01483690|Dexamethasone|dexamethasone|mesh-list
19942543|NCT01483690|Dexamethasone acetate|dexamethasone acetate|mesh-list
19942544|NCT01483690|Methotrexate|methotrexate|mesh-list
19942545|NCT01483690|Vincristine|vincristine|mesh-list
19942546|NCT01483690|Decitabine|decitabine|mesh-list
19942547|NCT01483690|Asparaginase|asparaginase|mesh-list
19942548|NCT01483690|Mitoxantrone|mitoxantrone|mesh-list
19942549|NCT01483690|Vorinostat|vorinostat|mesh-list
19942550|NCT01483690|Pegaspargase|pegaspargase|mesh-list
19942551|NCT01483690|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19942552|NCT01483690|BB 1101|bb 1101|mesh-list
19942553|NCT01483690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19942554|NCT01483690|Antiemetics|antiemetics|mesh-ancestor
19942555|NCT01483690|Autonomic Agents|autonomic agents|mesh-ancestor
19942556|NCT01483690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942557|NCT01483690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942558|NCT01483690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19942559|NCT01483690|Glucocorticoids|glucocorticoids|mesh-ancestor
19942560|NCT01483690|Hormones|hormones|mesh-ancestor
19942561|NCT01483690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19942562|NCT01483690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19942563|NCT01483690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942564|NCT01483690|Protease Inhibitors|protease inhibitors|mesh-ancestor
19942565|NCT01483690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942566|NCT01483690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942567|NCT01483690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19942568|NCT01483690|Abortifacient Agents|abortifacient agents|mesh-ancestor
19942569|NCT01483690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19942570|NCT01483690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19942571|NCT01483690|Antimetabolites|antimetabolites|mesh-ancestor
19942572|NCT01483690|Dermatologic Agents|dermatologic agents|mesh-ancestor
19942573|NCT01483690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19942574|NCT01483690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19942575|NCT01483690|Immunologic Factors|immunologic factors|mesh-ancestor
19942576|NCT01483690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19942577|NCT01483690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19942578|NCT01483690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19942579|NCT01483690|Tubulin Modulators|tubulin modulators|mesh-ancestor
19942580|NCT01483690|Antimitotic Agents|antimitotic agents|mesh-ancestor
19942581|NCT01483690|Mitosis Modulators|mitosis modulators|mesh-ancestor
19942582|NCT01483690|Analgesics|analgesics|mesh-ancestor
19942583|NCT01483690|Sensory System Agents|sensory system agents|mesh-ancestor
19942584|NCT01483690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19942585|NCT01483690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19942586|NCT01483690|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19942587|NCT01484041|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19942588|NCT01484041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19942589|NCT01484041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942590|NCT01484041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942591|NCT01484041|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19942592|NCT01484041|Hormone Antagonists|hormone antagonists|mesh-ancestor
19942593|NCT01484041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19942594|NCT01484041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942595|NCT01484197|Maleic acid|maleic acid|mesh-list
19942596|NCT01484197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942597|NCT01484197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942598|NCT01484275|Siltuximab|siltuximab|mesh-list
19942599|NCT01484275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942600|NCT01484340|Nicotine|nicotine|mesh-list
19942601|NCT01484340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19942602|NCT01484340|Autonomic Agents|autonomic agents|mesh-ancestor
19942603|NCT01484340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942604|NCT01484340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942605|NCT01484340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19942606|NCT01484340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19942607|NCT01484340|Cholinergic Agents|cholinergic agents|mesh-ancestor
19942608|NCT01484340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19942609|NCT01484340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942610|NCT01484431|Tadalafil|tadalafil|mesh-list
19942611|NCT01484431|Vasodilator Agents|vasodilator agents|mesh-ancestor
19942612|NCT01484431|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19942613|NCT01484431|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19942614|NCT01484431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942615|NCT01484431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942616|NCT01484431|Urological Agents|urological agents|mesh-ancestor
19942617|NCT01484496|Belimumab|belimumab|mesh-list
19942618|NCT01484496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19942619|NCT01484496|Immunologic Factors|immunologic factors|mesh-ancestor
19942620|NCT01484496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942621|NCT01484561|Tofacitinib|tofacitinib|mesh-list
19942622|NCT01484561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19942623|NCT01484561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942624|NCT01484561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942625|NCT01484626|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19942626|NCT01484626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19942627|NCT01484626|Alkylating Agents|alkylating agents|mesh-ancestor
19942628|NCT01484626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942629|NCT01484626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942630|NCT01484873|Exenatide|exenatide|mesh-list
19942631|NCT01484873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19942632|NCT01484873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942633|NCT01484873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19942634|NCT01484873|Incretins|incretins|mesh-ancestor
19942635|NCT01484873|Hormones|hormones|mesh-ancestor
19942636|NCT01484873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19942637|NCT01484951|Timolol|timolol|mesh-list
19942638|NCT01484951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19942639|NCT01484951|Brinzolamide|brinzolamide|mesh-list
19942640|NCT01484951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19942641|NCT01484951|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19942642|NCT01484951|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19942643|NCT01484951|Adrenergic Agents|adrenergic agents|mesh-ancestor
19942644|NCT01484951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19942645|NCT01484951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942646|NCT01484951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267386|NCT00525239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20267387|NCT00525239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20267388|NCT00525239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20267389|NCT00525239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20267390|NCT00525239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20267391|NCT00525239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20267392|NCT00525239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20267393|NCT00525252|Baclofen|baclofen|mesh-list
20267394|NCT00525252|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20267395|NCT00525252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267396|NCT00525252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20267397|NCT00525252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20267398|NCT00525252|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20267399|NCT00525252|GABA Agonists|gaba agonists|mesh-ancestor
19450231|NCT03430362|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19450232|NCT03430362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19450233|NCT03430362|Antiemetics|antiemetics|mesh-ancestor
19450234|NCT03430362|Autonomic Agents|autonomic agents|mesh-ancestor
19450235|NCT03430362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450236|NCT03430362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450237|NCT03430362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19450238|NCT03430362|Mydriatics|mydriatics|mesh-ancestor
19942647|NCT01484951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19942648|NCT01484951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19942649|NCT01484951|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19942650|NCT01484951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942651|NCT01484977|Lacosamide|lacosamide|mesh-list
19942652|NCT01484977|Anticonvulsants|anticonvulsants|mesh-ancestor
19942653|NCT01484977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19942654|NCT01484977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19942655|NCT01484977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19942656|NCT01484977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942657|NCT01485055|Infliximab|infliximab|mesh-list
19942658|NCT01485055|Basiliximab|basiliximab|mesh-list
19942659|NCT01485055|Dermatologic Agents|dermatologic agents|mesh-ancestor
19942660|NCT01485055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19942661|NCT01485055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19942662|NCT01485055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19942663|NCT01485055|Immunologic Factors|immunologic factors|mesh-ancestor
19942664|NCT01485055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942665|NCT01485094|Pregabalin|pregabalin|mesh-list
19942666|NCT01485094|Analgesics|analgesics|mesh-ancestor
19942667|NCT01485094|Sensory System Agents|sensory system agents|mesh-ancestor
19942668|NCT01485094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942669|NCT01485094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942670|NCT01485094|Anticonvulsants|anticonvulsants|mesh-ancestor
19942671|NCT01485094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19942672|NCT01485094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19942673|NCT01485094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942674|NCT01485094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19942675|NCT01485094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19942676|NCT01485094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19942677|NCT01485094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19942678|NCT01485094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19942679|NCT01485172|Ropinirole|ropinirole|mesh-list
19942680|NCT01485172|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19942681|NCT01485172|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19942682|NCT01485172|Dopamine Agonists|dopamine agonists|mesh-ancestor
19942683|NCT01485172|Dopamine Agents|dopamine agents|mesh-ancestor
19942684|NCT01485172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19942685|NCT01485172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942686|NCT01485172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942687|NCT01485380|Dexmedetomidine|dexmedetomidine|mesh-list
19942688|NCT01485380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19942689|NCT01485380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19942690|NCT01485380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942691|NCT01485380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19942692|NCT01485380|Analgesics|analgesics|mesh-ancestor
19942693|NCT01485380|Sensory System Agents|sensory system agents|mesh-ancestor
19942694|NCT01485380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20267400|NCT00525252|GABA Agents|gaba agents|mesh-ancestor
20267401|NCT00525252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20267402|NCT00525252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267403|NCT00525278|Levocetirizine|levocetirizine|mesh-list
20267404|NCT00525278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20267405|NCT00525278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20267406|NCT00525278|Histamine Antagonists|histamine antagonists|mesh-ancestor
20267407|NCT00525278|Histamine Agents|histamine agents|mesh-ancestor
20267408|NCT00525278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20267409|NCT00525278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267410|NCT00525278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267411|NCT00525382|Levocetirizine|levocetirizine|mesh-list
20267412|NCT00525382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20267413|NCT00525382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20267414|NCT00525382|Histamine Antagonists|histamine antagonists|mesh-ancestor
20267415|NCT00525382|Histamine Agents|histamine agents|mesh-ancestor
20267416|NCT00525382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20267417|NCT00525382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267418|NCT00525382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267419|NCT00525408|Docetaxel|docetaxel|mesh-list
20267420|NCT00525408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267421|NCT00525408|Tubulin Modulators|tubulin modulators|mesh-ancestor
20267422|NCT00525408|Antimitotic Agents|antimitotic agents|mesh-ancestor
20267423|NCT00525408|Mitosis Modulators|mitosis modulators|mesh-ancestor
20267424|NCT00525408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267425|NCT00525447|Dexamethasone|dexamethasone|mesh-list
20267426|NCT00525447|Lenalidomide|lenalidomide|mesh-list
20267427|NCT00525447|Dacetuzumab|dacetuzumab|mesh-list
20267428|NCT00525447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20267429|NCT00525447|Antiemetics|antiemetics|mesh-ancestor
20267430|NCT00525447|Autonomic Agents|autonomic agents|mesh-ancestor
20267431|NCT00525447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942695|NCT01485380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19942696|NCT01485380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19942697|NCT01485380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19942698|NCT01485380|Adrenergic Agents|adrenergic agents|mesh-ancestor
19942699|NCT01485380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19942700|NCT01485380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942701|NCT01485393|Dexmedetomidine|dexmedetomidine|mesh-list
19942702|NCT01485393|Zolpidem|zolpidem|mesh-list
19942703|NCT01485393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19942704|NCT01485393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19942705|NCT01485393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942706|NCT01485393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19942707|NCT01485393|Analgesics|analgesics|mesh-ancestor
19942708|NCT01485393|Sensory System Agents|sensory system agents|mesh-ancestor
19942709|NCT01485393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942710|NCT01485393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19942711|NCT01485393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19942712|NCT01485393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19942713|NCT01485393|Adrenergic Agents|adrenergic agents|mesh-ancestor
19942714|NCT01485393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19942715|NCT01485393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942716|NCT01485393|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19942717|NCT01485393|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19942718|NCT01485393|GABA Agonists|gaba agonists|mesh-ancestor
19942719|NCT01485393|GABA Agents|gaba agents|mesh-ancestor
19942720|NCT01485588|Immunoconjugates|immunoconjugates|mesh-list
19942721|NCT01485588|Immunologic Factors|immunologic factors|mesh-ancestor
19942722|NCT01485588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942723|NCT01485614|Metformin|metformin|mesh-list
19942724|NCT01485614|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19942725|NCT01485614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19942726|NCT01485614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942727|NCT01485614|Incretins|incretins|mesh-ancestor
19942728|NCT01485614|Hormones|hormones|mesh-ancestor
19942729|NCT01485614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19942730|NCT01485614|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19942731|NCT01485614|Protease Inhibitors|protease inhibitors|mesh-ancestor
19942732|NCT01485614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942733|NCT01485614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942734|NCT01485640|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19942735|NCT01485640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19942736|NCT01485640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19942737|NCT01485640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19942738|NCT01485640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942739|NCT01485640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19942740|NCT01485640|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19942741|NCT01485640|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19942742|NCT01485640|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19942743|NCT01485640|Adrenergic Agents|adrenergic agents|mesh-ancestor
19942744|NCT01485640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19942745|NCT01485640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942746|NCT01485640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19942747|NCT01485640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19942748|NCT01485640|Serotonin Agents|serotonin agents|mesh-ancestor
19942749|NCT01485640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19942750|NCT01485640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19942751|NCT01485640|Dopamine Agents|dopamine agents|mesh-ancestor
19942752|NCT01485796|Immunoglobulins|immunoglobulins|mesh-list
19942753|NCT01485796|Antibodies|antibodies|mesh-list
19942754|NCT01485796|gamma-Globulins|gamma-globulins|mesh-list
19942755|NCT01485796|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19942756|NCT01485796|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19942757|NCT01485796|Immunologic Factors|immunologic factors|mesh-ancestor
19942758|NCT01485796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942759|NCT01485887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19942760|NCT01485887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19942761|NCT01485887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19942762|NCT01485887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19942763|NCT01485887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942764|NCT01485887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19942765|NCT01485887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942766|NCT01485887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19942767|NCT01485887|Antidepressive Agents|antidepressive agents|mesh-ancestor
19942768|NCT01485887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19942769|NCT01485991|Simeprevir|simeprevir|mesh-list
19942770|NCT01485991|Antiviral Agents|antiviral agents|mesh-ancestor
19942771|NCT01485991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19942772|NCT01485991|Protease Inhibitors|protease inhibitors|mesh-ancestor
19942773|NCT01485991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942774|NCT01485991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942775|NCT01486043|Metformin|metformin|mesh-list
19942776|NCT01486043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19942777|NCT01486043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942778|NCT01486615|Melatonin|melatonin|mesh-list
19942779|NCT01486615|Alprazolam|alprazolam|mesh-list
19942780|NCT01486615|Azaperone|azaperone|mesh-list
19942781|NCT01486615|Antioxidants|antioxidants|mesh-ancestor
19942782|NCT01486615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942783|NCT01486615|Protective Agents|protective agents|mesh-ancestor
19942784|NCT01486615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942785|NCT01486615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19942786|NCT01486615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19942787|NCT01486615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19942788|NCT01486615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19942789|NCT01486615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19942790|NCT01486615|GABA Modulators|gaba modulators|mesh-ancestor
19942791|NCT01486615|GABA Agents|gaba agents|mesh-ancestor
19942792|NCT01486615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19942793|NCT01486615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19942794|NCT01486615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19942795|NCT01486615|Dopamine Agents|dopamine agents|mesh-ancestor
19942796|NCT01486758|Azithromycin|azithromycin|mesh-list
19942797|NCT01486758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19942798|NCT01486758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19942799|NCT01486810|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19942800|NCT01486810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19942801|NCT01486810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942802|NCT01486810|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19942803|NCT01486810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19942804|NCT01486810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20267432|NCT00525447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267433|NCT00525447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20267434|NCT00525447|Glucocorticoids|glucocorticoids|mesh-ancestor
20267435|NCT00525447|Hormones|hormones|mesh-ancestor
20267436|NCT00525447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20267437|NCT00525447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20267438|NCT00525447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267439|NCT00525447|Immunologic Factors|immunologic factors|mesh-ancestor
20267440|NCT00525447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20267441|NCT00525447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20267442|NCT00525447|Growth Substances|growth substances|mesh-ancestor
20267443|NCT00525447|Growth Inhibitors|growth inhibitors|mesh-ancestor
20267444|NCT00525447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20267445|NCT00525473|Azathioprine|azathioprine|mesh-list
20267446|NCT00525473|Antimetabolites|antimetabolites|mesh-ancestor
20267447|NCT00525473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267448|NCT00525473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20267449|NCT00525473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267450|NCT00525473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20267451|NCT00525473|Immunologic Factors|immunologic factors|mesh-ancestor
20267452|NCT00525473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267453|NCT00525473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20267454|NCT00525486|Nifedipine|nifedipine|mesh-list
20267455|NCT00525486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20267456|NCT00525486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20267457|NCT00525486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267458|NCT00525486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20267459|NCT00525486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267460|NCT00525486|Vasodilator Agents|vasodilator agents|mesh-ancestor
20267461|NCT00525486|Tocolytic Agents|tocolytic agents|mesh-ancestor
20267462|NCT00525486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20267463|NCT00525551|Acetylcysteine|acetylcysteine|mesh-list
19942805|NCT01486810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942806|NCT01486810|Dopamine Agents|dopamine agents|mesh-ancestor
19942807|NCT01486810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19942808|NCT01486927|Factor VIII|factor viii|mesh-list
19942809|NCT01486927|Coagulants|coagulants|mesh-ancestor
19942810|NCT01486966|Insulin|insulin|mesh-list
19942811|NCT01486966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19942812|NCT01486966|Metformin|metformin|mesh-list
19942813|NCT01486966|Insulin Aspart|insulin aspart|mesh-list
19942814|NCT01486966|Insulin Detemir|insulin detemir|mesh-list
19942815|NCT01486966|Isophane Insulin, Human|isophane insulin, human|mesh-list
19942816|NCT01486966|Insulin, Isophane|insulin, isophane|mesh-list
19942817|NCT01486966|Isophane insulin, beef|isophane insulin, beef|mesh-list
19942818|NCT01486966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19942819|NCT01486966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942820|NCT01487161|Triamcinolone|triamcinolone|mesh-list
19942821|NCT01487161|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19942822|NCT01487161|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19942823|NCT01487161|FX006|fx006|mesh-list
19942824|NCT01487161|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19942825|NCT01487161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19942826|NCT01487161|Glucocorticoids|glucocorticoids|mesh-ancestor
19942827|NCT01487161|Hormones|hormones|mesh-ancestor
19942828|NCT01487161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19942829|NCT01487161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942830|NCT01487161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19942831|NCT01487161|Immunologic Factors|immunologic factors|mesh-ancestor
19942832|NCT01487161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942833|NCT01487161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942834|NCT01487200|Triamcinolone|triamcinolone|mesh-list
19942835|NCT01487200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19942836|NCT01487200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19942837|NCT01487200|FX006|fx006|mesh-list
19942838|NCT01487200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19942839|NCT01487200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19942840|NCT01487200|Glucocorticoids|glucocorticoids|mesh-ancestor
19942841|NCT01487200|Hormones|hormones|mesh-ancestor
19942842|NCT01487200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19942843|NCT01487200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942844|NCT01487200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19942845|NCT01487200|Immunologic Factors|immunologic factors|mesh-ancestor
19942846|NCT01487200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942847|NCT01487200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942848|NCT01487265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19942849|NCT01487265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942850|NCT01487265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19942851|NCT01487265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942852|NCT01487265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942853|NCT01487577|Mycophenolic Acid|mycophenolic acid|mesh-list
19942854|NCT01487577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19942855|NCT01487577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942856|NCT01487577|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19942857|NCT01487577|Antitubercular Agents|antitubercular agents|mesh-ancestor
19942858|NCT01487577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19942859|NCT01487577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19942860|NCT01487577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942861|NCT01487577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942862|NCT01487863|Abiraterone Acetate|abiraterone acetate|mesh-list
19942863|NCT01487863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942864|NCT01487863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19942865|NCT01487863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942866|NCT01487863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942867|NCT01487863|Hormone Antagonists|hormone antagonists|mesh-ancestor
19942868|NCT01487863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19942869|NCT01487863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942870|NCT01487863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19973923|NCT01830543|Ticagrelor|ticagrelor|mesh-list
19973924|NCT01830543|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19973925|NCT01830543|Vitamins|vitamins|mesh-ancestor
19973926|NCT01830543|Micronutrients|micronutrients|mesh-ancestor
19973927|NCT01830543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973928|NCT01830543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19973929|NCT01830543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19973930|NCT01830543|Analgesics|analgesics|mesh-ancestor
19973931|NCT01830543|Sensory System Agents|sensory system agents|mesh-ancestor
19973932|NCT01830543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19973933|NCT01830543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19973934|NCT01830543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19973935|NCT01830543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19973936|NCT01830543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19973937|NCT01830543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942871|NCT01488019|Formoterol Fumarate|formoterol fumarate|mesh-list
19942872|NCT01488019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19942873|NCT01488019|Autonomic Agents|autonomic agents|mesh-ancestor
19942874|NCT01488019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942875|NCT01488019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942876|NCT01488019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19942877|NCT01488019|Respiratory System Agents|respiratory system agents|mesh-ancestor
19942878|NCT01488019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19942879|NCT01488019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19942880|NCT01488019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19942881|NCT01488019|Adrenergic Agents|adrenergic agents|mesh-ancestor
19942882|NCT01488019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19942883|NCT01488019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942884|NCT01488071|Vortioxetine|vortioxetine|mesh-list
19942885|NCT01488071|S 20098|s 20098|mesh-list
19942886|NCT01488071|Antidepressive Agents|antidepressive agents|mesh-ancestor
19942887|NCT01488071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19942888|NCT01488071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19942889|NCT01488071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19942890|NCT01488071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19942891|NCT01488071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942892|NCT01488071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19942893|NCT01488071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19942894|NCT01488071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19942895|NCT01488071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942896|NCT01488071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19942897|NCT01488071|Serotonin Agents|serotonin agents|mesh-ancestor
19942898|NCT01488071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19942899|NCT01488071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19942900|NCT01488071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19942901|NCT01488071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19942902|NCT01488071|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19942903|NCT01488188|Vaccines|vaccines|mesh-list
19942904|NCT01488188|Immunologic Factors|immunologic factors|mesh-ancestor
19942905|NCT01488188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942906|NCT01488279|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19942907|NCT01488279|Dexamethasone|dexamethasone|mesh-list
19942908|NCT01488279|Dexamethasone acetate|dexamethasone acetate|mesh-list
19942909|NCT01488279|BB 1101|bb 1101|mesh-list
19942910|NCT01488279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19942911|NCT01488279|Antiemetics|antiemetics|mesh-ancestor
19942912|NCT01488279|Autonomic Agents|autonomic agents|mesh-ancestor
20267464|NCT00525551|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20267465|NCT00525551|Antiviral Agents|antiviral agents|mesh-ancestor
20267466|NCT00525551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20267467|NCT00525551|Expectorants|expectorants|mesh-ancestor
20267468|NCT00525551|Respiratory System Agents|respiratory system agents|mesh-ancestor
20267469|NCT00525551|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20267470|NCT00525551|Antioxidants|antioxidants|mesh-ancestor
20267471|NCT00525551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267472|NCT00525551|Protective Agents|protective agents|mesh-ancestor
20267473|NCT00525551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267474|NCT00525551|Antidotes|antidotes|mesh-ancestor
20267475|NCT00525564|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20267476|NCT00525564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20267477|NCT00525564|Autonomic Agents|autonomic agents|mesh-ancestor
20267478|NCT00525564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20267479|NCT00525564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267480|NCT00525564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20267481|NCT00525564|Respiratory System Agents|respiratory system agents|mesh-ancestor
20267482|NCT00525564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20267483|NCT00525564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19942913|NCT01488279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942914|NCT01488279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942915|NCT01488279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19942916|NCT01488279|Glucocorticoids|glucocorticoids|mesh-ancestor
19942917|NCT01488279|Hormones|hormones|mesh-ancestor
19942918|NCT01488279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19942919|NCT01488279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19942920|NCT01488279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942921|NCT01488279|Protease Inhibitors|protease inhibitors|mesh-ancestor
19942922|NCT01488279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267484|NCT00525564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20267485|NCT00525564|Adrenergic Agents|adrenergic agents|mesh-ancestor
19942923|NCT01488279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942924|NCT01488279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19942925|NCT01488279|Incretins|incretins|mesh-ancestor
19942926|NCT01488279|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19942927|NCT01488318|Cetuximab|cetuximab|mesh-list
19942928|NCT01488318|Dasatinib|dasatinib|mesh-list
19942929|NCT01488318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19942930|NCT01488318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942931|NCT01488318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19942932|NCT01488318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19942933|NCT01488318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942934|NCT01488409|Acipimox|acipimox|mesh-list
19942935|NCT01488409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19942936|NCT01488409|Antimetabolites|antimetabolites|mesh-ancestor
19942937|NCT01488409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942938|NCT01488409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19942939|NCT01488487|Everolimus|everolimus|mesh-list
19942940|NCT01488487|Pasireotide|pasireotide|mesh-list
19942941|NCT01488487|Somatostatin|somatostatin|mesh-list
19942942|NCT01488487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942943|NCT01488487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19942944|NCT01488487|Immunologic Factors|immunologic factors|mesh-ancestor
19942945|NCT01488487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942946|NCT01488487|Hormones|hormones|mesh-ancestor
19942947|NCT01488487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19942948|NCT01488578|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19942949|NCT01488578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19942950|NCT01488578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19942951|NCT01488578|Cholinergic Agents|cholinergic agents|mesh-ancestor
19942952|NCT01488578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19942953|NCT01488578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942954|NCT01488578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942955|NCT01488578|Urological Agents|urological agents|mesh-ancestor
19942956|NCT01488877|Spironolactone|spironolactone|mesh-list
19942957|NCT01488877|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19942958|NCT01488877|Hormone Antagonists|hormone antagonists|mesh-ancestor
19942959|NCT01488877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19942960|NCT01488877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942961|NCT01488877|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19942962|NCT01488877|Diuretics|diuretics|mesh-ancestor
19942963|NCT01488877|Natriuretic Agents|natriuretic agents|mesh-ancestor
19942964|NCT01489020|Vaccines|vaccines|mesh-list
19942965|NCT01489020|Immunologic Factors|immunologic factors|mesh-ancestor
19942966|NCT01489020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942967|NCT01489189|Ranibizumab|ranibizumab|mesh-list
19942968|NCT01489189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19942969|NCT01489189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19942970|NCT01489189|Growth Substances|growth substances|mesh-ancestor
19942971|NCT01489189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942972|NCT01489189|Growth Inhibitors|growth inhibitors|mesh-ancestor
19942973|NCT01489189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19942974|NCT01489254|Glatiramer Acetate|glatiramer acetate|mesh-list
19942975|NCT01489254|(T,G)-A-L|(t,g)-a-l|mesh-list
19942976|NCT01489254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19942977|NCT01489254|Immunologic Factors|immunologic factors|mesh-ancestor
19942978|NCT01489254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942979|NCT01489254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19942980|NCT01489254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19942981|NCT01489670|Bimatoprost|bimatoprost|mesh-list
19942982|NCT01489670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19942983|NCT01489670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19942984|NCT01489670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19942985|NCT01489826|HU 211|hu 211|mesh-list
19942986|NCT01489826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20267486|NCT00525564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20267487|NCT00525564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267488|NCT00525577|Probucol|probucol|mesh-list
19732884|NCT04568772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19732885|NCT04568772|Antimalarials|antimalarials|mesh-ancestor
19732886|NCT04568772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20267489|NCT00525577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19732887|NCT04568772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19732888|NCT04568772|Antimetabolites|antimetabolites|mesh-ancestor
19732889|NCT04568603|Islatravir|islatravir|mesh-list
19732890|NCT04568603|Methadone|methadone|mesh-list
19732891|NCT04568603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19732892|NCT04568603|Narcotics|narcotics|mesh-ancestor
19732893|NCT04568603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19732894|NCT04568603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732895|NCT04568603|Analgesics|analgesics|mesh-ancestor
19942987|NCT01489826|Antiemetics|antiemetics|mesh-ancestor
19942988|NCT01489826|Autonomic Agents|autonomic agents|mesh-ancestor
19942989|NCT01489826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19942990|NCT01489826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19942991|NCT01489826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19942992|NCT01489826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19942993|NCT01489826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19942994|NCT01489826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19942995|NCT01489826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19942996|NCT01489826|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20267490|NCT00525577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20267491|NCT00525577|Antimetabolites|antimetabolites|mesh-ancestor
20267492|NCT00525577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267493|NCT00525577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20267494|NCT00525577|Antioxidants|antioxidants|mesh-ancestor
20267495|NCT00525577|Protective Agents|protective agents|mesh-ancestor
20267496|NCT00525577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267497|NCT00525616|Rituximab|rituximab|mesh-list
20267498|NCT00525616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20267499|NCT00525616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267500|NCT00525616|Immunologic Factors|immunologic factors|mesh-ancestor
20267501|NCT00525616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543051|NCT01867697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20543052|NCT01867697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20543053|NCT01867697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543054|NCT01867697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543055|NCT01867697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20543056|NCT01867697|Antidotes|antidotes|mesh-ancestor
20543057|NCT01867697|Protective Agents|protective agents|mesh-ancestor
20543058|NCT01867697|Vitamin B Complex|vitamin b complex|mesh-ancestor
20543059|NCT01867697|Vitamins|vitamins|mesh-ancestor
20543060|NCT01867697|Micronutrients|micronutrients|mesh-ancestor
20543061|NCT01867697|Hematinics|hematinics|mesh-ancestor
20543062|NCT01867697|Antacids|antacids|mesh-ancestor
20543063|NCT01867697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20543064|NCT01867775|Mirtazapine|mirtazapine|mesh-list
20543065|NCT01867775|Antidepressive Agents|antidepressive agents|mesh-ancestor
20543066|NCT01867775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20543067|NCT01867775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20543068|NCT01867775|Histamine Antagonists|histamine antagonists|mesh-ancestor
20543069|NCT01867775|Histamine Agents|histamine agents|mesh-ancestor
20543070|NCT01867775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20543071|NCT01867775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543072|NCT01867775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543073|NCT01867775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20543074|NCT01867775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20543075|NCT01867775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20543076|NCT01867775|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20543077|NCT01867775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20543078|NCT01867775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20543079|NCT01867775|Adrenergic Agents|adrenergic agents|mesh-ancestor
20543080|NCT01867775|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20543081|NCT01867775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20543082|NCT01867775|Serotonin Agents|serotonin agents|mesh-ancestor
20543083|NCT01867775|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20543084|NCT01867866|Trifluridine|trifluridine|mesh-list
20543085|NCT01867866|Antimetabolites|antimetabolites|mesh-ancestor
20543086|NCT01867866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543087|NCT01867866|Antiviral Agents|antiviral agents|mesh-ancestor
20543088|NCT01867866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20543089|NCT01867892|Leucovorin|leucovorin|mesh-list
19732896|NCT04568603|Sensory System Agents|sensory system agents|mesh-ancestor
19732897|NCT04568603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732898|NCT04568603|Antitussive Agents|antitussive agents|mesh-ancestor
19732899|NCT04568603|Respiratory System Agents|respiratory system agents|mesh-ancestor
19732900|NCT04568603|Antiviral Agents|antiviral agents|mesh-ancestor
19732901|NCT04568603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19942997|NCT01489826|Protective Agents|protective agents|mesh-ancestor
19942998|NCT01489891|Lidocaine|lidocaine|mesh-list
19942999|NCT01489891|Anesthetics, Local|anesthetics, local|mesh-ancestor
19943000|NCT01489891|Anesthetics|anesthetics|mesh-ancestor
20543090|NCT01867892|Gemcitabine|gemcitabine|mesh-list
19943001|NCT01489891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19943002|NCT01489891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943003|NCT01489891|Sensory System Agents|sensory system agents|mesh-ancestor
19943004|NCT01489891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19943005|NCT01489891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19943006|NCT01489891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19943007|NCT01489891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19943008|NCT01489891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19943009|NCT01489891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943010|NCT01489956|Freund's Adjuvant|freund's adjuvant|mesh-list
19943011|NCT01489956|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
19943012|NCT01489956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19943013|NCT01489956|Immunologic Factors|immunologic factors|mesh-ancestor
19943014|NCT01489956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943015|NCT01489969|Melatonin|melatonin|mesh-list
19943016|NCT01489969|Antioxidants|antioxidants|mesh-ancestor
19943017|NCT01489969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943018|NCT01489969|Protective Agents|protective agents|mesh-ancestor
19943019|NCT01489969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943020|NCT01489969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19943021|NCT01490060|Dexamethasone|dexamethasone|mesh-list
19943022|NCT01490060|Dexamethasone acetate|dexamethasone acetate|mesh-list
19943023|NCT01490060|Doxorubicin|doxorubicin|mesh-list
19943024|NCT01490060|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19943025|NCT01490060|Vincristine|vincristine|mesh-list
19943026|NCT01490060|Ifosfamide|ifosfamide|mesh-list
19943027|NCT01490060|Isophosphamide mustard|isophosphamide mustard|mesh-list
19943028|NCT01490060|Fosaprepitant|fosaprepitant|mesh-list
19943029|NCT01490060|Aprepitant|aprepitant|mesh-list
19943030|NCT01490060|BB 1101|bb 1101|mesh-list
19943031|NCT01490060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19943032|NCT01490060|Antiemetics|antiemetics|mesh-ancestor
19943033|NCT01490060|Autonomic Agents|autonomic agents|mesh-ancestor
19943034|NCT01490060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19943035|NCT01490060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943036|NCT01490060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19943037|NCT01490060|Glucocorticoids|glucocorticoids|mesh-ancestor
19943038|NCT01490060|Hormones|hormones|mesh-ancestor
19943039|NCT01490060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19943040|NCT01490060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19943041|NCT01490060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943042|NCT01490060|Protease Inhibitors|protease inhibitors|mesh-ancestor
19943043|NCT01490060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943044|NCT01490060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943045|NCT01490060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19943046|NCT01490060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19943047|NCT01490060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19943048|NCT01490060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19943049|NCT01490060|Tubulin Modulators|tubulin modulators|mesh-ancestor
19943050|NCT01490060|Antimitotic Agents|antimitotic agents|mesh-ancestor
19943051|NCT01490060|Mitosis Modulators|mitosis modulators|mesh-ancestor
19943052|NCT01490060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19943053|NCT01490060|Alkylating Agents|alkylating agents|mesh-ancestor
19943054|NCT01490060|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19943055|NCT01490060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19943056|NCT01490073|Nitroglycerin|nitroglycerin|mesh-list
19943057|NCT01490073|Vasodilator Agents|vasodilator agents|mesh-ancestor
19943058|NCT01490086|Aripiprazole|aripiprazole|mesh-list
19943059|NCT01490086|RP5063|rp5063|mesh-list
19943060|NCT01490086|Antidepressive Agents|antidepressive agents|mesh-ancestor
19943061|NCT01490086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19943062|NCT01490086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19943063|NCT01490086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19943064|NCT01490086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19943065|NCT01490086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943066|NCT01490086|Dopamine Agonists|dopamine agonists|mesh-ancestor
19943067|NCT01490086|Dopamine Agents|dopamine agents|mesh-ancestor
19943068|NCT01490086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19943069|NCT01490086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943070|NCT01490086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19943071|NCT01490086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19943072|NCT01490086|Serotonin Agents|serotonin agents|mesh-ancestor
19943073|NCT01490086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19943074|NCT01490086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19943075|NCT01490086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19943076|NCT01490086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19943077|NCT01490125|Glycopyrrolate|glycopyrrolate|mesh-list
19943078|NCT01490125|Albuterol|albuterol|mesh-list
19943079|NCT01490125|Tiotropium Bromide|tiotropium bromide|mesh-list
19943080|NCT01490125|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19943081|NCT01490125|Autonomic Agents|autonomic agents|mesh-ancestor
19943082|NCT01490125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19943083|NCT01490125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943084|NCT01490125|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19943085|NCT01490125|Respiratory System Agents|respiratory system agents|mesh-ancestor
19943086|NCT01490125|Parasympatholytics|parasympatholytics|mesh-ancestor
19943087|NCT01490125|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19943088|NCT01490125|Cholinergic Agents|cholinergic agents|mesh-ancestor
19943089|NCT01490125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19943090|NCT01490125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943091|NCT01490125|Tocolytic Agents|tocolytic agents|mesh-ancestor
19943092|NCT01490125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19943093|NCT01490125|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19943094|NCT01490125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19943095|NCT01490125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19943096|NCT01490125|Adrenergic Agents|adrenergic agents|mesh-ancestor
19943097|NCT01490125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19943098|NCT01490125|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19943099|NCT01490580|Atropine|atropine|mesh-list
19943100|NCT01490580|Sufentanil|sufentanil|mesh-list
19943101|NCT01490580|Propofol|propofol|mesh-list
19943102|NCT01490580|Atracurium|atracurium|mesh-list
19943103|NCT01490580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19943104|NCT01490580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19943105|NCT01490580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943106|NCT01490580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19943107|NCT01490580|Anesthetics, General|anesthetics, general|mesh-ancestor
19943108|NCT01490580|Anesthetics|anesthetics|mesh-ancestor
19943109|NCT01490580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19943110|NCT01490580|Narcotics|narcotics|mesh-ancestor
19943111|NCT01490580|Analgesics|analgesics|mesh-ancestor
19943112|NCT01490580|Sensory System Agents|sensory system agents|mesh-ancestor
19943113|NCT01490580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19943114|NCT01490580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19943115|NCT01490580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19943116|NCT01490580|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19943117|NCT01490580|Autonomic Agents|autonomic agents|mesh-ancestor
19943118|NCT01490580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19943119|NCT01490580|Respiratory System Agents|respiratory system agents|mesh-ancestor
19943120|NCT01490580|Mydriatics|mydriatics|mesh-ancestor
19943121|NCT01490580|Parasympatholytics|parasympatholytics|mesh-ancestor
19943122|NCT01490580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19943123|NCT01490580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19943124|NCT01490580|Cholinergic Agents|cholinergic agents|mesh-ancestor
19943125|NCT01490580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19943126|NCT01490580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943127|NCT01490580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19943128|NCT01490580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19943129|NCT01490580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19943130|NCT01490580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19943131|NCT01490697|Cycloserine|cycloserine|mesh-list
19943132|NCT01490697|Mifepristone|mifepristone|mesh-list
19943133|NCT01490697|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19943134|NCT01490697|Abortifacient Agents|abortifacient agents|mesh-ancestor
19943135|NCT01490697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19943136|NCT01490697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943137|NCT01490697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19943138|NCT01490697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19943139|NCT01490697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19943140|NCT01490697|Contraceptive Agents|contraceptive agents|mesh-ancestor
19943141|NCT01490697|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19943142|NCT01490697|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19943143|NCT01490697|Hormone Antagonists|hormone antagonists|mesh-ancestor
19943144|NCT01490697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19943145|NCT01490697|Luteolytic Agents|luteolytic agents|mesh-ancestor
19943146|NCT01490697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19943147|NCT01490697|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20543091|NCT01867892|Fluorouracil|fluorouracil|mesh-list
19943148|NCT01490697|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20543092|NCT01867892|Irinotecan|irinotecan|mesh-list
19943149|NCT01490697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19943150|NCT01490697|Renal Agents|renal agents|mesh-ancestor
19943151|NCT01490697|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19943152|NCT01490697|Antitubercular Agents|antitubercular agents|mesh-ancestor
19943153|NCT01490697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19943154|NCT01490697|Antimetabolites|antimetabolites|mesh-ancestor
19943155|NCT01490697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943156|NCT01490723|Mycophenolic Acid|mycophenolic acid|mesh-list
19943157|NCT01490723|Rituximab|rituximab|mesh-list
19943158|NCT01490723|Methotrexate|methotrexate|mesh-list
19943159|NCT01490723|Fludarabine|fludarabine|mesh-list
19943160|NCT01490723|Fludarabine phosphate|fludarabine phosphate|mesh-list
19943161|NCT01490723|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19943162|NCT01490723|Tacrolimus|tacrolimus|mesh-list
19943163|NCT01490723|Thymoglobulin|thymoglobulin|mesh-list
19943164|NCT01490723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19943165|NCT01490723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19943166|NCT01490723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19943167|NCT01490723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943168|NCT01490723|Immunologic Factors|immunologic factors|mesh-ancestor
19943169|NCT01490723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943170|NCT01490723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19943171|NCT01490723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19943172|NCT01490723|Abortifacient Agents|abortifacient agents|mesh-ancestor
19943173|NCT01490723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19943174|NCT01490723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19943175|NCT01490723|Antimetabolites|antimetabolites|mesh-ancestor
19943176|NCT01490723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943177|NCT01490723|Dermatologic Agents|dermatologic agents|mesh-ancestor
19943178|NCT01490723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943179|NCT01490723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19943180|NCT01490723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19943181|NCT01490723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19943182|NCT01490723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19943183|NCT01490723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19943184|NCT01490723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19943185|NCT01490723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19943186|NCT01490723|Antitubercular Agents|antitubercular agents|mesh-ancestor
19943187|NCT01490723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19943188|NCT01490723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19943189|NCT01490723|Alkylating Agents|alkylating agents|mesh-ancestor
19943190|NCT01490788|Amitriptyline|amitriptyline|mesh-list
19943191|NCT01490788|Cyclobenzaprine|cyclobenzaprine|mesh-list
19943192|NCT01490788|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19943193|NCT01490788|Antidepressive Agents|antidepressive agents|mesh-ancestor
19943194|NCT01490788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19943195|NCT01490788|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19943196|NCT01490788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943197|NCT01490788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19943198|NCT01490788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19943199|NCT01490788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19943200|NCT01490788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19943201|NCT01490788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19943202|NCT01490788|Analgesics|analgesics|mesh-ancestor
19943203|NCT01490788|Sensory System Agents|sensory system agents|mesh-ancestor
19943204|NCT01490788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19943205|NCT01490788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19943206|NCT01490788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19943207|NCT01490788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943208|NCT01490788|Adrenergic Agents|adrenergic agents|mesh-ancestor
19943209|NCT01490788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19943210|NCT01490866|Leucovorin|leucovorin|mesh-list
19943211|NCT01490866|Bevacizumab|bevacizumab|mesh-list
19943212|NCT01490866|Fluorouracil|fluorouracil|mesh-list
19943213|NCT01490866|Oxaliplatin|oxaliplatin|mesh-list
19943214|NCT01490866|Axitinib|axitinib|mesh-list
19943215|NCT01490866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19943216|NCT01490866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943217|NCT01490866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19943218|NCT01490866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19943219|NCT01490866|Growth Substances|growth substances|mesh-ancestor
20267502|NCT00525616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19943220|NCT01490866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943221|NCT01490866|Growth Inhibitors|growth inhibitors|mesh-ancestor
20267503|NCT00525642|Cyclophosphamide|cyclophosphamide|mesh-list
19943222|NCT01490866|Antimetabolites|antimetabolites|mesh-ancestor
19943223|NCT01490866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943224|NCT01490866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19943225|NCT01490866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19943226|NCT01490866|Immunologic Factors|immunologic factors|mesh-ancestor
19943227|NCT01490866|Antidotes|antidotes|mesh-ancestor
19943228|NCT01490866|Protective Agents|protective agents|mesh-ancestor
19943229|NCT01490866|Vitamin B Complex|vitamin b complex|mesh-ancestor
20267504|NCT00525642|Docetaxel|docetaxel|mesh-list
20267505|NCT00525642|Doxorubicin|doxorubicin|mesh-list
20267506|NCT00525642|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20267507|NCT00525642|Epirubicin|epirubicin|mesh-list
20267508|NCT00525642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20267509|NCT00525642|Immunologic Factors|immunologic factors|mesh-ancestor
20267510|NCT00525642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267511|NCT00525642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20267512|NCT00525642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20267513|NCT00525642|Alkylating Agents|alkylating agents|mesh-ancestor
20267514|NCT00525642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267515|NCT00525642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267516|NCT00525642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20267517|NCT00525642|Tubulin Modulators|tubulin modulators|mesh-ancestor
20267518|NCT00525642|Antimitotic Agents|antimitotic agents|mesh-ancestor
20267519|NCT00525642|Mitosis Modulators|mitosis modulators|mesh-ancestor
20267520|NCT00525642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20267521|NCT00525642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20267522|NCT00525642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20267523|NCT00525642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267524|NCT00525668|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20267525|NCT00525668|Antioxidants|antioxidants|mesh-ancestor
20267526|NCT00525668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267527|NCT00525668|Protective Agents|protective agents|mesh-ancestor
20267528|NCT00525668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267529|NCT00525668|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20267530|NCT00525668|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20267531|NCT00525668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267532|NCT00525668|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20267533|NCT00525681|Cyclosporine|cyclosporine|mesh-list
20267534|NCT00525681|Tacrolimus|tacrolimus|mesh-list
20267535|NCT00525681|Cyclosporins|cyclosporins|mesh-list
20267536|NCT00525681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20267537|NCT00525681|Immunologic Factors|immunologic factors|mesh-ancestor
20267538|NCT00525681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267539|NCT00525681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20267540|NCT00525681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267541|NCT00525681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267542|NCT00525681|Antifungal Agents|antifungal agents|mesh-ancestor
20267543|NCT00525681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20267544|NCT00525681|Dermatologic Agents|dermatologic agents|mesh-ancestor
20267545|NCT00525681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20267546|NCT00525694|Cocaine|cocaine|mesh-list
20267547|NCT00525694|Anesthetics, Local|anesthetics, local|mesh-ancestor
20267548|NCT00525694|Anesthetics|anesthetics|mesh-ancestor
20267549|NCT00525694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20267550|NCT00525694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267551|NCT00525694|Sensory System Agents|sensory system agents|mesh-ancestor
20267552|NCT00525694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20267553|NCT00525694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20267554|NCT00525694|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20267555|NCT00525694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20267556|NCT00525694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20267557|NCT00525694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267558|NCT00525694|Dopamine Agents|dopamine agents|mesh-ancestor
20267559|NCT00525694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20267560|NCT00525707|Tezosentan|tezosentan|mesh-list
20267561|NCT00525707|Vasodilator Agents|vasodilator agents|mesh-ancestor
20267562|NCT00525759|Zoledronic Acid|zoledronic acid|mesh-list
20267563|NCT00525759|Cyclophosphamide|cyclophosphamide|mesh-list
20267564|NCT00525759|Docetaxel|docetaxel|mesh-list
20267565|NCT00525759|Fluorouracil|fluorouracil|mesh-list
20267566|NCT00525759|Epirubicin|epirubicin|mesh-list
20543093|NCT01867892|Levoleucovorin|levoleucovorin|mesh-list
20267567|NCT00525759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19943230|NCT01490866|Vitamins|vitamins|mesh-ancestor
20267568|NCT00525759|Immunologic Factors|immunologic factors|mesh-ancestor
20267569|NCT00525759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267570|NCT00525759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20543094|NCT01867892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19943231|NCT01490866|Micronutrients|micronutrients|mesh-ancestor
19943232|NCT01490866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19943233|NCT01490866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943234|NCT01490918|Metformin|metformin|mesh-list
19943235|NCT01490918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19943236|NCT01490918|Acarbose|acarbose|mesh-list
19943237|NCT01490918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19943238|NCT01490918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943239|NCT01490918|Incretins|incretins|mesh-ancestor
19943240|NCT01490918|Hormones|hormones|mesh-ancestor
19943241|NCT01490918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19943242|NCT01490918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19943243|NCT01490918|Protease Inhibitors|protease inhibitors|mesh-ancestor
19943244|NCT01490918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943245|NCT01490918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943246|NCT01490918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19943247|NCT01490931|Ketorolac|ketorolac|mesh-list
19943248|NCT01490931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19943249|NCT01490931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19943250|NCT01490931|Analgesics|analgesics|mesh-ancestor
19943251|NCT01490931|Sensory System Agents|sensory system agents|mesh-ancestor
19943252|NCT01490931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19943253|NCT01490931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943254|NCT01490931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19943255|NCT01490931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19943256|NCT01490931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19943257|NCT01490931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943258|NCT01490931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943259|NCT01491022|4-Aminopyridine|4-aminopyridine|mesh-list
19943260|NCT01491022|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19943261|NCT01491022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19943262|NCT01491022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943263|NCT01491035|Vortioxetine|vortioxetine|mesh-list
19943264|NCT01491035|Antidepressive Agents|antidepressive agents|mesh-ancestor
19943265|NCT01491035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19943266|NCT01491035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19943267|NCT01491035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19943268|NCT01491035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19943269|NCT01491035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943270|NCT01491035|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19943271|NCT01491035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19943272|NCT01491035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19943273|NCT01491035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943274|NCT01491035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19943275|NCT01491035|Serotonin Agents|serotonin agents|mesh-ancestor
19943276|NCT01491035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19943277|NCT01491035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19943278|NCT01491035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19943279|NCT01491035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19943280|NCT01491113|Levetiracetam|levetiracetam|mesh-list
19943281|NCT01491113|Anticonvulsants|anticonvulsants|mesh-ancestor
19943282|NCT01491113|Nootropic Agents|nootropic agents|mesh-ancestor
19943283|NCT01491607|Vaccines|vaccines|mesh-list
19943284|NCT01491607|Immunologic Factors|immunologic factors|mesh-ancestor
19943285|NCT01491607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943286|NCT01491633|Dasatinib|dasatinib|mesh-list
19943287|NCT01491633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943288|NCT01491633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19943289|NCT01491633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943290|NCT01491633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943291|NCT01491672|Everolimus|everolimus|mesh-list
19943292|NCT01491672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943293|NCT01491672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19943294|NCT01491672|Immunologic Factors|immunologic factors|mesh-ancestor
19943295|NCT01491672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943296|NCT01491737|Trastuzumab|trastuzumab|mesh-list
19943297|NCT01491737|Pertuzumab|pertuzumab|mesh-list
19943298|NCT01491737|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19943299|NCT01491737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19943300|NCT01491737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943301|NCT01491737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19943302|NCT01491737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943303|NCT01491737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943304|NCT01491737|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19943305|NCT01491737|Hormone Antagonists|hormone antagonists|mesh-ancestor
19943306|NCT01491737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19943307|NCT01491737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943308|NCT01491841|Rituximab|rituximab|mesh-list
19943309|NCT01491841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19943310|NCT01491841|Pixantrone|pixantrone|mesh-list
19943311|NCT01491841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19943312|NCT01491841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943313|NCT01491841|Immunologic Factors|immunologic factors|mesh-ancestor
19943314|NCT01491841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943315|NCT01491841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19943316|NCT01491841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19943317|NCT01491841|Alkylating Agents|alkylating agents|mesh-ancestor
19943318|NCT01491841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943319|NCT01491841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19943320|NCT01491841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19943321|NCT01491841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943322|NCT01491919|Lisinopril|lisinopril|mesh-list
19943323|NCT01491919|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19943324|NCT01491919|Protease Inhibitors|protease inhibitors|mesh-ancestor
19943325|NCT01491919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943326|NCT01491919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943327|NCT01491919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19943328|NCT01491919|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19943329|NCT01491919|Protective Agents|protective agents|mesh-ancestor
19943330|NCT01491919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943331|NCT01491958|Methotrexate|methotrexate|mesh-list
19943332|NCT01491958|Atorvastatin|atorvastatin|mesh-list
19943333|NCT01491958|Tacrolimus|tacrolimus|mesh-list
19943334|NCT01491958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19943335|NCT01491958|Abortifacient Agents|abortifacient agents|mesh-ancestor
19943336|NCT01491958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19943337|NCT01491958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943338|NCT01491958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19943339|NCT01491958|Antimetabolites|antimetabolites|mesh-ancestor
19943340|NCT01491958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943341|NCT01491958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943342|NCT01491958|Dermatologic Agents|dermatologic agents|mesh-ancestor
19943343|NCT01491958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943344|NCT01491958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19943345|NCT01491958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19943346|NCT01491958|Immunologic Factors|immunologic factors|mesh-ancestor
19943347|NCT01491958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19943348|NCT01491958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19943349|NCT01491958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19943350|NCT01491958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19943351|NCT01491958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19943352|NCT01491958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19943353|NCT01491958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19943354|NCT01492088|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19943355|NCT01492088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19943356|NCT01492088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943357|NCT01492101|Etirinotecan pegol|etirinotecan pegol|mesh-list
19943358|NCT01492101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943359|NCT01492101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19943360|NCT01492101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19943361|NCT01492101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943362|NCT01492101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943363|NCT01492400|Dexamethasone|dexamethasone|mesh-list
19943364|NCT01492400|Ranibizumab|ranibizumab|mesh-list
19943365|NCT01492400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19943366|NCT01492400|Antiemetics|antiemetics|mesh-ancestor
19943367|NCT01492400|Autonomic Agents|autonomic agents|mesh-ancestor
19943368|NCT01492400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19943369|NCT01492400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943370|NCT01492400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19943371|NCT01492400|Glucocorticoids|glucocorticoids|mesh-ancestor
19943372|NCT01492400|Hormones|hormones|mesh-ancestor
19943373|NCT01492400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19943374|NCT01492400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19943375|NCT01492400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943376|NCT01492400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19943377|NCT01492400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19943378|NCT01492400|Growth Substances|growth substances|mesh-ancestor
19943379|NCT01492400|Growth Inhibitors|growth inhibitors|mesh-ancestor
19943380|NCT01492426|Ribavirin|ribavirin|mesh-list
19943381|NCT01492426|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20267571|NCT00525759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20267572|NCT00525759|Alkylating Agents|alkylating agents|mesh-ancestor
20267573|NCT00525759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267574|NCT00525759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267575|NCT00525759|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20267576|NCT00525759|Tubulin Modulators|tubulin modulators|mesh-ancestor
20267577|NCT00525759|Antimitotic Agents|antimitotic agents|mesh-ancestor
20267578|NCT00525759|Mitosis Modulators|mitosis modulators|mesh-ancestor
20267579|NCT00525759|Antimetabolites|antimetabolites|mesh-ancestor
20267580|NCT00525759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20267581|NCT00525759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20267582|NCT00525759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20267583|NCT00525759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20267584|NCT00525759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267585|NCT00525759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20267586|NCT00525772|Ciclesonide|ciclesonide|mesh-list
20267587|NCT00525772|Glucocorticoids|glucocorticoids|mesh-ancestor
20267588|NCT00525772|Hormones|hormones|mesh-ancestor
20267589|NCT00525772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20267590|NCT00525772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267591|NCT00525772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20267592|NCT00525889|Sirolimus|sirolimus|mesh-list
20267593|NCT00525889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20267594|NCT00525889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20267595|NCT00525889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20267596|NCT00525889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267597|NCT00525889|Antifungal Agents|antifungal agents|mesh-ancestor
20267598|NCT00525889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20267599|NCT00525889|Immunologic Factors|immunologic factors|mesh-ancestor
20267600|NCT00525889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267601|NCT00525928|Varenicline|varenicline|mesh-list
20267602|NCT00525928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20267603|NCT00525928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20267604|NCT00525928|Cholinergic Agents|cholinergic agents|mesh-ancestor
20267605|NCT00525928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20267606|NCT00525928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267607|NCT00525928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267608|NCT00525967|Acetaminophen|acetaminophen|mesh-list
20267609|NCT00525967|Methadone|methadone|mesh-list
20543095|NCT01867892|Antimetabolites|antimetabolites|mesh-ancestor
20543096|NCT01867892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543097|NCT01867892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543098|NCT01867892|Antiviral Agents|antiviral agents|mesh-ancestor
20543099|NCT01867892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20543100|NCT01867892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543101|NCT01867892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19943382|NCT01492426|Antimetabolites|antimetabolites|mesh-ancestor
19943383|NCT01492426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943384|NCT01492426|Antiviral Agents|antiviral agents|mesh-ancestor
19943385|NCT01492426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19943386|NCT01492582|Vaccines|vaccines|mesh-list
19943387|NCT01492582|Immunologic Factors|immunologic factors|mesh-ancestor
19943388|NCT01492582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943389|NCT01492673|Cyclophosphamide|cyclophosphamide|mesh-list
19943390|NCT01492673|Bevacizumab|bevacizumab|mesh-list
19943391|NCT01492673|Topotecan|topotecan|mesh-list
19943392|NCT01492673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19943393|NCT01492673|Immunologic Factors|immunologic factors|mesh-ancestor
19943394|NCT01492673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943395|NCT01492673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19943396|NCT01492673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19943397|NCT01492673|Alkylating Agents|alkylating agents|mesh-ancestor
19943398|NCT01492673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943399|NCT01492673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943400|NCT01492673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19943401|NCT01492673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19943402|NCT01492673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19943403|NCT01492673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20267610|NCT00525967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19943404|NCT01492673|Growth Substances|growth substances|mesh-ancestor
19943405|NCT01492673|Growth Inhibitors|growth inhibitors|mesh-ancestor
19943406|NCT01492673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19943407|NCT01492673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19943408|NCT01492673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943409|NCT01492686|Edaravone|edaravone|mesh-list
19943410|NCT01492686|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19943411|NCT01492686|Antioxidants|antioxidants|mesh-ancestor
19943412|NCT01492686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943413|NCT01492686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19943414|NCT01492686|Protective Agents|protective agents|mesh-ancestor
19943415|NCT01492686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943416|NCT01493089|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
19943417|NCT01493089|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19943418|NCT01493089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943419|NCT01493089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943420|NCT01493180|Rebamipide|rebamipide|mesh-list
19943421|NCT01493180|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19943422|NCT01493180|Hyaluronic Acid|hyaluronic acid|mesh-list
19943423|NCT01493180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19943424|NCT01493180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19943425|NCT01493180|Immunologic Factors|immunologic factors|mesh-ancestor
19943426|NCT01493180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943427|NCT01493180|Viscosupplements|viscosupplements|mesh-ancestor
19943428|NCT01493180|Protective Agents|protective agents|mesh-ancestor
19943429|NCT01493180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19943430|NCT01493180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19943431|NCT01493180|Antioxidants|antioxidants|mesh-ancestor
19943432|NCT01493180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943433|NCT01493180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943434|NCT01493427|Travoprost|travoprost|mesh-list
19943435|NCT01493427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19943436|NCT01493531|Allopurinol|allopurinol|mesh-list
19943437|NCT01493531|Lesinurad|lesinurad|mesh-list
19943438|NCT01493531|Antimetabolites|antimetabolites|mesh-ancestor
19943439|NCT01493531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943440|NCT01493531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943441|NCT01493531|Gout Suppressants|gout suppressants|mesh-ancestor
19943442|NCT01493531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19943443|NCT01493531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19943444|NCT01493531|Antioxidants|antioxidants|mesh-ancestor
19943445|NCT01493531|Protective Agents|protective agents|mesh-ancestor
19943446|NCT01493531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943447|NCT01493531|Uricosuric Agents|uricosuric agents|mesh-ancestor
19943448|NCT01493531|Renal Agents|renal agents|mesh-ancestor
19943449|NCT01493557|Pantoprazole|pantoprazole|mesh-list
19943450|NCT01493557|Dabigatran|dabigatran|mesh-list
19943451|NCT01493557|Antithrombins|antithrombins|mesh-ancestor
19943452|NCT01493557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19943453|NCT01493557|Protease Inhibitors|protease inhibitors|mesh-ancestor
19943454|NCT01493557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943455|NCT01493557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943456|NCT01493557|Anticoagulants|anticoagulants|mesh-ancestor
19943457|NCT01493557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19943458|NCT01493557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19943459|NCT01493557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19943460|NCT01493687|Azelaic acid|azelaic acid|mesh-list
19943461|NCT01493687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943462|NCT01493687|Dermatologic Agents|dermatologic agents|mesh-ancestor
19943463|NCT01493947|Metronidazole|metronidazole|mesh-list
19943464|NCT01493947|Ivermectin|ivermectin|mesh-list
19943465|NCT01493947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19943466|NCT01493947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19943467|NCT01493947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19943468|NCT01493947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19943469|NCT01494038|Isoniazid|isoniazid|mesh-list
19943470|NCT01494038|Antitubercular Agents|antitubercular agents|mesh-ancestor
19943471|NCT01494038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19943472|NCT01494038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19943473|NCT01494038|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19943474|NCT01494038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19943475|NCT01494038|Antimetabolites|antimetabolites|mesh-ancestor
20267611|NCT00525967|Analgesics|analgesics|mesh-ancestor
20267612|NCT00525967|Sensory System Agents|sensory system agents|mesh-ancestor
19943476|NCT01494038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267613|NCT00525967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19943477|NCT01494038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19943478|NCT01494350|Gentamicins|gentamicins|mesh-list
19943479|NCT01494350|Paromomycin|paromomycin|mesh-list
19943480|NCT01494350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19943481|NCT01494350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19943482|NCT01494350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20267614|NCT00525967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267615|NCT00525967|Antipyretics|antipyretics|mesh-ancestor
20267616|NCT00525967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20267617|NCT00525967|Narcotics|narcotics|mesh-ancestor
20267618|NCT00525967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20267619|NCT00525967|Antitussive Agents|antitussive agents|mesh-ancestor
20267620|NCT00525967|Respiratory System Agents|respiratory system agents|mesh-ancestor
20267621|NCT00525993|Etoricoxib|etoricoxib|mesh-list
20267622|NCT00525993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20267623|NCT00525993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20267624|NCT00525993|Analgesics|analgesics|mesh-ancestor
20267625|NCT00525993|Sensory System Agents|sensory system agents|mesh-ancestor
20267626|NCT00525993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20267627|NCT00525993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267628|NCT00525993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20267629|NCT00525993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20267630|NCT00525993|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20267631|NCT00525993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20267632|NCT00525993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267633|NCT00525993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267634|NCT00526006|Esomeprazole|esomeprazole|mesh-list
20267635|NCT00526006|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20267636|NCT00526006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20267637|NCT00526006|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20267638|NCT00526006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543102|NCT01867892|Immunologic Factors|immunologic factors|mesh-ancestor
20543103|NCT01867892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543104|NCT01867892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20543105|NCT01867892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20543106|NCT01867892|Antidotes|antidotes|mesh-ancestor
20543107|NCT01867892|Protective Agents|protective agents|mesh-ancestor
20543108|NCT01867892|Vitamin B Complex|vitamin b complex|mesh-ancestor
20543109|NCT01867892|Vitamins|vitamins|mesh-ancestor
20543110|NCT01867892|Micronutrients|micronutrients|mesh-ancestor
20543111|NCT01867957|Vaccines|vaccines|mesh-list
20543112|NCT01867957|Immunologic Factors|immunologic factors|mesh-ancestor
20543113|NCT01867957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543114|NCT01868048|Nabiximols|nabiximols|mesh-list
20543115|NCT01868048|Analgesics|analgesics|mesh-ancestor
20543116|NCT01868048|Sensory System Agents|sensory system agents|mesh-ancestor
20543117|NCT01868048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543118|NCT01868048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543119|NCT01868113|Fluticasone|fluticasone|mesh-list
20543120|NCT01868113|Xhance|xhance|mesh-list
20543121|NCT01868113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20543122|NCT01868113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20543123|NCT01868113|Autonomic Agents|autonomic agents|mesh-ancestor
20543124|NCT01868113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543125|NCT01868113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543126|NCT01868113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20543127|NCT01868113|Respiratory System Agents|respiratory system agents|mesh-ancestor
20543128|NCT01868113|Dermatologic Agents|dermatologic agents|mesh-ancestor
20543129|NCT01868113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20543130|NCT01868126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20543131|NCT01868126|Latanoprost|latanoprost|mesh-list
20543132|NCT01868126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20543133|NCT01868191|Thiamine|thiamine|mesh-list
20543134|NCT01868191|Benphothiamine|benphothiamine|mesh-list
20543135|NCT01868191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20543136|NCT01868191|Immunologic Factors|immunologic factors|mesh-ancestor
20543137|NCT01868191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543138|NCT01868191|Chelating Agents|chelating agents|mesh-ancestor
20543139|NCT01868191|Sequestering Agents|sequestering agents|mesh-ancestor
20543140|NCT01868191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943483|NCT01494350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943484|NCT01494350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943485|NCT01494350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19943486|NCT01494350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19943487|NCT01494467|Azelaic acid|azelaic acid|mesh-list
20543141|NCT01868191|Vitamin B Complex|vitamin b complex|mesh-ancestor
20543142|NCT01868191|Vitamins|vitamins|mesh-ancestor
20543143|NCT01868191|Micronutrients|micronutrients|mesh-ancestor
20543144|NCT01868360|Aflibercept|aflibercept|mesh-list
20543145|NCT01868360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19943488|NCT01494467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943489|NCT01494467|Dermatologic Agents|dermatologic agents|mesh-ancestor
19943490|NCT01494506|Leucovorin|leucovorin|mesh-list
19943491|NCT01494506|Fluorouracil|fluorouracil|mesh-list
19943492|NCT01494506|Antimetabolites|antimetabolites|mesh-ancestor
19943493|NCT01494506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943494|NCT01494506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19943495|NCT01494506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943496|NCT01494506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19943497|NCT01494506|Immunologic Factors|immunologic factors|mesh-ancestor
19943498|NCT01494506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943499|NCT01494506|Antidotes|antidotes|mesh-ancestor
19943500|NCT01494506|Protective Agents|protective agents|mesh-ancestor
19943501|NCT01494506|Vitamin B Complex|vitamin b complex|mesh-ancestor
19943502|NCT01494506|Vitamins|vitamins|mesh-ancestor
19943503|NCT01494506|Micronutrients|micronutrients|mesh-ancestor
19943504|NCT01494532|Ropinirole|ropinirole|mesh-list
19943505|NCT01494532|Levodopa|levodopa|mesh-list
19943506|NCT01494532|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
19943507|NCT01494532|Dopamine Agents|dopamine agents|mesh-ancestor
19943508|NCT01494532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19943509|NCT01494532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943510|NCT01494532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943511|NCT01494532|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19943512|NCT01494532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19943513|NCT01494532|Dopamine Agonists|dopamine agonists|mesh-ancestor
19943514|NCT01494584|Ezogabine|ezogabine|mesh-list
19943515|NCT01494584|Anticonvulsants|anticonvulsants|mesh-ancestor
19943516|NCT01494584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19943517|NCT01494584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943518|NCT01494610|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19943519|NCT01494610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19943520|NCT01494610|Autonomic Agents|autonomic agents|mesh-ancestor
19943521|NCT01494610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19943522|NCT01494610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943523|NCT01494610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19943524|NCT01494610|Respiratory System Agents|respiratory system agents|mesh-ancestor
19943525|NCT01494610|Glucocorticoids|glucocorticoids|mesh-ancestor
19943526|NCT01494610|Hormones|hormones|mesh-ancestor
19943527|NCT01494610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19943528|NCT01494610|Sympathomimetics|sympathomimetics|mesh-ancestor
19943529|NCT01494818|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19943530|NCT01494818|Contact Lens Solutions|contact lens solutions|mesh-list
19943531|NCT01494818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19943532|NCT01494818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19943533|NCT01494818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19943534|NCT01494818|Disinfectants|disinfectants|mesh-ancestor
19973938|NCT01830543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19973939|NCT01830543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19973940|NCT01830543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19973941|NCT01830543|Antipyretics|antipyretics|mesh-ancestor
19973942|NCT01830543|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19973943|NCT01830543|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19973944|NCT01830543|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19973945|NCT01830543|Purinergic Agents|purinergic agents|mesh-ancestor
19973946|NCT01830543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19973947|NCT01830543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19973948|NCT01830543|Antithrombins|antithrombins|mesh-ancestor
19973949|NCT01830543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19973950|NCT01830543|Protease Inhibitors|protease inhibitors|mesh-ancestor
19973951|NCT01830543|Anticoagulants|anticoagulants|mesh-ancestor
19973952|NCT01830543|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19973953|NCT01830543|Hemostatics|hemostatics|mesh-ancestor
19973954|NCT01830543|Coagulants|coagulants|mesh-ancestor
19973955|NCT01830595|Lactoferrin|lactoferrin|mesh-list
19973956|NCT01830595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19973957|NCT01830699|Triamcinolone|triamcinolone|mesh-list
19973958|NCT01830699|Rilonacept|rilonacept|mesh-list
19973959|NCT01830699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19973960|NCT01830699|Glucocorticoids|glucocorticoids|mesh-ancestor
19973961|NCT01830699|Hormones|hormones|mesh-ancestor
19973962|NCT01830699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20267639|NCT00526006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267640|NCT00526175|Cytarabine|cytarabine|mesh-list
19973963|NCT01830699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973964|NCT01830816|Ixazomib|ixazomib|mesh-list
19973965|NCT01830816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943535|NCT01494987|Glimepiride|glimepiride|mesh-list
19943536|NCT01494987|Ranolazine|ranolazine|mesh-list
19943537|NCT01494987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19943538|NCT01494987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19943539|NCT01494987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943540|NCT01494987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19943541|NCT01494987|Immunologic Factors|immunologic factors|mesh-ancestor
19943542|NCT01494987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19943543|NCT01494987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19943544|NCT01494987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943545|NCT01495000|Denosumab|denosumab|mesh-list
19943546|NCT01495000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19943547|NCT01495000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943548|NCT01495481|Adenosine|adenosine|mesh-list
19943549|NCT01495481|Dexmedetomidine|dexmedetomidine|mesh-list
19943550|NCT01495481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19943551|NCT01495481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19943552|NCT01495481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943553|NCT01495481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19943554|NCT01495481|Analgesics|analgesics|mesh-ancestor
19943555|NCT01495481|Sensory System Agents|sensory system agents|mesh-ancestor
19943556|NCT01495481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19943557|NCT01495481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19943558|NCT01495481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19943559|NCT01495481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19943560|NCT01495481|Adrenergic Agents|adrenergic agents|mesh-ancestor
19943561|NCT01495481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19943562|NCT01495481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943563|NCT01495481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19943564|NCT01495481|Vasodilator Agents|vasodilator agents|mesh-ancestor
19943565|NCT01495481|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19943566|NCT01495481|Purinergic Agonists|purinergic agonists|mesh-ancestor
19943567|NCT01495481|Purinergic Agents|purinergic agents|mesh-ancestor
19943568|NCT01495572|Aldesleukin|aldesleukin|mesh-list
19943569|NCT01495572|Cyclophosphamide|cyclophosphamide|mesh-list
19943570|NCT01495572|Fludarabine|fludarabine|mesh-list
19943571|NCT01495572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19943572|NCT01495572|Immunologic Factors|immunologic factors|mesh-ancestor
19943573|NCT01495572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943574|NCT01495572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19943575|NCT01495572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19943576|NCT01495572|Alkylating Agents|alkylating agents|mesh-ancestor
19943577|NCT01495572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943578|NCT01495572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943579|NCT01495572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19943580|NCT01495572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19943581|NCT01495572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19943582|NCT01495572|Antiviral Agents|antiviral agents|mesh-ancestor
19943583|NCT01495572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19943584|NCT01495585|Lonafarnib|lonafarnib|mesh-list
19943585|NCT01495585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943586|NCT01495585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943587|NCT01495702|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19943588|NCT01495702|Antiviral Agents|antiviral agents|mesh-ancestor
19943589|NCT01495702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19943590|NCT01495702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19943591|NCT01495702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19943592|NCT01495793|Rotigotine|rotigotine|mesh-list
19943593|NCT01495793|Dopamine Agonists|dopamine agonists|mesh-ancestor
19943594|NCT01495793|Dopamine Agents|dopamine agents|mesh-ancestor
19943595|NCT01495793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19943596|NCT01495793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943597|NCT01495793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943598|NCT01495819|Nicotine|nicotine|mesh-list
19943599|NCT01495819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19943600|NCT01495819|Autonomic Agents|autonomic agents|mesh-ancestor
19943601|NCT01495819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19943602|NCT01495819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943603|NCT01495819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19943604|NCT01495819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19943605|NCT01495819|Cholinergic Agents|cholinergic agents|mesh-ancestor
19943606|NCT01495819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19943607|NCT01495819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943608|NCT01495858|Naproxen|naproxen|mesh-list
19943609|NCT01495858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19943610|NCT01495858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19943611|NCT01495858|Analgesics|analgesics|mesh-ancestor
19943612|NCT01495858|Sensory System Agents|sensory system agents|mesh-ancestor
19943613|NCT01495858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19943614|NCT01495858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943615|NCT01495858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19943616|NCT01495858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19943617|NCT01495858|Gout Suppressants|gout suppressants|mesh-ancestor
19943618|NCT01495858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19943619|NCT01495858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943620|NCT01495858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943621|NCT01495923|Gabapentin|gabapentin|mesh-list
19943622|NCT01495923|Analgesics|analgesics|mesh-ancestor
19943623|NCT01495923|Sensory System Agents|sensory system agents|mesh-ancestor
19943624|NCT01495923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19943625|NCT01495923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943626|NCT01495923|Anticonvulsants|anticonvulsants|mesh-ancestor
19943627|NCT01495923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19943628|NCT01495923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19943629|NCT01495923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19943630|NCT01495923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19943631|NCT01495923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19943632|NCT01495923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20267641|NCT00526175|Prednisone|prednisone|mesh-list
20267642|NCT00526175|Cyclophosphamide|cyclophosphamide|mesh-list
20267643|NCT00526175|Methotrexate|methotrexate|mesh-list
20267644|NCT00526175|Vincristine|vincristine|mesh-list
20267645|NCT00526175|Daunorubicin|daunorubicin|mesh-list
20267646|NCT00526175|Asparaginase|asparaginase|mesh-list
20267647|NCT00526175|Mercaptopurine|mercaptopurine|mesh-list
20267648|NCT00526175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20267649|NCT00526175|Immunologic Factors|immunologic factors|mesh-ancestor
20267650|NCT00526175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267651|NCT00526175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20267652|NCT00526175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20267653|NCT00526175|Alkylating Agents|alkylating agents|mesh-ancestor
20267654|NCT00526175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943633|NCT01495923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19943634|NCT01495923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943635|NCT01495923|Antimanic Agents|antimanic agents|mesh-ancestor
19943636|NCT01496131|Cyclophosphamide|cyclophosphamide|mesh-list
19943637|NCT01496131|Goserelin|goserelin|mesh-list
19943638|NCT01496131|Immunologic Factors|immunologic factors|mesh-ancestor
19943639|NCT01496131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943640|NCT01496131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19943641|NCT01496131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19943642|NCT01496131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20267655|NCT00526175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267656|NCT00526175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20267657|NCT00526175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20267658|NCT00526175|Glucocorticoids|glucocorticoids|mesh-ancestor
20267659|NCT00526175|Hormones|hormones|mesh-ancestor
20267660|NCT00526175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20267661|NCT00526175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20267662|NCT00526175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20267663|NCT00526175|Abortifacient Agents|abortifacient agents|mesh-ancestor
20267664|NCT00526175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20267665|NCT00526175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20267666|NCT00526175|Antimetabolites|antimetabolites|mesh-ancestor
20267667|NCT00526175|Dermatologic Agents|dermatologic agents|mesh-ancestor
20267668|NCT00526175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267669|NCT00526175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20267670|NCT00526175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20267671|NCT00526175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20267672|NCT00526175|Tubulin Modulators|tubulin modulators|mesh-ancestor
20267673|NCT00526175|Antimitotic Agents|antimitotic agents|mesh-ancestor
20267674|NCT00526175|Mitosis Modulators|mitosis modulators|mesh-ancestor
20267675|NCT00526175|Antiviral Agents|antiviral agents|mesh-ancestor
19943643|NCT01496131|Alkylating Agents|alkylating agents|mesh-ancestor
19943644|NCT01496131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943645|NCT01496131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943646|NCT01496131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20267676|NCT00526175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19943647|NCT01496131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19943648|NCT01496183|Olanzapine|olanzapine|mesh-list
19943649|NCT01496183|Antiemetics|antiemetics|mesh-ancestor
19943650|NCT01496183|Autonomic Agents|autonomic agents|mesh-ancestor
19943651|NCT01496183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19943652|NCT01496183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943653|NCT01496183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19943654|NCT01496183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19943655|NCT01496183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19943656|NCT01496183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19943657|NCT01496183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19943658|NCT01496183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19943659|NCT01496183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19943660|NCT01496183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19943661|NCT01496183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943662|NCT01496183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19943663|NCT01496183|Serotonin Agents|serotonin agents|mesh-ancestor
19943664|NCT01496365|Pregabalin|pregabalin|mesh-list
19943665|NCT01496365|Analgesics|analgesics|mesh-ancestor
19943666|NCT01496365|Sensory System Agents|sensory system agents|mesh-ancestor
19943667|NCT01496365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19943668|NCT01496365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943669|NCT01496365|Anticonvulsants|anticonvulsants|mesh-ancestor
19943670|NCT01496365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19943671|NCT01496365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19973966|NCT01830816|Protease Inhibitors|protease inhibitors|mesh-ancestor
20267677|NCT00526175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20267678|NCT00526175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20267679|NCT00526175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20267680|NCT00526214|Celecoxib|celecoxib|mesh-list
20267681|NCT00526214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20267682|NCT00526214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20267683|NCT00526214|Analgesics|analgesics|mesh-ancestor
20267684|NCT00526214|Sensory System Agents|sensory system agents|mesh-ancestor
20267685|NCT00526214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20267686|NCT00526214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267687|NCT00526214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20267688|NCT00526214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20267689|NCT00526214|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20267690|NCT00526214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20267691|NCT00526214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267692|NCT00526214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267693|NCT00526305|Cytarabine|cytarabine|mesh-list
20267694|NCT00526305|Dexamethasone|dexamethasone|mesh-list
20267695|NCT00526305|Prednisone|prednisone|mesh-list
20267696|NCT00526305|Hydrocortisone|hydrocortisone|mesh-list
20267697|NCT00526305|Cyclophosphamide|cyclophosphamide|mesh-list
20267698|NCT00526305|Vincristine|vincristine|mesh-list
20267699|NCT00526305|Daunorubicin|daunorubicin|mesh-list
20267700|NCT00526305|Asparaginase|asparaginase|mesh-list
20267701|NCT00526305|Mercaptopurine|mercaptopurine|mesh-list
20267702|NCT00526305|Mitoxantrone|mitoxantrone|mesh-list
20267703|NCT00526305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20267704|NCT00526305|Immunologic Factors|immunologic factors|mesh-ancestor
20267705|NCT00526305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267706|NCT00526305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20267707|NCT00526305|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20267708|NCT00526305|Alkylating Agents|alkylating agents|mesh-ancestor
20267709|NCT00526305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267710|NCT00526305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267711|NCT00526305|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20267712|NCT00526305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20267713|NCT00526305|Antiemetics|antiemetics|mesh-ancestor
20267714|NCT00526305|Autonomic Agents|autonomic agents|mesh-ancestor
20543146|NCT01868360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20543147|NCT01868360|Growth Substances|growth substances|mesh-ancestor
20543148|NCT01868360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543149|NCT01868360|Growth Inhibitors|growth inhibitors|mesh-ancestor
20543150|NCT01868360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543151|NCT01868438|Artesunate|artesunate|mesh-list
20543152|NCT01868438|Pyronaridine|pyronaridine|mesh-list
20543153|NCT01868438|Antimalarials|antimalarials|mesh-ancestor
20543154|NCT01868438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20543155|NCT01868438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20267715|NCT00526305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543156|NCT01868438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20543157|NCT01868438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943672|NCT01496365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943673|NCT01496365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19943674|NCT01496365|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19943675|NCT01496365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19943676|NCT01496365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19943677|NCT01496365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19943678|NCT01496430|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19943679|NCT01496430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19943680|NCT01496430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19943681|NCT01496430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943682|NCT01496469|Febuxostat|febuxostat|mesh-list
19943683|NCT01496469|Gout Suppressants|gout suppressants|mesh-ancestor
19943684|NCT01496469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19943685|NCT01496612|Buspirone|buspirone|mesh-list
19943686|NCT01496612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19943687|NCT01496612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19943688|NCT01496612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19943689|NCT01496612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943690|NCT01496612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19943691|NCT01496612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19943692|NCT01496612|Serotonin Agents|serotonin agents|mesh-ancestor
19943693|NCT01496612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19943694|NCT01496612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943695|NCT01496807|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19943696|NCT01496807|Ipilimumab|ipilimumab|mesh-list
19943697|NCT01496807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19943698|NCT01496807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943699|NCT01496807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19943700|NCT01496807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943701|NCT01496807|Antiviral Agents|antiviral agents|mesh-ancestor
19943702|NCT01496807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19943703|NCT01496846|Lidocaine|lidocaine|mesh-list
19943704|NCT01496846|Carticaine|carticaine|mesh-list
19943705|NCT01496846|Anesthetics, Local|anesthetics, local|mesh-ancestor
19943706|NCT01496846|Anesthetics|anesthetics|mesh-ancestor
19943707|NCT01496846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19943708|NCT01496846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943709|NCT01496846|Sensory System Agents|sensory system agents|mesh-ancestor
19943710|NCT01496846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19943711|NCT01496846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19943712|NCT01496846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19943713|NCT01496846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19943714|NCT01496846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19943715|NCT01496846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943716|NCT01497197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19943717|NCT01497197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19943718|NCT01497197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943719|NCT01497262|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19943720|NCT01497262|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19943721|NCT01497262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943722|NCT01497262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19943723|NCT01497262|Immunologic Factors|immunologic factors|mesh-ancestor
19943724|NCT01497262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943725|NCT01497275|Rituximab|rituximab|mesh-list
19943726|NCT01497275|Bortezomib|bortezomib|mesh-list
19943727|NCT01497275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19943728|NCT01497275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943729|NCT01497275|Immunologic Factors|immunologic factors|mesh-ancestor
19943730|NCT01497275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943731|NCT01497275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19943732|NCT01497366|Sofosbuvir|sofosbuvir|mesh-list
19943733|NCT01497366|Antiviral Agents|antiviral agents|mesh-ancestor
19943734|NCT01497366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19943735|NCT01497496|Methylprednisolone|methylprednisolone|mesh-list
19943736|NCT01497496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19943737|NCT01497496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19943738|NCT01497496|Prednisolone|prednisolone|mesh-list
19943739|NCT01497496|Prednisolone acetate|prednisolone acetate|mesh-list
19943740|NCT01497496|Lenalidomide|lenalidomide|mesh-list
19943741|NCT01497496|Ofatumumab|ofatumumab|mesh-list
19943742|NCT01497496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19943743|NCT01497496|Prednisolone phosphate|prednisolone phosphate|mesh-list
19943744|NCT01497496|Immunologic Factors|immunologic factors|mesh-ancestor
19943745|NCT01497496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943746|NCT01497496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19943747|NCT01497496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19943748|NCT01497496|Growth Substances|growth substances|mesh-ancestor
19943749|NCT01497496|Growth Inhibitors|growth inhibitors|mesh-ancestor
19943750|NCT01497496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943751|NCT01497496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19943752|NCT01497496|Antiemetics|antiemetics|mesh-ancestor
19943753|NCT01497496|Autonomic Agents|autonomic agents|mesh-ancestor
19943754|NCT01497496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19943755|NCT01497496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19943756|NCT01497496|Glucocorticoids|glucocorticoids|mesh-ancestor
19943757|NCT01497496|Hormones|hormones|mesh-ancestor
19943758|NCT01497496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19943759|NCT01497496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19943760|NCT01497496|Protective Agents|protective agents|mesh-ancestor
19943761|NCT01497496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19943762|NCT01497808|Ipilimumab|ipilimumab|mesh-list
19943763|NCT01497808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19943764|NCT01497808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943765|NCT01497808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19943766|NCT01497808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943767|NCT01497860|Vinorelbine|vinorelbine|mesh-list
19943768|NCT01497860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19943769|NCT01497860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943770|NCT01497860|Tubulin Modulators|tubulin modulators|mesh-ancestor
19943771|NCT01497860|Antimitotic Agents|antimitotic agents|mesh-ancestor
19943772|NCT01497860|Mitosis Modulators|mitosis modulators|mesh-ancestor
19943773|NCT01497860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943774|NCT01497899|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19943775|NCT01497899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19943776|NCT01497899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19943777|NCT01497899|Antiviral Agents|antiviral agents|mesh-ancestor
19943778|NCT01497899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19943779|NCT01497938|Insulin|insulin|mesh-list
19943780|NCT01497938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19943781|NCT01497938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943782|NCT01498068|Interferons|interferons|mesh-list
19943783|NCT01498068|Ribavirin|ribavirin|mesh-list
19943784|NCT01498068|Interferon-alpha|interferon-alpha|mesh-list
19943785|NCT01498068|Interferon alpha-2|interferon alpha-2|mesh-list
19943786|NCT01498068|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19943787|NCT01498068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943788|NCT01498068|Antiviral Agents|antiviral agents|mesh-ancestor
19943789|NCT01498068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19943790|NCT01498068|Antimetabolites|antimetabolites|mesh-ancestor
19943791|NCT01498068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943792|NCT01498068|Immunologic Factors|immunologic factors|mesh-ancestor
19943793|NCT01498068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943794|NCT01498120|Rotigotine|rotigotine|mesh-list
19943795|NCT01498120|Dopamine Agonists|dopamine agonists|mesh-ancestor
19943796|NCT01498120|Dopamine Agents|dopamine agents|mesh-ancestor
19943797|NCT01498120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19943798|NCT01498120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943799|NCT01498120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943800|NCT01498185|Dapagliflozin|dapagliflozin|mesh-list
19943801|NCT01498185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19943802|NCT01498185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943803|NCT01498185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19943804|NCT01498185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943805|NCT01498289|Leucovorin|leucovorin|mesh-list
19943806|NCT01498289|Docetaxel|docetaxel|mesh-list
19943807|NCT01498289|Fluorouracil|fluorouracil|mesh-list
19943808|NCT01498289|Oxaliplatin|oxaliplatin|mesh-list
19943809|NCT01498289|Irinotecan|irinotecan|mesh-list
19943810|NCT01498289|Calcium|calcium|mesh-list
19943811|NCT01498289|Levoleucovorin|levoleucovorin|mesh-list
19943812|NCT01498289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943813|NCT01498289|Tubulin Modulators|tubulin modulators|mesh-ancestor
19943814|NCT01498289|Antimitotic Agents|antimitotic agents|mesh-ancestor
19943815|NCT01498289|Mitosis Modulators|mitosis modulators|mesh-ancestor
19943816|NCT01498289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943817|NCT01498289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19943818|NCT01498289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943819|NCT01498289|Antimetabolites|antimetabolites|mesh-ancestor
19943820|NCT01498289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19943821|NCT01498289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19943822|NCT01498289|Immunologic Factors|immunologic factors|mesh-ancestor
20267716|NCT00526305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20267717|NCT00526305|Glucocorticoids|glucocorticoids|mesh-ancestor
20267718|NCT00526305|Hormones|hormones|mesh-ancestor
20267719|NCT00526305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20267720|NCT00526305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20267721|NCT00526305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20267722|NCT00526305|Tubulin Modulators|tubulin modulators|mesh-ancestor
20267723|NCT00526305|Antimitotic Agents|antimitotic agents|mesh-ancestor
20267724|NCT00526305|Mitosis Modulators|mitosis modulators|mesh-ancestor
20267725|NCT00526305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20267726|NCT00526305|Antimetabolites|antimetabolites|mesh-ancestor
20267727|NCT00526305|Antiviral Agents|antiviral agents|mesh-ancestor
20267728|NCT00526305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20267729|NCT00526305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20267730|NCT00526305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20267731|NCT00526305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20267732|NCT00526305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267733|NCT00526305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20267734|NCT00526305|Analgesics|analgesics|mesh-ancestor
20267735|NCT00526305|Sensory System Agents|sensory system agents|mesh-ancestor
20267736|NCT00526318|Cyclophosphamide|cyclophosphamide|mesh-list
20267737|NCT00526318|Melphalan|melphalan|mesh-list
20267738|NCT00526318|Ifosfamide|ifosfamide|mesh-list
20267739|NCT00526318|Dacarbazine|dacarbazine|mesh-list
20267740|NCT00526318|Carboplatin|carboplatin|mesh-list
20267741|NCT00526318|Doxorubicin|doxorubicin|mesh-list
20267742|NCT00526318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20267743|NCT00526318|Etoposide|etoposide|mesh-list
20267744|NCT00526318|Vincristine|vincristine|mesh-list
20267745|NCT00526318|Topotecan|topotecan|mesh-list
20267746|NCT00526318|Etoposide phosphate|etoposide phosphate|mesh-list
20267747|NCT00526318|Vindesine|vindesine|mesh-list
20267748|NCT00526318|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20267749|NCT00526318|Isotretinoin|isotretinoin|mesh-list
20267750|NCT00526318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20267751|NCT00526318|Immunologic Factors|immunologic factors|mesh-ancestor
20267752|NCT00526318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267753|NCT00526318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20267754|NCT00526318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20267755|NCT00526318|Alkylating Agents|alkylating agents|mesh-ancestor
20267756|NCT00526318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267757|NCT00526318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267758|NCT00526318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20267759|NCT00526318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20267760|NCT00526318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20267761|NCT00526318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20267762|NCT00526318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267763|NCT00526318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20267764|NCT00526318|Tubulin Modulators|tubulin modulators|mesh-ancestor
20267765|NCT00526318|Antimitotic Agents|antimitotic agents|mesh-ancestor
20267766|NCT00526318|Mitosis Modulators|mitosis modulators|mesh-ancestor
20267767|NCT00526318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19943823|NCT01498289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20267768|NCT00526318|Dermatologic Agents|dermatologic agents|mesh-ancestor
20267769|NCT00526318|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19943824|NCT01498289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19943825|NCT01498289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943826|NCT01498289|Antidotes|antidotes|mesh-ancestor
19943827|NCT01498289|Protective Agents|protective agents|mesh-ancestor
19943828|NCT01498289|Vitamin B Complex|vitamin b complex|mesh-ancestor
19943829|NCT01498289|Vitamins|vitamins|mesh-ancestor
19943830|NCT01498289|Micronutrients|micronutrients|mesh-ancestor
19943831|NCT01498419|Moxifloxacin|moxifloxacin|mesh-list
19943832|NCT01498419|Pyrazinamide|pyrazinamide|mesh-list
19943833|NCT01498419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19943834|NCT01498419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19943835|NCT01498419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19943836|NCT01498419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19943837|NCT01498419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943838|NCT01498419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267770|NCT00526383|Antidepressive Agents|antidepressive agents|mesh-list
20267771|NCT00526383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
20267772|NCT00526383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20267773|NCT00526396|Cisplatin|cisplatin|mesh-list
19943839|NCT01498419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19973967|NCT01830816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267774|NCT00526396|Etoposide|etoposide|mesh-list
19943840|NCT01498419|Antitubercular Agents|antitubercular agents|mesh-ancestor
19943841|NCT01498445|Decitabine|decitabine|mesh-list
19943842|NCT01498445|Dasatinib|dasatinib|mesh-list
19943843|NCT01498445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19943844|NCT01498445|Antimetabolites|antimetabolites|mesh-ancestor
19943845|NCT01498445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943846|NCT01498445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943847|NCT01498445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943848|NCT01498445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19943849|NCT01498458|Capecitabine|capecitabine|mesh-list
19943850|NCT01498458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19943851|NCT01498458|Antimetabolites|antimetabolites|mesh-ancestor
19943852|NCT01498458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943853|NCT01498458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943854|NCT01498549|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19943855|NCT01498549|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19943856|NCT01498549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19943857|NCT01498549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19943858|NCT01498549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943859|NCT01498549|Adrenergic Agents|adrenergic agents|mesh-ancestor
19943860|NCT01498549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19943861|NCT01498549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943862|NCT01498588|Cyclophosphamide|cyclophosphamide|mesh-list
19943863|NCT01498588|Doxorubicin|doxorubicin|mesh-list
19943864|NCT01498588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19943865|NCT01498588|Immunologic Factors|immunologic factors|mesh-ancestor
19943866|NCT01498588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943867|NCT01498588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19943868|NCT01498588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19943869|NCT01498588|Alkylating Agents|alkylating agents|mesh-ancestor
19943870|NCT01498588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943871|NCT01498588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943872|NCT01498588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19943873|NCT01498588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19943874|NCT01498588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19943875|NCT01498588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19943876|NCT01498588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943877|NCT01498679|Fluticasone|fluticasone|mesh-list
19943878|NCT01498679|Xhance|xhance|mesh-list
19943879|NCT01498679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19943880|NCT01498679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19943881|NCT01498679|Autonomic Agents|autonomic agents|mesh-ancestor
19943882|NCT01498679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19943883|NCT01498679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943884|NCT01498679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19943885|NCT01498679|Respiratory System Agents|respiratory system agents|mesh-ancestor
19943886|NCT01498679|Dermatologic Agents|dermatologic agents|mesh-ancestor
19943887|NCT01498679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19943888|NCT01498744|Clindamycin|clindamycin|mesh-list
19943889|NCT01498744|Clindamycin palmitate|clindamycin palmitate|mesh-list
19943890|NCT01498744|Clindamycin phosphate|clindamycin phosphate|mesh-list
19943891|NCT01498744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19943892|NCT01498744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19943893|NCT01498744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19943894|NCT01498744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943895|NCT01498744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943896|NCT01498822|Oxcarbazepine|oxcarbazepine|mesh-list
19943897|NCT01498822|Levetiracetam|levetiracetam|mesh-list
19943898|NCT01498822|Anticonvulsants|anticonvulsants|mesh-ancestor
19943899|NCT01498822|Nootropic Agents|nootropic agents|mesh-ancestor
19943900|NCT01498822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19943901|NCT01498822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19943902|NCT01498822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19943903|NCT01498822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267775|NCT00526396|Etoposide phosphate|etoposide phosphate|mesh-list
19943904|NCT01498822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19943905|NCT01498822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19943906|NCT01498887|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19943907|NCT01498887|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19943908|NCT01498887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943909|NCT01498887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19943910|NCT01498887|Immunologic Factors|immunologic factors|mesh-ancestor
19943911|NCT01498887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943912|NCT01498952|Sorafenib|sorafenib|mesh-list
19943913|NCT01498952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943914|NCT01498952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19943915|NCT01498952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943916|NCT01498952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943917|NCT01498978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19943918|NCT01498978|Ipilimumab|ipilimumab|mesh-list
19943919|NCT01498978|Antibodies|antibodies|mesh-list
19943920|NCT01498978|Immunoglobulins|immunoglobulins|mesh-list
19943921|NCT01498978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19943922|NCT01498978|Immunologic Factors|immunologic factors|mesh-ancestor
19943923|NCT01498978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943924|NCT01498978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943925|NCT01498978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19943926|NCT01498978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943927|NCT01499134|Metoprolol|metoprolol|mesh-list
19943928|NCT01499134|Nebivolol|nebivolol|mesh-list
19943929|NCT01499134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19943930|NCT01499134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19943931|NCT01499134|Sympatholytics|sympatholytics|mesh-ancestor
19943932|NCT01499134|Autonomic Agents|autonomic agents|mesh-ancestor
19943933|NCT01499134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19943934|NCT01499134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943935|NCT01499134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19943936|NCT01499134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19943937|NCT01499134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19943938|NCT01499134|Adrenergic Agents|adrenergic agents|mesh-ancestor
19943939|NCT01499134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19943940|NCT01499134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943941|NCT01499134|Vasodilator Agents|vasodilator agents|mesh-ancestor
19943942|NCT01499134|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19943943|NCT01499134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20267776|NCT00526396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267777|NCT00526396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20267778|NCT00526396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20267779|NCT00526396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20267780|NCT00526396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267781|NCT00526396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267782|NCT00526409|Cytarabine|cytarabine|mesh-list
20267783|NCT00526409|Prednisolone|prednisolone|mesh-list
20267784|NCT00526409|Cyclophosphamide|cyclophosphamide|mesh-list
20267785|NCT00526409|Methotrexate|methotrexate|mesh-list
20267786|NCT00526409|Vincristine|vincristine|mesh-list
20267787|NCT00526409|Daunorubicin|daunorubicin|mesh-list
20267788|NCT00526409|Asparaginase|asparaginase|mesh-list
20267789|NCT00526409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20267790|NCT00526409|Immunologic Factors|immunologic factors|mesh-ancestor
20267791|NCT00526409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267792|NCT00526409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20267793|NCT00526409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20267794|NCT00526409|Alkylating Agents|alkylating agents|mesh-ancestor
20267795|NCT00526409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267796|NCT00526409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267797|NCT00526409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20267798|NCT00526409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20267799|NCT00526409|Abortifacient Agents|abortifacient agents|mesh-ancestor
20267800|NCT00526409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20267801|NCT00526409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20267802|NCT00526409|Antimetabolites|antimetabolites|mesh-ancestor
20267803|NCT00526409|Dermatologic Agents|dermatologic agents|mesh-ancestor
20267804|NCT00526409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267805|NCT00526409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20267806|NCT00526409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20267807|NCT00526409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20267808|NCT00526409|Tubulin Modulators|tubulin modulators|mesh-ancestor
19943944|NCT01499134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19943945|NCT01499147|Vidarabine|vidarabine|mesh-list
19943946|NCT01499147|Fludarabine|fludarabine|mesh-list
19943947|NCT01499147|Fludarabine phosphate|fludarabine phosphate|mesh-list
19943948|NCT01499147|Melphalan|melphalan|mesh-list
19943949|NCT01499147|Busulfan|busulfan|mesh-list
19943950|NCT01499147|Thymoglobulin|thymoglobulin|mesh-list
19943951|NCT01499147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943952|NCT01499147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19943953|NCT01499147|Antimetabolites|antimetabolites|mesh-ancestor
19943954|NCT01499147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943955|NCT01499147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19943956|NCT01499147|Immunologic Factors|immunologic factors|mesh-ancestor
19943957|NCT01499147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19943958|NCT01499147|Antiviral Agents|antiviral agents|mesh-ancestor
19943959|NCT01499147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19943960|NCT01499147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19943961|NCT01499147|Alkylating Agents|alkylating agents|mesh-ancestor
19943962|NCT01499147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19943963|NCT01499199|Dolutegravir|dolutegravir|mesh-list
19943964|NCT01499199|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19943965|NCT01499199|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19943966|NCT01499199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943967|NCT01499199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943968|NCT01499199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19943969|NCT01499199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19943970|NCT01499199|Antiviral Agents|antiviral agents|mesh-ancestor
19943971|NCT01499199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19943972|NCT01499277|Vancomycin|vancomycin|mesh-list
19943973|NCT01499277|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19943974|NCT01499277|Aztreonam|aztreonam|mesh-list
19943975|NCT01499277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19943976|NCT01499277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19943977|NCT01499290|Metronidazole|metronidazole|mesh-list
19943978|NCT01499290|Meropenem|meropenem|mesh-list
19943979|NCT01499290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19943980|NCT01499290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19943981|NCT01499290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19943982|NCT01499290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19943983|NCT01499355|Mycophenolic Acid|mycophenolic acid|mesh-list
19943984|NCT01499355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19943985|NCT01499355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19943986|NCT01499355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19943987|NCT01499355|Antitubercular Agents|antitubercular agents|mesh-ancestor
19943988|NCT01499355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19943989|NCT01499355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19943990|NCT01499355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943991|NCT01499355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19943992|NCT01499368|Omeprazole|omeprazole|mesh-list
19943993|NCT01499368|Famotidine|famotidine|mesh-list
19943994|NCT01499368|Lafutidine|lafutidine|mesh-list
19943995|NCT01499368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19943996|NCT01499368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19943997|NCT01499368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19943998|NCT01499368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19943999|NCT01499368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944000|NCT01499368|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19944001|NCT01499368|Histamine Antagonists|histamine antagonists|mesh-ancestor
19944002|NCT01499368|Histamine Agents|histamine agents|mesh-ancestor
19944003|NCT01499368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944004|NCT01499368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944005|NCT01499498|Sildenafil Citrate|sildenafil citrate|mesh-list
19944006|NCT01499498|Vasodilator Agents|vasodilator agents|mesh-ancestor
19944007|NCT01499498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19944008|NCT01499498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19944009|NCT01499498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944010|NCT01499498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944011|NCT01499498|Urological Agents|urological agents|mesh-ancestor
19944012|NCT01499576|Acetic Acid|acetic acid|mesh-list
19944013|NCT01499576|Retinol acetate|retinol acetate|mesh-list
19944014|NCT01499576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19944015|NCT01499576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19944016|NCT01499576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20267809|NCT00526409|Antimitotic Agents|antimitotic agents|mesh-ancestor
19944017|NCT01499576|Immunologic Factors|immunologic factors|mesh-ancestor
19944018|NCT01499576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944019|NCT01499576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19944020|NCT01499576|Protective Agents|protective agents|mesh-ancestor
19944021|NCT01499576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19944022|NCT01499654|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
19944023|NCT01499654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19944024|NCT01499654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944025|NCT01499667|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19944026|NCT01499667|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19944027|NCT01499667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944028|NCT01499667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19944029|NCT01499667|Immunologic Factors|immunologic factors|mesh-ancestor
19944030|NCT01499667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944031|NCT01499849|Dexamethasone|dexamethasone|mesh-list
19944032|NCT01499849|Granisetron|granisetron|mesh-list
19944033|NCT01499849|Rolapitant|rolapitant|mesh-list
19944034|NCT01499849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19944035|NCT01499849|Antiemetics|antiemetics|mesh-ancestor
19944036|NCT01499849|Autonomic Agents|autonomic agents|mesh-ancestor
19944037|NCT01499849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944038|NCT01499849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944039|NCT01499849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19944040|NCT01499849|Glucocorticoids|glucocorticoids|mesh-ancestor
19944041|NCT01499849|Hormones|hormones|mesh-ancestor
19944042|NCT01499849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19944043|NCT01499849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19944044|NCT01499849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19944045|NCT01499849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19944046|NCT01499849|Serotonin Agents|serotonin agents|mesh-ancestor
19944047|NCT01499849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944048|NCT01499849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944049|NCT01499849|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19944050|NCT01499940|Vitamin D|vitamin d|mesh-list
19944051|NCT01499940|Cholecalciferol|cholecalciferol|mesh-list
19944052|NCT01499940|Vitamins|vitamins|mesh-ancestor
19944053|NCT01499940|Micronutrients|micronutrients|mesh-ancestor
19944054|NCT01499940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944055|NCT01499940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19944056|NCT01499940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19944057|NCT01500083|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19944058|NCT01500083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19944059|NCT01500083|Alkylating Agents|alkylating agents|mesh-ancestor
19944060|NCT01500083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944061|NCT01500083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19944062|NCT01500213|Dexamethasone|dexamethasone|mesh-list
19944063|NCT01500213|Granisetron|granisetron|mesh-list
19944064|NCT01500213|Rolapitant|rolapitant|mesh-list
19944065|NCT01500213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19944066|NCT01500213|Antiemetics|antiemetics|mesh-ancestor
19944067|NCT01500213|Autonomic Agents|autonomic agents|mesh-ancestor
19944068|NCT01500213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944069|NCT01500213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944070|NCT01500213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19944071|NCT01500213|Glucocorticoids|glucocorticoids|mesh-ancestor
19944072|NCT01500213|Hormones|hormones|mesh-ancestor
19944073|NCT01500213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19944074|NCT01500213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19944075|NCT01500213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19944076|NCT01500213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19944077|NCT01500213|Serotonin Agents|serotonin agents|mesh-ancestor
19944078|NCT01500213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944079|NCT01500213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944080|NCT01500213|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19944081|NCT01500226|Dexamethasone|dexamethasone|mesh-list
19944082|NCT01500226|Granisetron|granisetron|mesh-list
19944083|NCT01500226|Rolapitant|rolapitant|mesh-list
19944084|NCT01500226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19944085|NCT01500226|Antiemetics|antiemetics|mesh-ancestor
19944086|NCT01500226|Autonomic Agents|autonomic agents|mesh-ancestor
19944087|NCT01500226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944088|NCT01500226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944089|NCT01500226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19944090|NCT01500226|Glucocorticoids|glucocorticoids|mesh-ancestor
19944091|NCT01500226|Hormones|hormones|mesh-ancestor
19944092|NCT01500226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19944093|NCT01500226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19944094|NCT01500226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19944095|NCT01500226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19944096|NCT01500226|Serotonin Agents|serotonin agents|mesh-ancestor
19944097|NCT01500226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944098|NCT01500226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944099|NCT01500226|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19944100|NCT01500278|Adalimumab|adalimumab|mesh-list
19944101|NCT01500278|Methotrexate|methotrexate|mesh-list
19944102|NCT01500278|Certolizumab Pegol|certolizumab pegol|mesh-list
19944103|NCT01500278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19944104|NCT01500278|Abortifacient Agents|abortifacient agents|mesh-ancestor
19944105|NCT01500278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19944106|NCT01500278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944107|NCT01500278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19944108|NCT01500278|Antimetabolites|antimetabolites|mesh-ancestor
19944109|NCT01500278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944110|NCT01500278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19944111|NCT01500278|Dermatologic Agents|dermatologic agents|mesh-ancestor
19944112|NCT01500278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944113|NCT01500278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19944114|NCT01500278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19944115|NCT01500278|Immunologic Factors|immunologic factors|mesh-ancestor
19944116|NCT01500278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19944117|NCT01500278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19944118|NCT01500278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19944119|NCT01500317|Oxycodone|oxycodone|mesh-list
19944120|NCT01500317|Tapentadol|tapentadol|mesh-list
19944121|NCT01500317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19944122|NCT01500317|Narcotics|narcotics|mesh-ancestor
19944123|NCT01500317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19944124|NCT01500317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944125|NCT01500317|Analgesics|analgesics|mesh-ancestor
19944126|NCT01500317|Sensory System Agents|sensory system agents|mesh-ancestor
19944127|NCT01500317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944128|NCT01500317|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19944129|NCT01500317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19944130|NCT01500317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19944131|NCT01500317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944132|NCT01500317|Adrenergic Agents|adrenergic agents|mesh-ancestor
19944133|NCT01500317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944134|NCT01500382|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19944135|NCT01500382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19944136|NCT01500382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19944137|NCT01500382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19944138|NCT01500382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19944139|NCT01500382|Cholinergic Agents|cholinergic agents|mesh-ancestor
19944140|NCT01500382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944141|NCT01500382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944142|NCT01500382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944143|NCT01500382|Urological Agents|urological agents|mesh-ancestor
19944144|NCT01500434|Aspirin|aspirin|mesh-list
19944145|NCT01500434|Ticlopidine|ticlopidine|mesh-list
19944146|NCT01500434|Clopidogrel|clopidogrel|mesh-list
19944147|NCT01500434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19944148|NCT01500434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19944149|NCT01500434|Analgesics|analgesics|mesh-ancestor
19944150|NCT01500434|Sensory System Agents|sensory system agents|mesh-ancestor
19944151|NCT01500434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944152|NCT01500434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944153|NCT01500434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19944154|NCT01500434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19944155|NCT01500434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19944156|NCT01500434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19944157|NCT01500434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944158|NCT01500434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19944159|NCT01500434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19944160|NCT01500434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944161|NCT01500434|Antipyretics|antipyretics|mesh-ancestor
19944162|NCT01500434|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19944163|NCT01500434|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19944164|NCT01500434|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19944165|NCT01500434|Purinergic Agents|purinergic agents|mesh-ancestor
19944166|NCT01500434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20267810|NCT00526409|Mitosis Modulators|mitosis modulators|mesh-ancestor
19944167|NCT01500434|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19944168|NCT01500434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19944169|NCT01500694|Guanfacine|guanfacine|mesh-list
19944170|NCT01500694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19944171|NCT01500694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19944172|NCT01500694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19944173|NCT01500694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19944174|NCT01500694|Adrenergic Agents|adrenergic agents|mesh-ancestor
19944175|NCT01500694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944176|NCT01500694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944177|NCT01500694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973968|NCT01830816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973969|NCT01830842|Nicotine|nicotine|mesh-list
19973970|NCT01830842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19973971|NCT01830842|Autonomic Agents|autonomic agents|mesh-ancestor
19973972|NCT01830842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19973973|NCT01830842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973974|NCT01830842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19973975|NCT01830842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19973976|NCT01830842|Cholinergic Agents|cholinergic agents|mesh-ancestor
19973977|NCT01830842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19973978|NCT01830842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973979|NCT01830881|Ibuprofen|ibuprofen|mesh-list
19973980|NCT01830881|Lidocaine|lidocaine|mesh-list
19973981|NCT01830881|Midazolam|midazolam|mesh-list
19973982|NCT01830881|Anesthetics, Local|anesthetics, local|mesh-ancestor
19973983|NCT01830881|Anesthetics|anesthetics|mesh-ancestor
19973984|NCT01830881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19973985|NCT01830881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973986|NCT01830881|Sensory System Agents|sensory system agents|mesh-ancestor
19973987|NCT01830881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19973988|NCT01830881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20267811|NCT00526409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20267812|NCT00526409|Glucocorticoids|glucocorticoids|mesh-ancestor
20267813|NCT00526409|Hormones|hormones|mesh-ancestor
20267814|NCT00526409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20267815|NCT00526409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20267816|NCT00526409|Antiviral Agents|antiviral agents|mesh-ancestor
20267817|NCT00526409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20267818|NCT00526409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20267819|NCT00526409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20267820|NCT00526409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20267821|NCT00526448|Ribavirin|ribavirin|mesh-list
20267822|NCT00526448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20267823|NCT00526448|Antimetabolites|antimetabolites|mesh-ancestor
20267824|NCT00526448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267825|NCT00526448|Antiviral Agents|antiviral agents|mesh-ancestor
20267826|NCT00526448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20267827|NCT00526513|Insulin glulisine|insulin glulisine|mesh-list
20267828|NCT00526513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20267829|NCT00526513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267830|NCT00526617|Temozolomide|temozolomide|mesh-list
20267831|NCT00526617|Veliparib|veliparib|mesh-list
20267832|NCT00526617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20267833|NCT00526617|Alkylating Agents|alkylating agents|mesh-ancestor
20267834|NCT00526617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267835|NCT00526617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267836|NCT00526617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20267837|NCT00526617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267838|NCT00526643|Gemcitabine|gemcitabine|mesh-list
20267839|NCT00526643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267840|NCT00526643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20267841|NCT00526643|Antimetabolites|antimetabolites|mesh-ancestor
20267842|NCT00526643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267843|NCT00526643|Antiviral Agents|antiviral agents|mesh-ancestor
20543158|NCT01868438|Antiviral Agents|antiviral agents|mesh-ancestor
19973989|NCT01830881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20543159|NCT01868438|Schistosomicides|schistosomicides|mesh-ancestor
20543160|NCT01868438|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20543161|NCT01868438|Anthelmintics|anthelmintics|mesh-ancestor
20543162|NCT01868451|Doxorubicin|doxorubicin|mesh-list
20543163|NCT01868451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20543164|NCT01868451|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20543165|NCT01868451|Dacarbazine|dacarbazine|mesh-list
19732902|NCT04568603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944178|NCT01500720|Topotecan|topotecan|mesh-list
19944179|NCT01500720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19944180|NCT01500720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19944181|NCT01500720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944182|NCT01500720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944183|NCT01500720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19944184|NCT01501110|Acetylcysteine|acetylcysteine|mesh-list
19944185|NCT01501110|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19944186|NCT01501110|Antiviral Agents|antiviral agents|mesh-ancestor
19944187|NCT01501110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19944188|NCT01501110|Expectorants|expectorants|mesh-ancestor
19944189|NCT01501110|Respiratory System Agents|respiratory system agents|mesh-ancestor
19944190|NCT01501110|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19944191|NCT01501110|Antioxidants|antioxidants|mesh-ancestor
19944192|NCT01501110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944193|NCT01501110|Protective Agents|protective agents|mesh-ancestor
19944194|NCT01501110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944195|NCT01501110|Antidotes|antidotes|mesh-ancestor
19944196|NCT01501162|Ethanol|ethanol|mesh-list
19944197|NCT01501162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19944198|NCT01501162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19944199|NCT01501162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19944200|NCT01501162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944201|NCT01501929|Metoprolol|metoprolol|mesh-list
19944202|NCT01501929|Nebivolol|nebivolol|mesh-list
19944203|NCT01501929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19944204|NCT01501929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19944205|NCT01501929|Sympatholytics|sympatholytics|mesh-ancestor
19944206|NCT01501929|Autonomic Agents|autonomic agents|mesh-ancestor
19944207|NCT01501929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944208|NCT01501929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944209|NCT01501929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19944210|NCT01501929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19944211|NCT01501929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19944212|NCT01501929|Adrenergic Agents|adrenergic agents|mesh-ancestor
19944213|NCT01501929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944214|NCT01501929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944215|NCT01501929|Vasodilator Agents|vasodilator agents|mesh-ancestor
19944216|NCT01501929|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19944217|NCT01501929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19944218|NCT01501929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19944219|NCT01502072|Ribavirin|ribavirin|mesh-list
19944220|NCT01502072|Antimetabolites|antimetabolites|mesh-ancestor
19944221|NCT01502072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944222|NCT01502072|Antiviral Agents|antiviral agents|mesh-ancestor
19944223|NCT01502072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19944224|NCT01502228|Sunitinib|sunitinib|mesh-list
19944225|NCT01502228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19944226|NCT01502228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19944227|NCT01502228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19944228|NCT01502228|Growth Substances|growth substances|mesh-ancestor
19944229|NCT01502228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944230|NCT01502228|Growth Inhibitors|growth inhibitors|mesh-ancestor
19944231|NCT01502228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19944232|NCT01502228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944233|NCT01502228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944234|NCT01502293|Interleukin-12|interleukin-12|mesh-list
19944235|NCT01502293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19944236|NCT01502293|Immunologic Factors|immunologic factors|mesh-ancestor
19944237|NCT01502293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944238|NCT01502293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19944239|NCT01502293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19944240|NCT01502293|Growth Substances|growth substances|mesh-ancestor
19944241|NCT01502293|Growth Inhibitors|growth inhibitors|mesh-ancestor
19944242|NCT01502293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19944243|NCT01502306|Nicotine|nicotine|mesh-list
19944244|NCT01502306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19944245|NCT01502306|Autonomic Agents|autonomic agents|mesh-ancestor
19944246|NCT01502306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944247|NCT01502306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944248|NCT01502306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19944249|NCT01502306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19944250|NCT01502306|Cholinergic Agents|cholinergic agents|mesh-ancestor
19944251|NCT01502306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944252|NCT01502306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944253|NCT01502410|Sorafenib|sorafenib|mesh-list
19944254|NCT01502410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19944255|NCT01502410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19944256|NCT01502410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944257|NCT01502410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944258|NCT01502423|Adalimumab|adalimumab|mesh-list
19450239|NCT03430362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19450240|NCT03430362|Cholinergic Agents|cholinergic agents|mesh-ancestor
19450241|NCT03430362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450242|NCT03430362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450243|NCT03430362|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19450244|NCT03430362|Parasympatholytics|parasympatholytics|mesh-ancestor
19450245|NCT03430297|Dacarbazine|dacarbazine|mesh-list
19450246|NCT03430297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19450247|NCT03430297|Alkylating Agents|alkylating agents|mesh-ancestor
19450248|NCT03430297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450249|NCT03430297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450250|NCT03430180|Naloxone|naloxone|mesh-list
19450251|NCT03430180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19450252|NCT03430180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450253|NCT03430180|Sensory System Agents|sensory system agents|mesh-ancestor
19450254|NCT03430180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450255|NCT03430024|Estrogens|estrogens|mesh-list
19450256|NCT03430024|Hormones|hormones|mesh-ancestor
19450257|NCT03430024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19450258|NCT03430024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450259|NCT03429998|Evolocumab|evolocumab|mesh-list
19944259|NCT01502423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19944260|NCT01502423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19944261|NCT01502644|Morphine|morphine|mesh-list
19944262|NCT01502644|Oxycodone|oxycodone|mesh-list
19944263|NCT01502644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19944264|NCT01502644|Narcotics|narcotics|mesh-ancestor
19944265|NCT01502644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19944266|NCT01502644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944267|NCT01502644|Analgesics|analgesics|mesh-ancestor
19944268|NCT01502644|Sensory System Agents|sensory system agents|mesh-ancestor
19944269|NCT01502644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944270|NCT01502761|Magnesium Sulfate|magnesium sulfate|mesh-list
19944271|NCT01502761|Analgesics|analgesics|mesh-ancestor
19944272|NCT01502761|Sensory System Agents|sensory system agents|mesh-ancestor
19944273|NCT01502761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944274|NCT01502761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944275|NCT01502761|Anesthetics|anesthetics|mesh-ancestor
19944276|NCT01502761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19944277|NCT01502761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19944278|NCT01502761|Anticonvulsants|anticonvulsants|mesh-ancestor
19944279|NCT01502761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19944280|NCT01502761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19944281|NCT01502761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944282|NCT01502761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19944283|NCT01502761|Tocolytic Agents|tocolytic agents|mesh-ancestor
19944284|NCT01502761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19944285|NCT01502787|Metoprolol|metoprolol|mesh-list
19944286|NCT01502787|Nebivolol|nebivolol|mesh-list
19944287|NCT01502787|Angiotensin II|angiotensin ii|mesh-list
19944288|NCT01502787|Giapreza|giapreza|mesh-list
19944289|NCT01502787|Angiotensinogen|angiotensinogen|mesh-list
19944290|NCT01502787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19944291|NCT01502787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19944292|NCT01502787|Sympatholytics|sympatholytics|mesh-ancestor
19944293|NCT01502787|Autonomic Agents|autonomic agents|mesh-ancestor
19944294|NCT01502787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944295|NCT01502787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944296|NCT01502787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19944297|NCT01502787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19944298|NCT01502787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19944299|NCT01502787|Adrenergic Agents|adrenergic agents|mesh-ancestor
19944300|NCT01502787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944301|NCT01502787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944302|NCT01502787|Vasodilator Agents|vasodilator agents|mesh-ancestor
19944303|NCT01502787|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19944304|NCT01502787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19944305|NCT01502787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19944306|NCT01502787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19944307|NCT01502787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19944308|NCT01502787|Protease Inhibitors|protease inhibitors|mesh-ancestor
19944309|NCT01502787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944310|NCT01502813|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19944311|NCT01502813|Nootropic Agents|nootropic agents|mesh-ancestor
19944312|NCT01502956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19944313|NCT01502956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20267844|NCT00526643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20267845|NCT00526643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267846|NCT00526643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20267847|NCT00526643|Immunologic Factors|immunologic factors|mesh-ancestor
20267848|NCT00526643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267849|NCT00526695|Sevoflurane|sevoflurane|mesh-list
20267850|NCT00526695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20267851|NCT00526695|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20267852|NCT00526695|Anesthetics, General|anesthetics, general|mesh-ancestor
20267853|NCT00526695|Anesthetics|anesthetics|mesh-ancestor
20267854|NCT00526695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20267855|NCT00526695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267856|NCT00526734|Melphalan|melphalan|mesh-list
20267857|NCT00526734|Immunologic Factors|immunologic factors|mesh-ancestor
20267858|NCT00526734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267859|NCT00526734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20267860|NCT00526734|Alkylating Agents|alkylating agents|mesh-ancestor
20267861|NCT00526734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267862|NCT00526734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267863|NCT00526734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20267864|NCT00526734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20267865|NCT00526760|Dexmedetomidine|dexmedetomidine|mesh-list
20267866|NCT00526760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20267867|NCT00526760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20267868|NCT00526760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267869|NCT00526760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20267870|NCT00526760|Analgesics|analgesics|mesh-ancestor
20267871|NCT00526760|Sensory System Agents|sensory system agents|mesh-ancestor
20267872|NCT00526760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20267873|NCT00526760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20267874|NCT00526760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20267875|NCT00526760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20267876|NCT00526760|Adrenergic Agents|adrenergic agents|mesh-ancestor
20267877|NCT00526760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20267878|NCT00526760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267879|NCT00526877|Risperidone|risperidone|mesh-list
20267880|NCT00526877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20543166|NCT01868451|Vinblastine|vinblastine|mesh-list
20543167|NCT01868451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20543168|NCT01868451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543169|NCT01868451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20543170|NCT01868451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20543171|NCT01868451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944314|NCT01502956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944315|NCT01502956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944316|NCT01502956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19944317|NCT01502956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19944318|NCT01502956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944319|NCT01502956|Cholinergic Agents|cholinergic agents|mesh-ancestor
19944320|NCT01502956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944321|NCT01503229|Prednisone|prednisone|mesh-list
19944322|NCT01503229|Cortisone|cortisone|mesh-list
19944323|NCT01503229|Abiraterone Acetate|abiraterone acetate|mesh-list
19944324|NCT01503229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19944325|NCT01503229|Glucocorticoids|glucocorticoids|mesh-ancestor
19944326|NCT01503229|Hormones|hormones|mesh-ancestor
19944327|NCT01503229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19944328|NCT01503229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944329|NCT01503229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19944330|NCT01503229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19944331|NCT01503229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19944332|NCT01503229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944333|NCT01503229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944334|NCT01503229|Hormone Antagonists|hormone antagonists|mesh-ancestor
19944335|NCT01503229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19944336|NCT01503749|Lenograstim|lenograstim|mesh-list
19944337|NCT01503749|Sargramostim|sargramostim|mesh-list
19944338|NCT01503749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19944339|NCT01503749|Immunologic Factors|immunologic factors|mesh-ancestor
19944340|NCT01503749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944341|NCT01504204|Adapalene|adapalene|mesh-list
19944342|NCT01504204|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
19944343|NCT01504204|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19944344|NCT01504204|Dermatologic Agents|dermatologic agents|mesh-ancestor
19944345|NCT01504204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19944346|NCT01504204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19944347|NCT01504204|Analgesics|analgesics|mesh-ancestor
19944348|NCT01504204|Sensory System Agents|sensory system agents|mesh-ancestor
19944349|NCT01504204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944350|NCT01504204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944351|NCT01504204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19944352|NCT01504204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19944353|NCT01504412|Pregabalin|pregabalin|mesh-list
19944354|NCT01504412|Analgesics|analgesics|mesh-ancestor
19944355|NCT01504412|Sensory System Agents|sensory system agents|mesh-ancestor
19944356|NCT01504412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944357|NCT01504412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944358|NCT01504412|Anticonvulsants|anticonvulsants|mesh-ancestor
19944359|NCT01504412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19944360|NCT01504412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19944361|NCT01504412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944362|NCT01504412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19944363|NCT01504412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19944364|NCT01504412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19944365|NCT01504412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19944366|NCT01504412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19944367|NCT01504477|Bortezomib|bortezomib|mesh-list
19944368|NCT01504477|Panitumumab|panitumumab|mesh-list
19944369|NCT01504477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19944370|NCT01504477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19944371|NCT01504711|Fosaprepitant|fosaprepitant|mesh-list
19944372|NCT01504711|Aprepitant|aprepitant|mesh-list
19944373|NCT01504711|Antiemetics|antiemetics|mesh-ancestor
19944374|NCT01504711|Autonomic Agents|autonomic agents|mesh-ancestor
19944375|NCT01504711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944376|NCT01504711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944377|NCT01504711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19944378|NCT01504711|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19944379|NCT01504711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944380|NCT01504711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944381|NCT01504841|Etravirine|etravirine|mesh-list
19944382|NCT01504841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19944383|NCT01504841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19944384|NCT01504841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944385|NCT01504841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944386|NCT01504841|Antiviral Agents|antiviral agents|mesh-ancestor
19944387|NCT01504841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19944388|NCT01504854|Resveratrol|resveratrol|mesh-list
19944389|NCT01504854|Antioxidants|antioxidants|mesh-ancestor
19944390|NCT01504854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944391|NCT01504854|Protective Agents|protective agents|mesh-ancestor
19944392|NCT01504854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944393|NCT01504854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944394|NCT01504854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19944395|NCT01504867|Aspirin|aspirin|mesh-list
19944396|NCT01504867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19944397|NCT01504867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19944398|NCT01504867|Analgesics|analgesics|mesh-ancestor
19944399|NCT01504867|Sensory System Agents|sensory system agents|mesh-ancestor
19944400|NCT01504867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944401|NCT01504867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944402|NCT01504867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19944403|NCT01504867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19944404|NCT01504867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19944405|NCT01504867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19944406|NCT01504867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944407|NCT01504867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19944408|NCT01504867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19944409|NCT01504867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944410|NCT01504867|Antipyretics|antipyretics|mesh-ancestor
19944411|NCT01504971|Rabeprazole|rabeprazole|mesh-list
19944412|NCT01504971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19944413|NCT01504971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19944414|NCT01504971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19944415|NCT01504971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944416|NCT01504971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944417|NCT01505114|Tenofovir|tenofovir|mesh-list
19944418|NCT01505114|Emtricitabine|emtricitabine|mesh-list
19944419|NCT01505114|Maraviroc|maraviroc|mesh-list
19944420|NCT01505114|Antiviral Agents|antiviral agents|mesh-ancestor
19944421|NCT01505114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19944422|NCT01505114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19944423|NCT01505114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19944424|NCT01505114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944425|NCT01505114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944426|NCT01505114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19944427|NCT01505114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19944428|NCT01505114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19944429|NCT01505114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19944430|NCT01505114|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19944431|NCT01505179|Ranolazine|ranolazine|mesh-list
19944432|NCT01505179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19944433|NCT01505179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19944434|NCT01505179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944435|NCT01505491|Adalimumab|adalimumab|mesh-list
19944436|NCT01505491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19944437|NCT01505491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19944438|NCT01505634|Ciprofloxacin|ciprofloxacin|mesh-list
19944439|NCT01505634|Imipenem|imipenem|mesh-list
19944440|NCT01505634|Relebactam|relebactam|mesh-list
19944441|NCT01505634|Cilastatin|cilastatin|mesh-list
19944442|NCT01505634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19732903|NCT04568603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732904|NCT04568603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19732905|NCT04568603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19732906|NCT04568603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19732907|NCT04568876|Palmidrol|palmidrol|mesh-list
19732908|NCT04568876|Analgesics|analgesics|mesh-ancestor
19732909|NCT04568876|Sensory System Agents|sensory system agents|mesh-ancestor
19732910|NCT04568876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732911|NCT04568876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732912|NCT04568876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19732913|NCT04568876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19732914|NCT04568876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19732915|NCT04568876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19732916|NCT04568876|Antiviral Agents|antiviral agents|mesh-ancestor
19732917|NCT04568876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19732918|NCT04568876|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19944443|NCT01505634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19944444|NCT01505634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19944445|NCT01505634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19944446|NCT01505634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944447|NCT01505634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944448|NCT01505634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19944449|NCT01505634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19944450|NCT01505634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19944451|NCT01505634|Protease Inhibitors|protease inhibitors|mesh-ancestor
19944452|NCT01505634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19944453|NCT01505647|Vaccines|vaccines|mesh-list
19944454|NCT01505647|Immunologic Factors|immunologic factors|mesh-ancestor
19944455|NCT01505647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944456|NCT01505673|Liraglutide|liraglutide|mesh-list
19944457|NCT01505673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19944458|NCT01505673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944459|NCT01505673|Incretins|incretins|mesh-ancestor
19944460|NCT01505673|Hormones|hormones|mesh-ancestor
19944461|NCT01505673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19944462|NCT01505868|Carboplatin|carboplatin|mesh-list
19944463|NCT01505868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19944464|NCT01505881|Warfarin|warfarin|mesh-list
19944465|NCT01505881|Dabigatran|dabigatran|mesh-list
19944466|NCT01505881|Anticoagulants|anticoagulants|mesh-ancestor
19944467|NCT01505881|Antithrombins|antithrombins|mesh-ancestor
19944468|NCT01505881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19944469|NCT01505881|Protease Inhibitors|protease inhibitors|mesh-ancestor
19944470|NCT01505881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944471|NCT01505881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944472|NCT01505933|Dexmedetomidine|dexmedetomidine|mesh-list
19944473|NCT01505933|Propofol|propofol|mesh-list
19944474|NCT01505933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19944475|NCT01505933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19944476|NCT01505933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944477|NCT01505933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19944478|NCT01505933|Anesthetics, General|anesthetics, general|mesh-ancestor
19944479|NCT01505933|Anesthetics|anesthetics|mesh-ancestor
19944480|NCT01505933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19944481|NCT01505933|Analgesics|analgesics|mesh-ancestor
19944482|NCT01505933|Sensory System Agents|sensory system agents|mesh-ancestor
19944483|NCT01505933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944484|NCT01505933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19944485|NCT01505933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19944486|NCT01505933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19944487|NCT01505933|Adrenergic Agents|adrenergic agents|mesh-ancestor
19944488|NCT01505933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944489|NCT01505933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944490|NCT01506193|Vaccines|vaccines|mesh-list
19944491|NCT01506193|Immunologic Factors|immunologic factors|mesh-ancestor
19944492|NCT01506193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944493|NCT01506271|Imipenem|imipenem|mesh-list
19944494|NCT01506271|Relebactam|relebactam|mesh-list
19944495|NCT01506271|Cilastatin|cilastatin|mesh-list
19944496|NCT01506271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19944497|NCT01506271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19944498|NCT01506271|Protease Inhibitors|protease inhibitors|mesh-ancestor
19944499|NCT01506271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944500|NCT01506271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944501|NCT01506271|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19944502|NCT01506453|Gabapentin|gabapentin|mesh-list
19944503|NCT01506453|Analgesics|analgesics|mesh-ancestor
19944504|NCT01506453|Sensory System Agents|sensory system agents|mesh-ancestor
19944505|NCT01506453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944506|NCT01506453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267881|NCT00526877|Serotonin Agents|serotonin agents|mesh-ancestor
20267882|NCT00526877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20267883|NCT00526877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267884|NCT00526877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267885|NCT00526877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20267886|NCT00526877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20267887|NCT00526877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20267888|NCT00526877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20267889|NCT00526877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20267890|NCT00526877|Dopamine Agents|dopamine agents|mesh-ancestor
20267891|NCT00526929|Darbepoetin alfa|darbepoetin alfa|mesh-list
20267892|NCT00526929|Hematinics|hematinics|mesh-ancestor
20287294|NCT05195034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288572|NCT05304663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288573|NCT05304663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288574|NCT05303038|Bevacizumab|bevacizumab|mesh-list
20288575|NCT05303038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20288576|NCT05303038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288577|NCT05303038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20288578|NCT05303038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20288579|NCT05303038|Growth Substances|growth substances|mesh-ancestor
20288580|NCT05303038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288581|NCT05303038|Growth Inhibitors|growth inhibitors|mesh-ancestor
20288653|NCT05252988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288654|NCT05252988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20288655|NCT05248984|Ketorolac|ketorolac|mesh-list
20288656|NCT05248984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20288657|NCT05248984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20288658|NCT05248984|Analgesics|analgesics|mesh-ancestor
20288659|NCT05248984|Sensory System Agents|sensory system agents|mesh-ancestor
20288660|NCT05248984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20288661|NCT05248984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288662|NCT05248984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20288663|NCT05248984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20288664|NCT05248984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20288665|NCT05248984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19450260|NCT03429998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19732919|NCT04568876|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19732920|NCT04568876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19732921|NCT04568876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944507|NCT01506453|Anticonvulsants|anticonvulsants|mesh-ancestor
19944508|NCT01506453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19944509|NCT01506453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19944510|NCT01506453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19944511|NCT01506453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19944512|NCT01506453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19944513|NCT01506453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19944514|NCT01506453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944515|NCT01506453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944516|NCT01506453|Antimanic Agents|antimanic agents|mesh-ancestor
19944517|NCT01506609|Paclitaxel|paclitaxel|mesh-list
19944518|NCT01506609|Carboplatin|carboplatin|mesh-list
19944519|NCT01506609|Temozolomide|temozolomide|mesh-list
19944520|NCT01506609|Veliparib|veliparib|mesh-list
19944521|NCT01506609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19944522|NCT01506609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19944523|NCT01506609|Tubulin Modulators|tubulin modulators|mesh-ancestor
19944524|NCT01506609|Antimitotic Agents|antimitotic agents|mesh-ancestor
19944525|NCT01506609|Mitosis Modulators|mitosis modulators|mesh-ancestor
19944526|NCT01506609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944527|NCT01506609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19944528|NCT01506609|Alkylating Agents|alkylating agents|mesh-ancestor
19944529|NCT01506609|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19944530|NCT01506609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944531|NCT01506726|Salicylic Acid|salicylic acid|mesh-list
19944532|NCT01506726|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19944533|NCT01506726|Salicylates|salicylates|mesh-list
19944534|NCT01506726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19944535|NCT01506726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19944536|NCT01506726|Analgesics|analgesics|mesh-ancestor
19944537|NCT01506726|Sensory System Agents|sensory system agents|mesh-ancestor
19944538|NCT01506726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944539|NCT01506726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944540|NCT01506726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19944541|NCT01506726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19944542|NCT01506726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19944543|NCT01506726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944544|NCT01506726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944545|NCT01506726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19944546|NCT01506726|Antifungal Agents|antifungal agents|mesh-ancestor
19944547|NCT01506726|Keratolytic Agents|keratolytic agents|mesh-ancestor
19944548|NCT01506726|Dermatologic Agents|dermatologic agents|mesh-ancestor
19944549|NCT01506882|Levetiracetam|levetiracetam|mesh-list
19944550|NCT01506882|Anticonvulsants|anticonvulsants|mesh-ancestor
19944551|NCT01506882|Nootropic Agents|nootropic agents|mesh-ancestor
19944552|NCT01506908|Nicotine|nicotine|mesh-list
19944553|NCT01506908|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19944554|NCT01506908|Autonomic Agents|autonomic agents|mesh-ancestor
19944555|NCT01506908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944556|NCT01506908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944557|NCT01506908|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19944558|NCT01506908|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19944559|NCT01506908|Cholinergic Agents|cholinergic agents|mesh-ancestor
19944560|NCT01506908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944561|NCT01506908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944562|NCT01506947|Darbepoetin alfa|darbepoetin alfa|mesh-list
19944563|NCT01506947|Hematinics|hematinics|mesh-ancestor
19944564|NCT01507051|Vitamin K|vitamin k|mesh-list
19944565|NCT01507051|Vitamin K 1|vitamin k 1|mesh-list
19944566|NCT01507051|Warfarin|warfarin|mesh-list
19944567|NCT01507051|Rivaroxaban|rivaroxaban|mesh-list
19944568|NCT01507051|Vitamins|vitamins|mesh-ancestor
19944569|NCT01507051|Micronutrients|micronutrients|mesh-ancestor
19944570|NCT01507051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944571|NCT01507051|Anticoagulants|anticoagulants|mesh-ancestor
19944572|NCT01507051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19732922|NCT04568876|Hormones|hormones|mesh-ancestor
19732923|NCT04568876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19732924|NCT04568837|Dexamethasone|dexamethasone|mesh-list
19732925|NCT04568837|Dexamethasone acetate|dexamethasone acetate|mesh-list
19732926|NCT04568837|Prednisone|prednisone|mesh-list
19732927|NCT04568837|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19732928|NCT04568837|BB 1101|bb 1101|mesh-list
19732929|NCT04568837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19944573|NCT01507051|Antithrombins|antithrombins|mesh-ancestor
19944574|NCT01507051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19944575|NCT01507051|Protease Inhibitors|protease inhibitors|mesh-ancestor
19944576|NCT01507051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944577|NCT01507051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944578|NCT01507051|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19944579|NCT01507051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19944580|NCT01507051|Hemostatics|hemostatics|mesh-ancestor
19944581|NCT01507051|Coagulants|coagulants|mesh-ancestor
19944582|NCT01507103|Cyclophosphamide|cyclophosphamide|mesh-list
19944583|NCT01507103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19944584|NCT01507103|Immunologic Factors|immunologic factors|mesh-ancestor
19944585|NCT01507103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944586|NCT01507103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19944587|NCT01507103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19944588|NCT01507103|Alkylating Agents|alkylating agents|mesh-ancestor
19944589|NCT01507103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944590|NCT01507103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19944591|NCT01507103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19944592|NCT01507181|Midazolam|midazolam|mesh-list
19944593|NCT01507181|Ketamine|ketamine|mesh-list
19944594|NCT01507181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
19944595|NCT01507181|N-Methylaspartate|n-methylaspartate|mesh-list
19944596|NCT01507181|Analgesics|analgesics|mesh-ancestor
19944597|NCT01507181|Sensory System Agents|sensory system agents|mesh-ancestor
19944598|NCT01507181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944599|NCT01507181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944600|NCT01507181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19944601|NCT01507181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19944602|NCT01507181|Anesthetics, General|anesthetics, general|mesh-ancestor
19944603|NCT01507181|Anesthetics|anesthetics|mesh-ancestor
19944604|NCT01507181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19944605|NCT01507181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19944606|NCT01507181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944607|NCT01507181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944608|NCT01507181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19944609|NCT01507181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19944610|NCT01507181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19944611|NCT01507181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19944612|NCT01507181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19944613|NCT01507181|GABA Modulators|gaba modulators|mesh-ancestor
19944614|NCT01507181|GABA Agents|gaba agents|mesh-ancestor
19944615|NCT01507181|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
19944616|NCT01507220|Morphine|morphine|mesh-list
19944617|NCT01507220|Bupivacaine|bupivacaine|mesh-list
19944618|NCT01507220|Anesthetics, Local|anesthetics, local|mesh-ancestor
19944619|NCT01507220|Anesthetics|anesthetics|mesh-ancestor
19944620|NCT01507220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19944621|NCT01507220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944622|NCT01507220|Sensory System Agents|sensory system agents|mesh-ancestor
19944623|NCT01507220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944624|NCT01507220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19944625|NCT01507220|Narcotics|narcotics|mesh-ancestor
19944626|NCT01507220|Analgesics|analgesics|mesh-ancestor
19944627|NCT01507246|Morphine|morphine|mesh-list
19944628|NCT01507246|Bupivacaine|bupivacaine|mesh-list
19944629|NCT01507246|Anesthetics, Local|anesthetics, local|mesh-ancestor
19944630|NCT01507246|Anesthetics|anesthetics|mesh-ancestor
19944631|NCT01507246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19944632|NCT01507246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944633|NCT01507246|Sensory System Agents|sensory system agents|mesh-ancestor
19944634|NCT01507246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944635|NCT01507246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19944636|NCT01507246|Narcotics|narcotics|mesh-ancestor
19944637|NCT01507246|Analgesics|analgesics|mesh-ancestor
19944638|NCT01507779|Vaccines|vaccines|mesh-list
19944639|NCT01507779|Immunologic Factors|immunologic factors|mesh-ancestor
19944640|NCT01507779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944641|NCT01507831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19944642|NCT01507831|Immunologic Factors|immunologic factors|mesh-ancestor
19944643|NCT01507831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944644|NCT01508117|Axitinib|axitinib|mesh-list
19944645|NCT01508117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19944646|NCT01508117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19944647|NCT01508117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944648|NCT01508117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944649|NCT01508325|Metoprolol|metoprolol|mesh-list
19944650|NCT01508325|Bisoprolol|bisoprolol|mesh-list
19944651|NCT01508325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19944652|NCT01508325|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19944653|NCT01508325|Sympatholytics|sympatholytics|mesh-ancestor
19944654|NCT01508325|Autonomic Agents|autonomic agents|mesh-ancestor
19944655|NCT01508325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944656|NCT01508325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944657|NCT01508325|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19944658|NCT01508325|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19944659|NCT01508325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19944660|NCT01508325|Adrenergic Agents|adrenergic agents|mesh-ancestor
19944661|NCT01508325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944662|NCT01508325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944663|NCT01508455|Fentanyl|fentanyl|mesh-list
19944664|NCT01508455|Midazolam|midazolam|mesh-list
19944665|NCT01508455|Dexmedetomidine|dexmedetomidine|mesh-list
19944666|NCT01508455|Morphine|morphine|mesh-list
19944667|NCT01508455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19944668|NCT01508455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19944669|NCT01508455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944670|NCT01508455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19944671|NCT01508455|Analgesics|analgesics|mesh-ancestor
19944672|NCT01508455|Sensory System Agents|sensory system agents|mesh-ancestor
19944673|NCT01508455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944674|NCT01508455|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19944675|NCT01508455|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19944676|NCT01508455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19944677|NCT01508455|Adrenergic Agents|adrenergic agents|mesh-ancestor
19944678|NCT01508455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944679|NCT01508455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944680|NCT01508455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19944681|NCT01508455|Narcotics|narcotics|mesh-ancestor
19944682|NCT01508455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19944683|NCT01508455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19944684|NCT01508455|Anesthetics, General|anesthetics, general|mesh-ancestor
19944685|NCT01508455|Anesthetics|anesthetics|mesh-ancestor
19944686|NCT01508455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19944687|NCT01508455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19944688|NCT01508455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19944689|NCT01508455|GABA Modulators|gaba modulators|mesh-ancestor
19944690|NCT01508455|GABA Agents|gaba agents|mesh-ancestor
19944691|NCT01508676|Diclofenac|diclofenac|mesh-list
19944692|NCT01508676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19944693|NCT01508676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19944694|NCT01508676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19944695|NCT01508676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19944696|NCT01508676|Analgesics|analgesics|mesh-ancestor
19944697|NCT01508676|Sensory System Agents|sensory system agents|mesh-ancestor
19944698|NCT01508676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944699|NCT01508676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944700|NCT01508676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19944701|NCT01508676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19944702|NCT01508676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944703|NCT01508676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944704|NCT01508702|Lesinurad|lesinurad|mesh-list
19944705|NCT01508702|Gout Suppressants|gout suppressants|mesh-ancestor
19944706|NCT01508702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19944707|NCT01508702|Uricosuric Agents|uricosuric agents|mesh-ancestor
19944708|NCT01508702|Renal Agents|renal agents|mesh-ancestor
19944709|NCT01508832|Lidocaine|lidocaine|mesh-list
19944710|NCT01508832|Bupivacaine|bupivacaine|mesh-list
19944711|NCT01508832|Anesthetics, Local|anesthetics, local|mesh-ancestor
19944712|NCT01508832|Anesthetics|anesthetics|mesh-ancestor
19944713|NCT01508832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19944714|NCT01508832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944715|NCT01508832|Sensory System Agents|sensory system agents|mesh-ancestor
19944716|NCT01508832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944717|NCT01508832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19944718|NCT01508832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19944719|NCT01508832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19944720|NCT01508832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19944721|NCT01508832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944722|NCT01508936|Reslizumab|reslizumab|mesh-list
19944723|NCT01508936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19944724|NCT01508936|Respiratory System Agents|respiratory system agents|mesh-ancestor
19944725|NCT01509079|Vitamin D|vitamin d|mesh-list
19944726|NCT01509079|Ergocalciferols|ergocalciferols|mesh-list
19944727|NCT01509079|Cholecalciferol|cholecalciferol|mesh-list
19944728|NCT01509079|Vitamins|vitamins|mesh-list
19944729|NCT01509079|Micronutrients|micronutrients|mesh-ancestor
19944730|NCT01509079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944731|NCT01509079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19944732|NCT01509079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19944733|NCT01509105|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19944734|NCT01509105|Immunologic Factors|immunologic factors|mesh-ancestor
19944735|NCT01509105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944736|NCT01509404|Valganciclovir|valganciclovir|mesh-list
19944737|NCT01509404|Antiviral Agents|antiviral agents|mesh-ancestor
19944738|NCT01509404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19944739|NCT01509547|Varenicline|varenicline|mesh-list
19944740|NCT01509547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19944741|NCT01509547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19944742|NCT01509547|Cholinergic Agents|cholinergic agents|mesh-ancestor
19944743|NCT01509547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944744|NCT01509547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944745|NCT01509547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19973990|NCT01830881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19973991|NCT01830881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19973992|NCT01830881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19973993|NCT01830881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19973994|NCT01830881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20267893|NCT00527020|Nicotine|nicotine|mesh-list
20267894|NCT00527020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20267895|NCT00527020|Autonomic Agents|autonomic agents|mesh-ancestor
20267896|NCT00527020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20267897|NCT00527020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267898|NCT00527020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20267899|NCT00527020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20267900|NCT00527020|Cholinergic Agents|cholinergic agents|mesh-ancestor
20267901|NCT00527020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20267902|NCT00527020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267903|NCT00527033|Mirabegron|mirabegron|mesh-list
20267904|NCT00527033|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20267905|NCT00527033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20267906|NCT00527033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20267907|NCT00527033|Adrenergic Agents|adrenergic agents|mesh-ancestor
20267908|NCT00527033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20267909|NCT00527033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267910|NCT00527033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267911|NCT00527033|Urological Agents|urological agents|mesh-ancestor
20267912|NCT00527059|Simendan|simendan|mesh-list
20267913|NCT00527059|Spironolactone|spironolactone|mesh-list
20267914|NCT00527059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20267915|NCT00527059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20267916|NCT00527059|Hormone Antagonists|hormone antagonists|mesh-ancestor
20267917|NCT00527059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20267918|NCT00527059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267919|NCT00527059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20267920|NCT00527059|Diuretics|diuretics|mesh-ancestor
20267921|NCT00527059|Natriuretic Agents|natriuretic agents|mesh-ancestor
20267922|NCT00527059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20267923|NCT00527059|Adrenergic Agents|adrenergic agents|mesh-ancestor
20267924|NCT00527059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20267925|NCT00527059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267926|NCT00527059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20267927|NCT00527059|Vasodilator Agents|vasodilator agents|mesh-ancestor
20267928|NCT00527059|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20267929|NCT00527059|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20267930|NCT00527059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267931|NCT00527059|Protective Agents|protective agents|mesh-ancestor
20267932|NCT00527085|Cinacalcet|cinacalcet|mesh-list
19973995|NCT01830881|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19973996|NCT01830881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19973997|NCT01830881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19973998|NCT01830881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19973999|NCT01830881|Anesthetics, General|anesthetics, general|mesh-ancestor
19974000|NCT01830881|GABA Modulators|gaba modulators|mesh-ancestor
19974001|NCT01830881|GABA Agents|gaba agents|mesh-ancestor
19974002|NCT01830881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20267933|NCT00527085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19944746|NCT01509586|Lobeline|lobeline|mesh-list
19944747|NCT01509586|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19944748|NCT01509586|Autonomic Agents|autonomic agents|mesh-ancestor
19944749|NCT01509586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944750|NCT01509586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944751|NCT01509586|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19944752|NCT01509586|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20267934|NCT00527085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267935|NCT00527085|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20267936|NCT00527085|Hormone Antagonists|hormone antagonists|mesh-ancestor
20267937|NCT00527085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20267938|NCT00527137|Darbepoetin alfa|darbepoetin alfa|mesh-list
20267939|NCT00527137|Hematinics|hematinics|mesh-ancestor
20267940|NCT00527150|Varenicline|varenicline|mesh-list
20267941|NCT00527150|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20267942|NCT00527150|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20267943|NCT00527150|Cholinergic Agents|cholinergic agents|mesh-ancestor
20267944|NCT00527150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20267945|NCT00527150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267946|NCT00527150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267947|NCT00527202|Botulinum Toxins|botulinum toxins|mesh-list
20267948|NCT00527202|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20267949|NCT00527202|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20267950|NCT00527202|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20543172|NCT01868451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543173|NCT01868451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20543174|NCT01868451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20543175|NCT01868451|Alkylating Agents|alkylating agents|mesh-ancestor
20543176|NCT01868451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20543177|NCT01868451|Tubulin Modulators|tubulin modulators|mesh-ancestor
20543178|NCT01868451|Antimitotic Agents|antimitotic agents|mesh-ancestor
20543179|NCT01868451|Mitosis Modulators|mitosis modulators|mesh-ancestor
20543180|NCT01868464|BCG Vaccine|bcg vaccine|mesh-list
20543181|NCT01868464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20543182|NCT01868464|Immunologic Factors|immunologic factors|mesh-ancestor
20543183|NCT01868464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543184|NCT01868529|Insulin|insulin|mesh-list
20543185|NCT01868529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20543186|NCT01868529|Insulin Glargine|insulin glargine|mesh-list
20543187|NCT01868529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20543188|NCT01868529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543189|NCT01868555|Insulin|insulin|mesh-list
20543190|NCT01868555|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20543191|NCT01868555|Insulin Aspart|insulin aspart|mesh-list
20543192|NCT01868555|Insulin, Long-Acting|insulin, long-acting|mesh-list
20543193|NCT01868555|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20543194|NCT01868555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20543195|NCT01868555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543196|NCT01868568|Insulin|insulin|mesh-list
20543197|NCT01868568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20543198|NCT01868568|Insulin Aspart|insulin aspart|mesh-list
20543199|NCT01868568|Insulin, Long-Acting|insulin, long-acting|mesh-list
20543200|NCT01868568|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20543201|NCT01868568|Biphasic Insulins|biphasic insulins|mesh-list
20543202|NCT01868568|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20543203|NCT01868568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20543204|NCT01868568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543205|NCT01868581|Insulin|insulin|mesh-list
20543206|NCT01868581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20543207|NCT01868581|Insulin Aspart|insulin aspart|mesh-list
20543208|NCT01868581|Insulin, Long-Acting|insulin, long-acting|mesh-list
20543209|NCT01868581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20543210|NCT01868581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543211|NCT01868750|Calcitriol|calcitriol|mesh-list
20543212|NCT01868750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20543213|NCT01868750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543214|NCT01868750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20543215|NCT01868750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20543216|NCT01868750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543217|NCT01868750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20543218|NCT01868750|Vitamins|vitamins|mesh-ancestor
20543219|NCT01868750|Micronutrients|micronutrients|mesh-ancestor
19732930|NCT04568837|Antiemetics|antiemetics|mesh-ancestor
19944753|NCT01509586|Cholinergic Agents|cholinergic agents|mesh-ancestor
20287295|NCT05177614|Micronutrients|micronutrients|mesh-list
19944754|NCT01509586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944755|NCT01509586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944756|NCT01509586|Respiratory System Agents|respiratory system agents|mesh-ancestor
19944757|NCT01509625|Fulvestrant|fulvestrant|mesh-list
19944758|NCT01509625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19944759|NCT01509625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19944760|NCT01509625|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19944761|NCT01509625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19944762|NCT01509625|Hormone Antagonists|hormone antagonists|mesh-ancestor
19944763|NCT01509625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19944764|NCT01509625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944765|NCT01509638|Bupivacaine|bupivacaine|mesh-list
19944766|NCT01509638|Anesthetics, Local|anesthetics, local|mesh-ancestor
19944767|NCT01509638|Anesthetics|anesthetics|mesh-ancestor
19944768|NCT01509638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19944769|NCT01509638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944770|NCT01509638|Sensory System Agents|sensory system agents|mesh-ancestor
19944771|NCT01509638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944772|NCT01509807|Morphine|morphine|mesh-list
19944773|NCT01509807|Bupivacaine|bupivacaine|mesh-list
19944774|NCT01509807|Anesthetics, Local|anesthetics, local|mesh-ancestor
19944775|NCT01509807|Anesthetics|anesthetics|mesh-ancestor
19944776|NCT01509807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19944777|NCT01509807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944778|NCT01509807|Sensory System Agents|sensory system agents|mesh-ancestor
19944779|NCT01509807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944780|NCT01509807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19944781|NCT01509807|Narcotics|narcotics|mesh-ancestor
20267951|NCT00527202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20267952|NCT00527202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267953|NCT00527202|Cholinergic Agents|cholinergic agents|mesh-ancestor
20267954|NCT00527202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20267955|NCT00527202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267956|NCT00527202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20267957|NCT00527202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20267958|NCT00527215|Darbepoetin alfa|darbepoetin alfa|mesh-list
20267959|NCT00527215|Hematinics|hematinics|mesh-ancestor
20267960|NCT00527228|Deflazacort|deflazacort|mesh-list
20543220|NCT01868750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20543221|NCT01868802|Ketamine|ketamine|mesh-list
20543222|NCT01868802|Analgesics|analgesics|mesh-ancestor
20543223|NCT01868802|Sensory System Agents|sensory system agents|mesh-ancestor
20543224|NCT01868802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543225|NCT01868802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543226|NCT01868802|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20543227|NCT01868802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20543228|NCT01868802|Anesthetics, General|anesthetics, general|mesh-ancestor
20543229|NCT01868802|Anesthetics|anesthetics|mesh-ancestor
20543230|NCT01868802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20543231|NCT01868802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20543232|NCT01868802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20543233|NCT01868802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20543234|NCT01868802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543235|NCT01868880|Bisoprolol|bisoprolol|mesh-list
20543236|NCT01868880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20543237|NCT01868880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20543238|NCT01868880|Adrenergic Agents|adrenergic agents|mesh-ancestor
20543239|NCT01868880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944782|NCT01509807|Analgesics|analgesics|mesh-ancestor
19944783|NCT01509846|Vaccines|vaccines|mesh-list
19944784|NCT01509846|Immunologic Factors|immunologic factors|mesh-ancestor
19944785|NCT01509846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944786|NCT01510145|Travoprost|travoprost|mesh-list
19944787|NCT01510145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19944788|NCT01510158|Allopurinol|allopurinol|mesh-list
19944789|NCT01510158|Lesinurad|lesinurad|mesh-list
19944790|NCT01510158|Antimetabolites|antimetabolites|mesh-ancestor
19944791|NCT01510158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944792|NCT01510158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944793|NCT01510158|Gout Suppressants|gout suppressants|mesh-ancestor
19944794|NCT01510158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19944795|NCT01510158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19944796|NCT01510158|Antioxidants|antioxidants|mesh-ancestor
19944797|NCT01510158|Protective Agents|protective agents|mesh-ancestor
19944798|NCT01510158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944799|NCT01510158|Uricosuric Agents|uricosuric agents|mesh-ancestor
19944800|NCT01510158|Renal Agents|renal agents|mesh-ancestor
19944801|NCT01510327|Aspirin|aspirin|mesh-list
19944802|NCT01510327|Everolimus|everolimus|mesh-list
19944803|NCT01510327|Ticlopidine|ticlopidine|mesh-list
19944804|NCT01510327|Clopidogrel|clopidogrel|mesh-list
19944805|NCT01510327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19944806|NCT01510327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19944807|NCT01510327|Analgesics|analgesics|mesh-ancestor
19944808|NCT01510327|Sensory System Agents|sensory system agents|mesh-ancestor
19944809|NCT01510327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944810|NCT01510327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944811|NCT01510327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19944812|NCT01510327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19944813|NCT01510327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19944814|NCT01510327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19944815|NCT01510327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944816|NCT01510327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19944817|NCT01510327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19944818|NCT01510327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944819|NCT01510327|Antipyretics|antipyretics|mesh-ancestor
19944820|NCT01510327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19944821|NCT01510327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19944822|NCT01510327|Immunologic Factors|immunologic factors|mesh-ancestor
19944823|NCT01510327|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19944824|NCT01510327|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19944825|NCT01510327|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19944826|NCT01510327|Purinergic Agents|purinergic agents|mesh-ancestor
19944827|NCT01510327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944828|NCT01510327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19944829|NCT01510327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19944830|NCT01510379|Promethazine|promethazine|mesh-list
19944831|NCT01510379|Diphenhydramine|diphenhydramine|mesh-list
19944832|NCT01510379|Ondansetron|ondansetron|mesh-list
19944833|NCT01510379|Antiemetics|antiemetics|mesh-ancestor
19944834|NCT01510379|Autonomic Agents|autonomic agents|mesh-ancestor
19944835|NCT01510379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732931|NCT04568837|Autonomic Agents|autonomic agents|mesh-ancestor
19732932|NCT04568837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732933|NCT04568837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732934|NCT04568837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19732935|NCT04568837|Glucocorticoids|glucocorticoids|mesh-ancestor
19732936|NCT04568837|Hormones|hormones|mesh-ancestor
19732937|NCT04568837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19732938|NCT04568837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19732939|NCT04568837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732940|NCT04568837|Protease Inhibitors|protease inhibitors|mesh-ancestor
19944836|NCT01510379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944837|NCT01510379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19944838|NCT01510379|Antipruritics|antipruritics|mesh-ancestor
19944839|NCT01510379|Dermatologic Agents|dermatologic agents|mesh-ancestor
19944840|NCT01510379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19944841|NCT01510379|Serotonin Agents|serotonin agents|mesh-ancestor
19944842|NCT01510379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944843|NCT01510379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944844|NCT01510379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19944845|NCT01510379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19944846|NCT01510379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19944847|NCT01510379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19944848|NCT01510379|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19944849|NCT01510379|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19944850|NCT01510379|Histamine Antagonists|histamine antagonists|mesh-ancestor
19944851|NCT01510379|Histamine Agents|histamine agents|mesh-ancestor
19944852|NCT01510379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19944853|NCT01510379|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19944854|NCT01510379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19944855|NCT01510379|Anesthetics, Local|anesthetics, local|mesh-ancestor
19944856|NCT01510379|Anesthetics|anesthetics|mesh-ancestor
19944857|NCT01510379|Sensory System Agents|sensory system agents|mesh-ancestor
19944858|NCT01510457|Milnacipran|milnacipran|mesh-list
19944859|NCT01510457|Levomilnacipran|levomilnacipran|mesh-list
19944860|NCT01510457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19944861|NCT01510457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19944862|NCT01510457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19944863|NCT01510457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944864|NCT01510457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944865|NCT01510457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944866|NCT01510457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19944867|NCT01510457|Analgesics|analgesics|mesh-ancestor
19944868|NCT01510457|Sensory System Agents|sensory system agents|mesh-ancestor
19944869|NCT01510457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944870|NCT01510457|Antidepressive Agents|antidepressive agents|mesh-ancestor
19944871|NCT01510457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19944872|NCT01510769|Febuxostat|febuxostat|mesh-list
19944873|NCT01510769|Lesinurad|lesinurad|mesh-list
19944874|NCT01510769|Gout Suppressants|gout suppressants|mesh-ancestor
19944875|NCT01510769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19944876|NCT01510769|Uricosuric Agents|uricosuric agents|mesh-ancestor
19944877|NCT01510769|Renal Agents|renal agents|mesh-ancestor
19944878|NCT01510912|Diclofenac|diclofenac|mesh-list
19944879|NCT01510912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19944880|NCT01510912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19944881|NCT01510912|Analgesics|analgesics|mesh-ancestor
19944882|NCT01510912|Sensory System Agents|sensory system agents|mesh-ancestor
19944883|NCT01510912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944884|NCT01510912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944885|NCT01510912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19944886|NCT01510912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19944887|NCT01510912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19944888|NCT01510912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944889|NCT01510912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944890|NCT01511068|Sargramostim|sargramostim|mesh-list
19944891|NCT01511068|Immunologic Factors|immunologic factors|mesh-ancestor
19944892|NCT01511068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944893|NCT01511107|Amoxicillin|amoxicillin|mesh-list
19944894|NCT01511107|Clavulanic Acid|clavulanic acid|mesh-list
19944895|NCT01511107|Clavulanic Acids|clavulanic acids|mesh-list
19944896|NCT01511107|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19944897|NCT01511107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19944898|NCT01511107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19944899|NCT01511107|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19944900|NCT01511107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944901|NCT01511107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944902|NCT01511315|Ustekinumab|ustekinumab|mesh-list
19944903|NCT01511315|Dermatologic Agents|dermatologic agents|mesh-ancestor
20267961|NCT00527228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20267962|NCT00527228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20267963|NCT00527228|Immunologic Factors|immunologic factors|mesh-ancestor
20267964|NCT00527228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267965|NCT00527267|Cinacalcet|cinacalcet|mesh-list
20267966|NCT00527267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20267967|NCT00527267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20267968|NCT00527267|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20267969|NCT00527267|Hormone Antagonists|hormone antagonists|mesh-ancestor
20267970|NCT00527267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20267971|NCT00527449|Carboplatin|carboplatin|mesh-list
20267972|NCT00527449|Docetaxel|docetaxel|mesh-list
20267973|NCT00527449|Epirubicin|epirubicin|mesh-list
20267974|NCT00527449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267975|NCT00527449|Tubulin Modulators|tubulin modulators|mesh-ancestor
20267976|NCT00527449|Antimitotic Agents|antimitotic agents|mesh-ancestor
20267977|NCT00527449|Mitosis Modulators|mitosis modulators|mesh-ancestor
20267978|NCT00527449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267979|NCT00527449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20267980|NCT00527449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20267981|NCT00527449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20267982|NCT00527449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267983|NCT00527501|Travoprost|travoprost|mesh-list
19944904|NCT01511445|Silicon|silicon|mesh-list
19944905|NCT01511445|Trace Elements|trace elements|mesh-ancestor
19944906|NCT01511445|Micronutrients|micronutrients|mesh-ancestor
19944907|NCT01511445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944908|NCT01511536|Prednisone|prednisone|mesh-list
19944909|NCT01511536|Abiraterone Acetate|abiraterone acetate|mesh-list
19944910|NCT01511536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19944911|NCT01511536|Glucocorticoids|glucocorticoids|mesh-ancestor
19944912|NCT01511536|Hormones|hormones|mesh-ancestor
19944913|NCT01511536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20267984|NCT00527501|Brinzolamide|brinzolamide|mesh-list
19944914|NCT01511536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944915|NCT01511536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19944916|NCT01511536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19944917|NCT01511536|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19944918|NCT01511536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944919|NCT01511536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944920|NCT01511536|Hormone Antagonists|hormone antagonists|mesh-ancestor
19944921|NCT01511536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19944922|NCT01511640|Pregabalin|pregabalin|mesh-list
19944923|NCT01511640|Analgesics|analgesics|mesh-ancestor
19944924|NCT01511640|Sensory System Agents|sensory system agents|mesh-ancestor
19944925|NCT01511640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944926|NCT01511640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944927|NCT01511640|Anticonvulsants|anticonvulsants|mesh-ancestor
19944928|NCT01511640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19944929|NCT01511640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19944930|NCT01511640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944931|NCT01511640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19944932|NCT01511640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19944933|NCT01511640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19944934|NCT01511640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19944935|NCT01511640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19732941|NCT04568837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732942|NCT04568837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732943|NCT04568265|Entecavir|entecavir|mesh-list
19732944|NCT04568265|Antiviral Agents|antiviral agents|mesh-ancestor
19732945|NCT04568265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19944936|NCT01511809|Ritonavir|ritonavir|mesh-list
19944937|NCT01511809|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19944938|NCT01511809|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19944939|NCT01511809|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19944940|NCT01511809|Protease Inhibitors|protease inhibitors|mesh-ancestor
19944941|NCT01511809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944942|NCT01511809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944943|NCT01511809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19944944|NCT01511809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19944945|NCT01511809|Antiviral Agents|antiviral agents|mesh-ancestor
19944946|NCT01511809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19944947|NCT01511809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19944948|NCT01511809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19944949|NCT01511939|Diclofenac|diclofenac|mesh-list
19944950|NCT01511939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19944951|NCT01511939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19944952|NCT01511939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19944953|NCT01511939|Analgesics|analgesics|mesh-ancestor
19944954|NCT01511939|Sensory System Agents|sensory system agents|mesh-ancestor
19944955|NCT01511939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944956|NCT01511939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944957|NCT01511939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19944958|NCT01511939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19944959|NCT01511939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944960|NCT01511939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944961|NCT01511978|Amifampridine|amifampridine|mesh-list
19944962|NCT01511978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19944963|NCT01511978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944964|NCT01511978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944965|NCT01511978|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19944966|NCT01511978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19944967|NCT01511978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944968|NCT01512108|Liraglutide|liraglutide|mesh-list
19732946|NCT04568421|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19732947|NCT04568421|Immunologic Factors|immunologic factors|mesh-ancestor
19732948|NCT04568421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732949|NCT04568304|Gemcitabine|gemcitabine|mesh-list
19732950|NCT04568304|Carboplatin|carboplatin|mesh-list
19732951|NCT04568304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732952|NCT04568304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19732953|NCT04568304|Antimetabolites|antimetabolites|mesh-ancestor
19732954|NCT04568304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732955|NCT04568304|Antiviral Agents|antiviral agents|mesh-ancestor
19732956|NCT04568304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19732957|NCT04568304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732958|NCT04568304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19732959|NCT04568304|Immunologic Factors|immunologic factors|mesh-ancestor
19944969|NCT01512108|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19944970|NCT01512108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944971|NCT01512108|Incretins|incretins|mesh-ancestor
19944972|NCT01512108|Hormones|hormones|mesh-ancestor
19944973|NCT01512108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19944974|NCT01512160|Ibuprofen|ibuprofen|mesh-list
19944975|NCT01512160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19944976|NCT01512160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19944977|NCT01512160|Analgesics|analgesics|mesh-ancestor
19944978|NCT01512160|Sensory System Agents|sensory system agents|mesh-ancestor
19944979|NCT01512160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944980|NCT01512160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944981|NCT01512160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19944982|NCT01512160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19944983|NCT01512160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19944984|NCT01512160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944985|NCT01512160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19732960|NCT04568304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732961|NCT04568096|Tamoxifen|tamoxifen|mesh-list
19732962|NCT04568096|Tretinoin|tretinoin|mesh-list
19944986|NCT01512225|Domperidone|domperidone|mesh-list
19944987|NCT01512225|Maleic acid|maleic acid|mesh-list
19944988|NCT01512225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19944989|NCT01512225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19944990|NCT01512225|Antiemetics|antiemetics|mesh-ancestor
19944991|NCT01512225|Autonomic Agents|autonomic agents|mesh-ancestor
19944992|NCT01512225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19944993|NCT01512225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19944994|NCT01512225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19944995|NCT01512225|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19944996|NCT01512225|Dopamine Agents|dopamine agents|mesh-ancestor
19944997|NCT01512225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19944998|NCT01512251|Vemurafenib|vemurafenib|mesh-list
19944999|NCT01512251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945000|NCT01512251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19945001|NCT01512251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945002|NCT01512251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945003|NCT01512446|Alendronate|alendronate|mesh-list
19945004|NCT01512446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19945005|NCT01512446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945006|NCT01512745|Apatinib|apatinib|mesh-list
19945007|NCT01512745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945008|NCT01512745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19945009|NCT01512745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945010|NCT01512745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945011|NCT01512797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19945012|NCT01512797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19945013|NCT01512797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945014|NCT01512797|Incretins|incretins|mesh-ancestor
19945015|NCT01512797|Hormones|hormones|mesh-ancestor
19945016|NCT01512797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19945017|NCT01512797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19945018|NCT01512797|Protease Inhibitors|protease inhibitors|mesh-ancestor
19945019|NCT01512797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945020|NCT01512797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945021|NCT01512979|Metformin|metformin|mesh-list
19945022|NCT01512979|Linagliptin|linagliptin|mesh-list
19945023|NCT01512979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19945024|NCT01512979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945025|NCT01512979|Incretins|incretins|mesh-ancestor
19945026|NCT01512979|Hormones|hormones|mesh-ancestor
19945027|NCT01512979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19945028|NCT01512979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19945029|NCT01512979|Protease Inhibitors|protease inhibitors|mesh-ancestor
19945030|NCT01512979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945031|NCT01512979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945032|NCT01513122|Ritonavir|ritonavir|mesh-list
19945033|NCT01513122|Lopinavir|lopinavir|mesh-list
19945034|NCT01513122|Raltegravir Potassium|raltegravir potassium|mesh-list
19732963|NCT04568096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19732964|NCT04568096|Hormone Antagonists|hormone antagonists|mesh-ancestor
19732965|NCT04568096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19732966|NCT04568096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732967|NCT04568096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19945035|NCT01513122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19945036|NCT01513122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19945037|NCT01513122|Protease Inhibitors|protease inhibitors|mesh-ancestor
19945038|NCT01513122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945039|NCT01513122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945040|NCT01513122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19945041|NCT01513122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19945042|NCT01513122|Antiviral Agents|antiviral agents|mesh-ancestor
19945043|NCT01513122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19945044|NCT01513122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19945045|NCT01513122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19945046|NCT01513122|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19945047|NCT01513122|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19945048|NCT01513317|Siltuximab|siltuximab|mesh-list
19945049|NCT01513317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945050|NCT01513460|Glycopyrrolate|glycopyrrolate|mesh-list
19945051|NCT01513460|Tiotropium Bromide|tiotropium bromide|mesh-list
19945052|NCT01513460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19945053|NCT01513460|Autonomic Agents|autonomic agents|mesh-ancestor
19945054|NCT01513460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19945055|NCT01513460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945056|NCT01513460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19945057|NCT01513460|Respiratory System Agents|respiratory system agents|mesh-ancestor
19945058|NCT01513460|Parasympatholytics|parasympatholytics|mesh-ancestor
19945059|NCT01513460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19945060|NCT01513460|Cholinergic Agents|cholinergic agents|mesh-ancestor
19945061|NCT01513460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945062|NCT01513460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945063|NCT01513460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19945064|NCT01513460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19945065|NCT01513473|Insulin|insulin|mesh-list
19945066|NCT01513473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19945067|NCT01513473|Insulin Aspart|insulin aspart|mesh-list
19945068|NCT01513473|Insulin Detemir|insulin detemir|mesh-list
19945069|NCT01513473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19945070|NCT01513473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945071|NCT01513551|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19945072|NCT01513551|Immunologic Factors|immunologic factors|mesh-ancestor
19945073|NCT01513551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945074|NCT01513590|Insulin|insulin|mesh-list
19945075|NCT01513590|Insulin Aspart|insulin aspart|mesh-list
19945076|NCT01513590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19945077|NCT01513590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945078|NCT01513759|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19945079|NCT01513759|Plasminogen|plasminogen|mesh-list
19945080|NCT01513759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19945081|NCT01513759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19945082|NCT01513759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945083|NCT01513902|Tofacitinib|tofacitinib|mesh-list
19945084|NCT01513902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19945085|NCT01513902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945086|NCT01513902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945087|NCT01514149|Metformin|metformin|mesh-list
19945088|NCT01514149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19945089|NCT01514149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945090|NCT01514201|Temozolomide|temozolomide|mesh-list
19945091|NCT01514201|Veliparib|veliparib|mesh-list
19945092|NCT01514201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19945093|NCT01514201|Alkylating Agents|alkylating agents|mesh-ancestor
19945094|NCT01514201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945095|NCT01514201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945096|NCT01514201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19945097|NCT01514201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945098|NCT01514240|Mesalamine|mesalamine|mesh-list
19945099|NCT01514240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19945100|NCT01514240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19945101|NCT01514240|Analgesics|analgesics|mesh-ancestor
19945102|NCT01514240|Sensory System Agents|sensory system agents|mesh-ancestor
19945103|NCT01514240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19945104|NCT01514240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945105|NCT01514240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19945106|NCT01514240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19945107|NCT01514357|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19945108|NCT01514357|Natriuretic Agents|natriuretic agents|mesh-ancestor
19945109|NCT01514357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945110|NCT01514370|Interferons|interferons|mesh-list
19945111|NCT01514370|Interferon-beta|interferon-beta|mesh-list
19945112|NCT01514370|Interferon beta-1a|interferon beta-1a|mesh-list
19945113|NCT01514370|Curcumin|curcumin|mesh-list
19945114|NCT01514370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945115|NCT01514370|Antiviral Agents|antiviral agents|mesh-ancestor
19945116|NCT01514370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19945117|NCT01514370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19945118|NCT01514370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19945119|NCT01514370|Analgesics|analgesics|mesh-ancestor
19945120|NCT01514370|Sensory System Agents|sensory system agents|mesh-ancestor
19945121|NCT01514370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19945122|NCT01514370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945123|NCT01514370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19945124|NCT01514370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19945125|NCT01514370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945126|NCT01514370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945127|NCT01514370|Immunologic Factors|immunologic factors|mesh-ancestor
19945128|NCT01514370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19945129|NCT01514422|Minocycline|minocycline|mesh-list
19945130|NCT01514422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19945131|NCT01514422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19945132|NCT01514448|Everolimus|everolimus|mesh-list
19945133|NCT01514448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945134|NCT01514448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19945135|NCT01514448|Immunologic Factors|immunologic factors|mesh-ancestor
19945136|NCT01514448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945137|NCT01514513|Permethrin|permethrin|mesh-list
19945138|NCT01514513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945139|NCT01514513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945140|NCT01514734|Timolol|timolol|mesh-list
19945141|NCT01514734|Brinzolamide|brinzolamide|mesh-list
19945142|NCT01514734|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19945143|NCT01514734|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19945144|NCT01514734|Adrenergic Agents|adrenergic agents|mesh-ancestor
19945145|NCT01514734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945146|NCT01514734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945147|NCT01514734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945148|NCT01514734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19945149|NCT01514734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19945150|NCT01514734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945151|NCT01514734|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19945152|NCT01514864|Dasatinib|dasatinib|mesh-list
19945153|NCT01514864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945154|NCT01514864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19945155|NCT01514864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945156|NCT01514864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945157|NCT01515046|Ascorbic Acid|ascorbic acid|mesh-list
19945158|NCT01515046|Gemcitabine|gemcitabine|mesh-list
19945159|NCT01515046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19945160|NCT01515046|Antimetabolites|antimetabolites|mesh-ancestor
19945161|NCT01515046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945162|NCT01515046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945163|NCT01515046|Antiviral Agents|antiviral agents|mesh-ancestor
19945164|NCT01515046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19945165|NCT01515046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945166|NCT01515046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19945167|NCT01515046|Immunologic Factors|immunologic factors|mesh-ancestor
19945168|NCT01515046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945169|NCT01515046|Antioxidants|antioxidants|mesh-ancestor
19945170|NCT01515046|Protective Agents|protective agents|mesh-ancestor
19945171|NCT01515046|Vitamins|vitamins|mesh-ancestor
19945172|NCT01515046|Micronutrients|micronutrients|mesh-ancestor
19945173|NCT01515176|Ofatumumab|ofatumumab|mesh-list
19945174|NCT01515176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19945175|NCT01515176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945176|NCT01515176|Immunologic Factors|immunologic factors|mesh-ancestor
19945177|NCT01515176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945178|NCT01515189|Ipilimumab|ipilimumab|mesh-list
19945179|NCT01515189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19945180|NCT01515189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945181|NCT01515189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19945182|NCT01515189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945183|NCT01515345|Clopidogrel|clopidogrel|mesh-list
19945184|NCT01515345|Ticagrelor|ticagrelor|mesh-list
19945185|NCT01515345|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19945186|NCT01515345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19945187|NCT01515345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19945188|NCT01515345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19945189|NCT01515345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19945190|NCT01515345|Purinergic Agents|purinergic agents|mesh-ancestor
19945191|NCT01515345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945192|NCT01515345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945193|NCT01515345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945194|NCT01515410|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19945195|NCT01515410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19945196|NCT01515410|Immunologic Factors|immunologic factors|mesh-ancestor
19945197|NCT01515410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945198|NCT01515410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19945199|NCT01515410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19945200|NCT01515410|Dopamine Agonists|dopamine agonists|mesh-ancestor
19945201|NCT01515410|Dopamine Agents|dopamine agents|mesh-ancestor
19945202|NCT01515410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945203|NCT01515410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945204|NCT01515423|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19945205|NCT01515423|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19945206|NCT01515423|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19945207|NCT01515423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19945208|NCT01515540|Lidocaine|lidocaine|mesh-list
19945209|NCT01515540|Anesthetics, Local|anesthetics, local|mesh-ancestor
19945210|NCT01515540|Anesthetics|anesthetics|mesh-ancestor
19945211|NCT01515540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19945212|NCT01515540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945213|NCT01515540|Sensory System Agents|sensory system agents|mesh-ancestor
19945214|NCT01515540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19945215|NCT01515540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19945216|NCT01515540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19945217|NCT01515540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19945218|NCT01515540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19945219|NCT01515540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945220|NCT01515566|Fentanyl|fentanyl|mesh-list
19945221|NCT01515566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19945222|NCT01515566|Narcotics|narcotics|mesh-ancestor
19945223|NCT01515566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19945224|NCT01515566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945225|NCT01515566|Analgesics|analgesics|mesh-ancestor
19945226|NCT01515566|Sensory System Agents|sensory system agents|mesh-ancestor
19945227|NCT01515566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19945228|NCT01515566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19945229|NCT01515566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19945230|NCT01515566|Anesthetics, General|anesthetics, general|mesh-ancestor
19945231|NCT01515566|Anesthetics|anesthetics|mesh-ancestor
19945232|NCT01515657|Aspirin|aspirin|mesh-list
19945233|NCT01515657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19945234|NCT01515657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19945235|NCT01515657|Analgesics|analgesics|mesh-ancestor
19945236|NCT01515657|Sensory System Agents|sensory system agents|mesh-ancestor
19945237|NCT01515657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19945238|NCT01515657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945239|NCT01515657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19945240|NCT01515657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19945241|NCT01515657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19945242|NCT01515657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19945243|NCT01515657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945244|NCT01515657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19945245|NCT01515657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19945246|NCT01515657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945247|NCT01515657|Antipyretics|antipyretics|mesh-ancestor
19945248|NCT01515865|Midodrine|midodrine|mesh-list
19945249|NCT01515865|Sympathomimetics|sympathomimetics|mesh-ancestor
19945250|NCT01515865|Autonomic Agents|autonomic agents|mesh-ancestor
19945251|NCT01515865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19945252|NCT01515865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945253|NCT01515865|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19945254|NCT01515865|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19945255|NCT01515865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19945256|NCT01515865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19945257|NCT01515865|Adrenergic Agents|adrenergic agents|mesh-ancestor
19945258|NCT01515865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945259|NCT01515865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974003|NCT01830881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19974004|NCT01830881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19974005|NCT01830881|Analgesics|analgesics|mesh-ancestor
19974006|NCT01830881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19974007|NCT01830881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19974008|NCT01830881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19974009|NCT01830881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974010|NCT01831089|Paclitaxel|paclitaxel|mesh-list
19974011|NCT01831089|Bevacizumab|bevacizumab|mesh-list
19974012|NCT01831089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19974013|NCT01831089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974014|NCT01831089|Tubulin Modulators|tubulin modulators|mesh-ancestor
19974015|NCT01831089|Antimitotic Agents|antimitotic agents|mesh-ancestor
19974016|NCT01831089|Mitosis Modulators|mitosis modulators|mesh-ancestor
19974017|NCT01831089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974018|NCT01831089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19974019|NCT01831089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19974020|NCT01831089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19974021|NCT01831089|Growth Substances|growth substances|mesh-ancestor
19974022|NCT01831089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974023|NCT01831089|Growth Inhibitors|growth inhibitors|mesh-ancestor
19974024|NCT01831232|Cytarabine|cytarabine|mesh-list
19974025|NCT01831232|Idarubicin|idarubicin|mesh-list
19974026|NCT01831232|Pravastatin|pravastatin|mesh-list
19974027|NCT01831232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19974028|NCT01831232|Antimetabolites|antimetabolites|mesh-ancestor
19974029|NCT01831232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974030|NCT01831232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974031|NCT01831232|Antiviral Agents|antiviral agents|mesh-ancestor
19974032|NCT01831232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19974033|NCT01831232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19974034|NCT01831232|Immunologic Factors|immunologic factors|mesh-ancestor
19974035|NCT01831232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974036|NCT01831232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19974037|NCT01831232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19974038|NCT01831232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19974039|NCT01831232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974040|NCT01831232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19974041|NCT01831232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19974042|NCT01831232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19974043|NCT01831232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19974044|NCT01831427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20267985|NCT00527501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20267986|NCT00527501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20267987|NCT00527501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20267988|NCT00527501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267989|NCT00527540|Interferons|interferons|mesh-list
20267990|NCT00527540|Ribavirin|ribavirin|mesh-list
20267991|NCT00527540|Interferon-alpha|interferon-alpha|mesh-list
20267992|NCT00527540|Interferon alpha-2|interferon alpha-2|mesh-list
20267993|NCT00527540|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20267994|NCT00527540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20267995|NCT00527540|Antiviral Agents|antiviral agents|mesh-ancestor
20267996|NCT00527540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20267997|NCT00527540|Antimetabolites|antimetabolites|mesh-ancestor
20267998|NCT00527540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20267999|NCT00527540|Immunologic Factors|immunologic factors|mesh-ancestor
20268000|NCT00527540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268001|NCT00527657|Thalidomide|thalidomide|mesh-list
20268002|NCT00527657|Temozolomide|temozolomide|mesh-list
20268003|NCT00527657|Lomustine|lomustine|mesh-list
20268004|NCT00527657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20268005|NCT00527657|Alkylating Agents|alkylating agents|mesh-ancestor
20268006|NCT00527657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268007|NCT00527657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268008|NCT00527657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20268009|NCT00527657|Immunologic Factors|immunologic factors|mesh-ancestor
20268010|NCT00527657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268011|NCT00527657|Leprostatic Agents|leprostatic agents|mesh-ancestor
20268012|NCT00527657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20268013|NCT00527657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19945260|NCT01515891|Opicapone|opicapone|mesh-list
19945261|NCT01515891|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19945262|NCT01515891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945263|NCT01515891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945264|NCT01515891|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19945265|NCT01515891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19945266|NCT01515995|Magnesium Sulfate|magnesium sulfate|mesh-list
19945267|NCT01515995|Analgesics|analgesics|mesh-ancestor
19945268|NCT01515995|Sensory System Agents|sensory system agents|mesh-ancestor
19945269|NCT01515995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19945270|NCT01515995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945271|NCT01515995|Anesthetics|anesthetics|mesh-ancestor
19945272|NCT01515995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19945273|NCT01515995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19945274|NCT01515995|Anticonvulsants|anticonvulsants|mesh-ancestor
19945275|NCT01515995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19945276|NCT01515995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19945277|NCT01515995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945278|NCT01515995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19945279|NCT01515995|Tocolytic Agents|tocolytic agents|mesh-ancestor
19945280|NCT01515995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19945281|NCT01516008|Tapentadol|tapentadol|mesh-list
19945282|NCT01516008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19945283|NCT01516008|Narcotics|narcotics|mesh-ancestor
19945284|NCT01516008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19945285|NCT01516008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945286|NCT01516008|Analgesics|analgesics|mesh-ancestor
19945287|NCT01516008|Sensory System Agents|sensory system agents|mesh-ancestor
19945288|NCT01516008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19945289|NCT01516008|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19945290|NCT01516008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19945291|NCT01516008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19945292|NCT01516008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945293|NCT01516008|Adrenergic Agents|adrenergic agents|mesh-ancestor
19945294|NCT01516008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945295|NCT01516268|Sufentanil|sufentanil|mesh-list
19945296|NCT01516268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19945297|NCT01516268|Narcotics|narcotics|mesh-ancestor
19945298|NCT01516268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19945299|NCT01516268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945300|NCT01516268|Analgesics|analgesics|mesh-ancestor
19945301|NCT01516268|Sensory System Agents|sensory system agents|mesh-ancestor
19945302|NCT01516268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19945303|NCT01516268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19945304|NCT01516268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19945305|NCT01516268|Anesthetics, General|anesthetics, general|mesh-ancestor
19945306|NCT01516268|Anesthetics|anesthetics|mesh-ancestor
19945307|NCT01516424|Risperidone|risperidone|mesh-list
19945308|NCT01516424|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19945309|NCT01516424|Serotonin Agents|serotonin agents|mesh-ancestor
19945310|NCT01516424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945311|NCT01516424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945312|NCT01516424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945313|NCT01516424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19945314|NCT01516424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19945315|NCT01516424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19945316|NCT01516424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19945317|NCT01516424|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19945318|NCT01516424|Dopamine Agents|dopamine agents|mesh-ancestor
19945319|NCT01516684|Lidocaine|lidocaine|mesh-list
19945320|NCT01516684|Fentanyl|fentanyl|mesh-list
19945321|NCT01516684|Anesthetics, Local|anesthetics, local|mesh-list
19945322|NCT01516684|Prilocaine|prilocaine|mesh-list
19945323|NCT01516684|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19945324|NCT01516684|Propofol|propofol|mesh-list
19945325|NCT01516684|Anesthetics|anesthetics|mesh-list
19945326|NCT01516684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19945327|NCT01516684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945328|NCT01516684|Sensory System Agents|sensory system agents|mesh-ancestor
19945329|NCT01516684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19945330|NCT01516684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19945331|NCT01516684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19945332|NCT01516684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19945333|NCT01516684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19945334|NCT01516684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945335|NCT01516684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19945336|NCT01516684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19945337|NCT01516684|Anesthetics, General|anesthetics, general|mesh-ancestor
19945338|NCT01516684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19945339|NCT01516684|Narcotics|narcotics|mesh-ancestor
19945340|NCT01516684|Analgesics|analgesics|mesh-ancestor
19945341|NCT01516684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19945342|NCT01516684|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19945343|NCT01516749|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19945344|NCT01516749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19945345|NCT01516879|Atorvastatin|atorvastatin|mesh-list
19945346|NCT01516879|Ezetimibe|ezetimibe|mesh-list
19945347|NCT01516879|Evolocumab|evolocumab|mesh-list
19945348|NCT01516879|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19945349|NCT01516879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19945350|NCT01516879|Antimetabolites|antimetabolites|mesh-ancestor
19945351|NCT01516879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945352|NCT01516879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19945353|NCT01516879|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19945354|NCT01516879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945355|NCT01516892|Botulinum Toxins|botulinum toxins|mesh-list
19945356|NCT01516892|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19945357|NCT01516892|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19945358|NCT01516892|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19945359|NCT01516892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19945360|NCT01516892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945361|NCT01516892|Cholinergic Agents|cholinergic agents|mesh-ancestor
19945362|NCT01516892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945363|NCT01516892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945364|NCT01516892|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19945365|NCT01516892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19945366|NCT01516957|Brodalumab|brodalumab|mesh-list
19945367|NCT01516957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19945368|NCT01516957|Dermatologic Agents|dermatologic agents|mesh-ancestor
19945369|NCT01516957|Immunologic Factors|immunologic factors|mesh-ancestor
19945370|NCT01516957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945371|NCT01516970|Ritonavir|ritonavir|mesh-list
19945372|NCT01516970|Lopinavir|lopinavir|mesh-list
19945373|NCT01516970|Darunavir|darunavir|mesh-list
19945374|NCT01516970|Zidovudine|zidovudine|mesh-list
19945375|NCT01516970|Efavirenz|efavirenz|mesh-list
19945376|NCT01516970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19945377|NCT01516970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19945378|NCT01516970|Protease Inhibitors|protease inhibitors|mesh-ancestor
19945379|NCT01516970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945380|NCT01516970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945381|NCT01516970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19945382|NCT01516970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19945383|NCT01516970|Antiviral Agents|antiviral agents|mesh-ancestor
19945384|NCT01516970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19945385|NCT01516970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19945386|NCT01516970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19945387|NCT01516970|Antimetabolites|antimetabolites|mesh-ancestor
19945388|NCT01516970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19945389|NCT01516970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19945390|NCT01516970|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19945391|NCT01516970|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19945392|NCT01516970|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19945393|NCT01516970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19945394|NCT01516970|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19945395|NCT01517074|Sirolimus|sirolimus|mesh-list
19945396|NCT01517074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19945397|NCT01517074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19945398|NCT01517074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19945399|NCT01517074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945400|NCT01517074|Antifungal Agents|antifungal agents|mesh-ancestor
19945401|NCT01517074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19945402|NCT01517074|Immunologic Factors|immunologic factors|mesh-ancestor
19945403|NCT01517074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945404|NCT01517295|Hydrocodone|hydrocodone|mesh-list
19945405|NCT01517295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19945406|NCT01517295|Narcotics|narcotics|mesh-ancestor
19945407|NCT01517295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19945408|NCT01517295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945409|NCT01517295|Analgesics|analgesics|mesh-ancestor
19945410|NCT01517295|Sensory System Agents|sensory system agents|mesh-ancestor
19945411|NCT01517295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19945412|NCT01517295|Antitussive Agents|antitussive agents|mesh-ancestor
19945413|NCT01517295|Respiratory System Agents|respiratory system agents|mesh-ancestor
19945414|NCT01517373|Glimepiride|glimepiride|mesh-list
19945415|NCT01517373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19945416|NCT01517373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19945417|NCT01517373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945418|NCT01517373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19945419|NCT01517373|Immunologic Factors|immunologic factors|mesh-ancestor
19945420|NCT01517412|Metformin|metformin|mesh-list
19945421|NCT01517412|Lixisenatide|lixisenatide|mesh-list
19945422|NCT01517412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19945423|NCT01517412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945424|NCT01517750|Immunoconjugates|immunoconjugates|mesh-list
19945425|NCT01517750|Immunologic Factors|immunologic factors|mesh-ancestor
19945426|NCT01517750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945427|NCT01517893|Simvastatin|simvastatin|mesh-list
19945428|NCT01517893|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19945429|NCT01517893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19945430|NCT01517893|Antimetabolites|antimetabolites|mesh-ancestor
19945431|NCT01517893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268014|NCT00527657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20268015|NCT00527657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20268016|NCT00527657|Growth Substances|growth substances|mesh-ancestor
20268017|NCT00527657|Growth Inhibitors|growth inhibitors|mesh-ancestor
20268018|NCT00527683|Vigabatrin|vigabatrin|mesh-list
20268019|NCT00527683|Anticonvulsants|anticonvulsants|mesh-ancestor
20268020|NCT00527683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268021|NCT00527683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268022|NCT00527683|GABA Agents|gaba agents|mesh-ancestor
20268023|NCT00527683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20268024|NCT00527683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268025|NCT00527761|Cisplatin|cisplatin|mesh-list
20268026|NCT00527761|Docetaxel|docetaxel|mesh-list
20268027|NCT00527761|Temozolomide|temozolomide|mesh-list
20268028|NCT00527761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268029|NCT00527761|Tubulin Modulators|tubulin modulators|mesh-ancestor
20268030|NCT00527761|Antimitotic Agents|antimitotic agents|mesh-ancestor
20268031|NCT00527761|Mitosis Modulators|mitosis modulators|mesh-ancestor
20268032|NCT00527761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268033|NCT00527761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20268034|NCT00527761|Alkylating Agents|alkylating agents|mesh-ancestor
20268035|NCT00527800|Lumefantrine|lumefantrine|mesh-list
20268036|NCT00527800|Artemether|artemether|mesh-list
20268037|NCT00527800|Piperaquine|piperaquine|mesh-list
20268038|NCT00527800|Trimethoprim|trimethoprim|mesh-list
20268039|NCT00527800|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20268040|NCT00527800|Artenimol|artenimol|mesh-list
20268041|NCT00527800|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20268042|NCT00527800|Sulfamethoxazole|sulfamethoxazole|mesh-list
20268043|NCT00527800|Antimalarials|antimalarials|mesh-ancestor
20268044|NCT00527800|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20268045|NCT00527800|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20268046|NCT00527800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268047|NCT00527800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20268048|NCT00527800|Renal Agents|renal agents|mesh-ancestor
20268049|NCT00527800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20268050|NCT00527800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268051|NCT00527800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268052|NCT00527800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20268053|NCT00527800|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20268054|NCT00527800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20268055|NCT00527800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20268056|NCT00527930|Oxaliplatin|oxaliplatin|mesh-list
20268057|NCT00527930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268058|NCT00527995|Sildenafil Citrate|sildenafil citrate|mesh-list
20268059|NCT00527995|Vasodilator Agents|vasodilator agents|mesh-ancestor
20268060|NCT00527995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20268061|NCT00527995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20268062|NCT00527995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945432|NCT01517893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19974045|NCT01831427|Immunologic Factors|immunologic factors|mesh-ancestor
20268063|NCT00527995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268064|NCT00527995|Urological Agents|urological agents|mesh-ancestor
20268065|NCT00528008|Chlorhexidine|chlorhexidine|mesh-list
19945433|NCT01517893|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19945434|NCT01517893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945435|NCT01517984|Mycophenolic Acid|mycophenolic acid|mesh-list
19945436|NCT01517984|Prednisone|prednisone|mesh-list
19945437|NCT01517984|Tacrolimus|tacrolimus|mesh-list
19945438|NCT01517984|Thymoglobulin|thymoglobulin|mesh-list
19945439|NCT01517984|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19945440|NCT01517984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19945441|NCT01517984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
19945442|NCT01517984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19945443|NCT01517984|Glucocorticoids|glucocorticoids|mesh-ancestor
19945444|NCT01517984|Hormones|hormones|mesh-ancestor
19945445|NCT01517984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19945446|NCT01517984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945447|NCT01517984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19945448|NCT01517984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945449|NCT01517984|Immunologic Factors|immunologic factors|mesh-ancestor
19945450|NCT01517984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945451|NCT01517984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945452|NCT01517984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19945453|NCT01517984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19945454|NCT01517984|Antitubercular Agents|antitubercular agents|mesh-ancestor
20268066|NCT00528008|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20268067|NCT00528008|Povidone-Iodine|povidone-iodine|mesh-list
20268068|NCT00528008|Povidone|povidone|mesh-list
20268069|NCT00528008|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20268070|NCT00528008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268071|NCT00528008|Disinfectants|disinfectants|mesh-ancestor
20268072|NCT00528008|Dermatologic Agents|dermatologic agents|mesh-ancestor
20268073|NCT00528008|Plasma Substitutes|plasma substitutes|mesh-ancestor
20268074|NCT00528008|Blood Substitutes|blood substitutes|mesh-ancestor
20268075|NCT00528060|Ritonavir|ritonavir|mesh-list
20268076|NCT00528060|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20268077|NCT00528060|Tenofovir|tenofovir|mesh-list
20268078|NCT00528060|Emtricitabine|emtricitabine|mesh-list
20268079|NCT00528060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20268080|NCT00528060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20268081|NCT00528060|Protease Inhibitors|protease inhibitors|mesh-ancestor
20268082|NCT00528060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268083|NCT00528060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268084|NCT00528060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20268085|NCT00528060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20268086|NCT00528060|Antiviral Agents|antiviral agents|mesh-ancestor
20268087|NCT00528060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268088|NCT00528060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20268089|NCT00528060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20268090|NCT00528060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20268091|NCT00528060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20268092|NCT00528073|Rifaximin|rifaximin|mesh-list
20268093|NCT00528073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20268094|NCT00528073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268095|NCT00528073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20268096|NCT00528151|Curcumin|curcumin|mesh-list
20268097|NCT00528151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20268098|NCT00528151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20268099|NCT00528151|Analgesics|analgesics|mesh-ancestor
20268100|NCT00528151|Sensory System Agents|sensory system agents|mesh-ancestor
20268101|NCT00528151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20268102|NCT00528151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268103|NCT00528151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20268104|NCT00528151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20268105|NCT00528151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268106|NCT00528151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268107|NCT00528151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268108|NCT00528177|Morphine|morphine|mesh-list
20268109|NCT00528177|Oxycodone|oxycodone|mesh-list
20268110|NCT00528177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20268111|NCT00528177|Narcotics|narcotics|mesh-ancestor
20268112|NCT00528177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20268113|NCT00528177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268114|NCT00528177|Analgesics|analgesics|mesh-ancestor
20554143|NCT01933542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19945455|NCT01517984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20268115|NCT00528177|Sensory System Agents|sensory system agents|mesh-ancestor
20268116|NCT00528177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20268117|NCT00528216|Capsaicin|capsaicin|mesh-list
20268118|NCT00528216|Antipruritics|antipruritics|mesh-ancestor
19945456|NCT01517984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19945457|NCT01518153|Vidarabine|vidarabine|mesh-list
19945458|NCT01518153|Methotrexate|methotrexate|mesh-list
19945459|NCT01518153|Fludarabine phosphate|fludarabine phosphate|mesh-list
19945460|NCT01518153|Fludarabine|fludarabine|mesh-list
19945461|NCT01518153|Melphalan|melphalan|mesh-list
19945462|NCT01518153|Alemtuzumab|alemtuzumab|mesh-list
19945463|NCT01518153|Tacrolimus|tacrolimus|mesh-list
19945464|NCT01518153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19945465|NCT01518153|Abortifacient Agents|abortifacient agents|mesh-ancestor
19945466|NCT01518153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19945467|NCT01518153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945468|NCT01518153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19945469|NCT01518153|Antimetabolites|antimetabolites|mesh-ancestor
19945470|NCT01518153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945471|NCT01518153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945472|NCT01518153|Dermatologic Agents|dermatologic agents|mesh-ancestor
19945473|NCT01518153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945474|NCT01518153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19945475|NCT01518153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19945476|NCT01518153|Immunologic Factors|immunologic factors|mesh-ancestor
19945477|NCT01518153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19945478|NCT01518153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19945479|NCT01518153|Antiviral Agents|antiviral agents|mesh-ancestor
19945480|NCT01518153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19945481|NCT01518153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19945482|NCT01518153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19945483|NCT01518153|Alkylating Agents|alkylating agents|mesh-ancestor
19945484|NCT01518153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19945485|NCT01518153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19945486|NCT01518192|Doxycycline|doxycycline|mesh-list
19945487|NCT01518192|Cefuroxime|cefuroxime|mesh-list
19945488|NCT01518192|Cefuroxime axetil|cefuroxime axetil|mesh-list
19945489|NCT01518192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19945490|NCT01518192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19945491|NCT01518192|Antimalarials|antimalarials|mesh-ancestor
19945492|NCT01518192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19945493|NCT01518192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19945494|NCT01518244|Timolol|timolol|mesh-list
19945495|NCT01518244|Brinzolamide|brinzolamide|mesh-list
19945496|NCT01518244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19945497|NCT01518244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19945498|NCT01518244|Adrenergic Agents|adrenergic agents|mesh-ancestor
19945499|NCT01518244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945500|NCT01518244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945501|NCT01518244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945502|NCT01518244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19945503|NCT01518244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19945504|NCT01518244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945505|NCT01518244|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19945506|NCT01518257|Botulinum Toxins|botulinum toxins|mesh-list
19945507|NCT01518257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19945508|NCT01518257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19945509|NCT01518257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19945510|NCT01518257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19945511|NCT01518257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945512|NCT01518257|Cholinergic Agents|cholinergic agents|mesh-ancestor
19945513|NCT01518257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945514|NCT01518257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945515|NCT01518257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19945516|NCT01518257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19945517|NCT01518309|Pimavanserin|pimavanserin|mesh-list
19945518|NCT01518309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19945519|NCT01518309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19945520|NCT01518309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19945521|NCT01518309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20268119|NCT00528216|Dermatologic Agents|dermatologic agents|mesh-ancestor
19945522|NCT01518309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19945523|NCT01518309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945524|NCT01518309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19945525|NCT01518309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19945526|NCT01518309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19945527|NCT01518309|Serotonin Agents|serotonin agents|mesh-ancestor
19945528|NCT01518309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945529|NCT01518309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945530|NCT01518699|Moxifloxacin|moxifloxacin|mesh-list
19945531|NCT01518699|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19945532|NCT01518699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19945533|NCT01518699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19945534|NCT01518699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19945535|NCT01518699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19945536|NCT01518699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945537|NCT01518699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945538|NCT01518699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945539|NCT01518699|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19945540|NCT01518699|Contraceptive Agents|contraceptive agents|mesh-ancestor
19945541|NCT01518699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19945542|NCT01518699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945543|NCT01518699|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19945544|NCT01518699|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19945545|NCT01518699|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19945546|NCT01518946|Midodrine|midodrine|mesh-list
19945547|NCT01518946|Sympathomimetics|sympathomimetics|mesh-ancestor
19945548|NCT01518946|Autonomic Agents|autonomic agents|mesh-ancestor
19945549|NCT01518946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19945550|NCT01518946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945551|NCT01518946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19945552|NCT01518946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19945553|NCT01518946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19945554|NCT01518946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19945555|NCT01518946|Adrenergic Agents|adrenergic agents|mesh-ancestor
19945556|NCT01518946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945557|NCT01518946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945558|NCT01518972|Prazosin|prazosin|mesh-list
19945559|NCT01518972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19945560|NCT01518972|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19945561|NCT01518972|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19945562|NCT01518972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19945563|NCT01518972|Adrenergic Agents|adrenergic agents|mesh-ancestor
19945564|NCT01518972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945565|NCT01518972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945566|NCT01518972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945567|NCT01519063|Naltrexone|naltrexone|mesh-list
19945568|NCT01519063|Memantine|memantine|mesh-list
19945569|NCT01519063|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19945570|NCT01519063|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19945571|NCT01519063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945572|NCT01519063|Sensory System Agents|sensory system agents|mesh-ancestor
19945573|NCT01519063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19945574|NCT01519063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19945575|NCT01519063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19945576|NCT01519063|Dopamine Agents|dopamine agents|mesh-ancestor
19945577|NCT01519063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945578|NCT01519063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945579|NCT01519063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19945580|NCT01519063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19945581|NCT01519089|Tofacitinib|tofacitinib|mesh-list
19945582|NCT01519089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19945583|NCT01519089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945584|NCT01519089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945585|NCT01519167|Fentanyl|fentanyl|mesh-list
19945586|NCT01519167|Midazolam|midazolam|mesh-list
19945587|NCT01519167|Dexmedetomidine|dexmedetomidine|mesh-list
19945588|NCT01519167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19945589|NCT01519167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19945590|NCT01519167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945591|NCT01519167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19945592|NCT01519167|Analgesics|analgesics|mesh-ancestor
19945593|NCT01519167|Sensory System Agents|sensory system agents|mesh-ancestor
19945594|NCT01519167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19945595|NCT01519167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19945596|NCT01519167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19945597|NCT01519167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19945598|NCT01519167|Adrenergic Agents|adrenergic agents|mesh-ancestor
19945599|NCT01519167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945600|NCT01519167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945601|NCT01519167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19945602|NCT01519167|Narcotics|narcotics|mesh-ancestor
19945603|NCT01519167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19945604|NCT01519167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19945605|NCT01519167|Anesthetics, General|anesthetics, general|mesh-ancestor
19945606|NCT01519167|Anesthetics|anesthetics|mesh-ancestor
19945607|NCT01519167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19945608|NCT01519167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19945609|NCT01519167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19945610|NCT01519167|GABA Modulators|gaba modulators|mesh-ancestor
19945611|NCT01519167|GABA Agents|gaba agents|mesh-ancestor
19945612|NCT01519245|Tranexamic Acid|tranexamic acid|mesh-list
19945613|NCT01519245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19945614|NCT01519245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19945615|NCT01519245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945616|NCT01519245|Hemostatics|hemostatics|mesh-ancestor
19945617|NCT01519245|Coagulants|coagulants|mesh-ancestor
19945618|NCT01519271|Rivastigmine|rivastigmine|mesh-list
19945619|NCT01519271|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19945620|NCT01519271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945621|NCT01519271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945622|NCT01519271|Cholinergic Agents|cholinergic agents|mesh-ancestor
19945623|NCT01519271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945624|NCT01519271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945625|NCT01519271|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19945626|NCT01519271|Protective Agents|protective agents|mesh-ancestor
19945627|NCT01519284|Levodopa|levodopa|mesh-list
19945628|NCT01519284|Carbidopa|carbidopa|mesh-list
19945629|NCT01519284|Opicapone|opicapone|mesh-list
19945630|NCT01519284|Entacapone|entacapone|mesh-list
19945631|NCT01519284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19945632|NCT01519284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19945633|NCT01519284|Dopamine Agents|dopamine agents|mesh-ancestor
19945634|NCT01519284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945635|NCT01519284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945636|NCT01519284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945637|NCT01519284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19945638|NCT01519284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945639|NCT01519284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19945640|NCT01519323|Vemurafenib|vemurafenib|mesh-list
19945641|NCT01519323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945642|NCT01519323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19945643|NCT01519323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945644|NCT01519323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945645|NCT01519518|Heparin|heparin|mesh-list
19945646|NCT01519518|Calcium heparin|calcium heparin|mesh-list
19945647|NCT01519518|Bivalirudin|bivalirudin|mesh-list
19945648|NCT01519518|Anticoagulants|anticoagulants|mesh-ancestor
19945649|NCT01519518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19945650|NCT01519518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19945651|NCT01519518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945652|NCT01519518|Antithrombins|antithrombins|mesh-ancestor
19945653|NCT01519518|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19945654|NCT01519518|Protease Inhibitors|protease inhibitors|mesh-ancestor
19945655|NCT01519518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945656|NCT01519635|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19945657|NCT01519635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19945658|NCT01519635|Diuretics|diuretics|mesh-ancestor
19945659|NCT01519635|Natriuretic Agents|natriuretic agents|mesh-ancestor
19945660|NCT01519635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945661|NCT01519635|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19945662|NCT01519635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19945663|NCT01519635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945664|NCT01519674|Insulin|insulin|mesh-list
19945665|NCT01519674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19945666|NCT01519674|Metformin|metformin|mesh-list
19945667|NCT01519674|Insulin Aspart|insulin aspart|mesh-list
19945668|NCT01519674|Insulin, Long-Acting|insulin, long-acting|mesh-list
19945669|NCT01519674|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19945670|NCT01519674|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19945671|NCT01519674|Biphasic Insulins|biphasic insulins|mesh-list
19945672|NCT01519674|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19945673|NCT01519674|Insulin, Isophane|insulin, isophane|mesh-list
19945674|NCT01519674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19945675|NCT01519674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945676|NCT01519674|Incretins|incretins|mesh-ancestor
19945677|NCT01519674|Hormones|hormones|mesh-ancestor
19945678|NCT01519674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19945679|NCT01519674|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19945680|NCT01519674|Protease Inhibitors|protease inhibitors|mesh-ancestor
19945681|NCT01519674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945682|NCT01519674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945683|NCT01519700|Lenograstim|lenograstim|mesh-list
19945684|NCT01519700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19945685|NCT01519700|Immunologic Factors|immunologic factors|mesh-ancestor
19945686|NCT01519700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945687|NCT01519765|Misoprostol|misoprostol|mesh-list
19945688|NCT01519765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19945689|NCT01519765|Abortifacient Agents|abortifacient agents|mesh-ancestor
19945690|NCT01519765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19945691|NCT01519765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945692|NCT01519765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19945693|NCT01519765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19945694|NCT01519765|Oxytocics|oxytocics|mesh-ancestor
19945695|NCT01519778|Tedizolid|tedizolid|mesh-list
19945696|NCT01519778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19945697|NCT01519778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19945698|NCT01519791|Methotrexate|methotrexate|mesh-list
19945699|NCT01519791|Certolizumab Pegol|certolizumab pegol|mesh-list
19945700|NCT01519791|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19945701|NCT01519791|Abortifacient Agents|abortifacient agents|mesh-ancestor
19945702|NCT01519791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19945703|NCT01519791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945704|NCT01519791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19945705|NCT01519791|Antimetabolites|antimetabolites|mesh-ancestor
19945706|NCT01519791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268120|NCT00528216|Sensory System Agents|sensory system agents|mesh-ancestor
20268121|NCT00528216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20268122|NCT00528216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268123|NCT00528255|Misoprostol|misoprostol|mesh-list
20268124|NCT00528255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20268125|NCT00528255|Abortifacient Agents|abortifacient agents|mesh-ancestor
20268126|NCT00528255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20268127|NCT00528255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268128|NCT00528255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20268129|NCT00528255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20268130|NCT00528255|Oxytocics|oxytocics|mesh-ancestor
20268131|NCT00528281|Pemetrexed|pemetrexed|mesh-list
20268132|NCT00528281|Lapatinib|lapatinib|mesh-list
20268133|NCT00528281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268134|NCT00528281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268135|NCT00528281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268136|NCT00528281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20268137|NCT00528281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20268138|NCT00528281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20268139|NCT00528359|Olanzapine|olanzapine|mesh-list
20268140|NCT00528359|Risperidone|risperidone|mesh-list
20268141|NCT00528359|Aripiprazole|aripiprazole|mesh-list
20268142|NCT00528359|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20268143|NCT00528359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20268144|NCT00528359|Serotonin Agents|serotonin agents|mesh-ancestor
20268145|NCT00528359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20268146|NCT00528359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268147|NCT00528359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268148|NCT00528359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20268149|NCT00528359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19945707|NCT01519791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945708|NCT01519791|Dermatologic Agents|dermatologic agents|mesh-ancestor
19945709|NCT01519791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945710|NCT01519791|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19945711|NCT01519791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19945712|NCT01519791|Immunologic Factors|immunologic factors|mesh-ancestor
19945713|NCT01519791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19945714|NCT01519791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19945715|NCT01519817|Vaccines|vaccines|mesh-list
19945716|NCT01519817|Immunologic Factors|immunologic factors|mesh-ancestor
19945717|NCT01519817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945718|NCT01519882|Rotigotine|rotigotine|mesh-list
19945719|NCT01519882|Dopamine Agonists|dopamine agonists|mesh-ancestor
19945720|NCT01519882|Dopamine Agents|dopamine agents|mesh-ancestor
20268150|NCT00528359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19945721|NCT01519882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945722|NCT01519882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945723|NCT01519882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945724|NCT01519921|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19945725|NCT01519921|Antiviral Agents|antiviral agents|mesh-ancestor
19945726|NCT01519921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19945727|NCT01519947|Epoetin Alfa|epoetin alfa|mesh-list
19945728|NCT01519947|Hematinics|hematinics|mesh-ancestor
19945729|NCT01520207|Mannitol|mannitol|mesh-list
19945730|NCT01520207|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19945731|NCT01520207|Diuretics|diuretics|mesh-ancestor
19945732|NCT01520207|Natriuretic Agents|natriuretic agents|mesh-ancestor
19945733|NCT01520207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945734|NCT01520363|Dextromethorphan|dextromethorphan|mesh-list
19945735|NCT01520363|Antitussive Agents|antitussive agents|mesh-ancestor
19945736|NCT01520363|Respiratory System Agents|respiratory system agents|mesh-ancestor
19945737|NCT01520363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19945738|NCT01520363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19945739|NCT01520363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945740|NCT01520363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945741|NCT01520363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945742|NCT01520402|Warfarin|warfarin|mesh-list
19945743|NCT01520402|Anticoagulants|anticoagulants|mesh-list
19945744|NCT01520454|Heparin|heparin|mesh-list
19945745|NCT01520454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19945746|NCT01520454|Anticoagulants|anticoagulants|mesh-ancestor
19945747|NCT01520454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19945748|NCT01520454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19945749|NCT01520454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945750|NCT01520454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19945751|NCT01520454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19945752|NCT01520454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19945753|NCT01520519|Rituximab|rituximab|mesh-list
19945754|NCT01520519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19945755|NCT01520519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945756|NCT01520519|Immunologic Factors|immunologic factors|mesh-ancestor
19945757|NCT01520519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945758|NCT01520519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19945759|NCT01520688|Fluticasone|fluticasone|mesh-list
19945760|NCT01520688|Xhance|xhance|mesh-list
19945761|NCT01520688|Budesonide|budesonide|mesh-list
19945762|NCT01520688|Beclomethasone|beclomethasone|mesh-list
19945763|NCT01520688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19945764|NCT01520688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19945765|NCT01520688|Autonomic Agents|autonomic agents|mesh-ancestor
19945766|NCT01520688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19945767|NCT01520688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945768|NCT01520688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19945769|NCT01520688|Respiratory System Agents|respiratory system agents|mesh-ancestor
19945770|NCT01520688|Dermatologic Agents|dermatologic agents|mesh-ancestor
19945771|NCT01520688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19945772|NCT01520688|Glucocorticoids|glucocorticoids|mesh-ancestor
19945773|NCT01520688|Hormones|hormones|mesh-ancestor
19945774|NCT01520688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19945775|NCT01520727|Opicapone|opicapone|mesh-list
19945776|NCT01520727|Entacapone|entacapone|mesh-list
19945777|NCT01520727|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19945778|NCT01520727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945779|NCT01520727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945780|NCT01520727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19945781|NCT01520727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19945782|NCT01520922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19945783|NCT01520922|Ofatumumab|ofatumumab|mesh-list
19945784|NCT01520922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19945785|NCT01520922|Alkylating Agents|alkylating agents|mesh-ancestor
19945786|NCT01520922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945787|NCT01520922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945788|NCT01520987|Opicapone|opicapone|mesh-list
19945789|NCT01520987|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19945790|NCT01520987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945791|NCT01520987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945792|NCT01520987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19945793|NCT01520987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19945794|NCT01521117|Donepezil|donepezil|mesh-list
19945795|NCT01521117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19945796|NCT01521117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945797|NCT01521117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945798|NCT01521117|Cholinergic Agents|cholinergic agents|mesh-ancestor
19945799|NCT01521117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945800|NCT01521117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945801|NCT01521117|Nootropic Agents|nootropic agents|mesh-ancestor
19945802|NCT01521260|Chlorhexidine|chlorhexidine|mesh-list
19945803|NCT01521260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19945804|NCT01521260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19945805|NCT01521260|Disinfectants|disinfectants|mesh-ancestor
19945806|NCT01521364|Clarithromycin|clarithromycin|mesh-list
19945807|NCT01521364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19945808|NCT01521364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19945809|NCT01521364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19945810|NCT01521364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945811|NCT01521364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945812|NCT01521364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19945813|NCT01521364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19945814|NCT01521546|Eplerenone|eplerenone|mesh-list
19945815|NCT01521546|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19945816|NCT01521546|Hormone Antagonists|hormone antagonists|mesh-ancestor
19945817|NCT01521546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19945818|NCT01521546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945819|NCT01521546|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19945820|NCT01521546|Diuretics|diuretics|mesh-ancestor
19945821|NCT01521546|Natriuretic Agents|natriuretic agents|mesh-ancestor
19945822|NCT01521546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19945823|NCT01521559|Aflibercept|aflibercept|mesh-list
19945824|NCT01521559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19945825|NCT01521559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19945826|NCT01521559|Growth Substances|growth substances|mesh-ancestor
19945827|NCT01521559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945828|NCT01521559|Growth Inhibitors|growth inhibitors|mesh-ancestor
19945829|NCT01521559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945830|NCT01521897|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19945831|NCT01521897|Immunologic Factors|immunologic factors|mesh-ancestor
19945832|NCT01521897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945833|NCT01521923|Methotrexate|methotrexate|mesh-list
19945834|NCT01521923|Certolizumab Pegol|certolizumab pegol|mesh-list
19945835|NCT01521923|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19945836|NCT01521923|Abortifacient Agents|abortifacient agents|mesh-ancestor
19945837|NCT01521923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19945838|NCT01521923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945839|NCT01521923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19945840|NCT01521923|Antimetabolites|antimetabolites|mesh-ancestor
19945841|NCT01521923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945842|NCT01521923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945843|NCT01521923|Dermatologic Agents|dermatologic agents|mesh-ancestor
19945844|NCT01521923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945845|NCT01521923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19945846|NCT01521923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19945847|NCT01521923|Immunologic Factors|immunologic factors|mesh-ancestor
19945848|NCT01521923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19945849|NCT01521923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19974046|NCT01831427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974047|NCT01831466|Tofacitinib|tofacitinib|mesh-list
19974048|NCT01831466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19974049|NCT01831466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974050|NCT01831466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974051|NCT01831765|Insulin|insulin|mesh-list
19974052|NCT01831765|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19974053|NCT01831765|Insulin Aspart|insulin aspart|mesh-list
19974054|NCT01831765|Insulin, Long-Acting|insulin, long-acting|mesh-list
19974055|NCT01831765|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19974056|NCT01831765|Insulin Detemir|insulin detemir|mesh-list
19974057|NCT01831765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19974058|NCT01831765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974059|NCT01831791|Dutasteride|dutasteride|mesh-list
19974060|NCT01831791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19974061|NCT01831791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19974062|NCT01831791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974063|NCT01831791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974064|NCT01831791|Hormone Antagonists|hormone antagonists|mesh-ancestor
19974065|NCT01831791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19974066|NCT01831791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974067|NCT01831817|Calcium, Dietary|calcium, dietary|mesh-list
19945850|NCT01522235|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19945851|NCT01522235|gamma-Globulins|gamma-globulins|mesh-list
19945852|NCT01522235|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19945853|NCT01522235|Immunologic Factors|immunologic factors|mesh-ancestor
19945854|NCT01522235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945855|NCT01522404|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19945856|NCT01522404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19945857|NCT01522404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19945858|NCT01522404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19945859|NCT01522404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945860|NCT01522404|Adrenergic Agents|adrenergic agents|mesh-ancestor
19945861|NCT01522404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945862|NCT01522404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945863|NCT01522417|Tirofiban|tirofiban|mesh-list
19945864|NCT01522417|Eptifibatide|eptifibatide|mesh-list
19945865|NCT01522417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19945866|NCT01522417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19945867|NCT01522417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945868|NCT01522417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19945869|NCT01522443|Prednisone|prednisone|mesh-list
19945870|NCT01522443|Mitoxantrone|mitoxantrone|mesh-list
19945871|NCT01522443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19945872|NCT01522443|Glucocorticoids|glucocorticoids|mesh-ancestor
19945873|NCT01522443|Hormones|hormones|mesh-ancestor
19945874|NCT01522443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19945875|NCT01522443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945876|NCT01522443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19945877|NCT01522443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945878|NCT01522443|Analgesics|analgesics|mesh-ancestor
19945879|NCT01522443|Sensory System Agents|sensory system agents|mesh-ancestor
19945880|NCT01522443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19945881|NCT01522443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19945882|NCT01522443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19945883|NCT01522443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945884|NCT01522443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945885|NCT01522456|Tretinoin|tretinoin|mesh-list
19945886|NCT01522456|Dermatologic Agents|dermatologic agents|mesh-ancestor
19945887|NCT01522456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945888|NCT01522456|Keratolytic Agents|keratolytic agents|mesh-ancestor
19945889|NCT01522651|Dronedarone|dronedarone|mesh-list
19945890|NCT01522651|Ranolazine|ranolazine|mesh-list
19945891|NCT01522651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19945892|NCT01522651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19945893|NCT01522651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945894|NCT01522651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19945895|NCT01522950|Atenolol|atenolol|mesh-list
19945896|NCT01522950|Nebivolol|nebivolol|mesh-list
19945897|NCT01522950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19945898|NCT01522950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20268151|NCT00528359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20268152|NCT00528359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20268153|NCT00528359|Dopamine Agents|dopamine agents|mesh-ancestor
20268154|NCT00528359|Antiemetics|antiemetics|mesh-ancestor
20268155|NCT00528359|Autonomic Agents|autonomic agents|mesh-ancestor
20268156|NCT00528359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20268157|NCT00528359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20268158|NCT00528359|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20268159|NCT00528359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20268160|NCT00528359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20268161|NCT00528359|Antidepressive Agents|antidepressive agents|mesh-ancestor
20268162|NCT00528359|Dopamine Agonists|dopamine agonists|mesh-ancestor
20268163|NCT00528359|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20268164|NCT00528359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20268165|NCT00528359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20268166|NCT00528359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20268167|NCT00528385|Spironolactone|spironolactone|mesh-list
20268168|NCT00528385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20268169|NCT00528385|Hormone Antagonists|hormone antagonists|mesh-ancestor
20268170|NCT00528385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20268171|NCT00528385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268172|NCT00528385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19945899|NCT01522950|Sympatholytics|sympatholytics|mesh-ancestor
19945900|NCT01522950|Autonomic Agents|autonomic agents|mesh-ancestor
19945901|NCT01522950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19945902|NCT01522950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945903|NCT01522950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19945904|NCT01522950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19945905|NCT01522950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19945906|NCT01522950|Adrenergic Agents|adrenergic agents|mesh-ancestor
19945907|NCT01522950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945908|NCT01522950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945909|NCT01522950|Vasodilator Agents|vasodilator agents|mesh-ancestor
19945910|NCT01522950|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19945911|NCT01522950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19945912|NCT01522950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19945913|NCT01522963|Nicotine|nicotine|mesh-list
19945914|NCT01522963|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19945915|NCT01522963|Autonomic Agents|autonomic agents|mesh-ancestor
19945916|NCT01522963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19945917|NCT01522963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945918|NCT01522963|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19945919|NCT01522963|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19945920|NCT01522963|Cholinergic Agents|cholinergic agents|mesh-ancestor
19945921|NCT01522963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945922|NCT01522963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945923|NCT01523275|Mitomycins|mitomycins|mesh-list
19945924|NCT01523275|Mitomycin|mitomycin|mesh-list
19945925|NCT01523275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19945926|NCT01523275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945927|NCT01523275|Alkylating Agents|alkylating agents|mesh-ancestor
19945928|NCT01523275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945929|NCT01523275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19945930|NCT01523275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945931|NCT01523301|Rotigotine|rotigotine|mesh-list
19945932|NCT01523301|Dopamine Agonists|dopamine agonists|mesh-ancestor
19945933|NCT01523301|Dopamine Agents|dopamine agents|mesh-ancestor
19945934|NCT01523301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945935|NCT01523301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945936|NCT01523301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945937|NCT01523366|Clopidogrel|clopidogrel|mesh-list
19945938|NCT01523366|Ticagrelor|ticagrelor|mesh-list
19945939|NCT01523366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19945940|NCT01523366|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19945941|NCT01523366|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19945942|NCT01523366|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19945943|NCT01523366|Purinergic Agents|purinergic agents|mesh-ancestor
19945944|NCT01523366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945945|NCT01523366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945946|NCT01523366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945947|NCT01523392|Clopidogrel|clopidogrel|mesh-list
19945948|NCT01523392|Ticagrelor|ticagrelor|mesh-list
19945949|NCT01523392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19945950|NCT01523392|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19945951|NCT01523392|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19945952|NCT01523392|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19945953|NCT01523392|Purinergic Agents|purinergic agents|mesh-ancestor
19945954|NCT01523392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945955|NCT01523392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945956|NCT01523392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945957|NCT01523457|Folfirinox|folfirinox|mesh-list
19945958|NCT01523457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945959|NCT01523496|Vitamin D|vitamin d|mesh-list
19945960|NCT01523496|Ergocalciferols|ergocalciferols|mesh-list
19945961|NCT01523496|Calcifediol|calcifediol|mesh-list
19945962|NCT01523496|Vitamins|vitamins|mesh-list
19945963|NCT01523496|Micronutrients|micronutrients|mesh-ancestor
19945964|NCT01523496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945965|NCT01523496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19945966|NCT01523496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19945967|NCT01523587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19945968|NCT01523587|Afatinib|afatinib|mesh-list
19945969|NCT01523587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945970|NCT01523587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19945971|NCT01523587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945972|NCT01523587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945973|NCT01523821|Protease Inhibitors|protease inhibitors|mesh-list
19945974|NCT01523821|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19945975|NCT01523821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945976|NCT01523821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945977|NCT01523821|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19945978|NCT01523821|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19945979|NCT01523834|Panobinostat|panobinostat|mesh-list
19945980|NCT01523834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19945981|NCT01523834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19945982|NCT01523834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19945983|NCT01523834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945984|NCT01523886|Rocuronium|rocuronium|mesh-list
19945985|NCT01523886|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19945986|NCT01523886|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19945987|NCT01523886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19945988|NCT01523886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19945989|NCT01523886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19945990|NCT01524133|Sertraline|sertraline|mesh-list
19945991|NCT01524133|Antidepressive Agents|antidepressive agents|mesh-ancestor
19945992|NCT01524133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19945993|NCT01524133|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19945994|NCT01524133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19945995|NCT01524133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19945996|NCT01524133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19945997|NCT01524133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19945998|NCT01524133|Serotonin Agents|serotonin agents|mesh-ancestor
19945999|NCT01524133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946000|NCT01524198|Budesonide|budesonide|mesh-list
19946001|NCT01524198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19946002|NCT01524198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19946003|NCT01524198|Autonomic Agents|autonomic agents|mesh-ancestor
19946004|NCT01524198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19946005|NCT01524198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946006|NCT01524198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19946007|NCT01524198|Respiratory System Agents|respiratory system agents|mesh-ancestor
19946008|NCT01524198|Glucocorticoids|glucocorticoids|mesh-ancestor
19946009|NCT01524198|Hormones|hormones|mesh-ancestor
19946010|NCT01524198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19946011|NCT01524289|Anacetrapib|anacetrapib|mesh-list
19946012|NCT01524289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19946013|NCT01524289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19946014|NCT01524289|Antimetabolites|antimetabolites|mesh-ancestor
19946015|NCT01524289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946016|NCT01524289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19946017|NCT01524302|Levofloxacin|levofloxacin|mesh-list
19946018|NCT01524302|Ofloxacin|ofloxacin|mesh-list
19946019|NCT01524302|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19946020|NCT01524302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19946021|NCT01524302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19946022|NCT01524302|Renal Agents|renal agents|mesh-ancestor
19946023|NCT01524302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19946024|NCT01524302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19946025|NCT01524302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19946026|NCT01524302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946027|NCT01524302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946028|NCT01524302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946029|NCT01524302|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19946030|NCT01524302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19946031|NCT01524627|Varenicline|varenicline|mesh-list
19946032|NCT01524627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19946033|NCT01524627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19946034|NCT01524627|Cholinergic Agents|cholinergic agents|mesh-ancestor
19946035|NCT01524627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19946036|NCT01524627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946037|NCT01524627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946038|NCT01524679|Interferons|interferons|mesh-list
19946039|NCT01524679|Interferon-alpha|interferon-alpha|mesh-list
19946040|NCT01524679|Interferon alpha-2|interferon alpha-2|mesh-list
19946041|NCT01524679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19946042|NCT01524679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946043|NCT01524679|Antiviral Agents|antiviral agents|mesh-ancestor
19946044|NCT01524679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19946045|NCT01524679|Immunologic Factors|immunologic factors|mesh-ancestor
19946046|NCT01524679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946047|NCT01524770|Dulaglutide|dulaglutide|mesh-list
19946048|NCT01524770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19946049|NCT01524770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946050|NCT01524783|Everolimus|everolimus|mesh-list
19946051|NCT01524783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946052|NCT01524783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19946053|NCT01524783|Immunologic Factors|immunologic factors|mesh-ancestor
19946054|NCT01524783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946055|NCT01524796|Pregabalin|pregabalin|mesh-list
19946056|NCT01524796|Analgesics|analgesics|mesh-ancestor
19946057|NCT01524796|Sensory System Agents|sensory system agents|mesh-ancestor
19946058|NCT01524796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19946059|NCT01524796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946060|NCT01524796|Anticonvulsants|anticonvulsants|mesh-ancestor
19946061|NCT01524796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19946062|NCT01524796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19946063|NCT01524796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946064|NCT01524796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19946065|NCT01524796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19946066|NCT01524796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19946067|NCT01524796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19946068|NCT01524796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19946069|NCT01524887|Immunoglobulins|immunoglobulins|mesh-list
19946070|NCT01524887|Antibodies|antibodies|mesh-list
19946071|NCT01524887|gamma-Globulins|gamma-globulins|mesh-list
19946072|NCT01524887|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19946073|NCT01524887|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19946074|NCT01524887|Immunologic Factors|immunologic factors|mesh-ancestor
19946075|NCT01524887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946076|NCT01524913|Hyaluronic Acid|hyaluronic acid|mesh-list
19946077|NCT01524913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19946078|NCT01524913|Immunologic Factors|immunologic factors|mesh-ancestor
19946079|NCT01524913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946080|NCT01524913|Viscosupplements|viscosupplements|mesh-ancestor
19946081|NCT01524913|Protective Agents|protective agents|mesh-ancestor
19946082|NCT01524978|Cetuximab|cetuximab|mesh-list
19946083|NCT01524978|Vemurafenib|vemurafenib|mesh-list
19946084|NCT01524978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19946085|NCT01524978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946086|NCT01524978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19946087|NCT01524978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946088|NCT01524978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946089|NCT01524991|Gemcitabine|gemcitabine|mesh-list
19946090|NCT01524991|Ipilimumab|ipilimumab|mesh-list
19946091|NCT01524991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946092|NCT01524991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19946093|NCT01524991|Antimetabolites|antimetabolites|mesh-ancestor
19946094|NCT01524991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946095|NCT01524991|Antiviral Agents|antiviral agents|mesh-ancestor
19946096|NCT01524991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19946097|NCT01524991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946098|NCT01524991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19946099|NCT01524991|Immunologic Factors|immunologic factors|mesh-ancestor
19946100|NCT01524991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946101|NCT01524991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19946102|NCT01524991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19946103|NCT01525082|Bevacizumab|bevacizumab|mesh-list
19946104|NCT01525082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19946105|NCT01525082|Capecitabine|capecitabine|mesh-list
19946106|NCT01525082|Temozolomide|temozolomide|mesh-list
19946107|NCT01525082|Antibodies|antibodies|mesh-list
19946108|NCT01525082|Immunoglobulins|immunoglobulins|mesh-list
19946109|NCT01525082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19946110|NCT01525082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946111|NCT01525082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19946112|NCT01525082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19946113|NCT01525082|Growth Substances|growth substances|mesh-ancestor
19946114|NCT01525082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946115|NCT01525082|Growth Inhibitors|growth inhibitors|mesh-ancestor
19946116|NCT01525082|Immunologic Factors|immunologic factors|mesh-ancestor
19946117|NCT01525082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19946118|NCT01525082|Antimetabolites|antimetabolites|mesh-ancestor
19946119|NCT01525082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946120|NCT01525082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19946121|NCT01525082|Alkylating Agents|alkylating agents|mesh-ancestor
19946122|NCT01525173|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19946123|NCT01525173|Bimatoprost|bimatoprost|mesh-list
19946124|NCT01525173|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19946125|NCT01525173|Latanoprost|latanoprost|mesh-list
19946126|NCT01525173|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19946127|NCT01525173|Lubricant Eye Drops|lubricant eye drops|mesh-list
19946128|NCT01525173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19946129|NCT01525173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19946130|NCT01525173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19946131|NCT01525173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19946132|NCT01525173|Adrenergic Agents|adrenergic agents|mesh-ancestor
19946133|NCT01525173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19946134|NCT01525173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946135|NCT01525173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268173|NCT00528385|Diuretics|diuretics|mesh-ancestor
20268174|NCT00528385|Natriuretic Agents|natriuretic agents|mesh-ancestor
20268175|NCT00528502|Lidocaine|lidocaine|mesh-list
20268176|NCT00528502|Anesthetics, Local|anesthetics, local|mesh-ancestor
20268177|NCT00528502|Anesthetics|anesthetics|mesh-ancestor
20268178|NCT00528502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20268179|NCT00528502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268180|NCT00528502|Sensory System Agents|sensory system agents|mesh-ancestor
20543240|NCT01868880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543241|NCT01868880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543242|NCT01868880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20543243|NCT01868880|Sympatholytics|sympatholytics|mesh-ancestor
20543244|NCT01868880|Autonomic Agents|autonomic agents|mesh-ancestor
20543245|NCT01868880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543246|NCT01868880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20543247|NCT01868906|Temozolomide|temozolomide|mesh-list
20543248|NCT01868906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20543249|NCT01868906|Alkylating Agents|alkylating agents|mesh-ancestor
20543250|NCT01868906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543251|NCT01868906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543252|NCT01868945|Vitamin D|vitamin d|mesh-list
20543253|NCT01868945|Cholecalciferol|cholecalciferol|mesh-list
20543254|NCT01868945|Calcifediol|calcifediol|mesh-list
20543255|NCT01868945|Vitamins|vitamins|mesh-ancestor
20543256|NCT01868945|Micronutrients|micronutrients|mesh-ancestor
20543257|NCT01868945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543258|NCT01868945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20543259|NCT01868945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20543260|NCT01868984|Paclitaxel|paclitaxel|mesh-list
20543261|NCT01868984|Heparin|heparin|mesh-list
20543262|NCT01868984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20543263|NCT01868984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543264|NCT01868984|Tubulin Modulators|tubulin modulators|mesh-ancestor
20543265|NCT01868984|Antimitotic Agents|antimitotic agents|mesh-ancestor
20543266|NCT01868984|Mitosis Modulators|mitosis modulators|mesh-ancestor
20543267|NCT01868984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543268|NCT01868984|Anticoagulants|anticoagulants|mesh-ancestor
20543269|NCT01868984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20543270|NCT01868984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20543271|NCT01869010|Tenofovir|tenofovir|mesh-list
20543272|NCT01869010|Antiviral Agents|antiviral agents|mesh-ancestor
20543273|NCT01869010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20543274|NCT01869010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20543275|NCT01869010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20543276|NCT01869010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543277|NCT01869010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543278|NCT01869010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20543279|NCT01869010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19946136|NCT01525225|Metformin|metformin|mesh-list
19946137|NCT01525225|Saxagliptin|saxagliptin|mesh-list
19946138|NCT01525225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19946139|NCT01525225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946140|NCT01525225|Incretins|incretins|mesh-ancestor
20268181|NCT00528502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20268182|NCT00528502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20268183|NCT00528502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20268184|NCT00528502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19946141|NCT01525225|Hormones|hormones|mesh-ancestor
19946142|NCT01525225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19946143|NCT01525225|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19946144|NCT01525225|Protease Inhibitors|protease inhibitors|mesh-ancestor
19946145|NCT01525225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946146|NCT01525225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946147|NCT01525238|Dapagliflozin|dapagliflozin|mesh-list
19946148|NCT01525238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19946149|NCT01525238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946150|NCT01525238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19946151|NCT01525238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946152|NCT01525407|Atorvastatin|atorvastatin|mesh-list
19946153|NCT01525407|Calcium|calcium|mesh-list
19946154|NCT01525407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19946155|NCT01525407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946156|NCT01525407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19946157|NCT01525407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20268185|NCT00528502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20268186|NCT00528502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268187|NCT00528515|Propofol|propofol|mesh-list
20268188|NCT00528515|Desflurane|desflurane|mesh-list
20268189|NCT00528515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20268190|NCT00528515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20268191|NCT00528515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268192|NCT00528515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20268193|NCT00528515|Anesthetics, General|anesthetics, general|mesh-ancestor
20268194|NCT00528515|Anesthetics|anesthetics|mesh-ancestor
20268195|NCT00528515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20268196|NCT00528593|Epoetin Alfa|epoetin alfa|mesh-list
20268197|NCT00528593|Hematinics|hematinics|mesh-ancestor
20268198|NCT00528619|Carboplatin|carboplatin|mesh-list
20268199|NCT00528619|Pemetrexed|pemetrexed|mesh-list
20268200|NCT00528619|Sunitinib|sunitinib|mesh-list
20268201|NCT00528619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268202|NCT00528619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268203|NCT00528619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268204|NCT00528619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20268205|NCT00528619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20268206|NCT00528619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20268207|NCT00528619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20268208|NCT00528619|Growth Substances|growth substances|mesh-ancestor
20268209|NCT00528619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268210|NCT00528619|Growth Inhibitors|growth inhibitors|mesh-ancestor
20268211|NCT00528619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20268212|NCT00528658|Acetaminophen|acetaminophen|mesh-list
20268213|NCT00528658|Ibuprofen|ibuprofen|mesh-list
20268214|NCT00528658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20268215|NCT00528658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20268216|NCT00528658|Analgesics|analgesics|mesh-ancestor
20268217|NCT00528658|Sensory System Agents|sensory system agents|mesh-ancestor
20268218|NCT00528658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20268219|NCT00528658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268220|NCT00528658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20268221|NCT00528658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20268222|NCT00528658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20268223|NCT00528658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268224|NCT00528658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268225|NCT00528658|Antipyretics|antipyretics|mesh-ancestor
20268226|NCT00528671|Phenprocoumon|phenprocoumon|mesh-list
20268227|NCT00528671|Anticoagulants|anticoagulants|mesh-ancestor
20268228|NCT00528723|Albuterol|albuterol|mesh-list
20268229|NCT00528723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20268230|NCT00528723|Autonomic Agents|autonomic agents|mesh-ancestor
20268231|NCT00528723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20268232|NCT00528723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268233|NCT00528723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20268234|NCT00528723|Respiratory System Agents|respiratory system agents|mesh-ancestor
20268235|NCT00528723|Tocolytic Agents|tocolytic agents|mesh-ancestor
20268236|NCT00528723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20268237|NCT00528723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20268238|NCT00528723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20268239|NCT00528723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20268240|NCT00528723|Adrenergic Agents|adrenergic agents|mesh-ancestor
20268241|NCT00528723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20268242|NCT00528723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268243|NCT00528814|Hand Sanitizers|hand sanitizers|mesh-list
20268244|NCT00528814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20268245|NCT00528814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268246|NCT00528814|Disinfectants|disinfectants|mesh-ancestor
19946158|NCT01525407|Antimetabolites|antimetabolites|mesh-ancestor
20268247|NCT00528827|Nicardipine|nicardipine|mesh-list
20268248|NCT00528827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19946159|NCT01525407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946160|NCT01525407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19946161|NCT01525407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19946162|NCT01525407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946163|NCT01525550|Sunitinib|sunitinib|mesh-list
19946164|NCT01525550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946165|NCT01525550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19946166|NCT01525550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19946167|NCT01525550|Growth Substances|growth substances|mesh-ancestor
19946168|NCT01525550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946169|NCT01525550|Growth Inhibitors|growth inhibitors|mesh-ancestor
19946170|NCT01525550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19946171|NCT01525550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946172|NCT01525550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946173|NCT01525602|Paclitaxel|paclitaxel|mesh-list
19946174|NCT01525602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19946175|NCT01525602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946176|NCT01525602|Tubulin Modulators|tubulin modulators|mesh-ancestor
19946177|NCT01525602|Antimitotic Agents|antimitotic agents|mesh-ancestor
19946178|NCT01525602|Mitosis Modulators|mitosis modulators|mesh-ancestor
19946179|NCT01525602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946180|NCT01525615|Tiotropium Bromide|tiotropium bromide|mesh-list
19946181|NCT01525615|Olodaterol|olodaterol|mesh-list
19946182|NCT01525615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19946183|NCT01525615|Autonomic Agents|autonomic agents|mesh-ancestor
19946184|NCT01525615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19946185|NCT01525615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946186|NCT01525615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19946187|NCT01525615|Respiratory System Agents|respiratory system agents|mesh-ancestor
19946188|NCT01525615|Parasympatholytics|parasympatholytics|mesh-ancestor
19946189|NCT01525615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19946190|NCT01525615|Cholinergic Agents|cholinergic agents|mesh-ancestor
19946191|NCT01525615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19946192|NCT01525615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946193|NCT01525628|Tolbutamide|tolbutamide|mesh-list
19946194|NCT01525628|Interferons|interferons|mesh-list
19946195|NCT01525628|Tenofovir|tenofovir|mesh-list
19946196|NCT01525628|Ribavirin|ribavirin|mesh-list
19946197|NCT01525628|Midazolam|midazolam|mesh-list
19946198|NCT01525628|Caffeine|caffeine|mesh-list
19946199|NCT01525628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946200|NCT01525628|Antiviral Agents|antiviral agents|mesh-ancestor
19946201|NCT01525628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19946202|NCT01525628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19946203|NCT01525628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19946204|NCT01525628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19946205|NCT01525628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946206|NCT01525628|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19946207|NCT01525628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19946208|NCT01525628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19946209|NCT01525628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19946210|NCT01525628|Anesthetics, General|anesthetics, general|mesh-ancestor
19946211|NCT01525628|Anesthetics|anesthetics|mesh-ancestor
19946212|NCT01525628|GABA Modulators|gaba modulators|mesh-ancestor
19946213|NCT01525628|GABA Agents|gaba agents|mesh-ancestor
19946214|NCT01525628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19946215|NCT01525628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946216|NCT01525628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19946217|NCT01525628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19946218|NCT01525628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946219|NCT01525628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19946220|NCT01525628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19946221|NCT01525628|Antimetabolites|antimetabolites|mesh-ancestor
19946222|NCT01525628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19946223|NCT01525628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19946224|NCT01525628|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19946225|NCT01525628|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19946226|NCT01525628|Purinergic Agents|purinergic agents|mesh-ancestor
19946227|NCT01525628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19946228|NCT01525641|Pramipexole|pramipexole|mesh-list
19946229|NCT01525641|Antioxidants|antioxidants|mesh-ancestor
19946230|NCT01525641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946231|NCT01525641|Protective Agents|protective agents|mesh-ancestor
19946232|NCT01525641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946233|NCT01525641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19946234|NCT01525641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19946235|NCT01525641|Dopamine Agonists|dopamine agonists|mesh-ancestor
19946236|NCT01525641|Dopamine Agents|dopamine agents|mesh-ancestor
19946237|NCT01525641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19946238|NCT01525875|Magnesium Oxide|magnesium oxide|mesh-list
19946239|NCT01525875|Antacids|antacids|mesh-ancestor
19946240|NCT01525875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946241|NCT01525875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19946242|NCT01526057|Rituximab|rituximab|mesh-list
19946243|NCT01526057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19946244|NCT01526057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946245|NCT01526057|Immunologic Factors|immunologic factors|mesh-ancestor
19946246|NCT01526057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946247|NCT01526057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19946248|NCT01526148|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19946249|NCT01526148|Lithium Carbonate|lithium carbonate|mesh-list
19946250|NCT01526148|Antidepressive Agents|antidepressive agents|mesh-ancestor
19946251|NCT01526148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19946252|NCT01526148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19946253|NCT01526148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19946254|NCT01526148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19946255|NCT01526148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946256|NCT01526148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946257|NCT01526148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946258|NCT01526148|Antimanic Agents|antimanic agents|mesh-ancestor
19946259|NCT01526213|Fexofenadine|fexofenadine|mesh-list
19946260|NCT01526213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19946261|NCT01526213|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19946262|NCT01526213|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19946263|NCT01526213|Histamine Antagonists|histamine antagonists|mesh-ancestor
19946264|NCT01526213|Histamine Agents|histamine agents|mesh-ancestor
19946265|NCT01526213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19946266|NCT01526213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946267|NCT01526213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946268|NCT01526356|Sirolimus|sirolimus|mesh-list
19946269|NCT01526356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19946270|NCT01526356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19946271|NCT01526356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19946272|NCT01526356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946273|NCT01526356|Antifungal Agents|antifungal agents|mesh-ancestor
19946274|NCT01526356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19946275|NCT01526356|Immunologic Factors|immunologic factors|mesh-ancestor
19946276|NCT01526356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946277|NCT01526538|Cycloserine|cycloserine|mesh-list
19946278|NCT01526538|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19946279|NCT01526538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19946280|NCT01526538|Renal Agents|renal agents|mesh-ancestor
19946281|NCT01526538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19946282|NCT01526538|Antitubercular Agents|antitubercular agents|mesh-ancestor
19946283|NCT01526538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19946284|NCT01526538|Antimetabolites|antimetabolites|mesh-ancestor
19946285|NCT01526538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946286|NCT01526551|Vaccines|vaccines|mesh-list
19946287|NCT01526551|Immunologic Factors|immunologic factors|mesh-ancestor
19946288|NCT01526551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946289|NCT01526577|Ticagrelor|ticagrelor|mesh-list
19946290|NCT01526577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19946291|NCT01526577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19946292|NCT01526577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19946293|NCT01526577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19946294|NCT01526577|Purinergic Agents|purinergic agents|mesh-ancestor
19946295|NCT01526577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19946296|NCT01526577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946297|NCT01526577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946298|NCT01526733|Insulin|insulin|mesh-list
19946299|NCT01526733|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19946300|NCT01526733|Insulin Aspart|insulin aspart|mesh-list
19946301|NCT01526733|Insulin Lispro|insulin lispro|mesh-list
19946302|NCT01526733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19946303|NCT01526733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946304|NCT01527045|Calcium, Dietary|calcium, dietary|mesh-list
19946305|NCT01527045|Cyclosporine|cyclosporine|mesh-list
19946306|NCT01527045|Mycophenolic Acid|mycophenolic acid|mesh-list
19946307|NCT01527045|Fludarabine|fludarabine|mesh-list
19946308|NCT01527045|Fludarabine phosphate|fludarabine phosphate|mesh-list
19946309|NCT01527045|Atorvastatin|atorvastatin|mesh-list
19946310|NCT01527045|Calcium|calcium|mesh-list
19946311|NCT01527045|Cyclosporins|cyclosporins|mesh-list
19946312|NCT01527045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19946313|NCT01527045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946314|NCT01527045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19946315|NCT01527045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946316|NCT01527045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19946317|NCT01527045|Antimetabolites|antimetabolites|mesh-ancestor
19946318|NCT01527045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946319|NCT01527045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19946320|NCT01527045|Immunologic Factors|immunologic factors|mesh-ancestor
19946321|NCT01527045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946322|NCT01527045|Antifungal Agents|antifungal agents|mesh-ancestor
19946323|NCT01527045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19946324|NCT01527045|Dermatologic Agents|dermatologic agents|mesh-ancestor
19946325|NCT01527045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19946326|NCT01527045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19946327|NCT01527045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19946328|NCT01527045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19946329|NCT01527045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19946330|NCT01527045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19946331|NCT01527045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19946332|NCT01527045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19946333|NCT01527045|Antitubercular Agents|antitubercular agents|mesh-ancestor
19946334|NCT01527045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19946335|NCT01527110|Zanamivir|zanamivir|mesh-list
19946336|NCT01527110|Antiviral Agents|antiviral agents|mesh-ancestor
19946337|NCT01527110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19946338|NCT01527110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946339|NCT01527110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946340|NCT01527357|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19946341|NCT01527357|Fibrin Foam|fibrin foam|mesh-list
19946342|NCT01527357|Hemostatics|hemostatics|mesh-ancestor
19946343|NCT01527357|Coagulants|coagulants|mesh-ancestor
19946344|NCT01527383|Vaccines|vaccines|mesh-list
19946345|NCT01527383|Immunologic Factors|immunologic factors|mesh-ancestor
19946346|NCT01527383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974068|NCT01831817|Listerine|listerine|mesh-list
19974069|NCT01831817|Calcium|calcium|mesh-list
19974070|NCT01831817|Fluorides|fluorides|mesh-list
19974071|NCT01831817|Sodium Fluoride|sodium fluoride|mesh-list
19974072|NCT01831817|Fluorophosphate|fluorophosphate|mesh-list
19974073|NCT01831817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19974074|NCT01831817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974075|NCT01831817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19974076|NCT01831817|Cariostatic Agents|cariostatic agents|mesh-ancestor
19974077|NCT01831817|Protective Agents|protective agents|mesh-ancestor
19974078|NCT01831817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19974079|NCT01831817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19974080|NCT01831934|Vaccines|vaccines|mesh-list
19974081|NCT01831934|Immunologic Factors|immunologic factors|mesh-ancestor
19974082|NCT01831934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974083|NCT01832038|Lacosamide|lacosamide|mesh-list
19974084|NCT01832038|Anticonvulsants|anticonvulsants|mesh-ancestor
19974085|NCT01832038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19974086|NCT01832038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19974087|NCT01832038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19974088|NCT01832038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974089|NCT01832402|Fentanyl|fentanyl|mesh-list
19974090|NCT01832402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19974091|NCT01832402|Narcotics|narcotics|mesh-ancestor
19974092|NCT01832402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19974093|NCT01832402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974094|NCT01832402|Analgesics|analgesics|mesh-ancestor
19974095|NCT01832402|Sensory System Agents|sensory system agents|mesh-ancestor
19974096|NCT01832402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19974097|NCT01832402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19974098|NCT01832402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19974099|NCT01832402|Anesthetics, General|anesthetics, general|mesh-ancestor
19974100|NCT01832402|Anesthetics|anesthetics|mesh-ancestor
19974101|NCT01832532|Liraglutide|liraglutide|mesh-list
20268249|NCT00528827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20268250|NCT00528827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20287296|NCT05177614|Trace Elements|trace elements|mesh-list
19974102|NCT01832532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19974103|NCT01832532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974104|NCT01832532|Incretins|incretins|mesh-ancestor
19946347|NCT01527487|Cyclophosphamide|cyclophosphamide|mesh-list
19946348|NCT01527487|Docetaxel|docetaxel|mesh-list
19946349|NCT01527487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19946350|NCT01527487|Immunologic Factors|immunologic factors|mesh-ancestor
19946351|NCT01527487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946352|NCT01527487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19946353|NCT01527487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19946354|NCT01527487|Alkylating Agents|alkylating agents|mesh-ancestor
19946355|NCT01527487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946356|NCT01527487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946357|NCT01527487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19946358|NCT01527487|Tubulin Modulators|tubulin modulators|mesh-ancestor
19946359|NCT01527487|Antimitotic Agents|antimitotic agents|mesh-ancestor
19946360|NCT01527487|Mitosis Modulators|mitosis modulators|mesh-ancestor
19946361|NCT01527513|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19946362|NCT01527513|Anticonvulsants|anticonvulsants|mesh-ancestor
19946363|NCT01527513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19946364|NCT01527513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19946365|NCT01527513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19946366|NCT01527513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946367|NCT01527682|Dorzolamide|dorzolamide|mesh-list
19946368|NCT01527682|Latanoprost|latanoprost|mesh-list
19946369|NCT01527682|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19946370|NCT01527682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19946371|NCT01527682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19946372|NCT01527682|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19946373|NCT01527682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946374|NCT01527682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946375|NCT01528254|Metformin|metformin|mesh-list
19946376|NCT01528254|Vildagliptin|vildagliptin|mesh-list
19946377|NCT01528254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19946378|NCT01528254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946379|NCT01528254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19946380|NCT01528254|Protease Inhibitors|protease inhibitors|mesh-ancestor
19946381|NCT01528254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946382|NCT01528254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974105|NCT01832532|Hormones|hormones|mesh-ancestor
19974106|NCT01832532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19974107|NCT01832727|Dexamethasone|dexamethasone|mesh-list
19974108|NCT01832727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19974109|NCT01832727|Antiemetics|antiemetics|mesh-ancestor
20268251|NCT00528827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268252|NCT00528827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20268253|NCT00528827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268254|NCT00528827|Vasodilator Agents|vasodilator agents|mesh-ancestor
20268255|NCT00528892|Raltegravir Potassium|raltegravir potassium|mesh-list
20268256|NCT00528892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20268257|NCT00528892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20268258|NCT00528892|Antiviral Agents|antiviral agents|mesh-ancestor
20268259|NCT00528892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268260|NCT00528892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20268261|NCT00528892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20268262|NCT00528892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268263|NCT00528892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268264|NCT00528918|Insulin glulisine|insulin glulisine|mesh-list
20268265|NCT00528918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20268266|NCT00528918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287297|NCT05177614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287298|NCT05159934|Nicotine|nicotine|mesh-list
20287299|NCT05159934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20287300|NCT05159934|Autonomic Agents|autonomic agents|mesh-ancestor
20287301|NCT05159934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287302|NCT05159934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287303|NCT05159934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20287304|NCT05159934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20287305|NCT05159934|Cholinergic Agents|cholinergic agents|mesh-ancestor
20287306|NCT05159934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20287307|NCT05159934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287308|NCT05151471|Edaravone|edaravone|mesh-list
20287309|NCT05151471|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20287310|NCT05151471|Antioxidants|antioxidants|mesh-ancestor
20287311|NCT05151471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287312|NCT05151471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20543280|NCT01869023|Gemcitabine|gemcitabine|mesh-list
19946383|NCT01528345|Fulvestrant|fulvestrant|mesh-list
19946384|NCT01528345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19946385|NCT01528345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946386|NCT01528345|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19946387|NCT01528345|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19946388|NCT01528345|Hormone Antagonists|hormone antagonists|mesh-ancestor
19946389|NCT01528345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19946390|NCT01528345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946391|NCT01528592|Levodopa|levodopa|mesh-list
19946392|NCT01528592|Carbidopa|carbidopa|mesh-list
19946393|NCT01528592|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19946394|NCT01528592|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19946395|NCT01528592|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19946396|NCT01528592|Dopamine Agents|dopamine agents|mesh-ancestor
19946397|NCT01528592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19946398|NCT01528592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946399|NCT01528592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946400|NCT01528592|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19946401|NCT01528592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946402|NCT01528592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19946403|NCT01528592|Immunologic Factors|immunologic factors|mesh-ancestor
19946404|NCT01528592|Dopamine Agonists|dopamine agonists|mesh-ancestor
19946405|NCT01528709|Atorvastatin|atorvastatin|mesh-list
19946406|NCT01528709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19946407|NCT01528709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19946408|NCT01528709|Antimetabolites|antimetabolites|mesh-ancestor
19946409|NCT01528709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946410|NCT01528709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19946411|NCT01528709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19946412|NCT01528709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946413|NCT01528735|Ribavirin|ribavirin|mesh-list
19946414|NCT01528735|Antimetabolites|antimetabolites|mesh-ancestor
19946415|NCT01528735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946416|NCT01528735|Antiviral Agents|antiviral agents|mesh-ancestor
19946417|NCT01528735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19946418|NCT01528787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19946419|NCT01528787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19946420|NCT01528891|Dexmedetomidine|dexmedetomidine|mesh-list
19946421|NCT01528891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19946422|NCT01528891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19946423|NCT01528891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946424|NCT01528891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19946425|NCT01528891|Analgesics|analgesics|mesh-ancestor
19946426|NCT01528891|Sensory System Agents|sensory system agents|mesh-ancestor
19946427|NCT01528891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19946428|NCT01528891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19946429|NCT01528891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19946430|NCT01528891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19946431|NCT01528891|Adrenergic Agents|adrenergic agents|mesh-ancestor
19946432|NCT01528891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19946433|NCT01528891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946434|NCT01528969|Sorbitol|sorbitol|mesh-list
19946435|NCT01528969|Cathartics|cathartics|mesh-ancestor
19946436|NCT01528969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19946437|NCT01529060|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
19946438|NCT01529060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946439|NCT01529112|Lenvatinib|lenvatinib|mesh-list
19946440|NCT01529112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946441|NCT01529112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20268267|NCT00528983|Azacitidine|azacitidine|mesh-list
20268268|NCT00528983|Cc-486|cc-486|mesh-list
20268269|NCT00528983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20268270|NCT00528983|Antimetabolites|antimetabolites|mesh-ancestor
20268271|NCT00528983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268272|NCT00528983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268273|NCT00528983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268274|NCT00529022|Carboplatin|carboplatin|mesh-list
20268275|NCT00529022|Azacitidine|azacitidine|mesh-list
20268276|NCT00529022|Valproic Acid|valproic acid|mesh-list
20268277|NCT00529022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268278|NCT00529022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20268279|NCT00529022|Antimetabolites|antimetabolites|mesh-ancestor
20268280|NCT00529022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946442|NCT01529112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268281|NCT00529022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946443|NCT01529112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946444|NCT01529203|Botulinum Toxins|botulinum toxins|mesh-list
19946445|NCT01529203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19946446|NCT01529203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19946447|NCT01529203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19946448|NCT01529203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19946449|NCT01529203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946450|NCT01529203|Cholinergic Agents|cholinergic agents|mesh-ancestor
19946451|NCT01529203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19946452|NCT01529203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946453|NCT01529203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19946454|NCT01529203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19946455|NCT01529268|Cysteamine|cysteamine|mesh-list
19946456|NCT01529268|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
19946457|NCT01529268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946458|NCT01529346|Ibuprofen|ibuprofen|mesh-list
19946459|NCT01529346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19946460|NCT01529346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19946461|NCT01529346|Analgesics|analgesics|mesh-ancestor
19946462|NCT01529346|Sensory System Agents|sensory system agents|mesh-ancestor
19946463|NCT01529346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19946464|NCT01529346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946465|NCT01529346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19946466|NCT01529346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19946467|NCT01529346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19946468|NCT01529346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946469|NCT01529346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946470|NCT01529502|Nitric Oxide|nitric oxide|mesh-list
19946471|NCT01529502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19946472|NCT01529502|Autonomic Agents|autonomic agents|mesh-ancestor
19946473|NCT01529502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19946474|NCT01529502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946475|NCT01529502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19946476|NCT01529502|Respiratory System Agents|respiratory system agents|mesh-ancestor
19946477|NCT01529502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19946478|NCT01529502|Antioxidants|antioxidants|mesh-ancestor
19946479|NCT01529502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946480|NCT01529502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19946481|NCT01529502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19946482|NCT01529502|Vasodilator Agents|vasodilator agents|mesh-ancestor
19946483|NCT01529502|Gasotransmitters|gasotransmitters|mesh-ancestor
19946484|NCT01529502|Protective Agents|protective agents|mesh-ancestor
19946485|NCT01529515|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19946486|NCT01529515|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19946487|NCT01529515|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19946488|NCT01529515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19946489|NCT01529632|Glycopyrrolate|glycopyrrolate|mesh-list
19946490|NCT01529632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19946491|NCT01529632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19946492|NCT01529632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19946493|NCT01529632|Cholinergic Agents|cholinergic agents|mesh-ancestor
19946494|NCT01529632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19946495|NCT01529632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946496|NCT01529632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946497|NCT01529645|Vaccines|vaccines|mesh-list
19946498|NCT01529645|Immunologic Factors|immunologic factors|mesh-ancestor
19946499|NCT01529645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946500|NCT01529749|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19946501|NCT01529749|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19946502|NCT01529749|Raltegravir Potassium|raltegravir potassium|mesh-list
19946503|NCT01529749|Losartan|losartan|mesh-list
19946504|NCT01529749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19946505|NCT01529749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19946506|NCT01529749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19946507|NCT01529749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19946508|NCT01529749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946509|NCT01529749|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19946510|NCT01529749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19946511|NCT01529749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946512|NCT01529749|Antiviral Agents|antiviral agents|mesh-ancestor
19946513|NCT01529749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19946514|NCT01529749|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19946515|NCT01529749|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19946516|NCT01529749|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19946517|NCT01529749|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19946518|NCT01529827|Mycophenolic Acid|mycophenolic acid|mesh-list
19946519|NCT01529827|Methotrexate|methotrexate|mesh-list
19946520|NCT01529827|Fludarabine phosphate|fludarabine phosphate|mesh-list
19946521|NCT01529827|Fludarabine|fludarabine|mesh-list
19946522|NCT01529827|Melphalan|melphalan|mesh-list
19946523|NCT01529827|Tacrolimus|tacrolimus|mesh-list
19946524|NCT01529827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19946525|NCT01529827|Abortifacient Agents|abortifacient agents|mesh-ancestor
19946526|NCT01529827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19946527|NCT01529827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946528|NCT01529827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19946529|NCT01529827|Antimetabolites|antimetabolites|mesh-ancestor
19946530|NCT01529827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946531|NCT01529827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946532|NCT01529827|Dermatologic Agents|dermatologic agents|mesh-ancestor
19946533|NCT01529827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946534|NCT01529827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19946535|NCT01529827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19946536|NCT01529827|Immunologic Factors|immunologic factors|mesh-ancestor
19946537|NCT01529827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19946538|NCT01529827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19946539|NCT01529827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19946540|NCT01529827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19946541|NCT01529827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19946542|NCT01529827|Antitubercular Agents|antitubercular agents|mesh-ancestor
19946543|NCT01529827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19946544|NCT01529827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19946545|NCT01529827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19946546|NCT01529827|Alkylating Agents|alkylating agents|mesh-ancestor
19946547|NCT01529827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19946548|NCT01530178|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19946549|NCT01530178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19946550|NCT01530178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946551|NCT01530178|Incretins|incretins|mesh-ancestor
19946552|NCT01530178|Hormones|hormones|mesh-ancestor
19946553|NCT01530178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19946554|NCT01530178|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19946555|NCT01530178|Protease Inhibitors|protease inhibitors|mesh-ancestor
19946556|NCT01530178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946557|NCT01530178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946558|NCT01530243|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19946559|NCT01530243|Terazosin|terazosin|mesh-list
19946560|NCT01530243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19946561|NCT01530243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19946562|NCT01530243|Cholinergic Agents|cholinergic agents|mesh-ancestor
19946563|NCT01530243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19946564|NCT01530243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946565|NCT01530243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946566|NCT01530243|Urological Agents|urological agents|mesh-ancestor
19946567|NCT01530243|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19946568|NCT01530243|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19946569|NCT01530243|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19946570|NCT01530243|Adrenergic Agents|adrenergic agents|mesh-ancestor
19946571|NCT01530334|Gefitinib|gefitinib|mesh-list
19946572|NCT01530334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946573|NCT01530334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19946574|NCT01530334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946575|NCT01530334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946576|NCT01530399|Tranexamic Acid|tranexamic acid|mesh-list
19946577|NCT01530399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19946578|NCT01530399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19946579|NCT01530399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946580|NCT01530399|Hemostatics|hemostatics|mesh-ancestor
19946581|NCT01530399|Coagulants|coagulants|mesh-ancestor
19946582|NCT01530464|Ambrisentan|ambrisentan|mesh-list
19946583|NCT01530464|Aminophylline|aminophylline|mesh-list
19946584|NCT01530464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19946585|NCT01530464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19946586|NCT01530464|Autonomic Agents|autonomic agents|mesh-ancestor
19946587|NCT01530464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19946588|NCT01530464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946589|NCT01530464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19946590|NCT01530464|Respiratory System Agents|respiratory system agents|mesh-ancestor
19946591|NCT01530464|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19946592|NCT01530464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19946593|NCT01530464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946594|NCT01530464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946595|NCT01530464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19946596|NCT01530464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19946597|NCT01530464|Purinergic Agents|purinergic agents|mesh-ancestor
19946598|NCT01530464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19946599|NCT01530464|Protective Agents|protective agents|mesh-ancestor
19946600|NCT01531153|Galantamine|galantamine|mesh-list
19946601|NCT01531153|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19946602|NCT01531153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946603|NCT01531153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946604|NCT01531153|Cholinergic Agents|cholinergic agents|mesh-ancestor
19946605|NCT01531153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19946606|NCT01531153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946607|NCT01531153|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19946608|NCT01531153|Autonomic Agents|autonomic agents|mesh-ancestor
19946609|NCT01531153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19946610|NCT01531153|Nootropic Agents|nootropic agents|mesh-ancestor
19946611|NCT01531205|Leuprolide|leuprolide|mesh-list
19946612|NCT01531205|Goserelin|goserelin|mesh-list
19946613|NCT01531205|Bicalutamide|bicalutamide|mesh-list
19946614|NCT01531205|Androgens|androgens|mesh-list
19946615|NCT01531205|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19946616|NCT01531205|Fertility Agents|fertility agents|mesh-ancestor
19946617|NCT01531205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19946618|NCT01531205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946619|NCT01531205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19946620|NCT01531205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946621|NCT01531205|Androgen Antagonists|androgen antagonists|mesh-ancestor
19946622|NCT01531205|Hormone Antagonists|hormone antagonists|mesh-ancestor
19946623|NCT01531205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19946624|NCT01531205|Hormones|hormones|mesh-ancestor
19946625|NCT01531439|Naloxone|naloxone|mesh-list
19946626|NCT01531439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19946627|NCT01531439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946628|NCT01531439|Sensory System Agents|sensory system agents|mesh-ancestor
19946629|NCT01531439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19946630|NCT01531673|Ivacaftor|ivacaftor|mesh-list
19946631|NCT01531673|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19946632|NCT01531673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19946633|NCT01531673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946634|NCT01531803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19946635|NCT01531959|Midodrine|midodrine|mesh-list
19946636|NCT01531959|Sympathomimetics|sympathomimetics|mesh-ancestor
19946637|NCT01531959|Autonomic Agents|autonomic agents|mesh-ancestor
19946638|NCT01531959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19946639|NCT01531959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946640|NCT01531959|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19946641|NCT01531959|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19946642|NCT01531959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19946643|NCT01531959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19946644|NCT01531959|Adrenergic Agents|adrenergic agents|mesh-ancestor
19946645|NCT01531959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19946646|NCT01531959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946647|NCT01531998|Dexamethasone|dexamethasone|mesh-list
19946648|NCT01531998|Lenalidomide|lenalidomide|mesh-list
19946649|NCT01531998|Bortezomib|bortezomib|mesh-list
19946650|NCT01531998|Siltuximab|siltuximab|mesh-list
19946651|NCT01531998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19946652|NCT01531998|Antiemetics|antiemetics|mesh-ancestor
19946653|NCT01531998|Autonomic Agents|autonomic agents|mesh-ancestor
19946654|NCT01531998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19946655|NCT01531998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946656|NCT01531998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19946657|NCT01531998|Glucocorticoids|glucocorticoids|mesh-ancestor
19946658|NCT01531998|Hormones|hormones|mesh-ancestor
19946659|NCT01531998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19946660|NCT01531998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19974110|NCT01832727|Autonomic Agents|autonomic agents|mesh-ancestor
19946661|NCT01531998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946662|NCT01531998|Immunologic Factors|immunologic factors|mesh-ancestor
19946663|NCT01531998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19946664|NCT01531998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19946665|NCT01531998|Growth Substances|growth substances|mesh-ancestor
20268282|NCT00529022|Anticonvulsants|anticonvulsants|mesh-ancestor
20268283|NCT00529022|GABA Agents|gaba agents|mesh-ancestor
20268284|NCT00529022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20268285|NCT00529022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268286|NCT00529022|Antimanic Agents|antimanic agents|mesh-ancestor
20268287|NCT00529022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20268288|NCT00529022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20268289|NCT00529022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20268290|NCT00529269|Mycophenolic Acid|mycophenolic acid|mesh-list
20268291|NCT00529269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20268292|NCT00529269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543281|NCT01869023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543282|NCT01869023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20543283|NCT01869023|Antimetabolites|antimetabolites|mesh-ancestor
20543284|NCT01869023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543285|NCT01869023|Antiviral Agents|antiviral agents|mesh-ancestor
20268293|NCT00529269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20268294|NCT00529269|Antitubercular Agents|antitubercular agents|mesh-ancestor
20268295|NCT00529269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20268296|NCT00529269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268297|NCT00529269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268298|NCT00529269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268299|NCT00529295|Misoprostol|misoprostol|mesh-list
20268300|NCT00529295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20268301|NCT00529295|Abortifacient Agents|abortifacient agents|mesh-ancestor
20543286|NCT01869023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20543287|NCT01869023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543288|NCT01869023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20543289|NCT01869023|Immunologic Factors|immunologic factors|mesh-ancestor
20543290|NCT01869023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543291|NCT01869036|Morphine|morphine|mesh-list
20543292|NCT01869036|Anesthetics|anesthetics|mesh-list
20543293|NCT01869036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20543294|NCT01869036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543295|NCT01869036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20543296|NCT01869036|Narcotics|narcotics|mesh-ancestor
20543297|NCT01869036|Analgesics|analgesics|mesh-ancestor
20543298|NCT01869036|Sensory System Agents|sensory system agents|mesh-ancestor
20543299|NCT01869036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543300|NCT01869205|Ivermectin|ivermectin|mesh-list
20543301|NCT01869205|Abamectin|abamectin|mesh-list
20543302|NCT01869205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20543303|NCT01869205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20543304|NCT01869205|Anthelmintics|anthelmintics|mesh-ancestor
20543305|NCT01869257|Triclosan|triclosan|mesh-list
20543306|NCT01869257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20543307|NCT01869257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20543308|NCT01869257|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20543309|NCT01869257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20543310|NCT01869257|Antimetabolites|antimetabolites|mesh-ancestor
20543311|NCT01869257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543312|NCT01869257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20543313|NCT01869309|Ticagrelor|ticagrelor|mesh-list
20543314|NCT01869309|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20543315|NCT01869309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20543316|NCT01869309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20543317|NCT01869309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19732968|NCT04568096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732969|NCT04568096|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19732970|NCT04568096|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19732971|NCT04568096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19732972|NCT04568096|Keratolytic Agents|keratolytic agents|mesh-ancestor
19732973|NCT04568096|Dermatologic Agents|dermatologic agents|mesh-ancestor
19732974|NCT04568161|Cyclophosphamide|cyclophosphamide|mesh-list
19732975|NCT04568161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19732976|NCT04568161|Immunologic Factors|immunologic factors|mesh-ancestor
19732977|NCT04568161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732978|NCT04568161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19732979|NCT04568161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19732980|NCT04568161|Alkylating Agents|alkylating agents|mesh-ancestor
19946666|NCT01531998|Growth Inhibitors|growth inhibitors|mesh-ancestor
19946667|NCT01532089|Bevacizumab|bevacizumab|mesh-list
19946668|NCT01532089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19946669|NCT01532089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19946670|NCT01532089|Endothelial Growth Factors|endothelial growth factors|mesh-list
19946671|NCT01532089|Antibodies|antibodies|mesh-list
19946672|NCT01532089|Immunoglobulins|immunoglobulins|mesh-list
19946673|NCT01532089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19946674|NCT01532089|Immunoglobulin G|immunoglobulin g|mesh-list
19946675|NCT01532089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946676|NCT01532089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19946677|NCT01532089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19946678|NCT01532089|Growth Substances|growth substances|mesh-ancestor
19946679|NCT01532089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946680|NCT01532089|Growth Inhibitors|growth inhibitors|mesh-ancestor
19946681|NCT01532089|Immunologic Factors|immunologic factors|mesh-ancestor
19946682|NCT01532089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19946683|NCT01532089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946684|NCT01532089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946685|NCT01532128|Opicapone|opicapone|mesh-list
19946686|NCT01532128|Rasagiline|rasagiline|mesh-list
19946687|NCT01532128|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19946688|NCT01532128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946689|NCT01532128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946690|NCT01532128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19946691|NCT01532128|Protective Agents|protective agents|mesh-ancestor
19946692|NCT01532128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946693|NCT01532128|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19946694|NCT01532128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19946695|NCT01532128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19946696|NCT01532141|Opicapone|opicapone|mesh-list
19946697|NCT01532141|Rasagiline|rasagiline|mesh-list
19946698|NCT01532141|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19946699|NCT01532141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946700|NCT01532141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946701|NCT01532141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19946702|NCT01532141|Protective Agents|protective agents|mesh-ancestor
19946703|NCT01532141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946704|NCT01532141|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19946705|NCT01532141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19946706|NCT01532141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19946707|NCT01532349|Cholecalciferol|cholecalciferol|mesh-list
19946708|NCT01532349|Vitamins|vitamins|mesh-ancestor
19946709|NCT01532349|Micronutrients|micronutrients|mesh-ancestor
19946710|NCT01532349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946711|NCT01532349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19946712|NCT01532349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19946713|NCT01532414|Enclomiphene|enclomiphene|mesh-list
19946714|NCT01532414|Clomiphene|clomiphene|mesh-list
19946715|NCT01532414|Zuclomiphene|zuclomiphene|mesh-list
19946716|NCT01532414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19946717|NCT01532414|Hormone Antagonists|hormone antagonists|mesh-ancestor
19946718|NCT01532414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19946719|NCT01532414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946720|NCT01532414|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19946721|NCT01532414|Fertility Agents|fertility agents|mesh-ancestor
19946722|NCT01532414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19946723|NCT01532414|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19946724|NCT01532414|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19946725|NCT01532648|Budesonide|budesonide|mesh-list
19946726|NCT01532648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19946727|NCT01532648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19946728|NCT01532648|Autonomic Agents|autonomic agents|mesh-ancestor
19946729|NCT01532648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19946730|NCT01532648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946731|NCT01532648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19946732|NCT01532648|Respiratory System Agents|respiratory system agents|mesh-ancestor
19946733|NCT01532648|Glucocorticoids|glucocorticoids|mesh-ancestor
19946734|NCT01532648|Hormones|hormones|mesh-ancestor
19946735|NCT01532648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19946736|NCT01532687|Gemcitabine|gemcitabine|mesh-list
19946737|NCT01532687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19946738|NCT01532687|Antimetabolites|antimetabolites|mesh-ancestor
19974111|NCT01832727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287313|NCT05151471|Protective Agents|protective agents|mesh-ancestor
19946739|NCT01532687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946740|NCT01532687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946741|NCT01532687|Antiviral Agents|antiviral agents|mesh-ancestor
19946742|NCT01532687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19946743|NCT01532687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946744|NCT01532687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19946745|NCT01532687|Immunologic Factors|immunologic factors|mesh-ancestor
19946746|NCT01532687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946747|NCT01532700|Ofatumumab|ofatumumab|mesh-list
19946748|NCT01532700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946749|NCT01532908|Sofosbuvir|sofosbuvir|mesh-list
19946750|NCT01532908|Antiviral Agents|antiviral agents|mesh-ancestor
19946751|NCT01532908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19946752|NCT01533077|Levodopa|levodopa|mesh-list
19946753|NCT01533077|Carbidopa|carbidopa|mesh-list
19946754|NCT01533077|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19946755|NCT01533077|Opicapone|opicapone|mesh-list
19946756|NCT01533077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19946757|NCT01533077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19946758|NCT01533077|Dopamine Agents|dopamine agents|mesh-ancestor
19946759|NCT01533077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19946760|NCT01533077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946761|NCT01533077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946762|NCT01533077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19946763|NCT01533077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946764|NCT01533077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19946765|NCT01533077|Immunologic Factors|immunologic factors|mesh-ancestor
19946766|NCT01533077|Dopamine Agonists|dopamine agonists|mesh-ancestor
19946767|NCT01533077|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19946768|NCT01533116|Levodopa|levodopa|mesh-list
19946769|NCT01533116|Carbidopa|carbidopa|mesh-list
19946770|NCT01533116|Opicapone|opicapone|mesh-list
19946771|NCT01533116|Benserazide|benserazide|mesh-list
19946772|NCT01533116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19946773|NCT01533116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19946774|NCT01533116|Dopamine Agents|dopamine agents|mesh-ancestor
19946775|NCT01533116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19946776|NCT01533116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946777|NCT01533116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946778|NCT01533116|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19946779|NCT01533116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946780|NCT01533116|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19946781|NCT01533181|Topotecan|topotecan|mesh-list
19946782|NCT01533181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19946783|NCT01533181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19946784|NCT01533181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946785|NCT01533181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946786|NCT01533181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946787|NCT01533207|Gemcitabine|gemcitabine|mesh-list
19946788|NCT01533207|Docetaxel|docetaxel|mesh-list
19946789|NCT01533207|Doxorubicin|doxorubicin|mesh-list
19946790|NCT01533207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19946791|NCT01533207|Lenograstim|lenograstim|mesh-list
19946792|NCT01533207|Sargramostim|sargramostim|mesh-list
19946793|NCT01533207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19946794|NCT01533207|Antimetabolites|antimetabolites|mesh-ancestor
19946795|NCT01533207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946796|NCT01533207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946797|NCT01533207|Antiviral Agents|antiviral agents|mesh-ancestor
19946798|NCT01533207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19946799|NCT01533207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946800|NCT01533207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19946801|NCT01533207|Immunologic Factors|immunologic factors|mesh-ancestor
19946802|NCT01533207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946803|NCT01533207|Tubulin Modulators|tubulin modulators|mesh-ancestor
19946804|NCT01533207|Antimitotic Agents|antimitotic agents|mesh-ancestor
19946805|NCT01533207|Mitosis Modulators|mitosis modulators|mesh-ancestor
19946806|NCT01533207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19946807|NCT01533207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19946808|NCT01533207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19946809|NCT01533207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19946810|NCT01533259|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19946811|NCT01533259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19946812|NCT01533259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19946813|NCT01533259|Antiviral Agents|antiviral agents|mesh-ancestor
19946814|NCT01533259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19946815|NCT01533428|Capsaicin|capsaicin|mesh-list
19946816|NCT01533428|Antipruritics|antipruritics|mesh-ancestor
19946817|NCT01533428|Dermatologic Agents|dermatologic agents|mesh-ancestor
19946818|NCT01533428|Sensory System Agents|sensory system agents|mesh-ancestor
20268302|NCT00529295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20268303|NCT00529295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268304|NCT00529295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20268305|NCT00529295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20268306|NCT00529295|Oxytocics|oxytocics|mesh-ancestor
20268307|NCT00529360|Clofarabine|clofarabine|mesh-list
20268308|NCT00529360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20268309|NCT00529360|Antimetabolites|antimetabolites|mesh-ancestor
20268310|NCT00529360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268311|NCT00529360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268312|NCT00529425|Ropivacaine|ropivacaine|mesh-list
20268313|NCT00529425|Anesthetics, Local|anesthetics, local|mesh-ancestor
20268314|NCT00529425|Anesthetics|anesthetics|mesh-ancestor
20268315|NCT00529425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20268316|NCT00529425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268317|NCT00529425|Sensory System Agents|sensory system agents|mesh-ancestor
20268318|NCT00529425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20268319|NCT00529594|Etoricoxib|etoricoxib|mesh-list
20268320|NCT00529594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20268321|NCT00529594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20268322|NCT00529594|Analgesics|analgesics|mesh-ancestor
20268323|NCT00529594|Sensory System Agents|sensory system agents|mesh-ancestor
20268324|NCT00529594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20268325|NCT00529594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268326|NCT00529594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20268327|NCT00529594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20268328|NCT00529594|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20268329|NCT00529594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20268330|NCT00529594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268331|NCT00529594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268332|NCT00529620|Pyrimethamine|pyrimethamine|mesh-list
20268333|NCT00529620|Piperaquine|piperaquine|mesh-list
20268334|NCT00529620|Sulfadoxine|sulfadoxine|mesh-list
20268335|NCT00529620|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
20268336|NCT00529620|Amodiaquine|amodiaquine|mesh-list
20268337|NCT00529620|Artenimol|artenimol|mesh-list
20268338|NCT00529620|Sulfalene|sulfalene|mesh-list
20268339|NCT00529620|Antimalarials|antimalarials|mesh-ancestor
20268340|NCT00529620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20268341|NCT00529620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20268342|NCT00529620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268343|NCT00529620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20268344|NCT00529620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268345|NCT00529620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268346|NCT00529620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20268347|NCT00529620|Renal Agents|renal agents|mesh-ancestor
20268348|NCT00529646|APD791|apd791|mesh-list
20268349|NCT00529646|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20268350|NCT00529646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20268351|NCT00529646|Serotonin Agents|serotonin agents|mesh-ancestor
20268352|NCT00529646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20268353|NCT00529646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268354|NCT00529646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268355|NCT00529750|Atenolol|atenolol|mesh-list
20268356|NCT00529750|Irbesartan|irbesartan|mesh-list
20268357|NCT00529750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20268358|NCT00529750|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20268359|NCT00529750|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20268360|NCT00529750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946819|NCT01533428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19946820|NCT01533428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946821|NCT01533493|Memantine|memantine|mesh-list
19946822|NCT01533493|Methylphenidate|methylphenidate|mesh-list
19946823|NCT01533493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19946824|NCT01533493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946825|NCT01533493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19946826|NCT01533493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19946827|NCT01533493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19946828|NCT01533493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946829|NCT01533493|Dopamine Agents|dopamine agents|mesh-ancestor
19946830|NCT01533493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19946831|NCT01533493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19946832|NCT01533493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19946833|NCT01533493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19946834|NCT01533493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19946835|NCT01533597|Tamsulosin|tamsulosin|mesh-list
19946836|NCT01533597|Solifenacin Succinate|solifenacin succinate|mesh-list
19946837|NCT01533597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19946838|NCT01533597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19946839|NCT01533597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19946840|NCT01533597|Adrenergic Agents|adrenergic agents|mesh-ancestor
19946841|NCT01533597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19946842|NCT01533597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946843|NCT01533597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946844|NCT01533597|Urological Agents|urological agents|mesh-ancestor
19946845|NCT01533597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19946846|NCT01533597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19946847|NCT01533597|Cholinergic Agents|cholinergic agents|mesh-ancestor
19946848|NCT01533688|Bisacodyl|bisacodyl|mesh-list
19946849|NCT01533688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19946850|NCT01533688|Cathartics|cathartics|mesh-ancestor
19946851|NCT01533688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19946852|NCT01533688|Laxatives|laxatives|mesh-ancestor
19946853|NCT01533922|Tiotropium Bromide|tiotropium bromide|mesh-list
19946854|NCT01533922|Olodaterol|olodaterol|mesh-list
19946855|NCT01533922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19946856|NCT01533922|Autonomic Agents|autonomic agents|mesh-ancestor
19946857|NCT01533922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19946858|NCT01533922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946859|NCT01533922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19946860|NCT01533922|Respiratory System Agents|respiratory system agents|mesh-ancestor
19946861|NCT01533922|Parasympatholytics|parasympatholytics|mesh-ancestor
19946862|NCT01533922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19946863|NCT01533922|Cholinergic Agents|cholinergic agents|mesh-ancestor
19946864|NCT01533922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19946865|NCT01533922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946866|NCT01533935|Tiotropium Bromide|tiotropium bromide|mesh-list
19946867|NCT01533935|Olodaterol|olodaterol|mesh-list
19946868|NCT01533935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19946869|NCT01533935|Autonomic Agents|autonomic agents|mesh-ancestor
19946870|NCT01533935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19946871|NCT01533935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946872|NCT01533935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19946873|NCT01533935|Respiratory System Agents|respiratory system agents|mesh-ancestor
19946874|NCT01533935|Parasympatholytics|parasympatholytics|mesh-ancestor
19946875|NCT01533935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19946876|NCT01533935|Cholinergic Agents|cholinergic agents|mesh-ancestor
19946877|NCT01533935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19946878|NCT01533935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946879|NCT01533948|Axitinib|axitinib|mesh-list
19946880|NCT01533948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946881|NCT01533948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19946882|NCT01533948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946883|NCT01533948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946884|NCT01534013|Insulin|insulin|mesh-list
19946885|NCT01534013|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19946886|NCT01534013|Pancrelipase|pancrelipase|mesh-list
19946887|NCT01534013|Pancreatin|pancreatin|mesh-list
19946888|NCT01534013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19946889|NCT01534013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946890|NCT01534013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19946891|NCT01534078|Doxorubicin|doxorubicin|mesh-list
19946892|NCT01534078|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19946893|NCT01534078|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19946894|NCT01534078|Dacarbazine|dacarbazine|mesh-list
19946895|NCT01534078|Vinblastine|vinblastine|mesh-list
19946896|NCT01534078|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19946897|NCT01534078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946898|NCT01534078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19946899|NCT01534078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19946900|NCT01534078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946901|NCT01534078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946902|NCT01534078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19946903|NCT01534078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19946904|NCT01534078|Alkylating Agents|alkylating agents|mesh-ancestor
20288582|NCT05296577|Vinorelbine|vinorelbine|mesh-list
19946905|NCT01534078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20268361|NCT00529750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20268362|NCT00529750|Sympatholytics|sympatholytics|mesh-ancestor
20268363|NCT00529750|Autonomic Agents|autonomic agents|mesh-ancestor
20268364|NCT00529750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20268365|NCT00529750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268366|NCT00529750|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20268367|NCT00529750|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20268368|NCT00529750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20268369|NCT00529750|Adrenergic Agents|adrenergic agents|mesh-ancestor
20543318|NCT01869309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20543319|NCT01869309|Purinergic Agents|purinergic agents|mesh-ancestor
20543320|NCT01869309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20543321|NCT01869309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543322|NCT01869309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543323|NCT01869413|Tranexamic Acid|tranexamic acid|mesh-list
20543324|NCT01869413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20543325|NCT01869413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20543326|NCT01869413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543327|NCT01869413|Hemostatics|hemostatics|mesh-ancestor
20543328|NCT01869413|Coagulants|coagulants|mesh-ancestor
20543329|NCT01869491|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
20543330|NCT01869491|Antacids|antacids|mesh-ancestor
20543331|NCT01869491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543332|NCT01869491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20543333|NCT01869556|Oxytocin|oxytocin|mesh-list
20543334|NCT01869556|Ergonovine|ergonovine|mesh-list
20543335|NCT01869556|Carboprost|carboprost|mesh-list
20543336|NCT01869556|Oxytocics|oxytocics|mesh-ancestor
20543337|NCT01869556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20543338|NCT01869556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543339|NCT01869556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20543340|NCT01869556|Abortifacient Agents|abortifacient agents|mesh-ancestor
20543341|NCT01869569|Pregabalin|pregabalin|mesh-list
20543342|NCT01869569|Analgesics|analgesics|mesh-ancestor
20543343|NCT01869569|Sensory System Agents|sensory system agents|mesh-ancestor
20543344|NCT01869569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543345|NCT01869569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543346|NCT01869569|Anticonvulsants|anticonvulsants|mesh-ancestor
20543347|NCT01869569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20543348|NCT01869569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20543349|NCT01869569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543350|NCT01869569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20543351|NCT01869569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20543352|NCT01869569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20543353|NCT01869569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20543354|NCT01869569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20543355|NCT01869621|Metformin|metformin|mesh-list
20543356|NCT01869621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20543357|NCT01869621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543358|NCT01869673|Anesthetics|anesthetics|mesh-list
20543359|NCT01869673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19946906|NCT01534078|Tubulin Modulators|tubulin modulators|mesh-ancestor
19946907|NCT01534078|Antimitotic Agents|antimitotic agents|mesh-ancestor
19946908|NCT01534078|Mitosis Modulators|mitosis modulators|mesh-ancestor
19946909|NCT01534182|Interferons|interferons|mesh-list
19946910|NCT01534182|Interferon-beta|interferon-beta|mesh-list
19946911|NCT01534182|Glatiramer Acetate|glatiramer acetate|mesh-list
19946912|NCT01534182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19946913|NCT01534182|(T,G)-A-L|(t,g)-a-l|mesh-list
19946914|NCT01534182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268370|NCT00529750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20268371|NCT00529841|Hydrocortisone|hydrocortisone|mesh-list
20268372|NCT00529841|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20268373|NCT00529841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20268374|NCT00529867|Lumefantrine|lumefantrine|mesh-list
20268375|NCT00529867|Artemether|artemether|mesh-list
20268376|NCT00529867|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20268377|NCT00529867|Antimalarials|antimalarials|mesh-ancestor
20268378|NCT00529867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20268379|NCT00529867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20268380|NCT00529867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268381|NCT00529880|Cytarabine|cytarabine|mesh-list
19946915|NCT01534182|Antiviral Agents|antiviral agents|mesh-ancestor
20268382|NCT00529880|Fludarabine|fludarabine|mesh-list
19946916|NCT01534182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19946917|NCT01534182|Immunologic Factors|immunologic factors|mesh-ancestor
19946918|NCT01534182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946919|NCT01534182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19946920|NCT01534182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946921|NCT01534182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20268383|NCT00529880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268384|NCT00529880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20268385|NCT00529880|Antimetabolites|antimetabolites|mesh-ancestor
20268386|NCT00529880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268387|NCT00529880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20268388|NCT00529880|Immunologic Factors|immunologic factors|mesh-ancestor
20268389|NCT00529880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268390|NCT00529880|Antiviral Agents|antiviral agents|mesh-ancestor
20268391|NCT00529880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268392|NCT00530101|Doxorubicin|doxorubicin|mesh-list
20268393|NCT00530101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20268394|NCT00530101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268395|NCT00530101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20268396|NCT00530101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20268397|NCT00530101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268398|NCT00530101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268399|NCT00530127|Deferiprone|deferiprone|mesh-list
20268400|NCT00530127|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20268401|NCT00530127|Chelating Agents|chelating agents|mesh-ancestor
20268402|NCT00530127|Sequestering Agents|sequestering agents|mesh-ancestor
20268403|NCT00530127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268404|NCT00530140|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
20268405|NCT00530140|Immunologic Factors|immunologic factors|mesh-ancestor
20268406|NCT00530140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268407|NCT00530361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20268408|NCT00530361|Natriuretic Agents|natriuretic agents|mesh-ancestor
20268409|NCT00530361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268410|NCT00530387|Ibuprofen|ibuprofen|mesh-list
20268411|NCT00530387|Diclofenac|diclofenac|mesh-list
20268412|NCT00530387|Ketoprofen|ketoprofen|mesh-list
20268413|NCT00530387|Piroxicam|piroxicam|mesh-list
20268414|NCT00530387|Salicylates|salicylates|mesh-list
20268415|NCT00530387|Etofenamate|etofenamate|mesh-list
20268416|NCT00530387|Sunscreening Agents|sunscreening agents|mesh-list
20268417|NCT00530387|Homosalate|homosalate|mesh-list
20268418|NCT00530387|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
20268419|NCT00530387|Benzophenone|benzophenone|mesh-list
20268420|NCT00530387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20268421|NCT00530387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20268422|NCT00530387|Analgesics|analgesics|mesh-ancestor
20268423|NCT00530387|Sensory System Agents|sensory system agents|mesh-ancestor
20268424|NCT00530387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20268425|NCT00530387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268426|NCT00530387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20268427|NCT00530387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20268428|NCT00530387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20268429|NCT00530387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543360|NCT01869673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543361|NCT01869751|Prucalopride|prucalopride|mesh-list
20543362|NCT01869751|Laxatives|laxatives|mesh-ancestor
20543363|NCT01869751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20543364|NCT01869751|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20543365|NCT01869751|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20543366|NCT01869751|Serotonin Agents|serotonin agents|mesh-ancestor
20543367|NCT01869751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20543368|NCT01869751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543369|NCT01869751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543370|NCT01869803|Gemtuzumab|gemtuzumab|mesh-list
20543371|NCT01869803|Calicheamicins|calicheamicins|mesh-list
20543372|NCT01869803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19946922|NCT01534182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19946923|NCT01534182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19946924|NCT01534195|Prednisolone|prednisolone|mesh-list
19946925|NCT01534195|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19946926|NCT01534195|Methylprednisolone|methylprednisolone|mesh-list
19946927|NCT01534195|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20543373|NCT01869803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946928|NCT01534195|Prednisolone acetate|prednisolone acetate|mesh-list
20268430|NCT00530387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946929|NCT01534195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19946930|NCT01534195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19946931|NCT01534195|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19946932|NCT01534195|Prednisolone phosphate|prednisolone phosphate|mesh-list
19946933|NCT01534195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19946934|NCT01534195|Glucocorticoids|glucocorticoids|mesh-ancestor
19946935|NCT01534195|Hormones|hormones|mesh-ancestor
19946936|NCT01534195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19946937|NCT01534195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946938|NCT01534195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19946939|NCT01534195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946940|NCT01534195|Antiemetics|antiemetics|mesh-ancestor
19946941|NCT01534195|Autonomic Agents|autonomic agents|mesh-ancestor
19946942|NCT01534195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19946943|NCT01534195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19946944|NCT01534195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19946945|NCT01534195|Protective Agents|protective agents|mesh-ancestor
19946946|NCT01534208|Enclomiphene|enclomiphene|mesh-list
19946947|NCT01534208|Clomiphene|clomiphene|mesh-list
19946948|NCT01534208|Zuclomiphene|zuclomiphene|mesh-list
19946949|NCT01534208|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19946950|NCT01534208|Hormone Antagonists|hormone antagonists|mesh-ancestor
19946951|NCT01534208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19946952|NCT01534208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946953|NCT01534208|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19946954|NCT01534208|Fertility Agents|fertility agents|mesh-ancestor
19946955|NCT01534208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19946956|NCT01534208|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19946957|NCT01534208|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19946958|NCT01534260|Bortezomib|bortezomib|mesh-list
19946959|NCT01534260|Sorafenib|sorafenib|mesh-list
19946960|NCT01534260|Vorinostat|vorinostat|mesh-list
19946961|NCT01534260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19946962|NCT01534260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19946963|NCT01534260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946964|NCT01534260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946965|NCT01534260|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19946966|NCT01534351|Tamsulosin|tamsulosin|mesh-list
19946967|NCT01534351|Finasteride|finasteride|mesh-list
19946968|NCT01534351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19946969|NCT01534351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19946970|NCT01534351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19946971|NCT01534351|Adrenergic Agents|adrenergic agents|mesh-ancestor
19946972|NCT01534351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19946973|NCT01534351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19946974|NCT01534351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946975|NCT01534351|Urological Agents|urological agents|mesh-ancestor
19946976|NCT01534351|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19946977|NCT01534351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19946978|NCT01534351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19946979|NCT01534351|Hormone Antagonists|hormone antagonists|mesh-ancestor
19946980|NCT01534351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19946981|NCT01534416|Bupivacaine|bupivacaine|mesh-list
19946982|NCT01534416|Anesthetics, Local|anesthetics, local|mesh-ancestor
19946983|NCT01534416|Anesthetics|anesthetics|mesh-ancestor
19946984|NCT01534416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19946985|NCT01534416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946986|NCT01534416|Sensory System Agents|sensory system agents|mesh-ancestor
19946987|NCT01534416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19946988|NCT01534520|Lidocaine|lidocaine|mesh-list
19946989|NCT01534520|Anesthetics, Local|anesthetics, local|mesh-ancestor
19946990|NCT01534520|Anesthetics|anesthetics|mesh-ancestor
19946991|NCT01534520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19946992|NCT01534520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19946993|NCT01534520|Sensory System Agents|sensory system agents|mesh-ancestor
19946994|NCT01534520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19946995|NCT01534520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19946996|NCT01534520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19946997|NCT01534520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19946998|NCT01534520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19946999|NCT01534520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947000|NCT01534637|Gemcitabine|gemcitabine|mesh-list
19947001|NCT01534637|Fluorouracil|fluorouracil|mesh-list
19947002|NCT01534637|Capecitabine|capecitabine|mesh-list
19947003|NCT01534637|Aprepitant|aprepitant|mesh-list
19947004|NCT01534637|Antiemetics|antiemetics|mesh-list
19947005|NCT01534637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19947006|NCT01534637|Antimetabolites|antimetabolites|mesh-ancestor
19947007|NCT01534637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947008|NCT01534637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947009|NCT01534637|Antiviral Agents|antiviral agents|mesh-ancestor
19947010|NCT01534637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19947011|NCT01534637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947012|NCT01534637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19947013|NCT01534637|Immunologic Factors|immunologic factors|mesh-ancestor
19947014|NCT01534637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947015|NCT01534637|Autonomic Agents|autonomic agents|mesh-ancestor
19947016|NCT01534637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947017|NCT01534637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19947018|NCT01534637|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19947019|NCT01534637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19947020|NCT01534897|Dabrafenib|dabrafenib|mesh-list
19947021|NCT01534897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947022|NCT01534897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19947023|NCT01534897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947024|NCT01534897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947025|NCT01534962|Ranolazine|ranolazine|mesh-list
19947026|NCT01534962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19947027|NCT01534962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19947028|NCT01534962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947029|NCT01535001|Acetaminophen|acetaminophen|mesh-list
19947030|NCT01535001|Pantoprazole|pantoprazole|mesh-list
19947031|NCT01535001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19947032|NCT01535001|Analgesics|analgesics|mesh-ancestor
19947033|NCT01535001|Sensory System Agents|sensory system agents|mesh-ancestor
19947034|NCT01535001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947035|NCT01535001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947036|NCT01535001|Antipyretics|antipyretics|mesh-ancestor
19947037|NCT01535001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19947038|NCT01535001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19947039|NCT01535001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19947040|NCT01535001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947041|NCT01535001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974112|NCT01832727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974113|NCT01832727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19974114|NCT01832727|Glucocorticoids|glucocorticoids|mesh-ancestor
19974115|NCT01832727|Hormones|hormones|mesh-ancestor
19974116|NCT01832727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19974117|NCT01832727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19974118|NCT01832727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974119|NCT01832766|Dronabinol|dronabinol|mesh-list
19974120|NCT01832766|Hallucinogens|hallucinogens|mesh-ancestor
19974121|NCT01832766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974122|NCT01832766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19974123|NCT01832766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19974124|NCT01832766|Analgesics|analgesics|mesh-ancestor
19974125|NCT01832766|Sensory System Agents|sensory system agents|mesh-ancestor
19974126|NCT01832766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19974127|NCT01832766|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19974128|NCT01832766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19974129|NCT01832766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19974130|NCT01832766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974131|NCT01832766|Hormones|hormones|mesh-ancestor
19974132|NCT01832766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19974133|NCT01832961|Bronchodilator Agents|bronchodilator agents|mesh-list
19974134|NCT01832961|Autonomic Agents|autonomic agents|mesh-ancestor
19974135|NCT01832961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19974136|NCT01832961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974137|NCT01832961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19974138|NCT01832961|Respiratory System Agents|respiratory system agents|mesh-ancestor
19974139|NCT01833026|Albuterol|albuterol|mesh-list
19974140|NCT01833026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19974141|NCT01833026|Autonomic Agents|autonomic agents|mesh-ancestor
19974142|NCT01833026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19974143|NCT01833026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974144|NCT01833026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20268431|NCT00530387|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20268432|NCT00530387|Protective Agents|protective agents|mesh-ancestor
19947042|NCT01535040|Memantine|memantine|mesh-list
19947043|NCT01535040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19947044|NCT01535040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19947045|NCT01535040|Dopamine Agents|dopamine agents|mesh-ancestor
19947046|NCT01535040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19947047|NCT01535040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947048|NCT01535040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947049|NCT01535040|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19947050|NCT01535040|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19947051|NCT01535053|Calcium, Dietary|calcium, dietary|mesh-list
19947052|NCT01535053|Leucovorin|leucovorin|mesh-list
19947053|NCT01535053|Folic Acid|folic acid|mesh-list
19947054|NCT01535053|Dactinomycin|dactinomycin|mesh-list
19947055|NCT01535053|Methotrexate|methotrexate|mesh-list
19947056|NCT01535053|Calcium|calcium|mesh-list
19947057|NCT01535053|Levoleucovorin|levoleucovorin|mesh-list
19947058|NCT01535053|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19947059|NCT01535053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947060|NCT01535053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19947061|NCT01535053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19947062|NCT01535053|Abortifacient Agents|abortifacient agents|mesh-ancestor
19947063|NCT01535053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19947064|NCT01535053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19947065|NCT01535053|Antimetabolites|antimetabolites|mesh-ancestor
19947066|NCT01535053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947067|NCT01535053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947068|NCT01535053|Dermatologic Agents|dermatologic agents|mesh-ancestor
19947069|NCT01535053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947070|NCT01535053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19947071|NCT01535053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19947072|NCT01535053|Immunologic Factors|immunologic factors|mesh-ancestor
19947073|NCT01535053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19947074|NCT01535053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19947075|NCT01535053|Antidotes|antidotes|mesh-ancestor
19947076|NCT01535053|Protective Agents|protective agents|mesh-ancestor
19947077|NCT01535053|Vitamin B Complex|vitamin b complex|mesh-ancestor
19947078|NCT01535053|Vitamins|vitamins|mesh-ancestor
19947079|NCT01535053|Micronutrients|micronutrients|mesh-ancestor
19947080|NCT01535053|Hematinics|hematinics|mesh-ancestor
19947081|NCT01535053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19947082|NCT01535053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19947083|NCT01535053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19947084|NCT01535053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19947085|NCT01535235|Lisinopril|lisinopril|mesh-list
19947086|NCT01535235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19947087|NCT01535235|Protease Inhibitors|protease inhibitors|mesh-ancestor
19947088|NCT01535235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947089|NCT01535235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947090|NCT01535235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19947091|NCT01535235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19947092|NCT01535235|Protective Agents|protective agents|mesh-ancestor
19947093|NCT01535235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947094|NCT01535261|Ranibizumab|ranibizumab|mesh-list
19947095|NCT01535261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19947096|NCT01535261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19947097|NCT01535261|Growth Substances|growth substances|mesh-ancestor
19947098|NCT01535261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947099|NCT01535261|Growth Inhibitors|growth inhibitors|mesh-ancestor
19947100|NCT01535261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947101|NCT01535287|Dexmedetomidine|dexmedetomidine|mesh-list
19947102|NCT01535287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19947103|NCT01535287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19947104|NCT01535287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947105|NCT01535287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19947106|NCT01535287|Analgesics|analgesics|mesh-ancestor
19947107|NCT01535287|Sensory System Agents|sensory system agents|mesh-ancestor
19947108|NCT01535287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947109|NCT01535287|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19947110|NCT01535287|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19947111|NCT01535287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19947112|NCT01535287|Adrenergic Agents|adrenergic agents|mesh-ancestor
19947113|NCT01535287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19947114|NCT01535287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947115|NCT01535443|Bromfenac|bromfenac|mesh-list
19947116|NCT01535443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19947117|NCT01535443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19947118|NCT01535443|Analgesics|analgesics|mesh-ancestor
19947119|NCT01535443|Sensory System Agents|sensory system agents|mesh-ancestor
19947120|NCT01535443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947121|NCT01535443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947122|NCT01535443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19947123|NCT01535443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19947124|NCT01535573|Dexetimide|dexetimide|mesh-list
19947125|NCT01535573|Citalopram|citalopram|mesh-list
19947126|NCT01535573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19947127|NCT01535573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19947128|NCT01535573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19947129|NCT01535573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947130|NCT01535573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19947131|NCT01535573|Serotonin Agents|serotonin agents|mesh-ancestor
19947132|NCT01535573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268433|NCT00530387|Dermatologic Agents|dermatologic agents|mesh-ancestor
20268434|NCT00530387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20268435|NCT00530400|Cefuroxime|cefuroxime|mesh-list
20268436|NCT00530400|Cefuroxime axetil|cefuroxime axetil|mesh-list
20268437|NCT00530400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20268438|NCT00530400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268439|NCT00530413|Phenobarbital|phenobarbital|mesh-list
20268440|NCT00530413|Anticonvulsants|anticonvulsants|mesh-ancestor
20268441|NCT00530413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20268442|NCT00530413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20268443|NCT00530413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268444|NCT00530413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20268445|NCT00530413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20268446|NCT00530413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20268447|NCT00530413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268448|NCT00530413|GABA Modulators|gaba modulators|mesh-ancestor
20268449|NCT00530413|GABA Agents|gaba agents|mesh-ancestor
20268450|NCT00530413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20268451|NCT00530413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20268452|NCT00530413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20268453|NCT00530478|Donepezil|donepezil|mesh-list
20268454|NCT00530478|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20268455|NCT00530478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268456|NCT00530478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268457|NCT00530478|Cholinergic Agents|cholinergic agents|mesh-ancestor
20268458|NCT00530478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20268459|NCT00530478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268460|NCT00530478|Nootropic Agents|nootropic agents|mesh-ancestor
20268461|NCT00530517|Sumatriptan|sumatriptan|mesh-list
20268462|NCT00530517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20268463|NCT00530517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20268464|NCT00530517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20268465|NCT00530517|Serotonin Agents|serotonin agents|mesh-ancestor
20268466|NCT00530517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20268467|NCT00530517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268468|NCT00530517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268469|NCT00530556|Zolpidem|zolpidem|mesh-list
20268470|NCT00530556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20268471|NCT00530556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20268472|NCT00530556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20268473|NCT00530556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268474|NCT00530556|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20268475|NCT00530556|GABA Agonists|gaba agonists|mesh-ancestor
20268476|NCT00530556|GABA Agents|gaba agents|mesh-ancestor
20268477|NCT00530556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19947133|NCT01535573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19947134|NCT01535573|Antidepressive Agents|antidepressive agents|mesh-ancestor
19947135|NCT01535573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19947136|NCT01535573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19947137|NCT01535573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19947138|NCT01535573|Parasympatholytics|parasympatholytics|mesh-ancestor
20268478|NCT00530556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268479|NCT00530582|Progesterone|progesterone|mesh-list
20268480|NCT00530582|Progestins|progestins|mesh-ancestor
20268481|NCT00530582|Hormones|hormones|mesh-ancestor
20268482|NCT00530582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20268483|NCT00530582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947139|NCT01535573|Autonomic Agents|autonomic agents|mesh-ancestor
19947140|NCT01535573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947141|NCT01535573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19947142|NCT01535573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19947143|NCT01535573|Cholinergic Agents|cholinergic agents|mesh-ancestor
19947144|NCT01535664|4-Aminopyridine|4-aminopyridine|mesh-list
19947145|NCT01535664|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19947146|NCT01535664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19947147|NCT01535664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268484|NCT00530595|Losartan|losartan|mesh-list
20268485|NCT00530595|Valsartan|valsartan|mesh-list
20268486|NCT00530595|Candesartan|candesartan|mesh-list
20268487|NCT00530595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20268488|NCT00530595|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20268489|NCT00530595|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20268490|NCT00530595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268491|NCT00530595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20268492|NCT00530868|Bevacizumab|bevacizumab|mesh-list
20268493|NCT00530868|Letrozole|letrozole|mesh-list
20268494|NCT00530868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20268495|NCT00530868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268496|NCT00530868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20268497|NCT00530868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20268498|NCT00530868|Growth Substances|growth substances|mesh-ancestor
20268499|NCT00530868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268500|NCT00530868|Growth Inhibitors|growth inhibitors|mesh-ancestor
20268501|NCT00530868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20268502|NCT00530868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20268503|NCT00530868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268504|NCT00530868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268505|NCT00530868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20268506|NCT00530868|Hormone Antagonists|hormone antagonists|mesh-ancestor
20268507|NCT00530868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20268508|NCT00530907|Bevacizumab|bevacizumab|mesh-list
20268509|NCT00530907|Valproic Acid|valproic acid|mesh-list
20268510|NCT00530907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20268511|NCT00530907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268512|NCT00530907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20268513|NCT00530907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20268514|NCT00530907|Growth Substances|growth substances|mesh-ancestor
20268515|NCT00530907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268516|NCT00530907|Growth Inhibitors|growth inhibitors|mesh-ancestor
20268517|NCT00530907|Anticonvulsants|anticonvulsants|mesh-ancestor
20268518|NCT00530907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268519|NCT00530907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268520|NCT00530907|GABA Agents|gaba agents|mesh-ancestor
20268521|NCT00530907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20268522|NCT00530907|Antimanic Agents|antimanic agents|mesh-ancestor
20268523|NCT00530907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20268524|NCT00530907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20268525|NCT00530907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20268526|NCT00530972|Ribavirin|ribavirin|mesh-list
20268527|NCT00530972|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20268528|NCT00530972|Antimetabolites|antimetabolites|mesh-ancestor
20268529|NCT00530972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268530|NCT00530972|Antiviral Agents|antiviral agents|mesh-ancestor
20268531|NCT00530972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268532|NCT00531024|Bevacizumab|bevacizumab|mesh-list
20543374|NCT01869803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20543375|NCT01869881|Sarpogrelate|sarpogrelate|mesh-list
20543376|NCT01869881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20543377|NCT01869881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20543378|NCT01869881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543379|NCT01869881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20543380|NCT01869881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20543381|NCT01869881|Serotonin Agents|serotonin agents|mesh-ancestor
20543382|NCT01869881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20543383|NCT01869881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543384|NCT01869907|Minocycline|minocycline|mesh-list
20543385|NCT01869907|Amitriptyline|amitriptyline|mesh-list
19947148|NCT01535924|Gemcitabine|gemcitabine|mesh-list
19947149|NCT01535924|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19947150|NCT01535924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19947151|NCT01535924|Antimetabolites|antimetabolites|mesh-ancestor
19974145|NCT01833026|Respiratory System Agents|respiratory system agents|mesh-ancestor
19947152|NCT01535924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947153|NCT01535924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947154|NCT01535924|Antiviral Agents|antiviral agents|mesh-ancestor
19947155|NCT01535924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19947156|NCT01535924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947157|NCT01535924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19947158|NCT01535924|Immunologic Factors|immunologic factors|mesh-ancestor
19947159|NCT01535924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947160|NCT01535924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19947161|NCT01535924|Alkylating Agents|alkylating agents|mesh-ancestor
19947162|NCT01535937|Midazolam|midazolam|mesh-list
19947163|NCT01535937|Ketamine|ketamine|mesh-list
19947164|NCT01535937|Analgesics|analgesics|mesh-ancestor
19947165|NCT01535937|Sensory System Agents|sensory system agents|mesh-ancestor
19947166|NCT01535937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947167|NCT01535937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947168|NCT01535937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19947169|NCT01535937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19947170|NCT01535937|Anesthetics, General|anesthetics, general|mesh-ancestor
19947171|NCT01535937|Anesthetics|anesthetics|mesh-ancestor
19947172|NCT01535937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19947173|NCT01535937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19947174|NCT01535937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19947175|NCT01535937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19947176|NCT01535937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947177|NCT01535937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19947178|NCT01535937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19947179|NCT01535937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19947180|NCT01535937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19947181|NCT01535937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19947182|NCT01535937|GABA Modulators|gaba modulators|mesh-ancestor
19947183|NCT01535937|GABA Agents|gaba agents|mesh-ancestor
19947184|NCT01535976|Ketamine|ketamine|mesh-list
19947185|NCT01535976|Analgesics|analgesics|mesh-ancestor
19947186|NCT01535976|Sensory System Agents|sensory system agents|mesh-ancestor
19947187|NCT01535976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947188|NCT01535976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947189|NCT01535976|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19947190|NCT01535976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19947191|NCT01535976|Anesthetics, General|anesthetics, general|mesh-ancestor
19947192|NCT01535976|Anesthetics|anesthetics|mesh-ancestor
19947193|NCT01535976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19947194|NCT01535976|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19947195|NCT01535976|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19947196|NCT01535976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19947197|NCT01535976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947198|NCT01536067|Bortezomib|bortezomib|mesh-list
19947199|NCT01536067|Ofatumumab|ofatumumab|mesh-list
19947200|NCT01536067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947201|NCT01536262|Tiotropium Bromide|tiotropium bromide|mesh-list
19947202|NCT01536262|Olodaterol|olodaterol|mesh-list
19947203|NCT01536262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19947204|NCT01536262|Autonomic Agents|autonomic agents|mesh-ancestor
19947205|NCT01536262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947206|NCT01536262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947207|NCT01536262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19947208|NCT01536262|Respiratory System Agents|respiratory system agents|mesh-ancestor
19947209|NCT01536262|Parasympatholytics|parasympatholytics|mesh-ancestor
19947210|NCT01536262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19947211|NCT01536262|Cholinergic Agents|cholinergic agents|mesh-ancestor
19947212|NCT01536262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19947213|NCT01536262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947214|NCT01536366|Repaglinide|repaglinide|mesh-list
19947215|NCT01536366|Opicapone|opicapone|mesh-list
19947216|NCT01536366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19947217|NCT01536366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947218|NCT01536366|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19947219|NCT01536366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947220|NCT01536366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947221|NCT01536366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19947222|NCT01536366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19947223|NCT01536379|Belimumab|belimumab|mesh-list
19947224|NCT01536379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19947225|NCT01536379|Immunologic Factors|immunologic factors|mesh-ancestor
19947226|NCT01536379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947227|NCT01536392|Ondansetron|ondansetron|mesh-list
19947228|NCT01536392|Granisetron|granisetron|mesh-list
19947229|NCT01536392|Antiemetics|antiemetics|mesh-ancestor
19947230|NCT01536392|Autonomic Agents|autonomic agents|mesh-ancestor
19947231|NCT01536392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947232|NCT01536392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947233|NCT01536392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19947234|NCT01536392|Antipruritics|antipruritics|mesh-ancestor
19947235|NCT01536392|Dermatologic Agents|dermatologic agents|mesh-ancestor
19947236|NCT01536392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19947237|NCT01536392|Serotonin Agents|serotonin agents|mesh-ancestor
19947238|NCT01536392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19947239|NCT01536392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947240|NCT01536392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19947241|NCT01536392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19947242|NCT01536392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19947243|NCT01536392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19947244|NCT01536392|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19947245|NCT01536535|Prednisone|prednisone|mesh-list
19947246|NCT01536535|Mesalamine|mesalamine|mesh-list
19947247|NCT01536535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19947248|NCT01536535|Glucocorticoids|glucocorticoids|mesh-ancestor
19947249|NCT01536535|Hormones|hormones|mesh-ancestor
19947250|NCT01536535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20268533|NCT00531024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20268534|NCT00531024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268535|NCT00531024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20268536|NCT00531024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20268537|NCT00531024|Growth Substances|growth substances|mesh-ancestor
20268538|NCT00531024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268539|NCT00531024|Growth Inhibitors|growth inhibitors|mesh-ancestor
20268540|NCT00531063|Everolimus|everolimus|mesh-list
20268541|NCT00531063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268542|NCT00531063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20268543|NCT00531063|Immunologic Factors|immunologic factors|mesh-ancestor
20268544|NCT00531063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268545|NCT00531076|Bevacizumab|bevacizumab|mesh-list
20268546|NCT00531076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20268547|NCT00531076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268548|NCT00531076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20543386|NCT01869907|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20543387|NCT01869907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20543388|NCT01869907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20543389|NCT01869907|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20543390|NCT01869907|Antidepressive Agents|antidepressive agents|mesh-ancestor
20543391|NCT01869907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20543392|NCT01869907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20543393|NCT01869907|Analgesics|analgesics|mesh-ancestor
20543394|NCT01869907|Sensory System Agents|sensory system agents|mesh-ancestor
20543395|NCT01869907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543396|NCT01869907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543397|NCT01869907|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20543398|NCT01869907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20543399|NCT01869907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20543400|NCT01869907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543401|NCT01869907|Adrenergic Agents|adrenergic agents|mesh-ancestor
20543402|NCT01869907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20543403|NCT01869907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20543404|NCT01869907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20543405|NCT01869907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20543406|NCT01869946|Ropivacaine|ropivacaine|mesh-list
20543407|NCT01869946|Anesthetics, Local|anesthetics, local|mesh-ancestor
20543408|NCT01869946|Anesthetics|anesthetics|mesh-ancestor
20543409|NCT01869946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20543410|NCT01869946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543411|NCT01869946|Sensory System Agents|sensory system agents|mesh-ancestor
20543412|NCT01869946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543413|NCT01870011|Anesthetics|anesthetics|mesh-list
20543414|NCT01870011|Propofol|propofol|mesh-list
20543415|NCT01870011|Desflurane|desflurane|mesh-list
20543416|NCT01870011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20543417|NCT01870011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543418|NCT01870011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20543419|NCT01870011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19974146|NCT01833026|Tocolytic Agents|tocolytic agents|mesh-ancestor
19947251|NCT01536535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947252|NCT01536535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19947253|NCT01536535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947254|NCT01536535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19947255|NCT01536535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19947256|NCT01536535|Analgesics|analgesics|mesh-ancestor
19947257|NCT01536535|Sensory System Agents|sensory system agents|mesh-ancestor
19947258|NCT01536535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947259|NCT01536535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19947260|NCT01536561|Tositumomab I-131|tositumomab i-131|mesh-list
19947261|NCT01536561|Antibodies|antibodies|mesh-list
19947262|NCT01536561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19947263|NCT01536561|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
19947264|NCT01536561|Immunologic Factors|immunologic factors|mesh-ancestor
19947265|NCT01536561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947266|NCT01536561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947267|NCT01536574|Ropinirole|ropinirole|mesh-list
19947268|NCT01536574|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19947269|NCT01536574|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19947270|NCT01536574|Dopamine Agonists|dopamine agonists|mesh-ancestor
19947271|NCT01536574|Dopamine Agents|dopamine agents|mesh-ancestor
19947272|NCT01536574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19947273|NCT01536574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947274|NCT01536574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947275|NCT01536587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19947276|NCT01536587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19947277|NCT01536587|Autonomic Agents|autonomic agents|mesh-ancestor
19947278|NCT01536587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947279|NCT01536587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947280|NCT01536587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19947281|NCT01536587|Respiratory System Agents|respiratory system agents|mesh-ancestor
19947282|NCT01536587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19947283|NCT01536587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19947284|NCT01536587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19947285|NCT01536587|Adrenergic Agents|adrenergic agents|mesh-ancestor
19947286|NCT01536587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19947287|NCT01536587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947288|NCT01536704|Nicotine|nicotine|mesh-list
19947289|NCT01536704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19947290|NCT01536704|Autonomic Agents|autonomic agents|mesh-ancestor
19947291|NCT01536704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947292|NCT01536704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947293|NCT01536704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19947294|NCT01536704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19947295|NCT01536704|Cholinergic Agents|cholinergic agents|mesh-ancestor
19947296|NCT01536704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19947297|NCT01536704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947298|NCT01536886|Betamethasone|betamethasone|mesh-list
19947299|NCT01536886|Calcipotriene|calcipotriene|mesh-list
19947300|NCT01536886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19947301|NCT01536886|Glucocorticoids|glucocorticoids|mesh-ancestor
19947302|NCT01536886|Hormones|hormones|mesh-ancestor
19947303|NCT01536886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19947304|NCT01536886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947305|NCT01536886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19947306|NCT01536886|Respiratory System Agents|respiratory system agents|mesh-ancestor
19947307|NCT01536886|Dermatologic Agents|dermatologic agents|mesh-ancestor
19947308|NCT01536938|Calcitriol|calcitriol|mesh-list
19947309|NCT01536938|Betamethasone|betamethasone|mesh-list
19947310|NCT01536938|Betamethasone Valerate|betamethasone valerate|mesh-list
19947311|NCT01536938|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19947312|NCT01536938|Betamethasone benzoate|betamethasone benzoate|mesh-list
19947313|NCT01536938|Calcipotriene|calcipotriene|mesh-list
19947314|NCT01536938|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19947315|NCT01536938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19947316|NCT01536938|Glucocorticoids|glucocorticoids|mesh-ancestor
19947317|NCT01536938|Hormones|hormones|mesh-ancestor
19947318|NCT01536938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19947319|NCT01536938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947320|NCT01536938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19947321|NCT01536938|Respiratory System Agents|respiratory system agents|mesh-ancestor
19947322|NCT01536938|Dermatologic Agents|dermatologic agents|mesh-ancestor
19947323|NCT01536938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19947324|NCT01536938|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20543420|NCT01870011|Anesthetics, General|anesthetics, general|mesh-ancestor
19947325|NCT01536938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19947326|NCT01536938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947327|NCT01536938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19947328|NCT01536938|Vitamins|vitamins|mesh-ancestor
19947329|NCT01536938|Micronutrients|micronutrients|mesh-ancestor
19947330|NCT01536938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19947331|NCT01536951|Moxifloxacin|moxifloxacin|mesh-list
19947332|NCT01536951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19947333|NCT01536951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19947334|NCT01536951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19947335|NCT01536951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19947336|NCT01536951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947337|NCT01536951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947338|NCT01536951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947339|NCT01537029|Cyclophosphamide|cyclophosphamide|mesh-list
19947340|NCT01537029|Doxorubicin|doxorubicin|mesh-list
19947341|NCT01537029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19947342|NCT01537029|Immunologic Factors|immunologic factors|mesh-ancestor
19947343|NCT01537029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947344|NCT01537029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19947345|NCT01537029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19947346|NCT01537029|Alkylating Agents|alkylating agents|mesh-ancestor
19947347|NCT01537029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947348|NCT01537029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947349|NCT01537029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19947350|NCT01537029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19947351|NCT01537029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19947352|NCT01537029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19947353|NCT01537029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947354|NCT01537042|Rotigotine|rotigotine|mesh-list
19947355|NCT01537042|Dopamine Agonists|dopamine agonists|mesh-ancestor
19947356|NCT01537042|Dopamine Agents|dopamine agents|mesh-ancestor
19947357|NCT01537042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19947358|NCT01537042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947359|NCT01537042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268549|NCT00531076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20268550|NCT00531076|Growth Substances|growth substances|mesh-ancestor
20268551|NCT00531076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268552|NCT00531076|Growth Inhibitors|growth inhibitors|mesh-ancestor
20268553|NCT00531089|Rituximab|rituximab|mesh-list
20268554|NCT00531089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20268555|NCT00531089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268556|NCT00531089|Immunologic Factors|immunologic factors|mesh-ancestor
20268557|NCT00531089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268558|NCT00531089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20287314|NCT05151471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287315|NCT05091866|Progesterone|progesterone|mesh-list
20287316|NCT05091866|Progestins|progestins|mesh-list
20287317|NCT05091866|Hormones|hormones|mesh-ancestor
20287318|NCT05091866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20287319|NCT05091866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287320|NCT05076006|PF-06700841|pf-06700841|mesh-list
20287321|NCT05076006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20287322|NCT05076006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287323|NCT05076006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287332|NCT05007691|Salicylic Acid|salicylic acid|mesh-list
20287333|NCT05007691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20287334|NCT05007691|Antifungal Agents|antifungal agents|mesh-ancestor
20287335|NCT05007691|Keratolytic Agents|keratolytic agents|mesh-ancestor
20287336|NCT05007691|Dermatologic Agents|dermatologic agents|mesh-ancestor
20287337|NCT04986605|Methoxsalen|methoxsalen|mesh-list
20287338|NCT04986605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20287339|NCT04986605|Dermatologic Agents|dermatologic agents|mesh-ancestor
20287340|NCT04982029|Cannabidiol|cannabidiol|mesh-list
20287341|NCT04982029|Anticonvulsants|anticonvulsants|mesh-ancestor
19947360|NCT01537068|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20287342|NCT04978428|Cannabidiol|cannabidiol|mesh-list
19947361|NCT01537068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19947362|NCT01537068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19947363|NCT01537068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19947364|NCT01537068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947365|NCT01537068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19947366|NCT01537068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947367|NCT01537068|Antidepressive Agents|antidepressive agents|mesh-ancestor
19947368|NCT01537068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19947369|NCT01537081|Phenylpropanolamine|phenylpropanolamine|mesh-list
19947370|NCT01537081|Guaifenesin|guaifenesin|mesh-list
19947371|NCT01537081|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
19947372|NCT01537081|Expectorants|expectorants|mesh-ancestor
19947373|NCT01537081|Respiratory System Agents|respiratory system agents|mesh-ancestor
19947374|NCT01537081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19947375|NCT01537081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19947376|NCT01537081|Adrenergic Agents|adrenergic agents|mesh-ancestor
19947377|NCT01537081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19947378|NCT01537081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947379|NCT01537081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947380|NCT01537081|Appetite Depressants|appetite depressants|mesh-ancestor
19947381|NCT01537081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19947382|NCT01537081|Sympathomimetics|sympathomimetics|mesh-ancestor
19947383|NCT01537081|Autonomic Agents|autonomic agents|mesh-ancestor
19947384|NCT01537081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947385|NCT01537081|Nasal Decongestants|nasal decongestants|mesh-ancestor
19947386|NCT01537081|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19947387|NCT01537120|Vildagliptin|vildagliptin|mesh-list
19947388|NCT01537120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19947389|NCT01537120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947390|NCT01537120|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19947391|NCT01537120|Protease Inhibitors|protease inhibitors|mesh-ancestor
19947392|NCT01537120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947393|NCT01537120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947394|NCT01537133|Fluticasone|fluticasone|mesh-list
19947395|NCT01537133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19947396|NCT01537133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19947397|NCT01537133|Autonomic Agents|autonomic agents|mesh-ancestor
19947398|NCT01537133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947399|NCT01537133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947400|NCT01537133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19947401|NCT01537133|Respiratory System Agents|respiratory system agents|mesh-ancestor
19947402|NCT01537133|Dermatologic Agents|dermatologic agents|mesh-ancestor
19947403|NCT01537133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19947404|NCT01537185|Aluminum sulfate|aluminum sulfate|mesh-list
19947405|NCT01537185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19947406|NCT01537185|Immunologic Factors|immunologic factors|mesh-ancestor
19947407|NCT01537185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947408|NCT01537315|Hydroxychloroquine|hydroxychloroquine|mesh-list
19947409|NCT01537315|Antimalarials|antimalarials|mesh-ancestor
19947410|NCT01537315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19947411|NCT01537315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19947412|NCT01537315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19947413|NCT01537315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947414|NCT01537315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947415|NCT01537315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19947416|NCT01537549|Thioctic Acid|thioctic acid|mesh-list
19947417|NCT01537549|Acetylcarnitine|acetylcarnitine|mesh-list
19947418|NCT01537549|Antioxidants|antioxidants|mesh-ancestor
19947419|NCT01537549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947420|NCT01537549|Protective Agents|protective agents|mesh-ancestor
19947421|NCT01537549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947422|NCT01537549|Vitamin B Complex|vitamin b complex|mesh-ancestor
19947423|NCT01537549|Vitamins|vitamins|mesh-ancestor
19947424|NCT01537549|Micronutrients|micronutrients|mesh-ancestor
19947425|NCT01537549|Nootropic Agents|nootropic agents|mesh-ancestor
19947426|NCT01537666|Vancomycin|vancomycin|mesh-list
19947427|NCT01537666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19947428|NCT01537666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19947429|NCT01537783|Chlorhexidine|chlorhexidine|mesh-list
19947430|NCT01537783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19947431|NCT01537783|Mupirocin|mupirocin|mesh-list
19947432|NCT01537783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19947433|NCT01537783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19947434|NCT01537783|Disinfectants|disinfectants|mesh-ancestor
19947435|NCT01537783|Dermatologic Agents|dermatologic agents|mesh-ancestor
19947436|NCT01537783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19947437|NCT01537783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19947438|NCT01537783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947439|NCT01537783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947440|NCT01537835|Anti-Infective Agents|anti-infective agents|mesh-list
19947441|NCT01537835|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19947442|NCT01537887|Moxifloxacin|moxifloxacin|mesh-list
19947443|NCT01537887|Evacetrapib|evacetrapib|mesh-list
19947444|NCT01537887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19947445|NCT01537887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268559|NCT00531115|Cetuximab|cetuximab|mesh-list
20268560|NCT00531115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20268561|NCT00531115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268562|NCT00531128|Gamma-sitosterol|gamma-sitosterol|mesh-list
20268563|NCT00531128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20268564|NCT00531128|Antimetabolites|antimetabolites|mesh-ancestor
20268565|NCT00531128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268566|NCT00531128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20268567|NCT00531167|Lamivudine|lamivudine|mesh-list
20268568|NCT00531167|Adefovir|adefovir|mesh-list
20268569|NCT00531167|Entecavir|entecavir|mesh-list
20268570|NCT00531167|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20268571|NCT00531167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20268572|NCT00531167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268573|NCT00531167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268574|NCT00531167|Antiviral Agents|antiviral agents|mesh-ancestor
20268575|NCT00531167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268576|NCT00531167|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20268577|NCT00531167|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20268578|NCT00531193|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
20268579|NCT00531193|SCH 442416|sch 442416|mesh-list
20268580|NCT00531193|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
20268581|NCT00531193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20268582|NCT00531193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20268583|NCT00531193|Purinergic Agents|purinergic agents|mesh-ancestor
20268584|NCT00531193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20268585|NCT00531193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268586|NCT00531193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268587|NCT00531245|Oxaliplatin|oxaliplatin|mesh-list
20268588|NCT00531245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268589|NCT00531271|Docetaxel|docetaxel|mesh-list
20268590|NCT00531271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268591|NCT00531271|Tubulin Modulators|tubulin modulators|mesh-ancestor
20268592|NCT00531271|Antimitotic Agents|antimitotic agents|mesh-ancestor
20268593|NCT00531271|Mitosis Modulators|mitosis modulators|mesh-ancestor
20268594|NCT00531271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268595|NCT00531310|Fludarabine|fludarabine|mesh-list
20268596|NCT00531310|Busulfan|busulfan|mesh-list
20268597|NCT00531310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268598|NCT00531310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268599|NCT00531310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20268600|NCT00531310|Immunologic Factors|immunologic factors|mesh-ancestor
20268601|NCT00531310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268602|NCT00531310|Alkylating Agents|alkylating agents|mesh-ancestor
20268603|NCT00531310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20268604|NCT00531310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20268605|NCT00531323|Etravirine|etravirine|mesh-list
20268606|NCT00531323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20268607|NCT00531323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20268608|NCT00531323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268609|NCT00531323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268610|NCT00531323|Antiviral Agents|antiviral agents|mesh-ancestor
20268611|NCT00531323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268612|NCT00531336|Bevacizumab|bevacizumab|mesh-list
20268613|NCT00531336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20268614|NCT00531336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268615|NCT00531336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20268616|NCT00531336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20268617|NCT00531336|Growth Substances|growth substances|mesh-ancestor
19947446|NCT01537887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19947447|NCT01537887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20287343|NCT04978428|Anticonvulsants|anticonvulsants|mesh-ancestor
19947448|NCT01537887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974147|NCT01833026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19947449|NCT01537887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947450|NCT01537887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947451|NCT01537887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19947452|NCT01537887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19947453|NCT01537887|Antimetabolites|antimetabolites|mesh-ancestor
19947454|NCT01537887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19947455|NCT01537900|Grazoprevir|grazoprevir|mesh-list
19947456|NCT01537900|Antiviral Agents|antiviral agents|mesh-ancestor
19947457|NCT01537900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19947458|NCT01537926|Acetylcysteine|acetylcysteine|mesh-list
19947459|NCT01537926|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19947460|NCT01537926|Antiviral Agents|antiviral agents|mesh-ancestor
19947461|NCT01537926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19947462|NCT01537926|Expectorants|expectorants|mesh-ancestor
19947463|NCT01537926|Respiratory System Agents|respiratory system agents|mesh-ancestor
19947464|NCT01537926|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19947465|NCT01537926|Antioxidants|antioxidants|mesh-ancestor
19947466|NCT01537926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947467|NCT01537926|Protective Agents|protective agents|mesh-ancestor
19947468|NCT01537926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947469|NCT01537926|Antidotes|antidotes|mesh-ancestor
19947470|NCT01538472|Cytarabine|cytarabine|mesh-list
19947471|NCT01538472|Rituximab|rituximab|mesh-list
19947472|NCT01538472|Melphalan|melphalan|mesh-list
19947473|NCT01538472|Carmustine|carmustine|mesh-list
19947474|NCT01538472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19947475|NCT01538472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19947476|NCT01538472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947477|NCT01538472|Immunologic Factors|immunologic factors|mesh-ancestor
19947478|NCT01538472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947479|NCT01538472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19947480|NCT01538472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19947481|NCT01538472|Antimetabolites|antimetabolites|mesh-ancestor
19947482|NCT01538472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947483|NCT01538472|Antiviral Agents|antiviral agents|mesh-ancestor
19947484|NCT01538472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19947485|NCT01538472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19947486|NCT01538472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19947487|NCT01538472|Alkylating Agents|alkylating agents|mesh-ancestor
19947488|NCT01538472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19947489|NCT01538719|Rilonacept|rilonacept|mesh-list
19947490|NCT01538719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19947491|NCT01538745|Ketamine|ketamine|mesh-list
19947492|NCT01538745|Morphine|morphine|mesh-list
19947493|NCT01538745|Analgesics|analgesics|mesh-ancestor
19947494|NCT01538745|Sensory System Agents|sensory system agents|mesh-ancestor
19947495|NCT01538745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947496|NCT01538745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947497|NCT01538745|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19947498|NCT01538745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19947499|NCT01538745|Anesthetics, General|anesthetics, general|mesh-ancestor
19947500|NCT01538745|Anesthetics|anesthetics|mesh-ancestor
19947501|NCT01538745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19947502|NCT01538745|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19947503|NCT01538745|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19947504|NCT01538745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19947505|NCT01538745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947506|NCT01538745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19947507|NCT01538745|Narcotics|narcotics|mesh-ancestor
19947508|NCT01538862|Sargramostim|sargramostim|mesh-list
19947509|NCT01538862|Lenograstim|lenograstim|mesh-list
19947510|NCT01538862|Immunologic Factors|immunologic factors|mesh-ancestor
19947511|NCT01538862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947512|NCT01538862|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19947513|NCT01539083|Thalidomide|thalidomide|mesh-list
19947514|NCT01539083|Dexamethasone|dexamethasone|mesh-list
19947515|NCT01539083|Prednisolone|prednisolone|mesh-list
19947516|NCT01539083|Cyclophosphamide|cyclophosphamide|mesh-list
19947517|NCT01539083|Bortezomib|bortezomib|mesh-list
19947518|NCT01539083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19947519|NCT01539083|Immunologic Factors|immunologic factors|mesh-ancestor
19947520|NCT01539083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947521|NCT01539083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19947522|NCT01539083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19947523|NCT01539083|Alkylating Agents|alkylating agents|mesh-ancestor
19947524|NCT01539083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947525|NCT01539083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947526|NCT01539083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19947527|NCT01539083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19947528|NCT01539083|Antiemetics|antiemetics|mesh-ancestor
19947529|NCT01539083|Autonomic Agents|autonomic agents|mesh-ancestor
19947530|NCT01539083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947531|NCT01539083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19947532|NCT01539083|Glucocorticoids|glucocorticoids|mesh-ancestor
19947533|NCT01539083|Hormones|hormones|mesh-ancestor
19947534|NCT01539083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19947535|NCT01539083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19947536|NCT01539083|Leprostatic Agents|leprostatic agents|mesh-ancestor
19947537|NCT01539083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19947538|NCT01539083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19947539|NCT01539083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19947540|NCT01539083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19947541|NCT01539083|Growth Substances|growth substances|mesh-ancestor
19947542|NCT01539083|Growth Inhibitors|growth inhibitors|mesh-ancestor
19947543|NCT01539135|Methylene Blue|methylene blue|mesh-list
19947544|NCT01539135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947545|NCT01539135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947546|NCT01539291|Idelalisib|idelalisib|mesh-list
19947547|NCT01539291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947548|NCT01539291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947549|NCT01539291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947550|NCT01539317|Lidocaine|lidocaine|mesh-list
19947551|NCT01539317|Anesthetics, Local|anesthetics, local|mesh-ancestor
19947552|NCT01539317|Anesthetics|anesthetics|mesh-ancestor
19947553|NCT01539317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19947554|NCT01539317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947555|NCT01539317|Sensory System Agents|sensory system agents|mesh-ancestor
19947556|NCT01539317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947557|NCT01539317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19947558|NCT01539317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19947559|NCT01539317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19947560|NCT01539317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19947561|NCT01539317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947562|NCT01539512|Rituximab|rituximab|mesh-list
19947563|NCT01539512|Idelalisib|idelalisib|mesh-list
19947564|NCT01539512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19947565|NCT01539512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947566|NCT01539512|Immunologic Factors|immunologic factors|mesh-ancestor
19947567|NCT01539512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947568|NCT01539512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19947569|NCT01539512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947570|NCT01539512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947571|NCT01539538|Sufentanil|sufentanil|mesh-list
19947572|NCT01539538|Morphine|morphine|mesh-list
19947573|NCT01539538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19947574|NCT01539538|Narcotics|narcotics|mesh-ancestor
19947575|NCT01539538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19947576|NCT01539538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947577|NCT01539538|Analgesics|analgesics|mesh-ancestor
19947578|NCT01539538|Sensory System Agents|sensory system agents|mesh-ancestor
19947579|NCT01539538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947580|NCT01539538|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19947581|NCT01539538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19947582|NCT01539538|Anesthetics, General|anesthetics, general|mesh-ancestor
19947583|NCT01539538|Anesthetics|anesthetics|mesh-ancestor
19947584|NCT01539642|Sufentanil|sufentanil|mesh-list
19947585|NCT01539642|Dsuvia|dsuvia|mesh-list
19947586|NCT01539642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19947587|NCT01539642|Narcotics|narcotics|mesh-ancestor
19947588|NCT01539642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19947589|NCT01539642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947590|NCT01539642|Analgesics|analgesics|mesh-ancestor
19947591|NCT01539642|Sensory System Agents|sensory system agents|mesh-ancestor
19947592|NCT01539642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947593|NCT01539642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19947594|NCT01539642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19947595|NCT01539642|Anesthetics, General|anesthetics, general|mesh-ancestor
19947596|NCT01539642|Anesthetics|anesthetics|mesh-ancestor
19947597|NCT01539837|Deferiprone|deferiprone|mesh-list
19947598|NCT01539837|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19947599|NCT01539837|Chelating Agents|chelating agents|mesh-ancestor
19947600|NCT01539837|Sequestering Agents|sequestering agents|mesh-ancestor
19947601|NCT01539837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947602|NCT01540474|Vaccines|vaccines|mesh-list
19947603|NCT01540474|Immunologic Factors|immunologic factors|mesh-ancestor
19947604|NCT01540474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947605|NCT01540487|Metformin|metformin|mesh-list
19947606|NCT01540487|Linagliptin|linagliptin|mesh-list
19947607|NCT01540487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19947608|NCT01540487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947609|NCT01540487|Incretins|incretins|mesh-ancestor
19947610|NCT01540487|Hormones|hormones|mesh-ancestor
19947611|NCT01540487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19947612|NCT01540487|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19947613|NCT01540487|Protease Inhibitors|protease inhibitors|mesh-ancestor
19947614|NCT01540487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947615|NCT01540487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947616|NCT01540565|Veliparib|veliparib|mesh-list
19947617|NCT01540565|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19947618|NCT01540565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947619|NCT01540565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947620|NCT01540565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947621|NCT01540838|Acetaminophen|acetaminophen|mesh-list
19947622|NCT01540838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19947623|NCT01540838|Analgesics|analgesics|mesh-ancestor
19947624|NCT01540838|Sensory System Agents|sensory system agents|mesh-ancestor
19947625|NCT01540838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947626|NCT01540838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947627|NCT01540838|Antipyretics|antipyretics|mesh-ancestor
19974148|NCT01833026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19974149|NCT01833026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19974150|NCT01833026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19974151|NCT01833026|Adrenergic Agents|adrenergic agents|mesh-ancestor
19974152|NCT01833026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19974153|NCT01833026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974154|NCT01833130|Botulinum Toxins|botulinum toxins|mesh-list
19974155|NCT01833130|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19974156|NCT01833130|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19974157|NCT01833130|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19974158|NCT01833130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19974159|NCT01833130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974160|NCT01833130|Cholinergic Agents|cholinergic agents|mesh-ancestor
19974161|NCT01833130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19974162|NCT01833130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974163|NCT01833130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19974164|NCT01833130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19974165|NCT01833143|Acyclovir|acyclovir|mesh-list
19974166|NCT01833143|Bortezomib|bortezomib|mesh-list
19974167|NCT01833143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974168|NCT01833143|Antiviral Agents|antiviral agents|mesh-ancestor
19974169|NCT01833143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19975444|NCT01849055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19975445|NCT01849055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19975446|NCT01849055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975447|NCT01849068|Ezetimibe|ezetimibe|mesh-list
19975448|NCT01849068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19975449|NCT01849068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19975450|NCT01849068|Antimetabolites|antimetabolites|mesh-ancestor
19975451|NCT01849068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975452|NCT01849068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19975453|NCT01849276|Metformin|metformin|mesh-list
19975454|NCT01849276|Cytarabine|cytarabine|mesh-list
19975455|NCT01849276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19975456|NCT01849276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975457|NCT01849276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19975458|NCT01849276|Antimetabolites|antimetabolites|mesh-ancestor
19975459|NCT01849276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975460|NCT01849276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975461|NCT01849276|Antiviral Agents|antiviral agents|mesh-ancestor
19975462|NCT01849276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19975463|NCT01849276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19975464|NCT01849276|Immunologic Factors|immunologic factors|mesh-ancestor
19975465|NCT01849289|Insulin|insulin|mesh-list
19975466|NCT01849289|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19975467|NCT01849289|Insulin Glargine|insulin glargine|mesh-list
19975468|NCT01849289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19975469|NCT01849289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975470|NCT01849419|Oxytocin|oxytocin|mesh-list
19975471|NCT01849419|Oxytocics|oxytocics|mesh-ancestor
19947628|NCT01541215|Metformin|metformin|mesh-list
19947629|NCT01541215|Liraglutide|liraglutide|mesh-list
19947630|NCT01541215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19947631|NCT01541215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947632|NCT01541215|Incretins|incretins|mesh-ancestor
19947633|NCT01541215|Hormones|hormones|mesh-ancestor
19947634|NCT01541215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19947635|NCT01541358|Listerine|listerine|mesh-list
19947636|NCT01541358|Fluorides|fluorides|mesh-list
19947637|NCT01541358|Sodium Fluoride|sodium fluoride|mesh-list
19947638|NCT01541358|Cariostatic Agents|cariostatic agents|mesh-ancestor
19947639|NCT01541358|Protective Agents|protective agents|mesh-ancestor
19947640|NCT01541358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947641|NCT01541358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19947642|NCT01541358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19947643|NCT01541371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19947644|NCT01541371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19947645|NCT01541371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19947646|NCT01541371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19947647|NCT01541371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947648|NCT01541371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19947649|NCT01541371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19947650|NCT01541371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19947651|NCT01541371|Serotonin Agents|serotonin agents|mesh-ancestor
19947652|NCT01541371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19947653|NCT01541371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947654|NCT01541371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19947655|NCT01541371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19947656|NCT01541371|Dopamine Agents|dopamine agents|mesh-ancestor
19947657|NCT01541735|Pantoprazole|pantoprazole|mesh-list
19947658|NCT01541735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19947659|NCT01541735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19947660|NCT01541735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19947661|NCT01541735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947662|NCT01541735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947663|NCT01541891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19947664|NCT01541891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19947665|NCT01541930|Metronidazole|metronidazole|mesh-list
19947666|NCT01541930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19947667|NCT01541930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19947668|NCT01541930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19947669|NCT01541930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19947670|NCT01542034|Deoxycholic Acid|deoxycholic acid|mesh-list
19947671|NCT01542034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19947672|NCT01542034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19947673|NCT01542125|Lidocaine|lidocaine|mesh-list
19947674|NCT01542125|Anesthetics, Local|anesthetics, local|mesh-ancestor
19947675|NCT01542125|Anesthetics|anesthetics|mesh-ancestor
19947676|NCT01542125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19947677|NCT01542125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947678|NCT01542125|Sensory System Agents|sensory system agents|mesh-ancestor
19947679|NCT01542125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947680|NCT01542125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19947681|NCT01542125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19947682|NCT01542125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19947683|NCT01542125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19947684|NCT01542125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947685|NCT01542255|Cyclophosphamide|cyclophosphamide|mesh-list
19947686|NCT01542255|Dacarbazine|dacarbazine|mesh-list
19947687|NCT01542255|Vinblastine|vinblastine|mesh-list
19947688|NCT01542255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19947689|NCT01542255|Immunologic Factors|immunologic factors|mesh-ancestor
19947690|NCT01542255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947691|NCT01542255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19947692|NCT01542255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19947693|NCT01542255|Alkylating Agents|alkylating agents|mesh-ancestor
19947694|NCT01542255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947695|NCT01542255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947696|NCT01542255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19947697|NCT01542255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19947698|NCT01542255|Tubulin Modulators|tubulin modulators|mesh-ancestor
19947699|NCT01542255|Antimitotic Agents|antimitotic agents|mesh-ancestor
19947700|NCT01542255|Mitosis Modulators|mitosis modulators|mesh-ancestor
19947701|NCT01542372|Prazosin|prazosin|mesh-list
19947702|NCT01542372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19974170|NCT01833455|Flecainide|flecainide|mesh-list
19947703|NCT01542372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19947704|NCT01542372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19947705|NCT01542372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19947706|NCT01542372|Adrenergic Agents|adrenergic agents|mesh-ancestor
19947707|NCT01542372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20268618|NCT00531336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268619|NCT00531336|Growth Inhibitors|growth inhibitors|mesh-ancestor
20268620|NCT00531349|Propofol|propofol|mesh-list
19450261|NCT03429998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19450262|NCT03429998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19450263|NCT03429998|Antimetabolites|antimetabolites|mesh-ancestor
19450264|NCT03429998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947708|NCT01542372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268621|NCT00531349|Sevoflurane|sevoflurane|mesh-list
20268622|NCT00531349|Anesthetics|anesthetics|mesh-ancestor
20268623|NCT00531349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20268624|NCT00531349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268625|NCT00531349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20268626|NCT00531349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20268627|NCT00531349|Anesthetics, General|anesthetics, general|mesh-ancestor
20268628|NCT00531349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20268629|NCT00531349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20268630|NCT00531362|Aspirin|aspirin|mesh-list
20268631|NCT00531362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20268632|NCT00531362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20268633|NCT00531362|Analgesics|analgesics|mesh-ancestor
20268634|NCT00531362|Sensory System Agents|sensory system agents|mesh-ancestor
20268635|NCT00531362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20268636|NCT00531362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268637|NCT00531362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20268638|NCT00531362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20268639|NCT00531362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20268640|NCT00531362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20268641|NCT00531362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268642|NCT00531362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20268643|NCT00531362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20268644|NCT00531362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268645|NCT00531362|Antipyretics|antipyretics|mesh-ancestor
20268646|NCT00531401|Farnesylthiosalicylic acid|farnesylthiosalicylic acid|mesh-list
20268647|NCT00531401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268648|NCT00531401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268649|NCT00531401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268650|NCT00531440|Everolimus|everolimus|mesh-list
20268651|NCT00531440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268652|NCT00531440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20268653|NCT00531440|Immunologic Factors|immunologic factors|mesh-ancestor
20268654|NCT00531440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268655|NCT00531466|Tolperisone|tolperisone|mesh-list
20268656|NCT00531466|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20268657|NCT00531466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268658|NCT00531466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20268659|NCT00531466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20268660|NCT00531544|Sunitinib|sunitinib|mesh-list
20268661|NCT00531544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268662|NCT00531544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20268663|NCT00531544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20268664|NCT00531544|Growth Substances|growth substances|mesh-ancestor
19947709|NCT01542372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947710|NCT01542502|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19947711|NCT01542502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19947712|NCT01542541|Rifaximin|rifaximin|mesh-list
19947713|NCT01542541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19947714|NCT01542541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268665|NCT00531544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268666|NCT00531544|Growth Inhibitors|growth inhibitors|mesh-ancestor
20268667|NCT00531544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19947715|NCT01542541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19947716|NCT01542645|Fentanyl|fentanyl|mesh-list
19947717|NCT01542645|Analgesics, Opioid|analgesics, opioid|mesh-list
19947718|NCT01542645|Methadone|methadone|mesh-list
19947719|NCT01542645|Narcotics|narcotics|mesh-ancestor
19947720|NCT01542645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20268668|NCT00531544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947721|NCT01542645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947722|NCT01542645|Analgesics|analgesics|mesh-ancestor
19947723|NCT01542645|Sensory System Agents|sensory system agents|mesh-ancestor
19947724|NCT01542645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947725|NCT01542645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19947726|NCT01542645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19947727|NCT01542645|Anesthetics, General|anesthetics, general|mesh-ancestor
19947728|NCT01542645|Anesthetics|anesthetics|mesh-ancestor
19947729|NCT01542645|Antitussive Agents|antitussive agents|mesh-ancestor
19947730|NCT01542645|Respiratory System Agents|respiratory system agents|mesh-ancestor
19947731|NCT01542684|Azacitidine|azacitidine|mesh-list
19947732|NCT01542684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19947733|NCT01542684|Antimetabolites|antimetabolites|mesh-ancestor
19947734|NCT01542684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947735|NCT01542684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947736|NCT01542684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947737|NCT01542788|Sofosbuvir|sofosbuvir|mesh-list
19947738|NCT01542788|Antiviral Agents|antiviral agents|mesh-ancestor
19947739|NCT01542788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19947740|NCT01543074|Allyl sulfide|allyl sulfide|mesh-list
19947741|NCT01543074|Antioxidants|antioxidants|mesh-ancestor
19947742|NCT01543074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947743|NCT01543074|Protective Agents|protective agents|mesh-ancestor
19947744|NCT01543074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947745|NCT01543074|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19947746|NCT01543074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947747|NCT01543074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19947748|NCT01543074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947749|NCT01543152|Cyclophosphamide|cyclophosphamide|mesh-list
20268669|NCT00531544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268670|NCT00531557|Ritonavir|ritonavir|mesh-list
20268671|NCT00531557|Darunavir|darunavir|mesh-list
20268672|NCT00531557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20268673|NCT00531557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20268674|NCT00531557|Protease Inhibitors|protease inhibitors|mesh-ancestor
20268675|NCT00531557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268676|NCT00531557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268677|NCT00531557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20268678|NCT00531557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19947750|NCT01543152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19947751|NCT01543152|Immunologic Factors|immunologic factors|mesh-ancestor
19947752|NCT01543152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947753|NCT01543152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19947754|NCT01543152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19947755|NCT01543152|Alkylating Agents|alkylating agents|mesh-ancestor
19947756|NCT01543152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947757|NCT01543152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947758|NCT01543152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19947759|NCT01543178|Rifaximin|rifaximin|mesh-list
20268679|NCT00531557|Antiviral Agents|antiviral agents|mesh-ancestor
20268680|NCT00531557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268681|NCT00531557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20268682|NCT00531557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20268683|NCT00531596|Selegiline|selegiline|mesh-list
20268684|NCT00531596|Antidepressive Agents|antidepressive agents|mesh-ancestor
20268685|NCT00531596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20268686|NCT00531596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20268687|NCT00531596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20268688|NCT00531596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20268689|NCT00531596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268690|NCT00531596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268691|NCT00531596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20268692|NCT00531596|Protective Agents|protective agents|mesh-ancestor
20268693|NCT00531596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268694|NCT00531635|Mycophenolic Acid|mycophenolic acid|mesh-list
20268695|NCT00531635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20268696|NCT00531635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268697|NCT00531635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20268698|NCT00531635|Antitubercular Agents|antitubercular agents|mesh-ancestor
20268699|NCT00531635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20268700|NCT00531635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268701|NCT00531635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268702|NCT00531635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268703|NCT00531674|Tocopherols|tocopherols|mesh-list
19947760|NCT01543178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20268704|NCT00531674|Antioxidants|antioxidants|mesh-ancestor
19947761|NCT01543178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19947762|NCT01543178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19947763|NCT01543204|Etanercept|etanercept|mesh-list
19947764|NCT01543204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19947765|NCT01543204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19947766|NCT01543204|Analgesics|analgesics|mesh-ancestor
19947767|NCT01543204|Sensory System Agents|sensory system agents|mesh-ancestor
19947768|NCT01543204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947769|NCT01543204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947770|NCT01543204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19947771|NCT01543204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19947772|NCT01543204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19947773|NCT01543204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19947774|NCT01543204|Immunologic Factors|immunologic factors|mesh-ancestor
19947775|NCT01543568|Aflibercept|aflibercept|mesh-list
19947776|NCT01543568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19947777|NCT01543568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19947778|NCT01543568|Growth Substances|growth substances|mesh-ancestor
19947779|NCT01543568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947780|NCT01543568|Growth Inhibitors|growth inhibitors|mesh-ancestor
19947781|NCT01543568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947782|NCT01543685|Celecoxib|celecoxib|mesh-list
19947783|NCT01543685|Indomethacin|indomethacin|mesh-list
19947784|NCT01543685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19947785|NCT01543685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19947786|NCT01543685|Analgesics|analgesics|mesh-ancestor
19947787|NCT01543685|Sensory System Agents|sensory system agents|mesh-ancestor
19947788|NCT01543685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947789|NCT01543685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947790|NCT01543685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19947791|NCT01543685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19947792|NCT01543685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19947793|NCT01543685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19947794|NCT01543685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947795|NCT01543685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947796|NCT01543685|Gout Suppressants|gout suppressants|mesh-ancestor
19947797|NCT01543685|Tocolytic Agents|tocolytic agents|mesh-ancestor
19947798|NCT01543685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19947799|NCT01543776|Abiraterone Acetate|abiraterone acetate|mesh-list
19947800|NCT01543776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947801|NCT01543776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19947802|NCT01543776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947803|NCT01543776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947804|NCT01543776|Hormone Antagonists|hormone antagonists|mesh-ancestor
19947805|NCT01543776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19947806|NCT01543776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947807|NCT01543776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19947808|NCT01543958|Sevelamer|sevelamer|mesh-list
19947809|NCT01543958|Chelating Agents|chelating agents|mesh-ancestor
19947810|NCT01543958|Sequestering Agents|sequestering agents|mesh-ancestor
19947811|NCT01543958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947812|NCT01544062|Acetaminophen|acetaminophen|mesh-list
19947813|NCT01544062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19947814|NCT01544062|Analgesics|analgesics|mesh-ancestor
19947815|NCT01544062|Sensory System Agents|sensory system agents|mesh-ancestor
19947816|NCT01544062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947817|NCT01544062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947818|NCT01544062|Antipyretics|antipyretics|mesh-ancestor
19947819|NCT01544114|Naproxen|naproxen|mesh-list
19947820|NCT01544114|Esomeprazole|esomeprazole|mesh-list
19947821|NCT01544114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19947822|NCT01544114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19947823|NCT01544114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19947824|NCT01544114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947825|NCT01544114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947826|NCT01544114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19947827|NCT01544114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19947828|NCT01544114|Analgesics|analgesics|mesh-ancestor
19947829|NCT01544114|Sensory System Agents|sensory system agents|mesh-ancestor
19947830|NCT01544114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947831|NCT01544114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947832|NCT01544114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19947833|NCT01544114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19947834|NCT01544114|Gout Suppressants|gout suppressants|mesh-ancestor
19947835|NCT01544114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19947836|NCT01544153|Nicotine|nicotine|mesh-list
19947837|NCT01544153|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19947838|NCT01544153|Autonomic Agents|autonomic agents|mesh-ancestor
19947839|NCT01544153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947840|NCT01544153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947841|NCT01544153|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19947842|NCT01544153|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19947843|NCT01544153|Cholinergic Agents|cholinergic agents|mesh-ancestor
19947844|NCT01544153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19947845|NCT01544153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947846|NCT01544179|Pemetrexed|pemetrexed|mesh-list
19947847|NCT01544179|Gefitinib|gefitinib|mesh-list
19947848|NCT01544179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947849|NCT01544179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947850|NCT01544179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947851|NCT01544179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19947852|NCT01544179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19947853|NCT01544179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19947854|NCT01544309|Atorvastatin|atorvastatin|mesh-list
19947855|NCT01544309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19947856|NCT01544309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19947857|NCT01544309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19947858|NCT01544309|Antimetabolites|antimetabolites|mesh-ancestor
19947859|NCT01544309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947860|NCT01544309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19947861|NCT01544309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19947862|NCT01544309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947863|NCT01544348|Omalizumab|omalizumab|mesh-list
19947864|NCT01544348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19947865|NCT01544348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19947866|NCT01544348|Respiratory System Agents|respiratory system agents|mesh-ancestor
19947867|NCT01544491|Everolimus|everolimus|mesh-list
19947868|NCT01544491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947869|NCT01544491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19947870|NCT01544491|Immunologic Factors|immunologic factors|mesh-ancestor
19947871|NCT01544491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947872|NCT01544920|Interferons|interferons|mesh-list
19947873|NCT01544920|Ribavirin|ribavirin|mesh-list
19947874|NCT01544920|Interferon-alpha|interferon-alpha|mesh-list
19947875|NCT01544920|Interferon alpha-2|interferon alpha-2|mesh-list
19947876|NCT01544920|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19947877|NCT01544920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947878|NCT01544920|Antiviral Agents|antiviral agents|mesh-ancestor
19947879|NCT01544920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19947880|NCT01544920|Antimetabolites|antimetabolites|mesh-ancestor
19947881|NCT01544920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947882|NCT01544920|Immunologic Factors|immunologic factors|mesh-ancestor
19947883|NCT01544920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947884|NCT01544998|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19947885|NCT01544998|Tadalafil|tadalafil|mesh-list
19947886|NCT01544998|Vasodilator Agents|vasodilator agents|mesh-ancestor
19947887|NCT01544998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19947888|NCT01544998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19947889|NCT01544998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947890|NCT01544998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947891|NCT01544998|Urological Agents|urological agents|mesh-ancestor
19947892|NCT01544998|Natriuretic Agents|natriuretic agents|mesh-ancestor
19947893|NCT01544998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947894|NCT01545076|Immunoglobulin G|immunoglobulin g|mesh-list
19947895|NCT01545076|Immunologic Factors|immunologic factors|mesh-ancestor
19947896|NCT01545076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947897|NCT01545141|Interferons|interferons|mesh-list
19947898|NCT01545141|Interferon-alpha|interferon-alpha|mesh-list
19947899|NCT01545141|Interferon alpha-2|interferon alpha-2|mesh-list
19947900|NCT01545141|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
19947901|NCT01545141|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
19947902|NCT01545141|Poly I-C|poly i-c|mesh-list
19947903|NCT01545141|Celecoxib|celecoxib|mesh-list
19947904|NCT01545141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947905|NCT01545141|Antiviral Agents|antiviral agents|mesh-ancestor
19947906|NCT01545141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19947907|NCT01545141|Immunologic Factors|immunologic factors|mesh-ancestor
19947908|NCT01545141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947909|NCT01545141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19947910|NCT01545141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19947911|NCT01545141|Analgesics|analgesics|mesh-ancestor
19947912|NCT01545141|Sensory System Agents|sensory system agents|mesh-ancestor
19947913|NCT01545141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947914|NCT01545141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19947915|NCT01545141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19947916|NCT01545141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19947917|NCT01545141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19947918|NCT01545141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947919|NCT01545141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947920|NCT01545141|Interferon Inducers|interferon inducers|mesh-ancestor
19947921|NCT01545336|Anastrozole|anastrozole|mesh-list
19947922|NCT01545336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19947923|NCT01545336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947924|NCT01545336|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19947925|NCT01545336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19947926|NCT01545336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947927|NCT01545336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947928|NCT01545336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19947929|NCT01545336|Hormone Antagonists|hormone antagonists|mesh-ancestor
19947930|NCT01545336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19947931|NCT01545336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947932|NCT01545375|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19947933|NCT01545375|Immunologic Factors|immunologic factors|mesh-ancestor
19947934|NCT01545375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947935|NCT01545388|Metformin|metformin|mesh-list
19947936|NCT01545388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19947937|NCT01545388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19947938|NCT01545388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947939|NCT01545388|Incretins|incretins|mesh-ancestor
19947940|NCT01545388|Hormones|hormones|mesh-ancestor
19947941|NCT01545388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19947942|NCT01545388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19947943|NCT01545388|Protease Inhibitors|protease inhibitors|mesh-ancestor
19947944|NCT01545388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947945|NCT01545388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947946|NCT01545700|Dexamethasone|dexamethasone|mesh-list
19947947|NCT01545700|Dexamethasone acetate|dexamethasone acetate|mesh-list
19947948|NCT01545700|BB 1101|bb 1101|mesh-list
19947949|NCT01545700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19947950|NCT01545700|Antiemetics|antiemetics|mesh-ancestor
19947951|NCT01545700|Autonomic Agents|autonomic agents|mesh-ancestor
19947952|NCT01545700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947953|NCT01545700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947954|NCT01545700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19947955|NCT01545700|Glucocorticoids|glucocorticoids|mesh-ancestor
19947956|NCT01545700|Hormones|hormones|mesh-ancestor
19947957|NCT01545700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19947958|NCT01545700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19947959|NCT01545700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947960|NCT01545700|Protease Inhibitors|protease inhibitors|mesh-ancestor
19947961|NCT01545700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947962|NCT01545700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947963|NCT01545765|Lidocaine|lidocaine|mesh-list
19947964|NCT01545765|Tetracaine|tetracaine|mesh-list
19947965|NCT01545765|Anesthetics, Local|anesthetics, local|mesh-ancestor
19947966|NCT01545765|Anesthetics|anesthetics|mesh-ancestor
19947967|NCT01545765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19947968|NCT01545765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947969|NCT01545765|Sensory System Agents|sensory system agents|mesh-ancestor
19947970|NCT01545765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19947971|NCT01545765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19947972|NCT01545765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19947973|NCT01545765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19947974|NCT01545765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19947975|NCT01545765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947976|NCT01545817|Everolimus|everolimus|mesh-list
19947977|NCT01545817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19947978|NCT01545817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19947979|NCT01545817|Immunologic Factors|immunologic factors|mesh-ancestor
19947980|NCT01545817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947981|NCT01545843|Fluoxetine|fluoxetine|mesh-list
19947982|NCT01545843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19947983|NCT01545843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19947984|NCT01545843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19947985|NCT01545843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19947986|NCT01545843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19947987|NCT01545843|Serotonin Agents|serotonin agents|mesh-ancestor
19947988|NCT01545843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19947989|NCT01545843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19947990|NCT01545843|Antidepressive Agents|antidepressive agents|mesh-ancestor
19947991|NCT01545843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19947992|NCT01545843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19947993|NCT01545843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19947994|NCT01545843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19947995|NCT01546038|Cytarabine|cytarabine|mesh-list
19947996|NCT01546038|Decitabine|decitabine|mesh-list
19947997|NCT01546038|Daunorubicin|daunorubicin|mesh-list
19947998|NCT01546038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19947999|NCT01546038|Antimetabolites|antimetabolites|mesh-ancestor
19948000|NCT01546038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948001|NCT01546038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948002|NCT01546038|Antiviral Agents|antiviral agents|mesh-ancestor
19948003|NCT01546038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19948004|NCT01546038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19948005|NCT01546038|Immunologic Factors|immunologic factors|mesh-ancestor
19948006|NCT01546038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948007|NCT01546038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948008|NCT01546038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19948009|NCT01546038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19948010|NCT01546038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19948011|NCT01546142|Deoxycholic Acid|deoxycholic acid|mesh-list
19948012|NCT01546142|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19948013|NCT01546142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19948014|NCT01546402|Dexamethasone|dexamethasone|mesh-list
19948015|NCT01546402|Dexamethasone acetate|dexamethasone acetate|mesh-list
19948016|NCT01546402|BB 1101|bb 1101|mesh-list
19948017|NCT01546402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19948018|NCT01546402|Antiemetics|antiemetics|mesh-ancestor
19948019|NCT01546402|Autonomic Agents|autonomic agents|mesh-ancestor
19948020|NCT01546402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19948021|NCT01546402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948022|NCT01546402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19948023|NCT01546402|Glucocorticoids|glucocorticoids|mesh-ancestor
19948024|NCT01546402|Hormones|hormones|mesh-ancestor
19948025|NCT01546402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19948026|NCT01546402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19948027|NCT01546402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948028|NCT01546402|Protease Inhibitors|protease inhibitors|mesh-ancestor
19948029|NCT01546402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948030|NCT01546402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948031|NCT01546454|Leuprolide|leuprolide|mesh-list
19948032|NCT01546454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19948033|NCT01546454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19948034|NCT01546454|Levonorgestrel|levonorgestrel|mesh-list
19948035|NCT01546454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19948036|NCT01546454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19948037|NCT01546454|Estradiol|estradiol|mesh-list
19948038|NCT01546454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20268705|NCT00531674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268706|NCT00531674|Protective Agents|protective agents|mesh-ancestor
20268707|NCT00531674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268708|NCT00531674|Vitamins|vitamins|mesh-ancestor
20268709|NCT00531674|Micronutrients|micronutrients|mesh-ancestor
20268710|NCT00531687|Gemcitabine|gemcitabine|mesh-list
20268711|NCT00531687|Paclitaxel|paclitaxel|mesh-list
20268712|NCT00531687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20268713|NCT00531687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268714|NCT00531687|Tubulin Modulators|tubulin modulators|mesh-ancestor
20268715|NCT00531687|Antimitotic Agents|antimitotic agents|mesh-ancestor
20268716|NCT00531687|Mitosis Modulators|mitosis modulators|mesh-ancestor
20268717|NCT00531687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268718|NCT00531687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19948039|NCT01546454|Progesterone|progesterone|mesh-list
19948040|NCT01546454|Estrogens|estrogens|mesh-ancestor
19948041|NCT01546454|Hormones|hormones|mesh-ancestor
19948042|NCT01546454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19948043|NCT01546454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268719|NCT00531687|Antimetabolites|antimetabolites|mesh-ancestor
19948044|NCT01546454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19948045|NCT01546454|Contraceptive Agents|contraceptive agents|mesh-ancestor
19948046|NCT01546454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19948047|NCT01546454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19948048|NCT01546454|Progestins|progestins|mesh-ancestor
19948049|NCT01546454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19948050|NCT01546454|Fertility Agents|fertility agents|mesh-ancestor
19948051|NCT01546454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19948052|NCT01546454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948053|NCT01546454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19948054|NCT01546454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19948055|NCT01546454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19948056|NCT01546454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19948057|NCT01546623|Leuprolide|leuprolide|mesh-list
19948058|NCT01546623|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19948059|NCT01546623|Fertility Agents|fertility agents|mesh-ancestor
19948060|NCT01546623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19948061|NCT01546623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948062|NCT01546623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19948063|NCT01546623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948064|NCT01546649|Leuprolide|leuprolide|mesh-list
19948065|NCT01546649|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19948066|NCT01546649|Fertility Agents|fertility agents|mesh-ancestor
19948067|NCT01546649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19948068|NCT01546649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948069|NCT01546649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19948070|NCT01546649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948071|NCT01546688|Zonisamide|zonisamide|mesh-list
19948072|NCT01546688|Anticonvulsants|anticonvulsants|mesh-ancestor
19948073|NCT01546688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19948074|NCT01546688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19948075|NCT01546688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948076|NCT01546688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19948077|NCT01546688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948078|NCT01546857|Gabapentin|gabapentin|mesh-list
19948079|NCT01546857|Analgesics|analgesics|mesh-ancestor
19948080|NCT01546857|Sensory System Agents|sensory system agents|mesh-ancestor
19948081|NCT01546857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19948082|NCT01546857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948083|NCT01546857|Anticonvulsants|anticonvulsants|mesh-ancestor
19948084|NCT01546857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19948085|NCT01546857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19948086|NCT01546857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19948087|NCT01546857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19948088|NCT01546857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19948089|NCT01546857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19948090|NCT01546857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19948091|NCT01546857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948092|NCT01546857|Antimanic Agents|antimanic agents|mesh-ancestor
19948093|NCT01546922|Hydrocortisone|hydrocortisone|mesh-list
19948094|NCT01546922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19948095|NCT01547000|Guanfacine|guanfacine|mesh-list
19948096|NCT01547000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19948097|NCT01547000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19948098|NCT01547000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19948099|NCT01547000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19948100|NCT01547000|Adrenergic Agents|adrenergic agents|mesh-ancestor
19948101|NCT01547000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19948102|NCT01547000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948103|NCT01547000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948104|NCT01547286|Methacholine Chloride|methacholine chloride|mesh-list
19948105|NCT01547286|Miotics|miotics|mesh-ancestor
19948106|NCT01547286|Autonomic Agents|autonomic agents|mesh-ancestor
19948107|NCT01547286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19948108|NCT01547286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948109|NCT01547286|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19948110|NCT01547286|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
19948111|NCT01547286|Respiratory System Agents|respiratory system agents|mesh-ancestor
19948112|NCT01547286|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19948113|NCT01547286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20268720|NCT00531687|Antiviral Agents|antiviral agents|mesh-ancestor
19948114|NCT01547286|Cholinergic Agents|cholinergic agents|mesh-ancestor
19948115|NCT01547286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19948116|NCT01547286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948117|NCT01547299|Leuprolide|leuprolide|mesh-list
19948118|NCT01547299|Dutasteride|dutasteride|mesh-list
19948119|NCT01547299|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19948120|NCT01547299|Fertility Agents|fertility agents|mesh-ancestor
19948121|NCT01547299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19948122|NCT01547299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948123|NCT01547299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19948124|NCT01547299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948125|NCT01547299|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19948126|NCT01547299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19948127|NCT01547299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948128|NCT01547299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948129|NCT01547299|Hormone Antagonists|hormone antagonists|mesh-ancestor
19948130|NCT01547299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19948131|NCT01547390|Aspirin|aspirin|mesh-list
19948132|NCT01547390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19948133|NCT01547390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19948134|NCT01547390|Analgesics|analgesics|mesh-ancestor
19948135|NCT01547390|Sensory System Agents|sensory system agents|mesh-ancestor
19948136|NCT01547390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19948137|NCT01547390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948138|NCT01547390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19948139|NCT01547390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19948140|NCT01547390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19948141|NCT01547390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19948142|NCT01547390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948143|NCT01547390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19948144|NCT01547390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19948145|NCT01547390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948146|NCT01547390|Antipyretics|antipyretics|mesh-ancestor
19948147|NCT01547598|Timolol|timolol|mesh-list
19948148|NCT01547598|Bimatoprost|bimatoprost|mesh-list
19948149|NCT01547598|Travoprost|travoprost|mesh-list
19948150|NCT01547598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19948151|NCT01547598|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19948152|NCT01547598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19948153|NCT01547598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19948154|NCT01547598|Adrenergic Agents|adrenergic agents|mesh-ancestor
19948155|NCT01547598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19948156|NCT01547598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948157|NCT01547598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948158|NCT01547598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19948159|NCT01547598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19974171|NCT01833455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19974172|NCT01833455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19974173|NCT01833455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19974174|NCT01833455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19974175|NCT01833455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974176|NCT01833533|Ribavirin|ribavirin|mesh-list
19974177|NCT01833533|Antimetabolites|antimetabolites|mesh-ancestor
19974178|NCT01833533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974179|NCT01833533|Antiviral Agents|antiviral agents|mesh-ancestor
19974180|NCT01833533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19974181|NCT01833546|Gemcitabine|gemcitabine|mesh-list
19974182|NCT01833546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19974183|NCT01833546|Antimetabolites|antimetabolites|mesh-ancestor
19974184|NCT01833546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974185|NCT01833546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974186|NCT01833546|Antiviral Agents|antiviral agents|mesh-ancestor
19974187|NCT01833546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19974188|NCT01833546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974189|NCT01833546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19974190|NCT01833546|Immunologic Factors|immunologic factors|mesh-ancestor
19974191|NCT01833546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974192|NCT01833741|Bimatoprost|bimatoprost|mesh-list
19974193|NCT01833741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19974194|NCT01833832|Sodium thiosulfate|sodium thiosulfate|mesh-list
19974195|NCT01833832|Antidotes|antidotes|mesh-ancestor
19974196|NCT01833832|Protective Agents|protective agents|mesh-ancestor
19974197|NCT01833832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974198|NCT01833832|Antioxidants|antioxidants|mesh-ancestor
19974199|NCT01833832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974200|NCT01833832|Antitubercular Agents|antitubercular agents|mesh-ancestor
19974201|NCT01833832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19948160|NCT01547806|Plerixafor|plerixafor|mesh-list
19948161|NCT01547806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19948162|NCT01547806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19948163|NCT01547806|Antiviral Agents|antiviral agents|mesh-ancestor
19948164|NCT01547806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19948165|NCT01548417|Mifepristone|mifepristone|mesh-list
19948166|NCT01548417|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19948167|NCT01548417|Abortifacient Agents|abortifacient agents|mesh-ancestor
19948168|NCT01548417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19948169|NCT01548417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948170|NCT01548417|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19948171|NCT01548417|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19948172|NCT01548417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19948173|NCT01548417|Contraceptive Agents|contraceptive agents|mesh-ancestor
19948174|NCT01548417|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19948175|NCT01548417|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19948176|NCT01548417|Hormone Antagonists|hormone antagonists|mesh-ancestor
19948177|NCT01548417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20268721|NCT00531687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268722|NCT00531687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268723|NCT00531687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20268724|NCT00531687|Immunologic Factors|immunologic factors|mesh-ancestor
20268725|NCT00531687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268726|NCT00531791|Prednisone|prednisone|mesh-list
20268727|NCT00531791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20268728|NCT00531791|Glucocorticoids|glucocorticoids|mesh-ancestor
20268729|NCT00531791|Hormones|hormones|mesh-ancestor
20268730|NCT00531791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20543421|NCT01870011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20543422|NCT01870024|Fosphenytoin|fosphenytoin|mesh-list
20543423|NCT01870024|Lorazepam|lorazepam|mesh-list
20543424|NCT01870024|Clonazepam|clonazepam|mesh-list
20543425|NCT01870024|Anticonvulsants|anticonvulsants|mesh-ancestor
20543426|NCT01870024|Antiemetics|antiemetics|mesh-ancestor
20543427|NCT01870024|Autonomic Agents|autonomic agents|mesh-ancestor
20543428|NCT01870024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543429|NCT01870024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543430|NCT01870024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20543431|NCT01870024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20543432|NCT01870024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20543433|NCT01870024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20543434|NCT01870024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20543435|NCT01870024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20543436|NCT01870024|GABA Modulators|gaba modulators|mesh-ancestor
20543437|NCT01870024|GABA Agents|gaba agents|mesh-ancestor
20543438|NCT01870024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20543439|NCT01870024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543440|NCT01870024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20543441|NCT01870024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20543442|NCT01870050|Dapsone|dapsone|mesh-list
20543443|NCT01870050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20543444|NCT01870050|Antimalarials|antimalarials|mesh-ancestor
20543445|NCT01870050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20543446|NCT01870050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20543447|NCT01870050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20543448|NCT01870050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543449|NCT01870050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543450|NCT01870050|Leprostatic Agents|leprostatic agents|mesh-ancestor
20543451|NCT01870050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20543452|NCT01870115|Vitamin D|vitamin d|mesh-list
20543453|NCT01870115|Cholecalciferol|cholecalciferol|mesh-list
20543454|NCT01870115|Melatonin|melatonin|mesh-list
20543455|NCT01870115|Vitamins|vitamins|mesh-ancestor
20543456|NCT01870115|Micronutrients|micronutrients|mesh-ancestor
20543457|NCT01870115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543458|NCT01870115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20543459|NCT01870115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543460|NCT01870115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20543461|NCT01870115|Antioxidants|antioxidants|mesh-ancestor
20543462|NCT01870115|Protective Agents|protective agents|mesh-ancestor
20543463|NCT01870115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19948178|NCT01548417|Luteolytic Agents|luteolytic agents|mesh-ancestor
20543464|NCT01870128|Hydroxychloroquine|hydroxychloroquine|mesh-list
20543465|NCT01870128|Sulfasalazine|sulfasalazine|mesh-list
20543466|NCT01870128|Methylprednisolone|methylprednisolone|mesh-list
20543467|NCT01870128|Methotrexate|methotrexate|mesh-list
19948179|NCT01548417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19948180|NCT01548417|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19948181|NCT01548573|Thalidomide|thalidomide|mesh-list
19948182|NCT01548573|Dexamethasone|dexamethasone|mesh-list
19948183|NCT01548573|Cyclophosphamide|cyclophosphamide|mesh-list
19948184|NCT01548573|Melphalan|melphalan|mesh-list
19948185|NCT01548573|Doxorubicin|doxorubicin|mesh-list
19948186|NCT01548573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19948187|NCT01548573|Etoposide|etoposide|mesh-list
19948188|NCT01548573|Bortezomib|bortezomib|mesh-list
19948189|NCT01548573|Etoposide phosphate|etoposide phosphate|mesh-list
19948190|NCT01548573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19948191|NCT01548573|Immunologic Factors|immunologic factors|mesh-ancestor
19948192|NCT01548573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948193|NCT01548573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19948194|NCT01548573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19948195|NCT01548573|Alkylating Agents|alkylating agents|mesh-ancestor
19948196|NCT01548573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948197|NCT01548573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948198|NCT01548573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19948199|NCT01548573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19948200|NCT01548573|Antiemetics|antiemetics|mesh-ancestor
19948201|NCT01548573|Autonomic Agents|autonomic agents|mesh-ancestor
19948202|NCT01548573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19948203|NCT01548573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19948204|NCT01548573|Glucocorticoids|glucocorticoids|mesh-ancestor
19948205|NCT01548573|Hormones|hormones|mesh-ancestor
19948206|NCT01548573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19948207|NCT01548573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19948208|NCT01548573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19948209|NCT01548573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19948210|NCT01548573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19948211|NCT01548573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948212|NCT01548573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19948213|NCT01548573|Leprostatic Agents|leprostatic agents|mesh-ancestor
19948214|NCT01548573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19948215|NCT01548573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19948216|NCT01548573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19948217|NCT01548573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19948218|NCT01548573|Growth Substances|growth substances|mesh-ancestor
19948219|NCT01548573|Growth Inhibitors|growth inhibitors|mesh-ancestor
19948220|NCT01548638|Galantamine|galantamine|mesh-list
19948221|NCT01548638|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19948222|NCT01548638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948223|NCT01548638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948224|NCT01548638|Cholinergic Agents|cholinergic agents|mesh-ancestor
19948225|NCT01548638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19948226|NCT01548638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948227|NCT01548638|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19948228|NCT01548638|Autonomic Agents|autonomic agents|mesh-ancestor
19948229|NCT01548638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19948230|NCT01548638|Nootropic Agents|nootropic agents|mesh-ancestor
19948231|NCT01548690|Phenylacetic acid|phenylacetic acid|mesh-list
19948232|NCT01548690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19948233|NCT01548690|Antimetabolites|antimetabolites|mesh-ancestor
19948234|NCT01548690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948235|NCT01548690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948236|NCT01548768|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
19948237|NCT01548768|Antirheumatic Agents|antirheumatic agents|mesh-list
19948238|NCT01548768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19948239|NCT01549002|Fentanyl|fentanyl|mesh-list
19948240|NCT01549002|Morphine|morphine|mesh-list
19948241|NCT01549002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19948242|NCT01549002|Narcotics|narcotics|mesh-ancestor
19948243|NCT01549002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19948244|NCT01549002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948245|NCT01549002|Analgesics|analgesics|mesh-ancestor
19948246|NCT01549002|Sensory System Agents|sensory system agents|mesh-ancestor
19948247|NCT01549002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19948248|NCT01549002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19948249|NCT01549002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19948250|NCT01549002|Anesthetics, General|anesthetics, general|mesh-ancestor
19948251|NCT01549002|Anesthetics|anesthetics|mesh-ancestor
19948252|NCT01549041|Asenapine|asenapine|mesh-list
19948253|NCT01549041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19948254|NCT01549041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19948255|NCT01549041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19948256|NCT01549041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268731|NCT00531791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268732|NCT00531791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20268733|NCT00531791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268734|NCT00531856|Carbon Monoxide|carbon monoxide|mesh-list
20268735|NCT00531856|Antimetabolites|antimetabolites|mesh-ancestor
20268736|NCT00531856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948257|NCT01549041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19948258|NCT01549223|Misoprostol|misoprostol|mesh-list
19948259|NCT01549223|Oxytocin|oxytocin|mesh-list
19948260|NCT01549223|Methylergonovine|methylergonovine|mesh-list
19948261|NCT01549223|Carboprost tromethamine|carboprost tromethamine|mesh-list
19948262|NCT01549223|Carboprost|carboprost|mesh-list
19948263|NCT01549223|Maleic acid|maleic acid|mesh-list
19948264|NCT01549223|Oxytocics|oxytocics|mesh-ancestor
20268737|NCT00531856|Gasotransmitters|gasotransmitters|mesh-ancestor
20268738|NCT00531856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20268739|NCT00531856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268740|NCT00531895|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20268741|NCT00531895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19948265|NCT01549223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19948266|NCT01549223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948267|NCT01549223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19948268|NCT01549223|Abortifacient Agents|abortifacient agents|mesh-ancestor
19948269|NCT01549223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19948270|NCT01549223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19948271|NCT01549223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268742|NCT00531895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20268743|NCT00531895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20268744|NCT00531895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268745|NCT00531895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20268746|NCT00531895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948272|NCT01549223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948273|NCT01549587|Listerine|listerine|mesh-list
19948274|NCT01549587|Cetylpyridinium|cetylpyridinium|mesh-list
19948275|NCT01549587|Fluorides|fluorides|mesh-list
19948276|NCT01549587|Sodium Fluoride|sodium fluoride|mesh-list
19948277|NCT01549587|Tin Fluorides|tin fluorides|mesh-list
19948278|NCT01549587|Cariostatic Agents|cariostatic agents|mesh-ancestor
19948279|NCT01549587|Protective Agents|protective agents|mesh-ancestor
19948280|NCT01549587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948281|NCT01549587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19948282|NCT01549587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20543468|NCT01870128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20543469|NCT01870128|Abortifacient Agents|abortifacient agents|mesh-ancestor
20543470|NCT01870128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20543471|NCT01870128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543472|NCT01870128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20543473|NCT01870128|Antimetabolites|antimetabolites|mesh-ancestor
20543474|NCT01870128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543475|NCT01870128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543476|NCT01870128|Dermatologic Agents|dermatologic agents|mesh-ancestor
20543477|NCT01870128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543478|NCT01870128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20543479|NCT01870128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20543480|NCT01870128|Immunologic Factors|immunologic factors|mesh-ancestor
20543481|NCT01870128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20543482|NCT01870128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20543483|NCT01870128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20543484|NCT01870128|Antiemetics|antiemetics|mesh-ancestor
20543485|NCT01870128|Autonomic Agents|autonomic agents|mesh-ancestor
20543486|NCT01870128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543487|NCT01870128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19948283|NCT01549613|Vancomycin|vancomycin|mesh-list
19948284|NCT01549613|Daptomycin|daptomycin|mesh-list
19948285|NCT01549613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19948286|NCT01549613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19948287|NCT01549652|Morphine|morphine|mesh-list
19948288|NCT01549652|Ondansetron|ondansetron|mesh-list
19948289|NCT01549652|Naloxone|naloxone|mesh-list
19948290|NCT01549652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19948291|NCT01549652|Narcotics|narcotics|mesh-ancestor
19948292|NCT01549652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19948293|NCT01549652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948294|NCT01549652|Analgesics|analgesics|mesh-ancestor
19948295|NCT01549652|Sensory System Agents|sensory system agents|mesh-ancestor
19948296|NCT01549652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19948297|NCT01549652|Antiemetics|antiemetics|mesh-ancestor
19948298|NCT01549652|Autonomic Agents|autonomic agents|mesh-ancestor
19948299|NCT01549652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19948300|NCT01549652|Antipruritics|antipruritics|mesh-ancestor
19948301|NCT01549652|Dermatologic Agents|dermatologic agents|mesh-ancestor
19948302|NCT01549652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19948303|NCT01549652|Serotonin Agents|serotonin agents|mesh-ancestor
19948304|NCT01549652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19948305|NCT01549652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948306|NCT01549652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19948307|NCT01549652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19948308|NCT01549652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19948309|NCT01549652|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19948310|NCT01549652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19948311|NCT01549873|Propofol|propofol|mesh-list
19948312|NCT01549873|Desflurane|desflurane|mesh-list
19948313|NCT01549873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19948314|NCT01549873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19948315|NCT01549873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948316|NCT01549873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19948317|NCT01549873|Anesthetics, General|anesthetics, general|mesh-ancestor
19948318|NCT01549873|Anesthetics|anesthetics|mesh-ancestor
19948319|NCT01549873|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19948320|NCT01549886|Rituximab|rituximab|mesh-list
19948321|NCT01549886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19948322|NCT01549886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948323|NCT01549886|Immunologic Factors|immunologic factors|mesh-ancestor
19948324|NCT01549886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948325|NCT01549886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19948326|NCT01549951|Prednisone|prednisone|mesh-list
19948327|NCT01549951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19948328|NCT01549951|Glucocorticoids|glucocorticoids|mesh-ancestor
19948329|NCT01549951|Hormones|hormones|mesh-ancestor
19948330|NCT01549951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19948331|NCT01549951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948332|NCT01549951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19948333|NCT01549951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948334|NCT01549964|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19948335|NCT01549964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19948336|NCT01549964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948337|NCT01549964|Incretins|incretins|mesh-ancestor
19948338|NCT01549964|Hormones|hormones|mesh-ancestor
19948339|NCT01549964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19948340|NCT01549964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19948341|NCT01549964|Protease Inhibitors|protease inhibitors|mesh-ancestor
19948342|NCT01549964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948343|NCT01549964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948344|NCT01550224|Temozolomide|temozolomide|mesh-list
19948345|NCT01550224|Vorinostat|vorinostat|mesh-list
19948346|NCT01550224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19948347|NCT01550224|Alkylating Agents|alkylating agents|mesh-ancestor
19948348|NCT01550224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948349|NCT01550224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948350|NCT01550224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19948351|NCT01550224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948352|NCT01550341|Buprenorphine|buprenorphine|mesh-list
19948353|NCT01550341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19948354|NCT01550341|Naloxone|naloxone|mesh-list
19948355|NCT01550341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19948356|NCT01550341|Narcotics|narcotics|mesh-ancestor
19948357|NCT01550341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19948358|NCT01550341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948359|NCT01550341|Analgesics|analgesics|mesh-ancestor
19948360|NCT01550341|Sensory System Agents|sensory system agents|mesh-ancestor
19948361|NCT01550341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19948362|NCT01550341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19948363|NCT01550367|Hydroxychloroquine|hydroxychloroquine|mesh-list
19948364|NCT01550367|Aldesleukin|aldesleukin|mesh-list
19948365|NCT01550367|Antimalarials|antimalarials|mesh-ancestor
19948366|NCT01550367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19948367|NCT01550367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19948368|NCT01550367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19948369|NCT01550367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948370|NCT01550367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948371|NCT01550367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19948372|NCT01550367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948373|NCT01550367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19948374|NCT01550367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19948375|NCT01550367|Antiviral Agents|antiviral agents|mesh-ancestor
19948376|NCT01550471|Ciclesonide|ciclesonide|mesh-list
19948377|NCT01550471|Beclomethasone|beclomethasone|mesh-list
19948378|NCT01550471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19948379|NCT01550471|Glucocorticoids|glucocorticoids|mesh-ancestor
19948380|NCT01550471|Hormones|hormones|mesh-ancestor
19948381|NCT01550471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19948382|NCT01550471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948383|NCT01550471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19948384|NCT01550471|Respiratory System Agents|respiratory system agents|mesh-ancestor
19948385|NCT01550471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19948386|NCT01550705|Isoniazid|isoniazid|mesh-list
19948387|NCT01550705|Antitubercular Agents|antitubercular agents|mesh-ancestor
19948388|NCT01550705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19948389|NCT01550705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19948390|NCT01550705|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19948391|NCT01550705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19948392|NCT01550705|Antimetabolites|antimetabolites|mesh-ancestor
19948393|NCT01550705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948394|NCT01550705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19948395|NCT01550744|Ustekinumab|ustekinumab|mesh-list
19948396|NCT01550744|Dermatologic Agents|dermatologic agents|mesh-ancestor
19948397|NCT01550965|Adalimumab|adalimumab|mesh-list
19948398|NCT01550965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19948399|NCT01550965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19948400|NCT01551056|Cetirizine|cetirizine|mesh-list
19948401|NCT01551056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19948402|NCT01551056|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19948403|NCT01551056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19948404|NCT01551056|Histamine Antagonists|histamine antagonists|mesh-ancestor
19948405|NCT01551056|Histamine Agents|histamine agents|mesh-ancestor
19948406|NCT01551056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19948407|NCT01551056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948408|NCT01551056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948409|NCT01551212|Everolimus|everolimus|mesh-list
19948410|NCT01551212|Tacrolimus|tacrolimus|mesh-list
19948411|NCT01551212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19948412|NCT01551212|Immunologic Factors|immunologic factors|mesh-ancestor
19948413|NCT01551212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948414|NCT01551212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19948415|NCT01551212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948416|NCT01551212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948417|NCT01551212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948418|NCT01551303|Oxytocin|oxytocin|mesh-list
19948419|NCT01551303|Oxytocics|oxytocics|mesh-ancestor
19948420|NCT01551303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19948421|NCT01551303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948422|NCT01551745|Bevacizumab|bevacizumab|mesh-list
19948423|NCT01551745|Vaccines|vaccines|mesh-list
19948424|NCT01551745|Immunologic Factors|immunologic factors|mesh-ancestor
19948425|NCT01551745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948426|NCT01551745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19948427|NCT01551745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948428|NCT01551745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19948429|NCT01551745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19948430|NCT01551745|Growth Substances|growth substances|mesh-ancestor
19948431|NCT01551745|Growth Inhibitors|growth inhibitors|mesh-ancestor
19948432|NCT01551888|Formoterol Fumarate|formoterol fumarate|mesh-list
19948433|NCT01551888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19948434|NCT01551888|Autonomic Agents|autonomic agents|mesh-ancestor
19948435|NCT01551888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19948436|NCT01551888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948437|NCT01551888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19948438|NCT01551888|Respiratory System Agents|respiratory system agents|mesh-ancestor
19948439|NCT01551888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19948440|NCT01551888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19948441|NCT01551888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19948442|NCT01551888|Adrenergic Agents|adrenergic agents|mesh-ancestor
19948443|NCT01551888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19974202|NCT01833832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19948444|NCT01551888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948445|NCT01552057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19948446|NCT01552057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19948447|NCT01552057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19948448|NCT01552057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19948449|NCT01552057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948450|NCT01552057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19948451|NCT01552057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948452|NCT01552057|Analgesics|analgesics|mesh-ancestor
19948453|NCT01552057|Sensory System Agents|sensory system agents|mesh-ancestor
19948454|NCT01552057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19948455|NCT01552057|Antidepressive Agents|antidepressive agents|mesh-ancestor
19948456|NCT01552057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19948457|NCT01552057|Dopamine Agents|dopamine agents|mesh-ancestor
19948458|NCT01552343|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19948459|NCT01552343|Hemostatics|hemostatics|mesh-ancestor
19948460|NCT01552343|Coagulants|coagulants|mesh-ancestor
19948461|NCT01552343|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19948462|NCT01552343|Natriuretic Agents|natriuretic agents|mesh-ancestor
19948463|NCT01552343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948464|NCT01552369|Valganciclovir|valganciclovir|mesh-list
19948465|NCT01552369|Antiviral Agents|antiviral agents|mesh-ancestor
19948466|NCT01552369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19948467|NCT01552408|Ranibizumab|ranibizumab|mesh-list
19948468|NCT01552408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19948469|NCT01552408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19948470|NCT01552408|Growth Substances|growth substances|mesh-ancestor
19948471|NCT01552408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948472|NCT01552408|Growth Inhibitors|growth inhibitors|mesh-ancestor
19948473|NCT01552408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948474|NCT01552603|Pancrelipase|pancrelipase|mesh-list
19948475|NCT01552603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19948476|NCT01552681|Immunoglobulins|immunoglobulins|mesh-list
19948477|NCT01552681|Immunologic Factors|immunologic factors|mesh-ancestor
19948478|NCT01552681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948479|NCT01552694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19948480|NCT01552694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19948481|NCT01552694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948482|NCT01552694|Incretins|incretins|mesh-ancestor
19948483|NCT01552694|Hormones|hormones|mesh-ancestor
19948484|NCT01552694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19948485|NCT01552694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19948486|NCT01552694|Protease Inhibitors|protease inhibitors|mesh-ancestor
19948487|NCT01552694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948488|NCT01552694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948489|NCT01552772|Aripiprazole|aripiprazole|mesh-list
19948490|NCT01552772|Antidepressive Agents|antidepressive agents|mesh-ancestor
19948491|NCT01552772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19948492|NCT01552772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19948493|NCT01552772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19948494|NCT01552772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19948495|NCT01552772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948496|NCT01552772|Dopamine Agonists|dopamine agonists|mesh-ancestor
19948497|NCT01552772|Dopamine Agents|dopamine agents|mesh-ancestor
19948498|NCT01552772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19948499|NCT01552772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948500|NCT01552772|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19948501|NCT01552772|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19948502|NCT01552772|Serotonin Agents|serotonin agents|mesh-ancestor
19948503|NCT01552772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19948504|NCT01552772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19948505|NCT01552772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19948506|NCT01552772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19948507|NCT01552902|Methylphenidate|methylphenidate|mesh-list
19948508|NCT01552902|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19948509|NCT01552902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19948510|NCT01552902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948511|NCT01552902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19948512|NCT01552902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19948513|NCT01552902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19948514|NCT01552902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948515|NCT01552902|Dopamine Agents|dopamine agents|mesh-ancestor
19948516|NCT01552902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19948517|NCT01552915|Methylphenidate|methylphenidate|mesh-list
19948518|NCT01552915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19948519|NCT01552915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19948520|NCT01552915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948521|NCT01552915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19948522|NCT01552915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19948523|NCT01552915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19948524|NCT01552915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948525|NCT01552915|Dopamine Agents|dopamine agents|mesh-ancestor
19948526|NCT01552915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19948527|NCT01552928|Moxifloxacin|moxifloxacin|mesh-list
19948528|NCT01552928|Anagrelide|anagrelide|mesh-list
19948529|NCT01552928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20268747|NCT00531895|Analgesics|analgesics|mesh-ancestor
20268748|NCT00531895|Sensory System Agents|sensory system agents|mesh-ancestor
20268749|NCT00531895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20268750|NCT00531895|Antidepressive Agents|antidepressive agents|mesh-ancestor
20268751|NCT00531895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20268752|NCT00531895|Dopamine Agents|dopamine agents|mesh-ancestor
20268753|NCT00531908|Furosemide|furosemide|mesh-list
20268754|NCT00531908|Diuretics|diuretics|mesh-ancestor
20268755|NCT00531908|Natriuretic Agents|natriuretic agents|mesh-ancestor
20268756|NCT00531908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268757|NCT00531908|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20268758|NCT00531908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20268759|NCT00531908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268760|NCT00531973|Doxorubicin|doxorubicin|mesh-list
20268761|NCT00531973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20268762|NCT00531973|Epirubicin|epirubicin|mesh-list
20268763|NCT00531973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20268764|NCT00531973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268765|NCT00531973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20268766|NCT00531973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20268767|NCT00531973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268768|NCT00531973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268769|NCT00531986|Lopinavir|lopinavir|mesh-list
20268770|NCT00531986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20268771|NCT00531986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20268772|NCT00531986|Protease Inhibitors|protease inhibitors|mesh-ancestor
20268773|NCT00531986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268774|NCT00531986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268775|NCT00531986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20268776|NCT00531986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20268777|NCT00531986|Antiviral Agents|antiviral agents|mesh-ancestor
20268778|NCT00531986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268779|NCT00531986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20268780|NCT00531986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20268781|NCT00531999|Ritonavir|ritonavir|mesh-list
20268782|NCT00531999|Lopinavir|lopinavir|mesh-list
20268783|NCT00531999|Raltegravir Potassium|raltegravir potassium|mesh-list
20268784|NCT00531999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20268785|NCT00531999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19948530|NCT01552928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19948531|NCT01552928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19948532|NCT01552928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19948533|NCT01552928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948534|NCT01552928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948535|NCT01552928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948536|NCT01552928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19948537|NCT01552928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19948538|NCT01552928|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19948539|NCT01552954|Angiotensin II|angiotensin ii|mesh-list
19948540|NCT01552954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19948541|NCT01553058|Adalimumab|adalimumab|mesh-list
19948542|NCT01553058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19948543|NCT01553058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19948544|NCT01553084|Nicotine|nicotine|mesh-list
19948545|NCT01553084|Varenicline|varenicline|mesh-list
19948546|NCT01553084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19948547|NCT01553084|Autonomic Agents|autonomic agents|mesh-ancestor
19948548|NCT01553084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19948549|NCT01553084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268786|NCT00531999|Protease Inhibitors|protease inhibitors|mesh-ancestor
20268787|NCT00531999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948550|NCT01553084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19450265|NCT03429998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19450266|NCT03429998|Immunologic Factors|immunologic factors|mesh-ancestor
19450267|NCT03429998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450268|NCT03429972|Paclitaxel|paclitaxel|mesh-list
19450269|NCT03429972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19450270|NCT03429972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450271|NCT03429972|Tubulin Modulators|tubulin modulators|mesh-ancestor
19450272|NCT03429972|Antimitotic Agents|antimitotic agents|mesh-ancestor
19450273|NCT03429972|Mitosis Modulators|mitosis modulators|mesh-ancestor
19450274|NCT03429972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450275|NCT03429946|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19450276|NCT03429946|Spironolactone|spironolactone|mesh-list
19450277|NCT03429946|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19450278|NCT03429946|Hormone Antagonists|hormone antagonists|mesh-ancestor
19948551|NCT01553084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19948552|NCT01553084|Cholinergic Agents|cholinergic agents|mesh-ancestor
19948553|NCT01553084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19948554|NCT01553084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948555|NCT01553136|Varenicline|varenicline|mesh-list
19948556|NCT01553136|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19948557|NCT01553136|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19948558|NCT01553136|Cholinergic Agents|cholinergic agents|mesh-ancestor
19948559|NCT01553136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19948560|NCT01553136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948561|NCT01553136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948562|NCT01553188|Prednisone|prednisone|mesh-list
19948563|NCT01553188|Trebananib|trebananib|mesh-list
19948564|NCT01553188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19948565|NCT01553188|Glucocorticoids|glucocorticoids|mesh-ancestor
19948566|NCT01553188|Hormones|hormones|mesh-ancestor
19948567|NCT01553188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19948568|NCT01553188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948569|NCT01553188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19948570|NCT01553188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948571|NCT01553188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19948572|NCT01553188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19948573|NCT01553188|Growth Substances|growth substances|mesh-ancestor
19948574|NCT01553188|Growth Inhibitors|growth inhibitors|mesh-ancestor
19948575|NCT01553201|Botulinum Toxins|botulinum toxins|mesh-list
19948576|NCT01553201|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19948577|NCT01553201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19948578|NCT01553201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948579|NCT01553201|Cholinergic Agents|cholinergic agents|mesh-ancestor
19948580|NCT01553201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19948581|NCT01553201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948582|NCT01553279|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20268788|NCT00531999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268789|NCT00531999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20268790|NCT00531999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20268791|NCT00531999|Antiviral Agents|antiviral agents|mesh-ancestor
20268792|NCT00531999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268793|NCT00531999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20268794|NCT00531999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20268795|NCT00531999|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20268796|NCT00531999|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20268797|NCT05319912|Molybdenum|molybdenum|mesh-list
20268798|NCT05319912|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
20268799|NCT05319912|Choline|choline|mesh-list
20268800|NCT05319912|Omeprazole|omeprazole|mesh-list
20268801|NCT05319912|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20268802|NCT05319912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20268803|NCT05319912|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20268804|NCT05319912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268805|NCT05319912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268806|NCT05319912|Lipotropic Agents|lipotropic agents|mesh-ancestor
20268807|NCT05319912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20268808|NCT05319912|Antimetabolites|antimetabolites|mesh-ancestor
20268809|NCT05319912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20268810|NCT05319912|Nootropic Agents|nootropic agents|mesh-ancestor
20268811|NCT05319912|Chelating Agents|chelating agents|mesh-ancestor
20268812|NCT05319912|Sequestering Agents|sequestering agents|mesh-ancestor
20268813|NCT05319912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20268814|NCT05319912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19948583|NCT01553279|Immunologic Factors|immunologic factors|mesh-ancestor
19948584|NCT01553279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948585|NCT01553292|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19948586|NCT01553292|Respiratory System Agents|respiratory system agents|mesh-ancestor
19948587|NCT01553318|Ketotifen|ketotifen|mesh-list
19948588|NCT01553318|Antipruritics|antipruritics|mesh-ancestor
19948589|NCT01553318|Dermatologic Agents|dermatologic agents|mesh-ancestor
19948590|NCT01553318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19948591|NCT01553318|Histamine Antagonists|histamine antagonists|mesh-ancestor
19948592|NCT01553318|Histamine Agents|histamine agents|mesh-ancestor
19948593|NCT01553318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19948594|NCT01553318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948595|NCT01553318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948596|NCT01553318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19948597|NCT01553539|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
19948598|NCT01553539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19948599|NCT01553539|Vasodilator Agents|vasodilator agents|mesh-ancestor
19948600|NCT01553591|Eluxadoline|eluxadoline|mesh-list
19948601|NCT01553591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19948602|NCT01553708|Sulfadiazine|sulfadiazine|mesh-list
19948603|NCT01553708|Silver Sulfadiazine|silver sulfadiazine|mesh-list
19948604|NCT01553708|Mitogens|mitogens|mesh-list
19948605|NCT01553708|Mitosis Modulators|mitosis modulators|mesh-ancestor
19948606|NCT01553708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948607|NCT01553708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19948608|NCT01553708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19948609|NCT01553708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19948610|NCT01553708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19948611|NCT01553708|Coccidiostats|coccidiostats|mesh-ancestor
19948612|NCT01553708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19948613|NCT01553747|Eluxadoline|eluxadoline|mesh-list
19948614|NCT01553747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19948615|NCT01553851|Trametinib|trametinib|mesh-list
19948616|NCT01553851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948617|NCT01553851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19948618|NCT01553851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948619|NCT01553851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948620|NCT01553916|Lithium Carbonate|lithium carbonate|mesh-list
19948621|NCT01553916|Antidepressive Agents|antidepressive agents|mesh-ancestor
19948622|NCT01553916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19948623|NCT01553916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948624|NCT01553916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948625|NCT01553916|Antimanic Agents|antimanic agents|mesh-ancestor
19948626|NCT01553916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19948627|NCT01553916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19948628|NCT01553916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948629|NCT01554241|Vitamin D|vitamin d|mesh-list
19948630|NCT01554241|Cholecalciferol|cholecalciferol|mesh-list
19948631|NCT01554241|Vitamins|vitamins|mesh-ancestor
19948632|NCT01554241|Micronutrients|micronutrients|mesh-ancestor
19948633|NCT01554241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948634|NCT01554241|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19948635|NCT01554241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19948636|NCT01554371|Cyclophosphamide|cyclophosphamide|mesh-list
19948637|NCT01554371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19948638|NCT01554371|Immunologic Factors|immunologic factors|mesh-ancestor
19948639|NCT01554371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948640|NCT01554371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19948641|NCT01554371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19948642|NCT01554371|Alkylating Agents|alkylating agents|mesh-ancestor
19948643|NCT01554371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948644|NCT01554371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948645|NCT01554371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19948646|NCT01554488|Fluticasone|fluticasone|mesh-list
19948647|NCT01554488|Xhance|xhance|mesh-list
19948648|NCT01554488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19948649|NCT01554488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19948650|NCT01554488|Autonomic Agents|autonomic agents|mesh-ancestor
19948651|NCT01554488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19948652|NCT01554488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948653|NCT01554488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19948654|NCT01554488|Respiratory System Agents|respiratory system agents|mesh-ancestor
19948655|NCT01554488|Dermatologic Agents|dermatologic agents|mesh-ancestor
19948656|NCT01554488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19948657|NCT01554514|Rituximab|rituximab|mesh-list
19948658|NCT01554514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19948659|NCT01554514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948660|NCT01554514|Immunologic Factors|immunologic factors|mesh-ancestor
19948661|NCT01554514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948662|NCT01554514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19948663|NCT01554618|Exenatide|exenatide|mesh-list
19948664|NCT01554618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19948665|NCT01554618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948666|NCT01554618|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19948667|NCT01554618|Incretins|incretins|mesh-ancestor
19948668|NCT01554618|Hormones|hormones|mesh-ancestor
19948669|NCT01554618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19948670|NCT01554683|Levetiracetam|levetiracetam|mesh-list
19948671|NCT01554683|Anticonvulsants|anticonvulsants|mesh-ancestor
19948672|NCT01554683|Nootropic Agents|nootropic agents|mesh-ancestor
19974203|NCT01833832|Chelating Agents|chelating agents|mesh-ancestor
19974204|NCT01833832|Sequestering Agents|sequestering agents|mesh-ancestor
19974205|NCT01833845|Ribavirin|ribavirin|mesh-list
19974206|NCT01833845|Hydroxychloroquine|hydroxychloroquine|mesh-list
19974207|NCT01833845|Antimetabolites|antimetabolites|mesh-ancestor
19974208|NCT01833845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974209|NCT01833845|Antiviral Agents|antiviral agents|mesh-ancestor
19974210|NCT01833845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19974211|NCT01833845|Antimalarials|antimalarials|mesh-ancestor
19974212|NCT01833845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19974213|NCT01833845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19974214|NCT01833845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974215|NCT01833845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19974216|NCT01833897|Cycloserine|cycloserine|mesh-list
19974217|NCT01833897|Ketamine|ketamine|mesh-list
19974218|NCT01833897|Olanzapine|olanzapine|mesh-list
19974219|NCT01833897|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19974220|NCT01833897|Fluoxetine|fluoxetine|mesh-list
19974221|NCT01833897|Analgesics|analgesics|mesh-ancestor
19974222|NCT01833897|Sensory System Agents|sensory system agents|mesh-ancestor
19974223|NCT01833897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19974224|NCT01833897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974225|NCT01833897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19974226|NCT01833897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19974227|NCT01833897|Anesthetics, General|anesthetics, general|mesh-ancestor
19974228|NCT01833897|Anesthetics|anesthetics|mesh-ancestor
19974229|NCT01833897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19974230|NCT01833897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19974231|NCT01833897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19974232|NCT01833897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19974233|NCT01833897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974234|NCT01833897|Antiemetics|antiemetics|mesh-ancestor
19974235|NCT01833897|Autonomic Agents|autonomic agents|mesh-ancestor
19974236|NCT01833897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19974237|NCT01833897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19974238|NCT01833897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19974239|NCT01833897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19974240|NCT01833897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19974241|NCT01833897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19974242|NCT01833897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19974243|NCT01833897|Serotonin Agents|serotonin agents|mesh-ancestor
19974244|NCT01833897|Antidepressive Agents|antidepressive agents|mesh-ancestor
19974245|NCT01833897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19974246|NCT01833897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19974247|NCT01833897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19974248|NCT01833897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974249|NCT01833897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19974250|NCT01833897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19974251|NCT01833897|Renal Agents|renal agents|mesh-ancestor
19974252|NCT01833897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19974253|NCT01833897|Antitubercular Agents|antitubercular agents|mesh-ancestor
19974254|NCT01833897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19974255|NCT01833897|Antimetabolites|antimetabolites|mesh-ancestor
19974256|NCT01833988|Pancrelipase|pancrelipase|mesh-list
19974257|NCT01833988|Pancreatin|pancreatin|mesh-list
19974258|NCT01833988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19974259|NCT01834261|Oxytocin|oxytocin|mesh-list
19974260|NCT01834261|Oxytocics|oxytocics|mesh-ancestor
19974261|NCT01834261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19974262|NCT01834261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974263|NCT01834274|Metformin|metformin|mesh-list
19974264|NCT01834274|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19974265|NCT01834274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19974266|NCT01834274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948673|NCT01555125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19948674|NCT01555125|Immunologic Factors|immunologic factors|mesh-ancestor
19948675|NCT01555125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948676|NCT01555138|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19948677|NCT01555138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19948678|NCT01555138|Autonomic Agents|autonomic agents|mesh-ancestor
19948679|NCT01555138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19948680|NCT01555138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948681|NCT01555138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19948682|NCT01555138|Respiratory System Agents|respiratory system agents|mesh-ancestor
19948683|NCT01555138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19948684|NCT01555138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19948685|NCT01555138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19948686|NCT01555138|Adrenergic Agents|adrenergic agents|mesh-ancestor
19948687|NCT01555138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19948688|NCT01555138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948689|NCT01555151|Mometasone Furoate|mometasone furoate|mesh-list
19948690|NCT01555151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19948691|NCT01555151|Dermatologic Agents|dermatologic agents|mesh-ancestor
19948692|NCT01555151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19948693|NCT01555164|Metformin|metformin|mesh-list
19948694|NCT01555164|Ranolazine|ranolazine|mesh-list
19948695|NCT01555164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19948696|NCT01555164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948697|NCT01555164|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19948698|NCT01555164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19948699|NCT01555164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268815|NCT05319912|Growth Substances|growth substances|mesh-ancestor
20268816|NCT05319912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268817|NCT05319912|Growth Inhibitors|growth inhibitors|mesh-ancestor
20268818|NCT05319912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268819|NCT05319912|Trace Elements|trace elements|mesh-ancestor
20268820|NCT05319912|Micronutrients|micronutrients|mesh-ancestor
20268821|NCT05319899|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
20268822|NCT05319899|Choline|choline|mesh-list
20268823|NCT05319899|Omeprazole|omeprazole|mesh-list
20268824|NCT05319899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20268825|NCT05319899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20268826|NCT05319899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20268827|NCT05319899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19732981|NCT04568161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268828|NCT05319899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268829|NCT05319899|Lipotropic Agents|lipotropic agents|mesh-ancestor
20268830|NCT05319899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20268831|NCT05319899|Antimetabolites|antimetabolites|mesh-ancestor
20268832|NCT05319899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20268833|NCT05319899|Nootropic Agents|nootropic agents|mesh-ancestor
20268834|NCT05319899|Chelating Agents|chelating agents|mesh-ancestor
20268835|NCT05319899|Sequestering Agents|sequestering agents|mesh-ancestor
20268836|NCT05319899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20268837|NCT05319899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20268838|NCT05319899|Growth Substances|growth substances|mesh-ancestor
20268839|NCT05319899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268840|NCT05319899|Growth Inhibitors|growth inhibitors|mesh-ancestor
20268841|NCT05319899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268842|NCT05319834|Aspirin|aspirin|mesh-list
20268843|NCT05319834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20268844|NCT05319834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20268845|NCT05319834|Analgesics|analgesics|mesh-ancestor
20268846|NCT05319834|Sensory System Agents|sensory system agents|mesh-ancestor
20268847|NCT05319834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20268848|NCT05319834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732982|NCT04568161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19732983|NCT04568161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19732984|NCT04568018|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19732985|NCT04568018|Respiratory System Agents|respiratory system agents|mesh-ancestor
19735741|NCT04536558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19735742|NCT04536558|Serotonin Agents|serotonin agents|mesh-ancestor
19735743|NCT04536558|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19735744|NCT04536662|Dexamethasone|dexamethasone|mesh-list
19735745|NCT04536662|Prednisone|prednisone|mesh-list
19735746|NCT04536662|Hydrocortisone|hydrocortisone|mesh-list
19735747|NCT04536662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19735748|NCT04536662|Antiemetics|antiemetics|mesh-ancestor
19735749|NCT04536662|Autonomic Agents|autonomic agents|mesh-ancestor
19735750|NCT04536662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19732986|NCT04567576|Antirheumatic Agents|antirheumatic agents|mesh-list
19732987|NCT04567433|Hydrocortisone|hydrocortisone|mesh-list
19732988|NCT04567433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19732989|NCT04567225|Insulin Glargine|insulin glargine|mesh-list
19732990|NCT04567225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19732991|NCT04567225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19732992|NCT04567290|Ticagrelor|ticagrelor|mesh-list
19732993|NCT04567290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19732994|NCT04567290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19732995|NCT04567290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19732996|NCT04567290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19732997|NCT04567290|Purinergic Agents|purinergic agents|mesh-ancestor
19732998|NCT04567290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19732999|NCT04567290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948700|NCT01555463|Azelaic acid|azelaic acid|mesh-list
19948701|NCT01555463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948702|NCT01555463|Dermatologic Agents|dermatologic agents|mesh-ancestor
19948703|NCT01555541|Cytarabine|cytarabine|mesh-list
19948704|NCT01555541|Etoposide|etoposide|mesh-list
19948705|NCT01555541|Ofatumumab|ofatumumab|mesh-list
19948706|NCT01555541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19948707|NCT01555541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948708|NCT01555541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19948709|NCT01555541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19948710|NCT01555541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948711|NCT01555541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948712|NCT01555541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19948713|NCT01555541|Antimetabolites|antimetabolites|mesh-ancestor
19948714|NCT01555541|Antiviral Agents|antiviral agents|mesh-ancestor
19948715|NCT01555541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19948716|NCT01555541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19948717|NCT01555541|Immunologic Factors|immunologic factors|mesh-ancestor
19948718|NCT01555541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948719|NCT01555671|Meperidine|meperidine|mesh-list
19948720|NCT01555671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19948721|NCT01555671|Narcotics|narcotics|mesh-ancestor
19948722|NCT01555671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19948723|NCT01555671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948724|NCT01555671|Analgesics|analgesics|mesh-ancestor
19948725|NCT01555671|Sensory System Agents|sensory system agents|mesh-ancestor
19948726|NCT01555671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19948727|NCT01555671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19948728|NCT01555697|Memantine|memantine|mesh-list
19948729|NCT01555697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19948730|NCT01555697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19948731|NCT01555697|Dopamine Agents|dopamine agents|mesh-ancestor
19948732|NCT01555697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19948733|NCT01555697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948734|NCT01555697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948735|NCT01555697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19948736|NCT01555697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19948737|NCT01555931|Levonorgestrel|levonorgestrel|mesh-list
19948738|NCT01555931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19948739|NCT01555931|Contraceptive Agents|contraceptive agents|mesh-ancestor
19948740|NCT01555931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19948741|NCT01555931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948742|NCT01555931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19948743|NCT01555931|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19948744|NCT01555931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19948745|NCT01556165|Rasagiline|rasagiline|mesh-list
19948746|NCT01556165|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19948747|NCT01556165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948748|NCT01556165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948749|NCT01556165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19948750|NCT01556165|Protective Agents|protective agents|mesh-ancestor
19948751|NCT01556165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948752|NCT01556347|Rituximab|rituximab|mesh-list
19948753|NCT01556347|Bortezomib|bortezomib|mesh-list
19948754|NCT01556347|Thymoglobulin|thymoglobulin|mesh-list
19948755|NCT01556347|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19948756|NCT01556347|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19948757|NCT01556347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19948758|NCT01556347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948759|NCT01556347|Immunologic Factors|immunologic factors|mesh-ancestor
19948760|NCT01556347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948761|NCT01556347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19948762|NCT01556347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19948763|NCT01556425|Naltrexone|naltrexone|mesh-list
19948764|NCT01556425|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19948765|NCT01556425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19948766|NCT01556425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948767|NCT01556425|Sensory System Agents|sensory system agents|mesh-ancestor
19948768|NCT01556425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19948769|NCT01556438|Dexamethasone|dexamethasone|mesh-list
19948770|NCT01556438|Bortezomib|bortezomib|mesh-list
19948771|NCT01556438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19948772|NCT01556438|Antiemetics|antiemetics|mesh-ancestor
19948773|NCT01556438|Autonomic Agents|autonomic agents|mesh-ancestor
19948774|NCT01556438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19948775|NCT01556438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948776|NCT01556438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19948777|NCT01556438|Glucocorticoids|glucocorticoids|mesh-ancestor
19948778|NCT01556438|Hormones|hormones|mesh-ancestor
19948779|NCT01556438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19948780|NCT01556438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19948781|NCT01556438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948782|NCT01556594|Glucagon|glucagon|mesh-list
19948783|NCT01556594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19948784|NCT01556594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19948785|NCT01556594|Hormones|hormones|mesh-ancestor
19948786|NCT01556594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19948787|NCT01556594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948788|NCT01556594|Incretins|incretins|mesh-ancestor
19948789|NCT01556633|Oseltamivir|oseltamivir|mesh-list
19948790|NCT01556633|Antiviral Agents|antiviral agents|mesh-ancestor
19948791|NCT01556633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19948792|NCT01556633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948793|NCT01556633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948794|NCT01556724|Ropivacaine|ropivacaine|mesh-list
19948795|NCT01556724|Anesthetics, Local|anesthetics, local|mesh-ancestor
19948796|NCT01556724|Anesthetics|anesthetics|mesh-ancestor
19948797|NCT01556724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19948798|NCT01556724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948799|NCT01556724|Sensory System Agents|sensory system agents|mesh-ancestor
19948800|NCT01556724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19948801|NCT01556763|Antipsychotic Agents|antipsychotic agents|mesh-list
19948802|NCT01556763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19948803|NCT01556763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19948804|NCT01556763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948805|NCT01556763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19948806|NCT01556932|Diphenhydramine|diphenhydramine|mesh-list
19948807|NCT01556932|Promethazine|promethazine|mesh-list
19948808|NCT01556932|Lorazepam|lorazepam|mesh-list
19948809|NCT01556932|Haloperidol|haloperidol|mesh-list
19948810|NCT01556932|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19948811|NCT01556932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19948812|NCT01556932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19948813|NCT01556932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948814|NCT01556932|Anesthetics, Local|anesthetics, local|mesh-ancestor
19948815|NCT01556932|Anesthetics|anesthetics|mesh-ancestor
19948816|NCT01556932|Sensory System Agents|sensory system agents|mesh-ancestor
19948817|NCT01556932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19948818|NCT01556932|Antiemetics|antiemetics|mesh-ancestor
19948819|NCT01556932|Autonomic Agents|autonomic agents|mesh-ancestor
19948820|NCT01556932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19948821|NCT01556932|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19948822|NCT01556932|Histamine Antagonists|histamine antagonists|mesh-ancestor
19948823|NCT01556932|Histamine Agents|histamine agents|mesh-ancestor
19948824|NCT01556932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19948825|NCT01556932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948826|NCT01556932|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19948827|NCT01556932|Antipruritics|antipruritics|mesh-ancestor
19948828|NCT01556932|Dermatologic Agents|dermatologic agents|mesh-ancestor
19948829|NCT01556932|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19948830|NCT01556932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19948831|NCT01556932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19948832|NCT01556932|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19948833|NCT01556932|Dopamine Agents|dopamine agents|mesh-ancestor
19948834|NCT01556932|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19948835|NCT01556932|Anticonvulsants|anticonvulsants|mesh-ancestor
19948836|NCT01556932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19948837|NCT01556932|GABA Modulators|gaba modulators|mesh-ancestor
19948838|NCT01556932|GABA Agents|gaba agents|mesh-ancestor
19948839|NCT01556997|Amlodipine|amlodipine|mesh-list
19948840|NCT01556997|Perindopril|perindopril|mesh-list
19948841|NCT01556997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19948842|NCT01556997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19948843|NCT01556997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19948844|NCT01556997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948845|NCT01556997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19948846|NCT01556997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948847|NCT01556997|Vasodilator Agents|vasodilator agents|mesh-ancestor
19948848|NCT01556997|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19948849|NCT01556997|Protease Inhibitors|protease inhibitors|mesh-ancestor
19948850|NCT01556997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948851|NCT01557166|Liraglutide|liraglutide|mesh-list
19948852|NCT01557166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19948853|NCT01557166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948854|NCT01557166|Incretins|incretins|mesh-ancestor
19948855|NCT01557166|Hormones|hormones|mesh-ancestor
19948856|NCT01557166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19948857|NCT01557244|Fesoterodine|fesoterodine|mesh-list
19948858|NCT01557244|Oxybutynin|oxybutynin|mesh-list
19948859|NCT01557244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19948860|NCT01557244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19948861|NCT01557244|Cholinergic Agents|cholinergic agents|mesh-ancestor
19948862|NCT01557244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19948863|NCT01557244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948864|NCT01557244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948865|NCT01557244|Urological Agents|urological agents|mesh-ancestor
19948866|NCT01557244|Parasympatholytics|parasympatholytics|mesh-ancestor
19948867|NCT01557244|Autonomic Agents|autonomic agents|mesh-ancestor
19948868|NCT01557244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19948869|NCT01557283|Etanercept|etanercept|mesh-list
19948870|NCT01557283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19948871|NCT01557283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19948872|NCT01557283|Analgesics|analgesics|mesh-ancestor
19948873|NCT01557283|Sensory System Agents|sensory system agents|mesh-ancestor
19948874|NCT01557283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19948875|NCT01557283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948876|NCT01557283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19948877|NCT01557283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19948878|NCT01557283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19948879|NCT01557283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19948880|NCT01557283|Immunologic Factors|immunologic factors|mesh-ancestor
19948881|NCT01557322|Etanercept|etanercept|mesh-list
19948882|NCT01557322|Methotrexate|methotrexate|mesh-list
19948883|NCT01557322|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19948884|NCT01557322|Abortifacient Agents|abortifacient agents|mesh-ancestor
19948885|NCT01557322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19948886|NCT01557322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948887|NCT01557322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19948888|NCT01557322|Antimetabolites|antimetabolites|mesh-ancestor
19948889|NCT01557322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948890|NCT01557322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948891|NCT01557322|Dermatologic Agents|dermatologic agents|mesh-ancestor
19948892|NCT01557322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948893|NCT01557322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19948894|NCT01557322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19948895|NCT01557322|Immunologic Factors|immunologic factors|mesh-ancestor
19948896|NCT01557322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19948897|NCT01557322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19948898|NCT01557322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19948899|NCT01557322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19948900|NCT01557322|Analgesics|analgesics|mesh-ancestor
19948901|NCT01557322|Sensory System Agents|sensory system agents|mesh-ancestor
19948902|NCT01557322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19948903|NCT01557322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19948904|NCT01557322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19948905|NCT01557452|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
19948906|NCT01557452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19948907|NCT01557452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948908|NCT01557452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948909|NCT01557504|Metformin|metformin|mesh-list
19948910|NCT01557504|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19948911|NCT01557504|Hormones|hormones|mesh-list
19948912|NCT01557504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19948913|NCT01557504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948914|NCT01557504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19948915|NCT01557504|Incretins|incretins|mesh-ancestor
19948916|NCT01557504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19948917|NCT01557504|Protease Inhibitors|protease inhibitors|mesh-ancestor
19948918|NCT01557504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948919|NCT01557504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948920|NCT01557517|Clobetasol|clobetasol|mesh-list
19948921|NCT01557517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19948922|NCT01557517|Glucocorticoids|glucocorticoids|mesh-ancestor
19948923|NCT01557517|Hormones|hormones|mesh-ancestor
19948924|NCT01557517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19948925|NCT01557517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268849|NCT05319834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20268850|NCT05319834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20268851|NCT05319834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20268852|NCT05319834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20268853|NCT05319834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268854|NCT05319834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20268855|NCT05319834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20268856|NCT05319834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268857|NCT05319834|Antipyretics|antipyretics|mesh-ancestor
20268858|NCT05319756|Oxycodone|oxycodone|mesh-list
20268859|NCT05319756|Gabapentin|gabapentin|mesh-list
20268860|NCT05319756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20268861|NCT05319756|Narcotics|narcotics|mesh-ancestor
20268862|NCT05319756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20268863|NCT05319756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268864|NCT05319756|Analgesics|analgesics|mesh-ancestor
20268865|NCT05319756|Sensory System Agents|sensory system agents|mesh-ancestor
20268866|NCT05319756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20268867|NCT05319756|Anticonvulsants|anticonvulsants|mesh-ancestor
20268868|NCT05319756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20268869|NCT05319756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20268870|NCT05319756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20268871|NCT05319756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19948926|NCT01557569|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20268872|NCT05319756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20268873|NCT05319756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20268874|NCT05319756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268875|NCT05319756|Antimanic Agents|antimanic agents|mesh-ancestor
20268876|NCT05319639|Leucovorin|leucovorin|mesh-list
20268877|NCT05319639|Paclitaxel|paclitaxel|mesh-list
20268878|NCT05319639|Fluorouracil|fluorouracil|mesh-list
20268879|NCT05319639|Oxaliplatin|oxaliplatin|mesh-list
20268880|NCT05319639|Irinotecan|irinotecan|mesh-list
20268881|NCT05319639|Levoleucovorin|levoleucovorin|mesh-list
20268882|NCT05319639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20268883|NCT05319639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268884|NCT05319639|Tubulin Modulators|tubulin modulators|mesh-ancestor
20268885|NCT05319639|Antimitotic Agents|antimitotic agents|mesh-ancestor
20268886|NCT05319639|Mitosis Modulators|mitosis modulators|mesh-ancestor
20268887|NCT05319639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268888|NCT05319639|Antimetabolites|antimetabolites|mesh-ancestor
20543488|NCT01870128|Glucocorticoids|glucocorticoids|mesh-ancestor
20543489|NCT01870128|Hormones|hormones|mesh-ancestor
19948927|NCT01557569|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19948928|NCT01557569|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19948929|NCT01557569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19948930|NCT01557569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948931|NCT01557569|Adrenergic Agents|adrenergic agents|mesh-ancestor
19948932|NCT01557569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19948933|NCT01557569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268889|NCT05319639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20268890|NCT05319639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20554144|NCT01933542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19948934|NCT01557868|Hyaluronic Acid|hyaluronic acid|mesh-list
19948935|NCT01557868|Hylan|hylan|mesh-list
19948936|NCT01557868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19948937|NCT01557868|Immunologic Factors|immunologic factors|mesh-ancestor
20268891|NCT05319639|Immunologic Factors|immunologic factors|mesh-ancestor
20268892|NCT05319639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268893|NCT05319639|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20268894|NCT05319639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20268895|NCT05319639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268896|NCT05319639|Antidotes|antidotes|mesh-ancestor
20268897|NCT05319639|Protective Agents|protective agents|mesh-ancestor
20268898|NCT05319639|Vitamin B Complex|vitamin b complex|mesh-ancestor
20268899|NCT05319639|Vitamins|vitamins|mesh-ancestor
20268900|NCT05319639|Micronutrients|micronutrients|mesh-ancestor
20268901|NCT05319587|Cytarabine|cytarabine|mesh-list
20268902|NCT05319587|Annamycin|annamycin|mesh-list
20268903|NCT05319587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20268904|NCT05319587|Antimetabolites|antimetabolites|mesh-ancestor
20268905|NCT05319587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268906|NCT05319587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268907|NCT05319587|Antiviral Agents|antiviral agents|mesh-ancestor
20268908|NCT05319587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20543490|NCT01870128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20543491|NCT01870128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20543492|NCT01870128|Protective Agents|protective agents|mesh-ancestor
20543493|NCT01870128|Antimalarials|antimalarials|mesh-ancestor
20543494|NCT01870128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20543495|NCT01870128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20543496|NCT01870128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20543497|NCT01870128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20543498|NCT01870128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20543499|NCT01870128|Analgesics|analgesics|mesh-ancestor
20543500|NCT01870128|Sensory System Agents|sensory system agents|mesh-ancestor
20543501|NCT01870167|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20543502|NCT01870167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20543503|NCT01870167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20543504|NCT01870167|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20543505|NCT01870167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948938|NCT01557868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543506|NCT01870167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543507|NCT01870219|Ketamine|ketamine|mesh-list
20543508|NCT01870219|Sevoflurane|sevoflurane|mesh-list
20543509|NCT01870219|Anesthetics|anesthetics|mesh-list
20543510|NCT01870219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
20543511|NCT01870219|Analgesics|analgesics|mesh-ancestor
20543512|NCT01870219|Sensory System Agents|sensory system agents|mesh-ancestor
20543513|NCT01870219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543514|NCT01870219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543515|NCT01870219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20543516|NCT01870219|Anesthetics, General|anesthetics, general|mesh-ancestor
20543517|NCT01870219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20543518|NCT01870219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20543519|NCT01870219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20543520|NCT01870219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20543521|NCT01870219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948939|NCT01557868|Viscosupplements|viscosupplements|mesh-ancestor
19948940|NCT01557868|Protective Agents|protective agents|mesh-ancestor
19948941|NCT01557920|Propofol|propofol|mesh-list
19948942|NCT01557920|Sevoflurane|sevoflurane|mesh-list
19948943|NCT01557920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19948944|NCT01557920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19948945|NCT01557920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948946|NCT01557920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19948947|NCT01557920|Anesthetics, General|anesthetics, general|mesh-ancestor
19948948|NCT01557920|Anesthetics|anesthetics|mesh-ancestor
19948949|NCT01557920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19948950|NCT01557920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19948951|NCT01557946|Citalopram|citalopram|mesh-list
19948952|NCT01557946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20268909|NCT05319587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19948953|NCT01557946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19948954|NCT01557946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19948955|NCT01557946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948956|NCT01557946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19948957|NCT01557946|Serotonin Agents|serotonin agents|mesh-ancestor
19948958|NCT01557946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948959|NCT01557946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19948960|NCT01557946|Antidepressive Agents|antidepressive agents|mesh-ancestor
19948961|NCT01557946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19948962|NCT01557959|Docetaxel|docetaxel|mesh-list
19948963|NCT01557959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19948964|NCT01557959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948965|NCT01557959|Tubulin Modulators|tubulin modulators|mesh-ancestor
19948966|NCT01557959|Antimitotic Agents|antimitotic agents|mesh-ancestor
19948967|NCT01557959|Mitosis Modulators|mitosis modulators|mesh-ancestor
19948968|NCT01557959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948969|NCT01557959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19948970|NCT01557959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948971|NCT01558063|Ketamine|ketamine|mesh-list
19948972|NCT01558063|Analgesics|analgesics|mesh-ancestor
19948973|NCT01558063|Sensory System Agents|sensory system agents|mesh-ancestor
19948974|NCT01558063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19948975|NCT01558063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948976|NCT01558063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19948977|NCT01558063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19948978|NCT01558063|Anesthetics, General|anesthetics, general|mesh-ancestor
19948979|NCT01558063|Anesthetics|anesthetics|mesh-ancestor
19948980|NCT01558063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19948981|NCT01558063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19948982|NCT01558063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19948983|NCT01558063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19948984|NCT01558063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948985|NCT01558089|Etanercept|etanercept|mesh-list
19948986|NCT01558089|Methotrexate|methotrexate|mesh-list
19948987|NCT01558089|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19948988|NCT01558089|Abortifacient Agents|abortifacient agents|mesh-ancestor
19948989|NCT01558089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19948990|NCT01558089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19948991|NCT01558089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19948992|NCT01558089|Antimetabolites|antimetabolites|mesh-ancestor
19948993|NCT01558089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19948994|NCT01558089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19948995|NCT01558089|Dermatologic Agents|dermatologic agents|mesh-ancestor
19948996|NCT01558089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19948997|NCT01558089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19948998|NCT01558089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19948999|NCT01558089|Immunologic Factors|immunologic factors|mesh-ancestor
19949000|NCT01558089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19949001|NCT01558089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19949002|NCT01558089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19949003|NCT01558089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19949004|NCT01558089|Analgesics|analgesics|mesh-ancestor
19949005|NCT01558089|Sensory System Agents|sensory system agents|mesh-ancestor
19949006|NCT01558089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19949007|NCT01558089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19949008|NCT01558089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19949009|NCT01558128|Amiodarone|amiodarone|mesh-list
19949010|NCT01558128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19949011|NCT01558128|Vasodilator Agents|vasodilator agents|mesh-ancestor
20268910|NCT05319587|Immunologic Factors|immunologic factors|mesh-ancestor
19949012|NCT01558128|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19949013|NCT01558128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19949014|NCT01558128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949015|NCT01558128|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19949016|NCT01558128|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19949017|NCT01558128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19949018|NCT01558128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949019|NCT01558128|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19949020|NCT01558128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19949021|NCT01558128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20268911|NCT05319587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949022|NCT01558271|Liraglutide|liraglutide|mesh-list
19949023|NCT01558271|Dulaglutide|dulaglutide|mesh-list
19949024|NCT01558271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19949025|NCT01558271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949026|NCT01558271|Incretins|incretins|mesh-ancestor
19949027|NCT01558271|Hormones|hormones|mesh-ancestor
19949028|NCT01558271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19949029|NCT01558661|Axitinib|axitinib|mesh-list
19949030|NCT01558661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19949031|NCT01558661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19949032|NCT01558661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949033|NCT01558661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949034|NCT01558674|Torsemide|torsemide|mesh-list
19949035|NCT01558674|Furosemide|furosemide|mesh-list
19949036|NCT01558674|Diuretics|diuretics|mesh-ancestor
19949037|NCT01558674|Natriuretic Agents|natriuretic agents|mesh-ancestor
19949038|NCT01558674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949039|NCT01558674|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19949040|NCT01558674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19949041|NCT01558674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949042|NCT01558674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19949043|NCT01558700|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19949044|NCT01558700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19949045|NCT01558700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19949046|NCT01558700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19949047|NCT01558700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949048|NCT01558700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949049|NCT01558700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949050|NCT01558700|Analgesics|analgesics|mesh-ancestor
19949051|NCT01558700|Sensory System Agents|sensory system agents|mesh-ancestor
19949052|NCT01558700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19949053|NCT01558700|Antidepressive Agents|antidepressive agents|mesh-ancestor
19949054|NCT01558700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19949055|NCT01558700|Dopamine Agents|dopamine agents|mesh-ancestor
20268912|NCT05319587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20268913|NCT05319431|Lenvatinib|lenvatinib|mesh-list
20268914|NCT05319431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268915|NCT05319431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20268916|NCT05319431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268917|NCT05319431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268918|NCT05319340|Anticoagulants|anticoagulants|mesh-list
20268919|NCT05319301|Melatonin|melatonin|mesh-list
20268920|NCT05319301|Antioxidants|antioxidants|mesh-ancestor
20268921|NCT05319301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268922|NCT05319301|Protective Agents|protective agents|mesh-ancestor
20268923|NCT05319301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268924|NCT05319301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20268925|NCT05319249|Talazoparib|talazoparib|mesh-list
20268926|NCT05319249|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20268927|NCT05319249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268928|NCT05319249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268929|NCT05319249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268930|NCT05319015|Pembrolizumab|pembrolizumab|mesh-list
20268931|NCT05319015|Lenvatinib|lenvatinib|mesh-list
20268932|NCT05319015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20268933|NCT05319015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268934|NCT05319015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20268935|NCT05319015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268936|NCT05319015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287352|NCT04923620|Cetuximab|cetuximab|mesh-list
20287353|NCT04923620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20287354|NCT04923620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287355|NCT04914234|Metoprolol|metoprolol|mesh-list
20287356|NCT04914234|Atenolol|atenolol|mesh-list
20287357|NCT04914234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20287358|NCT04914234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20287359|NCT04914234|Sympatholytics|sympatholytics|mesh-ancestor
20287360|NCT04914234|Autonomic Agents|autonomic agents|mesh-ancestor
19949056|NCT01559012|Clonidine|clonidine|mesh-list
19949057|NCT01559012|Analgesics|analgesics|mesh-ancestor
19949058|NCT01559012|Sensory System Agents|sensory system agents|mesh-ancestor
19949059|NCT01559012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19949060|NCT01559012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949061|NCT01559012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19949062|NCT01559012|Sympatholytics|sympatholytics|mesh-ancestor
19949063|NCT01559012|Autonomic Agents|autonomic agents|mesh-ancestor
19949064|NCT01559012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19949065|NCT01559012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19949066|NCT01559012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19949067|NCT01559012|Adrenergic Agents|adrenergic agents|mesh-ancestor
19949068|NCT01559012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949069|NCT01559012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949070|NCT01559064|Lidocaine|lidocaine|mesh-list
19949071|NCT01559064|Hyaluronic Acid|hyaluronic acid|mesh-list
19949072|NCT01559064|Anesthetics, Local|anesthetics, local|mesh-ancestor
19949073|NCT01559064|Anesthetics|anesthetics|mesh-ancestor
19949074|NCT01559064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19949075|NCT01559064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949076|NCT01559064|Sensory System Agents|sensory system agents|mesh-ancestor
19949077|NCT01559064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19949078|NCT01559064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19949079|NCT01559064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19949080|NCT01559064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19949081|NCT01559064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19949082|NCT01559064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949083|NCT01559064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19949084|NCT01559064|Immunologic Factors|immunologic factors|mesh-ancestor
19949085|NCT01559064|Viscosupplements|viscosupplements|mesh-ancestor
19949086|NCT01559064|Protective Agents|protective agents|mesh-ancestor
19949087|NCT01559090|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19949088|NCT01559090|Immunologic Factors|immunologic factors|mesh-ancestor
19949089|NCT01559090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949090|NCT01559116|Tiotropium Bromide|tiotropium bromide|mesh-list
19949091|NCT01559116|Olodaterol|olodaterol|mesh-list
19949092|NCT01559116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19949093|NCT01559116|Autonomic Agents|autonomic agents|mesh-ancestor
19949094|NCT01559116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19949095|NCT01559116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949096|NCT01559116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19949097|NCT01559116|Respiratory System Agents|respiratory system agents|mesh-ancestor
19949098|NCT01559116|Parasympatholytics|parasympatholytics|mesh-ancestor
19949099|NCT01559116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19949100|NCT01559116|Cholinergic Agents|cholinergic agents|mesh-ancestor
19949101|NCT01559116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949102|NCT01559116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949103|NCT01559129|Pomalidomide|pomalidomide|mesh-list
19949104|NCT01559129|Immunologic Factors|immunologic factors|mesh-ancestor
19949105|NCT01559129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949106|NCT01559129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19949107|NCT01559129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19949108|NCT01559129|Growth Substances|growth substances|mesh-ancestor
19949109|NCT01559129|Growth Inhibitors|growth inhibitors|mesh-ancestor
19949110|NCT01559129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19949111|NCT01559259|Acetaminophen|acetaminophen|mesh-list
19949112|NCT01559259|Ibuprofen|ibuprofen|mesh-list
19949113|NCT01559259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19949114|NCT01559259|Analgesics|analgesics|mesh-ancestor
19949115|NCT01559259|Sensory System Agents|sensory system agents|mesh-ancestor
19949116|NCT01559259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19949117|NCT01559259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949118|NCT01559259|Antipyretics|antipyretics|mesh-ancestor
19949119|NCT01559259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19949120|NCT01559259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19949121|NCT01559259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19949122|NCT01559259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19949123|NCT01559259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949124|NCT01559259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949125|NCT01559389|Solifenacin Succinate|solifenacin succinate|mesh-list
19949126|NCT01559389|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19949127|NCT01559389|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19949128|NCT01559389|Cholinergic Agents|cholinergic agents|mesh-ancestor
19949129|NCT01559389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19974267|NCT01834274|Incretins|incretins|mesh-ancestor
19949130|NCT01559389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949131|NCT01559389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949132|NCT01559389|Urological Agents|urological agents|mesh-ancestor
19949133|NCT01559454|Buprenorphine|buprenorphine|mesh-list
19949134|NCT01559454|Methadone|methadone|mesh-list
19949135|NCT01559454|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19949136|NCT01559454|Naloxone|naloxone|mesh-list
19949137|NCT01559454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19949138|NCT01559454|Narcotics|narcotics|mesh-ancestor
19949139|NCT01559454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19949140|NCT01559454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949141|NCT01559454|Analgesics|analgesics|mesh-ancestor
19949142|NCT01559454|Sensory System Agents|sensory system agents|mesh-ancestor
19949143|NCT01559454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19949144|NCT01559454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19949145|NCT01559454|Antitussive Agents|antitussive agents|mesh-ancestor
19949146|NCT01559454|Respiratory System Agents|respiratory system agents|mesh-ancestor
19949147|NCT01559675|Hydrocortisone|hydrocortisone|mesh-list
19949148|NCT01559675|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19949149|NCT01559675|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19949150|NCT01559675|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19949151|NCT01559675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19949152|NCT01559675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19949153|NCT01559675|Methylprednisolone|methylprednisolone|mesh-list
19949154|NCT01559675|Prednisolone|prednisolone|mesh-list
19949155|NCT01559675|Prednisolone acetate|prednisolone acetate|mesh-list
19949156|NCT01559675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19949157|NCT01559675|Prednisolone phosphate|prednisolone phosphate|mesh-list
19949158|NCT01559675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19949159|NCT01559675|Glucocorticoids|glucocorticoids|mesh-ancestor
19949160|NCT01559675|Hormones|hormones|mesh-ancestor
19949161|NCT01559675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19949162|NCT01559675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949163|NCT01559675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19949164|NCT01559675|Protective Agents|protective agents|mesh-ancestor
19949165|NCT01559675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19949166|NCT01559675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19949167|NCT01559675|Antiemetics|antiemetics|mesh-ancestor
19949168|NCT01559675|Autonomic Agents|autonomic agents|mesh-ancestor
19949169|NCT01559675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19949170|NCT01559675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19949171|NCT01559844|Ribavirin|ribavirin|mesh-list
19949172|NCT01559844|Sofosbuvir|sofosbuvir|mesh-list
19949173|NCT01559844|Antimetabolites|antimetabolites|mesh-ancestor
19949174|NCT01559844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949175|NCT01559844|Antiviral Agents|antiviral agents|mesh-ancestor
19949176|NCT01559844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19949177|NCT01559857|Pioglitazone|pioglitazone|mesh-list
19949178|NCT01559857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19949179|NCT01559857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949180|NCT01559922|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
19949181|NCT01559922|Vasodilator Agents|vasodilator agents|mesh-ancestor
19949182|NCT01559922|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19949183|NCT01559922|Protective Agents|protective agents|mesh-ancestor
19949184|NCT01559922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949185|NCT01560143|Tigecycline|tigecycline|mesh-list
19949186|NCT01560143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19949187|NCT01560143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19949188|NCT01560143|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19949189|NCT01560143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949190|NCT01560143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949191|NCT01560403|Teduglutide|teduglutide|mesh-list
19949192|NCT01560403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19949193|NCT01560403|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19949194|NCT01560403|Protective Agents|protective agents|mesh-ancestor
19949195|NCT01560403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949196|NCT01560416|Fulvestrant|fulvestrant|mesh-list
19949197|NCT01560416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19949198|NCT01560416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19949199|NCT01560416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19949200|NCT01560416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19949201|NCT01560416|Hormone Antagonists|hormone antagonists|mesh-ancestor
19949202|NCT01560416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19949203|NCT01560416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949204|NCT01560624|Treprostinil|treprostinil|mesh-list
19949205|NCT01560624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19949206|NCT01560780|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19949207|NCT01560780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19949208|NCT01560923|Tryptophan|tryptophan|mesh-list
19949209|NCT01560923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19949210|NCT01560923|Antidepressive Agents|antidepressive agents|mesh-ancestor
19949211|NCT01560923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19949212|NCT01560949|Gemcitabine|gemcitabine|mesh-list
19949213|NCT01560949|Fluorouracil|fluorouracil|mesh-list
19949214|NCT01560949|Oxaliplatin|oxaliplatin|mesh-list
19949215|NCT01560949|Irinotecan|irinotecan|mesh-list
19949216|NCT01560949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19949217|NCT01560949|Antimetabolites|antimetabolites|mesh-ancestor
19949218|NCT01560949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949219|NCT01560949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19949220|NCT01560949|Antiviral Agents|antiviral agents|mesh-ancestor
19949221|NCT01560949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19949222|NCT01560949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949223|NCT01560949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19949224|NCT01560949|Immunologic Factors|immunologic factors|mesh-ancestor
19949225|NCT01560949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949226|NCT01560949|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19949227|NCT01560949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19949228|NCT01561053|Immunoglobulins|immunoglobulins|mesh-list
19949229|NCT01561053|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19949230|NCT01561053|Antibodies|antibodies|mesh-list
19949231|NCT01561053|Immunologic Factors|immunologic factors|mesh-ancestor
19949232|NCT01561053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949233|NCT01561079|Buprenorphine|buprenorphine|mesh-list
19949234|NCT01561079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19949235|NCT01561079|Narcotics|narcotics|mesh-ancestor
19949236|NCT01561079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19949237|NCT01561079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949238|NCT01561079|Analgesics|analgesics|mesh-ancestor
19949239|NCT01561079|Sensory System Agents|sensory system agents|mesh-ancestor
19949240|NCT01561079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19949241|NCT01561079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19949242|NCT01561313|Adalimumab|adalimumab|mesh-list
19949243|NCT01561313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19949244|NCT01561313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19450279|NCT03429946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19949245|NCT01561469|Vancomycin|vancomycin|mesh-list
19949246|NCT01561469|Linezolid|linezolid|mesh-list
19949247|NCT01561469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19949248|NCT01561469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19949249|NCT01561469|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19949250|NCT01561469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949251|NCT01561469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974268|NCT01834274|Hormones|hormones|mesh-ancestor
19974269|NCT01834274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19974270|NCT01834274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19974271|NCT01834274|Protease Inhibitors|protease inhibitors|mesh-ancestor
19974272|NCT01834274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974273|NCT01834274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974274|NCT01834404|Topiramate|topiramate|mesh-list
19974275|NCT01834404|Phentermine|phentermine|mesh-list
19974276|NCT01834404|Anticonvulsants|anticonvulsants|mesh-ancestor
19974277|NCT01834404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19974278|NCT01834404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974279|NCT01834404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19974280|NCT01834404|Appetite Depressants|appetite depressants|mesh-ancestor
19974281|NCT01834404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19974282|NCT01834404|Sympathomimetics|sympathomimetics|mesh-ancestor
19974283|NCT01834404|Autonomic Agents|autonomic agents|mesh-ancestor
19974284|NCT01834404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19974285|NCT01834404|Adrenergic Agents|adrenergic agents|mesh-ancestor
19974286|NCT01834404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19974287|NCT01834404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974288|NCT01834586|Anesthetics|anesthetics|mesh-list
19974289|NCT01834586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19974290|NCT01834586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974291|NCT01834729|Alfuzosin|alfuzosin|mesh-list
19974292|NCT01834729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19974293|NCT01834729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19974294|NCT01834729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19949252|NCT01561703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19949253|NCT01561703|Amoxicillin|amoxicillin|mesh-list
19949254|NCT01561703|Azithromycin|azithromycin|mesh-list
19949255|NCT01561703|Clindamycin|clindamycin|mesh-list
19949256|NCT01561703|Clavulanic Acid|clavulanic acid|mesh-list
19949257|NCT01561703|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19949258|NCT01561703|Cephalexin|cephalexin|mesh-list
19949259|NCT01561703|Cefdinir|cefdinir|mesh-list
19949260|NCT01561703|Cefaclor|cefaclor|mesh-list
19949261|NCT01561703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19949262|NCT01561703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19949263|NCT01561703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949264|NCT01561703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949265|NCT01561703|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19949266|NCT01561755|Immunoglobulins|immunoglobulins|mesh-list
19949267|NCT01561755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19949268|NCT01561755|Antibodies|antibodies|mesh-list
19949269|NCT01561755|gamma-Globulins|gamma-globulins|mesh-list
19949270|NCT01561755|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19949271|NCT01561755|Immunologic Factors|immunologic factors|mesh-ancestor
19949272|NCT01561755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949273|NCT01561833|Sorafenib|sorafenib|mesh-list
19949274|NCT01561833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19949275|NCT01561833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19949276|NCT01561833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949277|NCT01561833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949278|NCT01561898|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19949279|NCT01561898|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19949280|NCT01561898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19949281|NCT01561898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19949282|NCT01561898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949283|NCT01561898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19949284|NCT01561898|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19949285|NCT01561898|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19949286|NCT01561898|Serotonin Agents|serotonin agents|mesh-ancestor
19949287|NCT01561898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949288|NCT01561898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949289|NCT01561898|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19949290|NCT01561898|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19949291|NCT01561898|Dopamine Agents|dopamine agents|mesh-ancestor
19949292|NCT01561963|Rifampin|rifampin|mesh-list
19949293|NCT01561963|Apremilast|apremilast|mesh-list
19949294|NCT01561963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19949295|NCT01561963|Antitubercular Agents|antitubercular agents|mesh-ancestor
19949296|NCT01561963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19949297|NCT01561963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19949298|NCT01561963|Leprostatic Agents|leprostatic agents|mesh-ancestor
19949299|NCT01561963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19949300|NCT01561963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949301|NCT01561963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949302|NCT01561963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19949303|NCT01561963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19949304|NCT01561963|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19949305|NCT01561963|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19949306|NCT01561963|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19949307|NCT01561963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19949308|NCT01561963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19949309|NCT01561963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19949310|NCT01561963|Analgesics|analgesics|mesh-ancestor
19949311|NCT01561963|Sensory System Agents|sensory system agents|mesh-ancestor
19949312|NCT01561963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19949313|NCT01561963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949314|NCT01561963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19949315|NCT01561963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19949316|NCT01561963|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19949317|NCT01561963|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19949318|NCT01561976|Metformin|metformin|mesh-list
19949319|NCT01561976|Glimepiride|glimepiride|mesh-list
19949320|NCT01561976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19949321|NCT01561976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949322|NCT01561976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19949323|NCT01561976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19949324|NCT01561976|Immunologic Factors|immunologic factors|mesh-ancestor
20554145|NCT01933542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19949325|NCT01562028|Bevacizumab|bevacizumab|mesh-list
19949326|NCT01562028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19949327|NCT01562028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19949328|NCT01562028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19949329|NCT01562028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19949330|NCT01562028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19949331|NCT01562028|Growth Substances|growth substances|mesh-ancestor
19949332|NCT01562028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949333|NCT01562028|Growth Inhibitors|growth inhibitors|mesh-ancestor
19949334|NCT01562028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19949335|NCT01562028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949336|NCT01562028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949337|NCT01562041|Ranolazine|ranolazine|mesh-list
19949338|NCT01562041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19949339|NCT01562041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19949340|NCT01562041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949341|NCT01562132|Fluconazole|fluconazole|mesh-list
19949342|NCT01562132|Flucytosine|flucytosine|mesh-list
19949343|NCT01562132|Antifungal Agents|antifungal agents|mesh-ancestor
19949344|NCT01562132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19949345|NCT01562132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19949346|NCT01562132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19949347|NCT01562132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949348|NCT01562132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949349|NCT01562132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19949350|NCT01562132|Hormone Antagonists|hormone antagonists|mesh-ancestor
19949351|NCT01562132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19949352|NCT01562132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949353|NCT01562132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19949354|NCT01562132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19949355|NCT01562132|Antimetabolites|antimetabolites|mesh-ancestor
19949356|NCT01562314|Cannabidiol|cannabidiol|mesh-list
19949357|NCT01562314|Anticonvulsants|anticonvulsants|mesh-ancestor
19949358|NCT01562548|Phenylpropanolamine|phenylpropanolamine|mesh-list
19949359|NCT01562548|Guaifenesin|guaifenesin|mesh-list
19949360|NCT01562548|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
19949361|NCT01562548|Expectorants|expectorants|mesh-ancestor
19949362|NCT01562548|Respiratory System Agents|respiratory system agents|mesh-ancestor
19949363|NCT01562548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19949364|NCT01562548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19949365|NCT01562548|Adrenergic Agents|adrenergic agents|mesh-ancestor
19949366|NCT01562548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949367|NCT01562548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949368|NCT01562548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949369|NCT01562548|Appetite Depressants|appetite depressants|mesh-ancestor
19949370|NCT01562548|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19949371|NCT01562548|Sympathomimetics|sympathomimetics|mesh-ancestor
19949372|NCT01562548|Autonomic Agents|autonomic agents|mesh-ancestor
19949373|NCT01562548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19949374|NCT01562548|Nasal Decongestants|nasal decongestants|mesh-ancestor
19949375|NCT01562548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19949376|NCT01562678|Liraglutide|liraglutide|mesh-list
19949377|NCT01562678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19949378|NCT01562678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949379|NCT01562678|Incretins|incretins|mesh-ancestor
19949380|NCT01562678|Hormones|hormones|mesh-ancestor
20268937|NCT05318794|Doxorubicin|doxorubicin|mesh-list
19949381|NCT01562678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19949382|NCT01562743|Rotigotine|rotigotine|mesh-list
19949383|NCT01562743|Dopamine Agonists|dopamine agonists|mesh-ancestor
19949384|NCT01562743|Dopamine Agents|dopamine agents|mesh-ancestor
19949385|NCT01562743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949386|NCT01562743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949387|NCT01562743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949388|NCT01562886|Rilpivirine|rilpivirine|mesh-list
19949389|NCT01562886|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19949390|NCT01562886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19949391|NCT01562886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949392|NCT01562886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949393|NCT01562886|Antiviral Agents|antiviral agents|mesh-ancestor
19949394|NCT01562886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268938|NCT05318794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268939|NCT05318794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19949395|NCT01562886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19949396|NCT01562886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19949397|NCT01563029|Fluticasone|fluticasone|mesh-list
19949398|NCT01563029|Xhance|xhance|mesh-list
19949399|NCT01563029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19949400|NCT01563029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19949401|NCT01563029|Autonomic Agents|autonomic agents|mesh-ancestor
19949402|NCT01563029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19949403|NCT01563029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949404|NCT01563029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19949405|NCT01563029|Respiratory System Agents|respiratory system agents|mesh-ancestor
19949406|NCT01563029|Dermatologic Agents|dermatologic agents|mesh-ancestor
19949407|NCT01563029|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19949408|NCT01563055|Ofatumumab|ofatumumab|mesh-list
19949409|NCT01563055|Chlorambucil|chlorambucil|mesh-list
19949410|NCT01563055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19949411|NCT01563055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19949412|NCT01563055|Alkylating Agents|alkylating agents|mesh-ancestor
19949413|NCT01563055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949414|NCT01563081|Cetirizine|cetirizine|mesh-list
19949415|NCT01563081|Levocetirizine|levocetirizine|mesh-list
19949416|NCT01563081|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19949417|NCT01563081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19949418|NCT01563081|Histamine Antagonists|histamine antagonists|mesh-ancestor
19949419|NCT01563081|Histamine Agents|histamine agents|mesh-ancestor
19949420|NCT01563081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949421|NCT01563081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949422|NCT01563081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949423|NCT01563081|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19949424|NCT01563172|Listerine|listerine|mesh-list
19949425|NCT01563172|Fluorides|fluorides|mesh-list
19949426|NCT01563172|Sodium Fluoride|sodium fluoride|mesh-list
19949427|NCT01563172|Cariostatic Agents|cariostatic agents|mesh-ancestor
19949428|NCT01563172|Protective Agents|protective agents|mesh-ancestor
19949429|NCT01563172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949430|NCT01563172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19949431|NCT01563172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19949432|NCT01563185|Ibuprofen|ibuprofen|mesh-list
19949433|NCT01563185|Famotidine|famotidine|mesh-list
19949434|NCT01563185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19949435|NCT01563185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19949436|NCT01563185|Analgesics|analgesics|mesh-ancestor
19949437|NCT01563185|Sensory System Agents|sensory system agents|mesh-ancestor
19949438|NCT01563185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19949439|NCT01563185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949440|NCT01563185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19949441|NCT01563185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19949442|NCT01563185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19949443|NCT01563185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949444|NCT01563185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949445|NCT01563185|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19949446|NCT01563185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19949447|NCT01563185|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19949448|NCT01563185|Histamine Antagonists|histamine antagonists|mesh-ancestor
19949449|NCT01563185|Histamine Agents|histamine agents|mesh-ancestor
19949450|NCT01563185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949451|NCT01563198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19949452|NCT01563198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19949453|NCT01563198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949454|NCT01563354|Everolimus|everolimus|mesh-list
19949455|NCT01563354|Pasireotide|pasireotide|mesh-list
19949456|NCT01563354|Somatostatin|somatostatin|mesh-list
19949457|NCT01563354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19949458|NCT01563354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19949459|NCT01563354|Immunologic Factors|immunologic factors|mesh-ancestor
19949460|NCT01563354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949461|NCT01563354|Hormones|hormones|mesh-ancestor
19949462|NCT01563354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19949463|NCT01563406|Ethanol|ethanol|mesh-list
19949464|NCT01563406|Chlorhexidine|chlorhexidine|mesh-list
19949465|NCT01563406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19949466|NCT01563406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19949467|NCT01563406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19949468|NCT01563406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949469|NCT01563406|Disinfectants|disinfectants|mesh-ancestor
19949470|NCT01563536|Ritonavir|ritonavir|mesh-list
19949471|NCT01563536|Ribavirin|ribavirin|mesh-list
19949472|NCT01563536|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19949473|NCT01563536|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19949474|NCT01563536|Protease Inhibitors|protease inhibitors|mesh-ancestor
19949475|NCT01563536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949476|NCT01563536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949477|NCT01563536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19949478|NCT01563536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19949479|NCT01563536|Antiviral Agents|antiviral agents|mesh-ancestor
19949480|NCT01563536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19949481|NCT01563536|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19949482|NCT01563536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19949483|NCT01563536|Antimetabolites|antimetabolites|mesh-ancestor
19949484|NCT01564277|Allopurinol|allopurinol|mesh-list
19949485|NCT01564277|Rasburicase|rasburicase|mesh-list
19949486|NCT01564277|Antimetabolites|antimetabolites|mesh-ancestor
19949487|NCT01564277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949488|NCT01564277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949489|NCT01564277|Gout Suppressants|gout suppressants|mesh-ancestor
19949490|NCT01564277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19949491|NCT01564277|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19949492|NCT01564277|Antioxidants|antioxidants|mesh-ancestor
19949493|NCT01564277|Protective Agents|protective agents|mesh-ancestor
19949494|NCT01564277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949495|NCT01564758|Linezolid|linezolid|mesh-list
19949496|NCT01564758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19949497|NCT01564758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19949498|NCT01564758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19949499|NCT01564758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949500|NCT01564758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949501|NCT01564784|Cytarabine|cytarabine|mesh-list
19949502|NCT01564784|Fludarabine|fludarabine|mesh-list
19949503|NCT01564784|Mitoxantrone|mitoxantrone|mesh-list
19949504|NCT01564784|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19949505|NCT01564784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19949506|NCT01564784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19949507|NCT01564784|Antimetabolites|antimetabolites|mesh-ancestor
19949508|NCT01564784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949509|NCT01564784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19949510|NCT01564784|Immunologic Factors|immunologic factors|mesh-ancestor
19949511|NCT01564784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949512|NCT01564784|Antiviral Agents|antiviral agents|mesh-ancestor
20268940|NCT05318794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20268941|NCT05318794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20268942|NCT05318794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268943|NCT05318794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268944|NCT05318755|Testosterone|testosterone|mesh-list
20543522|NCT01870219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20543523|NCT01870219|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19949513|NCT01564784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268945|NCT05318755|Androgens|androgens|mesh-ancestor
20268946|NCT05318755|Hormones|hormones|mesh-ancestor
20268947|NCT05318755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20543524|NCT01870284|Adalimumab|adalimumab|mesh-list
19949514|NCT01564784|Analgesics|analgesics|mesh-ancestor
19949515|NCT01564784|Sensory System Agents|sensory system agents|mesh-ancestor
19949516|NCT01564784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543525|NCT01870284|Ixekizumab|ixekizumab|mesh-list
20543526|NCT01870284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20543527|NCT01870284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20543528|NCT01870284|Dermatologic Agents|dermatologic agents|mesh-ancestor
20543529|NCT01870427|Aflibercept|aflibercept|mesh-list
20543530|NCT01870427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20543531|NCT01870427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20543532|NCT01870427|Growth Substances|growth substances|mesh-ancestor
20543533|NCT01870427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949517|NCT01564784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19949518|NCT01564784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19949519|NCT01564784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949520|NCT01564784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19949521|NCT01564784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19949522|NCT01564862|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19949523|NCT01564862|Vortioxetine|vortioxetine|mesh-list
19949524|NCT01564862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19949525|NCT01564862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19949526|NCT01564862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19949527|NCT01564862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949528|NCT01564862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949529|NCT01564862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949530|NCT01564862|Analgesics|analgesics|mesh-ancestor
19949531|NCT01564862|Sensory System Agents|sensory system agents|mesh-ancestor
19949532|NCT01564862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20268948|NCT05318755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268949|NCT05318573|Gemcitabine|gemcitabine|mesh-list
20268950|NCT05318573|Pembrolizumab|pembrolizumab|mesh-list
20268951|NCT05318573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20268952|NCT05318573|Antimetabolites|antimetabolites|mesh-ancestor
20268953|NCT05318573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268954|NCT05318573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268955|NCT05318573|Antiviral Agents|antiviral agents|mesh-ancestor
20268956|NCT05318573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19949533|NCT01564862|Antidepressive Agents|antidepressive agents|mesh-ancestor
19949534|NCT01564862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19949535|NCT01564862|Dopamine Agents|dopamine agents|mesh-ancestor
19949536|NCT01564862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19949537|NCT01564862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19949538|NCT01564862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19949539|NCT01564862|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19949540|NCT01564862|Serotonin Agents|serotonin agents|mesh-ancestor
19949541|NCT01564862|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19949542|NCT01564862|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19949543|NCT01564862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19949544|NCT01564862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19949545|NCT01564914|Bevacizumab|bevacizumab|mesh-list
19949546|NCT01564914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19949547|NCT01564914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19949548|NCT01564914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19949549|NCT01564914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19949550|NCT01564914|Growth Substances|growth substances|mesh-ancestor
19949551|NCT01564914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949552|NCT01564914|Growth Inhibitors|growth inhibitors|mesh-ancestor
19949553|NCT01565083|Trastuzumab|trastuzumab|mesh-list
19949554|NCT01565083|Pertuzumab|pertuzumab|mesh-list
19949555|NCT01565083|Vinorelbine|vinorelbine|mesh-list
19949556|NCT01565083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19949557|NCT01565083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19949558|NCT01565083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19949559|NCT01565083|Tubulin Modulators|tubulin modulators|mesh-ancestor
19949560|NCT01565083|Antimitotic Agents|antimitotic agents|mesh-ancestor
19949561|NCT01565083|Mitosis Modulators|mitosis modulators|mesh-ancestor
20268957|NCT05318573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20268958|NCT05318573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20268959|NCT05318573|Immunologic Factors|immunologic factors|mesh-ancestor
20268960|NCT05318573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268961|NCT05318573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19949562|NCT01565083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949563|NCT01565148|Ranibizumab|ranibizumab|mesh-list
19949564|NCT01565148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19949565|NCT01565148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19949566|NCT01565148|Growth Substances|growth substances|mesh-ancestor
19949567|NCT01565148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949568|NCT01565148|Growth Inhibitors|growth inhibitors|mesh-ancestor
19949569|NCT01565148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19949570|NCT01565499|Paclitaxel|paclitaxel|mesh-list
19949571|NCT01565499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19949572|NCT01565499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19949573|NCT01565499|Tubulin Modulators|tubulin modulators|mesh-ancestor
19949574|NCT01565499|Antimitotic Agents|antimitotic agents|mesh-ancestor
19949575|NCT01565499|Mitosis Modulators|mitosis modulators|mesh-ancestor
19949576|NCT01565499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949577|NCT01565538|Pemetrexed|pemetrexed|mesh-list
19949578|NCT01565538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19949579|NCT01565538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19949580|NCT01565538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949581|NCT01565538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949582|NCT01565538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19949583|NCT01565538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19949584|NCT01565538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19949585|NCT01565616|Fludarabine|fludarabine|mesh-list
19949586|NCT01565616|Busulfan|busulfan|mesh-list
19949587|NCT01565616|Thymoglobulin|thymoglobulin|mesh-list
19949588|NCT01565616|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19949589|NCT01565616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19949590|NCT01565616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949591|NCT01565616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19949592|NCT01565616|Immunologic Factors|immunologic factors|mesh-ancestor
19949593|NCT01565616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949594|NCT01565616|Alkylating Agents|alkylating agents|mesh-ancestor
19949595|NCT01565616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19949596|NCT01565616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19949597|NCT01565694|Solifenacin Succinate|solifenacin succinate|mesh-list
19949598|NCT01565694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19949599|NCT01565694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19949600|NCT01565694|Cholinergic Agents|cholinergic agents|mesh-ancestor
19949601|NCT01565694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949602|NCT01565694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949603|NCT01565694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949604|NCT01565694|Urological Agents|urological agents|mesh-ancestor
19949605|NCT01565707|Solifenacin Succinate|solifenacin succinate|mesh-list
19949606|NCT01565707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19949607|NCT01565707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19949608|NCT01565707|Cholinergic Agents|cholinergic agents|mesh-ancestor
19949609|NCT01565707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949610|NCT01565707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949611|NCT01565707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949612|NCT01565707|Urological Agents|urological agents|mesh-ancestor
19949613|NCT01565850|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19949614|NCT01565850|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19949615|NCT01565850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19949616|NCT01565850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949617|NCT01565850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949618|NCT01565850|Antiviral Agents|antiviral agents|mesh-ancestor
19949619|NCT01565850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19949620|NCT01565850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19949621|NCT01565850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19949622|NCT01565889|Ritonavir|ritonavir|mesh-list
19949623|NCT01565889|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19949624|NCT01565889|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19949625|NCT01565889|Ribavirin|ribavirin|mesh-list
19949626|NCT01565889|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19949627|NCT01565889|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19949628|NCT01565889|Protease Inhibitors|protease inhibitors|mesh-ancestor
19949629|NCT01565889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949630|NCT01565889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949631|NCT01565889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19949632|NCT01565889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19949633|NCT01565889|Antiviral Agents|antiviral agents|mesh-ancestor
19949634|NCT01565889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19949635|NCT01565889|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19949636|NCT01565889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19949637|NCT01565889|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19949638|NCT01565889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19949639|NCT01565889|Antimetabolites|antimetabolites|mesh-ancestor
19949640|NCT01565902|Siponimod|siponimod|mesh-list
19949641|NCT01565902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19949642|NCT01565902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949643|NCT01565902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19949644|NCT01565902|Immunologic Factors|immunologic factors|mesh-ancestor
19949645|NCT01565902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949646|NCT01565941|Insulin|insulin|mesh-list
19949647|NCT01565941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19949648|NCT01565941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19949649|NCT01565941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949650|NCT01566162|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19949651|NCT01566162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19949652|NCT01566162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19949653|NCT01566162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19949654|NCT01566162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949655|NCT01566162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19949656|NCT01566162|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19949657|NCT01566162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19949658|NCT01566162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19949659|NCT01566162|Adrenergic Agents|adrenergic agents|mesh-ancestor
19949660|NCT01566162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949661|NCT01566162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949662|NCT01566162|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19949663|NCT01566162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19949664|NCT01566162|Serotonin Agents|serotonin agents|mesh-ancestor
19949665|NCT01566162|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19949666|NCT01566162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19949667|NCT01566162|Dopamine Agents|dopamine agents|mesh-ancestor
19949668|NCT01566409|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19949669|NCT01566409|Laxatives|laxatives|mesh-ancestor
19949670|NCT01566409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19949671|NCT01566435|Paclitaxel|paclitaxel|mesh-list
19949672|NCT01566435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19949673|NCT01566435|Fluorouracil|fluorouracil|mesh-list
19949674|NCT01566435|Cetuximab|cetuximab|mesh-list
19949675|NCT01566435|Antibodies|antibodies|mesh-list
19949676|NCT01566435|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19949677|NCT01566435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19949678|NCT01566435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19949679|NCT01566435|Tubulin Modulators|tubulin modulators|mesh-ancestor
19949680|NCT01566435|Antimitotic Agents|antimitotic agents|mesh-ancestor
19949681|NCT01566435|Mitosis Modulators|mitosis modulators|mesh-ancestor
19949682|NCT01566435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949683|NCT01566435|Immunologic Factors|immunologic factors|mesh-ancestor
19949684|NCT01566435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949685|NCT01566435|Antimetabolites|antimetabolites|mesh-ancestor
19949686|NCT01566435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19949687|NCT01566435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19949688|NCT01566435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19949689|NCT01566448|Ketamine|ketamine|mesh-list
19949690|NCT01566448|Analgesics|analgesics|mesh-ancestor
19949691|NCT01566448|Sensory System Agents|sensory system agents|mesh-ancestor
19949692|NCT01566448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19949693|NCT01566448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949694|NCT01566448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19949695|NCT01566448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19949696|NCT01566448|Anesthetics, General|anesthetics, general|mesh-ancestor
19949697|NCT01566448|Anesthetics|anesthetics|mesh-ancestor
19949698|NCT01566448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19949699|NCT01566448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19949700|NCT01566448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19949701|NCT01566448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949702|NCT01566448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949703|NCT01566526|Dexamethasone|dexamethasone|mesh-list
19949704|NCT01566526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19949705|NCT01566526|Antiemetics|antiemetics|mesh-ancestor
19949706|NCT01566526|Autonomic Agents|autonomic agents|mesh-ancestor
19949707|NCT01566526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19949708|NCT01566526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949709|NCT01566526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19949710|NCT01566526|Glucocorticoids|glucocorticoids|mesh-ancestor
19949711|NCT01566526|Hormones|hormones|mesh-ancestor
19949712|NCT01566526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19949713|NCT01566526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19949714|NCT01566526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19949715|NCT01566539|Vasopressins|vasopressins|mesh-list
19949716|NCT01566539|Arginine Vasopressin|arginine vasopressin|mesh-list
19949717|NCT01566539|Lorazepam|lorazepam|mesh-list
19949718|NCT01566539|Oxytocin|oxytocin|mesh-list
19949719|NCT01566539|Oxytocics|oxytocics|mesh-ancestor
19949720|NCT01566539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19974295|NCT01834729|Adrenergic Agents|adrenergic agents|mesh-ancestor
19949721|NCT01566539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949722|NCT01566539|Anticonvulsants|anticonvulsants|mesh-ancestor
19949723|NCT01566539|Antiemetics|antiemetics|mesh-ancestor
19949724|NCT01566539|Autonomic Agents|autonomic agents|mesh-ancestor
19949725|NCT01566539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19949726|NCT01566539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19949727|NCT01566539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19949728|NCT01566539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19949729|NCT01566539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19949730|NCT01566539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19949731|NCT01566539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19949732|NCT01566539|GABA Modulators|gaba modulators|mesh-ancestor
19949733|NCT01566539|GABA Agents|gaba agents|mesh-ancestor
19949734|NCT01566539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949735|NCT01566539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949736|NCT01566539|Hemostatics|hemostatics|mesh-ancestor
19949737|NCT01566539|Coagulants|coagulants|mesh-ancestor
19949738|NCT01566539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19949739|NCT01566539|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19949740|NCT01566539|Natriuretic Agents|natriuretic agents|mesh-ancestor
19949741|NCT01566604|Glycopyrrolate|glycopyrrolate|mesh-list
19949742|NCT01566604|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19949743|NCT01566604|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19949744|NCT01566604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19949745|NCT01566604|Cholinergic Agents|cholinergic agents|mesh-ancestor
19949746|NCT01566604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949747|NCT01566604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949748|NCT01566604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949749|NCT01566721|Trastuzumab|trastuzumab|mesh-list
19949750|NCT01566721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19949751|NCT01566721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19949752|NCT01566773|Bromides|bromides|mesh-list
19949753|NCT01566773|Tiotropium Bromide|tiotropium bromide|mesh-list
19949754|NCT01566773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19949755|NCT01566773|Autonomic Agents|autonomic agents|mesh-ancestor
19949756|NCT01566773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19949757|NCT01566773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949758|NCT01566773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19949759|NCT01566773|Respiratory System Agents|respiratory system agents|mesh-ancestor
19949760|NCT01566773|Parasympatholytics|parasympatholytics|mesh-ancestor
19949761|NCT01566773|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19949762|NCT01566773|Cholinergic Agents|cholinergic agents|mesh-ancestor
19949763|NCT01566773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949764|NCT01566773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949765|NCT01566773|Anticonvulsants|anticonvulsants|mesh-ancestor
19949766|NCT01566838|Bupivacaine|bupivacaine|mesh-list
19949767|NCT01566838|Anesthetics, Local|anesthetics, local|mesh-ancestor
19949768|NCT01566838|Anesthetics|anesthetics|mesh-ancestor
19949769|NCT01566838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19949770|NCT01566838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949771|NCT01566838|Sensory System Agents|sensory system agents|mesh-ancestor
19949772|NCT01566838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19949773|NCT01567085|Eculizumab|eculizumab|mesh-list
19949774|NCT01567085|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19949775|NCT01567085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19949776|NCT01567085|Immunologic Factors|immunologic factors|mesh-ancestor
19949777|NCT01567085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949778|NCT01567163|Docetaxel|docetaxel|mesh-list
19949779|NCT01567163|Ramucirumab|ramucirumab|mesh-list
19949780|NCT01567163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19949781|NCT01567163|Tubulin Modulators|tubulin modulators|mesh-ancestor
19949782|NCT01567163|Antimitotic Agents|antimitotic agents|mesh-ancestor
19949783|NCT01567163|Mitosis Modulators|mitosis modulators|mesh-ancestor
19949784|NCT01567163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949785|NCT01567527|Aripiprazole|aripiprazole|mesh-list
19949786|NCT01567527|Antidepressive Agents|antidepressive agents|mesh-ancestor
19949787|NCT01567527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19949788|NCT01567527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19949789|NCT01567527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19949790|NCT01567527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19949791|NCT01567527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949792|NCT01567527|Dopamine Agonists|dopamine agonists|mesh-ancestor
19949793|NCT01567527|Dopamine Agents|dopamine agents|mesh-ancestor
19949794|NCT01567527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949795|NCT01567527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949796|NCT01567527|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19949797|NCT01567527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19949798|NCT01567527|Serotonin Agents|serotonin agents|mesh-ancestor
19949799|NCT01567527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19949800|NCT01567527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19949801|NCT01567527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19949802|NCT01567527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19974296|NCT01834729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19974297|NCT01834729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974298|NCT01834729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974299|NCT01834729|Urological Agents|urological agents|mesh-ancestor
19974300|NCT01835158|Sunitinib|sunitinib|mesh-list
19974301|NCT01835158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974302|NCT01835158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19974303|NCT01835158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19974304|NCT01835158|Growth Substances|growth substances|mesh-ancestor
19974305|NCT01835158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974306|NCT01835158|Growth Inhibitors|growth inhibitors|mesh-ancestor
19974307|NCT01835158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19974308|NCT01835158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974309|NCT01835158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974310|NCT01835262|Ketamine|ketamine|mesh-list
19974311|NCT01835262|Morphine|morphine|mesh-list
19974312|NCT01835262|Analgesics|analgesics|mesh-ancestor
19974313|NCT01835262|Sensory System Agents|sensory system agents|mesh-ancestor
19974314|NCT01835262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19974315|NCT01835262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974316|NCT01835262|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19974317|NCT01835262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19974318|NCT01835262|Anesthetics, General|anesthetics, general|mesh-ancestor
19974319|NCT01835262|Anesthetics|anesthetics|mesh-ancestor
19974320|NCT01835262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19974321|NCT01835262|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19974322|NCT01835262|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19974323|NCT01835262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19974324|NCT01835262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974325|NCT01835262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19974326|NCT01835262|Narcotics|narcotics|mesh-ancestor
19974327|NCT01835431|Insulin|insulin|mesh-list
19974328|NCT01835431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19974329|NCT01835431|Insulin Aspart|insulin aspart|mesh-list
19974330|NCT01835431|Insulin, Long-Acting|insulin, long-acting|mesh-list
19974331|NCT01835431|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19974332|NCT01835431|Insulin Detemir|insulin detemir|mesh-list
19974333|NCT01835431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19974334|NCT01835431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974335|NCT01835470|Abatacept|abatacept|mesh-list
19974336|NCT01835470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19974337|NCT01835470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974338|NCT01835470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974339|NCT01835470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19974340|NCT01835470|Immunologic Factors|immunologic factors|mesh-ancestor
19974341|NCT01835470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974342|NCT01835470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19974343|NCT01835496|Deferiprone|deferiprone|mesh-list
19974344|NCT01835496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19974345|NCT01835496|Chelating Agents|chelating agents|mesh-ancestor
19974346|NCT01835496|Sequestering Agents|sequestering agents|mesh-ancestor
19974347|NCT01835496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974348|NCT01835587|Cc-486|cc-486|mesh-list
19974349|NCT01835587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974350|NCT01835912|Citric Acid|citric acid|mesh-list
19974351|NCT01835912|Sodium Citrate|sodium citrate|mesh-list
19974352|NCT01835912|Anticoagulants|anticoagulants|mesh-ancestor
19974353|NCT01835912|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19974354|NCT01835912|Chelating Agents|chelating agents|mesh-ancestor
19974355|NCT01835912|Sequestering Agents|sequestering agents|mesh-ancestor
19974356|NCT01835912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974357|NCT01836029|Carboplatin|carboplatin|mesh-list
19974358|NCT01836029|Fluorouracil|fluorouracil|mesh-list
19974359|NCT01836029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974360|NCT01836029|Antimetabolites|antimetabolites|mesh-ancestor
19974361|NCT01836029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974362|NCT01836029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19974363|NCT01836029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19974364|NCT01836029|Immunologic Factors|immunologic factors|mesh-ancestor
19949803|NCT01567826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19949804|NCT01567826|Atorvastatin|atorvastatin|mesh-list
19949805|NCT01567826|Simvastatin|simvastatin|mesh-list
19949806|NCT01567826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19949807|NCT01567826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19949808|NCT01567826|Antimetabolites|antimetabolites|mesh-ancestor
19949809|NCT01567826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949810|NCT01567826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19949811|NCT01567826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19949812|NCT01567826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949813|NCT01567852|Ketamine|ketamine|mesh-list
19949814|NCT01567852|Methohexital|methohexital|mesh-list
19949815|NCT01567852|Analgesics|analgesics|mesh-ancestor
19949816|NCT01567852|Sensory System Agents|sensory system agents|mesh-ancestor
19949817|NCT01567852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19949818|NCT01567852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949819|NCT01567852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19949820|NCT01567852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19949821|NCT01567852|Anesthetics, General|anesthetics, general|mesh-ancestor
19949822|NCT01567852|Anesthetics|anesthetics|mesh-ancestor
19949823|NCT01567852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19949824|NCT01567852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19949825|NCT01567852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19949826|NCT01567852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949827|NCT01567852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949828|NCT01567865|Vaccines|vaccines|mesh-list
19949829|NCT01567865|Immunologic Factors|immunologic factors|mesh-ancestor
19949830|NCT01567865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949831|NCT01568008|Bimatoprost|bimatoprost|mesh-list
19949832|NCT01568008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19949833|NCT01568008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19949834|NCT01568008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19949835|NCT01568034|Levodopa|levodopa|mesh-list
19949836|NCT01568034|Carbidopa|carbidopa|mesh-list
19949837|NCT01568034|Opicapone|opicapone|mesh-list
19949838|NCT01568034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19949839|NCT01568034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19949840|NCT01568034|Dopamine Agents|dopamine agents|mesh-ancestor
19949841|NCT01568034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949842|NCT01568034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949843|NCT01568034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949844|NCT01568034|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19949845|NCT01568034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949846|NCT01568034|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19949847|NCT01568047|Levodopa|levodopa|mesh-list
19949848|NCT01568047|Carbidopa|carbidopa|mesh-list
19949849|NCT01568047|Opicapone|opicapone|mesh-list
19949850|NCT01568047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19949851|NCT01568047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19949852|NCT01568047|Dopamine Agents|dopamine agents|mesh-ancestor
19949853|NCT01568047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949854|NCT01568047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949855|NCT01568047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949856|NCT01568047|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19949857|NCT01568047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949858|NCT01568047|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19949859|NCT01568073|Levodopa|levodopa|mesh-list
19949860|NCT01568073|Carbidopa|carbidopa|mesh-list
19949861|NCT01568073|Opicapone|opicapone|mesh-list
19949862|NCT01568073|Entacapone|entacapone|mesh-list
19949863|NCT01568073|Benserazide|benserazide|mesh-list
19949864|NCT01568073|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19949865|NCT01568073|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19949866|NCT01568073|Dopamine Agents|dopamine agents|mesh-ancestor
19949867|NCT01568073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949868|NCT01568073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949869|NCT01568073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949870|NCT01568073|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19949871|NCT01568073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949872|NCT01568073|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19949873|NCT01568112|Aspirin|aspirin|mesh-list
19949874|NCT01568112|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19949875|NCT01568112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19949876|NCT01568112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19949877|NCT01568112|Analgesics|analgesics|mesh-ancestor
20543534|NCT01870427|Growth Inhibitors|growth inhibitors|mesh-ancestor
19949878|NCT01568112|Sensory System Agents|sensory system agents|mesh-ancestor
19949879|NCT01568112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19949880|NCT01568112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949881|NCT01568112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19949882|NCT01568112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19949883|NCT01568112|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19949884|NCT01568112|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19949885|NCT01568112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949886|NCT01568112|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19949887|NCT01568112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19949888|NCT01568112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949889|NCT01568112|Antipyretics|antipyretics|mesh-ancestor
19949890|NCT01568112|Dermatologic Agents|dermatologic agents|mesh-ancestor
19949891|NCT01568112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19949892|NCT01568112|Immunologic Factors|immunologic factors|mesh-ancestor
19949893|NCT01568255|Ergocalciferols|ergocalciferols|mesh-list
19949894|NCT01568255|Vitamin D|vitamin d|mesh-list
19949895|NCT01568255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19949896|NCT01568255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949897|NCT01568255|Vitamins|vitamins|mesh-ancestor
19949898|NCT01568255|Micronutrients|micronutrients|mesh-ancestor
19949899|NCT01568255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19949900|NCT01568528|Oxytocin|oxytocin|mesh-list
19949901|NCT01568528|Oxytocics|oxytocics|mesh-ancestor
19949902|NCT01568528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19949903|NCT01568528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949904|NCT01568866|Dexamethasone|dexamethasone|mesh-list
19949905|NCT01568866|Bortezomib|bortezomib|mesh-list
19949906|NCT01568866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19949907|NCT01568866|Antiemetics|antiemetics|mesh-ancestor
19949908|NCT01568866|Autonomic Agents|autonomic agents|mesh-ancestor
19949909|NCT01568866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19949910|NCT01568866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949911|NCT01568866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19949912|NCT01568866|Glucocorticoids|glucocorticoids|mesh-ancestor
19949913|NCT01568866|Hormones|hormones|mesh-ancestor
19949914|NCT01568866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19949915|NCT01568866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19949916|NCT01568866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19949917|NCT01568892|Dolutegravir|dolutegravir|mesh-list
19949918|NCT01568892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19949919|NCT01568892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19949920|NCT01568892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949921|NCT01568892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949922|NCT01568892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19949923|NCT01568892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19949924|NCT01568892|Antiviral Agents|antiviral agents|mesh-ancestor
19949925|NCT01568892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19949926|NCT01568905|Nicotine|nicotine|mesh-list
19949927|NCT01568905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19949928|NCT01568905|Autonomic Agents|autonomic agents|mesh-ancestor
19949929|NCT01568905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19949930|NCT01568905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949931|NCT01568905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19949932|NCT01568905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19949933|NCT01568905|Cholinergic Agents|cholinergic agents|mesh-ancestor
19949934|NCT01568905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949935|NCT01568905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949936|NCT01568944|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19949937|NCT01568944|Lansoprazole|lansoprazole|mesh-list
19949938|NCT01568944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19949939|NCT01568944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19949940|NCT01568944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19949941|NCT01568944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19949942|NCT01568944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949943|NCT01568944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949944|NCT01569087|Lenograstim|lenograstim|mesh-list
19949945|NCT01569087|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19949946|NCT01569087|Immunologic Factors|immunologic factors|mesh-ancestor
19949947|NCT01569087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949948|NCT01569126|Fluoxetine|fluoxetine|mesh-list
19949949|NCT01569126|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19949950|NCT01569126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20554146|NCT01933568|Cisplatin|cisplatin|mesh-list
19949951|NCT01569126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19974365|NCT01836029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949952|NCT01569126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949953|NCT01569126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949954|NCT01569126|Serotonin Agents|serotonin agents|mesh-ancestor
19949955|NCT01569126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949956|NCT01569126|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19949957|NCT01569126|Antidepressive Agents|antidepressive agents|mesh-ancestor
19949958|NCT01569126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19949959|NCT01569126|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19949960|NCT01569126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19949961|NCT01569126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949962|NCT01569152|Methotrexate|methotrexate|mesh-list
19949963|NCT01569152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19949964|NCT01569152|Abortifacient Agents|abortifacient agents|mesh-ancestor
19949965|NCT01569152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19949966|NCT01569152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949967|NCT01569152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19949968|NCT01569152|Antimetabolites|antimetabolites|mesh-ancestor
19949969|NCT01569152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949970|NCT01569152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19949971|NCT01569152|Dermatologic Agents|dermatologic agents|mesh-ancestor
19949972|NCT01569152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19949973|NCT01569152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19949974|NCT01569152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19949975|NCT01569152|Immunologic Factors|immunologic factors|mesh-ancestor
19949976|NCT01569152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19949977|NCT01569152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19949978|NCT01569191|Anti-Allergic Agents|anti-allergic agents|mesh-list
19949979|NCT01569191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19949980|NCT01569191|Lubricant Eye Drops|lubricant eye drops|mesh-list
19949981|NCT01569191|Epinastine|epinastine|mesh-list
19949982|NCT01569191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19949983|NCT01569191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19949984|NCT01569191|Histamine Antagonists|histamine antagonists|mesh-ancestor
19949985|NCT01569191|Histamine Agents|histamine agents|mesh-ancestor
19949986|NCT01569191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19949987|NCT01569191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19949988|NCT01569191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949989|NCT01569295|Rituximab|rituximab|mesh-list
19949990|NCT01569295|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19949991|NCT01569295|Idelalisib|idelalisib|mesh-list
19949992|NCT01569295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19949993|NCT01569295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19949994|NCT01569295|Immunologic Factors|immunologic factors|mesh-ancestor
19949995|NCT01569295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19949996|NCT01569295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20268962|NCT05318560|Lidocaine|lidocaine|mesh-list
20268963|NCT05318560|Anesthetics, Local|anesthetics, local|mesh-ancestor
20268964|NCT05318560|Anesthetics|anesthetics|mesh-ancestor
20268965|NCT05318560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20268966|NCT05318560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268967|NCT05318560|Sensory System Agents|sensory system agents|mesh-ancestor
20268968|NCT05318560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20268969|NCT05318560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20268970|NCT05318560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20268971|NCT05318560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20268972|NCT05318560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20268973|NCT05318560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268974|NCT05318469|Ivermectin|ivermectin|mesh-list
20268975|NCT05318469|Pembrolizumab|pembrolizumab|mesh-list
20268976|NCT05318469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20268977|NCT05318469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20268978|NCT05318469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20268979|NCT05318469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20268980|NCT05318248|Clonidine|clonidine|mesh-list
19949997|NCT01569295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19949998|NCT01569295|Alkylating Agents|alkylating agents|mesh-ancestor
19949999|NCT01569295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950000|NCT01569295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19950001|NCT01569451|Rituximab|rituximab|mesh-list
19950002|NCT01569451|Glatiramer Acetate|glatiramer acetate|mesh-list
19950003|NCT01569451|(T,G)-A-L|(t,g)-a-l|mesh-list
19950004|NCT01569451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20268981|NCT05318248|Analgesics|analgesics|mesh-ancestor
20268982|NCT05318248|Sensory System Agents|sensory system agents|mesh-ancestor
19950005|NCT01569451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950006|NCT01569451|Immunologic Factors|immunologic factors|mesh-ancestor
19950007|NCT01569451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950008|NCT01569451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19950009|NCT01569451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19950010|NCT01569451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19950011|NCT01569464|Rotigotine|rotigotine|mesh-list
19950012|NCT01569464|Dopamine Agonists|dopamine agonists|mesh-ancestor
19950013|NCT01569464|Dopamine Agents|dopamine agents|mesh-ancestor
19950014|NCT01569464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19950015|NCT01569464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950016|NCT01569464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950017|NCT01569815|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19950018|NCT01569815|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19950019|NCT01569815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950020|NCT01569828|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19950021|NCT01569828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19950022|NCT01569828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950023|NCT01569841|Insulin|insulin|mesh-list
19950024|NCT01569841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19950025|NCT01569841|Insulin Glargine|insulin glargine|mesh-list
19950026|NCT01569841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19950027|NCT01569841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950028|NCT01570036|Trastuzumab|trastuzumab|mesh-list
19950029|NCT01570036|Molgramostim|molgramostim|mesh-list
19950030|NCT01570036|Sargramostim|sargramostim|mesh-list
19950031|NCT01570036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19950032|NCT01570036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950033|NCT01570036|Immunologic Factors|immunologic factors|mesh-ancestor
19950034|NCT01570036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950035|NCT01570192|Vancomycin|vancomycin|mesh-list
19950036|NCT01570192|Gentamicins|gentamicins|mesh-list
19950037|NCT01570192|Meropenem|meropenem|mesh-list
19950038|NCT01570192|Linezolid|linezolid|mesh-list
19950039|NCT01570192|Tobramycin|tobramycin|mesh-list
19950040|NCT01570192|Amikacin|amikacin|mesh-list
20268983|NCT05318248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20268984|NCT05318248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20268985|NCT05318248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20268986|NCT05318248|Sympatholytics|sympatholytics|mesh-ancestor
20268987|NCT05318248|Autonomic Agents|autonomic agents|mesh-ancestor
20268988|NCT05318248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20268989|NCT05318248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20268990|NCT05318248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20268991|NCT05318248|Adrenergic Agents|adrenergic agents|mesh-ancestor
20268992|NCT05318248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20268993|NCT05318248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20268994|NCT05318066|Norepinephrine|norepinephrine|mesh-list
20268995|NCT05318066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20268996|NCT05318066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20268997|NCT05318066|Adrenergic Agents|adrenergic agents|mesh-ancestor
20268998|NCT05318066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20268999|NCT05318066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269000|NCT05318066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269001|NCT05318066|Sympathomimetics|sympathomimetics|mesh-ancestor
20269002|NCT05318066|Autonomic Agents|autonomic agents|mesh-ancestor
20269003|NCT05318066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269004|NCT05318066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20269005|NCT05317936|Venetoclax|venetoclax|mesh-list
20269006|NCT05317936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269007|NCT05317858|Pembrolizumab|pembrolizumab|mesh-list
20269008|NCT05317858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20269009|NCT05317858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269010|NCT05317806|Metformin|metformin|mesh-list
20269011|NCT05317806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20269012|NCT05317806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269013|NCT05317767|Vaccines|vaccines|mesh-list
20269014|NCT05317767|Immunologic Factors|immunologic factors|mesh-ancestor
20269015|NCT05317767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269016|NCT05317676|Palmidrol|palmidrol|mesh-list
20269017|NCT05317676|Analgesics|analgesics|mesh-ancestor
20269018|NCT05317676|Sensory System Agents|sensory system agents|mesh-ancestor
20269019|NCT05317676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950041|NCT01570192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20269020|NCT05317676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950042|NCT01570192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19950043|NCT01570192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19950044|NCT01570192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19950045|NCT01570192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950046|NCT01570244|Levonorgestrel|levonorgestrel|mesh-list
19950047|NCT01570244|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19950048|NCT01570244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19950049|NCT01570244|Contraceptive Agents|contraceptive agents|mesh-ancestor
19950050|NCT01570244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19950051|NCT01570244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950052|NCT01570244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19950053|NCT01570244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19950054|NCT01570244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19950055|NCT01570244|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19950056|NCT01570244|Estrogens|estrogens|mesh-ancestor
19950057|NCT01570244|Hormones|hormones|mesh-ancestor
19950058|NCT01570244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19450280|NCT03429946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450281|NCT03429946|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19450282|NCT03429946|Diuretics|diuretics|mesh-ancestor
19950059|NCT01570309|Ergocalciferols|ergocalciferols|mesh-list
19950060|NCT01570309|Vitamin D|vitamin d|mesh-list
19950061|NCT01570309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19950062|NCT01570309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950063|NCT01570309|Vitamins|vitamins|mesh-ancestor
19950064|NCT01570309|Micronutrients|micronutrients|mesh-ancestor
19950065|NCT01570309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19950066|NCT01570348|Mycophenolic Acid|mycophenolic acid|mesh-list
19950067|NCT01570348|Cyclophosphamide|cyclophosphamide|mesh-list
19950068|NCT01570348|Fludarabine|fludarabine|mesh-list
19950069|NCT01570348|Fludarabine phosphate|fludarabine phosphate|mesh-list
19950070|NCT01570348|Tacrolimus|tacrolimus|mesh-list
19950071|NCT01570348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19950072|NCT01570348|Immunologic Factors|immunologic factors|mesh-ancestor
19950073|NCT01570348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950074|NCT01570348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19950075|NCT01570348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19950076|NCT01570348|Alkylating Agents|alkylating agents|mesh-ancestor
19950077|NCT01570348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950078|NCT01570348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950079|NCT01570348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19950080|NCT01570348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19950081|NCT01570348|Antimetabolites|antimetabolites|mesh-ancestor
19950082|NCT01570348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19950083|NCT01570348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19950084|NCT01570348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19950085|NCT01570348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19950086|NCT01570348|Antitubercular Agents|antitubercular agents|mesh-ancestor
19950087|NCT01570348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19950088|NCT01570348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19950089|NCT01570361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19950090|NCT01570387|Dexamethasone|dexamethasone|mesh-list
19950091|NCT01570387|Dexamethasone acetate|dexamethasone acetate|mesh-list
19950092|NCT01570387|Pomalidomide|pomalidomide|mesh-list
19950093|NCT01570387|BB 1101|bb 1101|mesh-list
19950094|NCT01570387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19950095|NCT01570387|Antiemetics|antiemetics|mesh-ancestor
19950096|NCT01570387|Autonomic Agents|autonomic agents|mesh-ancestor
19950097|NCT01570387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950098|NCT01570387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950099|NCT01570387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19950100|NCT01570387|Glucocorticoids|glucocorticoids|mesh-ancestor
19950101|NCT01570387|Hormones|hormones|mesh-ancestor
19950102|NCT01570387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19950103|NCT01570387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19950104|NCT01570387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950105|NCT01570387|Protease Inhibitors|protease inhibitors|mesh-ancestor
20269021|NCT05317676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19950106|NCT01570387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19950107|NCT01570387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950108|NCT01570387|Immunologic Factors|immunologic factors|mesh-ancestor
20269022|NCT05317676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20269023|NCT05317676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19950109|NCT01570387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19950110|NCT01570387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19950111|NCT01570387|Growth Substances|growth substances|mesh-ancestor
19950112|NCT01570387|Growth Inhibitors|growth inhibitors|mesh-ancestor
19950113|NCT01570491|Anesthetics|anesthetics|mesh-list
19950114|NCT01570491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19950115|NCT01570491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950116|NCT01570751|Insulin|insulin|mesh-list
19950117|NCT01570751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19950118|NCT01570751|Insulin Glargine|insulin glargine|mesh-list
19950119|NCT01570751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19950120|NCT01570751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950121|NCT01570868|Ponatinib|ponatinib|mesh-list
19950122|NCT01570868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950123|NCT01570868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19950124|NCT01570868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19950125|NCT01570868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950126|NCT01571232|Dexamethasone|dexamethasone|mesh-list
19950127|NCT01571232|Bevacizumab|bevacizumab|mesh-list
19950128|NCT01571232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19950129|NCT01571232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950130|NCT01571232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19950131|NCT01571232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19950132|NCT01571232|Growth Substances|growth substances|mesh-ancestor
19950133|NCT01571232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950134|NCT01571232|Growth Inhibitors|growth inhibitors|mesh-ancestor
19950135|NCT01571232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19950136|NCT01571232|Antiemetics|antiemetics|mesh-ancestor
19950137|NCT01571232|Autonomic Agents|autonomic agents|mesh-ancestor
19950138|NCT01571232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950139|NCT01571232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19950140|NCT01571232|Glucocorticoids|glucocorticoids|mesh-ancestor
19950141|NCT01571232|Hormones|hormones|mesh-ancestor
19950142|NCT01571232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19950143|NCT01571232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19950144|NCT01571284|Aflibercept|aflibercept|mesh-list
19950145|NCT01571284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19950146|NCT01571284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19950147|NCT01571284|Growth Substances|growth substances|mesh-ancestor
19950148|NCT01571284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950149|NCT01571284|Growth Inhibitors|growth inhibitors|mesh-ancestor
19950150|NCT01571284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950151|NCT01571362|Naltrexone|naltrexone|mesh-list
19950152|NCT01571362|Oxycodone|oxycodone|mesh-list
19950153|NCT01571362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19950154|NCT01571362|Narcotics|narcotics|mesh-ancestor
19950155|NCT01571362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19950156|NCT01571362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950157|NCT01571362|Analgesics|analgesics|mesh-ancestor
19950158|NCT01571362|Sensory System Agents|sensory system agents|mesh-ancestor
19950159|NCT01571362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950160|NCT01571362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19950161|NCT01571362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19950162|NCT01571453|Vortioxetine|vortioxetine|mesh-list
19950163|NCT01571453|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19950164|NCT01571453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19950165|NCT01571453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19950166|NCT01571453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19950167|NCT01571453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950168|NCT01571453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19950169|NCT01571453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950170|NCT01571453|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19950171|NCT01571453|Antidepressive Agents|antidepressive agents|mesh-ancestor
19950172|NCT01571453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19950173|NCT01571453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19950174|NCT01571453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19950175|NCT01571453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19950176|NCT01571453|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19950177|NCT01571453|Serotonin Agents|serotonin agents|mesh-ancestor
19950178|NCT01571453|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19950179|NCT01571453|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19950180|NCT01571453|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19950181|NCT01571453|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19950182|NCT01571557|Dexamethasone|dexamethasone|mesh-list
19950183|NCT01571557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19950184|NCT01571557|Antiemetics|antiemetics|mesh-ancestor
19950185|NCT01571557|Autonomic Agents|autonomic agents|mesh-ancestor
19950186|NCT01571557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950187|NCT01571557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950188|NCT01571557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19950189|NCT01571557|Glucocorticoids|glucocorticoids|mesh-ancestor
19950190|NCT01571557|Hormones|hormones|mesh-ancestor
19950191|NCT01571557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19950192|NCT01571557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19950193|NCT01571557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950194|NCT01572038|Paclitaxel|paclitaxel|mesh-list
19950195|NCT01572038|Docetaxel|docetaxel|mesh-list
19950196|NCT01572038|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19950197|NCT01572038|Trastuzumab|trastuzumab|mesh-list
19950198|NCT01572038|Pertuzumab|pertuzumab|mesh-list
19950199|NCT01572038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19950200|NCT01572038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950201|NCT01572038|Tubulin Modulators|tubulin modulators|mesh-ancestor
19950202|NCT01572038|Antimitotic Agents|antimitotic agents|mesh-ancestor
19950203|NCT01572038|Mitosis Modulators|mitosis modulators|mesh-ancestor
19950204|NCT01572038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950205|NCT01572038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19950206|NCT01572727|Paclitaxel|paclitaxel|mesh-list
19950207|NCT01572727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19950208|NCT01572727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950209|NCT01572727|Tubulin Modulators|tubulin modulators|mesh-ancestor
19950210|NCT01572727|Antimitotic Agents|antimitotic agents|mesh-ancestor
19950211|NCT01572727|Mitosis Modulators|mitosis modulators|mesh-ancestor
19950212|NCT01572727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950213|NCT01572740|Liraglutide|liraglutide|mesh-list
19950214|NCT01572740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19950215|NCT01572740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950216|NCT01572740|Incretins|incretins|mesh-ancestor
19950217|NCT01572740|Hormones|hormones|mesh-ancestor
19950218|NCT01572740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19950219|NCT01572792|Bromides|bromides|mesh-list
19950220|NCT01572792|Formoterol Fumarate|formoterol fumarate|mesh-list
19950221|NCT01572792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19950222|NCT01572792|Autonomic Agents|autonomic agents|mesh-ancestor
19950223|NCT01572792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950224|NCT01572792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950225|NCT01572792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19950226|NCT01572792|Respiratory System Agents|respiratory system agents|mesh-ancestor
19950227|NCT01572792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19950228|NCT01572792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19950229|NCT01572792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19950230|NCT01572792|Adrenergic Agents|adrenergic agents|mesh-ancestor
19950231|NCT01572792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19950232|NCT01572792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950233|NCT01572792|Anticonvulsants|anticonvulsants|mesh-ancestor
19950234|NCT01572844|Sodium thiosulfate|sodium thiosulfate|mesh-list
19950235|NCT01572844|Antidotes|antidotes|mesh-ancestor
19950236|NCT01572844|Protective Agents|protective agents|mesh-ancestor
19950237|NCT01572844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950238|NCT01572844|Antioxidants|antioxidants|mesh-ancestor
19950239|NCT01572844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950240|NCT01572844|Antitubercular Agents|antitubercular agents|mesh-ancestor
19950241|NCT01572844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19950242|NCT01572844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19950243|NCT01572844|Chelating Agents|chelating agents|mesh-ancestor
19950244|NCT01572844|Sequestering Agents|sequestering agents|mesh-ancestor
19950245|NCT01573000|Tositumomab I-131|tositumomab i-131|mesh-list
19950246|NCT01573000|Antibodies|antibodies|mesh-list
19950247|NCT01573000|Immunoglobulins|immunoglobulins|mesh-list
19950248|NCT01573000|Immunologic Factors|immunologic factors|mesh-ancestor
19950249|NCT01573000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269024|NCT05317676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20269025|NCT05317676|Antiviral Agents|antiviral agents|mesh-ancestor
20269026|NCT05317676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20269027|NCT05317676|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20269028|NCT05317676|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20269029|NCT05317676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20269030|NCT05317676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269031|NCT05317676|Hormones|hormones|mesh-ancestor
19950250|NCT01573000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950251|NCT01573052|Chlordiazepoxide|chlordiazepoxide|mesh-list
19950252|NCT01573052|Gabapentin|gabapentin|mesh-list
19950253|NCT01573052|Analgesics|analgesics|mesh-ancestor
19950254|NCT01573052|Sensory System Agents|sensory system agents|mesh-ancestor
19950255|NCT01573052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950256|NCT01573052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950257|NCT01573052|Anticonvulsants|anticonvulsants|mesh-ancestor
19950258|NCT01573052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19950259|NCT01573052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19950260|NCT01573052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19950261|NCT01573052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19950262|NCT01573052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19950263|NCT01573052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19950264|NCT01573052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19950265|NCT01573052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950266|NCT01573052|Antimanic Agents|antimanic agents|mesh-ancestor
19950267|NCT01573052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19950268|NCT01573052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19950269|NCT01573052|GABA Modulators|gaba modulators|mesh-ancestor
19950270|NCT01573052|GABA Agents|gaba agents|mesh-ancestor
19950271|NCT01573169|Enoxaparin|enoxaparin|mesh-list
19950272|NCT01573169|Anticoagulants|anticoagulants|mesh-ancestor
19950273|NCT01573169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19950274|NCT01573169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19950275|NCT01573169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950276|NCT01573273|Oxytocin|oxytocin|mesh-list
19950277|NCT01573273|Oxytocics|oxytocics|mesh-ancestor
19950278|NCT01573273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19950279|NCT01573273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950280|NCT01573442|Testosterone|testosterone|mesh-list
19950281|NCT01573442|Androgens|androgens|mesh-ancestor
19950282|NCT01573442|Hormones|hormones|mesh-ancestor
19950283|NCT01573442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19950284|NCT01573442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950285|NCT01573533|Rituximab|rituximab|mesh-list
19950286|NCT01573533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19950287|NCT01573533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950288|NCT01573533|Immunologic Factors|immunologic factors|mesh-ancestor
19950289|NCT01573533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950290|NCT01573533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19950291|NCT01573702|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19950292|NCT01573702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950293|NCT01573702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19950294|NCT01573702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19950295|NCT01573702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950296|NCT01573767|Fluticasone|fluticasone|mesh-list
19950297|NCT01573767|Xhance|xhance|mesh-list
19950298|NCT01573767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19950299|NCT01573767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19950300|NCT01573767|Autonomic Agents|autonomic agents|mesh-ancestor
19950301|NCT01573767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950302|NCT01573767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950303|NCT01573767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19950304|NCT01573767|Respiratory System Agents|respiratory system agents|mesh-ancestor
19950305|NCT01573767|Dermatologic Agents|dermatologic agents|mesh-ancestor
19950306|NCT01573767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19950307|NCT01573910|Moxifloxacin|moxifloxacin|mesh-list
19950308|NCT01573910|Ofloxacin|ofloxacin|mesh-list
19950309|NCT01573910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19950310|NCT01573910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19950311|NCT01573910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19950312|NCT01573910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19950313|NCT01573910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19950314|NCT01573910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19950315|NCT01573910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19950316|NCT01573910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950317|NCT01573910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950318|NCT01573910|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19950319|NCT01573910|Renal Agents|renal agents|mesh-ancestor
19950320|NCT01573910|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19950321|NCT01573910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19950322|NCT01573949|Metformin|metformin|mesh-list
19950323|NCT01573949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19950324|NCT01573949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950325|NCT01574183|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
19950326|NCT01574183|Antidepressive Agents|antidepressive agents|mesh-ancestor
19950327|NCT01574183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19950328|NCT01574183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19950329|NCT01574183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19950330|NCT01574183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19950331|NCT01574183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950332|NCT01574183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19950333|NCT01574183|Serotonin Agents|serotonin agents|mesh-ancestor
19950334|NCT01574183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950335|NCT01574183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19950336|NCT01574183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19950337|NCT01574248|Icatibant|icatibant|mesh-list
19950338|NCT01574248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19950339|NCT01574248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19950340|NCT01574248|Analgesics|analgesics|mesh-ancestor
19950341|NCT01574248|Sensory System Agents|sensory system agents|mesh-ancestor
19950342|NCT01574248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950343|NCT01574248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950344|NCT01574248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19950345|NCT01574248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19950346|NCT01574248|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
19950347|NCT01574248|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
19950348|NCT01574248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950349|NCT01574248|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19950350|NCT01574248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19950351|NCT01574248|Immunologic Factors|immunologic factors|mesh-ancestor
19950352|NCT01574326|Sevelamer|sevelamer|mesh-list
19950353|NCT01574326|Chelating Agents|chelating agents|mesh-ancestor
19950354|NCT01574326|Sequestering Agents|sequestering agents|mesh-ancestor
19950355|NCT01574326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950356|NCT01574612|Acyclovir|acyclovir|mesh-list
19950357|NCT01574612|Hydrocortisone|hydrocortisone|mesh-list
19950358|NCT01574612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19950359|NCT01574612|Antiviral Agents|antiviral agents|mesh-ancestor
19950360|NCT01574612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19950361|NCT01574651|Glycopyrrolate|glycopyrrolate|mesh-list
19950362|NCT01574651|Formoterol Fumarate|formoterol fumarate|mesh-list
19950363|NCT01574651|Tiotropium Bromide|tiotropium bromide|mesh-list
19950364|NCT01574651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19950365|NCT01574651|Autonomic Agents|autonomic agents|mesh-ancestor
19950366|NCT01574651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950367|NCT01574651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950368|NCT01574651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19950369|NCT01574651|Respiratory System Agents|respiratory system agents|mesh-ancestor
19950370|NCT01574651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19950371|NCT01574651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19950372|NCT01574651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19950373|NCT01574651|Adrenergic Agents|adrenergic agents|mesh-ancestor
19950374|NCT01574651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19950375|NCT01574651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950376|NCT01574651|Parasympatholytics|parasympatholytics|mesh-ancestor
19950377|NCT01574651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19950378|NCT01574651|Cholinergic Agents|cholinergic agents|mesh-ancestor
19950379|NCT01574651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19950380|NCT01574651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19950381|NCT01574703|Bupropion|bupropion|mesh-list
19950382|NCT01574703|Nicotine|nicotine|mesh-list
19950383|NCT01574703|Varenicline|varenicline|mesh-list
19950384|NCT01574703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19950385|NCT01574703|Autonomic Agents|autonomic agents|mesh-ancestor
19950386|NCT01574703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950387|NCT01574703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950388|NCT01574703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19950389|NCT01574703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19950390|NCT01574703|Cholinergic Agents|cholinergic agents|mesh-ancestor
19950391|NCT01574703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19950392|NCT01574703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950393|NCT01574703|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19950394|NCT01574703|Antidepressive Agents|antidepressive agents|mesh-ancestor
19950395|NCT01574703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19950396|NCT01574703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19950397|NCT01574703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19950398|NCT01574703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19950399|NCT01574703|Dopamine Agents|dopamine agents|mesh-ancestor
19950400|NCT01574703|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19950401|NCT01574703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19950402|NCT01574703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19950403|NCT01574716|Gemcitabine|gemcitabine|mesh-list
19950404|NCT01574716|Docetaxel|docetaxel|mesh-list
19950405|NCT01574716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19950406|NCT01574716|Antimetabolites|antimetabolites|mesh-ancestor
19950407|NCT01574716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950408|NCT01574716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950409|NCT01574716|Antiviral Agents|antiviral agents|mesh-ancestor
19950410|NCT01574716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19950411|NCT01574716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19950412|NCT01574716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19950413|NCT01574716|Immunologic Factors|immunologic factors|mesh-ancestor
19950414|NCT01574716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950415|NCT01574716|Tubulin Modulators|tubulin modulators|mesh-ancestor
19950416|NCT01574716|Antimitotic Agents|antimitotic agents|mesh-ancestor
19950417|NCT01574716|Mitosis Modulators|mitosis modulators|mesh-ancestor
19974366|NCT01836133|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19974367|NCT01836133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974368|NCT01836133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19974369|NCT01836133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974370|NCT01836133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733000|NCT04567290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733001|NCT04567108|Benzocaine|benzocaine|mesh-list
19733002|NCT04567108|Anesthetics, Local|anesthetics, local|mesh-ancestor
19733003|NCT04567108|Anesthetics|anesthetics|mesh-ancestor
19733004|NCT04567108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19733005|NCT04567108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733006|NCT04567108|Sensory System Agents|sensory system agents|mesh-ancestor
19733007|NCT04567108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733008|NCT04566952|Olaparib|olaparib|mesh-list
19733009|NCT04566952|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19733010|NCT04566952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974371|NCT01836185|Evacetrapib|evacetrapib|mesh-list
19974372|NCT01836185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19974373|NCT01836185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19974374|NCT01836185|Antimetabolites|antimetabolites|mesh-ancestor
19974375|NCT01836185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974376|NCT01836185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19974377|NCT01836198|Clarithromycin|clarithromycin|mesh-list
19974378|NCT01836198|Ketoconazole|ketoconazole|mesh-list
19974379|NCT01836198|Gemfibrozil|gemfibrozil|mesh-list
19974380|NCT01836198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19974381|NCT01836198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19974382|NCT01836198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19974383|NCT01836198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974384|NCT01836198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974385|NCT01836198|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19974386|NCT01836198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19974387|NCT01836198|Antifungal Agents|antifungal agents|mesh-ancestor
19974388|NCT01836198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19974389|NCT01836198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19974390|NCT01836198|Hormone Antagonists|hormone antagonists|mesh-ancestor
19974391|NCT01836198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19974392|NCT01836198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974393|NCT01836198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19974394|NCT01836198|Antimetabolites|antimetabolites|mesh-ancestor
19974395|NCT01836198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19974396|NCT01836198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19974397|NCT01836276|Varenicline|varenicline|mesh-list
19974398|NCT01836276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19974399|NCT01836276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19974400|NCT01836276|Cholinergic Agents|cholinergic agents|mesh-ancestor
19974401|NCT01836276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19974402|NCT01836276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974403|NCT01836276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974404|NCT01836471|Fluticasone|fluticasone|mesh-list
19974405|NCT01836471|Xhance|xhance|mesh-list
19974406|NCT01836471|Indoleacetic Acids|indoleacetic acids|mesh-list
19974407|NCT01836471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19974408|NCT01836471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19974409|NCT01836471|Autonomic Agents|autonomic agents|mesh-ancestor
19974410|NCT01836471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543535|NCT01870427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543536|NCT01870440|Dexamethasone|dexamethasone|mesh-list
19950418|NCT01574807|Lidocaine|lidocaine|mesh-list
19950419|NCT01574807|Mepivacaine|mepivacaine|mesh-list
19950420|NCT01574807|Anesthetics, Local|anesthetics, local|mesh-ancestor
19950421|NCT01574807|Anesthetics|anesthetics|mesh-ancestor
19950422|NCT01574807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19950423|NCT01574807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950424|NCT01574807|Sensory System Agents|sensory system agents|mesh-ancestor
19950425|NCT01574807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950426|NCT01574807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19950427|NCT01574807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19950428|NCT01574807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19950429|NCT01574807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19950430|NCT01574807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950431|NCT01575054|Botulinum Toxins|botulinum toxins|mesh-list
20269032|NCT05317676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20269033|NCT05317611|Ondansetron|ondansetron|mesh-list
20269034|NCT05317611|Bupivacaine|bupivacaine|mesh-list
20269035|NCT05317611|Anesthetics, Local|anesthetics, local|mesh-ancestor
20269036|NCT05317611|Anesthetics|anesthetics|mesh-ancestor
20269037|NCT05317611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20269038|NCT05317611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269039|NCT05317611|Sensory System Agents|sensory system agents|mesh-ancestor
20269040|NCT05317611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269041|NCT05317611|Antiemetics|antiemetics|mesh-ancestor
20269042|NCT05317611|Autonomic Agents|autonomic agents|mesh-ancestor
20269043|NCT05317611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20269044|NCT05317611|Antipruritics|antipruritics|mesh-ancestor
20269045|NCT05317611|Dermatologic Agents|dermatologic agents|mesh-ancestor
20269046|NCT05317611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20269047|NCT05317611|Serotonin Agents|serotonin agents|mesh-ancestor
20269048|NCT05317611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20269049|NCT05317611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269050|NCT05317611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20269051|NCT05317611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20269052|NCT05317611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20269053|NCT05317611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20269054|NCT05317572|Morphine|morphine|mesh-list
20269055|NCT05317572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20269056|NCT05317572|Narcotics|narcotics|mesh-ancestor
20269057|NCT05317572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20269058|NCT05317572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269059|NCT05317572|Analgesics|analgesics|mesh-ancestor
20269060|NCT05317572|Sensory System Agents|sensory system agents|mesh-ancestor
20269061|NCT05317572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269062|NCT05306470|Lidocaine|lidocaine|mesh-list
20269063|NCT05306470|Ethyl Chloride|ethyl chloride|mesh-list
20269064|NCT05306470|Anesthetics, Local|anesthetics, local|mesh-ancestor
20269065|NCT05306470|Anesthetics|anesthetics|mesh-ancestor
20269066|NCT05306470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20269067|NCT05306470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269068|NCT05306470|Sensory System Agents|sensory system agents|mesh-ancestor
20269069|NCT05306470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269070|NCT05306470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20269071|NCT05306470|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20269072|NCT05306470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20269073|NCT05306470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20269074|NCT05306470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269075|NCT05303935|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20269076|NCT05303935|Antidepressive Agents|antidepressive agents|mesh-ancestor
20269077|NCT05303935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20269078|NCT05303935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20269079|NCT05303935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20269080|NCT05303935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20269081|NCT05303935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269082|NCT05302388|Diphenhydramine|diphenhydramine|mesh-list
20269083|NCT05302388|Promethazine|promethazine|mesh-list
20269084|NCT05302388|Dexamethasone|dexamethasone|mesh-list
20269085|NCT05302388|Prednisolone|prednisolone|mesh-list
20269086|NCT05302388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20269087|NCT05302388|Methylprednisolone|methylprednisolone|mesh-list
20269088|NCT05302388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20269089|NCT05302388|Prednisolone acetate|prednisolone acetate|mesh-list
20269090|NCT05302388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20269091|NCT05302388|Prednisolone phosphate|prednisolone phosphate|mesh-list
20269092|NCT05302388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20269093|NCT05302388|Antiemetics|antiemetics|mesh-ancestor
19950432|NCT01575054|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19950433|NCT01575054|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19950434|NCT01575054|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19950435|NCT01575054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19950436|NCT01575054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950437|NCT01575054|Cholinergic Agents|cholinergic agents|mesh-ancestor
19950438|NCT01575054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19950439|NCT01575054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950440|NCT01575054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19950441|NCT01575054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950442|NCT01575275|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19950443|NCT01575275|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19950444|NCT01575275|Dermatologic Agents|dermatologic agents|mesh-ancestor
19950445|NCT01575561|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19950446|NCT01575561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19950447|NCT01575561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19950448|NCT01575561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19950449|NCT01575561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950450|NCT01575561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19950451|NCT01575561|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19950452|NCT01575561|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19950453|NCT01575561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19950454|NCT01575561|Adrenergic Agents|adrenergic agents|mesh-ancestor
19950455|NCT01575561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19950456|NCT01575561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269094|NCT05302388|Autonomic Agents|autonomic agents|mesh-ancestor
20269095|NCT05302388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269096|NCT05302388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269097|NCT05302388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20269098|NCT05302388|Glucocorticoids|glucocorticoids|mesh-ancestor
20269099|NCT05302388|Hormones|hormones|mesh-ancestor
20269100|NCT05302388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20269101|NCT05302388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20269102|NCT05302388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269103|NCT05302388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20269104|NCT05302388|Protective Agents|protective agents|mesh-ancestor
20269105|NCT05302388|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20269106|NCT05302388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20269107|NCT05302388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20269108|NCT05302388|Anesthetics, Local|anesthetics, local|mesh-ancestor
20269109|NCT05302388|Anesthetics|anesthetics|mesh-ancestor
20269110|NCT05302388|Sensory System Agents|sensory system agents|mesh-ancestor
20269111|NCT05302388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20269112|NCT05302388|Histamine Antagonists|histamine antagonists|mesh-ancestor
20269113|NCT05302388|Histamine Agents|histamine agents|mesh-ancestor
20269114|NCT05302388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20269115|NCT05302388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269116|NCT05302388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20269117|NCT05302388|Antipruritics|antipruritics|mesh-ancestor
20269118|NCT05302388|Dermatologic Agents|dermatologic agents|mesh-ancestor
20287361|NCT04914234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287362|NCT04914234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287363|NCT04914234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20287364|NCT04914234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20287365|NCT04914234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20287366|NCT04914234|Adrenergic Agents|adrenergic agents|mesh-ancestor
20287367|NCT04914234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20287368|NCT04914234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287369|NCT04907370|Gemcitabine|gemcitabine|mesh-list
20287370|NCT04907370|Cisplatin|cisplatin|mesh-list
20287371|NCT04907370|Antibodies|antibodies|mesh-list
20543537|NCT01870440|Dexamethasone acetate|dexamethasone acetate|mesh-list
20543538|NCT01870440|BB 1101|bb 1101|mesh-list
20543539|NCT01870440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20543540|NCT01870440|Antiemetics|antiemetics|mesh-ancestor
20543541|NCT01870440|Autonomic Agents|autonomic agents|mesh-ancestor
20543542|NCT01870440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543543|NCT01870440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543544|NCT01870440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20543545|NCT01870440|Glucocorticoids|glucocorticoids|mesh-ancestor
20543546|NCT01870440|Hormones|hormones|mesh-ancestor
20543547|NCT01870440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20543548|NCT01870440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19950457|NCT01575561|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19950458|NCT01575561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19950459|NCT01575561|Serotonin Agents|serotonin agents|mesh-ancestor
19950460|NCT01575561|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19950461|NCT01575561|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19950462|NCT01575561|Dopamine Agents|dopamine agents|mesh-ancestor
19950463|NCT01575834|Denosumab|denosumab|mesh-list
19950464|NCT01575834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19950465|NCT01575834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950466|NCT01575860|Lenalidomide|lenalidomide|mesh-list
19950467|NCT01575860|Immunologic Factors|immunologic factors|mesh-ancestor
19950468|NCT01575860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950469|NCT01575860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19950470|NCT01575860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19950471|NCT01575860|Growth Substances|growth substances|mesh-ancestor
19950472|NCT01575860|Growth Inhibitors|growth inhibitors|mesh-ancestor
19950473|NCT01575860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950474|NCT01575873|Denosumab|denosumab|mesh-list
19950475|NCT01575873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19950476|NCT01575873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950477|NCT01575899|Amoxicillin|amoxicillin|mesh-list
19950478|NCT01575899|Clarithromycin|clarithromycin|mesh-list
19950479|NCT01575899|Levofloxacin|levofloxacin|mesh-list
19950480|NCT01575899|Ofloxacin|ofloxacin|mesh-list
19950481|NCT01575899|Clavulanic Acid|clavulanic acid|mesh-list
19950482|NCT01575899|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19950483|NCT01575899|Rabeprazole|rabeprazole|mesh-list
19950484|NCT01575899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19950485|NCT01575899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19950486|NCT01575899|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19950487|NCT01575899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19950488|NCT01575899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950489|NCT01575899|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19950490|NCT01575899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19950491|NCT01575899|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19950492|NCT01575899|Renal Agents|renal agents|mesh-ancestor
19950493|NCT01575899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19950494|NCT01575899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19950495|NCT01575899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269119|NCT05273671|Dexmedetomidine|dexmedetomidine|mesh-list
20269120|NCT05273671|Nalbuphine|nalbuphine|mesh-list
20269121|NCT05273671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20269122|NCT05273671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20269123|NCT05273671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269124|NCT05273671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20269125|NCT05273671|Analgesics|analgesics|mesh-ancestor
20269126|NCT05273671|Sensory System Agents|sensory system agents|mesh-ancestor
20269127|NCT05273671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269128|NCT05273671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20269129|NCT05273671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20269130|NCT05273671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20269131|NCT05273671|Adrenergic Agents|adrenergic agents|mesh-ancestor
20269132|NCT05273671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20269133|NCT05273671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269134|NCT05273671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20269135|NCT05273671|Narcotics|narcotics|mesh-ancestor
20269136|NCT05262387|Insulin Lispro|insulin lispro|mesh-list
20269137|NCT05262387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20269138|NCT05262387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269139|NCT05242315|Tacrolimus|tacrolimus|mesh-list
20269140|NCT05242315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20269141|NCT05242315|Immunologic Factors|immunologic factors|mesh-ancestor
19950496|NCT01575899|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19950497|NCT01575899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19950498|NCT01575899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19950499|NCT01575899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19950500|NCT01575899|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19950501|NCT01576042|Amiodarone|amiodarone|mesh-list
19950502|NCT01576042|Sotalol|sotalol|mesh-list
19950503|NCT01576042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19950504|NCT01576042|Vasodilator Agents|vasodilator agents|mesh-ancestor
19950505|NCT01576042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19950506|NCT01576042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19950507|NCT01576042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269142|NCT05242315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950508|NCT01576042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19950509|NCT01576042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19950510|NCT01576042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19950511|NCT01576042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19950512|NCT01576042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19950513|NCT01576042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19950514|NCT01576042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19950515|NCT01576042|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19950516|NCT01576042|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19950517|NCT01576042|Adrenergic Agents|adrenergic agents|mesh-ancestor
19950518|NCT01576042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19950519|NCT01576042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950520|NCT01576042|Sympatholytics|sympatholytics|mesh-ancestor
19950521|NCT01576042|Autonomic Agents|autonomic agents|mesh-ancestor
19950522|NCT01576042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950523|NCT01576172|Prednisone|prednisone|mesh-list
19950524|NCT01576172|Cortisone|cortisone|mesh-list
19950525|NCT01576172|Abiraterone Acetate|abiraterone acetate|mesh-list
19950526|NCT01576172|Veliparib|veliparib|mesh-list
19950527|NCT01576172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19950528|NCT01576172|Glucocorticoids|glucocorticoids|mesh-ancestor
19950529|NCT01576172|Hormones|hormones|mesh-ancestor
19950530|NCT01576172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19950531|NCT01576172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950532|NCT01576172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19950533|NCT01576172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950534|NCT01576172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19950535|NCT01576172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19950536|NCT01576172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950537|NCT01576172|Hormone Antagonists|hormone antagonists|mesh-ancestor
19950538|NCT01576172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19950539|NCT01576172|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19950540|NCT01576276|Ketorolac|ketorolac|mesh-list
19950541|NCT01576276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19950542|NCT01576276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19950543|NCT01576276|Analgesics|analgesics|mesh-ancestor
19950544|NCT01576276|Sensory System Agents|sensory system agents|mesh-ancestor
19950545|NCT01576276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950546|NCT01576276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950547|NCT01576276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19950548|NCT01576276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19950549|NCT01576276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19950550|NCT01576276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19950551|NCT01576276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950552|NCT01576341|Epoetin Alfa|epoetin alfa|mesh-list
19950553|NCT01576341|Hematinics|hematinics|mesh-ancestor
19950554|NCT01576406|Crizotinib|crizotinib|mesh-list
19950555|NCT01576406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950556|NCT01576406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19950557|NCT01576406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19950558|NCT01576406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950559|NCT01576484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19950560|NCT01576484|Immunologic Factors|immunologic factors|mesh-ancestor
19950561|NCT01576484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950562|NCT01576523|Complement C1s|complement c1s|mesh-list
19950563|NCT01576523|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19950564|NCT01576523|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
19950565|NCT01576523|Immunologic Factors|immunologic factors|mesh-ancestor
19950566|NCT01576523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950567|NCT01576523|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19950568|NCT01576523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19950569|NCT01576588|Rituximab|rituximab|mesh-list
19950570|NCT01576588|Glucocorticoids|glucocorticoids|mesh-list
19950571|NCT01576588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19950572|NCT01576588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950573|NCT01576588|Immunologic Factors|immunologic factors|mesh-ancestor
19950574|NCT01576588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950575|NCT01576588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19950576|NCT01576588|Hormones|hormones|mesh-ancestor
19950577|NCT01576588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19950578|NCT01576705|Leucovorin|leucovorin|mesh-list
19950579|NCT01576705|Folic Acid|folic acid|mesh-list
19950580|NCT01576705|Hormones|hormones|mesh-list
19950581|NCT01576705|Levoleucovorin|levoleucovorin|mesh-list
19950582|NCT01576705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19950583|NCT01576705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950584|NCT01576705|Antidotes|antidotes|mesh-ancestor
19950585|NCT01576705|Protective Agents|protective agents|mesh-ancestor
19950586|NCT01576705|Vitamin B Complex|vitamin b complex|mesh-ancestor
19950587|NCT01576705|Vitamins|vitamins|mesh-ancestor
19950588|NCT01576705|Micronutrients|micronutrients|mesh-ancestor
19950589|NCT01576705|Hematinics|hematinics|mesh-ancestor
19950590|NCT01576718|Fluticasone|fluticasone|mesh-list
19950591|NCT01576718|Xhance|xhance|mesh-list
19950592|NCT01576718|Albuterol|albuterol|mesh-list
19950593|NCT01576718|Adrenergic Agonists|adrenergic agonists|mesh-list
19950594|NCT01576718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19950595|NCT01576718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19950596|NCT01576718|Autonomic Agents|autonomic agents|mesh-ancestor
19950597|NCT01576718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950598|NCT01576718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950599|NCT01576718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19950600|NCT01576718|Respiratory System Agents|respiratory system agents|mesh-ancestor
19950601|NCT01576718|Dermatologic Agents|dermatologic agents|mesh-ancestor
19950602|NCT01576718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19950603|NCT01576718|Tocolytic Agents|tocolytic agents|mesh-ancestor
19950604|NCT01576718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19950605|NCT01576718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19950606|NCT01576718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19950607|NCT01576718|Adrenergic Agents|adrenergic agents|mesh-ancestor
19950608|NCT01576718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19950609|NCT01576718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950610|NCT01576809|Acetaminophen|acetaminophen|mesh-list
19950611|NCT01576809|Phenylpropanolamine|phenylpropanolamine|mesh-list
19950612|NCT01576809|Phenylephrine|phenylephrine|mesh-list
19950613|NCT01576809|Oxymetazoline|oxymetazoline|mesh-list
19950614|NCT01576809|Guaifenesin|guaifenesin|mesh-list
19950615|NCT01576809|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
19950616|NCT01576809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19950617|NCT01576809|Analgesics|analgesics|mesh-ancestor
19950618|NCT01576809|Sensory System Agents|sensory system agents|mesh-ancestor
19950619|NCT01576809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950620|NCT01576809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950621|NCT01576809|Antipyretics|antipyretics|mesh-ancestor
19950622|NCT01576809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19950623|NCT01576809|Mydriatics|mydriatics|mesh-ancestor
19950624|NCT01576809|Autonomic Agents|autonomic agents|mesh-ancestor
19950625|NCT01576809|Sympathomimetics|sympathomimetics|mesh-ancestor
19950626|NCT01576809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19950627|NCT01576809|Nasal Decongestants|nasal decongestants|mesh-ancestor
19950628|NCT01576809|Respiratory System Agents|respiratory system agents|mesh-ancestor
19950629|NCT01576809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19950630|NCT01576809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19950631|NCT01576809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19950632|NCT01576809|Adrenergic Agents|adrenergic agents|mesh-ancestor
19950633|NCT01576809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19950634|NCT01576809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950635|NCT01576809|Protective Agents|protective agents|mesh-ancestor
19950636|NCT01576809|Expectorants|expectorants|mesh-ancestor
19950637|NCT01576809|Appetite Depressants|appetite depressants|mesh-ancestor
19950638|NCT01576809|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19950639|NCT01576874|Oxytocin|oxytocin|mesh-list
19950640|NCT01576874|Oxytocics|oxytocics|mesh-ancestor
19950641|NCT01576874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19950642|NCT01576874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950643|NCT01576952|Bromfenac|bromfenac|mesh-list
19950644|NCT01576952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19950645|NCT01576952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19950646|NCT01576952|Analgesics|analgesics|mesh-ancestor
19950647|NCT01576952|Sensory System Agents|sensory system agents|mesh-ancestor
19950648|NCT01576952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950649|NCT01576952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950650|NCT01576952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19950651|NCT01576952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19950652|NCT01577160|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19950653|NCT01577160|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19950654|NCT01577160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19950655|NCT01577160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19950656|NCT01577160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950657|NCT01577160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19950658|NCT01577160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19950659|NCT01577160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19950660|NCT01577160|Serotonin Agents|serotonin agents|mesh-ancestor
19950661|NCT01577160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19950662|NCT01577160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733011|NCT04566952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733012|NCT04566952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733013|NCT04567069|Vaccines|vaccines|mesh-list
19733014|NCT04567069|Immunologic Factors|immunologic factors|mesh-ancestor
19733015|NCT04567069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950663|NCT01577160|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19950664|NCT01577160|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19950665|NCT01577160|Dopamine Agents|dopamine agents|mesh-ancestor
19950666|NCT01577186|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19950667|NCT01577186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19950668|NCT01577186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19950669|NCT01577186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19950670|NCT01577186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950671|NCT01577186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19950672|NCT01577186|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19950673|NCT01577186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19950674|NCT01577186|Serotonin Agents|serotonin agents|mesh-ancestor
19950675|NCT01577186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19950676|NCT01577186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950677|NCT01577186|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19950678|NCT01577186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19950679|NCT01577186|Dopamine Agents|dopamine agents|mesh-ancestor
19950680|NCT01577706|Alprazolam|alprazolam|mesh-list
19950681|NCT01577706|Dextroamphetamine|dextroamphetamine|mesh-list
20269143|NCT05242315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20269144|NCT05242315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20269145|NCT05242315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269146|NCT05238233|Proxymetacaine|proxymetacaine|mesh-list
20269147|NCT05238233|Pilocarpine|pilocarpine|mesh-list
20269148|NCT05238233|Tropicamide|tropicamide|mesh-list
20269149|NCT05238233|Miotics|miotics|mesh-ancestor
20269150|NCT05238233|Autonomic Agents|autonomic agents|mesh-ancestor
20269151|NCT05238233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269152|NCT05238233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269153|NCT05238233|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20269154|NCT05238233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20269155|NCT05238233|Cholinergic Agents|cholinergic agents|mesh-ancestor
20269156|NCT05238233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20269157|NCT05238233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269158|NCT05238233|Mydriatics|mydriatics|mesh-ancestor
20269159|NCT05238233|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20269160|NCT05238233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20269161|NCT05238233|Anesthetics, Local|anesthetics, local|mesh-ancestor
20269162|NCT05238233|Anesthetics|anesthetics|mesh-ancestor
20269163|NCT05238233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20269164|NCT05238233|Sensory System Agents|sensory system agents|mesh-ancestor
20269165|NCT05225363|Cyclophosphamide|cyclophosphamide|mesh-list
20269166|NCT05225363|Fludarabine|fludarabine|mesh-list
20269167|NCT05225363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20269168|NCT05225363|Immunologic Factors|immunologic factors|mesh-ancestor
20269169|NCT05225363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269170|NCT05225363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20269171|NCT05225363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20269172|NCT05225363|Alkylating Agents|alkylating agents|mesh-ancestor
20269173|NCT05225363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269174|NCT05225363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269175|NCT05225363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20269176|NCT05220722|Pembrolizumab|pembrolizumab|mesh-list
20269177|NCT05220722|Nivolumab|nivolumab|mesh-list
20269178|NCT05220722|Ipilimumab|ipilimumab|mesh-list
20269179|NCT05220722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20269180|NCT05220722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269181|NCT05220722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20269182|NCT05220722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269183|NCT05204927|Prednisone|prednisone|mesh-list
20269184|NCT05204927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19733016|NCT04566796|Neostigmine|neostigmine|mesh-list
19733017|NCT04566796|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19733018|NCT04566796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733019|NCT04566796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950682|NCT01577706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19950683|NCT01577706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19950684|NCT01577706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950685|NCT01577706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19950686|NCT01577706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19950687|NCT01577706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19950688|NCT01577706|GABA Modulators|gaba modulators|mesh-ancestor
19950689|NCT01577706|GABA Agents|gaba agents|mesh-ancestor
19950690|NCT01577706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19950691|NCT01577706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950692|NCT01577706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19950693|NCT01577706|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19950694|NCT01577706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19950695|NCT01577706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19950696|NCT01577706|Dopamine Agents|dopamine agents|mesh-ancestor
19950697|NCT01577966|Sulfasalazine|sulfasalazine|mesh-list
19950698|NCT01577966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19950699|NCT01577966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19950700|NCT01577966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19950701|NCT01577966|Analgesics|analgesics|mesh-ancestor
19950702|NCT01577966|Sensory System Agents|sensory system agents|mesh-ancestor
19950703|NCT01577966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950704|NCT01577966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950705|NCT01577966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19950706|NCT01577966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19950707|NCT01577966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19950708|NCT01578278|Fluticasone|fluticasone|mesh-list
19950709|NCT01578278|Xhance|xhance|mesh-list
19950710|NCT01578278|Bepotastine besilate|bepotastine besilate|mesh-list
19950711|NCT01578278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19950712|NCT01578278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19950713|NCT01578278|Autonomic Agents|autonomic agents|mesh-ancestor
19950714|NCT01578278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950715|NCT01578278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950716|NCT01578278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19950717|NCT01578278|Respiratory System Agents|respiratory system agents|mesh-ancestor
19950718|NCT01578278|Dermatologic Agents|dermatologic agents|mesh-ancestor
19950719|NCT01578278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19950720|NCT01578317|Vaccines|vaccines|mesh-list
19950721|NCT01578317|Immunologic Factors|immunologic factors|mesh-ancestor
19950722|NCT01578317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950723|NCT01578330|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19950724|NCT01578330|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19950725|NCT01578330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950726|NCT01578330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19950727|NCT01578330|Immunologic Factors|immunologic factors|mesh-ancestor
19950728|NCT01578330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950729|NCT01578486|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19950730|NCT01578486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19950731|NCT01578486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19950732|NCT01578486|Analgesics|analgesics|mesh-ancestor
19950733|NCT01578486|Sensory System Agents|sensory system agents|mesh-ancestor
19950734|NCT01578486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950735|NCT01578486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950736|NCT01578486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19950737|NCT01578486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19950738|NCT01578499|Methotrexate|methotrexate|mesh-list
19950739|NCT01578499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19950740|NCT01578499|Bexarotene|bexarotene|mesh-list
19950741|NCT01578499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19950742|NCT01578499|Abortifacient Agents|abortifacient agents|mesh-ancestor
19950743|NCT01578499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19950744|NCT01578499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950745|NCT01578499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19950746|NCT01578499|Antimetabolites|antimetabolites|mesh-ancestor
19950747|NCT01578499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950748|NCT01578499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950749|NCT01578499|Dermatologic Agents|dermatologic agents|mesh-ancestor
19950750|NCT01578499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19950751|NCT01578499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19950752|NCT01578499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19950753|NCT01578499|Immunologic Factors|immunologic factors|mesh-ancestor
19950754|NCT01578499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19950755|NCT01578499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19950756|NCT01578499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19950757|NCT01578551|Metformin|metformin|mesh-list
19950758|NCT01578551|Biguanides|biguanides|mesh-list
19950759|NCT01578551|Paclitaxel|paclitaxel|mesh-list
19950760|NCT01578551|Bevacizumab|bevacizumab|mesh-list
19950761|NCT01578551|Carboplatin|carboplatin|mesh-list
19950762|NCT01578551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19950763|NCT01578551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950764|NCT01578551|Tubulin Modulators|tubulin modulators|mesh-ancestor
19950765|NCT01578551|Antimitotic Agents|antimitotic agents|mesh-ancestor
19950766|NCT01578551|Mitosis Modulators|mitosis modulators|mesh-ancestor
19950767|NCT01578551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950768|NCT01578551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19950769|NCT01578551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19950770|NCT01578551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19950771|NCT01578551|Growth Substances|growth substances|mesh-ancestor
19950772|NCT01578551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950773|NCT01578551|Growth Inhibitors|growth inhibitors|mesh-ancestor
19950774|NCT01578551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19950775|NCT01578707|Ofatumumab|ofatumumab|mesh-list
19950776|NCT01578707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950777|NCT01578772|Telmisartan|telmisartan|mesh-list
19950778|NCT01578772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19950779|NCT01578772|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19950780|NCT01578772|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19950781|NCT01578772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950782|NCT01578850|Etanercept|etanercept|mesh-list
19950783|NCT01578850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19950784|NCT01578850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19950785|NCT01578850|Analgesics|analgesics|mesh-ancestor
19950786|NCT01578850|Sensory System Agents|sensory system agents|mesh-ancestor
19950787|NCT01578850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950788|NCT01578850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950789|NCT01578850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19950790|NCT01578850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19950791|NCT01578850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19733020|NCT04566796|Cholinergic Agents|cholinergic agents|mesh-ancestor
19733021|NCT04566796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19733022|NCT04566796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733023|NCT04566796|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19733024|NCT04566796|Autonomic Agents|autonomic agents|mesh-ancestor
19733025|NCT04566796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733026|NCT04566770|Vaccines|vaccines|mesh-list
19733027|NCT04566770|Immunologic Factors|immunologic factors|mesh-ancestor
19950792|NCT01578850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19950793|NCT01578850|Immunologic Factors|immunologic factors|mesh-ancestor
19950794|NCT01578980|Pancrelipase|pancrelipase|mesh-list
19950795|NCT01578980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19950796|NCT01579162|Cholic Acids|cholic acids|mesh-list
19950797|NCT01579162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19950798|NCT01579305|Lidocaine|lidocaine|mesh-list
19950799|NCT01579305|Anesthetics, Local|anesthetics, local|mesh-ancestor
19950800|NCT01579305|Anesthetics|anesthetics|mesh-ancestor
19950801|NCT01579305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19950802|NCT01579305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950803|NCT01579305|Sensory System Agents|sensory system agents|mesh-ancestor
19950804|NCT01579305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950805|NCT01579305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19950806|NCT01579305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19950807|NCT01579305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19950808|NCT01579305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19950809|NCT01579305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950810|NCT01579318|Interleukin-12|interleukin-12|mesh-list
19950811|NCT01579318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19950812|NCT01579318|Immunologic Factors|immunologic factors|mesh-ancestor
19950813|NCT01579318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950814|NCT01579318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19950815|NCT01579318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19950816|NCT01579318|Growth Substances|growth substances|mesh-ancestor
19950817|NCT01579318|Growth Inhibitors|growth inhibitors|mesh-ancestor
19950818|NCT01579318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950819|NCT01579513|Methylprednisolone|methylprednisolone|mesh-list
19950820|NCT01579513|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19950821|NCT01579513|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19950822|NCT01579513|Prednisolone|prednisolone|mesh-list
19950823|NCT01579513|Prednisolone acetate|prednisolone acetate|mesh-list
19950824|NCT01579513|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19950825|NCT01579513|Prednisolone phosphate|prednisolone phosphate|mesh-list
19950826|NCT01579513|Glucocorticoids|glucocorticoids|mesh-list
19950827|NCT01579513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19950828|NCT01579513|Antiemetics|antiemetics|mesh-ancestor
19950829|NCT01579513|Autonomic Agents|autonomic agents|mesh-ancestor
19950830|NCT01579513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950831|NCT01579513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950832|NCT01579513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19950833|NCT01579513|Hormones|hormones|mesh-ancestor
19950834|NCT01579513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19950835|NCT01579513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19950836|NCT01579513|Protective Agents|protective agents|mesh-ancestor
19950837|NCT01579513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19950838|NCT01579513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950839|NCT01579578|Paclitaxel|paclitaxel|mesh-list
19950840|NCT01579578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19950841|NCT01579578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950842|NCT01579578|Tubulin Modulators|tubulin modulators|mesh-ancestor
19950843|NCT01579578|Antimitotic Agents|antimitotic agents|mesh-ancestor
19950844|NCT01579578|Mitosis Modulators|mitosis modulators|mesh-ancestor
19950845|NCT01579578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950846|NCT01579812|Metformin|metformin|mesh-list
19950847|NCT01579812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19950848|NCT01579812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950849|NCT01580020|Dexamethasone|dexamethasone|mesh-list
19950850|NCT01580020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19950851|NCT01580020|Antiemetics|antiemetics|mesh-ancestor
19950852|NCT01580020|Autonomic Agents|autonomic agents|mesh-ancestor
19950853|NCT01580020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950854|NCT01580020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950855|NCT01580020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19950856|NCT01580020|Glucocorticoids|glucocorticoids|mesh-ancestor
19950857|NCT01580020|Hormones|hormones|mesh-ancestor
19950858|NCT01580020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19950859|NCT01580020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19950860|NCT01580020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950861|NCT01580293|Factor VIII|factor viii|mesh-list
19950862|NCT01580293|Coagulants|coagulants|mesh-ancestor
19950863|NCT01580410|Oxaliplatin|oxaliplatin|mesh-list
19950864|NCT01580410|Mitomycins|mitomycins|mesh-list
19950865|NCT01580410|Mitomycin|mitomycin|mesh-list
19950866|NCT01580410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950867|NCT01580410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19950868|NCT01580410|Alkylating Agents|alkylating agents|mesh-ancestor
19950869|NCT01580410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950870|NCT01580410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19950871|NCT01580410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19950872|NCT01580423|Aprepitant|aprepitant|mesh-list
19950873|NCT01580423|Antiemetics|antiemetics|mesh-ancestor
19950874|NCT01580423|Autonomic Agents|autonomic agents|mesh-ancestor
19950875|NCT01580423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950876|NCT01580423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950877|NCT01580423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19950878|NCT01580423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20269185|NCT05204927|Glucocorticoids|glucocorticoids|mesh-ancestor
20269186|NCT05204927|Hormones|hormones|mesh-ancestor
20269187|NCT05204927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20269188|NCT05204927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269189|NCT05204927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20269190|NCT05204927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269191|NCT05191940|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20269192|NCT05191940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20269193|NCT05191940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269194|NCT05183646|Proxigermanium|proxigermanium|mesh-list
20269195|NCT05183646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269196|NCT05183646|Interferon Inducers|interferon inducers|mesh-ancestor
20269197|NCT05183646|Immunologic Factors|immunologic factors|mesh-ancestor
20269198|NCT05183646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269199|NCT05165212|Amoxicillin|amoxicillin|mesh-list
20269200|NCT05165212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20269201|NCT05165212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19950879|NCT01580423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19950880|NCT01580423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950881|NCT01580488|Calcitriol|calcitriol|mesh-list
20269202|NCT05145764|Suvorexant|suvorexant|mesh-list
19950882|NCT01580488|Calcipotriene|calcipotriene|mesh-list
19950883|NCT01580488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19950884|NCT01580488|Dermatologic Agents|dermatologic agents|mesh-ancestor
19950885|NCT01580488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19950886|NCT01580488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950887|NCT01580488|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19950888|NCT01580488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19950889|NCT01580488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950890|NCT01580488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19950891|NCT01580488|Vitamins|vitamins|mesh-ancestor
19950892|NCT01580488|Micronutrients|micronutrients|mesh-ancestor
19950893|NCT01580488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19950894|NCT01580592|Omalizumab|omalizumab|mesh-list
19950895|NCT01580592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19950896|NCT01580592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19950897|NCT01580592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19950898|NCT01580592|Respiratory System Agents|respiratory system agents|mesh-ancestor
19950899|NCT01580592|Immunologic Factors|immunologic factors|mesh-ancestor
19950900|NCT01580592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950901|NCT01580618|Tenecteplase|tenecteplase|mesh-list
19950902|NCT01580618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19950903|NCT01580618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19950904|NCT01580618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950905|NCT01580670|Infliximab|infliximab|mesh-list
19950906|NCT01580670|Dermatologic Agents|dermatologic agents|mesh-ancestor
19950907|NCT01580670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19950908|NCT01580670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19950909|NCT01580969|Minocycline|minocycline|mesh-list
19950910|NCT01580969|Bevacizumab|bevacizumab|mesh-list
19950911|NCT01580969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19950912|NCT01580969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950913|NCT01580969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19950914|NCT01580969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19950915|NCT01580969|Growth Substances|growth substances|mesh-ancestor
19950916|NCT01580969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950917|NCT01580969|Growth Inhibitors|growth inhibitors|mesh-ancestor
19950918|NCT01580969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19950919|NCT01580969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19950920|NCT01580995|Valacyclovir|valacyclovir|mesh-list
19950921|NCT01580995|Antiviral Agents|antiviral agents|mesh-ancestor
19950922|NCT01580995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19950923|NCT01581281|Topiramate|topiramate|mesh-list
19950924|NCT01581281|Amitriptyline|amitriptyline|mesh-list
19950925|NCT01581281|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19950926|NCT01581281|Anticonvulsants|anticonvulsants|mesh-ancestor
19950927|NCT01581281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19950928|NCT01581281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950929|NCT01581281|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19950930|NCT01581281|Antidepressive Agents|antidepressive agents|mesh-ancestor
19950931|NCT01581281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19950932|NCT01581281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19950933|NCT01581281|Analgesics|analgesics|mesh-ancestor
19950934|NCT01581281|Sensory System Agents|sensory system agents|mesh-ancestor
19950935|NCT01581281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19950936|NCT01581281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19950937|NCT01581281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19950938|NCT01581281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19950939|NCT01581281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950940|NCT01581281|Adrenergic Agents|adrenergic agents|mesh-ancestor
19950941|NCT01581281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19950942|NCT01581281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19950943|NCT01581281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19950944|NCT01581281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19974411|NCT01836471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974412|NCT01836471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19974413|NCT01836471|Respiratory System Agents|respiratory system agents|mesh-ancestor
19974414|NCT01836471|Dermatologic Agents|dermatologic agents|mesh-ancestor
19974415|NCT01836471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19974416|NCT01836471|Plant Growth Regulators|plant growth regulators|mesh-ancestor
19974417|NCT01836471|Growth Substances|growth substances|mesh-ancestor
19974418|NCT01836523|Liraglutide|liraglutide|mesh-list
19974419|NCT01836523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20269203|NCT05145764|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19974420|NCT01836523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974421|NCT01836523|Incretins|incretins|mesh-ancestor
19950945|NCT01581307|Leucovorin|leucovorin|mesh-list
19950946|NCT01581307|Folic Acid|folic acid|mesh-list
19950947|NCT01581307|Fluorouracil|fluorouracil|mesh-list
19950948|NCT01581307|Oxaliplatin|oxaliplatin|mesh-list
19950949|NCT01581307|Levoleucovorin|levoleucovorin|mesh-list
19950950|NCT01581307|Antimetabolites|antimetabolites|mesh-ancestor
19950951|NCT01581307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950952|NCT01581307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19950953|NCT01581307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950954|NCT01581307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19950955|NCT01581307|Immunologic Factors|immunologic factors|mesh-ancestor
19950956|NCT01581307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950957|NCT01581307|Antidotes|antidotes|mesh-ancestor
19950958|NCT01581307|Protective Agents|protective agents|mesh-ancestor
19950959|NCT01581307|Vitamin B Complex|vitamin b complex|mesh-ancestor
19950960|NCT01581307|Vitamins|vitamins|mesh-ancestor
19950961|NCT01581307|Micronutrients|micronutrients|mesh-ancestor
19950962|NCT01581307|Hematinics|hematinics|mesh-ancestor
19950963|NCT01581541|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
19950964|NCT01581541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19950965|NCT01581658|Empagliflozin|empagliflozin|mesh-list
19950966|NCT01581658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19950967|NCT01581658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950968|NCT01581658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19950969|NCT01581658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950970|NCT01581710|Montelukast|montelukast|mesh-list
19950971|NCT01581710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19950972|NCT01581710|Respiratory System Agents|respiratory system agents|mesh-ancestor
19950973|NCT01581710|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19950974|NCT01581710|Hormone Antagonists|hormone antagonists|mesh-ancestor
19950975|NCT01581710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19950976|NCT01581710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950977|NCT01581710|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19950978|NCT01581710|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19950979|NCT01581710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950980|NCT01581931|Metformin|metformin|mesh-list
19950981|NCT01581931|Linagliptin|linagliptin|mesh-list
19950982|NCT01581931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19950983|NCT01581931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950984|NCT01581931|Incretins|incretins|mesh-ancestor
19950985|NCT01581931|Hormones|hormones|mesh-ancestor
19950986|NCT01581931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19950987|NCT01581931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19950988|NCT01581931|Protease Inhibitors|protease inhibitors|mesh-ancestor
19950989|NCT01581931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19950990|NCT01581931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19950991|NCT01581970|Cyclophosphamide|cyclophosphamide|mesh-list
19950992|NCT01581970|Cetuximab|cetuximab|mesh-list
19950993|NCT01581970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19950994|NCT01581970|Immunologic Factors|immunologic factors|mesh-ancestor
19950995|NCT01581970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19950996|NCT01581970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19950997|NCT01581970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19950998|NCT01581970|Alkylating Agents|alkylating agents|mesh-ancestor
19950999|NCT01581970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951000|NCT01581970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951001|NCT01581970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19951002|NCT01581970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19951003|NCT01582009|Everolimus|everolimus|mesh-list
19951004|NCT01582009|Panobinostat|panobinostat|mesh-list
19951005|NCT01582009|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19951006|NCT01582009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951007|NCT01582009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19951008|NCT01582009|Immunologic Factors|immunologic factors|mesh-ancestor
19951009|NCT01582009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951010|NCT01582009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951011|NCT01582009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951012|NCT01582061|Pasireotide|pasireotide|mesh-list
19951013|NCT01582061|Hormones|hormones|mesh-ancestor
19951014|NCT01582061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19951015|NCT01582061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951016|NCT01582152|Bevacizumab|bevacizumab|mesh-list
19951017|NCT01582152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19951018|NCT01582152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951019|NCT01582152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19951020|NCT01582152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19951021|NCT01582152|Growth Substances|growth substances|mesh-ancestor
19951022|NCT01582152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951023|NCT01582152|Growth Inhibitors|growth inhibitors|mesh-ancestor
19951024|NCT01582243|Vildagliptin|vildagliptin|mesh-list
19951025|NCT01582243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19951026|NCT01582243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951027|NCT01582243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19951028|NCT01582243|Protease Inhibitors|protease inhibitors|mesh-ancestor
19951029|NCT01582243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951030|NCT01582243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951031|NCT01582282|Psyllium|psyllium|mesh-list
19951032|NCT01582282|Calcium polycarbophil|calcium polycarbophil|mesh-list
19951033|NCT01582282|Cathartics|cathartics|mesh-ancestor
19951034|NCT01582282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19951035|NCT01582282|Antidiarrheals|antidiarrheals|mesh-ancestor
19951036|NCT01582308|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19951037|NCT01582308|Vildagliptin|vildagliptin|mesh-list
19951038|NCT01582308|Saxagliptin|saxagliptin|mesh-list
19951039|NCT01582308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19951040|NCT01582308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951041|NCT01582308|Incretins|incretins|mesh-ancestor
19951042|NCT01582308|Hormones|hormones|mesh-ancestor
19951043|NCT01582308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19951044|NCT01582308|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19951045|NCT01582308|Protease Inhibitors|protease inhibitors|mesh-ancestor
19951046|NCT01582308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951047|NCT01582308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951048|NCT01582451|Insulin|insulin|mesh-list
19951049|NCT01582451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19951050|NCT01582451|Insulin Glargine|insulin glargine|mesh-list
19951051|NCT01582451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20269204|NCT05145764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20269205|NCT05145764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20269206|NCT05145764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269207|NCT05145764|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20269208|NCT05145764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20269209|NCT05145764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269210|NCT05138614|Analgesics, Opioid|analgesics, opioid|mesh-list
20269211|NCT05138614|Narcotics|narcotics|mesh-ancestor
20269212|NCT05138614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20269213|NCT05138614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269214|NCT05138614|Analgesics|analgesics|mesh-ancestor
20269215|NCT05138614|Sensory System Agents|sensory system agents|mesh-ancestor
20269216|NCT05138614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269217|NCT05132660|Levodopa|levodopa|mesh-list
20269218|NCT05132660|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20269219|NCT05132660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20269220|NCT05132660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20269221|NCT05132660|Dopamine Agents|dopamine agents|mesh-ancestor
20269222|NCT05132660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20269223|NCT05132660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269224|NCT05132660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269225|NCT05132660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20269226|NCT05132660|Immunologic Factors|immunologic factors|mesh-ancestor
20269227|NCT05132660|Dopamine Agonists|dopamine agonists|mesh-ancestor
20269228|NCT05118854|Cisplatin|cisplatin|mesh-list
20269229|NCT05118854|Carboplatin|carboplatin|mesh-list
20269230|NCT05118854|Pemetrexed|pemetrexed|mesh-list
20269231|NCT05118854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269232|NCT05118854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20269233|NCT05118854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269234|NCT05118854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20269235|NCT05118854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20269236|NCT05109143|Indomethacin|indomethacin|mesh-list
20269237|NCT05109143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20269238|NCT05109143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20269239|NCT05109143|Analgesics|analgesics|mesh-ancestor
20269240|NCT05109143|Sensory System Agents|sensory system agents|mesh-ancestor
20269241|NCT05109143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19951052|NCT01582451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951053|NCT01582477|Bupivacaine|bupivacaine|mesh-list
19951054|NCT01582477|Anesthetics, Local|anesthetics, local|mesh-ancestor
19951055|NCT01582477|Anesthetics|anesthetics|mesh-ancestor
19951056|NCT01582477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19951057|NCT01582477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951058|NCT01582477|Sensory System Agents|sensory system agents|mesh-ancestor
19951059|NCT01582477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19951060|NCT01582490|Bupivacaine|bupivacaine|mesh-list
19951061|NCT01582490|Anesthetics, Local|anesthetics, local|mesh-ancestor
19951062|NCT01582490|Anesthetics|anesthetics|mesh-ancestor
19951063|NCT01582490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19951064|NCT01582490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951065|NCT01582490|Sensory System Agents|sensory system agents|mesh-ancestor
19951066|NCT01582490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19951067|NCT01582854|Actovegin|actovegin|mesh-list
19951068|NCT01582854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19951069|NCT01582854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951070|NCT01582854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19951071|NCT01582854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19951072|NCT01582854|Antioxidants|antioxidants|mesh-ancestor
19951073|NCT01582854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951074|NCT01582854|Protective Agents|protective agents|mesh-ancestor
19951075|NCT01582854|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19951076|NCT01582880|Riboflavin|riboflavin|mesh-list
19951077|NCT01582880|Vitamins|vitamins|mesh-ancestor
19951078|NCT01582880|Micronutrients|micronutrients|mesh-ancestor
19951079|NCT01582880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951080|NCT01582880|Vitamin B Complex|vitamin b complex|mesh-ancestor
19951081|NCT01582880|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19951082|NCT01582880|Dermatologic Agents|dermatologic agents|mesh-ancestor
19951083|NCT01582945|Ketamine|ketamine|mesh-list
19951084|NCT01582945|Analgesics|analgesics|mesh-ancestor
19951085|NCT01582945|Sensory System Agents|sensory system agents|mesh-ancestor
19951086|NCT01582945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19951087|NCT01582945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951088|NCT01582945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19951089|NCT01582945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19951090|NCT01582945|Anesthetics, General|anesthetics, general|mesh-ancestor
19951091|NCT01582945|Anesthetics|anesthetics|mesh-ancestor
19951092|NCT01582945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19951093|NCT01582945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19951094|NCT01582945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19951095|NCT01582945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19951096|NCT01582945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951097|NCT01583166|Epinephrine|epinephrine|mesh-list
19951098|NCT01583166|Bupivacaine|bupivacaine|mesh-list
19951099|NCT01583166|Anesthetics, Local|anesthetics, local|mesh-ancestor
19951100|NCT01583166|Anesthetics|anesthetics|mesh-ancestor
19951101|NCT01583166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19951102|NCT01583166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951103|NCT01583166|Sensory System Agents|sensory system agents|mesh-ancestor
20269242|NCT05109143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269243|NCT05109143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20269244|NCT05109143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20269245|NCT05109143|Gout Suppressants|gout suppressants|mesh-ancestor
20269246|NCT05109143|Tocolytic Agents|tocolytic agents|mesh-ancestor
20269247|NCT05109143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20269248|NCT05109143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20269249|NCT05109143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20269250|NCT05109143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269251|NCT05108454|Micronutrients|micronutrients|mesh-list
20269252|NCT05108454|Trace Elements|trace elements|mesh-list
20269253|NCT05108454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269254|NCT05096702|Primaquine|primaquine|mesh-list
20269255|NCT05096702|Tafenoquine|tafenoquine|mesh-list
20269256|NCT05096702|Antimalarials|antimalarials|mesh-ancestor
20269257|NCT05096702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20269258|NCT05096702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20269259|NCT05096702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20269260|NCT05085808|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20269261|NCT05085808|Trazodone|trazodone|mesh-list
20269262|NCT05085808|Antidepressive Agents|antidepressive agents|mesh-ancestor
19951104|NCT01583166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19951105|NCT01583166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19951106|NCT01583166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20269263|NCT05085808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20269264|NCT05085808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19951107|NCT01583166|Adrenergic Agents|adrenergic agents|mesh-ancestor
19951108|NCT01583166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19951109|NCT01583166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951110|NCT01583166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19951111|NCT01583166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19951112|NCT01583166|Autonomic Agents|autonomic agents|mesh-ancestor
19951113|NCT01583166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19951114|NCT01583166|Respiratory System Agents|respiratory system agents|mesh-ancestor
19951115|NCT01583166|Mydriatics|mydriatics|mesh-ancestor
19951116|NCT01583166|Sympathomimetics|sympathomimetics|mesh-ancestor
19951117|NCT01583166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19951118|NCT01583179|Buprenorphine|buprenorphine|mesh-list
19951119|NCT01583179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19951120|NCT01583179|Narcotics|narcotics|mesh-ancestor
19951121|NCT01583179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19951122|NCT01583179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951123|NCT01583179|Analgesics|analgesics|mesh-ancestor
19951124|NCT01583179|Sensory System Agents|sensory system agents|mesh-ancestor
19951125|NCT01583179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19951126|NCT01583179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19951127|NCT01583218|Enoxaparin|enoxaparin|mesh-list
19951128|NCT01583218|Betrixaban|betrixaban|mesh-list
19951129|NCT01583218|Anticoagulants|anticoagulants|mesh-ancestor
19951130|NCT01583218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19951131|NCT01583218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19951132|NCT01583218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951133|NCT01583218|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19951134|NCT01583218|Antithrombins|antithrombins|mesh-ancestor
19951135|NCT01583218|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19951136|NCT01583218|Protease Inhibitors|protease inhibitors|mesh-ancestor
19951137|NCT01583218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951138|NCT01583374|Thalidomide|thalidomide|mesh-list
19951139|NCT01583374|Apremilast|apremilast|mesh-list
19951140|NCT01583374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19951141|NCT01583374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19951142|NCT01583374|Analgesics|analgesics|mesh-ancestor
19951143|NCT01583374|Sensory System Agents|sensory system agents|mesh-ancestor
19951144|NCT01583374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19951145|NCT01583374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951146|NCT01583374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19951147|NCT01583374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19951148|NCT01583374|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19951149|NCT01583374|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19951150|NCT01583374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951151|NCT01583374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951152|NCT01583374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19951153|NCT01583374|Immunologic Factors|immunologic factors|mesh-ancestor
19951154|NCT01583374|Leprostatic Agents|leprostatic agents|mesh-ancestor
19951155|NCT01583374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19951156|NCT01583374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19951157|NCT01583374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19951158|NCT01583374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19951159|NCT01583374|Growth Substances|growth substances|mesh-ancestor
19951160|NCT01583374|Growth Inhibitors|growth inhibitors|mesh-ancestor
19951161|NCT01583374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951162|NCT01583530|Belimumab|belimumab|mesh-list
19951163|NCT01583530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19951164|NCT01583530|Immunologic Factors|immunologic factors|mesh-ancestor
19951165|NCT01583530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951166|NCT01583543|Olaparib|olaparib|mesh-list
19951167|NCT01583543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19951168|NCT01583543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951169|NCT01583543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951170|NCT01583543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951171|NCT01583686|Aldesleukin|aldesleukin|mesh-list
19951172|NCT01583686|Cyclophosphamide|cyclophosphamide|mesh-list
19951173|NCT01583686|Fludarabine|fludarabine|mesh-list
19951174|NCT01583686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19951175|NCT01583686|Immunologic Factors|immunologic factors|mesh-ancestor
19951176|NCT01583686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951177|NCT01583686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19951178|NCT01583686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19951179|NCT01583686|Alkylating Agents|alkylating agents|mesh-ancestor
19951180|NCT01583686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951181|NCT01583686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951182|NCT01583686|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19951183|NCT01583686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19951184|NCT01583686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19951185|NCT01583686|Antiviral Agents|antiviral agents|mesh-ancestor
19951186|NCT01583686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19951187|NCT01583985|Analgesics, Opioid|analgesics, opioid|mesh-list
19951188|NCT01583985|Narcotics|narcotics|mesh-ancestor
19951189|NCT01583985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19951190|NCT01583985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951191|NCT01583985|Analgesics|analgesics|mesh-ancestor
19951192|NCT01583985|Sensory System Agents|sensory system agents|mesh-ancestor
19951193|NCT01583985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19951194|NCT01584232|Insulin Glargine|insulin glargine|mesh-list
19951195|NCT01584232|Dulaglutide|dulaglutide|mesh-list
19951196|NCT01584232|Biguanides|biguanides|mesh-list
19951197|NCT01584232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19951198|NCT01584232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951199|NCT01584388|Rituximab|rituximab|mesh-list
19951200|NCT01584388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19951201|NCT01584388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951202|NCT01584388|Immunologic Factors|immunologic factors|mesh-ancestor
19951203|NCT01584388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951204|NCT01584388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19951205|NCT01584440|Quinidine|quinidine|mesh-list
19951206|NCT01584440|Dextromethorphan|dextromethorphan|mesh-list
19951207|NCT01584440|Antitussive Agents|antitussive agents|mesh-ancestor
19951208|NCT01584440|Respiratory System Agents|respiratory system agents|mesh-ancestor
19951209|NCT01584440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19951210|NCT01584440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19951211|NCT01584440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19951212|NCT01584440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951213|NCT01584440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951214|NCT01584440|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19951215|NCT01584440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19951216|NCT01584440|Adrenergic Agents|adrenergic agents|mesh-ancestor
19951217|NCT01584440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19951218|NCT01584440|Antimalarials|antimalarials|mesh-ancestor
19951219|NCT01584440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19951220|NCT01584440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19951221|NCT01584440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19951222|NCT01584440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951223|NCT01584440|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19951224|NCT01584440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19951225|NCT01584440|Cholinergic Agents|cholinergic agents|mesh-ancestor
19951226|NCT01584440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19951227|NCT01584440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19951228|NCT01584440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19951229|NCT01584440|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19951230|NCT01584440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19951231|NCT01584518|Furosemide|furosemide|mesh-list
19951232|NCT01584518|Diuretics|diuretics|mesh-ancestor
19951233|NCT01584518|Natriuretic Agents|natriuretic agents|mesh-ancestor
19951234|NCT01584518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951235|NCT01584518|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19951236|NCT01584518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19951237|NCT01584518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951238|NCT01584544|Capecitabine|capecitabine|mesh-list
19951239|NCT01584544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19951240|NCT01584544|Antimetabolites|antimetabolites|mesh-ancestor
19951241|NCT01584544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951242|NCT01584544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951243|NCT01584648|Trametinib|trametinib|mesh-list
19951244|NCT01584648|Dabrafenib|dabrafenib|mesh-list
19951245|NCT01584648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951246|NCT01584648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19951247|NCT01584648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951248|NCT01584648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951249|NCT01584843|Botulinum Toxins|botulinum toxins|mesh-list
19951250|NCT01584843|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19951251|NCT01584843|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19951252|NCT01584843|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19951253|NCT01584843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19951254|NCT01584843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951255|NCT01584843|Cholinergic Agents|cholinergic agents|mesh-ancestor
20269265|NCT05085808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19951256|NCT01584843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19951257|NCT01584843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951258|NCT01584843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19951259|NCT01584843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19951260|NCT01585025|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
19951261|NCT01585025|Cathartics|cathartics|mesh-ancestor
19951262|NCT01585025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19951263|NCT01585038|Efavirenz|efavirenz|mesh-list
19951264|NCT01585038|Rilpivirine|rilpivirine|mesh-list
20269266|NCT05085808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20543549|NCT01870440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543550|NCT01870440|Protease Inhibitors|protease inhibitors|mesh-ancestor
20543551|NCT01870440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543552|NCT01870440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543553|NCT01870466|Cilostazol|cilostazol|mesh-list
20543554|NCT01870466|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20543555|NCT01870466|Simvastatin|simvastatin|mesh-list
20543556|NCT01870466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20543557|NCT01870466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20543558|NCT01870466|Antimetabolites|antimetabolites|mesh-ancestor
20543559|NCT01870466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543560|NCT01870466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20543561|NCT01870466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20543562|NCT01870466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543563|NCT01870466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20543564|NCT01870466|Autonomic Agents|autonomic agents|mesh-ancestor
20543565|NCT01870466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543566|NCT01870466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543567|NCT01870466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20543568|NCT01870466|Respiratory System Agents|respiratory system agents|mesh-ancestor
20543569|NCT01870466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20543570|NCT01870466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20543571|NCT01870466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20543572|NCT01870466|Vasodilator Agents|vasodilator agents|mesh-ancestor
20543573|NCT01870466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20543574|NCT01870466|Protective Agents|protective agents|mesh-ancestor
20543575|NCT01870466|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20543576|NCT01870466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20543577|NCT01870492|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20543578|NCT01870492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20269267|NCT05085808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269268|NCT05085808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20269269|NCT05085808|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20269270|NCT05085808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20269271|NCT05085808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20269272|NCT05085808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269273|NCT05085808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20269274|NCT05085808|Serotonin Agents|serotonin agents|mesh-ancestor
20269275|NCT05085808|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20287372|NCT04907370|Antibodies, Blocking|antibodies, blocking|mesh-list
20287373|NCT04907370|Immunologic Factors|immunologic factors|mesh-ancestor
20287374|NCT04907370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287375|NCT04907370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287376|NCT04907370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20287377|NCT04907370|Antimetabolites|antimetabolites|mesh-ancestor
20287378|NCT04907370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287379|NCT04907370|Antiviral Agents|antiviral agents|mesh-ancestor
20287380|NCT04907370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20287381|NCT04907370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287382|NCT04907370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20287383|NCT04892706|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
20287384|NCT04892706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19951265|NCT01585038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19951266|NCT01585038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19951267|NCT01585038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951268|NCT01585038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951269|NCT01585038|Antiviral Agents|antiviral agents|mesh-ancestor
19951270|NCT01585038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19951271|NCT01585038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19951272|NCT01585038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19951273|NCT01585038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19951274|NCT01585038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19951275|NCT01585038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19951276|NCT01585038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19951277|NCT01585038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19951278|NCT01585038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19951279|NCT01585129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19951280|NCT01585129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19951281|NCT01585129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19951282|NCT01585129|Antitubercular Agents|antitubercular agents|mesh-ancestor
19951283|NCT01585168|Memantine|memantine|mesh-list
19951284|NCT01585168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19951285|NCT01585168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19951286|NCT01585168|Dopamine Agents|dopamine agents|mesh-ancestor
19951287|NCT01585168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19951288|NCT01585168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951289|NCT01585168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951290|NCT01585168|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19951291|NCT01585168|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19951292|NCT01585194|Nivolumab|nivolumab|mesh-list
19951293|NCT01585194|Ipilimumab|ipilimumab|mesh-list
19951294|NCT01585194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19951295|NCT01585194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951296|NCT01585194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19951297|NCT01585194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951298|NCT01585207|Vigabatrin|vigabatrin|mesh-list
19951299|NCT01585207|Anticonvulsants|anticonvulsants|mesh-ancestor
19951300|NCT01585207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951301|NCT01585207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951302|NCT01585207|GABA Agents|gaba agents|mesh-ancestor
19951303|NCT01585207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19951304|NCT01585207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951305|NCT01585246|Saw palmetto extract|saw palmetto extract|mesh-list
19951306|NCT01585246|Urological Agents|urological agents|mesh-ancestor
19951307|NCT01585272|Rivastigmine|rivastigmine|mesh-list
19951308|NCT01585272|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19951309|NCT01585272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951310|NCT01585272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951311|NCT01585272|Cholinergic Agents|cholinergic agents|mesh-ancestor
19951312|NCT01585272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19951313|NCT01585272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951314|NCT01585272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19951315|NCT01585272|Protective Agents|protective agents|mesh-ancestor
19951316|NCT01585298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19951317|NCT01585298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19951318|NCT01585298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951319|NCT01585298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19951320|NCT01585298|Immunologic Factors|immunologic factors|mesh-ancestor
19951321|NCT01585298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951322|NCT01585324|Ribavirin|ribavirin|mesh-list
19951323|NCT01585324|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19951324|NCT01585324|Antimetabolites|antimetabolites|mesh-ancestor
19951325|NCT01585324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951326|NCT01585324|Antiviral Agents|antiviral agents|mesh-ancestor
19951327|NCT01585324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19951328|NCT01585428|Aldesleukin|aldesleukin|mesh-list
19951329|NCT01585428|Cyclophosphamide|cyclophosphamide|mesh-list
19951330|NCT01585428|Fludarabine|fludarabine|mesh-list
19951331|NCT01585428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19951332|NCT01585428|Immunologic Factors|immunologic factors|mesh-ancestor
19951333|NCT01585428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951334|NCT01585428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19951335|NCT01585428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19951336|NCT01585428|Alkylating Agents|alkylating agents|mesh-ancestor
19951337|NCT01585428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951338|NCT01585428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951339|NCT01585428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19951340|NCT01585428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19951341|NCT01585428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19951342|NCT01585428|Antiviral Agents|antiviral agents|mesh-ancestor
19951343|NCT01585428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19951344|NCT01585441|Finasteride|finasteride|mesh-list
19951345|NCT01585441|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19951346|NCT01585441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19951347|NCT01585441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951348|NCT01585441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951349|NCT01585441|Hormone Antagonists|hormone antagonists|mesh-ancestor
19951350|NCT01585441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19951351|NCT01585441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951352|NCT01585441|Urological Agents|urological agents|mesh-ancestor
19951353|NCT01585558|Tamoxifen|tamoxifen|mesh-list
19951354|NCT01585558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19951355|NCT01585558|Hormone Antagonists|hormone antagonists|mesh-ancestor
19951356|NCT01585558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19951357|NCT01585558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951358|NCT01585558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19951359|NCT01585558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951360|NCT01585558|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19951361|NCT01585558|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19951362|NCT01585558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19951363|NCT01585584|Protease Inhibitors|protease inhibitors|mesh-list
19951364|NCT01585584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951365|NCT01585584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951366|NCT01585831|Testosterone|testosterone|mesh-list
19951367|NCT01585831|Androgens|androgens|mesh-ancestor
19951368|NCT01585831|Hormones|hormones|mesh-ancestor
19951369|NCT01585831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19951370|NCT01585831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951371|NCT01585987|Ipilimumab|ipilimumab|mesh-list
19951372|NCT01585987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19951373|NCT01585987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951374|NCT01585987|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19951375|NCT01585987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951376|NCT01586091|Fexofenadine|fexofenadine|mesh-list
19951377|NCT01586091|Levocetirizine|levocetirizine|mesh-list
19951378|NCT01586091|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19951379|NCT01586091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19951380|NCT01586091|Histamine Antagonists|histamine antagonists|mesh-ancestor
19951381|NCT01586091|Histamine Agents|histamine agents|mesh-ancestor
19951382|NCT01586091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19951383|NCT01586091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951384|NCT01586091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951385|NCT01586091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19951386|NCT01586156|Carvedilol|carvedilol|mesh-list
19951387|NCT01586156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19951388|NCT01586156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19951389|NCT01586156|Adrenergic Agents|adrenergic agents|mesh-ancestor
19951390|NCT01586156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19951391|NCT01586156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951392|NCT01586156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951393|NCT01586156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19951394|NCT01586156|Antioxidants|antioxidants|mesh-ancestor
19951395|NCT01586156|Protective Agents|protective agents|mesh-ancestor
19951396|NCT01586156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19951397|NCT01586156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19951398|NCT01586156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19951399|NCT01586156|Vasodilator Agents|vasodilator agents|mesh-ancestor
19951400|NCT01586156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19951401|NCT01586156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19951402|NCT01586195|Vemurafenib|vemurafenib|mesh-list
19951403|NCT01586195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951404|NCT01586195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19951405|NCT01586195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951406|NCT01586195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951407|NCT01586312|Hyaluronic Acid|hyaluronic acid|mesh-list
19951408|NCT01586312|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19951409|NCT01586312|Immunologic Factors|immunologic factors|mesh-ancestor
19951410|NCT01586312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951411|NCT01586312|Viscosupplements|viscosupplements|mesh-ancestor
19951412|NCT01586312|Protective Agents|protective agents|mesh-ancestor
19951413|NCT01586338|Hylan|hylan|mesh-list
19951414|NCT01586338|Viscosupplements|viscosupplements|mesh-ancestor
19951415|NCT01586338|Protective Agents|protective agents|mesh-ancestor
19951416|NCT01586338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951417|NCT01586806|Dexamethasone|dexamethasone|mesh-list
19951418|NCT01586806|Dexamethasone acetate|dexamethasone acetate|mesh-list
19951419|NCT01586806|Bupivacaine|bupivacaine|mesh-list
19951420|NCT01586806|BB 1101|bb 1101|mesh-list
19951421|NCT01586806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19951422|NCT01586806|Antiemetics|antiemetics|mesh-ancestor
19951423|NCT01586806|Autonomic Agents|autonomic agents|mesh-ancestor
19951424|NCT01586806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19951425|NCT01586806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951426|NCT01586806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19951427|NCT01586806|Glucocorticoids|glucocorticoids|mesh-ancestor
19951428|NCT01586806|Hormones|hormones|mesh-ancestor
19951429|NCT01586806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19951430|NCT01586806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19951431|NCT01586806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951432|NCT01586806|Protease Inhibitors|protease inhibitors|mesh-ancestor
19951433|NCT01586806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951434|NCT01586806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951435|NCT01586806|Anesthetics, Local|anesthetics, local|mesh-ancestor
19951436|NCT01586806|Anesthetics|anesthetics|mesh-ancestor
19951437|NCT01586806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19951438|NCT01586806|Sensory System Agents|sensory system agents|mesh-ancestor
19951439|NCT01586819|Botulinum Toxins|botulinum toxins|mesh-list
19951440|NCT01586819|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19951441|NCT01586819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19951442|NCT01586819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951443|NCT01586819|Cholinergic Agents|cholinergic agents|mesh-ancestor
19951444|NCT01586819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19951445|NCT01586819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951446|NCT01586962|Acetaminophen|acetaminophen|mesh-list
19951447|NCT01586962|Pseudoephedrine|pseudoephedrine|mesh-list
19951448|NCT01586962|Ephedrine|ephedrine|mesh-list
19951449|NCT01586962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19951450|NCT01586962|Analgesics|analgesics|mesh-ancestor
19951451|NCT01586962|Sensory System Agents|sensory system agents|mesh-ancestor
19951452|NCT01586962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19951453|NCT01586962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951454|NCT01586962|Antipyretics|antipyretics|mesh-ancestor
19951455|NCT01586962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19951456|NCT01586962|Autonomic Agents|autonomic agents|mesh-ancestor
19951457|NCT01586962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19951458|NCT01586962|Respiratory System Agents|respiratory system agents|mesh-ancestor
19951459|NCT01586962|Nasal Decongestants|nasal decongestants|mesh-ancestor
19951460|NCT01586962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19951461|NCT01586962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19951462|NCT01586962|Sympathomimetics|sympathomimetics|mesh-ancestor
19951463|NCT01586962|Adrenergic Agents|adrenergic agents|mesh-ancestor
19951464|NCT01586962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19951465|NCT01586962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951466|NCT01586975|Aspirin|aspirin|mesh-list
19951467|NCT01586975|Clopidogrel|clopidogrel|mesh-list
19951468|NCT01586975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19951469|NCT01586975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19951470|NCT01586975|Analgesics|analgesics|mesh-ancestor
19951471|NCT01586975|Sensory System Agents|sensory system agents|mesh-ancestor
19951472|NCT01586975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19951473|NCT01586975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951474|NCT01586975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19951475|NCT01586975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19951476|NCT01586975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19951477|NCT01586975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19951478|NCT01586975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951479|NCT01586975|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19951480|NCT01586975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19951481|NCT01586975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951482|NCT01586975|Antipyretics|antipyretics|mesh-ancestor
19951483|NCT01586975|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19951484|NCT01586975|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19951485|NCT01586975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19951486|NCT01586975|Purinergic Agents|purinergic agents|mesh-ancestor
19951487|NCT01586975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19951488|NCT01587001|Acetylcysteine|acetylcysteine|mesh-list
19951489|NCT01587001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19951490|NCT01587001|Antiviral Agents|antiviral agents|mesh-ancestor
19951491|NCT01587001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19951492|NCT01587001|Expectorants|expectorants|mesh-ancestor
19951493|NCT01587001|Respiratory System Agents|respiratory system agents|mesh-ancestor
19951494|NCT01587001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19951495|NCT01587001|Antioxidants|antioxidants|mesh-ancestor
19951496|NCT01587001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951497|NCT01587001|Protective Agents|protective agents|mesh-ancestor
19951498|NCT01587001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951499|NCT01587001|Antidotes|antidotes|mesh-ancestor
19951500|NCT01587027|Aminophylline|aminophylline|mesh-list
19951501|NCT01587027|Methazolamide|methazolamide|mesh-list
19951502|NCT01587027|Theophylline|theophylline|mesh-list
19951503|NCT01587027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19951504|NCT01587027|Autonomic Agents|autonomic agents|mesh-ancestor
19951505|NCT01587027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19951506|NCT01587027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951507|NCT01587027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19951508|NCT01587027|Respiratory System Agents|respiratory system agents|mesh-ancestor
19951509|NCT01587027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19951510|NCT01587027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951511|NCT01587027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951512|NCT01587027|Vasodilator Agents|vasodilator agents|mesh-ancestor
19951513|NCT01587027|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19951514|NCT01587027|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19951515|NCT01587027|Purinergic Agents|purinergic agents|mesh-ancestor
19951516|NCT01587027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19951517|NCT01587027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19951518|NCT01587027|Protective Agents|protective agents|mesh-ancestor
19951519|NCT01587027|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19951520|NCT01587027|Diuretics|diuretics|mesh-ancestor
19951521|NCT01587027|Natriuretic Agents|natriuretic agents|mesh-ancestor
19951522|NCT01587079|Tiotropium Bromide|tiotropium bromide|mesh-list
19951523|NCT01587079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19951524|NCT01587079|Autonomic Agents|autonomic agents|mesh-ancestor
19951525|NCT01587079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19951526|NCT01587079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951527|NCT01587079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19951528|NCT01587079|Respiratory System Agents|respiratory system agents|mesh-ancestor
19951529|NCT01587079|Parasympatholytics|parasympatholytics|mesh-ancestor
19951530|NCT01587079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19951531|NCT01587079|Cholinergic Agents|cholinergic agents|mesh-ancestor
19951532|NCT01587079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19951533|NCT01587079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951534|NCT01587118|Asenapine|asenapine|mesh-list
19951535|NCT01587118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19951536|NCT01587118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19951537|NCT01587118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19951538|NCT01587118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951539|NCT01587118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19951540|NCT01587274|Acetaminophen|acetaminophen|mesh-list
19951541|NCT01587274|Naproxen|naproxen|mesh-list
19951542|NCT01587274|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19951543|NCT01587274|Oxycodone|oxycodone|mesh-list
19951544|NCT01587274|Cyclobenzaprine|cyclobenzaprine|mesh-list
19951545|NCT01587274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19951546|NCT01587274|Analgesics|analgesics|mesh-ancestor
19951547|NCT01587274|Sensory System Agents|sensory system agents|mesh-ancestor
19951548|NCT01587274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19951549|NCT01587274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951550|NCT01587274|Antipyretics|antipyretics|mesh-ancestor
19951551|NCT01587274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19951552|NCT01587274|Narcotics|narcotics|mesh-ancestor
19951553|NCT01587274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19951554|NCT01587274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19951555|NCT01587274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19951556|NCT01587274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19951557|NCT01587274|Gout Suppressants|gout suppressants|mesh-ancestor
19951558|NCT01587274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19951559|NCT01587274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951560|NCT01587274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951561|NCT01587274|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19951562|NCT01587274|Antidepressive Agents|antidepressive agents|mesh-ancestor
19951563|NCT01587274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19951564|NCT01587274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19951565|NCT01587274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19951566|NCT01587274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19951567|NCT01587651|Ticagrelor|ticagrelor|mesh-list
19951568|NCT01587651|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19951569|NCT01587651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19951570|NCT01587651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19951571|NCT01587651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19951572|NCT01587651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19951573|NCT01587651|Purinergic Agents|purinergic agents|mesh-ancestor
19951574|NCT01587651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20269276|NCT05085067|Hyaluronic Acid|hyaluronic acid|mesh-list
20269277|NCT05085067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19450283|NCT03429946|Natriuretic Agents|natriuretic agents|mesh-ancestor
19450284|NCT03429738|Ibuprofen|ibuprofen|mesh-list
19450285|NCT03429738|Pseudoephedrine|pseudoephedrine|mesh-list
19450286|NCT03429738|Ephedrine|ephedrine|mesh-list
19450287|NCT03429738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19450288|NCT03429738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19450289|NCT03429738|Analgesics|analgesics|mesh-ancestor
19450290|NCT03429738|Sensory System Agents|sensory system agents|mesh-ancestor
19450291|NCT03429738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450292|NCT03429738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450293|NCT03429738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19450294|NCT03429738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19450295|NCT03429738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20269278|NCT05085067|Immunologic Factors|immunologic factors|mesh-ancestor
20269279|NCT05085067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269280|NCT05085067|Viscosupplements|viscosupplements|mesh-ancestor
20269281|NCT05085067|Protective Agents|protective agents|mesh-ancestor
20269282|NCT05075980|Cisplatin|cisplatin|mesh-list
20269283|NCT05075980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269284|NCT05069896|Mirikizumab|mirikizumab|mesh-list
20269285|NCT05069896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20269286|NCT05069896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20269287|NCT05069896|Analgesics|analgesics|mesh-ancestor
20269288|NCT05069896|Sensory System Agents|sensory system agents|mesh-ancestor
20269289|NCT05069896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269290|NCT05069896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269291|NCT05069896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20269292|NCT05069896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20269293|NCT05069896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20269294|NCT05069896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20269295|NCT05061654|Tazobactam|tazobactam|mesh-list
20269296|NCT05061654|Ceftolozane|ceftolozane|mesh-list
20269297|NCT05061654|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
20269298|NCT05061654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20269299|NCT05061654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20269300|NCT05061654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20269301|NCT05061654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20269302|NCT05061654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269303|NCT05061654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20269304|NCT05061654|Renal Agents|renal agents|mesh-ancestor
20269305|NCT05049213|Povidone-Iodine|povidone-iodine|mesh-list
20269306|NCT05049213|Povidone|povidone|mesh-list
20269307|NCT05049213|Plasma Substitutes|plasma substitutes|mesh-ancestor
20269308|NCT05049213|Blood Substitutes|blood substitutes|mesh-ancestor
20269309|NCT05049213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20269310|NCT05049213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20269311|NCT05045144|Vaccines|vaccines|mesh-list
20269312|NCT05045144|Immunologic Factors|immunologic factors|mesh-ancestor
20269313|NCT05045144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269314|NCT05037279|BCG Vaccine|bcg vaccine|mesh-list
20269315|NCT05037279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20269316|NCT05037279|Immunologic Factors|immunologic factors|mesh-ancestor
20269317|NCT05037279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269318|NCT05035316|Aspirin|aspirin|mesh-list
20269319|NCT05035316|Calcium|calcium|mesh-list
20269320|NCT05035316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20269321|NCT05035316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450296|NCT03429738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951575|NCT01587651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951576|NCT01587651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951577|NCT01587885|Omeprazole|omeprazole|mesh-list
19951578|NCT01587885|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19951579|NCT01587885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19951580|NCT01587885|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19951581|NCT01587885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951582|NCT01587885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951583|NCT01587989|Methotrexate|methotrexate|mesh-list
19951584|NCT01587989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19951585|NCT01587989|Abortifacient Agents|abortifacient agents|mesh-ancestor
19951586|NCT01587989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19951587|NCT01587989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951588|NCT01587989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19951589|NCT01587989|Antimetabolites|antimetabolites|mesh-ancestor
19951590|NCT01587989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951591|NCT01587989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951592|NCT01587989|Dermatologic Agents|dermatologic agents|mesh-ancestor
19951593|NCT01587989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951594|NCT01587989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19951595|NCT01587989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19951596|NCT01587989|Immunologic Factors|immunologic factors|mesh-ancestor
19951597|NCT01587989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19951598|NCT01587989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19974422|NCT01836523|Hormones|hormones|mesh-ancestor
19974423|NCT01836523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19974424|NCT01836549|Imetelstat|imetelstat|mesh-list
19974425|NCT01836549|Motesanib diphosphate|motesanib diphosphate|mesh-list
19974426|NCT01836549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974427|NCT01836549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974428|NCT01836549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19974429|NCT01837069|Metoprolol|metoprolol|mesh-list
19974430|NCT01837069|Lisinopril|lisinopril|mesh-list
19974431|NCT01837069|Atorvastatin|atorvastatin|mesh-list
19974432|NCT01837069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19974433|NCT01837069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19974434|NCT01837069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19974435|NCT01837069|Antimetabolites|antimetabolites|mesh-ancestor
19974436|NCT01837069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974437|NCT01837069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19974438|NCT01837069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19974439|NCT01837069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974440|NCT01837069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19974441|NCT01837069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19974442|NCT01837069|Sympatholytics|sympatholytics|mesh-ancestor
19974443|NCT01837069|Autonomic Agents|autonomic agents|mesh-ancestor
19974444|NCT01837069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19974445|NCT01837069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974446|NCT01837069|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19974447|NCT01837069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19974448|NCT01837069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19974449|NCT01837069|Adrenergic Agents|adrenergic agents|mesh-ancestor
19974450|NCT01837069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19974451|NCT01837069|Protease Inhibitors|protease inhibitors|mesh-ancestor
19974452|NCT01837069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19974453|NCT01837069|Protective Agents|protective agents|mesh-ancestor
19974454|NCT01837680|Insulin|insulin|mesh-list
19974455|NCT01837680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19974456|NCT01837680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19974457|NCT01837680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974458|NCT01837719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19974459|NCT01837719|Cobicistat|cobicistat|mesh-list
19974460|NCT01837719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19974461|NCT01837719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19974462|NCT01837719|Protease Inhibitors|protease inhibitors|mesh-ancestor
19974463|NCT01837719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974464|NCT01837719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974465|NCT01837719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19974466|NCT01837719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19974467|NCT01837719|Antiviral Agents|antiviral agents|mesh-ancestor
19974468|NCT01837719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19951599|NCT01588158|Acetaminophen|acetaminophen|mesh-list
19951600|NCT01588158|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19951601|NCT01588158|Hydrocodone|hydrocodone|mesh-list
19951602|NCT01588158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19951603|NCT01588158|Analgesics|analgesics|mesh-ancestor
19951604|NCT01588158|Sensory System Agents|sensory system agents|mesh-ancestor
19951605|NCT01588158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19951606|NCT01588158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951607|NCT01588158|Antipyretics|antipyretics|mesh-ancestor
19951608|NCT01588158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19951609|NCT01588158|Narcotics|narcotics|mesh-ancestor
19951610|NCT01588158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19951611|NCT01588158|Antitussive Agents|antitussive agents|mesh-ancestor
19951612|NCT01588158|Respiratory System Agents|respiratory system agents|mesh-ancestor
19951613|NCT01588158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19951614|NCT01588158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19951615|NCT01588158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19951616|NCT01588184|Bevacizumab|bevacizumab|mesh-list
19951617|NCT01588184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19951618|NCT01588184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951619|NCT01588184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19951620|NCT01588184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19951621|NCT01588184|Growth Substances|growth substances|mesh-ancestor
19951622|NCT01588184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951623|NCT01588184|Growth Inhibitors|growth inhibitors|mesh-ancestor
19951624|NCT01588405|Treprostinil|treprostinil|mesh-list
19951625|NCT01588405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19951626|NCT01588418|Exenatide|exenatide|mesh-list
19951627|NCT01588418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19951628|NCT01588418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951629|NCT01588418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19951630|NCT01588418|Incretins|incretins|mesh-ancestor
19951631|NCT01588418|Hormones|hormones|mesh-ancestor
19951632|NCT01588418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19951633|NCT01588457|Lamotrigine|lamotrigine|mesh-list
19951634|NCT01588457|Valproic Acid|valproic acid|mesh-list
19951635|NCT01588457|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19951636|NCT01588457|Lithium Carbonate|lithium carbonate|mesh-list
19951637|NCT01588457|Antidepressive Agents|antidepressive agents|mesh-ancestor
19951638|NCT01588457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19951639|NCT01588457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19951640|NCT01588457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19951641|NCT01588457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19951642|NCT01588457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951643|NCT01588457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951644|NCT01588457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951645|NCT01588457|Antimanic Agents|antimanic agents|mesh-ancestor
19951646|NCT01588457|Anticonvulsants|anticonvulsants|mesh-ancestor
19951647|NCT01588457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19951648|NCT01588457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19951649|NCT01588457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19951650|NCT01588457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19951651|NCT01588457|GABA Agents|gaba agents|mesh-ancestor
19951652|NCT01588457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19951653|NCT01588470|Pioglitazone|pioglitazone|mesh-list
19951654|NCT01588470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19951655|NCT01588470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951656|NCT01588496|Evolocumab|evolocumab|mesh-list
19951657|NCT01588496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19951658|NCT01588496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19951659|NCT01588496|Antimetabolites|antimetabolites|mesh-ancestor
19951660|NCT01588496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951661|NCT01588496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19951662|NCT01588561|Nicotine|nicotine|mesh-list
19951663|NCT01588561|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19951664|NCT01588561|Autonomic Agents|autonomic agents|mesh-ancestor
19951665|NCT01588561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19951666|NCT01588561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951667|NCT01588561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19951668|NCT01588561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19951669|NCT01588561|Cholinergic Agents|cholinergic agents|mesh-ancestor
19951670|NCT01588561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19951671|NCT01588561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951672|NCT01588951|Cytarabine|cytarabine|mesh-list
19951673|NCT01588951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19951674|NCT01588951|Antimetabolites|antimetabolites|mesh-ancestor
19951675|NCT01588951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951676|NCT01588951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951677|NCT01588951|Antiviral Agents|antiviral agents|mesh-ancestor
19951678|NCT01588951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19951679|NCT01588951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19951680|NCT01588951|Immunologic Factors|immunologic factors|mesh-ancestor
19951681|NCT01588951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951682|NCT01588990|Leucovorin|leucovorin|mesh-list
19951683|NCT01588990|Bevacizumab|bevacizumab|mesh-list
19951684|NCT01588990|Capecitabine|capecitabine|mesh-list
19951685|NCT01588990|Oxaliplatin|oxaliplatin|mesh-list
19951686|NCT01588990|Irinotecan|irinotecan|mesh-list
19951687|NCT01588990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19951688|NCT01588990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951689|NCT01588990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19951690|NCT01588990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19951691|NCT01588990|Growth Substances|growth substances|mesh-ancestor
19951692|NCT01588990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951693|NCT01588990|Growth Inhibitors|growth inhibitors|mesh-ancestor
19951694|NCT01588990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19951695|NCT01588990|Antimetabolites|antimetabolites|mesh-ancestor
19951696|NCT01588990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951697|NCT01588990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19951698|NCT01588990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19951699|NCT01588990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951700|NCT01588990|Antidotes|antidotes|mesh-ancestor
19951701|NCT01588990|Protective Agents|protective agents|mesh-ancestor
19951702|NCT01588990|Vitamin B Complex|vitamin b complex|mesh-ancestor
19951703|NCT01588990|Vitamins|vitamins|mesh-ancestor
19951704|NCT01588990|Micronutrients|micronutrients|mesh-ancestor
19951705|NCT01589094|Gemcitabine|gemcitabine|mesh-list
19951706|NCT01589094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951707|NCT01589094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19951708|NCT01589094|Antimetabolites|antimetabolites|mesh-ancestor
19951709|NCT01589094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951710|NCT01589094|Antiviral Agents|antiviral agents|mesh-ancestor
19951711|NCT01589094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19951712|NCT01589094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951713|NCT01589094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19951714|NCT01589094|Immunologic Factors|immunologic factors|mesh-ancestor
19951715|NCT01589094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951716|NCT01589263|Tamsulosin|tamsulosin|mesh-list
19951717|NCT01589263|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19951718|NCT01589263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19951719|NCT01589263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19951720|NCT01589263|Adrenergic Agents|adrenergic agents|mesh-ancestor
19951721|NCT01589263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19951722|NCT01589263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951723|NCT01589263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951724|NCT01589263|Urological Agents|urological agents|mesh-ancestor
19951725|NCT01589445|Metformin|metformin|mesh-list
19951726|NCT01589445|Pioglitazone|pioglitazone|mesh-list
19951727|NCT01589445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19951728|NCT01589445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951729|NCT01589497|Moxifloxacin|moxifloxacin|mesh-list
19951730|NCT01589497|Rifampin|rifampin|mesh-list
19951731|NCT01589497|Isoniazid|isoniazid|mesh-list
19951732|NCT01589497|Pyrazinamide|pyrazinamide|mesh-list
19951733|NCT01589497|Ethambutol|ethambutol|mesh-list
19951734|NCT01589497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19951735|NCT01589497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19951736|NCT01589497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19951737|NCT01589497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19951738|NCT01589497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951739|NCT01589497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951740|NCT01589497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951741|NCT01589497|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19951742|NCT01589497|Antitubercular Agents|antitubercular agents|mesh-ancestor
19951743|NCT01589497|Leprostatic Agents|leprostatic agents|mesh-ancestor
19951744|NCT01589497|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19951745|NCT01589497|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19951746|NCT01589497|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19951747|NCT01589497|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19951748|NCT01589497|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19951749|NCT01589497|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19951750|NCT01589497|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19951751|NCT01589497|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19951752|NCT01589497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19951753|NCT01589497|Antimetabolites|antimetabolites|mesh-ancestor
19951754|NCT01589497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19951755|NCT01589510|Bimatoprost|bimatoprost|mesh-list
19951756|NCT01589510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19951757|NCT01589510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19951758|NCT01589510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19951759|NCT01589653|Insulin|insulin|mesh-list
19951760|NCT01589653|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19951761|NCT01589653|Insulin Aspart|insulin aspart|mesh-list
19951762|NCT01589653|Insulin, Long-Acting|insulin, long-acting|mesh-list
19951763|NCT01589653|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19951764|NCT01589653|Biphasic Insulins|biphasic insulins|mesh-list
19951765|NCT01589653|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19951766|NCT01589653|Insulin, Isophane|insulin, isophane|mesh-list
19951767|NCT01589653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19951768|NCT01589653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951769|NCT01589822|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19951770|NCT01589822|Hemostatics|hemostatics|mesh-ancestor
19951771|NCT01589822|Coagulants|coagulants|mesh-ancestor
19951772|NCT01589978|Aspirin|aspirin|mesh-list
19951773|NCT01589978|Salicylic Acid|salicylic acid|mesh-list
19951774|NCT01589978|Salicylates|salicylates|mesh-list
19951775|NCT01589978|Ticlopidine|ticlopidine|mesh-list
19951776|NCT01589978|Clopidogrel|clopidogrel|mesh-list
19951777|NCT01589978|Ticagrelor|ticagrelor|mesh-list
19951778|NCT01589978|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19951779|NCT01589978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20269322|NCT05035316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20269323|NCT05035316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20269324|NCT05035316|Analgesics|analgesics|mesh-ancestor
20269325|NCT05035316|Sensory System Agents|sensory system agents|mesh-ancestor
20269326|NCT05035316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269327|NCT05035316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20269328|NCT05035316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20269329|NCT05035316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20269330|NCT05035316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20269331|NCT05035316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269332|NCT05035316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20269333|NCT05035316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19951780|NCT01589978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19951781|NCT01589978|Analgesics|analgesics|mesh-ancestor
19951782|NCT01589978|Sensory System Agents|sensory system agents|mesh-ancestor
19951783|NCT01589978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19951784|NCT01589978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951785|NCT01589978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19951786|NCT01589978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19951787|NCT01589978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19951788|NCT01589978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19951789|NCT01589978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951790|NCT01589978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19951791|NCT01589978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19951792|NCT01589978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951793|NCT01589978|Antipyretics|antipyretics|mesh-ancestor
19951794|NCT01589978|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19951795|NCT01589978|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19951796|NCT01589978|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19951797|NCT01589978|Purinergic Agents|purinergic agents|mesh-ancestor
19951798|NCT01589978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19951799|NCT01589978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19951800|NCT01589978|Antifungal Agents|antifungal agents|mesh-ancestor
19951801|NCT01589978|Keratolytic Agents|keratolytic agents|mesh-ancestor
19951802|NCT01589978|Dermatologic Agents|dermatologic agents|mesh-ancestor
19951803|NCT01589978|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19951804|NCT01589978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19951805|NCT01590017|Cisplatin|cisplatin|mesh-list
19951806|NCT01590017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951807|NCT01590082|Doxycycline|doxycycline|mesh-list
19951808|NCT01590082|Temozolomide|temozolomide|mesh-list
19951809|NCT01590082|Ipilimumab|ipilimumab|mesh-list
19951810|NCT01590082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19951811|NCT01590082|Alkylating Agents|alkylating agents|mesh-ancestor
19974469|NCT01837719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19951812|NCT01590082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951813|NCT01590082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951814|NCT01590082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19951815|NCT01590082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19951816|NCT01590082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19951817|NCT01590082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19951818|NCT01590082|Antimalarials|antimalarials|mesh-ancestor
19951819|NCT01590082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19951820|NCT01590082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19951821|NCT01590433|Exenatide|exenatide|mesh-list
19951822|NCT01590433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19951823|NCT01590433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269334|NCT05035316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20269335|NCT05035316|Antipyretics|antipyretics|mesh-ancestor
20269336|NCT05034536|Pembrolizumab|pembrolizumab|mesh-list
20269337|NCT05034536|Infliximab|infliximab|mesh-list
20269338|NCT05034536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20269339|NCT05034536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269340|NCT05034536|Dermatologic Agents|dermatologic agents|mesh-ancestor
20269341|NCT05034536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20269342|NCT05034536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20269343|NCT05013892|Memantine|memantine|mesh-list
20269344|NCT05013892|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20269345|NCT05013892|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20269346|NCT05013892|Dopamine Agents|dopamine agents|mesh-ancestor
20269347|NCT05013892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20269348|NCT05013892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269349|NCT05013892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269350|NCT05013892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20269351|NCT05013892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20269352|NCT04998240|Myeloma Proteins|myeloma proteins|mesh-list
20269353|NCT04998240|Paraproteins|paraproteins|mesh-list
20269354|NCT04998240|Immunologic Factors|immunologic factors|mesh-ancestor
20269355|NCT04998240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269356|NCT04988685|Sirolimus|sirolimus|mesh-list
20269357|NCT04988685|Paclitaxel|paclitaxel|mesh-list
20269358|NCT04988685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20269359|NCT04988685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269360|NCT04988685|Tubulin Modulators|tubulin modulators|mesh-ancestor
20269361|NCT04988685|Antimitotic Agents|antimitotic agents|mesh-ancestor
20269362|NCT04988685|Mitosis Modulators|mitosis modulators|mesh-ancestor
20269363|NCT04988685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269364|NCT04988685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20269365|NCT04988685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20269366|NCT04988685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20269367|NCT04988685|Antifungal Agents|antifungal agents|mesh-ancestor
20269368|NCT04988685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20543579|NCT01870492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20543580|NCT01870492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543581|NCT01870635|Ondansetron|ondansetron|mesh-list
20543582|NCT01870635|Antiemetics|antiemetics|mesh-ancestor
20543583|NCT01870635|Autonomic Agents|autonomic agents|mesh-ancestor
20543584|NCT01870635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543585|NCT01870635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543586|NCT01870635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20543587|NCT01870635|Antipruritics|antipruritics|mesh-ancestor
20543588|NCT01870635|Dermatologic Agents|dermatologic agents|mesh-ancestor
20543589|NCT01870635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20543590|NCT01870635|Serotonin Agents|serotonin agents|mesh-ancestor
20543591|NCT01870635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20543592|NCT01870635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543593|NCT01870635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20543594|NCT01870635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20543595|NCT01870635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20543596|NCT01870635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20543597|NCT01870635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20269369|NCT04988685|Immunologic Factors|immunologic factors|mesh-ancestor
20269370|NCT04988685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269371|NCT04987775|Acetylcysteine|acetylcysteine|mesh-list
20269372|NCT04987775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20269373|NCT04987775|Antiviral Agents|antiviral agents|mesh-ancestor
20269374|NCT04987775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20269375|NCT04987775|Expectorants|expectorants|mesh-ancestor
19951824|NCT01590433|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20543598|NCT01870648|Ondansetron|ondansetron|mesh-list
20269376|NCT04987775|Respiratory System Agents|respiratory system agents|mesh-ancestor
20543599|NCT01870648|Antiemetics|antiemetics|mesh-ancestor
19951825|NCT01590433|Incretins|incretins|mesh-ancestor
19951826|NCT01590433|Hormones|hormones|mesh-ancestor
19951827|NCT01590433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19951828|NCT01590550|Dialysis Solutions|dialysis solutions|mesh-list
19951829|NCT01590550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19951830|NCT01590758|Pexiganan|pexiganan|mesh-list
19951831|NCT01590758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19951832|NCT01590758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19951833|NCT01590771|Metformin|metformin|mesh-list
19951834|NCT01590771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19951835|NCT01590771|Glimepiride|glimepiride|mesh-list
19951836|NCT01590771|Gliclazide|gliclazide|mesh-list
19951837|NCT01590771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19951838|NCT01590771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951839|NCT01590771|Incretins|incretins|mesh-ancestor
19951840|NCT01590771|Hormones|hormones|mesh-ancestor
19951841|NCT01590771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19951842|NCT01590771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19951843|NCT01590771|Protease Inhibitors|protease inhibitors|mesh-ancestor
19951844|NCT01590771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951845|NCT01590771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951846|NCT01590771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19951847|NCT01590771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19951848|NCT01590771|Immunologic Factors|immunologic factors|mesh-ancestor
19951849|NCT01590797|Metformin|metformin|mesh-list
19951850|NCT01590797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19951851|NCT01590797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19951852|NCT01590797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951853|NCT01590797|Incretins|incretins|mesh-ancestor
19951854|NCT01590797|Hormones|hormones|mesh-ancestor
19951855|NCT01590797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19951856|NCT01590797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19951857|NCT01590797|Protease Inhibitors|protease inhibitors|mesh-ancestor
19951858|NCT01590797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951859|NCT01590797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951860|NCT01590875|Adenosine|adenosine|mesh-list
19951861|NCT01590875|Analgesics|analgesics|mesh-ancestor
19951862|NCT01590875|Sensory System Agents|sensory system agents|mesh-ancestor
19951863|NCT01590875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19951864|NCT01590875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951865|NCT01590875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19951866|NCT01590875|Vasodilator Agents|vasodilator agents|mesh-ancestor
19951867|NCT01590875|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19951868|NCT01590875|Purinergic Agonists|purinergic agonists|mesh-ancestor
19951869|NCT01590875|Purinergic Agents|purinergic agents|mesh-ancestor
19951870|NCT01590875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19951871|NCT01590875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951872|NCT01590979|Ranolazine|ranolazine|mesh-list
19951873|NCT01590979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19951874|NCT01590979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19951875|NCT01590979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951876|NCT01591317|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19951877|NCT01591317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19951878|NCT01591382|Ketamine|ketamine|mesh-list
19951879|NCT01591382|Hydromorphone|hydromorphone|mesh-list
19951880|NCT01591382|Analgesics|analgesics|mesh-ancestor
19951881|NCT01591382|Sensory System Agents|sensory system agents|mesh-ancestor
19951882|NCT01591382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19951883|NCT01591382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951884|NCT01591382|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19951885|NCT01591382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19951886|NCT01591382|Anesthetics, General|anesthetics, general|mesh-ancestor
19951887|NCT01591382|Anesthetics|anesthetics|mesh-ancestor
19951888|NCT01591382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19951889|NCT01591382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19951890|NCT01591382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19951891|NCT01591382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19951892|NCT01591382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951893|NCT01591382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19951894|NCT01591382|Narcotics|narcotics|mesh-ancestor
19951895|NCT01591460|Ribavirin|ribavirin|mesh-list
20269377|NCT04987775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20269378|NCT04987775|Antioxidants|antioxidants|mesh-ancestor
19951896|NCT01591460|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19951897|NCT01591460|Interferon-alpha|interferon-alpha|mesh-list
19951898|NCT01591460|Antimetabolites|antimetabolites|mesh-ancestor
19951899|NCT01591460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951900|NCT01591460|Antiviral Agents|antiviral agents|mesh-ancestor
19951901|NCT01591460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19951902|NCT01591460|Immunologic Factors|immunologic factors|mesh-ancestor
19951903|NCT01591460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951904|NCT01591616|Lidocaine|lidocaine|mesh-list
19951905|NCT01591616|Prilocaine|prilocaine|mesh-list
19951906|NCT01591616|Anesthetics, Local|anesthetics, local|mesh-ancestor
19951907|NCT01591616|Anesthetics|anesthetics|mesh-ancestor
19951908|NCT01591616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19951909|NCT01591616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951910|NCT01591616|Sensory System Agents|sensory system agents|mesh-ancestor
19733028|NCT04566770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733029|NCT04566718|Metformin|metformin|mesh-list
19733030|NCT04566718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19733031|NCT04566718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733032|NCT04566224|Pyrithione zinc|pyrithione zinc|mesh-list
19951911|NCT01591616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19951912|NCT01591616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19951913|NCT01591616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19951914|NCT01591616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19951915|NCT01591616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19951916|NCT01591616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951917|NCT01591733|Capecitabine|capecitabine|mesh-list
19951918|NCT01591733|Oxaliplatin|oxaliplatin|mesh-list
19951919|NCT01591733|Irinotecan|irinotecan|mesh-list
19951920|NCT01591733|Folfirinox|folfirinox|mesh-list
19951921|NCT01591733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19951922|NCT01591733|Antimetabolites|antimetabolites|mesh-ancestor
19951923|NCT01591733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951924|NCT01591733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951925|NCT01591733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19951926|NCT01591733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19951927|NCT01591733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19951928|NCT01591746|Botulinum Toxins|botulinum toxins|mesh-list
19951929|NCT01591746|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19951930|NCT01591746|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19951931|NCT01591746|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19951932|NCT01591746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19951933|NCT01591746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951934|NCT01591746|Cholinergic Agents|cholinergic agents|mesh-ancestor
19951935|NCT01591746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19951936|NCT01591746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951937|NCT01591746|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19951938|NCT01591746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19951939|NCT01591785|Retapamulin|retapamulin|mesh-list
19951940|NCT01591785|Petrolatum|petrolatum|mesh-list
19951941|NCT01591785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19951942|NCT01591785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19951943|NCT01591785|Emollients|emollients|mesh-ancestor
19951944|NCT01591785|Dermatologic Agents|dermatologic agents|mesh-ancestor
19951945|NCT01591837|Vaccines|vaccines|mesh-list
19951946|NCT01591837|Immunologic Factors|immunologic factors|mesh-ancestor
19951947|NCT01591837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951948|NCT01591863|Fidaxomicin|fidaxomicin|mesh-list
19951949|NCT01591863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19951950|NCT01591863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19951951|NCT01592006|Ribavirin|ribavirin|mesh-list
19951952|NCT01592006|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19951953|NCT01592006|Antimetabolites|antimetabolites|mesh-ancestor
19951954|NCT01592006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951955|NCT01592006|Antiviral Agents|antiviral agents|mesh-ancestor
19951956|NCT01592006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19951957|NCT01592045|Aldesleukin|aldesleukin|mesh-list
19951958|NCT01592045|Molgramostim|molgramostim|mesh-list
19951959|NCT01592045|Dinutuximab|dinutuximab|mesh-list
19951960|NCT01592045|Isotretinoin|isotretinoin|mesh-list
19951961|NCT01592045|Sargramostim|sargramostim|mesh-list
19951962|NCT01592045|Immunologic Factors|immunologic factors|mesh-ancestor
19951963|NCT01592045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543600|NCT01870648|Autonomic Agents|autonomic agents|mesh-ancestor
19951964|NCT01592045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733033|NCT04566224|Keratolytic Agents|keratolytic agents|mesh-ancestor
19733034|NCT04566224|Dermatologic Agents|dermatologic agents|mesh-ancestor
19733035|NCT04566211|Amoxicillin|amoxicillin|mesh-list
19733036|NCT04566211|Metronidazole|metronidazole|mesh-list
19733037|NCT04566211|Clarithromycin|clarithromycin|mesh-list
19733038|NCT04566211|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
19951965|NCT01592045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19951966|NCT01592045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19951967|NCT01592045|Antiviral Agents|antiviral agents|mesh-ancestor
19951968|NCT01592045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19951969|NCT01592045|Dermatologic Agents|dermatologic agents|mesh-ancestor
19951970|NCT01592240|Bococizumab|bococizumab|mesh-list
19951971|NCT01592240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19951972|NCT01592240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19951973|NCT01592240|Antimetabolites|antimetabolites|mesh-ancestor
19951974|NCT01592240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19951975|NCT01592240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19951976|NCT01592292|Adalimumab|adalimumab|mesh-list
19951977|NCT01592292|Etanercept|etanercept|mesh-list
19951978|NCT01592292|Rituximab|rituximab|mesh-list
19951979|NCT01592292|Infliximab|infliximab|mesh-list
19951980|NCT01592292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19951981|NCT01592292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19951982|NCT01592292|Immunologic Factors|immunologic factors|mesh-ancestor
19951983|NCT01592292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951984|NCT01592292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19951985|NCT01592292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19951986|NCT01592292|Dermatologic Agents|dermatologic agents|mesh-ancestor
19951987|NCT01592292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19951988|NCT01592292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19951989|NCT01592292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19951990|NCT01592292|Analgesics|analgesics|mesh-ancestor
19951991|NCT01592292|Sensory System Agents|sensory system agents|mesh-ancestor
19951992|NCT01592292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19951993|NCT01592292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19951994|NCT01592409|Dronabinol|dronabinol|mesh-list
19951995|NCT01592409|Hallucinogens|hallucinogens|mesh-ancestor
19951996|NCT01592409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19951997|NCT01592409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19951998|NCT01592409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19951999|NCT01592409|Analgesics|analgesics|mesh-ancestor
19952000|NCT01592409|Sensory System Agents|sensory system agents|mesh-ancestor
19952001|NCT01592409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19952002|NCT01592409|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19952003|NCT01592409|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19952004|NCT01592409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19952005|NCT01592409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952006|NCT01592409|Hormones|hormones|mesh-ancestor
19952007|NCT01592409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19952008|NCT01592695|Ethanol|ethanol|mesh-list
19952009|NCT01592695|Bupropion|bupropion|mesh-list
19952010|NCT01592695|Nicotine|nicotine|mesh-list
20269379|NCT04987775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269380|NCT04987775|Protective Agents|protective agents|mesh-ancestor
20269381|NCT04987775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269382|NCT04987775|Antidotes|antidotes|mesh-ancestor
19952011|NCT01592695|Varenicline|varenicline|mesh-list
19952012|NCT01592695|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19952013|NCT01592695|Autonomic Agents|autonomic agents|mesh-ancestor
19952014|NCT01592695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19952015|NCT01592695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952016|NCT01592695|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19952017|NCT01592695|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19952018|NCT01592695|Cholinergic Agents|cholinergic agents|mesh-ancestor
19952019|NCT01592695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19952020|NCT01592695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952021|NCT01592695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19952022|NCT01592695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19952023|NCT01592695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19952024|NCT01592695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19952025|NCT01592695|Antidepressive Agents|antidepressive agents|mesh-ancestor
19952026|NCT01592695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19952027|NCT01592695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19952028|NCT01592695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19952029|NCT01592695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19952030|NCT01592695|Dopamine Agents|dopamine agents|mesh-ancestor
19952031|NCT01592695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19952032|NCT01592695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19952033|NCT01592695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952034|NCT01592708|Erythromycin|erythromycin|mesh-list
19952035|NCT01592708|Ibuprofen|ibuprofen|mesh-list
19952036|NCT01592708|Ketorolac|ketorolac|mesh-list
19952037|NCT01592708|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19952038|NCT01592708|Fentanyl|fentanyl|mesh-list
19952039|NCT01592708|Scopolamine|scopolamine|mesh-list
19952040|NCT01592708|Droperidol|droperidol|mesh-list
19952041|NCT01592708|Remifentanil|remifentanil|mesh-list
19952042|NCT01592708|Hydrocodone|hydrocodone|mesh-list
19952043|NCT01592708|Ondansetron|ondansetron|mesh-list
19952044|NCT01592708|Antiemetics|antiemetics|mesh-list
19952045|NCT01592708|Propofol|propofol|mesh-list
19952046|NCT01592708|Anesthetics|anesthetics|mesh-ancestor
19952047|NCT01592708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19952048|NCT01592708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952049|NCT01592708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19952050|NCT01592708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19952051|NCT01592708|Anesthetics, General|anesthetics, general|mesh-ancestor
19952052|NCT01592708|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19952053|NCT01592708|Narcotics|narcotics|mesh-ancestor
19952054|NCT01592708|Analgesics|analgesics|mesh-ancestor
19952055|NCT01592708|Sensory System Agents|sensory system agents|mesh-ancestor
19952056|NCT01592708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19952057|NCT01592708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19952058|NCT01592708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19952059|NCT01592708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19952060|NCT01592708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19952061|NCT01592708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19952062|NCT01592708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19952063|NCT01592708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952064|NCT01592708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952065|NCT01592708|Autonomic Agents|autonomic agents|mesh-ancestor
19952066|NCT01592708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19952067|NCT01592708|Antipruritics|antipruritics|mesh-ancestor
19952068|NCT01592708|Dermatologic Agents|dermatologic agents|mesh-ancestor
19952069|NCT01592708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19952070|NCT01592708|Serotonin Agents|serotonin agents|mesh-ancestor
19952071|NCT01592708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19952072|NCT01592708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19952073|NCT01592708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19952074|NCT01592708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19952075|NCT01592708|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19952076|NCT01592708|Antitussive Agents|antitussive agents|mesh-ancestor
19952077|NCT01592708|Respiratory System Agents|respiratory system agents|mesh-ancestor
19952078|NCT01592708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19952079|NCT01592708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19952080|NCT01592708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19952081|NCT01592708|Mydriatics|mydriatics|mesh-ancestor
19952082|NCT01592708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19952083|NCT01592708|Cholinergic Agents|cholinergic agents|mesh-ancestor
19952084|NCT01592708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19952085|NCT01592708|Glucocorticoids|glucocorticoids|mesh-ancestor
19952086|NCT01592708|Hormones|hormones|mesh-ancestor
19952087|NCT01592708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19952088|NCT01592708|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19952089|NCT01592708|Protective Agents|protective agents|mesh-ancestor
19952090|NCT01592708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19952091|NCT01592708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952092|NCT01592708|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19952093|NCT01592708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19952094|NCT01592708|Dopamine Agents|dopamine agents|mesh-ancestor
19952095|NCT01592747|Memantine|memantine|mesh-list
19952096|NCT01592747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19952097|NCT01592747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19952098|NCT01592747|Dopamine Agents|dopamine agents|mesh-ancestor
19952099|NCT01592747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19952100|NCT01592747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952101|NCT01592747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952102|NCT01592747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19952103|NCT01592747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19952104|NCT01592773|Memantine|memantine|mesh-list
19952105|NCT01592773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19952106|NCT01592773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19952107|NCT01592773|Dopamine Agents|dopamine agents|mesh-ancestor
19952108|NCT01592773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19952109|NCT01592773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952110|NCT01592773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952111|NCT01592773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19952112|NCT01592773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19952113|NCT01592786|Memantine|memantine|mesh-list
19952114|NCT01592786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19952115|NCT01592786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19952116|NCT01592786|Dopamine Agents|dopamine agents|mesh-ancestor
19952117|NCT01592786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19952118|NCT01592786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952119|NCT01592786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952120|NCT01592786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19952121|NCT01592786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19952122|NCT01592851|Fluorides|fluorides|mesh-list
19952123|NCT01592851|Tin Fluorides|tin fluorides|mesh-list
20269383|NCT04982146|Acetylcysteine|acetylcysteine|mesh-list
20269384|NCT04982146|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20269385|NCT04982146|Antiviral Agents|antiviral agents|mesh-ancestor
20269386|NCT04982146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20269387|NCT04982146|Expectorants|expectorants|mesh-ancestor
19952124|NCT01592851|Fluorophosphate|fluorophosphate|mesh-list
20269388|NCT04982146|Respiratory System Agents|respiratory system agents|mesh-ancestor
20269389|NCT04982146|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20269390|NCT04982146|Antioxidants|antioxidants|mesh-ancestor
20269391|NCT04982146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269392|NCT04982146|Protective Agents|protective agents|mesh-ancestor
20269393|NCT04982146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269394|NCT04982146|Antidotes|antidotes|mesh-ancestor
20269395|NCT04974684|Apixaban|apixaban|mesh-list
20269396|NCT04974684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20269397|NCT04974684|Antithrombins|antithrombins|mesh-ancestor
20269398|NCT04974684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20269399|NCT04974684|Protease Inhibitors|protease inhibitors|mesh-ancestor
20269400|NCT04974684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20269401|NCT04974684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269402|NCT04974684|Anticoagulants|anticoagulants|mesh-ancestor
19952125|NCT01592851|Cariostatic Agents|cariostatic agents|mesh-ancestor
19952126|NCT01592851|Protective Agents|protective agents|mesh-ancestor
19952127|NCT01592851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952128|NCT01592864|Fluorides|fluorides|mesh-list
19952129|NCT01592864|Tin Fluorides|tin fluorides|mesh-list
19952130|NCT01592864|Fluorophosphate|fluorophosphate|mesh-list
19952131|NCT01592864|Cariostatic Agents|cariostatic agents|mesh-ancestor
19952132|NCT01592864|Protective Agents|protective agents|mesh-ancestor
20269403|NCT04924257|Esketamine|esketamine|mesh-list
20269404|NCT04924257|Antidepressive Agents|antidepressive agents|mesh-ancestor
20269405|NCT04924257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20269406|NCT04924101|Cisplatin|cisplatin|mesh-list
20269407|NCT04924101|Carboplatin|carboplatin|mesh-list
20269408|NCT04924101|Pembrolizumab|pembrolizumab|mesh-list
20269409|NCT04924101|Etoposide|etoposide|mesh-list
20269410|NCT04924101|Etoposide phosphate|etoposide phosphate|mesh-list
20269411|NCT04924101|Lenvatinib|lenvatinib|mesh-list
20269412|NCT04924101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269413|NCT04924101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20269414|NCT04924101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20269415|NCT04924101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20269416|NCT04924101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20269417|NCT04924101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20269418|NCT04924101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269419|NCT04924101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20269420|NCT04913220|Cemiplimab|cemiplimab|mesh-list
20269421|NCT04913220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20269422|NCT04913220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269423|NCT04892875|Cisplatin|cisplatin|mesh-list
20543601|NCT01870648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543602|NCT01870648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543603|NCT01870648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20543604|NCT01870648|Antipruritics|antipruritics|mesh-ancestor
20543605|NCT01870648|Dermatologic Agents|dermatologic agents|mesh-ancestor
20543606|NCT01870648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20543607|NCT01870648|Serotonin Agents|serotonin agents|mesh-ancestor
20543608|NCT01870648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20543609|NCT01870648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543610|NCT01870648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20543611|NCT01870648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19952133|NCT01592864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952134|NCT01593020|Paclitaxel|paclitaxel|mesh-list
19952135|NCT01593020|Cyclophosphamide|cyclophosphamide|mesh-list
20269424|NCT04892875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269425|NCT04886154|Vaccines|vaccines|mesh-list
19952136|NCT01593020|Doxorubicin|doxorubicin|mesh-list
19952137|NCT01593020|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19952138|NCT01593020|Fluorouracil|fluorouracil|mesh-list
19952139|NCT01593020|Epirubicin|epirubicin|mesh-list
19952140|NCT01593020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19952141|NCT01593020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952142|NCT01593020|Tubulin Modulators|tubulin modulators|mesh-ancestor
19952143|NCT01593020|Antimitotic Agents|antimitotic agents|mesh-ancestor
19952144|NCT01593020|Mitosis Modulators|mitosis modulators|mesh-ancestor
19952145|NCT01593020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952146|NCT01593020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19952147|NCT01593020|Immunologic Factors|immunologic factors|mesh-ancestor
19952148|NCT01593020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952149|NCT01593020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19952150|NCT01593020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19952151|NCT01593020|Alkylating Agents|alkylating agents|mesh-ancestor
19952152|NCT01593020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19952153|NCT01593020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19952154|NCT01593020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19952155|NCT01593020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19952156|NCT01593020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952157|NCT01593020|Antimetabolites|antimetabolites|mesh-ancestor
19952158|NCT01593020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19952159|NCT01593215|Yohimbine|yohimbine|mesh-list
19952160|NCT01593215|Mydriatics|mydriatics|mesh-ancestor
19952161|NCT01593215|Autonomic Agents|autonomic agents|mesh-ancestor
19952162|NCT01593215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19952163|NCT01593215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952164|NCT01593215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19952165|NCT01593215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19952166|NCT01593215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19952167|NCT01593215|Adrenergic Agents|adrenergic agents|mesh-ancestor
19952168|NCT01593215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19952169|NCT01593215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952170|NCT01593215|Urological Agents|urological agents|mesh-ancestor
19952171|NCT01593592|Amoxicillin|amoxicillin|mesh-list
19952172|NCT01593592|Clarithromycin|clarithromycin|mesh-list
19952173|NCT01593592|Omeprazole|omeprazole|mesh-list
19952174|NCT01593592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19952175|NCT01593592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19952176|NCT01593592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19952177|NCT01593592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19952178|NCT01593592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20269426|NCT04886154|Immunologic Factors|immunologic factors|mesh-ancestor
20269427|NCT04886154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269428|NCT04865835|Metformin|metformin|mesh-list
20269429|NCT04865835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20269430|NCT04865835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269431|NCT04857307|Alprazolam|alprazolam|mesh-list
20269432|NCT04857307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20269433|NCT04857307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20269434|NCT04857307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269435|NCT04857307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20543612|NCT01870648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20543613|NCT01870648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20543614|NCT01870648|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20543615|NCT01870674|Prucalopride|prucalopride|mesh-list
20543616|NCT01870674|YH12852|yh12852|mesh-list
19952179|NCT01593592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952180|NCT01593592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952181|NCT01593592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19952182|NCT01593592|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19952183|NCT01593592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19952184|NCT01593670|Decitabine|decitabine|mesh-list
19952185|NCT01593670|Interleukin-2|interleukin-2|mesh-list
19952186|NCT01593670|Vorinostat|vorinostat|mesh-list
19952187|NCT01593670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19952188|NCT01593670|Antimetabolites|antimetabolites|mesh-ancestor
19952189|NCT01593670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952190|NCT01593670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952191|NCT01593670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952192|NCT01593670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19952193|NCT01593670|Analgesics|analgesics|mesh-ancestor
19952194|NCT01593670|Sensory System Agents|sensory system agents|mesh-ancestor
19952195|NCT01593670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543617|NCT01870674|Laxatives|laxatives|mesh-ancestor
19952196|NCT01593670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952197|NCT01593670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19952198|NCT01593722|Ivermectin|ivermectin|mesh-list
19952199|NCT01593722|Diethylcarbamazine|diethylcarbamazine|mesh-list
19952200|NCT01593722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19952201|NCT01593722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19952202|NCT01593722|Filaricides|filaricides|mesh-ancestor
19952203|NCT01593722|Antinematodal Agents|antinematodal agents|mesh-ancestor
19952204|NCT01593722|Anthelmintics|anthelmintics|mesh-ancestor
19952205|NCT01593722|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19952206|NCT01593722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952207|NCT01593722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952208|NCT01593748|Gemcitabine|gemcitabine|mesh-list
19952209|NCT01593748|Docetaxel|docetaxel|mesh-list
19952210|NCT01593748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19952211|NCT01593748|Antimetabolites|antimetabolites|mesh-ancestor
19952212|NCT01593748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952213|NCT01593748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952214|NCT01593748|Antiviral Agents|antiviral agents|mesh-ancestor
19952215|NCT01593748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19952216|NCT01593748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952217|NCT01593748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19952218|NCT01593748|Immunologic Factors|immunologic factors|mesh-ancestor
19952219|NCT01593748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952220|NCT01593748|Tubulin Modulators|tubulin modulators|mesh-ancestor
19952221|NCT01593748|Antimitotic Agents|antimitotic agents|mesh-ancestor
19952222|NCT01593748|Mitosis Modulators|mitosis modulators|mesh-ancestor
19952223|NCT01593787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19952224|NCT01593787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19952225|NCT01593787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952226|NCT01594125|Nintedanib|nintedanib|mesh-list
19952227|NCT01594125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952228|NCT01594125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19952229|NCT01594125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952230|NCT01594125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952231|NCT01594281|Ranibizumab|ranibizumab|mesh-list
19952232|NCT01594281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19952233|NCT01594281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19952234|NCT01594281|Growth Substances|growth substances|mesh-ancestor
19952235|NCT01594281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952236|NCT01594281|Growth Inhibitors|growth inhibitors|mesh-ancestor
19952237|NCT01594281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952238|NCT01594294|Contact Lens Solutions|contact lens solutions|mesh-list
19952239|NCT01594294|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19952240|NCT01594294|Disinfectants|disinfectants|mesh-ancestor
19952241|NCT01594294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19952242|NCT01594333|Methotrexate|methotrexate|mesh-list
19952243|NCT01594333|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19952244|NCT01594333|Abortifacient Agents|abortifacient agents|mesh-ancestor
19952245|NCT01594333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19952246|NCT01594333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952247|NCT01594333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19952248|NCT01594333|Antimetabolites|antimetabolites|mesh-ancestor
19952249|NCT01594333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952250|NCT01594333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952251|NCT01594333|Dermatologic Agents|dermatologic agents|mesh-ancestor
19952252|NCT01594333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952253|NCT01594333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19952254|NCT01594333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19952255|NCT01594333|Immunologic Factors|immunologic factors|mesh-ancestor
19952256|NCT01594333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19952257|NCT01594333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19974470|NCT01837719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19974471|NCT01837797|Brexpiprazole|brexpiprazole|mesh-list
19974472|NCT01837797|Serotonin Agents|serotonin agents|mesh-ancestor
19974473|NCT01837797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19974474|NCT01837797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974475|NCT01837797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974476|NCT01837797|Dopamine Agonists|dopamine agonists|mesh-ancestor
19974477|NCT01837797|Dopamine Agents|dopamine agents|mesh-ancestor
19974478|NCT01837823|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19974479|NCT01837823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19974480|NCT01837823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19974481|NCT01837823|Antimetabolites|antimetabolites|mesh-ancestor
19952258|NCT01594424|Immunoglobulins|immunoglobulins|mesh-list
19952259|NCT01594424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19952260|NCT01594424|Antibodies|antibodies|mesh-list
19952261|NCT01594424|gamma-Globulins|gamma-globulins|mesh-list
19952262|NCT01594424|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19952263|NCT01594424|Immunologic Factors|immunologic factors|mesh-ancestor
19952264|NCT01594424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952265|NCT01594476|Levonorgestrel|levonorgestrel|mesh-list
19952266|NCT01594476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19952267|NCT01594476|Contraceptive Agents|contraceptive agents|mesh-ancestor
19952268|NCT01594476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19952269|NCT01594476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952270|NCT01594476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19952271|NCT01594476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19952272|NCT01594476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19952273|NCT01594749|Dexamethasone|dexamethasone|mesh-list
19952274|NCT01594749|Dexamethasone acetate|dexamethasone acetate|mesh-list
19952275|NCT01594749|Ondansetron|ondansetron|mesh-list
19952276|NCT01594749|Fosaprepitant|fosaprepitant|mesh-list
19952277|NCT01594749|Aprepitant|aprepitant|mesh-list
19952278|NCT01594749|BB 1101|bb 1101|mesh-list
19952279|NCT01594749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19952280|NCT01594749|Antiemetics|antiemetics|mesh-ancestor
19952281|NCT01594749|Autonomic Agents|autonomic agents|mesh-ancestor
19952282|NCT01594749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19952283|NCT01594749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952284|NCT01594749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19952285|NCT01594749|Glucocorticoids|glucocorticoids|mesh-ancestor
19952286|NCT01594749|Hormones|hormones|mesh-ancestor
19952287|NCT01594749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19952288|NCT01594749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19952289|NCT01594749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952290|NCT01594749|Protease Inhibitors|protease inhibitors|mesh-ancestor
19952291|NCT01594749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952292|NCT01594749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952293|NCT01594749|Antipruritics|antipruritics|mesh-ancestor
19952294|NCT01594749|Dermatologic Agents|dermatologic agents|mesh-ancestor
19952295|NCT01594749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19952296|NCT01594749|Serotonin Agents|serotonin agents|mesh-ancestor
19952297|NCT01594749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19952298|NCT01594749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19952299|NCT01594749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19952300|NCT01594749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19952301|NCT01594749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19952302|NCT01594749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19952303|NCT01594749|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19952304|NCT01594762|Pexiganan|pexiganan|mesh-list
19952305|NCT01594762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19952306|NCT01594762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19952307|NCT01594827|Chlorhexidine|chlorhexidine|mesh-list
19952308|NCT01594827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19952309|NCT01594827|Vancomycin|vancomycin|mesh-list
19952310|NCT01594827|Doxycycline|doxycycline|mesh-list
19952311|NCT01594827|Rifampin|rifampin|mesh-list
19952312|NCT01594827|Trimethoprim|trimethoprim|mesh-list
19952313|NCT01594827|Sulfamethoxazole|sulfamethoxazole|mesh-list
19952314|NCT01594827|Mupirocin|mupirocin|mesh-list
19952315|NCT01594827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19952316|NCT01594827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19952317|NCT01594827|Disinfectants|disinfectants|mesh-ancestor
19952318|NCT01594827|Dermatologic Agents|dermatologic agents|mesh-ancestor
19952319|NCT01594827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19952320|NCT01594827|Antimalarials|antimalarials|mesh-ancestor
19952321|NCT01594827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19952322|NCT01594827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19952323|NCT01594827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19952324|NCT01594827|Antitubercular Agents|antitubercular agents|mesh-ancestor
19952325|NCT01594827|Leprostatic Agents|leprostatic agents|mesh-ancestor
19952326|NCT01594827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19952327|NCT01594827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952328|NCT01594827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952329|NCT01594827|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19952330|NCT01594827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19952331|NCT01594827|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19952332|NCT01594827|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19952333|NCT01594827|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19952334|NCT01594827|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19952335|NCT01594827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19952336|NCT01594827|Renal Agents|renal agents|mesh-ancestor
19952337|NCT01594827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19952338|NCT01594827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19952339|NCT01594827|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19952340|NCT01594827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19952341|NCT01594827|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19952342|NCT01594931|Artesunate|artesunate|mesh-list
19952343|NCT01594931|Pyronaridine|pyronaridine|mesh-list
19952344|NCT01594931|Antimalarials|antimalarials|mesh-ancestor
19952345|NCT01594931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19952346|NCT01594931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19952347|NCT01594931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19952348|NCT01594931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952349|NCT01594931|Antiviral Agents|antiviral agents|mesh-ancestor
19952350|NCT01594931|Schistosomicides|schistosomicides|mesh-ancestor
19952351|NCT01594931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19952352|NCT01594931|Anthelmintics|anthelmintics|mesh-ancestor
19952353|NCT01594970|Bimatoprost|bimatoprost|mesh-list
19952354|NCT01594970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19952355|NCT01595282|Ibuprofen|ibuprofen|mesh-list
19952356|NCT01595282|Ketorolac|ketorolac|mesh-list
19952357|NCT01595282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19952358|NCT01595282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19952359|NCT01595282|Analgesics|analgesics|mesh-ancestor
19952360|NCT01595282|Sensory System Agents|sensory system agents|mesh-ancestor
19952361|NCT01595282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19952362|NCT01595282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952363|NCT01595282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19952364|NCT01595282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19952365|NCT01595282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19952366|NCT01595282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952367|NCT01595282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952368|NCT01595386|Hydrocortisone|hydrocortisone|mesh-list
19952369|NCT01595386|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19952370|NCT01595386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19952371|NCT01595438|Ciprofloxacin|ciprofloxacin|mesh-list
19952372|NCT01595438|Ceftazidime|ceftazidime|mesh-list
19952373|NCT01595438|Doripenem|doripenem|mesh-list
19952374|NCT01595438|Avibactam|avibactam|mesh-list
19952375|NCT01595438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19952376|NCT01595438|Trimethoprim|trimethoprim|mesh-list
19952377|NCT01595438|Sulfamethoxazole|sulfamethoxazole|mesh-list
19952378|NCT01595438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19952379|NCT01595438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19952380|NCT01595438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19952381|NCT01595438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19952382|NCT01595438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952383|NCT01595438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952384|NCT01595438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952385|NCT01595438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19952386|NCT01595438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19952387|NCT01595438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19952388|NCT01595438|Renal Agents|renal agents|mesh-ancestor
19952389|NCT01595438|Antimalarials|antimalarials|mesh-ancestor
19952390|NCT01595438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19952391|NCT01595438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19952392|NCT01595438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19952393|NCT01595438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19952394|NCT01595438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19952395|NCT01595438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19952396|NCT01595516|Ascorbic Acid|ascorbic acid|mesh-list
19952397|NCT01595516|Metoprolol|metoprolol|mesh-list
19952398|NCT01595516|Nebivolol|nebivolol|mesh-list
19952399|NCT01595516|Bradykinin|bradykinin|mesh-list
19952400|NCT01595516|Kininogens|kininogens|mesh-list
19952401|NCT01595516|Vitamins|vitamins|mesh-ancestor
19952402|NCT01595516|Micronutrients|micronutrients|mesh-ancestor
19952403|NCT01595516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952404|NCT01595516|Antioxidants|antioxidants|mesh-ancestor
19952405|NCT01595516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952406|NCT01595516|Protective Agents|protective agents|mesh-ancestor
19952407|NCT01595516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19952408|NCT01595516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19952409|NCT01595516|Sympatholytics|sympatholytics|mesh-ancestor
19952410|NCT01595516|Autonomic Agents|autonomic agents|mesh-ancestor
19952411|NCT01595516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269436|NCT04857307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19952412|NCT01595516|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19952413|NCT01595516|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19952414|NCT01595516|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19952415|NCT01595516|Adrenergic Agents|adrenergic agents|mesh-ancestor
19952416|NCT01595516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19952417|NCT01595516|Vasodilator Agents|vasodilator agents|mesh-ancestor
19952418|NCT01595516|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19952419|NCT01595516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19952420|NCT01595516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19952421|NCT01595516|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19952422|NCT01595516|Protease Inhibitors|protease inhibitors|mesh-ancestor
19952423|NCT01595516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952424|NCT01595529|Trimethoprim|trimethoprim|mesh-list
19952425|NCT01595529|Sulfamethoxazole|sulfamethoxazole|mesh-list
19952426|NCT01595529|Cephalexin|cephalexin|mesh-list
19952427|NCT01595529|Cefixime|cefixime|mesh-list
19952428|NCT01595529|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19952429|NCT01595529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19952430|NCT01595529|Renal Agents|renal agents|mesh-ancestor
19952431|NCT01595529|Antimalarials|antimalarials|mesh-ancestor
19952432|NCT01595529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19952433|NCT01595529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19952434|NCT01595529|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19952435|NCT01595529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952436|NCT01595529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952437|NCT01595529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19952438|NCT01595529|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19952439|NCT01595529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19952440|NCT01595529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19952441|NCT01595646|Insulin|insulin|mesh-list
19952442|NCT01595646|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19952443|NCT01595646|Insulin Detemir|insulin detemir|mesh-list
19952444|NCT01595646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19952445|NCT01595646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952446|NCT01595854|Dabigatran|dabigatran|mesh-list
19952447|NCT01595854|Ticagrelor|ticagrelor|mesh-list
19952448|NCT01595854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19952449|NCT01595854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19952450|NCT01595854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19952451|NCT01595854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19952452|NCT01595854|Purinergic Agents|purinergic agents|mesh-ancestor
19733039|NCT04566211|Pantoprazole|pantoprazole|mesh-list
19733040|NCT04566211|Bismuth|bismuth|mesh-list
19733041|NCT04566211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19733042|NCT04566211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19733043|NCT04566211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19733044|NCT04566211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19733045|NCT04566211|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19733046|NCT04566211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733047|NCT04566211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733048|NCT04566211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19733049|NCT04566211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19733050|NCT04566211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19733051|NCT04566211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19733052|NCT04566211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19733053|NCT04566211|Antacids|antacids|mesh-ancestor
19733054|NCT04565847|Albuterol|albuterol|mesh-list
19733055|NCT04565847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19733056|NCT04565847|Autonomic Agents|autonomic agents|mesh-ancestor
19733057|NCT04565847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733058|NCT04565847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733059|NCT04565847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19733060|NCT04565847|Respiratory System Agents|respiratory system agents|mesh-ancestor
19733061|NCT04565847|Tocolytic Agents|tocolytic agents|mesh-ancestor
19733062|NCT04565847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19733063|NCT04565847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19733064|NCT04565847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19733065|NCT04565847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19733066|NCT04565847|Adrenergic Agents|adrenergic agents|mesh-ancestor
19733067|NCT04565847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19733068|NCT04565847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735751|NCT04536662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735752|NCT04536662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19952453|NCT01595854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19952454|NCT01595854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952455|NCT01595854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952456|NCT01595854|Antithrombins|antithrombins|mesh-ancestor
19952457|NCT01595854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19952458|NCT01595854|Protease Inhibitors|protease inhibitors|mesh-ancestor
19952459|NCT01595854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952460|NCT01595854|Anticoagulants|anticoagulants|mesh-ancestor
19952461|NCT01596062|Cyclosporine|cyclosporine|mesh-list
19952462|NCT01596062|Mycophenolic Acid|mycophenolic acid|mesh-list
19952463|NCT01596062|Everolimus|everolimus|mesh-list
19952464|NCT01596062|Cyclosporins|cyclosporins|mesh-list
19952465|NCT01596062|Basiliximab|basiliximab|mesh-list
19952466|NCT01596062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952467|NCT01596062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952468|NCT01596062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19952469|NCT01596062|Immunologic Factors|immunologic factors|mesh-ancestor
19952470|NCT01596062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952471|NCT01596062|Antifungal Agents|antifungal agents|mesh-ancestor
19952472|NCT01596062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19952473|NCT01596062|Dermatologic Agents|dermatologic agents|mesh-ancestor
19952474|NCT01596062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19952475|NCT01596062|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19952476|NCT01596062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952477|NCT01596062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19952478|NCT01596062|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19952479|NCT01596062|Antitubercular Agents|antitubercular agents|mesh-ancestor
19952480|NCT01596062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19952481|NCT01596088|Dexrazoxane|dexrazoxane|mesh-list
19952482|NCT01596088|Razoxane|razoxane|mesh-list
19952483|NCT01596088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952484|NCT01596088|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19952485|NCT01596088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19952486|NCT01596088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19952487|NCT01596088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952488|NCT01596088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952489|NCT01596088|Protective Agents|protective agents|mesh-ancestor
19952490|NCT01596088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952491|NCT01596088|Antimitotic Agents|antimitotic agents|mesh-ancestor
19952492|NCT01596088|Mitosis Modulators|mitosis modulators|mesh-ancestor
19952493|NCT01596127|Rituximab|rituximab|mesh-list
19952494|NCT01596127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19952495|NCT01596127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952496|NCT01596127|Immunologic Factors|immunologic factors|mesh-ancestor
19952497|NCT01596127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952498|NCT01596127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19952499|NCT01596335|Immunoglobulins|immunoglobulins|mesh-list
19952500|NCT01596335|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19952501|NCT01596335|Antibodies|antibodies|mesh-list
19952502|NCT01596335|Immunologic Factors|immunologic factors|mesh-ancestor
19952503|NCT01596335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952504|NCT01596504|Metformin|metformin|mesh-list
19952505|NCT01596504|Insulin Glargine|insulin glargine|mesh-list
19952506|NCT01596504|Liraglutide|liraglutide|mesh-list
19952507|NCT01596504|Lixisenatide|lixisenatide|mesh-list
19952508|NCT01596504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20269437|NCT04857307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20269438|NCT04857307|GABA Modulators|gaba modulators|mesh-ancestor
19952509|NCT01596504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952510|NCT01596504|Incretins|incretins|mesh-ancestor
19952511|NCT01596504|Hormones|hormones|mesh-ancestor
19952512|NCT01596504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19952513|NCT01596699|Fludarabine|fludarabine|mesh-list
19952514|NCT01596699|Busulfan|busulfan|mesh-list
19952515|NCT01596699|Alemtuzumab|alemtuzumab|mesh-list
19952516|NCT01596699|Clofarabine|clofarabine|mesh-list
19952517|NCT01596699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952518|NCT01596699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19952519|NCT01596699|Antimetabolites|antimetabolites|mesh-ancestor
19952520|NCT01596699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952521|NCT01596699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19952522|NCT01596699|Immunologic Factors|immunologic factors|mesh-ancestor
19952523|NCT01596699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952524|NCT01596699|Alkylating Agents|alkylating agents|mesh-ancestor
19952525|NCT01596699|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19952526|NCT01596699|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19952527|NCT01596699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19952528|NCT01596842|Cholecalciferol|cholecalciferol|mesh-list
19952529|NCT01596842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19952530|NCT01596842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952531|NCT01596842|Vitamins|vitamins|mesh-ancestor
19952532|NCT01596842|Micronutrients|micronutrients|mesh-ancestor
19952533|NCT01596842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19952534|NCT01597193|Fulvestrant|fulvestrant|mesh-list
19952535|NCT01597193|Anastrozole|anastrozole|mesh-list
19952536|NCT01597193|Exemestane|exemestane|mesh-list
19952537|NCT01597193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19952538|NCT01597193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952539|NCT01597193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19952540|NCT01597193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19952541|NCT01597193|Hormone Antagonists|hormone antagonists|mesh-ancestor
19952542|NCT01597193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19952543|NCT01597193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952544|NCT01597193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19952545|NCT01597193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19952546|NCT01597193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952547|NCT01597193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952548|NCT01597245|Etanercept|etanercept|mesh-list
19952549|NCT01597245|Ixekizumab|ixekizumab|mesh-list
20269439|NCT04857307|GABA Agents|gaba agents|mesh-ancestor
20269440|NCT04857307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20269441|NCT04857307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269442|NCT04836910|Metformin|metformin|mesh-list
20269443|NCT04836910|Contraceptive Agents|contraceptive agents|mesh-list
20269444|NCT04836910|Contraceptives, Oral|contraceptives, oral|mesh-list
20269445|NCT04836910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
20269446|NCT04836910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20269447|NCT04836910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269448|NCT04836910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20269449|NCT04836910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20269450|NCT04818450|Gabapentin|gabapentin|mesh-list
20269451|NCT04818450|Analgesics|analgesics|mesh-ancestor
20269452|NCT04818450|Sensory System Agents|sensory system agents|mesh-ancestor
20269453|NCT04818450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269454|NCT04818450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269455|NCT04818450|Anticonvulsants|anticonvulsants|mesh-ancestor
20269456|NCT04818450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20269457|NCT04818450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20269458|NCT04818450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20269459|NCT04818450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20269460|NCT04818450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20269461|NCT04818450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20269462|NCT04818450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20269463|NCT04818450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269464|NCT04818450|Antimanic Agents|antimanic agents|mesh-ancestor
20269465|NCT04817033|Midazolam|midazolam|mesh-list
20269466|NCT04817033|Dexmedetomidine|dexmedetomidine|mesh-list
20269467|NCT04817033|Anesthetics|anesthetics|mesh-list
20269468|NCT04817033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20269469|NCT04817033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269470|NCT04817033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20269471|NCT04817033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20269472|NCT04817033|Analgesics|analgesics|mesh-ancestor
20269473|NCT04817033|Sensory System Agents|sensory system agents|mesh-ancestor
20269474|NCT04817033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269475|NCT04817033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20269476|NCT04817033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20269477|NCT04817033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20269478|NCT04817033|Adrenergic Agents|adrenergic agents|mesh-ancestor
20269479|NCT04817033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20269480|NCT04817033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269481|NCT04817033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20269482|NCT04817033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20269483|NCT04817033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20269484|NCT04817033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20269485|NCT04817033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20269486|NCT04817033|Anesthetics, General|anesthetics, general|mesh-ancestor
20269487|NCT04817033|GABA Modulators|gaba modulators|mesh-ancestor
20269488|NCT04817033|GABA Agents|gaba agents|mesh-ancestor
19952550|NCT01597245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19952551|NCT01597245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20287385|NCT04892706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19952552|NCT01597245|Analgesics|analgesics|mesh-ancestor
19952553|NCT01597245|Sensory System Agents|sensory system agents|mesh-ancestor
19952554|NCT01597245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19952555|NCT01597245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952556|NCT01597245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19952557|NCT01597245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19952558|NCT01597245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19952559|NCT01597245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20269489|NCT04759144|Insulin|insulin|mesh-list
20269490|NCT04759144|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20269491|NCT04759144|Insulin Aspart|insulin aspart|mesh-list
20269492|NCT04759144|Insulin, Long-Acting|insulin, long-acting|mesh-list
20269493|NCT04759144|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20269494|NCT04759144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20269495|NCT04759144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269496|NCT04752774|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20269497|NCT04752774|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20269498|NCT04752774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20269499|NCT04752774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269500|NCT04752774|Cholinergic Agents|cholinergic agents|mesh-ancestor
20269501|NCT04752774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20269502|NCT04752774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269503|NCT04748172|Antibodies|antibodies|mesh-list
20269504|NCT04748172|Immunologic Factors|immunologic factors|mesh-ancestor
20269505|NCT04748172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269506|NCT04743661|Antipyretics|antipyretics|mesh-list
20269507|NCT04743661|Dexamethasone|dexamethasone|mesh-list
20269508|NCT04743661|Bevacizumab|bevacizumab|mesh-list
20269509|NCT04743661|Irinotecan|irinotecan|mesh-list
20269510|NCT04743661|Temozolomide|temozolomide|mesh-list
20269511|NCT04743661|Antiemetics|antiemetics|mesh-list
20269512|NCT04743661|Emetics|emetics|mesh-list
20269513|NCT04743661|Histamine Antagonists|histamine antagonists|mesh-list
20269514|NCT04743661|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
20269515|NCT04743661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20269516|NCT04743661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269517|NCT04743661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20269518|NCT04743661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20269519|NCT04743661|Growth Substances|growth substances|mesh-ancestor
20269520|NCT04743661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269521|NCT04743661|Growth Inhibitors|growth inhibitors|mesh-ancestor
20269522|NCT04743661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20269523|NCT04743661|Autonomic Agents|autonomic agents|mesh-ancestor
20269524|NCT04743661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269525|NCT04743661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20269526|NCT04743661|Glucocorticoids|glucocorticoids|mesh-ancestor
20269527|NCT04743661|Hormones|hormones|mesh-ancestor
20269528|NCT04743661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20269529|NCT04743661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20269530|NCT04743661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20269531|NCT04743661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20269532|NCT04743661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20269533|NCT04743661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269534|NCT04743661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20269535|NCT04743661|Alkylating Agents|alkylating agents|mesh-ancestor
20269536|NCT04743661|Histamine Agents|histamine agents|mesh-ancestor
20269537|NCT04743661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20269538|NCT04724044|Moxifloxacin|moxifloxacin|mesh-list
20269539|NCT04724044|Clarithromycin|clarithromycin|mesh-list
20269540|NCT04724044|Ceftriaxone|ceftriaxone|mesh-list
20269541|NCT04724044|Lactams|lactams|mesh-list
20269542|NCT04724044|beta-Lactams|beta-lactams|mesh-list
20269543|NCT04724044|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20269544|NCT04724044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20269545|NCT04724044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20269546|NCT04724044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20269547|NCT04724044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20269548|NCT04724044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20269549|NCT04724044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952560|NCT01597245|Immunologic Factors|immunologic factors|mesh-ancestor
19952561|NCT01597245|Dermatologic Agents|dermatologic agents|mesh-ancestor
19952562|NCT01597258|Crizotinib|crizotinib|mesh-list
19952563|NCT01597258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952564|NCT01597258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19952565|NCT01597258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543618|NCT01870674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19952566|NCT01597258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952567|NCT01597375|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19952568|NCT01597375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19952569|NCT01597479|Anesthetics|anesthetics|mesh-list
19952570|NCT01597479|Levobupivacaine|levobupivacaine|mesh-list
19952571|NCT01597479|Anesthetics, Local|anesthetics, local|mesh-list
19952572|NCT01597479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19952573|NCT01597479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952574|NCT01597479|Sensory System Agents|sensory system agents|mesh-ancestor
19952575|NCT01597479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269550|NCT04724044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269551|NCT04724044|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20269552|NCT04724044|Contraceptive Agents|contraceptive agents|mesh-ancestor
20269553|NCT04724044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20269554|NCT04724044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269555|NCT04724044|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20269556|NCT04724044|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20269557|NCT04724044|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20269558|NCT04724044|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20269559|NCT04724044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20269560|NCT04724044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20269561|NCT04707391|Vaccines|vaccines|mesh-list
20269562|NCT04707391|Immunologic Factors|immunologic factors|mesh-ancestor
20269563|NCT04707391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269564|NCT04684420|Metformin|metformin|mesh-list
20269565|NCT04684420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20269566|NCT04684420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269567|NCT04659044|Rituximab|rituximab|mesh-list
20269568|NCT04659044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20269569|NCT04659044|Venetoclax|venetoclax|mesh-list
20269570|NCT04659044|Antibodies|antibodies|mesh-list
20269571|NCT04659044|Immunoglobulins|immunoglobulins|mesh-list
20269572|NCT04659044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20269573|NCT04659044|Immunoconjugates|immunoconjugates|mesh-list
20269574|NCT04659044|Immunologic Factors|immunologic factors|mesh-ancestor
20269575|NCT04659044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269576|NCT04659044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269577|NCT04659044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20269578|NCT04642378|Insulin|insulin|mesh-list
20269579|NCT04642378|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20269580|NCT04642378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20269581|NCT04642378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269582|NCT04630886|Lidocaine|lidocaine|mesh-list
20269583|NCT04630886|Epinephrine|epinephrine|mesh-list
20269584|NCT04630886|Tranexamic Acid|tranexamic acid|mesh-list
20269585|NCT04630886|Anesthetics, Local|anesthetics, local|mesh-ancestor
20269586|NCT04630886|Anesthetics|anesthetics|mesh-ancestor
20269587|NCT04630886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20269588|NCT04630886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269589|NCT04630886|Sensory System Agents|sensory system agents|mesh-ancestor
20269590|NCT04630886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269591|NCT04630886|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20269592|NCT04630886|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20269593|NCT04630886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20269594|NCT04630886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20269595|NCT04630886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269596|NCT04630886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20269597|NCT04630886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20269598|NCT04630886|Adrenergic Agents|adrenergic agents|mesh-ancestor
20269599|NCT04630886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19952576|NCT01597492|Vaccines|vaccines|mesh-list
19952577|NCT01597492|Belimumab|belimumab|mesh-list
19952578|NCT01597492|Immunologic Factors|immunologic factors|mesh-ancestor
19952579|NCT01597492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952580|NCT01597492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19952581|NCT01597505|Vancomycin|vancomycin|mesh-list
19952582|NCT01597505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19952583|NCT01597505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19952584|NCT01597557|Magnesium Sulfate|magnesium sulfate|mesh-list
19952585|NCT01597557|Analgesics|analgesics|mesh-ancestor
19952586|NCT01597557|Sensory System Agents|sensory system agents|mesh-ancestor
19952587|NCT01597557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19952588|NCT01597557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952589|NCT01597557|Anesthetics|anesthetics|mesh-ancestor
20269600|NCT04630886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20269601|NCT04630886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19952590|NCT01597557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19952591|NCT01597557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19952592|NCT01597557|Anticonvulsants|anticonvulsants|mesh-ancestor
19952593|NCT01597557|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19952594|NCT01597557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19952595|NCT01597557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952596|NCT01597557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19952597|NCT01597557|Tocolytic Agents|tocolytic agents|mesh-ancestor
19952598|NCT01597557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19952599|NCT01597622|Belimumab|belimumab|mesh-list
19952600|NCT01597622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19952601|NCT01597622|Immunologic Factors|immunologic factors|mesh-ancestor
19952602|NCT01597622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952603|NCT01597908|Trametinib|trametinib|mesh-list
19952604|NCT01597908|Vemurafenib|vemurafenib|mesh-list
19952605|NCT01597908|Dabrafenib|dabrafenib|mesh-list
19952606|NCT01597908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952607|NCT01597908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19952608|NCT01597908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952609|NCT01597908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269602|NCT04630886|Autonomic Agents|autonomic agents|mesh-ancestor
20269603|NCT04630886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20269604|NCT04630886|Respiratory System Agents|respiratory system agents|mesh-ancestor
20269605|NCT04630886|Mydriatics|mydriatics|mesh-ancestor
20269606|NCT04630886|Sympathomimetics|sympathomimetics|mesh-ancestor
20269607|NCT04630886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20269608|NCT04630886|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20269609|NCT04630886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20269610|NCT04630886|Hemostatics|hemostatics|mesh-ancestor
20269611|NCT04630886|Coagulants|coagulants|mesh-ancestor
20269612|NCT04549168|Lemborexant|lemborexant|mesh-list
20269613|NCT04549168|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20269614|NCT04549168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20269615|NCT04549168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269616|NCT04549168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20269617|NCT04549168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20269618|NCT04549168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20269619|NCT04549168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269620|NCT04527380|Adalimumab|adalimumab|mesh-list
20269621|NCT04527380|Ixekizumab|ixekizumab|mesh-list
20269622|NCT04527380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20269623|NCT04527380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20269624|NCT04527380|Dermatologic Agents|dermatologic agents|mesh-ancestor
20269625|NCT04502667|Vitamin D|vitamin d|mesh-list
20269626|NCT04502667|Cholecalciferol|cholecalciferol|mesh-list
20269627|NCT04502667|Vitamins|vitamins|mesh-ancestor
20269628|NCT04502667|Micronutrients|micronutrients|mesh-ancestor
20269629|NCT04502667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269630|NCT04502667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20269631|NCT04502667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20269632|NCT04497168|Citalopram|citalopram|mesh-list
20269633|NCT04497168|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20269634|NCT04497168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20269635|NCT04497168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20269636|NCT04497168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269637|NCT04497168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20269638|NCT04497168|Serotonin Agents|serotonin agents|mesh-ancestor
20269639|NCT04497168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269640|NCT04497168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20269641|NCT04497168|Antidepressive Agents|antidepressive agents|mesh-ancestor
20269642|NCT04497168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20269643|NCT04480502|Ipilimumab|ipilimumab|mesh-list
20269644|NCT04480502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20269645|NCT04480502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269646|NCT04480502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20269647|NCT04480502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269648|NCT04459611|Paclitaxel|paclitaxel|mesh-list
20269649|NCT04459611|Carboplatin|carboplatin|mesh-list
20269650|NCT04459611|Pemetrexed|pemetrexed|mesh-list
20269651|NCT04459611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20269652|NCT04459611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20269653|NCT04459611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269654|NCT04459611|Tubulin Modulators|tubulin modulators|mesh-ancestor
19952610|NCT01597973|Meropenem|meropenem|mesh-list
20269655|NCT04459611|Antimitotic Agents|antimitotic agents|mesh-ancestor
19952611|NCT01597973|Colistin|colistin|mesh-list
19952612|NCT01597973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19952613|NCT01597973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19952614|NCT01598090|Ribavirin|ribavirin|mesh-list
19952615|NCT01598090|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19952616|NCT01598090|Antimetabolites|antimetabolites|mesh-ancestor
19952617|NCT01598090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952618|NCT01598090|Antiviral Agents|antiviral agents|mesh-ancestor
19952619|NCT01598090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19952620|NCT01598207|Dronabinol|dronabinol|mesh-list
19952621|NCT01598207|Hallucinogens|hallucinogens|mesh-ancestor
19952622|NCT01598207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269656|NCT04459611|Mitosis Modulators|mitosis modulators|mesh-ancestor
20269657|NCT04459611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269658|NCT04459611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20269659|NCT04459611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20269660|NCT04459611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20269661|NCT04447716|Rituximab|rituximab|mesh-list
20269662|NCT04447716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20269663|NCT04447716|Lenalidomide|lenalidomide|mesh-list
20269664|NCT04447716|Venetoclax|venetoclax|mesh-list
20269665|NCT04447716|Piperidine|piperidine|mesh-list
20543619|NCT01870674|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20543620|NCT01870674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20543621|NCT01870674|Serotonin Agents|serotonin agents|mesh-ancestor
20543622|NCT01870674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20543623|NCT01870674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543624|NCT01870674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554147|NCT01933568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554148|NCT01933698|Amoxicillin|amoxicillin|mesh-list
20554149|NCT01933698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20554150|NCT01933698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20554151|NCT01933711|Rituximab|rituximab|mesh-list
20554152|NCT01933711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20554153|NCT01933711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554154|NCT01933711|Immunologic Factors|immunologic factors|mesh-ancestor
20554155|NCT01933711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554156|NCT01933711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20554157|NCT01933815|Bevacizumab|bevacizumab|mesh-list
20554158|NCT01933815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20554159|NCT01933815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554160|NCT01933815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20554161|NCT01933815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20554162|NCT01933815|Growth Substances|growth substances|mesh-ancestor
20554163|NCT01933815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554164|NCT01933815|Growth Inhibitors|growth inhibitors|mesh-ancestor
20554165|NCT01933906|Interferons|interferons|mesh-list
20554166|NCT01933906|Interferon-alpha|interferon-alpha|mesh-list
20554167|NCT01933906|Interferon alpha-2|interferon alpha-2|mesh-list
20554168|NCT01933906|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20554169|NCT01933906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554170|NCT01933906|Antiviral Agents|antiviral agents|mesh-ancestor
20554171|NCT01933906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20554172|NCT01933906|Immunologic Factors|immunologic factors|mesh-ancestor
20554173|NCT01933906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554174|NCT01933945|Sorafenib|sorafenib|mesh-list
20554175|NCT01933945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952623|NCT01598207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19952624|NCT01598207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19952625|NCT01598207|Analgesics|analgesics|mesh-ancestor
19952626|NCT01598207|Sensory System Agents|sensory system agents|mesh-ancestor
19952627|NCT01598207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19952628|NCT01598207|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19952629|NCT01598207|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19952630|NCT01598207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19952631|NCT01598207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952632|NCT01598207|Hormones|hormones|mesh-ancestor
20554176|NCT01933945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20554177|NCT01933945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554178|NCT01933945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554179|NCT01933971|Lenograstim|lenograstim|mesh-list
20554180|NCT01933971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20554181|NCT01933971|Immunologic Factors|immunologic factors|mesh-ancestor
20554182|NCT01933971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554183|NCT01933997|Pyridoxine|pyridoxine|mesh-list
19975472|NCT01849419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20269666|NCT04447716|Antibodies|antibodies|mesh-list
20554184|NCT01933997|Metadoxine|metadoxine|mesh-list
19952633|NCT01598207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19952634|NCT01598298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19952635|NCT01598298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19952636|NCT01598298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19952637|NCT01598298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19952638|NCT01598298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952639|NCT01598298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19952640|NCT01598298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952641|NCT01598298|Analgesics|analgesics|mesh-ancestor
19952642|NCT01598298|Sensory System Agents|sensory system agents|mesh-ancestor
19952643|NCT01598298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19952644|NCT01598298|Antidepressive Agents|antidepressive agents|mesh-ancestor
19952645|NCT01598298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19952646|NCT01598298|Dopamine Agents|dopamine agents|mesh-ancestor
19952647|NCT01598311|Vancomycin|vancomycin|mesh-list
19952648|NCT01598311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19952649|NCT01598311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19952650|NCT01598506|Hydromorphone|hydromorphone|mesh-list
19952651|NCT01598506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19952652|NCT01598506|Narcotics|narcotics|mesh-ancestor
19952653|NCT01598506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19952654|NCT01598506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952655|NCT01598506|Analgesics|analgesics|mesh-ancestor
19952656|NCT01598506|Sensory System Agents|sensory system agents|mesh-ancestor
19952657|NCT01598506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19952658|NCT01598545|Hydromorphone|hydromorphone|mesh-list
19952659|NCT01598545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19952660|NCT01598545|Narcotics|narcotics|mesh-ancestor
19952661|NCT01598545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19952662|NCT01598545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952663|NCT01598545|Analgesics|analgesics|mesh-ancestor
19952664|NCT01598545|Sensory System Agents|sensory system agents|mesh-ancestor
19952665|NCT01598545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19952666|NCT01598662|Levonorgestrel|levonorgestrel|mesh-list
19952667|NCT01598662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19952668|NCT01598662|Contraceptive Agents|contraceptive agents|mesh-ancestor
19952669|NCT01598662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19952670|NCT01598662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952671|NCT01598662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19952672|NCT01598662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19952673|NCT01598662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19952674|NCT01598701|Acetaminophen|acetaminophen|mesh-list
19952675|NCT01598701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19952676|NCT01598701|Analgesics|analgesics|mesh-ancestor
19952677|NCT01598701|Sensory System Agents|sensory system agents|mesh-ancestor
19952678|NCT01598701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19952679|NCT01598701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952680|NCT01598701|Antipyretics|antipyretics|mesh-ancestor
19952681|NCT01598740|Spironolactone|spironolactone|mesh-list
19952682|NCT01598740|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19952683|NCT01598740|Hormone Antagonists|hormone antagonists|mesh-ancestor
19952684|NCT01598740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19952685|NCT01598740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952686|NCT01598740|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19952687|NCT01598740|Diuretics|diuretics|mesh-ancestor
19952688|NCT01598740|Natriuretic Agents|natriuretic agents|mesh-ancestor
19952689|NCT01598753|Tramadol|tramadol|mesh-list
19952690|NCT01598753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19952691|NCT01598753|Narcotics|narcotics|mesh-ancestor
19952692|NCT01598753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19952693|NCT01598753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952694|NCT01598753|Analgesics|analgesics|mesh-ancestor
19952695|NCT01598753|Sensory System Agents|sensory system agents|mesh-ancestor
19952696|NCT01598753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19952697|NCT01598896|Clonidine|clonidine|mesh-list
19952698|NCT01598896|Dronabinol|dronabinol|mesh-list
19952699|NCT01598896|Analgesics|analgesics|mesh-ancestor
19952700|NCT01598896|Sensory System Agents|sensory system agents|mesh-ancestor
19952701|NCT01598896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19952702|NCT01598896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952703|NCT01598896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19952704|NCT01598896|Sympatholytics|sympatholytics|mesh-ancestor
19952705|NCT01598896|Autonomic Agents|autonomic agents|mesh-ancestor
20269667|NCT04447716|Immunoglobulins|immunoglobulins|mesh-list
19952706|NCT01598896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19952707|NCT01598896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19952708|NCT01598896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19952709|NCT01598896|Adrenergic Agents|adrenergic agents|mesh-ancestor
19952710|NCT01598896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19952711|NCT01598896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952712|NCT01598896|Hallucinogens|hallucinogens|mesh-ancestor
19952713|NCT01598896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19952714|NCT01598896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19952715|NCT01598896|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19952716|NCT01598896|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19952717|NCT01598896|Hormones|hormones|mesh-ancestor
19952718|NCT01598896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19952719|NCT01598987|Cyclosporine|cyclosporine|mesh-list
19952720|NCT01598987|Everolimus|everolimus|mesh-list
19952721|NCT01598987|Tacrolimus|tacrolimus|mesh-list
19952722|NCT01598987|Cyclosporins|cyclosporins|mesh-list
19952723|NCT01598987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19952724|NCT01598987|Immunologic Factors|immunologic factors|mesh-ancestor
19952725|NCT01598987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952726|NCT01598987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19952727|NCT01598987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952728|NCT01598987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952729|NCT01598987|Antifungal Agents|antifungal agents|mesh-ancestor
19952730|NCT01598987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19952731|NCT01598987|Dermatologic Agents|dermatologic agents|mesh-ancestor
19952732|NCT01598987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19952733|NCT01598987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952734|NCT01599104|Olmesartan|olmesartan|mesh-list
19952735|NCT01599104|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19952736|NCT01599104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19952737|NCT01599104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19952738|NCT01599104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19952739|NCT01599104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269668|NCT04447716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20269669|NCT04447716|Immunologic Factors|immunologic factors|mesh-ancestor
20269670|NCT04447716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269671|NCT04447716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269672|NCT04447716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20269673|NCT04447716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20269674|NCT04447716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20269675|NCT04447716|Growth Substances|growth substances|mesh-ancestor
20269676|NCT04447716|Growth Inhibitors|growth inhibitors|mesh-ancestor
20269677|NCT04447716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269678|NCT04447716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20269679|NCT04447716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20269680|NCT04447716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20269681|NCT04447040|Acetaminophen|acetaminophen|mesh-list
19952740|NCT01599234|Nabiximols|nabiximols|mesh-list
19952741|NCT01599234|Analgesics|analgesics|mesh-ancestor
19952742|NCT01599234|Sensory System Agents|sensory system agents|mesh-ancestor
19952743|NCT01599234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19952744|NCT01599234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952745|NCT01599325|Azacitidine|azacitidine|mesh-list
20269682|NCT04447040|Naproxen|naproxen|mesh-list
20269683|NCT04447040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19450297|NCT03429738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952746|NCT01599325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19952747|NCT01599325|Antimetabolites|antimetabolites|mesh-ancestor
19952748|NCT01599325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952749|NCT01599325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952750|NCT01599325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952751|NCT01599650|Ranibizumab|ranibizumab|mesh-list
19952752|NCT01599650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19952753|NCT01599650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19952754|NCT01599650|Growth Substances|growth substances|mesh-ancestor
19952755|NCT01599650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952756|NCT01599650|Growth Inhibitors|growth inhibitors|mesh-ancestor
19952757|NCT01599650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952758|NCT01599754|Axitinib|axitinib|mesh-list
19952759|NCT01599754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952760|NCT01599754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19952761|NCT01599754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20269684|NCT04447040|Analgesics|analgesics|mesh-ancestor
20287386|NCT04892706|Analgesics|analgesics|mesh-ancestor
19952762|NCT01599754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952763|NCT01599806|Ciprofloxacin|ciprofloxacin|mesh-list
19952764|NCT01599806|Ceftazidime|ceftazidime|mesh-list
19952765|NCT01599806|Doripenem|doripenem|mesh-list
19952766|NCT01599806|Avibactam|avibactam|mesh-list
19952767|NCT01599806|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19952768|NCT01599806|Trimethoprim|trimethoprim|mesh-list
19952769|NCT01599806|Sulfamethoxazole|sulfamethoxazole|mesh-list
19952770|NCT01599806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19952771|NCT01599806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19952772|NCT01599806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19952773|NCT01599806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19952774|NCT01599806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952775|NCT01599806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952776|NCT01599806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952777|NCT01599806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19952778|NCT01599806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19952779|NCT01599806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19952780|NCT01599806|Renal Agents|renal agents|mesh-ancestor
19952781|NCT01599806|Antimalarials|antimalarials|mesh-ancestor
19952782|NCT01599806|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19952783|NCT01599806|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20269685|NCT04447040|Sensory System Agents|sensory system agents|mesh-ancestor
20269686|NCT04447040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269687|NCT04447040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269688|NCT04447040|Antipyretics|antipyretics|mesh-ancestor
20269689|NCT04447040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20269690|NCT04447040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20269691|NCT04447040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20269692|NCT04447040|Gout Suppressants|gout suppressants|mesh-ancestor
20269693|NCT04447040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20269694|NCT04447040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20269695|NCT04447040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269696|NCT04420598|Trastuzumab|trastuzumab|mesh-list
20269697|NCT04420598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20269698|NCT04420598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269699|NCT04416984|Cyclophosphamide|cyclophosphamide|mesh-list
20269700|NCT04416984|Fludarabine|fludarabine|mesh-list
20269701|NCT04416984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20269702|NCT04416984|Immunologic Factors|immunologic factors|mesh-ancestor
20269703|NCT04416984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269704|NCT04416984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20269705|NCT04416984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20269706|NCT04416984|Alkylating Agents|alkylating agents|mesh-ancestor
20269707|NCT04416984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269708|NCT04416984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269709|NCT04416984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20287387|NCT04892706|Sensory System Agents|sensory system agents|mesh-ancestor
20287388|NCT04892706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287389|NCT04892706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287390|NCT04892706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20287391|NCT04892706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20287392|NCT04892706|Dermatologic Agents|dermatologic agents|mesh-ancestor
20287393|NCT04816643|Vaccines|vaccines|mesh-list
20287394|NCT04816643|Immunologic Factors|immunologic factors|mesh-ancestor
20287395|NCT04816643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287396|NCT04740008|Nicotine|nicotine|mesh-list
20287397|NCT04740008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20287398|NCT04740008|Autonomic Agents|autonomic agents|mesh-ancestor
20287399|NCT04740008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287400|NCT04740008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952784|NCT01599806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19952785|NCT01599806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19952786|NCT01599806|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19952787|NCT01599806|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19952788|NCT01600053|Lenalidomide|lenalidomide|mesh-list
19952789|NCT01600053|Immunologic Factors|immunologic factors|mesh-ancestor
19952790|NCT01600053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952791|NCT01600053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19952792|NCT01600053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19952793|NCT01600053|Growth Substances|growth substances|mesh-ancestor
19952794|NCT01600053|Growth Inhibitors|growth inhibitors|mesh-ancestor
19952795|NCT01600053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952796|NCT01600170|Atorvastatin|atorvastatin|mesh-list
19952797|NCT01600170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19952798|NCT01600170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19952799|NCT01600170|Antimetabolites|antimetabolites|mesh-ancestor
19952800|NCT01600170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952801|NCT01600170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19952802|NCT01600170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19952803|NCT01600170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952804|NCT01600287|Propofol|propofol|mesh-list
19952805|NCT01600287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19952806|NCT01600287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19952807|NCT01600287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952808|NCT01600287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19952809|NCT01600287|Anesthetics, General|anesthetics, general|mesh-ancestor
19952810|NCT01600287|Anesthetics|anesthetics|mesh-ancestor
19952811|NCT01600703|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19952812|NCT01600703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19952813|NCT01600703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952814|NCT01600703|Incretins|incretins|mesh-ancestor
19952815|NCT01600703|Hormones|hormones|mesh-ancestor
19952816|NCT01600703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19952817|NCT01600703|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19952818|NCT01600703|Protease Inhibitors|protease inhibitors|mesh-ancestor
19952819|NCT01600703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952820|NCT01600703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952821|NCT01600716|Botulinum Toxins|botulinum toxins|mesh-list
19952822|NCT01600716|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19952823|NCT01600716|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19952824|NCT01600716|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19952825|NCT01600716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19952826|NCT01600716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952827|NCT01600716|Cholinergic Agents|cholinergic agents|mesh-ancestor
19952828|NCT01600716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19952829|NCT01600716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952830|NCT01600716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19952831|NCT01600716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19974482|NCT01837823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974483|NCT01837823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19974484|NCT01837823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19974485|NCT01837823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974486|NCT01838044|Celecoxib|celecoxib|mesh-list
19974487|NCT01838044|Pregabalin|pregabalin|mesh-list
19974488|NCT01838044|Analgesics|analgesics|mesh-ancestor
19974489|NCT01838044|Sensory System Agents|sensory system agents|mesh-ancestor
19974490|NCT01838044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19974491|NCT01838044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974492|NCT01838044|Anticonvulsants|anticonvulsants|mesh-ancestor
19974493|NCT01838044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19974494|NCT01838044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19974495|NCT01838044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974496|NCT01838044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19974497|NCT01838044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19974498|NCT01838044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19974499|NCT01838044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19974500|NCT01838044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19974501|NCT01838044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19974502|NCT01838044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19974503|NCT01838044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19974504|NCT01838044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19974505|NCT01838044|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19974506|NCT01838044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19974507|NCT01838044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974508|NCT01838200|Isoniazid|isoniazid|mesh-list
19974509|NCT01838200|Ipilimumab|ipilimumab|mesh-list
19974510|NCT01838200|BCG Vaccine|bcg vaccine|mesh-list
19974511|NCT01838200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19974512|NCT01838200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974513|NCT01838200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19974514|NCT01838200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974515|NCT01838200|Antitubercular Agents|antitubercular agents|mesh-ancestor
19974516|NCT01838200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20269710|NCT04380740|Abatacept|abatacept|mesh-list
20269711|NCT04380740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19952832|NCT01600885|Guanfacine|guanfacine|mesh-list
19952833|NCT01600885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19952834|NCT01600885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19952835|NCT01600885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19952836|NCT01600885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19952837|NCT01600885|Adrenergic Agents|adrenergic agents|mesh-ancestor
19952838|NCT01600885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19952839|NCT01600885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952840|NCT01600885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952841|NCT01600950|Insulin Glargine|insulin glargine|mesh-list
19952842|NCT01600950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19952843|NCT01600950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952844|NCT01601132|Colchicine|colchicine|mesh-list
19952845|NCT01601132|Theophylline|theophylline|mesh-list
19952846|NCT01601132|Gout Suppressants|gout suppressants|mesh-ancestor
19952847|NCT01601132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19952848|NCT01601132|Tubulin Modulators|tubulin modulators|mesh-ancestor
19952849|NCT01601132|Antimitotic Agents|antimitotic agents|mesh-ancestor
19952850|NCT01601132|Mitosis Modulators|mitosis modulators|mesh-ancestor
19952851|NCT01601132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952852|NCT01601132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952853|NCT01601132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19952854|NCT01601132|Autonomic Agents|autonomic agents|mesh-ancestor
19952855|NCT01601132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19952856|NCT01601132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952857|NCT01601132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19952858|NCT01601132|Respiratory System Agents|respiratory system agents|mesh-ancestor
19952859|NCT01601132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19952860|NCT01601132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952861|NCT01601132|Vasodilator Agents|vasodilator agents|mesh-ancestor
19952862|NCT01601132|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19952863|NCT01601132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19952864|NCT01601132|Purinergic Agents|purinergic agents|mesh-ancestor
19952865|NCT01601132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19952866|NCT01601236|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19952867|NCT01601236|Hormones|hormones|mesh-ancestor
19952868|NCT01601236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19952869|NCT01601236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952870|NCT01601470|Sildenafil Citrate|sildenafil citrate|mesh-list
19952871|NCT01601470|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19952872|NCT01601470|Vasodilator Agents|vasodilator agents|mesh-ancestor
19952873|NCT01601470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19952874|NCT01601470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19952875|NCT01601470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952876|NCT01601470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952877|NCT01601470|Urological Agents|urological agents|mesh-ancestor
19952878|NCT01601470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19952879|NCT01601535|Irinotecan|irinotecan|mesh-list
19952880|NCT01601535|Temozolomide|temozolomide|mesh-list
19952881|NCT01601535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19952882|NCT01601535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19952883|NCT01601535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19952884|NCT01601535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952885|NCT01601535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952886|NCT01601535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19952887|NCT01601535|Alkylating Agents|alkylating agents|mesh-ancestor
19952888|NCT01601626|Pyridoxine|pyridoxine|mesh-list
19952889|NCT01601626|Vitamin B 6|vitamin b 6|mesh-list
19952890|NCT01601626|Ritonavir|ritonavir|mesh-list
19952891|NCT01601626|Lopinavir|lopinavir|mesh-list
19952892|NCT01601626|Raltegravir Potassium|raltegravir potassium|mesh-list
19952893|NCT01601626|Rifampin|rifampin|mesh-list
19952894|NCT01601626|Isoniazid|isoniazid|mesh-list
19952895|NCT01601626|Pyrazinamide|pyrazinamide|mesh-list
19952896|NCT01601626|Ethambutol|ethambutol|mesh-list
19952897|NCT01601626|Rifabutin|rifabutin|mesh-list
19952898|NCT01601626|Vitamins|vitamins|mesh-ancestor
19952899|NCT01601626|Micronutrients|micronutrients|mesh-ancestor
19952900|NCT01601626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952901|NCT01601626|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19952902|NCT01601626|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19952903|NCT01601626|Protease Inhibitors|protease inhibitors|mesh-ancestor
19952904|NCT01601626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287401|NCT04740008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19952905|NCT01601626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952906|NCT01601626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19952907|NCT01601626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19952908|NCT01601626|Antiviral Agents|antiviral agents|mesh-ancestor
19952909|NCT01601626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19952910|NCT01601626|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19952911|NCT01601626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19952912|NCT01601626|Vitamin B Complex|vitamin b complex|mesh-ancestor
19952913|NCT01601626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19952914|NCT01601626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19952915|NCT01601626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19952916|NCT01601626|Antitubercular Agents|antitubercular agents|mesh-ancestor
19952917|NCT01601626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19952918|NCT01601626|Leprostatic Agents|leprostatic agents|mesh-ancestor
19952919|NCT01601626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19952920|NCT01601626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19952921|NCT01601626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19952922|NCT01601626|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19952923|NCT01601626|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19952924|NCT01601626|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19952925|NCT01601626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19952926|NCT01601626|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19952927|NCT01601626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19952928|NCT01601626|Antimetabolites|antimetabolites|mesh-ancestor
19952929|NCT01601626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19952930|NCT01601704|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
19952931|NCT01601704|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19952932|NCT01601821|Sirolimus|sirolimus|mesh-list
19952933|NCT01601821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19952934|NCT01601821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19952935|NCT01601821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19952936|NCT01601821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952937|NCT01601821|Antifungal Agents|antifungal agents|mesh-ancestor
19952938|NCT01601821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19952939|NCT01601821|Immunologic Factors|immunologic factors|mesh-ancestor
19952940|NCT01601821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952941|NCT01601847|Vitamin D|vitamin d|mesh-list
19952942|NCT01601847|Cholecalciferol|cholecalciferol|mesh-list
19952943|NCT01601847|Vitamins|vitamins|mesh-ancestor
19952944|NCT01601847|Micronutrients|micronutrients|mesh-ancestor
19952945|NCT01601847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952946|NCT01601847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19952947|NCT01601847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19952948|NCT01601873|Heparin|heparin|mesh-list
19952949|NCT01601873|Anticoagulants|anticoagulants|mesh-ancestor
19952950|NCT01601873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19952951|NCT01601873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19952952|NCT01601873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952953|NCT01602068|Dexamethasone|dexamethasone|mesh-list
19952954|NCT01602068|Citric Acid|citric acid|mesh-list
19952955|NCT01602068|Sodium Citrate|sodium citrate|mesh-list
19952956|NCT01602068|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19952957|NCT01602068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19952958|NCT01602068|Antiemetics|antiemetics|mesh-ancestor
19952959|NCT01602068|Autonomic Agents|autonomic agents|mesh-ancestor
19952960|NCT01602068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19952961|NCT01602068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952962|NCT01602068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19952963|NCT01602068|Glucocorticoids|glucocorticoids|mesh-ancestor
19952964|NCT01602068|Hormones|hormones|mesh-ancestor
19952965|NCT01602068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19952966|NCT01602068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19952967|NCT01602068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952968|NCT01602068|Anticoagulants|anticoagulants|mesh-ancestor
19952969|NCT01602068|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19952970|NCT01602068|Chelating Agents|chelating agents|mesh-ancestor
19952971|NCT01602068|Sequestering Agents|sequestering agents|mesh-ancestor
19952972|NCT01602068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952973|NCT01602224|Dexamethasone|dexamethasone|mesh-list
19952974|NCT01602224|Bortezomib|bortezomib|mesh-list
19952975|NCT01602224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19952976|NCT01602224|Antiemetics|antiemetics|mesh-ancestor
19952977|NCT01602224|Autonomic Agents|autonomic agents|mesh-ancestor
19952978|NCT01602224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19952979|NCT01602224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952980|NCT01602224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19952981|NCT01602224|Glucocorticoids|glucocorticoids|mesh-ancestor
19952982|NCT01602224|Hormones|hormones|mesh-ancestor
19952983|NCT01602224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19952984|NCT01602224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19952985|NCT01602224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952986|NCT01602315|Cetuximab|cetuximab|mesh-list
19952987|NCT01602315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19952988|NCT01602315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19952989|NCT01602510|Lamotrigine|lamotrigine|mesh-list
19952990|NCT01602510|Anticonvulsants|anticonvulsants|mesh-ancestor
19952991|NCT01602510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19952992|NCT01602510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19952993|NCT01602510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19952994|NCT01602510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19952995|NCT01602510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19952996|NCT01602510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19952997|NCT01602510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19952998|NCT01602510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19952999|NCT01602510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19953000|NCT01602510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19953001|NCT01602562|Valacyclovir|valacyclovir|mesh-list
19953002|NCT01602562|Antiviral Agents|antiviral agents|mesh-ancestor
19953003|NCT01602562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19953004|NCT01602679|Progesterone|progesterone|mesh-list
19953005|NCT01602679|Progestins|progestins|mesh-ancestor
19953006|NCT01602679|Hormones|hormones|mesh-ancestor
19953007|NCT01602679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19953008|NCT01602679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953009|NCT01602692|Lidocaine|lidocaine|mesh-list
19953010|NCT01602692|Epinephrine|epinephrine|mesh-list
19953011|NCT01602692|Racepinephrine|racepinephrine|mesh-list
19953012|NCT01602692|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19953013|NCT01602692|Epinephryl borate|epinephryl borate|mesh-list
19953014|NCT01602692|Anesthetics, Local|anesthetics, local|mesh-ancestor
19953015|NCT01602692|Anesthetics|anesthetics|mesh-ancestor
19953016|NCT01602692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19953017|NCT01602692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953018|NCT01602692|Sensory System Agents|sensory system agents|mesh-ancestor
19953019|NCT01602692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953020|NCT01602692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19953021|NCT01602692|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19953022|NCT01602692|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19953023|NCT01602692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19953024|NCT01602692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953025|NCT01602692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19953026|NCT01602692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19953027|NCT01602692|Adrenergic Agents|adrenergic agents|mesh-ancestor
19953028|NCT01602692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953029|NCT01602692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19953030|NCT01602692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19953031|NCT01602692|Autonomic Agents|autonomic agents|mesh-ancestor
19953032|NCT01602692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19953033|NCT01602692|Respiratory System Agents|respiratory system agents|mesh-ancestor
19953034|NCT01602692|Mydriatics|mydriatics|mesh-ancestor
19953035|NCT01602692|Sympathomimetics|sympathomimetics|mesh-ancestor
19953036|NCT01602692|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19953037|NCT01603082|Clopidogrel|clopidogrel|mesh-list
19953038|NCT01603082|Ticagrelor|ticagrelor|mesh-list
19953039|NCT01603082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19953040|NCT01603082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19953041|NCT01603082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19953042|NCT01603082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19953043|NCT01603082|Purinergic Agents|purinergic agents|mesh-ancestor
19953044|NCT01603082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953045|NCT01603082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953046|NCT01603082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953047|NCT01603277|Antibodies|antibodies|mesh-list
19953048|NCT01603277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19953049|NCT01603277|Immunologic Factors|immunologic factors|mesh-ancestor
19953050|NCT01603277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953051|NCT01603420|Ascorbic Acid|ascorbic acid|mesh-list
19953052|NCT01603420|Docetaxel|docetaxel|mesh-list
19953053|NCT01603420|Methyltestosterone|methyltestosterone|mesh-list
19953054|NCT01603420|Hormones|hormones|mesh-list
19953055|NCT01603420|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19953056|NCT01603420|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19953057|NCT01603420|Androgens|androgens|mesh-list
19953058|NCT01603420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953059|NCT01603420|Tubulin Modulators|tubulin modulators|mesh-ancestor
19953060|NCT01603420|Antimitotic Agents|antimitotic agents|mesh-ancestor
19953061|NCT01603420|Mitosis Modulators|mitosis modulators|mesh-ancestor
19953062|NCT01603420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953063|NCT01603420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19953064|NCT01603420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953065|NCT01603420|Antioxidants|antioxidants|mesh-ancestor
19953066|NCT01603420|Protective Agents|protective agents|mesh-ancestor
19953067|NCT01603420|Vitamins|vitamins|mesh-ancestor
19953068|NCT01603420|Micronutrients|micronutrients|mesh-ancestor
19953069|NCT01603420|Estrogens|estrogens|mesh-ancestor
19953070|NCT01603420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19953071|NCT01603420|Anabolic Agents|anabolic agents|mesh-ancestor
19953072|NCT01603459|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19953073|NCT01603459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19953074|NCT01603459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953075|NCT01603459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953076|NCT01603459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19953077|NCT01603459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19953078|NCT01603459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953079|NCT01603459|Cholinergic Agents|cholinergic agents|mesh-ancestor
19953080|NCT01603459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953081|NCT01603602|Botulinum Toxins|botulinum toxins|mesh-list
19953082|NCT01603602|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19953083|NCT01603602|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19953084|NCT01603602|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19953085|NCT01603602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19953086|NCT01603602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953087|NCT01603602|Cholinergic Agents|cholinergic agents|mesh-ancestor
19953088|NCT01603602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20269712|NCT04380740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269713|NCT04380740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269714|NCT04380740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20269715|NCT04380740|Immunologic Factors|immunologic factors|mesh-ancestor
20269716|NCT04380740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269717|NCT04380740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20269718|NCT04338061|Teriflunomide|teriflunomide|mesh-list
20269719|NCT04338061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19953089|NCT01603602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953090|NCT01603602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19953091|NCT01603602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269720|NCT04338061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20269721|NCT04338061|Analgesics|analgesics|mesh-ancestor
20269722|NCT04338061|Sensory System Agents|sensory system agents|mesh-ancestor
20269723|NCT04338061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269724|NCT04338061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269725|NCT04338061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20269726|NCT04338061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20269727|NCT04338061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20269728|NCT04338061|Immunologic Factors|immunologic factors|mesh-ancestor
20269729|NCT04325685|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
20269730|NCT04325685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20269731|NCT04288323|Diethylenetriamine|diethylenetriamine|mesh-list
20269732|NCT04288323|Edetic Acid|edetic acid|mesh-list
20269733|NCT04288323|Pentetic Acid|pentetic acid|mesh-list
20269734|NCT04288323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20269735|NCT04288323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269736|NCT04288323|Antidotes|antidotes|mesh-ancestor
20269737|NCT04288323|Protective Agents|protective agents|mesh-ancestor
20269738|NCT04288323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543625|NCT01870804|Atorvastatin|atorvastatin|mesh-list
19953092|NCT01603615|Botulinum Toxins|botulinum toxins|mesh-list
19953093|NCT01603615|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19953094|NCT01603615|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19953095|NCT01603615|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19953096|NCT01603615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19953097|NCT01603615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953098|NCT01603615|Cholinergic Agents|cholinergic agents|mesh-ancestor
20269739|NCT04288323|Chelating Agents|chelating agents|mesh-ancestor
19953099|NCT01603615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953100|NCT01603615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953101|NCT01603615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19953102|NCT01603615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953103|NCT01603628|Botulinum Toxins|botulinum toxins|mesh-list
19953104|NCT01603628|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19953105|NCT01603628|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19953106|NCT01603628|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19953107|NCT01603628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19953108|NCT01603628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953109|NCT01603628|Cholinergic Agents|cholinergic agents|mesh-ancestor
19953110|NCT01603628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953111|NCT01603628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269740|NCT04288323|Sequestering Agents|sequestering agents|mesh-ancestor
20269741|NCT04288323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20269742|NCT04288323|Anticoagulants|anticoagulants|mesh-ancestor
20269743|NCT04288323|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20269744|NCT04283578|Oxytocin|oxytocin|mesh-list
20269745|NCT04283578|Oxytocics|oxytocics|mesh-ancestor
20269746|NCT04283578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20269747|NCT04283578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269748|NCT04263038|Rivaroxaban|rivaroxaban|mesh-list
20269749|NCT04263038|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20269750|NCT04263038|Antithrombins|antithrombins|mesh-ancestor
20269751|NCT04263038|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20269752|NCT04263038|Protease Inhibitors|protease inhibitors|mesh-ancestor
20269753|NCT04263038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20269754|NCT04263038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269755|NCT04263038|Anticoagulants|anticoagulants|mesh-ancestor
20269756|NCT04259346|Ixekizumab|ixekizumab|mesh-list
20269757|NCT04259346|Dermatologic Agents|dermatologic agents|mesh-ancestor
20269758|NCT04249232|Abaloparatide|abaloparatide|mesh-list
20269759|NCT04249232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20269760|NCT04249232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269761|NCT04231968|Ziresovir|ziresovir|mesh-list
20543626|NCT01870804|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20543627|NCT01870804|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20543628|NCT01870804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20543629|NCT01870804|Antimetabolites|antimetabolites|mesh-ancestor
20543630|NCT01870804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543631|NCT01870804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20543632|NCT01870804|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20543633|NCT01870804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543634|NCT01870895|Ramosetron|ramosetron|mesh-list
20543635|NCT01870895|Antiemetics|antiemetics|mesh-ancestor
20543636|NCT01870895|Autonomic Agents|autonomic agents|mesh-ancestor
20543637|NCT01870895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543638|NCT01870895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543639|NCT01870895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20543640|NCT01870895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20543641|NCT01870895|Serotonin Agents|serotonin agents|mesh-ancestor
20543642|NCT01870895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20543643|NCT01870895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543644|NCT01870908|Tacrolimus|tacrolimus|mesh-list
20543645|NCT01870908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20543646|NCT01870908|Immunologic Factors|immunologic factors|mesh-ancestor
20543647|NCT01870908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543648|NCT01870908|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20543649|NCT01870908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543650|NCT01870908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543651|NCT01870986|Adalimumab|adalimumab|mesh-list
20543652|NCT01870986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20543653|NCT01870986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20543654|NCT01871129|Dexmedetomidine|dexmedetomidine|mesh-list
20543655|NCT01871129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20543656|NCT01871129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20543657|NCT01871129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543658|NCT01871129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20543659|NCT01871129|Analgesics|analgesics|mesh-ancestor
20543660|NCT01871129|Sensory System Agents|sensory system agents|mesh-ancestor
20554185|NCT01933997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19953112|NCT01603628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19953113|NCT01603628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953114|NCT01603641|Botulinum Toxins|botulinum toxins|mesh-list
20269762|NCT04231968|Antiviral Agents|antiviral agents|mesh-ancestor
20269763|NCT04231968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19953115|NCT01603641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19953116|NCT01603641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19953117|NCT01603641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19953118|NCT01603641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19953119|NCT01603641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953120|NCT01603641|Cholinergic Agents|cholinergic agents|mesh-ancestor
19953121|NCT01603641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953122|NCT01603641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953123|NCT01603641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19953124|NCT01603641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953125|NCT01603940|Losartan|losartan|mesh-list
19953126|NCT01603940|Benazepril|benazepril|mesh-list
19953127|NCT01603940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19953128|NCT01603940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19953129|NCT01603940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19953130|NCT01603940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19953131|NCT01603940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953132|NCT01603940|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19953133|NCT01603940|Protease Inhibitors|protease inhibitors|mesh-ancestor
19953134|NCT01603940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19953135|NCT01604109|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
19953136|NCT01604109|Caseins|caseins|mesh-list
19953137|NCT01604109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19953138|NCT01604109|Serotonin Agents|serotonin agents|mesh-ancestor
19953139|NCT01604109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953140|NCT01604109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953141|NCT01604109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953142|NCT01604109|Chelating Agents|chelating agents|mesh-ancestor
19953143|NCT01604109|Sequestering Agents|sequestering agents|mesh-ancestor
19953144|NCT01604265|Nabiximols|nabiximols|mesh-list
19953145|NCT01604265|Analgesics|analgesics|mesh-ancestor
19953146|NCT01604265|Sensory System Agents|sensory system agents|mesh-ancestor
19953147|NCT01604265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953148|NCT01604265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953149|NCT01604278|Glycopyrrolate|glycopyrrolate|mesh-list
19953150|NCT01604278|Bromides|bromides|mesh-list
19953151|NCT01604278|Anticonvulsants|anticonvulsants|mesh-ancestor
19953152|NCT01604278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19953153|NCT01604278|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19953154|NCT01604278|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19953155|NCT01604278|Cholinergic Agents|cholinergic agents|mesh-ancestor
19953156|NCT01604278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953157|NCT01604278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953158|NCT01604278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953159|NCT01604343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19953160|NCT01604343|Immunologic Factors|immunologic factors|mesh-ancestor
19953161|NCT01604343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953162|NCT01604785|Dopamine|dopamine|mesh-list
19953163|NCT01604785|Propofol|propofol|mesh-list
19953164|NCT01604785|Dopamine Antagonists|dopamine antagonists|mesh-list
19953165|NCT01604785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19953166|NCT01604785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19953167|NCT01604785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953168|NCT01604785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19953169|NCT01604785|Anesthetics, General|anesthetics, general|mesh-ancestor
19953170|NCT01604785|Anesthetics|anesthetics|mesh-ancestor
19953171|NCT01604785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19953172|NCT01604785|Sympathomimetics|sympathomimetics|mesh-ancestor
19953173|NCT01604785|Autonomic Agents|autonomic agents|mesh-ancestor
19953174|NCT01604785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953175|NCT01604785|Dopamine Agents|dopamine agents|mesh-ancestor
19953176|NCT01604785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953177|NCT01604785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953178|NCT01604785|Protective Agents|protective agents|mesh-ancestor
19953179|NCT01604850|Sofosbuvir|sofosbuvir|mesh-list
19953180|NCT01604850|Antiviral Agents|antiviral agents|mesh-ancestor
19953181|NCT01604850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19953182|NCT01605032|Bortezomib|bortezomib|mesh-list
19953183|NCT01605032|Melphalan|melphalan|mesh-list
19953184|NCT01605032|Busulfan|busulfan|mesh-list
19953185|NCT01605032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953186|NCT01605032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19953187|NCT01605032|Alkylating Agents|alkylating agents|mesh-ancestor
19953188|NCT01605032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953189|NCT01605032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19953190|NCT01605032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19953191|NCT01605032|Immunologic Factors|immunologic factors|mesh-ancestor
19953192|NCT01605032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953193|NCT01605071|Estradiol|estradiol|mesh-list
19953194|NCT01605071|Estrogens|estrogens|mesh-ancestor
19953195|NCT01605071|Hormones|hormones|mesh-ancestor
19953196|NCT01605071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19953197|NCT01605071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953198|NCT01605136|Afamelanotide|afamelanotide|mesh-list
19953199|NCT01605136|Dermatologic Agents|dermatologic agents|mesh-ancestor
19953200|NCT01605227|Prednisone|prednisone|mesh-list
19953201|NCT01605227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19953202|NCT01605227|Glucocorticoids|glucocorticoids|mesh-ancestor
19953203|NCT01605227|Hormones|hormones|mesh-ancestor
19953204|NCT01605227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19953205|NCT01605227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953206|NCT01605227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19953207|NCT01605227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953208|NCT01605396|Exemestane|exemestane|mesh-list
19953209|NCT01605396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953210|NCT01605396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19953211|NCT01605396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19953212|NCT01605396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19953213|NCT01605396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953214|NCT01605396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19953215|NCT01605396|Hormone Antagonists|hormone antagonists|mesh-ancestor
19953216|NCT01605396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19953217|NCT01605396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953218|NCT01605539|Cannabidiol|cannabidiol|mesh-list
19953219|NCT01605539|Anticonvulsants|anticonvulsants|mesh-ancestor
19953220|NCT01605825|4-Aminopyridine|4-aminopyridine|mesh-list
19953221|NCT01605825|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19953222|NCT01605825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19953223|NCT01605825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953224|NCT01605890|Tenofovir|tenofovir|mesh-list
19953225|NCT01605890|Emtricitabine|emtricitabine|mesh-list
19953226|NCT01605890|Raltegravir Potassium|raltegravir potassium|mesh-list
19953227|NCT01605890|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19953228|NCT01605890|Antiviral Agents|antiviral agents|mesh-ancestor
19953229|NCT01605890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19953230|NCT01605890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19953231|NCT01605890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19953232|NCT01605890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19953233|NCT01605890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953234|NCT01605890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19953235|NCT01605890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19953236|NCT01605890|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19953237|NCT01605890|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19953238|NCT01605903|Acetaminophen|acetaminophen|mesh-list
19953239|NCT01605903|Ibuprofen|ibuprofen|mesh-list
19953240|NCT01605903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19953241|NCT01605903|Analgesics|analgesics|mesh-ancestor
19953242|NCT01605903|Sensory System Agents|sensory system agents|mesh-ancestor
19953243|NCT01605903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953244|NCT01605903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953245|NCT01605903|Antipyretics|antipyretics|mesh-ancestor
19953246|NCT01605903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19953247|NCT01605903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19953248|NCT01605903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19953249|NCT01605903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19953250|NCT01605903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19953251|NCT01605903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953252|NCT01605942|Dexamethasone|dexamethasone|mesh-list
19953253|NCT01605942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19953254|NCT01605942|Antiemetics|antiemetics|mesh-ancestor
19953255|NCT01605942|Autonomic Agents|autonomic agents|mesh-ancestor
19953256|NCT01605942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953257|NCT01605942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953258|NCT01605942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19953259|NCT01605942|Glucocorticoids|glucocorticoids|mesh-ancestor
20269764|NCT04167163|Abaloparatide|abaloparatide|mesh-list
20269765|NCT04167163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20269766|NCT04167163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953260|NCT01605942|Hormones|hormones|mesh-ancestor
19953261|NCT01605942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19953262|NCT01605942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19953263|NCT01605942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953264|NCT01606007|Metformin|metformin|mesh-list
19953265|NCT01606007|Dapagliflozin|dapagliflozin|mesh-list
19953266|NCT01606007|Saxagliptin|saxagliptin|mesh-list
19953267|NCT01606007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19953268|NCT01606007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953269|NCT01606007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19953270|NCT01606007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953271|NCT01606007|Incretins|incretins|mesh-ancestor
19953272|NCT01606007|Hormones|hormones|mesh-ancestor
19953273|NCT01606007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19953274|NCT01606007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19953275|NCT01606007|Protease Inhibitors|protease inhibitors|mesh-ancestor
19953276|NCT01606007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19953277|NCT01606124|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
19953278|NCT01606124|Antioxidants|antioxidants|mesh-ancestor
19953279|NCT01606124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953280|NCT01606124|Protective Agents|protective agents|mesh-ancestor
19953281|NCT01606124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953282|NCT01606124|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19953283|NCT01606124|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19953284|NCT01606124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953285|NCT01606124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19953286|NCT01606137|Nabiximols|nabiximols|mesh-list
19953287|NCT01606137|Analgesics|analgesics|mesh-ancestor
19953288|NCT01606137|Sensory System Agents|sensory system agents|mesh-ancestor
19953289|NCT01606137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953290|NCT01606137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953291|NCT01606176|Nabiximols|nabiximols|mesh-list
19953292|NCT01606176|Analgesics|analgesics|mesh-ancestor
19953293|NCT01606176|Sensory System Agents|sensory system agents|mesh-ancestor
19953294|NCT01606176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953295|NCT01606176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953296|NCT01606189|Nabiximols|nabiximols|mesh-list
19953297|NCT01606189|Analgesics|analgesics|mesh-ancestor
19953298|NCT01606189|Sensory System Agents|sensory system agents|mesh-ancestor
19953299|NCT01606189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953300|NCT01606189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953301|NCT01606202|Nabiximols|nabiximols|mesh-list
19953302|NCT01606202|Analgesics|analgesics|mesh-ancestor
19953303|NCT01606202|Sensory System Agents|sensory system agents|mesh-ancestor
19953304|NCT01606202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953305|NCT01606202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953306|NCT01606228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19953307|NCT01606228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19953308|NCT01606228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19953309|NCT01606228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19953310|NCT01606228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953311|NCT01606228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19953312|NCT01606228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19953313|NCT01606228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20269767|NCT04152551|Risedronic Acid|risedronic acid|mesh-list
20269768|NCT04152551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20269769|NCT04152551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20269770|NCT04152551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269771|NCT04152551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20269772|NCT04152551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269773|NCT04152551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20269774|NCT04151667|Dexamethasone|dexamethasone|mesh-list
20269775|NCT04151667|Lenalidomide|lenalidomide|mesh-list
20269776|NCT04151667|Bortezomib|bortezomib|mesh-list
20269777|NCT04151667|Daratumumab|daratumumab|mesh-list
19953314|NCT01606228|Serotonin Agents|serotonin agents|mesh-ancestor
19953315|NCT01606228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953316|NCT01606228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953317|NCT01606228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19953318|NCT01606228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19953319|NCT01606228|Dopamine Agents|dopamine agents|mesh-ancestor
19953320|NCT01606254|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19953321|NCT01606254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20269778|NCT04151667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20269779|NCT04151667|Antiemetics|antiemetics|mesh-ancestor
19953322|NCT01606254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19953323|NCT01606254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20269780|NCT04151667|Autonomic Agents|autonomic agents|mesh-ancestor
20269781|NCT04151667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269782|NCT04151667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269783|NCT04151667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20269784|NCT04151667|Glucocorticoids|glucocorticoids|mesh-ancestor
20269785|NCT04151667|Hormones|hormones|mesh-ancestor
20269786|NCT04151667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20269787|NCT04151667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20269788|NCT04151667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269789|NCT04151667|Immunologic Factors|immunologic factors|mesh-ancestor
20269790|NCT04151667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20269791|NCT04151667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20269792|NCT04151667|Growth Substances|growth substances|mesh-ancestor
20269793|NCT04151667|Growth Inhibitors|growth inhibitors|mesh-ancestor
20269794|NCT04137770|Ketorolac|ketorolac|mesh-list
20269795|NCT04137770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20269796|NCT04137770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20269797|NCT04137770|Analgesics|analgesics|mesh-ancestor
20269798|NCT04137770|Sensory System Agents|sensory system agents|mesh-ancestor
20269799|NCT04137770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269800|NCT04137770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269801|NCT04137770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20269802|NCT04137770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20269803|NCT04137770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20269804|NCT04137770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20269805|NCT04137770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269806|NCT04107675|Cyclosporine|cyclosporine|mesh-list
20269807|NCT04107675|Cyclosporins|cyclosporins|mesh-list
20269808|NCT04107675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20269809|NCT04107675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269810|NCT04107675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20269811|NCT04107675|Immunologic Factors|immunologic factors|mesh-ancestor
20269812|NCT04107675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269813|NCT04107675|Antifungal Agents|antifungal agents|mesh-ancestor
20269814|NCT04107675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20269815|NCT04107675|Dermatologic Agents|dermatologic agents|mesh-ancestor
20543661|NCT01871129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543662|NCT01871129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20543663|NCT01871129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20543664|NCT01871129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20543665|NCT01871129|Adrenergic Agents|adrenergic agents|mesh-ancestor
20543666|NCT01871129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20543667|NCT01871129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543668|NCT01871311|Cetuximab|cetuximab|mesh-list
20543669|NCT01871311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20543670|NCT01871311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543671|NCT01871363|Capecitabine|capecitabine|mesh-list
20543672|NCT01871363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543673|NCT01871363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20543674|NCT01871363|Antimetabolites|antimetabolites|mesh-ancestor
20543675|NCT01871363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543676|NCT01871376|Aflibercept|aflibercept|mesh-list
20543677|NCT01871376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20543678|NCT01871376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20543679|NCT01871376|Growth Substances|growth substances|mesh-ancestor
20543680|NCT01871376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543681|NCT01871376|Growth Inhibitors|growth inhibitors|mesh-ancestor
20543682|NCT01871376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543683|NCT01871454|Pentoxifylline|pentoxifylline|mesh-list
20543684|NCT01871454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20543685|NCT01871454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543686|NCT01871454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543687|NCT01871454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20543688|NCT01871454|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20543689|NCT01871454|Protective Agents|protective agents|mesh-ancestor
20543690|NCT01871454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953324|NCT01606254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953325|NCT01606254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19953326|NCT01606254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19953327|NCT01606254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19953328|NCT01606254|Serotonin Agents|serotonin agents|mesh-ancestor
19953329|NCT01606254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953330|NCT01606254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953331|NCT01606254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19953332|NCT01606254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19953333|NCT01606254|Dopamine Agents|dopamine agents|mesh-ancestor
19953334|NCT01606306|Fluticasone|fluticasone|mesh-list
19953335|NCT01606306|Xhance|xhance|mesh-list
19953336|NCT01606306|Montelukast|montelukast|mesh-list
19953337|NCT01606306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19953338|NCT01606306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19953339|NCT01606306|Autonomic Agents|autonomic agents|mesh-ancestor
19953340|NCT01606306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953341|NCT01606306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953342|NCT01606306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19953343|NCT01606306|Respiratory System Agents|respiratory system agents|mesh-ancestor
19953344|NCT01606306|Dermatologic Agents|dermatologic agents|mesh-ancestor
19953345|NCT01606306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19953346|NCT01606306|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19953347|NCT01606306|Hormone Antagonists|hormone antagonists|mesh-ancestor
19953348|NCT01606306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19953349|NCT01606306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19953350|NCT01606306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19953351|NCT01606306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953352|NCT01606319|Acetaminophen|acetaminophen|mesh-list
19953353|NCT01606319|Ibuprofen|ibuprofen|mesh-list
19953354|NCT01606319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19953355|NCT01606319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19953356|NCT01606319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19953357|NCT01606319|Analgesics|analgesics|mesh-ancestor
19953358|NCT01606319|Sensory System Agents|sensory system agents|mesh-ancestor
19953359|NCT01606319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953360|NCT01606319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953361|NCT01606319|Antipyretics|antipyretics|mesh-ancestor
19953362|NCT01606319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19953363|NCT01606319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19953364|NCT01606319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19953365|NCT01606319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953366|NCT01606748|Gemcitabine|gemcitabine|mesh-list
19953367|NCT01606748|Necitumumab|necitumumab|mesh-list
19953368|NCT01606748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953369|NCT01606748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19953370|NCT01606748|Antimetabolites|antimetabolites|mesh-ancestor
19953371|NCT01606748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953372|NCT01606748|Antiviral Agents|antiviral agents|mesh-ancestor
19953373|NCT01606748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19953374|NCT01606748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19953375|NCT01606748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19953376|NCT01606748|Immunologic Factors|immunologic factors|mesh-ancestor
20269816|NCT04107675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20269817|NCT04107675|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20269818|NCT04093167|Pembrolizumab|pembrolizumab|mesh-list
20269819|NCT04093167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20269820|NCT04093167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269821|NCT04091217|Bevacizumab|bevacizumab|mesh-list
20269822|NCT04091217|Atezolizumab|atezolizumab|mesh-list
20269823|NCT04091217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20269824|NCT04091217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269825|NCT04091217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20269826|NCT04091217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20269827|NCT04091217|Growth Substances|growth substances|mesh-ancestor
20269828|NCT04091217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269829|NCT04091217|Growth Inhibitors|growth inhibitors|mesh-ancestor
20269830|NCT04067726|Vitamin D|vitamin d|mesh-list
20269831|NCT04067726|Cholecalciferol|cholecalciferol|mesh-list
20269832|NCT04067726|Denosumab|denosumab|mesh-list
20269833|NCT04067726|Calcium|calcium|mesh-list
20269834|NCT04067726|Vitamins|vitamins|mesh-ancestor
20269835|NCT04067726|Micronutrients|micronutrients|mesh-ancestor
20269836|NCT04067726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953377|NCT01606748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953378|NCT01606748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20269837|NCT04067726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20269838|NCT04067726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20269839|NCT04050436|Cemiplimab|cemiplimab|mesh-list
19953379|NCT01606761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19953380|NCT01606761|Immunologic Factors|immunologic factors|mesh-ancestor
19953381|NCT01606761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953382|NCT01606787|Mannitol|mannitol|mesh-list
19953383|NCT01606787|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19953384|NCT01606787|Diuretics|diuretics|mesh-ancestor
19953385|NCT01606787|Natriuretic Agents|natriuretic agents|mesh-ancestor
19953386|NCT01606787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953387|NCT01606800|Ribavirin|ribavirin|mesh-list
19953388|NCT01606800|Interferon alpha-2|interferon alpha-2|mesh-list
19953389|NCT01606800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19953390|NCT01606800|Antimetabolites|antimetabolites|mesh-ancestor
19953391|NCT01606800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953392|NCT01606800|Antiviral Agents|antiviral agents|mesh-ancestor
19953393|NCT01606800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19953394|NCT01606800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953395|NCT01606852|Dexmedetomidine|dexmedetomidine|mesh-list
19953396|NCT01606852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19953397|NCT01606852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19953398|NCT01606852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953399|NCT01606852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19953400|NCT01606852|Analgesics|analgesics|mesh-ancestor
19953401|NCT01606852|Sensory System Agents|sensory system agents|mesh-ancestor
19953402|NCT01606852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953403|NCT01606852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19953404|NCT01606852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19953405|NCT01606852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19953406|NCT01606852|Adrenergic Agents|adrenergic agents|mesh-ancestor
19953407|NCT01606852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953408|NCT01606852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953409|NCT01607073|Verapamil|verapamil|mesh-list
19953410|NCT01607073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19953411|NCT01607073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19953412|NCT01607073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19953413|NCT01607073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953414|NCT01607073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19953415|NCT01607073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953416|NCT01607073|Vasodilator Agents|vasodilator agents|mesh-ancestor
19974517|NCT01838200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19974518|NCT01838200|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19974519|NCT01838200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19974520|NCT01838200|Antimetabolites|antimetabolites|mesh-ancestor
19974521|NCT01838200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19974522|NCT01838200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19974523|NCT01838200|Immunologic Factors|immunologic factors|mesh-ancestor
19974524|NCT01838200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974525|NCT01838317|Pioglitazone|pioglitazone|mesh-list
19974526|NCT01838317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19974527|NCT01838317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974528|NCT01838447|Vitamin D|vitamin d|mesh-list
19974529|NCT01838447|Cholecalciferol|cholecalciferol|mesh-list
19974530|NCT01838447|Vitamins|vitamins|mesh-ancestor
19974531|NCT01838447|Micronutrients|micronutrients|mesh-ancestor
19974532|NCT01838447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974533|NCT01838447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19974534|NCT01838447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19974535|NCT01838590|Sofosbuvir|sofosbuvir|mesh-list
19974536|NCT01838590|Antiviral Agents|antiviral agents|mesh-ancestor
19974537|NCT01838590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19974538|NCT01838616|Oxycodone|oxycodone|mesh-list
19974539|NCT01838616|Tapentadol|tapentadol|mesh-list
19974540|NCT01838616|Naloxone|naloxone|mesh-list
19974541|NCT01838616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19974542|NCT01838616|Narcotics|narcotics|mesh-ancestor
19974543|NCT01838616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19974544|NCT01838616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974545|NCT01838616|Analgesics|analgesics|mesh-ancestor
19974546|NCT01838616|Sensory System Agents|sensory system agents|mesh-ancestor
19974547|NCT01838616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19974548|NCT01838616|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19974549|NCT01838616|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19974550|NCT01838616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19974551|NCT01838616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19974552|NCT01838616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974553|NCT01838616|Adrenergic Agents|adrenergic agents|mesh-ancestor
19974554|NCT01838616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953417|NCT01607203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19953418|NCT01607203|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19953419|NCT01607203|Luteolytic Agents|luteolytic agents|mesh-ancestor
19953420|NCT01607203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19953421|NCT01607203|Contraceptive Agents|contraceptive agents|mesh-ancestor
19953422|NCT01607203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19953423|NCT01607203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953424|NCT01607203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19953425|NCT01607203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19953426|NCT01607203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953427|NCT01607346|Ezogabine|ezogabine|mesh-list
19953428|NCT01607346|Anticonvulsants|anticonvulsants|mesh-ancestor
19953429|NCT01607346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19953430|NCT01607346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953431|NCT01607411|Fluorides|fluorides|mesh-list
19953432|NCT01607411|Cariostatic Agents|cariostatic agents|mesh-ancestor
19953433|NCT01607411|Protective Agents|protective agents|mesh-ancestor
19953434|NCT01607411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953435|NCT01607450|Glucagon|glucagon|mesh-list
19953436|NCT01607450|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19953437|NCT01607450|Incretins|incretins|mesh-ancestor
19953438|NCT01607450|Hormones|hormones|mesh-ancestor
19953439|NCT01607450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19953440|NCT01607450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953441|NCT01607450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19953442|NCT01607476|Corticosterone|corticosterone|mesh-list
19953443|NCT01607476|Flutemetamol|flutemetamol|mesh-list
19953444|NCT01607476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19953445|NCT01607476|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19953446|NCT01607476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953447|NCT01607554|Irinotecan|irinotecan|mesh-list
19953448|NCT01607554|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19953449|NCT01607554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19953450|NCT01607554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19953451|NCT01607554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953452|NCT01607554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953453|NCT01607593|Sertraline|sertraline|mesh-list
19953454|NCT01607593|Antidepressive Agents|antidepressive agents|mesh-ancestor
19953455|NCT01607593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19953456|NCT01607593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19953457|NCT01607593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19953458|NCT01607593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19953459|NCT01607593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953460|NCT01607593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953461|NCT01607593|Serotonin Agents|serotonin agents|mesh-ancestor
19953462|NCT01607593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953463|NCT01607645|Cytarabine|cytarabine|mesh-list
19953464|NCT01607645|Decitabine|decitabine|mesh-list
19953465|NCT01607645|Azacitidine|azacitidine|mesh-list
19953466|NCT01607645|Idarubicin|idarubicin|mesh-list
19953467|NCT01607645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19953468|NCT01607645|Antimetabolites|antimetabolites|mesh-ancestor
19953469|NCT01607645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953470|NCT01607645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953471|NCT01607645|Antiviral Agents|antiviral agents|mesh-ancestor
19953472|NCT01607645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19953473|NCT01607645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19953474|NCT01607645|Immunologic Factors|immunologic factors|mesh-ancestor
19953475|NCT01607645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953476|NCT01607645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19953477|NCT01607645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19953478|NCT01607645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19953479|NCT01607645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19953480|NCT01607853|Calcitriol|calcitriol|mesh-list
19953481|NCT01607853|Betamethasone|betamethasone|mesh-list
19953482|NCT01607853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19953483|NCT01607853|Glucocorticoids|glucocorticoids|mesh-ancestor
19953484|NCT01607853|Hormones|hormones|mesh-ancestor
19953485|NCT01607853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19953486|NCT01607853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953487|NCT01607853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19953488|NCT01607853|Respiratory System Agents|respiratory system agents|mesh-ancestor
19953489|NCT01607853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19953490|NCT01607853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19953491|NCT01607853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19953492|NCT01607853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953493|NCT01607853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19953494|NCT01607853|Vitamins|vitamins|mesh-ancestor
19953495|NCT01607853|Micronutrients|micronutrients|mesh-ancestor
19953496|NCT01607853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19953497|NCT01607905|Acetaminophen|acetaminophen|mesh-list
19953498|NCT01607905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19953499|NCT01607905|Analgesics|analgesics|mesh-ancestor
19953500|NCT01607905|Sensory System Agents|sensory system agents|mesh-ancestor
19953501|NCT01607905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953502|NCT01607905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953503|NCT01607905|Antipyretics|antipyretics|mesh-ancestor
19953504|NCT01608087|Bevacizumab|bevacizumab|mesh-list
19953505|NCT01608087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19953506|NCT01608087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953507|NCT01608087|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19953508|NCT01608087|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19953509|NCT01608087|Growth Substances|growth substances|mesh-ancestor
19953510|NCT01608087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953511|NCT01608087|Growth Inhibitors|growth inhibitors|mesh-ancestor
19953512|NCT01608295|Paroxetine|paroxetine|mesh-list
19953513|NCT01608295|Antidepressive Agents|antidepressive agents|mesh-list
19953514|NCT01608295|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
19953515|NCT01608295|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19953516|NCT01608295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19953517|NCT01608295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19953518|NCT01608295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953519|NCT01608295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953520|NCT01608295|Serotonin Agents|serotonin agents|mesh-ancestor
19953521|NCT01608295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953522|NCT01608295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19953523|NCT01608295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19953524|NCT01608295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19953525|NCT01608295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19953526|NCT01608295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19953527|NCT01608295|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19953528|NCT01608295|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19953529|NCT01608308|Acetaminophen|acetaminophen|mesh-list
19953530|NCT01608308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19953531|NCT01608308|Analgesics|analgesics|mesh-ancestor
19953532|NCT01608308|Sensory System Agents|sensory system agents|mesh-ancestor
19953533|NCT01608308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953534|NCT01608308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953535|NCT01608308|Antipyretics|antipyretics|mesh-ancestor
19953536|NCT01608659|Botulinum Toxins|botulinum toxins|mesh-list
19953537|NCT01608659|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19953538|NCT01608659|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19953539|NCT01608659|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19953540|NCT01608659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19953541|NCT01608659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953542|NCT01608659|Cholinergic Agents|cholinergic agents|mesh-ancestor
19953543|NCT01608659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953544|NCT01608659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953545|NCT01608659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19953546|NCT01608659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953547|NCT01608672|Botulinum Toxins|botulinum toxins|mesh-list
19953548|NCT01608672|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19953549|NCT01608672|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19953550|NCT01608672|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19953551|NCT01608672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19953552|NCT01608672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953553|NCT01608672|Cholinergic Agents|cholinergic agents|mesh-ancestor
19953554|NCT01608672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953555|NCT01608672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953556|NCT01608672|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19953557|NCT01608672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953558|NCT01608724|Saxagliptin|saxagliptin|mesh-list
19953559|NCT01608724|Incretins|incretins|mesh-ancestor
19953560|NCT01608724|Hormones|hormones|mesh-ancestor
19953561|NCT01608724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19953562|NCT01608724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953563|NCT01608724|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19953564|NCT01608724|Protease Inhibitors|protease inhibitors|mesh-ancestor
19953565|NCT01608724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19953566|NCT01608724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953567|NCT01608724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19953568|NCT01609010|Interferons|interferons|mesh-list
19953569|NCT01609010|Interferon alpha-2|interferon alpha-2|mesh-list
19953570|NCT01609010|Rituximab|rituximab|mesh-list
19953571|NCT01609010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19953572|NCT01609010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953573|NCT01609010|Immunologic Factors|immunologic factors|mesh-ancestor
19953574|NCT01609010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953575|NCT01609010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19953576|NCT01609010|Antiviral Agents|antiviral agents|mesh-ancestor
19953577|NCT01609010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19953578|NCT01609023|Rituximab|rituximab|mesh-list
19953579|NCT01609023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19953580|NCT01609023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953581|NCT01609023|Immunologic Factors|immunologic factors|mesh-ancestor
19953582|NCT01609023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953583|NCT01609023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19953584|NCT01609218|Charcoal|charcoal|mesh-list
19953585|NCT01609218|Antidotes|antidotes|mesh-ancestor
19953586|NCT01609218|Protective Agents|protective agents|mesh-ancestor
19953587|NCT01609218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953588|NCT01609348|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19953589|NCT01609348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19953590|NCT01609348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19953591|NCT01609348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19953592|NCT01609348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953593|NCT01609348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953594|NCT01609348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953595|NCT01609348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19953596|NCT01609348|Antidepressive Agents|antidepressive agents|mesh-ancestor
19953597|NCT01609348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19953598|NCT01609478|Mometasone Furoate|mometasone furoate|mesh-list
19953599|NCT01609478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19953600|NCT01609478|Dermatologic Agents|dermatologic agents|mesh-ancestor
19953601|NCT01609478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19953602|NCT01609543|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19953603|NCT01609543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953604|NCT01609543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19953605|NCT01609543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19953606|NCT01609543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953607|NCT01609556|Maytansine|maytansine|mesh-list
19953608|NCT01609556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19953609|NCT01609556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953610|NCT01609556|Tubulin Modulators|tubulin modulators|mesh-ancestor
19953611|NCT01609556|Antimitotic Agents|antimitotic agents|mesh-ancestor
19953612|NCT01609556|Mitosis Modulators|mitosis modulators|mesh-ancestor
19953613|NCT01609556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953614|NCT01609933|Interferons|interferons|mesh-list
19953615|NCT01609933|Ritonavir|ritonavir|mesh-list
19953616|NCT01609933|Ribavirin|ribavirin|mesh-list
19953617|NCT01609933|Interferon-alpha|interferon-alpha|mesh-list
19953618|NCT01609933|Interferon alpha-2|interferon alpha-2|mesh-list
19953619|NCT01609933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19953620|NCT01609933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953621|NCT01609933|Antiviral Agents|antiviral agents|mesh-ancestor
19953622|NCT01609933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19953623|NCT01609933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19953624|NCT01609933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19953625|NCT01609933|Protease Inhibitors|protease inhibitors|mesh-ancestor
19953626|NCT01609933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19953627|NCT01609933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953628|NCT01609933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19953629|NCT01609933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19953630|NCT01609933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19953631|NCT01609933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19953632|NCT01609933|Antimetabolites|antimetabolites|mesh-ancestor
19953633|NCT01609933|Immunologic Factors|immunologic factors|mesh-ancestor
19953634|NCT01609933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269840|NCT04050436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20269841|NCT04050436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953635|NCT01610011|Glycine|glycine|mesh-list
19953636|NCT01610011|Glycine Agents|glycine agents|mesh-ancestor
19953637|NCT01610011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953638|NCT01610011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953639|NCT01610011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953640|NCT01610037|Tiotropium Bromide|tiotropium bromide|mesh-list
19953641|NCT01610037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19953642|NCT01610037|Autonomic Agents|autonomic agents|mesh-ancestor
19953643|NCT01610037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953644|NCT01610037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953645|NCT01610037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19953646|NCT01610037|Respiratory System Agents|respiratory system agents|mesh-ancestor
19953647|NCT01610037|Parasympatholytics|parasympatholytics|mesh-ancestor
19953648|NCT01610037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19953649|NCT01610037|Cholinergic Agents|cholinergic agents|mesh-ancestor
19953650|NCT01610037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953651|NCT01610037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953652|NCT01610154|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19953653|NCT01610154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19953654|NCT01610154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953655|NCT01610154|Incretins|incretins|mesh-ancestor
19953656|NCT01610154|Hormones|hormones|mesh-ancestor
19953657|NCT01610154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19953658|NCT01610154|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19953659|NCT01610154|Protease Inhibitors|protease inhibitors|mesh-ancestor
19953660|NCT01610154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19953661|NCT01610154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953662|NCT01610167|Listerine|listerine|mesh-list
19953663|NCT01610167|Fluorides|fluorides|mesh-list
19953664|NCT01610167|Sodium Fluoride|sodium fluoride|mesh-list
19953665|NCT01610167|Cariostatic Agents|cariostatic agents|mesh-ancestor
19953666|NCT01610167|Protective Agents|protective agents|mesh-ancestor
19953667|NCT01610167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953668|NCT01610167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19953669|NCT01610167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19953670|NCT01610206|Gemcitabine|gemcitabine|mesh-list
19953671|NCT01610206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19953672|NCT01610206|Antimetabolites|antimetabolites|mesh-ancestor
19953673|NCT01610206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953674|NCT01610206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953675|NCT01610206|Antiviral Agents|antiviral agents|mesh-ancestor
19953676|NCT01610206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19953677|NCT01610206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19953678|NCT01610206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19953679|NCT01610206|Immunologic Factors|immunologic factors|mesh-ancestor
19953680|NCT01610206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953681|NCT01610284|Fulvestrant|fulvestrant|mesh-list
19953682|NCT01610284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19953683|NCT01610284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953684|NCT01610284|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19953685|NCT01610284|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19953686|NCT01610284|Hormone Antagonists|hormone antagonists|mesh-ancestor
19953687|NCT01610284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19953688|NCT01610284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953689|NCT01610297|Deferasirox|deferasirox|mesh-list
19953690|NCT01610297|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19953691|NCT01610297|Chelating Agents|chelating agents|mesh-ancestor
19953692|NCT01610297|Sequestering Agents|sequestering agents|mesh-ancestor
19953693|NCT01610297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953694|NCT01610336|Gefitinib|gefitinib|mesh-list
19953695|NCT01610336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953696|NCT01610336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19953697|NCT01610336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19953698|NCT01610336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953699|NCT01610492|Belimumab|belimumab|mesh-list
19953700|NCT01610492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19953701|NCT01610492|Immunologic Factors|immunologic factors|mesh-ancestor
19953702|NCT01610492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953703|NCT01610557|Bevacizumab|bevacizumab|mesh-list
19953704|NCT01610557|Ranibizumab|ranibizumab|mesh-list
19953705|NCT01610557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19953706|NCT01610557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953707|NCT01610557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19953708|NCT01610557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19953709|NCT01610557|Growth Substances|growth substances|mesh-ancestor
19953710|NCT01610557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953711|NCT01610557|Growth Inhibitors|growth inhibitors|mesh-ancestor
19953712|NCT01610570|Plicamycin|plicamycin|mesh-list
19953713|NCT01610570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19953714|NCT01610570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953715|NCT01610570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19953716|NCT01610570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953717|NCT01610570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19953718|NCT01610570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19953719|NCT01610570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953720|NCT01610570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19953721|NCT01610596|Halobetasol|halobetasol|mesh-list
19953722|NCT01610596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19953723|NCT01610687|Nabiximols|nabiximols|mesh-list
19953724|NCT01610687|Analgesics|analgesics|mesh-ancestor
19953725|NCT01610687|Sensory System Agents|sensory system agents|mesh-ancestor
19953726|NCT01610687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953727|NCT01610687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953728|NCT01610700|Nabiximols|nabiximols|mesh-list
19953729|NCT01610700|Analgesics|analgesics|mesh-ancestor
19953730|NCT01610700|Sensory System Agents|sensory system agents|mesh-ancestor
19953731|NCT01610700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953732|NCT01610700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953733|NCT01610713|Nabiximols|nabiximols|mesh-list
19953734|NCT01610713|Analgesics|analgesics|mesh-ancestor
19953735|NCT01610713|Sensory System Agents|sensory system agents|mesh-ancestor
19953736|NCT01610713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953737|NCT01610713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953738|NCT01611090|Rituximab|rituximab|mesh-list
19953739|NCT01611090|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19953740|NCT01611090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19953741|NCT01611090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953742|NCT01611090|Immunologic Factors|immunologic factors|mesh-ancestor
19953743|NCT01611090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953744|NCT01611090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19953745|NCT01611090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19953746|NCT01611090|Alkylating Agents|alkylating agents|mesh-ancestor
19953747|NCT01611090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953748|NCT01611155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19953749|NCT01611155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19953750|NCT01611155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19953751|NCT01611155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19953752|NCT01611155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953753|NCT01611155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953754|NCT01611155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953755|NCT01611155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19953756|NCT01611155|Antidepressive Agents|antidepressive agents|mesh-ancestor
19953757|NCT01611155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19953758|NCT01611259|Rituximab|rituximab|mesh-list
19953759|NCT01611259|Lenalidomide|lenalidomide|mesh-list
19953760|NCT01611259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19953761|NCT01611259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953762|NCT01611259|Immunologic Factors|immunologic factors|mesh-ancestor
19953763|NCT01611259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953764|NCT01611259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19953765|NCT01611259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19953766|NCT01611259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19953767|NCT01611259|Growth Substances|growth substances|mesh-ancestor
19953768|NCT01611259|Growth Inhibitors|growth inhibitors|mesh-ancestor
19953769|NCT01611298|Vaccines|vaccines|mesh-list
19953770|NCT01611298|Immunologic Factors|immunologic factors|mesh-ancestor
19953771|NCT01611298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953772|NCT01611558|Ipilimumab|ipilimumab|mesh-list
19953773|NCT01611558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19953774|NCT01611558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953775|NCT01611558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19953776|NCT01611558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953777|NCT01611571|Teriparatide|teriparatide|mesh-list
19953778|NCT01611571|Risedronic Acid|risedronic acid|mesh-list
19953779|NCT01611571|Etidronic Acid|etidronic acid|mesh-list
19953780|NCT01611571|Parathyroid Hormone|parathyroid hormone|mesh-list
19953781|NCT01611571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19953782|NCT01611571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953783|NCT01611571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19953784|NCT01611571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19953785|NCT01611571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19953786|NCT01611571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953787|NCT01611662|Gemcitabine|gemcitabine|mesh-list
19953788|NCT01611662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953789|NCT01611662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19953790|NCT01611662|Antimetabolites|antimetabolites|mesh-ancestor
19953791|NCT01611662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953792|NCT01611662|Antiviral Agents|antiviral agents|mesh-ancestor
19953793|NCT01611662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19953794|NCT01611662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19953795|NCT01611662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19953796|NCT01611662|Immunologic Factors|immunologic factors|mesh-ancestor
19953797|NCT01611662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953798|NCT01611857|Leucovorin|leucovorin|mesh-list
19953799|NCT01611857|Fluorouracil|fluorouracil|mesh-list
19953800|NCT01611857|Oxaliplatin|oxaliplatin|mesh-list
19953801|NCT01611857|Levoleucovorin|levoleucovorin|mesh-list
19953802|NCT01611857|Antimetabolites|antimetabolites|mesh-ancestor
19953803|NCT01611857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953804|NCT01611857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19953805|NCT01611857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953806|NCT01611857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19953807|NCT01611857|Immunologic Factors|immunologic factors|mesh-ancestor
19953808|NCT01611857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953809|NCT01611857|Antidotes|antidotes|mesh-ancestor
19953810|NCT01611857|Protective Agents|protective agents|mesh-ancestor
19953811|NCT01611857|Vitamin B Complex|vitamin b complex|mesh-ancestor
19953812|NCT01611857|Vitamins|vitamins|mesh-ancestor
19953813|NCT01611857|Micronutrients|micronutrients|mesh-ancestor
19953814|NCT01611935|Vasopressins|vasopressins|mesh-list
19953815|NCT01611935|Arginine Vasopressin|arginine vasopressin|mesh-list
19953816|NCT01611935|Hemostatics|hemostatics|mesh-ancestor
19953817|NCT01611935|Coagulants|coagulants|mesh-ancestor
19953818|NCT01611935|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19953819|NCT01611935|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19953820|NCT01611935|Natriuretic Agents|natriuretic agents|mesh-ancestor
19953821|NCT01611935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953822|NCT01611948|Aprepitant|aprepitant|mesh-list
19953823|NCT01611948|Antiemetics|antiemetics|mesh-ancestor
19953824|NCT01611948|Autonomic Agents|autonomic agents|mesh-ancestor
19953825|NCT01611948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953826|NCT01611948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953827|NCT01611948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19953828|NCT01611948|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19953829|NCT01611948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953830|NCT01611948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953831|NCT01611974|Maribavir|maribavir|mesh-list
19953832|NCT01611974|Antiviral Agents|antiviral agents|mesh-ancestor
19953833|NCT01611974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19953834|NCT01612000|Hemagglutinins|hemagglutinins|mesh-list
19953835|NCT01612000|Agglutinins|agglutinins|mesh-ancestor
19953836|NCT01612000|Immunologic Factors|immunologic factors|mesh-ancestor
19953837|NCT01612000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953838|NCT01612156|Lidocaine|lidocaine|mesh-list
19953839|NCT01612156|Anesthetics, Local|anesthetics, local|mesh-ancestor
19953840|NCT01612156|Anesthetics|anesthetics|mesh-ancestor
19953841|NCT01612156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19953842|NCT01612156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953843|NCT01612156|Sensory System Agents|sensory system agents|mesh-ancestor
19953844|NCT01612156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953845|NCT01612156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19953846|NCT01612156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19953847|NCT01612156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19953848|NCT01612156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19953849|NCT01612156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953850|NCT01612221|Acetylcysteine|acetylcysteine|mesh-list
19953851|NCT01612221|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19953852|NCT01612221|Antiviral Agents|antiviral agents|mesh-ancestor
19953853|NCT01612221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20269842|NCT04049799|Analgesics, Opioid|analgesics, opioid|mesh-list
20269843|NCT04049799|Narcotics|narcotics|mesh-ancestor
19953854|NCT01612221|Expectorants|expectorants|mesh-ancestor
19953855|NCT01612221|Respiratory System Agents|respiratory system agents|mesh-ancestor
20269844|NCT04049799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19953856|NCT01612221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19953857|NCT01612221|Antioxidants|antioxidants|mesh-ancestor
19953858|NCT01612221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953859|NCT01612221|Protective Agents|protective agents|mesh-ancestor
19953860|NCT01612221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953861|NCT01612221|Antidotes|antidotes|mesh-ancestor
19953862|NCT01612546|Camptothecin|camptothecin|mesh-list
19953863|NCT01612546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19953864|NCT01612546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953865|NCT01612546|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19953866|NCT01612546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19953867|NCT01612546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19953868|NCT01612546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953869|NCT01612702|Dexamethasone|dexamethasone|mesh-list
19953870|NCT01612702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19953871|NCT01612702|Antiemetics|antiemetics|mesh-ancestor
19953872|NCT01612702|Autonomic Agents|autonomic agents|mesh-ancestor
19953873|NCT01612702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953874|NCT01612702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953875|NCT01612702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19953876|NCT01612702|Glucocorticoids|glucocorticoids|mesh-ancestor
19953877|NCT01612702|Hormones|hormones|mesh-ancestor
19953878|NCT01612702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19953879|NCT01612702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19953880|NCT01612702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953881|NCT01612858|Metformin|metformin|mesh-list
19953882|NCT01612858|Pioglitazone|pioglitazone|mesh-list
19953883|NCT01612858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19953884|NCT01612858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953885|NCT01612884|Clopidogrel|clopidogrel|mesh-list
19953886|NCT01612884|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19953887|NCT01612884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19953888|NCT01612884|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19953889|NCT01612884|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19953890|NCT01612884|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19953891|NCT01612884|Purinergic Agents|purinergic agents|mesh-ancestor
19953892|NCT01612884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953893|NCT01612884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953894|NCT01612884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953895|NCT01613027|Rituximab|rituximab|mesh-list
19953896|NCT01613027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19953897|NCT01613027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953898|NCT01613027|Immunologic Factors|immunologic factors|mesh-ancestor
19953899|NCT01613027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953900|NCT01613027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19953901|NCT01613131|Estradiol|estradiol|mesh-list
19953902|NCT01613131|Estrogens|estrogens|mesh-ancestor
19953903|NCT01613131|Hormones|hormones|mesh-ancestor
19953904|NCT01613131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19953905|NCT01613131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953906|NCT01613326|Glycopyrrolate|glycopyrrolate|mesh-list
19953907|NCT01613326|Albuterol|albuterol|mesh-list
19953908|NCT01613326|Tiotropium Bromide|tiotropium bromide|mesh-list
19953909|NCT01613326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19953910|NCT01613326|Autonomic Agents|autonomic agents|mesh-ancestor
19953911|NCT01613326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953912|NCT01613326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953913|NCT01613326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19953914|NCT01613326|Respiratory System Agents|respiratory system agents|mesh-ancestor
19953915|NCT01613326|Parasympatholytics|parasympatholytics|mesh-ancestor
19953916|NCT01613326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19953917|NCT01613326|Cholinergic Agents|cholinergic agents|mesh-ancestor
19953918|NCT01613326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953919|NCT01613326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953920|NCT01613326|Tocolytic Agents|tocolytic agents|mesh-ancestor
19953921|NCT01613326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19953922|NCT01613326|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19953923|NCT01613326|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19953924|NCT01613326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19953925|NCT01613326|Adrenergic Agents|adrenergic agents|mesh-ancestor
19953926|NCT01613326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19953927|NCT01613326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19953928|NCT01613599|Rituximab|rituximab|mesh-list
19953929|NCT01613599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19953930|NCT01613599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953931|NCT01613599|Immunologic Factors|immunologic factors|mesh-ancestor
19953932|NCT01613599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953933|NCT01613599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19974555|NCT01838642|Ponatinib|ponatinib|mesh-list
19974556|NCT01838642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974557|NCT01838642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19974558|NCT01838642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974559|NCT01838642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974560|NCT01838655|Nitisinone|nitisinone|mesh-list
19974561|NCT01838655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974562|NCT01838655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974563|NCT01838681|Brexpiprazole|brexpiprazole|mesh-list
19974564|NCT01838681|Serotonin Agents|serotonin agents|mesh-ancestor
19974565|NCT01838681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19974566|NCT01838681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974567|NCT01838681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974568|NCT01838681|Dopamine Agonists|dopamine agonists|mesh-ancestor
19974569|NCT01838681|Dopamine Agents|dopamine agents|mesh-ancestor
19974570|NCT01838876|Cariprazine|cariprazine|mesh-list
19974571|NCT01838876|Antidepressive Agents|antidepressive agents|mesh-list
19974572|NCT01838876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19974573|NCT01838876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19974574|NCT01838876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19974575|NCT01838876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19974576|NCT01838876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974577|NCT01838941|Betaine|betaine|mesh-list
19974578|NCT01838941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19974579|NCT01838941|Lipotropic Agents|lipotropic agents|mesh-ancestor
19974580|NCT01838941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19974581|NCT01838941|Antimetabolites|antimetabolites|mesh-ancestor
19974582|NCT01838941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974583|NCT01838941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19974584|NCT01839110|Ranolazine|ranolazine|mesh-list
19974585|NCT01839110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19974586|NCT01839110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19974587|NCT01839110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974588|NCT01839188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19974589|NCT01839188|Immunologic Factors|immunologic factors|mesh-ancestor
19974590|NCT01839188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974591|NCT01839279|Moxifloxacin|moxifloxacin|mesh-list
19974592|NCT01839279|Tizanidine|tizanidine|mesh-list
19974593|NCT01839279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19974594|NCT01839279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19974595|NCT01839279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19974596|NCT01839279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19974597|NCT01839279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974598|NCT01839279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974599|NCT01839279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974600|NCT01839279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974601|NCT01839279|Analgesics|analgesics|mesh-ancestor
19974602|NCT01839279|Sensory System Agents|sensory system agents|mesh-ancestor
19974603|NCT01839279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19974604|NCT01839279|Anticonvulsants|anticonvulsants|mesh-ancestor
19974605|NCT01839279|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19974606|NCT01839279|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19974607|NCT01839279|Parasympatholytics|parasympatholytics|mesh-ancestor
19974608|NCT01839279|Autonomic Agents|autonomic agents|mesh-ancestor
19974609|NCT01839279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19974610|NCT01839279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19974611|NCT01839279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19974612|NCT01839279|Adrenergic Agents|adrenergic agents|mesh-ancestor
19974613|NCT01839279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19974614|NCT01839487|Gemcitabine|gemcitabine|mesh-list
19974615|NCT01839487|Dexamethasone|dexamethasone|mesh-list
19974616|NCT01839487|Paclitaxel|paclitaxel|mesh-list
19974617|NCT01839487|Enoxaparin|enoxaparin|mesh-list
19974618|NCT01839487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19974619|NCT01839487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974620|NCT01839487|Tubulin Modulators|tubulin modulators|mesh-ancestor
19974621|NCT01839487|Antimitotic Agents|antimitotic agents|mesh-ancestor
19974622|NCT01839487|Mitosis Modulators|mitosis modulators|mesh-ancestor
19974623|NCT01839487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974624|NCT01839487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19974625|NCT01839487|Antiemetics|antiemetics|mesh-ancestor
19953934|NCT01613716|Dexamethasone|dexamethasone|mesh-list
19953935|NCT01613716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19953936|NCT01613716|Antiemetics|antiemetics|mesh-ancestor
20269845|NCT04049799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269846|NCT04049799|Analgesics|analgesics|mesh-ancestor
20269847|NCT04049799|Sensory System Agents|sensory system agents|mesh-ancestor
20269848|NCT04049799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269849|NCT04049084|Adenosine|adenosine|mesh-list
20269850|NCT04049084|Analgesics|analgesics|mesh-ancestor
20269851|NCT04049084|Sensory System Agents|sensory system agents|mesh-ancestor
20269852|NCT04049084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269853|NCT04049084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269854|NCT04049084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20269855|NCT04049084|Vasodilator Agents|vasodilator agents|mesh-ancestor
20269856|NCT04049084|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20269857|NCT04049084|Purinergic Agonists|purinergic agonists|mesh-ancestor
20269858|NCT04049084|Purinergic Agents|purinergic agents|mesh-ancestor
20269859|NCT04049084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20269860|NCT04049084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269861|NCT04033419|Memantine|memantine|mesh-list
20269862|NCT04033419|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20269863|NCT04033419|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20269864|NCT04033419|Dopamine Agents|dopamine agents|mesh-ancestor
20269865|NCT04033419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20269866|NCT04033419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269867|NCT04033419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269868|NCT04033419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20269869|NCT04033419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19953937|NCT01613716|Autonomic Agents|autonomic agents|mesh-ancestor
19953938|NCT01613716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953939|NCT01613716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953940|NCT01613716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20269870|NCT04020172|Dobutamine|dobutamine|mesh-list
20269871|NCT04020172|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20269872|NCT04020172|Sympathomimetics|sympathomimetics|mesh-ancestor
20269873|NCT04020172|Autonomic Agents|autonomic agents|mesh-ancestor
20269874|NCT04020172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269875|NCT04020172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269876|NCT04020172|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20269877|NCT04020172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20269878|NCT04020172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20269879|NCT04020172|Adrenergic Agents|adrenergic agents|mesh-ancestor
20269880|NCT04020172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20269881|NCT04020172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269882|NCT04020172|Protective Agents|protective agents|mesh-ancestor
20269883|NCT04003103|Islatravir|islatravir|mesh-list
20269884|NCT04003103|Antiviral Agents|antiviral agents|mesh-ancestor
19953941|NCT01613716|Glucocorticoids|glucocorticoids|mesh-ancestor
19953942|NCT01613716|Hormones|hormones|mesh-ancestor
19953943|NCT01613716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19953944|NCT01613716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19953945|NCT01613716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953946|NCT01614093|Oxytocin|oxytocin|mesh-list
19953947|NCT01614093|Oxytocics|oxytocics|mesh-ancestor
19953948|NCT01614093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19953949|NCT01614093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953950|NCT01614210|Tamoxifen|tamoxifen|mesh-list
19953951|NCT01614210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19953952|NCT01614210|Hormone Antagonists|hormone antagonists|mesh-ancestor
19953953|NCT01614210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19953954|NCT01614210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953955|NCT01614210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19953956|NCT01614210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953957|NCT01614210|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19953958|NCT01614210|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20287402|NCT04740008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19953959|NCT01614210|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19953960|NCT01614457|Ivacaftor|ivacaftor|mesh-list
19953961|NCT01614457|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19953962|NCT01614457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19953963|NCT01614457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953964|NCT01614470|Ivacaftor|ivacaftor|mesh-list
19953965|NCT01614470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19953966|NCT01614470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19953967|NCT01614470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953968|NCT01614509|Triamcinolone|triamcinolone|mesh-list
19953969|NCT01614509|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19953970|NCT01614509|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19953971|NCT01614509|Bevacizumab|bevacizumab|mesh-list
19953972|NCT01614509|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19953973|NCT01614509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19953974|NCT01614509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19953975|NCT01614509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19953976|NCT01614509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19953977|NCT01614509|Growth Substances|growth substances|mesh-ancestor
19953978|NCT01614509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953979|NCT01614509|Growth Inhibitors|growth inhibitors|mesh-ancestor
19953980|NCT01614509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19953981|NCT01614509|Glucocorticoids|glucocorticoids|mesh-ancestor
19953982|NCT01614509|Hormones|hormones|mesh-ancestor
19953983|NCT01614509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19953984|NCT01614509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19953985|NCT01614509|Immunologic Factors|immunologic factors|mesh-ancestor
19953986|NCT01614509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19953987|NCT01614509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953988|NCT01614743|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19953989|NCT01614743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19953990|NCT01614743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19953991|NCT01614743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19953992|NCT01614743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19953993|NCT01614743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19953994|NCT01614743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19953995|NCT01614743|Cholinergic Agents|cholinergic agents|mesh-ancestor
19953996|NCT01614743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19953997|NCT01614769|Glimepiride|glimepiride|mesh-list
19953998|NCT01614769|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19953999|NCT01614769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19954000|NCT01614769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954001|NCT01614769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19954002|NCT01614769|Immunologic Factors|immunologic factors|mesh-ancestor
19954003|NCT01614795|Sirolimus|sirolimus|mesh-list
19954004|NCT01614795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19954005|NCT01614795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19954006|NCT01614795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19954007|NCT01614795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19954008|NCT01614795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954009|NCT01614795|Antifungal Agents|antifungal agents|mesh-ancestor
19954010|NCT01614795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19954011|NCT01614795|Immunologic Factors|immunologic factors|mesh-ancestor
19954012|NCT01614795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954013|NCT01614847|Lubricant Eye Drops|lubricant eye drops|mesh-list
19954014|NCT01614847|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19954015|NCT01614847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20269885|NCT04003103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20269886|NCT04003103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20269887|NCT04003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269888|NCT04003103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20269889|NCT04003103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20269890|NCT04003103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20269891|NCT04000854|Calcium|calcium|mesh-list
20269892|NCT04000854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20269893|NCT04000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269894|NCT03997370|Carboplatin|carboplatin|mesh-list
20269895|NCT03997370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269896|NCT03981341|Bazedoxifene|bazedoxifene|mesh-list
20269897|NCT03981341|Estrogens|estrogens|mesh-list
20269898|NCT03981341|Hormones|hormones|mesh-ancestor
20269899|NCT03981341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19954016|NCT01614886|Rivastigmine|rivastigmine|mesh-list
19954017|NCT01614886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19954018|NCT01614886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19954019|NCT01614886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954020|NCT01614886|Cholinergic Agents|cholinergic agents|mesh-ancestor
19954021|NCT01614886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19954022|NCT01614886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954023|NCT01614886|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19954024|NCT01614886|Protective Agents|protective agents|mesh-ancestor
19954025|NCT01615198|Olmesartan|olmesartan|mesh-list
19954026|NCT01615198|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19954027|NCT01615198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19954028|NCT01615198|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19954029|NCT01615198|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19954030|NCT01615198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954031|NCT01615484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19954032|NCT01615731|Digoxin|digoxin|mesh-list
19954033|NCT01615731|Misoprostol|misoprostol|mesh-list
19954034|NCT01615731|Mifepristone|mifepristone|mesh-list
19954035|NCT01615731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19954036|NCT01615731|Abortifacient Agents|abortifacient agents|mesh-ancestor
19954037|NCT01615731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19954038|NCT01615731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954039|NCT01615731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19954040|NCT01615731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19954041|NCT01615731|Oxytocics|oxytocics|mesh-ancestor
19954042|NCT01615731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19954043|NCT01615731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19954044|NCT01615731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19954045|NCT01615731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954046|NCT01615731|Protective Agents|protective agents|mesh-ancestor
19954047|NCT01615731|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19954048|NCT01615731|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19954049|NCT01615731|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19954050|NCT01615731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19954051|NCT01615731|Contraceptive Agents|contraceptive agents|mesh-ancestor
19954052|NCT01615731|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19954053|NCT01615731|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19954054|NCT01615731|Hormone Antagonists|hormone antagonists|mesh-ancestor
19954055|NCT01615731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19954056|NCT01615731|Luteolytic Agents|luteolytic agents|mesh-ancestor
19954057|NCT01615731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19954058|NCT01615731|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19954059|NCT01615809|Amphotericin B|amphotericin b|mesh-list
19954060|NCT01615809|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19954061|NCT01615809|Amebicides|amebicides|mesh-ancestor
19954062|NCT01615809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19954063|NCT01615809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19954064|NCT01615809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19954065|NCT01615809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19954066|NCT01615809|Antifungal Agents|antifungal agents|mesh-ancestor
19954067|NCT01615822|Artefenomel|artefenomel|mesh-list
19954068|NCT01615822|Antimalarials|antimalarials|mesh-ancestor
19954069|NCT01615822|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19954070|NCT01615822|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19954071|NCT01615822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19954072|NCT01615939|Bupivacaine|bupivacaine|mesh-list
19954073|NCT01615939|Ropivacaine|ropivacaine|mesh-list
19954074|NCT01615939|Anesthetics, Local|anesthetics, local|mesh-ancestor
19954075|NCT01615939|Anesthetics|anesthetics|mesh-ancestor
19954076|NCT01615939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19954077|NCT01615939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954078|NCT01615939|Sensory System Agents|sensory system agents|mesh-ancestor
19954079|NCT01615939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19954080|NCT01616082|Phentermine|phentermine|mesh-list
19954081|NCT01616082|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19954082|NCT01616082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954083|NCT01616082|Appetite Depressants|appetite depressants|mesh-ancestor
19954084|NCT01616082|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19954085|NCT01616082|Sympathomimetics|sympathomimetics|mesh-ancestor
19954086|NCT01616082|Autonomic Agents|autonomic agents|mesh-ancestor
19954087|NCT01616082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19954088|NCT01616082|Adrenergic Agents|adrenergic agents|mesh-ancestor
19954089|NCT01616082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19954090|NCT01616082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954091|NCT01616160|Mometasone Furoate|mometasone furoate|mesh-list
19954092|NCT01616160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19954093|NCT01616160|Dermatologic Agents|dermatologic agents|mesh-ancestor
19954094|NCT01616160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19954095|NCT01616173|Dexamethasone|dexamethasone|mesh-list
19954096|NCT01616173|Dexamethasone acetate|dexamethasone acetate|mesh-list
19954097|NCT01616173|BB 1101|bb 1101|mesh-list
19954098|NCT01616173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19954099|NCT01616173|Antiemetics|antiemetics|mesh-ancestor
19954100|NCT01616173|Autonomic Agents|autonomic agents|mesh-ancestor
19954101|NCT01616173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19954102|NCT01616173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954103|NCT01616173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19954104|NCT01616173|Glucocorticoids|glucocorticoids|mesh-ancestor
19954105|NCT01616173|Hormones|hormones|mesh-ancestor
19954106|NCT01616173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19954107|NCT01616173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19954108|NCT01616173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954109|NCT01616173|Protease Inhibitors|protease inhibitors|mesh-ancestor
19954110|NCT01616173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19954111|NCT01616173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954112|NCT01616459|Vaccines|vaccines|mesh-list
19954113|NCT01616459|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19954114|NCT01616459|Immunologic Factors|immunologic factors|mesh-ancestor
19954115|NCT01616459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954116|NCT01616654|Tazarotene|tazarotene|mesh-list
19954117|NCT01616654|Trifarotene|trifarotene|mesh-list
19954118|NCT01616654|Dermatologic Agents|dermatologic agents|mesh-ancestor
19954119|NCT01616654|Keratolytic Agents|keratolytic agents|mesh-ancestor
19954120|NCT01616693|Zinc|zinc|mesh-list
19954121|NCT01616693|Vaccines|vaccines|mesh-list
19954122|NCT01616693|Immunologic Factors|immunologic factors|mesh-ancestor
19954123|NCT01616693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954124|NCT01616693|Trace Elements|trace elements|mesh-ancestor
19954125|NCT01616693|Micronutrients|micronutrients|mesh-ancestor
19954126|NCT01617083|Azithromycin|azithromycin|mesh-list
19954127|NCT01617083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19954128|NCT01617083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19954129|NCT01617148|Aflibercept|aflibercept|mesh-list
19954130|NCT01617148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19954131|NCT01617148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19954132|NCT01617148|Growth Substances|growth substances|mesh-ancestor
19954133|NCT01617148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954134|NCT01617148|Growth Inhibitors|growth inhibitors|mesh-ancestor
19954135|NCT01617148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954136|NCT01617434|Liraglutide|liraglutide|mesh-list
19954137|NCT01617434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19954138|NCT01617434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954139|NCT01617434|Incretins|incretins|mesh-ancestor
19954140|NCT01617434|Hormones|hormones|mesh-ancestor
19954141|NCT01617434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19954142|NCT01617447|Aripiprazole|aripiprazole|mesh-list
19954143|NCT01617447|Antidepressive Agents|antidepressive agents|mesh-ancestor
19954144|NCT01617447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19954145|NCT01617447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19954146|NCT01617447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19954147|NCT01617447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19954148|NCT01617447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954149|NCT01617447|Dopamine Agonists|dopamine agonists|mesh-ancestor
19954150|NCT01617447|Dopamine Agents|dopamine agents|mesh-ancestor
19954151|NCT01617447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19954152|NCT01617447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954153|NCT01617447|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19954154|NCT01617447|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19954155|NCT01617447|Serotonin Agents|serotonin agents|mesh-ancestor
19954156|NCT01617447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19954157|NCT01617447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19954158|NCT01617447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19954159|NCT01617447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19954160|NCT01617460|Aripiprazole|aripiprazole|mesh-list
19954161|NCT01617460|Antidepressive Agents|antidepressive agents|mesh-ancestor
19954162|NCT01617460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19954163|NCT01617460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19954164|NCT01617460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19954165|NCT01617460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19974626|NCT01839487|Autonomic Agents|autonomic agents|mesh-ancestor
19954166|NCT01617460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954167|NCT01617460|Dopamine Agonists|dopamine agonists|mesh-ancestor
19954168|NCT01617460|Dopamine Agents|dopamine agents|mesh-ancestor
19954169|NCT01617460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19954170|NCT01617460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954171|NCT01617460|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19954172|NCT01617460|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19954173|NCT01617460|Serotonin Agents|serotonin agents|mesh-ancestor
19954174|NCT01617460|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19954175|NCT01617460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19954176|NCT01617460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19954177|NCT01617460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19954178|NCT01617577|Lenograstim|lenograstim|mesh-list
19954179|NCT01617577|Sargramostim|sargramostim|mesh-list
19954180|NCT01617577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19954181|NCT01617577|Immunologic Factors|immunologic factors|mesh-ancestor
19954182|NCT01617577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954183|NCT01617655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19954184|NCT01617655|Immunologic Factors|immunologic factors|mesh-ancestor
19954185|NCT01617655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954186|NCT01617668|Paclitaxel|paclitaxel|mesh-list
19954187|NCT01617668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19954188|NCT01617668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954189|NCT01617668|Tubulin Modulators|tubulin modulators|mesh-ancestor
19954190|NCT01617668|Antimitotic Agents|antimitotic agents|mesh-ancestor
19954191|NCT01617668|Mitosis Modulators|mitosis modulators|mesh-ancestor
19954192|NCT01617668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954193|NCT01617681|Valsartan|valsartan|mesh-list
19954194|NCT01617681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19954195|NCT01617681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19954196|NCT01617681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19954197|NCT01617681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954198|NCT01618162|Liraglutide|liraglutide|mesh-list
19954199|NCT01618162|Xultophy|xultophy|mesh-list
19954200|NCT01618162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19954201|NCT01618162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954202|NCT01618162|Incretins|incretins|mesh-ancestor
19954203|NCT01618162|Hormones|hormones|mesh-ancestor
19954204|NCT01618162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19954205|NCT01618214|Insulin Aspart|insulin aspart|mesh-list
19954206|NCT01618214|Biphasic Insulins|biphasic insulins|mesh-list
19954207|NCT01618214|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19954208|NCT01618214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19954209|NCT01618214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954210|NCT01618266|Dexamethasone|dexamethasone|mesh-list
19954211|NCT01618266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19954212|NCT01618266|Antiemetics|antiemetics|mesh-ancestor
19954213|NCT01618266|Autonomic Agents|autonomic agents|mesh-ancestor
19954214|NCT01618266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19954215|NCT01618266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954216|NCT01618266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19954217|NCT01618266|Glucocorticoids|glucocorticoids|mesh-ancestor
19954218|NCT01618266|Hormones|hormones|mesh-ancestor
19954219|NCT01618266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19954220|NCT01618266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19954221|NCT01618266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954222|NCT01618305|Lamivudine|lamivudine|mesh-list
19954223|NCT01618305|Zidovudine|zidovudine|mesh-list
19954224|NCT01618305|Efavirenz|efavirenz|mesh-list
19954225|NCT01618305|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
19954226|NCT01618305|Raltegravir Potassium|raltegravir potassium|mesh-list
19954227|NCT01618305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19954228|NCT01618305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19954229|NCT01618305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19954230|NCT01618305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954231|NCT01618305|Antiviral Agents|antiviral agents|mesh-ancestor
19954232|NCT01618305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19954233|NCT01618305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19954234|NCT01618305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19954235|NCT01618305|Antimetabolites|antimetabolites|mesh-ancestor
19954236|NCT01618305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19954237|NCT01618305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20287403|NCT04740008|Cholinergic Agents|cholinergic agents|mesh-ancestor
19954238|NCT01618305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19954239|NCT01618305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19954240|NCT01618305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19954241|NCT01618305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19954242|NCT01618305|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19954243|NCT01618305|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19954244|NCT01618669|Regadenoson|regadenoson|mesh-list
19954245|NCT01618669|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19954246|NCT01618669|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19954247|NCT01618669|Purinergic Agonists|purinergic agonists|mesh-ancestor
19954248|NCT01618669|Purinergic Agents|purinergic agents|mesh-ancestor
19954249|NCT01618669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19954250|NCT01618669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954251|NCT01618669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954252|NCT01618708|Hylan|hylan|mesh-list
19954253|NCT01618708|Viscosupplements|viscosupplements|mesh-ancestor
19954254|NCT01618708|Protective Agents|protective agents|mesh-ancestor
19954255|NCT01618708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954256|NCT01619059|Metformin|metformin|mesh-list
19954257|NCT01619059|Dapagliflozin|dapagliflozin|mesh-list
19954258|NCT01619059|Saxagliptin|saxagliptin|mesh-list
19954259|NCT01619059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19954260|NCT01619059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954261|NCT01619059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19954262|NCT01619059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954263|NCT01619059|Incretins|incretins|mesh-ancestor
19954264|NCT01619059|Hormones|hormones|mesh-ancestor
19954265|NCT01619059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19954266|NCT01619059|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19954267|NCT01619059|Protease Inhibitors|protease inhibitors|mesh-ancestor
19954268|NCT01619059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19954269|NCT01619410|Clindamycin|clindamycin|mesh-list
19954270|NCT01619410|Clindamycin palmitate|clindamycin palmitate|mesh-list
19954271|NCT01619410|Clindamycin phosphate|clindamycin phosphate|mesh-list
19954272|NCT01619410|Linezolid|linezolid|mesh-list
19954273|NCT01619410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19954274|NCT01619410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19954275|NCT01619410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20269900|NCT03981341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269901|NCT03981341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20269902|NCT03981341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20269903|NCT03981341|Hormone Antagonists|hormone antagonists|mesh-ancestor
20269904|NCT03981341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20269905|NCT03959423|Insulin|insulin|mesh-list
20269906|NCT03959423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20269907|NCT03959423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287404|NCT04740008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19954276|NCT01619410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287405|NCT04740008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287406|NCT04736745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19954277|NCT01619410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954278|NCT01619423|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
19954279|NCT01619423|Edetic Acid|edetic acid|mesh-list
19954280|NCT01619423|Anticoagulants|anticoagulants|mesh-ancestor
19954281|NCT01619423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20287407|NCT04736745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20287408|NCT04736745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20287409|NCT04736745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287410|NCT04736745|Cholinergic Agents|cholinergic agents|mesh-ancestor
20287411|NCT04736745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20287412|NCT04736745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287413|NCT04676412|Pembrolizumab|pembrolizumab|mesh-list
20287414|NCT04676412|Lenvatinib|lenvatinib|mesh-list
20287415|NCT04676412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20287416|NCT04676412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287417|NCT04676412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20287418|NCT04676412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287419|NCT04676412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288583|NCT05296577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19954282|NCT01619423|Chelating Agents|chelating agents|mesh-ancestor
19954283|NCT01619423|Sequestering Agents|sequestering agents|mesh-ancestor
19954284|NCT01619423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954285|NCT01619423|Vitamin B Complex|vitamin b complex|mesh-ancestor
19954286|NCT01619423|Vitamins|vitamins|mesh-ancestor
19954287|NCT01619423|Micronutrients|micronutrients|mesh-ancestor
19954288|NCT01619423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954289|NCT01619774|Trametinib|trametinib|mesh-list
19954290|NCT01619774|Dabrafenib|dabrafenib|mesh-list
19954291|NCT01619774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954292|NCT01619774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19954293|NCT01619774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19954294|NCT01619774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954295|NCT01619852|Lidocaine|lidocaine|mesh-list
19954296|NCT01619852|Anesthetics, Local|anesthetics, local|mesh-ancestor
19954297|NCT01619852|Anesthetics|anesthetics|mesh-ancestor
19954298|NCT01619852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19954299|NCT01619852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954300|NCT01619852|Sensory System Agents|sensory system agents|mesh-ancestor
19954301|NCT01619852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19954302|NCT01619852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19954303|NCT01619852|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19954304|NCT01619852|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19954305|NCT01619852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19954306|NCT01619852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954307|NCT01619865|Edotreotide|edotreotide|mesh-list
19954308|NCT01619865|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19954309|NCT01619865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954310|NCT01619878|Lumefantrine|lumefantrine|mesh-list
19954311|NCT01619878|Artemether|artemether|mesh-list
19954312|NCT01619878|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19954313|NCT01619878|Antimalarials|antimalarials|mesh-ancestor
19954314|NCT01619878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19954315|NCT01619878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19954316|NCT01619878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19954317|NCT01619982|Vancomycin|vancomycin|mesh-list
19954318|NCT01619982|Cefazolin|cefazolin|mesh-list
19954319|NCT01619982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19954320|NCT01619982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19954321|NCT01620047|Fentanyl|fentanyl|mesh-list
19954322|NCT01620047|Ropivacaine|ropivacaine|mesh-list
19954323|NCT01620047|Anesthetics, Local|anesthetics, local|mesh-ancestor
19954324|NCT01620047|Anesthetics|anesthetics|mesh-ancestor
19954325|NCT01620047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19954326|NCT01620047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954327|NCT01620047|Sensory System Agents|sensory system agents|mesh-ancestor
19954328|NCT01620047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19954329|NCT01620047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19954330|NCT01620047|Narcotics|narcotics|mesh-ancestor
19954331|NCT01620047|Analgesics|analgesics|mesh-ancestor
19954332|NCT01620047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19954333|NCT01620047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19954334|NCT01620047|Anesthetics, General|anesthetics, general|mesh-ancestor
19954335|NCT01620060|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19954336|NCT01620060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19954337|NCT01620060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19954338|NCT01620060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19954339|NCT01620060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954340|NCT01620060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19954341|NCT01620060|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19954342|NCT01620060|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19954343|NCT01620060|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19954344|NCT01620060|Adrenergic Agents|adrenergic agents|mesh-ancestor
19954345|NCT01620060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19954346|NCT01620060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954347|NCT01620060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19954348|NCT01620060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19954349|NCT01620060|Serotonin Agents|serotonin agents|mesh-ancestor
19954350|NCT01620060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19954351|NCT01620060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19954352|NCT01620060|Dopamine Agents|dopamine agents|mesh-ancestor
19954353|NCT01620138|Cabergoline|cabergoline|mesh-list
19954354|NCT01620138|Pasireotide|pasireotide|mesh-list
19954355|NCT01620138|Hormones|hormones|mesh-ancestor
19954356|NCT01620138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19954357|NCT01620138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543691|NCT01871454|Vasodilator Agents|vasodilator agents|mesh-ancestor
19954358|NCT01620138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19954359|NCT01620138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19954360|NCT01620138|Dopamine Agonists|dopamine agonists|mesh-ancestor
19954361|NCT01620138|Dopamine Agents|dopamine agents|mesh-ancestor
19954362|NCT01620138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19954363|NCT01620138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954364|NCT01620177|Ethanol|ethanol|mesh-list
19954365|NCT01620177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19954366|NCT01620177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19954367|NCT01620177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19954368|NCT01620177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954369|NCT01620190|Paclitaxel|paclitaxel|mesh-list
19954370|NCT01620190|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19954371|NCT01620190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19954372|NCT01620190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954373|NCT01620190|Tubulin Modulators|tubulin modulators|mesh-ancestor
19954374|NCT01620190|Antimitotic Agents|antimitotic agents|mesh-ancestor
19954375|NCT01620190|Mitosis Modulators|mitosis modulators|mesh-ancestor
19954376|NCT01620190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954377|NCT01620216|Sorafenib|sorafenib|mesh-list
19954378|NCT01620216|Sunitinib|sunitinib|mesh-list
19954379|NCT01620216|Dasatinib|dasatinib|mesh-list
19954380|NCT01620216|Ponatinib|ponatinib|mesh-list
19954381|NCT01620216|Idelalisib|idelalisib|mesh-list
19954382|NCT01620216|Antineoplastic Agents|antineoplastic agents|mesh-list
19954383|NCT01620216|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
19954384|NCT01620216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19954385|NCT01620216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19954386|NCT01620216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954387|NCT01620216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19954388|NCT01620216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19954389|NCT01620216|Growth Substances|growth substances|mesh-ancestor
19954390|NCT01620216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954391|NCT01620216|Growth Inhibitors|growth inhibitors|mesh-ancestor
19954392|NCT01620489|Liraglutide|liraglutide|mesh-list
19954393|NCT01620489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19954394|NCT01620489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954395|NCT01620489|Incretins|incretins|mesh-ancestor
19954396|NCT01620489|Hormones|hormones|mesh-ancestor
19954397|NCT01620489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19954398|NCT01620593|Metformin|metformin|mesh-list
19954399|NCT01620593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19954400|NCT01620593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954401|NCT01621009|Bupropion|bupropion|mesh-list
19954402|NCT01621009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19954403|NCT01621009|Antidepressive Agents|antidepressive agents|mesh-ancestor
19954404|NCT01621009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20269908|NCT03950817|Ketamine|ketamine|mesh-list
20269909|NCT03950817|Analgesics|analgesics|mesh-ancestor
20269910|NCT03950817|Sensory System Agents|sensory system agents|mesh-ancestor
20269911|NCT03950817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269912|NCT03950817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269913|NCT03950817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20269914|NCT03950817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20269915|NCT03950817|Anesthetics, General|anesthetics, general|mesh-ancestor
20269916|NCT03950817|Anesthetics|anesthetics|mesh-ancestor
20269917|NCT03950817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20269918|NCT03950817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20269919|NCT03950817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20269920|NCT03950817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20269921|NCT03950817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269922|NCT03925025|Magnesium Sulfate|magnesium sulfate|mesh-list
20269923|NCT03925025|Nimodipine|nimodipine|mesh-list
20269924|NCT03925025|Analgesics|analgesics|mesh-ancestor
20269925|NCT03925025|Sensory System Agents|sensory system agents|mesh-ancestor
20269926|NCT03925025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269927|NCT03925025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269928|NCT03925025|Anesthetics|anesthetics|mesh-ancestor
20543692|NCT01871454|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20543693|NCT01871454|Antioxidants|antioxidants|mesh-ancestor
20543694|NCT01871467|Sargramostim|sargramostim|mesh-list
20543695|NCT01871467|Immunologic Factors|immunologic factors|mesh-ancestor
20543696|NCT01871467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954405|NCT01621009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19954406|NCT01621009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20287420|NCT04629443|Azacitidine|azacitidine|mesh-list
20543697|NCT01871480|Gefitinib|gefitinib|mesh-list
19954407|NCT01621009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19954408|NCT01621009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954409|NCT01621009|Dopamine Agents|dopamine agents|mesh-ancestor
19954410|NCT01621009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19954411|NCT01621009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954412|NCT01621009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19954413|NCT01621009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19954414|NCT01621009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974627|NCT01839487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19974628|NCT01839487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974629|NCT01839487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19974630|NCT01839487|Glucocorticoids|glucocorticoids|mesh-ancestor
19974631|NCT01839487|Hormones|hormones|mesh-ancestor
19974632|NCT01839487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19974633|NCT01839487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19974634|NCT01839487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19974635|NCT01839487|Antimetabolites|antimetabolites|mesh-ancestor
19974636|NCT01839487|Antiviral Agents|antiviral agents|mesh-ancestor
19974637|NCT01839487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19974638|NCT01839487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974639|NCT01839487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19974640|NCT01839487|Immunologic Factors|immunologic factors|mesh-ancestor
19974641|NCT01839487|Anticoagulants|anticoagulants|mesh-ancestor
19974642|NCT01839487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19974643|NCT01839487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19974644|NCT01839799|Gemcitabine|gemcitabine|mesh-list
19974645|NCT01839799|Paclitaxel|paclitaxel|mesh-list
19974646|NCT01839799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19974647|NCT01839799|Folfirinox|folfirinox|mesh-list
19974648|NCT01839799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19974649|NCT01839799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974650|NCT01839799|Tubulin Modulators|tubulin modulators|mesh-ancestor
19974651|NCT01839799|Antimitotic Agents|antimitotic agents|mesh-ancestor
19974652|NCT01839799|Mitosis Modulators|mitosis modulators|mesh-ancestor
19974653|NCT01839799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974654|NCT01839799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19974655|NCT01839799|Antimetabolites|antimetabolites|mesh-ancestor
19974656|NCT01839799|Antiviral Agents|antiviral agents|mesh-ancestor
19974657|NCT01839799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19974658|NCT01839799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974659|NCT01839799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19974660|NCT01839799|Immunologic Factors|immunologic factors|mesh-ancestor
19974661|NCT01839799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974662|NCT01840072|Antihypertensive Agents|antihypertensive agents|mesh-list
19974663|NCT01840228|Progesterone|progesterone|mesh-list
19974664|NCT01840228|Progestins|progestins|mesh-ancestor
19974665|NCT01840228|Hormones|hormones|mesh-ancestor
19974666|NCT01840228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19974667|NCT01840228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974668|NCT01840345|Acetylcysteine|acetylcysteine|mesh-list
19974669|NCT01840345|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19974670|NCT01840345|Antiviral Agents|antiviral agents|mesh-ancestor
19974671|NCT01840345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19974672|NCT01840345|Expectorants|expectorants|mesh-ancestor
19974673|NCT01840345|Respiratory System Agents|respiratory system agents|mesh-ancestor
19974674|NCT01840345|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19974675|NCT01840345|Antioxidants|antioxidants|mesh-ancestor
19974676|NCT01840345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974677|NCT01840345|Protective Agents|protective agents|mesh-ancestor
19974678|NCT01840345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974679|NCT01840345|Antidotes|antidotes|mesh-ancestor
19974680|NCT01840410|Ranibizumab|ranibizumab|mesh-list
19974681|NCT01840410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19974682|NCT01840410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19974683|NCT01840410|Growth Substances|growth substances|mesh-ancestor
19974684|NCT01840410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974685|NCT01840410|Growth Inhibitors|growth inhibitors|mesh-ancestor
19974686|NCT01840410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974687|NCT01840579|Paclitaxel|paclitaxel|mesh-list
19974688|NCT01840579|Etoposide|etoposide|mesh-list
20554186|NCT01933997|Vitamin B Complex|vitamin b complex|mesh-ancestor
19974689|NCT01840579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19974690|NCT01840579|Carboplatin|carboplatin|mesh-list
19974691|NCT01840579|Pembrolizumab|pembrolizumab|mesh-list
19974692|NCT01840579|Pemetrexed|pemetrexed|mesh-list
19974693|NCT01840579|Ipilimumab|ipilimumab|mesh-list
19974694|NCT01840579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19954415|NCT01621178|Insulin|insulin|mesh-list
19954416|NCT01621178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19954417|NCT01621178|Insulin Glargine|insulin glargine|mesh-list
19954418|NCT01621178|Insulin Lispro|insulin lispro|mesh-list
19954419|NCT01621178|Dulaglutide|dulaglutide|mesh-list
19954420|NCT01621178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19954421|NCT01621178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954422|NCT01621191|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19954423|NCT01621191|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19954424|NCT01621191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19954425|NCT01621191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19954426|NCT01621191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954427|NCT01621191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19954428|NCT01621191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954429|NCT01621191|Analgesics|analgesics|mesh-ancestor
19954430|NCT01621191|Sensory System Agents|sensory system agents|mesh-ancestor
19954431|NCT01621191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19954432|NCT01621191|Antidepressive Agents|antidepressive agents|mesh-ancestor
19954433|NCT01621191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19954434|NCT01621191|Dopamine Agents|dopamine agents|mesh-ancestor
19954435|NCT01621230|Fentanyl|fentanyl|mesh-list
19954436|NCT01621230|Bupivacaine|bupivacaine|mesh-list
19954437|NCT01621230|Anesthetics, Local|anesthetics, local|mesh-ancestor
19954438|NCT01621230|Anesthetics|anesthetics|mesh-ancestor
19954439|NCT01621230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19954440|NCT01621230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954441|NCT01621230|Sensory System Agents|sensory system agents|mesh-ancestor
19954442|NCT01621230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19954443|NCT01621230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19954444|NCT01621230|Narcotics|narcotics|mesh-ancestor
19954445|NCT01621230|Analgesics|analgesics|mesh-ancestor
19954446|NCT01621230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19954447|NCT01621230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19954448|NCT01621230|Anesthetics, General|anesthetics, general|mesh-ancestor
19954449|NCT01621477|Cytarabine|cytarabine|mesh-list
19954450|NCT01621477|Plerixafor|plerixafor|mesh-list
19954451|NCT01621477|Mycophenolic Acid|mycophenolic acid|mesh-list
19954452|NCT01621477|Cyclophosphamide|cyclophosphamide|mesh-list
19954453|NCT01621477|Busulfan|busulfan|mesh-list
19954454|NCT01621477|Clofarabine|clofarabine|mesh-list
19954455|NCT01621477|Tacrolimus|tacrolimus|mesh-list
19954456|NCT01621477|Thymoglobulin|thymoglobulin|mesh-list
19954457|NCT01621477|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19954458|NCT01621477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19954459|NCT01621477|Immunologic Factors|immunologic factors|mesh-ancestor
19954460|NCT01621477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954461|NCT01621477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19954462|NCT01621477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19954463|NCT01621477|Alkylating Agents|alkylating agents|mesh-ancestor
19954464|NCT01621477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954465|NCT01621477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954466|NCT01621477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19954467|NCT01621477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19954468|NCT01621477|Antimetabolites|antimetabolites|mesh-ancestor
19954469|NCT01621477|Antiviral Agents|antiviral agents|mesh-ancestor
19954470|NCT01621477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19954471|NCT01621477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19954472|NCT01621477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19954473|NCT01621477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19954474|NCT01621477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19954475|NCT01621477|Antitubercular Agents|antitubercular agents|mesh-ancestor
19954476|NCT01621477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19954477|NCT01621477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19954478|NCT01621477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19954479|NCT01621490|Nivolumab|nivolumab|mesh-list
19954480|NCT01621490|Ipilimumab|ipilimumab|mesh-list
19954481|NCT01621490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19954482|NCT01621490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954483|NCT01621490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19954484|NCT01621490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954485|NCT01621633|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19954486|NCT01621633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19954487|NCT01621633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954488|NCT01621672|Lenalidomide|lenalidomide|mesh-list
19954489|NCT01621672|Immunologic Factors|immunologic factors|mesh-ancestor
19954490|NCT01621672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954491|NCT01621672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19954492|NCT01621672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19954493|NCT01621672|Growth Substances|growth substances|mesh-ancestor
19954494|NCT01621672|Growth Inhibitors|growth inhibitors|mesh-ancestor
19954495|NCT01621672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954496|NCT01621776|Insulin|insulin|mesh-list
19954497|NCT01621776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19954498|NCT01621776|Insulin Aspart|insulin aspart|mesh-list
20269929|NCT03925025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19954499|NCT01621776|Insulin Lispro|insulin lispro|mesh-list
19954500|NCT01621776|Insulin glulisine|insulin glulisine|mesh-list
19954501|NCT01621776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19954502|NCT01621776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954503|NCT01621880|Methylprednisolone|methylprednisolone|mesh-list
19954504|NCT01621880|Bevacizumab|bevacizumab|mesh-list
19954505|NCT01621880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19954506|NCT01621880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269930|NCT03925025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20269931|NCT03925025|Anticonvulsants|anticonvulsants|mesh-ancestor
20269932|NCT03925025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20269933|NCT03925025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20269934|NCT03925025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269935|NCT03925025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20269936|NCT03925025|Tocolytic Agents|tocolytic agents|mesh-ancestor
20269937|NCT03925025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20269938|NCT03925025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20269939|NCT03925025|Vasodilator Agents|vasodilator agents|mesh-ancestor
20269940|NCT03924440|Nonoxynol|nonoxynol|mesh-list
20269941|NCT03924440|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
20269942|NCT03924440|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
20269943|NCT03924440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269944|NCT03924440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20269945|NCT03924440|Contraceptive Agents|contraceptive agents|mesh-ancestor
20269946|NCT03924440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20269947|NCT03924440|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20269948|NCT03856515|Nicotine|nicotine|mesh-list
20269949|NCT03856515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20269950|NCT03856515|Autonomic Agents|autonomic agents|mesh-ancestor
20269951|NCT03856515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269952|NCT03856515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269953|NCT03856515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20269954|NCT03856515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20269955|NCT03856515|Cholinergic Agents|cholinergic agents|mesh-ancestor
20269956|NCT03856515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20269957|NCT03856515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269958|NCT03841565|Dexamethasone|dexamethasone|mesh-list
20269959|NCT03841565|Dexamethasone acetate|dexamethasone acetate|mesh-list
20269960|NCT03841565|Daratumumab|daratumumab|mesh-list
20269961|NCT03841565|Pomalidomide|pomalidomide|mesh-list
20269962|NCT03841565|Ichthammol|ichthammol|mesh-list
20269963|NCT03841565|BB 1101|bb 1101|mesh-list
20269964|NCT03841565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20269965|NCT03841565|Antiemetics|antiemetics|mesh-ancestor
20269966|NCT03841565|Autonomic Agents|autonomic agents|mesh-ancestor
20269967|NCT03841565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269968|NCT03841565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269969|NCT03841565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20269970|NCT03841565|Glucocorticoids|glucocorticoids|mesh-ancestor
20269971|NCT03841565|Hormones|hormones|mesh-ancestor
20269972|NCT03841565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20543698|NCT01871480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543699|NCT01871480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20543700|NCT01871480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543701|NCT01871480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543702|NCT01871493|Insulin Lispro|insulin lispro|mesh-list
20543703|NCT01871493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20543704|NCT01871493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543705|NCT01871571|Leucovorin|leucovorin|mesh-list
20543706|NCT01871571|Bevacizumab|bevacizumab|mesh-list
20543707|NCT01871571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20543708|NCT01871571|Fluorouracil|fluorouracil|mesh-list
20543709|NCT01871571|Oxaliplatin|oxaliplatin|mesh-list
20543710|NCT01871571|Antibodies|antibodies|mesh-list
19954507|NCT01621880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20269973|NCT03841565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20269974|NCT03841565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543711|NCT01871571|Immunoglobulins|immunoglobulins|mesh-list
19954508|NCT01621880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19954509|NCT01621880|Growth Substances|growth substances|mesh-ancestor
19954510|NCT01621880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954511|NCT01621880|Growth Inhibitors|growth inhibitors|mesh-ancestor
19954512|NCT01621880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19954513|NCT01621880|Antiemetics|antiemetics|mesh-ancestor
19954514|NCT01621880|Autonomic Agents|autonomic agents|mesh-ancestor
19954515|NCT01621880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19954516|NCT01621880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19954517|NCT01621880|Glucocorticoids|glucocorticoids|mesh-ancestor
19954518|NCT01621880|Hormones|hormones|mesh-ancestor
19954519|NCT01621880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19954520|NCT01621880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19954521|NCT01621880|Protective Agents|protective agents|mesh-ancestor
19954522|NCT01622231|Fluticasone|fluticasone|mesh-list
19954523|NCT01622231|Xhance|xhance|mesh-list
19954524|NCT01622231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19954525|NCT01622231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19954526|NCT01622231|Autonomic Agents|autonomic agents|mesh-ancestor
19954527|NCT01622231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19954528|NCT01622231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954529|NCT01622231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19954530|NCT01622231|Respiratory System Agents|respiratory system agents|mesh-ancestor
19954531|NCT01622231|Dermatologic Agents|dermatologic agents|mesh-ancestor
19954532|NCT01622231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19954533|NCT01622257|Metformin|metformin|mesh-list
19954534|NCT01622257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20269975|NCT03841565|Protease Inhibitors|protease inhibitors|mesh-ancestor
20269976|NCT03841565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20269977|NCT03841565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269978|NCT03841565|Immunologic Factors|immunologic factors|mesh-ancestor
20269979|NCT03841565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20269980|NCT03841565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20269981|NCT03841565|Growth Substances|growth substances|mesh-ancestor
20269982|NCT03841565|Growth Inhibitors|growth inhibitors|mesh-ancestor
20269983|NCT03841565|Dermatologic Agents|dermatologic agents|mesh-ancestor
20269984|NCT03836261|Venetoclax|venetoclax|mesh-list
20269985|NCT03836261|Obinutuzumab|obinutuzumab|mesh-list
20269986|NCT03836261|Acalabrutinib|acalabrutinib|mesh-list
20269987|NCT03836261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20269988|NCT03836261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20269989|NCT03832998|Erenumab|erenumab|mesh-list
20269990|NCT03832998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20269991|NCT03832998|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
20269992|NCT03832998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20269993|NCT03832998|Analgesics|analgesics|mesh-ancestor
20269994|NCT03832998|Sensory System Agents|sensory system agents|mesh-ancestor
20269995|NCT03832998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20269996|NCT03832998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20269997|NCT03832998|Immunologic Factors|immunologic factors|mesh-ancestor
20269998|NCT03816176|Isavuconazole|isavuconazole|mesh-list
20269999|NCT03816176|Antifungal Agents|antifungal agents|mesh-ancestor
20270000|NCT03816176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20270001|NCT03741530|Glyburide|glyburide|mesh-list
20270002|NCT03741530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20270003|NCT03741530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270004|NCT03724890|Avelumab|avelumab|mesh-list
20270005|NCT03724890|Peposertib|peposertib|mesh-list
20270006|NCT03724890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20270007|NCT03724890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270008|NCT03724890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20270009|NCT03724890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270010|NCT03724890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270011|NCT03721341|Hormones|hormones|mesh-list
20270012|NCT03721341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20270013|NCT03721341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270014|NCT03713320|Vorinostat|vorinostat|mesh-list
20270015|NCT03713320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270016|NCT03713320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20270017|NCT03713320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270018|NCT03713320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270019|NCT03673787|Atezolizumab|atezolizumab|mesh-list
20270020|NCT03673787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954535|NCT01622257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954536|NCT01622296|Lidocaine|lidocaine|mesh-list
19954537|NCT01622296|Epinephrine|epinephrine|mesh-list
19954538|NCT01622296|Anesthetics, Local|anesthetics, local|mesh-list
19954539|NCT01622296|Anesthetics|anesthetics|mesh-list
19954540|NCT01622296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19954541|NCT01622296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954542|NCT01622296|Sensory System Agents|sensory system agents|mesh-ancestor
19954543|NCT01622296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19954544|NCT01622296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19954545|NCT01622296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19954546|NCT01622296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19954547|NCT01622296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19954548|NCT01622296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954549|NCT01622296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19954550|NCT01622296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19954551|NCT01622296|Adrenergic Agents|adrenergic agents|mesh-ancestor
19954552|NCT01622296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19954553|NCT01622296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19954554|NCT01622296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19954555|NCT01622296|Autonomic Agents|autonomic agents|mesh-ancestor
19954556|NCT01622296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19954557|NCT01622296|Respiratory System Agents|respiratory system agents|mesh-ancestor
19954558|NCT01622296|Mydriatics|mydriatics|mesh-ancestor
19954559|NCT01622296|Sympathomimetics|sympathomimetics|mesh-ancestor
19954560|NCT01622296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19954561|NCT01622543|Leucovorin|leucovorin|mesh-list
19954562|NCT01622543|Bevacizumab|bevacizumab|mesh-list
19954563|NCT01622543|Fluorouracil|fluorouracil|mesh-list
19954564|NCT01622543|Oxaliplatin|oxaliplatin|mesh-list
19954565|NCT01622543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19954566|NCT01622543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954567|NCT01622543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19954568|NCT01622543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19954569|NCT01622543|Growth Substances|growth substances|mesh-ancestor
19954570|NCT01622543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954571|NCT01622543|Growth Inhibitors|growth inhibitors|mesh-ancestor
19954572|NCT01622543|Antimetabolites|antimetabolites|mesh-ancestor
19954573|NCT01622543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954574|NCT01622543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19954575|NCT01622543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19954576|NCT01622543|Immunologic Factors|immunologic factors|mesh-ancestor
19954577|NCT01622543|Antidotes|antidotes|mesh-ancestor
19954578|NCT01622543|Protective Agents|protective agents|mesh-ancestor
19954579|NCT01622543|Vitamin B Complex|vitamin b complex|mesh-ancestor
19954580|NCT01622543|Vitamins|vitamins|mesh-ancestor
19954581|NCT01622543|Micronutrients|micronutrients|mesh-ancestor
19954582|NCT01622569|Fluticasone|fluticasone|mesh-list
19954583|NCT01622569|Xhance|xhance|mesh-list
19954584|NCT01622569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19954585|NCT01622569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19954586|NCT01622569|Autonomic Agents|autonomic agents|mesh-ancestor
19954587|NCT01622569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19954588|NCT01622569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954589|NCT01622569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19954590|NCT01622569|Respiratory System Agents|respiratory system agents|mesh-ancestor
19954591|NCT01622569|Dermatologic Agents|dermatologic agents|mesh-ancestor
19954592|NCT01622569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19954593|NCT01622660|Gemcitabine|gemcitabine|mesh-list
19954594|NCT01622660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19954595|NCT01622660|Antimetabolites|antimetabolites|mesh-ancestor
19954596|NCT01622660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954597|NCT01622660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954598|NCT01622660|Antiviral Agents|antiviral agents|mesh-ancestor
19954599|NCT01622660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19954600|NCT01622660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19954601|NCT01622660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19954602|NCT01622660|Immunologic Factors|immunologic factors|mesh-ancestor
19954603|NCT01622660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954604|NCT01622673|Raltegravir Potassium|raltegravir potassium|mesh-list
19954605|NCT01622673|Calcium Carbonate|calcium carbonate|mesh-list
19954606|NCT01622673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19954607|NCT01622673|Antacids|antacids|mesh-list
19954608|NCT01622673|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
19954609|NCT01622673|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
19954610|NCT01622673|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
19954611|NCT01622673|TEMPO|tempo|mesh-list
19954612|NCT01622673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954613|NCT01622673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19954614|NCT01622673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19954615|NCT01622673|Antiviral Agents|antiviral agents|mesh-ancestor
19954616|NCT01622673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19954617|NCT01622673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19954618|NCT01622673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19954619|NCT01622673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19954620|NCT01622673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954621|NCT01622673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19954622|NCT01622673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19954623|NCT01622673|Immunologic Factors|immunologic factors|mesh-ancestor
19954624|NCT01622673|Antioxidants|antioxidants|mesh-ancestor
19954625|NCT01622673|Protective Agents|protective agents|mesh-ancestor
19954626|NCT01623115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19954627|NCT01623115|Immunologic Factors|immunologic factors|mesh-ancestor
19954628|NCT01623115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954629|NCT01623271|Gabapentin|gabapentin|mesh-list
19954630|NCT01623271|Analgesics|analgesics|mesh-ancestor
19954631|NCT01623271|Sensory System Agents|sensory system agents|mesh-ancestor
19954632|NCT01623271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19954633|NCT01623271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954634|NCT01623271|Anticonvulsants|anticonvulsants|mesh-ancestor
19954635|NCT01623271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19954636|NCT01623271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19954637|NCT01623271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20270021|NCT03571802|Simvastatin|simvastatin|mesh-list
20270022|NCT03571802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20270023|NCT03571802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20270024|NCT03571802|Antimetabolites|antimetabolites|mesh-ancestor
20270025|NCT03571802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270026|NCT03571802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20270027|NCT03571802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20270028|NCT03571802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270029|NCT03568422|Paclitaxel|paclitaxel|mesh-list
20270030|NCT03568422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20270031|NCT03568422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270032|NCT03568422|Tubulin Modulators|tubulin modulators|mesh-ancestor
20270033|NCT03568422|Antimitotic Agents|antimitotic agents|mesh-ancestor
20270034|NCT03568422|Mitosis Modulators|mitosis modulators|mesh-ancestor
20270035|NCT03568422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270036|NCT03539614|Prazosin|prazosin|mesh-list
20270037|NCT03539614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20270038|NCT03539614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20270039|NCT03539614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20270040|NCT03539614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20270041|NCT03539614|Adrenergic Agents|adrenergic agents|mesh-ancestor
20270042|NCT03539614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20270043|NCT03539614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270044|NCT03539614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270045|NCT03532022|Dexamethasone|dexamethasone|mesh-list
20270046|NCT03532022|Prednisone|prednisone|mesh-list
20270047|NCT03532022|Prednisolone|prednisolone|mesh-list
20270048|NCT03532022|Hydrocortisone|hydrocortisone|mesh-list
20270049|NCT03532022|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20270050|NCT03532022|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20270051|NCT03532022|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20270052|NCT03532022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20270053|NCT03532022|Antiemetics|antiemetics|mesh-ancestor
20270054|NCT03532022|Autonomic Agents|autonomic agents|mesh-ancestor
19954638|NCT01623271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19954639|NCT01623271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19954640|NCT01623271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19954641|NCT01623271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19954642|NCT01623271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954643|NCT01623271|Antimanic Agents|antimanic agents|mesh-ancestor
19954644|NCT01623310|Fluticasone|fluticasone|mesh-list
19954645|NCT01623310|Xhance|xhance|mesh-list
19954646|NCT01623310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19954647|NCT01623310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19954648|NCT01623310|Autonomic Agents|autonomic agents|mesh-ancestor
19954649|NCT01623310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20270055|NCT03532022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20270056|NCT03532022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954650|NCT01623310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270057|NCT03532022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20270058|NCT03532022|Glucocorticoids|glucocorticoids|mesh-ancestor
19954651|NCT01623310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19954652|NCT01623310|Respiratory System Agents|respiratory system agents|mesh-ancestor
19954653|NCT01623310|Dermatologic Agents|dermatologic agents|mesh-ancestor
19954654|NCT01623310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19954655|NCT01623323|Fluticasone|fluticasone|mesh-list
19954656|NCT01623323|Xhance|xhance|mesh-list
19954657|NCT01623323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19954658|NCT01623323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19954659|NCT01623323|Autonomic Agents|autonomic agents|mesh-ancestor
19954660|NCT01623323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19954661|NCT01623323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954662|NCT01623323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19954663|NCT01623323|Respiratory System Agents|respiratory system agents|mesh-ancestor
19954664|NCT01623323|Dermatologic Agents|dermatologic agents|mesh-ancestor
19954665|NCT01623323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19954666|NCT01623466|Contraceptive Agents|contraceptive agents|mesh-list
19954667|NCT01623466|Levonorgestrel|levonorgestrel|mesh-list
19954668|NCT01623466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19954669|NCT01623466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954670|NCT01623466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19954671|NCT01623466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19954672|NCT01623466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19954673|NCT01623466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19954674|NCT01623479|Bimatoprost|bimatoprost|mesh-list
19954675|NCT01623479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19954676|NCT01623596|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19954677|NCT01623596|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19954678|NCT01623596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954679|NCT01623596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19954680|NCT01623596|Immunologic Factors|immunologic factors|mesh-ancestor
19954681|NCT01623596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954682|NCT01623752|Etanercept|etanercept|mesh-list
19954683|NCT01623752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19954684|NCT01623752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19954685|NCT01623752|Analgesics|analgesics|mesh-ancestor
19954686|NCT01623752|Sensory System Agents|sensory system agents|mesh-ancestor
19954687|NCT01623752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19954688|NCT01623752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954689|NCT01623752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19954690|NCT01623752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19954691|NCT01623752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19954692|NCT01623752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19954693|NCT01623752|Immunologic Factors|immunologic factors|mesh-ancestor
19954694|NCT01623869|Trebananib|trebananib|mesh-list
19954695|NCT01623869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19954696|NCT01623869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19954697|NCT01623869|Growth Substances|growth substances|mesh-ancestor
19954698|NCT01623869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954699|NCT01623869|Growth Inhibitors|growth inhibitors|mesh-ancestor
19954700|NCT01623869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954701|NCT01624090|Plicamycin|plicamycin|mesh-list
19954702|NCT01624090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19954703|NCT01624090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954704|NCT01624090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19954705|NCT01624090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954706|NCT01624090|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19954707|NCT01624090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19954708|NCT01624090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954709|NCT01624090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19954710|NCT01624142|Evolocumab|evolocumab|mesh-list
19954711|NCT01624142|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20270059|NCT03532022|Hormones|hormones|mesh-ancestor
20270060|NCT03532022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20270061|NCT03532022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20270062|NCT03532022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270063|NCT03491683|Temozolomide|temozolomide|mesh-list
20270064|NCT03491683|Cemiplimab|cemiplimab|mesh-list
20270065|NCT03491683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20270066|NCT03491683|Alkylating Agents|alkylating agents|mesh-ancestor
20270067|NCT03491683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270068|NCT03491683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954712|NCT01624142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19954713|NCT01624142|Antimetabolites|antimetabolites|mesh-ancestor
20270069|NCT03491683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19954714|NCT01624142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954715|NCT01624142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19954716|NCT01624194|Oxytocin|oxytocin|mesh-list
19954717|NCT01624194|Oxytocics|oxytocics|mesh-ancestor
19954718|NCT01624194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19954719|NCT01624194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954720|NCT01624233|Ixekizumab|ixekizumab|mesh-list
19954721|NCT01624233|Dermatologic Agents|dermatologic agents|mesh-ancestor
19954722|NCT01624259|Metformin|metformin|mesh-list
19954723|NCT01624259|Liraglutide|liraglutide|mesh-list
19954724|NCT01624259|Dulaglutide|dulaglutide|mesh-list
19954725|NCT01624259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19954726|NCT01624259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954727|NCT01624259|Incretins|incretins|mesh-ancestor
19954728|NCT01624259|Hormones|hormones|mesh-ancestor
19954729|NCT01624259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19954730|NCT01624467|Necitumumab|necitumumab|mesh-list
19954731|NCT01624467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19954732|NCT01624467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954733|NCT01624662|Fluticasone|fluticasone|mesh-list
19954734|NCT01624662|Xhance|xhance|mesh-list
19954735|NCT01624662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19954736|NCT01624662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19954737|NCT01624662|Autonomic Agents|autonomic agents|mesh-ancestor
19954738|NCT01624662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19954739|NCT01624662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954740|NCT01624662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19954741|NCT01624662|Respiratory System Agents|respiratory system agents|mesh-ancestor
19954742|NCT01624662|Dermatologic Agents|dermatologic agents|mesh-ancestor
19954743|NCT01624662|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19954744|NCT01624948|Mycophenolic Acid|mycophenolic acid|mesh-list
19954745|NCT01624948|Everolimus|everolimus|mesh-list
19954746|NCT01624948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954747|NCT01624948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19954748|NCT01624948|Immunologic Factors|immunologic factors|mesh-ancestor
19954749|NCT01624948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954750|NCT01624948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19954751|NCT01624948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19954752|NCT01624948|Antitubercular Agents|antitubercular agents|mesh-ancestor
19954753|NCT01624948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19954754|NCT01624948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19954755|NCT01624948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19954756|NCT01624948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954757|NCT01624974|Montelukast|montelukast|mesh-list
19954758|NCT01624974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19954759|NCT01624974|Respiratory System Agents|respiratory system agents|mesh-ancestor
19954760|NCT01624974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19954761|NCT01624974|Hormone Antagonists|hormone antagonists|mesh-ancestor
19954762|NCT01624974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19954763|NCT01624974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954764|NCT01624974|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19954765|NCT01624974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19954766|NCT01624974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954767|NCT01625000|Risperidone|risperidone|mesh-list
19954768|NCT01625000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19954769|NCT01625000|Serotonin Agents|serotonin agents|mesh-ancestor
19954770|NCT01625000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19954771|NCT01625000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954772|NCT01625000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954773|NCT01625000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19954774|NCT01625000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19954775|NCT01625000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20270070|NCT03481634|Aflibercept|aflibercept|mesh-list
20270071|NCT03481634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20270072|NCT03481634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20270073|NCT03481634|Growth Substances|growth substances|mesh-ancestor
20270074|NCT03481634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270075|NCT03481634|Growth Inhibitors|growth inhibitors|mesh-ancestor
20270076|NCT03481634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270077|NCT03472573|Dexamethasone|dexamethasone|mesh-list
20270078|NCT03472573|Palbociclib|palbociclib|mesh-list
20270079|NCT03472573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20270080|NCT03472573|Antiemetics|antiemetics|mesh-ancestor
19954776|NCT01625000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20270081|NCT03472573|Autonomic Agents|autonomic agents|mesh-ancestor
20270082|NCT03472573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20270083|NCT03472573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270084|NCT03472573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20270085|NCT03472573|Glucocorticoids|glucocorticoids|mesh-ancestor
20270086|NCT03472573|Hormones|hormones|mesh-ancestor
19733069|NCT04565496|Pembrolizumab|pembrolizumab|mesh-list
19733070|NCT04565496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19733071|NCT04565496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733072|NCT04565301|Dexamethasone|dexamethasone|mesh-list
19733073|NCT04565301|Neostigmine|neostigmine|mesh-list
19733074|NCT04565301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19733075|NCT04565301|Antiemetics|antiemetics|mesh-ancestor
20270087|NCT03472573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20543712|NCT01871571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20543713|NCT01871571|Levoleucovorin|levoleucovorin|mesh-list
20543714|NCT01871571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543715|NCT01871571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20543716|NCT01871571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20543717|NCT01871571|Growth Substances|growth substances|mesh-ancestor
20543718|NCT01871571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543719|NCT01871571|Growth Inhibitors|growth inhibitors|mesh-ancestor
20543720|NCT01871571|Immunologic Factors|immunologic factors|mesh-ancestor
20543721|NCT01871571|Antimetabolites|antimetabolites|mesh-ancestor
20543722|NCT01871571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543723|NCT01871571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20543724|NCT01871571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20543725|NCT01871571|Antidotes|antidotes|mesh-ancestor
20543726|NCT01871571|Protective Agents|protective agents|mesh-ancestor
20543727|NCT01871571|Vitamin B Complex|vitamin b complex|mesh-ancestor
20543728|NCT01871571|Vitamins|vitamins|mesh-ancestor
20543729|NCT01871571|Micronutrients|micronutrients|mesh-ancestor
20543730|NCT01871649|Golimumab|golimumab|mesh-list
20543731|NCT01871649|Methotrexate|methotrexate|mesh-list
20543732|NCT01871649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20543733|NCT01871649|Abortifacient Agents|abortifacient agents|mesh-ancestor
20543734|NCT01871649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20543735|NCT01871649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543736|NCT01871649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20543737|NCT01871649|Antimetabolites|antimetabolites|mesh-ancestor
20543738|NCT01871649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543739|NCT01871649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543740|NCT01871649|Dermatologic Agents|dermatologic agents|mesh-ancestor
20543741|NCT01871649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543742|NCT01871649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20543743|NCT01871649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20543744|NCT01871649|Immunologic Factors|immunologic factors|mesh-ancestor
20543745|NCT01871649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20543746|NCT01871649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20543747|NCT01871649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20543748|NCT01871649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20543749|NCT01871662|Interferons|interferons|mesh-list
20543750|NCT01871662|Ribavirin|ribavirin|mesh-list
20543751|NCT01871662|Interferon-alpha|interferon-alpha|mesh-list
20543752|NCT01871662|Interferon alpha-2|interferon alpha-2|mesh-list
20543753|NCT01871662|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20543754|NCT01871662|Silybin|silybin|mesh-list
20543755|NCT01871662|Silymarin|silymarin|mesh-list
20543756|NCT01871662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543757|NCT01871662|Antiviral Agents|antiviral agents|mesh-ancestor
19733076|NCT04565301|Autonomic Agents|autonomic agents|mesh-ancestor
19735753|NCT04536662|Glucocorticoids|glucocorticoids|mesh-ancestor
19954777|NCT01625000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19954778|NCT01625000|Dopamine Agents|dopamine agents|mesh-ancestor
19954779|NCT01625013|Hylan|hylan|mesh-list
19954780|NCT01625013|Viscosupplements|viscosupplements|mesh-ancestor
19954781|NCT01625013|Protective Agents|protective agents|mesh-ancestor
19954782|NCT01625013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954783|NCT01625091|Naltrexone|naltrexone|mesh-list
19954784|NCT01625091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19954785|NCT01625091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19954786|NCT01625091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954787|NCT01625091|Sensory System Agents|sensory system agents|mesh-ancestor
19954788|NCT01625091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19954789|NCT01625169|Etravirine|etravirine|mesh-list
19954790|NCT01625169|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19954791|NCT01625169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19954792|NCT01625169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19954793|NCT01625169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954794|NCT01625169|Antiviral Agents|antiviral agents|mesh-ancestor
19954795|NCT01625169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19954796|NCT01625182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19954797|NCT01625182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20270088|NCT03472573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20270089|NCT03472573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270090|NCT03472573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20270091|NCT03472573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554187|NCT01933997|Vitamins|vitamins|mesh-ancestor
19954798|NCT01625182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954799|NCT01625182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19954800|NCT01625182|Immunologic Factors|immunologic factors|mesh-ancestor
19954801|NCT01625182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954802|NCT01625338|Sofosbuvir|sofosbuvir|mesh-list
19954803|NCT01625338|Antiviral Agents|antiviral agents|mesh-ancestor
19954804|NCT01625338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19954805|NCT01625377|Mycophenolic Acid|mycophenolic acid|mesh-list
19954806|NCT01625377|Everolimus|everolimus|mesh-list
19954807|NCT01625377|Tacrolimus|tacrolimus|mesh-list
19954808|NCT01625377|Basiliximab|basiliximab|mesh-list
19954809|NCT01625377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19954810|NCT01625377|Immunologic Factors|immunologic factors|mesh-ancestor
19954811|NCT01625377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954812|NCT01625377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19954813|NCT01625377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19954814|NCT01625377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954815|NCT01625377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954816|NCT01625377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19954817|NCT01625377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19954818|NCT01625377|Antitubercular Agents|antitubercular agents|mesh-ancestor
19954819|NCT01625377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19954820|NCT01625377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19954821|NCT01625455|Aprepitant|aprepitant|mesh-list
19954822|NCT01625455|Antiemetics|antiemetics|mesh-ancestor
19954823|NCT01625455|Autonomic Agents|autonomic agents|mesh-ancestor
19954824|NCT01625455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19954825|NCT01625455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954826|NCT01625455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19954827|NCT01625455|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19954828|NCT01625455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19954829|NCT01625455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954830|NCT01625845|Pentoxifylline|pentoxifylline|mesh-list
19954831|NCT01625845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19954832|NCT01625845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19954833|NCT01625845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954834|NCT01625845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19954835|NCT01625845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19954836|NCT01625845|Protective Agents|protective agents|mesh-ancestor
19954837|NCT01625845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954838|NCT01625845|Vasodilator Agents|vasodilator agents|mesh-ancestor
19954839|NCT01625845|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19954840|NCT01625845|Antioxidants|antioxidants|mesh-ancestor
19954841|NCT01625897|Risperidone|risperidone|mesh-list
19954842|NCT01625897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19954843|NCT01625897|Serotonin Agents|serotonin agents|mesh-ancestor
19954844|NCT01625897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19954845|NCT01625897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954846|NCT01625897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954847|NCT01625897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19954848|NCT01625897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19954849|NCT01625897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19954850|NCT01625897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19954851|NCT01625897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19954852|NCT01625897|Dopamine Agents|dopamine agents|mesh-ancestor
19954853|NCT01625923|Olanzapine|olanzapine|mesh-list
19954854|NCT01625923|Antiemetics|antiemetics|mesh-ancestor
19954855|NCT01625923|Autonomic Agents|autonomic agents|mesh-ancestor
19954856|NCT01625923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19954857|NCT01625923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954858|NCT01625923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19954859|NCT01625923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19954860|NCT01625923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19954861|NCT01625923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19954862|NCT01625923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19954863|NCT01625923|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19954864|NCT01625923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19954865|NCT01625923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19954866|NCT01625923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954867|NCT01625923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19954868|NCT01625923|Serotonin Agents|serotonin agents|mesh-ancestor
19954869|NCT01626092|Cyclosporine|cyclosporine|mesh-list
19954870|NCT01626092|Mycophenolic Acid|mycophenolic acid|mesh-list
19954871|NCT01626092|Melphalan|melphalan|mesh-list
19954872|NCT01626092|Alemtuzumab|alemtuzumab|mesh-list
20270092|NCT03472573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270093|NCT03403569|Triptolide|triptolide|mesh-list
20270094|NCT03403569|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
19954873|NCT01626092|Clofarabine|clofarabine|mesh-list
19954874|NCT01626092|Cyclosporins|cyclosporins|mesh-list
19954875|NCT01626092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19954876|NCT01626092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954877|NCT01626092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19954878|NCT01626092|Immunologic Factors|immunologic factors|mesh-ancestor
19954879|NCT01626092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954880|NCT01626092|Antifungal Agents|antifungal agents|mesh-ancestor
19954881|NCT01626092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19954882|NCT01626092|Dermatologic Agents|dermatologic agents|mesh-ancestor
19954883|NCT01626092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19954884|NCT01626092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19954885|NCT01626092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19954886|NCT01626092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954887|NCT01626092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19954888|NCT01626092|Antitubercular Agents|antitubercular agents|mesh-ancestor
19954889|NCT01626092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19954890|NCT01626092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19954891|NCT01626092|Alkylating Agents|alkylating agents|mesh-ancestor
19954892|NCT01626092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19954893|NCT01626092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20270095|NCT03403569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270096|NCT03403569|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20270097|NCT03403569|Contraceptive Agents|contraceptive agents|mesh-ancestor
20270098|NCT03403569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20270099|NCT03403569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20270100|NCT03403569|Immunologic Factors|immunologic factors|mesh-ancestor
20270101|NCT03403569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20270102|NCT03403569|Alkylating Agents|alkylating agents|mesh-ancestor
20270103|NCT03403569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270104|NCT03403569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270105|NCT03336203|Allopurinol|allopurinol|mesh-list
20270106|NCT03336203|Febuxostat|febuxostat|mesh-list
20270107|NCT03336203|Antimetabolites|antimetabolites|mesh-ancestor
20270108|NCT03336203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270109|NCT03336203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270110|NCT03336203|Gout Suppressants|gout suppressants|mesh-ancestor
20270111|NCT03336203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19954894|NCT01626092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19954895|NCT01626092|Antimetabolites|antimetabolites|mesh-ancestor
19954896|NCT01626118|Indomethacin|indomethacin|mesh-list
19954897|NCT01626118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19954898|NCT01626118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19954899|NCT01626118|Analgesics|analgesics|mesh-ancestor
19954900|NCT01626118|Sensory System Agents|sensory system agents|mesh-ancestor
19954901|NCT01626118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20270112|NCT03336203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20270113|NCT03336203|Antioxidants|antioxidants|mesh-ancestor
20270114|NCT03336203|Protective Agents|protective agents|mesh-ancestor
20270115|NCT03336203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270116|NCT03315897|Epoetin Alfa|epoetin alfa|mesh-list
20270117|NCT03315897|Hematinics|hematinics|mesh-ancestor
20270118|NCT03288545|Gemcitabine|gemcitabine|mesh-list
20543758|NCT01871662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19954902|NCT01626118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954903|NCT01626118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19954904|NCT01626118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19954905|NCT01626118|Gout Suppressants|gout suppressants|mesh-ancestor
19954906|NCT01626118|Tocolytic Agents|tocolytic agents|mesh-ancestor
19954907|NCT01626118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19954908|NCT01626118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19954909|NCT01626118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19954910|NCT01626118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954911|NCT01626352|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19954912|NCT01626352|Ofatumumab|ofatumumab|mesh-list
19954913|NCT01626352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19954914|NCT01626352|Alkylating Agents|alkylating agents|mesh-ancestor
19954915|NCT01626352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954916|NCT01626352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954917|NCT01626664|Gemcitabine|gemcitabine|mesh-list
19954918|NCT01626664|Oxaliplatin|oxaliplatin|mesh-list
19954919|NCT01626664|Mogamulizumab|mogamulizumab|mesh-list
19954920|NCT01626664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19954921|NCT01626664|Antimetabolites|antimetabolites|mesh-ancestor
19954922|NCT01626664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954923|NCT01626664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954924|NCT01626664|Antiviral Agents|antiviral agents|mesh-ancestor
19954925|NCT01626664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19954926|NCT01626664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19954927|NCT01626664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19954928|NCT01626664|Immunologic Factors|immunologic factors|mesh-ancestor
19954929|NCT01626664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954930|NCT01626872|Risperidone|risperidone|mesh-list
19954931|NCT01626872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19954932|NCT01626872|Serotonin Agents|serotonin agents|mesh-ancestor
19954933|NCT01626872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19954934|NCT01626872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954935|NCT01626872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954936|NCT01626872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19954937|NCT01626872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19954938|NCT01626872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19954939|NCT01626872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19954940|NCT01626872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19954941|NCT01626872|Dopamine Agents|dopamine agents|mesh-ancestor
19954942|NCT01627067|Metformin|metformin|mesh-list
19954943|NCT01627067|Everolimus|everolimus|mesh-list
19954944|NCT01627067|Exemestane|exemestane|mesh-list
19954945|NCT01627067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19954946|NCT01627067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954947|NCT01627067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954948|NCT01627067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19954949|NCT01627067|Immunologic Factors|immunologic factors|mesh-ancestor
19954950|NCT01627067|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19954951|NCT01627067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19954952|NCT01627067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19954953|NCT01627067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954954|NCT01627067|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19954955|NCT01627067|Hormone Antagonists|hormone antagonists|mesh-ancestor
19954956|NCT01627067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19954957|NCT01627249|Bevacizumab|bevacizumab|mesh-list
19954958|NCT01627249|Ranibizumab|ranibizumab|mesh-list
19954959|NCT01627249|Aflibercept|aflibercept|mesh-list
19954960|NCT01627249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19954961|NCT01627249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954962|NCT01627249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19954963|NCT01627249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19954964|NCT01627249|Growth Substances|growth substances|mesh-ancestor
19954965|NCT01627249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543759|NCT01871662|Antimetabolites|antimetabolites|mesh-ancestor
19954966|NCT01627249|Growth Inhibitors|growth inhibitors|mesh-ancestor
19954967|NCT01627327|Fluticasone|fluticasone|mesh-list
20270119|NCT03288545|Carboplatin|carboplatin|mesh-list
20554188|NCT01933997|Micronutrients|micronutrients|mesh-ancestor
19954968|NCT01627327|Xhance|xhance|mesh-list
19954969|NCT01627327|Bromides|bromides|mesh-list
19954970|NCT01627327|Tiotropium Bromide|tiotropium bromide|mesh-list
19954971|NCT01627327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19954972|NCT01627327|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19954973|NCT01627327|Autonomic Agents|autonomic agents|mesh-ancestor
19954974|NCT01627327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19954975|NCT01627327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954976|NCT01627327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19954977|NCT01627327|Respiratory System Agents|respiratory system agents|mesh-ancestor
19954978|NCT01627327|Dermatologic Agents|dermatologic agents|mesh-ancestor
19954979|NCT01627327|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20270120|NCT03288545|Pembrolizumab|pembrolizumab|mesh-list
20270121|NCT03288545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270122|NCT03288545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20543760|NCT01871662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543761|NCT01871662|Immunologic Factors|immunologic factors|mesh-ancestor
20543762|NCT01871662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543763|NCT01871662|Antioxidants|antioxidants|mesh-ancestor
20543764|NCT01871662|Protective Agents|protective agents|mesh-ancestor
20543765|NCT01871662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20543766|NCT01871675|Rituximab|rituximab|mesh-list
20543767|NCT01871675|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20543768|NCT01871675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20543769|NCT01871675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543770|NCT01871675|Immunologic Factors|immunologic factors|mesh-ancestor
20543771|NCT01871675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543772|NCT01871675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20543773|NCT01871675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20543774|NCT01871675|Alkylating Agents|alkylating agents|mesh-ancestor
20543775|NCT01871675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543776|NCT01871701|Moxifloxacin|moxifloxacin|mesh-list
20543777|NCT01871701|Dexetimide|dexetimide|mesh-list
20543778|NCT01871701|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20543779|NCT01871701|Citalopram|citalopram|mesh-list
20543780|NCT01871701|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20543781|NCT01871701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20543782|NCT01871701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20543783|NCT01871701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20543784|NCT01871701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20543785|NCT01871701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543786|NCT01871701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543787|NCT01871701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19954980|NCT01627327|Parasympatholytics|parasympatholytics|mesh-ancestor
19954981|NCT01627327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19954982|NCT01627327|Cholinergic Agents|cholinergic agents|mesh-ancestor
19954983|NCT01627327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19954984|NCT01627327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19954985|NCT01627327|Anticonvulsants|anticonvulsants|mesh-ancestor
19954986|NCT01627782|Ketamine|ketamine|mesh-list
19954987|NCT01627782|Analgesics|analgesics|mesh-ancestor
19954988|NCT01627782|Sensory System Agents|sensory system agents|mesh-ancestor
19954989|NCT01627782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19954990|NCT01627782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19954991|NCT01627782|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19954992|NCT01627782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19954993|NCT01627782|Anesthetics, General|anesthetics, general|mesh-ancestor
19954994|NCT01627782|Anesthetics|anesthetics|mesh-ancestor
19954995|NCT01627782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19954996|NCT01627782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19954997|NCT01627782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19954998|NCT01627782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19954999|NCT01627782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955000|NCT01627860|Topiramate|topiramate|mesh-list
19955001|NCT01627860|Anticonvulsants|anticonvulsants|mesh-ancestor
19955002|NCT01627860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19955003|NCT01627860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955004|NCT01628107|Epoetin Alfa|epoetin alfa|mesh-list
19955005|NCT01628107|Hematinics|hematinics|mesh-ancestor
19955006|NCT01628120|Epoetin Alfa|epoetin alfa|mesh-list
19955007|NCT01628120|Hematinics|hematinics|mesh-ancestor
20270123|NCT03288545|Antimetabolites|antimetabolites|mesh-ancestor
20270124|NCT03288545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270125|NCT03288545|Antiviral Agents|antiviral agents|mesh-ancestor
20270126|NCT03288545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19955008|NCT01628393|Ozanimod|ozanimod|mesh-list
19955009|NCT01628393|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19955010|NCT01628393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955011|NCT01628393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19955012|NCT01628393|Immunologic Factors|immunologic factors|mesh-ancestor
19955013|NCT01628393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955014|NCT01628549|Sarecycline|sarecycline|mesh-list
19955015|NCT01628549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19955016|NCT01628549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19955017|NCT01628549|Dermatologic Agents|dermatologic agents|mesh-ancestor
19955018|NCT01628588|Bimatoprost|bimatoprost|mesh-list
19955019|NCT01628588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19955020|NCT01628601|Timolol|timolol|mesh-list
19955021|NCT01628601|Bimatoprost|bimatoprost|mesh-list
19955022|NCT01628601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19955023|NCT01628601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19955024|NCT01628601|Adrenergic Agents|adrenergic agents|mesh-ancestor
19955025|NCT01628601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955026|NCT01628601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955027|NCT01628601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955028|NCT01628601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19955029|NCT01628601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19955030|NCT01628692|Ribavirin|ribavirin|mesh-list
19955031|NCT01628692|Simeprevir|simeprevir|mesh-list
19955032|NCT01628692|Antimetabolites|antimetabolites|mesh-ancestor
19955033|NCT01628692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955034|NCT01628692|Antiviral Agents|antiviral agents|mesh-ancestor
19955035|NCT01628692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19955036|NCT01628692|Protease Inhibitors|protease inhibitors|mesh-ancestor
19955037|NCT01628692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955038|NCT01628874|Lidocaine|lidocaine|mesh-list
19955039|NCT01628874|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19955040|NCT01628874|Anesthetics, Local|anesthetics, local|mesh-ancestor
19955041|NCT01628874|Anesthetics|anesthetics|mesh-ancestor
19955042|NCT01628874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19955043|NCT01628874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955044|NCT01628874|Sensory System Agents|sensory system agents|mesh-ancestor
19955045|NCT01628874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955046|NCT01628874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19955047|NCT01628874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19955048|NCT01628874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19955049|NCT01628874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19955050|NCT01628874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955051|NCT01628874|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19955052|NCT01628913|Everolimus|everolimus|mesh-list
19955053|NCT01628913|Dactolisib|dactolisib|mesh-list
20270127|NCT03288545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270128|NCT03288545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20270129|NCT03288545|Immunologic Factors|immunologic factors|mesh-ancestor
20270130|NCT03288545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270131|NCT03288545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20270132|NCT03283566|Hydroxychloroquine|hydroxychloroquine|mesh-list
20270133|NCT03283566|Antimalarials|antimalarials|mesh-ancestor
20270134|NCT03283566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20270135|NCT03283566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20270136|NCT03283566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20270137|NCT03283566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270138|NCT03283566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270139|NCT03283566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20270140|NCT03278925|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20270141|NCT03278925|Antioxidants|antioxidants|mesh-ancestor
20270142|NCT03278925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270143|NCT03278925|Protective Agents|protective agents|mesh-ancestor
20270144|NCT03278925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270145|NCT03278925|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20270146|NCT03278925|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20270147|NCT03278925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270148|NCT03278925|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20270149|NCT03200379|Antiviral Agents|antiviral agents|mesh-list
20270150|NCT03200379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20270151|NCT03176134|Tedizolid|tedizolid|mesh-list
20270152|NCT03176134|Tedizolid phosphate|tedizolid phosphate|mesh-list
20270153|NCT03176134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20270154|NCT03176134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19955054|NCT01628913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19955055|NCT01628913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19955056|NCT01628913|Immunologic Factors|immunologic factors|mesh-ancestor
19955057|NCT01628913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955058|NCT01628926|Ropinirole|ropinirole|mesh-list
19955059|NCT01628926|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19955060|NCT01628926|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20270155|NCT03160638|Azithromycin|azithromycin|mesh-list
20270156|NCT03160638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20270157|NCT03160638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20270158|NCT03153150|Warfarin|warfarin|mesh-list
20270159|NCT03153150|Rivaroxaban|rivaroxaban|mesh-list
20270160|NCT03153150|Dabigatran|dabigatran|mesh-list
20270161|NCT03153150|Apixaban|apixaban|mesh-list
20270162|NCT03153150|Edoxaban|edoxaban|mesh-list
20270163|NCT03153150|Acenocoumarol|acenocoumarol|mesh-list
20270164|NCT03153150|Phenindione|phenindione|mesh-list
20270165|NCT03153150|Anticoagulants|anticoagulants|mesh-ancestor
20270166|NCT03153150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20270167|NCT03153150|Antithrombins|antithrombins|mesh-ancestor
20270168|NCT03153150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20270169|NCT03153150|Protease Inhibitors|protease inhibitors|mesh-ancestor
20270170|NCT03153150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270171|NCT03153150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287421|NCT04629443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20287422|NCT04629443|Antimetabolites|antimetabolites|mesh-ancestor
20287423|NCT04629443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287424|NCT04629443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287425|NCT04629443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287426|NCT04612725|Benralizumab|benralizumab|mesh-list
20287427|NCT04612725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19955061|NCT01628926|Dopamine Agonists|dopamine agonists|mesh-ancestor
19955062|NCT01628926|Dopamine Agents|dopamine agents|mesh-ancestor
19955063|NCT01628926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955064|NCT01628926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287428|NCT04612725|Respiratory System Agents|respiratory system agents|mesh-ancestor
20287429|NCT04607954|Durvalumab|durvalumab|mesh-list
20287430|NCT04607954|Topotecan|topotecan|mesh-list
20287431|NCT04607954|Immunoglobulins|immunoglobulins|mesh-list
20287432|NCT04607954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20287433|NCT04607954|Immunoglobulin G|immunoglobulin g|mesh-list
20287434|NCT04607954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20287435|NCT04607954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287436|NCT04607954|Immunologic Factors|immunologic factors|mesh-ancestor
20287437|NCT04607954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287438|NCT04607954|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20287439|NCT04607954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20287440|NCT04607954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287441|NCT04607954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287442|NCT04587791|Cannabidiol|cannabidiol|mesh-list
20287443|NCT04587791|Anticonvulsants|anticonvulsants|mesh-ancestor
20287444|NCT04569942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
20287445|NCT04553367|Meropenem|meropenem|mesh-list
20287446|NCT04553367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20287447|NCT04553367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20287448|NCT04542278|Prednisone|prednisone|mesh-list
20287449|NCT04542278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20287450|NCT04542278|Glucocorticoids|glucocorticoids|mesh-ancestor
20287451|NCT04542278|Hormones|hormones|mesh-ancestor
20287452|NCT04542278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20287453|NCT04542278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287454|NCT04542278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20287455|NCT04542278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287456|NCT04530838|Vaccines|vaccines|mesh-list
20287457|NCT04530838|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20287458|NCT04530838|Immunologic Factors|immunologic factors|mesh-ancestor
20287459|NCT04530838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287460|NCT04500665|Colchicine|colchicine|mesh-list
20287461|NCT04500665|Gout Suppressants|gout suppressants|mesh-ancestor
20287462|NCT04500665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19955065|NCT01628926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955066|NCT01628965|Rotigotine|rotigotine|mesh-list
19955067|NCT01628965|Dopamine Agonists|dopamine agonists|mesh-ancestor
19955068|NCT01628965|Dopamine Agents|dopamine agents|mesh-ancestor
19955069|NCT01628965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20287463|NCT04500665|Tubulin Modulators|tubulin modulators|mesh-ancestor
20287464|NCT04500665|Antimitotic Agents|antimitotic agents|mesh-ancestor
20287465|NCT04500665|Mitosis Modulators|mitosis modulators|mesh-ancestor
20287466|NCT04500665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270172|NCT03126331|Nivolumab|nivolumab|mesh-list
20270173|NCT03126331|Ipilimumab|ipilimumab|mesh-list
20270174|NCT03126331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20270175|NCT03126331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270176|NCT03126331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20270177|NCT03126331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270178|NCT03086642|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
20270179|NCT03086642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20270180|NCT03086642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19955070|NCT01628965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955071|NCT01628965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270181|NCT03077685|Paclitaxel|paclitaxel|mesh-list
20270182|NCT03077685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19955072|NCT01629134|Hyaluronic Acid|hyaluronic acid|mesh-list
19955073|NCT01629134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19955074|NCT01629134|Immunologic Factors|immunologic factors|mesh-ancestor
19955075|NCT01629134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270183|NCT03077685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270184|NCT03077685|Tubulin Modulators|tubulin modulators|mesh-ancestor
20270185|NCT03077685|Antimitotic Agents|antimitotic agents|mesh-ancestor
20270186|NCT03077685|Mitosis Modulators|mitosis modulators|mesh-ancestor
20270187|NCT03077685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270188|NCT03074539|Riociguat|riociguat|mesh-list
20270189|NCT03074539|Enzyme Activators|enzyme activators|mesh-ancestor
20270190|NCT03074539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270191|NCT03069378|Pembrolizumab|pembrolizumab|mesh-list
20270192|NCT03069378|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
20270193|NCT03069378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20270194|NCT03069378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270195|NCT03005782|Cemiplimab|cemiplimab|mesh-list
20270196|NCT03005782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20270197|NCT03005782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270198|NCT02978391|Epinephrine|epinephrine|mesh-list
20270199|NCT02978391|Hemostatics|hemostatics|mesh-list
20270200|NCT02978391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20270201|NCT02978391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20270202|NCT02978391|Adrenergic Agents|adrenergic agents|mesh-ancestor
20270203|NCT02978391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20270204|NCT02978391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270205|NCT02978391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270206|NCT02978391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20270207|NCT02978391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20270208|NCT02978391|Autonomic Agents|autonomic agents|mesh-ancestor
20270209|NCT02978391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20270210|NCT02978391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20270211|NCT02978391|Respiratory System Agents|respiratory system agents|mesh-ancestor
20270212|NCT02978391|Mydriatics|mydriatics|mesh-ancestor
20270213|NCT02978391|Sympathomimetics|sympathomimetics|mesh-ancestor
20270214|NCT02978391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20270215|NCT02978391|Coagulants|coagulants|mesh-ancestor
20270216|NCT02971956|Pembrolizumab|pembrolizumab|mesh-list
20270217|NCT02971956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20270218|NCT02971956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270219|NCT02963766|Dulaglutide|dulaglutide|mesh-list
20270220|NCT02963766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20270221|NCT02963766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270222|NCT02843230|Bevacizumab|bevacizumab|mesh-list
20270223|NCT02843230|Temozolomide|temozolomide|mesh-list
20270224|NCT02843230|Lomustine|lomustine|mesh-list
20270225|NCT02843230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20270226|NCT02843230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270227|NCT02843230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20270228|NCT02843230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20270229|NCT02843230|Growth Substances|growth substances|mesh-ancestor
20270230|NCT02843230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270231|NCT02843230|Growth Inhibitors|growth inhibitors|mesh-ancestor
20270232|NCT02843230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20270233|NCT02843230|Alkylating Agents|alkylating agents|mesh-ancestor
20270234|NCT02843230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270235|NCT02712814|Estrogens|estrogens|mesh-list
20270236|NCT02712814|Hormones|hormones|mesh-ancestor
20270237|NCT02712814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19955076|NCT01629134|Viscosupplements|viscosupplements|mesh-ancestor
19955077|NCT01629134|Protective Agents|protective agents|mesh-ancestor
19955078|NCT01629290|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
19955079|NCT01629290|Cariostatic Agents|cariostatic agents|mesh-ancestor
19955080|NCT01629290|Protective Agents|protective agents|mesh-ancestor
19955081|NCT01629290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955082|NCT01629381|Rivaroxaban|rivaroxaban|mesh-list
19955083|NCT01629381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19955084|NCT01629381|Antithrombins|antithrombins|mesh-ancestor
19955085|NCT01629381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19955086|NCT01629381|Protease Inhibitors|protease inhibitors|mesh-ancestor
20270238|NCT02712814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270239|NCT02670252|Cyclophosphamide|cyclophosphamide|mesh-list
20270240|NCT02670252|Busulfan|busulfan|mesh-list
20270241|NCT02670252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20270242|NCT02670252|Immunologic Factors|immunologic factors|mesh-ancestor
20270243|NCT02670252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955087|NCT01629381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955088|NCT01629381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955089|NCT01629381|Anticoagulants|anticoagulants|mesh-ancestor
19955090|NCT01629563|Ulipristal acetate|ulipristal acetate|mesh-list
20270244|NCT02670252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19955091|NCT01629563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19955092|NCT01629563|Contraceptive Agents|contraceptive agents|mesh-ancestor
19955093|NCT01629563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19955094|NCT01629563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955095|NCT01629563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19955096|NCT01629589|Vaccines|vaccines|mesh-list
19955097|NCT01629589|Immunologic Factors|immunologic factors|mesh-ancestor
19955098|NCT01629589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955099|NCT01629667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19955100|NCT01629667|Immunologic Factors|immunologic factors|mesh-ancestor
20270245|NCT02670252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20270246|NCT02670252|Alkylating Agents|alkylating agents|mesh-ancestor
20543788|NCT01871701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20543789|NCT01871701|Contraceptive Agents|contraceptive agents|mesh-ancestor
20543790|NCT01871701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20543791|NCT01871701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543792|NCT01871701|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20543793|NCT01871701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20543794|NCT01871701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20543795|NCT01871701|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20543796|NCT01871701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19955101|NCT01629667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955102|NCT01629966|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
19955103|NCT01629966|Antidepressive Agents|antidepressive agents|mesh-ancestor
19955104|NCT01629966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19955105|NCT01629966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19955106|NCT01629966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19955107|NCT01629966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19955108|NCT01629966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955109|NCT01629966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955110|NCT01629966|Serotonin Agents|serotonin agents|mesh-ancestor
19955111|NCT01629966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955112|NCT01629966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19955113|NCT01629966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19955114|NCT01630109|Metoclopramide|metoclopramide|mesh-list
19955115|NCT01630109|Antiemetics|antiemetics|mesh-ancestor
19955116|NCT01630109|Autonomic Agents|autonomic agents|mesh-ancestor
19955117|NCT01630109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955118|NCT01630109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955119|NCT01630109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19955120|NCT01630109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19955121|NCT01630109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19955122|NCT01630109|Dopamine Agents|dopamine agents|mesh-ancestor
20543797|NCT01871701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20543798|NCT01871701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20543799|NCT01871701|Serotonin Agents|serotonin agents|mesh-ancestor
20543800|NCT01871701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20543801|NCT01871701|Antidepressive Agents|antidepressive agents|mesh-ancestor
20543802|NCT01871701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19955123|NCT01630109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955124|NCT01630109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955125|NCT01630135|Fluticasone|fluticasone|mesh-list
19955126|NCT01630135|Xhance|xhance|mesh-list
19955127|NCT01630135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19955128|NCT01630135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19955129|NCT01630135|Autonomic Agents|autonomic agents|mesh-ancestor
19955130|NCT01630135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955131|NCT01630135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955132|NCT01630135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19955133|NCT01630135|Respiratory System Agents|respiratory system agents|mesh-ancestor
19955134|NCT01630135|Dermatologic Agents|dermatologic agents|mesh-ancestor
19955135|NCT01630135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19955136|NCT01630811|Quinidine|quinidine|mesh-list
19955137|NCT01630811|Dextromethorphan|dextromethorphan|mesh-list
19955138|NCT01630811|Antitussive Agents|antitussive agents|mesh-ancestor
19955139|NCT01630811|Respiratory System Agents|respiratory system agents|mesh-ancestor
19955140|NCT01630811|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19955141|NCT01630811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19955142|NCT01630811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955143|NCT01630811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955144|NCT01630811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955145|NCT01630811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19955146|NCT01630811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19955147|NCT01630811|Adrenergic Agents|adrenergic agents|mesh-ancestor
19955148|NCT01630811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19955149|NCT01630811|Antimalarials|antimalarials|mesh-ancestor
19955150|NCT01630811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19955151|NCT01630811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19955152|NCT01630811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19955153|NCT01630811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955154|NCT01630811|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19955155|NCT01630811|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19955156|NCT01630811|Cholinergic Agents|cholinergic agents|mesh-ancestor
19955157|NCT01630811|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19955158|NCT01630811|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19955159|NCT01630811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19955160|NCT01630811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19955161|NCT01630811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19955162|NCT01631110|Vaccines|vaccines|mesh-list
19955163|NCT01631110|Immunologic Factors|immunologic factors|mesh-ancestor
19955164|NCT01631110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955165|NCT01631149|Rocuronium|rocuronium|mesh-list
19955166|NCT01631149|Atracurium|atracurium|mesh-list
19955167|NCT01631149|Mivacurium|mivacurium|mesh-list
19955168|NCT01631149|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19955169|NCT01631149|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19955170|NCT01631149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19955171|NCT01631149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955172|NCT01631149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955173|NCT01631149|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19955174|NCT01631149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19955175|NCT01631149|Cholinergic Agents|cholinergic agents|mesh-ancestor
19955176|NCT01631149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955177|NCT01631149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955178|NCT01631214|Alendronate|alendronate|mesh-list
20270247|NCT02670252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270248|NCT02670252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270249|NCT02670252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20270250|NCT02665143|Nintedanib|nintedanib|mesh-list
20270251|NCT02665143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270252|NCT02665143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19955179|NCT01631214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19955180|NCT01631214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19955181|NCT01631214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955182|NCT01631214|Immunologic Factors|immunologic factors|mesh-ancestor
19955183|NCT01631227|Eprosartan|eprosartan|mesh-list
19955184|NCT01631227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19955185|NCT01631227|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
19955186|NCT01631227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19955187|NCT01631227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955188|NCT01631630|Pioglitazone|pioglitazone|mesh-list
19955189|NCT01631630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19955190|NCT01631630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955191|NCT01631656|Azelaic acid|azelaic acid|mesh-list
20270253|NCT02665143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270254|NCT02665143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270255|NCT02663271|Bevacizumab|bevacizumab|mesh-list
20270256|NCT02663271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20270257|NCT02663271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19955192|NCT01631656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19955193|NCT01631656|Dermatologic Agents|dermatologic agents|mesh-ancestor
19955194|NCT01631682|Propranolol|propranolol|mesh-list
19955195|NCT01631682|Oxytocin|oxytocin|mesh-list
19955196|NCT01631682|Mifepristone|mifepristone|mesh-list
19955197|NCT01631682|Oxytocics|oxytocics|mesh-ancestor
19955198|NCT01631682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19955199|NCT01631682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955200|NCT01631682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19955201|NCT01631682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19955202|NCT01631682|Adrenergic Agents|adrenergic agents|mesh-ancestor
19955203|NCT01631682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955204|NCT01631682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955205|NCT01631682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19955206|NCT01631682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19955207|NCT01631682|Vasodilator Agents|vasodilator agents|mesh-ancestor
19955208|NCT01631682|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19955209|NCT01631682|Abortifacient Agents|abortifacient agents|mesh-ancestor
19955210|NCT01631682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19955211|NCT01631682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19955212|NCT01631682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19955213|NCT01631682|Contraceptive Agents|contraceptive agents|mesh-ancestor
19955214|NCT01631682|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19955215|NCT01631682|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19955216|NCT01631682|Hormone Antagonists|hormone antagonists|mesh-ancestor
19955217|NCT01631682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19955218|NCT01631682|Luteolytic Agents|luteolytic agents|mesh-ancestor
19955219|NCT01631682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19955220|NCT01631682|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19955221|NCT01631825|Rotigotine|rotigotine|mesh-list
19955222|NCT01631825|Dopamine Agonists|dopamine agonists|mesh-ancestor
19955223|NCT01631825|Dopamine Agents|dopamine agents|mesh-ancestor
19955224|NCT01631825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955225|NCT01631825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955226|NCT01631825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955227|NCT01631864|Amlodipine|amlodipine|mesh-list
19955228|NCT01631864|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19955229|NCT01631864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19955230|NCT01631864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19955231|NCT01631864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19955232|NCT01631864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955233|NCT01631864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19955234|NCT01631864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955235|NCT01631864|Vasodilator Agents|vasodilator agents|mesh-ancestor
19955236|NCT01631864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19955237|NCT01632150|Thalidomide|thalidomide|mesh-list
19955238|NCT01632150|Dexamethasone|dexamethasone|mesh-list
19955239|NCT01632150|Dexamethasone acetate|dexamethasone acetate|mesh-list
19955240|NCT01632150|Cyclophosphamide|cyclophosphamide|mesh-list
19955241|NCT01632150|Elotuzumab|elotuzumab|mesh-list
19955242|NCT01632150|BB 1101|bb 1101|mesh-list
19955243|NCT01632150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19955244|NCT01632150|Immunologic Factors|immunologic factors|mesh-ancestor
19955245|NCT01632150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955246|NCT01632150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20270258|NCT02663271|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20270259|NCT02663271|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20270260|NCT02663271|Growth Substances|growth substances|mesh-ancestor
20270261|NCT02663271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270262|NCT02663271|Growth Inhibitors|growth inhibitors|mesh-ancestor
20270263|NCT02605538|Vaccines|vaccines|mesh-list
20270264|NCT02605538|Immunologic Factors|immunologic factors|mesh-ancestor
20270265|NCT02605538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270266|NCT02598661|Imetelstat|imetelstat|mesh-list
20270267|NCT02598661|Motesanib diphosphate|motesanib diphosphate|mesh-list
20270268|NCT02598661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270269|NCT02598661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270270|NCT02598661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20270271|NCT02566304|Vidarabine|vidarabine|mesh-list
20270272|NCT02566304|Mycophenolic Acid|mycophenolic acid|mesh-list
19955247|NCT01632150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19955248|NCT01632150|Alkylating Agents|alkylating agents|mesh-ancestor
19955249|NCT01632150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955250|NCT01632150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19955251|NCT01632150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19955252|NCT01632150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20270273|NCT02566304|Cyclophosphamide|cyclophosphamide|mesh-list
20270274|NCT02566304|Fludarabine|fludarabine|mesh-list
20270275|NCT02566304|Fludarabine phosphate|fludarabine phosphate|mesh-list
20270276|NCT02566304|Tacrolimus|tacrolimus|mesh-list
20270277|NCT02566304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20270278|NCT02566304|Immunologic Factors|immunologic factors|mesh-ancestor
20270279|NCT02566304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270280|NCT02566304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20270281|NCT02566304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20270282|NCT02566304|Alkylating Agents|alkylating agents|mesh-ancestor
20270283|NCT02566304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270284|NCT02566304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270285|NCT02566304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20270286|NCT02566304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20270287|NCT02566304|Antimetabolites|antimetabolites|mesh-ancestor
20270288|NCT02566304|Antiviral Agents|antiviral agents|mesh-ancestor
20270289|NCT02566304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20270290|NCT02566304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20270291|NCT02566304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270292|NCT02566304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20270293|NCT02566304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20270294|NCT02566304|Antitubercular Agents|antitubercular agents|mesh-ancestor
20270295|NCT02566304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20270296|NCT02550470|Sevoflurane|sevoflurane|mesh-list
20270297|NCT02550470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20270298|NCT02550470|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20270299|NCT02550470|Anesthetics, General|anesthetics, general|mesh-ancestor
20270300|NCT02550470|Anesthetics|anesthetics|mesh-ancestor
20270301|NCT02550470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20270302|NCT02550470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270303|NCT02542696|Apomorphine|apomorphine|mesh-list
20543803|NCT01871701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20543804|NCT01871701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20543805|NCT01871701|Parasympatholytics|parasympatholytics|mesh-ancestor
20543806|NCT01871701|Autonomic Agents|autonomic agents|mesh-ancestor
20543807|NCT01871701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543808|NCT01871701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20543809|NCT01871701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20543810|NCT01871701|Cholinergic Agents|cholinergic agents|mesh-ancestor
20543811|NCT01871701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20543812|NCT01871701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20543813|NCT01871701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20543814|NCT01871740|Folic Acid|folic acid|mesh-list
20543815|NCT01871740|Enalapril|enalapril|mesh-list
20543816|NCT01871740|Enalaprilat|enalaprilat|mesh-list
20543817|NCT01871740|Maleic acid|maleic acid|mesh-list
20543818|NCT01871740|Hematinics|hematinics|mesh-ancestor
20543819|NCT01871740|Vitamin B Complex|vitamin b complex|mesh-ancestor
20543820|NCT01871740|Vitamins|vitamins|mesh-ancestor
20543821|NCT01871740|Micronutrients|micronutrients|mesh-ancestor
19955253|NCT01632150|Antiemetics|antiemetics|mesh-ancestor
19955254|NCT01632150|Autonomic Agents|autonomic agents|mesh-ancestor
19955255|NCT01632150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955256|NCT01632150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19955257|NCT01632150|Glucocorticoids|glucocorticoids|mesh-ancestor
19955258|NCT01632150|Hormones|hormones|mesh-ancestor
19955259|NCT01632150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19955260|NCT01632150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19955261|NCT01632150|Protease Inhibitors|protease inhibitors|mesh-ancestor
19955262|NCT01632150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955263|NCT01632150|Leprostatic Agents|leprostatic agents|mesh-ancestor
19955264|NCT01632150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19955265|NCT01632150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19955266|NCT01632150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19955267|NCT01632150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19955268|NCT01632150|Growth Substances|growth substances|mesh-ancestor
20270304|NCT02542696|Emetics|emetics|mesh-ancestor
20543822|NCT01871740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955269|NCT01632150|Growth Inhibitors|growth inhibitors|mesh-ancestor
19955270|NCT01632215|Gabapentin|gabapentin|mesh-list
20270305|NCT02542696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270306|NCT02542696|Autonomic Agents|autonomic agents|mesh-ancestor
20270307|NCT02542696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20270308|NCT02542696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20270309|NCT02542696|Dopamine Agonists|dopamine agonists|mesh-ancestor
20270310|NCT02542696|Dopamine Agents|dopamine agents|mesh-ancestor
20270311|NCT02542696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20270312|NCT02542696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270313|NCT02523469|Nivolumab|nivolumab|mesh-list
20270314|NCT02523469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20270315|NCT02523469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270316|NCT02523469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20270317|NCT02523469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270318|NCT02503839|Etoricoxib|etoricoxib|mesh-list
20270319|NCT02503839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20270320|NCT02503839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20270321|NCT02503839|Analgesics|analgesics|mesh-ancestor
20270322|NCT02503839|Sensory System Agents|sensory system agents|mesh-ancestor
20270323|NCT02503839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20270324|NCT02503839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270325|NCT02503839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20270326|NCT02503839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20270327|NCT02503839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20270328|NCT02503839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20270329|NCT02503839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270330|NCT02503839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270331|NCT02467946|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20270332|NCT02467946|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20270333|NCT02467946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20270334|NCT02467946|Alkylating Agents|alkylating agents|mesh-ancestor
20270335|NCT02467946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270336|NCT02467946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270337|NCT02467946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20270338|NCT02384850|Leucovorin|leucovorin|mesh-list
20270339|NCT02384850|Folic Acid|folic acid|mesh-list
20270340|NCT02384850|Fluorouracil|fluorouracil|mesh-list
20270341|NCT02384850|Oxaliplatin|oxaliplatin|mesh-list
20270342|NCT02384850|Levoleucovorin|levoleucovorin|mesh-list
20270343|NCT02384850|Antimetabolites|antimetabolites|mesh-ancestor
20270344|NCT02384850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270345|NCT02384850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20270346|NCT02384850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19955271|NCT01632215|Anticonvulsants|anticonvulsants|mesh-list
19955272|NCT01632215|Analgesics|analgesics|mesh-ancestor
19955273|NCT01632215|Sensory System Agents|sensory system agents|mesh-ancestor
19955274|NCT01632215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955275|NCT01632215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955276|NCT01632215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19955277|NCT01632215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19955278|NCT01632215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19955279|NCT01632215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19955280|NCT01632215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19955281|NCT01632215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19955282|NCT01632215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955283|NCT01632215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955284|NCT01632215|Antimanic Agents|antimanic agents|mesh-ancestor
20270347|NCT02384850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20270348|NCT02384850|Immunologic Factors|immunologic factors|mesh-ancestor
20270349|NCT02384850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270350|NCT02384850|Antidotes|antidotes|mesh-ancestor
20270351|NCT02384850|Protective Agents|protective agents|mesh-ancestor
20270352|NCT02384850|Vitamin B Complex|vitamin b complex|mesh-ancestor
19955285|NCT01632241|Belimumab|belimumab|mesh-list
19955286|NCT01632241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19955287|NCT01632241|Immunologic Factors|immunologic factors|mesh-ancestor
19955288|NCT01632241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955289|NCT01632306|Leucovorin|leucovorin|mesh-list
19955290|NCT01632306|Gemcitabine|gemcitabine|mesh-list
19955291|NCT01632306|Paclitaxel|paclitaxel|mesh-list
19955292|NCT01632306|Fluorouracil|fluorouracil|mesh-list
19955293|NCT01632306|Oxaliplatin|oxaliplatin|mesh-list
19955294|NCT01632306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19955295|NCT01632306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270353|NCT02384850|Vitamins|vitamins|mesh-ancestor
20270354|NCT02384850|Micronutrients|micronutrients|mesh-ancestor
19955296|NCT01632306|Tubulin Modulators|tubulin modulators|mesh-ancestor
19955297|NCT01632306|Antimitotic Agents|antimitotic agents|mesh-ancestor
19955298|NCT01632306|Mitosis Modulators|mitosis modulators|mesh-ancestor
19955299|NCT01632306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955300|NCT01632306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19955301|NCT01632306|Antimetabolites|antimetabolites|mesh-ancestor
19955302|NCT01632306|Antiviral Agents|antiviral agents|mesh-ancestor
19955303|NCT01632306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19955304|NCT01632306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955305|NCT01632306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19955306|NCT01632306|Immunologic Factors|immunologic factors|mesh-ancestor
19955307|NCT01632306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955308|NCT01632306|Antidotes|antidotes|mesh-ancestor
19955309|NCT01632306|Protective Agents|protective agents|mesh-ancestor
19955310|NCT01632306|Vitamin B Complex|vitamin b complex|mesh-ancestor
19955311|NCT01632306|Vitamins|vitamins|mesh-ancestor
20270355|NCT02384850|Hematinics|hematinics|mesh-ancestor
20270356|NCT02352090|Dienogest|dienogest|mesh-list
20270357|NCT02352090|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20270358|NCT02352090|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20270359|NCT02352090|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20270360|NCT02352090|Estradiol|estradiol|mesh-list
20270361|NCT02352090|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20270362|NCT02352090|Nandrolone|nandrolone|mesh-list
20270363|NCT02352090|Estrogens|estrogens|mesh-ancestor
20270364|NCT02352090|Hormones|hormones|mesh-ancestor
20270365|NCT02352090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19955312|NCT01632306|Micronutrients|micronutrients|mesh-ancestor
19955313|NCT01632345|Efavirenz|efavirenz|mesh-list
19955314|NCT01632345|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19955315|NCT01632345|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19955316|NCT01632345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19955317|NCT01632345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955318|NCT01632345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955319|NCT01632345|Antiviral Agents|antiviral agents|mesh-ancestor
19955320|NCT01632345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19955321|NCT01632345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19955322|NCT01632345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19955323|NCT01632345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19955324|NCT01632345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19955325|NCT01632345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19955326|NCT01632345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19955327|NCT01632345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19955328|NCT01632345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19955329|NCT01632423|Bimatoprost|bimatoprost|mesh-list
19955330|NCT01632423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19955331|NCT01632566|Celecoxib|celecoxib|mesh-list
19955332|NCT01632566|Simvastatin|simvastatin|mesh-list
19955333|NCT01632566|LY3031207|ly3031207|mesh-list
19955334|NCT01632566|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19955335|NCT01632566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19955336|NCT01632566|Antimetabolites|antimetabolites|mesh-ancestor
20270366|NCT02352090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270367|NCT02352090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20270368|NCT02352090|Contraceptive Agents|contraceptive agents|mesh-ancestor
20270369|NCT02352090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20270370|NCT02352090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20270371|NCT02352090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20270372|NCT02352090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19955337|NCT01632566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955338|NCT01632566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19955339|NCT01632566|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19955340|NCT01632566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955341|NCT01632566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19955342|NCT01632566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19955343|NCT01632566|Analgesics|analgesics|mesh-ancestor
19955344|NCT01632566|Sensory System Agents|sensory system agents|mesh-ancestor
19955345|NCT01632566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955346|NCT01632566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955347|NCT01632566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19955348|NCT01632566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19955349|NCT01632566|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19955350|NCT01632566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19955351|NCT01632566|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
20270373|NCT02352090|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20270374|NCT02352090|Hormone Antagonists|hormone antagonists|mesh-ancestor
20270375|NCT02352090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20270376|NCT02352090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270377|NCT02352090|Androgens|androgens|mesh-ancestor
20270378|NCT02352090|Anabolic Agents|anabolic agents|mesh-ancestor
20270379|NCT02298257|Doxorubicin|doxorubicin|mesh-list
20270380|NCT02298257|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20270381|NCT02298257|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20270382|NCT02298257|Dacarbazine|dacarbazine|mesh-list
20270383|NCT02298257|Vinblastine|vinblastine|mesh-list
20270384|NCT02298257|Antibodies|antibodies|mesh-list
20270385|NCT02298257|Immunoglobulins|immunoglobulins|mesh-list
20270386|NCT02298257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20270387|NCT02298257|Immunoconjugates|immunoconjugates|mesh-list
20270388|NCT02298257|Immunologic Factors|immunologic factors|mesh-ancestor
20270389|NCT02298257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270390|NCT02298257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20270391|NCT02298257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270392|NCT02298257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19955352|NCT01632566|Hormone Antagonists|hormone antagonists|mesh-ancestor
19955353|NCT01632566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19955354|NCT01632579|Celecoxib|celecoxib|mesh-list
19955355|NCT01632579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19955356|NCT01632579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19955357|NCT01632579|Analgesics|analgesics|mesh-ancestor
19955358|NCT01632579|Sensory System Agents|sensory system agents|mesh-ancestor
19955359|NCT01632579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955360|NCT01632579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955361|NCT01632579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19955362|NCT01632579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19955363|NCT01632579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19955364|NCT01632579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19955365|NCT01632579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955366|NCT01632579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955367|NCT01632709|Bupivacaine|bupivacaine|mesh-list
19955368|NCT01632709|Anesthetics, Local|anesthetics, local|mesh-ancestor
19955369|NCT01632709|Anesthetics|anesthetics|mesh-ancestor
19955370|NCT01632709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19955371|NCT01632709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270393|NCT02298257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20270394|NCT02298257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270395|NCT02298257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270396|NCT02298257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20270397|NCT02298257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20270398|NCT02298257|Alkylating Agents|alkylating agents|mesh-ancestor
20270399|NCT02298257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20270400|NCT02298257|Tubulin Modulators|tubulin modulators|mesh-ancestor
20270401|NCT02298257|Antimitotic Agents|antimitotic agents|mesh-ancestor
20270402|NCT02298257|Mitosis Modulators|mitosis modulators|mesh-ancestor
20270403|NCT02274779|Leuprolide|leuprolide|mesh-list
20270404|NCT02274779|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20270405|NCT02274779|Fertility Agents|fertility agents|mesh-ancestor
20270406|NCT02274779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20270407|NCT02274779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270408|NCT02274779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20270409|NCT02274779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270410|NCT02143830|Cyclophosphamide|cyclophosphamide|mesh-list
20270411|NCT02143830|Busulfan|busulfan|mesh-list
20270412|NCT02143830|Fludarabine|fludarabine|mesh-list
20270413|NCT02143830|Thymoglobulin|thymoglobulin|mesh-list
20270414|NCT02143830|Sargramostim|sargramostim|mesh-list
20270415|NCT02143830|Lenograstim|lenograstim|mesh-list
20270416|NCT02143830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20270417|NCT02143830|Immunologic Factors|immunologic factors|mesh-ancestor
20270418|NCT02143830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270419|NCT02143830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20270420|NCT02143830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20270421|NCT02143830|Alkylating Agents|alkylating agents|mesh-ancestor
20270422|NCT02143830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270423|NCT02143830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270424|NCT02143830|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20270425|NCT02143830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20270426|NCT02042287|Metronidazole|metronidazole|mesh-list
20270427|NCT02042287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20270428|NCT02042287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20270429|NCT02042287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20270430|NCT02042287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20270431|NCT01964560|Lacosamide|lacosamide|mesh-list
20270432|NCT01964560|Anticonvulsants|anticonvulsants|mesh-ancestor
20270433|NCT01964560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20270434|NCT01964560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20270435|NCT01964560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20270436|NCT01964560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270437|NCT01840566|Cytarabine|cytarabine|mesh-list
20270438|NCT01840566|Etoposide|etoposide|mesh-list
20270439|NCT01840566|Melphalan|melphalan|mesh-list
20270440|NCT01840566|Carmustine|carmustine|mesh-list
20270441|NCT01840566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20270442|NCT01840566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270443|NCT01840566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20270444|NCT01840566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20270445|NCT01840566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270446|NCT01840566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270447|NCT01840566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20270448|NCT01840566|Antimetabolites|antimetabolites|mesh-ancestor
20270449|NCT01840566|Antiviral Agents|antiviral agents|mesh-ancestor
20270450|NCT01840566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20270451|NCT01840566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19955372|NCT01632709|Sensory System Agents|sensory system agents|mesh-ancestor
19955373|NCT01632709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955374|NCT01632891|Ritonavir|ritonavir|mesh-list
19955375|NCT01632891|Lopinavir|lopinavir|mesh-list
19955376|NCT01632891|Tenofovir|tenofovir|mesh-list
19955377|NCT01632891|Emtricitabine|emtricitabine|mesh-list
19955378|NCT01632891|Nevirapine|nevirapine|mesh-list
20270452|NCT01840566|Immunologic Factors|immunologic factors|mesh-ancestor
20270453|NCT01840566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270454|NCT01840566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20270455|NCT01840566|Alkylating Agents|alkylating agents|mesh-ancestor
20270456|NCT01840566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20270457|NCT01824537|Vaccines|vaccines|mesh-list
20270458|NCT01824537|Immunologic Factors|immunologic factors|mesh-ancestor
20270459|NCT01824537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955379|NCT01632891|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19955380|NCT01632891|Efavirenz|efavirenz|mesh-list
19955381|NCT01632891|Trimethoprim|trimethoprim|mesh-list
19955382|NCT01632891|Sulfamethoxazole|sulfamethoxazole|mesh-list
19955383|NCT01632891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19955384|NCT01632891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19955385|NCT01632891|Protease Inhibitors|protease inhibitors|mesh-ancestor
19955386|NCT01632891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955387|NCT01632891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955388|NCT01632891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19955389|NCT01632891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19955390|NCT01632891|Antiviral Agents|antiviral agents|mesh-ancestor
19955391|NCT01632891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19955392|NCT01632891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19955393|NCT01632891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19955394|NCT01632891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19955395|NCT01632891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19955396|NCT01632891|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19955397|NCT01632891|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19955398|NCT01632891|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19955399|NCT01632891|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20270460|NCT01730937|Sorafenib|sorafenib|mesh-list
20270461|NCT01730937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270462|NCT01730937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20270463|NCT01730937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270464|NCT01730937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270465|NCT01655225|Pemetrexed|pemetrexed|mesh-list
20270466|NCT01655225|Letrozole|letrozole|mesh-list
20270467|NCT01655225|Fulvestrant|fulvestrant|mesh-list
20270468|NCT01655225|Midazolam|midazolam|mesh-list
20270469|NCT01655225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270470|NCT01655225|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20270471|NCT01655225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19955400|NCT01632891|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20270472|NCT01655225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20270473|NCT01655225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270474|NCT01655225|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20270475|NCT01655225|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20270476|NCT01655225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20270477|NCT01655225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20270478|NCT01655225|Anesthetics, General|anesthetics, general|mesh-ancestor
20270479|NCT01655225|Anesthetics|anesthetics|mesh-ancestor
20270480|NCT01655225|GABA Modulators|gaba modulators|mesh-ancestor
20270481|NCT01655225|GABA Agents|gaba agents|mesh-ancestor
20270482|NCT01655225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955401|NCT01632891|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19955402|NCT01632891|Renal Agents|renal agents|mesh-ancestor
19955403|NCT01632891|Antimalarials|antimalarials|mesh-ancestor
19955404|NCT01632891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19955405|NCT01632891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19955406|NCT01632891|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19955407|NCT01632891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19955408|NCT01632891|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19955409|NCT01632904|Hydroxyurea|hydroxyurea|mesh-list
19955410|NCT01632904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19955411|NCT01632904|Antisickling Agents|antisickling agents|mesh-ancestor
19955412|NCT01632904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955413|NCT01632904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955414|NCT01632904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19955415|NCT01632995|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19955416|NCT01632995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20270483|NCT01655225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270484|NCT01655225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270485|NCT01655225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20270486|NCT01655225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20543823|NCT01871740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543824|NCT01871740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543825|NCT01871740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20543826|NCT01871740|Protease Inhibitors|protease inhibitors|mesh-ancestor
20543827|NCT01871740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20543828|NCT01871753|Anti-Infective Agents|anti-infective agents|mesh-list
19955417|NCT01632995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20270487|NCT01655225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19955418|NCT01632995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955419|NCT01632995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955420|NCT01632995|Antiviral Agents|antiviral agents|mesh-ancestor
19955421|NCT01632995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19955422|NCT01632995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20270488|NCT01655225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20270489|NCT01655225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20270490|NCT01655225|Hormone Antagonists|hormone antagonists|mesh-ancestor
20270491|NCT01655225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20270492|NCT01655225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20270493|NCT01655225|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20270494|NCT01614171|Hormones|hormones|mesh-list
20270495|NCT01614171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20543829|NCT01871766|Dactinomycin|dactinomycin|mesh-list
20543830|NCT01871766|Cyclophosphamide|cyclophosphamide|mesh-list
19955423|NCT01632995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19955424|NCT01633060|Fulvestrant|fulvestrant|mesh-list
19955425|NCT01633060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19955426|NCT01633060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543831|NCT01871766|Ifosfamide|ifosfamide|mesh-list
20543832|NCT01871766|Bevacizumab|bevacizumab|mesh-list
19733077|NCT04565301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733078|NCT04565301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733079|NCT04565301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19733080|NCT04565301|Glucocorticoids|glucocorticoids|mesh-ancestor
19733081|NCT04565301|Hormones|hormones|mesh-ancestor
19733082|NCT04565301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19733083|NCT04565301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19733084|NCT04565301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733085|NCT04565301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19733086|NCT04565301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733087|NCT04565301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733088|NCT04565301|Cholinergic Agents|cholinergic agents|mesh-ancestor
19733089|NCT04565301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19733090|NCT04565301|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19733091|NCT04565431|Natalizumab|natalizumab|mesh-list
19733092|NCT04565431|Immunologic Factors|immunologic factors|mesh-ancestor
19733093|NCT04565431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733094|NCT04565184|Artesunate|artesunate|mesh-list
19733095|NCT04565184|Lumefantrine|lumefantrine|mesh-list
19733096|NCT04565184|Artemether|artemether|mesh-list
19733097|NCT04565184|Amodiaquine|amodiaquine|mesh-list
19955427|NCT01633060|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19955428|NCT01633060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19955429|NCT01633060|Hormone Antagonists|hormone antagonists|mesh-ancestor
19955430|NCT01633060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20270496|NCT01614171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270497|NCT01582776|Lenalidomide|lenalidomide|mesh-list
20270498|NCT01582776|Obinutuzumab|obinutuzumab|mesh-list
20270499|NCT01582776|Immunologic Factors|immunologic factors|mesh-ancestor
20270500|NCT01582776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270501|NCT01582776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20270502|NCT01582776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20270503|NCT01582776|Growth Substances|growth substances|mesh-ancestor
20270504|NCT01582776|Growth Inhibitors|growth inhibitors|mesh-ancestor
20270505|NCT01582776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270506|NCT01582776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20270507|NCT01430390|Cyclophosphamide|cyclophosphamide|mesh-list
20270508|NCT01430390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20270509|NCT01430390|Immunologic Factors|immunologic factors|mesh-ancestor
20270510|NCT01430390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270511|NCT01430390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20270512|NCT01430390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20270513|NCT01430390|Alkylating Agents|alkylating agents|mesh-ancestor
20270514|NCT01430390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270515|NCT01430390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270516|NCT01430390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20270517|NCT01356290|Cytarabine|cytarabine|mesh-list
20270518|NCT01356290|Thalidomide|thalidomide|mesh-list
20270519|NCT01356290|Celecoxib|celecoxib|mesh-list
20270520|NCT01356290|Cyclophosphamide|cyclophosphamide|mesh-list
20270521|NCT01356290|Bevacizumab|bevacizumab|mesh-list
20270522|NCT01356290|Etoposide|etoposide|mesh-list
20270523|NCT01356290|Etoposide phosphate|etoposide phosphate|mesh-list
20270524|NCT01356290|Fenofibric acid|fenofibric acid|mesh-list
20270525|NCT01356290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20270526|NCT01356290|Immunologic Factors|immunologic factors|mesh-ancestor
20270527|NCT01356290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270528|NCT01356290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20270529|NCT01356290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20270530|NCT01356290|Alkylating Agents|alkylating agents|mesh-ancestor
20270531|NCT01356290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270532|NCT01356290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270533|NCT01356290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20270534|NCT01356290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20270535|NCT01356290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20270536|NCT01356290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20270537|NCT01356290|Growth Substances|growth substances|mesh-ancestor
20270538|NCT01356290|Growth Inhibitors|growth inhibitors|mesh-ancestor
20270539|NCT01356290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20270540|NCT01356290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20270541|NCT01356290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20270542|NCT01356290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270543|NCT01356290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20270544|NCT01356290|Antimetabolites|antimetabolites|mesh-ancestor
20270545|NCT01356290|Antiviral Agents|antiviral agents|mesh-ancestor
19955431|NCT01633060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955432|NCT01633112|Glatiramer Acetate|glatiramer acetate|mesh-list
19955433|NCT01633112|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19955434|NCT01633112|(T,G)-A-L|(t,g)-a-l|mesh-list
19955435|NCT01633112|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19955436|NCT01633112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955437|NCT01633112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20270546|NCT01356290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20270547|NCT01356290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19955438|NCT01633112|Immunologic Factors|immunologic factors|mesh-ancestor
20270548|NCT01356290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19733098|NCT04565184|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20270549|NCT01356290|Analgesics|analgesics|mesh-ancestor
19955439|NCT01633112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955440|NCT01633112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19955441|NCT01633112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19955442|NCT01633827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19955443|NCT01633827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19955444|NCT01633827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955445|NCT01633853|Vitamin D|vitamin d|mesh-list
19955446|NCT01633853|Ergocalciferols|ergocalciferols|mesh-list
19955447|NCT01633853|Calcitriol|calcitriol|mesh-list
19955448|NCT01633853|Vitamins|vitamins|mesh-list
19955449|NCT01633853|Micronutrients|micronutrients|mesh-ancestor
19955450|NCT01633853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955451|NCT01633853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19955452|NCT01633853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19955453|NCT01633853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19955454|NCT01633853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19955455|NCT01633853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955456|NCT01633853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19955457|NCT01633944|Buprenorphine|buprenorphine|mesh-list
19955458|NCT01633944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19955459|NCT01633944|Narcotics|narcotics|mesh-ancestor
19955460|NCT01633944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19955461|NCT01633944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955462|NCT01633944|Analgesics|analgesics|mesh-ancestor
19955463|NCT01633944|Sensory System Agents|sensory system agents|mesh-ancestor
19955464|NCT01633944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955465|NCT01633944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19955466|NCT01634100|Empagliflozin|empagliflozin|mesh-list
19955467|NCT01634100|Rifampin|rifampin|mesh-list
19955468|NCT01634100|Probenecid|probenecid|mesh-list
19955469|NCT01634100|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19955470|NCT01634100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955471|NCT01634100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19955472|NCT01634100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955473|NCT01634100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19955474|NCT01634100|Antitubercular Agents|antitubercular agents|mesh-ancestor
19955475|NCT01634100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19955476|NCT01634100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19955477|NCT01634100|Leprostatic Agents|leprostatic agents|mesh-ancestor
19955478|NCT01634100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19955479|NCT01634100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955480|NCT01634100|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19955481|NCT01634100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20270550|NCT01356290|Sensory System Agents|sensory system agents|mesh-ancestor
20270551|NCT01356290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20270552|NCT01356290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20270553|NCT01356290|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20270554|NCT01356290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20270555|NCT01356290|Leprostatic Agents|leprostatic agents|mesh-ancestor
20270556|NCT01356290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20270557|NCT01356290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20270558|NCT01356290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20543833|NCT01871766|Doxorubicin|doxorubicin|mesh-list
20543834|NCT01871766|Irinotecan|irinotecan|mesh-list
20543835|NCT01871766|Etoposide|etoposide|mesh-list
20543836|NCT01871766|Etoposide phosphate|etoposide phosphate|mesh-list
20543837|NCT01871766|Vincristine|vincristine|mesh-list
20543838|NCT01871766|Sorafenib|sorafenib|mesh-list
20543839|NCT01871766|Dexrazoxane|dexrazoxane|mesh-list
20543840|NCT01871766|Razoxane|razoxane|mesh-list
20543841|NCT01871766|Mitogens|mitogens|mesh-list
20543842|NCT01871766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20543843|NCT01871766|Immunologic Factors|immunologic factors|mesh-ancestor
20543844|NCT01871766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543845|NCT01871766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20543846|NCT01871766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20543847|NCT01871766|Alkylating Agents|alkylating agents|mesh-ancestor
20543848|NCT01871766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543849|NCT01871766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543850|NCT01871766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20543851|NCT01871766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20543852|NCT01871766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20543853|NCT01871766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19955482|NCT01634100|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20543854|NCT01871766|Growth Substances|growth substances|mesh-ancestor
20543855|NCT01871766|Growth Inhibitors|growth inhibitors|mesh-ancestor
20270559|NCT01356290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20270560|NCT01342952|Ambrisentan|ambrisentan|mesh-list
19955483|NCT01634100|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19955484|NCT01634100|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19955485|NCT01634100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19955486|NCT01634100|Uricosuric Agents|uricosuric agents|mesh-ancestor
19955487|NCT01634100|Gout Suppressants|gout suppressants|mesh-ancestor
19955488|NCT01634100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19955489|NCT01634100|Renal Agents|renal agents|mesh-ancestor
19955490|NCT01634113|Bromides|bromides|mesh-list
20270561|NCT01342952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20270562|NCT01220583|Cisplatin|cisplatin|mesh-list
20270563|NCT01220583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270564|NCT01148849|Margetuximab|margetuximab|mesh-list
20270565|NCT01148849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270566|NCT01145209|Cyclophosphamide|cyclophosphamide|mesh-list
19955491|NCT01634113|Tiotropium Bromide|tiotropium bromide|mesh-list
19955492|NCT01634113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19955493|NCT01634113|Autonomic Agents|autonomic agents|mesh-ancestor
19955494|NCT01634113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955495|NCT01634113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955496|NCT01634113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19955497|NCT01634113|Respiratory System Agents|respiratory system agents|mesh-ancestor
19955498|NCT01634113|Parasympatholytics|parasympatholytics|mesh-ancestor
19955499|NCT01634113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19955500|NCT01634113|Cholinergic Agents|cholinergic agents|mesh-ancestor
19955501|NCT01634113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955502|NCT01634113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955503|NCT01634113|Anticonvulsants|anticonvulsants|mesh-ancestor
19955504|NCT01634139|Tiotropium Bromide|tiotropium bromide|mesh-list
19955505|NCT01634139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19955506|NCT01634139|Autonomic Agents|autonomic agents|mesh-ancestor
19955507|NCT01634139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955508|NCT01634139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955509|NCT01634139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19955510|NCT01634139|Respiratory System Agents|respiratory system agents|mesh-ancestor
19955511|NCT01634139|Parasympatholytics|parasympatholytics|mesh-ancestor
19955512|NCT01634139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19955513|NCT01634139|Cholinergic Agents|cholinergic agents|mesh-ancestor
19955514|NCT01634139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955515|NCT01634139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955516|NCT01634152|Tiotropium Bromide|tiotropium bromide|mesh-list
19955517|NCT01634152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19955518|NCT01634152|Autonomic Agents|autonomic agents|mesh-ancestor
20270567|NCT01145209|Fludarabine|fludarabine|mesh-list
20270568|NCT01145209|Fludarabine phosphate|fludarabine phosphate|mesh-list
20270569|NCT01145209|Ofatumumab|ofatumumab|mesh-list
20270570|NCT01145209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20270571|NCT01145209|Immunologic Factors|immunologic factors|mesh-ancestor
20270572|NCT01145209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270573|NCT01145209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20270574|NCT01145209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20270575|NCT01145209|Alkylating Agents|alkylating agents|mesh-ancestor
20270576|NCT01145209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270577|NCT01145209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270578|NCT01145209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20270579|NCT01145209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20270580|NCT01145209|Antimetabolites|antimetabolites|mesh-ancestor
20270581|NCT01078662|Olaparib|olaparib|mesh-list
20270582|NCT01078662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20270583|NCT01078662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270584|NCT01078662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270585|NCT01078662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270586|NCT00971867|Paclitaxel|paclitaxel|mesh-list
20270587|NCT00971867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20270588|NCT00971867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270589|NCT00971867|Tubulin Modulators|tubulin modulators|mesh-ancestor
20270590|NCT00971867|Antimitotic Agents|antimitotic agents|mesh-ancestor
20270591|NCT00971867|Mitosis Modulators|mitosis modulators|mesh-ancestor
20270592|NCT00971867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270593|NCT00532025|Sorafenib|sorafenib|mesh-list
20270594|NCT00532025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270595|NCT00532025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20270596|NCT00532025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270597|NCT00532025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270598|NCT00532090|R04929097|r04929097|mesh-list
20270599|NCT00532090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270600|NCT00532090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270601|NCT00532116|Selegiline|selegiline|mesh-list
20270602|NCT00532116|Antidepressive Agents|antidepressive agents|mesh-ancestor
20270603|NCT00532116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20270604|NCT00532116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20270605|NCT00532116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20270606|NCT00532116|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20270607|NCT00532116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270608|NCT00532116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270609|NCT00532116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20270610|NCT00532116|Protective Agents|protective agents|mesh-ancestor
20270611|NCT00532116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270612|NCT00532142|Triamcinolone|triamcinolone|mesh-list
20270613|NCT00532142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20270614|NCT00532142|Glucocorticoids|glucocorticoids|mesh-ancestor
20270615|NCT00532142|Hormones|hormones|mesh-ancestor
20270616|NCT00532142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20270617|NCT00532142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270618|NCT00532168|Ritonavir|ritonavir|mesh-list
20270619|NCT00532168|Lopinavir|lopinavir|mesh-list
20270620|NCT00532168|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20270621|NCT00532168|Tenofovir|tenofovir|mesh-list
20270622|NCT00532168|Emtricitabine|emtricitabine|mesh-list
20270623|NCT00532168|Efavirenz|efavirenz|mesh-list
20270624|NCT00532168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20270625|NCT00532168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20270626|NCT00532168|Protease Inhibitors|protease inhibitors|mesh-ancestor
20270627|NCT00532168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270628|NCT00532168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270629|NCT00532168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20270630|NCT00532168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20270631|NCT00532168|Antiviral Agents|antiviral agents|mesh-ancestor
20270632|NCT00532168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20270633|NCT00532168|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20270634|NCT00532168|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20270635|NCT00532168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20270636|NCT00532168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20270637|NCT00532168|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20270638|NCT00532168|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20270639|NCT00532168|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20270640|NCT00532168|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20270641|NCT00532168|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20270642|NCT00532194|Cediranib|cediranib|mesh-list
20270643|NCT00532194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543856|NCT01871766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20543857|NCT01871766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20543858|NCT01871766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20543859|NCT01871766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543860|NCT01871766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20543861|NCT01871766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20543862|NCT01871766|Tubulin Modulators|tubulin modulators|mesh-ancestor
20543863|NCT01871766|Antimitotic Agents|antimitotic agents|mesh-ancestor
20543864|NCT01871766|Mitosis Modulators|mitosis modulators|mesh-ancestor
20543865|NCT01871766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20543866|NCT01871766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20543867|NCT01871766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20543868|NCT01871766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20543869|NCT01871766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20543870|NCT01871766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20543871|NCT01871766|Protective Agents|protective agents|mesh-ancestor
20543872|NCT01871792|Pitavastatin|pitavastatin|mesh-list
20543873|NCT01871792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20543874|NCT01871792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20543875|NCT01871792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20543876|NCT01871792|Antimetabolites|antimetabolites|mesh-ancestor
20543877|NCT01871792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543878|NCT01871792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543879|NCT01871792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20543880|NCT01871844|Octreotide|octreotide|mesh-list
19955519|NCT01634152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20270644|NCT00532194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20270645|NCT00532194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543881|NCT01871844|Somatostatin|somatostatin|mesh-list
20270646|NCT00532194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270647|NCT00532207|Teriparatide|teriparatide|mesh-list
20270648|NCT00532207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20270649|NCT00532207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270650|NCT00532207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20270651|NCT00532220|Ibandronic Acid|ibandronic acid|mesh-list
19955520|NCT01634152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955521|NCT01634152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19955522|NCT01634152|Respiratory System Agents|respiratory system agents|mesh-ancestor
19955523|NCT01634152|Parasympatholytics|parasympatholytics|mesh-ancestor
19955524|NCT01634152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19955525|NCT01634152|Cholinergic Agents|cholinergic agents|mesh-ancestor
19955526|NCT01634152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955527|NCT01634152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955528|NCT01634165|Insulin Glargine|insulin glargine|mesh-list
19955529|NCT01634165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19955530|NCT01634165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955531|NCT01634178|Apremilast|apremilast|mesh-list
19955532|NCT01634178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19955533|NCT01634178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19955534|NCT01634178|Analgesics|analgesics|mesh-ancestor
19955535|NCT01634178|Sensory System Agents|sensory system agents|mesh-ancestor
19955536|NCT01634178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955537|NCT01634178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955538|NCT01634178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19955539|NCT01634178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19955540|NCT01634178|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19955541|NCT01634178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19955542|NCT01634178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955543|NCT01634178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955544|NCT01634191|Apremilast|apremilast|mesh-list
19955545|NCT01634191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19955546|NCT01634191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19955547|NCT01634191|Analgesics|analgesics|mesh-ancestor
19955548|NCT01634191|Sensory System Agents|sensory system agents|mesh-ancestor
19955549|NCT01634191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955550|NCT01634191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955551|NCT01634191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19955552|NCT01634191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19955553|NCT01634191|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19955554|NCT01634191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19955555|NCT01634191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955556|NCT01634191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955557|NCT01634243|Rotigotine|rotigotine|mesh-list
19955558|NCT01634243|Dopamine Agonists|dopamine agonists|mesh-ancestor
19955559|NCT01634243|Dopamine Agents|dopamine agents|mesh-ancestor
19955560|NCT01634243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955561|NCT01634243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955562|NCT01634243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955563|NCT01634555|Leucovorin|leucovorin|mesh-list
19955564|NCT01634555|Folic Acid|folic acid|mesh-list
19955565|NCT01634555|Fluorouracil|fluorouracil|mesh-list
19955566|NCT01634555|Irinotecan|irinotecan|mesh-list
19955567|NCT01634555|Ramucirumab|ramucirumab|mesh-list
19955568|NCT01634555|Levoleucovorin|levoleucovorin|mesh-list
19955569|NCT01634555|Antimetabolites|antimetabolites|mesh-ancestor
19955570|NCT01634555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955571|NCT01634555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19955572|NCT01634555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19955573|NCT01634555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19955574|NCT01634555|Immunologic Factors|immunologic factors|mesh-ancestor
19955575|NCT01634555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955576|NCT01634555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19955577|NCT01634555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19955578|NCT01634555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955579|NCT01634555|Antidotes|antidotes|mesh-ancestor
19955580|NCT01634555|Protective Agents|protective agents|mesh-ancestor
19955581|NCT01634555|Vitamin B Complex|vitamin b complex|mesh-ancestor
19955582|NCT01634555|Vitamins|vitamins|mesh-ancestor
19955583|NCT01634555|Micronutrients|micronutrients|mesh-ancestor
19955584|NCT01634555|Hematinics|hematinics|mesh-ancestor
19955585|NCT01634854|Misoprostol|misoprostol|mesh-list
19955586|NCT01634854|Oxytocin|oxytocin|mesh-list
19955587|NCT01634854|Oxytocics|oxytocics|mesh-ancestor
19955588|NCT01634854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19955589|NCT01634854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955590|NCT01634854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19955591|NCT01634854|Abortifacient Agents|abortifacient agents|mesh-ancestor
19955592|NCT01634854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20270652|NCT00532220|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20270653|NCT00532220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270654|NCT00532246|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20270655|NCT00532246|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20270656|NCT00532246|Hormone Antagonists|hormone antagonists|mesh-ancestor
20270657|NCT00532246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20270658|NCT00532246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270659|NCT00532246|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20270660|NCT00532246|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20270661|NCT00532246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20270662|NCT00532272|Letrozole|letrozole|mesh-list
20270663|NCT00532272|Goserelin|goserelin|mesh-list
20270664|NCT00532272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270665|NCT00532272|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20270666|NCT00532272|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20270667|NCT00532272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270668|NCT00532272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270669|NCT00532272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20270670|NCT00532272|Hormone Antagonists|hormone antagonists|mesh-ancestor
20270671|NCT00532272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20270672|NCT00532272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270673|NCT00532272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20270674|NCT00532285|Gemcitabine|gemcitabine|mesh-list
20270675|NCT00532285|Paclitaxel|paclitaxel|mesh-list
20270676|NCT00532285|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20270677|NCT00532285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20270678|NCT00532285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270679|NCT00532285|Tubulin Modulators|tubulin modulators|mesh-ancestor
20270680|NCT00532285|Antimitotic Agents|antimitotic agents|mesh-ancestor
20270681|NCT00532285|Mitosis Modulators|mitosis modulators|mesh-ancestor
20270682|NCT00532285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270683|NCT00532285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20270684|NCT00532285|Antimetabolites|antimetabolites|mesh-ancestor
20270685|NCT00532285|Antiviral Agents|antiviral agents|mesh-ancestor
20270686|NCT00532285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20270687|NCT00532285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270688|NCT00532285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20270689|NCT00532285|Immunologic Factors|immunologic factors|mesh-ancestor
20270690|NCT00532285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270691|NCT00532324|Chlorhexidine|chlorhexidine|mesh-list
20270692|NCT00532324|Mupirocin|mupirocin|mesh-list
20543882|NCT01871844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20543883|NCT01871844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20543884|NCT01871844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543885|NCT01871844|Hormones|hormones|mesh-ancestor
20543886|NCT01871844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20543887|NCT01871844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543888|NCT01871857|Epinephrine|epinephrine|mesh-list
20543889|NCT01871857|Racepinephrine|racepinephrine|mesh-list
20543890|NCT01871857|Epinephryl borate|epinephryl borate|mesh-list
20543891|NCT01871857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20543892|NCT01871857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20543893|NCT01871857|Adrenergic Agents|adrenergic agents|mesh-ancestor
20543894|NCT01871857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20543895|NCT01871857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543896|NCT01871857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543897|NCT01871857|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20543898|NCT01871857|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20543899|NCT01871857|Autonomic Agents|autonomic agents|mesh-ancestor
20543900|NCT01871857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543901|NCT01871857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20543902|NCT01871857|Respiratory System Agents|respiratory system agents|mesh-ancestor
20543903|NCT01871857|Mydriatics|mydriatics|mesh-ancestor
20543904|NCT01871857|Sympathomimetics|sympathomimetics|mesh-ancestor
20543905|NCT01871857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19955593|NCT01634854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19955594|NCT01635062|Calcitriol|calcitriol|mesh-list
19955595|NCT01635062|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
19955596|NCT01635062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20270693|NCT00532324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20270694|NCT00532324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20270695|NCT00532324|Disinfectants|disinfectants|mesh-ancestor
20270696|NCT00532324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20270697|NCT00532324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19955597|NCT01635062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955598|NCT01635062|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19955599|NCT01635062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20270698|NCT00532324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270699|NCT00532324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270700|NCT00532350|Tiotropium Bromide|tiotropium bromide|mesh-list
20270701|NCT00532350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19955600|NCT01635062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955601|NCT01635062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19955602|NCT01635062|Vitamins|vitamins|mesh-ancestor
19955603|NCT01635062|Micronutrients|micronutrients|mesh-ancestor
19955604|NCT01635062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19955605|NCT01635101|Acetaminophen|acetaminophen|mesh-list
19955606|NCT01635101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19955607|NCT01635101|Analgesics|analgesics|mesh-ancestor
20270702|NCT00532350|Autonomic Agents|autonomic agents|mesh-ancestor
20270703|NCT00532350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20270704|NCT00532350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270705|NCT00532350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20270706|NCT00532350|Respiratory System Agents|respiratory system agents|mesh-ancestor
20270707|NCT00532350|Parasympatholytics|parasympatholytics|mesh-ancestor
20270708|NCT00532350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20270709|NCT00532350|Cholinergic Agents|cholinergic agents|mesh-ancestor
20270710|NCT00532350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955608|NCT01635101|Sensory System Agents|sensory system agents|mesh-ancestor
19955609|NCT01635101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955610|NCT01635101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955611|NCT01635101|Antipyretics|antipyretics|mesh-ancestor
19974695|NCT01840579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974696|NCT01840579|Tubulin Modulators|tubulin modulators|mesh-ancestor
19974697|NCT01840579|Antimitotic Agents|antimitotic agents|mesh-ancestor
19974698|NCT01840579|Mitosis Modulators|mitosis modulators|mesh-ancestor
19974699|NCT01840579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974700|NCT01840579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19974701|NCT01840579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19974702|NCT01840579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19974703|NCT01840579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974704|NCT01840579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19974705|NCT01840579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19974706|NCT01840579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19975473|NCT01849419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975474|NCT01849497|Evolocumab|evolocumab|mesh-list
19975475|NCT01849497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19975476|NCT01849497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19975477|NCT01849497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19975478|NCT01849497|Antimetabolites|antimetabolites|mesh-ancestor
19975479|NCT01849497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975480|NCT01849497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20270711|NCT00532350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270712|NCT00532389|Panobinostat|panobinostat|mesh-list
20270713|NCT00532389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270714|NCT00532389|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20270715|NCT00532389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270716|NCT00532389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270717|NCT00532415|Triamcinolone|triamcinolone|mesh-list
20270718|NCT00532415|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20270719|NCT00532415|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20270720|NCT00532415|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20270721|NCT00532415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20270722|NCT00532415|Glucocorticoids|glucocorticoids|mesh-ancestor
19975481|NCT01849497|Immunologic Factors|immunologic factors|mesh-ancestor
19975482|NCT01849497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270723|NCT00532415|Hormones|hormones|mesh-ancestor
20270724|NCT00532415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20270725|NCT00532415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543906|NCT01871922|Atropine|atropine|mesh-list
19975483|NCT01849562|Ribavirin|ribavirin|mesh-list
20270726|NCT00532415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20543907|NCT01871922|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20270727|NCT00532415|Immunologic Factors|immunologic factors|mesh-ancestor
20270728|NCT00532415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270729|NCT00532415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270730|NCT00532428|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
20270731|NCT00532428|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20270732|NCT00532428|Hormone Antagonists|hormone antagonists|mesh-ancestor
20270733|NCT00532428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20270734|NCT00532428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270735|NCT00532428|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20270736|NCT00532428|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20270737|NCT00532428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20270738|NCT00532454|Tamoxifen|tamoxifen|mesh-list
20270739|NCT00532454|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20270740|NCT00532454|Hormone Antagonists|hormone antagonists|mesh-ancestor
20270741|NCT00532454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20270742|NCT00532454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270743|NCT00532454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20270744|NCT00532454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270745|NCT00532454|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20270746|NCT00532454|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20270747|NCT00532454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20270748|NCT00532519|Citalopram|citalopram|mesh-list
20270749|NCT00532519|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20270750|NCT00532519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20270751|NCT00532519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20270752|NCT00532519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270753|NCT00532519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20270754|NCT00532519|Serotonin Agents|serotonin agents|mesh-ancestor
20270755|NCT00532519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270756|NCT00532519|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20270757|NCT00532519|Antidepressive Agents|antidepressive agents|mesh-ancestor
20270758|NCT00532519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20270759|NCT00532532|Tolperisone|tolperisone|mesh-list
20270760|NCT00532532|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20270761|NCT00532532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733099|NCT04565184|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
19733100|NCT04565184|Antimalarials|antimalarials|mesh-ancestor
19955612|NCT01635153|Micronutrients|micronutrients|mesh-list
19955613|NCT01635153|Trace Elements|trace elements|mesh-list
19955614|NCT01635153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955615|NCT01635218|Fluoxetine|fluoxetine|mesh-list
19955616|NCT01635218|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19955617|NCT01635218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19955618|NCT01635218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19955619|NCT01635218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955620|NCT01635218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955621|NCT01635218|Serotonin Agents|serotonin agents|mesh-ancestor
19955622|NCT01635218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955623|NCT01635218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19955624|NCT01635218|Antidepressive Agents|antidepressive agents|mesh-ancestor
19955625|NCT01635218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19955626|NCT01635218|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19955627|NCT01635218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19955628|NCT01635218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955629|NCT01635439|Dinoprostone|dinoprostone|mesh-list
19955630|NCT01635439|Oxytocics|oxytocics|mesh-ancestor
19955631|NCT01635439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19955632|NCT01635439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733101|NCT04565184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19733102|NCT04565184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19733103|NCT04565184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19733104|NCT04565184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733105|NCT04565184|Antiviral Agents|antiviral agents|mesh-ancestor
19733106|NCT04565184|Schistosomicides|schistosomicides|mesh-ancestor
19733107|NCT04565184|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19733108|NCT04565184|Anthelmintics|anthelmintics|mesh-ancestor
19955633|NCT01635504|Botulinum Toxins|botulinum toxins|mesh-list
19955634|NCT01635504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19955635|NCT01635504|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19955636|NCT01635504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19955637|NCT01635504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19974707|NCT01840605|Ketotifen|ketotifen|mesh-list
19955638|NCT01635504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955639|NCT01635504|Cholinergic Agents|cholinergic agents|mesh-ancestor
19955640|NCT01635504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955641|NCT01635504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955642|NCT01635504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19955643|NCT01635504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955644|NCT01635764|Adalimumab|adalimumab|mesh-list
19955645|NCT01635764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19955646|NCT01635764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19955647|NCT01636063|Misoprostol|misoprostol|mesh-list
19955648|NCT01636063|Mifepristone|mifepristone|mesh-list
19955649|NCT01636063|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19955650|NCT01636063|Abortifacient Agents|abortifacient agents|mesh-ancestor
19955651|NCT01636063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19955652|NCT01636063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955653|NCT01636063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19955654|NCT01636063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19955655|NCT01636063|Oxytocics|oxytocics|mesh-ancestor
19955656|NCT01636063|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19955657|NCT01636063|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19955658|NCT01636063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19955659|NCT01636063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19955660|NCT01636063|Contraceptive Agents|contraceptive agents|mesh-ancestor
19955661|NCT01636063|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19955662|NCT01636063|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19955663|NCT01636063|Hormone Antagonists|hormone antagonists|mesh-ancestor
19955664|NCT01636063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19733109|NCT04565171|Yimitasvir|yimitasvir|mesh-list
20270762|NCT00532532|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20270763|NCT00532532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20270764|NCT00532545|Teriparatide|teriparatide|mesh-list
20270765|NCT00532545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19955665|NCT01636063|Luteolytic Agents|luteolytic agents|mesh-ancestor
19955666|NCT01636063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19955667|NCT01636063|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19955668|NCT01636076|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19955669|NCT01636076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19955670|NCT01636076|Autonomic Agents|autonomic agents|mesh-ancestor
20270766|NCT00532545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270767|NCT00532545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20270768|NCT00532571|Coenzyme Q10|coenzyme q10|mesh-list
20270769|NCT00532571|Vitamins|vitamins|mesh-ancestor
20270770|NCT00532571|Micronutrients|micronutrients|mesh-ancestor
20270771|NCT00532571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955671|NCT01636076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955672|NCT01636076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955673|NCT01636076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19955674|NCT01636076|Respiratory System Agents|respiratory system agents|mesh-ancestor
19955675|NCT01636076|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19955676|NCT01636076|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19955677|NCT01636076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19955678|NCT01636076|Adrenergic Agents|adrenergic agents|mesh-ancestor
19955679|NCT01636076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955680|NCT01636076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955681|NCT01636206|Lifitegrast|lifitegrast|mesh-list
19955682|NCT01636206|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19955683|NCT01636206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19955684|NCT01636687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19955685|NCT01636687|Immunologic Factors|immunologic factors|mesh-ancestor
19955686|NCT01636687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955687|NCT01636934|Minocycline|minocycline|mesh-list
19955688|NCT01636934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19955689|NCT01636934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19955690|NCT01636947|Dexamethasone|dexamethasone|mesh-list
19955691|NCT01636947|Dexamethasone acetate|dexamethasone acetate|mesh-list
19733110|NCT04565171|Antiviral Agents|antiviral agents|mesh-ancestor
19733111|NCT04565171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19733112|NCT04565015|Immunoglobulins|immunoglobulins|mesh-list
19733113|NCT04565015|gamma-Globulins|gamma-globulins|mesh-list
19733114|NCT04565015|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19733115|NCT04565015|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19733116|NCT04565015|Immunologic Factors|immunologic factors|mesh-ancestor
19733117|NCT04565015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733118|NCT04564872|Linagliptin|linagliptin|mesh-list
19955692|NCT01636947|Ondansetron|ondansetron|mesh-list
19955693|NCT01636947|Aprepitant|aprepitant|mesh-list
19955694|NCT01636947|Fosaprepitant|fosaprepitant|mesh-list
19955695|NCT01636947|Metoclopramide|metoclopramide|mesh-list
19955696|NCT01636947|Granisetron|granisetron|mesh-list
19955697|NCT01636947|Tropisetron|tropisetron|mesh-list
19955698|NCT01636947|Dolasetron|dolasetron|mesh-list
20270772|NCT00532584|Beclomethasone|beclomethasone|mesh-list
20270773|NCT00532584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20270774|NCT00532584|Glucocorticoids|glucocorticoids|mesh-ancestor
20270775|NCT00532584|Hormones|hormones|mesh-ancestor
20270776|NCT00532584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20270777|NCT00532584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270778|NCT00532584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20270779|NCT00532584|Respiratory System Agents|respiratory system agents|mesh-ancestor
20270780|NCT00532623|Gemcitabine|gemcitabine|mesh-list
20270781|NCT00532623|Vinorelbine|vinorelbine|mesh-list
20270782|NCT00532623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19955699|NCT01636947|Alizapride|alizapride|mesh-list
19955700|NCT01636947|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19955701|NCT01636947|BB 1101|bb 1101|mesh-list
19955702|NCT01636947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19955703|NCT01636947|Antiemetics|antiemetics|mesh-ancestor
19955704|NCT01636947|Autonomic Agents|autonomic agents|mesh-ancestor
19955705|NCT01636947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955706|NCT01636947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955707|NCT01636947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19955708|NCT01636947|Glucocorticoids|glucocorticoids|mesh-ancestor
19955709|NCT01636947|Hormones|hormones|mesh-ancestor
19955710|NCT01636947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19955711|NCT01636947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19955712|NCT01636947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19955713|NCT01636947|Protease Inhibitors|protease inhibitors|mesh-ancestor
19955714|NCT01636947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955715|NCT01636947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955716|NCT01636947|Antipruritics|antipruritics|mesh-ancestor
19955717|NCT01636947|Dermatologic Agents|dermatologic agents|mesh-ancestor
19955718|NCT01636947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19955719|NCT01636947|Serotonin Agents|serotonin agents|mesh-ancestor
19955720|NCT01636947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955721|NCT01636947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20270783|NCT00532623|Antimetabolites|antimetabolites|mesh-ancestor
20270784|NCT00532623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270785|NCT00532623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270786|NCT00532623|Antiviral Agents|antiviral agents|mesh-ancestor
20270787|NCT00532623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20270788|NCT00532623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270789|NCT00532623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20270790|NCT00532623|Immunologic Factors|immunologic factors|mesh-ancestor
20270791|NCT00532623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270792|NCT00532623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19955722|NCT01636947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19955723|NCT01636947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19955724|NCT01636947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19955725|NCT01636947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19955726|NCT01636947|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19955727|NCT01636947|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19955728|NCT01636947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19955729|NCT01636947|Dopamine Agents|dopamine agents|mesh-ancestor
19955730|NCT01636947|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19955731|NCT01636960|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19955732|NCT01636960|Antiviral Agents|antiviral agents|mesh-ancestor
19955733|NCT01636960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19955734|NCT01637077|Pregabalin|pregabalin|mesh-list
19955735|NCT01637077|Analgesics|analgesics|mesh-ancestor
19955736|NCT01637077|Sensory System Agents|sensory system agents|mesh-ancestor
20270793|NCT00532623|Tubulin Modulators|tubulin modulators|mesh-ancestor
20270794|NCT00532623|Antimitotic Agents|antimitotic agents|mesh-ancestor
20270795|NCT00532623|Mitosis Modulators|mitosis modulators|mesh-ancestor
19955737|NCT01637077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955738|NCT01637077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955739|NCT01637077|Anticonvulsants|anticonvulsants|mesh-ancestor
19955740|NCT01637077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19955741|NCT01637077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20270796|NCT00532662|Ketamine|ketamine|mesh-list
19955742|NCT01637077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955743|NCT01637077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19955744|NCT01637077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19955745|NCT01637077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19955746|NCT01637077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19955747|NCT01637077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19955748|NCT01637090|Everolimus|everolimus|mesh-list
19955749|NCT01637090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19955750|NCT01637090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19955751|NCT01637090|Immunologic Factors|immunologic factors|mesh-ancestor
19955752|NCT01637090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955753|NCT01637272|Pasireotide|pasireotide|mesh-list
19955754|NCT01637272|Hormones|hormones|mesh-ancestor
19955755|NCT01637272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19955756|NCT01637272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955757|NCT01637402|Prednisone|prednisone|mesh-list
19955758|NCT01637402|Abiraterone Acetate|abiraterone acetate|mesh-list
19955759|NCT01637402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19955760|NCT01637402|Glucocorticoids|glucocorticoids|mesh-ancestor
19955761|NCT01637402|Hormones|hormones|mesh-ancestor
19955762|NCT01637402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19955763|NCT01637402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955764|NCT01637402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19955765|NCT01637402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270797|NCT00532662|Analgesics|analgesics|mesh-ancestor
20270798|NCT00532662|Sensory System Agents|sensory system agents|mesh-ancestor
20270799|NCT00532662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20270800|NCT00532662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955766|NCT01637402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19955767|NCT01637402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955768|NCT01637402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955769|NCT01637402|Hormone Antagonists|hormone antagonists|mesh-ancestor
19955770|NCT01637402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19955771|NCT01637584|Prazosin|prazosin|mesh-list
19955772|NCT01637584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19955773|NCT01637584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19955774|NCT01637584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20270801|NCT00532662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20270802|NCT00532662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20270803|NCT00532662|Anesthetics, General|anesthetics, general|mesh-ancestor
20270804|NCT00532662|Anesthetics|anesthetics|mesh-ancestor
20270805|NCT00532662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19955775|NCT01637584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19955776|NCT01637584|Adrenergic Agents|adrenergic agents|mesh-ancestor
19955777|NCT01637584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955778|NCT01637584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955779|NCT01637584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955780|NCT01637623|Allopurinol|allopurinol|mesh-list
19955781|NCT01637623|Losartan|losartan|mesh-list
19955782|NCT01637623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19955783|NCT01637623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19955784|NCT01637623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20270806|NCT00532662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20270807|NCT00532662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19955785|NCT01637623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19955786|NCT01637623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955787|NCT01637623|Antimetabolites|antimetabolites|mesh-ancestor
19955788|NCT01637623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955789|NCT01637623|Gout Suppressants|gout suppressants|mesh-ancestor
19955790|NCT01637623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19955791|NCT01637623|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19955792|NCT01637623|Antioxidants|antioxidants|mesh-ancestor
19955793|NCT01637623|Protective Agents|protective agents|mesh-ancestor
19955794|NCT01637623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955795|NCT01637935|Pioglitazone|pioglitazone|mesh-list
19955796|NCT01637935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19955797|NCT01637935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955798|NCT01638000|Solifenacin Succinate|solifenacin succinate|mesh-list
19955799|NCT01638000|Mirabegron|mirabegron|mesh-list
19955800|NCT01638000|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19955801|NCT01638000|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19955802|NCT01638000|Cholinergic Agents|cholinergic agents|mesh-ancestor
19955803|NCT01638000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955804|NCT01638000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955805|NCT01638000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955806|NCT01638000|Urological Agents|urological agents|mesh-ancestor
20270808|NCT00532662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20270809|NCT00532662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270810|NCT00532675|Lenalidomide|lenalidomide|mesh-list
20270811|NCT00532675|Panobinostat|panobinostat|mesh-list
20270812|NCT00532675|Immunologic Factors|immunologic factors|mesh-ancestor
20270813|NCT00532675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270814|NCT00532675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20270815|NCT00532675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20270816|NCT00532675|Growth Substances|growth substances|mesh-ancestor
20270817|NCT00532675|Growth Inhibitors|growth inhibitors|mesh-ancestor
20270818|NCT00532675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270819|NCT00532675|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20270820|NCT00532675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270821|NCT00532675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270822|NCT00532688|Acetylcysteine|acetylcysteine|mesh-list
20270823|NCT00532688|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20270824|NCT00532688|Antiviral Agents|antiviral agents|mesh-ancestor
20270825|NCT00532688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20270826|NCT00532688|Expectorants|expectorants|mesh-ancestor
20270827|NCT00532688|Respiratory System Agents|respiratory system agents|mesh-ancestor
20270828|NCT00532688|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20270829|NCT00532688|Antioxidants|antioxidants|mesh-ancestor
20270830|NCT00532688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270831|NCT00532688|Protective Agents|protective agents|mesh-ancestor
20270832|NCT00532688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270833|NCT00532688|Antidotes|antidotes|mesh-ancestor
20270834|NCT00532701|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20270835|NCT00532701|Interferon-alpha|interferon-alpha|mesh-list
20270836|NCT00532701|Ribavirin|ribavirin|mesh-list
20270837|NCT00532701|Antiviral Agents|antiviral agents|mesh-ancestor
20270838|NCT00532701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19955807|NCT01638000|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19955808|NCT01638000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19955809|NCT01638000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19955810|NCT01638000|Adrenergic Agents|adrenergic agents|mesh-ancestor
19955811|NCT01638013|Peficitinib|peficitinib|mesh-list
19955812|NCT01638013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955813|NCT01638013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955814|NCT01638013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19955815|NCT01638013|Immunologic Factors|immunologic factors|mesh-ancestor
19955816|NCT01638013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270839|NCT00532701|Immunologic Factors|immunologic factors|mesh-ancestor
20270840|NCT00532701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270841|NCT00532701|Antimetabolites|antimetabolites|mesh-ancestor
20270842|NCT00532701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270843|NCT00532714|Capecitabine|capecitabine|mesh-list
20270844|NCT00532714|Irinotecan|irinotecan|mesh-list
20270845|NCT00532714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20270846|NCT00532714|Antimetabolites|antimetabolites|mesh-ancestor
20270847|NCT00532714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270848|NCT00532714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270849|NCT00532714|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20270850|NCT00532714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20270851|NCT00532714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270852|NCT00532727|Carboplatin|carboplatin|mesh-list
20270853|NCT00532727|Docetaxel|docetaxel|mesh-list
20270854|NCT00532727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270855|NCT00532727|Tubulin Modulators|tubulin modulators|mesh-ancestor
20270856|NCT00532727|Antimitotic Agents|antimitotic agents|mesh-ancestor
20270857|NCT00532727|Mitosis Modulators|mitosis modulators|mesh-ancestor
20270858|NCT00532727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270859|NCT00532818|Hydralazine|hydralazine|mesh-list
20270860|NCT00532818|Valproic Acid|valproic acid|mesh-list
20270861|NCT00532818|Anticonvulsants|anticonvulsants|mesh-ancestor
20270862|NCT00532818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955817|NCT01638052|Clonidine|clonidine|mesh-list
19955818|NCT01638052|Bupivacaine|bupivacaine|mesh-list
19955819|NCT01638052|Anesthetics, Local|anesthetics, local|mesh-ancestor
19955820|NCT01638052|Anesthetics|anesthetics|mesh-ancestor
19955821|NCT01638052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19955822|NCT01638052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955823|NCT01638052|Sensory System Agents|sensory system agents|mesh-ancestor
19955824|NCT01638052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955825|NCT01638052|Analgesics|analgesics|mesh-ancestor
20270863|NCT00532818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270864|NCT00532818|GABA Agents|gaba agents|mesh-ancestor
19955826|NCT01638052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19955827|NCT01638052|Sympatholytics|sympatholytics|mesh-ancestor
19955828|NCT01638052|Autonomic Agents|autonomic agents|mesh-ancestor
19955829|NCT01638052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19955830|NCT01638052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19955831|NCT01638052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19955832|NCT01638052|Adrenergic Agents|adrenergic agents|mesh-ancestor
19955833|NCT01638052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955834|NCT01638052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955835|NCT01638429|Rifaximin|rifaximin|mesh-list
19955836|NCT01638429|Neomycin|neomycin|mesh-list
19955837|NCT01638429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19955838|NCT01638429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19955839|NCT01638429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19955840|NCT01638429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19955841|NCT01638429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955842|NCT01638429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955843|NCT01638546|Temozolomide|temozolomide|mesh-list
19955844|NCT01638546|Veliparib|veliparib|mesh-list
19955845|NCT01638546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19955846|NCT01638546|Alkylating Agents|alkylating agents|mesh-ancestor
19955847|NCT01638546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955848|NCT01638546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19955849|NCT01638546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19955850|NCT01638546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955851|NCT01639001|Carboplatin|carboplatin|mesh-list
19955852|NCT01639001|Pemetrexed|pemetrexed|mesh-list
19955853|NCT01639001|Crizotinib|crizotinib|mesh-list
19955854|NCT01639001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19955855|NCT01639001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955856|NCT01639001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955857|NCT01639001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19955858|NCT01639001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19955859|NCT01639001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20270865|NCT00532818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20270866|NCT00532818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270867|NCT00532818|Antimanic Agents|antimanic agents|mesh-ancestor
19955860|NCT01639040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19955861|NCT01639040|Immunologic Factors|immunologic factors|mesh-ancestor
19955862|NCT01639040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543908|NCT01871922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20543909|NCT01871922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20543910|NCT01871922|Autonomic Agents|autonomic agents|mesh-ancestor
20543911|NCT01871922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543912|NCT01871922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543913|NCT01871922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20543914|NCT01871922|Respiratory System Agents|respiratory system agents|mesh-ancestor
20543915|NCT01871922|Mydriatics|mydriatics|mesh-ancestor
20543916|NCT01871922|Parasympatholytics|parasympatholytics|mesh-ancestor
20543917|NCT01871922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20543918|NCT01871922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20543919|NCT01871922|Cholinergic Agents|cholinergic agents|mesh-ancestor
20543920|NCT01871922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20543921|NCT01871922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543922|NCT01871935|Sufentanil|sufentanil|mesh-list
20543923|NCT01871935|Remifentanil|remifentanil|mesh-list
20543924|NCT01871935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20543925|NCT01871935|Narcotics|narcotics|mesh-ancestor
19955863|NCT01639157|Buspirone|buspirone|mesh-list
19955864|NCT01639157|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19955865|NCT01639157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19955866|NCT01639157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19955867|NCT01639157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955868|NCT01639157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19955869|NCT01639157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19955870|NCT01639157|Serotonin Agents|serotonin agents|mesh-ancestor
19955871|NCT01639157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20543926|NCT01871935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19733119|NCT04564872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19733120|NCT04564872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733121|NCT04564872|Incretins|incretins|mesh-ancestor
19733122|NCT04564872|Hormones|hormones|mesh-ancestor
19733123|NCT04564872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19733124|NCT04564872|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19733125|NCT04564872|Protease Inhibitors|protease inhibitors|mesh-ancestor
19955872|NCT01639157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955873|NCT01639222|Calcium, Dietary|calcium, dietary|mesh-list
19955874|NCT01639222|Vitamin D|vitamin d|mesh-list
19955875|NCT01639222|Cholecalciferol|cholecalciferol|mesh-list
19955876|NCT01639222|Calcium|calcium|mesh-list
20270868|NCT00532818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20270869|NCT00532818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20270870|NCT00532818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20270871|NCT00532818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20270872|NCT00532818|Vasodilator Agents|vasodilator agents|mesh-ancestor
20270873|NCT00532857|Gemcitabine|gemcitabine|mesh-list
20270874|NCT00532857|Paclitaxel|paclitaxel|mesh-list
20270875|NCT00532857|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20270876|NCT00532857|Trastuzumab|trastuzumab|mesh-list
20270877|NCT00532857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20270878|NCT00532857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270879|NCT00532857|Tubulin Modulators|tubulin modulators|mesh-ancestor
20270880|NCT00532857|Antimitotic Agents|antimitotic agents|mesh-ancestor
20270881|NCT00532857|Mitosis Modulators|mitosis modulators|mesh-ancestor
19955877|NCT01639222|Vitamins|vitamins|mesh-ancestor
19955878|NCT01639222|Micronutrients|micronutrients|mesh-ancestor
19955879|NCT01639222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955880|NCT01639222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19955881|NCT01639222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19955882|NCT01639339|Belimumab|belimumab|mesh-list
19955883|NCT01639339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19955884|NCT01639339|Immunologic Factors|immunologic factors|mesh-ancestor
20270882|NCT00532857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270883|NCT00532857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20270884|NCT00532857|Antimetabolites|antimetabolites|mesh-ancestor
20270885|NCT00532857|Antiviral Agents|antiviral agents|mesh-ancestor
19955885|NCT01639339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955886|NCT01639352|Pasireotide|pasireotide|mesh-list
19955887|NCT01639352|Hormones|hormones|mesh-ancestor
19955888|NCT01639352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19955889|NCT01639352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955890|NCT01639560|Varenicline|varenicline|mesh-list
20270886|NCT00532857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20270887|NCT00532857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270888|NCT00532857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20270889|NCT00532857|Immunologic Factors|immunologic factors|mesh-ancestor
20270890|NCT00532857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270891|NCT00532857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20270892|NCT00532909|Bevacizumab|bevacizumab|mesh-list
20270893|NCT00532909|Capecitabine|capecitabine|mesh-list
20270894|NCT00532909|Oxaliplatin|oxaliplatin|mesh-list
20270895|NCT00532909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20270896|NCT00532909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270897|NCT00532909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20270898|NCT00532909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20270899|NCT00532909|Growth Substances|growth substances|mesh-ancestor
20270900|NCT00532909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270901|NCT00532909|Growth Inhibitors|growth inhibitors|mesh-ancestor
20270902|NCT00532909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20270903|NCT00532909|Antimetabolites|antimetabolites|mesh-ancestor
20270904|NCT00532909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270905|NCT00532961|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20270906|NCT00532961|Tobramycin|tobramycin|mesh-list
20270907|NCT00532961|Dexamethasone|dexamethasone|mesh-list
20270908|NCT00532961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20270909|NCT00532961|Antiemetics|antiemetics|mesh-ancestor
20270910|NCT00532961|Autonomic Agents|autonomic agents|mesh-ancestor
20270911|NCT00532961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20270912|NCT00532961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270913|NCT00532961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20270914|NCT00532961|Glucocorticoids|glucocorticoids|mesh-ancestor
20270915|NCT00532961|Hormones|hormones|mesh-ancestor
20270916|NCT00532961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20270917|NCT00532961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20270918|NCT00532961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450298|NCT03429738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19955891|NCT01639560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19955892|NCT01639560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19955893|NCT01639560|Cholinergic Agents|cholinergic agents|mesh-ancestor
19955894|NCT01639560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955895|NCT01639560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270919|NCT00532961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20270920|NCT00532961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20270921|NCT00532961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20270922|NCT00533026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20270923|NCT00533026|Warfarin|warfarin|mesh-list
20270924|NCT00533026|Anticoagulants|anticoagulants|mesh-ancestor
20270925|NCT00533026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20270926|NCT00533026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20270927|NCT00533026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20543927|NCT01871935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543928|NCT01871935|Analgesics|analgesics|mesh-ancestor
20543929|NCT01871935|Sensory System Agents|sensory system agents|mesh-ancestor
20543930|NCT01871935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543931|NCT01871935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20543932|NCT01871935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20543933|NCT01871935|Anesthetics, General|anesthetics, general|mesh-ancestor
20543934|NCT01871935|Anesthetics|anesthetics|mesh-ancestor
20543935|NCT01871961|Methotrexate|methotrexate|mesh-list
20543936|NCT01871961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20543937|NCT01871961|Abortifacient Agents|abortifacient agents|mesh-ancestor
19955896|NCT01639560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543938|NCT01871961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20543939|NCT01871961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543940|NCT01871961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20543941|NCT01871961|Antimetabolites|antimetabolites|mesh-ancestor
20543942|NCT01871961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543943|NCT01871961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543944|NCT01871961|Dermatologic Agents|dermatologic agents|mesh-ancestor
20543945|NCT01871961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20543946|NCT01871961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20543947|NCT01871961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20543948|NCT01871961|Immunologic Factors|immunologic factors|mesh-ancestor
20543949|NCT01871961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20543950|NCT01871961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19955897|NCT01639599|Dexamethasone|dexamethasone|mesh-list
19955898|NCT01639599|Dexamethasone acetate|dexamethasone acetate|mesh-list
19955899|NCT01639599|Haloperidol|haloperidol|mesh-list
19955900|NCT01639599|Haloperidol decanoate|haloperidol decanoate|mesh-list
19955901|NCT01639599|BB 1101|bb 1101|mesh-list
19955902|NCT01639599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19955903|NCT01639599|Antiemetics|antiemetics|mesh-ancestor
19955904|NCT01639599|Autonomic Agents|autonomic agents|mesh-ancestor
19955905|NCT01639599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955906|NCT01639599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543951|NCT01871974|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20543952|NCT01871974|Antidepressive Agents|antidepressive agents|mesh-ancestor
20543953|NCT01871974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20543954|NCT01871974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20543955|NCT01871974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20543956|NCT01871974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20543957|NCT01871974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543958|NCT01871987|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20543959|NCT01871987|Antidepressive Agents|antidepressive agents|mesh-ancestor
20543960|NCT01871987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20543961|NCT01871987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20543962|NCT01871987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20543963|NCT01871987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19955907|NCT01639599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19955908|NCT01639599|Glucocorticoids|glucocorticoids|mesh-ancestor
19955909|NCT01639599|Hormones|hormones|mesh-ancestor
19955910|NCT01639599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19955911|NCT01639599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19955912|NCT01639599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19955913|NCT01639599|Protease Inhibitors|protease inhibitors|mesh-ancestor
19955914|NCT01639599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955915|NCT01639599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955916|NCT01639599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19955917|NCT01639599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19955918|NCT01639599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19955919|NCT01639599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19955920|NCT01639599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19955921|NCT01639599|Dopamine Agents|dopamine agents|mesh-ancestor
20543964|NCT01871987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955922|NCT01639599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955923|NCT01639599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19955924|NCT01639729|Sufentanil|sufentanil|mesh-list
19955925|NCT01639729|Dsuvia|dsuvia|mesh-list
19955926|NCT01639729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19955927|NCT01639729|Narcotics|narcotics|mesh-ancestor
19955928|NCT01639729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19955929|NCT01639729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955930|NCT01639729|Analgesics|analgesics|mesh-ancestor
20270928|NCT00533026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270929|NCT00533026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20270930|NCT00533026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270931|NCT00533026|Analgesics|analgesics|mesh-ancestor
20270932|NCT00533026|Sensory System Agents|sensory system agents|mesh-ancestor
20270933|NCT00533026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20270934|NCT00533026|Antidepressive Agents|antidepressive agents|mesh-ancestor
20270935|NCT00533026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20270936|NCT00533026|Dopamine Agents|dopamine agents|mesh-ancestor
20270937|NCT00533039|Varespladib methyl|varespladib methyl|mesh-list
20270938|NCT00533039|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
20270939|NCT00533039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270940|NCT00533039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270941|NCT00533065|Donepezil|donepezil|mesh-list
20543965|NCT01872013|ASP7991|asp7991|mesh-list
20543966|NCT01872013|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20543967|NCT01872013|Hormone Antagonists|hormone antagonists|mesh-ancestor
20543968|NCT01872013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20543969|NCT01872013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543970|NCT01872026|ASP7991|asp7991|mesh-list
20543971|NCT01872026|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20543972|NCT01872026|Hormone Antagonists|hormone antagonists|mesh-ancestor
20543973|NCT01872026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20543974|NCT01872026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543975|NCT01872039|Nicardipine|nicardipine|mesh-list
20543976|NCT01872039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20543977|NCT01872039|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20543978|NCT01872039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20543979|NCT01872039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543980|NCT01872039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19955931|NCT01639729|Sensory System Agents|sensory system agents|mesh-ancestor
19955932|NCT01639729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955933|NCT01639729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19955934|NCT01639729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19955935|NCT01639729|Anesthetics, General|anesthetics, general|mesh-ancestor
19955936|NCT01639729|Anesthetics|anesthetics|mesh-ancestor
19955937|NCT01639833|Hemostatics|hemostatics|mesh-list
19955938|NCT01639833|Coagulants|coagulants|mesh-ancestor
19955939|NCT01639872|Risperidone|risperidone|mesh-list
19955940|NCT01639872|Clozapine|clozapine|mesh-list
19955941|NCT01639872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19955942|NCT01639872|Serotonin Agents|serotonin agents|mesh-ancestor
19955943|NCT01639872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19955944|NCT01639872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955945|NCT01639872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955946|NCT01639872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19955947|NCT01639872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19955948|NCT01639872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19955949|NCT01639872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19955950|NCT01639872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19955951|NCT01639872|Dopamine Agents|dopamine agents|mesh-ancestor
19955952|NCT01639872|GABA Antagonists|gaba antagonists|mesh-ancestor
19955953|NCT01639872|GABA Agents|gaba agents|mesh-ancestor
19955954|NCT01640171|Ketorolac|ketorolac|mesh-list
19955955|NCT01640171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19955956|NCT01640171|Lidocaine|lidocaine|mesh-list
19955957|NCT01640171|Proxymetacaine|proxymetacaine|mesh-list
19955958|NCT01640171|Anesthetics|anesthetics|mesh-list
19955959|NCT01640171|Anesthetics, Local|anesthetics, local|mesh-ancestor
19955960|NCT01640171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19955961|NCT01640171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955962|NCT01640171|Sensory System Agents|sensory system agents|mesh-ancestor
20543981|NCT01872039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20543982|NCT01872039|Vasodilator Agents|vasodilator agents|mesh-ancestor
20543983|NCT01872351|Thioctic Acid|thioctic acid|mesh-list
20543984|NCT01872351|Acetylcarnitine|acetylcarnitine|mesh-list
19955963|NCT01640171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955964|NCT01640171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19955965|NCT01640171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20270942|NCT00533065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20270943|NCT00533065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270944|NCT00533065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270945|NCT00533065|Cholinergic Agents|cholinergic agents|mesh-ancestor
20270946|NCT00533065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20270947|NCT00533065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270948|NCT00533065|Nootropic Agents|nootropic agents|mesh-ancestor
20270949|NCT00533091|Sifalimumab|sifalimumab|mesh-list
20270950|NCT00533091|Immunologic Factors|immunologic factors|mesh-ancestor
20270951|NCT00533091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270952|NCT00533169|Tretinoin|tretinoin|mesh-list
20270953|NCT00533169|Isotretinoin|isotretinoin|mesh-list
20270954|NCT00533169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20270955|NCT00533169|Keratolytic Agents|keratolytic agents|mesh-ancestor
20270956|NCT00533169|Dermatologic Agents|dermatologic agents|mesh-ancestor
20270957|NCT00533195|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
19955966|NCT01640171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19955967|NCT01640171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19955968|NCT01640171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955969|NCT01640171|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19955970|NCT01640171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19955971|NCT01640171|Analgesics|analgesics|mesh-ancestor
19955972|NCT01640171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19955973|NCT01640171|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19955974|NCT01640171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955975|NCT01640184|Vitamin D|vitamin d|mesh-list
19955976|NCT01640184|Vitamins|vitamins|mesh-ancestor
19955977|NCT01640184|Micronutrients|micronutrients|mesh-ancestor
19955978|NCT01640184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955979|NCT01640184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19955980|NCT01640197|Resveratrol|resveratrol|mesh-list
19955981|NCT01640197|Antioxidants|antioxidants|mesh-ancestor
19955982|NCT01640197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19955983|NCT01640197|Protective Agents|protective agents|mesh-ancestor
19955984|NCT01640197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19955985|NCT01640197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19955986|NCT01640197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19955987|NCT01640340|Dexamethasone|dexamethasone|mesh-list
19955988|NCT01640340|Ondansetron|ondansetron|mesh-list
19955989|NCT01640340|Aprepitant|aprepitant|mesh-list
20270958|NCT00533195|Methoxsalen|methoxsalen|mesh-list
20270959|NCT00533195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20270960|NCT00533195|Dermatologic Agents|dermatologic agents|mesh-ancestor
20270961|NCT00533195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20270962|NCT00533247|Celecoxib|celecoxib|mesh-list
20270963|NCT00533247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20270964|NCT00533247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20270965|NCT00533247|Analgesics|analgesics|mesh-ancestor
20270966|NCT00533247|Sensory System Agents|sensory system agents|mesh-ancestor
20270967|NCT00533247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20270968|NCT00533247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270969|NCT00533247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20270970|NCT00533247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20270971|NCT00533247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20270972|NCT00533247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20270973|NCT00533247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270974|NCT00533247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270975|NCT00533299|Hydralazine|hydralazine|mesh-list
20270976|NCT00533299|Valproic Acid|valproic acid|mesh-list
20270977|NCT00533299|Anticonvulsants|anticonvulsants|mesh-ancestor
20270978|NCT00533299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20270979|NCT00533299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270980|NCT00533299|GABA Agents|gaba agents|mesh-ancestor
19955990|NCT01640340|Palonosetron|palonosetron|mesh-list
19955991|NCT01640340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19955992|NCT01640340|Antiemetics|antiemetics|mesh-ancestor
19955993|NCT01640340|Autonomic Agents|autonomic agents|mesh-ancestor
20270981|NCT00533299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20270982|NCT00533299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270983|NCT00533299|Antimanic Agents|antimanic agents|mesh-ancestor
20270984|NCT00533299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20270985|NCT00533299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19955994|NCT01640340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19955995|NCT01640340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20270986|NCT00533299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20270987|NCT00533299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20270988|NCT00533299|Vasodilator Agents|vasodilator agents|mesh-ancestor
19955996|NCT01640340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19955997|NCT01640340|Glucocorticoids|glucocorticoids|mesh-ancestor
19955998|NCT01640340|Hormones|hormones|mesh-ancestor
19955999|NCT01640340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20270989|NCT00533312|Niacin|niacin|mesh-list
20270990|NCT00533312|Niacinamide|niacinamide|mesh-list
20270991|NCT00533312|Nicotinic Acids|nicotinic acids|mesh-list
20270992|NCT00533312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19956000|NCT01640340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19956001|NCT01640340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956002|NCT01640340|Antipruritics|antipruritics|mesh-ancestor
19956003|NCT01640340|Dermatologic Agents|dermatologic agents|mesh-ancestor
19956004|NCT01640340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19956005|NCT01640340|Serotonin Agents|serotonin agents|mesh-ancestor
19956006|NCT01640340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19956007|NCT01640340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956008|NCT01640340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19956009|NCT01640340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19956010|NCT01640340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20270993|NCT00533312|Antimetabolites|antimetabolites|mesh-ancestor
20270994|NCT00533312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20270995|NCT00533312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20270996|NCT00533312|Vasodilator Agents|vasodilator agents|mesh-ancestor
20270997|NCT00533312|Vitamin B Complex|vitamin b complex|mesh-ancestor
20270998|NCT00533312|Vitamins|vitamins|mesh-ancestor
20270999|NCT00533312|Micronutrients|micronutrients|mesh-ancestor
20271000|NCT00533312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271001|NCT00533390|Efavirenz|efavirenz|mesh-list
20271002|NCT00533390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20271003|NCT00533390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20271004|NCT00533390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271005|NCT00533390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271006|NCT00533390|Antiviral Agents|antiviral agents|mesh-ancestor
20271007|NCT00533390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271008|NCT00533390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20271009|NCT00533390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20271010|NCT00533390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19956011|NCT01640340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19956012|NCT01640340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19956013|NCT01640340|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19956014|NCT01640340|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19956015|NCT01640834|Glucagon|glucagon|mesh-list
19956016|NCT01640834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19956017|NCT01640834|Hormones|hormones|mesh-ancestor
19956018|NCT01640834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19956019|NCT01640834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956020|NCT01640925|Chlorhexidine|chlorhexidine|mesh-list
19956021|NCT01640925|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19956022|NCT01640925|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20271011|NCT00533390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20271012|NCT00533390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20271013|NCT00533390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20271014|NCT00533416|ON 01910|on 01910|mesh-list
20271015|NCT00533416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271016|NCT00533416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20271017|NCT00533416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271018|NCT00533416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271019|NCT00533455|Gabapentin|gabapentin|mesh-list
20271020|NCT00533455|Analgesics|analgesics|mesh-ancestor
20271021|NCT00533455|Sensory System Agents|sensory system agents|mesh-ancestor
20271022|NCT00533455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20271023|NCT00533455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271024|NCT00533455|Anticonvulsants|anticonvulsants|mesh-ancestor
20543985|NCT01872351|Antioxidants|antioxidants|mesh-ancestor
19956023|NCT01640925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19956024|NCT01640925|Disinfectants|disinfectants|mesh-ancestor
19956025|NCT01640925|Dermatologic Agents|dermatologic agents|mesh-ancestor
19956026|NCT01640951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19956027|NCT01640951|Immunologic Factors|immunologic factors|mesh-ancestor
19956028|NCT01640951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956029|NCT01640964|Terlipressin|terlipressin|mesh-list
20271025|NCT00533455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20271026|NCT00533455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20271027|NCT00533455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20271028|NCT00533455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20271029|NCT00533455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20271030|NCT00533455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20271031|NCT00533455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20271032|NCT00533455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271033|NCT00533455|Antimanic Agents|antimanic agents|mesh-ancestor
20271034|NCT00533468|Lidocaine|lidocaine|mesh-list
19956030|NCT01640964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19956031|NCT01640964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19956032|NCT01641081|Formoterol Fumarate|formoterol fumarate|mesh-list
19956033|NCT01641081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19956034|NCT01641081|Autonomic Agents|autonomic agents|mesh-ancestor
19956035|NCT01641081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19956036|NCT01641081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956037|NCT01641081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19956038|NCT01641081|Respiratory System Agents|respiratory system agents|mesh-ancestor
19956039|NCT01641081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19956040|NCT01641081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19956041|NCT01641081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19956042|NCT01641081|Adrenergic Agents|adrenergic agents|mesh-ancestor
19956043|NCT01641081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19956044|NCT01641081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956045|NCT01641120|Interferons|interferons|mesh-list
19956046|NCT01641120|Interferon-beta|interferon-beta|mesh-list
19956047|NCT01641120|Interferon beta-1a|interferon beta-1a|mesh-list
19956048|NCT01641120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956049|NCT01641120|Antiviral Agents|antiviral agents|mesh-ancestor
19956050|NCT01641120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19956051|NCT01641120|Immunologic Factors|immunologic factors|mesh-ancestor
19956052|NCT01641120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956053|NCT01641120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19956054|NCT01641133|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19956055|NCT01641133|Immunologic Factors|immunologic factors|mesh-ancestor
19956056|NCT01641133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956057|NCT01641159|Buspirone|buspirone|mesh-list
19956058|NCT01641159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19956059|NCT01641159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19956060|NCT01641159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19956061|NCT01641159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956062|NCT01641159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19956063|NCT01641159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19956064|NCT01641159|Serotonin Agents|serotonin agents|mesh-ancestor
19956065|NCT01641159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19956066|NCT01641159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956067|NCT01641237|Listerine|listerine|mesh-list
19956068|NCT01641237|Fluorides|fluorides|mesh-list
19956069|NCT01641237|Sodium Fluoride|sodium fluoride|mesh-list
19956070|NCT01641237|Cariostatic Agents|cariostatic agents|mesh-ancestor
19956071|NCT01641237|Protective Agents|protective agents|mesh-ancestor
19956072|NCT01641237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956073|NCT01641237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19956074|NCT01641237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271035|NCT00533468|Anesthetics, Local|anesthetics, local|mesh-ancestor
20271036|NCT00533468|Anesthetics|anesthetics|mesh-ancestor
20271037|NCT00533468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20271038|NCT00533468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271039|NCT00533468|Sensory System Agents|sensory system agents|mesh-ancestor
20271040|NCT00533468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20271041|NCT00533468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20271042|NCT00533468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20271043|NCT00533468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20271044|NCT00533468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20271045|NCT00533468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271046|NCT00533520|Ranibizumab|ranibizumab|mesh-list
20543986|NCT01872351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974708|NCT01840605|Bepotastine besilate|bepotastine besilate|mesh-list
19974709|NCT01840605|Antipruritics|antipruritics|mesh-ancestor
19974710|NCT01840605|Dermatologic Agents|dermatologic agents|mesh-ancestor
19974711|NCT01840605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19974712|NCT01840605|Histamine Antagonists|histamine antagonists|mesh-ancestor
19974713|NCT01840605|Histamine Agents|histamine agents|mesh-ancestor
19974714|NCT01840605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19974715|NCT01840605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271047|NCT00533520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20271048|NCT00533520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20271049|NCT00533520|Growth Substances|growth substances|mesh-ancestor
20271050|NCT00533520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271051|NCT00533520|Growth Inhibitors|growth inhibitors|mesh-ancestor
20271052|NCT00533520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271053|NCT00533533|Docetaxel|docetaxel|mesh-list
20271054|NCT00533533|Oxaliplatin|oxaliplatin|mesh-list
19956075|NCT01641367|Tenofovir|tenofovir|mesh-list
19956076|NCT01641367|Emtricitabine|emtricitabine|mesh-list
19956077|NCT01641367|Raltegravir Potassium|raltegravir potassium|mesh-list
19956078|NCT01641367|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19956079|NCT01641367|Darunavir|darunavir|mesh-list
19956080|NCT01641367|Etravirine|etravirine|mesh-list
19956081|NCT01641367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
19956082|NCT01641367|Protease Inhibitors|protease inhibitors|mesh-list
19956083|NCT01641367|Antiviral Agents|antiviral agents|mesh-ancestor
19956084|NCT01641367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19956085|NCT01641367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19956086|NCT01641367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19956087|NCT01641367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956088|NCT01641367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956089|NCT01641367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19956090|NCT01641367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19956091|NCT01641367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19956092|NCT01641367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19956093|NCT01641367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19956094|NCT01641445|Topiramate|topiramate|mesh-list
19956095|NCT01641445|Anticonvulsants|anticonvulsants|mesh-ancestor
20271055|NCT00533533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271056|NCT00533533|Tubulin Modulators|tubulin modulators|mesh-ancestor
20271057|NCT00533533|Antimitotic Agents|antimitotic agents|mesh-ancestor
20271058|NCT00533533|Mitosis Modulators|mitosis modulators|mesh-ancestor
20271059|NCT00533533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20543987|NCT01872351|Protective Agents|protective agents|mesh-ancestor
20543988|NCT01872351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956096|NCT01641445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19956097|NCT01641445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956098|NCT01641640|Sofosbuvir|sofosbuvir|mesh-list
19956099|NCT01641640|Ribavirin|ribavirin|mesh-list
19956100|NCT01641640|Antiviral Agents|antiviral agents|mesh-ancestor
19956101|NCT01641640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19956102|NCT01641640|Antimetabolites|antimetabolites|mesh-ancestor
19956103|NCT01641640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956104|NCT01641653|Midazolam|midazolam|mesh-list
19956105|NCT01641653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19956106|NCT01641653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19956107|NCT01641653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19956108|NCT01641653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956109|NCT01641653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19956110|NCT01641653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19956111|NCT01641653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19956112|NCT01641653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19956113|NCT01641653|Anesthetics, General|anesthetics, general|mesh-ancestor
19956114|NCT01641653|Anesthetics|anesthetics|mesh-ancestor
19956115|NCT01641653|GABA Modulators|gaba modulators|mesh-ancestor
19956116|NCT01641653|GABA Agents|gaba agents|mesh-ancestor
19956117|NCT01641653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19956118|NCT01641653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956119|NCT01641692|Albuterol|albuterol|mesh-list
19956120|NCT01641692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19956121|NCT01641692|Autonomic Agents|autonomic agents|mesh-ancestor
19956122|NCT01641692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19956123|NCT01641692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956124|NCT01641692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19956125|NCT01641692|Respiratory System Agents|respiratory system agents|mesh-ancestor
19956126|NCT01641692|Tocolytic Agents|tocolytic agents|mesh-ancestor
19956127|NCT01641692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19956128|NCT01641692|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19956129|NCT01641692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19956130|NCT01641692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19956131|NCT01641692|Adrenergic Agents|adrenergic agents|mesh-ancestor
19956132|NCT01641692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19956133|NCT01641692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956134|NCT01641809|Tenofovir|tenofovir|mesh-list
19956135|NCT01641809|Lamivudine|lamivudine|mesh-list
20543989|NCT01872351|Vitamin B Complex|vitamin b complex|mesh-ancestor
19956136|NCT01641809|Emtricitabine|emtricitabine|mesh-list
19956137|NCT01641809|Efavirenz|efavirenz|mesh-list
19956138|NCT01641809|Abacavir|abacavir|mesh-list
19956139|NCT01641809|Rilpivirine|rilpivirine|mesh-list
19956140|NCT01641809|Cabotegravir|cabotegravir|mesh-list
19956141|NCT01641809|Antiviral Agents|antiviral agents|mesh-ancestor
19956142|NCT01641809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19956143|NCT01641809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19956144|NCT01641809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20271060|NCT00533559|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20271061|NCT00533559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271062|NCT00533585|Paclitaxel|paclitaxel|mesh-list
20271063|NCT00533585|Bevacizumab|bevacizumab|mesh-list
20271064|NCT00533585|Carboplatin|carboplatin|mesh-list
19956145|NCT01641809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956146|NCT01641809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956147|NCT01641809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19956148|NCT01641809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20271065|NCT00533585|Sorafenib|sorafenib|mesh-list
20271066|NCT00533585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20271067|NCT00533585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956149|NCT01641809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19956150|NCT01641809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19956151|NCT01641809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19956152|NCT01641809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19956153|NCT01641809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19956154|NCT01641809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19956155|NCT01641809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19956156|NCT01641809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19956157|NCT01641822|Tobramycin|tobramycin|mesh-list
19956158|NCT01641822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19956159|NCT01641822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19956160|NCT01641900|Eszopiclone|eszopiclone|mesh-list
20271068|NCT00533585|Tubulin Modulators|tubulin modulators|mesh-ancestor
20271069|NCT00533585|Antimitotic Agents|antimitotic agents|mesh-ancestor
20271070|NCT00533585|Mitosis Modulators|mitosis modulators|mesh-ancestor
20271071|NCT00533585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271072|NCT00533585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19956161|NCT01641900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19956162|NCT01641900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19956163|NCT01641900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956164|NCT01641926|Interferons|interferons|mesh-list
19956165|NCT01641926|Interferon-alpha|interferon-alpha|mesh-list
19956166|NCT01641926|Interferon alpha-2|interferon alpha-2|mesh-list
19956167|NCT01641926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19956168|NCT01641926|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19956169|NCT01641926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956170|NCT01641926|Antiviral Agents|antiviral agents|mesh-ancestor
19956171|NCT01641926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19956172|NCT01641926|Immunologic Factors|immunologic factors|mesh-ancestor
19956173|NCT01641926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956174|NCT01641939|Trastuzumab|trastuzumab|mesh-list
19956175|NCT01641939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19956176|NCT01641939|Maytansine|maytansine|mesh-list
19956177|NCT01641939|Taxane|taxane|mesh-list
19956178|NCT01641939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19956179|NCT01641939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956180|NCT01641939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19956181|NCT01641939|Tubulin Modulators|tubulin modulators|mesh-ancestor
19956182|NCT01641939|Antimitotic Agents|antimitotic agents|mesh-ancestor
19956183|NCT01641939|Mitosis Modulators|mitosis modulators|mesh-ancestor
19956184|NCT01641939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956185|NCT01641952|Rituximab|rituximab|mesh-list
19956186|NCT01641952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19956187|NCT01641952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956188|NCT01641952|Immunologic Factors|immunologic factors|mesh-ancestor
19956189|NCT01641952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956190|NCT01641952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19956191|NCT01642082|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
19956192|NCT01642082|Immunologic Factors|immunologic factors|mesh-ancestor
19956193|NCT01642082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956194|NCT01642147|Anesthetics|anesthetics|mesh-list
19956195|NCT01642147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19956196|NCT01642147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956197|NCT01642212|Budesonide|budesonide|mesh-list
19956198|NCT01642212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20271073|NCT00533585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19956199|NCT01642212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19956200|NCT01642212|Autonomic Agents|autonomic agents|mesh-ancestor
20271074|NCT00533585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20271075|NCT00533585|Growth Substances|growth substances|mesh-ancestor
20271076|NCT00533585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271077|NCT00533585|Growth Inhibitors|growth inhibitors|mesh-ancestor
20271078|NCT00533585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20271079|NCT00533585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271080|NCT00533611|Niacin|niacin|mesh-list
20271081|NCT00533611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271082|NCT00533611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271083|NCT00533611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20271084|NCT00533611|Antimetabolites|antimetabolites|mesh-ancestor
20271085|NCT00533611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20271086|NCT00533611|Vasodilator Agents|vasodilator agents|mesh-ancestor
19956201|NCT01642212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19956202|NCT01642212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956203|NCT01642212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19956204|NCT01642212|Respiratory System Agents|respiratory system agents|mesh-ancestor
19956205|NCT01642212|Glucocorticoids|glucocorticoids|mesh-ancestor
19956206|NCT01642212|Hormones|hormones|mesh-ancestor
19956207|NCT01642212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20271087|NCT00533611|Vitamin B Complex|vitamin b complex|mesh-ancestor
20271088|NCT00533611|Vitamins|vitamins|mesh-ancestor
19956208|NCT01642238|Aspirin|aspirin|mesh-list
19956209|NCT01642238|Hirudins|hirudins|mesh-list
20271089|NCT00533611|Micronutrients|micronutrients|mesh-ancestor
20271090|NCT00533624|Mycophenolic Acid|mycophenolic acid|mesh-list
20271091|NCT00533624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20271092|NCT00533624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271093|NCT00533624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20271094|NCT00533624|Antitubercular Agents|antitubercular agents|mesh-ancestor
20271095|NCT00533624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20271096|NCT00533624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271097|NCT00533624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271098|NCT00533624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271099|NCT00533637|Cetirizine|cetirizine|mesh-list
20271100|NCT00533637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20271101|NCT00533637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20271102|NCT00533637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20271103|NCT00533637|Histamine Antagonists|histamine antagonists|mesh-ancestor
20271104|NCT00533637|Histamine Agents|histamine agents|mesh-ancestor
20271105|NCT00533637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20271106|NCT00533637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271107|NCT00533637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271108|NCT00533676|Oxymetazoline|oxymetazoline|mesh-list
20271109|NCT00533676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20271110|NCT00533676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20271111|NCT00533676|Adrenergic Agents|adrenergic agents|mesh-ancestor
20271112|NCT00533676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20271113|NCT00533676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271114|NCT00533676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271115|NCT00533676|Sympathomimetics|sympathomimetics|mesh-ancestor
20543990|NCT01872351|Vitamins|vitamins|mesh-ancestor
20543991|NCT01872351|Micronutrients|micronutrients|mesh-ancestor
20543992|NCT01872351|Nootropic Agents|nootropic agents|mesh-ancestor
20554189|NCT01933997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554190|NCT01934023|Varenicline|varenicline|mesh-list
20554191|NCT01934023|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20554192|NCT01934023|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20554193|NCT01934023|Cholinergic Agents|cholinergic agents|mesh-ancestor
20554194|NCT01934023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20554195|NCT01934023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554196|NCT01934023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554197|NCT01934049|Anesthetics|anesthetics|mesh-list
20554198|NCT01934049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20554199|NCT01934049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554200|NCT01934088|Fentanyl|fentanyl|mesh-list
20554201|NCT01934088|Midazolam|midazolam|mesh-list
20554202|NCT01934088|Propofol|propofol|mesh-list
20554203|NCT01934088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20554204|NCT01934088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20554205|NCT01934088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554206|NCT01934088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19956210|NCT01642238|Bivalirudin|bivalirudin|mesh-list
20554207|NCT01934088|Anesthetics, General|anesthetics, general|mesh-ancestor
20271116|NCT00533676|Autonomic Agents|autonomic agents|mesh-ancestor
19956211|NCT01642238|Clopidogrel|clopidogrel|mesh-list
19956212|NCT01642238|Ticagrelor|ticagrelor|mesh-list
19956213|NCT01642238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19956214|NCT01642238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19956215|NCT01642238|Analgesics|analgesics|mesh-ancestor
19956216|NCT01642238|Sensory System Agents|sensory system agents|mesh-ancestor
19956217|NCT01642238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19956218|NCT01642238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271117|NCT00533676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20271118|NCT00533676|Nasal Decongestants|nasal decongestants|mesh-ancestor
20271119|NCT00533676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20271120|NCT00533676|Respiratory System Agents|respiratory system agents|mesh-ancestor
20287467|NCT04500665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287468|NCT04429022|Acetaminophen|acetaminophen|mesh-list
20287469|NCT04429022|Celecoxib|celecoxib|mesh-list
20287470|NCT04429022|Ketorolac|ketorolac|mesh-list
20287471|NCT04429022|Oxycodone|oxycodone|mesh-list
19956219|NCT01642238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19956220|NCT01642238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19956221|NCT01642238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19956222|NCT01642238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19956223|NCT01642238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956224|NCT01642238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19956225|NCT01642238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19956226|NCT01642238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956227|NCT01642238|Antipyretics|antipyretics|mesh-ancestor
19956228|NCT01642238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20287472|NCT04429022|Gabapentin|gabapentin|mesh-list
20287473|NCT04429022|Hydromorphone|hydromorphone|mesh-list
20287474|NCT04429022|Ropivacaine|ropivacaine|mesh-list
20287475|NCT04429022|Anesthetics, Local|anesthetics, local|mesh-list
20287476|NCT04429022|Anesthetics|anesthetics|mesh-list
20287477|NCT04429022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20287478|NCT04429022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287479|NCT04429022|Sensory System Agents|sensory system agents|mesh-ancestor
20287480|NCT04429022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19956229|NCT01642238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19956230|NCT01642238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19956231|NCT01642238|Purinergic Agents|purinergic agents|mesh-ancestor
19956232|NCT01642238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19956233|NCT01642238|Antithrombins|antithrombins|mesh-ancestor
19956234|NCT01642238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19956235|NCT01642238|Protease Inhibitors|protease inhibitors|mesh-ancestor
19956236|NCT01642238|Anticoagulants|anticoagulants|mesh-ancestor
19956237|NCT01642251|Cisplatin|cisplatin|mesh-list
19956238|NCT01642251|Etoposide|etoposide|mesh-list
19956239|NCT01642251|Etoposide phosphate|etoposide phosphate|mesh-list
19956240|NCT01642251|Veliparib|veliparib|mesh-list
19956241|NCT01642251|Podophyllotoxin|podophyllotoxin|mesh-list
19956242|NCT01642251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956243|NCT01642251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19956244|NCT01642251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19956245|NCT01642251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19956246|NCT01642251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956247|NCT01642251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956248|NCT01642251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19956249|NCT01642251|Keratolytic Agents|keratolytic agents|mesh-ancestor
19956250|NCT01642251|Dermatologic Agents|dermatologic agents|mesh-ancestor
19956251|NCT01642251|Tubulin Modulators|tubulin modulators|mesh-ancestor
19956252|NCT01642251|Antimitotic Agents|antimitotic agents|mesh-ancestor
19956253|NCT01642251|Mitosis Modulators|mitosis modulators|mesh-ancestor
19956254|NCT01642277|Solifenacin Succinate|solifenacin succinate|mesh-list
19956255|NCT01642277|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20287481|NCT04429022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20287482|NCT04429022|Analgesics|analgesics|mesh-ancestor
20287483|NCT04429022|Antipyretics|antipyretics|mesh-ancestor
20287484|NCT04429022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20287485|NCT04429022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20287486|NCT04429022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20287487|NCT04429022|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20287488|NCT04429022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20287489|NCT04429022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287490|NCT04429022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956256|NCT01642277|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19956257|NCT01642277|Cholinergic Agents|cholinergic agents|mesh-ancestor
20287491|NCT04429022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20271121|NCT00533741|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20271122|NCT00533741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20271123|NCT00533741|Immunologic Factors|immunologic factors|mesh-ancestor
20271124|NCT00533741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271125|NCT00533741|Antacids|antacids|mesh-ancestor
20271126|NCT00533741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271127|NCT00533741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20543993|NCT01872403|Paclitaxel|paclitaxel|mesh-list
20543994|NCT01872403|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19956258|NCT01642277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19956259|NCT01642277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956260|NCT01642277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956261|NCT01642277|Urological Agents|urological agents|mesh-ancestor
19956262|NCT01642407|Sildenafil Citrate|sildenafil citrate|mesh-list
19956263|NCT01642407|Vasodilator Agents|vasodilator agents|mesh-ancestor
19956264|NCT01642407|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19956265|NCT01642407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19956266|NCT01642407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956267|NCT01642407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956268|NCT01642407|Urological Agents|urological agents|mesh-ancestor
19956269|NCT01642485|Moxifloxacin|moxifloxacin|mesh-list
19956270|NCT01642485|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19956271|NCT01642485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956272|NCT01642485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19956273|NCT01642485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19956274|NCT01642485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19956275|NCT01642485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19956276|NCT01642485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956277|NCT01642485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956278|NCT01642485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956279|NCT01642485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19956280|NCT01642485|Contraceptive Agents|contraceptive agents|mesh-ancestor
19956281|NCT01642485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19956282|NCT01642485|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19956283|NCT01642485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19956284|NCT01642485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19956285|NCT01642589|Vaccines|vaccines|mesh-list
19956286|NCT01642589|Immunologic Factors|immunologic factors|mesh-ancestor
19956287|NCT01642589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956288|NCT01642602|Dexlansoprazole|dexlansoprazole|mesh-list
19956289|NCT01642602|Lansoprazole|lansoprazole|mesh-list
19956290|NCT01642602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19956291|NCT01642602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19956292|NCT01642602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19956293|NCT01642602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956294|NCT01642602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956295|NCT01642615|Dexlansoprazole|dexlansoprazole|mesh-list
19956296|NCT01642615|Lansoprazole|lansoprazole|mesh-list
19956297|NCT01642615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19956298|NCT01642615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19956299|NCT01642615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19956300|NCT01642615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956301|NCT01642615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956302|NCT01642914|Linaclotide|linaclotide|mesh-list
19956303|NCT01642914|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19956304|NCT01642914|Enzyme Activators|enzyme activators|mesh-ancestor
19956305|NCT01642914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956306|NCT01642914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19956307|NCT01643382|Insulin|insulin|mesh-list
19956308|NCT01643382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19956309|NCT01643382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19956310|NCT01643382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956311|NCT01643408|Asparaginase|asparaginase|mesh-list
19956312|NCT01643408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956313|NCT01643616|Midazolam|midazolam|mesh-list
19956314|NCT01643616|Ropivacaine|ropivacaine|mesh-list
19956315|NCT01643616|Prilocaine|prilocaine|mesh-list
19956316|NCT01643616|Anesthetics, Local|anesthetics, local|mesh-ancestor
19956317|NCT01643616|Anesthetics|anesthetics|mesh-ancestor
19956318|NCT01643616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19956319|NCT01643616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956320|NCT01643616|Sensory System Agents|sensory system agents|mesh-ancestor
19956321|NCT01643616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20543995|NCT01872403|Carboplatin|carboplatin|mesh-list
20271128|NCT00533858|Losartan|losartan|mesh-list
19956322|NCT01643616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19956323|NCT01643616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19956324|NCT01643616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19956325|NCT01643616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19956326|NCT01643616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19956327|NCT01643616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19956328|NCT01643616|Anesthetics, General|anesthetics, general|mesh-ancestor
19956329|NCT01643616|GABA Modulators|gaba modulators|mesh-ancestor
19956330|NCT01643616|GABA Agents|gaba agents|mesh-ancestor
19956331|NCT01643616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19956332|NCT01643616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956333|NCT01643668|Busulfan|busulfan|mesh-list
19956334|NCT01643668|Clofarabine|clofarabine|mesh-list
19956335|NCT01643668|Alkylating Agents|alkylating agents|mesh-ancestor
20271129|NCT00533858|Lacidipine|lacidipine|mesh-list
20271130|NCT00533858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20271131|NCT00533858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20271132|NCT00533858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20271133|NCT00533858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20271134|NCT00533858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271135|NCT00533858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20271136|NCT00533858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20271137|NCT00533858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20271138|NCT00533858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271139|NCT00533923|Cyclosporine|cyclosporine|mesh-list
20271140|NCT00533923|Cyclophosphamide|cyclophosphamide|mesh-list
20271141|NCT00533923|Fludarabine|fludarabine|mesh-list
20271142|NCT00533923|Alemtuzumab|alemtuzumab|mesh-list
20271143|NCT00533923|Cyclosporins|cyclosporins|mesh-list
20271144|NCT00533923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20271145|NCT00533923|Immunologic Factors|immunologic factors|mesh-ancestor
20271146|NCT00533923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271147|NCT00533923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20271148|NCT00533923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20271149|NCT00533923|Alkylating Agents|alkylating agents|mesh-ancestor
20271150|NCT00533923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271151|NCT00533923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271152|NCT00533923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20271153|NCT00533923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956336|NCT01643668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956337|NCT01643668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19956338|NCT01643668|Immunologic Factors|immunologic factors|mesh-ancestor
19956339|NCT01643668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956340|NCT01643668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19956341|NCT01643668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956342|NCT01643668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19956343|NCT01643668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19956344|NCT01643668|Antimetabolites|antimetabolites|mesh-ancestor
19956345|NCT01643772|Oxycodone|oxycodone|mesh-list
19956346|NCT01643772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19956347|NCT01643772|Narcotics|narcotics|mesh-ancestor
20271154|NCT00533923|Antifungal Agents|antifungal agents|mesh-ancestor
20271155|NCT00533923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271156|NCT00533923|Dermatologic Agents|dermatologic agents|mesh-ancestor
20271157|NCT00533923|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20271158|NCT00533923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20271159|NCT00533936|Paclitaxel|paclitaxel|mesh-list
20271160|NCT00533936|Cyclophosphamide|cyclophosphamide|mesh-list
20271161|NCT00533936|Doxorubicin|doxorubicin|mesh-list
20271162|NCT00533936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20271163|NCT00533936|Fluorouracil|fluorouracil|mesh-list
20271164|NCT00533936|Trastuzumab|trastuzumab|mesh-list
20271165|NCT00533936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20271166|NCT00533936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271167|NCT00533936|Tubulin Modulators|tubulin modulators|mesh-ancestor
19956348|NCT01643772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19956349|NCT01643772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956350|NCT01643772|Analgesics|analgesics|mesh-ancestor
19956351|NCT01643772|Sensory System Agents|sensory system agents|mesh-ancestor
19956352|NCT01643772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19956353|NCT01643902|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19956354|NCT01643902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19956355|NCT01643902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19956356|NCT01643902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956357|NCT01643928|Rituximab|rituximab|mesh-list
20554208|NCT01934088|Anesthetics|anesthetics|mesh-ancestor
19956358|NCT01643928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19956359|NCT01643928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956360|NCT01643928|Immunologic Factors|immunologic factors|mesh-ancestor
19956361|NCT01643928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956362|NCT01643928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19956363|NCT01644175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19956364|NCT01644175|Immunologic Factors|immunologic factors|mesh-ancestor
19956365|NCT01644175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956366|NCT01644188|Ezetimibe|ezetimibe|mesh-list
19956367|NCT01644188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19956368|NCT01644188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19956369|NCT01644188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19956370|NCT01644188|Antimetabolites|antimetabolites|mesh-ancestor
19956371|NCT01644188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956372|NCT01644188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19956373|NCT01644188|Immunologic Factors|immunologic factors|mesh-ancestor
19956374|NCT01644188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956375|NCT01644331|Tolvaptan|tolvaptan|mesh-list
19956376|NCT01644331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19956377|NCT01644331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956378|NCT01644331|Natriuretic Agents|natriuretic agents|mesh-ancestor
19956379|NCT01644331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956380|NCT01644396|Adalimumab|adalimumab|mesh-list
19956381|NCT01644396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19956382|NCT01644396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19956383|NCT01644474|Ezetimibe|ezetimibe|mesh-list
19956384|NCT01644474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19956385|NCT01644474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19956386|NCT01644474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19956387|NCT01644474|Antimetabolites|antimetabolites|mesh-ancestor
19956388|NCT01644474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956389|NCT01644474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19956390|NCT01644474|Immunologic Factors|immunologic factors|mesh-ancestor
19956391|NCT01644474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956392|NCT01644500|Glimepiride|glimepiride|mesh-list
19956393|NCT01644500|Dulaglutide|dulaglutide|mesh-list
19956394|NCT01644500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19956395|NCT01644500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19956396|NCT01644500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956397|NCT01644500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19956398|NCT01644500|Immunologic Factors|immunologic factors|mesh-ancestor
19956399|NCT01644643|Metronidazole|metronidazole|mesh-list
19956400|NCT01644643|Ceftazidime|ceftazidime|mesh-list
19956401|NCT01644643|Avibactam|avibactam|mesh-list
19956402|NCT01644643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19956403|NCT01644643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19956404|NCT01644643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19956405|NCT01644643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19956406|NCT01644643|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19956407|NCT01644643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956408|NCT01644643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956409|NCT01644734|Tiotropium Bromide|tiotropium bromide|mesh-list
19956410|NCT01644734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19956411|NCT01644734|Autonomic Agents|autonomic agents|mesh-ancestor
19956412|NCT01644734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19956413|NCT01644734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956414|NCT01644734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19956415|NCT01644734|Respiratory System Agents|respiratory system agents|mesh-ancestor
19956416|NCT01644734|Parasympatholytics|parasympatholytics|mesh-ancestor
19956417|NCT01644734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19956418|NCT01644734|Cholinergic Agents|cholinergic agents|mesh-ancestor
19956419|NCT01644734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19956420|NCT01644734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956421|NCT01644890|Paclitaxel|paclitaxel|mesh-list
19956422|NCT01644890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19956423|NCT01644890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956424|NCT01644890|Tubulin Modulators|tubulin modulators|mesh-ancestor
19956425|NCT01644890|Antimitotic Agents|antimitotic agents|mesh-ancestor
20271168|NCT00533936|Antimitotic Agents|antimitotic agents|mesh-ancestor
20271169|NCT00533936|Mitosis Modulators|mitosis modulators|mesh-ancestor
20271170|NCT00533936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271171|NCT00533936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20271172|NCT00533936|Immunologic Factors|immunologic factors|mesh-ancestor
19956426|NCT01644890|Mitosis Modulators|mitosis modulators|mesh-ancestor
19956427|NCT01644890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956428|NCT01645098|Dexmedetomidine|dexmedetomidine|mesh-list
19956429|NCT01645098|Ketamine|ketamine|mesh-list
19956430|NCT01645098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19956431|NCT01645098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19956432|NCT01645098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956433|NCT01645098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19956434|NCT01645098|Analgesics|analgesics|mesh-ancestor
19956435|NCT01645098|Sensory System Agents|sensory system agents|mesh-ancestor
19956436|NCT01645098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19956437|NCT01645098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19956438|NCT01645098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19956439|NCT01645098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19956440|NCT01645098|Adrenergic Agents|adrenergic agents|mesh-ancestor
19956441|NCT01645098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19956442|NCT01645098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956443|NCT01645098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19956444|NCT01645098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19956445|NCT01645098|Anesthetics, General|anesthetics, general|mesh-ancestor
19956446|NCT01645098|Anesthetics|anesthetics|mesh-ancestor
19956447|NCT01645098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19956448|NCT01645098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19956449|NCT01645111|Clevidipine|clevidipine|mesh-list
20271173|NCT00533936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271174|NCT00533936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20271175|NCT00533936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20271176|NCT00533936|Alkylating Agents|alkylating agents|mesh-ancestor
20271177|NCT00533936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20271178|NCT00533936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20271179|NCT00533936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20271180|NCT00533936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20271181|NCT00533936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271182|NCT00533936|Antimetabolites|antimetabolites|mesh-ancestor
20271183|NCT00533936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20271184|NCT00533936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20271185|NCT00533962|Anecortave|anecortave|mesh-list
20271186|NCT00533962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20271187|NCT00533962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20271188|NCT00533962|Growth Substances|growth substances|mesh-ancestor
20271189|NCT00533962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271190|NCT00533962|Growth Inhibitors|growth inhibitors|mesh-ancestor
20271191|NCT00533962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271192|NCT00533988|Anti-Infective Agents|anti-infective agents|mesh-list
20271193|NCT00533988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20271194|NCT00534014|Ascorbic Acid|ascorbic acid|mesh-list
20271195|NCT00534014|Vitamins|vitamins|mesh-ancestor
20271196|NCT00534014|Micronutrients|micronutrients|mesh-ancestor
19956450|NCT01645111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20271197|NCT00534014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271198|NCT00534014|Antioxidants|antioxidants|mesh-ancestor
20271199|NCT00534014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271200|NCT00534014|Protective Agents|protective agents|mesh-ancestor
20271201|NCT00534144|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20271202|NCT00534144|Ferric gluconate|ferric gluconate|mesh-list
20271203|NCT00534144|Hematinics|hematinics|mesh-ancestor
20271204|NCT00534183|Haloperidol|haloperidol|mesh-list
20271205|NCT00534183|Olanzapine|olanzapine|mesh-list
20271206|NCT00534183|Risperidone|risperidone|mesh-list
20271207|NCT00534183|Haloperidol decanoate|haloperidol decanoate|mesh-list
20271208|NCT00534183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20271209|NCT00534183|Serotonin Agents|serotonin agents|mesh-ancestor
20271210|NCT00534183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20271211|NCT00534183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271212|NCT00534183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271213|NCT00534183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20271214|NCT00534183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20271215|NCT00534183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19956451|NCT01645111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20271216|NCT00534183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20271217|NCT00534183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20271218|NCT00534183|Dopamine Agents|dopamine agents|mesh-ancestor
20271219|NCT00534183|Antiemetics|antiemetics|mesh-ancestor
20271220|NCT00534183|Autonomic Agents|autonomic agents|mesh-ancestor
20271221|NCT00534183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20271222|NCT00534183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20271223|NCT00534183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20271224|NCT00534183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20271225|NCT00534183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20271226|NCT00534183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20271227|NCT00534261|Interferons|interferons|mesh-list
20271228|NCT00534261|Interferon-beta|interferon-beta|mesh-list
20271229|NCT00534261|Interferon beta-1a|interferon beta-1a|mesh-list
20271230|NCT00534261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271231|NCT00534261|Antiviral Agents|antiviral agents|mesh-ancestor
20271232|NCT00534261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271233|NCT00534261|Immunologic Factors|immunologic factors|mesh-ancestor
20271234|NCT00534261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271235|NCT00534261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20271236|NCT00534287|Moxifloxacin|moxifloxacin|mesh-list
20271237|NCT00534287|Meropenem|meropenem|mesh-list
19956452|NCT01645111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956453|NCT01645111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19956454|NCT01645111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956455|NCT01645176|Hydroxychloroquine|hydroxychloroquine|mesh-list
19956456|NCT01645176|Atorvastatin|atorvastatin|mesh-list
19956457|NCT01645176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19956458|NCT01645176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19956459|NCT01645176|Antimetabolites|antimetabolites|mesh-ancestor
19956460|NCT01645176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956461|NCT01645176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19956462|NCT01645176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19956463|NCT01645176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956464|NCT01645176|Antimalarials|antimalarials|mesh-ancestor
19956465|NCT01645176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19956466|NCT01645176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19956467|NCT01645176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19956468|NCT01645176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20271238|NCT00534287|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20271239|NCT00534287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20271240|NCT00534287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271241|NCT00534287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20271242|NCT00534287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20271243|NCT00534287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271244|NCT00534287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271245|NCT00534287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271246|NCT00534287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20271247|NCT00534287|Contraceptive Agents|contraceptive agents|mesh-ancestor
20271248|NCT00534287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20271249|NCT00534287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271250|NCT00534287|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20271251|NCT00534287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20271252|NCT00534287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20271253|NCT00534378|Midazolam|midazolam|mesh-list
20271254|NCT00534378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20271255|NCT00534378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20271256|NCT00534378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20271257|NCT00534378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271258|NCT00534378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20271259|NCT00534378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20271260|NCT00534378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20271261|NCT00534378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20271262|NCT00534378|Anesthetics, General|anesthetics, general|mesh-ancestor
20271263|NCT00534378|Anesthetics|anesthetics|mesh-ancestor
20271264|NCT00534378|GABA Modulators|gaba modulators|mesh-ancestor
20271265|NCT00534378|GABA Agents|gaba agents|mesh-ancestor
20271266|NCT00534378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20271267|NCT00534378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271268|NCT00534391|Polymyxins|polymyxins|mesh-list
20271269|NCT00534391|Neomycin|neomycin|mesh-list
20271270|NCT00534391|Polymyxin B|polymyxin b|mesh-list
20271271|NCT00534391|Gramicidin|gramicidin|mesh-list
19956469|NCT01645280|Methotrexate|methotrexate|mesh-list
19956470|NCT01645280|Ustekinumab|ustekinumab|mesh-list
19975484|NCT01849562|Odalasvir|odalasvir|mesh-list
20271272|NCT00534391|Lubricant Eye Drops|lubricant eye drops|mesh-list
20271273|NCT00534391|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19956471|NCT01645280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19956472|NCT01645280|Abortifacient Agents|abortifacient agents|mesh-ancestor
19956473|NCT01645280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19956474|NCT01645280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956475|NCT01645280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20271274|NCT00534391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20271275|NCT00534391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20271276|NCT00534391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271277|NCT00534391|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20271278|NCT00534391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271279|NCT00534391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271280|NCT00534391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20271281|NCT00534456|Darbepoetin alfa|darbepoetin alfa|mesh-list
19956476|NCT01645280|Antimetabolites|antimetabolites|mesh-ancestor
19956477|NCT01645280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956478|NCT01645280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956479|NCT01645280|Dermatologic Agents|dermatologic agents|mesh-ancestor
19956480|NCT01645280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956481|NCT01645280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19956482|NCT01645280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19956483|NCT01645280|Immunologic Factors|immunologic factors|mesh-ancestor
19956484|NCT01645280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19956485|NCT01645280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19956486|NCT01645735|Vancomycin|vancomycin|mesh-list
19956487|NCT01645735|Ceftriaxone|ceftriaxone|mesh-list
19956488|NCT01645735|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19956489|NCT01645735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19956490|NCT01645735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271282|NCT00534456|Hematinics|hematinics|mesh-ancestor
20271283|NCT00534508|Tacrolimus|tacrolimus|mesh-list
20271284|NCT00534508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20271285|NCT00534508|Immunologic Factors|immunologic factors|mesh-ancestor
20271286|NCT00534508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271287|NCT00534508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20271288|NCT00534508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271289|NCT00534508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271290|NCT00534573|Amisulpride|amisulpride|mesh-list
20271291|NCT00534573|Moclobemide|moclobemide|mesh-list
20271292|NCT00534573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20271293|NCT00534573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20271294|NCT00534573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20271295|NCT00534573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271296|NCT00534573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20271297|NCT00534573|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20543996|NCT01872403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20543997|NCT01872403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20543998|NCT01872403|Tubulin Modulators|tubulin modulators|mesh-ancestor
20543999|NCT01872403|Antimitotic Agents|antimitotic agents|mesh-ancestor
20544000|NCT01872403|Mitosis Modulators|mitosis modulators|mesh-ancestor
20544001|NCT01872403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544002|NCT01872416|Doxorubicin|doxorubicin|mesh-list
20544003|NCT01872416|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20544004|NCT01872416|Ifosfamide|ifosfamide|mesh-list
20544005|NCT01872416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20544006|NCT01872416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544007|NCT01872416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20544008|NCT01872416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19956491|NCT01645930|Dexamethasone|dexamethasone|mesh-list
19956492|NCT01645930|Lenalidomide|lenalidomide|mesh-list
19956493|NCT01645930|Ixazomib|ixazomib|mesh-list
19956494|NCT01645930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19956495|NCT01645930|Antiemetics|antiemetics|mesh-ancestor
19956496|NCT01645930|Autonomic Agents|autonomic agents|mesh-ancestor
19956497|NCT01645930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19956498|NCT01645930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956499|NCT01645930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19956500|NCT01645930|Glucocorticoids|glucocorticoids|mesh-ancestor
19956501|NCT01645930|Hormones|hormones|mesh-ancestor
19956502|NCT01645930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20544009|NCT01872416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956503|NCT01645930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19956504|NCT01645930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956505|NCT01645930|Immunologic Factors|immunologic factors|mesh-ancestor
19956506|NCT01645930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20544010|NCT01872416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956507|NCT01645930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19956508|NCT01645930|Growth Substances|growth substances|mesh-ancestor
19956509|NCT01645930|Growth Inhibitors|growth inhibitors|mesh-ancestor
19956510|NCT01645930|Protease Inhibitors|protease inhibitors|mesh-ancestor
20271298|NCT00534573|Dopamine Agents|dopamine agents|mesh-ancestor
20271299|NCT00534573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20271300|NCT00534573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271301|NCT00534573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20271302|NCT00534573|Antidepressive Agents|antidepressive agents|mesh-ancestor
20271303|NCT00534573|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20271304|NCT00534573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271305|NCT00534586|Ketamine|ketamine|mesh-list
20271306|NCT00534586|Remifentanil|remifentanil|mesh-list
20271307|NCT00534586|Propofol|propofol|mesh-list
20271308|NCT00534586|Sevoflurane|sevoflurane|mesh-list
20271309|NCT00534586|Esketamine|esketamine|mesh-list
20271310|NCT00534586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20271311|NCT00534586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20271312|NCT00534586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271313|NCT00534586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20271314|NCT00534586|Anesthetics, General|anesthetics, general|mesh-ancestor
20271315|NCT00534586|Anesthetics|anesthetics|mesh-ancestor
20271316|NCT00534586|Analgesics|analgesics|mesh-ancestor
20271317|NCT00534586|Sensory System Agents|sensory system agents|mesh-ancestor
20271318|NCT00534586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20271319|NCT00534586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20271320|NCT00534586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20271321|NCT00534586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20271322|NCT00534586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20544011|NCT01872416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20544012|NCT01872416|Alkylating Agents|alkylating agents|mesh-ancestor
19956511|NCT01645930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956512|NCT01645930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544013|NCT01872442|Interferons|interferons|mesh-list
20544014|NCT01872442|Interferon-alpha|interferon-alpha|mesh-list
20544015|NCT01872442|Interferon alpha-2|interferon alpha-2|mesh-list
20544016|NCT01872442|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20544017|NCT01872442|Dasatinib|dasatinib|mesh-list
20544018|NCT01872442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544019|NCT01872442|Antiviral Agents|antiviral agents|mesh-ancestor
20544020|NCT01872442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20544021|NCT01872442|Immunologic Factors|immunologic factors|mesh-ancestor
20544022|NCT01872442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544023|NCT01872442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20544024|NCT01872442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544025|NCT01872442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544026|NCT01872494|Flurbiprofen|flurbiprofen|mesh-list
20544027|NCT01872494|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
19956513|NCT01646021|Sirolimus|sirolimus|mesh-list
19956514|NCT01646021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20544028|NCT01872494|Pentazocine|pentazocine|mesh-list
20544029|NCT01872494|Palonosetron|palonosetron|mesh-list
20544030|NCT01872494|Ropivacaine|ropivacaine|mesh-list
20544031|NCT01872494|Anesthetics, Local|anesthetics, local|mesh-ancestor
20544032|NCT01872494|Anesthetics|anesthetics|mesh-ancestor
20544033|NCT01872494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20544034|NCT01872494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544035|NCT01872494|Sensory System Agents|sensory system agents|mesh-ancestor
20544036|NCT01872494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20544037|NCT01872494|Antiemetics|antiemetics|mesh-ancestor
20544038|NCT01872494|Autonomic Agents|autonomic agents|mesh-ancestor
20544039|NCT01872494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20544040|NCT01872494|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20544041|NCT01872494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20544042|NCT01872494|Serotonin Agents|serotonin agents|mesh-ancestor
20544043|NCT01872494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20544044|NCT01872494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544045|NCT01872494|Analgesics|analgesics|mesh-ancestor
20544046|NCT01872494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20544047|NCT01872494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20544048|NCT01872494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19956515|NCT01646021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19975485|NCT01849562|Antimetabolites|antimetabolites|mesh-ancestor
20271323|NCT00534586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544049|NCT01872494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20271324|NCT00534586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20271325|NCT00534586|Narcotics|narcotics|mesh-ancestor
20271326|NCT00534586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20271327|NCT00534586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20271328|NCT00534586|Antidepressive Agents|antidepressive agents|mesh-ancestor
20271329|NCT00534586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20271330|NCT00534625|Zileuton|zileuton|mesh-list
20271331|NCT00534625|Hydroxyurea|hydroxyurea|mesh-list
20271332|NCT00534625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20271333|NCT00534625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20271334|NCT00534625|Analgesics|analgesics|mesh-ancestor
20271335|NCT00534625|Sensory System Agents|sensory system agents|mesh-ancestor
19956516|NCT01646021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19956517|NCT01646021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956518|NCT01646021|Antifungal Agents|antifungal agents|mesh-ancestor
19956519|NCT01646021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19956520|NCT01646021|Immunologic Factors|immunologic factors|mesh-ancestor
19956521|NCT01646021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956522|NCT01646073|Adalimumab|adalimumab|mesh-list
19956523|NCT01646073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19956524|NCT01646073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19956525|NCT01646125|Docetaxel|docetaxel|mesh-list
19956526|NCT01646125|Pemetrexed|pemetrexed|mesh-list
19956527|NCT01646125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956528|NCT01646125|Tubulin Modulators|tubulin modulators|mesh-ancestor
19956529|NCT01646125|Antimitotic Agents|antimitotic agents|mesh-ancestor
19956530|NCT01646125|Mitosis Modulators|mitosis modulators|mesh-ancestor
19956531|NCT01646125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956532|NCT01646125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956533|NCT01646125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19956534|NCT01646125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20271336|NCT00534625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20271337|NCT00534625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271338|NCT00534625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20271339|NCT00534625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20271340|NCT00534625|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20271341|NCT00534625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271342|NCT00534625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271343|NCT00534625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20271344|NCT00534625|Hormone Antagonists|hormone antagonists|mesh-ancestor
20271345|NCT00534625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20271346|NCT00534625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271347|NCT00534625|Antisickling Agents|antisickling agents|mesh-ancestor
20271348|NCT00534625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20271349|NCT00534651|Acetaminophen|acetaminophen|mesh-list
20271350|NCT00534651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20271351|NCT00534651|Analgesics|analgesics|mesh-ancestor
19956535|NCT01646151|Bimatoprost|bimatoprost|mesh-list
19956536|NCT01646151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19956537|NCT01646177|Etanercept|etanercept|mesh-list
20271352|NCT00534651|Sensory System Agents|sensory system agents|mesh-ancestor
20271353|NCT00534651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20271354|NCT00534651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271355|NCT00534651|Antipyretics|antipyretics|mesh-ancestor
20271356|NCT00534677|Octreotide|octreotide|mesh-list
20271357|NCT00534677|Terlipressin|terlipressin|mesh-list
20271358|NCT00534677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20271359|NCT00534677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20271360|NCT00534677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271361|NCT00534677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20271362|NCT00534677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20271363|NCT00534729|Carboplatin|carboplatin|mesh-list
19956538|NCT01646177|Ixekizumab|ixekizumab|mesh-list
20271364|NCT00534729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271365|NCT00534807|Rifampin|rifampin|mesh-list
20271366|NCT00534807|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20271367|NCT00534807|Antitubercular Agents|antitubercular agents|mesh-ancestor
20271368|NCT00534807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20271369|NCT00534807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271370|NCT00534807|Leprostatic Agents|leprostatic agents|mesh-ancestor
20271371|NCT00534807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20271372|NCT00534807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271373|NCT00534807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271374|NCT00534807|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20287492|NCT04429022|Narcotics|narcotics|mesh-ancestor
19956539|NCT01646177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20271375|NCT00534807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20271376|NCT00534807|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20271377|NCT00534807|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20271378|NCT00534807|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20271379|NCT00534807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19956540|NCT01646177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19956541|NCT01646177|Analgesics|analgesics|mesh-ancestor
19956542|NCT01646177|Sensory System Agents|sensory system agents|mesh-ancestor
19956543|NCT01646177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19956544|NCT01646177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956545|NCT01646177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19956546|NCT01646177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19956547|NCT01646177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19956548|NCT01646177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19956549|NCT01646177|Immunologic Factors|immunologic factors|mesh-ancestor
19956550|NCT01646177|Dermatologic Agents|dermatologic agents|mesh-ancestor
19956551|NCT01646255|Levodopa|levodopa|mesh-list
19956552|NCT01646255|Rotigotine|rotigotine|mesh-list
19956553|NCT01646255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19956554|NCT01646255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19956555|NCT01646255|Dopamine Agents|dopamine agents|mesh-ancestor
19956556|NCT01646255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19956557|NCT01646255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956558|NCT01646255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956559|NCT01646255|Dopamine Agonists|dopamine agonists|mesh-ancestor
19956560|NCT01646268|Rotigotine|rotigotine|mesh-list
19956561|NCT01646268|Dopamine Agonists|dopamine agonists|mesh-ancestor
19956562|NCT01646268|Dopamine Agents|dopamine agents|mesh-ancestor
19956563|NCT01646268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19956564|NCT01646268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956565|NCT01646268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956566|NCT01646320|Metformin|metformin|mesh-list
19956567|NCT01646320|Dapagliflozin|dapagliflozin|mesh-list
19956568|NCT01646320|Saxagliptin|saxagliptin|mesh-list
19956569|NCT01646320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19956570|NCT01646320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956571|NCT01646320|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19956572|NCT01646320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956573|NCT01646320|Incretins|incretins|mesh-ancestor
19956574|NCT01646320|Hormones|hormones|mesh-ancestor
19956575|NCT01646320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19956576|NCT01646320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19956577|NCT01646320|Protease Inhibitors|protease inhibitors|mesh-ancestor
19956578|NCT01646320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956579|NCT01646385|Etanercept|etanercept|mesh-list
19956580|NCT01646385|Antirheumatic Agents|antirheumatic agents|mesh-list
19956581|NCT01646385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19956582|NCT01646385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19956583|NCT01646385|Analgesics|analgesics|mesh-ancestor
19956584|NCT01646385|Sensory System Agents|sensory system agents|mesh-ancestor
19956585|NCT01646385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19956586|NCT01646385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956587|NCT01646385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19956588|NCT01646385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19956589|NCT01646385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19956590|NCT01646385|Immunologic Factors|immunologic factors|mesh-ancestor
19956591|NCT01646398|Vaccines|vaccines|mesh-list
19956592|NCT01646398|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19956593|NCT01646398|Immunologic Factors|immunologic factors|mesh-ancestor
19956594|NCT01646398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956595|NCT01646671|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19956596|NCT01646671|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19956597|NCT01646671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956598|NCT01646762|Paclitaxel|paclitaxel|mesh-list
19956599|NCT01646762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19956600|NCT01646762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19956601|NCT01646762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956602|NCT01646762|Tubulin Modulators|tubulin modulators|mesh-ancestor
19956603|NCT01646762|Antimitotic Agents|antimitotic agents|mesh-ancestor
19956604|NCT01646762|Mitosis Modulators|mitosis modulators|mesh-ancestor
19956605|NCT01646762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956606|NCT01646827|Aripiprazole|aripiprazole|mesh-list
19956607|NCT01646827|Antidepressive Agents|antidepressive agents|mesh-ancestor
20271380|NCT00534846|Toremifene|toremifene|mesh-list
19956608|NCT01646827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19956609|NCT01646827|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19956610|NCT01646827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19956611|NCT01646827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19956612|NCT01646827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956613|NCT01646827|Dopamine Agonists|dopamine agonists|mesh-ancestor
19956614|NCT01646827|Dopamine Agents|dopamine agents|mesh-ancestor
19956615|NCT01646827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19956616|NCT01646827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956617|NCT01646827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19956618|NCT01646827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19956619|NCT01646827|Serotonin Agents|serotonin agents|mesh-ancestor
19956620|NCT01646827|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19956621|NCT01646827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19956622|NCT01646827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19956623|NCT01646827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19956624|NCT01647282|Minocycline|minocycline|mesh-list
20271381|NCT00534846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20271382|NCT00534846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271383|NCT00534846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20271384|NCT00534846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20271385|NCT00534846|Hormone Antagonists|hormone antagonists|mesh-ancestor
20271386|NCT00534846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20271387|NCT00534846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271388|NCT00534846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20271389|NCT00534898|Fenretinide|fenretinide|mesh-list
20271390|NCT00534898|Bexarotene|bexarotene|mesh-list
20271391|NCT00534898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271392|NCT00534898|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20271393|NCT00534898|Protective Agents|protective agents|mesh-ancestor
20271394|NCT00534898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271395|NCT00535080|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20271396|NCT00535080|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20271397|NCT00535080|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20271398|NCT00535080|Dermatologic Agents|dermatologic agents|mesh-ancestor
20271399|NCT00535119|Paclitaxel|paclitaxel|mesh-list
20271400|NCT00535119|Carboplatin|carboplatin|mesh-list
20271401|NCT00535119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20271402|NCT00535119|Veliparib|veliparib|mesh-list
20271403|NCT00535119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20271404|NCT00535119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271405|NCT00535119|Tubulin Modulators|tubulin modulators|mesh-ancestor
20271406|NCT00535119|Antimitotic Agents|antimitotic agents|mesh-ancestor
20271407|NCT00535119|Mitosis Modulators|mitosis modulators|mesh-ancestor
19956625|NCT01647282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19956626|NCT01647282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271408|NCT00535119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271409|NCT00535119|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20271410|NCT00535119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271411|NCT00535158|Vitamin D|vitamin d|mesh-list
20271412|NCT00535158|Ergocalciferols|ergocalciferols|mesh-list
20271413|NCT00535158|Vitamins|vitamins|mesh-ancestor
20271414|NCT00535158|Micronutrients|micronutrients|mesh-ancestor
20271415|NCT00535158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271416|NCT00535158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20271417|NCT00535158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20271418|NCT00535340|Amibegron|amibegron|mesh-list
20271419|NCT00535340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20271420|NCT00535340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20271421|NCT00535340|Adrenergic Agents|adrenergic agents|mesh-ancestor
20271422|NCT00535340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20271423|NCT00535340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271424|NCT00535340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271425|NCT00535353|Irinotecan|irinotecan|mesh-list
20271426|NCT00535353|Olaparib|olaparib|mesh-list
20271427|NCT00535353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20271428|NCT00535353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20271429|NCT00535353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271430|NCT00535353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271431|NCT00535353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271432|NCT00535353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20271433|NCT00535379|Sunitinib|sunitinib|mesh-list
20544050|NCT01872494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20271434|NCT00535379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956627|NCT01647516|Ozanimod|ozanimod|mesh-list
19956628|NCT01647516|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19956629|NCT01647516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956630|NCT01647516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19956631|NCT01647516|Immunologic Factors|immunologic factors|mesh-ancestor
19956632|NCT01647516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956633|NCT01647581|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19956634|NCT01647581|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
20271435|NCT00535379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20271436|NCT00535379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20271437|NCT00535379|Growth Substances|growth substances|mesh-ancestor
20271438|NCT00535379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271439|NCT00535379|Growth Inhibitors|growth inhibitors|mesh-ancestor
20271440|NCT00535379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20271441|NCT00535379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271442|NCT00535379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271443|NCT00535418|Letrozole|letrozole|mesh-list
20271444|NCT00535418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271445|NCT00535418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20271446|NCT00535418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20271447|NCT00535418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271448|NCT00535418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271449|NCT00535418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20271450|NCT00535418|Hormone Antagonists|hormone antagonists|mesh-ancestor
20271451|NCT00535418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20271452|NCT00535418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544051|NCT01872494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544052|NCT01872494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20544053|NCT01872494|Narcotics|narcotics|mesh-ancestor
20544054|NCT01872494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20544055|NCT01872494|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20544056|NCT01872546|Adalimumab|adalimumab|mesh-list
20544057|NCT01872546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20544058|NCT01872546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20544059|NCT01872702|Piperaquine|piperaquine|mesh-list
20544060|NCT01872702|Primaquine|primaquine|mesh-list
20544061|NCT01872702|Artenimol|artenimol|mesh-list
20544062|NCT01872702|Antimalarials|antimalarials|mesh-ancestor
20544063|NCT01872702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20544064|NCT01872702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20544065|NCT01872702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20544066|NCT01872728|Anesthetics|anesthetics|mesh-list
20544067|NCT01872728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19956635|NCT01647581|beta-Endorphin|beta-endorphin|mesh-list
19956636|NCT01647581|Hormones|hormones|mesh-ancestor
19956637|NCT01647581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19956638|NCT01647581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956639|NCT01647581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19956640|NCT01647581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956641|NCT01647945|Tacrolimus|tacrolimus|mesh-list
19956642|NCT01647945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19956643|NCT01647945|Immunologic Factors|immunologic factors|mesh-ancestor
19956644|NCT01647945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956645|NCT01647945|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19956646|NCT01647945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956647|NCT01647945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956648|NCT01648101|Ezogabine|ezogabine|mesh-list
19956649|NCT01648101|Anticonvulsants|anticonvulsants|mesh-ancestor
19956650|NCT01648101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19956651|NCT01648101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956652|NCT01648140|Interferons|interferons|mesh-list
19956653|NCT01648140|Ribavirin|ribavirin|mesh-list
19956654|NCT01648140|Interferon-alpha|interferon-alpha|mesh-list
19956655|NCT01648140|Interferon alpha-2|interferon alpha-2|mesh-list
19956656|NCT01648140|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19956657|NCT01648140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956658|NCT01648140|Antiviral Agents|antiviral agents|mesh-ancestor
19956659|NCT01648140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19956660|NCT01648140|Antimetabolites|antimetabolites|mesh-ancestor
19956661|NCT01648140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956662|NCT01648140|Immunologic Factors|immunologic factors|mesh-ancestor
19956663|NCT01648140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544068|NCT01872728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544069|NCT01872754|Remifentanil|remifentanil|mesh-list
20544070|NCT01872754|Propofol|propofol|mesh-list
20271453|NCT00535470|Mechlorethamine|mechlorethamine|mesh-list
20271454|NCT00535470|Alkylating Agents|alkylating agents|mesh-ancestor
20271455|NCT00535470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271456|NCT00535470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20271457|NCT00535470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271458|NCT00535509|Cisplatin|cisplatin|mesh-list
20271459|NCT00535509|Docetaxel|docetaxel|mesh-list
20271460|NCT00535509|Trastuzumab|trastuzumab|mesh-list
20271461|NCT00535509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271462|NCT00535509|Tubulin Modulators|tubulin modulators|mesh-ancestor
20271463|NCT00535509|Antimitotic Agents|antimitotic agents|mesh-ancestor
20271464|NCT00535509|Mitosis Modulators|mitosis modulators|mesh-ancestor
20271465|NCT00535509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271466|NCT00535509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20287493|NCT04429022|Anticonvulsants|anticonvulsants|mesh-ancestor
20287494|NCT04429022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20287495|NCT04429022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20287496|NCT04429022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20287497|NCT04429022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20287498|NCT04429022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20287499|NCT04429022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20287500|NCT04429022|Antimanic Agents|antimanic agents|mesh-ancestor
20287501|NCT04413279|Dexamethasone|dexamethasone|mesh-list
20287502|NCT04413279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20287503|NCT04413279|Antiemetics|antiemetics|mesh-ancestor
20287504|NCT04413279|Autonomic Agents|autonomic agents|mesh-ancestor
20287505|NCT04413279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287506|NCT04413279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287507|NCT04413279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20287508|NCT04413279|Glucocorticoids|glucocorticoids|mesh-ancestor
20287509|NCT04413279|Hormones|hormones|mesh-ancestor
20287510|NCT04413279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20287511|NCT04413279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20287512|NCT04413279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287513|NCT04413253|Dexamethasone|dexamethasone|mesh-list
20287514|NCT04413253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20287515|NCT04413253|Lifitegrast|lifitegrast|mesh-list
20287516|NCT04413253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20287517|NCT04413253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20287518|NCT04413253|Antiemetics|antiemetics|mesh-ancestor
20287519|NCT04413253|Autonomic Agents|autonomic agents|mesh-ancestor
20287520|NCT04413253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287521|NCT04413253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287522|NCT04413253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20287523|NCT04413253|Glucocorticoids|glucocorticoids|mesh-ancestor
20287524|NCT04413253|Hormones|hormones|mesh-ancestor
20287525|NCT04413253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20287526|NCT04413253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20287527|NCT04413253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287528|NCT04333407|Aspirin|aspirin|mesh-list
20287529|NCT04333407|Omeprazole|omeprazole|mesh-list
20287530|NCT04333407|Rivaroxaban|rivaroxaban|mesh-list
20287531|NCT04333407|Clopidogrel|clopidogrel|mesh-list
20287532|NCT04333407|Atorvastatin|atorvastatin|mesh-list
20287533|NCT04333407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20287534|NCT04333407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20287535|NCT04333407|Analgesics|analgesics|mesh-ancestor
20287536|NCT04333407|Sensory System Agents|sensory system agents|mesh-ancestor
20287537|NCT04333407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287538|NCT04333407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287539|NCT04333407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20287540|NCT04333407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20287541|NCT04333407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20287542|NCT04333407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20287543|NCT04333407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287544|NCT04333407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20287545|NCT04333407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20287546|NCT04333407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287547|NCT04333407|Antipyretics|antipyretics|mesh-ancestor
20287548|NCT04333407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20287549|NCT04333407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20287550|NCT04333407|Antimetabolites|antimetabolites|mesh-ancestor
20287551|NCT04333407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20287552|NCT04333407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20287553|NCT04333407|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20287554|NCT04333407|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19956664|NCT01648283|Methadone|methadone|mesh-list
19956665|NCT01648283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19956666|NCT01648283|Narcotics|narcotics|mesh-ancestor
19956667|NCT01648283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19956668|NCT01648283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956669|NCT01648283|Analgesics|analgesics|mesh-ancestor
19956670|NCT01648283|Sensory System Agents|sensory system agents|mesh-ancestor
19956671|NCT01648283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19956672|NCT01648283|Antitussive Agents|antitussive agents|mesh-ancestor
20271467|NCT00535574|Bexarotene|bexarotene|mesh-list
20271468|NCT00535574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271469|NCT00535665|Vaccines|vaccines|mesh-list
20271470|NCT00535665|Immunologic Factors|immunologic factors|mesh-ancestor
20271471|NCT00535665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271472|NCT00535691|Tacrolimus|tacrolimus|mesh-list
20271473|NCT00535691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20271474|NCT00535691|Immunologic Factors|immunologic factors|mesh-ancestor
20271475|NCT00535691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271476|NCT00535691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20271477|NCT00535691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271478|NCT00535691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271479|NCT00535808|Nitroprusside|nitroprusside|mesh-list
20271480|NCT00535808|Nitroglycerin|nitroglycerin|mesh-list
20271481|NCT00535808|Sevoflurane|sevoflurane|mesh-list
20271482|NCT00535808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20271483|NCT00535808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20271484|NCT00535808|Anesthetics, General|anesthetics, general|mesh-ancestor
20271485|NCT00535808|Anesthetics|anesthetics|mesh-ancestor
19956673|NCT01648283|Respiratory System Agents|respiratory system agents|mesh-ancestor
19956674|NCT01648348|Bevacizumab|bevacizumab|mesh-list
19956675|NCT01648348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19956676|NCT01648348|Endothelial Growth Factors|endothelial growth factors|mesh-list
19956677|NCT01648348|Antibodies|antibodies|mesh-list
19956678|NCT01648348|Immunoglobulins|immunoglobulins|mesh-list
19956679|NCT01648348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19956680|NCT01648348|Immunoglobulin G|immunoglobulin g|mesh-list
19956681|NCT01648348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956682|NCT01648348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19956683|NCT01648348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19956684|NCT01648348|Growth Substances|growth substances|mesh-ancestor
19956685|NCT01648348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956686|NCT01648348|Growth Inhibitors|growth inhibitors|mesh-ancestor
19956687|NCT01648348|Immunologic Factors|immunologic factors|mesh-ancestor
19956688|NCT01648582|Metformin|metformin|mesh-list
20271486|NCT00535808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20271487|NCT00535808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544071|NCT01872754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20544072|NCT01872754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20544073|NCT01872754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544074|NCT01872754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20544075|NCT01872754|Anesthetics, General|anesthetics, general|mesh-ancestor
20544076|NCT01872754|Anesthetics|anesthetics|mesh-ancestor
20544077|NCT01872754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20544078|NCT01872754|Narcotics|narcotics|mesh-ancestor
20544079|NCT01872754|Analgesics|analgesics|mesh-ancestor
20544080|NCT01872754|Sensory System Agents|sensory system agents|mesh-ancestor
20544081|NCT01872754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19956689|NCT01648582|Insulin Glargine|insulin glargine|mesh-list
20544082|NCT01872780|Rosiglitazone|rosiglitazone|mesh-list
20544083|NCT01872780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20544084|NCT01872780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544085|NCT01872832|Verinurad|verinurad|mesh-list
20544086|NCT01872832|Gout Suppressants|gout suppressants|mesh-ancestor
20544087|NCT01872832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20544088|NCT01872845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20544089|NCT01872845|Pravastatin|pravastatin|mesh-list
20544090|NCT01872845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20544091|NCT01872845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20544092|NCT01872845|Antimetabolites|antimetabolites|mesh-ancestor
20544093|NCT01872845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544094|NCT01872845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20544095|NCT01872845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20544096|NCT01872845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544097|NCT01872858|Aspirin|aspirin|mesh-list
20271488|NCT00535808|Vasodilator Agents|vasodilator agents|mesh-ancestor
20544098|NCT01872858|Cilostazol|cilostazol|mesh-list
19956690|NCT01648582|Dulaglutide|dulaglutide|mesh-list
19956691|NCT01648582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20271489|NCT00535808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20271490|NCT00535808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20271491|NCT00535808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271492|NCT00535860|Teriparatide|teriparatide|mesh-list
20271493|NCT00535860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20271494|NCT00535860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271495|NCT00535860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20271496|NCT00535951|Panobinostat|panobinostat|mesh-list
20271497|NCT00535951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271498|NCT00535951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20271499|NCT00535951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271500|NCT00535951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271501|NCT00536003|Progesterone|progesterone|mesh-list
20271502|NCT00536003|Progestins|progestins|mesh-ancestor
20271503|NCT00536003|Hormones|hormones|mesh-ancestor
20271504|NCT00536003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20271505|NCT00536003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271506|NCT00536042|Minocycline|minocycline|mesh-list
20271507|NCT00536042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19956692|NCT01648582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956693|NCT01648699|Hydromorphone|hydromorphone|mesh-list
19956694|NCT01648699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19956695|NCT01648699|Narcotics|narcotics|mesh-ancestor
19956696|NCT01648699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19956697|NCT01648699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956698|NCT01648699|Analgesics|analgesics|mesh-ancestor
19956699|NCT01648699|Sensory System Agents|sensory system agents|mesh-ancestor
19956700|NCT01648699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19956701|NCT01648790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19956702|NCT01648790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19956703|NCT01649180|Axitinib|axitinib|mesh-list
19956704|NCT01649180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956705|NCT01649180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19956706|NCT01649180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956707|NCT01649180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956708|NCT01649271|Trastuzumab|trastuzumab|mesh-list
19956709|NCT01649271|Afatinib|afatinib|mesh-list
19956710|NCT01649271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19956711|NCT01649271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956712|NCT01649271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19956713|NCT01649271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956714|NCT01649271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956715|NCT01649297|Empagliflozin|empagliflozin|mesh-list
19956716|NCT01649297|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19956717|NCT01649297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956718|NCT01649297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19956719|NCT01649297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956720|NCT01649375|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19956721|NCT01649375|Immunologic Factors|immunologic factors|mesh-ancestor
19956722|NCT01649375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956723|NCT01649427|Tacrolimus|tacrolimus|mesh-list
19956724|NCT01649427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19956725|NCT01649427|Immunologic Factors|immunologic factors|mesh-ancestor
19956726|NCT01649427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956727|NCT01649427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19956728|NCT01649427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956729|NCT01649427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956730|NCT01649609|Mycophenolic Acid|mycophenolic acid|mesh-list
19956731|NCT01649609|Sirolimus|sirolimus|mesh-list
19956732|NCT01649609|Tacrolimus|tacrolimus|mesh-list
19956733|NCT01649609|Antimetabolites|antimetabolites|mesh-list
19956734|NCT01649609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19956735|NCT01649609|Immunologic Factors|immunologic factors|mesh-ancestor
19956736|NCT01649609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956737|NCT01649609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19956738|NCT01649609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271508|NCT00536042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271509|NCT00536068|Acetaminophen|acetaminophen|mesh-list
20271510|NCT00536068|Aspirin|aspirin|mesh-list
20271511|NCT00536068|Diclofenac|diclofenac|mesh-list
20271512|NCT00536068|Naproxen|naproxen|mesh-list
20271513|NCT00536068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20271514|NCT00536068|Analgesics|analgesics|mesh-ancestor
20271515|NCT00536068|Sensory System Agents|sensory system agents|mesh-ancestor
20271516|NCT00536068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20271517|NCT00536068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271518|NCT00536068|Antipyretics|antipyretics|mesh-ancestor
20271519|NCT00536068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19956739|NCT01649609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956740|NCT01649609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19956741|NCT01649609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956742|NCT01649609|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19956743|NCT01649609|Antitubercular Agents|antitubercular agents|mesh-ancestor
19956744|NCT01649609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19956745|NCT01649609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19956746|NCT01649609|Antifungal Agents|antifungal agents|mesh-ancestor
19956747|NCT01649765|Belimumab|belimumab|mesh-list
19956748|NCT01649765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19956749|NCT01649765|Immunologic Factors|immunologic factors|mesh-ancestor
19956750|NCT01649765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271520|NCT00536068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20271521|NCT00536068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20271522|NCT00536068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20271523|NCT00536068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271524|NCT00536068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271525|NCT00536068|Gout Suppressants|gout suppressants|mesh-ancestor
20271526|NCT00536068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20271527|NCT00536068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20271528|NCT00536068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20271529|NCT00536211|Metformin|metformin|mesh-list
20271530|NCT00536211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20271531|NCT00536211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271532|NCT00536237|Niacin|niacin|mesh-list
20271533|NCT00536237|Niacinamide|niacinamide|mesh-list
20271534|NCT00536237|Nicotinic Acids|nicotinic acids|mesh-list
20271535|NCT00536237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271536|NCT00536237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271537|NCT00536237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20271538|NCT00536237|Antimetabolites|antimetabolites|mesh-ancestor
20271539|NCT00536237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20271540|NCT00536237|Vasodilator Agents|vasodilator agents|mesh-ancestor
20271541|NCT00536237|Vitamin B Complex|vitamin b complex|mesh-ancestor
20271542|NCT00536237|Vitamins|vitamins|mesh-ancestor
20271543|NCT00536237|Micronutrients|micronutrients|mesh-ancestor
20271544|NCT00536276|Vitamin D|vitamin d|mesh-list
20271545|NCT00536276|Ergocalciferols|ergocalciferols|mesh-list
20271546|NCT00536276|Cholecalciferol|cholecalciferol|mesh-list
20271547|NCT00536276|Vitamins|vitamins|mesh-list
20271548|NCT00536276|Micronutrients|micronutrients|mesh-ancestor
20271549|NCT00536276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271550|NCT00536276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20544099|NCT01872858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20544100|NCT01872858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20544101|NCT01872858|Analgesics|analgesics|mesh-ancestor
20544102|NCT01872858|Sensory System Agents|sensory system agents|mesh-ancestor
20544103|NCT01872858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20544104|NCT01872858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544105|NCT01872858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20544106|NCT01872858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20544107|NCT01872858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19956751|NCT01649791|Lenalidomide|lenalidomide|mesh-list
19956752|NCT01649791|Immunologic Factors|immunologic factors|mesh-ancestor
19956753|NCT01649791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956754|NCT01649791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19956755|NCT01649791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19956756|NCT01649791|Growth Substances|growth substances|mesh-ancestor
19956757|NCT01649791|Growth Inhibitors|growth inhibitors|mesh-ancestor
19956758|NCT01649791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956759|NCT01649856|Rituximab|rituximab|mesh-list
19956760|NCT01649856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19956761|NCT01649856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956762|NCT01649856|Immunologic Factors|immunologic factors|mesh-ancestor
19956763|NCT01649856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956764|NCT01649856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19956765|NCT01649869|Valganciclovir|valganciclovir|mesh-list
19956766|NCT01649869|Antiviral Agents|antiviral agents|mesh-ancestor
19956767|NCT01649869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19956768|NCT01649947|Hydroxychloroquine|hydroxychloroquine|mesh-list
20544108|NCT01872858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19956769|NCT01649947|Paclitaxel|paclitaxel|mesh-list
20544109|NCT01872858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956770|NCT01649947|Bevacizumab|bevacizumab|mesh-list
19956771|NCT01649947|Carboplatin|carboplatin|mesh-list
19956772|NCT01649947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19956773|NCT01649947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956774|NCT01649947|Tubulin Modulators|tubulin modulators|mesh-ancestor
19956775|NCT01649947|Antimitotic Agents|antimitotic agents|mesh-ancestor
19956776|NCT01649947|Mitosis Modulators|mitosis modulators|mesh-ancestor
19956777|NCT01649947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956778|NCT01649947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19956779|NCT01649947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19956780|NCT01649947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19956781|NCT01649947|Growth Substances|growth substances|mesh-ancestor
19956782|NCT01649947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956783|NCT01649947|Growth Inhibitors|growth inhibitors|mesh-ancestor
19956784|NCT01649947|Antimalarials|antimalarials|mesh-ancestor
19956785|NCT01649947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19956786|NCT01649947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20271551|NCT00536276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20271552|NCT00536393|Doxorubicin|doxorubicin|mesh-list
20271553|NCT00536393|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20271554|NCT00536393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20271555|NCT00536393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271556|NCT00536393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19956787|NCT01649947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19956788|NCT01649947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956789|NCT01649947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19956790|NCT01650194|Prednisone|prednisone|mesh-list
19956791|NCT01650194|Abiraterone Acetate|abiraterone acetate|mesh-list
19956792|NCT01650194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19956793|NCT01650194|Glucocorticoids|glucocorticoids|mesh-ancestor
19956794|NCT01650194|Hormones|hormones|mesh-ancestor
19956795|NCT01650194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19956796|NCT01650194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956797|NCT01650194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19956798|NCT01650194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956799|NCT01650194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19956800|NCT01650194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956801|NCT01650194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956802|NCT01650194|Hormone Antagonists|hormone antagonists|mesh-ancestor
19956803|NCT01650194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19956804|NCT01650246|Lesinurad|lesinurad|mesh-list
19956805|NCT01650246|Gout Suppressants|gout suppressants|mesh-ancestor
19956806|NCT01650246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19956807|NCT01650246|Uricosuric Agents|uricosuric agents|mesh-ancestor
19956808|NCT01650246|Renal Agents|renal agents|mesh-ancestor
19956809|NCT01650298|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
19956810|NCT01650298|Thrombin|thrombin|mesh-list
19956811|NCT01650298|Hemostatics|hemostatics|mesh-ancestor
19956812|NCT01650298|Coagulants|coagulants|mesh-ancestor
19956813|NCT01650298|Antithrombins|antithrombins|mesh-ancestor
19956814|NCT01650298|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19956815|NCT01650298|Protease Inhibitors|protease inhibitors|mesh-ancestor
19956816|NCT01650298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956817|NCT01650298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956818|NCT01650298|Anticoagulants|anticoagulants|mesh-ancestor
20271557|NCT00536393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20271558|NCT00536393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271559|NCT00536393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271560|NCT00536419|Methylphenidate|methylphenidate|mesh-list
20271561|NCT00536419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20271562|NCT00536419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271563|NCT00536419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20271564|NCT00536419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20271565|NCT00536419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20271566|NCT00536419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271567|NCT00536419|Dopamine Agents|dopamine agents|mesh-ancestor
20271568|NCT00536419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20271569|NCT00536614|Cetuximab|cetuximab|mesh-list
20271570|NCT00536614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20271571|NCT00536614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271572|NCT00536640|Gemcitabine|gemcitabine|mesh-list
20271573|NCT00536640|Bevacizumab|bevacizumab|mesh-list
20554209|NCT01934088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19956819|NCT01650402|Antihypertensive Agents|antihypertensive agents|mesh-list
19956820|NCT01650519|Ibuprofen|ibuprofen|mesh-list
19956821|NCT01650519|Ketorolac|ketorolac|mesh-list
20271574|NCT00536640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20271575|NCT00536640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20271576|NCT00536640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271577|NCT00536640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20271578|NCT00536640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20271579|NCT00536640|Growth Substances|growth substances|mesh-ancestor
20271580|NCT00536640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271581|NCT00536640|Growth Inhibitors|growth inhibitors|mesh-ancestor
20271582|NCT00536640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20271583|NCT00536640|Antimetabolites|antimetabolites|mesh-ancestor
20271584|NCT00536640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271585|NCT00536640|Antiviral Agents|antiviral agents|mesh-ancestor
20271586|NCT00536640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271587|NCT00536640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271588|NCT00536640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20271589|NCT00536640|Immunologic Factors|immunologic factors|mesh-ancestor
20271590|NCT00536640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20271591|NCT00536653|Calcium, Dietary|calcium, dietary|mesh-list
20271592|NCT00536653|Vitamin D|vitamin d|mesh-list
20271593|NCT00536653|Ergocalciferols|ergocalciferols|mesh-list
20271594|NCT00536653|Vitamins|vitamins|mesh-list
20271595|NCT00536653|Goserelin|goserelin|mesh-list
20544110|NCT01872858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20544111|NCT01872858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20544112|NCT01872858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544113|NCT01872858|Antipyretics|antipyretics|mesh-ancestor
20544114|NCT01872858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20544115|NCT01872858|Autonomic Agents|autonomic agents|mesh-ancestor
20544116|NCT01872858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20544117|NCT01872858|Respiratory System Agents|respiratory system agents|mesh-ancestor
19956822|NCT01650519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19956823|NCT01650519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19956824|NCT01650519|Analgesics|analgesics|mesh-ancestor
19956825|NCT01650519|Sensory System Agents|sensory system agents|mesh-ancestor
19956826|NCT01650519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19956827|NCT01650519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956828|NCT01650519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19956829|NCT01650519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19956830|NCT01650519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19956831|NCT01650519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956832|NCT01650519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956833|NCT01650545|Cyclosporine|cyclosporine|mesh-list
19956834|NCT01650545|Sirolimus|sirolimus|mesh-list
19956835|NCT01650545|Tacrolimus|tacrolimus|mesh-list
19956836|NCT01650545|Cyclosporins|cyclosporins|mesh-list
19956837|NCT01650545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19956838|NCT01650545|Immunologic Factors|immunologic factors|mesh-ancestor
19956839|NCT01650545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956840|NCT01650545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19956841|NCT01650545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956842|NCT01650545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956843|NCT01650545|Antifungal Agents|antifungal agents|mesh-ancestor
19956844|NCT01650545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19956845|NCT01650545|Dermatologic Agents|dermatologic agents|mesh-ancestor
19956846|NCT01650545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19956847|NCT01650545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19956848|NCT01650545|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19956849|NCT01650545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956850|NCT01650558|Chloroquine|chloroquine|mesh-list
19956851|NCT01650558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19956852|NCT01650558|Amebicides|amebicides|mesh-ancestor
19956853|NCT01650558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19956854|NCT01650558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19956855|NCT01650558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19956856|NCT01650558|Antimalarials|antimalarials|mesh-ancestor
19956857|NCT01650558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19956858|NCT01650558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19956859|NCT01650558|Renal Agents|renal agents|mesh-ancestor
19956860|NCT01650558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19956861|NCT01650805|Imatinib Mesylate|imatinib mesylate|mesh-list
19956862|NCT01650805|Ponatinib|ponatinib|mesh-list
19956863|NCT01650805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956864|NCT01650805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20271596|NCT00536653|Bicalutamide|bicalutamide|mesh-list
20271597|NCT00536653|Calcium|calcium|mesh-list
20544118|NCT01872858|Vasodilator Agents|vasodilator agents|mesh-ancestor
20271598|NCT00536653|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20271599|NCT00536653|Micronutrients|micronutrients|mesh-ancestor
20271600|NCT00536653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271601|NCT00536653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20271602|NCT00536653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20271603|NCT00536653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20271604|NCT00536653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271605|NCT00536653|Androgen Antagonists|androgen antagonists|mesh-ancestor
20271606|NCT00536653|Hormone Antagonists|hormone antagonists|mesh-ancestor
20271607|NCT00536653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20271608|NCT00536653|Hormones|hormones|mesh-ancestor
20271609|NCT00536692|Mecamylamine|mecamylamine|mesh-list
20271610|NCT00536692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20271611|NCT00536692|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
19956865|NCT01650805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956866|NCT01650805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956867|NCT01651000|Calcifediol|calcifediol|mesh-list
19956868|NCT01651000|Vitamins|vitamins|mesh-ancestor
19956869|NCT01651000|Micronutrients|micronutrients|mesh-ancestor
19956870|NCT01651000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956871|NCT01651000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19956872|NCT01651039|Dexamethasone|dexamethasone|mesh-list
19956873|NCT01651039|Lenalidomide|lenalidomide|mesh-list
19956874|NCT01651039|Panobinostat|panobinostat|mesh-list
19956875|NCT01651039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19956876|NCT01651039|Antiemetics|antiemetics|mesh-ancestor
20271612|NCT00536692|Autonomic Agents|autonomic agents|mesh-ancestor
20271613|NCT00536692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20271614|NCT00536692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271615|NCT00536692|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20271616|NCT00536692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20271617|NCT00536692|Cholinergic Agents|cholinergic agents|mesh-ancestor
20271618|NCT00536692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20271619|NCT00536692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271620|NCT00536705|Montelukast|montelukast|mesh-list
20271621|NCT00536705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20271622|NCT00536705|Respiratory System Agents|respiratory system agents|mesh-ancestor
20271623|NCT00536705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20271624|NCT00536705|Hormone Antagonists|hormone antagonists|mesh-ancestor
20271625|NCT00536705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20271626|NCT00536705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271627|NCT00536705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20271628|NCT00536705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20271629|NCT00536705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271630|NCT00536770|Calcitriol|calcitriol|mesh-list
20271631|NCT00536770|Gemcitabine|gemcitabine|mesh-list
20271632|NCT00536770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20271633|NCT00536770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20271634|NCT00536770|Antimetabolites|antimetabolites|mesh-ancestor
20271635|NCT00536770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271636|NCT00536770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271637|NCT00536770|Antiviral Agents|antiviral agents|mesh-ancestor
20271638|NCT00536770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19956877|NCT01651039|Autonomic Agents|autonomic agents|mesh-ancestor
19956878|NCT01651039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20271639|NCT00536770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271640|NCT00536770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20271641|NCT00536770|Immunologic Factors|immunologic factors|mesh-ancestor
20271642|NCT00536770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271643|NCT00536770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20271644|NCT00536770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20271645|NCT00536770|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20271646|NCT00536770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20271647|NCT00536770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20271648|NCT00536770|Vitamins|vitamins|mesh-ancestor
20271649|NCT00536770|Micronutrients|micronutrients|mesh-ancestor
20271650|NCT00536770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20271651|NCT00536783|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20271652|NCT00536783|Antidepressive Agents|antidepressive agents|mesh-ancestor
20271653|NCT00536783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20271654|NCT00536783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20544119|NCT01872858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20271655|NCT00536783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20271656|NCT00536783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20271657|NCT00536783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271658|NCT00536848|Metronidazole|metronidazole|mesh-list
20271659|NCT00536848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271660|NCT00536848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20271661|NCT00536848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20271662|NCT00536848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20271663|NCT00536861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20271664|NCT00536861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271665|NCT00536861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20271666|NCT00536861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271667|NCT00536861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271668|NCT00536887|Atorvastatin|atorvastatin|mesh-list
20271669|NCT00536887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20271670|NCT00536887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20271671|NCT00536887|Antimetabolites|antimetabolites|mesh-ancestor
20271672|NCT00536887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271673|NCT00536887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20271674|NCT00536887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20544120|NCT01872858|Protective Agents|protective agents|mesh-ancestor
20544121|NCT01872858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20544122|NCT01872858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20544123|NCT01872871|Acetaminophen|acetaminophen|mesh-list
20544124|NCT01872871|Anesthetics|anesthetics|mesh-list
20544125|NCT01872871|Anesthetics, Local|anesthetics, local|mesh-list
20544126|NCT01872871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20544127|NCT01872871|Analgesics|analgesics|mesh-ancestor
20544128|NCT01872871|Sensory System Agents|sensory system agents|mesh-ancestor
20544129|NCT01872871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20544130|NCT01872871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544131|NCT01872871|Antipyretics|antipyretics|mesh-ancestor
20544132|NCT01872871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20544133|NCT01872884|Remifentanil|remifentanil|mesh-list
20544134|NCT01872884|Sevoflurane|sevoflurane|mesh-list
20544135|NCT01872884|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20544136|NCT01872884|Narcotics|narcotics|mesh-ancestor
19956879|NCT01651039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956880|NCT01651039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19956881|NCT01651039|Glucocorticoids|glucocorticoids|mesh-ancestor
19956882|NCT01651039|Hormones|hormones|mesh-ancestor
19956883|NCT01651039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20544137|NCT01872884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20544138|NCT01872884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544139|NCT01872884|Analgesics|analgesics|mesh-ancestor
20544140|NCT01872884|Sensory System Agents|sensory system agents|mesh-ancestor
20544141|NCT01872884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20544142|NCT01872884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20544143|NCT01872884|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20544144|NCT01872884|Anesthetics, General|anesthetics, general|mesh-ancestor
20544145|NCT01872884|Anesthetics|anesthetics|mesh-ancestor
20544146|NCT01872897|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
20544147|NCT01872897|Antacids|antacids|mesh-ancestor
20544148|NCT01872897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544149|NCT01872897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20544150|NCT01872923|Bleomycin|bleomycin|mesh-list
20544151|NCT01872923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20544152|NCT01872923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544153|NCT01872936|Ribavirin|ribavirin|mesh-list
20544154|NCT01872936|Antimetabolites|antimetabolites|mesh-ancestor
20544155|NCT01872936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544156|NCT01872936|Antiviral Agents|antiviral agents|mesh-ancestor
20544157|NCT01872936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20544158|NCT01872962|Gemcitabine|gemcitabine|mesh-list
20544159|NCT01872962|Cisplatin|cisplatin|mesh-list
20544160|NCT01872962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544161|NCT01872962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20544162|NCT01872962|Antimetabolites|antimetabolites|mesh-ancestor
20544163|NCT01872962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544164|NCT01872962|Antiviral Agents|antiviral agents|mesh-ancestor
20544165|NCT01872962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20544166|NCT01872962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544167|NCT01872962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20544168|NCT01872962|Immunologic Factors|immunologic factors|mesh-ancestor
20271675|NCT00536887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271676|NCT00537121|Leucovorin|leucovorin|mesh-list
20271677|NCT00537121|Fluorouracil|fluorouracil|mesh-list
20271678|NCT00537121|Irinotecan|irinotecan|mesh-list
20271679|NCT00537121|Vorinostat|vorinostat|mesh-list
20271680|NCT00537121|Calcium|calcium|mesh-list
20271681|NCT00537121|Levoleucovorin|levoleucovorin|mesh-list
19956884|NCT01651039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19956885|NCT01651039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956886|NCT01651039|Immunologic Factors|immunologic factors|mesh-ancestor
19956887|NCT01651039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19956888|NCT01651039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19956889|NCT01651039|Growth Substances|growth substances|mesh-ancestor
19956890|NCT01651039|Growth Inhibitors|growth inhibitors|mesh-ancestor
19956891|NCT01651039|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19956892|NCT01651039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956893|NCT01651039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956894|NCT01651351|Protease Inhibitors|protease inhibitors|mesh-list
19956895|NCT01651351|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19956896|NCT01651351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956897|NCT01651351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956898|NCT01651351|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19956899|NCT01651351|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19956900|NCT01651442|Zolpidem|zolpidem|mesh-list
19956901|NCT01651442|Trazodone|trazodone|mesh-list
20271682|NCT00537121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20271683|NCT00537121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271684|NCT00537121|Antimetabolites|antimetabolites|mesh-ancestor
20271685|NCT00537121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271686|NCT00537121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20271687|NCT00537121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271688|NCT00537121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20271689|NCT00537121|Immunologic Factors|immunologic factors|mesh-ancestor
20271690|NCT00537121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20271691|NCT00537121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20271692|NCT00537121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271693|NCT00537121|Antidotes|antidotes|mesh-ancestor
20271694|NCT00537121|Protective Agents|protective agents|mesh-ancestor
20271695|NCT00537121|Vitamin B Complex|vitamin b complex|mesh-ancestor
20271696|NCT00537121|Vitamins|vitamins|mesh-ancestor
20271697|NCT00537121|Micronutrients|micronutrients|mesh-ancestor
20271698|NCT00537121|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20271699|NCT00537173|Paclitaxel|paclitaxel|mesh-list
20271700|NCT00537173|Bevacizumab|bevacizumab|mesh-list
20271701|NCT00537173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20271702|NCT00537173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271703|NCT00537173|Tubulin Modulators|tubulin modulators|mesh-ancestor
20271704|NCT00537173|Antimitotic Agents|antimitotic agents|mesh-ancestor
20271705|NCT00537173|Mitosis Modulators|mitosis modulators|mesh-ancestor
20271706|NCT00537173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271707|NCT00537173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20271708|NCT00537173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20271709|NCT00537173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20271710|NCT00537173|Growth Substances|growth substances|mesh-ancestor
20271711|NCT00537173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271712|NCT00537173|Growth Inhibitors|growth inhibitors|mesh-ancestor
20271713|NCT00537251|Insulin Glargine|insulin glargine|mesh-list
20271714|NCT00537251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20271715|NCT00537251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271716|NCT00537355|Histamine|histamine|mesh-list
20271717|NCT00537355|Histamine Agonists|histamine agonists|mesh-ancestor
20271718|NCT00537355|Histamine Agents|histamine agents|mesh-ancestor
20271719|NCT00537355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20271720|NCT00537355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271721|NCT00537355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271722|NCT00537420|Sibutramine|sibutramine|mesh-list
20271723|NCT00537420|Antidepressive Agents|antidepressive agents|mesh-ancestor
20271724|NCT00537420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20271725|NCT00537420|Appetite Depressants|appetite depressants|mesh-ancestor
20271726|NCT00537420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20271727|NCT00537472|Bupivacaine|bupivacaine|mesh-list
20271728|NCT00537472|Anesthetics|anesthetics|mesh-list
20271729|NCT00537472|Anesthetics, Local|anesthetics, local|mesh-ancestor
20271730|NCT00537472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19956902|NCT01651442|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20271731|NCT00537472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271732|NCT00537472|Sensory System Agents|sensory system agents|mesh-ancestor
19956903|NCT01651442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19956904|NCT01651442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19956905|NCT01651442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956906|NCT01651442|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19956907|NCT01651442|GABA Agonists|gaba agonists|mesh-ancestor
19956908|NCT01651442|GABA Agents|gaba agents|mesh-ancestor
19956909|NCT01651442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19956910|NCT01651442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956911|NCT01651442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19956912|NCT01651442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19956913|NCT01651442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19956914|NCT01651442|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19956915|NCT01651442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19956916|NCT01651442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19956917|NCT01651442|Serotonin Agents|serotonin agents|mesh-ancestor
19956918|NCT01651442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19956919|NCT01651442|Antidepressive Agents|antidepressive agents|mesh-ancestor
19956920|NCT01651780|Heparin|heparin|mesh-list
20271733|NCT00537472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20271734|NCT00537524|Vaccines|vaccines|mesh-list
20271735|NCT00537524|Immunologic Factors|immunologic factors|mesh-ancestor
20271736|NCT00537524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271737|NCT00537537|Telbivudine|telbivudine|mesh-list
20271738|NCT00537537|Antiviral Agents|antiviral agents|mesh-ancestor
20271739|NCT00537537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271740|NCT00537537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20271741|NCT00537537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271742|NCT00537537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271743|NCT00537550|Methotrexate|methotrexate|mesh-list
20271744|NCT00537550|Vincristine|vincristine|mesh-list
20271745|NCT00537550|Asparaginase|asparaginase|mesh-list
20271746|NCT00537550|Daunorubicin|daunorubicin|mesh-list
20271747|NCT00537550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20271748|NCT00537550|Abortifacient Agents|abortifacient agents|mesh-ancestor
20271749|NCT00537550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20271750|NCT00537550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271751|NCT00537550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20271752|NCT00537550|Antimetabolites|antimetabolites|mesh-ancestor
20271753|NCT00537550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271754|NCT00537550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271755|NCT00537550|Dermatologic Agents|dermatologic agents|mesh-ancestor
20271756|NCT00537550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271757|NCT00537550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20271758|NCT00537550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20271759|NCT00537550|Immunologic Factors|immunologic factors|mesh-ancestor
20271760|NCT00537550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20271761|NCT00537550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20271762|NCT00537550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20271763|NCT00537550|Tubulin Modulators|tubulin modulators|mesh-ancestor
20271764|NCT00537550|Antimitotic Agents|antimitotic agents|mesh-ancestor
20271765|NCT00537550|Mitosis Modulators|mitosis modulators|mesh-ancestor
20271766|NCT00537550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20271767|NCT00537550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20271768|NCT00537550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20271769|NCT00537563|Telithromycin|telithromycin|mesh-list
20271770|NCT00537563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20271771|NCT00537563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271772|NCT00537602|Miglustat|miglustat|mesh-list
20271773|NCT00537602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271774|NCT00537602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956921|NCT01651780|Calcium heparin|calcium heparin|mesh-list
20271775|NCT00537602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20271776|NCT00537602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20271777|NCT00537602|Antiviral Agents|antiviral agents|mesh-ancestor
20271778|NCT00537602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271779|NCT00537602|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20271780|NCT00537602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20271781|NCT00537602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287555|NCT04333407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20287556|NCT04333407|Purinergic Agents|purinergic agents|mesh-ancestor
20287557|NCT04333407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20287558|NCT04333407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20287559|NCT04333407|Antithrombins|antithrombins|mesh-ancestor
20287560|NCT04333407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19450299|NCT03429738|Autonomic Agents|autonomic agents|mesh-ancestor
20271782|NCT00537667|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20271783|NCT00537667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20271784|NCT00537732|Omeprazole|omeprazole|mesh-list
20271785|NCT00537732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20271786|NCT00537732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20271787|NCT00537732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20271788|NCT00537732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271789|NCT00537732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271790|NCT00537836|Estradiol|estradiol|mesh-list
20271791|NCT00537836|Estrogens|estrogens|mesh-ancestor
20271792|NCT00537836|Hormones|hormones|mesh-ancestor
19956922|NCT01651780|Bivalirudin|bivalirudin|mesh-list
19956923|NCT01651780|Anticoagulants|anticoagulants|mesh-ancestor
19956924|NCT01651780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19956925|NCT01651780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19956926|NCT01651780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956927|NCT01651780|Antithrombins|antithrombins|mesh-ancestor
20271793|NCT00537836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20271794|NCT00537836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271795|NCT00537862|Mycophenolic Acid|mycophenolic acid|mesh-list
20271796|NCT00537862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20271797|NCT00537862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271798|NCT00537862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20271799|NCT00537862|Antitubercular Agents|antitubercular agents|mesh-ancestor
20271800|NCT00537862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20271801|NCT00537862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271802|NCT00537862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271803|NCT00537862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271804|NCT00537888|Fluconazole|fluconazole|mesh-list
20544169|NCT01872962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544170|NCT01872988|Tenofovir|tenofovir|mesh-list
19956928|NCT01651780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19956929|NCT01651780|Protease Inhibitors|protease inhibitors|mesh-ancestor
19956930|NCT01651780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956931|NCT01651793|Caffeine|caffeine|mesh-list
19956932|NCT01651793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19956933|NCT01651793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956934|NCT01651793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19956935|NCT01651793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956936|NCT01651793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956937|NCT01651793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19956938|NCT01651793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19956939|NCT01651793|Purinergic Agents|purinergic agents|mesh-ancestor
19956940|NCT01651793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19956941|NCT01651806|Tranexamic Acid|tranexamic acid|mesh-list
19956942|NCT01651806|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19956943|NCT01651806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19956944|NCT01651806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956945|NCT01651806|Hemostatics|hemostatics|mesh-ancestor
19956946|NCT01651806|Coagulants|coagulants|mesh-ancestor
19956947|NCT01651936|Methotrexate|methotrexate|mesh-list
19956948|NCT01651936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19956949|NCT01651936|Abortifacient Agents|abortifacient agents|mesh-ancestor
19956950|NCT01651936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19956951|NCT01651936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956952|NCT01651936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19956953|NCT01651936|Antimetabolites|antimetabolites|mesh-ancestor
20544171|NCT01872988|Antiviral Agents|antiviral agents|mesh-ancestor
20544172|NCT01872988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20544173|NCT01872988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20544174|NCT01872988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20544175|NCT01872988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544176|NCT01872988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544177|NCT01872988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20544178|NCT01872988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20544179|NCT01873001|Pioglitazone|pioglitazone|mesh-list
20544180|NCT01873001|Abiraterone Acetate|abiraterone acetate|mesh-list
20544181|NCT01873001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19956954|NCT01651936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956955|NCT01651936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956956|NCT01651936|Dermatologic Agents|dermatologic agents|mesh-ancestor
19956957|NCT01651936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544182|NCT01873001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956958|NCT01651936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19956959|NCT01651936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19956960|NCT01651936|Immunologic Factors|immunologic factors|mesh-ancestor
19956961|NCT01651936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19956962|NCT01651936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19956963|NCT01652040|Methyltestosterone|methyltestosterone|mesh-list
20271805|NCT00537888|Antifungal Agents|antifungal agents|mesh-ancestor
20271806|NCT00537888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271807|NCT00537888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20271808|NCT00537888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20271809|NCT00537888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271810|NCT00537888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271811|NCT00537888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20271812|NCT00537888|Hormone Antagonists|hormone antagonists|mesh-ancestor
20271813|NCT00537888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20271814|NCT00537888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271815|NCT00537888|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20271816|NCT00537888|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20271817|NCT00537901|Bevacizumab|bevacizumab|mesh-list
20271818|NCT00537901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20271819|NCT00537901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271820|NCT00537901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20271821|NCT00537901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20271822|NCT00537901|Growth Substances|growth substances|mesh-ancestor
20271823|NCT00537901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271824|NCT00537901|Growth Inhibitors|growth inhibitors|mesh-ancestor
20271825|NCT00537953|Miltefosine|miltefosine|mesh-list
20271826|NCT00537953|Meglumine Antimoniate|meglumine antimoniate|mesh-list
20271827|NCT00537953|Antifungal Agents|antifungal agents|mesh-ancestor
20271828|NCT00537953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271829|NCT00537953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271830|NCT00537953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20271831|NCT00537953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19956964|NCT01652040|Testosterone|testosterone|mesh-list
19956965|NCT01652040|Testosterone undecanoate|testosterone undecanoate|mesh-list
19956966|NCT01652040|Testosterone enanthate|testosterone enanthate|mesh-list
19956967|NCT01652040|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19956968|NCT01652040|Androgens|androgens|mesh-ancestor
19956969|NCT01652040|Hormones|hormones|mesh-ancestor
19956970|NCT01652040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19956971|NCT01652040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19956972|NCT01652040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19956973|NCT01652040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956974|NCT01652040|Anabolic Agents|anabolic agents|mesh-ancestor
19956975|NCT01652469|Docetaxel|docetaxel|mesh-list
19733126|NCT04564872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733127|NCT04564872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733128|NCT04564638|Cyclosporine|cyclosporine|mesh-list
19733129|NCT04564638|Cyclosporins|cyclosporins|mesh-list
19733130|NCT04564638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733131|NCT04564638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733132|NCT04564638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19733133|NCT04564638|Immunologic Factors|immunologic factors|mesh-ancestor
20271832|NCT00537966|Ritonavir|ritonavir|mesh-list
20271833|NCT00537966|Darunavir|darunavir|mesh-list
20271834|NCT00537966|Tenofovir|tenofovir|mesh-list
20271835|NCT00537966|Lamivudine|lamivudine|mesh-list
20271836|NCT00537966|Emtricitabine|emtricitabine|mesh-list
20271837|NCT00537966|Raltegravir Potassium|raltegravir potassium|mesh-list
20271838|NCT00537966|Abacavir|abacavir|mesh-list
20554210|NCT01934088|Narcotics|narcotics|mesh-ancestor
19956976|NCT01652469|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19956977|NCT01652469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19956978|NCT01652469|Tubulin Modulators|tubulin modulators|mesh-ancestor
19956979|NCT01652469|Antimitotic Agents|antimitotic agents|mesh-ancestor
19956980|NCT01652469|Mitosis Modulators|mitosis modulators|mesh-ancestor
19956981|NCT01652469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19956982|NCT01652469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19956983|NCT01652469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19956984|NCT01652495|Methylprednisolone|methylprednisolone|mesh-list
19956985|NCT01652495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19956986|NCT01652495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19956987|NCT01652495|Prednisolone|prednisolone|mesh-list
19956988|NCT01652495|Prednisolone acetate|prednisolone acetate|mesh-list
19956989|NCT01652495|Triamcinolone|triamcinolone|mesh-list
20271839|NCT00537966|Dolutegravir|dolutegravir|mesh-list
20271840|NCT00537966|Cobicistat|cobicistat|mesh-list
20271841|NCT00537966|Rilpivirine|rilpivirine|mesh-list
20271842|NCT00537966|Elvitegravir|elvitegravir|mesh-list
20271843|NCT00537966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20271844|NCT00537966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20271845|NCT00537966|Protease Inhibitors|protease inhibitors|mesh-ancestor
19956990|NCT01652495|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19956991|NCT01652495|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19956992|NCT01652495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19956993|NCT01652495|Prednisolone phosphate|prednisolone phosphate|mesh-list
19956994|NCT01652495|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19956995|NCT01652495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19956996|NCT01652495|Antiemetics|antiemetics|mesh-ancestor
19956997|NCT01652495|Autonomic Agents|autonomic agents|mesh-ancestor
19956998|NCT01652495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19956999|NCT01652495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957000|NCT01652495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19957001|NCT01652495|Glucocorticoids|glucocorticoids|mesh-ancestor
19957002|NCT01652495|Hormones|hormones|mesh-ancestor
19957003|NCT01652495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19957004|NCT01652495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19957005|NCT01652495|Protective Agents|protective agents|mesh-ancestor
20271846|NCT00537966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271847|NCT00537966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271848|NCT00537966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20271849|NCT00537966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20271850|NCT00537966|Antiviral Agents|antiviral agents|mesh-ancestor
20271851|NCT00537966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271852|NCT00537966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20271853|NCT00537966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20271854|NCT00537966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20271855|NCT00537966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20271856|NCT00537966|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20271857|NCT00537966|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20271858|NCT00538005|Bevacizumab|bevacizumab|mesh-list
20271859|NCT00538005|Oxaliplatin|oxaliplatin|mesh-list
20271860|NCT00538005|Sorafenib|sorafenib|mesh-list
20271861|NCT00538005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20271862|NCT00538005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271863|NCT00538005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20271864|NCT00538005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20271865|NCT00538005|Growth Substances|growth substances|mesh-ancestor
20271866|NCT00538005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271867|NCT00538005|Growth Inhibitors|growth inhibitors|mesh-ancestor
20271868|NCT00538005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20271869|NCT00538005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271870|NCT00538005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271871|NCT00538018|Telithromycin|telithromycin|mesh-list
20271872|NCT00538018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20271873|NCT00538018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271874|NCT00538044|Simvastatin|simvastatin|mesh-list
20271875|NCT00538044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20271876|NCT00538044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20271877|NCT00538044|Antimetabolites|antimetabolites|mesh-ancestor
20271878|NCT00538044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271879|NCT00538044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20271880|NCT00538044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20271881|NCT00538044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271882|NCT00538070|Glycine|glycine|mesh-list
20271883|NCT00538070|Glycine Agents|glycine agents|mesh-ancestor
20271884|NCT00538070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20271885|NCT00538070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271886|NCT00538070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271887|NCT00538096|Blinatumomab|blinatumomab|mesh-list
20271888|NCT00538096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271889|NCT00538109|Imatinib Mesylate|imatinib mesylate|mesh-list
20271890|NCT00538109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271891|NCT00538109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20271892|NCT00538109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271893|NCT00538109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271894|NCT00538148|Telithromycin|telithromycin|mesh-list
20271895|NCT00538148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20554211|NCT01934088|Analgesics|analgesics|mesh-ancestor
20271896|NCT00538148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271897|NCT00538174|Dapagliflozin|dapagliflozin|mesh-list
20287561|NCT04333407|Protease Inhibitors|protease inhibitors|mesh-ancestor
20554212|NCT01934088|Sensory System Agents|sensory system agents|mesh-ancestor
20271898|NCT00538174|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20271899|NCT00538174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271900|NCT00538174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20271901|NCT00538174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271902|NCT00538187|Bortezomib|bortezomib|mesh-list
20271903|NCT00538187|Obatoclax|obatoclax|mesh-list
20271904|NCT00538187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271905|NCT00538187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271906|NCT00538187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271907|NCT00538239|Sirolimus|sirolimus|mesh-list
19957006|NCT01652495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19957007|NCT01652495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957008|NCT01652495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19957009|NCT01652495|Immunologic Factors|immunologic factors|mesh-ancestor
19957010|NCT01652495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957011|NCT01652495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957012|NCT01652573|Calcitonin|calcitonin|mesh-list
19957013|NCT01652573|Salmon calcitonin|salmon calcitonin|mesh-list
19957014|NCT01652573|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
19957015|NCT01652573|Katacalcin|katacalcin|mesh-list
19957016|NCT01652573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19957017|NCT01652573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957018|NCT01652573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19957019|NCT01652573|Vasodilator Agents|vasodilator agents|mesh-ancestor
19957020|NCT01652664|Timolol|timolol|mesh-list
19957021|NCT01652664|Travoprost|travoprost|mesh-list
19957022|NCT01652664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20544183|NCT01873001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544184|NCT01873001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20544185|NCT01873001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544186|NCT01873001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271908|NCT00538239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20271909|NCT00538239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271910|NCT00538239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20271911|NCT00538239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271912|NCT00538239|Antifungal Agents|antifungal agents|mesh-ancestor
20544187|NCT01873001|Hormone Antagonists|hormone antagonists|mesh-ancestor
20544188|NCT01873001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20544189|NCT01873001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20544190|NCT01873027|Sirolimus|sirolimus|mesh-list
20544191|NCT01873027|Umirolimus|umirolimus|mesh-list
20271913|NCT00538239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20271914|NCT00538239|Immunologic Factors|immunologic factors|mesh-ancestor
20271915|NCT00538239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271916|NCT00538265|Mycophenolic Acid|mycophenolic acid|mesh-list
20271917|NCT00538265|Tacrolimus|tacrolimus|mesh-list
20271918|NCT00538265|Thymoglobulin|thymoglobulin|mesh-list
20271919|NCT00538265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20271920|NCT00538265|Immunologic Factors|immunologic factors|mesh-ancestor
20271921|NCT00538265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271922|NCT00538265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20544192|NCT01873027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20544193|NCT01873027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20544194|NCT01873027|Immunologic Factors|immunologic factors|mesh-ancestor
20544195|NCT01873027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544196|NCT01873027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20544197|NCT01873027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20544198|NCT01873027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20544199|NCT01873027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544200|NCT01873027|Antifungal Agents|antifungal agents|mesh-ancestor
20544201|NCT01873079|Esomeprazole|esomeprazole|mesh-list
20544202|NCT01873079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20544203|NCT01873079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20544204|NCT01873079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20544205|NCT01873079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544206|NCT01873079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544207|NCT01873131|Timolol|timolol|mesh-list
20544208|NCT01873131|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20544209|NCT01873131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20544210|NCT01873131|Adrenergic Agents|adrenergic agents|mesh-ancestor
20544211|NCT01873131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20544212|NCT01873131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544213|NCT01873131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544214|NCT01873131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20544215|NCT01873131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20544216|NCT01873144|Epinephrine|epinephrine|mesh-list
20544217|NCT01873144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20544218|NCT01873144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20544219|NCT01873144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20544220|NCT01873144|Adrenergic Agents|adrenergic agents|mesh-ancestor
20544221|NCT01873144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20544222|NCT01873144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544223|NCT01873144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544224|NCT01873144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20544225|NCT01873144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20544226|NCT01873144|Autonomic Agents|autonomic agents|mesh-ancestor
20544227|NCT01873144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20544228|NCT01873144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20544229|NCT01873144|Respiratory System Agents|respiratory system agents|mesh-ancestor
20544230|NCT01873144|Mydriatics|mydriatics|mesh-ancestor
20544231|NCT01873144|Sympathomimetics|sympathomimetics|mesh-ancestor
20544232|NCT01873144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20544233|NCT01873157|Bortezomib|bortezomib|mesh-list
20544234|NCT01873157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544235|NCT01873222|Sirolimus|sirolimus|mesh-list
20544236|NCT01873222|Umirolimus|umirolimus|mesh-list
20544237|NCT01873222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20544238|NCT01873222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20544239|NCT01873222|Immunologic Factors|immunologic factors|mesh-ancestor
20544240|NCT01873222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544241|NCT01873222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20544242|NCT01873222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20544243|NCT01873222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20544244|NCT01873222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544245|NCT01873222|Antifungal Agents|antifungal agents|mesh-ancestor
20544246|NCT01873313|Ropivacaine|ropivacaine|mesh-list
20544247|NCT01873313|Anesthetics, Local|anesthetics, local|mesh-ancestor
20544248|NCT01873313|Anesthetics|anesthetics|mesh-ancestor
20544249|NCT01873313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20544250|NCT01873313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544251|NCT01873313|Sensory System Agents|sensory system agents|mesh-ancestor
20544252|NCT01873313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20544253|NCT01873326|Paclitaxel|paclitaxel|mesh-list
20544254|NCT01873326|Etoposide|etoposide|mesh-list
20544255|NCT01873326|Ifosfamide|ifosfamide|mesh-list
20544256|NCT01873326|Bleomycin|bleomycin|mesh-list
20544257|NCT01873326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20271923|NCT00538265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271924|NCT00538265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271925|NCT00538265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20271926|NCT00538265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271927|NCT00538265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20271928|NCT00538265|Antitubercular Agents|antitubercular agents|mesh-ancestor
20271929|NCT00538265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20271930|NCT00538265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271931|NCT00538317|Tirofiban|tirofiban|mesh-list
20271932|NCT00538317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20271933|NCT00538317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20271934|NCT00538317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271935|NCT00538317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19957023|NCT01652664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19957024|NCT01652664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19957025|NCT01652664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19957026|NCT01652664|Adrenergic Agents|adrenergic agents|mesh-ancestor
19957027|NCT01652664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19957028|NCT01652664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957029|NCT01652664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271936|NCT00538330|Tamoxifen|tamoxifen|mesh-list
20271937|NCT00538330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20271938|NCT00538330|Hormone Antagonists|hormone antagonists|mesh-ancestor
20271939|NCT00538330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20271940|NCT00538330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271941|NCT00538330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20271942|NCT00538330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271943|NCT00538330|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20271944|NCT00538330|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20271945|NCT00538330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20271946|NCT00538382|Artesunate|artesunate|mesh-list
20271947|NCT00538382|Antimalarials|antimalarials|mesh-ancestor
20271948|NCT00538382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20271949|NCT00538382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20271950|NCT00538382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20271951|NCT00538382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20271952|NCT00538382|Antiviral Agents|antiviral agents|mesh-ancestor
20271953|NCT00538382|Schistosomicides|schistosomicides|mesh-ancestor
20271954|NCT00538382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20271955|NCT00538382|Anthelmintics|anthelmintics|mesh-ancestor
20271956|NCT00538395|Cyclophosphamide|cyclophosphamide|mesh-list
20271957|NCT00538395|Doxorubicin|doxorubicin|mesh-list
20271958|NCT00538395|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20271959|NCT00538395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20271960|NCT00538395|Immunologic Factors|immunologic factors|mesh-ancestor
20271961|NCT00538395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957030|NCT01652664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19957031|NCT01652664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19957032|NCT01652690|Denosumab|denosumab|mesh-list
19957033|NCT01652690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19957034|NCT01652690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957035|NCT01652703|Evolocumab|evolocumab|mesh-list
19957036|NCT01652703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19957037|NCT01652703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19957038|NCT01652703|Antimetabolites|antimetabolites|mesh-ancestor
19957039|NCT01652703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271962|NCT00538395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20271963|NCT00538395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20271964|NCT00538395|Alkylating Agents|alkylating agents|mesh-ancestor
20271965|NCT00538395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271966|NCT00538395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957040|NCT01652703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19957041|NCT01652716|Exenatide|exenatide|mesh-list
19957042|NCT01652716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19957043|NCT01652716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957044|NCT01652716|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19957045|NCT01652716|Incretins|incretins|mesh-ancestor
19957046|NCT01652716|Hormones|hormones|mesh-ancestor
19957047|NCT01652716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19957048|NCT01652729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19957049|NCT01652729|Exenatide|exenatide|mesh-list
19957050|NCT01652729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19957051|NCT01652729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957052|NCT01652729|Incretins|incretins|mesh-ancestor
19957053|NCT01652729|Hormones|hormones|mesh-ancestor
19957054|NCT01652729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20271967|NCT00538395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20271968|NCT00538395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20271969|NCT00538395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20271970|NCT00538395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20271971|NCT00538395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20271972|NCT00538421|Propofol|propofol|mesh-list
20271973|NCT00538421|Sevoflurane|sevoflurane|mesh-list
20271974|NCT00538421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20271975|NCT00538421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20271976|NCT00538421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271977|NCT00538421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20271978|NCT00538421|Anesthetics, General|anesthetics, general|mesh-ancestor
20271979|NCT00538421|Anesthetics|anesthetics|mesh-ancestor
20271980|NCT00538421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20271981|NCT00538421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20271982|NCT00538486|Metformin|metformin|mesh-list
20271983|NCT00538486|Amlodipine|amlodipine|mesh-list
20271984|NCT00538486|Telmisartan|telmisartan|mesh-list
20271985|NCT00538486|Candesartan|candesartan|mesh-list
20271986|NCT00538486|Candesartan cilexetil|candesartan cilexetil|mesh-list
20271987|NCT00538486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20271988|NCT00538486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20271989|NCT00538486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20271990|NCT00538486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20271991|NCT00538486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20271992|NCT00538486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20271993|NCT00538486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20271994|NCT00538486|Vasodilator Agents|vasodilator agents|mesh-ancestor
20271995|NCT00538486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20271996|NCT00538486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20271997|NCT00538499|Fentanyl|fentanyl|mesh-list
20271998|NCT00538499|Bupivacaine|bupivacaine|mesh-list
20271999|NCT00538499|Anesthetics, Local|anesthetics, local|mesh-ancestor
20272000|NCT00538499|Anesthetics|anesthetics|mesh-ancestor
20272001|NCT00538499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20272002|NCT00538499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272003|NCT00538499|Sensory System Agents|sensory system agents|mesh-ancestor
20272004|NCT00538499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20272005|NCT00538499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20272006|NCT00538499|Narcotics|narcotics|mesh-ancestor
20272007|NCT00538499|Analgesics|analgesics|mesh-ancestor
20272008|NCT00538499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20272009|NCT00538499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20272010|NCT00538499|Anesthetics, General|anesthetics, general|mesh-ancestor
20272011|NCT00538525|Docetaxel|docetaxel|mesh-list
20272012|NCT00538525|Doxorubicin|doxorubicin|mesh-list
20272013|NCT00538525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272014|NCT00538525|Tubulin Modulators|tubulin modulators|mesh-ancestor
20272015|NCT00538525|Antimitotic Agents|antimitotic agents|mesh-ancestor
20272016|NCT00538525|Mitosis Modulators|mitosis modulators|mesh-ancestor
20272017|NCT00538525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272018|NCT00538525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20272019|NCT00538525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20272020|NCT00538525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20272021|NCT00538525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272022|NCT00538538|Ranibizumab|ranibizumab|mesh-list
20272023|NCT00538538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20272024|NCT00538538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20272025|NCT00538538|Growth Substances|growth substances|mesh-ancestor
20272026|NCT00538538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272027|NCT00538538|Growth Inhibitors|growth inhibitors|mesh-ancestor
20272028|NCT00538538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272029|NCT00538564|Tadalafil|tadalafil|mesh-list
20272030|NCT00538564|Vasodilator Agents|vasodilator agents|mesh-ancestor
20272031|NCT00538564|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20272032|NCT00538564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20272033|NCT00538564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957055|NCT01652729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19957056|NCT01652729|Protease Inhibitors|protease inhibitors|mesh-ancestor
19957057|NCT01652729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957058|NCT01652729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957059|NCT01652729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19957060|NCT01652872|Darbepoetin alfa|darbepoetin alfa|mesh-list
20287562|NCT04333407|Anticoagulants|anticoagulants|mesh-ancestor
19957061|NCT01652872|Hematinics|hematinics|mesh-ancestor
19957062|NCT01652976|Leucovorin|leucovorin|mesh-list
19957063|NCT01652976|Fluorouracil|fluorouracil|mesh-list
19957064|NCT01652976|Oxaliplatin|oxaliplatin|mesh-list
19957065|NCT01652976|Dasatinib|dasatinib|mesh-list
19957066|NCT01652976|Antimetabolites|antimetabolites|mesh-ancestor
19957067|NCT01652976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957068|NCT01652976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19957069|NCT01652976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957070|NCT01652976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19957071|NCT01652976|Immunologic Factors|immunologic factors|mesh-ancestor
19957072|NCT01652976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957073|NCT01652976|Antidotes|antidotes|mesh-ancestor
19957074|NCT01652976|Protective Agents|protective agents|mesh-ancestor
19957075|NCT01652976|Vitamin B Complex|vitamin b complex|mesh-ancestor
20272034|NCT00538564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272035|NCT00538564|Urological Agents|urological agents|mesh-ancestor
20272036|NCT00538603|Paclitaxel|paclitaxel|mesh-list
20272037|NCT00538603|Carboplatin|carboplatin|mesh-list
20272038|NCT00538603|Doxorubicin|doxorubicin|mesh-list
20272039|NCT00538603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20272040|NCT00538603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20272041|NCT00538603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272042|NCT00538603|Tubulin Modulators|tubulin modulators|mesh-ancestor
20272043|NCT00538603|Antimitotic Agents|antimitotic agents|mesh-ancestor
20272044|NCT00538603|Mitosis Modulators|mitosis modulators|mesh-ancestor
20272045|NCT00538603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272046|NCT00538603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20272047|NCT00538603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20272048|NCT00538603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19957076|NCT01652976|Vitamins|vitamins|mesh-ancestor
19957077|NCT01652976|Micronutrients|micronutrients|mesh-ancestor
19957078|NCT01652976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19957079|NCT01652976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957080|NCT01653158|Docetaxel|docetaxel|mesh-list
20272049|NCT00538603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544258|NCT01873326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544259|NCT01873326|Tubulin Modulators|tubulin modulators|mesh-ancestor
20544260|NCT01873326|Antimitotic Agents|antimitotic agents|mesh-ancestor
20544261|NCT01873326|Mitosis Modulators|mitosis modulators|mesh-ancestor
20544262|NCT01873326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544263|NCT01873326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20544264|NCT01873326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20544265|NCT01873326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544266|NCT01873326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20544267|NCT01873326|Alkylating Agents|alkylating agents|mesh-ancestor
20544268|NCT01873326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20544269|NCT01873339|Midazolam|midazolam|mesh-list
20544270|NCT01873339|Darapladib|darapladib|mesh-list
20544271|NCT01873339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20544272|NCT01873339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20544273|NCT01873339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20544274|NCT01873339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544275|NCT01873339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20544276|NCT01873339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20544277|NCT01873339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20544278|NCT01873339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20544279|NCT01873339|Anesthetics, General|anesthetics, general|mesh-ancestor
20544280|NCT01873339|Anesthetics|anesthetics|mesh-ancestor
20544281|NCT01873339|GABA Modulators|gaba modulators|mesh-ancestor
19735754|NCT04536662|Hormones|hormones|mesh-ancestor
19735755|NCT04536662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19735756|NCT04536662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19735757|NCT04536662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19735758|NCT04536675|Bromides|bromides|mesh-list
19735759|NCT04536675|Anticonvulsants|anticonvulsants|mesh-ancestor
19735760|NCT04536363|Alprostadil|alprostadil|mesh-list
19735761|NCT04536363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19735762|NCT04536363|Vasodilator Agents|vasodilator agents|mesh-ancestor
19735763|NCT04536363|Urological Agents|urological agents|mesh-ancestor
19735764|NCT04536532|Entecavir|entecavir|mesh-list
19735765|NCT04536532|Antiviral Agents|antiviral agents|mesh-ancestor
19735766|NCT04536532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19735767|NCT04536415|Oseltamivir|oseltamivir|mesh-list
19735768|NCT04536415|Antiviral Agents|antiviral agents|mesh-ancestor
19735769|NCT04536415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19735770|NCT04536415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736030|NCT04533724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19957081|NCT01653158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957082|NCT01653158|Tubulin Modulators|tubulin modulators|mesh-ancestor
19957083|NCT01653158|Antimitotic Agents|antimitotic agents|mesh-ancestor
19957084|NCT01653158|Mitosis Modulators|mitosis modulators|mesh-ancestor
19957085|NCT01653158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957086|NCT01653262|Brivaracetam|brivaracetam|mesh-list
19957087|NCT01653262|Anticonvulsants|anticonvulsants|mesh-ancestor
19957088|NCT01653327|Ketamine|ketamine|mesh-list
19957089|NCT01653327|Analgesics|analgesics|mesh-ancestor
19957090|NCT01653327|Sensory System Agents|sensory system agents|mesh-ancestor
19957091|NCT01653327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19957092|NCT01653327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957093|NCT01653327|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19957094|NCT01653327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19957095|NCT01653327|Anesthetics, General|anesthetics, general|mesh-ancestor
19957096|NCT01653327|Anesthetics|anesthetics|mesh-ancestor
19957097|NCT01653327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19957098|NCT01653327|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19957099|NCT01653327|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19957100|NCT01653327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19957101|NCT01653327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957102|NCT01653418|Cytarabine|cytarabine|mesh-list
19957103|NCT01653418|Etoposide|etoposide|mesh-list
19957104|NCT01653418|Bortezomib|bortezomib|mesh-list
19957105|NCT01653418|Melphalan|melphalan|mesh-list
19957106|NCT01653418|Carmustine|carmustine|mesh-list
19957107|NCT01653418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19957108|NCT01653418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957109|NCT01653418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19957110|NCT01653418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19957111|NCT01653418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957112|NCT01653418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957113|NCT01653418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19957114|NCT01653418|Antimetabolites|antimetabolites|mesh-ancestor
19957115|NCT01653418|Antiviral Agents|antiviral agents|mesh-ancestor
19957116|NCT01653418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20272050|NCT00538655|Modafinil|modafinil|mesh-list
20272051|NCT00538655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20272052|NCT00538655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272053|NCT00538655|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20272054|NCT00538655|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20272055|NCT00538655|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20272056|NCT00538655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272057|NCT00538694|Daptomycin|daptomycin|mesh-list
20272058|NCT00538694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20272059|NCT00538694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20272060|NCT00538720|Vitamin D|vitamin d|mesh-list
20272061|NCT00538720|Ergocalciferols|ergocalciferols|mesh-list
20272062|NCT00538720|Vitamins|vitamins|mesh-ancestor
20272063|NCT00538720|Micronutrients|micronutrients|mesh-ancestor
20272064|NCT00538720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272065|NCT00538720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20272066|NCT00538720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19957117|NCT01653418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19957118|NCT01653418|Immunologic Factors|immunologic factors|mesh-ancestor
19957119|NCT01653418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957120|NCT01653418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19957121|NCT01653418|Alkylating Agents|alkylating agents|mesh-ancestor
19957122|NCT01653418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19957123|NCT01653509|Acyclovir|acyclovir|mesh-list
19957124|NCT01653509|Antiviral Agents|antiviral agents|mesh-ancestor
19957125|NCT01653509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19957126|NCT01653743|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19957127|NCT01653743|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19957128|NCT01653743|Hormones|hormones|mesh-ancestor
20272067|NCT00538811|Interferons|interferons|mesh-list
20272068|NCT00538811|Ribavirin|ribavirin|mesh-list
20272069|NCT00538811|Interferon-alpha|interferon-alpha|mesh-list
20272070|NCT00538811|Interferon alpha-2|interferon alpha-2|mesh-list
20272071|NCT00538811|Interferon-gamma|interferon-gamma|mesh-list
20272072|NCT00538811|Amantadine|amantadine|mesh-list
19957129|NCT01653743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19957130|NCT01653743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272073|NCT00538811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272074|NCT00538811|Antiviral Agents|antiviral agents|mesh-ancestor
19957131|NCT01653743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19957132|NCT01653847|Mycophenolic Acid|mycophenolic acid|mesh-list
19957133|NCT01653847|Everolimus|everolimus|mesh-list
19957134|NCT01653847|Tacrolimus|tacrolimus|mesh-list
19957135|NCT01653847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20272075|NCT00538811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19957136|NCT01653847|Immunologic Factors|immunologic factors|mesh-ancestor
19957137|NCT01653847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957138|NCT01653847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19957139|NCT01653847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957140|NCT01653847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957141|NCT01653847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957142|NCT01653847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19957143|NCT01653847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19957144|NCT01653847|Antitubercular Agents|antitubercular agents|mesh-ancestor
19957145|NCT01653847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19957146|NCT01653847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19957147|NCT01653912|Paclitaxel|paclitaxel|mesh-list
19957148|NCT01653912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19957149|NCT01653912|Carboplatin|carboplatin|mesh-list
19957150|NCT01653912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19957151|NCT01653912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957152|NCT01653912|Tubulin Modulators|tubulin modulators|mesh-ancestor
19957153|NCT01653912|Antimitotic Agents|antimitotic agents|mesh-ancestor
19957154|NCT01653912|Mitosis Modulators|mitosis modulators|mesh-ancestor
19957155|NCT01653912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957156|NCT01654107|Nicotine|nicotine|mesh-list
19957157|NCT01654107|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19957158|NCT01654107|Autonomic Agents|autonomic agents|mesh-ancestor
19957159|NCT01654107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19957160|NCT01654107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957161|NCT01654107|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19957162|NCT01654107|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19957163|NCT01654107|Cholinergic Agents|cholinergic agents|mesh-ancestor
19957164|NCT01654107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19957165|NCT01654107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957166|NCT01654224|Vaccines|vaccines|mesh-list
19957167|NCT01654224|Immunologic Factors|immunologic factors|mesh-ancestor
19957168|NCT01654224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957169|NCT01654276|Febuxostat|febuxostat|mesh-list
19957170|NCT01654276|Gout Suppressants|gout suppressants|mesh-ancestor
19957171|NCT01654276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19957172|NCT01654302|Lidocaine|lidocaine|mesh-list
19957173|NCT01654302|Tetracaine|tetracaine|mesh-list
19957174|NCT01654302|Anesthetics, Local|anesthetics, local|mesh-ancestor
19957175|NCT01654302|Anesthetics|anesthetics|mesh-ancestor
19957176|NCT01654302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19957177|NCT01654302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957178|NCT01654302|Sensory System Agents|sensory system agents|mesh-ancestor
19957179|NCT01654302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19957180|NCT01654302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19957181|NCT01654302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19957182|NCT01654302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19957183|NCT01654302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19957184|NCT01654302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957185|NCT01654380|Insulin Glargine|insulin glargine|mesh-list
19957186|NCT01654380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19957187|NCT01654380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957188|NCT01654445|Tenecteplase|tenecteplase|mesh-list
19957189|NCT01654445|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19957190|NCT01654445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19957191|NCT01654445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974716|NCT01840605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974717|NCT01840605|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19974718|NCT01840943|Topotecan|topotecan|mesh-list
19974719|NCT01840943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19974720|NCT01840943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19974721|NCT01840943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974722|NCT01840943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974723|NCT01840943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974724|NCT01841021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19974725|NCT01841021|Immunoconjugates|immunoconjugates|mesh-list
20272076|NCT00538811|Antimetabolites|antimetabolites|mesh-ancestor
20287563|NCT04333407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20544282|NCT01873339|GABA Agents|gaba agents|mesh-ancestor
20544283|NCT01873339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20544284|NCT01873339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957192|NCT01654536|Ciclesonide|ciclesonide|mesh-list
19957193|NCT01654536|Glucocorticoids|glucocorticoids|mesh-ancestor
19957194|NCT01654536|Hormones|hormones|mesh-ancestor
19957195|NCT01654536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19957196|NCT01654536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957197|NCT01654536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19957198|NCT01654601|Clozapine|clozapine|mesh-list
19957199|NCT01654601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19957200|NCT01654601|Serotonin Agents|serotonin agents|mesh-ancestor
20544285|NCT01873339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
20544286|NCT01873339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544287|NCT01873378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20544288|NCT01873378|Luteolytic Agents|luteolytic agents|mesh-ancestor
20544289|NCT01873378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20544290|NCT01873378|Contraceptive Agents|contraceptive agents|mesh-ancestor
20544291|NCT01873378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20544292|NCT01873378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544293|NCT01873378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20544294|NCT01873378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20544295|NCT01873378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544296|NCT01873430|Melatonin|melatonin|mesh-list
20544297|NCT01873430|Antioxidants|antioxidants|mesh-ancestor
20544298|NCT01873430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544299|NCT01873430|Protective Agents|protective agents|mesh-ancestor
20544300|NCT01873430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544301|NCT01873430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20544302|NCT01873443|Folic Acid|folic acid|mesh-list
20544303|NCT01873443|Rituximab|rituximab|mesh-list
20544304|NCT01873443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20544305|NCT01873443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544306|NCT01873443|Immunologic Factors|immunologic factors|mesh-ancestor
20544307|NCT01873443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544308|NCT01873443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20544309|NCT01873443|Hematinics|hematinics|mesh-ancestor
20544310|NCT01873443|Vitamin B Complex|vitamin b complex|mesh-ancestor
20544311|NCT01873443|Vitamins|vitamins|mesh-ancestor
20544312|NCT01873443|Micronutrients|micronutrients|mesh-ancestor
20544313|NCT01873573|Triamcinolone|triamcinolone|mesh-list
20544314|NCT01873573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20544315|NCT01873573|Glucocorticoids|glucocorticoids|mesh-ancestor
20544316|NCT01873573|Hormones|hormones|mesh-ancestor
20544317|NCT01873573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19957201|NCT01654601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19957202|NCT01654601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957203|NCT01654601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957204|NCT01654601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19957205|NCT01654601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19957206|NCT01654601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19957207|NCT01654601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19957208|NCT01654601|GABA Antagonists|gaba antagonists|mesh-ancestor
19957209|NCT01654601|GABA Agents|gaba agents|mesh-ancestor
19957210|NCT01654861|Ascorbic Acid|ascorbic acid|mesh-list
19957211|NCT01654861|Gemcitabine|gemcitabine|mesh-list
19957212|NCT01654861|Vitamins|vitamins|mesh-ancestor
19957213|NCT01654861|Micronutrients|micronutrients|mesh-ancestor
19957214|NCT01654861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544318|NCT01873573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544319|NCT01873690|Ciprofloxacin|ciprofloxacin|mesh-list
20544320|NCT01873690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20544321|NCT01873690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20544322|NCT01873690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20544323|NCT01873690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20544324|NCT01873690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544325|NCT01873690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544326|NCT01873690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544327|NCT01873690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20544328|NCT01873690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20544329|NCT01873768|Tranexamic Acid|tranexamic acid|mesh-list
20544330|NCT01873768|Aminocaproic Acid|aminocaproic acid|mesh-list
20544331|NCT01873768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20544332|NCT01873768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20544333|NCT01873768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272077|NCT00538811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272078|NCT00538811|Immunologic Factors|immunologic factors|mesh-ancestor
20272079|NCT00538811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272080|NCT00538811|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20272081|NCT00538811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20272082|NCT00538811|Dopamine Agents|dopamine agents|mesh-ancestor
20272083|NCT00538811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20272084|NCT00538811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20272085|NCT00538811|Analgesics|analgesics|mesh-ancestor
20272086|NCT00538811|Sensory System Agents|sensory system agents|mesh-ancestor
20272087|NCT00538811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20272088|NCT00538876|Decitabine|decitabine|mesh-list
20272089|NCT00538876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20272090|NCT00538876|Antimetabolites|antimetabolites|mesh-ancestor
20272091|NCT00538876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272092|NCT00538876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272093|NCT00538876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272094|NCT00538889|Citalopram|citalopram|mesh-list
19957215|NCT01654861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19957216|NCT01654861|Antimetabolites|antimetabolites|mesh-ancestor
19957217|NCT01654861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957218|NCT01654861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957219|NCT01654861|Antiviral Agents|antiviral agents|mesh-ancestor
19957220|NCT01654861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19957221|NCT01654861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957222|NCT01654861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19957223|NCT01654861|Immunologic Factors|immunologic factors|mesh-ancestor
19957224|NCT01654861|Antioxidants|antioxidants|mesh-ancestor
19957225|NCT01654861|Protective Agents|protective agents|mesh-ancestor
19957226|NCT01655043|Regadenoson|regadenoson|mesh-list
19957227|NCT01655043|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19957228|NCT01655043|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19957229|NCT01655043|Purinergic Agonists|purinergic agonists|mesh-ancestor
19957230|NCT01655043|Purinergic Agents|purinergic agents|mesh-ancestor
19957231|NCT01655043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19957232|NCT01655043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957233|NCT01655043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957234|NCT01655069|Solifenacin Succinate|solifenacin succinate|mesh-list
19957235|NCT01655069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19957236|NCT01655069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19957237|NCT01655069|Cholinergic Agents|cholinergic agents|mesh-ancestor
19957238|NCT01655069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19957239|NCT01655069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957240|NCT01655069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957241|NCT01655069|Urological Agents|urological agents|mesh-ancestor
19957242|NCT01655563|Tacrolimus|tacrolimus|mesh-list
19957243|NCT01655563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19957244|NCT01655563|Immunologic Factors|immunologic factors|mesh-ancestor
19957245|NCT01655563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957246|NCT01655563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19957247|NCT01655563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957248|NCT01655563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957249|NCT01655693|Doxorubicin|doxorubicin|mesh-list
19957250|NCT01655693|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19957251|NCT01655693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19957252|NCT01655693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957253|NCT01655693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19957254|NCT01655693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19957255|NCT01655693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957256|NCT01655693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957257|NCT01655719|Pioglitazone|pioglitazone|mesh-list
19957258|NCT01655719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20272095|NCT00538889|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20272096|NCT00538889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20272097|NCT00538889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20272098|NCT00538889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272099|NCT00538889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20272100|NCT00538889|Serotonin Agents|serotonin agents|mesh-ancestor
20272101|NCT00538889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272102|NCT00538889|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20272103|NCT00538889|Antidepressive Agents|antidepressive agents|mesh-ancestor
20272104|NCT00538889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20272105|NCT00538954|Magnesium Oxide|magnesium oxide|mesh-list
20272106|NCT00538954|Antacids|antacids|mesh-ancestor
20272107|NCT00538954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272108|NCT00538954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20272109|NCT00538967|Doxycycline|doxycycline|mesh-list
20272110|NCT00538967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20272111|NCT00538967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20272112|NCT00538967|Antimalarials|antimalarials|mesh-ancestor
20272113|NCT00538967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20272114|NCT00538967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20272115|NCT00539071|Risperidone|risperidone|mesh-list
20272116|NCT00539071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20272117|NCT00539071|Serotonin Agents|serotonin agents|mesh-ancestor
20272118|NCT00539071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20272119|NCT00539071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272120|NCT00539071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272121|NCT00539071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20272122|NCT00539071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20272123|NCT00539071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20272124|NCT00539071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20272125|NCT00539071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20272126|NCT00539071|Dopamine Agents|dopamine agents|mesh-ancestor
20272127|NCT00539123|Buprenorphine|buprenorphine|mesh-list
20272128|NCT00539123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20272129|NCT00539123|Narcotics|narcotics|mesh-ancestor
20272130|NCT00539123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20272131|NCT00539123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272132|NCT00539123|Analgesics|analgesics|mesh-ancestor
20272133|NCT00539123|Sensory System Agents|sensory system agents|mesh-ancestor
20272134|NCT00539123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20272135|NCT00539123|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20272136|NCT00539149|Amoxicillin|amoxicillin|mesh-list
20272137|NCT00539149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20272138|NCT00539149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20272139|NCT00539331|Paclitaxel|paclitaxel|mesh-list
20272140|NCT00539331|Carboplatin|carboplatin|mesh-list
20272141|NCT00539331|Cediranib|cediranib|mesh-list
20272142|NCT00539331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20272143|NCT00539331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272144|NCT00539331|Tubulin Modulators|tubulin modulators|mesh-ancestor
20272145|NCT00539331|Antimitotic Agents|antimitotic agents|mesh-ancestor
20272146|NCT00539331|Mitosis Modulators|mitosis modulators|mesh-ancestor
20272147|NCT00539331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272148|NCT00539331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20272149|NCT00539331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272150|NCT00539396|Insulin|insulin|mesh-list
19957259|NCT01655719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957260|NCT01655823|Tetrodotoxin|tetrodotoxin|mesh-list
19957261|NCT01655823|Anesthetics, Local|anesthetics, local|mesh-ancestor
19957262|NCT01655823|Anesthetics|anesthetics|mesh-ancestor
19957263|NCT01655823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19957264|NCT01655823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957265|NCT01655823|Sensory System Agents|sensory system agents|mesh-ancestor
19957266|NCT01655823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19957267|NCT01655823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19957268|NCT01655823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19957269|NCT01655823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957270|NCT01656031|Cytarabine|cytarabine|mesh-list
19957271|NCT01656031|Clofarabine|clofarabine|mesh-list
19957272|NCT01656031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19957273|NCT01656031|Antimetabolites|antimetabolites|mesh-ancestor
19957274|NCT01656031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957275|NCT01656031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957276|NCT01656031|Antiviral Agents|antiviral agents|mesh-ancestor
19957277|NCT01656031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20272151|NCT00539396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20272152|NCT00539396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272153|NCT00539409|Insulin|insulin|mesh-list
20272154|NCT00539409|Insulin Aspart|insulin aspart|mesh-list
20272155|NCT00539409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20272156|NCT00539409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20272157|NCT00539409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272158|NCT00539435|Insulin|insulin|mesh-list
20272159|NCT00539435|Insulin Aspart|insulin aspart|mesh-list
20272160|NCT00539435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20272161|NCT00539435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272162|NCT00539448|Insulin|insulin|mesh-list
20272163|NCT00539448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20272164|NCT00539448|Insulin Glargine|insulin glargine|mesh-list
20272165|NCT00539448|Insulin glulisine|insulin glulisine|mesh-list
19957278|NCT01656031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19957279|NCT01656031|Immunologic Factors|immunologic factors|mesh-ancestor
19957280|NCT01656031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957281|NCT01656161|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19957282|NCT01656161|Luteolytic Agents|luteolytic agents|mesh-ancestor
19957283|NCT01656161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19957284|NCT01656161|Contraceptive Agents|contraceptive agents|mesh-ancestor
19957285|NCT01656161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19957286|NCT01656161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957287|NCT01656161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19957288|NCT01656161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19957289|NCT01656161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272166|NCT00539448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20272167|NCT00539448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287564|NCT04333407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20287565|NCT04333407|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20287566|NCT04290546|Ipilimumab|ipilimumab|mesh-list
20287567|NCT04290546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20287568|NCT04290546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20287569|NCT04290546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287570|NCT04290546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287571|NCT04286529|Calcitriol|calcitriol|mesh-list
20287572|NCT04286529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20287573|NCT04286529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287574|NCT04286529|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20287575|NCT04286529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20287576|NCT04286529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287577|NCT04286529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20287578|NCT04286529|Vitamins|vitamins|mesh-ancestor
20287579|NCT04286529|Micronutrients|micronutrients|mesh-ancestor
20287580|NCT04286529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20287581|NCT04269200|Paclitaxel|paclitaxel|mesh-list
20287582|NCT04269200|Carboplatin|carboplatin|mesh-list
20544334|NCT01873768|Hemostatics|hemostatics|mesh-ancestor
20544335|NCT01873768|Coagulants|coagulants|mesh-ancestor
20544336|NCT01873807|Cyclophosphamide|cyclophosphamide|mesh-list
20544337|NCT01873807|Etoposide|etoposide|mesh-list
20544338|NCT01873807|Idarubicin|idarubicin|mesh-list
20544339|NCT01873807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20544340|NCT01873807|Immunologic Factors|immunologic factors|mesh-ancestor
20544341|NCT01873807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544342|NCT01873807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20544343|NCT01873807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20544344|NCT01873807|Alkylating Agents|alkylating agents|mesh-ancestor
20544345|NCT01873807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544346|NCT01873807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544347|NCT01873807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20544348|NCT01873807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20544349|NCT01873807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19733134|NCT04564638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957290|NCT01656187|Memantine|memantine|mesh-list
19957291|NCT01656187|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19957292|NCT01656187|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19957293|NCT01656187|Dopamine Agents|dopamine agents|mesh-ancestor
19957294|NCT01656187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19957295|NCT01656187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957296|NCT01656187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957297|NCT01656187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19957298|NCT01656187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19957299|NCT01656252|Cytarabine|cytarabine|mesh-list
19957300|NCT01656252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19733135|NCT04564638|Antifungal Agents|antifungal agents|mesh-ancestor
19733136|NCT04564638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19733137|NCT04564638|Dermatologic Agents|dermatologic agents|mesh-ancestor
19733138|NCT04564638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19733139|NCT04564638|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19957301|NCT01656252|Antimetabolites|antimetabolites|mesh-ancestor
19957302|NCT01656252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957303|NCT01656252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287583|NCT04269200|Durvalumab|durvalumab|mesh-list
19733140|NCT04564521|Nitroglycerin|nitroglycerin|mesh-list
19733141|NCT04564521|Vasodilator Agents|vasodilator agents|mesh-ancestor
19733142|NCT04564326|Fentanyl|fentanyl|mesh-list
20272168|NCT00539565|Prednisolone|prednisolone|mesh-list
20272169|NCT00539565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20272170|NCT00539565|Glucocorticoids|glucocorticoids|mesh-ancestor
20272171|NCT00539565|Hormones|hormones|mesh-ancestor
20272172|NCT00539565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20272173|NCT00539565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272174|NCT00539565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20272175|NCT00539565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272176|NCT00539630|Docetaxel|docetaxel|mesh-list
20272177|NCT00539630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272178|NCT00539630|Tubulin Modulators|tubulin modulators|mesh-ancestor
20272179|NCT00539630|Antimitotic Agents|antimitotic agents|mesh-ancestor
20272180|NCT00539630|Mitosis Modulators|mitosis modulators|mesh-ancestor
20272181|NCT00539630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272182|NCT00539669|Docetaxel|docetaxel|mesh-list
20272183|NCT00539669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272184|NCT00539669|Tubulin Modulators|tubulin modulators|mesh-ancestor
20272185|NCT00539669|Antimitotic Agents|antimitotic agents|mesh-ancestor
20272186|NCT00539669|Mitosis Modulators|mitosis modulators|mesh-ancestor
20272187|NCT00539669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272188|NCT00539773|Interferons|interferons|mesh-list
20272189|NCT00539773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272190|NCT00539773|Antiviral Agents|antiviral agents|mesh-ancestor
20272191|NCT00539773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20272192|NCT00539786|Rabeprazole|rabeprazole|mesh-list
20272193|NCT00539786|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20272194|NCT00539786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20272195|NCT00539786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20272196|NCT00539786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272197|NCT00539786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272198|NCT00539799|Prednisolone|prednisolone|mesh-list
20272199|NCT00539799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20272200|NCT00539799|Glucocorticoids|glucocorticoids|mesh-ancestor
20272201|NCT00539799|Hormones|hormones|mesh-ancestor
20272202|NCT00539799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20272203|NCT00539799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272204|NCT00539799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20272205|NCT00539799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272206|NCT00539877|Irinotecan|irinotecan|mesh-list
20272207|NCT00539877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20272208|NCT00539877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20272209|NCT00539877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272210|NCT00539877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272211|NCT00539877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272212|NCT00539890|Insulin|insulin|mesh-list
20272213|NCT00539890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20272214|NCT00539890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272215|NCT00539968|Docetaxel|docetaxel|mesh-list
20272216|NCT00539968|Lonafarnib|lonafarnib|mesh-list
20272217|NCT00539968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272218|NCT00539968|Tubulin Modulators|tubulin modulators|mesh-ancestor
20272219|NCT00539968|Antimitotic Agents|antimitotic agents|mesh-ancestor
20272220|NCT00539968|Mitosis Modulators|mitosis modulators|mesh-ancestor
20272221|NCT00539968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272222|NCT00539968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272223|NCT00540072|Daptomycin|daptomycin|mesh-list
20272224|NCT00540072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20272225|NCT00540072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20272226|NCT00540085|Rocuronium|rocuronium|mesh-list
20272227|NCT00540085|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20272228|NCT00540085|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20272229|NCT00540085|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20272230|NCT00540085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20272231|NCT00540085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272232|NCT00540098|Paroxetine|paroxetine|mesh-list
20272233|NCT00540098|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20272234|NCT00540098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20272235|NCT00540098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20272236|NCT00540098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272237|NCT00540098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20272238|NCT00540098|Serotonin Agents|serotonin agents|mesh-ancestor
20272239|NCT00540098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272240|NCT00540098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19957304|NCT01656252|Antiviral Agents|antiviral agents|mesh-ancestor
20272241|NCT00540098|Antidepressive Agents|antidepressive agents|mesh-ancestor
20272242|NCT00540098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20272243|NCT00540098|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20272244|NCT00540098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20272245|NCT00540098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272246|NCT00540137|Ritonavir|ritonavir|mesh-list
20272247|NCT00540137|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20272248|NCT00540137|Nevirapine|nevirapine|mesh-list
20272249|NCT00540137|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20272250|NCT00540137|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20272251|NCT00540137|Protease Inhibitors|protease inhibitors|mesh-ancestor
20272252|NCT00540137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272253|NCT00540137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272254|NCT00540137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20272255|NCT00540137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20272256|NCT00540137|Antiviral Agents|antiviral agents|mesh-ancestor
20272257|NCT00540137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19957305|NCT01656252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19957306|NCT01656252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19957307|NCT01656252|Immunologic Factors|immunologic factors|mesh-ancestor
19957308|NCT01656252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957309|NCT01656304|Bevacizumab|bevacizumab|mesh-list
20272258|NCT00540137|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20272259|NCT00540137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20272260|NCT00540137|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20272261|NCT00540137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20272262|NCT00540137|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20272263|NCT00540137|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20272264|NCT00540202|Lumefantrine|lumefantrine|mesh-list
20272265|NCT00540202|Artemether|artemether|mesh-list
20272266|NCT00540202|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20272267|NCT00540202|Quinine|quinine|mesh-list
20272268|NCT00540202|Antimalarials|antimalarials|mesh-ancestor
20272269|NCT00540202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20272270|NCT00540202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20272271|NCT00540202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20272272|NCT00540202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20272273|NCT00540202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272274|NCT00540202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20272275|NCT00540202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20272276|NCT00540202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20272277|NCT00540202|Analgesics|analgesics|mesh-ancestor
20272278|NCT00540202|Sensory System Agents|sensory system agents|mesh-ancestor
20272279|NCT00540241|Pemetrexed|pemetrexed|mesh-list
19957310|NCT01656304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19957311|NCT01656304|Antibodies|antibodies|mesh-list
19957312|NCT01656304|Immunoglobulins|immunoglobulins|mesh-list
19957313|NCT01656304|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19957314|NCT01656304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957315|NCT01656304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19957316|NCT01656304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19957317|NCT01656304|Growth Substances|growth substances|mesh-ancestor
19957318|NCT01656304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957319|NCT01656304|Growth Inhibitors|growth inhibitors|mesh-ancestor
20272280|NCT00540241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272281|NCT00540241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544350|NCT01873807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20544351|NCT01873807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544352|NCT01873807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20544353|NCT01873820|Ascorbic Acid|ascorbic acid|mesh-list
20544354|NCT01873820|Calcium ascorbate|calcium ascorbate|mesh-list
20544355|NCT01873820|Calcium|calcium|mesh-list
20544356|NCT01873820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20544357|NCT01873820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544358|NCT01873820|Antioxidants|antioxidants|mesh-ancestor
20544359|NCT01873820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544360|NCT01873820|Protective Agents|protective agents|mesh-ancestor
20544361|NCT01873820|Vitamins|vitamins|mesh-ancestor
20544362|NCT01873820|Micronutrients|micronutrients|mesh-ancestor
20544363|NCT01873833|Cyclophosphamide|cyclophosphamide|mesh-list
20544364|NCT01873833|Capecitabine|capecitabine|mesh-list
20544365|NCT01873833|Trastuzumab|trastuzumab|mesh-list
20544366|NCT01873833|Lapatinib|lapatinib|mesh-list
19957320|NCT01656304|Immunologic Factors|immunologic factors|mesh-ancestor
19957321|NCT01656395|Montelukast|montelukast|mesh-list
20272282|NCT00540241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544367|NCT01873833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20544368|NCT01873833|Immunologic Factors|immunologic factors|mesh-ancestor
20272283|NCT00540241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19957322|NCT01656395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19957323|NCT01656395|Respiratory System Agents|respiratory system agents|mesh-ancestor
19957324|NCT01656395|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19957325|NCT01656395|Hormone Antagonists|hormone antagonists|mesh-ancestor
19957326|NCT01656395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19957327|NCT01656395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957328|NCT01656395|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19957329|NCT01656395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19957330|NCT01656395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957331|NCT01656629|Vitamin D|vitamin d|mesh-list
19957332|NCT01656629|Alendronate|alendronate|mesh-list
19957333|NCT01656629|Teriparatide|teriparatide|mesh-list
19957334|NCT01656629|Calcium|calcium|mesh-list
19957335|NCT01656629|Vitamins|vitamins|mesh-ancestor
19957336|NCT01656629|Micronutrients|micronutrients|mesh-ancestor
20272284|NCT00540241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20272285|NCT00540280|Gemcitabine|gemcitabine|mesh-list
20272286|NCT00540280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272287|NCT00540280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20272288|NCT00540280|Antimetabolites|antimetabolites|mesh-ancestor
20272289|NCT00540280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272290|NCT00540280|Antiviral Agents|antiviral agents|mesh-ancestor
20272291|NCT00540280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20272292|NCT00540280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272293|NCT00540280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20272294|NCT00540280|Immunologic Factors|immunologic factors|mesh-ancestor
20272295|NCT00540280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272296|NCT00540345|Interferons|interferons|mesh-list
20272297|NCT00540345|Ribavirin|ribavirin|mesh-list
20272298|NCT00540345|Interferon-alpha|interferon-alpha|mesh-list
20272299|NCT00540345|Interferon alpha-2|interferon alpha-2|mesh-list
20272300|NCT00540345|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20272301|NCT00540345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272302|NCT00540345|Antiviral Agents|antiviral agents|mesh-ancestor
20272303|NCT00540345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20272304|NCT00540345|Antimetabolites|antimetabolites|mesh-ancestor
20272305|NCT00540345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272306|NCT00540345|Immunologic Factors|immunologic factors|mesh-ancestor
20272307|NCT00540345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272308|NCT00540384|Darbepoetin alfa|darbepoetin alfa|mesh-list
20272309|NCT00540384|Hematinics|hematinics|mesh-ancestor
20272310|NCT00540410|Artesunate|artesunate|mesh-list
20272311|NCT00540410|Lumefantrine|lumefantrine|mesh-list
19957337|NCT01656629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957338|NCT01656629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19957339|NCT01656629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19957340|NCT01656733|Nicotine|nicotine|mesh-list
19957341|NCT01656733|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19957342|NCT01656733|Autonomic Agents|autonomic agents|mesh-ancestor
19957343|NCT01656733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19957344|NCT01656733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957345|NCT01656733|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19957346|NCT01656733|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19957347|NCT01656733|Cholinergic Agents|cholinergic agents|mesh-ancestor
19957348|NCT01656733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19957349|NCT01656733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272312|NCT00540410|Amodiaquine|amodiaquine|mesh-list
20272313|NCT00540410|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20272314|NCT00540410|Antimalarials|antimalarials|mesh-ancestor
20272315|NCT00540410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20272316|NCT00540410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20272317|NCT00540410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20272318|NCT00540410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272319|NCT00540410|Antiviral Agents|antiviral agents|mesh-ancestor
20272320|NCT00540410|Schistosomicides|schistosomicides|mesh-ancestor
20272321|NCT00540410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20272322|NCT00540410|Anthelmintics|anthelmintics|mesh-ancestor
20272323|NCT00540501|Oseltamivir|oseltamivir|mesh-list
20272324|NCT00540501|Zanamivir|zanamivir|mesh-list
20272325|NCT00540501|Antiviral Agents|antiviral agents|mesh-ancestor
20272326|NCT00540501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20272327|NCT00540501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272328|NCT00540501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272329|NCT00540527|Plasminogen|plasminogen|mesh-list
20272330|NCT00540527|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20272331|NCT00540527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20272332|NCT00540527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20272333|NCT00540527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272334|NCT00540605|Tenofovir|tenofovir|mesh-list
20272335|NCT00540605|Antiviral Agents|antiviral agents|mesh-ancestor
20272336|NCT00540605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20272337|NCT00540605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20272338|NCT00540605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20272339|NCT00540605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272340|NCT00540605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272341|NCT00540605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20272342|NCT00540605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20272343|NCT00540696|Darbepoetin alfa|darbepoetin alfa|mesh-list
20272344|NCT00540696|Hematinics|hematinics|mesh-ancestor
20272345|NCT00540709|Insulin Glargine|insulin glargine|mesh-list
20272346|NCT00540709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20272347|NCT00540709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272348|NCT00540748|Oxytocin|oxytocin|mesh-list
20272349|NCT00540748|Oxytocics|oxytocics|mesh-ancestor
20272350|NCT00540748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20272351|NCT00540748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272352|NCT00540787|Quinidine|quinidine|mesh-list
20272353|NCT00540787|Amiodarone|amiodarone|mesh-list
20272354|NCT00540787|Sotalol|sotalol|mesh-list
20272355|NCT00540787|Flecainide|flecainide|mesh-list
20272356|NCT00540787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
20272357|NCT00540787|Propafenone|propafenone|mesh-list
20272358|NCT00540787|Dofetilide|dofetilide|mesh-list
20272359|NCT00540787|Cifenline|cifenline|mesh-list
19957350|NCT01657019|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19957351|NCT01657019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19957352|NCT01657019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957353|NCT01657019|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19957354|NCT01657019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19957355|NCT01657019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19957356|NCT01657019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957357|NCT01657019|Dopamine Agents|dopamine agents|mesh-ancestor
19957358|NCT01657019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19957359|NCT01657162|Alendronate|alendronate|mesh-list
19957360|NCT01657162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19957361|NCT01657162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957362|NCT01657266|Nepafenac|nepafenac|mesh-list
19957363|NCT01657266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19957364|NCT01657266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19957365|NCT01657266|Analgesics|analgesics|mesh-ancestor
19957366|NCT01657266|Sensory System Agents|sensory system agents|mesh-ancestor
19957367|NCT01657266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19957368|NCT01657266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957369|NCT01657266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19957370|NCT01657266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19957371|NCT01657292|Octenidine|octenidine|mesh-list
19957372|NCT01657292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19957373|NCT01657292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19957374|NCT01657461|Plasminogen|plasminogen|mesh-list
19957375|NCT01657461|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19957376|NCT01657461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19957377|NCT01657461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19957378|NCT01657461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957379|NCT01657760|Citalopram|citalopram|mesh-list
19957380|NCT01657760|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19957381|NCT01657760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19957382|NCT01657760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19957383|NCT01657760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957384|NCT01657760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19957385|NCT01657760|Serotonin Agents|serotonin agents|mesh-ancestor
19957386|NCT01657760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957387|NCT01657760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19957388|NCT01657760|Antidepressive Agents|antidepressive agents|mesh-ancestor
19957389|NCT01657760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19957390|NCT01657799|Veliparib|veliparib|mesh-list
19957391|NCT01657799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20272360|NCT00540787|Calcium Channel Blockers|calcium channel blockers|mesh-list
20272361|NCT00540787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20272362|NCT00540787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272363|NCT00540787|Vasodilator Agents|vasodilator agents|mesh-ancestor
20272364|NCT00540787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20272365|NCT00540787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20272366|NCT00540787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272367|NCT00540787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20272368|NCT00540787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20272369|NCT00540787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20272370|NCT00540787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272371|NCT00540787|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20272372|NCT00540787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20272373|NCT00540787|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20272374|NCT00540787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20272375|NCT00540787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20272376|NCT00540787|Adrenergic Agents|adrenergic agents|mesh-ancestor
20272377|NCT00540787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20272378|NCT00540787|Sympatholytics|sympatholytics|mesh-ancestor
20272379|NCT00540787|Autonomic Agents|autonomic agents|mesh-ancestor
20272380|NCT00540787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20272381|NCT00540787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20272382|NCT00540787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20272383|NCT00540787|Antimalarials|antimalarials|mesh-ancestor
20272384|NCT00540787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20272385|NCT00540787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20272386|NCT00540787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20272387|NCT00540787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20272388|NCT00540787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20272389|NCT00540787|Cholinergic Agents|cholinergic agents|mesh-ancestor
20272390|NCT00540800|Docetaxel|docetaxel|mesh-list
20272391|NCT00540800|Capecitabine|capecitabine|mesh-list
20272392|NCT00540800|Epirubicin|epirubicin|mesh-list
20272393|NCT00540800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272394|NCT00540800|Tubulin Modulators|tubulin modulators|mesh-ancestor
20272395|NCT00540800|Antimitotic Agents|antimitotic agents|mesh-ancestor
20272396|NCT00540800|Mitosis Modulators|mitosis modulators|mesh-ancestor
20272397|NCT00540800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272398|NCT00540800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20272399|NCT00540800|Antimetabolites|antimetabolites|mesh-ancestor
20272400|NCT00540800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20272401|NCT00540800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20272402|NCT00540800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20272403|NCT00540800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272404|NCT00540826|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20272405|NCT00540826|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20272406|NCT00540826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20272407|NCT00540826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20272408|NCT00540826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272409|NCT00540826|Adrenergic Agents|adrenergic agents|mesh-ancestor
20272410|NCT00540826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20272411|NCT00540826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272412|NCT00540891|Alfuzosin|alfuzosin|mesh-list
20272413|NCT00540891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20272414|NCT00540891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20272415|NCT00540891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20272416|NCT00540891|Adrenergic Agents|adrenergic agents|mesh-ancestor
20272417|NCT00540891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20272418|NCT00540891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272419|NCT00540891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272420|NCT00540891|Urological Agents|urological agents|mesh-ancestor
20272421|NCT00540930|Ranibizumab|ranibizumab|mesh-list
20272422|NCT00540930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20272423|NCT00540930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20272424|NCT00540930|Growth Substances|growth substances|mesh-ancestor
20272425|NCT00540930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957392|NCT01657799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957393|NCT01657799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957394|NCT01657799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957395|NCT01657877|Calcium|calcium|mesh-list
19957396|NCT01657877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19957397|NCT01657877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957398|NCT01657903|Listerine|listerine|mesh-list
19957399|NCT01657903|Fluorides|fluorides|mesh-list
19957400|NCT01657903|Sodium Fluoride|sodium fluoride|mesh-list
19957401|NCT01657903|Cariostatic Agents|cariostatic agents|mesh-ancestor
20272426|NCT00540930|Growth Inhibitors|growth inhibitors|mesh-ancestor
19957402|NCT01657903|Protective Agents|protective agents|mesh-ancestor
19957403|NCT01657903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957404|NCT01657903|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19957405|NCT01657903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19957406|NCT01658020|Moxifloxacin|moxifloxacin|mesh-list
19957407|NCT01658020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19957408|NCT01658020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20272427|NCT00540930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272428|NCT00540943|Irinotecan|irinotecan|mesh-list
20272429|NCT00540943|Cetuximab|cetuximab|mesh-list
20272430|NCT00540943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20272431|NCT00540943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20272432|NCT00540943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957409|NCT01658020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19957410|NCT01658020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19957411|NCT01658020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957412|NCT01658020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957413|NCT01658020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957414|NCT01658150|Isradipine|isradipine|mesh-list
19957415|NCT01658150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19957416|NCT01658150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19957417|NCT01658150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19957418|NCT01658150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957419|NCT01658150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19957420|NCT01658150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957421|NCT01658150|Vasodilator Agents|vasodilator agents|mesh-ancestor
19957422|NCT01658228|Donepezil|donepezil|mesh-list
19957423|NCT01658228|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19957424|NCT01658228|Citalopram|citalopram|mesh-list
19957425|NCT01658228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19957426|NCT01658228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957427|NCT01658228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957428|NCT01658228|Cholinergic Agents|cholinergic agents|mesh-ancestor
19957429|NCT01658228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19957430|NCT01658228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957431|NCT01658228|Nootropic Agents|nootropic agents|mesh-ancestor
19957432|NCT01658228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19957433|NCT01658228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19957434|NCT01658228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19957435|NCT01658228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19957436|NCT01658228|Antidepressive Agents|antidepressive agents|mesh-ancestor
19957437|NCT01658228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19957438|NCT01658228|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19957439|NCT01658228|Serotonin Agents|serotonin agents|mesh-ancestor
19957440|NCT01658436|Dactolisib|dactolisib|mesh-list
19957441|NCT01658436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272433|NCT00540943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272434|NCT00540943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272435|NCT00540943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20272436|NCT00540956|Cytarabine|cytarabine|mesh-list
20272437|NCT00540956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20272438|NCT00540956|Antimetabolites|antimetabolites|mesh-ancestor
20272439|NCT00540956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272440|NCT00540956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544369|NCT01873833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544370|NCT01873833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20544371|NCT01873833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20544372|NCT01873833|Alkylating Agents|alkylating agents|mesh-ancestor
19957442|NCT01658579|Insulin|insulin|mesh-list
19957443|NCT01658579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19957444|NCT01658579|Insulin Glargine|insulin glargine|mesh-list
19957445|NCT01658579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19957446|NCT01658579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957447|NCT01658657|Metoprolol|metoprolol|mesh-list
19957448|NCT01658657|Amlodipine|amlodipine|mesh-list
19957449|NCT01658657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19957450|NCT01658657|Lisinopril|lisinopril|mesh-list
19957451|NCT01658657|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
19957452|NCT01658657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19957453|NCT01658657|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19957454|NCT01658657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20272441|NCT00540956|Antiviral Agents|antiviral agents|mesh-ancestor
20554213|NCT01934088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19957455|NCT01658657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272442|NCT00540956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20272443|NCT00540956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20272444|NCT00540956|Immunologic Factors|immunologic factors|mesh-ancestor
20272445|NCT00540956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272446|NCT00541008|Sunitinib|sunitinib|mesh-list
20272447|NCT00541008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272448|NCT00541008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20272449|NCT00541008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20272450|NCT00541008|Growth Substances|growth substances|mesh-ancestor
19450300|NCT03429738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19450301|NCT03429738|Respiratory System Agents|respiratory system agents|mesh-ancestor
19450302|NCT03429738|Nasal Decongestants|nasal decongestants|mesh-ancestor
19450303|NCT03429738|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19450304|NCT03429738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19450305|NCT03429738|Sympathomimetics|sympathomimetics|mesh-ancestor
19450306|NCT03429738|Adrenergic Agents|adrenergic agents|mesh-ancestor
19450307|NCT03429738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450308|NCT03429621|Simethicone|simethicone|mesh-list
19450309|NCT03429621|Antifoaming Agents|antifoaming agents|mesh-ancestor
19450310|NCT03429621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957456|NCT01658657|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20272451|NCT00541008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272452|NCT00541008|Growth Inhibitors|growth inhibitors|mesh-ancestor
20272453|NCT00541008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20272454|NCT00541008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272455|NCT00541008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272456|NCT00541021|Gemcitabine|gemcitabine|mesh-list
20272457|NCT00541021|Sorafenib|sorafenib|mesh-list
20272458|NCT00541021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20272459|NCT00541021|Antimetabolites|antimetabolites|mesh-ancestor
20272460|NCT00541021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272461|NCT00541021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272462|NCT00541021|Antiviral Agents|antiviral agents|mesh-ancestor
20272463|NCT00541021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20272464|NCT00541021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272465|NCT00541021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20272466|NCT00541021|Immunologic Factors|immunologic factors|mesh-ancestor
20272467|NCT00541021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272468|NCT00541021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19957457|NCT01658657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957458|NCT01658657|Vasodilator Agents|vasodilator agents|mesh-ancestor
19957459|NCT01658657|Diuretics|diuretics|mesh-ancestor
19957460|NCT01658657|Natriuretic Agents|natriuretic agents|mesh-ancestor
19957461|NCT01658657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19957462|NCT01658657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19957463|NCT01658657|Sympatholytics|sympatholytics|mesh-ancestor
19957464|NCT01658657|Autonomic Agents|autonomic agents|mesh-ancestor
19957465|NCT01658657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19957466|NCT01658657|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20272469|NCT00541047|Leuprolide|leuprolide|mesh-list
20272470|NCT00541047|Goserelin|goserelin|mesh-list
20272471|NCT00541047|Bicalutamide|bicalutamide|mesh-list
20272472|NCT00541047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20272473|NCT00541047|Fertility Agents|fertility agents|mesh-ancestor
20272474|NCT00541047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20272475|NCT00541047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272476|NCT00541047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20272477|NCT00541047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272478|NCT00541047|Androgen Antagonists|androgen antagonists|mesh-ancestor
20272479|NCT00541047|Hormone Antagonists|hormone antagonists|mesh-ancestor
20272480|NCT00541047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20272481|NCT00541073|Vitamin B 12|vitamin b 12|mesh-list
20272482|NCT00541073|Hydroxocobalamin|hydroxocobalamin|mesh-list
20272483|NCT00541073|Pemetrexed|pemetrexed|mesh-list
20272484|NCT00541073|Vitamins|vitamins|mesh-ancestor
20272485|NCT00541073|Micronutrients|micronutrients|mesh-ancestor
20272486|NCT00541073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957467|NCT01658657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19957468|NCT01658657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19957469|NCT01658657|Adrenergic Agents|adrenergic agents|mesh-ancestor
20272487|NCT00541073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272488|NCT00541073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272489|NCT00541073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957470|NCT01658657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19957471|NCT01658657|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19957472|NCT01658657|Protease Inhibitors|protease inhibitors|mesh-ancestor
19957473|NCT01658657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957474|NCT01658657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19957475|NCT01658657|Protective Agents|protective agents|mesh-ancestor
19957476|NCT01658839|Travoprost|travoprost|mesh-list
19957477|NCT01658839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19957478|NCT01658839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20272490|NCT00541073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20272491|NCT00541073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20272492|NCT00541073|Vitamin B Complex|vitamin b complex|mesh-ancestor
20272493|NCT00541073|Hematinics|hematinics|mesh-ancestor
20272494|NCT00541086|Tamoxifen|tamoxifen|mesh-list
20272495|NCT00541086|Letrozole|letrozole|mesh-list
20272496|NCT00541086|Anastrozole|anastrozole|mesh-list
20272497|NCT00541086|Exemestane|exemestane|mesh-list
20272498|NCT00541086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272499|NCT00541086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272500|NCT00541086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20272501|NCT00541086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20272502|NCT00541086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272503|NCT00541086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20272504|NCT00541086|Hormone Antagonists|hormone antagonists|mesh-ancestor
20272505|NCT00541086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20272506|NCT00541086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272507|NCT00541086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20272508|NCT00541086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20287584|NCT04269200|Olaparib|olaparib|mesh-list
20544373|NCT01873833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544374|NCT01873833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544375|NCT01873833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20544376|NCT01873833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20544377|NCT01873833|Antimetabolites|antimetabolites|mesh-ancestor
20544378|NCT01873833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20544379|NCT01873833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20544380|NCT01873833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544381|NCT01873885|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
20544382|NCT01873885|Vasodilator Agents|vasodilator agents|mesh-ancestor
20544383|NCT01874002|Sirolimus|sirolimus|mesh-list
20544384|NCT01874002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20544385|NCT01874002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20544386|NCT01874002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20544387|NCT01874002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957479|NCT01658839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19957480|NCT01658904|Melphalan|melphalan|mesh-list
19957481|NCT01658904|Immunologic Factors|immunologic factors|mesh-ancestor
19957482|NCT01658904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957483|NCT01658904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19957484|NCT01658904|Alkylating Agents|alkylating agents|mesh-ancestor
19957485|NCT01658904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957486|NCT01658904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957487|NCT01658904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19957488|NCT01658904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19957489|NCT01658943|Fluorouracil|fluorouracil|mesh-list
19957490|NCT01658943|Oxaliplatin|oxaliplatin|mesh-list
20544388|NCT01874002|Antifungal Agents|antifungal agents|mesh-ancestor
20544389|NCT01874002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20544390|NCT01874002|Immunologic Factors|immunologic factors|mesh-ancestor
20544391|NCT01874002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554214|NCT01934088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20554215|NCT01934088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20554216|NCT01934088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20554217|NCT01934088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20554218|NCT01934088|GABA Modulators|gaba modulators|mesh-ancestor
19450311|NCT03429621|Emollients|emollients|mesh-ancestor
19957491|NCT01658943|Antimetabolites|antimetabolites|mesh-ancestor
20287585|NCT04269200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20287586|NCT04269200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20287587|NCT04269200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287588|NCT04269200|Tubulin Modulators|tubulin modulators|mesh-ancestor
20287589|NCT04269200|Antimitotic Agents|antimitotic agents|mesh-ancestor
20287590|NCT04269200|Mitosis Modulators|mitosis modulators|mesh-ancestor
20287591|NCT04269200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287592|NCT04269200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20272509|NCT00541086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20272510|NCT00541086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20272511|NCT00541112|Leucovorin|leucovorin|mesh-list
20272512|NCT00541112|Fluorouracil|fluorouracil|mesh-list
20272513|NCT00541112|Capecitabine|capecitabine|mesh-list
20272514|NCT00541112|Oxaliplatin|oxaliplatin|mesh-list
20272515|NCT00541112|Cetuximab|cetuximab|mesh-list
20272516|NCT00541112|Calcium|calcium|mesh-list
20272517|NCT00541112|Levoleucovorin|levoleucovorin|mesh-list
20272518|NCT00541112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20272519|NCT00541112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272520|NCT00541112|Antimetabolites|antimetabolites|mesh-ancestor
20272521|NCT00541112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272522|NCT00541112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20272523|NCT00541112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272524|NCT00541112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20272525|NCT00541112|Immunologic Factors|immunologic factors|mesh-ancestor
20272526|NCT00541112|Antidotes|antidotes|mesh-ancestor
20272527|NCT00541112|Protective Agents|protective agents|mesh-ancestor
20272528|NCT00541112|Vitamin B Complex|vitamin b complex|mesh-ancestor
20272529|NCT00541112|Vitamins|vitamins|mesh-ancestor
20272530|NCT00541112|Micronutrients|micronutrients|mesh-ancestor
20272531|NCT00541112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20272532|NCT00541125|Leucovorin|leucovorin|mesh-list
19957492|NCT01658943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957493|NCT01658943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19957494|NCT01658943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957495|NCT01658943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19957496|NCT01658943|Immunologic Factors|immunologic factors|mesh-ancestor
19957497|NCT01658943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957498|NCT01658995|Doxycycline|doxycycline|mesh-list
19957499|NCT01658995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19957500|NCT01658995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19957501|NCT01658995|Antimalarials|antimalarials|mesh-ancestor
20272533|NCT00541125|Bevacizumab|bevacizumab|mesh-list
20272534|NCT00541125|Fluorouracil|fluorouracil|mesh-list
20272535|NCT00541125|Irinotecan|irinotecan|mesh-list
20272536|NCT00541125|Calcium|calcium|mesh-list
20272537|NCT00541125|Levoleucovorin|levoleucovorin|mesh-list
20272538|NCT00541125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20272539|NCT00541125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272540|NCT00541125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20272541|NCT00541125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20272542|NCT00541125|Growth Substances|growth substances|mesh-ancestor
20272543|NCT00541125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272544|NCT00541125|Growth Inhibitors|growth inhibitors|mesh-ancestor
20272545|NCT00541125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20272546|NCT00541125|Antimetabolites|antimetabolites|mesh-ancestor
20272547|NCT00541125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957502|NCT01658995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19957503|NCT01658995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19957504|NCT01659021|Ofatumumab|ofatumumab|mesh-list
19957505|NCT01659021|Idelalisib|idelalisib|mesh-list
19957506|NCT01659021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957507|NCT01659021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957508|NCT01659021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957509|NCT01659320|Minocycline|minocycline|mesh-list
19957510|NCT01659320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19957511|NCT01659320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19957512|NCT01659567|Interferons|interferons|mesh-list
19957513|NCT01659567|Ribavirin|ribavirin|mesh-list
19957514|NCT01659567|Interferon-alpha|interferon-alpha|mesh-list
19957515|NCT01659567|Interferon alpha-2|interferon alpha-2|mesh-list
19957516|NCT01659567|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19957517|NCT01659567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957518|NCT01659567|Antiviral Agents|antiviral agents|mesh-ancestor
19957519|NCT01659567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19957520|NCT01659567|Antimetabolites|antimetabolites|mesh-ancestor
19957521|NCT01659567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957522|NCT01659567|Immunologic Factors|immunologic factors|mesh-ancestor
19957523|NCT01659567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957524|NCT01659853|Azelaic acid|azelaic acid|mesh-list
19957525|NCT01659853|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20272548|NCT00541125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20272549|NCT00541125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19957526|NCT01659853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20272550|NCT00541125|Immunologic Factors|immunologic factors|mesh-ancestor
20272551|NCT00541125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20272552|NCT00541125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20272553|NCT00541125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272554|NCT00541125|Antidotes|antidotes|mesh-ancestor
20272555|NCT00541125|Protective Agents|protective agents|mesh-ancestor
20272556|NCT00541125|Vitamin B Complex|vitamin b complex|mesh-ancestor
20272557|NCT00541125|Vitamins|vitamins|mesh-ancestor
20272558|NCT00541125|Micronutrients|micronutrients|mesh-ancestor
20272559|NCT00541138|Tamoxifen|tamoxifen|mesh-list
20272560|NCT00541138|Carboplatin|carboplatin|mesh-list
20272561|NCT00541138|Topotecan|topotecan|mesh-list
20272562|NCT00541138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272563|NCT00541138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272564|NCT00541138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20272565|NCT00541138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20272566|NCT00541138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272567|NCT00541138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20272568|NCT00541138|Hormone Antagonists|hormone antagonists|mesh-ancestor
20272569|NCT00541138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20272570|NCT00541138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272571|NCT00541138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20272572|NCT00541138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20272573|NCT00541138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20272574|NCT00541138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20272575|NCT00541164|Ubiquinone|ubiquinone|mesh-list
20272576|NCT00541164|Coenzyme Q10|coenzyme q10|mesh-list
20272577|NCT00541164|Micronutrients|micronutrients|mesh-ancestor
20272578|NCT00541164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272579|NCT00541164|Vitamins|vitamins|mesh-ancestor
20272580|NCT00541177|Atropine|atropine|mesh-list
20272581|NCT00541177|Tropicamide|tropicamide|mesh-list
20272582|NCT00541177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20272583|NCT00541177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20272584|NCT00541177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20272585|NCT00541177|Autonomic Agents|autonomic agents|mesh-ancestor
20272586|NCT00541177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20272587|NCT00541177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272588|NCT00541177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20272589|NCT00541177|Respiratory System Agents|respiratory system agents|mesh-ancestor
20272590|NCT00541177|Mydriatics|mydriatics|mesh-ancestor
20272591|NCT00541177|Parasympatholytics|parasympatholytics|mesh-ancestor
20272592|NCT00541177|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20272593|NCT00541177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20272594|NCT00541177|Cholinergic Agents|cholinergic agents|mesh-ancestor
20272595|NCT00541177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20272596|NCT00541177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957527|NCT01659853|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19957528|NCT01659853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19957529|NCT01659853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19957530|NCT01659853|Adrenergic Agents|adrenergic agents|mesh-ancestor
19957531|NCT01659853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19957532|NCT01659853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957533|NCT01659853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957534|NCT01659853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957535|NCT01659853|Dermatologic Agents|dermatologic agents|mesh-ancestor
19957536|NCT01659866|Ciprofloxacin|ciprofloxacin|mesh-list
19957537|NCT01659866|Gentamicins|gentamicins|mesh-list
19957538|NCT01659866|Ceftriaxone|ceftriaxone|mesh-list
19957539|NCT01659866|Imipenem|imipenem|mesh-list
19957540|NCT01659866|Amikacin|amikacin|mesh-list
19957541|NCT01659866|Cefuroxime|cefuroxime|mesh-list
19957542|NCT01659866|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19957543|NCT01659866|Aztreonam|aztreonam|mesh-list
19957544|NCT01659866|Trimethoprim|trimethoprim|mesh-list
19957545|NCT01659866|Sulfamethoxazole|sulfamethoxazole|mesh-list
19957546|NCT01659866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19957547|NCT01659866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19957548|NCT01659866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19957549|NCT01659866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19957550|NCT01659866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957551|NCT01659866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957552|NCT01659866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957553|NCT01659866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19957554|NCT01659866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20272597|NCT00541216|Ephedrine|ephedrine|mesh-list
20272598|NCT00541216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19957555|NCT01659866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19957556|NCT01659866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19957557|NCT01659866|Renal Agents|renal agents|mesh-ancestor
19957558|NCT01659866|Antimalarials|antimalarials|mesh-ancestor
19957559|NCT01659866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19957560|NCT01659866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19957561|NCT01659866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19957562|NCT01659866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19957563|NCT01659866|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19957564|NCT01660022|Piperaquine|piperaquine|mesh-list
19957565|NCT01660022|Artefenomel|artefenomel|mesh-list
19957566|NCT01660022|Antimalarials|antimalarials|mesh-ancestor
19957567|NCT01660022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19957568|NCT01660022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19957569|NCT01660022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19957570|NCT01660191|Atorvastatin|atorvastatin|mesh-list
19957571|NCT01660191|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19957572|NCT01660191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19957573|NCT01660191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19957574|NCT01660191|Antimetabolites|antimetabolites|mesh-ancestor
19957575|NCT01660191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272599|NCT00541216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272600|NCT00541216|Sympathomimetics|sympathomimetics|mesh-ancestor
20272601|NCT00541216|Autonomic Agents|autonomic agents|mesh-ancestor
20272602|NCT00541216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20272603|NCT00541216|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20272604|NCT00541216|Adrenergic Agents|adrenergic agents|mesh-ancestor
20272605|NCT00541216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20272606|NCT00541216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272607|NCT00541281|Prednisone|prednisone|mesh-list
20272608|NCT00541281|Docetaxel|docetaxel|mesh-list
20272609|NCT00541281|Estramustine|estramustine|mesh-list
20272610|NCT00541281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272611|NCT00541281|Tubulin Modulators|tubulin modulators|mesh-ancestor
20272612|NCT00541281|Antimitotic Agents|antimitotic agents|mesh-ancestor
20272613|NCT00541281|Mitosis Modulators|mitosis modulators|mesh-ancestor
20272614|NCT00541281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272615|NCT00541281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20272616|NCT00541281|Glucocorticoids|glucocorticoids|mesh-ancestor
20272617|NCT00541281|Hormones|hormones|mesh-ancestor
20272618|NCT00541281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20272619|NCT00541281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272620|NCT00541281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20272621|NCT00541281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20272622|NCT00541281|Alkylating Agents|alkylating agents|mesh-ancestor
19957576|NCT01660191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20272623|NCT00541320|2-(5-chlorothien-2-yl)-N-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|2-(5-chlorothien-2-yl)-n-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|mesh-list
20272624|NCT00541320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20272625|NCT00541320|Antithrombins|antithrombins|mesh-ancestor
20272626|NCT00541320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20272627|NCT00541320|Protease Inhibitors|protease inhibitors|mesh-ancestor
20272628|NCT00541320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957577|NCT01660191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19957578|NCT01660191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957579|NCT01660256|Rebamipide|rebamipide|mesh-list
19957580|NCT01660256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19957581|NCT01660256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20272629|NCT00541320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272630|NCT00541320|Anticoagulants|anticoagulants|mesh-ancestor
20272631|NCT00541333|Glatiramer Acetate|glatiramer acetate|mesh-list
20272632|NCT00541333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20272633|NCT00541333|Immunologic Factors|immunologic factors|mesh-ancestor
20272634|NCT00541333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272635|NCT00541333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20272636|NCT00541333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20287593|NCT04269200|Immunologic Factors|immunologic factors|mesh-ancestor
20287594|NCT04269200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287595|NCT04269200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20287596|NCT04269200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287597|NCT04235062|Furosemide|furosemide|mesh-list
19957582|NCT01660256|Antioxidants|antioxidants|mesh-ancestor
20272637|NCT00541359|Bortezomib|bortezomib|mesh-list
20272638|NCT00541359|Topotecan|topotecan|mesh-list
20272639|NCT00541359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272640|NCT00541359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20272641|NCT00541359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20272642|NCT00541359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272643|NCT00541359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272644|NCT00541372|Insulin|insulin|mesh-list
20272645|NCT00541372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20272646|NCT00541372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272647|NCT00541411|Dactinomycin|dactinomycin|mesh-list
20272648|NCT00541411|Vincristine|vincristine|mesh-list
20272649|NCT00541411|Ifosfamide|ifosfamide|mesh-list
20272650|NCT00541411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20272651|NCT00541411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272652|NCT00541411|Tubulin Modulators|tubulin modulators|mesh-ancestor
20272653|NCT00541411|Antimitotic Agents|antimitotic agents|mesh-ancestor
20272654|NCT00541411|Mitosis Modulators|mitosis modulators|mesh-ancestor
20272655|NCT00541411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272656|NCT00541411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20272657|NCT00541411|Alkylating Agents|alkylating agents|mesh-ancestor
20272658|NCT00541411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20272659|NCT00541411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20272660|NCT00541411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20272661|NCT00541411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20272662|NCT00541411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272663|NCT00541411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20272664|NCT00541463|Nelfinavir|nelfinavir|mesh-list
20272665|NCT00541463|Indinavir|indinavir|mesh-list
20272666|NCT00541463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272667|NCT00541463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20272668|NCT00541463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20272669|NCT00541463|Protease Inhibitors|protease inhibitors|mesh-ancestor
20272670|NCT00541463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272671|NCT00541463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20272672|NCT00541463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20272673|NCT00541463|Antiviral Agents|antiviral agents|mesh-ancestor
20272674|NCT00541463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20272675|NCT00541489|Naproxen|naproxen|mesh-list
20272676|NCT00541489|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
20272677|NCT00541489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20272678|NCT00541489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20272679|NCT00541489|Analgesics|analgesics|mesh-ancestor
20272680|NCT00541489|Sensory System Agents|sensory system agents|mesh-ancestor
20272681|NCT00541489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20544392|NCT01874028|Trientine|trientine|mesh-list
20544393|NCT01874028|Chelating Agents|chelating agents|mesh-ancestor
20544394|NCT01874028|Sequestering Agents|sequestering agents|mesh-ancestor
20544395|NCT01874028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544396|NCT01874041|Salicylic Acid|salicylic acid|mesh-list
20544397|NCT01874041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20544398|NCT01874041|Antifungal Agents|antifungal agents|mesh-ancestor
20544399|NCT01874041|Keratolytic Agents|keratolytic agents|mesh-ancestor
20544400|NCT01874041|Dermatologic Agents|dermatologic agents|mesh-ancestor
20544401|NCT01874080|Metformin|metformin|mesh-list
20544402|NCT01874080|Saxagliptin|saxagliptin|mesh-list
20544403|NCT01874080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20544404|NCT01874080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544405|NCT01874080|Incretins|incretins|mesh-ancestor
20544406|NCT01874080|Hormones|hormones|mesh-ancestor
20544407|NCT01874080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20544408|NCT01874080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20272682|NCT00541489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272683|NCT00541489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20272684|NCT00541489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20272685|NCT00541489|Gout Suppressants|gout suppressants|mesh-ancestor
20287598|NCT04235062|Calcium|calcium|mesh-list
20287599|NCT04235062|Diuretics|diuretics|mesh-list
20287600|NCT04235062|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
20287601|NCT04235062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20287602|NCT04235062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287603|NCT04235062|Natriuretic Agents|natriuretic agents|mesh-ancestor
20287604|NCT04235062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20287605|NCT04235062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287606|NCT04088864|Cyclophosphamide|cyclophosphamide|mesh-list
20272686|NCT00541489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20272687|NCT00541489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272688|NCT00541489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272689|NCT00541489|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20272690|NCT00541515|Insulin|insulin|mesh-list
20272691|NCT00541515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20272692|NCT00541515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272693|NCT00541554|Aripiprazole|aripiprazole|mesh-list
20272694|NCT00541554|Antidepressive Agents|antidepressive agents|mesh-ancestor
20272695|NCT00541554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20272696|NCT00541554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20272697|NCT00541554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20272698|NCT00541554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20272699|NCT00541554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272700|NCT00541554|Dopamine Agonists|dopamine agonists|mesh-ancestor
20272701|NCT00541554|Dopamine Agents|dopamine agents|mesh-ancestor
20272702|NCT00541554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20272703|NCT00541554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272704|NCT00541554|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20272705|NCT00541554|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20272706|NCT00541554|Serotonin Agents|serotonin agents|mesh-ancestor
20272707|NCT00541554|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20272708|NCT00541554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20272709|NCT00541554|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20272710|NCT00541554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20272711|NCT00541567|Ibipinabant|ibipinabant|mesh-list
20272712|NCT00541567|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20272713|NCT00541567|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19957583|NCT01660256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957584|NCT01660256|Protective Agents|protective agents|mesh-ancestor
19957585|NCT01660256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957586|NCT01660256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957587|NCT01660334|Voriconazole|voriconazole|mesh-list
19957588|NCT01660334|Antifungal Agents|antifungal agents|mesh-ancestor
19957589|NCT01660334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19957590|NCT01660334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19957591|NCT01660334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20272714|NCT00541567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20272715|NCT00541567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272716|NCT00541567|Hormones|hormones|mesh-ancestor
20272717|NCT00541567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20272718|NCT00541567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272719|NCT00541710|Genistein|genistein|mesh-list
20272720|NCT00541710|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20272721|NCT00541710|Protective Agents|protective agents|mesh-ancestor
20272722|NCT00541710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272723|NCT00541710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272724|NCT00541710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20272725|NCT00541710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272726|NCT00541710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272727|NCT00541710|Phytoestrogens|phytoestrogens|mesh-ancestor
20272728|NCT00541710|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20272729|NCT00541710|Estrogens|estrogens|mesh-ancestor
20272730|NCT00541710|Hormones|hormones|mesh-ancestor
20272731|NCT00541710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20272732|NCT00541723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20272733|NCT00541723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20272734|NCT00541723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20272735|NCT00541723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272736|NCT00541723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20272737|NCT00541723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20272738|NCT00541723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272739|NCT00541723|Cholinergic Agents|cholinergic agents|mesh-ancestor
20272740|NCT00541723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20272741|NCT00541736|Nitroglycerin|nitroglycerin|mesh-list
20272742|NCT00541736|Vasodilator Agents|vasodilator agents|mesh-ancestor
20272743|NCT00541814|Cyclosporine|cyclosporine|mesh-list
20272744|NCT00541814|Cyclosporins|cyclosporins|mesh-list
20272745|NCT00541814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272746|NCT00541814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272747|NCT00541814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19957592|NCT01660334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272748|NCT00541814|Immunologic Factors|immunologic factors|mesh-ancestor
20272749|NCT00541814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272750|NCT00541814|Antifungal Agents|antifungal agents|mesh-ancestor
20272751|NCT00541814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20272752|NCT00541814|Dermatologic Agents|dermatologic agents|mesh-ancestor
20272753|NCT00541814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20272754|NCT00541814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20272755|NCT00541840|Sorafenib|sorafenib|mesh-list
20272756|NCT00541840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272757|NCT00541840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20272758|NCT00541840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272759|NCT00541840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272760|NCT00541853|Candesartan|candesartan|mesh-list
20272761|NCT00541853|Candesartan cilexetil|candesartan cilexetil|mesh-list
20272762|NCT00541853|Cilnidipine|cilnidipine|mesh-list
20272763|NCT00541853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20272764|NCT00541853|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20272765|NCT00541853|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20544409|NCT01874080|Protease Inhibitors|protease inhibitors|mesh-ancestor
20544410|NCT01874080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544411|NCT01874080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544412|NCT01874171|Cetuximab|cetuximab|mesh-list
20544413|NCT01874171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544414|NCT01874171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20544415|NCT01874236|Bupivacaine|bupivacaine|mesh-list
20544416|NCT01874236|Anesthetics, Local|anesthetics, local|mesh-ancestor
20544417|NCT01874236|Anesthetics|anesthetics|mesh-ancestor
20544418|NCT01874236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20544419|NCT01874236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544420|NCT01874236|Sensory System Agents|sensory system agents|mesh-ancestor
20544421|NCT01874236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20544422|NCT01874314|Moxifloxacin|moxifloxacin|mesh-list
20544423|NCT01874314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20544424|NCT01874314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20544425|NCT01874314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20544426|NCT01874314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20544427|NCT01874314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544428|NCT01874314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544429|NCT01874314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544430|NCT01874470|Antihypertensive Agents|antihypertensive agents|mesh-list
20544431|NCT01874470|Diuretics|diuretics|mesh-list
20544432|NCT01874470|Natriuretic Agents|natriuretic agents|mesh-ancestor
20544433|NCT01874470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544434|NCT01874561|Moxifloxacin|moxifloxacin|mesh-list
20544435|NCT01874561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20544436|NCT01874561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20544437|NCT01874561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20544438|NCT01874561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20544439|NCT01874561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544440|NCT01874561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544441|NCT01874561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544442|NCT01874574|Triamcinolone|triamcinolone|mesh-list
20544443|NCT01874574|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20544444|NCT01874574|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20544445|NCT01874574|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20544446|NCT01874574|Hylan|hylan|mesh-list
20544447|NCT01874574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20544448|NCT01874574|Glucocorticoids|glucocorticoids|mesh-ancestor
20544449|NCT01874574|Hormones|hormones|mesh-ancestor
20554219|NCT01934088|GABA Agents|gaba agents|mesh-ancestor
20287607|NCT04088864|Fludarabine|fludarabine|mesh-list
20287608|NCT04088864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20287609|NCT04088864|Immunologic Factors|immunologic factors|mesh-ancestor
20287610|NCT04088864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287611|NCT04088864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20287612|NCT04088864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20287613|NCT04088864|Alkylating Agents|alkylating agents|mesh-ancestor
20287614|NCT04088864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287615|NCT04088864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287616|NCT04088864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20287617|NCT04035486|Carboplatin|carboplatin|mesh-list
20287618|NCT04035486|Pemetrexed|pemetrexed|mesh-list
20287619|NCT04035486|Osimertinib|osimertinib|mesh-list
20287620|NCT04035486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287621|NCT04035486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272766|NCT00541853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272767|NCT00541853|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20272768|NCT00541853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20272769|NCT00541853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20272770|NCT00541853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272771|NCT00541905|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20272772|NCT00541905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20272773|NCT00541905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20272774|NCT00541905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272775|NCT00541905|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20272776|NCT00541905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20272777|NCT00541905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272778|NCT00541905|Cholinergic Agents|cholinergic agents|mesh-ancestor
20272779|NCT00541905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20272780|NCT00541918|Propofol|propofol|mesh-list
20272781|NCT00541918|Sevoflurane|sevoflurane|mesh-list
20272782|NCT00541918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20272783|NCT00541918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20272784|NCT00541918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272785|NCT00541918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20272786|NCT00541918|Anesthetics, General|anesthetics, general|mesh-ancestor
20272787|NCT00541918|Anesthetics|anesthetics|mesh-ancestor
20272788|NCT00541918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20272789|NCT00541918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20272790|NCT00542022|Oxymetazoline|oxymetazoline|mesh-list
20272791|NCT00542022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20272792|NCT00542022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20272793|NCT00542022|Adrenergic Agents|adrenergic agents|mesh-ancestor
20272794|NCT00542022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20272795|NCT00542022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272796|NCT00542022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272797|NCT00542022|Sympathomimetics|sympathomimetics|mesh-ancestor
20272798|NCT00542022|Autonomic Agents|autonomic agents|mesh-ancestor
20272799|NCT00542022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20272800|NCT00542022|Nasal Decongestants|nasal decongestants|mesh-ancestor
20272801|NCT00542022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20272802|NCT00542022|Respiratory System Agents|respiratory system agents|mesh-ancestor
20272803|NCT00542074|Ethanol|ethanol|mesh-list
20272804|NCT00542074|Emollients|emollients|mesh-list
20272805|NCT00542074|Dermatologic Agents|dermatologic agents|mesh-ancestor
20272806|NCT00542074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20272807|NCT00542074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20272808|NCT00542074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20272809|NCT00542074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272810|NCT00542126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20272811|NCT00542126|Luteolytic Agents|luteolytic agents|mesh-ancestor
20272812|NCT00542126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20272813|NCT00542126|Contraceptive Agents|contraceptive agents|mesh-ancestor
20272814|NCT00542126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20272815|NCT00542126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272816|NCT00542126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20272817|NCT00542126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20272818|NCT00542126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272819|NCT00542139|Betamethasone|betamethasone|mesh-list
20272820|NCT00542139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20272821|NCT00542139|Glucocorticoids|glucocorticoids|mesh-ancestor
20272822|NCT00542139|Hormones|hormones|mesh-ancestor
20272823|NCT00542139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20272824|NCT00542139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272825|NCT00542139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20272826|NCT00542139|Respiratory System Agents|respiratory system agents|mesh-ancestor
20272827|NCT00542152|Cyclosporine|cyclosporine|mesh-list
20272828|NCT00542152|Infliximab|infliximab|mesh-list
20272829|NCT00542152|Cyclosporins|cyclosporins|mesh-list
20272830|NCT00542152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544450|NCT01874574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20544451|NCT01874574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544452|NCT01874574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20544453|NCT01874574|Immunologic Factors|immunologic factors|mesh-ancestor
20544454|NCT01874574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544455|NCT01874574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272831|NCT00542152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272832|NCT00542152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20272833|NCT00542152|Immunologic Factors|immunologic factors|mesh-ancestor
20272834|NCT00542152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272835|NCT00542152|Antifungal Agents|antifungal agents|mesh-ancestor
20272836|NCT00542152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20272837|NCT00542152|Dermatologic Agents|dermatologic agents|mesh-ancestor
20272838|NCT00542152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20272839|NCT00542152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20272840|NCT00542152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20272841|NCT00542165|Alfuzosin|alfuzosin|mesh-list
20272842|NCT00542165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20272843|NCT00542165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20272844|NCT00542165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20272845|NCT00542165|Adrenergic Agents|adrenergic agents|mesh-ancestor
20272846|NCT00542165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20272847|NCT00542165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272848|NCT00542165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272849|NCT00542165|Urological Agents|urological agents|mesh-ancestor
20272850|NCT00542243|Finasteride|finasteride|mesh-list
19957593|NCT01660334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957594|NCT01660334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19957595|NCT01660334|Hormone Antagonists|hormone antagonists|mesh-ancestor
19957596|NCT01660334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19957597|NCT01660334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957598|NCT01660334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19957599|NCT01660672|Levetiracetam|levetiracetam|mesh-list
19957600|NCT01660672|Anticonvulsants|anticonvulsants|mesh-ancestor
19957601|NCT01660672|Nootropic Agents|nootropic agents|mesh-ancestor
19957602|NCT01660711|Leucovorin|leucovorin|mesh-list
19957603|NCT01660711|Fluorouracil|fluorouracil|mesh-list
19957604|NCT01660711|Oxaliplatin|oxaliplatin|mesh-list
20272851|NCT00542243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20272852|NCT00542243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20272853|NCT00542243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272854|NCT00542243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272855|NCT00542243|Hormone Antagonists|hormone antagonists|mesh-ancestor
20272856|NCT00542243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20272857|NCT00542243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272858|NCT00542243|Urological Agents|urological agents|mesh-ancestor
20272859|NCT00542295|Mebeverine|mebeverine|mesh-list
20272860|NCT00542295|Alverine|alverine|mesh-list
20272861|NCT00542295|Parasympatholytics|parasympatholytics|mesh-ancestor
20272862|NCT00542295|Autonomic Agents|autonomic agents|mesh-ancestor
19957605|NCT01660711|Irinotecan|irinotecan|mesh-list
20272863|NCT00542295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20272864|NCT00542295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272865|NCT00542295|Anticonvulsants|anticonvulsants|mesh-ancestor
20272866|NCT00542347|Esomeprazole|esomeprazole|mesh-list
20272867|NCT00542347|Omeprazole|omeprazole|mesh-list
20272868|NCT00542347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20272869|NCT00542347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20272870|NCT00542347|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20272871|NCT00542347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272872|NCT00542347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272873|NCT00542399|Insulin Detemir|insulin detemir|mesh-list
20272874|NCT00542399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20272875|NCT00542399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272876|NCT00542412|Riluzole|riluzole|mesh-list
20544456|NCT01874574|Viscosupplements|viscosupplements|mesh-ancestor
19957606|NCT01660711|Antimetabolites|antimetabolites|mesh-ancestor
19957607|NCT01660711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957608|NCT01660711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19957609|NCT01660711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957610|NCT01660711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19957611|NCT01660711|Immunologic Factors|immunologic factors|mesh-ancestor
19957612|NCT01660711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957613|NCT01660711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19957614|NCT01660711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19957615|NCT01660711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957616|NCT01660711|Antidotes|antidotes|mesh-ancestor
19957617|NCT01660711|Protective Agents|protective agents|mesh-ancestor
19957618|NCT01660711|Vitamin B Complex|vitamin b complex|mesh-ancestor
19957619|NCT01660711|Vitamins|vitamins|mesh-ancestor
19957620|NCT01660711|Micronutrients|micronutrients|mesh-ancestor
19957621|NCT01660763|Sufentanil|sufentanil|mesh-list
19957622|NCT01660763|Dsuvia|dsuvia|mesh-list
19957623|NCT01660763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19957624|NCT01660763|Narcotics|narcotics|mesh-ancestor
19957625|NCT01660763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19957626|NCT01660763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957627|NCT01660763|Analgesics|analgesics|mesh-ancestor
19957628|NCT01660763|Sensory System Agents|sensory system agents|mesh-ancestor
19957629|NCT01660763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19957630|NCT01660763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19957631|NCT01660763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19957632|NCT01660763|Anesthetics, General|anesthetics, general|mesh-ancestor
19957633|NCT01660763|Anesthetics|anesthetics|mesh-ancestor
19957634|NCT01660802|Dexamethasone|dexamethasone|mesh-list
19957635|NCT01660802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19957636|NCT01660802|Antiemetics|antiemetics|mesh-ancestor
19957637|NCT01660802|Autonomic Agents|autonomic agents|mesh-ancestor
19957638|NCT01660802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19957639|NCT01660802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957640|NCT01660802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19957641|NCT01660802|Glucocorticoids|glucocorticoids|mesh-ancestor
19957642|NCT01660802|Hormones|hormones|mesh-ancestor
19957643|NCT01660802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19957644|NCT01660802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19957645|NCT01660802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957646|NCT01660893|Phenylephrine|phenylephrine|mesh-list
19957647|NCT01660893|Oxymetazoline|oxymetazoline|mesh-list
19957648|NCT01660893|Tetracaine|tetracaine|mesh-list
19957649|NCT01660893|Anesthetics, Local|anesthetics, local|mesh-ancestor
19957650|NCT01660893|Anesthetics|anesthetics|mesh-ancestor
19957651|NCT01660893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19957652|NCT01660893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957653|NCT01660893|Sensory System Agents|sensory system agents|mesh-ancestor
19957654|NCT01660893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19957655|NCT01660893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19957656|NCT01660893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19957657|NCT01660893|Adrenergic Agents|adrenergic agents|mesh-ancestor
19957658|NCT01660893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19957659|NCT01660893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957660|NCT01660893|Sympathomimetics|sympathomimetics|mesh-ancestor
19957661|NCT01660893|Autonomic Agents|autonomic agents|mesh-ancestor
19957662|NCT01660893|Nasal Decongestants|nasal decongestants|mesh-ancestor
19957663|NCT01660893|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19957664|NCT01660893|Respiratory System Agents|respiratory system agents|mesh-ancestor
19957665|NCT01660893|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19957666|NCT01660893|Mydriatics|mydriatics|mesh-ancestor
19957667|NCT01660893|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19957668|NCT01660893|Protective Agents|protective agents|mesh-ancestor
19957669|NCT01660906|Dasatinib|dasatinib|mesh-list
19957670|NCT01660906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957671|NCT01660906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19957672|NCT01660906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957673|NCT01660906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957674|NCT01661088|Folfirinox|folfirinox|mesh-list
19957675|NCT01661088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957676|NCT01661114|Gemcitabine|gemcitabine|mesh-list
19957677|NCT01661114|Fluorouracil|fluorouracil|mesh-list
19957678|NCT01661114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957679|NCT01661114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19957680|NCT01661114|Antimetabolites|antimetabolites|mesh-ancestor
19957681|NCT01661114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957682|NCT01661114|Antiviral Agents|antiviral agents|mesh-ancestor
19957683|NCT01661114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19957684|NCT01661114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957685|NCT01661114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19957686|NCT01661114|Immunologic Factors|immunologic factors|mesh-ancestor
19957687|NCT01661114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957688|NCT01661140|Methotrexate|methotrexate|mesh-list
19957689|NCT01661140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19957690|NCT01661140|Abortifacient Agents|abortifacient agents|mesh-ancestor
19957691|NCT01661140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19957692|NCT01661140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957693|NCT01661140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19957694|NCT01661140|Antimetabolites|antimetabolites|mesh-ancestor
19957695|NCT01661140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957696|NCT01661140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957697|NCT01661140|Dermatologic Agents|dermatologic agents|mesh-ancestor
19957698|NCT01661140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957699|NCT01661140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19957700|NCT01661140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19957701|NCT01661140|Immunologic Factors|immunologic factors|mesh-ancestor
19957702|NCT01661140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19957703|NCT01661140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19957704|NCT01661270|Aflibercept|aflibercept|mesh-list
19957705|NCT01661270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19957706|NCT01661270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19957707|NCT01661270|Growth Substances|growth substances|mesh-ancestor
19957708|NCT01661270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957709|NCT01661270|Growth Inhibitors|growth inhibitors|mesh-ancestor
19957710|NCT01661270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957711|NCT01661283|Bevacizumab|bevacizumab|mesh-list
19957712|NCT01661283|Everolimus|everolimus|mesh-list
19957713|NCT01661283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19957714|NCT01661283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957715|NCT01661283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19957716|NCT01661283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19957717|NCT01661283|Growth Substances|growth substances|mesh-ancestor
19957718|NCT01661283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957719|NCT01661283|Growth Inhibitors|growth inhibitors|mesh-ancestor
19957720|NCT01661283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19957721|NCT01661283|Immunologic Factors|immunologic factors|mesh-ancestor
19957722|NCT01661595|Sildenafil Citrate|sildenafil citrate|mesh-list
19957723|NCT01661595|Tadalafil|tadalafil|mesh-list
19957724|NCT01661595|Vasodilator Agents|vasodilator agents|mesh-ancestor
19957725|NCT01661595|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19957726|NCT01661595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19957727|NCT01661595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957728|NCT01661595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957729|NCT01661595|Urological Agents|urological agents|mesh-ancestor
19957730|NCT01661621|Doxazosin|doxazosin|mesh-list
19957731|NCT01661621|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19957732|NCT01661621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19957733|NCT01661621|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19957734|NCT01661621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19957735|NCT01661621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19957736|NCT01661621|Adrenergic Agents|adrenergic agents|mesh-ancestor
19957737|NCT01661621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19957738|NCT01661621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957739|NCT01661621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957740|NCT01661621|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19957741|NCT01661621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19957742|NCT01661621|Cholinergic Agents|cholinergic agents|mesh-ancestor
19957743|NCT01661621|Urological Agents|urological agents|mesh-ancestor
19974726|NCT01841021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19974727|NCT01841021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974728|NCT01841021|Immunologic Factors|immunologic factors|mesh-ancestor
19974729|NCT01841021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974730|NCT01841593|Raltegravir Potassium|raltegravir potassium|mesh-list
19974731|NCT01841593|Amlodipine|amlodipine|mesh-list
19974732|NCT01841593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19974733|NCT01841593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19974734|NCT01841593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19974735|NCT01841593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974736|NCT01841593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19974737|NCT01841593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974738|NCT01841593|Vasodilator Agents|vasodilator agents|mesh-ancestor
19974739|NCT01841593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19974740|NCT01841593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19974741|NCT01841593|Antiviral Agents|antiviral agents|mesh-ancestor
19974742|NCT01841593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19974743|NCT01841593|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19974744|NCT01841593|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19974745|NCT01841593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974746|NCT01841606|Ondansetron|ondansetron|mesh-list
19974747|NCT01841606|Antiemetics|antiemetics|mesh-ancestor
19974748|NCT01841606|Autonomic Agents|autonomic agents|mesh-ancestor
19974749|NCT01841606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19974750|NCT01841606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974751|NCT01841606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19974752|NCT01841606|Antipruritics|antipruritics|mesh-ancestor
19974753|NCT01841606|Dermatologic Agents|dermatologic agents|mesh-ancestor
19957744|NCT01661790|Bevacizumab|bevacizumab|mesh-list
19957745|NCT01661790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19957746|NCT01661790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957747|NCT01661790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19957748|NCT01661790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19957749|NCT01661790|Growth Substances|growth substances|mesh-ancestor
19957750|NCT01661790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957751|NCT01661790|Growth Inhibitors|growth inhibitors|mesh-ancestor
19957752|NCT01661881|Cytarabine|cytarabine|mesh-list
19957753|NCT01661881|Rituximab|rituximab|mesh-list
19957754|NCT01661881|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19957755|NCT01661881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19957756|NCT01661881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957757|NCT01661881|Immunologic Factors|immunologic factors|mesh-ancestor
19957758|NCT01661881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957759|NCT01661881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19957760|NCT01661881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19957761|NCT01661881|Antimetabolites|antimetabolites|mesh-ancestor
19957762|NCT01661881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957763|NCT01661881|Antiviral Agents|antiviral agents|mesh-ancestor
19957764|NCT01661881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19957765|NCT01661881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19957766|NCT01661881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19957767|NCT01661881|Alkylating Agents|alkylating agents|mesh-ancestor
19957768|NCT01661946|Bevacizumab|bevacizumab|mesh-list
19957769|NCT01661946|Ranibizumab|ranibizumab|mesh-list
19957770|NCT01661946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19957771|NCT01661946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957772|NCT01661946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19957773|NCT01661946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19957774|NCT01661946|Growth Substances|growth substances|mesh-ancestor
19957775|NCT01661946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957776|NCT01661946|Growth Inhibitors|growth inhibitors|mesh-ancestor
19957777|NCT01661972|Capecitabine|capecitabine|mesh-list
19957778|NCT01661972|Aflibercept|aflibercept|mesh-list
19957779|NCT01661972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19957780|NCT01661972|Antimetabolites|antimetabolites|mesh-ancestor
19957781|NCT01661972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957782|NCT01661972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957783|NCT01661972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19957784|NCT01661972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19957785|NCT01661972|Growth Substances|growth substances|mesh-ancestor
19957786|NCT01661972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957787|NCT01661972|Growth Inhibitors|growth inhibitors|mesh-ancestor
19957788|NCT01662115|Nicotine|nicotine|mesh-list
19957789|NCT01662115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19957790|NCT01662115|Autonomic Agents|autonomic agents|mesh-ancestor
19957791|NCT01662115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19957792|NCT01662115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957793|NCT01662115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19957794|NCT01662115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20272877|NCT00542412|Anticonvulsants|anticonvulsants|mesh-ancestor
20272878|NCT00542412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19957795|NCT01662115|Cholinergic Agents|cholinergic agents|mesh-ancestor
19957796|NCT01662115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19957797|NCT01662115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957798|NCT01662297|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19957799|NCT01662297|Trazodone|trazodone|mesh-list
19957800|NCT01662297|Antidepressive Agents|antidepressive agents|mesh-ancestor
19957801|NCT01662297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19957802|NCT01662297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19957803|NCT01662297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19957804|NCT01662297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19957805|NCT01662297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957806|NCT01662297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19957807|NCT01662297|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19957808|NCT01662297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19957809|NCT01662297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19957810|NCT01662297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957811|NCT01662297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19957812|NCT01662297|Serotonin Agents|serotonin agents|mesh-ancestor
19957813|NCT01662297|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20272879|NCT00542412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19957814|NCT01662310|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19957815|NCT01662310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19957816|NCT01662310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19957817|NCT01662310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19957818|NCT01662310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957819|NCT01662310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19957820|NCT01662310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19957821|NCT01662310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19957822|NCT01662310|Serotonin Agents|serotonin agents|mesh-ancestor
19957823|NCT01662310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19957824|NCT01662310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957825|NCT01662310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20272880|NCT00542412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20272881|NCT00542412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272882|NCT00542412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272883|NCT00542412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20272884|NCT00542412|Protective Agents|protective agents|mesh-ancestor
20272885|NCT00542451|Paclitaxel|paclitaxel|mesh-list
20272886|NCT00542451|Trastuzumab|trastuzumab|mesh-list
20272887|NCT00542451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20272888|NCT00542451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272889|NCT00542451|Tubulin Modulators|tubulin modulators|mesh-ancestor
20272890|NCT00542451|Antimitotic Agents|antimitotic agents|mesh-ancestor
20272891|NCT00542451|Mitosis Modulators|mitosis modulators|mesh-ancestor
20272892|NCT00542451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272893|NCT00542451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20272894|NCT00542555|Naproxen|naproxen|mesh-list
20272895|NCT00542555|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
20272896|NCT00542555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20272897|NCT00542555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20272898|NCT00542555|Analgesics|analgesics|mesh-ancestor
20272899|NCT00542555|Sensory System Agents|sensory system agents|mesh-ancestor
20272900|NCT00542555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20272901|NCT00542555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272902|NCT00542555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20272903|NCT00542555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20272904|NCT00542555|Gout Suppressants|gout suppressants|mesh-ancestor
19957826|NCT01662310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19957827|NCT01662310|Dopamine Agents|dopamine agents|mesh-ancestor
19957828|NCT01662336|Ritonavir|ritonavir|mesh-list
19957829|NCT01662336|Lopinavir|lopinavir|mesh-list
19957830|NCT01662336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19957831|NCT01662336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19957832|NCT01662336|Protease Inhibitors|protease inhibitors|mesh-ancestor
19957833|NCT01662336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957834|NCT01662336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957835|NCT01662336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19957836|NCT01662336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19957837|NCT01662336|Antiviral Agents|antiviral agents|mesh-ancestor
19957838|NCT01662336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19957839|NCT01662336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19957840|NCT01662336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19957841|NCT01662492|Botulinum Toxins|botulinum toxins|mesh-list
19957842|NCT01662492|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19957843|NCT01662492|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19957844|NCT01662492|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19957845|NCT01662492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19957846|NCT01662492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957847|NCT01662492|Cholinergic Agents|cholinergic agents|mesh-ancestor
19957848|NCT01662492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19957849|NCT01662492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957850|NCT01662492|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19957851|NCT01662492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19957852|NCT01662648|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19957853|NCT01662648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19957854|NCT01662648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19957855|NCT01662648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19957856|NCT01662648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957857|NCT01662648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19957858|NCT01662648|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19957859|NCT01662648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19957860|NCT01662648|Serotonin Agents|serotonin agents|mesh-ancestor
19957861|NCT01662648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20272905|NCT00542555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19957862|NCT01662648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957863|NCT01662648|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19957864|NCT01662648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19957865|NCT01662648|Dopamine Agents|dopamine agents|mesh-ancestor
19957866|NCT01662791|Rifaximin|rifaximin|mesh-list
19957867|NCT01662791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19957868|NCT01662791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19957869|NCT01662791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19957870|NCT01662856|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19957871|NCT01662856|Hemostatics|hemostatics|mesh-ancestor
19957872|NCT01662856|Coagulants|coagulants|mesh-ancestor
20272906|NCT00542555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272907|NCT00542555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272908|NCT00542555|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20272909|NCT00542568|Epoetin Alfa|epoetin alfa|mesh-list
20272910|NCT00542568|Hematinics|hematinics|mesh-ancestor
20272911|NCT00542607|Levocetirizine|levocetirizine|mesh-list
20272912|NCT00542607|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20272913|NCT00542607|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20272914|NCT00542607|Histamine Antagonists|histamine antagonists|mesh-ancestor
20272915|NCT00542607|Histamine Agents|histamine agents|mesh-ancestor
19957873|NCT01662895|Deferoxamine|deferoxamine|mesh-list
19957874|NCT01662895|Siderophores|siderophores|mesh-ancestor
19957875|NCT01662895|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19957876|NCT01662895|Chelating Agents|chelating agents|mesh-ancestor
19957877|NCT01662895|Sequestering Agents|sequestering agents|mesh-ancestor
20272916|NCT00542607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20272917|NCT00542607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272918|NCT00542607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272919|NCT00542711|Curcumin|curcumin|mesh-list
20272920|NCT00542711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20272921|NCT00542711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20272922|NCT00542711|Analgesics|analgesics|mesh-ancestor
20272923|NCT00542711|Sensory System Agents|sensory system agents|mesh-ancestor
20272924|NCT00542711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20272925|NCT00542711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272926|NCT00542711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20272927|NCT00542711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20272928|NCT00542711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272929|NCT00542711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272930|NCT00542711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272931|NCT00542763|Mycophenolic Acid|mycophenolic acid|mesh-list
20272932|NCT00542763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20272933|NCT00542763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272934|NCT00542763|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20272935|NCT00542763|Antitubercular Agents|antitubercular agents|mesh-ancestor
20272936|NCT00542763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20272937|NCT00542763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20544457|NCT01874574|Protective Agents|protective agents|mesh-ancestor
19733143|NCT04564326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19957878|NCT01662895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957879|NCT01662908|Heparin|heparin|mesh-list
19957880|NCT01662908|Enoxaparin|enoxaparin|mesh-list
19957881|NCT01662908|Calcium heparin|calcium heparin|mesh-list
19957882|NCT01662908|Warfarin|warfarin|mesh-list
19957883|NCT01662908|Edoxaban|edoxaban|mesh-list
19957884|NCT01662908|Anticoagulants|anticoagulants|mesh-ancestor
19957885|NCT01662908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19957886|NCT01662908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19957887|NCT01662908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957888|NCT01662908|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19957889|NCT01662908|Antithrombins|antithrombins|mesh-ancestor
19733144|NCT04564326|Narcotics|narcotics|mesh-ancestor
19733145|NCT04564326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19733146|NCT04564326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733147|NCT04564326|Analgesics|analgesics|mesh-ancestor
19733148|NCT04564326|Sensory System Agents|sensory system agents|mesh-ancestor
19733149|NCT04564326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733150|NCT04564326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19733151|NCT04564326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19733152|NCT04564326|Anesthetics, General|anesthetics, general|mesh-ancestor
19733153|NCT04564326|Anesthetics|anesthetics|mesh-ancestor
19733154|NCT04564690|Vitamin E|vitamin e|mesh-list
19733155|NCT04564690|Selenium|selenium|mesh-list
19733156|NCT04564690|Vitamins|vitamins|mesh-ancestor
19733157|NCT04564690|Micronutrients|micronutrients|mesh-ancestor
20272938|NCT00542763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544458|NCT01874639|Hemostatics|hemostatics|mesh-list
19733158|NCT04564690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733159|NCT04564690|Antioxidants|antioxidants|mesh-ancestor
19733160|NCT04564690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733161|NCT04564690|Protective Agents|protective agents|mesh-ancestor
19733162|NCT04564690|Trace Elements|trace elements|mesh-ancestor
19733163|NCT04564469|Furosemide|furosemide|mesh-list
19733164|NCT04564469|Diuretics|diuretics|mesh-ancestor
19733165|NCT04564469|Natriuretic Agents|natriuretic agents|mesh-ancestor
19733166|NCT04564469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733167|NCT04564469|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19957890|NCT01662908|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19957891|NCT01662908|Protease Inhibitors|protease inhibitors|mesh-ancestor
19957892|NCT01662908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957893|NCT01662986|Bromides|bromides|mesh-list
19957894|NCT01662986|Tiotropium Bromide|tiotropium bromide|mesh-list
19957895|NCT01662986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19957896|NCT01662986|Autonomic Agents|autonomic agents|mesh-ancestor
19957897|NCT01662986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19957898|NCT01662986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957899|NCT01662986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19957900|NCT01662986|Respiratory System Agents|respiratory system agents|mesh-ancestor
19957901|NCT01662986|Parasympatholytics|parasympatholytics|mesh-ancestor
19957902|NCT01662986|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19957903|NCT01662986|Cholinergic Agents|cholinergic agents|mesh-ancestor
19957904|NCT01662986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19957905|NCT01662986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957906|NCT01662986|Anticonvulsants|anticonvulsants|mesh-ancestor
19957907|NCT01662999|Dapagliflozin|dapagliflozin|mesh-list
19957908|NCT01662999|Saxagliptin|saxagliptin|mesh-list
19957909|NCT01662999|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19957910|NCT01662999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957911|NCT01662999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19957912|NCT01662999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957913|NCT01662999|Incretins|incretins|mesh-ancestor
19957914|NCT01662999|Hormones|hormones|mesh-ancestor
19957915|NCT01662999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19957916|NCT01662999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19957917|NCT01662999|Protease Inhibitors|protease inhibitors|mesh-ancestor
19957918|NCT01662999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957919|NCT01663012|Etirinotecan pegol|etirinotecan pegol|mesh-list
19957920|NCT01663012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957921|NCT01663012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19957922|NCT01663012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19957923|NCT01663012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272939|NCT00542763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272940|NCT00542802|Carbamazepine|carbamazepine|mesh-list
20272941|NCT00542802|Levetiracetam|levetiracetam|mesh-list
20272942|NCT00542802|Anticonvulsants|anticonvulsants|mesh-ancestor
20272943|NCT00542802|Nootropic Agents|nootropic agents|mesh-ancestor
20272944|NCT00542802|Antimanic Agents|antimanic agents|mesh-ancestor
20272945|NCT00542802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20272946|NCT00542802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20272947|NCT00542802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272948|NCT00542802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20272949|NCT00542802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20272950|NCT00542802|Analgesics|analgesics|mesh-ancestor
20272951|NCT00542802|Sensory System Agents|sensory system agents|mesh-ancestor
20272952|NCT00542802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20272953|NCT00542802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20272954|NCT00542802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19957924|NCT01663012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957925|NCT01663103|Rilonacept|rilonacept|mesh-list
19957926|NCT01663103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19957927|NCT01663233|Amlodipine|amlodipine|mesh-list
19957928|NCT01663233|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19957929|NCT01663233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19957930|NCT01663233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19957931|NCT01663233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19957932|NCT01663233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957933|NCT01663233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19957934|NCT01663233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957935|NCT01663233|Vasodilator Agents|vasodilator agents|mesh-ancestor
20272955|NCT00542802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957936|NCT01663233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19957937|NCT01663259|Cetuximab|cetuximab|mesh-list
19957938|NCT01663259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19957939|NCT01663259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957940|NCT01663272|Gemcitabine|gemcitabine|mesh-list
19957941|NCT01663272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19957942|NCT01663272|Antimetabolites|antimetabolites|mesh-ancestor
19957943|NCT01663272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957944|NCT01663272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957945|NCT01663272|Antiviral Agents|antiviral agents|mesh-ancestor
19957946|NCT01663272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19957947|NCT01663272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19957948|NCT01663272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19957949|NCT01663272|Immunologic Factors|immunologic factors|mesh-ancestor
19957950|NCT01663272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957951|NCT01663532|Aripiprazole|aripiprazole|mesh-list
19957952|NCT01663532|Antidepressive Agents|antidepressive agents|mesh-ancestor
19957953|NCT01663532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20272956|NCT00542802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20272957|NCT00542802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20272958|NCT00542841|Hydrocortisone|hydrocortisone|mesh-list
20272959|NCT00542841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20272960|NCT00542893|Dacarbazine|dacarbazine|mesh-list
20272961|NCT00542893|Oblimersen|oblimersen|mesh-list
20272962|NCT00542893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20272963|NCT00542893|Alkylating Agents|alkylating agents|mesh-ancestor
20272964|NCT00542893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272965|NCT00542893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272966|NCT00542984|Teriparatide|teriparatide|mesh-list
20272967|NCT00542984|Calcitonin|calcitonin|mesh-list
20272968|NCT00542984|Salmon calcitonin|salmon calcitonin|mesh-list
20272969|NCT00542984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
20272970|NCT00542984|Katacalcin|katacalcin|mesh-list
20272971|NCT00542984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20272972|NCT00542984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272973|NCT00542984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20272974|NCT00542984|Vasodilator Agents|vasodilator agents|mesh-ancestor
20272975|NCT00543023|Teriparatide|teriparatide|mesh-list
20272976|NCT00543023|Calcitonin|calcitonin|mesh-list
20272977|NCT00543023|Salmon calcitonin|salmon calcitonin|mesh-list
20272978|NCT00543023|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
20272979|NCT00543023|Katacalcin|katacalcin|mesh-list
20272980|NCT00543023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20272981|NCT00543023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272982|NCT00543023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20272983|NCT00543023|Vasodilator Agents|vasodilator agents|mesh-ancestor
20272984|NCT00543049|Sunitinib|sunitinib|mesh-list
20272985|NCT00543049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272986|NCT00543049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20272987|NCT00543049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20272988|NCT00543049|Growth Substances|growth substances|mesh-ancestor
20272989|NCT00543049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20272990|NCT00543049|Growth Inhibitors|growth inhibitors|mesh-ancestor
20272991|NCT00543049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20272992|NCT00543049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20272993|NCT00543049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20272994|NCT00543075|Oblimersen|oblimersen|mesh-list
20272995|NCT00543075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20272996|NCT00543114|Rituximab|rituximab|mesh-list
20272997|NCT00543114|Fludarabine|fludarabine|mesh-list
20272998|NCT00543114|Lenalidomide|lenalidomide|mesh-list
20272999|NCT00543114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20273000|NCT00543114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273001|NCT00543114|Immunologic Factors|immunologic factors|mesh-ancestor
20273002|NCT00543114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273003|NCT00543114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20273004|NCT00543114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20273005|NCT00543114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20273006|NCT00543114|Growth Substances|growth substances|mesh-ancestor
20273007|NCT00543114|Growth Inhibitors|growth inhibitors|mesh-ancestor
20273008|NCT00543166|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19957954|NCT01663532|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20273009|NCT00543166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20273010|NCT00543166|Immunologic Factors|immunologic factors|mesh-ancestor
20273011|NCT00543166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957955|NCT01663532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19957956|NCT01663532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19957957|NCT01663532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957958|NCT01663532|Dopamine Agonists|dopamine agonists|mesh-ancestor
19957959|NCT01663532|Dopamine Agents|dopamine agents|mesh-ancestor
19957960|NCT01663532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19957961|NCT01663532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957962|NCT01663532|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19957963|NCT01663532|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19957964|NCT01663532|Serotonin Agents|serotonin agents|mesh-ancestor
19957965|NCT01663532|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19957966|NCT01663532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19957967|NCT01663532|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19957968|NCT01663532|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20273012|NCT00543179|Lanreotide|lanreotide|mesh-list
20273013|NCT00543179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287622|NCT04035486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287623|NCT04035486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20287624|NCT04035486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20287625|NCT04035486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20287626|NCT04029116|Fluconazole|fluconazole|mesh-list
20544459|NCT01874639|Coagulants|coagulants|mesh-ancestor
20544460|NCT01874678|Cisplatin|cisplatin|mesh-list
20544461|NCT01874678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544462|NCT01874717|Midazolam|midazolam|mesh-list
20544463|NCT01874717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20544464|NCT01874717|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20544465|NCT01874717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20544466|NCT01874717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544467|NCT01874717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20544468|NCT01874717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20544469|NCT01874717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20544470|NCT01874717|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20544471|NCT01874717|Anesthetics, General|anesthetics, general|mesh-ancestor
20544472|NCT01874717|Anesthetics|anesthetics|mesh-ancestor
20544473|NCT01874717|GABA Modulators|gaba modulators|mesh-ancestor
20544474|NCT01874717|GABA Agents|gaba agents|mesh-ancestor
20544475|NCT01874717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20544476|NCT01874717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544477|NCT01874730|Anesthetics|anesthetics|mesh-list
20544478|NCT01874730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20544479|NCT01874730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544480|NCT01874743|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20544481|NCT01874743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19957969|NCT01663623|Azathioprine|azathioprine|mesh-list
19957970|NCT01663623|Belimumab|belimumab|mesh-list
19957971|NCT01663623|Antimetabolites|antimetabolites|mesh-ancestor
19957972|NCT01663623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957973|NCT01663623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19957974|NCT01663623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957975|NCT01663623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19957976|NCT01663623|Immunologic Factors|immunologic factors|mesh-ancestor
19957977|NCT01663623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957978|NCT01663623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19957979|NCT01663714|Tositumomab I-131|tositumomab i-131|mesh-list
19957980|NCT01663714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19957981|NCT01663727|Paclitaxel|paclitaxel|mesh-list
19957982|NCT01663727|Bevacizumab|bevacizumab|mesh-list
20544482|NCT01874743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20544483|NCT01874743|Antimetabolites|antimetabolites|mesh-ancestor
20544484|NCT01874743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544485|NCT01874743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20544486|NCT01874743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20544487|NCT01874743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544488|NCT01874847|Melatonin|melatonin|mesh-list
19957983|NCT01663727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19957984|NCT01663727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544489|NCT01874847|Antioxidants|antioxidants|mesh-ancestor
20544490|NCT01874847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544491|NCT01874847|Protective Agents|protective agents|mesh-ancestor
20544492|NCT01874847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544493|NCT01874847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19450312|NCT03429621|Dermatologic Agents|dermatologic agents|mesh-ancestor
20287627|NCT04029116|Ibrexafungerp|ibrexafungerp|mesh-list
20287628|NCT04029116|Antifungal Agents|antifungal agents|mesh-ancestor
20287629|NCT04029116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20273014|NCT00543205|Oblimersen|oblimersen|mesh-list
20273015|NCT00543205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273016|NCT00543218|Teriparatide|teriparatide|mesh-list
20273017|NCT00543218|Calcitonin|calcitonin|mesh-list
20273018|NCT00543218|Salmon calcitonin|salmon calcitonin|mesh-list
20273019|NCT00543218|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
20273020|NCT00543218|Katacalcin|katacalcin|mesh-list
20273021|NCT00543218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20273022|NCT00543218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273023|NCT00543218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20273024|NCT00543218|Vasodilator Agents|vasodilator agents|mesh-ancestor
19957985|NCT01663727|Tubulin Modulators|tubulin modulators|mesh-ancestor
19957986|NCT01663727|Antimitotic Agents|antimitotic agents|mesh-ancestor
19957987|NCT01663727|Mitosis Modulators|mitosis modulators|mesh-ancestor
19957988|NCT01663727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19957989|NCT01663727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19957990|NCT01663727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19957991|NCT01663727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19957992|NCT01663727|Growth Substances|growth substances|mesh-ancestor
19957993|NCT01663727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19957994|NCT01663727|Growth Inhibitors|growth inhibitors|mesh-ancestor
20273025|NCT00543231|Oblimersen|oblimersen|mesh-list
20273026|NCT00543231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273027|NCT00543244|Interferons|interferons|mesh-list
20273028|NCT00543244|Ribavirin|ribavirin|mesh-list
20273029|NCT00543244|Interferon-alpha|interferon-alpha|mesh-list
20273030|NCT00543244|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20273031|NCT00543244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273032|NCT00543244|Antiviral Agents|antiviral agents|mesh-ancestor
19957995|NCT01663740|Valganciclovir|valganciclovir|mesh-list
19957996|NCT01663740|Antiviral Agents|antiviral agents|mesh-ancestor
19957997|NCT01663740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19957998|NCT01663857|Gemcitabine|gemcitabine|mesh-list
19957999|NCT01663857|Carboplatin|carboplatin|mesh-list
19958000|NCT01663857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958001|NCT01663857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19958002|NCT01663857|Antimetabolites|antimetabolites|mesh-ancestor
19958003|NCT01663857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958004|NCT01663857|Antiviral Agents|antiviral agents|mesh-ancestor
19958005|NCT01663857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19958006|NCT01663857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958007|NCT01663857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19958008|NCT01663857|Immunologic Factors|immunologic factors|mesh-ancestor
19958009|NCT01663857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958010|NCT01663935|Levodopa|levodopa|mesh-list
19958011|NCT01663935|Carbidopa|carbidopa|mesh-list
20273033|NCT00543244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20273034|NCT00543244|Antimetabolites|antimetabolites|mesh-ancestor
20273035|NCT00543244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273036|NCT00543244|Immunologic Factors|immunologic factors|mesh-ancestor
20273037|NCT00543244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273038|NCT00543335|Sorafenib|sorafenib|mesh-list
20544494|NCT01874860|Doxycycline|doxycycline|mesh-list
19958012|NCT01663935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19958013|NCT01663935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19958014|NCT01663935|Dopamine Agents|dopamine agents|mesh-ancestor
19958015|NCT01663935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19958016|NCT01663935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958017|NCT01663935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958018|NCT01663935|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19958019|NCT01663935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958020|NCT01663987|Bromides|bromides|mesh-list
19958021|NCT01663987|Tiotropium Bromide|tiotropium bromide|mesh-list
19958022|NCT01663987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19958023|NCT01663987|Autonomic Agents|autonomic agents|mesh-ancestor
19958024|NCT01663987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19958025|NCT01663987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958026|NCT01663987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19958027|NCT01663987|Respiratory System Agents|respiratory system agents|mesh-ancestor
19958028|NCT01663987|Parasympatholytics|parasympatholytics|mesh-ancestor
19958029|NCT01663987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19958030|NCT01663987|Cholinergic Agents|cholinergic agents|mesh-ancestor
19958031|NCT01663987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19974754|NCT01841606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20273039|NCT00543335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273040|NCT00543335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20273041|NCT00543335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958032|NCT01663987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958033|NCT01663987|Anticonvulsants|anticonvulsants|mesh-ancestor
19958034|NCT01664039|Bimatoprost|bimatoprost|mesh-list
19958035|NCT01664039|Travoprost|travoprost|mesh-list
19958036|NCT01664039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19958037|NCT01664039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19958038|NCT01664039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19958039|NCT01664247|Liraglutide|liraglutide|mesh-list
19958040|NCT01664247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19958041|NCT01664247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958042|NCT01664247|Incretins|incretins|mesh-ancestor
19958043|NCT01664247|Hormones|hormones|mesh-ancestor
19958044|NCT01664247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19958045|NCT01664494|Capecitabine|capecitabine|mesh-list
19958046|NCT01664494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19958047|NCT01664494|Antimetabolites|antimetabolites|mesh-ancestor
20273042|NCT00543335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273043|NCT00543361|Metformin|metformin|mesh-list
20544495|NCT01874860|Clindamycin|clindamycin|mesh-list
20544496|NCT01874860|Clindamycin palmitate|clindamycin palmitate|mesh-list
20544497|NCT01874860|Clindamycin phosphate|clindamycin phosphate|mesh-list
19958048|NCT01664494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958049|NCT01664494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958050|NCT01664533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19958051|NCT01664533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958052|NCT01664533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19958053|NCT01664533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958054|NCT01664533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958055|NCT01664559|Ketorolac|ketorolac|mesh-list
19958056|NCT01664559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19958057|NCT01664559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20544498|NCT01874860|Hydrocortisone|hydrocortisone|mesh-list
20544499|NCT01874860|Methylprednisolone|methylprednisolone|mesh-list
20544500|NCT01874860|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20544501|NCT01874860|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20544502|NCT01874860|Prednisolone|prednisolone|mesh-list
20544503|NCT01874860|Prednisolone acetate|prednisolone acetate|mesh-list
20544504|NCT01874860|Sunscreening Agents|sunscreening agents|mesh-list
20544505|NCT01874860|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20544506|NCT01874860|Prednisolone phosphate|prednisolone phosphate|mesh-list
20544507|NCT01874860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20544508|NCT01874860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20544509|NCT01874860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20544510|NCT01874860|Antimalarials|antimalarials|mesh-ancestor
20544511|NCT01874860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20544512|NCT01874860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20544513|NCT01874860|Antiemetics|antiemetics|mesh-ancestor
20544514|NCT01874860|Autonomic Agents|autonomic agents|mesh-ancestor
20544515|NCT01874860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20544516|NCT01874860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544517|NCT01874860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20544518|NCT01874860|Glucocorticoids|glucocorticoids|mesh-ancestor
19958058|NCT01664559|Analgesics|analgesics|mesh-ancestor
19958059|NCT01664559|Sensory System Agents|sensory system agents|mesh-ancestor
19958060|NCT01664559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20544519|NCT01874860|Hormones|hormones|mesh-ancestor
19958061|NCT01664559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958062|NCT01664559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19958063|NCT01664559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19958064|NCT01664559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19958065|NCT01664559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958066|NCT01664559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273044|NCT00543361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20273045|NCT00543361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273046|NCT00543413|Enalapril|enalapril|mesh-list
20273047|NCT00543413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20273048|NCT00543413|Protease Inhibitors|protease inhibitors|mesh-ancestor
20273049|NCT00543413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273050|NCT00543413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273051|NCT00543413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20273052|NCT00543504|Bevacizumab|bevacizumab|mesh-list
20273053|NCT00543504|Trastuzumab|trastuzumab|mesh-list
20273054|NCT00543504|Cetuximab|cetuximab|mesh-list
20273055|NCT00543504|Sunitinib|sunitinib|mesh-list
20273056|NCT00543504|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20273057|NCT00543504|Sorafenib|sorafenib|mesh-list
20273058|NCT00543504|Lapatinib|lapatinib|mesh-list
20273059|NCT00543504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20273060|NCT00543504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273061|NCT00543504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20273062|NCT00543504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20273063|NCT00543504|Growth Substances|growth substances|mesh-ancestor
20273064|NCT00543504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273065|NCT00543504|Growth Inhibitors|growth inhibitors|mesh-ancestor
20273066|NCT00543504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20273067|NCT00543504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273068|NCT00543504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273069|NCT00543608|Vancomycin|vancomycin|mesh-list
20273070|NCT00543608|Iclaprim|iclaprim|mesh-list
20273071|NCT00543608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20273072|NCT00543608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20273073|NCT00543608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20273074|NCT00543608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273075|NCT00543608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273076|NCT00543634|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20273077|NCT00543634|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20273078|NCT00543634|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20273079|NCT00543634|Contraceptive Agents|contraceptive agents|mesh-ancestor
20273080|NCT00543634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20273081|NCT00543634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273082|NCT00543634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20273083|NCT00543634|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20273084|NCT00543634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20273085|NCT00543634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273086|NCT00543634|Estrogens|estrogens|mesh-ancestor
20273087|NCT00543634|Hormones|hormones|mesh-ancestor
20273088|NCT00543634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20273089|NCT00543647|Fenofibrate|fenofibrate|mesh-list
20273090|NCT00543647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20273091|NCT00543647|Antimetabolites|antimetabolites|mesh-ancestor
20273092|NCT00543647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273093|NCT00543647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20273094|NCT00543686|Fluticasone|fluticasone|mesh-list
20273095|NCT00543686|Montelukast|montelukast|mesh-list
20273096|NCT00543686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20273097|NCT00543686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20273098|NCT00543686|Autonomic Agents|autonomic agents|mesh-ancestor
20273099|NCT00543686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20273100|NCT00543686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273101|NCT00543686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20273102|NCT00543686|Respiratory System Agents|respiratory system agents|mesh-ancestor
20273103|NCT00543686|Dermatologic Agents|dermatologic agents|mesh-ancestor
20273104|NCT00543686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20273105|NCT00543686|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20273106|NCT00543686|Hormone Antagonists|hormone antagonists|mesh-ancestor
20273107|NCT00543686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20273108|NCT00543686|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20273109|NCT00543686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20273110|NCT00543686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273111|NCT00543829|Tamoxifen|tamoxifen|mesh-list
20273112|NCT00543829|Docetaxel|docetaxel|mesh-list
20273113|NCT00543829|Doxorubicin|doxorubicin|mesh-list
20273114|NCT00543829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20273115|NCT00543829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273116|NCT00543829|Tubulin Modulators|tubulin modulators|mesh-ancestor
20273117|NCT00543829|Antimitotic Agents|antimitotic agents|mesh-ancestor
20273118|NCT00543829|Mitosis Modulators|mitosis modulators|mesh-ancestor
20273119|NCT00543829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273120|NCT00543829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20273121|NCT00543829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20273122|NCT00543829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20273123|NCT00543829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273124|NCT00543829|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20273125|NCT00543829|Hormone Antagonists|hormone antagonists|mesh-ancestor
20273126|NCT00543829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20273127|NCT00543829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273128|NCT00543829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20273129|NCT00543829|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20273130|NCT00543829|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19958067|NCT01664624|Exenatide|exenatide|mesh-list
19958068|NCT01664624|Alogliptin|alogliptin|mesh-list
19958069|NCT01664624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19958070|NCT01664624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958071|NCT01664624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20273131|NCT00543829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20273132|NCT00543842|Bevacizumab|bevacizumab|mesh-list
20273133|NCT00543842|Capecitabine|capecitabine|mesh-list
20273134|NCT00543842|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20273135|NCT00543842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20273136|NCT00543842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273137|NCT00543842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20273138|NCT00543842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20273139|NCT00543842|Growth Substances|growth substances|mesh-ancestor
20273140|NCT00543842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273141|NCT00543842|Growth Inhibitors|growth inhibitors|mesh-ancestor
19958072|NCT01664624|Incretins|incretins|mesh-ancestor
19958073|NCT01664624|Hormones|hormones|mesh-ancestor
19958074|NCT01664624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19958075|NCT01664624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19958076|NCT01664624|Protease Inhibitors|protease inhibitors|mesh-ancestor
19958077|NCT01664624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958078|NCT01664624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958079|NCT01664741|Nicotine|nicotine|mesh-list
19958080|NCT01664741|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19958081|NCT01664741|Autonomic Agents|autonomic agents|mesh-ancestor
19958082|NCT01664741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20273142|NCT00543842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20273143|NCT00543842|Antimetabolites|antimetabolites|mesh-ancestor
20273144|NCT00543842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273145|NCT00543842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20273146|NCT00543842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273147|NCT00543933|Nitric Oxide|nitric oxide|mesh-list
20273148|NCT00543933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20273149|NCT00543933|Autonomic Agents|autonomic agents|mesh-ancestor
20273150|NCT00543933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20273151|NCT00543933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273152|NCT00543933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20273153|NCT00543933|Respiratory System Agents|respiratory system agents|mesh-ancestor
20273154|NCT00543933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20273155|NCT00543933|Antioxidants|antioxidants|mesh-ancestor
20273156|NCT00543933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273157|NCT00543933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20273158|NCT00543933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20273159|NCT00543933|Vasodilator Agents|vasodilator agents|mesh-ancestor
20273160|NCT00543933|Gasotransmitters|gasotransmitters|mesh-ancestor
20273161|NCT00543933|Protective Agents|protective agents|mesh-ancestor
20273162|NCT00543959|Pioglitazone|pioglitazone|mesh-list
20273163|NCT00543959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20273164|NCT00543959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273165|NCT00544011|Bevacizumab|bevacizumab|mesh-list
20273166|NCT00544011|Fluorouracil|fluorouracil|mesh-list
20273167|NCT00544011|Capecitabine|capecitabine|mesh-list
20273168|NCT00544011|Irinotecan|irinotecan|mesh-list
20273169|NCT00544011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20273170|NCT00544011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273171|NCT00544011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20273172|NCT00544011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20273173|NCT00544011|Growth Substances|growth substances|mesh-ancestor
20273174|NCT00544011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273175|NCT00544011|Growth Inhibitors|growth inhibitors|mesh-ancestor
20273176|NCT00544011|Antimetabolites|antimetabolites|mesh-ancestor
20273177|NCT00544011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273178|NCT00544011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20273179|NCT00544011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20273180|NCT00544011|Immunologic Factors|immunologic factors|mesh-ancestor
20273181|NCT00544011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20273182|NCT00544011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20273183|NCT00544011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273184|NCT00544037|Interferons|interferons|mesh-list
20544520|NCT01874860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19958083|NCT01664741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273185|NCT00544037|Interferon-beta|interferon-beta|mesh-list
20273186|NCT00544037|Interferon beta-1b|interferon beta-1b|mesh-list
20273187|NCT00544037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273188|NCT00544037|Antiviral Agents|antiviral agents|mesh-ancestor
20273189|NCT00544037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20273190|NCT00544037|Immunologic Factors|immunologic factors|mesh-ancestor
20273191|NCT00544037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273192|NCT00544037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20273193|NCT00544050|Levetiracetam|levetiracetam|mesh-list
20273194|NCT00544050|Anticonvulsants|anticonvulsants|mesh-ancestor
20273195|NCT00544050|Nootropic Agents|nootropic agents|mesh-ancestor
20273196|NCT00544063|Oxaliplatin|oxaliplatin|mesh-list
20273197|NCT00544063|Irinotecan|irinotecan|mesh-list
20273198|NCT00544063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273199|NCT00544063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20273200|NCT00544063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20273201|NCT00544063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273202|NCT00544063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273203|NCT00544128|Ritonavir|ritonavir|mesh-list
20273204|NCT00544128|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20273205|NCT00544128|Tenofovir|tenofovir|mesh-list
20273206|NCT00544128|Lamivudine|lamivudine|mesh-list
20273207|NCT00544128|Emtricitabine|emtricitabine|mesh-list
20273208|NCT00544128|Abacavir|abacavir|mesh-list
19958084|NCT01664741|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19958085|NCT01664741|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19958086|NCT01664741|Cholinergic Agents|cholinergic agents|mesh-ancestor
19958087|NCT01664741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19958088|NCT01664741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958089|NCT01664793|Vaccines|vaccines|mesh-list
19958090|NCT01664793|Immunologic Factors|immunologic factors|mesh-ancestor
19958091|NCT01664793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958092|NCT01664858|Calcium|calcium|mesh-list
20273209|NCT00544128|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20273210|NCT00544128|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20273211|NCT00544128|Protease Inhibitors|protease inhibitors|mesh-ancestor
20273212|NCT00544128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273213|NCT00544128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273214|NCT00544128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20273215|NCT00544128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19958093|NCT01664858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19958094|NCT01664858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958095|NCT01664897|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19958096|NCT01664897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958097|NCT01664897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19958098|NCT01664897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958099|NCT01664897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958100|NCT01664923|Bicalutamide|bicalutamide|mesh-list
19958101|NCT01664923|Androgen Antagonists|androgen antagonists|mesh-ancestor
19958102|NCT01664923|Hormone Antagonists|hormone antagonists|mesh-ancestor
19958103|NCT01664923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19958104|NCT01664923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958105|NCT01664923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958106|NCT01664949|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19958107|NCT01664949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19958108|NCT01664949|Lubricant Eye Drops|lubricant eye drops|mesh-list
19958109|NCT01664949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19958110|NCT01664949|Laxatives|laxatives|mesh-ancestor
19958111|NCT01664949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19958112|NCT01665508|Nebivolol|nebivolol|mesh-list
19958113|NCT01665508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19958114|NCT01665508|Vasodilator Agents|vasodilator agents|mesh-ancestor
19958115|NCT01665508|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19958116|NCT01665508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19958117|NCT01665508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19958118|NCT01665508|Adrenergic Agents|adrenergic agents|mesh-ancestor
19958119|NCT01665508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19958120|NCT01665508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958121|NCT01665508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958122|NCT01665599|Testosterone|testosterone|mesh-list
19958123|NCT01665599|Androgens|androgens|mesh-ancestor
19958124|NCT01665599|Hormones|hormones|mesh-ancestor
19958125|NCT01665599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19958126|NCT01665599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273216|NCT00544128|Antiviral Agents|antiviral agents|mesh-ancestor
20273217|NCT00544128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19958127|NCT01665768|Rituximab|rituximab|mesh-list
19958128|NCT01665768|Everolimus|everolimus|mesh-list
19958129|NCT01665768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19958130|NCT01665768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958131|NCT01665768|Immunologic Factors|immunologic factors|mesh-ancestor
19958132|NCT01665768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958133|NCT01665768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19958134|NCT01665768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19733168|NCT04564469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19733169|NCT04564469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733170|NCT04564456|Fluticasone|fluticasone|mesh-list
19733171|NCT04564456|Xhance|xhance|mesh-list
19733172|NCT04564456|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20273218|NCT00544128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20273219|NCT00544128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20273220|NCT00544128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20273221|NCT00544128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20273222|NCT00544154|Certolizumab Pegol|certolizumab pegol|mesh-list
20273223|NCT00544154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20273224|NCT00544154|Immunologic Factors|immunologic factors|mesh-ancestor
20273225|NCT00544154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273226|NCT00544154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20273227|NCT00544180|Risedronic Acid|risedronic acid|mesh-list
20273228|NCT00544180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20273229|NCT00544180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20273230|NCT00544180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544521|NCT01874860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20544522|NCT01874860|Protective Agents|protective agents|mesh-ancestor
20544523|NCT01874860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20544524|NCT01874860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733173|NCT04564456|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19733174|NCT04564456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19733175|NCT04564456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19733176|NCT04564456|Autonomic Agents|autonomic agents|mesh-ancestor
19733177|NCT04564456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733178|NCT04564456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733179|NCT04564456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19733180|NCT04564456|Respiratory System Agents|respiratory system agents|mesh-ancestor
19733181|NCT04564456|Dermatologic Agents|dermatologic agents|mesh-ancestor
19733182|NCT04564456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20544525|NCT01874860|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20544526|NCT01874860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544527|NCT01874860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544528|NCT01874860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20544529|NCT01874860|Dermatologic Agents|dermatologic agents|mesh-ancestor
20544530|NCT01874964|Methadone|methadone|mesh-list
20544531|NCT01874964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20544532|NCT01874964|Narcotics|narcotics|mesh-ancestor
20544533|NCT01874964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20544534|NCT01874964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544535|NCT01874964|Analgesics|analgesics|mesh-ancestor
20544536|NCT01874964|Sensory System Agents|sensory system agents|mesh-ancestor
20544537|NCT01874964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20544538|NCT01874964|Antitussive Agents|antitussive agents|mesh-ancestor
20544539|NCT01874964|Respiratory System Agents|respiratory system agents|mesh-ancestor
20544540|NCT01875107|Insulin|insulin|mesh-list
20544541|NCT01875107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20544542|NCT01875107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544543|NCT01875172|Bupropion|bupropion|mesh-list
20544544|NCT01875172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20544545|NCT01875172|Antidepressive Agents|antidepressive agents|mesh-ancestor
20544546|NCT01875172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20544547|NCT01875172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20544548|NCT01875172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20544549|NCT01875172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20544550|NCT01875172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544551|NCT01875172|Dopamine Agents|dopamine agents|mesh-ancestor
20544552|NCT01875172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20544553|NCT01875172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544554|NCT01875172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20544555|NCT01875172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20544556|NCT01875172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958135|NCT01665911|Listerine|listerine|mesh-list
20273231|NCT00544180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20273232|NCT00544180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273233|NCT00544180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20273234|NCT00544193|Gemcitabine|gemcitabine|mesh-list
20273235|NCT00544193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20273236|NCT00544193|Antimetabolites|antimetabolites|mesh-ancestor
20273237|NCT00544193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273238|NCT00544193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273239|NCT00544193|Antiviral Agents|antiviral agents|mesh-ancestor
20273240|NCT00544193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20273241|NCT00544193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273242|NCT00544193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20273243|NCT00544193|Immunologic Factors|immunologic factors|mesh-ancestor
19733183|NCT04564456|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19733184|NCT04564456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19733185|NCT04564456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19733186|NCT04564456|Adrenergic Agents|adrenergic agents|mesh-ancestor
19733187|NCT04564456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19733188|NCT04564456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733189|NCT04564456|Glucocorticoids|glucocorticoids|mesh-ancestor
19733190|NCT04564456|Hormones|hormones|mesh-ancestor
19733191|NCT04564456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19733192|NCT04564456|Sympathomimetics|sympathomimetics|mesh-ancestor
19733193|NCT04564430|Clonidine|clonidine|mesh-list
19733194|NCT04564430|Analgesics|analgesics|mesh-ancestor
19733195|NCT04564430|Sensory System Agents|sensory system agents|mesh-ancestor
19733196|NCT04564430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733197|NCT04564430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733198|NCT04564430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19733199|NCT04564430|Sympatholytics|sympatholytics|mesh-ancestor
20273244|NCT00544193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273245|NCT00544219|Prednisone|prednisone|mesh-list
20273246|NCT00544219|Cyclophosphamide|cyclophosphamide|mesh-list
20273247|NCT00544219|Rituximab|rituximab|mesh-list
20273248|NCT00544219|Doxorubicin|doxorubicin|mesh-list
19733200|NCT04564430|Autonomic Agents|autonomic agents|mesh-ancestor
19733201|NCT04564430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19733202|NCT04564430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19733203|NCT04564430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19733204|NCT04564430|Adrenergic Agents|adrenergic agents|mesh-ancestor
19733205|NCT04564430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19733206|NCT04564430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733207|NCT04564144|Meclizine|meclizine|mesh-list
19733208|NCT04564144|Antiemetics|antiemetics|mesh-ancestor
19733209|NCT04564144|Autonomic Agents|autonomic agents|mesh-ancestor
19733210|NCT04564144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733211|NCT04564144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273249|NCT00544219|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20273250|NCT00544219|Vincristine|vincristine|mesh-list
20273251|NCT00544219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20273252|NCT00544219|Immunologic Factors|immunologic factors|mesh-ancestor
20273253|NCT00544219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273254|NCT00544219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19733212|NCT04564144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19733213|NCT04564144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19733214|NCT04564144|Histamine Antagonists|histamine antagonists|mesh-ancestor
20273255|NCT00544219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20273256|NCT00544219|Alkylating Agents|alkylating agents|mesh-ancestor
20273257|NCT00544219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273258|NCT00544219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273259|NCT00544219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20273260|NCT00544219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20273261|NCT00544219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20273262|NCT00544219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20273263|NCT00544219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20273264|NCT00544219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273265|NCT00544219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20273266|NCT00544219|Glucocorticoids|glucocorticoids|mesh-ancestor
20273267|NCT00544219|Hormones|hormones|mesh-ancestor
20273268|NCT00544219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20273269|NCT00544219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20273270|NCT00544219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20273271|NCT00544219|Tubulin Modulators|tubulin modulators|mesh-ancestor
19733215|NCT04564144|Histamine Agents|histamine agents|mesh-ancestor
19958136|NCT01665911|Fluorides|fluorides|mesh-list
19958137|NCT01665911|Sodium Fluoride|sodium fluoride|mesh-list
19958138|NCT01665911|Cariostatic Agents|cariostatic agents|mesh-ancestor
19958139|NCT01665911|Protective Agents|protective agents|mesh-ancestor
19958140|NCT01665911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958141|NCT01665911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19958142|NCT01665911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19958143|NCT01665950|Simvastatin|simvastatin|mesh-list
20273272|NCT00544219|Antimitotic Agents|antimitotic agents|mesh-ancestor
20273273|NCT00544219|Mitosis Modulators|mitosis modulators|mesh-ancestor
20273274|NCT00544232|Paclitaxel|paclitaxel|mesh-list
20273275|NCT00544232|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20273276|NCT00544232|Cyclophosphamide|cyclophosphamide|mesh-list
20273277|NCT00544232|Methotrexate|methotrexate|mesh-list
20273278|NCT00544232|Epirubicin|epirubicin|mesh-list
20273279|NCT00544232|Darbepoetin alfa|darbepoetin alfa|mesh-list
20273280|NCT00544232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20273281|NCT00544232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273282|NCT00544232|Tubulin Modulators|tubulin modulators|mesh-ancestor
20273283|NCT00544232|Antimitotic Agents|antimitotic agents|mesh-ancestor
20273284|NCT00544232|Mitosis Modulators|mitosis modulators|mesh-ancestor
20273285|NCT00544232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273286|NCT00544232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20273287|NCT00544232|Immunologic Factors|immunologic factors|mesh-ancestor
20273288|NCT00544232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273289|NCT00544232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20273290|NCT00544232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20273291|NCT00544232|Alkylating Agents|alkylating agents|mesh-ancestor
20273292|NCT00544232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20273293|NCT00544232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20273294|NCT00544232|Abortifacient Agents|abortifacient agents|mesh-ancestor
20273295|NCT00544232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20273296|NCT00544232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20273297|NCT00544232|Antimetabolites|antimetabolites|mesh-ancestor
20273298|NCT00544232|Dermatologic Agents|dermatologic agents|mesh-ancestor
20273299|NCT00544232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273300|NCT00544232|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20273301|NCT00544232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20273302|NCT00544232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20273303|NCT00544232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20273304|NCT00544232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20273305|NCT00544232|Hematinics|hematinics|mesh-ancestor
20273306|NCT00544284|Bortezomib|bortezomib|mesh-list
20273307|NCT00544284|Temozolomide|temozolomide|mesh-list
20273308|NCT00544284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273309|NCT00544284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20273310|NCT00544284|Alkylating Agents|alkylating agents|mesh-ancestor
20273311|NCT00544284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273312|NCT00544349|Leucovorin|leucovorin|mesh-list
20273313|NCT00544349|Fluorouracil|fluorouracil|mesh-list
20273314|NCT00544349|Oxaliplatin|oxaliplatin|mesh-list
20273315|NCT00544349|Cetuximab|cetuximab|mesh-list
20273316|NCT00544349|Calcium|calcium|mesh-list
20544557|NCT01875185|Aspirin|aspirin|mesh-list
20544558|NCT01875185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20544559|NCT01875185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20544560|NCT01875185|Analgesics|analgesics|mesh-ancestor
20544561|NCT01875185|Sensory System Agents|sensory system agents|mesh-ancestor
20544562|NCT01875185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19958144|NCT01665950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19958145|NCT01665950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19958146|NCT01665950|Antimetabolites|antimetabolites|mesh-ancestor
19958147|NCT01665950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958148|NCT01665950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19958149|NCT01665950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19958150|NCT01665950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958151|NCT01666119|Buprenorphine|buprenorphine|mesh-list
19958152|NCT01666119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19958153|NCT01666119|Narcotics|narcotics|mesh-ancestor
20273317|NCT00544349|Levoleucovorin|levoleucovorin|mesh-list
20273318|NCT00544349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20273319|NCT00544349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544563|NCT01875185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544564|NCT01875185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20544565|NCT01875185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20544566|NCT01875185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20544567|NCT01875185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20273320|NCT00544349|Antimetabolites|antimetabolites|mesh-ancestor
20273321|NCT00544349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273322|NCT00544349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19958154|NCT01666119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19958155|NCT01666119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958156|NCT01666119|Analgesics|analgesics|mesh-ancestor
19958157|NCT01666119|Sensory System Agents|sensory system agents|mesh-ancestor
19958158|NCT01666119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19958159|NCT01666119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19958160|NCT01666197|Diclofenac|diclofenac|mesh-list
20273323|NCT00544349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273324|NCT00544349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20273325|NCT00544349|Immunologic Factors|immunologic factors|mesh-ancestor
20273326|NCT00544349|Antidotes|antidotes|mesh-ancestor
20273327|NCT00544349|Protective Agents|protective agents|mesh-ancestor
20273328|NCT00544349|Vitamin B Complex|vitamin b complex|mesh-ancestor
20273329|NCT00544349|Vitamins|vitamins|mesh-ancestor
20273330|NCT00544349|Micronutrients|micronutrients|mesh-ancestor
20273331|NCT00544349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20273332|NCT00544362|Fluorouracil|fluorouracil|mesh-list
20273333|NCT00544362|Cetuximab|cetuximab|mesh-list
20273334|NCT00544362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958161|NCT01666197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19958162|NCT01666197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19958163|NCT01666197|Analgesics|analgesics|mesh-ancestor
19958164|NCT01666197|Sensory System Agents|sensory system agents|mesh-ancestor
19958165|NCT01666197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19958166|NCT01666197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958167|NCT01666197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19958168|NCT01666197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19958169|NCT01666197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19958170|NCT01666197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958171|NCT01666197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958172|NCT01666210|Dexamethasone|dexamethasone|mesh-list
19958173|NCT01666210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19958174|NCT01666210|Antiemetics|antiemetics|mesh-ancestor
19958175|NCT01666210|Autonomic Agents|autonomic agents|mesh-ancestor
19958176|NCT01666210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19958177|NCT01666210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958178|NCT01666210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19958179|NCT01666210|Glucocorticoids|glucocorticoids|mesh-ancestor
20273335|NCT00544362|Antimetabolites|antimetabolites|mesh-ancestor
20273336|NCT00544362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273337|NCT00544362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20273338|NCT00544362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20273339|NCT00544362|Immunologic Factors|immunologic factors|mesh-ancestor
20273340|NCT00544362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273341|NCT00544362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20273342|NCT00544388|Levocetirizine|levocetirizine|mesh-list
20273343|NCT00544388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20273344|NCT00544388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20273345|NCT00544388|Histamine Antagonists|histamine antagonists|mesh-ancestor
20273346|NCT00544388|Histamine Agents|histamine agents|mesh-ancestor
20273347|NCT00544388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20273348|NCT00544388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273349|NCT00544388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273350|NCT00544505|Cyclophosphamide|cyclophosphamide|mesh-list
20273351|NCT00544505|Fluorouracil|fluorouracil|mesh-list
20273352|NCT00544505|Epirubicin|epirubicin|mesh-list
20273353|NCT00544505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20273354|NCT00544505|Immunologic Factors|immunologic factors|mesh-ancestor
20273355|NCT00544505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273356|NCT00544505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19958180|NCT01666210|Hormones|hormones|mesh-ancestor
19958181|NCT01666210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19958182|NCT01666210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19958183|NCT01666210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958184|NCT01666314|Prednisone|prednisone|mesh-list
19958185|NCT01666314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19958186|NCT01666314|Glucocorticoids|glucocorticoids|mesh-ancestor
19958187|NCT01666314|Hormones|hormones|mesh-ancestor
19958188|NCT01666314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19958189|NCT01666314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958190|NCT01666314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19958191|NCT01666314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958192|NCT01666444|Doxorubicin|doxorubicin|mesh-list
19958193|NCT01666444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19958194|NCT01666444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19958195|NCT01666444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958196|NCT01666444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19958197|NCT01666444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19958198|NCT01666444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958199|NCT01666444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958200|NCT01666652|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19958201|NCT01666652|Aluminum sulfate|aluminum sulfate|mesh-list
19958202|NCT01666652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19958203|NCT01666652|Immunologic Factors|immunologic factors|mesh-ancestor
19958204|NCT01666652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958205|NCT01666652|Antacids|antacids|mesh-ancestor
19958206|NCT01666652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958207|NCT01666652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19958208|NCT01666730|Leucovorin|leucovorin|mesh-list
19958209|NCT01666730|Metformin|metformin|mesh-list
20273357|NCT00544505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20273358|NCT00544505|Alkylating Agents|alkylating agents|mesh-ancestor
20273359|NCT00544505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273360|NCT00544505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273361|NCT00544505|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19958210|NCT01666730|Fluorouracil|fluorouracil|mesh-list
19958211|NCT01666730|Oxaliplatin|oxaliplatin|mesh-list
19958212|NCT01666730|Calcium|calcium|mesh-list
20273362|NCT00544505|Antimetabolites|antimetabolites|mesh-ancestor
20273363|NCT00544505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20273364|NCT00544505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20273365|NCT00544505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20273366|NCT00544505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20273367|NCT00544505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273368|NCT00544518|Metformin|metformin|mesh-list
20273369|NCT00544518|Benfluorex|benfluorex|mesh-list
20273370|NCT00544518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20273371|NCT00544518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273372|NCT00544518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19958213|NCT01666730|Levoleucovorin|levoleucovorin|mesh-list
19958214|NCT01666730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19958215|NCT01666730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958216|NCT01666730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19958217|NCT01666730|Antimetabolites|antimetabolites|mesh-ancestor
19958218|NCT01666730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958219|NCT01666730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19958220|NCT01666730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958221|NCT01666730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19958222|NCT01666730|Immunologic Factors|immunologic factors|mesh-ancestor
20273373|NCT00544518|Antimetabolites|antimetabolites|mesh-ancestor
20273374|NCT00544518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273375|NCT00544518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19958223|NCT01666730|Antidotes|antidotes|mesh-ancestor
19958224|NCT01666730|Protective Agents|protective agents|mesh-ancestor
19958225|NCT01666730|Vitamin B Complex|vitamin b complex|mesh-ancestor
19958226|NCT01666730|Vitamins|vitamins|mesh-ancestor
19958227|NCT01666730|Micronutrients|micronutrients|mesh-ancestor
19958228|NCT01666782|Vaccines|vaccines|mesh-list
20273376|NCT00544518|Appetite Depressants|appetite depressants|mesh-ancestor
20273377|NCT00544518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20273378|NCT00544570|Cyclophosphamide|cyclophosphamide|mesh-list
20273379|NCT00544570|Melphalan|melphalan|mesh-list
20273380|NCT00544570|Carmustine|carmustine|mesh-list
20273381|NCT00544570|Etoposide|etoposide|mesh-list
20273382|NCT00544570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20273383|NCT00544570|Immunologic Factors|immunologic factors|mesh-ancestor
20273384|NCT00544570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273385|NCT00544570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20273386|NCT00544570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20273387|NCT00544570|Alkylating Agents|alkylating agents|mesh-ancestor
20273388|NCT00544570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273389|NCT00544570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273390|NCT00544570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20273391|NCT00544570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19958229|NCT01666782|Immunologic Factors|immunologic factors|mesh-ancestor
19958230|NCT01666782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958231|NCT01666912|Contraceptive Agents|contraceptive agents|mesh-list
19958232|NCT01666912|Etonogestrel|etonogestrel|mesh-list
20273392|NCT00544570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20273393|NCT00544570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20273394|NCT00544570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958233|NCT01666912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19958234|NCT01666912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958235|NCT01666912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19958236|NCT01666912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19958237|NCT01666951|Tacrolimus|tacrolimus|mesh-list
19958238|NCT01666951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19958239|NCT01666951|Immunologic Factors|immunologic factors|mesh-ancestor
19958240|NCT01666951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958241|NCT01666951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19958242|NCT01666951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958243|NCT01666951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958244|NCT01667029|Sulfasalazine|sulfasalazine|mesh-list
20273395|NCT00544596|Acetic Acid|acetic acid|mesh-list
20273396|NCT00544596|Etoposide|etoposide|mesh-list
20273397|NCT00544596|Etoposide phosphate|etoposide phosphate|mesh-list
20273398|NCT00544596|Retinol acetate|retinol acetate|mesh-list
19958245|NCT01667029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19958246|NCT01667029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19958247|NCT01667029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19958248|NCT01667029|Analgesics|analgesics|mesh-ancestor
19958249|NCT01667029|Sensory System Agents|sensory system agents|mesh-ancestor
20273399|NCT00544596|Gossypol acetic acid|gossypol acetic acid|mesh-list
20273400|NCT00544596|Gossypol|gossypol|mesh-list
20273401|NCT00544596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273402|NCT00544596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20273403|NCT00544596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20273404|NCT00544596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20273405|NCT00544596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273406|NCT00544596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273407|NCT00544596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20273408|NCT00544596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20273409|NCT00544596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20273410|NCT00544596|Immunologic Factors|immunologic factors|mesh-ancestor
20273411|NCT00544596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273412|NCT00544596|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20273413|NCT00544596|Protective Agents|protective agents|mesh-ancestor
20273414|NCT00544596|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20544568|NCT01875185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544569|NCT01875185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20544570|NCT01875185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20544571|NCT01875185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544572|NCT01875185|Antipyretics|antipyretics|mesh-ancestor
20544573|NCT01875224|Abatacept|abatacept|mesh-list
20544574|NCT01875224|Tacrolimus|tacrolimus|mesh-list
20544575|NCT01875224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20544576|NCT01875224|Immunologic Factors|immunologic factors|mesh-ancestor
20544577|NCT01875224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958250|NCT01667029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19958251|NCT01667029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958252|NCT01667029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19958253|NCT01667029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19958254|NCT01667029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19958255|NCT01667107|Posaconazole|posaconazole|mesh-list
19958256|NCT01667107|Antifungal Agents|antifungal agents|mesh-ancestor
19958257|NCT01667107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19958258|NCT01667107|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19958259|NCT01667107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19958260|NCT01667107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19958261|NCT01667107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19958262|NCT01667107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19958263|NCT01667107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958264|NCT01667107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958265|NCT01667107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19958266|NCT01667107|Hormone Antagonists|hormone antagonists|mesh-ancestor
19958267|NCT01667107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19958268|NCT01667107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974755|NCT01841606|Serotonin Agents|serotonin agents|mesh-ancestor
19974756|NCT01841606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19974757|NCT01841606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273415|NCT00544596|Contraceptive Agents|contraceptive agents|mesh-ancestor
20273416|NCT00544596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20273417|NCT00544596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20273418|NCT00544596|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
20273419|NCT00544596|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
20273420|NCT00544609|Sorafenib|sorafenib|mesh-list
20273421|NCT00544609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273422|NCT00544609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20273423|NCT00544609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273424|NCT00544609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273425|NCT00544687|Mometasone Furoate|mometasone furoate|mesh-list
20273426|NCT00544687|Nortriptyline|nortriptyline|mesh-list
20273427|NCT00544687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20273428|NCT00544687|Dermatologic Agents|dermatologic agents|mesh-ancestor
20273429|NCT00544687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20273430|NCT00544687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20273431|NCT00544687|Antidepressive Agents|antidepressive agents|mesh-ancestor
20273432|NCT00544687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20273433|NCT00544687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20273434|NCT00544687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20273435|NCT00544687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20273436|NCT00544687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273437|NCT00544687|Adrenergic Agents|adrenergic agents|mesh-ancestor
19958269|NCT01667419|Vemurafenib|vemurafenib|mesh-list
19958270|NCT01667419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958271|NCT01667419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19958272|NCT01667419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958273|NCT01667419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958274|NCT01667432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19958275|NCT01667432|Antiviral Agents|antiviral agents|mesh-ancestor
19958276|NCT01667432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19958277|NCT01667562|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19958278|NCT01667562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958279|NCT01667562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19958280|NCT01667562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958281|NCT01667562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958282|NCT01667679|Sumatriptan|sumatriptan|mesh-list
19958283|NCT01667679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19958284|NCT01667679|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20273438|NCT00544687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20273439|NCT00544687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273440|NCT00544700|Bevacizumab|bevacizumab|mesh-list
20273441|NCT00544700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20273442|NCT00544700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273443|NCT00544700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20273444|NCT00544700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20273445|NCT00544700|Growth Substances|growth substances|mesh-ancestor
20273446|NCT00544700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273447|NCT00544700|Growth Inhibitors|growth inhibitors|mesh-ancestor
20273448|NCT00544791|Melatonin|melatonin|mesh-list
20273449|NCT00544791|Antioxidants|antioxidants|mesh-ancestor
20273450|NCT00544791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273451|NCT00544791|Protective Agents|protective agents|mesh-ancestor
20273452|NCT00544791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273453|NCT00544791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20273454|NCT00544804|Lapatinib|lapatinib|mesh-list
20273455|NCT00544804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273456|NCT00544804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20273457|NCT00544804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273458|NCT00544804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273459|NCT00544986|Anastrozole|anastrozole|mesh-list
20273460|NCT00544986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20273461|NCT00544986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273462|NCT00544986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20273463|NCT00544986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20273464|NCT00544986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273465|NCT00544986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273466|NCT00544986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20273467|NCT00544986|Hormone Antagonists|hormone antagonists|mesh-ancestor
20273468|NCT00544986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20273469|NCT00544986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273470|NCT00544999|Cytarabine|cytarabine|mesh-list
20273471|NCT00544999|Everolimus|everolimus|mesh-list
19958285|NCT01667679|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19958286|NCT01667679|Serotonin Agents|serotonin agents|mesh-ancestor
19958287|NCT01667679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19958288|NCT01667679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958289|NCT01667679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958290|NCT01667731|Sofosbuvir|sofosbuvir|mesh-list
19958291|NCT01667731|Antiviral Agents|antiviral agents|mesh-ancestor
19958292|NCT01667731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19958293|NCT01667796|Vitamin D|vitamin d|mesh-list
19958294|NCT01667796|Cholecalciferol|cholecalciferol|mesh-list
19958295|NCT01667796|Vitamins|vitamins|mesh-ancestor
19958296|NCT01667796|Micronutrients|micronutrients|mesh-ancestor
19958297|NCT01667796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958298|NCT01667796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19958299|NCT01667796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19958300|NCT01667900|Dulaglutide|dulaglutide|mesh-list
19958301|NCT01667900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19958302|NCT01667900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958303|NCT01667926|Ketamine|ketamine|mesh-list
19958304|NCT01667926|Analgesics|analgesics|mesh-ancestor
19958305|NCT01667926|Sensory System Agents|sensory system agents|mesh-ancestor
19958306|NCT01667926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19958307|NCT01667926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958308|NCT01667926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19958309|NCT01667926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19958310|NCT01667926|Anesthetics, General|anesthetics, general|mesh-ancestor
20273472|NCT00544999|Daunorubicin|daunorubicin|mesh-list
20273473|NCT00544999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20273474|NCT00544999|Antimetabolites|antimetabolites|mesh-ancestor
20273475|NCT00544999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273476|NCT00544999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273477|NCT00544999|Antiviral Agents|antiviral agents|mesh-ancestor
20273478|NCT00544999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20273479|NCT00544999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20273480|NCT00544999|Immunologic Factors|immunologic factors|mesh-ancestor
20273481|NCT00544999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273482|NCT00544999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20273483|NCT00544999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20273484|NCT00544999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20273485|NCT00544999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958311|NCT01667926|Anesthetics|anesthetics|mesh-ancestor
19958312|NCT01667926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19958313|NCT01667926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19958314|NCT01667926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19958315|NCT01667926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20273486|NCT00545012|Levetiracetam|levetiracetam|mesh-list
20273487|NCT00545012|Anticonvulsants|anticonvulsants|mesh-ancestor
20273488|NCT00545012|Nootropic Agents|nootropic agents|mesh-ancestor
20287630|NCT04029116|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20287631|NCT04029116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20287632|NCT04029116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287633|NCT04029116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287634|NCT04029116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20287635|NCT04029116|Hormone Antagonists|hormone antagonists|mesh-ancestor
20287636|NCT04029116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20287637|NCT04029116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287638|NCT04029116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20287639|NCT04029116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20287640|NCT04020185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
20287641|NCT04020185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287642|NCT04020185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287643|NCT04019964|Nivolumab|nivolumab|mesh-list
20287644|NCT04019964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20287645|NCT04019964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287646|NCT04019964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20287647|NCT04019964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958316|NCT01667926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958317|NCT01667978|Ritonavir|ritonavir|mesh-list
19958318|NCT01667978|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19958319|NCT01667978|Norethindrone|norethindrone|mesh-list
19958320|NCT01667978|Norethindrone Acetate|norethindrone acetate|mesh-list
19958321|NCT01667978|Protease Inhibitors|protease inhibitors|mesh-list
19958322|NCT01667978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19958323|NCT01667978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19958324|NCT01667978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958325|NCT01667978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958326|NCT01667978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19958327|NCT01667978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19958328|NCT01667978|Antiviral Agents|antiviral agents|mesh-ancestor
19958329|NCT01667978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19958330|NCT01667978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19958331|NCT01667978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19958332|NCT01667978|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19958333|NCT01667978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19958334|NCT01667978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19958335|NCT01667978|Contraceptive Agents|contraceptive agents|mesh-ancestor
19958336|NCT01667978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19958337|NCT01667978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273489|NCT00545090|Ibandronic Acid|ibandronic acid|mesh-list
20273490|NCT00545090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20273491|NCT00545090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273492|NCT00545129|Tanezumab|tanezumab|mesh-list
20273493|NCT00545129|Analgesics|analgesics|mesh-ancestor
20273494|NCT00545129|Sensory System Agents|sensory system agents|mesh-ancestor
20273495|NCT00545129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20273496|NCT00545129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273497|NCT00545142|Valproic Acid|valproic acid|mesh-list
20273498|NCT00545142|Aripiprazole|aripiprazole|mesh-list
20273499|NCT00545142|Antidepressive Agents|antidepressive agents|mesh-ancestor
20273500|NCT00545142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20273501|NCT00545142|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20273502|NCT00545142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20273503|NCT00545142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20273504|NCT00545142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273505|NCT00545142|Dopamine Agonists|dopamine agonists|mesh-ancestor
20273506|NCT00545142|Dopamine Agents|dopamine agents|mesh-ancestor
20273507|NCT00545142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20273508|NCT00545142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273509|NCT00545142|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20273510|NCT00545142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20273511|NCT00545142|Serotonin Agents|serotonin agents|mesh-ancestor
20273512|NCT00545142|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20273513|NCT00545142|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20273514|NCT00545142|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20273515|NCT00545142|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20273516|NCT00545142|Anticonvulsants|anticonvulsants|mesh-ancestor
20273517|NCT00545142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273518|NCT00545142|GABA Agents|gaba agents|mesh-ancestor
20273519|NCT00545142|Antimanic Agents|antimanic agents|mesh-ancestor
20273520|NCT00545194|Dinoprostone|dinoprostone|mesh-list
20273521|NCT00545194|Oxytocics|oxytocics|mesh-ancestor
20273522|NCT00545194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20273523|NCT00545194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273524|NCT00545207|Ibandronic Acid|ibandronic acid|mesh-list
20273525|NCT00545207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20273526|NCT00545207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273527|NCT00545246|Docetaxel|docetaxel|mesh-list
20273528|NCT00545246|Aflibercept|aflibercept|mesh-list
20273529|NCT00545246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273530|NCT00545246|Tubulin Modulators|tubulin modulators|mesh-ancestor
20544578|NCT01875224|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20544579|NCT01875224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958338|NCT01667978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19958339|NCT01667978|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19958340|NCT01668004|Golimumab|golimumab|mesh-list
19958341|NCT01668004|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19958342|NCT01668004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19958343|NCT01668004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20273531|NCT00545246|Antimitotic Agents|antimitotic agents|mesh-ancestor
20273532|NCT00545246|Mitosis Modulators|mitosis modulators|mesh-ancestor
20287648|NCT04019015|Thrombin|thrombin|mesh-list
20287649|NCT04019015|Hemostatics|hemostatics|mesh-ancestor
20287650|NCT04019015|Coagulants|coagulants|mesh-ancestor
20287651|NCT03980769|Vidarabine|vidarabine|mesh-list
20287652|NCT03980769|Fludarabine|fludarabine|mesh-list
20287653|NCT03980769|Fludarabine phosphate|fludarabine phosphate|mesh-list
20287654|NCT03980769|Thiotepa|thiotepa|mesh-list
20287655|NCT03980769|Treosulfan|treosulfan|mesh-list
20287656|NCT03980769|Busulfan|busulfan|mesh-list
20287657|NCT03980769|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20287658|NCT03980769|Thymoglobulin|thymoglobulin|mesh-list
19958344|NCT01668004|Immunologic Factors|immunologic factors|mesh-ancestor
19958345|NCT01668004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958346|NCT01668017|Niacinamide|niacinamide|mesh-list
19958347|NCT01668017|Vitamin B Complex|vitamin b complex|mesh-ancestor
19958348|NCT01668017|Vitamins|vitamins|mesh-ancestor
19958349|NCT01668017|Micronutrients|micronutrients|mesh-ancestor
19958350|NCT01668017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958351|NCT01668030|Bacitracin|bacitracin|mesh-list
19958352|NCT01668030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19958353|NCT01668030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19958354|NCT01668030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19958355|NCT01668654|Ezogabine|ezogabine|mesh-list
19958356|NCT01668654|Anticonvulsants|anticonvulsants|mesh-ancestor
19958357|NCT01668654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19958358|NCT01668654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958359|NCT01668667|Gabapentin|gabapentin|mesh-list
19958360|NCT01668667|Analgesics|analgesics|mesh-ancestor
19958361|NCT01668667|Sensory System Agents|sensory system agents|mesh-ancestor
19958362|NCT01668667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19958363|NCT01668667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958364|NCT01668667|Anticonvulsants|anticonvulsants|mesh-ancestor
19958365|NCT01668667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19958366|NCT01668667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19958367|NCT01668667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19958368|NCT01668667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19958369|NCT01668667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19958370|NCT01668667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19958371|NCT01668667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19958372|NCT01668667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958373|NCT01668667|Antimanic Agents|antimanic agents|mesh-ancestor
20273533|NCT00545246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273534|NCT00545246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20273535|NCT00545246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20273536|NCT00545246|Growth Substances|growth substances|mesh-ancestor
20273537|NCT00545246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273538|NCT00545246|Growth Inhibitors|growth inhibitors|mesh-ancestor
20273539|NCT00545311|Glycopyrrolate|glycopyrrolate|mesh-list
20544580|NCT01875224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544581|NCT01875224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20544582|NCT01875224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544583|NCT01875224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20544584|NCT01875263|Levofloxacin|levofloxacin|mesh-list
20544585|NCT01875263|Ofloxacin|ofloxacin|mesh-list
20544586|NCT01875263|Cloxacillin|cloxacillin|mesh-list
20544587|NCT01875263|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20544588|NCT01875263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20544589|NCT01875263|Renal Agents|renal agents|mesh-ancestor
20544590|NCT01875263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20544591|NCT01875263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20544592|NCT01875263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20544593|NCT01875263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544594|NCT01875263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544595|NCT01875263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544596|NCT01875263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20544597|NCT01875263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19958374|NCT01668797|Brexpiprazole|brexpiprazole|mesh-list
19958375|NCT01668797|Serotonin Agents|serotonin agents|mesh-ancestor
19958376|NCT01668797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19958377|NCT01668797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544598|NCT01875653|Molgramostim|molgramostim|mesh-list
20544599|NCT01875653|Sargramostim|sargramostim|mesh-list
20544600|NCT01875653|Immunologic Factors|immunologic factors|mesh-ancestor
20544601|NCT01875653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544602|NCT01875653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544603|NCT01875666|Trastuzumab|trastuzumab|mesh-list
20273540|NCT00545311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20273541|NCT00545311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20273542|NCT00545311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20273543|NCT00545311|Cholinergic Agents|cholinergic agents|mesh-ancestor
20273544|NCT00545311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19958378|NCT01668797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958379|NCT01668797|Dopamine Agonists|dopamine agonists|mesh-ancestor
19958380|NCT01668797|Dopamine Agents|dopamine agents|mesh-ancestor
19958381|NCT01668836|Resveratrol|resveratrol|mesh-list
20273545|NCT00545311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273546|NCT00545311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273547|NCT00545389|Mesalamine|mesalamine|mesh-list
20273548|NCT00545389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19958382|NCT01668836|Antioxidants|antioxidants|mesh-ancestor
19958383|NCT01668836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958384|NCT01668836|Protective Agents|protective agents|mesh-ancestor
19958385|NCT01668836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958386|NCT01668836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958387|NCT01668836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19958388|NCT01669122|Nicotine|nicotine|mesh-list
19958389|NCT01669122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19958390|NCT01669122|Autonomic Agents|autonomic agents|mesh-ancestor
19958391|NCT01669122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19958392|NCT01669122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958393|NCT01669122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19958394|NCT01669122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19958395|NCT01669122|Cholinergic Agents|cholinergic agents|mesh-ancestor
19958396|NCT01669122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19958397|NCT01669122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273549|NCT00545389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20273550|NCT00545389|Analgesics|analgesics|mesh-ancestor
20273551|NCT00545389|Sensory System Agents|sensory system agents|mesh-ancestor
20273552|NCT00545389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20273553|NCT00545389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273554|NCT00545389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20273555|NCT00545389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20273556|NCT00545467|Aripiprazole|aripiprazole|mesh-list
20273557|NCT00545467|Antidepressive Agents|antidepressive agents|mesh-ancestor
20273558|NCT00545467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20273559|NCT00545467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20273560|NCT00545467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20273561|NCT00545467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20273562|NCT00545467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273563|NCT00545467|Dopamine Agonists|dopamine agonists|mesh-ancestor
20273564|NCT00545467|Dopamine Agents|dopamine agents|mesh-ancestor
20273565|NCT00545467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20273566|NCT00545467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273567|NCT00545467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20273568|NCT00545467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20273569|NCT00545467|Serotonin Agents|serotonin agents|mesh-ancestor
20273570|NCT00545467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20273571|NCT00545467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20273572|NCT00545467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19958398|NCT01669343|Letrozole|letrozole|mesh-list
19958399|NCT01669343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958400|NCT01669343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19958401|NCT01669343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19958402|NCT01669343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958403|NCT01669343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958404|NCT01669343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19958405|NCT01669343|Hormone Antagonists|hormone antagonists|mesh-ancestor
19958406|NCT01669343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20273573|NCT00545467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20273574|NCT00545480|Ibandronic Acid|ibandronic acid|mesh-list
20273575|NCT00545480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20273576|NCT00545480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273577|NCT00545493|Tacrolimus|tacrolimus|mesh-list
20273578|NCT00545493|Immunoglobulins|immunoglobulins|mesh-list
20273579|NCT00545493|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20273580|NCT00545493|Antibodies|antibodies|mesh-list
20273581|NCT00545493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20273582|NCT00545493|Immunologic Factors|immunologic factors|mesh-ancestor
20273583|NCT00545493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273584|NCT00545493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20273585|NCT00545493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273586|NCT00545493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273587|NCT00545519|Thymoglobulin|thymoglobulin|mesh-list
20273588|NCT00545519|Immunologic Factors|immunologic factors|mesh-ancestor
20273589|NCT00545519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273590|NCT00545519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20273591|NCT00545558|Tenofovir|tenofovir|mesh-list
20273592|NCT00545558|Emtricitabine|emtricitabine|mesh-list
20273593|NCT00545558|Efavirenz|efavirenz|mesh-list
20273594|NCT00545558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19958407|NCT01669343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958408|NCT01669421|Protease Inhibitors|protease inhibitors|mesh-list
19958409|NCT01669421|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
20273595|NCT00545558|Antiviral Agents|antiviral agents|mesh-ancestor
20273596|NCT00545558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20273597|NCT00545558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20273598|NCT00545558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20273599|NCT00545558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273600|NCT00545558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273601|NCT00545558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20273602|NCT00545558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20273603|NCT00545558|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20273604|NCT00545558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20273605|NCT00545558|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20273606|NCT00545558|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20273607|NCT00545558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20273608|NCT00545558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20273609|NCT00545675|Valproic Acid|valproic acid|mesh-list
20273610|NCT00545675|Aripiprazole|aripiprazole|mesh-list
20273611|NCT00545675|Antidepressive Agents|antidepressive agents|mesh-ancestor
20273612|NCT00545675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20273613|NCT00545675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20273614|NCT00545675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19450313|NCT03429439|Antiviral Agents|antiviral agents|mesh-list
19450314|NCT03429439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19450315|NCT03429400|Morphine|morphine|mesh-list
19450316|NCT03429400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19958410|NCT01669421|Protein C Inhibitor|protein c inhibitor|mesh-list
20273615|NCT00545675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20544604|NCT01875666|Pertuzumab|pertuzumab|mesh-list
20544605|NCT01875666|Lapatinib|lapatinib|mesh-list
20544606|NCT01875666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20544607|NCT01875666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544608|NCT01875666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20544609|NCT01875666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544610|NCT01875666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554220|NCT01934088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20554221|NCT01934088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554222|NCT01934127|Vaccines|vaccines|mesh-list
20554223|NCT01934127|Immunologic Factors|immunologic factors|mesh-ancestor
20554224|NCT01934127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554225|NCT01934166|Nalmefene|nalmefene|mesh-list
20554226|NCT01934166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20554227|NCT01934166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554228|NCT01934166|Sensory System Agents|sensory system agents|mesh-ancestor
20554229|NCT01934166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554230|NCT01934361|Carboplatin|carboplatin|mesh-list
20554231|NCT01934361|Lomustine|lomustine|mesh-list
20554232|NCT01934361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554233|NCT01934361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20554234|NCT01934361|Alkylating Agents|alkylating agents|mesh-ancestor
20554235|NCT01934361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555042|NCT01938417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20555043|NCT01938443|Trametinib|trametinib|mesh-list
20555044|NCT01938443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555045|NCT01938443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20555046|NCT01938443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555047|NCT01938443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555048|NCT01938456|Docetaxel|docetaxel|mesh-list
20555049|NCT01938456|Trametinib|trametinib|mesh-list
20555050|NCT01938456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450317|NCT03429400|Narcotics|narcotics|mesh-ancestor
19958411|NCT01669421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974758|NCT01841606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20555051|NCT01938456|Tubulin Modulators|tubulin modulators|mesh-ancestor
20273616|NCT00545675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273617|NCT00545675|Dopamine Agonists|dopamine agonists|mesh-ancestor
20273618|NCT00545675|Dopamine Agents|dopamine agents|mesh-ancestor
20273619|NCT00545675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20273620|NCT00545675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273621|NCT00545675|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20273622|NCT00545675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19958412|NCT01669421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958413|NCT01669421|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19958414|NCT01669421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19958415|NCT01669434|Ramipril|ramipril|mesh-list
19958416|NCT01669434|Enalapril|enalapril|mesh-list
19958417|NCT01669434|Enalaprilat|enalaprilat|mesh-list
19958418|NCT01669434|Lisinopril|lisinopril|mesh-list
19958419|NCT01669434|Perindopril|perindopril|mesh-list
19958420|NCT01669434|Benazepril|benazepril|mesh-list
19958421|NCT01669434|Captopril|captopril|mesh-list
19958422|NCT01669434|Quinapril|quinapril|mesh-list
19958423|NCT01669434|Trandolapril|trandolapril|mesh-list
19958424|NCT01669434|Fosinopril|fosinopril|mesh-list
19958425|NCT01669434|Moexipril|moexipril|mesh-list
19958426|NCT01669434|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19958427|NCT01669434|Protease Inhibitors|protease inhibitors|mesh-ancestor
19958428|NCT01669434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958429|NCT01669434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958430|NCT01669434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19958431|NCT01669434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19958432|NCT01669434|Protective Agents|protective agents|mesh-ancestor
19958433|NCT01669434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958434|NCT01669538|Galantamine|galantamine|mesh-list
19958435|NCT01669538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19958436|NCT01669538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958437|NCT01669538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958438|NCT01669538|Cholinergic Agents|cholinergic agents|mesh-ancestor
19958439|NCT01669538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19958440|NCT01669538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958441|NCT01669538|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19958442|NCT01669538|Autonomic Agents|autonomic agents|mesh-ancestor
19958443|NCT01669538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19958444|NCT01669538|Nootropic Agents|nootropic agents|mesh-ancestor
19958445|NCT01669642|Ketamine|ketamine|mesh-list
19958446|NCT01669642|Analgesics|analgesics|mesh-ancestor
19958447|NCT01669642|Sensory System Agents|sensory system agents|mesh-ancestor
20273623|NCT00545675|Serotonin Agents|serotonin agents|mesh-ancestor
20273624|NCT00545675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20273625|NCT00545675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20273626|NCT00545675|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20273627|NCT00545675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20273628|NCT00545675|Anticonvulsants|anticonvulsants|mesh-ancestor
20273629|NCT00545675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273630|NCT00545675|GABA Agents|gaba agents|mesh-ancestor
20273631|NCT00545675|Antimanic Agents|antimanic agents|mesh-ancestor
20273632|NCT00545831|Taurolidine|taurolidine|mesh-list
20273633|NCT00545831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20273634|NCT00545831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20273635|NCT00545831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273636|NCT00545857|Pioglitazone|pioglitazone|mesh-list
20273637|NCT00545857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20273638|NCT00545857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273639|NCT00545870|Bevacizumab|bevacizumab|mesh-list
20273640|NCT00545870|Ranibizumab|ranibizumab|mesh-list
20273641|NCT00545870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20273642|NCT00545870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273643|NCT00545870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20273644|NCT00545870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20273645|NCT00545870|Growth Substances|growth substances|mesh-ancestor
20273646|NCT00545870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273647|NCT00545870|Growth Inhibitors|growth inhibitors|mesh-ancestor
20273648|NCT00545909|Ibandronic Acid|ibandronic acid|mesh-list
20273649|NCT00545909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20273650|NCT00545909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273651|NCT00545935|Artesunate|artesunate|mesh-list
20273652|NCT00545935|Amodiaquine|amodiaquine|mesh-list
20544611|NCT01875705|Ravoxertinib|ravoxertinib|mesh-list
19958448|NCT01669642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19958449|NCT01669642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958450|NCT01669642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20273653|NCT00545935|Antimalarials|antimalarials|mesh-ancestor
20273654|NCT00545935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20273655|NCT00545935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20273656|NCT00545935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20273657|NCT00545935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273658|NCT00545935|Antiviral Agents|antiviral agents|mesh-ancestor
19958451|NCT01669642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19958452|NCT01669642|Anesthetics, General|anesthetics, general|mesh-ancestor
19958453|NCT01669642|Anesthetics|anesthetics|mesh-ancestor
19958454|NCT01669642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19958455|NCT01669642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19958456|NCT01669642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19958457|NCT01669642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19958458|NCT01669642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958459|NCT01669720|Aflibercept|aflibercept|mesh-list
20273659|NCT00545935|Schistosomicides|schistosomicides|mesh-ancestor
20273660|NCT00545935|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20273661|NCT00545935|Anthelmintics|anthelmintics|mesh-ancestor
20273662|NCT00545961|Amoxicillin|amoxicillin|mesh-list
20273663|NCT00545961|Clavulanic Acid|clavulanic acid|mesh-list
20273664|NCT00545961|Clavulanic Acids|clavulanic acids|mesh-list
20273665|NCT00545961|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20273666|NCT00545961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20273667|NCT00545961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20273668|NCT00545961|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19958460|NCT01669720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19958461|NCT01669720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19958462|NCT01669720|Growth Substances|growth substances|mesh-ancestor
19958463|NCT01669720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958464|NCT01669720|Growth Inhibitors|growth inhibitors|mesh-ancestor
19958465|NCT01669720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958466|NCT01669785|Listerine|listerine|mesh-list
19958467|NCT01669785|Fluorides|fluorides|mesh-list
19958468|NCT01669785|Sodium Fluoride|sodium fluoride|mesh-list
19958469|NCT01669785|Cariostatic Agents|cariostatic agents|mesh-ancestor
19958470|NCT01669785|Protective Agents|protective agents|mesh-ancestor
19958471|NCT01669785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958472|NCT01669785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19958473|NCT01669785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20273669|NCT00545961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273670|NCT00545961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273671|NCT00546039|Genistein|genistein|mesh-list
20273672|NCT00546039|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20273673|NCT00546039|Protective Agents|protective agents|mesh-ancestor
19958474|NCT01669798|Nintedanib|nintedanib|mesh-list
19958475|NCT01669798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958476|NCT01669798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19958477|NCT01669798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958478|NCT01669798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958479|NCT01669811|Esomeprazole|esomeprazole|mesh-list
19958480|NCT01669811|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19958481|NCT01669811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19958482|NCT01669811|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19958483|NCT01669811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958484|NCT01669811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273674|NCT00546039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273675|NCT00546039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273676|NCT00546039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19958485|NCT01669928|Antihypertensive Agents|antihypertensive agents|mesh-list
20273677|NCT00546039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273678|NCT00546039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273679|NCT00546039|Phytoestrogens|phytoestrogens|mesh-ancestor
20273680|NCT00546039|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20273681|NCT00546039|Estrogens|estrogens|mesh-ancestor
20273682|NCT00546039|Hormones|hormones|mesh-ancestor
20273683|NCT00546039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20273684|NCT00546065|Esomeprazole|esomeprazole|mesh-list
20273685|NCT00546065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20273686|NCT00546065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20273687|NCT00546065|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20273688|NCT00546065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273689|NCT00546065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273690|NCT00546130|polysaccharide-K|polysaccharide-k|mesh-list
20273691|NCT00546130|Cisplatin|cisplatin|mesh-list
19958486|NCT01669928|Calcium Channel Blockers|calcium channel blockers|mesh-list
20273692|NCT00546130|Irinotecan|irinotecan|mesh-list
20273693|NCT00546130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273694|NCT00546130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20273695|NCT00546130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20273696|NCT00546130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544612|NCT01875705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544613|NCT01875705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20544614|NCT01875705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544615|NCT01875705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544616|NCT01875757|Vitamin D|vitamin d|mesh-list
20544617|NCT01875757|Cholecalciferol|cholecalciferol|mesh-list
19958487|NCT01669928|Angiotensin II|angiotensin ii|mesh-list
19958488|NCT01669928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19958489|NCT01669928|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19958490|NCT01669928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19958491|NCT01669928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958492|NCT01669928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958493|NCT01669928|Protease Inhibitors|protease inhibitors|mesh-ancestor
19958494|NCT01669928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958495|NCT01669928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19958496|NCT01669928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19958497|NCT01670019|Asenapine|asenapine|mesh-list
19958498|NCT01670019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19958499|NCT01670019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19958500|NCT01670019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19958501|NCT01670019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958502|NCT01670019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20273697|NCT00546130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273698|NCT00546130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20544618|NCT01875757|Vitamins|vitamins|mesh-ancestor
20544619|NCT01875757|Micronutrients|micronutrients|mesh-ancestor
20544620|NCT01875757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544621|NCT01875757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20544622|NCT01875757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20544623|NCT01875822|Curcumin|curcumin|mesh-list
20544624|NCT01875822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20273699|NCT00546130|Immunologic Factors|immunologic factors|mesh-ancestor
20273700|NCT00546130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273701|NCT00546130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20273702|NCT00546130|Antiviral Agents|antiviral agents|mesh-ancestor
20273703|NCT00546130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20273704|NCT00546130|Interferon Inducers|interferon inducers|mesh-ancestor
20273705|NCT00546130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20273706|NCT00546130|Protective Agents|protective agents|mesh-ancestor
20273707|NCT00546143|Omalizumab|omalizumab|mesh-list
20273708|NCT00546143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20273709|NCT00546143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20273710|NCT00546143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20273711|NCT00546143|Respiratory System Agents|respiratory system agents|mesh-ancestor
20273712|NCT00546143|Immunologic Factors|immunologic factors|mesh-ancestor
20273713|NCT00546143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273714|NCT00546169|Thrombin|thrombin|mesh-list
20273715|NCT00546169|Hemostatics|hemostatics|mesh-ancestor
20273716|NCT00546169|Coagulants|coagulants|mesh-ancestor
20273717|NCT00546234|Tiotropium Bromide|tiotropium bromide|mesh-list
20273718|NCT00546234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20273719|NCT00546234|Autonomic Agents|autonomic agents|mesh-ancestor
20273720|NCT00546234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20273721|NCT00546234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544625|NCT01875822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20544626|NCT01875822|Analgesics|analgesics|mesh-ancestor
20544627|NCT01875822|Sensory System Agents|sensory system agents|mesh-ancestor
20273722|NCT00546234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20544628|NCT01875822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20544629|NCT01875822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544630|NCT01875822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20544631|NCT01875822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20544632|NCT01875822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544633|NCT01875822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544634|NCT01875822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544635|NCT01875926|Gontivimab|gontivimab|mesh-list
20544636|NCT01875926|Antiviral Agents|antiviral agents|mesh-ancestor
20544637|NCT01875926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20544638|NCT01875952|Isoniazid|isoniazid|mesh-list
20544639|NCT01875952|Antitubercular Agents|antitubercular agents|mesh-ancestor
20544640|NCT01875952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20273723|NCT00546234|Respiratory System Agents|respiratory system agents|mesh-ancestor
20273724|NCT00546234|Parasympatholytics|parasympatholytics|mesh-ancestor
20273725|NCT00546234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20273726|NCT00546234|Cholinergic Agents|cholinergic agents|mesh-ancestor
20273727|NCT00546234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20273728|NCT00546234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273729|NCT00546286|Timolol|timolol|mesh-list
20273730|NCT00546286|Dorzolamide|dorzolamide|mesh-list
20273731|NCT00546286|Maleic acid|maleic acid|mesh-list
20273732|NCT00546286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20273733|NCT00546286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20273734|NCT00546286|Adrenergic Agents|adrenergic agents|mesh-ancestor
20273735|NCT00546286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20273736|NCT00546286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273737|NCT00546286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273738|NCT00546286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20273739|NCT00546286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20273740|NCT00546286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273741|NCT00546286|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20273742|NCT00546325|Rimonabant|rimonabant|mesh-list
20273743|NCT00546325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20273744|NCT00546325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20273745|NCT00546325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20273746|NCT00546325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20273747|NCT00546325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273748|NCT00546325|Hormones|hormones|mesh-ancestor
20273749|NCT00546325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20273750|NCT00546325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273751|NCT00546403|Modafinil|modafinil|mesh-list
20273752|NCT00546403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19958503|NCT01670097|Dexamethasone|dexamethasone|mesh-list
19958504|NCT01670097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19958505|NCT01670097|Antiemetics|antiemetics|mesh-ancestor
19958506|NCT01670097|Autonomic Agents|autonomic agents|mesh-ancestor
19958507|NCT01670097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19958508|NCT01670097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958509|NCT01670097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19958510|NCT01670097|Glucocorticoids|glucocorticoids|mesh-ancestor
19958511|NCT01670097|Hormones|hormones|mesh-ancestor
19958512|NCT01670097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19958513|NCT01670097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19958514|NCT01670097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958515|NCT01670110|Pasireotide|pasireotide|mesh-list
19958516|NCT01670110|Hormones|hormones|mesh-ancestor
19958517|NCT01670110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19958518|NCT01670110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958519|NCT01670279|Brexpiprazole|brexpiprazole|mesh-list
19958520|NCT01670279|Serotonin Agents|serotonin agents|mesh-ancestor
19958521|NCT01670279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19958522|NCT01670279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958523|NCT01670279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958524|NCT01670279|Dopamine Agonists|dopamine agonists|mesh-ancestor
19958525|NCT01670279|Dopamine Agents|dopamine agents|mesh-ancestor
19958526|NCT01670526|Rivastigmine|rivastigmine|mesh-list
19958527|NCT01670526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
19958528|NCT01670526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958529|NCT01670526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958530|NCT01670526|Cholinergic Agents|cholinergic agents|mesh-ancestor
19958531|NCT01670526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19958532|NCT01670526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958533|NCT01670526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19958534|NCT01670526|Protective Agents|protective agents|mesh-ancestor
19958535|NCT01670721|Leucovorin|leucovorin|mesh-list
19958536|NCT01670721|Fluorouracil|fluorouracil|mesh-list
20273753|NCT00546403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273754|NCT00546403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20273755|NCT00546403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20273756|NCT00546403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20273757|NCT00546403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273758|NCT00546442|Metformin|metformin|mesh-list
20273759|NCT00546442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20544641|NCT01875952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19958537|NCT01670721|Irinotecan|irinotecan|mesh-list
20273760|NCT00546442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273761|NCT00546494|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20273762|NCT00546494|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20273763|NCT00546494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20273764|NCT00546494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20273765|NCT00546494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273766|NCT00546494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20273767|NCT00546494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273768|NCT00546494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20273769|NCT00546494|Antidepressive Agents|antidepressive agents|mesh-ancestor
20273770|NCT00546494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20273771|NCT00546507|Celecoxib|celecoxib|mesh-list
20273772|NCT00546507|Diclofenac|diclofenac|mesh-list
20273773|NCT00546507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20273774|NCT00546507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20273775|NCT00546507|Analgesics|analgesics|mesh-ancestor
20273776|NCT00546507|Sensory System Agents|sensory system agents|mesh-ancestor
20273777|NCT00546507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20273778|NCT00546507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273779|NCT00546507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20273780|NCT00546507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20273781|NCT00546507|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20273782|NCT00546507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20273783|NCT00546507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273784|NCT00546507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273785|NCT00546520|Ciclesonide|ciclesonide|mesh-list
20273786|NCT00546520|Glucocorticoids|glucocorticoids|mesh-ancestor
20273787|NCT00546520|Hormones|hormones|mesh-ancestor
20273788|NCT00546520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20273789|NCT00546520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273790|NCT00546520|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20273791|NCT00546533|Etanercept|etanercept|mesh-list
20273792|NCT00546533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20273793|NCT00546533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20273794|NCT00546533|Analgesics|analgesics|mesh-ancestor
20273795|NCT00546533|Sensory System Agents|sensory system agents|mesh-ancestor
20273796|NCT00546533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20273797|NCT00546533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273798|NCT00546533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20273799|NCT00546533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20273800|NCT00546533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20273801|NCT00546533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20273802|NCT00546533|Immunologic Factors|immunologic factors|mesh-ancestor
20273803|NCT00546546|Methotrexate|methotrexate|mesh-list
20273804|NCT00546546|Azathioprine|azathioprine|mesh-list
20273805|NCT00546546|Immunosuppressive Agents|immunosuppressive agents|mesh-list
20273806|NCT00546546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19958538|NCT01670721|Aflibercept|aflibercept|mesh-list
19958539|NCT01670721|Antimetabolites|antimetabolites|mesh-ancestor
19958540|NCT01670721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958541|NCT01670721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19958542|NCT01670721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958543|NCT01670721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19958544|NCT01670721|Immunologic Factors|immunologic factors|mesh-ancestor
19958545|NCT01670721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958546|NCT01670721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19958547|NCT01670721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19958548|NCT01670721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958549|NCT01670721|Antidotes|antidotes|mesh-ancestor
19958550|NCT01670721|Protective Agents|protective agents|mesh-ancestor
20273807|NCT00546546|Abortifacient Agents|abortifacient agents|mesh-ancestor
20273808|NCT00546546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20273809|NCT00546546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273810|NCT00546546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20273811|NCT00546546|Antimetabolites|antimetabolites|mesh-ancestor
20273812|NCT00546546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273813|NCT00546546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273814|NCT00546546|Dermatologic Agents|dermatologic agents|mesh-ancestor
20273815|NCT00546546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273816|NCT00546546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20273817|NCT00546546|Immunologic Factors|immunologic factors|mesh-ancestor
20273818|NCT00546546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19958551|NCT01670721|Vitamin B Complex|vitamin b complex|mesh-ancestor
19958552|NCT01670721|Vitamins|vitamins|mesh-ancestor
19958553|NCT01670721|Micronutrients|micronutrients|mesh-ancestor
19958554|NCT01670721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19958555|NCT01670721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19958556|NCT01670721|Growth Substances|growth substances|mesh-ancestor
19958557|NCT01670721|Growth Inhibitors|growth inhibitors|mesh-ancestor
19958558|NCT01671280|Azithromycin|azithromycin|mesh-list
19958559|NCT01671280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19958560|NCT01671280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19958561|NCT01671319|Cyclophosphamide|cyclophosphamide|mesh-list
19958562|NCT01671319|Docetaxel|docetaxel|mesh-list
19958563|NCT01671319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19958564|NCT01671319|Immunologic Factors|immunologic factors|mesh-ancestor
19958565|NCT01671319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273819|NCT00546546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20273820|NCT00546559|Simvastatin|simvastatin|mesh-list
20273821|NCT00546559|Pravastatin|pravastatin|mesh-list
20273822|NCT00546559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20273823|NCT00546559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20273824|NCT00546559|Antimetabolites|antimetabolites|mesh-ancestor
20273825|NCT00546559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273826|NCT00546559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20273827|NCT00546559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20273828|NCT00546559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273829|NCT00546650|Sumatriptan|sumatriptan|mesh-list
20273830|NCT00546650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20273831|NCT00546650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20273832|NCT00546650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20273833|NCT00546650|Serotonin Agents|serotonin agents|mesh-ancestor
20273834|NCT00546650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20273835|NCT00546650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273836|NCT00546650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273837|NCT00546676|Telithromycin|telithromycin|mesh-list
20273838|NCT00546676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20273839|NCT00546676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20273840|NCT00546741|Metformin|metformin|mesh-list
20273841|NCT00546741|Dapagliflozin|dapagliflozin|mesh-list
20273842|NCT00546741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20273843|NCT00546741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273844|NCT00546741|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20273845|NCT00546741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273846|NCT00546832|Celecoxib|celecoxib|mesh-list
20273847|NCT00546832|Diclofenac|diclofenac|mesh-list
20273848|NCT00546832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20273849|NCT00546832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20273850|NCT00546832|Analgesics|analgesics|mesh-ancestor
20273851|NCT00546832|Sensory System Agents|sensory system agents|mesh-ancestor
20544642|NCT01875952|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20544643|NCT01875952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20544644|NCT01875952|Antimetabolites|antimetabolites|mesh-ancestor
20544645|NCT01875952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544646|NCT01875952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20544647|NCT01876004|Methotrexate|methotrexate|mesh-list
20544648|NCT01876004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20544649|NCT01876004|Abortifacient Agents|abortifacient agents|mesh-ancestor
20544650|NCT01876004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20544651|NCT01876004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544652|NCT01876004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20544653|NCT01876004|Antimetabolites|antimetabolites|mesh-ancestor
20544654|NCT01876004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544655|NCT01876004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544656|NCT01876004|Dermatologic Agents|dermatologic agents|mesh-ancestor
20544657|NCT01876004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544658|NCT01876004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20544659|NCT01876004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20544660|NCT01876004|Immunologic Factors|immunologic factors|mesh-ancestor
19958566|NCT01671319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19958567|NCT01671319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19958568|NCT01671319|Alkylating Agents|alkylating agents|mesh-ancestor
19958569|NCT01671319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958570|NCT01671319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958571|NCT01671319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19958572|NCT01671319|Tubulin Modulators|tubulin modulators|mesh-ancestor
19958573|NCT01671319|Antimitotic Agents|antimitotic agents|mesh-ancestor
19958574|NCT01671319|Mitosis Modulators|mitosis modulators|mesh-ancestor
19958575|NCT01671332|Suramin|suramin|mesh-list
19958576|NCT01671332|Docetaxel|docetaxel|mesh-list
19958577|NCT01671332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958578|NCT01671332|Tubulin Modulators|tubulin modulators|mesh-ancestor
19958579|NCT01671332|Antimitotic Agents|antimitotic agents|mesh-ancestor
19958580|NCT01671332|Mitosis Modulators|mitosis modulators|mesh-ancestor
19958581|NCT01671332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958582|NCT01671332|Antinematodal Agents|antinematodal agents|mesh-ancestor
19958583|NCT01671332|Anthelmintics|anthelmintics|mesh-ancestor
19958584|NCT01671332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19958585|NCT01671332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19958586|NCT01671332|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19958587|NCT01671332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19958588|NCT01671423|Prednisone|prednisone|mesh-list
19958589|NCT01671423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19958590|NCT01671423|Glucocorticoids|glucocorticoids|mesh-ancestor
19958591|NCT01671423|Hormones|hormones|mesh-ancestor
19958592|NCT01671423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19958593|NCT01671423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958594|NCT01671423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19958595|NCT01671423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958596|NCT01671488|Mitomycins|mitomycins|mesh-list
19958597|NCT01671488|Mitomycin|mitomycin|mesh-list
19958598|NCT01671488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19958599|NCT01671488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958600|NCT01671488|Alkylating Agents|alkylating agents|mesh-ancestor
19958601|NCT01671488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958602|NCT01671488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19958603|NCT01671488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958604|NCT01672710|Niacin|niacin|mesh-list
19958605|NCT01672710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19958606|NCT01672710|Antimetabolites|antimetabolites|mesh-ancestor
19958607|NCT01672710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958608|NCT01672710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19958609|NCT01672710|Vasodilator Agents|vasodilator agents|mesh-ancestor
19958610|NCT01672710|Vitamin B Complex|vitamin b complex|mesh-ancestor
19958611|NCT01672710|Vitamins|vitamins|mesh-ancestor
19958612|NCT01672710|Micronutrients|micronutrients|mesh-ancestor
19958613|NCT01672710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273852|NCT00546832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20273853|NCT00546832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273854|NCT00546832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20273855|NCT00546832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20273856|NCT00546832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20273857|NCT00546832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20273858|NCT00546832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273859|NCT00546832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273860|NCT00546923|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20273861|NCT00546923|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20273862|NCT00546923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20273863|NCT00546923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20273864|NCT00546923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273865|NCT00546923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20273866|NCT00546923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273867|NCT00546923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20273868|NCT00546923|Antidepressive Agents|antidepressive agents|mesh-ancestor
20273869|NCT00546923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20273870|NCT00546936|Ranibizumab|ranibizumab|mesh-list
20273871|NCT00546936|Verteporfin|verteporfin|mesh-list
20273872|NCT00546936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20273873|NCT00546936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20273874|NCT00546936|Growth Substances|growth substances|mesh-ancestor
20273875|NCT00546936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273876|NCT00546936|Growth Inhibitors|growth inhibitors|mesh-ancestor
20273877|NCT00546936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273878|NCT00546936|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20273879|NCT00546936|Dermatologic Agents|dermatologic agents|mesh-ancestor
20273880|NCT00547001|Estradiol|estradiol|mesh-list
19958614|NCT01672723|Naltrexone|naltrexone|mesh-list
19958615|NCT01672723|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19958616|NCT01672723|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19958617|NCT01672723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958618|NCT01672723|Sensory System Agents|sensory system agents|mesh-ancestor
20273881|NCT00547001|Estrogens|estrogens|mesh-ancestor
20273882|NCT00547001|Hormones|hormones|mesh-ancestor
20273883|NCT00547001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20273884|NCT00547001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273885|NCT00547053|Amiloride|amiloride|mesh-list
20273886|NCT00547053|Diuretics|diuretics|mesh-ancestor
20273887|NCT00547053|Natriuretic Agents|natriuretic agents|mesh-ancestor
20273888|NCT00547053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273889|NCT00547053|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20273890|NCT00547053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20273891|NCT00547053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20273892|NCT00547053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273893|NCT00547053|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20273894|NCT00547053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20273895|NCT00547092|Sildenafil Citrate|sildenafil citrate|mesh-list
20273896|NCT00547092|Tadalafil|tadalafil|mesh-list
19958619|NCT01672723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19958620|NCT01672736|Dexamethasone|dexamethasone|mesh-list
20273897|NCT00547092|Vasodilator Agents|vasodilator agents|mesh-ancestor
20273898|NCT00547092|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20273899|NCT00547092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20273900|NCT00547092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273901|NCT00547092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958621|NCT01672736|Dexamethasone acetate|dexamethasone acetate|mesh-list
19958622|NCT01672736|Bortezomib|bortezomib|mesh-list
19958623|NCT01672736|BB 1101|bb 1101|mesh-list
19958624|NCT01672736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19958625|NCT01672736|Antiemetics|antiemetics|mesh-ancestor
19958626|NCT01672736|Autonomic Agents|autonomic agents|mesh-ancestor
20273902|NCT00547092|Urological Agents|urological agents|mesh-ancestor
20273903|NCT00547131|Temozolomide|temozolomide|mesh-list
20273904|NCT00547131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20273905|NCT00547131|Alkylating Agents|alkylating agents|mesh-ancestor
20273906|NCT00547131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273907|NCT00547131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273908|NCT00547144|Gemcitabine|gemcitabine|mesh-list
20273909|NCT00547144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20273910|NCT00547144|Antimetabolites|antimetabolites|mesh-ancestor
20273911|NCT00547144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273912|NCT00547144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273913|NCT00547144|Antiviral Agents|antiviral agents|mesh-ancestor
20273914|NCT00547144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20273915|NCT00547144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273916|NCT00547144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20273917|NCT00547144|Immunologic Factors|immunologic factors|mesh-ancestor
20273918|NCT00547144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273919|NCT00547170|Doxycycline|doxycycline|mesh-list
20273920|NCT00547170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20273921|NCT00547170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20273922|NCT00547170|Antimalarials|antimalarials|mesh-ancestor
20273923|NCT00547170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20273924|NCT00547170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20273925|NCT00547183|Tadalafil|tadalafil|mesh-list
20273926|NCT00547183|Vasodilator Agents|vasodilator agents|mesh-ancestor
20273927|NCT00547183|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20273928|NCT00547183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20273929|NCT00547183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273930|NCT00547183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273931|NCT00547183|Urological Agents|urological agents|mesh-ancestor
20273932|NCT00547196|Cyclosporine|cyclosporine|mesh-list
20273933|NCT00547196|Mycophenolic Acid|mycophenolic acid|mesh-list
20273934|NCT00547196|Cyclophosphamide|cyclophosphamide|mesh-list
20273935|NCT00547196|Melphalan|melphalan|mesh-list
20273936|NCT00547196|Busulfan|busulfan|mesh-list
20273937|NCT00547196|Fludarabine|fludarabine|mesh-list
20273938|NCT00547196|Fludarabine phosphate|fludarabine phosphate|mesh-list
20273939|NCT00547196|Cyclosporins|cyclosporins|mesh-list
20273940|NCT00547196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20273941|NCT00547196|Immunologic Factors|immunologic factors|mesh-ancestor
19958627|NCT01672736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19958628|NCT01672736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958629|NCT01672736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19958630|NCT01672736|Glucocorticoids|glucocorticoids|mesh-ancestor
19958631|NCT01672736|Hormones|hormones|mesh-ancestor
19974759|NCT01841606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20273942|NCT00547196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273943|NCT00547196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20273944|NCT00547196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20273945|NCT00547196|Alkylating Agents|alkylating agents|mesh-ancestor
20273946|NCT00547196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273947|NCT00547196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273948|NCT00547196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20273949|NCT00547196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20273950|NCT00547196|Antimetabolites|antimetabolites|mesh-ancestor
20273951|NCT00547196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273952|NCT00547196|Antifungal Agents|antifungal agents|mesh-ancestor
20273953|NCT00547196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20273954|NCT00547196|Dermatologic Agents|dermatologic agents|mesh-ancestor
20273955|NCT00547196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20273956|NCT00547196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20273957|NCT00547196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20273958|NCT00547196|Antitubercular Agents|antitubercular agents|mesh-ancestor
20273959|NCT00547196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20273960|NCT00547209|Nitrous Oxide|nitrous oxide|mesh-list
20273961|NCT00547209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20273962|NCT00547209|Anesthetics, General|anesthetics, general|mesh-ancestor
20273963|NCT00547209|Anesthetics|anesthetics|mesh-ancestor
20273964|NCT00547209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20273965|NCT00547209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20273966|NCT00547209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20273967|NCT00547209|Analgesics|analgesics|mesh-ancestor
20273968|NCT00547209|Sensory System Agents|sensory system agents|mesh-ancestor
20273969|NCT00547209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287659|NCT03980769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287660|NCT03980769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20287661|NCT03980769|Antimetabolites|antimetabolites|mesh-ancestor
20287662|NCT03980769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287663|NCT03980769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20287664|NCT03980769|Immunologic Factors|immunologic factors|mesh-ancestor
19958632|NCT01672736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19958633|NCT01672736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19958634|NCT01672736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958635|NCT01672736|Protease Inhibitors|protease inhibitors|mesh-ancestor
19958636|NCT01672736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958637|NCT01672736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958638|NCT01672788|Metformin|metformin|mesh-list
19958639|NCT01672788|Empagliflozin|empagliflozin|mesh-list
19958640|NCT01672788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19958641|NCT01672788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958642|NCT01672788|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19958643|NCT01672788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958644|NCT01672801|Nimodipine|nimodipine|mesh-list
19958645|NCT01672801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19958646|NCT01672801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19958647|NCT01672801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19958648|NCT01672801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958649|NCT01672801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19958650|NCT01672801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958651|NCT01672801|Vasodilator Agents|vasodilator agents|mesh-ancestor
20287665|NCT03980769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287666|NCT03980769|Antiviral Agents|antiviral agents|mesh-ancestor
20287667|NCT03980769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20544661|NCT01876004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20544662|NCT01876004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20544663|NCT01876108|Amoxicillin|amoxicillin|mesh-list
20544664|NCT01876108|Azithromycin|azithromycin|mesh-list
20544665|NCT01876108|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
20544666|NCT01876108|Omeprazole|omeprazole|mesh-list
20544667|NCT01876108|Bismuth|bismuth|mesh-list
20544668|NCT01876108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20544669|NCT01876108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20544670|NCT01876108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20544671|NCT01876108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20544672|NCT01876108|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20544673|NCT01876108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544674|NCT01876108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544675|NCT01876108|Antacids|antacids|mesh-ancestor
20544676|NCT01876121|Celecoxib|celecoxib|mesh-list
20544677|NCT01876121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19958652|NCT01672827|Flutemetamol|flutemetamol|mesh-list
19958653|NCT01672827|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19958654|NCT01672827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958655|NCT01672957|Mycophenolic Acid|mycophenolic acid|mesh-list
19958656|NCT01672957|Immunosuppressive Agents|immunosuppressive agents|mesh-list
19958657|NCT01672957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19958658|NCT01672957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958659|NCT01672957|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20273970|NCT00547287|Sildenafil Citrate|sildenafil citrate|mesh-list
20273971|NCT00547287|Tadalafil|tadalafil|mesh-list
20273972|NCT00547287|Vasodilator Agents|vasodilator agents|mesh-ancestor
20273973|NCT00547287|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20273974|NCT00547287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20273975|NCT00547287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273976|NCT00547287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273977|NCT00547287|Urological Agents|urological agents|mesh-ancestor
20544678|NCT01876121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20544679|NCT01876121|Analgesics|analgesics|mesh-ancestor
20544680|NCT01876121|Sensory System Agents|sensory system agents|mesh-ancestor
20544681|NCT01876121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20544682|NCT01876121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544683|NCT01876121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20544684|NCT01876121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20544685|NCT01876121|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20544686|NCT01876121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20544687|NCT01876121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544688|NCT01876121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544689|NCT01876186|Solifenacin Succinate|solifenacin succinate|mesh-list
20544690|NCT01876186|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20544691|NCT01876186|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20544692|NCT01876186|Cholinergic Agents|cholinergic agents|mesh-ancestor
20544693|NCT01876186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20544694|NCT01876186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544695|NCT01876186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544696|NCT01876186|Urological Agents|urological agents|mesh-ancestor
20544697|NCT01876290|Dexamethasone|dexamethasone|mesh-list
20544698|NCT01876290|Ondansetron|ondansetron|mesh-list
20544699|NCT01876290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20544700|NCT01876290|Antiemetics|antiemetics|mesh-ancestor
20544701|NCT01876290|Autonomic Agents|autonomic agents|mesh-ancestor
20544702|NCT01876290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20544703|NCT01876290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544704|NCT01876290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20544705|NCT01876290|Glucocorticoids|glucocorticoids|mesh-ancestor
20544706|NCT01876290|Hormones|hormones|mesh-ancestor
20544707|NCT01876290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20544708|NCT01876290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20544709|NCT01876290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544710|NCT01876290|Antipruritics|antipruritics|mesh-ancestor
20544711|NCT01876290|Dermatologic Agents|dermatologic agents|mesh-ancestor
20544712|NCT01876290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20544713|NCT01876290|Serotonin Agents|serotonin agents|mesh-ancestor
20544714|NCT01876290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20544715|NCT01876290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544716|NCT01876290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20544717|NCT01876290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20544718|NCT01876290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20544719|NCT01876290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20544720|NCT01876290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20544721|NCT01876316|Moxifloxacin|moxifloxacin|mesh-list
20544722|NCT01876316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20544723|NCT01876316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19958660|NCT01672957|Antitubercular Agents|antitubercular agents|mesh-ancestor
19958661|NCT01672957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19958662|NCT01672957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19958663|NCT01672957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958664|NCT01672957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958665|NCT01672957|Immunologic Factors|immunologic factors|mesh-ancestor
19958666|NCT01672957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958667|NCT01672983|Ritonavir|ritonavir|mesh-list
19958668|NCT01672983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19958669|NCT01672983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19958670|NCT01672983|Protease Inhibitors|protease inhibitors|mesh-ancestor
20273978|NCT00547352|Sildenafil Citrate|sildenafil citrate|mesh-list
20273979|NCT00547352|Tadalafil|tadalafil|mesh-list
20273980|NCT00547352|Vasodilator Agents|vasodilator agents|mesh-ancestor
20273981|NCT00547352|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20273982|NCT00547352|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19958671|NCT01672983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958672|NCT01672983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958673|NCT01672983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19958674|NCT01672983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19958675|NCT01672983|Antiviral Agents|antiviral agents|mesh-ancestor
19958676|NCT01672983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19958677|NCT01672983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19958678|NCT01672983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19958679|NCT01673009|Imatinib Mesylate|imatinib mesylate|mesh-list
19958680|NCT01673009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958681|NCT01673009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19958682|NCT01673009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958683|NCT01673009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958684|NCT01673191|Dexamethasone|dexamethasone|mesh-list
19958685|NCT01673191|Prednisolone acetate|prednisolone acetate|mesh-list
19958686|NCT01673191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20273983|NCT00547352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273984|NCT00547352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273985|NCT00547352|Urological Agents|urological agents|mesh-ancestor
20273986|NCT00547417|Tadalafil|tadalafil|mesh-list
20273987|NCT00547417|Vasodilator Agents|vasodilator agents|mesh-ancestor
20273988|NCT00547417|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20273989|NCT00547417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20273990|NCT00547417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20273991|NCT00547417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20273992|NCT00547417|Urological Agents|urological agents|mesh-ancestor
19958687|NCT01673191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19958688|NCT01673191|Antiemetics|antiemetics|mesh-ancestor
19958689|NCT01673191|Autonomic Agents|autonomic agents|mesh-ancestor
19958690|NCT01673191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19958691|NCT01673191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958692|NCT01673191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19958693|NCT01673191|Glucocorticoids|glucocorticoids|mesh-ancestor
19958694|NCT01673191|Hormones|hormones|mesh-ancestor
19958695|NCT01673191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19958696|NCT01673191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19958697|NCT01673191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958698|NCT01673191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19958699|NCT01673282|Lacosamide|lacosamide|mesh-list
19958700|NCT01673282|Anticonvulsants|anticonvulsants|mesh-ancestor
19958701|NCT01673282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19958702|NCT01673282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19958703|NCT01673282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19958704|NCT01673282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974760|NCT01841606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19974761|NCT01841606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19974762|NCT01841606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19974763|NCT01841697|Metformin|metformin|mesh-list
19974764|NCT01841697|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19974765|NCT01841697|Glimepiride|glimepiride|mesh-list
19974766|NCT01841697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19974767|NCT01841697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974768|NCT01841697|Incretins|incretins|mesh-ancestor
19974769|NCT01841697|Hormones|hormones|mesh-ancestor
19974770|NCT01841697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19974771|NCT01841697|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19974772|NCT01841697|Protease Inhibitors|protease inhibitors|mesh-ancestor
19974773|NCT01841697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974774|NCT01841697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974775|NCT01841697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19974776|NCT01841697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19974777|NCT01841697|Immunologic Factors|immunologic factors|mesh-ancestor
19974778|NCT01841762|Macitentan|macitentan|mesh-list
19974779|NCT01841762|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19974780|NCT01841762|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19974781|NCT01841762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974782|NCT01841762|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19958705|NCT01673386|Sunitinib|sunitinib|mesh-list
19958706|NCT01673386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958707|NCT01673386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19958708|NCT01673386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19958709|NCT01673386|Growth Substances|growth substances|mesh-ancestor
19958710|NCT01673386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958711|NCT01673386|Growth Inhibitors|growth inhibitors|mesh-ancestor
19958712|NCT01673386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19958713|NCT01673386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958714|NCT01673386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958715|NCT01673490|Tamsulosin|tamsulosin|mesh-list
19958716|NCT01673490|Dutasteride|dutasteride|mesh-list
19958717|NCT01673490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19958718|NCT01673490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19958719|NCT01673490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19958720|NCT01673490|Adrenergic Agents|adrenergic agents|mesh-ancestor
19958721|NCT01673490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19958722|NCT01673490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958723|NCT01673490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958724|NCT01673490|Urological Agents|urological agents|mesh-ancestor
19958725|NCT01673490|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19958726|NCT01673490|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19958727|NCT01673490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958728|NCT01673490|Hormone Antagonists|hormone antagonists|mesh-ancestor
19958729|NCT01673490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19958730|NCT01673594|Naltrexone|naltrexone|mesh-list
19958731|NCT01673594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19958732|NCT01673594|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19958733|NCT01673594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958734|NCT01673594|Sensory System Agents|sensory system agents|mesh-ancestor
19958735|NCT01673594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19958736|NCT01673646|Pasireotide|pasireotide|mesh-list
19958737|NCT01673646|Hormones|hormones|mesh-ancestor
19958738|NCT01673646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20273993|NCT00547443|Paclitaxel|paclitaxel|mesh-list
20273994|NCT00547443|Carboplatin|carboplatin|mesh-list
20273995|NCT00547443|Sorafenib|sorafenib|mesh-list
20273996|NCT00547443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20273997|NCT00547443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20273998|NCT00547443|Tubulin Modulators|tubulin modulators|mesh-ancestor
20273999|NCT00547443|Antimitotic Agents|antimitotic agents|mesh-ancestor
20274000|NCT00547443|Mitosis Modulators|mitosis modulators|mesh-ancestor
20274001|NCT00547443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274002|NCT00547443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20274003|NCT00547443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274004|NCT00547495|Tadalafil|tadalafil|mesh-list
20274005|NCT00547495|Vasodilator Agents|vasodilator agents|mesh-ancestor
20274006|NCT00547495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20274007|NCT00547495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20274008|NCT00547495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274009|NCT00547495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274010|NCT00547495|Urological Agents|urological agents|mesh-ancestor
20274011|NCT00547508|Tadalafil|tadalafil|mesh-list
20274012|NCT00547508|Vasodilator Agents|vasodilator agents|mesh-ancestor
20274013|NCT00547508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20274014|NCT00547508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20274015|NCT00547508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274016|NCT00547508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274017|NCT00547508|Urological Agents|urological agents|mesh-ancestor
20274018|NCT00547547|Selenium|selenium|mesh-list
20274019|NCT00547547|Capecitabine|capecitabine|mesh-list
20274020|NCT00547547|Irinotecan|irinotecan|mesh-list
20544724|NCT01876316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20544725|NCT01876316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20544726|NCT01876316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544727|NCT01876316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544728|NCT01876316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544729|NCT01876355|Clonidine|clonidine|mesh-list
20544730|NCT01876355|Analgesics|analgesics|mesh-ancestor
20544731|NCT01876355|Sensory System Agents|sensory system agents|mesh-ancestor
20544732|NCT01876355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20544733|NCT01876355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544734|NCT01876355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20544735|NCT01876355|Sympatholytics|sympatholytics|mesh-ancestor
20544736|NCT01876355|Autonomic Agents|autonomic agents|mesh-ancestor
19958739|NCT01673646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958740|NCT01673828|Pregnanolone|pregnanolone|mesh-list
19958741|NCT01673828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20274021|NCT00547547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20274022|NCT00547547|Antimetabolites|antimetabolites|mesh-ancestor
20274023|NCT00547547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274024|NCT00547547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274025|NCT00547547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20274026|NCT00547547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20274027|NCT00547547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274028|NCT00547547|Antioxidants|antioxidants|mesh-ancestor
20274029|NCT00547547|Protective Agents|protective agents|mesh-ancestor
20274030|NCT00547547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274031|NCT00547547|Trace Elements|trace elements|mesh-ancestor
20274032|NCT00547547|Micronutrients|micronutrients|mesh-ancestor
20274033|NCT00547573|Tadalafil|tadalafil|mesh-list
20274034|NCT00547573|Vasodilator Agents|vasodilator agents|mesh-ancestor
20274035|NCT00547573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20274036|NCT00547573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20274037|NCT00547573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274038|NCT00547573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274039|NCT00547573|Urological Agents|urological agents|mesh-ancestor
20274040|NCT00547599|Tadalafil|tadalafil|mesh-list
20274041|NCT00547599|Vasodilator Agents|vasodilator agents|mesh-ancestor
20274042|NCT00547599|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20274043|NCT00547599|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20274044|NCT00547599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274045|NCT00547599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274046|NCT00547599|Urological Agents|urological agents|mesh-ancestor
20274047|NCT00547612|Substance P|substance p|mesh-list
20274048|NCT00547612|Neurokinin A|neurokinin a|mesh-list
20274049|NCT00547612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20274050|NCT00547612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274051|NCT00547612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274052|NCT00547625|Tadalafil|tadalafil|mesh-list
20274053|NCT00547625|Vasodilator Agents|vasodilator agents|mesh-ancestor
20274054|NCT00547625|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20274055|NCT00547625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20274056|NCT00547625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274057|NCT00547625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274058|NCT00547625|Urological Agents|urological agents|mesh-ancestor
20274059|NCT00547664|Morphine|morphine|mesh-list
20274060|NCT00547664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20274061|NCT00547664|Narcotics|narcotics|mesh-ancestor
20274062|NCT00547664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20274063|NCT00547664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274064|NCT00547664|Analgesics|analgesics|mesh-ancestor
20274065|NCT00547664|Sensory System Agents|sensory system agents|mesh-ancestor
20274066|NCT00547664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20274067|NCT00547768|Fexofenadine|fexofenadine|mesh-list
20274068|NCT00547768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20274069|NCT00547768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20274070|NCT00547768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20274071|NCT00547768|Histamine Antagonists|histamine antagonists|mesh-ancestor
20274072|NCT00547768|Histamine Agents|histamine agents|mesh-ancestor
20274073|NCT00547768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20274074|NCT00547768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274075|NCT00547768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274076|NCT00547885|Dihydrocodeine|dihydrocodeine|mesh-list
20274077|NCT00547885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20274078|NCT00547885|Narcotics|narcotics|mesh-ancestor
20274079|NCT00547885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19958742|NCT01673828|Anesthetics|anesthetics|mesh-ancestor
19958743|NCT01673828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19958744|NCT01673828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958745|NCT01673854|Ipilimumab|ipilimumab|mesh-list
19958746|NCT01673854|Vemurafenib|vemurafenib|mesh-list
19958747|NCT01673854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19958748|NCT01673854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958749|NCT01673854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20274080|NCT00547885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274081|NCT00547885|Analgesics|analgesics|mesh-ancestor
20274082|NCT00547885|Sensory System Agents|sensory system agents|mesh-ancestor
20274083|NCT00547885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20274084|NCT00547989|Bupivacaine|bupivacaine|mesh-list
20274085|NCT00547989|Ropivacaine|ropivacaine|mesh-list
20274086|NCT00547989|Anesthetics, Local|anesthetics, local|mesh-ancestor
20274087|NCT00547989|Anesthetics|anesthetics|mesh-ancestor
20274088|NCT00547989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20274089|NCT00547989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274090|NCT00547989|Sensory System Agents|sensory system agents|mesh-ancestor
20274091|NCT00547989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20274092|NCT00548002|Levofloxacin|levofloxacin|mesh-list
20274093|NCT00548002|Ofloxacin|ofloxacin|mesh-list
19958750|NCT01673854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274094|NCT00548002|Trovafloxacin|trovafloxacin|mesh-list
20274095|NCT00548002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20274096|NCT00548002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20274097|NCT00548002|Renal Agents|renal agents|mesh-ancestor
20274098|NCT00548002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20274099|NCT00548002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20274100|NCT00548002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20274101|NCT00548002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274102|NCT00548002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274103|NCT00548002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274104|NCT00548002|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20274105|NCT00548002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20544737|NCT01876355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20544738|NCT01876355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20544739|NCT01876355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19958751|NCT01673854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19958752|NCT01673854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958753|NCT01673984|Goserelin|goserelin|mesh-list
19958754|NCT01673984|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19958755|NCT01673984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19958756|NCT01673984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958757|NCT01673984|Luteolytic Agents|luteolytic agents|mesh-ancestor
19958758|NCT01673984|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19958759|NCT01673984|Contraceptive Agents|contraceptive agents|mesh-ancestor
19958760|NCT01673984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19958761|NCT01673984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958762|NCT01673984|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19958763|NCT01674010|Inositol|inositol|mesh-list
20544740|NCT01876355|Adrenergic Agents|adrenergic agents|mesh-ancestor
20544741|NCT01876355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20544742|NCT01876355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544743|NCT01876433|Mirabegron|mirabegron|mesh-list
20544744|NCT01876433|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20544745|NCT01876433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20544746|NCT01876433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20544747|NCT01876433|Adrenergic Agents|adrenergic agents|mesh-ancestor
20544748|NCT01876433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20544749|NCT01876433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544750|NCT01876433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544751|NCT01876433|Urological Agents|urological agents|mesh-ancestor
20544752|NCT01876550|Mupirocin|mupirocin|mesh-list
20544753|NCT01876550|Calcium|calcium|mesh-list
20544754|NCT01876550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20544755|NCT01876550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544756|NCT01876550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20544757|NCT01876550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20544758|NCT01876550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20544759|NCT01876550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544760|NCT01876550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544761|NCT01876563|Vitamin D|vitamin d|mesh-list
20544762|NCT01876563|Vitamins|vitamins|mesh-ancestor
20544763|NCT01876563|Micronutrients|micronutrients|mesh-ancestor
19958764|NCT01674010|Lamotrigine|lamotrigine|mesh-list
19958765|NCT01674010|Valproic Acid|valproic acid|mesh-list
20544764|NCT01876563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958766|NCT01674010|Anticonvulsants|anticonvulsants|mesh-ancestor
19958767|NCT01674010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19958768|NCT01674010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20274106|NCT00548067|Amlodipine|amlodipine|mesh-list
20274107|NCT00548067|Valsartan|valsartan|mesh-list
20274108|NCT00548067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20274109|NCT00548067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20274110|NCT00548067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20274111|NCT00548067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20274112|NCT00548067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274113|NCT00548067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20274114|NCT00548067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274115|NCT00548067|Vasodilator Agents|vasodilator agents|mesh-ancestor
20274116|NCT00548067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20274117|NCT00548067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20274118|NCT00548067|Diuretics|diuretics|mesh-ancestor
20274119|NCT00548067|Natriuretic Agents|natriuretic agents|mesh-ancestor
19958769|NCT01674010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958770|NCT01674010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19958771|NCT01674010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958772|NCT01674010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19958773|NCT01674010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19958774|NCT01674010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20274120|NCT00548067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20274121|NCT00548080|Caspofungin|caspofungin|mesh-list
20274122|NCT00548080|Antifungal Agents|antifungal agents|mesh-ancestor
20274123|NCT00548080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20274124|NCT00548080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274125|NCT00548080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274126|NCT00548288|Pamidronate|pamidronate|mesh-list
20274127|NCT00548288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20274128|NCT00548288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274129|NCT00548301|Cyclosporine|cyclosporine|mesh-list
20274130|NCT00548301|Cyclosporins|cyclosporins|mesh-list
20274131|NCT00548301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274132|NCT00548301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274133|NCT00548301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20274134|NCT00548301|Immunologic Factors|immunologic factors|mesh-ancestor
20544765|NCT01876563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20544766|NCT01876615|Diclofenac|diclofenac|mesh-list
20544767|NCT01876615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20544768|NCT01876615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20544769|NCT01876615|Analgesics|analgesics|mesh-ancestor
20544770|NCT01876615|Sensory System Agents|sensory system agents|mesh-ancestor
20544771|NCT01876615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20544772|NCT01876615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544773|NCT01876615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20544774|NCT01876615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20544775|NCT01876615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20544776|NCT01876615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544777|NCT01876615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544778|NCT01876628|Clindamycin|clindamycin|mesh-list
20544779|NCT01876628|Clindamycin palmitate|clindamycin palmitate|mesh-list
20544780|NCT01876628|Clindamycin phosphate|clindamycin phosphate|mesh-list
20544781|NCT01876628|Floxacillin|floxacillin|mesh-list
19958775|NCT01674010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19958776|NCT01674010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19958777|NCT01674010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958778|NCT01674010|GABA Agents|gaba agents|mesh-ancestor
19958779|NCT01674010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19958780|NCT01674010|Antimanic Agents|antimanic agents|mesh-ancestor
19958781|NCT01674010|Vitamin B Complex|vitamin b complex|mesh-ancestor
19958782|NCT01674010|Vitamins|vitamins|mesh-ancestor
19958783|NCT01674010|Micronutrients|micronutrients|mesh-ancestor
19958784|NCT01674062|Trastuzumab|trastuzumab|mesh-list
19958785|NCT01674062|Pertuzumab|pertuzumab|mesh-list
19958786|NCT01674062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19958787|NCT01674062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958788|NCT01674569|Ranibizumab|ranibizumab|mesh-list
19958789|NCT01674569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19958790|NCT01674569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19958791|NCT01674569|Growth Substances|growth substances|mesh-ancestor
19958792|NCT01674569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958793|NCT01674569|Growth Inhibitors|growth inhibitors|mesh-ancestor
19958794|NCT01674569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958795|NCT01674621|Abaloparatide|abaloparatide|mesh-list
19958796|NCT01674621|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
20544782|NCT01876628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20274135|NCT00548301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274136|NCT00548301|Antifungal Agents|antifungal agents|mesh-ancestor
20274137|NCT00548301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20274138|NCT00548301|Dermatologic Agents|dermatologic agents|mesh-ancestor
20274139|NCT00548301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20274140|NCT00548301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20274141|NCT00548379|Vitamin D|vitamin d|mesh-list
20274142|NCT00548379|Vitamins|vitamins|mesh-ancestor
20274143|NCT00548379|Micronutrients|micronutrients|mesh-ancestor
20274144|NCT00548379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274145|NCT00548379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20274146|NCT00548483|Dexamethasone|dexamethasone|mesh-list
20274147|NCT00548483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20274148|NCT00548483|Antiemetics|antiemetics|mesh-ancestor
20274149|NCT00548483|Autonomic Agents|autonomic agents|mesh-ancestor
20274150|NCT00548483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20274151|NCT00548483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274152|NCT00548483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20274153|NCT00548483|Glucocorticoids|glucocorticoids|mesh-ancestor
20274154|NCT00548483|Hormones|hormones|mesh-ancestor
20274155|NCT00548483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20274156|NCT00548483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20274157|NCT00548483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274158|NCT00548509|Vitamin K|vitamin k|mesh-list
20274159|NCT00548509|Vitamin K 2|vitamin k 2|mesh-list
20274160|NCT00548509|Menatetrenone|menatetrenone|mesh-list
20274161|NCT00548509|Vitamins|vitamins|mesh-ancestor
20274162|NCT00548509|Micronutrients|micronutrients|mesh-ancestor
20274163|NCT00548509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274164|NCT00548509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20274165|NCT00548509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20274166|NCT00548509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274167|NCT00548509|Hemostatics|hemostatics|mesh-ancestor
20274168|NCT00548509|Coagulants|coagulants|mesh-ancestor
20274169|NCT00548561|Dexrazoxane|dexrazoxane|mesh-list
20274170|NCT00548561|Razoxane|razoxane|mesh-list
19958797|NCT01674621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19958798|NCT01674621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958799|NCT01674621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19958800|NCT01674647|Vitamin K|vitamin k|mesh-list
19958801|NCT01674647|Rivaroxaban|rivaroxaban|mesh-list
19958802|NCT01674647|Vitamins|vitamins|mesh-ancestor
19958803|NCT01674647|Micronutrients|micronutrients|mesh-ancestor
20274171|NCT00548561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274172|NCT00548561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20274173|NCT00548561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20274174|NCT00548561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20274175|NCT00548561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274176|NCT00548561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274177|NCT00548561|Protective Agents|protective agents|mesh-ancestor
20274178|NCT00548561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274179|NCT00548561|Antimitotic Agents|antimitotic agents|mesh-ancestor
20274180|NCT00548561|Mitosis Modulators|mitosis modulators|mesh-ancestor
20274181|NCT00548574|Mesalamine|mesalamine|mesh-list
20274182|NCT00548574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20274183|NCT00548574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20274184|NCT00548574|Analgesics|analgesics|mesh-ancestor
20274185|NCT00548574|Sensory System Agents|sensory system agents|mesh-ancestor
20274186|NCT00548574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20274187|NCT00548574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274188|NCT00548574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20274189|NCT00548574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20274190|NCT00548678|Aspirin|aspirin|mesh-list
20274191|NCT00548678|Diclofenac|diclofenac|mesh-list
20274192|NCT00548678|Ketorolac|ketorolac|mesh-list
20274193|NCT00548678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20274194|NCT00548678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20274195|NCT00548678|Analgesics|analgesics|mesh-ancestor
19958804|NCT01674647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958805|NCT01674647|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19958806|NCT01674647|Antithrombins|antithrombins|mesh-ancestor
19958807|NCT01674647|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19958808|NCT01674647|Protease Inhibitors|protease inhibitors|mesh-ancestor
19958809|NCT01674647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274196|NCT00548678|Sensory System Agents|sensory system agents|mesh-ancestor
20274197|NCT00548678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20274198|NCT00548678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274199|NCT00548678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20274200|NCT00548678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20274201|NCT00548678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20274202|NCT00548678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20274203|NCT00548678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274204|NCT00548678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20274205|NCT00548678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20274206|NCT00548678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274207|NCT00548678|Antipyretics|antipyretics|mesh-ancestor
20274208|NCT00548704|Dexrazoxane|dexrazoxane|mesh-list
20274209|NCT00548704|Razoxane|razoxane|mesh-list
20274210|NCT00548704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274211|NCT00548704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20274212|NCT00548704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20274213|NCT00548704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20274214|NCT00548704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274215|NCT00548704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274216|NCT00548704|Protective Agents|protective agents|mesh-ancestor
20274217|NCT00548704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274218|NCT00548704|Antimitotic Agents|antimitotic agents|mesh-ancestor
20274219|NCT00548704|Mitosis Modulators|mitosis modulators|mesh-ancestor
20274220|NCT00548821|Cisplatin|cisplatin|mesh-list
20274221|NCT00548821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274222|NCT00548834|Certolizumab Pegol|certolizumab pegol|mesh-list
20274223|NCT00548834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20274224|NCT00548834|Immunologic Factors|immunologic factors|mesh-ancestor
20274225|NCT00548834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274226|NCT00548834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20274227|NCT00548899|Sorafenib|sorafenib|mesh-list
20274228|NCT00548899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274229|NCT00548899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20274230|NCT00548899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274231|NCT00548899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274232|NCT00548938|Temozolomide|temozolomide|mesh-list
20274233|NCT00548938|Carmustine|carmustine|mesh-list
20274234|NCT00548938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20274235|NCT00548938|Alkylating Agents|alkylating agents|mesh-ancestor
20274236|NCT00548938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274237|NCT00548938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274238|NCT00548964|Ketamine|ketamine|mesh-list
20274239|NCT00548964|Lithium Carbonate|lithium carbonate|mesh-list
20274240|NCT00548964|Analgesics|analgesics|mesh-ancestor
20274241|NCT00548964|Sensory System Agents|sensory system agents|mesh-ancestor
20274242|NCT00548964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20274243|NCT00548964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274244|NCT00548964|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20274245|NCT00548964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20274246|NCT00548964|Anesthetics, General|anesthetics, general|mesh-ancestor
20274247|NCT00548964|Anesthetics|anesthetics|mesh-ancestor
20274248|NCT00548964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20544783|NCT01876628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20544784|NCT01876628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20544785|NCT01876628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544786|NCT01876628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544787|NCT01876641|Decitabine|decitabine|mesh-list
20544788|NCT01876641|Vemurafenib|vemurafenib|mesh-list
20544789|NCT01876641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20544790|NCT01876641|Antimetabolites|antimetabolites|mesh-ancestor
20544791|NCT01876641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544792|NCT01876641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544793|NCT01876641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958810|NCT01674647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958811|NCT01674647|Anticoagulants|anticoagulants|mesh-ancestor
19958812|NCT01674647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19958813|NCT01674647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19958814|NCT01674647|Hemostatics|hemostatics|mesh-ancestor
19958815|NCT01674647|Coagulants|coagulants|mesh-ancestor
19958816|NCT01674712|Simvastatin|simvastatin|mesh-list
19958817|NCT01674712|Fenofibrate|fenofibrate|mesh-list
19958818|NCT01674712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19958819|NCT01674712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19958820|NCT01674712|Antimetabolites|antimetabolites|mesh-ancestor
19958821|NCT01674712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958822|NCT01674712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20274249|NCT00548964|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20274250|NCT00548964|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20274251|NCT00548964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20274252|NCT00548964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274253|NCT00548964|Antidepressive Agents|antidepressive agents|mesh-ancestor
20274254|NCT00548964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20274255|NCT00548964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958823|NCT01674712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19958824|NCT01674712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958825|NCT01674725|Ribavirin|ribavirin|mesh-list
19958826|NCT01674725|Antimetabolites|antimetabolites|mesh-ancestor
19958827|NCT01674725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958828|NCT01674725|Antiviral Agents|antiviral agents|mesh-ancestor
19958829|NCT01674725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19958830|NCT01675050|Cyproheptadine|cyproheptadine|mesh-list
19958831|NCT01675050|Antipruritics|antipruritics|mesh-ancestor
19958832|NCT01675050|Dermatologic Agents|dermatologic agents|mesh-ancestor
19958833|NCT01675050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19958834|NCT01675050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19958835|NCT01675050|Histamine Antagonists|histamine antagonists|mesh-ancestor
19958836|NCT01675050|Histamine Agents|histamine agents|mesh-ancestor
19958837|NCT01675050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19958838|NCT01675050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958839|NCT01675050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958840|NCT01675050|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20274256|NCT00548964|Antimanic Agents|antimanic agents|mesh-ancestor
20274257|NCT00548964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20274258|NCT00549068|Risedronic Acid|risedronic acid|mesh-list
20544794|NCT01876641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20544795|NCT01876771|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19958841|NCT01675050|Serotonin Agents|serotonin agents|mesh-ancestor
19958842|NCT01675050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19958843|NCT01675128|Irinotecan|irinotecan|mesh-list
19958844|NCT01675128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19958845|NCT01675128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19958846|NCT01675128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958847|NCT01675128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958848|NCT01675128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544796|NCT01876771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544797|NCT01876771|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20544798|NCT01876797|Ticagrelor|ticagrelor|mesh-list
20544799|NCT01876797|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20544800|NCT01876797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20544801|NCT01876797|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20544802|NCT01876797|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20544803|NCT01876797|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20544804|NCT01876797|Purinergic Agents|purinergic agents|mesh-ancestor
20544805|NCT01876797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20544806|NCT01876797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544807|NCT01876797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544808|NCT01876849|Exenatide|exenatide|mesh-list
20544809|NCT01876849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20544810|NCT01876849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544811|NCT01876849|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20544812|NCT01876849|Incretins|incretins|mesh-ancestor
20544813|NCT01876849|Hormones|hormones|mesh-ancestor
20544814|NCT01876849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20544815|NCT01876862|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20544816|NCT01876862|Antiviral Agents|antiviral agents|mesh-ancestor
20544817|NCT01876862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20544818|NCT01876966|Ritonavir|ritonavir|mesh-list
20544819|NCT01876966|Darunavir|darunavir|mesh-list
20544820|NCT01876966|Lumefantrine|lumefantrine|mesh-list
20544821|NCT01876966|Artemether|artemether|mesh-list
20544822|NCT01876966|Etravirine|etravirine|mesh-list
20544823|NCT01876966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20544824|NCT01876966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20544825|NCT01876966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20544826|NCT01876966|Protease Inhibitors|protease inhibitors|mesh-ancestor
20544827|NCT01876966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544828|NCT01876966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544829|NCT01876966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20544830|NCT01876966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20544831|NCT01876966|Antiviral Agents|antiviral agents|mesh-ancestor
20544832|NCT01876966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19958849|NCT01675141|Lenalidomide|lenalidomide|mesh-list
19958850|NCT01675141|Immunologic Factors|immunologic factors|mesh-ancestor
19958851|NCT01675141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274259|NCT00549068|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20274260|NCT00549068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20274261|NCT00549068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274262|NCT00549068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20274263|NCT00549068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274264|NCT00549068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20274265|NCT00549107|Simendan|simendan|mesh-list
20274266|NCT00549107|Milrinone|milrinone|mesh-list
20274267|NCT00549107|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20274268|NCT00549107|Vasodilator Agents|vasodilator agents|mesh-ancestor
20274269|NCT00549107|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20274270|NCT00549107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20274271|NCT00549107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274272|NCT00549107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274273|NCT00549107|Protective Agents|protective agents|mesh-ancestor
20274274|NCT00549107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274275|NCT00549107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20274276|NCT00549120|Propranolol|propranolol|mesh-list
19958852|NCT01675141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19958853|NCT01675141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19958854|NCT01675141|Growth Substances|growth substances|mesh-ancestor
19958855|NCT01675141|Growth Inhibitors|growth inhibitors|mesh-ancestor
19958856|NCT01675141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958857|NCT01675154|Orlistat|orlistat|mesh-list
19958858|NCT01675154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958859|NCT01675154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958860|NCT01675154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19958861|NCT01675154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19958862|NCT01675167|Buprenorphine|buprenorphine|mesh-list
20274277|NCT00549120|Albuterol|albuterol|mesh-list
20274278|NCT00549120|Ipratropium|ipratropium|mesh-list
20274279|NCT00549120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20274280|NCT00549120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20274281|NCT00549120|Adrenergic Agents|adrenergic agents|mesh-ancestor
20274282|NCT00549120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20274283|NCT00549120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274284|NCT00549120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274285|NCT00549120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20274286|NCT00549120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20274287|NCT00549120|Vasodilator Agents|vasodilator agents|mesh-ancestor
20274288|NCT00549120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20274289|NCT00549120|Autonomic Agents|autonomic agents|mesh-ancestor
20274290|NCT00549120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20274291|NCT00549120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20274292|NCT00549120|Respiratory System Agents|respiratory system agents|mesh-ancestor
20274293|NCT00549120|Tocolytic Agents|tocolytic agents|mesh-ancestor
20274294|NCT00549120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20274295|NCT00549120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20274296|NCT00549120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20274297|NCT00549120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20274298|NCT00549120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20274299|NCT00549120|Cholinergic Agents|cholinergic agents|mesh-ancestor
20274300|NCT00549133|Irbesartan|irbesartan|mesh-list
20274301|NCT00549133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20274302|NCT00549133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20274303|NCT00549133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20274304|NCT00549133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274305|NCT00549146|Fluticasone|fluticasone|mesh-list
20274306|NCT00549146|Xhance|xhance|mesh-list
20274307|NCT00549146|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20274308|NCT00549146|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20274309|NCT00549146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20554236|NCT01934569|Losartan|losartan|mesh-list
19958863|NCT01675167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19958864|NCT01675167|Narcotics|narcotics|mesh-ancestor
19958865|NCT01675167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19958866|NCT01675167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958867|NCT01675167|Analgesics|analgesics|mesh-ancestor
19958868|NCT01675167|Sensory System Agents|sensory system agents|mesh-ancestor
19958869|NCT01675167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19958870|NCT01675167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20274310|NCT00549146|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20274311|NCT00549146|Autonomic Agents|autonomic agents|mesh-ancestor
20274312|NCT00549146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20274313|NCT00549146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274314|NCT00549146|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20274315|NCT00549146|Respiratory System Agents|respiratory system agents|mesh-ancestor
20274316|NCT00549146|Dermatologic Agents|dermatologic agents|mesh-ancestor
20274317|NCT00549146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20274318|NCT00549146|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20274319|NCT00549146|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20274320|NCT00549146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20274321|NCT00549146|Adrenergic Agents|adrenergic agents|mesh-ancestor
20274322|NCT00549146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20274323|NCT00549146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274324|NCT00549146|Glucocorticoids|glucocorticoids|mesh-ancestor
20274325|NCT00549146|Hormones|hormones|mesh-ancestor
20274326|NCT00549146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20274327|NCT00549146|Sympathomimetics|sympathomimetics|mesh-ancestor
20287668|NCT03980769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19958871|NCT01675297|Cholecalciferol|cholecalciferol|mesh-list
19958872|NCT01675297|Risedronic Acid|risedronic acid|mesh-list
19958873|NCT01675297|Etidronic Acid|etidronic acid|mesh-list
19958874|NCT01675297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19958875|NCT01675297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958876|NCT01675297|Vitamins|vitamins|mesh-ancestor
19958877|NCT01675297|Micronutrients|micronutrients|mesh-ancestor
19958878|NCT01675297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19958879|NCT01675297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19958880|NCT01675297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19958881|NCT01675297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958882|NCT01675531|Oxycodone|oxycodone|mesh-list
19958883|NCT01675531|Naloxone|naloxone|mesh-list
19958884|NCT01675531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19958885|NCT01675531|Narcotics|narcotics|mesh-ancestor
19958886|NCT01675531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20287669|NCT03980769|Alkylating Agents|alkylating agents|mesh-ancestor
20287670|NCT03980769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20287671|NCT03936192|Meloxicam|meloxicam|mesh-list
20287672|NCT03936192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20287673|NCT03936192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20287674|NCT03936192|Analgesics|analgesics|mesh-ancestor
20287675|NCT03936192|Sensory System Agents|sensory system agents|mesh-ancestor
20287676|NCT03936192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287677|NCT03936192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287678|NCT03936192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20287679|NCT03936192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20287680|NCT03936192|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20287681|NCT03936192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20287682|NCT03936192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287683|NCT03936192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287684|NCT03929627|Hydrocortisone|hydrocortisone|mesh-list
20287685|NCT03929627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20287686|NCT03901729|Furosemide|furosemide|mesh-list
20544833|NCT01876966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20544834|NCT01876966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20544835|NCT01876966|Antimalarials|antimalarials|mesh-ancestor
20544836|NCT01876966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20544837|NCT01876966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20544838|NCT01876966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20544839|NCT01876966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20544840|NCT01877122|Ibuprofen|ibuprofen|mesh-list
20544841|NCT01877122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20544842|NCT01877122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20544843|NCT01877122|Analgesics|analgesics|mesh-ancestor
20544844|NCT01877122|Sensory System Agents|sensory system agents|mesh-ancestor
20544845|NCT01877122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20544846|NCT01877122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544847|NCT01877122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20544848|NCT01877122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20544849|NCT01877122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20544850|NCT01877122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958887|NCT01675531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958888|NCT01675531|Analgesics|analgesics|mesh-ancestor
19958889|NCT01675531|Sensory System Agents|sensory system agents|mesh-ancestor
20287687|NCT03901729|Diuretics|diuretics|mesh-ancestor
20287688|NCT03901729|Natriuretic Agents|natriuretic agents|mesh-ancestor
20274328|NCT00549289|Cyclosporine|cyclosporine|mesh-list
20274329|NCT00549289|Cyclosporins|cyclosporins|mesh-list
20274330|NCT00549289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274331|NCT00549289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274332|NCT00549289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19450318|NCT03429400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19450319|NCT03429400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450320|NCT03429400|Analgesics|analgesics|mesh-ancestor
19450321|NCT03429400|Sensory System Agents|sensory system agents|mesh-ancestor
20274333|NCT00549289|Immunologic Factors|immunologic factors|mesh-ancestor
20274334|NCT00549289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274335|NCT00549289|Antifungal Agents|antifungal agents|mesh-ancestor
20274336|NCT00549289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20274337|NCT00549289|Dermatologic Agents|dermatologic agents|mesh-ancestor
19958890|NCT01675531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19958891|NCT01675531|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19958892|NCT01675622|Morphine|morphine|mesh-list
19958893|NCT01675622|Oxycodone|oxycodone|mesh-list
19958894|NCT01675622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19958895|NCT01675622|Narcotics|narcotics|mesh-ancestor
19958896|NCT01675622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19958897|NCT01675622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958898|NCT01675622|Analgesics|analgesics|mesh-ancestor
19958899|NCT01675622|Sensory System Agents|sensory system agents|mesh-ancestor
19958900|NCT01675622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19958901|NCT01675635|Morphine|morphine|mesh-list
19958902|NCT01675635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19958903|NCT01675635|Narcotics|narcotics|mesh-ancestor
19958904|NCT01675635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19958905|NCT01675635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958906|NCT01675635|Analgesics|analgesics|mesh-ancestor
19958907|NCT01675635|Sensory System Agents|sensory system agents|mesh-ancestor
19958908|NCT01675635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19958909|NCT01675661|Acetylcysteine|acetylcysteine|mesh-list
19958910|NCT01675661|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19958911|NCT01675661|Antiviral Agents|antiviral agents|mesh-ancestor
19958912|NCT01675661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19958913|NCT01675661|Expectorants|expectorants|mesh-ancestor
19958914|NCT01675661|Respiratory System Agents|respiratory system agents|mesh-ancestor
19958915|NCT01675661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20274338|NCT00549289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20274339|NCT00549289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20274340|NCT00549341|Botulinum Toxins|botulinum toxins|mesh-list
20274341|NCT00549341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20274342|NCT00549341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20274343|NCT00549341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274344|NCT00549341|Cholinergic Agents|cholinergic agents|mesh-ancestor
20274345|NCT00549341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20274346|NCT00549341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274347|NCT00549419|Dobutamine|dobutamine|mesh-list
20274348|NCT00549419|Norepinephrine|norepinephrine|mesh-list
20274349|NCT00549419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20274350|NCT00549419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20274351|NCT00549419|Adrenergic Agents|adrenergic agents|mesh-ancestor
20274352|NCT00549419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20274353|NCT00549419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958916|NCT01675661|Antioxidants|antioxidants|mesh-ancestor
19958917|NCT01675661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958918|NCT01675661|Protective Agents|protective agents|mesh-ancestor
19958919|NCT01675661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274354|NCT00549419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274355|NCT00549419|Sympathomimetics|sympathomimetics|mesh-ancestor
20274356|NCT00549419|Autonomic Agents|autonomic agents|mesh-ancestor
20274357|NCT00549419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20274358|NCT00549419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20274359|NCT00549419|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20274360|NCT00549419|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20274361|NCT00549419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20274362|NCT00549419|Protective Agents|protective agents|mesh-ancestor
20274363|NCT00549471|Botulinum Toxins|botulinum toxins|mesh-list
19450322|NCT03429400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452681|NCT03411798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19452682|NCT03411798|Antimalarials|antimalarials|mesh-ancestor
19452683|NCT03411798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19452684|NCT03411798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19452685|NCT03411798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20274364|NCT00549471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20274365|NCT00549471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20274366|NCT00549471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20274367|NCT00549471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20274368|NCT00549471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274369|NCT00549471|Cholinergic Agents|cholinergic agents|mesh-ancestor
20274370|NCT00549471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20274371|NCT00549471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274372|NCT00549471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20544851|NCT01877122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544852|NCT01877226|Tapentadol|tapentadol|mesh-list
20544853|NCT01877226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20544854|NCT01877226|Narcotics|narcotics|mesh-ancestor
20544855|NCT01877226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20544856|NCT01877226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544857|NCT01877226|Analgesics|analgesics|mesh-ancestor
20544858|NCT01877226|Sensory System Agents|sensory system agents|mesh-ancestor
20544859|NCT01877226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20544860|NCT01877226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20544861|NCT01877226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20544862|NCT01877226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20544863|NCT01877226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544864|NCT01877226|Adrenergic Agents|adrenergic agents|mesh-ancestor
20544865|NCT01877226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20544866|NCT01877356|Anesthetics|anesthetics|mesh-list
20544867|NCT01877356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20544868|NCT01877356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544869|NCT01877512|Hormones|hormones|mesh-list
20544870|NCT01877512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20544871|NCT01877512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554237|NCT01934569|Midazolam|midazolam|mesh-list
20554238|NCT01934569|Caffeine|caffeine|mesh-list
20554239|NCT01934569|Omeprazole|omeprazole|mesh-list
20554240|NCT01934569|Pravastatin|pravastatin|mesh-list
20554241|NCT01934569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20554242|NCT01934569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20554243|NCT01934569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20554244|NCT01934569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554245|NCT01934569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20554246|NCT01934569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20554247|NCT01934569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20554248|NCT01934569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20554249|NCT01934569|Anesthetics, General|anesthetics, general|mesh-ancestor
20554250|NCT01934569|Anesthetics|anesthetics|mesh-ancestor
20554251|NCT01934569|GABA Modulators|gaba modulators|mesh-ancestor
20554252|NCT01934569|GABA Agents|gaba agents|mesh-ancestor
20554253|NCT01934569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20554254|NCT01934569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554255|NCT01934569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20554256|NCT01934569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20554257|NCT01934569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20554258|NCT01934569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20554259|NCT01934569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20554260|NCT01934569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20554261|NCT01934569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20554262|NCT01934569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554263|NCT01934569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20554264|NCT01934569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20554265|NCT01934569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20554266|NCT01934569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20554267|NCT01934569|Purinergic Agents|purinergic agents|mesh-ancestor
20554268|NCT01934569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20554269|NCT01934569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20554270|NCT01934569|Antimetabolites|antimetabolites|mesh-ancestor
20554271|NCT01934569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20554272|NCT01934569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20274373|NCT00549471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20274374|NCT00549536|Calcium, Dietary|calcium, dietary|mesh-list
20274375|NCT00549536|Calcium|calcium|mesh-list
20274376|NCT00549536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20274377|NCT00549536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274378|NCT00549536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20274379|NCT00549588|Sunscreening Agents|sunscreening agents|mesh-list
20544872|NCT01877577|Vitamin D|vitamin d|mesh-list
20544873|NCT01877577|Ergocalciferols|ergocalciferols|mesh-list
20544874|NCT01877577|Cholecalciferol|cholecalciferol|mesh-list
20544875|NCT01877577|Vitamins|vitamins|mesh-list
20544876|NCT01877577|Micronutrients|micronutrients|mesh-ancestor
20544877|NCT01877577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544878|NCT01877577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20544879|NCT01877577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20544880|NCT01877590|Thioctic Acid|thioctic acid|mesh-list
20544881|NCT01877590|Antioxidants|antioxidants|mesh-ancestor
20544882|NCT01877590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958920|NCT01675661|Antidotes|antidotes|mesh-ancestor
19958921|NCT01675765|Cyclophosphamide|cyclophosphamide|mesh-list
19958922|NCT01675765|Cisplatin|cisplatin|mesh-list
19958923|NCT01675765|Pemetrexed|pemetrexed|mesh-list
19958924|NCT01675765|Immunologic Factors|immunologic factors|mesh-list
19958925|NCT01675765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19958926|NCT01675765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958927|NCT01675765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19958928|NCT01675765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19958929|NCT01675765|Alkylating Agents|alkylating agents|mesh-ancestor
19958930|NCT01675765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958931|NCT01675765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958932|NCT01675765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19958933|NCT01675765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958934|NCT01675765|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19958935|NCT01675765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19958936|NCT01675778|Hydromorphone|hydromorphone|mesh-list
19958937|NCT01675778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19958938|NCT01675778|Narcotics|narcotics|mesh-ancestor
19958939|NCT01675778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19958940|NCT01675778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544883|NCT01877590|Protective Agents|protective agents|mesh-ancestor
19450323|NCT03429309|Propofol|propofol|mesh-list
19958941|NCT01675778|Analgesics|analgesics|mesh-ancestor
20274380|NCT00549588|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20274381|NCT00549588|Protective Agents|protective agents|mesh-ancestor
20274382|NCT00549588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274383|NCT00549588|Dermatologic Agents|dermatologic agents|mesh-ancestor
20274384|NCT00549614|Acipimox|acipimox|mesh-list
20274385|NCT00549614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20274386|NCT00549614|Antimetabolites|antimetabolites|mesh-ancestor
19958942|NCT01675778|Sensory System Agents|sensory system agents|mesh-ancestor
19958943|NCT01675778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19958944|NCT01676116|Liraglutide|liraglutide|mesh-list
19958945|NCT01676116|Exenatide|exenatide|mesh-list
19958946|NCT01676116|Xultophy|xultophy|mesh-list
19958947|NCT01676116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19958948|NCT01676116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958949|NCT01676116|Incretins|incretins|mesh-ancestor
19958950|NCT01676116|Hormones|hormones|mesh-ancestor
19958951|NCT01676116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19958952|NCT01676116|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19958953|NCT01676220|Insulin|insulin|mesh-list
19958954|NCT01676220|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19958955|NCT01676220|Insulin Glargine|insulin glargine|mesh-list
19958956|NCT01676220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19958957|NCT01676220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958958|NCT01676311|Huperzine A|huperzine a|mesh-list
19958959|NCT01676311|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19958960|NCT01676311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19958961|NCT01676311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958962|NCT01676311|Cholinergic Agents|cholinergic agents|mesh-ancestor
19958963|NCT01676311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19958964|NCT01676311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958965|NCT01676311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19958966|NCT01676311|Protective Agents|protective agents|mesh-ancestor
20274387|NCT00549614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274388|NCT00549614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20274389|NCT00549666|Moxifloxacin|moxifloxacin|mesh-list
20274390|NCT00549666|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20274391|NCT00549666|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20274392|NCT00549666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20274393|NCT00549666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20274394|NCT00549666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20274395|NCT00549666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274396|NCT00549666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19958967|NCT01676415|Mometasone Furoate|mometasone furoate|mesh-list
19958968|NCT01676415|Prednisone|prednisone|mesh-list
19958969|NCT01676415|Glucocorticoids|glucocorticoids|mesh-list
19958970|NCT01676415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19958971|NCT01676415|Hormones|hormones|mesh-ancestor
19958972|NCT01676415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19958973|NCT01676415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958974|NCT01676415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19958975|NCT01676415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19958976|NCT01676415|Dermatologic Agents|dermatologic agents|mesh-ancestor
20274397|NCT00549666|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20274398|NCT00549666|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20274399|NCT00549666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20274400|NCT00549666|Adrenergic Agents|adrenergic agents|mesh-ancestor
20274401|NCT00549666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20274402|NCT00549666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274403|NCT00549666|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20274404|NCT00549666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20274405|NCT00549666|Serotonin Agents|serotonin agents|mesh-ancestor
20274406|NCT00549666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20274407|NCT00549666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20274408|NCT00549666|Dopamine Agents|dopamine agents|mesh-ancestor
20274409|NCT00549666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20274410|NCT00549666|Contraceptive Agents|contraceptive agents|mesh-ancestor
19958977|NCT01676415|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19958978|NCT01677195|Calcium Carbonate|calcium carbonate|mesh-list
19958979|NCT01677195|Antacids|antacids|mesh-ancestor
19958980|NCT01677195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958981|NCT01677195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19958982|NCT01677286|Doxycycline|doxycycline|mesh-list
19958983|NCT01677286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19958984|NCT01677286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19958985|NCT01677286|Antimalarials|antimalarials|mesh-ancestor
20274411|NCT00549666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20274412|NCT00549666|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20274413|NCT00549666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19958986|NCT01677286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19958987|NCT01677286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19958988|NCT01677299|Metformin|metformin|mesh-list
19958989|NCT01677299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19958990|NCT01677299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958991|NCT01677377|Risperidone|risperidone|mesh-list
19958992|NCT01677377|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19958993|NCT01677377|Serotonin Agents|serotonin agents|mesh-ancestor
19958994|NCT01677377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19958995|NCT01677377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19958996|NCT01677377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19958997|NCT01677377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19958998|NCT01677377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19958999|NCT01677377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19959000|NCT01677377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20274414|NCT00549666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20274415|NCT00549666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20274416|NCT00549666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20274417|NCT00549666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20274418|NCT00549666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20274419|NCT00549666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274420|NCT00549666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274421|NCT00549874|Rosiglitazone|rosiglitazone|mesh-list
20274422|NCT00549874|Glyburide|glyburide|mesh-list
20274423|NCT00549874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20274424|NCT00549874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274425|NCT00549887|Insulin|insulin|mesh-list
20274426|NCT00549887|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20274427|NCT00549887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20274428|NCT00549887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274429|NCT00549926|Atorvastatin|atorvastatin|mesh-list
20274430|NCT00549926|Pravastatin|pravastatin|mesh-list
20274431|NCT00549926|Pitavastatin|pitavastatin|mesh-list
20274432|NCT00549926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20274433|NCT00549926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20274434|NCT00549926|Antimetabolites|antimetabolites|mesh-ancestor
20274435|NCT00549926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274436|NCT00549926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20274437|NCT00549926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20274438|NCT00549926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274439|NCT00549965|Risedronic Acid|risedronic acid|mesh-list
20274440|NCT00549965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20274441|NCT00549965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20274442|NCT00549965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274443|NCT00549965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20274444|NCT00549965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274445|NCT00549965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20274446|NCT00550004|Gemcitabine|gemcitabine|mesh-list
20274447|NCT00550004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20274448|NCT00550004|Antimetabolites|antimetabolites|mesh-ancestor
20274449|NCT00550004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274450|NCT00550004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274451|NCT00550004|Antiviral Agents|antiviral agents|mesh-ancestor
20274452|NCT00550004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20274453|NCT00550004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274454|NCT00550004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20274455|NCT00550004|Immunologic Factors|immunologic factors|mesh-ancestor
20274456|NCT00550004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274457|NCT00550095|Valsartan|valsartan|mesh-list
20274458|NCT00550095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20274459|NCT00550095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20274460|NCT00550095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20274461|NCT00550095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274462|NCT00550108|Ethanol|ethanol|mesh-list
20274463|NCT00550108|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20274464|NCT00550108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20274465|NCT00550108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20274466|NCT00550108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274467|NCT00550121|Ascorbic Acid|ascorbic acid|mesh-list
20274468|NCT00550121|Vitamins|vitamins|mesh-ancestor
20274469|NCT00550121|Micronutrients|micronutrients|mesh-ancestor
20554273|NCT01934634|Gemcitabine|gemcitabine|mesh-list
20274470|NCT00550121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274471|NCT00550121|Antioxidants|antioxidants|mesh-ancestor
20274472|NCT00550121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274473|NCT00550121|Protective Agents|protective agents|mesh-ancestor
20274474|NCT00550160|Artesunate|artesunate|mesh-list
20274475|NCT00550160|Amodiaquine|amodiaquine|mesh-list
20274476|NCT00550160|Antimalarials|antimalarials|mesh-ancestor
20274477|NCT00550160|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20274478|NCT00550160|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20274479|NCT00550160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20274480|NCT00550160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274481|NCT00550160|Antiviral Agents|antiviral agents|mesh-ancestor
20274482|NCT00550160|Schistosomicides|schistosomicides|mesh-ancestor
20274483|NCT00550160|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20274484|NCT00550160|Anthelmintics|anthelmintics|mesh-ancestor
19959001|NCT01677377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19959002|NCT01677377|Dopamine Agents|dopamine agents|mesh-ancestor
19959003|NCT01677507|Timolol|timolol|mesh-list
19959004|NCT01677507|Latanoprost|latanoprost|mesh-list
19959005|NCT01677507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20274485|NCT00550199|Gemcitabine|gemcitabine|mesh-list
20274486|NCT00550199|Panobinostat|panobinostat|mesh-list
20274487|NCT00550199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20274488|NCT00550199|Antimetabolites|antimetabolites|mesh-ancestor
20274489|NCT00550199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274490|NCT00550199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274491|NCT00550199|Antiviral Agents|antiviral agents|mesh-ancestor
20274492|NCT00550199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20274493|NCT00550199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274494|NCT00550199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20274495|NCT00550199|Immunologic Factors|immunologic factors|mesh-ancestor
20274496|NCT00550199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274497|NCT00550199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20274498|NCT00550303|Bazedoxifene|bazedoxifene|mesh-list
20274499|NCT00550303|Estrogens|estrogens|mesh-list
20274500|NCT00550303|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20274501|NCT00550303|Hormones|hormones|mesh-ancestor
20274502|NCT00550303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20274503|NCT00550303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274504|NCT00550303|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20274505|NCT00550303|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20274506|NCT00550303|Hormone Antagonists|hormone antagonists|mesh-ancestor
20274507|NCT00550303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20274508|NCT00550329|Glipizide|glipizide|mesh-list
20274509|NCT00550329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20274510|NCT00550329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274511|NCT00550342|Rituximab|rituximab|mesh-list
20274512|NCT00550342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20274513|NCT00550342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274514|NCT00550342|Immunologic Factors|immunologic factors|mesh-ancestor
19959006|NCT01677507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19959007|NCT01677507|Adrenergic Agents|adrenergic agents|mesh-ancestor
20274515|NCT00550342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274516|NCT00550342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20274517|NCT00550433|Bazedoxifene|bazedoxifene|mesh-list
20274518|NCT00550433|Estrogens|estrogens|mesh-list
19959008|NCT01677507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19959009|NCT01677507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959010|NCT01677507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959011|NCT01677507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19959012|NCT01677507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19959013|NCT01677507|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19959014|NCT01677507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19959015|NCT01677741|Dabrafenib|dabrafenib|mesh-list
19959016|NCT01677741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959017|NCT01677741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19959018|NCT01677741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959019|NCT01677741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959020|NCT01677858|Dexamethasone|dexamethasone|mesh-list
19959021|NCT01677858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19959022|NCT01677858|Antiemetics|antiemetics|mesh-ancestor
19959023|NCT01677858|Autonomic Agents|autonomic agents|mesh-ancestor
19959024|NCT01677858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20274519|NCT00550433|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20274520|NCT00550433|Hormones|hormones|mesh-ancestor
19959025|NCT01677858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274521|NCT00550433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20274522|NCT00550433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274523|NCT00550433|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20274524|NCT00550433|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20274525|NCT00550433|Hormone Antagonists|hormone antagonists|mesh-ancestor
20274526|NCT00550433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20274527|NCT00550485|Citalopram|citalopram|mesh-list
20274528|NCT00550485|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20274529|NCT00550485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20274530|NCT00550485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20274531|NCT00550485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274532|NCT00550485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20274533|NCT00550485|Serotonin Agents|serotonin agents|mesh-ancestor
20274534|NCT00550485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274535|NCT00550485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20274536|NCT00550485|Antidepressive Agents|antidepressive agents|mesh-ancestor
20274537|NCT00550485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20274538|NCT00550563|Cholecalciferol|cholecalciferol|mesh-list
20544884|NCT01877590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959026|NCT01677858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19959027|NCT01677858|Glucocorticoids|glucocorticoids|mesh-ancestor
19959028|NCT01677858|Hormones|hormones|mesh-ancestor
19959029|NCT01677858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19959030|NCT01677858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19959031|NCT01677858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959032|NCT01677988|Folfirinox|folfirinox|mesh-list
19959033|NCT01677988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959034|NCT01678131|Ribavirin|ribavirin|mesh-list
19959035|NCT01678131|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19959036|NCT01678131|Interferon alpha-2|interferon alpha-2|mesh-list
19959037|NCT01678131|Liver Extracts|liver extracts|mesh-list
19959038|NCT01678131|Antimetabolites|antimetabolites|mesh-ancestor
19959039|NCT01678131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959040|NCT01678131|Antiviral Agents|antiviral agents|mesh-ancestor
19959041|NCT01678131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19959042|NCT01678131|Hematinics|hematinics|mesh-ancestor
19959043|NCT01678131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959044|NCT01678209|Methylphenidate|methylphenidate|mesh-list
19959045|NCT01678209|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19959046|NCT01678209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19959047|NCT01678209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959048|NCT01678209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19959049|NCT01678209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19959050|NCT01678209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19959051|NCT01678209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959052|NCT01678209|Dopamine Agents|dopamine agents|mesh-ancestor
19959053|NCT01678209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19959054|NCT01678209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19959055|NCT01678209|Adrenergic Agents|adrenergic agents|mesh-ancestor
19959056|NCT01678313|Celecoxib|celecoxib|mesh-list
19959057|NCT01678313|Doxazosin|doxazosin|mesh-list
19959058|NCT01678313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19959059|NCT01678313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19959060|NCT01678313|Analgesics|analgesics|mesh-ancestor
19959061|NCT01678313|Sensory System Agents|sensory system agents|mesh-ancestor
19959062|NCT01678313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19959063|NCT01678313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959064|NCT01678313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19959065|NCT01678313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19959066|NCT01678313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19959067|NCT01678313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19959068|NCT01678313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959069|NCT01678313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959070|NCT01678313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19959071|NCT01678313|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19959072|NCT01678313|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19959073|NCT01678313|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19959074|NCT01678313|Adrenergic Agents|adrenergic agents|mesh-ancestor
19959075|NCT01678313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19959076|NCT01678443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19959077|NCT01678443|Antibodies|antibodies|mesh-list
19959078|NCT01678443|Immunoglobulins|immunoglobulins|mesh-list
19959079|NCT01678443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20274539|NCT00550563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20274540|NCT00550563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274541|NCT00550563|Vitamins|vitamins|mesh-ancestor
20274542|NCT00550563|Micronutrients|micronutrients|mesh-ancestor
20274543|NCT00550563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19959080|NCT01678443|Immunologic Factors|immunologic factors|mesh-ancestor
19959081|NCT01678443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959082|NCT01678443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959083|NCT01678794|Candesartan|candesartan|mesh-list
19959084|NCT01678794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19959085|NCT01678794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19959086|NCT01678794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19959087|NCT01678794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274544|NCT00550628|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20274545|NCT00550628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20274546|NCT00550628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274547|NCT00550693|Chlorhexidine|chlorhexidine|mesh-list
20274548|NCT00550693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20274549|NCT00550693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20274550|NCT00550693|Disinfectants|disinfectants|mesh-ancestor
20274551|NCT00550784|Paclitaxel|paclitaxel|mesh-list
20274552|NCT00550784|Cyclophosphamide|cyclophosphamide|mesh-list
20274553|NCT00550784|Melphalan|melphalan|mesh-list
20274554|NCT00550784|Topotecan|topotecan|mesh-list
20274555|NCT00550784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20274556|NCT00550784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274557|NCT00550784|Tubulin Modulators|tubulin modulators|mesh-ancestor
20274558|NCT00550784|Antimitotic Agents|antimitotic agents|mesh-ancestor
20544885|NCT01877590|Vitamin B Complex|vitamin b complex|mesh-ancestor
20544886|NCT01877590|Vitamins|vitamins|mesh-ancestor
20544887|NCT01877590|Micronutrients|micronutrients|mesh-ancestor
20544888|NCT01877746|Prednisone|prednisone|mesh-list
20544889|NCT01877746|Azathioprine|azathioprine|mesh-list
20544890|NCT01877746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20544891|NCT01877746|Glucocorticoids|glucocorticoids|mesh-ancestor
20544892|NCT01877746|Hormones|hormones|mesh-ancestor
20544893|NCT01877746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20544894|NCT01877746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544895|NCT01877746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20544896|NCT01877746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544897|NCT01877746|Antimetabolites|antimetabolites|mesh-ancestor
20544898|NCT01877746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544899|NCT01877746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20544900|NCT01877746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20544901|NCT01877746|Immunologic Factors|immunologic factors|mesh-ancestor
20544902|NCT01877746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20544903|NCT01877811|Agerafenib|agerafenib|mesh-list
20544904|NCT01877811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20544905|NCT01877811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544906|NCT01877811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544907|NCT01877889|Dapagliflozin|dapagliflozin|mesh-list
20544908|NCT01877889|Canagliflozin|canagliflozin|mesh-list
20544909|NCT01877889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20544910|NCT01877889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544911|NCT01877889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20544912|NCT01877889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544913|NCT01877954|Fluticasone|fluticasone|mesh-list
20544914|NCT01877954|Xhance|xhance|mesh-list
20544915|NCT01877954|Beclomethasone|beclomethasone|mesh-list
20544916|NCT01877954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20544917|NCT01877954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20544918|NCT01877954|Autonomic Agents|autonomic agents|mesh-ancestor
20544919|NCT01877954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20544920|NCT01877954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544921|NCT01877954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20544922|NCT01877954|Respiratory System Agents|respiratory system agents|mesh-ancestor
20544923|NCT01877954|Dermatologic Agents|dermatologic agents|mesh-ancestor
20544924|NCT01877954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20544925|NCT01877954|Glucocorticoids|glucocorticoids|mesh-ancestor
20544926|NCT01877954|Hormones|hormones|mesh-ancestor
19959088|NCT01678820|Metformin|metformin|mesh-list
20274559|NCT00550784|Mitosis Modulators|mitosis modulators|mesh-ancestor
20544927|NCT01877954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20274560|NCT00550784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274561|NCT00550784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20274562|NCT00550784|Immunologic Factors|immunologic factors|mesh-ancestor
20274563|NCT00550784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274564|NCT00550784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20274565|NCT00550784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20274566|NCT00550784|Alkylating Agents|alkylating agents|mesh-ancestor
20274567|NCT00550784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20274568|NCT00550784|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20274569|NCT00550784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20544928|NCT01878136|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20544929|NCT01878136|Plasminogen|plasminogen|mesh-list
20544930|NCT01878136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20544931|NCT01878136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20544932|NCT01878136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544933|NCT01878188|BCG Vaccine|bcg vaccine|mesh-list
20544934|NCT01878188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20544935|NCT01878188|Immunologic Factors|immunologic factors|mesh-ancestor
20544936|NCT01878188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544937|NCT01878201|Valsartan|valsartan|mesh-list
20544938|NCT01878201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20544939|NCT01878201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20544940|NCT01878201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20544941|NCT01878201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544942|NCT01878227|Fenofibrate|fenofibrate|mesh-list
20544943|NCT01878227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20544944|NCT01878227|Antimetabolites|antimetabolites|mesh-ancestor
20544945|NCT01878227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544946|NCT01878227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20544947|NCT01878318|Methotrexate|methotrexate|mesh-list
20544948|NCT01878318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20544949|NCT01878318|Abortifacient Agents|abortifacient agents|mesh-ancestor
20544950|NCT01878318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20544951|NCT01878318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544952|NCT01878318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20544953|NCT01878318|Antimetabolites|antimetabolites|mesh-ancestor
20544954|NCT01878318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544955|NCT01878318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544956|NCT01878318|Dermatologic Agents|dermatologic agents|mesh-ancestor
20544957|NCT01878318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20544958|NCT01878318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20544959|NCT01878318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20544960|NCT01878318|Immunologic Factors|immunologic factors|mesh-ancestor
20544961|NCT01878318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20544962|NCT01878318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20544963|NCT01878357|Piperaquine|piperaquine|mesh-list
20544964|NCT01878357|Primaquine|primaquine|mesh-list
20544965|NCT01878357|Artenimol|artenimol|mesh-list
20544966|NCT01878357|Antimalarials|antimalarials|mesh-ancestor
20544967|NCT01878357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20544968|NCT01878357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20544969|NCT01878357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20544970|NCT01878422|Leucovorin|leucovorin|mesh-list
20544971|NCT01878422|Bevacizumab|bevacizumab|mesh-list
20544972|NCT01878422|Cetuximab|cetuximab|mesh-list
20544973|NCT01878422|Fluorouracil|fluorouracil|mesh-list
20544974|NCT01878422|Oxaliplatin|oxaliplatin|mesh-list
20544975|NCT01878422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20544976|NCT01878422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20544977|NCT01878422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20544978|NCT01878422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20544979|NCT01878422|Growth Substances|growth substances|mesh-ancestor
20544980|NCT01878422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544981|NCT01878422|Growth Inhibitors|growth inhibitors|mesh-ancestor
20544982|NCT01878422|Antimetabolites|antimetabolites|mesh-ancestor
20544983|NCT01878422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544984|NCT01878422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20544985|NCT01878422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20544986|NCT01878422|Immunologic Factors|immunologic factors|mesh-ancestor
20544987|NCT01878422|Antidotes|antidotes|mesh-ancestor
20544988|NCT01878422|Protective Agents|protective agents|mesh-ancestor
20544989|NCT01878422|Vitamin B Complex|vitamin b complex|mesh-ancestor
20544990|NCT01878422|Vitamins|vitamins|mesh-ancestor
20544991|NCT01878422|Micronutrients|micronutrients|mesh-ancestor
20544992|NCT01878513|Risperidone|risperidone|mesh-list
20544993|NCT01878513|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20544994|NCT01878513|Serotonin Agents|serotonin agents|mesh-ancestor
20544995|NCT01878513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20274570|NCT00550784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274571|NCT00550810|Sunitinib|sunitinib|mesh-list
20274572|NCT00550810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274573|NCT00550810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20274574|NCT00550810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20274575|NCT00550810|Growth Substances|growth substances|mesh-ancestor
20274576|NCT00550810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274577|NCT00550810|Growth Inhibitors|growth inhibitors|mesh-ancestor
20274578|NCT00550810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20274579|NCT00550810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274580|NCT00550810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274581|NCT00550901|Dexrazoxane|dexrazoxane|mesh-list
20274582|NCT00550901|Razoxane|razoxane|mesh-list
20274583|NCT00550901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274584|NCT00550901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20274585|NCT00550901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20274586|NCT00550901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20274587|NCT00550901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274588|NCT00550901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274589|NCT00550901|Protective Agents|protective agents|mesh-ancestor
20274590|NCT00550901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959089|NCT01678820|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19959090|NCT01678820|Glimepiride|glimepiride|mesh-list
19959091|NCT01678820|Simvastatin|simvastatin|mesh-list
19959092|NCT01678820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19959093|NCT01678820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959094|NCT01678820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19959095|NCT01678820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19959096|NCT01678820|Antimetabolites|antimetabolites|mesh-ancestor
19959097|NCT01678820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959098|NCT01678820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19959099|NCT01678820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19959100|NCT01678820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959101|NCT01678820|Incretins|incretins|mesh-ancestor
19959102|NCT01678820|Hormones|hormones|mesh-ancestor
19959103|NCT01678820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19959104|NCT01678820|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19959105|NCT01678820|Protease Inhibitors|protease inhibitors|mesh-ancestor
19959106|NCT01678820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19959107|NCT01678820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19959108|NCT01678820|Immunologic Factors|immunologic factors|mesh-ancestor
19959109|NCT01678911|Gabapentin|gabapentin|mesh-list
19959110|NCT01678911|Analgesics|analgesics|mesh-ancestor
19959111|NCT01678911|Sensory System Agents|sensory system agents|mesh-ancestor
19959112|NCT01678911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19959113|NCT01678911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959114|NCT01678911|Anticonvulsants|anticonvulsants|mesh-ancestor
19959115|NCT01678911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19959116|NCT01678911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19959117|NCT01678911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20274591|NCT00550901|Antimitotic Agents|antimitotic agents|mesh-ancestor
20274592|NCT00550901|Mitosis Modulators|mitosis modulators|mesh-ancestor
20274593|NCT00550927|Bevacizumab|bevacizumab|mesh-list
20274594|NCT00550927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20274595|NCT00550927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274596|NCT00550927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20274597|NCT00550927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20274598|NCT00550927|Growth Substances|growth substances|mesh-ancestor
20274599|NCT00550927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274600|NCT00550927|Growth Inhibitors|growth inhibitors|mesh-ancestor
20274601|NCT00550992|Leucovorin|leucovorin|mesh-list
20274602|NCT00550992|Cytarabine|cytarabine|mesh-list
20274603|NCT00550992|Cyclosporine|cyclosporine|mesh-list
20274604|NCT00550992|Prednisone|prednisone|mesh-list
20274605|NCT00550992|Prednisolone|prednisolone|mesh-list
20274606|NCT00550992|Hydrocortisone|hydrocortisone|mesh-list
20274607|NCT00550992|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20274608|NCT00550992|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20274609|NCT00550992|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20274610|NCT00550992|Cyclophosphamide|cyclophosphamide|mesh-list
20274611|NCT00550992|Melphalan|melphalan|mesh-list
20274612|NCT00550992|Busulfan|busulfan|mesh-list
20274613|NCT00550992|Methotrexate|methotrexate|mesh-list
20274614|NCT00550992|Etoposide|etoposide|mesh-list
20274615|NCT00550992|Vincristine|vincristine|mesh-list
20274616|NCT00550992|Daunorubicin|daunorubicin|mesh-list
20274617|NCT00550992|Asparaginase|asparaginase|mesh-list
20274618|NCT00550992|Mercaptopurine|mercaptopurine|mesh-list
20274619|NCT00550992|Mitoxantrone|mitoxantrone|mesh-list
20274620|NCT00550992|Pegaspargase|pegaspargase|mesh-list
20274621|NCT00550992|Thioguanine|thioguanine|mesh-list
20274622|NCT00550992|Cyclosporins|cyclosporins|mesh-list
20274623|NCT00550992|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20274624|NCT00550992|Levoleucovorin|levoleucovorin|mesh-list
20274625|NCT00550992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20274626|NCT00550992|Immunologic Factors|immunologic factors|mesh-ancestor
20274627|NCT00550992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274628|NCT00550992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20274629|NCT00550992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20274630|NCT00550992|Alkylating Agents|alkylating agents|mesh-ancestor
20274631|NCT00550992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274632|NCT00550992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274633|NCT00550992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20274634|NCT00550992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20274635|NCT00550992|Glucocorticoids|glucocorticoids|mesh-ancestor
20274636|NCT00550992|Hormones|hormones|mesh-ancestor
20274637|NCT00550992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20274638|NCT00550992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20274639|NCT00550992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20274640|NCT00550992|Abortifacient Agents|abortifacient agents|mesh-ancestor
20274641|NCT00550992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20274642|NCT00550992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20274643|NCT00550992|Antimetabolites|antimetabolites|mesh-ancestor
20274644|NCT00550992|Dermatologic Agents|dermatologic agents|mesh-ancestor
20274645|NCT00550992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274646|NCT00550992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20274647|NCT00550992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20274648|NCT00550992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20274649|NCT00550992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20274650|NCT00550992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20274651|NCT00550992|Antiviral Agents|antiviral agents|mesh-ancestor
20274652|NCT00550992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20544996|NCT01878513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20544997|NCT01878513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20544998|NCT01878513|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20544999|NCT01878513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20545000|NCT01878513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20545001|NCT01878513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20545002|NCT01878513|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20545003|NCT01878513|Dopamine Agents|dopamine agents|mesh-ancestor
20545004|NCT01878539|Anticoagulants|anticoagulants|mesh-list
20545005|NCT01878578|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
20545006|NCT01878578|Phenytoin|phenytoin|mesh-list
20545007|NCT01878578|Anticonvulsants|anticonvulsants|mesh-ancestor
20545008|NCT01878578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20545009|NCT01878578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20545010|NCT01878578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20545011|NCT01878578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545012|NCT01878578|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20545013|NCT01878578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20545014|NCT01878643|Vancomycin|vancomycin|mesh-list
20545015|NCT01878643|Gentamicins|gentamicins|mesh-list
19959118|NCT01678911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19959119|NCT01678911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19959120|NCT01678911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19959121|NCT01678911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19959122|NCT01678911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274653|NCT00550992|Antidotes|antidotes|mesh-ancestor
20545016|NCT01878643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20545017|NCT01878643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20545018|NCT01878643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20545019|NCT01878643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545020|NCT01878643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545021|NCT01878695|Acetylcysteine|acetylcysteine|mesh-list
20545022|NCT01878695|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20545023|NCT01878695|Antiviral Agents|antiviral agents|mesh-ancestor
20545024|NCT01878695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20545025|NCT01878695|Expectorants|expectorants|mesh-ancestor
20545026|NCT01878695|Respiratory System Agents|respiratory system agents|mesh-ancestor
20545027|NCT01878695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20545028|NCT01878695|Antioxidants|antioxidants|mesh-ancestor
20545029|NCT01878695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274654|NCT00550992|Protective Agents|protective agents|mesh-ancestor
20274655|NCT00550992|Vitamin B Complex|vitamin b complex|mesh-ancestor
20274656|NCT00550992|Vitamins|vitamins|mesh-ancestor
20274657|NCT00550992|Micronutrients|micronutrients|mesh-ancestor
20274658|NCT00550992|Tubulin Modulators|tubulin modulators|mesh-ancestor
20274659|NCT00550992|Antimitotic Agents|antimitotic agents|mesh-ancestor
20274660|NCT00550992|Mitosis Modulators|mitosis modulators|mesh-ancestor
20274661|NCT00550992|Antifungal Agents|antifungal agents|mesh-ancestor
20274662|NCT00550992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20274663|NCT00550992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20274664|NCT00550992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20274665|NCT00550992|Analgesics|analgesics|mesh-ancestor
20274666|NCT00550992|Sensory System Agents|sensory system agents|mesh-ancestor
20274667|NCT00551005|Celecoxib|celecoxib|mesh-list
20274668|NCT00551005|Etoposide|etoposide|mesh-list
20274669|NCT00551005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20274670|NCT00551005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274671|NCT00551005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20274672|NCT00551005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20274673|NCT00551005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274674|NCT00551005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274675|NCT00551005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20274676|NCT00551005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20274677|NCT00551005|Analgesics|analgesics|mesh-ancestor
20274678|NCT00551005|Sensory System Agents|sensory system agents|mesh-ancestor
20274679|NCT00551005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20274680|NCT00551005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274681|NCT00551005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20274682|NCT00551005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20274683|NCT00551005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20274684|NCT00551005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20274685|NCT00551018|Tenofovir|tenofovir|mesh-list
20274686|NCT00551018|Emtricitabine|emtricitabine|mesh-list
20274687|NCT00551018|Antiviral Agents|antiviral agents|mesh-ancestor
20274688|NCT00551018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20274689|NCT00551018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20274690|NCT00551018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20274691|NCT00551018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274692|NCT00551018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274693|NCT00551018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20274694|NCT00551018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20274695|NCT00551044|Bicalutamide|bicalutamide|mesh-list
20274696|NCT00551044|Androgen Antagonists|androgen antagonists|mesh-ancestor
20274697|NCT00551044|Hormone Antagonists|hormone antagonists|mesh-ancestor
20274698|NCT00551044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20274699|NCT00551044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274700|NCT00551044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274701|NCT00551096|Gemcitabine|gemcitabine|mesh-list
20274702|NCT00551096|Capecitabine|capecitabine|mesh-list
20274703|NCT00551096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20274704|NCT00551096|Antimetabolites|antimetabolites|mesh-ancestor
20274705|NCT00551096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274706|NCT00551096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274707|NCT00551096|Antiviral Agents|antiviral agents|mesh-ancestor
20274708|NCT00551096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20274709|NCT00551096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274710|NCT00551096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20274711|NCT00551096|Immunologic Factors|immunologic factors|mesh-ancestor
20274712|NCT00551096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274713|NCT00551109|SA 4503|sa 4503|mesh-list
19959123|NCT01678911|Antimanic Agents|antimanic agents|mesh-ancestor
19959124|NCT01678976|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19959125|NCT01678976|Oxcarbazepine|oxcarbazepine|mesh-list
19959126|NCT01678976|Anticonvulsants|anticonvulsants|mesh-ancestor
19959127|NCT01678976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19959128|NCT01678976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19959129|NCT01678976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19959130|NCT01678976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959131|NCT01678976|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19959132|NCT01678976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20274714|NCT00551109|Nootropic Agents|nootropic agents|mesh-ancestor
20274715|NCT00551122|Gemcitabine|gemcitabine|mesh-list
20545030|NCT01878695|Protective Agents|protective agents|mesh-ancestor
20545031|NCT01878695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274716|NCT00551122|Paclitaxel|paclitaxel|mesh-list
20274717|NCT00551122|Ifosfamide|ifosfamide|mesh-list
20274718|NCT00551122|Lenograstim|lenograstim|mesh-list
20274719|NCT00551122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20274720|NCT00551122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274721|NCT00551122|Tubulin Modulators|tubulin modulators|mesh-ancestor
20274722|NCT00551122|Antimitotic Agents|antimitotic agents|mesh-ancestor
20274723|NCT00551122|Mitosis Modulators|mitosis modulators|mesh-ancestor
20274724|NCT00551122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274725|NCT00551122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20274726|NCT00551122|Antimetabolites|antimetabolites|mesh-ancestor
20274727|NCT00551122|Antiviral Agents|antiviral agents|mesh-ancestor
20274728|NCT00551122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20274729|NCT00551122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274730|NCT00551122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20274731|NCT00551122|Immunologic Factors|immunologic factors|mesh-ancestor
20274732|NCT00551122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274733|NCT00551122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20274734|NCT00551122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20274735|NCT00551122|Alkylating Agents|alkylating agents|mesh-ancestor
20274736|NCT00551239|Rituximab|rituximab|mesh-list
20274737|NCT00551239|Fludarabine|fludarabine|mesh-list
20274738|NCT00551239|Fludarabine phosphate|fludarabine phosphate|mesh-list
20274739|NCT00551239|Pixantrone|pixantrone|mesh-list
20274740|NCT00551239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20274741|NCT00551239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274742|NCT00551239|Immunologic Factors|immunologic factors|mesh-ancestor
20274743|NCT00551239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274744|NCT00551239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20274745|NCT00551239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20274746|NCT00551239|Antimetabolites|antimetabolites|mesh-ancestor
20274747|NCT00551239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274748|NCT00551239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20274749|NCT00551239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20274750|NCT00551239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20274751|NCT00551239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274752|NCT00551252|Gemcitabine|gemcitabine|mesh-list
20274753|NCT00551252|Imatinib Mesylate|imatinib mesylate|mesh-list
20274754|NCT00551252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20274755|NCT00551252|Antimetabolites|antimetabolites|mesh-ancestor
20274756|NCT00551252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274757|NCT00551252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274758|NCT00551252|Antiviral Agents|antiviral agents|mesh-ancestor
20274759|NCT00551252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20274760|NCT00551252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274761|NCT00551252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20274762|NCT00551252|Immunologic Factors|immunologic factors|mesh-ancestor
20274763|NCT00551252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274764|NCT00551252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20274765|NCT00551265|Cyclophosphamide|cyclophosphamide|mesh-list
20274766|NCT00551265|Oregovomab|oregovomab|mesh-list
20274767|NCT00551265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20274768|NCT00551265|Antibodies|antibodies|mesh-list
20274769|NCT00551265|Immunoglobulins|immunoglobulins|mesh-list
20274770|NCT00551265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19959133|NCT01679002|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19959134|NCT01679002|Oxcarbazepine|oxcarbazepine|mesh-list
19959135|NCT01679002|Anticonvulsants|anticonvulsants|mesh-ancestor
19959136|NCT01679002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19959137|NCT01679002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19959138|NCT01679002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19959139|NCT01679002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959140|NCT01679002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19959141|NCT01679002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19959142|NCT01679405|Gemcitabine|gemcitabine|mesh-list
19959143|NCT01679405|Cisplatin|cisplatin|mesh-list
20274771|NCT00551265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20274772|NCT00551265|Immunologic Factors|immunologic factors|mesh-ancestor
20274773|NCT00551265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274774|NCT00551265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20274775|NCT00551265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20274776|NCT00551265|Alkylating Agents|alkylating agents|mesh-ancestor
20274777|NCT00551265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959144|NCT01679405|Afatinib|afatinib|mesh-list
20274778|NCT00551265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274779|NCT00551265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19959145|NCT01679405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287689|NCT03901729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959146|NCT01679405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19959147|NCT01679405|Antimetabolites|antimetabolites|mesh-ancestor
19959148|NCT01679405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959149|NCT01679405|Antiviral Agents|antiviral agents|mesh-ancestor
19959150|NCT01679405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19959151|NCT01679405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959152|NCT01679405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19959153|NCT01679405|Immunologic Factors|immunologic factors|mesh-ancestor
19959154|NCT01679405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959155|NCT01679405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19959156|NCT01679613|Ketoconazole|ketoconazole|mesh-list
19959157|NCT01679613|Nintedanib|nintedanib|mesh-list
19959158|NCT01679613|Antifungal Agents|antifungal agents|mesh-ancestor
19959159|NCT01679613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20274780|NCT00551317|Darapladib|darapladib|mesh-list
20274781|NCT00551317|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
20274782|NCT00551317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274783|NCT00551317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545032|NCT01878695|Antidotes|antidotes|mesh-ancestor
20545033|NCT01878708|Dexamethasone|dexamethasone|mesh-list
20545034|NCT01878708|Dexamethasone acetate|dexamethasone acetate|mesh-list
20545035|NCT01878708|Asparaginase|asparaginase|mesh-list
20545036|NCT01878708|Pegaspargase|pegaspargase|mesh-list
20545037|NCT01878708|BB 1101|bb 1101|mesh-list
20545038|NCT01878708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20545039|NCT01878708|Antiemetics|antiemetics|mesh-ancestor
20545040|NCT01878708|Autonomic Agents|autonomic agents|mesh-ancestor
20545041|NCT01878708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545042|NCT01878708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545043|NCT01878708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20545044|NCT01878708|Glucocorticoids|glucocorticoids|mesh-ancestor
20545045|NCT01878708|Hormones|hormones|mesh-ancestor
20545046|NCT01878708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20545047|NCT01878708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20545048|NCT01878708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20545049|NCT01878708|Protease Inhibitors|protease inhibitors|mesh-ancestor
20545050|NCT01878708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545051|NCT01878708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545052|NCT01878734|Micronutrients|micronutrients|mesh-list
20545053|NCT01878734|Trace Elements|trace elements|mesh-list
20545054|NCT01878734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545055|NCT01878864|Lidocaine|lidocaine|mesh-list
20545056|NCT01878864|Bupivacaine|bupivacaine|mesh-list
20545057|NCT01878864|Anesthetics, Local|anesthetics, local|mesh-ancestor
20545058|NCT01878864|Anesthetics|anesthetics|mesh-ancestor
20545059|NCT01878864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20545060|NCT01878864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545061|NCT01878864|Sensory System Agents|sensory system agents|mesh-ancestor
20545062|NCT01878864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545063|NCT01878864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20545064|NCT01878864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20545065|NCT01878864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20545066|NCT01878864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20545067|NCT01878864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545068|NCT01878942|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
20545069|NCT01878942|Hallucinogens|hallucinogens|mesh-ancestor
20545070|NCT01878942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545071|NCT01878942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20545072|NCT01878942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20545073|NCT01878942|Serotonin Agents|serotonin agents|mesh-ancestor
20545074|NCT01878942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20545075|NCT01878942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545076|NCT01878942|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20545077|NCT01879007|Gemifloxacin|gemifloxacin|mesh-list
20545078|NCT01879007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20545079|NCT01879007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20545080|NCT01879007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20545081|NCT01879007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20545082|NCT01879007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554274|NCT01934634|Paclitaxel|paclitaxel|mesh-list
19959160|NCT01679613|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20274784|NCT00551343|Exenatide|exenatide|mesh-list
20274785|NCT00551343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20274786|NCT00551343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274787|NCT00551343|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20274788|NCT00551343|Incretins|incretins|mesh-ancestor
20274789|NCT00551343|Hormones|hormones|mesh-ancestor
20274790|NCT00551343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20274791|NCT00551356|Insulin Lispro|insulin lispro|mesh-list
20274792|NCT00551356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20274793|NCT00551356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274794|NCT00551382|Montelukast|montelukast|mesh-list
20274795|NCT00551382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20274796|NCT00551382|Respiratory System Agents|respiratory system agents|mesh-ancestor
20274797|NCT00551382|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20274798|NCT00551382|Hormone Antagonists|hormone antagonists|mesh-ancestor
20274799|NCT00551382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20274800|NCT00551382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274801|NCT00551382|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20274802|NCT00551382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20274803|NCT00551382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274804|NCT00551512|Cisplatin|cisplatin|mesh-list
20545083|NCT01879007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545084|NCT01879007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20545085|NCT01879033|Insulin|insulin|mesh-list
20545086|NCT01879033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20545087|NCT01879033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545088|NCT01879202|Methylphenidate|methylphenidate|mesh-list
20545089|NCT01879202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20545090|NCT01879202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545091|NCT01879202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19959161|NCT01679613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19959162|NCT01679613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545092|NCT01879202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20545093|NCT01879202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20545094|NCT01879202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545095|NCT01879202|Dopamine Agents|dopamine agents|mesh-ancestor
20545096|NCT01879202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20545097|NCT01879241|Rasagiline|rasagiline|mesh-list
20545098|NCT01879241|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20545099|NCT01879241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545100|NCT01879241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545101|NCT01879241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20545102|NCT01879241|Protective Agents|protective agents|mesh-ancestor
20545103|NCT01879241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545104|NCT01879293|Metformin|metformin|mesh-list
20545105|NCT01879293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20545106|NCT01879293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545107|NCT01879358|Sirolimus|sirolimus|mesh-list
20545108|NCT01879358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20545109|NCT01879358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20545110|NCT01879358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20545111|NCT01879358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20545112|NCT01879358|Antifungal Agents|antifungal agents|mesh-ancestor
20545113|NCT01879358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20545114|NCT01879358|Immunologic Factors|immunologic factors|mesh-ancestor
20545115|NCT01879358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554275|NCT01934634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20554276|NCT01934634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554277|NCT01934634|Tubulin Modulators|tubulin modulators|mesh-ancestor
20554278|NCT01934634|Antimitotic Agents|antimitotic agents|mesh-ancestor
20554279|NCT01934634|Mitosis Modulators|mitosis modulators|mesh-ancestor
20554280|NCT01934634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554281|NCT01934634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20554282|NCT01934634|Antimetabolites|antimetabolites|mesh-ancestor
20554283|NCT01934634|Antiviral Agents|antiviral agents|mesh-ancestor
20554284|NCT01934634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20554285|NCT01934634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554286|NCT01934634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20554287|NCT01934634|Immunologic Factors|immunologic factors|mesh-ancestor
20554288|NCT01934634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554289|NCT01934712|Insulin|insulin|mesh-list
20554290|NCT01934712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20554291|NCT01934712|Insulin Aspart|insulin aspart|mesh-list
20274805|NCT00551512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274806|NCT00551538|Insulin Glargine|insulin glargine|mesh-list
20274807|NCT00551538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20274808|NCT00551538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274809|NCT00551564|Rosiglitazone|rosiglitazone|mesh-list
20274810|NCT00551564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20274811|NCT00551564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274812|NCT00551577|Carboplatin|carboplatin|mesh-list
20274813|NCT00551577|Docetaxel|docetaxel|mesh-list
20274814|NCT00551577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274815|NCT00551577|Tubulin Modulators|tubulin modulators|mesh-ancestor
20274816|NCT00551577|Antimitotic Agents|antimitotic agents|mesh-ancestor
20274817|NCT00551577|Mitosis Modulators|mitosis modulators|mesh-ancestor
20274818|NCT00551577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274819|NCT00551590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20274820|NCT00551590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19959163|NCT01679613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959164|NCT01679613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19959165|NCT01679613|Hormone Antagonists|hormone antagonists|mesh-ancestor
20274821|NCT00551590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274822|NCT00551590|Incretins|incretins|mesh-ancestor
20274823|NCT00551590|Hormones|hormones|mesh-ancestor
20274824|NCT00551590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20274825|NCT00551590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20274826|NCT00551590|Protease Inhibitors|protease inhibitors|mesh-ancestor
20274827|NCT00551590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274828|NCT00551590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274829|NCT00551733|Paclitaxel|paclitaxel|mesh-list
20274830|NCT00551733|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20274831|NCT00551733|Carboplatin|carboplatin|mesh-list
20274832|NCT00551733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
20274833|NCT00551733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20274834|NCT00551733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274835|NCT00551733|Tubulin Modulators|tubulin modulators|mesh-ancestor
20274836|NCT00551733|Antimitotic Agents|antimitotic agents|mesh-ancestor
20274837|NCT00551733|Mitosis Modulators|mitosis modulators|mesh-ancestor
20274838|NCT00551733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274839|NCT00551824|Mitomycins|mitomycins|mesh-list
20274840|NCT00551824|Mitomycin|mitomycin|mesh-list
20274841|NCT00551824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20274842|NCT00551824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274843|NCT00551824|Alkylating Agents|alkylating agents|mesh-ancestor
20274844|NCT00551824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274845|NCT00551824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20274846|NCT00551824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274847|NCT00551850|MP 412|mp 412|mesh-list
20274848|NCT00551850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274849|NCT00551850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20274850|NCT00551850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274851|NCT00551850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274852|NCT00551889|Celecoxib|celecoxib|mesh-list
20274853|NCT00551889|Cyclophosphamide|cyclophosphamide|mesh-list
20274854|NCT00551889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20274855|NCT00551889|Immunologic Factors|immunologic factors|mesh-ancestor
20274856|NCT00551889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274857|NCT00551889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20274858|NCT00551889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20274859|NCT00551889|Alkylating Agents|alkylating agents|mesh-ancestor
20274860|NCT00551889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274861|NCT00551889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274862|NCT00551889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20274863|NCT00551889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20274864|NCT00551889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20274865|NCT00551889|Analgesics|analgesics|mesh-ancestor
20274866|NCT00551889|Sensory System Agents|sensory system agents|mesh-ancestor
20274867|NCT00551889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20274868|NCT00551889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20545116|NCT01879423|Lamotrigine|lamotrigine|mesh-list
19959166|NCT01679613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19959167|NCT01679613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959168|NCT01679613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19959169|NCT01679613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274869|NCT00551889|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20274870|NCT00551889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20274871|NCT00551889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274872|NCT00551954|Acarbose|acarbose|mesh-list
20274873|NCT00551954|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20274874|NCT00551954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545117|NCT01879423|Anticonvulsants|anticonvulsants|mesh-list
20545118|NCT01879423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20545119|NCT01879423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20545120|NCT01879423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545121|NCT01879423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20545122|NCT01879423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545123|NCT01879423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20545124|NCT01879423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20545125|NCT01879423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20545126|NCT01879423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20545127|NCT01879423|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20545128|NCT01879488|Edetic Acid|edetic acid|mesh-list
20545129|NCT01879488|Pentetic Acid|pentetic acid|mesh-list
20545130|NCT01879488|Antidotes|antidotes|mesh-ancestor
20545131|NCT01879488|Protective Agents|protective agents|mesh-ancestor
20545132|NCT01879488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545133|NCT01879488|Chelating Agents|chelating agents|mesh-ancestor
20545134|NCT01879488|Sequestering Agents|sequestering agents|mesh-ancestor
19959170|NCT01679613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19959171|NCT01680172|Ketamine|ketamine|mesh-list
19959172|NCT01680172|Analgesics|analgesics|mesh-ancestor
19959173|NCT01680172|Sensory System Agents|sensory system agents|mesh-ancestor
19959174|NCT01680172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19959175|NCT01680172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959176|NCT01680172|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19959177|NCT01680172|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19959178|NCT01680172|Anesthetics, General|anesthetics, general|mesh-ancestor
19959179|NCT01680172|Anesthetics|anesthetics|mesh-ancestor
19959180|NCT01680172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19959181|NCT01680172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19959182|NCT01680172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20274875|NCT00551954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545135|NCT01879488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545136|NCT01879488|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20545137|NCT01879488|Anticoagulants|anticoagulants|mesh-ancestor
20545138|NCT01879488|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20545139|NCT01879514|Prednisone|prednisone|mesh-list
20545140|NCT01879514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20545141|NCT01879514|Glucocorticoids|glucocorticoids|mesh-ancestor
20545142|NCT01879514|Hormones|hormones|mesh-ancestor
20545143|NCT01879514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20545144|NCT01879514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545145|NCT01879514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20545146|NCT01879514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20545147|NCT01879527|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20545148|NCT01879527|Amiloride|amiloride|mesh-list
20545149|NCT01879527|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
20545150|NCT01879527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20545151|NCT01879527|Diuretics|diuretics|mesh-ancestor
20545152|NCT01879527|Natriuretic Agents|natriuretic agents|mesh-ancestor
20545153|NCT01879527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545154|NCT01879527|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20545155|NCT01879527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20545156|NCT01879527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545157|NCT01879527|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20545158|NCT01879527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20545159|NCT01879527|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20545160|NCT01879527|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20545161|NCT01879605|Bisacodyl|bisacodyl|mesh-list
20545162|NCT01879605|Sorbitol|sorbitol|mesh-list
20545163|NCT01879605|Cathartics|cathartics|mesh-ancestor
20545164|NCT01879605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20545165|NCT01879605|Laxatives|laxatives|mesh-ancestor
20545166|NCT01879748|Rasagiline|rasagiline|mesh-list
20545167|NCT01879748|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20545168|NCT01879748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545169|NCT01879748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545170|NCT01879748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20274876|NCT00551954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19959183|NCT01680172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19959184|NCT01680172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959185|NCT01680341|Insulin|insulin|mesh-list
19959186|NCT01680341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19959187|NCT01680341|Insulin Aspart|insulin aspart|mesh-list
19959188|NCT01680341|Insulin, Long-Acting|insulin, long-acting|mesh-list
19959189|NCT01680341|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19959190|NCT01680341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19959191|NCT01680341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959192|NCT01680458|Fluconazole|fluconazole|mesh-list
19959193|NCT01680458|Antifungal Agents|antifungal agents|mesh-ancestor
19959194|NCT01680458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19959195|NCT01680458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19959196|NCT01680458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19959197|NCT01680458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959198|NCT01680458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959199|NCT01680458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19959200|NCT01680458|Hormone Antagonists|hormone antagonists|mesh-ancestor
19959201|NCT01680458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19959202|NCT01680458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959203|NCT01680458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19959204|NCT01680458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19959205|NCT01680497|Hyaluronic Acid|hyaluronic acid|mesh-list
19959206|NCT01680497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19959207|NCT01680497|Immunologic Factors|immunologic factors|mesh-ancestor
19959208|NCT01680497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959209|NCT01680497|Viscosupplements|viscosupplements|mesh-ancestor
19959210|NCT01680497|Protective Agents|protective agents|mesh-ancestor
19974783|NCT01842308|Melphalan|melphalan|mesh-list
19974784|NCT01842308|Mechlorethamine|mechlorethamine|mesh-list
19974785|NCT01842308|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19974786|NCT01842308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19974787|NCT01842308|Alkylating Agents|alkylating agents|mesh-ancestor
19974788|NCT01842308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974789|NCT01842308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974790|NCT01842308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19974791|NCT01842308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19974792|NCT01842308|Immunologic Factors|immunologic factors|mesh-ancestor
19974793|NCT01842308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974794|NCT01842334|Nicotine|nicotine|mesh-list
19974795|NCT01842334|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19974796|NCT01842334|Autonomic Agents|autonomic agents|mesh-ancestor
20274877|NCT00551954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274878|NCT00552149|Cetuximab|cetuximab|mesh-list
20274879|NCT00552149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20274880|NCT00552149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274881|NCT00552201|Tacrolimus|tacrolimus|mesh-list
20274882|NCT00552201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20274883|NCT00552201|Immunologic Factors|immunologic factors|mesh-ancestor
20274884|NCT00552201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274885|NCT00552201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20274886|NCT00552201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274887|NCT00552201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274888|NCT00552227|Ruboxistaurin|ruboxistaurin|mesh-list
20274889|NCT00552227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274890|NCT00552227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274891|NCT00552266|Methylphenidate|methylphenidate|mesh-list
20274892|NCT00552266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20274893|NCT00552266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274894|NCT00552266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20274895|NCT00552266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20274896|NCT00552266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20274897|NCT00552266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274898|NCT00552266|Dopamine Agents|dopamine agents|mesh-ancestor
20274899|NCT00552266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20274900|NCT00552370|Insulin Glargine|insulin glargine|mesh-list
20274901|NCT00552370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20274902|NCT00552370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274903|NCT00552461|Rituximab|rituximab|mesh-list
20274904|NCT00552461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20274905|NCT00552461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274906|NCT00552461|Immunologic Factors|immunologic factors|mesh-ancestor
20274907|NCT00552461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274908|NCT00552461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20274909|NCT00552500|Valproic Acid|valproic acid|mesh-list
20274910|NCT00552500|Anticonvulsants|anticonvulsants|mesh-ancestor
20274911|NCT00552500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20274912|NCT00552500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274913|NCT00552500|GABA Agents|gaba agents|mesh-ancestor
20274914|NCT00552500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20274915|NCT00552500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274916|NCT00552500|Antimanic Agents|antimanic agents|mesh-ancestor
20274917|NCT00552500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20274918|NCT00552500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20274919|NCT00552500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20274920|NCT00552526|Anticonvulsants|anticonvulsants|mesh-list
20274921|NCT00552630|Penicillamine|penicillamine|mesh-list
20274922|NCT00552630|Antidotes|antidotes|mesh-ancestor
20274923|NCT00552630|Protective Agents|protective agents|mesh-ancestor
20274924|NCT00552630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274925|NCT00552630|Chelating Agents|chelating agents|mesh-ancestor
20274926|NCT00552630|Sequestering Agents|sequestering agents|mesh-ancestor
20274927|NCT00552630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274928|NCT00552630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20274929|NCT00552656|Sirolimus|sirolimus|mesh-list
20274930|NCT00552656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20274931|NCT00552656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20274932|NCT00552656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20274933|NCT00552656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20274934|NCT00552656|Antifungal Agents|antifungal agents|mesh-ancestor
20274935|NCT00552656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20274936|NCT00552656|Immunologic Factors|immunologic factors|mesh-ancestor
20274937|NCT00552656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274938|NCT00552682|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20274939|NCT00552682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20274940|NCT00552682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20274941|NCT00552682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20274942|NCT00552682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274943|NCT00552682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20274944|NCT00552682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274945|NCT00552682|Analgesics|analgesics|mesh-ancestor
20274946|NCT00552682|Sensory System Agents|sensory system agents|mesh-ancestor
20274947|NCT00552682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20274948|NCT00552682|Antidepressive Agents|antidepressive agents|mesh-ancestor
20274949|NCT00552682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20274950|NCT00552682|Dopamine Agents|dopamine agents|mesh-ancestor
20274951|NCT00552734|Insulin|insulin|mesh-list
20274952|NCT00552734|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20274953|NCT00552734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20274954|NCT00552734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274955|NCT00552747|Fenofibrate|fenofibrate|mesh-list
20274956|NCT00552747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20274957|NCT00552747|Antimetabolites|antimetabolites|mesh-ancestor
20274958|NCT00552747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274959|NCT00552747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20274960|NCT00552799|Penicillins|penicillins|mesh-list
20274961|NCT00552799|Penicillin V|penicillin v|mesh-list
20274962|NCT00552799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20274963|NCT00552799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20274964|NCT00552838|Anti-Infective Agents|anti-infective agents|mesh-list
20274965|NCT00552838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20274966|NCT00552864|Ropivacaine|ropivacaine|mesh-list
20274967|NCT00552864|Levobupivacaine|levobupivacaine|mesh-list
20274968|NCT00552864|Anesthetics, Local|anesthetics, local|mesh-ancestor
20274969|NCT00552864|Anesthetics|anesthetics|mesh-ancestor
20274970|NCT00552864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20274971|NCT00552864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274972|NCT00552864|Sensory System Agents|sensory system agents|mesh-ancestor
20274973|NCT00552864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20274974|NCT00553020|Insulin Glargine|insulin glargine|mesh-list
20274975|NCT00553020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20274976|NCT00553020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274977|NCT00553072|Magnesium Sulfate|magnesium sulfate|mesh-list
20274978|NCT00553072|Analgesics|analgesics|mesh-ancestor
20274979|NCT00553072|Sensory System Agents|sensory system agents|mesh-ancestor
20274980|NCT00553072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20274981|NCT00553072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274982|NCT00553072|Anesthetics|anesthetics|mesh-ancestor
20274983|NCT00553072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20274984|NCT00553072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20274985|NCT00553072|Anticonvulsants|anticonvulsants|mesh-ancestor
20274986|NCT00553072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20274987|NCT00553072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20274988|NCT00553072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274989|NCT00553072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20274990|NCT00553072|Tocolytic Agents|tocolytic agents|mesh-ancestor
20274991|NCT00553072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20274992|NCT00553124|Vitamin E|vitamin e|mesh-list
20274993|NCT00553124|Selenium|selenium|mesh-list
20274994|NCT00553124|Vitamins|vitamins|mesh-ancestor
20274995|NCT00553124|Micronutrients|micronutrients|mesh-ancestor
20274996|NCT00553124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20274997|NCT00553124|Antioxidants|antioxidants|mesh-ancestor
20274998|NCT00553124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20274999|NCT00553124|Protective Agents|protective agents|mesh-ancestor
20275000|NCT00553124|Trace Elements|trace elements|mesh-ancestor
20275001|NCT00553137|Fluconazole|fluconazole|mesh-list
20275002|NCT00553137|Antifungal Agents|antifungal agents|mesh-ancestor
20275003|NCT00553137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20275004|NCT00553137|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20275005|NCT00553137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20275006|NCT00553137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275007|NCT00553137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275008|NCT00553137|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20275009|NCT00553137|Hormone Antagonists|hormone antagonists|mesh-ancestor
20275010|NCT00553137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20275011|NCT00553137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275012|NCT00553137|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20275013|NCT00553137|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20287690|NCT03901729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20287691|NCT03901729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20287692|NCT03901729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287693|NCT03897335|Aminophylline|aminophylline|mesh-list
20287694|NCT03897335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20287695|NCT03897335|Autonomic Agents|autonomic agents|mesh-ancestor
20287696|NCT03897335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287697|NCT03897335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287698|NCT03897335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20287699|NCT03897335|Respiratory System Agents|respiratory system agents|mesh-ancestor
20287700|NCT03897335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20287701|NCT03897335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20287702|NCT03897335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287703|NCT03897335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287704|NCT03897335|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20287705|NCT03897335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20287706|NCT03897335|Purinergic Agents|purinergic agents|mesh-ancestor
20287707|NCT03897335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20287708|NCT03897335|Protective Agents|protective agents|mesh-ancestor
20287709|NCT03896230|Ketamine|ketamine|mesh-list
19959211|NCT01680549|Gabapentin|gabapentin|mesh-list
19959212|NCT01680549|Analgesics|analgesics|mesh-ancestor
19959213|NCT01680549|Sensory System Agents|sensory system agents|mesh-ancestor
19959214|NCT01680549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19959215|NCT01680549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959216|NCT01680549|Anticonvulsants|anticonvulsants|mesh-ancestor
19959217|NCT01680549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19959218|NCT01680549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19959219|NCT01680549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19959220|NCT01680549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19959221|NCT01680549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19959222|NCT01680549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19959223|NCT01680549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19959224|NCT01680549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959225|NCT01680549|Antimanic Agents|antimanic agents|mesh-ancestor
19959226|NCT01680653|Glucagon|glucagon|mesh-list
19959227|NCT01680653|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19959228|NCT01680653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19959229|NCT01680653|Hormones|hormones|mesh-ancestor
19959230|NCT01680653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19959231|NCT01680653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959232|NCT01680653|Incretins|incretins|mesh-ancestor
19959233|NCT01680861|Mycophenolic Acid|mycophenolic acid|mesh-list
19959234|NCT01680861|Methylprednisolone|methylprednisolone|mesh-list
19959235|NCT01680861|Everolimus|everolimus|mesh-list
19959236|NCT01680861|Tacrolimus|tacrolimus|mesh-list
19959237|NCT01680861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19959238|NCT01680861|Immunologic Factors|immunologic factors|mesh-ancestor
19959239|NCT01680861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959240|NCT01680861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19959241|NCT01680861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959242|NCT01680861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959243|NCT01680861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959244|NCT01680861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19959245|NCT01680861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19959246|NCT01680861|Antitubercular Agents|antitubercular agents|mesh-ancestor
19959247|NCT01680861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19959248|NCT01680861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19959249|NCT01680861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19959250|NCT01680861|Antiemetics|antiemetics|mesh-ancestor
19959251|NCT01680861|Autonomic Agents|autonomic agents|mesh-ancestor
19959252|NCT01680861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19959253|NCT01680861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19959254|NCT01680861|Glucocorticoids|glucocorticoids|mesh-ancestor
19959255|NCT01680861|Hormones|hormones|mesh-ancestor
19959256|NCT01680861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19959257|NCT01680861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19959258|NCT01680861|Protective Agents|protective agents|mesh-ancestor
19959259|NCT01680887|Varenicline|varenicline|mesh-list
19959260|NCT01680887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19959261|NCT01680887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19959262|NCT01680887|Cholinergic Agents|cholinergic agents|mesh-ancestor
19959263|NCT01680887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19959264|NCT01680887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959265|NCT01680887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959266|NCT01680900|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
19959267|NCT01680900|Antidepressive Agents|antidepressive agents|mesh-ancestor
19959268|NCT01680900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19959269|NCT01680900|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19959270|NCT01680900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19959271|NCT01680900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19959272|NCT01680900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959273|NCT01680900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19959274|NCT01680900|Serotonin Agents|serotonin agents|mesh-ancestor
19959275|NCT01680900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959276|NCT01680900|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19959277|NCT01680900|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19959278|NCT01680991|Obinutuzumab|obinutuzumab|mesh-list
19959279|NCT01680991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19959280|NCT01680991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959281|NCT01681030|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19959282|NCT01681030|Hemostatics|hemostatics|mesh-ancestor
19959283|NCT01681030|Coagulants|coagulants|mesh-ancestor
19959284|NCT01681095|Tryptophan|tryptophan|mesh-list
19959285|NCT01681095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19959286|NCT01681095|Antidepressive Agents|antidepressive agents|mesh-ancestor
19959287|NCT01681095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19959288|NCT01681186|Lansoprazole|lansoprazole|mesh-list
19959289|NCT01681186|Dexlansoprazole|dexlansoprazole|mesh-list
19959290|NCT01681186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19959291|NCT01681186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19959292|NCT01681186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19959293|NCT01681186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959294|NCT01681186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959295|NCT01681212|Ipilimumab|ipilimumab|mesh-list
19959296|NCT01681212|Dacarbazine|dacarbazine|mesh-list
19959297|NCT01681212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19959298|NCT01681212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959299|NCT01681212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19959300|NCT01681212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959301|NCT01681212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19959302|NCT01681212|Alkylating Agents|alkylating agents|mesh-ancestor
19959303|NCT01681433|Prednisone|prednisone|mesh-list
19959304|NCT01681433|Abiraterone Acetate|abiraterone acetate|mesh-list
19959305|NCT01681433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19959306|NCT01681433|Glucocorticoids|glucocorticoids|mesh-ancestor
19959307|NCT01681433|Hormones|hormones|mesh-ancestor
19959308|NCT01681433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19959309|NCT01681433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959310|NCT01681433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19959311|NCT01681433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959312|NCT01681433|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19959313|NCT01681433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959314|NCT01681433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959315|NCT01681433|Hormone Antagonists|hormone antagonists|mesh-ancestor
19959316|NCT01681433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19959317|NCT01681472|Leucovorin|leucovorin|mesh-list
19959318|NCT01681472|Tetrahydrofolates|tetrahydrofolates|mesh-list
19959319|NCT01681472|Levoleucovorin|levoleucovorin|mesh-list
19959320|NCT01681472|Antidotes|antidotes|mesh-ancestor
19959321|NCT01681472|Protective Agents|protective agents|mesh-ancestor
19959322|NCT01681472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959323|NCT01681472|Vitamin B Complex|vitamin b complex|mesh-ancestor
19959324|NCT01681472|Vitamins|vitamins|mesh-ancestor
19959325|NCT01681472|Micronutrients|micronutrients|mesh-ancestor
19959326|NCT01681576|Valsartan|valsartan|mesh-list
19959327|NCT01681576|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19959328|NCT01681576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19959329|NCT01681576|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19959330|NCT01681576|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19959331|NCT01681576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959332|NCT01681849|Paroxetine|paroxetine|mesh-list
19959333|NCT01681849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19959334|NCT01681849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19959335|NCT01681849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19959336|NCT01681849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959337|NCT01681849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19959338|NCT01681849|Serotonin Agents|serotonin agents|mesh-ancestor
19959339|NCT01681849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959340|NCT01681849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19959341|NCT01681849|Antidepressive Agents|antidepressive agents|mesh-ancestor
19959342|NCT01681849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19959343|NCT01681849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19959344|NCT01681849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19959345|NCT01681849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959346|NCT01681992|Vaccines|vaccines|mesh-list
19959347|NCT01681992|Immunologic Factors|immunologic factors|mesh-ancestor
19959348|NCT01681992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959349|NCT01682031|Selenium|selenium|mesh-list
19959350|NCT01682031|Antioxidants|antioxidants|mesh-ancestor
19959351|NCT01682031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959352|NCT01682031|Protective Agents|protective agents|mesh-ancestor
19959353|NCT01682031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959354|NCT01682031|Trace Elements|trace elements|mesh-ancestor
19959355|NCT01682031|Micronutrients|micronutrients|mesh-ancestor
19959356|NCT01682044|Rituximab|rituximab|mesh-list
19959357|NCT01682044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19959358|NCT01682044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959359|NCT01682044|Immunologic Factors|immunologic factors|mesh-ancestor
19959360|NCT01682044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959361|NCT01682044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19959362|NCT01682083|Trametinib|trametinib|mesh-list
19959363|NCT01682083|Dabrafenib|dabrafenib|mesh-list
19959364|NCT01682083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959365|NCT01682083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19959366|NCT01682083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959367|NCT01682083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959368|NCT01682135|Ramucirumab|ramucirumab|mesh-list
19959369|NCT01682135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959370|NCT01682148|Botulinum Toxins|botulinum toxins|mesh-list
19959371|NCT01682148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19959372|NCT01682148|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19959373|NCT01682148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19959374|NCT01682148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19959375|NCT01682148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959376|NCT01682148|Cholinergic Agents|cholinergic agents|mesh-ancestor
19959377|NCT01682148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19959378|NCT01682148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959379|NCT01682148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19959380|NCT01682148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19959381|NCT01682213|Dabrafenib|dabrafenib|mesh-list
19959382|NCT01682213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959383|NCT01682213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19959384|NCT01682213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959385|NCT01682213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959386|NCT01682460|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19959387|NCT01682460|Lubricant Eye Drops|lubricant eye drops|mesh-list
19959388|NCT01682460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19959389|NCT01682512|Rituximab|rituximab|mesh-list
19959390|NCT01682512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19959391|NCT01682512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959392|NCT01682512|Immunologic Factors|immunologic factors|mesh-ancestor
19959393|NCT01682512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959394|NCT01682512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20275014|NCT00553189|Topotecan|topotecan|mesh-list
20275015|NCT00553189|Veliparib|veliparib|mesh-list
20275016|NCT00553189|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20275017|NCT00553189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20275018|NCT00553189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275019|NCT00553189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275020|NCT00553189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275021|NCT00553189|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20275022|NCT00553293|Hormones|hormones|mesh-list
20275023|NCT00553293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20275024|NCT00553293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20275025|NCT00553293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275026|NCT00553345|Vitamin E|vitamin e|mesh-list
20275027|NCT00553345|Selenium|selenium|mesh-list
20275028|NCT00553345|Vitamins|vitamins|mesh-ancestor
20275029|NCT00553345|Micronutrients|micronutrients|mesh-ancestor
20275030|NCT00553345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275031|NCT00553345|Antioxidants|antioxidants|mesh-ancestor
20275032|NCT00553345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275033|NCT00553345|Protective Agents|protective agents|mesh-ancestor
20275034|NCT00553345|Trace Elements|trace elements|mesh-ancestor
20275035|NCT00553423|Lactulose|lactulose|mesh-list
20275036|NCT00553423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20275037|NCT00553449|Rabeprazole|rabeprazole|mesh-list
20275038|NCT00553449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20275039|NCT00553449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20275040|NCT00553449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20275041|NCT00553449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275042|NCT00553449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275043|NCT00553488|Insulin|insulin|mesh-list
20275044|NCT00553488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20275045|NCT00553488|Insulin Lispro|insulin lispro|mesh-list
20275046|NCT00553488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20275047|NCT00553488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275048|NCT00553553|Morphine|morphine|mesh-list
20275049|NCT00553553|Remifentanil|remifentanil|mesh-list
20275050|NCT00553553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20275051|NCT00553553|Narcotics|narcotics|mesh-ancestor
20275052|NCT00553553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20275053|NCT00553553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275054|NCT00553553|Analgesics|analgesics|mesh-ancestor
20275055|NCT00553553|Sensory System Agents|sensory system agents|mesh-ancestor
20275056|NCT00553553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275057|NCT00553618|Aldesleukin|aldesleukin|mesh-list
20275058|NCT00553618|Dacarbazine|dacarbazine|mesh-list
20275059|NCT00553618|Interleukin-2|interleukin-2|mesh-list
20545171|NCT01879748|Protective Agents|protective agents|mesh-ancestor
20545172|NCT01879748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545173|NCT01879917|Liraglutide|liraglutide|mesh-list
20545174|NCT01879917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20545175|NCT01879917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545176|NCT01879917|Incretins|incretins|mesh-ancestor
20545177|NCT01879917|Hormones|hormones|mesh-ancestor
20545178|NCT01879917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20545179|NCT01879930|Doxycycline|doxycycline|mesh-list
19959395|NCT01682538|Nitisinone|nitisinone|mesh-list
19959396|NCT01682538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275060|NCT00553618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20275061|NCT00553618|Alkylating Agents|alkylating agents|mesh-ancestor
20275062|NCT00553618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545180|NCT01879930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19959397|NCT01682538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959398|NCT01682603|Botulinum Toxins|botulinum toxins|mesh-list
19959399|NCT01682603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19959400|NCT01682603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19959401|NCT01682603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19959402|NCT01682603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19959403|NCT01682603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959404|NCT01682603|Cholinergic Agents|cholinergic agents|mesh-ancestor
19959405|NCT01682603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19959406|NCT01682603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275063|NCT00553618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275064|NCT00553618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20275065|NCT00553618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20275066|NCT00553618|Antiviral Agents|antiviral agents|mesh-ancestor
20275067|NCT00553618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20275068|NCT00553618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20275069|NCT00553618|Analgesics|analgesics|mesh-ancestor
20275070|NCT00553618|Sensory System Agents|sensory system agents|mesh-ancestor
20275071|NCT00553618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275072|NCT00553618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275073|NCT00553683|Cyclophosphamide|cyclophosphamide|mesh-list
20275074|NCT00553683|Poly ICLC|poly iclc|mesh-list
20275075|NCT00553683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20275076|NCT00553683|Immunologic Factors|immunologic factors|mesh-ancestor
20275077|NCT00553683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275078|NCT00553683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20275079|NCT00553683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20275080|NCT00553683|Alkylating Agents|alkylating agents|mesh-ancestor
20275081|NCT00553683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275082|NCT00553683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275083|NCT00553683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20275084|NCT00553683|Interferon Inducers|interferon inducers|mesh-ancestor
20275085|NCT00553709|Nicotine|nicotine|mesh-list
20275086|NCT00553709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20275087|NCT00553709|Autonomic Agents|autonomic agents|mesh-ancestor
20275088|NCT00553709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275089|NCT00553709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275090|NCT00553709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20275091|NCT00553709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20275092|NCT00553709|Cholinergic Agents|cholinergic agents|mesh-ancestor
20275093|NCT00553709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20275094|NCT00553709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275095|NCT00553722|Eplerenone|eplerenone|mesh-list
20275096|NCT00553722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20275097|NCT00553722|Hormone Antagonists|hormone antagonists|mesh-ancestor
20275098|NCT00553722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20275099|NCT00553722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275100|NCT00553722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20275101|NCT00553722|Diuretics|diuretics|mesh-ancestor
20275102|NCT00553722|Natriuretic Agents|natriuretic agents|mesh-ancestor
20275103|NCT00553722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20275104|NCT00553748|Alovudine|alovudine|mesh-list
20545181|NCT01879930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19959407|NCT01682603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19959408|NCT01682603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19959409|NCT01682642|Goserelin|goserelin|mesh-list
19959410|NCT01682642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19959411|NCT01682642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959412|NCT01682681|Topiramate|topiramate|mesh-list
19959413|NCT01682681|Anticonvulsants|anticonvulsants|mesh-ancestor
19959414|NCT01682681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19959415|NCT01682681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959416|NCT01682720|Sofosbuvir|sofosbuvir|mesh-list
19959417|NCT01682720|Antiviral Agents|antiviral agents|mesh-ancestor
19959418|NCT01682720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19959419|NCT01682759|Metformin|metformin|mesh-list
19959420|NCT01682759|Insulin Glargine|insulin glargine|mesh-list
20545182|NCT01879930|Antimalarials|antimalarials|mesh-ancestor
20545183|NCT01879930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19959421|NCT01682759|Glimepiride|glimepiride|mesh-list
19959422|NCT01682759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19959423|NCT01682759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959424|NCT01682759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19959425|NCT01682759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20545184|NCT01879930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20545185|NCT01880112|Cefazolin|cefazolin|mesh-list
19959426|NCT01682759|Immunologic Factors|immunologic factors|mesh-ancestor
19959427|NCT01682811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19959428|NCT01682811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19959429|NCT01682811|Dermatologic Agents|dermatologic agents|mesh-ancestor
19959430|NCT01682837|Potassium Citrate|potassium citrate|mesh-list
19959431|NCT01682837|Magnesium citrate|magnesium citrate|mesh-list
19959432|NCT01682837|Citric Acid|citric acid|mesh-list
19959433|NCT01682837|Sodium Citrate|sodium citrate|mesh-list
19959434|NCT01682837|Anticoagulants|anticoagulants|mesh-ancestor
19959435|NCT01682837|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19959436|NCT01682837|Chelating Agents|chelating agents|mesh-ancestor
19959437|NCT01682837|Sequestering Agents|sequestering agents|mesh-ancestor
19959438|NCT01682837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959439|NCT01682837|Diuretics|diuretics|mesh-ancestor
19959440|NCT01682837|Natriuretic Agents|natriuretic agents|mesh-ancestor
19959441|NCT01682837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959442|NCT01682837|Expectorants|expectorants|mesh-ancestor
19959443|NCT01682837|Respiratory System Agents|respiratory system agents|mesh-ancestor
19959444|NCT01682837|Cathartics|cathartics|mesh-ancestor
19959445|NCT01682837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19959446|NCT01682863|Glycopyrrolate|glycopyrrolate|mesh-list
19959447|NCT01682863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19959448|NCT01682863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19959449|NCT01682863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19959450|NCT01682863|Cholinergic Agents|cholinergic agents|mesh-ancestor
19959451|NCT01682863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19959452|NCT01682863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959453|NCT01682863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959454|NCT01683058|Aripiprazole|aripiprazole|mesh-list
19959455|NCT01683058|Antidepressive Agents|antidepressive agents|mesh-ancestor
19959456|NCT01683058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19959457|NCT01683058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19959458|NCT01683058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19959459|NCT01683058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19959460|NCT01683058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959461|NCT01683058|Dopamine Agonists|dopamine agonists|mesh-ancestor
19959462|NCT01683058|Dopamine Agents|dopamine agents|mesh-ancestor
19959463|NCT01683058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19959464|NCT01683058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959465|NCT01683058|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19959466|NCT01683058|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19959467|NCT01683058|Serotonin Agents|serotonin agents|mesh-ancestor
19959468|NCT01683058|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19959469|NCT01683058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19959470|NCT01683058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19959471|NCT01683058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19959472|NCT01683071|Bupivacaine|bupivacaine|mesh-list
19959473|NCT01683071|Anesthetics, Local|anesthetics, local|mesh-ancestor
19959474|NCT01683071|Anesthetics|anesthetics|mesh-ancestor
19959475|NCT01683071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19959476|NCT01683071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959477|NCT01683071|Sensory System Agents|sensory system agents|mesh-ancestor
19959478|NCT01683071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19959479|NCT01683266|Insulin|insulin|mesh-list
19959480|NCT01683266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19959481|NCT01683266|Insulin Glargine|insulin glargine|mesh-list
19959482|NCT01683266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19959483|NCT01683266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959484|NCT01683331|Insulin|insulin|mesh-list
19959485|NCT01683331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19959486|NCT01683331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959487|NCT01683422|Gemcitabine|gemcitabine|mesh-list
19959488|NCT01683422|Capecitabine|capecitabine|mesh-list
19959489|NCT01683422|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19959490|NCT01683422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19959491|NCT01683422|Antimetabolites|antimetabolites|mesh-ancestor
19959492|NCT01683422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959493|NCT01683422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959494|NCT01683422|Antiviral Agents|antiviral agents|mesh-ancestor
19959495|NCT01683422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19959496|NCT01683422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959497|NCT01683422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19959498|NCT01683422|Immunologic Factors|immunologic factors|mesh-ancestor
19959499|NCT01683422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959500|NCT01683422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19959501|NCT01683838|4-Aminopyridine|4-aminopyridine|mesh-list
19959502|NCT01683838|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19959503|NCT01683838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19959504|NCT01683838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959505|NCT01683994|Prednisone|prednisone|mesh-list
19959506|NCT01683994|Docetaxel|docetaxel|mesh-list
19959507|NCT01683994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959508|NCT01683994|Tubulin Modulators|tubulin modulators|mesh-ancestor
19959509|NCT01683994|Antimitotic Agents|antimitotic agents|mesh-ancestor
19959510|NCT01683994|Mitosis Modulators|mitosis modulators|mesh-ancestor
19959511|NCT01683994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959512|NCT01683994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19959513|NCT01683994|Glucocorticoids|glucocorticoids|mesh-ancestor
19959514|NCT01683994|Hormones|hormones|mesh-ancestor
19959515|NCT01683994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19959516|NCT01683994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959517|NCT01683994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19959518|NCT01684020|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19959519|NCT01684020|Hemostatics|hemostatics|mesh-ancestor
19959520|NCT01684020|Coagulants|coagulants|mesh-ancestor
19959521|NCT01684202|Tolvaptan|tolvaptan|mesh-list
19959522|NCT01684202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19959523|NCT01684202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959524|NCT01684202|Natriuretic Agents|natriuretic agents|mesh-ancestor
19959525|NCT01684202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959526|NCT01684215|Letrozole|letrozole|mesh-list
19959527|NCT01684215|Palbociclib|palbociclib|mesh-list
19959528|NCT01684215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959529|NCT01684215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19959530|NCT01684215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19959531|NCT01684215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959532|NCT01684215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959533|NCT01684215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19959534|NCT01684215|Hormone Antagonists|hormone antagonists|mesh-ancestor
19959535|NCT01684215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19959536|NCT01684215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959537|NCT01684215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19959538|NCT01684410|Protease Inhibitors|protease inhibitors|mesh-list
19959539|NCT01684410|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19959540|NCT01684410|Protein C Inhibitor|protein c inhibitor|mesh-list
19959541|NCT01684410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959542|NCT01684410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959543|NCT01684410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19959544|NCT01684410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19959545|NCT01684423|Rivaroxaban|rivaroxaban|mesh-list
19959546|NCT01684423|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19959547|NCT01684423|Antithrombins|antithrombins|mesh-ancestor
19959548|NCT01684423|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19959549|NCT01684423|Protease Inhibitors|protease inhibitors|mesh-ancestor
19959550|NCT01684423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959551|NCT01684423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959552|NCT01684423|Anticoagulants|anticoagulants|mesh-ancestor
19959553|NCT01684722|Vitamin D|vitamin d|mesh-list
19959554|NCT01684722|Ergocalciferols|ergocalciferols|mesh-list
19959555|NCT01684722|Vitamins|vitamins|mesh-list
19959556|NCT01684722|Micronutrients|micronutrients|mesh-ancestor
19959557|NCT01684722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959558|NCT01684722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19959559|NCT01684722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19959560|NCT01684748|Olmesartan|olmesartan|mesh-list
19959561|NCT01684748|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19959562|NCT01684748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19959563|NCT01684748|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19959564|NCT01684748|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19959565|NCT01684748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959566|NCT01684878|Gemcitabine|gemcitabine|mesh-list
19959567|NCT01684878|Paclitaxel|paclitaxel|mesh-list
19959568|NCT01684878|Topotecan|topotecan|mesh-list
19959569|NCT01684878|Pertuzumab|pertuzumab|mesh-list
19959570|NCT01684878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19959571|NCT01684878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959572|NCT01684878|Tubulin Modulators|tubulin modulators|mesh-ancestor
19959573|NCT01684878|Antimitotic Agents|antimitotic agents|mesh-ancestor
19959574|NCT01684878|Mitosis Modulators|mitosis modulators|mesh-ancestor
19959575|NCT01684878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959576|NCT01684878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19959577|NCT01684878|Antimetabolites|antimetabolites|mesh-ancestor
19959578|NCT01684878|Antiviral Agents|antiviral agents|mesh-ancestor
19959579|NCT01684878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19959580|NCT01684878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959581|NCT01684878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19959582|NCT01684878|Immunologic Factors|immunologic factors|mesh-ancestor
19959583|NCT01684878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959584|NCT01684878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19959585|NCT01684878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19959586|NCT01684878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19959587|NCT01684943|Insulin|insulin|mesh-list
19959588|NCT01684943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19959589|NCT01684943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959590|NCT01685060|Ceritinib|ceritinib|mesh-list
19959591|NCT01685060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959592|NCT01685060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19959593|NCT01685060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959594|NCT01685060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959595|NCT01685073|Zolpidem|zolpidem|mesh-list
19959596|NCT01685073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19959597|NCT01685073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19959598|NCT01685073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19959599|NCT01685073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959600|NCT01685073|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19959601|NCT01685073|GABA Agonists|gaba agonists|mesh-ancestor
19959602|NCT01685073|GABA Agents|gaba agents|mesh-ancestor
19959603|NCT01685073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19959604|NCT01685073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959605|NCT01685138|Ceritinib|ceritinib|mesh-list
19959606|NCT01685138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959607|NCT01685138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19959608|NCT01685138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959609|NCT01685138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959610|NCT01685203|Ribavirin|ribavirin|mesh-list
19959611|NCT01685203|Antimetabolites|antimetabolites|mesh-ancestor
19959612|NCT01685203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959613|NCT01685203|Antiviral Agents|antiviral agents|mesh-ancestor
19959614|NCT01685203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19959615|NCT01685242|Cetirizine|cetirizine|mesh-list
19959616|NCT01685242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19959617|NCT01685242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19959618|NCT01685242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19959619|NCT01685242|Histamine Antagonists|histamine antagonists|mesh-ancestor
19959620|NCT01685242|Histamine Agents|histamine agents|mesh-ancestor
19959621|NCT01685242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19959622|NCT01685242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959623|NCT01685242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959624|NCT01685372|Vaccines|vaccines|mesh-list
19959625|NCT01685372|Immunologic Factors|immunologic factors|mesh-ancestor
19959626|NCT01685372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959627|NCT01685411|Mycophenolic Acid|mycophenolic acid|mesh-list
19959628|NCT01685411|Cyclophosphamide|cyclophosphamide|mesh-list
19959629|NCT01685411|Busulfan|busulfan|mesh-list
19959630|NCT01685411|Allopurinol|allopurinol|mesh-list
19959631|NCT01685411|Levetiracetam|levetiracetam|mesh-list
19959632|NCT01685411|Tacrolimus|tacrolimus|mesh-list
19959633|NCT01685411|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19959634|NCT01685411|Lenograstim|lenograstim|mesh-list
19959635|NCT01685411|Sargramostim|sargramostim|mesh-list
19959636|NCT01685411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19959637|NCT01685411|Immunologic Factors|immunologic factors|mesh-ancestor
19959638|NCT01685411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959639|NCT01685411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19959640|NCT01685411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19959641|NCT01685411|Alkylating Agents|alkylating agents|mesh-ancestor
19959642|NCT01685411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275105|NCT00553748|Antiviral Agents|antiviral agents|mesh-ancestor
20275106|NCT00553748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19959643|NCT01685411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959644|NCT01685411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19959645|NCT01685411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19959646|NCT01685411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19959647|NCT01685411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959648|NCT01685411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19959649|NCT01685411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19959650|NCT01685411|Antitubercular Agents|antitubercular agents|mesh-ancestor
19959651|NCT01685411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19959652|NCT01685411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19959653|NCT01685411|Anticonvulsants|anticonvulsants|mesh-ancestor
19959654|NCT01685411|Nootropic Agents|nootropic agents|mesh-ancestor
19959655|NCT01685411|Antimetabolites|antimetabolites|mesh-ancestor
19959656|NCT01685411|Gout Suppressants|gout suppressants|mesh-ancestor
19959657|NCT01685411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19959658|NCT01685411|Antioxidants|antioxidants|mesh-ancestor
19959659|NCT01685411|Protective Agents|protective agents|mesh-ancestor
19959660|NCT01685684|Oxycodone|oxycodone|mesh-list
19959661|NCT01685684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19959662|NCT01685684|Narcotics|narcotics|mesh-ancestor
19959663|NCT01685684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19959664|NCT01685684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959665|NCT01685684|Analgesics|analgesics|mesh-ancestor
19959666|NCT01685684|Sensory System Agents|sensory system agents|mesh-ancestor
19959667|NCT01685684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19959668|NCT01685801|Ivacaftor|ivacaftor|mesh-list
19959669|NCT01685801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19959670|NCT01685801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19959671|NCT01685801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974797|NCT01842334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19974798|NCT01842334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974799|NCT01842334|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19974800|NCT01842334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19974801|NCT01842334|Cholinergic Agents|cholinergic agents|mesh-ancestor
19974802|NCT01842334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19974803|NCT01842334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974804|NCT01842581|Rifaximin|rifaximin|mesh-list
19974805|NCT01842581|Lactulose|lactulose|mesh-list
19974806|NCT01842581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19974807|NCT01842581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19974808|NCT01842581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19974809|NCT01842594|Sirolimus|sirolimus|mesh-list
19974810|NCT01842594|Hydroxychloroquine|hydroxychloroquine|mesh-list
19974811|NCT01842594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19974812|NCT01842594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19974813|NCT01842594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19974814|NCT01842594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974815|NCT01842594|Antifungal Agents|antifungal agents|mesh-ancestor
19974816|NCT01842594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19974817|NCT01842594|Immunologic Factors|immunologic factors|mesh-ancestor
19974818|NCT01842594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974819|NCT01842594|Antimalarials|antimalarials|mesh-ancestor
19974820|NCT01842594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19974821|NCT01842594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19974822|NCT01842594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974823|NCT01842594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974824|NCT01842594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19974825|NCT01842620|Metformin|metformin|mesh-list
19974826|NCT01842620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19974827|NCT01842620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974828|NCT01842633|Acetaminophen|acetaminophen|mesh-list
19974829|NCT01842633|Ibuprofen|ibuprofen|mesh-list
19974830|NCT01842633|Caffeine|caffeine|mesh-list
19974831|NCT01842633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19974832|NCT01842633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19974833|NCT01842633|Analgesics|analgesics|mesh-ancestor
19974834|NCT01842633|Sensory System Agents|sensory system agents|mesh-ancestor
19974835|NCT01842633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19974836|NCT01842633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974837|NCT01842633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20275107|NCT00553800|Bevacizumab|bevacizumab|mesh-list
20275108|NCT00553800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20275109|NCT00553800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19974838|NCT01842633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19974839|NCT01842633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19974840|NCT01842633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974841|NCT01842633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287710|NCT03896230|Analgesics|analgesics|mesh-ancestor
19959672|NCT01685983|Prednisolone|prednisolone|mesh-list
19959673|NCT01685983|Abiraterone Acetate|abiraterone acetate|mesh-list
19959674|NCT01685983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20275110|NCT00553800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275111|NCT00553800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20275112|NCT00553800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20275113|NCT00553800|Growth Substances|growth substances|mesh-ancestor
20275114|NCT00553800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959675|NCT01685983|Glucocorticoids|glucocorticoids|mesh-ancestor
19959676|NCT01685983|Hormones|hormones|mesh-ancestor
19959677|NCT01685983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19959678|NCT01685983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959679|NCT01685983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19959680|NCT01685983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959681|NCT01685983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19959682|NCT01685983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959683|NCT01685983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959684|NCT01685983|Hormone Antagonists|hormone antagonists|mesh-ancestor
19959685|NCT01685983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19959686|NCT01685996|Zonisamide|zonisamide|mesh-list
19959687|NCT01685996|Anticonvulsants|anticonvulsants|mesh-ancestor
19959688|NCT01685996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19959689|NCT01685996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19959690|NCT01685996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959691|NCT01685996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19959692|NCT01685996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959693|NCT01686152|Imiquimod|imiquimod|mesh-list
19959694|NCT01686152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19959695|NCT01686152|Immunologic Factors|immunologic factors|mesh-ancestor
19959696|NCT01686152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959697|NCT01686152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959698|NCT01686152|Interferon Inducers|interferon inducers|mesh-ancestor
19959699|NCT01686165|Rituximab|rituximab|mesh-list
19959700|NCT01686165|Belinostat|belinostat|mesh-list
19959701|NCT01686165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19959702|NCT01686165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19959703|NCT01686165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959704|NCT01686165|Immunologic Factors|immunologic factors|mesh-ancestor
19959705|NCT01686165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275115|NCT00553800|Growth Inhibitors|growth inhibitors|mesh-ancestor
20275116|NCT00553800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20275117|NCT00553800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275118|NCT00553800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275119|NCT00553878|Dutasteride|dutasteride|mesh-list
20275120|NCT00553878|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20275121|NCT00553878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20275122|NCT00553878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275123|NCT00553878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275124|NCT00553878|Hormone Antagonists|hormone antagonists|mesh-ancestor
20275125|NCT00553878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20275126|NCT00553878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275127|NCT00553930|Interferons|interferons|mesh-list
20275128|NCT00553930|Ribavirin|ribavirin|mesh-list
20275129|NCT00553930|Interferon-alpha|interferon-alpha|mesh-list
20275130|NCT00553930|Interferon alpha-2|interferon alpha-2|mesh-list
20275131|NCT00553930|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20275132|NCT00553930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275133|NCT00553930|Antiviral Agents|antiviral agents|mesh-ancestor
20275134|NCT00553930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20275135|NCT00553930|Antimetabolites|antimetabolites|mesh-ancestor
19959706|NCT01686165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19959707|NCT01686165|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19959708|NCT01686165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959709|NCT01686165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959710|NCT01686451|Simvastatin|simvastatin|mesh-list
19959711|NCT01686451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19959712|NCT01686451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19959713|NCT01686451|Antimetabolites|antimetabolites|mesh-ancestor
19959714|NCT01686451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959715|NCT01686451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20275136|NCT00553930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959716|NCT01686451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19959717|NCT01686451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959718|NCT01686581|Botulinum Toxins|botulinum toxins|mesh-list
19959719|NCT01686581|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19959720|NCT01686581|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19959721|NCT01686581|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19959722|NCT01686581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19959723|NCT01686581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959724|NCT01686581|Cholinergic Agents|cholinergic agents|mesh-ancestor
19959725|NCT01686581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19959726|NCT01686581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959727|NCT01686581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19959728|NCT01686581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19959729|NCT01686633|Fluticasone|fluticasone|mesh-list
19959730|NCT01686633|Xhance|xhance|mesh-list
19959731|NCT01686633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19959732|NCT01686633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19959733|NCT01686633|Autonomic Agents|autonomic agents|mesh-ancestor
19959734|NCT01686633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19959735|NCT01686633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959736|NCT01686633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19959737|NCT01686633|Respiratory System Agents|respiratory system agents|mesh-ancestor
19959738|NCT01686633|Dermatologic Agents|dermatologic agents|mesh-ancestor
19959739|NCT01686633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19959740|NCT01686646|Acetaminophen|acetaminophen|mesh-list
19959741|NCT01686646|Caffeine|caffeine|mesh-list
19959742|NCT01686646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19959743|NCT01686646|Analgesics|analgesics|mesh-ancestor
19959744|NCT01686646|Sensory System Agents|sensory system agents|mesh-ancestor
19959745|NCT01686646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19959746|NCT01686646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959747|NCT01686646|Antipyretics|antipyretics|mesh-ancestor
19959748|NCT01686646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19959749|NCT01686646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19959750|NCT01686646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275137|NCT00553930|Immunologic Factors|immunologic factors|mesh-ancestor
20275138|NCT00553930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275139|NCT00553943|Cytarabine|cytarabine|mesh-list
20275140|NCT00553943|Rituximab|rituximab|mesh-list
20275141|NCT00553943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20275142|NCT00553943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275143|NCT00553943|Immunologic Factors|immunologic factors|mesh-ancestor
20275144|NCT00553943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275145|NCT00553943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20275146|NCT00553943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20275147|NCT00553943|Antimetabolites|antimetabolites|mesh-ancestor
20275148|NCT00553943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275149|NCT00553943|Antiviral Agents|antiviral agents|mesh-ancestor
20275150|NCT00553943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20275151|NCT00553943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20275152|NCT00553995|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
20275153|NCT00553995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20275154|NCT00553995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20275155|NCT00553995|Analgesics|analgesics|mesh-ancestor
20275156|NCT00553995|Sensory System Agents|sensory system agents|mesh-ancestor
20275157|NCT00553995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275158|NCT00553995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275159|NCT00553995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20275160|NCT00553995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20275161|NCT00554086|Bicalutamide|bicalutamide|mesh-list
20275162|NCT00554086|Androgen Antagonists|androgen antagonists|mesh-ancestor
20275163|NCT00554086|Hormone Antagonists|hormone antagonists|mesh-ancestor
20275164|NCT00554086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20275165|NCT00554086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275166|NCT00554086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275167|NCT00554125|Sirolimus|sirolimus|mesh-list
20275168|NCT00554125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20275169|NCT00554125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20275170|NCT00554125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20275171|NCT00554125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275172|NCT00554125|Antifungal Agents|antifungal agents|mesh-ancestor
20275173|NCT00554125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20275174|NCT00554125|Immunologic Factors|immunologic factors|mesh-ancestor
20275175|NCT00554125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275176|NCT00554138|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19959751|NCT01686646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959752|NCT01686646|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19959753|NCT01686646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19959754|NCT01686646|Purinergic Agents|purinergic agents|mesh-ancestor
19959755|NCT01686646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19959756|NCT01686828|Letrozole|letrozole|mesh-list
19959757|NCT01686828|Methyltestosterone|methyltestosterone|mesh-list
19959758|NCT01686828|Acyline|acyline|mesh-list
19959759|NCT01686828|Testosterone|testosterone|mesh-list
19959760|NCT01686828|Testosterone undecanoate|testosterone undecanoate|mesh-list
19959761|NCT01686828|Testosterone enanthate|testosterone enanthate|mesh-list
19959762|NCT01686828|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19959763|NCT01686828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959764|NCT01686828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19959765|NCT01686828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19959766|NCT01686828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959767|NCT01686828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959768|NCT01686828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19959769|NCT01686828|Hormone Antagonists|hormone antagonists|mesh-ancestor
19959770|NCT01686828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19959771|NCT01686828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959772|NCT01686828|Androgens|androgens|mesh-ancestor
19959773|NCT01686828|Hormones|hormones|mesh-ancestor
19959774|NCT01686828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19959775|NCT01686828|Anabolic Agents|anabolic agents|mesh-ancestor
19959776|NCT01686932|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19959777|NCT01686932|Vildagliptin|vildagliptin|mesh-list
19959778|NCT01686932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19959779|NCT01686932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959780|NCT01686932|Incretins|incretins|mesh-ancestor
19959781|NCT01686932|Hormones|hormones|mesh-ancestor
19959782|NCT01686932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19959783|NCT01686932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19959784|NCT01686932|Protease Inhibitors|protease inhibitors|mesh-ancestor
19959785|NCT01686932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959786|NCT01686932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959787|NCT01687101|Menthol|menthol|mesh-list
19959788|NCT01687101|Antipruritics|antipruritics|mesh-ancestor
19959789|NCT01687101|Dermatologic Agents|dermatologic agents|mesh-ancestor
19959790|NCT01687166|Acifluorfen|acifluorfen|mesh-list
19959791|NCT01687166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959792|NCT01687166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959793|NCT01687179|Sirolimus|sirolimus|mesh-list
19959794|NCT01687179|Hydroxychloroquine|hydroxychloroquine|mesh-list
19959795|NCT01687179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19959796|NCT01687179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19959797|NCT01687179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19959798|NCT01687179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959799|NCT01687179|Antifungal Agents|antifungal agents|mesh-ancestor
19959800|NCT01687179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19959801|NCT01687179|Immunologic Factors|immunologic factors|mesh-ancestor
19959802|NCT01687179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959803|NCT01687179|Antimalarials|antimalarials|mesh-ancestor
19959804|NCT01687179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19959805|NCT01687179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19959806|NCT01687179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959807|NCT01687179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959808|NCT01687179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19959809|NCT01687218|Tenofovir|tenofovir|mesh-list
19959810|NCT01687218|Emtricitabine|emtricitabine|mesh-list
19959811|NCT01687218|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19959812|NCT01687218|Glycerol|glycerol|mesh-list
19959813|NCT01687218|Antiviral Agents|antiviral agents|mesh-ancestor
19959814|NCT01687218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19959815|NCT01687218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19959816|NCT01687218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19959817|NCT01687218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959818|NCT01687218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959819|NCT01687218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19959820|NCT01687218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19959821|NCT01687218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19959822|NCT01687218|Protective Agents|protective agents|mesh-ancestor
19959823|NCT01687218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275177|NCT00554138|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19959824|NCT01687257|Sofosbuvir|sofosbuvir|mesh-list
19959825|NCT01687257|Antiviral Agents|antiviral agents|mesh-ancestor
19959826|NCT01687257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19959827|NCT01687270|Sofosbuvir|sofosbuvir|mesh-list
19959828|NCT01687270|Ribavirin|ribavirin|mesh-list
19959829|NCT01687270|Antiviral Agents|antiviral agents|mesh-ancestor
19959830|NCT01687270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19959831|NCT01687270|Antimetabolites|antimetabolites|mesh-ancestor
19959832|NCT01687270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959833|NCT01687283|Fluticasone|fluticasone|mesh-list
19959834|NCT01687283|Xhance|xhance|mesh-list
19959835|NCT01687283|Budesonide|budesonide|mesh-list
19959836|NCT01687283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19959837|NCT01687283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19959838|NCT01687283|Autonomic Agents|autonomic agents|mesh-ancestor
19959839|NCT01687283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19959840|NCT01687283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959841|NCT01687283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19959842|NCT01687283|Respiratory System Agents|respiratory system agents|mesh-ancestor
19959843|NCT01687283|Dermatologic Agents|dermatologic agents|mesh-ancestor
19959844|NCT01687283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19959845|NCT01687283|Glucocorticoids|glucocorticoids|mesh-ancestor
19959846|NCT01687283|Hormones|hormones|mesh-ancestor
19959847|NCT01687283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19959848|NCT01687296|Fluticasone|fluticasone|mesh-list
19959849|NCT01687296|Xhance|xhance|mesh-list
19959850|NCT01687296|Prednisone|prednisone|mesh-list
19959851|NCT01687296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19959852|NCT01687296|Albuterol|albuterol|mesh-list
19959853|NCT01687296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19959854|NCT01687296|Glucocorticoids|glucocorticoids|mesh-ancestor
19959855|NCT01687296|Hormones|hormones|mesh-ancestor
19959856|NCT01687296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19959857|NCT01687296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959858|NCT01687296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19959859|NCT01687296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959860|NCT01687296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19959861|NCT01687296|Autonomic Agents|autonomic agents|mesh-ancestor
19959862|NCT01687296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19959863|NCT01687296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19959864|NCT01687296|Respiratory System Agents|respiratory system agents|mesh-ancestor
19959865|NCT01687296|Dermatologic Agents|dermatologic agents|mesh-ancestor
19959866|NCT01687296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19959867|NCT01687296|Tocolytic Agents|tocolytic agents|mesh-ancestor
19959868|NCT01687296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19959869|NCT01687296|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19959870|NCT01687296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19959871|NCT01687296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19959872|NCT01687296|Adrenergic Agents|adrenergic agents|mesh-ancestor
19959873|NCT01687296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19959874|NCT01687296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959875|NCT01687387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19959876|NCT01687400|Decitabine|decitabine|mesh-list
19959877|NCT01687400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19959878|NCT01687400|Antimetabolites|antimetabolites|mesh-ancestor
19959879|NCT01687400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959880|NCT01687400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959881|NCT01687400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959882|NCT01687413|Cisplatin|cisplatin|mesh-list
19959883|NCT01687413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959884|NCT01687478|Olanzapine|olanzapine|mesh-list
19959885|NCT01687478|Fluoxetine|fluoxetine|mesh-list
19450324|NCT03429309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19450325|NCT03429309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19450326|NCT03429309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450327|NCT03429309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19450328|NCT03429309|Anesthetics, General|anesthetics, general|mesh-ancestor
19450329|NCT03429309|Anesthetics|anesthetics|mesh-ancestor
19450330|NCT03429179|Butorphanol|butorphanol|mesh-list
19450331|NCT03429179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19450332|NCT03429179|Narcotics|narcotics|mesh-ancestor
19450333|NCT03429179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19450334|NCT03429179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450335|NCT03429179|Analgesics|analgesics|mesh-ancestor
19450336|NCT03429179|Sensory System Agents|sensory system agents|mesh-ancestor
19450337|NCT03429179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19959886|NCT01687478|Antiemetics|antiemetics|mesh-ancestor
19959887|NCT01687478|Autonomic Agents|autonomic agents|mesh-ancestor
19959888|NCT01687478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19959889|NCT01687478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959890|NCT01687478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19959891|NCT01687478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19959892|NCT01687478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19959893|NCT01687478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19959894|NCT01687478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19959895|NCT01687478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19959896|NCT01687478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19959897|NCT01687478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19959898|NCT01687478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959899|NCT01687478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19959900|NCT01687478|Serotonin Agents|serotonin agents|mesh-ancestor
19959901|NCT01687478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19959902|NCT01687478|Antidepressive Agents|antidepressive agents|mesh-ancestor
19959903|NCT01687478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19959904|NCT01687478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19959905|NCT01687478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959906|NCT01687673|Sirolimus|sirolimus|mesh-list
19959907|NCT01687673|Sorafenib|sorafenib|mesh-list
19959908|NCT01687673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959909|NCT01687673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20275178|NCT00554138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20275179|NCT00554138|Antimetabolites|antimetabolites|mesh-ancestor
20275180|NCT00554138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275181|NCT00554138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20275182|NCT00554138|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20275183|NCT00554138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275184|NCT00554164|Prednisone|prednisone|mesh-list
20275185|NCT00554164|Cyclophosphamide|cyclophosphamide|mesh-list
20275186|NCT00554164|Doxorubicin|doxorubicin|mesh-list
20275187|NCT00554164|Vincristine|vincristine|mesh-list
20275188|NCT00554164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20275189|NCT00554164|Immunologic Factors|immunologic factors|mesh-ancestor
20275190|NCT00554164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275191|NCT00554164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20275192|NCT00554164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20275193|NCT00554164|Alkylating Agents|alkylating agents|mesh-ancestor
20275194|NCT00554164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275195|NCT00554164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275196|NCT00554164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20275197|NCT00554164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20275198|NCT00554164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20275199|NCT00554164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20275200|NCT00554164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275201|NCT00554164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20275202|NCT00554164|Glucocorticoids|glucocorticoids|mesh-ancestor
20275203|NCT00554164|Hormones|hormones|mesh-ancestor
20275204|NCT00554164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20275205|NCT00554164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20275206|NCT00554164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20275207|NCT00554164|Tubulin Modulators|tubulin modulators|mesh-ancestor
20275208|NCT00554164|Antimitotic Agents|antimitotic agents|mesh-ancestor
20275209|NCT00554164|Mitosis Modulators|mitosis modulators|mesh-ancestor
20275210|NCT00554177|Mifepristone|mifepristone|mesh-list
20275211|NCT00554177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20275212|NCT00554177|Abortifacient Agents|abortifacient agents|mesh-ancestor
19959910|NCT01687673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959911|NCT01687673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959912|NCT01687673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19959913|NCT01687673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19959914|NCT01687673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19959915|NCT01687673|Antifungal Agents|antifungal agents|mesh-ancestor
19959916|NCT01687673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19959917|NCT01687673|Immunologic Factors|immunologic factors|mesh-ancestor
19959918|NCT01687673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959919|NCT01687712|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19959920|NCT01687712|Hormones|hormones|mesh-ancestor
19959921|NCT01687712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19959922|NCT01687712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959923|NCT01687998|Evacetrapib|evacetrapib|mesh-list
19959924|NCT01687998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19959925|NCT01687998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20275213|NCT00554177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19959926|NCT01687998|Antimetabolites|antimetabolites|mesh-ancestor
19959927|NCT01687998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959928|NCT01687998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19959929|NCT01688037|Tetrabenazine|tetrabenazine|mesh-list
19959930|NCT01688037|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19959931|NCT01688037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19959932|NCT01688037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19959933|NCT01688037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959934|NCT01688037|Adrenergic Agents|adrenergic agents|mesh-ancestor
19959935|NCT01688037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19959936|NCT01688037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959937|NCT01688102|Vitamin D|vitamin d|mesh-list
19959938|NCT01688102|Cholecalciferol|cholecalciferol|mesh-list
19959939|NCT01688102|Vitamins|vitamins|mesh-ancestor
19959940|NCT01688102|Micronutrients|micronutrients|mesh-ancestor
20275214|NCT00554177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275215|NCT00554177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20275216|NCT00554177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20275217|NCT00554177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20275218|NCT00554177|Contraceptive Agents|contraceptive agents|mesh-ancestor
20275219|NCT00554177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20275220|NCT00554177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20275221|NCT00554177|Hormone Antagonists|hormone antagonists|mesh-ancestor
20275222|NCT00554177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20275223|NCT00554177|Luteolytic Agents|luteolytic agents|mesh-ancestor
20275224|NCT00554177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20275225|NCT00554177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20275226|NCT00554203|Sulfasalazine|sulfasalazine|mesh-list
20275227|NCT00554203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20275228|NCT00554203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20275229|NCT00554203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20275230|NCT00554203|Analgesics|analgesics|mesh-ancestor
20275231|NCT00554203|Sensory System Agents|sensory system agents|mesh-ancestor
20275232|NCT00554203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275233|NCT00554203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959941|NCT01688102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959942|NCT01688102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20275234|NCT00554203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19959943|NCT01688102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19959944|NCT01688336|Leucovorin|leucovorin|mesh-list
19959945|NCT01688336|Oxaliplatin|oxaliplatin|mesh-list
19959946|NCT01688336|Irinotecan|irinotecan|mesh-list
20275235|NCT00554203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20275236|NCT00554203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20275237|NCT00554242|Ascorbic Acid|ascorbic acid|mesh-list
20275238|NCT00554242|Grape Seed Extract|grape seed extract|mesh-list
20275239|NCT00554242|Antioxidants|antioxidants|mesh-ancestor
20275240|NCT00554242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275241|NCT00554242|Protective Agents|protective agents|mesh-ancestor
20275242|NCT00554242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275243|NCT00554242|Vitamins|vitamins|mesh-ancestor
20275244|NCT00554242|Micronutrients|micronutrients|mesh-ancestor
20275245|NCT00554242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20275246|NCT00554242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275247|NCT00554346|Etoricoxib|etoricoxib|mesh-list
20275248|NCT00554346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20275249|NCT00554346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20275250|NCT00554346|Analgesics|analgesics|mesh-ancestor
19959947|NCT01688336|Folfirinox|folfirinox|mesh-list
19959948|NCT01688336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959949|NCT01688336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19959950|NCT01688336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19959951|NCT01688336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959952|NCT01688336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959953|NCT01688336|Antidotes|antidotes|mesh-ancestor
19959954|NCT01688336|Protective Agents|protective agents|mesh-ancestor
19959955|NCT01688336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959956|NCT01688336|Vitamin B Complex|vitamin b complex|mesh-ancestor
19959957|NCT01688336|Vitamins|vitamins|mesh-ancestor
19959958|NCT01688336|Micronutrients|micronutrients|mesh-ancestor
19959959|NCT01688466|Pomalidomide|pomalidomide|mesh-list
19959960|NCT01688466|Immunologic Factors|immunologic factors|mesh-ancestor
19959961|NCT01688466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959962|NCT01688466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19959963|NCT01688466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19959964|NCT01688466|Growth Substances|growth substances|mesh-ancestor
19959965|NCT01688466|Growth Inhibitors|growth inhibitors|mesh-ancestor
19959966|NCT01688466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959967|NCT01688596|Bupivacaine|bupivacaine|mesh-list
19959968|NCT01688596|Anesthetics, Local|anesthetics, local|mesh-ancestor
19959969|NCT01688596|Anesthetics|anesthetics|mesh-ancestor
19959970|NCT01688596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19959971|NCT01688596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959972|NCT01688596|Sensory System Agents|sensory system agents|mesh-ancestor
19959973|NCT01688596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19959974|NCT01688609|Paclitaxel|paclitaxel|mesh-list
19959975|NCT01688609|Trastuzumab|trastuzumab|mesh-list
19959976|NCT01688609|Lapatinib|lapatinib|mesh-list
19959977|NCT01688609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19959978|NCT01688609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19959979|NCT01688609|Tubulin Modulators|tubulin modulators|mesh-ancestor
19959980|NCT01688609|Antimitotic Agents|antimitotic agents|mesh-ancestor
19959981|NCT01688609|Mitosis Modulators|mitosis modulators|mesh-ancestor
19959982|NCT01688609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959983|NCT01688609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19959984|NCT01688609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19959985|NCT01688609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19959986|NCT01688635|Insulin Glargine|insulin glargine|mesh-list
19959987|NCT01688635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19959988|NCT01688635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959989|NCT01688726|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19959990|NCT01688726|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19959991|NCT01688739|Erenumab|erenumab|mesh-list
19959992|NCT01688739|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19959993|NCT01688739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19959994|NCT01688739|Analgesics|analgesics|mesh-ancestor
19959995|NCT01688739|Sensory System Agents|sensory system agents|mesh-ancestor
19959996|NCT01688739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19959997|NCT01688739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19959998|NCT01688830|Dabigatran|dabigatran|mesh-list
19959999|NCT01688830|Antithrombins|antithrombins|mesh-ancestor
19960000|NCT01688830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19960001|NCT01688830|Protease Inhibitors|protease inhibitors|mesh-ancestor
19450338|NCT03429179|Antitussive Agents|antitussive agents|mesh-ancestor
19450339|NCT03429179|Respiratory System Agents|respiratory system agents|mesh-ancestor
19960002|NCT01688830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19960003|NCT01688830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960004|NCT01688830|Anticoagulants|anticoagulants|mesh-ancestor
19960005|NCT01688921|Vaccines|vaccines|mesh-list
19960006|NCT01688921|Immunologic Factors|immunologic factors|mesh-ancestor
19960007|NCT01688921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960008|NCT01688973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19960009|NCT01688973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960010|NCT01688973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19960011|NCT01688973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19960012|NCT01688973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960013|NCT01689207|Aztreonam|aztreonam|mesh-list
19960014|NCT01689207|Avibactam|avibactam|mesh-list
19960015|NCT01689207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19960016|NCT01689207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19960017|NCT01689207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19960018|NCT01689207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19960019|NCT01689207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960020|NCT01689324|Vaccines|vaccines|mesh-list
19960021|NCT01689324|Immunologic Factors|immunologic factors|mesh-ancestor
19960022|NCT01689324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960023|NCT01689363|Histamine|histamine|mesh-list
19960024|NCT01689363|Histamine Agonists|histamine agonists|mesh-ancestor
19960025|NCT01689363|Histamine Agents|histamine agents|mesh-ancestor
19960026|NCT01689363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19960027|NCT01689363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960028|NCT01689363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960029|NCT01689441|Calcitriol|calcitriol|mesh-list
19960030|NCT01689441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19960031|NCT01689441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960032|NCT01689441|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19960033|NCT01689441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19960034|NCT01689441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960035|NCT01689441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19960036|NCT01689441|Vitamins|vitamins|mesh-ancestor
19960037|NCT01689441|Micronutrients|micronutrients|mesh-ancestor
19960038|NCT01689441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19960039|NCT01689532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19960040|NCT01689532|Immunologic Factors|immunologic factors|mesh-ancestor
19960041|NCT01689532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275251|NCT00554346|Sensory System Agents|sensory system agents|mesh-ancestor
20275252|NCT00554346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275253|NCT00554346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275254|NCT00554346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20275255|NCT00554346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19960042|NCT01689649|Topiramate|topiramate|mesh-list
19960043|NCT01689649|Anticonvulsants|anticonvulsants|mesh-ancestor
19960044|NCT01689649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19960045|NCT01689649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960046|NCT01689779|Vitamin D|vitamin d|mesh-list
19960047|NCT01689779|Cholecalciferol|cholecalciferol|mesh-list
19960048|NCT01689779|Vitamins|vitamins|mesh-ancestor
19960049|NCT01689779|Micronutrients|micronutrients|mesh-ancestor
19960050|NCT01689779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960051|NCT01689779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19960052|NCT01689779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19960053|NCT01690000|Melatonin|melatonin|mesh-list
19960054|NCT01690000|Antioxidants|antioxidants|mesh-ancestor
19960055|NCT01690000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960056|NCT01690000|Protective Agents|protective agents|mesh-ancestor
19960057|NCT01690000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960058|NCT01690000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19960059|NCT01690052|Pilocarpine|pilocarpine|mesh-list
19960060|NCT01690052|Cevimeline|cevimeline|mesh-list
19960061|NCT01690052|Miotics|miotics|mesh-ancestor
19960062|NCT01690052|Autonomic Agents|autonomic agents|mesh-ancestor
19960063|NCT01690052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960064|NCT01690052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960065|NCT01690052|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19960066|NCT01690052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19960067|NCT01690052|Cholinergic Agents|cholinergic agents|mesh-ancestor
19960068|NCT01690052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19960069|NCT01690052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960070|NCT01690052|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19960071|NCT01690143|Melphalan|melphalan|mesh-list
19960072|NCT01690143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19960073|NCT01690143|Alkylating Agents|alkylating agents|mesh-ancestor
19960074|NCT01690143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275256|NCT00554346|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20275257|NCT00554346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20275258|NCT00554346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275259|NCT00554346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275260|NCT00554398|Raltegravir Potassium|raltegravir potassium|mesh-list
20275261|NCT00554398|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20275262|NCT00554398|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20275263|NCT00554398|Antiviral Agents|antiviral agents|mesh-ancestor
20275264|NCT00554398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20275265|NCT00554398|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20275266|NCT00554398|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20275267|NCT00554398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275268|NCT00554398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275269|NCT00554424|Lidocaine|lidocaine|mesh-list
20275270|NCT00554424|Anesthetics, Local|anesthetics, local|mesh-ancestor
20275271|NCT00554424|Anesthetics|anesthetics|mesh-ancestor
20545186|NCT01880112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20545187|NCT01880112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20545188|NCT01880125|Acetaminophen|acetaminophen|mesh-list
20545189|NCT01880125|Tramadol|tramadol|mesh-list
20545190|NCT01880125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20545191|NCT01880125|Analgesics|analgesics|mesh-ancestor
20545192|NCT01880125|Sensory System Agents|sensory system agents|mesh-ancestor
20545193|NCT01880125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545194|NCT01880125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545195|NCT01880125|Antipyretics|antipyretics|mesh-ancestor
20545196|NCT01880125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20545197|NCT01880125|Narcotics|narcotics|mesh-ancestor
20545198|NCT01880125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20545199|NCT01880138|Anesthetics|anesthetics|mesh-list
19960075|NCT01690143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960076|NCT01690143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19960077|NCT01690143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19960078|NCT01690143|Immunologic Factors|immunologic factors|mesh-ancestor
19960079|NCT01690143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960080|NCT01690520|Cyclosporine|cyclosporine|mesh-list
19960081|NCT01690520|Mycophenolic Acid|mycophenolic acid|mesh-list
19960082|NCT01690520|Cyclophosphamide|cyclophosphamide|mesh-list
19960083|NCT01690520|Thiotepa|thiotepa|mesh-list
19960084|NCT01690520|Fludarabine|fludarabine|mesh-list
19960085|NCT01690520|Fludarabine phosphate|fludarabine phosphate|mesh-list
19960086|NCT01690520|Cyclosporins|cyclosporins|mesh-list
19960087|NCT01690520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19960088|NCT01690520|Immunologic Factors|immunologic factors|mesh-ancestor
19960089|NCT01690520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960090|NCT01690520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19960091|NCT01690520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19960092|NCT01690520|Alkylating Agents|alkylating agents|mesh-ancestor
19960093|NCT01690520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960094|NCT01690520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960095|NCT01690520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19960096|NCT01690520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19960097|NCT01690520|Antimetabolites|antimetabolites|mesh-ancestor
19960098|NCT01690520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19960099|NCT01690520|Antifungal Agents|antifungal agents|mesh-ancestor
19960100|NCT01690520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19960101|NCT01690520|Dermatologic Agents|dermatologic agents|mesh-ancestor
19960102|NCT01690520|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19960103|NCT01690520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19960104|NCT01690520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19960105|NCT01690520|Antitubercular Agents|antitubercular agents|mesh-ancestor
19960106|NCT01690520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19960107|NCT01690546|Naltrexone|naltrexone|mesh-list
19960108|NCT01690546|Buprenorphine|buprenorphine|mesh-list
19960109|NCT01690546|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19960110|NCT01690546|Naloxone|naloxone|mesh-list
19960111|NCT01690546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19960112|NCT01690546|Narcotics|narcotics|mesh-ancestor
19960113|NCT01690546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19960114|NCT01690546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960115|NCT01690546|Analgesics|analgesics|mesh-ancestor
19960116|NCT01690546|Sensory System Agents|sensory system agents|mesh-ancestor
19960117|NCT01690546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960118|NCT01690546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19960119|NCT01690546|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19960120|NCT01690663|Dexamethasone|dexamethasone|mesh-list
19960121|NCT01690663|Bupivacaine|bupivacaine|mesh-list
19960122|NCT01690663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19960123|NCT01690663|Antiemetics|antiemetics|mesh-ancestor
19960124|NCT01690663|Autonomic Agents|autonomic agents|mesh-ancestor
19960125|NCT01690663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960126|NCT01690663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960127|NCT01690663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19960128|NCT01690663|Glucocorticoids|glucocorticoids|mesh-ancestor
19960129|NCT01690663|Hormones|hormones|mesh-ancestor
19960130|NCT01690663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19960131|NCT01690663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19960132|NCT01690663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960133|NCT01690663|Anesthetics, Local|anesthetics, local|mesh-ancestor
19960134|NCT01690663|Anesthetics|anesthetics|mesh-ancestor
19960135|NCT01690663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19960136|NCT01690663|Sensory System Agents|sensory system agents|mesh-ancestor
19960137|NCT01690988|Ketamine|ketamine|mesh-list
19960138|NCT01690988|Analgesics|analgesics|mesh-ancestor
19960139|NCT01690988|Sensory System Agents|sensory system agents|mesh-ancestor
19960140|NCT01690988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960141|NCT01690988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960142|NCT01690988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19960143|NCT01690988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19960144|NCT01690988|Anesthetics, General|anesthetics, general|mesh-ancestor
19960145|NCT01690988|Anesthetics|anesthetics|mesh-ancestor
19960146|NCT01690988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20275272|NCT00554424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20275273|NCT00554424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960147|NCT01690988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19960148|NCT01690988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19974842|NCT01842633|Antipyretics|antipyretics|mesh-ancestor
20275274|NCT00554424|Sensory System Agents|sensory system agents|mesh-ancestor
20275275|NCT00554424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275276|NCT00554424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20275277|NCT00554424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20275278|NCT00554424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20275279|NCT00554424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20275280|NCT00554424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275281|NCT00554450|Dapagliflozin|dapagliflozin|mesh-list
20275282|NCT00554450|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20275283|NCT00554450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275284|NCT00554450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20275285|NCT00554450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275286|NCT00554476|Triamcinolone|triamcinolone|mesh-list
20275287|NCT00554476|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20275288|NCT00554476|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20275289|NCT00554476|Indomethacin|indomethacin|mesh-list
19960149|NCT01690988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19960150|NCT01690988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960151|NCT01691092|Ketamine|ketamine|mesh-list
19960152|NCT01691092|Analgesics|analgesics|mesh-ancestor
19960153|NCT01691092|Sensory System Agents|sensory system agents|mesh-ancestor
19960154|NCT01691092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960155|NCT01691092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960156|NCT01691092|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19960157|NCT01691092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19960158|NCT01691092|Anesthetics, General|anesthetics, general|mesh-ancestor
19960159|NCT01691092|Anesthetics|anesthetics|mesh-ancestor
19960160|NCT01691092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19960161|NCT01691092|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19960162|NCT01691092|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19960163|NCT01691092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19960164|NCT01691092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960165|NCT01691248|Fidaxomicin|fidaxomicin|mesh-list
19960166|NCT01691248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19960167|NCT01691248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19960168|NCT01691313|Vanoxerine|vanoxerine|mesh-list
19960169|NCT01691313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19960170|NCT01691313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19960171|NCT01691313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19960172|NCT01691313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960173|NCT01691313|Dopamine Agents|dopamine agents|mesh-ancestor
19960174|NCT01691313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19960175|NCT01691313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960176|NCT01691326|Vaccines|vaccines|mesh-list
19960177|NCT01691326|Immunologic Factors|immunologic factors|mesh-ancestor
19960178|NCT01691326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960179|NCT01691339|Vaccines|vaccines|mesh-list
19960180|NCT01691339|Immunologic Factors|immunologic factors|mesh-ancestor
19960181|NCT01691339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960182|NCT01691482|Albuterol|albuterol|mesh-list
19960183|NCT01691482|Ipratropium|ipratropium|mesh-list
19960184|NCT01691482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19960185|NCT01691482|Autonomic Agents|autonomic agents|mesh-ancestor
19960186|NCT01691482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960187|NCT01691482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960188|NCT01691482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19960189|NCT01691482|Respiratory System Agents|respiratory system agents|mesh-ancestor
19960190|NCT01691482|Tocolytic Agents|tocolytic agents|mesh-ancestor
19960191|NCT01691482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19960192|NCT01691482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19960193|NCT01691482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19960194|NCT01691482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20275290|NCT00554476|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20275291|NCT00554476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20275292|NCT00554476|Glucocorticoids|glucocorticoids|mesh-ancestor
20275293|NCT00554476|Hormones|hormones|mesh-ancestor
20275294|NCT00554476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20275295|NCT00554476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275296|NCT00554476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20275297|NCT00554476|Immunologic Factors|immunologic factors|mesh-ancestor
20275298|NCT00554476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275299|NCT00554476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960195|NCT01691482|Adrenergic Agents|adrenergic agents|mesh-ancestor
19960196|NCT01691482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19960197|NCT01691482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960198|NCT01691482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19960199|NCT01691482|Cholinergic Agents|cholinergic agents|mesh-ancestor
19960200|NCT01691508|Prednisone|prednisone|mesh-list
19960201|NCT01691508|Prednisolone|prednisolone|mesh-list
19960202|NCT01691508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19960203|NCT01691508|Glucocorticoids|glucocorticoids|mesh-ancestor
19960204|NCT01691508|Hormones|hormones|mesh-ancestor
19960205|NCT01691508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19960206|NCT01691508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960207|NCT01691508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19960208|NCT01691508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960209|NCT01691534|Pyrazinamide|pyrazinamide|mesh-list
19960210|NCT01691534|Clofazimine|clofazimine|mesh-list
19960211|NCT01691534|Antitubercular Agents|antitubercular agents|mesh-ancestor
19960212|NCT01691534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19960213|NCT01691534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19960214|NCT01691534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19960215|NCT01691534|Leprostatic Agents|leprostatic agents|mesh-ancestor
19960216|NCT01691560|Calcium, Dietary|calcium, dietary|mesh-list
19960217|NCT01691560|Listerine|listerine|mesh-list
19960218|NCT01691560|Calcium|calcium|mesh-list
19960219|NCT01691560|Fluorides|fluorides|mesh-list
19960220|NCT01691560|Sodium Fluoride|sodium fluoride|mesh-list
19960221|NCT01691560|Fluorophosphate|fluorophosphate|mesh-list
19960222|NCT01691560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19960223|NCT01691560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960224|NCT01691560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19960225|NCT01691560|Cariostatic Agents|cariostatic agents|mesh-ancestor
19960226|NCT01691560|Protective Agents|protective agents|mesh-ancestor
19960227|NCT01691560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20275300|NCT00554476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20275301|NCT00554476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20275302|NCT00554476|Analgesics|analgesics|mesh-ancestor
19960228|NCT01691560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19960229|NCT01691690|Acetaminophen|acetaminophen|mesh-list
19960230|NCT01691690|Dexamethasone|dexamethasone|mesh-list
19960231|NCT01691690|Midazolam|midazolam|mesh-list
19960232|NCT01691690|Morphine|morphine|mesh-list
19960233|NCT01691690|Nitrous Oxide|nitrous oxide|mesh-list
19960234|NCT01691690|Ondansetron|ondansetron|mesh-list
19960235|NCT01691690|Propofol|propofol|mesh-list
19960236|NCT01691690|Sevoflurane|sevoflurane|mesh-list
19960237|NCT01691690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19960238|NCT01691690|Antiemetics|antiemetics|mesh-ancestor
19960239|NCT01691690|Autonomic Agents|autonomic agents|mesh-ancestor
19960240|NCT01691690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960241|NCT01691690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960242|NCT01691690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19960243|NCT01691690|Glucocorticoids|glucocorticoids|mesh-ancestor
19960244|NCT01691690|Hormones|hormones|mesh-ancestor
19960245|NCT01691690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19960246|NCT01691690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19960247|NCT01691690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960248|NCT01691690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19960249|NCT01691690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19960250|NCT01691690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19960251|NCT01691690|Anesthetics, General|anesthetics, general|mesh-ancestor
19960252|NCT01691690|Anesthetics|anesthetics|mesh-ancestor
19960253|NCT01691690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19960254|NCT01691690|Narcotics|narcotics|mesh-ancestor
19960255|NCT01691690|Analgesics|analgesics|mesh-ancestor
19960256|NCT01691690|Sensory System Agents|sensory system agents|mesh-ancestor
19960257|NCT01691690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19960258|NCT01691690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19960259|NCT01691690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20275303|NCT00554476|Sensory System Agents|sensory system agents|mesh-ancestor
20275304|NCT00554476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275305|NCT00554476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20275306|NCT00554476|Gout Suppressants|gout suppressants|mesh-ancestor
20275307|NCT00554476|Tocolytic Agents|tocolytic agents|mesh-ancestor
20275308|NCT00554476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20275309|NCT00554476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19960260|NCT01691690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19960261|NCT01691690|GABA Modulators|gaba modulators|mesh-ancestor
19960262|NCT01691690|GABA Agents|gaba agents|mesh-ancestor
19960263|NCT01691690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19960264|NCT01691690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275310|NCT00554502|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19960265|NCT01691690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19960266|NCT01691690|Antipyretics|antipyretics|mesh-ancestor
19960267|NCT01691690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19960268|NCT01691690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19960269|NCT01691690|Antipruritics|antipruritics|mesh-ancestor
19960270|NCT01691690|Dermatologic Agents|dermatologic agents|mesh-ancestor
19960271|NCT01691690|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19960272|NCT01691690|Serotonin Agents|serotonin agents|mesh-ancestor
19960273|NCT01691690|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19960274|NCT01691768|Tenofovir|tenofovir|mesh-list
19960275|NCT01691768|Antiviral Agents|antiviral agents|mesh-ancestor
19960276|NCT01691768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19960277|NCT01691768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19960278|NCT01691768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19960279|NCT01691768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19960280|NCT01691768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960281|NCT01691768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19960282|NCT01691768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19974843|NCT01842633|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19974844|NCT01842633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19974845|NCT01842633|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19974846|NCT01842633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19974847|NCT01842633|Purinergic Agents|purinergic agents|mesh-ancestor
19974848|NCT01842633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19974849|NCT01843023|Naltrexone|naltrexone|mesh-list
19974850|NCT01843023|Buprenorphine|buprenorphine|mesh-list
20275311|NCT00554502|Immunosuppressive Agents|immunosuppressive agents|mesh-list
20275312|NCT00554502|Protease Inhibitors|protease inhibitors|mesh-ancestor
20275313|NCT00554502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275314|NCT00554502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275315|NCT00554502|Immunologic Factors|immunologic factors|mesh-ancestor
20275316|NCT00554502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275317|NCT00554528|Meloxicam|meloxicam|mesh-list
20275318|NCT00554528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20275319|NCT00554528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20275320|NCT00554528|Analgesics|analgesics|mesh-ancestor
20275321|NCT00554528|Sensory System Agents|sensory system agents|mesh-ancestor
20275322|NCT00554528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275323|NCT00554528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275324|NCT00554528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20275325|NCT00554528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20275326|NCT00554528|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20275327|NCT00554528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20275328|NCT00554528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275329|NCT00554528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275330|NCT00554632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20275331|NCT00554632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20275332|NCT00554632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20275333|NCT00554632|Norgestimate|norgestimate|mesh-list
20275334|NCT00554632|Norelgestromin|norelgestromin|mesh-list
20275335|NCT00554632|Ortho Evra|ortho evra|mesh-list
20275336|NCT00554632|Estradiol|estradiol|mesh-list
20275337|NCT00554632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20275338|NCT00554632|Estrogens|estrogens|mesh-ancestor
20275339|NCT00554632|Hormones|hormones|mesh-ancestor
20275340|NCT00554632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20275341|NCT00554632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275342|NCT00554632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20275343|NCT00554632|Contraceptive Agents|contraceptive agents|mesh-ancestor
20275344|NCT00554632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20275345|NCT00554632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20275346|NCT00554632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20275347|NCT00554632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20275348|NCT00554632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20275349|NCT00554658|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20275350|NCT00554658|Antidepressive Agents|antidepressive agents|mesh-ancestor
20275351|NCT00554658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20275352|NCT00554658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20275353|NCT00554658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20275354|NCT00554658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20275355|NCT00554658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275356|NCT00554710|Methylprednisolone|methylprednisolone|mesh-list
19974851|NCT01843023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19974852|NCT01843023|Narcotics|narcotics|mesh-ancestor
20275357|NCT00554710|Budesonide|budesonide|mesh-list
20275358|NCT00554710|Azathioprine|azathioprine|mesh-list
20275359|NCT00554710|Infliximab|infliximab|mesh-list
20275360|NCT00554710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20275361|NCT00554710|Antiemetics|antiemetics|mesh-ancestor
20275362|NCT00554710|Autonomic Agents|autonomic agents|mesh-ancestor
20275363|NCT00554710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275364|NCT00554710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275365|NCT00554710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20275366|NCT00554710|Glucocorticoids|glucocorticoids|mesh-ancestor
20275367|NCT00554710|Hormones|hormones|mesh-ancestor
20275368|NCT00554710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20275369|NCT00554710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20275370|NCT00554710|Protective Agents|protective agents|mesh-ancestor
20275371|NCT00554710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275372|NCT00554710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20275373|NCT00554710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19960283|NCT01691781|Lisinopril|lisinopril|mesh-list
19960284|NCT01691781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19960285|NCT01691781|Protease Inhibitors|protease inhibitors|mesh-ancestor
19960286|NCT01691781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19960287|NCT01691781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960288|NCT01691781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19960289|NCT01691781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19960290|NCT01691781|Protective Agents|protective agents|mesh-ancestor
20275374|NCT00554710|Respiratory System Agents|respiratory system agents|mesh-ancestor
20275375|NCT00554710|Dermatologic Agents|dermatologic agents|mesh-ancestor
20275376|NCT00554710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20275377|NCT00554710|Antimetabolites|antimetabolites|mesh-ancestor
20275378|NCT00554710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275379|NCT00554710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20275380|NCT00554710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20275381|NCT00554710|Immunologic Factors|immunologic factors|mesh-ancestor
20275382|NCT00554775|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20275383|NCT00554775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960291|NCT01691781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960292|NCT01691794|Ritonavir|ritonavir|mesh-list
19960293|NCT01691794|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19960294|NCT01691794|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19960295|NCT01691794|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19960296|NCT01691794|Protease Inhibitors|protease inhibitors|mesh-ancestor
19960297|NCT01691794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19960298|NCT01691794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960299|NCT01691794|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19960300|NCT01691794|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19960301|NCT01691794|Antiviral Agents|antiviral agents|mesh-ancestor
19960302|NCT01691794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19960303|NCT01691794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19960304|NCT01691794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19960305|NCT01691833|Vitamin D|vitamin d|mesh-list
19960306|NCT01691833|Vitamins|vitamins|mesh-ancestor
19960307|NCT01691833|Micronutrients|micronutrients|mesh-ancestor
19960308|NCT01691833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960309|NCT01691833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19960310|NCT01691885|Fluticasone|fluticasone|mesh-list
19960311|NCT01691885|Xhance|xhance|mesh-list
19960312|NCT01691885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19960313|NCT01691885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19960314|NCT01691885|Autonomic Agents|autonomic agents|mesh-ancestor
19960315|NCT01691885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960316|NCT01691885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960317|NCT01691885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19960318|NCT01691885|Respiratory System Agents|respiratory system agents|mesh-ancestor
19960319|NCT01691885|Dermatologic Agents|dermatologic agents|mesh-ancestor
19960320|NCT01691885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19960321|NCT01691898|Rituximab|rituximab|mesh-list
19960322|NCT01691898|Obinutuzumab|obinutuzumab|mesh-list
19960323|NCT01691898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19960324|NCT01691898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960325|NCT01691898|Immunologic Factors|immunologic factors|mesh-ancestor
19960326|NCT01691898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960327|NCT01691898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19960328|NCT01692197|Cytarabine|cytarabine|mesh-list
19960329|NCT01692197|Dexamethasone|dexamethasone|mesh-list
19960330|NCT01692197|Idarubicin|idarubicin|mesh-list
20275384|NCT00554775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19960331|NCT01692197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19960332|NCT01692197|Antiemetics|antiemetics|mesh-ancestor
19960333|NCT01692197|Autonomic Agents|autonomic agents|mesh-ancestor
19960334|NCT01692197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960335|NCT01692197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960336|NCT01692197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19960337|NCT01692197|Glucocorticoids|glucocorticoids|mesh-ancestor
19960338|NCT01692197|Hormones|hormones|mesh-ancestor
19960339|NCT01692197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19960340|NCT01692197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19960341|NCT01692197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960342|NCT01692197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19960343|NCT01692197|Antimetabolites|antimetabolites|mesh-ancestor
19960344|NCT01692197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960345|NCT01692197|Antiviral Agents|antiviral agents|mesh-ancestor
19960346|NCT01692197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19960347|NCT01692197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19960348|NCT01692197|Immunologic Factors|immunologic factors|mesh-ancestor
19960349|NCT01692197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19960350|NCT01692197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19960351|NCT01692197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19960352|NCT01692197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19960353|NCT01692301|Amlodipine|amlodipine|mesh-list
19960354|NCT01692301|Valsartan|valsartan|mesh-list
19960355|NCT01692301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19960356|NCT01692301|Olmesartan|olmesartan|mesh-list
19960357|NCT01692301|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19960358|NCT01692301|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19960359|NCT01692301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19960360|NCT01692301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19960361|NCT01692301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19960362|NCT01692301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960363|NCT01692301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19960364|NCT01692301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960365|NCT01692301|Vasodilator Agents|vasodilator agents|mesh-ancestor
19960366|NCT01692301|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19960367|NCT01692301|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19960368|NCT01692301|Diuretics|diuretics|mesh-ancestor
19960369|NCT01692301|Natriuretic Agents|natriuretic agents|mesh-ancestor
19960370|NCT01692301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19960371|NCT01692340|Lycopene|lycopene|mesh-list
19960372|NCT01692340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19960373|NCT01692340|Antioxidants|antioxidants|mesh-ancestor
19960374|NCT01692340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960375|NCT01692340|Protective Agents|protective agents|mesh-ancestor
19960376|NCT01692340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960377|NCT01692340|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19960378|NCT01692340|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19960379|NCT01692340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960380|NCT01692626|Pimecrolimus|pimecrolimus|mesh-list
19960381|NCT01692626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19960382|NCT01692626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19960383|NCT01692626|Analgesics|analgesics|mesh-ancestor
19960384|NCT01692626|Sensory System Agents|sensory system agents|mesh-ancestor
20275385|NCT00554775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275386|NCT00554775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275387|NCT00554827|Vitamins|vitamins|mesh-list
20275388|NCT00554827|Folic Acid|folic acid|mesh-list
20275389|NCT00554827|Vitamin B 12|vitamin b 12|mesh-list
20275390|NCT00554827|Hydroxocobalamin|hydroxocobalamin|mesh-list
20275391|NCT00554827|Vitamin B Complex|vitamin b complex|mesh-list
20275392|NCT00554827|10-deazaaminopterin|10-deazaaminopterin|mesh-list
20275393|NCT00554827|Aminopterin|aminopterin|mesh-list
20275394|NCT00554827|Micronutrients|micronutrients|mesh-ancestor
20275395|NCT00554827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275396|NCT00554827|Hematinics|hematinics|mesh-ancestor
20275397|NCT00554827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20275398|NCT00554827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275399|NCT00554827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275400|NCT00554827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275401|NCT00554918|Zoledronic Acid|zoledronic acid|mesh-list
20275402|NCT00554918|Prednisolone|prednisolone|mesh-list
20275403|NCT00554918|Docetaxel|docetaxel|mesh-list
20275404|NCT00554918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275405|NCT00554918|Tubulin Modulators|tubulin modulators|mesh-ancestor
19960385|NCT01692626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960386|NCT01692626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960387|NCT01692626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19960388|NCT01692626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19960389|NCT01692626|Dermatologic Agents|dermatologic agents|mesh-ancestor
19960390|NCT01692626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19960391|NCT01692626|Immunologic Factors|immunologic factors|mesh-ancestor
19960392|NCT01692626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19960393|NCT01692626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19960394|NCT01692626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960395|NCT01692756|Triamcinolone|triamcinolone|mesh-list
19960396|NCT01692756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19960397|NCT01692756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19960398|NCT01692756|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19960399|NCT01692756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19960400|NCT01692756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19960401|NCT01692756|Glucocorticoids|glucocorticoids|mesh-ancestor
20275406|NCT00554918|Antimitotic Agents|antimitotic agents|mesh-ancestor
20275407|NCT00554918|Mitosis Modulators|mitosis modulators|mesh-ancestor
20275408|NCT00554918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275409|NCT00554918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19960402|NCT01692756|Hormones|hormones|mesh-ancestor
19960403|NCT01692756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19960404|NCT01692756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960405|NCT01692756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19960406|NCT01692756|Immunologic Factors|immunologic factors|mesh-ancestor
19960407|NCT01692756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19960408|NCT01692756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960409|NCT01693029|Epoetin Alfa|epoetin alfa|mesh-list
19960410|NCT01693029|Hematinics|hematinics|mesh-ancestor
19960411|NCT01693068|Dacarbazine|dacarbazine|mesh-list
19960412|NCT01693068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19960413|NCT01693068|Alkylating Agents|alkylating agents|mesh-ancestor
19960414|NCT01693068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960415|NCT01693068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960416|NCT01693185|Midazolam|midazolam|mesh-list
19960417|NCT01693185|Meperidine|meperidine|mesh-list
19960418|NCT01693185|Remifentanil|remifentanil|mesh-list
19960419|NCT01693185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19960420|NCT01693185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19960421|NCT01693185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19960422|NCT01693185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960423|NCT01693185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20275410|NCT00554918|Glucocorticoids|glucocorticoids|mesh-ancestor
20275411|NCT00554918|Hormones|hormones|mesh-ancestor
20275412|NCT00554918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20275413|NCT00554918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275414|NCT00554918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20545200|NCT01880138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19960424|NCT01693185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19960425|NCT01693185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19960426|NCT01693185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19960427|NCT01693185|Anesthetics, General|anesthetics, general|mesh-ancestor
19960428|NCT01693185|Anesthetics|anesthetics|mesh-ancestor
19960429|NCT01693185|GABA Modulators|gaba modulators|mesh-ancestor
19960430|NCT01693185|GABA Agents|gaba agents|mesh-ancestor
19960431|NCT01693185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19960432|NCT01693185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960433|NCT01693185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19960434|NCT01693185|Narcotics|narcotics|mesh-ancestor
19960435|NCT01693185|Analgesics|analgesics|mesh-ancestor
19960436|NCT01693185|Sensory System Agents|sensory system agents|mesh-ancestor
19960437|NCT01693185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960438|NCT01693523|Minocycline|minocycline|mesh-list
19960439|NCT01693523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19960440|NCT01693523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19960441|NCT01693562|Durvalumab|durvalumab|mesh-list
19960442|NCT01693562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19960443|NCT01693562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20545201|NCT01880138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545202|NCT01880216|Enoxaparin|enoxaparin|mesh-list
20545203|NCT01880216|Enoxaparin sodium|enoxaparin sodium|mesh-list
20545204|NCT01880216|Bemiparin|bemiparin|mesh-list
20545205|NCT01880216|Anticoagulants|anticoagulants|mesh-ancestor
19960444|NCT01694108|BCG Vaccine|bcg vaccine|mesh-list
20545206|NCT01880216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20275415|NCT00554918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19960445|NCT01694108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19960446|NCT01694108|Immunologic Factors|immunologic factors|mesh-ancestor
19960447|NCT01694108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960448|NCT01694420|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19960449|NCT01694420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20275416|NCT00555022|Bromides|bromides|mesh-list
20275417|NCT00555022|Tiotropium Bromide|tiotropium bromide|mesh-list
20275418|NCT00555022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20275419|NCT00555022|Autonomic Agents|autonomic agents|mesh-ancestor
20275420|NCT00555022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275421|NCT00555022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275422|NCT00555022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20275423|NCT00555022|Respiratory System Agents|respiratory system agents|mesh-ancestor
20275424|NCT00555022|Parasympatholytics|parasympatholytics|mesh-ancestor
20275425|NCT00555022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20275426|NCT00555022|Cholinergic Agents|cholinergic agents|mesh-ancestor
20275427|NCT00555022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20275428|NCT00555022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275429|NCT00555022|Anticonvulsants|anticonvulsants|mesh-ancestor
20275430|NCT00555087|Methyltestosterone|methyltestosterone|mesh-list
20275431|NCT00555087|Testosterone|testosterone|mesh-list
20275432|NCT00555087|Testosterone undecanoate|testosterone undecanoate|mesh-list
20275433|NCT00555087|Testosterone enanthate|testosterone enanthate|mesh-list
20275434|NCT00555087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20275435|NCT00555087|Androgens|androgens|mesh-ancestor
20275436|NCT00555087|Hormones|hormones|mesh-ancestor
20275437|NCT00555087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20275438|NCT00555087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275439|NCT00555087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20275440|NCT00555087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275441|NCT00555087|Anabolic Agents|anabolic agents|mesh-ancestor
20275442|NCT00555100|Dexamethasone|dexamethasone|mesh-list
20275443|NCT00555100|Lenalidomide|lenalidomide|mesh-list
20275444|NCT00555100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20275445|NCT00555100|Antiemetics|antiemetics|mesh-ancestor
20275446|NCT00555100|Autonomic Agents|autonomic agents|mesh-ancestor
20275447|NCT00555100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275448|NCT00555100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275449|NCT00555100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20275450|NCT00555100|Glucocorticoids|glucocorticoids|mesh-ancestor
20275451|NCT00555100|Hormones|hormones|mesh-ancestor
20275452|NCT00555100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20275453|NCT00555100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20275454|NCT00555100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275455|NCT00555100|Immunologic Factors|immunologic factors|mesh-ancestor
20275456|NCT00555100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20275457|NCT00555100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20275458|NCT00555100|Growth Substances|growth substances|mesh-ancestor
20275459|NCT00555100|Growth Inhibitors|growth inhibitors|mesh-ancestor
20275460|NCT00555139|Alprazolam|alprazolam|mesh-list
20275461|NCT00555139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20275462|NCT00555139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20275463|NCT00555139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275464|NCT00555139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20545207|NCT01880216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20545208|NCT01880216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545209|NCT01880307|Prednisolone|prednisolone|mesh-list
20545210|NCT01880307|Azathioprine|azathioprine|mesh-list
20545211|NCT01880307|Infliximab|infliximab|mesh-list
20545212|NCT01880307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20545213|NCT01880307|Glucocorticoids|glucocorticoids|mesh-ancestor
20545214|NCT01880307|Hormones|hormones|mesh-ancestor
20545215|NCT01880307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20545216|NCT01880307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545217|NCT01880307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20545218|NCT01880307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20545219|NCT01880307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20545220|NCT01880307|Dermatologic Agents|dermatologic agents|mesh-ancestor
19960450|NCT01694420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19960451|NCT01694420|Antiviral Agents|antiviral agents|mesh-ancestor
19960452|NCT01694420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19960453|NCT01694433|Vitamin D|vitamin d|mesh-list
19960454|NCT01694433|Calcitriol|calcitriol|mesh-list
19960455|NCT01694433|Calcipotriene|calcipotriene|mesh-list
19960456|NCT01694433|Vitamins|vitamins|mesh-ancestor
19960457|NCT01694433|Micronutrients|micronutrients|mesh-ancestor
19960458|NCT01694433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960459|NCT01694433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19960460|NCT01694433|Dermatologic Agents|dermatologic agents|mesh-ancestor
19960461|NCT01694433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19960462|NCT01694433|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19960463|NCT01694433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19960464|NCT01694433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960465|NCT01694433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19960466|NCT01694706|Omeprazole|omeprazole|mesh-list
19960467|NCT01694706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19960468|NCT01694706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19960469|NCT01694706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19960470|NCT01694706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19960471|NCT01694706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960472|NCT01694771|Tiotropium Bromide|tiotropium bromide|mesh-list
19960473|NCT01694771|Olodaterol|olodaterol|mesh-list
19960474|NCT01694771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19960475|NCT01694771|Autonomic Agents|autonomic agents|mesh-ancestor
19960476|NCT01694771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275465|NCT00555139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20275466|NCT00555139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20275467|NCT00555139|GABA Modulators|gaba modulators|mesh-ancestor
20275468|NCT00555139|GABA Agents|gaba agents|mesh-ancestor
20275469|NCT00555139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20275470|NCT00555139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287711|NCT03896230|Sensory System Agents|sensory system agents|mesh-ancestor
20287712|NCT03896230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287713|NCT03896230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287714|NCT03896230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20287715|NCT03896230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20287716|NCT03896230|Anesthetics, General|anesthetics, general|mesh-ancestor
20287717|NCT03896230|Anesthetics|anesthetics|mesh-ancestor
20287718|NCT03896230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20287719|NCT03896230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20287720|NCT03896230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20287721|NCT03896230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20287722|NCT03896230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287723|NCT03879577|Tamoxifen|tamoxifen|mesh-list
20287724|NCT03879577|Docetaxel|docetaxel|mesh-list
20287725|NCT03879577|Trastuzumab|trastuzumab|mesh-list
20287726|NCT03879577|Letrozole|letrozole|mesh-list
20287727|NCT03879577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960477|NCT01694771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960478|NCT01694771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19960479|NCT01694771|Respiratory System Agents|respiratory system agents|mesh-ancestor
19960480|NCT01694771|Parasympatholytics|parasympatholytics|mesh-ancestor
19960481|NCT01694771|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19960482|NCT01694771|Cholinergic Agents|cholinergic agents|mesh-ancestor
19960483|NCT01694771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19960484|NCT01694771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960485|NCT01694966|Methylene Blue|methylene blue|mesh-list
19960486|NCT01694966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19960487|NCT01694966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960488|NCT01695135|Prednisone|prednisone|mesh-list
19960489|NCT01695135|Abiraterone Acetate|abiraterone acetate|mesh-list
19960490|NCT01695135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20287728|NCT03879577|Tubulin Modulators|tubulin modulators|mesh-ancestor
20287729|NCT03879577|Antimitotic Agents|antimitotic agents|mesh-ancestor
20545221|NCT01880307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19960491|NCT01695135|Glucocorticoids|glucocorticoids|mesh-ancestor
19960492|NCT01695135|Hormones|hormones|mesh-ancestor
19960493|NCT01695135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19960494|NCT01695135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960495|NCT01695135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19960496|NCT01695135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960497|NCT01695135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19960498|NCT01695135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19960499|NCT01695135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960500|NCT01695135|Hormone Antagonists|hormone antagonists|mesh-ancestor
19960501|NCT01695135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19960502|NCT01695239|Adalimumab|adalimumab|mesh-list
20287730|NCT03879577|Mitosis Modulators|mitosis modulators|mesh-ancestor
19960503|NCT01695239|Ixekizumab|ixekizumab|mesh-list
19960504|NCT01695239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19960505|NCT01695239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19960506|NCT01695239|Dermatologic Agents|dermatologic agents|mesh-ancestor
19960507|NCT01695291|Minocycline|minocycline|mesh-list
19960508|NCT01695291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19960509|NCT01695291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19960510|NCT01695330|Bortezomib|bortezomib|mesh-list
19960511|NCT01695330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960512|NCT01695668|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19960513|NCT01695668|Cyclosporine|cyclosporine|mesh-list
20275471|NCT00555230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20275472|NCT00555230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20275473|NCT00555230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20275474|NCT00555230|Antimetabolites|antimetabolites|mesh-ancestor
20275475|NCT00555230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275476|NCT00555230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20275477|NCT00555230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20275478|NCT00555230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275479|NCT00555256|Sirolimus|sirolimus|mesh-list
20275480|NCT00555256|Sunitinib|sunitinib|mesh-list
20275481|NCT00555256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275482|NCT00555256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20275483|NCT00555256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20275484|NCT00555256|Growth Substances|growth substances|mesh-ancestor
20275485|NCT00555256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275486|NCT00555256|Growth Inhibitors|growth inhibitors|mesh-ancestor
19960514|NCT01695668|Cyclosporins|cyclosporins|mesh-list
19960515|NCT01695668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19960516|NCT01695668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960517|NCT01695668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19960518|NCT01695668|Immunologic Factors|immunologic factors|mesh-ancestor
19960519|NCT01695668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960520|NCT01695668|Antifungal Agents|antifungal agents|mesh-ancestor
19960521|NCT01695668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19960522|NCT01695668|Dermatologic Agents|dermatologic agents|mesh-ancestor
20545222|NCT01880307|Antimetabolites|antimetabolites|mesh-ancestor
20545223|NCT01880307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545224|NCT01880307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20545225|NCT01880307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20545226|NCT01880307|Immunologic Factors|immunologic factors|mesh-ancestor
20545227|NCT01880346|Vitamin D|vitamin d|mesh-list
20545228|NCT01880346|Ergocalciferols|ergocalciferols|mesh-list
20545229|NCT01880346|Cholecalciferol|cholecalciferol|mesh-list
20545230|NCT01880346|Vitamins|vitamins|mesh-list
20545231|NCT01880346|Micronutrients|micronutrients|mesh-ancestor
20545232|NCT01880346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545233|NCT01880346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20545234|NCT01880346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20545235|NCT01880372|Thioctic Acid|thioctic acid|mesh-list
20545236|NCT01880372|Antioxidants|antioxidants|mesh-ancestor
20545237|NCT01880372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545238|NCT01880372|Protective Agents|protective agents|mesh-ancestor
20545239|NCT01880372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545240|NCT01880372|Vitamin B Complex|vitamin b complex|mesh-ancestor
20545241|NCT01880372|Vitamins|vitamins|mesh-ancestor
20545242|NCT01880372|Micronutrients|micronutrients|mesh-ancestor
20545243|NCT01880385|Cyclophosphamide|cyclophosphamide|mesh-list
20545244|NCT01880385|Bevacizumab|bevacizumab|mesh-list
20545245|NCT01880385|Docetaxel|docetaxel|mesh-list
20545246|NCT01880385|Fluorouracil|fluorouracil|mesh-list
20545247|NCT01880385|Trastuzumab|trastuzumab|mesh-list
20545248|NCT01880385|Epirubicin|epirubicin|mesh-list
20545249|NCT01880385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20545250|NCT01880385|Immunologic Factors|immunologic factors|mesh-ancestor
20545251|NCT01880385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545252|NCT01880385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19960523|NCT01695668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19960524|NCT01695668|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19960525|NCT01695668|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19960526|NCT01695772|Bevacizumab|bevacizumab|mesh-list
19960527|NCT01695772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19960528|NCT01695772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960529|NCT01695772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19960530|NCT01695772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19960531|NCT01695772|Growth Substances|growth substances|mesh-ancestor
20545253|NCT01880385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20545254|NCT01880385|Alkylating Agents|alkylating agents|mesh-ancestor
19960532|NCT01695772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960533|NCT01695772|Growth Inhibitors|growth inhibitors|mesh-ancestor
19960534|NCT01695954|Ritonavir|ritonavir|mesh-list
19960535|NCT01695954|Darunavir|darunavir|mesh-list
19960536|NCT01695954|Efavirenz|efavirenz|mesh-list
19960537|NCT01695954|Pitavastatin|pitavastatin|mesh-list
19960538|NCT01695954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19960539|NCT01695954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19960540|NCT01695954|Protease Inhibitors|protease inhibitors|mesh-ancestor
19960541|NCT01695954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19960542|NCT01695954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960543|NCT01695954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19960544|NCT01695954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19960545|NCT01695954|Antiviral Agents|antiviral agents|mesh-ancestor
19960546|NCT01695954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19960547|NCT01695954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19960548|NCT01695954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19960549|NCT01695954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19960550|NCT01695954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19960551|NCT01695954|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19960552|NCT01695954|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19960553|NCT01695954|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19960554|NCT01695954|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19960555|NCT01695954|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19960556|NCT01695954|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19960557|NCT01695954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20275487|NCT00555256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20275488|NCT00555256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275489|NCT00555256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275490|NCT00555256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20275491|NCT00555256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20275492|NCT00555256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20275493|NCT00555256|Antifungal Agents|antifungal agents|mesh-ancestor
20275494|NCT00555256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19960558|NCT01695954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19960559|NCT01695954|Antimetabolites|antimetabolites|mesh-ancestor
19960560|NCT01695954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19960561|NCT01696032|Gemcitabine|gemcitabine|mesh-list
19960562|NCT01696032|Paclitaxel|paclitaxel|mesh-list
19960563|NCT01696032|Carboplatin|carboplatin|mesh-list
19960564|NCT01696032|Doxorubicin|doxorubicin|mesh-list
19960565|NCT01696032|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19960566|NCT01696032|Topotecan|topotecan|mesh-list
19960567|NCT01696032|Guadecitabine|guadecitabine|mesh-list
19960568|NCT01696032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19960569|NCT01696032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960570|NCT01696032|Tubulin Modulators|tubulin modulators|mesh-ancestor
19960571|NCT01696032|Antimitotic Agents|antimitotic agents|mesh-ancestor
19960572|NCT01696032|Mitosis Modulators|mitosis modulators|mesh-ancestor
19960573|NCT01696032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960574|NCT01696032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19960575|NCT01696032|Antimetabolites|antimetabolites|mesh-ancestor
19960576|NCT01696032|Antiviral Agents|antiviral agents|mesh-ancestor
19960577|NCT01696032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20275495|NCT00555256|Immunologic Factors|immunologic factors|mesh-ancestor
20275496|NCT00555334|Lamivudine|lamivudine|mesh-list
20275497|NCT00555334|Entecavir|entecavir|mesh-list
19960578|NCT01696032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19960579|NCT01696032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19960580|NCT01696032|Immunologic Factors|immunologic factors|mesh-ancestor
19960581|NCT01696032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960582|NCT01696032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19960583|NCT01696032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19960584|NCT01696032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19960585|NCT01696032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19960586|NCT01696045|Ipilimumab|ipilimumab|mesh-list
19960587|NCT01696045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19960588|NCT01696045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960589|NCT01696045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19960590|NCT01696045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960591|NCT01696058|Tiotropium Bromide|tiotropium bromide|mesh-list
19960592|NCT01696058|Olodaterol|olodaterol|mesh-list
19960593|NCT01696058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20545255|NCT01880385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960594|NCT01696058|Autonomic Agents|autonomic agents|mesh-ancestor
20275498|NCT00555334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20275499|NCT00555334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20275500|NCT00555334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275501|NCT00555334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275502|NCT00555334|Antiviral Agents|antiviral agents|mesh-ancestor
20275503|NCT00555334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20275504|NCT00555334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20275505|NCT00555334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20275506|NCT00555347|Modafinil|modafinil|mesh-list
20275507|NCT00555347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20275508|NCT00555347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275509|NCT00555347|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20275510|NCT00555347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20275511|NCT00555347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20275512|NCT00555347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275513|NCT00555373|Sirolimus|sirolimus|mesh-list
20275514|NCT00555373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20275515|NCT00555373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20275516|NCT00555373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20275517|NCT00555373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275518|NCT00555373|Antifungal Agents|antifungal agents|mesh-ancestor
20275519|NCT00555373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20275520|NCT00555373|Immunologic Factors|immunologic factors|mesh-ancestor
20275521|NCT00555373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275522|NCT00555386|Selenium|selenium|mesh-list
20275523|NCT00555386|Antioxidants|antioxidants|mesh-ancestor
20275524|NCT00555386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275525|NCT00555386|Protective Agents|protective agents|mesh-ancestor
20275526|NCT00555386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275527|NCT00555386|Trace Elements|trace elements|mesh-ancestor
20275528|NCT00555386|Micronutrients|micronutrients|mesh-ancestor
20275529|NCT00555399|Temozolomide|temozolomide|mesh-list
20275530|NCT00555399|Vorinostat|vorinostat|mesh-list
20275531|NCT00555399|Isotretinoin|isotretinoin|mesh-list
20275532|NCT00555399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20275533|NCT00555399|Alkylating Agents|alkylating agents|mesh-ancestor
20275534|NCT00555399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275535|NCT00555399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275536|NCT00555399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20275537|NCT00555399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275538|NCT00555399|Dermatologic Agents|dermatologic agents|mesh-ancestor
20275539|NCT00555412|Loxapine|loxapine|mesh-list
20275540|NCT00555412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20275541|NCT00555412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20275542|NCT00555412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20275543|NCT00555412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275544|NCT00555412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20275545|NCT00555412|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20275546|NCT00555412|Dopamine Agents|dopamine agents|mesh-ancestor
20275547|NCT00555412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20275548|NCT00555412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275549|NCT00555542|Rituximab|rituximab|mesh-list
20275550|NCT00555542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20275551|NCT00555542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275552|NCT00555542|Immunologic Factors|immunologic factors|mesh-ancestor
20275553|NCT00555542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275554|NCT00555542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20275555|NCT00555594|Bevacizumab|bevacizumab|mesh-list
20275556|NCT00555594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20275557|NCT00555594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275558|NCT00555594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20275559|NCT00555594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20275560|NCT00555594|Growth Substances|growth substances|mesh-ancestor
20275561|NCT00555594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275562|NCT00555594|Growth Inhibitors|growth inhibitors|mesh-ancestor
20275563|NCT00555607|Prednisolone|prednisolone|mesh-list
20275564|NCT00555607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20275565|NCT00555607|Glucocorticoids|glucocorticoids|mesh-ancestor
20275566|NCT00555607|Hormones|hormones|mesh-ancestor
20275567|NCT00555607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20275568|NCT00555607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275569|NCT00555607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20275570|NCT00555607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20545256|NCT01880385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275571|NCT00555776|Gabapentin|gabapentin|mesh-list
20275572|NCT00555776|Analgesics|analgesics|mesh-ancestor
20275573|NCT00555776|Sensory System Agents|sensory system agents|mesh-ancestor
20275574|NCT00555776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275575|NCT00555776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275576|NCT00555776|Anticonvulsants|anticonvulsants|mesh-ancestor
20275577|NCT00555776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20275578|NCT00555776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20275579|NCT00555776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19960595|NCT01696058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960596|NCT01696058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960597|NCT01696058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19960598|NCT01696058|Respiratory System Agents|respiratory system agents|mesh-ancestor
19960599|NCT01696058|Parasympatholytics|parasympatholytics|mesh-ancestor
19960600|NCT01696058|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19960601|NCT01696058|Cholinergic Agents|cholinergic agents|mesh-ancestor
19960602|NCT01696058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19960603|NCT01696058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960604|NCT01696071|Tiotropium Bromide|tiotropium bromide|mesh-list
19960605|NCT01696071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19960606|NCT01696071|Autonomic Agents|autonomic agents|mesh-ancestor
19960607|NCT01696071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275580|NCT00555776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20275581|NCT00555776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20275582|NCT00555776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20275583|NCT00555776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20275584|NCT00555776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275585|NCT00555776|Antimanic Agents|antimanic agents|mesh-ancestor
20275586|NCT00555854|Benzocaine|benzocaine|mesh-list
20275587|NCT00555854|Anesthetics, Local|anesthetics, local|mesh-ancestor
20275588|NCT00555854|Anesthetics|anesthetics|mesh-ancestor
20275589|NCT00555854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19960608|NCT01696071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960609|NCT01696071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19960610|NCT01696071|Respiratory System Agents|respiratory system agents|mesh-ancestor
19960611|NCT01696071|Parasympatholytics|parasympatholytics|mesh-ancestor
19960612|NCT01696071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19960613|NCT01696071|Cholinergic Agents|cholinergic agents|mesh-ancestor
19960614|NCT01696071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19960615|NCT01696071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960616|NCT01696084|Cytarabine|cytarabine|mesh-list
19960617|NCT01696084|Daunorubicin|daunorubicin|mesh-list
19960618|NCT01696084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19960619|NCT01696084|Antimetabolites|antimetabolites|mesh-ancestor
19960620|NCT01696084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960621|NCT01696084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960622|NCT01696084|Antiviral Agents|antiviral agents|mesh-ancestor
19960623|NCT01696084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19960624|NCT01696084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19960625|NCT01696084|Immunologic Factors|immunologic factors|mesh-ancestor
19960626|NCT01696084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960627|NCT01696084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19960628|NCT01696084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19960629|NCT01696084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19960630|NCT01696084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19960631|NCT01696214|Fluticasone|fluticasone|mesh-list
19960632|NCT01696214|Xhance|xhance|mesh-list
19960633|NCT01696214|Theophylline|theophylline|mesh-list
19960634|NCT01696214|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19960635|NCT01696214|Ipratropium|ipratropium|mesh-list
19960636|NCT01696214|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19960637|NCT01696214|Montelukast|montelukast|mesh-list
19960638|NCT01696214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19960639|NCT01696214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19960640|NCT01696214|Autonomic Agents|autonomic agents|mesh-ancestor
19960641|NCT01696214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960642|NCT01696214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960643|NCT01696214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19960644|NCT01696214|Respiratory System Agents|respiratory system agents|mesh-ancestor
19960645|NCT01696214|Dermatologic Agents|dermatologic agents|mesh-ancestor
19960646|NCT01696214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20275590|NCT00555854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960647|NCT01696214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20275591|NCT00555854|Sensory System Agents|sensory system agents|mesh-ancestor
19960648|NCT01696214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19960649|NCT01696214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19960650|NCT01696214|Adrenergic Agents|adrenergic agents|mesh-ancestor
19960651|NCT01696214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19960652|NCT01696214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960653|NCT01696214|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19960654|NCT01696214|Hormone Antagonists|hormone antagonists|mesh-ancestor
19960655|NCT01696214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19960656|NCT01696214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19960657|NCT01696214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19960658|NCT01696214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19960659|NCT01696214|Cholinergic Agents|cholinergic agents|mesh-ancestor
19960660|NCT01696214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19960661|NCT01696214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19960662|NCT01696214|Vasodilator Agents|vasodilator agents|mesh-ancestor
19960663|NCT01696214|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19960664|NCT01696214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19960665|NCT01696214|Purinergic Agents|purinergic agents|mesh-ancestor
19960666|NCT01696214|Glucocorticoids|glucocorticoids|mesh-ancestor
19960667|NCT01696214|Hormones|hormones|mesh-ancestor
19960668|NCT01696214|Sympathomimetics|sympathomimetics|mesh-ancestor
19960669|NCT01696279|Calcium Carbonate|calcium carbonate|mesh-list
19960670|NCT01696279|Calcium|calcium|mesh-list
19960671|NCT01696279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19960672|NCT01696279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275592|NCT00555854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275593|NCT00555867|Anastrozole|anastrozole|mesh-list
20275594|NCT00555867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20275595|NCT00555867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275596|NCT00555867|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20275597|NCT00555867|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20275598|NCT00555867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275599|NCT00555867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275600|NCT00555867|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20275601|NCT00555867|Hormone Antagonists|hormone antagonists|mesh-ancestor
20275602|NCT00555867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20275603|NCT00555867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275604|NCT00555984|Remifentanil|remifentanil|mesh-list
20275605|NCT00555984|Propofol|propofol|mesh-list
20275606|NCT00555984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
20275607|NCT00555984|Sevoflurane|sevoflurane|mesh-list
20275608|NCT00555984|Anesthetics|anesthetics|mesh-list
20275609|NCT00555984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20275610|NCT00555984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20275611|NCT00555984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960673|NCT01696279|Antacids|antacids|mesh-ancestor
19960674|NCT01696279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960675|NCT01696279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19960676|NCT01696695|Capecitabine|capecitabine|mesh-list
19960677|NCT01696695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19960678|NCT01696695|Antimetabolites|antimetabolites|mesh-ancestor
19960679|NCT01696695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960680|NCT01696695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960681|NCT01696760|Aspirin|aspirin|mesh-list
19960682|NCT01696760|Enoxaparin|enoxaparin|mesh-list
19960683|NCT01696760|Enoxaparin sodium|enoxaparin sodium|mesh-list
19960684|NCT01696760|Anticoagulants|anticoagulants|mesh-ancestor
19960685|NCT01696760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19960686|NCT01696760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19960687|NCT01696760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960688|NCT01696760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19960689|NCT01696760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19960690|NCT01696760|Analgesics|analgesics|mesh-ancestor
19960691|NCT01696760|Sensory System Agents|sensory system agents|mesh-ancestor
19960692|NCT01696760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960693|NCT01696760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960694|NCT01696760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19960695|NCT01696760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19960696|NCT01696760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20275612|NCT00555984|Anesthetics, General|anesthetics, general|mesh-ancestor
20275613|NCT00555984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20275614|NCT00555984|Narcotics|narcotics|mesh-ancestor
20275615|NCT00555984|Analgesics|analgesics|mesh-ancestor
20275616|NCT00555984|Sensory System Agents|sensory system agents|mesh-ancestor
20275617|NCT00555984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545257|NCT01880385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20545258|NCT01880385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20545259|NCT01880385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20545260|NCT01880385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20545261|NCT01880385|Growth Substances|growth substances|mesh-ancestor
20545262|NCT01880385|Growth Inhibitors|growth inhibitors|mesh-ancestor
20545263|NCT01880385|Tubulin Modulators|tubulin modulators|mesh-ancestor
20545264|NCT01880385|Antimitotic Agents|antimitotic agents|mesh-ancestor
20545265|NCT01880385|Mitosis Modulators|mitosis modulators|mesh-ancestor
20545266|NCT01880385|Antimetabolites|antimetabolites|mesh-ancestor
20545267|NCT01880385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20545268|NCT01880385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20545269|NCT01880385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20545270|NCT01880385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20545271|NCT01880385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545272|NCT01880463|Vitamin D|vitamin d|mesh-list
20545273|NCT01880463|Ergocalciferols|ergocalciferols|mesh-list
19960697|NCT01696760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19960698|NCT01696760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19960699|NCT01696760|Antipyretics|antipyretics|mesh-ancestor
19960700|NCT01696877|Cyclophosphamide|cyclophosphamide|mesh-list
19960701|NCT01696877|Molgramostim|molgramostim|mesh-list
19960702|NCT01696877|Sargramostim|sargramostim|mesh-list
19960703|NCT01696877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19960704|NCT01696877|Immunologic Factors|immunologic factors|mesh-ancestor
19960705|NCT01696877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960706|NCT01696877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19960707|NCT01696877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19960708|NCT01696877|Alkylating Agents|alkylating agents|mesh-ancestor
19960709|NCT01696877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960710|NCT01696877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960711|NCT01696877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19960712|NCT01696942|Mesalamine|mesalamine|mesh-list
20275618|NCT00555984|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20545274|NCT01880463|Cholecalciferol|cholecalciferol|mesh-list
20545275|NCT01880463|Vitamins|vitamins|mesh-list
20545276|NCT01880463|Micronutrients|micronutrients|mesh-ancestor
20545277|NCT01880463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545278|NCT01880463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20545279|NCT01880463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20545280|NCT01880619|Tamsulosin|tamsulosin|mesh-list
20545281|NCT01880619|Solifenacin Succinate|solifenacin succinate|mesh-list
20545282|NCT01880619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20545283|NCT01880619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20545284|NCT01880619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20545285|NCT01880619|Adrenergic Agents|adrenergic agents|mesh-ancestor
20545286|NCT01880619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20545287|NCT01880619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545288|NCT01880619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545289|NCT01880619|Urological Agents|urological agents|mesh-ancestor
20545290|NCT01880619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20545291|NCT01880619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20545292|NCT01880619|Cholinergic Agents|cholinergic agents|mesh-ancestor
20545293|NCT01880658|Capecitabine|capecitabine|mesh-list
20545294|NCT01880658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20545295|NCT01880658|Antimetabolites|antimetabolites|mesh-ancestor
20275619|NCT00555984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20275620|NCT00556023|Gemcitabine|gemcitabine|mesh-list
20275621|NCT00556023|Tremelimumab|tremelimumab|mesh-list
20275622|NCT00556023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20275623|NCT00556023|Antimetabolites|antimetabolites|mesh-ancestor
20275624|NCT00556023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275625|NCT00556023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275626|NCT00556023|Antiviral Agents|antiviral agents|mesh-ancestor
20275627|NCT00556023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20275628|NCT00556023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275629|NCT00556023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20275630|NCT00556023|Immunologic Factors|immunologic factors|mesh-ancestor
20275631|NCT00556023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275632|NCT00556062|Vaccines|vaccines|mesh-list
20275633|NCT00556062|Immunologic Factors|immunologic factors|mesh-ancestor
20275634|NCT00556062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545296|NCT01880658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275635|NCT00556088|Paclitaxel|paclitaxel|mesh-list
20275636|NCT00556088|Bevacizumab|bevacizumab|mesh-list
19960713|NCT01696942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960714|NCT01696942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19960715|NCT01696942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19960716|NCT01696942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19960717|NCT01696942|Analgesics|analgesics|mesh-ancestor
19960718|NCT01696942|Sensory System Agents|sensory system agents|mesh-ancestor
19960719|NCT01696942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960720|NCT01696942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19960721|NCT01696955|Cetuximab|cetuximab|mesh-list
19960722|NCT01696955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19960723|NCT01696955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960724|NCT01697345|Testosterone|testosterone|mesh-list
19960725|NCT01697345|Androgens|androgens|mesh-ancestor
19960726|NCT01697345|Hormones|hormones|mesh-ancestor
19960727|NCT01697345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19960728|NCT01697345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960729|NCT01697579|Ondansetron|ondansetron|mesh-list
19960730|NCT01697579|Fosaprepitant|fosaprepitant|mesh-list
19960731|NCT01697579|Aprepitant|aprepitant|mesh-list
19960732|NCT01697579|Serotonin|serotonin|mesh-list
19960733|NCT01697579|Antiemetics|antiemetics|mesh-ancestor
19960734|NCT01697579|Autonomic Agents|autonomic agents|mesh-ancestor
19960735|NCT01697579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960736|NCT01697579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960737|NCT01697579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19960738|NCT01697579|Antipruritics|antipruritics|mesh-ancestor
19960739|NCT01697579|Dermatologic Agents|dermatologic agents|mesh-ancestor
19960740|NCT01697579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19960741|NCT01697579|Serotonin Agents|serotonin agents|mesh-ancestor
19960742|NCT01697579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19960743|NCT01697579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960744|NCT01697579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19960745|NCT01697579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19960746|NCT01697579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19960747|NCT01697579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19960748|NCT01697579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19960749|NCT01697579|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19960750|NCT01697579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19960751|NCT01697696|Glycopyrrolate|glycopyrrolate|mesh-list
19960752|NCT01697696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19960753|NCT01697696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19960754|NCT01697696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19960755|NCT01697696|Cholinergic Agents|cholinergic agents|mesh-ancestor
19960756|NCT01697696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19960757|NCT01697696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960758|NCT01697696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960759|NCT01697709|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19960760|NCT01697709|Antidepressive Agents|antidepressive agents|mesh-ancestor
19960761|NCT01697709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19960762|NCT01697709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19960763|NCT01697709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20275637|NCT00556088|Carboplatin|carboplatin|mesh-list
20275638|NCT00556088|Panobinostat|panobinostat|mesh-list
20275639|NCT00556088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20275640|NCT00556088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275641|NCT00556088|Tubulin Modulators|tubulin modulators|mesh-ancestor
20275642|NCT00556088|Antimitotic Agents|antimitotic agents|mesh-ancestor
20275643|NCT00556088|Mitosis Modulators|mitosis modulators|mesh-ancestor
20275644|NCT00556088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275645|NCT00556088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20275646|NCT00556088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20275647|NCT00556088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20275648|NCT00556088|Growth Substances|growth substances|mesh-ancestor
20275649|NCT00556088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275650|NCT00556088|Growth Inhibitors|growth inhibitors|mesh-ancestor
20275651|NCT00556088|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20275652|NCT00556088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275653|NCT00556127|Cytarabine|cytarabine|mesh-list
20275654|NCT00556127|Dexamethasone|dexamethasone|mesh-list
20275655|NCT00556127|Prednisone|prednisone|mesh-list
20275656|NCT00556127|Cyclophosphamide|cyclophosphamide|mesh-list
20275657|NCT00556127|Melphalan|melphalan|mesh-list
20275658|NCT00556127|Carmustine|carmustine|mesh-list
20275659|NCT00556127|Rituximab|rituximab|mesh-list
20275660|NCT00556127|Etoposide|etoposide|mesh-list
20275661|NCT00556127|Vincristine|vincristine|mesh-list
20275662|NCT00556127|Epirubicin|epirubicin|mesh-list
19960764|NCT01697709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19960765|NCT01697709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960766|NCT01697956|Beclomethasone|beclomethasone|mesh-list
19960767|NCT01697956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19960768|NCT01697956|Glucocorticoids|glucocorticoids|mesh-ancestor
19960769|NCT01697956|Hormones|hormones|mesh-ancestor
19960770|NCT01697956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19960771|NCT01697956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960772|NCT01697956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19960773|NCT01697956|Respiratory System Agents|respiratory system agents|mesh-ancestor
19960774|NCT01697969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19960775|NCT01697969|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19960776|NCT01697969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19960777|NCT01697969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19960778|NCT01697969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19960779|NCT01697969|Analgesics|analgesics|mesh-ancestor
19960780|NCT01697969|Sensory System Agents|sensory system agents|mesh-ancestor
19960781|NCT01697969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275663|NCT00556127|Mitoxantrone|mitoxantrone|mesh-list
20275664|NCT00556127|Sargramostim|sargramostim|mesh-list
20275665|NCT00556127|Lenograstim|lenograstim|mesh-list
20275666|NCT00556127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20275667|NCT00556127|Immunologic Factors|immunologic factors|mesh-ancestor
20275668|NCT00556127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275669|NCT00556127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20275670|NCT00556127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20275671|NCT00556127|Alkylating Agents|alkylating agents|mesh-ancestor
20275672|NCT00556127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275673|NCT00556127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275674|NCT00556127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20275675|NCT00556127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20275676|NCT00556127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20275677|NCT00556127|Antiemetics|antiemetics|mesh-ancestor
20275678|NCT00556127|Autonomic Agents|autonomic agents|mesh-ancestor
20275679|NCT00556127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275680|NCT00556127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20275681|NCT00556127|Glucocorticoids|glucocorticoids|mesh-ancestor
20275682|NCT00556127|Hormones|hormones|mesh-ancestor
20275683|NCT00556127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20275684|NCT00556127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20275685|NCT00556127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20275686|NCT00556127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20275687|NCT00556127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20275688|NCT00556127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275689|NCT00556127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20275690|NCT00556127|Antimetabolites|antimetabolites|mesh-ancestor
20275691|NCT00556127|Antiviral Agents|antiviral agents|mesh-ancestor
20275692|NCT00556127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20275693|NCT00556127|Tubulin Modulators|tubulin modulators|mesh-ancestor
20275694|NCT00556127|Antimitotic Agents|antimitotic agents|mesh-ancestor
20275695|NCT00556127|Mitosis Modulators|mitosis modulators|mesh-ancestor
20275696|NCT00556127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20275697|NCT00556127|Analgesics|analgesics|mesh-ancestor
20545297|NCT01880658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20545298|NCT01880749|Everolimus|everolimus|mesh-list
20545299|NCT01880749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20545300|NCT01880749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20545301|NCT01880749|Immunologic Factors|immunologic factors|mesh-ancestor
20545302|NCT01880749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545303|NCT01880775|Bupivacaine|bupivacaine|mesh-list
20545304|NCT01880775|Prilocaine|prilocaine|mesh-list
20545305|NCT01880775|Anesthetics, Local|anesthetics, local|mesh-ancestor
20545306|NCT01880775|Anesthetics|anesthetics|mesh-ancestor
20545307|NCT01880775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19960782|NCT01697969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960783|NCT01697969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19960784|NCT01697969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19960785|NCT01697969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19960786|NCT01697969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19960787|NCT01697969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19960788|NCT01697969|Histamine Antagonists|histamine antagonists|mesh-ancestor
19960789|NCT01697969|Histamine Agents|histamine agents|mesh-ancestor
20275698|NCT00556127|Sensory System Agents|sensory system agents|mesh-ancestor
20545308|NCT01880775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960790|NCT01697969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19960791|NCT01697969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960792|NCT01698320|Albuterol|albuterol|mesh-list
20275699|NCT00556127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20275700|NCT00556153|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
20275701|NCT00556153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275702|NCT00556192|Rituximab|rituximab|mesh-list
20275703|NCT00556192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20275704|NCT00556192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275705|NCT00556192|Immunologic Factors|immunologic factors|mesh-ancestor
20275706|NCT00556192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275707|NCT00556192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20275708|NCT00556205|Bevacizumab|bevacizumab|mesh-list
20275709|NCT00556205|Sunitinib|sunitinib|mesh-list
20275710|NCT00556205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19960793|NCT01698320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19960794|NCT01698320|Autonomic Agents|autonomic agents|mesh-ancestor
19960795|NCT01698320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960796|NCT01698320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960797|NCT01698320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19960798|NCT01698320|Respiratory System Agents|respiratory system agents|mesh-ancestor
19960799|NCT01698320|Tocolytic Agents|tocolytic agents|mesh-ancestor
19960800|NCT01698320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19960801|NCT01698320|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19960802|NCT01698320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19960803|NCT01698320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19960804|NCT01698320|Adrenergic Agents|adrenergic agents|mesh-ancestor
19960805|NCT01698320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19960806|NCT01698320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960807|NCT01698554|Bimatoprost|bimatoprost|mesh-list
19960808|NCT01698554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19960809|NCT01698554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19974853|NCT01843023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19974854|NCT01843023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974855|NCT01843023|Analgesics|analgesics|mesh-ancestor
19974856|NCT01843023|Sensory System Agents|sensory system agents|mesh-ancestor
19974857|NCT01843023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19974858|NCT01843023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19974859|NCT01843023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19974860|NCT01843205|Methamphetamine|methamphetamine|mesh-list
20275711|NCT00556205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275712|NCT00556205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20275713|NCT00556205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20275714|NCT00556205|Growth Substances|growth substances|mesh-ancestor
20275715|NCT00556205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275716|NCT00556205|Growth Inhibitors|growth inhibitors|mesh-ancestor
20275717|NCT00556205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20275718|NCT00556205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275719|NCT00556205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275720|NCT00556257|Cyclosporine|cyclosporine|mesh-list
19974861|NCT01843205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19974862|NCT01843205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974863|NCT01843205|Sympathomimetics|sympathomimetics|mesh-ancestor
19974864|NCT01843205|Autonomic Agents|autonomic agents|mesh-ancestor
19974865|NCT01843205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19974866|NCT01843205|Dopamine Agents|dopamine agents|mesh-ancestor
19974867|NCT01843205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19974868|NCT01843205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974869|NCT01843205|Adrenergic Agents|adrenergic agents|mesh-ancestor
19974870|NCT01843205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19974871|NCT01843205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19974872|NCT01843205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19974873|NCT01843205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19974874|NCT01843348|Cyclosporine|cyclosporine|mesh-list
19974875|NCT01843348|Mycophenolic Acid|mycophenolic acid|mesh-list
19974876|NCT01843348|Everolimus|everolimus|mesh-list
19974877|NCT01843348|Tacrolimus|tacrolimus|mesh-list
19974878|NCT01843348|Cyclosporins|cyclosporins|mesh-list
19960810|NCT01698710|Paclitaxel|paclitaxel|mesh-list
19960811|NCT01698710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19960812|NCT01698710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19960813|NCT01698710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960814|NCT01698710|Tubulin Modulators|tubulin modulators|mesh-ancestor
19960815|NCT01698710|Antimitotic Agents|antimitotic agents|mesh-ancestor
19960816|NCT01698710|Mitosis Modulators|mitosis modulators|mesh-ancestor
19960817|NCT01698710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960818|NCT01698775|Glipizide|glipizide|mesh-list
19960819|NCT01698775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19960820|NCT01698775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960821|NCT01698801|Dexamethasone|dexamethasone|mesh-list
19960822|NCT01698801|Lenalidomide|lenalidomide|mesh-list
19960823|NCT01698801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20275721|NCT00556257|Cyclosporins|cyclosporins|mesh-list
20275722|NCT00556257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275723|NCT00556257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275724|NCT00556257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20275725|NCT00556257|Immunologic Factors|immunologic factors|mesh-ancestor
20275726|NCT00556257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275727|NCT00556257|Antifungal Agents|antifungal agents|mesh-ancestor
20275728|NCT00556257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20275729|NCT00556257|Dermatologic Agents|dermatologic agents|mesh-ancestor
20275730|NCT00556257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19960824|NCT01698801|Antiemetics|antiemetics|mesh-ancestor
20275731|NCT00556257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20275732|NCT00556270|Fentanyl|fentanyl|mesh-list
20275733|NCT00556270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20275734|NCT00556270|Narcotics|narcotics|mesh-ancestor
20545309|NCT01880775|Sensory System Agents|sensory system agents|mesh-ancestor
20545310|NCT01880775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545311|NCT01880931|Remifentanil|remifentanil|mesh-list
20545312|NCT01880931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20545313|NCT01880931|Narcotics|narcotics|mesh-ancestor
20545314|NCT01880931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20545315|NCT01880931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545316|NCT01880931|Analgesics|analgesics|mesh-ancestor
20545317|NCT01880931|Sensory System Agents|sensory system agents|mesh-ancestor
20545318|NCT01880931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545319|NCT01880957|Lamotrigine|lamotrigine|mesh-list
20545320|NCT01880957|Lithium Carbonate|lithium carbonate|mesh-list
20545321|NCT01880957|Antidepressive Agents|antidepressive agents|mesh-ancestor
20545322|NCT01880957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20545323|NCT01880957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545324|NCT01880957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545325|NCT01880957|Antimanic Agents|antimanic agents|mesh-ancestor
20545326|NCT01880957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20545327|NCT01880957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20545328|NCT01880957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545329|NCT01880957|Anticonvulsants|anticonvulsants|mesh-ancestor
20545330|NCT01880957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20545331|NCT01880957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20545332|NCT01880957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20545333|NCT01880957|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20545334|NCT01880957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20545335|NCT01881074|Listerine|listerine|mesh-list
20545336|NCT01881074|Triclosan|triclosan|mesh-list
20545337|NCT01881074|Sodium Fluoride|sodium fluoride|mesh-list
20545338|NCT01881074|Cariostatic Agents|cariostatic agents|mesh-ancestor
20545339|NCT01881074|Protective Agents|protective agents|mesh-ancestor
20545340|NCT01881074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545341|NCT01881074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20545342|NCT01881074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20545343|NCT01881074|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20545344|NCT01881074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20545345|NCT01881074|Antimetabolites|antimetabolites|mesh-ancestor
20545346|NCT01881074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545347|NCT01881074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20545348|NCT01881100|Listerine|listerine|mesh-list
20545349|NCT01881100|Fluorides|fluorides|mesh-list
20545350|NCT01881100|Fluorides, Topical|fluorides, topical|mesh-list
20545351|NCT01881100|Sodium Fluoride|sodium fluoride|mesh-list
20545352|NCT01881100|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
20545353|NCT01881100|Cariostatic Agents|cariostatic agents|mesh-ancestor
20545354|NCT01881100|Protective Agents|protective agents|mesh-ancestor
19960825|NCT01698801|Autonomic Agents|autonomic agents|mesh-ancestor
20545355|NCT01881100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960826|NCT01698801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960827|NCT01698801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275735|NCT00556270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20275736|NCT00556270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275737|NCT00556270|Analgesics|analgesics|mesh-ancestor
20275738|NCT00556270|Sensory System Agents|sensory system agents|mesh-ancestor
20275739|NCT00556270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275740|NCT00556270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19960828|NCT01698801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19960829|NCT01698801|Glucocorticoids|glucocorticoids|mesh-ancestor
19960830|NCT01698801|Hormones|hormones|mesh-ancestor
19960831|NCT01698801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19960832|NCT01698801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19960833|NCT01698801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960834|NCT01698801|Immunologic Factors|immunologic factors|mesh-ancestor
19960835|NCT01698801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19960836|NCT01698801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19960837|NCT01698801|Growth Substances|growth substances|mesh-ancestor
19960838|NCT01698801|Growth Inhibitors|growth inhibitors|mesh-ancestor
19960839|NCT01698814|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19960840|NCT01698814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19960841|NCT01698814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19960842|NCT01698814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19960843|NCT01698814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19960844|NCT01698814|Analgesics|analgesics|mesh-ancestor
19960845|NCT01698814|Sensory System Agents|sensory system agents|mesh-ancestor
19960846|NCT01698814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960847|NCT01698814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960848|NCT01698814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19960849|NCT01698814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19960850|NCT01698814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19960851|NCT01698814|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19960852|NCT01698814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19960853|NCT01698814|Histamine Antagonists|histamine antagonists|mesh-ancestor
19960854|NCT01698814|Histamine Agents|histamine agents|mesh-ancestor
19960855|NCT01698814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19960856|NCT01698814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960857|NCT01698879|Gemtuzumab|gemtuzumab|mesh-list
19960858|NCT01698879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19960859|NCT01698879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960860|NCT01699022|CycloProvera|cycloprovera|mesh-list
19960861|NCT01699022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19960862|NCT01699022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19960863|NCT01699022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19960864|NCT01699022|Contraceptive Agents|contraceptive agents|mesh-ancestor
19960865|NCT01699022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19960866|NCT01699022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960867|NCT01699022|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19960868|NCT01699022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19960869|NCT01699178|Methyltestosterone|methyltestosterone|mesh-list
19960870|NCT01699178|Testosterone|testosterone|mesh-list
19960871|NCT01699178|Testosterone undecanoate|testosterone undecanoate|mesh-list
19960872|NCT01699178|Testosterone enanthate|testosterone enanthate|mesh-list
19960873|NCT01699178|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19960874|NCT01699178|Androgens|androgens|mesh-ancestor
19960875|NCT01699178|Hormones|hormones|mesh-ancestor
19960876|NCT01699178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19960877|NCT01699178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960878|NCT01699178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19960879|NCT01699178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960880|NCT01699178|Anabolic Agents|anabolic agents|mesh-ancestor
19960881|NCT01699607|Amphetamine|amphetamine|mesh-list
19960882|NCT01699607|Dextroamphetamine|dextroamphetamine|mesh-list
19974879|NCT01843348|Basiliximab|basiliximab|mesh-list
20275741|NCT00556270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20275742|NCT00556270|Anesthetics, General|anesthetics, general|mesh-ancestor
20275743|NCT00556270|Anesthetics|anesthetics|mesh-ancestor
20275744|NCT00556296|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20275745|NCT00556296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20275746|NCT00556296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275747|NCT00556296|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20275748|NCT00556296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20275749|NCT00556296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20275750|NCT00556296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275751|NCT00556296|Dopamine Agents|dopamine agents|mesh-ancestor
20275752|NCT00556296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20275753|NCT00556348|Bevacizumab|bevacizumab|mesh-list
20275754|NCT00556348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20275755|NCT00556348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275756|NCT00556348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20275757|NCT00556348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20275758|NCT00556348|Growth Substances|growth substances|mesh-ancestor
20275759|NCT00556348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275760|NCT00556348|Growth Inhibitors|growth inhibitors|mesh-ancestor
20275761|NCT00556361|Ketamine|ketamine|mesh-list
20275762|NCT00556361|Analgesics|analgesics|mesh-ancestor
20275763|NCT00556361|Sensory System Agents|sensory system agents|mesh-ancestor
20275764|NCT00556361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275765|NCT00556361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275766|NCT00556361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20275767|NCT00556361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20275768|NCT00556361|Anesthetics, General|anesthetics, general|mesh-ancestor
19960883|NCT01699607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19960884|NCT01699607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960885|NCT01699607|Sympathomimetics|sympathomimetics|mesh-ancestor
19960886|NCT01699607|Autonomic Agents|autonomic agents|mesh-ancestor
19960887|NCT01699607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960888|NCT01699607|Dopamine Agents|dopamine agents|mesh-ancestor
19960889|NCT01699607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19960890|NCT01699607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960891|NCT01699607|Adrenergic Agents|adrenergic agents|mesh-ancestor
19960892|NCT01699607|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19960893|NCT01699607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19960894|NCT01699607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19960895|NCT01699607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19960896|NCT01699685|Glycopyrrolate|glycopyrrolate|mesh-list
19960897|NCT01699685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19960898|NCT01699685|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19960899|NCT01699685|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19960900|NCT01699685|Cholinergic Agents|cholinergic agents|mesh-ancestor
19960901|NCT01699685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19960902|NCT01699685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960903|NCT01699685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960904|NCT01699815|Acetaminophen|acetaminophen|mesh-list
19960905|NCT01699815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19960906|NCT01699815|Analgesics|analgesics|mesh-ancestor
19960907|NCT01699815|Sensory System Agents|sensory system agents|mesh-ancestor
19960908|NCT01699815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960909|NCT01699815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960910|NCT01699815|Antipyretics|antipyretics|mesh-ancestor
19960911|NCT01700036|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19960912|NCT01700036|Protein C Inhibitor|protein c inhibitor|mesh-list
19960913|NCT01700036|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19960914|NCT01700036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19960915|NCT01700036|Protease Inhibitors|protease inhibitors|mesh-ancestor
19960916|NCT01700036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19960917|NCT01700036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960918|NCT01700179|Ribavirin|ribavirin|mesh-list
20275769|NCT00556361|Anesthetics|anesthetics|mesh-ancestor
20275770|NCT00556361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20275771|NCT00556361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20275772|NCT00556361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20275773|NCT00556361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19960919|NCT01700179|Antimetabolites|antimetabolites|mesh-ancestor
19960920|NCT01700179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960921|NCT01700179|Antiviral Agents|antiviral agents|mesh-ancestor
19960922|NCT01700179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19960923|NCT01700192|Mometasone Furoate|mometasone furoate|mesh-list
19960924|NCT01700192|Loratadine|loratadine|mesh-list
19960925|NCT01700192|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19960926|NCT01700192|Epinephrine|epinephrine|mesh-list
19960927|NCT01700192|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19960928|NCT01700192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19960929|NCT01700192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19960930|NCT01700192|Adrenergic Agents|adrenergic agents|mesh-ancestor
20275774|NCT00556361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960931|NCT01700192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19960932|NCT01700192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960933|NCT01700192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960934|NCT01700192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19960935|NCT01700192|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19960936|NCT01700192|Autonomic Agents|autonomic agents|mesh-ancestor
19960937|NCT01700192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960938|NCT01700192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19960939|NCT01700192|Respiratory System Agents|respiratory system agents|mesh-ancestor
19960940|NCT01700192|Mydriatics|mydriatics|mesh-ancestor
19960941|NCT01700192|Sympathomimetics|sympathomimetics|mesh-ancestor
19960942|NCT01700192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19960943|NCT01700192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19960944|NCT01700192|Dermatologic Agents|dermatologic agents|mesh-ancestor
19960945|NCT01700192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20275775|NCT00556387|Ketamine|ketamine|mesh-list
20275776|NCT00556387|Analgesics|analgesics|mesh-ancestor
20275777|NCT00556387|Sensory System Agents|sensory system agents|mesh-ancestor
20275778|NCT00556387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275779|NCT00556387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275780|NCT00556387|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19960946|NCT01700192|Antipruritics|antipruritics|mesh-ancestor
19960947|NCT01700192|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19960948|NCT01700192|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19960949|NCT01700192|Histamine Antagonists|histamine antagonists|mesh-ancestor
19960950|NCT01700192|Histamine Agents|histamine agents|mesh-ancestor
19960951|NCT01700192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19960952|NCT01700192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19960953|NCT01700192|Analgesics|analgesics|mesh-ancestor
19960954|NCT01700192|Sensory System Agents|sensory system agents|mesh-ancestor
19960955|NCT01700192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19960956|NCT01700192|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19960957|NCT01700387|Topiramate|topiramate|mesh-list
19960958|NCT01700387|Botulinum Toxins|botulinum toxins|mesh-list
19960959|NCT01700387|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19960960|NCT01700387|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19960961|NCT01700387|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19960962|NCT01700387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19960963|NCT01700387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960964|NCT01700387|Cholinergic Agents|cholinergic agents|mesh-ancestor
19960965|NCT01700387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19960966|NCT01700387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960967|NCT01700387|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19960968|NCT01700387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960969|NCT01700387|Anticonvulsants|anticonvulsants|mesh-ancestor
19960970|NCT01700387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19960971|NCT01700517|Anesthetics|anesthetics|mesh-list
19960972|NCT01700517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19960973|NCT01700517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960974|NCT01700530|Simvastatin|simvastatin|mesh-list
19960975|NCT01700530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19960976|NCT01700530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19960977|NCT01700530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19960978|NCT01700530|Antimetabolites|antimetabolites|mesh-ancestor
19960979|NCT01700530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960980|NCT01700530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19960981|NCT01700530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19960982|NCT01700621|Vaccines|vaccines|mesh-list
19960983|NCT01700621|Immunologic Factors|immunologic factors|mesh-ancestor
19960984|NCT01700621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960985|NCT01700673|Azacitidine|azacitidine|mesh-list
19960986|NCT01700673|Sargramostim|sargramostim|mesh-list
19960987|NCT01700673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19960988|NCT01700673|Antimetabolites|antimetabolites|mesh-ancestor
19960989|NCT01700673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19960990|NCT01700673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19960991|NCT01700673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19960992|NCT01700673|Immunologic Factors|immunologic factors|mesh-ancestor
19960993|NCT01700673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19960994|NCT01700829|Midazolam|midazolam|mesh-list
19960995|NCT01700829|Ketamine|ketamine|mesh-list
19960996|NCT01700829|Analgesics|analgesics|mesh-ancestor
20275781|NCT00556387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20275782|NCT00556387|Anesthetics, General|anesthetics, general|mesh-ancestor
20275783|NCT00556387|Anesthetics|anesthetics|mesh-ancestor
20275784|NCT00556387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20554292|NCT01934712|Insulin, Long-Acting|insulin, long-acting|mesh-list
20275785|NCT00556387|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20275786|NCT00556387|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20275787|NCT00556387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20275788|NCT00556387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275789|NCT00556413|Leucovorin|leucovorin|mesh-list
20275790|NCT00556413|Fluorouracil|fluorouracil|mesh-list
20275791|NCT00556413|Oxaliplatin|oxaliplatin|mesh-list
19960997|NCT01700829|Sensory System Agents|sensory system agents|mesh-ancestor
19960998|NCT01700829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19960999|NCT01700829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961000|NCT01700829|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19961001|NCT01700829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19961002|NCT01700829|Anesthetics, General|anesthetics, general|mesh-ancestor
19961003|NCT01700829|Anesthetics|anesthetics|mesh-ancestor
19961004|NCT01700829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19961005|NCT01700829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19961006|NCT01700829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19961007|NCT01700829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19961008|NCT01700829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961009|NCT01700829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19961010|NCT01700829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19961011|NCT01700829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19961012|NCT01700829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19961013|NCT01700829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19961014|NCT01700829|GABA Modulators|gaba modulators|mesh-ancestor
19961015|NCT01700829|GABA Agents|gaba agents|mesh-ancestor
19961016|NCT01700907|Sevoflurane|sevoflurane|mesh-list
19961017|NCT01700907|Desflurane|desflurane|mesh-list
19961018|NCT01700907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19961019|NCT01700907|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19961020|NCT01700907|Anesthetics, General|anesthetics, general|mesh-ancestor
19961021|NCT01700907|Anesthetics|anesthetics|mesh-ancestor
19961022|NCT01700907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19961023|NCT01700907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961024|NCT01700959|Melatonin|melatonin|mesh-list
19961025|NCT01700959|Antioxidants|antioxidants|mesh-ancestor
19961026|NCT01700959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961027|NCT01700959|Protective Agents|protective agents|mesh-ancestor
19961028|NCT01700959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961029|NCT01700959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19961030|NCT01701037|Trametinib|trametinib|mesh-list
19961031|NCT01701037|Dabrafenib|dabrafenib|mesh-list
19961032|NCT01701037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19961033|NCT01701037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19961034|NCT01701037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961035|NCT01701037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961036|NCT01701063|Ribavirin|ribavirin|mesh-list
19961037|NCT01701063|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19961038|NCT01701063|Antimetabolites|antimetabolites|mesh-ancestor
19961039|NCT01701063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961040|NCT01701063|Antiviral Agents|antiviral agents|mesh-ancestor
19961041|NCT01701063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19961042|NCT01701102|Fentanyl|fentanyl|mesh-list
19961043|NCT01701102|Mepivacaine|mepivacaine|mesh-list
19961044|NCT01701102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19961045|NCT01701102|Narcotics|narcotics|mesh-ancestor
19961046|NCT01701102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19961047|NCT01701102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961048|NCT01701102|Analgesics|analgesics|mesh-ancestor
19961049|NCT01701102|Sensory System Agents|sensory system agents|mesh-ancestor
19961050|NCT01701102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961051|NCT01701102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19961052|NCT01701102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19961053|NCT01701102|Anesthetics, General|anesthetics, general|mesh-ancestor
19961054|NCT01701102|Anesthetics|anesthetics|mesh-ancestor
19961055|NCT01701102|Anesthetics, Local|anesthetics, local|mesh-ancestor
19961056|NCT01701115|Bupivacaine|bupivacaine|mesh-list
19961057|NCT01701115|Anesthetics, Local|anesthetics, local|mesh-list
19961058|NCT01701115|Mepivacaine|mepivacaine|mesh-list
19961059|NCT01701115|Anesthetics|anesthetics|mesh-list
19961060|NCT01701115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19961061|NCT01701115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275792|NCT00556413|Irinotecan|irinotecan|mesh-list
20275793|NCT00556413|Cetuximab|cetuximab|mesh-list
20275794|NCT00556413|Calcium|calcium|mesh-list
19961062|NCT01701115|Sensory System Agents|sensory system agents|mesh-ancestor
19961063|NCT01701115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275795|NCT00556413|Levoleucovorin|levoleucovorin|mesh-list
20275796|NCT00556413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20275797|NCT00556413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275798|NCT00556413|Antimetabolites|antimetabolites|mesh-ancestor
20275799|NCT00556413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961064|NCT01701258|Amisulpride|amisulpride|mesh-list
19961065|NCT01701258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19961066|NCT01701258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19961067|NCT01701258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19961068|NCT01701258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961069|NCT01701258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19961070|NCT01701258|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19961071|NCT01701258|Dopamine Agents|dopamine agents|mesh-ancestor
19961072|NCT01701258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19961073|NCT01701258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961074|NCT01701258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19961075|NCT01701258|Antidepressive Agents|antidepressive agents|mesh-ancestor
19961076|NCT01701362|Pregabalin|pregabalin|mesh-list
19961077|NCT01701362|Analgesics|analgesics|mesh-ancestor
19961078|NCT01701362|Sensory System Agents|sensory system agents|mesh-ancestor
19961079|NCT01701362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961080|NCT01701362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961081|NCT01701362|Anticonvulsants|anticonvulsants|mesh-ancestor
19961082|NCT01701362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19961083|NCT01701362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19961084|NCT01701362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961085|NCT01701362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19961086|NCT01701362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19961087|NCT01701362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19961088|NCT01701362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19961089|NCT01701362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19961090|NCT01701375|Palbociclib|palbociclib|mesh-list
19961091|NCT01701375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19961092|NCT01701375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19961093|NCT01701375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961094|NCT01701375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961095|NCT01701401|Sofosbuvir|sofosbuvir|mesh-list
19961096|NCT01701401|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19961097|NCT01701401|Ledipasvir|ledipasvir|mesh-list
19961098|NCT01701401|Antiviral Agents|antiviral agents|mesh-ancestor
19961099|NCT01701401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19961100|NCT01701414|Bupivacaine|bupivacaine|mesh-list
19961101|NCT01701414|Anesthetics, Local|anesthetics, local|mesh-ancestor
19961102|NCT01701414|Anesthetics|anesthetics|mesh-ancestor
19961103|NCT01701414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19961104|NCT01701414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961105|NCT01701414|Sensory System Agents|sensory system agents|mesh-ancestor
19961106|NCT01701414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961107|NCT01701505|Phenylephrine|phenylephrine|mesh-list
19961108|NCT01701505|Oxymetazoline|oxymetazoline|mesh-list
19961109|NCT01701505|Tetracaine|tetracaine|mesh-list
19961110|NCT01701505|Anesthetics, Local|anesthetics, local|mesh-ancestor
19961111|NCT01701505|Anesthetics|anesthetics|mesh-ancestor
19961112|NCT01701505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19961113|NCT01701505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961114|NCT01701505|Sensory System Agents|sensory system agents|mesh-ancestor
19961115|NCT01701505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961116|NCT01701505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19961117|NCT01701505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19961118|NCT01701505|Adrenergic Agents|adrenergic agents|mesh-ancestor
19961119|NCT01701505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19961120|NCT01701505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961121|NCT01701505|Sympathomimetics|sympathomimetics|mesh-ancestor
19961122|NCT01701505|Autonomic Agents|autonomic agents|mesh-ancestor
20275800|NCT00556413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20555052|NCT01938456|Antimitotic Agents|antimitotic agents|mesh-ancestor
19733216|NCT04564144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19733217|NCT04564144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733218|NCT04564144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19733219|NCT04564040|Acalabrutinib|acalabrutinib|mesh-list
19733220|NCT04564040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733221|NCT04564222|Micronutrients|micronutrients|mesh-list
19733222|NCT04564222|Trace Elements|trace elements|mesh-list
19733223|NCT04564222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733224|NCT04563936|Goserelin|goserelin|mesh-list
19733225|NCT04563936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19733226|NCT04563936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733227|NCT04563975|Paclitaxel|paclitaxel|mesh-list
19733228|NCT04563975|Docetaxel|docetaxel|mesh-list
19961123|NCT01701505|Nasal Decongestants|nasal decongestants|mesh-ancestor
19961124|NCT01701505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19961125|NCT01701505|Respiratory System Agents|respiratory system agents|mesh-ancestor
19961126|NCT01701505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19961127|NCT01701505|Mydriatics|mydriatics|mesh-ancestor
19961128|NCT01701505|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19961129|NCT01701505|Protective Agents|protective agents|mesh-ancestor
19961130|NCT01701973|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19961131|NCT01701973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19961132|NCT01701973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961133|NCT01701973|Incretins|incretins|mesh-ancestor
19961134|NCT01701973|Hormones|hormones|mesh-ancestor
19961135|NCT01701973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19961136|NCT01701973|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19961137|NCT01701973|Protease Inhibitors|protease inhibitors|mesh-ancestor
19961138|NCT01701973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961139|NCT01701973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961140|NCT01702025|Aminophylline|aminophylline|mesh-list
19961141|NCT01702025|Methazolamide|methazolamide|mesh-list
19961142|NCT01702025|Theophylline|theophylline|mesh-list
19961143|NCT01702025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19961144|NCT01702025|Autonomic Agents|autonomic agents|mesh-ancestor
19961145|NCT01702025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961146|NCT01702025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961147|NCT01702025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19961148|NCT01702025|Respiratory System Agents|respiratory system agents|mesh-ancestor
20275801|NCT00556413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275802|NCT00556413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20275803|NCT00556413|Immunologic Factors|immunologic factors|mesh-ancestor
20275804|NCT00556413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20275805|NCT00556413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20275806|NCT00556413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275807|NCT00556413|Antidotes|antidotes|mesh-ancestor
20275808|NCT00556413|Protective Agents|protective agents|mesh-ancestor
20275809|NCT00556413|Vitamin B Complex|vitamin b complex|mesh-ancestor
20275810|NCT00556413|Vitamins|vitamins|mesh-ancestor
20275811|NCT00556413|Micronutrients|micronutrients|mesh-ancestor
20275812|NCT00556413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20275813|NCT00556465|Acetylcysteine|acetylcysteine|mesh-list
20275814|NCT00556465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20275815|NCT00556465|Antiviral Agents|antiviral agents|mesh-ancestor
20275816|NCT00556465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20275817|NCT00556465|Expectorants|expectorants|mesh-ancestor
20275818|NCT00556465|Respiratory System Agents|respiratory system agents|mesh-ancestor
20275819|NCT00556465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20275820|NCT00556465|Antioxidants|antioxidants|mesh-ancestor
20275821|NCT00556465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275822|NCT00556465|Protective Agents|protective agents|mesh-ancestor
20275823|NCT00556465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275824|NCT00556465|Antidotes|antidotes|mesh-ancestor
20545356|NCT01881100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20545357|NCT01881100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20554293|NCT01934712|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20554294|NCT01934712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20554295|NCT01934712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554296|NCT01934777|Vitamin E|vitamin e|mesh-list
20554297|NCT01934777|Choline|choline|mesh-list
20554298|NCT01934777|Vitamins|vitamins|mesh-ancestor
20554299|NCT01934777|Micronutrients|micronutrients|mesh-ancestor
20554300|NCT01934777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554301|NCT01934777|Antioxidants|antioxidants|mesh-ancestor
19733229|NCT04563975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19733230|NCT04563975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733231|NCT04563975|Tubulin Modulators|tubulin modulators|mesh-ancestor
19733232|NCT04563975|Antimitotic Agents|antimitotic agents|mesh-ancestor
19733233|NCT04563975|Mitosis Modulators|mitosis modulators|mesh-ancestor
19733234|NCT04563975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733235|NCT04563962|Methamphetamine|methamphetamine|mesh-list
19733236|NCT04563962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19733237|NCT04563962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733238|NCT04563962|Sympathomimetics|sympathomimetics|mesh-ancestor
19733239|NCT04563962|Autonomic Agents|autonomic agents|mesh-ancestor
20275825|NCT00556608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20275826|NCT00556608|Hyaluronic Acid|hyaluronic acid|mesh-list
20275827|NCT00556608|Hylan|hylan|mesh-list
20275828|NCT00556608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20275829|NCT00556608|Immunologic Factors|immunologic factors|mesh-ancestor
20275830|NCT00556608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275831|NCT00556608|Viscosupplements|viscosupplements|mesh-ancestor
20275832|NCT00556608|Protective Agents|protective agents|mesh-ancestor
20275833|NCT00556621|Gemcitabine|gemcitabine|mesh-list
19961149|NCT01702025|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19961150|NCT01702025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961151|NCT01702025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961152|NCT01702025|Vasodilator Agents|vasodilator agents|mesh-ancestor
19961153|NCT01702025|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20275834|NCT00556621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275835|NCT00556621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20275836|NCT00556621|Antimetabolites|antimetabolites|mesh-ancestor
20275837|NCT00556621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275838|NCT00556621|Antiviral Agents|antiviral agents|mesh-ancestor
20275839|NCT00556621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20275840|NCT00556621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275841|NCT00556621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20275842|NCT00556621|Immunologic Factors|immunologic factors|mesh-ancestor
20275843|NCT00556621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275844|NCT00556634|Efavirenz|efavirenz|mesh-list
20275845|NCT00556634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20275846|NCT00556634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20275847|NCT00556634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275848|NCT00556634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450340|NCT03429179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19450341|NCT03429127|Plasma-lyte 148|plasma-lyte 148|mesh-list
19450342|NCT03429127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20275849|NCT00556634|Antiviral Agents|antiviral agents|mesh-ancestor
20275850|NCT00556634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20275851|NCT00556634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20275852|NCT00556634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20275853|NCT00556634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20275854|NCT00556634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20275855|NCT00556634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20275856|NCT00556634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20275857|NCT00556699|Rituximab|rituximab|mesh-list
20275858|NCT00556699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20275859|NCT00556699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275860|NCT00556699|Immunologic Factors|immunologic factors|mesh-ancestor
20275861|NCT00556699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275862|NCT00556699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20275863|NCT00556959|Clonidine|clonidine|mesh-list
20275864|NCT00556959|Analgesics|analgesics|mesh-ancestor
20275865|NCT00556959|Sensory System Agents|sensory system agents|mesh-ancestor
20275866|NCT00556959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275867|NCT00556959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275868|NCT00556959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20275869|NCT00556959|Sympatholytics|sympatholytics|mesh-ancestor
20275870|NCT00556959|Autonomic Agents|autonomic agents|mesh-ancestor
20275871|NCT00556959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20275872|NCT00556959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20275873|NCT00556959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20275874|NCT00556959|Adrenergic Agents|adrenergic agents|mesh-ancestor
20275875|NCT00556959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20275876|NCT00556959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275877|NCT00557011|Amphetamine|amphetamine|mesh-list
20275878|NCT00557011|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20275879|NCT00557011|Adderall|adderall|mesh-list
20275880|NCT00557011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20275881|NCT00557011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275882|NCT00557011|Sympathomimetics|sympathomimetics|mesh-ancestor
20275883|NCT00557011|Autonomic Agents|autonomic agents|mesh-ancestor
20275884|NCT00557011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275885|NCT00557011|Dopamine Agents|dopamine agents|mesh-ancestor
20275886|NCT00557011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20275887|NCT00557011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275888|NCT00557011|Adrenergic Agents|adrenergic agents|mesh-ancestor
19450343|NCT03429127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19450344|NCT03429101|Trastuzumab|trastuzumab|mesh-list
19961154|NCT01702025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19961155|NCT01702025|Purinergic Agents|purinergic agents|mesh-ancestor
19961156|NCT01702025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19961157|NCT01702025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19961158|NCT01702025|Protective Agents|protective agents|mesh-ancestor
19961159|NCT01702025|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19961160|NCT01702025|Diuretics|diuretics|mesh-ancestor
19961161|NCT01702025|Natriuretic Agents|natriuretic agents|mesh-ancestor
19961162|NCT01702233|Dexamethasone|dexamethasone|mesh-list
19961163|NCT01702233|Dexamethasone acetate|dexamethasone acetate|mesh-list
19961164|NCT01702233|BB 1101|bb 1101|mesh-list
19961165|NCT01702233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19961166|NCT01702233|Antiemetics|antiemetics|mesh-ancestor
20275889|NCT00557011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20275890|NCT00557011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20275891|NCT00557011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20275892|NCT00557011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20275893|NCT00557102|Leucovorin|leucovorin|mesh-list
19961167|NCT01702233|Autonomic Agents|autonomic agents|mesh-ancestor
19961168|NCT01702233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961169|NCT01702233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961170|NCT01702233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19961171|NCT01702233|Glucocorticoids|glucocorticoids|mesh-ancestor
19961172|NCT01702233|Hormones|hormones|mesh-ancestor
19961173|NCT01702233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19961174|NCT01702233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19961175|NCT01702233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19961176|NCT01702233|Protease Inhibitors|protease inhibitors|mesh-ancestor
19961177|NCT01702233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961178|NCT01702233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961179|NCT01702246|Simvastatin|simvastatin|mesh-list
19961180|NCT01702246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19961181|NCT01702246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19961182|NCT01702246|Antimetabolites|antimetabolites|mesh-ancestor
19961183|NCT01702246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961184|NCT01702246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19961185|NCT01702246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19961186|NCT01702246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961187|NCT01702298|Metformin|metformin|mesh-list
19961188|NCT01702298|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19961189|NCT01702298|Simvastatin|simvastatin|mesh-list
19961190|NCT01702298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19961191|NCT01702298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961192|NCT01702298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19961193|NCT01702298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19961194|NCT01702298|Antimetabolites|antimetabolites|mesh-ancestor
19961195|NCT01702298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961196|NCT01702298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19961197|NCT01702298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19961198|NCT01702298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961199|NCT01702298|Incretins|incretins|mesh-ancestor
19961200|NCT01702298|Hormones|hormones|mesh-ancestor
19961201|NCT01702298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19961202|NCT01702298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19961203|NCT01702298|Protease Inhibitors|protease inhibitors|mesh-ancestor
19961204|NCT01702311|Insulin Aspart|insulin aspart|mesh-list
19961205|NCT01702311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19961206|NCT01702311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733240|NCT04563962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733241|NCT04563962|Dopamine Agents|dopamine agents|mesh-ancestor
19733242|NCT04563962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19733243|NCT04563962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961207|NCT01702428|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19961208|NCT01702428|Immunologic Factors|immunologic factors|mesh-ancestor
19961209|NCT01702428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961210|NCT01702519|Nicotine|nicotine|mesh-list
20275894|NCT00557102|Fluorouracil|fluorouracil|mesh-list
20275895|NCT00557102|Irinotecan|irinotecan|mesh-list
19733244|NCT04563962|Adrenergic Agents|adrenergic agents|mesh-ancestor
19733245|NCT04563962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19733246|NCT04563962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19733247|NCT04563962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19961211|NCT01702519|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19961212|NCT01702519|Autonomic Agents|autonomic agents|mesh-ancestor
19961213|NCT01702519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961214|NCT01702519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961215|NCT01702519|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19961216|NCT01702519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19961217|NCT01702519|Cholinergic Agents|cholinergic agents|mesh-ancestor
19961218|NCT01702519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19961219|NCT01702519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961220|NCT01702532|Nicotine|nicotine|mesh-list
19961221|NCT01702532|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19961222|NCT01702532|Autonomic Agents|autonomic agents|mesh-ancestor
19961223|NCT01702532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961224|NCT01702532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961225|NCT01702532|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19961226|NCT01702532|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19961227|NCT01702532|Cholinergic Agents|cholinergic agents|mesh-ancestor
19961228|NCT01702532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19961229|NCT01702532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961230|NCT01702558|Capecitabine|capecitabine|mesh-list
19961231|NCT01702558|Trastuzumab|trastuzumab|mesh-list
19961232|NCT01702558|Maytansine|maytansine|mesh-list
20275896|NCT00557102|Cetuximab|cetuximab|mesh-list
20275897|NCT00557102|Calcium|calcium|mesh-list
20275898|NCT00557102|Levoleucovorin|levoleucovorin|mesh-list
20275899|NCT00557102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20275900|NCT00557102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275901|NCT00557102|Antimetabolites|antimetabolites|mesh-ancestor
20275902|NCT00557102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275903|NCT00557102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20275904|NCT00557102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275905|NCT00557102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20275906|NCT00557102|Immunologic Factors|immunologic factors|mesh-ancestor
20275907|NCT00557102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20275908|NCT00557102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20275909|NCT00557102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275910|NCT00557102|Antidotes|antidotes|mesh-ancestor
20275911|NCT00557102|Protective Agents|protective agents|mesh-ancestor
20275912|NCT00557102|Vitamin B Complex|vitamin b complex|mesh-ancestor
20275913|NCT00557102|Vitamins|vitamins|mesh-ancestor
20275914|NCT00557102|Micronutrients|micronutrients|mesh-ancestor
20275915|NCT00557102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20287731|NCT03879577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287732|NCT03879577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20287733|NCT03879577|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20287734|NCT03879577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20287735|NCT03879577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287736|NCT03879577|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20287737|NCT03879577|Hormone Antagonists|hormone antagonists|mesh-ancestor
20287738|NCT03879577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20287739|NCT03879577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287740|NCT03879577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20287741|NCT03879577|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20287742|NCT03879577|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20287743|NCT03879577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20287744|NCT03830866|Carboplatin|carboplatin|mesh-list
20287745|NCT03830866|Durvalumab|durvalumab|mesh-list
20287746|NCT03830866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287747|NCT03830866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20287748|NCT03822871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
20287749|NCT03822871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20287750|NCT03822871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287751|NCT03736863|Apatinib|apatinib|mesh-list
20287752|NCT03736863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287753|NCT03736863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20287754|NCT03736863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287755|NCT03736863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287756|NCT03711305|Carboplatin|carboplatin|mesh-list
20287757|NCT03711305|Etoposide|etoposide|mesh-list
20287758|NCT03711305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287759|NCT03711305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19961233|NCT01702558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19961234|NCT01702558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19961235|NCT01702558|Antimetabolites|antimetabolites|mesh-ancestor
19961236|NCT01702558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961237|NCT01702558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19961238|NCT01702558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19961239|NCT01702558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19961240|NCT01702558|Tubulin Modulators|tubulin modulators|mesh-ancestor
19961241|NCT01702558|Antimitotic Agents|antimitotic agents|mesh-ancestor
19961242|NCT01702558|Mitosis Modulators|mitosis modulators|mesh-ancestor
19961243|NCT01702844|Paclitaxel|paclitaxel|mesh-list
19961244|NCT01702844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19961245|NCT01702844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19961246|NCT01702844|Tubulin Modulators|tubulin modulators|mesh-ancestor
19961247|NCT01702844|Antimitotic Agents|antimitotic agents|mesh-ancestor
19961248|NCT01702844|Mitosis Modulators|mitosis modulators|mesh-ancestor
19961249|NCT01702844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961250|NCT01702961|Cytarabine|cytarabine|mesh-list
19961251|NCT01702961|Etoposide|etoposide|mesh-list
19961252|NCT01702961|Rituximab|rituximab|mesh-list
19961253|NCT01702961|Melphalan|melphalan|mesh-list
19961254|NCT01702961|Carmustine|carmustine|mesh-list
19961255|NCT01702961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19961256|NCT01702961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19961257|NCT01702961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19961258|NCT01702961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19961259|NCT01702961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961260|NCT01702961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961261|NCT01702961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19961262|NCT01702961|Antimetabolites|antimetabolites|mesh-ancestor
19961263|NCT01702961|Antiviral Agents|antiviral agents|mesh-ancestor
19961264|NCT01702961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19961265|NCT01702961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19961266|NCT01702961|Immunologic Factors|immunologic factors|mesh-ancestor
19961267|NCT01702961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961268|NCT01702961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19961269|NCT01702961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19961270|NCT01702961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19961271|NCT01702961|Alkylating Agents|alkylating agents|mesh-ancestor
19961272|NCT01702961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19961273|NCT01702987|Coenzyme Q10|coenzyme q10|mesh-list
19961274|NCT01702987|Atorvastatin|atorvastatin|mesh-list
19961275|NCT01702987|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19961276|NCT01702987|Simvastatin|simvastatin|mesh-list
19961277|NCT01702987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19961278|NCT01702987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19961279|NCT01702987|Antimetabolites|antimetabolites|mesh-ancestor
19961280|NCT01702987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961281|NCT01702987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19961282|NCT01702987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19961283|NCT01702987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961284|NCT01702987|Micronutrients|micronutrients|mesh-ancestor
19961285|NCT01702987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961286|NCT01702987|Vitamins|vitamins|mesh-ancestor
19961287|NCT01703039|Riluzole|riluzole|mesh-list
19961288|NCT01703039|Sertraline|sertraline|mesh-list
19961289|NCT01703039|Antidepressive Agents|antidepressive agents|mesh-ancestor
19961290|NCT01703039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19961291|NCT01703039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19961292|NCT01703039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19961293|NCT01703039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19961294|NCT01703039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961295|NCT01703039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19961296|NCT01703039|Serotonin Agents|serotonin agents|mesh-ancestor
19961297|NCT01703039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961298|NCT01703039|Anticonvulsants|anticonvulsants|mesh-ancestor
19961299|NCT01703039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19961300|NCT01703039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19961301|NCT01703039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19961302|NCT01703039|Protective Agents|protective agents|mesh-ancestor
19961303|NCT01703091|Docetaxel|docetaxel|mesh-list
19961304|NCT01703091|Ramucirumab|ramucirumab|mesh-list
19961305|NCT01703091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19961306|NCT01703091|Tubulin Modulators|tubulin modulators|mesh-ancestor
19961307|NCT01703091|Antimitotic Agents|antimitotic agents|mesh-ancestor
19961308|NCT01703091|Mitosis Modulators|mitosis modulators|mesh-ancestor
19961309|NCT01703091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961310|NCT01703117|Riluzole|riluzole|mesh-list
19961311|NCT01703117|Anticonvulsants|anticonvulsants|mesh-ancestor
19961312|NCT01703117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20275916|NCT00557180|Beclomethasone|beclomethasone|mesh-list
20275917|NCT00557180|Bromides|bromides|mesh-list
20275918|NCT00557180|Tiotropium Bromide|tiotropium bromide|mesh-list
20275919|NCT00557180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20275920|NCT00557180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20275921|NCT00557180|Autonomic Agents|autonomic agents|mesh-ancestor
20275922|NCT00557180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275923|NCT00557180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275924|NCT00557180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20275925|NCT00557180|Respiratory System Agents|respiratory system agents|mesh-ancestor
20275926|NCT00557180|Parasympatholytics|parasympatholytics|mesh-ancestor
20275927|NCT00557180|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20275928|NCT00557180|Cholinergic Agents|cholinergic agents|mesh-ancestor
20275929|NCT00557180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20275930|NCT00557180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275931|NCT00557180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20275932|NCT00557180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20275933|NCT00557180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20275934|NCT00557180|Adrenergic Agents|adrenergic agents|mesh-ancestor
20275935|NCT00557180|Anticonvulsants|anticonvulsants|mesh-ancestor
20275936|NCT00557180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20275937|NCT00557180|Glucocorticoids|glucocorticoids|mesh-ancestor
19961313|NCT01703117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19961314|NCT01703117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19961315|NCT01703117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961316|NCT01703117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961317|NCT01703117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19961318|NCT01703117|Protective Agents|protective agents|mesh-ancestor
19961319|NCT01703221|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19961320|NCT01703221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19961321|NCT01703221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961322|NCT01703221|Incretins|incretins|mesh-ancestor
19961323|NCT01703221|Hormones|hormones|mesh-ancestor
19961324|NCT01703221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19961325|NCT01703221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19961326|NCT01703221|Protease Inhibitors|protease inhibitors|mesh-ancestor
19961327|NCT01703221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961328|NCT01703221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961329|NCT01703260|Pioglitazone|pioglitazone|mesh-list
19961330|NCT01703260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19961331|NCT01703260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961332|NCT01703286|Glimepiride|glimepiride|mesh-list
19961333|NCT01703286|Linagliptin|linagliptin|mesh-list
19961334|NCT01703286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19961335|NCT01703286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19961336|NCT01703286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961337|NCT01703286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19961338|NCT01703286|Immunologic Factors|immunologic factors|mesh-ancestor
19961339|NCT01703286|Incretins|incretins|mesh-ancestor
19961340|NCT01703286|Hormones|hormones|mesh-ancestor
19961341|NCT01703286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19961342|NCT01703286|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19961343|NCT01703286|Protease Inhibitors|protease inhibitors|mesh-ancestor
19961344|NCT01703286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20275938|NCT00557180|Hormones|hormones|mesh-ancestor
20275939|NCT00557180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19961345|NCT01703286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961346|NCT01703507|Ipilimumab|ipilimumab|mesh-list
19961347|NCT01703507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19961348|NCT01703507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275940|NCT00557206|Docetaxel|docetaxel|mesh-list
20275941|NCT00557206|Oxaliplatin|oxaliplatin|mesh-list
20275942|NCT00557206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275943|NCT00557206|Tubulin Modulators|tubulin modulators|mesh-ancestor
20275944|NCT00557206|Antimitotic Agents|antimitotic agents|mesh-ancestor
20275945|NCT00557206|Mitosis Modulators|mitosis modulators|mesh-ancestor
20275946|NCT00557206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275947|NCT00557219|Fenoldopam|fenoldopam|mesh-list
20275948|NCT00557219|Ketanserin|ketanserin|mesh-list
20275949|NCT00557219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20275950|NCT00557219|Vasodilator Agents|vasodilator agents|mesh-ancestor
20275951|NCT00557219|Dopamine Agonists|dopamine agonists|mesh-ancestor
20275952|NCT00557219|Dopamine Agents|dopamine agents|mesh-ancestor
20275953|NCT00557219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20275954|NCT00557219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275955|NCT00557219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275956|NCT00557219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20275957|NCT00557219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20275958|NCT00557219|Serotonin Agents|serotonin agents|mesh-ancestor
20275959|NCT00557232|Bevacizumab|bevacizumab|mesh-list
20275960|NCT00557232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20275961|NCT00557232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20275962|NCT00557232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20275963|NCT00557232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20275964|NCT00557232|Growth Substances|growth substances|mesh-ancestor
20275965|NCT00557232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275966|NCT00557232|Growth Inhibitors|growth inhibitors|mesh-ancestor
20275967|NCT00557427|Fluoxetine|fluoxetine|mesh-list
20275968|NCT00557427|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20275969|NCT00557427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20275970|NCT00557427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20275971|NCT00557427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275972|NCT00557427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20275973|NCT00557427|Serotonin Agents|serotonin agents|mesh-ancestor
20275974|NCT00557427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275975|NCT00557427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20275976|NCT00557427|Antidepressive Agents|antidepressive agents|mesh-ancestor
20275977|NCT00557427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20275978|NCT00557427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20275979|NCT00557427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20275980|NCT00557427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545358|NCT01881347|Resveratrol|resveratrol|mesh-list
20545359|NCT01881347|Antioxidants|antioxidants|mesh-ancestor
20545360|NCT01881347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545361|NCT01881347|Protective Agents|protective agents|mesh-ancestor
20545362|NCT01881347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545363|NCT01881347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545364|NCT01881347|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20545365|NCT01881464|Adalimumab|adalimumab|mesh-list
20545366|NCT01881464|Infliximab|infliximab|mesh-list
20545367|NCT01881464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20545368|NCT01881464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20545369|NCT01881464|Dermatologic Agents|dermatologic agents|mesh-ancestor
20545370|NCT01881464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20545371|NCT01881503|HBOC 201|hboc 201|mesh-list
20545372|NCT01881503|Blood Substitutes|blood substitutes|mesh-ancestor
20545373|NCT01881568|Tranexamic Acid|tranexamic acid|mesh-list
20545374|NCT01881568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20545375|NCT01881568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20545376|NCT01881568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545377|NCT01881568|Hemostatics|hemostatics|mesh-ancestor
20545378|NCT01881568|Coagulants|coagulants|mesh-ancestor
19961349|NCT01703507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19961350|NCT01703507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961351|NCT01703741|Testosterone|testosterone|mesh-list
19961352|NCT01703741|Androgens|androgens|mesh-ancestor
19961353|NCT01703741|Hormones|hormones|mesh-ancestor
19961354|NCT01703741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20545379|NCT01881763|Ketamine|ketamine|mesh-list
20545380|NCT01881763|Methohexital|methohexital|mesh-list
20545381|NCT01881763|Analgesics|analgesics|mesh-ancestor
19961355|NCT01703741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961356|NCT01703845|Tiotropium Bromide|tiotropium bromide|mesh-list
19961357|NCT01703845|Olodaterol|olodaterol|mesh-list
19961358|NCT01703845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19961359|NCT01703845|Autonomic Agents|autonomic agents|mesh-ancestor
19961360|NCT01703845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961361|NCT01703845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961362|NCT01703845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19961363|NCT01703845|Respiratory System Agents|respiratory system agents|mesh-ancestor
19961364|NCT01703845|Parasympatholytics|parasympatholytics|mesh-ancestor
19961365|NCT01703845|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19961366|NCT01703845|Cholinergic Agents|cholinergic agents|mesh-ancestor
19961367|NCT01703845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19961368|NCT01703845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961369|NCT01703858|Pantoprazole|pantoprazole|mesh-list
19961370|NCT01703858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19961371|NCT01703858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19961372|NCT01703858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19961373|NCT01703858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961374|NCT01703858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961375|NCT01704079|Calcifediol|calcifediol|mesh-list
19961376|NCT01704079|Vitamins|vitamins|mesh-ancestor
19961377|NCT01704079|Micronutrients|micronutrients|mesh-ancestor
19961378|NCT01704079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961379|NCT01704079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19961380|NCT01704261|Metformin|metformin|mesh-list
19961381|NCT01704261|Glimepiride|glimepiride|mesh-list
19961382|NCT01704261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19961383|NCT01704261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961384|NCT01704261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19961385|NCT01704261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20275981|NCT00557453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20275982|NCT00557453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20275983|NCT00557453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20275984|NCT00557453|Antitubercular Agents|antitubercular agents|mesh-ancestor
20275985|NCT00557544|Ketoprofen|ketoprofen|mesh-list
20275986|NCT00557544|Metoclopramide|metoclopramide|mesh-list
20275987|NCT00557544|Antiemetics|antiemetics|mesh-ancestor
20275988|NCT00557544|Autonomic Agents|autonomic agents|mesh-ancestor
20275989|NCT00557544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20275990|NCT00557544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20275991|NCT00557544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19961386|NCT01704261|Immunologic Factors|immunologic factors|mesh-ancestor
19961387|NCT01704287|Paclitaxel|paclitaxel|mesh-list
19961388|NCT01704287|Carboplatin|carboplatin|mesh-list
19961389|NCT01704287|Pembrolizumab|pembrolizumab|mesh-list
19961390|NCT01704287|Temozolomide|temozolomide|mesh-list
19961391|NCT01704287|Dacarbazine|dacarbazine|mesh-list
19961392|NCT01704287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20275992|NCT00557544|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20275993|NCT00557544|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20275994|NCT00557544|Dopamine Agents|dopamine agents|mesh-ancestor
20275995|NCT00557544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20275996|NCT00557544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20275997|NCT00557544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20275998|NCT00557544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20275999|NCT00557544|Analgesics|analgesics|mesh-ancestor
20276000|NCT00557544|Sensory System Agents|sensory system agents|mesh-ancestor
20276001|NCT00557544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20276002|NCT00557544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20276003|NCT00557544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20276004|NCT00557544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276005|NCT00557557|Oxaliplatin|oxaliplatin|mesh-list
20276006|NCT00557557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276007|NCT00557700|Bromides|bromides|mesh-list
20276008|NCT00557700|Tiotropium Bromide|tiotropium bromide|mesh-list
20276009|NCT00557700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20276010|NCT00557700|Autonomic Agents|autonomic agents|mesh-ancestor
20276011|NCT00557700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20276012|NCT00557700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276013|NCT00557700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20276014|NCT00557700|Respiratory System Agents|respiratory system agents|mesh-ancestor
19961393|NCT01704287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276015|NCT00557700|Parasympatholytics|parasympatholytics|mesh-ancestor
20555053|NCT01938456|Mitosis Modulators|mitosis modulators|mesh-ancestor
19961394|NCT01704287|Tubulin Modulators|tubulin modulators|mesh-ancestor
20276016|NCT00557700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20276017|NCT00557700|Cholinergic Agents|cholinergic agents|mesh-ancestor
19961395|NCT01704287|Antimitotic Agents|antimitotic agents|mesh-ancestor
19961396|NCT01704287|Mitosis Modulators|mitosis modulators|mesh-ancestor
19961397|NCT01704287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961398|NCT01704287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19961399|NCT01704287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19961400|NCT01704287|Alkylating Agents|alkylating agents|mesh-ancestor
19961401|NCT01704521|Ribavirin|ribavirin|mesh-list
19961402|NCT01704521|Antimetabolites|antimetabolites|mesh-ancestor
19961403|NCT01704521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961404|NCT01704521|Antiviral Agents|antiviral agents|mesh-ancestor
19961405|NCT01704521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19961406|NCT01704599|Vitamins|vitamins|mesh-list
19961407|NCT01704599|Folic Acid|folic acid|mesh-list
19961408|NCT01704599|Vitamin B 12|vitamin b 12|mesh-list
19961409|NCT01704599|Pyridoxine|pyridoxine|mesh-list
19961410|NCT01704599|Vitamin B 6|vitamin b 6|mesh-list
19961411|NCT01704599|Vitamin B Complex|vitamin b complex|mesh-list
19961412|NCT01704599|Adalimumab|adalimumab|mesh-list
19961413|NCT01704599|Micronutrients|micronutrients|mesh-ancestor
19961414|NCT01704599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961415|NCT01704599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19961416|NCT01704599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19961417|NCT01704599|Hematinics|hematinics|mesh-ancestor
19961418|NCT01704651|Alvimopan|alvimopan|mesh-list
19961419|NCT01704651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19961420|NCT01704755|Ribavirin|ribavirin|mesh-list
19961421|NCT01704755|Antimetabolites|antimetabolites|mesh-ancestor
19961422|NCT01704755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961423|NCT01704755|Antiviral Agents|antiviral agents|mesh-ancestor
19961424|NCT01704755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19961425|NCT01704781|Lenalidomide|lenalidomide|mesh-list
19961426|NCT01704781|Immunologic Factors|immunologic factors|mesh-ancestor
19961427|NCT01704781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961428|NCT01704781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19961429|NCT01704781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19961430|NCT01704781|Growth Substances|growth substances|mesh-ancestor
19961431|NCT01704781|Growth Inhibitors|growth inhibitors|mesh-ancestor
19961432|NCT01704781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974880|NCT01843348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19974881|NCT01843348|Immunologic Factors|immunologic factors|mesh-ancestor
19974882|NCT01843348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974883|NCT01843348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19974884|NCT01843348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974885|NCT01843348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974886|NCT01843348|Antifungal Agents|antifungal agents|mesh-ancestor
19974887|NCT01843348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19974888|NCT01843348|Dermatologic Agents|dermatologic agents|mesh-ancestor
20276018|NCT00557700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20276019|NCT00557700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276020|NCT00557700|Anticonvulsants|anticonvulsants|mesh-ancestor
20276021|NCT00557713|Bevacizumab|bevacizumab|mesh-list
19974889|NCT01843348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19974890|NCT01843348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974891|NCT01843348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19974892|NCT01843348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19974893|NCT01843348|Antitubercular Agents|antitubercular agents|mesh-ancestor
19974894|NCT01843348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19974895|NCT01843621|Vaccines|vaccines|mesh-list
19974896|NCT01843621|Immunologic Factors|immunologic factors|mesh-ancestor
19974897|NCT01843621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974898|NCT01843660|Acetaminophen|acetaminophen|mesh-list
19974899|NCT01843660|Tramadol|tramadol|mesh-list
19974900|NCT01843660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19974901|NCT01843660|Analgesics|analgesics|mesh-ancestor
19974902|NCT01843660|Sensory System Agents|sensory system agents|mesh-ancestor
19974903|NCT01843660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19974904|NCT01843660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974905|NCT01843660|Antipyretics|antipyretics|mesh-ancestor
19974906|NCT01843660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19974907|NCT01843660|Narcotics|narcotics|mesh-ancestor
19974908|NCT01843660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19974909|NCT01843751|Buprenorphine|buprenorphine|mesh-list
19974910|NCT01843751|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19974911|NCT01843751|Naloxone|naloxone|mesh-list
19974912|NCT01843751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19974913|NCT01843751|Narcotics|narcotics|mesh-ancestor
19974914|NCT01843751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19961433|NCT01705145|Ivacaftor|ivacaftor|mesh-list
19961434|NCT01705145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19961435|NCT01705145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19961436|NCT01705145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961437|NCT01705236|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19961438|NCT01705236|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19961439|NCT01705236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961440|NCT01705236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20276022|NCT00557713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20276023|NCT00557713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276024|NCT00557713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20276025|NCT00557713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20276026|NCT00557713|Growth Substances|growth substances|mesh-ancestor
20276027|NCT00557713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276028|NCT00557713|Growth Inhibitors|growth inhibitors|mesh-ancestor
20276029|NCT00557739|Mometasone Furoate|mometasone furoate|mesh-list
20276030|NCT00557739|Nortriptyline|nortriptyline|mesh-list
20276031|NCT00557739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20276032|NCT00557739|Dermatologic Agents|dermatologic agents|mesh-ancestor
20276033|NCT00557739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20276034|NCT00557739|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20276035|NCT00557739|Antidepressive Agents|antidepressive agents|mesh-ancestor
20276036|NCT00557739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20276037|NCT00557739|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20276038|NCT00557739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20276039|NCT00557739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20276040|NCT00557739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961441|NCT01705236|Immunologic Factors|immunologic factors|mesh-ancestor
19961442|NCT01705236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961443|NCT01705288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19961444|NCT01705288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19961445|NCT01705288|Morphine|morphine|mesh-list
19961446|NCT01705288|Narcotics|narcotics|mesh-list
19961447|NCT01705288|Anesthetics|anesthetics|mesh-list
19961448|NCT01705288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19961449|NCT01705288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961450|NCT01705288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19961451|NCT01705288|Analgesics|analgesics|mesh-ancestor
19961452|NCT01705288|Sensory System Agents|sensory system agents|mesh-ancestor
19961453|NCT01705288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961454|NCT01705288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19961455|NCT01705288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19961456|NCT01705496|Fialuridine|fialuridine|mesh-list
19961457|NCT01705496|Antiviral Agents|antiviral agents|mesh-ancestor
19961458|NCT01705496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19961459|NCT01705496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19961460|NCT01705496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961461|NCT01705496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961462|NCT01705509|Ranolazine|ranolazine|mesh-list
19961463|NCT01705509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19961464|NCT01705509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19961465|NCT01705509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961466|NCT01705574|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19961467|NCT01705574|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19961468|NCT01705574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19961469|NCT01705574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961470|NCT01705574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961471|NCT01705574|Antiviral Agents|antiviral agents|mesh-ancestor
19961472|NCT01705574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19961473|NCT01705574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19961474|NCT01705574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19961475|NCT01705587|Teriparatide|teriparatide|mesh-list
19961476|NCT01705587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19961477|NCT01705587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961478|NCT01705587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20276041|NCT00557739|Adrenergic Agents|adrenergic agents|mesh-ancestor
20276042|NCT00557739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20276043|NCT00557739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276044|NCT00557791|Ranibizumab|ranibizumab|mesh-list
20276045|NCT00557791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20545382|NCT01881763|Sensory System Agents|sensory system agents|mesh-ancestor
20276046|NCT00557791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20545383|NCT01881763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961479|NCT01705691|Paclitaxel|paclitaxel|mesh-list
19961480|NCT01705691|Cyclophosphamide|cyclophosphamide|mesh-list
19961481|NCT01705691|Doxorubicin|doxorubicin|mesh-list
19961482|NCT01705691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19961483|NCT01705691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19961484|NCT01705691|Tubulin Modulators|tubulin modulators|mesh-ancestor
19961485|NCT01705691|Antimitotic Agents|antimitotic agents|mesh-ancestor
19961486|NCT01705691|Mitosis Modulators|mitosis modulators|mesh-ancestor
19961487|NCT01705691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961488|NCT01705691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19961489|NCT01705691|Immunologic Factors|immunologic factors|mesh-ancestor
19961490|NCT01705691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961491|NCT01705691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19961492|NCT01705691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19961493|NCT01705691|Alkylating Agents|alkylating agents|mesh-ancestor
19961494|NCT01705691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19961495|NCT01705691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19961496|NCT01705691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19961497|NCT01705691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19961498|NCT01705691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961499|NCT01705964|Epinephrine|epinephrine|mesh-list
19961500|NCT01705964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19961501|NCT01705964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19961502|NCT01705964|Adrenergic Agents|adrenergic agents|mesh-ancestor
19961503|NCT01705964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19961504|NCT01705964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961505|NCT01705964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961506|NCT01705964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19961507|NCT01705964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19961508|NCT01705964|Autonomic Agents|autonomic agents|mesh-ancestor
19961509|NCT01705964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961510|NCT01705964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19961511|NCT01705964|Respiratory System Agents|respiratory system agents|mesh-ancestor
19961512|NCT01705964|Mydriatics|mydriatics|mesh-ancestor
19961513|NCT01705964|Sympathomimetics|sympathomimetics|mesh-ancestor
19961514|NCT01705964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19961515|NCT01706146|Rivaroxaban|rivaroxaban|mesh-list
19961516|NCT01706146|Apixaban|apixaban|mesh-list
19961517|NCT01706146|Dabigatran|dabigatran|mesh-list
19961518|NCT01706146|Anticoagulants|anticoagulants|mesh-list
19961519|NCT01706146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19961520|NCT01706146|Antithrombins|antithrombins|mesh-ancestor
19961521|NCT01706146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19961522|NCT01706146|Protease Inhibitors|protease inhibitors|mesh-ancestor
19961523|NCT01706146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961524|NCT01706146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961525|NCT01706198|Fluticasone|fluticasone|mesh-list
19961526|NCT01706198|Xhance|xhance|mesh-list
19961527|NCT01706198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19961528|NCT01706198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19961529|NCT01706198|Autonomic Agents|autonomic agents|mesh-ancestor
19961530|NCT01706198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961531|NCT01706198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961532|NCT01706198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19961533|NCT01706198|Respiratory System Agents|respiratory system agents|mesh-ancestor
19961534|NCT01706198|Dermatologic Agents|dermatologic agents|mesh-ancestor
19961535|NCT01706198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19961536|NCT01706250|Salicylic Acid|salicylic acid|mesh-list
19961537|NCT01706250|Salicylates|salicylates|mesh-list
19961538|NCT01706250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19961539|NCT01706250|Antifungal Agents|antifungal agents|mesh-ancestor
19961540|NCT01706250|Keratolytic Agents|keratolytic agents|mesh-ancestor
20276047|NCT00557791|Growth Substances|growth substances|mesh-ancestor
20276048|NCT00557791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276049|NCT00557791|Growth Inhibitors|growth inhibitors|mesh-ancestor
20276050|NCT00557791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276051|NCT00557817|Darbepoetin alfa|darbepoetin alfa|mesh-list
20276052|NCT00557817|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20276053|NCT00557817|Hematinics|hematinics|mesh-ancestor
20276054|NCT00557843|Bupivacaine|bupivacaine|mesh-list
20276055|NCT00557843|Anesthetics, Local|anesthetics, local|mesh-ancestor
20276056|NCT00557843|Anesthetics|anesthetics|mesh-ancestor
20276057|NCT00557843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20276058|NCT00557843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276059|NCT00557843|Sensory System Agents|sensory system agents|mesh-ancestor
19961541|NCT01706250|Dermatologic Agents|dermatologic agents|mesh-ancestor
20276060|NCT00557843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20276061|NCT00557921|Aspirin|aspirin|mesh-list
20545384|NCT01881763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961542|NCT01706250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19961543|NCT01706250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19961544|NCT01706250|Analgesics|analgesics|mesh-ancestor
19961545|NCT01706250|Sensory System Agents|sensory system agents|mesh-ancestor
19961546|NCT01706250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961547|NCT01706250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961548|NCT01706250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19961549|NCT01706250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19961550|NCT01706250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19961551|NCT01706250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961552|NCT01706250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961553|NCT01706263|Salicylic Acid|salicylic acid|mesh-list
19961554|NCT01706263|Salicylates|salicylates|mesh-list
19961555|NCT01706263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19961556|NCT01706263|Antifungal Agents|antifungal agents|mesh-ancestor
19961557|NCT01706263|Keratolytic Agents|keratolytic agents|mesh-ancestor
20545385|NCT01881763|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20545386|NCT01881763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20545387|NCT01881763|Anesthetics, General|anesthetics, general|mesh-ancestor
20545388|NCT01881763|Anesthetics|anesthetics|mesh-ancestor
20545389|NCT01881763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20545390|NCT01881763|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19961558|NCT01706263|Dermatologic Agents|dermatologic agents|mesh-ancestor
19961559|NCT01706263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19961560|NCT01706263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19961561|NCT01706263|Analgesics|analgesics|mesh-ancestor
19961562|NCT01706263|Sensory System Agents|sensory system agents|mesh-ancestor
19961563|NCT01706263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961564|NCT01706263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961565|NCT01706263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19961566|NCT01706263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19961567|NCT01706263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19961568|NCT01706263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961569|NCT01706263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961570|NCT01706328|Fluticasone|fluticasone|mesh-list
19961571|NCT01706328|Xhance|xhance|mesh-list
19961572|NCT01706328|Albuterol|albuterol|mesh-list
19961573|NCT01706328|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19961574|NCT01706328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19961575|NCT01706328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19961576|NCT01706328|Autonomic Agents|autonomic agents|mesh-ancestor
20276062|NCT00557921|Omeprazole|omeprazole|mesh-list
20276063|NCT00557921|Clopidogrel|clopidogrel|mesh-list
20276064|NCT00557921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19961577|NCT01706328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961578|NCT01706328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961579|NCT01706328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19961580|NCT01706328|Respiratory System Agents|respiratory system agents|mesh-ancestor
19961581|NCT01706328|Dermatologic Agents|dermatologic agents|mesh-ancestor
19961582|NCT01706328|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19961583|NCT01706328|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19961584|NCT01706328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19961585|NCT01706328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19961586|NCT01706328|Adrenergic Agents|adrenergic agents|mesh-ancestor
19961587|NCT01706328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20276065|NCT00557921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20276066|NCT00557921|Analgesics|analgesics|mesh-ancestor
20276067|NCT00557921|Sensory System Agents|sensory system agents|mesh-ancestor
20276068|NCT00557921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20276069|NCT00557921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276070|NCT00557921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20276071|NCT00557921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20276072|NCT00557921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20276073|NCT00557921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20276074|NCT00557921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276075|NCT00557921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20276076|NCT00557921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20276077|NCT00557921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961588|NCT01706328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276078|NCT00557921|Antipyretics|antipyretics|mesh-ancestor
19961589|NCT01706328|Tocolytic Agents|tocolytic agents|mesh-ancestor
19961590|NCT01706328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19961591|NCT01706575|Interferons|interferons|mesh-list
19961592|NCT01706575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19961593|NCT01706575|Antiviral Agents|antiviral agents|mesh-ancestor
19961594|NCT01706575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19961595|NCT01706588|Diclofenac|diclofenac|mesh-list
19961596|NCT01706588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19961597|NCT01706588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19961598|NCT01706588|Analgesics|analgesics|mesh-ancestor
19961599|NCT01706588|Sensory System Agents|sensory system agents|mesh-ancestor
19961600|NCT01706588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961601|NCT01706588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961602|NCT01706588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19961603|NCT01706588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19961604|NCT01706588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19961605|NCT01706588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961606|NCT01706588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961607|NCT01706666|Dexamethasone|dexamethasone|mesh-list
19961608|NCT01706666|Cyclophosphamide|cyclophosphamide|mesh-list
19961609|NCT01706666|Lenalidomide|lenalidomide|mesh-list
19961610|NCT01706666|Bortezomib|bortezomib|mesh-list
19961611|NCT01706666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19961612|NCT01706666|Immunologic Factors|immunologic factors|mesh-ancestor
19961613|NCT01706666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961614|NCT01706666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19961615|NCT01706666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19961616|NCT01706666|Alkylating Agents|alkylating agents|mesh-ancestor
19961617|NCT01706666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961618|NCT01706666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19961619|NCT01706666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19961620|NCT01706666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19961621|NCT01706666|Antiemetics|antiemetics|mesh-ancestor
19961622|NCT01706666|Autonomic Agents|autonomic agents|mesh-ancestor
19961623|NCT01706666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961624|NCT01706666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19961625|NCT01706666|Glucocorticoids|glucocorticoids|mesh-ancestor
19961626|NCT01706666|Hormones|hormones|mesh-ancestor
19961627|NCT01706666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19961628|NCT01706666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19961629|NCT01706666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19961630|NCT01706666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19961631|NCT01706666|Growth Substances|growth substances|mesh-ancestor
19961632|NCT01706666|Growth Inhibitors|growth inhibitors|mesh-ancestor
19961633|NCT01706926|Mavrilimumab|mavrilimumab|mesh-list
19961634|NCT01706926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19961635|NCT01706926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19961636|NCT01706926|Immunologic Factors|immunologic factors|mesh-ancestor
19961637|NCT01706926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961638|NCT01706952|Epinephrine|epinephrine|mesh-list
19961639|NCT01706952|Racepinephrine|racepinephrine|mesh-list
19961640|NCT01706952|Cocaine|cocaine|mesh-list
19961641|NCT01706952|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19961642|NCT01706952|Epinephryl borate|epinephryl borate|mesh-list
19961643|NCT01706952|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19961644|NCT01706952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20276079|NCT00557921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20276080|NCT00557921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20276081|NCT00557921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20276082|NCT00557921|Purinergic Agents|purinergic agents|mesh-ancestor
20276083|NCT00557921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20276084|NCT00557921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20276085|NCT00557921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20276086|NCT00557921|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20276087|NCT00557934|Dobutamine|dobutamine|mesh-list
20276088|NCT00557934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20276089|NCT00557934|Sympathomimetics|sympathomimetics|mesh-ancestor
20276090|NCT00557934|Autonomic Agents|autonomic agents|mesh-ancestor
19961645|NCT01706952|Adrenergic Agents|adrenergic agents|mesh-ancestor
20276091|NCT00557934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20276092|NCT00557934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276093|NCT00557934|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20276094|NCT00557934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20276095|NCT00557934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20276096|NCT00557934|Adrenergic Agents|adrenergic agents|mesh-ancestor
19961646|NCT01706952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19961647|NCT01706952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961648|NCT01706952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961649|NCT01706952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19961650|NCT01706952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19961651|NCT01706952|Autonomic Agents|autonomic agents|mesh-ancestor
19961652|NCT01706952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961653|NCT01706952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19961654|NCT01706952|Respiratory System Agents|respiratory system agents|mesh-ancestor
19961655|NCT01706952|Mydriatics|mydriatics|mesh-ancestor
19961656|NCT01706952|Sympathomimetics|sympathomimetics|mesh-ancestor
19961657|NCT01706952|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19961658|NCT01706952|Anesthetics, Local|anesthetics, local|mesh-ancestor
19961659|NCT01706952|Anesthetics|anesthetics|mesh-ancestor
19961660|NCT01706952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19961661|NCT01706952|Sensory System Agents|sensory system agents|mesh-ancestor
19961662|NCT01706952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19961663|NCT01706952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19961664|NCT01706952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19961665|NCT01706952|Dopamine Agents|dopamine agents|mesh-ancestor
19961666|NCT01707004|Vidarabine|vidarabine|mesh-list
19961667|NCT01707004|Mycophenolic Acid|mycophenolic acid|mesh-list
19961668|NCT01707004|Cyclophosphamide|cyclophosphamide|mesh-list
19961669|NCT01707004|Busulfan|busulfan|mesh-list
19961670|NCT01707004|Fludarabine|fludarabine|mesh-list
19961671|NCT01707004|Fludarabine phosphate|fludarabine phosphate|mesh-list
19961672|NCT01707004|Azacitidine|azacitidine|mesh-list
19961673|NCT01707004|Decitabine|decitabine|mesh-list
19961674|NCT01707004|Tacrolimus|tacrolimus|mesh-list
19961675|NCT01707004|Lenograstim|lenograstim|mesh-list
19961676|NCT01707004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19961677|NCT01707004|Immunologic Factors|immunologic factors|mesh-ancestor
19961678|NCT01707004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961679|NCT01707004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19961680|NCT01707004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19961681|NCT01707004|Alkylating Agents|alkylating agents|mesh-ancestor
19961682|NCT01707004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276097|NCT00557934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20276098|NCT00557934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276099|NCT00557934|Protective Agents|protective agents|mesh-ancestor
20276100|NCT00557960|Amphetamine|amphetamine|mesh-list
19961683|NCT01707004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19961684|NCT01707004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19961685|NCT01707004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19961686|NCT01707004|Antimetabolites|antimetabolites|mesh-ancestor
19961687|NCT01707004|Antiviral Agents|antiviral agents|mesh-ancestor
19961688|NCT01707004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19961689|NCT01707004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19961690|NCT01707004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19961691|NCT01707004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961692|NCT01707004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19961693|NCT01707004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19961694|NCT01707004|Antitubercular Agents|antitubercular agents|mesh-ancestor
19961695|NCT01707004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19961696|NCT01707043|Calcitriol|calcitriol|mesh-list
19961697|NCT01707043|Betamethasone|betamethasone|mesh-list
19961698|NCT01707043|Betamethasone Valerate|betamethasone valerate|mesh-list
19961699|NCT01707043|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19961700|NCT01707043|Betamethasone benzoate|betamethasone benzoate|mesh-list
19961701|NCT01707043|Calcipotriene|calcipotriene|mesh-list
19961702|NCT01707043|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19961703|NCT01707043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19961704|NCT01707043|Glucocorticoids|glucocorticoids|mesh-ancestor
19961705|NCT01707043|Hormones|hormones|mesh-ancestor
19961706|NCT01707043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19961707|NCT01707043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961708|NCT01707043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20276101|NCT00557960|Adderall|adderall|mesh-list
19961709|NCT01707043|Respiratory System Agents|respiratory system agents|mesh-ancestor
19961710|NCT01707043|Dermatologic Agents|dermatologic agents|mesh-ancestor
19961711|NCT01707043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19961712|NCT01707043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19961713|NCT01707043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19961714|NCT01707043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961715|NCT01707043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19961716|NCT01707043|Vitamins|vitamins|mesh-ancestor
19961717|NCT01707043|Micronutrients|micronutrients|mesh-ancestor
19961718|NCT01707043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20276102|NCT00557960|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20276103|NCT00557960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20276104|NCT00557960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20276105|NCT00557960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20276106|NCT00557960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276107|NCT00557960|Adrenergic Agents|adrenergic agents|mesh-ancestor
20276108|NCT00557960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20276109|NCT00557960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276110|NCT00557960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20276111|NCT00557960|Sympathomimetics|sympathomimetics|mesh-ancestor
20276112|NCT00557960|Autonomic Agents|autonomic agents|mesh-ancestor
20276113|NCT00557960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20276114|NCT00557960|Dopamine Agents|dopamine agents|mesh-ancestor
20276115|NCT00557960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20276116|NCT00558051|Vaccines|vaccines|mesh-list
20276117|NCT00558051|Immunologic Factors|immunologic factors|mesh-ancestor
20276118|NCT00558051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276119|NCT00558077|Metformin|metformin|mesh-list
20276120|NCT00558077|Clomiphene|clomiphene|mesh-list
20276121|NCT00558077|Enclomiphene|enclomiphene|mesh-list
20276122|NCT00558077|Zuclomiphene|zuclomiphene|mesh-list
20276123|NCT00558077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20276124|NCT00558077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961719|NCT01707147|Linagliptin|linagliptin|mesh-list
19961720|NCT01707147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19961721|NCT01707147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961722|NCT01707147|Incretins|incretins|mesh-ancestor
19961723|NCT01707147|Hormones|hormones|mesh-ancestor
19961724|NCT01707147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19961725|NCT01707147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19961726|NCT01707147|Protease Inhibitors|protease inhibitors|mesh-ancestor
19961727|NCT01707147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961728|NCT01707147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961729|NCT01707225|Octreotide|octreotide|mesh-list
19961730|NCT01707225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19961731|NCT01707225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19961732|NCT01707225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19961733|NCT01707290|Ivacaftor|ivacaftor|mesh-list
19961734|NCT01707290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19961735|NCT01707290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19961736|NCT01707290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961737|NCT01707381|Timolol|timolol|mesh-list
19961738|NCT01707381|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19961739|NCT01707381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19961740|NCT01707381|Adrenergic Agents|adrenergic agents|mesh-ancestor
19961741|NCT01707381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19961742|NCT01707381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961743|NCT01707381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961744|NCT01707381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19961745|NCT01707381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19961746|NCT01707420|Gabapentin|gabapentin|mesh-list
19961747|NCT01707420|Analgesics|analgesics|mesh-ancestor
19961748|NCT01707420|Sensory System Agents|sensory system agents|mesh-ancestor
20276125|NCT00558077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20276126|NCT00558077|Hormone Antagonists|hormone antagonists|mesh-ancestor
19961749|NCT01707420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961750|NCT01707420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961751|NCT01707420|Anticonvulsants|anticonvulsants|mesh-ancestor
19961752|NCT01707420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19961753|NCT01707420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19961754|NCT01707420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19961755|NCT01707420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19961756|NCT01707420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19961757|NCT01707420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19961758|NCT01707420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19961759|NCT01707420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961760|NCT01707420|Antimanic Agents|antimanic agents|mesh-ancestor
19961761|NCT01707667|Prucalopride|prucalopride|mesh-list
20276127|NCT00558077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20276128|NCT00558077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20276129|NCT00558077|Fertility Agents|fertility agents|mesh-ancestor
20276130|NCT00558077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20276131|NCT00558077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20276132|NCT00558077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20276133|NCT00558090|Morphine|morphine|mesh-list
20276134|NCT00558090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20276135|NCT00558090|Narcotics|narcotics|mesh-ancestor
20276136|NCT00558090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20276137|NCT00558090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276138|NCT00558090|Analgesics|analgesics|mesh-ancestor
20276139|NCT00558090|Sensory System Agents|sensory system agents|mesh-ancestor
20276140|NCT00558090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20276141|NCT00558142|Acetylcysteine|acetylcysteine|mesh-list
20276142|NCT00558142|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20276143|NCT00558142|Antiviral Agents|antiviral agents|mesh-ancestor
20276144|NCT00558142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20276145|NCT00558142|Expectorants|expectorants|mesh-ancestor
20276146|NCT00558142|Respiratory System Agents|respiratory system agents|mesh-ancestor
20276147|NCT00558142|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20276148|NCT00558142|Antioxidants|antioxidants|mesh-ancestor
20276149|NCT00558142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276150|NCT00558142|Protective Agents|protective agents|mesh-ancestor
20276151|NCT00558142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276152|NCT00558142|Antidotes|antidotes|mesh-ancestor
20276153|NCT00558181|Methylprednisolone|methylprednisolone|mesh-list
20276154|NCT00558181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20276155|NCT00558181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20276156|NCT00558181|Prednisolone|prednisolone|mesh-list
20276157|NCT00558181|Prednisolone acetate|prednisolone acetate|mesh-list
20276158|NCT00558181|Rituximab|rituximab|mesh-list
20276159|NCT00558181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19961762|NCT01707667|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19961763|NCT01707667|Laxatives|laxatives|mesh-ancestor
19961764|NCT01707667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19961765|NCT01707667|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19961766|NCT01707667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19961767|NCT01707667|Serotonin Agents|serotonin agents|mesh-ancestor
19961768|NCT01707667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19961769|NCT01707667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961770|NCT01707667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961771|NCT01708122|Fentanyl|fentanyl|mesh-list
19961772|NCT01708122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19961773|NCT01708122|Narcotics|narcotics|mesh-ancestor
19961774|NCT01708122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19961775|NCT01708122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961776|NCT01708122|Analgesics|analgesics|mesh-ancestor
19961777|NCT01708122|Sensory System Agents|sensory system agents|mesh-ancestor
20276160|NCT00558181|Prednisolone phosphate|prednisolone phosphate|mesh-list
20276161|NCT00558181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20276162|NCT00558181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276163|NCT00558181|Immunologic Factors|immunologic factors|mesh-ancestor
20276164|NCT00558181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276165|NCT00558181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20276166|NCT00558181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20276167|NCT00558181|Antiemetics|antiemetics|mesh-ancestor
20276168|NCT00558181|Autonomic Agents|autonomic agents|mesh-ancestor
20276169|NCT00558181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20276170|NCT00558181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20276171|NCT00558181|Glucocorticoids|glucocorticoids|mesh-ancestor
20276172|NCT00558181|Hormones|hormones|mesh-ancestor
19961778|NCT01708122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961779|NCT01708122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19961780|NCT01708122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19961781|NCT01708122|Anesthetics, General|anesthetics, general|mesh-ancestor
19961782|NCT01708122|Anesthetics|anesthetics|mesh-ancestor
19961783|NCT01708278|Folic Acid|folic acid|mesh-list
19961784|NCT01708278|Quercetin|quercetin|mesh-list
19961785|NCT01708278|Hematinics|hematinics|mesh-ancestor
20276173|NCT00558181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19961786|NCT01708278|Vitamin B Complex|vitamin b complex|mesh-ancestor
19961787|NCT01708278|Vitamins|vitamins|mesh-ancestor
19961788|NCT01708278|Micronutrients|micronutrients|mesh-ancestor
19961789|NCT01708278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961790|NCT01708278|Antioxidants|antioxidants|mesh-ancestor
19961791|NCT01708278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961792|NCT01708278|Protective Agents|protective agents|mesh-ancestor
19961793|NCT01708525|Deuterium Oxide|deuterium oxide|mesh-list
20276174|NCT00558181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20276175|NCT00558181|Protective Agents|protective agents|mesh-ancestor
20276176|NCT00558181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20276177|NCT00558298|Risperidone|risperidone|mesh-list
20276178|NCT00558298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19961794|NCT01708525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19961795|NCT01708525|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19961796|NCT01708525|Protective Agents|protective agents|mesh-ancestor
19961797|NCT01708525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961798|NCT01708590|Brodalumab|brodalumab|mesh-list
19961799|NCT01708590|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19961800|NCT01708590|Dermatologic Agents|dermatologic agents|mesh-ancestor
20276179|NCT00558298|Serotonin Agents|serotonin agents|mesh-ancestor
20276180|NCT00558298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20276181|NCT00558298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961801|NCT01708590|Immunologic Factors|immunologic factors|mesh-ancestor
19961802|NCT01708590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961803|NCT01708603|Ustekinumab|ustekinumab|mesh-list
19961804|NCT01708603|Brodalumab|brodalumab|mesh-list
19961805|NCT01708603|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19961806|NCT01708603|Dermatologic Agents|dermatologic agents|mesh-ancestor
19961807|NCT01708603|Immunologic Factors|immunologic factors|mesh-ancestor
19961808|NCT01708603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961809|NCT01708629|Ustekinumab|ustekinumab|mesh-list
19961810|NCT01708629|Brodalumab|brodalumab|mesh-list
19961811|NCT01708629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19961812|NCT01708629|Dermatologic Agents|dermatologic agents|mesh-ancestor
19961813|NCT01708629|Immunologic Factors|immunologic factors|mesh-ancestor
19961814|NCT01708629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961815|NCT01708902|Metformin|metformin|mesh-list
19961816|NCT01708902|Linagliptin|linagliptin|mesh-list
19961817|NCT01708902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19961818|NCT01708902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961819|NCT01708902|Incretins|incretins|mesh-ancestor
19961820|NCT01708902|Hormones|hormones|mesh-ancestor
19961821|NCT01708902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19961822|NCT01708902|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19961823|NCT01708902|Protease Inhibitors|protease inhibitors|mesh-ancestor
19961824|NCT01708902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961825|NCT01708902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961826|NCT01708915|Nicotinic Acids|nicotinic acids|mesh-list
19961827|NCT01708915|Capsaicin|capsaicin|mesh-list
19961828|NCT01708915|Nonivamide|nonivamide|mesh-list
19961829|NCT01708915|Vitamin B Complex|vitamin b complex|mesh-ancestor
19961830|NCT01708915|Vitamins|vitamins|mesh-ancestor
19961831|NCT01708915|Micronutrients|micronutrients|mesh-ancestor
19961832|NCT01708915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961833|NCT01708915|Sensory System Agents|sensory system agents|mesh-ancestor
19961834|NCT01708915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961835|NCT01708915|Antipruritics|antipruritics|mesh-ancestor
19961836|NCT01708915|Dermatologic Agents|dermatologic agents|mesh-ancestor
19961837|NCT01709032|Deferasirox|deferasirox|mesh-list
19961838|NCT01709032|Deferiprone|deferiprone|mesh-list
19961839|NCT01709032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19961840|NCT01709032|Chelating Agents|chelating agents|mesh-ancestor
19961841|NCT01709032|Sequestering Agents|sequestering agents|mesh-ancestor
19961842|NCT01709032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961843|NCT01709084|Tenofovir|tenofovir|mesh-list
19961844|NCT01709084|Emtricitabine|emtricitabine|mesh-list
19961845|NCT01709084|Efavirenz|efavirenz|mesh-list
19961846|NCT01709084|Rilpivirine|rilpivirine|mesh-list
19961847|NCT01709084|Antiviral Agents|antiviral agents|mesh-ancestor
19961848|NCT01709084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19961849|NCT01709084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19961850|NCT01709084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19961851|NCT01709084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961852|NCT01709084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961853|NCT01709084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19961854|NCT01709084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19961855|NCT01709084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19961856|NCT01709084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19961857|NCT01709084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19961858|NCT01709084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19961859|NCT01709084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19961860|NCT01709084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19961861|NCT01709110|Vitamin D|vitamin d|mesh-list
19961862|NCT01709110|Teriparatide|teriparatide|mesh-list
19961863|NCT01709110|Risedronic Acid|risedronic acid|mesh-list
19961864|NCT01709110|Calcium|calcium|mesh-list
19961865|NCT01709110|Vitamins|vitamins|mesh-ancestor
19961866|NCT01709110|Micronutrients|micronutrients|mesh-ancestor
19961867|NCT01709110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961868|NCT01709110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19961869|NCT01709110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19961870|NCT01709110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19961871|NCT01709110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19961872|NCT01709110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961873|NCT01709149|Riluzole|riluzole|mesh-list
19961874|NCT01709149|Anticonvulsants|anticonvulsants|mesh-ancestor
19961875|NCT01709149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19961876|NCT01709149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19961877|NCT01709149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19961878|NCT01709149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961879|NCT01709149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961880|NCT01709149|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19961881|NCT01709149|Protective Agents|protective agents|mesh-ancestor
19961882|NCT01709162|Ipilimumab|ipilimumab|mesh-list
19961883|NCT01709162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19961884|NCT01709162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19961885|NCT01709162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19961886|NCT01709162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961887|NCT01709227|Furosemide|furosemide|mesh-list
19961888|NCT01709227|Diuretics|diuretics|mesh-ancestor
19961889|NCT01709227|Natriuretic Agents|natriuretic agents|mesh-ancestor
20276182|NCT00558298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276183|NCT00558298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20276184|NCT00558298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20276185|NCT00558298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20276186|NCT00558298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20276187|NCT00558298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20276188|NCT00558298|Dopamine Agents|dopamine agents|mesh-ancestor
20276189|NCT00558337|Levodopa|levodopa|mesh-list
20276190|NCT00558337|Carbidopa|carbidopa|mesh-list
20276191|NCT00558337|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20276192|NCT00558337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20276193|NCT00558337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20276194|NCT00558337|Dopamine Agents|dopamine agents|mesh-ancestor
20276195|NCT00558337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20276196|NCT00558337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276197|NCT00558337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276198|NCT00558337|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20276199|NCT00558337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276200|NCT00558337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20276201|NCT00558337|Immunologic Factors|immunologic factors|mesh-ancestor
20276202|NCT00558337|Dopamine Agonists|dopamine agonists|mesh-ancestor
20276203|NCT00558376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20276204|NCT00558376|Laxatives|laxatives|mesh-ancestor
20276205|NCT00558376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20276206|NCT00558454|Ferrous succinate|ferrous succinate|mesh-list
20276207|NCT00558454|Hematinics|hematinics|mesh-ancestor
20276208|NCT00558480|Vitamins|vitamins|mesh-list
20276209|NCT00558480|Vitamin A|vitamin a|mesh-list
20276210|NCT00558480|Retinol palmitate|retinol palmitate|mesh-list
20276211|NCT00558480|Micronutrients|micronutrients|mesh-ancestor
20276212|NCT00558480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276213|NCT00558480|Antioxidants|antioxidants|mesh-ancestor
20276214|NCT00558480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276215|NCT00558480|Protective Agents|protective agents|mesh-ancestor
20276216|NCT00558480|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20276217|NCT00558480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276218|NCT00558493|Clevudine|clevudine|mesh-list
20276219|NCT00558493|Antiviral Agents|antiviral agents|mesh-ancestor
20276220|NCT00558493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20276221|NCT00558506|Abatacept|abatacept|mesh-list
20276222|NCT00558506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20287760|NCT03711305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20276223|NCT00558506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276224|NCT00558506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276225|NCT00558506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20276226|NCT00558506|Immunologic Factors|immunologic factors|mesh-ancestor
20276227|NCT00558506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276228|NCT00558506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20276229|NCT00558623|Calcium Carbonate|calcium carbonate|mesh-list
20276230|NCT00558623|Calcium|calcium|mesh-list
20276231|NCT00558623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20276232|NCT00558623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276233|NCT00558623|Antacids|antacids|mesh-ancestor
20276234|NCT00558623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276235|NCT00558623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20276236|NCT00558662|Monensin|monensin|mesh-list
20276237|NCT00558662|Antifungal Agents|antifungal agents|mesh-ancestor
20276238|NCT00558662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20276239|NCT00558662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20276240|NCT00558662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20276241|NCT00558662|Coccidiostats|coccidiostats|mesh-ancestor
19961890|NCT01709227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961891|NCT01709227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19961892|NCT01709227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19961893|NCT01709227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961894|NCT01709305|Metformin|metformin|mesh-list
19961895|NCT01709305|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19961896|NCT01709305|Glimepiride|glimepiride|mesh-list
19961897|NCT01709305|Acarbose|acarbose|mesh-list
19961898|NCT01709305|Repaglinide|repaglinide|mesh-list
19961899|NCT01709305|Gliclazide|gliclazide|mesh-list
19961900|NCT01709305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19961901|NCT01709305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961902|NCT01709305|Incretins|incretins|mesh-ancestor
19961903|NCT01709305|Hormones|hormones|mesh-ancestor
19961904|NCT01709305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19961905|NCT01709305|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19961906|NCT01709305|Protease Inhibitors|protease inhibitors|mesh-ancestor
19961907|NCT01709305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961908|NCT01709305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961909|NCT01709305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19961910|NCT01709305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19961911|NCT01709305|Immunologic Factors|immunologic factors|mesh-ancestor
19961912|NCT01709305|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20276242|NCT00558662|Proton Ionophores|proton ionophores|mesh-ancestor
20276243|NCT00558662|Uncoupling Agents|uncoupling agents|mesh-ancestor
20276244|NCT00558662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276245|NCT00558662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276246|NCT00558662|Ionophores|ionophores|mesh-ancestor
20276247|NCT00558662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20276248|NCT00558662|Sodium Ionophores|sodium ionophores|mesh-ancestor
20276249|NCT00558818|Clevudine|clevudine|mesh-list
20276250|NCT00558818|Antiviral Agents|antiviral agents|mesh-ancestor
20276251|NCT00558818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20276252|NCT00558883|Acarbose|acarbose|mesh-list
20276253|NCT00558883|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19961913|NCT01709409|Poractant alfa|poractant alfa|mesh-list
19961914|NCT01709409|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
19961915|NCT01709409|Respiratory System Agents|respiratory system agents|mesh-ancestor
19961916|NCT01709422|Midazolam|midazolam|mesh-list
20276254|NCT00558883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961917|NCT01709422|Meperidine|meperidine|mesh-list
19961918|NCT01709422|Propofol|propofol|mesh-list
19961919|NCT01709422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19961920|NCT01709422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19961921|NCT01709422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961922|NCT01709422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19961923|NCT01709422|Anesthetics, General|anesthetics, general|mesh-ancestor
19961924|NCT01709422|Anesthetics|anesthetics|mesh-ancestor
19961925|NCT01709422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19961926|NCT01709422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19961927|NCT01709422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19961928|NCT01709422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19961929|NCT01709422|GABA Modulators|gaba modulators|mesh-ancestor
19961930|NCT01709422|GABA Agents|gaba agents|mesh-ancestor
19961931|NCT01709422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20276255|NCT00558883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961932|NCT01709422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961933|NCT01709422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19961934|NCT01709422|Narcotics|narcotics|mesh-ancestor
19961935|NCT01709422|Analgesics|analgesics|mesh-ancestor
19961936|NCT01709422|Sensory System Agents|sensory system agents|mesh-ancestor
19961937|NCT01709422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961938|NCT01709474|Vitamin D|vitamin d|mesh-list
19961939|NCT01709474|Ergocalciferols|ergocalciferols|mesh-list
19961940|NCT01709474|Cholecalciferol|cholecalciferol|mesh-list
19961941|NCT01709474|Vitamins|vitamins|mesh-list
19961942|NCT01709474|Micronutrients|micronutrients|mesh-ancestor
19961943|NCT01709474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961944|NCT01709474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19961945|NCT01709474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19961946|NCT01709500|Atorvastatin|atorvastatin|mesh-list
19961947|NCT01709500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19961948|NCT01709500|Simvastatin|simvastatin|mesh-list
19961949|NCT01709500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19961950|NCT01709500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19961951|NCT01709500|Antimetabolites|antimetabolites|mesh-ancestor
19961952|NCT01709500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276256|NCT00558883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20276257|NCT00558883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961953|NCT01709500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19961954|NCT01709500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19961955|NCT01709500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961956|NCT01709513|Atorvastatin|atorvastatin|mesh-list
19961957|NCT01709513|Ezetimibe|ezetimibe|mesh-list
19961958|NCT01709513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19961959|NCT01709513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19961960|NCT01709513|Antimetabolites|antimetabolites|mesh-ancestor
19961961|NCT01709513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961962|NCT01709513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19961963|NCT01709513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19961964|NCT01709513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961965|NCT01709578|Hydroxychloroquine|hydroxychloroquine|mesh-list
19961966|NCT01709578|Sulfasalazine|sulfasalazine|mesh-list
19961967|NCT01709578|Methotrexate|methotrexate|mesh-list
19961968|NCT01709578|Leflunomide|leflunomide|mesh-list
19961969|NCT01709578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19961970|NCT01709578|Abortifacient Agents|abortifacient agents|mesh-ancestor
19961971|NCT01709578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19961972|NCT01709578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19961973|NCT01709578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19961974|NCT01709578|Antimetabolites|antimetabolites|mesh-ancestor
19961975|NCT01709578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19961976|NCT01709578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19961977|NCT01709578|Dermatologic Agents|dermatologic agents|mesh-ancestor
19961978|NCT01709578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19961979|NCT01709578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19961980|NCT01709578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19961981|NCT01709578|Immunologic Factors|immunologic factors|mesh-ancestor
19961982|NCT01709578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19961983|NCT01709578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19961984|NCT01709578|Antimalarials|antimalarials|mesh-ancestor
19961985|NCT01709578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19961986|NCT01709578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19961987|NCT01709578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19961988|NCT01709578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19961989|NCT01709578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19961990|NCT01709578|Analgesics|analgesics|mesh-ancestor
19961991|NCT01709578|Sensory System Agents|sensory system agents|mesh-ancestor
19961992|NCT01709578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19961993|NCT01709578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19961994|NCT01709578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19961995|NCT01709695|Guanfacine|guanfacine|mesh-list
19961996|NCT01709695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19961997|NCT01709695|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19961998|NCT01709695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19961999|NCT01709695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19962000|NCT01709695|Adrenergic Agents|adrenergic agents|mesh-ancestor
19962001|NCT01709695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19962002|NCT01709695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962003|NCT01709695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962004|NCT01709708|Bupivacaine|bupivacaine|mesh-list
19962005|NCT01709708|Anesthetics, Local|anesthetics, local|mesh-ancestor
19962006|NCT01709708|Anesthetics|anesthetics|mesh-ancestor
19962007|NCT01709708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19962008|NCT01709708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962009|NCT01709708|Sensory System Agents|sensory system agents|mesh-ancestor
20276258|NCT00558961|Imatinib Mesylate|imatinib mesylate|mesh-list
20276259|NCT00558961|Chlorambucil|chlorambucil|mesh-list
20276260|NCT00558961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276261|NCT00558961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20276262|NCT00558961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276263|NCT00558961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276264|NCT00558961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20276265|NCT00558961|Alkylating Agents|alkylating agents|mesh-ancestor
19962010|NCT01709708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20276266|NCT00559026|Dacarbazine|dacarbazine|mesh-list
20276267|NCT00559026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20276268|NCT00559026|Alkylating Agents|alkylating agents|mesh-ancestor
20276269|NCT00559026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276270|NCT00559026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20545391|NCT01881763|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20545392|NCT01881763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20545393|NCT01881763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545394|NCT01881919|Quercetin|quercetin|mesh-list
20545395|NCT01881919|Antioxidants|antioxidants|mesh-ancestor
20545396|NCT01881919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545397|NCT01881919|Protective Agents|protective agents|mesh-ancestor
20545398|NCT01881919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962011|NCT01709721|Hydromorphone|hydromorphone|mesh-list
20545399|NCT01881971|Calcium|calcium|mesh-list
20545400|NCT01881971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20545401|NCT01881971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545402|NCT01881997|Fentanyl|fentanyl|mesh-list
20545403|NCT01881997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20545404|NCT01881997|Narcotics|narcotics|mesh-ancestor
20545405|NCT01881997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20545406|NCT01881997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545407|NCT01881997|Analgesics|analgesics|mesh-ancestor
20545408|NCT01881997|Sensory System Agents|sensory system agents|mesh-ancestor
20545409|NCT01881997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545410|NCT01881997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20545411|NCT01881997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20545412|NCT01881997|Anesthetics, General|anesthetics, general|mesh-ancestor
20545413|NCT01881997|Anesthetics|anesthetics|mesh-ancestor
20545414|NCT01882010|Sargramostim|sargramostim|mesh-list
20545415|NCT01882010|Immunologic Factors|immunologic factors|mesh-ancestor
20545416|NCT01882010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545417|NCT01882075|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20545418|NCT01882075|Plasma Substitutes|plasma substitutes|mesh-ancestor
20545419|NCT01882075|Blood Substitutes|blood substitutes|mesh-ancestor
20545420|NCT01882127|Dexamethasone|dexamethasone|mesh-list
20545421|NCT01882127|Tretinoin|tretinoin|mesh-list
20545422|NCT01882127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19962012|NCT01709721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19962013|NCT01709721|Narcotics|narcotics|mesh-ancestor
19962014|NCT01709721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19962015|NCT01709721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962016|NCT01709721|Analgesics|analgesics|mesh-ancestor
19962017|NCT01709721|Sensory System Agents|sensory system agents|mesh-ancestor
19962018|NCT01709721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19962019|NCT01709747|Hydromorphone|hydromorphone|mesh-list
19962020|NCT01709747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19962021|NCT01709747|Narcotics|narcotics|mesh-ancestor
19962022|NCT01709747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19962023|NCT01709747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962024|NCT01709747|Analgesics|analgesics|mesh-ancestor
19962025|NCT01709747|Sensory System Agents|sensory system agents|mesh-ancestor
20276271|NCT00559052|Pancrelipase|pancrelipase|mesh-list
20545423|NCT01882127|Antiemetics|antiemetics|mesh-ancestor
20276272|NCT00559052|Pancreatin|pancreatin|mesh-list
20276273|NCT00559052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20276274|NCT00559091|Ribavirin|ribavirin|mesh-list
20276275|NCT00559091|Antimetabolites|antimetabolites|mesh-ancestor
20276276|NCT00559091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276277|NCT00559091|Antiviral Agents|antiviral agents|mesh-ancestor
20276278|NCT00559091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20276279|NCT00559169|Verapamil|verapamil|mesh-list
20276280|NCT00559169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20276281|NCT00559169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20276282|NCT00559169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20276283|NCT00559169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276284|NCT00559169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20276285|NCT00559169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276286|NCT00559169|Vasodilator Agents|vasodilator agents|mesh-ancestor
20276287|NCT00559182|Omeprazole|omeprazole|mesh-list
20276288|NCT00559182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20276289|NCT00559182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20276290|NCT00559182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20276291|NCT00559182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276292|NCT00559182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276293|NCT00559195|Epoetin Alfa|epoetin alfa|mesh-list
20276294|NCT00559195|Hematinics|hematinics|mesh-ancestor
20287761|NCT03711305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20287762|NCT03711305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287763|NCT03711305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962026|NCT01709747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19962027|NCT01709838|Deferasirox|deferasirox|mesh-list
19962028|NCT01709838|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19962029|NCT01709838|Chelating Agents|chelating agents|mesh-ancestor
19962030|NCT01709838|Sequestering Agents|sequestering agents|mesh-ancestor
19962031|NCT01709838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962032|NCT01709864|Glycopyrrolate|glycopyrrolate|mesh-list
19962033|NCT01709864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19962034|NCT01709864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19962035|NCT01709864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19962036|NCT01709864|Cholinergic Agents|cholinergic agents|mesh-ancestor
19962037|NCT01709864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19962038|NCT01709864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962039|NCT01709864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962040|NCT01709903|Fluticasone|fluticasone|mesh-list
19962041|NCT01709903|Xhance|xhance|mesh-list
19962042|NCT01709903|Glycopyrrolate|glycopyrrolate|mesh-list
19962043|NCT01709903|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19962044|NCT01709903|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19962045|NCT01709903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19962046|NCT01709903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20287764|NCT03672695|Venetoclax|venetoclax|mesh-list
20287765|NCT03672695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287766|NCT03638128|Denosumab|denosumab|mesh-list
20287767|NCT03638128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20287768|NCT03638128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288584|NCT05296577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288585|NCT05296577|Tubulin Modulators|tubulin modulators|mesh-ancestor
20288586|NCT05296577|Antimitotic Agents|antimitotic agents|mesh-ancestor
20288587|NCT05296577|Mitosis Modulators|mitosis modulators|mesh-ancestor
20288588|NCT05296577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545424|NCT01882127|Autonomic Agents|autonomic agents|mesh-ancestor
20545425|NCT01882127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545426|NCT01882127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545427|NCT01882127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20545428|NCT01882127|Glucocorticoids|glucocorticoids|mesh-ancestor
20545429|NCT01882127|Hormones|hormones|mesh-ancestor
20545430|NCT01882127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20545431|NCT01882127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20545432|NCT01882127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20545433|NCT01882127|Keratolytic Agents|keratolytic agents|mesh-ancestor
20545434|NCT01882127|Dermatologic Agents|dermatologic agents|mesh-ancestor
20545435|NCT01882179|Canrenoic Acid|canrenoic acid|mesh-list
20545436|NCT01882179|Mineralocorticoids|mineralocorticoids|mesh-list
20545437|NCT01882179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
20545438|NCT01882179|Hormones|hormones|mesh-ancestor
19962047|NCT01709903|Autonomic Agents|autonomic agents|mesh-ancestor
20288589|NCT05289869|Oxytocin|oxytocin|mesh-list
20276295|NCT00559286|Telmisartan|telmisartan|mesh-list
20276296|NCT00559286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20276297|NCT00559286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20276298|NCT00559286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20276299|NCT00559286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276300|NCT00559312|Fluticasone|fluticasone|mesh-list
20276301|NCT00559312|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20276302|NCT00559312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20276303|NCT00559312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20276304|NCT00559312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20276305|NCT00559312|Autonomic Agents|autonomic agents|mesh-ancestor
20276306|NCT00559312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20276307|NCT00559312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276308|NCT00559312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20276309|NCT00559312|Respiratory System Agents|respiratory system agents|mesh-ancestor
20276310|NCT00559312|Dermatologic Agents|dermatologic agents|mesh-ancestor
20276311|NCT00559312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20276312|NCT00559312|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20276313|NCT00559312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20276314|NCT00559312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20276315|NCT00559312|Adrenergic Agents|adrenergic agents|mesh-ancestor
20276316|NCT00559312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20276317|NCT00559312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276318|NCT00559312|Glucocorticoids|glucocorticoids|mesh-ancestor
20276319|NCT00559312|Hormones|hormones|mesh-ancestor
20276320|NCT00559312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20276321|NCT00559312|Sympathomimetics|sympathomimetics|mesh-ancestor
20276322|NCT00559338|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20276323|NCT00559338|Natriuretic Agents|natriuretic agents|mesh-ancestor
20276324|NCT00559338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276325|NCT00559351|Fluorouracil|fluorouracil|mesh-list
20276326|NCT00559351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276327|NCT00559351|Antimetabolites|antimetabolites|mesh-ancestor
20276328|NCT00559351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276329|NCT00559351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20276330|NCT00559351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20276331|NCT00559351|Immunologic Factors|immunologic factors|mesh-ancestor
20276332|NCT00559351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276333|NCT00559429|Docetaxel|docetaxel|mesh-list
20276334|NCT00559429|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
20276335|NCT00559429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276336|NCT00559429|Tubulin Modulators|tubulin modulators|mesh-ancestor
20276337|NCT00559429|Antimitotic Agents|antimitotic agents|mesh-ancestor
20276338|NCT00559429|Mitosis Modulators|mitosis modulators|mesh-ancestor
20276339|NCT00559429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276340|NCT00559429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20276341|NCT00559429|Analgesics|analgesics|mesh-ancestor
20276342|NCT00559429|Sensory System Agents|sensory system agents|mesh-ancestor
20276343|NCT00559429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20276344|NCT00559429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276345|NCT00559455|Leucovorin|leucovorin|mesh-list
20276346|NCT00559455|Fluorouracil|fluorouracil|mesh-list
20276347|NCT00559455|Oxaliplatin|oxaliplatin|mesh-list
20276348|NCT00559455|Antimetabolites|antimetabolites|mesh-ancestor
20276349|NCT00559455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276350|NCT00559455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20276351|NCT00559455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276352|NCT00559455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20276353|NCT00559455|Immunologic Factors|immunologic factors|mesh-ancestor
20276354|NCT00559455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276355|NCT00559455|Antidotes|antidotes|mesh-ancestor
20276356|NCT00559455|Protective Agents|protective agents|mesh-ancestor
20276357|NCT00559455|Vitamin B Complex|vitamin b complex|mesh-ancestor
19962048|NCT01709903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19962049|NCT01709903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962050|NCT01709903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19962051|NCT01709903|Respiratory System Agents|respiratory system agents|mesh-ancestor
19962052|NCT01709903|Dermatologic Agents|dermatologic agents|mesh-ancestor
19962053|NCT01709903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19962054|NCT01709903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19962055|NCT01709903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20276358|NCT00559455|Vitamins|vitamins|mesh-ancestor
20276359|NCT00559455|Micronutrients|micronutrients|mesh-ancestor
20276360|NCT00559481|Ketoconazole|ketoconazole|mesh-list
20276361|NCT00559481|Dexamethasone|dexamethasone|mesh-list
20276362|NCT00559481|Hydrocortisone|hydrocortisone|mesh-list
20276363|NCT00559481|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
20276364|NCT00559481|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
20276365|NCT00559481|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
20276366|NCT00559481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20276367|NCT00559481|Antiemetics|antiemetics|mesh-ancestor
20276368|NCT00559481|Autonomic Agents|autonomic agents|mesh-ancestor
20276369|NCT00559481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20276370|NCT00559481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276371|NCT00559481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20276372|NCT00559481|Glucocorticoids|glucocorticoids|mesh-ancestor
20276373|NCT00559481|Hormones|hormones|mesh-ancestor
20276374|NCT00559481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20276375|NCT00559481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19962056|NCT01709903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19962057|NCT01709903|Adrenergic Agents|adrenergic agents|mesh-ancestor
19962058|NCT01709903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20276376|NCT00559481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276377|NCT00559481|Antifungal Agents|antifungal agents|mesh-ancestor
20276378|NCT00559481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20276379|NCT00559481|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20276380|NCT00559481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20276381|NCT00559481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276382|NCT00559481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276383|NCT00559481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20276384|NCT00559481|Hormone Antagonists|hormone antagonists|mesh-ancestor
20276385|NCT00559481|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20276386|NCT00559494|Minocycline|minocycline|mesh-list
20276387|NCT00559494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20276388|NCT00559494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20276389|NCT00559546|Montelukast|montelukast|mesh-list
20276390|NCT00559546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20276391|NCT00559546|Respiratory System Agents|respiratory system agents|mesh-ancestor
20276392|NCT00559546|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20276393|NCT00559546|Hormone Antagonists|hormone antagonists|mesh-ancestor
20276394|NCT00559546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20276395|NCT00559546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276396|NCT00559546|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20276397|NCT00559546|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20276398|NCT00559546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276399|NCT00559676|Leucovorin|leucovorin|mesh-list
20276400|NCT00559676|Fluorouracil|fluorouracil|mesh-list
20276401|NCT00559676|Capecitabine|capecitabine|mesh-list
20276402|NCT00559676|Oxaliplatin|oxaliplatin|mesh-list
20276403|NCT00559676|Irinotecan|irinotecan|mesh-list
20276404|NCT00559676|Calcium|calcium|mesh-list
20276405|NCT00559676|Levoleucovorin|levoleucovorin|mesh-list
20276406|NCT00559676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20276407|NCT00559676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276408|NCT00559676|Antimetabolites|antimetabolites|mesh-ancestor
20276409|NCT00559676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276410|NCT00559676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20276411|NCT00559676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276412|NCT00559676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20276413|NCT00559676|Immunologic Factors|immunologic factors|mesh-ancestor
20276414|NCT00559676|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19962059|NCT01709903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962060|NCT01709903|Glucocorticoids|glucocorticoids|mesh-ancestor
19962061|NCT01709903|Hormones|hormones|mesh-ancestor
19962062|NCT01709903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19962063|NCT01709903|Sympathomimetics|sympathomimetics|mesh-ancestor
19962064|NCT01709903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19962065|NCT01709903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19962066|NCT01709903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19962067|NCT01709903|Cholinergic Agents|cholinergic agents|mesh-ancestor
19962068|NCT01710020|Tofacitinib|tofacitinib|mesh-list
19962069|NCT01710020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19962070|NCT01710020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962071|NCT01710020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962072|NCT01710033|Tofacitinib|tofacitinib|mesh-list
19962073|NCT01710033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19962074|NCT01710033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276415|NCT00559676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20276416|NCT00559676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276417|NCT00559676|Antidotes|antidotes|mesh-ancestor
20276418|NCT00559676|Protective Agents|protective agents|mesh-ancestor
20276419|NCT00559676|Vitamin B Complex|vitamin b complex|mesh-ancestor
20276420|NCT00559676|Vitamins|vitamins|mesh-ancestor
20276421|NCT00559676|Micronutrients|micronutrients|mesh-ancestor
20276422|NCT00559689|Budesonide|budesonide|mesh-list
20276423|NCT00559689|Beclomethasone|beclomethasone|mesh-list
20276424|NCT00559689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20276425|NCT00559689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20276426|NCT00559689|Autonomic Agents|autonomic agents|mesh-ancestor
20276427|NCT00559689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20276428|NCT00559689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276429|NCT00559689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20276430|NCT00559689|Respiratory System Agents|respiratory system agents|mesh-ancestor
20276431|NCT00559689|Glucocorticoids|glucocorticoids|mesh-ancestor
20276432|NCT00559689|Hormones|hormones|mesh-ancestor
20276433|NCT00559689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20276434|NCT00559702|Natalizumab|natalizumab|mesh-list
20276435|NCT00559702|Immunologic Factors|immunologic factors|mesh-ancestor
20276436|NCT00559702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276437|NCT00559715|Bevacizumab|bevacizumab|mesh-list
20276438|NCT00559715|Ranibizumab|ranibizumab|mesh-list
20276439|NCT00559715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20276440|NCT00559715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276441|NCT00559715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20276442|NCT00559715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20276443|NCT00559715|Growth Substances|growth substances|mesh-ancestor
20276444|NCT00559715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276445|NCT00559715|Growth Inhibitors|growth inhibitors|mesh-ancestor
20276446|NCT00559741|Leucovorin|leucovorin|mesh-list
20276447|NCT00559741|Fluorouracil|fluorouracil|mesh-list
20276448|NCT00559741|Irinotecan|irinotecan|mesh-list
20276449|NCT00559741|Cetuximab|cetuximab|mesh-list
20276450|NCT00559741|Calcium|calcium|mesh-list
20276451|NCT00559741|Levoleucovorin|levoleucovorin|mesh-list
20276452|NCT00559741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20276453|NCT00559741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276454|NCT00559741|Antimetabolites|antimetabolites|mesh-ancestor
20276455|NCT00559741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276456|NCT00559741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20276457|NCT00559741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276458|NCT00559741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20276459|NCT00559741|Immunologic Factors|immunologic factors|mesh-ancestor
20276460|NCT00559741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20276461|NCT00559741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20276462|NCT00559741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276463|NCT00559741|Antidotes|antidotes|mesh-ancestor
20276464|NCT00559741|Protective Agents|protective agents|mesh-ancestor
20276465|NCT00559741|Vitamin B Complex|vitamin b complex|mesh-ancestor
20276466|NCT00559741|Vitamins|vitamins|mesh-ancestor
19962075|NCT01710033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962076|NCT01710046|Tofacitinib|tofacitinib|mesh-list
19962077|NCT01710046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19962078|NCT01710046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962079|NCT01710046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276467|NCT00559741|Micronutrients|micronutrients|mesh-ancestor
20276468|NCT00559741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20276469|NCT00559858|Pyridoxine|pyridoxine|mesh-list
20276470|NCT00559858|Vitamin B 6|vitamin b 6|mesh-list
20276471|NCT00559858|Vitamin B Complex|vitamin b complex|mesh-ancestor
20276472|NCT00559858|Vitamins|vitamins|mesh-ancestor
20276473|NCT00559858|Micronutrients|micronutrients|mesh-ancestor
20276474|NCT00559858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276475|NCT00559975|Vaccines|vaccines|mesh-list
20276476|NCT00559975|Immunologic Factors|immunologic factors|mesh-ancestor
20276477|NCT00559975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276478|NCT00560079|Allopurinol|allopurinol|mesh-list
20276479|NCT00560079|Dipyridamole|dipyridamole|mesh-list
20276480|NCT00560079|Antimetabolites|antimetabolites|mesh-ancestor
20276481|NCT00560079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276482|NCT00560079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962080|NCT01710137|Varenicline|varenicline|mesh-list
20276483|NCT00560079|Gout Suppressants|gout suppressants|mesh-ancestor
20276484|NCT00560079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20276485|NCT00560079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20276486|NCT00560079|Antioxidants|antioxidants|mesh-ancestor
20276487|NCT00560079|Protective Agents|protective agents|mesh-ancestor
20276488|NCT00560079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276489|NCT00560079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20276490|NCT00560079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20276491|NCT00560079|Vasodilator Agents|vasodilator agents|mesh-ancestor
20276492|NCT00560092|Magnesium Sulfate|magnesium sulfate|mesh-list
20545439|NCT01882179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20545440|NCT01882179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545441|NCT01882179|Hormone Antagonists|hormone antagonists|mesh-ancestor
20545442|NCT01882179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20545443|NCT01882179|Diuretics|diuretics|mesh-ancestor
20545444|NCT01882179|Natriuretic Agents|natriuretic agents|mesh-ancestor
20545445|NCT01882296|Pantoprazole|pantoprazole|mesh-list
20545446|NCT01882296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20545447|NCT01882296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20545448|NCT01882296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20545449|NCT01882296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545450|NCT01882296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545451|NCT01882322|Tacrolimus|tacrolimus|mesh-list
20545452|NCT01882322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20545453|NCT01882322|Immunologic Factors|immunologic factors|mesh-ancestor
20545454|NCT01882322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545455|NCT01882322|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20545456|NCT01882322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545457|NCT01882322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545458|NCT01882361|Naltrexone|naltrexone|mesh-list
20545459|NCT01882361|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20545460|NCT01882361|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20545461|NCT01882361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545462|NCT01882361|Sensory System Agents|sensory system agents|mesh-ancestor
20545463|NCT01882361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545464|NCT01882374|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
20545465|NCT01882374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20545466|NCT01882374|Vasodilator Agents|vasodilator agents|mesh-ancestor
20545467|NCT01882387|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
20545468|NCT01882387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20545469|NCT01882387|Vasodilator Agents|vasodilator agents|mesh-ancestor
20545470|NCT01882400|Alendronate|alendronate|mesh-list
20545471|NCT01882400|Risedronic Acid|risedronic acid|mesh-list
19962081|NCT01710137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19962082|NCT01710137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19962083|NCT01710137|Cholinergic Agents|cholinergic agents|mesh-ancestor
19962084|NCT01710137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19962085|NCT01710137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545472|NCT01882400|Diphosphonates|diphosphonates|mesh-list
20545473|NCT01882400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20545474|NCT01882400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545475|NCT01882400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20545476|NCT01882400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20545477|NCT01882400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545478|NCT01882400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20545479|NCT01882530|Acetaminophen|acetaminophen|mesh-list
20545480|NCT01882530|Ketoprofen|ketoprofen|mesh-list
20545481|NCT01882530|Morphine|morphine|mesh-list
20545482|NCT01882530|Nefopam|nefopam|mesh-list
20545483|NCT01882530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20545484|NCT01882530|Narcotics|narcotics|mesh-ancestor
20545485|NCT01882530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20545486|NCT01882530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545487|NCT01882530|Analgesics|analgesics|mesh-ancestor
20545488|NCT01882530|Sensory System Agents|sensory system agents|mesh-ancestor
20545489|NCT01882530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545490|NCT01882530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20545491|NCT01882530|Antipyretics|antipyretics|mesh-ancestor
20545492|NCT01882530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20545493|NCT01882530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20545494|NCT01882530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20545495|NCT01882530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19962086|NCT01710137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962087|NCT01710254|Regadenoson|regadenoson|mesh-list
20276493|NCT00560092|Analgesics|analgesics|mesh-ancestor
20276494|NCT00560092|Sensory System Agents|sensory system agents|mesh-ancestor
20276495|NCT00560092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20276496|NCT00560092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276497|NCT00560092|Anesthetics|anesthetics|mesh-ancestor
20545496|NCT01882530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276498|NCT00560092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19962088|NCT01710254|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19962089|NCT01710254|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19962090|NCT01710254|Purinergic Agonists|purinergic agonists|mesh-ancestor
19962091|NCT01710254|Purinergic Agents|purinergic agents|mesh-ancestor
19962092|NCT01710254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19962093|NCT01710254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962094|NCT01710254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962095|NCT01710332|Aflibercept|aflibercept|mesh-list
19962096|NCT01710332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19962097|NCT01710332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19962098|NCT01710332|Growth Substances|growth substances|mesh-ancestor
19962099|NCT01710332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962100|NCT01710332|Growth Inhibitors|growth inhibitors|mesh-ancestor
19962101|NCT01710332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962102|NCT01710345|Sufentanil|sufentanil|mesh-list
19962103|NCT01710345|Dsuvia|dsuvia|mesh-list
19962104|NCT01710345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20276499|NCT00560092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20276500|NCT00560092|Anticonvulsants|anticonvulsants|mesh-ancestor
20276501|NCT00560092|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20545497|NCT01882530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545498|NCT01882556|Botulinum Toxins|botulinum toxins|mesh-list
20545499|NCT01882556|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20545500|NCT01882556|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20545501|NCT01882556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20545502|NCT01882556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20545503|NCT01882556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545504|NCT01882556|Cholinergic Agents|cholinergic agents|mesh-ancestor
20545505|NCT01882556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20545506|NCT01882556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545507|NCT01882556|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20545508|NCT01882556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545509|NCT01882660|Decitabine|decitabine|mesh-list
20545510|NCT01882660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20545511|NCT01882660|Antimetabolites|antimetabolites|mesh-ancestor
20545512|NCT01882660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545513|NCT01882660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20545514|NCT01882660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554302|NCT01934777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554303|NCT01934777|Protective Agents|protective agents|mesh-ancestor
20554304|NCT01934777|Lipotropic Agents|lipotropic agents|mesh-ancestor
20554305|NCT01934777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20554306|NCT01934777|Antimetabolites|antimetabolites|mesh-ancestor
20554307|NCT01934777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20554308|NCT01934777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20554309|NCT01934777|Nootropic Agents|nootropic agents|mesh-ancestor
20554310|NCT01934816|Liraglutide|liraglutide|mesh-list
20554311|NCT01934816|Exenatide|exenatide|mesh-list
20554312|NCT01934816|Glucagon|glucagon|mesh-list
20554313|NCT01934816|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20554314|NCT01934816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20554315|NCT01934816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554316|NCT01934816|Incretins|incretins|mesh-ancestor
20554317|NCT01934816|Hormones|hormones|mesh-ancestor
20554318|NCT01934816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20554319|NCT01934816|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20554320|NCT01934816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20554321|NCT01934829|Sorafenib|sorafenib|mesh-list
20554322|NCT01934829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554323|NCT01934829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20554324|NCT01934829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554325|NCT01934829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962105|NCT01710345|Narcotics|narcotics|mesh-ancestor
19962106|NCT01710345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19962107|NCT01710345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962108|NCT01710345|Analgesics|analgesics|mesh-ancestor
19962109|NCT01710345|Sensory System Agents|sensory system agents|mesh-ancestor
20276502|NCT00560092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20276503|NCT00560092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276504|NCT00560092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20276505|NCT00560092|Tocolytic Agents|tocolytic agents|mesh-ancestor
20276506|NCT00560092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20276507|NCT00560118|Fotemustine|fotemustine|mesh-list
20276508|NCT00560118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276509|NCT00560144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20276510|NCT00560144|Immunologic Factors|immunologic factors|mesh-ancestor
20276511|NCT00560144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276512|NCT00560170|Simvastatin|simvastatin|mesh-list
20276513|NCT00560170|Ezetimibe|ezetimibe|mesh-list
20276514|NCT00560170|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
20276515|NCT00560170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20276516|NCT00560170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20276517|NCT00560170|Antimetabolites|antimetabolites|mesh-ancestor
20276518|NCT00560170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276519|NCT00560170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20276520|NCT00560170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20276521|NCT00560170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276522|NCT00560209|Landiolol|landiolol|mesh-list
20276523|NCT00560209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20276524|NCT00560209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20276525|NCT00560209|Adrenergic Agents|adrenergic agents|mesh-ancestor
20276526|NCT00560209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20276527|NCT00560209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276528|NCT00560209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276529|NCT00560209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20276530|NCT00560222|Lactoferrin|lactoferrin|mesh-list
20276531|NCT00560222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20276532|NCT00560274|Ribavirin|ribavirin|mesh-list
19962110|NCT01710345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19962111|NCT01710345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19962112|NCT01710345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20276533|NCT00560274|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20276534|NCT00560274|Antimetabolites|antimetabolites|mesh-ancestor
20276535|NCT00560274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276536|NCT00560274|Antiviral Agents|antiviral agents|mesh-ancestor
20276537|NCT00560274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20276538|NCT00560300|Vitamin D|vitamin d|mesh-list
20276539|NCT00560300|Cholecalciferol|cholecalciferol|mesh-list
20276540|NCT00560300|Calcitriol|calcitriol|mesh-list
20276541|NCT00560300|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
20276542|NCT00560300|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
20276543|NCT00560300|Calcium Carbonate|calcium carbonate|mesh-list
20276544|NCT00560300|Calcium|calcium|mesh-list
20276545|NCT00560300|Sevelamer|sevelamer|mesh-list
20276546|NCT00560300|Vitamins|vitamins|mesh-ancestor
20276547|NCT00560300|Micronutrients|micronutrients|mesh-ancestor
20276548|NCT00560300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276549|NCT00560300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20276550|NCT00560300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20276551|NCT00560300|Antacids|antacids|mesh-ancestor
20276552|NCT00560300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276553|NCT00560300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20276554|NCT00560300|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20276555|NCT00560300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20276556|NCT00560300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20276557|NCT00560300|Chelating Agents|chelating agents|mesh-ancestor
20276558|NCT00560300|Sequestering Agents|sequestering agents|mesh-ancestor
20276559|NCT00560326|Tacrolimus|tacrolimus|mesh-list
19962113|NCT01710345|Anesthetics, General|anesthetics, general|mesh-ancestor
19962114|NCT01710345|Anesthetics|anesthetics|mesh-ancestor
19962115|NCT01710358|Adalimumab|adalimumab|mesh-list
20276560|NCT00560326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20276561|NCT00560326|Immunologic Factors|immunologic factors|mesh-ancestor
20276562|NCT00560326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276563|NCT00560326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20276564|NCT00560326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276565|NCT00560326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276566|NCT00560378|Tacrolimus|tacrolimus|mesh-list
20276567|NCT00560378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20276568|NCT00560378|Immunologic Factors|immunologic factors|mesh-ancestor
20276569|NCT00560378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962116|NCT01710358|Methotrexate|methotrexate|mesh-list
19962117|NCT01710358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19962118|NCT01710358|Abortifacient Agents|abortifacient agents|mesh-ancestor
19962119|NCT01710358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19962120|NCT01710358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276570|NCT00560378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20276571|NCT00560378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276572|NCT00560378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276573|NCT00560430|Telmisartan|telmisartan|mesh-list
20276574|NCT00560430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20276575|NCT00560430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20276576|NCT00560430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20276577|NCT00560430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276578|NCT00560443|Ketorolac|ketorolac|mesh-list
20276579|NCT00560443|Tramadol|tramadol|mesh-list
20276580|NCT00560443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20276581|NCT00560443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20276582|NCT00560443|Analgesics|analgesics|mesh-ancestor
20276583|NCT00560443|Sensory System Agents|sensory system agents|mesh-ancestor
20276584|NCT00560443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20276585|NCT00560443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276586|NCT00560443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20276587|NCT00560443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20276588|NCT00560443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20276589|NCT00560443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276590|NCT00560443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276591|NCT00560443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20276592|NCT00560443|Narcotics|narcotics|mesh-ancestor
20276593|NCT00560443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20276594|NCT00560495|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
20276595|NCT00560495|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
20276596|NCT00560495|Chelating Agents|chelating agents|mesh-ancestor
20276597|NCT00560495|Sequestering Agents|sequestering agents|mesh-ancestor
20276598|NCT00560495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276599|NCT00560495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276600|NCT00560495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20276601|NCT00560495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20276602|NCT00560495|Growth Substances|growth substances|mesh-ancestor
20276603|NCT00560495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276604|NCT00560495|Growth Inhibitors|growth inhibitors|mesh-ancestor
20276605|NCT00560495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276606|NCT00560495|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20276607|NCT00560547|Epoetin Alfa|epoetin alfa|mesh-list
20276608|NCT00560547|Hematinics|hematinics|mesh-ancestor
20276609|NCT00560586|Budesonide|budesonide|mesh-list
20276610|NCT00560586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20276611|NCT00560586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20276612|NCT00560586|Autonomic Agents|autonomic agents|mesh-ancestor
20545515|NCT01882920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20545516|NCT01883011|Piracetam|piracetam|mesh-list
20545517|NCT01883011|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20545518|NCT01883011|Protective Agents|protective agents|mesh-ancestor
20545519|NCT01883011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545520|NCT01883011|Nootropic Agents|nootropic agents|mesh-ancestor
20545521|NCT01883024|Insulin|insulin|mesh-list
20545522|NCT01883024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20545523|NCT01883024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962121|NCT01710358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19962122|NCT01710358|Antimetabolites|antimetabolites|mesh-ancestor
19962123|NCT01710358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962124|NCT01710358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962125|NCT01710358|Dermatologic Agents|dermatologic agents|mesh-ancestor
19962126|NCT01710358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962127|NCT01710358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20276613|NCT00560586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287769|NCT03608657|Apremilast|apremilast|mesh-list
20287770|NCT03608657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20287771|NCT03608657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20287772|NCT03608657|Analgesics|analgesics|mesh-ancestor
20287773|NCT03608657|Sensory System Agents|sensory system agents|mesh-ancestor
20287774|NCT03608657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287775|NCT03608657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287776|NCT03608657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20287777|NCT03608657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20287778|NCT03608657|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20287779|NCT03608657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20287780|NCT03608657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287781|NCT03608657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287782|NCT03576885|Nitric Oxide|nitric oxide|mesh-list
20287783|NCT03576885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20276614|NCT00560586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276615|NCT00560586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20276616|NCT00560586|Respiratory System Agents|respiratory system agents|mesh-ancestor
20276617|NCT00560586|Glucocorticoids|glucocorticoids|mesh-ancestor
20545524|NCT01883102|Capsaicin|capsaicin|mesh-list
20545525|NCT01883102|Antipruritics|antipruritics|mesh-ancestor
20545526|NCT01883102|Dermatologic Agents|dermatologic agents|mesh-ancestor
20545527|NCT01883102|Sensory System Agents|sensory system agents|mesh-ancestor
20545528|NCT01883102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545529|NCT01883102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545530|NCT01883167|Febuxostat|febuxostat|mesh-list
20545531|NCT01883167|Verinurad|verinurad|mesh-list
20545532|NCT01883167|Gout Suppressants|gout suppressants|mesh-ancestor
20545533|NCT01883167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20545534|NCT01883193|Micronutrients|micronutrients|mesh-list
20545535|NCT01883193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545536|NCT01883232|Lidocaine|lidocaine|mesh-list
20545537|NCT01883232|Epinephrine|epinephrine|mesh-list
20545538|NCT01883232|Anesthetics, Local|anesthetics, local|mesh-ancestor
20545539|NCT01883232|Anesthetics|anesthetics|mesh-ancestor
20545540|NCT01883232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20545541|NCT01883232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545542|NCT01883232|Sensory System Agents|sensory system agents|mesh-ancestor
20545543|NCT01883232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545544|NCT01883232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20545545|NCT01883232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20545546|NCT01883232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20545547|NCT01883232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20545548|NCT01883232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545549|NCT01883232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20545550|NCT01883232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20545551|NCT01883232|Adrenergic Agents|adrenergic agents|mesh-ancestor
20545552|NCT01883232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19962128|NCT01710358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19962129|NCT01710358|Immunologic Factors|immunologic factors|mesh-ancestor
19962130|NCT01710358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20545553|NCT01883232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20545554|NCT01883232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20545555|NCT01883232|Autonomic Agents|autonomic agents|mesh-ancestor
20545556|NCT01883232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20545557|NCT01883232|Respiratory System Agents|respiratory system agents|mesh-ancestor
20545558|NCT01883232|Mydriatics|mydriatics|mesh-ancestor
20545559|NCT01883232|Sympathomimetics|sympathomimetics|mesh-ancestor
20545560|NCT01883232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20545561|NCT01883297|Aldesleukin|aldesleukin|mesh-list
20545562|NCT01883297|Cyclophosphamide|cyclophosphamide|mesh-list
20545563|NCT01883297|Interleukin-2|interleukin-2|mesh-list
20545564|NCT01883297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20545565|NCT01883297|Immunologic Factors|immunologic factors|mesh-ancestor
19962131|NCT01710358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19962132|NCT01710358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19974915|NCT01843751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974916|NCT01843751|Analgesics|analgesics|mesh-ancestor
19974917|NCT01843751|Sensory System Agents|sensory system agents|mesh-ancestor
19974918|NCT01843751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19974919|NCT01843751|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19974920|NCT01843920|Trimethoprim|trimethoprim|mesh-list
19974921|NCT01843920|Polymyxins|polymyxins|mesh-list
19974922|NCT01843920|Polymyxin B|polymyxin b|mesh-list
19974923|NCT01843920|Prednisolone|prednisolone|mesh-list
19974924|NCT01843920|Timolol|timolol|mesh-list
19974925|NCT01843920|Dorzolamide|dorzolamide|mesh-list
19974926|NCT01843920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19974927|NCT01843920|Glucocorticoids|glucocorticoids|mesh-ancestor
19974928|NCT01843920|Hormones|hormones|mesh-ancestor
19974929|NCT01843920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19974930|NCT01843920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974931|NCT01843920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19974932|NCT01843920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276618|NCT00560586|Hormones|hormones|mesh-ancestor
20276619|NCT00560586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20276620|NCT00560599|Chlorhexidine|chlorhexidine|mesh-list
20276621|NCT00560599|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20276622|NCT00560599|Mupirocin|mupirocin|mesh-list
20276623|NCT00560599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20276624|NCT00560599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20276625|NCT00560599|Disinfectants|disinfectants|mesh-ancestor
20276626|NCT00560599|Dermatologic Agents|dermatologic agents|mesh-ancestor
20276627|NCT00560599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20276628|NCT00560599|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20276629|NCT00560599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276630|NCT00560599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276631|NCT00560638|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20276632|NCT00560638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20276633|NCT00560690|Metformin|metformin|mesh-list
20276634|NCT00560690|Interferons|interferons|mesh-list
20276635|NCT00560690|Ribavirin|ribavirin|mesh-list
20276636|NCT00560690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20276637|NCT00560690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276638|NCT00560690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276639|NCT00560690|Antiviral Agents|antiviral agents|mesh-ancestor
20276640|NCT00560690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20276641|NCT00560690|Antimetabolites|antimetabolites|mesh-ancestor
20276642|NCT00560690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276643|NCT00560820|Deferasirox|deferasirox|mesh-list
20276644|NCT00560820|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20276645|NCT00560820|Chelating Agents|chelating agents|mesh-ancestor
20276646|NCT00560820|Sequestering Agents|sequestering agents|mesh-ancestor
20276647|NCT00560820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276648|NCT00560898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20276649|NCT00560924|Estradiol|estradiol|mesh-list
20276650|NCT00560924|Estrogens|estrogens|mesh-ancestor
20276651|NCT00560924|Hormones|hormones|mesh-ancestor
20276652|NCT00560924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20276653|NCT00560924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276654|NCT00560963|Everolimus|everolimus|mesh-list
20276655|NCT00560963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276656|NCT00560963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20276657|NCT00560963|Immunologic Factors|immunologic factors|mesh-ancestor
20276658|NCT00560963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276659|NCT00560976|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20276660|NCT00560976|Ferric gluconate|ferric gluconate|mesh-list
20276661|NCT00560976|Hematinics|hematinics|mesh-ancestor
20276662|NCT00561028|Antibodies|antibodies|mesh-list
20276663|NCT00561028|Immunologic Factors|immunologic factors|mesh-ancestor
20276664|NCT00561028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276665|NCT00561054|Cetuximab|cetuximab|mesh-list
20276666|NCT00561054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20276667|NCT00561054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276668|NCT00561067|Methylprednisolone|methylprednisolone|mesh-list
20276669|NCT00561067|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20276670|NCT00561067|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20276671|NCT00561067|Prednisolone|prednisolone|mesh-list
20276672|NCT00561067|Prednisolone acetate|prednisolone acetate|mesh-list
20276673|NCT00561067|Epoetin Alfa|epoetin alfa|mesh-list
20276674|NCT00561067|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20276675|NCT00561067|Prednisolone phosphate|prednisolone phosphate|mesh-list
20276676|NCT00561067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20276677|NCT00561067|Antiemetics|antiemetics|mesh-ancestor
20276678|NCT00561067|Autonomic Agents|autonomic agents|mesh-ancestor
20276679|NCT00561067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20276680|NCT00561067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276681|NCT00561067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20276682|NCT00561067|Glucocorticoids|glucocorticoids|mesh-ancestor
20276683|NCT00561067|Hormones|hormones|mesh-ancestor
20276684|NCT00561067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20276685|NCT00561067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20276686|NCT00561067|Protective Agents|protective agents|mesh-ancestor
20276687|NCT00561067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20276688|NCT00561067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276689|NCT00561067|Hematinics|hematinics|mesh-ancestor
20276690|NCT00561093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20276691|NCT00561093|Pentoxifylline|pentoxifylline|mesh-list
20276692|NCT00561093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20276693|NCT00561093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276694|NCT00561093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276695|NCT00561093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20276696|NCT00561093|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20276697|NCT00561093|Protective Agents|protective agents|mesh-ancestor
20276698|NCT00561093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545566|NCT01883297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276699|NCT00561093|Vasodilator Agents|vasodilator agents|mesh-ancestor
20276700|NCT00561093|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20276701|NCT00561093|Antioxidants|antioxidants|mesh-ancestor
20276702|NCT00561106|Valacyclovir|valacyclovir|mesh-list
20276703|NCT00561106|Prednisone|prednisone|mesh-list
20276704|NCT00561106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20276705|NCT00561106|Glucocorticoids|glucocorticoids|mesh-ancestor
20276706|NCT00561106|Hormones|hormones|mesh-ancestor
20276707|NCT00561106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20276708|NCT00561106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276709|NCT00561106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20276710|NCT00561106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276711|NCT00561106|Antiviral Agents|antiviral agents|mesh-ancestor
20276712|NCT00561106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20287784|NCT03576885|Autonomic Agents|autonomic agents|mesh-ancestor
20287785|NCT03576885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287786|NCT03576885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287787|NCT03576885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20287788|NCT03576885|Respiratory System Agents|respiratory system agents|mesh-ancestor
20287789|NCT03576885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20287790|NCT03576885|Antioxidants|antioxidants|mesh-ancestor
20287791|NCT03576885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287792|NCT03576885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20287793|NCT03576885|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20287794|NCT03576885|Vasodilator Agents|vasodilator agents|mesh-ancestor
19962133|NCT01710501|Interferons|interferons|mesh-list
19962134|NCT01710501|Ribavirin|ribavirin|mesh-list
19962135|NCT01710501|Interferon-alpha|interferon-alpha|mesh-list
19962136|NCT01710501|Interferon alpha-2|interferon alpha-2|mesh-list
19962137|NCT01710501|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19962138|NCT01710501|Grazoprevir|grazoprevir|mesh-list
19962139|NCT01710501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962140|NCT01710501|Antiviral Agents|antiviral agents|mesh-ancestor
19962141|NCT01710501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19962142|NCT01710501|Antimetabolites|antimetabolites|mesh-ancestor
19962143|NCT01710501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962144|NCT01710501|Immunologic Factors|immunologic factors|mesh-ancestor
19962145|NCT01710501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287795|NCT03576885|Gasotransmitters|gasotransmitters|mesh-ancestor
20287796|NCT03576885|Protective Agents|protective agents|mesh-ancestor
20287797|NCT03573648|Palbociclib|palbociclib|mesh-list
20287798|NCT03573648|Avelumab|avelumab|mesh-list
20287799|NCT03573648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287800|NCT03573648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20287801|NCT03573648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287802|NCT03573648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287803|NCT03573648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20287804|NCT03570814|Azithromycin|azithromycin|mesh-list
20287805|NCT03570814|Ivermectin|ivermectin|mesh-list
20287806|NCT03570814|Albendazole|albendazole|mesh-list
20287807|NCT03570814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20287808|NCT03570814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20287809|NCT03570814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20287810|NCT03570814|Anthelmintics|anthelmintics|mesh-ancestor
20287811|NCT03570814|Anticestodal Agents|anticestodal agents|mesh-ancestor
20287812|NCT03570814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20287813|NCT03570814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20287814|NCT03570814|Tubulin Modulators|tubulin modulators|mesh-ancestor
20287815|NCT03570814|Antimitotic Agents|antimitotic agents|mesh-ancestor
20287816|NCT03570814|Mitosis Modulators|mitosis modulators|mesh-ancestor
20287817|NCT03570814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287818|NCT03570814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287819|NCT03561376|Petrolatum|petrolatum|mesh-list
20287820|NCT03561376|Zinc Oxide|zinc oxide|mesh-list
20287821|NCT03561376|Emollients|emollients|mesh-ancestor
20287822|NCT03561376|Dermatologic Agents|dermatologic agents|mesh-ancestor
20287823|NCT03561376|Sunscreening Agents|sunscreening agents|mesh-ancestor
20545567|NCT01883297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19962146|NCT01710527|Metformin|metformin|mesh-list
19962147|NCT01710527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20287824|NCT03561376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20287825|NCT03561376|Protective Agents|protective agents|mesh-ancestor
20545568|NCT01883297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20545569|NCT01883297|Alkylating Agents|alkylating agents|mesh-ancestor
20545570|NCT01883297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545571|NCT01883297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20545572|NCT01883297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20545573|NCT01883297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20545574|NCT01883297|Analgesics|analgesics|mesh-ancestor
20545575|NCT01883297|Sensory System Agents|sensory system agents|mesh-ancestor
20276713|NCT00561119|Gemcitabine|gemcitabine|mesh-list
20276714|NCT00561119|Paclitaxel|paclitaxel|mesh-list
20276715|NCT00561119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20276716|NCT00561119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276717|NCT00561119|Tubulin Modulators|tubulin modulators|mesh-ancestor
20276718|NCT00561119|Antimitotic Agents|antimitotic agents|mesh-ancestor
20276719|NCT00561119|Mitosis Modulators|mitosis modulators|mesh-ancestor
20276720|NCT00561119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276721|NCT00561119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20276722|NCT00561119|Antimetabolites|antimetabolites|mesh-ancestor
20276723|NCT00561119|Antiviral Agents|antiviral agents|mesh-ancestor
20276724|NCT00561119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20276725|NCT00561119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276726|NCT00561119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20276727|NCT00561119|Immunologic Factors|immunologic factors|mesh-ancestor
20276728|NCT00561119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276729|NCT00561132|Vanadyl sulfate|vanadyl sulfate|mesh-list
20276730|NCT00561132|Magnesium Oxide|magnesium oxide|mesh-list
20276731|NCT00561132|Antacids|antacids|mesh-ancestor
20276732|NCT00561132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276733|NCT00561132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20276734|NCT00561132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20276735|NCT00561132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276736|NCT00561184|Vaccines|vaccines|mesh-list
20276737|NCT00561184|Immunologic Factors|immunologic factors|mesh-ancestor
20276738|NCT00561184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276739|NCT00561197|Gossypol acetic acid|gossypol acetic acid|mesh-list
20276740|NCT00561197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20276741|NCT00561197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276742|NCT00561197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20276743|NCT00561197|Contraceptive Agents|contraceptive agents|mesh-ancestor
20276744|NCT00561197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20276745|NCT00561197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276746|NCT00561197|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
20276747|NCT00561197|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
20276748|NCT00561197|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20276749|NCT00561223|Iloprost|iloprost|mesh-list
20276750|NCT00561223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20276751|NCT00561223|Vasodilator Agents|vasodilator agents|mesh-ancestor
20276752|NCT00561288|Acetaminophen|acetaminophen|mesh-list
20276753|NCT00561288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20276754|NCT00561288|Analgesics|analgesics|mesh-ancestor
20276755|NCT00561288|Sensory System Agents|sensory system agents|mesh-ancestor
20276756|NCT00561288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20276757|NCT00561288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276758|NCT00561288|Antipyretics|antipyretics|mesh-ancestor
20276759|NCT00561327|Losartan|losartan|mesh-list
20276760|NCT00561327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20276761|NCT00561327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20276762|NCT00561327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20276763|NCT00561327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20276764|NCT00561327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276765|NCT00561379|Rituximab|rituximab|mesh-list
20276766|NCT00561379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20276767|NCT00561379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276768|NCT00561379|Immunologic Factors|immunologic factors|mesh-ancestor
20276769|NCT00561379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276770|NCT00561379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20276771|NCT00561496|Tenofovir|tenofovir|mesh-list
20276772|NCT00561496|Antiviral Agents|antiviral agents|mesh-ancestor
20276773|NCT00561496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20276774|NCT00561496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20276775|NCT00561496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20276776|NCT00561496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276777|NCT00561496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276778|NCT00561496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20276779|NCT00561496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20276780|NCT00561509|Antidepressive Agents|antidepressive agents|mesh-list
20276781|NCT00561509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20276782|NCT00561522|Capecitabine|capecitabine|mesh-list
20276783|NCT00561522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20276784|NCT00561522|Antimetabolites|antimetabolites|mesh-ancestor
20276785|NCT00561522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276786|NCT00561522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276787|NCT00561587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20276788|NCT00561587|Antidepressive Agents|antidepressive agents|mesh-ancestor
20276789|NCT00561587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20276790|NCT00561587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20276791|NCT00561587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20276792|NCT00561587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20276793|NCT00561587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276794|NCT00561613|Spermatocidal Agents|spermatocidal agents|mesh-list
20276795|NCT00561613|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
20276796|NCT00561613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276797|NCT00561613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20276798|NCT00561613|Contraceptive Agents|contraceptive agents|mesh-ancestor
20276799|NCT00561613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20276800|NCT00561691|Nimotuzumab|nimotuzumab|mesh-list
20276801|NCT00561691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20276802|NCT00561691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276803|NCT00561704|Losartan|losartan|mesh-list
20276804|NCT00561704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20276805|NCT00561704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20276806|NCT00561704|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20276807|NCT00561704|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20276808|NCT00561704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276809|NCT00561717|Cetirizine|cetirizine|mesh-list
20276810|NCT00561717|Loratadine|loratadine|mesh-list
20276811|NCT00561717|Azelastine|azelastine|mesh-list
20276812|NCT00561717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20276813|NCT00561717|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20276814|NCT00561717|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20276815|NCT00561717|Histamine Antagonists|histamine antagonists|mesh-ancestor
20276816|NCT00561717|Histamine Agents|histamine agents|mesh-ancestor
20276817|NCT00561717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450345|NCT03429101|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20276818|NCT00561717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276819|NCT00561717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276820|NCT00561717|Antipruritics|antipruritics|mesh-ancestor
20276821|NCT00561717|Dermatologic Agents|dermatologic agents|mesh-ancestor
20276822|NCT00561717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20276823|NCT00561717|Autonomic Agents|autonomic agents|mesh-ancestor
20276824|NCT00561717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20276825|NCT00561717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20276826|NCT00561717|Respiratory System Agents|respiratory system agents|mesh-ancestor
20276827|NCT00561717|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20276828|NCT00561717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276829|NCT00561756|Vaccines|vaccines|mesh-list
20276830|NCT00561756|Immunologic Factors|immunologic factors|mesh-ancestor
20276831|NCT00561756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276832|NCT00561886|Formoterol Fumarate|formoterol fumarate|mesh-list
20276833|NCT00561886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20276834|NCT00561886|Autonomic Agents|autonomic agents|mesh-ancestor
20276835|NCT00561886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20276836|NCT00561886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276837|NCT00561886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20276838|NCT00561886|Respiratory System Agents|respiratory system agents|mesh-ancestor
20276839|NCT00561886|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20276840|NCT00561886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20276841|NCT00561886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19450346|NCT03429101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19450347|NCT03429101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450348|NCT03429101|Tubulin Modulators|tubulin modulators|mesh-ancestor
19450349|NCT03429101|Antimitotic Agents|antimitotic agents|mesh-ancestor
19450350|NCT03429101|Mitosis Modulators|mitosis modulators|mesh-ancestor
19450351|NCT03429101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450352|NCT03429075|Citalopram|citalopram|mesh-list
19450353|NCT03429075|Psilocybin|psilocybin|mesh-list
20276842|NCT00561886|Adrenergic Agents|adrenergic agents|mesh-ancestor
20276843|NCT00561886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20276844|NCT00561886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276845|NCT00561899|Piperaquine|piperaquine|mesh-list
20276846|NCT00561899|Amodiaquine|amodiaquine|mesh-list
20276847|NCT00561899|Antimalarials|antimalarials|mesh-ancestor
20276848|NCT00561899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20276849|NCT00561899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20545576|NCT01883297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450354|NCT03429075|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20276850|NCT00561899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20276851|NCT00561964|Irbesartan|irbesartan|mesh-list
20276852|NCT00561964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20276853|NCT00561964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20276854|NCT00561964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20276855|NCT00561964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276856|NCT00561990|Nimotuzumab|nimotuzumab|mesh-list
20276857|NCT00561990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20276858|NCT00561990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276859|NCT00562055|Reboxetine|reboxetine|mesh-list
19962148|NCT01710527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276860|NCT00562055|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20276861|NCT00562055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20276862|NCT00562055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20276863|NCT00562055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20276864|NCT00562055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276865|NCT00562055|Adrenergic Agents|adrenergic agents|mesh-ancestor
20545577|NCT01883297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20545578|NCT01883297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20545579|NCT01883297|Antiviral Agents|antiviral agents|mesh-ancestor
20545580|NCT01883297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20545581|NCT01883323|Aldesleukin|aldesleukin|mesh-list
20545582|NCT01883323|Cyclophosphamide|cyclophosphamide|mesh-list
20545583|NCT01883323|Fludarabine|fludarabine|mesh-list
20545584|NCT01883323|Interleukin-2|interleukin-2|mesh-list
20545585|NCT01883323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20545586|NCT01883323|Immunologic Factors|immunologic factors|mesh-ancestor
20545587|NCT01883323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545588|NCT01883323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20545589|NCT01883323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20545590|NCT01883323|Alkylating Agents|alkylating agents|mesh-ancestor
20545591|NCT01883323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545592|NCT01883323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20545593|NCT01883323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20545594|NCT01883323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20545595|NCT01883323|Analgesics|analgesics|mesh-ancestor
20545596|NCT01883323|Sensory System Agents|sensory system agents|mesh-ancestor
20545597|NCT01883323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545598|NCT01883323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20545599|NCT01883323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20545600|NCT01883323|Antiviral Agents|antiviral agents|mesh-ancestor
20545601|NCT01883323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20545602|NCT01883505|Levodopa|levodopa|mesh-list
20545603|NCT01883505|Carbidopa|carbidopa|mesh-list
20545604|NCT01883505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20545605|NCT01883505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20545606|NCT01883505|Dopamine Agents|dopamine agents|mesh-ancestor
20545607|NCT01883505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20545608|NCT01883505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545609|NCT01883505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545610|NCT01883505|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20545611|NCT01883505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545612|NCT01883518|Vaccines|vaccines|mesh-list
20545613|NCT01883518|Immunologic Factors|immunologic factors|mesh-ancestor
20545614|NCT01883518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545615|NCT01883531|Mannitol|mannitol|mesh-list
20545616|NCT01883531|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20545617|NCT01883531|Diuretics|diuretics|mesh-ancestor
20545618|NCT01883531|Natriuretic Agents|natriuretic agents|mesh-ancestor
20545619|NCT01883531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545620|NCT01883596|Chlorhexidine|chlorhexidine|mesh-list
20545621|NCT01883596|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20545622|NCT01883596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20545623|NCT01883596|Disinfectants|disinfectants|mesh-ancestor
20545624|NCT01883869|Ticagrelor|ticagrelor|mesh-list
20545625|NCT01883869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20545626|NCT01883869|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19733248|NCT04563962|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19733249|NCT04563871|Osimertinib|osimertinib|mesh-list
19733250|NCT04563871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733251|NCT04563871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19733252|NCT04563871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733253|NCT04563871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733254|NCT04564001|Infliximab|infliximab|mesh-list
19733255|NCT04564001|Dermatologic Agents|dermatologic agents|mesh-ancestor
20276866|NCT00562055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20276867|NCT00562055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276868|NCT00562055|Antidepressive Agents|antidepressive agents|mesh-ancestor
20276869|NCT00562055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20276870|NCT00562068|Prednisolone|prednisolone|mesh-list
20276871|NCT00562068|Cyclophosphamide|cyclophosphamide|mesh-list
20276872|NCT00562068|Doxorubicin|doxorubicin|mesh-list
20276873|NCT00562068|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20276874|NCT00562068|Vincristine|vincristine|mesh-list
20276875|NCT00562068|Alemtuzumab|alemtuzumab|mesh-list
20276876|NCT00562068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20276877|NCT00562068|Immunologic Factors|immunologic factors|mesh-ancestor
20276878|NCT00562068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276879|NCT00562068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20276880|NCT00562068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20276881|NCT00562068|Alkylating Agents|alkylating agents|mesh-ancestor
20276882|NCT00562068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276883|NCT00562068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276884|NCT00562068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20276885|NCT00562068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20276886|NCT00562068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20276887|NCT00562068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20276888|NCT00562068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276889|NCT00562068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20276890|NCT00562068|Tubulin Modulators|tubulin modulators|mesh-ancestor
20276891|NCT00562068|Antimitotic Agents|antimitotic agents|mesh-ancestor
20276892|NCT00562068|Mitosis Modulators|mitosis modulators|mesh-ancestor
20276893|NCT00562068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20276894|NCT00562068|Glucocorticoids|glucocorticoids|mesh-ancestor
20276895|NCT00562068|Hormones|hormones|mesh-ancestor
20276896|NCT00562068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20276897|NCT00562068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20276898|NCT00562068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20276899|NCT00562133|Insulin|insulin|mesh-list
20276900|NCT00562133|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20276901|NCT00562133|Insulin glulisine|insulin glulisine|mesh-list
19733256|NCT04564001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20276902|NCT00562133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20276903|NCT00562133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276904|NCT00562172|Metformin|metformin|mesh-list
20276905|NCT00562172|Insulin Glargine|insulin glargine|mesh-list
20276906|NCT00562172|Glimepiride|glimepiride|mesh-list
20276907|NCT00562172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20276908|NCT00562172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276909|NCT00562172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20276910|NCT00562172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20276911|NCT00562172|Immunologic Factors|immunologic factors|mesh-ancestor
20276912|NCT00562185|Carboplatin|carboplatin|mesh-list
20276913|NCT00562185|Doxorubicin|doxorubicin|mesh-list
20276914|NCT00562185|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20276915|NCT00562185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276916|NCT00562185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20276917|NCT00562185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20276918|NCT00562185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20276919|NCT00562185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276920|NCT00562185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276921|NCT00562198|Carbidopa|carbidopa|mesh-list
20276922|NCT00562198|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20276923|NCT00562198|Entacapone|entacapone|mesh-list
20276924|NCT00562198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20276925|NCT00562198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20276926|NCT00562198|Dopamine Agents|dopamine agents|mesh-ancestor
20276927|NCT00562198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20276928|NCT00562198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276929|NCT00562198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276930|NCT00562198|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20276931|NCT00562198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276932|NCT00562198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20276933|NCT00562198|Immunologic Factors|immunologic factors|mesh-ancestor
20276934|NCT00562198|Dopamine Agonists|dopamine agonists|mesh-ancestor
20276935|NCT00562198|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20276936|NCT00562224|Abexinostat|abexinostat|mesh-list
20276937|NCT00562224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19733257|NCT04564001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19733258|NCT04563780|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
19733259|NCT04563780|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19733260|NCT04563780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545627|NCT01883869|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20545628|NCT01883869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20545629|NCT01883869|Purinergic Agents|purinergic agents|mesh-ancestor
20545630|NCT01883869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20545631|NCT01883869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545632|NCT01883869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545633|NCT01883882|Analgesics, Opioid|analgesics, opioid|mesh-list
20545634|NCT01883882|Narcotics|narcotics|mesh-ancestor
20545635|NCT01883882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20545636|NCT01883882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545637|NCT01883882|Analgesics|analgesics|mesh-ancestor
20545638|NCT01883882|Sensory System Agents|sensory system agents|mesh-ancestor
20545639|NCT01883882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545640|NCT01883921|Immunoglobulins|immunoglobulins|mesh-list
20545641|NCT01883921|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20545642|NCT01883921|Antibodies|antibodies|mesh-list
20545643|NCT01883921|Immunologic Factors|immunologic factors|mesh-ancestor
20545644|NCT01883921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545645|NCT01884038|Treprostinil|treprostinil|mesh-list
20545646|NCT01884038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20276938|NCT00562224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276939|NCT00562224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276940|NCT00562250|Dapagliflozin|dapagliflozin|mesh-list
20276941|NCT00562250|Glimepiride|glimepiride|mesh-list
20276942|NCT00562250|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20276943|NCT00562250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276944|NCT00562250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20276945|NCT00562250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276946|NCT00562250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20545647|NCT01884116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
20545648|NCT01884116|Capsaicin|capsaicin|mesh-list
20545649|NCT01884116|Antipruritics|antipruritics|mesh-ancestor
20545650|NCT01884116|Dermatologic Agents|dermatologic agents|mesh-ancestor
20545651|NCT01884116|Sensory System Agents|sensory system agents|mesh-ancestor
20545652|NCT01884116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545653|NCT01884116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545654|NCT01884116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19962149|NCT01710657|Lacosamide|lacosamide|mesh-list
20276947|NCT00562250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20276948|NCT00562250|Immunologic Factors|immunologic factors|mesh-ancestor
20276949|NCT00562289|Aspirin|aspirin|mesh-list
20276950|NCT00562289|Dipyridamole|dipyridamole|mesh-list
20276951|NCT00562289|Rivaroxaban|rivaroxaban|mesh-list
20276952|NCT00562289|Apixaban|apixaban|mesh-list
20276953|NCT00562289|Dabigatran|dabigatran|mesh-list
20276954|NCT00562289|Antivitamins K|antivitamins k|mesh-list
20276955|NCT00562289|Clopidogrel|clopidogrel|mesh-list
20276956|NCT00562289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20276957|NCT00562289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20276958|NCT00562289|Analgesics|analgesics|mesh-ancestor
20276959|NCT00562289|Sensory System Agents|sensory system agents|mesh-ancestor
20276960|NCT00562289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545655|NCT01884116|Analgesics|analgesics|mesh-ancestor
19733261|NCT04563299|Prednisolone|prednisolone|mesh-list
19733262|NCT04563299|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19733263|NCT04563299|Methylprednisolone|methylprednisolone|mesh-list
19733264|NCT04563299|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19733265|NCT04563299|Prednisolone acetate|prednisolone acetate|mesh-list
19733266|NCT04563299|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19733267|NCT04563299|Prednisolone phosphate|prednisolone phosphate|mesh-list
19733268|NCT04563299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19733269|NCT04563299|Glucocorticoids|glucocorticoids|mesh-ancestor
19733270|NCT04563299|Hormones|hormones|mesh-ancestor
19733271|NCT04563299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19733272|NCT04563299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733273|NCT04563299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19733274|NCT04563299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962150|NCT01710657|Anticonvulsants|anticonvulsants|mesh-ancestor
19962151|NCT01710657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19962152|NCT01710657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19962153|NCT01710657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19962154|NCT01710657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962155|NCT01710709|Aripiprazole|aripiprazole|mesh-list
19962156|NCT01710709|Antidepressive Agents|antidepressive agents|mesh-ancestor
19962157|NCT01710709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20276961|NCT00562289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276962|NCT00562289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20276963|NCT00562289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20276964|NCT00562289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20276965|NCT00562289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20276966|NCT00562289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276967|NCT00562289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20276968|NCT00562289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20276969|NCT00562289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276970|NCT00562289|Antipyretics|antipyretics|mesh-ancestor
20276971|NCT00562289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20276972|NCT00562289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20276973|NCT00562289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20276974|NCT00562289|Purinergic Agents|purinergic agents|mesh-ancestor
20276975|NCT00562289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20276976|NCT00562289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20276977|NCT00562289|Antithrombins|antithrombins|mesh-ancestor
20276978|NCT00562289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20276979|NCT00562289|Protease Inhibitors|protease inhibitors|mesh-ancestor
20276980|NCT00562289|Anticoagulants|anticoagulants|mesh-ancestor
20276981|NCT00562289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20276982|NCT00562289|Vasodilator Agents|vasodilator agents|mesh-ancestor
20276983|NCT00562406|Ranibizumab|ranibizumab|mesh-list
20276984|NCT00562406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20276985|NCT00562406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20276986|NCT00562406|Growth Substances|growth substances|mesh-ancestor
20276987|NCT00562406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20276988|NCT00562406|Growth Inhibitors|growth inhibitors|mesh-ancestor
20276989|NCT00562406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276990|NCT00562419|Irinotecan|irinotecan|mesh-list
20276991|NCT00562419|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20276992|NCT00562419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20276993|NCT00562419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20276994|NCT00562419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20276995|NCT00562419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276996|NCT00562458|Anastrozole|anastrozole|mesh-list
20276997|NCT00562458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20276998|NCT00562458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20276999|NCT00562458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20277000|NCT00562458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20277001|NCT00562458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277002|NCT00562458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277003|NCT00562458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20277004|NCT00562458|Hormone Antagonists|hormone antagonists|mesh-ancestor
20277005|NCT00562458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20277006|NCT00562458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277007|NCT00562510|Raltegravir Potassium|raltegravir potassium|mesh-list
20277008|NCT00562510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20277009|NCT00562510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20277010|NCT00562510|Antiviral Agents|antiviral agents|mesh-ancestor
20277011|NCT00562510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20277012|NCT00562510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20277013|NCT00562510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20277014|NCT00562510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277015|NCT00562510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277016|NCT00562523|Sorafenib|sorafenib|mesh-list
20277017|NCT00562523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277018|NCT00562523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20277019|NCT00562523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277020|NCT00562523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277021|NCT00562640|Cyclophosphamide|cyclophosphamide|mesh-list
20277022|NCT00562640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20277023|NCT00562640|Immunologic Factors|immunologic factors|mesh-ancestor
20277024|NCT00562640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277025|NCT00562640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20277026|NCT00562640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20277027|NCT00562640|Alkylating Agents|alkylating agents|mesh-ancestor
20277028|NCT00562640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277029|NCT00562640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277030|NCT00562640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20277031|NCT00562692|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20277032|NCT00562692|Natriuretic Agents|natriuretic agents|mesh-ancestor
20277033|NCT00562692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277034|NCT00562705|Hormones|hormones|mesh-list
20277035|NCT00562705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20277036|NCT00562705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277037|NCT00562770|Valacyclovir|valacyclovir|mesh-list
20277038|NCT00562770|Valganciclovir|valganciclovir|mesh-list
20277039|NCT00562770|Antiviral Agents|antiviral agents|mesh-ancestor
20277040|NCT00562770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20277041|NCT00562809|Irbesartan|irbesartan|mesh-list
20277042|NCT00562809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20277043|NCT00562809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20277044|NCT00562809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20277045|NCT00562809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277046|NCT00562835|Thiamine|thiamine|mesh-list
20277047|NCT00562835|Methylprednisolone|methylprednisolone|mesh-list
20277048|NCT00562835|Vitamins|vitamins|mesh-ancestor
20277049|NCT00562835|Micronutrients|micronutrients|mesh-ancestor
20277050|NCT00562835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277051|NCT00562835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20277052|NCT00562835|Antiemetics|antiemetics|mesh-ancestor
20277053|NCT00562835|Autonomic Agents|autonomic agents|mesh-ancestor
20277054|NCT00562835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20277055|NCT00562835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20277056|NCT00562835|Glucocorticoids|glucocorticoids|mesh-ancestor
20277057|NCT00562835|Hormones|hormones|mesh-ancestor
20277058|NCT00562835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20277059|NCT00562835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20277060|NCT00562835|Protective Agents|protective agents|mesh-ancestor
20277061|NCT00562835|Vitamin B Complex|vitamin b complex|mesh-ancestor
20287826|NCT03561376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287827|NCT03486314|Rifampin|rifampin|mesh-list
20287828|NCT03486314|Paclitaxel|paclitaxel|mesh-list
20287829|NCT03486314|Docetaxel|docetaxel|mesh-list
20287830|NCT03486314|Carboplatin|carboplatin|mesh-list
20287831|NCT03486314|Pevonedistat|pevonedistat|mesh-list
20287832|NCT03486314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20287833|NCT03486314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287834|NCT03486314|Tubulin Modulators|tubulin modulators|mesh-ancestor
20287835|NCT03486314|Antimitotic Agents|antimitotic agents|mesh-ancestor
20287836|NCT03486314|Mitosis Modulators|mitosis modulators|mesh-ancestor
20287837|NCT03486314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287838|NCT03486314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20287839|NCT03486314|Antitubercular Agents|antitubercular agents|mesh-ancestor
20287840|NCT03486314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20287841|NCT03486314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20287842|NCT03486314|Leprostatic Agents|leprostatic agents|mesh-ancestor
20287843|NCT03486314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20287844|NCT03486314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287845|NCT03486314|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20287846|NCT03486314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20287847|NCT03486314|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20287848|NCT03486314|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20287849|NCT03486314|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20287850|NCT03486314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20287851|NCT03425812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
20287852|NCT03425812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20287853|NCT03425812|Analgesics|analgesics|mesh-ancestor
20287854|NCT03425812|Sensory System Agents|sensory system agents|mesh-ancestor
20287855|NCT03425812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287856|NCT03425812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287857|NCT03425812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20287858|NCT03425812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20287859|NCT03413995|Rucaparib|rucaparib|mesh-list
20287860|NCT03413995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20277062|NCT00562913|Sorafenib|sorafenib|mesh-list
20277063|NCT00562913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277064|NCT00562913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20277065|NCT00562913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277066|NCT00562913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277067|NCT00562939|Vaccines|vaccines|mesh-list
20277068|NCT00562939|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20277069|NCT00562939|Immunologic Factors|immunologic factors|mesh-ancestor
20277070|NCT00562939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277071|NCT00562952|Telmisartan|telmisartan|mesh-list
20277072|NCT00562952|Bisoprolol|bisoprolol|mesh-list
20277073|NCT00562952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20277074|NCT00562952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20277075|NCT00562952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20277076|NCT00562952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277077|NCT00562952|Sympatholytics|sympatholytics|mesh-ancestor
20277078|NCT00562952|Autonomic Agents|autonomic agents|mesh-ancestor
20277079|NCT00562952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20277080|NCT00562952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277081|NCT00562952|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20545656|NCT01884116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20545657|NCT01884116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20545658|NCT01884272|Naproxen|naproxen|mesh-list
20545659|NCT01884272|Indomethacin|indomethacin|mesh-list
20545660|NCT01884272|Lesinurad|lesinurad|mesh-list
20545661|NCT01884272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20545662|NCT01884272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20545663|NCT01884272|Analgesics|analgesics|mesh-ancestor
20545664|NCT01884272|Sensory System Agents|sensory system agents|mesh-ancestor
20545665|NCT01884272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545666|NCT01884272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545667|NCT01884272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20545668|NCT01884272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20545669|NCT01884272|Gout Suppressants|gout suppressants|mesh-ancestor
20545670|NCT01884272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20545671|NCT01884272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545672|NCT01884272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545673|NCT01884272|Tocolytic Agents|tocolytic agents|mesh-ancestor
20545674|NCT01884272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20545675|NCT01884272|Uricosuric Agents|uricosuric agents|mesh-ancestor
20545676|NCT01884272|Renal Agents|renal agents|mesh-ancestor
20545677|NCT01884285|Abiraterone Acetate|abiraterone acetate|mesh-list
20545678|NCT01884285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20545679|NCT01884285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20545680|NCT01884285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545681|NCT01884285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545682|NCT01884285|Hormone Antagonists|hormone antagonists|mesh-ancestor
20545683|NCT01884285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20545684|NCT01884285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545685|NCT01884285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20545686|NCT01884298|Lidocaine|lidocaine|mesh-list
20545687|NCT01884298|Remifentanil|remifentanil|mesh-list
20545688|NCT01884298|Anesthetics, Local|anesthetics, local|mesh-ancestor
20545689|NCT01884298|Anesthetics|anesthetics|mesh-ancestor
20545690|NCT01884298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20545691|NCT01884298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545692|NCT01884298|Sensory System Agents|sensory system agents|mesh-ancestor
20545693|NCT01884298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545694|NCT01884298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20545695|NCT01884298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20545696|NCT01884298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20545697|NCT01884298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20545698|NCT01884298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545699|NCT01884298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20545700|NCT01884298|Narcotics|narcotics|mesh-ancestor
20545701|NCT01884298|Analgesics|analgesics|mesh-ancestor
20545702|NCT01884402|Ribavirin|ribavirin|mesh-list
20545703|NCT01884402|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19733275|NCT04563299|Antiemetics|antiemetics|mesh-ancestor
19733276|NCT04563299|Autonomic Agents|autonomic agents|mesh-ancestor
19733277|NCT04563299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733278|NCT04563299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19733279|NCT04563299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20277082|NCT00562952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20277083|NCT00562952|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20277084|NCT00562952|Adrenergic Agents|adrenergic agents|mesh-ancestor
20277085|NCT00562952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277086|NCT00563017|Risperidone|risperidone|mesh-list
20277087|NCT00563017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20277088|NCT00563017|Serotonin Agents|serotonin agents|mesh-ancestor
20277089|NCT00563017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277090|NCT00563017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277091|NCT00563017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277092|NCT00563017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20277093|NCT00563017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20277094|NCT00563017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20277095|NCT00563017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20277096|NCT00563017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20277097|NCT00563017|Dopamine Agents|dopamine agents|mesh-ancestor
20277098|NCT00563056|Fluticasone|fluticasone|mesh-list
20277099|NCT00563056|Formoterol Fumarate|formoterol fumarate|mesh-list
20277100|NCT00563056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20277101|NCT00563056|Autonomic Agents|autonomic agents|mesh-ancestor
20277102|NCT00563056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20277103|NCT00563056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277104|NCT00563056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20277105|NCT00563056|Respiratory System Agents|respiratory system agents|mesh-ancestor
20277106|NCT00563056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20277107|NCT00563056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20277108|NCT00563056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20277109|NCT00563056|Adrenergic Agents|adrenergic agents|mesh-ancestor
20277110|NCT00563056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277111|NCT00563056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277112|NCT00563056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20277113|NCT00563056|Dermatologic Agents|dermatologic agents|mesh-ancestor
20277114|NCT00563056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20277115|NCT00563069|Midazolam|midazolam|mesh-list
20277116|NCT00563069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20277117|NCT00563069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20277118|NCT00563069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20277119|NCT00563069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277120|NCT00563069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20277121|NCT00563069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20277122|NCT00563069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20545704|NCT01884402|Antimetabolites|antimetabolites|mesh-ancestor
20545705|NCT01884402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545706|NCT01884402|Antiviral Agents|antiviral agents|mesh-ancestor
20545707|NCT01884402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20545708|NCT01884415|Vaccines|vaccines|mesh-list
20545709|NCT01884415|Immunologic Factors|immunologic factors|mesh-ancestor
20545710|NCT01884415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545711|NCT01884428|Gemcitabine|gemcitabine|mesh-list
20545712|NCT01884428|Prednisolone|prednisolone|mesh-list
20545713|NCT01884428|Vinorelbine|vinorelbine|mesh-list
20545714|NCT01884428|Ifosfamide|ifosfamide|mesh-list
20545715|NCT01884428|Panobinostat|panobinostat|mesh-list
20545716|NCT01884428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20545717|NCT01884428|Antimetabolites|antimetabolites|mesh-ancestor
20545718|NCT01884428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545719|NCT01884428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20545720|NCT01884428|Antiviral Agents|antiviral agents|mesh-ancestor
20545721|NCT01884428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20545722|NCT01884428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545723|NCT01884428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20545724|NCT01884428|Immunologic Factors|immunologic factors|mesh-ancestor
20545725|NCT01884428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545726|NCT01884428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20545727|NCT01884428|Glucocorticoids|glucocorticoids|mesh-ancestor
20545728|NCT01884428|Hormones|hormones|mesh-ancestor
20545729|NCT01884428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20545730|NCT01884428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20545731|NCT01884428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20545732|NCT01884428|Tubulin Modulators|tubulin modulators|mesh-ancestor
20277123|NCT00563069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20277124|NCT00563069|Anesthetics, General|anesthetics, general|mesh-ancestor
20545733|NCT01884428|Antimitotic Agents|antimitotic agents|mesh-ancestor
20545734|NCT01884428|Mitosis Modulators|mitosis modulators|mesh-ancestor
20545735|NCT01884428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20277125|NCT00563069|Anesthetics|anesthetics|mesh-ancestor
20277126|NCT00563069|GABA Modulators|gaba modulators|mesh-ancestor
20277127|NCT00563069|GABA Agents|gaba agents|mesh-ancestor
20277128|NCT00563069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277129|NCT00563069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277130|NCT00563095|Interferons|interferons|mesh-list
20277131|NCT00563095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277132|NCT00563095|Antiviral Agents|antiviral agents|mesh-ancestor
19733280|NCT04563299|Protective Agents|protective agents|mesh-ancestor
19733281|NCT04563260|Palonosetron|palonosetron|mesh-list
19733282|NCT04563260|Antiemetics|antiemetics|mesh-ancestor
19733283|NCT04563260|Autonomic Agents|autonomic agents|mesh-ancestor
19733284|NCT04563260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733285|NCT04563260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733286|NCT04563260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20545736|NCT01884428|Alkylating Agents|alkylating agents|mesh-ancestor
20545737|NCT01884428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20545738|NCT01884441|Gemcitabine|gemcitabine|mesh-list
20545739|NCT01884441|Vinorelbine|vinorelbine|mesh-list
20545740|NCT01884441|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20545741|NCT01884441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20545742|NCT01884441|Antimetabolites|antimetabolites|mesh-ancestor
20545743|NCT01884441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545744|NCT01884441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20545745|NCT01884441|Antiviral Agents|antiviral agents|mesh-ancestor
20545746|NCT01884441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20545747|NCT01884441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545748|NCT01884441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20545749|NCT01884441|Immunologic Factors|immunologic factors|mesh-ancestor
20545750|NCT01884441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545751|NCT01884441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20545752|NCT01884441|Tubulin Modulators|tubulin modulators|mesh-ancestor
20545753|NCT01884441|Antimitotic Agents|antimitotic agents|mesh-ancestor
20545754|NCT01884441|Mitosis Modulators|mitosis modulators|mesh-ancestor
20545755|NCT01884441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20545756|NCT01884441|Alkylating Agents|alkylating agents|mesh-ancestor
20545757|NCT01884467|Gentamicins|gentamicins|mesh-list
20545758|NCT01884467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20545759|NCT01884467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20545760|NCT01884467|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20545761|NCT01884467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545762|NCT01884467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554326|NCT01934868|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20554327|NCT01934933|Celecoxib|celecoxib|mesh-list
20554328|NCT01934933|Etanercept|etanercept|mesh-list
20554329|NCT01934933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20554330|NCT01934933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20554331|NCT01934933|Analgesics|analgesics|mesh-ancestor
20554332|NCT01934933|Sensory System Agents|sensory system agents|mesh-ancestor
20554333|NCT01934933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554334|NCT01934933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554335|NCT01934933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20554336|NCT01934933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20554337|NCT01934933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20554338|NCT01934933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20554339|NCT01934933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554340|NCT01934933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554341|NCT01934933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20554342|NCT01934933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20554343|NCT01934933|Immunologic Factors|immunologic factors|mesh-ancestor
20554344|NCT01935063|Lidocaine|lidocaine|mesh-list
20554345|NCT01935063|Anesthetics, Local|anesthetics, local|mesh-ancestor
20554346|NCT01935063|Anesthetics|anesthetics|mesh-ancestor
20554347|NCT01935063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20554348|NCT01935063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277133|NCT00563095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20277134|NCT00563108|Basiliximab|basiliximab|mesh-list
20277135|NCT00563108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20277136|NCT00563108|Immunologic Factors|immunologic factors|mesh-ancestor
20277137|NCT00563108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277138|NCT00563147|Sirolimus|sirolimus|mesh-list
20277139|NCT00563147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20277140|NCT00563147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20277141|NCT00563147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20277142|NCT00563147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277143|NCT00563147|Antifungal Agents|antifungal agents|mesh-ancestor
20277144|NCT00563147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20277145|NCT00563147|Immunologic Factors|immunologic factors|mesh-ancestor
20277146|NCT00563147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277147|NCT00563160|Gemcitabine|gemcitabine|mesh-list
20277148|NCT00563160|Carboplatin|carboplatin|mesh-list
20277149|NCT00563160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277150|NCT00563160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20277151|NCT00563160|Antimetabolites|antimetabolites|mesh-ancestor
20277152|NCT00563160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277153|NCT00563160|Antiviral Agents|antiviral agents|mesh-ancestor
20277154|NCT00563160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20277155|NCT00563160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277156|NCT00563160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20277157|NCT00563160|Immunologic Factors|immunologic factors|mesh-ancestor
20277158|NCT00563160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277159|NCT00563212|Interferons|interferons|mesh-list
20277160|NCT00563212|Interferon-gamma|interferon-gamma|mesh-list
20277161|NCT00563212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277162|NCT00563212|Antiviral Agents|antiviral agents|mesh-ancestor
20277163|NCT00563212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20277164|NCT00563225|Insulin Glargine|insulin glargine|mesh-list
20277165|NCT00563225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20277166|NCT00563225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277167|NCT00563238|Metoprolol|metoprolol|mesh-list
20277168|NCT00563238|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20277169|NCT00563238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20277170|NCT00563238|Sympatholytics|sympatholytics|mesh-ancestor
20277171|NCT00563238|Autonomic Agents|autonomic agents|mesh-ancestor
20277172|NCT00563238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20277173|NCT00563238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277174|NCT00563238|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20277175|NCT00563238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20277176|NCT00563238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20277177|NCT00563238|Adrenergic Agents|adrenergic agents|mesh-ancestor
20277178|NCT00563238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277179|NCT00563238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277180|NCT00563251|Azithromycin|azithromycin|mesh-list
20277181|NCT00563251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20277182|NCT00563251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20277183|NCT00563303|Hydrocortisone|hydrocortisone|mesh-list
20277184|NCT00563303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20277185|NCT00563342|Ethanol|ethanol|mesh-list
20277186|NCT00563342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20277187|NCT00563342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20277188|NCT00563342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20277189|NCT00563342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277190|NCT00563355|Epoetin Alfa|epoetin alfa|mesh-list
20277191|NCT00563355|Hematinics|hematinics|mesh-ancestor
20277192|NCT00563394|Ofloxacin|ofloxacin|mesh-list
20277193|NCT00563394|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20277194|NCT00563394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20277195|NCT00563394|Renal Agents|renal agents|mesh-ancestor
20277196|NCT00563394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20277197|NCT00563394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20277198|NCT00563394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20277199|NCT00563394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277200|NCT00563394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277201|NCT00563394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277202|NCT00563394|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20277203|NCT00563394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20277204|NCT00563433|Ofloxacin|ofloxacin|mesh-list
20277205|NCT00563433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20277206|NCT00563433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20277207|NCT00563433|Renal Agents|renal agents|mesh-ancestor
20277208|NCT00563433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20277209|NCT00563433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20277210|NCT00563433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20277211|NCT00563433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277212|NCT00563433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277213|NCT00563433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277214|NCT00563433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20277215|NCT00563433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20277216|NCT00563446|Darbepoetin alfa|darbepoetin alfa|mesh-list
20277217|NCT00563446|Hematinics|hematinics|mesh-ancestor
20277218|NCT00563472|Desogestrel|desogestrel|mesh-list
20277219|NCT00563472|Progesterone|progesterone|mesh-list
20277220|NCT00563472|Progestins|progestins|mesh-ancestor
20277221|NCT00563472|Hormones|hormones|mesh-ancestor
20277222|NCT00563472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20277223|NCT00563472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277224|NCT00563472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20277225|NCT00563472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20277226|NCT00563472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20277227|NCT00563472|Contraceptive Agents|contraceptive agents|mesh-ancestor
20277228|NCT00563472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19962158|NCT01710709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19962159|NCT01710709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19962160|NCT01710709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19962161|NCT01710709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962162|NCT01710709|Dopamine Agonists|dopamine agonists|mesh-ancestor
19962163|NCT01710709|Dopamine Agents|dopamine agents|mesh-ancestor
19962164|NCT01710709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19962165|NCT01710709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962166|NCT01710709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19962167|NCT01710709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19962168|NCT01710709|Serotonin Agents|serotonin agents|mesh-ancestor
19962169|NCT01710709|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20277229|NCT00563472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20277230|NCT00563472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20277231|NCT00563485|Doxazosin|doxazosin|mesh-list
20277232|NCT00563485|Terazosin|terazosin|mesh-list
20277233|NCT00563485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20277234|NCT00563485|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20277235|NCT00563485|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20277236|NCT00563485|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20277237|NCT00563485|Adrenergic Agents|adrenergic agents|mesh-ancestor
20277238|NCT00563485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277239|NCT00563485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277240|NCT00563485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277241|NCT00563485|Urological Agents|urological agents|mesh-ancestor
20277242|NCT00563524|Fezakinumab|fezakinumab|mesh-list
20277243|NCT00563524|Dermatologic Agents|dermatologic agents|mesh-ancestor
20277244|NCT00563589|Cyclosporine|cyclosporine|mesh-list
20277245|NCT00563589|Mycophenolic Acid|mycophenolic acid|mesh-list
20277246|NCT00563589|Methotrexate|methotrexate|mesh-list
20277247|NCT00563589|Cyclosporins|cyclosporins|mesh-list
20277248|NCT00563589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20277249|NCT00563589|Abortifacient Agents|abortifacient agents|mesh-ancestor
20277250|NCT00563589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20277251|NCT00563589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277252|NCT00563589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20277253|NCT00563589|Antimetabolites|antimetabolites|mesh-ancestor
20277254|NCT00563589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277255|NCT00563589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277256|NCT00563589|Dermatologic Agents|dermatologic agents|mesh-ancestor
20277257|NCT00563589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277258|NCT00563589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20277259|NCT00563589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20277260|NCT00563589|Immunologic Factors|immunologic factors|mesh-ancestor
20277261|NCT00563589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20277262|NCT00563589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20277263|NCT00563589|Antifungal Agents|antifungal agents|mesh-ancestor
20277264|NCT00563589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20277265|NCT00563589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20277266|NCT00563589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20277267|NCT00563589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20277268|NCT00563589|Antitubercular Agents|antitubercular agents|mesh-ancestor
20277269|NCT00563589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20277270|NCT00563615|Tegaserod|tegaserod|mesh-list
20277271|NCT00563615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20277272|NCT00563615|Serotonin Agents|serotonin agents|mesh-ancestor
20277273|NCT00563615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277274|NCT00563615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277275|NCT00563615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277276|NCT00563641|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20277277|NCT00563641|Respiratory System Agents|respiratory system agents|mesh-ancestor
20277278|NCT00563654|Alfuzosin|alfuzosin|mesh-list
20277279|NCT00563654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19962170|NCT01710709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20277280|NCT00563654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20277281|NCT00563654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20277282|NCT00563654|Adrenergic Agents|adrenergic agents|mesh-ancestor
20277283|NCT00563654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277284|NCT00563654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277285|NCT00563654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277286|NCT00563654|Urological Agents|urological agents|mesh-ancestor
20277287|NCT00563758|Tegaserod|tegaserod|mesh-list
20545763|NCT01884506|Iron|iron|mesh-list
20545764|NCT01884506|Ascorbic Acid|ascorbic acid|mesh-list
20545765|NCT01884506|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20545766|NCT01884506|Trace Elements|trace elements|mesh-ancestor
20545767|NCT01884506|Micronutrients|micronutrients|mesh-ancestor
20545768|NCT01884506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545769|NCT01884506|Antioxidants|antioxidants|mesh-ancestor
20545770|NCT01884506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545771|NCT01884506|Protective Agents|protective agents|mesh-ancestor
20545772|NCT01884506|Vitamins|vitamins|mesh-ancestor
20545773|NCT01884558|Metformin|metformin|mesh-list
20545774|NCT01884558|Isavuconazole|isavuconazole|mesh-list
20545775|NCT01884558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19450355|NCT03429075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19450356|NCT03429075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19450357|NCT03429075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450358|NCT03429075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450359|NCT03429075|Serotonin Agents|serotonin agents|mesh-ancestor
19450360|NCT03429075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277288|NCT00563758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20545776|NCT01884558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545777|NCT01884558|Antifungal Agents|antifungal agents|mesh-ancestor
20545778|NCT01884558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20545779|NCT01884623|Methotrexate|methotrexate|mesh-list
20545780|NCT01884623|Cetuximab|cetuximab|mesh-list
20545781|NCT01884623|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20545782|NCT01884623|Abortifacient Agents|abortifacient agents|mesh-ancestor
20545783|NCT01884623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20545784|NCT01884623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545785|NCT01884623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20545786|NCT01884623|Antimetabolites|antimetabolites|mesh-ancestor
20545787|NCT01884623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545788|NCT01884623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20545789|NCT01884623|Dermatologic Agents|dermatologic agents|mesh-ancestor
20545790|NCT01884623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545791|NCT01884623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20545792|NCT01884623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20545793|NCT01884623|Immunologic Factors|immunologic factors|mesh-ancestor
20545794|NCT01884623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20545795|NCT01884623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20545796|NCT01884623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20545797|NCT01884636|Isavuconazole|isavuconazole|mesh-list
20545798|NCT01884636|Methotrexate|methotrexate|mesh-list
20545799|NCT01884636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20545800|NCT01884636|Abortifacient Agents|abortifacient agents|mesh-ancestor
20545801|NCT01884636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20545802|NCT01884636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545803|NCT01884636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20545804|NCT01884636|Antimetabolites|antimetabolites|mesh-ancestor
20545805|NCT01884636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545806|NCT01884636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20545807|NCT01884636|Dermatologic Agents|dermatologic agents|mesh-ancestor
20545808|NCT01884636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545809|NCT01884636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20545810|NCT01884636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20545811|NCT01884636|Immunologic Factors|immunologic factors|mesh-ancestor
20545812|NCT01884636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20545813|NCT01884636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20545814|NCT01884636|Antifungal Agents|antifungal agents|mesh-ancestor
20545815|NCT01884636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20277289|NCT00563758|Serotonin Agents|serotonin agents|mesh-ancestor
20277290|NCT00563758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277291|NCT00563758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277292|NCT00563758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277293|NCT00563771|Rasburicase|rasburicase|mesh-list
20277294|NCT00563771|Gout Suppressants|gout suppressants|mesh-ancestor
20545816|NCT01884740|Bevacizumab|bevacizumab|mesh-list
20277295|NCT00563771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20277296|NCT00563823|Vatalanib|vatalanib|mesh-list
20277297|NCT00563823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20277298|NCT00563823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545817|NCT01884740|Cetuximab|cetuximab|mesh-list
20545818|NCT01884740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20545819|NCT01884740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20545820|NCT01884740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20545821|NCT01884740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20545822|NCT01884740|Growth Substances|growth substances|mesh-ancestor
20545823|NCT01884740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545824|NCT01884740|Growth Inhibitors|growth inhibitors|mesh-ancestor
20277299|NCT00563823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277300|NCT00563836|Catumaxomab|catumaxomab|mesh-list
20277301|NCT00563836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20277302|NCT00563849|Leflunomide|leflunomide|mesh-list
20277303|NCT00563849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277304|NCT00563849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277305|NCT00563849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20277306|NCT00563849|Immunologic Factors|immunologic factors|mesh-ancestor
20277307|NCT00563849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277308|NCT00563862|Fluorouracil|fluorouracil|mesh-list
20277309|NCT00563862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277310|NCT00563862|Antimetabolites|antimetabolites|mesh-ancestor
20277311|NCT00563862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277312|NCT00563862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20277313|NCT00563862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20277314|NCT00563862|Immunologic Factors|immunologic factors|mesh-ancestor
20277315|NCT00563862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277316|NCT00563875|Aspirin|aspirin|mesh-list
20277317|NCT00563875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20277318|NCT00563875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20277319|NCT00563875|Analgesics|analgesics|mesh-ancestor
20277320|NCT00563875|Sensory System Agents|sensory system agents|mesh-ancestor
20277321|NCT00563875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20277322|NCT00563875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277323|NCT00563875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20277324|NCT00563875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20277325|NCT00563875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20277326|NCT00563875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20277327|NCT00563875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277328|NCT00563875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20545825|NCT01884857|Metoprolol|metoprolol|mesh-list
20277329|NCT00563875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20277330|NCT00563875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277331|NCT00563875|Antipyretics|antipyretics|mesh-ancestor
20277332|NCT00563914|Amodiaquine|amodiaquine|mesh-list
20277333|NCT00563914|Ferroquine|ferroquine|mesh-list
20277334|NCT00563914|Antimalarials|antimalarials|mesh-ancestor
20277335|NCT00563914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20277336|NCT00563914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20277337|NCT00563914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20277338|NCT00563927|Fluorouracil|fluorouracil|mesh-list
20277339|NCT00563927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277340|NCT00563927|Antimetabolites|antimetabolites|mesh-ancestor
20277341|NCT00563927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277342|NCT00563927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20277343|NCT00563927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20277344|NCT00563927|Immunologic Factors|immunologic factors|mesh-ancestor
20277345|NCT00563927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277346|NCT00563953|Doxorubicin|doxorubicin|mesh-list
20277347|NCT00563953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20277348|NCT00563953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277349|NCT00563953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20277350|NCT00563953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20277351|NCT00563953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277352|NCT00563953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277353|NCT00563992|Valproic Acid|valproic acid|mesh-list
20277354|NCT00563992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20277355|NCT00563992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277356|NCT00563992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277357|NCT00563992|Antimanic Agents|antimanic agents|mesh-ancestor
20277358|NCT00563992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20277359|NCT00563992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20277360|NCT00563992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277361|NCT00563992|Anticonvulsants|anticonvulsants|mesh-ancestor
20277362|NCT00563992|GABA Agents|gaba agents|mesh-ancestor
20277363|NCT00563992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277364|NCT00564031|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20277365|NCT00564031|Medroxyprogesterone|medroxyprogesterone|mesh-list
20277366|NCT00564031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20277367|NCT00564031|Contraceptive Agents|contraceptive agents|mesh-ancestor
20277368|NCT00564031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20277369|NCT00564031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277370|NCT00564031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20277371|NCT00564031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20277372|NCT00564031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20277373|NCT00564031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277374|NCT00564031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20277375|NCT00564031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20277376|NCT00564031|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20277377|NCT00564057|Candesartan|candesartan|mesh-list
20277378|NCT00564057|Lercanidipine|lercanidipine|mesh-list
20277379|NCT00564057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20277380|NCT00564057|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20277381|NCT00564057|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20277382|NCT00564057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277383|NCT00564057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20277384|NCT00564057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20277385|NCT00564057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20277386|NCT00564057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277387|NCT00564148|Bevacizumab|bevacizumab|mesh-list
20277388|NCT00564148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20277389|NCT00564148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277390|NCT00564148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20277391|NCT00564148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20277392|NCT00564148|Growth Substances|growth substances|mesh-ancestor
20277393|NCT00564148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277394|NCT00564148|Growth Inhibitors|growth inhibitors|mesh-ancestor
20277395|NCT00564174|Aspirin|aspirin|mesh-list
20277396|NCT00564174|Heparin|heparin|mesh-list
20277397|NCT00564174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20277398|NCT00564174|Tinzaparin|tinzaparin|mesh-list
20277399|NCT00564174|Dalteparin|dalteparin|mesh-list
20277400|NCT00564174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20277401|NCT00564174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20277402|NCT00564174|Analgesics|analgesics|mesh-ancestor
20277403|NCT00564174|Sensory System Agents|sensory system agents|mesh-ancestor
20277404|NCT00564174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20277405|NCT00564174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277406|NCT00564174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20277407|NCT00564174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20277408|NCT00564174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20277409|NCT00564174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20277410|NCT00564174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277411|NCT00564174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20545826|NCT01884857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20545827|NCT01884857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20545828|NCT01884857|Sympatholytics|sympatholytics|mesh-ancestor
20545829|NCT01884857|Autonomic Agents|autonomic agents|mesh-ancestor
20545830|NCT01884857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545831|NCT01884857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545832|NCT01884857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20545833|NCT01884857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20545834|NCT01884857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20545835|NCT01884857|Adrenergic Agents|adrenergic agents|mesh-ancestor
20545836|NCT01884857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20545837|NCT01884857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545838|NCT01884896|Metoprolol|metoprolol|mesh-list
20545839|NCT01884896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20545840|NCT01884896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20545841|NCT01884896|Sympatholytics|sympatholytics|mesh-ancestor
20545842|NCT01884896|Autonomic Agents|autonomic agents|mesh-ancestor
20545843|NCT01884896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545844|NCT01884896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545845|NCT01884896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20545846|NCT01884896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20545847|NCT01884896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20545848|NCT01884896|Adrenergic Agents|adrenergic agents|mesh-ancestor
20545849|NCT01884896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20545850|NCT01884896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545851|NCT01884909|Metoprolol|metoprolol|mesh-list
20545852|NCT01884909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20545853|NCT01884909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20545854|NCT01884909|Sympatholytics|sympatholytics|mesh-ancestor
20545855|NCT01884909|Autonomic Agents|autonomic agents|mesh-ancestor
20545856|NCT01884909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545857|NCT01884909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545858|NCT01884909|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20545859|NCT01884909|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20545860|NCT01884909|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20545861|NCT01884909|Adrenergic Agents|adrenergic agents|mesh-ancestor
20545862|NCT01884909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20545863|NCT01884909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545864|NCT01884935|Natalizumab|natalizumab|mesh-list
20545865|NCT01884935|Immunologic Factors|immunologic factors|mesh-ancestor
20545866|NCT01884935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545867|NCT01885013|Metformin|metformin|mesh-list
20545868|NCT01885013|Cyclophosphamide|cyclophosphamide|mesh-list
20545869|NCT01885013|Doxorubicin|doxorubicin|mesh-list
20545870|NCT01885013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20545871|NCT01885013|Immunologic Factors|immunologic factors|mesh-ancestor
20545872|NCT01885013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545873|NCT01885013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20277412|NCT00564174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20277413|NCT00564174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277414|NCT00564174|Antipyretics|antipyretics|mesh-ancestor
20277415|NCT00564174|Anticoagulants|anticoagulants|mesh-ancestor
20277416|NCT00564187|Irbesartan|irbesartan|mesh-list
20277417|NCT00564187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20287861|NCT03413995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287862|NCT03413995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287863|NCT03413995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287864|NCT03377387|Capecitabine|capecitabine|mesh-list
20287865|NCT03377387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20287866|NCT03377387|Antimetabolites|antimetabolites|mesh-ancestor
20287867|NCT03377387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287868|NCT03377387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287869|NCT03335488|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20287870|NCT03335488|Glycerol|glycerol|mesh-list
20287871|NCT03335488|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20277418|NCT00564187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20277419|NCT00564187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20277420|NCT00564187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277421|NCT00564200|Dexamethasone|dexamethasone|mesh-list
20277422|NCT00564200|Fludarabine|fludarabine|mesh-list
20277423|NCT00564200|Bortezomib|bortezomib|mesh-list
20277424|NCT00564200|Melphalan|melphalan|mesh-list
20277425|NCT00564200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20277426|NCT00564200|Antiemetics|antiemetics|mesh-ancestor
20277427|NCT00564200|Autonomic Agents|autonomic agents|mesh-ancestor
20277428|NCT00564200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20277429|NCT00564200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277430|NCT00564200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20277431|NCT00564200|Glucocorticoids|glucocorticoids|mesh-ancestor
20545874|NCT01885013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20545875|NCT01885013|Alkylating Agents|alkylating agents|mesh-ancestor
20545876|NCT01885013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545877|NCT01885013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20545878|NCT01885013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20545879|NCT01885013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20545880|NCT01885013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20545881|NCT01885013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20545882|NCT01885013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20545883|NCT01885013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545884|NCT01885091|Kinetin|kinetin|mesh-list
20545885|NCT01885091|Plant Growth Regulators|plant growth regulators|mesh-ancestor
20545886|NCT01885091|Growth Substances|growth substances|mesh-ancestor
20545887|NCT01885091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545888|NCT01885130|Dimenhydrinate|dimenhydrinate|mesh-list
20545889|NCT01885130|Antiemetics|antiemetics|mesh-ancestor
20545890|NCT01885130|Autonomic Agents|autonomic agents|mesh-ancestor
20545891|NCT01885130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545892|NCT01885130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545893|NCT01885130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20545894|NCT01885130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20545895|NCT01885130|Histamine Antagonists|histamine antagonists|mesh-ancestor
20545896|NCT01885130|Histamine Agents|histamine agents|mesh-ancestor
20545897|NCT01885130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20545898|NCT01885130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545899|NCT01885338|Acetylcysteine|acetylcysteine|mesh-list
20545900|NCT01885338|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20545901|NCT01885338|Antiviral Agents|antiviral agents|mesh-ancestor
20545902|NCT01885338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20545903|NCT01885338|Expectorants|expectorants|mesh-ancestor
20545904|NCT01885338|Respiratory System Agents|respiratory system agents|mesh-ancestor
20545905|NCT01885338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20545906|NCT01885338|Antioxidants|antioxidants|mesh-ancestor
20277432|NCT00564200|Hormones|hormones|mesh-ancestor
20277433|NCT00564200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20277434|NCT00564200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20277435|NCT00564200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277436|NCT00564200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545907|NCT01885338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545908|NCT01885338|Protective Agents|protective agents|mesh-ancestor
20545909|NCT01885338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545910|NCT01885338|Antidotes|antidotes|mesh-ancestor
20545911|NCT01885364|Remifentanil|remifentanil|mesh-list
19733287|NCT04563260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19733288|NCT04563260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19733289|NCT04563260|Serotonin Agents|serotonin agents|mesh-ancestor
19733290|NCT04563260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19733291|NCT04563260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733292|NCT04563533|Vaccines|vaccines|mesh-list
19733293|NCT04563533|Immunologic Factors|immunologic factors|mesh-ancestor
20545912|NCT01885364|Propofol|propofol|mesh-list
20545913|NCT01885364|Esmolol|esmolol|mesh-list
20545914|NCT01885364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20545915|NCT01885364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20545916|NCT01885364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545917|NCT01885364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20545918|NCT01885364|Anesthetics, General|anesthetics, general|mesh-ancestor
20277437|NCT00564200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20545919|NCT01885364|Anesthetics|anesthetics|mesh-ancestor
20545920|NCT01885364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20545921|NCT01885364|Narcotics|narcotics|mesh-ancestor
20545922|NCT01885364|Analgesics|analgesics|mesh-ancestor
20277438|NCT00564200|Immunologic Factors|immunologic factors|mesh-ancestor
20277439|NCT00564200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20277440|NCT00564200|Alkylating Agents|alkylating agents|mesh-ancestor
20277441|NCT00564200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19962171|NCT01710709|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20277442|NCT00564213|Mitomycins|mitomycins|mesh-list
20277443|NCT00564213|Mitomycin|mitomycin|mesh-list
20277444|NCT00564213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20277445|NCT00564213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277446|NCT00564213|Alkylating Agents|alkylating agents|mesh-ancestor
20277447|NCT00564213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277448|NCT00564213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20277449|NCT00564213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277450|NCT00564252|Finasteride|finasteride|mesh-list
20277451|NCT00564252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20277452|NCT00564252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20277453|NCT00564252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277454|NCT00564252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277455|NCT00564252|Hormone Antagonists|hormone antagonists|mesh-ancestor
20277456|NCT00564252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20277457|NCT00564252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277458|NCT00564252|Urological Agents|urological agents|mesh-ancestor
20277459|NCT00564330|Esomeprazole|esomeprazole|mesh-list
20277460|NCT00564330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19962172|NCT01710709|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19962173|NCT01710787|Phenylephrine|phenylephrine|mesh-list
19962174|NCT01710787|Oxymetazoline|oxymetazoline|mesh-list
19962175|NCT01710787|Tetracaine|tetracaine|mesh-list
19962176|NCT01710787|Anesthetics, Local|anesthetics, local|mesh-ancestor
20277461|NCT00564330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20277462|NCT00564330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20277463|NCT00564330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277464|NCT00564330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277465|NCT00564408|Carbachol|carbachol|mesh-list
20277466|NCT00564408|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20277467|NCT00564408|Miotics|miotics|mesh-ancestor
20277468|NCT00564408|Autonomic Agents|autonomic agents|mesh-ancestor
20277469|NCT00564408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20277470|NCT00564408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277471|NCT00564408|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20277472|NCT00564408|Cholinergic Agents|cholinergic agents|mesh-ancestor
20277473|NCT00564408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277474|NCT00564408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277475|NCT00564408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20277476|NCT00564408|Analgesics|analgesics|mesh-ancestor
20277477|NCT00564408|Sensory System Agents|sensory system agents|mesh-ancestor
20277478|NCT00564408|Protective Agents|protective agents|mesh-ancestor
20277479|NCT00564460|Finasteride|finasteride|mesh-list
20277480|NCT00564460|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20277481|NCT00564460|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20277482|NCT00564460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277483|NCT00564460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277484|NCT00564460|Hormone Antagonists|hormone antagonists|mesh-ancestor
20277485|NCT00564460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20277486|NCT00564460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545923|NCT01885364|Sensory System Agents|sensory system agents|mesh-ancestor
20545924|NCT01885364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545925|NCT01885364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20545926|NCT01885364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20545927|NCT01885364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20545928|NCT01885364|Adrenergic Agents|adrenergic agents|mesh-ancestor
19962177|NCT01710787|Anesthetics|anesthetics|mesh-ancestor
19962178|NCT01710787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19962179|NCT01710787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962180|NCT01710787|Sensory System Agents|sensory system agents|mesh-ancestor
20545929|NCT01885364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20545930|NCT01885364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545931|NCT01885481|Dexamethasone|dexamethasone|mesh-list
20545932|NCT01885481|Dexamethasone acetate|dexamethasone acetate|mesh-list
20545933|NCT01885481|Betamethasone|betamethasone|mesh-list
20545934|NCT01885481|Betamethasone Valerate|betamethasone valerate|mesh-list
20545935|NCT01885481|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20545936|NCT01885481|Betamethasone benzoate|betamethasone benzoate|mesh-list
19962181|NCT01710787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20277487|NCT00564460|Urological Agents|urological agents|mesh-ancestor
20277488|NCT00564512|Cyclophosphamide|cyclophosphamide|mesh-list
20277489|NCT00564512|Rituximab|rituximab|mesh-list
20277490|NCT00564512|Fludarabine|fludarabine|mesh-list
20277491|NCT00564512|Alemtuzumab|alemtuzumab|mesh-list
20277492|NCT00564512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20277493|NCT00564512|Immunologic Factors|immunologic factors|mesh-ancestor
20277494|NCT00564512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277495|NCT00564512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20277496|NCT00564512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20277497|NCT00564512|Alkylating Agents|alkylating agents|mesh-ancestor
20277498|NCT00564512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277499|NCT00564512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277500|NCT00564512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20545937|NCT01885481|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20545938|NCT01885481|BB 1101|bb 1101|mesh-list
20545939|NCT01885481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20545940|NCT01885481|Antiemetics|antiemetics|mesh-ancestor
20545941|NCT01885481|Autonomic Agents|autonomic agents|mesh-ancestor
20545942|NCT01885481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545943|NCT01885481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545944|NCT01885481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20545945|NCT01885481|Glucocorticoids|glucocorticoids|mesh-ancestor
20545946|NCT01885481|Hormones|hormones|mesh-ancestor
20545947|NCT01885481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20545948|NCT01885481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20545949|NCT01885481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20545950|NCT01885481|Protease Inhibitors|protease inhibitors|mesh-ancestor
20545951|NCT01885481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545952|NCT01885481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545953|NCT01885481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20545954|NCT01885481|Respiratory System Agents|respiratory system agents|mesh-ancestor
20545955|NCT01885585|Apixaban|apixaban|mesh-list
19962182|NCT01710787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19962183|NCT01710787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19962184|NCT01710787|Adrenergic Agents|adrenergic agents|mesh-ancestor
19962185|NCT01710787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19962186|NCT01710787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962187|NCT01710787|Sympathomimetics|sympathomimetics|mesh-ancestor
19962188|NCT01710787|Autonomic Agents|autonomic agents|mesh-ancestor
19962189|NCT01710787|Nasal Decongestants|nasal decongestants|mesh-ancestor
19962190|NCT01710787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19962191|NCT01710787|Respiratory System Agents|respiratory system agents|mesh-ancestor
19962192|NCT01710787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19962193|NCT01710787|Mydriatics|mydriatics|mesh-ancestor
19962194|NCT01710787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19962195|NCT01710787|Protective Agents|protective agents|mesh-ancestor
19962196|NCT01710800|Esomeprazole|esomeprazole|mesh-list
20545956|NCT01885585|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19962197|NCT01710800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19962198|NCT01710800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19962199|NCT01710800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19962200|NCT01710800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962201|NCT01710800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962202|NCT01710839|Ranibizumab|ranibizumab|mesh-list
19962203|NCT01710839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20287872|NCT03335488|Protective Agents|protective agents|mesh-ancestor
20287873|NCT03335488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287874|NCT03335488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287875|NCT03219268|Margetuximab|margetuximab|mesh-list
20287876|NCT03219268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287877|NCT03194893|Crizotinib|crizotinib|mesh-list
20287878|NCT03194893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287879|NCT03194893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20287880|NCT03194893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287881|NCT03194893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287882|NCT03096418|Paclitaxel|paclitaxel|mesh-list
20287883|NCT03096418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20287884|NCT03096418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287885|NCT03096418|Tubulin Modulators|tubulin modulators|mesh-ancestor
20287886|NCT03096418|Antimitotic Agents|antimitotic agents|mesh-ancestor
20287887|NCT03096418|Mitosis Modulators|mitosis modulators|mesh-ancestor
20287888|NCT03096418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287889|NCT03085004|Gemcitabine|gemcitabine|mesh-list
20287890|NCT03085004|Ethanol|ethanol|mesh-list
20287891|NCT03085004|Paclitaxel|paclitaxel|mesh-list
20277501|NCT00564512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20287892|NCT03085004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20287893|NCT03085004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287894|NCT03085004|Tubulin Modulators|tubulin modulators|mesh-ancestor
20287895|NCT03085004|Antimitotic Agents|antimitotic agents|mesh-ancestor
20287896|NCT03085004|Mitosis Modulators|mitosis modulators|mesh-ancestor
20287897|NCT03085004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287898|NCT03085004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20287899|NCT03085004|Antimetabolites|antimetabolites|mesh-ancestor
20287900|NCT03085004|Antiviral Agents|antiviral agents|mesh-ancestor
20287901|NCT03085004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20287902|NCT03085004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287903|NCT03085004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20287904|NCT03085004|Immunologic Factors|immunologic factors|mesh-ancestor
20287905|NCT03085004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287906|NCT03085004|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20287907|NCT03085004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20287908|NCT02993198|Carvedilol|carvedilol|mesh-list
20287909|NCT02993198|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20287910|NCT02993198|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20287911|NCT02993198|Adrenergic Agents|adrenergic agents|mesh-ancestor
20287912|NCT02993198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20287913|NCT02993198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287914|NCT02993198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287915|NCT02993198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20287916|NCT02993198|Antioxidants|antioxidants|mesh-ancestor
20287917|NCT02993198|Protective Agents|protective agents|mesh-ancestor
20287918|NCT02993198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20287919|NCT02993198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20287920|NCT02993198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20287921|NCT02993198|Vasodilator Agents|vasodilator agents|mesh-ancestor
20287922|NCT02993198|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20287923|NCT02993198|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20287924|NCT02795858|Octreotide|octreotide|mesh-list
20287925|NCT02795858|Ramucirumab|ramucirumab|mesh-list
20287926|NCT02795858|Lanreotide|lanreotide|mesh-list
20287927|NCT02795858|Somatostatin|somatostatin|mesh-list
20287928|NCT02795858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20287929|NCT02795858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20545957|NCT01885585|Antithrombins|antithrombins|mesh-ancestor
20545958|NCT01885585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20545959|NCT01885585|Protease Inhibitors|protease inhibitors|mesh-ancestor
20545960|NCT01885585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545961|NCT01885585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545962|NCT01885585|Anticoagulants|anticoagulants|mesh-ancestor
20545963|NCT01885598|Apixaban|apixaban|mesh-list
20545964|NCT01885598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20545965|NCT01885598|Antithrombins|antithrombins|mesh-ancestor
20545966|NCT01885598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20545967|NCT01885598|Protease Inhibitors|protease inhibitors|mesh-ancestor
20545968|NCT01885598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545969|NCT01885598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545970|NCT01885598|Anticoagulants|anticoagulants|mesh-ancestor
20545971|NCT01885715|Neostigmine|neostigmine|mesh-list
20545972|NCT01885715|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20545973|NCT01885715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20545974|NCT01885715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545975|NCT01885715|Cholinergic Agents|cholinergic agents|mesh-ancestor
20545976|NCT01885715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20545977|NCT01885715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545978|NCT01885715|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19962204|NCT01710839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19962205|NCT01710839|Growth Substances|growth substances|mesh-ancestor
19962206|NCT01710839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545979|NCT01885715|Autonomic Agents|autonomic agents|mesh-ancestor
19962207|NCT01710839|Growth Inhibitors|growth inhibitors|mesh-ancestor
19962208|NCT01710839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962209|NCT01711177|Travoprost|travoprost|mesh-list
19962210|NCT01711177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19962211|NCT01711359|Folic Acid|folic acid|mesh-list
19962212|NCT01711359|Methotrexate|methotrexate|mesh-list
19962213|NCT01711359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20545980|NCT01885715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20545981|NCT01885988|Nebivolol|nebivolol|mesh-list
20545982|NCT01885988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20277502|NCT00564525|Amitriptyline|amitriptyline|mesh-list
20277503|NCT00564525|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20277504|NCT00564525|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20277505|NCT00564525|Antidepressive Agents|antidepressive agents|mesh-ancestor
20545983|NCT01885988|Vasodilator Agents|vasodilator agents|mesh-ancestor
20545984|NCT01885988|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20545985|NCT01885988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20545986|NCT01885988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20545987|NCT01885988|Adrenergic Agents|adrenergic agents|mesh-ancestor
20545988|NCT01885988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20545989|NCT01885988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20545990|NCT01885988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20545991|NCT01886001|Chlorhexidine|chlorhexidine|mesh-list
20545992|NCT01886001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20545993|NCT01886001|Povidone-Iodine|povidone-iodine|mesh-list
20545994|NCT01886001|Povidone|povidone|mesh-list
20545995|NCT01886001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20545996|NCT01886001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20545997|NCT01886001|Disinfectants|disinfectants|mesh-ancestor
20545998|NCT01886001|Dermatologic Agents|dermatologic agents|mesh-ancestor
20545999|NCT01886001|Plasma Substitutes|plasma substitutes|mesh-ancestor
20546000|NCT01886001|Blood Substitutes|blood substitutes|mesh-ancestor
20546001|NCT01886014|Oxytocin|oxytocin|mesh-list
20546002|NCT01886014|Oxytocics|oxytocics|mesh-ancestor
20546003|NCT01886014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20546004|NCT01886014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546005|NCT01886053|Ertapenem|ertapenem|mesh-list
20546006|NCT01886053|beta-Lactams|beta-lactams|mesh-list
20546007|NCT01886053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20546008|NCT01886053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20546009|NCT01886079|Dexmedetomidine|dexmedetomidine|mesh-list
20546010|NCT01886079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20546011|NCT01886079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20546012|NCT01886079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546013|NCT01886079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20546014|NCT01886079|Analgesics|analgesics|mesh-ancestor
20546015|NCT01886079|Sensory System Agents|sensory system agents|mesh-ancestor
20546016|NCT01886079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546017|NCT01886079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20546018|NCT01886079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20546019|NCT01886079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20546020|NCT01886079|Adrenergic Agents|adrenergic agents|mesh-ancestor
20546021|NCT01886079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20546022|NCT01886079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554349|NCT01935063|Sensory System Agents|sensory system agents|mesh-ancestor
20554350|NCT01935063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554351|NCT01935063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20554352|NCT01935063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20554353|NCT01935063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19962214|NCT01711359|Abortifacient Agents|abortifacient agents|mesh-ancestor
19962215|NCT01711359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19962216|NCT01711359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277506|NCT00564525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20277507|NCT00564525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20277508|NCT00564525|Analgesics|analgesics|mesh-ancestor
20277509|NCT00564525|Sensory System Agents|sensory system agents|mesh-ancestor
19962217|NCT01711359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19962218|NCT01711359|Antimetabolites|antimetabolites|mesh-ancestor
19962219|NCT01711359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962220|NCT01711359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962221|NCT01711359|Dermatologic Agents|dermatologic agents|mesh-ancestor
19962222|NCT01711359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962223|NCT01711359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19962224|NCT01711359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20277510|NCT00564525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20277511|NCT00564525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277512|NCT00564525|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20277513|NCT00564525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20277514|NCT00564525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20277515|NCT00564525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277516|NCT00564525|Adrenergic Agents|adrenergic agents|mesh-ancestor
20277517|NCT00564525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277518|NCT00564525|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20277519|NCT00564525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20277520|NCT00564525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20277521|NCT00564538|Tacrolimus|tacrolimus|mesh-list
20277522|NCT00564538|Thymoglobulin|thymoglobulin|mesh-list
20277523|NCT00564538|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20277524|NCT00564538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20277525|NCT00564538|Immunologic Factors|immunologic factors|mesh-ancestor
20277526|NCT00564538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277527|NCT00564538|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20277528|NCT00564538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277529|NCT00564538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277530|NCT00564551|Calcium, Dietary|calcium, dietary|mesh-list
20277531|NCT00564551|Calcium|calcium|mesh-list
20277532|NCT00564551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20277533|NCT00564551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277534|NCT00564551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20277535|NCT00564564|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20277536|NCT00564564|Clomipramine|clomipramine|mesh-list
20277537|NCT00564564|Antidepressive Agents|antidepressive agents|mesh-ancestor
20277538|NCT00564564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20277539|NCT00564564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20277540|NCT00564564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20277541|NCT00564564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20277542|NCT00564564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277543|NCT00564564|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20277544|NCT00564564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20277545|NCT00564564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20277546|NCT00564564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20277547|NCT00564564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277548|NCT00564564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277549|NCT00564564|Serotonin Agents|serotonin agents|mesh-ancestor
20277550|NCT00564590|Melatonin|melatonin|mesh-list
20277551|NCT00564590|Omeprazole|omeprazole|mesh-list
20277552|NCT00564590|Antioxidants|antioxidants|mesh-ancestor
20277553|NCT00564590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277554|NCT00564590|Protective Agents|protective agents|mesh-ancestor
20277555|NCT00564590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277556|NCT00564590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20277557|NCT00564590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20277558|NCT00564590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20277559|NCT00564590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20277560|NCT00564590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277561|NCT00564603|Dexamethasone|dexamethasone|mesh-list
20277562|NCT00564603|Dexamethasone acetate|dexamethasone acetate|mesh-list
20277563|NCT00564603|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20277564|NCT00564603|BB 1101|bb 1101|mesh-list
20277565|NCT00564603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20277566|NCT00564603|Antiemetics|antiemetics|mesh-ancestor
20277567|NCT00564603|Autonomic Agents|autonomic agents|mesh-ancestor
20277568|NCT00564603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20277569|NCT00564603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277570|NCT00564603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20277571|NCT00564603|Glucocorticoids|glucocorticoids|mesh-ancestor
20277572|NCT00564603|Hormones|hormones|mesh-ancestor
20277573|NCT00564603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20277574|NCT00564603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20277575|NCT00564603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277576|NCT00564603|Protease Inhibitors|protease inhibitors|mesh-ancestor
20277577|NCT00564603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962225|NCT01711359|Immunologic Factors|immunologic factors|mesh-ancestor
20546023|NCT01886196|Ibuprofen|ibuprofen|mesh-list
20546024|NCT01886196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
20546025|NCT01886196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20546026|NCT01886196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20546027|NCT01886196|Analgesics|analgesics|mesh-ancestor
20546028|NCT01886196|Sensory System Agents|sensory system agents|mesh-ancestor
20546029|NCT01886196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546030|NCT01886196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546031|NCT01886196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20546032|NCT01886196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20546033|NCT01886196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546034|NCT01886196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546035|NCT01886209|Prednisone|prednisone|mesh-list
20546036|NCT01886209|Methylprednisolone|methylprednisolone|mesh-list
20546037|NCT01886209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20277578|NCT00564603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277579|NCT00564642|Acetylcysteine|acetylcysteine|mesh-list
20277580|NCT00564642|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20277581|NCT00564642|Antiviral Agents|antiviral agents|mesh-ancestor
20277582|NCT00564642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20277583|NCT00564642|Expectorants|expectorants|mesh-ancestor
20277584|NCT00564642|Respiratory System Agents|respiratory system agents|mesh-ancestor
20277585|NCT00564642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20277586|NCT00564642|Antioxidants|antioxidants|mesh-ancestor
20277587|NCT00564642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277588|NCT00564642|Protective Agents|protective agents|mesh-ancestor
20277589|NCT00564642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277590|NCT00564642|Antidotes|antidotes|mesh-ancestor
20277591|NCT00564655|Epinephrine|epinephrine|mesh-list
20277592|NCT00564655|Racepinephrine|racepinephrine|mesh-list
20277593|NCT00564655|Bupivacaine|bupivacaine|mesh-list
20277594|NCT00564655|Epinephryl borate|epinephryl borate|mesh-list
20277595|NCT00564655|Anesthetics, Local|anesthetics, local|mesh-ancestor
20277596|NCT00564655|Anesthetics|anesthetics|mesh-ancestor
20277597|NCT00564655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20277598|NCT00564655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277599|NCT00564655|Sensory System Agents|sensory system agents|mesh-ancestor
20277600|NCT00564655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20277601|NCT00564655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20277602|NCT00564655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20277603|NCT00564655|Adrenergic Agents|adrenergic agents|mesh-ancestor
20277604|NCT00564655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277605|NCT00564655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277606|NCT00564655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20277607|NCT00564655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20277608|NCT00564655|Autonomic Agents|autonomic agents|mesh-ancestor
20277609|NCT00564655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20277610|NCT00564655|Respiratory System Agents|respiratory system agents|mesh-ancestor
20277611|NCT00564655|Mydriatics|mydriatics|mesh-ancestor
20277612|NCT00564655|Sympathomimetics|sympathomimetics|mesh-ancestor
20277613|NCT00564655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20277614|NCT00564668|Insulin Aspart|insulin aspart|mesh-list
20277615|NCT00564668|Biphasic Insulins|biphasic insulins|mesh-list
20277616|NCT00564668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20277617|NCT00564668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277618|NCT00564707|Botulinum Toxins|botulinum toxins|mesh-list
20546038|NCT01886209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20546039|NCT01886209|Prednisolone|prednisolone|mesh-list
20546040|NCT01886209|Prednisolone acetate|prednisolone acetate|mesh-list
20546041|NCT01886209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20546042|NCT01886209|Prednisolone phosphate|prednisolone phosphate|mesh-list
19733294|NCT04563533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733295|NCT04563494|Dexamethasone|dexamethasone|mesh-list
19733296|NCT04563494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19733297|NCT04563494|Antiemetics|antiemetics|mesh-ancestor
19733298|NCT04563494|Autonomic Agents|autonomic agents|mesh-ancestor
20546043|NCT01886209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20546044|NCT01886209|Glucocorticoids|glucocorticoids|mesh-ancestor
20546045|NCT01886209|Hormones|hormones|mesh-ancestor
20546046|NCT01886209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20546047|NCT01886209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546048|NCT01886209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20546049|NCT01886209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20546050|NCT01886209|Antiemetics|antiemetics|mesh-ancestor
20546051|NCT01886209|Autonomic Agents|autonomic agents|mesh-ancestor
20546052|NCT01886209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546053|NCT01886209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20546054|NCT01886209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20546055|NCT01886209|Protective Agents|protective agents|mesh-ancestor
20546056|NCT01886248|Antithrombins|antithrombins|mesh-list
20546057|NCT01886248|Antithrombin III|antithrombin iii|mesh-list
20546058|NCT01886248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20546059|NCT01886248|Protease Inhibitors|protease inhibitors|mesh-ancestor
20546060|NCT01886248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546061|NCT01886248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546062|NCT01886248|Anticoagulants|anticoagulants|mesh-ancestor
20546063|NCT01886352|Levobupivacaine|levobupivacaine|mesh-list
20546064|NCT01886352|Anesthetics, Local|anesthetics, local|mesh-ancestor
20546065|NCT01886352|Anesthetics|anesthetics|mesh-ancestor
20546066|NCT01886352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20277619|NCT00564707|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20277620|NCT00564707|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20277621|NCT00564707|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20277622|NCT00564707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20277623|NCT00564707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277624|NCT00564707|Cholinergic Agents|cholinergic agents|mesh-ancestor
20277625|NCT00564707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277626|NCT00564707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277627|NCT00564707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20277628|NCT00564707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20277629|NCT00564720|Gemcitabine|gemcitabine|mesh-list
20277630|NCT00564720|Oxaliplatin|oxaliplatin|mesh-list
20277631|NCT00564720|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20277632|NCT00564720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20277633|NCT00564720|Antimetabolites|antimetabolites|mesh-ancestor
20277634|NCT00564720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277635|NCT00564720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277636|NCT00564720|Antiviral Agents|antiviral agents|mesh-ancestor
20277637|NCT00564720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20277638|NCT00564720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277639|NCT00564720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20277640|NCT00564720|Immunologic Factors|immunologic factors|mesh-ancestor
20277641|NCT00564720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277642|NCT00564720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20277643|NCT00564772|Ritonavir|ritonavir|mesh-list
20277644|NCT00564772|Lopinavir|lopinavir|mesh-list
20277645|NCT00564772|Raltegravir Potassium|raltegravir potassium|mesh-list
20277646|NCT00564772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20277647|NCT00564772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20277648|NCT00564772|Protease Inhibitors|protease inhibitors|mesh-ancestor
20277649|NCT00564772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277650|NCT00564772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277651|NCT00564772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20277652|NCT00564772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20277653|NCT00564772|Antiviral Agents|antiviral agents|mesh-ancestor
20277654|NCT00564772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20277655|NCT00564772|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20277656|NCT00564772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20277657|NCT00564772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20277658|NCT00564772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20277659|NCT00564824|Caffeine|caffeine|mesh-list
20277660|NCT00564824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20277661|NCT00564824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277662|NCT00564824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20277663|NCT00564824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277664|NCT00564824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277665|NCT00564824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20277666|NCT00564824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20277667|NCT00564824|Purinergic Agents|purinergic agents|mesh-ancestor
20277668|NCT00564824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277669|NCT00564941|Deferasirox|deferasirox|mesh-list
20277670|NCT00564941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20277671|NCT00564941|Chelating Agents|chelating agents|mesh-ancestor
20277672|NCT00564941|Sequestering Agents|sequestering agents|mesh-ancestor
20277673|NCT00564941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277674|NCT00564993|Dobutamine|dobutamine|mesh-list
20277675|NCT00564993|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20277676|NCT00564993|Sympathomimetics|sympathomimetics|mesh-ancestor
20277677|NCT00564993|Autonomic Agents|autonomic agents|mesh-ancestor
20277678|NCT00564993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20277679|NCT00564993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277680|NCT00564993|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20277681|NCT00564993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20277682|NCT00564993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20277683|NCT00564993|Adrenergic Agents|adrenergic agents|mesh-ancestor
20277684|NCT00564993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277685|NCT00564993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277686|NCT00564993|Protective Agents|protective agents|mesh-ancestor
20277687|NCT00565006|Anacetrapib|anacetrapib|mesh-list
20277688|NCT00565006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20277689|NCT00565006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20277690|NCT00565006|Antimetabolites|antimetabolites|mesh-ancestor
20277691|NCT00565006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277692|NCT00565006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20277693|NCT00565019|Triamcinolone|triamcinolone|mesh-list
20277694|NCT00565019|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20277695|NCT00565019|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20277696|NCT00565019|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20277697|NCT00565019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20277698|NCT00565019|Glucocorticoids|glucocorticoids|mesh-ancestor
20277699|NCT00565019|Hormones|hormones|mesh-ancestor
20277700|NCT00565019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20277701|NCT00565019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277702|NCT00565019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20277703|NCT00565019|Immunologic Factors|immunologic factors|mesh-ancestor
20277704|NCT00565019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277705|NCT00565019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277706|NCT00565097|Lanreotide|lanreotide|mesh-list
20277707|NCT00565097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277708|NCT00565123|Levofloxacin|levofloxacin|mesh-list
20277709|NCT00565123|Ofloxacin|ofloxacin|mesh-list
20277710|NCT00565123|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20546067|NCT01886352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546068|NCT01886352|Sensory System Agents|sensory system agents|mesh-ancestor
20546069|NCT01886352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546070|NCT01886365|Insulin|insulin|mesh-list
20546071|NCT01886365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20546072|NCT01886365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546073|NCT01886404|Efavirenz|efavirenz|mesh-list
20546074|NCT01886404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20546075|NCT01886404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20546076|NCT01886404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962226|NCT01711359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20288590|NCT05289869|Oxytocics|oxytocics|mesh-ancestor
20288591|NCT05289869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20288592|NCT05289869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288593|NCT05288777|Capecitabine|capecitabine|mesh-list
20288594|NCT05288777|Trastuzumab|trastuzumab|mesh-list
20288595|NCT05288777|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20288596|NCT05288777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20288597|NCT05288777|Antimetabolites|antimetabolites|mesh-ancestor
20288598|NCT05288777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277711|NCT00565123|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20277712|NCT00565123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20277713|NCT00565123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20277714|NCT00565123|Renal Agents|renal agents|mesh-ancestor
20277715|NCT00565123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20277716|NCT00565123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20277717|NCT00565123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20277718|NCT00565123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277719|NCT00565123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277720|NCT00565123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277721|NCT00565123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20277722|NCT00565123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20277723|NCT00565162|Insulin Glargine|insulin glargine|mesh-list
20277724|NCT00565162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20277725|NCT00565162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277726|NCT00565175|Famotidine|famotidine|mesh-list
20277727|NCT00565175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20277728|NCT00565175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20277729|NCT00565175|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20277730|NCT00565175|Histamine Antagonists|histamine antagonists|mesh-ancestor
20277731|NCT00565175|Histamine Agents|histamine agents|mesh-ancestor
20277732|NCT00565175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277733|NCT00565175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277734|NCT00565175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277735|NCT00565188|Adenosine|adenosine|mesh-list
20277736|NCT00565188|Analgesics|analgesics|mesh-ancestor
20277737|NCT00565188|Sensory System Agents|sensory system agents|mesh-ancestor
20277738|NCT00565188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20277739|NCT00565188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277740|NCT00565188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20546077|NCT01886404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546078|NCT01886404|Antiviral Agents|antiviral agents|mesh-ancestor
20546079|NCT01886404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20546080|NCT01886404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20546081|NCT01886404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20546082|NCT01886404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20546083|NCT01886404|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20546084|NCT01886404|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20546085|NCT01886404|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20546086|NCT01886443|Tocopherols|tocopherols|mesh-list
20546087|NCT01886443|Vitamin E|vitamin e|mesh-list
20546088|NCT01886443|alpha-Tocopherol|alpha-tocopherol|mesh-list
20546089|NCT01886443|Infliximab|infliximab|mesh-list
20546090|NCT01886443|Epoprostenol|epoprostenol|mesh-list
20546091|NCT01886443|Tezosentan|tezosentan|mesh-list
20546092|NCT01886443|Melatonin|melatonin|mesh-list
20546093|NCT01886443|Antithrombins|antithrombins|mesh-list
20546094|NCT01886443|Antithrombin III|antithrombin iii|mesh-list
20546095|NCT01886443|Epoetin Alfa|epoetin alfa|mesh-list
20546096|NCT01886443|Dermatologic Agents|dermatologic agents|mesh-ancestor
20546097|NCT01886443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19962227|NCT01711359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19962228|NCT01711359|Hematinics|hematinics|mesh-ancestor
19962229|NCT01711359|Vitamin B Complex|vitamin b complex|mesh-ancestor
19962230|NCT01711359|Vitamins|vitamins|mesh-ancestor
19962231|NCT01711359|Micronutrients|micronutrients|mesh-ancestor
19962232|NCT01711645|Aluminum phosphate|aluminum phosphate|mesh-list
19962233|NCT01711645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19962234|NCT01711645|Immunologic Factors|immunologic factors|mesh-ancestor
19962235|NCT01711645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962236|NCT01711645|Antacids|antacids|mesh-ancestor
19962237|NCT01711645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962238|NCT01711645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19962239|NCT01711658|Lapatinib|lapatinib|mesh-list
19962240|NCT01711658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962241|NCT01711658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19962242|NCT01711658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962243|NCT01711658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962244|NCT01711853|Dabigatran|dabigatran|mesh-list
19962245|NCT01711853|Antithrombins|antithrombins|mesh-ancestor
19962246|NCT01711853|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19962247|NCT01711853|Protease Inhibitors|protease inhibitors|mesh-ancestor
20277741|NCT00565188|Vasodilator Agents|vasodilator agents|mesh-ancestor
20546098|NCT01886443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20546099|NCT01886443|Antioxidants|antioxidants|mesh-ancestor
20546100|NCT01886443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277742|NCT00565188|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20277743|NCT00565188|Purinergic Agonists|purinergic agonists|mesh-ancestor
20277744|NCT00565188|Purinergic Agents|purinergic agents|mesh-ancestor
20277745|NCT00565188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277746|NCT00565188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277747|NCT00565214|Vitamins|vitamins|mesh-list
20277748|NCT00565214|Vitamin E|vitamin e|mesh-list
20277749|NCT00565214|Selenium|selenium|mesh-list
20277750|NCT00565214|Micronutrients|micronutrients|mesh-ancestor
19962248|NCT01711853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277751|NCT00565214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277752|NCT00565214|Antioxidants|antioxidants|mesh-ancestor
20277753|NCT00565214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277754|NCT00565214|Protective Agents|protective agents|mesh-ancestor
20277755|NCT00565214|Trace Elements|trace elements|mesh-ancestor
20277756|NCT00565227|Docetaxel|docetaxel|mesh-list
20277757|NCT00565227|Vorinostat|vorinostat|mesh-list
20277758|NCT00565227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277759|NCT00565227|Tubulin Modulators|tubulin modulators|mesh-ancestor
20277760|NCT00565227|Antimitotic Agents|antimitotic agents|mesh-ancestor
20277761|NCT00565227|Mitosis Modulators|mitosis modulators|mesh-ancestor
20277762|NCT00565227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277763|NCT00565227|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20277764|NCT00565227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277765|NCT00565240|Letrozole|letrozole|mesh-list
20277766|NCT00565240|NuvaRing|nuvaring|mesh-list
20277767|NCT00565240|Desogestrel|desogestrel|mesh-list
20277768|NCT00565240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277769|NCT00565240|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20277770|NCT00565240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20277771|NCT00565240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277772|NCT00565240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277773|NCT00565240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20277774|NCT00565240|Hormone Antagonists|hormone antagonists|mesh-ancestor
20277775|NCT00565240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20277776|NCT00565240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277777|NCT00565240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20277778|NCT00565240|Contraceptive Agents|contraceptive agents|mesh-ancestor
20277779|NCT00565240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20277780|NCT00565240|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20277781|NCT00565240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20277782|NCT00565240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20277783|NCT00565240|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20277784|NCT00565240|Progestins|progestins|mesh-ancestor
20277785|NCT00565240|Hormones|hormones|mesh-ancestor
20277786|NCT00565253|Nitric Oxide|nitric oxide|mesh-list
20277787|NCT00565253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20277788|NCT00565253|Autonomic Agents|autonomic agents|mesh-ancestor
20277789|NCT00565253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20277790|NCT00565253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277791|NCT00565253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20277792|NCT00565253|Respiratory System Agents|respiratory system agents|mesh-ancestor
20277793|NCT00565253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20277794|NCT00565253|Antioxidants|antioxidants|mesh-ancestor
20277795|NCT00565253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277796|NCT00565253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277797|NCT00565253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20277798|NCT00565253|Vasodilator Agents|vasodilator agents|mesh-ancestor
20277799|NCT00565253|Gasotransmitters|gasotransmitters|mesh-ancestor
20277800|NCT00565253|Protective Agents|protective agents|mesh-ancestor
20277801|NCT00565292|Anacetrapib|anacetrapib|mesh-list
20277802|NCT00565292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20277803|NCT00565292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20277804|NCT00565292|Antimetabolites|antimetabolites|mesh-ancestor
20277805|NCT00565292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277806|NCT00565292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20546101|NCT01886443|Protective Agents|protective agents|mesh-ancestor
19962249|NCT01711853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962250|NCT01711853|Anticoagulants|anticoagulants|mesh-ancestor
19962251|NCT01711866|Rotigotine|rotigotine|mesh-list
20277807|NCT00565318|Benphothiamine|benphothiamine|mesh-list
20277808|NCT00565318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20277809|NCT00565318|Immunologic Factors|immunologic factors|mesh-ancestor
20277810|NCT00565318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277811|NCT00565318|Chelating Agents|chelating agents|mesh-ancestor
20277812|NCT00565318|Sequestering Agents|sequestering agents|mesh-ancestor
20277813|NCT00565318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277814|NCT00565331|Rituximab|rituximab|mesh-list
20277815|NCT00565331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20277816|NCT00565331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277817|NCT00565331|Immunologic Factors|immunologic factors|mesh-ancestor
20277818|NCT00565331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277819|NCT00565331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20277820|NCT00565383|Fentanyl|fentanyl|mesh-list
20277821|NCT00565383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20277822|NCT00565383|Narcotics|narcotics|mesh-ancestor
20277823|NCT00565383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20277824|NCT00565383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962252|NCT01711866|Dopamine Agonists|dopamine agonists|mesh-ancestor
19962253|NCT01711866|Dopamine Agents|dopamine agents|mesh-ancestor
19962254|NCT01711866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20546102|NCT01886443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546103|NCT01886443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20546104|NCT01886443|Hematinics|hematinics|mesh-ancestor
20546105|NCT01886443|Vitamins|vitamins|mesh-ancestor
20546106|NCT01886443|Micronutrients|micronutrients|mesh-ancestor
20546107|NCT01886443|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20546108|NCT01886443|Protease Inhibitors|protease inhibitors|mesh-ancestor
20546109|NCT01886443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546110|NCT01886443|Anticoagulants|anticoagulants|mesh-ancestor
20546111|NCT01886443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20546112|NCT01886443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20546113|NCT01886443|Vasodilator Agents|vasodilator agents|mesh-ancestor
20546114|NCT01886534|Diuretics|diuretics|mesh-list
20546115|NCT01886534|Natriuretic Agents|natriuretic agents|mesh-ancestor
20546116|NCT01886534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546117|NCT01886560|Doxycycline|doxycycline|mesh-list
20546118|NCT01886560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20546119|NCT01886560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20546120|NCT01886560|Antimalarials|antimalarials|mesh-ancestor
20546121|NCT01886560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20546122|NCT01886560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20546123|NCT01886573|Azacitidine|azacitidine|mesh-list
20546124|NCT01886573|Entinostat|entinostat|mesh-list
20546125|NCT01886573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20546126|NCT01886573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20546127|NCT01886573|Antimetabolites|antimetabolites|mesh-ancestor
20546128|NCT01886573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546129|NCT01886573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20546130|NCT01886573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546131|NCT01886599|Asunaprevir|asunaprevir|mesh-list
20546132|NCT01886599|Protease Inhibitors|protease inhibitors|mesh-ancestor
20546133|NCT01886599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546134|NCT01886599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546135|NCT01886638|Abacavir|abacavir|mesh-list
20546136|NCT01886638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20546137|NCT01886638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20546138|NCT01886638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546139|NCT01886638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546140|NCT01886638|Antiviral Agents|antiviral agents|mesh-ancestor
20546141|NCT01886638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20546142|NCT01886638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20546143|NCT01886638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20546144|NCT01886664|Sevoflurane|sevoflurane|mesh-list
20546145|NCT01886664|Desflurane|desflurane|mesh-list
20546146|NCT01886664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20546147|NCT01886664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20546148|NCT01886664|Anesthetics, General|anesthetics, general|mesh-ancestor
20546149|NCT01886664|Anesthetics|anesthetics|mesh-ancestor
20546150|NCT01886664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20546151|NCT01886664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962255|NCT01711866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962256|NCT01711866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962257|NCT01711918|Domperidone|domperidone|mesh-list
19962258|NCT01711918|Antiemetics|antiemetics|mesh-ancestor
19962259|NCT01711918|Autonomic Agents|autonomic agents|mesh-ancestor
20277825|NCT00565383|Analgesics|analgesics|mesh-ancestor
20277826|NCT00565383|Sensory System Agents|sensory system agents|mesh-ancestor
20277827|NCT00565383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20277828|NCT00565383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20277829|NCT00565383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20277830|NCT00565383|Anesthetics, General|anesthetics, general|mesh-ancestor
20277831|NCT00565383|Anesthetics|anesthetics|mesh-ancestor
20277832|NCT00565396|Losartan|losartan|mesh-list
20277833|NCT00565396|Fosinopril|fosinopril|mesh-list
20277834|NCT00565396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20277835|NCT00565396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20277836|NCT00565396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20277837|NCT00565396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20277838|NCT00565396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277839|NCT00565396|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20277840|NCT00565396|Protease Inhibitors|protease inhibitors|mesh-ancestor
20277841|NCT00565396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277842|NCT00565422|Citalopram|citalopram|mesh-list
20277843|NCT00565422|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20277844|NCT00565422|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20277845|NCT00565422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20277846|NCT00565422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277847|NCT00565422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277848|NCT00565422|Serotonin Agents|serotonin agents|mesh-ancestor
20277849|NCT00565422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277850|NCT00565422|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20277851|NCT00565422|Antidepressive Agents|antidepressive agents|mesh-ancestor
20277852|NCT00565422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20277853|NCT00565461|Vaccines|vaccines|mesh-list
20277854|NCT00565461|Immunologic Factors|immunologic factors|mesh-ancestor
20277855|NCT00565461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277856|NCT00565487|Capecitabine|capecitabine|mesh-list
20277857|NCT00565487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20277858|NCT00565487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20277859|NCT00565487|Antimetabolites|antimetabolites|mesh-ancestor
20546152|NCT01886768|Anesthetics|anesthetics|mesh-list
20546153|NCT01886768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20546154|NCT01886768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546155|NCT01886794|Estrogens|estrogens|mesh-list
20546156|NCT01886794|Hormones|hormones|mesh-ancestor
20546157|NCT01886794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20546158|NCT01886794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546159|NCT01887119|Eplerenone|eplerenone|mesh-list
20546160|NCT01887119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20546161|NCT01887119|Hormone Antagonists|hormone antagonists|mesh-ancestor
20546162|NCT01887119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20546163|NCT01887119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546164|NCT01887119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20546165|NCT01887119|Diuretics|diuretics|mesh-ancestor
20546166|NCT01887119|Natriuretic Agents|natriuretic agents|mesh-ancestor
20546167|NCT01887119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20546168|NCT01887158|Bisacodyl|bisacodyl|mesh-list
20546169|NCT01887158|Cathartics|cathartics|mesh-ancestor
20546170|NCT01887158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20546171|NCT01887158|Laxatives|laxatives|mesh-ancestor
20546172|NCT01887184|Dexmedetomidine|dexmedetomidine|mesh-list
20546173|NCT01887184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20546174|NCT01887184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20546175|NCT01887184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546176|NCT01887184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20546177|NCT01887184|Analgesics|analgesics|mesh-ancestor
20546178|NCT01887184|Sensory System Agents|sensory system agents|mesh-ancestor
20546179|NCT01887184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546180|NCT01887184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20546181|NCT01887184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20546182|NCT01887184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20546183|NCT01887184|Adrenergic Agents|adrenergic agents|mesh-ancestor
20546184|NCT01887184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20546185|NCT01887184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546186|NCT01887197|Mannitol|mannitol|mesh-list
20546187|NCT01887197|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20546188|NCT01887197|Diuretics|diuretics|mesh-ancestor
20546189|NCT01887197|Natriuretic Agents|natriuretic agents|mesh-ancestor
20546190|NCT01887197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546191|NCT01887223|Timolol|timolol|mesh-list
20546192|NCT01887223|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20277860|NCT00565487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277861|NCT00565487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277862|NCT00565487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20277863|NCT00565487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277864|NCT00565500|Ibuprofen|ibuprofen|mesh-list
20277865|NCT00565500|Celecoxib|celecoxib|mesh-list
20277866|NCT00565500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20277867|NCT00565500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20277868|NCT00565500|Analgesics|analgesics|mesh-ancestor
20277869|NCT00565500|Sensory System Agents|sensory system agents|mesh-ancestor
20277870|NCT00565500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20277871|NCT00565500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277872|NCT00565500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20277873|NCT00565500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20277874|NCT00565500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20277875|NCT00565500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277876|NCT00565500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277877|NCT00565500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20277878|NCT00565539|Interferons|interferons|mesh-list
20277879|NCT00565539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277880|NCT00565539|Antiviral Agents|antiviral agents|mesh-ancestor
20277881|NCT00565539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20277882|NCT00565591|Albuterol|albuterol|mesh-list
20277883|NCT00565591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20277884|NCT00565591|Autonomic Agents|autonomic agents|mesh-ancestor
20277885|NCT00565591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20277886|NCT00565591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277887|NCT00565591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20277888|NCT00565591|Respiratory System Agents|respiratory system agents|mesh-ancestor
20277889|NCT00565591|Tocolytic Agents|tocolytic agents|mesh-ancestor
20277890|NCT00565591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20277891|NCT00565591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20277892|NCT00565591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20277893|NCT00565591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20277894|NCT00565591|Adrenergic Agents|adrenergic agents|mesh-ancestor
20277895|NCT00565591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277896|NCT00565591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277897|NCT00565630|Moxifloxacin|moxifloxacin|mesh-list
20277898|NCT00565630|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20277899|NCT00565630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20277900|NCT00565630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20277901|NCT00565630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20277902|NCT00565630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20277903|NCT00565630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277904|NCT00565630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277905|NCT00565630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277906|NCT00565630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20546193|NCT01887223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20546194|NCT01887223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20546195|NCT01887223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20546196|NCT01887223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20546197|NCT01887223|Adrenergic Agents|adrenergic agents|mesh-ancestor
20546198|NCT01887223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20546199|NCT01887223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546200|NCT01887223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546201|NCT01887223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20546202|NCT01887223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20546203|NCT01887223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20546204|NCT01887249|Metronidazole|metronidazole|mesh-list
20546205|NCT01887249|Clarithromycin|clarithromycin|mesh-list
20546206|NCT01887249|Esomeprazole|esomeprazole|mesh-list
20546207|NCT01887249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20546208|NCT01887249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20546209|NCT01887249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20546210|NCT01887249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20546211|NCT01887249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20546212|NCT01887249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20546213|NCT01887249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20546214|NCT01887249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546215|NCT01887249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546216|NCT01887249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20546217|NCT01887249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20546218|NCT01887249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20277907|NCT00565630|Contraceptive Agents|contraceptive agents|mesh-ancestor
20277908|NCT00565630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20277909|NCT00565630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277910|NCT00565630|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20277911|NCT00565630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20277912|NCT00565630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20277913|NCT00565656|Bevacizumab|bevacizumab|mesh-list
20277914|NCT00565656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20277915|NCT00565656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277916|NCT00565656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20277917|NCT00565656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20277918|NCT00565656|Growth Substances|growth substances|mesh-ancestor
20277919|NCT00565656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277920|NCT00565656|Growth Inhibitors|growth inhibitors|mesh-ancestor
20277921|NCT00565682|Etoricoxib|etoricoxib|mesh-list
20277922|NCT00565682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20277923|NCT00565682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20277924|NCT00565682|Analgesics|analgesics|mesh-ancestor
20277925|NCT00565682|Sensory System Agents|sensory system agents|mesh-ancestor
20546219|NCT01887275|Interferons|interferons|mesh-list
20546220|NCT01887275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20546221|NCT01887275|Antiviral Agents|antiviral agents|mesh-ancestor
20546222|NCT01887275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20546223|NCT01887301|Nabiximols|nabiximols|mesh-list
20546224|NCT01887301|Analgesics|analgesics|mesh-ancestor
20546225|NCT01887301|Sensory System Agents|sensory system agents|mesh-ancestor
20546226|NCT01887301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546227|NCT01887301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546228|NCT01887340|Carboplatin|carboplatin|mesh-list
20546229|NCT01887340|Etoposide|etoposide|mesh-list
20546230|NCT01887340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20546231|NCT01887340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20546232|NCT01887340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20546233|NCT01887340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20546234|NCT01887340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546235|NCT01887340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546236|NCT01887379|Furosemide|furosemide|mesh-list
20546237|NCT01887379|Diuretics|diuretics|mesh-ancestor
20546238|NCT01887379|Natriuretic Agents|natriuretic agents|mesh-ancestor
20546239|NCT01887379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546240|NCT01887379|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20546241|NCT01887379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20546242|NCT01887379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546243|NCT01887405|Epinephrine|epinephrine|mesh-list
20546244|NCT01887405|Racepinephrine|racepinephrine|mesh-list
20546245|NCT01887405|Epinephryl borate|epinephryl borate|mesh-list
20546246|NCT01887405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20546247|NCT01887405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20546248|NCT01887405|Adrenergic Agents|adrenergic agents|mesh-ancestor
20546249|NCT01887405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20546250|NCT01887405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546251|NCT01887405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546252|NCT01887405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20546253|NCT01887405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20546254|NCT01887405|Autonomic Agents|autonomic agents|mesh-ancestor
20546255|NCT01887405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546256|NCT01887405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20546257|NCT01887405|Respiratory System Agents|respiratory system agents|mesh-ancestor
20546258|NCT01887405|Mydriatics|mydriatics|mesh-ancestor
20546259|NCT01887405|Sympathomimetics|sympathomimetics|mesh-ancestor
20546260|NCT01887405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20546261|NCT01887457|Voriconazole|voriconazole|mesh-list
20546262|NCT01887457|Antifungal Agents|antifungal agents|mesh-ancestor
20546263|NCT01887457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20546264|NCT01887457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20546265|NCT01887457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20546266|NCT01887457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546267|NCT01887457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546268|NCT01887457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20546269|NCT01887457|Hormone Antagonists|hormone antagonists|mesh-ancestor
20546270|NCT01887457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20546271|NCT01887457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546272|NCT01887457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20277926|NCT00565682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20277927|NCT00565682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277928|NCT00565682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20277929|NCT00565682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20277930|NCT00565682|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20277931|NCT00565682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20277932|NCT00565682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277933|NCT00565682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277934|NCT00565708|Aspirin|aspirin|mesh-list
20277935|NCT00565708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20277936|NCT00565708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20277937|NCT00565708|Analgesics|analgesics|mesh-ancestor
20277938|NCT00565708|Sensory System Agents|sensory system agents|mesh-ancestor
20546280|NCT01887561|Dasatinib|dasatinib|mesh-list
20546281|NCT01887561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20546282|NCT01887561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20546283|NCT01887561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546284|NCT01887561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546285|NCT01887613|Gabapentin|gabapentin|mesh-list
20546286|NCT01887613|Analgesics|analgesics|mesh-ancestor
20546287|NCT01887613|Sensory System Agents|sensory system agents|mesh-ancestor
20546288|NCT01887613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546289|NCT01887613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546290|NCT01887613|Anticonvulsants|anticonvulsants|mesh-ancestor
20546291|NCT01887613|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20546292|NCT01887613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20546293|NCT01887613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20546294|NCT01887613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20546295|NCT01887613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20546296|NCT01887613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20546297|NCT01887613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20546298|NCT01887613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546299|NCT01887613|Antimanic Agents|antimanic agents|mesh-ancestor
20546300|NCT01887626|Ticagrelor|ticagrelor|mesh-list
20546301|NCT01887626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20546302|NCT01887626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20546303|NCT01887626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20546304|NCT01887626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20546305|NCT01887626|Purinergic Agents|purinergic agents|mesh-ancestor
20546306|NCT01887626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20546307|NCT01887626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546308|NCT01887626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546309|NCT01887691|Eszopiclone|eszopiclone|mesh-list
20546310|NCT01887691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20546311|NCT01887691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20546312|NCT01887691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546313|NCT01887704|Aspirin|aspirin|mesh-list
20546314|NCT01887704|Sirolimus|sirolimus|mesh-list
20546315|NCT01887704|Paclitaxel|paclitaxel|mesh-list
20546316|NCT01887704|Everolimus|everolimus|mesh-list
20546317|NCT01887704|Clopidogrel|clopidogrel|mesh-list
20546318|NCT01887704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20546319|NCT01887704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20546320|NCT01887704|Tubulin Modulators|tubulin modulators|mesh-ancestor
20546321|NCT01887704|Antimitotic Agents|antimitotic agents|mesh-ancestor
20546322|NCT01887704|Mitosis Modulators|mitosis modulators|mesh-ancestor
20546323|NCT01887704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546324|NCT01887704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20546325|NCT01887704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20546326|NCT01887704|Analgesics|analgesics|mesh-ancestor
20546327|NCT01887704|Sensory System Agents|sensory system agents|mesh-ancestor
20546328|NCT01887704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546329|NCT01887704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546330|NCT01887704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20546331|NCT01887704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20546332|NCT01887704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19962260|NCT01711918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20277939|NCT00565708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20277940|NCT00565708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277941|NCT00565708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20277942|NCT00565708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20277943|NCT00565708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20546333|NCT01887704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20546334|NCT01887704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20546335|NCT01887704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20546336|NCT01887704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546337|NCT01887704|Antipyretics|antipyretics|mesh-ancestor
20546338|NCT01887704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20546339|NCT01887704|Immunologic Factors|immunologic factors|mesh-ancestor
20546340|NCT01887704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20546341|NCT01887704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20546342|NCT01887704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20546343|NCT01887704|Purinergic Agents|purinergic agents|mesh-ancestor
20546344|NCT01887704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20546345|NCT01887704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20546346|NCT01887704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20546347|NCT01887704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20546348|NCT01887704|Antifungal Agents|antifungal agents|mesh-ancestor
20546349|NCT01887743|Pantoprazole|pantoprazole|mesh-list
20546350|NCT01887743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20546351|NCT01887743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20546352|NCT01887743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19733299|NCT04563494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733300|NCT04563494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733301|NCT04563494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19733302|NCT04563494|Glucocorticoids|glucocorticoids|mesh-ancestor
19733303|NCT04563494|Hormones|hormones|mesh-ancestor
19733304|NCT04563494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19962261|NCT01711918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962262|NCT01711918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19962263|NCT01711918|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19962264|NCT01711918|Dopamine Agents|dopamine agents|mesh-ancestor
19962265|NCT01711918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277944|NCT00565708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20546353|NCT01887743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546354|NCT01887743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554354|NCT01935063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20554355|NCT01935063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554356|NCT01935089|Interferons|interferons|mesh-list
20554357|NCT01935089|Interferon-alpha|interferon-alpha|mesh-list
20554358|NCT01935089|Interferon alpha-2|interferon alpha-2|mesh-list
20554359|NCT01935089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20554360|NCT01935089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554361|NCT01935089|Antiviral Agents|antiviral agents|mesh-ancestor
20554362|NCT01935089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20554363|NCT01935089|Immunologic Factors|immunologic factors|mesh-ancestor
20554364|NCT01935089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554365|NCT01935115|Ketamine|ketamine|mesh-list
20554366|NCT01935115|Propofol|propofol|mesh-list
20554367|NCT01935115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20554368|NCT01935115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20554369|NCT01935115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554370|NCT01935115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20554371|NCT01935115|Anesthetics, General|anesthetics, general|mesh-ancestor
20554372|NCT01935115|Anesthetics|anesthetics|mesh-ancestor
20554373|NCT01935115|Analgesics|analgesics|mesh-ancestor
20554374|NCT01935115|Sensory System Agents|sensory system agents|mesh-ancestor
20554375|NCT01935115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554376|NCT01935115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20554377|NCT01935115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20554378|NCT01935115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20554379|NCT01935115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20277945|NCT00565708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277946|NCT00565708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20277947|NCT00565708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20277948|NCT00565708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277949|NCT00565708|Antipyretics|antipyretics|mesh-ancestor
20277950|NCT00565955|Montelukast|montelukast|mesh-list
20277951|NCT00565955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20277952|NCT00565955|Respiratory System Agents|respiratory system agents|mesh-ancestor
20277953|NCT00565955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19962266|NCT01711918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962267|NCT01712009|Loratadine|loratadine|mesh-list
19962268|NCT01712009|Naproxen|naproxen|mesh-list
19962269|NCT01712009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19962270|NCT01712009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19962271|NCT01712009|Analgesics|analgesics|mesh-ancestor
19962272|NCT01712009|Sensory System Agents|sensory system agents|mesh-ancestor
20277954|NCT00565955|Hormone Antagonists|hormone antagonists|mesh-ancestor
20277955|NCT00565955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20277956|NCT00565955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277957|NCT00565955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20546355|NCT01887795|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20546356|NCT01887795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20546357|NCT01887795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20546358|NCT01887795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546359|NCT01887795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546360|NCT01887821|Chloroquine|chloroquine|mesh-list
20546361|NCT01887821|Piperaquine|piperaquine|mesh-list
20546362|NCT01887821|Artenimol|artenimol|mesh-list
20546363|NCT01887821|Amebicides|amebicides|mesh-ancestor
20546364|NCT01887821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20546365|NCT01887821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20546366|NCT01887821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20546367|NCT01887821|Antimalarials|antimalarials|mesh-ancestor
20546368|NCT01887821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20546369|NCT01887847|Nicotine|nicotine|mesh-list
20546370|NCT01887847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20546371|NCT01887847|Autonomic Agents|autonomic agents|mesh-ancestor
20546372|NCT01887847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546373|NCT01887847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546374|NCT01887847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20546375|NCT01887847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20546376|NCT01887847|Cholinergic Agents|cholinergic agents|mesh-ancestor
20546377|NCT01887847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20546378|NCT01887847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546379|NCT01887873|Hyaluronic Acid|hyaluronic acid|mesh-list
20546380|NCT01887873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20546381|NCT01887873|Immunologic Factors|immunologic factors|mesh-ancestor
20546382|NCT01887873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546383|NCT01887873|Viscosupplements|viscosupplements|mesh-ancestor
20546384|NCT01887873|Protective Agents|protective agents|mesh-ancestor
20546385|NCT01887951|Tramadol|tramadol|mesh-list
20546386|NCT01887951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20546387|NCT01887951|Narcotics|narcotics|mesh-ancestor
20546388|NCT01887951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20546389|NCT01887951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546390|NCT01887951|Analgesics|analgesics|mesh-ancestor
20546391|NCT01887951|Sensory System Agents|sensory system agents|mesh-ancestor
20546392|NCT01887951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546393|NCT01888042|Everolimus|everolimus|mesh-list
20546394|NCT01888042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20546395|NCT01888042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20546396|NCT01888042|Immunologic Factors|immunologic factors|mesh-ancestor
20546397|NCT01888042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546398|NCT01888107|Risperidone|risperidone|mesh-list
20546399|NCT01888107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20546400|NCT01888107|Serotonin Agents|serotonin agents|mesh-ancestor
20546401|NCT01888107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20546402|NCT01888107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546403|NCT01888107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546404|NCT01888107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20546405|NCT01888107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20546406|NCT01888107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20546407|NCT01888107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20546408|NCT01888107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20546409|NCT01888107|Dopamine Agents|dopamine agents|mesh-ancestor
20546410|NCT01888120|Ziconotide|ziconotide|mesh-list
20546411|NCT01888120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20546412|NCT01888120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20546413|NCT01888120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277958|NCT00565955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20277959|NCT00565955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277960|NCT00565968|Sorafenib|sorafenib|mesh-list
20277961|NCT00565968|Melphalan|melphalan|mesh-list
20277962|NCT00565968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277963|NCT00565968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20277964|NCT00565968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20277965|NCT00565968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277966|NCT00565968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20277967|NCT00565968|Alkylating Agents|alkylating agents|mesh-ancestor
20277968|NCT00565968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20277969|NCT00565968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20277970|NCT00565968|Immunologic Factors|immunologic factors|mesh-ancestor
20277971|NCT00565968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277972|NCT00565981|Fludarabine|fludarabine|mesh-list
20277973|NCT00565981|Fludarabine phosphate|fludarabine phosphate|mesh-list
20277974|NCT00565981|Alemtuzumab|alemtuzumab|mesh-list
20277975|NCT00565981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20277976|NCT00565981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20277977|NCT00565981|Antimetabolites|antimetabolites|mesh-ancestor
20277978|NCT00565981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20277979|NCT00565981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20277980|NCT00565981|Immunologic Factors|immunologic factors|mesh-ancestor
20277981|NCT00565981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277982|NCT00565981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20277983|NCT00566046|Levetiracetam|levetiracetam|mesh-list
20277984|NCT00566046|Anticonvulsants|anticonvulsants|mesh-ancestor
20277985|NCT00566046|Nootropic Agents|nootropic agents|mesh-ancestor
20277986|NCT00566124|Insulin|insulin|mesh-list
20277987|NCT00566124|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20277988|NCT00566124|Insulin Glargine|insulin glargine|mesh-list
20277989|NCT00566124|Insulin Detemir|insulin detemir|mesh-list
20277990|NCT00566124|Isophane Insulin, Human|isophane insulin, human|mesh-list
20277991|NCT00566124|Insulin, Isophane|insulin, isophane|mesh-list
20277992|NCT00566124|Isophane insulin, beef|isophane insulin, beef|mesh-list
20277993|NCT00566124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20277994|NCT00566124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277995|NCT00566241|Mecasermin|mecasermin|mesh-list
20277996|NCT00566241|Growth Substances|growth substances|mesh-ancestor
20277997|NCT00566241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20277998|NCT00566267|Simvastatin|simvastatin|mesh-list
20277999|NCT00566267|Ezetimibe|ezetimibe|mesh-list
20546414|NCT01888120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20546415|NCT01888120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546416|NCT01888120|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20546417|NCT01888120|Protective Agents|protective agents|mesh-ancestor
20546418|NCT01888120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20546419|NCT01888120|Analgesics|analgesics|mesh-ancestor
20546420|NCT01888120|Sensory System Agents|sensory system agents|mesh-ancestor
20546421|NCT01888120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546422|NCT01888224|Isotretinoin|isotretinoin|mesh-list
20546423|NCT01888224|Dermatologic Agents|dermatologic agents|mesh-ancestor
20546424|NCT01888250|Lamotrigine|lamotrigine|mesh-list
20546425|NCT01888250|Anticonvulsants|anticonvulsants|mesh-ancestor
20546426|NCT01888250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20546427|NCT01888250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20546428|NCT01888250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546429|NCT01888250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20546430|NCT01888250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546431|NCT01888250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20546432|NCT01888250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20546433|NCT01888250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20546434|NCT01888250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20546435|NCT01888250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20546436|NCT01888263|Lamotrigine|lamotrigine|mesh-list
20546437|NCT01888263|Anticonvulsants|anticonvulsants|mesh-ancestor
20546438|NCT01888263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20546439|NCT01888263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20546440|NCT01888263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546441|NCT01888263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20546442|NCT01888263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546443|NCT01888263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20546444|NCT01888263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20546445|NCT01888263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20546446|NCT01888263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20546447|NCT01888263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20546448|NCT01888289|Isotretinoin|isotretinoin|mesh-list
20546449|NCT01888289|Dermatologic Agents|dermatologic agents|mesh-ancestor
20278000|NCT00566267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20278001|NCT00566267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20278002|NCT00566267|Antimetabolites|antimetabolites|mesh-ancestor
20278003|NCT00566267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278004|NCT00566267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20278005|NCT00566267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20278006|NCT00566267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278007|NCT00566332|Fludarabine|fludarabine|mesh-list
20278008|NCT00566332|Chlorambucil|chlorambucil|mesh-list
20278009|NCT00566332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278010|NCT00566332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278011|NCT00566332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20278012|NCT00566332|Alkylating Agents|alkylating agents|mesh-ancestor
20278013|NCT00566371|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20278014|NCT00566371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20278015|NCT00566371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20278016|NCT00566371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20278017|NCT00566371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278018|NCT00566371|Adrenergic Agents|adrenergic agents|mesh-ancestor
20278019|NCT00566371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20278020|NCT00566371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278021|NCT00566384|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20278022|NCT00566384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20278023|NCT00566384|Immunologic Factors|immunologic factors|mesh-ancestor
20278024|NCT00566384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287930|NCT02795858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287931|NCT02795858|Hormones|hormones|mesh-ancestor
20287932|NCT02795858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20287933|NCT02795858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287934|NCT02794883|Durvalumab|durvalumab|mesh-list
20287935|NCT02794883|Ipilimumab|ipilimumab|mesh-list
20546450|NCT01888302|Gemcitabine|gemcitabine|mesh-list
20546451|NCT01888302|Sirolimus|sirolimus|mesh-list
20546452|NCT01888302|Cisplatin|cisplatin|mesh-list
20546453|NCT01888302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20546454|NCT01888302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20546455|NCT01888302|Antimetabolites|antimetabolites|mesh-ancestor
20546456|NCT01888302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546457|NCT01888302|Antiviral Agents|antiviral agents|mesh-ancestor
20546458|NCT01888302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20546459|NCT01888302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546460|NCT01888302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20546461|NCT01888302|Immunologic Factors|immunologic factors|mesh-ancestor
20546462|NCT01888302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546463|NCT01888302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20546464|NCT01888302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20546465|NCT01888302|Antifungal Agents|antifungal agents|mesh-ancestor
20546466|NCT01888328|Isotretinoin|isotretinoin|mesh-list
20546467|NCT01888328|Dermatologic Agents|dermatologic agents|mesh-ancestor
20546468|NCT01888341|Isotretinoin|isotretinoin|mesh-list
20546469|NCT01888341|Dermatologic Agents|dermatologic agents|mesh-ancestor
20546470|NCT01888354|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20546471|NCT01888354|Hormones|hormones|mesh-ancestor
20546472|NCT01888354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20546473|NCT01888354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546474|NCT01888393|Ivacaftor|ivacaftor|mesh-list
20546475|NCT01888393|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20546476|NCT01888393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20546477|NCT01888393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962273|NCT01712009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20287936|NCT02794883|Tremelimumab|tremelimumab|mesh-list
20287937|NCT02794883|Immunoglobulins|immunoglobulins|mesh-list
20287938|NCT02794883|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20287939|NCT02794883|Immunoglobulin G|immunoglobulin g|mesh-list
20287940|NCT02794883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20287941|NCT02794883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287942|NCT02794883|Immunologic Factors|immunologic factors|mesh-ancestor
20287943|NCT02794883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20287944|NCT02794883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20287945|NCT02794883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287946|NCT02771249|Pyridoxine|pyridoxine|mesh-list
20287947|NCT02771249|Darunavir|darunavir|mesh-list
20287948|NCT02771249|Cobicistat|cobicistat|mesh-list
20287949|NCT02771249|Isoniazid|isoniazid|mesh-list
20287950|NCT02771249|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20287951|NCT02771249|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20278025|NCT00566553|Grape Seed Extract|grape seed extract|mesh-list
20278026|NCT00566553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20278027|NCT00566553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278028|NCT00566553|Antioxidants|antioxidants|mesh-ancestor
20278029|NCT00566553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278030|NCT00566553|Protective Agents|protective agents|mesh-ancestor
20278031|NCT00566553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278032|NCT00566592|Ethanol|ethanol|mesh-list
20278033|NCT00566592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20278034|NCT00566592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20278035|NCT00566592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20278036|NCT00566592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278037|NCT00566644|Levonorgestrel|levonorgestrel|mesh-list
20278038|NCT00566644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20278039|NCT00566644|Contraceptive Agents|contraceptive agents|mesh-ancestor
20278040|NCT00566644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20278041|NCT00566644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278042|NCT00566644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20278043|NCT00566644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20278044|NCT00566644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20278045|NCT00566683|Meperidine|meperidine|mesh-list
20278046|NCT00566683|Diazepam|diazepam|mesh-list
20278047|NCT00566683|Alfentanil|alfentanil|mesh-list
20278048|NCT00566683|Propofol|propofol|mesh-list
20278049|NCT00566683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20278050|NCT00566683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20278051|NCT00566683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278052|NCT00566683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20278053|NCT00566683|Anesthetics, General|anesthetics, general|mesh-ancestor
20278054|NCT00566683|Anesthetics|anesthetics|mesh-ancestor
20278055|NCT00566683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20278056|NCT00566683|Narcotics|narcotics|mesh-ancestor
20278057|NCT00566683|Analgesics|analgesics|mesh-ancestor
20278058|NCT00566683|Sensory System Agents|sensory system agents|mesh-ancestor
20278059|NCT00566683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20278060|NCT00566683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20278061|NCT00566683|Anticonvulsants|anticonvulsants|mesh-ancestor
20278062|NCT00566683|Antiemetics|antiemetics|mesh-ancestor
20278063|NCT00566683|Autonomic Agents|autonomic agents|mesh-ancestor
20278064|NCT00566683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20278065|NCT00566683|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20278066|NCT00566683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20278067|NCT00566683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20278068|NCT00566683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20546478|NCT01888445|Darbepoetin alfa|darbepoetin alfa|mesh-list
20546479|NCT01888445|Hematinics|hematinics|mesh-ancestor
20546480|NCT01888458|Micafungin|micafungin|mesh-list
20546481|NCT01888458|Antifungal Agents|antifungal agents|mesh-ancestor
20546482|NCT01888458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20546483|NCT01888536|Pregabalin|pregabalin|mesh-list
20546484|NCT01888536|Alprostadil|alprostadil|mesh-list
20546485|NCT01888536|Analgesics|analgesics|mesh-ancestor
20546486|NCT01888536|Sensory System Agents|sensory system agents|mesh-ancestor
20546487|NCT01888536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546488|NCT01888536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278069|NCT00566683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20278070|NCT00566683|GABA Modulators|gaba modulators|mesh-ancestor
20278071|NCT00566683|GABA Agents|gaba agents|mesh-ancestor
20278072|NCT00566683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20278073|NCT00566683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546489|NCT01888536|Anticonvulsants|anticonvulsants|mesh-ancestor
20546490|NCT01888536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20546491|NCT01888536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20546492|NCT01888536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546493|NCT01888536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20546494|NCT01888536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20546495|NCT01888536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20546496|NCT01888536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20546497|NCT01888536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20546498|NCT01888536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20546499|NCT01888536|Vasodilator Agents|vasodilator agents|mesh-ancestor
20546500|NCT01888536|Urological Agents|urological agents|mesh-ancestor
20546501|NCT01888562|Ponatinib|ponatinib|mesh-list
20546502|NCT01888562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20546503|NCT01888562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20278074|NCT00566761|Triamcinolone|triamcinolone|mesh-list
20546504|NCT01888562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278075|NCT00566761|Bevacizumab|bevacizumab|mesh-list
20278076|NCT00566761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20278077|NCT00566761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278078|NCT00566761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20278079|NCT00566761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20278080|NCT00566761|Growth Substances|growth substances|mesh-ancestor
20278081|NCT00566761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278082|NCT00566761|Growth Inhibitors|growth inhibitors|mesh-ancestor
20278083|NCT00566761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20278084|NCT00566761|Glucocorticoids|glucocorticoids|mesh-ancestor
20278085|NCT00566761|Hormones|hormones|mesh-ancestor
20278086|NCT00566761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20278087|NCT00566800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20278088|NCT00566800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278089|NCT00566800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20546505|NCT01888562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546506|NCT01888575|Aspirin|aspirin|mesh-list
20546507|NCT01888575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20546508|NCT01888575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20546509|NCT01888575|Analgesics|analgesics|mesh-ancestor
20546510|NCT01888575|Sensory System Agents|sensory system agents|mesh-ancestor
20546511|NCT01888575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546512|NCT01888575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546513|NCT01888575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20546514|NCT01888575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20546515|NCT01888575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20546516|NCT01888575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20546517|NCT01888575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546518|NCT01888575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20546519|NCT01888575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20546520|NCT01888575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546521|NCT01888575|Antipyretics|antipyretics|mesh-ancestor
20546522|NCT01888718|Fexofenadine|fexofenadine|mesh-list
20546523|NCT01888718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20546524|NCT01888718|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20546525|NCT01888718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20546526|NCT01888718|Histamine Antagonists|histamine antagonists|mesh-ancestor
20546527|NCT01888718|Histamine Agents|histamine agents|mesh-ancestor
20546528|NCT01888718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20546529|NCT01888718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546530|NCT01888718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546531|NCT01888731|Lamotrigine|lamotrigine|mesh-list
20546532|NCT01888731|Anticonvulsants|anticonvulsants|mesh-ancestor
20546533|NCT01888731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20546534|NCT01888731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20546535|NCT01888731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546536|NCT01888731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20546537|NCT01888731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546538|NCT01888731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20546539|NCT01888731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20546540|NCT01888731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20546541|NCT01888731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20546542|NCT01888731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20546543|NCT01888744|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20546544|NCT01888744|Cetrorelix|cetrorelix|mesh-list
20546545|NCT01888744|Progesterone|progesterone|mesh-list
20546546|NCT01888744|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20546547|NCT01888744|Ganirelix|ganirelix|mesh-list
20546548|NCT01888744|Progestins|progestins|mesh-ancestor
20546549|NCT01888744|Hormones|hormones|mesh-ancestor
20546550|NCT01888744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20546551|NCT01888744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546552|NCT01888744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20546553|NCT01888744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20546554|NCT01888744|Fertility Agents|fertility agents|mesh-ancestor
20546555|NCT01888744|Hormone Antagonists|hormone antagonists|mesh-ancestor
20546556|NCT01888757|Lamotrigine|lamotrigine|mesh-list
20546557|NCT01888757|Anticonvulsants|anticonvulsants|mesh-ancestor
20546558|NCT01888757|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20546559|NCT01888757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20546560|NCT01888757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546561|NCT01888757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20278090|NCT00566800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278091|NCT00566800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278092|NCT00566865|Gemfibrozil|gemfibrozil|mesh-list
20278093|NCT00566865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20546562|NCT01888757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546563|NCT01888757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20546564|NCT01888757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20546565|NCT01888757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20546566|NCT01888757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20546567|NCT01888757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20546568|NCT01888796|Linagliptin|linagliptin|mesh-list
20546569|NCT01888796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20546570|NCT01888796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546571|NCT01888796|Incretins|incretins|mesh-ancestor
20546572|NCT01888796|Hormones|hormones|mesh-ancestor
20278094|NCT00566865|Antimetabolites|antimetabolites|mesh-ancestor
20278095|NCT00566865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278096|NCT00566865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20278097|NCT00566865|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20278098|NCT00566865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20278099|NCT00566865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278100|NCT00566891|Tirofiban|tirofiban|mesh-list
20278101|NCT00566891|Clopidogrel|clopidogrel|mesh-list
20278102|NCT00566891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20278103|NCT00566891|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20278104|NCT00566891|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20278105|NCT00566891|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20278106|NCT00566891|Purinergic Agents|purinergic agents|mesh-ancestor
20278107|NCT00566891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20278108|NCT00566891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278109|NCT00566891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278110|NCT00566891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20278111|NCT00566891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20278112|NCT00566904|Aspirin|aspirin|mesh-list
20278113|NCT00566904|Lidocaine|lidocaine|mesh-list
20278114|NCT00566904|Anesthetics, Local|anesthetics, local|mesh-list
20278115|NCT00566904|Anesthetics|anesthetics|mesh-list
20278116|NCT00566904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20278117|NCT00566904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278118|NCT00566904|Sensory System Agents|sensory system agents|mesh-ancestor
20278119|NCT00566904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20278120|NCT00566904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20278121|NCT00566904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20278122|NCT00566904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20278123|NCT00566904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20278124|NCT00566904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278125|NCT00566904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20278126|NCT00566904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20278127|NCT00566904|Analgesics|analgesics|mesh-ancestor
20278128|NCT00566904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20278129|NCT00566904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20278130|NCT00566904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20278131|NCT00566904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20278132|NCT00566904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20278133|NCT00566904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20278134|NCT00566904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278135|NCT00566904|Antipyretics|antipyretics|mesh-ancestor
20278136|NCT00567034|Naltrexone|naltrexone|mesh-list
20278137|NCT00567034|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20278138|NCT00567034|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20278139|NCT00567034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278140|NCT00567034|Sensory System Agents|sensory system agents|mesh-ancestor
20278141|NCT00567034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20278142|NCT00567047|Vildagliptin|vildagliptin|mesh-list
20278143|NCT00567047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20278144|NCT00567047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278145|NCT00567047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20278146|NCT00567047|Protease Inhibitors|protease inhibitors|mesh-ancestor
20278147|NCT00567047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278148|NCT00567047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278149|NCT00567060|Piracetam|piracetam|mesh-list
20278150|NCT00567060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20278151|NCT00567060|Protective Agents|protective agents|mesh-ancestor
20278152|NCT00567060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278153|NCT00567060|Nootropic Agents|nootropic agents|mesh-ancestor
20278154|NCT00567099|Aripiprazole|aripiprazole|mesh-list
20278155|NCT00567099|Antidepressive Agents|antidepressive agents|mesh-ancestor
20278156|NCT00567099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20278157|NCT00567099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20278158|NCT00567099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20278159|NCT00567099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20278160|NCT00567099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278161|NCT00567099|Dopamine Agonists|dopamine agonists|mesh-ancestor
20278162|NCT00567099|Dopamine Agents|dopamine agents|mesh-ancestor
20278163|NCT00567099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19962274|NCT01712009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962275|NCT01712009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20278164|NCT00567099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278165|NCT00567099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20278166|NCT00567099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20278167|NCT00567099|Serotonin Agents|serotonin agents|mesh-ancestor
20278168|NCT00567099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20278169|NCT00567099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20278170|NCT00567099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20278171|NCT00567099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20278172|NCT00567177|Cyclosporine|cyclosporine|mesh-list
20278173|NCT00567177|Cyclosporins|cyclosporins|mesh-list
20278174|NCT00567177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278175|NCT00567177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278176|NCT00567177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20278177|NCT00567177|Immunologic Factors|immunologic factors|mesh-ancestor
20278178|NCT00567177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278179|NCT00567177|Antifungal Agents|antifungal agents|mesh-ancestor
20278180|NCT00567177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20278181|NCT00567177|Dermatologic Agents|dermatologic agents|mesh-ancestor
20278182|NCT00567177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20278183|NCT00567177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20278184|NCT00567216|Nadolol|nadolol|mesh-list
20278185|NCT00567216|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20278186|NCT00567216|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20278187|NCT00567216|Adrenergic Agents|adrenergic agents|mesh-ancestor
20278188|NCT00567216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20278189|NCT00567216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962276|NCT01712009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20278190|NCT00567216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278191|NCT00567216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20278192|NCT00567216|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20278193|NCT00567216|Sympatholytics|sympatholytics|mesh-ancestor
20278194|NCT00567216|Autonomic Agents|autonomic agents|mesh-ancestor
20278195|NCT00567216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20278196|NCT00567372|Bevacizumab|bevacizumab|mesh-list
20278197|NCT00567372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20278198|NCT00567372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278199|NCT00567372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20278200|NCT00567372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20278201|NCT00567372|Growth Substances|growth substances|mesh-ancestor
20278202|NCT00567372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278203|NCT00567372|Growth Inhibitors|growth inhibitors|mesh-ancestor
20278204|NCT00567411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20278205|NCT00567411|Apraclonidine|apraclonidine|mesh-list
20278206|NCT00567411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20278207|NCT00567411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20278208|NCT00567411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20278209|NCT00567411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20278210|NCT00567411|Adrenergic Agents|adrenergic agents|mesh-ancestor
20278211|NCT00567411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20278212|NCT00567411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278213|NCT00567411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278214|NCT00567450|Ropivacaine|ropivacaine|mesh-list
20278215|NCT00567450|Mepivacaine|mepivacaine|mesh-list
20278216|NCT00567450|Anesthetics, Local|anesthetics, local|mesh-ancestor
20278217|NCT00567450|Anesthetics|anesthetics|mesh-ancestor
20278218|NCT00567450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20278219|NCT00567450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278220|NCT00567450|Sensory System Agents|sensory system agents|mesh-ancestor
20278221|NCT00567450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20278222|NCT00567463|Fluticasone|fluticasone|mesh-list
20278223|NCT00567463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20278224|NCT00567463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20278225|NCT00567463|Autonomic Agents|autonomic agents|mesh-ancestor
20278226|NCT00567463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20278227|NCT00567463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278228|NCT00567463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20278229|NCT00567463|Respiratory System Agents|respiratory system agents|mesh-ancestor
20278230|NCT00567463|Dermatologic Agents|dermatologic agents|mesh-ancestor
20278231|NCT00567463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20278232|NCT00567528|Ibuprofen|ibuprofen|mesh-list
20278233|NCT00567528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20278234|NCT00567528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20278235|NCT00567528|Analgesics|analgesics|mesh-ancestor
20278236|NCT00567528|Sensory System Agents|sensory system agents|mesh-ancestor
20278237|NCT00567528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20278238|NCT00567528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278239|NCT00567528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20278240|NCT00567528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20278241|NCT00567528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20278242|NCT00567528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278243|NCT00567528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278244|NCT00567554|Paclitaxel|paclitaxel|mesh-list
20278245|NCT00567554|Docetaxel|docetaxel|mesh-list
20278246|NCT00567554|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20278247|NCT00567554|Cyclophosphamide|cyclophosphamide|mesh-list
20278248|NCT00567554|Bevacizumab|bevacizumab|mesh-list
20278249|NCT00567554|Trastuzumab|trastuzumab|mesh-list
20278250|NCT00567554|Everolimus|everolimus|mesh-list
20278251|NCT00567554|Epirubicin|epirubicin|mesh-list
20278252|NCT00567554|Lapatinib|lapatinib|mesh-list
20278253|NCT00567554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20278254|NCT00567554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278255|NCT00567554|Tubulin Modulators|tubulin modulators|mesh-ancestor
20278256|NCT00567554|Antimitotic Agents|antimitotic agents|mesh-ancestor
20278257|NCT00567554|Mitosis Modulators|mitosis modulators|mesh-ancestor
20278258|NCT00567554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278259|NCT00567554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20278260|NCT00567554|Immunologic Factors|immunologic factors|mesh-ancestor
20278261|NCT00567554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278262|NCT00567554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20278263|NCT00567554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20278264|NCT00567554|Alkylating Agents|alkylating agents|mesh-ancestor
20278265|NCT00567554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20278266|NCT00567554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20278267|NCT00567554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20278268|NCT00567554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20278269|NCT00567554|Growth Substances|growth substances|mesh-ancestor
20278270|NCT00567554|Growth Inhibitors|growth inhibitors|mesh-ancestor
20278271|NCT00567554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20278272|NCT00567554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20278273|NCT00567554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20278274|NCT00567554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278275|NCT00567554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20278276|NCT00567606|Risedronic Acid|risedronic acid|mesh-list
20278277|NCT00567606|Calcium|calcium|mesh-list
20278278|NCT00567606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20278279|NCT00567606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278280|NCT00567606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20278281|NCT00567606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20278282|NCT00567606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278283|NCT00567606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20278284|NCT00567658|Esomeprazole|esomeprazole|mesh-list
20278285|NCT00567658|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20278286|NCT00567658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20278287|NCT00567658|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20278288|NCT00567658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278289|NCT00567658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278290|NCT00567697|Ranibizumab|ranibizumab|mesh-list
20278291|NCT00567697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20278292|NCT00567697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20278293|NCT00567697|Growth Substances|growth substances|mesh-ancestor
20278294|NCT00567697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278295|NCT00567697|Growth Inhibitors|growth inhibitors|mesh-ancestor
20278296|NCT00567697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278297|NCT00567710|Risperidone|risperidone|mesh-list
20278298|NCT00567710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20278299|NCT00567710|Serotonin Agents|serotonin agents|mesh-ancestor
20278300|NCT00567710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20278301|NCT00567710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278302|NCT00567710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278303|NCT00567710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20278304|NCT00567710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20278305|NCT00567710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20278306|NCT00567710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20278307|NCT00567710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20278308|NCT00567710|Dopamine Agents|dopamine agents|mesh-ancestor
20278309|NCT00567762|Tacrolimus|tacrolimus|mesh-list
20278310|NCT00567762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20278311|NCT00567762|Immunologic Factors|immunologic factors|mesh-ancestor
20278312|NCT00567762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278313|NCT00567762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20278314|NCT00567762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278315|NCT00567762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278316|NCT00567775|Insulin|insulin|mesh-list
20278317|NCT00567775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20278318|NCT00567775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20278319|NCT00567775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278320|NCT00567788|Bimatoprost|bimatoprost|mesh-list
20278321|NCT00567788|Latanoprost|latanoprost|mesh-list
20278322|NCT00567788|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20546573|NCT01888796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20546574|NCT01888796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20546575|NCT01888796|Protease Inhibitors|protease inhibitors|mesh-ancestor
20546576|NCT01888796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546577|NCT01888796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546578|NCT01888822|Ciprofloxacin|ciprofloxacin|mesh-list
20546579|NCT01888822|Ampicillin|ampicillin|mesh-list
20546580|NCT01888822|Sulbactam|sulbactam|mesh-list
20546581|NCT01888822|Sultamicillin|sultamicillin|mesh-list
20546582|NCT01888822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20546583|NCT01888822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20546584|NCT01888822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20546585|NCT01888822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20278323|NCT00567788|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20278324|NCT00567788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20278325|NCT00567814|Oxazepam|oxazepam|mesh-list
20278326|NCT00567814|Metyrapone|metyrapone|mesh-list
20278327|NCT00567814|Antimetabolites|antimetabolites|mesh-ancestor
20278328|NCT00567814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278329|NCT00567814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278330|NCT00567814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20278331|NCT00567814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20278332|NCT00567814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278333|NCT00567814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20278334|NCT00567814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20278335|NCT00567814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20278336|NCT00567814|GABA Modulators|gaba modulators|mesh-ancestor
20278337|NCT00567814|GABA Agents|gaba agents|mesh-ancestor
20278338|NCT00567814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20278339|NCT00567866|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20278340|NCT00567866|Antidepressive Agents|antidepressive agents|mesh-ancestor
20278341|NCT00567866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20278342|NCT00567866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20278343|NCT00567866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20278344|NCT00567866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20278345|NCT00567866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278346|NCT00567918|Tacrolimus|tacrolimus|mesh-list
20278347|NCT00567918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20278348|NCT00567918|Immunologic Factors|immunologic factors|mesh-ancestor
20278349|NCT00567918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546586|NCT01888822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546587|NCT01888822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546588|NCT01888822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20546589|NCT01888822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20546590|NCT01888822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20546591|NCT01888822|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20546592|NCT01888835|Mirtazapine|mirtazapine|mesh-list
20546593|NCT01888835|Antidepressive Agents|antidepressive agents|mesh-ancestor
20546594|NCT01888835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20546595|NCT01888835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20546596|NCT01888835|Histamine Antagonists|histamine antagonists|mesh-ancestor
20546597|NCT01888835|Histamine Agents|histamine agents|mesh-ancestor
20546598|NCT01888835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20546599|NCT01888835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546600|NCT01888835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546601|NCT01888835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20546602|NCT01888835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20546603|NCT01888835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20546604|NCT01888835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20546605|NCT01888835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20546606|NCT01888835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20546607|NCT01888835|Adrenergic Agents|adrenergic agents|mesh-ancestor
20546608|NCT01888835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20546609|NCT01888835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20546610|NCT01888835|Serotonin Agents|serotonin agents|mesh-ancestor
20546611|NCT01888835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20546612|NCT01888861|Thioctic Acid|thioctic acid|mesh-list
20546613|NCT01888861|Antioxidants|antioxidants|mesh-ancestor
20546614|NCT01888861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546615|NCT01888861|Protective Agents|protective agents|mesh-ancestor
20546616|NCT01888861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546617|NCT01888861|Vitamin B Complex|vitamin b complex|mesh-ancestor
20546618|NCT01888861|Vitamins|vitamins|mesh-ancestor
20546619|NCT01888861|Micronutrients|micronutrients|mesh-ancestor
19962277|NCT01712009|Gout Suppressants|gout suppressants|mesh-ancestor
19962278|NCT01712009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19962279|NCT01712009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962280|NCT01712009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546620|NCT01888978|Leucovorin|leucovorin|mesh-list
20546621|NCT01888978|Gemcitabine|gemcitabine|mesh-list
20546622|NCT01888978|Fluorouracil|fluorouracil|mesh-list
20546623|NCT01888978|Docetaxel|docetaxel|mesh-list
20546624|NCT01888978|Oxaliplatin|oxaliplatin|mesh-list
20546625|NCT01888978|Irinotecan|irinotecan|mesh-list
20546626|NCT01888978|Levoleucovorin|levoleucovorin|mesh-list
20546627|NCT01888978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20546628|NCT01888978|Antimetabolites|antimetabolites|mesh-ancestor
19962281|NCT01712009|Antipruritics|antipruritics|mesh-ancestor
20278350|NCT00567918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20278351|NCT00567918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278352|NCT00567918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278353|NCT00567931|Tryptophan|tryptophan|mesh-list
20278354|NCT00567931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20278355|NCT00567931|Antidepressive Agents|antidepressive agents|mesh-ancestor
20278356|NCT00567931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20278357|NCT00567957|Remifentanil|remifentanil|mesh-list
20278358|NCT00567957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20278359|NCT00567957|Narcotics|narcotics|mesh-ancestor
20278360|NCT00567957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20278361|NCT00567957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278362|NCT00567957|Analgesics|analgesics|mesh-ancestor
20278363|NCT00567957|Sensory System Agents|sensory system agents|mesh-ancestor
20278364|NCT00567957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20278365|NCT00567983|Cyclosporine|cyclosporine|mesh-list
20278366|NCT00567983|Cyclosporins|cyclosporins|mesh-list
20278367|NCT00567983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278368|NCT00567983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278369|NCT00567983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20278370|NCT00567983|Immunologic Factors|immunologic factors|mesh-ancestor
20278371|NCT00567983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278372|NCT00567983|Antifungal Agents|antifungal agents|mesh-ancestor
20278373|NCT00567983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20278374|NCT00567983|Dermatologic Agents|dermatologic agents|mesh-ancestor
20278375|NCT00567983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20278376|NCT00567983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20278377|NCT00568048|Bevacizumab|bevacizumab|mesh-list
20278378|NCT00568048|Temozolomide|temozolomide|mesh-list
20278379|NCT00568048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20278380|NCT00568048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278381|NCT00568048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20278382|NCT00568048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20278383|NCT00568048|Growth Substances|growth substances|mesh-ancestor
20278384|NCT00568048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278385|NCT00568048|Growth Inhibitors|growth inhibitors|mesh-ancestor
20278386|NCT00568048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20278387|NCT00568048|Alkylating Agents|alkylating agents|mesh-ancestor
20278388|NCT00568048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278389|NCT00568074|Repaglinide|repaglinide|mesh-list
20278390|NCT00568074|Acarbose|acarbose|mesh-list
20278391|NCT00568074|Gliquidone|gliquidone|mesh-list
20278392|NCT00568074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20278393|NCT00568074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278394|NCT00568074|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20278395|NCT00568074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278396|NCT00568074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278397|NCT00568113|Acetylcysteine|acetylcysteine|mesh-list
20278398|NCT00568113|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20278399|NCT00568113|Antiviral Agents|antiviral agents|mesh-ancestor
20278400|NCT00568113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20278401|NCT00568113|Expectorants|expectorants|mesh-ancestor
20278402|NCT00568113|Respiratory System Agents|respiratory system agents|mesh-ancestor
20278403|NCT00568113|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20278404|NCT00568113|Antioxidants|antioxidants|mesh-ancestor
20278405|NCT00568113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278406|NCT00568113|Protective Agents|protective agents|mesh-ancestor
20278407|NCT00568113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278408|NCT00568113|Antidotes|antidotes|mesh-ancestor
20278409|NCT00568152|Aspirin|aspirin|mesh-list
20278410|NCT00568152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20278411|NCT00568152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20278412|NCT00568152|Analgesics|analgesics|mesh-ancestor
20278413|NCT00568152|Sensory System Agents|sensory system agents|mesh-ancestor
20278414|NCT00568152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20278415|NCT00568152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278416|NCT00568152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20278417|NCT00568152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20278418|NCT00568152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20278419|NCT00568152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20278420|NCT00568152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278421|NCT00568152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20278422|NCT00568152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20278423|NCT00568152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278424|NCT00568152|Antipyretics|antipyretics|mesh-ancestor
20278425|NCT00568217|Acetaminophen|acetaminophen|mesh-list
20278426|NCT00568217|Ibuprofen|ibuprofen|mesh-list
20278427|NCT00568217|Diclofenac|diclofenac|mesh-list
20278428|NCT00568217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20278429|NCT00568217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20278430|NCT00568217|Analgesics|analgesics|mesh-ancestor
20278431|NCT00568217|Sensory System Agents|sensory system agents|mesh-ancestor
20278432|NCT00568217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20278433|NCT00568217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278434|NCT00568217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20278435|NCT00568217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20278436|NCT00568217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20278437|NCT00568217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278438|NCT00568217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278439|NCT00568217|Antipyretics|antipyretics|mesh-ancestor
20278440|NCT00568295|Acetaminophen|acetaminophen|mesh-list
20278441|NCT00568295|Rofecoxib|rofecoxib|mesh-list
20278442|NCT00568295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20278443|NCT00568295|Analgesics|analgesics|mesh-ancestor
20278444|NCT00568295|Sensory System Agents|sensory system agents|mesh-ancestor
20278445|NCT00568295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20278446|NCT00568295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278447|NCT00568295|Antipyretics|antipyretics|mesh-ancestor
20278448|NCT00568295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20278449|NCT00568295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20278450|NCT00568295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278451|NCT00568295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278452|NCT00568295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20278453|NCT00568295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20278454|NCT00568295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20278455|NCT00568347|Fluticasone|fluticasone|mesh-list
20278456|NCT00568347|Xhance|xhance|mesh-list
20278457|NCT00568347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20278458|NCT00568347|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20278459|NCT00568347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20278460|NCT00568347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20278461|NCT00568347|Autonomic Agents|autonomic agents|mesh-ancestor
20278462|NCT00568347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20278463|NCT00568347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278464|NCT00568347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20278465|NCT00568347|Respiratory System Agents|respiratory system agents|mesh-ancestor
20278466|NCT00568347|Dermatologic Agents|dermatologic agents|mesh-ancestor
20278467|NCT00568347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20278468|NCT00568347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20278469|NCT00568347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20278470|NCT00568347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20278471|NCT00568347|Adrenergic Agents|adrenergic agents|mesh-ancestor
20278472|NCT00568347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20278473|NCT00568347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278474|NCT00568347|Glucocorticoids|glucocorticoids|mesh-ancestor
20278475|NCT00568347|Hormones|hormones|mesh-ancestor
20278476|NCT00568347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20278477|NCT00568347|Sympathomimetics|sympathomimetics|mesh-ancestor
20278478|NCT00568412|Pimecrolimus|pimecrolimus|mesh-list
20278479|NCT00568412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20278480|NCT00568412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20278481|NCT00568412|Analgesics|analgesics|mesh-ancestor
20278482|NCT00568412|Sensory System Agents|sensory system agents|mesh-ancestor
20278483|NCT00568412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20278484|NCT00568412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278485|NCT00568412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20278486|NCT00568412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20278487|NCT00568412|Dermatologic Agents|dermatologic agents|mesh-ancestor
20278488|NCT00568412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20278489|NCT00568412|Immunologic Factors|immunologic factors|mesh-ancestor
20278490|NCT00568412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20278491|NCT00568412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278492|NCT00568412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287952|NCT02771249|Protease Inhibitors|protease inhibitors|mesh-ancestor
20287953|NCT02771249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546629|NCT01888978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546630|NCT01888978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20546631|NCT01888978|Antiviral Agents|antiviral agents|mesh-ancestor
20546632|NCT01888978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20287954|NCT02771249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278493|NCT00568477|Rituximab|rituximab|mesh-list
20278494|NCT00568477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20278495|NCT00568477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278496|NCT00568477|Immunologic Factors|immunologic factors|mesh-ancestor
20278497|NCT00568477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278498|NCT00568477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20278499|NCT00568503|Bromides|bromides|mesh-list
20278500|NCT00568503|Tiotropium Bromide|tiotropium bromide|mesh-list
20278501|NCT00568503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20278502|NCT00568503|Autonomic Agents|autonomic agents|mesh-ancestor
20278503|NCT00568503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20278504|NCT00568503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278505|NCT00568503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20278506|NCT00568503|Respiratory System Agents|respiratory system agents|mesh-ancestor
20278507|NCT00568503|Parasympatholytics|parasympatholytics|mesh-ancestor
20278508|NCT00568503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20278509|NCT00568503|Cholinergic Agents|cholinergic agents|mesh-ancestor
20278510|NCT00568503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20278511|NCT00568503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278512|NCT00568503|Anticonvulsants|anticonvulsants|mesh-ancestor
20278513|NCT00568529|Capecitabine|capecitabine|mesh-list
20278514|NCT00568529|Oxaliplatin|oxaliplatin|mesh-list
20278515|NCT00568529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20278516|NCT00568529|Antimetabolites|antimetabolites|mesh-ancestor
20278517|NCT00568529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278518|NCT00568529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278519|NCT00568542|Epoetin Alfa|epoetin alfa|mesh-list
20278520|NCT00568542|Hematinics|hematinics|mesh-ancestor
20278521|NCT00568568|Hormones|hormones|mesh-list
20278522|NCT00568568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20278523|NCT00568568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546633|NCT01888978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546634|NCT01888978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20546635|NCT01888978|Immunologic Factors|immunologic factors|mesh-ancestor
20546636|NCT01888978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546637|NCT01888978|Tubulin Modulators|tubulin modulators|mesh-ancestor
20546638|NCT01888978|Antimitotic Agents|antimitotic agents|mesh-ancestor
20546639|NCT01888978|Mitosis Modulators|mitosis modulators|mesh-ancestor
20546640|NCT01888978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20546641|NCT01888978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20546642|NCT01888978|Antidotes|antidotes|mesh-ancestor
20546643|NCT01888978|Protective Agents|protective agents|mesh-ancestor
20546644|NCT01888978|Vitamin B Complex|vitamin b complex|mesh-ancestor
20546645|NCT01888978|Vitamins|vitamins|mesh-ancestor
20546646|NCT01888978|Micronutrients|micronutrients|mesh-ancestor
20546647|NCT01889004|Dexmedetomidine|dexmedetomidine|mesh-list
20546648|NCT01889004|Propofol|propofol|mesh-list
20546649|NCT01889004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20546650|NCT01889004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20546651|NCT01889004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546652|NCT01889004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20546653|NCT01889004|Anesthetics, General|anesthetics, general|mesh-ancestor
20546654|NCT01889004|Anesthetics|anesthetics|mesh-ancestor
20546655|NCT01889004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20546656|NCT01889004|Analgesics|analgesics|mesh-ancestor
20546657|NCT01889004|Sensory System Agents|sensory system agents|mesh-ancestor
20546658|NCT01889004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546659|NCT01889004|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20546660|NCT01889004|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20546661|NCT01889004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20546662|NCT01889004|Adrenergic Agents|adrenergic agents|mesh-ancestor
20546663|NCT01889004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20546664|NCT01889004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546665|NCT01889056|Epoetin Alfa|epoetin alfa|mesh-list
20546666|NCT01889056|Hematinics|hematinics|mesh-ancestor
20546667|NCT01889095|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20546668|NCT01889095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20546669|NCT01889095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546670|NCT01889134|Alendronate|alendronate|mesh-list
20546671|NCT01889134|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20546672|NCT01889134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546673|NCT01889173|Cyclobenzaprine|cyclobenzaprine|mesh-list
20546674|NCT01889173|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20546675|NCT01889173|Antidepressive Agents|antidepressive agents|mesh-ancestor
19962282|NCT01712009|Dermatologic Agents|dermatologic agents|mesh-ancestor
20278524|NCT00568672|Olanzapine|olanzapine|mesh-list
20278525|NCT00568672|Antiemetics|antiemetics|mesh-ancestor
20278526|NCT00568672|Autonomic Agents|autonomic agents|mesh-ancestor
20278527|NCT00568672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20278528|NCT00568672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278529|NCT00568672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20278530|NCT00568672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20278531|NCT00568672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20278532|NCT00568672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20278533|NCT00568672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20278534|NCT00568672|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20278535|NCT00568672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20278536|NCT00568672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20278537|NCT00568672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278538|NCT00568672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20278539|NCT00568672|Serotonin Agents|serotonin agents|mesh-ancestor
20278540|NCT00568711|Doxycycline|doxycycline|mesh-list
20278541|NCT00568711|Rifampin|rifampin|mesh-list
20278542|NCT00568711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20278543|NCT00568711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20278544|NCT00568711|Antimalarials|antimalarials|mesh-ancestor
20278545|NCT00568711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20278546|NCT00568711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20278547|NCT00568711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20278548|NCT00568711|Antitubercular Agents|antitubercular agents|mesh-ancestor
20278549|NCT00568711|Leprostatic Agents|leprostatic agents|mesh-ancestor
20278550|NCT00568711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20278551|NCT00568711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278552|NCT00568711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278553|NCT00568711|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20278554|NCT00568711|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20546676|NCT01889173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20546677|NCT01889173|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20546678|NCT01889173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546679|NCT01889173|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20546680|NCT01889173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546681|NCT01889173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20546682|NCT01889173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20546683|NCT01889212|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20546684|NCT01889212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20546685|NCT01889212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20546686|NCT01889212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546687|NCT01889212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546688|NCT01889290|Methylnaltrexone|methylnaltrexone|mesh-list
20546689|NCT01889290|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20546690|NCT01889290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546691|NCT01889290|Sensory System Agents|sensory system agents|mesh-ancestor
20546692|NCT01889290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546693|NCT01889368|Grape Seed Extract|grape seed extract|mesh-list
20546694|NCT01889368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19962283|NCT01712009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19962284|NCT01712009|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19962285|NCT01712009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19962286|NCT01712009|Histamine Antagonists|histamine antagonists|mesh-ancestor
19962287|NCT01712009|Histamine Agents|histamine agents|mesh-ancestor
19962288|NCT01712009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19962289|NCT01712178|Adalimumab|adalimumab|mesh-list
20287955|NCT02771249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19962290|NCT01712178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20287956|NCT02771249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20287957|NCT02771249|Antiviral Agents|antiviral agents|mesh-ancestor
20287958|NCT02771249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20287959|NCT02771249|Antitubercular Agents|antitubercular agents|mesh-ancestor
20287960|NCT02771249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20287961|NCT02771249|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20287962|NCT02771249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20287963|NCT02771249|Antimetabolites|antimetabolites|mesh-ancestor
20287964|NCT02771249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20287965|NCT02771249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20287966|NCT02771249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20287967|NCT02771249|Vitamin B Complex|vitamin b complex|mesh-ancestor
20287968|NCT02771249|Vitamins|vitamins|mesh-ancestor
20287969|NCT02771249|Micronutrients|micronutrients|mesh-ancestor
20287970|NCT02771249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278555|NCT00568711|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20278556|NCT00568711|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20278557|NCT00568711|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20278558|NCT00568711|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20278559|NCT00568737|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
20278560|NCT00568737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20278561|NCT00568750|Dasatinib|dasatinib|mesh-list
20278562|NCT00568750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278563|NCT00568750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20278564|NCT00568750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278565|NCT00568750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278566|NCT00568763|Sargramostim|sargramostim|mesh-list
20278567|NCT00568763|Immunologic Factors|immunologic factors|mesh-ancestor
20278568|NCT00568763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278569|NCT00568789|Zolpidem|zolpidem|mesh-list
20278570|NCT00568789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20278571|NCT00568789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20278572|NCT00568789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20278573|NCT00568789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278574|NCT00568789|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20278575|NCT00568789|GABA Agonists|gaba agonists|mesh-ancestor
20278576|NCT00568789|GABA Agents|gaba agents|mesh-ancestor
20278577|NCT00568789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20278578|NCT00568789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278579|NCT00568815|Rituximab|rituximab|mesh-list
20278580|NCT00568815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20278581|NCT00568815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278582|NCT00568815|Immunologic Factors|immunologic factors|mesh-ancestor
20278583|NCT00568815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278584|NCT00568815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20278585|NCT00568841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20278586|NCT00568841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278587|NCT00568841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20278588|NCT00568841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278589|NCT00568841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278590|NCT00568880|Hydroxychloroquine|hydroxychloroquine|mesh-list
20278591|NCT00568880|Bortezomib|bortezomib|mesh-list
20278592|NCT00568880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278593|NCT00568880|Antimalarials|antimalarials|mesh-ancestor
20278594|NCT00568880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20278595|NCT00568880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20278596|NCT00568880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20278597|NCT00568880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278598|NCT00568880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962291|NCT01712178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19962292|NCT01712204|Febuxostat|febuxostat|mesh-list
20278599|NCT00568880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20278600|NCT00568893|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
20278601|NCT00568893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20278602|NCT00568971|Docetaxel|docetaxel|mesh-list
20278603|NCT00568971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278604|NCT00568971|Tubulin Modulators|tubulin modulators|mesh-ancestor
20278605|NCT00568971|Antimitotic Agents|antimitotic agents|mesh-ancestor
19962293|NCT01712204|Gout Suppressants|gout suppressants|mesh-ancestor
19962294|NCT01712204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19962295|NCT01712230|Leuprolide|leuprolide|mesh-list
19962296|NCT01712230|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19962297|NCT01712230|Fertility Agents|fertility agents|mesh-ancestor
19962298|NCT01712230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20278606|NCT00568971|Mitosis Modulators|mitosis modulators|mesh-ancestor
20278607|NCT00568971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278608|NCT00568984|Metformin|metformin|mesh-list
20278609|NCT00568984|Repaglinide|repaglinide|mesh-list
20278610|NCT00568984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20278611|NCT00568984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278612|NCT00569088|Mannitol|mannitol|mesh-list
19962299|NCT01712230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962300|NCT01712230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19962301|NCT01712230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962302|NCT01712360|Naftifine|naftifine|mesh-list
19962303|NCT01712360|Antifungal Agents|antifungal agents|mesh-ancestor
19962304|NCT01712360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19962305|NCT01712399|Mavrilimumab|mavrilimumab|mesh-list
19962306|NCT01712399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19962307|NCT01712516|Glycopyrrolate|glycopyrrolate|mesh-list
19962308|NCT01712516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20278613|NCT00569088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20278614|NCT00569088|Diuretics|diuretics|mesh-ancestor
20278615|NCT00569088|Natriuretic Agents|natriuretic agents|mesh-ancestor
20278616|NCT00569088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278617|NCT00569101|Tacrolimus|tacrolimus|mesh-list
20278618|NCT00569101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20278619|NCT00569101|Immunologic Factors|immunologic factors|mesh-ancestor
20278620|NCT00569101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278621|NCT00569101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20278622|NCT00569101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278623|NCT00569101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278624|NCT00569244|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
20278625|NCT00569244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20278626|NCT00569244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278627|NCT00569296|Aldesleukin|aldesleukin|mesh-list
20278628|NCT00569296|Sargramostim|sargramostim|mesh-list
20278629|NCT00569296|Immunologic Factors|immunologic factors|mesh-ancestor
20278630|NCT00569296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278631|NCT00569296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278632|NCT00569296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20278633|NCT00569296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20278634|NCT00569296|Antiviral Agents|antiviral agents|mesh-ancestor
20278635|NCT00569296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20278636|NCT00569335|Bevacizumab|bevacizumab|mesh-list
20278637|NCT00569335|Irinotecan|irinotecan|mesh-list
20278638|NCT00569335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20278639|NCT00569335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278640|NCT00569335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20278641|NCT00569335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20278642|NCT00569335|Growth Substances|growth substances|mesh-ancestor
20278643|NCT00569335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962309|NCT01712516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19962310|NCT01712516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19962311|NCT01712516|Cholinergic Agents|cholinergic agents|mesh-ancestor
19962312|NCT01712516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19962313|NCT01712516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278644|NCT00569335|Growth Inhibitors|growth inhibitors|mesh-ancestor
20278645|NCT00569335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20278646|NCT00569335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19962314|NCT01712516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962315|NCT01712984|Fluconazole|fluconazole|mesh-list
20278647|NCT00569335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278648|NCT00569335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278649|NCT00569400|Insulin|insulin|mesh-list
20278650|NCT00569400|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20546695|NCT01889368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20546696|NCT01889368|Antioxidants|antioxidants|mesh-ancestor
20546697|NCT01889368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546698|NCT01889368|Protective Agents|protective agents|mesh-ancestor
20546699|NCT01889368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962316|NCT01712984|Vaccines|vaccines|mesh-list
19962317|NCT01712984|Immunologic Factors|immunologic factors|mesh-ancestor
19962318|NCT01712984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962319|NCT01712984|Antifungal Agents|antifungal agents|mesh-ancestor
19962320|NCT01712984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20278651|NCT00569400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20278652|NCT00569400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278653|NCT00569452|Insulin|insulin|mesh-list
20546700|NCT01889407|Idarubicin|idarubicin|mesh-list
20546701|NCT01889407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20546702|NCT01889407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278654|NCT00569452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20278655|NCT00569452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20278656|NCT00569452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278657|NCT00569465|Acetylcysteine|acetylcysteine|mesh-list
20278658|NCT00569465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20278659|NCT00569465|Antiviral Agents|antiviral agents|mesh-ancestor
20278660|NCT00569465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20278661|NCT00569465|Expectorants|expectorants|mesh-ancestor
20278662|NCT00569465|Respiratory System Agents|respiratory system agents|mesh-ancestor
20278663|NCT00569465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20278664|NCT00569465|Antioxidants|antioxidants|mesh-ancestor
20278665|NCT00569465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278666|NCT00569465|Protective Agents|protective agents|mesh-ancestor
20278667|NCT00569465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278668|NCT00569465|Antidotes|antidotes|mesh-ancestor
20278669|NCT00569621|Moxaverine|moxaverine|mesh-list
20278670|NCT00569621|Parasympatholytics|parasympatholytics|mesh-ancestor
20278671|NCT00569621|Autonomic Agents|autonomic agents|mesh-ancestor
20278672|NCT00569621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20278673|NCT00569621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962321|NCT01712984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19962322|NCT01712984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19962323|NCT01712984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962324|NCT01712984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962325|NCT01712984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19962326|NCT01712984|Hormone Antagonists|hormone antagonists|mesh-ancestor
19962327|NCT01712984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19962328|NCT01712984|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19962329|NCT01712984|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19962330|NCT01713283|Sofosbuvir|sofosbuvir|mesh-list
19962331|NCT01713283|Antiviral Agents|antiviral agents|mesh-ancestor
19962332|NCT01713283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19962333|NCT01713400|Sirolimus|sirolimus|mesh-list
19962334|NCT01713400|Ustekinumab|ustekinumab|mesh-list
19962335|NCT01713400|Tacrolimus|tacrolimus|mesh-list
19962336|NCT01713400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20278674|NCT00569699|Bevacizumab|bevacizumab|mesh-list
20278675|NCT00569699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20278676|NCT00569699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278677|NCT00569699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20278678|NCT00569699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20278679|NCT00569699|Growth Substances|growth substances|mesh-ancestor
20278680|NCT00569699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278681|NCT00569699|Growth Inhibitors|growth inhibitors|mesh-ancestor
20278682|NCT00569712|Budesonide|budesonide|mesh-list
20278683|NCT00569712|Formoterol Fumarate|formoterol fumarate|mesh-list
20278684|NCT00569712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20278685|NCT00569712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20278686|NCT00569712|Autonomic Agents|autonomic agents|mesh-ancestor
20278687|NCT00569712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20278688|NCT00569712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278689|NCT00569712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20278690|NCT00569712|Respiratory System Agents|respiratory system agents|mesh-ancestor
20278691|NCT00569712|Glucocorticoids|glucocorticoids|mesh-ancestor
20278692|NCT00569712|Hormones|hormones|mesh-ancestor
19962337|NCT01713400|Immunologic Factors|immunologic factors|mesh-ancestor
20278693|NCT00569712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20287971|NCT02659059|Paclitaxel|paclitaxel|mesh-list
20278694|NCT00569712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20278695|NCT00569712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20278696|NCT00569712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20278697|NCT00569712|Adrenergic Agents|adrenergic agents|mesh-ancestor
20278698|NCT00569712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20278699|NCT00569712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278700|NCT00569751|Paclitaxel|paclitaxel|mesh-list
20278701|NCT00569751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20278702|NCT00569751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278703|NCT00569751|Tubulin Modulators|tubulin modulators|mesh-ancestor
20278704|NCT00569751|Antimitotic Agents|antimitotic agents|mesh-ancestor
20278705|NCT00569751|Mitosis Modulators|mitosis modulators|mesh-ancestor
20278706|NCT00569751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278707|NCT00569790|Bevacizumab|bevacizumab|mesh-list
20278708|NCT00569790|Irinotecan|irinotecan|mesh-list
20278709|NCT00569790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20278710|NCT00569790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278711|NCT00569790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20278712|NCT00569790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19962338|NCT01713400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962339|NCT01713400|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19962340|NCT01713400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962341|NCT01713400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962342|NCT01713400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19962343|NCT01713400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19962344|NCT01713400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19962345|NCT01713400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962346|NCT01713400|Antifungal Agents|antifungal agents|mesh-ancestor
19962347|NCT01713400|Dermatologic Agents|dermatologic agents|mesh-ancestor
19962348|NCT01713530|Insulin|insulin|mesh-list
19962349|NCT01713530|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19962350|NCT01713530|Insulin Aspart|insulin aspart|mesh-list
19962351|NCT01713530|Insulin, Long-Acting|insulin, long-acting|mesh-list
19962352|NCT01713530|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19962353|NCT01713530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19962354|NCT01713530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962355|NCT01713608|Artefenomel|artefenomel|mesh-list
19962356|NCT01713608|Antimalarials|antimalarials|mesh-ancestor
19962357|NCT01713608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19962358|NCT01713608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19962359|NCT01713608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19962360|NCT01713621|Artefenomel|artefenomel|mesh-list
19962361|NCT01713621|Antimalarials|antimalarials|mesh-ancestor
19962362|NCT01713621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20278713|NCT00569790|Growth Substances|growth substances|mesh-ancestor
20278714|NCT00569790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278715|NCT00569790|Growth Inhibitors|growth inhibitors|mesh-ancestor
20278716|NCT00569790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20546703|NCT01889407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20546704|NCT01889407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20546705|NCT01889407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546706|NCT01889407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554380|NCT01935115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554381|NCT01935141|Triiodobenzoic Acids|triiodobenzoic acids|mesh-list
20554382|NCT01935141|Plant Growth Regulators|plant growth regulators|mesh-ancestor
20554383|NCT01935141|Growth Substances|growth substances|mesh-ancestor
20554384|NCT01935141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554385|NCT01935193|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
20554386|NCT01935193|Analgesics|analgesics|mesh-ancestor
20554387|NCT01935193|Sensory System Agents|sensory system agents|mesh-ancestor
20554388|NCT01935193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554389|NCT01935193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554390|NCT01935193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20554391|NCT01935193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20554392|NCT01935193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20554393|NCT01935193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20554394|NCT01935193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20554395|NCT01935193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19962363|NCT01713621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19962364|NCT01713621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20278717|NCT00569790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20278718|NCT00569790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278719|NCT00569790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278720|NCT00569816|Sevoflurane|sevoflurane|mesh-list
20278721|NCT00569816|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20278722|NCT00569816|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20278723|NCT00569816|Anesthetics, General|anesthetics, general|mesh-ancestor
20278724|NCT00569816|Anesthetics|anesthetics|mesh-ancestor
20278725|NCT00569816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20278726|NCT00569816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278727|NCT00569881|Moxifloxacin|moxifloxacin|mesh-list
19962365|NCT01713946|Everolimus|everolimus|mesh-list
19962366|NCT01713946|Anticonvulsants|anticonvulsants|mesh-list
19962367|NCT01713946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962368|NCT01713946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19962369|NCT01713946|Immunologic Factors|immunologic factors|mesh-ancestor
20278728|NCT00569881|Gatifloxacin|gatifloxacin|mesh-list
20278729|NCT00569881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20278730|NCT00569881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20278731|NCT00569881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20278732|NCT00569881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20278733|NCT00569881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278734|NCT00569881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278735|NCT00569881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278736|NCT00569881|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20278737|NCT00569881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20278738|NCT00569920|Dexamethasone|dexamethasone|mesh-list
20278739|NCT00569920|Dexamethasone acetate|dexamethasone acetate|mesh-list
20278740|NCT00569920|BB 1101|bb 1101|mesh-list
20278741|NCT00569920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20278742|NCT00569920|Antiemetics|antiemetics|mesh-ancestor
20278743|NCT00569920|Autonomic Agents|autonomic agents|mesh-ancestor
20278744|NCT00569920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20278745|NCT00569920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278746|NCT00569920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20278747|NCT00569920|Glucocorticoids|glucocorticoids|mesh-ancestor
19962370|NCT01713946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962371|NCT01714310|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19962372|NCT01714310|Fluoxetine|fluoxetine|mesh-list
20278748|NCT00569920|Hormones|hormones|mesh-ancestor
20278749|NCT00569920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20278750|NCT00569920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20278751|NCT00569920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278752|NCT00569920|Protease Inhibitors|protease inhibitors|mesh-ancestor
20278753|NCT00569920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278754|NCT00569920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278755|NCT00569985|Cyclophosphamide|cyclophosphamide|mesh-list
20278756|NCT00569985|Carmustine|carmustine|mesh-list
20278757|NCT00569985|Etoposide|etoposide|mesh-list
20278758|NCT00569985|Etoposide phosphate|etoposide phosphate|mesh-list
20278759|NCT00569985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20278760|NCT00569985|Immunologic Factors|immunologic factors|mesh-ancestor
20278761|NCT00569985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278762|NCT00569985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20278763|NCT00569985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20278764|NCT00569985|Alkylating Agents|alkylating agents|mesh-ancestor
20278765|NCT00569985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278766|NCT00569985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278767|NCT00569985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20278768|NCT00569985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20278769|NCT00569985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20278770|NCT00569985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19962373|NCT01714310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19962374|NCT01714310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19962375|NCT01714310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19962376|NCT01714310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278771|NCT00569985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278772|NCT00570050|Insulin|insulin|mesh-list
20278773|NCT00570050|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20278774|NCT00570050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20278775|NCT00570050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278776|NCT00570180|Bortezomib|bortezomib|mesh-list
20278777|NCT00570180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278778|NCT00570193|Ranibizumab|ranibizumab|mesh-list
20278779|NCT00570193|Verteporfin|verteporfin|mesh-list
20278780|NCT00570193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20278781|NCT00570193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20278782|NCT00570193|Growth Substances|growth substances|mesh-ancestor
20278783|NCT00570193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278784|NCT00570193|Growth Inhibitors|growth inhibitors|mesh-ancestor
20278785|NCT00570193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278786|NCT00570193|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20278787|NCT00570193|Dermatologic Agents|dermatologic agents|mesh-ancestor
20278788|NCT00570219|Valproic Acid|valproic acid|mesh-list
20278789|NCT00570219|Anticonvulsants|anticonvulsants|mesh-ancestor
20278790|NCT00570219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278791|NCT00570219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278792|NCT00570219|GABA Agents|gaba agents|mesh-ancestor
20278793|NCT00570219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20278794|NCT00570219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278795|NCT00570219|Antimanic Agents|antimanic agents|mesh-ancestor
20278796|NCT00570219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20278797|NCT00570219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20278798|NCT00570219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20278799|NCT00570245|Nitric Oxide|nitric oxide|mesh-list
20278800|NCT00570245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20278801|NCT00570245|Autonomic Agents|autonomic agents|mesh-ancestor
20278802|NCT00570245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20278803|NCT00570245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278804|NCT00570245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20278805|NCT00570245|Respiratory System Agents|respiratory system agents|mesh-ancestor
20278806|NCT00570245|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20278807|NCT00570245|Antioxidants|antioxidants|mesh-ancestor
20278808|NCT00570245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278809|NCT00570245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20278810|NCT00570245|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20278811|NCT00570245|Vasodilator Agents|vasodilator agents|mesh-ancestor
20278812|NCT00570245|Gasotransmitters|gasotransmitters|mesh-ancestor
20278813|NCT00570245|Protective Agents|protective agents|mesh-ancestor
20278814|NCT00570284|Panobinostat|panobinostat|mesh-list
20278815|NCT00570284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278816|NCT00570284|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20278817|NCT00570284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278818|NCT00570284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278819|NCT00570375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20278820|NCT00570375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278821|NCT00570375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20278822|NCT00570375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278823|NCT00570375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278824|NCT00570440|Levonorgestrel|levonorgestrel|mesh-list
20278825|NCT00570440|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20278826|NCT00570440|Contraceptive Agents|contraceptive agents|mesh-list
20278827|NCT00570440|Contraceptives, Oral|contraceptives, oral|mesh-list
20278828|NCT00570440|Estradiol|estradiol|mesh-list
20278829|NCT00570440|Estrogens|estrogens|mesh-ancestor
20278830|NCT00570440|Hormones|hormones|mesh-ancestor
20278831|NCT00570440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20278832|NCT00570440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278833|NCT00570440|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20278834|NCT00570440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20278835|NCT00570440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20278836|NCT00570440|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20278837|NCT00570440|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20287972|NCT02659059|Cisplatin|cisplatin|mesh-list
20287973|NCT02659059|Carboplatin|carboplatin|mesh-list
20287974|NCT02659059|Nivolumab|nivolumab|mesh-list
20287975|NCT02659059|Pemetrexed|pemetrexed|mesh-list
20287976|NCT02659059|Ipilimumab|ipilimumab|mesh-list
20287977|NCT02659059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20287978|NCT02659059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287979|NCT02659059|Tubulin Modulators|tubulin modulators|mesh-ancestor
20287980|NCT02659059|Antimitotic Agents|antimitotic agents|mesh-ancestor
20287981|NCT02659059|Mitosis Modulators|mitosis modulators|mesh-ancestor
20287982|NCT02659059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287983|NCT02659059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20287984|NCT02659059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20278838|NCT00570479|Anecortave|anecortave|mesh-list
20278839|NCT00570479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20278840|NCT00570479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20278841|NCT00570479|Growth Substances|growth substances|mesh-ancestor
20278842|NCT00570479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278843|NCT00570479|Growth Inhibitors|growth inhibitors|mesh-ancestor
20278844|NCT00570479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278845|NCT00570544|Tiotropium Bromide|tiotropium bromide|mesh-list
20278846|NCT00570544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20278847|NCT00570544|Autonomic Agents|autonomic agents|mesh-ancestor
20278848|NCT00570544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20278849|NCT00570544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278850|NCT00570544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20278851|NCT00570544|Respiratory System Agents|respiratory system agents|mesh-ancestor
20278852|NCT00570544|Parasympatholytics|parasympatholytics|mesh-ancestor
20278853|NCT00570544|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20278854|NCT00570544|Cholinergic Agents|cholinergic agents|mesh-ancestor
20278855|NCT00570544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20278856|NCT00570544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278857|NCT00570622|Pioglitazone|pioglitazone|mesh-list
20278858|NCT00570622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20278859|NCT00570622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278860|NCT00570648|Hyaluronic Acid|hyaluronic acid|mesh-list
20278861|NCT00570648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20278862|NCT00570648|Immunologic Factors|immunologic factors|mesh-ancestor
20278863|NCT00570648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278864|NCT00570648|Viscosupplements|viscosupplements|mesh-ancestor
20278865|NCT00570648|Protective Agents|protective agents|mesh-ancestor
20278866|NCT00570726|Ranibizumab|ranibizumab|mesh-list
20278867|NCT00570726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20278868|NCT00570726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20278869|NCT00570726|Growth Substances|growth substances|mesh-ancestor
20278870|NCT00570726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278871|NCT00570726|Growth Inhibitors|growth inhibitors|mesh-ancestor
20278872|NCT00570726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278873|NCT00570830|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
20278874|NCT00570830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20278875|NCT00570830|Glucocorticoids|glucocorticoids|mesh-ancestor
20278876|NCT00570830|Hormones|hormones|mesh-ancestor
20278877|NCT00570830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20278878|NCT00570830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278879|NCT00570843|Lubricant Eye Drops|lubricant eye drops|mesh-list
20546707|NCT01889433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20546708|NCT01889433|Antiviral Agents|antiviral agents|mesh-ancestor
20546709|NCT01889433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20546710|NCT01889446|Calcium|calcium|mesh-list
20546711|NCT01889446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20546712|NCT01889446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546713|NCT01889498|Acetazolamide|acetazolamide|mesh-list
20546714|NCT01889498|Anticonvulsants|anticonvulsants|mesh-ancestor
20546715|NCT01889498|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20546716|NCT01889498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546717|NCT01889498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546718|NCT01889498|Diuretics|diuretics|mesh-ancestor
20546719|NCT01889498|Natriuretic Agents|natriuretic agents|mesh-ancestor
20546720|NCT01889498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546721|NCT01889576|Magnesium Oxide|magnesium oxide|mesh-list
20546722|NCT01889576|Antacids|antacids|mesh-ancestor
20546723|NCT01889576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546724|NCT01889576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20546725|NCT01889680|Leucovorin|leucovorin|mesh-list
20546726|NCT01889680|Fluorouracil|fluorouracil|mesh-list
20546727|NCT01889680|Oxaliplatin|oxaliplatin|mesh-list
20546728|NCT01889680|Aflibercept|aflibercept|mesh-list
20546729|NCT01889680|Levoleucovorin|levoleucovorin|mesh-list
20546730|NCT01889680|Antimetabolites|antimetabolites|mesh-ancestor
20546731|NCT01889680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546732|NCT01889680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20546733|NCT01889680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20546734|NCT01889680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20546735|NCT01889680|Immunologic Factors|immunologic factors|mesh-ancestor
20546736|NCT01889680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546737|NCT01889680|Antidotes|antidotes|mesh-ancestor
20278880|NCT00570843|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20546738|NCT01889680|Protective Agents|protective agents|mesh-ancestor
20546739|NCT01889680|Vitamin B Complex|vitamin b complex|mesh-ancestor
20546740|NCT01889680|Vitamins|vitamins|mesh-ancestor
20278881|NCT00570843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20278882|NCT00570856|Folic Acid|folic acid|mesh-list
20278883|NCT00570856|Hematinics|hematinics|mesh-ancestor
20278884|NCT00570856|Vitamin B Complex|vitamin b complex|mesh-ancestor
20278885|NCT00570856|Vitamins|vitamins|mesh-ancestor
20278886|NCT00570856|Micronutrients|micronutrients|mesh-ancestor
20278887|NCT00570856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278888|NCT00570882|Sunitinib|sunitinib|mesh-list
20278889|NCT00570882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278890|NCT00570882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20278891|NCT00570882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20278892|NCT00570882|Growth Substances|growth substances|mesh-ancestor
20278893|NCT00570882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278894|NCT00570882|Growth Inhibitors|growth inhibitors|mesh-ancestor
20278895|NCT00570882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20278896|NCT00570882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278897|NCT00570882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278898|NCT00570895|Ascorbic Acid|ascorbic acid|mesh-list
20278899|NCT00570895|Vitamins|vitamins|mesh-ancestor
20278900|NCT00570895|Micronutrients|micronutrients|mesh-ancestor
20278901|NCT00570895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278902|NCT00570895|Antioxidants|antioxidants|mesh-ancestor
20278903|NCT00570895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278904|NCT00570895|Protective Agents|protective agents|mesh-ancestor
20278905|NCT00570934|Calcium, Dietary|calcium, dietary|mesh-list
20278906|NCT00570934|Cholecalciferol|cholecalciferol|mesh-list
20278907|NCT00570934|Calcium|calcium|mesh-list
20278908|NCT00570934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20278909|NCT00570934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278910|NCT00570934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20278911|NCT00570934|Vitamins|vitamins|mesh-ancestor
20278912|NCT00570934|Micronutrients|micronutrients|mesh-ancestor
20278913|NCT00570999|Mitogens|mitogens|mesh-list
20278914|NCT00570999|Mitosis Modulators|mitosis modulators|mesh-ancestor
20546741|NCT01889680|Micronutrients|micronutrients|mesh-ancestor
20546742|NCT01889680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20546743|NCT01889680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20546744|NCT01889680|Growth Substances|growth substances|mesh-ancestor
20546745|NCT01889680|Growth Inhibitors|growth inhibitors|mesh-ancestor
20546746|NCT01889758|Tacrolimus|tacrolimus|mesh-list
20546747|NCT01889758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20546748|NCT01889758|Immunologic Factors|immunologic factors|mesh-ancestor
20546749|NCT01889758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546750|NCT01889758|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20546751|NCT01889758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546752|NCT01889758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546753|NCT01889771|Nicotine|nicotine|mesh-list
20546754|NCT01889771|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20546755|NCT01889771|Autonomic Agents|autonomic agents|mesh-ancestor
20546756|NCT01889771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546757|NCT01889771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546758|NCT01889771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20546759|NCT01889771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20546760|NCT01889771|Cholinergic Agents|cholinergic agents|mesh-ancestor
20546761|NCT01889771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20546762|NCT01889771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546763|NCT01889810|Vitamin D|vitamin d|mesh-list
20546764|NCT01889810|Cholecalciferol|cholecalciferol|mesh-list
20546765|NCT01889810|Vitamins|vitamins|mesh-ancestor
20546766|NCT01889810|Micronutrients|micronutrients|mesh-ancestor
20278915|NCT00570999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278916|NCT00571116|Arsenic Trioxide|arsenic trioxide|mesh-list
20554396|NCT01935193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278917|NCT00571116|Disulfiram|disulfiram|mesh-list
20278918|NCT00571116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278919|NCT00571116|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20278920|NCT00571116|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20278921|NCT00571116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278922|NCT00571116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278923|NCT00571129|Mitomycins|mitomycins|mesh-list
20278924|NCT00571129|Mitomycin|mitomycin|mesh-list
20278925|NCT00571129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20278926|NCT00571129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278927|NCT00571129|Alkylating Agents|alkylating agents|mesh-ancestor
20278928|NCT00571129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278929|NCT00571129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20278930|NCT00571129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278931|NCT00571142|Bevacizumab|bevacizumab|mesh-list
20278932|NCT00571142|Temazepam|temazepam|mesh-list
20278933|NCT00571142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20278934|NCT00571142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278935|NCT00571142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20278936|NCT00571142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20278937|NCT00571142|Growth Substances|growth substances|mesh-ancestor
20278938|NCT00571142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278939|NCT00571142|Growth Inhibitors|growth inhibitors|mesh-ancestor
20278940|NCT00571142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20278941|NCT00571142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20278942|NCT00571142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20278943|NCT00571142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20278944|NCT00571142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20278945|NCT00571142|GABA Modulators|gaba modulators|mesh-ancestor
20278946|NCT00571142|GABA Agents|gaba agents|mesh-ancestor
20278947|NCT00571142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20278948|NCT00571142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278949|NCT00571155|Levetiracetam|levetiracetam|mesh-list
20278950|NCT00571155|Anticonvulsants|anticonvulsants|mesh-ancestor
20278951|NCT00571155|Nootropic Agents|nootropic agents|mesh-ancestor
20278952|NCT00571246|Topiramate|topiramate|mesh-list
20278953|NCT00571246|Lamotrigine|lamotrigine|mesh-list
20278954|NCT00571246|Anticonvulsants|anticonvulsants|mesh-ancestor
20278955|NCT00571246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20278956|NCT00571246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278957|NCT00571246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20278958|NCT00571246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20278959|NCT00571246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278960|NCT00571246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20278961|NCT00571246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20278962|NCT00571246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20278963|NCT00571246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20278964|NCT00571246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20278965|NCT00571246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20278966|NCT00571285|Vitamin D|vitamin d|mesh-list
20278967|NCT00571285|Ergocalciferols|ergocalciferols|mesh-list
20278968|NCT00571285|Cholecalciferol|cholecalciferol|mesh-list
20278969|NCT00571285|Vitamins|vitamins|mesh-list
20546767|NCT01889810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546768|NCT01889810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20546769|NCT01889810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20546770|NCT01889849|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20546771|NCT01889849|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20546772|NCT01889849|Antiviral Agents|antiviral agents|mesh-ancestor
20546773|NCT01889849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20546774|NCT01889914|Insulin|insulin|mesh-list
20546775|NCT01889914|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20546776|NCT01889914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20546777|NCT01889914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546778|NCT01889966|Sildenafil Citrate|sildenafil citrate|mesh-list
20546779|NCT01889966|Vasodilator Agents|vasodilator agents|mesh-ancestor
20546780|NCT01889966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20546781|NCT01889966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20278970|NCT00571285|Micronutrients|micronutrients|mesh-ancestor
20278971|NCT00571285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278972|NCT00571285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20278973|NCT00571285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20278974|NCT00571298|Gemcitabine|gemcitabine|mesh-list
20278975|NCT00571298|Sodium thiosulfate|sodium thiosulfate|mesh-list
20278976|NCT00571298|Amifostine|amifostine|mesh-list
20278977|NCT00571298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20278978|NCT00571298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20278979|NCT00571298|Antimetabolites|antimetabolites|mesh-ancestor
20278980|NCT00571298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20278981|NCT00571298|Antiviral Agents|antiviral agents|mesh-ancestor
20278982|NCT00571298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20278983|NCT00571298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20278984|NCT00571298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20278985|NCT00571298|Immunologic Factors|immunologic factors|mesh-ancestor
20278986|NCT00571298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20278987|NCT00571298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20278988|NCT00571298|Protective Agents|protective agents|mesh-ancestor
20278989|NCT00571298|Antidotes|antidotes|mesh-ancestor
20278990|NCT00571298|Antioxidants|antioxidants|mesh-ancestor
20278991|NCT00571298|Antitubercular Agents|antitubercular agents|mesh-ancestor
20278992|NCT00571298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20278993|NCT00571298|Chelating Agents|chelating agents|mesh-ancestor
20278994|NCT00571298|Sequestering Agents|sequestering agents|mesh-ancestor
20278995|NCT00571337|Infliximab|infliximab|mesh-list
20278996|NCT00571337|Dermatologic Agents|dermatologic agents|mesh-ancestor
20278997|NCT00571337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20278998|NCT00571337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20278999|NCT00571506|Pioglitazone|pioglitazone|mesh-list
20279000|NCT00571506|Rosiglitazone|rosiglitazone|mesh-list
20279001|NCT00571506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20279002|NCT00571506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279003|NCT00571558|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20279004|NCT00571558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20279005|NCT00571558|Dermatologic Agents|dermatologic agents|mesh-ancestor
20279006|NCT00571636|Fentanyl|fentanyl|mesh-list
20279007|NCT00571636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20279008|NCT00571636|Narcotics|narcotics|mesh-ancestor
20279009|NCT00571636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20279010|NCT00571636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279011|NCT00571636|Analgesics|analgesics|mesh-ancestor
20546782|NCT01889966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546783|NCT01889966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546784|NCT01889966|Urological Agents|urological agents|mesh-ancestor
20546785|NCT01889979|Tramadol|tramadol|mesh-list
20546786|NCT01889979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20546787|NCT01889979|Narcotics|narcotics|mesh-ancestor
20546788|NCT01889979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20546789|NCT01889979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546790|NCT01889979|Analgesics|analgesics|mesh-ancestor
20546791|NCT01889979|Sensory System Agents|sensory system agents|mesh-ancestor
20546792|NCT01889979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546793|NCT01889992|Sirolimus|sirolimus|mesh-list
20546794|NCT01889992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20546795|NCT01889992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20546796|NCT01889992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20546797|NCT01889992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20546798|NCT01889992|Antifungal Agents|antifungal agents|mesh-ancestor
20546799|NCT01889992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20546800|NCT01889992|Immunologic Factors|immunologic factors|mesh-ancestor
20546801|NCT01889992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546802|NCT01890005|Aspirin|aspirin|mesh-list
20546803|NCT01890005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20546804|NCT01890005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20546805|NCT01890005|Analgesics|analgesics|mesh-ancestor
20546806|NCT01890005|Sensory System Agents|sensory system agents|mesh-ancestor
20546807|NCT01890005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546808|NCT01890005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546809|NCT01890005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20546810|NCT01890005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20546811|NCT01890005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20546812|NCT01890005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20546813|NCT01890005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546814|NCT01890005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20546815|NCT01890005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20546816|NCT01890005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279012|NCT00571636|Sensory System Agents|sensory system agents|mesh-ancestor
20279013|NCT00571636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20279014|NCT00571636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20279015|NCT00571636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20279016|NCT00571636|Anesthetics, General|anesthetics, general|mesh-ancestor
20279017|NCT00571636|Anesthetics|anesthetics|mesh-ancestor
20279018|NCT00571675|Prednisone|prednisone|mesh-list
20279019|NCT00571675|Docetaxel|docetaxel|mesh-list
20279020|NCT00571675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279021|NCT00571675|Tubulin Modulators|tubulin modulators|mesh-ancestor
20279022|NCT00571675|Antimitotic Agents|antimitotic agents|mesh-ancestor
20279023|NCT00571675|Mitosis Modulators|mitosis modulators|mesh-ancestor
20279024|NCT00571675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279025|NCT00571675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20279026|NCT00571675|Glucocorticoids|glucocorticoids|mesh-ancestor
20279027|NCT00571675|Hormones|hormones|mesh-ancestor
20279028|NCT00571675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20279029|NCT00571675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279030|NCT00571675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20279031|NCT00571714|Ribavirin|ribavirin|mesh-list
20279032|NCT00571714|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20279033|NCT00571714|Interferon-alpha|interferon-alpha|mesh-list
20279034|NCT00571714|Betaine|betaine|mesh-list
20279035|NCT00571714|Antimetabolites|antimetabolites|mesh-ancestor
20279036|NCT00571714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279037|NCT00571714|Antiviral Agents|antiviral agents|mesh-ancestor
20279038|NCT00571714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20279039|NCT00571714|Immunologic Factors|immunologic factors|mesh-ancestor
20279040|NCT00571714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279041|NCT00571714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20279042|NCT00571714|Lipotropic Agents|lipotropic agents|mesh-ancestor
20279043|NCT00571714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20279044|NCT00571714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20279045|NCT00571727|Mecasermin|mecasermin|mesh-list
20279046|NCT00571727|Growth Substances|growth substances|mesh-ancestor
20279047|NCT00571727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279048|NCT00571740|Leucovorin|leucovorin|mesh-list
20279049|NCT00571740|Bevacizumab|bevacizumab|mesh-list
20279050|NCT00571740|Cetuximab|cetuximab|mesh-list
20279051|NCT00571740|Fluorouracil|fluorouracil|mesh-list
20279052|NCT00571740|Oxaliplatin|oxaliplatin|mesh-list
20279053|NCT00571740|Calcium|calcium|mesh-list
20279054|NCT00571740|Levoleucovorin|levoleucovorin|mesh-list
20279055|NCT00571740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20279056|NCT00571740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279057|NCT00571740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20279058|NCT00571740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20279059|NCT00571740|Growth Substances|growth substances|mesh-ancestor
20279060|NCT00571740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279061|NCT00571740|Growth Inhibitors|growth inhibitors|mesh-ancestor
20279062|NCT00571740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20279063|NCT00571740|Antimetabolites|antimetabolites|mesh-ancestor
20279064|NCT00571740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279065|NCT00571740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19962377|NCT01714310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19962378|NCT01714310|Serotonin Agents|serotonin agents|mesh-ancestor
19962379|NCT01714310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962380|NCT01714310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20279066|NCT00571740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20279067|NCT00571740|Immunologic Factors|immunologic factors|mesh-ancestor
20279068|NCT00571740|Antidotes|antidotes|mesh-ancestor
20279069|NCT00571740|Protective Agents|protective agents|mesh-ancestor
20279070|NCT00571740|Vitamin B Complex|vitamin b complex|mesh-ancestor
19962381|NCT01714310|Antidepressive Agents|antidepressive agents|mesh-ancestor
19962382|NCT01714310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19962383|NCT01714310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19962384|NCT01714310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19962385|NCT01714310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962386|NCT01714310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19962387|NCT01714310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19962388|NCT01714310|Dopamine Agents|dopamine agents|mesh-ancestor
19962389|NCT01714336|Tranexamic Acid|tranexamic acid|mesh-list
19962390|NCT01714336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19962391|NCT01714336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19974933|NCT01843920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20279071|NCT00571740|Vitamins|vitamins|mesh-ancestor
20279072|NCT00571740|Micronutrients|micronutrients|mesh-ancestor
20279073|NCT00571753|Isoniazid|isoniazid|mesh-list
20279074|NCT00571753|Antitubercular Agents|antitubercular agents|mesh-ancestor
20287985|NCT02659059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279075|NCT00571753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20279076|NCT00571753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20279077|NCT00571753|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20279078|NCT00571753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20279079|NCT00571753|Antimetabolites|antimetabolites|mesh-ancestor
20279080|NCT00571753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279081|NCT00571753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20279082|NCT00571805|Varenicline|varenicline|mesh-list
20279083|NCT00571805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20279084|NCT00571805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20279085|NCT00571805|Cholinergic Agents|cholinergic agents|mesh-ancestor
20279086|NCT00571805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20279087|NCT00571805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279088|NCT00571805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279089|NCT00571870|Cetrorelix|cetrorelix|mesh-list
19962392|NCT01714336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962393|NCT01714336|Hemostatics|hemostatics|mesh-ancestor
19962394|NCT01714336|Coagulants|coagulants|mesh-ancestor
19962395|NCT01714544|Clocortolone pivalate|clocortolone pivalate|mesh-list
19962396|NCT01714544|Glucocorticoids|glucocorticoids|mesh-ancestor
19962397|NCT01714544|Hormones|hormones|mesh-ancestor
19962398|NCT01714544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20279090|NCT00571870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20279091|NCT00571870|Fertility Agents|fertility agents|mesh-ancestor
20279092|NCT00571870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20279093|NCT00571870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279094|NCT00571870|Hormone Antagonists|hormone antagonists|mesh-ancestor
20279095|NCT00571870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20279096|NCT00571935|Insulin|insulin|mesh-list
20279097|NCT00571935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20279098|NCT00571935|Insulin Aspart|insulin aspart|mesh-list
20279099|NCT00571935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20279100|NCT00571935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279101|NCT00572013|Rituximab|rituximab|mesh-list
20279102|NCT00572013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20279103|NCT00572013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279104|NCT00572013|Immunologic Factors|immunologic factors|mesh-ancestor
20279105|NCT00572013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279106|NCT00572013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20279107|NCT00572026|Methylphenidate|methylphenidate|mesh-list
20279108|NCT00572026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20279109|NCT00572026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279110|NCT00572026|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20279111|NCT00572026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20279112|NCT00572026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20279113|NCT00572026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279114|NCT00572026|Dopamine Agents|dopamine agents|mesh-ancestor
20279115|NCT00572026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20279116|NCT00572065|Cytarabine|cytarabine|mesh-list
20279117|NCT00572065|Arsenic Trioxide|arsenic trioxide|mesh-list
20279118|NCT00572065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20279119|NCT00572065|Antimetabolites|antimetabolites|mesh-ancestor
20279120|NCT00572065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279121|NCT00572065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279122|NCT00572065|Antiviral Agents|antiviral agents|mesh-ancestor
20279123|NCT00572065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20279124|NCT00572065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20279125|NCT00572065|Immunologic Factors|immunologic factors|mesh-ancestor
20279126|NCT00572065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279127|NCT00572078|Sorafenib|sorafenib|mesh-list
20279128|NCT00572078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279129|NCT00572078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20279130|NCT00572078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279131|NCT00572078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279132|NCT00572169|Thalidomide|thalidomide|mesh-list
20279133|NCT00572169|Dexamethasone|dexamethasone|mesh-list
20279134|NCT00572169|Cyclophosphamide|cyclophosphamide|mesh-list
20279135|NCT00572169|Cisplatin|cisplatin|mesh-list
19962399|NCT01714544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962400|NCT01714609|Sorafenib|sorafenib|mesh-list
19962401|NCT01714609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962402|NCT01714609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19962403|NCT01714609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962404|NCT01714609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279136|NCT00572169|Doxorubicin|doxorubicin|mesh-list
20279137|NCT00572169|Etoposide|etoposide|mesh-list
20279138|NCT00572169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20279139|NCT00572169|Bortezomib|bortezomib|mesh-list
20279140|NCT00572169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20279141|NCT00572169|Immunologic Factors|immunologic factors|mesh-ancestor
20279142|NCT00572169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279143|NCT00572169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20279144|NCT00572169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20279145|NCT00572169|Alkylating Agents|alkylating agents|mesh-ancestor
20279146|NCT00572169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279147|NCT00572169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279148|NCT00572169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20279149|NCT00572169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20279150|NCT00572169|Antiemetics|antiemetics|mesh-ancestor
20279151|NCT00572169|Autonomic Agents|autonomic agents|mesh-ancestor
20279152|NCT00572169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20279153|NCT00572169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20279154|NCT00572169|Glucocorticoids|glucocorticoids|mesh-ancestor
20279155|NCT00572169|Hormones|hormones|mesh-ancestor
20279156|NCT00572169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20279157|NCT00572169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19962405|NCT01715129|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19962406|NCT01715129|Luteolytic Agents|luteolytic agents|mesh-ancestor
19962407|NCT01715129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19962408|NCT01715129|Contraceptive Agents|contraceptive agents|mesh-ancestor
19962409|NCT01715129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19962410|NCT01715129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962411|NCT01715129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19962412|NCT01715129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19962413|NCT01715129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962414|NCT01715207|Atenolol|atenolol|mesh-list
20279158|NCT00572169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20279159|NCT00572169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20279160|NCT00572169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20279161|NCT00572169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279162|NCT00572169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20279163|NCT00572169|Leprostatic Agents|leprostatic agents|mesh-ancestor
20279164|NCT00572169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20279165|NCT00572169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20279166|NCT00572169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20279167|NCT00572169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20279168|NCT00572169|Growth Substances|growth substances|mesh-ancestor
20279169|NCT00572169|Growth Inhibitors|growth inhibitors|mesh-ancestor
20546817|NCT01890005|Antipyretics|antipyretics|mesh-ancestor
20546818|NCT01890200|Ribavirin|ribavirin|mesh-list
20546819|NCT01890200|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20546820|NCT01890200|Antimetabolites|antimetabolites|mesh-ancestor
20546821|NCT01890200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546822|NCT01890200|Antiviral Agents|antiviral agents|mesh-ancestor
20546823|NCT01890200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20546824|NCT01890408|Ropivacaine|ropivacaine|mesh-list
20546825|NCT01890408|Anesthetics, Local|anesthetics, local|mesh-ancestor
20546826|NCT01890408|Anesthetics|anesthetics|mesh-ancestor
20546827|NCT01890408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20546828|NCT01890408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546829|NCT01890408|Sensory System Agents|sensory system agents|mesh-ancestor
20546830|NCT01890408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733305|NCT04563494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19733306|NCT04563494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733307|NCT04563351|Anesthetics|anesthetics|mesh-list
19733308|NCT04563351|Anesthetics, Local|anesthetics, local|mesh-list
19733309|NCT04563351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19733310|NCT04563351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733311|NCT04563351|Sensory System Agents|sensory system agents|mesh-ancestor
19733312|NCT04563351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733313|NCT04563507|Letrozole|letrozole|mesh-list
19733314|NCT04563507|Palbociclib|palbociclib|mesh-list
19733315|NCT04563507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733316|NCT04563507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20546831|NCT01890538|Dimenhydrinate|dimenhydrinate|mesh-list
20546832|NCT01890538|Piracetam|piracetam|mesh-list
20546833|NCT01890538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20546834|NCT01890538|Protective Agents|protective agents|mesh-ancestor
19962415|NCT01715207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20546835|NCT01890538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279170|NCT00572208|Gabapentin|gabapentin|mesh-list
20279171|NCT00572208|Analgesics|analgesics|mesh-ancestor
20279172|NCT00572208|Sensory System Agents|sensory system agents|mesh-ancestor
20279173|NCT00572208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20279174|NCT00572208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279175|NCT00572208|Anticonvulsants|anticonvulsants|mesh-ancestor
20279176|NCT00572208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20279177|NCT00572208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20279178|NCT00572208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20279179|NCT00572208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20279180|NCT00572208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20279181|NCT00572208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20279182|NCT00572208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20279183|NCT00572208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279184|NCT00572208|Antimanic Agents|antimanic agents|mesh-ancestor
20279185|NCT00572299|Alendronate|alendronate|mesh-list
20279186|NCT00572299|Prednisone|prednisone|mesh-list
20279187|NCT00572299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20279188|NCT00572299|Glucocorticoids|glucocorticoids|mesh-ancestor
20279189|NCT00572299|Hormones|hormones|mesh-ancestor
20279190|NCT00572299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20279191|NCT00572299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279192|NCT00572299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19962416|NCT01715207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19962417|NCT01715207|Sympatholytics|sympatholytics|mesh-ancestor
19962418|NCT01715207|Autonomic Agents|autonomic agents|mesh-ancestor
19962419|NCT01715207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20279193|NCT00572299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279194|NCT00572299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20279195|NCT00572312|Atorvastatin|atorvastatin|mesh-list
20279196|NCT00572312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20279197|NCT00572312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20279198|NCT00572312|Antimetabolites|antimetabolites|mesh-ancestor
20279199|NCT00572312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279200|NCT00572312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20279201|NCT00572312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20279202|NCT00572312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279203|NCT00572364|Olaparib|olaparib|mesh-list
20279204|NCT00572364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
20279205|NCT00572364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279206|NCT00572364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279207|NCT00572364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287986|NCT02659059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20287987|NCT02659059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20287988|NCT02419287|Crizotinib|crizotinib|mesh-list
20287989|NCT02419287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20287990|NCT02419287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20287991|NCT02419287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20287992|NCT02419287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287993|NCT02342444|Enoxaparin|enoxaparin|mesh-list
20287994|NCT02342444|Enoxaparin sodium|enoxaparin sodium|mesh-list
20287995|NCT02342444|Anticoagulants|anticoagulants|mesh-ancestor
20287996|NCT02342444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20287997|NCT02342444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20287998|NCT02342444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20287999|NCT02339922|Rituximab|rituximab|mesh-list
20288000|NCT02339922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20288001|NCT02339922|Ixazomib|ixazomib|mesh-list
20288002|NCT02339922|Antibodies|antibodies|mesh-list
20288003|NCT02339922|Immunoglobulins|immunoglobulins|mesh-list
20288004|NCT02339922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20288005|NCT02339922|Glycine|glycine|mesh-list
20288006|NCT02339922|Immunologic Factors|immunologic factors|mesh-ancestor
20288007|NCT02339922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288008|NCT02339922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288009|NCT02339922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20288010|NCT02339922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288011|NCT02339922|Protease Inhibitors|protease inhibitors|mesh-ancestor
20288012|NCT02339922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288013|NCT02339922|Glycine Agents|glycine agents|mesh-ancestor
20288014|NCT02339922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20288015|NCT02337829|Acalabrutinib|acalabrutinib|mesh-list
20288016|NCT02337829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288017|NCT02074631|Vitamin D|vitamin d|mesh-list
19962420|NCT01715207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288018|NCT02074631|Cholecalciferol|cholecalciferol|mesh-list
20279208|NCT00572390|Estrogens|estrogens|mesh-list
20279209|NCT00572390|Hormones|hormones|mesh-ancestor
20279210|NCT00572390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20279211|NCT00572390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279212|NCT00572559|Vancomycin|vancomycin|mesh-list
20279213|NCT00572559|Linezolid|linezolid|mesh-list
20279214|NCT00572559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20279215|NCT00572559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20279216|NCT00572559|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19450361|NCT03429075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20279217|NCT00572559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279218|NCT00572559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450362|NCT03429075|Antidepressive Agents|antidepressive agents|mesh-ancestor
19450363|NCT03429075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19450364|NCT03429075|Hallucinogens|hallucinogens|mesh-ancestor
19450365|NCT03429010|Anesthetics|anesthetics|mesh-list
19450366|NCT03429010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19450367|NCT03429010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279219|NCT00572637|Delanzomib|delanzomib|mesh-list
20279220|NCT00572637|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
20279221|NCT00572637|Protease Inhibitors|protease inhibitors|mesh-ancestor
20279222|NCT00572637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279223|NCT00572637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450368|NCT03428906|Oxytocin|oxytocin|mesh-list
19450369|NCT03428906|Oxytocics|oxytocics|mesh-ancestor
19450370|NCT03428906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20279224|NCT00572650|Vildagliptin|vildagliptin|mesh-list
20279225|NCT00572650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20279226|NCT00572650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279227|NCT00572650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20279228|NCT00572650|Protease Inhibitors|protease inhibitors|mesh-ancestor
20279229|NCT00572650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279230|NCT00572650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279231|NCT00572663|Acetylcysteine|acetylcysteine|mesh-list
20279232|NCT00572663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20279233|NCT00572663|Antiviral Agents|antiviral agents|mesh-ancestor
20279234|NCT00572663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20279235|NCT00572663|Expectorants|expectorants|mesh-ancestor
20279236|NCT00572663|Respiratory System Agents|respiratory system agents|mesh-ancestor
20279237|NCT00572663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20279238|NCT00572663|Antioxidants|antioxidants|mesh-ancestor
20279239|NCT00572663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279240|NCT00572663|Protective Agents|protective agents|mesh-ancestor
20279241|NCT00572663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279242|NCT00572663|Antidotes|antidotes|mesh-ancestor
20279243|NCT00572689|Exenatide|exenatide|mesh-list
20279244|NCT00572689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20279245|NCT00572689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279246|NCT00572689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20279247|NCT00572689|Incretins|incretins|mesh-ancestor
20279248|NCT00572689|Hormones|hormones|mesh-ancestor
20279249|NCT00572689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20279250|NCT00572741|Ascorbic Acid|ascorbic acid|mesh-list
20279251|NCT00572741|Cod Liver Oil|cod liver oil|mesh-list
20279252|NCT00572741|Vitamins|vitamins|mesh-ancestor
20279253|NCT00572741|Micronutrients|micronutrients|mesh-ancestor
20279254|NCT00572741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279255|NCT00572741|Antioxidants|antioxidants|mesh-ancestor
20279256|NCT00572741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279257|NCT00572741|Protective Agents|protective agents|mesh-ancestor
20279258|NCT00572806|Insulin Aspart|insulin aspart|mesh-list
20279259|NCT00572806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20279260|NCT00572806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279261|NCT00572819|Misoprostol|misoprostol|mesh-list
20279262|NCT00572819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20279263|NCT00572819|Abortifacient Agents|abortifacient agents|mesh-ancestor
20279264|NCT00572819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20279265|NCT00572819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279266|NCT00572819|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20279267|NCT00572819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20279268|NCT00572819|Oxytocics|oxytocics|mesh-ancestor
20279269|NCT00572884|Permethrin|permethrin|mesh-list
20279270|NCT00572884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279271|NCT00572884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279272|NCT00573001|Ritonavir|ritonavir|mesh-list
20279273|NCT00573001|Lopinavir|lopinavir|mesh-list
20279274|NCT00573001|Tenofovir|tenofovir|mesh-list
20279275|NCT00573001|Zidovudine|zidovudine|mesh-list
20279276|NCT00573001|Emtricitabine|emtricitabine|mesh-list
20279277|NCT00573001|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20279278|NCT00573001|Nevirapine|nevirapine|mesh-list
20546836|NCT01890538|Nootropic Agents|nootropic agents|mesh-ancestor
20546837|NCT01890538|Antiemetics|antiemetics|mesh-ancestor
20546838|NCT01890538|Autonomic Agents|autonomic agents|mesh-ancestor
20546839|NCT01890538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546840|NCT01890538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20546841|NCT01890538|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20546842|NCT01890538|Histamine Antagonists|histamine antagonists|mesh-ancestor
20546843|NCT01890538|Histamine Agents|histamine agents|mesh-ancestor
20546844|NCT01890538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20546845|NCT01890538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546846|NCT01890629|Metformin|metformin|mesh-list
20546847|NCT01890629|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20546848|NCT01890629|Glimepiride|glimepiride|mesh-list
20546849|NCT01890629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20546850|NCT01890629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546851|NCT01890629|Incretins|incretins|mesh-ancestor
20546852|NCT01890629|Hormones|hormones|mesh-ancestor
20546853|NCT01890629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20546854|NCT01890629|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20546855|NCT01890629|Protease Inhibitors|protease inhibitors|mesh-ancestor
20546856|NCT01890629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546857|NCT01890629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546858|NCT01890629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20546859|NCT01890629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20546860|NCT01890629|Immunologic Factors|immunologic factors|mesh-ancestor
20546861|NCT01890772|Vitamin D|vitamin d|mesh-list
20546862|NCT01890772|Ribavirin|ribavirin|mesh-list
20546863|NCT01890772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20546864|NCT01890772|Vitamins|vitamins|mesh-ancestor
20546865|NCT01890772|Micronutrients|micronutrients|mesh-ancestor
20546866|NCT01890772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546867|NCT01890772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20546868|NCT01890772|Antimetabolites|antimetabolites|mesh-ancestor
20546869|NCT01890772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546870|NCT01890772|Antiviral Agents|antiviral agents|mesh-ancestor
20546871|NCT01890772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20546872|NCT01890863|Fluticasone|fluticasone|mesh-list
20546873|NCT01890863|Xhance|xhance|mesh-list
20546874|NCT01890863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20546875|NCT01890863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20546876|NCT01890863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20546877|NCT01890863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20546878|NCT01890863|Autonomic Agents|autonomic agents|mesh-ancestor
20546879|NCT01890863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546880|NCT01890863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546881|NCT01890863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20546882|NCT01890863|Respiratory System Agents|respiratory system agents|mesh-ancestor
20279279|NCT00573001|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20279280|NCT00573001|Efavirenz|efavirenz|mesh-list
20279281|NCT00573001|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20279282|NCT00573001|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20279283|NCT00573001|Protease Inhibitors|protease inhibitors|mesh-ancestor
20279284|NCT00573001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279285|NCT00573001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279286|NCT00573001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20279287|NCT00573001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20279288|NCT00573001|Antiviral Agents|antiviral agents|mesh-ancestor
20279289|NCT00573001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20279290|NCT00573001|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20279291|NCT00573001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20279292|NCT00573001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20279293|NCT00573001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20279294|NCT00573001|Antimetabolites|antimetabolites|mesh-ancestor
19962421|NCT01715207|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19962422|NCT01715207|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19962423|NCT01715207|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19962424|NCT01715207|Adrenergic Agents|adrenergic agents|mesh-ancestor
19962425|NCT01715207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19962426|NCT01715207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962427|NCT01715233|Leucovorin|leucovorin|mesh-list
20279295|NCT00573001|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20279296|NCT00573001|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20279297|NCT00573001|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20279298|NCT00573001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20279299|NCT00573001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20279300|NCT00573222|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20279301|NCT00573222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20279302|NCT00573222|Respiratory System Agents|respiratory system agents|mesh-ancestor
20279303|NCT00573326|Imatinib Mesylate|imatinib mesylate|mesh-list
20279304|NCT00573326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279305|NCT00573326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20279306|NCT00573326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279307|NCT00573326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279308|NCT00573378|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20279309|NCT00573378|Antiviral Agents|antiviral agents|mesh-ancestor
20279310|NCT00573378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20279311|NCT00573404|Sunitinib|sunitinib|mesh-list
20279312|NCT00573404|Imatinib Mesylate|imatinib mesylate|mesh-list
20279313|NCT00573404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20546883|NCT01890863|Dermatologic Agents|dermatologic agents|mesh-ancestor
20546884|NCT01890863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20546885|NCT01890863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20546886|NCT01890863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20546887|NCT01890863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20546888|NCT01890863|Adrenergic Agents|adrenergic agents|mesh-ancestor
20546889|NCT01890863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20546890|NCT01890863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546891|NCT01890863|Glucocorticoids|glucocorticoids|mesh-ancestor
20546892|NCT01890863|Hormones|hormones|mesh-ancestor
20546893|NCT01890863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20546894|NCT01890863|Sympathomimetics|sympathomimetics|mesh-ancestor
20546895|NCT01890889|Ezetimibe|ezetimibe|mesh-list
20546896|NCT01890889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20546897|NCT01890889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20546898|NCT01890889|Antimetabolites|antimetabolites|mesh-ancestor
20546899|NCT01890889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546900|NCT01890889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20546901|NCT01890902|Ketoprofen|ketoprofen|mesh-list
20546902|NCT01890902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19962428|NCT01715233|Carboplatin|carboplatin|mesh-list
19962429|NCT01715233|Docetaxel|docetaxel|mesh-list
19962430|NCT01715233|Fluorouracil|fluorouracil|mesh-list
19962431|NCT01715233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962432|NCT01715233|Tubulin Modulators|tubulin modulators|mesh-ancestor
20546903|NCT01890902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20546904|NCT01890902|Analgesics|analgesics|mesh-ancestor
20546905|NCT01890902|Sensory System Agents|sensory system agents|mesh-ancestor
20546906|NCT01890902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19962433|NCT01715233|Antimitotic Agents|antimitotic agents|mesh-ancestor
19962434|NCT01715233|Mitosis Modulators|mitosis modulators|mesh-ancestor
20279314|NCT00573404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20279315|NCT00573404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20279316|NCT00573404|Growth Substances|growth substances|mesh-ancestor
20279317|NCT00573404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279318|NCT00573404|Growth Inhibitors|growth inhibitors|mesh-ancestor
20279319|NCT00573404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20279320|NCT00573404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279321|NCT00573404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279322|NCT00573417|Modafinil|modafinil|mesh-list
20279323|NCT00573417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20279324|NCT00573417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279325|NCT00573417|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20279326|NCT00573417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20279327|NCT00573417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20279328|NCT00573417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279329|NCT00573495|BIRC5 protein, human|birc5 protein, human|mesh-list
20279330|NCT00573495|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20279331|NCT00573495|Protease Inhibitors|protease inhibitors|mesh-ancestor
20279332|NCT00573495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279333|NCT00573495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279334|NCT00573547|Fluoxetine|fluoxetine|mesh-list
20279335|NCT00573547|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20279336|NCT00573547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20279337|NCT00573547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20279338|NCT00573547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279339|NCT00573547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20279340|NCT00573547|Serotonin Agents|serotonin agents|mesh-ancestor
20279341|NCT00573547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279342|NCT00573547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20279343|NCT00573547|Antidepressive Agents|antidepressive agents|mesh-ancestor
20279344|NCT00573547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20279345|NCT00573547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20279346|NCT00573547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20279347|NCT00573547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279348|NCT00573599|Diphenhydramine|diphenhydramine|mesh-list
20279349|NCT00573599|Prochlorperazine|prochlorperazine|mesh-list
20279350|NCT00573599|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20279351|NCT00573599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20279352|NCT00573599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20546907|NCT01890902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546908|NCT01890902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20546909|NCT01890902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20546910|NCT01890902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20546911|NCT01890902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546912|NCT01890902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546913|NCT01890941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20546914|NCT01890941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20546915|NCT01890993|Liraglutide|liraglutide|mesh-list
20546916|NCT01890993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20546917|NCT01890993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546918|NCT01890993|Incretins|incretins|mesh-ancestor
20546919|NCT01890993|Hormones|hormones|mesh-ancestor
20546920|NCT01890993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20546921|NCT01891019|Thalidomide|thalidomide|mesh-list
20546922|NCT01891019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20546923|NCT01891019|Immunologic Factors|immunologic factors|mesh-ancestor
20546924|NCT01891019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546925|NCT01891019|Leprostatic Agents|leprostatic agents|mesh-ancestor
20546926|NCT01891019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20546927|NCT01891019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20546928|NCT01891019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20546929|NCT01891019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20546930|NCT01891019|Growth Substances|growth substances|mesh-ancestor
20546931|NCT01891019|Growth Inhibitors|growth inhibitors|mesh-ancestor
20546932|NCT01891019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20546933|NCT01891084|Acetaminophen|acetaminophen|mesh-list
20546934|NCT01891084|Ibuprofen|ibuprofen|mesh-list
20546935|NCT01891084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20546936|NCT01891084|Analgesics|analgesics|mesh-ancestor
20546937|NCT01891084|Sensory System Agents|sensory system agents|mesh-ancestor
20546938|NCT01891084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546939|NCT01891084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279353|NCT00573599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279354|NCT00573599|Anesthetics, Local|anesthetics, local|mesh-ancestor
20279355|NCT00573599|Anesthetics|anesthetics|mesh-ancestor
20279356|NCT00573599|Sensory System Agents|sensory system agents|mesh-ancestor
20279357|NCT00573599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20279358|NCT00573599|Antiemetics|antiemetics|mesh-ancestor
20279359|NCT00573599|Autonomic Agents|autonomic agents|mesh-ancestor
20279360|NCT00573599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20279361|NCT00573599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20279362|NCT00573599|Histamine Antagonists|histamine antagonists|mesh-ancestor
20279363|NCT00573599|Histamine Agents|histamine agents|mesh-ancestor
20279364|NCT00573599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20279365|NCT00573599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279366|NCT00573599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20279367|NCT00573599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20279368|NCT00573599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20279369|NCT00573599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20279370|NCT00573599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20279371|NCT00573599|Dopamine Agents|dopamine agents|mesh-ancestor
19962435|NCT01715233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279372|NCT00573638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20279373|NCT00573638|Latanoprost|latanoprost|mesh-list
20279374|NCT00573638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20279375|NCT00573664|Gabapentin|gabapentin|mesh-list
20279376|NCT00573664|Analgesics|analgesics|mesh-ancestor
20279377|NCT00573664|Sensory System Agents|sensory system agents|mesh-ancestor
20279378|NCT00573664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20279379|NCT00573664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279380|NCT00573664|Anticonvulsants|anticonvulsants|mesh-ancestor
20279381|NCT00573664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20279382|NCT00573664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20279383|NCT00573664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20279384|NCT00573664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20279385|NCT00573664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20279386|NCT00573664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20279387|NCT00573664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20279388|NCT00573664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279389|NCT00573664|Antimanic Agents|antimanic agents|mesh-ancestor
20279390|NCT00573690|Carboplatin|carboplatin|mesh-list
20279391|NCT00573690|Etoposide|etoposide|mesh-list
20279392|NCT00573690|Pemetrexed|pemetrexed|mesh-list
20279393|NCT00573690|Sorafenib|sorafenib|mesh-list
20279394|NCT00573690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279395|NCT00573690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20279396|NCT00573690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20279397|NCT00573690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20279398|NCT00573690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279399|NCT00573690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279400|NCT00573690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20279401|NCT00573690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20279402|NCT00573690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20279403|NCT00573742|Candesartan|candesartan|mesh-list
20279404|NCT00573742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20279405|NCT00573742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20279406|NCT00573742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20279407|NCT00573742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962436|NCT01715233|Antimetabolites|antimetabolites|mesh-ancestor
19962437|NCT01715233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19962438|NCT01715233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19962439|NCT01715233|Immunologic Factors|immunologic factors|mesh-ancestor
19962440|NCT01715233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962441|NCT01715233|Antidotes|antidotes|mesh-ancestor
19962442|NCT01715233|Protective Agents|protective agents|mesh-ancestor
19962443|NCT01715233|Vitamin B Complex|vitamin b complex|mesh-ancestor
19962444|NCT01715233|Vitamins|vitamins|mesh-ancestor
19962445|NCT01715233|Micronutrients|micronutrients|mesh-ancestor
19962446|NCT01715298|Glycopyrrolate|glycopyrrolate|mesh-list
19962447|NCT01715298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19962448|NCT01715298|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19962449|NCT01715298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19962450|NCT01715298|Cholinergic Agents|cholinergic agents|mesh-ancestor
20279408|NCT00573885|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20279409|NCT00573885|Antioxidants|antioxidants|mesh-ancestor
20279410|NCT00573885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279411|NCT00573885|Protective Agents|protective agents|mesh-ancestor
20279412|NCT00573885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279413|NCT00573885|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20279414|NCT00573885|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20279415|NCT00573885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279416|NCT00573885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20279417|NCT00573924|Lansoprazole|lansoprazole|mesh-list
20546940|NCT01891084|Antipyretics|antipyretics|mesh-ancestor
20546941|NCT01891084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20546942|NCT01891084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20546943|NCT01891084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20546944|NCT01891084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20546945|NCT01891084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546946|NCT01891084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554397|NCT01935193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554398|NCT01935206|Naloxone|naloxone|mesh-list
20554399|NCT01935206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20554400|NCT01935206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554401|NCT01935206|Sensory System Agents|sensory system agents|mesh-ancestor
20554402|NCT01935206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554403|NCT01935310|Imiquimod|imiquimod|mesh-list
20554404|NCT01935310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20554405|NCT01935310|Immunologic Factors|immunologic factors|mesh-ancestor
20554406|NCT01935310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554407|NCT01935310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554408|NCT01935310|Interferon Inducers|interferon inducers|mesh-ancestor
20554409|NCT01935492|Paclitaxel|paclitaxel|mesh-list
20554410|NCT01935492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20554411|NCT01935492|Bevacizumab|bevacizumab|mesh-list
20554412|NCT01935492|Doxorubicin|doxorubicin|mesh-list
20554413|NCT01935492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20554414|NCT01935492|Capecitabine|capecitabine|mesh-list
20554415|NCT01935492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20554416|NCT01935492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279418|NCT00573924|Dexlansoprazole|dexlansoprazole|mesh-list
20279419|NCT00573924|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
20279420|NCT00573924|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20554417|NCT01935492|Tubulin Modulators|tubulin modulators|mesh-ancestor
20279421|NCT00573924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20279422|NCT00573924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279423|NCT00573924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279424|NCT00573950|Cilostazol|cilostazol|mesh-list
20279425|NCT00573950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20279426|NCT00573950|Autonomic Agents|autonomic agents|mesh-ancestor
20279427|NCT00573950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20279428|NCT00573950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279429|NCT00573950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20279430|NCT00573950|Respiratory System Agents|respiratory system agents|mesh-ancestor
20279431|NCT00573950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20279432|NCT00573950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20279433|NCT00573950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279434|NCT00573950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20279435|NCT00573950|Vasodilator Agents|vasodilator agents|mesh-ancestor
20279436|NCT00573950|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20279437|NCT00573950|Protective Agents|protective agents|mesh-ancestor
20279438|NCT00573950|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20279439|NCT00573950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20279440|NCT00573950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279441|NCT00573963|Ropivacaine|ropivacaine|mesh-list
20279442|NCT00573963|Anesthetics, Local|anesthetics, local|mesh-ancestor
20279443|NCT00573963|Anesthetics|anesthetics|mesh-ancestor
20279444|NCT00573963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20279445|NCT00573963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279446|NCT00573963|Sensory System Agents|sensory system agents|mesh-ancestor
20279447|NCT00573963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20279448|NCT00574015|Acetaminophen|acetaminophen|mesh-list
20279449|NCT00574015|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20279450|NCT00574015|Hydrocodone|hydrocodone|mesh-list
20279451|NCT00574015|Bupivacaine|bupivacaine|mesh-list
20279452|NCT00574015|Anesthetics, Local|anesthetics, local|mesh-ancestor
20279453|NCT00574015|Anesthetics|anesthetics|mesh-ancestor
20279454|NCT00574015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20279455|NCT00574015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279456|NCT00574015|Sensory System Agents|sensory system agents|mesh-ancestor
20279457|NCT00574015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20279458|NCT00574015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20279459|NCT00574015|Analgesics|analgesics|mesh-ancestor
20279460|NCT00574015|Antipyretics|antipyretics|mesh-ancestor
20546947|NCT01891175|Anesthetics|anesthetics|mesh-list
20546948|NCT01891175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20546949|NCT01891175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546950|NCT01891201|Oxytocin|oxytocin|mesh-list
20546951|NCT01891201|Oxytocics|oxytocics|mesh-ancestor
20546952|NCT01891201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20546953|NCT01891201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546954|NCT01891227|Capecitabine|capecitabine|mesh-list
20546955|NCT01891227|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20546956|NCT01891227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20546957|NCT01891227|Antimetabolites|antimetabolites|mesh-ancestor
20546958|NCT01891227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546959|NCT01891227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20546960|NCT01891227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20546961|NCT01891227|Alkylating Agents|alkylating agents|mesh-ancestor
20546962|NCT01891292|Acetylcysteine|acetylcysteine|mesh-list
20546963|NCT01891292|Enalapril|enalapril|mesh-list
20546964|NCT01891292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20546965|NCT01891292|Antiviral Agents|antiviral agents|mesh-ancestor
20546966|NCT01891292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20546967|NCT01891292|Expectorants|expectorants|mesh-ancestor
20546968|NCT01891292|Respiratory System Agents|respiratory system agents|mesh-ancestor
20546969|NCT01891292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20546970|NCT01891292|Antioxidants|antioxidants|mesh-ancestor
20546971|NCT01891292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546972|NCT01891292|Protective Agents|protective agents|mesh-ancestor
20546973|NCT01891292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20546974|NCT01891292|Antidotes|antidotes|mesh-ancestor
20546975|NCT01891292|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20546976|NCT01891292|Protease Inhibitors|protease inhibitors|mesh-ancestor
20546977|NCT01891292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546978|NCT01891292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20546979|NCT01891435|Acetaminophen|acetaminophen|mesh-list
20546980|NCT01891435|Diclofenac|diclofenac|mesh-list
20546981|NCT01891435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20279461|NCT00574015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20279462|NCT00574015|Narcotics|narcotics|mesh-ancestor
20279463|NCT00574015|Antitussive Agents|antitussive agents|mesh-ancestor
20279464|NCT00574015|Respiratory System Agents|respiratory system agents|mesh-ancestor
20279465|NCT00574015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20279466|NCT00574015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20279467|NCT00574015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20279468|NCT00574041|Interferons|interferons|mesh-list
20279469|NCT00574041|Interferon-beta|interferon-beta|mesh-list
20279470|NCT00574041|Interferon beta-1a|interferon beta-1a|mesh-list
20279471|NCT00574041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279472|NCT00574041|Antiviral Agents|antiviral agents|mesh-ancestor
20279473|NCT00574041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20279474|NCT00574041|Immunologic Factors|immunologic factors|mesh-ancestor
20279475|NCT00574041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279476|NCT00574041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20279477|NCT00574093|Ranibizumab|ranibizumab|mesh-list
20279478|NCT00574093|Verteporfin|verteporfin|mesh-list
20279479|NCT00574093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20279480|NCT00574093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19962451|NCT01715298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19962452|NCT01715298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962453|NCT01715298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962454|NCT01715415|Ribavirin|ribavirin|mesh-list
19962455|NCT01715415|Antimetabolites|antimetabolites|mesh-ancestor
19962456|NCT01715415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962457|NCT01715415|Antiviral Agents|antiviral agents|mesh-ancestor
19962458|NCT01715415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20279481|NCT00574093|Growth Substances|growth substances|mesh-ancestor
20279482|NCT00574093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279483|NCT00574093|Growth Inhibitors|growth inhibitors|mesh-ancestor
20279484|NCT00574093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279485|NCT00574093|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20279486|NCT00574093|Dermatologic Agents|dermatologic agents|mesh-ancestor
20288019|NCT02074631|Ergocalciferols|ergocalciferols|mesh-list
20288020|NCT02074631|Pamidronate|pamidronate|mesh-list
20288021|NCT02074631|Calcium|calcium|mesh-list
20288022|NCT02074631|Vitamins|vitamins|mesh-ancestor
20288023|NCT02074631|Micronutrients|micronutrients|mesh-ancestor
20288024|NCT02074631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288025|NCT02074631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20288026|NCT02074631|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20288027|NCT02020707|Paclitaxel|paclitaxel|mesh-list
20288028|NCT02020707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20288029|NCT02020707|Bevacizumab|bevacizumab|mesh-list
20288030|NCT02020707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20288031|NCT02020707|Endothelial Growth Factors|endothelial growth factors|mesh-list
20288032|NCT02020707|Antibodies|antibodies|mesh-list
20288033|NCT02020707|Immunoglobulins|immunoglobulins|mesh-list
20288034|NCT02020707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20288035|NCT02020707|Immunoglobulin G|immunoglobulin g|mesh-list
20288036|NCT02020707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20288037|NCT02020707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288038|NCT02020707|Tubulin Modulators|tubulin modulators|mesh-ancestor
20288039|NCT02020707|Antimitotic Agents|antimitotic agents|mesh-ancestor
20288040|NCT02020707|Mitosis Modulators|mitosis modulators|mesh-ancestor
20288041|NCT02020707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288042|NCT02020707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20288043|NCT02020707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20288044|NCT02020707|Growth Substances|growth substances|mesh-ancestor
20288045|NCT02020707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288046|NCT02020707|Growth Inhibitors|growth inhibitors|mesh-ancestor
20288047|NCT02020707|Immunologic Factors|immunologic factors|mesh-ancestor
20288048|NCT01928394|Nivolumab|nivolumab|mesh-list
20288049|NCT01928394|Ipilimumab|ipilimumab|mesh-list
20288050|NCT01928394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20288051|NCT01928394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288052|NCT01928394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20546982|NCT01891435|Analgesics|analgesics|mesh-ancestor
20546983|NCT01891435|Sensory System Agents|sensory system agents|mesh-ancestor
20546984|NCT01891435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20546985|NCT01891435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288053|NCT01928394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288054|NCT01657500|Gentamicins|gentamicins|mesh-list
20288055|NCT01657500|Dextrans|dextrans|mesh-list
20288056|NCT01657500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20546986|NCT01891435|Antipyretics|antipyretics|mesh-ancestor
20279487|NCT00574353|Misonidazole|misonidazole|mesh-list
20279488|NCT00574353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279489|NCT00574353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20279490|NCT00574353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20279491|NCT00574353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20279492|NCT00574366|Everolimus|everolimus|mesh-list
20279493|NCT00574366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20279494|NCT00574366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279495|NCT00574366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20279496|NCT00574366|Immunologic Factors|immunologic factors|mesh-ancestor
20279497|NCT00574366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279498|NCT00574366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20279499|NCT00574366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279500|NCT00574366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279501|NCT00574470|Infliximab|infliximab|mesh-list
20279502|NCT00574470|Daclizumab|daclizumab|mesh-list
20279503|NCT00574470|Dermatologic Agents|dermatologic agents|mesh-ancestor
20279504|NCT00574470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20279505|NCT00574470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20279506|NCT00574470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20279507|NCT00574470|Immunologic Factors|immunologic factors|mesh-ancestor
20279508|NCT00574470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279509|NCT00574483|Quinacrine|quinacrine|mesh-list
20279510|NCT00574483|Anticestodal Agents|anticestodal agents|mesh-ancestor
20279511|NCT00574483|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20279512|NCT00574483|Anthelmintics|anthelmintics|mesh-ancestor
20279513|NCT00574483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19962459|NCT01715805|Cariprazine|cariprazine|mesh-list
19962460|NCT01715805|Antidepressive Agents|antidepressive agents|mesh-list
19962461|NCT01715805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19962462|NCT01715805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19962463|NCT01715805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19962464|NCT01715805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19962465|NCT01715805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962466|NCT01715896|Golimumab|golimumab|mesh-list
19962467|NCT01715896|Mavrilimumab|mavrilimumab|mesh-list
19962468|NCT01715896|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19962469|NCT01715896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19962470|NCT01715896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20279514|NCT00574483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20279515|NCT00574483|Antimalarials|antimalarials|mesh-ancestor
20279516|NCT00574483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20279517|NCT00574483|Antinematodal Agents|antinematodal agents|mesh-ancestor
20279518|NCT00574483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279519|NCT00574483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279520|NCT00574483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279521|NCT00574509|Tositumomab I-131|tositumomab i-131|mesh-list
19962471|NCT01715896|Immunologic Factors|immunologic factors|mesh-ancestor
19962472|NCT01715896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962473|NCT01715896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19962474|NCT01716039|Adalimumab|adalimumab|mesh-list
19962475|NCT01716039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19962476|NCT01716039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19962477|NCT01716156|Ribavirin|ribavirin|mesh-list
20279522|NCT00574509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279523|NCT00574600|Vaccines|vaccines|mesh-list
20279524|NCT00574600|Immunologic Factors|immunologic factors|mesh-ancestor
20279525|NCT00574600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279526|NCT00574639|Alprazolam|alprazolam|mesh-list
20279527|NCT00574639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20279528|NCT00574639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20279529|NCT00574639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279530|NCT00574639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20279531|NCT00574639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20279532|NCT00574639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20279533|NCT00574639|GABA Modulators|gaba modulators|mesh-ancestor
20279534|NCT00574639|GABA Agents|gaba agents|mesh-ancestor
20279535|NCT00574639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20279536|NCT00574639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279537|NCT00574652|Aldesleukin|aldesleukin|mesh-list
20279538|NCT00574652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279539|NCT00574652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19962478|NCT01716156|Grazoprevir|grazoprevir|mesh-list
20279540|NCT00574652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19962479|NCT01716156|Antimetabolites|antimetabolites|mesh-ancestor
19974934|NCT01843920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20279541|NCT00574652|Antiviral Agents|antiviral agents|mesh-ancestor
20279542|NCT00574652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20279543|NCT00574730|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20279544|NCT00574730|Rituximab|rituximab|mesh-list
20279545|NCT00574730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20279546|NCT00574730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279547|NCT00574730|Immunologic Factors|immunologic factors|mesh-ancestor
19962480|NCT01716156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962481|NCT01716156|Antiviral Agents|antiviral agents|mesh-ancestor
19962482|NCT01716156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19962483|NCT01716195|Paclitaxel|paclitaxel|mesh-list
19962484|NCT01716195|Carboplatin|carboplatin|mesh-list
19962485|NCT01716195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20279548|NCT00574730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279549|NCT00574730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20279550|NCT00574730|Antiviral Agents|antiviral agents|mesh-ancestor
20279551|NCT00574730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20279552|NCT00574743|Mycophenolic Acid|mycophenolic acid|mesh-list
20279553|NCT00574743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20279554|NCT00574743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279555|NCT00574743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20279556|NCT00574743|Antitubercular Agents|antitubercular agents|mesh-ancestor
20279557|NCT00574743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20279558|NCT00574743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20279559|NCT00574743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279560|NCT00574743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279561|NCT00574756|Ranolazine|ranolazine|mesh-list
20279562|NCT00574756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20279563|NCT00574756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20279564|NCT00574756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279565|NCT00574769|Bevacizumab|bevacizumab|mesh-list
20279566|NCT00574769|Docetaxel|docetaxel|mesh-list
20279567|NCT00574769|Everolimus|everolimus|mesh-list
20279568|NCT00574769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20279569|NCT00574769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279570|NCT00574769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20279571|NCT00574769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20279572|NCT00574769|Growth Substances|growth substances|mesh-ancestor
20279573|NCT00574769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279574|NCT00574769|Growth Inhibitors|growth inhibitors|mesh-ancestor
20279575|NCT00574769|Tubulin Modulators|tubulin modulators|mesh-ancestor
20279576|NCT00574769|Antimitotic Agents|antimitotic agents|mesh-ancestor
20279577|NCT00574769|Mitosis Modulators|mitosis modulators|mesh-ancestor
20279578|NCT00574769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279579|NCT00574769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20279580|NCT00574769|Immunologic Factors|immunologic factors|mesh-ancestor
20279581|NCT00574925|Esomeprazole|esomeprazole|mesh-list
20279582|NCT00574925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20279583|NCT00574925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20279584|NCT00574925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20279585|NCT00574925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279586|NCT00574925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279587|NCT00574964|Temozolomide|temozolomide|mesh-list
20279588|NCT00574964|Carmustine|carmustine|mesh-list
20279589|NCT00574964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20279590|NCT00574964|Alkylating Agents|alkylating agents|mesh-ancestor
20279591|NCT00574964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279592|NCT00574964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279593|NCT00575068|Galiximab|galiximab|mesh-list
20279594|NCT00575068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20279595|NCT00575068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279596|NCT00575224|Interferons|interferons|mesh-list
20279597|NCT00575224|Ribavirin|ribavirin|mesh-list
20279598|NCT00575224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279599|NCT00575224|Antiviral Agents|antiviral agents|mesh-ancestor
20279600|NCT00575224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20279601|NCT00575224|Antimetabolites|antimetabolites|mesh-ancestor
20279602|NCT00575224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279603|NCT00575302|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20279604|NCT00575302|Hormones|hormones|mesh-ancestor
20279605|NCT00575302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20279606|NCT00575302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279607|NCT00575341|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20279608|NCT00575341|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20279609|NCT00575341|Immunologic Factors|immunologic factors|mesh-ancestor
20279610|NCT00575341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279611|NCT00575354|Sevoflurane|sevoflurane|mesh-list
20279612|NCT00575354|Isoflurane|isoflurane|mesh-list
20279613|NCT00575354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20279614|NCT00575354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20279615|NCT00575354|Anesthetics, General|anesthetics, general|mesh-ancestor
20279616|NCT00575354|Anesthetics|anesthetics|mesh-ancestor
20279617|NCT00575354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20279618|NCT00575354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279619|NCT00575393|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
20279620|NCT00575393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20279621|NCT00575406|Prednisolone|prednisolone|mesh-list
20279622|NCT00575406|Cyclophosphamide|cyclophosphamide|mesh-list
20279623|NCT00575406|Rituximab|rituximab|mesh-list
20279624|NCT00575406|Doxorubicin|doxorubicin|mesh-list
20279625|NCT00575406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20279626|NCT00575406|Vincristine|vincristine|mesh-list
20279627|NCT00575406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20279628|NCT00575406|Immunologic Factors|immunologic factors|mesh-ancestor
20279629|NCT00575406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279630|NCT00575406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20279631|NCT00575406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20279632|NCT00575406|Alkylating Agents|alkylating agents|mesh-ancestor
20279633|NCT00575406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279634|NCT00575406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279635|NCT00575406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20279636|NCT00575406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20279637|NCT00575406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20279638|NCT00575406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20279639|NCT00575406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20279640|NCT00575406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279641|NCT00575406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20279642|NCT00575406|Glucocorticoids|glucocorticoids|mesh-ancestor
20279643|NCT00575406|Hormones|hormones|mesh-ancestor
20279644|NCT00575406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20279645|NCT00575406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20279646|NCT00575406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20279647|NCT00575406|Tubulin Modulators|tubulin modulators|mesh-ancestor
20279648|NCT00575406|Antimitotic Agents|antimitotic agents|mesh-ancestor
20279649|NCT00575406|Mitosis Modulators|mitosis modulators|mesh-ancestor
20279650|NCT00575419|Acetylcysteine|acetylcysteine|mesh-list
20279651|NCT00575419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20279652|NCT00575419|Antiviral Agents|antiviral agents|mesh-ancestor
20279653|NCT00575419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20279654|NCT00575419|Expectorants|expectorants|mesh-ancestor
20279655|NCT00575419|Respiratory System Agents|respiratory system agents|mesh-ancestor
20279656|NCT00575419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20279657|NCT00575419|Antioxidants|antioxidants|mesh-ancestor
20279658|NCT00575419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279659|NCT00575419|Protective Agents|protective agents|mesh-ancestor
20546987|NCT01891435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20546988|NCT01891435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20546989|NCT01891435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20546990|NCT01891435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20546991|NCT01891435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20546992|NCT01891435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20546993|NCT01891461|Hemostatics|hemostatics|mesh-list
20546994|NCT01891461|Coagulants|coagulants|mesh-ancestor
20546995|NCT01891487|Bimatoprost|bimatoprost|mesh-list
20546996|NCT01891487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20546997|NCT01891500|Nitric Oxide|nitric oxide|mesh-list
20546998|NCT01891500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20546999|NCT01891500|Autonomic Agents|autonomic agents|mesh-ancestor
20547000|NCT01891500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19962486|NCT01716195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962487|NCT01716195|Tubulin Modulators|tubulin modulators|mesh-ancestor
19962488|NCT01716195|Antimitotic Agents|antimitotic agents|mesh-ancestor
20279660|NCT00575419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279661|NCT00575419|Antidotes|antidotes|mesh-ancestor
20279662|NCT00575523|Atropine|atropine|mesh-list
20279663|NCT00575523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20279664|NCT00575523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20279665|NCT00575523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20279666|NCT00575523|Autonomic Agents|autonomic agents|mesh-ancestor
20279667|NCT00575523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20279668|NCT00575523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279669|NCT00575523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20279670|NCT00575523|Respiratory System Agents|respiratory system agents|mesh-ancestor
20279671|NCT00575523|Mydriatics|mydriatics|mesh-ancestor
20279672|NCT00575523|Parasympatholytics|parasympatholytics|mesh-ancestor
20279673|NCT00575523|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20279674|NCT00575523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20279675|NCT00575523|Cholinergic Agents|cholinergic agents|mesh-ancestor
20279676|NCT00575523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20279677|NCT00575523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279678|NCT00575549|Dobutamine|dobutamine|mesh-list
20279679|NCT00575549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20279680|NCT00575549|Sympathomimetics|sympathomimetics|mesh-ancestor
20279681|NCT00575549|Autonomic Agents|autonomic agents|mesh-ancestor
20279682|NCT00575549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20279683|NCT00575549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279684|NCT00575549|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20279685|NCT00575549|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20279686|NCT00575549|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20279687|NCT00575549|Adrenergic Agents|adrenergic agents|mesh-ancestor
20279688|NCT00575549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20279689|NCT00575549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279690|NCT00575549|Protective Agents|protective agents|mesh-ancestor
20279691|NCT00575601|Simvastatin|simvastatin|mesh-list
20279692|NCT00575601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20279693|NCT00575601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20279694|NCT00575601|Antimetabolites|antimetabolites|mesh-ancestor
20279695|NCT00575601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279696|NCT00575601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20279697|NCT00575601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20279698|NCT00575601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279699|NCT00575614|Prucalopride|prucalopride|mesh-list
20279700|NCT00575614|Laxatives|laxatives|mesh-ancestor
20279701|NCT00575614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20279702|NCT00575614|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20279703|NCT00575614|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20279704|NCT00575614|Serotonin Agents|serotonin agents|mesh-ancestor
20279705|NCT00575614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20279706|NCT00575614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279707|NCT00575614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279708|NCT00575627|Interferons|interferons|mesh-list
20279709|NCT00575627|Ribavirin|ribavirin|mesh-list
20279710|NCT00575627|Interferon-alpha|interferon-alpha|mesh-list
20279711|NCT00575627|Interferon alpha-2|interferon alpha-2|mesh-list
20279712|NCT00575627|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20279713|NCT00575627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279714|NCT00575627|Antiviral Agents|antiviral agents|mesh-ancestor
20279715|NCT00575627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20279716|NCT00575627|Antimetabolites|antimetabolites|mesh-ancestor
20279717|NCT00575627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279718|NCT00575627|Immunologic Factors|immunologic factors|mesh-ancestor
20279719|NCT00575627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279720|NCT00575640|Hydralazine|hydralazine|mesh-list
20279721|NCT00575640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20279722|NCT00575640|Vasodilator Agents|vasodilator agents|mesh-ancestor
20279723|NCT00575718|Nicotine|nicotine|mesh-list
20279724|NCT00575718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20279725|NCT00575718|Autonomic Agents|autonomic agents|mesh-ancestor
20279726|NCT00575718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20279727|NCT00575718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279728|NCT00575718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20279729|NCT00575718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20279730|NCT00575718|Cholinergic Agents|cholinergic agents|mesh-ancestor
20279731|NCT00575718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20279732|NCT00575718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279733|NCT00575796|Vinblastine|vinblastine|mesh-list
20279734|NCT00575796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20279735|NCT00575796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279736|NCT00575796|Tubulin Modulators|tubulin modulators|mesh-ancestor
20279737|NCT00575796|Antimitotic Agents|antimitotic agents|mesh-ancestor
20279738|NCT00575796|Mitosis Modulators|mitosis modulators|mesh-ancestor
20279739|NCT00575796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279740|NCT00575835|Vitamin D|vitamin d|mesh-list
20279741|NCT00575835|Ergocalciferols|ergocalciferols|mesh-list
20279742|NCT00575835|Cholecalciferol|cholecalciferol|mesh-list
20279743|NCT00575835|Vitamins|vitamins|mesh-list
20279744|NCT00575835|Micronutrients|micronutrients|mesh-ancestor
20279745|NCT00575835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279746|NCT00575835|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20279747|NCT00575835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20279748|NCT00575848|Glycine|glycine|mesh-list
20279749|NCT00575848|Glycine Agents|glycine agents|mesh-ancestor
20279750|NCT00575848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20279751|NCT00575848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279752|NCT00575848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279753|NCT00575861|Zileuton|zileuton|mesh-list
20279754|NCT00575861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20279755|NCT00575861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20279756|NCT00575861|Analgesics|analgesics|mesh-ancestor
20279757|NCT00575861|Sensory System Agents|sensory system agents|mesh-ancestor
20279758|NCT00575861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20279759|NCT00575861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279760|NCT00575861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20279761|NCT00575861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20279762|NCT00575861|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20279763|NCT00575861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279764|NCT00575861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279765|NCT00575861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20279766|NCT00575861|Hormone Antagonists|hormone antagonists|mesh-ancestor
20279767|NCT00575861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20279768|NCT00575874|Pioglitazone|pioglitazone|mesh-list
20279769|NCT00575874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20279770|NCT00575874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279771|NCT00575913|Alfuzosin|alfuzosin|mesh-list
20279772|NCT00575913|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19962489|NCT01716195|Mitosis Modulators|mitosis modulators|mesh-ancestor
19962490|NCT01716195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962491|NCT01716208|Ofatumumab|ofatumumab|mesh-list
19962492|NCT01716208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962493|NCT01716221|Dexetimide|dexetimide|mesh-list
20279773|NCT00575913|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20279774|NCT00575913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20279775|NCT00575913|Adrenergic Agents|adrenergic agents|mesh-ancestor
20279776|NCT00575913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20279777|NCT00575913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962494|NCT01716221|Bupropion|bupropion|mesh-list
20279778|NCT00575913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279779|NCT00575913|Urological Agents|urological agents|mesh-ancestor
20279780|NCT00575952|Paclitaxel|paclitaxel|mesh-list
20279781|NCT00575952|Doxorubicin|doxorubicin|mesh-list
20279782|NCT00575952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20279783|NCT00575952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20279784|NCT00575952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279785|NCT00575952|Tubulin Modulators|tubulin modulators|mesh-ancestor
20279786|NCT00575952|Antimitotic Agents|antimitotic agents|mesh-ancestor
20279787|NCT00575952|Mitosis Modulators|mitosis modulators|mesh-ancestor
20279788|NCT00575952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279789|NCT00575952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20547001|NCT01891500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554418|NCT01935492|Antimitotic Agents|antimitotic agents|mesh-ancestor
19962495|NCT01716221|Citalopram|citalopram|mesh-list
19962496|NCT01716221|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19962497|NCT01716221|Antidepressive Agents|antidepressive agents|mesh-ancestor
19962498|NCT01716221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19962499|NCT01716221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19962500|NCT01716221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19974935|NCT01843920|Adrenergic Agents|adrenergic agents|mesh-ancestor
20279790|NCT00575952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20279791|NCT00575952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20279792|NCT00575952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279793|NCT00575978|Hydralazine|hydralazine|mesh-list
20279794|NCT00575978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20279795|NCT00575978|Vasodilator Agents|vasodilator agents|mesh-ancestor
19962501|NCT01716221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19962502|NCT01716221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962503|NCT01716221|Dopamine Agents|dopamine agents|mesh-ancestor
19962504|NCT01716221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20279796|NCT00576017|Fentanyl|fentanyl|mesh-list
20279797|NCT00576017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20279798|NCT00576017|Narcotics|narcotics|mesh-ancestor
20279799|NCT00576017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20279800|NCT00576017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279801|NCT00576017|Analgesics|analgesics|mesh-ancestor
20279802|NCT00576017|Sensory System Agents|sensory system agents|mesh-ancestor
20279803|NCT00576017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20279804|NCT00576017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20279805|NCT00576017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20279806|NCT00576017|Anesthetics, General|anesthetics, general|mesh-ancestor
20279807|NCT00576017|Anesthetics|anesthetics|mesh-ancestor
20279808|NCT00576069|Fluticasone|fluticasone|mesh-list
20279809|NCT00576069|Mometasone Furoate|mometasone furoate|mesh-list
20279810|NCT00576069|Prednisone|prednisone|mesh-list
20547002|NCT01891500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20547003|NCT01891500|Respiratory System Agents|respiratory system agents|mesh-ancestor
20547004|NCT01891500|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20547005|NCT01891500|Antioxidants|antioxidants|mesh-ancestor
20547006|NCT01891500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547007|NCT01891500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20547008|NCT01891500|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20547009|NCT01891500|Vasodilator Agents|vasodilator agents|mesh-ancestor
20547010|NCT01891500|Gasotransmitters|gasotransmitters|mesh-ancestor
20547011|NCT01891500|Protective Agents|protective agents|mesh-ancestor
20547012|NCT01891513|Losartan|losartan|mesh-list
20547013|NCT01891513|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20547014|NCT01891513|Perindopril|perindopril|mesh-list
20547015|NCT01891513|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20547016|NCT01891513|Diuretics|diuretics|mesh-list
20547017|NCT01891513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
20547018|NCT01891513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20547019|NCT01891513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20547020|NCT01891513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20547021|NCT01891513|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20547022|NCT01891513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547023|NCT01891513|Natriuretic Agents|natriuretic agents|mesh-ancestor
20547024|NCT01891513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547025|NCT01891513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20547026|NCT01891513|Protease Inhibitors|protease inhibitors|mesh-ancestor
20547027|NCT01891513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547028|NCT01891526|Tretinoin|tretinoin|mesh-list
20547029|NCT01891526|Alitretinoin|alitretinoin|mesh-list
20547030|NCT01891526|Isotretinoin|isotretinoin|mesh-list
20547031|NCT01891526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20547032|NCT01891526|Keratolytic Agents|keratolytic agents|mesh-ancestor
20547033|NCT01891526|Dermatologic Agents|dermatologic agents|mesh-ancestor
20547034|NCT01891643|Dexamethasone|dexamethasone|mesh-list
20547035|NCT01891643|Dexamethasone acetate|dexamethasone acetate|mesh-list
20547036|NCT01891643|Lenalidomide|lenalidomide|mesh-list
19962505|NCT01716221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962506|NCT01716221|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19962507|NCT01716221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19962508|NCT01716221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962509|NCT01716221|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19962510|NCT01716221|Serotonin Agents|serotonin agents|mesh-ancestor
19962511|NCT01716221|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19962512|NCT01716221|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19962513|NCT01716221|Parasympatholytics|parasympatholytics|mesh-ancestor
19962514|NCT01716221|Autonomic Agents|autonomic agents|mesh-ancestor
19962515|NCT01716221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19962516|NCT01716221|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19962517|NCT01716221|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19962518|NCT01716221|Cholinergic Agents|cholinergic agents|mesh-ancestor
20279811|NCT00576069|Budesonide|budesonide|mesh-list
20279812|NCT00576069|Formoterol Fumarate|formoterol fumarate|mesh-list
20547037|NCT01891643|Elotuzumab|elotuzumab|mesh-list
20279813|NCT00576069|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20279814|NCT00576069|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20279815|NCT00576069|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20279816|NCT00576069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20279817|NCT00576069|Glucocorticoids|glucocorticoids|mesh-ancestor
20279818|NCT00576069|Hormones|hormones|mesh-ancestor
20279819|NCT00576069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20279820|NCT00576069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279821|NCT00576069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20279822|NCT00576069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279823|NCT00576069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20279824|NCT00576069|Autonomic Agents|autonomic agents|mesh-ancestor
20279825|NCT00576069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20279826|NCT00576069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20279827|NCT00576069|Respiratory System Agents|respiratory system agents|mesh-ancestor
20279828|NCT00576069|Dermatologic Agents|dermatologic agents|mesh-ancestor
20279829|NCT00576069|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20279830|NCT00576069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20279831|NCT00576069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20279832|NCT00576069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20279833|NCT00576069|Adrenergic Agents|adrenergic agents|mesh-ancestor
20279834|NCT00576069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20279835|NCT00576069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279836|NCT00576069|Sympathomimetics|sympathomimetics|mesh-ancestor
20288057|NCT01657500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19962519|NCT01716234|Posaconazole|posaconazole|mesh-list
19962520|NCT01716234|Antifungal Agents|antifungal agents|mesh-ancestor
19962521|NCT01716234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19962522|NCT01716234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19962523|NCT01716234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20288058|NCT01657500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20288059|NCT01657500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20288060|NCT01657500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288061|NCT01657500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288062|NCT01657500|Anticoagulants|anticoagulants|mesh-ancestor
20288063|NCT01657500|Plasma Substitutes|plasma substitutes|mesh-ancestor
20288064|NCT01657500|Blood Substitutes|blood substitutes|mesh-ancestor
20288065|NCT01497509|Epinephrine|epinephrine|mesh-list
19450371|NCT03428906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450372|NCT03428880|Morphine|morphine|mesh-list
19450373|NCT03428880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19450374|NCT03428880|Narcotics|narcotics|mesh-ancestor
19450375|NCT03428880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19450376|NCT03428880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450377|NCT03428880|Analgesics|analgesics|mesh-ancestor
19450378|NCT03428880|Sensory System Agents|sensory system agents|mesh-ancestor
19450379|NCT03428880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450380|NCT03428802|Pembrolizumab|pembrolizumab|mesh-list
19450381|NCT03428802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20288066|NCT01497509|Racepinephrine|racepinephrine|mesh-list
20288067|NCT01497509|Fentanyl|fentanyl|mesh-list
20288068|NCT01497509|Bupivacaine|bupivacaine|mesh-list
20288069|NCT01497509|Epinephryl borate|epinephryl borate|mesh-list
20288070|NCT01497509|Anesthetics, Local|anesthetics, local|mesh-ancestor
20288071|NCT01497509|Anesthetics|anesthetics|mesh-ancestor
20288072|NCT01497509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20288073|NCT01497509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288074|NCT01497509|Sensory System Agents|sensory system agents|mesh-ancestor
20288075|NCT01497509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20288076|NCT01497509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20288077|NCT01497509|Narcotics|narcotics|mesh-ancestor
20288078|NCT01497509|Analgesics|analgesics|mesh-ancestor
20288079|NCT01497509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20288080|NCT01497509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20288081|NCT01497509|Anesthetics, General|anesthetics, general|mesh-ancestor
20288082|NCT01497509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20288083|NCT01497509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20288084|NCT01497509|Adrenergic Agents|adrenergic agents|mesh-ancestor
20288085|NCT01497509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20288086|NCT01497509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288087|NCT01497509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20288088|NCT01497509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20288089|NCT01497509|Autonomic Agents|autonomic agents|mesh-ancestor
19450382|NCT03428802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962524|NCT01716234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20279837|NCT00576173|Acetaminophen|acetaminophen|mesh-list
20279838|NCT00576173|Tramadol|tramadol|mesh-list
20279839|NCT00576173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20279840|NCT00576173|Analgesics|analgesics|mesh-ancestor
20279841|NCT00576173|Sensory System Agents|sensory system agents|mesh-ancestor
20279842|NCT00576173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20279843|NCT00576173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279844|NCT00576173|Antipyretics|antipyretics|mesh-ancestor
20279845|NCT00576173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20279846|NCT00576173|Narcotics|narcotics|mesh-ancestor
20279847|NCT00576173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20279848|NCT00576225|Paclitaxel|paclitaxel|mesh-list
20279849|NCT00576225|Carboplatin|carboplatin|mesh-list
20279850|NCT00576225|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
20279851|NCT00576225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20279852|NCT00576225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279853|NCT00576225|Tubulin Modulators|tubulin modulators|mesh-ancestor
20279854|NCT00576225|Antimitotic Agents|antimitotic agents|mesh-ancestor
20279855|NCT00576225|Mitosis Modulators|mitosis modulators|mesh-ancestor
20279856|NCT00576225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279857|NCT00576238|Betamethasone|betamethasone|mesh-list
20279858|NCT00576238|Betamethasone Valerate|betamethasone valerate|mesh-list
20279859|NCT00576238|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20279860|NCT00576238|Betamethasone benzoate|betamethasone benzoate|mesh-list
20279861|NCT00576238|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20279862|NCT00576238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20279863|NCT00576238|Glucocorticoids|glucocorticoids|mesh-ancestor
20279864|NCT00576238|Hormones|hormones|mesh-ancestor
20279865|NCT00576238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20279866|NCT00576238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279867|NCT00576238|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20279868|NCT00576238|Respiratory System Agents|respiratory system agents|mesh-ancestor
20279869|NCT00576329|Ketorolac|ketorolac|mesh-list
20279870|NCT00576329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20279871|NCT00576329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20279872|NCT00576329|Analgesics|analgesics|mesh-ancestor
20279873|NCT00576329|Sensory System Agents|sensory system agents|mesh-ancestor
20279874|NCT00576329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20279875|NCT00576329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279876|NCT00576329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20279877|NCT00576329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20279878|NCT00576329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20279879|NCT00576329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279880|NCT00576329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279881|NCT00576368|Insulin Glargine|insulin glargine|mesh-list
20279882|NCT00576368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20279883|NCT00576368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279884|NCT00576394|Insulin|insulin|mesh-list
20279885|NCT00576394|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20279886|NCT00576394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20279887|NCT00576394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279888|NCT00576433|Rituximab|rituximab|mesh-list
20279889|NCT00576433|Methotrexate|methotrexate|mesh-list
20279890|NCT00576433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20279891|NCT00576433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279892|NCT00576433|Immunologic Factors|immunologic factors|mesh-ancestor
20279893|NCT00576433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279894|NCT00576433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20279895|NCT00576433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20279896|NCT00576433|Abortifacient Agents|abortifacient agents|mesh-ancestor
20279897|NCT00576433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20279898|NCT00576433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20279899|NCT00576433|Antimetabolites|antimetabolites|mesh-ancestor
20279900|NCT00576433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279901|NCT00576433|Dermatologic Agents|dermatologic agents|mesh-ancestor
20279902|NCT00576433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279903|NCT00576433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20279904|NCT00576433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20279905|NCT00576433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20279906|NCT00576459|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
20279907|NCT00576459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20279908|NCT00576459|Glucocorticoids|glucocorticoids|mesh-ancestor
20279909|NCT00576459|Hormones|hormones|mesh-ancestor
20279910|NCT00576459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20279911|NCT00576459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279912|NCT00576511|Prucalopride|prucalopride|mesh-list
20279913|NCT00576511|Laxatives|laxatives|mesh-ancestor
20279914|NCT00576511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20279915|NCT00576511|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20279916|NCT00576511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20279917|NCT00576511|Serotonin Agents|serotonin agents|mesh-ancestor
20279918|NCT00576511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20279919|NCT00576511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279920|NCT00576511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279921|NCT00576550|Betamethasone|betamethasone|mesh-list
20279922|NCT00576550|Betamethasone Valerate|betamethasone valerate|mesh-list
20279923|NCT00576550|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20279924|NCT00576550|Betamethasone benzoate|betamethasone benzoate|mesh-list
20279925|NCT00576550|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20279926|NCT00576550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20279927|NCT00576550|Glucocorticoids|glucocorticoids|mesh-ancestor
20547038|NCT01891643|BB 1101|bb 1101|mesh-list
20547039|NCT01891643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20547040|NCT01891643|Antiemetics|antiemetics|mesh-ancestor
20547041|NCT01891643|Autonomic Agents|autonomic agents|mesh-ancestor
20547042|NCT01891643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20547043|NCT01891643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547044|NCT01891643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20547045|NCT01891643|Glucocorticoids|glucocorticoids|mesh-ancestor
20547046|NCT01891643|Hormones|hormones|mesh-ancestor
20279928|NCT00576550|Hormones|hormones|mesh-ancestor
20279929|NCT00576550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20279930|NCT00576550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279931|NCT00576550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20279932|NCT00576550|Respiratory System Agents|respiratory system agents|mesh-ancestor
20279933|NCT00576602|Epoetin Alfa|epoetin alfa|mesh-list
20279934|NCT00576602|Hematinics|hematinics|mesh-ancestor
20279935|NCT00576615|Propofol|propofol|mesh-list
20279936|NCT00576615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20279937|NCT00576615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20279938|NCT00576615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279939|NCT00576615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20547047|NCT01891643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20547048|NCT01891643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20547049|NCT01891643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20547050|NCT01891643|Protease Inhibitors|protease inhibitors|mesh-ancestor
20547051|NCT01891643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547052|NCT01891643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547053|NCT01891643|Immunologic Factors|immunologic factors|mesh-ancestor
20547054|NCT01891643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20547055|NCT01891643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20547056|NCT01891643|Growth Substances|growth substances|mesh-ancestor
20547057|NCT01891643|Growth Inhibitors|growth inhibitors|mesh-ancestor
20547058|NCT01891708|Bevacizumab|bevacizumab|mesh-list
20547059|NCT01891708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20547060|NCT01891708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20547061|NCT01891708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20547062|NCT01891708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20547063|NCT01891708|Growth Substances|growth substances|mesh-ancestor
20547064|NCT01891708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547065|NCT01891708|Growth Inhibitors|growth inhibitors|mesh-ancestor
20547066|NCT01891812|Nitrous Oxide|nitrous oxide|mesh-list
20547067|NCT01891812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20547068|NCT01891812|Anesthetics, General|anesthetics, general|mesh-ancestor
20547069|NCT01891812|Anesthetics|anesthetics|mesh-ancestor
20547070|NCT01891812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20547071|NCT01891812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547072|NCT01891812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20547073|NCT01891812|Analgesics|analgesics|mesh-ancestor
20547074|NCT01891812|Sensory System Agents|sensory system agents|mesh-ancestor
20547075|NCT01891812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20547076|NCT01891851|Ritonavir|ritonavir|mesh-list
20547077|NCT01891851|Simeprevir|simeprevir|mesh-list
20547078|NCT01891851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20547079|NCT01891851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20547080|NCT01891851|Protease Inhibitors|protease inhibitors|mesh-ancestor
20547081|NCT01891851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547082|NCT01891851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279940|NCT00576615|Anesthetics, General|anesthetics, general|mesh-ancestor
20547083|NCT01891851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20279941|NCT00576615|Anesthetics|anesthetics|mesh-ancestor
20279942|NCT00576706|Misoprostol|misoprostol|mesh-list
20279943|NCT00576706|Rebamipide|rebamipide|mesh-list
20279944|NCT00576706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20279945|NCT00576706|Abortifacient Agents|abortifacient agents|mesh-ancestor
20279946|NCT00576706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20279947|NCT00576706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279948|NCT00576706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20279949|NCT00576706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20279950|NCT00576706|Oxytocics|oxytocics|mesh-ancestor
20279951|NCT00576706|Antioxidants|antioxidants|mesh-ancestor
20279952|NCT00576706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279953|NCT00576706|Protective Agents|protective agents|mesh-ancestor
20279954|NCT00576706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20279955|NCT00576784|Pioglitazone|pioglitazone|mesh-list
20279956|NCT00576784|Glimepiride|glimepiride|mesh-list
20279957|NCT00576784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20279958|NCT00576784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279959|NCT00576784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20279960|NCT00576784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20279961|NCT00576784|Immunologic Factors|immunologic factors|mesh-ancestor
20279962|NCT00576862|Insulin Glargine|insulin glargine|mesh-list
20279963|NCT00576862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20279964|NCT00576862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279965|NCT00576914|Endostatins|endostatins|mesh-list
20279966|NCT00576914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20279967|NCT00576914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20279968|NCT00576914|Growth Substances|growth substances|mesh-ancestor
20279969|NCT00576914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279970|NCT00576914|Growth Inhibitors|growth inhibitors|mesh-ancestor
20279971|NCT00576914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279972|NCT00577018|Prucalopride|prucalopride|mesh-list
20279973|NCT00577018|Laxatives|laxatives|mesh-ancestor
20279974|NCT00577018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20279975|NCT00577018|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20279976|NCT00577018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20279977|NCT00577018|Serotonin Agents|serotonin agents|mesh-ancestor
20279978|NCT00577018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20279979|NCT00577018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279980|NCT00577018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279981|NCT00577057|Fluorouracil|fluorouracil|mesh-list
20279982|NCT00577057|Capecitabine|capecitabine|mesh-list
20279983|NCT00577057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279984|NCT00577057|Antimetabolites|antimetabolites|mesh-ancestor
20279985|NCT00577057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20279986|NCT00577057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20279987|NCT00577057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20279988|NCT00577057|Immunologic Factors|immunologic factors|mesh-ancestor
20279989|NCT00577057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20279990|NCT00577109|Leucovorin|leucovorin|mesh-list
20279991|NCT00577109|Bevacizumab|bevacizumab|mesh-list
20279992|NCT00577109|Cetuximab|cetuximab|mesh-list
20279993|NCT00577109|Irinotecan|irinotecan|mesh-list
20279994|NCT00577109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20279995|NCT00577109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20279996|NCT00577109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20279997|NCT00577109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20279998|NCT00577109|Growth Substances|growth substances|mesh-ancestor
20279999|NCT00577109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547084|NCT01891851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19962525|NCT01716234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19962526|NCT01716234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19962527|NCT01716234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962528|NCT01716234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962529|NCT01716234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19962530|NCT01716234|Hormone Antagonists|hormone antagonists|mesh-ancestor
19962531|NCT01716234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19962532|NCT01716234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962533|NCT01716585|Ribavirin|ribavirin|mesh-list
19962534|NCT01716585|Antimetabolites|antimetabolites|mesh-ancestor
19962535|NCT01716585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280000|NCT00577109|Growth Inhibitors|growth inhibitors|mesh-ancestor
20280001|NCT00577109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20280002|NCT00577109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20547085|NCT01891851|Antiviral Agents|antiviral agents|mesh-ancestor
20280003|NCT00577109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20280004|NCT00577109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280005|NCT00577109|Antidotes|antidotes|mesh-ancestor
20280006|NCT00577109|Protective Agents|protective agents|mesh-ancestor
20280007|NCT00577109|Vitamin B Complex|vitamin b complex|mesh-ancestor
20280008|NCT00577109|Vitamins|vitamins|mesh-ancestor
20280009|NCT00577109|Micronutrients|micronutrients|mesh-ancestor
20280010|NCT00577161|Vidarabine|vidarabine|mesh-list
20280011|NCT00577161|Rituximab|rituximab|mesh-list
20280012|NCT00577161|Fludarabine|fludarabine|mesh-list
20280013|NCT00577161|Fludarabine phosphate|fludarabine phosphate|mesh-list
20280014|NCT00577161|Pixantrone|pixantrone|mesh-list
20280015|NCT00577161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20280016|NCT00577161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280017|NCT00577161|Immunologic Factors|immunologic factors|mesh-ancestor
20280018|NCT00577161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280019|NCT00577161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20280020|NCT00577161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20280021|NCT00577161|Antimetabolites|antimetabolites|mesh-ancestor
20280022|NCT00577161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280023|NCT00577161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20280024|NCT00577161|Antiviral Agents|antiviral agents|mesh-ancestor
20280025|NCT00577161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20280026|NCT00577161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20280027|NCT00577161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20280028|NCT00577161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20280029|NCT00577200|Midazolam|midazolam|mesh-list
20280030|NCT00577200|Sufentanil|sufentanil|mesh-list
20280031|NCT00577200|Propofol|propofol|mesh-list
20280032|NCT00577200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20280033|NCT00577200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20280034|NCT00577200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280035|NCT00577200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20280036|NCT00577200|Anesthetics, General|anesthetics, general|mesh-ancestor
20280037|NCT00577200|Anesthetics|anesthetics|mesh-ancestor
20280038|NCT00577200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20280039|NCT00577200|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20280040|NCT00577200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20280041|NCT00577200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20280042|NCT00577200|GABA Modulators|gaba modulators|mesh-ancestor
20280043|NCT00577200|GABA Agents|gaba agents|mesh-ancestor
20280044|NCT00577200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20280045|NCT00577200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280046|NCT00577200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20280047|NCT00577200|Narcotics|narcotics|mesh-ancestor
20280048|NCT00577200|Analgesics|analgesics|mesh-ancestor
20280049|NCT00577200|Sensory System Agents|sensory system agents|mesh-ancestor
20280050|NCT00577200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280051|NCT00577304|Nitroglycerin|nitroglycerin|mesh-list
20280052|NCT00577304|Vasodilator Agents|vasodilator agents|mesh-ancestor
20280053|NCT00577369|Desflurane|desflurane|mesh-list
20280054|NCT00577369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20280055|NCT00577369|Anesthetics, General|anesthetics, general|mesh-ancestor
20280056|NCT00577369|Anesthetics|anesthetics|mesh-ancestor
20280057|NCT00577369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20280058|NCT00577369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280059|NCT00577421|Risedronic Acid|risedronic acid|mesh-list
20280060|NCT00577421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20280061|NCT00577421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20280062|NCT00577421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280063|NCT00577421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20280064|NCT00577421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280065|NCT00577421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20280066|NCT00577668|Thalidomide|thalidomide|mesh-list
20547086|NCT01891851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19962536|NCT01716585|Antiviral Agents|antiviral agents|mesh-ancestor
19962537|NCT01716585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19962538|NCT01716715|Paclitaxel|paclitaxel|mesh-list
19962539|NCT01716715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19962540|NCT01716715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19962541|NCT01716715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962542|NCT01716715|Tubulin Modulators|tubulin modulators|mesh-ancestor
19962543|NCT01716715|Antimitotic Agents|antimitotic agents|mesh-ancestor
19962544|NCT01716715|Mitosis Modulators|mitosis modulators|mesh-ancestor
19962545|NCT01716715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280067|NCT00577668|Dexamethasone|dexamethasone|mesh-list
20280068|NCT00577668|Melphalan|melphalan|mesh-list
20280069|NCT00577668|Bortezomib|bortezomib|mesh-list
20280070|NCT00577668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20280071|NCT00577668|Antiemetics|antiemetics|mesh-ancestor
20280072|NCT00577668|Autonomic Agents|autonomic agents|mesh-ancestor
20280073|NCT00577668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280074|NCT00577668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280075|NCT00577668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20280076|NCT00577668|Glucocorticoids|glucocorticoids|mesh-ancestor
20280077|NCT00577668|Hormones|hormones|mesh-ancestor
20280078|NCT00577668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20280079|NCT00577668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20280080|NCT00577668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20547087|NCT01891851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20547088|NCT01891851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20547089|NCT01891916|Caseins|caseins|mesh-list
20547090|NCT01891916|Chelating Agents|chelating agents|mesh-ancestor
20547091|NCT01891916|Sequestering Agents|sequestering agents|mesh-ancestor
20547092|NCT01891916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547093|NCT01891981|Immunotoxin HA22|immunotoxin ha22|mesh-list
20547094|NCT01891981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20547095|NCT01892098|Zinc Sulfate|zinc sulfate|mesh-list
20547096|NCT01892098|Astringents|astringents|mesh-ancestor
20547097|NCT01892098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547098|NCT01892098|Dermatologic Agents|dermatologic agents|mesh-ancestor
20547099|NCT01892150|Sunscreening Agents|sunscreening agents|mesh-list
20547100|NCT01892150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20547101|NCT01892150|Protective Agents|protective agents|mesh-ancestor
20547102|NCT01892150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547103|NCT01892150|Dermatologic Agents|dermatologic agents|mesh-ancestor
20547104|NCT01892176|Ubiquinone|ubiquinone|mesh-list
20547105|NCT01892176|Coenzyme Q10|coenzyme q10|mesh-list
20547106|NCT01892176|Micronutrients|micronutrients|mesh-ancestor
20547107|NCT01892176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547108|NCT01892176|Vitamins|vitamins|mesh-ancestor
20547109|NCT01892241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20547110|NCT01892241|Entecavir|entecavir|mesh-list
20547111|NCT01892241|Antiviral Agents|antiviral agents|mesh-ancestor
20547112|NCT01892241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20547113|NCT01892254|Metformin|metformin|mesh-list
20547114|NCT01892254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20547115|NCT01892254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547116|NCT01892319|Insulin Detemir|insulin detemir|mesh-list
20547117|NCT01892319|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20547118|NCT01892319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547119|NCT01892332|Lidocaine|lidocaine|mesh-list
20547120|NCT01892332|Fentanyl|fentanyl|mesh-list
20547121|NCT01892332|Anesthetics, Local|anesthetics, local|mesh-ancestor
20547122|NCT01892332|Anesthetics|anesthetics|mesh-ancestor
20547123|NCT01892332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20547124|NCT01892332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547125|NCT01892332|Sensory System Agents|sensory system agents|mesh-ancestor
20280081|NCT00577668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20280082|NCT00577668|Alkylating Agents|alkylating agents|mesh-ancestor
20280083|NCT00577668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280084|NCT00577668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20280085|NCT00577668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20280086|NCT00577668|Immunologic Factors|immunologic factors|mesh-ancestor
20280087|NCT00577668|Leprostatic Agents|leprostatic agents|mesh-ancestor
20280088|NCT00577668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20280089|NCT00577668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20280090|NCT00577668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20280091|NCT00577668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20280092|NCT00577668|Growth Substances|growth substances|mesh-ancestor
20280093|NCT00577668|Growth Inhibitors|growth inhibitors|mesh-ancestor
20280094|NCT00577681|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19962546|NCT01716754|Omalizumab|omalizumab|mesh-list
20280095|NCT00577681|Antiviral Agents|antiviral agents|mesh-ancestor
20280096|NCT00577681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20280097|NCT00577694|Clofarabine|clofarabine|mesh-list
20280098|NCT00577694|Gemtuzumab|gemtuzumab|mesh-list
20280099|NCT00577694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20280100|NCT00577694|Antimetabolites|antimetabolites|mesh-ancestor
20280101|NCT00577694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280102|NCT00577694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280103|NCT00577694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20280104|NCT00577798|Doxorubicin|doxorubicin|mesh-list
20280105|NCT00577798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20280106|NCT00577798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20280107|NCT00577798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280108|NCT00577798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20280109|NCT00577798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20280110|NCT00577798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20280111|NCT00577798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280112|NCT00577837|Risedronic Acid|risedronic acid|mesh-list
20280113|NCT00577837|Etidronic Acid|etidronic acid|mesh-list
20280114|NCT00577837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20280115|NCT00577837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20280116|NCT00577837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280117|NCT00577837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20280118|NCT00577837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280119|NCT00577837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20280120|NCT00577850|Alendronate|alendronate|mesh-list
20280121|NCT00577850|Risedronic Acid|risedronic acid|mesh-list
20280122|NCT00577850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20280123|NCT00577850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280124|NCT00577850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20280125|NCT00577850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20280126|NCT00577850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280127|NCT00577850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20280128|NCT00577967|Gabapentin|gabapentin|mesh-list
20280129|NCT00577967|Analgesics|analgesics|mesh-ancestor
20280130|NCT00577967|Sensory System Agents|sensory system agents|mesh-ancestor
20280131|NCT00577967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280132|NCT00577967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280133|NCT00577967|Anticonvulsants|anticonvulsants|mesh-ancestor
20280134|NCT00577967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20280135|NCT00577967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20280136|NCT00577967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20280137|NCT00577967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20280138|NCT00577967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20280139|NCT00577967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20280140|NCT00577967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20280141|NCT00577967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280142|NCT00577967|Antimanic Agents|antimanic agents|mesh-ancestor
19962547|NCT01716754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20280143|NCT00577980|Testosterone|testosterone|mesh-list
20280144|NCT00577980|Androgens|androgens|mesh-ancestor
20280145|NCT00577980|Hormones|hormones|mesh-ancestor
20280146|NCT00577980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20280147|NCT00577980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280148|NCT00578097|Botulinum Toxins|botulinum toxins|mesh-list
20280149|NCT00578097|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20280150|NCT00578097|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20547126|NCT01892332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280151|NCT00578097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20280152|NCT00578097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20280153|NCT00578097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280154|NCT00578097|Cholinergic Agents|cholinergic agents|mesh-ancestor
20280155|NCT00578097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20280156|NCT00578097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280157|NCT00578097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20280158|NCT00578097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280159|NCT00578149|Paclitaxel|paclitaxel|mesh-list
20280160|NCT00578149|Bevacizumab|bevacizumab|mesh-list
20280161|NCT00578149|Carboplatin|carboplatin|mesh-list
20280162|NCT00578149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20280163|NCT00578149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280164|NCT00578149|Tubulin Modulators|tubulin modulators|mesh-ancestor
20280165|NCT00578149|Antimitotic Agents|antimitotic agents|mesh-ancestor
20280166|NCT00578149|Mitosis Modulators|mitosis modulators|mesh-ancestor
20280167|NCT00578149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280168|NCT00578149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20280169|NCT00578149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20280170|NCT00578149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20280171|NCT00578149|Growth Substances|growth substances|mesh-ancestor
20280172|NCT00578149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280173|NCT00578149|Growth Inhibitors|growth inhibitors|mesh-ancestor
20280174|NCT00578201|Cetuximab|cetuximab|mesh-list
20280175|NCT00578201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20280176|NCT00578201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288090|NCT01497509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20288091|NCT01497509|Respiratory System Agents|respiratory system agents|mesh-ancestor
20288092|NCT01497509|Mydriatics|mydriatics|mesh-ancestor
20288093|NCT01497509|Sympathomimetics|sympathomimetics|mesh-ancestor
20288094|NCT01497509|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20288095|NCT01013649|Gemcitabine|gemcitabine|mesh-list
20288096|NCT01013649|Fluorouracil|fluorouracil|mesh-list
20288097|NCT01013649|Capecitabine|capecitabine|mesh-list
20288098|NCT01013649|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20288099|NCT01013649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20288100|NCT01013649|Antimetabolites|antimetabolites|mesh-ancestor
20288101|NCT01013649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288102|NCT01013649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288103|NCT01013649|Antiviral Agents|antiviral agents|mesh-ancestor
20288104|NCT01013649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20288105|NCT01013649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288106|NCT01013649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20288107|NCT01013649|Immunologic Factors|immunologic factors|mesh-ancestor
20288108|NCT01013649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288109|NCT01013649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20288110|NCT00669734|Metronidazole|metronidazole|mesh-list
20288111|NCT00669734|Tricyclodecane-9-yl-xanthogenate|tricyclodecane-9-yl-xanthogenate|mesh-list
20288112|NCT00669734|Vaccines|vaccines|mesh-list
20288113|NCT00669734|Sargramostim|sargramostim|mesh-list
20288114|NCT00669734|Immunologic Factors|immunologic factors|mesh-ancestor
20288115|NCT00669734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288116|NCT00669734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288117|NCT00669734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20547127|NCT01892332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20547128|NCT01892332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20547129|NCT01892332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20547130|NCT01892332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20547131|NCT01892332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547132|NCT01892332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20547133|NCT01892332|Narcotics|narcotics|mesh-ancestor
20547134|NCT01892332|Analgesics|analgesics|mesh-ancestor
20547135|NCT01892332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20547136|NCT01892332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20547137|NCT01892332|Anesthetics, General|anesthetics, general|mesh-ancestor
20547138|NCT01892384|BI 409306|bi 409306|mesh-list
20547139|NCT01892384|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20547140|NCT01892384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547141|NCT01892384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547142|NCT01892488|Sultamicillin|sultamicillin|mesh-list
20547143|NCT01892488|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
20288118|NCT00669734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20288119|NCT00669734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20288120|NCT00669734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20288121|NCT00669734|Antioxidants|antioxidants|mesh-ancestor
20280177|NCT00578266|Cyclophosphamide|cyclophosphamide|mesh-list
20280178|NCT00578266|Alemtuzumab|alemtuzumab|mesh-list
20280179|NCT00578266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20280180|NCT00578266|Immunologic Factors|immunologic factors|mesh-ancestor
20280181|NCT00578266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280182|NCT00578266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20280183|NCT00578266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20280184|NCT00578266|Alkylating Agents|alkylating agents|mesh-ancestor
20280185|NCT00578266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280186|NCT00578266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280187|NCT00578266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20280188|NCT00578266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20280189|NCT00578370|Cyclosporine|cyclosporine|mesh-list
20280190|NCT00578370|Betamethasone|betamethasone|mesh-list
20280191|NCT00578370|Calcipotriene|calcipotriene|mesh-list
20280192|NCT00578370|Cyclosporins|cyclosporins|mesh-list
20280193|NCT00578370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20280194|NCT00578370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280195|NCT00578370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20280196|NCT00578370|Immunologic Factors|immunologic factors|mesh-ancestor
20280197|NCT00578370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280198|NCT00578370|Antifungal Agents|antifungal agents|mesh-ancestor
20280199|NCT00578370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20280200|NCT00578370|Dermatologic Agents|dermatologic agents|mesh-ancestor
20280201|NCT00578370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20280202|NCT00578370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20280203|NCT00578370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20280204|NCT00578370|Glucocorticoids|glucocorticoids|mesh-ancestor
20280205|NCT00578370|Hormones|hormones|mesh-ancestor
20280206|NCT00578370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20280207|NCT00578370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20280208|NCT00578370|Respiratory System Agents|respiratory system agents|mesh-ancestor
20280209|NCT00578435|Cyclophosphamide|cyclophosphamide|mesh-list
20280210|NCT00578435|Busulfan|busulfan|mesh-list
20280211|NCT00578435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20280212|NCT00578435|Immunologic Factors|immunologic factors|mesh-ancestor
20280213|NCT00578435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280214|NCT00578435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20280215|NCT00578435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20280216|NCT00578435|Alkylating Agents|alkylating agents|mesh-ancestor
20280217|NCT00578435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280218|NCT00578435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280219|NCT00578435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20280220|NCT00578526|Sunitinib|sunitinib|mesh-list
20280221|NCT00578526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280222|NCT00578526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20280223|NCT00578526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20280224|NCT00578526|Growth Substances|growth substances|mesh-ancestor
20280225|NCT00578526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280226|NCT00578526|Growth Inhibitors|growth inhibitors|mesh-ancestor
20280227|NCT00578526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20280228|NCT00578526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20280229|NCT00578526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280230|NCT00578591|Rituximab|rituximab|mesh-list
20280231|NCT00578591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20280232|NCT00578591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280233|NCT00578591|Immunologic Factors|immunologic factors|mesh-ancestor
20280234|NCT00578591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280235|NCT00578591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20280236|NCT00578721|Aspirin|aspirin|mesh-list
20280237|NCT00578721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20280238|NCT00578721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20280239|NCT00578721|Analgesics|analgesics|mesh-ancestor
20280240|NCT00578721|Sensory System Agents|sensory system agents|mesh-ancestor
20280241|NCT00578721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280242|NCT00578721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280243|NCT00578721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20280244|NCT00578721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20280245|NCT00578721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20280246|NCT00578721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20280247|NCT00578721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280248|NCT00578721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20280249|NCT00578721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20280250|NCT00578721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20280251|NCT00578721|Antipyretics|antipyretics|mesh-ancestor
20280252|NCT00578760|Aspirin|aspirin|mesh-list
20280253|NCT00578760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20280254|NCT00578760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20280255|NCT00578760|Analgesics|analgesics|mesh-ancestor
20280256|NCT00578760|Sensory System Agents|sensory system agents|mesh-ancestor
20280257|NCT00578760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280258|NCT00578760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280259|NCT00578760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20280260|NCT00578760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20280261|NCT00578760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20280262|NCT00578760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20280263|NCT00578760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280264|NCT00578760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20280265|NCT00578760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20280266|NCT00578760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20280267|NCT00578760|Antipyretics|antipyretics|mesh-ancestor
20280268|NCT00578825|Ritonavir|ritonavir|mesh-list
20280269|NCT00578825|Lopinavir|lopinavir|mesh-list
20280270|NCT00578825|Ribavirin|ribavirin|mesh-list
20280271|NCT00578825|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20280272|NCT00578825|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20280273|NCT00578825|Protease Inhibitors|protease inhibitors|mesh-ancestor
20280274|NCT00578825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20280275|NCT00578825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280276|NCT00578825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20280277|NCT00578825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20280278|NCT00578825|Antiviral Agents|antiviral agents|mesh-ancestor
20280279|NCT00578825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20280280|NCT00578825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20280281|NCT00578825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20280282|NCT00578825|Antimetabolites|antimetabolites|mesh-ancestor
20280283|NCT00579046|Darbepoetin alfa|darbepoetin alfa|mesh-list
20280284|NCT00579046|Hematinics|hematinics|mesh-ancestor
20280285|NCT00579085|Ketamine|ketamine|mesh-list
20280286|NCT00579085|Analgesics|analgesics|mesh-ancestor
20280287|NCT00579085|Sensory System Agents|sensory system agents|mesh-ancestor
20280288|NCT00579085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280289|NCT00579085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547144|NCT01892488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20547145|NCT01892488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20547146|NCT01892488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547147|NCT01892488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547148|NCT01892527|Cetuximab|cetuximab|mesh-list
19962548|NCT01716754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19962549|NCT01716754|Respiratory System Agents|respiratory system agents|mesh-ancestor
19974936|NCT01843920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19974937|NCT01843920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974938|NCT01843920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20547149|NCT01892527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20547150|NCT01892527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20547151|NCT01892618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20547152|NCT01892618|Immunologic Factors|immunologic factors|mesh-ancestor
20547153|NCT01892618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547154|NCT01892631|Vaccines|vaccines|mesh-list
20547155|NCT01892631|Immunologic Factors|immunologic factors|mesh-ancestor
20547156|NCT01892631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547157|NCT01892644|Deferasirox|deferasirox|mesh-list
20547158|NCT01892644|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20547159|NCT01892644|Chelating Agents|chelating agents|mesh-ancestor
20547160|NCT01892644|Sequestering Agents|sequestering agents|mesh-ancestor
20547161|NCT01892644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547162|NCT01892683|Propofol|propofol|mesh-list
20547163|NCT01892683|Anesthetics|anesthetics|mesh-ancestor
20547164|NCT01892683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20547165|NCT01892683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547166|NCT01892683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20547167|NCT01892683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20547168|NCT01892683|Anesthetics, General|anesthetics, general|mesh-ancestor
20547169|NCT01892748|Vitamin D|vitamin d|mesh-list
20547170|NCT01892748|Cholecalciferol|cholecalciferol|mesh-list
20547171|NCT01892748|Vitamins|vitamins|mesh-ancestor
20547172|NCT01892748|Micronutrients|micronutrients|mesh-ancestor
20280290|NCT00579085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20280291|NCT00579085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20280292|NCT00579085|Anesthetics, General|anesthetics, general|mesh-ancestor
20280293|NCT00579085|Anesthetics|anesthetics|mesh-ancestor
20280294|NCT00579085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20280295|NCT00579085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20280296|NCT00579085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20280297|NCT00579085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20280298|NCT00579085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280299|NCT00579475|Mifepristone|mifepristone|mesh-list
20280300|NCT00579475|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20280301|NCT00579475|Abortifacient Agents|abortifacient agents|mesh-ancestor
20280302|NCT00579475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20280303|NCT00579475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280304|NCT00579475|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20280305|NCT00579475|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20280306|NCT00579475|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20280307|NCT00579475|Contraceptive Agents|contraceptive agents|mesh-ancestor
20280308|NCT00579475|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20280309|NCT00579475|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20280310|NCT00579475|Hormone Antagonists|hormone antagonists|mesh-ancestor
20280311|NCT00579475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20280312|NCT00579475|Luteolytic Agents|luteolytic agents|mesh-ancestor
20280313|NCT00579475|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20280314|NCT00579475|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20280315|NCT00579592|Mycophenolic Acid|mycophenolic acid|mesh-list
20280316|NCT00579592|Rituximab|rituximab|mesh-list
20280317|NCT00579592|Alemtuzumab|alemtuzumab|mesh-list
20280318|NCT00579592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20280319|NCT00579592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280320|NCT00579592|Immunologic Factors|immunologic factors|mesh-ancestor
19962550|NCT01717040|Pioglitazone|pioglitazone|mesh-list
19962551|NCT01717040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19962552|NCT01717040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962553|NCT01717053|Prednisone|prednisone|mesh-list
19962554|NCT01717053|Abiraterone Acetate|abiraterone acetate|mesh-list
19962555|NCT01717053|Androgens|androgens|mesh-list
19962556|NCT01717053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19962557|NCT01717053|Glucocorticoids|glucocorticoids|mesh-ancestor
19962558|NCT01717053|Hormones|hormones|mesh-ancestor
19962559|NCT01717053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19962560|NCT01717053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962561|NCT01717053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19962562|NCT01717053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280321|NCT00579592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280322|NCT00579592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20280323|NCT00579592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20280324|NCT00579592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20280325|NCT00579592|Antitubercular Agents|antitubercular agents|mesh-ancestor
20280326|NCT00579592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19733317|NCT04563507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19733318|NCT04563507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733319|NCT04563507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280327|NCT00579592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20280328|NCT00579592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20280329|NCT00579592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280330|NCT00579644|Minocycline|minocycline|mesh-list
20280331|NCT00579644|Methotrexate|methotrexate|mesh-list
20280332|NCT00579644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20280333|NCT00579644|Abortifacient Agents|abortifacient agents|mesh-ancestor
20280334|NCT00579644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20280335|NCT00579644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280336|NCT00579644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20280337|NCT00579644|Antimetabolites|antimetabolites|mesh-ancestor
20280338|NCT00579644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280339|NCT00579644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280340|NCT00579644|Dermatologic Agents|dermatologic agents|mesh-ancestor
19733320|NCT04563507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19733321|NCT04563507|Hormone Antagonists|hormone antagonists|mesh-ancestor
19733322|NCT04563507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19733323|NCT04563507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733324|NCT04563507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19733325|NCT04563429|Vitamin A|vitamin a|mesh-list
19733326|NCT04563429|Vitamins|vitamins|mesh-ancestor
20280341|NCT00579644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20280342|NCT00579644|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20280343|NCT00579644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20280344|NCT00579644|Immunologic Factors|immunologic factors|mesh-ancestor
20280345|NCT00579644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20280346|NCT00579644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20280347|NCT00579644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20280348|NCT00579644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20280349|NCT00579956|Meropenem|meropenem|mesh-list
20280350|NCT00579956|Ceftazidime|ceftazidime|mesh-list
20280351|NCT00579956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20280352|NCT00579956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20280353|NCT00579969|Timolol|timolol|mesh-list
20280354|NCT00579969|Latanoprost|latanoprost|mesh-list
20280355|NCT00579969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20280356|NCT00579969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20280357|NCT00579969|Adrenergic Agents|adrenergic agents|mesh-ancestor
20280358|NCT00579969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20280359|NCT00579969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280360|NCT00579969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280361|NCT00579969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20280362|NCT00579969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20280363|NCT00579969|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20280364|NCT00579969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20280365|NCT00579995|Acetylcysteine|acetylcysteine|mesh-list
20280366|NCT00579995|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20280367|NCT00579995|Antiviral Agents|antiviral agents|mesh-ancestor
20280368|NCT00579995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20280369|NCT00579995|Expectorants|expectorants|mesh-ancestor
20280370|NCT00579995|Respiratory System Agents|respiratory system agents|mesh-ancestor
20280371|NCT00579995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20280372|NCT00579995|Antioxidants|antioxidants|mesh-ancestor
20280373|NCT00579995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280374|NCT00579995|Protective Agents|protective agents|mesh-ancestor
20280375|NCT00579995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280376|NCT00579995|Antidotes|antidotes|mesh-ancestor
20280377|NCT00580060|Molgramostim|molgramostim|mesh-list
20280378|NCT00580060|Sargramostim|sargramostim|mesh-list
20280379|NCT00580060|Immunologic Factors|immunologic factors|mesh-ancestor
20280380|NCT00580060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280381|NCT00580060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280382|NCT00580112|Dexamethasone|dexamethasone|mesh-list
20280383|NCT00580112|Trabectedin|trabectedin|mesh-list
20280384|NCT00580112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20280385|NCT00580112|Antiemetics|antiemetics|mesh-ancestor
20280386|NCT00580112|Autonomic Agents|autonomic agents|mesh-ancestor
20280387|NCT00580112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280388|NCT00580112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280389|NCT00580112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20280390|NCT00580112|Glucocorticoids|glucocorticoids|mesh-ancestor
20280391|NCT00580112|Hormones|hormones|mesh-ancestor
20280392|NCT00580112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20280393|NCT00580112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20280394|NCT00580112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280395|NCT00580112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20280396|NCT00580112|Alkylating Agents|alkylating agents|mesh-ancestor
20280397|NCT00580112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280398|NCT00580190|Alprazolam|alprazolam|mesh-list
20280399|NCT00580190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20280400|NCT00580190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20280401|NCT00580190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280402|NCT00580190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20280403|NCT00580190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20280404|NCT00580190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20280405|NCT00580190|GABA Modulators|gaba modulators|mesh-ancestor
20280406|NCT00580190|GABA Agents|gaba agents|mesh-ancestor
20280407|NCT00580190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19733327|NCT04563429|Micronutrients|micronutrients|mesh-ancestor
19733328|NCT04563429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735771|NCT04536415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735772|NCT04536129|Hydrocortisone|hydrocortisone|mesh-list
19962563|NCT01717053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19962564|NCT01717053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20280408|NCT00580190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280409|NCT00580242|Lenalidomide|lenalidomide|mesh-list
20280410|NCT00580242|Bortezomib|bortezomib|mesh-list
20280411|NCT00580242|Immunologic Factors|immunologic factors|mesh-ancestor
19962565|NCT01717053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962566|NCT01717053|Hormone Antagonists|hormone antagonists|mesh-ancestor
19962567|NCT01717053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20280412|NCT00580242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280413|NCT00580242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20280414|NCT00580242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20280415|NCT00580242|Growth Substances|growth substances|mesh-ancestor
20280416|NCT00580242|Growth Inhibitors|growth inhibitors|mesh-ancestor
20280417|NCT00580242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280418|NCT00580320|Bortezomib|bortezomib|mesh-list
20280419|NCT00580320|Dacarbazine|dacarbazine|mesh-list
20280420|NCT00580320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280421|NCT00580320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20280422|NCT00580320|Alkylating Agents|alkylating agents|mesh-ancestor
20280423|NCT00580320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280424|NCT00580359|Capecitabine|capecitabine|mesh-list
20280425|NCT00580359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20280426|NCT00580359|Antimetabolites|antimetabolites|mesh-ancestor
20280427|NCT00580359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280428|NCT00580359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280429|NCT00580424|Norethindrone|norethindrone|mesh-list
20280430|NCT00580424|Norethindrone Acetate|norethindrone acetate|mesh-list
20280431|NCT00580424|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20280432|NCT00580424|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20280433|NCT00580424|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20280434|NCT00580424|Contraceptive Agents|contraceptive agents|mesh-ancestor
20280435|NCT00580424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20280436|NCT00580424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280437|NCT00580424|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20280438|NCT00580424|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20288122|NCT00669734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288123|NCT00669734|Protective Agents|protective agents|mesh-ancestor
20288124|NCT00669734|Antiviral Agents|antiviral agents|mesh-ancestor
20288125|NCT00669734|Growth Inhibitors|growth inhibitors|mesh-ancestor
20288126|NCT00669734|Growth Substances|growth substances|mesh-ancestor
20288127|NCT00669734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20288128|NCT00669734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288129|NCT00630565|Dexamethasone|dexamethasone|mesh-list
20288130|NCT00630565|Cyclophosphamide|cyclophosphamide|mesh-list
20288131|NCT00630565|Busulfan|busulfan|mesh-list
20288132|NCT00630565|Etoposide|etoposide|mesh-list
20288133|NCT00630565|Sargramostim|sargramostim|mesh-list
20288134|NCT00630565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20288135|NCT00630565|Immunologic Factors|immunologic factors|mesh-ancestor
20288136|NCT00630565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288137|NCT00630565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20288138|NCT00630565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20288139|NCT00630565|Alkylating Agents|alkylating agents|mesh-ancestor
20288140|NCT00630565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288141|NCT00630565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288142|NCT00630565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20288143|NCT00630565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20288144|NCT00630565|Antiemetics|antiemetics|mesh-ancestor
20288145|NCT00630565|Autonomic Agents|autonomic agents|mesh-ancestor
20288146|NCT00630565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20288147|NCT00630565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20288148|NCT00630565|Glucocorticoids|glucocorticoids|mesh-ancestor
20288149|NCT00630565|Hormones|hormones|mesh-ancestor
20288150|NCT00630565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20288151|NCT00630565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20288152|NCT00630565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20288153|NCT00630565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20288154|NCT00630565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20288155|NCT00630565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288156|NCT05338086|Vitamin D|vitamin d|mesh-list
20288157|NCT05338086|Denosumab|denosumab|mesh-list
20288158|NCT05338086|Calcium|calcium|mesh-list
20288159|NCT05338086|Vitamins|vitamins|mesh-ancestor
20288160|NCT05338086|Micronutrients|micronutrients|mesh-ancestor
20288161|NCT05338086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288162|NCT05338086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20288163|NCT05338086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20288164|NCT05338021|Vancomycin|vancomycin|mesh-list
20288165|NCT05338021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20547173|NCT01892748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280439|NCT00580437|Dobutamine|dobutamine|mesh-list
20280440|NCT00580437|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20280441|NCT00580437|Sympathomimetics|sympathomimetics|mesh-ancestor
20280442|NCT00580437|Autonomic Agents|autonomic agents|mesh-ancestor
20280443|NCT00580437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280444|NCT00580437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280445|NCT00580437|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20280446|NCT00580437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20280447|NCT00580437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20280448|NCT00580437|Adrenergic Agents|adrenergic agents|mesh-ancestor
20280449|NCT00580437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20280450|NCT00580437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280451|NCT00580437|Protective Agents|protective agents|mesh-ancestor
20280452|NCT00580450|Thymalfasin|thymalfasin|mesh-list
20280453|NCT00580450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20280454|NCT00580450|Immunologic Factors|immunologic factors|mesh-ancestor
20280455|NCT00580450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280456|NCT00580489|Fentanyl|fentanyl|mesh-list
20280457|NCT00580489|Morphine|morphine|mesh-list
20280458|NCT00580489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20280459|NCT00580489|Narcotics|narcotics|mesh-ancestor
20280460|NCT00580489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20280461|NCT00580489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280462|NCT00580489|Analgesics|analgesics|mesh-ancestor
20280463|NCT00580489|Sensory System Agents|sensory system agents|mesh-ancestor
20280464|NCT00580489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280465|NCT00580489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20280466|NCT00580489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20280467|NCT00580489|Anesthetics, General|anesthetics, general|mesh-ancestor
20280468|NCT00580489|Anesthetics|anesthetics|mesh-ancestor
20280469|NCT00580619|Methyldopa|methyldopa|mesh-list
20280470|NCT00580619|Trimethaphan|trimethaphan|mesh-list
20547174|NCT01892748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20547175|NCT01892748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20547176|NCT01892787|Formoterol Fumarate|formoterol fumarate|mesh-list
20547177|NCT01892787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20547178|NCT01892787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20547179|NCT01892787|Autonomic Agents|autonomic agents|mesh-ancestor
20547180|NCT01892787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20547181|NCT01892787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547182|NCT01892787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20547183|NCT01892787|Respiratory System Agents|respiratory system agents|mesh-ancestor
20547184|NCT01892787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20547185|NCT01892787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20547186|NCT01892787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20547187|NCT01892787|Adrenergic Agents|adrenergic agents|mesh-ancestor
20547188|NCT01892787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20547189|NCT01892787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547190|NCT01892813|Bupropion|bupropion|mesh-list
20547191|NCT01892813|Nicotine|nicotine|mesh-list
20547192|NCT01892813|Varenicline|varenicline|mesh-list
20547193|NCT01892813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20547194|NCT01892813|Autonomic Agents|autonomic agents|mesh-ancestor
20547195|NCT01892813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20547196|NCT01892813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547197|NCT01892813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20547198|NCT01892813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20547199|NCT01892813|Cholinergic Agents|cholinergic agents|mesh-ancestor
20547200|NCT01892813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20547201|NCT01892813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547202|NCT01892813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20547203|NCT01892813|Antidepressive Agents|antidepressive agents|mesh-ancestor
20547204|NCT01892813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20547205|NCT01892813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20547206|NCT01892813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20547207|NCT01892813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20547208|NCT01892813|Dopamine Agents|dopamine agents|mesh-ancestor
20547209|NCT01892813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20547210|NCT01892813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20547211|NCT01892813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547212|NCT01892839|Dialysis Solutions|dialysis solutions|mesh-list
20547213|NCT01892839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20554419|NCT01935492|Mitosis Modulators|mitosis modulators|mesh-ancestor
20554420|NCT01935492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280471|NCT00580619|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
20280472|NCT00580619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280473|NCT00580619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20280474|NCT00580619|Sympatholytics|sympatholytics|mesh-ancestor
20280475|NCT00580619|Autonomic Agents|autonomic agents|mesh-ancestor
20280476|NCT00580619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280477|NCT00580619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280478|NCT00580619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20547214|NCT01892995|Ketamine|ketamine|mesh-list
20547215|NCT01892995|Analgesics|analgesics|mesh-ancestor
20547216|NCT01892995|Sensory System Agents|sensory system agents|mesh-ancestor
20547217|NCT01892995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20547218|NCT01892995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547219|NCT01892995|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20547220|NCT01892995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20547221|NCT01892995|Anesthetics, General|anesthetics, general|mesh-ancestor
20547222|NCT01892995|Anesthetics|anesthetics|mesh-ancestor
20547223|NCT01892995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20547224|NCT01892995|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20547225|NCT01892995|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20547226|NCT01892995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20547227|NCT01892995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547228|NCT01893060|Chlorhexidine|chlorhexidine|mesh-list
20547229|NCT01893060|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20547230|NCT01893060|Povidone-Iodine|povidone-iodine|mesh-list
20547231|NCT01893060|Povidone|povidone|mesh-list
20547232|NCT01893060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20547233|NCT01893060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20547234|NCT01893060|Disinfectants|disinfectants|mesh-ancestor
20547235|NCT01893060|Dermatologic Agents|dermatologic agents|mesh-ancestor
20547236|NCT01893060|Plasma Substitutes|plasma substitutes|mesh-ancestor
20547237|NCT01893060|Blood Substitutes|blood substitutes|mesh-ancestor
20547238|NCT01893099|Sorafenib|sorafenib|mesh-list
20547239|NCT01893099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20547240|NCT01893099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20547241|NCT01893099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547242|NCT01893099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547243|NCT01893177|Vaccines|vaccines|mesh-list
20547244|NCT01893177|Immunologic Factors|immunologic factors|mesh-ancestor
20547245|NCT01893177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547246|NCT01893229|Oxcarbazepine|oxcarbazepine|mesh-list
20547247|NCT01893229|Valproic Acid|valproic acid|mesh-list
20547248|NCT01893229|Olanzapine|olanzapine|mesh-list
20547249|NCT01893229|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20547250|NCT01893229|Ziprasidone|ziprasidone|mesh-list
20547251|NCT01893229|Lithium Carbonate|lithium carbonate|mesh-list
20547252|NCT01893229|Antiemetics|antiemetics|mesh-ancestor
20547253|NCT01893229|Autonomic Agents|autonomic agents|mesh-ancestor
20547254|NCT01893229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20547255|NCT01893229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547256|NCT01893229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20547257|NCT01893229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19962568|NCT01717209|Epoprostenol|epoprostenol|mesh-list
20280479|NCT00580619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20280480|NCT00580619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19962569|NCT01717209|Nitric Oxide|nitric oxide|mesh-list
19962570|NCT01717209|Tezosentan|tezosentan|mesh-list
19962571|NCT01717209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19962572|NCT01717209|Autonomic Agents|autonomic agents|mesh-ancestor
20280481|NCT00580619|Adrenergic Agents|adrenergic agents|mesh-ancestor
20280482|NCT00580619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20280483|NCT00580619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20280484|NCT00580619|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
20280485|NCT00580619|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20280486|NCT00580619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20280487|NCT00580619|Cholinergic Agents|cholinergic agents|mesh-ancestor
20280488|NCT00580619|Vasodilator Agents|vasodilator agents|mesh-ancestor
20280489|NCT00580814|Methylphenidate|methylphenidate|mesh-list
20280490|NCT00580814|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20280491|NCT00580814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280492|NCT00580814|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20280493|NCT00580814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20280494|NCT00580814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20280495|NCT00580814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547258|NCT01893229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20547259|NCT01893229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20547260|NCT01893229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20280496|NCT00580814|Dopamine Agents|dopamine agents|mesh-ancestor
20280497|NCT00580814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20280498|NCT00580827|Disulfiram|disulfiram|mesh-list
20280499|NCT00580827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20280500|NCT00580827|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20280501|NCT00580827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20280502|NCT00580827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280503|NCT00580905|Adenosine|adenosine|mesh-list
20280504|NCT00580905|Nitroprusside|nitroprusside|mesh-list
20280505|NCT00580905|Analgesics|analgesics|mesh-ancestor
20280506|NCT00580905|Sensory System Agents|sensory system agents|mesh-ancestor
20280507|NCT00580905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280508|NCT00580905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280509|NCT00580905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20280510|NCT00580905|Vasodilator Agents|vasodilator agents|mesh-ancestor
20280511|NCT00580905|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20280512|NCT00580905|Purinergic Agonists|purinergic agonists|mesh-ancestor
20280513|NCT00580905|Purinergic Agents|purinergic agents|mesh-ancestor
20280514|NCT00580905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20280515|NCT00580905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280516|NCT00580905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20280517|NCT00580905|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20280518|NCT00580931|Niacinamide|niacinamide|mesh-list
20280519|NCT00580931|Niacin|niacin|mesh-list
20280520|NCT00580931|Nicotinic Acids|nicotinic acids|mesh-list
20280521|NCT00580931|Vitamin B Complex|vitamin b complex|mesh-ancestor
20280522|NCT00580931|Vitamins|vitamins|mesh-ancestor
20280523|NCT00580931|Micronutrients|micronutrients|mesh-ancestor
20280524|NCT00580931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280525|NCT00580931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20280526|NCT00580931|Antimetabolites|antimetabolites|mesh-ancestor
20280527|NCT00580931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280528|NCT00580931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19962573|NCT01717209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19962574|NCT01717209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962575|NCT01717209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19962576|NCT01717209|Respiratory System Agents|respiratory system agents|mesh-ancestor
19962577|NCT01717209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19962578|NCT01717209|Antioxidants|antioxidants|mesh-ancestor
19962579|NCT01717209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962580|NCT01717209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19962581|NCT01717209|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19962582|NCT01717209|Vasodilator Agents|vasodilator agents|mesh-ancestor
19962583|NCT01717209|Gasotransmitters|gasotransmitters|mesh-ancestor
19962584|NCT01717209|Protective Agents|protective agents|mesh-ancestor
19962585|NCT01717209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19962586|NCT01717209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20280529|NCT00580931|Vasodilator Agents|vasodilator agents|mesh-ancestor
20280530|NCT00581009|Lithium Carbonate|lithium carbonate|mesh-list
20280531|NCT00581009|Sertraline|sertraline|mesh-list
20280532|NCT00581009|Antidepressive Agents|antidepressive agents|mesh-ancestor
20280533|NCT00581009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20280534|NCT00581009|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20280535|NCT00581009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20280536|NCT00581009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20280537|NCT00581009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280538|NCT00581009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20280539|NCT00581009|Serotonin Agents|serotonin agents|mesh-ancestor
20280540|NCT00581009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280541|NCT00581009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20280542|NCT00581009|Antimanic Agents|antimanic agents|mesh-ancestor
20280543|NCT00581009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20280544|NCT00581009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20280545|NCT00581035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20280546|NCT00581035|Immunologic Factors|immunologic factors|mesh-ancestor
20280547|NCT00581035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280548|NCT00581139|Midazolam|midazolam|mesh-list
20280549|NCT00581139|Anesthetics|anesthetics|mesh-ancestor
20280550|NCT00581139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20280551|NCT00581139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280552|NCT00581139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20280553|NCT00581139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20280554|NCT00581139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20280555|NCT00581139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20280556|NCT00581139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20280557|NCT00581139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20280558|NCT00581139|Anesthetics, General|anesthetics, general|mesh-ancestor
20280559|NCT00581139|GABA Modulators|gaba modulators|mesh-ancestor
20280560|NCT00581139|GABA Agents|gaba agents|mesh-ancestor
20280561|NCT00581139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20280562|NCT00581139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280563|NCT00581165|Etanercept|etanercept|mesh-list
20280564|NCT00581165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20280565|NCT00581165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20280566|NCT00581165|Analgesics|analgesics|mesh-ancestor
20280567|NCT00581165|Sensory System Agents|sensory system agents|mesh-ancestor
20280568|NCT00581165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280569|NCT00581165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280570|NCT00581165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20280571|NCT00581165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20280572|NCT00581165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20280573|NCT00581165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20280574|NCT00581165|Immunologic Factors|immunologic factors|mesh-ancestor
20280575|NCT00581217|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20280576|NCT00581217|Laxatives|laxatives|mesh-ancestor
20280577|NCT00581217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20280578|NCT00581425|Interferons|interferons|mesh-list
20280579|NCT00581425|Interferon-alpha|interferon-alpha|mesh-list
20280580|NCT00581425|Imiquimod|imiquimod|mesh-list
20280581|NCT00581425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280582|NCT00581425|Antiviral Agents|antiviral agents|mesh-ancestor
20280583|NCT00581425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20280584|NCT00581425|Immunologic Factors|immunologic factors|mesh-ancestor
20280585|NCT00581425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280586|NCT00581425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20280587|NCT00581425|Interferon Inducers|interferon inducers|mesh-ancestor
20280588|NCT00581607|Bosentan|bosentan|mesh-list
20280589|NCT00581607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20280590|NCT00581607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20280591|NCT00581607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280592|NCT00581685|Celecoxib|celecoxib|mesh-list
20280593|NCT00581685|Pregabalin|pregabalin|mesh-list
20280594|NCT00581685|Analgesics|analgesics|mesh-ancestor
20280595|NCT00581685|Sensory System Agents|sensory system agents|mesh-ancestor
20280596|NCT00581685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280597|NCT00581685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280598|NCT00581685|Anticonvulsants|anticonvulsants|mesh-ancestor
20280599|NCT00581685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20280600|NCT00581685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20280601|NCT00581685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280602|NCT00581685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20280603|NCT00581685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20280604|NCT00581685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20280605|NCT00581685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20280606|NCT00581685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20280607|NCT00581685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20280608|NCT00581685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20280609|NCT00581685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20280610|NCT00581685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20280611|NCT00581685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20280612|NCT00581685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20280613|NCT00581685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20280614|NCT00581789|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20280615|NCT00581789|Sunitinib|sunitinib|mesh-list
20280616|NCT00581789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280617|NCT00581789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20280618|NCT00581789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20280619|NCT00581789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280620|NCT00581789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20280621|NCT00581789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20280622|NCT00581789|Growth Substances|growth substances|mesh-ancestor
20280623|NCT00581789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280624|NCT00581789|Growth Inhibitors|growth inhibitors|mesh-ancestor
20288166|NCT05338021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20288167|NCT05338008|Vancomycin|vancomycin|mesh-list
20288168|NCT05338008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20288169|NCT05338008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20288170|NCT05337969|Metformin|metformin|mesh-list
19962587|NCT01717287|Raltegravir Potassium|raltegravir potassium|mesh-list
20288171|NCT05337969|Vildagliptin|vildagliptin|mesh-list
20547261|NCT01893229|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20280625|NCT00582582|Vitamin D|vitamin d|mesh-list
20280626|NCT00582582|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
20280627|NCT00582582|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
20280628|NCT00582582|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
20280629|NCT00582582|Docetaxel|docetaxel|mesh-list
20280630|NCT00582582|Vitamins|vitamins|mesh-ancestor
20280631|NCT00582582|Micronutrients|micronutrients|mesh-ancestor
20280632|NCT00582582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280633|NCT00582582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280634|NCT00582582|Tubulin Modulators|tubulin modulators|mesh-ancestor
20280635|NCT00582582|Antimitotic Agents|antimitotic agents|mesh-ancestor
20280636|NCT00582582|Mitosis Modulators|mitosis modulators|mesh-ancestor
20280637|NCT00582582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280638|NCT00582582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20280639|NCT00582634|Docetaxel|docetaxel|mesh-list
20280640|NCT00582634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280641|NCT00582634|Tubulin Modulators|tubulin modulators|mesh-ancestor
20280642|NCT00582634|Antimitotic Agents|antimitotic agents|mesh-ancestor
20280643|NCT00582634|Mitosis Modulators|mitosis modulators|mesh-ancestor
20280644|NCT00582634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280645|NCT00582920|Zoledronic Acid|zoledronic acid|mesh-list
20280646|NCT00582920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20280647|NCT00582920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280648|NCT00582985|Antibodies|antibodies|mesh-list
20280649|NCT00582985|Immunologic Factors|immunologic factors|mesh-ancestor
20280650|NCT00582985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280651|NCT00583063|Sirolimus|sirolimus|mesh-list
20280652|NCT00583063|Sunitinib|sunitinib|mesh-list
20280653|NCT00583063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280654|NCT00583063|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20280655|NCT00583063|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20280656|NCT00583063|Growth Substances|growth substances|mesh-ancestor
20280657|NCT00583063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280658|NCT00583063|Growth Inhibitors|growth inhibitors|mesh-ancestor
20280659|NCT00583063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20280660|NCT00583063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20280661|NCT00583063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280662|NCT00583063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20280663|NCT00583063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20280664|NCT00583063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20280665|NCT00583063|Antifungal Agents|antifungal agents|mesh-ancestor
20280666|NCT00583063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20280667|NCT00583063|Immunologic Factors|immunologic factors|mesh-ancestor
20280668|NCT00583180|Capsaicin|capsaicin|mesh-list
20280669|NCT00583180|Antipruritics|antipruritics|mesh-ancestor
20280670|NCT00583180|Dermatologic Agents|dermatologic agents|mesh-ancestor
20280671|NCT00583180|Sensory System Agents|sensory system agents|mesh-ancestor
20280672|NCT00583180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280673|NCT00583180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280674|NCT00583193|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20280675|NCT00583193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20280676|NCT00583193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20280677|NCT00583193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20280678|NCT00583193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280679|NCT00583193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20280680|NCT00583193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280681|NCT00583193|Analgesics|analgesics|mesh-ancestor
20280682|NCT00583193|Sensory System Agents|sensory system agents|mesh-ancestor
20280683|NCT00583193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280684|NCT00583193|Antidepressive Agents|antidepressive agents|mesh-ancestor
20280685|NCT00583193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20280686|NCT00583193|Dopamine Agents|dopamine agents|mesh-ancestor
20280687|NCT00583258|Alfuzosin|alfuzosin|mesh-list
20280688|NCT00583258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20280689|NCT00583258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20280690|NCT00583258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20280691|NCT00583258|Adrenergic Agents|adrenergic agents|mesh-ancestor
20280692|NCT00583258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20280693|NCT00583258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280694|NCT00583258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280695|NCT00583258|Urological Agents|urological agents|mesh-ancestor
20280696|NCT00583271|Triamcinolone|triamcinolone|mesh-list
20280697|NCT00583271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20280698|NCT00583271|Glucocorticoids|glucocorticoids|mesh-ancestor
20280699|NCT00583271|Hormones|hormones|mesh-ancestor
20280700|NCT00583271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20280701|NCT00583271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280702|NCT00583323|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
20280703|NCT00583323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20280704|NCT00583349|Paclitaxel|paclitaxel|mesh-list
20280705|NCT00583349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20280706|NCT00583349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280707|NCT00583349|Tubulin Modulators|tubulin modulators|mesh-ancestor
20280708|NCT00583349|Antimitotic Agents|antimitotic agents|mesh-ancestor
20280709|NCT00583349|Mitosis Modulators|mitosis modulators|mesh-ancestor
20280710|NCT00583349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280711|NCT00583427|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
20280712|NCT00583427|Anticoagulants|anticoagulants|mesh-ancestor
20280713|NCT00583427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20280714|NCT00583427|Antimetabolites|antimetabolites|mesh-ancestor
20280715|NCT00583427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280716|NCT00583427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20280717|NCT00583427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20280718|NCT00583427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20280719|NCT00583427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20280720|NCT00583427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280721|NCT00583518|Hormones|hormones|mesh-list
20280722|NCT00583518|Parathyroid Hormone|parathyroid hormone|mesh-list
20280723|NCT00583518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20280724|NCT00583518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280725|NCT00583518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20280726|NCT00583869|Pregabalin|pregabalin|mesh-list
20280727|NCT00583869|Analgesics|analgesics|mesh-ancestor
20280728|NCT00583869|Sensory System Agents|sensory system agents|mesh-ancestor
20280729|NCT00583869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20547262|NCT01893229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20547263|NCT01893229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20547264|NCT01893229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547265|NCT01893229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20547266|NCT01893229|Serotonin Agents|serotonin agents|mesh-ancestor
20547267|NCT01893229|Antidepressive Agents|antidepressive agents|mesh-ancestor
20547268|NCT01893229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547269|NCT01893229|Antimanic Agents|antimanic agents|mesh-ancestor
20547270|NCT01893229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20547271|NCT01893229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20547272|NCT01893229|Dopamine Agents|dopamine agents|mesh-ancestor
20547273|NCT01893229|Anticonvulsants|anticonvulsants|mesh-ancestor
20547274|NCT01893229|GABA Agents|gaba agents|mesh-ancestor
20547275|NCT01893229|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20547276|NCT01893229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20547277|NCT01893229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20547278|NCT01893229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20547279|NCT01893294|Gemcitabine|gemcitabine|mesh-list
20547280|NCT01893294|Fluorouracil|fluorouracil|mesh-list
20547281|NCT01893294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20547282|NCT01893294|Antimetabolites|antimetabolites|mesh-ancestor
20547283|NCT01893294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547284|NCT01893294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20547285|NCT01893294|Antiviral Agents|antiviral agents|mesh-ancestor
20547286|NCT01893294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20547287|NCT01893294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547288|NCT01893294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20547289|NCT01893294|Immunologic Factors|immunologic factors|mesh-ancestor
20547290|NCT01893294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547291|NCT01893385|Vitamin D|vitamin d|mesh-list
20547292|NCT01893385|Vitamins|vitamins|mesh-ancestor
20547293|NCT01893385|Micronutrients|micronutrients|mesh-ancestor
20547294|NCT01893385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547295|NCT01893385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20547296|NCT01893424|Dronabinol|dronabinol|mesh-list
20547297|NCT01893424|Nabiximols|nabiximols|mesh-list
20547298|NCT01893424|Cannabidiol|cannabidiol|mesh-list
20547299|NCT01893424|Piperine|piperine|mesh-list
20547300|NCT01893424|Anticonvulsants|anticonvulsants|mesh-ancestor
20547301|NCT01893424|Hallucinogens|hallucinogens|mesh-ancestor
20547302|NCT01893424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547303|NCT01893424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20547304|NCT01893424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20547305|NCT01893424|Analgesics|analgesics|mesh-ancestor
20280730|NCT00583869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280731|NCT00583869|Anticonvulsants|anticonvulsants|mesh-ancestor
20280732|NCT00583869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20280733|NCT00583869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20280734|NCT00583869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280735|NCT00583869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20280736|NCT00583869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20280737|NCT00583869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20280738|NCT00583869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20280739|NCT00583869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20280740|NCT00583986|Albuterol|albuterol|mesh-list
20280741|NCT00583986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20280742|NCT00583986|Autonomic Agents|autonomic agents|mesh-ancestor
20280743|NCT00583986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280744|NCT00583986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280745|NCT00583986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20280746|NCT00583986|Respiratory System Agents|respiratory system agents|mesh-ancestor
20280747|NCT00583986|Tocolytic Agents|tocolytic agents|mesh-ancestor
20280748|NCT00583986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20280749|NCT00583986|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20280750|NCT00583986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20280751|NCT00583986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20280752|NCT00583986|Adrenergic Agents|adrenergic agents|mesh-ancestor
20280753|NCT00583986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20280754|NCT00583986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280755|NCT00584090|Solifenacin Succinate|solifenacin succinate|mesh-list
20547306|NCT01893424|Sensory System Agents|sensory system agents|mesh-ancestor
20547307|NCT01893424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20547308|NCT01893424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20547309|NCT01893424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20547310|NCT01893424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20547311|NCT01893424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547312|NCT01893424|Hormones|hormones|mesh-ancestor
20547313|NCT01893424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20547314|NCT01893424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20547315|NCT01893424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547316|NCT01893450|Pentoxifylline|pentoxifylline|mesh-list
20547317|NCT01893450|Bromocriptine|bromocriptine|mesh-list
20547318|NCT01893450|Methimazole|methimazole|mesh-list
20547319|NCT01893450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20547320|NCT01893450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547321|NCT01893450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547322|NCT01893450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20547323|NCT01893450|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20547324|NCT01893450|Protective Agents|protective agents|mesh-ancestor
20547325|NCT01893450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547326|NCT01893450|Vasodilator Agents|vasodilator agents|mesh-ancestor
20547327|NCT01893450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20547328|NCT01893450|Antioxidants|antioxidants|mesh-ancestor
20547329|NCT01893450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20547330|NCT01893450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20547331|NCT01893450|Hormone Antagonists|hormone antagonists|mesh-ancestor
20547332|NCT01893450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20547333|NCT01893450|Dopamine Agonists|dopamine agonists|mesh-ancestor
20547334|NCT01893450|Dopamine Agents|dopamine agents|mesh-ancestor
20547335|NCT01893450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20547336|NCT01893450|Antithyroid Agents|antithyroid agents|mesh-ancestor
20547337|NCT01893541|Propranolol|propranolol|mesh-list
20547338|NCT01893541|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20547339|NCT01893541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20547340|NCT01893541|Adrenergic Agents|adrenergic agents|mesh-ancestor
20547341|NCT01893541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20547342|NCT01893541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547343|NCT01893541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547344|NCT01893541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20547345|NCT01893541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20547346|NCT01893541|Vasodilator Agents|vasodilator agents|mesh-ancestor
20547347|NCT01893658|Omalizumab|omalizumab|mesh-list
20547348|NCT01893658|Prednisone|prednisone|mesh-list
20547349|NCT01893658|Prednisolone|prednisolone|mesh-list
20547350|NCT01893658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20547351|NCT01893658|Glucocorticoids|glucocorticoids|mesh-ancestor
20547352|NCT01893658|Hormones|hormones|mesh-ancestor
20280756|NCT00584090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20280757|NCT00584090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20280758|NCT00584090|Cholinergic Agents|cholinergic agents|mesh-ancestor
20280759|NCT00584090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20280760|NCT00584090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280761|NCT00584090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280762|NCT00584090|Urological Agents|urological agents|mesh-ancestor
20280763|NCT00584155|Ofloxacin|ofloxacin|mesh-list
20280764|NCT00584155|Levofloxacin|levofloxacin|mesh-list
20280765|NCT00584155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20280766|NCT00584155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20280767|NCT00584155|Renal Agents|renal agents|mesh-ancestor
20280768|NCT00584155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20280769|NCT00584155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20280770|NCT00584155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20280771|NCT00584155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20280772|NCT00584155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280773|NCT00584155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280774|NCT00584155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20280775|NCT00584155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20280776|NCT00584168|Dexamethasone|dexamethasone|mesh-list
20280777|NCT00584168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20280778|NCT00584168|Antiemetics|antiemetics|mesh-ancestor
20280779|NCT00584168|Autonomic Agents|autonomic agents|mesh-ancestor
20280780|NCT00584168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280781|NCT00584168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280782|NCT00584168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20280783|NCT00584168|Glucocorticoids|glucocorticoids|mesh-ancestor
20280784|NCT00584168|Hormones|hormones|mesh-ancestor
20280785|NCT00584168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20280786|NCT00584168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20280787|NCT00584168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280788|NCT00584298|Octreotide|octreotide|mesh-list
20280789|NCT00584298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20280790|NCT00584298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20280791|NCT00584298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280792|NCT00584376|Pregabalin|pregabalin|mesh-list
20280793|NCT00584376|Analgesics|analgesics|mesh-ancestor
20280794|NCT00584376|Sensory System Agents|sensory system agents|mesh-ancestor
19962588|NCT01717287|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19962589|NCT01717287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19962590|NCT01717287|Antiviral Agents|antiviral agents|mesh-ancestor
19962591|NCT01717287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19962592|NCT01717287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19962593|NCT01717287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20547353|NCT01893658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20547354|NCT01893658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547355|NCT01893658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20547356|NCT01893658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20547357|NCT01893658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20547358|NCT01893658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20547359|NCT01893658|Respiratory System Agents|respiratory system agents|mesh-ancestor
20547360|NCT01893723|Remifentanil|remifentanil|mesh-list
20547361|NCT01893723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20547362|NCT01893723|Narcotics|narcotics|mesh-ancestor
20547363|NCT01893723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20547364|NCT01893723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547365|NCT01893723|Analgesics|analgesics|mesh-ancestor
20547366|NCT01893723|Sensory System Agents|sensory system agents|mesh-ancestor
20547367|NCT01893723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20547368|NCT01893788|Eplerenone|eplerenone|mesh-list
20547369|NCT01893788|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20547370|NCT01893788|Hormone Antagonists|hormone antagonists|mesh-ancestor
20547371|NCT01893788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20547372|NCT01893788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547373|NCT01893788|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20547374|NCT01893788|Diuretics|diuretics|mesh-ancestor
20547375|NCT01893788|Natriuretic Agents|natriuretic agents|mesh-ancestor
20547376|NCT01893788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20547377|NCT01893996|Adalimumab|adalimumab|mesh-list
20547378|NCT01893996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20547379|NCT01893996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20547380|NCT01894035|Iloprost|iloprost|mesh-list
20547381|NCT01894035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20280795|NCT00584376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280796|NCT00584376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280797|NCT00584376|Anticonvulsants|anticonvulsants|mesh-ancestor
20280798|NCT00584376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20280799|NCT00584376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20280800|NCT00584376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280801|NCT00584376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20280802|NCT00584376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20280803|NCT00584376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20280804|NCT00584376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20280805|NCT00584376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20280806|NCT00584389|Rimonabant|rimonabant|mesh-list
20280807|NCT00584389|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20280808|NCT00584389|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20280809|NCT00584389|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20280810|NCT00584389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20280811|NCT00584389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280812|NCT00584389|Hormones|hormones|mesh-ancestor
20280813|NCT00584389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20280814|NCT00584389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280815|NCT00584493|Tremelimumab|tremelimumab|mesh-list
20280816|NCT00584493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280817|NCT00584532|Genistein|genistein|mesh-list
20280818|NCT00584532|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20280819|NCT00584532|Protective Agents|protective agents|mesh-ancestor
20280820|NCT00584532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280821|NCT00584532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280822|NCT00584532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20280823|NCT00584532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20280824|NCT00584532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280825|NCT00584532|Phytoestrogens|phytoestrogens|mesh-ancestor
20280826|NCT00584532|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20280827|NCT00584532|Estrogens|estrogens|mesh-ancestor
20280828|NCT00584532|Hormones|hormones|mesh-ancestor
20280829|NCT00584532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20280830|NCT00584571|Dexetimide|dexetimide|mesh-list
20280831|NCT00584571|Citalopram|citalopram|mesh-list
20280832|NCT00584571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20280833|NCT00584571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20280834|NCT00584571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20280835|NCT00584571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280836|NCT00584571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20280837|NCT00584571|Serotonin Agents|serotonin agents|mesh-ancestor
20280838|NCT00584571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280839|NCT00584571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20280840|NCT00584571|Antidepressive Agents|antidepressive agents|mesh-ancestor
20280841|NCT00584571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20280842|NCT00584571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20280843|NCT00584571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20280844|NCT00584571|Parasympatholytics|parasympatholytics|mesh-ancestor
20280845|NCT00584571|Autonomic Agents|autonomic agents|mesh-ancestor
20280846|NCT00584571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280847|NCT00584571|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20280848|NCT00584571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20280849|NCT00584571|Cholinergic Agents|cholinergic agents|mesh-ancestor
20280850|NCT00584610|Copper|copper|mesh-list
20280851|NCT00584610|Levonorgestrel|levonorgestrel|mesh-list
20280852|NCT00584610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20280853|NCT00584610|Contraceptive Agents|contraceptive agents|mesh-ancestor
20280854|NCT00584610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20280855|NCT00584610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280856|NCT00584610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20280857|NCT00584610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20280858|NCT00584610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20280859|NCT00584610|Trace Elements|trace elements|mesh-ancestor
20280860|NCT00584610|Micronutrients|micronutrients|mesh-ancestor
20288172|NCT05337969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20288173|NCT05337969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288174|NCT05337969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20288175|NCT05337969|Protease Inhibitors|protease inhibitors|mesh-ancestor
20288176|NCT05337969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288599|NCT05288777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20547382|NCT01894035|Vasodilator Agents|vasodilator agents|mesh-ancestor
20280861|NCT00584636|Budesonide|budesonide|mesh-list
20280862|NCT00584636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20280863|NCT00584636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20280864|NCT00584636|Autonomic Agents|autonomic agents|mesh-ancestor
20280865|NCT00584636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280866|NCT00584636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280867|NCT00584636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20280868|NCT00584636|Respiratory System Agents|respiratory system agents|mesh-ancestor
20280869|NCT00584636|Glucocorticoids|glucocorticoids|mesh-ancestor
20280870|NCT00584636|Hormones|hormones|mesh-ancestor
20280871|NCT00584636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20280872|NCT00584662|Phenylephrine|phenylephrine|mesh-list
20280873|NCT00584662|Oxymetazoline|oxymetazoline|mesh-list
20280874|NCT00584662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20280875|NCT00584662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20280876|NCT00584662|Adrenergic Agents|adrenergic agents|mesh-ancestor
20280877|NCT00584662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20280878|NCT00584662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280879|NCT00584662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280880|NCT00584662|Sympathomimetics|sympathomimetics|mesh-ancestor
20280881|NCT00584662|Autonomic Agents|autonomic agents|mesh-ancestor
20280882|NCT00584662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280883|NCT00584662|Nasal Decongestants|nasal decongestants|mesh-ancestor
20280884|NCT00584662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20280885|NCT00584662|Respiratory System Agents|respiratory system agents|mesh-ancestor
20280886|NCT00584662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20280887|NCT00584662|Mydriatics|mydriatics|mesh-ancestor
20280888|NCT00584662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20547383|NCT01894048|Beclomethasone|beclomethasone|mesh-list
20547384|NCT01894048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20547385|NCT01894048|Glucocorticoids|glucocorticoids|mesh-ancestor
20547386|NCT01894048|Hormones|hormones|mesh-ancestor
20547387|NCT01894048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20547388|NCT01894048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547389|NCT01894048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20547390|NCT01894048|Respiratory System Agents|respiratory system agents|mesh-ancestor
20547391|NCT01894061|Bevacizumab|bevacizumab|mesh-list
20547392|NCT01894061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20547393|NCT01894061|Antibodies|antibodies|mesh-list
20547394|NCT01894061|Immunoglobulins|immunoglobulins|mesh-list
20547395|NCT01894061|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20547396|NCT01894061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20547397|NCT01894061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20547398|NCT01894061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20547399|NCT01894061|Growth Substances|growth substances|mesh-ancestor
20547400|NCT01894061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547401|NCT01894061|Growth Inhibitors|growth inhibitors|mesh-ancestor
20547402|NCT01894061|Immunologic Factors|immunologic factors|mesh-ancestor
20547403|NCT01894269|Lamivudine|lamivudine|mesh-list
20547404|NCT01894269|Entecavir|entecavir|mesh-list
20547405|NCT01894269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20547406|NCT01894269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20547407|NCT01894269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547408|NCT01894269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547409|NCT01894269|Antiviral Agents|antiviral agents|mesh-ancestor
20547410|NCT01894269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20547411|NCT01894269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20547412|NCT01894269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20547413|NCT01894295|Vitamin D|vitamin d|mesh-list
20547414|NCT01894295|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
20547415|NCT01894295|Vitamins|vitamins|mesh-ancestor
20547416|NCT01894295|Micronutrients|micronutrients|mesh-ancestor
20547417|NCT01894295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547418|NCT01894295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20547419|NCT01894308|Testosterone|testosterone|mesh-list
20547420|NCT01894308|Androgens|androgens|mesh-ancestor
20547421|NCT01894308|Hormones|hormones|mesh-ancestor
20547422|NCT01894308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20547423|NCT01894308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547424|NCT01894334|Edaravone|edaravone|mesh-list
20547425|NCT01894334|Tranexamic Acid|tranexamic acid|mesh-list
20547426|NCT01894334|Urinastatin|urinastatin|mesh-list
20547427|NCT01894334|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20547428|NCT01894334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20547429|NCT01894334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547430|NCT01894334|Hemostatics|hemostatics|mesh-ancestor
20547431|NCT01894334|Coagulants|coagulants|mesh-ancestor
20280889|NCT00584662|Protective Agents|protective agents|mesh-ancestor
20280890|NCT00584688|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20280891|NCT00584688|Antidepressive Agents|antidepressive agents|mesh-ancestor
20280892|NCT00584688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20280893|NCT00584688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20280894|NCT00584688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20280895|NCT00584688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20280896|NCT00584688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280897|NCT00584779|Gabapentin|gabapentin|mesh-list
20280898|NCT00584779|Analgesics|analgesics|mesh-ancestor
20280899|NCT00584779|Sensory System Agents|sensory system agents|mesh-ancestor
20280900|NCT00584779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280901|NCT00584779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280902|NCT00584779|Anticonvulsants|anticonvulsants|mesh-ancestor
20280903|NCT00584779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20280904|NCT00584779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20280905|NCT00584779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20280906|NCT00584779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20280907|NCT00584779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20280908|NCT00584779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20280909|NCT00584779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20280910|NCT00584779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280911|NCT00584779|Antimanic Agents|antimanic agents|mesh-ancestor
20280912|NCT00585000|Tremelimumab|tremelimumab|mesh-list
20280913|NCT00585000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280914|NCT00585091|Phenylephrine|phenylephrine|mesh-list
20280915|NCT00585091|Oxymetazoline|oxymetazoline|mesh-list
20280916|NCT00585091|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20280917|NCT00585091|Mydriatics|mydriatics|mesh-ancestor
20280918|NCT00585091|Autonomic Agents|autonomic agents|mesh-ancestor
20280919|NCT00585091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280920|NCT00585091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280921|NCT00585091|Sympathomimetics|sympathomimetics|mesh-ancestor
20280922|NCT00585091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20280923|NCT00585091|Nasal Decongestants|nasal decongestants|mesh-ancestor
20280924|NCT00585091|Respiratory System Agents|respiratory system agents|mesh-ancestor
20280925|NCT00585091|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20280926|NCT00585091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20280927|NCT00585091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20280928|NCT00585091|Adrenergic Agents|adrenergic agents|mesh-ancestor
20280929|NCT00585091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20280930|NCT00585091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280931|NCT00585091|Protective Agents|protective agents|mesh-ancestor
20280932|NCT00585143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20280933|NCT00585143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20280934|NCT00585143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20280935|NCT00585143|Antimetabolites|antimetabolites|mesh-ancestor
20280936|NCT00585143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280937|NCT00585143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20280938|NCT00585143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20280939|NCT00585143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20280940|NCT00585156|Celecoxib|celecoxib|mesh-list
20280941|NCT00585156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20280942|NCT00585156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20280943|NCT00585156|Analgesics|analgesics|mesh-ancestor
20280944|NCT00585156|Sensory System Agents|sensory system agents|mesh-ancestor
20280945|NCT00585156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280946|NCT00585156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280947|NCT00585156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20280948|NCT00585156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20280949|NCT00585156|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20280950|NCT00585156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20280951|NCT00585156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20280952|NCT00585156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280953|NCT00585260|Mannitol|mannitol|mesh-list
20280954|NCT00585260|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20280955|NCT00585260|Diuretics|diuretics|mesh-ancestor
20280956|NCT00585260|Natriuretic Agents|natriuretic agents|mesh-ancestor
20280957|NCT00585260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280958|NCT00585442|Vitamin D|vitamin d|mesh-list
20280959|NCT00585442|Calcitriol|calcitriol|mesh-list
20280960|NCT00585442|Vitamins|vitamins|mesh-ancestor
20280961|NCT00585442|Micronutrients|micronutrients|mesh-ancestor
20280962|NCT00585442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280963|NCT00585442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20280964|NCT00585442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20280965|NCT00585442|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20280966|NCT00585442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20280967|NCT00585442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280968|NCT00585442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20280969|NCT00585455|Sertraline|sertraline|mesh-list
20280970|NCT00585455|Antidepressive Agents|antidepressive agents|mesh-ancestor
20280971|NCT00585455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20280972|NCT00585455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20280973|NCT00585455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20280974|NCT00585455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20280975|NCT00585455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547432|NCT01894334|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20547433|NCT01894334|Antioxidants|antioxidants|mesh-ancestor
20547434|NCT01894334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20547435|NCT01894334|Protective Agents|protective agents|mesh-ancestor
20547436|NCT01894334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547437|NCT01894334|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20547438|NCT01894334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20547439|NCT01894334|Protease Inhibitors|protease inhibitors|mesh-ancestor
20547440|NCT01894334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547441|NCT01894360|Belimumab|belimumab|mesh-list
20547442|NCT01894360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20547443|NCT01894360|Immunologic Factors|immunologic factors|mesh-ancestor
20547444|NCT01894360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547445|NCT01894412|Etanercept|etanercept|mesh-list
20547446|NCT01894412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20547447|NCT01894412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20547448|NCT01894412|Analgesics|analgesics|mesh-ancestor
20547449|NCT01894412|Sensory System Agents|sensory system agents|mesh-ancestor
20547450|NCT01894412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20547451|NCT01894412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547452|NCT01894412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20547453|NCT01894412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20547454|NCT01894412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20547455|NCT01894412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20547456|NCT01894412|Immunologic Factors|immunologic factors|mesh-ancestor
20547457|NCT01894451|Bevacizumab|bevacizumab|mesh-list
20547458|NCT01894451|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
20547459|NCT01894451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20547460|NCT01894451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20547461|NCT01894451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20547462|NCT01894451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20547463|NCT01894451|Growth Substances|growth substances|mesh-ancestor
20547464|NCT01894451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547465|NCT01894451|Growth Inhibitors|growth inhibitors|mesh-ancestor
20547466|NCT01894451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20547467|NCT01894451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547468|NCT01894633|Chloroquine|chloroquine|mesh-list
20547469|NCT01894633|Amebicides|amebicides|mesh-ancestor
20547470|NCT01894633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20547471|NCT01894633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20547472|NCT01894633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20547473|NCT01894633|Antimalarials|antimalarials|mesh-ancestor
20547474|NCT01894633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20554421|NCT01935492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20554422|NCT01935492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20554423|NCT01935492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20554424|NCT01935492|Growth Substances|growth substances|mesh-ancestor
20554425|NCT01935492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554426|NCT01935492|Growth Inhibitors|growth inhibitors|mesh-ancestor
20554427|NCT01935492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20554428|NCT01935492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20554429|NCT01935492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20554430|NCT01935492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962594|NCT01717287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962595|NCT01717287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20280976|NCT00585455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20280977|NCT00585455|Serotonin Agents|serotonin agents|mesh-ancestor
20280978|NCT00585455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280979|NCT00585507|Fulvestrant|fulvestrant|mesh-list
20280980|NCT00585507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20554431|NCT01935492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20554432|NCT01935492|Antimetabolites|antimetabolites|mesh-ancestor
20280981|NCT00585507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20280982|NCT00585507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20280983|NCT00585507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20280984|NCT00585507|Hormone Antagonists|hormone antagonists|mesh-ancestor
20280985|NCT00585507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20280986|NCT00585507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280987|NCT00585520|Progesterone|progesterone|mesh-list
20280988|NCT00585520|Progestins|progestins|mesh-ancestor
20280989|NCT00585520|Hormones|hormones|mesh-ancestor
20280990|NCT00585520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20280991|NCT00585520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20280992|NCT00585559|Acetaminophen|acetaminophen|mesh-list
20280993|NCT00585559|Acetylcysteine|acetylcysteine|mesh-list
20280994|NCT00585559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20280995|NCT00585559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20280996|NCT00585559|Analgesics|analgesics|mesh-ancestor
20280997|NCT00585559|Sensory System Agents|sensory system agents|mesh-ancestor
20280998|NCT00585559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20280999|NCT00585559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281000|NCT00585559|Antipyretics|antipyretics|mesh-ancestor
20281001|NCT00585559|Antiviral Agents|antiviral agents|mesh-ancestor
20281002|NCT00585559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20281003|NCT00585559|Expectorants|expectorants|mesh-ancestor
20281004|NCT00585559|Respiratory System Agents|respiratory system agents|mesh-ancestor
20281005|NCT00585559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20281006|NCT00585559|Antioxidants|antioxidants|mesh-ancestor
20281007|NCT00585559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281008|NCT00585559|Protective Agents|protective agents|mesh-ancestor
20281009|NCT00585559|Antidotes|antidotes|mesh-ancestor
20281010|NCT00585741|Alovudine|alovudine|mesh-list
20281011|NCT00585741|Antiviral Agents|antiviral agents|mesh-ancestor
20281012|NCT00585741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20281013|NCT00585754|Guanfacine|guanfacine|mesh-list
20281014|NCT00585754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20281015|NCT00585754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20281016|NCT00585754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20281017|NCT00585754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20281018|NCT00585754|Adrenergic Agents|adrenergic agents|mesh-ancestor
20281019|NCT00585754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20281020|NCT00585754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281021|NCT00585754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281022|NCT00585793|Lopinavir|lopinavir|mesh-list
20281023|NCT00585793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20281024|NCT00585793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20281025|NCT00585793|Protease Inhibitors|protease inhibitors|mesh-ancestor
20281026|NCT00585793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281027|NCT00585793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281028|NCT00585793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20281029|NCT00585793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20281030|NCT00585793|Antiviral Agents|antiviral agents|mesh-ancestor
20281031|NCT00585793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20281032|NCT00585793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20281033|NCT00585793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20281034|NCT00585871|Metoprolol|metoprolol|mesh-list
20281035|NCT00585871|Clonidine|clonidine|mesh-list
20281036|NCT00585871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20281037|NCT00585871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20281038|NCT00585871|Sympatholytics|sympatholytics|mesh-ancestor
20281039|NCT00585871|Autonomic Agents|autonomic agents|mesh-ancestor
20281040|NCT00585871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20281041|NCT00585871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962596|NCT01717313|Metformin|metformin|mesh-list
19962597|NCT01717313|Glimepiride|glimepiride|mesh-list
19962598|NCT01717313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19962599|NCT01717313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962600|NCT01717313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19962601|NCT01717313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19962602|NCT01717313|Immunologic Factors|immunologic factors|mesh-ancestor
19962603|NCT01717326|Ribavirin|ribavirin|mesh-list
20281042|NCT00585871|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20281043|NCT00585871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20281044|NCT00585871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20281045|NCT00585871|Adrenergic Agents|adrenergic agents|mesh-ancestor
20281046|NCT00585871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20281047|NCT00585871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962604|NCT01717326|Grazoprevir|grazoprevir|mesh-list
20281048|NCT00585871|Analgesics|analgesics|mesh-ancestor
20281049|NCT00585871|Sensory System Agents|sensory system agents|mesh-ancestor
20281050|NCT00585871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20281051|NCT00585871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20281052|NCT00585871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20281053|NCT00586092|Bevacizumab|bevacizumab|mesh-list
20281054|NCT00586092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20281055|NCT00586092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281056|NCT00586092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20281057|NCT00586092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20281058|NCT00586092|Growth Substances|growth substances|mesh-ancestor
20281059|NCT00586092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281060|NCT00586092|Growth Inhibitors|growth inhibitors|mesh-ancestor
20281061|NCT00586118|Propofol|propofol|mesh-list
20281062|NCT00586118|Sevoflurane|sevoflurane|mesh-list
20281063|NCT00586118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20281064|NCT00586118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20281065|NCT00586118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281066|NCT00586118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20281067|NCT00586118|Anesthetics, General|anesthetics, general|mesh-ancestor
20281068|NCT00586118|Anesthetics|anesthetics|mesh-ancestor
20281069|NCT00586118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20281070|NCT00586118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20281071|NCT00586131|Citric Acid|citric acid|mesh-list
20281072|NCT00586131|Sodium Citrate|sodium citrate|mesh-list
20281073|NCT00586131|Anticoagulants|anticoagulants|mesh-ancestor
20281074|NCT00586131|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20281075|NCT00586131|Chelating Agents|chelating agents|mesh-ancestor
20281076|NCT00586131|Sequestering Agents|sequestering agents|mesh-ancestor
20281077|NCT00586131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281078|NCT00586274|Fludarabine|fludarabine|mesh-list
20281079|NCT00586274|Alemtuzumab|alemtuzumab|mesh-list
20281080|NCT00586274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281081|NCT00586274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20281082|NCT00586287|Phenprocoumon|phenprocoumon|mesh-list
20281083|NCT00586287|Anticoagulants|anticoagulants|mesh-ancestor
20281084|NCT00586365|Naproxen|naproxen|mesh-list
20281085|NCT00586365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20281086|NCT00586365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20281087|NCT00586365|Analgesics|analgesics|mesh-ancestor
20281088|NCT00586365|Sensory System Agents|sensory system agents|mesh-ancestor
20281089|NCT00586365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20281090|NCT00586365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281091|NCT00586365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20281092|NCT00586365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20281093|NCT00586365|Gout Suppressants|gout suppressants|mesh-ancestor
20281094|NCT00586365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20281095|NCT00586365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281096|NCT00586365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281097|NCT00586430|Lorazepam|lorazepam|mesh-list
20281098|NCT00586430|Anticonvulsants|anticonvulsants|mesh-ancestor
20281099|NCT00586430|Antiemetics|antiemetics|mesh-ancestor
20281100|NCT00586430|Autonomic Agents|autonomic agents|mesh-ancestor
20281101|NCT00586430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20281102|NCT00586430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281103|NCT00586430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20281104|NCT00586430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20281105|NCT00586430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20281106|NCT00586430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20281107|NCT00586430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20281108|NCT00586430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20281109|NCT00586430|GABA Modulators|gaba modulators|mesh-ancestor
20281110|NCT00586430|GABA Agents|gaba agents|mesh-ancestor
20281111|NCT00586430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20281112|NCT00586430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281113|NCT00586443|Bevacizumab|bevacizumab|mesh-list
20281114|NCT00586443|Panitumumab|panitumumab|mesh-list
20281115|NCT00586443|Everolimus|everolimus|mesh-list
20281116|NCT00586443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20281117|NCT00586443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281118|NCT00586443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20281119|NCT00586443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20281120|NCT00586443|Growth Substances|growth substances|mesh-ancestor
20281121|NCT00586443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281122|NCT00586443|Growth Inhibitors|growth inhibitors|mesh-ancestor
20281123|NCT00586443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20281124|NCT00586443|Immunologic Factors|immunologic factors|mesh-ancestor
20281125|NCT00586560|Cyclophosphamide|cyclophosphamide|mesh-list
20281126|NCT00586560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20281127|NCT00586560|Immunologic Factors|immunologic factors|mesh-ancestor
20281128|NCT00586560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281129|NCT00586560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20281130|NCT00586560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20281131|NCT00586560|Alkylating Agents|alkylating agents|mesh-ancestor
20281132|NCT00586560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281133|NCT00586560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281134|NCT00586560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20281135|NCT00586794|Sildenafil Citrate|sildenafil citrate|mesh-list
20281136|NCT00586794|Vasodilator Agents|vasodilator agents|mesh-ancestor
20281137|NCT00586794|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20281138|NCT00586794|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20281139|NCT00586794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547475|NCT01894685|Mesalamine|mesalamine|mesh-list
20547476|NCT01894685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20547477|NCT01894685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20547478|NCT01894685|Analgesics|analgesics|mesh-ancestor
20547479|NCT01894685|Sensory System Agents|sensory system agents|mesh-ancestor
20547480|NCT01894685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20547481|NCT01894685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547482|NCT01894685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20547483|NCT01894685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20547484|NCT01894711|Trastuzumab|trastuzumab|mesh-list
20547485|NCT01894711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20547486|NCT01894711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20547487|NCT01894789|Clopidogrel|clopidogrel|mesh-list
20547488|NCT01894789|Ticagrelor|ticagrelor|mesh-list
20547489|NCT01894789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20547490|NCT01894789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20547491|NCT01894789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20547492|NCT01894789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20281140|NCT00586794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281141|NCT00586794|Urological Agents|urological agents|mesh-ancestor
20281142|NCT00586833|Neurotransmitter Agents|neurotransmitter agents|mesh-list
20281143|NCT00586833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281144|NCT00586833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281145|NCT00586911|Betaine|betaine|mesh-list
20281146|NCT00586911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20281147|NCT00586911|Lipotropic Agents|lipotropic agents|mesh-ancestor
20281148|NCT00586911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20281149|NCT00586911|Antimetabolites|antimetabolites|mesh-ancestor
20547493|NCT01894789|Purinergic Agents|purinergic agents|mesh-ancestor
20547494|NCT01894789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20547495|NCT01894789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547496|NCT01894789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547497|NCT01894815|Dexetimide|dexetimide|mesh-list
20547498|NCT01894815|Citalopram|citalopram|mesh-list
20547499|NCT01894815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20547500|NCT01894815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20547501|NCT01894815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20547502|NCT01894815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547503|NCT01894815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20547504|NCT01894815|Serotonin Agents|serotonin agents|mesh-ancestor
20547505|NCT01894815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547506|NCT01894815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20547507|NCT01894815|Antidepressive Agents|antidepressive agents|mesh-ancestor
20547508|NCT01894815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20547509|NCT01894815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20547510|NCT01894815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20547511|NCT01894815|Parasympatholytics|parasympatholytics|mesh-ancestor
20547512|NCT01894815|Autonomic Agents|autonomic agents|mesh-ancestor
20547513|NCT01894815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20547514|NCT01894815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20547515|NCT01894815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20547516|NCT01894815|Cholinergic Agents|cholinergic agents|mesh-ancestor
20547517|NCT01894867|Magnesium Oxide|magnesium oxide|mesh-list
20547518|NCT01894867|Antacids|antacids|mesh-ancestor
20547519|NCT01894867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547520|NCT01894867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20547521|NCT01895010|Tropisetron|tropisetron|mesh-list
20547522|NCT01895010|Antiemetics|antiemetics|mesh-ancestor
20547523|NCT01895010|Autonomic Agents|autonomic agents|mesh-ancestor
20281150|NCT00586911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281151|NCT00586911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20288177|NCT05337969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288600|NCT05288777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20288601|NCT05288777|Tubulin Modulators|tubulin modulators|mesh-ancestor
20288602|NCT05288777|Antimitotic Agents|antimitotic agents|mesh-ancestor
20288603|NCT05288777|Mitosis Modulators|mitosis modulators|mesh-ancestor
20288604|NCT05284214|Ipilimumab|ipilimumab|mesh-list
20288605|NCT05284214|Sargramostim|sargramostim|mesh-list
20288606|NCT05284214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20288607|NCT05284214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288608|NCT05284214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20288609|NCT05284214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288610|NCT05284214|Immunologic Factors|immunologic factors|mesh-ancestor
20288611|NCT05284214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288612|NCT05279963|Amitriptyline|amitriptyline|mesh-list
20288613|NCT05279963|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20288614|NCT05279963|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20288615|NCT05279963|Antidepressive Agents|antidepressive agents|mesh-ancestor
20288616|NCT05279963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20288617|NCT05279963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20288618|NCT05279963|Analgesics|analgesics|mesh-ancestor
20288619|NCT05279963|Sensory System Agents|sensory system agents|mesh-ancestor
20288620|NCT05279963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20288621|NCT05279963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288622|NCT05279963|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20288623|NCT05279963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20288624|NCT05279963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20547524|NCT01895010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20547525|NCT01895010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547526|NCT01895010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20547527|NCT01895010|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20547528|NCT01895010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20547529|NCT01895010|Serotonin Agents|serotonin agents|mesh-ancestor
20547530|NCT01895010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20547531|NCT01895010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547532|NCT01895023|Midazolam|midazolam|mesh-list
20547533|NCT01895023|Dexmedetomidine|dexmedetomidine|mesh-list
20547534|NCT01895023|GABA Modulators|gaba modulators|mesh-list
20547535|NCT01895023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20547536|NCT01895023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20547537|NCT01895023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547538|NCT01895023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20547539|NCT01895023|Analgesics|analgesics|mesh-ancestor
20547540|NCT01895023|Sensory System Agents|sensory system agents|mesh-ancestor
20547541|NCT01895023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20547542|NCT01895023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20547543|NCT01895023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20547544|NCT01895023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20547545|NCT01895023|Adrenergic Agents|adrenergic agents|mesh-ancestor
20547546|NCT01895023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20547547|NCT01895023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547548|NCT01895023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20547549|NCT01895023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20547550|NCT01895023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19962605|NCT01717326|Antimetabolites|antimetabolites|mesh-ancestor
20547551|NCT01895023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20547552|NCT01895023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19962606|NCT01717326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962607|NCT01717326|Antiviral Agents|antiviral agents|mesh-ancestor
19962608|NCT01717326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19962609|NCT01717456|Loperamide|loperamide|mesh-list
19962610|NCT01717456|Antidiarrheals|antidiarrheals|mesh-list
19962611|NCT01717456|Laxatives|laxatives|mesh-list
19962612|NCT01717456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19962613|NCT01717638|Vaccines|vaccines|mesh-list
19962614|NCT01717638|Immunologic Factors|immunologic factors|mesh-ancestor
19962615|NCT01717638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962616|NCT01717742|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19962617|NCT01717742|Plasminogen|plasminogen|mesh-list
19962618|NCT01717742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19962619|NCT01717742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19974939|NCT01843920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20281152|NCT00586924|Immunotoxin HA22|immunotoxin ha22|mesh-list
20281153|NCT00586924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281154|NCT00586976|Ropivacaine|ropivacaine|mesh-list
20281155|NCT00586976|Anesthetics, Local|anesthetics, local|mesh-ancestor
20281156|NCT00586976|Anesthetics|anesthetics|mesh-ancestor
20281157|NCT00586976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20281158|NCT00586976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281159|NCT00586976|Sensory System Agents|sensory system agents|mesh-ancestor
20281160|NCT00586976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20281161|NCT00587015|Immunotoxin HA22|immunotoxin ha22|mesh-list
20281162|NCT00587015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281163|NCT00587119|Budesonide|budesonide|mesh-list
20281164|NCT00587119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20281165|NCT00587119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20281166|NCT00587119|Autonomic Agents|autonomic agents|mesh-ancestor
20281167|NCT00587119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20281168|NCT00587119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281169|NCT00587119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20281170|NCT00587119|Respiratory System Agents|respiratory system agents|mesh-ancestor
20281171|NCT00587119|Glucocorticoids|glucocorticoids|mesh-ancestor
20281172|NCT00587119|Hormones|hormones|mesh-ancestor
20281173|NCT00587119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20281174|NCT00587145|Docetaxel|docetaxel|mesh-list
20281175|NCT00587145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281176|NCT00587145|Tubulin Modulators|tubulin modulators|mesh-ancestor
20547553|NCT01895023|Anesthetics, General|anesthetics, general|mesh-ancestor
20547554|NCT01895023|Anesthetics|anesthetics|mesh-ancestor
20547555|NCT01895023|GABA Agents|gaba agents|mesh-ancestor
20547556|NCT01895049|Mycophenolic Acid|mycophenolic acid|mesh-list
20547557|NCT01895049|Prednisone|prednisone|mesh-list
20547558|NCT01895049|Everolimus|everolimus|mesh-list
20547559|NCT01895049|Tacrolimus|tacrolimus|mesh-list
20547560|NCT01895049|Thymoglobulin|thymoglobulin|mesh-list
20547561|NCT01895049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20547562|NCT01895049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20547563|NCT01895049|Glucocorticoids|glucocorticoids|mesh-ancestor
20547564|NCT01895049|Hormones|hormones|mesh-ancestor
20547565|NCT01895049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20547566|NCT01895049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547567|NCT01895049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20547568|NCT01895049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20547569|NCT01895049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20547570|NCT01895049|Immunologic Factors|immunologic factors|mesh-ancestor
20547571|NCT01895049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20547572|NCT01895049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547573|NCT01895049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547574|NCT01895049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20547575|NCT01895049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20547576|NCT01895049|Antitubercular Agents|antitubercular agents|mesh-ancestor
20547577|NCT01895049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20547578|NCT01895049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20547579|NCT01895075|Budesonide|budesonide|mesh-list
20547580|NCT01895075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20547581|NCT01895075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20547582|NCT01895075|Autonomic Agents|autonomic agents|mesh-ancestor
20547583|NCT01895075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20547584|NCT01895075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547585|NCT01895075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20547586|NCT01895075|Respiratory System Agents|respiratory system agents|mesh-ancestor
20547587|NCT01895075|Glucocorticoids|glucocorticoids|mesh-ancestor
20547588|NCT01895075|Hormones|hormones|mesh-ancestor
20547589|NCT01895075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20547590|NCT01895205|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
20547591|NCT01895205|Hematinics|hematinics|mesh-ancestor
20547592|NCT01895218|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
20547593|NCT01895218|Hematinics|hematinics|mesh-ancestor
20547594|NCT01895231|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
20547595|NCT01895231|Hematinics|hematinics|mesh-ancestor
20547596|NCT01895257|Leucovorin|leucovorin|mesh-list
20547597|NCT01895257|Fluorouracil|fluorouracil|mesh-list
20547598|NCT01895257|Levoleucovorin|levoleucovorin|mesh-list
20547599|NCT01895257|Antidotes|antidotes|mesh-ancestor
20547600|NCT01895257|Protective Agents|protective agents|mesh-ancestor
20281177|NCT00587145|Antimitotic Agents|antimitotic agents|mesh-ancestor
20281178|NCT00587145|Mitosis Modulators|mitosis modulators|mesh-ancestor
20547601|NCT01895257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547602|NCT01895257|Vitamin B Complex|vitamin b complex|mesh-ancestor
20281179|NCT00587145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281180|NCT00587249|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20281181|NCT00587249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20281182|NCT00587249|Immunologic Factors|immunologic factors|mesh-ancestor
20281183|NCT00587249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281184|NCT00587249|Antacids|antacids|mesh-ancestor
20281185|NCT00587249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281186|NCT00587249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20281187|NCT00587327|Atosiban|atosiban|mesh-list
20281188|NCT00587327|Hormone Antagonists|hormone antagonists|mesh-ancestor
20281189|NCT00587327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20281190|NCT00587327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281191|NCT00587327|Tocolytic Agents|tocolytic agents|mesh-ancestor
20281192|NCT00587327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20281193|NCT00587379|Atorvastatin|atorvastatin|mesh-list
20281194|NCT00587379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20281195|NCT00587379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20281196|NCT00587379|Antimetabolites|antimetabolites|mesh-ancestor
20281197|NCT00587379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281198|NCT00587379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20281199|NCT00587379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20281200|NCT00587379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281201|NCT00587444|Heparin|heparin|mesh-list
20281202|NCT00587444|Calcium heparin|calcium heparin|mesh-list
20281203|NCT00587444|Anticoagulants|anticoagulants|mesh-ancestor
20281204|NCT00587444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20281205|NCT00587444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20281206|NCT00587444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281207|NCT00587470|Candesartan|candesartan|mesh-list
20281208|NCT00587470|Candesartan cilexetil|candesartan cilexetil|mesh-list
19450383|NCT03428685|Dydrogesterone|dydrogesterone|mesh-list
19450384|NCT03428685|Progestins|progestins|mesh-ancestor
19450385|NCT03428685|Hormones|hormones|mesh-ancestor
20281209|NCT00587470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20281210|NCT00587470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20281211|NCT00587470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20288178|NCT05337657|Letrozole|letrozole|mesh-list
19450386|NCT03428685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19962620|NCT01717742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962621|NCT01717768|Testosterone|testosterone|mesh-list
19962622|NCT01717768|Androgens|androgens|mesh-ancestor
19962623|NCT01717768|Hormones|hormones|mesh-ancestor
19962624|NCT01717768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19962625|NCT01717768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962626|NCT01717872|Pyrithione zinc|pyrithione zinc|mesh-list
19962627|NCT01717872|Keratolytic Agents|keratolytic agents|mesh-ancestor
19962628|NCT01717872|Dermatologic Agents|dermatologic agents|mesh-ancestor
19962629|NCT01717898|Prednisone|prednisone|mesh-list
19962630|NCT01717898|Abiraterone Acetate|abiraterone acetate|mesh-list
19962631|NCT01717898|Dactolisib|dactolisib|mesh-list
19962632|NCT01717898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19962633|NCT01717898|Glucocorticoids|glucocorticoids|mesh-ancestor
19962634|NCT01717898|Hormones|hormones|mesh-ancestor
19962635|NCT01717898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19962636|NCT01717898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962637|NCT01717898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19962638|NCT01717898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962639|NCT01717898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19962640|NCT01717898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962641|NCT01717898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962642|NCT01717898|Hormone Antagonists|hormone antagonists|mesh-ancestor
19962643|NCT01717898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19962644|NCT01718353|Prednisone|prednisone|mesh-list
19962645|NCT01718353|Docetaxel|docetaxel|mesh-list
19962646|NCT01718353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962647|NCT01718353|Tubulin Modulators|tubulin modulators|mesh-ancestor
19962648|NCT01718353|Antimitotic Agents|antimitotic agents|mesh-ancestor
19962649|NCT01718353|Mitosis Modulators|mitosis modulators|mesh-ancestor
19962650|NCT01718353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962651|NCT01718353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19962652|NCT01718353|Glucocorticoids|glucocorticoids|mesh-ancestor
19962653|NCT01718353|Hormones|hormones|mesh-ancestor
19962654|NCT01718353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20281212|NCT00587470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281213|NCT00587496|Aspirin|aspirin|mesh-list
20281214|NCT00587496|Valacyclovir|valacyclovir|mesh-list
20281215|NCT00587496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20281216|NCT00587496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20281217|NCT00587496|Analgesics|analgesics|mesh-ancestor
20281218|NCT00587496|Sensory System Agents|sensory system agents|mesh-ancestor
20281219|NCT00587496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20281220|NCT00587496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281221|NCT00587496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20281222|NCT00587496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20281223|NCT00587496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20281224|NCT00587496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20281225|NCT00587496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281226|NCT00587496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20281227|NCT00587496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20281228|NCT00587496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281229|NCT00587496|Antipyretics|antipyretics|mesh-ancestor
20281230|NCT00587496|Antiviral Agents|antiviral agents|mesh-ancestor
20281231|NCT00587496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20281232|NCT00587548|Diethylenetriamine|diethylenetriamine|mesh-list
20281233|NCT00587548|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20281234|NCT00587548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281235|NCT00587665|Ketamine|ketamine|mesh-list
20281236|NCT00587665|Analgesics|analgesics|mesh-ancestor
20281237|NCT00587665|Sensory System Agents|sensory system agents|mesh-ancestor
20281238|NCT00587665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20281239|NCT00587665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281240|NCT00587665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20281241|NCT00587665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20281242|NCT00587665|Anesthetics, General|anesthetics, general|mesh-ancestor
20281243|NCT00587665|Anesthetics|anesthetics|mesh-ancestor
20281244|NCT00587665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20281245|NCT00587665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20281246|NCT00587665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20281247|NCT00587665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20281248|NCT00587665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281249|NCT00587717|Simvastatin|simvastatin|mesh-list
20281250|NCT00587717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20281251|NCT00587717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20281252|NCT00587717|Antimetabolites|antimetabolites|mesh-ancestor
20281253|NCT00587717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281254|NCT00587717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20281255|NCT00587717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20281256|NCT00587717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962655|NCT01718353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962656|NCT01718353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19962657|NCT01718483|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19962658|NCT01718483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19962659|NCT01718483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962660|NCT01718483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19962661|NCT01718483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19962662|NCT01718483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19962663|NCT01718483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962664|NCT01718483|Dopamine Agents|dopamine agents|mesh-ancestor
19962665|NCT01718483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20281257|NCT00587873|Leucovorin|leucovorin|mesh-list
20281258|NCT00587873|Methotrexate|methotrexate|mesh-list
20281259|NCT00587873|Thioguanine|thioguanine|mesh-list
20281260|NCT00587873|Calcium|calcium|mesh-list
20281261|NCT00587873|Levoleucovorin|levoleucovorin|mesh-list
20281262|NCT00587873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20281263|NCT00587873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281264|NCT00587873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20281265|NCT00587873|Abortifacient Agents|abortifacient agents|mesh-ancestor
20281266|NCT00587873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20281267|NCT00587873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20281268|NCT00587873|Antimetabolites|antimetabolites|mesh-ancestor
20281269|NCT00587873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281270|NCT00587873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281271|NCT00587873|Dermatologic Agents|dermatologic agents|mesh-ancestor
20281272|NCT00587873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281273|NCT00587873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20281274|NCT00587873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20281275|NCT00587873|Immunologic Factors|immunologic factors|mesh-ancestor
20281276|NCT00587873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20281277|NCT00587873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20281278|NCT00587873|Antidotes|antidotes|mesh-ancestor
20281279|NCT00587873|Protective Agents|protective agents|mesh-ancestor
20281280|NCT00587873|Vitamin B Complex|vitamin b complex|mesh-ancestor
20281281|NCT00587873|Vitamins|vitamins|mesh-ancestor
20281282|NCT00587873|Micronutrients|micronutrients|mesh-ancestor
20281283|NCT00588003|Anastrozole|anastrozole|mesh-list
20281284|NCT00588003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20281285|NCT00588003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281286|NCT00588003|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20281287|NCT00588003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20281288|NCT00588003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281289|NCT00588003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281290|NCT00588003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20281291|NCT00588003|Hormone Antagonists|hormone antagonists|mesh-ancestor
20281292|NCT00588003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20281293|NCT00588003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281294|NCT00588016|Itraconazole|itraconazole|mesh-list
20547603|NCT01895257|Vitamins|vitamins|mesh-ancestor
20547604|NCT01895257|Micronutrients|micronutrients|mesh-ancestor
20547605|NCT01895257|Antimetabolites|antimetabolites|mesh-ancestor
20547606|NCT01895257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547607|NCT01895257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20547608|NCT01895257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20547609|NCT01895257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20547610|NCT01895257|Immunologic Factors|immunologic factors|mesh-ancestor
19962666|NCT01718509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19962667|NCT01718509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19962668|NCT01718509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962669|NCT01718509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19962670|NCT01718509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19962671|NCT01718509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19962672|NCT01718509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962673|NCT01718509|Dopamine Agents|dopamine agents|mesh-ancestor
20547611|NCT01895296|Pasireotide|pasireotide|mesh-list
20547612|NCT01895296|Hormones|hormones|mesh-ancestor
20547613|NCT01895296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20547614|NCT01895296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547615|NCT01895348|Dexmedetomidine|dexmedetomidine|mesh-list
20547616|NCT01895348|Remifentanil|remifentanil|mesh-list
20547617|NCT01895348|Propofol|propofol|mesh-list
20547618|NCT01895348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20547619|NCT01895348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20547620|NCT01895348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547621|NCT01895348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20547622|NCT01895348|Anesthetics, General|anesthetics, general|mesh-ancestor
20547623|NCT01895348|Anesthetics|anesthetics|mesh-ancestor
20547624|NCT01895348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20547625|NCT01895348|Analgesics|analgesics|mesh-ancestor
20547626|NCT01895348|Sensory System Agents|sensory system agents|mesh-ancestor
20547627|NCT01895348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20281295|NCT00588016|Antifungal Agents|antifungal agents|mesh-ancestor
20281296|NCT00588016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20281297|NCT00588016|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20281298|NCT00588016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20281299|NCT00588016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281300|NCT00588016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281301|NCT00588016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20281302|NCT00588016|Hormone Antagonists|hormone antagonists|mesh-ancestor
20281303|NCT00588016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20281304|NCT00588016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281305|NCT00588016|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20281306|NCT00588133|Tranexamic Acid|tranexamic acid|mesh-list
20281307|NCT00588133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20281308|NCT00588133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20281309|NCT00588133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281310|NCT00588133|Hemostatics|hemostatics|mesh-ancestor
20281311|NCT00588133|Coagulants|coagulants|mesh-ancestor
20281312|NCT00588172|Metformin|metformin|mesh-list
20281313|NCT00588172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20281314|NCT00588172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281315|NCT00588302|Moexipril|moexipril|mesh-list
20281316|NCT00588302|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20281317|NCT00588302|Protease Inhibitors|protease inhibitors|mesh-ancestor
20281318|NCT00588302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281319|NCT00588302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281320|NCT00588302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20281321|NCT00588523|Temozolomide|temozolomide|mesh-list
20281322|NCT00588523|Busulfan|busulfan|mesh-list
20281323|NCT00588523|Thiotepa|thiotepa|mesh-list
20281324|NCT00588523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20281325|NCT00588523|Alkylating Agents|alkylating agents|mesh-ancestor
20281326|NCT00588523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281327|NCT00588523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281328|NCT00588523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20281329|NCT00588523|Immunologic Factors|immunologic factors|mesh-ancestor
20281330|NCT00588523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281331|NCT00588523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20281332|NCT00588835|Dexamethasone|dexamethasone|mesh-list
20281333|NCT00588835|Ondansetron|ondansetron|mesh-list
20281334|NCT00588835|Aprepitant|aprepitant|mesh-list
20281335|NCT00588835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20281336|NCT00588835|Antiemetics|antiemetics|mesh-ancestor
20281337|NCT00588835|Autonomic Agents|autonomic agents|mesh-ancestor
20281338|NCT00588835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20281339|NCT00588835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281340|NCT00588835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20281341|NCT00588835|Glucocorticoids|glucocorticoids|mesh-ancestor
20281342|NCT00588835|Hormones|hormones|mesh-ancestor
20547628|NCT01895348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20547629|NCT01895348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20547630|NCT01895348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20547631|NCT01895348|Adrenergic Agents|adrenergic agents|mesh-ancestor
20547632|NCT01895348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20547633|NCT01895348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547634|NCT01895348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20547635|NCT01895348|Narcotics|narcotics|mesh-ancestor
20547636|NCT01895400|Cilostazol|cilostazol|mesh-list
20547637|NCT01895400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20547638|NCT01895400|Autonomic Agents|autonomic agents|mesh-ancestor
20547639|NCT01895400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20547640|NCT01895400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547641|NCT01895400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20547642|NCT01895400|Respiratory System Agents|respiratory system agents|mesh-ancestor
20547643|NCT01895400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20547644|NCT01895400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20547645|NCT01895400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547646|NCT01895400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20547647|NCT01895400|Vasodilator Agents|vasodilator agents|mesh-ancestor
20547648|NCT01895400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20547649|NCT01895400|Protective Agents|protective agents|mesh-ancestor
20547650|NCT01895400|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20281343|NCT00588835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20281344|NCT00588835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20281345|NCT00588835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281346|NCT00588835|Antipruritics|antipruritics|mesh-ancestor
20281347|NCT00588835|Dermatologic Agents|dermatologic agents|mesh-ancestor
20281348|NCT00588835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20281349|NCT00588835|Serotonin Agents|serotonin agents|mesh-ancestor
20281350|NCT00588835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20281351|NCT00588835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281352|NCT00588835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20281353|NCT00588835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20281354|NCT00588835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20281355|NCT00588835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20281356|NCT00588835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20281357|NCT00588835|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20288179|NCT05337657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288180|NCT05337657|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20288181|NCT05337657|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20288182|NCT05337657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288183|NCT05337657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288184|NCT05337657|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20288185|NCT05337657|Hormone Antagonists|hormone antagonists|mesh-ancestor
19450387|NCT03428685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288186|NCT05337657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20288187|NCT05337657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288188|NCT05337449|Fluorides|fluorides|mesh-list
20288189|NCT05337449|Cariostatic Agents|cariostatic agents|mesh-ancestor
20288190|NCT05337449|Protective Agents|protective agents|mesh-ancestor
20288191|NCT05337449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962674|NCT01718509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19962675|NCT01718691|Rituximab|rituximab|mesh-list
19962676|NCT01718691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19962677|NCT01718691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962678|NCT01718691|Immunologic Factors|immunologic factors|mesh-ancestor
19962679|NCT01718691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962680|NCT01718691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19962681|NCT01719003|Metformin|metformin|mesh-list
19962682|NCT01719003|Empagliflozin|empagliflozin|mesh-list
20288192|NCT05337332|Triamcinolone|triamcinolone|mesh-list
20288193|NCT05337332|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20288194|NCT05337332|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20288195|NCT05337332|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20288196|NCT05337332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20288197|NCT05337332|Glucocorticoids|glucocorticoids|mesh-ancestor
20288198|NCT05337332|Hormones|hormones|mesh-ancestor
20288199|NCT05337332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20288200|NCT05337332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288201|NCT05337332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20288202|NCT05337332|Immunologic Factors|immunologic factors|mesh-ancestor
20288203|NCT05337332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288204|NCT05337332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288205|NCT05337254|Dihydroergotamine|dihydroergotamine|mesh-list
20288206|NCT05337254|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20288207|NCT05337254|Dopamine Agonists|dopamine agonists|mesh-ancestor
20288208|NCT05337254|Dopamine Agents|dopamine agents|mesh-ancestor
20288209|NCT05337254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20288210|NCT05337254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288211|NCT05337254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288212|NCT05337254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20288213|NCT05337254|Analgesics|analgesics|mesh-ancestor
20288214|NCT05337254|Sensory System Agents|sensory system agents|mesh-ancestor
20288215|NCT05337254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20288216|NCT05337085|Midazolam|midazolam|mesh-list
20288217|NCT05337085|Dexmedetomidine|dexmedetomidine|mesh-list
20288218|NCT05337085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20288219|NCT05337085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20288220|NCT05337085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288221|NCT05337085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20288222|NCT05337085|Analgesics|analgesics|mesh-ancestor
20288223|NCT05337085|Sensory System Agents|sensory system agents|mesh-ancestor
20288224|NCT05337085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20288225|NCT05337085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19962683|NCT01719003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19962684|NCT01719003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281358|NCT00588913|Zoledronic Acid|zoledronic acid|mesh-list
20281359|NCT00588913|Aldesleukin|aldesleukin|mesh-list
20281360|NCT00588913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281361|NCT00588913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20281362|NCT00588913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20281363|NCT00588913|Antiviral Agents|antiviral agents|mesh-ancestor
20281364|NCT00588913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20281365|NCT00588913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20281366|NCT00588913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281367|NCT00588926|Remifentanil|remifentanil|mesh-list
20281368|NCT00588926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20281369|NCT00588926|Narcotics|narcotics|mesh-ancestor
20281370|NCT00588926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20281371|NCT00588926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281372|NCT00588926|Analgesics|analgesics|mesh-ancestor
20281373|NCT00588926|Sensory System Agents|sensory system agents|mesh-ancestor
20281374|NCT00588926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20281375|NCT00589082|Daunorubicin|daunorubicin|mesh-list
20281376|NCT00589082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20281377|NCT00589082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281378|NCT00589082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20281379|NCT00589082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20281380|NCT00589082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281381|NCT00589082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281382|NCT00589134|Ganirelix|ganirelix|mesh-list
20281383|NCT00589134|Hormone Antagonists|hormone antagonists|mesh-ancestor
20281384|NCT00589134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20281385|NCT00589134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281386|NCT00589186|Celecoxib|celecoxib|mesh-list
20281387|NCT00589186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20281388|NCT00589186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20281389|NCT00589186|Analgesics|analgesics|mesh-ancestor
20281390|NCT00589186|Sensory System Agents|sensory system agents|mesh-ancestor
20281391|NCT00589186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20281392|NCT00589186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281393|NCT00589186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20281394|NCT00589186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20281395|NCT00589186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20281396|NCT00589186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20281397|NCT00589186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281398|NCT00589186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281399|NCT00589238|Paclitaxel|paclitaxel|mesh-list
20281400|NCT00589238|Cyclophosphamide|cyclophosphamide|mesh-list
20281401|NCT00589238|Carboplatin|carboplatin|mesh-list
20281402|NCT00589238|Doxorubicin|doxorubicin|mesh-list
20281403|NCT00589238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20281404|NCT00589238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20281405|NCT00589238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281406|NCT00589238|Tubulin Modulators|tubulin modulators|mesh-ancestor
20281407|NCT00589238|Antimitotic Agents|antimitotic agents|mesh-ancestor
20281408|NCT00589238|Mitosis Modulators|mitosis modulators|mesh-ancestor
20281409|NCT00589238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281410|NCT00589238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20281411|NCT00589238|Immunologic Factors|immunologic factors|mesh-ancestor
20281412|NCT00589238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281413|NCT00589238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20281414|NCT00589238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20281415|NCT00589238|Alkylating Agents|alkylating agents|mesh-ancestor
20281416|NCT00589238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20281417|NCT00589238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19962685|NCT01719003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19962686|NCT01719003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962687|NCT01719172|Hemostatics|hemostatics|mesh-list
19962688|NCT01719172|Coagulants|coagulants|mesh-ancestor
19962689|NCT01719367|Atenolol|atenolol|mesh-list
19962690|NCT01719367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19962691|NCT01719367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19962692|NCT01719367|Sympatholytics|sympatholytics|mesh-ancestor
19962693|NCT01719367|Autonomic Agents|autonomic agents|mesh-ancestor
19962694|NCT01719367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19962695|NCT01719367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962696|NCT01719367|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19962697|NCT01719367|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20281418|NCT00589238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20281419|NCT00589238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20281420|NCT00589238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281421|NCT00589251|Penicillins|penicillins|mesh-list
20281422|NCT00589251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20281423|NCT00589251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20281424|NCT00589264|Copper|copper|mesh-list
20281425|NCT00589264|Trace Elements|trace elements|mesh-ancestor
20281426|NCT00589264|Micronutrients|micronutrients|mesh-ancestor
20281427|NCT00589264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281428|NCT00589316|Iodine|iodine|mesh-list
20281429|NCT00589316|Mycophenolic Acid|mycophenolic acid|mesh-list
20281430|NCT00589316|Cadexomer iodine|cadexomer iodine|mesh-list
20281431|NCT00589316|Cyclophosphamide|cyclophosphamide|mesh-list
20281432|NCT00589316|Fludarabine|fludarabine|mesh-list
20281433|NCT00589316|Fludarabine phosphate|fludarabine phosphate|mesh-list
20281434|NCT00589316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20281435|NCT00589316|Tacrolimus|tacrolimus|mesh-list
20281436|NCT00589316|Antibodies|antibodies|mesh-list
20281437|NCT00589316|Immunoglobulins|immunoglobulins|mesh-list
20281438|NCT00589316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20281439|NCT00589316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20281440|NCT00589316|Immunologic Factors|immunologic factors|mesh-ancestor
20281441|NCT00589316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281442|NCT00589316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20281443|NCT00589316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20281444|NCT00589316|Alkylating Agents|alkylating agents|mesh-ancestor
20281445|NCT00589316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281446|NCT00589316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281447|NCT00589316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20281448|NCT00589316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20281449|NCT00589316|Antimetabolites|antimetabolites|mesh-ancestor
20281450|NCT00589316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20281451|NCT00589316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281452|NCT00589316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20281453|NCT00589316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20281454|NCT00589316|Antitubercular Agents|antitubercular agents|mesh-ancestor
20281455|NCT00589316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20281456|NCT00589316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20281457|NCT00589316|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20281458|NCT00589316|Trace Elements|trace elements|mesh-ancestor
20281459|NCT00589316|Micronutrients|micronutrients|mesh-ancestor
20281460|NCT00589381|Fenretinide|fenretinide|mesh-list
20281461|NCT00589381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281462|NCT00589381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20281463|NCT00589381|Protective Agents|protective agents|mesh-ancestor
20281464|NCT00589381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547651|NCT01895400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20547652|NCT01895400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547653|NCT01895569|Metformin|metformin|mesh-list
20547654|NCT01895569|Pioglitazone|pioglitazone|mesh-list
20547655|NCT01895569|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20547656|NCT01895569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20547657|NCT01895569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547658|NCT01895569|Incretins|incretins|mesh-ancestor
20547659|NCT01895569|Hormones|hormones|mesh-ancestor
20547660|NCT01895569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20547661|NCT01895569|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20547662|NCT01895569|Protease Inhibitors|protease inhibitors|mesh-ancestor
20547663|NCT01895569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547664|NCT01895569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547665|NCT01895621|Thioctic Acid|thioctic acid|mesh-list
20547666|NCT01895621|Antioxidants|antioxidants|mesh-ancestor
20547667|NCT01895621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547668|NCT01895621|Protective Agents|protective agents|mesh-ancestor
20547669|NCT01895621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547670|NCT01895621|Vitamin B Complex|vitamin b complex|mesh-ancestor
20547671|NCT01895621|Vitamins|vitamins|mesh-ancestor
20547672|NCT01895621|Micronutrients|micronutrients|mesh-ancestor
20547673|NCT01895764|Adalimumab|adalimumab|mesh-list
20547674|NCT01895764|Methotrexate|methotrexate|mesh-list
20547675|NCT01895764|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20547676|NCT01895764|Abortifacient Agents|abortifacient agents|mesh-ancestor
20547677|NCT01895764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20547678|NCT01895764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281465|NCT00589394|Vaccines|vaccines|mesh-list
20281466|NCT00589394|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20281467|NCT00589394|Immunologic Factors|immunologic factors|mesh-ancestor
20547679|NCT01895764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20281468|NCT00589394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281469|NCT00589485|Cobalt|cobalt|mesh-list
20281470|NCT00589485|Trace Elements|trace elements|mesh-ancestor
20281471|NCT00589485|Micronutrients|micronutrients|mesh-ancestor
20281472|NCT00589485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281473|NCT00589732|Valsartan|valsartan|mesh-list
20281474|NCT00589732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20281475|NCT00589732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20281476|NCT00589732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20281477|NCT00589732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281478|NCT00589862|Clopidogrel|clopidogrel|mesh-list
20281479|NCT00589862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20281480|NCT00589862|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20281481|NCT00589862|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20281482|NCT00589862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20281483|NCT00589862|Purinergic Agents|purinergic agents|mesh-ancestor
20281484|NCT00589862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20281485|NCT00589862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281486|NCT00589862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281487|NCT00589901|Cyclophosphamide|cyclophosphamide|mesh-list
20281488|NCT00589901|Capecitabine|capecitabine|mesh-list
20281489|NCT00589901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20281490|NCT00589901|Immunologic Factors|immunologic factors|mesh-ancestor
20281491|NCT00589901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281492|NCT00589901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20281493|NCT00589901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20281494|NCT00589901|Alkylating Agents|alkylating agents|mesh-ancestor
20281495|NCT00589901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281496|NCT00589901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281497|NCT00589901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20281498|NCT00589901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20281499|NCT00589901|Antimetabolites|antimetabolites|mesh-ancestor
20281500|NCT00589927|Cilostazol|cilostazol|mesh-list
20281501|NCT00589927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20281502|NCT00589927|Autonomic Agents|autonomic agents|mesh-ancestor
20281503|NCT00589927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20281504|NCT00589927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281505|NCT00589927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20281506|NCT00589927|Respiratory System Agents|respiratory system agents|mesh-ancestor
20281507|NCT00589927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20281508|NCT00589927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20281509|NCT00589927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281510|NCT00589927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20281511|NCT00589927|Vasodilator Agents|vasodilator agents|mesh-ancestor
20281512|NCT00589927|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20281513|NCT00589927|Protective Agents|protective agents|mesh-ancestor
20281514|NCT00589927|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20281515|NCT00589927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20281516|NCT00589927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281517|NCT00589953|Epoetin Alfa|epoetin alfa|mesh-list
20281518|NCT00589953|Hematinics|hematinics|mesh-ancestor
20281519|NCT00589992|Ibutilide|ibutilide|mesh-list
20281520|NCT00589992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20281521|NCT00590070|Adenosine|adenosine|mesh-list
20547680|NCT01895764|Antimetabolites|antimetabolites|mesh-ancestor
20547681|NCT01895764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281522|NCT00590070|Nitroprusside|nitroprusside|mesh-list
20281523|NCT00590070|Analgesics|analgesics|mesh-ancestor
20281524|NCT00590070|Sensory System Agents|sensory system agents|mesh-ancestor
20281525|NCT00590070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20281526|NCT00590070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281527|NCT00590070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20281528|NCT00590070|Vasodilator Agents|vasodilator agents|mesh-ancestor
20281529|NCT00590070|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20281530|NCT00590070|Purinergic Agonists|purinergic agonists|mesh-ancestor
20281531|NCT00590070|Purinergic Agents|purinergic agents|mesh-ancestor
20281532|NCT00590070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20281533|NCT00590070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281534|NCT00590070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20281535|NCT00590070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20281536|NCT00590122|Levodopa|levodopa|mesh-list
20281537|NCT00590122|Carbidopa|carbidopa|mesh-list
20281538|NCT00590122|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20281539|NCT00590122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20281540|NCT00590122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20281541|NCT00590122|Dopamine Agents|dopamine agents|mesh-ancestor
20281542|NCT00590122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20281543|NCT00590122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281544|NCT00590122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281545|NCT00590122|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20281546|NCT00590122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281547|NCT00590122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20281548|NCT00590122|Immunologic Factors|immunologic factors|mesh-ancestor
20281549|NCT00590122|Dopamine Agonists|dopamine agonists|mesh-ancestor
20281550|NCT00590174|Aspirin|aspirin|mesh-list
20281551|NCT00590174|Clopidogrel|clopidogrel|mesh-list
20281552|NCT00590174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20281553|NCT00590174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20281554|NCT00590174|Analgesics|analgesics|mesh-ancestor
20281555|NCT00590174|Sensory System Agents|sensory system agents|mesh-ancestor
20281556|NCT00590174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20281557|NCT00590174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281558|NCT00590174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20281559|NCT00590174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20281560|NCT00590174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20281561|NCT00590174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20281562|NCT00590174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281563|NCT00590174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20281564|NCT00590174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20281565|NCT00590174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281566|NCT00590174|Antipyretics|antipyretics|mesh-ancestor
20281567|NCT00590174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20281568|NCT00590174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20281569|NCT00590174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20281570|NCT00590174|Purinergic Agents|purinergic agents|mesh-ancestor
20281571|NCT00590174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20281572|NCT00590213|Bicalutamide|bicalutamide|mesh-list
20281573|NCT00590213|Androgen Antagonists|androgen antagonists|mesh-ancestor
20281574|NCT00590213|Hormone Antagonists|hormone antagonists|mesh-ancestor
20281575|NCT00590213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20281576|NCT00590213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281577|NCT00590213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281578|NCT00590278|Raltitrexed|raltitrexed|mesh-list
20281579|NCT00590278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20281580|NCT00590278|Antimetabolites|antimetabolites|mesh-ancestor
20281581|NCT00590278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281582|NCT00590278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281583|NCT00590278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20281584|NCT00590278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281585|NCT00590343|Vatalanib|vatalanib|mesh-list
20281586|NCT00590343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20281587|NCT00590343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281588|NCT00590343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281589|NCT00590408|Ubiquinone|ubiquinone|mesh-list
20281590|NCT00590408|Coenzyme Q10|coenzyme q10|mesh-list
20281591|NCT00590408|Micronutrients|micronutrients|mesh-ancestor
20281592|NCT00590408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281593|NCT00590408|Vitamins|vitamins|mesh-ancestor
20281594|NCT00590447|Rituximab|rituximab|mesh-list
20281595|NCT00590447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20281596|NCT00590447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281597|NCT00590447|Immunologic Factors|immunologic factors|mesh-ancestor
20281598|NCT00590447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281599|NCT00590447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20281600|NCT00590603|Ascorbic Acid|ascorbic acid|mesh-list
20281601|NCT00590603|Bortezomib|bortezomib|mesh-list
20281602|NCT00590603|Arsenic Trioxide|arsenic trioxide|mesh-list
20281603|NCT00590603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281604|NCT00590603|Antioxidants|antioxidants|mesh-ancestor
20281605|NCT00590603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281606|NCT00590603|Protective Agents|protective agents|mesh-ancestor
20281607|NCT00590603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281608|NCT00590603|Vitamins|vitamins|mesh-ancestor
20281609|NCT00590603|Micronutrients|micronutrients|mesh-ancestor
20281610|NCT00590629|Niacin|niacin|mesh-list
20281611|NCT00590629|Nicotinic Acids|nicotinic acids|mesh-list
20281612|NCT00590629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20281613|NCT00590629|Antimetabolites|antimetabolites|mesh-ancestor
20281614|NCT00590629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281615|NCT00590629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20281616|NCT00590629|Vasodilator Agents|vasodilator agents|mesh-ancestor
20281617|NCT00590629|Vitamin B Complex|vitamin b complex|mesh-ancestor
20281618|NCT00590629|Vitamins|vitamins|mesh-ancestor
20281619|NCT00590629|Micronutrients|micronutrients|mesh-ancestor
20281620|NCT00590629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281621|NCT00590694|Ranibizumab|ranibizumab|mesh-list
20281622|NCT00590694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20281623|NCT00590694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20281624|NCT00590694|Growth Substances|growth substances|mesh-ancestor
20281625|NCT00590694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281626|NCT00590694|Growth Inhibitors|growth inhibitors|mesh-ancestor
20281627|NCT00590694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281628|NCT00590785|Tamoxifen|tamoxifen|mesh-list
20281629|NCT00590785|Ciprofloxacin|ciprofloxacin|mesh-list
20281630|NCT00590785|Cyclophosphamide|cyclophosphamide|mesh-list
20281631|NCT00590785|Doxorubicin|doxorubicin|mesh-list
20281632|NCT00590785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20281633|NCT00590785|Immunologic Factors|immunologic factors|mesh-ancestor
20281634|NCT00590785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281635|NCT00590785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20281636|NCT00590785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20281637|NCT00590785|Alkylating Agents|alkylating agents|mesh-ancestor
20281638|NCT00590785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281639|NCT00590785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281640|NCT00590785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20281641|NCT00590785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20281642|NCT00590785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20281643|NCT00590785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20281644|NCT00590785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281645|NCT00590785|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20281646|NCT00590785|Hormone Antagonists|hormone antagonists|mesh-ancestor
20281647|NCT00590785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20281648|NCT00590785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20281649|NCT00590785|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20547682|NCT01895764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20547683|NCT01895764|Dermatologic Agents|dermatologic agents|mesh-ancestor
20547684|NCT01895764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547685|NCT01895764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20547686|NCT01895764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20547687|NCT01895764|Immunologic Factors|immunologic factors|mesh-ancestor
20547688|NCT01895764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20547689|NCT01895764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20547690|NCT01895764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20547691|NCT01895829|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20547692|NCT01895829|Hematinics|hematinics|mesh-ancestor
20547693|NCT01895829|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20547694|NCT01895829|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20547695|NCT01895881|Estradiol|estradiol|mesh-list
20547696|NCT01895881|Estrogens|estrogens|mesh-ancestor
20547697|NCT01895881|Hormones|hormones|mesh-ancestor
20547698|NCT01895881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20547699|NCT01895881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547700|NCT01895894|Mycophenolic Acid|mycophenolic acid|mesh-list
20547701|NCT01895894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20547702|NCT01895894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20547703|NCT01895894|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20547704|NCT01895894|Antitubercular Agents|antitubercular agents|mesh-ancestor
20547705|NCT01895894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20547706|NCT01895894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20547707|NCT01895894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547708|NCT01895894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547709|NCT01895998|Albuterol|albuterol|mesh-list
20547710|NCT01895998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20547711|NCT01895998|Autonomic Agents|autonomic agents|mesh-ancestor
20547712|NCT01895998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20547713|NCT01895998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547714|NCT01895998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20547715|NCT01895998|Respiratory System Agents|respiratory system agents|mesh-ancestor
20547716|NCT01895998|Tocolytic Agents|tocolytic agents|mesh-ancestor
20547717|NCT01895998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20547718|NCT01895998|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20547719|NCT01895998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20547720|NCT01895998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20547721|NCT01895998|Adrenergic Agents|adrenergic agents|mesh-ancestor
20281650|NCT00590785|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20281651|NCT00590785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20281652|NCT00590785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20281653|NCT00590785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20281654|NCT00590785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20281655|NCT00590785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20281656|NCT00590837|Lomustine|lomustine|mesh-list
20281657|NCT00590837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20281658|NCT00590837|Alkylating Agents|alkylating agents|mesh-ancestor
20281659|NCT00590837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281660|NCT00590837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281661|NCT00590915|Asparaginase|asparaginase|mesh-list
20281662|NCT00590915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281663|NCT00590928|Esomeprazole|esomeprazole|mesh-list
20281664|NCT00590928|Ranitidine|ranitidine|mesh-list
20281665|NCT00590928|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20281666|NCT00590928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20281667|NCT00590928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20281668|NCT00590928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20281669|NCT00590928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281670|NCT00590928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281671|NCT00590928|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20281672|NCT00590928|Histamine Antagonists|histamine antagonists|mesh-ancestor
20281673|NCT00590928|Histamine Agents|histamine agents|mesh-ancestor
20281674|NCT00590928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20281675|NCT00590928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288226|NCT05337085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20288227|NCT05337085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20288228|NCT05337085|Adrenergic Agents|adrenergic agents|mesh-ancestor
20288229|NCT05337085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20288230|NCT05337085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288231|NCT05337085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20288232|NCT05337085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20288233|NCT05337085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20288234|NCT05337085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20288235|NCT05337085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20288236|NCT05337085|Anesthetics, General|anesthetics, general|mesh-ancestor
20288237|NCT05337085|Anesthetics|anesthetics|mesh-ancestor
20288238|NCT05337085|GABA Modulators|gaba modulators|mesh-ancestor
20288239|NCT05337085|GABA Agents|gaba agents|mesh-ancestor
20288240|NCT05336825|Lidocaine|lidocaine|mesh-list
20288241|NCT05336825|Anesthetics, Local|anesthetics, local|mesh-ancestor
20288242|NCT05336825|Anesthetics|anesthetics|mesh-ancestor
20288243|NCT05336825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20288244|NCT05336825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288245|NCT05336825|Sensory System Agents|sensory system agents|mesh-ancestor
20288246|NCT05336825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20288247|NCT05336825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20288248|NCT05336825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20288249|NCT05336825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20288250|NCT05336825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20288251|NCT05336825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288252|NCT05336812|Venetoclax|venetoclax|mesh-list
20288253|NCT05336812|Obinutuzumab|obinutuzumab|mesh-list
20288254|NCT05336812|Acalabrutinib|acalabrutinib|mesh-list
20547722|NCT01895998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20547723|NCT01895998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547724|NCT01896011|Teriparatide|teriparatide|mesh-list
20547725|NCT01896011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20547726|NCT01896011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547727|NCT01896011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20547728|NCT01896180|Latanoprost|latanoprost|mesh-list
20547729|NCT01896180|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20547730|NCT01896180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20547731|NCT01896245|Sevoflurane|sevoflurane|mesh-list
20547732|NCT01896245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20547733|NCT01896245|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20547734|NCT01896245|Anesthetics, General|anesthetics, general|mesh-ancestor
20547735|NCT01896245|Anesthetics|anesthetics|mesh-ancestor
20547736|NCT01896245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20547737|NCT01896245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547738|NCT01896284|Aflibercept|aflibercept|mesh-list
20547739|NCT01896284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20288255|NCT05336812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281676|NCT00591162|Tetracycline|tetracycline|mesh-list
20281677|NCT00591162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20281678|NCT00591162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20281679|NCT00591162|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20281680|NCT00591162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281681|NCT00591162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281682|NCT00591188|Interferons|interferons|mesh-list
20281683|NCT00591188|Interferon-alpha|interferon-alpha|mesh-list
20281684|NCT00591188|Capecitabine|capecitabine|mesh-list
20281685|NCT00591188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20281686|NCT00591188|Antimetabolites|antimetabolites|mesh-ancestor
20281687|NCT00591188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281688|NCT00591188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281689|NCT00591188|Antiviral Agents|antiviral agents|mesh-ancestor
20281690|NCT00591188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20281691|NCT00591188|Immunologic Factors|immunologic factors|mesh-ancestor
20281692|NCT00591188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281693|NCT00591201|Infliximab|infliximab|mesh-list
20281694|NCT00591201|Dermatologic Agents|dermatologic agents|mesh-ancestor
20281695|NCT00591201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20281696|NCT00591201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20281697|NCT00591357|Loperamide|loperamide|mesh-list
20281698|NCT00591357|Antidiarrheals|antidiarrheals|mesh-list
20281699|NCT00591357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20281700|NCT00591383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20281701|NCT00591383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281702|NCT00591383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20281703|NCT00591383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281704|NCT00591383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281705|NCT00591487|Lidocaine|lidocaine|mesh-list
20281706|NCT00591487|Anesthetics, Local|anesthetics, local|mesh-ancestor
20281707|NCT00591487|Anesthetics|anesthetics|mesh-ancestor
20281708|NCT00591487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20281709|NCT00591487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281710|NCT00591487|Sensory System Agents|sensory system agents|mesh-ancestor
20281711|NCT00591487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20281712|NCT00591487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20281713|NCT00591487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20281714|NCT00591487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20281715|NCT00591487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20281716|NCT00591487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281717|NCT00591526|Cytarabine|cytarabine|mesh-list
20281718|NCT00591526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20281719|NCT00591526|Antimetabolites|antimetabolites|mesh-ancestor
20281720|NCT00591526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281721|NCT00591526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281722|NCT00591526|Antiviral Agents|antiviral agents|mesh-ancestor
20281723|NCT00591526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20281724|NCT00591526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20281725|NCT00591526|Immunologic Factors|immunologic factors|mesh-ancestor
20281726|NCT00591526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281727|NCT00591604|Vitamin D|vitamin d|mesh-list
20281728|NCT00591604|Vitamins|vitamins|mesh-ancestor
20281729|NCT00591604|Micronutrients|micronutrients|mesh-ancestor
20281730|NCT00591604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281731|NCT00591604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20281732|NCT00591617|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20281733|NCT00591617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20281734|NCT00591617|Narcotics|narcotics|mesh-ancestor
20281735|NCT00591617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20281736|NCT00591617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281737|NCT00591617|Analgesics|analgesics|mesh-ancestor
20281738|NCT00591617|Sensory System Agents|sensory system agents|mesh-ancestor
20281739|NCT00591617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20281740|NCT00591617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20281741|NCT00591643|Epinephrine|epinephrine|mesh-list
20281742|NCT00591643|Racepinephrine|racepinephrine|mesh-list
20281743|NCT00591643|Epinephryl borate|epinephryl borate|mesh-list
20281744|NCT00591643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20281745|NCT00591643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20281746|NCT00591643|Adrenergic Agents|adrenergic agents|mesh-ancestor
20281747|NCT00591643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20281748|NCT00591643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281749|NCT00591643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281750|NCT00591643|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20281751|NCT00591643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20281752|NCT00591643|Autonomic Agents|autonomic agents|mesh-ancestor
20281753|NCT00591643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20281754|NCT00591643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20281755|NCT00591643|Respiratory System Agents|respiratory system agents|mesh-ancestor
20281756|NCT00591643|Mydriatics|mydriatics|mesh-ancestor
20281757|NCT00591643|Sympathomimetics|sympathomimetics|mesh-ancestor
20281758|NCT00591643|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20281759|NCT00591708|Calcium, Dietary|calcium, dietary|mesh-list
20281760|NCT00591708|Citric Acid|citric acid|mesh-list
20281761|NCT00591708|Sodium Citrate|sodium citrate|mesh-list
20281762|NCT00591708|Calcium|calcium|mesh-list
20281763|NCT00591708|Calcium citrate malate|calcium citrate malate|mesh-list
20281764|NCT00591708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20281765|NCT00591708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281766|NCT00591708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20281767|NCT00591708|Anticoagulants|anticoagulants|mesh-ancestor
20281768|NCT00591708|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20281769|NCT00591708|Chelating Agents|chelating agents|mesh-ancestor
20281770|NCT00591708|Sequestering Agents|sequestering agents|mesh-ancestor
20281771|NCT00591708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281772|NCT00591916|Thrombin|thrombin|mesh-list
20281773|NCT00591916|Hyaluronic Acid|hyaluronic acid|mesh-list
20281774|NCT00591916|Hemostatics|hemostatics|mesh-ancestor
20281775|NCT00591916|Coagulants|coagulants|mesh-ancestor
20281776|NCT00591916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20281777|NCT00591916|Immunologic Factors|immunologic factors|mesh-ancestor
20281778|NCT00591916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281779|NCT00591916|Viscosupplements|viscosupplements|mesh-ancestor
20281780|NCT00591916|Protective Agents|protective agents|mesh-ancestor
20281781|NCT00591994|Piribedil|piribedil|mesh-list
20281782|NCT00591994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20281783|NCT00591994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20281784|NCT00591994|Dopamine Agonists|dopamine agonists|mesh-ancestor
20281785|NCT00591994|Dopamine Agents|dopamine agents|mesh-ancestor
20281786|NCT00591994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20281787|NCT00591994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281788|NCT00591994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281789|NCT00592111|Prednisone|prednisone|mesh-list
20281790|NCT00592111|Cyclophosphamide|cyclophosphamide|mesh-list
19962698|NCT01719367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20281791|NCT00592111|Etoposide|etoposide|mesh-list
20281792|NCT00592111|Vincristine|vincristine|mesh-list
19962699|NCT01719367|Adrenergic Agents|adrenergic agents|mesh-ancestor
20281793|NCT00592111|Doxorubicin|doxorubicin|mesh-list
20281794|NCT00592111|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20281795|NCT00592111|Bleomycin|bleomycin|mesh-list
20281796|NCT00592111|Vinblastine|vinblastine|mesh-list
20281797|NCT00592111|Procarbazine|procarbazine|mesh-list
20281798|NCT00592111|Mitogens|mitogens|mesh-list
20281799|NCT00592111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20281800|NCT00592111|Immunologic Factors|immunologic factors|mesh-ancestor
20281801|NCT00592111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281802|NCT00592111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20281803|NCT00592111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20281804|NCT00592111|Alkylating Agents|alkylating agents|mesh-ancestor
20281805|NCT00592111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281806|NCT00592111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281807|NCT00592111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20281808|NCT00592111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20281809|NCT00592111|Glucocorticoids|glucocorticoids|mesh-ancestor
20281810|NCT00592111|Hormones|hormones|mesh-ancestor
20281811|NCT00592111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20281812|NCT00592111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20281813|NCT00592111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20281814|NCT00592111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20281815|NCT00592111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20281816|NCT00592111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281817|NCT00592111|Tubulin Modulators|tubulin modulators|mesh-ancestor
20281818|NCT00592111|Antimitotic Agents|antimitotic agents|mesh-ancestor
20281819|NCT00592111|Mitosis Modulators|mitosis modulators|mesh-ancestor
20547740|NCT01896284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20281820|NCT00592111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20281821|NCT00592137|Calcium, Dietary|calcium, dietary|mesh-list
20281822|NCT00592137|Calcium|calcium|mesh-list
20281823|NCT00592137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20281824|NCT00592137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281825|NCT00592137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20281826|NCT00592150|Fenoldopam|fenoldopam|mesh-list
20281827|NCT00592150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20281828|NCT00592150|Vasodilator Agents|vasodilator agents|mesh-ancestor
20281829|NCT00592150|Dopamine Agonists|dopamine agonists|mesh-ancestor
20281830|NCT00592150|Dopamine Agents|dopamine agents|mesh-ancestor
20281831|NCT00592150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20281832|NCT00592150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281833|NCT00592150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281834|NCT00592215|Misoprostol|misoprostol|mesh-list
20281835|NCT00592215|Mifepristone|mifepristone|mesh-list
20281836|NCT00592215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20281837|NCT00592215|Abortifacient Agents|abortifacient agents|mesh-ancestor
20281838|NCT00592215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20281839|NCT00592215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281840|NCT00592215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20281841|NCT00592215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20281842|NCT00592215|Oxytocics|oxytocics|mesh-ancestor
20281843|NCT00592215|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20281844|NCT00592215|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20281845|NCT00592215|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20281846|NCT00592215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20281847|NCT00592215|Contraceptive Agents|contraceptive agents|mesh-ancestor
20281848|NCT00592215|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20281849|NCT00592215|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20281850|NCT00592215|Hormone Antagonists|hormone antagonists|mesh-ancestor
20281851|NCT00592215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20281852|NCT00592215|Luteolytic Agents|luteolytic agents|mesh-ancestor
20281853|NCT00592215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20281854|NCT00592215|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20281855|NCT00592241|Insulin|insulin|mesh-list
20281856|NCT00592241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20281857|NCT00592241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20281858|NCT00592241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281859|NCT00592280|Pancrelipase|pancrelipase|mesh-list
20281860|NCT00592280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20281861|NCT00592306|Thymoglobulin|thymoglobulin|mesh-list
20281862|NCT00592306|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20281863|NCT00592306|Immunologic Factors|immunologic factors|mesh-ancestor
20281864|NCT00592306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281865|NCT00592306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20281866|NCT00592332|Alprazolam|alprazolam|mesh-list
20281867|NCT00592332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20281868|NCT00592332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20281869|NCT00592332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281870|NCT00592332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20281871|NCT00592332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20281872|NCT00592332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20281873|NCT00592332|GABA Modulators|gaba modulators|mesh-ancestor
20281874|NCT00592332|GABA Agents|gaba agents|mesh-ancestor
20281875|NCT00592332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20281876|NCT00592332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281877|NCT00592410|Insulin|insulin|mesh-list
20281878|NCT00592410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20281879|NCT00592410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20281880|NCT00592410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281881|NCT00592527|Insulin Detemir|insulin detemir|mesh-list
20281882|NCT00592527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20281883|NCT00592527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281884|NCT00592566|Dexamethasone|dexamethasone|mesh-list
20281885|NCT00592566|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20281886|NCT00592566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20281887|NCT00592566|Antiemetics|antiemetics|mesh-ancestor
20281888|NCT00592566|Autonomic Agents|autonomic agents|mesh-ancestor
20281889|NCT00592566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20281890|NCT00592566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281891|NCT00592566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20281892|NCT00592566|Glucocorticoids|glucocorticoids|mesh-ancestor
20281893|NCT00592566|Hormones|hormones|mesh-ancestor
20281894|NCT00592566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20281895|NCT00592566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20281896|NCT00592566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281897|NCT00592566|Hemostatics|hemostatics|mesh-ancestor
20281898|NCT00592566|Coagulants|coagulants|mesh-ancestor
20281899|NCT00592566|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20281900|NCT00592566|Natriuretic Agents|natriuretic agents|mesh-ancestor
20281901|NCT00592579|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
20281902|NCT00592579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281903|NCT00592579|Tubulin Modulators|tubulin modulators|mesh-ancestor
20281904|NCT00592579|Antimitotic Agents|antimitotic agents|mesh-ancestor
20281905|NCT00592579|Mitosis Modulators|mitosis modulators|mesh-ancestor
20281906|NCT00592579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281907|NCT00592618|Acetylcysteine|acetylcysteine|mesh-list
20281908|NCT00592618|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20547741|NCT01896284|Growth Substances|growth substances|mesh-ancestor
20547742|NCT01896284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547743|NCT01896284|Growth Inhibitors|growth inhibitors|mesh-ancestor
20547744|NCT01896284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20547745|NCT01896323|Ketoconazole|ketoconazole|mesh-list
20547746|NCT01896323|Antifungal Agents|antifungal agents|mesh-ancestor
20547747|NCT01896323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20547748|NCT01896323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20547749|NCT01896323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20547750|NCT01896323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547751|NCT01896323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547752|NCT01896323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20547753|NCT01896323|Hormone Antagonists|hormone antagonists|mesh-ancestor
20547754|NCT01896323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20547755|NCT01896323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547756|NCT01896323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19962700|NCT01719367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19962701|NCT01719367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962702|NCT01719380|Cetuximab|cetuximab|mesh-list
19962703|NCT01719380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20547757|NCT01896336|Zolpidem|zolpidem|mesh-list
20547758|NCT01896336|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20547759|NCT01896336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20547760|NCT01896336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20547761|NCT01896336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547762|NCT01896336|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20547763|NCT01896336|GABA Agonists|gaba agonists|mesh-ancestor
20547764|NCT01896336|GABA Agents|gaba agents|mesh-ancestor
20547765|NCT01896336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20547766|NCT01896336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547767|NCT01896349|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20547768|NCT01896349|Amitriptyline|amitriptyline|mesh-list
20547769|NCT01896349|Risperidone|risperidone|mesh-list
20547770|NCT01896349|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20547771|NCT01896349|Sulpiride|sulpiride|mesh-list
20547772|NCT01896349|Mirtazapine|mirtazapine|mesh-list
20547773|NCT01896349|Trazodone|trazodone|mesh-list
20547774|NCT01896349|Fluvoxamine|fluvoxamine|mesh-list
20547775|NCT01896349|Tranylcypromine|tranylcypromine|mesh-list
20547776|NCT01896349|Citalopram|citalopram|mesh-list
20547777|NCT01896349|Bupropion|bupropion|mesh-list
20547778|NCT01896349|Sertraline|sertraline|mesh-list
20547779|NCT01896349|Fluoxetine|fluoxetine|mesh-list
20547780|NCT01896349|Paroxetine|paroxetine|mesh-list
20547781|NCT01896349|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20547782|NCT01896349|Nortriptyline|nortriptyline|mesh-list
20547783|NCT01896349|Imipramine|imipramine|mesh-list
19962704|NCT01719380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962705|NCT01719653|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19962706|NCT01719653|Laxatives|laxatives|mesh-ancestor
19962707|NCT01719653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19962708|NCT01719757|Oxycodone|oxycodone|mesh-list
19962709|NCT01719757|Naloxone|naloxone|mesh-list
19962710|NCT01719757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19962711|NCT01719757|Narcotics|narcotics|mesh-ancestor
19962712|NCT01719757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19962713|NCT01719757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962714|NCT01719757|Analgesics|analgesics|mesh-ancestor
19962715|NCT01719757|Sensory System Agents|sensory system agents|mesh-ancestor
19962716|NCT01719757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19962717|NCT01719757|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19962718|NCT01719783|Vaccines|vaccines|mesh-list
19962719|NCT01719783|Immunologic Factors|immunologic factors|mesh-ancestor
19962720|NCT01719783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962721|NCT01719861|Desipramine|desipramine|mesh-list
19962722|NCT01719861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19962723|NCT01719861|Antidepressive Agents|antidepressive agents|mesh-ancestor
20281909|NCT00592618|Antiviral Agents|antiviral agents|mesh-ancestor
20281910|NCT00592618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20281911|NCT00592618|Expectorants|expectorants|mesh-ancestor
20281912|NCT00592618|Respiratory System Agents|respiratory system agents|mesh-ancestor
20281913|NCT00592618|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20281914|NCT00592618|Antioxidants|antioxidants|mesh-ancestor
20281915|NCT00592618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281916|NCT00592618|Protective Agents|protective agents|mesh-ancestor
20281917|NCT00592618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281918|NCT00592618|Antidotes|antidotes|mesh-ancestor
20281919|NCT00592670|Fluoxetine|fluoxetine|mesh-list
20281920|NCT00592670|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20281921|NCT00592670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20281922|NCT00592670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20281923|NCT00592670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281924|NCT00592670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20281925|NCT00592670|Serotonin Agents|serotonin agents|mesh-ancestor
20281926|NCT00592670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281927|NCT00592670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20281928|NCT00592670|Antidepressive Agents|antidepressive agents|mesh-ancestor
20281929|NCT00592670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20281930|NCT00592670|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20281931|NCT00592670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20281932|NCT00592670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281933|NCT00592917|Cholecalciferol|cholecalciferol|mesh-list
20281934|NCT00592917|Calcium Carbonate|calcium carbonate|mesh-list
20281935|NCT00592917|Calcium|calcium|mesh-list
20281936|NCT00592917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20281937|NCT00592917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281938|NCT00592917|Vitamins|vitamins|mesh-ancestor
20281939|NCT00592917|Micronutrients|micronutrients|mesh-ancestor
20281940|NCT00592917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20281941|NCT00592917|Antacids|antacids|mesh-ancestor
20281942|NCT00592917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281943|NCT00592917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20281944|NCT00592930|Olanzapine|olanzapine|mesh-list
20281945|NCT00592930|Antiemetics|antiemetics|mesh-ancestor
20281946|NCT00592930|Autonomic Agents|autonomic agents|mesh-ancestor
20281947|NCT00592930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20281948|NCT00592930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281949|NCT00592930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20281950|NCT00592930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20281951|NCT00592930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20281952|NCT00592930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20281953|NCT00592930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20281954|NCT00592930|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20281955|NCT00592930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20281956|NCT00592930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20281957|NCT00592930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281958|NCT00592930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20281959|NCT00592930|Serotonin Agents|serotonin agents|mesh-ancestor
20281960|NCT00592969|Metformin|metformin|mesh-list
20281961|NCT00592969|Insulin Aspart|insulin aspart|mesh-list
20281962|NCT00592969|Biphasic Insulins|biphasic insulins|mesh-list
20281963|NCT00592969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20281964|NCT00592969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281965|NCT00593008|Gemcitabine|gemcitabine|mesh-list
20281966|NCT00593008|Sirolimus|sirolimus|mesh-list
20281967|NCT00593008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20281968|NCT00593008|Antimetabolites|antimetabolites|mesh-ancestor
20281969|NCT00593008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281970|NCT00593008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281971|NCT00593008|Antiviral Agents|antiviral agents|mesh-ancestor
20281972|NCT00593008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20281973|NCT00593008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20281974|NCT00593008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20281975|NCT00593008|Immunologic Factors|immunologic factors|mesh-ancestor
20281976|NCT00593008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281977|NCT00593008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20281978|NCT00593008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20281979|NCT00593008|Antifungal Agents|antifungal agents|mesh-ancestor
20281980|NCT00593060|Sirolimus|sirolimus|mesh-list
20281981|NCT00593060|Cetuximab|cetuximab|mesh-list
20281982|NCT00593060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20547784|NCT01896349|Clomipramine|clomipramine|mesh-list
20281983|NCT00593060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20281984|NCT00593060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20281985|NCT00593060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20281986|NCT00593060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20281987|NCT00593060|Antifungal Agents|antifungal agents|mesh-ancestor
20281988|NCT00593060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20281989|NCT00593060|Immunologic Factors|immunologic factors|mesh-ancestor
20281990|NCT00593060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20281991|NCT00593099|Bupropion|bupropion|mesh-list
20281992|NCT00593099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20281993|NCT00593099|Antidepressive Agents|antidepressive agents|mesh-ancestor
20281994|NCT00593099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20281995|NCT00593099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20281996|NCT00593099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20281997|NCT00593099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20281998|NCT00593099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20281999|NCT00593099|Dopamine Agents|dopamine agents|mesh-ancestor
20282000|NCT00593099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20282001|NCT00593099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282002|NCT00593099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20282003|NCT00593099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20282004|NCT00593099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288256|NCT05336812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20288257|NCT05336721|Capecitabine|capecitabine|mesh-list
20288258|NCT05336721|Chiauranib|chiauranib|mesh-list
20288259|NCT05336721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20288260|NCT05336721|Antimetabolites|antimetabolites|mesh-ancestor
20288261|NCT05336721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288262|NCT05336721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288263|NCT05336721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20288264|NCT05336721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288265|NCT05336513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20288266|NCT05336266|Ketorolac|ketorolac|mesh-list
20288267|NCT05336266|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20288268|NCT05336266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20288269|NCT05336266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20547785|NCT01896349|Antidepressive Agents|antidepressive agents|mesh-list
20547786|NCT01896349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20547787|NCT01896349|Serotonin Agents|serotonin agents|mesh-ancestor
20547788|NCT01896349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20547789|NCT01896349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547790|NCT01896349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547791|NCT01896349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20547792|NCT01896349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20547793|NCT01896349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20547794|NCT01896349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20547795|NCT01896349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20547796|NCT01896349|Dopamine Agents|dopamine agents|mesh-ancestor
20547797|NCT01896349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20547798|NCT01896349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20547799|NCT01896349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20547800|NCT01896349|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20547801|NCT01896349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20547802|NCT01896349|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20547803|NCT01896349|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20547804|NCT01896349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20547805|NCT01896349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547806|NCT01896349|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20547807|NCT01896349|Analgesics|analgesics|mesh-ancestor
20547808|NCT01896349|Sensory System Agents|sensory system agents|mesh-ancestor
20547809|NCT01896349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20547810|NCT01896349|Histamine Antagonists|histamine antagonists|mesh-ancestor
20547811|NCT01896349|Histamine Agents|histamine agents|mesh-ancestor
20547812|NCT01896349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20547813|NCT01896349|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20547814|NCT01896349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20282005|NCT00593125|Levetiracetam|levetiracetam|mesh-list
20282006|NCT00593125|Anticonvulsants|anticonvulsants|mesh-ancestor
20282007|NCT00593125|Nootropic Agents|nootropic agents|mesh-ancestor
20282008|NCT00593138|Methylphenidate|methylphenidate|mesh-list
20282009|NCT00593138|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
20282010|NCT00593138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20282011|NCT00593138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282012|NCT00593138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20282013|NCT00593138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20282014|NCT00593138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20282015|NCT00593138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282016|NCT00593138|Dopamine Agents|dopamine agents|mesh-ancestor
20282017|NCT00593138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20282018|NCT00593151|Interferons|interferons|mesh-list
20282019|NCT00593151|Interferon-alpha|interferon-alpha|mesh-list
20282020|NCT00593151|Interferon alpha-2|interferon alpha-2|mesh-list
20282021|NCT00593151|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20282022|NCT00593151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282023|NCT00593151|Antiviral Agents|antiviral agents|mesh-ancestor
20282024|NCT00593151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20282025|NCT00593151|Immunologic Factors|immunologic factors|mesh-ancestor
20282026|NCT00593151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282027|NCT00593164|Magnesium Sulfate|magnesium sulfate|mesh-list
20282028|NCT00593164|Analgesics|analgesics|mesh-ancestor
20282029|NCT00593164|Sensory System Agents|sensory system agents|mesh-ancestor
20282030|NCT00593164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20282031|NCT00593164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282032|NCT00593164|Anesthetics|anesthetics|mesh-ancestor
20282033|NCT00593164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20282034|NCT00593164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20282035|NCT00593164|Anticonvulsants|anticonvulsants|mesh-ancestor
20282036|NCT00593164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20282037|NCT00593164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20282038|NCT00593164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282039|NCT00593164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20282040|NCT00593164|Tocolytic Agents|tocolytic agents|mesh-ancestor
20282041|NCT00593164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20282042|NCT00593177|Parathyroid Hormone|parathyroid hormone|mesh-list
20282043|NCT00593177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20282044|NCT00593177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282045|NCT00593255|Insulin|insulin|mesh-list
20282046|NCT00593255|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20282047|NCT00593255|Insulin Aspart|insulin aspart|mesh-list
20282048|NCT00593255|Isophane Insulin, Human|isophane insulin, human|mesh-list
20282049|NCT00593255|Insulin, Isophane|insulin, isophane|mesh-list
20282050|NCT00593255|Isophane insulin, beef|isophane insulin, beef|mesh-list
20282051|NCT00593255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20282052|NCT00593255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282053|NCT00593294|Drospirenone|drospirenone|mesh-list
20282054|NCT00593294|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20282055|NCT00593294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282056|NCT00593294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20282057|NCT00593294|Hormone Antagonists|hormone antagonists|mesh-ancestor
20282058|NCT00593294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20282059|NCT00593294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20282060|NCT00593294|Diuretics|diuretics|mesh-ancestor
20282061|NCT00593294|Natriuretic Agents|natriuretic agents|mesh-ancestor
20282062|NCT00593294|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20282063|NCT00593294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20282064|NCT00593294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20282065|NCT00593294|Contraceptive Agents|contraceptive agents|mesh-ancestor
20282066|NCT00593294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20282067|NCT00593294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20282068|NCT00593294|Estrogens|estrogens|mesh-ancestor
20282069|NCT00593294|Hormones|hormones|mesh-ancestor
20282070|NCT00593463|Cycloserine|cycloserine|mesh-list
20282071|NCT00593463|Verapamil|verapamil|mesh-list
20282072|NCT00593463|Diltiazem|diltiazem|mesh-list
20282073|NCT00593463|Isradipine|isradipine|mesh-list
20282074|NCT00593463|Nifedipine|nifedipine|mesh-list
20282075|NCT00593463|Gabapentin|gabapentin|mesh-list
20282076|NCT00593463|Naloxone|naloxone|mesh-list
20282077|NCT00593463|Analgesics|analgesics|mesh-ancestor
20547815|NCT01896349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20547816|NCT01896349|Adrenergic Agents|adrenergic agents|mesh-ancestor
20282078|NCT00593463|Sensory System Agents|sensory system agents|mesh-ancestor
20282079|NCT00593463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20282080|NCT00593463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282081|NCT00593463|Anticonvulsants|anticonvulsants|mesh-ancestor
20282082|NCT00593463|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20282083|NCT00593463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20282084|NCT00593463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20282085|NCT00593463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20282086|NCT00593463|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20282087|NCT00593463|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20282088|NCT00593463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20282089|NCT00593463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282090|NCT00593463|Antimanic Agents|antimanic agents|mesh-ancestor
20282091|NCT00593463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20282092|NCT00593463|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20282093|NCT00593463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20282094|NCT00593463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20282095|NCT00593463|Vasodilator Agents|vasodilator agents|mesh-ancestor
20282096|NCT00593463|Tocolytic Agents|tocolytic agents|mesh-ancestor
20282097|NCT00593463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20282098|NCT00593463|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20282099|NCT00593463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20282100|NCT00593463|Renal Agents|renal agents|mesh-ancestor
20282101|NCT00593463|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20282102|NCT00593463|Antitubercular Agents|antitubercular agents|mesh-ancestor
20282103|NCT00593463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20282104|NCT00593463|Antimetabolites|antimetabolites|mesh-ancestor
20282105|NCT00593463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20282106|NCT00593463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20282107|NCT00593502|Oseltamivir|oseltamivir|mesh-list
20282108|NCT00593502|Antiviral Agents|antiviral agents|mesh-ancestor
20282109|NCT00593502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20282110|NCT00593502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282111|NCT00593502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282127|NCT00593580|Cholecalciferol|cholecalciferol|mesh-list
20282128|NCT00593580|Alendronate|alendronate|mesh-list
20282129|NCT00593580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20282130|NCT00593580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282131|NCT00593580|Vitamins|vitamins|mesh-ancestor
20282132|NCT00593580|Micronutrients|micronutrients|mesh-ancestor
20282133|NCT00593580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20282134|NCT00593619|Iron|iron|mesh-list
20282135|NCT00593619|Dextrans|dextrans|mesh-list
20282136|NCT00593619|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20282137|NCT00593619|Iron-Dextran Complex|iron-dextran complex|mesh-list
20282138|NCT00593619|Trace Elements|trace elements|mesh-ancestor
20282139|NCT00593619|Micronutrients|micronutrients|mesh-ancestor
20282140|NCT00593619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282141|NCT00593619|Hematinics|hematinics|mesh-ancestor
20282142|NCT00593619|Anticoagulants|anticoagulants|mesh-ancestor
20282143|NCT00593619|Plasma Substitutes|plasma substitutes|mesh-ancestor
20282144|NCT00593619|Blood Substitutes|blood substitutes|mesh-ancestor
20282145|NCT00593658|Pentoxifylline|pentoxifylline|mesh-list
20282146|NCT00593658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20282147|NCT00593658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282148|NCT00593658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282149|NCT00593658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20282150|NCT00593658|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20282151|NCT00593658|Protective Agents|protective agents|mesh-ancestor
20282152|NCT00593658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282153|NCT00593658|Vasodilator Agents|vasodilator agents|mesh-ancestor
20282154|NCT00593658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20282155|NCT00593658|Antioxidants|antioxidants|mesh-ancestor
20282156|NCT00593697|Docetaxel|docetaxel|mesh-list
20282157|NCT00593697|Trastuzumab|trastuzumab|mesh-list
20282158|NCT00593697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282159|NCT00593697|Tubulin Modulators|tubulin modulators|mesh-ancestor
20282160|NCT00593697|Antimitotic Agents|antimitotic agents|mesh-ancestor
20282161|NCT00593697|Mitosis Modulators|mitosis modulators|mesh-ancestor
20282162|NCT00593697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282163|NCT00593697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20282164|NCT00593710|Losartan|losartan|mesh-list
20282165|NCT00593710|Atenolol|atenolol|mesh-list
20282166|NCT00593710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20282167|NCT00593710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20282168|NCT00593710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20282169|NCT00593710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20282170|NCT00593710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282171|NCT00593710|Sympatholytics|sympatholytics|mesh-ancestor
20282172|NCT00593710|Autonomic Agents|autonomic agents|mesh-ancestor
20282173|NCT00593710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20282174|NCT00593710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282175|NCT00593710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20282176|NCT00593710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20282177|NCT00593710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20282178|NCT00593710|Adrenergic Agents|adrenergic agents|mesh-ancestor
20282179|NCT00593710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20282180|NCT00593801|Epoetin Alfa|epoetin alfa|mesh-list
20282181|NCT00593801|Hematinics|hematinics|mesh-ancestor
20282182|NCT00593853|Methylphenidate|methylphenidate|mesh-list
20282183|NCT00593853|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20282184|NCT00593853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282185|NCT00593853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20282186|NCT00593853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20547817|NCT01896349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19962724|NCT01719861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20547818|NCT01896349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20547819|NCT01896349|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20547820|NCT01896349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20547821|NCT01896349|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20547822|NCT01896349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20547823|NCT01896349|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20547824|NCT01896349|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20547825|NCT01896388|Ifenprodil|ifenprodil|mesh-list
20547826|NCT01896388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20547827|NCT01896388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20547828|NCT01896388|Adrenergic Agents|adrenergic agents|mesh-ancestor
20547829|NCT01896388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20547830|NCT01896388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547831|NCT01896388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547832|NCT01896388|Vasodilator Agents|vasodilator agents|mesh-ancestor
20547833|NCT01896388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20547834|NCT01896388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20547835|NCT01896440|Ondansetron|ondansetron|mesh-list
20547836|NCT01896440|Antiemetics|antiemetics|mesh-ancestor
20547837|NCT01896440|Autonomic Agents|autonomic agents|mesh-ancestor
20547838|NCT01896440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20547839|NCT01896440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547840|NCT01896440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20547841|NCT01896440|Antipruritics|antipruritics|mesh-ancestor
20547842|NCT01896440|Dermatologic Agents|dermatologic agents|mesh-ancestor
20547843|NCT01896440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20547844|NCT01896440|Serotonin Agents|serotonin agents|mesh-ancestor
20547845|NCT01896440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20547846|NCT01896440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547847|NCT01896440|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20547848|NCT01896440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20547849|NCT01896440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20547850|NCT01896440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20547851|NCT01896440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20554433|NCT01935505|Bupropion|bupropion|mesh-list
20554434|NCT01935505|Nicotine|nicotine|mesh-list
20554435|NCT01935505|Varenicline|varenicline|mesh-list
20554436|NCT01935505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20282187|NCT00593853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20282188|NCT00593853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282189|NCT00593853|Dopamine Agents|dopamine agents|mesh-ancestor
20282190|NCT00593853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20282191|NCT00593879|Mecamylamine|mecamylamine|mesh-list
20282192|NCT00593879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20282193|NCT00593879|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
20282194|NCT00593879|Autonomic Agents|autonomic agents|mesh-ancestor
20282195|NCT00593879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20282196|NCT00593879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282197|NCT00593879|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20282198|NCT00593879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20282199|NCT00593879|Cholinergic Agents|cholinergic agents|mesh-ancestor
20282200|NCT00593879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20282201|NCT00593879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282202|NCT00593996|Vitamin D|vitamin d|mesh-list
20282203|NCT00593996|Ergocalciferols|ergocalciferols|mesh-list
20282204|NCT00593996|Vitamins|vitamins|mesh-ancestor
20282205|NCT00593996|Micronutrients|micronutrients|mesh-ancestor
20282206|NCT00593996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282207|NCT00593996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20282208|NCT00593996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20282209|NCT00594087|Eszopiclone|eszopiclone|mesh-list
20282210|NCT00594087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20282211|NCT00594087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20282212|NCT00594087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282213|NCT00594126|Imetelstat|imetelstat|mesh-list
20282214|NCT00594126|Motesanib diphosphate|motesanib diphosphate|mesh-list
20282215|NCT00594126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282216|NCT00594126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282217|NCT00594126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20282218|NCT00594191|Simvastatin|simvastatin|mesh-list
20282219|NCT00594191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20282220|NCT00594191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20282221|NCT00594191|Antimetabolites|antimetabolites|mesh-ancestor
20282222|NCT00594191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282223|NCT00594191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20282224|NCT00594191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20282225|NCT00594191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282226|NCT00594217|Progesterone|progesterone|mesh-list
20282227|NCT00594217|Progestins|progestins|mesh-ancestor
20282228|NCT00594217|Hormones|hormones|mesh-ancestor
20282229|NCT00594217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20282230|NCT00594217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282231|NCT00594269|Risperidone|risperidone|mesh-list
20282232|NCT00594269|Citalopram|citalopram|mesh-list
20282233|NCT00594269|Sertraline|sertraline|mesh-list
20282234|NCT00594269|Paroxetine|paroxetine|mesh-list
20282235|NCT00594269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20282236|NCT00594269|Serotonin Agents|serotonin agents|mesh-ancestor
20282237|NCT00594269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20282238|NCT00594269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282239|NCT00594269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282240|NCT00594269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20282241|NCT00594269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20282242|NCT00594269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20282243|NCT00594269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20282244|NCT00594269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20282245|NCT00594269|Dopamine Agents|dopamine agents|mesh-ancestor
20282246|NCT00594269|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20282247|NCT00594269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20282248|NCT00594269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20282249|NCT00594269|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20282250|NCT00594269|Antidepressive Agents|antidepressive agents|mesh-ancestor
20282251|NCT00594269|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20282252|NCT00594269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20282253|NCT00594269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282254|NCT00594334|Risedronic Acid|risedronic acid|mesh-list
20282255|NCT00594334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20282256|NCT00594334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20282257|NCT00594334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282258|NCT00594334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19450388|NCT03428633|Morphine|morphine|mesh-list
20282259|NCT00594334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282260|NCT00594334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20282261|NCT00594347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20282262|NCT00594347|Immunologic Factors|immunologic factors|mesh-ancestor
20282263|NCT00594347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282264|NCT00594373|Tenofovir|tenofovir|mesh-list
20282265|NCT00594373|Antiviral Agents|antiviral agents|mesh-ancestor
20282266|NCT00594373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20282267|NCT00594373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20282268|NCT00594373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20282269|NCT00594373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282270|NCT00594373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282271|NCT00594373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20282272|NCT00594373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20282273|NCT00594542|Lidocaine|lidocaine|mesh-list
20282274|NCT00594542|Anesthetics, Local|anesthetics, local|mesh-ancestor
20282275|NCT00594542|Anesthetics|anesthetics|mesh-ancestor
20282276|NCT00594542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20282277|NCT00594542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282278|NCT00594542|Sensory System Agents|sensory system agents|mesh-ancestor
20282279|NCT00594542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20282280|NCT00594542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20282281|NCT00594542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20282282|NCT00594542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20282283|NCT00594542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20282284|NCT00594542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282285|NCT00594555|Cytarabine|cytarabine|mesh-list
20282286|NCT00594555|Imatinib Mesylate|imatinib mesylate|mesh-list
20282287|NCT00594555|Cladribine|cladribine|mesh-list
20282288|NCT00594555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20282289|NCT00594555|Antimetabolites|antimetabolites|mesh-ancestor
20282290|NCT00594555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282291|NCT00594555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282292|NCT00594555|Antiviral Agents|antiviral agents|mesh-ancestor
20282293|NCT00594555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20282294|NCT00594555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20282295|NCT00594555|Immunologic Factors|immunologic factors|mesh-ancestor
20282296|NCT00594555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282297|NCT00594555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20282298|NCT00594555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282299|NCT00594633|Donepezil|donepezil|mesh-list
20282300|NCT00594633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20282301|NCT00594633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282302|NCT00594633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282303|NCT00594633|Cholinergic Agents|cholinergic agents|mesh-ancestor
20282304|NCT00594633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20282305|NCT00594633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282306|NCT00594633|Nootropic Agents|nootropic agents|mesh-ancestor
20282307|NCT00594737|Memantine|memantine|mesh-list
20282308|NCT00594737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20282309|NCT00594737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20282310|NCT00594737|Dopamine Agents|dopamine agents|mesh-ancestor
20282311|NCT00594737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20282312|NCT00594737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282313|NCT00594737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282314|NCT00594737|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20282315|NCT00594737|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20282316|NCT00594867|Aspirin|aspirin|mesh-list
20282317|NCT00594867|Acetaminophen|acetaminophen|mesh-list
20282318|NCT00594867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20282319|NCT00594867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20282320|NCT00594867|Analgesics|analgesics|mesh-ancestor
20282321|NCT00594867|Sensory System Agents|sensory system agents|mesh-ancestor
20282322|NCT00594867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20282323|NCT00594867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282324|NCT00594867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20282325|NCT00594867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20282326|NCT00594867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20282327|NCT00594867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20282328|NCT00594867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282329|NCT00594867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20282330|NCT00594867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20282331|NCT00594867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282332|NCT00594867|Antipyretics|antipyretics|mesh-ancestor
20282333|NCT00595049|Bosentan|bosentan|mesh-list
20282334|NCT00595049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20282335|NCT00595049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20282336|NCT00595049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282337|NCT00595140|Octreotide|octreotide|mesh-list
20282338|NCT00595140|Dopamine|dopamine|mesh-list
20282339|NCT00595140|Cabergoline|cabergoline|mesh-list
20282340|NCT00595140|Somatostatin|somatostatin|mesh-list
20282341|NCT00595140|Dopamine Agonists|dopamine agonists|mesh-list
20282342|NCT00595140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20282343|NCT00595140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20282344|NCT00595140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282345|NCT00595140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20282346|NCT00595140|Sympathomimetics|sympathomimetics|mesh-ancestor
20282347|NCT00595140|Autonomic Agents|autonomic agents|mesh-ancestor
20282348|NCT00595140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20282349|NCT00595140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282350|NCT00595140|Dopamine Agents|dopamine agents|mesh-ancestor
20282351|NCT00595140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20282352|NCT00595140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282353|NCT00595140|Protective Agents|protective agents|mesh-ancestor
20282354|NCT00595140|Hormones|hormones|mesh-ancestor
20282355|NCT00595140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20282356|NCT00595140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20282357|NCT00595140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20288270|NCT05336266|Analgesics|analgesics|mesh-ancestor
20288271|NCT05336266|Sensory System Agents|sensory system agents|mesh-ancestor
20288272|NCT05336266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20288273|NCT05336266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288274|NCT05336266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20288275|NCT05336266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20288276|NCT05336266|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20547852|NCT01896518|Nicotine|nicotine|mesh-list
20547853|NCT01896518|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20547854|NCT01896518|Autonomic Agents|autonomic agents|mesh-ancestor
20547855|NCT01896518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20547856|NCT01896518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547857|NCT01896518|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20547858|NCT01896518|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20547859|NCT01896518|Cholinergic Agents|cholinergic agents|mesh-ancestor
20547860|NCT01896518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20547861|NCT01896518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547862|NCT01896609|Interferons|interferons|mesh-list
20547863|NCT01896609|Ribavirin|ribavirin|mesh-list
20547864|NCT01896609|Interferon-alpha|interferon-alpha|mesh-list
20547865|NCT01896609|Interferon alpha-2|interferon alpha-2|mesh-list
20547866|NCT01896609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20547867|NCT01896609|Nitazoxanide|nitazoxanide|mesh-list
20547868|NCT01896609|Complement Factor H|complement factor h|mesh-list
20547869|NCT01896609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20547870|NCT01896609|Antiviral Agents|antiviral agents|mesh-ancestor
20547871|NCT01896609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20547872|NCT01896609|Antimetabolites|antimetabolites|mesh-ancestor
20547873|NCT01896609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547874|NCT01896609|Immunologic Factors|immunologic factors|mesh-ancestor
20547875|NCT01896609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547876|NCT01896609|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20547877|NCT01896609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20547878|NCT01896609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20547879|NCT01896622|Ritonavir|ritonavir|mesh-list
20547880|NCT01896622|Cobicistat|cobicistat|mesh-list
20547881|NCT01896622|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20547882|NCT01896622|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20547883|NCT01896622|Protease Inhibitors|protease inhibitors|mesh-ancestor
20547884|NCT01896622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547885|NCT01896622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547886|NCT01896622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20547887|NCT01896622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20547888|NCT01896622|Antiviral Agents|antiviral agents|mesh-ancestor
20547889|NCT01896622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20547890|NCT01896622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20547891|NCT01896622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20547892|NCT01896661|Amlodipine|amlodipine|mesh-list
20288277|NCT05336266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547893|NCT01896661|Chlorthalidone|chlorthalidone|mesh-list
20547894|NCT01896661|Calcium Channel Blockers|calcium channel blockers|mesh-list
20282358|NCT00595322|Bevacizumab|bevacizumab|mesh-list
20282359|NCT00595322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20282360|NCT00595322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282361|NCT00595322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20282362|NCT00595322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20282363|NCT00595322|Growth Substances|growth substances|mesh-ancestor
20282364|NCT00595322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282365|NCT00595322|Growth Inhibitors|growth inhibitors|mesh-ancestor
20282366|NCT00595374|Insulin|insulin|mesh-list
20282367|NCT00595374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20282368|NCT00595374|Insulin Aspart|insulin aspart|mesh-list
20282369|NCT00595374|Insulin Detemir|insulin detemir|mesh-list
20282370|NCT00595374|Isophane Insulin, Human|isophane insulin, human|mesh-list
20282371|NCT00595374|Insulin, Isophane|insulin, isophane|mesh-list
20282372|NCT00595374|Isophane insulin, beef|isophane insulin, beef|mesh-list
20282373|NCT00595374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20282374|NCT00595374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282375|NCT00595543|Diclofenac|diclofenac|mesh-list
20282376|NCT00595543|Ketorolac|ketorolac|mesh-list
20282377|NCT00595543|Bromfenac|bromfenac|mesh-list
20282378|NCT00595543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20282379|NCT00595543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20282380|NCT00595543|Analgesics|analgesics|mesh-ancestor
20282381|NCT00595543|Sensory System Agents|sensory system agents|mesh-ancestor
20282382|NCT00595543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20282383|NCT00595543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282384|NCT00595543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20282385|NCT00595543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20282386|NCT00595543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20282387|NCT00595543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282388|NCT00595543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282389|NCT00595569|Insulin|insulin|mesh-list
20282390|NCT00595569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20282391|NCT00595569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282392|NCT00595933|Muramidase|muramidase|mesh-list
20282393|NCT00595933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20282394|NCT00595972|Endostar protein|endostar protein|mesh-list
20282395|NCT00595972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20282396|NCT00595972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20282397|NCT00595972|Growth Substances|growth substances|mesh-ancestor
20282398|NCT00595972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282399|NCT00595972|Growth Inhibitors|growth inhibitors|mesh-ancestor
20282400|NCT00595972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282401|NCT00595985|Sorafenib|sorafenib|mesh-list
20282402|NCT00595985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282403|NCT00595985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20282404|NCT00595985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282405|NCT00595985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282406|NCT00596037|Hormones|hormones|mesh-list
20282407|NCT00596037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20282408|NCT00596037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282409|NCT00596050|Lidocaine|lidocaine|mesh-list
20282410|NCT00596050|Fentanyl|fentanyl|mesh-list
20282411|NCT00596050|Midazolam|midazolam|mesh-list
20547895|NCT01896661|Amiloride|amiloride|mesh-list
20547896|NCT01896661|Calcium|calcium|mesh-list
20547897|NCT01896661|Diuretics|diuretics|mesh-list
20547898|NCT01896661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20547899|NCT01896661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547900|NCT01896661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20547901|NCT01896661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20547902|NCT01896661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547903|NCT01896661|Vasodilator Agents|vasodilator agents|mesh-ancestor
20547904|NCT01896661|Natriuretic Agents|natriuretic agents|mesh-ancestor
20547905|NCT01896661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20547906|NCT01896661|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20547907|NCT01896661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20547908|NCT01896661|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20547909|NCT01896661|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20547910|NCT01896739|Vaccines|vaccines|mesh-list
20547911|NCT01896739|Immunologic Factors|immunologic factors|mesh-ancestor
20547912|NCT01896739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547913|NCT01896960|Fentanyl|fentanyl|mesh-list
20547914|NCT01896960|Bupivacaine|bupivacaine|mesh-list
20282412|NCT00596050|Ketamine|ketamine|mesh-list
20282413|NCT00596050|Etomidate|etomidate|mesh-list
20282414|NCT00596050|Anesthetics, Local|anesthetics, local|mesh-ancestor
20282415|NCT00596050|Anesthetics|anesthetics|mesh-ancestor
20282416|NCT00596050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20282417|NCT00596050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282418|NCT00596050|Sensory System Agents|sensory system agents|mesh-ancestor
20282419|NCT00596050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20282420|NCT00596050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20282421|NCT00596050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20282422|NCT00596050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20282423|NCT00596050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20282424|NCT00596050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282425|NCT00596050|Analgesics|analgesics|mesh-ancestor
20282426|NCT00596050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20282427|NCT00596050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20282428|NCT00596050|Anesthetics, General|anesthetics, general|mesh-ancestor
20282429|NCT00596050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20282430|NCT00596050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20282431|NCT00596050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20282432|NCT00596050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20282433|NCT00596050|Narcotics|narcotics|mesh-ancestor
20282434|NCT00596050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20282435|NCT00596050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20282436|NCT00596050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20282437|NCT00596050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20282438|NCT00596050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20282439|NCT00596050|GABA Modulators|gaba modulators|mesh-ancestor
20282440|NCT00596050|GABA Agents|gaba agents|mesh-ancestor
20282441|NCT00596063|Insulin|insulin|mesh-list
20282442|NCT00596063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20282443|NCT00596063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282444|NCT00596115|Pramipexole|pramipexole|mesh-list
20282445|NCT00596115|Antioxidants|antioxidants|mesh-ancestor
20282446|NCT00596115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282447|NCT00596115|Protective Agents|protective agents|mesh-ancestor
20282448|NCT00596115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282449|NCT00596115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20282450|NCT00596115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20282451|NCT00596115|Dopamine Agonists|dopamine agonists|mesh-ancestor
20282452|NCT00596115|Dopamine Agents|dopamine agents|mesh-ancestor
20282453|NCT00596115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20282454|NCT00596128|Insulin|insulin|mesh-list
20282455|NCT00596128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20282456|NCT00596128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282457|NCT00596154|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20282458|NCT00596154|Cyclophosphamide|cyclophosphamide|mesh-list
20282459|NCT00596154|Busulfan|busulfan|mesh-list
20282460|NCT00596154|Thiotepa|thiotepa|mesh-list
20282461|NCT00596154|Rituximab|rituximab|mesh-list
20282462|NCT00596154|Methotrexate|methotrexate|mesh-list
20282463|NCT00596154|Vincristine|vincristine|mesh-list
20282464|NCT00596154|Procarbazine|procarbazine|mesh-list
20282465|NCT00596154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20282466|NCT00596154|Immunologic Factors|immunologic factors|mesh-ancestor
20282467|NCT00596154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282468|NCT00596154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20282469|NCT00596154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20282470|NCT00596154|Alkylating Agents|alkylating agents|mesh-ancestor
20282471|NCT00596154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282472|NCT00596154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282473|NCT00596154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20282474|NCT00596154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20282475|NCT00596154|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20282476|NCT00596154|Abortifacient Agents|abortifacient agents|mesh-ancestor
20282477|NCT00596154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20282478|NCT00596154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20282479|NCT00596154|Antimetabolites|antimetabolites|mesh-ancestor
20282480|NCT00596154|Dermatologic Agents|dermatologic agents|mesh-ancestor
20282481|NCT00596154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282482|NCT00596154|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20282483|NCT00596154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20282484|NCT00596154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20282485|NCT00596154|Tubulin Modulators|tubulin modulators|mesh-ancestor
20282486|NCT00596154|Antimitotic Agents|antimitotic agents|mesh-ancestor
20282487|NCT00596154|Mitosis Modulators|mitosis modulators|mesh-ancestor
20282488|NCT00596154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20282489|NCT00596206|Leflunomide|leflunomide|mesh-list
20282490|NCT00596206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282491|NCT00596206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282492|NCT00596206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20282493|NCT00596206|Immunologic Factors|immunologic factors|mesh-ancestor
20282494|NCT00596206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282495|NCT00596219|Celecoxib|celecoxib|mesh-list
20282496|NCT00596219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20282497|NCT00596219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20282498|NCT00596219|Analgesics|analgesics|mesh-ancestor
20282499|NCT00596219|Sensory System Agents|sensory system agents|mesh-ancestor
20282500|NCT00596219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20282501|NCT00596219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282502|NCT00596219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20282503|NCT00596219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20282504|NCT00596219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20282505|NCT00596219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20282506|NCT00596219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282507|NCT00596219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282508|NCT00596297|Bevacizumab|bevacizumab|mesh-list
20282509|NCT00596297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19962725|NCT01719861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962726|NCT01719861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962727|NCT01719861|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19962728|NCT01719861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20282510|NCT00596297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282511|NCT00596297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20282512|NCT00596297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20282513|NCT00596297|Growth Substances|growth substances|mesh-ancestor
20282514|NCT00596297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282515|NCT00596297|Growth Inhibitors|growth inhibitors|mesh-ancestor
20282516|NCT00596336|Imiquimod|imiquimod|mesh-list
20282517|NCT00596336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20282518|NCT00596336|Immunologic Factors|immunologic factors|mesh-ancestor
20282519|NCT00596336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282520|NCT00596336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282521|NCT00596336|Interferon Inducers|interferon inducers|mesh-ancestor
20282522|NCT00596375|Lidocaine|lidocaine|mesh-list
20282523|NCT00596375|Anesthetics, Local|anesthetics, local|mesh-ancestor
20282524|NCT00596375|Anesthetics|anesthetics|mesh-ancestor
20282525|NCT00596375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20282526|NCT00596375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282527|NCT00596375|Sensory System Agents|sensory system agents|mesh-ancestor
20282528|NCT00596375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20282529|NCT00596375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20282530|NCT00596375|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20282531|NCT00596375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20282532|NCT00596375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20282533|NCT00596375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282534|NCT00596414|Midazolam|midazolam|mesh-list
20282535|NCT00596414|Meperidine|meperidine|mesh-list
20282536|NCT00596414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20282537|NCT00596414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20282538|NCT00596414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20282539|NCT00596414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282540|NCT00596414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20282541|NCT00596414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20282542|NCT00596414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20282543|NCT00596414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19962729|NCT01719861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19962730|NCT01719861|Adrenergic Agents|adrenergic agents|mesh-ancestor
19962731|NCT01719861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19962732|NCT01719861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962733|NCT01720043|Bortezomib|bortezomib|mesh-list
19962734|NCT01720043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962735|NCT01720173|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
19962736|NCT01720173|Immunologic Factors|immunologic factors|mesh-ancestor
19962737|NCT01720173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962738|NCT01720225|Azacitidine|azacitidine|mesh-list
19962739|NCT01720225|Decitabine|decitabine|mesh-list
19962740|NCT01720225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19962741|NCT01720225|Antimetabolites|antimetabolites|mesh-ancestor
19962742|NCT01720225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962743|NCT01720225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962744|NCT01720225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282544|NCT00596414|Anesthetics, General|anesthetics, general|mesh-ancestor
20282545|NCT00596414|Anesthetics|anesthetics|mesh-ancestor
20282546|NCT00596414|GABA Modulators|gaba modulators|mesh-ancestor
20282547|NCT00596414|GABA Agents|gaba agents|mesh-ancestor
20282548|NCT00596414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20282549|NCT00596414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282550|NCT00596414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20282551|NCT00596414|Narcotics|narcotics|mesh-ancestor
20282552|NCT00596414|Analgesics|analgesics|mesh-ancestor
20282553|NCT00596414|Sensory System Agents|sensory system agents|mesh-ancestor
20282554|NCT00596414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20282555|NCT00596479|Lenograstim|lenograstim|mesh-list
20282556|NCT00596479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20282557|NCT00596479|Immunologic Factors|immunologic factors|mesh-ancestor
20282558|NCT00596479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282559|NCT00596531|Acamprosate|acamprosate|mesh-list
20282560|NCT00596531|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20282561|NCT00596557|Everolimus|everolimus|mesh-list
20282562|NCT00596557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282563|NCT00596557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20282564|NCT00596557|Immunologic Factors|immunologic factors|mesh-ancestor
20282565|NCT00596557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282566|NCT00596596|Prucalopride|prucalopride|mesh-list
20282567|NCT00596596|Laxatives|laxatives|mesh-ancestor
20282568|NCT00596596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20282569|NCT00596596|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20282570|NCT00596596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20282571|NCT00596596|Serotonin Agents|serotonin agents|mesh-ancestor
20282572|NCT00596596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20282573|NCT00596596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282574|NCT00596596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282575|NCT00596609|Morphine|morphine|mesh-list
20282576|NCT00596609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20282577|NCT00596609|Narcotics|narcotics|mesh-ancestor
20282578|NCT00596609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20282579|NCT00596609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282580|NCT00596609|Analgesics|analgesics|mesh-ancestor
20282581|NCT00596609|Sensory System Agents|sensory system agents|mesh-ancestor
20282582|NCT00596609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20282583|NCT00596648|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20282584|NCT00596648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282585|NCT00596648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20282586|NCT00596648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282587|NCT00596648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282588|NCT00596804|Veltuzumab|veltuzumab|mesh-list
20282589|NCT00596804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282590|NCT00596986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20282591|NCT00596986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20282592|NCT00596986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20282593|NCT00596986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20282594|NCT00596986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282595|NCT00596986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20282596|NCT00596986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282597|NCT00596986|Analgesics|analgesics|mesh-ancestor
20282598|NCT00596986|Sensory System Agents|sensory system agents|mesh-ancestor
20282599|NCT00596986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20282600|NCT00596986|Antidepressive Agents|antidepressive agents|mesh-ancestor
20282601|NCT00596986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20282602|NCT00596986|Dopamine Agents|dopamine agents|mesh-ancestor
20282603|NCT00597064|Prednisone|prednisone|mesh-list
20547915|NCT01896960|Anesthetics, Local|anesthetics, local|mesh-ancestor
20547916|NCT01896960|Anesthetics|anesthetics|mesh-ancestor
20547917|NCT01896960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20547918|NCT01896960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547919|NCT01896960|Sensory System Agents|sensory system agents|mesh-ancestor
20547920|NCT01896960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20547921|NCT01896960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20547922|NCT01896960|Narcotics|narcotics|mesh-ancestor
20547923|NCT01896960|Analgesics|analgesics|mesh-ancestor
20547924|NCT01896960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20547925|NCT01896960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20547926|NCT01896960|Anesthetics, General|anesthetics, general|mesh-ancestor
20547927|NCT01897012|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20547928|NCT01897012|Romidepsin|romidepsin|mesh-list
20547929|NCT01897012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20547930|NCT01897012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20547931|NCT01897012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20547932|NCT01897038|Sorafenib|sorafenib|mesh-list
20282604|NCT00597064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20282605|NCT00597064|Glucocorticoids|glucocorticoids|mesh-ancestor
20282606|NCT00597064|Hormones|hormones|mesh-ancestor
20282607|NCT00597064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20282608|NCT00597064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282609|NCT00597064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20282610|NCT00597064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282611|NCT00597181|Mitomycins|mitomycins|mesh-list
20282612|NCT00597181|Mitomycin|mitomycin|mesh-list
20282613|NCT00597181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20282614|NCT00597181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282615|NCT00597181|Alkylating Agents|alkylating agents|mesh-ancestor
20282616|NCT00597181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282617|NCT00597181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20282618|NCT00597181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288278|NCT05336266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288279|NCT05336175|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
20288280|NCT05336175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20288281|NCT05336175|Vasodilator Agents|vasodilator agents|mesh-ancestor
20288282|NCT05335941|Pemetrexed|pemetrexed|mesh-list
20288283|NCT05335941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288284|NCT05335941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288285|NCT05335941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288286|NCT05335941|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20288287|NCT05335941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20288288|NCT05335928|Abatacept|abatacept|mesh-list
20288289|NCT05335928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20288290|NCT05335928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288291|NCT05335928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288292|NCT05335928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20288293|NCT05335928|Immunologic Factors|immunologic factors|mesh-ancestor
20288294|NCT05335928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288295|NCT05335928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20288296|NCT05335915|Nicotine|nicotine|mesh-list
20288297|NCT05335915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20288298|NCT05335915|Autonomic Agents|autonomic agents|mesh-ancestor
20288299|NCT05335915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20288300|NCT05335915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288301|NCT05335915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20288302|NCT05335915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20288303|NCT05335915|Cholinergic Agents|cholinergic agents|mesh-ancestor
20288304|NCT05335915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20288305|NCT05335915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288625|NCT05279963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288626|NCT05279963|Adrenergic Agents|adrenergic agents|mesh-ancestor
20288627|NCT05279963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20288628|NCT05279963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20288629|NCT05279963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20288630|NCT05279963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20288631|NCT05267626|Aldesleukin|aldesleukin|mesh-list
20288632|NCT05267626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288633|NCT05267626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20288634|NCT05267626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20288635|NCT05267626|Antiviral Agents|antiviral agents|mesh-ancestor
20288636|NCT05267626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20288637|NCT05266456|Vaccines|vaccines|mesh-list
20288638|NCT05266456|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20288639|NCT05266456|Immunologic Factors|immunologic factors|mesh-ancestor
20288640|NCT05266456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288641|NCT05258747|Olaparib|olaparib|mesh-list
20288642|NCT05258747|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20288643|NCT05258747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288644|NCT05258747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288645|NCT05258747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288646|NCT05252988|Loperamide|loperamide|mesh-list
19962745|NCT01720264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19962746|NCT01720264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19962747|NCT01720264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962748|NCT01720264|Incretins|incretins|mesh-ancestor
19962749|NCT01720264|Hormones|hormones|mesh-ancestor
19962750|NCT01720264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19962751|NCT01720264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19962752|NCT01720264|Protease Inhibitors|protease inhibitors|mesh-ancestor
20282619|NCT00597233|Insulin|insulin|mesh-list
20282620|NCT00597233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20282621|NCT00597233|Insulin Aspart|insulin aspart|mesh-list
20282622|NCT00597233|Isophane Insulin, Human|isophane insulin, human|mesh-list
20282623|NCT00597233|Insulin, Isophane|insulin, isophane|mesh-list
20282624|NCT00597233|Isophane insulin, beef|isophane insulin, beef|mesh-list
20282625|NCT00597233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20282626|NCT00597233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282627|NCT00597259|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20282628|NCT00597259|Entecavir|entecavir|mesh-list
19962753|NCT01720264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962754|NCT01720264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962755|NCT01720277|Vaccines|vaccines|mesh-list
19962756|NCT01720277|Immunologic Factors|immunologic factors|mesh-ancestor
19962757|NCT01720277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962758|NCT01720316|Glycine|glycine|mesh-list
19962759|NCT01720316|Glycine Agents|glycine agents|mesh-ancestor
20282629|NCT00597259|Antiviral Agents|antiviral agents|mesh-ancestor
20282630|NCT00597259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20282631|NCT00597389|Propranolol|propranolol|mesh-list
20282632|NCT00597389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20282633|NCT00597389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20282634|NCT00597389|Adrenergic Agents|adrenergic agents|mesh-ancestor
20282635|NCT00597389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20282636|NCT00597389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282637|NCT00597389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282638|NCT00597389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20282639|NCT00597389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20282640|NCT00597389|Vasodilator Agents|vasodilator agents|mesh-ancestor
20282641|NCT00597415|Celecoxib|celecoxib|mesh-list
20282642|NCT00597415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20282643|NCT00597415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20282644|NCT00597415|Analgesics|analgesics|mesh-ancestor
20282645|NCT00597415|Sensory System Agents|sensory system agents|mesh-ancestor
20282646|NCT00597415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20282647|NCT00597415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962760|NCT01720316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19962761|NCT01720316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962762|NCT01720316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962763|NCT01720524|Sildenafil Citrate|sildenafil citrate|mesh-list
19962764|NCT01720524|Vasodilator Agents|vasodilator agents|mesh-ancestor
19962765|NCT01720524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20282648|NCT00597415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20282649|NCT00597415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20282650|NCT00597415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20282651|NCT00597415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20282652|NCT00597415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282653|NCT00597415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282654|NCT00597597|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20282655|NCT00597597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282656|NCT00597597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20282657|NCT00597597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282658|NCT00597597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282659|NCT00597623|Adalimumab|adalimumab|mesh-list
20282660|NCT00597623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20282661|NCT00597623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20282662|NCT00597662|Icodextrin|icodextrin|mesh-list
20282663|NCT00597662|Dialysis Solutions|dialysis solutions|mesh-ancestor
20282664|NCT00597662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20282665|NCT00597688|Chlorhexidine|chlorhexidine|mesh-list
20282666|NCT00597688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20282667|NCT00597688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20282668|NCT00597688|Disinfectants|disinfectants|mesh-ancestor
20282669|NCT00597857|Hydrocortisone|hydrocortisone|mesh-list
20282670|NCT00597857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20282671|NCT00598013|Pioglitazone|pioglitazone|mesh-list
20282672|NCT00598013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20282673|NCT00598013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282674|NCT00598052|Citalopram|citalopram|mesh-list
20282675|NCT00598052|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20282676|NCT00598052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20282677|NCT00598052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20282678|NCT00598052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282679|NCT00598052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20282680|NCT00598052|Serotonin Agents|serotonin agents|mesh-ancestor
20282681|NCT00598052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282682|NCT00598052|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20282683|NCT00598052|Antidepressive Agents|antidepressive agents|mesh-ancestor
20282684|NCT00598052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20282685|NCT00598091|Gemcitabine|gemcitabine|mesh-list
20282686|NCT00598091|Dasatinib|dasatinib|mesh-list
20282687|NCT00598091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20282688|NCT00598091|Antimetabolites|antimetabolites|mesh-ancestor
20282689|NCT00598091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282690|NCT00598091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282691|NCT00598091|Antiviral Agents|antiviral agents|mesh-ancestor
20282692|NCT00598091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20282693|NCT00598091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282694|NCT00598091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20282695|NCT00598091|Immunologic Factors|immunologic factors|mesh-ancestor
20282696|NCT00598091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282697|NCT00598091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20547933|NCT01897038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20547934|NCT01897038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20547935|NCT01897038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547936|NCT01897038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547937|NCT01897051|Rifaximin|rifaximin|mesh-list
20547938|NCT01897051|Propranolol|propranolol|mesh-list
20547939|NCT01897051|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20547940|NCT01897051|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20547941|NCT01897051|Adrenergic Agents|adrenergic agents|mesh-ancestor
20547942|NCT01897051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20547943|NCT01897051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547944|NCT01897051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547945|NCT01897051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20547946|NCT01897051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20547947|NCT01897051|Vasodilator Agents|vasodilator agents|mesh-ancestor
20547948|NCT01897051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20547949|NCT01897051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20547950|NCT01897051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20547951|NCT01897116|Hydroxychloroquine|hydroxychloroquine|mesh-list
20547952|NCT01897116|Vemurafenib|vemurafenib|mesh-list
20547953|NCT01897116|Antimalarials|antimalarials|mesh-ancestor
20547954|NCT01897116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20547955|NCT01897116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20547956|NCT01897116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20547957|NCT01897116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547958|NCT01897116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547959|NCT01897116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20547960|NCT01897116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20547961|NCT01897116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20547962|NCT01897324|Hormones|hormones|mesh-list
20547963|NCT01897324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20547964|NCT01897324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547965|NCT01897337|Aprepitant|aprepitant|mesh-list
20547966|NCT01897337|Antiemetics|antiemetics|mesh-ancestor
20547967|NCT01897337|Autonomic Agents|autonomic agents|mesh-ancestor
20547968|NCT01897337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20547969|NCT01897337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547970|NCT01897337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20547971|NCT01897337|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20547972|NCT01897337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20547973|NCT01897337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547974|NCT01897428|Bepotastine besilate|bepotastine besilate|mesh-list
20547975|NCT01897428|Salicylates|salicylates|mesh-list
20547976|NCT01897428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20547977|NCT01897428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20547978|NCT01897428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20547979|NCT01897428|Analgesics|analgesics|mesh-ancestor
20547980|NCT01897428|Sensory System Agents|sensory system agents|mesh-ancestor
20547981|NCT01897428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20547982|NCT01897428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20547983|NCT01897428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20547984|NCT01897428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20547985|NCT01897428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20547986|NCT01897428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20547987|NCT01897428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20547988|NCT01897441|Paclitaxel|paclitaxel|mesh-list
20282698|NCT00598156|Bevacizumab|bevacizumab|mesh-list
19450389|NCT03428633|Ropivacaine|ropivacaine|mesh-list
20282699|NCT00598156|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20282700|NCT00598156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20282701|NCT00598156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282702|NCT00598156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20282703|NCT00598156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20282704|NCT00598156|Growth Substances|growth substances|mesh-ancestor
20282705|NCT00598156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282706|NCT00598156|Growth Inhibitors|growth inhibitors|mesh-ancestor
20282707|NCT00598156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20282708|NCT00598156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282709|NCT00598156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282710|NCT00598169|Dexamethasone|dexamethasone|mesh-list
20282711|NCT00598169|Rituximab|rituximab|mesh-list
20282712|NCT00598169|Carboplatin|carboplatin|mesh-list
20282713|NCT00598169|Etoposide|etoposide|mesh-list
20282714|NCT00598169|Bortezomib|bortezomib|mesh-list
20282715|NCT00598169|Ifosfamide|ifosfamide|mesh-list
20282716|NCT00598169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20282717|NCT00598169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282718|NCT00598169|Immunologic Factors|immunologic factors|mesh-ancestor
20282719|NCT00598169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282720|NCT00598169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20282721|NCT00598169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20282722|NCT00598169|Antiemetics|antiemetics|mesh-ancestor
20282723|NCT00598169|Autonomic Agents|autonomic agents|mesh-ancestor
20282724|NCT00598169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20282725|NCT00598169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20282726|NCT00598169|Glucocorticoids|glucocorticoids|mesh-ancestor
20282727|NCT00598169|Hormones|hormones|mesh-ancestor
20282728|NCT00598169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20282729|NCT00598169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20282730|NCT00598169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20547989|NCT01897441|Cyclophosphamide|cyclophosphamide|mesh-list
20547990|NCT01897441|Doxorubicin|doxorubicin|mesh-list
20547991|NCT01897441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20547992|NCT01897441|Trastuzumab|trastuzumab|mesh-list
20547993|NCT01897441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20547994|NCT01897441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20547995|NCT01897441|Antibodies|antibodies|mesh-list
20547996|NCT01897441|Immunoglobulins|immunoglobulins|mesh-list
20547997|NCT01897441|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20547998|NCT01897441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20547999|NCT01897441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548000|NCT01897441|Tubulin Modulators|tubulin modulators|mesh-ancestor
20548001|NCT01897441|Antimitotic Agents|antimitotic agents|mesh-ancestor
20548002|NCT01897441|Mitosis Modulators|mitosis modulators|mesh-ancestor
20548003|NCT01897441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548004|NCT01897441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20548005|NCT01897441|Immunologic Factors|immunologic factors|mesh-ancestor
20548006|NCT01897441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962766|NCT01720524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19962767|NCT01720524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962768|NCT01720524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962769|NCT01720524|Urological Agents|urological agents|mesh-ancestor
19962770|NCT01720602|Letrozole|letrozole|mesh-list
19962771|NCT01720602|Vorinostat|vorinostat|mesh-list
19962772|NCT01720602|Anastrozole|anastrozole|mesh-list
19962773|NCT01720602|Exemestane|exemestane|mesh-list
19962774|NCT01720602|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19962775|NCT01720602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962776|NCT01720602|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19962777|NCT01720602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19962778|NCT01720602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962779|NCT01720602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962780|NCT01720602|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19962781|NCT01720602|Hormone Antagonists|hormone antagonists|mesh-ancestor
19974940|NCT01843920|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20548007|NCT01897441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20282731|NCT00598169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20282732|NCT00598169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20282733|NCT00598169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282734|NCT00598169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282735|NCT00598169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20282736|NCT00598169|Alkylating Agents|alkylating agents|mesh-ancestor
20282737|NCT00598195|Ketamine|ketamine|mesh-list
20282738|NCT00598195|Analgesics|analgesics|mesh-ancestor
20282739|NCT00598195|Sensory System Agents|sensory system agents|mesh-ancestor
20282740|NCT00598195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20282741|NCT00598195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282742|NCT00598195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20282743|NCT00598195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20282744|NCT00598195|Anesthetics, General|anesthetics, general|mesh-ancestor
20282745|NCT00598195|Anesthetics|anesthetics|mesh-ancestor
20282746|NCT00598195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20282747|NCT00598195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20282748|NCT00598195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20282749|NCT00598195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20282750|NCT00598195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282751|NCT00598234|Celecoxib|celecoxib|mesh-list
20282752|NCT00598234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20282753|NCT00598234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20282754|NCT00598234|Analgesics|analgesics|mesh-ancestor
20282755|NCT00598234|Sensory System Agents|sensory system agents|mesh-ancestor
20282756|NCT00598234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20282757|NCT00598234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282758|NCT00598234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20282759|NCT00598234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20282760|NCT00598234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20282761|NCT00598234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20282762|NCT00598234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282763|NCT00598234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282764|NCT00598247|Paclitaxel|paclitaxel|mesh-list
20282765|NCT00598247|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
20282766|NCT00598247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20282767|NCT00598247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282768|NCT00598247|Tubulin Modulators|tubulin modulators|mesh-ancestor
20282769|NCT00598247|Antimitotic Agents|antimitotic agents|mesh-ancestor
20282770|NCT00598247|Mitosis Modulators|mitosis modulators|mesh-ancestor
20282771|NCT00598247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282772|NCT00598338|Prucalopride|prucalopride|mesh-list
20282773|NCT00598338|Laxatives|laxatives|mesh-ancestor
20282774|NCT00598338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20282775|NCT00598338|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20282776|NCT00598338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20282777|NCT00598338|Serotonin Agents|serotonin agents|mesh-ancestor
20282778|NCT00598338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20282779|NCT00598338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282780|NCT00598338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282781|NCT00598377|Cosyntropin|cosyntropin|mesh-list
20282782|NCT00598377|Hormones|hormones|mesh-ancestor
20282783|NCT00598377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20282784|NCT00598377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282785|NCT00598403|Ciprofloxacin|ciprofloxacin|mesh-list
20282786|NCT00598403|Cefditoren|cefditoren|mesh-list
20282787|NCT00598403|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
20282788|NCT00598403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20282789|NCT00598403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20282790|NCT00598403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20282791|NCT00598403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20282792|NCT00598403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282793|NCT00598403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282794|NCT00598403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282795|NCT00598403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20282796|NCT00598403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20282797|NCT00598429|Alprostadil|alprostadil|mesh-list
20282798|NCT00598429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20282799|NCT00598429|Vasodilator Agents|vasodilator agents|mesh-ancestor
20282800|NCT00598429|Urological Agents|urological agents|mesh-ancestor
20282801|NCT00598533|Sirolimus|sirolimus|mesh-list
20282802|NCT00598533|Probucol|probucol|mesh-list
20282803|NCT00598533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20282804|NCT00598533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20282805|NCT00598533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20282806|NCT00598533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282807|NCT00598533|Antifungal Agents|antifungal agents|mesh-ancestor
20282808|NCT00598533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20282809|NCT00598533|Immunologic Factors|immunologic factors|mesh-ancestor
20282810|NCT00598533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282811|NCT00598533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20282812|NCT00598533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20282813|NCT00598533|Antimetabolites|antimetabolites|mesh-ancestor
20282814|NCT00598533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282815|NCT00598533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20282816|NCT00598533|Antioxidants|antioxidants|mesh-ancestor
20282817|NCT00598533|Protective Agents|protective agents|mesh-ancestor
20282818|NCT00598572|Deferoxamine|deferoxamine|mesh-list
20282819|NCT00598572|Siderophores|siderophores|mesh-ancestor
20282820|NCT00598572|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20282821|NCT00598572|Chelating Agents|chelating agents|mesh-ancestor
20282822|NCT00598572|Sequestering Agents|sequestering agents|mesh-ancestor
20282823|NCT00598572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282824|NCT00598611|Loratadine|loratadine|mesh-list
20282825|NCT00598611|Desloratadine|desloratadine|mesh-list
20282826|NCT00598611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20282827|NCT00598611|Cholinergic Agents|cholinergic agents|mesh-ancestor
20282828|NCT00598611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20282829|NCT00598611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282830|NCT00598611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282831|NCT00598611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20282832|NCT00598611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20282833|NCT00598611|Histamine Antagonists|histamine antagonists|mesh-ancestor
20282834|NCT00598611|Histamine Agents|histamine agents|mesh-ancestor
20282835|NCT00598611|Antipruritics|antipruritics|mesh-ancestor
20282836|NCT00598611|Dermatologic Agents|dermatologic agents|mesh-ancestor
20282837|NCT00598611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20282838|NCT00598624|Treosulfan|treosulfan|mesh-list
20282839|NCT00598624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20282840|NCT00598624|Alkylating Agents|alkylating agents|mesh-ancestor
20282841|NCT00598624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282842|NCT00598624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282843|NCT00598637|Everolimus|everolimus|mesh-list
20282844|NCT00598637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282845|NCT00598637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20282846|NCT00598637|Immunologic Factors|immunologic factors|mesh-ancestor
20282847|NCT00598637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282848|NCT00598676|Sirolimus|sirolimus|mesh-list
20282849|NCT00598676|Everolimus|everolimus|mesh-list
20282850|NCT00598676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282851|NCT00598676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20282852|NCT00598676|Immunologic Factors|immunologic factors|mesh-ancestor
20282853|NCT00598676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282854|NCT00598676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20282855|NCT00598676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20282856|NCT00598676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20282857|NCT00598676|Antifungal Agents|antifungal agents|mesh-ancestor
20282858|NCT00598715|Sirolimus|sirolimus|mesh-list
20282859|NCT00598715|Paclitaxel|paclitaxel|mesh-list
20548008|NCT01897441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20548009|NCT01897441|Alkylating Agents|alkylating agents|mesh-ancestor
20548010|NCT01897441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20548011|NCT01897441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20548012|NCT01897441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20548013|NCT01897441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20548014|NCT01897441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548015|NCT01897454|Calcium, Dietary|calcium, dietary|mesh-list
20548016|NCT01897454|Leucovorin|leucovorin|mesh-list
20548017|NCT01897454|Folic Acid|folic acid|mesh-list
20548018|NCT01897454|Gemcitabine|gemcitabine|mesh-list
20548019|NCT01897454|Fluorouracil|fluorouracil|mesh-list
20548020|NCT01897454|Oxaliplatin|oxaliplatin|mesh-list
20548021|NCT01897454|Irinotecan|irinotecan|mesh-list
20548022|NCT01897454|Camptothecin|camptothecin|mesh-list
20548023|NCT01897454|Calcium|calcium|mesh-list
20548024|NCT01897454|Levoleucovorin|levoleucovorin|mesh-list
20282860|NCT00598715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20282861|NCT00598715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548025|NCT01897454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20548026|NCT01897454|Antimetabolites|antimetabolites|mesh-ancestor
20548027|NCT01897454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282862|NCT00598715|Tubulin Modulators|tubulin modulators|mesh-ancestor
20282863|NCT00598715|Antimitotic Agents|antimitotic agents|mesh-ancestor
20282864|NCT00598715|Mitosis Modulators|mitosis modulators|mesh-ancestor
20282865|NCT00598715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282866|NCT00598715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20282867|NCT00598715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20282868|NCT00598715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20282869|NCT00598715|Antifungal Agents|antifungal agents|mesh-ancestor
20282870|NCT00598715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20282871|NCT00598715|Immunologic Factors|immunologic factors|mesh-ancestor
20282872|NCT00598715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282873|NCT00598793|Insulin|insulin|mesh-list
20282874|NCT00598793|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20282875|NCT00598793|Metformin|metformin|mesh-list
20282876|NCT00598793|Insulin Glargine|insulin glargine|mesh-list
20282877|NCT00598793|Pioglitazone|pioglitazone|mesh-list
20282878|NCT00598793|Insulin Aspart|insulin aspart|mesh-list
20282879|NCT00598793|Biphasic Insulins|biphasic insulins|mesh-list
20282880|NCT00598793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20548028|NCT01897454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548029|NCT01897454|Antiviral Agents|antiviral agents|mesh-ancestor
20548030|NCT01897454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548031|NCT01897454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548032|NCT01897454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20548033|NCT01897454|Immunologic Factors|immunologic factors|mesh-ancestor
20548034|NCT01897454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548035|NCT01897454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20548036|NCT01897454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20548037|NCT01897454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20548038|NCT01897454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20548039|NCT01897454|Antidotes|antidotes|mesh-ancestor
20548040|NCT01897454|Protective Agents|protective agents|mesh-ancestor
20548041|NCT01897454|Vitamin B Complex|vitamin b complex|mesh-ancestor
20548042|NCT01897454|Vitamins|vitamins|mesh-ancestor
20548043|NCT01897454|Micronutrients|micronutrients|mesh-ancestor
20548044|NCT01897454|Hematinics|hematinics|mesh-ancestor
20548045|NCT01897454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20548046|NCT01897636|Vaccines|vaccines|mesh-list
20548047|NCT01897636|Immunologic Factors|immunologic factors|mesh-ancestor
20548048|NCT01897636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548049|NCT01897740|Sildenafil Citrate|sildenafil citrate|mesh-list
20548050|NCT01897740|Vasodilator Agents|vasodilator agents|mesh-ancestor
20548051|NCT01897740|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20548052|NCT01897740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20548053|NCT01897740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548054|NCT01897740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548055|NCT01897740|Urological Agents|urological agents|mesh-ancestor
20548056|NCT01897753|Hormones|hormones|mesh-list
20548057|NCT01897753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20548058|NCT01897753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548059|NCT01897779|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
20548060|NCT01897779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548061|NCT01897779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548062|NCT01897779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20548063|NCT01897779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548064|NCT01897844|Somatostatin|somatostatin|mesh-list
20548065|NCT01897844|Hormones|hormones|mesh-ancestor
20548066|NCT01897844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20548067|NCT01897844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962782|NCT01720602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19962783|NCT01720602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962784|NCT01720602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19962785|NCT01720602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19962786|NCT01720602|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19962787|NCT01720667|Levetiracetam|levetiracetam|mesh-list
19962788|NCT01720667|Phenobarbital|phenobarbital|mesh-list
19962789|NCT01720667|Anticonvulsants|anticonvulsants|mesh-ancestor
19962790|NCT01720667|Nootropic Agents|nootropic agents|mesh-ancestor
19962791|NCT01720667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19962792|NCT01720667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19962793|NCT01720667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962794|NCT01720667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20282881|NCT00598793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282882|NCT00598858|Prednisone|prednisone|mesh-list
20548068|NCT01898000|Chlorhexidine|chlorhexidine|mesh-list
20282883|NCT00598858|Cortisone|cortisone|mesh-list
20282884|NCT00598858|Docetaxel|docetaxel|mesh-list
20282885|NCT00598858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282886|NCT00598858|Tubulin Modulators|tubulin modulators|mesh-ancestor
20282887|NCT00598858|Antimitotic Agents|antimitotic agents|mesh-ancestor
20282888|NCT00598858|Mitosis Modulators|mitosis modulators|mesh-ancestor
20282889|NCT00598858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282890|NCT00598858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20282891|NCT00598858|Glucocorticoids|glucocorticoids|mesh-ancestor
20282892|NCT00598858|Hormones|hormones|mesh-ancestor
20282893|NCT00598858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20282894|NCT00598858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282895|NCT00598858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20282896|NCT00598897|Clarithromycin|clarithromycin|mesh-list
20282897|NCT00598897|Rifabutin|rifabutin|mesh-list
20282898|NCT00598897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20282899|NCT00598897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20282900|NCT00598897|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20282901|NCT00598897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282902|NCT00598897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282903|NCT00598897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20282904|NCT00598897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20282905|NCT00598897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20282906|NCT00598897|Antitubercular Agents|antitubercular agents|mesh-ancestor
20282907|NCT00598923|Topiramate|topiramate|mesh-list
20282908|NCT00598923|Phenytoin|phenytoin|mesh-list
20282909|NCT00598923|Anticonvulsants|anticonvulsants|mesh-ancestor
20282910|NCT00598923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20282911|NCT00598923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282912|NCT00598923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20282913|NCT00598923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20282914|NCT00598923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20282915|NCT00598923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282916|NCT00598923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20282917|NCT00598923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20282918|NCT00598962|Azithromycin|azithromycin|mesh-list
20282919|NCT00598962|Rifampin|rifampin|mesh-list
20282920|NCT00598962|Rifabutin|rifabutin|mesh-list
20282921|NCT00598962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20282922|NCT00598962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20282923|NCT00598962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20282924|NCT00598962|Antitubercular Agents|antitubercular agents|mesh-ancestor
20282925|NCT00598962|Leprostatic Agents|leprostatic agents|mesh-ancestor
20282926|NCT00598962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20282927|NCT00598962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282928|NCT00598962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282929|NCT00598962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20282930|NCT00598962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20282931|NCT00598962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20282932|NCT00598962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20282933|NCT00598962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20282934|NCT00598962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20282935|NCT00599079|Azithromycin|azithromycin|mesh-list
20282936|NCT00599079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20282937|NCT00599079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20288306|NCT05335837|Anesthetics|anesthetics|mesh-list
20288307|NCT05335837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20288308|NCT05335837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288309|NCT05335655|Dexmedetomidine|dexmedetomidine|mesh-list
20288310|NCT05335655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20288311|NCT05335655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20288312|NCT05335655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288313|NCT05335655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20288314|NCT05335655|Analgesics|analgesics|mesh-ancestor
20288315|NCT05335655|Sensory System Agents|sensory system agents|mesh-ancestor
20288316|NCT05335655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20288317|NCT05335655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20288318|NCT05335655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20288319|NCT05335655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20288320|NCT05335655|Adrenergic Agents|adrenergic agents|mesh-ancestor
20288321|NCT05335655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20288322|NCT05335655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288323|NCT05335629|Dapagliflozin|dapagliflozin|mesh-list
20282938|NCT00599222|Ranibizumab|ranibizumab|mesh-list
20282939|NCT00599222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20282940|NCT00599222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20282941|NCT00599222|Growth Substances|growth substances|mesh-ancestor
20282942|NCT00599222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282943|NCT00599222|Growth Inhibitors|growth inhibitors|mesh-ancestor
20282944|NCT00599222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282945|NCT00599235|Hydralazine|hydralazine|mesh-list
20282946|NCT00599235|Sildenafil Citrate|sildenafil citrate|mesh-list
20282947|NCT00599235|Vasodilator Agents|vasodilator agents|mesh-ancestor
20282948|NCT00599235|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20282949|NCT00599235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20282950|NCT00599235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282951|NCT00599235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282952|NCT00599235|Urological Agents|urological agents|mesh-ancestor
20282953|NCT00599235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20282954|NCT00599274|Interferons|interferons|mesh-list
20282955|NCT00599274|Interferon-beta|interferon-beta|mesh-list
20282956|NCT00599274|Interferon beta-1a|interferon beta-1a|mesh-list
20282957|NCT00599274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20282958|NCT00599274|Antiviral Agents|antiviral agents|mesh-ancestor
20548069|NCT01898000|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20548070|NCT01898000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548071|NCT01898000|Disinfectants|disinfectants|mesh-ancestor
20548072|NCT01898039|Cyclophosphamide|cyclophosphamide|mesh-list
20548073|NCT01898039|Vaccines|vaccines|mesh-list
20548074|NCT01898039|Immunologic Factors|immunologic factors|mesh-ancestor
20548075|NCT01898039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548076|NCT01898039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20548077|NCT01898039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20548078|NCT01898039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20548079|NCT01898039|Alkylating Agents|alkylating agents|mesh-ancestor
20548080|NCT01898039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548081|NCT01898039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548082|NCT01898039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20548083|NCT01898052|Anesthetics|anesthetics|mesh-list
20548084|NCT01898052|Levobupivacaine|levobupivacaine|mesh-list
20548085|NCT01898052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20548086|NCT01898052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548087|NCT01898052|Anesthetics, Local|anesthetics, local|mesh-ancestor
20548088|NCT01898052|Sensory System Agents|sensory system agents|mesh-ancestor
20548089|NCT01898052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548090|NCT01898065|Misonidazole|misonidazole|mesh-list
20548091|NCT01898065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548092|NCT01898065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20548093|NCT01898065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20548094|NCT01898065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548095|NCT01898104|Capecitabine|capecitabine|mesh-list
20548096|NCT01898104|Valproic Acid|valproic acid|mesh-list
20548097|NCT01898104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20548098|NCT01898104|Antimetabolites|antimetabolites|mesh-ancestor
20548099|NCT01898104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548100|NCT01898104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548101|NCT01898104|Anticonvulsants|anticonvulsants|mesh-ancestor
20548102|NCT01898104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548103|NCT01898104|GABA Agents|gaba agents|mesh-ancestor
20548104|NCT01898104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20548105|NCT01898104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548106|NCT01898104|Antimanic Agents|antimanic agents|mesh-ancestor
20548107|NCT01898104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20548108|NCT01898104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20548109|NCT01898104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20548110|NCT01898169|Nicotine|nicotine|mesh-list
20548111|NCT01898169|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20548112|NCT01898169|Autonomic Agents|autonomic agents|mesh-ancestor
20548113|NCT01898169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548114|NCT01898169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548115|NCT01898169|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20548116|NCT01898169|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20548117|NCT01898169|Cholinergic Agents|cholinergic agents|mesh-ancestor
20548118|NCT01898169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20548119|NCT01898169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548120|NCT01898182|Kinetin|kinetin|mesh-list
20548121|NCT01898182|Plant Growth Regulators|plant growth regulators|mesh-ancestor
20548122|NCT01898182|Growth Substances|growth substances|mesh-ancestor
20282959|NCT00599274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20554437|NCT01935505|Autonomic Agents|autonomic agents|mesh-ancestor
20282960|NCT00599274|Immunologic Factors|immunologic factors|mesh-ancestor
20282961|NCT00599274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282962|NCT00599274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20282963|NCT00599287|Haloperidol|haloperidol|mesh-list
20282964|NCT00599287|Haloperidol decanoate|haloperidol decanoate|mesh-list
20282965|NCT00599287|Methylphenidate|methylphenidate|mesh-list
20282966|NCT00599287|Rivastigmine|rivastigmine|mesh-list
20282967|NCT00599287|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20282968|NCT00599287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282969|NCT00599287|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20282970|NCT00599287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20282971|NCT00599287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20282972|NCT00599287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20282973|NCT00599287|Dopamine Agents|dopamine agents|mesh-ancestor
20282974|NCT00599287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20282975|NCT00599287|Antiemetics|antiemetics|mesh-ancestor
20282976|NCT00599287|Autonomic Agents|autonomic agents|mesh-ancestor
20282977|NCT00599287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20282978|NCT00599287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20282979|NCT00599287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20282980|NCT00599287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20282981|NCT00599287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20282982|NCT00599287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20282983|NCT00599287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20282984|NCT00599287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20282985|NCT00599287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20282986|NCT00599287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20282987|NCT00599287|Cholinergic Agents|cholinergic agents|mesh-ancestor
20282988|NCT00599287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20282989|NCT00599287|Protective Agents|protective agents|mesh-ancestor
20282990|NCT00599417|Broncho-Vaxom|broncho-vaxom|mesh-list
20282991|NCT00599417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20282992|NCT00599417|Immunologic Factors|immunologic factors|mesh-ancestor
20282993|NCT00599417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20282994|NCT00599534|Montelukast|montelukast|mesh-list
20282995|NCT00599534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20282996|NCT00599534|Respiratory System Agents|respiratory system agents|mesh-ancestor
20282997|NCT00599534|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20282998|NCT00599534|Hormone Antagonists|hormone antagonists|mesh-ancestor
20282999|NCT00599534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20283000|NCT00599534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283001|NCT00599534|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20283002|NCT00599534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20283003|NCT00599534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283004|NCT00599560|Vasopressins|vasopressins|mesh-list
20283005|NCT00599560|Arginine Vasopressin|arginine vasopressin|mesh-list
20283006|NCT00599560|Hemostatics|hemostatics|mesh-ancestor
20283007|NCT00599560|Coagulants|coagulants|mesh-ancestor
20283008|NCT00599560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20283009|NCT00599560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20283010|NCT00599560|Natriuretic Agents|natriuretic agents|mesh-ancestor
20283011|NCT00599560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283012|NCT00599573|Ondansetron|ondansetron|mesh-list
20283013|NCT00599573|Antiemetics|antiemetics|mesh-ancestor
20283014|NCT00599573|Autonomic Agents|autonomic agents|mesh-ancestor
20283015|NCT00599573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20283016|NCT00599573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283017|NCT00599573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20283018|NCT00599573|Antipruritics|antipruritics|mesh-ancestor
20283019|NCT00599573|Dermatologic Agents|dermatologic agents|mesh-ancestor
20283020|NCT00599573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20283021|NCT00599573|Serotonin Agents|serotonin agents|mesh-ancestor
20283022|NCT00599573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283023|NCT00599573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283024|NCT00599573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20283025|NCT00599573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20283026|NCT00599573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20283027|NCT00599573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20283028|NCT00599573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20283029|NCT00599625|Pravastatin|pravastatin|mesh-list
20283030|NCT00599625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20283031|NCT00599625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20283032|NCT00599625|Antimetabolites|antimetabolites|mesh-ancestor
20283033|NCT00599625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548123|NCT01898182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283034|NCT00599625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20283035|NCT00599625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20283036|NCT00599625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283037|NCT00599651|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20283038|NCT00599651|Respiratory System Agents|respiratory system agents|mesh-ancestor
19962795|NCT01720667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19962796|NCT01720667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19974941|NCT01843920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20283039|NCT00599716|Hyaluronic Acid|hyaluronic acid|mesh-list
20283040|NCT00599716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20283041|NCT00599716|Immunologic Factors|immunologic factors|mesh-ancestor
20283042|NCT00599716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283043|NCT00599716|Viscosupplements|viscosupplements|mesh-ancestor
20283044|NCT00599716|Protective Agents|protective agents|mesh-ancestor
20283045|NCT00599807|Vitamin D|vitamin d|mesh-list
20283046|NCT00599807|Cholecalciferol|cholecalciferol|mesh-list
20283047|NCT00599807|Vitamins|vitamins|mesh-ancestor
20283048|NCT00599807|Micronutrients|micronutrients|mesh-ancestor
20283049|NCT00599807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283050|NCT00599807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20283051|NCT00599807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20283052|NCT00599820|Bevacizumab|bevacizumab|mesh-list
20283053|NCT00599820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20283054|NCT00599820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283055|NCT00599820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20283056|NCT00599820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20283057|NCT00599820|Growth Substances|growth substances|mesh-ancestor
20283058|NCT00599820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283059|NCT00599820|Growth Inhibitors|growth inhibitors|mesh-ancestor
20283060|NCT00599833|Cetuximab|cetuximab|mesh-list
20283061|NCT00599833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20548124|NCT01898221|Ethanol|ethanol|mesh-list
20548125|NCT01898221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20548126|NCT01898221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548127|NCT01898221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20548128|NCT01898221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554438|NCT01935505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554439|NCT01935505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554440|NCT01935505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20554441|NCT01935505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20554442|NCT01935505|Cholinergic Agents|cholinergic agents|mesh-ancestor
20554443|NCT01935505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20554444|NCT01935505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554445|NCT01935505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20554446|NCT01935505|Antidepressive Agents|antidepressive agents|mesh-ancestor
20554447|NCT01935505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20554448|NCT01935505|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20554449|NCT01935505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20554450|NCT01935505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20554451|NCT01935505|Dopamine Agents|dopamine agents|mesh-ancestor
20554452|NCT01935505|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20554453|NCT01935505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20554454|NCT01935505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554455|NCT01935518|Fasudil|fasudil|mesh-list
20554456|NCT01935518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20554457|NCT01935518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20554458|NCT01935518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554459|NCT01935518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20554460|NCT01935518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554461|NCT01935518|Vasodilator Agents|vasodilator agents|mesh-ancestor
20554462|NCT01935518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20554463|NCT01935518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554464|NCT01935531|Diclofenac|diclofenac|mesh-list
20554465|NCT01935531|Hyaluronic Acid|hyaluronic acid|mesh-list
20554466|NCT01935531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20554467|NCT01935531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20554468|NCT01935531|Analgesics|analgesics|mesh-ancestor
20283062|NCT00599833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283063|NCT00599885|Valsartan|valsartan|mesh-list
20283064|NCT00599885|Telmisartan|telmisartan|mesh-list
20283065|NCT00599885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20283066|NCT00599885|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20283067|NCT00599885|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20283068|NCT00599885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283069|NCT00599898|Nifedipine|nifedipine|mesh-list
20283070|NCT00599898|Atosiban|atosiban|mesh-list
20283071|NCT00599898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20283072|NCT00599898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20283073|NCT00599898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283074|NCT00599898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20283075|NCT00599898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283076|NCT00599898|Vasodilator Agents|vasodilator agents|mesh-ancestor
20283077|NCT00599898|Tocolytic Agents|tocolytic agents|mesh-ancestor
20283078|NCT00599898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20283079|NCT00599898|Hormone Antagonists|hormone antagonists|mesh-ancestor
20283080|NCT00599898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20283081|NCT00599911|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20283082|NCT00599911|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20283083|NCT00599911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20283084|NCT00599911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20283085|NCT00599911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962797|NCT01720667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962798|NCT01720667|GABA Modulators|gaba modulators|mesh-ancestor
19962799|NCT01720667|GABA Agents|gaba agents|mesh-ancestor
19962800|NCT01720667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19962801|NCT01720667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19962802|NCT01720667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19962803|NCT01720797|Chlorhexidine|chlorhexidine|mesh-list
19962804|NCT01720797|Anesthetics|anesthetics|mesh-list
19962805|NCT01720797|Anesthetics, Local|anesthetics, local|mesh-list
19962806|NCT01720797|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19962807|NCT01720797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19962808|NCT01720797|Disinfectants|disinfectants|mesh-ancestor
19962809|NCT01720797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20283086|NCT00599911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283087|NCT00599911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283088|NCT00599911|Analgesics|analgesics|mesh-ancestor
20283089|NCT00599911|Sensory System Agents|sensory system agents|mesh-ancestor
20283090|NCT00599911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20283091|NCT00599911|Antidepressive Agents|antidepressive agents|mesh-ancestor
20283092|NCT00599911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20283093|NCT00599911|Dopamine Agents|dopamine agents|mesh-ancestor
20283094|NCT00599937|Tretinoin|tretinoin|mesh-list
20283095|NCT00599937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283096|NCT00599937|Keratolytic Agents|keratolytic agents|mesh-ancestor
20283097|NCT00599937|Dermatologic Agents|dermatologic agents|mesh-ancestor
20283098|NCT00599950|Mitomycins|mitomycins|mesh-list
20283099|NCT00599950|Mitomycin|mitomycin|mesh-list
20283100|NCT00599950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20283101|NCT00599950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283102|NCT00599950|Alkylating Agents|alkylating agents|mesh-ancestor
20283103|NCT00599950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283104|NCT00599950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20283105|NCT00599950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283106|NCT00600041|Pantoprazole|pantoprazole|mesh-list
20283107|NCT00600041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20283108|NCT00600041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20283109|NCT00600041|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20283110|NCT00600041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283111|NCT00600041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283112|NCT00600054|Nimotuzumab|nimotuzumab|mesh-list
20283113|NCT00600054|Antibodies|antibodies|mesh-list
20283114|NCT00600054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20283115|NCT00600054|Immunologic Factors|immunologic factors|mesh-ancestor
20283116|NCT00600054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283117|NCT00600054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20283118|NCT00600054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283119|NCT00600093|Amantadine|amantadine|mesh-list
20283120|NCT00600093|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19962810|NCT01720797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283121|NCT00600093|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20283122|NCT00600093|Antiviral Agents|antiviral agents|mesh-ancestor
20283123|NCT00600093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20283124|NCT00600093|Dopamine Agents|dopamine agents|mesh-ancestor
20283125|NCT00600093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283126|NCT00600093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283127|NCT00600093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283128|NCT00600093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20283129|NCT00600093|Analgesics|analgesics|mesh-ancestor
19962811|NCT01720797|Sensory System Agents|sensory system agents|mesh-ancestor
20283130|NCT00600093|Sensory System Agents|sensory system agents|mesh-ancestor
20283131|NCT00600093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20283132|NCT00600145|Mirtazapine|mirtazapine|mesh-list
20283133|NCT00600145|Antidepressive Agents|antidepressive agents|mesh-ancestor
20283134|NCT00600145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20283135|NCT00600145|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20283136|NCT00600145|Histamine Antagonists|histamine antagonists|mesh-ancestor
20283137|NCT00600145|Histamine Agents|histamine agents|mesh-ancestor
20283138|NCT00600145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283139|NCT00600145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283140|NCT00600145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283141|NCT00600145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20283142|NCT00600145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20283143|NCT00600145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20283144|NCT00600145|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20283145|NCT00600145|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20283146|NCT00600145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20283147|NCT00600145|Adrenergic Agents|adrenergic agents|mesh-ancestor
20283148|NCT00600145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20283149|NCT00600145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20283150|NCT00600145|Serotonin Agents|serotonin agents|mesh-ancestor
20283151|NCT00600145|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20283152|NCT00600158|Lidocaine|lidocaine|mesh-list
20283153|NCT00600158|Hydromorphone|hydromorphone|mesh-list
20283154|NCT00600158|Bupivacaine|bupivacaine|mesh-list
20283155|NCT00600158|Anesthetics, Local|anesthetics, local|mesh-ancestor
20283156|NCT00600158|Anesthetics|anesthetics|mesh-ancestor
20283157|NCT00600158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20283158|NCT00600158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283159|NCT00600158|Sensory System Agents|sensory system agents|mesh-ancestor
20283160|NCT00600158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20283161|NCT00600158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20283162|NCT00600158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20548129|NCT01898338|Daptomycin|daptomycin|mesh-list
20548130|NCT01898338|Fosfomycin|fosfomycin|mesh-list
20548131|NCT01898338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20548132|NCT01898338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548133|NCT01898377|Mycophenolic Acid|mycophenolic acid|mesh-list
20548134|NCT01898377|Imatinib Mesylate|imatinib mesylate|mesh-list
20548135|NCT01898377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20548136|NCT01898377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548137|NCT01898377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20548138|NCT01898377|Antitubercular Agents|antitubercular agents|mesh-ancestor
20548139|NCT01898377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20548140|NCT01898377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548141|NCT01898377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548142|NCT01898377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548143|NCT01898377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20548144|NCT01898416|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20548145|NCT01898416|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19962812|NCT01720797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19962813|NCT01721070|Ketoconazole|ketoconazole|mesh-list
19962814|NCT01721070|Sufentanil|sufentanil|mesh-list
19962815|NCT01721070|Dsuvia|dsuvia|mesh-list
19962816|NCT01721070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20283163|NCT00600158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20283164|NCT00600158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20283165|NCT00600158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283166|NCT00600158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20283167|NCT00600158|Narcotics|narcotics|mesh-ancestor
20283168|NCT00600158|Analgesics|analgesics|mesh-ancestor
20283169|NCT00600210|Bevacizumab|bevacizumab|mesh-list
20283170|NCT00600210|Carboplatin|carboplatin|mesh-list
20283171|NCT00600210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20283172|NCT00600210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283173|NCT00600210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20283174|NCT00600210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20283175|NCT00600210|Growth Substances|growth substances|mesh-ancestor
20283176|NCT00600210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283177|NCT00600210|Growth Inhibitors|growth inhibitors|mesh-ancestor
20283178|NCT00600249|Docetaxel|docetaxel|mesh-list
20283179|NCT00600249|Cetuximab|cetuximab|mesh-list
20283180|NCT00600249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283181|NCT00600249|Tubulin Modulators|tubulin modulators|mesh-ancestor
20283182|NCT00600249|Antimitotic Agents|antimitotic agents|mesh-ancestor
20283183|NCT00600249|Mitosis Modulators|mitosis modulators|mesh-ancestor
20283184|NCT00600249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283185|NCT00600249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20283186|NCT00600262|Bevacizumab|bevacizumab|mesh-list
20283187|NCT00600262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20283188|NCT00600262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283189|NCT00600262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20283190|NCT00600262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20283191|NCT00600262|Growth Substances|growth substances|mesh-ancestor
20283192|NCT00600262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283193|NCT00600262|Growth Inhibitors|growth inhibitors|mesh-ancestor
20283194|NCT00600301|Triamcinolone|triamcinolone|mesh-list
20283195|NCT00600301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20283196|NCT00600301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20283197|NCT00600301|Bevacizumab|bevacizumab|mesh-list
20283198|NCT00600301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20283199|NCT00600301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20283200|NCT00600301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283201|NCT00600301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20283202|NCT00600301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20283203|NCT00600301|Growth Substances|growth substances|mesh-ancestor
20283204|NCT00600301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283205|NCT00600301|Growth Inhibitors|growth inhibitors|mesh-ancestor
20283206|NCT00600301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20283207|NCT00600301|Glucocorticoids|glucocorticoids|mesh-ancestor
20283208|NCT00600301|Hormones|hormones|mesh-ancestor
20283209|NCT00600301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20283210|NCT00600301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20283211|NCT00600301|Immunologic Factors|immunologic factors|mesh-ancestor
20283212|NCT00600301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283213|NCT00600301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283214|NCT00600366|Insulin Aspart|insulin aspart|mesh-list
20283215|NCT00600366|Biphasic Insulins|biphasic insulins|mesh-list
20283216|NCT00600366|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20283217|NCT00600366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20283218|NCT00600366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283219|NCT00600405|Ibuprofen|ibuprofen|mesh-list
20283220|NCT00600405|Oxycodone|oxycodone|mesh-list
20283221|NCT00600405|Tamsulosin|tamsulosin|mesh-list
20283222|NCT00600405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20283223|NCT00600405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20283224|NCT00600405|Analgesics|analgesics|mesh-ancestor
20283225|NCT00600405|Sensory System Agents|sensory system agents|mesh-ancestor
20283226|NCT00600405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20283227|NCT00600405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283228|NCT00600405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20283229|NCT00600405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20283230|NCT00600405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20283231|NCT00600405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283232|NCT00600405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283233|NCT00600405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20283234|NCT00600405|Narcotics|narcotics|mesh-ancestor
20283235|NCT00600405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20283236|NCT00600405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20283237|NCT00600405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20283238|NCT00600405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20283239|NCT00600405|Adrenergic Agents|adrenergic agents|mesh-ancestor
20283240|NCT00600405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283241|NCT00600405|Urological Agents|urological agents|mesh-ancestor
20283242|NCT00600509|Levetiracetam|levetiracetam|mesh-list
20283243|NCT00600509|Anticonvulsants|anticonvulsants|mesh-ancestor
20283244|NCT00600509|Nootropic Agents|nootropic agents|mesh-ancestor
20283245|NCT00600535|Abiraterone Acetate|abiraterone acetate|mesh-list
20283246|NCT00600535|Glucocorticoids|glucocorticoids|mesh-list
20283247|NCT00600535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283248|NCT00600535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20283249|NCT00600535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283250|NCT00600535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283251|NCT00600535|Hormone Antagonists|hormone antagonists|mesh-ancestor
20283252|NCT00600535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20548146|NCT01898416|Dermatologic Agents|dermatologic agents|mesh-ancestor
20548147|NCT01898494|Carboplatin|carboplatin|mesh-list
20548148|NCT01898494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548149|NCT01898507|Nicotine|nicotine|mesh-list
20548150|NCT01898507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20548151|NCT01898507|Autonomic Agents|autonomic agents|mesh-ancestor
20548152|NCT01898507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548153|NCT01898507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548154|NCT01898507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20548155|NCT01898507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20548156|NCT01898507|Cholinergic Agents|cholinergic agents|mesh-ancestor
20548157|NCT01898507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20548158|NCT01898507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548159|NCT01898520|Nabiximols|nabiximols|mesh-list
20548160|NCT01898520|Analgesics|analgesics|mesh-ancestor
20548161|NCT01898520|Sensory System Agents|sensory system agents|mesh-ancestor
19962817|NCT01721070|Narcotics|narcotics|mesh-ancestor
19962818|NCT01721070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19962819|NCT01721070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962820|NCT01721070|Analgesics|analgesics|mesh-ancestor
19962821|NCT01721070|Sensory System Agents|sensory system agents|mesh-ancestor
19962822|NCT01721070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19962823|NCT01721070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20548162|NCT01898520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548163|NCT01898520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548164|NCT01898585|Vemurafenib|vemurafenib|mesh-list
20548165|NCT01898585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548166|NCT01898585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20548167|NCT01898585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548168|NCT01898585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548169|NCT01898624|Mirabegron|mirabegron|mesh-list
20548170|NCT01898624|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20548171|NCT01898624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20548172|NCT01898624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20548173|NCT01898624|Adrenergic Agents|adrenergic agents|mesh-ancestor
20548174|NCT01898624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20548175|NCT01898624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548176|NCT01898624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548177|NCT01898624|Urological Agents|urological agents|mesh-ancestor
20548178|NCT01898676|Valproic Acid|valproic acid|mesh-list
20548179|NCT01898676|Anticonvulsants|anticonvulsants|mesh-ancestor
20548180|NCT01898676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548181|NCT01898676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548182|NCT01898676|GABA Agents|gaba agents|mesh-ancestor
20548183|NCT01898676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20548184|NCT01898676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548185|NCT01898676|Antimanic Agents|antimanic agents|mesh-ancestor
20548186|NCT01898676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20548187|NCT01898676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20548188|NCT01898676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20548189|NCT01898728|Iodine|iodine|mesh-list
20548190|NCT01898728|Cadexomer iodine|cadexomer iodine|mesh-list
20548191|NCT01898728|Povidone-Iodine|povidone-iodine|mesh-list
20548192|NCT01898728|Povidone|povidone|mesh-list
20548193|NCT01898728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20548194|NCT01898728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20548195|NCT01898728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20548196|NCT01898728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548197|NCT01898728|Trace Elements|trace elements|mesh-ancestor
20548198|NCT01898728|Micronutrients|micronutrients|mesh-ancestor
19962824|NCT01721070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19962825|NCT01721070|Anesthetics, General|anesthetics, general|mesh-ancestor
19962826|NCT01721070|Anesthetics|anesthetics|mesh-ancestor
19962827|NCT01721070|Antifungal Agents|antifungal agents|mesh-ancestor
19962828|NCT01721070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19962829|NCT01721070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19962830|NCT01721070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19962831|NCT01721070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962832|NCT01721070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962833|NCT01721070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19962834|NCT01721070|Hormone Antagonists|hormone antagonists|mesh-ancestor
19962835|NCT01721070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19962836|NCT01721070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19962837|NCT01721109|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19962838|NCT01721109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19962839|NCT01721109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19962840|NCT01721109|Antiviral Agents|antiviral agents|mesh-ancestor
19962841|NCT01721109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19962842|NCT01721226|Opiate Alkaloids|opiate alkaloids|mesh-list
19962843|NCT01721226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19962844|NCT01721226|Narcotics|narcotics|mesh-ancestor
19962845|NCT01721226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19962846|NCT01721226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962847|NCT01721226|Analgesics|analgesics|mesh-ancestor
19962848|NCT01721226|Sensory System Agents|sensory system agents|mesh-ancestor
19962849|NCT01721226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19962850|NCT01721317|Ezogabine|ezogabine|mesh-list
19962851|NCT01721317|Anticonvulsants|anticonvulsants|mesh-ancestor
19962852|NCT01721317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19962853|NCT01721317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962854|NCT01721330|Naltrexone|naltrexone|mesh-list
19962855|NCT01721330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19962856|NCT01721330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19962857|NCT01721330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283253|NCT00600535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283254|NCT00600535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20283255|NCT00600535|Hormones|hormones|mesh-ancestor
20283256|NCT00600548|Miltefosine|miltefosine|mesh-list
20283257|NCT00600548|Meglumine Antimoniate|meglumine antimoniate|mesh-list
20283258|NCT00600548|Antifungal Agents|antifungal agents|mesh-ancestor
20283259|NCT00600548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20283260|NCT00600548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283261|NCT00600548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20283262|NCT00600548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20283263|NCT00600587|Gemcitabine|gemcitabine|mesh-list
20283264|NCT00600587|Carboplatin|carboplatin|mesh-list
20283265|NCT00600587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20283266|NCT00600587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283267|NCT00600587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20283268|NCT00600587|Antimetabolites|antimetabolites|mesh-ancestor
20283269|NCT00600587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283270|NCT00600587|Antiviral Agents|antiviral agents|mesh-ancestor
20283271|NCT00600587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20283272|NCT00600587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283273|NCT00600587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20283274|NCT00600587|Immunologic Factors|immunologic factors|mesh-ancestor
20283275|NCT00600587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283276|NCT00600587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20283277|NCT00600600|Tigecycline|tigecycline|mesh-list
20283278|NCT00600600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20283279|NCT00600600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20283280|NCT00600600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20283281|NCT00600600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283282|NCT00600600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283283|NCT00600626|Insulin|insulin|mesh-list
20283284|NCT00600626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20283285|NCT00600626|Insulin Aspart|insulin aspart|mesh-list
20283286|NCT00600626|Insulin, Long-Acting|insulin, long-acting|mesh-list
20283287|NCT00600626|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20283288|NCT00600626|Biphasic Insulins|biphasic insulins|mesh-list
20283289|NCT00600626|Isophane Insulin, Human|isophane insulin, human|mesh-list
20283290|NCT00600626|Insulin, Isophane|insulin, isophane|mesh-list
20283291|NCT00600626|Isophane insulin, beef|isophane insulin, beef|mesh-list
20283292|NCT00600626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20283293|NCT00600626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283294|NCT00600639|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20283295|NCT00600639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20283296|NCT00600639|Prednisolone|prednisolone|mesh-list
20283297|NCT00600639|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20283298|NCT00600639|Methylprednisolone|methylprednisolone|mesh-list
20283299|NCT00600639|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20283300|NCT00600639|Prednisolone acetate|prednisolone acetate|mesh-list
20283301|NCT00600639|Albuterol|albuterol|mesh-list
20283302|NCT00600639|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20283303|NCT00600639|Prednisolone phosphate|prednisolone phosphate|mesh-list
20283304|NCT00600639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20283305|NCT00600639|Antitubercular Agents|antitubercular agents|mesh-ancestor
20283306|NCT00600639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20283307|NCT00600639|Glucocorticoids|glucocorticoids|mesh-ancestor
20283308|NCT00600639|Hormones|hormones|mesh-ancestor
20283309|NCT00600639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20283310|NCT00600639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283311|NCT00600639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20283312|NCT00600639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283313|NCT00600639|Antiemetics|antiemetics|mesh-ancestor
20283314|NCT00600639|Autonomic Agents|autonomic agents|mesh-ancestor
20283315|NCT00600639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20283316|NCT00600639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20283317|NCT00600639|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20283318|NCT00600639|Protective Agents|protective agents|mesh-ancestor
20283319|NCT00600639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20283320|NCT00600639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20283321|NCT00600639|Respiratory System Agents|respiratory system agents|mesh-ancestor
19962858|NCT01721330|Sensory System Agents|sensory system agents|mesh-ancestor
19962859|NCT01721330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19962860|NCT01721408|Imipenem|imipenem|mesh-list
20283322|NCT00600639|Tocolytic Agents|tocolytic agents|mesh-ancestor
20283323|NCT00600639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20283324|NCT00600639|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20283325|NCT00600639|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20283326|NCT00600639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20283327|NCT00600639|Adrenergic Agents|adrenergic agents|mesh-ancestor
20283328|NCT00600639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283329|NCT00600639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283330|NCT00600691|Finasteride|finasteride|mesh-list
20283331|NCT00600691|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20283332|NCT00600691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20283333|NCT00600691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283334|NCT00600691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283335|NCT00600691|Hormone Antagonists|hormone antagonists|mesh-ancestor
20283336|NCT00600691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20283337|NCT00600691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283338|NCT00600691|Urological Agents|urological agents|mesh-ancestor
20283339|NCT00600730|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20283340|NCT00600730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283341|NCT00600769|Clarithromycin|clarithromycin|mesh-list
20283342|NCT00600769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20283343|NCT00600769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20283344|NCT00600769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20283345|NCT00600769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962861|NCT01721408|Tigecycline|tigecycline|mesh-list
19962862|NCT01721408|Cilastatin|cilastatin|mesh-list
19962863|NCT01721408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19962864|NCT01721408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19962865|NCT01721408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19962866|NCT01721408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962867|NCT01721408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962868|NCT01721408|Protease Inhibitors|protease inhibitors|mesh-ancestor
19962869|NCT01721460|Dexmedetomidine|dexmedetomidine|mesh-list
19962870|NCT01721460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19962871|NCT01721460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19962872|NCT01721460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962873|NCT01721460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19962874|NCT01721460|Analgesics|analgesics|mesh-ancestor
19962875|NCT01721460|Sensory System Agents|sensory system agents|mesh-ancestor
19962876|NCT01721460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19962877|NCT01721460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19962878|NCT01721460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20283346|NCT00600769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283347|NCT00600769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20283348|NCT00600769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20283349|NCT00600847|Loratadine|loratadine|mesh-list
20283350|NCT00600847|Desloratadine|desloratadine|mesh-list
20283351|NCT00600847|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20283352|NCT00600847|Cholinergic Agents|cholinergic agents|mesh-ancestor
20283353|NCT00600847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283354|NCT00600847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283355|NCT00600847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283356|NCT00600847|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20283357|NCT00600847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20283358|NCT00600847|Histamine Antagonists|histamine antagonists|mesh-ancestor
19962879|NCT01721460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19962880|NCT01721460|Adrenergic Agents|adrenergic agents|mesh-ancestor
19962881|NCT01721460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19962882|NCT01721460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962883|NCT01721486|Acetaminophen|acetaminophen|mesh-list
19962884|NCT01721486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19962885|NCT01721486|Analgesics|analgesics|mesh-ancestor
19962886|NCT01721486|Sensory System Agents|sensory system agents|mesh-ancestor
19962887|NCT01721486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19962888|NCT01721486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962889|NCT01721486|Antipyretics|antipyretics|mesh-ancestor
19962890|NCT01721564|Bosentan|bosentan|mesh-list
19962891|NCT01721564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19962892|NCT01721564|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19962893|NCT01721564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962894|NCT01721603|Trametinib|trametinib|mesh-list
19962895|NCT01721603|Dabrafenib|dabrafenib|mesh-list
19962896|NCT01721603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962897|NCT01721603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19962898|NCT01721603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283359|NCT00600847|Histamine Agents|histamine agents|mesh-ancestor
20283360|NCT00600847|Antipruritics|antipruritics|mesh-ancestor
20283361|NCT00600847|Dermatologic Agents|dermatologic agents|mesh-ancestor
20283362|NCT00600847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20283363|NCT00600873|Pramipexole|pramipexole|mesh-list
20283364|NCT00600873|Antioxidants|antioxidants|mesh-ancestor
20548199|NCT01898728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733329|NCT04563000|Ascorbic Acid|ascorbic acid|mesh-list
19733330|NCT04563000|Vitamins|vitamins|mesh-ancestor
19733331|NCT04563000|Micronutrients|micronutrients|mesh-ancestor
19733332|NCT04563000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733333|NCT04563000|Antioxidants|antioxidants|mesh-ancestor
19733334|NCT04563000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733335|NCT04563000|Protective Agents|protective agents|mesh-ancestor
19733336|NCT04562532|Sirolimus|sirolimus|mesh-list
19733337|NCT04562532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19733338|NCT04562532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19733339|NCT04562532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19733340|NCT04562532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733341|NCT04562532|Antifungal Agents|antifungal agents|mesh-ancestor
19733342|NCT04562532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20548200|NCT01898728|Plasma Substitutes|plasma substitutes|mesh-ancestor
20548201|NCT01898728|Blood Substitutes|blood substitutes|mesh-ancestor
20548202|NCT01898819|Dexmedetomidine|dexmedetomidine|mesh-list
19733343|NCT04562532|Immunologic Factors|immunologic factors|mesh-ancestor
19962899|NCT01721603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962900|NCT01721772|Nivolumab|nivolumab|mesh-list
19962901|NCT01721772|Dacarbazine|dacarbazine|mesh-list
19962902|NCT01721772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19962903|NCT01721772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962904|NCT01721772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19962905|NCT01721772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962906|NCT01721772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19962907|NCT01721772|Alkylating Agents|alkylating agents|mesh-ancestor
19962908|NCT01721876|Cytarabine|cytarabine|mesh-list
19962909|NCT01721876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19962910|NCT01721876|Antimetabolites|antimetabolites|mesh-ancestor
19962911|NCT01721876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962912|NCT01721876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962913|NCT01721876|Antiviral Agents|antiviral agents|mesh-ancestor
19962914|NCT01721876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19962915|NCT01721876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20283365|NCT00600873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283366|NCT00600873|Protective Agents|protective agents|mesh-ancestor
20283367|NCT00600873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283368|NCT00600873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20283369|NCT00600873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20283370|NCT00600873|Dopamine Agonists|dopamine agonists|mesh-ancestor
20283371|NCT00600873|Dopamine Agents|dopamine agents|mesh-ancestor
20283372|NCT00600873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283373|NCT00600912|SMOFlipid|smoflipid|mesh-list
20283374|NCT00600912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20283375|NCT00600912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20283376|NCT00600912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20288324|NCT05335629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20288325|NCT05335629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288326|NCT05335629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20288327|NCT05335629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288328|NCT05335460|Capecitabine|capecitabine|mesh-list
20288329|NCT05335460|Oxaliplatin|oxaliplatin|mesh-list
20288330|NCT05335460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20288331|NCT05335460|Antimetabolites|antimetabolites|mesh-ancestor
20288332|NCT05335460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288333|NCT05335460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288336|NCT05335278|Nintedanib|nintedanib|mesh-list
20288337|NCT05335278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288338|NCT05335278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20288339|NCT05335278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962916|NCT01721876|Immunologic Factors|immunologic factors|mesh-ancestor
19962917|NCT01721876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962918|NCT01721967|Ranolazine|ranolazine|mesh-list
19962919|NCT01721967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19962920|NCT01721967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20288340|NCT05335278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288341|NCT05335122|Bimatoprost|bimatoprost|mesh-list
20288342|NCT05335122|Travoprost|travoprost|mesh-list
20288343|NCT05335122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20288344|NCT05334745|Hyaluronic Acid|hyaluronic acid|mesh-list
20288345|NCT05334745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20288346|NCT05334745|Immunologic Factors|immunologic factors|mesh-ancestor
20548203|NCT01898819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20548204|NCT01898819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20548205|NCT01898819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548206|NCT01898819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20548207|NCT01898819|Analgesics|analgesics|mesh-ancestor
20548208|NCT01898819|Sensory System Agents|sensory system agents|mesh-ancestor
20548209|NCT01898819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548210|NCT01898819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20548211|NCT01898819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20548212|NCT01898819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20548213|NCT01898819|Adrenergic Agents|adrenergic agents|mesh-ancestor
19962921|NCT01721967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962922|NCT01722045|Aflibercept|aflibercept|mesh-list
19962923|NCT01722045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19962924|NCT01722045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19962925|NCT01722045|Growth Substances|growth substances|mesh-ancestor
19962926|NCT01722045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962927|NCT01722045|Growth Inhibitors|growth inhibitors|mesh-ancestor
19962928|NCT01722045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962929|NCT01722071|Oxytocin|oxytocin|mesh-list
20548214|NCT01898819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20548215|NCT01898819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962930|NCT01722071|Oxytocics|oxytocics|mesh-ancestor
19962931|NCT01722071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19962932|NCT01722071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962933|NCT01722097|Rocuronium|rocuronium|mesh-list
19962934|NCT01722097|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19962935|NCT01722097|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19962936|NCT01722097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19962937|NCT01722097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19962938|NCT01722097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962939|NCT01722162|Bevacizumab|bevacizumab|mesh-list
19962940|NCT01722162|Capecitabine|capecitabine|mesh-list
19962941|NCT01722162|Levocetirizine|levocetirizine|mesh-list
19962942|NCT01722162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19962943|NCT01722162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962944|NCT01722162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19962945|NCT01722162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19962946|NCT01722162|Growth Substances|growth substances|mesh-ancestor
19962947|NCT01722162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962948|NCT01722162|Growth Inhibitors|growth inhibitors|mesh-ancestor
19962949|NCT01722162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19962950|NCT01722162|Antimetabolites|antimetabolites|mesh-ancestor
19962951|NCT01722162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962952|NCT01722162|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19962953|NCT01722162|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19962954|NCT01722162|Histamine Antagonists|histamine antagonists|mesh-ancestor
19962955|NCT01722162|Histamine Agents|histamine agents|mesh-ancestor
19962956|NCT01722162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19962957|NCT01722266|Liraglutide|liraglutide|mesh-list
19962958|NCT01722266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19962959|NCT01722266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962960|NCT01722266|Incretins|incretins|mesh-ancestor
19962961|NCT01722266|Hormones|hormones|mesh-ancestor
19962962|NCT01722266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19962963|NCT01722292|Carboplatin|carboplatin|mesh-list
19962964|NCT01722292|Etoposide|etoposide|mesh-list
19962965|NCT01722292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962966|NCT01722292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19962967|NCT01722292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19962968|NCT01722292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19962969|NCT01722292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962970|NCT01722292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962971|NCT01722318|Plecanatide|plecanatide|mesh-list
19962972|NCT01722318|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19962973|NCT01722318|Enzyme Activators|enzyme activators|mesh-ancestor
19962974|NCT01722318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962975|NCT01722318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19962976|NCT01722435|Opiate Alkaloids|opiate alkaloids|mesh-list
19962977|NCT01722435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19962978|NCT01722435|Narcotics|narcotics|mesh-ancestor
19962979|NCT01722435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19962980|NCT01722435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962981|NCT01722435|Analgesics|analgesics|mesh-ancestor
19962982|NCT01722435|Sensory System Agents|sensory system agents|mesh-ancestor
19962983|NCT01722435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19962984|NCT01722487|Chlorambucil|chlorambucil|mesh-list
19962985|NCT01722487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19962986|NCT01722487|Alkylating Agents|alkylating agents|mesh-ancestor
19962987|NCT01722487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962988|NCT01722487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19962989|NCT01722604|Brinzolamide|brinzolamide|mesh-list
19962990|NCT01722604|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19962991|NCT01722604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19962992|NCT01722604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962993|NCT01722669|Quercetin|quercetin|mesh-list
19962994|NCT01722669|Antioxidants|antioxidants|mesh-ancestor
19962995|NCT01722669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19962996|NCT01722669|Protective Agents|protective agents|mesh-ancestor
19962997|NCT01722669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19962998|NCT01723072|Omalizumab|omalizumab|mesh-list
19962999|NCT01723072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19963000|NCT01723072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19963001|NCT01723072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19963002|NCT01723072|Respiratory System Agents|respiratory system agents|mesh-ancestor
19963003|NCT01723072|Immunologic Factors|immunologic factors|mesh-ancestor
19963004|NCT01723072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963005|NCT01723228|Rasagiline|rasagiline|mesh-list
19963006|NCT01723228|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19963007|NCT01723228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963008|NCT01723228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963009|NCT01723228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19963010|NCT01723228|Protective Agents|protective agents|mesh-ancestor
19963011|NCT01723228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963012|NCT01723254|Immunoglobulin E|immunoglobulin e|mesh-list
19963013|NCT01723254|Immunologic Factors|immunologic factors|mesh-ancestor
20283377|NCT00600964|Obatoclax|obatoclax|mesh-list
20283378|NCT00600964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283379|NCT00600964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283380|NCT00600977|Doxorubicin|doxorubicin|mesh-list
20283381|NCT00600977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20283382|NCT00600977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20283383|NCT00600977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283384|NCT00600977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20283385|NCT00600977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20283386|NCT00600977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283387|NCT00600977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283388|NCT00600990|Vestipitant|vestipitant|mesh-list
19963014|NCT01723254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963015|NCT01723384|Naltrexone|naltrexone|mesh-list
19963016|NCT01723384|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19963017|NCT01723384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19963018|NCT01723384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963019|NCT01723384|Sensory System Agents|sensory system agents|mesh-ancestor
19963020|NCT01723384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20283389|NCT00600990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20283390|NCT00600990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283391|NCT00600990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283392|NCT00600990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283393|NCT00601016|Imiquimod|imiquimod|mesh-list
20283394|NCT00601016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20283395|NCT00601016|Immunologic Factors|immunologic factors|mesh-ancestor
20283396|NCT00601016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283397|NCT00601016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283398|NCT00601016|Interferon Inducers|interferon inducers|mesh-ancestor
20283399|NCT00601042|Lobeline|lobeline|mesh-list
20283400|NCT00601042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20283401|NCT00601042|Autonomic Agents|autonomic agents|mesh-ancestor
20283402|NCT00601042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20283403|NCT00601042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283404|NCT00601042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20283405|NCT00601042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20283406|NCT00601042|Cholinergic Agents|cholinergic agents|mesh-ancestor
20283407|NCT00601042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283408|NCT00601042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963021|NCT01723514|Erenumab|erenumab|mesh-list
19963022|NCT01723514|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19963023|NCT01723514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963024|NCT01723514|Analgesics|analgesics|mesh-ancestor
19963025|NCT01723514|Sensory System Agents|sensory system agents|mesh-ancestor
19963026|NCT01723514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19963027|NCT01723514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963028|NCT01723696|Vitamins|vitamins|mesh-list
19963029|NCT01723696|Ascorbic Acid|ascorbic acid|mesh-list
19963030|NCT01723696|Micronutrients|micronutrients|mesh-ancestor
19963031|NCT01723696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283409|NCT00601042|Respiratory System Agents|respiratory system agents|mesh-ancestor
20283410|NCT00601198|Leucovorin|leucovorin|mesh-list
20283411|NCT00601198|Oxaliplatin|oxaliplatin|mesh-list
20283412|NCT00601198|Levoleucovorin|levoleucovorin|mesh-list
20283413|NCT00601198|Amifostine|amifostine|mesh-list
20283414|NCT00601198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283415|NCT00601198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283416|NCT00601198|Antidotes|antidotes|mesh-ancestor
20283417|NCT00601198|Protective Agents|protective agents|mesh-ancestor
20283418|NCT00601198|Vitamin B Complex|vitamin b complex|mesh-ancestor
20283419|NCT00601198|Vitamins|vitamins|mesh-ancestor
20283420|NCT00601198|Micronutrients|micronutrients|mesh-ancestor
19963032|NCT01723696|Antioxidants|antioxidants|mesh-ancestor
19963033|NCT01723696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963034|NCT01723696|Protective Agents|protective agents|mesh-ancestor
19963035|NCT01723722|Methadone|methadone|mesh-list
19963036|NCT01723722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19963037|NCT01723722|Narcotics|narcotics|mesh-ancestor
19963038|NCT01723722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19963039|NCT01723722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963040|NCT01723722|Analgesics|analgesics|mesh-ancestor
19963041|NCT01723722|Sensory System Agents|sensory system agents|mesh-ancestor
20283421|NCT00601198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20283422|NCT00601211|Pilocarpine|pilocarpine|mesh-list
20283423|NCT00601211|Miotics|miotics|mesh-ancestor
20283424|NCT00601211|Autonomic Agents|autonomic agents|mesh-ancestor
20283425|NCT00601211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20283426|NCT00601211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283427|NCT00601211|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20283428|NCT00601211|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20283429|NCT00601211|Cholinergic Agents|cholinergic agents|mesh-ancestor
20283430|NCT00601211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283431|NCT00601211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283432|NCT00601276|Leuprolide|leuprolide|mesh-list
20283433|NCT00601276|Cyproterone Acetate|cyproterone acetate|mesh-list
20283434|NCT00601276|Cyproterone|cyproterone|mesh-list
20283435|NCT00601276|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20283436|NCT00601276|Fertility Agents|fertility agents|mesh-ancestor
19963042|NCT01723722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20283437|NCT00601276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20283438|NCT00601276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283439|NCT00601276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20283440|NCT00601276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283441|NCT00601276|Androgen Antagonists|androgen antagonists|mesh-ancestor
20283442|NCT00601276|Hormone Antagonists|hormone antagonists|mesh-ancestor
20283443|NCT00601276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19963043|NCT01723722|Antitussive Agents|antitussive agents|mesh-ancestor
20283444|NCT00601276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20283445|NCT00601276|Contraceptive Agents|contraceptive agents|mesh-ancestor
20283446|NCT00601289|Temozolomide|temozolomide|mesh-list
20283447|NCT00601289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20283448|NCT00601289|Alkylating Agents|alkylating agents|mesh-ancestor
20283449|NCT00601289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283450|NCT00601289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963044|NCT01723722|Respiratory System Agents|respiratory system agents|mesh-ancestor
19974942|NCT01843920|Renal Agents|renal agents|mesh-ancestor
19974943|NCT01843920|Antimalarials|antimalarials|mesh-ancestor
20283451|NCT00601302|Amlodipine|amlodipine|mesh-list
20283452|NCT00601302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20283453|NCT00601302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20283454|NCT00601302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20283455|NCT00601302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283456|NCT00601302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20283457|NCT00601302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283458|NCT00601302|Vasodilator Agents|vasodilator agents|mesh-ancestor
20283459|NCT00601315|Clarithromycin|clarithromycin|mesh-list
20283460|NCT00601315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20283461|NCT00601315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20283462|NCT00601315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20283463|NCT00601315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283464|NCT00601315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283465|NCT00601315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20283466|NCT00601315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20283467|NCT00601328|Calcitriol|calcitriol|mesh-list
20283468|NCT00601328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20283469|NCT00601328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283470|NCT00601328|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20283471|NCT00601328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20283472|NCT00601328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283473|NCT00601328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20283474|NCT00601328|Vitamins|vitamins|mesh-ancestor
19974944|NCT01843920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19974945|NCT01843920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19974946|NCT01843920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19974947|NCT01843920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974948|NCT01843920|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19974949|NCT01843920|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19974950|NCT01843920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19974951|NCT01843920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20283475|NCT00601328|Micronutrients|micronutrients|mesh-ancestor
20283476|NCT00601328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20283477|NCT00601432|Levofloxacin|levofloxacin|mesh-list
20283478|NCT00601432|Ofloxacin|ofloxacin|mesh-list
20283479|NCT00601432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20548216|NCT01898897|Anesthetics|anesthetics|mesh-list
19974952|NCT01843920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19974953|NCT01844076|Quinacrine|quinacrine|mesh-list
20283480|NCT00601432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20283481|NCT00601432|Renal Agents|renal agents|mesh-ancestor
20283482|NCT00601432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20283483|NCT00601432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20283484|NCT00601432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20283485|NCT00601432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283486|NCT00601432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283487|NCT00601432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963045|NCT01723904|Rotigotine|rotigotine|mesh-list
19963046|NCT01723904|Dopamine Agonists|dopamine agonists|mesh-ancestor
19963047|NCT01723904|Dopamine Agents|dopamine agents|mesh-ancestor
19963048|NCT01723904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19963049|NCT01723904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963050|NCT01723904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963051|NCT01724021|Prednisone|prednisone|mesh-list
19963052|NCT01724021|Prednisolone|prednisolone|mesh-list
19963053|NCT01724021|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19963054|NCT01724021|Methylprednisolone|methylprednisolone|mesh-list
19963055|NCT01724021|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19963056|NCT01724021|Prednisolone acetate|prednisolone acetate|mesh-list
19963057|NCT01724021|Cyclophosphamide|cyclophosphamide|mesh-list
19963058|NCT01724021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19963059|NCT01724021|Rituximab|rituximab|mesh-list
19963060|NCT01724021|Vincristine|vincristine|mesh-list
19963061|NCT01724021|Doxorubicin|doxorubicin|mesh-list
19963062|NCT01724021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20283488|NCT00601432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20283489|NCT00601432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20283490|NCT00601510|Capecitabine|capecitabine|mesh-list
20283491|NCT00601510|Imatinib Mesylate|imatinib mesylate|mesh-list
20283492|NCT00601510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283493|NCT00601510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20283494|NCT00601510|Antimetabolites|antimetabolites|mesh-ancestor
20283495|NCT00601510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283496|NCT00601510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20283497|NCT00601510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283498|NCT00601536|Lithium Carbonate|lithium carbonate|mesh-list
20283499|NCT00601536|Antidepressive Agents|antidepressive agents|mesh-ancestor
20283500|NCT00601536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20283501|NCT00601536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283502|NCT00601536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283503|NCT00601536|Antimanic Agents|antimanic agents|mesh-ancestor
20283504|NCT00601536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20283505|NCT00601536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20283506|NCT00601536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283507|NCT00601562|Zidovudine|zidovudine|mesh-list
20283508|NCT00601562|Antimetabolites|antimetabolites|mesh-ancestor
20283509|NCT00601562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283510|NCT00601562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20283511|NCT00601562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20283512|NCT00601562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283513|NCT00601562|Antiviral Agents|antiviral agents|mesh-ancestor
20283514|NCT00601562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20283515|NCT00601562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20283516|NCT00601562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20548217|NCT01898897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20548218|NCT01898897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548219|NCT01899027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19963063|NCT01724021|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19963064|NCT01724021|Prednisolone phosphate|prednisolone phosphate|mesh-list
19963065|NCT01724021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19963066|NCT01724021|Immunologic Factors|immunologic factors|mesh-ancestor
19963067|NCT01724021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963068|NCT01724021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19963069|NCT01724021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19963070|NCT01724021|Alkylating Agents|alkylating agents|mesh-ancestor
19963071|NCT01724021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963072|NCT01724021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963073|NCT01724021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19963074|NCT01724021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19963075|NCT01724021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20283517|NCT00601575|Lithium Carbonate|lithium carbonate|mesh-list
20548220|NCT01899027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19963076|NCT01724021|Glucocorticoids|glucocorticoids|mesh-ancestor
20283518|NCT00601575|Antidepressive Agents|antidepressive agents|mesh-ancestor
19963077|NCT01724021|Hormones|hormones|mesh-ancestor
19963078|NCT01724021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19963079|NCT01724021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20283519|NCT00601575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20283520|NCT00601575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283521|NCT00601575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283522|NCT00601575|Antimanic Agents|antimanic agents|mesh-ancestor
20283523|NCT00601575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20283524|NCT00601575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20283525|NCT00601575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963080|NCT01724021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19963081|NCT01724021|Tubulin Modulators|tubulin modulators|mesh-ancestor
20283526|NCT00601588|Sertraline|sertraline|mesh-list
20283527|NCT00601588|Antidepressive Agents|antidepressive agents|mesh-ancestor
20283528|NCT00601588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19963082|NCT01724021|Antimitotic Agents|antimitotic agents|mesh-ancestor
19963083|NCT01724021|Mitosis Modulators|mitosis modulators|mesh-ancestor
19963084|NCT01724021|Antiemetics|antiemetics|mesh-ancestor
19963085|NCT01724021|Autonomic Agents|autonomic agents|mesh-ancestor
19963086|NCT01724021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19963087|NCT01724021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19963088|NCT01724021|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20283529|NCT00601588|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20283530|NCT00601588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20283531|NCT00601588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20283532|NCT00601588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283533|NCT00601588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283534|NCT00601588|Serotonin Agents|serotonin agents|mesh-ancestor
20283535|NCT00601588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283536|NCT00601614|Temozolomide|temozolomide|mesh-list
20283537|NCT00601614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20283538|NCT00601614|Alkylating Agents|alkylating agents|mesh-ancestor
20283539|NCT00601614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283540|NCT00601614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283541|NCT00601666|Zolpidem|zolpidem|mesh-list
20283542|NCT00601666|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20283543|NCT00601666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20283544|NCT00601666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20283545|NCT00601666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283546|NCT00601666|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20283547|NCT00601666|GABA Agonists|gaba agonists|mesh-ancestor
20283548|NCT00601666|GABA Agents|gaba agents|mesh-ancestor
20283549|NCT00601666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283550|NCT00601666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283551|NCT00601692|Docetaxel|docetaxel|mesh-list
20283552|NCT00601692|Irinotecan|irinotecan|mesh-list
20283553|NCT00601692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283554|NCT00601692|Tubulin Modulators|tubulin modulators|mesh-ancestor
20283555|NCT00601692|Antimitotic Agents|antimitotic agents|mesh-ancestor
20283556|NCT00601692|Mitosis Modulators|mitosis modulators|mesh-ancestor
20283557|NCT00601692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283558|NCT00601692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20283559|NCT00601692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20283560|NCT00601692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283561|NCT00601874|Pilocarpine|pilocarpine|mesh-list
20283562|NCT00601874|Miotics|miotics|mesh-ancestor
20283563|NCT00601874|Autonomic Agents|autonomic agents|mesh-ancestor
19963089|NCT01724021|Protective Agents|protective agents|mesh-ancestor
19963090|NCT01724021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19963091|NCT01724021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20283564|NCT00601874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19963092|NCT01724021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19963093|NCT01724021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963094|NCT01724177|Lenalidomide|lenalidomide|mesh-list
19963095|NCT01724177|Immunologic Factors|immunologic factors|mesh-ancestor
19963096|NCT01724177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963097|NCT01724177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19963098|NCT01724177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19963099|NCT01724177|Growth Substances|growth substances|mesh-ancestor
19963100|NCT01724177|Growth Inhibitors|growth inhibitors|mesh-ancestor
19963101|NCT01724177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963102|NCT01724359|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19963103|NCT01724359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19963104|NCT01724359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20283565|NCT00601874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283566|NCT00601874|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20283567|NCT00601874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20283568|NCT00601874|Cholinergic Agents|cholinergic agents|mesh-ancestor
20283569|NCT00601874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283570|NCT00601874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283571|NCT00601887|Meloxicam|meloxicam|mesh-list
20283572|NCT00601887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20283573|NCT00601887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20283574|NCT00601887|Analgesics|analgesics|mesh-ancestor
20283575|NCT00601887|Sensory System Agents|sensory system agents|mesh-ancestor
19963105|NCT01724359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20283576|NCT00601887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20283577|NCT00601887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283578|NCT00601887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20283579|NCT00601887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20283580|NCT00601887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20283581|NCT00601887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20283582|NCT00601887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283583|NCT00601887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283584|NCT00601913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20283585|NCT00601913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283586|NCT00601913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20283587|NCT00601913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963106|NCT01724359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963107|NCT01724359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19963108|NCT01724359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19963109|NCT01724359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19963110|NCT01724359|Serotonin Agents|serotonin agents|mesh-ancestor
19963111|NCT01724359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19963112|NCT01724359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963113|NCT01724359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19963114|NCT01724359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19963115|NCT01724359|Dopamine Agents|dopamine agents|mesh-ancestor
19963116|NCT01724489|Hormones|hormones|mesh-list
19963117|NCT01724489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19963118|NCT01724489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963119|NCT01724528|Allopurinol|allopurinol|mesh-list
19963120|NCT01724528|Febuxostat|febuxostat|mesh-list
19963121|NCT01724528|Antimetabolites|antimetabolites|mesh-ancestor
19963122|NCT01724528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963123|NCT01724528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963124|NCT01724528|Gout Suppressants|gout suppressants|mesh-ancestor
19963125|NCT01724528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19963126|NCT01724528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19963127|NCT01724528|Antioxidants|antioxidants|mesh-ancestor
19963128|NCT01724528|Protective Agents|protective agents|mesh-ancestor
19963129|NCT01724528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963130|NCT01725126|Metformin|metformin|mesh-list
19963131|NCT01725126|Liraglutide|liraglutide|mesh-list
19963132|NCT01725126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19963133|NCT01725126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963134|NCT01725126|Incretins|incretins|mesh-ancestor
19963135|NCT01725126|Hormones|hormones|mesh-ancestor
19963136|NCT01725126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19963137|NCT01725282|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19963138|NCT01725282|Antidepressive Agents|antidepressive agents|mesh-ancestor
19963139|NCT01725282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19963140|NCT01725282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19963141|NCT01725282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19963142|NCT01725282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19963143|NCT01725282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963144|NCT01725308|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19963145|NCT01725308|Antidepressive Agents|antidepressive agents|mesh-ancestor
19963146|NCT01725308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19963147|NCT01725308|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19963148|NCT01725308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20283588|NCT00601913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283589|NCT00601978|Levodopa|levodopa|mesh-list
20283590|NCT00601978|Carbidopa|carbidopa|mesh-list
20283591|NCT00601978|Entacapone|entacapone|mesh-list
20283592|NCT00601978|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20283593|NCT00601978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19963149|NCT01725308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19963150|NCT01725308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963151|NCT01725386|Capecitabine|capecitabine|mesh-list
19963152|NCT01725386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19963153|NCT01725386|Antimetabolites|antimetabolites|mesh-ancestor
19963154|NCT01725386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963155|NCT01725386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963156|NCT01725451|Testosterone|testosterone|mesh-list
19963157|NCT01725451|Androgens|androgens|mesh-ancestor
19963158|NCT01725451|Hormones|hormones|mesh-ancestor
19963159|NCT01725451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19963160|NCT01725451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963161|NCT01725529|Ribavirin|ribavirin|mesh-list
19963162|NCT01725529|Simeprevir|simeprevir|mesh-list
19963163|NCT01725529|Antimetabolites|antimetabolites|mesh-ancestor
19963164|NCT01725529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963165|NCT01725529|Antiviral Agents|antiviral agents|mesh-ancestor
19963166|NCT01725529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19963167|NCT01725529|Protease Inhibitors|protease inhibitors|mesh-ancestor
19963168|NCT01725529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963169|NCT01726023|Metronidazole|metronidazole|mesh-list
19963170|NCT01726023|Meropenem|meropenem|mesh-list
19963171|NCT01726023|Ceftazidime|ceftazidime|mesh-list
19963172|NCT01726023|Avibactam|avibactam|mesh-list
19963173|NCT01726023|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
19963174|NCT01726023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19963175|NCT01726023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19963176|NCT01726023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19963177|NCT01726023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19963178|NCT01726023|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19963179|NCT01726023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963180|NCT01726023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963181|NCT01726049|Sildenafil Citrate|sildenafil citrate|mesh-list
19963182|NCT01726049|Vasodilator Agents|vasodilator agents|mesh-ancestor
19963183|NCT01726049|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19963184|NCT01726049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19963185|NCT01726049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963186|NCT01726049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963187|NCT01726049|Urological Agents|urological agents|mesh-ancestor
19963188|NCT01726270|Tamsulosin|tamsulosin|mesh-list
19963189|NCT01726270|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19963190|NCT01726270|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19963191|NCT01726270|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19963192|NCT01726270|Adrenergic Agents|adrenergic agents|mesh-ancestor
19963193|NCT01726270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19963194|NCT01726270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963195|NCT01726270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963196|NCT01726270|Urological Agents|urological agents|mesh-ancestor
19963197|NCT01726335|Risperidone|risperidone|mesh-list
19963198|NCT01726335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19963199|NCT01726335|Serotonin Agents|serotonin agents|mesh-ancestor
19963200|NCT01726335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19963201|NCT01726335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963202|NCT01726335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963203|NCT01726335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19963204|NCT01726335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19963205|NCT01726335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19963206|NCT01726335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19963207|NCT01726335|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19963208|NCT01726335|Dopamine Agents|dopamine agents|mesh-ancestor
19963209|NCT01726517|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19963210|NCT01726517|Antiviral Agents|antiviral agents|mesh-ancestor
19963211|NCT01726517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19963212|NCT01726621|Insulin|insulin|mesh-list
19963213|NCT01726621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19963214|NCT01726621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963215|NCT01726738|Trametinib|trametinib|mesh-list
19963216|NCT01726738|Dabrafenib|dabrafenib|mesh-list
19963217|NCT01726738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963218|NCT01726738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19963219|NCT01726738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963220|NCT01726738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963221|NCT01727024|Tiotropium Bromide|tiotropium bromide|mesh-list
19963222|NCT01727024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19963223|NCT01727024|Autonomic Agents|autonomic agents|mesh-ancestor
20288647|NCT05252988|Antidiarrheals|antidiarrheals|mesh-list
19974954|NCT01844076|Capecitabine|capecitabine|mesh-list
19963224|NCT01727024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19963225|NCT01727024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963226|NCT01727024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19963227|NCT01727024|Respiratory System Agents|respiratory system agents|mesh-ancestor
19963228|NCT01727024|Parasympatholytics|parasympatholytics|mesh-ancestor
19963229|NCT01727024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19963230|NCT01727024|Cholinergic Agents|cholinergic agents|mesh-ancestor
19963231|NCT01727024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19963232|NCT01727024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963233|NCT01727089|Bevacizumab|bevacizumab|mesh-list
19963234|NCT01727089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19963235|NCT01727089|Endothelial Growth Factors|endothelial growth factors|mesh-list
19963236|NCT01727089|Antibodies|antibodies|mesh-list
19963237|NCT01727089|Immunoglobulins|immunoglobulins|mesh-list
19963238|NCT01727089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19963239|NCT01727089|Immunoglobulin G|immunoglobulin g|mesh-list
19963240|NCT01727089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963241|NCT01727089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19963242|NCT01727089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19963243|NCT01727089|Growth Substances|growth substances|mesh-ancestor
19963244|NCT01727089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963245|NCT01727089|Growth Inhibitors|growth inhibitors|mesh-ancestor
19963246|NCT01727089|Immunologic Factors|immunologic factors|mesh-ancestor
19963247|NCT01727141|Glycopyrrolate|glycopyrrolate|mesh-list
19963248|NCT01727141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19963249|NCT01727141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19963250|NCT01727141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19963251|NCT01727141|Cholinergic Agents|cholinergic agents|mesh-ancestor
19963252|NCT01727141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19963253|NCT01727141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963254|NCT01727141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963255|NCT01727258|Fluorides|fluorides|mesh-list
19963256|NCT01727258|Cariostatic Agents|cariostatic agents|mesh-ancestor
19963257|NCT01727258|Protective Agents|protective agents|mesh-ancestor
19963258|NCT01727258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963259|NCT01727336|Axitinib|axitinib|mesh-list
19963260|NCT01727336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963261|NCT01727336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19963262|NCT01727336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963263|NCT01727336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963264|NCT01727414|Methylphenidate|methylphenidate|mesh-list
19963265|NCT01727414|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19963266|NCT01727414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963267|NCT01727414|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19963268|NCT01727414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19963269|NCT01727414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19963270|NCT01727414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963271|NCT01727414|Dopamine Agents|dopamine agents|mesh-ancestor
19963272|NCT01727414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19963273|NCT01727700|Aripiprazole|aripiprazole|mesh-list
19963274|NCT01727700|Antidepressive Agents|antidepressive agents|mesh-ancestor
19963275|NCT01727700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19963276|NCT01727700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19963277|NCT01727700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19963278|NCT01727700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19963279|NCT01727700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963280|NCT01727700|Dopamine Agonists|dopamine agonists|mesh-ancestor
19963281|NCT01727700|Dopamine Agents|dopamine agents|mesh-ancestor
19963282|NCT01727700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19963283|NCT01727700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963284|NCT01727700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19963285|NCT01727700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19963286|NCT01727700|Serotonin Agents|serotonin agents|mesh-ancestor
19963287|NCT01727700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19963288|NCT01727700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19963289|NCT01727700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19963290|NCT01727700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19963291|NCT01727713|Aripiprazole|aripiprazole|mesh-list
19963292|NCT01727713|Antidepressive Agents|antidepressive agents|mesh-ancestor
19963293|NCT01727713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19963294|NCT01727713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19963295|NCT01727713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19963296|NCT01727713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19963297|NCT01727713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963298|NCT01727713|Dopamine Agonists|dopamine agonists|mesh-ancestor
19963299|NCT01727713|Dopamine Agents|dopamine agents|mesh-ancestor
19963300|NCT01727713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19963301|NCT01727713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963302|NCT01727713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19963303|NCT01727713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19963304|NCT01727713|Serotonin Agents|serotonin agents|mesh-ancestor
19963305|NCT01727713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19963306|NCT01727713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20283594|NCT00601978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20283595|NCT00601978|Dopamine Agents|dopamine agents|mesh-ancestor
20283596|NCT00601978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283597|NCT00601978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283598|NCT00601978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283599|NCT00601978|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20283600|NCT00601978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283601|NCT00601978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20283602|NCT00601978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19963307|NCT01727713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19963308|NCT01727713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19963309|NCT01727726|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19963310|NCT01727726|Brexpiprazole|brexpiprazole|mesh-list
19963311|NCT01727726|Antidepressive Agents|antidepressive agents|mesh-ancestor
19963312|NCT01727726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19963313|NCT01727726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19963314|NCT01727726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19963315|NCT01727726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19963316|NCT01727726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963317|NCT01727726|Serotonin Agents|serotonin agents|mesh-ancestor
19963318|NCT01727726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19963319|NCT01727726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963320|NCT01727726|Dopamine Agonists|dopamine agonists|mesh-ancestor
19963321|NCT01727726|Dopamine Agents|dopamine agents|mesh-ancestor
20283603|NCT00601978|Immunologic Factors|immunologic factors|mesh-ancestor
20283604|NCT00601978|Dopamine Agonists|dopamine agonists|mesh-ancestor
20283605|NCT00601991|Aflibercept|aflibercept|mesh-list
20283606|NCT00601991|Endothelial Growth Factors|endothelial growth factors|mesh-list
20283607|NCT00601991|Growth Substances|growth substances|mesh-ancestor
20283608|NCT00601991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283609|NCT00601991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20283610|NCT00601991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20283611|NCT00601991|Growth Inhibitors|growth inhibitors|mesh-ancestor
20283612|NCT00601991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283613|NCT00602004|Losartan|losartan|mesh-list
19963322|NCT01727791|Pregabalin|pregabalin|mesh-list
19963323|NCT01727791|Analgesics|analgesics|mesh-ancestor
19963324|NCT01727791|Sensory System Agents|sensory system agents|mesh-ancestor
20283614|NCT00602004|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20283615|NCT00602004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20283616|NCT00602004|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20283617|NCT00602004|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20283618|NCT00602004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283619|NCT00601159|Gemcitabine|gemcitabine|mesh-list
20283620|NCT00601159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283621|NCT00601159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20283622|NCT00601159|Antimetabolites|antimetabolites|mesh-ancestor
20283623|NCT00601159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283624|NCT00601159|Antiviral Agents|antiviral agents|mesh-ancestor
20283625|NCT00601159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20283626|NCT00601159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963325|NCT01727791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20283627|NCT00601159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19963326|NCT01727791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963327|NCT01727791|Anticonvulsants|anticonvulsants|mesh-ancestor
19963328|NCT01727791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19963329|NCT01727791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19963330|NCT01727791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283628|NCT00601159|Immunologic Factors|immunologic factors|mesh-ancestor
20283629|NCT00601159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283630|NCT00602017|Amlodipine|amlodipine|mesh-list
20283631|NCT00602017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20283632|NCT00602017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20283633|NCT00602017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20283634|NCT00602017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283635|NCT00602017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20283636|NCT00602017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283637|NCT00602017|Vasodilator Agents|vasodilator agents|mesh-ancestor
20283638|NCT00602030|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20283639|NCT00602030|Entinostat|entinostat|mesh-list
20283640|NCT00602030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283641|NCT00602030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20283642|NCT00602030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283643|NCT00602030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283644|NCT00602030|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20283645|NCT00602056|Vaccines|vaccines|mesh-list
20283646|NCT00602056|Immunologic Factors|immunologic factors|mesh-ancestor
20283647|NCT00602056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283648|NCT00602082|Capecitabine|capecitabine|mesh-list
20283649|NCT00602082|Streptozocin|streptozocin|mesh-list
20283650|NCT00602082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283651|NCT00602082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20283652|NCT00602082|Antimetabolites|antimetabolites|mesh-ancestor
20283653|NCT00602082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283654|NCT00602082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20283655|NCT00602095|Misoprostol|misoprostol|mesh-list
20283656|NCT00602095|Dinoprostone|dinoprostone|mesh-list
20283657|NCT00602095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20283658|NCT00602095|Abortifacient Agents|abortifacient agents|mesh-ancestor
19963331|NCT01727791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19963332|NCT01727791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19963333|NCT01727791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19963334|NCT01727791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19963335|NCT01727791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19963336|NCT01728077|Brivaracetam|brivaracetam|mesh-list
19963337|NCT01728077|Anticonvulsants|anticonvulsants|mesh-ancestor
19963338|NCT01728194|Citalopram|citalopram|mesh-list
19963339|NCT01728194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19963340|NCT01728194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19963341|NCT01728194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19963342|NCT01728194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963343|NCT01728194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19963344|NCT01728194|Serotonin Agents|serotonin agents|mesh-ancestor
19963345|NCT01728194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963346|NCT01728194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19963347|NCT01728194|Antidepressive Agents|antidepressive agents|mesh-ancestor
19963348|NCT01728194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19963349|NCT01728246|Acetaminophen|acetaminophen|mesh-list
19963350|NCT01728246|Tramadol|tramadol|mesh-list
19963351|NCT01728246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19963352|NCT01728246|Analgesics|analgesics|mesh-ancestor
19963353|NCT01728246|Sensory System Agents|sensory system agents|mesh-ancestor
19963354|NCT01728246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19963355|NCT01728246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963356|NCT01728246|Antipyretics|antipyretics|mesh-ancestor
19963357|NCT01728246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19963358|NCT01728246|Narcotics|narcotics|mesh-ancestor
19963359|NCT01728246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19963360|NCT01728324|Ribavirin|ribavirin|mesh-list
19963361|NCT01728324|Antimetabolites|antimetabolites|mesh-ancestor
19963362|NCT01728324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963363|NCT01728324|Antiviral Agents|antiviral agents|mesh-ancestor
19963364|NCT01728324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19963365|NCT01728337|Botulinum Toxins|botulinum toxins|mesh-list
19963366|NCT01728337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19963367|NCT01728337|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19963368|NCT01728337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19963369|NCT01728337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19963370|NCT01728337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963371|NCT01728337|Cholinergic Agents|cholinergic agents|mesh-ancestor
19963372|NCT01728337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19963373|NCT01728337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963374|NCT01728337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19963375|NCT01728337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19963376|NCT01728376|Daptomycin|daptomycin|mesh-list
20283659|NCT00602095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19963377|NCT01728376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19963378|NCT01728376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19963379|NCT01728584|Bromides|bromides|mesh-list
19963380|NCT01728584|Rocuronium|rocuronium|mesh-list
19963381|NCT01728584|Anticonvulsants|anticonvulsants|mesh-ancestor
19963382|NCT01728584|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19963383|NCT01728584|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19963384|NCT01728584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19963385|NCT01728584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19963386|NCT01728584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963387|NCT01728623|Lenvatinib|lenvatinib|mesh-list
19963388|NCT01728623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963389|NCT01728623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19963390|NCT01728623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963391|NCT01728623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963392|NCT01728636|Tranexamic Acid|tranexamic acid|mesh-list
19963393|NCT01728636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19963394|NCT01728636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19963395|NCT01728636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963396|NCT01728636|Hemostatics|hemostatics|mesh-ancestor
19963397|NCT01728636|Coagulants|coagulants|mesh-ancestor
19963398|NCT01728779|Nelfinavir|nelfinavir|mesh-list
19963399|NCT01728779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19963400|NCT01728779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19963401|NCT01728779|Protease Inhibitors|protease inhibitors|mesh-ancestor
19963402|NCT01728779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963403|NCT01728779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963404|NCT01728779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19963405|NCT01728779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19963406|NCT01728779|Antiviral Agents|antiviral agents|mesh-ancestor
19963407|NCT01728779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19963408|NCT01728805|Vorinostat|vorinostat|mesh-list
19963409|NCT01728805|Mogamulizumab|mogamulizumab|mesh-list
19963410|NCT01728805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963411|NCT01728805|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19963412|NCT01728805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963413|NCT01728805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963414|NCT01729156|Metformin|metformin|mesh-list
19963415|NCT01729156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19963416|NCT01729156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963417|NCT01729338|Cyclophosphamide|cyclophosphamide|mesh-list
19963418|NCT01729338|Lenalidomide|lenalidomide|mesh-list
19963419|NCT01729338|Bortezomib|bortezomib|mesh-list
19963420|NCT01729338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19963421|NCT01729338|Immunologic Factors|immunologic factors|mesh-ancestor
19963422|NCT01729338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963423|NCT01729338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19963424|NCT01729338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19963425|NCT01729338|Alkylating Agents|alkylating agents|mesh-ancestor
19963426|NCT01729338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963427|NCT01729338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963428|NCT01729338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19963429|NCT01729338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19963430|NCT01729338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19963431|NCT01729338|Growth Substances|growth substances|mesh-ancestor
19963432|NCT01729338|Growth Inhibitors|growth inhibitors|mesh-ancestor
19963433|NCT01729494|Mycophenolic Acid|mycophenolic acid|mesh-list
19963434|NCT01729494|Prednisone|prednisone|mesh-list
19963435|NCT01729494|Alemtuzumab|alemtuzumab|mesh-list
19963436|NCT01729494|Abatacept|abatacept|mesh-list
19963437|NCT01729494|Tacrolimus|tacrolimus|mesh-list
19963438|NCT01729494|Thymoglobulin|thymoglobulin|mesh-list
20283660|NCT00602095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283661|NCT00602095|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20283662|NCT00602095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20283663|NCT00602095|Oxytocics|oxytocics|mesh-ancestor
20283664|NCT00602134|Mercaptopurine|mercaptopurine|mesh-list
19963439|NCT01729494|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19963440|NCT01729494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19963441|NCT01729494|Glucocorticoids|glucocorticoids|mesh-ancestor
19963442|NCT01729494|Hormones|hormones|mesh-ancestor
19963443|NCT01729494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20283665|NCT00602134|Antimetabolites|antimetabolites|mesh-ancestor
20283666|NCT00602134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283667|NCT00602134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20283668|NCT00602134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283669|NCT00602134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20283670|NCT00602134|Immunologic Factors|immunologic factors|mesh-ancestor
20283671|NCT00602134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283672|NCT00602134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20283673|NCT00602134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283674|NCT00602173|Cilostazol|cilostazol|mesh-list
20283675|NCT00602173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20283676|NCT00602173|Autonomic Agents|autonomic agents|mesh-ancestor
20283677|NCT00602173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20283678|NCT00602173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283679|NCT00602173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20283680|NCT00602173|Respiratory System Agents|respiratory system agents|mesh-ancestor
20283681|NCT00602173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20283682|NCT00602173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20283683|NCT00602173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283684|NCT00602173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20283685|NCT00602173|Vasodilator Agents|vasodilator agents|mesh-ancestor
20283686|NCT00602173|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20283687|NCT00602173|Protective Agents|protective agents|mesh-ancestor
20283688|NCT00602173|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20283689|NCT00602173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20283690|NCT00602173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283691|NCT00602186|Prazosin|prazosin|mesh-list
20283692|NCT00602186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20283693|NCT00602186|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20283694|NCT00602186|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20283695|NCT00602186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20283696|NCT00602186|Adrenergic Agents|adrenergic agents|mesh-ancestor
20283697|NCT00602186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283698|NCT00602186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283699|NCT00602186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283700|NCT00602251|Terbinafine|terbinafine|mesh-list
20283701|NCT00602251|Antifungal Agents|antifungal agents|mesh-ancestor
20283702|NCT00602251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20283703|NCT00602251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283704|NCT00602251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283705|NCT00602303|Torsemide|torsemide|mesh-list
20283706|NCT00602303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20283707|NCT00602303|Diuretics|diuretics|mesh-ancestor
20283708|NCT00602303|Natriuretic Agents|natriuretic agents|mesh-ancestor
20283709|NCT00602303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283710|NCT00602303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20283711|NCT00602303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20283712|NCT00602303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963444|NCT01729494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963445|NCT01729494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19963446|NCT01729494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963447|NCT01729494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19963448|NCT01729494|Immunologic Factors|immunologic factors|mesh-ancestor
19963449|NCT01729494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19963450|NCT01729494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963451|NCT01729494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963452|NCT01729494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19963453|NCT01729494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19963454|NCT01729494|Antitubercular Agents|antitubercular agents|mesh-ancestor
19963455|NCT01729494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19963456|NCT01729494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19963457|NCT01729494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19963458|NCT01729494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19963459|NCT01729494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19963460|NCT01729559|Heparin|heparin|mesh-list
19963461|NCT01729559|Enoxaparin|enoxaparin|mesh-list
19963462|NCT01729559|Calcium heparin|calcium heparin|mesh-list
20283713|NCT00602316|Chelating Agents|chelating agents|mesh-list
20548221|NCT01899027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20283714|NCT00602316|Sequestering Agents|sequestering agents|mesh-ancestor
20283715|NCT00602316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283716|NCT00602342|Terbinafine|terbinafine|mesh-list
20283717|NCT00602342|Antifungal Agents|antifungal agents|mesh-ancestor
20283718|NCT00602342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20283719|NCT00602342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283720|NCT00602342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548222|NCT01899027|Antimetabolites|antimetabolites|mesh-ancestor
20548223|NCT01899027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548224|NCT01899027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19963463|NCT01729559|Enoxaparin sodium|enoxaparin sodium|mesh-list
19963464|NCT01729559|Anticoagulants|anticoagulants|mesh-ancestor
19963465|NCT01729559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19963466|NCT01729559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19963467|NCT01729559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963468|NCT01729598|Valproic Acid|valproic acid|mesh-list
19963469|NCT01729598|Anticonvulsants|anticonvulsants|mesh-ancestor
19963470|NCT01729598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963471|NCT01729598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963472|NCT01729598|GABA Agents|gaba agents|mesh-ancestor
19963473|NCT01729598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283721|NCT00602381|Lithium Carbonate|lithium carbonate|mesh-list
20283722|NCT00602381|Antidepressive Agents|antidepressive agents|mesh-ancestor
20283723|NCT00602381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20283724|NCT00602381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283725|NCT00602381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283726|NCT00602381|Antimanic Agents|antimanic agents|mesh-ancestor
20283727|NCT00602381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20283728|NCT00602381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20283729|NCT00602381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283730|NCT00602394|Lithium Carbonate|lithium carbonate|mesh-list
20283731|NCT00602394|Antidepressive Agents|antidepressive agents|mesh-ancestor
20283732|NCT00602394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20283733|NCT00602394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283734|NCT00602394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283735|NCT00602394|Antimanic Agents|antimanic agents|mesh-ancestor
20283736|NCT00602394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20283737|NCT00602394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20283738|NCT00602394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283739|NCT00602407|Cilostazol|cilostazol|mesh-list
20283740|NCT00602407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20283741|NCT00602407|Autonomic Agents|autonomic agents|mesh-ancestor
20283742|NCT00602407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20283743|NCT00602407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283744|NCT00602407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20283745|NCT00602407|Respiratory System Agents|respiratory system agents|mesh-ancestor
20283746|NCT00602407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20283747|NCT00602407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20283748|NCT00602407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283749|NCT00602407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20283750|NCT00602407|Vasodilator Agents|vasodilator agents|mesh-ancestor
20283751|NCT00602407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20283752|NCT00602407|Protective Agents|protective agents|mesh-ancestor
20283753|NCT00602407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20283754|NCT00602407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20283755|NCT00602407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283756|NCT00602498|Clarithromycin|clarithromycin|mesh-list
20548225|NCT01899027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20548226|NCT01899027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548227|NCT01899066|Carboplatin|carboplatin|mesh-list
20548228|NCT01899066|Etoposide|etoposide|mesh-list
20548229|NCT01899066|Vincristine|vincristine|mesh-list
20548230|NCT01899066|Ranibizumab|ranibizumab|mesh-list
19963474|NCT01729598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963475|NCT01729598|Antimanic Agents|antimanic agents|mesh-ancestor
19963476|NCT01729598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19963477|NCT01729598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19963478|NCT01729598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19963479|NCT01729728|Tapentadol|tapentadol|mesh-list
19963480|NCT01729728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19963481|NCT01729728|Narcotics|narcotics|mesh-ancestor
19963482|NCT01729728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19963483|NCT01729728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963484|NCT01729728|Analgesics|analgesics|mesh-ancestor
19963485|NCT01729728|Sensory System Agents|sensory system agents|mesh-ancestor
19963486|NCT01729728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20283757|NCT00602498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20283758|NCT00602498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20283759|NCT00602498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20283760|NCT00602498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283761|NCT00602498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283762|NCT00602498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20283763|NCT00602498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20283764|NCT00602511|Thalidomide|thalidomide|mesh-list
20283765|NCT00602511|Bortezomib|bortezomib|mesh-list
20283766|NCT00602511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283767|NCT00602511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20283768|NCT00602511|Immunologic Factors|immunologic factors|mesh-ancestor
20283769|NCT00602511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283770|NCT00602511|Leprostatic Agents|leprostatic agents|mesh-ancestor
20283771|NCT00602511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20283772|NCT00602511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20283773|NCT00602511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19963487|NCT01729728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19963488|NCT01729728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19963489|NCT01729728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19963490|NCT01729728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963491|NCT01729728|Adrenergic Agents|adrenergic agents|mesh-ancestor
19963492|NCT01729728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19963493|NCT01729819|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19963494|NCT01729819|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19963495|NCT01729819|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19963496|NCT01729819|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19963497|NCT01729819|Cholinergic Agents|cholinergic agents|mesh-ancestor
19963498|NCT01729819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19963499|NCT01729819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963500|NCT01729819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963501|NCT01729819|Urological Agents|urological agents|mesh-ancestor
19963502|NCT01729819|Hemostatics|hemostatics|mesh-ancestor
19963503|NCT01729819|Coagulants|coagulants|mesh-ancestor
19963504|NCT01729819|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19963505|NCT01729819|Natriuretic Agents|natriuretic agents|mesh-ancestor
19963506|NCT01729845|Cytarabine|cytarabine|mesh-list
19963507|NCT01729845|Etoposide|etoposide|mesh-list
19963508|NCT01729845|Podophyllotoxin|podophyllotoxin|mesh-list
19963509|NCT01729845|Mitoxantrone|mitoxantrone|mesh-list
19963510|NCT01729845|Etoposide phosphate|etoposide phosphate|mesh-list
19963511|NCT01729845|Decitabine|decitabine|mesh-list
19963512|NCT01729845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19963513|NCT01729845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283774|NCT00602511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20283775|NCT00602511|Growth Substances|growth substances|mesh-ancestor
20283776|NCT00602511|Growth Inhibitors|growth inhibitors|mesh-ancestor
20283777|NCT00602524|Pilocarpine|pilocarpine|mesh-list
20283778|NCT00602524|Miotics|miotics|mesh-ancestor
20283779|NCT00602524|Autonomic Agents|autonomic agents|mesh-ancestor
20283780|NCT00602524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20283781|NCT00602524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283782|NCT00602524|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20283783|NCT00602524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20283784|NCT00602524|Cholinergic Agents|cholinergic agents|mesh-ancestor
20283785|NCT00602524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283786|NCT00602524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283787|NCT00602550|Zidovudine|zidovudine|mesh-list
20283788|NCT00602550|Antimetabolites|antimetabolites|mesh-ancestor
20283789|NCT00602550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963514|NCT01729845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19963515|NCT01729845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19963516|NCT01729845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963517|NCT01729845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963518|NCT01729845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19963519|NCT01729845|Antimetabolites|antimetabolites|mesh-ancestor
19963520|NCT01729845|Antiviral Agents|antiviral agents|mesh-ancestor
19963521|NCT01729845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19963522|NCT01729845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19963523|NCT01729845|Immunologic Factors|immunologic factors|mesh-ancestor
19963524|NCT01729845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963525|NCT01729845|Analgesics|analgesics|mesh-ancestor
19963526|NCT01729845|Sensory System Agents|sensory system agents|mesh-ancestor
20283790|NCT00602550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19963527|NCT01729845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19963528|NCT01729845|Keratolytic Agents|keratolytic agents|mesh-ancestor
20283791|NCT00602550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20283792|NCT00602550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283793|NCT00602550|Antiviral Agents|antiviral agents|mesh-ancestor
20283794|NCT00602550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20283795|NCT00602550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20283796|NCT00602550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20283797|NCT00602589|Levofloxacin|levofloxacin|mesh-list
20283798|NCT00602589|Ofloxacin|ofloxacin|mesh-list
20283799|NCT00602589|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20283800|NCT00602589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20283801|NCT00602589|Renal Agents|renal agents|mesh-ancestor
20283802|NCT00602589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20283803|NCT00602589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20283804|NCT00602589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20283805|NCT00602589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283806|NCT00602589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283807|NCT00602589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283808|NCT00602589|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20283809|NCT00602589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20283810|NCT00602615|Torsemide|torsemide|mesh-list
20283811|NCT00602615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20283812|NCT00602615|Diuretics|diuretics|mesh-ancestor
20548231|NCT01899066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548232|NCT01899066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20548233|NCT01899066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20548234|NCT01899066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20548235|NCT01899066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548236|NCT01899066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548237|NCT01899066|Tubulin Modulators|tubulin modulators|mesh-ancestor
20548238|NCT01899066|Antimitotic Agents|antimitotic agents|mesh-ancestor
20548239|NCT01899066|Mitosis Modulators|mitosis modulators|mesh-ancestor
20548240|NCT01899066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20548241|NCT01899066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20548242|NCT01899066|Growth Substances|growth substances|mesh-ancestor
20548243|NCT01899066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548244|NCT01899066|Growth Inhibitors|growth inhibitors|mesh-ancestor
19963529|NCT01729845|Dermatologic Agents|dermatologic agents|mesh-ancestor
19963530|NCT01729845|Tubulin Modulators|tubulin modulators|mesh-ancestor
19963531|NCT01729845|Antimitotic Agents|antimitotic agents|mesh-ancestor
19963532|NCT01729845|Mitosis Modulators|mitosis modulators|mesh-ancestor
19963533|NCT01729871|Vitamin K|vitamin k|mesh-list
19963534|NCT01729871|Rivaroxaban|rivaroxaban|mesh-list
19963535|NCT01729871|Vitamins|vitamins|mesh-ancestor
19963536|NCT01729871|Micronutrients|micronutrients|mesh-ancestor
19963537|NCT01729871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963538|NCT01729871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19963539|NCT01729871|Antithrombins|antithrombins|mesh-ancestor
19963540|NCT01729871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19963541|NCT01729871|Protease Inhibitors|protease inhibitors|mesh-ancestor
19963542|NCT01729871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963543|NCT01729871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963544|NCT01729871|Anticoagulants|anticoagulants|mesh-ancestor
19963545|NCT01729871|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19963546|NCT01729871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19963547|NCT01729871|Hemostatics|hemostatics|mesh-ancestor
19963548|NCT01729871|Coagulants|coagulants|mesh-ancestor
19963549|NCT01729923|Celecoxib|celecoxib|mesh-list
19963550|NCT01729923|Capecitabine|capecitabine|mesh-list
19963551|NCT01729923|Benzenesulfonamide|benzenesulfonamide|mesh-list
19963552|NCT01729923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19963553|NCT01729923|Antimetabolites|antimetabolites|mesh-ancestor
19963554|NCT01729923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963555|NCT01729923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548245|NCT01899105|Ivacaftor|ivacaftor|mesh-list
20548246|NCT01899105|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20548247|NCT01899105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19963556|NCT01729923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19963557|NCT01729923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19963558|NCT01729923|Analgesics|analgesics|mesh-ancestor
19963559|NCT01729923|Sensory System Agents|sensory system agents|mesh-ancestor
19963560|NCT01729923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19963561|NCT01729923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283813|NCT00602615|Natriuretic Agents|natriuretic agents|mesh-ancestor
19963562|NCT01729923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19963563|NCT01729923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19963564|NCT01729923|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19963565|NCT01729923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19963566|NCT01729923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963567|NCT01729923|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19963568|NCT01730040|Atorvastatin|atorvastatin|mesh-list
19963569|NCT01730040|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19963570|NCT01730040|Ezetimibe|ezetimibe|mesh-list
19963571|NCT01730040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19963572|NCT01730040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19963573|NCT01730040|Antimetabolites|antimetabolites|mesh-ancestor
19963574|NCT01730040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963575|NCT01730040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20283814|NCT00602615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283815|NCT00602615|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20283816|NCT00602615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20283817|NCT00602615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283818|NCT00602680|Donepezil|donepezil|mesh-list
20283819|NCT00602680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20283820|NCT00602680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283821|NCT00602680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283822|NCT00602680|Cholinergic Agents|cholinergic agents|mesh-ancestor
20283823|NCT00602680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283824|NCT00602680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283825|NCT00602680|Nootropic Agents|nootropic agents|mesh-ancestor
20283826|NCT00602693|Sirolimus|sirolimus|mesh-list
20283827|NCT00602693|Cyclophosphamide|cyclophosphamide|mesh-list
20283828|NCT00602693|Fludarabine|fludarabine|mesh-list
20283829|NCT00602693|Fludarabine phosphate|fludarabine phosphate|mesh-list
20283830|NCT00602693|Allopurinol|allopurinol|mesh-list
20283831|NCT00602693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20283832|NCT00602693|Immunologic Factors|immunologic factors|mesh-ancestor
20283833|NCT00602693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283834|NCT00602693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20283835|NCT00602693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20283836|NCT00602693|Alkylating Agents|alkylating agents|mesh-ancestor
20283837|NCT00602693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963576|NCT01730040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19963577|NCT01730040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963578|NCT01730053|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19963579|NCT01730053|Ezetimibe|ezetimibe|mesh-list
19963580|NCT01730053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19733344|NCT04562532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733345|NCT04562441|Avelumab|avelumab|mesh-list
19733346|NCT04562441|Axitinib|axitinib|mesh-list
19963581|NCT01730053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19963582|NCT01730053|Antimetabolites|antimetabolites|mesh-ancestor
19963583|NCT01730053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963584|NCT01730053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20283838|NCT00602693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283839|NCT00602693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20283840|NCT00602693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20283841|NCT00602693|Antimetabolites|antimetabolites|mesh-ancestor
19963585|NCT01730053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19963586|NCT01730053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963587|NCT01730378|Vaccines|vaccines|mesh-list
20548248|NCT01899105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548249|NCT01899118|Capecitabine|capecitabine|mesh-list
20548250|NCT01899118|Oxaliplatin|oxaliplatin|mesh-list
20548251|NCT01899118|Nimotuzumab|nimotuzumab|mesh-list
20548252|NCT01899118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20548253|NCT01899118|Antimetabolites|antimetabolites|mesh-ancestor
20548254|NCT01899118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548255|NCT01899118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548256|NCT01899118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20548257|NCT01899170|Carfentanil|carfentanil|mesh-list
20548258|NCT01899170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20548259|NCT01899170|Narcotics|narcotics|mesh-ancestor
19733347|NCT04562441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19733348|NCT04562441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733349|NCT04562441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19733350|NCT04562441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733351|NCT04562441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733352|NCT04561934|Fluorides|fluorides|mesh-list
20283842|NCT00602693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20283843|NCT00602693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19963588|NCT01730378|Immunologic Factors|immunologic factors|mesh-ancestor
19963589|NCT01730378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963590|NCT01730534|Dapagliflozin|dapagliflozin|mesh-list
19963591|NCT01730534|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19963592|NCT01730534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963593|NCT01730534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19963594|NCT01730534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963595|NCT01730586|Paclitaxel|paclitaxel|mesh-list
19963596|NCT01730586|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19963597|NCT01730586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19963598|NCT01730586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963599|NCT01730586|Tubulin Modulators|tubulin modulators|mesh-ancestor
19963600|NCT01730586|Antimitotic Agents|antimitotic agents|mesh-ancestor
19963601|NCT01730586|Mitosis Modulators|mitosis modulators|mesh-ancestor
19963602|NCT01730586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963603|NCT01730729|Cabergoline|cabergoline|mesh-list
19963604|NCT01730729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19963605|NCT01730729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19963606|NCT01730729|Dopamine Agonists|dopamine agonists|mesh-ancestor
20283844|NCT00602693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20283845|NCT00602693|Antifungal Agents|antifungal agents|mesh-ancestor
20283846|NCT00602693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963607|NCT01730729|Dopamine Agents|dopamine agents|mesh-ancestor
19963608|NCT01730729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19963609|NCT01730729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963610|NCT01730729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963611|NCT01730846|Doxazosin|doxazosin|mesh-list
19963612|NCT01730846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19963613|NCT01730846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19963614|NCT01730846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19963615|NCT01730846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19963616|NCT01730846|Adrenergic Agents|adrenergic agents|mesh-ancestor
19963617|NCT01730846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283847|NCT00602693|Gout Suppressants|gout suppressants|mesh-ancestor
20283848|NCT00602693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20283849|NCT00602693|Antioxidants|antioxidants|mesh-ancestor
20283850|NCT00602693|Protective Agents|protective agents|mesh-ancestor
20283851|NCT00602706|Melphalan|melphalan|mesh-list
20283852|NCT00602706|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
20283853|NCT00602706|Sargramostim|sargramostim|mesh-list
20283854|NCT00602706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20283855|NCT00602706|Alkylating Agents|alkylating agents|mesh-ancestor
20283856|NCT00602706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283857|NCT00602706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963618|NCT01730846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963619|NCT01730846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963620|NCT01730872|Prednisolone|prednisolone|mesh-list
19963621|NCT01730872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19963622|NCT01730872|Methylprednisolone|methylprednisolone|mesh-list
19963623|NCT01730872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19963624|NCT01730872|Prednisolone acetate|prednisolone acetate|mesh-list
19963625|NCT01730872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19963626|NCT01730872|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20283858|NCT00602706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20283859|NCT00602706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20283860|NCT00602706|Immunologic Factors|immunologic factors|mesh-ancestor
20283861|NCT00602706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283862|NCT00602706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20283863|NCT00602706|Analgesics|analgesics|mesh-ancestor
20283864|NCT00602706|Sensory System Agents|sensory system agents|mesh-ancestor
20283865|NCT00602706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20283866|NCT00602719|Zolpidem|zolpidem|mesh-list
20283867|NCT00602719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20283868|NCT00602719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20283869|NCT00602719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20283870|NCT00602719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283871|NCT00602719|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20283872|NCT00602719|GABA Agonists|gaba agonists|mesh-ancestor
20283873|NCT00602719|GABA Agents|gaba agents|mesh-ancestor
20283874|NCT00602719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283875|NCT00602719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450390|NCT03428633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19963627|NCT01730872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19963628|NCT01730872|Prednisolone phosphate|prednisolone phosphate|mesh-list
20283876|NCT00602849|Sertraline|sertraline|mesh-list
20283877|NCT00602849|Antidepressive Agents|antidepressive agents|mesh-ancestor
20283878|NCT00602849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20283879|NCT00602849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20283880|NCT00602849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20283881|NCT00602849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20283882|NCT00602849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283883|NCT00602849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283884|NCT00602849|Serotonin Agents|serotonin agents|mesh-ancestor
20283885|NCT00602849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288347|NCT05334745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288348|NCT05334745|Viscosupplements|viscosupplements|mesh-ancestor
20288349|NCT05334745|Protective Agents|protective agents|mesh-ancestor
20288350|NCT05334472|Ofatumumab|ofatumumab|mesh-list
20288351|NCT05334472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288352|NCT05334329|Cyclophosphamide|cyclophosphamide|mesh-list
20288353|NCT05334329|Fludarabine|fludarabine|mesh-list
20288354|NCT05334329|Atezolizumab|atezolizumab|mesh-list
19963629|NCT01730872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19963630|NCT01730872|Glucocorticoids|glucocorticoids|mesh-ancestor
19963631|NCT01730872|Hormones|hormones|mesh-ancestor
19963632|NCT01730872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19963633|NCT01730872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963634|NCT01730872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19963635|NCT01730872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963636|NCT01730872|Antiemetics|antiemetics|mesh-ancestor
19963637|NCT01730872|Autonomic Agents|autonomic agents|mesh-ancestor
19963638|NCT01730872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19963639|NCT01730872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19963640|NCT01730872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19963641|NCT01730872|Protective Agents|protective agents|mesh-ancestor
19963642|NCT01730950|Bevacizumab|bevacizumab|mesh-list
19963643|NCT01730950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19963644|NCT01730950|Antibodies|antibodies|mesh-list
19963645|NCT01730950|Immunoglobulins|immunoglobulins|mesh-list
19963646|NCT01730950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19963647|NCT01730950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963648|NCT01730950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19963649|NCT01730950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19963650|NCT01730950|Growth Substances|growth substances|mesh-ancestor
19963651|NCT01730950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963652|NCT01730950|Growth Inhibitors|growth inhibitors|mesh-ancestor
19963653|NCT01730950|Immunologic Factors|immunologic factors|mesh-ancestor
19963654|NCT01731002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19963655|NCT01731002|Latanoprost|latanoprost|mesh-list
19963656|NCT01731002|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19963657|NCT01731041|Ticagrelor|ticagrelor|mesh-list
19963658|NCT01731041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19963659|NCT01731041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20288355|NCT05334329|Antineoplastic Agents|antineoplastic agents|mesh-list
20288356|NCT05334329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19963660|NCT01731041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19963661|NCT01731041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19963662|NCT01731041|Purinergic Agents|purinergic agents|mesh-ancestor
20288357|NCT05334329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20288358|NCT05334329|Immunologic Factors|immunologic factors|mesh-ancestor
20288359|NCT05334329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288360|NCT05334329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19963663|NCT01731041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19963664|NCT01731041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963665|NCT01731041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963666|NCT01731119|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19963667|NCT01731119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19963668|NCT01731119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19963669|NCT01731119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19963670|NCT01731119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963671|NCT01731119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20288361|NCT05334329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20288362|NCT05334329|Alkylating Agents|alkylating agents|mesh-ancestor
20288363|NCT05334329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288364|NCT05334329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20288365|NCT05334316|Dexamethasone|dexamethasone|mesh-list
20288366|NCT05334316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20283886|NCT00602862|Bevacizumab|bevacizumab|mesh-list
20283887|NCT00602862|Sorafenib|sorafenib|mesh-list
20283888|NCT00602862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19963672|NCT01731119|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19963673|NCT01731119|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19963674|NCT01731119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19963675|NCT01731119|Adrenergic Agents|adrenergic agents|mesh-ancestor
19963676|NCT01731119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283889|NCT00602862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283890|NCT00602862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20283891|NCT00602862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20283892|NCT00602862|Growth Substances|growth substances|mesh-ancestor
20283893|NCT00602862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283894|NCT00602862|Growth Inhibitors|growth inhibitors|mesh-ancestor
19963677|NCT01731119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963678|NCT01731119|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19963679|NCT01731119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19963680|NCT01731119|Serotonin Agents|serotonin agents|mesh-ancestor
19963681|NCT01731119|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19963682|NCT01731119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19963683|NCT01731119|Dopamine Agents|dopamine agents|mesh-ancestor
19963684|NCT01731691|Protease Inhibitors|protease inhibitors|mesh-list
19963685|NCT01731691|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19963686|NCT01731691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963687|NCT01731691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963688|NCT01731691|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19963689|NCT01731691|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19963690|NCT01731886|Dexamethasone|dexamethasone|mesh-list
19963691|NCT01731886|Cyclophosphamide|cyclophosphamide|mesh-list
19963692|NCT01731886|Melphalan|melphalan|mesh-list
19963693|NCT01731886|Lenalidomide|lenalidomide|mesh-list
19963694|NCT01731886|Sargramostim|sargramostim|mesh-list
19963695|NCT01731886|Lenograstim|lenograstim|mesh-list
19963696|NCT01731886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19963697|NCT01731886|Immunologic Factors|immunologic factors|mesh-ancestor
19963698|NCT01731886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963699|NCT01731886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20283895|NCT00602862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20283896|NCT00602862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283897|NCT00602862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283898|NCT00602901|Naproxen|naproxen|mesh-list
20283899|NCT00602901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20283900|NCT00602901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20283901|NCT00602901|Analgesics|analgesics|mesh-ancestor
20283902|NCT00602901|Sensory System Agents|sensory system agents|mesh-ancestor
20283903|NCT00602901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20283904|NCT00602901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283905|NCT00602901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20283906|NCT00602901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20283907|NCT00602901|Gout Suppressants|gout suppressants|mesh-ancestor
19963700|NCT01731886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19963701|NCT01731886|Alkylating Agents|alkylating agents|mesh-ancestor
19963702|NCT01731886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963703|NCT01731886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963704|NCT01731886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19963705|NCT01731886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19963706|NCT01731886|Antiemetics|antiemetics|mesh-ancestor
19963707|NCT01731886|Autonomic Agents|autonomic agents|mesh-ancestor
19963708|NCT01731886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19963709|NCT01731886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19963710|NCT01731886|Glucocorticoids|glucocorticoids|mesh-ancestor
19963711|NCT01731886|Hormones|hormones|mesh-ancestor
19963712|NCT01731886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19963713|NCT01731886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19963714|NCT01731886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19963715|NCT01731886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19963716|NCT01731886|Growth Substances|growth substances|mesh-ancestor
19963717|NCT01731886|Growth Inhibitors|growth inhibitors|mesh-ancestor
19963718|NCT01731886|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19963719|NCT01731938|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19963720|NCT01731938|Hemostatics|hemostatics|mesh-ancestor
19963721|NCT01731938|Coagulants|coagulants|mesh-ancestor
19963722|NCT01731951|Imetelstat|imetelstat|mesh-list
19963723|NCT01731951|Motesanib diphosphate|motesanib diphosphate|mesh-list
19963724|NCT01731951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288367|NCT05334316|Antiemetics|antiemetics|mesh-ancestor
19963725|NCT01731951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963726|NCT01731951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19974955|NCT01844076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19974956|NCT01844076|Antimetabolites|antimetabolites|mesh-ancestor
19974957|NCT01844076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974958|NCT01844076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19974959|NCT01844076|Anticestodal Agents|anticestodal agents|mesh-ancestor
19974960|NCT01844076|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19974961|NCT01844076|Anthelmintics|anthelmintics|mesh-ancestor
19974962|NCT01844076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19974963|NCT01844076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19974964|NCT01844076|Antimalarials|antimalarials|mesh-ancestor
19974965|NCT01844076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19974966|NCT01844076|Antinematodal Agents|antinematodal agents|mesh-ancestor
19974967|NCT01844076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974968|NCT01844115|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
19974969|NCT01844115|Antidepressive Agents|antidepressive agents|mesh-ancestor
20283908|NCT00602901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20283909|NCT00602901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283910|NCT00602901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974970|NCT01844115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19974971|NCT01844115|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19974972|NCT01844115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19974973|NCT01844115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19974974|NCT01844115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974975|NCT01844115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19974976|NCT01844115|Serotonin Agents|serotonin agents|mesh-ancestor
19974977|NCT01844115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283911|NCT00603031|Glucagon|glucagon|mesh-list
20283912|NCT00603031|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
20283913|NCT00603031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20283914|NCT00603031|Hormones|hormones|mesh-ancestor
20283915|NCT00603031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20283916|NCT00603031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283917|NCT00603031|Incretins|incretins|mesh-ancestor
20283918|NCT00603083|Ketorolac|ketorolac|mesh-list
20283919|NCT00603083|Ropivacaine|ropivacaine|mesh-list
19974978|NCT01844115|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19974979|NCT01844115|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19974980|NCT01844388|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19974981|NCT01844388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20283920|NCT00603083|Anesthetics, Local|anesthetics, local|mesh-ancestor
20283921|NCT00603083|Anesthetics|anesthetics|mesh-ancestor
20283922|NCT00603083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20283923|NCT00603083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974982|NCT01844388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19974983|NCT01844388|Laxatives|laxatives|mesh-ancestor
19974984|NCT01844388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19974985|NCT01844531|Metformin|metformin|mesh-list
19974986|NCT01844531|Empagliflozin|empagliflozin|mesh-list
19974987|NCT01844531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19974988|NCT01844531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19974989|NCT01844531|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19974990|NCT01844531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974991|NCT01844583|Rifampin|rifampin|mesh-list
19974992|NCT01844583|Esomeprazole|esomeprazole|mesh-list
19974993|NCT01844583|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19974994|NCT01844583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19974995|NCT01844583|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19974996|NCT01844583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19974997|NCT01844583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19974998|NCT01844583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19974999|NCT01844583|Antitubercular Agents|antitubercular agents|mesh-ancestor
19975000|NCT01844583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19975001|NCT01844583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19975002|NCT01844583|Leprostatic Agents|leprostatic agents|mesh-ancestor
20283924|NCT00603083|Sensory System Agents|sensory system agents|mesh-ancestor
20283925|NCT00603083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20283926|NCT00603083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20283927|NCT00603083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20283928|NCT00603083|Analgesics|analgesics|mesh-ancestor
20283929|NCT00603083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20283930|NCT00603083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20288368|NCT05334316|Autonomic Agents|autonomic agents|mesh-ancestor
19963727|NCT01732445|Danazol|danazol|mesh-list
19963728|NCT01732445|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
19963729|NCT01732445|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19963730|NCT01732445|Hormone Antagonists|hormone antagonists|mesh-ancestor
19963731|NCT01732445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19963732|NCT01732445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283931|NCT00603083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20283932|NCT00603083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733353|NCT04561934|Cariostatic Agents|cariostatic agents|mesh-ancestor
19733354|NCT04561934|Protective Agents|protective agents|mesh-ancestor
19733355|NCT04561934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733356|NCT04561960|Fluorides|fluorides|mesh-list
19963733|NCT01732445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19963734|NCT01732445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963735|NCT01732445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963736|NCT01732458|Ondansetron|ondansetron|mesh-list
19963737|NCT01732458|Aprepitant|aprepitant|mesh-list
19963738|NCT01732458|Fosaprepitant|fosaprepitant|mesh-list
19963739|NCT01732458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19963740|NCT01732458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963741|NCT01732458|Antiemetics|antiemetics|mesh-ancestor
19733357|NCT04561960|Cariostatic Agents|cariostatic agents|mesh-ancestor
19733358|NCT04561960|Protective Agents|protective agents|mesh-ancestor
19733359|NCT04561960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963742|NCT01732458|Autonomic Agents|autonomic agents|mesh-ancestor
19963743|NCT01732458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19963744|NCT01732458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19963745|NCT01732458|Antipruritics|antipruritics|mesh-ancestor
19963746|NCT01732458|Dermatologic Agents|dermatologic agents|mesh-ancestor
19963747|NCT01732458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19963748|NCT01732458|Serotonin Agents|serotonin agents|mesh-ancestor
19963749|NCT01732458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19963750|NCT01732458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963751|NCT01732458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19963752|NCT01732458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19963753|NCT01732458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19963754|NCT01732458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19963755|NCT01732458|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19963756|NCT01732536|Mometasone Furoate|mometasone furoate|mesh-list
19963757|NCT01732536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19963758|NCT01732536|Dermatologic Agents|dermatologic agents|mesh-ancestor
19963759|NCT01732536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19963760|NCT01732588|Artefenomel|artefenomel|mesh-list
19963761|NCT01732588|Antimalarials|antimalarials|mesh-ancestor
19963762|NCT01732588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19963763|NCT01732588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19963764|NCT01732588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19963765|NCT01732640|Paclitaxel|paclitaxel|mesh-list
19963766|NCT01732640|Cisplatin|cisplatin|mesh-list
19963767|NCT01732640|Carboplatin|carboplatin|mesh-list
19963768|NCT01732640|Afatinib|afatinib|mesh-list
19963769|NCT01732640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19963770|NCT01732640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963771|NCT01732640|Tubulin Modulators|tubulin modulators|mesh-ancestor
19963772|NCT01732640|Antimitotic Agents|antimitotic agents|mesh-ancestor
19963773|NCT01732640|Mitosis Modulators|mitosis modulators|mesh-ancestor
19963774|NCT01732640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963775|NCT01732640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19963776|NCT01732640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963777|NCT01732718|Atorvastatin|atorvastatin|mesh-list
19963778|NCT01732718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19963779|NCT01732718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19963780|NCT01732718|Antimetabolites|antimetabolites|mesh-ancestor
19963781|NCT01732718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283933|NCT00603083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283934|NCT00603109|Rimonabant|rimonabant|mesh-list
20283935|NCT00603109|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20283936|NCT00603109|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
20283937|NCT00603109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20283938|NCT00603109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283939|NCT00603109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283940|NCT00603109|Hormones|hormones|mesh-ancestor
20283941|NCT00603109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20283942|NCT00603109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733360|NCT04562103|Epinephrine|epinephrine|mesh-list
19733361|NCT04562103|Ropivacaine|ropivacaine|mesh-list
19963782|NCT01732718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19963783|NCT01732718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19963784|NCT01732718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963785|NCT01732757|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19963786|NCT01732757|Dextrans|dextrans|mesh-list
19963787|NCT01732757|Alcaftadine|alcaftadine|mesh-list
19963788|NCT01732757|Anticoagulants|anticoagulants|mesh-ancestor
19963789|NCT01732757|Plasma Substitutes|plasma substitutes|mesh-ancestor
19963790|NCT01732757|Blood Substitutes|blood substitutes|mesh-ancestor
19963791|NCT01732757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19963792|NCT01732757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19963793|NCT01732757|Analgesics|analgesics|mesh-ancestor
20283943|NCT00603135|Levetiracetam|levetiracetam|mesh-list
20283944|NCT00603135|Anticonvulsants|anticonvulsants|mesh-ancestor
20283945|NCT00603135|Nootropic Agents|nootropic agents|mesh-ancestor
20283946|NCT00603317|Amoxicillin|amoxicillin|mesh-list
20283947|NCT00603317|Clavulanic Acids|clavulanic acids|mesh-list
20283948|NCT00603317|Clavulanic Acid|clavulanic acid|mesh-list
20283949|NCT00603317|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20283950|NCT00603317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20283951|NCT00603317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19963794|NCT01732757|Sensory System Agents|sensory system agents|mesh-ancestor
19963795|NCT01732757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19963796|NCT01732757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963797|NCT01732757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19963798|NCT01732757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19963799|NCT01732757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19963800|NCT01732757|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19963801|NCT01732757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19963802|NCT01732757|Histamine Antagonists|histamine antagonists|mesh-ancestor
19963803|NCT01732757|Histamine Agents|histamine agents|mesh-ancestor
19963804|NCT01732757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19963805|NCT01732757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963806|NCT01732770|Zoledronic Acid|zoledronic acid|mesh-list
19963807|NCT01732770|Denosumab|denosumab|mesh-list
19963808|NCT01732770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19963809|NCT01732770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963810|NCT01732783|Panitumumab|panitumumab|mesh-list
19963811|NCT01732783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19963812|NCT01732783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963813|NCT01732796|Ribavirin|ribavirin|mesh-list
19963814|NCT01732796|Antimetabolites|antimetabolites|mesh-ancestor
19963815|NCT01732796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963816|NCT01732796|Antiviral Agents|antiviral agents|mesh-ancestor
19963817|NCT01732796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19963818|NCT05317468|Contraceptive Agents|contraceptive agents|mesh-list
19963819|NCT05317468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19963820|NCT05317468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963821|NCT05317364|Estradiol|estradiol|mesh-list
19963822|NCT05317364|Estrogens|estrogens|mesh-ancestor
19963823|NCT05317364|Hormones|hormones|mesh-ancestor
19963824|NCT05317364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19963825|NCT05317364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963826|NCT05317325|Vaccines|vaccines|mesh-list
19963827|NCT05317325|Immunologic Factors|immunologic factors|mesh-ancestor
19963828|NCT05317325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963829|NCT05317260|Antiviral Agents|antiviral agents|mesh-list
19963830|NCT05317260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19963831|NCT05317039|Calcium|calcium|mesh-list
19963832|NCT05317039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19963833|NCT05317039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283952|NCT00603317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283953|NCT00603317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283954|NCT00603317|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20283955|NCT00603343|Propiverine|propiverine|mesh-list
20283956|NCT00603343|Parasympatholytics|parasympatholytics|mesh-ancestor
20283957|NCT00603343|Autonomic Agents|autonomic agents|mesh-ancestor
20283958|NCT00603343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20283959|NCT00603343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283960|NCT00603343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20283961|NCT00603343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20283962|NCT00603343|Cholinergic Agents|cholinergic agents|mesh-ancestor
20283963|NCT00603343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19963834|NCT05316935|Letrozole|letrozole|mesh-list
20283964|NCT00603343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963835|NCT05316935|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19963836|NCT05316935|Cyproterone|cyproterone|mesh-list
19963837|NCT05316935|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
19963838|NCT05316935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963839|NCT05316935|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19963840|NCT05316935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19963841|NCT05316935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19963842|NCT05316935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963843|NCT05316935|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19963844|NCT05316935|Hormone Antagonists|hormone antagonists|mesh-ancestor
19963845|NCT05316935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19963846|NCT05316935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963847|NCT05316935|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19963848|NCT05316935|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19963849|NCT05316935|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19963850|NCT05316935|Contraceptive Agents|contraceptive agents|mesh-ancestor
19963851|NCT05316935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19963852|NCT05316935|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19963853|NCT05316935|Estrogens|estrogens|mesh-ancestor
19963854|NCT05316935|Hormones|hormones|mesh-ancestor
19963855|NCT05316935|Androgen Antagonists|androgen antagonists|mesh-ancestor
19963856|NCT05316883|Clozapine|clozapine|mesh-list
19963857|NCT05316883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19963858|NCT05316883|Serotonin Agents|serotonin agents|mesh-ancestor
19963859|NCT05316883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19963860|NCT05316883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963861|NCT05316883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963862|NCT05316883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19963863|NCT05316883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19963864|NCT05316883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20283965|NCT00603343|Urological Agents|urological agents|mesh-ancestor
20283966|NCT00603356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20283967|NCT00603356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283968|NCT00603356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20283969|NCT00603356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283970|NCT00603356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283971|NCT00603434|Methylphenidate|methylphenidate|mesh-list
20283972|NCT00603434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20283973|NCT00603434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283974|NCT00603434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20283975|NCT00603434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20283976|NCT00603434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20283977|NCT00603434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283978|NCT00603434|Dopamine Agents|dopamine agents|mesh-ancestor
20283979|NCT00603434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20283980|NCT00603759|Celecoxib|celecoxib|mesh-list
20283981|NCT00603759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20283982|NCT00603759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19963865|NCT05316883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19963866|NCT05316883|GABA Antagonists|gaba antagonists|mesh-ancestor
19963867|NCT05316883|GABA Agents|gaba agents|mesh-ancestor
19963868|NCT05316857|Itraconazole|itraconazole|mesh-list
19963869|NCT05316857|Rifampin|rifampin|mesh-list
19963870|NCT05316857|Antifungal Agents|antifungal agents|mesh-ancestor
19963871|NCT05316857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19963872|NCT05316857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19963873|NCT05316857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19963874|NCT05316857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283983|NCT00603759|Analgesics|analgesics|mesh-ancestor
20283984|NCT00603759|Sensory System Agents|sensory system agents|mesh-ancestor
20283985|NCT00603759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20283986|NCT00603759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963875|NCT05316857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963876|NCT05316857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19963877|NCT05316857|Hormone Antagonists|hormone antagonists|mesh-ancestor
19963878|NCT05316857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19963879|NCT05316857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963880|NCT05316857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19963881|NCT05316857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19963882|NCT05316857|Antitubercular Agents|antitubercular agents|mesh-ancestor
19963883|NCT05316857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19963884|NCT05316857|Leprostatic Agents|leprostatic agents|mesh-ancestor
19963885|NCT05316857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19963886|NCT05316857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19963887|NCT05316857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19963888|NCT05316857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19963889|NCT05316857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19963890|NCT05316857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19963891|NCT05316857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19963892|NCT05316831|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19963893|NCT05316831|Immunologic Factors|immunologic factors|mesh-ancestor
19963894|NCT05316831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963895|NCT05316675|Isotretinoin|isotretinoin|mesh-list
19963896|NCT05316675|Dermatologic Agents|dermatologic agents|mesh-ancestor
19963897|NCT05316493|Megestrol|megestrol|mesh-list
19963898|NCT05316493|Megestrol Acetate|megestrol acetate|mesh-list
19963899|NCT05316493|Contraceptive Agents|contraceptive agents|mesh-list
20283987|NCT00603759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20283988|NCT00603759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20283989|NCT00603759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20283990|NCT00603759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20283991|NCT00603759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20283992|NCT00603759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20283993|NCT00603772|Tretinoin|tretinoin|mesh-list
20283994|NCT00603772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20283995|NCT00603772|Keratolytic Agents|keratolytic agents|mesh-ancestor
20283996|NCT00603772|Dermatologic Agents|dermatologic agents|mesh-ancestor
20283997|NCT00603785|Omalizumab|omalizumab|mesh-list
20283998|NCT00603785|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19963900|NCT05316493|Levonorgestrel|levonorgestrel|mesh-list
19963901|NCT05316493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19963902|NCT05316493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20283999|NCT00603785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20284000|NCT00603785|Respiratory System Agents|respiratory system agents|mesh-ancestor
20284001|NCT00603824|PENTA|penta|mesh-list
20284002|NCT00603824|Lepirudin|lepirudin|mesh-list
20284003|NCT00603824|Fondaparinux|fondaparinux|mesh-list
19963903|NCT05316493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19963904|NCT05316493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19963905|NCT05316493|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19963906|NCT05316493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19963907|NCT05316493|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19963908|NCT05316493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19963909|NCT05316493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963910|NCT05316493|Appetite Stimulants|appetite stimulants|mesh-ancestor
20284004|NCT00603824|Argatroban|argatroban|mesh-list
20284005|NCT00603824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20284006|NCT00603824|Antithrombins|antithrombins|mesh-ancestor
20284007|NCT00603824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20284008|NCT00603824|Protease Inhibitors|protease inhibitors|mesh-ancestor
20284009|NCT00603824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284010|NCT00603824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284011|NCT00603824|Anticoagulants|anticoagulants|mesh-ancestor
20284012|NCT00603824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20284013|NCT00603824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20284014|NCT00603824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20284015|NCT00604006|Spironolactone|spironolactone|mesh-list
20284016|NCT00604006|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20284017|NCT00604006|Hormone Antagonists|hormone antagonists|mesh-ancestor
20284018|NCT00604006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20284019|NCT00604006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963911|NCT05316493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19963912|NCT05316480|Nimotuzumab|nimotuzumab|mesh-list
19963913|NCT05316480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19963914|NCT05316480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963915|NCT05316467|Megestrol|megestrol|mesh-list
19963916|NCT05316467|Megestrol Acetate|megestrol acetate|mesh-list
19963917|NCT05316467|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19963918|NCT05316467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19963919|NCT05316467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19963920|NCT05316467|Contraceptive Agents|contraceptive agents|mesh-ancestor
19963921|NCT05316467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19963922|NCT05316467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284020|NCT00604006|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20284021|NCT00604006|Diuretics|diuretics|mesh-ancestor
20284022|NCT00604006|Natriuretic Agents|natriuretic agents|mesh-ancestor
20284023|NCT00604032|Tretinoin|tretinoin|mesh-list
20284024|NCT00604032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284025|NCT00604032|Keratolytic Agents|keratolytic agents|mesh-ancestor
20284026|NCT00604032|Dermatologic Agents|dermatologic agents|mesh-ancestor
20284027|NCT00604058|Vaccines|vaccines|mesh-list
20284028|NCT00604058|Immunologic Factors|immunologic factors|mesh-ancestor
20284029|NCT00604058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284030|NCT00604084|Ivermectin|ivermectin|mesh-list
20284031|NCT00604084|Permethrin|permethrin|mesh-list
20284032|NCT00604084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20284033|NCT00604084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20284034|NCT00604084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284035|NCT00604084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284036|NCT00604253|Insulin|insulin|mesh-list
20284037|NCT00604253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20284038|NCT00604253|Insulin Detemir|insulin detemir|mesh-list
20284039|NCT00604253|Isophane Insulin, Human|isophane insulin, human|mesh-list
20284040|NCT00604253|Insulin, Isophane|insulin, isophane|mesh-list
19963923|NCT05316467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19963924|NCT05316467|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19963925|NCT05316467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19963926|NCT05316467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963927|NCT05316467|Appetite Stimulants|appetite stimulants|mesh-ancestor
19963928|NCT05316467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19963929|NCT05316376|Paclitaxel|paclitaxel|mesh-list
19963930|NCT05316376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19963931|NCT05316376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19963932|NCT05316376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963933|NCT05316376|Tubulin Modulators|tubulin modulators|mesh-ancestor
19963934|NCT05316376|Antimitotic Agents|antimitotic agents|mesh-ancestor
19963935|NCT05316376|Mitosis Modulators|mitosis modulators|mesh-ancestor
19963936|NCT05316376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963937|NCT05316298|Gentamicins|gentamicins|mesh-list
19963938|NCT05316298|Calcium|calcium|mesh-list
19963939|NCT05316298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19963940|NCT05316298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963941|NCT05316298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19963942|NCT05316298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19963943|NCT05316298|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19963944|NCT05316298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284041|NCT00604253|Isophane insulin, beef|isophane insulin, beef|mesh-list
20284042|NCT00604253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20284043|NCT00604253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963945|NCT05316298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963946|NCT05316246|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19963947|NCT05316246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19963948|NCT05316246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963949|NCT05316168|Dexamethasone|dexamethasone|mesh-list
19963950|NCT05316168|Bupivacaine|bupivacaine|mesh-list
19963951|NCT05316168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19963952|NCT05316168|Antiemetics|antiemetics|mesh-ancestor
19963953|NCT05316168|Autonomic Agents|autonomic agents|mesh-ancestor
19963954|NCT05316168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19963955|NCT05316168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963956|NCT05316168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19963957|NCT05316168|Glucocorticoids|glucocorticoids|mesh-ancestor
19963958|NCT05316168|Hormones|hormones|mesh-ancestor
19963959|NCT05316168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19963960|NCT05316168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19963961|NCT05316168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19963962|NCT05316168|Anesthetics, Local|anesthetics, local|mesh-ancestor
19963963|NCT05316168|Anesthetics|anesthetics|mesh-ancestor
19963964|NCT05316168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19963965|NCT05316168|Sensory System Agents|sensory system agents|mesh-ancestor
19963966|NCT05316129|Hormones|hormones|mesh-list
19963967|NCT05316129|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19963968|NCT05316129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19963969|NCT05316129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963970|NCT05316116|Siltuximab|siltuximab|mesh-list
19963971|NCT05316116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975003|NCT01844583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20284044|NCT00604344|Insulin|insulin|mesh-list
19450391|NCT03428633|Narcotics|narcotics|mesh-ancestor
19975004|NCT01844583|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20284045|NCT00604344|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20284046|NCT00604344|Insulin Detemir|insulin detemir|mesh-list
19733362|NCT04562103|Anesthetics, Local|anesthetics, local|mesh-ancestor
19733363|NCT04562103|Anesthetics|anesthetics|mesh-ancestor
19963972|NCT05315999|Palonosetron|palonosetron|mesh-list
19963973|NCT05315999|Antiemetics|antiemetics|mesh-ancestor
19963974|NCT05315999|Autonomic Agents|autonomic agents|mesh-ancestor
19963975|NCT05315999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19963976|NCT05315999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963977|NCT05315999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19963978|NCT05315999|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19963979|NCT05315999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19963980|NCT05315999|Serotonin Agents|serotonin agents|mesh-ancestor
19963981|NCT05315999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19963982|NCT05315999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19963983|NCT05315830|Vaccines|vaccines|mesh-list
19963984|NCT05315830|Immunologic Factors|immunologic factors|mesh-ancestor
19963985|NCT05315830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963986|NCT05315817|Dialysis Solutions|dialysis solutions|mesh-list
19963987|NCT05315817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19963988|NCT05315648|Anesthetics|anesthetics|mesh-list
19963989|NCT05315648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19963990|NCT05315648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19963991|NCT05315557|Terlipressin|terlipressin|mesh-list
19963992|NCT05315557|Vasopressins|vasopressins|mesh-list
19963993|NCT05315557|Arginine Vasopressin|arginine vasopressin|mesh-list
19963994|NCT05315557|Hemostatics|hemostatics|mesh-ancestor
19963995|NCT05315557|Coagulants|coagulants|mesh-ancestor
19963996|NCT05315557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19963997|NCT05315557|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19963998|NCT05315557|Natriuretic Agents|natriuretic agents|mesh-ancestor
19963999|NCT05315557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964000|NCT05315557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19964014|NCT05315388|Vitamins|vitamins|mesh-list
19964015|NCT05315388|Micronutrients|micronutrients|mesh-ancestor
19964016|NCT05315388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964017|NCT05315206|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19964018|NCT05315206|Nootropic Agents|nootropic agents|mesh-ancestor
19964019|NCT05315128|Methotrexate|methotrexate|mesh-list
19964020|NCT05315128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19964021|NCT05315128|Abortifacient Agents|abortifacient agents|mesh-ancestor
19964022|NCT05315128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19964023|NCT05315128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964024|NCT05315128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19964025|NCT05315128|Antimetabolites|antimetabolites|mesh-ancestor
19964026|NCT05315128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964027|NCT05315128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964028|NCT05315128|Dermatologic Agents|dermatologic agents|mesh-ancestor
19964029|NCT05315128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964030|NCT05315128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19964031|NCT05315128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19964032|NCT05315128|Immunologic Factors|immunologic factors|mesh-ancestor
19964033|NCT05315128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20548260|NCT01899170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19733364|NCT04562103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19733365|NCT04562103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733366|NCT04562103|Sensory System Agents|sensory system agents|mesh-ancestor
19733367|NCT04562103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733368|NCT04562103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19733369|NCT04562103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19733370|NCT04562103|Adrenergic Agents|adrenergic agents|mesh-ancestor
19733371|NCT04562103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19733372|NCT04562103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964034|NCT05315128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19964035|NCT05314933|Deoxyglucose|deoxyglucose|mesh-list
19964036|NCT05314933|Antimetabolites|antimetabolites|mesh-ancestor
19733373|NCT04562103|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19733374|NCT04562103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19733375|NCT04562103|Autonomic Agents|autonomic agents|mesh-ancestor
19733376|NCT04562103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19733377|NCT04562103|Respiratory System Agents|respiratory system agents|mesh-ancestor
19733378|NCT04562103|Mydriatics|mydriatics|mesh-ancestor
19733379|NCT04562103|Sympathomimetics|sympathomimetics|mesh-ancestor
19964037|NCT05314933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964038|NCT05314933|Antiviral Agents|antiviral agents|mesh-ancestor
19964039|NCT05314933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19964040|NCT05309564|Botulinum Toxins|botulinum toxins|mesh-list
19964041|NCT05309564|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19964042|NCT05309564|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19964043|NCT05309564|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19964044|NCT05309564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19964045|NCT05309564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964046|NCT05309564|Cholinergic Agents|cholinergic agents|mesh-ancestor
19964047|NCT05309564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19964048|NCT05309564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733380|NCT04562103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19733381|NCT04561635|Micronutrients|micronutrients|mesh-list
20284047|NCT00604344|Isophane Insulin, Human|isophane insulin, human|mesh-list
20284048|NCT00604344|Insulin, Isophane|insulin, isophane|mesh-list
20284049|NCT00604344|Isophane insulin, beef|isophane insulin, beef|mesh-list
20284050|NCT00604344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20284051|NCT00604344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284052|NCT00604357|Sirolimus|sirolimus|mesh-list
20284053|NCT00604357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20284054|NCT00604357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20284055|NCT00604357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20284056|NCT00604357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284057|NCT00604357|Antifungal Agents|antifungal agents|mesh-ancestor
20284058|NCT00604357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20284059|NCT00604357|Immunologic Factors|immunologic factors|mesh-ancestor
19964049|NCT05309564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19964050|NCT05309564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964051|NCT05308420|Morphine|morphine|mesh-list
20284060|NCT00604357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284061|NCT00604396|Insulin|insulin|mesh-list
20284062|NCT00604396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20284063|NCT00604396|Insulin Detemir|insulin detemir|mesh-list
20284064|NCT00604396|Isophane Insulin, Human|isophane insulin, human|mesh-list
20284065|NCT00604396|Insulin, Isophane|insulin, isophane|mesh-list
20284066|NCT00604396|Isophane insulin, beef|isophane insulin, beef|mesh-list
20284067|NCT00604396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19964052|NCT05308420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19964053|NCT05308420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964054|NCT05308420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19964055|NCT05308420|Narcotics|narcotics|mesh-ancestor
19964056|NCT05308420|Analgesics|analgesics|mesh-ancestor
19964057|NCT05308420|Sensory System Agents|sensory system agents|mesh-ancestor
19964058|NCT05308420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964059|NCT05303792|Cytarabine|cytarabine|mesh-list
19964060|NCT05303792|Dexamethasone|dexamethasone|mesh-list
19964061|NCT05303792|Prednisone|prednisone|mesh-list
19964062|NCT05303792|Methylprednisolone|methylprednisolone|mesh-list
19964063|NCT05303792|Cyclophosphamide|cyclophosphamide|mesh-list
19964064|NCT05303792|Rituximab|rituximab|mesh-list
20284068|NCT00604396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284069|NCT00604409|Capecitabine|capecitabine|mesh-list
20284070|NCT00604409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20284071|NCT00604409|Antimetabolites|antimetabolites|mesh-ancestor
20284072|NCT00604409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284073|NCT00604409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284074|NCT00604435|Docetaxel|docetaxel|mesh-list
20284075|NCT00604435|Epirubicin|epirubicin|mesh-list
20284076|NCT00604435|Endostatins|endostatins|mesh-list
20284077|NCT00604435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284078|NCT00604435|Tubulin Modulators|tubulin modulators|mesh-ancestor
20284079|NCT00604435|Antimitotic Agents|antimitotic agents|mesh-ancestor
19964065|NCT05303792|Doxorubicin|doxorubicin|mesh-list
20284080|NCT00604435|Mitosis Modulators|mitosis modulators|mesh-ancestor
19733382|NCT04561635|Trace Elements|trace elements|mesh-list
19964066|NCT05303792|Methotrexate|methotrexate|mesh-list
19964067|NCT05303792|Vincristine|vincristine|mesh-list
20284081|NCT00604435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284082|NCT00604435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20284083|NCT00604435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20284084|NCT00604435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20284085|NCT00604435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284086|NCT00604435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20284087|NCT00604435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20284088|NCT00604435|Growth Substances|growth substances|mesh-ancestor
20284089|NCT00604435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284090|NCT00604435|Growth Inhibitors|growth inhibitors|mesh-ancestor
20284091|NCT00604578|Pioglitazone|pioglitazone|mesh-list
20284092|NCT00604578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20284093|NCT00604578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284094|NCT00604591|Tolcapone|tolcapone|mesh-list
20284095|NCT00604591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20284096|NCT00604591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20284097|NCT00604591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20284098|NCT00604591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284099|NCT00604591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284100|NCT00604630|Epoetin Alfa|epoetin alfa|mesh-list
20284101|NCT00604630|Hematinics|hematinics|mesh-ancestor
20284102|NCT00604656|Insulin Aspart|insulin aspart|mesh-list
20284103|NCT00604656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20284104|NCT00604656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284105|NCT00604682|Apremilast|apremilast|mesh-list
20284106|NCT00604682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20284107|NCT00604682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20284108|NCT00604682|Analgesics|analgesics|mesh-ancestor
20284109|NCT00604682|Sensory System Agents|sensory system agents|mesh-ancestor
20284110|NCT00604682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964068|NCT05303792|Mercaptopurine|mercaptopurine|mesh-list
19964069|NCT05303792|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19964070|NCT05303792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19964071|NCT05303792|Immunologic Factors|immunologic factors|mesh-ancestor
19964072|NCT05303792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964073|NCT05303792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19964074|NCT05303792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19964075|NCT05303792|Alkylating Agents|alkylating agents|mesh-ancestor
19964076|NCT05303792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964077|NCT05303792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964078|NCT05303792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19964079|NCT05303792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19964080|NCT05303792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19964081|NCT05303792|Antiemetics|antiemetics|mesh-ancestor
19964082|NCT05303792|Autonomic Agents|autonomic agents|mesh-ancestor
19964083|NCT05303792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20284111|NCT00604682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284112|NCT00604682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20284113|NCT00604682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20284114|NCT00604682|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20284115|NCT00604682|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20284116|NCT00604682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284117|NCT00604682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284118|NCT00604864|Infliximab|infliximab|mesh-list
20284119|NCT00604864|Antibodies|antibodies|mesh-list
20284120|NCT00604864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20284121|NCT00604864|Immunologic Factors|immunologic factors|mesh-ancestor
20284122|NCT00604864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284123|NCT00604864|Dermatologic Agents|dermatologic agents|mesh-ancestor
19964084|NCT05303792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19964085|NCT05303792|Glucocorticoids|glucocorticoids|mesh-ancestor
20284124|NCT00604864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20284125|NCT00604864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19964086|NCT05303792|Hormones|hormones|mesh-ancestor
19964087|NCT05303792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19964088|NCT05303792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19964089|NCT05303792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19964090|NCT05303792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19964091|NCT05303792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19964092|NCT05303792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964093|NCT05303792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19964094|NCT05303792|Abortifacient Agents|abortifacient agents|mesh-ancestor
19964095|NCT05303792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20284126|NCT00604942|Domperidone|domperidone|mesh-list
20284127|NCT00604942|Esomeprazole|esomeprazole|mesh-list
20284128|NCT00604942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20284129|NCT00604942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20284130|NCT00604942|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20284131|NCT00604942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284132|NCT00604942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284133|NCT00604942|Antiemetics|antiemetics|mesh-ancestor
20284134|NCT00604942|Autonomic Agents|autonomic agents|mesh-ancestor
20284135|NCT00604942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20284136|NCT00604942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284137|NCT00604942|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20284138|NCT00604942|Dopamine Agents|dopamine agents|mesh-ancestor
20284139|NCT00604942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20284140|NCT00604955|Paromomycin|paromomycin|mesh-list
20284141|NCT00604955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20284142|NCT00604955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20284143|NCT00604955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20284144|NCT00604955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19964096|NCT05303792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19964097|NCT05303792|Antimetabolites|antimetabolites|mesh-ancestor
19964098|NCT05303792|Dermatologic Agents|dermatologic agents|mesh-ancestor
20288369|NCT05334316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964099|NCT05303792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19964100|NCT05303792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19964101|NCT05303792|Antiviral Agents|antiviral agents|mesh-ancestor
19964102|NCT05303792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19964103|NCT05303792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19964104|NCT05303792|Tubulin Modulators|tubulin modulators|mesh-ancestor
19964105|NCT05303792|Antimitotic Agents|antimitotic agents|mesh-ancestor
19964106|NCT05303792|Mitosis Modulators|mitosis modulators|mesh-ancestor
19964107|NCT05303792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19964108|NCT05303792|Protective Agents|protective agents|mesh-ancestor
19964109|NCT05302011|Carboplatin|carboplatin|mesh-list
19964110|NCT05302011|Docetaxel|docetaxel|mesh-list
19964111|NCT05302011|Pembrolizumab|pembrolizumab|mesh-list
19964112|NCT05302011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964113|NCT05302011|Tubulin Modulators|tubulin modulators|mesh-ancestor
19964114|NCT05302011|Antimitotic Agents|antimitotic agents|mesh-ancestor
20288370|NCT05334316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288371|NCT05334316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20288372|NCT05334316|Glucocorticoids|glucocorticoids|mesh-ancestor
20288373|NCT05334316|Hormones|hormones|mesh-ancestor
20288374|NCT05334316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20288375|NCT05334316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20288376|NCT05334316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288377|NCT05334277|Bevacizumab|bevacizumab|mesh-list
20288378|NCT05334277|Carboplatin|carboplatin|mesh-list
20288379|NCT05334277|Pemetrexed|pemetrexed|mesh-list
20288380|NCT05334277|Aflutinib|aflutinib|mesh-list
20288381|NCT05334277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19964115|NCT05302011|Mitosis Modulators|mitosis modulators|mesh-ancestor
19964116|NCT05302011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964117|NCT05302011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19964118|NCT05297396|Analgesics, Opioid|analgesics, opioid|mesh-list
19964119|NCT05297396|Narcotics|narcotics|mesh-ancestor
19964120|NCT05297396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19964121|NCT05297396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964122|NCT05297396|Analgesics|analgesics|mesh-ancestor
19964123|NCT05297396|Sensory System Agents|sensory system agents|mesh-ancestor
19964124|NCT05297396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964125|NCT05296837|Doxycycline|doxycycline|mesh-list
19964126|NCT05296837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19964127|NCT05296837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19964128|NCT05296837|Antimalarials|antimalarials|mesh-ancestor
19964129|NCT05296837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19964130|NCT05296837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19964131|NCT05282550|Trazodone|trazodone|mesh-list
19964132|NCT05282550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19964133|NCT05282550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19964134|NCT05282550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19964135|NCT05282550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964136|NCT05282550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19964137|NCT05282550|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19964138|NCT05282550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20288382|NCT05334277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964139|NCT05282550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19964140|NCT05282550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964141|NCT05282550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19964142|NCT05282550|Serotonin Agents|serotonin agents|mesh-ancestor
19964143|NCT05282550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19964144|NCT05282550|Antidepressive Agents|antidepressive agents|mesh-ancestor
19975005|NCT01844583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19975006|NCT01844583|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19975007|NCT01844583|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19975008|NCT01844583|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19975009|NCT01844583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19975010|NCT01844687|Cannabidiol|cannabidiol|mesh-list
19975011|NCT01844687|Anticonvulsants|anticonvulsants|mesh-ancestor
19975012|NCT01844700|Risperidone|risperidone|mesh-list
19975013|NCT01844700|Aripiprazole|aripiprazole|mesh-list
19975014|NCT01844700|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19975015|NCT01844700|Ziprasidone|ziprasidone|mesh-list
19975016|NCT01844700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19975017|NCT01844700|Serotonin Agents|serotonin agents|mesh-ancestor
19975018|NCT01844700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975019|NCT01844700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975020|NCT01844700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975021|NCT01844700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19975022|NCT01844700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19975023|NCT01844700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19975024|NCT01844700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19975025|NCT01844700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19975026|NCT01844700|Dopamine Agents|dopamine agents|mesh-ancestor
19975027|NCT01844700|Antidepressive Agents|antidepressive agents|mesh-ancestor
19975028|NCT01844700|Dopamine Agonists|dopamine agonists|mesh-ancestor
19975029|NCT01844700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19975030|NCT01844700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19975031|NCT01844700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19975032|NCT01844700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19975033|NCT01844778|Tobramycin|tobramycin|mesh-list
19975034|NCT01844778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19975035|NCT01844778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19975036|NCT01844830|Phenylephrine|phenylephrine|mesh-list
19975037|NCT01844830|Oxymetazoline|oxymetazoline|mesh-list
19975038|NCT01844830|Tetracaine|tetracaine|mesh-list
19975039|NCT01844830|Anesthetics, Local|anesthetics, local|mesh-ancestor
19975040|NCT01844830|Anesthetics|anesthetics|mesh-ancestor
19975041|NCT01844830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19975042|NCT01844830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975043|NCT01844830|Sensory System Agents|sensory system agents|mesh-ancestor
20284145|NCT00605020|Insulin|insulin|mesh-list
20284146|NCT00605020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20284147|NCT00605020|Insulin Aspart|insulin aspart|mesh-list
20284148|NCT00605020|Insulin, Long-Acting|insulin, long-acting|mesh-list
20284149|NCT00605020|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19975044|NCT01844830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975045|NCT01844830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19975046|NCT01844830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19975047|NCT01844830|Adrenergic Agents|adrenergic agents|mesh-ancestor
19975048|NCT01844830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975049|NCT01844830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975050|NCT01844830|Sympathomimetics|sympathomimetics|mesh-ancestor
19975051|NCT01844830|Autonomic Agents|autonomic agents|mesh-ancestor
19975052|NCT01844830|Nasal Decongestants|nasal decongestants|mesh-ancestor
19975053|NCT01844830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19975054|NCT01844830|Respiratory System Agents|respiratory system agents|mesh-ancestor
19975055|NCT01844830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19975056|NCT01844830|Mydriatics|mydriatics|mesh-ancestor
19975057|NCT01844830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19975058|NCT01844830|Protective Agents|protective agents|mesh-ancestor
19975059|NCT01844895|Abatacept|abatacept|mesh-list
19975060|NCT01844895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19975061|NCT01844895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975062|NCT01844895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975063|NCT01844895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19975064|NCT01844895|Immunologic Factors|immunologic factors|mesh-ancestor
19975065|NCT01844895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975066|NCT01844895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19975067|NCT01845025|Fluticasone|fluticasone|mesh-list
20284150|NCT00605020|Insulin Detemir|insulin detemir|mesh-list
20284151|NCT00605020|Biphasic Insulins|biphasic insulins|mesh-list
20284152|NCT00605020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19964145|NCT05251259|Montelukast|montelukast|mesh-list
19964146|NCT05251259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19964147|NCT05251259|Respiratory System Agents|respiratory system agents|mesh-ancestor
20284153|NCT00605020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284154|NCT00605098|Ritonavir|ritonavir|mesh-list
20284155|NCT00605098|Lopinavir|lopinavir|mesh-list
19964148|NCT05251259|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19964149|NCT05251259|Hormone Antagonists|hormone antagonists|mesh-ancestor
19964150|NCT05251259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19964151|NCT05251259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964152|NCT05251259|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19964153|NCT05251259|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19964154|NCT05251259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964155|NCT05220748|Pembrolizumab|pembrolizumab|mesh-list
19964156|NCT05220748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19964157|NCT05220748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964158|NCT05213169|Apomorphine|apomorphine|mesh-list
19964159|NCT05213169|Emetics|emetics|mesh-ancestor
19964160|NCT05213169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964161|NCT05213169|Autonomic Agents|autonomic agents|mesh-ancestor
19964162|NCT05213169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964163|NCT05213169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19964164|NCT05213169|Dopamine Agonists|dopamine agonists|mesh-ancestor
19964165|NCT05213169|Dopamine Agents|dopamine agents|mesh-ancestor
19964166|NCT05213169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19964167|NCT05213169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964168|NCT05212623|Vaccines|vaccines|mesh-list
19964169|NCT05212623|Immunologic Factors|immunologic factors|mesh-ancestor
19964170|NCT05212623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964171|NCT05201638|Calcium, Dietary|calcium, dietary|mesh-list
19964172|NCT05201638|Calcium|calcium|mesh-list
19964173|NCT05201638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19964174|NCT05201638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964175|NCT05201638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19964176|NCT05192265|Artesunate|artesunate|mesh-list
19964177|NCT05192265|Lumefantrine|lumefantrine|mesh-list
19964178|NCT05192265|Artemether|artemether|mesh-list
19964179|NCT05192265|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19964180|NCT05192265|Pyronaridine|pyronaridine|mesh-list
19964181|NCT05192265|Antimalarials|antimalarials|mesh-list
19964182|NCT05192265|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19964183|NCT05192265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19964184|NCT05192265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19964185|NCT05192265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964186|NCT05192265|Antiviral Agents|antiviral agents|mesh-ancestor
19964187|NCT05192265|Schistosomicides|schistosomicides|mesh-ancestor
19964188|NCT05192265|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19964189|NCT05192265|Anthelmintics|anthelmintics|mesh-ancestor
19964190|NCT05191004|Fulvestrant|fulvestrant|mesh-list
19964191|NCT05191004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19964192|NCT05191004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964193|NCT05191004|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19964194|NCT05191004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19964195|NCT05191004|Hormone Antagonists|hormone antagonists|mesh-ancestor
19964196|NCT05191004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19964197|NCT05191004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964198|NCT05176509|Pembrolizumab|pembrolizumab|mesh-list
19964199|NCT05176509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19964200|NCT05176509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964201|NCT05174650|Atezolizumab|atezolizumab|mesh-list
19964202|NCT05174650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964203|NCT05171686|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19964204|NCT05171686|Chlorthalidone|chlorthalidone|mesh-list
19964205|NCT05171686|Torsemide|torsemide|mesh-list
19964206|NCT05171686|Furosemide|furosemide|mesh-list
19964207|NCT05171686|Bumetanide|bumetanide|mesh-list
19964208|NCT05171686|Diuretics|diuretics|mesh-list
19964209|NCT05171686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19964210|NCT05171686|Natriuretic Agents|natriuretic agents|mesh-ancestor
19964211|NCT05171686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964212|NCT05171686|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19964213|NCT05171686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19964214|NCT05171686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964215|NCT05171686|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19964216|NCT05169372|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19964217|NCT05169372|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19964218|NCT05169372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964219|NCT05167643|Anastrozole|anastrozole|mesh-list
19964220|NCT05167643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19964221|NCT05167643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964222|NCT05167643|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19964223|NCT05167643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19964224|NCT05167643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964225|NCT05167643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964226|NCT05167643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19964227|NCT05167643|Hormone Antagonists|hormone antagonists|mesh-ancestor
19964228|NCT05167643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19964229|NCT05167643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964230|NCT05166343|Epinephrine|epinephrine|mesh-list
19964231|NCT05166343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19964232|NCT05166343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19964233|NCT05166343|Adrenergic Agents|adrenergic agents|mesh-ancestor
19964234|NCT05166343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19964235|NCT05166343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964236|NCT05166343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964237|NCT05166343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19964238|NCT05166343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19964239|NCT05166343|Autonomic Agents|autonomic agents|mesh-ancestor
19964240|NCT05166343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964241|NCT05166343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19964242|NCT05166343|Respiratory System Agents|respiratory system agents|mesh-ancestor
19964243|NCT05166343|Mydriatics|mydriatics|mesh-ancestor
19964244|NCT05166343|Sympathomimetics|sympathomimetics|mesh-ancestor
19964245|NCT05166343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19964246|NCT05161338|Estradiol|estradiol|mesh-list
19964247|NCT05161338|Progesterone|progesterone|mesh-list
19964248|NCT05161338|Estrogens|estrogens|mesh-ancestor
19964249|NCT05161338|Hormones|hormones|mesh-ancestor
19964250|NCT05161338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19964251|NCT05161338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964252|NCT05161338|Progestins|progestins|mesh-ancestor
19964253|NCT05137054|Dexamethasone|dexamethasone|mesh-list
19964254|NCT05137054|Lenalidomide|lenalidomide|mesh-list
19964255|NCT05137054|Bortezomib|bortezomib|mesh-list
19964256|NCT05137054|Daratumumab|daratumumab|mesh-list
19964257|NCT05137054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19964258|NCT05137054|Antiemetics|antiemetics|mesh-ancestor
19964259|NCT05137054|Autonomic Agents|autonomic agents|mesh-ancestor
19964260|NCT05137054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964261|NCT05137054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964262|NCT05137054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19964263|NCT05137054|Glucocorticoids|glucocorticoids|mesh-ancestor
19964264|NCT05137054|Hormones|hormones|mesh-ancestor
19964265|NCT05137054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19964266|NCT05137054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19964267|NCT05137054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964268|NCT05137054|Immunologic Factors|immunologic factors|mesh-ancestor
19964269|NCT05137054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20284156|NCT00605098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20284157|NCT00605098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20284158|NCT00605098|Protease Inhibitors|protease inhibitors|mesh-ancestor
20284159|NCT00605098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964270|NCT05137054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19964271|NCT05137054|Growth Substances|growth substances|mesh-ancestor
19964272|NCT05137054|Growth Inhibitors|growth inhibitors|mesh-ancestor
19964273|NCT05127928|Vitamins|vitamins|mesh-list
19964274|NCT05127928|Ascorbic Acid|ascorbic acid|mesh-list
19964275|NCT05127928|Vitamin E|vitamin e|mesh-list
19964276|NCT05127928|Tocopherols|tocopherols|mesh-list
19964277|NCT05127928|Micronutrients|micronutrients|mesh-ancestor
19964278|NCT05127928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964279|NCT05127928|Antioxidants|antioxidants|mesh-ancestor
19964280|NCT05127928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964281|NCT05127928|Protective Agents|protective agents|mesh-ancestor
19964282|NCT05115409|Rituximab|rituximab|mesh-list
19964283|NCT05115409|Antibodies|antibodies|mesh-list
19964284|NCT05115409|Immunologic Factors|immunologic factors|mesh-ancestor
19964285|NCT05115409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964286|NCT05115409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19964287|NCT05115409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964288|NCT05115409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19964289|NCT05113186|Lenvatinib|lenvatinib|mesh-list
19964290|NCT05113186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284160|NCT00605098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284161|NCT00605098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20284162|NCT00605098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20284163|NCT00605098|Antiviral Agents|antiviral agents|mesh-ancestor
20284164|NCT00605098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19964291|NCT05113186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19964292|NCT05113186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964293|NCT05113186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964294|NCT05112536|Paclitaxel|paclitaxel|mesh-list
19964295|NCT05112536|Carboplatin|carboplatin|mesh-list
19964296|NCT05112536|Doxorubicin|doxorubicin|mesh-list
19964297|NCT05112536|Pembrolizumab|pembrolizumab|mesh-list
19964298|NCT05112536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19964299|NCT05112536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964300|NCT05112536|Tubulin Modulators|tubulin modulators|mesh-ancestor
19964301|NCT05112536|Antimitotic Agents|antimitotic agents|mesh-ancestor
19964302|NCT05112536|Mitosis Modulators|mitosis modulators|mesh-ancestor
19964303|NCT05112536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964304|NCT05112536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19964305|NCT05112536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19964306|NCT05112536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19964307|NCT05112536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964308|NCT05112536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19964309|NCT05111808|Methylene Blue|methylene blue|mesh-list
19964310|NCT05111808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964311|NCT05111808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964312|NCT05093140|Prednisone|prednisone|mesh-list
19964313|NCT05093140|Cyclophosphamide|cyclophosphamide|mesh-list
19964314|NCT05093140|Vincristine|vincristine|mesh-list
19964315|NCT05093140|Doxorubicin|doxorubicin|mesh-list
19964316|NCT05093140|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19964317|NCT05093140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19964318|NCT05093140|Immunologic Factors|immunologic factors|mesh-ancestor
19964319|NCT05093140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964320|NCT05093140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20284165|NCT00605098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20284166|NCT00605098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20284167|NCT00605111|Insulin Aspart|insulin aspart|mesh-list
20284168|NCT00605111|Biphasic Insulins|biphasic insulins|mesh-list
20284169|NCT00605111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20284170|NCT00605111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284171|NCT00605137|Insulin|insulin|mesh-list
20284172|NCT00605137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20284173|NCT00605137|Insulin Detemir|insulin detemir|mesh-list
20284174|NCT00605137|Isophane Insulin, Human|isophane insulin, human|mesh-list
20284175|NCT00605137|Insulin, Isophane|insulin, isophane|mesh-list
20284176|NCT00605137|Isophane insulin, beef|isophane insulin, beef|mesh-list
20284177|NCT00605137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20284178|NCT00605137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284179|NCT00605371|Lamotrigine|lamotrigine|mesh-list
20284180|NCT00605371|Anticonvulsants|anticonvulsants|mesh-list
20284181|NCT00605371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20284182|NCT00605371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19964321|NCT05093140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19964322|NCT05093140|Alkylating Agents|alkylating agents|mesh-ancestor
19964323|NCT05093140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964324|NCT05093140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964325|NCT05093140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19964326|NCT05093140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19964327|NCT05093140|Glucocorticoids|glucocorticoids|mesh-ancestor
19964328|NCT05093140|Hormones|hormones|mesh-ancestor
19964329|NCT05093140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19964330|NCT05093140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19964331|NCT05093140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19964332|NCT05093140|Tubulin Modulators|tubulin modulators|mesh-ancestor
19964333|NCT05093140|Antimitotic Agents|antimitotic agents|mesh-ancestor
19964334|NCT05093140|Mitosis Modulators|mitosis modulators|mesh-ancestor
19964335|NCT05093140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19964336|NCT05093140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19964337|NCT05093140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19964338|NCT05093140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964339|NCT05090371|Ofatumumab|ofatumumab|mesh-list
19975068|NCT01845025|Xhance|xhance|mesh-list
20284183|NCT00605371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964340|NCT05090371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964341|NCT05082025|Fulvestrant|fulvestrant|mesh-list
19964342|NCT05082025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19964343|NCT05082025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284184|NCT00605371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20284185|NCT00605371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284186|NCT00605371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20284187|NCT00605371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20284188|NCT00605371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20284189|NCT00605371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20284190|NCT00605371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20284191|NCT00605397|Trastuzumab|trastuzumab|mesh-list
20284192|NCT00605397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20548261|NCT01899170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548262|NCT01899170|Analgesics|analgesics|mesh-ancestor
20548263|NCT01899170|Sensory System Agents|sensory system agents|mesh-ancestor
20548264|NCT01899170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548265|NCT01899248|Sevoflurane|sevoflurane|mesh-list
20548266|NCT01899248|Desflurane|desflurane|mesh-list
20548267|NCT01899248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20548268|NCT01899248|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20548269|NCT01899248|Anesthetics, General|anesthetics, general|mesh-ancestor
20548270|NCT01899248|Anesthetics|anesthetics|mesh-ancestor
20548271|NCT01899248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20548272|NCT01899248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548273|NCT01899326|Desipramine|desipramine|mesh-list
20548274|NCT01899326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548275|NCT01899326|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19964344|NCT05082025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19964345|NCT05082025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19964346|NCT05082025|Hormone Antagonists|hormone antagonists|mesh-ancestor
19964347|NCT05082025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19964348|NCT05082025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975069|NCT01845025|Formoterol Fumarate|formoterol fumarate|mesh-list
19975070|NCT01845025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19975071|NCT01845025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19975072|NCT01845025|Autonomic Agents|autonomic agents|mesh-ancestor
19975073|NCT01845025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975074|NCT01845025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975075|NCT01845025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19975076|NCT01845025|Respiratory System Agents|respiratory system agents|mesh-ancestor
19975077|NCT01845025|Dermatologic Agents|dermatologic agents|mesh-ancestor
19975078|NCT01845025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19975079|NCT01845025|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19975080|NCT01845025|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19975081|NCT01845025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19975082|NCT01845025|Adrenergic Agents|adrenergic agents|mesh-ancestor
19975083|NCT01845025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975084|NCT01845025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975085|NCT01845077|Metformin|metformin|mesh-list
19975086|NCT01845077|Linagliptin|linagliptin|mesh-list
20548276|NCT01899326|Antidepressive Agents|antidepressive agents|mesh-ancestor
20548277|NCT01899326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19975087|NCT01845077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19975088|NCT01845077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975089|NCT01845077|Incretins|incretins|mesh-ancestor
19975090|NCT01845077|Hormones|hormones|mesh-ancestor
19975091|NCT01845077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19975092|NCT01845077|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19975093|NCT01845077|Protease Inhibitors|protease inhibitors|mesh-ancestor
19975094|NCT01845077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19975095|NCT01845077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975096|NCT01845636|Atropine|atropine|mesh-list
19975097|NCT01845636|Donepezil|donepezil|mesh-list
19975098|NCT01845636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19975099|NCT01845636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19975100|NCT01845636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19975101|NCT01845636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19975102|NCT01845636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975103|NCT01845636|Cholinergic Agents|cholinergic agents|mesh-ancestor
19975104|NCT01845636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975105|NCT01845636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975106|NCT01845636|Nootropic Agents|nootropic agents|mesh-ancestor
19964349|NCT05061368|Sildenafil Citrate|sildenafil citrate|mesh-list
19964350|NCT05061368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964351|NCT05061368|Vasodilator Agents|vasodilator agents|mesh-ancestor
20284193|NCT00605397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284194|NCT00605410|Bromides|bromides|mesh-list
19964352|NCT05061368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20284195|NCT00605410|Ipratropium|ipratropium|mesh-list
20284196|NCT00605410|Anticonvulsants|anticonvulsants|mesh-ancestor
20284197|NCT00605410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20284198|NCT00605410|Autonomic Agents|autonomic agents|mesh-ancestor
20284199|NCT00605410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20284200|NCT00605410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284201|NCT00605410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20284202|NCT00605410|Respiratory System Agents|respiratory system agents|mesh-ancestor
20284203|NCT00605410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20284204|NCT00605410|Cholinergic Agents|cholinergic agents|mesh-ancestor
20284205|NCT00605410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20284206|NCT00605410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284207|NCT00605605|Dextromethorphan|dextromethorphan|mesh-list
20284208|NCT00605605|Antitussive Agents|antitussive agents|mesh-ancestor
20284209|NCT00605605|Respiratory System Agents|respiratory system agents|mesh-ancestor
20284210|NCT00605605|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20284211|NCT00605605|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20284212|NCT00605605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20284213|NCT00605605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284214|NCT00605605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284215|NCT00605683|Cabergoline|cabergoline|mesh-list
20284216|NCT00605683|Pramipexole|pramipexole|mesh-list
20284217|NCT00605683|Ropinirole|ropinirole|mesh-list
20284218|NCT00605683|Bromocriptine|bromocriptine|mesh-list
20284219|NCT00605683|Lisuride|lisuride|mesh-list
20284220|NCT00605683|Apomorphine|apomorphine|mesh-list
20284221|NCT00605683|Pergolide|pergolide|mesh-list
20284222|NCT00605683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20284223|NCT00605683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20284224|NCT00605683|Dopamine Agonists|dopamine agonists|mesh-ancestor
20284225|NCT00605683|Dopamine Agents|dopamine agents|mesh-ancestor
20284226|NCT00605683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20284227|NCT00605683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284228|NCT00605683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284229|NCT00605683|Antioxidants|antioxidants|mesh-ancestor
20284230|NCT00605683|Protective Agents|protective agents|mesh-ancestor
20284231|NCT00605683|Hormone Antagonists|hormone antagonists|mesh-ancestor
20284232|NCT00605683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20284233|NCT00605683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20284234|NCT00605683|Serotonin Agents|serotonin agents|mesh-ancestor
20284235|NCT00605683|Emetics|emetics|mesh-ancestor
20284236|NCT00605683|Autonomic Agents|autonomic agents|mesh-ancestor
20284237|NCT00605683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20284238|NCT00605683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20284239|NCT00605774|Epinephrine|epinephrine|mesh-list
20284240|NCT00605774|Racepinephrine|racepinephrine|mesh-list
20284241|NCT00605774|Epinephryl borate|epinephryl borate|mesh-list
20284242|NCT00605774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20284243|NCT00605774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20284244|NCT00605774|Adrenergic Agents|adrenergic agents|mesh-ancestor
20284245|NCT00605774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20284246|NCT00605774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964353|NCT05061368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19964354|NCT05061368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964355|NCT05061368|Urological Agents|urological agents|mesh-ancestor
19964356|NCT05058404|Prednisone|prednisone|mesh-list
19964357|NCT05058404|Rituximab|rituximab|mesh-list
19964358|NCT05058404|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19964359|NCT05058404|Cyclophosphamide|cyclophosphamide|mesh-list
20284247|NCT00605774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284248|NCT00605774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20284249|NCT00605774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20548278|NCT01899326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548279|NCT01899326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548280|NCT01899326|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20548281|NCT01899326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20548282|NCT01899326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20548283|NCT01899326|Adrenergic Agents|adrenergic agents|mesh-ancestor
20548284|NCT01899326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19964360|NCT05058404|Vincristine|vincristine|mesh-list
20284250|NCT00605774|Autonomic Agents|autonomic agents|mesh-ancestor
20284251|NCT00605774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20284252|NCT00605774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20284253|NCT00605774|Respiratory System Agents|respiratory system agents|mesh-ancestor
20284254|NCT00605774|Mydriatics|mydriatics|mesh-ancestor
20284255|NCT00605774|Sympathomimetics|sympathomimetics|mesh-ancestor
19964361|NCT05058404|Doxorubicin|doxorubicin|mesh-list
19964362|NCT05058404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19964363|NCT05058404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964364|NCT05058404|Immunologic Factors|immunologic factors|mesh-ancestor
19964365|NCT05058404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964366|NCT05058404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19964367|NCT05058404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20284256|NCT00605774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20284257|NCT00605787|1-(carboxymethylthio)tetradecane|1-(carboxymethylthio)tetradecane|mesh-list
20284258|NCT00605787|Antioxidants|antioxidants|mesh-ancestor
20284259|NCT00605787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284260|NCT00605787|Protective Agents|protective agents|mesh-ancestor
20284261|NCT00605787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284262|NCT00605787|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20284263|NCT00605891|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20284264|NCT00605891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20284265|NCT00605891|Autonomic Agents|autonomic agents|mesh-ancestor
20284266|NCT00605891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20284267|NCT00605891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284268|NCT00605891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20284269|NCT00605891|Respiratory System Agents|respiratory system agents|mesh-ancestor
20284270|NCT00605891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20284271|NCT00605891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20284272|NCT00605891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20284273|NCT00605891|Adrenergic Agents|adrenergic agents|mesh-ancestor
19964368|NCT05058404|Alkylating Agents|alkylating agents|mesh-ancestor
19964369|NCT05058404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964370|NCT05058404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19964371|NCT05058404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19964372|NCT05058404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19964373|NCT05058404|Glucocorticoids|glucocorticoids|mesh-ancestor
19964374|NCT05058404|Hormones|hormones|mesh-ancestor
19964375|NCT05058404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20284274|NCT00605891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20284275|NCT00605891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284276|NCT00605930|Niacinamide|niacinamide|mesh-list
20284277|NCT00605930|Niacin|niacin|mesh-list
20284278|NCT00605930|Nicotinic Acids|nicotinic acids|mesh-list
20284279|NCT00605930|Vitamin B Complex|vitamin b complex|mesh-ancestor
20284280|NCT00605930|Vitamins|vitamins|mesh-ancestor
20284281|NCT00605930|Micronutrients|micronutrients|mesh-ancestor
20284282|NCT00605930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284283|NCT00605930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20284284|NCT00605930|Antimetabolites|antimetabolites|mesh-ancestor
20284285|NCT00605930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284286|NCT00605930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20284287|NCT00605930|Vasodilator Agents|vasodilator agents|mesh-ancestor
20284288|NCT00605995|Simvastatin|simvastatin|mesh-list
20284289|NCT00605995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19964376|NCT05058404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19964377|NCT05058404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19964378|NCT05058404|Tubulin Modulators|tubulin modulators|mesh-ancestor
19964379|NCT05058404|Antimitotic Agents|antimitotic agents|mesh-ancestor
19964380|NCT05058404|Mitosis Modulators|mitosis modulators|mesh-ancestor
19964381|NCT05058404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19964382|NCT05058404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19964383|NCT05058404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19964384|NCT05058404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964385|NCT05036681|Pembrolizumab|pembrolizumab|mesh-list
19964386|NCT05036681|Futibatinib|futibatinib|mesh-list
19964387|NCT05036681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19964388|NCT05036681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964389|NCT05017012|Paclitaxel|paclitaxel|mesh-list
19964390|NCT05017012|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19964391|NCT05017012|Carboplatin|carboplatin|mesh-list
19964392|NCT05017012|Pembrolizumab|pembrolizumab|mesh-list
19964393|NCT05017012|Pemetrexed|pemetrexed|mesh-list
19964394|NCT05017012|Axitinib|axitinib|mesh-list
19964395|NCT05017012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20284290|NCT00605995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19964396|NCT05017012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964397|NCT05017012|Tubulin Modulators|tubulin modulators|mesh-ancestor
19964398|NCT05017012|Antimitotic Agents|antimitotic agents|mesh-ancestor
19964399|NCT05017012|Mitosis Modulators|mitosis modulators|mesh-ancestor
19964400|NCT05017012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964401|NCT05017012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19964402|NCT05017012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964403|NCT05017012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19964404|NCT05017012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19964405|NCT05017012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19964406|NCT04985929|Sildenafil Citrate|sildenafil citrate|mesh-list
19964407|NCT04985929|Vasodilator Agents|vasodilator agents|mesh-ancestor
19964408|NCT04985929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19964409|NCT04985929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19964410|NCT04985929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964411|NCT04985929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964412|NCT04985929|Urological Agents|urological agents|mesh-ancestor
19964413|NCT04955236|Fentanyl|fentanyl|mesh-list
19964414|NCT04955236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19964415|NCT04955236|Narcotics|narcotics|mesh-ancestor
19964416|NCT04955236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19964417|NCT04955236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964418|NCT04955236|Analgesics|analgesics|mesh-ancestor
19964419|NCT04955236|Sensory System Agents|sensory system agents|mesh-ancestor
19964420|NCT04955236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964421|NCT04955236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19964422|NCT04955236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19964423|NCT04955236|Anesthetics, General|anesthetics, general|mesh-ancestor
19964424|NCT04955236|Anesthetics|anesthetics|mesh-ancestor
19964425|NCT04934722|Pembrolizumab|pembrolizumab|mesh-list
19964426|NCT04934722|Androgens|androgens|mesh-list
19964427|NCT04934722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19964428|NCT04934722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284291|NCT00605995|Antimetabolites|antimetabolites|mesh-ancestor
20284292|NCT00605995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284293|NCT00605995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20284294|NCT00605995|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20284295|NCT00605995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284296|NCT00606060|Factor VIII|factor viii|mesh-list
20284297|NCT00606060|Coagulants|coagulants|mesh-ancestor
20284298|NCT00606099|Adefovir|adefovir|mesh-list
20284299|NCT00606099|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
20284300|NCT00606099|Telbivudine|telbivudine|mesh-list
20284301|NCT00606099|Antiviral Agents|antiviral agents|mesh-ancestor
19964429|NCT04934722|Hormones|hormones|mesh-ancestor
19964430|NCT04934722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20284302|NCT00606099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20284303|NCT00606099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20284304|NCT00606099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20284305|NCT00606099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284306|NCT00606099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284307|NCT00606125|Sorafenib|sorafenib|mesh-list
20284308|NCT00606125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284309|NCT00606125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20284310|NCT00606125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284311|NCT00606125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284312|NCT00606164|Bryostatin 1|bryostatin 1|mesh-list
20284313|NCT00606164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20284314|NCT00606164|Immunologic Factors|immunologic factors|mesh-ancestor
20284315|NCT00606164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284316|NCT00606164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964431|NCT04934722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964432|NCT04908956|Osimertinib|osimertinib|mesh-list
19964433|NCT04908956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964434|NCT04908956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19964435|NCT04908956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964436|NCT04908956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964437|NCT04907227|Dexamethasone|dexamethasone|mesh-list
19964438|NCT04907227|Prednisone|prednisone|mesh-list
19964439|NCT04907227|Docetaxel|docetaxel|mesh-list
19964440|NCT04907227|Pembrolizumab|pembrolizumab|mesh-list
19964441|NCT04907227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19964442|NCT04907227|Antiemetics|antiemetics|mesh-ancestor
19964443|NCT04907227|Autonomic Agents|autonomic agents|mesh-ancestor
20284317|NCT00606203|Milnacipran|milnacipran|mesh-list
20284318|NCT00606203|Levomilnacipran|levomilnacipran|mesh-list
19964444|NCT04907227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964445|NCT04907227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964446|NCT04907227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20284319|NCT00606203|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20284320|NCT00606203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20284321|NCT00606203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20284322|NCT00606203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284323|NCT00606203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20284324|NCT00606203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284325|NCT00606203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20284326|NCT00606203|Analgesics|analgesics|mesh-ancestor
20284327|NCT00606203|Sensory System Agents|sensory system agents|mesh-ancestor
20284328|NCT00606203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964447|NCT04907227|Glucocorticoids|glucocorticoids|mesh-ancestor
19964448|NCT04907227|Hormones|hormones|mesh-ancestor
19964449|NCT04907227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19964450|NCT04907227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19964451|NCT04907227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964452|NCT04907227|Tubulin Modulators|tubulin modulators|mesh-ancestor
19964453|NCT04907227|Antimitotic Agents|antimitotic agents|mesh-ancestor
19964454|NCT04907227|Mitosis Modulators|mitosis modulators|mesh-ancestor
19964455|NCT04907227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964456|NCT04907227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19964457|NCT04903652|Vinorelbine|vinorelbine|mesh-list
19964458|NCT04903652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19964459|NCT04903652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964460|NCT04903652|Tubulin Modulators|tubulin modulators|mesh-ancestor
19964461|NCT04903652|Antimitotic Agents|antimitotic agents|mesh-ancestor
19964462|NCT04903652|Mitosis Modulators|mitosis modulators|mesh-ancestor
19964463|NCT04903652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964464|NCT04894188|Goserelin|goserelin|mesh-list
19964465|NCT04894188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19964466|NCT04894188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964467|NCT04887285|Anesthetics|anesthetics|mesh-list
20284329|NCT00606203|Antidepressive Agents|antidepressive agents|mesh-ancestor
20284330|NCT00606203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20284331|NCT00606242|Fluticasone|fluticasone|mesh-list
19964468|NCT04887285|Anesthetics, Local|anesthetics, local|mesh-list
19964469|NCT04887285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19964470|NCT04887285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964471|NCT04887285|Sensory System Agents|sensory system agents|mesh-ancestor
19964472|NCT04887285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964473|NCT04882241|Leucovorin|leucovorin|mesh-list
19964474|NCT04882241|Docetaxel|docetaxel|mesh-list
19964475|NCT04882241|Pembrolizumab|pembrolizumab|mesh-list
19964476|NCT04882241|Fluorouracil|fluorouracil|mesh-list
19964477|NCT04882241|Capecitabine|capecitabine|mesh-list
19964478|NCT04882241|Oxaliplatin|oxaliplatin|mesh-list
19964479|NCT04882241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964480|NCT04882241|Tubulin Modulators|tubulin modulators|mesh-ancestor
19964481|NCT04882241|Antimitotic Agents|antimitotic agents|mesh-ancestor
19964482|NCT04882241|Mitosis Modulators|mitosis modulators|mesh-ancestor
19964483|NCT04882241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964484|NCT04882241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20284332|NCT00606242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19964485|NCT04882241|Antimetabolites|antimetabolites|mesh-ancestor
19964486|NCT04882241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19964487|NCT04882241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19964488|NCT04882241|Immunologic Factors|immunologic factors|mesh-ancestor
19964489|NCT04882241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964490|NCT04882241|Antidotes|antidotes|mesh-ancestor
19964491|NCT04882241|Protective Agents|protective agents|mesh-ancestor
19964492|NCT04882241|Vitamin B Complex|vitamin b complex|mesh-ancestor
19964493|NCT04882241|Vitamins|vitamins|mesh-ancestor
19964494|NCT04882241|Micronutrients|micronutrients|mesh-ancestor
19964495|NCT04870112|Carboplatin|carboplatin|mesh-list
19964496|NCT04870112|Etoposide|etoposide|mesh-list
19964497|NCT04870112|Durvalumab|durvalumab|mesh-list
19964498|NCT04870112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964499|NCT04870112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19964500|NCT04870112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20548285|NCT01899430|Metformin|metformin|mesh-list
19964501|NCT04870112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19964502|NCT04870112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964503|NCT04870112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964504|NCT04870112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19964505|NCT04867135|Amikacin|amikacin|mesh-list
19964506|NCT04867135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19964507|NCT04867135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19964508|NCT04865887|Pembrolizumab|pembrolizumab|mesh-list
19964509|NCT04865887|Lenvatinib|lenvatinib|mesh-list
19964510|NCT04865887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19964511|NCT04865887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964512|NCT04865887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19964513|NCT04865887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964514|NCT04865887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964515|NCT04863716|Fentanyl|fentanyl|mesh-list
19964516|NCT04863716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19964517|NCT04863716|Narcotics|narcotics|mesh-ancestor
19964518|NCT04863716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19964519|NCT04863716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964520|NCT04863716|Analgesics|analgesics|mesh-ancestor
20284333|NCT00606242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20284334|NCT00606242|Autonomic Agents|autonomic agents|mesh-ancestor
20284335|NCT00606242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20284336|NCT00606242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284337|NCT00606242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20284338|NCT00606242|Respiratory System Agents|respiratory system agents|mesh-ancestor
20284339|NCT00606242|Dermatologic Agents|dermatologic agents|mesh-ancestor
20284340|NCT00606242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20284341|NCT00606268|Micafungin|micafungin|mesh-list
20284342|NCT00606268|Antifungal Agents|antifungal agents|mesh-ancestor
20284343|NCT00606268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20284344|NCT00606333|Sirolimus|sirolimus|mesh-list
20284345|NCT00606333|Paclitaxel|paclitaxel|mesh-list
19964521|NCT04863716|Sensory System Agents|sensory system agents|mesh-ancestor
19964522|NCT04863716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964523|NCT04863716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19964524|NCT04863716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19964525|NCT04863716|Anesthetics, General|anesthetics, general|mesh-ancestor
19964526|NCT04863716|Anesthetics|anesthetics|mesh-ancestor
19964527|NCT04860661|Esketamine|esketamine|mesh-list
19964528|NCT04860661|Antidepressive Agents|antidepressive agents|mesh-ancestor
19964529|NCT04860661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19964530|NCT04858776|Dexamethasone|dexamethasone|mesh-list
19964531|NCT04858776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19964532|NCT04858776|Antiemetics|antiemetics|mesh-ancestor
19964533|NCT04858776|Autonomic Agents|autonomic agents|mesh-ancestor
19964534|NCT04858776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20284346|NCT00606333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20284347|NCT00606333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20284348|NCT00606333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284349|NCT00606333|Tubulin Modulators|tubulin modulators|mesh-ancestor
20284350|NCT00606333|Antimitotic Agents|antimitotic agents|mesh-ancestor
20284351|NCT00606333|Mitosis Modulators|mitosis modulators|mesh-ancestor
20284352|NCT00606333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284353|NCT00606333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20284354|NCT00606333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20284355|NCT00606333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20284356|NCT00606333|Antifungal Agents|antifungal agents|mesh-ancestor
20284357|NCT00606333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20284358|NCT00606333|Immunologic Factors|immunologic factors|mesh-ancestor
20284359|NCT00606333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284360|NCT00606411|Topiramate|topiramate|mesh-list
20284361|NCT00606411|Anticonvulsants|anticonvulsants|mesh-ancestor
20284362|NCT00606411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20284363|NCT00606411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284364|NCT00606437|Fludarabine|fludarabine|mesh-list
20284365|NCT00606437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284366|NCT00606450|Thalidomide|thalidomide|mesh-list
20284367|NCT00606450|Apremilast|apremilast|mesh-list
20284368|NCT00606450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20284369|NCT00606450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19964535|NCT04858776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964536|NCT04858776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19964537|NCT04858776|Glucocorticoids|glucocorticoids|mesh-ancestor
19964538|NCT04858776|Hormones|hormones|mesh-ancestor
19964539|NCT04858776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19964540|NCT04858776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20284370|NCT00606450|Analgesics|analgesics|mesh-ancestor
20284371|NCT00606450|Sensory System Agents|sensory system agents|mesh-ancestor
20284372|NCT00606450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964541|NCT04858776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964542|NCT04854512|Metformin|metformin|mesh-list
19964543|NCT04854512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19964544|NCT04854512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964545|NCT04838717|Doxycycline|doxycycline|mesh-list
19964546|NCT04838717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19964547|NCT04838717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19964548|NCT04838717|Antimalarials|antimalarials|mesh-ancestor
19964549|NCT04838717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19964550|NCT04838717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19964551|NCT04834557|Digoxin|digoxin|mesh-list
19964552|NCT04834557|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19964553|NCT04834557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19964554|NCT04834557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19964555|NCT04834557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964556|NCT04834557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964557|NCT04834557|Protective Agents|protective agents|mesh-ancestor
19964558|NCT04834557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964559|NCT04834557|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19964560|NCT04834557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20284373|NCT00606450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548286|NCT01899430|Liraglutide|liraglutide|mesh-list
20548287|NCT01899430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20548288|NCT01899430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548289|NCT01899430|Incretins|incretins|mesh-ancestor
20548290|NCT01899430|Hormones|hormones|mesh-ancestor
20548291|NCT01899430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20548292|NCT01899521|Zinc Sulfate|zinc sulfate|mesh-list
20548293|NCT01899521|Astringents|astringents|mesh-ancestor
19964561|NCT04826692|Metformin|metformin|mesh-list
19964562|NCT04826692|Biguanides|biguanides|mesh-list
19964563|NCT04826692|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19964564|NCT04826692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964565|NCT04826237|Dexamethasone|dexamethasone|mesh-list
19964566|NCT04826237|Methylprednisolone|methylprednisolone|mesh-list
19964567|NCT04826237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20548294|NCT01899521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548295|NCT01899521|Dermatologic Agents|dermatologic agents|mesh-ancestor
20548296|NCT01899690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20548297|NCT01899690|Clindamycin|clindamycin|mesh-list
19964568|NCT04826237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19964569|NCT04826237|Prednisolone|prednisolone|mesh-list
19964570|NCT04826237|Prednisolone acetate|prednisolone acetate|mesh-list
19964571|NCT04826237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
19964572|NCT04826237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19964573|NCT04826237|Prednisolone phosphate|prednisolone phosphate|mesh-list
19964574|NCT04826237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19964575|NCT04826237|Antiemetics|antiemetics|mesh-ancestor
19964576|NCT04826237|Autonomic Agents|autonomic agents|mesh-ancestor
19964577|NCT04826237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964578|NCT04826237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964579|NCT04826237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19964580|NCT04826237|Glucocorticoids|glucocorticoids|mesh-ancestor
19964581|NCT04826237|Hormones|hormones|mesh-ancestor
19964582|NCT04826237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19964583|NCT04826237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19964584|NCT04826237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964585|NCT04826237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19964586|NCT04826237|Protective Agents|protective agents|mesh-ancestor
19964587|NCT04826237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20284374|NCT00606450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20284375|NCT00606450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20284376|NCT00606450|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20284377|NCT00606450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20284378|NCT00606450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284379|NCT00606450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284380|NCT00606450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20284381|NCT00606450|Immunologic Factors|immunologic factors|mesh-ancestor
20284382|NCT00606450|Leprostatic Agents|leprostatic agents|mesh-ancestor
20548298|NCT01899690|Cephalexin|cephalexin|mesh-list
19964588|NCT04826237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19964589|NCT04826237|Antimetabolites|antimetabolites|mesh-ancestor
19964590|NCT04826237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964591|NCT04826237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964592|NCT04826237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19964593|NCT04825990|Pembrolizumab|pembrolizumab|mesh-list
19964594|NCT04825990|Olaparib|olaparib|mesh-list
19964595|NCT04825990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19964596|NCT04825990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964597|NCT04825990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19964598|NCT04825990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284383|NCT00606450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20284384|NCT00606450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20284385|NCT00606450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19964599|NCT04825990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964600|NCT04825652|177Lu-PSMA-617|177lu-psma-617|mesh-list
19964601|NCT04825652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19964602|NCT04825652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964603|NCT04812626|Triamcinolone|triamcinolone|mesh-list
19964604|NCT04812626|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19964605|NCT04812626|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20284386|NCT00606450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20284387|NCT00606450|Growth Substances|growth substances|mesh-ancestor
20284388|NCT00606450|Growth Inhibitors|growth inhibitors|mesh-ancestor
20284389|NCT00606450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284390|NCT00606515|Paclitaxel|paclitaxel|mesh-list
20284391|NCT00606515|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20284392|NCT00606515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20284393|NCT00606515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284394|NCT00606515|Tubulin Modulators|tubulin modulators|mesh-ancestor
20284395|NCT00606515|Antimitotic Agents|antimitotic agents|mesh-ancestor
19964606|NCT04812626|Fluorouracil|fluorouracil|mesh-list
19964607|NCT04812626|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19964608|NCT04812626|Antimetabolites|antimetabolites|mesh-ancestor
19964609|NCT04812626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964610|NCT04812626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19964611|NCT04812626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964612|NCT04812626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19964613|NCT04812626|Immunologic Factors|immunologic factors|mesh-ancestor
19964614|NCT04812626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964615|NCT04812626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19964616|NCT04812626|Glucocorticoids|glucocorticoids|mesh-ancestor
19964617|NCT04812626|Hormones|hormones|mesh-ancestor
19964618|NCT04812626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19964619|NCT04812626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964620|NCT04810494|Lidocaine|lidocaine|mesh-list
19964621|NCT04810494|Anesthetics, Local|anesthetics, local|mesh-ancestor
19964622|NCT04810494|Anesthetics|anesthetics|mesh-ancestor
19964623|NCT04810494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19964624|NCT04810494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964625|NCT04810494|Sensory System Agents|sensory system agents|mesh-ancestor
19964626|NCT04810494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964627|NCT04810494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19964628|NCT04810494|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19964629|NCT04810494|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19964630|NCT04810494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19964631|NCT04810494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964632|NCT04803747|Tranexamic Acid|tranexamic acid|mesh-list
20284396|NCT00606515|Mitosis Modulators|mitosis modulators|mesh-ancestor
20284397|NCT00606515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284398|NCT00606541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19964633|NCT04803747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19964634|NCT04803747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19964635|NCT04803747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964636|NCT04803747|Hemostatics|hemostatics|mesh-ancestor
19964637|NCT04803747|Coagulants|coagulants|mesh-ancestor
19964638|NCT04797156|Tranexamic Acid|tranexamic acid|mesh-list
19964639|NCT04797156|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19964640|NCT04797156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20284399|NCT00606541|Antidepressive Agents|antidepressive agents|mesh-ancestor
20284400|NCT00606541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20284401|NCT00606541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20284402|NCT00606541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20284403|NCT00606541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20284404|NCT00606541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284405|NCT00606775|Carvedilol|carvedilol|mesh-list
20284406|NCT00606775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20284407|NCT00606775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19964641|NCT04797156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284408|NCT00606775|Adrenergic Agents|adrenergic agents|mesh-ancestor
20284409|NCT00606775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20284410|NCT00606775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964642|NCT04797156|Hemostatics|hemostatics|mesh-ancestor
19964643|NCT04797156|Coagulants|coagulants|mesh-ancestor
19975107|NCT01845636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19975108|NCT01845636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19975109|NCT01845636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19975110|NCT01845636|Autonomic Agents|autonomic agents|mesh-ancestor
19975111|NCT01845636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975112|NCT01845636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19975113|NCT01845636|Respiratory System Agents|respiratory system agents|mesh-ancestor
20284411|NCT00606775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284412|NCT00606775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20284413|NCT00606775|Antioxidants|antioxidants|mesh-ancestor
20284414|NCT00606775|Protective Agents|protective agents|mesh-ancestor
19975114|NCT01845636|Mydriatics|mydriatics|mesh-ancestor
19975115|NCT01845636|Parasympatholytics|parasympatholytics|mesh-ancestor
19975116|NCT01845636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19975117|NCT01845636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19975118|NCT01845792|Abiraterone Acetate|abiraterone acetate|mesh-list
19975119|NCT01845792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975120|NCT01845792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19975121|NCT01845792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19975122|NCT01845792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284415|NCT00606775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20284416|NCT00606775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19975123|NCT01845792|Hormone Antagonists|hormone antagonists|mesh-ancestor
19975124|NCT01845792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19975125|NCT01845792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975126|NCT01845792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19975127|NCT01845831|Metformin|metformin|mesh-list
19975128|NCT01845831|Insulin Glargine|insulin glargine|mesh-list
19975129|NCT01845831|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19975130|NCT01845831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19975131|NCT01845831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975132|NCT01845831|Incretins|incretins|mesh-ancestor
19975133|NCT01845831|Hormones|hormones|mesh-ancestor
19975134|NCT01845831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19975135|NCT01845831|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20284417|NCT00606775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20284418|NCT00606775|Vasodilator Agents|vasodilator agents|mesh-ancestor
20284419|NCT00606775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20284420|NCT00606775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20284421|NCT00606814|Docetaxel|docetaxel|mesh-list
20284422|NCT00606814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284423|NCT00606814|Tubulin Modulators|tubulin modulators|mesh-ancestor
20284424|NCT00606814|Antimitotic Agents|antimitotic agents|mesh-ancestor
19975136|NCT01845831|Protease Inhibitors|protease inhibitors|mesh-ancestor
19975137|NCT01845831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19975138|NCT01845831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975139|NCT01846039|Hyaluronic Acid|hyaluronic acid|mesh-list
19975140|NCT01846039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19975141|NCT01846039|Immunologic Factors|immunologic factors|mesh-ancestor
19975142|NCT01846039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975143|NCT01846039|Viscosupplements|viscosupplements|mesh-ancestor
19975144|NCT01846039|Protective Agents|protective agents|mesh-ancestor
19975145|NCT01846104|Vaccines|vaccines|mesh-list
19975146|NCT01846104|Immunologic Factors|immunologic factors|mesh-ancestor
19975147|NCT01846104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975148|NCT01846221|Clonidine|clonidine|mesh-list
19975149|NCT01846221|Fentanyl|fentanyl|mesh-list
19975150|NCT01846221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19975151|NCT01846221|Narcotics|narcotics|mesh-ancestor
19975152|NCT01846221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20284425|NCT00606814|Mitosis Modulators|mitosis modulators|mesh-ancestor
20284426|NCT00606814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284427|NCT00606866|Sorafenib|sorafenib|mesh-list
20284428|NCT00606866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284429|NCT00606866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20284430|NCT00606866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284431|NCT00606866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284432|NCT00606957|Vitamin D|vitamin d|mesh-list
20284433|NCT00606957|Cholecalciferol|cholecalciferol|mesh-list
20284434|NCT00606957|Vitamins|vitamins|mesh-ancestor
19964644|NCT04790175|Tolvaptan|tolvaptan|mesh-list
19964645|NCT04790175|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19964646|NCT04790175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964647|NCT04790175|Natriuretic Agents|natriuretic agents|mesh-ancestor
19964648|NCT04790175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964649|NCT04785300|Dasatinib|dasatinib|mesh-list
19964650|NCT04785300|Quercetin|quercetin|mesh-list
19964651|NCT04785300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964652|NCT04785300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19964653|NCT04785300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964654|NCT04785300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284435|NCT00606957|Micronutrients|micronutrients|mesh-ancestor
20284436|NCT00606957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284437|NCT00606957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20284438|NCT00606957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20284439|NCT00606983|Tamsulosin|tamsulosin|mesh-list
20284440|NCT00606983|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20284441|NCT00606983|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20284442|NCT00606983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20284443|NCT00606983|Adrenergic Agents|adrenergic agents|mesh-ancestor
20284444|NCT00606983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20284445|NCT00606983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284446|NCT00606983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284447|NCT00606983|Urological Agents|urological agents|mesh-ancestor
20284448|NCT00607035|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20284449|NCT00607035|Olmesartan|olmesartan|mesh-list
19964655|NCT04785300|Antioxidants|antioxidants|mesh-ancestor
19964656|NCT04785300|Protective Agents|protective agents|mesh-ancestor
19964657|NCT04785300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964658|NCT04778904|Nivolumab|nivolumab|mesh-list
19964659|NCT04778904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19964660|NCT04778904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964661|NCT04778904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19964662|NCT04778904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964663|NCT04771481|Metoclopramide|metoclopramide|mesh-list
19964664|NCT04771481|Antiemetics|antiemetics|mesh-ancestor
19964665|NCT04771481|Autonomic Agents|autonomic agents|mesh-ancestor
20284450|NCT00607035|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20284451|NCT00607035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20284452|NCT00607035|Diuretics|diuretics|mesh-ancestor
20284453|NCT00607035|Natriuretic Agents|natriuretic agents|mesh-ancestor
20284454|NCT00607035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284455|NCT00607035|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19964666|NCT04771481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964667|NCT04771481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964668|NCT04771481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19964669|NCT04771481|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19964670|NCT04771481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19964671|NCT04771481|Dopamine Agents|dopamine agents|mesh-ancestor
19964672|NCT04771481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19964673|NCT04771481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964674|NCT04764162|Choline|choline|mesh-list
19964675|NCT04764162|Lipotropic Agents|lipotropic agents|mesh-ancestor
19964676|NCT04764162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19964677|NCT04764162|Antimetabolites|antimetabolites|mesh-ancestor
19964678|NCT04764162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964679|NCT04764162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19964680|NCT04764162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19964681|NCT04764162|Nootropic Agents|nootropic agents|mesh-ancestor
19964682|NCT04745910|Rasburicase|rasburicase|mesh-list
19964683|NCT04745910|Uric Acid|uric acid|mesh-list
19964684|NCT04745910|Gout Suppressants|gout suppressants|mesh-ancestor
19964685|NCT04745910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19964686|NCT04745910|Antioxidants|antioxidants|mesh-ancestor
20284456|NCT00607035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20284457|NCT00607035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964687|NCT04745910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284458|NCT00607035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20284459|NCT00607035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20284460|NCT00607074|Albendazole|albendazole|mesh-list
20284461|NCT00607074|Anthelmintics|anthelmintics|mesh-list
20284462|NCT00607074|Secnidazole|secnidazole|mesh-list
20284463|NCT00607074|Metronidazole|metronidazole|mesh-list
20284464|NCT00607074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20284465|NCT00607074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20284466|NCT00607074|Anticestodal Agents|anticestodal agents|mesh-ancestor
20284467|NCT00607074|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19964688|NCT04745910|Protective Agents|protective agents|mesh-ancestor
19964689|NCT04745910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964690|NCT04728217|Factor VIII|factor viii|mesh-list
19964691|NCT04728217|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
19964692|NCT04728217|Coagulants|coagulants|mesh-ancestor
19964693|NCT04728217|Immunologic Factors|immunologic factors|mesh-ancestor
19964694|NCT04728217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964695|NCT04725695|Lidocaine|lidocaine|mesh-list
19964696|NCT04725695|Anesthetics, Local|anesthetics, local|mesh-ancestor
19964697|NCT04725695|Anesthetics|anesthetics|mesh-ancestor
19964698|NCT04725695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19964699|NCT04725695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964700|NCT04725695|Sensory System Agents|sensory system agents|mesh-ancestor
19964701|NCT04725695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964702|NCT04725695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19964703|NCT04725695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19964704|NCT04725695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19964705|NCT04725695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19964706|NCT04725695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284468|NCT00607074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20284469|NCT00607074|Tubulin Modulators|tubulin modulators|mesh-ancestor
20284470|NCT00607074|Antimitotic Agents|antimitotic agents|mesh-ancestor
20284471|NCT00607074|Mitosis Modulators|mitosis modulators|mesh-ancestor
20284472|NCT00607074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284473|NCT00607074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284474|NCT00607074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20284475|NCT00607152|Allopurinol|allopurinol|mesh-list
20284476|NCT00607152|Rasburicase|rasburicase|mesh-list
20284477|NCT00607152|Antimetabolites|antimetabolites|mesh-ancestor
20284478|NCT00607152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284479|NCT00607152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964707|NCT04724772|Tranexamic Acid|tranexamic acid|mesh-list
19964708|NCT04724772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19964709|NCT04724772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19964710|NCT04724772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964711|NCT04724772|Hemostatics|hemostatics|mesh-ancestor
19964712|NCT04724772|Coagulants|coagulants|mesh-ancestor
19964713|NCT04721691|Cannabidiol|cannabidiol|mesh-list
19964714|NCT04721691|Anticonvulsants|anticonvulsants|mesh-ancestor
20284480|NCT00607152|Gout Suppressants|gout suppressants|mesh-ancestor
20284481|NCT00607152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20284482|NCT00607152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20284483|NCT00607152|Antioxidants|antioxidants|mesh-ancestor
20284484|NCT00607152|Protective Agents|protective agents|mesh-ancestor
20284485|NCT00607152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284486|NCT00607178|Vaccines|vaccines|mesh-list
20284487|NCT00607178|Immunologic Factors|immunologic factors|mesh-ancestor
20284488|NCT00607178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284489|NCT00607217|Vaccines|vaccines|mesh-list
20284490|NCT00607217|Immunologic Factors|immunologic factors|mesh-ancestor
20284491|NCT00607217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288383|NCT05334277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19964715|NCT04669002|Olaparib|olaparib|mesh-list
20288384|NCT05334277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20288385|NCT05334277|Growth Substances|growth substances|mesh-ancestor
20288386|NCT05334277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288387|NCT05334277|Growth Inhibitors|growth inhibitors|mesh-ancestor
20288388|NCT05334277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288389|NCT05334277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288390|NCT05334277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20288391|NCT05334277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20288392|NCT05334277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20288393|NCT05334251|Anesthetics|anesthetics|mesh-list
20288394|NCT05334251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20288395|NCT05334251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288396|NCT05334043|Curcumin|curcumin|mesh-list
20288397|NCT05334043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20288398|NCT05334043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19964716|NCT04669002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19964717|NCT04669002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19975153|NCT01846221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964718|NCT04669002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964719|NCT04669002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964720|NCT04660799|Diphenhydramine|diphenhydramine|mesh-list
19964721|NCT04660799|Promethazine|promethazine|mesh-list
19964722|NCT04660799|Prednisone|prednisone|mesh-list
19964723|NCT04660799|Cyclophosphamide|cyclophosphamide|mesh-list
19964724|NCT04660799|Rituximab|rituximab|mesh-list
19964725|NCT04660799|Doxorubicin|doxorubicin|mesh-list
19964726|NCT04660799|Vincristine|vincristine|mesh-list
19964727|NCT04660799|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
19964728|NCT04660799|Histamine Antagonists|histamine antagonists|mesh-list
19964729|NCT04660799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19964730|NCT04660799|Immunologic Factors|immunologic factors|mesh-ancestor
19964731|NCT04660799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964732|NCT04660799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19964733|NCT04660799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19964734|NCT04660799|Alkylating Agents|alkylating agents|mesh-ancestor
19964735|NCT04660799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964736|NCT04660799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284492|NCT00607282|Udenafil|udenafil|mesh-list
20284493|NCT00607282|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20284494|NCT00607282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20284495|NCT00607282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284496|NCT00607282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284497|NCT00607438|Paclitaxel|paclitaxel|mesh-list
20284498|NCT00607438|Sorafenib|sorafenib|mesh-list
20284499|NCT00607438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20284500|NCT00607438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20284501|NCT00607438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284502|NCT00607438|Tubulin Modulators|tubulin modulators|mesh-ancestor
20284503|NCT00607438|Antimitotic Agents|antimitotic agents|mesh-ancestor
20284504|NCT00607438|Mitosis Modulators|mitosis modulators|mesh-ancestor
20284505|NCT00607438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284506|NCT00607438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20284507|NCT00607438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284508|NCT00607503|Terbutaline|terbutaline|mesh-list
20284509|NCT00607503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19964737|NCT04660799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19964738|NCT04660799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19964739|NCT04660799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19964740|NCT04660799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19964741|NCT04660799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19964742|NCT04660799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964743|NCT04660799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19964744|NCT04660799|Glucocorticoids|glucocorticoids|mesh-ancestor
19964745|NCT04660799|Hormones|hormones|mesh-ancestor
19964746|NCT04660799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20284510|NCT00607503|Autonomic Agents|autonomic agents|mesh-ancestor
20284511|NCT00607503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20284512|NCT00607503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964747|NCT04660799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19964748|NCT04660799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19964749|NCT04660799|Tubulin Modulators|tubulin modulators|mesh-ancestor
19964750|NCT04660799|Antimitotic Agents|antimitotic agents|mesh-ancestor
19964751|NCT04660799|Mitosis Modulators|mitosis modulators|mesh-ancestor
19964752|NCT04660799|Sensory System Agents|sensory system agents|mesh-ancestor
19964753|NCT04660799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964754|NCT04660799|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19964755|NCT04660799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19964756|NCT04660799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20548299|NCT01899690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548300|NCT01899690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19964757|NCT04660799|Anesthetics, Local|anesthetics, local|mesh-ancestor
19964758|NCT04660799|Anesthetics|anesthetics|mesh-ancestor
19964759|NCT04660799|Antiemetics|antiemetics|mesh-ancestor
19964760|NCT04660799|Autonomic Agents|autonomic agents|mesh-ancestor
19964761|NCT04660799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20548301|NCT01899690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548302|NCT01899690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548303|NCT01899703|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20548304|NCT01899703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20548305|NCT01899703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20548306|NCT01899755|Adalimumab|adalimumab|mesh-list
20548307|NCT01899755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19964762|NCT04660799|Histamine Agents|histamine agents|mesh-ancestor
19964763|NCT04660799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19964764|NCT04660799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19964765|NCT04660799|Antipruritics|antipruritics|mesh-ancestor
19964766|NCT04660799|Dermatologic Agents|dermatologic agents|mesh-ancestor
19964767|NCT04642287|Fluorouracil|fluorouracil|mesh-list
19964768|NCT04642287|Calcipotriene|calcipotriene|mesh-list
19964769|NCT04642287|Petrolatum|petrolatum|mesh-list
19964770|NCT04642287|Antimetabolites|antimetabolites|mesh-ancestor
19964771|NCT04642287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964772|NCT04642287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19964773|NCT04642287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964774|NCT04642287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19964775|NCT04642287|Immunologic Factors|immunologic factors|mesh-ancestor
19964776|NCT04642287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964777|NCT04642287|Dermatologic Agents|dermatologic agents|mesh-ancestor
19964778|NCT04642287|Emollients|emollients|mesh-ancestor
19964779|NCT04639960|Risperidone|risperidone|mesh-list
19964780|NCT04639960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19964781|NCT04639960|Serotonin Agents|serotonin agents|mesh-ancestor
19964782|NCT04639960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19964783|NCT04639960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964784|NCT04639960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964785|NCT04639960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19964786|NCT04639960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19964787|NCT04639960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19964788|NCT04639960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20284513|NCT00607503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20284514|NCT00607503|Respiratory System Agents|respiratory system agents|mesh-ancestor
20284515|NCT00607503|Sympathomimetics|sympathomimetics|mesh-ancestor
20284516|NCT00607503|Tocolytic Agents|tocolytic agents|mesh-ancestor
20284517|NCT00607503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20284518|NCT00607503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20284519|NCT00607503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20284520|NCT00607503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20284521|NCT00607503|Adrenergic Agents|adrenergic agents|mesh-ancestor
20284522|NCT00607503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20284523|NCT00607503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284524|NCT00607542|Baclofen|baclofen|mesh-list
20284525|NCT00607542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20284526|NCT00607542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284527|NCT00607542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20284528|NCT00607542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20284529|NCT00607542|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20284530|NCT00607542|GABA Agonists|gaba agonists|mesh-ancestor
20284531|NCT00607542|GABA Agents|gaba agents|mesh-ancestor
19964789|NCT04639960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19964790|NCT04639960|Dopamine Agents|dopamine agents|mesh-ancestor
19964791|NCT04637763|Cyclophosphamide|cyclophosphamide|mesh-list
19964792|NCT04637763|Fludarabine|fludarabine|mesh-list
19964793|NCT04637763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19964794|NCT04637763|Immunologic Factors|immunologic factors|mesh-ancestor
19964795|NCT04637763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964796|NCT04637763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19964797|NCT04637763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19964798|NCT04637763|Alkylating Agents|alkylating agents|mesh-ancestor
19964799|NCT04637763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964800|NCT04637763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964801|NCT04637763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20284532|NCT00607542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20284533|NCT00607542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284534|NCT00607568|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20284535|NCT00607568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20284536|NCT00607568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20284537|NCT00607568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20284538|NCT00607568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284539|NCT00607568|Adrenergic Agents|adrenergic agents|mesh-ancestor
20284540|NCT00607568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20284541|NCT00607568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284542|NCT00607581|Dexamethasone|dexamethasone|mesh-list
20284543|NCT00607581|Cyclophosphamide|cyclophosphamide|mesh-list
19964802|NCT04633278|Pembrolizumab|pembrolizumab|mesh-list
20284544|NCT00607581|Lenalidomide|lenalidomide|mesh-list
19964803|NCT04633278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19975154|NCT01846221|Analgesics|analgesics|mesh-ancestor
20284545|NCT00607581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20284546|NCT00607581|Immunologic Factors|immunologic factors|mesh-ancestor
19964804|NCT04633278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964805|NCT04622228|Carboplatin|carboplatin|mesh-list
19964806|NCT04622228|Etoposide|etoposide|mesh-list
19964807|NCT04622228|Atezolizumab|atezolizumab|mesh-list
19964808|NCT04622228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964809|NCT04622228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19964810|NCT04622228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19964811|NCT04622228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19964812|NCT04622228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964813|NCT04622228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964814|NCT04581343|Gemcitabine|gemcitabine|mesh-list
19964815|NCT04581343|Paclitaxel|paclitaxel|mesh-list
20284547|NCT00607581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284548|NCT00607581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20284549|NCT00607581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20284550|NCT00607581|Alkylating Agents|alkylating agents|mesh-ancestor
20284551|NCT00607581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284552|NCT00607581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284553|NCT00607581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20284554|NCT00607581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20284555|NCT00607581|Antiemetics|antiemetics|mesh-ancestor
20284556|NCT00607581|Autonomic Agents|autonomic agents|mesh-ancestor
20284557|NCT00607581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20284558|NCT00607581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20284559|NCT00607581|Glucocorticoids|glucocorticoids|mesh-ancestor
20284560|NCT00607581|Hormones|hormones|mesh-ancestor
20284561|NCT00607581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20284562|NCT00607581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20284563|NCT00607581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20284564|NCT00607581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20284565|NCT00607581|Growth Substances|growth substances|mesh-ancestor
20284566|NCT00607581|Growth Inhibitors|growth inhibitors|mesh-ancestor
19964816|NCT04581343|Spartalizumab|spartalizumab|mesh-list
19964817|NCT04581343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19964818|NCT04581343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964819|NCT04581343|Tubulin Modulators|tubulin modulators|mesh-ancestor
19964820|NCT04581343|Antimitotic Agents|antimitotic agents|mesh-ancestor
19964821|NCT04581343|Mitosis Modulators|mitosis modulators|mesh-ancestor
19964822|NCT04581343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733383|NCT04561635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733384|NCT04561921|Magnesium Sulfate|magnesium sulfate|mesh-list
20284567|NCT00607646|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20284568|NCT00607646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20284569|NCT00607646|Immunologic Factors|immunologic factors|mesh-ancestor
20284570|NCT00607646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284571|NCT00607685|Fluorouracil|fluorouracil|mesh-list
20284572|NCT00607685|Hyaluronic Acid|hyaluronic acid|mesh-list
20284573|NCT00607685|Antimetabolites|antimetabolites|mesh-ancestor
20284574|NCT00607685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284575|NCT00607685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20284576|NCT00607685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284577|NCT00607685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20284578|NCT00607685|Immunologic Factors|immunologic factors|mesh-ancestor
20284579|NCT00607685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284580|NCT00607685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20284581|NCT00607685|Viscosupplements|viscosupplements|mesh-ancestor
20284582|NCT00607685|Protective Agents|protective agents|mesh-ancestor
20284583|NCT00607711|Isophosphamide mustard|isophosphamide mustard|mesh-list
20284584|NCT00607711|Ifosfamide|ifosfamide|mesh-list
19733385|NCT04561921|Nordefrin|nordefrin|mesh-list
19733386|NCT04561921|Mepivacaine|mepivacaine|mesh-list
19733387|NCT04561921|Analgesics|analgesics|mesh-ancestor
19733388|NCT04561921|Sensory System Agents|sensory system agents|mesh-ancestor
20284585|NCT00607711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20284586|NCT00607711|Alkylating Agents|alkylating agents|mesh-ancestor
20284587|NCT00607711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733389|NCT04561921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733390|NCT04561921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733391|NCT04561921|Anesthetics|anesthetics|mesh-ancestor
19733392|NCT04561921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19733393|NCT04561921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19733394|NCT04561921|Anticonvulsants|anticonvulsants|mesh-ancestor
19733395|NCT04561921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20284588|NCT00607711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284589|NCT00607737|Insulin Detemir|insulin detemir|mesh-list
20284590|NCT00607737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20284591|NCT00607737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284592|NCT00607750|Mecamylamine|mecamylamine|mesh-list
20284593|NCT00607750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20284594|NCT00607750|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
20284595|NCT00607750|Autonomic Agents|autonomic agents|mesh-ancestor
20284596|NCT00607750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20284597|NCT00607750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284598|NCT00607750|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20284599|NCT00607750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20284600|NCT00607750|Cholinergic Agents|cholinergic agents|mesh-ancestor
20284601|NCT00607750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20284602|NCT00607750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284603|NCT00607763|Micafungin|micafungin|mesh-list
20284604|NCT00607763|Antifungal Agents|antifungal agents|mesh-ancestor
19964823|NCT04581343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19964824|NCT04581343|Antimetabolites|antimetabolites|mesh-ancestor
19964825|NCT04581343|Antiviral Agents|antiviral agents|mesh-ancestor
19964826|NCT04581343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19964827|NCT04581343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964828|NCT04581343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19964829|NCT04581343|Immunologic Factors|immunologic factors|mesh-ancestor
19964830|NCT04581343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964831|NCT04581343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19964832|NCT04580771|Cisplatin|cisplatin|mesh-list
19964833|NCT04580771|Vaccines|vaccines|mesh-list
19964834|NCT04580771|Immunologic Factors|immunologic factors|mesh-ancestor
19964835|NCT04580771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964836|NCT04580771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964837|NCT04579120|Corticosterone|corticosterone|mesh-list
19964838|NCT04579120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19964839|NCT04566016|Anesthetics|anesthetics|mesh-list
19964840|NCT04566016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19964841|NCT04566016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964842|NCT04552795|Lamivudine|lamivudine|mesh-list
19964843|NCT04552795|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19964844|NCT04552795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19964845|NCT04552795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964846|NCT04552795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964847|NCT04552795|Antiviral Agents|antiviral agents|mesh-ancestor
19964848|NCT04552795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19964849|NCT04552795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19964850|NCT04552795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19964851|NCT04537234|Vaccines|vaccines|mesh-list
19964852|NCT04537234|Immunologic Factors|immunologic factors|mesh-ancestor
19964853|NCT04537234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964854|NCT04514653|Ranibizumab|ranibizumab|mesh-list
19964855|NCT04514653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19964856|NCT04514653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19964857|NCT04514653|Growth Substances|growth substances|mesh-ancestor
19964858|NCT04514653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964859|NCT04514653|Growth Inhibitors|growth inhibitors|mesh-ancestor
20284605|NCT00607763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20284606|NCT00607932|Indole-3-carbinol|indole-3-carbinol|mesh-list
20284607|NCT00607932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20284608|NCT00607932|Protective Agents|protective agents|mesh-ancestor
20284609|NCT00607932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284610|NCT00607932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284611|NCT00607945|Rosiglitazone|rosiglitazone|mesh-list
20284612|NCT00607945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20284613|NCT00607945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548308|NCT01899755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20548309|NCT01899755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20548310|NCT01899781|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20548311|NCT01899781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548312|NCT01899794|Mandelic Acids|mandelic acids|mesh-list
20548313|NCT01899794|Oxybutynin|oxybutynin|mesh-list
19964860|NCT04514653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964861|NCT04514393|Methotrexate|methotrexate|mesh-list
19964862|NCT04514393|Temozolomide|temozolomide|mesh-list
19964863|NCT04514393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19964864|NCT04514393|Abortifacient Agents|abortifacient agents|mesh-ancestor
19964865|NCT04514393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20284614|NCT00607958|Ritonavir|ritonavir|mesh-list
20284615|NCT00607958|Tipranavir|tipranavir|mesh-list
20548314|NCT01899794|Parasympatholytics|parasympatholytics|mesh-ancestor
19964866|NCT04514393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964867|NCT04514393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19964868|NCT04514393|Antimetabolites|antimetabolites|mesh-ancestor
19964869|NCT04514393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964870|NCT04514393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964871|NCT04514393|Dermatologic Agents|dermatologic agents|mesh-ancestor
19964872|NCT04514393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964873|NCT04514393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19964874|NCT04514393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19964875|NCT04514393|Immunologic Factors|immunologic factors|mesh-ancestor
19964876|NCT04514393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19733396|NCT04561921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19733397|NCT04561921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733398|NCT04561921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19733399|NCT04561921|Tocolytic Agents|tocolytic agents|mesh-ancestor
19733400|NCT04561921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19733401|NCT04561921|Anesthetics, Local|anesthetics, local|mesh-ancestor
19733402|NCT04561921|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19733403|NCT04561687|Azelastine|azelastine|mesh-list
19733404|NCT04561687|Budesonide|budesonide|mesh-list
20284616|NCT00607958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20284617|NCT00607958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20284618|NCT00607958|Protease Inhibitors|protease inhibitors|mesh-ancestor
20284619|NCT00607958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284620|NCT00607958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284621|NCT00607958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20284622|NCT00607958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20284623|NCT00607958|Antiviral Agents|antiviral agents|mesh-ancestor
20284624|NCT00607958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19733405|NCT04561687|Montelukast|montelukast|mesh-list
19733406|NCT04561687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19964877|NCT04514393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19964878|NCT04514393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19964879|NCT04514393|Alkylating Agents|alkylating agents|mesh-ancestor
19975155|NCT01846221|Sensory System Agents|sensory system agents|mesh-ancestor
19975156|NCT01846221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975157|NCT01846221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19975158|NCT01846221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19975159|NCT01846221|Anesthetics, General|anesthetics, general|mesh-ancestor
19975160|NCT01846221|Anesthetics|anesthetics|mesh-ancestor
19975161|NCT01846221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19975162|NCT01846221|Sympatholytics|sympatholytics|mesh-ancestor
19975163|NCT01846221|Autonomic Agents|autonomic agents|mesh-ancestor
19975164|NCT01846221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19975165|NCT01846221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19975166|NCT01846221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19975167|NCT01846221|Adrenergic Agents|adrenergic agents|mesh-ancestor
19975168|NCT01846221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975169|NCT01846221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975170|NCT01846299|Ranibizumab|ranibizumab|mesh-list
19975171|NCT01846299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19975172|NCT01846299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19975173|NCT01846299|Growth Substances|growth substances|mesh-ancestor
19975174|NCT01846299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975175|NCT01846299|Growth Inhibitors|growth inhibitors|mesh-ancestor
19975176|NCT01846299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975177|NCT01846416|Atezolizumab|atezolizumab|mesh-list
19975178|NCT01846416|Antibodies|antibodies|mesh-list
19975179|NCT01846416|Immunologic Factors|immunologic factors|mesh-ancestor
19975180|NCT01846416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975181|NCT01846416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975182|NCT01846442|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19975183|NCT01846442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19975184|NCT01846442|Immunologic Factors|immunologic factors|mesh-ancestor
19975185|NCT01846442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975186|NCT01846455|Promethazine|promethazine|mesh-list
19975187|NCT01846455|Diphenhydramine|diphenhydramine|mesh-list
19975188|NCT01846455|Buprenorphine|buprenorphine|mesh-list
20284625|NCT00607958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20548315|NCT01899794|Autonomic Agents|autonomic agents|mesh-ancestor
20548316|NCT01899794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548317|NCT01899794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975189|NCT01846455|Naloxone|naloxone|mesh-list
19733407|NCT04561687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19975190|NCT01846455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20284626|NCT00607958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20284627|NCT00607971|Renzapride|renzapride|mesh-list
20284628|NCT00607971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20284629|NCT00607971|Serotonin Agents|serotonin agents|mesh-ancestor
20284630|NCT00607971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19964880|NCT04507711|Palonosetron|palonosetron|mesh-list
19964881|NCT04507711|Antiemetics|antiemetics|mesh-ancestor
19964882|NCT04507711|Autonomic Agents|autonomic agents|mesh-ancestor
19964883|NCT04507711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964884|NCT04507711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964885|NCT04507711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19964886|NCT04507711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19964887|NCT04507711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19964888|NCT04507711|Serotonin Agents|serotonin agents|mesh-ancestor
19964889|NCT04507711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19964890|NCT04507711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964891|NCT04504123|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19964892|NCT04504123|Doxycycline|doxycycline|mesh-list
19964893|NCT04504123|Tetracycline|tetracycline|mesh-list
19964894|NCT04504123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19964895|NCT04504123|Antimalarials|antimalarials|mesh-ancestor
19964896|NCT04504123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19964897|NCT04504123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19964898|NCT04504123|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19964899|NCT04504123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964900|NCT04504123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964901|NCT04499274|Ondansetron|ondansetron|mesh-list
19964902|NCT04499274|Antiemetics|antiemetics|mesh-ancestor
19964903|NCT04499274|Autonomic Agents|autonomic agents|mesh-ancestor
19964904|NCT04499274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964905|NCT04499274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964906|NCT04499274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19964907|NCT04499274|Antipruritics|antipruritics|mesh-ancestor
19964908|NCT04499274|Dermatologic Agents|dermatologic agents|mesh-ancestor
19964909|NCT04499274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19964910|NCT04499274|Serotonin Agents|serotonin agents|mesh-ancestor
19964911|NCT04499274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19964912|NCT04499274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964913|NCT04499274|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19964914|NCT04499274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19964915|NCT04499274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19964916|NCT04499274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19964917|NCT04499274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19964918|NCT04484025|Ebselen|ebselen|mesh-list
19964919|NCT04484025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19964920|NCT04484025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19964921|NCT04484025|Analgesics|analgesics|mesh-ancestor
19964922|NCT04484025|Sensory System Agents|sensory system agents|mesh-ancestor
19964923|NCT04484025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964924|NCT04484025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964925|NCT04484025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19964926|NCT04484025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20284631|NCT00607971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284632|NCT00607971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284633|NCT00607984|Melphalan|melphalan|mesh-list
20284634|NCT00607984|Thiotepa|thiotepa|mesh-list
20284635|NCT00607984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20284636|NCT00607984|Alkylating Agents|alkylating agents|mesh-ancestor
20284637|NCT00607984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284638|NCT00607984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964927|NCT04484025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19964928|NCT04484025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19964929|NCT04484025|Antioxidants|antioxidants|mesh-ancestor
19964930|NCT04484025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964931|NCT04484025|Protective Agents|protective agents|mesh-ancestor
19964932|NCT04484025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19964933|NCT04484025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964934|NCT04484025|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19964935|NCT04483973|Ebselen|ebselen|mesh-list
19964936|NCT04483973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19964937|NCT04483973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19964938|NCT04483973|Analgesics|analgesics|mesh-ancestor
19964939|NCT04483973|Sensory System Agents|sensory system agents|mesh-ancestor
19964940|NCT04483973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964941|NCT04483973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284639|NCT00607984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20284640|NCT00607984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20284641|NCT00607984|Immunologic Factors|immunologic factors|mesh-ancestor
20284642|NCT00607984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284643|NCT00608075|Lithium Carbonate|lithium carbonate|mesh-list
19964942|NCT04483973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19964943|NCT04483973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19964944|NCT04483973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19964945|NCT04483973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19964946|NCT04483973|Antioxidants|antioxidants|mesh-ancestor
19964947|NCT04483973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964948|NCT04483973|Protective Agents|protective agents|mesh-ancestor
19964949|NCT04483973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19964950|NCT04483973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964951|NCT04483973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19964952|NCT04471714|Baclofen|baclofen|mesh-list
19964953|NCT04471714|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19964954|NCT04471714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964955|NCT04471714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19964956|NCT04471714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19964957|NCT04471714|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19964958|NCT04471714|GABA Agonists|gaba agonists|mesh-ancestor
19964959|NCT04471714|GABA Agents|gaba agents|mesh-ancestor
19964960|NCT04471714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19964961|NCT04471714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964962|NCT04454567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
19964963|NCT04454567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19964964|NCT04454567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964965|NCT04454567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964966|NCT04454567|Antiviral Agents|antiviral agents|mesh-ancestor
19964967|NCT04454567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19964968|NCT04428866|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19964969|NCT04428866|Glucagon|glucagon|mesh-list
19964970|NCT04428866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19964971|NCT04428866|Hormones|hormones|mesh-ancestor
19964972|NCT04428866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19964973|NCT04428866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964974|NCT04425239|Leucovorin|leucovorin|mesh-list
19964975|NCT04425239|Folic Acid|folic acid|mesh-list
19964976|NCT04425239|Fluorouracil|fluorouracil|mesh-list
19964977|NCT04425239|Irinotecan|irinotecan|mesh-list
19964978|NCT04425239|Panitumumab|panitumumab|mesh-list
19964979|NCT04425239|Levoleucovorin|levoleucovorin|mesh-list
19964980|NCT04425239|Antimetabolites|antimetabolites|mesh-ancestor
19964981|NCT04425239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19964982|NCT04425239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19964983|NCT04425239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19964984|NCT04425239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19964985|NCT04425239|Immunologic Factors|immunologic factors|mesh-ancestor
19964986|NCT04425239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19964987|NCT04425239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19964988|NCT04425239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19964989|NCT04425239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19964990|NCT04425239|Antidotes|antidotes|mesh-ancestor
19964991|NCT04425239|Protective Agents|protective agents|mesh-ancestor
19964992|NCT04425239|Vitamin B Complex|vitamin b complex|mesh-ancestor
19964993|NCT04425239|Vitamins|vitamins|mesh-ancestor
19964994|NCT04425239|Micronutrients|micronutrients|mesh-ancestor
19964995|NCT04425239|Hematinics|hematinics|mesh-ancestor
19964996|NCT04425239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19964997|NCT04417166|Pembrolizumab|pembrolizumab|mesh-list
19964998|NCT04417166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19964999|NCT04417166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965000|NCT04413344|Bromocriptine|bromocriptine|mesh-list
19733408|NCT04561687|Autonomic Agents|autonomic agents|mesh-ancestor
19733409|NCT04561687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733410|NCT04561687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733411|NCT04561687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19733412|NCT04561687|Respiratory System Agents|respiratory system agents|mesh-ancestor
19733413|NCT04561687|Glucocorticoids|glucocorticoids|mesh-ancestor
19733414|NCT04561687|Hormones|hormones|mesh-ancestor
19733415|NCT04561687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19733416|NCT04561687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19733417|NCT04561687|Hormone Antagonists|hormone antagonists|mesh-ancestor
20284644|NCT00608075|Antidepressive Agents|antidepressive agents|mesh-ancestor
20284645|NCT00608075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20284646|NCT00608075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284647|NCT00608075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284648|NCT00608075|Antimanic Agents|antimanic agents|mesh-ancestor
20284649|NCT00608075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20284650|NCT00608075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20284651|NCT00608075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284652|NCT00608101|Dexamethasone|dexamethasone|mesh-list
19965001|NCT04413344|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19965002|NCT04413344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19965003|NCT04413344|Hormone Antagonists|hormone antagonists|mesh-ancestor
20284653|NCT00608101|Fludrocortisone|fludrocortisone|mesh-list
20284654|NCT00608101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20284655|NCT00608101|Antiemetics|antiemetics|mesh-ancestor
20284656|NCT00608101|Autonomic Agents|autonomic agents|mesh-ancestor
20284657|NCT00608101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20284658|NCT00608101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284659|NCT00608101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20284660|NCT00608101|Glucocorticoids|glucocorticoids|mesh-ancestor
20284661|NCT00608101|Hormones|hormones|mesh-ancestor
20284662|NCT00608101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20284663|NCT00608101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20284664|NCT00608101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284665|NCT00608179|Glimepiride|glimepiride|mesh-list
20284666|NCT00608179|Glyburide|glyburide|mesh-list
20284667|NCT00608179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20284668|NCT00608179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20284669|NCT00608179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284670|NCT00608179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20284671|NCT00608179|Immunologic Factors|immunologic factors|mesh-ancestor
19965004|NCT04413344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19965005|NCT04413344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965006|NCT04413344|Dopamine Agonists|dopamine agonists|mesh-ancestor
19965007|NCT04413344|Dopamine Agents|dopamine agents|mesh-ancestor
19965008|NCT04413344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19965009|NCT04413344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965010|NCT04386057|Hydroxychloroquine|hydroxychloroquine|mesh-list
19965011|NCT04386057|Antimalarials|antimalarials|mesh-ancestor
20284672|NCT00608218|Ciclesonide|ciclesonide|mesh-list
20284673|NCT00608218|Glucocorticoids|glucocorticoids|mesh-ancestor
20284674|NCT00608218|Hormones|hormones|mesh-ancestor
20284675|NCT00608218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20284676|NCT00608218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284677|NCT00608218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19965012|NCT04386057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19965013|NCT04386057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19965014|NCT04386057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19965015|NCT04386057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965016|NCT04386057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965017|NCT04386057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19965018|NCT04381936|Aspirin|aspirin|mesh-list
19965019|NCT04381936|Empagliflozin|empagliflozin|mesh-list
19965020|NCT04381936|Ritonavir|ritonavir|mesh-list
19965021|NCT04381936|Lopinavir|lopinavir|mesh-list
19965022|NCT04381936|Azithromycin|azithromycin|mesh-list
19965023|NCT04381936|Hydroxychloroquine|hydroxychloroquine|mesh-list
19965024|NCT04381936|Colchicine|colchicine|mesh-list
19965025|NCT04381936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19965026|NCT04381936|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19965027|NCT04381936|Antibodies|antibodies|mesh-list
19965028|NCT04381936|Immunoglobulins|immunoglobulins|mesh-list
19965029|NCT04381936|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19965030|NCT04381936|Immunologic Factors|immunologic factors|mesh-ancestor
19965031|NCT04381936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965032|NCT04381936|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19965033|NCT04381936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20284678|NCT00608231|Dexmedetomidine|dexmedetomidine|mesh-list
19965034|NCT04381936|Analgesics|analgesics|mesh-ancestor
20284679|NCT00608231|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20284680|NCT00608231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20284681|NCT00608231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284682|NCT00608231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20284683|NCT00608231|Analgesics|analgesics|mesh-ancestor
19965035|NCT04381936|Sensory System Agents|sensory system agents|mesh-ancestor
19965036|NCT04381936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965037|NCT04381936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19965038|NCT04381936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19965039|NCT04381936|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19965040|NCT04381936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19965041|NCT04381936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965042|NCT04381936|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19965043|NCT04381936|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19965044|NCT04381936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965045|NCT04381936|Antipyretics|antipyretics|mesh-ancestor
19965046|NCT04381936|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19965047|NCT04381936|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19965048|NCT04381936|Protease Inhibitors|protease inhibitors|mesh-ancestor
19965049|NCT04381936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20284684|NCT00608231|Sensory System Agents|sensory system agents|mesh-ancestor
20284685|NCT00608231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20284686|NCT00608231|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20284687|NCT00608231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20284688|NCT00608231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20284689|NCT00608231|Adrenergic Agents|adrenergic agents|mesh-ancestor
20284690|NCT00608231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20284691|NCT00608231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965050|NCT04381936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19965051|NCT04381936|Antiviral Agents|antiviral agents|mesh-ancestor
19965052|NCT04381936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20284692|NCT00608335|Micafungin|micafungin|mesh-list
20284693|NCT00608335|Antifungal Agents|antifungal agents|mesh-ancestor
20284694|NCT00608335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20284695|NCT00608361|Dasatinib|dasatinib|mesh-list
20284696|NCT00608361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965053|NCT04381936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19965054|NCT04381936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19965055|NCT04381936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20284697|NCT00608361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20284698|NCT00608361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965056|NCT04381936|Antimalarials|antimalarials|mesh-ancestor
19965057|NCT04381936|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19965058|NCT04381936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19965059|NCT04381936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19965060|NCT04381936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19965061|NCT04381936|Gout Suppressants|gout suppressants|mesh-ancestor
19965062|NCT04381936|Tubulin Modulators|tubulin modulators|mesh-ancestor
19965063|NCT04381936|Antimitotic Agents|antimitotic agents|mesh-ancestor
19965064|NCT04381936|Mitosis Modulators|mitosis modulators|mesh-ancestor
20284699|NCT00608361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284700|NCT00608374|Fludarabine|fludarabine|mesh-list
20284701|NCT00608374|Fludarabine phosphate|fludarabine phosphate|mesh-list
20284702|NCT00608374|Chlorambucil|chlorambucil|mesh-list
20284703|NCT00608374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284704|NCT00608374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20284705|NCT00608374|Antimetabolites|antimetabolites|mesh-ancestor
20284706|NCT00608374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284707|NCT00608374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19733418|NCT04561687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19733419|NCT04561687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19733420|NCT04561687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733421|NCT04561687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19733422|NCT04561687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733423|NCT04561687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19733424|NCT04561687|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19733425|NCT04561687|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19733426|NCT04561687|Histamine Antagonists|histamine antagonists|mesh-ancestor
19733427|NCT04561687|Histamine Agents|histamine agents|mesh-ancestor
19733428|NCT04561687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19965065|NCT04381936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284708|NCT00608374|Immunologic Factors|immunologic factors|mesh-ancestor
20288399|NCT05334043|Analgesics|analgesics|mesh-ancestor
20548318|NCT01899794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20284709|NCT00608374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284710|NCT00608374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19965066|NCT04381936|Dermatologic Agents|dermatologic agents|mesh-ancestor
19965067|NCT04381936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19965068|NCT04379999|Aspirin|aspirin|mesh-list
19965069|NCT04379999|Atorvastatin|atorvastatin|mesh-list
19965070|NCT04379999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19965071|NCT04379999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19965072|NCT04379999|Analgesics|analgesics|mesh-ancestor
19965073|NCT04379999|Sensory System Agents|sensory system agents|mesh-ancestor
19965074|NCT04379999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965075|NCT04379999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965076|NCT04379999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19965077|NCT04379999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19965078|NCT04379999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19965079|NCT04379999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20284711|NCT00608374|Alkylating Agents|alkylating agents|mesh-ancestor
20284712|NCT00608595|Celecoxib|celecoxib|mesh-list
20284713|NCT00608595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20284714|NCT00608595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20284715|NCT00608595|Analgesics|analgesics|mesh-ancestor
20284716|NCT00608595|Sensory System Agents|sensory system agents|mesh-ancestor
20284717|NCT00608595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548319|NCT01899794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20548320|NCT01899794|Cholinergic Agents|cholinergic agents|mesh-ancestor
20548321|NCT01899794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20548322|NCT01899794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548323|NCT01899794|Urological Agents|urological agents|mesh-ancestor
20548324|NCT01899794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20548325|NCT01899794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548326|NCT01899794|Renal Agents|renal agents|mesh-ancestor
19965080|NCT04379999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965081|NCT04379999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19965082|NCT04379999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20548327|NCT01899820|Lumefantrine|lumefantrine|mesh-list
20548328|NCT01899820|Artemether|artemether|mesh-list
20548329|NCT01899820|Piperaquine|piperaquine|mesh-list
20548330|NCT01899820|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20548331|NCT01899820|Artenimol|artenimol|mesh-list
20548332|NCT01899820|Antimalarials|antimalarials|mesh-ancestor
20548333|NCT01899820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20548334|NCT01899820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19965083|NCT04379999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965084|NCT04379999|Antipyretics|antipyretics|mesh-ancestor
19965085|NCT04379999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20548335|NCT01899820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548336|NCT01899833|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
19965086|NCT04379999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19965087|NCT04379999|Antimetabolites|antimetabolites|mesh-ancestor
19965088|NCT04379999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19965089|NCT04379999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19965090|NCT04369365|Azithromycin|azithromycin|mesh-list
19965091|NCT04369365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19965092|NCT04369365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548337|NCT01899833|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19965093|NCT04329221|Calcitriol|calcitriol|mesh-list
19965094|NCT04329221|Fluorouracil|fluorouracil|mesh-list
19965095|NCT04329221|Calcipotriene|calcipotriene|mesh-list
19965096|NCT04329221|Petrolatum|petrolatum|mesh-list
19965097|NCT04329221|Antimetabolites|antimetabolites|mesh-ancestor
19965098|NCT04329221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965099|NCT04329221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19965100|NCT04329221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965101|NCT04329221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19965102|NCT04329221|Immunologic Factors|immunologic factors|mesh-ancestor
20548338|NCT01899833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548339|NCT01899846|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
20548340|NCT01899846|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
20548341|NCT01899846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20548342|NCT01899846|Hormone Antagonists|hormone antagonists|mesh-ancestor
19965103|NCT04329221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965104|NCT04329221|Dermatologic Agents|dermatologic agents|mesh-ancestor
19965105|NCT04329221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20548343|NCT01899846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20548344|NCT01899846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284718|NCT00608595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284719|NCT00608595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20284720|NCT00608595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20284721|NCT00608595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20284722|NCT00608595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20284723|NCT00608595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284724|NCT00608595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284725|NCT00608673|Betamethasone|betamethasone|mesh-list
20284726|NCT00608673|Betamethasone Valerate|betamethasone valerate|mesh-list
20284727|NCT00608673|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20284728|NCT00608673|Betamethasone benzoate|betamethasone benzoate|mesh-list
20284729|NCT00608673|Pimecrolimus|pimecrolimus|mesh-list
20284730|NCT00608673|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20284731|NCT00608673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20284732|NCT00608673|Glucocorticoids|glucocorticoids|mesh-ancestor
20284733|NCT00608673|Hormones|hormones|mesh-ancestor
20284734|NCT00608673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20284735|NCT00608673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284736|NCT00608673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20284737|NCT00608673|Respiratory System Agents|respiratory system agents|mesh-ancestor
20284738|NCT00608673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20284739|NCT00608673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20284740|NCT00608673|Analgesics|analgesics|mesh-ancestor
20284741|NCT00608673|Sensory System Agents|sensory system agents|mesh-ancestor
20284742|NCT00608673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20284743|NCT00608673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20284744|NCT00608673|Dermatologic Agents|dermatologic agents|mesh-ancestor
20284745|NCT00608673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20284746|NCT00608673|Immunologic Factors|immunologic factors|mesh-ancestor
20284747|NCT00608673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20284748|NCT00608673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284749|NCT00608673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284750|NCT00608699|Niacin|niacin|mesh-list
20284751|NCT00608699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20284752|NCT00608699|Antimetabolites|antimetabolites|mesh-ancestor
20284753|NCT00608699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284754|NCT00608699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20284755|NCT00608699|Vasodilator Agents|vasodilator agents|mesh-ancestor
20284756|NCT00608699|Vitamin B Complex|vitamin b complex|mesh-ancestor
20284757|NCT00608699|Vitamins|vitamins|mesh-ancestor
20284758|NCT00608699|Micronutrients|micronutrients|mesh-ancestor
20284759|NCT00608699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284760|NCT00608712|Esomeprazole|esomeprazole|mesh-list
20284761|NCT00608712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20284762|NCT00608712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20284763|NCT00608712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20284764|NCT00608712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284765|NCT00608712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284766|NCT00608725|Propranolol|propranolol|mesh-list
20284767|NCT00608725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20284768|NCT00608725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20284769|NCT00608725|Adrenergic Agents|adrenergic agents|mesh-ancestor
20284770|NCT00608725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20284771|NCT00608725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284772|NCT00608725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284773|NCT00608725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20284774|NCT00608725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20284775|NCT00608725|Vasodilator Agents|vasodilator agents|mesh-ancestor
20284776|NCT00608790|Albuterol|albuterol|mesh-list
20284777|NCT00608790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20284778|NCT00608790|Autonomic Agents|autonomic agents|mesh-ancestor
20284779|NCT00608790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20284780|NCT00608790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284781|NCT00608790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20284782|NCT00608790|Respiratory System Agents|respiratory system agents|mesh-ancestor
20284783|NCT00608790|Tocolytic Agents|tocolytic agents|mesh-ancestor
20284784|NCT00608790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20284785|NCT00608790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20284786|NCT00608790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20284787|NCT00608790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20284788|NCT00608790|Adrenergic Agents|adrenergic agents|mesh-ancestor
20284789|NCT00608790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20548345|NCT01899846|Progestins|progestins|mesh-ancestor
20548346|NCT01899846|Hormones|hormones|mesh-ancestor
20284790|NCT00608790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284791|NCT00608803|Doxorubicin|doxorubicin|mesh-list
20284792|NCT00608803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20284793|NCT00608803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284794|NCT00608803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20284795|NCT00608803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19965106|NCT04329221|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19965107|NCT04329221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19965108|NCT04329221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19965109|NCT04329221|Vitamins|vitamins|mesh-ancestor
19965110|NCT04329221|Micronutrients|micronutrients|mesh-ancestor
19965111|NCT04329221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19965112|NCT04329221|Emollients|emollients|mesh-ancestor
19965113|NCT04292483|Nitric Oxide|nitric oxide|mesh-list
19965114|NCT04292483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19965115|NCT04292483|Autonomic Agents|autonomic agents|mesh-ancestor
19965116|NCT04292483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965117|NCT04292483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965118|NCT04292483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19965119|NCT04292483|Respiratory System Agents|respiratory system agents|mesh-ancestor
19965120|NCT04292483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19965121|NCT04292483|Antioxidants|antioxidants|mesh-ancestor
19965122|NCT04292483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965123|NCT04292483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19965124|NCT04292483|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19965125|NCT04292483|Vasodilator Agents|vasodilator agents|mesh-ancestor
20284796|NCT00608803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284797|NCT00608803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284798|NCT00608816|Epinephrine|epinephrine|mesh-list
20284799|NCT00608816|Racepinephrine|racepinephrine|mesh-list
20284800|NCT00608816|Epinephryl borate|epinephryl borate|mesh-list
20284801|NCT00608816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20284802|NCT00608816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20284803|NCT00608816|Adrenergic Agents|adrenergic agents|mesh-ancestor
20284804|NCT00608816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20284805|NCT00608816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284806|NCT00608816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284807|NCT00608816|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20284808|NCT00608816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20284809|NCT00608816|Autonomic Agents|autonomic agents|mesh-ancestor
20284810|NCT00608816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20284811|NCT00608816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20284812|NCT00608816|Respiratory System Agents|respiratory system agents|mesh-ancestor
20284813|NCT00608816|Mydriatics|mydriatics|mesh-ancestor
20284814|NCT00608816|Sympathomimetics|sympathomimetics|mesh-ancestor
20284815|NCT00608816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20284816|NCT00608946|Copper|copper|mesh-list
20284817|NCT00608946|Trace Elements|trace elements|mesh-ancestor
20284818|NCT00608946|Micronutrients|micronutrients|mesh-ancestor
20548347|NCT01899898|Anticonvulsants|anticonvulsants|mesh-list
20554469|NCT01935531|Sensory System Agents|sensory system agents|mesh-ancestor
20554470|NCT01935531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554471|NCT01935531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554472|NCT01935531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20554473|NCT01935531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20554474|NCT01935531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20554475|NCT01935531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554476|NCT01935531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554477|NCT01935531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20554478|NCT01935531|Immunologic Factors|immunologic factors|mesh-ancestor
20554479|NCT01935531|Viscosupplements|viscosupplements|mesh-ancestor
20554480|NCT01935531|Protective Agents|protective agents|mesh-ancestor
20554481|NCT01935544|Botulinum Toxins|botulinum toxins|mesh-list
20554482|NCT01935544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20554483|NCT01935544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20554484|NCT01935544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554485|NCT01935544|Cholinergic Agents|cholinergic agents|mesh-ancestor
20554486|NCT01935544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20554487|NCT01935544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554488|NCT01935557|Heparin|heparin|mesh-list
20554489|NCT01935557|Calcium heparin|calcium heparin|mesh-list
20554490|NCT01935557|Anticoagulants|anticoagulants|mesh-ancestor
20554491|NCT01935557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20554492|NCT01935557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20554493|NCT01935557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284819|NCT00608946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284820|NCT00608972|Bevacizumab|bevacizumab|mesh-list
20284821|NCT00608972|Carboplatin|carboplatin|mesh-list
20284822|NCT00608972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20284823|NCT00608972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284824|NCT00608972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20284825|NCT00608972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20284826|NCT00608972|Growth Substances|growth substances|mesh-ancestor
20284827|NCT00608972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284828|NCT00608972|Growth Inhibitors|growth inhibitors|mesh-ancestor
20284829|NCT00609011|Temozolomide|temozolomide|mesh-list
20284830|NCT00609011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20284831|NCT00609011|Alkylating Agents|alkylating agents|mesh-ancestor
20284832|NCT00609011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284833|NCT00609011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284834|NCT00609063|Atorvastatin|atorvastatin|mesh-list
20284835|NCT00609063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20284836|NCT00609063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20284837|NCT00609063|Antimetabolites|antimetabolites|mesh-ancestor
20284838|NCT00609063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284839|NCT00609063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20284840|NCT00609063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20284841|NCT00609063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284842|NCT00609115|Methylamphotericin B|methylamphotericin b|mesh-list
20284843|NCT00609115|Antifungal Agents|antifungal agents|mesh-ancestor
20284844|NCT00609115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20284845|NCT00609141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20284846|NCT00609141|Immunologic Factors|immunologic factors|mesh-ancestor
20284847|NCT00609141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284848|NCT00609154|Glucagon|glucagon|mesh-list
20284849|NCT00609154|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20284850|NCT00609154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20284851|NCT00609154|Hormones|hormones|mesh-ancestor
20284852|NCT00609154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20284853|NCT00609154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284854|NCT00609154|Incretins|incretins|mesh-ancestor
20284855|NCT00609180|Antioxidants|antioxidants|mesh-list
20284856|NCT00609180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284857|NCT00609180|Protective Agents|protective agents|mesh-ancestor
20284858|NCT00609180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284859|NCT00609193|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20284860|NCT00609193|Antidepressive Agents|antidepressive agents|mesh-ancestor
20284861|NCT00609193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20284862|NCT00609193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20284863|NCT00609193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20284864|NCT00609193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19965126|NCT04292483|Gasotransmitters|gasotransmitters|mesh-ancestor
19965127|NCT04292483|Protective Agents|protective agents|mesh-ancestor
19965128|NCT04291508|Acetaminophen|acetaminophen|mesh-list
20284865|NCT00609193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284866|NCT00609284|Carboplatin|carboplatin|mesh-list
19965129|NCT04291508|Ascorbic Acid|ascorbic acid|mesh-list
19965130|NCT04291508|Vitamins|vitamins|mesh-ancestor
19965131|NCT04291508|Micronutrients|micronutrients|mesh-ancestor
19965132|NCT04291508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965133|NCT04291508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19965134|NCT04291508|Analgesics|analgesics|mesh-ancestor
19965135|NCT04291508|Sensory System Agents|sensory system agents|mesh-ancestor
20284867|NCT00609284|Cetuximab|cetuximab|mesh-list
20284868|NCT00609284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284869|NCT00609284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20288400|NCT05334043|Sensory System Agents|sensory system agents|mesh-ancestor
20288401|NCT05334043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20288402|NCT05334043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288403|NCT05334043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20288404|NCT05334043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20288405|NCT05334043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288406|NCT05334043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288407|NCT05334043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288648|NCT05252988|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20288649|NCT05252988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20288650|NCT05252988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20288651|NCT05252988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20288652|NCT05252988|Antimetabolites|antimetabolites|mesh-ancestor
19965136|NCT04291508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20284870|NCT00609375|Cefepime|cefepime|mesh-list
20284871|NCT00609375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20284872|NCT00609375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20284873|NCT00609388|Tacrolimus|tacrolimus|mesh-list
20284874|NCT00609388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20284875|NCT00609388|Immunologic Factors|immunologic factors|mesh-ancestor
20284876|NCT00609388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284877|NCT00609388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20284878|NCT00609388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284879|NCT00609388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284880|NCT00609401|Sorafenib|sorafenib|mesh-list
20284881|NCT00609401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284882|NCT00609401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20284883|NCT00609401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284884|NCT00609401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965137|NCT04291508|Antipyretics|antipyretics|mesh-ancestor
19965138|NCT04291508|Antioxidants|antioxidants|mesh-ancestor
20284885|NCT00609531|Citalopram|citalopram|mesh-list
20284886|NCT00609531|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20284887|NCT00609531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20284888|NCT00609531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20284889|NCT00609531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284890|NCT00609531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20284891|NCT00609531|Serotonin Agents|serotonin agents|mesh-ancestor
20284892|NCT00609531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284893|NCT00609531|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20284894|NCT00609531|Antidepressive Agents|antidepressive agents|mesh-ancestor
20284895|NCT00609531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20284896|NCT00609544|Rilonacept|rilonacept|mesh-list
20284897|NCT00609544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20284898|NCT00609557|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20284899|NCT00609557|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20284900|NCT00609557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20284901|NCT00609557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20284902|NCT00609557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284903|NCT00609557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20284904|NCT00609557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284905|NCT00609557|Analgesics|analgesics|mesh-ancestor
20284906|NCT00609557|Sensory System Agents|sensory system agents|mesh-ancestor
20284907|NCT00609557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20284908|NCT00609557|Antidepressive Agents|antidepressive agents|mesh-ancestor
20284909|NCT00609557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20284910|NCT00609557|Dopamine Agents|dopamine agents|mesh-ancestor
20284911|NCT00609570|Calcium|calcium|mesh-list
20284912|NCT00609570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20284913|NCT00609570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284914|NCT00609596|Dutasteride|dutasteride|mesh-list
20284915|NCT00609596|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20284916|NCT00609596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20284917|NCT00609596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284918|NCT00609596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284919|NCT00609596|Hormone Antagonists|hormone antagonists|mesh-ancestor
20284920|NCT00609596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20284921|NCT00609596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284922|NCT00609752|Prednisolone|prednisolone|mesh-list
20284923|NCT00609752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20284924|NCT00609752|Glucocorticoids|glucocorticoids|mesh-ancestor
20284925|NCT00609752|Hormones|hormones|mesh-ancestor
20284926|NCT00609752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20284927|NCT00609752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284928|NCT00609752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20284929|NCT00609752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284930|NCT00609817|Dexamethasone|dexamethasone|mesh-list
20284931|NCT00609817|Bortezomib|bortezomib|mesh-list
20284932|NCT00609817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20284933|NCT00609817|Antiemetics|antiemetics|mesh-ancestor
20284934|NCT00609817|Autonomic Agents|autonomic agents|mesh-ancestor
20548348|NCT01900015|Efavirenz|efavirenz|mesh-list
19965139|NCT04291508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548349|NCT01900015|Raltegravir Potassium|raltegravir potassium|mesh-list
19965140|NCT04291508|Protective Agents|protective agents|mesh-ancestor
20284935|NCT00609817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548350|NCT01900015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20284936|NCT00609817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284937|NCT00609817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20284938|NCT00609817|Glucocorticoids|glucocorticoids|mesh-ancestor
20284939|NCT00609817|Hormones|hormones|mesh-ancestor
20284940|NCT00609817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20284941|NCT00609817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20284942|NCT00609817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284943|NCT00609843|Ethiodized Oil|ethiodized oil|mesh-list
20284944|NCT00609843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284945|NCT00609856|Insulin Glargine|insulin glargine|mesh-list
20284946|NCT00609856|Pioglitazone|pioglitazone|mesh-list
20284947|NCT00609856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20284948|NCT00609856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284949|NCT00609895|Insulin Glargine|insulin glargine|mesh-list
20284950|NCT00609895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20284951|NCT00609895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284952|NCT00609934|Sorafenib|sorafenib|mesh-list
20284953|NCT00609934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284954|NCT00609934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20284955|NCT00609934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284956|NCT00609934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284957|NCT00609960|Midazolam|midazolam|mesh-list
20284958|NCT00609960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20284959|NCT00609960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20284960|NCT00609960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20284961|NCT00609960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284962|NCT00609960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20284963|NCT00609960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20284964|NCT00609960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20284965|NCT00609960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20284966|NCT00609960|Anesthetics, General|anesthetics, general|mesh-ancestor
20284967|NCT00609960|Anesthetics|anesthetics|mesh-ancestor
20284968|NCT00609960|GABA Modulators|gaba modulators|mesh-ancestor
20284969|NCT00609960|GABA Agents|gaba agents|mesh-ancestor
20284970|NCT00609960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20284971|NCT00609960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284972|NCT00609999|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20284973|NCT00609999|Dasatinib|dasatinib|mesh-list
20284974|NCT00609999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284975|NCT00609999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20284976|NCT00609999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284977|NCT00609999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20284978|NCT00610038|Glyburide|glyburide|mesh-list
20284979|NCT00610038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20284980|NCT00610038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284981|NCT00610051|Alprostadil|alprostadil|mesh-list
20284982|NCT00610051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20284983|NCT00610051|Vasodilator Agents|vasodilator agents|mesh-ancestor
20284984|NCT00610051|Urological Agents|urological agents|mesh-ancestor
20284985|NCT00610077|Letrozole|letrozole|mesh-list
20284986|NCT00610077|Clomiphene|clomiphene|mesh-list
20284987|NCT00610077|Enclomiphene|enclomiphene|mesh-list
20284988|NCT00610077|Zuclomiphene|zuclomiphene|mesh-list
20284989|NCT00610077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965141|NCT04278768|Azacitidine|azacitidine|mesh-list
19965142|NCT04278768|Venetoclax|venetoclax|mesh-list
19965143|NCT04278768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19965144|NCT04278768|Antimetabolites|antimetabolites|mesh-ancestor
19965145|NCT04278768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965146|NCT04278768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965147|NCT04278768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965148|NCT04268771|Rituximab|rituximab|mesh-list
19965149|NCT04268771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19965150|NCT04268771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965151|NCT04268771|Immunologic Factors|immunologic factors|mesh-ancestor
19965152|NCT04268771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965153|NCT04268771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19965154|NCT04267120|Pembrolizumab|pembrolizumab|mesh-list
19965155|NCT04267120|Lenvatinib|lenvatinib|mesh-list
19965156|NCT04267120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19965157|NCT04267120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965158|NCT04267120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20284990|NCT00610077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20284991|NCT00610077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20284992|NCT00610077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19965159|NCT04267120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965160|NCT04267120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965161|NCT04265651|Infigratinib|infigratinib|mesh-list
19965162|NCT04265651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965163|NCT04246619|Pregabalin|pregabalin|mesh-list
19965164|NCT04246619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19965165|NCT04246619|Analgesics|analgesics|mesh-ancestor
19965166|NCT04246619|Sensory System Agents|sensory system agents|mesh-ancestor
19965167|NCT04246619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965168|NCT04246619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965169|NCT04246619|Anticonvulsants|anticonvulsants|mesh-ancestor
19965170|NCT04246619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19965171|NCT04246619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19965172|NCT04246619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965173|NCT04246619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19965174|NCT04246619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19965175|NCT04246619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19965176|NCT04246619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19965177|NCT04246619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19965178|NCT04246619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19965179|NCT04246619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19965180|NCT04246619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19965181|NCT04246619|Antidepressive Agents|antidepressive agents|mesh-ancestor
19965182|NCT04246619|Dopamine Agents|dopamine agents|mesh-ancestor
19965183|NCT04246359|Interferons|interferons|mesh-list
19965184|NCT04246359|Rituximab|rituximab|mesh-list
20284993|NCT00610077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20284994|NCT00610077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20284995|NCT00610077|Hormone Antagonists|hormone antagonists|mesh-ancestor
20284996|NCT00610077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20284997|NCT00610077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20284998|NCT00610077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20284999|NCT00610077|Fertility Agents|fertility agents|mesh-ancestor
20285000|NCT00610077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20285001|NCT00610077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20285002|NCT00610077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20285003|NCT00610103|Apomorphine|apomorphine|mesh-list
20285004|NCT00610103|Emetics|emetics|mesh-ancestor
20285005|NCT00610103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285006|NCT00610103|Autonomic Agents|autonomic agents|mesh-ancestor
20285007|NCT00610103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20285008|NCT00610103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20285009|NCT00610103|Dopamine Agonists|dopamine agonists|mesh-ancestor
20285010|NCT00610103|Dopamine Agents|dopamine agents|mesh-ancestor
20285011|NCT00610103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20285012|NCT00610103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285013|NCT00610142|Hydrocortisone|hydrocortisone|mesh-list
20285014|NCT00610142|Pimecrolimus|pimecrolimus|mesh-list
20285015|NCT00610142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19965185|NCT04246359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19965186|NCT04246359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965187|NCT04246359|Immunologic Factors|immunologic factors|mesh-ancestor
19965188|NCT04246359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965189|NCT04246359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19965190|NCT04246359|Antiviral Agents|antiviral agents|mesh-ancestor
20285016|NCT00610142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20285017|NCT00610142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20285018|NCT00610142|Analgesics|analgesics|mesh-ancestor
20285019|NCT00610142|Sensory System Agents|sensory system agents|mesh-ancestor
20285020|NCT00610142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20285021|NCT00610142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285022|NCT00610142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20285023|NCT00610142|Dermatologic Agents|dermatologic agents|mesh-ancestor
20285024|NCT00610142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20285025|NCT00610142|Immunologic Factors|immunologic factors|mesh-ancestor
20285026|NCT00610142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20285027|NCT00610142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285028|NCT00610142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285029|NCT00610246|Sorafenib|sorafenib|mesh-list
20285030|NCT00610246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285031|NCT00610246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20285032|NCT00610246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288408|NCT05334004|Ritonavir|ritonavir|mesh-list
19965191|NCT04246359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20285033|NCT00610246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965192|NCT04241640|Nefopam|nefopam|mesh-list
19965193|NCT04241640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19965194|NCT04241640|Analgesics|analgesics|mesh-ancestor
19965195|NCT04241640|Sensory System Agents|sensory system agents|mesh-ancestor
19965196|NCT04241640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965197|NCT04241640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965198|NCT04232683|Tamsulosin|tamsulosin|mesh-list
19965199|NCT04232683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19965200|NCT04232683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19965201|NCT04232683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19965202|NCT04232683|Adrenergic Agents|adrenergic agents|mesh-ancestor
19965203|NCT04232683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19965204|NCT04232683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965205|NCT04232683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965206|NCT04232683|Urological Agents|urological agents|mesh-ancestor
19965207|NCT04231773|Nitric Oxide|nitric oxide|mesh-list
19965208|NCT04231773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19965209|NCT04231773|Autonomic Agents|autonomic agents|mesh-ancestor
19965210|NCT04231773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965211|NCT04231773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965212|NCT04231773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19965213|NCT04231773|Respiratory System Agents|respiratory system agents|mesh-ancestor
19965214|NCT04231773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19965215|NCT04231773|Antioxidants|antioxidants|mesh-ancestor
19965216|NCT04231773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965217|NCT04231773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19965218|NCT04231773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19965219|NCT04231773|Vasodilator Agents|vasodilator agents|mesh-ancestor
19965220|NCT04231773|Gasotransmitters|gasotransmitters|mesh-ancestor
19965221|NCT04231773|Protective Agents|protective agents|mesh-ancestor
19965222|NCT04231760|Nitric Oxide|nitric oxide|mesh-list
19965223|NCT04231760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19965224|NCT04231760|Autonomic Agents|autonomic agents|mesh-ancestor
19965225|NCT04231760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965226|NCT04231760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965227|NCT04231760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19965228|NCT04231760|Respiratory System Agents|respiratory system agents|mesh-ancestor
19965229|NCT04231760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19965230|NCT04231760|Antioxidants|antioxidants|mesh-ancestor
19965231|NCT04231760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965232|NCT04231760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19965233|NCT04231760|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19965234|NCT04231760|Vasodilator Agents|vasodilator agents|mesh-ancestor
19965235|NCT04231760|Gasotransmitters|gasotransmitters|mesh-ancestor
19965236|NCT04231760|Protective Agents|protective agents|mesh-ancestor
19965237|NCT04216927|Nitric Oxide|nitric oxide|mesh-list
19965238|NCT04216927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19965239|NCT04216927|Autonomic Agents|autonomic agents|mesh-ancestor
19965240|NCT04216927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965241|NCT04216927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965242|NCT04216927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19965243|NCT04216927|Respiratory System Agents|respiratory system agents|mesh-ancestor
19965244|NCT04216927|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19965245|NCT04216927|Antioxidants|antioxidants|mesh-ancestor
19965246|NCT04216927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965247|NCT04216927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19965248|NCT04216927|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19965249|NCT04216927|Vasodilator Agents|vasodilator agents|mesh-ancestor
19965250|NCT04216927|Gasotransmitters|gasotransmitters|mesh-ancestor
19965251|NCT04216927|Protective Agents|protective agents|mesh-ancestor
19965252|NCT04196868|Metformin|metformin|mesh-list
19965253|NCT04196868|Methotrexate|methotrexate|mesh-list
19965254|NCT04196868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19965255|NCT04196868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965256|NCT04196868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20285034|NCT00610324|Chlorhexidine|chlorhexidine|mesh-list
20285035|NCT00610324|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20285036|NCT00610324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20285037|NCT00610324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20285038|NCT00610324|Disinfectants|disinfectants|mesh-ancestor
20285039|NCT00610324|Dermatologic Agents|dermatologic agents|mesh-ancestor
20285040|NCT00610350|Simendan|simendan|mesh-list
20285041|NCT00610350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20285042|NCT00610350|Vasodilator Agents|vasodilator agents|mesh-ancestor
20285043|NCT00610350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20548351|NCT01900015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20548352|NCT01900015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548353|NCT01900015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548354|NCT01900015|Antiviral Agents|antiviral agents|mesh-ancestor
19965257|NCT04196868|Abortifacient Agents|abortifacient agents|mesh-ancestor
19965258|NCT04196868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19965259|NCT04196868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19965260|NCT04196868|Antimetabolites|antimetabolites|mesh-ancestor
19965261|NCT04196868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965262|NCT04196868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965263|NCT04196868|Dermatologic Agents|dermatologic agents|mesh-ancestor
19965264|NCT04196868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965265|NCT04196868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19965266|NCT04196868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20548355|NCT01900015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548356|NCT01900015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20548357|NCT01900015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20548358|NCT01900015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20548359|NCT01900015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20548360|NCT01900015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20548361|NCT01900015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20548362|NCT01900015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20548363|NCT01900015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20548364|NCT01900015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20548365|NCT01900015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20548366|NCT01900028|Itraconazole|itraconazole|mesh-list
20548367|NCT01900028|Olaparib|olaparib|mesh-list
20548368|NCT01900028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20548369|NCT01900028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548370|NCT01900028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548371|NCT01900028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548372|NCT01900028|Antifungal Agents|antifungal agents|mesh-ancestor
20548373|NCT01900028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548374|NCT01900028|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20548375|NCT01900028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20548376|NCT01900028|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20548377|NCT01900028|Hormone Antagonists|hormone antagonists|mesh-ancestor
20548378|NCT01900028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20548379|NCT01900028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548380|NCT01900028|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20548381|NCT01900041|Minoxidil|minoxidil|mesh-list
20548382|NCT01900041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20548383|NCT01900041|Vasodilator Agents|vasodilator agents|mesh-ancestor
20548384|NCT01900093|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20548385|NCT01900093|Hormones|hormones|mesh-ancestor
20548386|NCT01900093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20548387|NCT01900093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548388|NCT01900106|Ritonavir|ritonavir|mesh-list
20548389|NCT01900106|Darunavir|darunavir|mesh-list
20548390|NCT01900106|Lamivudine|lamivudine|mesh-list
20548391|NCT01900106|Raltegravir Potassium|raltegravir potassium|mesh-list
20548392|NCT01900106|Abacavir|abacavir|mesh-list
20548393|NCT01900106|Dideoxynucleosides|dideoxynucleosides|mesh-list
20548394|NCT01900106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20548395|NCT01900106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20548396|NCT01900106|Protease Inhibitors|protease inhibitors|mesh-ancestor
20548397|NCT01900106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548398|NCT01900106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548399|NCT01900106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20548400|NCT01900106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20548401|NCT01900106|Antiviral Agents|antiviral agents|mesh-ancestor
20548402|NCT01900106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20554494|NCT01935596|Ropivacaine|ropivacaine|mesh-list
19965267|NCT04196868|Immunologic Factors|immunologic factors|mesh-ancestor
20285044|NCT00610350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20285045|NCT00610350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285046|NCT00610350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285047|NCT00610350|Protective Agents|protective agents|mesh-ancestor
20285048|NCT00610350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285049|NCT00610454|Levetiracetam|levetiracetam|mesh-list
20285050|NCT00610454|Anticonvulsants|anticonvulsants|mesh-ancestor
20285051|NCT00610454|Nootropic Agents|nootropic agents|mesh-ancestor
20285052|NCT00610493|Sirolimus|sirolimus|mesh-list
20285053|NCT00610493|Bevacizumab|bevacizumab|mesh-list
20285054|NCT00610493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20285055|NCT00610493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285056|NCT00610493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20285057|NCT00610493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20285058|NCT00610493|Growth Substances|growth substances|mesh-ancestor
20285059|NCT00610493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285060|NCT00610493|Growth Inhibitors|growth inhibitors|mesh-ancestor
20285061|NCT00610493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20285062|NCT00610493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20285063|NCT00610493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20285064|NCT00610493|Antifungal Agents|antifungal agents|mesh-ancestor
20285065|NCT00610493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20285066|NCT00610493|Immunologic Factors|immunologic factors|mesh-ancestor
20285067|NCT00610506|Dexetimide|dexetimide|mesh-list
20285068|NCT00610506|Citalopram|citalopram|mesh-list
20285069|NCT00610506|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20285070|NCT00610506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20285071|NCT00610506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20285072|NCT00610506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285073|NCT00610506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20285074|NCT00610506|Serotonin Agents|serotonin agents|mesh-ancestor
20285075|NCT00610506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285076|NCT00610506|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20285077|NCT00610506|Antidepressive Agents|antidepressive agents|mesh-ancestor
20285078|NCT00610506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20285079|NCT00610506|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20285080|NCT00610506|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19965268|NCT04196868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19965269|NCT04196868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19975191|NCT01846455|Narcotics|narcotics|mesh-ancestor
19975192|NCT01846455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19975193|NCT01846455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975194|NCT01846455|Analgesics|analgesics|mesh-ancestor
19975195|NCT01846455|Sensory System Agents|sensory system agents|mesh-ancestor
19975196|NCT01846455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975197|NCT01846455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19975198|NCT01846455|Antipruritics|antipruritics|mesh-ancestor
19975199|NCT01846455|Dermatologic Agents|dermatologic agents|mesh-ancestor
19975200|NCT01846455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19975201|NCT01846455|Histamine Antagonists|histamine antagonists|mesh-ancestor
19975202|NCT01846455|Histamine Agents|histamine agents|mesh-ancestor
19975203|NCT01846455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975204|NCT01846455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975205|NCT01846455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19975206|NCT01846455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19975207|NCT01846455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19975208|NCT01846455|Anesthetics, Local|anesthetics, local|mesh-ancestor
20285081|NCT00610506|Parasympatholytics|parasympatholytics|mesh-ancestor
20285082|NCT00610506|Autonomic Agents|autonomic agents|mesh-ancestor
20285083|NCT00610506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975209|NCT01846455|Anesthetics|anesthetics|mesh-ancestor
19975210|NCT01846455|Antiemetics|antiemetics|mesh-ancestor
19975211|NCT01846455|Autonomic Agents|autonomic agents|mesh-ancestor
19975212|NCT01846455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20285084|NCT00610506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20285085|NCT00610506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20548403|NCT01900106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20548404|NCT01900106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20548405|NCT01900106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20548406|NCT01900106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20548407|NCT01900106|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20548408|NCT01900106|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20548409|NCT01900106|Antimetabolites|antimetabolites|mesh-ancestor
20548410|NCT01900158|Gemcitabine|gemcitabine|mesh-list
20548411|NCT01900158|Cisplatin|cisplatin|mesh-list
20548412|NCT01900158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548413|NCT01900158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19975213|NCT01846507|Tranexamic Acid|tranexamic acid|mesh-list
19975214|NCT01846507|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20285086|NCT00610506|Cholinergic Agents|cholinergic agents|mesh-ancestor
20285087|NCT00610545|Atorvastatin|atorvastatin|mesh-list
20285088|NCT00610545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19965270|NCT04181359|Nitric Oxide|nitric oxide|mesh-list
19965271|NCT04181359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19965272|NCT04181359|Autonomic Agents|autonomic agents|mesh-ancestor
19965273|NCT04181359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965274|NCT04181359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965275|NCT04181359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19965276|NCT04181359|Respiratory System Agents|respiratory system agents|mesh-ancestor
19965277|NCT04181359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19965278|NCT04181359|Antioxidants|antioxidants|mesh-ancestor
20285089|NCT00610545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20285090|NCT00610545|Antimetabolites|antimetabolites|mesh-ancestor
20285091|NCT00610545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285092|NCT00610545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20285093|NCT00610545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20285094|NCT00610545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285095|NCT00610571|Temozolomide|temozolomide|mesh-list
20285096|NCT00610571|Topotecan|topotecan|mesh-list
20285097|NCT00610571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20285098|NCT00610571|Alkylating Agents|alkylating agents|mesh-ancestor
20285099|NCT00610571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285100|NCT00610571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285101|NCT00610571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20285102|NCT00610571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20285103|NCT00610571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285104|NCT00610584|Cetirizine|cetirizine|mesh-list
20285105|NCT00610584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20285106|NCT00610584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20285107|NCT00610584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20285108|NCT00610584|Histamine Antagonists|histamine antagonists|mesh-ancestor
20285109|NCT00610584|Histamine Agents|histamine agents|mesh-ancestor
20285110|NCT00610584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20285111|NCT00610584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285112|NCT00610584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285113|NCT00610610|Paroxetine|paroxetine|mesh-list
20285114|NCT00610610|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20285115|NCT00610610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20285116|NCT00610610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20285117|NCT00610610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285118|NCT00610610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20285119|NCT00610610|Serotonin Agents|serotonin agents|mesh-ancestor
20285120|NCT00610610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285121|NCT00610610|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20285122|NCT00610610|Antidepressive Agents|antidepressive agents|mesh-ancestor
20285123|NCT00610610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20285124|NCT00610610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20285125|NCT00610610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20285126|NCT00610610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285127|NCT00610623|Azithromycin|azithromycin|mesh-list
20285128|NCT00610623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20285129|NCT00610623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20285130|NCT00610792|Doxorubicin|doxorubicin|mesh-list
20285131|NCT00610792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20285132|NCT00610792|Bortezomib|bortezomib|mesh-list
20285133|NCT00610792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20285134|NCT00610792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285135|NCT00610792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20285136|NCT00610792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20285137|NCT00610792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285138|NCT00610792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285139|NCT00610818|Mitogens|mitogens|mesh-list
20285140|NCT00610818|Mitosis Modulators|mitosis modulators|mesh-ancestor
20285141|NCT00610818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285142|NCT00610870|Atorvastatin|atorvastatin|mesh-list
20285143|NCT00610870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20285144|NCT00610870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20285145|NCT00610870|Antimetabolites|antimetabolites|mesh-ancestor
20285146|NCT00610870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285147|NCT00610870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20285148|NCT00610870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20285149|NCT00610870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285150|NCT00610909|Paroxetine|paroxetine|mesh-list
20285151|NCT00610909|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19965279|NCT04181359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965280|NCT04181359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19965281|NCT04181359|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19965282|NCT04181359|Vasodilator Agents|vasodilator agents|mesh-ancestor
20285152|NCT00610909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20285153|NCT00610909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20285154|NCT00610909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285155|NCT00610909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20285156|NCT00610909|Serotonin Agents|serotonin agents|mesh-ancestor
20285157|NCT00610909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285158|NCT00610909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20285159|NCT00610909|Antidepressive Agents|antidepressive agents|mesh-ancestor
20285160|NCT00610909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20285161|NCT00610909|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20285162|NCT00610909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20285163|NCT00610909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285164|NCT00610948|Leucovorin|leucovorin|mesh-list
20285165|NCT00610948|Fluorouracil|fluorouracil|mesh-list
20285166|NCT00610948|Oxaliplatin|oxaliplatin|mesh-list
20285167|NCT00610948|Everolimus|everolimus|mesh-list
20285168|NCT00610948|Panitumumab|panitumumab|mesh-list
19965283|NCT04181359|Gasotransmitters|gasotransmitters|mesh-ancestor
19965284|NCT04181359|Protective Agents|protective agents|mesh-ancestor
19965285|NCT04172701|Cholinergic Agents|cholinergic agents|mesh-list
19965286|NCT04172701|Muscarinic Antagonists|muscarinic antagonists|mesh-list
19965287|NCT04172701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19965288|NCT04172701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965289|NCT04172701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285169|NCT00610948|Calcium|calcium|mesh-list
20285170|NCT00610948|Levoleucovorin|levoleucovorin|mesh-list
20285171|NCT00610948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20285172|NCT00610948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285173|NCT00610948|Antimetabolites|antimetabolites|mesh-ancestor
20285174|NCT00610948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285175|NCT00610948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20285176|NCT00610948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285177|NCT00610948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20285178|NCT00610948|Immunologic Factors|immunologic factors|mesh-ancestor
20285179|NCT00610948|Antidotes|antidotes|mesh-ancestor
20285180|NCT00610948|Protective Agents|protective agents|mesh-ancestor
20285181|NCT00610948|Vitamin B Complex|vitamin b complex|mesh-ancestor
20285182|NCT00610948|Vitamins|vitamins|mesh-ancestor
20285183|NCT00610948|Micronutrients|micronutrients|mesh-ancestor
20285184|NCT00610948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20285185|NCT00611000|Folic Acid|folic acid|mesh-list
20285186|NCT00611000|Hematinics|hematinics|mesh-ancestor
20285187|NCT00611000|Vitamin B Complex|vitamin b complex|mesh-ancestor
20285188|NCT00611000|Vitamins|vitamins|mesh-ancestor
20285189|NCT00611000|Micronutrients|micronutrients|mesh-ancestor
20285190|NCT00611000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285191|NCT00611039|Ritonavir|ritonavir|mesh-list
20285192|NCT00611039|Darunavir|darunavir|mesh-list
20285193|NCT00611039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20285194|NCT00611039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20285195|NCT00611039|Protease Inhibitors|protease inhibitors|mesh-ancestor
20285196|NCT00611039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285197|NCT00611039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285198|NCT00611039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20285199|NCT00611039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20285200|NCT00611039|Antiviral Agents|antiviral agents|mesh-ancestor
20285201|NCT00611039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20285202|NCT00611039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20285203|NCT00611039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20285204|NCT05331664|Moxifloxacin|moxifloxacin|mesh-list
20285205|NCT05331664|Polymyxins|polymyxins|mesh-list
20285206|NCT05331664|Trimethoprim|trimethoprim|mesh-list
19965290|NCT04172701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19965291|NCT04166435|Temozolomide|temozolomide|mesh-list
20285207|NCT05331664|Prednisolone|prednisolone|mesh-list
20285208|NCT05331664|Prednisolone acetate|prednisolone acetate|mesh-list
20285209|NCT05331664|Triamcinolone|triamcinolone|mesh-list
20285210|NCT05331664|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20288409|NCT05334004|Lopinavir|lopinavir|mesh-list
20285211|NCT05331664|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20285212|NCT05331664|Atropine|atropine|mesh-list
20285213|NCT05331664|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20285214|NCT05331664|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20285215|NCT05331664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20285216|NCT05331664|Glucocorticoids|glucocorticoids|mesh-ancestor
20285217|NCT05331664|Hormones|hormones|mesh-ancestor
20548414|NCT01900158|Antimetabolites|antimetabolites|mesh-ancestor
20548415|NCT01900158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548416|NCT01900158|Antiviral Agents|antiviral agents|mesh-ancestor
20548417|NCT01900158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548418|NCT01900158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548419|NCT01900158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20548420|NCT01900158|Immunologic Factors|immunologic factors|mesh-ancestor
20548421|NCT01900158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548422|NCT01900197|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
20548423|NCT01900197|Hematinics|hematinics|mesh-ancestor
20548424|NCT01900301|Scopolamine|scopolamine|mesh-list
20548425|NCT01900301|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20548426|NCT01900301|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20548427|NCT01900301|Antiemetics|antiemetics|mesh-ancestor
20548428|NCT01900301|Autonomic Agents|autonomic agents|mesh-ancestor
20548429|NCT01900301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548430|NCT01900301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548431|NCT01900301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20548432|NCT01900301|Mydriatics|mydriatics|mesh-ancestor
20548433|NCT01900301|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20548434|NCT01900301|Cholinergic Agents|cholinergic agents|mesh-ancestor
20548435|NCT01900301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20548436|NCT01900301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548437|NCT01900301|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20548438|NCT01900301|Parasympatholytics|parasympatholytics|mesh-ancestor
20548439|NCT01900327|Gemcitabine|gemcitabine|mesh-list
20548440|NCT01900327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20548441|NCT01900327|Antimetabolites|antimetabolites|mesh-ancestor
20548442|NCT01900327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548443|NCT01900327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548444|NCT01900327|Antiviral Agents|antiviral agents|mesh-ancestor
19733429|NCT04561947|Mitogens|mitogens|mesh-list
19733430|NCT04561947|Mitosis Modulators|mitosis modulators|mesh-ancestor
19733431|NCT04561947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733432|NCT04561739|Aspirin|aspirin|mesh-list
19733433|NCT04561739|Sirolimus|sirolimus|mesh-list
19733434|NCT04561739|Paclitaxel|paclitaxel|mesh-list
19733435|NCT04561739|Clopidogrel|clopidogrel|mesh-list
19733436|NCT04561739|Ticagrelor|ticagrelor|mesh-list
20548445|NCT01900327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548446|NCT01900327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548447|NCT01900327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20548448|NCT01900327|Immunologic Factors|immunologic factors|mesh-ancestor
20548449|NCT01900327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548450|NCT01900405|Dexmedetomidine|dexmedetomidine|mesh-list
20548451|NCT01900405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20548452|NCT01900405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20548453|NCT01900405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548454|NCT01900405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20548455|NCT01900405|Analgesics|analgesics|mesh-ancestor
20548456|NCT01900405|Sensory System Agents|sensory system agents|mesh-ancestor
20548457|NCT01900405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733437|NCT04561739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19733438|NCT04561739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733439|NCT04561739|Tubulin Modulators|tubulin modulators|mesh-ancestor
19733440|NCT04561739|Antimitotic Agents|antimitotic agents|mesh-ancestor
19733441|NCT04561739|Mitosis Modulators|mitosis modulators|mesh-ancestor
19733442|NCT04561739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733443|NCT04561739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20548458|NCT01900405|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19733444|NCT04561739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20285218|NCT05331664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20285219|NCT05331664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285220|NCT05331664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20285221|NCT05331664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285222|NCT05331664|Autonomic Agents|autonomic agents|mesh-ancestor
20548459|NCT01900405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20285223|NCT05331664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20285224|NCT05331664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20285225|NCT05331664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20285226|NCT05331664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20285227|NCT05331664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20285228|NCT05331664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285229|NCT05331664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965292|NCT04166435|Olaparib|olaparib|mesh-list
19965293|NCT04166435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19965294|NCT04166435|Alkylating Agents|alkylating agents|mesh-ancestor
19965295|NCT04166435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965296|NCT04166435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965297|NCT04166435|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19965298|NCT04166435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285230|NCT05331664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20285231|NCT05331664|Contraceptive Agents|contraceptive agents|mesh-ancestor
20285232|NCT05331664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20285233|NCT05331664|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20285234|NCT05331664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20285235|NCT05331664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20285236|NCT05331664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20285237|NCT05331664|Immunologic Factors|immunologic factors|mesh-ancestor
20285238|NCT05331664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20285239|NCT05331664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20285240|NCT05331664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20285241|NCT05331664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20285242|NCT05331664|Respiratory System Agents|respiratory system agents|mesh-ancestor
20285243|NCT05331664|Mydriatics|mydriatics|mesh-ancestor
20285244|NCT05331664|Parasympatholytics|parasympatholytics|mesh-ancestor
20285245|NCT05331664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20285246|NCT05331664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20285247|NCT05331664|Cholinergic Agents|cholinergic agents|mesh-ancestor
20285248|NCT05331664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20285249|NCT05331664|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20285250|NCT05331664|Renal Agents|renal agents|mesh-ancestor
20285251|NCT05331664|Antimalarials|antimalarials|mesh-ancestor
20285252|NCT05331664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20285253|NCT05331664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20285254|NCT05331664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20285255|NCT05331664|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20285256|NCT05331664|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20285257|NCT05331664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20285258|NCT05331651|Glycopyrrolate|glycopyrrolate|mesh-list
20285259|NCT05331651|Tropisetron|tropisetron|mesh-list
20285260|NCT05331651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20285261|NCT05331651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20285262|NCT05331651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20285263|NCT05331651|Cholinergic Agents|cholinergic agents|mesh-ancestor
20285264|NCT05331651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20285265|NCT05331651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285266|NCT05331651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285267|NCT05331651|Antiemetics|antiemetics|mesh-ancestor
20285268|NCT05331651|Autonomic Agents|autonomic agents|mesh-ancestor
20285269|NCT05331651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20285270|NCT05331651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20285271|NCT05331651|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20285272|NCT05331651|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20285273|NCT05331651|Serotonin Agents|serotonin agents|mesh-ancestor
20285274|NCT05331573|Apomorphine|apomorphine|mesh-list
20285275|NCT05331573|Emetics|emetics|mesh-ancestor
20285276|NCT05331573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285277|NCT05331573|Autonomic Agents|autonomic agents|mesh-ancestor
20285278|NCT05331573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20285279|NCT05331573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20285280|NCT05331573|Dopamine Agonists|dopamine agonists|mesh-ancestor
20285281|NCT05331573|Dopamine Agents|dopamine agents|mesh-ancestor
20285282|NCT05331573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20285283|NCT05331573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288410|NCT05334004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20288411|NCT05334004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20288412|NCT05334004|Protease Inhibitors|protease inhibitors|mesh-ancestor
20288413|NCT05334004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288414|NCT05334004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288415|NCT05334004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20285284|NCT05331521|Vincristine|vincristine|mesh-list
20285285|NCT05331521|Temozolomide|temozolomide|mesh-list
20285286|NCT05331521|Lomustine|lomustine|mesh-list
20285287|NCT05331521|Procarbazine|procarbazine|mesh-list
20285288|NCT05331521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20285289|NCT05331521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965299|NCT04154150|Ketamine|ketamine|mesh-list
19965300|NCT04154150|Analgesics|analgesics|mesh-ancestor
19965301|NCT04154150|Sensory System Agents|sensory system agents|mesh-ancestor
20285290|NCT05331521|Tubulin Modulators|tubulin modulators|mesh-ancestor
20285291|NCT05331521|Antimitotic Agents|antimitotic agents|mesh-ancestor
20285292|NCT05331521|Mitosis Modulators|mitosis modulators|mesh-ancestor
20285293|NCT05331521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285294|NCT05331521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20285295|NCT05331521|Alkylating Agents|alkylating agents|mesh-ancestor
19965302|NCT04154150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965303|NCT04154150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965304|NCT04154150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19965305|NCT04154150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19965306|NCT04154150|Anesthetics, General|anesthetics, general|mesh-ancestor
19965307|NCT04154150|Anesthetics|anesthetics|mesh-ancestor
19965308|NCT04154150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19965309|NCT04154150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20285296|NCT05331469|Insulin|insulin|mesh-list
20285297|NCT05331469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20285298|NCT05331469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285299|NCT05331183|Ivacaftor|ivacaftor|mesh-list
20285300|NCT05331183|Elexacaftor|elexacaftor|mesh-list
20548460|NCT01900405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20548461|NCT01900405|Adrenergic Agents|adrenergic agents|mesh-ancestor
20548462|NCT01900405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20548463|NCT01900405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548464|NCT01900496|Rituximab|rituximab|mesh-list
20548465|NCT01900496|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20548466|NCT01900496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20548467|NCT01900496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548468|NCT01900496|Immunologic Factors|immunologic factors|mesh-ancestor
20548469|NCT01900496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548470|NCT01900496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20548471|NCT01900509|Dexamethasone|dexamethasone|mesh-list
20548472|NCT01900509|Etoposide|etoposide|mesh-list
20548473|NCT01900509|Etoposide phosphate|etoposide phosphate|mesh-list
20548474|NCT01900509|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20548475|NCT01900509|Clofarabine|clofarabine|mesh-list
20548476|NCT01900509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20548477|NCT01900509|Antiemetics|antiemetics|mesh-ancestor
20548478|NCT01900509|Autonomic Agents|autonomic agents|mesh-ancestor
20548479|NCT01900509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548480|NCT01900509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548481|NCT01900509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20548482|NCT01900509|Glucocorticoids|glucocorticoids|mesh-ancestor
20548483|NCT01900509|Hormones|hormones|mesh-ancestor
19965310|NCT04154150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19965311|NCT04154150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19965312|NCT04154150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965313|NCT04107051|Nalmefene|nalmefene|mesh-list
19965314|NCT04107051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19965315|NCT04107051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965316|NCT04107051|Sensory System Agents|sensory system agents|mesh-ancestor
19965317|NCT04107051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965318|NCT04090567|Olaparib|olaparib|mesh-list
19965319|NCT04090567|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
20285301|NCT05331183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20548484|NCT01900509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20548485|NCT01900509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19965320|NCT04090567|Cediranib|cediranib|mesh-list
19965321|NCT04090567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965322|NCT04090567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965323|NCT04090567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965324|NCT04090567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19965325|NCT04062097|Vitamin K|vitamin k|mesh-list
19965326|NCT04062097|Dabigatran|dabigatran|mesh-list
19965327|NCT04062097|Vitamins|vitamins|mesh-ancestor
19965328|NCT04062097|Micronutrients|micronutrients|mesh-ancestor
19965329|NCT04062097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965330|NCT04062097|Antithrombins|antithrombins|mesh-ancestor
20548486|NCT01900509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285302|NCT05331183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20285303|NCT05331183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285304|NCT05331144|Losartan|losartan|mesh-list
20285305|NCT05331144|Amlodipine|amlodipine|mesh-list
20285306|NCT05331144|Calcium Channel Blockers|calcium channel blockers|mesh-list
20285307|NCT05331144|Angiotensin II|angiotensin ii|mesh-list
20285308|NCT05331144|Giapreza|giapreza|mesh-list
20285309|NCT05331144|Calcium|calcium|mesh-list
20285310|NCT05331144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
19965331|NCT04062097|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19965332|NCT04062097|Protease Inhibitors|protease inhibitors|mesh-ancestor
19965333|NCT04062097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965334|NCT04062097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965335|NCT04062097|Anticoagulants|anticoagulants|mesh-ancestor
19965336|NCT04062097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19965337|NCT04062097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19965338|NCT04062097|Hemostatics|hemostatics|mesh-ancestor
19965339|NCT04062097|Coagulants|coagulants|mesh-ancestor
19965340|NCT04026009|Vaccines|vaccines|mesh-list
19965341|NCT04026009|Immunologic Factors|immunologic factors|mesh-ancestor
19965342|NCT04026009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965343|NCT04007874|Vitamin E|vitamin e|mesh-list
19965344|NCT04007874|Levonorgestrel|levonorgestrel|mesh-list
19965345|NCT04007874|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19965346|NCT04007874|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19965347|NCT04007874|Vitamins|vitamins|mesh-ancestor
19965348|NCT04007874|Micronutrients|micronutrients|mesh-ancestor
20285311|NCT05331144|Angiotensinogen|angiotensinogen|mesh-list
20285312|NCT05331144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20285313|NCT05331144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285314|NCT05331144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20285315|NCT05331144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20285316|NCT05331144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285317|NCT05331144|Vasodilator Agents|vasodilator agents|mesh-ancestor
20285318|NCT05331144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20285319|NCT05331144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20285320|NCT05331144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20285321|NCT05331144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20285322|NCT05331144|Protease Inhibitors|protease inhibitors|mesh-ancestor
20285323|NCT05331144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285324|NCT05331131|Ketamine|ketamine|mesh-list
20285325|NCT05331131|Analgesics|analgesics|mesh-ancestor
20285326|NCT05331131|Sensory System Agents|sensory system agents|mesh-ancestor
20285327|NCT05331131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20285328|NCT05331131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285329|NCT05331131|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20285330|NCT05331131|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20285331|NCT05331131|Anesthetics, General|anesthetics, general|mesh-ancestor
20285332|NCT05331131|Anesthetics|anesthetics|mesh-ancestor
20285333|NCT05331131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20285334|NCT05331131|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20285335|NCT05331131|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20285336|NCT05331131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20285337|NCT05331131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285338|NCT05331053|Atorvastatin|atorvastatin|mesh-list
19965349|NCT04007874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965350|NCT04007874|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19965351|NCT04007874|Contraceptive Agents|contraceptive agents|mesh-ancestor
19965352|NCT04007874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20285339|NCT05331053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20285340|NCT05331053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20285341|NCT05331053|Antimetabolites|antimetabolites|mesh-ancestor
20285342|NCT05331053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285343|NCT05331053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20285344|NCT05331053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20285345|NCT05331053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285346|NCT05330871|Vaccines|vaccines|mesh-list
20285347|NCT05330871|Immunologic Factors|immunologic factors|mesh-ancestor
20285348|NCT05330871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285349|NCT05330858|Rabeprazole|rabeprazole|mesh-list
19965353|NCT04007874|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19965354|NCT04007874|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20285350|NCT05330858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20548487|NCT01900509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19965355|NCT04007874|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20285351|NCT05330858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20285352|NCT05330858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20285353|NCT05330858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285354|NCT05330858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285355|NCT05330429|Leucovorin|leucovorin|mesh-list
20285356|NCT05330429|Bevacizumab|bevacizumab|mesh-list
20285357|NCT05330429|Magrolimab|magrolimab|mesh-list
20285358|NCT05330429|Fluorouracil|fluorouracil|mesh-list
19965356|NCT04007874|Antioxidants|antioxidants|mesh-ancestor
19965357|NCT04007874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965358|NCT04007874|Protective Agents|protective agents|mesh-ancestor
19965359|NCT04007874|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19965360|NCT04007874|Estrogens|estrogens|mesh-ancestor
19965361|NCT04007874|Hormones|hormones|mesh-ancestor
19965362|NCT04007874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19965363|NCT04007874|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19965364|NCT04005079|Ofloxacin|ofloxacin|mesh-list
19965365|NCT04005079|Prednisolone|prednisolone|mesh-list
19965366|NCT04005079|Pilocarpine|pilocarpine|mesh-list
19965367|NCT04005079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19965368|NCT04005079|Glucocorticoids|glucocorticoids|mesh-ancestor
19965369|NCT04005079|Hormones|hormones|mesh-ancestor
19965370|NCT04005079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20285359|NCT05330429|Irinotecan|irinotecan|mesh-list
20285360|NCT05330429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19965371|NCT04005079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285361|NCT05330429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285362|NCT05330429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20285363|NCT05330429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20285364|NCT05330429|Growth Substances|growth substances|mesh-ancestor
20285365|NCT05330429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285366|NCT05330429|Growth Inhibitors|growth inhibitors|mesh-ancestor
20285367|NCT05330429|Antimetabolites|antimetabolites|mesh-ancestor
20285368|NCT05330429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285369|NCT05330429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20285370|NCT05330429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20285371|NCT05330429|Immunologic Factors|immunologic factors|mesh-ancestor
20285372|NCT05330429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20285373|NCT05330429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20285374|NCT05330429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285375|NCT05330429|Antidotes|antidotes|mesh-ancestor
20285376|NCT05330429|Protective Agents|protective agents|mesh-ancestor
20285377|NCT05330429|Vitamin B Complex|vitamin b complex|mesh-ancestor
20285378|NCT05330429|Vitamins|vitamins|mesh-ancestor
20285379|NCT05330429|Micronutrients|micronutrients|mesh-ancestor
20285380|NCT05330390|Levetiracetam|levetiracetam|mesh-list
20285381|NCT05330390|Anticonvulsants|anticonvulsants|mesh-ancestor
20285382|NCT05330390|Nootropic Agents|nootropic agents|mesh-ancestor
20285383|NCT05330377|Cytarabine|cytarabine|mesh-list
20285384|NCT05330377|Mitoxantrone|mitoxantrone|mesh-list
20285385|NCT05330377|Cladribine|cladribine|mesh-list
20285386|NCT05330377|Lenograstim|lenograstim|mesh-list
19965372|NCT04005079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19965373|NCT04005079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965374|NCT04005079|Autonomic Agents|autonomic agents|mesh-ancestor
19965375|NCT04005079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965376|NCT04005079|Miotics|miotics|mesh-ancestor
19965377|NCT04005079|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19965378|NCT04005079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19965379|NCT04005079|Cholinergic Agents|cholinergic agents|mesh-ancestor
19965380|NCT04005079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19965381|NCT04005079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965382|NCT04005079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19965383|NCT04005079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19965384|NCT04005079|Renal Agents|renal agents|mesh-ancestor
19965385|NCT04005079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19965386|NCT04005079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19965387|NCT04005079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19965388|NCT04005079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965389|NCT04005079|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19965390|NCT04005079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19965391|NCT04004611|Mirikizumab|mirikizumab|mesh-list
19965392|NCT04004611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19965393|NCT04004611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20285387|NCT05330377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20285388|NCT05330377|Antimetabolites|antimetabolites|mesh-ancestor
20554495|NCT01935596|Levobupivacaine|levobupivacaine|mesh-list
20285389|NCT05330377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285390|NCT05330377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285391|NCT05330377|Antiviral Agents|antiviral agents|mesh-ancestor
20285392|NCT05330377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20285393|NCT05330377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20285394|NCT05330377|Immunologic Factors|immunologic factors|mesh-ancestor
20285395|NCT05330377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285396|NCT05330377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20285397|NCT05330377|Analgesics|analgesics|mesh-ancestor
19965394|NCT04004611|Analgesics|analgesics|mesh-ancestor
19965395|NCT04004611|Sensory System Agents|sensory system agents|mesh-ancestor
19965396|NCT04004611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965397|NCT04004611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965398|NCT04004611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19965399|NCT04004611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19965400|NCT04004611|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19965401|NCT04004611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19965402|NCT03999749|Nivolumab|nivolumab|mesh-list
19965403|NCT03999749|Ipilimumab|ipilimumab|mesh-list
19965404|NCT03999749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20285398|NCT05330377|Sensory System Agents|sensory system agents|mesh-ancestor
20285399|NCT05330377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20285400|NCT05330377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20285401|NCT05330377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20285402|NCT05330377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285403|NCT05330273|Efavirenz|efavirenz|mesh-list
20285404|NCT05330273|Lumefantrine|lumefantrine|mesh-list
20285405|NCT05330273|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20285406|NCT05330273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20285407|NCT05330273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285408|NCT05330273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285409|NCT05330273|Antiviral Agents|antiviral agents|mesh-ancestor
20285410|NCT05330273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20285411|NCT05330273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20285412|NCT05330273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20285413|NCT05330273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20285414|NCT05330273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20285415|NCT05330273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20285416|NCT05330273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20285417|NCT05330273|Antimalarials|antimalarials|mesh-ancestor
20285418|NCT05330273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20285419|NCT05330273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20285420|NCT05330143|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20285421|NCT05330143|Antiviral Agents|antiviral agents|mesh-ancestor
20285422|NCT05330143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20285423|NCT05330130|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20285424|NCT05330130|Hormones|hormones|mesh-ancestor
19965405|NCT03999749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965406|NCT03999749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19965407|NCT03999749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965408|NCT03957304|Dexmedetomidine|dexmedetomidine|mesh-list
19965409|NCT03957304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19965410|NCT03957304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19965411|NCT03957304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965412|NCT03957304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19965413|NCT03957304|Analgesics|analgesics|mesh-ancestor
19965414|NCT03957304|Sensory System Agents|sensory system agents|mesh-ancestor
19965415|NCT03957304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965416|NCT03957304|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19965417|NCT03957304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19965418|NCT03957304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19965419|NCT03957304|Adrenergic Agents|adrenergic agents|mesh-ancestor
19965420|NCT03957304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19965421|NCT03957304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965422|NCT03924791|Dexamethasone|dexamethasone|mesh-list
19965423|NCT03924791|Methylprednisolone|methylprednisolone|mesh-list
19965424|NCT03924791|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19965425|NCT03924791|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19965426|NCT03924791|Prednisolone|prednisolone|mesh-list
19965427|NCT03924791|Prednisolone acetate|prednisolone acetate|mesh-list
19965428|NCT03924791|Lidocaine|lidocaine|mesh-list
19965429|NCT03924791|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20554496|NCT01935596|Anesthetics, Local|anesthetics, local|mesh-ancestor
19965430|NCT03924791|Prednisolone phosphate|prednisolone phosphate|mesh-list
20285425|NCT05330130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20285426|NCT05330130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285427|NCT05330078|Botulinum Toxins|botulinum toxins|mesh-list
20285428|NCT05330078|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20285429|NCT05330078|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20285430|NCT05330078|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20285431|NCT05330078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20285432|NCT05330078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285433|NCT05330078|Cholinergic Agents|cholinergic agents|mesh-ancestor
20285434|NCT05330078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20285435|NCT05330078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285436|NCT05330078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20285437|NCT05330078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20285438|NCT05330065|Bevacizumab|bevacizumab|mesh-list
20285439|NCT05330065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20285440|NCT05330065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285441|NCT05330065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20548488|NCT01900509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20548489|NCT01900509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20548490|NCT01900509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965431|NCT03924791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19965432|NCT03924791|Antiemetics|antiemetics|mesh-ancestor
19965433|NCT03924791|Autonomic Agents|autonomic agents|mesh-ancestor
20548491|NCT01900509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548492|NCT01900509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20548493|NCT01900509|Alkylating Agents|alkylating agents|mesh-ancestor
20548494|NCT01900509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20548495|NCT01900509|Antimetabolites|antimetabolites|mesh-ancestor
20548496|NCT01900587|Tapentadol|tapentadol|mesh-list
20548497|NCT01900587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20548498|NCT01900587|Narcotics|narcotics|mesh-ancestor
20548499|NCT01900587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20548500|NCT01900587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733445|NCT04561739|Analgesics|analgesics|mesh-ancestor
19733446|NCT04561739|Sensory System Agents|sensory system agents|mesh-ancestor
19733447|NCT04561739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733448|NCT04561739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733449|NCT04561739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19733450|NCT04561739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19733451|NCT04561739|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19733452|NCT04561739|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19733453|NCT04561739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19965434|NCT03924791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965435|NCT03924791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965436|NCT03924791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19965437|NCT03924791|Glucocorticoids|glucocorticoids|mesh-ancestor
19965438|NCT03924791|Hormones|hormones|mesh-ancestor
19965439|NCT03924791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19965440|NCT03924791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19965441|NCT03924791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965442|NCT03924791|Anesthetics, Local|anesthetics, local|mesh-ancestor
19965443|NCT03924791|Anesthetics|anesthetics|mesh-ancestor
19965444|NCT03924791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19965445|NCT03924791|Sensory System Agents|sensory system agents|mesh-ancestor
19965446|NCT03924791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19965447|NCT03924791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20285442|NCT05330065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19965448|NCT03924791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19965449|NCT03924791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19965450|NCT03924791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285443|NCT05330065|Growth Substances|growth substances|mesh-ancestor
20285444|NCT05330065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285445|NCT05330065|Growth Inhibitors|growth inhibitors|mesh-ancestor
19965451|NCT03924791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19965452|NCT03924791|Protective Agents|protective agents|mesh-ancestor
19965453|NCT03914443|Cisplatin|cisplatin|mesh-list
19965454|NCT03914443|Docetaxel|docetaxel|mesh-list
19965455|NCT03914443|Fluorouracil|fluorouracil|mesh-list
19965456|NCT03914443|Nivolumab|nivolumab|mesh-list
19965457|NCT03914443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965458|NCT03914443|Tubulin Modulators|tubulin modulators|mesh-ancestor
19965459|NCT03914443|Antimitotic Agents|antimitotic agents|mesh-ancestor
19965460|NCT03914443|Mitosis Modulators|mitosis modulators|mesh-ancestor
19965461|NCT03914443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965462|NCT03914443|Antimetabolites|antimetabolites|mesh-ancestor
19965463|NCT03914443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19965464|NCT03914443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19965465|NCT03914443|Immunologic Factors|immunologic factors|mesh-ancestor
19965466|NCT03914443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965467|NCT03914443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19965468|NCT03914443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19965469|NCT03899103|Mycophenolic Acid|mycophenolic acid|mesh-list
19965470|NCT03899103|Rituximab|rituximab|mesh-list
19965471|NCT03899103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19965472|NCT03899103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965473|NCT03899103|Immunologic Factors|immunologic factors|mesh-ancestor
19965474|NCT03899103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285446|NCT05330000|Voriconazole|voriconazole|mesh-list
20285447|NCT05330000|Antifungal Agents|antifungal agents|mesh-ancestor
20285448|NCT05330000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20285449|NCT05330000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20285450|NCT05330000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20285451|NCT05330000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285452|NCT05330000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285453|NCT05330000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20285454|NCT05330000|Hormone Antagonists|hormone antagonists|mesh-ancestor
20285455|NCT05330000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20285456|NCT05330000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285457|NCT05330000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20285458|NCT05329857|Metformin|metformin|mesh-list
20285459|NCT05329857|Vildagliptin|vildagliptin|mesh-list
20285460|NCT05329857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20285461|NCT05329857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285462|NCT05329857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20285463|NCT05329857|Protease Inhibitors|protease inhibitors|mesh-ancestor
19965475|NCT03899103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19965476|NCT03899103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19965477|NCT03899103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19965478|NCT03899103|Antitubercular Agents|antitubercular agents|mesh-ancestor
19965479|NCT03899103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19965480|NCT03899103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19965481|NCT03899103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285464|NCT05329857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548501|NCT01900587|Analgesics|analgesics|mesh-ancestor
19965482|NCT03899103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965483|NCT03878472|Oxaliplatin|oxaliplatin|mesh-list
19965484|NCT03878472|Apatinib|apatinib|mesh-list
19965485|NCT03878472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965486|NCT03878472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19965487|NCT03878472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965488|NCT03878472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965489|NCT03861871|Fenfluramine|fenfluramine|mesh-list
19965490|NCT03861871|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19965491|NCT03861871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19965492|NCT03861871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19965493|NCT03861871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965494|NCT03861871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19965495|NCT03861871|Serotonin Agents|serotonin agents|mesh-ancestor
20285465|NCT05329857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285466|NCT05329844|Vildagliptin|vildagliptin|mesh-list
20285467|NCT05329844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20285468|NCT05329844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285469|NCT05329844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20285470|NCT05329844|Protease Inhibitors|protease inhibitors|mesh-ancestor
20285471|NCT05329844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285472|NCT05329844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288416|NCT05334004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20288417|NCT05334004|Antiviral Agents|antiviral agents|mesh-ancestor
20288418|NCT05334004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20288419|NCT05334004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20288420|NCT05334004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20288421|NCT05333809|Pembrolizumab|pembrolizumab|mesh-list
20288422|NCT05333809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20288423|NCT05333809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288424|NCT05333744|Prednisone|prednisone|mesh-list
20288425|NCT05333744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20288426|NCT05333744|Glucocorticoids|glucocorticoids|mesh-ancestor
20288427|NCT05333744|Hormones|hormones|mesh-ancestor
20288428|NCT05333744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19965496|NCT03861871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965497|NCT03856216|Rituximab|rituximab|mesh-list
19965498|NCT03856216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20288429|NCT05333744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288430|NCT05333744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20288431|NCT05333744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288432|NCT05333731|Oxytocin|oxytocin|mesh-list
20288433|NCT05333731|Oxytocics|oxytocics|mesh-ancestor
20288434|NCT05333731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20288435|NCT05333731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288436|NCT05333640|Sirolimus|sirolimus|mesh-list
20288437|NCT05333640|Paclitaxel|paclitaxel|mesh-list
20288438|NCT05333640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20288439|NCT05333640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288440|NCT05333640|Tubulin Modulators|tubulin modulators|mesh-ancestor
20288441|NCT05333640|Antimitotic Agents|antimitotic agents|mesh-ancestor
20288442|NCT05333640|Mitosis Modulators|mitosis modulators|mesh-ancestor
20288443|NCT05333640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288444|NCT05333640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20288445|NCT05333640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20288446|NCT05333640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20288447|NCT05333640|Antifungal Agents|antifungal agents|mesh-ancestor
20288448|NCT05333640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20288449|NCT05333640|Immunologic Factors|immunologic factors|mesh-ancestor
20288450|NCT05333640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288451|NCT05333419|Latanoprost|latanoprost|mesh-list
20288452|NCT05333419|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20288453|NCT05333419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20288454|NCT05327647|Bicalutamide|bicalutamide|mesh-list
20288455|NCT05327647|Androgen Antagonists|androgen antagonists|mesh-list
19965499|NCT03856216|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
19965500|NCT03856216|Methotrexate|methotrexate|mesh-list
19965501|NCT03856216|Fludarabine|fludarabine|mesh-list
19965502|NCT03856216|Melphalan|melphalan|mesh-list
19965503|NCT03856216|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19965504|NCT03856216|Mechlorethamine|mechlorethamine|mesh-list
19965505|NCT03856216|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19965506|NCT03856216|Antibodies|antibodies|mesh-list
19965507|NCT03856216|Immunoglobulins|immunoglobulins|mesh-list
19965508|NCT03856216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19965509|NCT03856216|Lenograstim|lenograstim|mesh-list
19965510|NCT03856216|Tacrolimus|tacrolimus|mesh-list
20285473|NCT05329740|Methylprednisolone|methylprednisolone|mesh-list
20285474|NCT05329740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20285475|NCT05329740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20285476|NCT05329740|Prednisolone|prednisolone|mesh-list
19965511|NCT03856216|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19965512|NCT03856216|Immunologic Factors|immunologic factors|mesh-ancestor
19965513|NCT03856216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965514|NCT03856216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965515|NCT03856216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19965516|NCT03856216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19965517|NCT03856216|Abortifacient Agents|abortifacient agents|mesh-ancestor
19965518|NCT03856216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19965519|NCT03856216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19965520|NCT03856216|Antimetabolites|antimetabolites|mesh-ancestor
19965521|NCT03856216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965522|NCT03856216|Dermatologic Agents|dermatologic agents|mesh-ancestor
20285477|NCT05329740|Prednisolone acetate|prednisolone acetate|mesh-list
20285478|NCT05329740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20285479|NCT05329740|Prednisolone phosphate|prednisolone phosphate|mesh-list
20285480|NCT05329740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20285481|NCT05329740|Antiemetics|antiemetics|mesh-ancestor
20285482|NCT05329740|Autonomic Agents|autonomic agents|mesh-ancestor
20285483|NCT05329740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965523|NCT03856216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965524|NCT03856216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19965525|NCT03856216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19965526|NCT03856216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19965527|NCT03856216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19965528|NCT03856216|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19965529|NCT03856216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19965530|NCT03856216|Alkylating Agents|alkylating agents|mesh-ancestor
19965531|NCT03856216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19965532|NCT03856216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20285484|NCT05329740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285485|NCT05329740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20285486|NCT05329740|Glucocorticoids|glucocorticoids|mesh-ancestor
20285487|NCT05329740|Hormones|hormones|mesh-ancestor
20285488|NCT05329740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20285489|NCT05329740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20285490|NCT05329740|Protective Agents|protective agents|mesh-ancestor
20285491|NCT05329740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20285492|NCT05329740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285493|NCT05329454|Ibuprofen|ibuprofen|mesh-list
20285494|NCT05329454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20285495|NCT05329454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20285496|NCT05329454|Analgesics|analgesics|mesh-ancestor
20285497|NCT05329454|Sensory System Agents|sensory system agents|mesh-ancestor
20285498|NCT05329454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20285499|NCT05329454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285500|NCT05329454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20285501|NCT05329454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20285502|NCT05329454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20285503|NCT05329454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285504|NCT05329454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285505|NCT05329428|Vitamin D|vitamin d|mesh-list
20285506|NCT05329428|Ergocalciferols|ergocalciferols|mesh-list
20285507|NCT05329428|Vitamins|vitamins|mesh-list
20285508|NCT05329428|Micronutrients|micronutrients|mesh-ancestor
20285509|NCT05329428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285510|NCT05329428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20285511|NCT05329428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20285512|NCT05327348|Ascorbic Acid|ascorbic acid|mesh-list
20285513|NCT05327348|Antioxidants|antioxidants|mesh-ancestor
20285514|NCT05327348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285515|NCT05327348|Protective Agents|protective agents|mesh-ancestor
20285516|NCT05327348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285517|NCT05327348|Vitamins|vitamins|mesh-ancestor
20548502|NCT01900587|Sensory System Agents|sensory system agents|mesh-ancestor
20548503|NCT01900587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548504|NCT01900587|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20548505|NCT01900587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19965533|NCT03813199|Methotrexate|methotrexate|mesh-list
20285518|NCT05327348|Micronutrients|micronutrients|mesh-ancestor
20285519|NCT05322512|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19965534|NCT03813199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19965535|NCT03813199|Abortifacient Agents|abortifacient agents|mesh-ancestor
19965536|NCT03813199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19965537|NCT03813199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965538|NCT03813199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20285520|NCT05322512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20285521|NCT05322512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965539|NCT03813199|Antimetabolites|antimetabolites|mesh-ancestor
19965540|NCT03813199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285522|NCT05321199|Tranexamic Acid|tranexamic acid|mesh-list
20285523|NCT05321199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20285524|NCT05321199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20285525|NCT05321199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285526|NCT05321199|Hemostatics|hemostatics|mesh-ancestor
20285527|NCT05321199|Coagulants|coagulants|mesh-ancestor
20285528|NCT05320731|Lidocaine|lidocaine|mesh-list
20285529|NCT05320731|Anesthetics, Local|anesthetics, local|mesh-ancestor
20285530|NCT05320731|Anesthetics|anesthetics|mesh-ancestor
20285531|NCT05320731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20285532|NCT05320731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285533|NCT05320731|Sensory System Agents|sensory system agents|mesh-ancestor
20285534|NCT05320731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20285535|NCT05320731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19965541|NCT03813199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965542|NCT03813199|Dermatologic Agents|dermatologic agents|mesh-ancestor
19965543|NCT03813199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965544|NCT03813199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20285536|NCT05320731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20285537|NCT05320731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20285538|NCT05320731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20285539|NCT05320731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285540|NCT05310253|Fludrocortisone|fludrocortisone|mesh-list
20285541|NCT05310253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20285542|NCT05308901|Pembrolizumab|pembrolizumab|mesh-list
20285543|NCT05308901|Lenvatinib|lenvatinib|mesh-list
20285544|NCT05308901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20285545|NCT05308901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285546|NCT05308901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20285547|NCT05308901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285548|NCT05308901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285549|NCT05291403|Erythromycin|erythromycin|mesh-list
20285550|NCT05291403|Erythromycin Estolate|erythromycin estolate|mesh-list
20285551|NCT05291403|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20285552|NCT05291403|Erythromycin stearate|erythromycin stearate|mesh-list
20285553|NCT05291403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20285554|NCT05291403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20285555|NCT05291403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20285556|NCT05291403|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20285557|NCT05291403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285558|NCT05291403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285559|NCT05281510|Vesatolimod|vesatolimod|mesh-list
20285560|NCT05281510|Antiviral Agents|antiviral agents|mesh-ancestor
20285561|NCT05281510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20285562|NCT05267470|Docetaxel|docetaxel|mesh-list
19965545|NCT03813199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19965546|NCT03813199|Immunologic Factors|immunologic factors|mesh-ancestor
19965547|NCT03813199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19965548|NCT03813199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20285563|NCT05267470|Bemarituzumab|bemarituzumab|mesh-list
20285564|NCT05267470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285565|NCT05267470|Tubulin Modulators|tubulin modulators|mesh-ancestor
20285566|NCT05267470|Antimitotic Agents|antimitotic agents|mesh-ancestor
20285567|NCT05267470|Mitosis Modulators|mitosis modulators|mesh-ancestor
20285568|NCT05267470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285569|NCT05267470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20285570|NCT05256381|Pembrolizumab|pembrolizumab|mesh-list
20285571|NCT05256381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20285572|NCT05256381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285573|NCT05244018|Vitamin D|vitamin d|mesh-list
20285574|NCT05244018|Ergocalciferols|ergocalciferols|mesh-list
20285575|NCT05244018|Cholecalciferol|cholecalciferol|mesh-list
19965549|NCT03809234|Ondansetron|ondansetron|mesh-list
19965550|NCT03809234|Antiemetics|antiemetics|mesh-ancestor
19965551|NCT03809234|Autonomic Agents|autonomic agents|mesh-ancestor
19965552|NCT03809234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20285576|NCT05244018|Vitamins|vitamins|mesh-list
20285577|NCT05244018|Micronutrients|micronutrients|mesh-ancestor
20285578|NCT05244018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285579|NCT05244018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20285580|NCT05244018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20285581|NCT05232929|Risdiplam|risdiplam|mesh-list
20285582|NCT05232929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19965553|NCT03809234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965554|NCT03809234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19965555|NCT03809234|Antipruritics|antipruritics|mesh-ancestor
20285583|NCT05232929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20285584|NCT05232929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965556|NCT03809234|Dermatologic Agents|dermatologic agents|mesh-ancestor
19965557|NCT03809234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19965558|NCT03809234|Serotonin Agents|serotonin agents|mesh-ancestor
19965559|NCT03809234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19965560|NCT03809234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965561|NCT03809234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19965562|NCT03809234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19965563|NCT03809234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19965564|NCT03809234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19965565|NCT03809234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19965566|NCT03804580|Osimertinib|osimertinib|mesh-list
19965567|NCT03804580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965568|NCT03804580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19965569|NCT03804580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965570|NCT03804580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965571|NCT03781765|Methylphenidate|methylphenidate|mesh-list
19965572|NCT03781765|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19965573|NCT03781765|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19965574|NCT03781765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965575|NCT03781765|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19965576|NCT03781765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19965577|NCT03781765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19965578|NCT03781765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965579|NCT03781765|Dopamine Agents|dopamine agents|mesh-ancestor
19965580|NCT03781765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19965581|NCT03781765|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20285585|NCT05223673|Trifluridine|trifluridine|mesh-list
20285586|NCT05223673|Antimetabolites|antimetabolites|mesh-ancestor
20285587|NCT05223673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285588|NCT05223673|Antiviral Agents|antiviral agents|mesh-ancestor
20285589|NCT05223673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20285590|NCT05214807|Chitosan|chitosan|mesh-list
20285591|NCT05214807|Hylan|hylan|mesh-list
20285592|NCT05214807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20285593|NCT05214807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20285594|NCT05214807|Antimetabolites|antimetabolites|mesh-ancestor
20285595|NCT05214807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285596|NCT05214807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20285597|NCT05214807|Chelating Agents|chelating agents|mesh-ancestor
20285598|NCT05214807|Sequestering Agents|sequestering agents|mesh-ancestor
20285599|NCT05214807|Hemostatics|hemostatics|mesh-ancestor
19965582|NCT03781765|Adrenergic Agents|adrenergic agents|mesh-ancestor
19965583|NCT03781752|Methylphenidate|methylphenidate|mesh-list
19965584|NCT03781752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19965585|NCT03781752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965586|NCT03781752|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19965587|NCT03781752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19965588|NCT03781752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19965589|NCT03781752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965590|NCT03781752|Dopamine Agents|dopamine agents|mesh-ancestor
19965591|NCT03781752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19965592|NCT03749629|Psychotropic Drugs|psychotropic drugs|mesh-list
19975215|NCT01846507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19975216|NCT01846507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975217|NCT01846507|Hemostatics|hemostatics|mesh-ancestor
19975218|NCT01846507|Coagulants|coagulants|mesh-ancestor
19975219|NCT01846611|Dexamethasone|dexamethasone|mesh-list
19975220|NCT01846611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19975221|NCT01846611|Doxorubicin|doxorubicin|mesh-list
20285600|NCT05214807|Coagulants|coagulants|mesh-ancestor
20285601|NCT05214807|Viscosupplements|viscosupplements|mesh-ancestor
20554497|NCT01935596|Anesthetics|anesthetics|mesh-ancestor
20285602|NCT05214807|Protective Agents|protective agents|mesh-ancestor
19965593|NCT03718065|Lofexidine|lofexidine|mesh-list
19965594|NCT03718065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19965595|NCT03718065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19965596|NCT03718065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965597|NCT03718065|Sensory System Agents|sensory system agents|mesh-ancestor
19965598|NCT03718065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965599|NCT03718065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19965600|NCT03718065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19965601|NCT03718065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20285603|NCT05214807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548506|NCT01900587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20548507|NCT01900587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548508|NCT01900587|Adrenergic Agents|adrenergic agents|mesh-ancestor
20548509|NCT01900587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20548510|NCT01900639|Aspirin|aspirin|mesh-list
20548511|NCT01900639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20548512|NCT01900639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20548513|NCT01900639|Analgesics|analgesics|mesh-ancestor
20548514|NCT01900639|Sensory System Agents|sensory system agents|mesh-ancestor
20548515|NCT01900639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548516|NCT01900639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548517|NCT01900639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20548518|NCT01900639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20548519|NCT01900639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20548520|NCT01900639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20548521|NCT01900639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548522|NCT01900639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20548523|NCT01900639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20548524|NCT01900639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548525|NCT01900639|Antipyretics|antipyretics|mesh-ancestor
20548526|NCT01900717|Leucovorin|leucovorin|mesh-list
20548527|NCT01900717|Bevacizumab|bevacizumab|mesh-list
19965602|NCT03718065|Adrenergic Agents|adrenergic agents|mesh-ancestor
19965603|NCT03718065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19965604|NCT03718065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965605|NCT03714828|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19965606|NCT03714828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19965607|NCT03714828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965608|NCT03711188|Nivolumab|nivolumab|mesh-list
19965609|NCT03711188|Ipilimumab|ipilimumab|mesh-list
19965610|NCT03711188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19965611|NCT03711188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965612|NCT03711188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20548528|NCT01900717|Fluorouracil|fluorouracil|mesh-list
20548529|NCT01900717|Oxaliplatin|oxaliplatin|mesh-list
20548530|NCT01900717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20285604|NCT05188508|Pembrolizumab|pembrolizumab|mesh-list
20285605|NCT05188508|Temozolomide|temozolomide|mesh-list
20285606|NCT05188508|Olaparib|olaparib|mesh-list
20285607|NCT05188508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20285608|NCT05188508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285609|NCT05188508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20285610|NCT05188508|Alkylating Agents|alkylating agents|mesh-ancestor
20285611|NCT05188508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285612|NCT05188508|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20285613|NCT05188508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288456|NCT05327647|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
20288457|NCT05327647|Hormone Antagonists|hormone antagonists|mesh-ancestor
20288458|NCT05327647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20288459|NCT05327647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288460|NCT05327647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288461|NCT05326425|Lazertinib|lazertinib|mesh-list
20288462|NCT05326425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20288463|NCT05326425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288464|NCT05326425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288465|NCT05326360|Ramosetron|ramosetron|mesh-list
20288466|NCT05326360|Antiemetics|antiemetics|mesh-ancestor
20288467|NCT05326360|Autonomic Agents|autonomic agents|mesh-ancestor
20288468|NCT05326360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20288469|NCT05326360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288470|NCT05326360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20548531|NCT01900717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548532|NCT01900717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20285614|NCT05176314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20285615|NCT05176314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20285616|NCT05176314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20285617|NCT05176314|Antimetabolites|antimetabolites|mesh-ancestor
19965613|NCT03711188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965614|NCT03696199|Anesthetics|anesthetics|mesh-list
19965615|NCT03696199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19965616|NCT03696199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965617|NCT03684785|Pembrolizumab|pembrolizumab|mesh-list
19965618|NCT03684785|Cemiplimab|cemiplimab|mesh-list
19965619|NCT03684785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19965620|NCT03684785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965621|NCT03682393|Hydrocortisone|hydrocortisone|mesh-list
19965622|NCT03682393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19965623|NCT03679312|Nitric Oxide|nitric oxide|mesh-list
19965624|NCT03679312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19965625|NCT03679312|Autonomic Agents|autonomic agents|mesh-ancestor
19965626|NCT03679312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965627|NCT03679312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965628|NCT03679312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19965629|NCT03679312|Respiratory System Agents|respiratory system agents|mesh-ancestor
19965630|NCT03679312|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19965631|NCT03679312|Antioxidants|antioxidants|mesh-ancestor
19965632|NCT03679312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965633|NCT03679312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20285618|NCT05176314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285619|NCT05176314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20285620|NCT05176314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20285621|NCT05176314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285622|NCT05142254|Hydroxyurea|hydroxyurea|mesh-list
20285623|NCT05142254|Tadalafil|tadalafil|mesh-list
20285624|NCT05142254|Vasodilator Agents|vasodilator agents|mesh-ancestor
20285625|NCT05142254|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20285626|NCT05142254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20285627|NCT05142254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285628|NCT05142254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285629|NCT05142254|Urological Agents|urological agents|mesh-ancestor
20285630|NCT05142254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965634|NCT03679312|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19965635|NCT03679312|Vasodilator Agents|vasodilator agents|mesh-ancestor
19965636|NCT03679312|Gasotransmitters|gasotransmitters|mesh-ancestor
19965637|NCT03679312|Protective Agents|protective agents|mesh-ancestor
19965638|NCT03654833|Bevacizumab|bevacizumab|mesh-list
19965639|NCT03654833|Pembrolizumab|pembrolizumab|mesh-list
19965640|NCT03654833|Atezolizumab|atezolizumab|mesh-list
19965641|NCT03654833|Niraparib|niraparib|mesh-list
19965642|NCT03654833|Rucaparib|rucaparib|mesh-list
19965643|NCT03654833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19965644|NCT03654833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285631|NCT05142254|Antisickling Agents|antisickling agents|mesh-ancestor
20285632|NCT05142254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20285633|NCT05137717|Maribavir|maribavir|mesh-list
20285634|NCT05137717|Antiviral Agents|antiviral agents|mesh-ancestor
20285635|NCT05137717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20285636|NCT05132595|Ketorolac|ketorolac|mesh-list
20285637|NCT05132595|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20285638|NCT05132595|Esketamine|esketamine|mesh-list
20285639|NCT05132595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20285640|NCT05132595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20285641|NCT05132595|Analgesics|analgesics|mesh-ancestor
20285642|NCT05132595|Sensory System Agents|sensory system agents|mesh-ancestor
20285643|NCT05132595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20285644|NCT05132595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285645|NCT05132595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20285646|NCT05132595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20285647|NCT05132595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20285648|NCT05132595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285649|NCT05132595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285650|NCT05132595|Antidepressive Agents|antidepressive agents|mesh-ancestor
20285651|NCT05132595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20285652|NCT05123703|Ocrelizumab|ocrelizumab|mesh-list
20285653|NCT05123703|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20285654|NCT05123703|Immunologic Factors|immunologic factors|mesh-ancestor
20548533|NCT01900717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19965645|NCT03654833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19975222|NCT01846611|Trabectedin|trabectedin|mesh-list
20285655|NCT05123703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285656|NCT05123703|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20285657|NCT05123703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285658|NCT05123703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20285659|NCT05082909|Probenecid|probenecid|mesh-list
20285660|NCT05082909|Uricosuric Agents|uricosuric agents|mesh-ancestor
20285661|NCT05082909|Gout Suppressants|gout suppressants|mesh-ancestor
20285662|NCT05082909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20285663|NCT05082909|Renal Agents|renal agents|mesh-ancestor
20285664|NCT05069935|Cyclophosphamide|cyclophosphamide|mesh-list
20285665|NCT05069935|Fludarabine|fludarabine|mesh-list
20285666|NCT05069935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20285667|NCT05069935|Antibodies|antibodies|mesh-list
20285668|NCT05069935|Immunoglobulins|immunoglobulins|mesh-list
20285669|NCT05069935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20285670|NCT05069935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20285671|NCT05069935|Immunologic Factors|immunologic factors|mesh-ancestor
20285672|NCT05069935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965646|NCT03654833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19965647|NCT03654833|Growth Substances|growth substances|mesh-ancestor
19965648|NCT03654833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965649|NCT03654833|Growth Inhibitors|growth inhibitors|mesh-ancestor
19965650|NCT03654833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19965651|NCT03654833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965652|NCT03654833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965653|NCT03646175|Choline|choline|mesh-list
19965654|NCT03646175|Lipotropic Agents|lipotropic agents|mesh-ancestor
19965655|NCT03646175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19965656|NCT03646175|Antimetabolites|antimetabolites|mesh-ancestor
19965657|NCT03646175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965658|NCT03646175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19965659|NCT03646175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19965660|NCT03646175|Nootropic Agents|nootropic agents|mesh-ancestor
19965661|NCT03634839|Nicotine|nicotine|mesh-list
19965662|NCT03634839|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19965663|NCT03634839|Autonomic Agents|autonomic agents|mesh-ancestor
19965664|NCT03634839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965665|NCT03634839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965666|NCT03634839|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19965667|NCT03634839|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19965668|NCT03634839|Cholinergic Agents|cholinergic agents|mesh-ancestor
19965669|NCT03634839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20285673|NCT05069935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20285674|NCT05069935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20285675|NCT05069935|Alkylating Agents|alkylating agents|mesh-ancestor
20285676|NCT05069935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285677|NCT05069935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285678|NCT05069935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20285679|NCT05069740|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
20285680|NCT05069740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20285681|NCT05069740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20285682|NCT05069740|Analgesics|analgesics|mesh-ancestor
20285683|NCT05069740|Sensory System Agents|sensory system agents|mesh-ancestor
20285684|NCT05069740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20285685|NCT05069740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285686|NCT05069740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20285687|NCT05069740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20285688|NCT05059626|Bazedoxifene|bazedoxifene|mesh-list
20285689|NCT05059626|Simvastatin|simvastatin|mesh-list
20285690|NCT05059626|Estrogens|estrogens|mesh-list
20285691|NCT05059626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20285692|NCT05059626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20285693|NCT05059626|Antimetabolites|antimetabolites|mesh-ancestor
20285694|NCT05059626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285695|NCT05059626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20285696|NCT05059626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20285697|NCT05059626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285698|NCT05059626|Hormones|hormones|mesh-ancestor
20285699|NCT05059626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20285700|NCT05059626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285701|NCT05059626|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20285702|NCT05059626|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20285703|NCT05059626|Hormone Antagonists|hormone antagonists|mesh-ancestor
20285704|NCT05059626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20285705|NCT05051449|Ketamine|ketamine|mesh-list
20285706|NCT05051449|Analgesics|analgesics|mesh-ancestor
20285707|NCT05051449|Sensory System Agents|sensory system agents|mesh-ancestor
20285708|NCT05051449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20285709|NCT05051449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285710|NCT05051449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20285711|NCT05051449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20285712|NCT05051449|Anesthetics, General|anesthetics, general|mesh-ancestor
20285713|NCT05051449|Anesthetics|anesthetics|mesh-ancestor
20285714|NCT05051449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20285715|NCT05051449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20285716|NCT05051449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20285717|NCT05051449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20285718|NCT05051449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285719|NCT05009069|Fluorouracil|fluorouracil|mesh-list
20285720|NCT05009069|Capecitabine|capecitabine|mesh-list
20285721|NCT05009069|Atezolizumab|atezolizumab|mesh-list
20285722|NCT05009069|Antimetabolites|antimetabolites|mesh-ancestor
20285723|NCT05009069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285724|NCT05009069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20285725|NCT05009069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285726|NCT05009069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19965670|NCT03634839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965671|NCT03573921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19965672|NCT03552471|Rucaparib|rucaparib|mesh-list
19965673|NCT03552471|Maytansine|maytansine|mesh-list
19965674|NCT03552471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19965675|NCT03552471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965676|NCT03552471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965677|NCT03552471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965678|NCT03552471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19965679|NCT03552471|Tubulin Modulators|tubulin modulators|mesh-ancestor
19965680|NCT03552471|Antimitotic Agents|antimitotic agents|mesh-ancestor
19965681|NCT03552471|Mitosis Modulators|mitosis modulators|mesh-ancestor
19965682|NCT03535506|Palbociclib|palbociclib|mesh-list
19965683|NCT03535506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965684|NCT03535506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19965685|NCT03535506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965686|NCT03535506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965687|NCT03527108|Nivolumab|nivolumab|mesh-list
19965688|NCT03527108|Ramucirumab|ramucirumab|mesh-list
19965689|NCT03527108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19965690|NCT03527108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285727|NCT05009069|Immunologic Factors|immunologic factors|mesh-ancestor
20285728|NCT05009069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285729|NCT05005273|Nivolumab|nivolumab|mesh-list
20285730|NCT05005273|Ipilimumab|ipilimumab|mesh-list
20285731|NCT05005273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19965691|NCT03527108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20285732|NCT05005273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285733|NCT05005273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20285734|NCT05005273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285735|NCT04998812|Ocrelizumab|ocrelizumab|mesh-list
20285736|NCT04998812|Immunologic Factors|immunologic factors|mesh-ancestor
20285737|NCT04998812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285738|NCT04981041|Clopidogrel|clopidogrel|mesh-list
20285739|NCT04981041|Ticagrelor|ticagrelor|mesh-list
20285740|NCT04981041|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20285741|NCT04981041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20285742|NCT04981041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20285743|NCT04981041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20285744|NCT04981041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20285745|NCT04981041|Purinergic Agents|purinergic agents|mesh-ancestor
20285746|NCT04981041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20285747|NCT04981041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285748|NCT04981041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285749|NCT04967508|Ustekinumab|ustekinumab|mesh-list
20285750|NCT04967508|Dermatologic Agents|dermatologic agents|mesh-ancestor
20285751|NCT04965714|Nivolumab|nivolumab|mesh-list
20285752|NCT04965714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20285753|NCT04965714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285754|NCT04965714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20285755|NCT04965714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285756|NCT04963036|Anesthetics|anesthetics|mesh-list
20285757|NCT04963036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20285758|NCT04963036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285759|NCT04939467|Pirfenidone|pirfenidone|mesh-list
20285760|NCT04939467|Nintedanib|nintedanib|mesh-list
20285761|NCT04939467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285762|NCT04939467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20285763|NCT04939467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285764|NCT04939467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285765|NCT04939467|Analgesics|analgesics|mesh-ancestor
20285766|NCT04939467|Sensory System Agents|sensory system agents|mesh-ancestor
20285767|NCT04939467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965692|NCT03527108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965693|NCT03516305|Alprazolam|alprazolam|mesh-list
19965694|NCT03516305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19965695|NCT03516305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19965696|NCT03516305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285768|NCT04939467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285769|NCT04939467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20285770|NCT04939467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20285771|NCT04939467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20285772|NCT04939467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20285773|NCT04938232|Nivolumab|nivolumab|mesh-list
20285774|NCT04938232|Ipilimumab|ipilimumab|mesh-list
20285775|NCT04938232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20285776|NCT04938232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285777|NCT04938232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20285778|NCT04938232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285779|NCT04928222|Doxorubicin|doxorubicin|mesh-list
20285780|NCT04928222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20285781|NCT04928222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285782|NCT04928222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20285783|NCT04928222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20285784|NCT04928222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285785|NCT04928222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285786|NCT04908605|Melatonin|melatonin|mesh-list
20285787|NCT04908605|Mirtazapine|mirtazapine|mesh-list
20285788|NCT04908605|Antioxidants|antioxidants|mesh-ancestor
20285789|NCT04908605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965697|NCT03516305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19965698|NCT03516305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19965699|NCT03516305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19965700|NCT03516305|GABA Modulators|gaba modulators|mesh-ancestor
19965701|NCT03516305|GABA Agents|gaba agents|mesh-ancestor
19965702|NCT03516305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19965703|NCT03516305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965704|NCT03499483|Tenofovir|tenofovir|mesh-list
19450392|NCT03428633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19450393|NCT03428633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450394|NCT03428633|Analgesics|analgesics|mesh-ancestor
19450395|NCT03428633|Sensory System Agents|sensory system agents|mesh-ancestor
19450396|NCT03428633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965705|NCT03499483|Emtricitabine|emtricitabine|mesh-list
19965706|NCT03499483|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19965707|NCT03499483|Antiviral Agents|antiviral agents|mesh-ancestor
19965708|NCT03499483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20285790|NCT04908605|Protective Agents|protective agents|mesh-ancestor
20285791|NCT04908605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285792|NCT04908605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20285793|NCT04908605|Antidepressive Agents|antidepressive agents|mesh-ancestor
20285794|NCT04908605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20285795|NCT04908605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20285796|NCT04908605|Histamine Antagonists|histamine antagonists|mesh-ancestor
20285797|NCT04908605|Histamine Agents|histamine agents|mesh-ancestor
20285798|NCT04908605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20285799|NCT04908605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20285800|NCT04908605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20285801|NCT04908605|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20285802|NCT04908605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20285803|NCT04908605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20285804|NCT04908605|Adrenergic Agents|adrenergic agents|mesh-ancestor
20285805|NCT04908605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20548534|NCT01900717|Growth Substances|growth substances|mesh-ancestor
19450397|NCT03428633|Anesthetics, Local|anesthetics, local|mesh-ancestor
19965709|NCT03499483|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20285806|NCT04908605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20285807|NCT04908605|Serotonin Agents|serotonin agents|mesh-ancestor
20285808|NCT04908605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20285809|NCT04901689|Leronlimab|leronlimab|mesh-list
20285810|NCT04901689|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20285811|NCT04901689|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20285812|NCT04901689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285813|NCT04901689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20285814|NCT04901689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20285815|NCT04901689|Antiviral Agents|antiviral agents|mesh-ancestor
20285816|NCT04901689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20285817|NCT04901676|Leronlimab|leronlimab|mesh-list
20285818|NCT04901676|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20285819|NCT04901676|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20285820|NCT04901676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285821|NCT04901676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20285822|NCT04901676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20285823|NCT04901676|Antiviral Agents|antiviral agents|mesh-ancestor
20285824|NCT04901676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20285825|NCT04895046|Niraparib|niraparib|mesh-list
20285826|NCT04895046|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20285827|NCT04895046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285828|NCT04895046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285829|NCT04895046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285830|NCT04879225|Menthol|menthol|mesh-list
20285831|NCT04879225|Antipruritics|antipruritics|mesh-ancestor
20285832|NCT04879225|Dermatologic Agents|dermatologic agents|mesh-ancestor
20285833|NCT04871594|Nivolumab|nivolumab|mesh-list
20285834|NCT04871594|Ipilimumab|ipilimumab|mesh-list
20285835|NCT04871594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20285836|NCT04871594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285837|NCT04871594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20285838|NCT04871594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285839|NCT04871412|Vitamin D|vitamin d|mesh-list
20285840|NCT04871412|Ergocalciferols|ergocalciferols|mesh-list
20285841|NCT04871412|Vitamins|vitamins|mesh-list
20285842|NCT04871412|Curcumin|curcumin|mesh-list
20285843|NCT04871412|Micronutrients|micronutrients|mesh-ancestor
20285844|NCT04871412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285845|NCT04871412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20285846|NCT04871412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20285847|NCT04871412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20285848|NCT04871412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20285849|NCT04871412|Analgesics|analgesics|mesh-ancestor
20285850|NCT04871412|Sensory System Agents|sensory system agents|mesh-ancestor
20285851|NCT04871412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20285852|NCT04871412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20285853|NCT04871412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20285854|NCT04871412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285855|NCT04871412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285856|NCT04871412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288471|NCT05326360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20288472|NCT05326360|Serotonin Agents|serotonin agents|mesh-ancestor
20288473|NCT05326360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20288474|NCT05326360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288475|NCT05325853|Proxymetacaine|proxymetacaine|mesh-list
20288476|NCT05325853|Propoxycaine|propoxycaine|mesh-list
20288477|NCT05325853|Anesthetics, Local|anesthetics, local|mesh-ancestor
20288478|NCT05325853|Anesthetics|anesthetics|mesh-ancestor
20288479|NCT05325853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20288480|NCT05325853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288481|NCT05325853|Sensory System Agents|sensory system agents|mesh-ancestor
20288482|NCT05325853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20288483|NCT05325164|Morphine|morphine|mesh-list
20288484|NCT05325164|Methadone|methadone|mesh-list
20288485|NCT05325164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20288486|NCT05325164|Narcotics|narcotics|mesh-ancestor
20288487|NCT05325164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20288488|NCT05325164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288489|NCT05325164|Analgesics|analgesics|mesh-ancestor
20288490|NCT05325164|Sensory System Agents|sensory system agents|mesh-ancestor
20288491|NCT05325164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20288492|NCT05325164|Antitussive Agents|antitussive agents|mesh-ancestor
20288493|NCT05325164|Respiratory System Agents|respiratory system agents|mesh-ancestor
20288494|NCT05324059|Pregabalin|pregabalin|mesh-list
20288495|NCT05324059|Tramadol|tramadol|mesh-list
20285857|NCT04833140|Estradiol|estradiol|mesh-list
20285858|NCT04833140|Estrogens|estrogens|mesh-ancestor
20285859|NCT04833140|Hormones|hormones|mesh-ancestor
20285860|NCT04833140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20285861|NCT04833140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285862|NCT04810078|Nivolumab|nivolumab|mesh-list
19965710|NCT03499483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19965711|NCT03499483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965712|NCT03499483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965713|NCT03499483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19965714|NCT03499483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19965715|NCT03494530|Edoxaban|edoxaban|mesh-list
19965716|NCT03494530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19965717|NCT03494530|Antithrombins|antithrombins|mesh-ancestor
19965718|NCT03494530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19965719|NCT03494530|Protease Inhibitors|protease inhibitors|mesh-ancestor
20285863|NCT04810078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20285864|NCT04810078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285865|NCT04810078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20285866|NCT04810078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285867|NCT04808934|Rivaroxaban|rivaroxaban|mesh-list
20285868|NCT04808934|Apixaban|apixaban|mesh-list
20285869|NCT04808934|Dabigatran|dabigatran|mesh-list
20285870|NCT04808934|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20285871|NCT04808934|Antithrombins|antithrombins|mesh-ancestor
20285872|NCT04808934|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20285873|NCT04808934|Protease Inhibitors|protease inhibitors|mesh-ancestor
20285874|NCT04808934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285875|NCT04808934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285876|NCT04808934|Anticoagulants|anticoagulants|mesh-ancestor
20285877|NCT04786548|Celecoxib|celecoxib|mesh-list
20285878|NCT04786548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20285879|NCT04786548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20285880|NCT04786548|Analgesics|analgesics|mesh-ancestor
20285881|NCT04786548|Sensory System Agents|sensory system agents|mesh-ancestor
20285882|NCT04786548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20285883|NCT04786548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285884|NCT04786548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20285885|NCT04786548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19965720|NCT03494530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965721|NCT03494530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965722|NCT03494530|Anticoagulants|anticoagulants|mesh-ancestor
19965723|NCT03478956|Etrolizumab|etrolizumab|mesh-list
19965724|NCT03478956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19965725|NCT03478956|Immunologic Factors|immunologic factors|mesh-ancestor
19965726|NCT03478956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965727|NCT03453489|Tryptophan|tryptophan|mesh-list
19965728|NCT03453489|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19965729|NCT03453489|Antidepressive Agents|antidepressive agents|mesh-ancestor
19965730|NCT03453489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20285886|NCT04786548|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20285887|NCT04786548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20285888|NCT04786548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285889|NCT04786548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285890|NCT04786275|Fentanyl|fentanyl|mesh-list
20285891|NCT04786275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20285892|NCT04786275|Narcotics|narcotics|mesh-ancestor
20285893|NCT04786275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20285894|NCT04786275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285895|NCT04786275|Analgesics|analgesics|mesh-ancestor
20285896|NCT04786275|Sensory System Agents|sensory system agents|mesh-ancestor
20285897|NCT04786275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20285898|NCT04786275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20285899|NCT04786275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20285900|NCT04786275|Anesthetics, General|anesthetics, general|mesh-ancestor
20285901|NCT04786275|Anesthetics|anesthetics|mesh-ancestor
20285902|NCT04785651|Tranexamic Acid|tranexamic acid|mesh-list
20285903|NCT04785651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20285904|NCT04785651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20285905|NCT04785651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285906|NCT04785651|Hemostatics|hemostatics|mesh-ancestor
20285907|NCT04785651|Coagulants|coagulants|mesh-ancestor
20285908|NCT04745832|Prednisone|prednisone|mesh-list
19965731|NCT03399292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19965732|NCT03399292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20285909|NCT04745832|Cyclophosphamide|cyclophosphamide|mesh-list
20285910|NCT04745832|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20285911|NCT04745832|Rituximab|rituximab|mesh-list
20285912|NCT04745832|Vincristine|vincristine|mesh-list
20285913|NCT04745832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20285914|NCT04745832|Immunologic Factors|immunologic factors|mesh-ancestor
20285915|NCT04745832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285916|NCT04745832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20285917|NCT04745832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20285918|NCT04745832|Alkylating Agents|alkylating agents|mesh-ancestor
20285919|NCT04745832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285920|NCT04745832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285921|NCT04745832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20285922|NCT04745832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20285923|NCT04745832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20285924|NCT04745832|Glucocorticoids|glucocorticoids|mesh-ancestor
20285925|NCT04745832|Hormones|hormones|mesh-ancestor
20285926|NCT04745832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20285927|NCT04745832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20285928|NCT04745832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20285929|NCT04745832|Tubulin Modulators|tubulin modulators|mesh-ancestor
20285930|NCT04745832|Antimitotic Agents|antimitotic agents|mesh-ancestor
20285931|NCT04745832|Mitosis Modulators|mitosis modulators|mesh-ancestor
20285932|NCT04721548|Minoxidil|minoxidil|mesh-list
20285933|NCT04721548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20285934|NCT04721548|Vasodilator Agents|vasodilator agents|mesh-ancestor
20285935|NCT04675866|Paclitaxel|paclitaxel|mesh-list
20285936|NCT04675866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20285937|NCT04675866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20285938|NCT04675866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285939|NCT04675866|Tubulin Modulators|tubulin modulators|mesh-ancestor
20285940|NCT04675866|Antimitotic Agents|antimitotic agents|mesh-ancestor
20285941|NCT04675866|Mitosis Modulators|mitosis modulators|mesh-ancestor
20285942|NCT04675866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285943|NCT04666740|Pembrolizumab|pembrolizumab|mesh-list
20285944|NCT04666740|Olaparib|olaparib|mesh-list
20285945|NCT04666740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20285946|NCT04666740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285947|NCT04666740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20285948|NCT04666740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285949|NCT04666740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285950|NCT04657081|Decitabine|decitabine|mesh-list
20285951|NCT04657081|Venetoclax|venetoclax|mesh-list
20285952|NCT04657081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19965733|NCT03356860|Paclitaxel|paclitaxel|mesh-list
19965734|NCT03356860|Cyclophosphamide|cyclophosphamide|mesh-list
19965735|NCT03356860|Durvalumab|durvalumab|mesh-list
20285953|NCT04657081|Antimetabolites|antimetabolites|mesh-ancestor
20285954|NCT04657081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965736|NCT03356860|Epirubicin|epirubicin|mesh-list
19965737|NCT03356860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19965738|NCT03356860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965739|NCT03356860|Tubulin Modulators|tubulin modulators|mesh-ancestor
19965740|NCT03356860|Antimitotic Agents|antimitotic agents|mesh-ancestor
19965741|NCT03356860|Mitosis Modulators|mitosis modulators|mesh-ancestor
19965742|NCT03356860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965743|NCT03356860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19965744|NCT03356860|Immunologic Factors|immunologic factors|mesh-ancestor
19965745|NCT03356860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965746|NCT03356860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19965747|NCT03356860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19965748|NCT03356860|Alkylating Agents|alkylating agents|mesh-ancestor
19965749|NCT03356860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19965750|NCT03356860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19965751|NCT03356860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19965752|NCT03356860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19965753|NCT03356860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19965754|NCT03356860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965755|NCT03348930|Tolcapone|tolcapone|mesh-list
19965756|NCT03348930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20285955|NCT04657081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285956|NCT04657081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20285957|NCT04639219|Trastuzumab|trastuzumab|mesh-list
20285958|NCT04639219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19965757|NCT03348930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20285959|NCT04639219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20285960|NCT04623944|Cytarabine|cytarabine|mesh-list
19965758|NCT03348930|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19965759|NCT03348930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965760|NCT03348930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965761|NCT03336216|Leucovorin|leucovorin|mesh-list
19965762|NCT03336216|Gemcitabine|gemcitabine|mesh-list
19965763|NCT03336216|Paclitaxel|paclitaxel|mesh-list
19965764|NCT03336216|Fluorouracil|fluorouracil|mesh-list
19965765|NCT03336216|Oxaliplatin|oxaliplatin|mesh-list
19965766|NCT03336216|Nivolumab|nivolumab|mesh-list
19965767|NCT03336216|Irinotecan|irinotecan|mesh-list
19965768|NCT03336216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19965769|NCT03336216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965770|NCT03336216|Tubulin Modulators|tubulin modulators|mesh-ancestor
19965771|NCT03336216|Antimitotic Agents|antimitotic agents|mesh-ancestor
19965772|NCT03336216|Mitosis Modulators|mitosis modulators|mesh-ancestor
19965773|NCT03336216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965774|NCT03336216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19965775|NCT03336216|Antimetabolites|antimetabolites|mesh-ancestor
19965776|NCT03336216|Antiviral Agents|antiviral agents|mesh-ancestor
19965777|NCT03336216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19965778|NCT03336216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965779|NCT03336216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19965780|NCT03336216|Immunologic Factors|immunologic factors|mesh-ancestor
20285961|NCT04623944|Cyclophosphamide|cyclophosphamide|mesh-list
20285962|NCT04623944|Fludarabine|fludarabine|mesh-list
20285963|NCT04623944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20285964|NCT04623944|Immunologic Factors|immunologic factors|mesh-ancestor
20285965|NCT04623944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285966|NCT04623944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20285967|NCT04623944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20285968|NCT04623944|Alkylating Agents|alkylating agents|mesh-ancestor
20285969|NCT04623944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285970|NCT04623944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450398|NCT03428633|Anesthetics|anesthetics|mesh-ancestor
20548535|NCT01900717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548536|NCT01900717|Growth Inhibitors|growth inhibitors|mesh-ancestor
20548537|NCT01900717|Antimetabolites|antimetabolites|mesh-ancestor
20548538|NCT01900717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548539|NCT01900717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20548540|NCT01900717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20548541|NCT01900717|Immunologic Factors|immunologic factors|mesh-ancestor
20548542|NCT01900717|Antidotes|antidotes|mesh-ancestor
20548543|NCT01900717|Protective Agents|protective agents|mesh-ancestor
20548544|NCT01900717|Vitamin B Complex|vitamin b complex|mesh-ancestor
20548545|NCT01900717|Vitamins|vitamins|mesh-ancestor
20548546|NCT01900717|Micronutrients|micronutrients|mesh-ancestor
20548547|NCT01900795|Ibuprofen|ibuprofen|mesh-list
20548548|NCT01900795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20548549|NCT01900795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20548550|NCT01900795|Analgesics|analgesics|mesh-ancestor
20548551|NCT01900795|Sensory System Agents|sensory system agents|mesh-ancestor
20548552|NCT01900795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548553|NCT01900795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548554|NCT01900795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20548555|NCT01900795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20548556|NCT01900795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20548557|NCT01900795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548558|NCT01900795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548559|NCT01900847|Ketamine|ketamine|mesh-list
20548560|NCT01900847|Morphine|morphine|mesh-list
20548561|NCT01900847|Analgesics|analgesics|mesh-ancestor
20548562|NCT01900847|Sensory System Agents|sensory system agents|mesh-ancestor
20548563|NCT01900847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548564|NCT01900847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548565|NCT01900847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20548566|NCT01900847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20548567|NCT01900847|Anesthetics, General|anesthetics, general|mesh-ancestor
20548568|NCT01900847|Anesthetics|anesthetics|mesh-ancestor
20548569|NCT01900847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20548570|NCT01900847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20548571|NCT01900847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20548572|NCT01900847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20548573|NCT01900847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450399|NCT03428607|Olaparib|olaparib|mesh-list
19965781|NCT03336216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965782|NCT03336216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19965783|NCT03336216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19965784|NCT03336216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19965785|NCT03336216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19965786|NCT03336216|Antidotes|antidotes|mesh-ancestor
19965787|NCT03336216|Protective Agents|protective agents|mesh-ancestor
19965788|NCT03336216|Vitamin B Complex|vitamin b complex|mesh-ancestor
19965789|NCT03336216|Vitamins|vitamins|mesh-ancestor
19965790|NCT03336216|Micronutrients|micronutrients|mesh-ancestor
20285971|NCT04623944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20285972|NCT04623944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20285973|NCT04623944|Antimetabolites|antimetabolites|mesh-ancestor
20285974|NCT04623944|Antiviral Agents|antiviral agents|mesh-ancestor
20285975|NCT04623944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20285976|NCT04620759|Psilocybin|psilocybin|mesh-list
20285977|NCT04620759|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
20285978|NCT04620759|Hallucinogens|hallucinogens|mesh-ancestor
20285979|NCT04620759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20285980|NCT04620759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20285981|NCT04620759|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20285982|NCT04620759|Serotonin Agents|serotonin agents|mesh-ancestor
20285983|NCT04620759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20285984|NCT04620759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285985|NCT04620759|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20285986|NCT04612790|Benralizumab|benralizumab|mesh-list
20285987|NCT04612790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20285988|NCT04612790|Respiratory System Agents|respiratory system agents|mesh-ancestor
20285989|NCT04607460|Coal Tar|coal tar|mesh-list
20285990|NCT04607460|Keratolytic Agents|keratolytic agents|mesh-ancestor
20548574|NCT01900847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20548575|NCT01900847|Narcotics|narcotics|mesh-ancestor
20548576|NCT01900860|Vitamin D|vitamin d|mesh-list
20548577|NCT01900860|Ergocalciferols|ergocalciferols|mesh-list
20548578|NCT01900860|Cholecalciferol|cholecalciferol|mesh-list
20548579|NCT01900860|Vitamins|vitamins|mesh-list
20548580|NCT01900860|Micronutrients|micronutrients|mesh-ancestor
20548581|NCT01900860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548582|NCT01900860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20548583|NCT01900860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20548584|NCT01900886|Ribavirin|ribavirin|mesh-list
20548585|NCT01900886|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20548586|NCT01900886|Antimetabolites|antimetabolites|mesh-ancestor
20548587|NCT01900886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548588|NCT01900886|Antiviral Agents|antiviral agents|mesh-ancestor
20548589|NCT01900886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548590|NCT01900938|Midazolam|midazolam|mesh-list
20548591|NCT01900938|Propofol|propofol|mesh-list
20548592|NCT01900938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20548593|NCT01900938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20548594|NCT01900938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548595|NCT01900938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20548596|NCT01900938|Anesthetics, General|anesthetics, general|mesh-ancestor
20548597|NCT01900938|Anesthetics|anesthetics|mesh-ancestor
19965791|NCT03290391|Naltrexone|naltrexone|mesh-list
19965792|NCT03290391|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19965793|NCT03290391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19965794|NCT03290391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548598|NCT01900938|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20548599|NCT01900938|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20548600|NCT01900938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20548601|NCT01900938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20548602|NCT01900938|GABA Modulators|gaba modulators|mesh-ancestor
20548603|NCT01900938|GABA Agents|gaba agents|mesh-ancestor
20548604|NCT01900938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19965795|NCT03290391|Sensory System Agents|sensory system agents|mesh-ancestor
19965796|NCT03290391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965797|NCT03282240|Vaccines|vaccines|mesh-list
19965798|NCT03282240|Immunologic Factors|immunologic factors|mesh-ancestor
19965799|NCT03282240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965800|NCT03263429|Irinotecan|irinotecan|mesh-list
19965801|NCT03263429|Panitumumab|panitumumab|mesh-list
19965802|NCT03263429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20548605|NCT01900938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548606|NCT01900951|Temozolomide|temozolomide|mesh-list
20548607|NCT01900951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19965803|NCT03263429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20285991|NCT04607460|Dermatologic Agents|dermatologic agents|mesh-ancestor
20548608|NCT01900951|Alkylating Agents|alkylating agents|mesh-ancestor
19965804|NCT03263429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965805|NCT03263429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965806|NCT03263429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965807|NCT03263429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19965808|NCT03260868|Insulin|insulin|mesh-list
19965809|NCT03260868|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19965810|NCT03260868|Insulin Glargine|insulin glargine|mesh-list
19965811|NCT03260868|Insulin Lispro|insulin lispro|mesh-list
19965812|NCT03260868|Insulin Aspart|insulin aspart|mesh-list
19965813|NCT03260868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19965814|NCT03260868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965815|NCT03244020|Aspirin|aspirin|mesh-list
19965816|NCT03244020|Enoxaparin|enoxaparin|mesh-list
19965817|NCT03244020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20285992|NCT04605978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20285993|NCT04592991|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
20285994|NCT04592991|Chelating Agents|chelating agents|mesh-ancestor
20285995|NCT04592991|Sequestering Agents|sequestering agents|mesh-ancestor
20285996|NCT04592991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20285997|NCT04562090|Mirabegron|mirabegron|mesh-list
20285998|NCT04562090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20285999|NCT04562090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20286000|NCT04562090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20286001|NCT04562090|Adrenergic Agents|adrenergic agents|mesh-ancestor
20286002|NCT04562090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20286003|NCT04562090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286004|NCT04562090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286005|NCT04562090|Urological Agents|urological agents|mesh-ancestor
20286006|NCT04559906|Ethyl Chloride|ethyl chloride|mesh-list
20286007|NCT04559906|Anesthetics, Local|anesthetics, local|mesh-ancestor
20286008|NCT04559906|Anesthetics|anesthetics|mesh-ancestor
20286009|NCT04559906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20286010|NCT04559906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286011|NCT04559906|Sensory System Agents|sensory system agents|mesh-ancestor
20286012|NCT04559906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20286013|NCT04554485|Blinatumomab|blinatumomab|mesh-list
20286014|NCT04554485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286015|NCT04554459|Ponatinib|ponatinib|mesh-list
20286016|NCT04554459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286017|NCT04554459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20286018|NCT04554459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286019|NCT04554459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286020|NCT04536298|Vitamin D|vitamin d|mesh-list
20286021|NCT04536298|Ergocalciferols|ergocalciferols|mesh-list
20286022|NCT04536298|Cholecalciferol|cholecalciferol|mesh-list
20286023|NCT04536298|Vitamins|vitamins|mesh-list
20286024|NCT04536298|Micronutrients|micronutrients|mesh-ancestor
20286025|NCT04536298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286026|NCT04536298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20286027|NCT04536298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19965818|NCT03244020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19965819|NCT03244020|Analgesics|analgesics|mesh-ancestor
19965820|NCT03244020|Sensory System Agents|sensory system agents|mesh-ancestor
19965821|NCT03244020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965822|NCT03244020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965823|NCT03244020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19965824|NCT03244020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19965825|NCT03244020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19965826|NCT03244020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19965827|NCT03244020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965828|NCT03244020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19965829|NCT03244020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19965830|NCT03244020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965831|NCT03244020|Antipyretics|antipyretics|mesh-ancestor
19965832|NCT03244020|Anticoagulants|anticoagulants|mesh-ancestor
19965833|NCT03211286|Tranexamic Acid|tranexamic acid|mesh-list
19965834|NCT03211286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19965835|NCT03211286|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19965836|NCT03211286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19965837|NCT03211286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965838|NCT03211286|Hemostatics|hemostatics|mesh-ancestor
20286028|NCT04524130|Lidocaine|lidocaine|mesh-list
20286029|NCT04524130|Ketamine|ketamine|mesh-list
20286030|NCT04524130|Anesthetics, Local|anesthetics, local|mesh-ancestor
20286031|NCT04524130|Anesthetics|anesthetics|mesh-ancestor
19965839|NCT03211286|Coagulants|coagulants|mesh-ancestor
20286032|NCT04524130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20286033|NCT04524130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286034|NCT04524130|Sensory System Agents|sensory system agents|mesh-ancestor
20286035|NCT04524130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20286036|NCT04524130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20286037|NCT04524130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20286038|NCT04524130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20286039|NCT04524130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20286040|NCT04524130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286041|NCT04524130|Analgesics|analgesics|mesh-ancestor
20286042|NCT04524130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20286043|NCT04524130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20286044|NCT04524130|Anesthetics, General|anesthetics, general|mesh-ancestor
20286045|NCT04524130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20286046|NCT04524130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20286047|NCT04524130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20286048|NCT04484532|Vaccines|vaccines|mesh-list
20286049|NCT04484532|Immunologic Factors|immunologic factors|mesh-ancestor
19965840|NCT03164616|Gemcitabine|gemcitabine|mesh-list
19965841|NCT03164616|Cisplatin|cisplatin|mesh-list
19965842|NCT03164616|Carboplatin|carboplatin|mesh-list
19965843|NCT03164616|Pemetrexed|pemetrexed|mesh-list
19965844|NCT03164616|Durvalumab|durvalumab|mesh-list
19965845|NCT03164616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19965846|NCT03164616|Tremelimumab|tremelimumab|mesh-list
20286050|NCT04484532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286051|NCT04479436|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
20286052|NCT04479436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20286053|NCT04479436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286054|NCT04475432|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20286055|NCT04475432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20286056|NCT04472637|Atorvastatin|atorvastatin|mesh-list
20286057|NCT04472637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20286058|NCT04472637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20286059|NCT04472637|Antimetabolites|antimetabolites|mesh-ancestor
20286060|NCT04472637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286061|NCT04472637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20286062|NCT04472637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20548609|NCT01900951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548610|NCT01900951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548611|NCT01901003|Lorazepam|lorazepam|mesh-list
20548612|NCT01901003|Anticonvulsants|anticonvulsants|mesh-ancestor
20548613|NCT01901003|Antiemetics|antiemetics|mesh-ancestor
20548614|NCT01901003|Autonomic Agents|autonomic agents|mesh-ancestor
20548615|NCT01901003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548616|NCT01901003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548617|NCT01901003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20548618|NCT01901003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20548619|NCT01901003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20548620|NCT01901003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20548621|NCT01901003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20548622|NCT01901003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20548623|NCT01901003|GABA Modulators|gaba modulators|mesh-ancestor
20548624|NCT01901003|GABA Agents|gaba agents|mesh-ancestor
20548625|NCT01901003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20548626|NCT01901003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548627|NCT01901120|Mirabegron|mirabegron|mesh-list
20548628|NCT01901120|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20548629|NCT01901120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20548630|NCT01901120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20548631|NCT01901120|Adrenergic Agents|adrenergic agents|mesh-ancestor
20548632|NCT01901120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20548633|NCT01901120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548634|NCT01901120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548635|NCT01901120|Urological Agents|urological agents|mesh-ancestor
20548636|NCT01901172|Posaconazole|posaconazole|mesh-list
20548637|NCT01901172|Antifungal Agents|antifungal agents|mesh-ancestor
20548638|NCT01901172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548639|NCT01901172|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20548640|NCT01901172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20548641|NCT01901172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20548642|NCT01901172|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20548643|NCT01901172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20548644|NCT01901172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965847|NCT03164616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286063|NCT04472637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286064|NCT04450329|Aflibercept|aflibercept|mesh-list
20286065|NCT04450329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20286066|NCT04450329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20286067|NCT04450329|Growth Substances|growth substances|mesh-ancestor
20286068|NCT04450329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286069|NCT04450329|Growth Inhibitors|growth inhibitors|mesh-ancestor
20286070|NCT04450329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288496|NCT05324059|Analgesics|analgesics|mesh-ancestor
20288497|NCT05324059|Sensory System Agents|sensory system agents|mesh-ancestor
20288498|NCT05324059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20288499|NCT05324059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288500|NCT05324059|Anticonvulsants|anticonvulsants|mesh-ancestor
20288501|NCT05324059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20288502|NCT05324059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20288503|NCT05324059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288504|NCT05324059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20288505|NCT05324059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20288506|NCT05324059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20288507|NCT05324059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20288508|NCT05324059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20548645|NCT01901172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548646|NCT01901172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20548647|NCT01901172|Hormone Antagonists|hormone antagonists|mesh-ancestor
20548648|NCT01901172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20548649|NCT01901172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548650|NCT01901198|Interferons|interferons|mesh-list
20548651|NCT01901198|Interferon-alpha|interferon-alpha|mesh-list
20548652|NCT01901198|Interferon alpha-2|interferon alpha-2|mesh-list
20548653|NCT01901198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548654|NCT01901198|Antiviral Agents|antiviral agents|mesh-ancestor
20548655|NCT01901198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548656|NCT01901198|Immunologic Factors|immunologic factors|mesh-ancestor
20548657|NCT01901198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548658|NCT01901276|Omeprazole|omeprazole|mesh-list
20548659|NCT01901276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20548660|NCT01901276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20548661|NCT01901276|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20548662|NCT01901276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548663|NCT01901276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548664|NCT01901380|Caseins|caseins|mesh-list
20548665|NCT01901380|Chelating Agents|chelating agents|mesh-ancestor
20548666|NCT01901380|Sequestering Agents|sequestering agents|mesh-ancestor
20548667|NCT01901380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548668|NCT01901432|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
19965848|NCT03164616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19965849|NCT03164616|Antimetabolites|antimetabolites|mesh-ancestor
19965850|NCT03164616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965851|NCT03164616|Antiviral Agents|antiviral agents|mesh-ancestor
19965852|NCT03164616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19965853|NCT03164616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965854|NCT03164616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20548669|NCT01901432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20548670|NCT01901432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548671|NCT01901432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548672|NCT01901471|Cyclosporine|cyclosporine|mesh-list
20548673|NCT01901471|Cyclosporins|cyclosporins|mesh-list
20548674|NCT01901471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548675|NCT01901471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548676|NCT01901471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20548677|NCT01901471|Immunologic Factors|immunologic factors|mesh-ancestor
20548678|NCT01901471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548679|NCT01901471|Antifungal Agents|antifungal agents|mesh-ancestor
19965855|NCT03164616|Immunologic Factors|immunologic factors|mesh-ancestor
19965856|NCT03164616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965857|NCT03164616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19965858|NCT03164616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19965859|NCT03164616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19965860|NCT03162510|Paclitaxel|paclitaxel|mesh-list
19965861|NCT03162510|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20288509|NCT05324059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20288510|NCT05324059|Narcotics|narcotics|mesh-ancestor
19965862|NCT03162510|Oxaliplatin|oxaliplatin|mesh-list
19965863|NCT03162510|Tegafur|tegafur|mesh-list
19965864|NCT03162510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19965865|NCT03162510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965866|NCT03162510|Tubulin Modulators|tubulin modulators|mesh-ancestor
19965867|NCT03162510|Antimitotic Agents|antimitotic agents|mesh-ancestor
19965868|NCT03162510|Mitosis Modulators|mitosis modulators|mesh-ancestor
19965869|NCT03162510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965870|NCT03162510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19965871|NCT03162510|Antimetabolites|antimetabolites|mesh-ancestor
19965872|NCT03162497|Azithromycin|azithromycin|mesh-list
19965873|NCT03162497|Doxycycline|doxycycline|mesh-list
19965874|NCT03162497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19965875|NCT03162497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19965876|NCT03162497|Antimalarials|antimalarials|mesh-ancestor
20286071|NCT04432623|Benserazide|benserazide|mesh-list
20286072|NCT04432623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20286073|NCT04432623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20286074|NCT04432623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286075|NCT04432623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286076|NCT04432623|Dopamine Agents|dopamine agents|mesh-ancestor
20286077|NCT04432623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20286078|NCT04432623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286079|NCT04431778|Ethosuximide|ethosuximide|mesh-list
20286080|NCT04431778|Anticonvulsants|anticonvulsants|mesh-ancestor
20286081|NCT04423029|Nivolumab|nivolumab|mesh-list
20286082|NCT04423029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20286083|NCT04423029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548680|NCT01901471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548681|NCT01901471|Dermatologic Agents|dermatologic agents|mesh-ancestor
20548682|NCT01901471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20548683|NCT01901471|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20548684|NCT01901484|Praziquantel|praziquantel|mesh-list
20548685|NCT01901484|Anthelmintics|anthelmintics|mesh-ancestor
20548686|NCT01901484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20548687|NCT01901484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548688|NCT01901549|Metoprolol|metoprolol|mesh-list
20548689|NCT01901549|Lisinopril|lisinopril|mesh-list
20548690|NCT01901549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20548691|NCT01901549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20548692|NCT01901549|Sympatholytics|sympatholytics|mesh-ancestor
20548693|NCT01901549|Autonomic Agents|autonomic agents|mesh-ancestor
20548694|NCT01901549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548695|NCT01901549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548696|NCT01901549|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20548697|NCT01901549|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20548698|NCT01901549|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20548699|NCT01901549|Adrenergic Agents|adrenergic agents|mesh-ancestor
20548700|NCT01901549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20548701|NCT01901549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548702|NCT01901549|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20548703|NCT01901549|Protease Inhibitors|protease inhibitors|mesh-ancestor
20548704|NCT01901549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548705|NCT01901549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20548706|NCT01901549|Protective Agents|protective agents|mesh-ancestor
20548707|NCT01901601|Anesthetics|anesthetics|mesh-list
20548708|NCT01901601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20548709|NCT01901601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548710|NCT01901640|Udenafil|udenafil|mesh-list
20548711|NCT01901640|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20548712|NCT01901640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20548713|NCT01901640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548714|NCT01901640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548715|NCT01901666|Hormones|hormones|mesh-list
20548716|NCT01901666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20548717|NCT01901666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548718|NCT01901692|Sorafenib|sorafenib|mesh-list
20548719|NCT01901692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548720|NCT01901692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20548721|NCT01901692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548722|NCT01901692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554498|NCT01935596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19965877|NCT03162497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20554499|NCT01935596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965878|NCT03162497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19965879|NCT03161756|Denosumab|denosumab|mesh-list
20286084|NCT04423029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20286085|NCT04423029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286086|NCT04417049|Pentoxifylline|pentoxifylline|mesh-list
20286087|NCT04417049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20286088|NCT04417049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286089|NCT04417049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286090|NCT04417049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20286091|NCT04417049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20286092|NCT04417049|Protective Agents|protective agents|mesh-ancestor
20286093|NCT04417049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286094|NCT04417049|Vasodilator Agents|vasodilator agents|mesh-ancestor
20286095|NCT04417049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20286096|NCT04417049|Antioxidants|antioxidants|mesh-ancestor
20286097|NCT04372927|Cisplatin|cisplatin|mesh-list
20286098|NCT04372927|Etoposide|etoposide|mesh-list
20286099|NCT04372927|Pemetrexed|pemetrexed|mesh-list
20286100|NCT04372927|Etoposide phosphate|etoposide phosphate|mesh-list
20286101|NCT04372927|Durvalumab|durvalumab|mesh-list
20286102|NCT04372927|Podophyllotoxin|podophyllotoxin|mesh-list
20286103|NCT04372927|Immunoglobulins|immunoglobulins|mesh-list
20286104|NCT04372927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20286105|NCT04372927|Immunoglobulin G|immunoglobulin g|mesh-list
20286106|NCT04372927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286107|NCT04372927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20286108|NCT04372927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20548723|NCT01901861|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20548724|NCT01901861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20548725|NCT01901861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548726|NCT01901861|Incretins|incretins|mesh-ancestor
20548727|NCT01901861|Hormones|hormones|mesh-ancestor
20548728|NCT01901861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20548729|NCT01901861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20548730|NCT01901861|Protease Inhibitors|protease inhibitors|mesh-ancestor
20548731|NCT01901861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548732|NCT01901861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548733|NCT01902017|Ketotifen|ketotifen|mesh-list
20548734|NCT01902017|Antipruritics|antipruritics|mesh-ancestor
20548735|NCT01902017|Dermatologic Agents|dermatologic agents|mesh-ancestor
20548736|NCT01902017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20548737|NCT01902017|Histamine Antagonists|histamine antagonists|mesh-ancestor
20548738|NCT01902017|Histamine Agents|histamine agents|mesh-ancestor
20548739|NCT01902017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20548740|NCT01902017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548741|NCT01902017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548742|NCT01902017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20548743|NCT01902108|Clonidine|clonidine|mesh-list
20548744|NCT01902108|Bupivacaine|bupivacaine|mesh-list
20548745|NCT01902108|Anesthetics, Local|anesthetics, local|mesh-ancestor
20548746|NCT01902108|Anesthetics|anesthetics|mesh-ancestor
20548747|NCT01902108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20548748|NCT01902108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548749|NCT01902108|Sensory System Agents|sensory system agents|mesh-ancestor
20548750|NCT01902108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548751|NCT01902108|Analgesics|analgesics|mesh-ancestor
20548752|NCT01902108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20548753|NCT01902108|Sympatholytics|sympatholytics|mesh-ancestor
19965880|NCT03161756|Nivolumab|nivolumab|mesh-list
19965881|NCT03161756|Ipilimumab|ipilimumab|mesh-list
19965882|NCT03161756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19965883|NCT03161756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965884|NCT03161756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19965885|NCT03161756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965886|NCT03161756|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19965887|NCT03161756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965888|NCT03157037|Immunoglobulins|immunoglobulins|mesh-list
20548754|NCT01902108|Autonomic Agents|autonomic agents|mesh-ancestor
20548755|NCT01902108|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20548756|NCT01902108|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20548757|NCT01902108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20548758|NCT01902108|Adrenergic Agents|adrenergic agents|mesh-ancestor
19965889|NCT03157037|Immunoglobulin G|immunoglobulin g|mesh-list
19965890|NCT03157037|Immunologic Factors|immunologic factors|mesh-ancestor
20548759|NCT01902108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20554500|NCT01935596|Sensory System Agents|sensory system agents|mesh-ancestor
19965891|NCT03157037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286109|NCT04372927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19965892|NCT03127007|Atezolizumab|atezolizumab|mesh-list
19965893|NCT03127007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965894|NCT03101748|Paclitaxel|paclitaxel|mesh-list
19965895|NCT03101748|Cyclophosphamide|cyclophosphamide|mesh-list
19965896|NCT03101748|Doxorubicin|doxorubicin|mesh-list
19965897|NCT03101748|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19965898|NCT03101748|Trastuzumab|trastuzumab|mesh-list
19965899|NCT03101748|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19965900|NCT03101748|Daunorubicin|daunorubicin|mesh-list
19965901|NCT03101748|Pertuzumab|pertuzumab|mesh-list
19965902|NCT03101748|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
19965903|NCT03101748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19965904|NCT03101748|Antibodies|antibodies|mesh-list
19965905|NCT03101748|Immunoglobulins|immunoglobulins|mesh-list
19965906|NCT03101748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19965907|NCT03101748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19965908|NCT03101748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965909|NCT03101748|Tubulin Modulators|tubulin modulators|mesh-ancestor
19965910|NCT03101748|Antimitotic Agents|antimitotic agents|mesh-ancestor
19965911|NCT03101748|Mitosis Modulators|mitosis modulators|mesh-ancestor
19965912|NCT03101748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965913|NCT03101748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19965914|NCT03101748|Immunologic Factors|immunologic factors|mesh-ancestor
19965915|NCT03101748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286110|NCT04372927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286111|NCT04372927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286112|NCT04372927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20286113|NCT04372927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20286114|NCT04372927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20286115|NCT04372927|Immunologic Factors|immunologic factors|mesh-ancestor
20286116|NCT04372927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965916|NCT03101748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19965917|NCT03101748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19965918|NCT03101748|Alkylating Agents|alkylating agents|mesh-ancestor
19965919|NCT03101748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19965920|NCT03101748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19965921|NCT03101748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19965922|NCT03101748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19965923|NCT03101748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965924|NCT03065218|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
19965925|NCT03065218|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19965926|NCT03065218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975223|NCT01846611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19975224|NCT01846611|Antiemetics|antiemetics|mesh-ancestor
19975225|NCT01846611|Autonomic Agents|autonomic agents|mesh-ancestor
19975226|NCT01846611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20286117|NCT04372927|Keratolytic Agents|keratolytic agents|mesh-ancestor
20286118|NCT04372927|Dermatologic Agents|dermatologic agents|mesh-ancestor
20286119|NCT04372927|Tubulin Modulators|tubulin modulators|mesh-ancestor
20286120|NCT04372927|Antimitotic Agents|antimitotic agents|mesh-ancestor
20286121|NCT04372927|Mitosis Modulators|mitosis modulators|mesh-ancestor
20286122|NCT04356599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20286123|NCT04356599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20286124|NCT04356599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286125|NCT04349267|Nivolumab|nivolumab|mesh-list
20286126|NCT04349267|Cetuximab|cetuximab|mesh-list
20286127|NCT04349267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20286128|NCT04349267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286129|NCT04349267|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20286130|NCT04349267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286131|NCT04322006|Antibodies|antibodies|mesh-list
20286132|NCT04322006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20286133|NCT04322006|Immunologic Factors|immunologic factors|mesh-ancestor
20286134|NCT04322006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286135|NCT04303702|Oxytocin|oxytocin|mesh-list
20286136|NCT04303702|Oxytocics|oxytocics|mesh-ancestor
20286137|NCT04303702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20286138|NCT04303702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286139|NCT04291703|Thymoglobulin|thymoglobulin|mesh-list
20286140|NCT04291703|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20286141|NCT04291703|Immunologic Factors|immunologic factors|mesh-ancestor
20286142|NCT04291703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286143|NCT04291703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20286144|NCT04247542|Vancomycin|vancomycin|mesh-list
19975227|NCT01846611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975228|NCT01846611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20286145|NCT04247542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20286146|NCT04247542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20286147|NCT04246437|Carbidopa|carbidopa|mesh-list
20286148|NCT04246437|Entacapone|entacapone|mesh-list
20286149|NCT04246437|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20286150|NCT04246437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20286151|NCT04246437|Dopamine Agents|dopamine agents|mesh-ancestor
20286152|NCT04246437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20286153|NCT04246437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286154|NCT04246437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965927|NCT03058757|Mitomycins|mitomycins|mesh-list
19965928|NCT03058757|Mitomycin|mitomycin|mesh-list
19965929|NCT03058757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19965930|NCT03058757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965931|NCT03058757|Alkylating Agents|alkylating agents|mesh-ancestor
19965932|NCT03058757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965933|NCT03058757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19965934|NCT03058757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965935|NCT02996760|Mitogens|mitogens|mesh-list
19965936|NCT02996760|Mitosis Modulators|mitosis modulators|mesh-ancestor
20286155|NCT04246437|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
20286156|NCT04246437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286157|NCT04246437|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20286158|NCT04234113|Pembrolizumab|pembrolizumab|mesh-list
20286159|NCT04234113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20286160|NCT04234113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286161|NCT04196413|Cyclophosphamide|cyclophosphamide|mesh-list
20286162|NCT04196413|Fludarabine|fludarabine|mesh-list
20548760|NCT01902108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548761|NCT01902121|Insulin|insulin|mesh-list
20548762|NCT01902121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20548763|NCT01902121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19965937|NCT02996760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965938|NCT02991651|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19965939|NCT02991651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965940|NCT02991651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19965941|NCT02991651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965942|NCT02991651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965943|NCT02987946|Nadroparin|nadroparin|mesh-list
19965944|NCT02987946|Anticoagulants|anticoagulants|mesh-ancestor
19965945|NCT02987946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20286163|NCT04196413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20548764|NCT01902121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548765|NCT01902160|Sirolimus|sirolimus|mesh-list
20548766|NCT01902160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20548767|NCT01902160|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20548768|NCT01902160|Antibodies|antibodies|mesh-list
20548769|NCT01902160|Immunoglobulins|immunoglobulins|mesh-list
20548770|NCT01902160|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20548771|NCT01902160|Immunoconjugates|immunoconjugates|mesh-list
20548772|NCT01902160|Immunologic Factors|immunologic factors|mesh-ancestor
20548773|NCT01902160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548774|NCT01902160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548775|NCT01902160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20548776|NCT01902160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20286164|NCT04196413|Immunologic Factors|immunologic factors|mesh-ancestor
20286165|NCT04196413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286166|NCT04196413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20286167|NCT04196413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20286168|NCT04196413|Alkylating Agents|alkylating agents|mesh-ancestor
20286169|NCT04196413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286170|NCT04196413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286171|NCT04196413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20286172|NCT04186442|Botulinum Toxins|botulinum toxins|mesh-list
20286173|NCT04186442|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20286174|NCT04186442|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20286175|NCT04186442|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20286176|NCT04186442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20286177|NCT04186442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286178|NCT04186442|Cholinergic Agents|cholinergic agents|mesh-ancestor
20286179|NCT04186442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20286180|NCT04186442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965946|NCT02987946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19965947|NCT02987946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965948|NCT02969083|Gemcitabine|gemcitabine|mesh-list
19965949|NCT02969083|Cisplatin|cisplatin|mesh-list
19965950|NCT02969083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965951|NCT02969083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19965952|NCT02969083|Antimetabolites|antimetabolites|mesh-ancestor
19965953|NCT02969083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286181|NCT04186442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20286182|NCT04186442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20286183|NCT04177953|Carboplatin|carboplatin|mesh-list
20286184|NCT04177953|Nivolumab|nivolumab|mesh-list
20286185|NCT04177953|Pemetrexed|pemetrexed|mesh-list
19965954|NCT02969083|Antiviral Agents|antiviral agents|mesh-ancestor
19965955|NCT02969083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19965956|NCT02969083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19965957|NCT02969083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19965958|NCT02969083|Immunologic Factors|immunologic factors|mesh-ancestor
19965959|NCT02969083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965960|NCT02965963|Dopamine|dopamine|mesh-list
19965961|NCT02965963|Metoclopramide|metoclopramide|mesh-list
19965962|NCT02965963|Antiemetics|antiemetics|mesh-ancestor
19965963|NCT02965963|Autonomic Agents|autonomic agents|mesh-ancestor
19965964|NCT02965963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965965|NCT02965963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286186|NCT04177953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286187|NCT04177953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20286188|NCT04177953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20548777|NCT01902160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20548778|NCT01902160|Antifungal Agents|antifungal agents|mesh-ancestor
20548779|NCT01902160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20548780|NCT01902186|Ritonavir|ritonavir|mesh-list
20548781|NCT01902186|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20548782|NCT01902186|Tenofovir|tenofovir|mesh-list
20548783|NCT01902186|Emtricitabine|emtricitabine|mesh-list
20548784|NCT01902186|Raltegravir Potassium|raltegravir potassium|mesh-list
20548785|NCT01902186|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20548786|NCT01902186|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20548787|NCT01902186|Protease Inhibitors|protease inhibitors|mesh-ancestor
20548788|NCT01902186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548789|NCT01902186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548790|NCT01902186|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20548791|NCT01902186|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20548792|NCT01902186|Antiviral Agents|antiviral agents|mesh-ancestor
20548793|NCT01902186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548794|NCT01902186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20548795|NCT01902186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20548796|NCT01902186|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20548797|NCT01902186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20548798|NCT01902186|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20548799|NCT01902186|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20548800|NCT01902225|Doxorubicin|doxorubicin|mesh-list
20548801|NCT01902225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20548802|NCT01902225|Romidepsin|romidepsin|mesh-list
20548803|NCT01902225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20548804|NCT01902225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975229|NCT01846611|Glucocorticoids|glucocorticoids|mesh-ancestor
20548805|NCT01902225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20548806|NCT01902225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20286189|NCT04177953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286190|NCT04177953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286191|NCT04177953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20286192|NCT04177953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20286193|NCT04153422|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20286194|NCT04153422|Immunologic Factors|immunologic factors|mesh-ancestor
20286195|NCT04153422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286196|NCT04151082|Prednisone|prednisone|mesh-list
20286197|NCT04151082|Methylprednisolone|methylprednisolone|mesh-list
20286198|NCT04151082|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20288511|NCT05323708|Denosumab|denosumab|mesh-list
20548807|NCT01902225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548808|NCT01902225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548809|NCT01902238|Ethanol|ethanol|mesh-list
20548810|NCT01902238|Ethiodized Oil|ethiodized oil|mesh-list
20548811|NCT01902238|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20548812|NCT01902238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548813|NCT01902238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20548814|NCT01902238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548815|NCT01902238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548816|NCT01902342|Oseltamivir|oseltamivir|mesh-list
20548817|NCT01902342|Antiviral Agents|antiviral agents|mesh-ancestor
20548818|NCT01902342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548819|NCT01902342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548820|NCT01902342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548821|NCT01902446|Chlorhexidine|chlorhexidine|mesh-list
20548822|NCT01902446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20548823|NCT01902446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20548824|NCT01902446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548825|NCT01902446|Disinfectants|disinfectants|mesh-ancestor
20548826|NCT01902446|Dermatologic Agents|dermatologic agents|mesh-ancestor
20548827|NCT01902485|Contraceptive Agents|contraceptive agents|mesh-list
19965966|NCT02965963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19965967|NCT02965963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19965968|NCT02965963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19965969|NCT02965963|Dopamine Agents|dopamine agents|mesh-ancestor
19965970|NCT02965963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20548828|NCT01902485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20548829|NCT01902485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548830|NCT01902498|Aspirin|aspirin|mesh-list
20548831|NCT01902498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20548832|NCT01902498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19965971|NCT02965963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965972|NCT02965963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19965973|NCT02965963|Sympathomimetics|sympathomimetics|mesh-ancestor
19965974|NCT02965963|Protective Agents|protective agents|mesh-ancestor
19965975|NCT02868567|4-Aminopyridine|4-aminopyridine|mesh-list
19965976|NCT02868567|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19965977|NCT02868567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19965978|NCT02868567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965979|NCT02866383|Nivolumab|nivolumab|mesh-list
19965980|NCT02866383|Ipilimumab|ipilimumab|mesh-list
19965981|NCT02866383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19965982|NCT02866383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548833|NCT01902498|Analgesics|analgesics|mesh-ancestor
20548834|NCT01902498|Sensory System Agents|sensory system agents|mesh-ancestor
20548835|NCT01902498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548836|NCT01902498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548837|NCT01902498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20548838|NCT01902498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20548839|NCT01902498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20548840|NCT01902498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20548841|NCT01902498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548842|NCT01902498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20548843|NCT01902498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20548844|NCT01902498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548845|NCT01902498|Antipyretics|antipyretics|mesh-ancestor
20548846|NCT01902511|Epoetin Alfa|epoetin alfa|mesh-list
20548847|NCT01902511|Lenograstim|lenograstim|mesh-list
20548848|NCT01902511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19965983|NCT02866383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20548849|NCT01902511|Immunologic Factors|immunologic factors|mesh-ancestor
20548850|NCT01902511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548851|NCT01902511|Hematinics|hematinics|mesh-ancestor
20548852|NCT01902524|Fentanyl|fentanyl|mesh-list
20286199|NCT04151082|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20286200|NCT04151082|Prednisolone|prednisolone|mesh-list
20286201|NCT04151082|Prednisolone acetate|prednisolone acetate|mesh-list
20286202|NCT04151082|Cortisone|cortisone|mesh-list
20286203|NCT04151082|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20286204|NCT04151082|Prednisolone phosphate|prednisolone phosphate|mesh-list
20286205|NCT04151082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20286206|NCT04151082|Glucocorticoids|glucocorticoids|mesh-ancestor
20286207|NCT04151082|Hormones|hormones|mesh-ancestor
20286208|NCT04151082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20286209|NCT04151082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548853|NCT01902524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20548854|NCT01902524|Narcotics|narcotics|mesh-ancestor
20548855|NCT01902524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20548856|NCT01902524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548857|NCT01902524|Analgesics|analgesics|mesh-ancestor
20548858|NCT01902524|Sensory System Agents|sensory system agents|mesh-ancestor
20548859|NCT01902524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548860|NCT01902524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20548861|NCT01902524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20548862|NCT01902524|Anesthetics, General|anesthetics, general|mesh-ancestor
20548863|NCT01902524|Anesthetics|anesthetics|mesh-ancestor
20548864|NCT01902537|Prucalopride|prucalopride|mesh-list
20548865|NCT01902537|Laxatives|laxatives|mesh-ancestor
20548866|NCT01902537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20548867|NCT01902537|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
20548868|NCT01902537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20548869|NCT01902537|Serotonin Agents|serotonin agents|mesh-ancestor
20548870|NCT01902537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20548871|NCT01902537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548872|NCT01902537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548873|NCT01902550|Metoprolol|metoprolol|mesh-list
20548874|NCT01902550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20548875|NCT01902550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20548876|NCT01902550|Sympatholytics|sympatholytics|mesh-ancestor
20548877|NCT01902550|Autonomic Agents|autonomic agents|mesh-ancestor
20548878|NCT01902550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548879|NCT01902550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548880|NCT01902550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20548881|NCT01902550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20548882|NCT01902550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20548883|NCT01902550|Adrenergic Agents|adrenergic agents|mesh-ancestor
19965984|NCT02866383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965985|NCT02865473|Pilocarpine|pilocarpine|mesh-list
19965986|NCT02865473|Miotics|miotics|mesh-ancestor
19965987|NCT02865473|Autonomic Agents|autonomic agents|mesh-ancestor
19965988|NCT02865473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19965989|NCT02865473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19965990|NCT02865473|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19965991|NCT02865473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19965992|NCT02865473|Cholinergic Agents|cholinergic agents|mesh-ancestor
19965993|NCT02865473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19965994|NCT02865473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19965995|NCT02850419|Doxorubicin|doxorubicin|mesh-list
19965996|NCT02850419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19965997|NCT02850419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19965998|NCT02850419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19965999|NCT02850419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19966000|NCT02850419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19966001|NCT02850419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966002|NCT02850419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966003|NCT02847624|Tolvaptan|tolvaptan|mesh-list
20548884|NCT01902550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20548885|NCT01902550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548886|NCT01902641|Rocuronium|rocuronium|mesh-list
20548887|NCT01902641|Succinylcholine|succinylcholine|mesh-list
20548888|NCT01902641|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20548889|NCT01902641|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20548890|NCT01902641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20548891|NCT01902641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19966004|NCT02847624|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20286210|NCT04151082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20548892|NCT01902641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548893|NCT01902641|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
20286211|NCT04151082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286212|NCT04151082|Antiemetics|antiemetics|mesh-ancestor
19966005|NCT02847624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966006|NCT02847624|Natriuretic Agents|natriuretic agents|mesh-ancestor
19966007|NCT02847624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966008|NCT02841371|Edetic Acid|edetic acid|mesh-list
19966009|NCT02841371|Pentetic Acid|pentetic acid|mesh-list
19966010|NCT02841371|Antidotes|antidotes|mesh-ancestor
19966011|NCT02841371|Protective Agents|protective agents|mesh-ancestor
19966012|NCT02841371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966013|NCT02841371|Chelating Agents|chelating agents|mesh-ancestor
19966014|NCT02841371|Sequestering Agents|sequestering agents|mesh-ancestor
19966015|NCT02841371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966016|NCT02841371|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19966017|NCT02841371|Anticoagulants|anticoagulants|mesh-ancestor
20286213|NCT04151082|Autonomic Agents|autonomic agents|mesh-ancestor
20286214|NCT04151082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20286215|NCT04151082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20286216|NCT04151082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20286217|NCT04151082|Protective Agents|protective agents|mesh-ancestor
20548894|NCT01902771|Imiquimod|imiquimod|mesh-list
20548895|NCT01902771|Vaccines|vaccines|mesh-list
20548896|NCT01902771|Immunologic Factors|immunologic factors|mesh-ancestor
20548897|NCT01902771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548898|NCT01902771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20548899|NCT01902771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966018|NCT02841371|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19966019|NCT02822625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19966020|NCT02822625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19966021|NCT02822625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966022|NCT02811133|Inositol|inositol|mesh-list
19966023|NCT02811133|Vitamin B Complex|vitamin b complex|mesh-ancestor
19966024|NCT02811133|Vitamins|vitamins|mesh-ancestor
19966025|NCT02811133|Micronutrients|micronutrients|mesh-ancestor
19966026|NCT02811133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548900|NCT01902771|Interferon Inducers|interferon inducers|mesh-ancestor
20548901|NCT01902810|Propranolol|propranolol|mesh-list
20548902|NCT01902810|Metoprolol|metoprolol|mesh-list
20548903|NCT01902810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20548904|NCT01902810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20548905|NCT01902810|Adrenergic Agents|adrenergic agents|mesh-ancestor
20548906|NCT01902810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20548907|NCT01902810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548908|NCT01902810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548909|NCT01902810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20548910|NCT01902810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20548911|NCT01902810|Vasodilator Agents|vasodilator agents|mesh-ancestor
20548912|NCT01902810|Sympatholytics|sympatholytics|mesh-ancestor
20548913|NCT01902810|Autonomic Agents|autonomic agents|mesh-ancestor
20548914|NCT01902810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548915|NCT01902810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20548916|NCT01902862|Rituximab|rituximab|mesh-list
20548917|NCT01902862|Bortezomib|bortezomib|mesh-list
20548918|NCT01902862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20548919|NCT01902862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966027|NCT02788708|Paclitaxel|paclitaxel|mesh-list
19966028|NCT02788708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19966029|NCT02788708|Lenvatinib|lenvatinib|mesh-list
20548920|NCT01902862|Immunologic Factors|immunologic factors|mesh-ancestor
20548921|NCT01902862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733454|NCT04561739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19733455|NCT04561739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733456|NCT04561739|Antipyretics|antipyretics|mesh-ancestor
19733457|NCT04561739|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19733458|NCT04561739|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19733459|NCT04561739|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19733460|NCT04561739|Purinergic Agents|purinergic agents|mesh-ancestor
19733461|NCT04561739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20548922|NCT01902862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20548923|NCT01902875|Paclitaxel|paclitaxel|mesh-list
20286218|NCT04145076|Citalopram|citalopram|mesh-list
20286219|NCT04145076|Tianeptine|tianeptine|mesh-list
20286220|NCT04145076|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19733462|NCT04561739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20286221|NCT04145076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20548924|NCT01902875|Cisplatin|cisplatin|mesh-list
20548925|NCT01902875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20548926|NCT01902875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286222|NCT04145076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19966030|NCT02788708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19966031|NCT02788708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966032|NCT02788708|Tubulin Modulators|tubulin modulators|mesh-ancestor
19966033|NCT02788708|Antimitotic Agents|antimitotic agents|mesh-ancestor
19966034|NCT02788708|Mitosis Modulators|mitosis modulators|mesh-ancestor
19966035|NCT02788708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966036|NCT02788708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19966037|NCT02788708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286223|NCT04145076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286224|NCT04145076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20286225|NCT04145076|Serotonin Agents|serotonin agents|mesh-ancestor
20286226|NCT04145076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286227|NCT04145076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20286228|NCT04145076|Antidepressive Agents|antidepressive agents|mesh-ancestor
20286229|NCT04145076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20286230|NCT04145076|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20286231|NCT04133948|Nivolumab|nivolumab|mesh-list
20286232|NCT04133948|Ipilimumab|ipilimumab|mesh-list
20286233|NCT04133948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20286234|NCT04133948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286235|NCT04133948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20286236|NCT04133948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286237|NCT04123795|Certolizumab Pegol|certolizumab pegol|mesh-list
20286238|NCT04123795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20548927|NCT01902875|Tubulin Modulators|tubulin modulators|mesh-ancestor
20548928|NCT01902875|Antimitotic Agents|antimitotic agents|mesh-ancestor
20286239|NCT04123795|Immunologic Factors|immunologic factors|mesh-ancestor
20286240|NCT04123795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286241|NCT04123795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20286242|NCT04117672|Antisecretory factor|antisecretory factor|mesh-list
20548929|NCT01902875|Mitosis Modulators|mitosis modulators|mesh-ancestor
20548930|NCT01902875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548931|NCT01903018|Cisplatin|cisplatin|mesh-list
20548932|NCT01903018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548933|NCT01903057|Azithromycin|azithromycin|mesh-list
20548934|NCT01903057|Ivermectin|ivermectin|mesh-list
20548935|NCT01903057|Albendazole|albendazole|mesh-list
20548936|NCT01903057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20548937|NCT01903057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548938|NCT01903057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20548939|NCT01903057|Anthelmintics|anthelmintics|mesh-ancestor
20548940|NCT01903057|Anticestodal Agents|anticestodal agents|mesh-ancestor
20548941|NCT01903057|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20548942|NCT01903057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20548943|NCT01903057|Tubulin Modulators|tubulin modulators|mesh-ancestor
20548944|NCT01903057|Antimitotic Agents|antimitotic agents|mesh-ancestor
20548945|NCT01903057|Mitosis Modulators|mitosis modulators|mesh-ancestor
20548946|NCT01903057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548947|NCT01903057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548948|NCT01903070|Linagliptin|linagliptin|mesh-list
20548949|NCT01903070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20548950|NCT01903070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548951|NCT01903070|Incretins|incretins|mesh-ancestor
20548952|NCT01903070|Hormones|hormones|mesh-ancestor
20548953|NCT01903070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20548954|NCT01903070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20548955|NCT01903070|Protease Inhibitors|protease inhibitors|mesh-ancestor
20548956|NCT01903070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548957|NCT01903070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548958|NCT01903083|Gemcitabine|gemcitabine|mesh-list
20548959|NCT01903083|Tadalafil|tadalafil|mesh-list
20548960|NCT01903083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20548961|NCT01903083|Antimetabolites|antimetabolites|mesh-ancestor
20548962|NCT01903083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548963|NCT01903083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20548964|NCT01903083|Antiviral Agents|antiviral agents|mesh-ancestor
20548965|NCT01903083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20548966|NCT01903083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20548967|NCT01903083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20548968|NCT01903083|Immunologic Factors|immunologic factors|mesh-ancestor
20548969|NCT01903083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548970|NCT01903083|Vasodilator Agents|vasodilator agents|mesh-ancestor
20286243|NCT04117672|Antidiarrheals|antidiarrheals|mesh-ancestor
20286244|NCT04117672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20286245|NCT04094961|Dexamethasone|dexamethasone|mesh-list
19966038|NCT02783859|Amoxicillin|amoxicillin|mesh-list
19966039|NCT02783859|Clavulanic Acids|clavulanic acids|mesh-list
19966040|NCT02783859|Clavulanic Acid|clavulanic acid|mesh-list
19966041|NCT02783859|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19966042|NCT02783859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19966043|NCT02783859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19966044|NCT02783859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966045|NCT02783859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966046|NCT02783859|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19966047|NCT02706405|Cyclophosphamide|cyclophosphamide|mesh-list
19966048|NCT02706405|Fludarabine|fludarabine|mesh-list
19966049|NCT02706405|Durvalumab|durvalumab|mesh-list
19966050|NCT02706405|Immunoglobulins|immunoglobulins|mesh-list
20286246|NCT04094961|Dexamethasone acetate|dexamethasone acetate|mesh-list
20286247|NCT04094961|Pomalidomide|pomalidomide|mesh-list
20286248|NCT04094961|Ixazomib|ixazomib|mesh-list
20286249|NCT04094961|BB 1101|bb 1101|mesh-list
20286250|NCT04094961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20286251|NCT04094961|Antiemetics|antiemetics|mesh-ancestor
20286252|NCT04094961|Autonomic Agents|autonomic agents|mesh-ancestor
20286253|NCT04094961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20286254|NCT04094961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286255|NCT04094961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20286256|NCT04094961|Glucocorticoids|glucocorticoids|mesh-ancestor
20286257|NCT04094961|Hormones|hormones|mesh-ancestor
20286258|NCT04094961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20548971|NCT01903083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20548972|NCT01903083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20548973|NCT01903083|Urological Agents|urological agents|mesh-ancestor
20548974|NCT01903096|Antidepressive Agents|antidepressive agents|mesh-list
20548975|NCT01903096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20548976|NCT01903109|Cevimeline|cevimeline|mesh-list
20548977|NCT01903109|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20548978|NCT01903109|Autonomic Agents|autonomic agents|mesh-ancestor
20548979|NCT01903109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548980|NCT01903109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548981|NCT01903109|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20548982|NCT01903109|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20548983|NCT01903109|Cholinergic Agents|cholinergic agents|mesh-ancestor
20548984|NCT01903109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20548985|NCT01903109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548986|NCT01903122|Cevimeline|cevimeline|mesh-list
20548987|NCT01903122|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20548988|NCT01903122|Autonomic Agents|autonomic agents|mesh-ancestor
20548989|NCT01903122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20548990|NCT01903122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20548991|NCT01903122|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20548992|NCT01903122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20548993|NCT01903122|Cholinergic Agents|cholinergic agents|mesh-ancestor
20548994|NCT01903122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20548995|NCT01903122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20548996|NCT01903200|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20548997|NCT01903200|Antidepressive Agents|antidepressive agents|mesh-ancestor
20548998|NCT01903200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20548999|NCT01903200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20549000|NCT01903200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20549001|NCT01903200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20549002|NCT01903200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549003|NCT01903278|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20549004|NCT01903278|Antiviral Agents|antiviral agents|mesh-ancestor
20549005|NCT01903278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549006|NCT01903291|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20549007|NCT01903291|Dermatologic Agents|dermatologic agents|mesh-ancestor
20549008|NCT01903291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20549009|NCT01903291|Immunologic Factors|immunologic factors|mesh-ancestor
20549010|NCT01903291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549011|NCT01903421|Fentanyl|fentanyl|mesh-list
20549012|NCT01903421|Bupivacaine|bupivacaine|mesh-list
20549013|NCT01903421|Anesthetics|anesthetics|mesh-list
19966051|NCT02706405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19966052|NCT02706405|Immunoglobulin G|immunoglobulin g|mesh-list
20286259|NCT04094961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20286260|NCT04094961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549014|NCT01903421|Propofol|propofol|mesh-list
20549015|NCT01903421|Sevoflurane|sevoflurane|mesh-list
20549016|NCT01903421|Isoflurane|isoflurane|mesh-list
20286261|NCT04094961|Protease Inhibitors|protease inhibitors|mesh-ancestor
20286262|NCT04094961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286263|NCT04094961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286264|NCT04094961|Immunologic Factors|immunologic factors|mesh-ancestor
20286265|NCT04094961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20286266|NCT04094961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20286267|NCT04094961|Growth Substances|growth substances|mesh-ancestor
20286268|NCT04094961|Growth Inhibitors|growth inhibitors|mesh-ancestor
20286269|NCT04067752|Dialysis Solutions|dialysis solutions|mesh-list
20286270|NCT04067752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20286271|NCT04054674|Salicylic Acid|salicylic acid|mesh-list
20286272|NCT04054674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20286273|NCT04054674|Antifungal Agents|antifungal agents|mesh-ancestor
20549017|NCT01903421|Anesthetics, Local|anesthetics, local|mesh-ancestor
20549018|NCT01903421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20549019|NCT01903421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549020|NCT01903421|Sensory System Agents|sensory system agents|mesh-ancestor
20549021|NCT01903421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20549022|NCT01903421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20549023|NCT01903421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20549024|NCT01903421|Anesthetics, General|anesthetics, general|mesh-ancestor
20549025|NCT01903421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20549026|NCT01903421|Narcotics|narcotics|mesh-ancestor
20549027|NCT01903421|Analgesics|analgesics|mesh-ancestor
20549028|NCT01903421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20549029|NCT01903421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20549030|NCT01903421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20554501|NCT01935596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554502|NCT01935648|Ropivacaine|ropivacaine|mesh-list
20554503|NCT01935648|Anesthetics, Local|anesthetics, local|mesh-ancestor
20554504|NCT01935648|Anesthetics|anesthetics|mesh-ancestor
20554505|NCT01935648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20554506|NCT01935648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554507|NCT01935648|Sensory System Agents|sensory system agents|mesh-ancestor
20554508|NCT01935648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554509|NCT01935674|Ritonavir|ritonavir|mesh-list
20554510|NCT01935674|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20554511|NCT01935674|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20554512|NCT01935674|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20554513|NCT01935674|Protease Inhibitors|protease inhibitors|mesh-ancestor
20554514|NCT01935674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554515|NCT01935674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554516|NCT01935674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19966053|NCT02706405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19966054|NCT02706405|Immunologic Factors|immunologic factors|mesh-ancestor
19966055|NCT02706405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554517|NCT01935674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20554518|NCT01935674|Antiviral Agents|antiviral agents|mesh-ancestor
20554519|NCT01935674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20554520|NCT01935674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20554521|NCT01935674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20554522|NCT01935674|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20554523|NCT01935674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20554524|NCT01935674|Antimetabolites|antimetabolites|mesh-ancestor
20554525|NCT01935674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20554526|NCT01935674|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20554527|NCT01935713|Nicotine|nicotine|mesh-list
20554528|NCT01935713|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20554529|NCT01935713|Autonomic Agents|autonomic agents|mesh-ancestor
20554530|NCT01935713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554531|NCT01935713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554532|NCT01935713|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20554533|NCT01935713|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20554534|NCT01935713|Cholinergic Agents|cholinergic agents|mesh-ancestor
20554535|NCT01935713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20554536|NCT01935713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554537|NCT01935778|Docetaxel|docetaxel|mesh-list
20554538|NCT01935778|Capecitabine|capecitabine|mesh-list
19966056|NCT02706405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19966057|NCT02706405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19966058|NCT02706405|Alkylating Agents|alkylating agents|mesh-ancestor
19966059|NCT02706405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966060|NCT02706405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966061|NCT02706405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19975230|NCT01846611|Hormones|hormones|mesh-ancestor
20549031|NCT01903473|Sirolimus|sirolimus|mesh-list
20549032|NCT01903473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20549033|NCT01903473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549034|NCT01903473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20549035|NCT01903473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549036|NCT01903473|Antifungal Agents|antifungal agents|mesh-ancestor
20549037|NCT01903473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20549038|NCT01903473|Immunologic Factors|immunologic factors|mesh-ancestor
20549039|NCT01903473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549040|NCT01903681|Melatonin|melatonin|mesh-list
20549041|NCT01903681|Antioxidants|antioxidants|mesh-ancestor
20549042|NCT01903681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549043|NCT01903681|Protective Agents|protective agents|mesh-ancestor
20549044|NCT01903681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549045|NCT01903681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20549046|NCT01903694|Sorafenib|sorafenib|mesh-list
20549047|NCT01903694|Pravastatin|pravastatin|mesh-list
20549048|NCT01903694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549049|NCT01903694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20549050|NCT01903694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549051|NCT01903694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549052|NCT01903694|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20549053|NCT01903694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20549054|NCT01903694|Antimetabolites|antimetabolites|mesh-ancestor
20549055|NCT01903694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20549056|NCT01903694|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20549057|NCT01903785|Albuterol|albuterol|mesh-list
20549058|NCT01903785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20549059|NCT01903785|Autonomic Agents|autonomic agents|mesh-ancestor
20549060|NCT01903785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20549061|NCT01903785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966062|NCT02706405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19966063|NCT02655523|Dexamethasone|dexamethasone|mesh-list
20549062|NCT01903785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20549063|NCT01903785|Respiratory System Agents|respiratory system agents|mesh-ancestor
20549064|NCT01903785|Tocolytic Agents|tocolytic agents|mesh-ancestor
20549065|NCT01903785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20549066|NCT01903785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20549067|NCT01903785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20549068|NCT01903785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20549069|NCT01903785|Adrenergic Agents|adrenergic agents|mesh-ancestor
20549070|NCT01903785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20549071|NCT01903785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549072|NCT01903824|Modafinil|modafinil|mesh-list
20549073|NCT01903824|Donepezil|donepezil|mesh-list
20549074|NCT01903824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20549075|NCT01903824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549076|NCT01903824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549077|NCT01903824|Cholinergic Agents|cholinergic agents|mesh-ancestor
20549078|NCT01903824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20549079|NCT01903824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549080|NCT01903824|Nootropic Agents|nootropic agents|mesh-ancestor
20549081|NCT01903824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20549082|NCT01903824|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20549083|NCT01903824|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20549084|NCT01903824|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20549085|NCT01904045|Tacrolimus|tacrolimus|mesh-list
20549086|NCT01904045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20549087|NCT01904045|Immunologic Factors|immunologic factors|mesh-ancestor
20549088|NCT01904045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549089|NCT01904045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20549090|NCT01904045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549091|NCT01904045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549092|NCT01904097|Pregabalin|pregabalin|mesh-list
20549093|NCT01904097|Analgesics|analgesics|mesh-ancestor
20549094|NCT01904097|Sensory System Agents|sensory system agents|mesh-ancestor
20549095|NCT01904097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20549096|NCT01904097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549097|NCT01904097|Anticonvulsants|anticonvulsants|mesh-ancestor
20549098|NCT01904097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20549099|NCT01904097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20549100|NCT01904097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966064|NCT02655523|Triamcinolone|triamcinolone|mesh-list
19966065|NCT02655523|Bupivacaine|bupivacaine|mesh-list
20549101|NCT01904097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20549102|NCT01904097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20549103|NCT01904097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20549104|NCT01904097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20549105|NCT01904097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20549106|NCT01904110|Cholecalciferol|cholecalciferol|mesh-list
20549107|NCT01904110|Risedronic Acid|risedronic acid|mesh-list
20549108|NCT01904110|Etidronic Acid|etidronic acid|mesh-list
20549109|NCT01904110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20549110|NCT01904110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549111|NCT01904110|Vitamins|vitamins|mesh-ancestor
20549112|NCT01904110|Micronutrients|micronutrients|mesh-ancestor
20549113|NCT01904110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20549114|NCT01904110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20549115|NCT01904110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20549116|NCT01904110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549117|NCT01904162|Finafloxacin|finafloxacin|mesh-list
20549118|NCT01904162|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20549119|NCT01904162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549120|NCT01904162|Renal Agents|renal agents|mesh-ancestor
20549121|NCT01904162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20549122|NCT01904162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20549123|NCT01904162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20549124|NCT01904162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549125|NCT01904162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549126|NCT01904162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549127|NCT01904214|Siponimod|siponimod|mesh-list
20549128|NCT01904214|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20549129|NCT01904214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549130|NCT01904214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20549131|NCT01904214|Immunologic Factors|immunologic factors|mesh-ancestor
20549132|NCT01904214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549133|NCT01904253|Topotecan|topotecan|mesh-list
20549134|NCT01904253|Amrubicin|amrubicin|mesh-list
20549135|NCT01904253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20549136|NCT01904253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20549137|NCT01904253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966066|NCT02655523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19966067|NCT02655523|Antiemetics|antiemetics|mesh-ancestor
19966068|NCT02655523|Autonomic Agents|autonomic agents|mesh-ancestor
19966069|NCT02655523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19966070|NCT02655523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966071|NCT02655523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19966072|NCT02655523|Glucocorticoids|glucocorticoids|mesh-ancestor
19966073|NCT02655523|Hormones|hormones|mesh-ancestor
19966074|NCT02655523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19966075|NCT02655523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19966076|NCT02655523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966077|NCT02655523|Anesthetics, Local|anesthetics, local|mesh-ancestor
19966078|NCT02655523|Anesthetics|anesthetics|mesh-ancestor
19966079|NCT02655523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19966080|NCT02655523|Sensory System Agents|sensory system agents|mesh-ancestor
19966081|NCT02652169|Amikacin|amikacin|mesh-list
19966082|NCT02652169|Teicoplanin|teicoplanin|mesh-list
19966083|NCT02652169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19966084|NCT02652169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19966085|NCT02636270|Mecasermin|mecasermin|mesh-list
19966086|NCT02636270|Growth Substances|growth substances|mesh-ancestor
19966087|NCT02636270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549138|NCT01904253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549139|NCT01904253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549140|NCT01904357|Cefazolin|cefazolin|mesh-list
20549141|NCT01904357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20549142|NCT01904357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549143|NCT01904487|Tiagabine|tiagabine|mesh-list
20549144|NCT01904487|Flumazenil|flumazenil|mesh-list
20549145|NCT01904487|Antidotes|antidotes|mesh-ancestor
20549146|NCT01904487|Protective Agents|protective agents|mesh-ancestor
20549147|NCT01904487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549148|NCT01904487|GABA Modulators|gaba modulators|mesh-ancestor
20549149|NCT01904487|GABA Agents|gaba agents|mesh-ancestor
20549150|NCT01904487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20549151|NCT01904487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549152|NCT01904487|Anticonvulsants|anticonvulsants|mesh-ancestor
20549153|NCT01904487|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
20549154|NCT01904487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20549155|NCT01904487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20549156|NCT01904500|Cefazolin|cefazolin|mesh-list
20549157|NCT01904500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20549158|NCT01904500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549159|NCT01904539|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
20549160|NCT01904539|Cathartics|cathartics|mesh-ancestor
20549161|NCT01904539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20549162|NCT01904591|Vitamin E|vitamin e|mesh-list
20549163|NCT01904591|Selenium|selenium|mesh-list
19966088|NCT02620865|Calcium, Dietary|calcium, dietary|mesh-list
19966089|NCT02620865|Leucovorin|leucovorin|mesh-list
19966090|NCT02620865|Folic Acid|folic acid|mesh-list
20549164|NCT01904591|Vitamins|vitamins|mesh-ancestor
20549165|NCT01904591|Micronutrients|micronutrients|mesh-ancestor
20549166|NCT01904591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549167|NCT01904591|Antioxidants|antioxidants|mesh-ancestor
20549168|NCT01904591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549169|NCT01904591|Protective Agents|protective agents|mesh-ancestor
20549170|NCT01904591|Trace Elements|trace elements|mesh-ancestor
20549171|NCT01904643|Cytarabine|cytarabine|mesh-list
20549172|NCT01904643|Etoposide|etoposide|mesh-list
20549173|NCT01904643|Mitoxantrone|mitoxantrone|mesh-list
20549174|NCT01904643|Lenalidomide|lenalidomide|mesh-list
20549175|NCT01904643|Etoposide phosphate|etoposide phosphate|mesh-list
20549176|NCT01904643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20549177|NCT01904643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549178|NCT01904643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20549179|NCT01904643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20549180|NCT01904643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549181|NCT01904643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549182|NCT01904643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20549183|NCT01904643|Antimetabolites|antimetabolites|mesh-ancestor
20549184|NCT01904643|Antiviral Agents|antiviral agents|mesh-ancestor
20549185|NCT01904643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549186|NCT01904643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20549187|NCT01904643|Immunologic Factors|immunologic factors|mesh-ancestor
20549188|NCT01904643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549189|NCT01904643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20549190|NCT01904643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20549191|NCT01904643|Growth Substances|growth substances|mesh-ancestor
20549192|NCT01904643|Growth Inhibitors|growth inhibitors|mesh-ancestor
20549193|NCT01904643|Analgesics|analgesics|mesh-ancestor
20549194|NCT01904643|Sensory System Agents|sensory system agents|mesh-ancestor
20549195|NCT01904643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20549196|NCT01904682|ON 01910|on 01910|mesh-list
20549197|NCT01904682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549198|NCT01904682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20549199|NCT01904682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549200|NCT01904682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549201|NCT01904695|Antihypertensive Agents|antihypertensive agents|mesh-list
20549202|NCT01904695|Diuretics|diuretics|mesh-list
20549203|NCT01904695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20549204|NCT01904695|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
20549205|NCT01904695|Natriuretic Agents|natriuretic agents|mesh-ancestor
20549206|NCT01904695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549207|NCT01904695|Protease Inhibitors|protease inhibitors|mesh-ancestor
20549208|NCT01904695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549209|NCT01904695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549210|NCT01904695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20549211|NCT01904734|Clomiphene|clomiphene|mesh-list
20549212|NCT01904734|Enclomiphene|enclomiphene|mesh-list
20549213|NCT01904734|Zuclomiphene|zuclomiphene|mesh-list
20549214|NCT01904734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20549215|NCT01904734|Hormone Antagonists|hormone antagonists|mesh-ancestor
20549216|NCT01904734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20549217|NCT01904734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549218|NCT01904734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20549219|NCT01904734|Fertility Agents|fertility agents|mesh-ancestor
20549220|NCT01904734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20549221|NCT01904734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19966091|NCT02620865|Gemcitabine|gemcitabine|mesh-list
19966092|NCT02620865|Aldesleukin|aldesleukin|mesh-list
20549222|NCT01904734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19966093|NCT02620865|Paclitaxel|paclitaxel|mesh-list
19966094|NCT02620865|Camptothecin|camptothecin|mesh-list
20549223|NCT01904747|Palbociclib|palbociclib|mesh-list
20549224|NCT01904747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549225|NCT01904747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20549226|NCT01904747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549227|NCT01904747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549228|NCT01904786|Melatonin|melatonin|mesh-list
20549229|NCT01904786|Antioxidants|antioxidants|mesh-ancestor
20549230|NCT01904786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549231|NCT01904786|Protective Agents|protective agents|mesh-ancestor
20549232|NCT01904786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549233|NCT01904786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20549234|NCT01904981|Atenolol|atenolol|mesh-list
20549235|NCT01904981|Valsartan|valsartan|mesh-list
20549236|NCT01904981|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
20549237|NCT01904981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20549238|NCT01904981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20549239|NCT01904981|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20549240|NCT01904981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549241|NCT01904981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20549242|NCT01904981|Adrenergic Agents|adrenergic agents|mesh-ancestor
20549243|NCT01904981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20549244|NCT01904981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549245|NCT01904981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20549246|NCT01904981|Sympatholytics|sympatholytics|mesh-ancestor
20549247|NCT01904981|Autonomic Agents|autonomic agents|mesh-ancestor
20549248|NCT01904981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20549249|NCT01904981|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20549250|NCT01904994|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20549251|NCT01904994|Antiviral Agents|antiviral agents|mesh-ancestor
20549252|NCT01904994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549253|NCT01905059|Lamivudine|lamivudine|mesh-list
20549254|NCT01905059|Lopinavir|lopinavir|mesh-list
20549255|NCT01905059|Darunavir|darunavir|mesh-list
20549256|NCT01905059|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
20549257|NCT01905059|Protease Inhibitors|protease inhibitors|mesh-list
20549258|NCT01905059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20549259|NCT01905059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20549260|NCT01905059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549261|NCT01905059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549262|NCT01905059|Antiviral Agents|antiviral agents|mesh-ancestor
20549263|NCT01905059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549264|NCT01905059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20549265|NCT01905059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20549266|NCT01905059|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20549267|NCT01905059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20549268|NCT01905059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20549269|NCT01905137|Botulinum Toxins|botulinum toxins|mesh-list
20549270|NCT01905137|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20549271|NCT01905137|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20549272|NCT01905137|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20549273|NCT01905137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20549274|NCT01905137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549275|NCT01905137|Cholinergic Agents|cholinergic agents|mesh-ancestor
20549276|NCT01905137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20549277|NCT01905137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549278|NCT01905137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20549279|NCT01905137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20549280|NCT01905150|Leucovorin|leucovorin|mesh-list
20549281|NCT01905150|Ascorbic Acid|ascorbic acid|mesh-list
20549282|NCT01905150|Gemcitabine|gemcitabine|mesh-list
20549283|NCT01905150|Fluorouracil|fluorouracil|mesh-list
20549284|NCT01905150|Docetaxel|docetaxel|mesh-list
20549285|NCT01905150|Oxaliplatin|oxaliplatin|mesh-list
20549286|NCT01905150|Irinotecan|irinotecan|mesh-list
20549287|NCT01905150|Mitomycins|mitomycins|mesh-list
20549288|NCT01905150|Mitomycin|mitomycin|mesh-list
20549289|NCT01905150|Levoleucovorin|levoleucovorin|mesh-list
20549290|NCT01905150|Vitamins|vitamins|mesh-ancestor
20549291|NCT01905150|Micronutrients|micronutrients|mesh-ancestor
20549292|NCT01905150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549293|NCT01905150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20549294|NCT01905150|Antimetabolites|antimetabolites|mesh-ancestor
20549295|NCT01905150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549296|NCT01905150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966095|NCT02620865|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20549297|NCT01905150|Antiviral Agents|antiviral agents|mesh-ancestor
20549298|NCT01905150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19966096|NCT02620865|Fluorouracil|fluorouracil|mesh-list
20549299|NCT01905150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549300|NCT01905150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20549301|NCT01905150|Immunologic Factors|immunologic factors|mesh-ancestor
20549302|NCT01905150|Tubulin Modulators|tubulin modulators|mesh-ancestor
20549303|NCT01905150|Antimitotic Agents|antimitotic agents|mesh-ancestor
20549304|NCT01905150|Mitosis Modulators|mitosis modulators|mesh-ancestor
20549305|NCT01905150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20549306|NCT01905150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20549307|NCT01905150|Antidotes|antidotes|mesh-ancestor
20549308|NCT01905150|Protective Agents|protective agents|mesh-ancestor
20549309|NCT01905150|Vitamin B Complex|vitamin b complex|mesh-ancestor
20549310|NCT01905150|Antioxidants|antioxidants|mesh-ancestor
20549311|NCT01905150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20549312|NCT01905150|Alkylating Agents|alkylating agents|mesh-ancestor
20549313|NCT01905150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20554539|NCT01935778|Oxaliplatin|oxaliplatin|mesh-list
20554540|NCT01935778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554541|NCT01935778|Tubulin Modulators|tubulin modulators|mesh-ancestor
20554542|NCT01935778|Antimitotic Agents|antimitotic agents|mesh-ancestor
20554543|NCT01935778|Mitosis Modulators|mitosis modulators|mesh-ancestor
20554544|NCT01935778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554545|NCT01935778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20554546|NCT01935778|Antimetabolites|antimetabolites|mesh-ancestor
20554547|NCT01935804|Metformin|metformin|mesh-list
20554548|NCT01935804|Pioglitazone|pioglitazone|mesh-list
20554549|NCT01935804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20554550|NCT01935804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554551|NCT01935817|Vitamin E|vitamin e|mesh-list
20554552|NCT01935817|Silybin|silybin|mesh-list
20554553|NCT01935817|Vitamins|vitamins|mesh-ancestor
20554554|NCT01935817|Micronutrients|micronutrients|mesh-ancestor
20554555|NCT01935817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554556|NCT01935817|Antioxidants|antioxidants|mesh-ancestor
20554557|NCT01935817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554558|NCT01935817|Protective Agents|protective agents|mesh-ancestor
20554559|NCT01935817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20554560|NCT01935817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554561|NCT01935830|Ritonavir|ritonavir|mesh-list
20554562|NCT01935830|Efavirenz|efavirenz|mesh-list
20554563|NCT01935830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20554564|NCT01935830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20554565|NCT01935830|Protease Inhibitors|protease inhibitors|mesh-ancestor
20554566|NCT01935830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554567|NCT01935830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554568|NCT01935830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20554569|NCT01935830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20554570|NCT01935830|Antiviral Agents|antiviral agents|mesh-ancestor
19966097|NCT02620865|Oxaliplatin|oxaliplatin|mesh-list
19966098|NCT02620865|Irinotecan|irinotecan|mesh-list
19966099|NCT02620865|Interleukin-2|interleukin-2|mesh-list
19966100|NCT02620865|Antibodies|antibodies|mesh-list
19966101|NCT02620865|Immunoglobulins|immunoglobulins|mesh-list
19966102|NCT02620865|Sargramostim|sargramostim|mesh-list
19966103|NCT02620865|Calcium|calcium|mesh-list
19966104|NCT02620865|Levoleucovorin|levoleucovorin|mesh-list
19966105|NCT02620865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19966106|NCT02620865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966107|NCT02620865|Tubulin Modulators|tubulin modulators|mesh-ancestor
19966108|NCT02620865|Antimitotic Agents|antimitotic agents|mesh-ancestor
19966109|NCT02620865|Mitosis Modulators|mitosis modulators|mesh-ancestor
19966110|NCT02620865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554571|NCT01935830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20554572|NCT01935830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20554573|NCT01935830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20554574|NCT01935830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19966111|NCT02620865|Immunologic Factors|immunologic factors|mesh-ancestor
19966112|NCT02620865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966113|NCT02620865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19966114|NCT02620865|Antimetabolites|antimetabolites|mesh-ancestor
19966115|NCT02620865|Antiviral Agents|antiviral agents|mesh-ancestor
19966116|NCT02620865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19966117|NCT02620865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554575|NCT01935830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20554576|NCT01935830|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20554577|NCT01935830|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19966118|NCT02620865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19966119|NCT02620865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20549314|NCT01905215|Vaccines|vaccines|mesh-list
20549315|NCT01905215|Immunologic Factors|immunologic factors|mesh-ancestor
20549316|NCT01905215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549317|NCT01905371|Amphetamine|amphetamine|mesh-list
20549318|NCT01905371|Dextroamphetamine|dextroamphetamine|mesh-list
20549319|NCT01905371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20549320|NCT01905371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549321|NCT01905371|Sympathomimetics|sympathomimetics|mesh-ancestor
20549322|NCT01905371|Autonomic Agents|autonomic agents|mesh-ancestor
20549323|NCT01905371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20549324|NCT01905371|Dopamine Agents|dopamine agents|mesh-ancestor
20549325|NCT01905371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20549326|NCT01905371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549327|NCT01905371|Adrenergic Agents|adrenergic agents|mesh-ancestor
20549328|NCT01905371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20549329|NCT01905371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20549330|NCT01905371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20549331|NCT01905371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20549332|NCT01905501|Anesthetics|anesthetics|mesh-list
20549333|NCT01905501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20549334|NCT01905501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549335|NCT01905566|Clopidogrel|clopidogrel|mesh-list
20549336|NCT01905566|Ticagrelor|ticagrelor|mesh-list
19966120|NCT02620865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19966121|NCT02620865|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19966122|NCT02620865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19966123|NCT02620865|Antidotes|antidotes|mesh-ancestor
19966124|NCT02620865|Protective Agents|protective agents|mesh-ancestor
19966125|NCT02620865|Vitamin B Complex|vitamin b complex|mesh-ancestor
19966126|NCT02620865|Vitamins|vitamins|mesh-ancestor
19966127|NCT02620865|Micronutrients|micronutrients|mesh-ancestor
19966128|NCT02620865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19966129|NCT02620865|Analgesics|analgesics|mesh-ancestor
19966130|NCT02620865|Sensory System Agents|sensory system agents|mesh-ancestor
19966131|NCT02620865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19966132|NCT02620865|Hematinics|hematinics|mesh-ancestor
19966133|NCT02620865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19966134|NCT02620865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19966135|NCT02611960|Gemcitabine|gemcitabine|mesh-list
20549337|NCT01905566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20549338|NCT01905566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20549339|NCT01905566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20549340|NCT01905566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20549341|NCT01905566|Purinergic Agents|purinergic agents|mesh-ancestor
20549342|NCT01905566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20549343|NCT01905566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549344|NCT01905566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549345|NCT01905618|Nicotine|nicotine|mesh-list
20549346|NCT01905618|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20549347|NCT01905618|Autonomic Agents|autonomic agents|mesh-ancestor
20549348|NCT01905618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20549349|NCT01905618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549350|NCT01905618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20549351|NCT01905618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20549352|NCT01905618|Cholinergic Agents|cholinergic agents|mesh-ancestor
20549353|NCT01905618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20549354|NCT01905618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549355|NCT01905631|Diphenhydramine|diphenhydramine|mesh-list
20549356|NCT01905631|Promethazine|promethazine|mesh-list
20549357|NCT01905631|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20549358|NCT01905631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20549359|NCT01905631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20549360|NCT01905631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549361|NCT01905631|Anesthetics, Local|anesthetics, local|mesh-ancestor
20549362|NCT01905631|Anesthetics|anesthetics|mesh-ancestor
19966136|NCT02611960|Capecitabine|capecitabine|mesh-list
19966137|NCT02611960|Docetaxel|docetaxel|mesh-list
19966138|NCT02611960|Pembrolizumab|pembrolizumab|mesh-list
19966139|NCT02611960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19966140|NCT02611960|Antimetabolites|antimetabolites|mesh-ancestor
19966141|NCT02611960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966142|NCT02611960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549363|NCT01905631|Sensory System Agents|sensory system agents|mesh-ancestor
19966143|NCT02611960|Antiviral Agents|antiviral agents|mesh-ancestor
19966144|NCT02611960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19966145|NCT02611960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549364|NCT01905631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20549365|NCT01905631|Antiemetics|antiemetics|mesh-ancestor
20549366|NCT01905631|Autonomic Agents|autonomic agents|mesh-ancestor
20549367|NCT01905631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20549368|NCT01905631|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20549369|NCT01905631|Histamine Antagonists|histamine antagonists|mesh-ancestor
20549370|NCT01905631|Histamine Agents|histamine agents|mesh-ancestor
20549371|NCT01905631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20549372|NCT01905631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549373|NCT01905631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20549374|NCT01905631|Antipruritics|antipruritics|mesh-ancestor
20549375|NCT01905631|Dermatologic Agents|dermatologic agents|mesh-ancestor
20549376|NCT01905696|Acetylcysteine|acetylcysteine|mesh-list
20549377|NCT01905696|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20549378|NCT01905696|Antiviral Agents|antiviral agents|mesh-ancestor
20549379|NCT01905696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549380|NCT01905696|Expectorants|expectorants|mesh-ancestor
20549381|NCT01905696|Respiratory System Agents|respiratory system agents|mesh-ancestor
20549382|NCT01905696|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20549383|NCT01905696|Antioxidants|antioxidants|mesh-ancestor
20549384|NCT01905696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549385|NCT01905696|Protective Agents|protective agents|mesh-ancestor
20549386|NCT01905696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549387|NCT01905696|Antidotes|antidotes|mesh-ancestor
20549388|NCT01905774|Deferasirox|deferasirox|mesh-list
20549389|NCT01905774|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20549390|NCT01905774|Chelating Agents|chelating agents|mesh-ancestor
20549391|NCT01905774|Sequestering Agents|sequestering agents|mesh-ancestor
20549392|NCT01905774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549393|NCT01905904|Sevoflurane|sevoflurane|mesh-list
20549394|NCT01905904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20549395|NCT01905904|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20549396|NCT01905904|Anesthetics, General|anesthetics, general|mesh-ancestor
20549397|NCT01905904|Anesthetics|anesthetics|mesh-ancestor
20549398|NCT01905904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20549399|NCT01905904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549400|NCT01906073|Fentanyl|fentanyl|mesh-list
20549401|NCT01906073|Morphine|morphine|mesh-list
20549402|NCT01906073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20549403|NCT01906073|Narcotics|narcotics|mesh-ancestor
20549404|NCT01906073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20549405|NCT01906073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549406|NCT01906073|Analgesics|analgesics|mesh-ancestor
20549407|NCT01906073|Sensory System Agents|sensory system agents|mesh-ancestor
20549408|NCT01906073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20549409|NCT01906073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20549410|NCT01906073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20549411|NCT01906073|Anesthetics, General|anesthetics, general|mesh-ancestor
20549412|NCT01906073|Anesthetics|anesthetics|mesh-ancestor
20549413|NCT01906125|Palbociclib|palbociclib|mesh-list
20549414|NCT01906125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549415|NCT01906125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20549416|NCT01906125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549417|NCT01906125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549418|NCT01906216|Sorafenib|sorafenib|mesh-list
20549419|NCT01906216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733463|NCT04561739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19733464|NCT04561739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19733465|NCT04561739|Antifungal Agents|antifungal agents|mesh-ancestor
19733466|NCT04561739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19733467|NCT04561739|Immunologic Factors|immunologic factors|mesh-ancestor
20549420|NCT01906216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20549421|NCT01906216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549422|NCT01906216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549423|NCT01906242|Chlorhexidine|chlorhexidine|mesh-list
20549424|NCT01906242|Sodium Hypochlorite|sodium hypochlorite|mesh-list
20549425|NCT01906242|Eusol|eusol|mesh-list
20549426|NCT01906242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20549427|NCT01906242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549428|NCT01906242|Disinfectants|disinfectants|mesh-ancestor
20549429|NCT01906294|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20549430|NCT01906294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733468|NCT04561466|Bezafibrate|bezafibrate|mesh-list
20549431|NCT01906307|Angiotensin II|angiotensin ii|mesh-list
20549432|NCT01906307|Giapreza|giapreza|mesh-list
20549433|NCT01906307|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19966146|NCT02611960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19966147|NCT02611960|Immunologic Factors|immunologic factors|mesh-ancestor
19966148|NCT02611960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966149|NCT02611960|Tubulin Modulators|tubulin modulators|mesh-ancestor
19966150|NCT02611960|Antimitotic Agents|antimitotic agents|mesh-ancestor
19966151|NCT02611960|Mitosis Modulators|mitosis modulators|mesh-ancestor
20549434|NCT01906411|Dopamine|dopamine|mesh-list
20549435|NCT01906411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20549436|NCT01906411|Sympathomimetics|sympathomimetics|mesh-ancestor
20549437|NCT01906411|Autonomic Agents|autonomic agents|mesh-ancestor
20549438|NCT01906411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20549439|NCT01906411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549440|NCT01906411|Dopamine Agents|dopamine agents|mesh-ancestor
20549441|NCT01906411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20549442|NCT01906411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966152|NCT02611960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19966153|NCT02611323|Rituximab|rituximab|mesh-list
19966154|NCT02611323|Obinutuzumab|obinutuzumab|mesh-list
19966155|NCT02611323|Venetoclax|venetoclax|mesh-list
19966156|NCT02611323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19966157|NCT02611323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966158|NCT02611323|Immunologic Factors|immunologic factors|mesh-ancestor
19966159|NCT02611323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966160|NCT02611323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19966161|NCT02585375|Latanoprost|latanoprost|mesh-list
19966162|NCT02585375|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19966163|NCT02585375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19966164|NCT02566395|Cyclophosphamide|cyclophosphamide|mesh-list
19966165|NCT02566395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20549443|NCT01906411|Protective Agents|protective agents|mesh-ancestor
20549444|NCT01906450|Azithromycin|azithromycin|mesh-list
20549445|NCT01906450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20549446|NCT01906450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549447|NCT01906528|Mivacurium|mivacurium|mesh-list
19966166|NCT02566395|Immunologic Factors|immunologic factors|mesh-ancestor
19966167|NCT02566395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966168|NCT02566395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19966169|NCT02566395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20549448|NCT01906528|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20549449|NCT01906528|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20549450|NCT01906528|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20549451|NCT01906528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20549452|NCT01906528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549453|NCT01906580|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20549454|NCT01906580|Entecavir|entecavir|mesh-list
20549455|NCT01906580|Antiviral Agents|antiviral agents|mesh-ancestor
20549456|NCT01906580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549457|NCT01906671|Mercaptopurine|mercaptopurine|mesh-list
20549458|NCT01906671|Antimetabolites|antimetabolites|mesh-ancestor
20549459|NCT01906671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549460|NCT01906671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20549461|NCT01906671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549462|NCT01906671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20549463|NCT01906671|Immunologic Factors|immunologic factors|mesh-ancestor
20549464|NCT01906671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549465|NCT01906671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20549466|NCT01906671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549467|NCT01906749|Colchicine|colchicine|mesh-list
20549468|NCT01906749|Gout Suppressants|gout suppressants|mesh-ancestor
20549469|NCT01906749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20549470|NCT01906749|Tubulin Modulators|tubulin modulators|mesh-ancestor
20549471|NCT01906749|Antimitotic Agents|antimitotic agents|mesh-ancestor
20549472|NCT01906749|Mitosis Modulators|mitosis modulators|mesh-ancestor
20549473|NCT01906749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549474|NCT01906749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549475|NCT01906762|Acetaminophen|acetaminophen|mesh-list
20549476|NCT01906762|Morphine|morphine|mesh-list
20549477|NCT01906762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20549478|NCT01906762|Narcotics|narcotics|mesh-ancestor
19966170|NCT02566395|Alkylating Agents|alkylating agents|mesh-ancestor
19966171|NCT02566395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966172|NCT02566395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966173|NCT02566395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19966174|NCT02556099|Hydroxyurea|hydroxyurea|mesh-list
20549479|NCT01906762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20549480|NCT01906762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549481|NCT01906762|Analgesics|analgesics|mesh-ancestor
20549482|NCT01906762|Sensory System Agents|sensory system agents|mesh-ancestor
20549483|NCT01906762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20549484|NCT01906762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20549485|NCT01906762|Antipyretics|antipyretics|mesh-ancestor
20549486|NCT01906788|Lumefantrine|lumefantrine|mesh-list
20549487|NCT01906788|Artemether|artemether|mesh-list
20549488|NCT01906788|Primaquine|primaquine|mesh-list
20549489|NCT01906788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20549490|NCT01906788|Antimalarials|antimalarials|mesh-ancestor
20549491|NCT01906788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20549492|NCT01906788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20549493|NCT01906788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549494|NCT01906801|Diacetylrhein|diacetylrhein|mesh-list
20549495|NCT01906801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20549496|NCT01906814|Carboplatin|carboplatin|mesh-list
20549497|NCT01906814|Etoposide|etoposide|mesh-list
20549498|NCT01906814|Etoposide phosphate|etoposide phosphate|mesh-list
20549499|NCT01906814|Vincristine|vincristine|mesh-list
20549500|NCT01906814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549501|NCT01906814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20549502|NCT01906814|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20549503|NCT01906814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20549504|NCT01906814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549505|NCT01906814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549506|NCT01906814|Tubulin Modulators|tubulin modulators|mesh-ancestor
20549507|NCT01906814|Antimitotic Agents|antimitotic agents|mesh-ancestor
20549508|NCT01906814|Mitosis Modulators|mitosis modulators|mesh-ancestor
20554578|NCT01935830|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20554579|NCT01935830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20554580|NCT01935830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20554581|NCT01935869|Petrolatum|petrolatum|mesh-list
20554582|NCT01935869|Emollients|emollients|mesh-ancestor
20554583|NCT01935869|Dermatologic Agents|dermatologic agents|mesh-ancestor
20554584|NCT01935882|Lumefantrine|lumefantrine|mesh-list
20554585|NCT01935882|Artemether|artemether|mesh-list
20554586|NCT01935882|Primaquine|primaquine|mesh-list
20554587|NCT01935882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20554588|NCT01935882|Antimalarials|antimalarials|mesh-ancestor
20554589|NCT01935882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20554590|NCT01935882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20554591|NCT01935882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20554592|NCT01935908|Levetiracetam|levetiracetam|mesh-list
20554593|NCT01935908|Anticonvulsants|anticonvulsants|mesh-ancestor
20554594|NCT01935908|Nootropic Agents|nootropic agents|mesh-ancestor
20554595|NCT01935973|Trametinib|trametinib|mesh-list
20554596|NCT01935973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554597|NCT01935973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20554598|NCT01935973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554599|NCT01935973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555054|NCT01938456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555055|NCT01938456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20555056|NCT01938456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555057|NCT01938508|Minocycline|minocycline|mesh-list
20555058|NCT01938508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20555059|NCT01938508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20555060|NCT01938547|Clevidipine|clevidipine|mesh-list
20555061|NCT01938547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20555062|NCT01938547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20555063|NCT01938547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555064|NCT01938547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20555065|NCT01938547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555066|NCT01938612|Durvalumab|durvalumab|mesh-list
20555067|NCT01938612|Tremelimumab|tremelimumab|mesh-list
20555068|NCT01938612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20555069|NCT01938612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555070|NCT01938729|Gemcitabine|gemcitabine|mesh-list
20555071|NCT01938729|Dexamethasone|dexamethasone|mesh-list
20555072|NCT01938729|Floxuridine|floxuridine|mesh-list
20555073|NCT01938729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20555074|NCT01938729|Antiemetics|antiemetics|mesh-ancestor
20555075|NCT01938729|Autonomic Agents|autonomic agents|mesh-ancestor
20555076|NCT01938729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20555077|NCT01938729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555078|NCT01938729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20555079|NCT01938729|Glucocorticoids|glucocorticoids|mesh-ancestor
20555080|NCT01938729|Hormones|hormones|mesh-ancestor
20549509|NCT01906853|Vaccines|vaccines|mesh-list
20549510|NCT01906853|BCG Vaccine|bcg vaccine|mesh-list
20549511|NCT01906853|Immunologic Factors|immunologic factors|mesh-ancestor
20549512|NCT01906853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549513|NCT01906853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20549514|NCT01906879|Bismuth|bismuth|mesh-list
20549515|NCT01906879|Antacids|antacids|mesh-ancestor
20549516|NCT01906879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549517|NCT01906879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20549518|NCT01906944|Triamcinolone|triamcinolone|mesh-list
20549519|NCT01906944|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20549520|NCT01906944|Bupivacaine|bupivacaine|mesh-list
20549521|NCT01906944|Anesthetics, Local|anesthetics, local|mesh-ancestor
20549522|NCT01906944|Anesthetics|anesthetics|mesh-ancestor
20549523|NCT01906944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20549524|NCT01906944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549525|NCT01906944|Sensory System Agents|sensory system agents|mesh-ancestor
20549526|NCT01906944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20549527|NCT01906944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20549528|NCT01906944|Glucocorticoids|glucocorticoids|mesh-ancestor
20549529|NCT01906944|Hormones|hormones|mesh-ancestor
20549530|NCT01906944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20549531|NCT01906944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20549532|NCT01906944|Immunologic Factors|immunologic factors|mesh-ancestor
20549533|NCT01907009|Melphalan|melphalan|mesh-list
20549534|NCT01907009|Lenograstim|lenograstim|mesh-list
20549535|NCT01907009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20549536|NCT01907009|Alkylating Agents|alkylating agents|mesh-ancestor
20554600|NCT01936012|Lisinopril|lisinopril|mesh-list
19966175|NCT02556099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966176|NCT02556099|Antisickling Agents|antisickling agents|mesh-ancestor
19966177|NCT02556099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966178|NCT02556099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966179|NCT02556099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19966180|NCT02516813|Peposertib|peposertib|mesh-list
19966181|NCT02516813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19966182|NCT02516813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286274|NCT04054674|Keratolytic Agents|keratolytic agents|mesh-ancestor
20286275|NCT04054674|Dermatologic Agents|dermatologic agents|mesh-ancestor
20286276|NCT04052490|Salicylic Acid|salicylic acid|mesh-list
20286277|NCT04052490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20286278|NCT04052490|Antifungal Agents|antifungal agents|mesh-ancestor
20286279|NCT04052490|Keratolytic Agents|keratolytic agents|mesh-ancestor
20286280|NCT04052490|Dermatologic Agents|dermatologic agents|mesh-ancestor
20286281|NCT03992443|Reteplase|reteplase|mesh-list
20286282|NCT03992443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20286283|NCT03992443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20286284|NCT03992443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286285|NCT03960554|Denosumab|denosumab|mesh-list
20286286|NCT03960554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20286287|NCT03960554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286288|NCT03950739|Treprostinil|treprostinil|mesh-list
20286289|NCT03950739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20286290|NCT03929601|Rituximab|rituximab|mesh-list
20286291|NCT03929601|Abatacept|abatacept|mesh-list
20286292|NCT03929601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20286293|NCT03929601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286294|NCT03929601|Immunologic Factors|immunologic factors|mesh-ancestor
20286295|NCT03929601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286296|NCT03929601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20286297|NCT03929601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20286298|NCT03929601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286299|NCT03929601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20286300|NCT03910660|Pembrolizumab|pembrolizumab|mesh-list
20286301|NCT03910660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20286302|NCT03910660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286303|NCT03899636|Folfirinox|folfirinox|mesh-list
20286304|NCT03899636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286305|NCT03889756|Midazolam|midazolam|mesh-list
20286306|NCT03889756|Ketamine|ketamine|mesh-list
20286307|NCT03889756|Analgesics|analgesics|mesh-ancestor
20286308|NCT03889756|Sensory System Agents|sensory system agents|mesh-ancestor
20286309|NCT03889756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20286310|NCT03889756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286311|NCT03889756|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20286312|NCT03889756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19966183|NCT02516813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966184|NCT02498392|JNJ-42165279|jnj-42165279|mesh-list
19966185|NCT02498392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966186|NCT02498392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966187|NCT02478775|Cetrorelix|cetrorelix|mesh-list
19966188|NCT02478775|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19966189|NCT02478775|Fertility Agents|fertility agents|mesh-ancestor
19966190|NCT02478775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19966191|NCT02478775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966192|NCT02478775|Hormone Antagonists|hormone antagonists|mesh-ancestor
20549537|NCT01907009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549538|NCT01907009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549539|NCT01907009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20549540|NCT01907009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20549541|NCT01907009|Immunologic Factors|immunologic factors|mesh-ancestor
20549542|NCT01907009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549543|NCT01907009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20549544|NCT01907048|Rivaroxaban|rivaroxaban|mesh-list
20549545|NCT01907048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20549546|NCT01907048|Antithrombins|antithrombins|mesh-ancestor
20549547|NCT01907048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20549548|NCT01907048|Protease Inhibitors|protease inhibitors|mesh-ancestor
19966193|NCT02478775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19966194|NCT02437071|Pembrolizumab|pembrolizumab|mesh-list
19966195|NCT02437071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19966196|NCT02437071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966197|NCT02422641|Methotrexate|methotrexate|mesh-list
19966198|NCT02422641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19966199|NCT02422641|Abortifacient Agents|abortifacient agents|mesh-ancestor
19966200|NCT02422641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19966201|NCT02422641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966202|NCT02422641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19966203|NCT02422641|Antimetabolites|antimetabolites|mesh-ancestor
19966204|NCT02422641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966205|NCT02422641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549549|NCT01907048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549550|NCT01907048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549551|NCT01907048|Anticoagulants|anticoagulants|mesh-ancestor
20549552|NCT01907061|Acetylcysteine|acetylcysteine|mesh-list
20549553|NCT01907061|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20549554|NCT01907061|Antiviral Agents|antiviral agents|mesh-ancestor
20549555|NCT01907061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549556|NCT01907061|Expectorants|expectorants|mesh-ancestor
20549557|NCT01907061|Respiratory System Agents|respiratory system agents|mesh-ancestor
20549558|NCT01907061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20549559|NCT01907061|Antioxidants|antioxidants|mesh-ancestor
20549560|NCT01907061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549561|NCT01907061|Protective Agents|protective agents|mesh-ancestor
20549562|NCT01907061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549563|NCT01907061|Antidotes|antidotes|mesh-ancestor
20549564|NCT01907165|Copper|copper|mesh-list
20549565|NCT01907165|Temozolomide|temozolomide|mesh-list
20549566|NCT01907165|Disulfiram|disulfiram|mesh-list
20549567|NCT01907165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20549568|NCT01907165|Alkylating Agents|alkylating agents|mesh-ancestor
20549569|NCT01907165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549570|NCT01907165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549571|NCT01907165|Trace Elements|trace elements|mesh-ancestor
20549572|NCT01907165|Micronutrients|micronutrients|mesh-ancestor
20549573|NCT01907165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549574|NCT01907165|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20549575|NCT01907165|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20549576|NCT01907165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549577|NCT01907191|Bupivacaine|bupivacaine|mesh-list
20549578|NCT01907191|Anesthetics, Local|anesthetics, local|mesh-ancestor
20549579|NCT01907191|Anesthetics|anesthetics|mesh-ancestor
20549580|NCT01907191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20549581|NCT01907191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549582|NCT01907191|Sensory System Agents|sensory system agents|mesh-ancestor
20549583|NCT01907191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20549584|NCT01907204|Methylprednisolone|methylprednisolone|mesh-list
20549585|NCT01907204|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20549586|NCT01907204|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20549587|NCT01907204|Prednisolone|prednisolone|mesh-list
20549588|NCT01907204|Prednisolone acetate|prednisolone acetate|mesh-list
20549589|NCT01907204|Budesonide|budesonide|mesh-list
20549590|NCT01907204|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20549591|NCT01907204|Prednisolone phosphate|prednisolone phosphate|mesh-list
20549592|NCT01907204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20549593|NCT01907204|Antiemetics|antiemetics|mesh-ancestor
20549594|NCT01907204|Autonomic Agents|autonomic agents|mesh-ancestor
20549595|NCT01907204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20549596|NCT01907204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549597|NCT01907204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20549598|NCT01907204|Glucocorticoids|glucocorticoids|mesh-ancestor
20549599|NCT01907204|Hormones|hormones|mesh-ancestor
20549600|NCT01907204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20549601|NCT01907204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20549602|NCT01907204|Protective Agents|protective agents|mesh-ancestor
19966206|NCT02422641|Dermatologic Agents|dermatologic agents|mesh-ancestor
19966207|NCT02422641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966208|NCT02422641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19966209|NCT02422641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19966210|NCT02422641|Immunologic Factors|immunologic factors|mesh-ancestor
19966211|NCT02422641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20549603|NCT01907204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20549604|NCT01907204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450400|NCT03428607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19450401|NCT03428607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19450402|NCT03428607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733469|NCT04561466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20549605|NCT01907204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20549606|NCT01907204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20549607|NCT01907204|Respiratory System Agents|respiratory system agents|mesh-ancestor
20549608|NCT01907230|Entecavir|entecavir|mesh-list
20549609|NCT01907230|Antiviral Agents|antiviral agents|mesh-ancestor
20549610|NCT01907230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549611|NCT01907308|Docetaxel|docetaxel|mesh-list
20549612|NCT01907308|Trebananib|trebananib|mesh-list
20549613|NCT01907308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549614|NCT01907308|Tubulin Modulators|tubulin modulators|mesh-ancestor
20549615|NCT01907308|Antimitotic Agents|antimitotic agents|mesh-ancestor
20549616|NCT01907308|Mitosis Modulators|mitosis modulators|mesh-ancestor
20549617|NCT01907308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549618|NCT01907308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20549619|NCT01907308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20549620|NCT01907308|Growth Substances|growth substances|mesh-ancestor
20549621|NCT01907308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549622|NCT01907308|Growth Inhibitors|growth inhibitors|mesh-ancestor
20549623|NCT01907373|Probenecid|probenecid|mesh-list
20549624|NCT01907373|Olmesartan|olmesartan|mesh-list
20549625|NCT01907373|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
20549626|NCT01907373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20549627|NCT01907373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20549628|NCT01907373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20549629|NCT01907373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549630|NCT01907373|Uricosuric Agents|uricosuric agents|mesh-ancestor
20549631|NCT01907373|Gout Suppressants|gout suppressants|mesh-ancestor
20549632|NCT01907373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20549633|NCT01907373|Renal Agents|renal agents|mesh-ancestor
20549634|NCT01907529|Cyclophosphamide|cyclophosphamide|mesh-list
20549635|NCT01907529|Docetaxel|docetaxel|mesh-list
20549636|NCT01907529|Epirubicin|epirubicin|mesh-list
20549637|NCT01907529|Endostar protein|endostar protein|mesh-list
20549638|NCT01907529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20549639|NCT01907529|Immunologic Factors|immunologic factors|mesh-ancestor
20549640|NCT01907529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549641|NCT01907529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19733470|NCT04561466|Antimetabolites|antimetabolites|mesh-ancestor
20549642|NCT01907529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20549643|NCT01907529|Alkylating Agents|alkylating agents|mesh-ancestor
20549644|NCT01907529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549645|NCT01907529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549646|NCT01907529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20549647|NCT01907529|Tubulin Modulators|tubulin modulators|mesh-ancestor
20549648|NCT01907529|Antimitotic Agents|antimitotic agents|mesh-ancestor
20549649|NCT01907529|Mitosis Modulators|mitosis modulators|mesh-ancestor
20549650|NCT01907529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20549651|NCT01907529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19733471|NCT04561466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549652|NCT01907529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20549653|NCT01907529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549654|NCT01907529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20549655|NCT01907529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19450403|NCT03428607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450404|NCT03428568|Clarithromycin|clarithromycin|mesh-list
19450405|NCT03428568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19450406|NCT03428568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549656|NCT01907529|Growth Substances|growth substances|mesh-ancestor
20549657|NCT01907529|Growth Inhibitors|growth inhibitors|mesh-ancestor
20549658|NCT01907594|Cycloserine|cycloserine|mesh-list
20549659|NCT01907594|Nicotine|nicotine|mesh-list
20549660|NCT01907594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20549661|NCT01907594|Autonomic Agents|autonomic agents|mesh-ancestor
20549662|NCT01907594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20549663|NCT01907594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549664|NCT01907594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20549665|NCT01907594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20549666|NCT01907594|Cholinergic Agents|cholinergic agents|mesh-ancestor
20549667|NCT01907594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20549668|NCT01907594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549669|NCT01907594|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20549670|NCT01907594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549671|NCT01907594|Renal Agents|renal agents|mesh-ancestor
20549672|NCT01907594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20549673|NCT01907594|Antitubercular Agents|antitubercular agents|mesh-ancestor
20549674|NCT01907594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20549675|NCT01907594|Antimetabolites|antimetabolites|mesh-ancestor
20549676|NCT01907633|Domperidone|domperidone|mesh-list
20549677|NCT01907633|Antiemetics|antiemetics|mesh-ancestor
20549678|NCT01907633|Autonomic Agents|autonomic agents|mesh-ancestor
20549679|NCT01907633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20549680|NCT01907633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450407|NCT03428568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19450408|NCT03428568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19450409|NCT03428568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966212|NCT02422641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19966213|NCT02411656|Pembrolizumab|pembrolizumab|mesh-list
19966214|NCT02411656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19966215|NCT02411656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549681|NCT01907633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20549682|NCT01907633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20549683|NCT01907633|Dopamine Agents|dopamine agents|mesh-ancestor
19966216|NCT02394132|Imiquimod|imiquimod|mesh-list
19966217|NCT02394132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19966218|NCT02394132|Immunologic Factors|immunologic factors|mesh-ancestor
19966219|NCT02394132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966220|NCT02394132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966221|NCT02394132|Interferon Inducers|interferon inducers|mesh-ancestor
19966222|NCT02392871|Trametinib|trametinib|mesh-list
19966223|NCT02392871|Dabrafenib|dabrafenib|mesh-list
19966224|NCT02392871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966225|NCT02392871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19966226|NCT02392871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966227|NCT02392871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966228|NCT02382575|Rituximab|rituximab|mesh-list
19966229|NCT02382575|Tacrolimus|tacrolimus|mesh-list
19966230|NCT02382575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
20549684|NCT01907633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20549685|NCT01907633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549686|NCT01907685|Docetaxel|docetaxel|mesh-list
20549687|NCT01907685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549688|NCT01907685|Tubulin Modulators|tubulin modulators|mesh-ancestor
20549689|NCT01907685|Antimitotic Agents|antimitotic agents|mesh-ancestor
20549690|NCT01907685|Mitosis Modulators|mitosis modulators|mesh-ancestor
20549691|NCT01907685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549692|NCT01907724|Simeprevir|simeprevir|mesh-list
20549693|NCT01907724|Antiviral Agents|antiviral agents|mesh-ancestor
19966231|NCT02382575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19966232|NCT02382575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966233|NCT02382575|Immunologic Factors|immunologic factors|mesh-ancestor
20549694|NCT01907724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19966234|NCT02382575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549695|NCT01907724|Protease Inhibitors|protease inhibitors|mesh-ancestor
20549696|NCT01907724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966235|NCT02382575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19966236|NCT02382575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20549697|NCT01907724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549698|NCT01907776|Arbekacin|arbekacin|mesh-list
20549699|NCT01907776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20549700|NCT01907776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549701|NCT01907802|Dabrafenib|dabrafenib|mesh-list
20549702|NCT01907802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549703|NCT01907802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20549704|NCT01907802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549705|NCT01907802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549706|NCT01907867|Finafloxacin|finafloxacin|mesh-list
20549707|NCT01907867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20549708|NCT01907867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549709|NCT01907867|Renal Agents|renal agents|mesh-ancestor
20549710|NCT01907867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20549711|NCT01907867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20549712|NCT01907867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20549713|NCT01907867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549714|NCT01907867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549715|NCT01907867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549716|NCT01907880|Zoledronic Acid|zoledronic acid|mesh-list
20549717|NCT01907880|Pamidronate|pamidronate|mesh-list
20549718|NCT01907880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20549719|NCT01907880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549720|NCT01907984|Diclofenac|diclofenac|mesh-list
20549721|NCT01907984|Midazolam|midazolam|mesh-list
20549722|NCT01907984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20549723|NCT01907984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20549724|NCT01907984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19966237|NCT02382575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966238|NCT02382575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549725|NCT01907984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549726|NCT01907984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20549727|NCT01907984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20549728|NCT01907984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20549729|NCT01907984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20549730|NCT01907984|Anesthetics, General|anesthetics, general|mesh-ancestor
20549731|NCT01907984|Anesthetics|anesthetics|mesh-ancestor
20549732|NCT01907984|GABA Modulators|gaba modulators|mesh-ancestor
20549733|NCT01907984|GABA Agents|gaba agents|mesh-ancestor
20549734|NCT01907984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20549735|NCT01907984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549736|NCT01907984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20549737|NCT01907984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20549738|NCT01907984|Analgesics|analgesics|mesh-ancestor
20549739|NCT01907984|Sensory System Agents|sensory system agents|mesh-ancestor
20549740|NCT01907984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20549741|NCT01907984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20549742|NCT01907984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20549743|NCT01907984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20549744|NCT01907984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549745|NCT01907997|Lidocaine|lidocaine|mesh-list
20549746|NCT01907997|Anesthetics, Local|anesthetics, local|mesh-ancestor
20549747|NCT01907997|Anesthetics|anesthetics|mesh-ancestor
20549748|NCT01907997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20549749|NCT01907997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549750|NCT01907997|Sensory System Agents|sensory system agents|mesh-ancestor
20549751|NCT01907997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20549752|NCT01907997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20549753|NCT01907997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20549754|NCT01907997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19966239|NCT02239874|Vitamin D|vitamin d|mesh-list
19966240|NCT02239874|Ergocalciferols|ergocalciferols|mesh-list
19966241|NCT02239874|Vitamins|vitamins|mesh-list
19966242|NCT02239874|Micronutrients|micronutrients|mesh-ancestor
19966243|NCT02239874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966244|NCT02239874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19966245|NCT02239874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19966246|NCT02236910|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
19966247|NCT02236910|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19966248|NCT02236910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966249|NCT02199236|Capecitabine|capecitabine|mesh-list
20549755|NCT01907997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20549756|NCT01907997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966250|NCT02199236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20549757|NCT01908075|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20549758|NCT01908075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19966251|NCT02199236|Antimetabolites|antimetabolites|mesh-ancestor
19966252|NCT02199236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966253|NCT02199236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966254|NCT02153580|Cyclophosphamide|cyclophosphamide|mesh-list
19966255|NCT02153580|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19966256|NCT02153580|Fludarabine|fludarabine|mesh-list
19966257|NCT02153580|Fludarabine phosphate|fludarabine phosphate|mesh-list
19966258|NCT02153580|Etoposide|etoposide|mesh-list
19966259|NCT02153580|Etoposide phosphate|etoposide phosphate|mesh-list
19966260|NCT02153580|Podophyllotoxin|podophyllotoxin|mesh-list
19966261|NCT02153580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19966262|NCT02153580|Immunologic Factors|immunologic factors|mesh-ancestor
19966263|NCT02153580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966264|NCT02153580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19966265|NCT02153580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19966266|NCT02153580|Alkylating Agents|alkylating agents|mesh-ancestor
19966267|NCT02153580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966268|NCT02153580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966269|NCT02153580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19966270|NCT02153580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19966271|NCT02153580|Antimetabolites|antimetabolites|mesh-ancestor
19966272|NCT02153580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19966273|NCT02153580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19966274|NCT02153580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19966275|NCT02153580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966276|NCT02153580|Keratolytic Agents|keratolytic agents|mesh-ancestor
19966277|NCT02153580|Dermatologic Agents|dermatologic agents|mesh-ancestor
19966278|NCT02153580|Tubulin Modulators|tubulin modulators|mesh-ancestor
19966279|NCT02153580|Antimitotic Agents|antimitotic agents|mesh-ancestor
19966280|NCT02153580|Mitosis Modulators|mitosis modulators|mesh-ancestor
19966281|NCT02118584|Etrolizumab|etrolizumab|mesh-list
19966282|NCT02118584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19966283|NCT02118584|Immunologic Factors|immunologic factors|mesh-ancestor
19966284|NCT02118584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966285|NCT02115997|Prednisone|prednisone|mesh-list
20549759|NCT01908075|Autonomic Agents|autonomic agents|mesh-ancestor
20549760|NCT01908075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20549761|NCT01908075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549762|NCT01908075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20549763|NCT01908075|Respiratory System Agents|respiratory system agents|mesh-ancestor
20549764|NCT01908075|Glucocorticoids|glucocorticoids|mesh-ancestor
20549765|NCT01908075|Hormones|hormones|mesh-ancestor
20549766|NCT01908075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20549767|NCT01908075|Sympathomimetics|sympathomimetics|mesh-ancestor
20549768|NCT01908114|Vaccines|vaccines|mesh-list
20549769|NCT01908114|Immunologic Factors|immunologic factors|mesh-ancestor
20549770|NCT01908114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549771|NCT01908257|Lesinurad|lesinurad|mesh-list
20549772|NCT01908257|Ranitidine|ranitidine|mesh-list
20549773|NCT01908257|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20549774|NCT01908257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20549775|NCT01908257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20549776|NCT01908257|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20549777|NCT01908257|Histamine Antagonists|histamine antagonists|mesh-ancestor
20549778|NCT01908257|Histamine Agents|histamine agents|mesh-ancestor
20549779|NCT01908257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20549780|NCT01908257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549781|NCT01908257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549782|NCT01908257|Gout Suppressants|gout suppressants|mesh-ancestor
20549783|NCT01908257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20549784|NCT01908257|Uricosuric Agents|uricosuric agents|mesh-ancestor
20549785|NCT01908257|Renal Agents|renal agents|mesh-ancestor
20549786|NCT01908283|Vaccines|vaccines|mesh-list
19966286|NCT02115997|Methylprednisolone|methylprednisolone|mesh-list
19966287|NCT02115997|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19966288|NCT02115997|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19966289|NCT02115997|Prednisolone|prednisolone|mesh-list
19966290|NCT02115997|Prednisolone acetate|prednisolone acetate|mesh-list
19966291|NCT02115997|Rituximab|rituximab|mesh-list
19966292|NCT02115997|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19966293|NCT02115997|Prednisolone phosphate|prednisolone phosphate|mesh-list
19966294|NCT02115997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19966295|NCT02115997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966296|NCT02115997|Immunologic Factors|immunologic factors|mesh-ancestor
20549787|NCT01908283|Immunologic Factors|immunologic factors|mesh-ancestor
19966297|NCT02115997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966298|NCT02115997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19966299|NCT02115997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19966300|NCT02115997|Glucocorticoids|glucocorticoids|mesh-ancestor
19966301|NCT02115997|Hormones|hormones|mesh-ancestor
19966302|NCT02115997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19966303|NCT02115997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19966304|NCT02115997|Antiemetics|antiemetics|mesh-ancestor
19966305|NCT02115997|Autonomic Agents|autonomic agents|mesh-ancestor
19966306|NCT02115997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19966307|NCT02115997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19966308|NCT02115997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19966309|NCT02115997|Protective Agents|protective agents|mesh-ancestor
19966310|NCT02003144|Eculizumab|eculizumab|mesh-list
19966311|NCT02003144|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19966312|NCT02003144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19966313|NCT02003144|Immunologic Factors|immunologic factors|mesh-ancestor
19966314|NCT02003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966315|NCT01746238|Bevacizumab|bevacizumab|mesh-list
19966316|NCT01746238|Doxorubicin|doxorubicin|mesh-list
19966317|NCT01746238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19966318|NCT01746238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966319|NCT01746238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19966320|NCT01746238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19966321|NCT01746238|Growth Substances|growth substances|mesh-ancestor
19966322|NCT01746238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966323|NCT01746238|Growth Inhibitors|growth inhibitors|mesh-ancestor
19966324|NCT01746238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19966325|NCT01746238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19966326|NCT01746238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19966327|NCT01746238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966328|NCT01746238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966329|NCT01648205|Ranolazine|ranolazine|mesh-list
19966330|NCT01648205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19966331|NCT01648205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19966332|NCT01648205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286313|NCT03889756|Anesthetics, General|anesthetics, general|mesh-ancestor
20286314|NCT03889756|Anesthetics|anesthetics|mesh-ancestor
20286315|NCT03889756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20286316|NCT03889756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20286317|NCT03889756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20286318|NCT03889756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20286319|NCT03889756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286320|NCT03889756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20286321|NCT03889756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20286322|NCT03889756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20286323|NCT03889756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20286324|NCT03889756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20286325|NCT03889756|GABA Modulators|gaba modulators|mesh-ancestor
20286326|NCT03889756|GABA Agents|gaba agents|mesh-ancestor
20288512|NCT05323708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20288513|NCT05323708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288514|NCT05322902|Propofol|propofol|mesh-list
20288515|NCT05322902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20288516|NCT05322902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20288517|NCT05322902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288518|NCT05322902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20288519|NCT05322902|Anesthetics, General|anesthetics, general|mesh-ancestor
20288520|NCT05322902|Anesthetics|anesthetics|mesh-ancestor
20288521|NCT05322733|Cyclophosphamide|cyclophosphamide|mesh-list
20288522|NCT05322733|Fludarabine|fludarabine|mesh-list
20288523|NCT05322733|Obinutuzumab|obinutuzumab|mesh-list
20288524|NCT05322733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20288525|NCT05322733|Immunologic Factors|immunologic factors|mesh-ancestor
20288526|NCT05322733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288527|NCT05322733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20288528|NCT05322733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20288529|NCT05322733|Alkylating Agents|alkylating agents|mesh-ancestor
20288530|NCT05322733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288531|NCT05322733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288532|NCT05322733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20288533|NCT05322733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19966333|NCT01642901|Zoledronic Acid|zoledronic acid|mesh-list
19966334|NCT01642901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20549788|NCT01908283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966335|NCT01642901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966336|NCT01641055|Caseins|caseins|mesh-list
19966337|NCT01641055|Chelating Agents|chelating agents|mesh-ancestor
19966338|NCT01641055|Sequestering Agents|sequestering agents|mesh-ancestor
19966339|NCT01641055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966340|NCT01420874|Leucovorin|leucovorin|mesh-list
19966341|NCT01420874|Fluorouracil|fluorouracil|mesh-list
19966342|NCT01420874|Oxaliplatin|oxaliplatin|mesh-list
19966343|NCT01420874|Antimetabolites|antimetabolites|mesh-ancestor
19966344|NCT01420874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966345|NCT01420874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19966346|NCT01420874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966347|NCT01420874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19966348|NCT01420874|Immunologic Factors|immunologic factors|mesh-ancestor
19966349|NCT01420874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966350|NCT01420874|Antidotes|antidotes|mesh-ancestor
19966351|NCT01420874|Protective Agents|protective agents|mesh-ancestor
19966352|NCT01420874|Vitamin B Complex|vitamin b complex|mesh-ancestor
20549789|NCT01908296|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20549790|NCT01908296|Fluvoxamine|fluvoxamine|mesh-list
20549791|NCT01908296|Antidepressive Agents|antidepressive agents|mesh-ancestor
20549792|NCT01908296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20549793|NCT01908296|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20549794|NCT01908296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20549795|NCT01908296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20549796|NCT01908296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549797|NCT01908296|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19966353|NCT01420874|Vitamins|vitamins|mesh-ancestor
19966354|NCT01420874|Micronutrients|micronutrients|mesh-ancestor
19966355|NCT01312922|Dexetimide|dexetimide|mesh-list
19966356|NCT01312922|Pipamperone|pipamperone|mesh-list
19966357|NCT01312922|Citalopram|citalopram|mesh-list
19966358|NCT01312922|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19966359|NCT01312922|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19966360|NCT01312922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19966361|NCT01312922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966362|NCT01312922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19966363|NCT01312922|Serotonin Agents|serotonin agents|mesh-ancestor
19966364|NCT01312922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966365|NCT01312922|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19966366|NCT01312922|Antidepressive Agents|antidepressive agents|mesh-ancestor
19966367|NCT01312922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19966368|NCT01312922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19966369|NCT01312922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19966370|NCT01312922|Parasympatholytics|parasympatholytics|mesh-ancestor
19966371|NCT01312922|Autonomic Agents|autonomic agents|mesh-ancestor
20286327|NCT03851627|Methyltestosterone|methyltestosterone|mesh-list
20286328|NCT03851627|Testosterone|testosterone|mesh-list
20286329|NCT03851627|Testosterone undecanoate|testosterone undecanoate|mesh-list
20286330|NCT03851627|Testosterone enanthate|testosterone enanthate|mesh-list
20286331|NCT03851627|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20286332|NCT03851627|Androgens|androgens|mesh-ancestor
20286333|NCT03851627|Hormones|hormones|mesh-ancestor
20286334|NCT03851627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20286335|NCT03851627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286336|NCT03851627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20286337|NCT03851627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286338|NCT03851627|Anabolic Agents|anabolic agents|mesh-ancestor
20286339|NCT03834948|Paclitaxel|paclitaxel|mesh-list
20286340|NCT03834948|Pembrolizumab|pembrolizumab|mesh-list
20286341|NCT03834948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20286342|NCT03834948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286343|NCT03834948|Tubulin Modulators|tubulin modulators|mesh-ancestor
20286344|NCT03834948|Antimitotic Agents|antimitotic agents|mesh-ancestor
20286345|NCT03834948|Mitosis Modulators|mitosis modulators|mesh-ancestor
20286346|NCT03834948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286347|NCT03834948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20286348|NCT03773445|Golimumab|golimumab|mesh-list
20286349|NCT03773445|Antibodies|antibodies|mesh-list
20286350|NCT03773445|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20286351|NCT03773445|Immunologic Factors|immunologic factors|mesh-ancestor
20286352|NCT03773445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286353|NCT03773445|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20549798|NCT01908296|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20549799|NCT01908296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20549800|NCT01908296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20549801|NCT01908296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549802|NCT01908296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20549803|NCT01908296|Serotonin Agents|serotonin agents|mesh-ancestor
20549804|NCT01908296|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20549805|NCT01908296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20549806|NCT01908296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20549807|NCT01908296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549808|NCT01908296|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20549809|NCT01908322|Sorafenib|sorafenib|mesh-list
20549810|NCT01908322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549811|NCT01908322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20549812|NCT01908322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549813|NCT01908322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549814|NCT01908335|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20549815|NCT01908335|Interferon-alpha|interferon-alpha|mesh-list
20549816|NCT01908335|Antiviral Agents|antiviral agents|mesh-ancestor
20549817|NCT01908335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549818|NCT01908335|Immunologic Factors|immunologic factors|mesh-ancestor
20549819|NCT01908335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549820|NCT01908348|Erythritol|erythritol|mesh-list
20549821|NCT01908348|Vasodilator Agents|vasodilator agents|mesh-ancestor
20549822|NCT01908387|Azacitidine|azacitidine|mesh-list
19966372|NCT01312922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19966373|NCT01312922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19966374|NCT01312922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20549823|NCT01908387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20549824|NCT01908387|Antimetabolites|antimetabolites|mesh-ancestor
20549825|NCT01908387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549826|NCT01908387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549827|NCT01908387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549828|NCT01908452|Pyridoxine|pyridoxine|mesh-list
20549829|NCT01908452|Vitamin B Complex|vitamin b complex|mesh-ancestor
20549830|NCT01908452|Vitamins|vitamins|mesh-ancestor
20549831|NCT01908452|Micronutrients|micronutrients|mesh-ancestor
20549832|NCT01908452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549833|NCT01908465|Ebastine|ebastine|mesh-list
20549834|NCT01908465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20549835|NCT01908465|Histamine Antagonists|histamine antagonists|mesh-ancestor
20549836|NCT01908465|Histamine Agents|histamine agents|mesh-ancestor
20549837|NCT01908465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20549838|NCT01908465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549839|NCT01908465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549840|NCT01908478|Gemcitabine|gemcitabine|mesh-list
20549841|NCT01908478|Veliparib|veliparib|mesh-list
20549842|NCT01908478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20549843|NCT01908478|Antimetabolites|antimetabolites|mesh-ancestor
20549844|NCT01908478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549845|NCT01908478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549846|NCT01908478|Antiviral Agents|antiviral agents|mesh-ancestor
20549847|NCT01908478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549848|NCT01908478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549849|NCT01908478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20549850|NCT01908478|Immunologic Factors|immunologic factors|mesh-ancestor
20549851|NCT01908478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549852|NCT01908478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20554601|NCT01936012|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20554602|NCT01936012|Protease Inhibitors|protease inhibitors|mesh-ancestor
20554603|NCT01936012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554604|NCT01936012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554605|NCT01936012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20554606|NCT01936012|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20554607|NCT01936012|Protective Agents|protective agents|mesh-ancestor
20554608|NCT01936012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554609|NCT01936025|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20554610|NCT01936025|Dextromethorphan|dextromethorphan|mesh-list
20554611|NCT01936025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20554612|NCT01936025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554613|NCT01936025|Incretins|incretins|mesh-ancestor
20554614|NCT01936025|Hormones|hormones|mesh-ancestor
20554615|NCT01936025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19966375|NCT01312922|Cholinergic Agents|cholinergic agents|mesh-ancestor
20549853|NCT01908556|Letrozole|letrozole|mesh-list
20549854|NCT01908556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549855|NCT01908556|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20549856|NCT01908556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20549857|NCT01908556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549858|NCT01908556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549859|NCT01908556|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20549860|NCT01908556|Hormone Antagonists|hormone antagonists|mesh-ancestor
20549861|NCT01908556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20549862|NCT01908556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549863|NCT01908621|Cytarabine|cytarabine|mesh-list
20549864|NCT01908621|Lenograstim|lenograstim|mesh-list
20549865|NCT01908621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20549866|NCT01908621|Immunologic Factors|immunologic factors|mesh-ancestor
20549867|NCT01908621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549868|NCT01908621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20549869|NCT01908621|Antimetabolites|antimetabolites|mesh-ancestor
20549870|NCT01908621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549871|NCT01908621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549872|NCT01908621|Antiviral Agents|antiviral agents|mesh-ancestor
20549873|NCT01908621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549874|NCT01908621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20549875|NCT01908660|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20549876|NCT01908660|Antiviral Agents|antiviral agents|mesh-ancestor
19966376|NCT01312922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19966377|NCT01312922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19966378|NCT01312922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19966379|NCT01312922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19966380|NCT01091831|Dexamethasone|dexamethasone|mesh-list
19966381|NCT01091831|Cyclophosphamide|cyclophosphamide|mesh-list
19966382|NCT01091831|Melphalan|melphalan|mesh-list
19966383|NCT01091831|Lenalidomide|lenalidomide|mesh-list
19966384|NCT01091831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19966385|NCT01091831|Immunologic Factors|immunologic factors|mesh-ancestor
19966386|NCT01091831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966387|NCT01091831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19966388|NCT01091831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19966389|NCT01091831|Alkylating Agents|alkylating agents|mesh-ancestor
19966390|NCT01091831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966391|NCT01091831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966392|NCT01091831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19966393|NCT01091831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19966394|NCT01091831|Antiemetics|antiemetics|mesh-ancestor
19966395|NCT01091831|Autonomic Agents|autonomic agents|mesh-ancestor
19966396|NCT01091831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19966397|NCT01091831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19966398|NCT01091831|Glucocorticoids|glucocorticoids|mesh-ancestor
19966399|NCT01091831|Hormones|hormones|mesh-ancestor
19966400|NCT01091831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19966401|NCT01091831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19966402|NCT01091831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19966403|NCT01091831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19966404|NCT01091831|Growth Substances|growth substances|mesh-ancestor
19966405|NCT01091831|Growth Inhibitors|growth inhibitors|mesh-ancestor
19966406|NCT01063517|Paclitaxel|paclitaxel|mesh-list
19966407|NCT01063517|Olaparib|olaparib|mesh-list
19966408|NCT01063517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19966409|NCT01063517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966410|NCT01063517|Tubulin Modulators|tubulin modulators|mesh-ancestor
19966411|NCT01063517|Antimitotic Agents|antimitotic agents|mesh-ancestor
19966412|NCT01063517|Mitosis Modulators|mitosis modulators|mesh-ancestor
19966413|NCT01063517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966414|NCT01063517|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19966415|NCT01063517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966416|NCT00915681|Silybin|silybin|mesh-list
19966417|NCT00915681|Protective Agents|protective agents|mesh-ancestor
20549877|NCT01908660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19966418|NCT00915681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966419|NCT00915681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19966420|NCT00915681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549878|NCT01908777|Cytarabine|cytarabine|mesh-list
20549879|NCT01908777|Etoposide|etoposide|mesh-list
20549880|NCT01908777|Melphalan|melphalan|mesh-list
20549881|NCT01908777|Carmustine|carmustine|mesh-list
20549882|NCT01908777|Romidepsin|romidepsin|mesh-list
20549883|NCT01908777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20549884|NCT01908777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549885|NCT01908777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20549886|NCT01908777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20549887|NCT01908777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549888|NCT01908777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549889|NCT01908777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20549890|NCT01908777|Antimetabolites|antimetabolites|mesh-ancestor
20549891|NCT01908777|Antiviral Agents|antiviral agents|mesh-ancestor
20549892|NCT01908777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549893|NCT01908777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20549894|NCT01908777|Immunologic Factors|immunologic factors|mesh-ancestor
20549895|NCT01908777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549896|NCT01908777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20549897|NCT01908777|Alkylating Agents|alkylating agents|mesh-ancestor
20549898|NCT01908777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20549899|NCT01908777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20549900|NCT01908894|Insulin Lispro|insulin lispro|mesh-list
20549901|NCT01908894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20549902|NCT01908894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549903|NCT01909037|Curcumin|curcumin|mesh-list
20549904|NCT01909037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20549905|NCT01909037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20549906|NCT01909037|Analgesics|analgesics|mesh-ancestor
20549907|NCT01909037|Sensory System Agents|sensory system agents|mesh-ancestor
20549908|NCT01909037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20549909|NCT01909037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549910|NCT01909037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20549911|NCT01909037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20549912|NCT01909037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549913|NCT01909037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549914|NCT01909037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549915|NCT01909063|Vitamin D|vitamin d|mesh-list
20549916|NCT01909063|Ergocalciferols|ergocalciferols|mesh-list
20549917|NCT01909063|Vitamins|vitamins|mesh-list
20549918|NCT01909063|Vitamin E|vitamin e|mesh-list
20549919|NCT01909063|Vitamin A|vitamin a|mesh-list
20549920|NCT01909063|Micronutrients|micronutrients|mesh-ancestor
19966421|NCT00813423|Hydroxychloroquine|hydroxychloroquine|mesh-list
19966422|NCT00813423|Sunitinib|sunitinib|mesh-list
19966423|NCT00813423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966424|NCT00813423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19966425|NCT00813423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19966426|NCT00813423|Growth Substances|growth substances|mesh-ancestor
19966427|NCT00813423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966428|NCT00813423|Growth Inhibitors|growth inhibitors|mesh-ancestor
20549921|NCT01909063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549922|NCT01909063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20549923|NCT01909063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20549924|NCT01909063|Antioxidants|antioxidants|mesh-ancestor
20549925|NCT01909063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549926|NCT01909063|Protective Agents|protective agents|mesh-ancestor
20549927|NCT01909089|Chloroprocaine|chloroprocaine|mesh-list
20549928|NCT01909089|Anesthetics, Local|anesthetics, local|mesh-ancestor
20549929|NCT01909089|Anesthetics|anesthetics|mesh-ancestor
20549930|NCT01909089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20549931|NCT01909089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549932|NCT01909089|Sensory System Agents|sensory system agents|mesh-ancestor
20549933|NCT01909089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20549934|NCT01909115|Vitamin D|vitamin d|mesh-list
20549935|NCT01909115|Ergocalciferols|ergocalciferols|mesh-list
20549936|NCT01909115|Cholecalciferol|cholecalciferol|mesh-list
20549937|NCT01909115|Vitamins|vitamins|mesh-list
20549938|NCT01909115|Micronutrients|micronutrients|mesh-ancestor
20549939|NCT01909115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549940|NCT01909115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20549941|NCT01909115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20549942|NCT01909219|Magnesium citrate|magnesium citrate|mesh-list
20549943|NCT01909219|Picosulfate sodium|picosulfate sodium|mesh-list
20549944|NCT01909219|Cathartics|cathartics|mesh-ancestor
20549945|NCT01909219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20549946|NCT01909557|Acetylcarnitine|acetylcarnitine|mesh-list
20549947|NCT01909557|Vitamin B Complex|vitamin b complex|mesh-ancestor
20549948|NCT01909557|Vitamins|vitamins|mesh-ancestor
20549949|NCT01909557|Micronutrients|micronutrients|mesh-ancestor
19966429|NCT00813423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20549950|NCT01909557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966430|NCT00813423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549951|NCT01909557|Nootropic Agents|nootropic agents|mesh-ancestor
20549952|NCT01909622|Vitamin D|vitamin d|mesh-list
20549953|NCT01909622|Ergocalciferols|ergocalciferols|mesh-list
20549954|NCT01909622|Vitamins|vitamins|mesh-list
20549955|NCT01909622|Micronutrients|micronutrients|mesh-ancestor
20549956|NCT01909622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549957|NCT01909622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20549958|NCT01909622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20549959|NCT01909661|Caseins|caseins|mesh-list
19966431|NCT00813423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966432|NCT00813423|Antimalarials|antimalarials|mesh-ancestor
19966433|NCT00813423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19966434|NCT00813423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19966435|NCT00813423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19966436|NCT00813423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19966437|NCT00773695|Paclitaxel|paclitaxel|mesh-list
19966438|NCT00773695|Docetaxel|docetaxel|mesh-list
19966439|NCT00773695|Cyclophosphamide|cyclophosphamide|mesh-list
19966440|NCT00773695|Bevacizumab|bevacizumab|mesh-list
19966441|NCT00773695|Fluorouracil|fluorouracil|mesh-list
19966442|NCT00773695|Epirubicin|epirubicin|mesh-list
19966443|NCT00773695|Aromatase Inhibitors|aromatase inhibitors|mesh-list
19966444|NCT00773695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19966445|NCT00773695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966446|NCT00773695|Tubulin Modulators|tubulin modulators|mesh-ancestor
19966447|NCT00773695|Antimitotic Agents|antimitotic agents|mesh-ancestor
19966448|NCT00773695|Mitosis Modulators|mitosis modulators|mesh-ancestor
19966449|NCT00773695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966450|NCT00773695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19966451|NCT00773695|Immunologic Factors|immunologic factors|mesh-ancestor
19966452|NCT00773695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966453|NCT00773695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19966454|NCT00773695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19966455|NCT00773695|Alkylating Agents|alkylating agents|mesh-ancestor
19966456|NCT00773695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19966457|NCT00773695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19966458|NCT00773695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19966459|NCT00773695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19966460|NCT00773695|Growth Substances|growth substances|mesh-ancestor
20549960|NCT01909661|Chelating Agents|chelating agents|mesh-ancestor
20549961|NCT01909661|Sequestering Agents|sequestering agents|mesh-ancestor
20549962|NCT01909661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549963|NCT01909752|Cyclophosphamide|cyclophosphamide|mesh-list
20549964|NCT01909752|Imiquimod|imiquimod|mesh-list
20549965|NCT01909752|Vaccines|vaccines|mesh-list
20549966|NCT01909752|Immunologic Factors|immunologic factors|mesh-ancestor
20549967|NCT01909752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549968|NCT01909752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20549969|NCT01909752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20549970|NCT01909752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20549971|NCT01909752|Alkylating Agents|alkylating agents|mesh-ancestor
20549972|NCT01909752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549973|NCT01909752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549974|NCT01909752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20549975|NCT01909752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20549976|NCT01909752|Interferon Inducers|interferon inducers|mesh-ancestor
20549977|NCT01909830|Gemcitabine|gemcitabine|mesh-list
20549978|NCT01909830|Pemetrexed|pemetrexed|mesh-list
20549979|NCT01909830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20549980|NCT01909830|Antimetabolites|antimetabolites|mesh-ancestor
20549981|NCT01909830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20549982|NCT01909830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549983|NCT01909830|Antiviral Agents|antiviral agents|mesh-ancestor
20549984|NCT01909830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549985|NCT01909830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20549986|NCT01909830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20549987|NCT01909830|Immunologic Factors|immunologic factors|mesh-ancestor
20549988|NCT01909830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20549989|NCT01909830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20549990|NCT01909830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20549991|NCT01909843|Gontivimab|gontivimab|mesh-list
20549992|NCT01909843|Antiviral Agents|antiviral agents|mesh-ancestor
19966461|NCT00773695|Growth Inhibitors|growth inhibitors|mesh-ancestor
19966462|NCT00773695|Antimetabolites|antimetabolites|mesh-ancestor
19966463|NCT00773695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20549993|NCT01909843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20549994|NCT01909856|Dexamethasone|dexamethasone|mesh-list
20549995|NCT01909856|Palonosetron|palonosetron|mesh-list
19966464|NCT00773695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19966465|NCT00773695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966466|NCT00773695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20549996|NCT01909856|Granisetron|granisetron|mesh-list
20549997|NCT01909856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20549998|NCT01909856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20549999|NCT01909856|Antiemetics|antiemetics|mesh-ancestor
20550000|NCT01909856|Autonomic Agents|autonomic agents|mesh-ancestor
20550001|NCT01909856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550002|NCT01909856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550003|NCT01909856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20550004|NCT01909856|Glucocorticoids|glucocorticoids|mesh-ancestor
20550005|NCT01909856|Hormones|hormones|mesh-ancestor
20550006|NCT01909856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20550007|NCT01909856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20550008|NCT01909856|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20550009|NCT01909856|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20550010|NCT01909856|Serotonin Agents|serotonin agents|mesh-ancestor
20550011|NCT01909856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20550012|NCT01909856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550013|NCT01910077|Tacrolimus|tacrolimus|mesh-list
20550014|NCT01910077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20550015|NCT01910077|Immunologic Factors|immunologic factors|mesh-ancestor
20550016|NCT01910077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966467|NCT00773695|Hormone Antagonists|hormone antagonists|mesh-ancestor
19966468|NCT00773695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19966469|NCT00773695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19966470|NCT00773695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19966471|NCT00773695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19966472|NCT00700596|Salvinorin A|salvinorin a|mesh-list
20550017|NCT01910077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20550018|NCT01910077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550019|NCT01910077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550020|NCT01910090|Flurbiprofen|flurbiprofen|mesh-list
20550021|NCT01910090|Famotidine|famotidine|mesh-list
20550022|NCT01910090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20550023|NCT01910090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20550024|NCT01910090|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20550025|NCT01910090|Histamine Antagonists|histamine antagonists|mesh-ancestor
19966473|NCT00700596|Hallucinogens|hallucinogens|mesh-ancestor
19966474|NCT00700596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550026|NCT01910090|Histamine Agents|histamine agents|mesh-ancestor
20550027|NCT01910090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20550028|NCT01910090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550029|NCT01910090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550030|NCT01910090|Analgesics|analgesics|mesh-ancestor
20550031|NCT01910090|Sensory System Agents|sensory system agents|mesh-ancestor
20550032|NCT01910090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550033|NCT01910090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19966475|NCT00700596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19966476|NCT01732809|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19966477|NCT01732809|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19966478|NCT01732809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19966479|NCT01732809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19966480|NCT01732809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966481|NCT01732809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19966482|NCT01732809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20286354|NCT03773445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20286355|NCT03773445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20286356|NCT03769311|Cetuximab|cetuximab|mesh-list
20286357|NCT03769311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20286358|NCT03769311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286359|NCT03739931|Durvalumab|durvalumab|mesh-list
20286360|NCT03739931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20286361|NCT03739931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286362|NCT03710772|Cytarabine|cytarabine|mesh-list
20286363|NCT03710772|Dexamethasone|dexamethasone|mesh-list
20286364|NCT03710772|Dexamethasone acetate|dexamethasone acetate|mesh-list
20286365|NCT03710772|Cyclophosphamide|cyclophosphamide|mesh-list
20286366|NCT03710772|Rituximab|rituximab|mesh-list
20286367|NCT03710772|Doxorubicin|doxorubicin|mesh-list
20286368|NCT03710772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20286369|NCT03710772|Methotrexate|methotrexate|mesh-list
20286370|NCT03710772|Vincristine|vincristine|mesh-list
20286371|NCT03710772|Venetoclax|venetoclax|mesh-list
20550034|NCT01910090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20550035|NCT01910090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20550036|NCT01910090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20550037|NCT01910090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20550038|NCT01910090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550039|NCT01910142|Vitamin K|vitamin k|mesh-list
20550040|NCT01910142|Calcium|calcium|mesh-list
20550041|NCT01910142|Vitamins|vitamins|mesh-ancestor
20550042|NCT01910142|Micronutrients|micronutrients|mesh-ancestor
20550043|NCT01910142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550044|NCT01910142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20550045|NCT01910142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20550046|NCT01910142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20550047|NCT01910142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550048|NCT01910142|Hemostatics|hemostatics|mesh-ancestor
20550049|NCT01910142|Coagulants|coagulants|mesh-ancestor
20550050|NCT01910155|Ciprofloxacin|ciprofloxacin|mesh-list
20550051|NCT01910155|Dexamethasone|dexamethasone|mesh-list
20550052|NCT01910155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20550053|NCT01910155|Antiemetics|antiemetics|mesh-ancestor
20550054|NCT01910155|Autonomic Agents|autonomic agents|mesh-ancestor
20550055|NCT01910155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550056|NCT01910155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550057|NCT01910155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20550058|NCT01910155|Glucocorticoids|glucocorticoids|mesh-ancestor
20550059|NCT01910155|Hormones|hormones|mesh-ancestor
20550060|NCT01910155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20550061|NCT01910155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20550062|NCT01910155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550063|NCT01910155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20550064|NCT01910155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20550065|NCT01910155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20550066|NCT01910155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20550067|NCT01910155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550068|NCT01910155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550069|NCT01910155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20550070|NCT01910155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20550071|NCT01910194|Insulin Glargine|insulin glargine|mesh-list
20550072|NCT01910194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20550073|NCT01910194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550074|NCT01910246|Metformin|metformin|mesh-list
20550075|NCT01910246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20550076|NCT01910246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966483|NCT01732809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966484|NCT01732809|Cholinergic Agents|cholinergic agents|mesh-ancestor
19966485|NCT01732809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19966486|NCT01732822|Clopidogrel|clopidogrel|mesh-list
19966487|NCT01732822|Ticagrelor|ticagrelor|mesh-list
19966488|NCT01732822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20550077|NCT01910259|Amiloride|amiloride|mesh-list
20550078|NCT01910259|Riluzole|riluzole|mesh-list
20550079|NCT01910259|Fluoxetine|fluoxetine|mesh-list
19966489|NCT01732822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19966490|NCT01732822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19966491|NCT01732822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19966492|NCT01732822|Purinergic Agents|purinergic agents|mesh-ancestor
19966493|NCT01732822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20550080|NCT01910259|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20550081|NCT01910259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20550082|NCT01910259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20550083|NCT01910259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550084|NCT01910259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20550085|NCT01910259|Serotonin Agents|serotonin agents|mesh-ancestor
20550086|NCT01910259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550087|NCT01910259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20550088|NCT01910259|Antidepressive Agents|antidepressive agents|mesh-ancestor
20550089|NCT01910259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20550090|NCT01910259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20550091|NCT01910259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20550092|NCT01910259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550093|NCT01910259|Anticonvulsants|anticonvulsants|mesh-ancestor
20550094|NCT01910259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20550095|NCT01910259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19966494|NCT01732822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966495|NCT01732822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550096|NCT01910259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20550097|NCT01910259|Protective Agents|protective agents|mesh-ancestor
20550098|NCT01910259|Diuretics|diuretics|mesh-ancestor
20550099|NCT01910259|Natriuretic Agents|natriuretic agents|mesh-ancestor
20550100|NCT01910259|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20550101|NCT01910259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20550102|NCT01910259|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20550103|NCT01910259|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20550104|NCT01910285|Sufentanil|sufentanil|mesh-list
20550105|NCT01910285|Dsuvia|dsuvia|mesh-list
20550106|NCT01910285|Remifentanil|remifentanil|mesh-list
20550107|NCT01910285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20550108|NCT01910285|Narcotics|narcotics|mesh-ancestor
20550109|NCT01910285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20550110|NCT01910285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550111|NCT01910285|Analgesics|analgesics|mesh-ancestor
20550112|NCT01910285|Sensory System Agents|sensory system agents|mesh-ancestor
20550113|NCT01910285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550114|NCT01910285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20550115|NCT01910285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20550116|NCT01910285|Anesthetics, General|anesthetics, general|mesh-ancestor
20550117|NCT01910285|Anesthetics|anesthetics|mesh-ancestor
20550118|NCT01910363|Botulinum Toxins|botulinum toxins|mesh-list
20550119|NCT01910363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20550120|NCT01910363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20550121|NCT01910363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20550122|NCT01910363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20550123|NCT01910363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550124|NCT01910363|Cholinergic Agents|cholinergic agents|mesh-ancestor
20550125|NCT01910363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20550126|NCT01910363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550127|NCT01910363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20550128|NCT01910363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550129|NCT01910415|Moxifloxacin|moxifloxacin|mesh-list
20550130|NCT01910415|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
20550131|NCT01910415|Ivacaftor|ivacaftor|mesh-list
20550132|NCT01910415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20550133|NCT01910415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20550134|NCT01910415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20550135|NCT01910415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20550136|NCT01910415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550137|NCT01910415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550138|NCT01910415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550139|NCT01910415|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20550140|NCT01910415|Contraceptive Agents|contraceptive agents|mesh-ancestor
20550141|NCT01910415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20550142|NCT01910415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550143|NCT01910415|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20550144|NCT01910415|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20550145|NCT01910415|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20550146|NCT01910415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20550147|NCT01910415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20554616|NCT01936025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20554617|NCT01936025|Protease Inhibitors|protease inhibitors|mesh-ancestor
20554618|NCT01936025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554619|NCT01936025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554620|NCT01936025|Antitussive Agents|antitussive agents|mesh-ancestor
20554621|NCT01936025|Respiratory System Agents|respiratory system agents|mesh-ancestor
20554622|NCT01936025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20554623|NCT01936025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20554624|NCT01936025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20554625|NCT01936064|Cyclophosphamide|cyclophosphamide|mesh-list
20554626|NCT01936064|Epirubicin|epirubicin|mesh-list
20554627|NCT01936064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20554628|NCT01936064|Immunologic Factors|immunologic factors|mesh-ancestor
20554629|NCT01936064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554630|NCT01936064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20554631|NCT01936064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20554632|NCT01936064|Alkylating Agents|alkylating agents|mesh-ancestor
20554633|NCT01936064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554634|NCT01936064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550148|NCT01910428|Asparaginase|asparaginase|mesh-list
20550149|NCT01910428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550150|NCT01910480|Ketoconazole|ketoconazole|mesh-list
20550151|NCT01910480|Antifungal Agents|antifungal agents|mesh-ancestor
20550152|NCT01910480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20550153|NCT01910480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20550154|NCT01910480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20550155|NCT01910480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550156|NCT01910480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550157|NCT01910480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20550158|NCT01910480|Hormone Antagonists|hormone antagonists|mesh-ancestor
20550159|NCT01910480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20550160|NCT01910480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550161|NCT01910480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20550162|NCT01910506|Verinurad|verinurad|mesh-list
20550163|NCT01910506|Gout Suppressants|gout suppressants|mesh-ancestor
20550164|NCT01910506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20550165|NCT01910532|Clevidipine|clevidipine|mesh-list
20550166|NCT01910532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20550167|NCT01910532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20550168|NCT01910532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550169|NCT01910532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20550170|NCT01910532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550171|NCT01910545|OTS167|ots167|mesh-list
20550172|NCT01910545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20550173|NCT01910545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550174|NCT01910545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550175|NCT01910610|Bevacizumab|bevacizumab|mesh-list
20550176|NCT01910610|Cetuximab|cetuximab|mesh-list
20550177|NCT01910610|Panitumumab|panitumumab|mesh-list
20550178|NCT01910610|Irinotecan|irinotecan|mesh-list
20550179|NCT01910610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20550180|NCT01910610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550181|NCT01910610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19733472|NCT04561466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19733473|NCT04561856|Dexamethasone|dexamethasone|mesh-list
19733474|NCT04561856|Dexamethasone acetate|dexamethasone acetate|mesh-list
20550182|NCT01910610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20550183|NCT01910610|Growth Substances|growth substances|mesh-ancestor
20550184|NCT01910610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550185|NCT01910610|Growth Inhibitors|growth inhibitors|mesh-ancestor
20550186|NCT01910610|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20550187|NCT01910610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20550188|NCT01910610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966496|NCT01733121|Tetrabenazine|tetrabenazine|mesh-list
19966497|NCT01733121|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19966498|NCT01733121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19966499|NCT01733121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20550189|NCT01910610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550190|NCT01910766|Ubiquinone|ubiquinone|mesh-list
20550191|NCT01910766|Coenzyme Q10|coenzyme q10|mesh-list
20550192|NCT01910766|Clomiphene|clomiphene|mesh-list
20550193|NCT01910766|Enclomiphene|enclomiphene|mesh-list
20550194|NCT01910766|Zuclomiphene|zuclomiphene|mesh-list
20550195|NCT01910766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20550196|NCT01910766|Hormone Antagonists|hormone antagonists|mesh-ancestor
20550197|NCT01910766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20550198|NCT01910766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550199|NCT01910766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20550200|NCT01910766|Fertility Agents|fertility agents|mesh-ancestor
20550201|NCT01910766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20550202|NCT01910766|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20550203|NCT01910766|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20550204|NCT01910766|Micronutrients|micronutrients|mesh-ancestor
20550205|NCT01910766|Vitamins|vitamins|mesh-ancestor
20550206|NCT01910844|Cyclophosphamide|cyclophosphamide|mesh-list
20550207|NCT01910844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20550208|NCT01910844|Immunologic Factors|immunologic factors|mesh-ancestor
20550209|NCT01910844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550210|NCT01910844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20550211|NCT01910844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20550212|NCT01910844|Alkylating Agents|alkylating agents|mesh-ancestor
20550213|NCT01910844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733475|NCT04561856|BB 1101|bb 1101|mesh-list
20550214|NCT01910844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550215|NCT01910844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20550216|NCT01910870|Cyclophosphamide|cyclophosphamide|mesh-list
20550217|NCT01910870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20550218|NCT01910870|Immunologic Factors|immunologic factors|mesh-ancestor
20550219|NCT01910870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550220|NCT01910870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20550221|NCT01910870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20550222|NCT01910870|Alkylating Agents|alkylating agents|mesh-ancestor
20550223|NCT01910870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550224|NCT01910870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550225|NCT01910870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20550226|NCT01910883|Finafloxacin|finafloxacin|mesh-list
20550227|NCT01910883|Fluoroquinolones|fluoroquinolones|mesh-list
20550228|NCT01910883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20550229|NCT01910883|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20550230|NCT01910883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20550231|NCT01910883|Renal Agents|renal agents|mesh-ancestor
20550232|NCT01910883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20550233|NCT01910883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20550234|NCT01910883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20550235|NCT01910883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550236|NCT01910883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550237|NCT01910883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550238|NCT01910883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20550239|NCT01910987|Dexamethasone|dexamethasone|mesh-list
20550240|NCT01910987|Dexamethasone acetate|dexamethasone acetate|mesh-list
20550241|NCT01910987|Bortezomib|bortezomib|mesh-list
20550242|NCT01910987|BB 1101|bb 1101|mesh-list
20550243|NCT01910987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20550244|NCT01910987|Antiemetics|antiemetics|mesh-ancestor
19966500|NCT01733121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966501|NCT01733121|Adrenergic Agents|adrenergic agents|mesh-ancestor
19966502|NCT01733121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19966503|NCT01733121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966504|NCT01733316|Cysteamine|cysteamine|mesh-list
19966505|NCT01733316|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
19966506|NCT01733316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966507|NCT01733329|Folic Acid|folic acid|mesh-list
19966508|NCT01733329|Misoprostol|misoprostol|mesh-list
19966509|NCT01733329|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19966510|NCT01733329|Abortifacient Agents|abortifacient agents|mesh-ancestor
19966511|NCT01733329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19966512|NCT01733329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966513|NCT01733329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19966514|NCT01733329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19966515|NCT01733329|Oxytocics|oxytocics|mesh-ancestor
19966516|NCT01733329|Hematinics|hematinics|mesh-ancestor
19966517|NCT01733329|Vitamin B Complex|vitamin b complex|mesh-ancestor
19966518|NCT01733329|Vitamins|vitamins|mesh-ancestor
19966519|NCT01733329|Micronutrients|micronutrients|mesh-ancestor
19966520|NCT01733472|Remifentanil|remifentanil|mesh-list
19966521|NCT01733472|Propofol|propofol|mesh-list
19966522|NCT01733472|Anesthetics|anesthetics|mesh-ancestor
20550245|NCT01910987|Autonomic Agents|autonomic agents|mesh-ancestor
20550246|NCT01910987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550247|NCT01910987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550248|NCT01910987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20550249|NCT01910987|Glucocorticoids|glucocorticoids|mesh-ancestor
20550250|NCT01910987|Hormones|hormones|mesh-ancestor
20550251|NCT01910987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20550252|NCT01910987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20550253|NCT01910987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550254|NCT01910987|Protease Inhibitors|protease inhibitors|mesh-ancestor
20550255|NCT01910987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550256|NCT01910987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550257|NCT01911195|Isoflurane|isoflurane|mesh-list
20550258|NCT01911195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20550259|NCT01911195|Anesthetics, General|anesthetics, general|mesh-ancestor
20550260|NCT01911195|Anesthetics|anesthetics|mesh-ancestor
20550261|NCT01911195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20550262|NCT01911195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550263|NCT01911234|Freund's Adjuvant|freund's adjuvant|mesh-list
20550264|NCT01911234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19966523|NCT01733472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20550265|NCT01911234|Immunologic Factors|immunologic factors|mesh-ancestor
20550266|NCT01911234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550267|NCT01911247|Metformin|metformin|mesh-list
20550268|NCT01911247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20550269|NCT01911247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550270|NCT01911299|Choline|choline|mesh-list
20550271|NCT01911299|Glycerol|glycerol|mesh-list
20550272|NCT01911299|Lipotropic Agents|lipotropic agents|mesh-ancestor
20550273|NCT01911299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20550274|NCT01911299|Antimetabolites|antimetabolites|mesh-ancestor
20550275|NCT01911299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550276|NCT01911299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20550277|NCT01911299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20550278|NCT01911299|Nootropic Agents|nootropic agents|mesh-ancestor
20550279|NCT01911299|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20550280|NCT01911299|Protective Agents|protective agents|mesh-ancestor
20550281|NCT01911299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550282|NCT01911325|Docetaxel|docetaxel|mesh-list
20550283|NCT01911325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550284|NCT01911325|Tubulin Modulators|tubulin modulators|mesh-ancestor
20550285|NCT01911325|Antimitotic Agents|antimitotic agents|mesh-ancestor
20550286|NCT01911325|Mitosis Modulators|mitosis modulators|mesh-ancestor
20550287|NCT01911325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550288|NCT01911364|Tiotropium Bromide|tiotropium bromide|mesh-list
20550289|NCT01911364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20550290|NCT01911364|Autonomic Agents|autonomic agents|mesh-ancestor
20550291|NCT01911364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550292|NCT01911364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550293|NCT01911364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20550294|NCT01911364|Respiratory System Agents|respiratory system agents|mesh-ancestor
20550295|NCT01911364|Parasympatholytics|parasympatholytics|mesh-ancestor
20550296|NCT01911364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20550297|NCT01911364|Cholinergic Agents|cholinergic agents|mesh-ancestor
20550298|NCT01911364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20550299|NCT01911364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550300|NCT01911377|Botulinum Toxins|botulinum toxins|mesh-list
20550301|NCT01911377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20550302|NCT01911377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20550303|NCT01911377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20550304|NCT01911377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20550305|NCT01911377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550306|NCT01911377|Cholinergic Agents|cholinergic agents|mesh-ancestor
20550307|NCT01911377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19966524|NCT01733472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966525|NCT01733472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19966526|NCT01733472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19966527|NCT01733472|Anesthetics, General|anesthetics, general|mesh-ancestor
19966528|NCT01733472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19966529|NCT01733472|Narcotics|narcotics|mesh-ancestor
19966530|NCT01733472|Analgesics|analgesics|mesh-ancestor
19966531|NCT01733472|Sensory System Agents|sensory system agents|mesh-ancestor
19966532|NCT01733472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550308|NCT01911377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550309|NCT01911377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20550310|NCT01911377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550311|NCT01911455|Acamprosate|acamprosate|mesh-list
20550312|NCT01911455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20550313|NCT01911468|Metformin|metformin|mesh-list
20550314|NCT01911468|Liraglutide|liraglutide|mesh-list
20550315|NCT01911468|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20550316|NCT01911468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19733476|NCT04561856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19733477|NCT04561856|Antiemetics|antiemetics|mesh-ancestor
19733478|NCT04561856|Autonomic Agents|autonomic agents|mesh-ancestor
19733479|NCT04561856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733480|NCT04561856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733481|NCT04561856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19733482|NCT04561856|Glucocorticoids|glucocorticoids|mesh-ancestor
19733483|NCT04561856|Hormones|hormones|mesh-ancestor
19733484|NCT04561856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19733485|NCT04561856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19733486|NCT04561856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733487|NCT04561856|Protease Inhibitors|protease inhibitors|mesh-ancestor
19733488|NCT04561856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550317|NCT01911468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966533|NCT01733680|Amiloride|amiloride|mesh-list
20550318|NCT01911468|Incretins|incretins|mesh-ancestor
20550319|NCT01911468|Hormones|hormones|mesh-ancestor
20550320|NCT01911468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20550321|NCT01911494|Magnesium Sulfate|magnesium sulfate|mesh-list
20550322|NCT01911494|Methyldopa|methyldopa|mesh-list
20550323|NCT01911494|Analgesics|analgesics|mesh-ancestor
20550324|NCT01911494|Sensory System Agents|sensory system agents|mesh-ancestor
20550325|NCT01911494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550326|NCT01911494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550327|NCT01911494|Anesthetics|anesthetics|mesh-ancestor
20550328|NCT01911494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20550329|NCT01911494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20550330|NCT01911494|Anticonvulsants|anticonvulsants|mesh-ancestor
20550331|NCT01911494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20550332|NCT01911494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19966534|NCT01733680|Diuretics|diuretics|mesh-ancestor
19966535|NCT01733680|Natriuretic Agents|natriuretic agents|mesh-ancestor
19966536|NCT01733680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550333|NCT01911494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966537|NCT01733680|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
19966538|NCT01733680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19966539|NCT01733680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19966540|NCT01733680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966541|NCT01733680|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19966542|NCT01733680|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19966543|NCT01733732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19966544|NCT01733732|Lubricant Eye Drops|lubricant eye drops|mesh-list
19966545|NCT01733732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19966546|NCT01733745|Vitamins|vitamins|mesh-list
19966547|NCT01733745|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19966548|NCT01733745|Micronutrients|micronutrients|mesh-ancestor
19966549|NCT01733745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966550|NCT01733745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19966551|NCT01733758|Liraglutide|liraglutide|mesh-list
19966552|NCT01733758|rGLP-1 protein|rglp-1 protein|mesh-list
19966553|NCT01733758|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19966554|NCT01733758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19966555|NCT01733758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966556|NCT01733758|Incretins|incretins|mesh-ancestor
19966557|NCT01733758|Hormones|hormones|mesh-ancestor
19966558|NCT01733758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19966559|NCT01733953|Atorvastatin|atorvastatin|mesh-list
19966560|NCT01733953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19966561|NCT01733953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19966562|NCT01733953|Antimetabolites|antimetabolites|mesh-ancestor
19966563|NCT01733953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966564|NCT01733953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19966565|NCT01733953|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19966566|NCT01733953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966567|NCT01734161|Dexamethasone|dexamethasone|mesh-list
19966568|NCT01734161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20550334|NCT01911494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20550335|NCT01911494|Tocolytic Agents|tocolytic agents|mesh-ancestor
20550336|NCT01911494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20550337|NCT01911494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20550338|NCT01911494|Sympatholytics|sympatholytics|mesh-ancestor
20550339|NCT01911494|Autonomic Agents|autonomic agents|mesh-ancestor
20550340|NCT01911494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20550341|NCT01911494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20550342|NCT01911494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20550343|NCT01911494|Adrenergic Agents|adrenergic agents|mesh-ancestor
20550344|NCT01911494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20550345|NCT01911507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20550346|NCT01911507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550347|NCT01911507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20550348|NCT01911507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550349|NCT01911507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550350|NCT01911598|Paclitaxel|paclitaxel|mesh-list
20550351|NCT01911598|Carboplatin|carboplatin|mesh-list
20550352|NCT01911598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20550353|NCT01911598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550354|NCT01911598|Tubulin Modulators|tubulin modulators|mesh-ancestor
20550355|NCT01911598|Antimitotic Agents|antimitotic agents|mesh-ancestor
20550356|NCT01911598|Mitosis Modulators|mitosis modulators|mesh-ancestor
20550357|NCT01911598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550358|NCT01911624|Enoxaparin|enoxaparin|mesh-list
20550359|NCT01911624|Dabigatran|dabigatran|mesh-list
20550360|NCT01911624|Argatroban|argatroban|mesh-list
20550361|NCT01911624|Thrombin|thrombin|mesh-list
20550362|NCT01911624|Anticoagulants|anticoagulants|mesh-ancestor
20550363|NCT01911624|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20550364|NCT01911624|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20550365|NCT01911624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550366|NCT01911624|Antithrombins|antithrombins|mesh-ancestor
20550367|NCT01911624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20550368|NCT01911624|Protease Inhibitors|protease inhibitors|mesh-ancestor
20550369|NCT01911624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550370|NCT01911624|Hemostatics|hemostatics|mesh-ancestor
20550371|NCT01911624|Coagulants|coagulants|mesh-ancestor
19966569|NCT01734161|Antiemetics|antiemetics|mesh-ancestor
19966570|NCT01734161|Autonomic Agents|autonomic agents|mesh-ancestor
19966571|NCT01734161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19966572|NCT01734161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966573|NCT01734161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19966574|NCT01734161|Glucocorticoids|glucocorticoids|mesh-ancestor
19966575|NCT01734161|Hormones|hormones|mesh-ancestor
19966576|NCT01734161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19966577|NCT01734161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20288534|NCT05321875|Candesartan|candesartan|mesh-list
20288535|NCT05321875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20288536|NCT05321875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20288537|NCT05321875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20288538|NCT05321875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288539|NCT05321043|Riboflavin|riboflavin|mesh-list
20288540|NCT05321043|Vitamins|vitamins|mesh-ancestor
20288541|NCT05321043|Micronutrients|micronutrients|mesh-ancestor
20288542|NCT05321043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288543|NCT05321043|Vitamin B Complex|vitamin b complex|mesh-ancestor
20288544|NCT05321043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20288545|NCT05321043|Dermatologic Agents|dermatologic agents|mesh-ancestor
20288546|NCT05319561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20288547|NCT05319561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20288548|NCT05311176|Paclitaxel|paclitaxel|mesh-list
20550372|NCT01911624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20550373|NCT01911728|Pioglitazone|pioglitazone|mesh-list
20550374|NCT01911728|Midazolam|midazolam|mesh-list
20550375|NCT01911728|Omeprazole|omeprazole|mesh-list
20550376|NCT01911728|Warfarin|warfarin|mesh-list
20550377|NCT01911728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20550378|NCT01911728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20550379|NCT01911728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20550380|NCT01911728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550381|NCT01911728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20550382|NCT01911728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20550383|NCT01911728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20550384|NCT01911728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20550385|NCT01911728|Anesthetics, General|anesthetics, general|mesh-ancestor
20550386|NCT01911728|Anesthetics|anesthetics|mesh-ancestor
19966578|NCT01734161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966579|NCT01734239|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19966580|NCT01734239|Immunologic Factors|immunologic factors|mesh-ancestor
19966581|NCT01734239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966582|NCT01734395|Galantamine|galantamine|mesh-list
19966583|NCT01734395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19966584|NCT01734395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966585|NCT01734395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966586|NCT01734395|Cholinergic Agents|cholinergic agents|mesh-ancestor
19966587|NCT01734395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19966588|NCT01734395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966589|NCT01734395|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19966590|NCT01734395|Autonomic Agents|autonomic agents|mesh-ancestor
19966591|NCT01734395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19966592|NCT01734395|Nootropic Agents|nootropic agents|mesh-ancestor
20550387|NCT01911728|GABA Modulators|gaba modulators|mesh-ancestor
20550388|NCT01911728|GABA Agents|gaba agents|mesh-ancestor
19966593|NCT01734512|Everolimus|everolimus|mesh-list
19966594|NCT01734512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966595|NCT01734512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19966596|NCT01734512|Immunologic Factors|immunologic factors|mesh-ancestor
19966597|NCT01734512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966598|NCT01734525|Anidulafungin|anidulafungin|mesh-list
19966599|NCT01734525|Antifungal Agents|antifungal agents|mesh-ancestor
19966600|NCT01734525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19966601|NCT01734551|Clonidine|clonidine|mesh-list
20550389|NCT01911728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20550390|NCT01911728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550391|NCT01911728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20550392|NCT01911728|Anticoagulants|anticoagulants|mesh-ancestor
20550393|NCT01911728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20550394|NCT01911728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20550395|NCT01911728|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20550396|NCT01911728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550397|NCT01911767|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20550398|NCT01911767|Dermatologic Agents|dermatologic agents|mesh-ancestor
20550399|NCT01911767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20550400|NCT01911767|Immunologic Factors|immunologic factors|mesh-ancestor
20550401|NCT01911767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550402|NCT01911949|Epinephrine|epinephrine|mesh-list
20550403|NCT01911949|Bupivacaine|bupivacaine|mesh-list
20550404|NCT01911949|Anesthetics, Local|anesthetics, local|mesh-ancestor
20550405|NCT01911949|Anesthetics|anesthetics|mesh-ancestor
20550406|NCT01911949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20550407|NCT01911949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550408|NCT01911949|Sensory System Agents|sensory system agents|mesh-ancestor
20550409|NCT01911949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550410|NCT01911949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20550411|NCT01911949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20550412|NCT01911949|Adrenergic Agents|adrenergic agents|mesh-ancestor
20550413|NCT01911949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20550414|NCT01911949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550415|NCT01911949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20550416|NCT01911949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20550417|NCT01911949|Autonomic Agents|autonomic agents|mesh-ancestor
20550418|NCT01911949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20550419|NCT01911949|Respiratory System Agents|respiratory system agents|mesh-ancestor
20550420|NCT01911949|Mydriatics|mydriatics|mesh-ancestor
20550421|NCT01911949|Sympathomimetics|sympathomimetics|mesh-ancestor
19966602|NCT01734551|Morphine|morphine|mesh-list
20550422|NCT01911949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20550423|NCT01911975|Lacosamide|lacosamide|mesh-list
20550424|NCT01911975|Anticonvulsants|anticonvulsants|mesh-ancestor
20550425|NCT01911975|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20550426|NCT01911975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20550427|NCT01911975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20550428|NCT01911975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550429|NCT01912053|Gemcitabine|gemcitabine|mesh-list
20550430|NCT01912053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550431|NCT01912053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20550432|NCT01912053|Antimetabolites|antimetabolites|mesh-ancestor
20550433|NCT01912053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550434|NCT01912053|Antiviral Agents|antiviral agents|mesh-ancestor
20550435|NCT01912053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20550436|NCT01912053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550437|NCT01912053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20550438|NCT01912053|Immunologic Factors|immunologic factors|mesh-ancestor
20550439|NCT01912053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550440|NCT01912066|Aceclofenac|aceclofenac|mesh-list
20550441|NCT01912066|Misoprostol|misoprostol|mesh-list
20550442|NCT01912066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20550443|NCT01912066|Abortifacient Agents|abortifacient agents|mesh-ancestor
20550444|NCT01912066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20550445|NCT01912066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550446|NCT01912066|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20550447|NCT01912066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20550448|NCT01912066|Oxytocics|oxytocics|mesh-ancestor
20550449|NCT01912066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20550450|NCT01912066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20550451|NCT01912066|Analgesics|analgesics|mesh-ancestor
20550452|NCT01912066|Sensory System Agents|sensory system agents|mesh-ancestor
20550453|NCT01912066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550454|NCT01912066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20550455|NCT01912066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20554635|NCT01936064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20554636|NCT01936064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20554637|NCT01936064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20554638|NCT01936064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20554639|NCT01936064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554640|NCT01936090|Bortezomib|bortezomib|mesh-list
20554641|NCT01936090|Melphalan|melphalan|mesh-list
20554642|NCT01936090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554643|NCT01936090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20554644|NCT01936090|Alkylating Agents|alkylating agents|mesh-ancestor
20554645|NCT01936090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554646|NCT01936090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20554647|NCT01936090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20554648|NCT01936090|Immunologic Factors|immunologic factors|mesh-ancestor
19966603|NCT01734551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20554649|NCT01936090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554650|NCT01936103|Atorvastatin|atorvastatin|mesh-list
20554651|NCT01936103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20554652|NCT01936103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20554653|NCT01936103|Antimetabolites|antimetabolites|mesh-ancestor
20554654|NCT01936103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554655|NCT01936103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20554656|NCT01936103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20554657|NCT01936103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554658|NCT01936129|Glatiramer Acetate|glatiramer acetate|mesh-list
20554659|NCT01936129|(T,G)-A-L|(t,g)-a-l|mesh-list
20554660|NCT01936129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20554661|NCT01936129|Immunologic Factors|immunologic factors|mesh-ancestor
20554662|NCT01936129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554663|NCT01936129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20554664|NCT01936129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20554665|NCT01936220|Antipsychotic Agents|antipsychotic agents|mesh-list
20554666|NCT01936220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20554667|NCT01936220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20554668|NCT01936220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554669|NCT01936220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20554670|NCT01936233|Aspirin|aspirin|mesh-list
20554671|NCT01936233|Lamivudine|lamivudine|mesh-list
20554672|NCT01936233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20554673|NCT01936233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20554674|NCT01936233|Analgesics|analgesics|mesh-ancestor
20554675|NCT01936233|Sensory System Agents|sensory system agents|mesh-ancestor
20550456|NCT01912118|Remifentanil|remifentanil|mesh-list
20550457|NCT01912118|Propofol|propofol|mesh-list
20550458|NCT01912118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20550459|NCT01912118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20550460|NCT01912118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550461|NCT01912118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20550462|NCT01912118|Anesthetics, General|anesthetics, general|mesh-ancestor
20550463|NCT01912118|Anesthetics|anesthetics|mesh-ancestor
20550464|NCT01912118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20550465|NCT01912118|Narcotics|narcotics|mesh-ancestor
20550466|NCT01912118|Analgesics|analgesics|mesh-ancestor
20550467|NCT01912118|Sensory System Agents|sensory system agents|mesh-ancestor
20550468|NCT01912118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550469|NCT01912378|Oxytocin|oxytocin|mesh-list
20550470|NCT01912378|Oxytocics|oxytocics|mesh-ancestor
20550471|NCT01912378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20550472|NCT01912378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550473|NCT01912391|Selegiline|selegiline|mesh-list
20550474|NCT01912391|Antidepressive Agents|antidepressive agents|mesh-ancestor
20550475|NCT01912391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20550476|NCT01912391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20550477|NCT01912391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20550478|NCT01912391|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20550479|NCT01912391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550480|NCT01912391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550481|NCT01912391|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20550482|NCT01912391|Protective Agents|protective agents|mesh-ancestor
20550483|NCT01912391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550484|NCT01912443|Bevacizumab|bevacizumab|mesh-list
20550485|NCT01912443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20550486|NCT01912443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550487|NCT01912443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20550488|NCT01912443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20550489|NCT01912443|Growth Substances|growth substances|mesh-ancestor
19733489|NCT04561856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733490|NCT04561817|Paclitaxel|paclitaxel|mesh-list
19733491|NCT04561817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19733492|NCT04561817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733493|NCT04561817|Tubulin Modulators|tubulin modulators|mesh-ancestor
20550490|NCT01912443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550491|NCT01912443|Growth Inhibitors|growth inhibitors|mesh-ancestor
20550492|NCT01912534|Valsartan|valsartan|mesh-list
20550493|NCT01912534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20550494|NCT01912534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20550495|NCT01912534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20550496|NCT01912534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550497|NCT01912573|Naloxone|naloxone|mesh-list
20550498|NCT01912573|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20550499|NCT01912573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550500|NCT01912573|Sensory System Agents|sensory system agents|mesh-ancestor
20550501|NCT01912573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550502|NCT01912586|Sildenafil Citrate|sildenafil citrate|mesh-list
20550503|NCT01912586|Vasodilator Agents|vasodilator agents|mesh-ancestor
20550504|NCT01912586|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20550505|NCT01912586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20550506|NCT01912586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550507|NCT01912586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550508|NCT01912586|Urological Agents|urological agents|mesh-ancestor
20550509|NCT01912638|Hyaluronic Acid|hyaluronic acid|mesh-list
20550510|NCT01912638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20550511|NCT01912638|Immunologic Factors|immunologic factors|mesh-ancestor
20550512|NCT01912638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550513|NCT01912638|Viscosupplements|viscosupplements|mesh-ancestor
20550514|NCT01912638|Protective Agents|protective agents|mesh-ancestor
20550515|NCT01912651|Cephalexin|cephalexin|mesh-list
20550516|NCT01912651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20550517|NCT01912651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20550518|NCT01912677|Labetalol|labetalol|mesh-list
20550519|NCT01912677|Methyldopa|methyldopa|mesh-list
20550520|NCT01912677|Nifedipine|nifedipine|mesh-list
20550521|NCT01912677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20550522|NCT01912677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20550523|NCT01912677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550524|NCT01912677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20550525|NCT01912677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550526|NCT01912677|Vasodilator Agents|vasodilator agents|mesh-ancestor
20550527|NCT01912677|Tocolytic Agents|tocolytic agents|mesh-ancestor
20550528|NCT01912677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20550529|NCT01912677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20550530|NCT01912677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20550531|NCT01912677|Adrenergic Agents|adrenergic agents|mesh-ancestor
20550532|NCT01912677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20550533|NCT01912677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20550534|NCT01912677|Sympathomimetics|sympathomimetics|mesh-ancestor
19733494|NCT04561817|Antimitotic Agents|antimitotic agents|mesh-ancestor
19733495|NCT04561817|Mitosis Modulators|mitosis modulators|mesh-ancestor
20550535|NCT01912677|Autonomic Agents|autonomic agents|mesh-ancestor
20550536|NCT01912677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550537|NCT01912677|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20550538|NCT01912677|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20550539|NCT01912677|Sympatholytics|sympatholytics|mesh-ancestor
19966604|NCT01734551|Narcotics|narcotics|mesh-ancestor
19966605|NCT01734551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19966606|NCT01734551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550540|NCT01912677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20550541|NCT01912677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20550542|NCT01912677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20550543|NCT01912755|Lidocaine|lidocaine|mesh-list
20550544|NCT01912755|Epinephrine|epinephrine|mesh-list
20550545|NCT01912755|Racepinephrine|racepinephrine|mesh-list
20550546|NCT01912755|Carticaine|carticaine|mesh-list
20550547|NCT01912755|Epinephryl borate|epinephryl borate|mesh-list
20550548|NCT01912755|Anesthetics, Local|anesthetics, local|mesh-ancestor
20550549|NCT01912755|Anesthetics|anesthetics|mesh-ancestor
20550550|NCT01912755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20550551|NCT01912755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550552|NCT01912755|Sensory System Agents|sensory system agents|mesh-ancestor
20550553|NCT01912755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550554|NCT01912755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20550555|NCT01912755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20550556|NCT01912755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20550557|NCT01912755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20550558|NCT01912755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550559|NCT01912755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20550560|NCT01912755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20550561|NCT01912755|Adrenergic Agents|adrenergic agents|mesh-ancestor
20550562|NCT01912755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20550563|NCT01912755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20550564|NCT01912755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20550565|NCT01912755|Autonomic Agents|autonomic agents|mesh-ancestor
20550566|NCT01912755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20550567|NCT01912755|Respiratory System Agents|respiratory system agents|mesh-ancestor
20550568|NCT01912755|Mydriatics|mydriatics|mesh-ancestor
20550569|NCT01912755|Sympathomimetics|sympathomimetics|mesh-ancestor
20550570|NCT01912755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20550571|NCT01912820|Quercetin|quercetin|mesh-list
20550572|NCT01912820|Antioxidants|antioxidants|mesh-ancestor
20550573|NCT01912820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550574|NCT01912820|Protective Agents|protective agents|mesh-ancestor
20550575|NCT01912820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550576|NCT01912898|Vitamin D|vitamin d|mesh-list
20550577|NCT01912898|Ergocalciferols|ergocalciferols|mesh-list
20550578|NCT01912898|Vitamins|vitamins|mesh-list
20550579|NCT01912898|Micronutrients|micronutrients|mesh-ancestor
20550580|NCT01912898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550581|NCT01912898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20550582|NCT01912898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20550583|NCT01912976|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20550584|NCT01912976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20550585|NCT01912976|Dermatologic Agents|dermatologic agents|mesh-ancestor
20550586|NCT01913002|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20550587|NCT01913002|Moxifloxacin|moxifloxacin|mesh-list
20550588|NCT01913002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20550589|NCT01913002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20550590|NCT01913002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19733496|NCT04561817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550591|NCT01913002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20550592|NCT01913002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550593|NCT01913002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550594|NCT01913002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550595|NCT01913002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550596|NCT01913002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20550597|NCT01913002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20550598|NCT01913015|Abiraterone Acetate|abiraterone acetate|mesh-list
19966607|NCT01734551|Analgesics|analgesics|mesh-ancestor
19966608|NCT01734551|Sensory System Agents|sensory system agents|mesh-ancestor
19966609|NCT01734551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19966610|NCT01734551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19966611|NCT01734551|Sympatholytics|sympatholytics|mesh-ancestor
19966612|NCT01734551|Autonomic Agents|autonomic agents|mesh-ancestor
19966613|NCT01734551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19966614|NCT01734551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19966615|NCT01734551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20550599|NCT01913015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550600|NCT01913015|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20550601|NCT01913015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550602|NCT01913015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550603|NCT01913015|Hormone Antagonists|hormone antagonists|mesh-ancestor
20550604|NCT01913015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20550605|NCT01913015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550606|NCT01913015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20550607|NCT01913054|Fentanyl|fentanyl|mesh-list
20550608|NCT01913054|Propofol|propofol|mesh-list
20550609|NCT01913054|Etomidate|etomidate|mesh-list
20550610|NCT01913054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20550611|NCT01913054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20550612|NCT01913054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550613|NCT01913054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20550614|NCT01913054|Anesthetics, General|anesthetics, general|mesh-ancestor
20550615|NCT01913054|Anesthetics|anesthetics|mesh-ancestor
20550616|NCT01913054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20550617|NCT01913054|Narcotics|narcotics|mesh-ancestor
20550618|NCT01913054|Analgesics|analgesics|mesh-ancestor
20550619|NCT01913054|Sensory System Agents|sensory system agents|mesh-ancestor
20550620|NCT01913054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550621|NCT01913054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20550622|NCT01913106|Valacyclovir|valacyclovir|mesh-list
20550623|NCT01913106|Antiviral Agents|antiviral agents|mesh-ancestor
20550624|NCT01913106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20550625|NCT01913119|Romidepsin|romidepsin|mesh-list
20550626|NCT01913119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20550627|NCT01913119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550628|NCT01913379|Itraconazole|itraconazole|mesh-list
20550629|NCT01913379|Gemfibrozil|gemfibrozil|mesh-list
20550630|NCT01913379|Antifungal Agents|antifungal agents|mesh-ancestor
20550631|NCT01913379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20550632|NCT01913379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20550633|NCT01913379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20550634|NCT01913379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550635|NCT01913379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550636|NCT01913379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20550637|NCT01913379|Hormone Antagonists|hormone antagonists|mesh-ancestor
20550638|NCT01913379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20550639|NCT01913379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550640|NCT01913379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20550641|NCT01913379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20550642|NCT01913379|Antimetabolites|antimetabolites|mesh-ancestor
20550643|NCT01913379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20550644|NCT01913379|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20550645|NCT01913431|Entecavir|entecavir|mesh-list
20550646|NCT01913431|Antiviral Agents|antiviral agents|mesh-ancestor
20550647|NCT01913431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20550648|NCT01913444|Antithrombins|antithrombins|mesh-list
20550649|NCT01913444|Antithrombin III|antithrombin iii|mesh-list
20550650|NCT01913444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20550651|NCT01913444|Protease Inhibitors|protease inhibitors|mesh-ancestor
19966616|NCT01734551|Adrenergic Agents|adrenergic agents|mesh-ancestor
19966617|NCT01734551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19966618|NCT01734551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966619|NCT01734772|Dabigatran|dabigatran|mesh-list
20550652|NCT01913444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550653|NCT01913444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550654|NCT01913444|Anticoagulants|anticoagulants|mesh-ancestor
20550655|NCT01913691|Ipilimumab|ipilimumab|mesh-list
20550656|NCT01913691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20550657|NCT01913691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550658|NCT01913691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20550659|NCT01913691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550660|NCT01913808|Iron|iron|mesh-list
19966620|NCT01734772|Ticagrelor|ticagrelor|mesh-list
19966621|NCT01734772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19966622|NCT01734772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19966623|NCT01734772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20550661|NCT01913808|Glycine|glycine|mesh-list
20550662|NCT01913808|Trace Elements|trace elements|mesh-ancestor
20550663|NCT01913808|Micronutrients|micronutrients|mesh-ancestor
20550664|NCT01913808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550665|NCT01913808|Glycine Agents|glycine agents|mesh-ancestor
20550666|NCT01913808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20550667|NCT01913808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550668|NCT01913834|Teriparatide|teriparatide|mesh-list
20550669|NCT01913834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20550670|NCT01913834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550671|NCT01913834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20550672|NCT01913847|Sildenafil Citrate|sildenafil citrate|mesh-list
20550673|NCT01913847|Vasodilator Agents|vasodilator agents|mesh-ancestor
20550674|NCT01913847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20550675|NCT01913847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20550676|NCT01913847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550677|NCT01913847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550678|NCT01913847|Urological Agents|urological agents|mesh-ancestor
20550679|NCT01913860|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20550680|NCT01913860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20554676|NCT01936233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554677|NCT01936233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554678|NCT01936233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20554679|NCT01936233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20554680|NCT01936233|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20554681|NCT01936233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20554682|NCT01936233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554683|NCT01936233|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20554684|NCT01936233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20554685|NCT01936233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554686|NCT01936233|Antipyretics|antipyretics|mesh-ancestor
20554687|NCT01936233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20554688|NCT01936233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20554689|NCT01936233|Antiviral Agents|antiviral agents|mesh-ancestor
20554690|NCT01936233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20554691|NCT01936233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20554692|NCT01936233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20554693|NCT01936285|Colchicine|colchicine|mesh-list
20554694|NCT01936285|Gout Suppressants|gout suppressants|mesh-ancestor
20554695|NCT01936285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20554696|NCT01936285|Tubulin Modulators|tubulin modulators|mesh-ancestor
20554697|NCT01936285|Antimitotic Agents|antimitotic agents|mesh-ancestor
20554698|NCT01936285|Mitosis Modulators|mitosis modulators|mesh-ancestor
20554699|NCT01936285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554700|NCT01936285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554701|NCT01936350|Sildenafil Citrate|sildenafil citrate|mesh-list
20554702|NCT01936350|Vasodilator Agents|vasodilator agents|mesh-ancestor
20554703|NCT01936350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20554704|NCT01936350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20554705|NCT01936350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554706|NCT01936350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554707|NCT01936350|Urological Agents|urological agents|mesh-ancestor
20554708|NCT01936532|Dexamethasone|dexamethasone|mesh-list
20554709|NCT01936532|Lenalidomide|lenalidomide|mesh-list
20554710|NCT01936532|Ixazomib|ixazomib|mesh-list
20554711|NCT01936532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20554712|NCT01936532|Antiemetics|antiemetics|mesh-ancestor
20554713|NCT01936532|Autonomic Agents|autonomic agents|mesh-ancestor
20554714|NCT01936532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554715|NCT01936532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554716|NCT01936532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20550681|NCT01913964|Acetylcarnitine|acetylcarnitine|mesh-list
20550682|NCT01913964|Vitamin B Complex|vitamin b complex|mesh-ancestor
20550683|NCT01913964|Vitamins|vitamins|mesh-ancestor
20550684|NCT01913964|Micronutrients|micronutrients|mesh-ancestor
20550685|NCT01913964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550686|NCT01913964|Nootropic Agents|nootropic agents|mesh-ancestor
20550687|NCT01913990|Dexamethasone|dexamethasone|mesh-list
20550688|NCT01913990|Ondansetron|ondansetron|mesh-list
20550689|NCT01913990|Aprepitant|aprepitant|mesh-list
20550690|NCT01913990|Antiemetics|antiemetics|mesh-list
20550691|NCT01913990|Emetics|emetics|mesh-list
20550692|NCT01913990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20550693|NCT01913990|Autonomic Agents|autonomic agents|mesh-ancestor
20550694|NCT01913990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550695|NCT01913990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550696|NCT01913990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20550697|NCT01913990|Glucocorticoids|glucocorticoids|mesh-ancestor
20550698|NCT01913990|Hormones|hormones|mesh-ancestor
20550699|NCT01913990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20550700|NCT01913990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20550701|NCT01913990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550702|NCT01913990|Antipruritics|antipruritics|mesh-ancestor
20550703|NCT01913990|Dermatologic Agents|dermatologic agents|mesh-ancestor
20550704|NCT01913990|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20550705|NCT01913990|Serotonin Agents|serotonin agents|mesh-ancestor
20550706|NCT01913990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20550707|NCT01913990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550708|NCT01913990|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20550709|NCT01913990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20550710|NCT01913990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20550711|NCT01913990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20550712|NCT01913990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20550713|NCT01913990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20550714|NCT01914042|Morphine|morphine|mesh-list
20550715|NCT01914042|Milnacipran|milnacipran|mesh-list
20550716|NCT01914042|Levomilnacipran|levomilnacipran|mesh-list
20550717|NCT01914042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20550718|NCT01914042|Narcotics|narcotics|mesh-ancestor
20550719|NCT01914042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20550720|NCT01914042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550721|NCT01914042|Analgesics|analgesics|mesh-ancestor
20550722|NCT01914042|Sensory System Agents|sensory system agents|mesh-ancestor
20550723|NCT01914042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550724|NCT01914042|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20550725|NCT01914042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20550726|NCT01914042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20550727|NCT01914042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550728|NCT01914042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20550729|NCT01914042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20550730|NCT01914042|Antidepressive Agents|antidepressive agents|mesh-ancestor
20550731|NCT01914042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20550732|NCT01914081|Resveratrol|resveratrol|mesh-list
20550733|NCT01914081|Antioxidants|antioxidants|mesh-ancestor
20550734|NCT01914081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550735|NCT01914081|Protective Agents|protective agents|mesh-ancestor
20550736|NCT01914081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550737|NCT01914081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550738|NCT01914081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20550739|NCT01914133|Acarbose|acarbose|mesh-list
19966624|NCT01734772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19966625|NCT01734772|Purinergic Agents|purinergic agents|mesh-ancestor
19966626|NCT01734772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19966627|NCT01734772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966628|NCT01734772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966629|NCT01734772|Antithrombins|antithrombins|mesh-ancestor
19966630|NCT01734772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19966631|NCT01734772|Protease Inhibitors|protease inhibitors|mesh-ancestor
19966632|NCT01734772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966633|NCT01734772|Anticoagulants|anticoagulants|mesh-ancestor
19966634|NCT01734785|Empagliflozin|empagliflozin|mesh-list
19966635|NCT01734785|Linagliptin|linagliptin|mesh-list
20550740|NCT01914133|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
20550741|NCT01914133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550742|NCT01914133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288549|NCT05311176|Pembrolizumab|pembrolizumab|mesh-list
20550743|NCT01914133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20550744|NCT01914133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550745|NCT01914146|Insulin|insulin|mesh-list
20550746|NCT01914146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20550747|NCT01914146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20550748|NCT01914146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550749|NCT01914211|Tranexamic Acid|tranexamic acid|mesh-list
20550750|NCT01914211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20550751|NCT01914211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20550752|NCT01914211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550753|NCT01914211|Hemostatics|hemostatics|mesh-ancestor
20550754|NCT01914211|Coagulants|coagulants|mesh-ancestor
20550755|NCT01914237|Castor Oil|castor oil|mesh-list
20550756|NCT01914237|Cathartics|cathartics|mesh-ancestor
20550757|NCT01914237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20550758|NCT01914250|Analgesics|analgesics|mesh-list
20550759|NCT01914250|Tetracaine|tetracaine|mesh-list
20550760|NCT01914250|Sensory System Agents|sensory system agents|mesh-ancestor
20550761|NCT01914250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550762|NCT01914250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550763|NCT01914250|Anesthetics, Local|anesthetics, local|mesh-ancestor
20550764|NCT01914250|Anesthetics|anesthetics|mesh-ancestor
20550765|NCT01914250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20550766|NCT01914367|Vaccines|vaccines|mesh-list
20550767|NCT01914367|Immunologic Factors|immunologic factors|mesh-ancestor
20550768|NCT01914367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550769|NCT01914380|Aflibercept|aflibercept|mesh-list
20550770|NCT01914380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20550771|NCT01914380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20550772|NCT01914380|Growth Substances|growth substances|mesh-ancestor
20550773|NCT01914380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550774|NCT01914380|Growth Inhibitors|growth inhibitors|mesh-ancestor
20550775|NCT01914380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550776|NCT01914419|Oxytocin|oxytocin|mesh-list
20550777|NCT01914419|Oxytocics|oxytocics|mesh-ancestor
20550778|NCT01914419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20550779|NCT01914419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550780|NCT01914432|Telmisartan|telmisartan|mesh-list
20550781|NCT01914432|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20550782|NCT01914432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20550783|NCT01914432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20550784|NCT01914432|Antimetabolites|antimetabolites|mesh-ancestor
20550785|NCT01914432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550786|NCT01914432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20550787|NCT01914432|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20550788|NCT01914432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550789|NCT01914432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20550790|NCT01914432|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20288550|NCT05311176|Irinotecan|irinotecan|mesh-list
20550791|NCT01914432|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20550792|NCT01914562|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
20550793|NCT01914562|Cathartics|cathartics|mesh-ancestor
20550794|NCT01914562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20550795|NCT01914627|Salicylic Acid|salicylic acid|mesh-list
20550796|NCT01914627|Salicylates|salicylates|mesh-list
20550797|NCT01914627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20550798|NCT01914627|Antifungal Agents|antifungal agents|mesh-ancestor
20550799|NCT01914627|Keratolytic Agents|keratolytic agents|mesh-ancestor
20550800|NCT01914627|Dermatologic Agents|dermatologic agents|mesh-ancestor
20550801|NCT01914627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20550802|NCT01914627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20550803|NCT01914627|Analgesics|analgesics|mesh-ancestor
20550804|NCT01914627|Sensory System Agents|sensory system agents|mesh-ancestor
20550805|NCT01914627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550806|NCT01914627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550807|NCT01914627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20550808|NCT01914627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20550809|NCT01914627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20550810|NCT01914627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550811|NCT01914627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550812|NCT01914692|Somatostatin|somatostatin|mesh-list
20550813|NCT01914692|Hormones|hormones|mesh-ancestor
20550814|NCT01914692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20550815|NCT01914692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966636|NCT01734785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19966637|NCT01734785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966638|NCT01734785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19966639|NCT01734785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966640|NCT01734785|Incretins|incretins|mesh-ancestor
19966641|NCT01734785|Hormones|hormones|mesh-ancestor
19966642|NCT01734785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19966643|NCT01734785|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19966644|NCT01734785|Protease Inhibitors|protease inhibitors|mesh-ancestor
19966645|NCT01734785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966646|NCT01734850|Busulfan|busulfan|mesh-list
19966647|NCT01734850|Alkylating Agents|alkylating agents|mesh-ancestor
19966648|NCT01734850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966649|NCT01734850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19966650|NCT01734850|Immunologic Factors|immunologic factors|mesh-ancestor
20550816|NCT01914718|Rituximab|rituximab|mesh-list
20550817|NCT01914718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20550818|NCT01914718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550819|NCT01914718|Immunologic Factors|immunologic factors|mesh-ancestor
20550820|NCT01914718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550821|NCT01914718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20550822|NCT01914744|Lamivudine|lamivudine|mesh-list
20550823|NCT01914744|Entecavir|entecavir|mesh-list
20550824|NCT01914744|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20550825|NCT01914744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20550826|NCT01914744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550827|NCT01914744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550828|NCT01914744|Antiviral Agents|antiviral agents|mesh-ancestor
20550829|NCT01914744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20550830|NCT01914744|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20550831|NCT01914744|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20550832|NCT01914770|Belimumab|belimumab|mesh-list
20550833|NCT01914770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20550834|NCT01914770|Immunologic Factors|immunologic factors|mesh-ancestor
20550835|NCT01914770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550836|NCT01914822|Methylphenidate|methylphenidate|mesh-list
20550837|NCT01914822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20550838|NCT01914822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550839|NCT01914822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20550840|NCT01914822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20550841|NCT01914822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20550842|NCT01914822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550843|NCT01914822|Dopamine Agents|dopamine agents|mesh-ancestor
20550844|NCT01914822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20550845|NCT01914900|Docetaxel|docetaxel|mesh-list
20550846|NCT01914900|Fluorouracil|fluorouracil|mesh-list
20550847|NCT01914900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550848|NCT01914900|Tubulin Modulators|tubulin modulators|mesh-ancestor
19966651|NCT01734850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550849|NCT01914900|Antimitotic Agents|antimitotic agents|mesh-ancestor
20550850|NCT01914900|Mitosis Modulators|mitosis modulators|mesh-ancestor
20550851|NCT01914900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550852|NCT01914900|Antimetabolites|antimetabolites|mesh-ancestor
20550853|NCT01914900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20550854|NCT01914900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20550855|NCT01914900|Immunologic Factors|immunologic factors|mesh-ancestor
20550856|NCT01914900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550857|NCT01914939|Oxytocin|oxytocin|mesh-list
20550858|NCT01914939|Oxytocics|oxytocics|mesh-ancestor
20550859|NCT01914939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20550860|NCT01914939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550861|NCT01914965|Bupropion|bupropion|mesh-list
20550862|NCT01914965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20550863|NCT01914965|Antidepressive Agents|antidepressive agents|mesh-ancestor
20550864|NCT01914965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20550865|NCT01914965|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20550866|NCT01914965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20550867|NCT01914965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19966652|NCT01734850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19966653|NCT01734850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550868|NCT01914965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550869|NCT01914965|Dopamine Agents|dopamine agents|mesh-ancestor
20550870|NCT01914965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20550871|NCT01914965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550872|NCT01914965|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20550873|NCT01914965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20550874|NCT01914965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550875|NCT01915069|Cilostazol|cilostazol|mesh-list
20550876|NCT01915069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20550877|NCT01915069|Autonomic Agents|autonomic agents|mesh-ancestor
20550878|NCT01915069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550879|NCT01915069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550880|NCT01915069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20550881|NCT01915069|Respiratory System Agents|respiratory system agents|mesh-ancestor
20550882|NCT01915069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20550883|NCT01915069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20550884|NCT01915069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966654|NCT01734850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19966655|NCT01734889|Nitisinone|nitisinone|mesh-list
19966656|NCT01734889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966657|NCT01734889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966658|NCT01734902|Scopolamine|scopolamine|mesh-list
19966659|NCT01734902|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19966660|NCT01734902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19966661|NCT01734902|Antiemetics|antiemetics|mesh-ancestor
19966662|NCT01734902|Autonomic Agents|autonomic agents|mesh-ancestor
19966663|NCT01734902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19966664|NCT01734902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966665|NCT01734902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19966666|NCT01734902|Mydriatics|mydriatics|mesh-ancestor
19966667|NCT01734902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19966668|NCT01734902|Cholinergic Agents|cholinergic agents|mesh-ancestor
19966669|NCT01734902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19966670|NCT01734902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966671|NCT01734902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19966672|NCT01734902|Parasympatholytics|parasympatholytics|mesh-ancestor
20550885|NCT01915069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20550886|NCT01915069|Vasodilator Agents|vasodilator agents|mesh-ancestor
20550887|NCT01915069|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20550888|NCT01915069|Protective Agents|protective agents|mesh-ancestor
20550889|NCT01915069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20550890|NCT01915069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20550891|NCT01915069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550892|NCT01915082|Azithromycin|azithromycin|mesh-list
20550893|NCT01915082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20550894|NCT01915082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20550895|NCT01915134|Gemcitabine|gemcitabine|mesh-list
20550896|NCT01915134|Cisplatin|cisplatin|mesh-list
20550897|NCT01915134|Endostatins|endostatins|mesh-list
20550898|NCT01915134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550899|NCT01915134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20550900|NCT01915134|Antimetabolites|antimetabolites|mesh-ancestor
20550901|NCT01915134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966673|NCT01735279|Mineral Oil|mineral oil|mesh-list
19966674|NCT01735279|Emollients|emollients|mesh-ancestor
20550902|NCT01915134|Antiviral Agents|antiviral agents|mesh-ancestor
20550903|NCT01915134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20550904|NCT01915134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550905|NCT01915134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20550906|NCT01915134|Immunologic Factors|immunologic factors|mesh-ancestor
20550907|NCT01915134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550908|NCT01915134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20550909|NCT01915134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20550910|NCT01915134|Growth Substances|growth substances|mesh-ancestor
20550911|NCT01915134|Growth Inhibitors|growth inhibitors|mesh-ancestor
20550912|NCT01915186|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20550913|NCT01915186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20550914|NCT01915186|Immunologic Factors|immunologic factors|mesh-ancestor
20550915|NCT01915186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550916|NCT01915264|Metformin|metformin|mesh-list
20550917|NCT01915264|Acarbose|acarbose|mesh-list
20550918|NCT01915264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20550919|NCT01915264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550920|NCT01915264|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20550921|NCT01915264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550922|NCT01915264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550923|NCT01915277|Dexmedetomidine|dexmedetomidine|mesh-list
20550924|NCT01915277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20550925|NCT01915277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20550926|NCT01915277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550927|NCT01915277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20550928|NCT01915277|Analgesics|analgesics|mesh-ancestor
20550929|NCT01915277|Sensory System Agents|sensory system agents|mesh-ancestor
20550930|NCT01915277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550931|NCT01915277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20550932|NCT01915277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20550933|NCT01915277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20550934|NCT01915277|Adrenergic Agents|adrenergic agents|mesh-ancestor
19733497|NCT04561219|Nitazoxanide|nitazoxanide|mesh-list
19733498|NCT04561219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19733499|NCT04561219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19735773|NCT04536129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19735774|NCT04535973|Hormones|hormones|mesh-list
19735775|NCT04535973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19735776|NCT04535973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735777|NCT04536051|Acetaminophen|acetaminophen|mesh-list
19735778|NCT04536051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19735779|NCT04536051|Analgesics|analgesics|mesh-ancestor
19735780|NCT04536051|Sensory System Agents|sensory system agents|mesh-ancestor
19735781|NCT04536051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19735782|NCT04536051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735783|NCT04536051|Antipyretics|antipyretics|mesh-ancestor
19735784|NCT04536493|Lidocaine|lidocaine|mesh-list
19735785|NCT04536493|Epinephrine|epinephrine|mesh-list
20550935|NCT01915277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20550936|NCT01915277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554717|NCT01936532|Glucocorticoids|glucocorticoids|mesh-ancestor
20554718|NCT01936532|Hormones|hormones|mesh-ancestor
20554719|NCT01936532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20554720|NCT01936532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20554721|NCT01936532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554722|NCT01936532|Immunologic Factors|immunologic factors|mesh-ancestor
20554723|NCT01936532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20554724|NCT01936532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20554725|NCT01936532|Growth Substances|growth substances|mesh-ancestor
20554726|NCT01936532|Growth Inhibitors|growth inhibitors|mesh-ancestor
20554727|NCT01936532|Protease Inhibitors|protease inhibitors|mesh-ancestor
20554728|NCT01936532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554729|NCT01936532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554730|NCT01936545|Propofol|propofol|mesh-list
20554731|NCT01936545|Desflurane|desflurane|mesh-list
20554732|NCT01936545|Liver Extracts|liver extracts|mesh-list
20554733|NCT01936545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20554734|NCT01936545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20554735|NCT01936545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554736|NCT01936545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20554737|NCT01936545|Anesthetics, General|anesthetics, general|mesh-ancestor
20554738|NCT01936545|Anesthetics|anesthetics|mesh-ancestor
20554739|NCT01936545|Hematinics|hematinics|mesh-ancestor
20554740|NCT01936545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20554741|NCT01936636|Fentanyl|fentanyl|mesh-list
20550937|NCT01915459|Botulinum Toxins|botulinum toxins|mesh-list
20550938|NCT01915459|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20550939|NCT01915459|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20550940|NCT01915459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20550941|NCT01915459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20550942|NCT01915459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966675|NCT01735279|Dermatologic Agents|dermatologic agents|mesh-ancestor
19966676|NCT01735396|Abiraterone Acetate|abiraterone acetate|mesh-list
19966677|NCT01735396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966678|NCT01735396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19966679|NCT01735396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966680|NCT01735396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966681|NCT01735396|Hormone Antagonists|hormone antagonists|mesh-ancestor
19966682|NCT01735396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19966683|NCT01735396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550943|NCT01915459|Cholinergic Agents|cholinergic agents|mesh-ancestor
20550944|NCT01915459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20550945|NCT01915459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550946|NCT01915459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20550947|NCT01915459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550948|NCT01915472|Irinotecan|irinotecan|mesh-list
20550949|NCT01915472|Labetuzumab|labetuzumab|mesh-list
20550950|NCT01915472|Immunoconjugates|immunoconjugates|mesh-list
20550951|NCT01915472|Immunologic Factors|immunologic factors|mesh-ancestor
20550952|NCT01915472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550953|NCT01915472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20550954|NCT01915472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20550955|NCT01915472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550956|NCT01915472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550957|NCT01915472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550958|NCT01915472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20550959|NCT01915537|Infliximab|infliximab|mesh-list
20550960|NCT01915537|Dermatologic Agents|dermatologic agents|mesh-ancestor
20550961|NCT01915537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20550962|NCT01915537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20550963|NCT01915550|Insulin|insulin|mesh-list
20550964|NCT01915550|Metformin|metformin|mesh-list
20550965|NCT01915550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20550966|NCT01915550|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
20550967|NCT01915550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20550968|NCT01915550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550969|NCT01915602|Sorafenib|sorafenib|mesh-list
20550970|NCT01915602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550971|NCT01915602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20550972|NCT01915602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550973|NCT01915602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550974|NCT01915758|Clindamycin|clindamycin|mesh-list
20550975|NCT01915758|Clindamycin palmitate|clindamycin palmitate|mesh-list
20550976|NCT01915758|Clindamycin phosphate|clindamycin phosphate|mesh-list
20550977|NCT01915758|Tretinoin|tretinoin|mesh-list
20550978|NCT01915758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20550979|NCT01915758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20550980|NCT01915758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20550981|NCT01915758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20550982|NCT01915758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550983|NCT01915758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20550984|NCT01915758|Keratolytic Agents|keratolytic agents|mesh-ancestor
20550985|NCT01915758|Dermatologic Agents|dermatologic agents|mesh-ancestor
20550986|NCT01915810|Nicotine|nicotine|mesh-list
20550987|NCT01915810|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20550988|NCT01915810|Autonomic Agents|autonomic agents|mesh-ancestor
20550989|NCT01915810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20550990|NCT01915810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20550991|NCT01915810|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20550992|NCT01915810|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20550993|NCT01915810|Cholinergic Agents|cholinergic agents|mesh-ancestor
20550994|NCT01915810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20550995|NCT01915810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20550996|NCT01915901|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20550997|NCT01915901|Bismuth|bismuth|mesh-list
20550998|NCT01915901|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
20550999|NCT01915901|Antacids|antacids|mesh-ancestor
20551000|NCT01915901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551001|NCT01915901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20551002|NCT01915901|Dermatologic Agents|dermatologic agents|mesh-ancestor
20551003|NCT01915901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20551004|NCT01915901|Immunologic Factors|immunologic factors|mesh-ancestor
20551005|NCT01915901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551006|NCT01915901|Antidiarrheals|antidiarrheals|mesh-ancestor
20551007|NCT01915979|Betamethasone|betamethasone|mesh-list
20551008|NCT01915979|Mitogens|mitogens|mesh-list
20551009|NCT01915979|Mitosis Modulators|mitosis modulators|mesh-ancestor
20551010|NCT01915979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551011|NCT01915979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20551012|NCT01915979|Glucocorticoids|glucocorticoids|mesh-ancestor
20551013|NCT01915979|Hormones|hormones|mesh-ancestor
20551014|NCT01915979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20551015|NCT01915979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551016|NCT01915979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20551017|NCT01915979|Respiratory System Agents|respiratory system agents|mesh-ancestor
20551018|NCT01916005|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20551019|NCT01916005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20551020|NCT01916005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551021|NCT01916057|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20551022|NCT01916057|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20551023|NCT01916057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551024|NCT01916174|Insulin|insulin|mesh-list
20551025|NCT01916174|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20551026|NCT01916174|Liraglutide|liraglutide|mesh-list
20551027|NCT01916174|Insulin, Long-Acting|insulin, long-acting|mesh-list
20551028|NCT01916174|Xultophy|xultophy|mesh-list
20551029|NCT01916174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20551030|NCT01916174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551031|NCT01916174|Incretins|incretins|mesh-ancestor
20551032|NCT01916174|Hormones|hormones|mesh-ancestor
20551033|NCT01916174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20551034|NCT01916187|Imetelstat|imetelstat|mesh-list
20551035|NCT01916187|Motesanib diphosphate|motesanib diphosphate|mesh-list
20551036|NCT01916187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20551037|NCT01916187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551038|NCT01916187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20551039|NCT01916200|Paroxetine|paroxetine|mesh-list
20551040|NCT01916200|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20551041|NCT01916200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20551042|NCT01916200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20551043|NCT01916200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551044|NCT01916200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20551045|NCT01916200|Serotonin Agents|serotonin agents|mesh-ancestor
20551046|NCT01916200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551047|NCT01916200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20551048|NCT01916200|Antidepressive Agents|antidepressive agents|mesh-ancestor
20551049|NCT01916200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20551050|NCT01916200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20551051|NCT01916200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20551052|NCT01916200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20551053|NCT01916213|Hyaluronic Acid|hyaluronic acid|mesh-list
20551054|NCT01916213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20551055|NCT01916213|Immunologic Factors|immunologic factors|mesh-ancestor
20551056|NCT01916213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551057|NCT01916213|Viscosupplements|viscosupplements|mesh-ancestor
20551058|NCT01916213|Protective Agents|protective agents|mesh-ancestor
20551059|NCT01916252|Dexamethasone|dexamethasone|mesh-list
20551060|NCT01916252|Dexamethasone acetate|dexamethasone acetate|mesh-list
20551061|NCT01916252|Lenalidomide|lenalidomide|mesh-list
20551062|NCT01916252|Bortezomib|bortezomib|mesh-list
20551063|NCT01916252|Melphalan|melphalan|mesh-list
20551064|NCT01916252|Busulfan|busulfan|mesh-list
20551065|NCT01916252|BB 1101|bb 1101|mesh-list
20551066|NCT01916252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20551067|NCT01916252|Antiemetics|antiemetics|mesh-ancestor
20551068|NCT01916252|Autonomic Agents|autonomic agents|mesh-ancestor
20551069|NCT01916252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551070|NCT01916252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551071|NCT01916252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20551072|NCT01916252|Glucocorticoids|glucocorticoids|mesh-ancestor
20551073|NCT01916252|Hormones|hormones|mesh-ancestor
20551074|NCT01916252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20551075|NCT01916252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20551076|NCT01916252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551077|NCT01916252|Immunologic Factors|immunologic factors|mesh-ancestor
20551078|NCT01916252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20551079|NCT01916252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20551080|NCT01916252|Growth Substances|growth substances|mesh-ancestor
20551081|NCT01916252|Growth Inhibitors|growth inhibitors|mesh-ancestor
20551082|NCT01916252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20551083|NCT01916252|Alkylating Agents|alkylating agents|mesh-ancestor
20551084|NCT01916252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551085|NCT01916252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20551086|NCT01916252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20551087|NCT01916252|Protease Inhibitors|protease inhibitors|mesh-ancestor
20551088|NCT01916252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20551089|NCT01916265|Glucagon|glucagon|mesh-list
20551090|NCT01916265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20551091|NCT01916265|Hormones|hormones|mesh-ancestor
20551092|NCT01916265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20551093|NCT01916265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551094|NCT01916278|Lidocaine|lidocaine|mesh-list
20551095|NCT01916278|Anesthetics, Local|anesthetics, local|mesh-ancestor
20551096|NCT01916278|Anesthetics|anesthetics|mesh-ancestor
20551097|NCT01916278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20551098|NCT01916278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551099|NCT01916278|Sensory System Agents|sensory system agents|mesh-ancestor
20551100|NCT01916278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551101|NCT01916278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20551102|NCT01916278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20551103|NCT01916278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20551104|NCT01916278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19966684|NCT01735396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19966685|NCT01735617|Hydrocortisone|hydrocortisone|mesh-list
19966686|NCT01735617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19966687|NCT01735630|Inositol|inositol|mesh-list
19966688|NCT01735630|Vitamin B Complex|vitamin b complex|mesh-ancestor
19966689|NCT01735630|Vitamins|vitamins|mesh-ancestor
19966690|NCT01735630|Micronutrients|micronutrients|mesh-ancestor
19966691|NCT01735630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966692|NCT01736085|Nicotine|nicotine|mesh-list
19966693|NCT01736085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19966694|NCT01736085|Autonomic Agents|autonomic agents|mesh-ancestor
19966695|NCT01736085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19966696|NCT01736085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966697|NCT01736085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19966698|NCT01736085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19966699|NCT01736085|Cholinergic Agents|cholinergic agents|mesh-ancestor
19966700|NCT01736085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19966701|NCT01736085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966702|NCT01736176|Levodopa|levodopa|mesh-list
20551105|NCT01916278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551106|NCT01916382|Nitisinone|nitisinone|mesh-list
20551107|NCT01916382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20551108|NCT01916382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551109|NCT01916395|Sumatriptan|sumatriptan|mesh-list
20551110|NCT01916395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20551111|NCT01916395|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20551112|NCT01916395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20551113|NCT01916395|Serotonin Agents|serotonin agents|mesh-ancestor
20551114|NCT01916395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20551115|NCT01916395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551116|NCT01916395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551117|NCT01916408|Wobenzym|wobenzym|mesh-list
20551118|NCT01916408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20551119|NCT01916408|Immunologic Factors|immunologic factors|mesh-ancestor
20551120|NCT01916408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551121|NCT01916447|Bevacizumab|bevacizumab|mesh-list
20551122|NCT01916447|Irinotecan|irinotecan|mesh-list
20551123|NCT01916447|Camptothecin|camptothecin|mesh-list
20551124|NCT01916447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20551125|NCT01916447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551126|NCT01916447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20551127|NCT01916447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20551128|NCT01916447|Growth Substances|growth substances|mesh-ancestor
20551129|NCT01916447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551130|NCT01916447|Growth Inhibitors|growth inhibitors|mesh-ancestor
20551131|NCT01916447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20551132|NCT01916447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20551133|NCT01916447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20551134|NCT01916447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551135|NCT01916447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20551136|NCT01916577|Plerixafor|plerixafor|mesh-list
20551137|NCT01916577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20551138|NCT01916577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20551139|NCT01916577|Antiviral Agents|antiviral agents|mesh-ancestor
20551140|NCT01916577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20551141|NCT01916642|Lidocaine|lidocaine|mesh-list
20551142|NCT01916642|Etomidate|etomidate|mesh-list
20551143|NCT01916642|Anesthetics, Local|anesthetics, local|mesh-ancestor
20551144|NCT01916642|Anesthetics|anesthetics|mesh-ancestor
20551145|NCT01916642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20551146|NCT01916642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551147|NCT01916642|Sensory System Agents|sensory system agents|mesh-ancestor
20551148|NCT01916642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551149|NCT01916642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20551150|NCT01916642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20551151|NCT01916642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20551152|NCT01916642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20551153|NCT01916642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551154|NCT01916642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20551155|NCT01916642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20551156|NCT01916642|Anesthetics, General|anesthetics, general|mesh-ancestor
20551157|NCT01916707|Enoxaparin|enoxaparin|mesh-list
20551158|NCT01916707|Anticoagulants|anticoagulants|mesh-ancestor
20551159|NCT01916707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20551160|NCT01916707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20551161|NCT01916707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551162|NCT01916733|Insulin|insulin|mesh-list
20551163|NCT01916733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20551164|NCT01916733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551165|NCT01916785|Dasatinib|dasatinib|mesh-list
20551166|NCT01916785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551167|NCT01916785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20551168|NCT01916785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20551169|NCT01916785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551170|NCT01916798|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20551171|NCT01916798|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20551172|NCT01916798|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20551173|NCT01916798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20551174|NCT01916850|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20551175|NCT01916850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20551176|NCT01916850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551177|NCT01916850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20551178|NCT01916850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551179|NCT01916863|Canagliflozin|canagliflozin|mesh-list
20551180|NCT01916863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20551181|NCT01916863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20551182|NCT01916863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551183|NCT01916863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20551184|NCT01916863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551185|NCT01916902|Ticagrelor|ticagrelor|mesh-list
20551186|NCT01916902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20551187|NCT01916902|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20551188|NCT01916902|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20551189|NCT01916902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20551190|NCT01916902|Purinergic Agents|purinergic agents|mesh-ancestor
20551191|NCT01916902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20551192|NCT01916902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551193|NCT01916902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551194|NCT01916915|Tramadol|tramadol|mesh-list
20551195|NCT01916915|Levobupivacaine|levobupivacaine|mesh-list
20551196|NCT01916915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20551197|NCT01916915|Narcotics|narcotics|mesh-ancestor
20551198|NCT01916915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20551199|NCT01916915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551200|NCT01916915|Analgesics|analgesics|mesh-ancestor
20551201|NCT01916915|Sensory System Agents|sensory system agents|mesh-ancestor
20551202|NCT01916915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551203|NCT01916915|Anesthetics, Local|anesthetics, local|mesh-ancestor
20551204|NCT01916915|Anesthetics|anesthetics|mesh-ancestor
20551205|NCT01916954|Lumefantrine|lumefantrine|mesh-list
20551206|NCT01916954|Artemether|artemether|mesh-list
20551207|NCT01916954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20551208|NCT01916954|Antimalarials|antimalarials|mesh-ancestor
20551209|NCT01916954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20551210|NCT01916954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20551211|NCT01916954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20551212|NCT01917019|4-Aminopyridine|4-aminopyridine|mesh-list
20551213|NCT01917019|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20551214|NCT01917019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20551215|NCT01917019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551216|NCT01917032|Folic Acid|folic acid|mesh-list
20551217|NCT01917032|Vitamin A|vitamin a|mesh-list
20551218|NCT01917032|Micronutrients|micronutrients|mesh-list
20551219|NCT01917032|Trace Elements|trace elements|mesh-list
20551220|NCT01917032|Tretinoin|tretinoin|mesh-list
20551221|NCT01917032|Vitamins|vitamins|mesh-ancestor
20551222|NCT01917032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551223|NCT01917032|Hematinics|hematinics|mesh-ancestor
20551224|NCT01917032|Vitamin B Complex|vitamin b complex|mesh-ancestor
20551225|NCT01917032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551226|NCT01917032|Keratolytic Agents|keratolytic agents|mesh-ancestor
20551227|NCT01917032|Dermatologic Agents|dermatologic agents|mesh-ancestor
20551228|NCT01917045|Sufentanil|sufentanil|mesh-list
20551229|NCT01917045|Morphine|morphine|mesh-list
20551230|NCT01917045|Dsuvia|dsuvia|mesh-list
20551231|NCT01917045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20551232|NCT01917045|Narcotics|narcotics|mesh-ancestor
20551233|NCT01917045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20551234|NCT01917045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551235|NCT01917045|Analgesics|analgesics|mesh-ancestor
20551236|NCT01917045|Sensory System Agents|sensory system agents|mesh-ancestor
20551237|NCT01917045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551238|NCT01917045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19966703|NCT01736176|Carbidopa|carbidopa|mesh-list
19966704|NCT01736176|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19966705|NCT01736176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20551239|NCT01917045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20551240|NCT01917045|Anesthetics, General|anesthetics, general|mesh-ancestor
20551241|NCT01917045|Anesthetics|anesthetics|mesh-ancestor
20551242|NCT01917058|Abatacept|abatacept|mesh-list
20551243|NCT01917058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19966706|NCT01736176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19966707|NCT01736176|Dopamine Agents|dopamine agents|mesh-ancestor
19966708|NCT01736176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19966709|NCT01736176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551244|NCT01917058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551245|NCT01917058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551246|NCT01917058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20551247|NCT01917058|Immunologic Factors|immunologic factors|mesh-ancestor
20551248|NCT01917058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551249|NCT01917058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20554742|NCT01936636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20554743|NCT01936636|Narcotics|narcotics|mesh-ancestor
20554744|NCT01936636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20554745|NCT01936636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554746|NCT01936636|Analgesics|analgesics|mesh-ancestor
20554747|NCT01936636|Sensory System Agents|sensory system agents|mesh-ancestor
20554748|NCT01936636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554749|NCT01936636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20554750|NCT01936636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20554751|NCT01936636|Anesthetics, General|anesthetics, general|mesh-ancestor
20286372|NCT03710772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20286373|NCT03710772|Antibodies|antibodies|mesh-list
20286374|NCT03710772|Immunoglobulins|immunoglobulins|mesh-list
20551250|NCT01917097|Dexmedetomidine|dexmedetomidine|mesh-list
20551251|NCT01917097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20551252|NCT01917097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20551253|NCT01917097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551254|NCT01917097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20551255|NCT01917097|Analgesics|analgesics|mesh-ancestor
20551256|NCT01917097|Sensory System Agents|sensory system agents|mesh-ancestor
20551257|NCT01917097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551258|NCT01917097|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20551259|NCT01917097|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20551260|NCT01917097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20551261|NCT01917097|Adrenergic Agents|adrenergic agents|mesh-ancestor
20551262|NCT01917097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20551263|NCT01917097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551264|NCT01917149|Metoprolol|metoprolol|mesh-list
20551265|NCT01917149|Valsartan|valsartan|mesh-list
20551266|NCT01917149|Benazepril|benazepril|mesh-list
20551267|NCT01917149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20551268|NCT01917149|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20551269|NCT01917149|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20551270|NCT01917149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551271|NCT01917149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20551272|NCT01917149|Sympatholytics|sympatholytics|mesh-ancestor
20551273|NCT01917149|Autonomic Agents|autonomic agents|mesh-ancestor
20551274|NCT01917149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551275|NCT01917149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551276|NCT01917149|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20551277|NCT01917149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20551278|NCT01917149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20551279|NCT01917149|Adrenergic Agents|adrenergic agents|mesh-ancestor
20551280|NCT01917149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20551281|NCT01917149|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20551282|NCT01917149|Protease Inhibitors|protease inhibitors|mesh-ancestor
20551283|NCT01917149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20551284|NCT01917279|Docetaxel|docetaxel|mesh-list
20551285|NCT01917279|Capecitabine|capecitabine|mesh-list
20551286|NCT01917279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551287|NCT01917279|Tubulin Modulators|tubulin modulators|mesh-ancestor
20551288|NCT01917279|Antimitotic Agents|antimitotic agents|mesh-ancestor
20551289|NCT01917279|Mitosis Modulators|mitosis modulators|mesh-ancestor
20551290|NCT01917279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551291|NCT01917279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20551292|NCT01917279|Antimetabolites|antimetabolites|mesh-ancestor
20551293|NCT01917318|Iloperidone|iloperidone|mesh-list
20551294|NCT01917318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20551295|NCT01917318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20551296|NCT01917318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20551297|NCT01917318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551298|NCT01917318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20551299|NCT01917331|Beclomethasone|beclomethasone|mesh-list
20551300|NCT01917331|Glycopyrrolate|glycopyrrolate|mesh-list
20551301|NCT01917331|Formoterol Fumarate|formoterol fumarate|mesh-list
20551302|NCT01917331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20551303|NCT01917331|Autonomic Agents|autonomic agents|mesh-ancestor
20551304|NCT01917331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551305|NCT01917331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551306|NCT01917331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20551307|NCT01917331|Respiratory System Agents|respiratory system agents|mesh-ancestor
20551308|NCT01917331|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20551309|NCT01917331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20551310|NCT01917331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20551311|NCT01917331|Adrenergic Agents|adrenergic agents|mesh-ancestor
20551312|NCT01917331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20551313|NCT01917331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551314|NCT01917331|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20551315|NCT01917331|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20551316|NCT01917331|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20551317|NCT01917331|Cholinergic Agents|cholinergic agents|mesh-ancestor
20551318|NCT01917331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20551319|NCT01917331|Glucocorticoids|glucocorticoids|mesh-ancestor
20551320|NCT01917331|Hormones|hormones|mesh-ancestor
20551321|NCT01917331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20551322|NCT01917448|Morphine|morphine|mesh-list
20551323|NCT01917448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20551324|NCT01917448|Narcotics|narcotics|mesh-ancestor
20551325|NCT01917448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20551326|NCT01917448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551327|NCT01917448|Analgesics|analgesics|mesh-ancestor
20551328|NCT01917448|Sensory System Agents|sensory system agents|mesh-ancestor
20551329|NCT01917448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551330|NCT01917552|Capecitabine|capecitabine|mesh-list
20551331|NCT01917552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20551332|NCT01917552|Antimetabolites|antimetabolites|mesh-ancestor
20551333|NCT01917552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551334|NCT01917552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551335|NCT01917578|Paclitaxel|paclitaxel|mesh-list
20551336|NCT01917578|Docetaxel|docetaxel|mesh-list
20551337|NCT01917578|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20551338|NCT01917578|Cyclophosphamide|cyclophosphamide|mesh-list
20551339|NCT01917578|Carboplatin|carboplatin|mesh-list
20551340|NCT01917578|Doxorubicin|doxorubicin|mesh-list
20551341|NCT01917578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20551342|NCT01917578|Fluorouracil|fluorouracil|mesh-list
20551343|NCT01917578|Trastuzumab|trastuzumab|mesh-list
20551344|NCT01917578|Epirubicin|epirubicin|mesh-list
20551345|NCT01917578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20551346|NCT01917578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551347|NCT01917578|Tubulin Modulators|tubulin modulators|mesh-ancestor
20551348|NCT01917578|Antimitotic Agents|antimitotic agents|mesh-ancestor
20551349|NCT01917578|Mitosis Modulators|mitosis modulators|mesh-ancestor
20551350|NCT01917578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966710|NCT01736176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966711|NCT01736176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19966712|NCT01736176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966713|NCT01736176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19966714|NCT01736176|Immunologic Factors|immunologic factors|mesh-ancestor
19966715|NCT01736176|Dopamine Agonists|dopamine agonists|mesh-ancestor
20551351|NCT01917578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20551352|NCT01917578|Immunologic Factors|immunologic factors|mesh-ancestor
20551353|NCT01917578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551354|NCT01917578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20551355|NCT01917578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19966716|NCT01736189|Adalimumab|adalimumab|mesh-list
19966717|NCT01736189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19966718|NCT01736189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19966719|NCT01736215|Epoetin Alfa|epoetin alfa|mesh-list
19966720|NCT01736215|Hematinics|hematinics|mesh-ancestor
19966721|NCT01736254|Gemfibrozil|gemfibrozil|mesh-list
19966722|NCT01736254|Evacetrapib|evacetrapib|mesh-list
20551356|NCT01917578|Alkylating Agents|alkylating agents|mesh-ancestor
20551357|NCT01917578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19966723|NCT01736254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19966724|NCT01736254|Antimetabolites|antimetabolites|mesh-ancestor
19966725|NCT01736254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966726|NCT01736254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19966727|NCT01736254|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19966728|NCT01736254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19966729|NCT01736254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966730|NCT01736254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20551358|NCT01917578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20551359|NCT01917578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19966731|NCT01736358|Ketorolac|ketorolac|mesh-list
19966732|NCT01736358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20551360|NCT01917578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20551361|NCT01917578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20551362|NCT01917578|Antimetabolites|antimetabolites|mesh-ancestor
20551363|NCT01917578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20551364|NCT01917578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20551365|NCT01917617|Gemcitabine|gemcitabine|mesh-list
20551366|NCT01917617|Cisplatin|cisplatin|mesh-list
20551367|NCT01917617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20551368|NCT01917617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551369|NCT01917617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20551370|NCT01917617|Antimetabolites|antimetabolites|mesh-ancestor
20551371|NCT01917617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551372|NCT01917617|Antiviral Agents|antiviral agents|mesh-ancestor
20551373|NCT01917617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20551374|NCT01917617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20551375|NCT01917617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20551376|NCT01917617|Immunologic Factors|immunologic factors|mesh-ancestor
20551377|NCT01917617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551378|NCT01917708|Abatacept|abatacept|mesh-list
20551379|NCT01917708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20551380|NCT01917708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551381|NCT01917708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551382|NCT01917708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20551383|NCT01917708|Immunologic Factors|immunologic factors|mesh-ancestor
20551384|NCT01917708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551385|NCT01917708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20551386|NCT01917721|Doxycycline|doxycycline|mesh-list
20551387|NCT01917721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19966733|NCT01736358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19966734|NCT01736358|Analgesics|analgesics|mesh-ancestor
19966735|NCT01736358|Sensory System Agents|sensory system agents|mesh-ancestor
19966736|NCT01736358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19966737|NCT01736358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966738|NCT01736358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19966739|NCT01736358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19966740|NCT01736358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19966741|NCT01736358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966742|NCT01736358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551388|NCT01917721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20551389|NCT01917721|Antimalarials|antimalarials|mesh-ancestor
20551390|NCT01917721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20551391|NCT01917721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20551392|NCT01917799|Aspirin|aspirin|mesh-list
20551393|NCT01917799|Heparin|heparin|mesh-list
20551394|NCT01917799|Enoxaparin|enoxaparin|mesh-list
20551395|NCT01917799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20551396|NCT01917799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20551397|NCT01917799|Analgesics|analgesics|mesh-ancestor
20551398|NCT01917799|Sensory System Agents|sensory system agents|mesh-ancestor
20551399|NCT01917799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551400|NCT01917799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551401|NCT01917799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20551402|NCT01917799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20551403|NCT01917799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20551404|NCT01917799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20551405|NCT01917799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551406|NCT01917799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20551407|NCT01917799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20551408|NCT01917799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20551409|NCT01917799|Antipyretics|antipyretics|mesh-ancestor
20551410|NCT01917799|Anticoagulants|anticoagulants|mesh-ancestor
20551411|NCT01917877|Dexamethasone|dexamethasone|mesh-list
20551412|NCT01917877|Bevacizumab|bevacizumab|mesh-list
20551413|NCT01917877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20551414|NCT01917877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551415|NCT01917877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20551416|NCT01917877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20551417|NCT01917877|Growth Substances|growth substances|mesh-ancestor
20551418|NCT01917877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551419|NCT01917877|Growth Inhibitors|growth inhibitors|mesh-ancestor
20551420|NCT01917877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20551421|NCT01917877|Antiemetics|antiemetics|mesh-ancestor
20551422|NCT01917877|Autonomic Agents|autonomic agents|mesh-ancestor
20551423|NCT01917877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551424|NCT01917877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20551425|NCT01917877|Glucocorticoids|glucocorticoids|mesh-ancestor
20551426|NCT01917877|Hormones|hormones|mesh-ancestor
20551427|NCT01917877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20551428|NCT01917877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20551429|NCT01917890|Curcumin|curcumin|mesh-list
19966743|NCT01736475|Factor VIII|factor viii|mesh-list
19966744|NCT01736475|BAX 855|bax 855|mesh-list
19966745|NCT01736475|Coagulants|coagulants|mesh-ancestor
19966746|NCT01736527|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19966747|NCT01736527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20551430|NCT01917890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20551431|NCT01917890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20551432|NCT01917890|Analgesics|analgesics|mesh-ancestor
20551433|NCT01917890|Sensory System Agents|sensory system agents|mesh-ancestor
20551434|NCT01917890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551435|NCT01917890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551436|NCT01917890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20551437|NCT01917890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19966748|NCT01736579|Immunoglobulins|immunoglobulins|mesh-list
19966749|NCT01736579|Antibodies|antibodies|mesh-list
20551438|NCT01917890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551439|NCT01917890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20551440|NCT01917890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551441|NCT01918098|Oxycodone|oxycodone|mesh-list
20551442|NCT01918098|Naloxone|naloxone|mesh-list
20551443|NCT01918098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20551444|NCT01918098|Narcotics|narcotics|mesh-ancestor
20551445|NCT01918098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20551446|NCT01918098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551447|NCT01918098|Analgesics|analgesics|mesh-ancestor
20551448|NCT01918098|Sensory System Agents|sensory system agents|mesh-ancestor
20551449|NCT01918098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551450|NCT01918098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20551451|NCT01918111|Adenosine|adenosine|mesh-list
20551452|NCT01918111|Analgesics|analgesics|mesh-ancestor
20551453|NCT01918111|Sensory System Agents|sensory system agents|mesh-ancestor
20551454|NCT01918111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551455|NCT01918111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551456|NCT01918111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20551457|NCT01918111|Vasodilator Agents|vasodilator agents|mesh-ancestor
20551458|NCT01918111|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20551459|NCT01918111|Purinergic Agonists|purinergic agonists|mesh-ancestor
20551460|NCT01918111|Purinergic Agents|purinergic agents|mesh-ancestor
20551461|NCT01918111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20551462|NCT01918111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551463|NCT01918124|Paclitaxel|paclitaxel|mesh-list
20551464|NCT01918124|Cyclophosphamide|cyclophosphamide|mesh-list
20551465|NCT01918124|Cisplatin|cisplatin|mesh-list
20551466|NCT01918124|Carboplatin|carboplatin|mesh-list
20551467|NCT01918124|Doxorubicin|doxorubicin|mesh-list
20551468|NCT01918124|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20551469|NCT01918124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551470|NCT01918124|Tubulin Modulators|tubulin modulators|mesh-ancestor
20551471|NCT01918124|Antimitotic Agents|antimitotic agents|mesh-ancestor
20551472|NCT01918124|Mitosis Modulators|mitosis modulators|mesh-ancestor
20551473|NCT01918124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551474|NCT01918124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20551475|NCT01918124|Immunologic Factors|immunologic factors|mesh-ancestor
20551476|NCT01918124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551477|NCT01918124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20551478|NCT01918124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20551479|NCT01918124|Alkylating Agents|alkylating agents|mesh-ancestor
20551480|NCT01918124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20551481|NCT01918124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20551482|NCT01918124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20551483|NCT01918124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20551484|NCT01918124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20551485|NCT01918150|Cobalt|cobalt|mesh-list
20551486|NCT01918150|Chromium|chromium|mesh-list
20551487|NCT01918150|Trace Elements|trace elements|mesh-ancestor
20551488|NCT01918150|Micronutrients|micronutrients|mesh-ancestor
20551489|NCT01918150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551490|NCT01918176|Palbociclib|palbociclib|mesh-list
20551491|NCT01918176|Rabeprazole|rabeprazole|mesh-list
20551492|NCT01918176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450410|NCT03428568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19450411|NCT03428568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19450412|NCT03428529|Fluorouracil|fluorouracil|mesh-list
19450413|NCT03428529|Capecitabine|capecitabine|mesh-list
19450414|NCT03428529|Antimetabolites|antimetabolites|mesh-ancestor
19450415|NCT03428529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551493|NCT01918176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20551494|NCT01918176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20551495|NCT01918176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551496|NCT01918176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20551497|NCT01918176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20551498|NCT01918176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20551499|NCT01918241|Lenograstim|lenograstim|mesh-list
20551500|NCT01918241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20551501|NCT01918241|Immunologic Factors|immunologic factors|mesh-ancestor
20551502|NCT01918241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551503|NCT01918254|Paclitaxel|paclitaxel|mesh-list
20551504|NCT01918254|Pertuzumab|pertuzumab|mesh-list
20551505|NCT01918254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20551506|NCT01918254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551507|NCT01918254|Tubulin Modulators|tubulin modulators|mesh-ancestor
20551508|NCT01918254|Antimitotic Agents|antimitotic agents|mesh-ancestor
20551509|NCT01918254|Mitosis Modulators|mitosis modulators|mesh-ancestor
20551510|NCT01918254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551511|NCT01918254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20551512|NCT01918358|Valsartan|valsartan|mesh-list
20551513|NCT01918358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20551514|NCT01918358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20551515|NCT01918358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20551516|NCT01918358|Antimetabolites|antimetabolites|mesh-ancestor
20551517|NCT01918358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551518|NCT01918358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20551519|NCT01918358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20551520|NCT01918358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20551521|NCT01918358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20551522|NCT01918358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20551523|NCT01918358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20551524|NCT01918384|Arbekacin|arbekacin|mesh-list
20551525|NCT01918384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20551526|NCT01918475|Carbetocin|carbetocin|mesh-list
20551527|NCT01918475|Oxytocics|oxytocics|mesh-ancestor
20551528|NCT01918475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20551529|NCT01918475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551530|NCT01918488|Amiloride|amiloride|mesh-list
20551531|NCT01918488|Triamterene|triamterene|mesh-list
20551532|NCT01918488|Diuretics|diuretics|mesh-ancestor
20551533|NCT01918488|Natriuretic Agents|natriuretic agents|mesh-ancestor
20551534|NCT01918488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551535|NCT01918488|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
20551536|NCT01918488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20551537|NCT01918488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20551538|NCT01918488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551539|NCT01918488|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
20551540|NCT01918488|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20551541|NCT01918514|Magnesium Sulfate|magnesium sulfate|mesh-list
20551542|NCT01918514|Analgesics|analgesics|mesh-ancestor
20551543|NCT01918514|Sensory System Agents|sensory system agents|mesh-ancestor
20551544|NCT01918514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551545|NCT01918514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551546|NCT01918514|Anesthetics|anesthetics|mesh-ancestor
20551547|NCT01918514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20551548|NCT01918514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20551549|NCT01918514|Anticonvulsants|anticonvulsants|mesh-ancestor
20551550|NCT01918514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20551551|NCT01918514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20551552|NCT01918514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551553|NCT01918514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20551554|NCT01918514|Tocolytic Agents|tocolytic agents|mesh-ancestor
20551555|NCT01918514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20551556|NCT01918527|Capecitabine|capecitabine|mesh-list
20551557|NCT01918527|Oxaliplatin|oxaliplatin|mesh-list
20551558|NCT01918527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20551559|NCT01918527|Antimetabolites|antimetabolites|mesh-ancestor
20551560|NCT01918527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551561|NCT01918527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551562|NCT01918631|Tenofovir|tenofovir|mesh-list
20551563|NCT01918631|Entecavir|entecavir|mesh-list
20551564|NCT01918631|Antiviral Agents|antiviral agents|mesh-ancestor
20551565|NCT01918631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20551566|NCT01918631|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20551567|NCT01918631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20551568|NCT01918631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20551569|NCT01918631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551570|NCT01918631|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20551571|NCT01918631|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20551572|NCT01918644|Capecitabine|capecitabine|mesh-list
20551573|NCT01918644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19966750|NCT01736579|gamma-Globulins|gamma-globulins|mesh-list
19966751|NCT01736579|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19966752|NCT01736579|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19966753|NCT01736579|Immunologic Factors|immunologic factors|mesh-ancestor
19966754|NCT01736579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966755|NCT01736696|Tofacitinib|tofacitinib|mesh-list
19966756|NCT01736696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19966757|NCT01736696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966758|NCT01736696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966759|NCT01736852|Oxytocin|oxytocin|mesh-list
19966760|NCT01736852|Oxytocics|oxytocics|mesh-ancestor
19966761|NCT01736852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20551574|NCT01918644|Antimetabolites|antimetabolites|mesh-ancestor
20551575|NCT01918644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551576|NCT01918644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551577|NCT01918709|Valsartan|valsartan|mesh-list
20551578|NCT01918709|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20551579|NCT01918709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20551580|NCT01918709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20551581|NCT01918709|Antimetabolites|antimetabolites|mesh-ancestor
20551582|NCT01918709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551583|NCT01918709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20551584|NCT01918709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20551585|NCT01918709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20551586|NCT01918709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20551587|NCT01918709|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20551588|NCT01918709|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20554752|NCT01936636|Anesthetics|anesthetics|mesh-ancestor
20554753|NCT01936805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20554754|NCT01936805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20554755|NCT01936805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20554756|NCT01936805|Antimetabolites|antimetabolites|mesh-ancestor
20554757|NCT01936805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554758|NCT01936805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20554759|NCT01936805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20554760|NCT01936805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554761|NCT01936961|Antibodies|antibodies|mesh-list
20554762|NCT01936961|Immunologic Factors|immunologic factors|mesh-ancestor
20554763|NCT01936961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554764|NCT01937013|Oxytocin|oxytocin|mesh-list
20554765|NCT01937013|Oxytocics|oxytocics|mesh-ancestor
20554766|NCT01937013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20554767|NCT01937013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966762|NCT01736852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966763|NCT01736865|Cholecalciferol|cholecalciferol|mesh-list
20551589|NCT01918813|Vancomycin|vancomycin|mesh-list
20551590|NCT01918813|Mupirocin|mupirocin|mesh-list
20551591|NCT01918813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20551592|NCT01918813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20551593|NCT01918813|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20551594|NCT01918813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20551595|NCT01918813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551596|NCT01918852|Bevacizumab|bevacizumab|mesh-list
20551597|NCT01918852|Capecitabine|capecitabine|mesh-list
20551598|NCT01918852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20551599|NCT01918852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551600|NCT01918852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20551601|NCT01918852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20551602|NCT01918852|Growth Substances|growth substances|mesh-ancestor
20551603|NCT01918852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551604|NCT01918852|Growth Inhibitors|growth inhibitors|mesh-ancestor
20551605|NCT01918852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20551606|NCT01918852|Antimetabolites|antimetabolites|mesh-ancestor
20551607|NCT01918852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551608|NCT01918865|Metformin|metformin|mesh-list
20551609|NCT01918865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20551610|NCT01918865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551611|NCT01918878|Aflibercept|aflibercept|mesh-list
20551612|NCT01918878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20551613|NCT01918878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20551614|NCT01918878|Growth Substances|growth substances|mesh-ancestor
20551615|NCT01918878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551616|NCT01918878|Growth Inhibitors|growth inhibitors|mesh-ancestor
20551617|NCT01918878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551618|NCT01918904|Sodium thiosulfate|sodium thiosulfate|mesh-list
20551619|NCT01918904|Antidotes|antidotes|mesh-ancestor
19966764|NCT01736865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19966765|NCT01736865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966766|NCT01736865|Vitamins|vitamins|mesh-ancestor
19966767|NCT01736865|Micronutrients|micronutrients|mesh-ancestor
19966768|NCT01736865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19966769|NCT01736917|Dexamethasone|dexamethasone|mesh-list
19966770|NCT01736917|Fosaprepitant|fosaprepitant|mesh-list
19966771|NCT01736917|Aprepitant|aprepitant|mesh-list
19966772|NCT01736917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19966773|NCT01736917|Antiemetics|antiemetics|mesh-ancestor
19966774|NCT01736917|Autonomic Agents|autonomic agents|mesh-ancestor
19966775|NCT01736917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19966776|NCT01736917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966777|NCT01736917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19966778|NCT01736917|Glucocorticoids|glucocorticoids|mesh-ancestor
19966779|NCT01736917|Hormones|hormones|mesh-ancestor
19966780|NCT01736917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19966781|NCT01736917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19966782|NCT01736917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966783|NCT01736917|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19966784|NCT01736917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19966785|NCT01736917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966786|NCT01736943|Doxorubicin|doxorubicin|mesh-list
19966787|NCT01736943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19966788|NCT01736943|Bortezomib|bortezomib|mesh-list
19966789|NCT01736943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19966790|NCT01736943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966791|NCT01736943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20551620|NCT01918904|Protective Agents|protective agents|mesh-ancestor
19966792|NCT01736943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19966793|NCT01736943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966794|NCT01736943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966795|NCT01737268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19966796|NCT01737268|Antidepressive Agents|antidepressive agents|mesh-ancestor
19966797|NCT01737268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19966798|NCT01737268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19966799|NCT01737268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19966800|NCT01737268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19966801|NCT01737268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551621|NCT01918904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551622|NCT01918904|Antioxidants|antioxidants|mesh-ancestor
20551623|NCT01918904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551624|NCT01918904|Antitubercular Agents|antitubercular agents|mesh-ancestor
20551625|NCT01918904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20551626|NCT01918904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20551627|NCT01918904|Chelating Agents|chelating agents|mesh-ancestor
20551628|NCT01918904|Sequestering Agents|sequestering agents|mesh-ancestor
20551629|NCT01918917|Dexmedetomidine|dexmedetomidine|mesh-list
20551630|NCT01918917|Morphine|morphine|mesh-list
20551631|NCT01918917|Levobupivacaine|levobupivacaine|mesh-list
20551632|NCT01918917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20551633|NCT01918917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20551634|NCT01918917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551635|NCT01918917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19975231|NCT01846611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19975232|NCT01846611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20551636|NCT01918917|Analgesics|analgesics|mesh-ancestor
20551637|NCT01918917|Sensory System Agents|sensory system agents|mesh-ancestor
20551638|NCT01918917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551639|NCT01918917|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20551640|NCT01918917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20551641|NCT01918917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20551642|NCT01918917|Adrenergic Agents|adrenergic agents|mesh-ancestor
20551643|NCT01918917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20551644|NCT01918917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551645|NCT01918917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20551646|NCT01918917|Narcotics|narcotics|mesh-ancestor
20551647|NCT01918917|Anesthetics, Local|anesthetics, local|mesh-ancestor
20551648|NCT01918917|Anesthetics|anesthetics|mesh-ancestor
20551649|NCT01918995|Regadenoson|regadenoson|mesh-list
20551650|NCT01918995|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20551651|NCT01918995|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20551652|NCT01918995|Purinergic Agonists|purinergic agonists|mesh-ancestor
20551653|NCT01918995|Purinergic Agents|purinergic agents|mesh-ancestor
20551654|NCT01918995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20551655|NCT01918995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551656|NCT01918995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551657|NCT01919008|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20551658|NCT01919008|Antidepressive Agents|antidepressive agents|mesh-ancestor
20551659|NCT01919008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20551660|NCT01919008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20551661|NCT01919008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20551662|NCT01919008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20551663|NCT01919008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551664|NCT01919047|Mirabegron|mirabegron|mesh-list
20551665|NCT01919047|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20551666|NCT01919047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20551667|NCT01919047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20551668|NCT01919047|Adrenergic Agents|adrenergic agents|mesh-ancestor
20551669|NCT01919047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20551670|NCT01919047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551671|NCT01919047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551672|NCT01919047|Urological Agents|urological agents|mesh-ancestor
20551673|NCT01919203|Remifentanil|remifentanil|mesh-list
20551674|NCT01919203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20551675|NCT01919203|Narcotics|narcotics|mesh-ancestor
20551676|NCT01919203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20551677|NCT01919203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551678|NCT01919203|Analgesics|analgesics|mesh-ancestor
20551679|NCT01919203|Sensory System Agents|sensory system agents|mesh-ancestor
19966802|NCT01737593|Acetaminophen|acetaminophen|mesh-list
19966803|NCT01737593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19966804|NCT01737593|Analgesics|analgesics|mesh-ancestor
19966805|NCT01737593|Sensory System Agents|sensory system agents|mesh-ancestor
19966806|NCT01737593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19966807|NCT01737593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966808|NCT01737593|Antipyretics|antipyretics|mesh-ancestor
19966809|NCT01737710|Vaccines|vaccines|mesh-list
19966810|NCT01737710|Immunologic Factors|immunologic factors|mesh-ancestor
19966811|NCT01737710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966812|NCT01737840|Pantoprazole|pantoprazole|mesh-list
20551680|NCT01919203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551681|NCT01919255|Picosulfate sodium|picosulfate sodium|mesh-list
20551682|NCT01919255|Sodium sulfate|sodium sulfate|mesh-list
20551683|NCT01919255|Magnesium Oxide|magnesium oxide|mesh-list
20551684|NCT01919255|Sodium Citrate|sodium citrate|mesh-list
20551685|NCT01919255|Citric Acid|citric acid|mesh-list
20551686|NCT01919255|Anticoagulants|anticoagulants|mesh-ancestor
20551687|NCT01919255|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20551688|NCT01919255|Chelating Agents|chelating agents|mesh-ancestor
20551689|NCT01919255|Sequestering Agents|sequestering agents|mesh-ancestor
19966813|NCT01737840|Ranitidine|ranitidine|mesh-list
19966814|NCT01737840|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20551690|NCT01919255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551691|NCT01919255|Cathartics|cathartics|mesh-ancestor
20551692|NCT01919255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20551693|NCT01919255|Antacids|antacids|mesh-ancestor
20551694|NCT01919294|Methyltestosterone|methyltestosterone|mesh-list
20551695|NCT01919294|Testosterone|testosterone|mesh-list
20551696|NCT01919294|Testosterone undecanoate|testosterone undecanoate|mesh-list
20551697|NCT01919294|Testosterone enanthate|testosterone enanthate|mesh-list
20551698|NCT01919294|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20551699|NCT01919294|Androgens|androgens|mesh-ancestor
20551700|NCT01919294|Hormones|hormones|mesh-ancestor
20551701|NCT01919294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20551702|NCT01919294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551703|NCT01919294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20551704|NCT01919294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551705|NCT01919294|Anabolic Agents|anabolic agents|mesh-ancestor
20551706|NCT01919346|Eculizumab|eculizumab|mesh-list
20551707|NCT01919346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20551708|NCT01919346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20551709|NCT01919346|Immunologic Factors|immunologic factors|mesh-ancestor
20551710|NCT01919346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551711|NCT01919424|Methacholine Chloride|methacholine chloride|mesh-list
20551712|NCT01919424|Miotics|miotics|mesh-ancestor
20551713|NCT01919424|Autonomic Agents|autonomic agents|mesh-ancestor
20551714|NCT01919424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551715|NCT01919424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551716|NCT01919424|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20551717|NCT01919424|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20551718|NCT01919424|Respiratory System Agents|respiratory system agents|mesh-ancestor
20551719|NCT01919424|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20551720|NCT01919424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20551721|NCT01919424|Cholinergic Agents|cholinergic agents|mesh-ancestor
20551722|NCT01919424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20551723|NCT01919424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551724|NCT01919593|Chlorhexidine|chlorhexidine|mesh-list
20551725|NCT01919593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20551726|NCT01919593|Povidone-Iodine|povidone-iodine|mesh-list
20551727|NCT01919593|Povidone|povidone|mesh-list
20551728|NCT01919593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20551729|NCT01919593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20551730|NCT01919593|Disinfectants|disinfectants|mesh-ancestor
20551731|NCT01919593|Dermatologic Agents|dermatologic agents|mesh-ancestor
20551732|NCT01919593|Plasma Substitutes|plasma substitutes|mesh-ancestor
20551733|NCT01919593|Blood Substitutes|blood substitutes|mesh-ancestor
20551734|NCT01919619|Lenalidomide|lenalidomide|mesh-list
20551735|NCT01919619|Ipilimumab|ipilimumab|mesh-list
20551736|NCT01919619|Immunologic Factors|immunologic factors|mesh-ancestor
20551737|NCT01919619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551738|NCT01919619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20551739|NCT01919619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20551740|NCT01919619|Growth Substances|growth substances|mesh-ancestor
20551741|NCT01919619|Growth Inhibitors|growth inhibitors|mesh-ancestor
20551742|NCT01919619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551743|NCT01919619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19966815|NCT01737840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19966816|NCT01737840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19966817|NCT01737840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19966818|NCT01737840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966819|NCT01737840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966820|NCT01737840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19966821|NCT01737840|Histamine Antagonists|histamine antagonists|mesh-ancestor
19966822|NCT01737840|Histamine Agents|histamine agents|mesh-ancestor
19966823|NCT01737840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19966824|NCT01737840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966825|NCT01737879|Epoetin Alfa|epoetin alfa|mesh-list
19966826|NCT01737879|Hematinics|hematinics|mesh-ancestor
19966827|NCT01737931|Diphenhydramine|diphenhydramine|mesh-list
19966828|NCT01737931|Promethazine|promethazine|mesh-list
19966829|NCT01737931|Dexamethasone|dexamethasone|mesh-list
19966830|NCT01737931|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
19966831|NCT01737931|Histamine Antagonists|histamine antagonists|mesh-list
19966832|NCT01737931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19966833|NCT01737931|Antiemetics|antiemetics|mesh-ancestor
19966834|NCT01737931|Autonomic Agents|autonomic agents|mesh-ancestor
19966835|NCT01737931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551744|NCT01919619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20551745|NCT01919619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551746|NCT01919788|Insulin|insulin|mesh-list
20551747|NCT01919788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20551748|NCT01919788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551749|NCT01919879|Cetuximab|cetuximab|mesh-list
20551750|NCT01919879|Afatinib|afatinib|mesh-list
20551751|NCT01919879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20551752|NCT01919879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551753|NCT01919879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20551754|NCT01919879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20551755|NCT01919879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551756|NCT01919892|Lithium Carbonate|lithium carbonate|mesh-list
20551757|NCT01919892|Antidepressive Agents|antidepressive agents|mesh-ancestor
20551758|NCT01919892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20551759|NCT01919892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20551760|NCT01919892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551761|NCT01919892|Antimanic Agents|antimanic agents|mesh-ancestor
20551762|NCT01919892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20551763|NCT01919892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20551764|NCT01919892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551765|NCT01919905|Vitamin D|vitamin d|mesh-list
20551766|NCT01919905|Vitamins|vitamins|mesh-ancestor
20551767|NCT01919905|Micronutrients|micronutrients|mesh-ancestor
20551768|NCT01919905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551769|NCT01919905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20551770|NCT01919918|Adenosine|adenosine|mesh-list
20551771|NCT01919918|Analgesics|analgesics|mesh-ancestor
19966836|NCT01737931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286375|NCT03710772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20551772|NCT01919918|Sensory System Agents|sensory system agents|mesh-ancestor
20551773|NCT01919918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551774|NCT01919918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551775|NCT01919918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20551776|NCT01919918|Vasodilator Agents|vasodilator agents|mesh-ancestor
20551777|NCT01919918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20551778|NCT01919918|Purinergic Agonists|purinergic agonists|mesh-ancestor
20551779|NCT01919918|Purinergic Agents|purinergic agents|mesh-ancestor
20551780|NCT01919918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20551781|NCT01919918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551782|NCT01920022|Contraceptive Agents|contraceptive agents|mesh-list
20551783|NCT01920022|Mifepristone|mifepristone|mesh-list
20551784|NCT01920022|Etonogestrel|etonogestrel|mesh-list
20551785|NCT01920022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20551786|NCT01920022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551787|NCT01920022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20551788|NCT01920022|Abortifacient Agents|abortifacient agents|mesh-ancestor
20551789|NCT01920022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20551790|NCT01920022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20551791|NCT01920022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20551792|NCT01920022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20551793|NCT01920022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20551794|NCT01920022|Hormone Antagonists|hormone antagonists|mesh-ancestor
20551795|NCT01920022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20551796|NCT01920022|Luteolytic Agents|luteolytic agents|mesh-ancestor
20551797|NCT01920022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20551798|NCT01920022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20551799|NCT01920074|Nitroglycerin|nitroglycerin|mesh-list
20551800|NCT01920074|Vasodilator Agents|vasodilator agents|mesh-ancestor
20551801|NCT01920113|Dexmedetomidine|dexmedetomidine|mesh-list
20551802|NCT01920113|Remifentanil|remifentanil|mesh-list
20551803|NCT01920113|Propofol|propofol|mesh-list
20551804|NCT01920113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20551805|NCT01920113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20551806|NCT01920113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551807|NCT01920113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20551808|NCT01920113|Anesthetics, General|anesthetics, general|mesh-ancestor
20551809|NCT01920113|Anesthetics|anesthetics|mesh-ancestor
20551810|NCT01920113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20551811|NCT01920113|Analgesics|analgesics|mesh-ancestor
20551812|NCT01920113|Sensory System Agents|sensory system agents|mesh-ancestor
20551813|NCT01920113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551814|NCT01920113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20551815|NCT01920113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20551816|NCT01920113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20551817|NCT01920113|Adrenergic Agents|adrenergic agents|mesh-ancestor
20551818|NCT01920113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20551819|NCT01920113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551820|NCT01920113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19966837|NCT01737931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19966838|NCT01737931|Glucocorticoids|glucocorticoids|mesh-ancestor
19966839|NCT01737931|Hormones|hormones|mesh-ancestor
19966840|NCT01737931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19966841|NCT01737931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19966842|NCT01737931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966843|NCT01737931|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19966844|NCT01737931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19966845|NCT01737931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19966846|NCT01737931|Anesthetics, Local|anesthetics, local|mesh-ancestor
19966847|NCT01737931|Anesthetics|anesthetics|mesh-ancestor
19966848|NCT01737931|Sensory System Agents|sensory system agents|mesh-ancestor
19966849|NCT01737931|Histamine Agents|histamine agents|mesh-ancestor
19966850|NCT01737931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19966851|NCT01737931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551821|NCT01920113|Narcotics|narcotics|mesh-ancestor
20551822|NCT01920191|Poly ICLC|poly iclc|mesh-list
20551823|NCT01920191|Interferon Inducers|interferon inducers|mesh-ancestor
20551824|NCT01920191|Immunologic Factors|immunologic factors|mesh-ancestor
20551825|NCT01920191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551826|NCT01920204|Midostaurin|midostaurin|mesh-list
20551827|NCT01920204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551828|NCT01920204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19966852|NCT01737931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19966853|NCT01737931|Antipruritics|antipruritics|mesh-ancestor
19966854|NCT01737931|Dermatologic Agents|dermatologic agents|mesh-ancestor
19966855|NCT01737944|Methotrexate|methotrexate|mesh-list
19966856|NCT01737944|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19966857|NCT01737944|Abortifacient Agents|abortifacient agents|mesh-ancestor
19966858|NCT01737944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19966859|NCT01737944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966860|NCT01737944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19966861|NCT01737944|Antimetabolites|antimetabolites|mesh-ancestor
19966862|NCT01737944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966863|NCT01737944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966864|NCT01737944|Dermatologic Agents|dermatologic agents|mesh-ancestor
19966865|NCT01737944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966866|NCT01737944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19966867|NCT01737944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19966868|NCT01737944|Immunologic Factors|immunologic factors|mesh-ancestor
20551829|NCT01920204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20551830|NCT01920204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551831|NCT01920269|Mitomycins|mitomycins|mesh-list
20551832|NCT01920269|Mitomycin|mitomycin|mesh-list
20551833|NCT01920269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20551834|NCT01920269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551835|NCT01920269|Alkylating Agents|alkylating agents|mesh-ancestor
20551836|NCT01920269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551837|NCT01920269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20551838|NCT01920269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20551839|NCT01920334|Zolpidem|zolpidem|mesh-list
20551840|NCT01920334|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20551841|NCT01920334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20551842|NCT01920334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20551843|NCT01920334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551844|NCT01920334|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20551845|NCT01920334|GABA Agonists|gaba agonists|mesh-ancestor
20551846|NCT01920334|GABA Agents|gaba agents|mesh-ancestor
20551847|NCT01920334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20551848|NCT01920334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551849|NCT01920386|Acetaminophen|acetaminophen|mesh-list
20551850|NCT01920386|Tramadol|tramadol|mesh-list
20551851|NCT01920386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20551852|NCT01920386|Analgesics|analgesics|mesh-ancestor
20551853|NCT01920386|Sensory System Agents|sensory system agents|mesh-ancestor
20551854|NCT01920386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551855|NCT01920386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551856|NCT01920386|Antipyretics|antipyretics|mesh-ancestor
20551857|NCT01920386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20551858|NCT01920386|Narcotics|narcotics|mesh-ancestor
20551859|NCT01920386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20554768|NCT01937078|Famotidine|famotidine|mesh-list
20554769|NCT01937078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20554770|NCT01937078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20554771|NCT01937078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20554772|NCT01937078|Histamine Antagonists|histamine antagonists|mesh-ancestor
20554773|NCT01937078|Histamine Agents|histamine agents|mesh-ancestor
20554774|NCT01937078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20554775|NCT01937078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554776|NCT01937078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554777|NCT01937104|Remifentanil|remifentanil|mesh-list
20554778|NCT01937104|Desflurane|desflurane|mesh-list
20554779|NCT01937104|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20554780|NCT01937104|Narcotics|narcotics|mesh-ancestor
20554781|NCT01937104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20554782|NCT01937104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554783|NCT01937104|Analgesics|analgesics|mesh-ancestor
20554784|NCT01937104|Sensory System Agents|sensory system agents|mesh-ancestor
20554785|NCT01937104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554786|NCT01937104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20554787|NCT01937104|Anesthetics, General|anesthetics, general|mesh-ancestor
20554788|NCT01937104|Anesthetics|anesthetics|mesh-ancestor
20554789|NCT01937156|Granisetron|granisetron|mesh-list
20554790|NCT01937156|Antiemetics|antiemetics|mesh-ancestor
20554791|NCT01937156|Autonomic Agents|autonomic agents|mesh-ancestor
20554792|NCT01937156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554793|NCT01937156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554794|NCT01937156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20554795|NCT01937156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20554796|NCT01937156|Serotonin Agents|serotonin agents|mesh-ancestor
20554797|NCT01937156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20554798|NCT01937156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554799|NCT01937169|Levodopa|levodopa|mesh-list
20554800|NCT01937169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20554801|NCT01937169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20554802|NCT01937169|Dopamine Agents|dopamine agents|mesh-ancestor
20554803|NCT01937169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20554804|NCT01937169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554805|NCT01937169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551860|NCT01920503|Doxorubicin|doxorubicin|mesh-list
20551861|NCT01920503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20551862|NCT01920503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551863|NCT01920503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20551864|NCT01920503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20551865|NCT01920503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20551866|NCT01920503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551867|NCT01920516|Melphalan|melphalan|mesh-list
20551868|NCT01920516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20551869|NCT01920516|Alkylating Agents|alkylating agents|mesh-ancestor
20551870|NCT01920516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551871|NCT01920516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551872|NCT01920516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20551873|NCT01920516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20551874|NCT01920516|Immunologic Factors|immunologic factors|mesh-ancestor
20551875|NCT01920516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551876|NCT01920542|Dexmedetomidine|dexmedetomidine|mesh-list
20551877|NCT01920542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20551878|NCT01920542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20551879|NCT01920542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551880|NCT01920542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20551881|NCT01920542|Analgesics|analgesics|mesh-ancestor
20551882|NCT01920542|Sensory System Agents|sensory system agents|mesh-ancestor
20551883|NCT01920542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551884|NCT01920542|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20551885|NCT01920542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20551886|NCT01920542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20551887|NCT01920542|Adrenergic Agents|adrenergic agents|mesh-ancestor
19966869|NCT01737944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19966870|NCT01737944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19966871|NCT01738191|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19966872|NCT01738191|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19966873|NCT01738191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19966874|NCT01738191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19966875|NCT01738191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966876|NCT01738191|Adrenergic Agents|adrenergic agents|mesh-ancestor
19966877|NCT01738191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19966878|NCT01738191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966879|NCT01738503|Buprenorphine|buprenorphine|mesh-list
19966880|NCT01738503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19966881|NCT01738503|Narcotics|narcotics|mesh-ancestor
19966882|NCT01738503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19966883|NCT01738503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966884|NCT01738503|Analgesics|analgesics|mesh-ancestor
19966885|NCT01738503|Sensory System Agents|sensory system agents|mesh-ancestor
19966886|NCT01738503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19966887|NCT01738503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19966888|NCT01738594|Romidepsin|romidepsin|mesh-list
19966889|NCT01738594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19966890|NCT01738594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966891|NCT01738646|Bevacizumab|bevacizumab|mesh-list
19966892|NCT01738646|Vorinostat|vorinostat|mesh-list
19966893|NCT01738646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19966894|NCT01738646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966895|NCT01738646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19966896|NCT01738646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19966897|NCT01738646|Growth Substances|growth substances|mesh-ancestor
19966898|NCT01738646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551888|NCT01920542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20551889|NCT01920542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551890|NCT01920737|Leucovorin|leucovorin|mesh-list
20551891|NCT01920737|Cytarabine|cytarabine|mesh-list
20551892|NCT01920737|Dexamethasone|dexamethasone|mesh-list
20551893|NCT01920737|Prednisone|prednisone|mesh-list
20551894|NCT01920737|Cyclophosphamide|cyclophosphamide|mesh-list
20551895|NCT01920737|Methotrexate|methotrexate|mesh-list
20551896|NCT01920737|Vincristine|vincristine|mesh-list
19966899|NCT01738646|Growth Inhibitors|growth inhibitors|mesh-ancestor
19966900|NCT01738646|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19966901|NCT01738646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966902|NCT01738646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966903|NCT01738672|Nitrous Oxide|nitrous oxide|mesh-list
19966904|NCT01738672|Entonox|entonox|mesh-list
19966905|NCT01738672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19966906|NCT01738672|Anesthetics, General|anesthetics, general|mesh-ancestor
19966907|NCT01738672|Anesthetics|anesthetics|mesh-ancestor
19966908|NCT01738672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19966909|NCT01738672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966910|NCT01738672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19966911|NCT01738672|Analgesics|analgesics|mesh-ancestor
19966912|NCT01738672|Sensory System Agents|sensory system agents|mesh-ancestor
19966913|NCT01738672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19966914|NCT01738672|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19966915|NCT01738971|Progestins|progestins|mesh-list
19966916|NCT01738971|Hormones|hormones|mesh-ancestor
19966917|NCT01738971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19966918|NCT01738971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966919|NCT01739335|Mifepristone|mifepristone|mesh-list
19966920|NCT01739335|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19966921|NCT01739335|Abortifacient Agents|abortifacient agents|mesh-ancestor
19966922|NCT01739335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20551897|NCT01920737|Daunorubicin|daunorubicin|mesh-list
20551898|NCT01920737|Asparaginase|asparaginase|mesh-list
20551899|NCT01920737|Mercaptopurine|mercaptopurine|mesh-list
20551900|NCT01920737|Pegaspargase|pegaspargase|mesh-list
20551901|NCT01920737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20551902|NCT01920737|Immunologic Factors|immunologic factors|mesh-ancestor
20551903|NCT01920737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551904|NCT01920737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20551905|NCT01920737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20551906|NCT01920737|Alkylating Agents|alkylating agents|mesh-ancestor
20551907|NCT01920737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551908|NCT01920737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551909|NCT01920737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20551910|NCT01920737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20551911|NCT01920737|Antiemetics|antiemetics|mesh-ancestor
20551912|NCT01920737|Autonomic Agents|autonomic agents|mesh-ancestor
20551913|NCT01920737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551914|NCT01920737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20551915|NCT01920737|Glucocorticoids|glucocorticoids|mesh-ancestor
20551916|NCT01920737|Hormones|hormones|mesh-ancestor
20551917|NCT01920737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20551918|NCT01920737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20551919|NCT01920737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20551920|NCT01920737|Abortifacient Agents|abortifacient agents|mesh-ancestor
20551921|NCT01920737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20554806|NCT01937182|Citalopram|citalopram|mesh-list
20551922|NCT01920737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20551923|NCT01920737|Antimetabolites|antimetabolites|mesh-ancestor
20551924|NCT01920737|Dermatologic Agents|dermatologic agents|mesh-ancestor
20551925|NCT01920737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20551926|NCT01920737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20551927|NCT01920737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20551928|NCT01920737|Antiviral Agents|antiviral agents|mesh-ancestor
20551929|NCT01920737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20551930|NCT01920737|Antidotes|antidotes|mesh-ancestor
19966923|NCT01739335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966924|NCT01739335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19966925|NCT01739335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19966926|NCT01739335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19966927|NCT01739335|Contraceptive Agents|contraceptive agents|mesh-ancestor
20551931|NCT01920737|Protective Agents|protective agents|mesh-ancestor
20551932|NCT01920737|Vitamin B Complex|vitamin b complex|mesh-ancestor
20551933|NCT01920737|Vitamins|vitamins|mesh-ancestor
20551934|NCT01920737|Micronutrients|micronutrients|mesh-ancestor
20551935|NCT01920737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20551936|NCT01920737|Tubulin Modulators|tubulin modulators|mesh-ancestor
20551937|NCT01920737|Antimitotic Agents|antimitotic agents|mesh-ancestor
20551938|NCT01920737|Mitosis Modulators|mitosis modulators|mesh-ancestor
20551939|NCT01920737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20551940|NCT01920737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20551941|NCT01920737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20551942|NCT01920919|Dexamethasone|dexamethasone|mesh-list
20551943|NCT01920919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20551944|NCT01920919|Antiemetics|antiemetics|mesh-ancestor
20551945|NCT01920919|Autonomic Agents|autonomic agents|mesh-ancestor
19966928|NCT01739335|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19966929|NCT01739335|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19966930|NCT01739335|Hormone Antagonists|hormone antagonists|mesh-ancestor
19966931|NCT01739335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20551946|NCT01920919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551947|NCT01920919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551948|NCT01920919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20551949|NCT01920919|Glucocorticoids|glucocorticoids|mesh-ancestor
20551950|NCT01920919|Hormones|hormones|mesh-ancestor
19966932|NCT01739335|Luteolytic Agents|luteolytic agents|mesh-ancestor
19966933|NCT01739335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19966934|NCT01739335|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19966935|NCT01739361|Acetaminophen|acetaminophen|mesh-list
19966936|NCT01739361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19966937|NCT01739361|Analgesics|analgesics|mesh-ancestor
19966938|NCT01739361|Sensory System Agents|sensory system agents|mesh-ancestor
19966939|NCT01739361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19966940|NCT01739361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966941|NCT01739361|Antipyretics|antipyretics|mesh-ancestor
19966942|NCT01739400|Macitentan|macitentan|mesh-list
19966943|NCT01739400|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19966944|NCT01739400|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19966945|NCT01739400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966946|NCT01739400|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19966947|NCT01739595|Enclomiphene|enclomiphene|mesh-list
19966948|NCT01739595|Clomiphene|clomiphene|mesh-list
19966949|NCT01739595|Zuclomiphene|zuclomiphene|mesh-list
19966950|NCT01739595|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19966951|NCT01739595|Hormone Antagonists|hormone antagonists|mesh-ancestor
19966952|NCT01739595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19966953|NCT01739595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966954|NCT01739595|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19966955|NCT01739595|Fertility Agents|fertility agents|mesh-ancestor
19966956|NCT01739595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19966957|NCT01739595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19966958|NCT01739595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19966959|NCT01739699|Acetaminophen|acetaminophen|mesh-list
19966960|NCT01739699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19966961|NCT01739699|Analgesics|analgesics|mesh-ancestor
19966962|NCT01739699|Sensory System Agents|sensory system agents|mesh-ancestor
19966963|NCT01739699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19966964|NCT01739699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966965|NCT01739699|Antipyretics|antipyretics|mesh-ancestor
19966966|NCT01739764|Vemurafenib|vemurafenib|mesh-list
19966967|NCT01739764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19966968|NCT01739764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19966969|NCT01739764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19966970|NCT01739764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19966971|NCT01739790|Acetylcysteine|acetylcysteine|mesh-list
19966972|NCT01739790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19966973|NCT01739790|Antiviral Agents|antiviral agents|mesh-ancestor
19966974|NCT01739790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20551951|NCT01920919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20551952|NCT01920919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20551953|NCT01920919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551954|NCT01920945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20551955|NCT01920945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20551956|NCT01920945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20551957|NCT01920945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20551958|NCT01920945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551959|NCT01920945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20551960|NCT01920945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20551961|NCT01920945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551962|NCT01920945|Cholinergic Agents|cholinergic agents|mesh-ancestor
20551963|NCT01920945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20551964|NCT01920984|Bevacizumab|bevacizumab|mesh-list
20551965|NCT01920984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20551966|NCT01920984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20551967|NCT01920984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20551968|NCT01920984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20551969|NCT01920984|Growth Substances|growth substances|mesh-ancestor
20551970|NCT01920984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966975|NCT01739790|Expectorants|expectorants|mesh-ancestor
19966976|NCT01739790|Respiratory System Agents|respiratory system agents|mesh-ancestor
19966977|NCT01739790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19966978|NCT01739790|Antioxidants|antioxidants|mesh-ancestor
19966979|NCT01739790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551971|NCT01920984|Growth Inhibitors|growth inhibitors|mesh-ancestor
20551972|NCT01921010|Niacin|niacin|mesh-list
20551973|NCT01921010|Nicotinic Acids|nicotinic acids|mesh-list
20551974|NCT01921010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20551975|NCT01921010|Antimetabolites|antimetabolites|mesh-ancestor
20551976|NCT01921010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20551977|NCT01921010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20551978|NCT01921010|Vasodilator Agents|vasodilator agents|mesh-ancestor
20551979|NCT01921010|Vitamin B Complex|vitamin b complex|mesh-ancestor
20551980|NCT01921010|Vitamins|vitamins|mesh-ancestor
20551981|NCT01921010|Micronutrients|micronutrients|mesh-ancestor
20551982|NCT01921010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551983|NCT01921192|Folic Acid|folic acid|mesh-list
20551984|NCT01921192|Hematinics|hematinics|mesh-ancestor
20551985|NCT01921192|Vitamin B Complex|vitamin b complex|mesh-ancestor
20551986|NCT01921192|Vitamins|vitamins|mesh-ancestor
20551987|NCT01921192|Micronutrients|micronutrients|mesh-ancestor
20551988|NCT01921192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20551989|NCT01921218|Cyclosporine|cyclosporine|mesh-list
20551990|NCT01921218|Mycophenolic Acid|mycophenolic acid|mesh-list
20551991|NCT01921218|Prednisone|prednisone|mesh-list
20551992|NCT01921218|Abatacept|abatacept|mesh-list
20551993|NCT01921218|Tacrolimus|tacrolimus|mesh-list
20551994|NCT01921218|Cyclosporins|cyclosporins|mesh-list
20551995|NCT01921218|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
20551996|NCT01921218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20551997|NCT01921218|Glucocorticoids|glucocorticoids|mesh-ancestor
20551998|NCT01921218|Hormones|hormones|mesh-ancestor
20551999|NCT01921218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20552000|NCT01921218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552001|NCT01921218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20552002|NCT01921218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552003|NCT01921218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20552004|NCT01921218|Immunologic Factors|immunologic factors|mesh-ancestor
20552005|NCT01921218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552006|NCT01921218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552007|NCT01921218|Antifungal Agents|antifungal agents|mesh-ancestor
20552008|NCT01921218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20552009|NCT01921218|Dermatologic Agents|dermatologic agents|mesh-ancestor
20552010|NCT01921218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20552011|NCT01921218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20552012|NCT01921218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20552013|NCT01921218|Antitubercular Agents|antitubercular agents|mesh-ancestor
20552014|NCT01921218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20552015|NCT01921218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20552016|NCT01921231|Bupivacaine|bupivacaine|mesh-list
20552017|NCT01921231|Prilocaine|prilocaine|mesh-list
20552018|NCT01921231|Anesthetics, Local|anesthetics, local|mesh-ancestor
20552019|NCT01921231|Anesthetics|anesthetics|mesh-ancestor
20552020|NCT01921231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20552021|NCT01921231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552022|NCT01921231|Sensory System Agents|sensory system agents|mesh-ancestor
20552023|NCT01921231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552024|NCT01921361|Dexmedetomidine|dexmedetomidine|mesh-list
20552025|NCT01921361|Levobupivacaine|levobupivacaine|mesh-list
20552026|NCT01921361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20552027|NCT01921361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20552028|NCT01921361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552029|NCT01921361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20552030|NCT01921361|Analgesics|analgesics|mesh-ancestor
20552031|NCT01921361|Sensory System Agents|sensory system agents|mesh-ancestor
20552032|NCT01921361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552033|NCT01921361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20552034|NCT01921361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20552035|NCT01921361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20552036|NCT01921361|Adrenergic Agents|adrenergic agents|mesh-ancestor
20552037|NCT01921361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20552038|NCT01921361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552039|NCT01921361|Anesthetics, Local|anesthetics, local|mesh-ancestor
20552040|NCT01921361|Anesthetics|anesthetics|mesh-ancestor
20552041|NCT01921374|Vitamin B 12|vitamin b 12|mesh-list
20552042|NCT01921374|Interferons|interferons|mesh-list
20552043|NCT01921374|Interferon-gamma|interferon-gamma|mesh-list
20552044|NCT01921374|Interleukin-2|interleukin-2|mesh-list
20552045|NCT01921374|Interleukin-4|interleukin-4|mesh-list
20552046|NCT01921374|Dinoprostone|dinoprostone|mesh-list
20552047|NCT01921374|Hormones|hormones|mesh-list
20552048|NCT01921374|Estradiol|estradiol|mesh-list
20552049|NCT01921374|Testosterone|testosterone|mesh-list
20552050|NCT01921374|Progesterone|progesterone|mesh-list
19966980|NCT01739790|Protective Agents|protective agents|mesh-ancestor
19966981|NCT01739790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966982|NCT01739790|Antidotes|antidotes|mesh-ancestor
20552051|NCT01921374|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20552052|NCT01921374|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20552053|NCT01921374|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
20552054|NCT01921374|Immunoglobulins|immunoglobulins|mesh-list
20552055|NCT01921374|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20552056|NCT01921374|Antibodies|antibodies|mesh-list
20552057|NCT01921374|Immunoglobulin G|immunoglobulin g|mesh-list
20552058|NCT01921374|Complement System Proteins|complement system proteins|mesh-list
20552059|NCT01921374|Immunoglobulin A|immunoglobulin a|mesh-list
20552060|NCT01921374|Immunoglobulin M|immunoglobulin m|mesh-list
20552061|NCT01921374|beta-Endorphin|beta-endorphin|mesh-list
19966983|NCT01739933|Dexmedetomidine|dexmedetomidine|mesh-list
20552062|NCT01921374|Uric Acid|uric acid|mesh-list
20552063|NCT01921374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552064|NCT01921374|Vitamins|vitamins|mesh-ancestor
19966984|NCT01739933|Propofol|propofol|mesh-list
19966985|NCT01739933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19966986|NCT01739933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19966987|NCT01739933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19966988|NCT01739933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19966989|NCT01739933|Anesthetics, General|anesthetics, general|mesh-ancestor
19966990|NCT01739933|Anesthetics|anesthetics|mesh-ancestor
19966991|NCT01739933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19966992|NCT01739933|Analgesics|analgesics|mesh-ancestor
20552065|NCT01921374|Micronutrients|micronutrients|mesh-ancestor
20552066|NCT01921374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552067|NCT01921374|Antiviral Agents|antiviral agents|mesh-ancestor
20552068|NCT01921374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20552069|NCT01921374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19966993|NCT01739933|Sensory System Agents|sensory system agents|mesh-ancestor
19966994|NCT01739933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552070|NCT01921374|Estrogens|estrogens|mesh-ancestor
20552071|NCT01921374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20552072|NCT01921374|Androgens|androgens|mesh-ancestor
20552073|NCT01921374|Immunologic Factors|immunologic factors|mesh-ancestor
20552074|NCT01921374|Progestins|progestins|mesh-ancestor
20552075|NCT01921374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20552076|NCT01921374|Analgesics|analgesics|mesh-ancestor
20552077|NCT01921374|Sensory System Agents|sensory system agents|mesh-ancestor
20552078|NCT01921374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552079|NCT01921374|Vitamin B Complex|vitamin b complex|mesh-ancestor
20552080|NCT01921374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20552081|NCT01921374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552082|NCT01921374|Antioxidants|antioxidants|mesh-ancestor
20552083|NCT01921374|Protective Agents|protective agents|mesh-ancestor
20552084|NCT01921374|Oxytocics|oxytocics|mesh-ancestor
20552085|NCT01921374|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20552086|NCT01921374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20552087|NCT01921426|Avasopasem manganese|avasopasem manganese|mesh-list
20552088|NCT01921426|Antioxidants|antioxidants|mesh-ancestor
19966995|NCT01739933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19966996|NCT01739933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19966997|NCT01739933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19966998|NCT01739933|Adrenergic Agents|adrenergic agents|mesh-ancestor
19966999|NCT01739933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967000|NCT01739933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967001|NCT01740089|Ribavirin|ribavirin|mesh-list
19967002|NCT01740089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19967003|NCT01740089|Antimetabolites|antimetabolites|mesh-ancestor
19967004|NCT01740089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967005|NCT01740089|Antiviral Agents|antiviral agents|mesh-ancestor
19967006|NCT01740089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19967007|NCT01740206|Methylphenidate|methylphenidate|mesh-list
19967008|NCT01740206|Amphetamine|amphetamine|mesh-list
19967009|NCT01740206|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19967010|NCT01740206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967011|NCT01740206|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20552089|NCT01921426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552090|NCT01921426|Protective Agents|protective agents|mesh-ancestor
20552091|NCT01921426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552092|NCT01921582|Methylphenidate|methylphenidate|mesh-list
20552093|NCT01921582|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20552094|NCT01921582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552095|NCT01921582|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20552096|NCT01921582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20552097|NCT01921582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20552098|NCT01921582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552099|NCT01921582|Dopamine Agents|dopamine agents|mesh-ancestor
20552100|NCT01921582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20552101|NCT01921647|Amoxicillin|amoxicillin|mesh-list
20552102|NCT01921647|Clarithromycin|clarithromycin|mesh-list
20552103|NCT01921647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20552104|NCT01921647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20552105|NCT01921647|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20552106|NCT01921647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552107|NCT01921647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552108|NCT01921647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20552109|NCT01921647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20552110|NCT01921673|Docetaxel|docetaxel|mesh-list
20552111|NCT01921673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552112|NCT01921673|Tubulin Modulators|tubulin modulators|mesh-ancestor
20552113|NCT01921673|Antimitotic Agents|antimitotic agents|mesh-ancestor
20552114|NCT01921673|Mitosis Modulators|mitosis modulators|mesh-ancestor
20552115|NCT01921673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552116|NCT01921738|Azithromycin|azithromycin|mesh-list
20552117|NCT01921738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20552118|NCT01921738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20552119|NCT01921790|Gemcitabine|gemcitabine|mesh-list
20552120|NCT01921790|Dexamethasone|dexamethasone|mesh-list
20552121|NCT01921790|Oxaliplatin|oxaliplatin|mesh-list
20552122|NCT01921790|Bevacizumab|bevacizumab|mesh-list
20552123|NCT01921790|Pegaspargase|pegaspargase|mesh-list
20552124|NCT01921790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20552125|NCT01921790|Antiemetics|antiemetics|mesh-ancestor
20552126|NCT01921790|Autonomic Agents|autonomic agents|mesh-ancestor
20552127|NCT01921790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552128|NCT01921790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552129|NCT01921790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20552130|NCT01921790|Glucocorticoids|glucocorticoids|mesh-ancestor
20552131|NCT01921790|Hormones|hormones|mesh-ancestor
20552132|NCT01921790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20552133|NCT01921790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20552134|NCT01921790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552135|NCT01921790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20552136|NCT01921790|Antimetabolites|antimetabolites|mesh-ancestor
20552137|NCT01921790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552138|NCT01921790|Antiviral Agents|antiviral agents|mesh-ancestor
20552139|NCT01921790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20552140|NCT01921790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552141|NCT01921790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20552142|NCT01921790|Immunologic Factors|immunologic factors|mesh-ancestor
20552143|NCT01921790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20552144|NCT01921790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20552145|NCT01921790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19967012|NCT01740206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19967013|NCT01740206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20552146|NCT01921790|Growth Substances|growth substances|mesh-ancestor
20552147|NCT01921790|Growth Inhibitors|growth inhibitors|mesh-ancestor
20552148|NCT01921816|Dialysis Solutions|dialysis solutions|mesh-list
20552149|NCT01921816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20552150|NCT01921868|Acetylcarnitine|acetylcarnitine|mesh-list
20552151|NCT01921868|Vitamin B Complex|vitamin b complex|mesh-ancestor
20552152|NCT01921868|Vitamins|vitamins|mesh-ancestor
20552153|NCT01921868|Micronutrients|micronutrients|mesh-ancestor
20552154|NCT01921868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552155|NCT01921868|Nootropic Agents|nootropic agents|mesh-ancestor
20552156|NCT01921920|Omeprazole|omeprazole|mesh-list
20552157|NCT01921920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20552158|NCT01921920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20552159|NCT01921920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20552160|NCT01921920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552161|NCT01921920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967014|NCT01740206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967015|NCT01740206|Dopamine Agents|dopamine agents|mesh-ancestor
19967016|NCT01740206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20552162|NCT01921946|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20552163|NCT01921946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20552164|NCT01921946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20552165|NCT01921946|Antimetabolites|antimetabolites|mesh-ancestor
19967017|NCT01740206|Sympathomimetics|sympathomimetics|mesh-ancestor
19967018|NCT01740206|Autonomic Agents|autonomic agents|mesh-ancestor
19967019|NCT01740206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19967020|NCT01740206|Adrenergic Agents|adrenergic agents|mesh-ancestor
19967021|NCT01740206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19967022|NCT01740258|Bevacizumab|bevacizumab|mesh-list
20552166|NCT01921946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552167|NCT01921946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20552168|NCT01921946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20552169|NCT01921946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552170|NCT01921972|Memantine|memantine|mesh-list
20552171|NCT01921972|Galantamine|galantamine|mesh-list
20552172|NCT01921972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20552173|NCT01921972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20552174|NCT01921972|Dopamine Agents|dopamine agents|mesh-ancestor
20552175|NCT01921972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20552176|NCT01921972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552177|NCT01921972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552178|NCT01921972|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20552179|NCT01921972|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20552180|NCT01921972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20552181|NCT01921972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552182|NCT01921972|Cholinergic Agents|cholinergic agents|mesh-ancestor
20552183|NCT01921972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20552184|NCT01921972|Autonomic Agents|autonomic agents|mesh-ancestor
20552185|NCT01921972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552186|NCT01921972|Nootropic Agents|nootropic agents|mesh-ancestor
20552187|NCT01921985|Terlipressin|terlipressin|mesh-list
20552188|NCT01921985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19967023|NCT01740258|Temozolomide|temozolomide|mesh-list
20286376|NCT03710772|BB 1101|bb 1101|mesh-list
19967024|NCT01740258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19967025|NCT01740258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967026|NCT01740258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19967027|NCT01740258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19967028|NCT01740258|Growth Substances|growth substances|mesh-ancestor
19967029|NCT01740258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967030|NCT01740258|Growth Inhibitors|growth inhibitors|mesh-ancestor
19967031|NCT01740258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19967032|NCT01740258|Alkylating Agents|alkylating agents|mesh-ancestor
19967033|NCT01740258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967034|NCT01740323|Curcumin|curcumin|mesh-list
19967035|NCT01740323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19967036|NCT01740323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19967037|NCT01740323|Analgesics|analgesics|mesh-ancestor
20552189|NCT01921985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20552190|NCT01922141|Amlodipine|amlodipine|mesh-list
20552191|NCT01922141|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20552192|NCT01922141|Ramipril|ramipril|mesh-list
19450416|NCT03428529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19450417|NCT03428529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450418|NCT03428529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19450419|NCT03428529|Immunologic Factors|immunologic factors|mesh-ancestor
19450420|NCT03428529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450421|NCT03428503|Acetaminophen|acetaminophen|mesh-list
19450422|NCT03428503|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19450423|NCT03428503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20552193|NCT01922141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20552194|NCT01922141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20552195|NCT01922141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20552196|NCT01922141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552197|NCT01922141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20552198|NCT01922141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552199|NCT01922141|Vasodilator Agents|vasodilator agents|mesh-ancestor
20552200|NCT01922141|Diuretics|diuretics|mesh-ancestor
20552201|NCT01922141|Natriuretic Agents|natriuretic agents|mesh-ancestor
20552202|NCT01922141|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20552203|NCT01922141|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19967038|NCT01740323|Sensory System Agents|sensory system agents|mesh-ancestor
19967039|NCT01740323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19967040|NCT01740323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967041|NCT01740323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19967042|NCT01740323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19967043|NCT01740323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967044|NCT01740323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967045|NCT01740323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967046|NCT01740362|Tofacitinib|tofacitinib|mesh-list
19967047|NCT01740362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20552204|NCT01922141|Protease Inhibitors|protease inhibitors|mesh-ancestor
20552205|NCT01922141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552206|NCT01922154|Ranibizumab|ranibizumab|mesh-list
20552207|NCT01922154|Mitomycin|mitomycin|mesh-list
19967048|NCT01740362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967049|NCT01740362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967050|NCT01740388|Besifloxacin|besifloxacin|mesh-list
19967051|NCT01740388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19967052|NCT01740388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19967053|NCT01740388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19967054|NCT01740388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20552208|NCT01922154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20552209|NCT01922154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19967055|NCT01740388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967056|NCT01740388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967057|NCT01740388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967058|NCT01740401|Cyclophosphamide|cyclophosphamide|mesh-list
19967059|NCT01740401|Ipilimumab|ipilimumab|mesh-list
19967060|NCT01740401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19967061|NCT01740401|Immunologic Factors|immunologic factors|mesh-ancestor
19967062|NCT01740401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967063|NCT01740401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19967064|NCT01740401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19967065|NCT01740401|Alkylating Agents|alkylating agents|mesh-ancestor
20552210|NCT01922154|Growth Substances|growth substances|mesh-ancestor
20552211|NCT01922154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552212|NCT01922154|Growth Inhibitors|growth inhibitors|mesh-ancestor
20552213|NCT01922154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552214|NCT01922154|Alkylating Agents|alkylating agents|mesh-ancestor
20552215|NCT01922154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552216|NCT01922154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20552217|NCT01922154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20552218|NCT01922154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552219|NCT01922193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20552220|NCT01922193|Hormones|hormones|mesh-ancestor
20552221|NCT01922193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20552222|NCT01922193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554807|NCT01937182|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
20554808|NCT01937182|Serotonin|serotonin|mesh-list
20554809|NCT01937182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20554810|NCT01937182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20554811|NCT01937182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554812|NCT01937182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20554813|NCT01937182|Serotonin Agents|serotonin agents|mesh-ancestor
20554814|NCT01937182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554815|NCT01937182|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20554816|NCT01937182|Antidepressive Agents|antidepressive agents|mesh-ancestor
20554817|NCT01937182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20554818|NCT01937182|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20554819|NCT01937234|Metoclopramide|metoclopramide|mesh-list
20554820|NCT01937234|Antiemetics|antiemetics|mesh-ancestor
20554821|NCT01937234|Autonomic Agents|autonomic agents|mesh-ancestor
20554822|NCT01937234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554823|NCT01937234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554824|NCT01937234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20554825|NCT01937234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20554826|NCT01937234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20554827|NCT01937234|Dopamine Agents|dopamine agents|mesh-ancestor
20554828|NCT01937234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20554829|NCT01937234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554830|NCT01937325|Ivacaftor|ivacaftor|mesh-list
20554831|NCT01937325|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20554832|NCT01937325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20554833|NCT01937325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554834|NCT01937338|AZD7624|azd7624|mesh-list
20554835|NCT01937338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20554836|NCT01937338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20554837|NCT01937338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554838|NCT01937442|Thalidomide|thalidomide|mesh-list
19967066|NCT01740401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967067|NCT01740401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967068|NCT01740401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19967069|NCT01740401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19967070|NCT01740401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19967071|NCT01740414|Ibudilast|ibudilast|mesh-list
19967072|NCT01740414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19967073|NCT01740414|Autonomic Agents|autonomic agents|mesh-ancestor
19967074|NCT01740414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19967075|NCT01740414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967076|NCT01740414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19967077|NCT01740414|Respiratory System Agents|respiratory system agents|mesh-ancestor
19967078|NCT01740414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19967079|NCT01740414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967080|NCT01740414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967081|NCT01740414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19967082|NCT01740414|Vasodilator Agents|vasodilator agents|mesh-ancestor
19967083|NCT01740713|Deferiprone|deferiprone|mesh-list
20554839|NCT01937442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20554840|NCT01937442|Immunologic Factors|immunologic factors|mesh-ancestor
20554841|NCT01937442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554842|NCT01937442|Leprostatic Agents|leprostatic agents|mesh-ancestor
20552223|NCT01922375|Naftopidil|naftopidil|mesh-list
20552224|NCT01922375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19967084|NCT01740713|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19967085|NCT01740713|Chelating Agents|chelating agents|mesh-ancestor
19967086|NCT01740713|Sequestering Agents|sequestering agents|mesh-ancestor
20552225|NCT01922375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20552226|NCT01922375|Adrenergic Agents|adrenergic agents|mesh-ancestor
20552227|NCT01922375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20552228|NCT01922375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552229|NCT01922375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552230|NCT01922375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19967087|NCT01740713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967088|NCT01740726|Fluoxetine|fluoxetine|mesh-list
19967089|NCT01740726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19967090|NCT01740726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19967091|NCT01740726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19967092|NCT01740726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967093|NCT01740726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967094|NCT01740726|Serotonin Agents|serotonin agents|mesh-ancestor
19967095|NCT01740726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967096|NCT01740726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19967097|NCT01740726|Antidepressive Agents|antidepressive agents|mesh-ancestor
19967098|NCT01740726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19967099|NCT01740726|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19967100|NCT01740726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19967101|NCT01740726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967102|NCT01740791|Velpatasvir|velpatasvir|mesh-list
19967103|NCT01740791|Antiviral Agents|antiviral agents|mesh-ancestor
19967104|NCT01740791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19967105|NCT01740817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19967106|NCT01740817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19967107|NCT01740817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20552231|NCT01922375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20552232|NCT01922375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20552233|NCT01922375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20552234|NCT01922375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20552235|NCT01922427|RNS60|rns60|mesh-list
20552236|NCT01922427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19967108|NCT01740817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20552237|NCT01922427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20552238|NCT01922427|Analgesics|analgesics|mesh-ancestor
20552239|NCT01922427|Sensory System Agents|sensory system agents|mesh-ancestor
19967109|NCT01741259|Meperidine|meperidine|mesh-list
19967110|NCT01741259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19967111|NCT01741259|Narcotics|narcotics|mesh-ancestor
19967112|NCT01741259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19967113|NCT01741259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967114|NCT01741259|Analgesics|analgesics|mesh-ancestor
20552240|NCT01922427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552241|NCT01922427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552242|NCT01922427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20552243|NCT01922427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20552244|NCT01922427|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20552245|NCT01922466|Loxoprofen|loxoprofen|mesh-list
20552246|NCT01922466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20552247|NCT01922466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20552248|NCT01922466|Analgesics|analgesics|mesh-ancestor
20552249|NCT01922466|Sensory System Agents|sensory system agents|mesh-ancestor
19967115|NCT01741259|Sensory System Agents|sensory system agents|mesh-ancestor
19450424|NCT03428503|Analgesics|analgesics|mesh-ancestor
19450425|NCT03428503|Sensory System Agents|sensory system agents|mesh-ancestor
20552250|NCT01922466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552251|NCT01922466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552252|NCT01922466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20552253|NCT01922466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20552254|NCT01922492|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20552255|NCT01922492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552256|NCT01922596|Ropivacaine|ropivacaine|mesh-list
20552257|NCT01922596|Anesthetics, Local|anesthetics, local|mesh-ancestor
20552258|NCT01922596|Anesthetics|anesthetics|mesh-ancestor
20552259|NCT01922596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20552260|NCT01922596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552261|NCT01922596|Sensory System Agents|sensory system agents|mesh-ancestor
20552262|NCT01922596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552263|NCT01922687|Amlodipine|amlodipine|mesh-list
20552264|NCT01922687|Atorvastatin|atorvastatin|mesh-list
20552265|NCT01922687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20552266|NCT01922687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20552267|NCT01922687|Antimetabolites|antimetabolites|mesh-ancestor
20552268|NCT01922687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552269|NCT01922687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20552270|NCT01922687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20552271|NCT01922687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552272|NCT01922687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20552273|NCT01922687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20552274|NCT01922687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20552275|NCT01922687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20552276|NCT01922687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552277|NCT01922687|Vasodilator Agents|vasodilator agents|mesh-ancestor
20552278|NCT01922713|Vitamin A|vitamin a|mesh-list
20552279|NCT01922713|Beta Carotene|beta carotene|mesh-list
20552280|NCT01922713|Retinol palmitate|retinol palmitate|mesh-list
20552281|NCT01922713|Vitamins|vitamins|mesh-ancestor
20552282|NCT01922713|Micronutrients|micronutrients|mesh-ancestor
20552283|NCT01922713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552284|NCT01922713|Antioxidants|antioxidants|mesh-ancestor
20552285|NCT01922713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552286|NCT01922713|Protective Agents|protective agents|mesh-ancestor
20286377|NCT03710772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20286378|NCT03710772|Immunologic Factors|immunologic factors|mesh-ancestor
20286379|NCT03710772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286380|NCT03710772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20286381|NCT03710772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20286382|NCT03710772|Alkylating Agents|alkylating agents|mesh-ancestor
20286383|NCT03710772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286384|NCT03710772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286385|NCT03710772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20286386|NCT03710772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20286387|NCT03710772|Antiemetics|antiemetics|mesh-ancestor
20286388|NCT03710772|Autonomic Agents|autonomic agents|mesh-ancestor
20286389|NCT03710772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20286390|NCT03710772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20286391|NCT03710772|Glucocorticoids|glucocorticoids|mesh-ancestor
20286392|NCT03710772|Hormones|hormones|mesh-ancestor
20286393|NCT03710772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20286394|NCT03710772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20286395|NCT03710772|Protease Inhibitors|protease inhibitors|mesh-ancestor
20286396|NCT03710772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20286397|NCT03710772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20286398|NCT03710772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20286399|NCT03710772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20286400|NCT03710772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20286401|NCT03710772|Abortifacient Agents|abortifacient agents|mesh-ancestor
20286402|NCT03710772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20286403|NCT03710772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20286404|NCT03710772|Antimetabolites|antimetabolites|mesh-ancestor
20286405|NCT03710772|Dermatologic Agents|dermatologic agents|mesh-ancestor
20286406|NCT03710772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20286407|NCT03710772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20286408|NCT03710772|Antiviral Agents|antiviral agents|mesh-ancestor
20286409|NCT03710772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20286410|NCT03710772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20286411|NCT03710772|Tubulin Modulators|tubulin modulators|mesh-ancestor
20286412|NCT03710772|Antimitotic Agents|antimitotic agents|mesh-ancestor
20286413|NCT03710772|Mitosis Modulators|mitosis modulators|mesh-ancestor
20286414|NCT03690089|Atropine|atropine|mesh-list
20286415|NCT03690089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20286416|NCT03690089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20286417|NCT03690089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20286418|NCT03690089|Autonomic Agents|autonomic agents|mesh-ancestor
20286419|NCT03690089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20286420|NCT03690089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286421|NCT03690089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20286422|NCT03690089|Respiratory System Agents|respiratory system agents|mesh-ancestor
20552287|NCT01922713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20552288|NCT01922713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552289|NCT01922713|Provitamins|provitamins|mesh-ancestor
20552290|NCT01922765|Amoxicillin|amoxicillin|mesh-list
20552291|NCT01922765|Metronidazole|metronidazole|mesh-list
20286423|NCT03690089|Mydriatics|mydriatics|mesh-ancestor
20286424|NCT03690089|Parasympatholytics|parasympatholytics|mesh-ancestor
20286425|NCT03690089|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20286426|NCT03690089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20286427|NCT03690089|Cholinergic Agents|cholinergic agents|mesh-ancestor
20286428|NCT03690089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20552292|NCT01922765|Clarithromycin|clarithromycin|mesh-list
20552293|NCT01922765|Rabeprazole|rabeprazole|mesh-list
20552294|NCT01922765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20552295|NCT01922765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20552296|NCT01922765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20552297|NCT01922765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20552298|NCT01922765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20552299|NCT01922765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552300|NCT01922765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552301|NCT01922765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20552302|NCT01922765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20552303|NCT01922765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20552304|NCT01922765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20552305|NCT01922765|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20552306|NCT01922804|Vitamins|vitamins|mesh-list
20552307|NCT01922804|Micronutrients|micronutrients|mesh-ancestor
20552308|NCT01922804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552309|NCT01922817|Saxagliptin|saxagliptin|mesh-list
20552310|NCT01922817|Incretins|incretins|mesh-ancestor
20552311|NCT01922817|Hormones|hormones|mesh-ancestor
20552312|NCT01922817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20552313|NCT01922817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552314|NCT01922817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20552315|NCT01922817|Protease Inhibitors|protease inhibitors|mesh-ancestor
20552316|NCT01922817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552317|NCT01922817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552318|NCT01922817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20552319|NCT01922921|polysaccharide-K|polysaccharide-k|mesh-list
20552320|NCT01922921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20552321|NCT01922921|Trastuzumab|trastuzumab|mesh-list
20552322|NCT01922921|Pertuzumab|pertuzumab|mesh-list
20552323|NCT01922921|Antibodies|antibodies|mesh-list
20552324|NCT01922921|Immunoglobulins|immunoglobulins|mesh-list
20552325|NCT01922921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20552326|NCT01922921|Immunologic Factors|immunologic factors|mesh-ancestor
20552327|NCT01922921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552328|NCT01922921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552329|NCT01922921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20552330|NCT01922921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20552331|NCT01922921|Antiviral Agents|antiviral agents|mesh-ancestor
20552332|NCT01922921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20552333|NCT01922921|Interferon Inducers|interferon inducers|mesh-ancestor
20552334|NCT01922921|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20552335|NCT01922921|Protective Agents|protective agents|mesh-ancestor
20552336|NCT01922999|Melatonin|melatonin|mesh-list
20552337|NCT01922999|Antioxidants|antioxidants|mesh-ancestor
20552338|NCT01922999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552339|NCT01922999|Protective Agents|protective agents|mesh-ancestor
20552340|NCT01922999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552341|NCT01922999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20552342|NCT01923012|Vitamin K|vitamin k|mesh-list
20552343|NCT01923012|Vitamin K 2|vitamin k 2|mesh-list
20552344|NCT01923012|Vitamins|vitamins|mesh-ancestor
20552345|NCT01923012|Micronutrients|micronutrients|mesh-ancestor
20552346|NCT01923012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552347|NCT01923012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20552348|NCT01923012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20552349|NCT01923012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552350|NCT01923012|Hemostatics|hemostatics|mesh-ancestor
20552351|NCT01923012|Coagulants|coagulants|mesh-ancestor
20552352|NCT01923064|Ethiodized Oil|ethiodized oil|mesh-list
20552353|NCT01923064|Polidocanol|polidocanol|mesh-list
20552354|NCT01923064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552355|NCT01923064|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
20552356|NCT01923064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20552357|NCT01923077|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20552358|NCT01923077|Simvastatin|simvastatin|mesh-list
20552359|NCT01923077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20552360|NCT01923077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20552361|NCT01923077|Antimetabolites|antimetabolites|mesh-ancestor
20552362|NCT01923077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552363|NCT01923077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20552364|NCT01923077|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20552365|NCT01923077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552366|NCT01923090|Finasteride|finasteride|mesh-list
20552367|NCT01923090|Dutasteride|dutasteride|mesh-list
20552368|NCT01923090|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20552369|NCT01923090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20552370|NCT01923090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552371|NCT01923090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552372|NCT01923090|Hormone Antagonists|hormone antagonists|mesh-ancestor
20552373|NCT01923090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20552374|NCT01923090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552375|NCT01923090|Urological Agents|urological agents|mesh-ancestor
20552376|NCT01923194|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20552377|NCT01923194|Hormones|hormones|mesh-ancestor
20552378|NCT01923194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20552379|NCT01923194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552380|NCT01923259|Donepezil|donepezil|mesh-list
20552381|NCT01923259|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20552382|NCT01923259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552383|NCT01923259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552384|NCT01923259|Cholinergic Agents|cholinergic agents|mesh-ancestor
20552385|NCT01923259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20552386|NCT01923259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552387|NCT01923259|Nootropic Agents|nootropic agents|mesh-ancestor
20552388|NCT01923337|Irinotecan|irinotecan|mesh-list
20552389|NCT01923337|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20552390|NCT01923337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20552391|NCT01923337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552392|NCT01923337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552393|NCT01923337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552394|NCT01923376|Lactulose|lactulose|mesh-list
20552395|NCT01923376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
20552396|NCT01923376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20552397|NCT01923376|Laxatives|laxatives|mesh-ancestor
20552398|NCT01923454|Acetazolamide|acetazolamide|mesh-list
20552399|NCT01923454|Anticonvulsants|anticonvulsants|mesh-ancestor
20552400|NCT01923454|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19733500|NCT04561336|Cetuximab|cetuximab|mesh-list
19733501|NCT04561336|Avelumab|avelumab|mesh-list
20552401|NCT01923454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552402|NCT01923454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967116|NCT01741259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19967117|NCT01741259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19967118|NCT01741454|Tamsulosin|tamsulosin|mesh-list
19967119|NCT01741454|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19967120|NCT01741454|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19733502|NCT04561336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20552403|NCT01923454|Diuretics|diuretics|mesh-ancestor
20552404|NCT01923454|Natriuretic Agents|natriuretic agents|mesh-ancestor
20552405|NCT01923454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552406|NCT01923545|Lenograstim|lenograstim|mesh-list
20552407|NCT01923545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20552408|NCT01923545|Immunologic Factors|immunologic factors|mesh-ancestor
20552409|NCT01923545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552410|NCT01923558|Donepezil|donepezil|mesh-list
20552411|NCT01923558|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20552412|NCT01923558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552413|NCT01923558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552414|NCT01923558|Cholinergic Agents|cholinergic agents|mesh-ancestor
20552415|NCT01923558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20552416|NCT01923558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552417|NCT01923558|Nootropic Agents|nootropic agents|mesh-ancestor
20552418|NCT01923584|Ubiquinone|ubiquinone|mesh-list
20552419|NCT01923584|Micronutrients|micronutrients|mesh-ancestor
20552420|NCT01923584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735786|NCT04536493|Racepinephrine|racepinephrine|mesh-list
20552421|NCT01923597|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
20552422|NCT01923597|Antioxidants|antioxidants|mesh-ancestor
19967121|NCT01741454|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19967122|NCT01741454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19967123|NCT01741454|Adrenergic Agents|adrenergic agents|mesh-ancestor
19967124|NCT01741454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967125|NCT01741454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967126|NCT01741454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552423|NCT01923597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552424|NCT01923597|Protective Agents|protective agents|mesh-ancestor
20552425|NCT01923597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552426|NCT01923597|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20552427|NCT01923597|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20552428|NCT01923597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552429|NCT01923597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20552430|NCT01923623|Ropivacaine|ropivacaine|mesh-list
20552431|NCT01923623|Anesthetics, Local|anesthetics, local|mesh-ancestor
20552432|NCT01923623|Anesthetics|anesthetics|mesh-ancestor
20552433|NCT01923623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20552434|NCT01923623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552435|NCT01923623|Sensory System Agents|sensory system agents|mesh-ancestor
20552436|NCT01923623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552437|NCT01923649|Lanreotide|lanreotide|mesh-list
20552438|NCT01923649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552439|NCT01923818|Aspirin|aspirin|mesh-list
20552440|NCT01923818|Rivaroxaban|rivaroxaban|mesh-list
20552441|NCT01923818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20552442|NCT01923818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20552443|NCT01923818|Analgesics|analgesics|mesh-ancestor
20552444|NCT01923818|Sensory System Agents|sensory system agents|mesh-ancestor
20552445|NCT01923818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552446|NCT01923818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552447|NCT01923818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20552448|NCT01923818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20552449|NCT01923818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20552450|NCT01923818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20552451|NCT01923818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552452|NCT01923818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20552453|NCT01923818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20552454|NCT01923818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552455|NCT01923818|Antipyretics|antipyretics|mesh-ancestor
20552456|NCT01923818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20552457|NCT01923818|Antithrombins|antithrombins|mesh-ancestor
20552458|NCT01923818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20552459|NCT01923818|Protease Inhibitors|protease inhibitors|mesh-ancestor
20552460|NCT01923818|Anticoagulants|anticoagulants|mesh-ancestor
20552461|NCT01923831|Dexamethasone|dexamethasone|mesh-list
20552462|NCT01923831|Magnesium Sulfate|magnesium sulfate|mesh-list
20552463|NCT01923831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20552464|NCT01923831|Antiemetics|antiemetics|mesh-ancestor
20552465|NCT01923831|Autonomic Agents|autonomic agents|mesh-ancestor
20552466|NCT01923831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552467|NCT01923831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552468|NCT01923831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20552469|NCT01923831|Glucocorticoids|glucocorticoids|mesh-ancestor
20552470|NCT01923831|Hormones|hormones|mesh-ancestor
20552471|NCT01923831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20552472|NCT01923831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20552473|NCT01923831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552474|NCT01923831|Analgesics|analgesics|mesh-ancestor
20552475|NCT01923831|Sensory System Agents|sensory system agents|mesh-ancestor
20552476|NCT01923831|Anesthetics|anesthetics|mesh-ancestor
20552477|NCT01923831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20552478|NCT01923831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20552479|NCT01923831|Anticonvulsants|anticonvulsants|mesh-ancestor
20552480|NCT01923831|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20552481|NCT01923831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20552482|NCT01923831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552483|NCT01923831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20552484|NCT01923831|Tocolytic Agents|tocolytic agents|mesh-ancestor
20552485|NCT01923831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20552486|NCT01923844|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20552487|NCT01923844|Beractant|beractant|mesh-list
19735787|NCT04536493|Tetracaine|tetracaine|mesh-list
20552488|NCT01923844|Respiratory System Agents|respiratory system agents|mesh-ancestor
20552489|NCT01923857|Enclomiphene|enclomiphene|mesh-list
20552490|NCT01923857|Clomiphene|clomiphene|mesh-list
20552491|NCT01923857|Zuclomiphene|zuclomiphene|mesh-list
20552492|NCT01923857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20552493|NCT01923857|Hormone Antagonists|hormone antagonists|mesh-ancestor
20552494|NCT01923857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20552495|NCT01923857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552496|NCT01923857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20552497|NCT01923857|Fertility Agents|fertility agents|mesh-ancestor
20552498|NCT01923857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20552499|NCT01923857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20552500|NCT01923857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20554843|NCT01937442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20554844|NCT01937442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20554845|NCT01937442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20554846|NCT01937442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20554847|NCT01937442|Growth Substances|growth substances|mesh-ancestor
20554848|NCT01937442|Growth Inhibitors|growth inhibitors|mesh-ancestor
20554849|NCT01937442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554850|NCT01937494|Benzyl Alcohol|benzyl alcohol|mesh-list
20554851|NCT01937494|Histamine|histamine|mesh-list
20554852|NCT01937494|Histamine Agonists|histamine agonists|mesh-ancestor
20554853|NCT01937494|Histamine Agents|histamine agents|mesh-ancestor
20554854|NCT01937494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20554855|NCT01937494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554856|NCT01937494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554857|NCT01937494|Anesthetics, Local|anesthetics, local|mesh-ancestor
20554858|NCT01937494|Anesthetics|anesthetics|mesh-ancestor
20554859|NCT01937494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20554860|NCT01937494|Sensory System Agents|sensory system agents|mesh-ancestor
20286429|NCT03690089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286430|NCT03690037|Tranexamic Acid|tranexamic acid|mesh-list
20286431|NCT03690037|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20286432|NCT03690037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20286433|NCT03690037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286434|NCT03690037|Hemostatics|hemostatics|mesh-ancestor
20286435|NCT03690037|Coagulants|coagulants|mesh-ancestor
20286436|NCT03686332|Atezolizumab|atezolizumab|mesh-list
20286437|NCT03686332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20286438|NCT03686332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286439|NCT03686332|Immunologic Factors|immunologic factors|mesh-ancestor
20286440|NCT03686332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286441|NCT03594552|Baclofen|baclofen|mesh-list
20286442|NCT03594552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20286443|NCT03594552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286444|NCT03594552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20286445|NCT03594552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552501|NCT01923870|Enclomiphene|enclomiphene|mesh-list
20552502|NCT01923870|Clomiphene|clomiphene|mesh-list
20552503|NCT01923870|Zuclomiphene|zuclomiphene|mesh-list
20552504|NCT01923870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20552505|NCT01923870|Hormone Antagonists|hormone antagonists|mesh-ancestor
20552506|NCT01923870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20552507|NCT01923870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552508|NCT01923870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20552509|NCT01923870|Fertility Agents|fertility agents|mesh-ancestor
20552510|NCT01923870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20552511|NCT01923870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20552512|NCT01923870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20552513|NCT01923909|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20552514|NCT01923909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20552515|NCT01923935|Melphalan|melphalan|mesh-list
20552516|NCT01923935|Busulfan|busulfan|mesh-list
20552517|NCT01923935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20552518|NCT01923935|Alkylating Agents|alkylating agents|mesh-ancestor
20552519|NCT01923935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552520|NCT01923935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552521|NCT01923935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20552522|NCT01923935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20552523|NCT01923935|Immunologic Factors|immunologic factors|mesh-ancestor
20552524|NCT01923935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552525|NCT01923948|Pregabalin|pregabalin|mesh-list
20552526|NCT01923948|Analgesics|analgesics|mesh-ancestor
20552527|NCT01923948|Sensory System Agents|sensory system agents|mesh-ancestor
20552528|NCT01923948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552529|NCT01923948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552530|NCT01923948|Anticonvulsants|anticonvulsants|mesh-ancestor
20552531|NCT01923948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20552532|NCT01923948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19967127|NCT01741454|Urological Agents|urological agents|mesh-ancestor
19967128|NCT01741454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19967129|NCT01741454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19967130|NCT01741454|Cholinergic Agents|cholinergic agents|mesh-ancestor
19967131|NCT01741532|Deferiprone|deferiprone|mesh-list
19967132|NCT01741532|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19967133|NCT01741532|Chelating Agents|chelating agents|mesh-ancestor
19967134|NCT01741532|Sequestering Agents|sequestering agents|mesh-ancestor
19967135|NCT01741532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552533|NCT01923948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552534|NCT01923948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20552535|NCT01923948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20286446|NCT03594552|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20552536|NCT01923948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20552537|NCT01923948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20552538|NCT01923948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20552539|NCT01923974|Melatonin|melatonin|mesh-list
20552540|NCT01923974|Antioxidants|antioxidants|mesh-ancestor
20552541|NCT01923974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552542|NCT01923974|Protective Agents|protective agents|mesh-ancestor
20552543|NCT01923974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552544|NCT01923974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20552545|NCT01923987|Cetuximab|cetuximab|mesh-list
19733503|NCT04561336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967136|NCT01741545|Interferons|interferons|mesh-list
19967137|NCT01741545|Ribavirin|ribavirin|mesh-list
19967138|NCT01741545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967139|NCT01741545|Antiviral Agents|antiviral agents|mesh-ancestor
19967140|NCT01741545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19967141|NCT01741545|Antimetabolites|antimetabolites|mesh-ancestor
19967142|NCT01741545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967143|NCT01741792|Blinatumomab|blinatumomab|mesh-list
19967144|NCT01741792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967145|NCT01742117|Clopidogrel|clopidogrel|mesh-list
19967146|NCT01742117|Ticagrelor|ticagrelor|mesh-list
19967147|NCT01742117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20552546|NCT01923987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20552547|NCT01923987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552548|NCT01924000|Minoxidil|minoxidil|mesh-list
19967148|NCT01742117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20286447|NCT03594552|GABA Agonists|gaba agonists|mesh-ancestor
20552549|NCT01924000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20552550|NCT01924000|Vasodilator Agents|vasodilator agents|mesh-ancestor
20552551|NCT01924013|Vitamin D|vitamin d|mesh-list
20552552|NCT01924013|Cholecalciferol|cholecalciferol|mesh-list
20552553|NCT01924013|Vitamins|vitamins|mesh-ancestor
20552554|NCT01924013|Micronutrients|micronutrients|mesh-ancestor
20552555|NCT01924013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552556|NCT01924013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20552557|NCT01924013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20552558|NCT01924052|Calcitonin|calcitonin|mesh-list
20552559|NCT01924052|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
20552560|NCT01924052|Katacalcin|katacalcin|mesh-list
20552561|NCT01924052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20552562|NCT01924052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552563|NCT01924052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20552564|NCT01924052|Vasodilator Agents|vasodilator agents|mesh-ancestor
20552565|NCT01924065|Anticoagulants|anticoagulants|mesh-list
20552566|NCT01924078|Capecitabine|capecitabine|mesh-list
20552567|NCT01924078|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20552568|NCT01924078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20552569|NCT01924078|Antimetabolites|antimetabolites|mesh-ancestor
20552570|NCT01924078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552571|NCT01924078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552572|NCT01924078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20552573|NCT01924078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552574|NCT01924078|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20552575|NCT01924078|Hormone Antagonists|hormone antagonists|mesh-ancestor
20552576|NCT01924078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19967149|NCT01742117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19967150|NCT01742117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20552577|NCT01924078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552578|NCT01924091|Dapivirine|dapivirine|mesh-list
20552579|NCT01924091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20552580|NCT01924091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20552581|NCT01924091|Antiviral Agents|antiviral agents|mesh-ancestor
20552582|NCT01924091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20552583|NCT01924104|Aspirin|aspirin|mesh-list
20552584|NCT01924104|Heparin|heparin|mesh-list
20552585|NCT01924104|Calcium heparin|calcium heparin|mesh-list
20552586|NCT01924104|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20552587|NCT01924104|Tinzaparin|tinzaparin|mesh-list
19967151|NCT01742117|Purinergic Agents|purinergic agents|mesh-ancestor
19967152|NCT01742117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967153|NCT01742117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967154|NCT01742117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967155|NCT01742208|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19967156|NCT01742208|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19967157|NCT01742208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967158|NCT01742208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19967159|NCT01742208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967160|NCT01742286|Ceritinib|ceritinib|mesh-list
19967161|NCT01742286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967162|NCT01742286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19967163|NCT01742286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967164|NCT01742286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967165|NCT01742832|Citalopram|citalopram|mesh-list
19967166|NCT01742832|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
20552588|NCT01924104|Dalteparin|dalteparin|mesh-list
20552589|NCT01924104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20552590|NCT01924104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20552591|NCT01924104|Analgesics|analgesics|mesh-ancestor
20552592|NCT01924104|Sensory System Agents|sensory system agents|mesh-ancestor
20552593|NCT01924104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552594|NCT01924104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552595|NCT01924104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19967167|NCT01742832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19967168|NCT01742832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19967169|NCT01742832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19967170|NCT01742832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552596|NCT01924104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20552597|NCT01924104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20552598|NCT01924104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20552599|NCT01924104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552600|NCT01924104|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20552601|NCT01924104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20552602|NCT01924104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552603|NCT01924104|Antipyretics|antipyretics|mesh-ancestor
20552604|NCT01924104|Anticoagulants|anticoagulants|mesh-ancestor
20552605|NCT01924234|Morphine|morphine|mesh-list
20552606|NCT01924234|Remifentanil|remifentanil|mesh-list
20552607|NCT01924234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20552608|NCT01924234|Narcotics|narcotics|mesh-ancestor
20552609|NCT01924234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20552610|NCT01924234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552611|NCT01924234|Analgesics|analgesics|mesh-ancestor
20552612|NCT01924234|Sensory System Agents|sensory system agents|mesh-ancestor
20552613|NCT01924234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552614|NCT01924260|Gemcitabine|gemcitabine|mesh-list
20552615|NCT01924260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20552616|NCT01924260|Antimetabolites|antimetabolites|mesh-ancestor
20552617|NCT01924260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552618|NCT01924260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552619|NCT01924260|Antiviral Agents|antiviral agents|mesh-ancestor
20552620|NCT01924260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20552621|NCT01924260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552622|NCT01924260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20552623|NCT01924260|Immunologic Factors|immunologic factors|mesh-ancestor
20552624|NCT01924260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552625|NCT01924273|Talaporfin|talaporfin|mesh-list
20552626|NCT01924273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552627|NCT01924273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20552628|NCT01924273|Dermatologic Agents|dermatologic agents|mesh-ancestor
20552629|NCT01924286|Prednisone|prednisone|mesh-list
20552630|NCT01924286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20552631|NCT01924286|Glucocorticoids|glucocorticoids|mesh-ancestor
20552632|NCT01924286|Hormones|hormones|mesh-ancestor
20552633|NCT01924286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20552634|NCT01924286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552635|NCT01924286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19967171|NCT01742832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967172|NCT01742832|Serotonin Agents|serotonin agents|mesh-ancestor
19967173|NCT01742832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967174|NCT01742832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19967175|NCT01742832|Antidepressive Agents|antidepressive agents|mesh-ancestor
19967176|NCT01742832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19967177|NCT01742832|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19967178|NCT01742832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19967179|NCT01742897|Fentanyl|fentanyl|mesh-list
19967180|NCT01742897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19967181|NCT01742897|Narcotics|narcotics|mesh-ancestor
19967182|NCT01742897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19967183|NCT01742897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967184|NCT01742897|Analgesics|analgesics|mesh-ancestor
19967185|NCT01742897|Sensory System Agents|sensory system agents|mesh-ancestor
20552636|NCT01924286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552637|NCT01924325|Aspirin|aspirin|mesh-list
20552638|NCT01924325|Apixaban|apixaban|mesh-list
20552639|NCT01924325|Clopidogrel|clopidogrel|mesh-list
20552640|NCT01924325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20552641|NCT01924325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20552642|NCT01924325|Analgesics|analgesics|mesh-ancestor
20552643|NCT01924325|Sensory System Agents|sensory system agents|mesh-ancestor
20552644|NCT01924325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552645|NCT01924325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552646|NCT01924325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20552647|NCT01924325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20552648|NCT01924325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20552649|NCT01924325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20552650|NCT01924325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552651|NCT01924325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20552652|NCT01924325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20552653|NCT01924325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552654|NCT01924325|Antipyretics|antipyretics|mesh-ancestor
20552655|NCT01924325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20552656|NCT01924325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20552657|NCT01924325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20552658|NCT01924325|Purinergic Agents|purinergic agents|mesh-ancestor
20552659|NCT01924325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20552660|NCT01924325|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20552661|NCT01924325|Antithrombins|antithrombins|mesh-ancestor
20552662|NCT01924325|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20552663|NCT01924325|Protease Inhibitors|protease inhibitors|mesh-ancestor
20552664|NCT01924325|Anticoagulants|anticoagulants|mesh-ancestor
20552665|NCT01924468|Haloperidol|haloperidol|mesh-list
20552666|NCT01924468|Haloperidol decanoate|haloperidol decanoate|mesh-list
20552667|NCT01924468|Methylphenidate|methylphenidate|mesh-list
20552668|NCT01924468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20552669|NCT01924468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552670|NCT01924468|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20552671|NCT01924468|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20552672|NCT01924468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20552673|NCT01924468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552674|NCT01924468|Dopamine Agents|dopamine agents|mesh-ancestor
20552675|NCT01924468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20552676|NCT01924468|Antiemetics|antiemetics|mesh-ancestor
19967186|NCT01742897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552677|NCT01924468|Autonomic Agents|autonomic agents|mesh-ancestor
20552678|NCT01924468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552679|NCT01924468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20552680|NCT01924468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20552681|NCT01924468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20552682|NCT01924468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20552683|NCT01924468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20552684|NCT01924468|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20552685|NCT01924468|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20552686|NCT01924481|Theobromine|theobromine|mesh-list
20552687|NCT01924481|Caffeine|caffeine|mesh-list
20552688|NCT01924481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20552689|NCT01924481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552690|NCT01924481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20552691|NCT01924481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552692|NCT01924481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552693|NCT01924481|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20552694|NCT01924481|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20552695|NCT01924481|Purinergic Agents|purinergic agents|mesh-ancestor
20552696|NCT01924481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20552697|NCT01924481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20552698|NCT01924481|Autonomic Agents|autonomic agents|mesh-ancestor
20552699|NCT01924481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552700|NCT01924481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20552701|NCT01924481|Respiratory System Agents|respiratory system agents|mesh-ancestor
20552702|NCT01924481|Vasodilator Agents|vasodilator agents|mesh-ancestor
20552703|NCT01924520|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20552704|NCT01924520|Antidepressive Agents|antidepressive agents|mesh-ancestor
20552705|NCT01924520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20552706|NCT01924520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20552707|NCT01924520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20552708|NCT01924520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20552709|NCT01924520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552710|NCT01924624|Thalidomide|thalidomide|mesh-list
20552711|NCT01924624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20552712|NCT01924624|Immunologic Factors|immunologic factors|mesh-ancestor
20552713|NCT01924624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552714|NCT01924624|Leprostatic Agents|leprostatic agents|mesh-ancestor
20552715|NCT01924624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20552716|NCT01924624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20552717|NCT01924624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20552718|NCT01924624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20552719|NCT01924624|Growth Substances|growth substances|mesh-ancestor
20552720|NCT01924624|Growth Inhibitors|growth inhibitors|mesh-ancestor
20552721|NCT01924624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552722|NCT01924637|Insulin|insulin|mesh-list
20552723|NCT01924637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20552724|NCT01924637|Insulin Aspart|insulin aspart|mesh-list
20552725|NCT01924637|Insulin, Long-Acting|insulin, long-acting|mesh-list
20552726|NCT01924637|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20552727|NCT01924637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20552728|NCT01924637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552729|NCT01924676|Oxycodone|oxycodone|mesh-list
20552730|NCT01924676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20552731|NCT01924676|Narcotics|narcotics|mesh-ancestor
20552732|NCT01924676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20552733|NCT01924676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552734|NCT01924676|Analgesics|analgesics|mesh-ancestor
20552735|NCT01924676|Sensory System Agents|sensory system agents|mesh-ancestor
20552736|NCT01924676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552737|NCT01924832|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20552738|NCT01924832|Dermatologic Agents|dermatologic agents|mesh-ancestor
20552739|NCT01924832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20552740|NCT01924832|Immunologic Factors|immunologic factors|mesh-ancestor
20552741|NCT01924832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552742|NCT01924910|Vitamin D|vitamin d|mesh-list
20552743|NCT01924910|Cholecalciferol|cholecalciferol|mesh-list
20552744|NCT01924910|Vitamins|vitamins|mesh-ancestor
20552745|NCT01924910|Micronutrients|micronutrients|mesh-ancestor
20552746|NCT01924910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552747|NCT01924910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20552748|NCT01924910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20552749|NCT01925001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20552750|NCT01925027|Sirolimus|sirolimus|mesh-list
20552751|NCT01925027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20552752|NCT01925027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20552753|NCT01925027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20552754|NCT01925027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552755|NCT01925027|Antifungal Agents|antifungal agents|mesh-ancestor
20552756|NCT01925027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20552757|NCT01925027|Immunologic Factors|immunologic factors|mesh-ancestor
20552758|NCT01925027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552759|NCT01925066|Vancomycin|vancomycin|mesh-list
20552760|NCT01925066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20552761|NCT01925066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20552762|NCT01925092|Mifepristone|mifepristone|mesh-list
20552763|NCT01925092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20552764|NCT01925092|Abortifacient Agents|abortifacient agents|mesh-ancestor
20552765|NCT01925092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20552766|NCT01925092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552767|NCT01925092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20552768|NCT01925092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20552769|NCT01925092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20552770|NCT01925092|Contraceptive Agents|contraceptive agents|mesh-ancestor
20552771|NCT01925092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20552772|NCT01925092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20552773|NCT01925092|Hormone Antagonists|hormone antagonists|mesh-ancestor
20552774|NCT01925092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20552775|NCT01925092|Luteolytic Agents|luteolytic agents|mesh-ancestor
20552776|NCT01925092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20286448|NCT03594552|GABA Agents|gaba agents|mesh-ancestor
20286449|NCT03594552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20286450|NCT03594552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552777|NCT01925092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20552778|NCT01925287|Curcumin|curcumin|mesh-list
20552779|NCT01925287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19967187|NCT01742897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19967188|NCT01742897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19967189|NCT01742897|Anesthetics, General|anesthetics, general|mesh-ancestor
20552780|NCT01925287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20552781|NCT01925287|Analgesics|analgesics|mesh-ancestor
20552782|NCT01925287|Sensory System Agents|sensory system agents|mesh-ancestor
20552783|NCT01925287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552784|NCT01925287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552785|NCT01925287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20552786|NCT01925287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19967190|NCT01742897|Anesthetics|anesthetics|mesh-ancestor
19967191|NCT01743001|Macitentan|macitentan|mesh-list
20552787|NCT01925287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552788|NCT01925287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552789|NCT01925287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552790|NCT01925300|Bisoprolol|bisoprolol|mesh-list
20552791|NCT01925300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20552792|NCT01925300|Calcium|calcium|mesh-list
20552793|NCT01925300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20552794|NCT01925300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552795|NCT01925300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20552796|NCT01925300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20552797|NCT01925300|Antimetabolites|antimetabolites|mesh-ancestor
20552798|NCT01925300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552799|NCT01925300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19967192|NCT01743001|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19967193|NCT01743001|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19967194|NCT01743001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967195|NCT01743001|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19967196|NCT01743027|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19967197|NCT01743027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19967198|NCT01743027|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19967199|NCT01743027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19967200|NCT01743027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19967201|NCT01743027|Analgesics|analgesics|mesh-ancestor
20552800|NCT01925300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20552801|NCT01925300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552802|NCT01925300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20552803|NCT01925300|Sympatholytics|sympatholytics|mesh-ancestor
20552804|NCT01925300|Autonomic Agents|autonomic agents|mesh-ancestor
20552805|NCT01925300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552806|NCT01925300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20552807|NCT01925300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20552808|NCT01925300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19967202|NCT01743027|Sensory System Agents|sensory system agents|mesh-ancestor
19967203|NCT01743027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19967204|NCT01743027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967205|NCT01743027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19967206|NCT01743027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19967207|NCT01743027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19967208|NCT01743027|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19967209|NCT01743027|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19967210|NCT01743027|Histamine Antagonists|histamine antagonists|mesh-ancestor
19967211|NCT01743027|Histamine Agents|histamine agents|mesh-ancestor
19967212|NCT01743027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967213|NCT01743027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967214|NCT01743131|Abatacept|abatacept|mesh-list
19967215|NCT01743131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19967216|NCT01743131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967217|NCT01743131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967218|NCT01743131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19967219|NCT01743131|Immunologic Factors|immunologic factors|mesh-ancestor
19967220|NCT01743131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552809|NCT01925300|Adrenergic Agents|adrenergic agents|mesh-ancestor
20552810|NCT01925300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20552811|NCT01925352|Mitogens|mitogens|mesh-list
20552812|NCT01925352|Mitosis Modulators|mitosis modulators|mesh-ancestor
20552813|NCT01925352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552814|NCT01925378|Nelfinavir|nelfinavir|mesh-list
20552815|NCT01925378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20552816|NCT01925378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20552817|NCT01925378|Protease Inhibitors|protease inhibitors|mesh-ancestor
20552818|NCT01925378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552819|NCT01925378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552820|NCT01925378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20552821|NCT01925378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20552822|NCT01925378|Antiviral Agents|antiviral agents|mesh-ancestor
20552823|NCT01925378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20552824|NCT01925456|Fesoterodine|fesoterodine|mesh-list
20552825|NCT01925456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20552826|NCT01925456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20552827|NCT01925456|Cholinergic Agents|cholinergic agents|mesh-ancestor
20552828|NCT01925456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20552829|NCT01925456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552830|NCT01925456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552831|NCT01925456|Urological Agents|urological agents|mesh-ancestor
20552832|NCT01925547|Curcumin|curcumin|mesh-list
20552833|NCT01925547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20552834|NCT01925547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20552835|NCT01925547|Analgesics|analgesics|mesh-ancestor
20552836|NCT01925547|Sensory System Agents|sensory system agents|mesh-ancestor
20552837|NCT01925547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552838|NCT01925547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552839|NCT01925547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20552840|NCT01925547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20552841|NCT01925547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552842|NCT01925547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552843|NCT01925547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554861|NCT01937494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552844|NCT01925638|Ketoconazole|ketoconazole|mesh-list
20552845|NCT01925638|Antifungal Agents|antifungal agents|mesh-ancestor
20552846|NCT01925638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20552847|NCT01925638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20552848|NCT01925638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20552849|NCT01925638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552850|NCT01925638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552851|NCT01925638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20552852|NCT01925638|Hormone Antagonists|hormone antagonists|mesh-ancestor
20552853|NCT01925638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20552854|NCT01925638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552855|NCT01925638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20552856|NCT01925729|Phenylephrine|phenylephrine|mesh-list
20552857|NCT01925729|Pseudoephedrine|pseudoephedrine|mesh-list
20552858|NCT01925729|Oxymetazoline|oxymetazoline|mesh-list
20552859|NCT01925729|Ephedrine|ephedrine|mesh-list
20552860|NCT01925729|Histamine|histamine|mesh-list
20552861|NCT01925729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20552862|NCT01925729|Autonomic Agents|autonomic agents|mesh-ancestor
20552863|NCT01925729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552864|NCT01925729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552865|NCT01925729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20552866|NCT01925729|Respiratory System Agents|respiratory system agents|mesh-ancestor
20552867|NCT01925729|Nasal Decongestants|nasal decongestants|mesh-ancestor
20552868|NCT01925729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20552869|NCT01925729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20552870|NCT01925729|Sympathomimetics|sympathomimetics|mesh-ancestor
20552871|NCT01925729|Adrenergic Agents|adrenergic agents|mesh-ancestor
20552872|NCT01925729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20552873|NCT01925729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552874|NCT01925729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20552875|NCT01925729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20552876|NCT01925729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20552877|NCT01925729|Mydriatics|mydriatics|mesh-ancestor
20554862|NCT01937611|Midazolam|midazolam|mesh-list
19967221|NCT01743131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19967222|NCT01743521|Ribavirin|ribavirin|mesh-list
19967223|NCT01743521|Antimetabolites|antimetabolites|mesh-ancestor
19967224|NCT01743521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967225|NCT01743521|Antiviral Agents|antiviral agents|mesh-ancestor
19967226|NCT01743521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19967227|NCT01743560|Everolimus|everolimus|mesh-list
19967228|NCT01743560|Exemestane|exemestane|mesh-list
19967229|NCT01743560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967230|NCT01743560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19967231|NCT01743560|Immunologic Factors|immunologic factors|mesh-ancestor
19967232|NCT01743560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967233|NCT01743560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19967234|NCT01743560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19967235|NCT01743560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967236|NCT01743560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967237|NCT01743560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19967238|NCT01743560|Hormone Antagonists|hormone antagonists|mesh-ancestor
19967239|NCT01743560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19967240|NCT01743677|Moxifloxacin|moxifloxacin|mesh-list
19967241|NCT01743677|Tofacitinib|tofacitinib|mesh-list
19967242|NCT01743677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19967243|NCT01743677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19967244|NCT01743677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19967245|NCT01743677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19967246|NCT01743677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967247|NCT01743677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967248|NCT01743677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967249|NCT01743677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19967250|NCT01743729|Lifitegrast|lifitegrast|mesh-list
19967251|NCT01743729|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19967252|NCT01743729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19967253|NCT01743859|Lenalidomide|lenalidomide|mesh-list
19967254|NCT01743859|Azacitidine|azacitidine|mesh-list
19967255|NCT01743859|Immunologic Factors|immunologic factors|mesh-ancestor
19967256|NCT01743859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967257|NCT01743859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20552878|NCT01925729|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20552879|NCT01925729|Protective Agents|protective agents|mesh-ancestor
20552880|NCT01925729|Histamine Agonists|histamine agonists|mesh-ancestor
20552881|NCT01925729|Histamine Agents|histamine agents|mesh-ancestor
20552882|NCT01925755|Rivaroxaban|rivaroxaban|mesh-list
20552883|NCT01925755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20552884|NCT01925755|Antithrombins|antithrombins|mesh-ancestor
20552885|NCT01925755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20552886|NCT01925755|Protease Inhibitors|protease inhibitors|mesh-ancestor
20552887|NCT01925755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552888|NCT01925755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967258|NCT01743859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19967259|NCT01743859|Growth Substances|growth substances|mesh-ancestor
19967260|NCT01743859|Growth Inhibitors|growth inhibitors|mesh-ancestor
19967261|NCT01743859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967262|NCT01743859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20552889|NCT01925755|Anticoagulants|anticoagulants|mesh-ancestor
20552890|NCT01925820|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19967263|NCT01743859|Antimetabolites|antimetabolites|mesh-ancestor
19967264|NCT01743859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967265|NCT01743859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967266|NCT01743976|Donepezil|donepezil|mesh-list
20552891|NCT01925820|Entecavir|entecavir|mesh-list
20552892|NCT01925820|Antiviral Agents|antiviral agents|mesh-ancestor
20552893|NCT01925820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20552894|NCT01925859|Dexamethasone|dexamethasone|mesh-list
20552895|NCT01925859|Dexamethasone acetate|dexamethasone acetate|mesh-list
20552896|NCT01925859|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20552897|NCT01925859|BB 1101|bb 1101|mesh-list
20552898|NCT01925859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20552899|NCT01925859|Antiemetics|antiemetics|mesh-ancestor
20552900|NCT01925859|Autonomic Agents|autonomic agents|mesh-ancestor
20552901|NCT01925859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552902|NCT01925859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552903|NCT01925859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20552904|NCT01925859|Glucocorticoids|glucocorticoids|mesh-ancestor
20552905|NCT01925859|Hormones|hormones|mesh-ancestor
20554863|NCT01937611|Dexmedetomidine|dexmedetomidine|mesh-list
20554864|NCT01937611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20554865|NCT01937611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20554866|NCT01937611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554867|NCT01937611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20554868|NCT01937611|Analgesics|analgesics|mesh-ancestor
20554869|NCT01937611|Sensory System Agents|sensory system agents|mesh-ancestor
20554870|NCT01937611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554871|NCT01937611|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20554872|NCT01937611|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20554873|NCT01937611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20554874|NCT01937611|Adrenergic Agents|adrenergic agents|mesh-ancestor
20552906|NCT01925859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20552907|NCT01925859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20552908|NCT01925859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552909|NCT01925859|Protease Inhibitors|protease inhibitors|mesh-ancestor
20552910|NCT01925859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552911|NCT01925859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552912|NCT01925898|Midazolam|midazolam|mesh-list
20552913|NCT01925898|Ketamine|ketamine|mesh-list
20552914|NCT01925898|Analgesics|analgesics|mesh-ancestor
20552915|NCT01925898|Sensory System Agents|sensory system agents|mesh-ancestor
20552916|NCT01925898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20552917|NCT01925898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552918|NCT01925898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20552919|NCT01925898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20552920|NCT01925898|Anesthetics, General|anesthetics, general|mesh-ancestor
20552921|NCT01925898|Anesthetics|anesthetics|mesh-ancestor
20552922|NCT01925898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20552923|NCT01925898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20552924|NCT01925898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20552925|NCT01925898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20552926|NCT01925898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552927|NCT01925898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20552928|NCT01925898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20552929|NCT01925898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20552930|NCT01925898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20552931|NCT01925898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20552932|NCT01925898|GABA Modulators|gaba modulators|mesh-ancestor
20552933|NCT01925898|GABA Agents|gaba agents|mesh-ancestor
20552934|NCT01925911|Midazolam|midazolam|mesh-list
20552935|NCT01925911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20552936|NCT01925911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20552937|NCT01925911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20552938|NCT01925911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552939|NCT01925911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20552940|NCT01925911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20552941|NCT01925911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20552942|NCT01925911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20552943|NCT01925911|Anesthetics, General|anesthetics, general|mesh-ancestor
20552944|NCT01925911|Anesthetics|anesthetics|mesh-ancestor
20552945|NCT01925911|GABA Modulators|gaba modulators|mesh-ancestor
20552946|NCT01925911|GABA Agents|gaba agents|mesh-ancestor
20552947|NCT01925911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20552948|NCT01925911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552949|NCT01925937|Ubiquinone|ubiquinone|mesh-list
20552950|NCT01925937|Coenzyme Q10|coenzyme q10|mesh-list
20552951|NCT01925937|Atorvastatin|atorvastatin|mesh-list
20552952|NCT01925937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20552953|NCT01925937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20552954|NCT01925937|Antimetabolites|antimetabolites|mesh-ancestor
20552955|NCT01925937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552956|NCT01925937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20552957|NCT01925937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20552958|NCT01925937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552959|NCT01925937|Micronutrients|micronutrients|mesh-ancestor
20552960|NCT01925937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552961|NCT01925937|Vitamins|vitamins|mesh-ancestor
20552962|NCT01926041|Varenicline|varenicline|mesh-list
20552963|NCT01926041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20552964|NCT01926041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20552965|NCT01926041|Cholinergic Agents|cholinergic agents|mesh-ancestor
20552966|NCT01926041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967267|NCT01743976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19967268|NCT01743976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552967|NCT01926041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552968|NCT01926041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552969|NCT01926132|Ascorbic Acid|ascorbic acid|mesh-list
20552970|NCT01926132|Antioxidants|antioxidants|mesh-ancestor
20552971|NCT01926132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552972|NCT01926132|Protective Agents|protective agents|mesh-ancestor
20552973|NCT01926132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552974|NCT01926132|Vitamins|vitamins|mesh-ancestor
20552975|NCT01926132|Micronutrients|micronutrients|mesh-ancestor
20552976|NCT01926158|Denosumab|denosumab|mesh-list
20552977|NCT01926158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20552978|NCT01926158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552979|NCT01926197|Leucovorin|leucovorin|mesh-list
20552980|NCT01926197|Oxaliplatin|oxaliplatin|mesh-list
20552981|NCT01926197|Irinotecan|irinotecan|mesh-list
20552982|NCT01926197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552983|NCT01926197|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20552984|NCT01926197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20552985|NCT01926197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552986|NCT01926197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552987|NCT01926197|Antidotes|antidotes|mesh-ancestor
20552988|NCT01926197|Protective Agents|protective agents|mesh-ancestor
20552989|NCT01926197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20552990|NCT01926197|Vitamin B Complex|vitamin b complex|mesh-ancestor
20552991|NCT01926197|Vitamins|vitamins|mesh-ancestor
20552992|NCT01926197|Micronutrients|micronutrients|mesh-ancestor
20552993|NCT01926210|Letrozole|letrozole|mesh-list
20552994|NCT01926210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20552995|NCT01926210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20552996|NCT01926210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20552997|NCT01926210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20552998|NCT01926210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20552999|NCT01926210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20553000|NCT01926210|Hormone Antagonists|hormone antagonists|mesh-ancestor
20553001|NCT01926210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20553002|NCT01926210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553003|NCT01926236|Leucovorin|leucovorin|mesh-list
20553004|NCT01926236|Folic Acid|folic acid|mesh-list
20553005|NCT01926236|Fluorouracil|fluorouracil|mesh-list
20553006|NCT01926236|Oxaliplatin|oxaliplatin|mesh-list
20553007|NCT01926236|Levoleucovorin|levoleucovorin|mesh-list
20553008|NCT01926236|Antimetabolites|antimetabolites|mesh-ancestor
19967269|NCT01743976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967270|NCT01743976|Cholinergic Agents|cholinergic agents|mesh-ancestor
19967271|NCT01743976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967272|NCT01743976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967273|NCT01743976|Nootropic Agents|nootropic agents|mesh-ancestor
19967274|NCT01744197|Lidocaine|lidocaine|mesh-list
19967275|NCT01744197|Tetracaine|tetracaine|mesh-list
19967276|NCT01744197|Anesthetics, Local|anesthetics, local|mesh-ancestor
19967277|NCT01744197|Anesthetics|anesthetics|mesh-ancestor
19967278|NCT01744197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19967279|NCT01744197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967280|NCT01744197|Sensory System Agents|sensory system agents|mesh-ancestor
19967281|NCT01744197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19967282|NCT01744197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19967283|NCT01744197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20553009|NCT01926236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553010|NCT01926236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20553011|NCT01926236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553012|NCT01926236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20553013|NCT01926236|Immunologic Factors|immunologic factors|mesh-ancestor
20553014|NCT01926236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553015|NCT01926236|Antidotes|antidotes|mesh-ancestor
20553016|NCT01926236|Protective Agents|protective agents|mesh-ancestor
19967284|NCT01744197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19967285|NCT01744197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19967286|NCT01744197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967287|NCT01744353|Oxaliplatin|oxaliplatin|mesh-list
19967288|NCT01744353|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19967289|NCT01744353|Paclitaxel|paclitaxel|mesh-list
19967290|NCT01744353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967291|NCT01744353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967292|NCT01744353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19967293|NCT01744353|Tubulin Modulators|tubulin modulators|mesh-ancestor
19967294|NCT01744353|Antimitotic Agents|antimitotic agents|mesh-ancestor
19967295|NCT01744353|Mitosis Modulators|mitosis modulators|mesh-ancestor
19967296|NCT01744496|Rotigotine|rotigotine|mesh-list
19967297|NCT01744496|Dopamine Agonists|dopamine agonists|mesh-ancestor
19967298|NCT01744496|Dopamine Agents|dopamine agents|mesh-ancestor
19967299|NCT01744496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967300|NCT01744496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967301|NCT01744496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967302|NCT01744574|Progesterone|progesterone|mesh-list
19967303|NCT01744574|Progestins|progestins|mesh-ancestor
19967304|NCT01744574|Hormones|hormones|mesh-ancestor
19967305|NCT01744574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19967306|NCT01744574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967307|NCT01744704|Mitogens|mitogens|mesh-list
20553017|NCT01926236|Vitamin B Complex|vitamin b complex|mesh-ancestor
20553018|NCT01926236|Vitamins|vitamins|mesh-ancestor
20553019|NCT01926236|Micronutrients|micronutrients|mesh-ancestor
20553020|NCT01926236|Hematinics|hematinics|mesh-ancestor
20553021|NCT01926288|Entecavir|entecavir|mesh-list
20553022|NCT01926288|Maleic acid|maleic acid|mesh-list
20553023|NCT01926288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553024|NCT01926288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967308|NCT01744704|Mitosis Modulators|mitosis modulators|mesh-ancestor
19967309|NCT01744704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967310|NCT01744730|Clindamycin|clindamycin|mesh-list
19967311|NCT01744730|Clindamycin palmitate|clindamycin palmitate|mesh-list
19967312|NCT01744730|Clindamycin phosphate|clindamycin phosphate|mesh-list
19967313|NCT01744730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19967314|NCT01744730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19967315|NCT01744730|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20553025|NCT01926288|Antiviral Agents|antiviral agents|mesh-ancestor
20553026|NCT01926288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20553027|NCT01926379|Isoniazid|isoniazid|mesh-list
20553028|NCT01926379|Antitubercular Agents|antitubercular agents|mesh-ancestor
20553029|NCT01926379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20553030|NCT01926379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20553031|NCT01926379|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19967316|NCT01744730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967317|NCT01744730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967318|NCT01744782|Cysteamine|cysteamine|mesh-list
19967319|NCT01744782|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
19967320|NCT01744782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967321|NCT01744821|Vitamin D|vitamin d|mesh-list
19967322|NCT01744821|Cholecalciferol|cholecalciferol|mesh-list
19967323|NCT01744821|Vitamins|vitamins|mesh-ancestor
19967324|NCT01744821|Micronutrients|micronutrients|mesh-ancestor
19967325|NCT01744821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967326|NCT01744821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19967327|NCT01744821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19975233|NCT01846611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975234|NCT01846611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19975235|NCT01846611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19975236|NCT01846611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19975237|NCT01846611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19975238|NCT01846611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975239|NCT01846611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20553032|NCT01926379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20553033|NCT01926379|Antimetabolites|antimetabolites|mesh-ancestor
20553034|NCT01926379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553035|NCT01926379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20553036|NCT01926392|Sulfadiazine|sulfadiazine|mesh-list
20553037|NCT01926392|Silver Sulfadiazine|silver sulfadiazine|mesh-list
20553038|NCT01926392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20553039|NCT01926392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20553040|NCT01926392|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20553041|NCT01926392|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20553042|NCT01926392|Coccidiostats|coccidiostats|mesh-ancestor
20553043|NCT01926392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20553044|NCT01926548|Imatinib Mesylate|imatinib mesylate|mesh-list
20553045|NCT01926548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553046|NCT01926548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20553047|NCT01926548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553048|NCT01926548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553049|NCT01926587|Azacitidine|azacitidine|mesh-list
20553050|NCT01926587|ON 01910|on 01910|mesh-list
20553051|NCT01926587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19967328|NCT01745055|Methotrexate|methotrexate|mesh-list
19967329|NCT01745055|Tofacitinib|tofacitinib|mesh-list
19967330|NCT01745055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20553052|NCT01926587|Antimetabolites|antimetabolites|mesh-ancestor
19967331|NCT01745055|Abortifacient Agents|abortifacient agents|mesh-ancestor
19967332|NCT01745055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19967333|NCT01745055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967334|NCT01745055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19967335|NCT01745055|Antimetabolites|antimetabolites|mesh-ancestor
19967336|NCT01745055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967337|NCT01745055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967338|NCT01745055|Dermatologic Agents|dermatologic agents|mesh-ancestor
19967339|NCT01745055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967340|NCT01745055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19967341|NCT01745055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19967342|NCT01745055|Immunologic Factors|immunologic factors|mesh-ancestor
19967343|NCT01745055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19967344|NCT01745055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20553053|NCT01926587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967345|NCT01745055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20553054|NCT01926587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553055|NCT01926587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553056|NCT01926587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20553057|NCT01926639|Rituximab|rituximab|mesh-list
20553058|NCT01926639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20553059|NCT01926639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553060|NCT01926639|Immunologic Factors|immunologic factors|mesh-ancestor
20553061|NCT01926639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553062|NCT01926639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20553063|NCT01926652|Amlodipine|amlodipine|mesh-list
20553064|NCT01926652|Candesartan|candesartan|mesh-list
20553065|NCT01926652|Candesartan cilexetil|candesartan cilexetil|mesh-list
20553066|NCT01926652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20553067|NCT01926652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20553068|NCT01926652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20553069|NCT01926652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553070|NCT01926652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20553071|NCT01926652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553072|NCT01926652|Vasodilator Agents|vasodilator agents|mesh-ancestor
20553073|NCT01926652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19967346|NCT01745094|Solifenacin Succinate|solifenacin succinate|mesh-list
19967347|NCT01745094|Mirabegron|mirabegron|mesh-list
19967348|NCT01745094|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19967349|NCT01745094|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19967350|NCT01745094|Cholinergic Agents|cholinergic agents|mesh-ancestor
19967351|NCT01745094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967352|NCT01745094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967353|NCT01745094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967354|NCT01745094|Urological Agents|urological agents|mesh-ancestor
19967355|NCT01745094|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19967356|NCT01745094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19967357|NCT01745094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19967358|NCT01745094|Adrenergic Agents|adrenergic agents|mesh-ancestor
19967359|NCT01745133|Calcitriol|calcitriol|mesh-list
19967360|NCT01745133|Clobetasol|clobetasol|mesh-list
19967361|NCT01745133|Calcipotriene|calcipotriene|mesh-list
19967362|NCT01745133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19967363|NCT01745133|Glucocorticoids|glucocorticoids|mesh-ancestor
19967364|NCT01745133|Hormones|hormones|mesh-ancestor
19967365|NCT01745133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20553074|NCT01926652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20553075|NCT01926665|Dexamethasone|dexamethasone|mesh-list
20553076|NCT01926665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20553077|NCT01926665|Antiemetics|antiemetics|mesh-ancestor
20553078|NCT01926665|Autonomic Agents|autonomic agents|mesh-ancestor
20553079|NCT01926665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20553080|NCT01926665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553081|NCT01926665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20553082|NCT01926665|Glucocorticoids|glucocorticoids|mesh-ancestor
20553083|NCT01926665|Hormones|hormones|mesh-ancestor
20553084|NCT01926665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20553085|NCT01926665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20553086|NCT01926665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553087|NCT01926769|Metformin|metformin|mesh-list
20553088|NCT01926769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20553089|NCT01926769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553090|NCT01926821|Sizofiran|sizofiran|mesh-list
20553091|NCT01926821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20553092|NCT01926821|Immunologic Factors|immunologic factors|mesh-ancestor
20553093|NCT01926821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553094|NCT01926821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20553095|NCT01926821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553096|NCT01926847|Riociguat|riociguat|mesh-list
20553097|NCT01926847|Enzyme Activators|enzyme activators|mesh-ancestor
20553098|NCT01926847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553099|NCT01926860|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20553100|NCT01926860|Immunologic Factors|immunologic factors|mesh-ancestor
20553101|NCT01926860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553102|NCT01926899|Bortezomib|bortezomib|mesh-list
20553103|NCT01926899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553104|NCT01927029|Progesterone|progesterone|mesh-list
20553105|NCT01927029|Progestins|progestins|mesh-ancestor
20553106|NCT01927029|Hormones|hormones|mesh-ancestor
20553107|NCT01927029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20553108|NCT01927029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553109|NCT01927224|Nifurtimox|nifurtimox|mesh-list
20553110|NCT01927224|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20553111|NCT01927224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20553112|NCT01927224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20553113|NCT01927224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20554875|NCT01937611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20554876|NCT01937611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554877|NCT01937611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20554878|NCT01937611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20554879|NCT01937611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20554880|NCT01937611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20554881|NCT01937611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20554882|NCT01937611|Anesthetics, General|anesthetics, general|mesh-ancestor
20554883|NCT01937611|Anesthetics|anesthetics|mesh-ancestor
20554884|NCT01937611|GABA Modulators|gaba modulators|mesh-ancestor
20554885|NCT01937611|GABA Agents|gaba agents|mesh-ancestor
20554886|NCT01937650|Metronidazole|metronidazole|mesh-list
20554887|NCT01937650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20554888|NCT01937650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20554889|NCT01937650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20554890|NCT01937650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20554891|NCT01937728|Interferons|interferons|mesh-list
20554892|NCT01937728|Ribavirin|ribavirin|mesh-list
20554893|NCT01937728|Interferon-alpha|interferon-alpha|mesh-list
20554894|NCT01937728|Interferon alpha-2|interferon alpha-2|mesh-list
20554895|NCT01937728|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20554896|NCT01937728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20554897|NCT01937728|Antiviral Agents|antiviral agents|mesh-ancestor
20554898|NCT01937728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20554899|NCT01937728|Antimetabolites|antimetabolites|mesh-ancestor
20554900|NCT01937728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554901|NCT01937728|Immunologic Factors|immunologic factors|mesh-ancestor
20554902|NCT01937728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554903|NCT01937754|Nitric Oxide|nitric oxide|mesh-list
20554904|NCT01937754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20554905|NCT01937754|Autonomic Agents|autonomic agents|mesh-ancestor
20554906|NCT01937754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20554907|NCT01937754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20554908|NCT01937754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20554909|NCT01937754|Respiratory System Agents|respiratory system agents|mesh-ancestor
20554910|NCT01937754|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20554911|NCT01937754|Antioxidants|antioxidants|mesh-ancestor
20554912|NCT01937754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20554913|NCT01937754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20553114|NCT01927263|Infliximab|infliximab|mesh-list
19733504|NCT04561076|Myeloma Proteins|myeloma proteins|mesh-list
19733505|NCT04561076|Paraproteins|paraproteins|mesh-list
19733506|NCT04561076|Immunologic Factors|immunologic factors|mesh-ancestor
19733507|NCT04561076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733508|NCT04560894|Sorafenib|sorafenib|mesh-list
19733509|NCT04560894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733510|NCT04560894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19733511|NCT04560894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733512|NCT04560894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733513|NCT04561063|Sofosbuvir|sofosbuvir|mesh-list
19733514|NCT04561063|Nitazoxanide|nitazoxanide|mesh-list
19967366|NCT01745133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967367|NCT01745133|Dermatologic Agents|dermatologic agents|mesh-ancestor
19967368|NCT01745133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19967369|NCT01745133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19967370|NCT01745133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19967371|NCT01745133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967372|NCT01745133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19967373|NCT01745133|Vitamins|vitamins|mesh-ancestor
19967374|NCT01745133|Micronutrients|micronutrients|mesh-ancestor
19967375|NCT01745133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19967376|NCT01745367|Paclitaxel|paclitaxel|mesh-list
19967377|NCT01745367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19967378|NCT01745367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967379|NCT01745367|Tubulin Modulators|tubulin modulators|mesh-ancestor
19967380|NCT01745367|Antimitotic Agents|antimitotic agents|mesh-ancestor
19967381|NCT01745367|Mitosis Modulators|mitosis modulators|mesh-ancestor
19967382|NCT01745367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967383|NCT01745380|Phenylephrine|phenylephrine|mesh-list
19967384|NCT01745380|Oxymetazoline|oxymetazoline|mesh-list
19967385|NCT01745380|Tetracaine|tetracaine|mesh-list
19967386|NCT01745380|Anesthetics, Local|anesthetics, local|mesh-ancestor
19967387|NCT01745380|Anesthetics|anesthetics|mesh-ancestor
19967388|NCT01745380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19733515|NCT04561063|Antiviral Agents|antiviral agents|mesh-ancestor
20553115|NCT01927263|Dermatologic Agents|dermatologic agents|mesh-ancestor
20553116|NCT01927263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20553117|NCT01927263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20553118|NCT01927315|Fenofibrate|fenofibrate|mesh-list
20553119|NCT01927315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20553120|NCT01927315|Antimetabolites|antimetabolites|mesh-ancestor
20553121|NCT01927315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553122|NCT01927315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20553123|NCT01927328|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
20553124|NCT01927328|Hematinics|hematinics|mesh-ancestor
20553125|NCT01927406|Timolol|timolol|mesh-list
20553126|NCT01927406|Bimatoprost|bimatoprost|mesh-list
20553127|NCT01927406|Travoprost|travoprost|mesh-list
20553128|NCT01927406|Latanoprost|latanoprost|mesh-list
20553129|NCT01927406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20553130|NCT01927406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20553131|NCT01927406|Adrenergic Agents|adrenergic agents|mesh-ancestor
20553132|NCT01927406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20553133|NCT01927406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553134|NCT01927406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553135|NCT01927406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20553136|NCT01927406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20553137|NCT01927406|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20553138|NCT01927406|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20553139|NCT01927484|Methotrexate|methotrexate|mesh-list
20553140|NCT01927484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20553141|NCT01927484|Abortifacient Agents|abortifacient agents|mesh-ancestor
20553142|NCT01927484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20553143|NCT01927484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553144|NCT01927484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20553145|NCT01927484|Antimetabolites|antimetabolites|mesh-ancestor
19967389|NCT01745380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967390|NCT01745380|Sensory System Agents|sensory system agents|mesh-ancestor
19967391|NCT01745380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19967392|NCT01745380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19733516|NCT04561063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19733517|NCT04561063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19733518|NCT04560660|Midazolam|midazolam|mesh-list
19733519|NCT04560660|Ketamine|ketamine|mesh-list
19733520|NCT04560660|Analgesics|analgesics|mesh-ancestor
19733521|NCT04560660|Sensory System Agents|sensory system agents|mesh-ancestor
19733522|NCT04560660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733523|NCT04560660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733524|NCT04560660|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19733525|NCT04560660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19733526|NCT04560660|Anesthetics, General|anesthetics, general|mesh-ancestor
19733527|NCT04560660|Anesthetics|anesthetics|mesh-ancestor
19733528|NCT04560660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19733529|NCT04560660|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19733530|NCT04560660|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19733531|NCT04560660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19733532|NCT04560660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553146|NCT01927484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553147|NCT01927484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553148|NCT01927484|Dermatologic Agents|dermatologic agents|mesh-ancestor
20553149|NCT01927484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553150|NCT01927484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20553151|NCT01927484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20553152|NCT01927484|Immunologic Factors|immunologic factors|mesh-ancestor
20553153|NCT01927484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20553154|NCT01927484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20553155|NCT01927588|Prednisone|prednisone|mesh-list
20553156|NCT01927588|Everolimus|everolimus|mesh-list
20553157|NCT01927588|Tacrolimus|tacrolimus|mesh-list
20553158|NCT01927588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20553159|NCT01927588|Glucocorticoids|glucocorticoids|mesh-ancestor
20553160|NCT01927588|Hormones|hormones|mesh-ancestor
20553161|NCT01927588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20553162|NCT01927588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553163|NCT01927588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20553164|NCT01927588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553165|NCT01927588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20553166|NCT01927588|Immunologic Factors|immunologic factors|mesh-ancestor
20553167|NCT01927588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20553168|NCT01927588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553169|NCT01927588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553170|NCT01927640|Cocaine|cocaine|mesh-list
19967393|NCT01745380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19967394|NCT01745380|Adrenergic Agents|adrenergic agents|mesh-ancestor
19967395|NCT01745380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967396|NCT01745380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967397|NCT01745380|Sympathomimetics|sympathomimetics|mesh-ancestor
19967398|NCT01745380|Autonomic Agents|autonomic agents|mesh-ancestor
19967399|NCT01745380|Nasal Decongestants|nasal decongestants|mesh-ancestor
19967400|NCT01745380|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19967401|NCT01745380|Respiratory System Agents|respiratory system agents|mesh-ancestor
19967402|NCT01745380|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19967403|NCT01745380|Mydriatics|mydriatics|mesh-ancestor
19967404|NCT01745380|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19967405|NCT01745380|Protective Agents|protective agents|mesh-ancestor
19967406|NCT01745822|Tenofovir|tenofovir|mesh-list
19967407|NCT01745822|Antiviral Agents|antiviral agents|mesh-ancestor
19967408|NCT01745822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19967409|NCT01745822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19967410|NCT01745822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19967411|NCT01745822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967412|NCT01745822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967413|NCT01745822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19967414|NCT01745822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19967415|NCT01746043|Minocycline|minocycline|mesh-list
19967416|NCT01746043|Modafinil|modafinil|mesh-list
19967417|NCT01746043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19967418|NCT01746043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19967419|NCT01746043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19967420|NCT01746043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967421|NCT01746043|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19967422|NCT01746043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19967423|NCT01746043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19967424|NCT01746043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967425|NCT01746095|Vancomycin|vancomycin|mesh-list
19967426|NCT01746095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19967427|NCT01746095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19967428|NCT01746173|Gemcitabine|gemcitabine|mesh-list
19967429|NCT01746173|Plerixafor|plerixafor|mesh-list
19967430|NCT01746173|Prednisone|prednisone|mesh-list
19967431|NCT01746173|Cyclophosphamide|cyclophosphamide|mesh-list
19967432|NCT01746173|Melphalan|melphalan|mesh-list
19967433|NCT01746173|Busulfan|busulfan|mesh-list
19967434|NCT01746173|Doxorubicin|doxorubicin|mesh-list
19967435|NCT01746173|Etoposide|etoposide|mesh-list
19967436|NCT01746173|Etoposide phosphate|etoposide phosphate|mesh-list
19967437|NCT01746173|Vincristine|vincristine|mesh-list
19967438|NCT01746173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19967439|NCT01746173|Immunologic Factors|immunologic factors|mesh-ancestor
19967440|NCT01746173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967441|NCT01746173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19967442|NCT01746173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19967443|NCT01746173|Alkylating Agents|alkylating agents|mesh-ancestor
19967444|NCT01746173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967445|NCT01746173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967446|NCT01746173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19967447|NCT01746173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19967448|NCT01746173|Antimetabolites|antimetabolites|mesh-ancestor
19967449|NCT01746173|Antiviral Agents|antiviral agents|mesh-ancestor
19967450|NCT01746173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19967451|NCT01746173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967452|NCT01746173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19967453|NCT01746173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19967454|NCT01746173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19967455|NCT01746173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19967456|NCT01746173|Glucocorticoids|glucocorticoids|mesh-ancestor
19967457|NCT01746173|Hormones|hormones|mesh-ancestor
19967458|NCT01746173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19967459|NCT01746173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19967460|NCT01746173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19967461|NCT01746173|Tubulin Modulators|tubulin modulators|mesh-ancestor
19967462|NCT01746173|Antimitotic Agents|antimitotic agents|mesh-ancestor
19967463|NCT01746173|Mitosis Modulators|mitosis modulators|mesh-ancestor
19967464|NCT01746173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19967465|NCT01746173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19967466|NCT01746225|Paclitaxel|paclitaxel|mesh-list
19967467|NCT01746225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19967468|NCT01746225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967469|NCT01746225|Tubulin Modulators|tubulin modulators|mesh-ancestor
19967470|NCT01746225|Antimitotic Agents|antimitotic agents|mesh-ancestor
19967471|NCT01746225|Mitosis Modulators|mitosis modulators|mesh-ancestor
19967472|NCT01746225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967473|NCT01746264|Vitamin D|vitamin d|mesh-list
19967474|NCT01746264|Cholecalciferol|cholecalciferol|mesh-list
19967475|NCT01746264|Vitamins|vitamins|mesh-ancestor
19967476|NCT01746264|Micronutrients|micronutrients|mesh-ancestor
19967477|NCT01746264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967478|NCT01746264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19967479|NCT01746264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19967480|NCT01746420|Becaplermin|becaplermin|mesh-list
19967481|NCT01746420|Anticoagulants|anticoagulants|mesh-ancestor
19967482|NCT01746420|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
19967483|NCT01746420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19967484|NCT01746420|Growth Substances|growth substances|mesh-ancestor
19967485|NCT01746420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967486|NCT01746511|Glycerol|glycerol|mesh-list
19967487|NCT01746511|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19967488|NCT01746511|Protective Agents|protective agents|mesh-ancestor
19967489|NCT01746511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967490|NCT01746732|Moxifloxacin|moxifloxacin|mesh-list
19967491|NCT01746732|Evacetrapib|evacetrapib|mesh-list
19967492|NCT01746732|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19967493|NCT01746732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19967494|NCT01746732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19967495|NCT01746732|Antimetabolites|antimetabolites|mesh-ancestor
19450426|NCT03428503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450427|NCT03428503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450428|NCT03428503|Antipyretics|antipyretics|mesh-ancestor
19967496|NCT01746732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967497|NCT01746732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19967498|NCT01746732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19967499|NCT01746732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19967500|NCT01746732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19967501|NCT01746732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19967502|NCT01746732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967503|NCT01746732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967504|NCT01746732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19967505|NCT01746732|Contraceptive Agents|contraceptive agents|mesh-ancestor
19967506|NCT01746732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19967507|NCT01746732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967508|NCT01746732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19967509|NCT01746732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19967510|NCT01746732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19967511|NCT01746901|Naltrexone|naltrexone|mesh-list
19967512|NCT01746901|Oxycodone|oxycodone|mesh-list
19967513|NCT01746901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19967514|NCT01746901|Narcotics|narcotics|mesh-ancestor
19967515|NCT01746901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19967516|NCT01746901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967517|NCT01746901|Analgesics|analgesics|mesh-ancestor
19967518|NCT01746901|Sensory System Agents|sensory system agents|mesh-ancestor
19967519|NCT01746901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19967520|NCT01746901|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19967521|NCT01746901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19967522|NCT01746940|Cocaine|cocaine|mesh-list
19967523|NCT01746940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19967524|NCT01746940|Anesthetics, Local|anesthetics, local|mesh-ancestor
19967525|NCT01746940|Anesthetics|anesthetics|mesh-ancestor
19967526|NCT01746940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19967527|NCT01746940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967528|NCT01746940|Sensory System Agents|sensory system agents|mesh-ancestor
19967529|NCT01746940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19967530|NCT01746940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19967531|NCT01746940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19967532|NCT01746940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19967533|NCT01746940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19967534|NCT01746940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967535|NCT01746940|Dopamine Agents|dopamine agents|mesh-ancestor
19967536|NCT01746940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967537|NCT01746979|Gemcitabine|gemcitabine|mesh-list
19967538|NCT01746979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19967539|NCT01746979|Antimetabolites|antimetabolites|mesh-ancestor
19967540|NCT01746979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967541|NCT01746979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967542|NCT01746979|Antiviral Agents|antiviral agents|mesh-ancestor
19967543|NCT01746979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19967544|NCT01746979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967545|NCT01746979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19967546|NCT01746979|Immunologic Factors|immunologic factors|mesh-ancestor
19967547|NCT01746979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967548|NCT01747330|Pancreatin|pancreatin|mesh-list
19967549|NCT01747330|Pancrelipase|pancrelipase|mesh-list
19967550|NCT01747330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19967551|NCT01747499|Azacitidine|azacitidine|mesh-list
19967552|NCT01747499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19967553|NCT01747499|Antimetabolites|antimetabolites|mesh-ancestor
19967554|NCT01747499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967555|NCT01747499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967556|NCT01747499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967557|NCT01747551|Leucovorin|leucovorin|mesh-list
19967558|NCT01747551|Fluorouracil|fluorouracil|mesh-list
19967559|NCT01747551|Oxaliplatin|oxaliplatin|mesh-list
19967560|NCT01747551|Aflibercept|aflibercept|mesh-list
19967561|NCT01747551|Antimetabolites|antimetabolites|mesh-ancestor
19967562|NCT01747551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967563|NCT01747551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19967564|NCT01747551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967565|NCT01747551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19967566|NCT01747551|Immunologic Factors|immunologic factors|mesh-ancestor
19967567|NCT01747551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967568|NCT01747551|Antidotes|antidotes|mesh-ancestor
19967569|NCT01747551|Protective Agents|protective agents|mesh-ancestor
19967570|NCT01747551|Vitamin B Complex|vitamin b complex|mesh-ancestor
19967571|NCT01747551|Vitamins|vitamins|mesh-ancestor
19967572|NCT01747551|Micronutrients|micronutrients|mesh-ancestor
19967573|NCT01747551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19967574|NCT01747551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19967575|NCT01747551|Growth Substances|growth substances|mesh-ancestor
19967576|NCT01747551|Growth Inhibitors|growth inhibitors|mesh-ancestor
19967577|NCT01747629|Albuterol|albuterol|mesh-list
19967578|NCT01747629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19967579|NCT01747629|Autonomic Agents|autonomic agents|mesh-ancestor
19967580|NCT01747629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19967581|NCT01747629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967582|NCT01747629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19967583|NCT01747629|Respiratory System Agents|respiratory system agents|mesh-ancestor
19967584|NCT01747629|Tocolytic Agents|tocolytic agents|mesh-ancestor
19967585|NCT01747629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19967586|NCT01747629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19967587|NCT01747629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19967588|NCT01747629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19967589|NCT01747629|Adrenergic Agents|adrenergic agents|mesh-ancestor
19967590|NCT01747629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967591|NCT01747629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967592|NCT01747850|Ethanol|ethanol|mesh-list
19967593|NCT01747850|Nabiximols|nabiximols|mesh-list
19967594|NCT01747850|Dronabinol|dronabinol|mesh-list
19967595|NCT01747850|Cannabidiol|cannabidiol|mesh-list
19967596|NCT01747850|Peppermint oil|peppermint oil|mesh-list
19967597|NCT01747850|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19967598|NCT01747850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19967599|NCT01747850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19967600|NCT01747850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967601|NCT01747850|Anticonvulsants|anticonvulsants|mesh-ancestor
19967602|NCT01747850|Analgesics|analgesics|mesh-ancestor
19967603|NCT01747850|Sensory System Agents|sensory system agents|mesh-ancestor
19967604|NCT01747850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20553171|NCT01927640|Dexmedetomidine|dexmedetomidine|mesh-list
20553172|NCT01927640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19733533|NCT04560660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19733534|NCT04560660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19733535|NCT04560660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20553173|NCT01927640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20553174|NCT01927640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553175|NCT01927640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20553176|NCT01927640|Analgesics|analgesics|mesh-ancestor
20553177|NCT01927640|Sensory System Agents|sensory system agents|mesh-ancestor
20553178|NCT01927640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733536|NCT04560660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19733537|NCT04560660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19733538|NCT04560660|GABA Modulators|gaba modulators|mesh-ancestor
19733539|NCT04560660|GABA Agents|gaba agents|mesh-ancestor
19733540|NCT04560465|Tranexamic Acid|tranexamic acid|mesh-list
19733541|NCT04560465|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19733542|NCT04560465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19735788|NCT04536493|Epinephryl borate|epinephryl borate|mesh-list
19967605|NCT01747850|Hallucinogens|hallucinogens|mesh-ancestor
19967606|NCT01747850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19967607|NCT01747850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19967608|NCT01747850|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19967609|NCT01747850|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19967610|NCT01747850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967611|NCT01747850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967612|NCT01747850|Hormones|hormones|mesh-ancestor
20553179|NCT01927640|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19967613|NCT01747850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19967614|NCT01747850|Antiemetics|antiemetics|mesh-ancestor
19967615|NCT01747850|Autonomic Agents|autonomic agents|mesh-ancestor
19967616|NCT01747850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19967617|NCT01747850|Parasympatholytics|parasympatholytics|mesh-ancestor
19967618|NCT01747915|Pregabalin|pregabalin|mesh-list
19967619|NCT01747915|Analgesics|analgesics|mesh-ancestor
19967620|NCT01747915|Sensory System Agents|sensory system agents|mesh-ancestor
19967621|NCT01747915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19967622|NCT01747915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967623|NCT01747915|Anticonvulsants|anticonvulsants|mesh-ancestor
19967624|NCT01747915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19967625|NCT01747915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19967626|NCT01747915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967627|NCT01747915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19967628|NCT01747915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19967629|NCT01747915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19967630|NCT01747915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19967631|NCT01747915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19967632|NCT01748045|Nitric Oxide|nitric oxide|mesh-list
19967633|NCT01748045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19967634|NCT01748045|Autonomic Agents|autonomic agents|mesh-ancestor
20553180|NCT01927640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20553181|NCT01927640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20553182|NCT01927640|Adrenergic Agents|adrenergic agents|mesh-ancestor
20553183|NCT01927640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20553184|NCT01927640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553185|NCT01927640|Anesthetics, Local|anesthetics, local|mesh-ancestor
20553186|NCT01927640|Anesthetics|anesthetics|mesh-ancestor
20553187|NCT01927640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20553188|NCT01927640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20553189|NCT01927640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20553190|NCT01927640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20553191|NCT01927640|Dopamine Agents|dopamine agents|mesh-ancestor
20553192|NCT01927679|Vitamin E|vitamin e|mesh-list
20553193|NCT01927679|Antioxidants|antioxidants|mesh-list
20553194|NCT01927679|Vitamins|vitamins|mesh-ancestor
20553195|NCT01927679|Micronutrients|micronutrients|mesh-ancestor
20553196|NCT01927679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967635|NCT01748045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19967636|NCT01748045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967637|NCT01748045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19967638|NCT01748045|Respiratory System Agents|respiratory system agents|mesh-ancestor
19967639|NCT01748045|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19967640|NCT01748045|Antioxidants|antioxidants|mesh-ancestor
19967641|NCT01748045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967642|NCT01748045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967643|NCT01748045|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19967644|NCT01748045|Vasodilator Agents|vasodilator agents|mesh-ancestor
19967645|NCT01748045|Gasotransmitters|gasotransmitters|mesh-ancestor
19967646|NCT01748045|Protective Agents|protective agents|mesh-ancestor
19967647|NCT01748240|Azacitidine|azacitidine|mesh-list
19967648|NCT01748240|Vorinostat|vorinostat|mesh-list
19967649|NCT01748240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19967650|NCT01748240|Antimetabolites|antimetabolites|mesh-ancestor
19967651|NCT01748240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967652|NCT01748240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967653|NCT01748240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967654|NCT01748240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19967655|NCT01748292|Ranibizumab|ranibizumab|mesh-list
19967656|NCT01748292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19967657|NCT01748292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19967658|NCT01748292|Growth Substances|growth substances|mesh-ancestor
19967659|NCT01748292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967660|NCT01748292|Growth Inhibitors|growth inhibitors|mesh-ancestor
19967661|NCT01748292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967662|NCT01748643|Glycopyrrolate|glycopyrrolate|mesh-list
19967663|NCT01748643|Rocuronium|rocuronium|mesh-list
19967664|NCT01748643|Neostigmine|neostigmine|mesh-list
19967665|NCT01748643|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19967666|NCT01748643|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19967667|NCT01748643|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19967668|NCT01748643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19967669|NCT01748643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967670|NCT01748643|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19967671|NCT01748643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967672|NCT01748643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967673|NCT01748643|Cholinergic Agents|cholinergic agents|mesh-ancestor
19967674|NCT01748643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967675|NCT01748643|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19967676|NCT01748643|Autonomic Agents|autonomic agents|mesh-ancestor
19967677|NCT01748643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19967678|NCT01748643|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19967679|NCT01748643|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19967680|NCT01748799|Ethanol|ethanol|mesh-list
19967681|NCT01748799|Nabiximols|nabiximols|mesh-list
19967682|NCT01748799|Dronabinol|dronabinol|mesh-list
19967683|NCT01748799|Cannabidiol|cannabidiol|mesh-list
19967684|NCT01748799|Peppermint oil|peppermint oil|mesh-list
19967685|NCT01748799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19967686|NCT01748799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19967687|NCT01748799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19967688|NCT01748799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967689|NCT01748799|Anticonvulsants|anticonvulsants|mesh-ancestor
19967690|NCT01748799|Analgesics|analgesics|mesh-ancestor
19967691|NCT01748799|Sensory System Agents|sensory system agents|mesh-ancestor
19967692|NCT01748799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19967693|NCT01748799|Hallucinogens|hallucinogens|mesh-ancestor
19967694|NCT01748799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19967695|NCT01748799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19967696|NCT01748799|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19967697|NCT01748799|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19967698|NCT01748799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967699|NCT01748799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967700|NCT01748799|Hormones|hormones|mesh-ancestor
19967701|NCT01748799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19967702|NCT01748799|Antiemetics|antiemetics|mesh-ancestor
19967703|NCT01748799|Autonomic Agents|autonomic agents|mesh-ancestor
19967704|NCT01748799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19967705|NCT01748799|Parasympatholytics|parasympatholytics|mesh-ancestor
19967706|NCT01748825|Adavosertib|adavosertib|mesh-list
19967707|NCT01748825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967708|NCT01748825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967709|NCT01748942|Dexamethasone|dexamethasone|mesh-list
19967710|NCT01748942|Dexamethasone acetate|dexamethasone acetate|mesh-list
19967711|NCT01748942|Ichthammol|ichthammol|mesh-list
19967712|NCT01748942|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19967713|NCT01748942|BB 1101|bb 1101|mesh-list
19967714|NCT01748942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19967715|NCT01748942|Antiemetics|antiemetics|mesh-ancestor
19967716|NCT01748942|Autonomic Agents|autonomic agents|mesh-ancestor
19967717|NCT01748942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19967718|NCT01748942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967719|NCT01748942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19967720|NCT01748942|Glucocorticoids|glucocorticoids|mesh-ancestor
19967721|NCT01748942|Hormones|hormones|mesh-ancestor
19967722|NCT01748942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19967723|NCT01748942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19967724|NCT01748942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967725|NCT01748942|Protease Inhibitors|protease inhibitors|mesh-ancestor
19967726|NCT01748942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967727|NCT01748942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967728|NCT01748942|Dermatologic Agents|dermatologic agents|mesh-ancestor
19967729|NCT01748955|Bupropion|bupropion|mesh-list
19967730|NCT01748955|Paroxetine|paroxetine|mesh-list
19967731|NCT01748955|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19967732|NCT01748955|Antidepressive Agents|antidepressive agents|mesh-ancestor
19967733|NCT01748955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19967734|NCT01748955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19967735|NCT01748955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19967736|NCT01748955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19967737|NCT01748955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967738|NCT01748955|Dopamine Agents|dopamine agents|mesh-ancestor
19967739|NCT01748955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967740|NCT01748955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967741|NCT01748955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19967742|NCT01748955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19967743|NCT01748955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967744|NCT01748955|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19967745|NCT01748955|Serotonin Agents|serotonin agents|mesh-ancestor
19967746|NCT01748994|Pioglitazone|pioglitazone|mesh-list
19967747|NCT01748994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19967748|NCT01748994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967749|NCT01749215|Topiramate|topiramate|mesh-list
19967750|NCT01749215|Anticonvulsants|anticonvulsants|mesh-ancestor
19967751|NCT01749215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19967752|NCT01749215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967753|NCT01749293|Cyclophosphamide|cyclophosphamide|mesh-list
19967754|NCT01749293|Busulfan|busulfan|mesh-list
19967755|NCT01749293|Fludarabine|fludarabine|mesh-list
19967756|NCT01749293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19967757|NCT01749293|Immunologic Factors|immunologic factors|mesh-ancestor
19967758|NCT01749293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967759|NCT01749293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19967760|NCT01749293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19967761|NCT01749293|Alkylating Agents|alkylating agents|mesh-ancestor
19967762|NCT01749293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967763|NCT01749293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967764|NCT01749293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19967765|NCT01749410|Botulinum Toxins|botulinum toxins|mesh-list
19967766|NCT01749410|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19967767|NCT01749410|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19967768|NCT01749410|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19967769|NCT01749410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19967770|NCT01749410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967771|NCT01749410|Cholinergic Agents|cholinergic agents|mesh-ancestor
19967772|NCT01749410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967773|NCT01749410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967774|NCT01749410|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19967775|NCT01749410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19967776|NCT01749501|Rocuronium|rocuronium|mesh-list
19967777|NCT01749501|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19967778|NCT01749501|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19967779|NCT01749501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19967780|NCT01749501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450429|NCT03428503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19450430|NCT03428503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19450431|NCT03428503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19450432|NCT03428477|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
19450433|NCT03428477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19450434|NCT03428477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19450435|NCT03428425|Paclitaxel|paclitaxel|mesh-list
19450436|NCT03428425|Apatinib|apatinib|mesh-list
19975240|NCT01846611|Alkylating Agents|alkylating agents|mesh-ancestor
19967781|NCT01749501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967782|NCT01749605|Ciprofloxacin|ciprofloxacin|mesh-list
19967783|NCT01749605|Nitrofurantoin|nitrofurantoin|mesh-list
19967784|NCT01749605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19967785|NCT01749605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19967786|NCT01749605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19967787|NCT01749605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19733543|NCT04560465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967788|NCT01749605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967789|NCT01749605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967790|NCT01749605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967791|NCT01749605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19967792|NCT01749605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19733544|NCT04560465|Hemostatics|hemostatics|mesh-ancestor
19733545|NCT04560465|Coagulants|coagulants|mesh-ancestor
19733546|NCT04560322|Venetoclax|venetoclax|mesh-list
19967793|NCT01749605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19967794|NCT01749605|Renal Agents|renal agents|mesh-ancestor
19967795|NCT01749904|Timolol|timolol|mesh-list
19967796|NCT01749904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19967797|NCT01749904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19967798|NCT01749904|Adrenergic Agents|adrenergic agents|mesh-ancestor
19967799|NCT01749904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967800|NCT01749904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967801|NCT01749904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967802|NCT01749904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19967803|NCT01749904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19967804|NCT01749930|Timolol|timolol|mesh-list
19967805|NCT01749930|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19967806|NCT01749930|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19967807|NCT01749930|Adrenergic Agents|adrenergic agents|mesh-ancestor
19967808|NCT01749930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967809|NCT01749930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967810|NCT01749930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967811|NCT01749930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19967812|NCT01749930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19967813|NCT01749956|Leucovorin|leucovorin|mesh-list
19967814|NCT01749956|Fluorouracil|fluorouracil|mesh-list
19967815|NCT01749956|Oxaliplatin|oxaliplatin|mesh-list
19967816|NCT01749956|Aflibercept|aflibercept|mesh-list
19967817|NCT01749956|Antimetabolites|antimetabolites|mesh-ancestor
19967818|NCT01749956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967819|NCT01749956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19967820|NCT01749956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967821|NCT01749956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19733547|NCT04560322|Obinutuzumab|obinutuzumab|mesh-list
19733548|NCT04560322|Acalabrutinib|acalabrutinib|mesh-list
19733549|NCT04560322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733550|NCT04560322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19733551|NCT04560751|Lenvatinib|lenvatinib|mesh-list
19733552|NCT04560751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967822|NCT01749956|Immunologic Factors|immunologic factors|mesh-ancestor
19967823|NCT01749956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967824|NCT01749956|Antidotes|antidotes|mesh-ancestor
19967825|NCT01749956|Protective Agents|protective agents|mesh-ancestor
19967826|NCT01749956|Vitamin B Complex|vitamin b complex|mesh-ancestor
19967827|NCT01749956|Vitamins|vitamins|mesh-ancestor
19967828|NCT01749956|Micronutrients|micronutrients|mesh-ancestor
19967829|NCT01749956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19967830|NCT01749956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19967831|NCT01749956|Growth Substances|growth substances|mesh-ancestor
19967832|NCT01749956|Growth Inhibitors|growth inhibitors|mesh-ancestor
19967833|NCT01749982|Choline|choline|mesh-list
19967834|NCT01749982|Betaine|betaine|mesh-list
19967835|NCT01749982|Lipotropic Agents|lipotropic agents|mesh-ancestor
19967836|NCT01749982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19967837|NCT01749982|Antimetabolites|antimetabolites|mesh-ancestor
19967838|NCT01749982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967839|NCT01749982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19967840|NCT01749982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19967841|NCT01749982|Nootropic Agents|nootropic agents|mesh-ancestor
19967842|NCT01750086|Denosumab|denosumab|mesh-list
19967843|NCT01750086|Alendronate|alendronate|mesh-list
19967844|NCT01750086|Teriparatide|teriparatide|mesh-list
19967845|NCT01750086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19967846|NCT01750086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967847|NCT01750086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19967848|NCT01750268|Topiramate|topiramate|mesh-list
19967849|NCT01750268|Anticonvulsants|anticonvulsants|mesh-ancestor
19967850|NCT01750268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19967851|NCT01750268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967852|NCT01750294|Chlorthalidone|chlorthalidone|mesh-list
19967853|NCT01750294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19967854|NCT01750294|Diuretics|diuretics|mesh-ancestor
19967855|NCT01750294|Natriuretic Agents|natriuretic agents|mesh-ancestor
19967856|NCT01750294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967857|NCT01750294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19967858|NCT01750294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19975241|NCT01846624|Decitabine|decitabine|mesh-list
19967859|NCT01750294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967860|NCT01750398|Methyltestosterone|methyltestosterone|mesh-list
19967861|NCT01750398|Leuprolide|leuprolide|mesh-list
19967862|NCT01750398|Goserelin|goserelin|mesh-list
19967863|NCT01750398|Testosterone|testosterone|mesh-list
19967864|NCT01750398|Testosterone undecanoate|testosterone undecanoate|mesh-list
19967865|NCT01750398|Testosterone enanthate|testosterone enanthate|mesh-list
19967866|NCT01750398|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19967867|NCT01750398|Androgens|androgens|mesh-ancestor
19967868|NCT01750398|Hormones|hormones|mesh-ancestor
19967869|NCT01750398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19967870|NCT01750398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967871|NCT01750398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19967872|NCT01750398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967873|NCT01750398|Anabolic Agents|anabolic agents|mesh-ancestor
19967874|NCT01750398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19967875|NCT01750398|Fertility Agents|fertility agents|mesh-ancestor
19967876|NCT01750398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19967877|NCT01750697|Rituximab|rituximab|mesh-list
19967878|NCT01750697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19967879|NCT01750697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967880|NCT01750697|Immunologic Factors|immunologic factors|mesh-ancestor
19967881|NCT01750697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967882|NCT01750697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19967883|NCT01750840|Cimetidine|cimetidine|mesh-list
19967884|NCT01750840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19967885|NCT01750840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19967886|NCT01750840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19967887|NCT01750840|Histamine Antagonists|histamine antagonists|mesh-ancestor
19967888|NCT01750840|Histamine Agents|histamine agents|mesh-ancestor
19967889|NCT01750840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967890|NCT01750840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967891|NCT01750840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967892|NCT01750840|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19967893|NCT01750840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19967894|NCT01750840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967895|NCT01750918|Fluorouracil|fluorouracil|mesh-list
19967896|NCT01750918|Panitumumab|panitumumab|mesh-list
19967897|NCT01750918|Trametinib|trametinib|mesh-list
19967898|NCT01750918|Dabrafenib|dabrafenib|mesh-list
19967899|NCT01750918|Antimetabolites|antimetabolites|mesh-ancestor
19967900|NCT01750918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967901|NCT01750918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19967902|NCT01750918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967903|NCT01750918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19967904|NCT01750918|Immunologic Factors|immunologic factors|mesh-ancestor
19967905|NCT01750918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967906|NCT01750918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19967907|NCT01750918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19967908|NCT01750918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967909|NCT01750931|Meloxicam|meloxicam|mesh-list
19967910|NCT01750931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19967911|NCT01750931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19967912|NCT01750931|Analgesics|analgesics|mesh-ancestor
19967913|NCT01750931|Sensory System Agents|sensory system agents|mesh-ancestor
19967914|NCT01750931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19967915|NCT01750931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967916|NCT01750931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19967917|NCT01750931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19967918|NCT01750931|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19967919|NCT01750931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19967920|NCT01750931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967921|NCT01750931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967922|NCT01751087|Vitamins|vitamins|mesh-list
19967923|NCT01751087|Vitamin B 12|vitamin b 12|mesh-list
19967924|NCT01751087|Misoprostol|misoprostol|mesh-list
19967925|NCT01751087|Mifepristone|mifepristone|mesh-list
19967926|NCT01751087|Micronutrients|micronutrients|mesh-ancestor
19967927|NCT01751087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967928|NCT01751087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19967929|NCT01751087|Abortifacient Agents|abortifacient agents|mesh-ancestor
19967930|NCT01751087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19967931|NCT01751087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19967932|NCT01751087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19967933|NCT01751087|Oxytocics|oxytocics|mesh-ancestor
19967934|NCT01751087|Vitamin B Complex|vitamin b complex|mesh-ancestor
19967935|NCT01751087|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19967936|NCT01751087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19967937|NCT01751087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19967938|NCT01751087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19967939|NCT01751087|Contraceptive Agents|contraceptive agents|mesh-ancestor
19967940|NCT01751087|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19967941|NCT01751087|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19967942|NCT01751087|Hormone Antagonists|hormone antagonists|mesh-ancestor
19967943|NCT01751087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19967944|NCT01751087|Luteolytic Agents|luteolytic agents|mesh-ancestor
19967945|NCT01751087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19967946|NCT01751087|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19967947|NCT01751113|Fluticasone|fluticasone|mesh-list
19967948|NCT01751113|Xhance|xhance|mesh-list
19967949|NCT01751113|Bromides|bromides|mesh-list
19967950|NCT01751113|Tiotropium Bromide|tiotropium bromide|mesh-list
19967951|NCT01751113|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19967952|NCT01751113|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19967953|NCT01751113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19967954|NCT01751113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19967955|NCT01751113|Autonomic Agents|autonomic agents|mesh-ancestor
19967956|NCT01751113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19967957|NCT01751113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967958|NCT01751113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19967959|NCT01751113|Respiratory System Agents|respiratory system agents|mesh-ancestor
19967960|NCT01751113|Dermatologic Agents|dermatologic agents|mesh-ancestor
19967961|NCT01751113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19967962|NCT01751113|Parasympatholytics|parasympatholytics|mesh-ancestor
19967963|NCT01751113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19967964|NCT01751113|Cholinergic Agents|cholinergic agents|mesh-ancestor
19733553|NCT04560751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19733554|NCT04560751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733555|NCT04560751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733556|NCT04560816|Moxifloxacin|moxifloxacin|mesh-list
19733557|NCT04560816|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
19733558|NCT04560816|Choline|choline|mesh-list
19733559|NCT04560816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19733560|NCT04560816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19733561|NCT04560816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19733562|NCT04560816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19733563|NCT04560816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733564|NCT04560816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733565|NCT04560816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733566|NCT04560816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733567|NCT04560816|Lipotropic Agents|lipotropic agents|mesh-ancestor
19967965|NCT01751113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967966|NCT01751113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967967|NCT01751113|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19967968|NCT01751113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19967969|NCT01751113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19967970|NCT01751113|Adrenergic Agents|adrenergic agents|mesh-ancestor
19967971|NCT01751113|Anticonvulsants|anticonvulsants|mesh-ancestor
19967972|NCT01751113|Glucocorticoids|glucocorticoids|mesh-ancestor
19967973|NCT01751113|Hormones|hormones|mesh-ancestor
19967974|NCT01751113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19967975|NCT01751113|Sympathomimetics|sympathomimetics|mesh-ancestor
19967976|NCT01751178|Ethanol|ethanol|mesh-list
19967977|NCT01751178|Chlorhexidine|chlorhexidine|mesh-list
19967978|NCT01751178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19967979|NCT01751178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19967980|NCT01751178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19967981|NCT01751178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19967982|NCT01751178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967983|NCT01751178|Disinfectants|disinfectants|mesh-ancestor
19967984|NCT01751178|Dermatologic Agents|dermatologic agents|mesh-ancestor
19975242|NCT01846624|Azacitidine|azacitidine|mesh-list
19975243|NCT01846624|Midostaurin|midostaurin|mesh-list
19975244|NCT01846624|Staurosporine|staurosporine|mesh-list
19975245|NCT01846624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19975246|NCT01846624|Antimetabolites|antimetabolites|mesh-ancestor
19975247|NCT01846624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975248|NCT01846624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975249|NCT01846624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19975250|NCT01846624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19975251|NCT01846728|Estrogens|estrogens|mesh-list
19975252|NCT01846728|Hormones|hormones|mesh-ancestor
19975253|NCT01846728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19975254|NCT01846728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975255|NCT01847001|Paclitaxel|paclitaxel|mesh-list
19975256|NCT01847001|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19975257|NCT01847001|Cyclophosphamide|cyclophosphamide|mesh-list
19975258|NCT01847001|Doxorubicin|doxorubicin|mesh-list
19975259|NCT01847001|Trastuzumab|trastuzumab|mesh-list
19975260|NCT01847001|Pertuzumab|pertuzumab|mesh-list
19975261|NCT01847001|Propranolol|propranolol|mesh-list
19967985|NCT01751386|Baclofen|baclofen|mesh-list
19967986|NCT01751386|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19967987|NCT01751386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733568|NCT04560816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19733569|NCT04560816|Antimetabolites|antimetabolites|mesh-ancestor
19733570|NCT04560816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19733571|NCT04560816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19733572|NCT04560816|Nootropic Agents|nootropic agents|mesh-ancestor
19733573|NCT04560816|Chelating Agents|chelating agents|mesh-ancestor
19733574|NCT04560816|Sequestering Agents|sequestering agents|mesh-ancestor
19733575|NCT04560816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19450437|NCT03428425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19450438|NCT03428425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450439|NCT03428425|Tubulin Modulators|tubulin modulators|mesh-ancestor
19450440|NCT03428425|Antimitotic Agents|antimitotic agents|mesh-ancestor
19967988|NCT01751386|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19967989|NCT01751386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19967990|NCT01751386|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19967991|NCT01751386|GABA Agonists|gaba agonists|mesh-ancestor
19967992|NCT01751386|GABA Agents|gaba agents|mesh-ancestor
19733576|NCT04560816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19733577|NCT04560816|Growth Substances|growth substances|mesh-ancestor
19733578|NCT04560816|Growth Inhibitors|growth inhibitors|mesh-ancestor
19733579|NCT04560569|Antibodies|antibodies|mesh-list
19733580|NCT04560569|Immunologic Factors|immunologic factors|mesh-ancestor
19733581|NCT04560569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19967993|NCT01751386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19967994|NCT01751386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967995|NCT01751451|Abiraterone Acetate|abiraterone acetate|mesh-list
19450441|NCT03428425|Mitosis Modulators|mitosis modulators|mesh-ancestor
19450442|NCT03428425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19967996|NCT01751451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19967997|NCT01751451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19450443|NCT03428425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19450444|NCT03428425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19450445|NCT03428373|Aspirin|aspirin|mesh-list
19450446|NCT03428373|Rivaroxaban|rivaroxaban|mesh-list
19450447|NCT03428373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19450448|NCT03428373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19967998|NCT01751451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19967999|NCT01751451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968000|NCT01751451|Hormone Antagonists|hormone antagonists|mesh-ancestor
19968001|NCT01751451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19968002|NCT01751451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968003|NCT01751451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19968004|NCT01751568|Raltegravir Potassium|raltegravir potassium|mesh-list
19968005|NCT01751568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19968006|NCT01751568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19968007|NCT01751568|Antiviral Agents|antiviral agents|mesh-ancestor
19968008|NCT01751568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19968009|NCT01751568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19968010|NCT01751568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19968011|NCT01751568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968012|NCT01751568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968013|NCT01751646|Vitamin D|vitamin d|mesh-list
19968014|NCT01751646|Ergocalciferols|ergocalciferols|mesh-list
19968015|NCT01751646|Cholecalciferol|cholecalciferol|mesh-list
19968016|NCT01751646|Vitamins|vitamins|mesh-list
19968017|NCT01751646|Micronutrients|micronutrients|mesh-ancestor
19968018|NCT01751646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968019|NCT01751646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19968020|NCT01751646|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19968021|NCT01751724|Caffeine|caffeine|mesh-list
20553197|NCT01927679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553198|NCT01927679|Protective Agents|protective agents|mesh-ancestor
20553199|NCT01927835|Vaccines|vaccines|mesh-list
20553200|NCT01927835|Immunologic Factors|immunologic factors|mesh-ancestor
20553201|NCT01927835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553202|NCT01927874|Bupivacaine|bupivacaine|mesh-list
20553203|NCT01927874|Anesthetics, Local|anesthetics, local|mesh-ancestor
20553204|NCT01927874|Anesthetics|anesthetics|mesh-ancestor
20553205|NCT01927874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20553206|NCT01927874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553207|NCT01927874|Sensory System Agents|sensory system agents|mesh-ancestor
20553208|NCT01927874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20553209|NCT01927913|Deferasirox|deferasirox|mesh-list
20553210|NCT01927913|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20553211|NCT01927913|Chelating Agents|chelating agents|mesh-ancestor
20553212|NCT01927913|Sequestering Agents|sequestering agents|mesh-ancestor
20553213|NCT01927913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968022|NCT01751724|Caffeine citrate|caffeine citrate|mesh-list
19968023|NCT01751724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968024|NCT01751724|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19968025|NCT01751724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968026|NCT01751724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20553214|NCT01927965|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
19968027|NCT01751724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968028|NCT01751724|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19968029|NCT01751724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19968030|NCT01751724|Purinergic Agents|purinergic agents|mesh-ancestor
19968031|NCT01751724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19968032|NCT01751802|Ecopipam|ecopipam|mesh-list
19968033|NCT01751802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19968034|NCT01751802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19968035|NCT01751802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19968036|NCT01751802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968037|NCT01751802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19968038|NCT01751802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19968039|NCT01751802|Dopamine Agents|dopamine agents|mesh-ancestor
19968040|NCT01751802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19968041|NCT01751802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968042|NCT01751867|Decitabine|decitabine|mesh-list
19968043|NCT01751867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19968044|NCT01751867|Antimetabolites|antimetabolites|mesh-ancestor
19968045|NCT01751867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968046|NCT01751867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968047|NCT01751867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968048|NCT01752413|Ferrous gluconate|ferrous gluconate|mesh-list
19968049|NCT01752413|Hematinics|hematinics|mesh-ancestor
19968050|NCT01752426|Deuterium Oxide|deuterium oxide|mesh-list
19968051|NCT01752426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968052|NCT01752426|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19968053|NCT01752426|Protective Agents|protective agents|mesh-ancestor
19968054|NCT01752426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968055|NCT01752712|Oxytocin|oxytocin|mesh-list
19968056|NCT01752712|Oxytocics|oxytocics|mesh-ancestor
19968057|NCT01752712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19968058|NCT01752712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968059|NCT01752842|Fenofibrate|fenofibrate|mesh-list
19968060|NCT01752842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19968061|NCT01752842|Antimetabolites|antimetabolites|mesh-ancestor
19968062|NCT01752842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968063|NCT01752842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19968064|NCT01752855|Adalimumab|adalimumab|mesh-list
19968065|NCT01752855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19968066|NCT01752855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19968067|NCT01752933|Guadecitabine|guadecitabine|mesh-list
19968068|NCT01752933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968069|NCT01753115|Ciprofloxacin|ciprofloxacin|mesh-list
19968070|NCT01753115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19968071|NCT01753115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19968072|NCT01753115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19968073|NCT01753115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19968074|NCT01753115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968075|NCT01753115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968076|NCT01753115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968077|NCT01753115|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19968078|NCT01753115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19968079|NCT01753297|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19968080|NCT01753297|Luteolytic Agents|luteolytic agents|mesh-ancestor
19968081|NCT01753297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19968082|NCT01753297|Contraceptive Agents|contraceptive agents|mesh-ancestor
19968083|NCT01753297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19968084|NCT01753297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968085|NCT01753297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19968086|NCT01753297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19968087|NCT01753297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968088|NCT01753310|Botulinum Toxins|botulinum toxins|mesh-list
19968089|NCT01753310|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19968090|NCT01753310|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19968091|NCT01753310|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19968092|NCT01753310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19968093|NCT01753310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968094|NCT01753310|Cholinergic Agents|cholinergic agents|mesh-ancestor
19968095|NCT01753310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19968096|NCT01753310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968097|NCT01753310|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19968098|NCT01753310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19968099|NCT01753336|Botulinum Toxins|botulinum toxins|mesh-list
19968100|NCT01753336|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19968101|NCT01753336|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19968102|NCT01753336|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19968103|NCT01753336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19968104|NCT01753336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968105|NCT01753336|Cholinergic Agents|cholinergic agents|mesh-ancestor
19968106|NCT01753336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19968107|NCT01753336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968108|NCT01753336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19968109|NCT01753336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19968110|NCT01753362|Liraglutide|liraglutide|mesh-list
19968111|NCT01753362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19968112|NCT01753362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968113|NCT01753362|Incretins|incretins|mesh-ancestor
19968114|NCT01753362|Hormones|hormones|mesh-ancestor
19968115|NCT01753362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19968116|NCT01753401|Prednisone|prednisone|mesh-list
19968117|NCT01753401|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19968118|NCT01753401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19968119|NCT01753401|Glucocorticoids|glucocorticoids|mesh-ancestor
19968120|NCT01753401|Hormones|hormones|mesh-ancestor
19968121|NCT01753401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19968122|NCT01753401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968123|NCT01753401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19968124|NCT01753401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968125|NCT01753557|Interferon alpha-2|interferon alpha-2|mesh-list
19968126|NCT01753557|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19968127|NCT01753557|Antiviral Agents|antiviral agents|mesh-ancestor
19968128|NCT01753557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19968129|NCT01753557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968130|NCT01753570|Interferon-beta|interferon-beta|mesh-list
19968131|NCT01753570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968132|NCT01753570|Antiviral Agents|antiviral agents|mesh-ancestor
19968133|NCT01753570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19968134|NCT01753570|Immunologic Factors|immunologic factors|mesh-ancestor
19968135|NCT01753570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968136|NCT01753739|Bepotastine besilate|bepotastine besilate|mesh-list
19968137|NCT01753739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19968138|NCT01753856|Vitamin D|vitamin d|mesh-list
19968139|NCT01753856|Denosumab|denosumab|mesh-list
19968140|NCT01753856|Teriparatide|teriparatide|mesh-list
19968141|NCT01753856|Tetracycline|tetracycline|mesh-list
19968142|NCT01753856|Demeclocycline|demeclocycline|mesh-list
19968143|NCT01753856|Calcium|calcium|mesh-list
19968144|NCT01753856|Vitamins|vitamins|mesh-ancestor
19968145|NCT01753856|Micronutrients|micronutrients|mesh-ancestor
19968146|NCT01753856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968147|NCT01753856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19968148|NCT01753856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19968149|NCT01753856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19968150|NCT01753856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19968151|NCT01753856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19968152|NCT01753856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968153|NCT01753856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968154|NCT01754259|Ranolazine|ranolazine|mesh-list
19968155|NCT01754259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19968156|NCT01754259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19968157|NCT01754259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968158|NCT01754376|Aldesleukin|aldesleukin|mesh-list
19968159|NCT01754376|Interleukin-2|interleukin-2|mesh-list
19968160|NCT01754376|Vemurafenib|vemurafenib|mesh-list
19968161|NCT01754376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968162|NCT01754376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19968163|NCT01754376|Analgesics|analgesics|mesh-ancestor
19968164|NCT01754376|Sensory System Agents|sensory system agents|mesh-ancestor
19968165|NCT01754376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19968166|NCT01754376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968167|NCT01754376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19968168|NCT01754376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19968169|NCT01754376|Antiviral Agents|antiviral agents|mesh-ancestor
19968170|NCT01754376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19968171|NCT01754376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19968172|NCT01754376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968173|NCT01754376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968174|NCT01754389|Sirolimus|sirolimus|mesh-list
19968175|NCT01754389|Methotrexate|methotrexate|mesh-list
19968176|NCT01754389|Bortezomib|bortezomib|mesh-list
19968177|NCT01754389|Tacrolimus|tacrolimus|mesh-list
19968178|NCT01754389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19968179|NCT01754389|Abortifacient Agents|abortifacient agents|mesh-ancestor
19968180|NCT01754389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19968181|NCT01754389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968182|NCT01754389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19968183|NCT01754389|Antimetabolites|antimetabolites|mesh-ancestor
19968184|NCT01754389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968185|NCT01754389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968186|NCT01754389|Dermatologic Agents|dermatologic agents|mesh-ancestor
19968187|NCT01754389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968188|NCT01754389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19968189|NCT01754389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19968190|NCT01754389|Immunologic Factors|immunologic factors|mesh-ancestor
19968191|NCT01754389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19968192|NCT01754389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19968193|NCT01754389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19968194|NCT01754389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19968195|NCT01754389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19968196|NCT01754389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19968197|NCT01754389|Antifungal Agents|antifungal agents|mesh-ancestor
19968198|NCT01754402|Dexamethasone|dexamethasone|mesh-list
19968199|NCT01754402|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19968200|NCT01754402|Pomalidomide|pomalidomide|mesh-list
19968201|NCT01754402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19968202|NCT01754402|Antiemetics|antiemetics|mesh-ancestor
19968203|NCT01754402|Autonomic Agents|autonomic agents|mesh-ancestor
19968204|NCT01754402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19968205|NCT01754402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968206|NCT01754402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19968207|NCT01754402|Glucocorticoids|glucocorticoids|mesh-ancestor
19968208|NCT01754402|Hormones|hormones|mesh-ancestor
19968209|NCT01754402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19968210|NCT01754402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19968211|NCT01754402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968212|NCT01754402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19968213|NCT01754402|Alkylating Agents|alkylating agents|mesh-ancestor
19968214|NCT01754402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968215|NCT01754402|Immunologic Factors|immunologic factors|mesh-ancestor
19968216|NCT01754402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19968217|NCT01754402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19968218|NCT01754402|Growth Substances|growth substances|mesh-ancestor
19968219|NCT01754402|Growth Inhibitors|growth inhibitors|mesh-ancestor
19968220|NCT01754480|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19968221|NCT01754480|Hemostatics|hemostatics|mesh-ancestor
19968222|NCT01754480|Coagulants|coagulants|mesh-ancestor
19968223|NCT01754493|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19968224|NCT01754493|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19968225|NCT01754493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19968226|NCT01754493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19968227|NCT01754493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733582|NCT04560426|Parathyroid Hormone|parathyroid hormone|mesh-list
19733583|NCT04560426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20553215|NCT01927965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20553216|NCT01927965|Alkylating Agents|alkylating agents|mesh-ancestor
20553217|NCT01927965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553218|NCT01927965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553219|NCT01928043|Curcumin|curcumin|mesh-list
20553220|NCT01928043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19968228|NCT01754493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19968229|NCT01754493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968230|NCT01754493|Analgesics|analgesics|mesh-ancestor
19968231|NCT01754493|Sensory System Agents|sensory system agents|mesh-ancestor
19968232|NCT01754493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733584|NCT04560426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733585|NCT04560673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19733586|NCT04560673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19733587|NCT04560673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19733588|NCT04560673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19733589|NCT04560673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733590|NCT04560673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19968233|NCT01754493|Antidepressive Agents|antidepressive agents|mesh-ancestor
19968234|NCT01754493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19968235|NCT01754493|Dopamine Agents|dopamine agents|mesh-ancestor
19968236|NCT01754623|Gemcitabine|gemcitabine|mesh-list
19968237|NCT01754623|Fluorouracil|fluorouracil|mesh-list
19968238|NCT01754623|Capecitabine|capecitabine|mesh-list
19968239|NCT01754623|Docetaxel|docetaxel|mesh-list
19968240|NCT01754623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19968241|NCT01754623|Antimetabolites|antimetabolites|mesh-ancestor
20553221|NCT01928043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20553222|NCT01928043|Analgesics|analgesics|mesh-ancestor
20553223|NCT01928043|Sensory System Agents|sensory system agents|mesh-ancestor
20553224|NCT01928043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20553225|NCT01928043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553226|NCT01928043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20553227|NCT01928043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20553228|NCT01928043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553229|NCT01928043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20553230|NCT01928043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553231|NCT01928056|Montelukast|montelukast|mesh-list
20553232|NCT01928056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19733591|NCT04560673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733592|NCT04560673|Analgesics|analgesics|mesh-ancestor
19733593|NCT04560673|Sensory System Agents|sensory system agents|mesh-ancestor
19733594|NCT04560673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19733595|NCT04560673|Antidepressive Agents|antidepressive agents|mesh-ancestor
19733596|NCT04560673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19733597|NCT04560673|Dopamine Agents|dopamine agents|mesh-ancestor
19968242|NCT01754623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968243|NCT01754623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968244|NCT01754623|Antiviral Agents|antiviral agents|mesh-ancestor
19968245|NCT01754623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19968246|NCT01754623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968247|NCT01754623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19968248|NCT01754623|Immunologic Factors|immunologic factors|mesh-ancestor
19968249|NCT01754623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968250|NCT01754623|Tubulin Modulators|tubulin modulators|mesh-ancestor
19968251|NCT01754623|Antimitotic Agents|antimitotic agents|mesh-ancestor
19968252|NCT01754623|Mitosis Modulators|mitosis modulators|mesh-ancestor
19968253|NCT01754909|Enalapril|enalapril|mesh-list
19968254|NCT01754909|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19968255|NCT01754909|Protease Inhibitors|protease inhibitors|mesh-ancestor
19968256|NCT01754909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968257|NCT01754909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968258|NCT01754909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19968259|NCT01755026|Cefazolin|cefazolin|mesh-list
19968260|NCT01755026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19968261|NCT01755026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19968262|NCT01755091|Dronabinol|dronabinol|mesh-list
19968263|NCT01755091|Hallucinogens|hallucinogens|mesh-ancestor
19733598|NCT04559880|Tranexamic Acid|tranexamic acid|mesh-list
19968264|NCT01755091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968265|NCT01755091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19968266|NCT01755091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19968267|NCT01755091|Analgesics|analgesics|mesh-ancestor
19968268|NCT01755091|Sensory System Agents|sensory system agents|mesh-ancestor
19968269|NCT01755091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19968270|NCT01755091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19968271|NCT01755091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19968272|NCT01755091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19968273|NCT01755091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968274|NCT01755091|Hormones|hormones|mesh-ancestor
19968275|NCT01755091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19968276|NCT01755156|Metformin|metformin|mesh-list
19968277|NCT01755156|Insulin Glargine|insulin glargine|mesh-list
19968278|NCT01755156|Glimepiride|glimepiride|mesh-list
19968279|NCT01755156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19968280|NCT01755156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968281|NCT01755156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19968282|NCT01755156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19968283|NCT01755156|Immunologic Factors|immunologic factors|mesh-ancestor
19968284|NCT01755169|Ketamine|ketamine|mesh-list
19968285|NCT01755169|Analgesics|analgesics|mesh-ancestor
19968286|NCT01755169|Sensory System Agents|sensory system agents|mesh-ancestor
19968287|NCT01755169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19968288|NCT01755169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968289|NCT01755169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19968290|NCT01755169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19968291|NCT01755169|Anesthetics, General|anesthetics, general|mesh-ancestor
19968292|NCT01755169|Anesthetics|anesthetics|mesh-ancestor
19968293|NCT01755169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19968294|NCT01755169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19968295|NCT01755169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19968296|NCT01755169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19968297|NCT01755169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968298|NCT01755234|Propofol|propofol|mesh-list
19968299|NCT01755234|Sevoflurane|sevoflurane|mesh-list
19968300|NCT01755234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19968301|NCT01755234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19968302|NCT01755234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968303|NCT01755234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19968304|NCT01755234|Anesthetics, General|anesthetics, general|mesh-ancestor
19968305|NCT01755234|Anesthetics|anesthetics|mesh-ancestor
19968306|NCT01755234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19968307|NCT01755234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19968308|NCT01755416|Insulin|insulin|mesh-list
19968309|NCT01755416|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19968310|NCT01755416|Liraglutide|liraglutide|mesh-list
19968311|NCT01755416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19968312|NCT01755416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968313|NCT01755416|Incretins|incretins|mesh-ancestor
19968314|NCT01755416|Hormones|hormones|mesh-ancestor
19968315|NCT01755416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19968316|NCT01755546|Buprenorphine|buprenorphine|mesh-list
19968317|NCT01755546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19968318|NCT01755546|Narcotics|narcotics|mesh-ancestor
19968319|NCT01755546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19968320|NCT01755546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450449|NCT03428373|Analgesics|analgesics|mesh-ancestor
19450450|NCT03428373|Sensory System Agents|sensory system agents|mesh-ancestor
19968321|NCT01755546|Analgesics|analgesics|mesh-ancestor
19968322|NCT01755546|Sensory System Agents|sensory system agents|mesh-ancestor
19968323|NCT01755546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19968324|NCT01755546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19968325|NCT01755637|Albendazole|albendazole|mesh-list
19968326|NCT01755637|Anthelmintics|anthelmintics|mesh-ancestor
19968327|NCT01755637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19450451|NCT03428373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450452|NCT03428373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968328|NCT01755637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19968329|NCT01755637|Anticestodal Agents|anticestodal agents|mesh-ancestor
19450453|NCT03428373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19450454|NCT03428373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19450455|NCT03428373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19450456|NCT03428373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19450457|NCT03428373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450458|NCT03428373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19450459|NCT03428373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19450460|NCT03428373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19450461|NCT03428373|Antipyretics|antipyretics|mesh-ancestor
19968330|NCT01755637|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19968331|NCT01755637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19735789|NCT04536493|Anesthetics, Local|anesthetics, local|mesh-ancestor
19968332|NCT01755637|Tubulin Modulators|tubulin modulators|mesh-ancestor
19968333|NCT01755637|Antimitotic Agents|antimitotic agents|mesh-ancestor
19968334|NCT01755637|Mitosis Modulators|mitosis modulators|mesh-ancestor
19968335|NCT01755637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968336|NCT01755637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968337|NCT01755702|Acetaminophen|acetaminophen|mesh-list
19968338|NCT01755702|Ibuprofen|ibuprofen|mesh-list
19968339|NCT01755702|Caffeine|caffeine|mesh-list
19968340|NCT01755702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19968341|NCT01755702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19968342|NCT01755702|Analgesics|analgesics|mesh-ancestor
19968343|NCT01755702|Sensory System Agents|sensory system agents|mesh-ancestor
19968344|NCT01755702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19968345|NCT01755702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968346|NCT01755702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19968347|NCT01755702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19968348|NCT01755702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19968349|NCT01755702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968350|NCT01755702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968351|NCT01755702|Antipyretics|antipyretics|mesh-ancestor
19735790|NCT04536493|Anesthetics|anesthetics|mesh-ancestor
19735791|NCT04536493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19735792|NCT04536493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19735793|NCT04536493|Sensory System Agents|sensory system agents|mesh-ancestor
19735794|NCT04536493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19735795|NCT04536493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19735796|NCT04536493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19735797|NCT04536493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19735798|NCT04536493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19735799|NCT04536493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19735800|NCT04536493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19735801|NCT04536493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19735802|NCT04536493|Adrenergic Agents|adrenergic agents|mesh-ancestor
19735803|NCT04536493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19968352|NCT01755702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19968353|NCT01755702|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19968354|NCT01755702|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19968355|NCT01755702|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19968356|NCT01755702|Purinergic Agents|purinergic agents|mesh-ancestor
19968357|NCT01755702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19968358|NCT01755949|Colchicine|colchicine|mesh-list
19968359|NCT01755949|Gout Suppressants|gout suppressants|mesh-ancestor
19968360|NCT01755949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19968361|NCT01755949|Tubulin Modulators|tubulin modulators|mesh-ancestor
19968362|NCT01755949|Antimitotic Agents|antimitotic agents|mesh-ancestor
19968363|NCT01755949|Mitosis Modulators|mitosis modulators|mesh-ancestor
19968364|NCT01755949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968365|NCT01755949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968366|NCT01756079|Ribavirin|ribavirin|mesh-list
19968367|NCT01756079|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19968368|NCT01756079|Antimetabolites|antimetabolites|mesh-ancestor
19968369|NCT01756079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968370|NCT01756079|Antiviral Agents|antiviral agents|mesh-ancestor
19968371|NCT01756079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19968372|NCT01756157|Complement C1s|complement c1s|mesh-list
19968373|NCT01756157|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19968374|NCT01756157|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
19968375|NCT01756157|Immunologic Factors|immunologic factors|mesh-ancestor
19968376|NCT01756157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968377|NCT01756157|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19968378|NCT01756157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19968379|NCT01756209|Acetaminophen|acetaminophen|mesh-list
19968380|NCT01756209|Ibuprofen|ibuprofen|mesh-list
19968381|NCT01756209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19968382|NCT01756209|Analgesics|analgesics|mesh-ancestor
19968383|NCT01756209|Sensory System Agents|sensory system agents|mesh-ancestor
19968384|NCT01756209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19968385|NCT01756209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968386|NCT01756209|Antipyretics|antipyretics|mesh-ancestor
19968387|NCT01756209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19968388|NCT01756209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19968389|NCT01756209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19968390|NCT01756209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19968391|NCT01756209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968392|NCT01756209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968393|NCT01756456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19968394|NCT01756456|Mitogens|mitogens|mesh-list
19968395|NCT01756456|Mitosis Modulators|mitosis modulators|mesh-ancestor
19968396|NCT01756456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968397|NCT01756833|Doxycycline|doxycycline|mesh-list
19968398|NCT01756833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19968399|NCT01756833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19968400|NCT01756833|Antimalarials|antimalarials|mesh-ancestor
19968401|NCT01756833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19968402|NCT01756833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19968403|NCT01756885|Varenicline|varenicline|mesh-list
19968404|NCT01756885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19968405|NCT01756885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19968406|NCT01756885|Cholinergic Agents|cholinergic agents|mesh-ancestor
19968407|NCT01756885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19968408|NCT01756885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968409|NCT01756885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968410|NCT01757275|Esomeprazole|esomeprazole|mesh-list
19968411|NCT01757275|Cimetidine|cimetidine|mesh-list
19968412|NCT01757275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19968413|NCT01757275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19968414|NCT01757275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19968415|NCT01757275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968416|NCT01757275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968417|NCT01757275|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19968418|NCT01757275|Histamine Antagonists|histamine antagonists|mesh-ancestor
19968419|NCT01757275|Histamine Agents|histamine agents|mesh-ancestor
19968420|NCT01757275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19968421|NCT01757275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553233|NCT01928056|Respiratory System Agents|respiratory system agents|mesh-ancestor
20553234|NCT01928056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20553235|NCT01928056|Hormone Antagonists|hormone antagonists|mesh-ancestor
20553236|NCT01928056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20553237|NCT01928056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553238|NCT01928056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20553239|NCT01928056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20553240|NCT01928056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553241|NCT01928069|Montelukast|montelukast|mesh-list
20553242|NCT01928069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20553243|NCT01928069|Respiratory System Agents|respiratory system agents|mesh-ancestor
20553244|NCT01928069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20553245|NCT01928069|Hormone Antagonists|hormone antagonists|mesh-ancestor
20553246|NCT01928069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20553247|NCT01928069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553248|NCT01928069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20553249|NCT01928069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20553250|NCT01928069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553251|NCT01928134|Calcium Carbonate|calcium carbonate|mesh-list
20553252|NCT01928134|Calcium|calcium|mesh-list
20553253|NCT01928134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20553254|NCT01928134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20553255|NCT01928134|Antacids|antacids|mesh-ancestor
20553256|NCT01928134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553257|NCT01928134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19968422|NCT01757275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19968423|NCT01757275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19968424|NCT01757288|Paclitaxel|paclitaxel|mesh-list
19968425|NCT01757288|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19968426|NCT01757288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19968427|NCT01757288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968428|NCT01757288|Tubulin Modulators|tubulin modulators|mesh-ancestor
19968429|NCT01757288|Antimitotic Agents|antimitotic agents|mesh-ancestor
19968430|NCT01757288|Mitosis Modulators|mitosis modulators|mesh-ancestor
19968431|NCT01757288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968432|NCT01757561|Propofol|propofol|mesh-list
19968433|NCT01757561|Sevoflurane|sevoflurane|mesh-list
19968434|NCT01757561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19968435|NCT01757561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19968436|NCT01757561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968437|NCT01757561|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19968438|NCT01757561|Anesthetics, General|anesthetics, general|mesh-ancestor
19968439|NCT01757561|Anesthetics|anesthetics|mesh-ancestor
19968440|NCT01757561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19968441|NCT01757561|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19975262|NCT01847001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19975263|NCT01847001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975264|NCT01847001|Tubulin Modulators|tubulin modulators|mesh-ancestor
19975265|NCT01847001|Antimitotic Agents|antimitotic agents|mesh-ancestor
19975266|NCT01847001|Mitosis Modulators|mitosis modulators|mesh-ancestor
19975267|NCT01847001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975268|NCT01847001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20553258|NCT01928160|Carboplatin|carboplatin|mesh-list
20553259|NCT01928160|Pemetrexed|pemetrexed|mesh-list
20553260|NCT01928160|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20553261|NCT01928160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20553262|NCT01928160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19975269|NCT01847001|Immunologic Factors|immunologic factors|mesh-ancestor
19975270|NCT01847001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975271|NCT01847001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19975272|NCT01847001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19975273|NCT01847001|Alkylating Agents|alkylating agents|mesh-ancestor
19975274|NCT01847001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19975275|NCT01847001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19975276|NCT01847001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19975277|NCT01847001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19975278|NCT01847001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19975279|NCT01847001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19975280|NCT01847001|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19975281|NCT01847001|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19975282|NCT01847001|Adrenergic Agents|adrenergic agents|mesh-ancestor
19975283|NCT01847001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975284|NCT01847001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19975285|NCT01847001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19975286|NCT01847001|Vasodilator Agents|vasodilator agents|mesh-ancestor
19975287|NCT01847014|Macitentan|macitentan|mesh-list
19975288|NCT01847014|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19975289|NCT01847014|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19975290|NCT01847014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975291|NCT01847014|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
20553263|NCT01928160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20553264|NCT01928160|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20553265|NCT01928160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20553266|NCT01928160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20553267|NCT01928316|Mizolastine|mizolastine|mesh-list
20553268|NCT01928316|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20553269|NCT01928316|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20553270|NCT01928316|Histamine Antagonists|histamine antagonists|mesh-ancestor
19968442|NCT01757691|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19968443|NCT01757691|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19968444|NCT01757691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968445|NCT01757691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19968446|NCT01757691|Immunologic Factors|immunologic factors|mesh-ancestor
19968447|NCT01757691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968448|NCT01758432|Apixaban|apixaban|mesh-list
19968449|NCT01758432|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19968450|NCT01758432|Antithrombins|antithrombins|mesh-ancestor
19968451|NCT01758432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19968452|NCT01758432|Protease Inhibitors|protease inhibitors|mesh-ancestor
19968453|NCT01758432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968454|NCT01758432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968455|NCT01758432|Anticoagulants|anticoagulants|mesh-ancestor
19968456|NCT01758523|Dutasteride|dutasteride|mesh-list
19968457|NCT01758523|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19968458|NCT01758523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19968459|NCT01758523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968460|NCT01758523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968461|NCT01758523|Hormone Antagonists|hormone antagonists|mesh-ancestor
19968462|NCT01758523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19968463|NCT01758523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968464|NCT01758588|Interferons|interferons|mesh-list
19968465|NCT01758588|Interferon-alpha|interferon-alpha|mesh-list
19968466|NCT01758588|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19968467|NCT01758588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286469|NCT03539952|Penicillamine|penicillamine|mesh-list
20286470|NCT03539952|Trientine|trientine|mesh-list
20286471|NCT03539952|Chelating Agents|chelating agents|mesh-ancestor
20286472|NCT03539952|Sequestering Agents|sequestering agents|mesh-ancestor
20286473|NCT03539952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20286474|NCT03539952|Antidotes|antidotes|mesh-ancestor
20286475|NCT03539952|Protective Agents|protective agents|mesh-ancestor
20286476|NCT03539952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286477|NCT03539952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20286478|NCT03513562|Venetoclax|venetoclax|mesh-list
19968468|NCT01758588|Antiviral Agents|antiviral agents|mesh-ancestor
19968469|NCT01758588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19968470|NCT01758588|Immunologic Factors|immunologic factors|mesh-ancestor
19968471|NCT01758588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968472|NCT01758731|Cetuximab|cetuximab|mesh-list
19968473|NCT01758731|Olaparib|olaparib|mesh-list
19968474|NCT01758731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19968475|NCT01758731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968476|NCT01758731|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19968477|NCT01758731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968478|NCT01758731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968479|NCT01759277|Anesthetics|anesthetics|mesh-list
19968480|NCT01759277|Anesthetics, Local|anesthetics, local|mesh-list
19968481|NCT01759277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19968482|NCT01759277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968483|NCT01759277|Sensory System Agents|sensory system agents|mesh-ancestor
19968484|NCT01759277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19968485|NCT01759407|Epinephrine|epinephrine|mesh-list
19968486|NCT01759407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19968487|NCT01759407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19968488|NCT01759407|Adrenergic Agents|adrenergic agents|mesh-ancestor
19968489|NCT01759407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19968490|NCT01759407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968491|NCT01759407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968492|NCT01759407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19968493|NCT01759407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19968494|NCT01759407|Autonomic Agents|autonomic agents|mesh-ancestor
19968495|NCT01759407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19968496|NCT01759407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19968497|NCT01759407|Respiratory System Agents|respiratory system agents|mesh-ancestor
19968498|NCT01759407|Mydriatics|mydriatics|mesh-ancestor
19968499|NCT01759407|Sympathomimetics|sympathomimetics|mesh-ancestor
19968500|NCT01759407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19968501|NCT01759420|Ondansetron|ondansetron|mesh-list
19968502|NCT01759420|Antiemetics|antiemetics|mesh-ancestor
19968503|NCT01759420|Autonomic Agents|autonomic agents|mesh-ancestor
19968504|NCT01759420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19968505|NCT01759420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968506|NCT01759420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19968507|NCT01759420|Antipruritics|antipruritics|mesh-ancestor
19968508|NCT01759420|Dermatologic Agents|dermatologic agents|mesh-ancestor
19968509|NCT01759420|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19968510|NCT01759420|Serotonin Agents|serotonin agents|mesh-ancestor
19968511|NCT01759420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19968512|NCT01759420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968513|NCT01759420|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19968514|NCT01759420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19968515|NCT01759420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19968516|NCT01759420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19968517|NCT01759420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19968518|NCT01759602|Complement C1s|complement c1s|mesh-list
19968519|NCT01759602|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19968520|NCT01759602|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
20286479|NCT03513562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286480|NCT03454451|Pembrolizumab|pembrolizumab|mesh-list
20286481|NCT03454451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20286482|NCT03454451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20286483|NCT03441893|Nitazoxanide|nitazoxanide|mesh-list
20286484|NCT03441893|Mesalamine|mesalamine|mesh-list
20286485|NCT03441893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19968521|NCT01759602|Immunologic Factors|immunologic factors|mesh-ancestor
19968522|NCT01759602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968523|NCT01759602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19968524|NCT01759602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20286486|NCT03441893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20286487|NCT03441893|Analgesics|analgesics|mesh-ancestor
19968525|NCT01759862|Aminophylline|aminophylline|mesh-list
19968526|NCT01759862|Theophylline|theophylline|mesh-list
19968527|NCT01759862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19968528|NCT01759862|Autonomic Agents|autonomic agents|mesh-ancestor
19968529|NCT01759862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19968530|NCT01759862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968531|NCT01759862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19968532|NCT01759862|Respiratory System Agents|respiratory system agents|mesh-ancestor
19968533|NCT01759862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19968534|NCT01759862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968535|NCT01759862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968536|NCT01759862|Vasodilator Agents|vasodilator agents|mesh-ancestor
19968537|NCT01759862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20286488|NCT03441893|Sensory System Agents|sensory system agents|mesh-ancestor
20286489|NCT03441893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20286490|NCT03441893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20286491|NCT03441893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19968538|NCT01759862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19968539|NCT01759862|Purinergic Agents|purinergic agents|mesh-ancestor
19968540|NCT01759862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19968541|NCT01759862|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19968542|NCT01759862|Protective Agents|protective agents|mesh-ancestor
19968543|NCT01760304|Budesonide|budesonide|mesh-list
19968544|NCT01760304|Formoterol Fumarate|formoterol fumarate|mesh-list
19968545|NCT01760304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19968546|NCT01760304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19968547|NCT01760304|Autonomic Agents|autonomic agents|mesh-ancestor
19968548|NCT01760304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19968549|NCT01760304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968550|NCT01760304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19968551|NCT01760304|Respiratory System Agents|respiratory system agents|mesh-ancestor
19968552|NCT01760304|Glucocorticoids|glucocorticoids|mesh-ancestor
19968553|NCT01760304|Hormones|hormones|mesh-ancestor
19975292|NCT01847131|Phenylephrine|phenylephrine|mesh-list
19975293|NCT01847131|Oxymetazoline|oxymetazoline|mesh-list
19968554|NCT01760304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19968555|NCT01760304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19968556|NCT01760304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19968557|NCT01760304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19968558|NCT01760304|Adrenergic Agents|adrenergic agents|mesh-ancestor
19968559|NCT01760304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19968560|NCT01760304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968561|NCT01760447|Metformin|metformin|mesh-list
19968562|NCT01760447|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19968563|NCT01760447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19968564|NCT01760447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968565|NCT01760447|Incretins|incretins|mesh-ancestor
19968566|NCT01760447|Hormones|hormones|mesh-ancestor
19968567|NCT01760447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19968568|NCT01760447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19968569|NCT01760447|Protease Inhibitors|protease inhibitors|mesh-ancestor
19968570|NCT01760447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968571|NCT01760447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968572|NCT01760785|Valproic Acid|valproic acid|mesh-list
19968573|NCT01760785|Anticonvulsants|anticonvulsants|mesh-ancestor
19968574|NCT01760785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968575|NCT01760785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968576|NCT01760785|GABA Agents|gaba agents|mesh-ancestor
19968577|NCT01760785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19968578|NCT01760785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968579|NCT01760785|Antimanic Agents|antimanic agents|mesh-ancestor
19968580|NCT01760785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19968581|NCT01760785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19968582|NCT01760785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19968583|NCT01761292|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
19968584|NCT01761292|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19968585|NCT01761292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968586|NCT01761292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968587|NCT01761747|Ponatinib|ponatinib|mesh-list
19968588|NCT01761747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968589|NCT01761747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19968590|NCT01761747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968591|NCT01761747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968592|NCT01762059|Pancrelipase|pancrelipase|mesh-list
19968593|NCT01762059|Pancreatin|pancreatin|mesh-list
19968594|NCT01762059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19968595|NCT01762501|Amlodipine|amlodipine|mesh-list
19968596|NCT01762501|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19968597|NCT01762501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19968598|NCT01762501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19968599|NCT01762501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19968600|NCT01762501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968601|NCT01762501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19968602|NCT01762501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968603|NCT01762501|Vasodilator Agents|vasodilator agents|mesh-ancestor
19968604|NCT01762501|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19968605|NCT01762501|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19968606|NCT01762800|Fluticasone|fluticasone|mesh-list
19968607|NCT01762800|Xhance|xhance|mesh-list
19968608|NCT01762800|Bromides|bromides|mesh-list
19968609|NCT01762800|Tiotropium Bromide|tiotropium bromide|mesh-list
19968610|NCT01762800|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19968611|NCT01762800|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19968612|NCT01762800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19968613|NCT01762800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19968614|NCT01762800|Autonomic Agents|autonomic agents|mesh-ancestor
19968615|NCT01762800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19968616|NCT01762800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968617|NCT01762800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19968618|NCT01762800|Respiratory System Agents|respiratory system agents|mesh-ancestor
19968619|NCT01762800|Dermatologic Agents|dermatologic agents|mesh-ancestor
19968620|NCT01762800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19968621|NCT01762800|Parasympatholytics|parasympatholytics|mesh-ancestor
19968622|NCT01762800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19968623|NCT01762800|Cholinergic Agents|cholinergic agents|mesh-ancestor
19968624|NCT01762800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19968625|NCT01762800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968626|NCT01762800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19968627|NCT01762800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19968628|NCT01762800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19968629|NCT01762800|Adrenergic Agents|adrenergic agents|mesh-ancestor
19968630|NCT01762800|Anticonvulsants|anticonvulsants|mesh-ancestor
19968631|NCT01762800|Glucocorticoids|glucocorticoids|mesh-ancestor
19968632|NCT01762800|Hormones|hormones|mesh-ancestor
19968633|NCT01762800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19968634|NCT01762800|Sympathomimetics|sympathomimetics|mesh-ancestor
19968635|NCT01762904|Ethanol|ethanol|mesh-list
19968636|NCT01762904|Chlorhexidine|chlorhexidine|mesh-list
19968637|NCT01762904|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19968638|NCT01762904|Triclosan|triclosan|mesh-list
19968639|NCT01762904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
19968640|NCT01762904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19968641|NCT01762904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19968642|NCT01762904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968643|NCT01762904|Disinfectants|disinfectants|mesh-ancestor
19968644|NCT01762904|Dermatologic Agents|dermatologic agents|mesh-ancestor
19968645|NCT01762904|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19968646|NCT01762904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19968647|NCT01762904|Antimetabolites|antimetabolites|mesh-ancestor
19968648|NCT01762904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968649|NCT01762904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19968650|NCT01762943|Leuprolide|leuprolide|mesh-list
19968651|NCT01762943|Estradiol|estradiol|mesh-list
19968652|NCT01762943|Progesterone|progesterone|mesh-list
19968653|NCT01762943|Estrogens|estrogens|mesh-ancestor
19968654|NCT01762943|Hormones|hormones|mesh-ancestor
19968655|NCT01762943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19968656|NCT01762943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968657|NCT01762943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19968658|NCT01762943|Progestins|progestins|mesh-ancestor
19968659|NCT01762943|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19968660|NCT01762943|Fertility Agents|fertility agents|mesh-ancestor
19968661|NCT01762943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19968662|NCT01762943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968663|NCT01762982|Benzalkonium Compounds|benzalkonium compounds|mesh-list
19968664|NCT01762982|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19968665|NCT01762982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19968666|NCT01763164|Dacarbazine|dacarbazine|mesh-list
19968667|NCT01763164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19968668|NCT01763164|Alkylating Agents|alkylating agents|mesh-ancestor
19968669|NCT01763164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968670|NCT01763164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968671|NCT01763346|Metformin|metformin|mesh-list
19968672|NCT01763346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19968673|NCT01763346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968674|NCT01763606|Aspirin|aspirin|mesh-list
19968675|NCT01763606|Enoxaparin|enoxaparin|mesh-list
19968676|NCT01763606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19968677|NCT01763606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19968678|NCT01763606|Analgesics|analgesics|mesh-ancestor
19968679|NCT01763606|Sensory System Agents|sensory system agents|mesh-ancestor
19968680|NCT01763606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19968681|NCT01763606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968682|NCT01763606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19968683|NCT01763606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19968684|NCT01763606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19968685|NCT01763606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19968686|NCT01763606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968687|NCT01763606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19968688|NCT01763606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19968689|NCT01763606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968690|NCT01763606|Antipyretics|antipyretics|mesh-ancestor
19968691|NCT01763606|Anticoagulants|anticoagulants|mesh-ancestor
19968692|NCT01763645|Paclitaxel|paclitaxel|mesh-list
19968693|NCT01763645|Bevacizumab|bevacizumab|mesh-list
19968694|NCT01763645|Carboplatin|carboplatin|mesh-list
19968695|NCT01763645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19968696|NCT01763645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968697|NCT01763645|Tubulin Modulators|tubulin modulators|mesh-ancestor
19733599|NCT04559880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19968698|NCT01763645|Antimitotic Agents|antimitotic agents|mesh-ancestor
19968699|NCT01763645|Mitosis Modulators|mitosis modulators|mesh-ancestor
19968700|NCT01763645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968701|NCT01763645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19968702|NCT01763645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19968703|NCT01763645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19968704|NCT01763645|Growth Substances|growth substances|mesh-ancestor
19968705|NCT01763645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968706|NCT01763645|Growth Inhibitors|growth inhibitors|mesh-ancestor
19968707|NCT01763827|Ezetimibe|ezetimibe|mesh-list
19968708|NCT01763827|Evolocumab|evolocumab|mesh-list
19968709|NCT01763827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19968710|NCT01763827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19968711|NCT01763827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19968712|NCT01763827|Antimetabolites|antimetabolites|mesh-ancestor
19968713|NCT01763827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968714|NCT01763827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19968715|NCT01763827|Immunologic Factors|immunologic factors|mesh-ancestor
19968716|NCT01763827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968717|NCT01763866|Atorvastatin|atorvastatin|mesh-list
19733600|NCT04559880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19733601|NCT04559880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733602|NCT04559880|Hemostatics|hemostatics|mesh-ancestor
19733603|NCT04559880|Coagulants|coagulants|mesh-ancestor
19733604|NCT04560010|Tranexamic Acid|tranexamic acid|mesh-list
19733605|NCT04560010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19733606|NCT04560010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19733607|NCT04560010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733608|NCT04560010|Hemostatics|hemostatics|mesh-ancestor
19968718|NCT01763866|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19968719|NCT01763866|Simvastatin|simvastatin|mesh-list
19968720|NCT01763866|Ezetimibe|ezetimibe|mesh-list
19968721|NCT01763866|Evolocumab|evolocumab|mesh-list
19968722|NCT01763866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19968723|NCT01763866|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19968724|NCT01763866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19968725|NCT01763866|Antimetabolites|antimetabolites|mesh-ancestor
19968726|NCT01763866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968727|NCT01763866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19968728|NCT01763866|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19968729|NCT01763866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968730|NCT01763866|Immunologic Factors|immunologic factors|mesh-ancestor
19968731|NCT01763866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968732|NCT01763905|Ezetimibe|ezetimibe|mesh-list
19968733|NCT01763905|Evolocumab|evolocumab|mesh-list
19968734|NCT01763905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19968735|NCT01763905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19968736|NCT01763905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19968737|NCT01763905|Antimetabolites|antimetabolites|mesh-ancestor
19968738|NCT01763905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968739|NCT01763905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19968740|NCT01763905|Immunologic Factors|immunologic factors|mesh-ancestor
19968741|NCT01763905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968742|NCT01763918|Evolocumab|evolocumab|mesh-list
19968743|NCT01763918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19968744|NCT01763918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19968745|NCT01763918|Antimetabolites|antimetabolites|mesh-ancestor
19968746|NCT01763918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968747|NCT01763918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19968748|NCT01763931|Digoxin|digoxin|mesh-list
19968749|NCT01763931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19968750|NCT01763931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19968751|NCT01763931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968752|NCT01763931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968753|NCT01763931|Protective Agents|protective agents|mesh-ancestor
19968754|NCT01763931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968755|NCT01763996|Febuxostat|febuxostat|mesh-list
19968756|NCT01763996|Gout Suppressants|gout suppressants|mesh-ancestor
19968757|NCT01763996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19968758|NCT01764022|Paclitaxel|paclitaxel|mesh-list
19968759|NCT01764022|Trastuzumab|trastuzumab|mesh-list
19968760|NCT01764022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19968761|NCT01764022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19733609|NCT04560010|Coagulants|coagulants|mesh-ancestor
19733610|NCT04560231|Remdesivir|remdesivir|mesh-list
19733611|NCT04560231|Antimetabolites|antimetabolites|mesh-ancestor
19968762|NCT01764022|Tubulin Modulators|tubulin modulators|mesh-ancestor
19968763|NCT01764022|Antimitotic Agents|antimitotic agents|mesh-ancestor
19968764|NCT01764022|Mitosis Modulators|mitosis modulators|mesh-ancestor
19968765|NCT01764022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968766|NCT01764022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19968767|NCT01764464|Gabapentin|gabapentin|mesh-list
19968768|NCT01764464|Analgesics|analgesics|mesh-ancestor
19968769|NCT01764464|Sensory System Agents|sensory system agents|mesh-ancestor
19968770|NCT01764464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19968771|NCT01764464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968772|NCT01764464|Anticonvulsants|anticonvulsants|mesh-ancestor
19968773|NCT01764464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19968774|NCT01764464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19968775|NCT01764464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19968776|NCT01764464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19968777|NCT01764464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19968778|NCT01764464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19968779|NCT01764464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19968780|NCT01764464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968781|NCT01764464|Antimanic Agents|antimanic agents|mesh-ancestor
19968782|NCT01764607|Sirolimus|sirolimus|mesh-list
19733612|NCT04560231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733613|NCT04560231|Antiviral Agents|antiviral agents|mesh-ancestor
19733614|NCT04560231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19733615|NCT04560101|Botulinum Toxins|botulinum toxins|mesh-list
19733616|NCT04560101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19450462|NCT03428373|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19450463|NCT03428373|Antithrombins|antithrombins|mesh-ancestor
19450464|NCT03428373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19968783|NCT01764607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19450465|NCT03428373|Protease Inhibitors|protease inhibitors|mesh-ancestor
19450466|NCT03428373|Anticoagulants|anticoagulants|mesh-ancestor
19450467|NCT03428282|Anesthetics|anesthetics|mesh-list
19450468|NCT03428282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19450469|NCT03428282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450470|NCT03428256|Anesthetics|anesthetics|mesh-list
19968784|NCT01764607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19968785|NCT01764607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19968786|NCT01764607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968787|NCT01764607|Antifungal Agents|antifungal agents|mesh-ancestor
19968788|NCT01764607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19968789|NCT01764607|Immunologic Factors|immunologic factors|mesh-ancestor
19968790|NCT01764607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968791|NCT01764633|Evolocumab|evolocumab|mesh-list
19968792|NCT01764633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19968793|NCT01764633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19968794|NCT01764633|Antimetabolites|antimetabolites|mesh-ancestor
19968795|NCT01764633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968796|NCT01764633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19968797|NCT01764685|Topiramate|topiramate|mesh-list
19968798|NCT01764685|Anticonvulsants|anticonvulsants|mesh-ancestor
19968799|NCT01764685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19968800|NCT01764685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968801|NCT01764841|Ciprofloxacin|ciprofloxacin|mesh-list
19968802|NCT01764841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19968803|NCT01764841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19968804|NCT01764841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19968805|NCT01764841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19968806|NCT01764841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968807|NCT01764841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968808|NCT01764841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968809|NCT01764841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19968810|NCT01764841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19968811|NCT01765179|Methyltestosterone|methyltestosterone|mesh-list
19968812|NCT01765179|Testosterone|testosterone|mesh-list
19968813|NCT01765179|Testosterone undecanoate|testosterone undecanoate|mesh-list
19968814|NCT01765179|Testosterone enanthate|testosterone enanthate|mesh-list
19968815|NCT01765179|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19968816|NCT01765179|Androgens|androgens|mesh-ancestor
19968817|NCT01765179|Hormones|hormones|mesh-ancestor
19968818|NCT01765179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19968819|NCT01765179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968820|NCT01765179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19968821|NCT01765179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968822|NCT01765179|Anabolic Agents|anabolic agents|mesh-ancestor
19968823|NCT01765192|Montelukast|montelukast|mesh-list
19968824|NCT01765192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19968825|NCT01765192|Respiratory System Agents|respiratory system agents|mesh-ancestor
19968826|NCT01765192|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19968827|NCT01765192|Hormone Antagonists|hormone antagonists|mesh-ancestor
19968828|NCT01765192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19733617|NCT04560101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19733618|NCT04560101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19968829|NCT01765192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968830|NCT01765192|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19968831|NCT01765192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19968832|NCT01765192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968833|NCT01765270|Saxagliptin|saxagliptin|mesh-list
19968834|NCT01765270|Incretins|incretins|mesh-ancestor
19968835|NCT01765270|Hormones|hormones|mesh-ancestor
19968836|NCT01765270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19968837|NCT01765270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968838|NCT01765270|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19968839|NCT01765270|Protease Inhibitors|protease inhibitors|mesh-ancestor
19968840|NCT01765270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968841|NCT01765270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968842|NCT01765270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19968843|NCT01765543|Rifampin|rifampin|mesh-list
19968844|NCT01765543|Vemurafenib|vemurafenib|mesh-list
19968845|NCT01765543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19968846|NCT01765543|Antitubercular Agents|antitubercular agents|mesh-ancestor
19968847|NCT01765543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19968848|NCT01765543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19968849|NCT01765543|Leprostatic Agents|leprostatic agents|mesh-ancestor
19733619|NCT04560101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19733620|NCT04560101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733621|NCT04560101|Cholinergic Agents|cholinergic agents|mesh-ancestor
19733622|NCT04560101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19733623|NCT04560101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968850|NCT01765543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19968851|NCT01765543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968852|NCT01765543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968853|NCT01765543|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19968854|NCT01765543|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19968855|NCT01765543|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19968856|NCT01765543|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19968857|NCT01765543|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19968858|NCT01765543|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19968859|NCT01765543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968860|NCT01765543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19968861|NCT01765569|Vemurafenib|vemurafenib|mesh-list
19968862|NCT01765569|Digoxin|digoxin|mesh-list
19968863|NCT01765569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19968864|NCT01765569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19968865|NCT01765569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968866|NCT01765569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968867|NCT01765569|Protective Agents|protective agents|mesh-ancestor
19968868|NCT01765569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968869|NCT01765569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968870|NCT01765569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19968871|NCT01765582|Leucovorin|leucovorin|mesh-list
19968872|NCT01765582|Folic Acid|folic acid|mesh-list
19968873|NCT01765582|Bevacizumab|bevacizumab|mesh-list
19968874|NCT01765582|Fluorouracil|fluorouracil|mesh-list
19968875|NCT01765582|Capecitabine|capecitabine|mesh-list
19968876|NCT01765582|Oxaliplatin|oxaliplatin|mesh-list
19968877|NCT01765582|Irinotecan|irinotecan|mesh-list
19968878|NCT01765582|Levoleucovorin|levoleucovorin|mesh-list
19968879|NCT01765582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19968880|NCT01765582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968881|NCT01765582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19968882|NCT01765582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19968883|NCT01765582|Growth Substances|growth substances|mesh-ancestor
19968884|NCT01765582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968885|NCT01765582|Growth Inhibitors|growth inhibitors|mesh-ancestor
19968886|NCT01765582|Antimetabolites|antimetabolites|mesh-ancestor
19968887|NCT01765582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968888|NCT01765582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19968889|NCT01765582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19968890|NCT01765582|Immunologic Factors|immunologic factors|mesh-ancestor
19968891|NCT01765582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19968892|NCT01765582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19968893|NCT01765582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968894|NCT01765582|Antidotes|antidotes|mesh-ancestor
19968895|NCT01765582|Protective Agents|protective agents|mesh-ancestor
19968896|NCT01765582|Vitamin B Complex|vitamin b complex|mesh-ancestor
19968897|NCT01765582|Vitamins|vitamins|mesh-ancestor
19968898|NCT01765582|Micronutrients|micronutrients|mesh-ancestor
19968899|NCT01765582|Hematinics|hematinics|mesh-ancestor
19968900|NCT01765764|Bimatoprost|bimatoprost|mesh-list
19968901|NCT01765764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19968902|NCT01765764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19968903|NCT01765803|Thioridazine|thioridazine|mesh-list
19968904|NCT01765803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19968905|NCT01765803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19968906|NCT01765803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19968907|NCT01765803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968908|NCT01765803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19968909|NCT01765803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19968910|NCT01765803|Dopamine Agents|dopamine agents|mesh-ancestor
19968911|NCT01765803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19968912|NCT01765803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968913|NCT01766024|Interferons|interferons|mesh-list
19968914|NCT01766024|Interferon-beta|interferon-beta|mesh-list
19968915|NCT01766024|Interferon beta-1a|interferon beta-1a|mesh-list
19968916|NCT01766024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968917|NCT01766024|Antiviral Agents|antiviral agents|mesh-ancestor
19968918|NCT01766024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19968919|NCT01766024|Immunologic Factors|immunologic factors|mesh-ancestor
19968920|NCT01766024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968921|NCT01766024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19975294|NCT01847131|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19975295|NCT01847131|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19975296|NCT01847131|Adrenergic Agents|adrenergic agents|mesh-ancestor
19975297|NCT01847131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975298|NCT01847131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975299|NCT01847131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975300|NCT01847131|Sympathomimetics|sympathomimetics|mesh-ancestor
19975301|NCT01847131|Autonomic Agents|autonomic agents|mesh-ancestor
19975302|NCT01847131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975303|NCT01847131|Nasal Decongestants|nasal decongestants|mesh-ancestor
19975304|NCT01847131|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19975305|NCT01847131|Respiratory System Agents|respiratory system agents|mesh-ancestor
19975306|NCT01847131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19975307|NCT01847131|Mydriatics|mydriatics|mesh-ancestor
19975308|NCT01847131|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19975309|NCT01847131|Protective Agents|protective agents|mesh-ancestor
19975486|NCT01849562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975487|NCT01849562|Antiviral Agents|antiviral agents|mesh-ancestor
19975488|NCT01849562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19975489|NCT01849588|Sorafenib|sorafenib|mesh-list
19975490|NCT01849588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975491|NCT01849588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19975492|NCT01849588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19975493|NCT01849588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968922|NCT01766050|Abatacept|abatacept|mesh-list
19968923|NCT01766050|Losartan|losartan|mesh-list
19968924|NCT01766050|Midazolam|midazolam|mesh-list
19968925|NCT01766050|Dextromethorphan|dextromethorphan|mesh-list
19968926|NCT01766050|Caffeine|caffeine|mesh-list
19968927|NCT01766050|Omeprazole|omeprazole|mesh-list
19968928|NCT01766050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19968929|NCT01766050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19968930|NCT01766050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19968931|NCT01766050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968932|NCT01766050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19968933|NCT01766050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19968934|NCT01766050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19968935|NCT01766050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19968936|NCT01766050|Anesthetics, General|anesthetics, general|mesh-ancestor
19968937|NCT01766050|Anesthetics|anesthetics|mesh-ancestor
19968938|NCT01766050|GABA Modulators|gaba modulators|mesh-ancestor
19968939|NCT01766050|GABA Agents|gaba agents|mesh-ancestor
19968940|NCT01766050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19968941|NCT01766050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968942|NCT01766050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19968943|NCT01766050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19968944|NCT01766050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19968945|NCT01766050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19968946|NCT01766050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19968947|NCT01766050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19968948|NCT01766050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19968949|NCT01766050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968950|NCT01766050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19968951|NCT01766050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19968952|NCT01766050|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19968953|NCT01766050|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19968954|NCT01766050|Purinergic Agents|purinergic agents|mesh-ancestor
19968955|NCT01766050|Antitussive Agents|antitussive agents|mesh-ancestor
19968956|NCT01766050|Respiratory System Agents|respiratory system agents|mesh-ancestor
19968957|NCT01766050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19968958|NCT01766050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19968959|NCT01766050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19968960|NCT01766050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19968961|NCT01766050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19968962|NCT01766050|Immunologic Factors|immunologic factors|mesh-ancestor
19968963|NCT01766050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19968964|NCT01766076|Atorvastatin|atorvastatin|mesh-list
19968965|NCT01766076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19968966|NCT01766076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19968967|NCT01766076|Antimetabolites|antimetabolites|mesh-ancestor
19968968|NCT01766076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968969|NCT01766076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19968970|NCT01766076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19968971|NCT01766076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19968972|NCT01766219|Thioctic Acid|thioctic acid|mesh-list
19968973|NCT01766219|Antioxidants|antioxidants|mesh-ancestor
19968974|NCT01766219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968975|NCT01766219|Protective Agents|protective agents|mesh-ancestor
19968976|NCT01766219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968977|NCT01766219|Vitamin B Complex|vitamin b complex|mesh-ancestor
19968978|NCT01766219|Vitamins|vitamins|mesh-ancestor
19968979|NCT01766219|Micronutrients|micronutrients|mesh-ancestor
19968980|NCT01766310|Folic Acid|folic acid|mesh-list
19968981|NCT01766310|Hematinics|hematinics|mesh-ancestor
19968982|NCT01766310|Vitamin B Complex|vitamin b complex|mesh-ancestor
19968983|NCT01766310|Vitamins|vitamins|mesh-ancestor
19968984|NCT01766310|Micronutrients|micronutrients|mesh-ancestor
19968985|NCT01766310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968986|NCT01766336|Inositol|inositol|mesh-list
19968987|NCT01766336|Vitamin B Complex|vitamin b complex|mesh-ancestor
19968988|NCT01766336|Vitamins|vitamins|mesh-ancestor
19968989|NCT01766336|Micronutrients|micronutrients|mesh-ancestor
19968990|NCT01766336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968991|NCT01766440|Calcitriol|calcitriol|mesh-list
19968992|NCT01766440|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19968993|NCT01766440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19968994|NCT01766440|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19968995|NCT01766440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19968996|NCT01766440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19968997|NCT01766440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19968998|NCT01766440|Vitamins|vitamins|mesh-ancestor
19968999|NCT01766440|Micronutrients|micronutrients|mesh-ancestor
19969000|NCT01766440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19969001|NCT01766466|Ticagrelor|ticagrelor|mesh-list
19969002|NCT01766466|Cangrelor|cangrelor|mesh-list
19969003|NCT01766466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19969004|NCT01766466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19969005|NCT01766466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19969006|NCT01766466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19969007|NCT01766466|Purinergic Agents|purinergic agents|mesh-ancestor
19969008|NCT01766466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19969009|NCT01766466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969010|NCT01766466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969011|NCT01766713|Ezetimibe|ezetimibe|mesh-list
19969012|NCT01766713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19969013|NCT01766713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19969014|NCT01766713|Antimetabolites|antimetabolites|mesh-ancestor
19969015|NCT01766713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969016|NCT01766713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19969017|NCT01766778|Metformin|metformin|mesh-list
19969018|NCT01766778|Vildagliptin|vildagliptin|mesh-list
19969019|NCT01766778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19969020|NCT01766778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969021|NCT01766778|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19969022|NCT01766778|Protease Inhibitors|protease inhibitors|mesh-ancestor
19969023|NCT01766778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969024|NCT01766778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969025|NCT01767103|Deferiprone|deferiprone|mesh-list
19969026|NCT01767103|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19969027|NCT01767103|Chelating Agents|chelating agents|mesh-ancestor
19969028|NCT01767103|Sequestering Agents|sequestering agents|mesh-ancestor
19969029|NCT01767103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969030|NCT01767116|Ribavirin|ribavirin|mesh-list
19969031|NCT01767116|Antimetabolites|antimetabolites|mesh-ancestor
19969032|NCT01767116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969033|NCT01767116|Antiviral Agents|antiviral agents|mesh-ancestor
19969034|NCT01767116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19969035|NCT01767155|Doxorubicin|doxorubicin|mesh-list
19969036|NCT01767155|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19969037|NCT01767155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19969038|NCT01767155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19969039|NCT01767155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19969040|NCT01767155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19969041|NCT01767155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969042|NCT01767155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969043|NCT01767285|Etonogestrel|etonogestrel|mesh-list
19969044|NCT01767285|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19969045|NCT01767285|Contraceptive Agents|contraceptive agents|mesh-ancestor
19969046|NCT01767285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19969047|NCT01767285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969048|NCT01767285|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19969049|NCT01767506|Azithromycin|azithromycin|mesh-list
19969050|NCT01767506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19969051|NCT01767506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19969052|NCT01767519|Solifenacin Succinate|solifenacin succinate|mesh-list
19969053|NCT01767519|Botulinum Toxins|botulinum toxins|mesh-list
19969054|NCT01767519|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19969055|NCT01767519|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19969056|NCT01767519|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19969057|NCT01767519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19969058|NCT01767519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969059|NCT01767519|Cholinergic Agents|cholinergic agents|mesh-ancestor
19969060|NCT01767519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19969061|NCT01767519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969062|NCT01767519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19969063|NCT01767519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969064|NCT01767519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19969065|NCT01767519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19969066|NCT01767519|Urological Agents|urological agents|mesh-ancestor
19969067|NCT01767701|Raltegravir Potassium|raltegravir potassium|mesh-list
19969068|NCT01767701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19969069|NCT01767701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19969070|NCT01767701|Antiviral Agents|antiviral agents|mesh-ancestor
19969071|NCT01767701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19969072|NCT01767701|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19969073|NCT01767701|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19969074|NCT01767701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969075|NCT01767701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969076|NCT01767792|Bevacizumab|bevacizumab|mesh-list
19969077|NCT01767792|Endothelial Growth Factors|endothelial growth factors|mesh-list
19969078|NCT01767792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19969079|NCT01767792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19969080|NCT01767792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19969081|NCT01767792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19969082|NCT01767792|Growth Substances|growth substances|mesh-ancestor
19969083|NCT01767792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969084|NCT01767792|Growth Inhibitors|growth inhibitors|mesh-ancestor
19969085|NCT01767909|Insulin|insulin|mesh-list
19969086|NCT01767909|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19969087|NCT01767909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19969088|NCT01767909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969089|NCT01767987|Ranolazine|ranolazine|mesh-list
19969090|NCT01767987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19969091|NCT01767987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19969092|NCT01767987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969093|NCT01768286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19969094|NCT01768286|Ledipasvir|ledipasvir|mesh-list
19969095|NCT01768286|Antiviral Agents|antiviral agents|mesh-ancestor
19969096|NCT01768286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19969097|NCT01768520|Celecoxib|celecoxib|mesh-list
19969098|NCT01768520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19969099|NCT01768520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19969100|NCT01768520|Analgesics|analgesics|mesh-ancestor
19969101|NCT01768520|Sensory System Agents|sensory system agents|mesh-ancestor
19969102|NCT01768520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969103|NCT01768520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969104|NCT01768520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19969105|NCT01768520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19969106|NCT01768520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19969107|NCT01768520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19969108|NCT01768520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969109|NCT01768520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969110|NCT01768559|Insulin|insulin|mesh-list
19969111|NCT01768559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19969112|NCT01768559|Metformin|metformin|mesh-list
19969113|NCT01768559|Insulin Glargine|insulin glargine|mesh-list
19969114|NCT01768559|Insulin glulisine|insulin glulisine|mesh-list
19969115|NCT01768559|Lixisenatide|lixisenatide|mesh-list
19969116|NCT01768559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19969117|NCT01768559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969118|NCT01768572|Hydroxychloroquine|hydroxychloroquine|mesh-list
19969119|NCT01768572|Sulfasalazine|sulfasalazine|mesh-list
19969120|NCT01768572|Methotrexate|methotrexate|mesh-list
19969121|NCT01768572|Leflunomide|leflunomide|mesh-list
19969122|NCT01768572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19969123|NCT01768572|Abortifacient Agents|abortifacient agents|mesh-ancestor
19969124|NCT01768572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19969125|NCT01768572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969126|NCT01768572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19969127|NCT01768572|Antimetabolites|antimetabolites|mesh-ancestor
19969128|NCT01768572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969129|NCT01768572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19969130|NCT01768572|Dermatologic Agents|dermatologic agents|mesh-ancestor
19969131|NCT01768572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969132|NCT01768572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19969133|NCT01768572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19969134|NCT01768572|Immunologic Factors|immunologic factors|mesh-ancestor
19969135|NCT01768572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19969136|NCT01768572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19969137|NCT01768572|Antimalarials|antimalarials|mesh-ancestor
19969138|NCT01768572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19969139|NCT01768572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19969140|NCT01768572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19969141|NCT01768572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19969142|NCT01768572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19969143|NCT01768572|Analgesics|analgesics|mesh-ancestor
19969144|NCT01768572|Sensory System Agents|sensory system agents|mesh-ancestor
19969145|NCT01768572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969146|NCT01768572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19969147|NCT01768572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19969148|NCT01768637|Aspirin|aspirin|mesh-list
19969149|NCT01768637|Clopidogrel|clopidogrel|mesh-list
19969150|NCT01768637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19969151|NCT01768637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19969152|NCT01768637|Analgesics|analgesics|mesh-ancestor
19969153|NCT01768637|Sensory System Agents|sensory system agents|mesh-ancestor
19969154|NCT01768637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969155|NCT01768637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969156|NCT01768637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19969157|NCT01768637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19969158|NCT01768637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19969159|NCT01768637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19969160|NCT01768637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969161|NCT01768637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19969162|NCT01768637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19969163|NCT01768637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969164|NCT01768637|Antipyretics|antipyretics|mesh-ancestor
19969165|NCT01768637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19969166|NCT01768637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19969167|NCT01768637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19969168|NCT01768637|Purinergic Agents|purinergic agents|mesh-ancestor
19969169|NCT01768637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19969170|NCT01768858|Adalimumab|adalimumab|mesh-list
19969171|NCT01768858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19969172|NCT01768858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19969173|NCT01769170|Cidofovir|cidofovir|mesh-list
19969174|NCT01769170|Brincidofovir|brincidofovir|mesh-list
19969175|NCT01769170|Antiviral Agents|antiviral agents|mesh-ancestor
19969176|NCT01769170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19969177|NCT01769170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969178|NCT01769170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969179|NCT01769209|Cytarabine|cytarabine|mesh-list
19969180|NCT01769209|Dexamethasone|dexamethasone|mesh-list
19969181|NCT01769209|Doxorubicin|doxorubicin|mesh-list
19969182|NCT01769209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19969183|NCT01769209|Methotrexate|methotrexate|mesh-list
19969184|NCT01769209|Vincristine|vincristine|mesh-list
19969185|NCT01769209|Bortezomib|bortezomib|mesh-list
19969186|NCT01769209|Asparaginase|asparaginase|mesh-list
19969187|NCT01769209|Pegaspargase|pegaspargase|mesh-list
19969188|NCT01769209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19969189|NCT01769209|Antiemetics|antiemetics|mesh-ancestor
19969190|NCT01769209|Autonomic Agents|autonomic agents|mesh-ancestor
19969191|NCT01769209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969192|NCT01769209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969193|NCT01769209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19969194|NCT01769209|Glucocorticoids|glucocorticoids|mesh-ancestor
19969195|NCT01769209|Hormones|hormones|mesh-ancestor
19969196|NCT01769209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19969197|NCT01769209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19969198|NCT01769209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19969199|NCT01769209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19969200|NCT01769209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19969201|NCT01769209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19969202|NCT01769209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969203|NCT01769209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969204|NCT01769209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19969205|NCT01769209|Abortifacient Agents|abortifacient agents|mesh-ancestor
19969206|NCT01769209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19969207|NCT01769209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19969208|NCT01769209|Antimetabolites|antimetabolites|mesh-ancestor
19969209|NCT01769209|Dermatologic Agents|dermatologic agents|mesh-ancestor
19969210|NCT01769209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19969211|NCT01769209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19969212|NCT01769209|Immunologic Factors|immunologic factors|mesh-ancestor
19969213|NCT01769209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19969214|NCT01769209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19969215|NCT01769209|Antiviral Agents|antiviral agents|mesh-ancestor
19969216|NCT01769209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19969217|NCT01769209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19969218|NCT01769209|Tubulin Modulators|tubulin modulators|mesh-ancestor
19969219|NCT01769209|Antimitotic Agents|antimitotic agents|mesh-ancestor
19969220|NCT01769209|Mitosis Modulators|mitosis modulators|mesh-ancestor
19969221|NCT01769222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19969222|NCT01769222|Ipilimumab|ipilimumab|mesh-list
19969223|NCT01769222|Antibodies|antibodies|mesh-list
19969224|NCT01769222|Immunoglobulins|immunoglobulins|mesh-list
19969225|NCT01769222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19969226|NCT01769222|Immunologic Factors|immunologic factors|mesh-ancestor
19969227|NCT01769222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969228|NCT01769222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19969229|NCT01769222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19969230|NCT01769222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969231|NCT01769339|Miconazole|miconazole|mesh-list
19969232|NCT01769339|Hydrocortisone|hydrocortisone|mesh-list
19969233|NCT01769339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19969234|NCT01769339|Antifungal Agents|antifungal agents|mesh-ancestor
19969235|NCT01769339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19969236|NCT01769339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19969237|NCT01769339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19969238|NCT01769339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969239|NCT01769339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969240|NCT01769339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19969241|NCT01769339|Hormone Antagonists|hormone antagonists|mesh-ancestor
19969242|NCT01769339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19969243|NCT01769339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969244|NCT01769339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19969245|NCT01769339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19969246|NCT01769352|Prednisolone acetate|prednisolone acetate|mesh-list
19969247|NCT01769352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19969248|NCT01769365|Amoxicillin|amoxicillin|mesh-list
19969249|NCT01769365|Metronidazole|metronidazole|mesh-list
19969250|NCT01769365|Clarithromycin|clarithromycin|mesh-list
19969251|NCT01769365|Pantoprazole|pantoprazole|mesh-list
19969252|NCT01769365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19969253|NCT01769365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19969254|NCT01769365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19969255|NCT01769365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19969256|NCT01769365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19969257|NCT01769365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969258|NCT01769365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969259|NCT01769365|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19969260|NCT01769365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19969261|NCT01769365|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19969262|NCT01769365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19969263|NCT01769365|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19969264|NCT01769378|Glimepiride|glimepiride|mesh-list
19969265|NCT01769378|Dulaglutide|dulaglutide|mesh-list
19969266|NCT01769378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19969267|NCT01769378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19969268|NCT01769378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969269|NCT01769378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19969270|NCT01769378|Immunologic Factors|immunologic factors|mesh-ancestor
19969271|NCT01769391|Paclitaxel|paclitaxel|mesh-list
19969272|NCT01769391|Carboplatin|carboplatin|mesh-list
19969273|NCT01769391|Necitumumab|necitumumab|mesh-list
19969274|NCT01769391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19969275|NCT01769391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19969276|NCT01769391|Tubulin Modulators|tubulin modulators|mesh-ancestor
19969277|NCT01769391|Antimitotic Agents|antimitotic agents|mesh-ancestor
19969278|NCT01769391|Mitosis Modulators|mitosis modulators|mesh-ancestor
19969279|NCT01769391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969280|NCT01769391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19969281|NCT01769404|Insulin Glargine|insulin glargine|mesh-list
19969282|NCT01769404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19450471|NCT03428256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19450472|NCT03428256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450473|NCT03428191|Dexmedetomidine|dexmedetomidine|mesh-list
19450474|NCT03428191|Remifentanil|remifentanil|mesh-list
19450475|NCT03428191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19450476|NCT03428191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19450477|NCT03428191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450478|NCT03428191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19450479|NCT03428191|Analgesics|analgesics|mesh-ancestor
19450480|NCT03428191|Sensory System Agents|sensory system agents|mesh-ancestor
19450481|NCT03428191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19450482|NCT03428191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19450483|NCT03428191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19450484|NCT03428191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19450485|NCT03428191|Adrenergic Agents|adrenergic agents|mesh-ancestor
19450486|NCT03428191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19450487|NCT03428191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969283|NCT01769404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969284|NCT01769456|Tenofovir|tenofovir|mesh-list
19969285|NCT01769456|Emtricitabine|emtricitabine|mesh-list
19969286|NCT01769456|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19969287|NCT01769456|Antiviral Agents|antiviral agents|mesh-ancestor
19969288|NCT01769456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19969289|NCT01769456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19969290|NCT01769456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19969291|NCT01769456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969292|NCT01769456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969293|NCT01769456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19969294|NCT01769456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19969295|NCT01769469|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19969296|NCT01769469|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19975310|NCT01847313|Liraglutide|liraglutide|mesh-list
19969297|NCT01769469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19969298|NCT01769469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969299|NCT01769469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969300|NCT01769469|Antiviral Agents|antiviral agents|mesh-ancestor
19969301|NCT01769469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19969302|NCT01769469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19969303|NCT01769469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19969304|NCT01769508|Fluorouracil|fluorouracil|mesh-list
19969305|NCT01769508|Oxaliplatin|oxaliplatin|mesh-list
19969306|NCT01769508|Lapatinib|lapatinib|mesh-list
19969307|NCT01769508|Antimetabolites|antimetabolites|mesh-ancestor
19969308|NCT01769508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969309|NCT01769508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19969310|NCT01769508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19969311|NCT01769508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19969312|NCT01769508|Immunologic Factors|immunologic factors|mesh-ancestor
19969313|NCT01769508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969314|NCT01769508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19969315|NCT01769508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969316|NCT01769586|Diphenhydramine|diphenhydramine|mesh-list
19969317|NCT01769586|Promethazine|promethazine|mesh-list
19969318|NCT01769586|Midazolam|midazolam|mesh-list
19969319|NCT01769586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19969320|NCT01769586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19969321|NCT01769586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19969322|NCT01769586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969323|NCT01769586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19969324|NCT01769586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19969325|NCT01769586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19969326|NCT01769586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19969327|NCT01769586|Anesthetics, General|anesthetics, general|mesh-ancestor
19969328|NCT01769586|Anesthetics|anesthetics|mesh-ancestor
19969329|NCT01769586|GABA Modulators|gaba modulators|mesh-ancestor
19969330|NCT01769586|GABA Agents|gaba agents|mesh-ancestor
19969331|NCT01769586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19969332|NCT01769586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969333|NCT01769586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19969334|NCT01769586|Anesthetics, Local|anesthetics, local|mesh-ancestor
19969335|NCT01769586|Sensory System Agents|sensory system agents|mesh-ancestor
19975311|NCT01847313|Glucagon|glucagon|mesh-list
19969336|NCT01769586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969337|NCT01769586|Antiemetics|antiemetics|mesh-ancestor
19969338|NCT01769586|Autonomic Agents|autonomic agents|mesh-ancestor
19969339|NCT01769586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19969340|NCT01769586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19969341|NCT01769586|Histamine Antagonists|histamine antagonists|mesh-ancestor
19969342|NCT01769586|Histamine Agents|histamine agents|mesh-ancestor
19969343|NCT01769586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19969344|NCT01769586|Antipruritics|antipruritics|mesh-ancestor
19969345|NCT01769586|Dermatologic Agents|dermatologic agents|mesh-ancestor
19969346|NCT01770145|Levodopa|levodopa|mesh-list
19969347|NCT01770145|Carbidopa|carbidopa|mesh-list
19969348|NCT01770145|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19969349|NCT01770145|Trimethobenzamide|trimethobenzamide|mesh-list
19969350|NCT01770145|Apomorphine|apomorphine|mesh-list
19969351|NCT01770145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19969352|NCT01770145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19969353|NCT01770145|Dopamine Agents|dopamine agents|mesh-ancestor
19969354|NCT01770145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19969355|NCT01770145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969356|NCT01770145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969357|NCT01770145|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19969358|NCT01770145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969359|NCT01770145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19969360|NCT01770145|Immunologic Factors|immunologic factors|mesh-ancestor
19969361|NCT01770145|Dopamine Agonists|dopamine agonists|mesh-ancestor
19969362|NCT01770145|Emetics|emetics|mesh-ancestor
19969363|NCT01770145|Autonomic Agents|autonomic agents|mesh-ancestor
19969364|NCT01770145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969365|NCT01770145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19969366|NCT01770145|Antiemetics|antiemetics|mesh-ancestor
19969367|NCT01770353|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19969368|NCT01770353|Hematinics|hematinics|mesh-ancestor
19969369|NCT01770353|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19969370|NCT01770353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19969371|NCT01770392|Rifampin|rifampin|mesh-list
19969372|NCT01770392|Nintedanib|nintedanib|mesh-list
19969373|NCT01770392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19969374|NCT01770392|Antitubercular Agents|antitubercular agents|mesh-ancestor
19969375|NCT01770392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19969376|NCT01770392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19969377|NCT01770392|Leprostatic Agents|leprostatic agents|mesh-ancestor
19969378|NCT01770392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19969379|NCT01770392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969380|NCT01770392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969381|NCT01770392|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19969382|NCT01770392|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19969383|NCT01770392|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19969384|NCT01770392|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19969385|NCT01770392|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19969386|NCT01770392|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19969387|NCT01770392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19969388|NCT01770392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19969389|NCT01770483|Interferons|interferons|mesh-list
19969390|NCT01770483|Ribavirin|ribavirin|mesh-list
19969391|NCT01770483|Interferon-alpha|interferon-alpha|mesh-list
19969392|NCT01770483|Nitazoxanide|nitazoxanide|mesh-list
19969393|NCT01770483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19969394|NCT01770483|Antiviral Agents|antiviral agents|mesh-ancestor
19969395|NCT01770483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19969396|NCT01770483|Antimetabolites|antimetabolites|mesh-ancestor
19969397|NCT01770483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969398|NCT01770483|Immunologic Factors|immunologic factors|mesh-ancestor
19969399|NCT01770483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969400|NCT01770483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19969401|NCT01770652|Deferiprone|deferiprone|mesh-list
19969402|NCT01770652|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19969403|NCT01770652|Chelating Agents|chelating agents|mesh-ancestor
19969404|NCT01770652|Sequestering Agents|sequestering agents|mesh-ancestor
19969405|NCT01770652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969406|NCT01770743|Vaccines|vaccines|mesh-list
19969407|NCT01770743|Immunologic Factors|immunologic factors|mesh-ancestor
19969408|NCT01770743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969409|NCT01770912|Triamcinolone|triamcinolone|mesh-list
19969410|NCT01770912|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19969411|NCT01770912|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19969412|NCT01770912|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19969413|NCT01770912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19969414|NCT01770912|Glucocorticoids|glucocorticoids|mesh-ancestor
19969415|NCT01770912|Hormones|hormones|mesh-ancestor
19969416|NCT01770912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19969417|NCT01770912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969418|NCT01770912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19969419|NCT01770912|Immunologic Factors|immunologic factors|mesh-ancestor
19969420|NCT01770912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19975312|NCT01847313|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19969421|NCT01770912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969422|NCT01771250|Insulin|insulin|mesh-list
19969423|NCT01771250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19969424|NCT01771250|Insulin Glargine|insulin glargine|mesh-list
19969425|NCT01771250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19969426|NCT01771250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969427|NCT01771627|Nicotine|nicotine|mesh-list
19969428|NCT01771627|Varenicline|varenicline|mesh-list
19969429|NCT01771627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19969430|NCT01771627|Autonomic Agents|autonomic agents|mesh-ancestor
19969431|NCT01771627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969432|NCT01771627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969433|NCT01771627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19969434|NCT01771627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19969435|NCT01771627|Cholinergic Agents|cholinergic agents|mesh-ancestor
19969436|NCT01771627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19969437|NCT01771627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969438|NCT01771666|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
19969439|NCT01771666|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19969440|NCT01771666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969441|NCT01771952|Hyaluronic Acid|hyaluronic acid|mesh-list
19969442|NCT01771952|Hylan|hylan|mesh-list
19969443|NCT01771952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19969444|NCT01771952|Immunologic Factors|immunologic factors|mesh-ancestor
19969445|NCT01771952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969446|NCT01771952|Viscosupplements|viscosupplements|mesh-ancestor
19969447|NCT01771952|Protective Agents|protective agents|mesh-ancestor
19969448|NCT01772134|Fluticasone|fluticasone|mesh-list
19969449|NCT01772134|Xhance|xhance|mesh-list
19450488|NCT03428191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19450489|NCT03428191|Narcotics|narcotics|mesh-ancestor
19450490|NCT03428139|Thioctic Acid|thioctic acid|mesh-list
19450491|NCT03428139|Antioxidants|antioxidants|mesh-ancestor
19450492|NCT03428139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450493|NCT03428139|Protective Agents|protective agents|mesh-ancestor
19450494|NCT03428139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19450495|NCT03428139|Vitamin B Complex|vitamin b complex|mesh-ancestor
19450496|NCT03428139|Vitamins|vitamins|mesh-ancestor
19450497|NCT03428139|Micronutrients|micronutrients|mesh-ancestor
19450498|NCT03428022|Apatinib|apatinib|mesh-list
19450499|NCT03428022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19450500|NCT03428022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19450501|NCT03428022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19450502|NCT03428022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19450503|NCT03427944|Calcium Dobesilate|calcium dobesilate|mesh-list
19450504|NCT03427944|Calcium|calcium|mesh-list
19969450|NCT01772134|Bromides|bromides|mesh-list
19969451|NCT01772134|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19969452|NCT01772134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19969453|NCT01772134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19969454|NCT01772134|Autonomic Agents|autonomic agents|mesh-ancestor
19969455|NCT01772134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969456|NCT01772134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969457|NCT01772134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19969458|NCT01772134|Respiratory System Agents|respiratory system agents|mesh-ancestor
19969459|NCT01772134|Dermatologic Agents|dermatologic agents|mesh-ancestor
19733624|NCT04560101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19733625|NCT04560101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969460|NCT01772134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19969461|NCT01772134|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19969462|NCT01772134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19969463|NCT01772134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19969464|NCT01772134|Adrenergic Agents|adrenergic agents|mesh-ancestor
19969465|NCT01772134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19969466|NCT01772134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969467|NCT01772134|Anticonvulsants|anticonvulsants|mesh-ancestor
19969468|NCT01772147|Fluticasone|fluticasone|mesh-list
19969469|NCT01772147|Xhance|xhance|mesh-list
19969470|NCT01772147|Bromides|bromides|mesh-list
19969471|NCT01772147|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19969472|NCT01772147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19969473|NCT01772147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19969474|NCT01772147|Autonomic Agents|autonomic agents|mesh-ancestor
19969475|NCT01772147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969476|NCT01772147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969477|NCT01772147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19969478|NCT01772147|Respiratory System Agents|respiratory system agents|mesh-ancestor
19969479|NCT01772147|Dermatologic Agents|dermatologic agents|mesh-ancestor
19969480|NCT01772147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19969481|NCT01772147|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19969482|NCT01772147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19969483|NCT01772147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19733626|NCT04560218|Misoprostol|misoprostol|mesh-list
19733627|NCT04560218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19733628|NCT04560218|Abortifacient Agents|abortifacient agents|mesh-ancestor
19733629|NCT04560218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19733630|NCT04560218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19733631|NCT04560218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19733632|NCT04560218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19733633|NCT04560218|Oxytocics|oxytocics|mesh-ancestor
19733634|NCT04560049|Phenol|phenol|mesh-list
19733635|NCT04560049|Silver Nitrate|silver nitrate|mesh-list
19733636|NCT04560049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19969484|NCT01772147|Adrenergic Agents|adrenergic agents|mesh-ancestor
19969485|NCT01772147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19969486|NCT01772147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969487|NCT01772147|Anticonvulsants|anticonvulsants|mesh-ancestor
19969488|NCT01772368|Fluticasone|fluticasone|mesh-list
19969489|NCT01772368|Xhance|xhance|mesh-list
19969490|NCT01772368|Albuterol|albuterol|mesh-list
19969491|NCT01772368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19969492|NCT01772368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19969493|NCT01772368|Adrenergic Agonists|adrenergic agonists|mesh-list
19969494|NCT01772368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19969495|NCT01772368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19969496|NCT01772368|Autonomic Agents|autonomic agents|mesh-ancestor
19969497|NCT01772368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19969498|NCT01772368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969499|NCT01772368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19969500|NCT01772368|Respiratory System Agents|respiratory system agents|mesh-ancestor
19969501|NCT01772368|Dermatologic Agents|dermatologic agents|mesh-ancestor
19452881|NCT03408847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19969502|NCT01772368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19969503|NCT01772368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19969504|NCT01772368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19969505|NCT01772368|Adrenergic Agents|adrenergic agents|mesh-ancestor
19969506|NCT01772368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19969507|NCT01772368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969508|NCT01772368|Tocolytic Agents|tocolytic agents|mesh-ancestor
19969509|NCT01772368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19969510|NCT01772368|Glucocorticoids|glucocorticoids|mesh-ancestor
19969511|NCT01772368|Hormones|hormones|mesh-ancestor
19969512|NCT01772368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19969513|NCT01772368|Sympathomimetics|sympathomimetics|mesh-ancestor
19969514|NCT01772537|Propofol|propofol|mesh-list
19969515|NCT01772537|Isoflurane|isoflurane|mesh-list
19969516|NCT01772537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19969517|NCT01772537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19969518|NCT01772537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969519|NCT01772537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19969520|NCT01772537|Anesthetics, General|anesthetics, general|mesh-ancestor
19969521|NCT01772537|Anesthetics|anesthetics|mesh-ancestor
19969522|NCT01772537|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19975313|NCT01847313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19975314|NCT01847313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975315|NCT01847313|Incretins|incretins|mesh-ancestor
19975316|NCT01847313|Hormones|hormones|mesh-ancestor
19975317|NCT01847313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19975318|NCT01847313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19975319|NCT01847443|Nicotine|nicotine|mesh-list
19975320|NCT01847443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19975321|NCT01847443|Autonomic Agents|autonomic agents|mesh-ancestor
19975322|NCT01847443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975323|NCT01847443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975324|NCT01847443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19975325|NCT01847443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19975326|NCT01847443|Cholinergic Agents|cholinergic agents|mesh-ancestor
19975327|NCT01847443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975328|NCT01847443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975329|NCT01847469|Zonisamide|zonisamide|mesh-list
19975330|NCT01847469|Anticonvulsants|anticonvulsants|mesh-ancestor
19975331|NCT01847469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19975332|NCT01847469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19975333|NCT01847469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969523|NCT01772758|Antioxidants|antioxidants|mesh-list
19969524|NCT01772758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733637|NCT04560049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19733638|NCT04560049|Disinfectants|disinfectants|mesh-ancestor
19969525|NCT01772758|Protective Agents|protective agents|mesh-ancestor
19969526|NCT01772758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19969527|NCT01772823|Tenofovir|tenofovir|mesh-list
19969528|NCT01772823|Emtricitabine|emtricitabine|mesh-list
19969529|NCT01772823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19969530|NCT01772823|Antiviral Agents|antiviral agents|mesh-ancestor
19969531|NCT01772823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19969532|NCT01772823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19969533|NCT01772823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19969534|NCT01772823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969535|NCT01772823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969536|NCT01772823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19969537|NCT01772823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19969538|NCT01773070|Ritonavir|ritonavir|mesh-list
19969539|NCT01773070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19969540|NCT01773070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19969541|NCT01773070|Protease Inhibitors|protease inhibitors|mesh-ancestor
19969542|NCT01773070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969543|NCT01773070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969544|NCT01773070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19969545|NCT01773070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19969546|NCT01773070|Antiviral Agents|antiviral agents|mesh-ancestor
19969547|NCT01773070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19969548|NCT01773070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19969549|NCT01773070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19969550|NCT01773109|Irinotecan|irinotecan|mesh-list
19969551|NCT01773109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
19969552|NCT01773109|Etirinotecan pegol|etirinotecan pegol|mesh-list
19733639|NCT04560049|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19733640|NCT04560049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19733641|NCT04559841|Simvastatin|simvastatin|mesh-list
19733642|NCT04559841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19969553|NCT01773109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19969554|NCT01773109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19969555|NCT01773109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19969556|NCT01773109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19969557|NCT01773109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19969558|NCT01773122|Dapsone|dapsone|mesh-list
19969559|NCT01773122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19969560|NCT01773122|Antimalarials|antimalarials|mesh-ancestor
19969561|NCT01773122|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19969562|NCT01773122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19969563|NCT01773122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19969564|NCT01773122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19975494|NCT01849692|Ranibizumab|ranibizumab|mesh-list
19733643|NCT04559841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19733644|NCT04559841|Antimetabolites|antimetabolites|mesh-ancestor
19733645|NCT04559841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19733646|NCT04559841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19733647|NCT04559841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19733648|NCT04559841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19733649|NCT04559425|Dexamethasone|dexamethasone|mesh-list
19733650|NCT04559425|Dexamethasone acetate|dexamethasone acetate|mesh-list
19733651|NCT04559425|BB 1101|bb 1101|mesh-list
19733652|NCT04559425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19733653|NCT04559425|Antiemetics|antiemetics|mesh-ancestor
19975503|NCT01849770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19975504|NCT01849770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19975505|NCT01849770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19975506|NCT01849770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975507|NCT01850030|Progesterone|progesterone|mesh-list
19975508|NCT01850030|Dydrogesterone|dydrogesterone|mesh-list
19975509|NCT01850030|Progestins|progestins|mesh-ancestor
19975510|NCT01850030|Hormones|hormones|mesh-ancestor
19975511|NCT01850030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19975512|NCT01850030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975513|NCT01850394|Tranexamic Acid|tranexamic acid|mesh-list
19975514|NCT01850394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19975515|NCT01850394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19975516|NCT01850394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975517|NCT01850394|Hemostatics|hemostatics|mesh-ancestor
19975518|NCT01850394|Coagulants|coagulants|mesh-ancestor
19975519|NCT01850446|Oseltamivir|oseltamivir|mesh-list
19975520|NCT01850446|Antiviral Agents|antiviral agents|mesh-ancestor
19975521|NCT01850446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19975522|NCT01850446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19975523|NCT01850446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975524|NCT01850602|Sevelamer|sevelamer|mesh-list
19975525|NCT01850602|Chelating Agents|chelating agents|mesh-ancestor
19975526|NCT01850602|Sequestering Agents|sequestering agents|mesh-ancestor
19975527|NCT01850602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975528|NCT01850615|Insulin|insulin|mesh-list
19975529|NCT01850615|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19975530|NCT01850615|Insulin Aspart|insulin aspart|mesh-list
19975531|NCT01850615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19975532|NCT01850615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975533|NCT01850823|Mometasone Furoate|mometasone furoate|mesh-list
19975534|NCT01850823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19975535|NCT01850823|Dermatologic Agents|dermatologic agents|mesh-ancestor
19975536|NCT01850823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19975537|NCT01851330|Sofosbuvir|sofosbuvir|mesh-list
19975538|NCT01851330|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19975539|NCT01851330|Ledipasvir|ledipasvir|mesh-list
19975540|NCT01851330|Antiviral Agents|antiviral agents|mesh-ancestor
19975541|NCT01851330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19975542|NCT01851590|Terbinafine|terbinafine|mesh-list
19975543|NCT01851590|Amorolfine|amorolfine|mesh-list
19975544|NCT01851590|Antifungal Agents|antifungal agents|mesh-ancestor
19975545|NCT01851590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19975546|NCT01851590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19975547|NCT01851590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975548|NCT01851720|Fentanyl|fentanyl|mesh-list
19975549|NCT01851720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19975550|NCT01851720|Narcotics|narcotics|mesh-ancestor
19975551|NCT01851720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19975552|NCT01851720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975553|NCT01851720|Analgesics|analgesics|mesh-ancestor
19975554|NCT01851720|Sensory System Agents|sensory system agents|mesh-ancestor
19975555|NCT01851720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975556|NCT01851720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19975557|NCT01851720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19975558|NCT01851720|Anesthetics, General|anesthetics, general|mesh-ancestor
19975559|NCT01851720|Anesthetics|anesthetics|mesh-ancestor
19975560|NCT01851863|Flupenthixol|flupenthixol|mesh-list
19975561|NCT01851863|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
19975562|NCT01851863|Omeprazole|omeprazole|mesh-list
19975563|NCT01851863|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19975564|NCT01851863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19975565|NCT01851863|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19975566|NCT01851863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19975567|NCT01851863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975568|NCT01851863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19975569|NCT01851863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19975570|NCT01851863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19975571|NCT01851863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975572|NCT01851863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19975573|NCT01851863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19975574|NCT01851863|Dopamine Agents|dopamine agents|mesh-ancestor
19975575|NCT01851863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975576|NCT01852019|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19975577|NCT01852019|Cangrelor|cangrelor|mesh-list
19975578|NCT01852019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19975579|NCT01852019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19975580|NCT01852019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19975581|NCT01852019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19975582|NCT01852019|Purinergic Agents|purinergic agents|mesh-ancestor
19975583|NCT01852019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975584|NCT01852019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975585|NCT01852019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975586|NCT01852045|Botulinum Toxins|botulinum toxins|mesh-list
19975587|NCT01852045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19975588|NCT01852045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19975589|NCT01852045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19975590|NCT01852045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19975591|NCT01852045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975592|NCT01852045|Cholinergic Agents|cholinergic agents|mesh-ancestor
19975593|NCT01852045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975594|NCT01852045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975595|NCT01852045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19975596|NCT01852045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975597|NCT01852058|Botulinum Toxins|botulinum toxins|mesh-list
19975598|NCT01852058|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19975599|NCT01852058|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19975600|NCT01852058|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19975601|NCT01852058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19975602|NCT01852058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975603|NCT01852058|Cholinergic Agents|cholinergic agents|mesh-ancestor
19975604|NCT01852058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975605|NCT01852058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975606|NCT01852058|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19975607|NCT01852058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975608|NCT01852071|Busulfan|busulfan|mesh-list
19975609|NCT01852071|Alkylating Agents|alkylating agents|mesh-ancestor
19975610|NCT01852071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975611|NCT01852071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19975612|NCT01852071|Immunologic Factors|immunologic factors|mesh-ancestor
19975613|NCT01852071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975614|NCT01852071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19975615|NCT01852071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975616|NCT01852071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19975617|NCT01852162|Dabigatran|dabigatran|mesh-list
19975618|NCT01852162|Antithrombins|antithrombins|mesh-ancestor
19975619|NCT01852162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19975620|NCT01852162|Protease Inhibitors|protease inhibitors|mesh-ancestor
19975621|NCT01852162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555081|NCT01938729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20555082|NCT01938729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19975622|NCT01852162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975623|NCT01852162|Anticoagulants|anticoagulants|mesh-ancestor
19975624|NCT01852175|Ticagrelor|ticagrelor|mesh-list
19975625|NCT01852175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19975626|NCT01852175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19975627|NCT01852175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19975628|NCT01852175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19975629|NCT01852175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19975630|NCT01852175|Purinergic Agents|purinergic agents|mesh-ancestor
19975631|NCT01852175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975632|NCT01852175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975633|NCT01852175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975634|NCT01852214|Ticagrelor|ticagrelor|mesh-list
19975635|NCT01852214|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19975636|NCT01852214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19975637|NCT01852214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19975638|NCT01852214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19975639|NCT01852214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19975640|NCT01852214|Purinergic Agents|purinergic agents|mesh-ancestor
19975641|NCT01852214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975642|NCT01852214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975643|NCT01852214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975644|NCT01852292|Paclitaxel|paclitaxel|mesh-list
19975645|NCT01852292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19975646|NCT01852292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975647|NCT01852292|Tubulin Modulators|tubulin modulators|mesh-ancestor
19975648|NCT01852292|Antimitotic Agents|antimitotic agents|mesh-ancestor
19975649|NCT01852292|Mitosis Modulators|mitosis modulators|mesh-ancestor
19975650|NCT01852292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975651|NCT01852344|Methylphenidate|methylphenidate|mesh-list
19975652|NCT01852344|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19975653|NCT01852344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975654|NCT01852344|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19975655|NCT01852344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19975656|NCT01852344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19975657|NCT01852344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975658|NCT01852344|Dopamine Agents|dopamine agents|mesh-ancestor
19975659|NCT01852344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975660|NCT01852383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19975661|NCT01852383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19975662|NCT01852383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19975663|NCT01852383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19975664|NCT01852383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555083|NCT01938729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555084|NCT01938729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20555085|NCT01938729|Antimetabolites|antimetabolites|mesh-ancestor
20555086|NCT01938729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555087|NCT01938729|Antiviral Agents|antiviral agents|mesh-ancestor
20555088|NCT01938729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20555089|NCT01938729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555090|NCT01938729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20555091|NCT01938729|Immunologic Factors|immunologic factors|mesh-ancestor
20555092|NCT01938755|Levobupivacaine|levobupivacaine|mesh-list
20555093|NCT01938755|Anesthetics, Local|anesthetics, local|mesh-ancestor
20555094|NCT01938755|Anesthetics|anesthetics|mesh-ancestor
20555095|NCT01938755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20555096|NCT01938755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555097|NCT01938755|Sensory System Agents|sensory system agents|mesh-ancestor
20555098|NCT01938755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975665|NCT01852383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975666|NCT01852383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975667|NCT01852383|Analgesics|analgesics|mesh-ancestor
19975668|NCT01852383|Sensory System Agents|sensory system agents|mesh-ancestor
19975669|NCT01852383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975670|NCT01852383|Antidepressive Agents|antidepressive agents|mesh-ancestor
19975671|NCT01852383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19975672|NCT01852383|Dopamine Agents|dopamine agents|mesh-ancestor
20555099|NCT01938781|Entecavir|entecavir|mesh-list
20555100|NCT01938781|Antiviral Agents|antiviral agents|mesh-ancestor
20555101|NCT01938781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20555102|NCT01938820|Entecavir|entecavir|mesh-list
20555103|NCT01938820|Antiviral Agents|antiviral agents|mesh-ancestor
20555104|NCT01938820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20555105|NCT01938859|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20555106|NCT01938859|Antidepressive Agents|antidepressive agents|mesh-ancestor
20555107|NCT01938859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20555108|NCT01938859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20555109|NCT01938859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20555110|NCT01938859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20555111|NCT01938859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555112|NCT01938872|Paclitaxel|paclitaxel|mesh-list
20555113|NCT01938872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20555114|NCT01938872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555115|NCT01938872|Tubulin Modulators|tubulin modulators|mesh-ancestor
20555116|NCT01938872|Antimitotic Agents|antimitotic agents|mesh-ancestor
20555117|NCT01938872|Mitosis Modulators|mitosis modulators|mesh-ancestor
19452945|NCT03407976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452946|NCT03407937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19452947|NCT03407937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19452948|NCT03407937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452949|NCT03407872|Esketamine|esketamine|mesh-list
19452950|NCT03407872|Antidepressive Agents|antidepressive agents|mesh-ancestor
19452951|NCT03407872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19452952|NCT03407703|Grazoprevir|grazoprevir|mesh-list
19452953|NCT03407703|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
19452954|NCT03407703|Antiviral Agents|antiviral agents|mesh-ancestor
19452955|NCT03407703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19452956|NCT03407599|Insulin Aspart|insulin aspart|mesh-list
19452957|NCT03407599|Insulin, Long-Acting|insulin, long-acting|mesh-list
19452958|NCT03407599|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19452959|NCT03407599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19452960|NCT03407599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452961|NCT03407521|Isosorbide|isosorbide|mesh-list
19452962|NCT03407521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19452963|NCT03407521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19452964|NCT03407521|Misoprostol|misoprostol|mesh-list
19452965|NCT03407521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19452966|NCT03407521|Abortifacient Agents|abortifacient agents|mesh-ancestor
19452967|NCT03407521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19452968|NCT03407521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452969|NCT03407521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19452970|NCT03407521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19452971|NCT03407521|Oxytocics|oxytocics|mesh-ancestor
19452972|NCT03407521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19452973|NCT03407521|Diuretics|diuretics|mesh-ancestor
19452974|NCT03407521|Natriuretic Agents|natriuretic agents|mesh-ancestor
19452975|NCT03407521|Vasodilator Agents|vasodilator agents|mesh-ancestor
19452976|NCT03407521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19452977|NCT03407521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452978|NCT03407404|Midazolam|midazolam|mesh-list
19452979|NCT03407404|Ketamine|ketamine|mesh-list
19975673|NCT01852591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19975674|NCT01852591|Immunologic Factors|immunologic factors|mesh-ancestor
19975675|NCT01852591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975676|NCT01852669|Furosemide|furosemide|mesh-list
19975677|NCT01852669|Diuretics|diuretics|mesh-ancestor
19975678|NCT01852669|Natriuretic Agents|natriuretic agents|mesh-ancestor
19975679|NCT01852669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975680|NCT01852669|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19975681|NCT01852669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19975682|NCT01852669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555118|NCT01938872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555119|NCT01938911|Oxytocin|oxytocin|mesh-list
20555120|NCT01938911|Oxytocics|oxytocics|mesh-ancestor
19452980|NCT03407404|Morphine|morphine|mesh-list
19975683|NCT01852942|Losartan|losartan|mesh-list
19975684|NCT01852942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19975685|NCT01852942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19975686|NCT01852942|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19975687|NCT01852942|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19975688|NCT01852942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975689|NCT01852955|Acetaminophen|acetaminophen|mesh-list
19975690|NCT01852955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19975691|NCT01852955|Analgesics|analgesics|mesh-ancestor
19975692|NCT01852955|Sensory System Agents|sensory system agents|mesh-ancestor
19975693|NCT01852955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975694|NCT01852955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975695|NCT01852955|Antipyretics|antipyretics|mesh-ancestor
19975696|NCT01853072|Prednisolone|prednisolone|mesh-list
19975697|NCT01853072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19975698|NCT01853072|Methylprednisolone|methylprednisolone|mesh-list
19975699|NCT01853072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19975700|NCT01853072|Prednisolone acetate|prednisolone acetate|mesh-list
19975701|NCT01853072|Nepafenac|nepafenac|mesh-list
19975702|NCT01853072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19975703|NCT01853072|Prednisolone phosphate|prednisolone phosphate|mesh-list
20555121|NCT01938911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20555122|NCT01938911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555123|NCT01939054|Docetaxel|docetaxel|mesh-list
20555124|NCT01939054|Capecitabine|capecitabine|mesh-list
20555125|NCT01939054|Nimotuzumab|nimotuzumab|mesh-list
19975704|NCT01853072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19975705|NCT01853072|Glucocorticoids|glucocorticoids|mesh-ancestor
19975706|NCT01853072|Hormones|hormones|mesh-ancestor
19975707|NCT01853072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19975708|NCT01853072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975709|NCT01853072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19975710|NCT01853072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555126|NCT01939054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555127|NCT01939054|Tubulin Modulators|tubulin modulators|mesh-ancestor
20555128|NCT01939054|Antimitotic Agents|antimitotic agents|mesh-ancestor
19975711|NCT01853072|Antiemetics|antiemetics|mesh-ancestor
19975712|NCT01853072|Autonomic Agents|autonomic agents|mesh-ancestor
19975713|NCT01853072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975714|NCT01853072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19975715|NCT01853072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19975716|NCT01853072|Protective Agents|protective agents|mesh-ancestor
19975717|NCT01853072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19975718|NCT01853072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19975719|NCT01853072|Analgesics|analgesics|mesh-ancestor
19975720|NCT01853072|Sensory System Agents|sensory system agents|mesh-ancestor
19975721|NCT01853072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19975722|NCT01853085|Bimatoprost|bimatoprost|mesh-list
19975723|NCT01853085|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19975724|NCT01853085|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19975725|NCT01853085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19975726|NCT01853228|Cytarabine|cytarabine|mesh-list
19975727|NCT01853228|Decitabine|decitabine|mesh-list
19975728|NCT01853228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19975729|NCT01853228|Antimetabolites|antimetabolites|mesh-ancestor
19975730|NCT01853228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975731|NCT01853228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975732|NCT01853228|Antiviral Agents|antiviral agents|mesh-ancestor
19975733|NCT01853228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19975734|NCT01853228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19975735|NCT01853228|Immunologic Factors|immunologic factors|mesh-ancestor
19975736|NCT01853228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975737|NCT01853228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19975738|NCT01853254|Ribavirin|ribavirin|mesh-list
19975739|NCT01853254|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19975740|NCT01853254|Antimetabolites|antimetabolites|mesh-ancestor
19975741|NCT01853254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975742|NCT01853254|Antiviral Agents|antiviral agents|mesh-ancestor
19975743|NCT01853254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19975744|NCT01853280|Methylphenidate|methylphenidate|mesh-list
19975745|NCT01853280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19975746|NCT01853280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975747|NCT01853280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19975748|NCT01853280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19975749|NCT01853280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19975750|NCT01853280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975751|NCT01853280|Dopamine Agents|dopamine agents|mesh-ancestor
19975752|NCT01853280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975753|NCT01853475|Artefenomel|artefenomel|mesh-list
19975754|NCT01853475|Antimalarials|antimalarials|mesh-ancestor
19975755|NCT01853475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19975756|NCT01853475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19975757|NCT01853475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19975758|NCT01853553|Spironolactone|spironolactone|mesh-list
19975759|NCT01853553|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19975760|NCT01853553|Hormone Antagonists|hormone antagonists|mesh-ancestor
19975761|NCT01853553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19975762|NCT01853553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975763|NCT01853553|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19975764|NCT01853553|Diuretics|diuretics|mesh-ancestor
19975765|NCT01853553|Natriuretic Agents|natriuretic agents|mesh-ancestor
19975766|NCT01853618|Tremelimumab|tremelimumab|mesh-list
19975767|NCT01853618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288666|NCT05248984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288667|NCT05246007|Dexmedetomidine|dexmedetomidine|mesh-list
20288668|NCT05246007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20288669|NCT05246007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20288670|NCT05246007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288671|NCT05246007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20288672|NCT05246007|Analgesics|analgesics|mesh-ancestor
20288673|NCT05246007|Sensory System Agents|sensory system agents|mesh-ancestor
20288674|NCT05246007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20288675|NCT05246007|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20555129|NCT01939054|Mitosis Modulators|mitosis modulators|mesh-ancestor
20555130|NCT01939054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288676|NCT05246007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20288677|NCT05246007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20288678|NCT05246007|Adrenergic Agents|adrenergic agents|mesh-ancestor
20288679|NCT05246007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20555131|NCT01939054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20555132|NCT01939054|Antimetabolites|antimetabolites|mesh-ancestor
20555133|NCT01939054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20555134|NCT01939093|Thiamine|thiamine|mesh-list
20555135|NCT01939093|Cinnarizine|cinnarizine|mesh-list
20555136|NCT01939093|Diazepam|diazepam|mesh-list
20555137|NCT01939093|Vitamins|vitamins|mesh-ancestor
20555138|NCT01939093|Micronutrients|micronutrients|mesh-ancestor
20555139|NCT01939093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555140|NCT01939093|Vitamin B Complex|vitamin b complex|mesh-ancestor
20555141|NCT01939093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20555142|NCT01939093|Anticonvulsants|anticonvulsants|mesh-ancestor
20555143|NCT01939093|Antiemetics|antiemetics|mesh-ancestor
20555144|NCT01939093|Autonomic Agents|autonomic agents|mesh-ancestor
19975768|NCT01853696|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19975769|NCT01853696|Prednisolone|prednisolone|mesh-list
19975770|NCT01853696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19975771|NCT01853696|Methylprednisolone|methylprednisolone|mesh-list
19975772|NCT01853696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19975773|NCT01853696|Prednisolone acetate|prednisolone acetate|mesh-list
19975774|NCT01853696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19975775|NCT01853696|Prednisolone phosphate|prednisolone phosphate|mesh-list
19975776|NCT01853696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19975777|NCT01853696|Glucocorticoids|glucocorticoids|mesh-ancestor
19975778|NCT01853696|Hormones|hormones|mesh-ancestor
19975779|NCT01853696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19975780|NCT01853696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975781|NCT01853696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19975782|NCT01853696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975783|NCT01853696|Antiemetics|antiemetics|mesh-ancestor
19975784|NCT01853696|Autonomic Agents|autonomic agents|mesh-ancestor
19975785|NCT01853696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975786|NCT01853696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19975787|NCT01853696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19975788|NCT01853696|Protective Agents|protective agents|mesh-ancestor
19975789|NCT01853696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19975790|NCT01854047|Albuterol|albuterol|mesh-list
19975791|NCT01854047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19975792|NCT01854047|Autonomic Agents|autonomic agents|mesh-ancestor
19975793|NCT01854047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975794|NCT01854047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975795|NCT01854047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19975796|NCT01854047|Respiratory System Agents|respiratory system agents|mesh-ancestor
19975797|NCT01854047|Tocolytic Agents|tocolytic agents|mesh-ancestor
20555145|NCT01939093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20555146|NCT01939093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20555147|NCT01939093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20555148|NCT01939093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20555149|NCT01939093|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20555150|NCT01939093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19975798|NCT01854047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19975799|NCT01854047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19975800|NCT01854047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19975801|NCT01854047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19975802|NCT01854047|Adrenergic Agents|adrenergic agents|mesh-ancestor
19975803|NCT01854047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975804|NCT01854047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975805|NCT01854177|Aprepitant|aprepitant|mesh-list
19975806|NCT01854177|Fosaprepitant|fosaprepitant|mesh-list
19975807|NCT01854177|Antiemetics|antiemetics|mesh-ancestor
19975808|NCT01854177|Autonomic Agents|autonomic agents|mesh-ancestor
20555151|NCT01939093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20555152|NCT01939093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20555153|NCT01939093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20555154|NCT01939093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20555155|NCT01939093|Anesthetics, General|anesthetics, general|mesh-ancestor
20555156|NCT01939093|Anesthetics|anesthetics|mesh-ancestor
20555157|NCT01939093|GABA Modulators|gaba modulators|mesh-ancestor
20555158|NCT01939093|GABA Agents|gaba agents|mesh-ancestor
20555159|NCT01939093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975809|NCT01854177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975810|NCT01854177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975811|NCT01854177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19975812|NCT01854177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19975813|NCT01854177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975814|NCT01854177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975815|NCT01854359|Idebenone|idebenone|mesh-list
19975816|NCT01854359|Antioxidants|antioxidants|mesh-ancestor
19975817|NCT01854359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975818|NCT01854359|Protective Agents|protective agents|mesh-ancestor
20555160|NCT01939093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555161|NCT01939093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20555162|NCT01939093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20555163|NCT01939093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20555164|NCT01939093|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19975819|NCT01854359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975820|NCT01854528|Interferons|interferons|mesh-list
19975821|NCT01854528|Ribavirin|ribavirin|mesh-list
19975822|NCT01854528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975823|NCT01854528|Antiviral Agents|antiviral agents|mesh-ancestor
19975824|NCT01854528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19975825|NCT01854528|Antimetabolites|antimetabolites|mesh-ancestor
19975826|NCT01854528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975827|NCT01854593|Bevacizumab|bevacizumab|mesh-list
19975828|NCT01854593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19975829|NCT01854593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975830|NCT01854593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19975831|NCT01854593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19975832|NCT01854593|Growth Substances|growth substances|mesh-ancestor
19975833|NCT01854593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975834|NCT01854593|Growth Inhibitors|growth inhibitors|mesh-ancestor
19975835|NCT01854645|Bromides|bromides|mesh-list
19975836|NCT01854645|Tiotropium Bromide|tiotropium bromide|mesh-list
19975837|NCT01854645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19975838|NCT01854645|Autonomic Agents|autonomic agents|mesh-ancestor
19975839|NCT01854645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975840|NCT01854645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975841|NCT01854645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19975842|NCT01854645|Respiratory System Agents|respiratory system agents|mesh-ancestor
19975843|NCT01854645|Parasympatholytics|parasympatholytics|mesh-ancestor
19975844|NCT01854645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19975845|NCT01854645|Cholinergic Agents|cholinergic agents|mesh-ancestor
19975846|NCT01854645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975847|NCT01854645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975848|NCT01854645|Anticonvulsants|anticonvulsants|mesh-ancestor
19975849|NCT01854658|Glycopyrrolate|glycopyrrolate|mesh-list
19975850|NCT01854658|Formoterol Fumarate|formoterol fumarate|mesh-list
19975851|NCT01854658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19975852|NCT01854658|Autonomic Agents|autonomic agents|mesh-ancestor
19975853|NCT01854658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19975854|NCT01854658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975855|NCT01854658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19975856|NCT01854658|Respiratory System Agents|respiratory system agents|mesh-ancestor
19975857|NCT01854658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19975858|NCT01854658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20555165|NCT01939093|Histamine Antagonists|histamine antagonists|mesh-ancestor
20555166|NCT01939093|Histamine Agents|histamine agents|mesh-ancestor
20555167|NCT01939171|Thymoglobulin|thymoglobulin|mesh-list
20555168|NCT01939171|Immunologic Factors|immunologic factors|mesh-ancestor
20555169|NCT01939171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555170|NCT01939171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20555171|NCT01939327|Rituximab|rituximab|mesh-list
20555172|NCT01939327|Lenalidomide|lenalidomide|mesh-list
20555173|NCT01939327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20555174|NCT01939327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555175|NCT01939327|Immunologic Factors|immunologic factors|mesh-ancestor
19975859|NCT01854658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19975860|NCT01854658|Adrenergic Agents|adrenergic agents|mesh-ancestor
19975861|NCT01854658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975862|NCT01854658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975863|NCT01854658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19975864|NCT01854658|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19975865|NCT01854658|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19975866|NCT01854658|Cholinergic Agents|cholinergic agents|mesh-ancestor
19975867|NCT01854697|Interferons|interferons|mesh-list
19975868|NCT01854697|Ribavirin|ribavirin|mesh-list
19975869|NCT01854697|Interferon-alpha|interferon-alpha|mesh-list
19975870|NCT01854697|Interferon alpha-2|interferon alpha-2|mesh-list
19975871|NCT01854697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19975872|NCT01854697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975873|NCT01854697|Antiviral Agents|antiviral agents|mesh-ancestor
19975874|NCT01854697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19975875|NCT01854697|Antimetabolites|antimetabolites|mesh-ancestor
20555176|NCT01939327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555177|NCT01939327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20555178|NCT01939327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20555179|NCT01939327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20555180|NCT01939327|Growth Substances|growth substances|mesh-ancestor
19975876|NCT01854697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975877|NCT01854697|Immunologic Factors|immunologic factors|mesh-ancestor
19975878|NCT01854697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555181|NCT01939327|Growth Inhibitors|growth inhibitors|mesh-ancestor
19452981|NCT03407404|Analgesics|analgesics|mesh-ancestor
19975879|NCT01854710|Moxifloxacin|moxifloxacin|mesh-list
20555182|NCT01939379|Acetaminophen|acetaminophen|mesh-list
20555183|NCT01939379|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20555184|NCT01939379|Morphine|morphine|mesh-list
20555185|NCT01939379|Oxycodone|oxycodone|mesh-list
20555186|NCT01939379|Analgesics|analgesics|mesh-list
20555187|NCT01939379|Ropivacaine|ropivacaine|mesh-list
20555188|NCT01939379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20555189|NCT01939379|Narcotics|narcotics|mesh-ancestor
19975880|NCT01854710|Loxapine|loxapine|mesh-list
19975881|NCT01854710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19975882|NCT01854710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19975883|NCT01854710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19975884|NCT01854710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19975885|NCT01854710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19975886|NCT01854710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975887|NCT01854710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975888|NCT01854710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975889|NCT01854710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19975890|NCT01854710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19975891|NCT01854710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19975892|NCT01854710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19975893|NCT01854710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19975894|NCT01854710|Dopamine Agents|dopamine agents|mesh-ancestor
19975895|NCT01854710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975896|NCT01854775|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19975897|NCT01854775|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19975898|NCT01854775|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19975899|NCT01854775|Antiviral Agents|antiviral agents|mesh-ancestor
19975900|NCT01854775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19975901|NCT01854827|Immunoglobulins|immunoglobulins|mesh-list
19975902|NCT01854827|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19975903|NCT01854827|Antibodies|antibodies|mesh-list
19975904|NCT01854827|gamma-Globulins|gamma-globulins|mesh-list
19975905|NCT01854827|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19975906|NCT01854827|Immunologic Factors|immunologic factors|mesh-ancestor
19975907|NCT01854827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975908|NCT01854918|Evolocumab|evolocumab|mesh-list
19975909|NCT01854918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19975910|NCT01854918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19975911|NCT01854918|Antimetabolites|antimetabolites|mesh-ancestor
19975912|NCT01854918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975913|NCT01854918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19975914|NCT01854944|Brexpiprazole|brexpiprazole|mesh-list
19975915|NCT01854944|Serotonin Agents|serotonin agents|mesh-ancestor
19975916|NCT01854944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975917|NCT01854944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975918|NCT01854944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975919|NCT01854944|Dopamine Agonists|dopamine agonists|mesh-ancestor
19975920|NCT01854944|Dopamine Agents|dopamine agents|mesh-ancestor
19975921|NCT01855074|Risperidone|risperidone|mesh-list
19975922|NCT01855074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19975923|NCT01855074|Serotonin Agents|serotonin agents|mesh-ancestor
19975924|NCT01855074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19975925|NCT01855074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975926|NCT01855074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975927|NCT01855074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19975928|NCT01855074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19975929|NCT01855074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19975930|NCT01855074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19975931|NCT01855074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19975932|NCT01855074|Dopamine Agents|dopamine agents|mesh-ancestor
19975933|NCT01855243|Insulin|insulin|mesh-list
19975934|NCT01855243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19975935|NCT01855243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19975936|NCT01855243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975937|NCT01855360|Doxycycline|doxycycline|mesh-list
19975938|NCT01855360|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
19975939|NCT01855360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19975940|NCT01855360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19975941|NCT01855360|Antimalarials|antimalarials|mesh-ancestor
19975942|NCT01855360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19975943|NCT01855360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20555190|NCT01939379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20555191|NCT01939379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555192|NCT01939379|Sensory System Agents|sensory system agents|mesh-ancestor
20555193|NCT01939379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20555194|NCT01939379|Anesthetics, Local|anesthetics, local|mesh-ancestor
20555195|NCT01939379|Anesthetics|anesthetics|mesh-ancestor
20555196|NCT01939379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20555197|NCT01939379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20555198|NCT01939379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19975944|NCT01855360|Antiviral Agents|antiviral agents|mesh-ancestor
19975945|NCT01855360|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19975946|NCT01855360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19975947|NCT01855750|Prednisone|prednisone|mesh-list
19975948|NCT01855750|Cyclophosphamide|cyclophosphamide|mesh-list
19975949|NCT01855750|Rituximab|rituximab|mesh-list
19975950|NCT01855750|Doxorubicin|doxorubicin|mesh-list
19975951|NCT01855750|Vincristine|vincristine|mesh-list
19975952|NCT01855750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19975953|NCT01855750|Immunologic Factors|immunologic factors|mesh-ancestor
19975954|NCT01855750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975955|NCT01855750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19975956|NCT01855750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20555199|NCT01939379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20555200|NCT01939379|Antipyretics|antipyretics|mesh-ancestor
20555201|NCT01939418|Gemcitabine|gemcitabine|mesh-list
20555202|NCT01939418|Everolimus|everolimus|mesh-list
19975957|NCT01855750|Alkylating Agents|alkylating agents|mesh-ancestor
19975958|NCT01855750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975959|NCT01855750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975960|NCT01855750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19975961|NCT01855750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19975962|NCT01855750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19975963|NCT01855750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19975964|NCT01855750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19975965|NCT01855750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19975966|NCT01855750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19975967|NCT01855750|Glucocorticoids|glucocorticoids|mesh-ancestor
19975968|NCT01855750|Hormones|hormones|mesh-ancestor
19975969|NCT01855750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19975970|NCT01855750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20555203|NCT01939418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555204|NCT01939418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19975971|NCT01855750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19975972|NCT01855750|Tubulin Modulators|tubulin modulators|mesh-ancestor
19975973|NCT01855750|Antimitotic Agents|antimitotic agents|mesh-ancestor
19975974|NCT01855750|Mitosis Modulators|mitosis modulators|mesh-ancestor
19975975|NCT01855789|Methotrexate|methotrexate|mesh-list
19975976|NCT01855789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19975977|NCT01855789|Abortifacient Agents|abortifacient agents|mesh-ancestor
19975978|NCT01855789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19975979|NCT01855789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19975980|NCT01855789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19975981|NCT01855789|Antimetabolites|antimetabolites|mesh-ancestor
19975982|NCT01855789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19975983|NCT01855789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975984|NCT01855789|Dermatologic Agents|dermatologic agents|mesh-ancestor
19975985|NCT01855789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19975986|NCT01855789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19975987|NCT01855789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19975988|NCT01855789|Immunologic Factors|immunologic factors|mesh-ancestor
19975989|NCT01855789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19975990|NCT01855789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19975991|NCT01855828|Paclitaxel|paclitaxel|mesh-list
19975992|NCT01855828|Cyclophosphamide|cyclophosphamide|mesh-list
19975993|NCT01855828|Fluorouracil|fluorouracil|mesh-list
19975994|NCT01855828|Trastuzumab|trastuzumab|mesh-list
20555205|NCT01939418|Antimetabolites|antimetabolites|mesh-ancestor
20555206|NCT01939418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555207|NCT01939418|Antiviral Agents|antiviral agents|mesh-ancestor
20555208|NCT01939418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20555209|NCT01939418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555210|NCT01939418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20555211|NCT01939418|Immunologic Factors|immunologic factors|mesh-ancestor
20555212|NCT01939418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555213|NCT01939444|Naloxone|naloxone|mesh-list
20555214|NCT01939444|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20555215|NCT01939444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555216|NCT01939444|Sensory System Agents|sensory system agents|mesh-ancestor
20555217|NCT01939444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20555218|NCT01939457|Misoprostol|misoprostol|mesh-list
20555219|NCT01939457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20555220|NCT01939457|Abortifacient Agents|abortifacient agents|mesh-ancestor
20555221|NCT01939457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20555222|NCT01939457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736038|NCT04533867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19736039|NCT04533867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736040|NCT04533867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19736041|NCT04533867|Antipruritics|antipruritics|mesh-ancestor
19736042|NCT04533867|Dermatologic Agents|dermatologic agents|mesh-ancestor
19736043|NCT04533867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19736044|NCT04533867|Serotonin Agents|serotonin agents|mesh-ancestor
19736045|NCT04533867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19736046|NCT04533867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736047|NCT04533867|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19736048|NCT04533867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19736049|NCT04533867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19736050|NCT04533867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19736051|NCT04533867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19975995|NCT01855828|Epirubicin|epirubicin|mesh-list
19975996|NCT01855828|Pertuzumab|pertuzumab|mesh-list
19975997|NCT01855828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19975998|NCT01855828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19975999|NCT01855828|Tubulin Modulators|tubulin modulators|mesh-ancestor
19976000|NCT01855828|Antimitotic Agents|antimitotic agents|mesh-ancestor
19976001|NCT01855828|Mitosis Modulators|mitosis modulators|mesh-ancestor
19976002|NCT01855828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976003|NCT01855828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19976004|NCT01855828|Immunologic Factors|immunologic factors|mesh-ancestor
19976005|NCT01855828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976006|NCT01855828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19976007|NCT01855828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19976008|NCT01855828|Alkylating Agents|alkylating agents|mesh-ancestor
19976009|NCT01855828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20555223|NCT01939457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19976010|NCT01855828|Antimetabolites|antimetabolites|mesh-ancestor
19976011|NCT01855828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19976012|NCT01855828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19976013|NCT01855828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19976014|NCT01855828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19976015|NCT01855828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19976016|NCT01855828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976017|NCT01855919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19976018|NCT01855919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19976019|NCT01855919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19976020|NCT01855919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20555224|NCT01939457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20555225|NCT01939457|Oxytocics|oxytocics|mesh-ancestor
20555226|NCT01939483|Irinotecan|irinotecan|mesh-list
20555227|NCT01939483|Camptothecin|camptothecin|mesh-list
20555228|NCT01939483|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20555229|NCT01939483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20555230|NCT01939483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555231|NCT01939483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555232|NCT01939483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555233|NCT01939483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20555234|NCT01939509|Atenolol|atenolol|mesh-list
20555235|NCT01939509|Bisoprolol|bisoprolol|mesh-list
20555236|NCT01939509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20555237|NCT01939509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20555238|NCT01939509|Sympatholytics|sympatholytics|mesh-ancestor
19976021|NCT01855919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976022|NCT01855919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19976023|NCT01855919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976024|NCT01855919|Analgesics|analgesics|mesh-ancestor
20555239|NCT01939509|Autonomic Agents|autonomic agents|mesh-ancestor
20555240|NCT01939509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20555241|NCT01939509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555242|NCT01939509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19452982|NCT03407404|Sensory System Agents|sensory system agents|mesh-ancestor
19452983|NCT03407404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19452984|NCT03407404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19452985|NCT03407404|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19452986|NCT03407404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19452987|NCT03407404|Anesthetics, General|anesthetics, general|mesh-ancestor
19452988|NCT03407404|Anesthetics|anesthetics|mesh-ancestor
19452989|NCT03407404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19452990|NCT03407404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19976025|NCT01855919|Sensory System Agents|sensory system agents|mesh-ancestor
19976026|NCT01855919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976027|NCT01855919|Antidepressive Agents|antidepressive agents|mesh-ancestor
19976028|NCT01855919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19976029|NCT01855919|Dopamine Agents|dopamine agents|mesh-ancestor
19976030|NCT01855997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19976031|NCT01855997|Interferon alpha-2|interferon alpha-2|mesh-list
19976032|NCT01855997|Antiviral Agents|antiviral agents|mesh-ancestor
19976033|NCT01855997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19976034|NCT01855997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976035|NCT01856114|Fentanyl|fentanyl|mesh-list
19976036|NCT01856114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19976037|NCT01856114|Narcotics|narcotics|mesh-ancestor
19976038|NCT01856114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19976039|NCT01856114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976040|NCT01856114|Analgesics|analgesics|mesh-ancestor
19976041|NCT01856114|Sensory System Agents|sensory system agents|mesh-ancestor
19976042|NCT01856114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976043|NCT01856114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19976044|NCT01856114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19976045|NCT01856114|Anesthetics, General|anesthetics, general|mesh-ancestor
19976046|NCT01856114|Anesthetics|anesthetics|mesh-ancestor
19976047|NCT01856257|Mycophenolic Acid|mycophenolic acid|mesh-list
19976048|NCT01856257|Methylprednisolone|methylprednisolone|mesh-list
19976049|NCT01856257|Abatacept|abatacept|mesh-list
19976050|NCT01856257|Tacrolimus|tacrolimus|mesh-list
19976051|NCT01856257|Thymoglobulin|thymoglobulin|mesh-list
19976052|NCT01856257|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19976053|NCT01856257|Basiliximab|basiliximab|mesh-list
19976054|NCT01856257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19976055|NCT01856257|Immunologic Factors|immunologic factors|mesh-ancestor
19976056|NCT01856257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976057|NCT01856257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19976058|NCT01856257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976059|NCT01856257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976060|NCT01856257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19976061|NCT01856257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976062|NCT01856257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19976063|NCT01856257|Antitubercular Agents|antitubercular agents|mesh-ancestor
19976064|NCT01856257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20555243|NCT01939509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20555244|NCT01939509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20555245|NCT01939509|Adrenergic Agents|adrenergic agents|mesh-ancestor
20555246|NCT01939509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20555247|NCT01939509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976065|NCT01856257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19976066|NCT01856257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19976067|NCT01856257|Antiemetics|antiemetics|mesh-ancestor
19976068|NCT01856257|Autonomic Agents|autonomic agents|mesh-ancestor
19976069|NCT01856257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976070|NCT01856257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19976071|NCT01856257|Glucocorticoids|glucocorticoids|mesh-ancestor
19976072|NCT01856257|Hormones|hormones|mesh-ancestor
19976073|NCT01856257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19976074|NCT01856257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19976075|NCT01856257|Protective Agents|protective agents|mesh-ancestor
19976076|NCT01856257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19976077|NCT01856257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19976078|NCT01856309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19976079|NCT01856309|Immunologic Factors|immunologic factors|mesh-ancestor
19976080|NCT01856309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976081|NCT01856530|Oxytocin|oxytocin|mesh-list
20555248|NCT01939522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20555249|NCT01939522|Immunologic Factors|immunologic factors|mesh-ancestor
20555250|NCT01939522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555251|NCT01939561|Lamotrigine|lamotrigine|mesh-list
20555252|NCT01939561|Anticonvulsants|anticonvulsants|mesh-ancestor
20555253|NCT01939561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20555254|NCT01939561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20555255|NCT01939561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555256|NCT01939561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20555257|NCT01939561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555258|NCT01939561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20555259|NCT01939561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20555260|NCT01939561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20555261|NCT01939561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20555262|NCT01939561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20555263|NCT01939574|Bevacizumab|bevacizumab|mesh-list
20555264|NCT01939574|Temozolomide|temozolomide|mesh-list
19976082|NCT01856530|Oxytocics|oxytocics|mesh-ancestor
19976083|NCT01856530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19976084|NCT01856530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976085|NCT01856543|Mometasone Furoate|mometasone furoate|mesh-list
19976086|NCT01856543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19976087|NCT01856543|Dermatologic Agents|dermatologic agents|mesh-ancestor
19976088|NCT01856543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19976089|NCT01856712|Naltrexone|naltrexone|mesh-list
19976090|NCT01856712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19976091|NCT01856712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19976092|NCT01856712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976093|NCT01856712|Sensory System Agents|sensory system agents|mesh-ancestor
19976094|NCT01856712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976095|NCT01856790|Liraglutide|liraglutide|mesh-list
19976096|NCT01856790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19976097|NCT01856790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976098|NCT01856790|Incretins|incretins|mesh-ancestor
19976099|NCT01856790|Hormones|hormones|mesh-ancestor
19976100|NCT01856790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19976101|NCT01856907|Metformin|metformin|mesh-list
19976102|NCT01856907|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19976103|NCT01856907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19976104|NCT01856907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976105|NCT01856907|Incretins|incretins|mesh-ancestor
19976106|NCT01856907|Hormones|hormones|mesh-ancestor
20555265|NCT01939574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20555266|NCT01939574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555267|NCT01939574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20555268|NCT01939574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20555269|NCT01939574|Growth Substances|growth substances|mesh-ancestor
20555270|NCT01939574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555271|NCT01939574|Growth Inhibitors|growth inhibitors|mesh-ancestor
19976107|NCT01856907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19976108|NCT01856907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19976109|NCT01856907|Protease Inhibitors|protease inhibitors|mesh-ancestor
19976110|NCT01856907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976111|NCT01856907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976112|NCT01857206|Vaccines|vaccines|mesh-list
19976113|NCT01857206|Immunologic Factors|immunologic factors|mesh-ancestor
19976114|NCT01857206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976115|NCT01857232|Dexamethasone|dexamethasone|mesh-list
19976116|NCT01857232|Ondansetron|ondansetron|mesh-list
19976117|NCT01857232|Fosaprepitant|fosaprepitant|mesh-list
19976118|NCT01857232|Aprepitant|aprepitant|mesh-list
19976119|NCT01857232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19976120|NCT01857232|Antiemetics|antiemetics|mesh-ancestor
19976121|NCT01857232|Autonomic Agents|autonomic agents|mesh-ancestor
19976122|NCT01857232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976123|NCT01857232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976124|NCT01857232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19976125|NCT01857232|Glucocorticoids|glucocorticoids|mesh-ancestor
19976126|NCT01857232|Hormones|hormones|mesh-ancestor
19976127|NCT01857232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19976128|NCT01857232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19976129|NCT01857232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976130|NCT01857232|Antipruritics|antipruritics|mesh-ancestor
19976131|NCT01857232|Dermatologic Agents|dermatologic agents|mesh-ancestor
19976132|NCT01857232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19976133|NCT01857232|Serotonin Agents|serotonin agents|mesh-ancestor
19976134|NCT01857232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19976135|NCT01857232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976136|NCT01857232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19976137|NCT01857232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19976138|NCT01857232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19976139|NCT01857232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19976140|NCT01857232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19976141|NCT01857232|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19976142|NCT01857297|Vaccines|vaccines|mesh-list
19976143|NCT01857297|Immunologic Factors|immunologic factors|mesh-ancestor
19976144|NCT01857297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976145|NCT01857310|Folic Acid|folic acid|mesh-list
19976146|NCT01857310|Hematinics|hematinics|mesh-ancestor
19976147|NCT01857310|Vitamin B Complex|vitamin b complex|mesh-ancestor
19976148|NCT01857310|Vitamins|vitamins|mesh-ancestor
19976149|NCT01857310|Micronutrients|micronutrients|mesh-ancestor
19976150|NCT01857310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976151|NCT01857323|Albuterol|albuterol|mesh-list
19976152|NCT01857323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19976153|NCT01857323|Autonomic Agents|autonomic agents|mesh-ancestor
19976154|NCT01857323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976155|NCT01857323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976156|NCT01857323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19976157|NCT01857323|Respiratory System Agents|respiratory system agents|mesh-ancestor
19976158|NCT01857323|Tocolytic Agents|tocolytic agents|mesh-ancestor
19976159|NCT01857323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19976160|NCT01857323|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19976161|NCT01857323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19976162|NCT01857323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19976163|NCT01857323|Adrenergic Agents|adrenergic agents|mesh-ancestor
19976164|NCT01857323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19976165|NCT01857323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976166|NCT01857362|Nitisinone|nitisinone|mesh-list
19976167|NCT01857362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976168|NCT01857362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976169|NCT01857531|Nicotine|nicotine|mesh-list
19976170|NCT01857531|Ganaxolone|ganaxolone|mesh-list
19976171|NCT01857531|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19976172|NCT01857531|Autonomic Agents|autonomic agents|mesh-ancestor
19976173|NCT01857531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976174|NCT01857531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976175|NCT01857531|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19976176|NCT01857531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19976177|NCT01857531|Cholinergic Agents|cholinergic agents|mesh-ancestor
19976178|NCT01857531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19976179|NCT01857531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976180|NCT01857531|Neurosteroids|neurosteroids|mesh-ancestor
19976181|NCT01857531|GABA Modulators|gaba modulators|mesh-ancestor
19976182|NCT01857531|GABA Agents|gaba agents|mesh-ancestor
19976183|NCT01857583|PENTA|penta|mesh-list
19976184|NCT01857583|Edoxaban|edoxaban|mesh-list
19976185|NCT01857583|Fondaparinux|fondaparinux|mesh-list
19976186|NCT01857583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19976187|NCT01857583|Antithrombins|antithrombins|mesh-ancestor
19976188|NCT01857583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19976189|NCT01857583|Protease Inhibitors|protease inhibitors|mesh-ancestor
19976190|NCT01857583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976191|NCT01857583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976192|NCT01857583|Anticoagulants|anticoagulants|mesh-ancestor
19976193|NCT01857583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19976194|NCT01857583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19976195|NCT01857622|Edoxaban|edoxaban|mesh-list
19976196|NCT01857622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19976197|NCT01857622|Antithrombins|antithrombins|mesh-ancestor
19976198|NCT01857622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19976199|NCT01857622|Protease Inhibitors|protease inhibitors|mesh-ancestor
19976200|NCT01857622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976201|NCT01857622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976202|NCT01857622|Anticoagulants|anticoagulants|mesh-ancestor
19976203|NCT01858363|Paclitaxel|paclitaxel|mesh-list
19976204|NCT01858363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19976205|NCT01858363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976206|NCT01858363|Tubulin Modulators|tubulin modulators|mesh-ancestor
19976207|NCT01858363|Antimitotic Agents|antimitotic agents|mesh-ancestor
19976208|NCT01858363|Mitosis Modulators|mitosis modulators|mesh-ancestor
19976209|NCT01858363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976210|NCT01858428|Paclitaxel|paclitaxel|mesh-list
19976211|NCT01858428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19976212|NCT01858428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976213|NCT01858428|Tubulin Modulators|tubulin modulators|mesh-ancestor
19976214|NCT01858428|Antimitotic Agents|antimitotic agents|mesh-ancestor
19976215|NCT01858428|Mitosis Modulators|mitosis modulators|mesh-ancestor
19976216|NCT01858428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976217|NCT01858532|Atrasentan|atrasentan|mesh-list
19976218|NCT01858532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976219|NCT01858532|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19976220|NCT01858532|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19976221|NCT01858532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976222|NCT01858766|Ribavirin|ribavirin|mesh-list
19976223|NCT01858766|Antiviral Agents|antiviral agents|mesh-ancestor
19976224|NCT01858766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19976225|NCT01858766|Antimetabolites|antimetabolites|mesh-ancestor
19976226|NCT01858766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976227|NCT01859013|Topiramate|topiramate|mesh-list
19976228|NCT01859013|Anticonvulsants|anticonvulsants|mesh-ancestor
19976229|NCT01859013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19976230|NCT01859013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976231|NCT01859078|Digoxin|digoxin|mesh-list
19976232|NCT01859078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19976233|NCT01859078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19976234|NCT01859078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976235|NCT01859078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555272|NCT01939574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20555273|NCT01939574|Alkylating Agents|alkylating agents|mesh-ancestor
20555274|NCT01939574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555275|NCT01939639|Oxytocin|oxytocin|mesh-list
20555276|NCT01939639|Oxytocics|oxytocics|mesh-ancestor
20555277|NCT01939639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20555278|NCT01939639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976236|NCT01859078|Protective Agents|protective agents|mesh-ancestor
19976237|NCT01859078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976238|NCT01859312|Hydrocortisone|hydrocortisone|mesh-list
19976239|NCT01859312|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19976240|NCT01859312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19976241|NCT01859390|Antioxidants|antioxidants|mesh-list
19976242|NCT01859390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976243|NCT01859390|Protective Agents|protective agents|mesh-ancestor
19976244|NCT01859390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976245|NCT01859637|Lenograstim|lenograstim|mesh-list
19976246|NCT01859637|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19976247|NCT01859637|Immunologic Factors|immunologic factors|mesh-ancestor
19976248|NCT01859637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976249|NCT01859702|Moxifloxacin|moxifloxacin|mesh-list
19976250|NCT01859702|Dexamethasone|dexamethasone|mesh-list
19976251|NCT01859702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19976252|NCT01859702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19976253|NCT01859702|Antiemetics|antiemetics|mesh-ancestor
19976254|NCT01859702|Autonomic Agents|autonomic agents|mesh-ancestor
19976255|NCT01859702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976256|NCT01859702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976257|NCT01859702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19976258|NCT01859702|Glucocorticoids|glucocorticoids|mesh-ancestor
19976259|NCT01859702|Hormones|hormones|mesh-ancestor
19976260|NCT01859702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19976261|NCT01859702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19976262|NCT01859702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976263|NCT01859702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19976264|NCT01859702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19976265|NCT01859702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19976266|NCT01859702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19976267|NCT01859702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19976268|NCT01859702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976269|NCT01859702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288680|NCT05246007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288681|NCT05245292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20288682|NCT05245292|Antibodies|antibodies|mesh-list
20288683|NCT05245292|Immunoglobulins|immunoglobulins|mesh-list
20288684|NCT05245292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20288685|NCT05245292|Antibodies, Blocking|antibodies, blocking|mesh-list
20288686|NCT05245292|Immunologic Factors|immunologic factors|mesh-ancestor
20288687|NCT05245292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288688|NCT05245292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288689|NCT05243940|Lidocaine|lidocaine|mesh-list
20288690|NCT05243940|Dexmedetomidine|dexmedetomidine|mesh-list
20288691|NCT05243940|Ketamine|ketamine|mesh-list
20288692|NCT05243940|Remifentanil|remifentanil|mesh-list
20288693|NCT05243940|Anesthetics, Local|anesthetics, local|mesh-ancestor
20288694|NCT05243940|Anesthetics|anesthetics|mesh-ancestor
20288695|NCT05243940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20288696|NCT05243940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288697|NCT05243940|Sensory System Agents|sensory system agents|mesh-ancestor
20288698|NCT05243940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20288699|NCT05243940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20288700|NCT05243940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20288701|NCT05243940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20288702|NCT05243940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20288703|NCT05243940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288704|NCT05243940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20288705|NCT05243940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20288706|NCT05243940|Analgesics|analgesics|mesh-ancestor
20288707|NCT05243940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20288708|NCT05243940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20288709|NCT05243940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20288710|NCT05243940|Adrenergic Agents|adrenergic agents|mesh-ancestor
20288711|NCT05243940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20288712|NCT05243940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19976270|NCT01859715|Oxycodone|oxycodone|mesh-list
19976271|NCT01859715|Hydrocodone|hydrocodone|mesh-list
19976272|NCT01859715|Ondansetron|ondansetron|mesh-list
19976273|NCT01859715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19976274|NCT01859715|Narcotics|narcotics|mesh-ancestor
19976275|NCT01859715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19976276|NCT01859715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976277|NCT01859715|Analgesics|analgesics|mesh-ancestor
19976278|NCT01859715|Sensory System Agents|sensory system agents|mesh-ancestor
19976279|NCT01859715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976280|NCT01859715|Antiemetics|antiemetics|mesh-ancestor
19976281|NCT01859715|Autonomic Agents|autonomic agents|mesh-ancestor
19976282|NCT01859715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19976283|NCT01859715|Antipruritics|antipruritics|mesh-ancestor
19976284|NCT01859715|Dermatologic Agents|dermatologic agents|mesh-ancestor
19976285|NCT01859715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19976286|NCT01859715|Serotonin Agents|serotonin agents|mesh-ancestor
19976287|NCT01859715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19976288|NCT01859715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976289|NCT01859715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19976290|NCT01859715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19976291|NCT01859715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19976292|NCT01859715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19976293|NCT01859715|Antitussive Agents|antitussive agents|mesh-ancestor
19976294|NCT01859715|Respiratory System Agents|respiratory system agents|mesh-ancestor
19976295|NCT01859741|Carboplatin|carboplatin|mesh-list
19976296|NCT01859741|Etoposide|etoposide|mesh-list
19976297|NCT01859741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976298|NCT01859741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19976299|NCT01859741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19976300|NCT01859741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19976301|NCT01859741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976302|NCT01859741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976303|NCT01859793|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19976304|NCT01859793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19976305|NCT01859793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976306|NCT01859793|Incretins|incretins|mesh-ancestor
19976307|NCT01859793|Hormones|hormones|mesh-ancestor
19976308|NCT01859793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19976309|NCT01859793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19976310|NCT01859793|Protease Inhibitors|protease inhibitors|mesh-ancestor
19976311|NCT01859793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976312|NCT01859793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976313|NCT01860170|Cyclophosphamide|cyclophosphamide|mesh-list
19976314|NCT01860170|Bortezomib|bortezomib|mesh-list
19976315|NCT01860170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19976316|NCT01860170|Immunologic Factors|immunologic factors|mesh-ancestor
19976317|NCT01860170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976318|NCT01860170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19976319|NCT01860170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19976320|NCT01860170|Alkylating Agents|alkylating agents|mesh-ancestor
19976321|NCT01860170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976322|NCT01860170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976323|NCT01860170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19976324|NCT01860287|Buprenorphine|buprenorphine|mesh-list
19976325|NCT01860287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19976326|NCT01860287|Narcotics|narcotics|mesh-ancestor
19976327|NCT01860287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19976328|NCT01860287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976329|NCT01860287|Analgesics|analgesics|mesh-ancestor
19976330|NCT01860287|Sensory System Agents|sensory system agents|mesh-ancestor
19976331|NCT01860287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976332|NCT01860287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19976333|NCT01860521|Sufentanil|sufentanil|mesh-list
19976334|NCT01860521|Levobupivacaine|levobupivacaine|mesh-list
19976335|NCT01860521|Gemeprost|gemeprost|mesh-list
19976336|NCT01860521|Anesthetics, Local|anesthetics, local|mesh-ancestor
19976337|NCT01860521|Anesthetics|anesthetics|mesh-ancestor
19976338|NCT01860521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19976339|NCT01860521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976340|NCT01860521|Sensory System Agents|sensory system agents|mesh-ancestor
19976341|NCT01860521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976342|NCT01860521|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19976343|NCT01860521|Narcotics|narcotics|mesh-ancestor
19976344|NCT01860521|Analgesics|analgesics|mesh-ancestor
19976345|NCT01860521|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19976346|NCT01860521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19976347|NCT01860521|Anesthetics, General|anesthetics, general|mesh-ancestor
19976348|NCT01860521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19976349|NCT01860521|Abortifacient Agents|abortifacient agents|mesh-ancestor
19976350|NCT01860521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19976351|NCT01860586|Bevacizumab|bevacizumab|mesh-list
19976352|NCT01860586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19976353|NCT01860586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976354|NCT01860586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19976355|NCT01860586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19976356|NCT01860586|Growth Substances|growth substances|mesh-ancestor
19976357|NCT01860586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976358|NCT01860586|Growth Inhibitors|growth inhibitors|mesh-ancestor
19976359|NCT01860703|Moxifloxacin|moxifloxacin|mesh-list
19976360|NCT01860703|Deferiprone|deferiprone|mesh-list
19976361|NCT01860703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19976362|NCT01860703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19976363|NCT01860703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19976364|NCT01860703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19976365|NCT01860703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976366|NCT01860703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976367|NCT01860703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976368|NCT01860703|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19976369|NCT01860703|Chelating Agents|chelating agents|mesh-ancestor
19976370|NCT01860703|Sequestering Agents|sequestering agents|mesh-ancestor
19976371|NCT01860807|Ibudilast|ibudilast|mesh-list
19976372|NCT01860807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19976373|NCT01860807|Autonomic Agents|autonomic agents|mesh-ancestor
19976374|NCT01860807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976375|NCT01860807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976376|NCT01860807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19976377|NCT01860807|Respiratory System Agents|respiratory system agents|mesh-ancestor
19976378|NCT01860807|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19976379|NCT01860807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555279|NCT01939691|Prednisolone|prednisolone|mesh-list
20555280|NCT01939691|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20555281|NCT01939691|Methylprednisolone|methylprednisolone|mesh-list
20555282|NCT01939691|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20555283|NCT01939691|Prednisolone acetate|prednisolone acetate|mesh-list
20555284|NCT01939691|Nepafenac|nepafenac|mesh-list
20555285|NCT01939691|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20555286|NCT01939691|Prednisolone phosphate|prednisolone phosphate|mesh-list
20555287|NCT01939691|Difluprednate|difluprednate|mesh-list
19976380|NCT01860807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976381|NCT01860807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19976382|NCT01860807|Vasodilator Agents|vasodilator agents|mesh-ancestor
19976383|NCT01861002|Vidarabine|vidarabine|mesh-list
19976384|NCT01861002|Cytarabine|cytarabine|mesh-list
19976385|NCT01861002|Methotrexate|methotrexate|mesh-list
19976386|NCT01861002|Fludarabine phosphate|fludarabine phosphate|mesh-list
19976387|NCT01861002|Azacitidine|azacitidine|mesh-list
19976388|NCT01861002|Fludarabine|fludarabine|mesh-list
19976389|NCT01861002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19976390|NCT01861002|Abortifacient Agents|abortifacient agents|mesh-ancestor
19976391|NCT01861002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19976392|NCT01861002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976393|NCT01861002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19976394|NCT01861002|Antimetabolites|antimetabolites|mesh-ancestor
19976395|NCT01861002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555288|NCT01939691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20555289|NCT01939691|Glucocorticoids|glucocorticoids|mesh-ancestor
20555290|NCT01939691|Hormones|hormones|mesh-ancestor
20555291|NCT01939691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20555292|NCT01939691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976396|NCT01861002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976397|NCT01861002|Dermatologic Agents|dermatologic agents|mesh-ancestor
19976398|NCT01861002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976399|NCT01861002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19976400|NCT01861002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19976401|NCT01861002|Immunologic Factors|immunologic factors|mesh-ancestor
19976402|NCT01861002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19976403|NCT01861002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19976404|NCT01861002|Antiviral Agents|antiviral agents|mesh-ancestor
19976405|NCT01861002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19976406|NCT01861457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
19976407|NCT01861457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19976408|NCT01861522|Bepotastine besilate|bepotastine besilate|mesh-list
19976409|NCT01861522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19976410|NCT01861665|Bupivacaine|bupivacaine|mesh-list
19976411|NCT01861665|Anesthetics, Local|anesthetics, local|mesh-ancestor
19976412|NCT01861665|Anesthetics|anesthetics|mesh-ancestor
19976413|NCT01861665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19976414|NCT01861665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976415|NCT01861665|Sensory System Agents|sensory system agents|mesh-ancestor
19976416|NCT01861665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976417|NCT01862250|Clonidine|clonidine|mesh-list
19976418|NCT01862250|Analgesics|analgesics|mesh-ancestor
19976419|NCT01862250|Sensory System Agents|sensory system agents|mesh-ancestor
19976420|NCT01862250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976421|NCT01862250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976422|NCT01862250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19976423|NCT01862250|Sympatholytics|sympatholytics|mesh-ancestor
19976424|NCT01862250|Autonomic Agents|autonomic agents|mesh-ancestor
19976425|NCT01862250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19976426|NCT01862250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19976427|NCT01862250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19976428|NCT01862250|Adrenergic Agents|adrenergic agents|mesh-ancestor
19976429|NCT01862250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20555293|NCT01939691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20555294|NCT01939691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555295|NCT01939691|Antiemetics|antiemetics|mesh-ancestor
20555296|NCT01939691|Autonomic Agents|autonomic agents|mesh-ancestor
20555297|NCT01939691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20555298|NCT01939691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20555299|NCT01939691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20555300|NCT01939691|Protective Agents|protective agents|mesh-ancestor
20555301|NCT01939691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20555302|NCT01939691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20555303|NCT01939691|Analgesics|analgesics|mesh-ancestor
20555304|NCT01939691|Sensory System Agents|sensory system agents|mesh-ancestor
20555305|NCT01939691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20555306|NCT01939730|Rituximab|rituximab|mesh-list
20555307|NCT01939730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20555308|NCT01939730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976430|NCT01862250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976431|NCT01862328|Gemcitabine|gemcitabine|mesh-list
19976432|NCT01862328|Paclitaxel|paclitaxel|mesh-list
19976433|NCT01862328|Docetaxel|docetaxel|mesh-list
19976434|NCT01862328|Carboplatin|carboplatin|mesh-list
19976435|NCT01862328|Pevonedistat|pevonedistat|mesh-list
19976436|NCT01862328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19976437|NCT01862328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976438|NCT01862328|Tubulin Modulators|tubulin modulators|mesh-ancestor
19976439|NCT01862328|Antimitotic Agents|antimitotic agents|mesh-ancestor
19976440|NCT01862328|Mitosis Modulators|mitosis modulators|mesh-ancestor
19976441|NCT01862328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976442|NCT01862328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20555309|NCT01939730|Immunologic Factors|immunologic factors|mesh-ancestor
20555310|NCT01939730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555311|NCT01939730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20555312|NCT01939743|Diclofenac|diclofenac|mesh-list
20555313|NCT01939743|Lidocaine|lidocaine|mesh-list
20555314|NCT01939743|Anesthetics, Local|anesthetics, local|mesh-ancestor
20555315|NCT01939743|Anesthetics|anesthetics|mesh-ancestor
20555316|NCT01939743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20555317|NCT01939743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555318|NCT01939743|Sensory System Agents|sensory system agents|mesh-ancestor
20555319|NCT01939743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976443|NCT01862328|Antimetabolites|antimetabolites|mesh-ancestor
19976444|NCT01862328|Antiviral Agents|antiviral agents|mesh-ancestor
19976445|NCT01862328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19976446|NCT01862328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976447|NCT01862328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19976448|NCT01862328|Immunologic Factors|immunologic factors|mesh-ancestor
19976449|NCT01862328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976450|NCT01862536|Tadalafil|tadalafil|mesh-list
19976451|NCT01862536|Vasodilator Agents|vasodilator agents|mesh-ancestor
19976452|NCT01862536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19976453|NCT01862536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19976454|NCT01862536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555320|NCT01939743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20555321|NCT01939743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20555322|NCT01939743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20555323|NCT01939743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20555324|NCT01939743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555325|NCT01939743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20555326|NCT01939743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20555327|NCT01939743|Analgesics|analgesics|mesh-ancestor
20555328|NCT01939743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20555329|NCT01939743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20555330|NCT01939743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19976455|NCT01862536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976456|NCT01862536|Urological Agents|urological agents|mesh-ancestor
19976457|NCT01862614|Epinephrine|epinephrine|mesh-list
19976458|NCT01862614|Racepinephrine|racepinephrine|mesh-list
19976459|NCT01862614|Carticaine|carticaine|mesh-list
19976460|NCT01862614|Epinephryl borate|epinephryl borate|mesh-list
19976461|NCT01862614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19976462|NCT01862614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19976463|NCT01862614|Adrenergic Agents|adrenergic agents|mesh-ancestor
19976464|NCT01862614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19976465|NCT01862614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976466|NCT01862614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976467|NCT01862614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19976468|NCT01862614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19976469|NCT01862614|Autonomic Agents|autonomic agents|mesh-ancestor
19976470|NCT01862614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976471|NCT01862614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19976472|NCT01862614|Respiratory System Agents|respiratory system agents|mesh-ancestor
19976473|NCT01862614|Mydriatics|mydriatics|mesh-ancestor
19976474|NCT01862614|Sympathomimetics|sympathomimetics|mesh-ancestor
19976475|NCT01862614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19976476|NCT01862614|Anesthetics, Local|anesthetics, local|mesh-ancestor
19976477|NCT01862614|Anesthetics|anesthetics|mesh-ancestor
19976478|NCT01862614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20555331|NCT01939743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555332|NCT01939834|Insulin|insulin|mesh-list
19976479|NCT01862614|Sensory System Agents|sensory system agents|mesh-ancestor
19976480|NCT01862640|Brexpiprazole|brexpiprazole|mesh-list
19976481|NCT01862640|Serotonin Agents|serotonin agents|mesh-ancestor
19976482|NCT01862640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19976483|NCT01862640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976484|NCT01862640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976485|NCT01862640|Dopamine Agonists|dopamine agonists|mesh-ancestor
19976486|NCT01862640|Dopamine Agents|dopamine agents|mesh-ancestor
19976487|NCT01862874|Vaccines|vaccines|mesh-list
19976488|NCT01862874|Immunologic Factors|immunologic factors|mesh-ancestor
19976489|NCT01862874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976490|NCT01862991|Digoxin|digoxin|mesh-list
19976491|NCT01862991|Misoprostol|misoprostol|mesh-list
19976492|NCT01862991|Mifepristone|mifepristone|mesh-list
19976493|NCT01862991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19976494|NCT01862991|Abortifacient Agents|abortifacient agents|mesh-ancestor
20555333|NCT01939834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19976495|NCT01862991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19976496|NCT01862991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976497|NCT01862991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19976498|NCT01862991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19976499|NCT01862991|Oxytocics|oxytocics|mesh-ancestor
19976500|NCT01862991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19976501|NCT01862991|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19976502|NCT01862991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976503|NCT01862991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976504|NCT01862991|Protective Agents|protective agents|mesh-ancestor
19976505|NCT01862991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19976506|NCT01862991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19976507|NCT01862991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19976508|NCT01862991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19976509|NCT01862991|Contraceptive Agents|contraceptive agents|mesh-ancestor
19976510|NCT01862991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19976511|NCT01862991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19976512|NCT01862991|Hormone Antagonists|hormone antagonists|mesh-ancestor
19976513|NCT01862991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19976514|NCT01862991|Luteolytic Agents|luteolytic agents|mesh-ancestor
19976515|NCT01862991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19976516|NCT01862991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19976517|NCT01863134|Eptifibatide|eptifibatide|mesh-list
19976518|NCT01863134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19976519|NCT01863368|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19976520|NCT01863368|Lubricant Eye Drops|lubricant eye drops|mesh-list
19976521|NCT01863368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19976522|NCT01863667|Glimepiride|glimepiride|mesh-list
19976523|NCT01863667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19976524|NCT01863667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19976525|NCT01863667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976526|NCT01863667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19976527|NCT01863667|Immunologic Factors|immunologic factors|mesh-ancestor
19976528|NCT01863680|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19976529|NCT01863680|Hormones|hormones|mesh-list
19976530|NCT01863680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19976531|NCT01863680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19976532|NCT01863680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976533|NCT01863680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19976534|NCT01863771|Golimumab|golimumab|mesh-list
19976535|NCT01863771|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19976536|NCT01863771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19976537|NCT01863771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19976538|NCT01863771|Immunologic Factors|immunologic factors|mesh-ancestor
19976539|NCT01863771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976540|NCT01863849|Vaccines|vaccines|mesh-list
19976541|NCT01863849|Immunologic Factors|immunologic factors|mesh-ancestor
19976542|NCT01863849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976543|NCT01863953|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19976544|NCT01863953|Bimatoprost|bimatoprost|mesh-list
19976545|NCT01863953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19976546|NCT01863953|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19976547|NCT01863953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19976548|NCT01863953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19976549|NCT01863953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19976550|NCT01863953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19976551|NCT01863953|Adrenergic Agents|adrenergic agents|mesh-ancestor
19976552|NCT01863953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19976553|NCT01863953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976554|NCT01863953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976555|NCT01864005|Clopidogrel|clopidogrel|mesh-list
19976556|NCT01864005|Ticagrelor|ticagrelor|mesh-list
19976557|NCT01864005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19976558|NCT01864005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19976559|NCT01864005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19976560|NCT01864005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19976561|NCT01864005|Purinergic Agents|purinergic agents|mesh-ancestor
19976562|NCT01864005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19976563|NCT01864005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976564|NCT01864005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976565|NCT01864148|Interferons|interferons|mesh-list
19976566|NCT01864148|Interferon-beta|interferon-beta|mesh-list
19976567|NCT01864148|Interferon beta-1a|interferon beta-1a|mesh-list
19976568|NCT01864148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976569|NCT01864148|Antiviral Agents|antiviral agents|mesh-ancestor
19976570|NCT01864148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19976571|NCT01864148|Immunologic Factors|immunologic factors|mesh-ancestor
19976572|NCT01864148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976573|NCT01864148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19976574|NCT01864174|Metformin|metformin|mesh-list
19976575|NCT01864174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19976576|NCT01864174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976577|NCT01865084|Tadalafil|tadalafil|mesh-list
19976578|NCT01865084|Vasodilator Agents|vasodilator agents|mesh-ancestor
19976579|NCT01865084|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19976580|NCT01865084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19976581|NCT01865084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976582|NCT01865084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976583|NCT01865084|Urological Agents|urological agents|mesh-ancestor
19976584|NCT01865552|Etanercept|etanercept|mesh-list
19976585|NCT01865552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19976586|NCT01865552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19976587|NCT01865552|Analgesics|analgesics|mesh-ancestor
19976588|NCT01865552|Sensory System Agents|sensory system agents|mesh-ancestor
19976589|NCT01865552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976590|NCT01865552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976591|NCT01865552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19976592|NCT01865552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19976593|NCT01865552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19976594|NCT01865552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19976595|NCT01865552|Immunologic Factors|immunologic factors|mesh-ancestor
19976596|NCT01865708|Ethanol|ethanol|mesh-list
19976597|NCT01865708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19976598|NCT01865708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19976599|NCT01865708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19976600|NCT01865708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976601|NCT01865747|Everolimus|everolimus|mesh-list
19976602|NCT01865747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976603|NCT01865747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19976604|NCT01865747|Immunologic Factors|immunologic factors|mesh-ancestor
19976605|NCT01865747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976606|NCT01865812|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
19976607|NCT01865812|Cathartics|cathartics|mesh-ancestor
19976608|NCT01865812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19976609|NCT01866098|Naltrexone|naltrexone|mesh-list
19976610|NCT01866098|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19976611|NCT01866098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19976612|NCT01866098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976613|NCT01866098|Sensory System Agents|sensory system agents|mesh-ancestor
19976614|NCT01866098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976615|NCT01866319|Pembrolizumab|pembrolizumab|mesh-list
19976616|NCT01866319|Ipilimumab|ipilimumab|mesh-list
19976617|NCT01866319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19976618|NCT01866319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976619|NCT01866319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19976620|NCT01866319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976621|NCT01866410|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19976622|NCT01866410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976623|NCT01866410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19976624|NCT01866410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976625|NCT01866410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976626|NCT01866592|Adalimumab|adalimumab|mesh-list
19976627|NCT01866592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19976628|NCT01866592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19976629|NCT01866826|Rifaximin|rifaximin|mesh-list
19976630|NCT01866826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19976631|NCT01866826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19976632|NCT01866826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19976633|NCT01866917|Ropivacaine|ropivacaine|mesh-list
19976634|NCT01866917|Anesthetics, Local|anesthetics, local|mesh-ancestor
19976635|NCT01866917|Anesthetics|anesthetics|mesh-ancestor
19976636|NCT01866917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19976637|NCT01866917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976638|NCT01866917|Sensory System Agents|sensory system agents|mesh-ancestor
19976639|NCT01866917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976640|NCT01866943|Tranexamic Acid|tranexamic acid|mesh-list
19976641|NCT01866943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19976642|NCT01866943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19976643|NCT01866943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976644|NCT01866943|Hemostatics|hemostatics|mesh-ancestor
19976645|NCT01866943|Coagulants|coagulants|mesh-ancestor
19976646|NCT01867021|Vaccines|vaccines|mesh-list
19976647|NCT01867021|Immunologic Factors|immunologic factors|mesh-ancestor
19976648|NCT01867021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976649|NCT01867047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19976650|NCT01867047|Protease Inhibitors|protease inhibitors|mesh-ancestor
19976651|NCT01867047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976652|NCT01867047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976653|NCT01867086|Carboplatin|carboplatin|mesh-list
19976654|NCT01867086|Vaccines|vaccines|mesh-list
19976655|NCT01867086|Immunologic Factors|immunologic factors|mesh-ancestor
19976656|NCT01867086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976657|NCT01867086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976658|NCT01867294|Doxycycline|doxycycline|mesh-list
19976659|NCT01867294|Hydrocortisone|hydrocortisone|mesh-list
19976660|NCT01867294|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19976661|NCT01867294|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19976662|NCT01867294|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19976663|NCT01867294|Spironolactone|spironolactone|mesh-list
19976664|NCT01867294|Sunscreening Agents|sunscreening agents|mesh-list
19976665|NCT01867294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19976666|NCT01867294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19976667|NCT01867294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19976668|NCT01867294|Antimalarials|antimalarials|mesh-ancestor
19976669|NCT01867294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19976670|NCT01867294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19976671|NCT01867294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19976672|NCT01867294|Hormone Antagonists|hormone antagonists|mesh-ancestor
19976673|NCT01867294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19976674|NCT01867294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976675|NCT01867294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19976676|NCT01867294|Diuretics|diuretics|mesh-ancestor
19976677|NCT01867294|Natriuretic Agents|natriuretic agents|mesh-ancestor
19976678|NCT01867294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19976679|NCT01867294|Protective Agents|protective agents|mesh-ancestor
19976680|NCT01867294|Dermatologic Agents|dermatologic agents|mesh-ancestor
19976681|NCT01867307|Empagliflozin|empagliflozin|mesh-list
19976682|NCT01867307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19976683|NCT01867307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976684|NCT01867307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19976685|NCT01867307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288713|NCT05243940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20288714|NCT05243940|Anesthetics, General|anesthetics, general|mesh-ancestor
20288715|NCT05243940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20288716|NCT05243940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20288717|NCT05243940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20288718|NCT05243940|Narcotics|narcotics|mesh-ancestor
20288719|NCT05237141|Etonogestrel|etonogestrel|mesh-list
20288720|NCT05237141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20288721|NCT05237141|Contraceptive Agents|contraceptive agents|mesh-ancestor
20288722|NCT05237141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20288723|NCT05237141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288724|NCT05237141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20288725|NCT05228288|Pyrithione zinc|pyrithione zinc|mesh-list
20288726|NCT05228288|Keratolytic Agents|keratolytic agents|mesh-ancestor
20288727|NCT05228288|Dermatologic Agents|dermatologic agents|mesh-ancestor
19976686|NCT01867671|Immunologic Factors|immunologic factors|mesh-list
19976687|NCT01867671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976688|NCT01867710|Dexamethasone|dexamethasone|mesh-list
19976689|NCT01867710|Prednisone|prednisone|mesh-list
19976690|NCT01867710|Abiraterone Acetate|abiraterone acetate|mesh-list
19976691|NCT01867710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19976692|NCT01867710|Antiemetics|antiemetics|mesh-ancestor
19976693|NCT01867710|Autonomic Agents|autonomic agents|mesh-ancestor
19976694|NCT01867710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976695|NCT01867710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976696|NCT01867710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19976697|NCT01867710|Glucocorticoids|glucocorticoids|mesh-ancestor
19976698|NCT01867710|Hormones|hormones|mesh-ancestor
19976699|NCT01867710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19976700|NCT01867710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19976701|NCT01867710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976702|NCT01867710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19976703|NCT01867710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976704|NCT01867710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976705|NCT01867710|Hormone Antagonists|hormone antagonists|mesh-ancestor
19976706|NCT01867710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19976707|NCT01868022|Paclitaxel|paclitaxel|mesh-list
19976708|NCT01868022|Docetaxel|docetaxel|mesh-list
19976709|NCT01868022|Carboplatin|carboplatin|mesh-list
19976710|NCT01868022|Pemetrexed|pemetrexed|mesh-list
19976711|NCT01868022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19976712|NCT01868022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976713|NCT01868022|Tubulin Modulators|tubulin modulators|mesh-ancestor
19976714|NCT01868022|Antimitotic Agents|antimitotic agents|mesh-ancestor
19976715|NCT01868022|Mitosis Modulators|mitosis modulators|mesh-ancestor
19976716|NCT01868022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976717|NCT01868022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976718|NCT01868022|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19976719|NCT01868022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19976720|NCT01868035|Tositumomab I-131|tositumomab i-131|mesh-list
19976721|NCT01868035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976722|NCT01868243|Warfarin|warfarin|mesh-list
19976723|NCT01868243|Dabigatran|dabigatran|mesh-list
19976724|NCT01868243|Anticoagulants|anticoagulants|mesh-ancestor
19976725|NCT01868243|Antithrombins|antithrombins|mesh-ancestor
19976726|NCT01868243|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19976727|NCT01868243|Protease Inhibitors|protease inhibitors|mesh-ancestor
19976728|NCT01868243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976729|NCT01868243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976730|NCT01868334|Vaccines|vaccines|mesh-list
19976731|NCT01868334|Immunologic Factors|immunologic factors|mesh-ancestor
19976732|NCT01868334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976733|NCT01868425|Acetaminophen|acetaminophen|mesh-list
19976734|NCT01868425|Ketamine|ketamine|mesh-list
19976735|NCT01868425|Gabapentin|gabapentin|mesh-list
19976736|NCT01868425|Bupivacaine|bupivacaine|mesh-list
19976737|NCT01868425|Anesthetics, Local|anesthetics, local|mesh-ancestor
19976738|NCT01868425|Anesthetics|anesthetics|mesh-ancestor
19976739|NCT01868425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19976740|NCT01868425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976741|NCT01868425|Sensory System Agents|sensory system agents|mesh-ancestor
19976742|NCT01868425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976743|NCT01868425|Analgesics|analgesics|mesh-ancestor
19976744|NCT01868425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19976745|NCT01868425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19976746|NCT01868425|Anesthetics, General|anesthetics, general|mesh-ancestor
19976747|NCT01868425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19976748|NCT01868425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19976749|NCT01868425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19976750|NCT01868425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976751|NCT01868425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19976752|NCT01868425|Antipyretics|antipyretics|mesh-ancestor
19976753|NCT01868425|Anticonvulsants|anticonvulsants|mesh-ancestor
19976754|NCT01868425|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19976755|NCT01868425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19976756|NCT01868425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19976757|NCT01868425|Antimanic Agents|antimanic agents|mesh-ancestor
19976758|NCT01868477|Epoetin Alfa|epoetin alfa|mesh-list
19976759|NCT01868477|Deferasirox|deferasirox|mesh-list
19976760|NCT01868477|Hematinics|hematinics|mesh-ancestor
19976761|NCT01868477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19976762|NCT01868477|Chelating Agents|chelating agents|mesh-ancestor
19976763|NCT01868477|Sequestering Agents|sequestering agents|mesh-ancestor
19976764|NCT01868477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976765|NCT01868503|Lapatinib|lapatinib|mesh-list
19976766|NCT01868503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976767|NCT01868503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19976768|NCT01868503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976769|NCT01868503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976770|NCT01868542|Insulin Detemir|insulin detemir|mesh-list
19976771|NCT01868542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19976772|NCT01868542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555334|NCT01939834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555335|NCT01939886|Artesunate|artesunate|mesh-list
20555336|NCT01939886|Lumefantrine|lumefantrine|mesh-list
20555337|NCT01939886|Artemether|artemether|mesh-list
20555338|NCT01939886|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20555339|NCT01939886|Mefloquine|mefloquine|mesh-list
20555340|NCT01939886|Antimalarials|antimalarials|mesh-ancestor
20555341|NCT01939886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20555342|NCT01939886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20555343|NCT01939886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20555344|NCT01939886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976773|NCT01868633|Dexamethasone|dexamethasone|mesh-list
19976774|NCT01868633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19976775|NCT01868633|Antiemetics|antiemetics|mesh-ancestor
20555345|NCT01939886|Antiviral Agents|antiviral agents|mesh-ancestor
19976776|NCT01868633|Autonomic Agents|autonomic agents|mesh-ancestor
19976777|NCT01868633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976778|NCT01868633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976779|NCT01868633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19976780|NCT01868633|Glucocorticoids|glucocorticoids|mesh-ancestor
19976781|NCT01868633|Hormones|hormones|mesh-ancestor
19976782|NCT01868633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19976783|NCT01868633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19976784|NCT01868633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976785|NCT01868776|Lidocaine|lidocaine|mesh-list
19976786|NCT01868776|Anesthetics, Local|anesthetics, local|mesh-ancestor
19976787|NCT01868776|Anesthetics|anesthetics|mesh-ancestor
19976788|NCT01868776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19976789|NCT01868776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976790|NCT01868776|Sensory System Agents|sensory system agents|mesh-ancestor
19976791|NCT01868776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976792|NCT01868776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19976793|NCT01868776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19976794|NCT01868776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19976795|NCT01868776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19976796|NCT01868776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976797|NCT01868893|Obinutuzumab|obinutuzumab|mesh-list
19976798|NCT01868893|Chlorambucil|chlorambucil|mesh-list
19976799|NCT01868893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20555346|NCT01939886|Schistosomicides|schistosomicides|mesh-ancestor
20555347|NCT01939886|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20555348|NCT01939886|Anthelmintics|anthelmintics|mesh-ancestor
20555349|NCT01939912|Adenosine|adenosine|mesh-list
20555350|NCT01939912|Analgesics|analgesics|mesh-ancestor
20555351|NCT01939912|Sensory System Agents|sensory system agents|mesh-ancestor
19976800|NCT01868893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976801|NCT01868893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19976802|NCT01868893|Alkylating Agents|alkylating agents|mesh-ancestor
19976803|NCT01868893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976804|NCT01869192|Cyclophosphamide|cyclophosphamide|mesh-list
19976805|NCT01869192|Docetaxel|docetaxel|mesh-list
19976806|NCT01869192|Capecitabine|capecitabine|mesh-list
19976807|NCT01869192|Epirubicin|epirubicin|mesh-list
19976808|NCT01869192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19976809|NCT01869192|Immunologic Factors|immunologic factors|mesh-ancestor
19976810|NCT01869192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976811|NCT01869192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19976812|NCT01869192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19976813|NCT01869192|Alkylating Agents|alkylating agents|mesh-ancestor
19976814|NCT01869192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976815|NCT01869192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976816|NCT01869192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19976817|NCT01869192|Tubulin Modulators|tubulin modulators|mesh-ancestor
19976818|NCT01869192|Antimitotic Agents|antimitotic agents|mesh-ancestor
19976819|NCT01869192|Mitosis Modulators|mitosis modulators|mesh-ancestor
19976820|NCT01869192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19976821|NCT01869192|Antimetabolites|antimetabolites|mesh-ancestor
19976822|NCT01869192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19976823|NCT01869192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19976824|NCT01869192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19976825|NCT01869192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976826|NCT01869634|Ritonavir|ritonavir|mesh-list
19976827|NCT01869634|Darunavir|darunavir|mesh-list
20555352|NCT01939912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20555353|NCT01939912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555354|NCT01939912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20555355|NCT01939912|Vasodilator Agents|vasodilator agents|mesh-ancestor
20555356|NCT01939912|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20555357|NCT01939912|Purinergic Agonists|purinergic agonists|mesh-ancestor
20555358|NCT01939912|Purinergic Agents|purinergic agents|mesh-ancestor
20555359|NCT01939912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20555360|NCT01939912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555361|NCT01939990|Nebivolol|nebivolol|mesh-list
20555362|NCT01939990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20555363|NCT01939990|Vasodilator Agents|vasodilator agents|mesh-ancestor
20555364|NCT01939990|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20555365|NCT01939990|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20555366|NCT01939990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19976828|NCT01869634|Emtricitabine|emtricitabine|mesh-list
19976829|NCT01869634|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19976830|NCT01869634|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19976831|NCT01869634|Protease Inhibitors|protease inhibitors|mesh-ancestor
19976832|NCT01869634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976833|NCT01869634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976834|NCT01869634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19976835|NCT01869634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19976836|NCT01869634|Antiviral Agents|antiviral agents|mesh-ancestor
19976837|NCT01869634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19976838|NCT01869634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19976839|NCT01869634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19976840|NCT01869634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19976841|NCT01869634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19976842|NCT01869686|Denosumab|denosumab|mesh-list
19976843|NCT01869686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19976844|NCT01869686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976845|NCT01869699|Acetaminophen|acetaminophen|mesh-list
19976846|NCT01869699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19976847|NCT01869699|Analgesics|analgesics|mesh-ancestor
19976848|NCT01869699|Sensory System Agents|sensory system agents|mesh-ancestor
19976849|NCT01869699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976850|NCT01869699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976851|NCT01869699|Antipyretics|antipyretics|mesh-ancestor
19976852|NCT01869725|Octreotide|octreotide|mesh-list
19976853|NCT01869725|Edotreotide|edotreotide|mesh-list
19976854|NCT01869725|Indium-111-octreotide|indium-111-octreotide|mesh-list
19976855|NCT01869725|Somatostatin|somatostatin|mesh-list
19976856|NCT01869725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19976857|NCT01869725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19976858|NCT01869725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976859|NCT01869725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976860|NCT01869725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976861|NCT01869725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19976862|NCT01869725|Hormones|hormones|mesh-ancestor
20288728|NCT05225610|Dexmedetomidine|dexmedetomidine|mesh-list
19976863|NCT01869725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19976864|NCT01870297|Liraglutide|liraglutide|mesh-list
19976865|NCT01870297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19976866|NCT01870297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976867|NCT01870297|Incretins|incretins|mesh-ancestor
19976868|NCT01870297|Hormones|hormones|mesh-ancestor
19976869|NCT01870297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19976870|NCT01870583|Iodine|iodine|mesh-list
19976871|NCT01870583|Chlorhexidine|chlorhexidine|mesh-list
19976872|NCT01870583|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19976873|NCT01870583|Cadexomer iodine|cadexomer iodine|mesh-list
19976874|NCT01870583|Povidone|povidone|mesh-list
19976875|NCT01870583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19976876|NCT01870583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19976877|NCT01870583|Disinfectants|disinfectants|mesh-ancestor
19976878|NCT01870583|Dermatologic Agents|dermatologic agents|mesh-ancestor
19976879|NCT01870583|Trace Elements|trace elements|mesh-ancestor
19976880|NCT01870583|Micronutrients|micronutrients|mesh-ancestor
19976881|NCT01870583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976882|NCT01870583|Plasma Substitutes|plasma substitutes|mesh-ancestor
19976883|NCT01870583|Blood Substitutes|blood substitutes|mesh-ancestor
19976884|NCT01870596|Cytarabine|cytarabine|mesh-list
19976885|NCT01870596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20555367|NCT01939990|Adrenergic Agents|adrenergic agents|mesh-ancestor
20555368|NCT01939990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19976886|NCT01870596|Antimetabolites|antimetabolites|mesh-ancestor
19976887|NCT01870596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976888|NCT01870596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976889|NCT01870596|Antiviral Agents|antiviral agents|mesh-ancestor
19976890|NCT01870596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19976891|NCT01870596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19976892|NCT01870596|Immunologic Factors|immunologic factors|mesh-ancestor
19976893|NCT01870596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976894|NCT01870739|Amlodipine|amlodipine|mesh-list
19976895|NCT01870739|Valsartan|valsartan|mesh-list
19976896|NCT01870739|Olmesartan|olmesartan|mesh-list
19976897|NCT01870739|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19976898|NCT01870739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19976899|NCT01870739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19976900|NCT01870739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19976901|NCT01870739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19976902|NCT01870739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976903|NCT01870739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19976904|NCT01870739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976905|NCT01870739|Vasodilator Agents|vasodilator agents|mesh-ancestor
19976906|NCT01870739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19976907|NCT01870739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19976908|NCT01870843|Citalopram|citalopram|mesh-list
19976909|NCT01870843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19976910|NCT01870843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19976911|NCT01870843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19976912|NCT01870843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976913|NCT01870843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19976914|NCT01870843|Serotonin Agents|serotonin agents|mesh-ancestor
19976915|NCT01870843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976916|NCT01870843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20555369|NCT01939990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555370|NCT01939990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555371|NCT01940081|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
20555372|NCT01940081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555373|NCT01940081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555374|NCT01940081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555375|NCT01940081|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20555376|NCT01940172|Conatumumab|conatumumab|mesh-list
20555377|NCT01940172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20555378|NCT01940172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555379|NCT01940224|Pregabalin|pregabalin|mesh-list
20555380|NCT01940224|Morphine|morphine|mesh-list
20555381|NCT01940224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19976917|NCT01870843|Antidepressive Agents|antidepressive agents|mesh-ancestor
19976918|NCT01870843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19976919|NCT01870921|Ticagrelor|ticagrelor|mesh-list
19976920|NCT01870921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19976921|NCT01870921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19976922|NCT01870921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19976923|NCT01870921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19976924|NCT01870921|Purinergic Agents|purinergic agents|mesh-ancestor
19976925|NCT01870921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19976926|NCT01870921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976927|NCT01870921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976928|NCT01870973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19976929|NCT01870973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19976930|NCT01870973|Analgesics|analgesics|mesh-list
19976931|NCT01870973|Anesthetics|anesthetics|mesh-list
19976932|NCT01870973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19976933|NCT01870973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976934|NCT01870973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19976935|NCT01870973|Antitubercular Agents|antitubercular agents|mesh-ancestor
19976936|NCT01870973|Sensory System Agents|sensory system agents|mesh-ancestor
19976937|NCT01870973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976938|NCT01870999|Aripiprazole|aripiprazole|mesh-list
19976939|NCT01870999|Antidepressive Agents|antidepressive agents|mesh-ancestor
19976940|NCT01870999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19976941|NCT01870999|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19976942|NCT01870999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19976943|NCT01870999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19976944|NCT01870999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976945|NCT01870999|Dopamine Agonists|dopamine agonists|mesh-ancestor
19976946|NCT01870999|Dopamine Agents|dopamine agents|mesh-ancestor
19976947|NCT01870999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19976948|NCT01870999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976949|NCT01870999|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19976950|NCT01870999|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19976951|NCT01870999|Serotonin Agents|serotonin agents|mesh-ancestor
19976952|NCT01870999|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19976953|NCT01870999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19976954|NCT01870999|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19976955|NCT01870999|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19976956|NCT01871077|Ketorolac|ketorolac|mesh-list
19976957|NCT01871077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19976958|NCT01871077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19976959|NCT01871077|Analgesics|analgesics|mesh-ancestor
19976960|NCT01871077|Sensory System Agents|sensory system agents|mesh-ancestor
19976961|NCT01871077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976962|NCT01871077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976963|NCT01871077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19976964|NCT01871077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19976965|NCT01871077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19976966|NCT01871077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976967|NCT01871077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976968|NCT01871285|Morphine|morphine|mesh-list
19976969|NCT01871285|Oxycodone|oxycodone|mesh-list
19976970|NCT01871285|Buprenorphine|buprenorphine|mesh-list
19976971|NCT01871285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19976972|NCT01871285|Narcotics|narcotics|mesh-ancestor
19976973|NCT01871285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19976974|NCT01871285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976975|NCT01871285|Analgesics|analgesics|mesh-ancestor
19976976|NCT01871285|Sensory System Agents|sensory system agents|mesh-ancestor
19976977|NCT01871285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19976978|NCT01871285|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19976979|NCT01871441|Mycophenolic Acid|mycophenolic acid|mesh-list
19976980|NCT01871441|Cyclophosphamide|cyclophosphamide|mesh-list
19976981|NCT01871441|Tacrolimus|tacrolimus|mesh-list
19976982|NCT01871441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19976983|NCT01871441|Immunologic Factors|immunologic factors|mesh-ancestor
19976984|NCT01871441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19976985|NCT01871441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19976986|NCT01871441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19976987|NCT01871441|Alkylating Agents|alkylating agents|mesh-ancestor
19976988|NCT01871441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19976989|NCT01871441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19976990|NCT01871441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19976991|NCT01871441|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19976992|NCT01871441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19976993|NCT01871441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19976994|NCT01871441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19976995|NCT01871441|Antitubercular Agents|antitubercular agents|mesh-ancestor
19976996|NCT01871441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19976997|NCT01871441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19976998|NCT01871532|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19976999|NCT01871532|Hormones|hormones|mesh-ancestor
19977000|NCT01871532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19977001|NCT01871532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977002|NCT01871558|Metformin|metformin|mesh-list
19977003|NCT01871558|Vildagliptin|vildagliptin|mesh-list
19977004|NCT01871558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19977005|NCT01871558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977006|NCT01871558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19977007|NCT01871558|Protease Inhibitors|protease inhibitors|mesh-ancestor
19977008|NCT01871558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977009|NCT01871558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977010|NCT01871870|Pancrelipase|pancrelipase|mesh-list
19977011|NCT01871870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19977012|NCT01872611|Prednisolone|prednisolone|mesh-list
19977013|NCT01872611|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19977014|NCT01872611|Methylprednisolone|methylprednisolone|mesh-list
19977015|NCT01872611|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19977016|NCT01872611|Prednisolone acetate|prednisolone acetate|mesh-list
19977017|NCT01872611|Nepafenac|nepafenac|mesh-list
19977018|NCT01872611|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19977019|NCT01872611|Prednisolone phosphate|prednisolone phosphate|mesh-list
19977020|NCT01872611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19977021|NCT01872611|Glucocorticoids|glucocorticoids|mesh-ancestor
19977022|NCT01872611|Hormones|hormones|mesh-ancestor
19977023|NCT01872611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19977024|NCT01872611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977025|NCT01872611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19977026|NCT01872611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977027|NCT01872611|Antiemetics|antiemetics|mesh-ancestor
19977028|NCT01872611|Autonomic Agents|autonomic agents|mesh-ancestor
19977029|NCT01872611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977030|NCT01872611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19977031|NCT01872611|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19977032|NCT01872611|Protective Agents|protective agents|mesh-ancestor
19977033|NCT01872611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19977034|NCT01872611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19977035|NCT01872611|Analgesics|analgesics|mesh-ancestor
19977036|NCT01872611|Sensory System Agents|sensory system agents|mesh-ancestor
19977037|NCT01872611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19977038|NCT01872689|Pirfenidone|pirfenidone|mesh-list
19977039|NCT01872689|Analgesics|analgesics|mesh-ancestor
19977040|NCT01872689|Sensory System Agents|sensory system agents|mesh-ancestor
19977041|NCT01872689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977042|NCT01872689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977043|NCT01872689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19977044|NCT01872689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19977045|NCT01872689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19977046|NCT01872689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19977047|NCT01872689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977048|NCT01872715|Doxycycline|doxycycline|mesh-list
19977049|NCT01872715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19977050|NCT01872715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19977051|NCT01872715|Antimalarials|antimalarials|mesh-ancestor
19977052|NCT01872715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19977053|NCT01872715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19977054|NCT01872819|Antineoplastic Agents|antineoplastic agents|mesh-list
19977055|NCT01872910|Celecoxib|celecoxib|mesh-list
19977056|NCT01872910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19977057|NCT01872910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19977058|NCT01872910|Analgesics|analgesics|mesh-ancestor
19977059|NCT01872910|Sensory System Agents|sensory system agents|mesh-ancestor
19977060|NCT01872910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977061|NCT01872910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977062|NCT01872910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19977063|NCT01872910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19977064|NCT01872910|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19977065|NCT01872910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19977066|NCT01872910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977067|NCT01872910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977068|NCT01873417|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19977069|NCT01873417|Dermatologic Agents|dermatologic agents|mesh-ancestor
19977070|NCT01873417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19977071|NCT01873417|Immunologic Factors|immunologic factors|mesh-ancestor
19977072|NCT01873417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977073|NCT01873495|Homoharringtonine|homoharringtonine|mesh-list
19977074|NCT01873495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19977075|NCT01873495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977076|NCT01873495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19977077|NCT01873495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977078|NCT01873495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977079|NCT01873729|Naltrexone|naltrexone|mesh-list
19977080|NCT01873729|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19977081|NCT01873729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19977082|NCT01873729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977083|NCT01873729|Sensory System Agents|sensory system agents|mesh-ancestor
19977084|NCT01873729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977085|NCT01873859|Metformin|metformin|mesh-list
19977086|NCT01873859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19977087|NCT01873859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977088|NCT01873950|Quinidine|quinidine|mesh-list
19977089|NCT01873950|Quinidine gluconate|quinidine gluconate|mesh-list
19977090|NCT01873950|Verapamil|verapamil|mesh-list
19977091|NCT01873950|Dofetilide|dofetilide|mesh-list
19977092|NCT01873950|Ranolazine|ranolazine|mesh-list
19977093|NCT01873950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19977094|NCT01873950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19977095|NCT01873950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19977096|NCT01873950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977097|NCT01873950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19977098|NCT01873950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977099|NCT01873950|Vasodilator Agents|vasodilator agents|mesh-ancestor
19977100|NCT01873950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19977101|NCT01873950|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19977102|NCT01873950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19977103|NCT01873950|Adrenergic Agents|adrenergic agents|mesh-ancestor
19977104|NCT01873950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19977105|NCT01873950|Antimalarials|antimalarials|mesh-ancestor
19977106|NCT01873950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19977107|NCT01873950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19977108|NCT01873950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19977109|NCT01873950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977110|NCT01873950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19977111|NCT01873950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19977112|NCT01873950|Cholinergic Agents|cholinergic agents|mesh-ancestor
19977113|NCT01873950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19977114|NCT01873950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19977115|NCT01873950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19977116|NCT01873950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19977117|NCT01873989|Testosterone|testosterone|mesh-list
19977118|NCT01873989|Androgens|androgens|mesh-ancestor
19977119|NCT01873989|Hormones|hormones|mesh-ancestor
19977120|NCT01873989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19977121|NCT01873989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977122|NCT01874054|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19977123|NCT01874054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19977124|NCT01874054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19977125|NCT01874054|Alkylating Agents|alkylating agents|mesh-ancestor
19977126|NCT01874054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977127|NCT01874054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977128|NCT01874054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19977129|NCT01874119|Fosaprepitant|fosaprepitant|mesh-list
19977130|NCT01874119|Aprepitant|aprepitant|mesh-list
19977131|NCT01874119|Antiemetics|antiemetics|mesh-ancestor
19977132|NCT01874119|Autonomic Agents|autonomic agents|mesh-ancestor
19977133|NCT01874119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977134|NCT01874119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977135|NCT01874119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19977136|NCT01874119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19977137|NCT01874119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19977138|NCT01874119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977139|NCT01874145|Glatiramer Acetate|glatiramer acetate|mesh-list
19977140|NCT01874145|(T,G)-A-L|(t,g)-a-l|mesh-list
19977141|NCT01874145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19977142|NCT01874145|Immunologic Factors|immunologic factors|mesh-ancestor
19977143|NCT01874145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977144|NCT01874145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19977145|NCT01874145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19977146|NCT01874392|Insulin|insulin|mesh-list
19977147|NCT01874392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19977148|NCT01874392|Pancrelipase|pancrelipase|mesh-list
19977149|NCT01874392|Pancreatin|pancreatin|mesh-list
19977150|NCT01874392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19977151|NCT01874392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977152|NCT01874392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19977153|NCT01874535|Esomeprazole|esomeprazole|mesh-list
19977154|NCT01874535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19977155|NCT01874535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19977156|NCT01874535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19977157|NCT01874535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977158|NCT01874535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977159|NCT01874665|Ponatinib|ponatinib|mesh-list
19977160|NCT01874665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977161|NCT01874665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19977162|NCT01874665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977163|NCT01874665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977164|NCT01874951|Naltrexone|naltrexone|mesh-list
19977165|NCT01874951|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19977166|NCT01874951|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19977167|NCT01874951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977168|NCT01874951|Sensory System Agents|sensory system agents|mesh-ancestor
19977169|NCT01874951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977170|NCT01875159|Caffeine|caffeine|mesh-list
19977171|NCT01875159|Caffeine citrate|caffeine citrate|mesh-list
19977172|NCT01875159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977173|NCT01875159|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20555382|NCT01940224|Narcotics|narcotics|mesh-ancestor
20555383|NCT01940224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20555384|NCT01940224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555385|NCT01940224|Analgesics|analgesics|mesh-ancestor
20555386|NCT01940224|Sensory System Agents|sensory system agents|mesh-ancestor
20555387|NCT01940224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20555388|NCT01940224|Anticonvulsants|anticonvulsants|mesh-ancestor
20555389|NCT01940224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20555390|NCT01940224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20555391|NCT01940224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555392|NCT01940224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20555393|NCT01940224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20555394|NCT01940224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20555395|NCT01940224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20555396|NCT01940250|Magnesium Sulfate|magnesium sulfate|mesh-list
20555397|NCT01940250|Analgesics|analgesics|mesh-ancestor
20555398|NCT01940250|Sensory System Agents|sensory system agents|mesh-ancestor
19977174|NCT01875159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977175|NCT01875159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19977176|NCT01875159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977177|NCT01875159|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19977178|NCT01875159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19977179|NCT01875159|Purinergic Agents|purinergic agents|mesh-ancestor
19977180|NCT01875159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19977181|NCT01875237|Methylprednisolone|methylprednisolone|mesh-list
19977182|NCT01875237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19977183|NCT01875237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19977184|NCT01875237|Prednisolone|prednisolone|mesh-list
19977185|NCT01875237|Prednisolone acetate|prednisolone acetate|mesh-list
19977186|NCT01875237|Methotrexate|methotrexate|mesh-list
19977187|NCT01875237|Fludarabine phosphate|fludarabine phosphate|mesh-list
19977188|NCT01875237|Fludarabine|fludarabine|mesh-list
19977189|NCT01875237|Melphalan|melphalan|mesh-list
19977190|NCT01875237|Alemtuzumab|alemtuzumab|mesh-list
19977191|NCT01875237|Tacrolimus|tacrolimus|mesh-list
19977192|NCT01875237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19977193|NCT01875237|Prednisolone phosphate|prednisolone phosphate|mesh-list
19977194|NCT01875237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19977195|NCT01875237|Abortifacient Agents|abortifacient agents|mesh-ancestor
19977196|NCT01875237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19977197|NCT01875237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977198|NCT01875237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19977199|NCT01875237|Antimetabolites|antimetabolites|mesh-ancestor
19977200|NCT01875237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977201|NCT01875237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977202|NCT01875237|Dermatologic Agents|dermatologic agents|mesh-ancestor
19977203|NCT01875237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977204|NCT01875237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19977205|NCT01875237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19977206|NCT01875237|Immunologic Factors|immunologic factors|mesh-ancestor
19977207|NCT01875237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19977208|NCT01875237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19977209|NCT01875237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19977210|NCT01875237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19977211|NCT01875237|Antiemetics|antiemetics|mesh-ancestor
19977212|NCT01875237|Autonomic Agents|autonomic agents|mesh-ancestor
19977213|NCT01875237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977214|NCT01875237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19977215|NCT01875237|Glucocorticoids|glucocorticoids|mesh-ancestor
19977216|NCT01875237|Hormones|hormones|mesh-ancestor
19977217|NCT01875237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19977218|NCT01875237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19977219|NCT01875237|Protective Agents|protective agents|mesh-ancestor
19977220|NCT01875237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19977221|NCT01875237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19977222|NCT01875237|Alkylating Agents|alkylating agents|mesh-ancestor
19977223|NCT01875237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19977224|NCT01875237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19977225|NCT01875250|Metronidazole|metronidazole|mesh-list
19977226|NCT01875250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19977227|NCT01875250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19977228|NCT01875250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19977229|NCT01875250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19977230|NCT01875367|Trastuzumab|trastuzumab|mesh-list
19977231|NCT01875367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19977232|NCT01875367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977233|NCT01875445|Inositol|inositol|mesh-list
19977234|NCT01875445|Vitamin B Complex|vitamin b complex|mesh-ancestor
19977235|NCT01875445|Vitamins|vitamins|mesh-ancestor
19977236|NCT01875445|Micronutrients|micronutrients|mesh-ancestor
19977237|NCT01875445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977238|NCT01875510|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19977239|NCT01875510|SMOFlipid|smoflipid|mesh-list
19977240|NCT01875510|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19977241|NCT01875510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19977242|NCT01875510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20288729|NCT05225610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20288730|NCT05225610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20288731|NCT05225610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977243|NCT01875848|Buprenorphine|buprenorphine|mesh-list
19977244|NCT01875848|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19977245|NCT01875848|Naloxone|naloxone|mesh-list
19977246|NCT01875848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19977247|NCT01875848|Narcotics|narcotics|mesh-ancestor
19977248|NCT01875848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19977249|NCT01875848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977250|NCT01875848|Analgesics|analgesics|mesh-ancestor
19977251|NCT01875848|Sensory System Agents|sensory system agents|mesh-ancestor
19977252|NCT01875848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977253|NCT01875848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19977254|NCT01875991|Etanercept|etanercept|mesh-list
19977255|NCT01875991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19977256|NCT01875991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19977257|NCT01875991|Analgesics|analgesics|mesh-ancestor
19977258|NCT01875991|Sensory System Agents|sensory system agents|mesh-ancestor
19977259|NCT01875991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977260|NCT01875991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977261|NCT01875991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19977262|NCT01875991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19977263|NCT01875991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19977264|NCT01875991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19977265|NCT01875991|Immunologic Factors|immunologic factors|mesh-ancestor
19977266|NCT01876082|Methotrexate|methotrexate|mesh-list
19977267|NCT01876082|Vinblastine|vinblastine|mesh-list
19977268|NCT01876082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19977269|NCT01876082|Abortifacient Agents|abortifacient agents|mesh-ancestor
19977270|NCT01876082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19977271|NCT01876082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977272|NCT01876082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19977273|NCT01876082|Antimetabolites|antimetabolites|mesh-ancestor
19977274|NCT01876082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977275|NCT01876082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977276|NCT01876082|Dermatologic Agents|dermatologic agents|mesh-ancestor
19977277|NCT01876082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977278|NCT01876082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19977279|NCT01876082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19977280|NCT01876082|Immunologic Factors|immunologic factors|mesh-ancestor
19977281|NCT01876082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19977282|NCT01876082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19977283|NCT01876082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19977284|NCT01876082|Tubulin Modulators|tubulin modulators|mesh-ancestor
19977285|NCT01876082|Antimitotic Agents|antimitotic agents|mesh-ancestor
19977286|NCT01876082|Mitosis Modulators|mitosis modulators|mesh-ancestor
19977287|NCT01876212|Dasatinib|dasatinib|mesh-list
19977288|NCT01876212|Vaccines|vaccines|mesh-list
19977289|NCT01876212|Immunologic Factors|immunologic factors|mesh-ancestor
19977290|NCT01876212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977291|NCT01876212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977292|NCT01876212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19977293|NCT01876212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977294|NCT01876212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977295|NCT01876251|Docetaxel|docetaxel|mesh-list
19977296|NCT01876251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977297|NCT01876251|Tubulin Modulators|tubulin modulators|mesh-ancestor
19977298|NCT01876251|Antimitotic Agents|antimitotic agents|mesh-ancestor
19977299|NCT01876251|Mitosis Modulators|mitosis modulators|mesh-ancestor
19977300|NCT01876251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977301|NCT01876368|Olmesartan|olmesartan|mesh-list
19977302|NCT01876368|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19977303|NCT01876368|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19977304|NCT01876368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19977305|NCT01876368|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19977306|NCT01876368|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19977307|NCT01876368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977308|NCT01876381|Tolvaptan|tolvaptan|mesh-list
19977309|NCT01876381|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19977310|NCT01876381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977311|NCT01876381|Natriuretic Agents|natriuretic agents|mesh-ancestor
19977312|NCT01876381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977313|NCT01876446|Irinotecan|irinotecan|mesh-list
19452991|NCT03407404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19452992|NCT03407404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19452993|NCT03407404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19452994|NCT03407404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19452995|NCT03407404|Narcotics|narcotics|mesh-ancestor
19452996|NCT03407404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19452997|NCT03407404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19452998|NCT03407404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19452999|NCT03407404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19453000|NCT03407404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19453001|NCT03407404|GABA Modulators|gaba modulators|mesh-ancestor
19453002|NCT03407404|GABA Agents|gaba agents|mesh-ancestor
19453003|NCT03407300|Docetaxel|docetaxel|mesh-list
19453004|NCT03407300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453005|NCT03407300|Tubulin Modulators|tubulin modulators|mesh-ancestor
19453006|NCT03407300|Antimitotic Agents|antimitotic agents|mesh-ancestor
19453007|NCT03407300|Mitosis Modulators|mitosis modulators|mesh-ancestor
19453008|NCT03407300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453009|NCT03407209|Anesthetics|anesthetics|mesh-list
19453010|NCT03407209|Anesthetics, Local|anesthetics, local|mesh-list
19453011|NCT03407209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19453012|NCT03407209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453013|NCT03407209|Sensory System Agents|sensory system agents|mesh-ancestor
19453014|NCT03407209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19453015|NCT03407196|Dapagliflozin|dapagliflozin|mesh-list
19453016|NCT03407196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19453017|NCT03407196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453018|NCT03407196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19453019|NCT03407196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977314|NCT01876446|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20555399|NCT01940250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20555400|NCT01940250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555401|NCT01940250|Anesthetics|anesthetics|mesh-ancestor
19453020|NCT03407105|Ipilimumab|ipilimumab|mesh-list
19453021|NCT03407105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19453022|NCT03407105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453023|NCT03407105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19453024|NCT03407105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453025|NCT03407027|Triamcinolone|triamcinolone|mesh-list
19453026|NCT03407027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19453027|NCT03407027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19453028|NCT03407027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19453029|NCT03407027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19453030|NCT03407027|Glucocorticoids|glucocorticoids|mesh-ancestor
19453031|NCT03407027|Hormones|hormones|mesh-ancestor
19453032|NCT03407027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19453033|NCT03407027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453034|NCT03407027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19453035|NCT03407027|Immunologic Factors|immunologic factors|mesh-ancestor
19453036|NCT03407027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453037|NCT03407027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453038|NCT03406988|Nifedipine|nifedipine|mesh-list
19453039|NCT03406988|Iloprost|iloprost|mesh-list
19453040|NCT03406988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19453041|NCT03406988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19453042|NCT03406988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977315|NCT01876446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19977316|NCT01876446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977317|NCT01876446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977318|NCT01876446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977319|NCT01876511|Pembrolizumab|pembrolizumab|mesh-list
19977320|NCT01876511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20555402|NCT01940250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20555403|NCT01940250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20555404|NCT01940250|Anticonvulsants|anticonvulsants|mesh-ancestor
20555405|NCT01940250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20555406|NCT01940250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19977321|NCT01876511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977322|NCT01876732|Vitamin B 12|vitamin b 12|mesh-list
19977323|NCT01876732|Hydroxocobalamin|hydroxocobalamin|mesh-list
19977324|NCT01876732|Vitamins|vitamins|mesh-ancestor
19977325|NCT01876732|Micronutrients|micronutrients|mesh-ancestor
19977326|NCT01876732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977327|NCT01876732|Vitamin B Complex|vitamin b complex|mesh-ancestor
19977328|NCT01876732|Hematinics|hematinics|mesh-ancestor
19977329|NCT01876810|Gemfibrozil|gemfibrozil|mesh-list
19977330|NCT01876810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19977331|NCT01876810|Antimetabolites|antimetabolites|mesh-ancestor
19977332|NCT01876810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977333|NCT01876810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19977334|NCT01876810|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19977335|NCT01876810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19977336|NCT01876810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977337|NCT01876823|Memantine|memantine|mesh-list
19977338|NCT01876823|Citalopram|citalopram|mesh-list
19977339|NCT01876823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19977340|NCT01876823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19977341|NCT01876823|Dopamine Agents|dopamine agents|mesh-ancestor
19977342|NCT01876823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19977343|NCT01876823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977344|NCT01876823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977345|NCT01876823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19977346|NCT01876823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19977347|NCT01876823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19977348|NCT01876823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19977349|NCT01876823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19977350|NCT01876823|Serotonin Agents|serotonin agents|mesh-ancestor
19977351|NCT01876823|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19977352|NCT01876823|Antidepressive Agents|antidepressive agents|mesh-ancestor
19977353|NCT01876823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19977354|NCT01876992|Metformin|metformin|mesh-list
19977355|NCT01876992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19977356|NCT01876992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977357|NCT01877083|Lenvatinib|lenvatinib|mesh-list
19977358|NCT01877083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977359|NCT01877083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19977360|NCT01877083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977361|NCT01877083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977362|NCT01877187|Ethiodized Oil|ethiodized oil|mesh-list
19977363|NCT01877187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977364|NCT01877538|Donepezil|donepezil|mesh-list
19977365|NCT01877538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19977366|NCT01877538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977367|NCT01877538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977368|NCT01877538|Cholinergic Agents|cholinergic agents|mesh-ancestor
19977369|NCT01877538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19977370|NCT01877538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977371|NCT01877538|Nootropic Agents|nootropic agents|mesh-ancestor
19977372|NCT01877551|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
19977373|NCT01877551|Antiviral Agents|antiviral agents|mesh-ancestor
19977374|NCT01877551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19977375|NCT01877551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19977376|NCT01877551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19977377|NCT01877642|Lorazepam|lorazepam|mesh-list
19977378|NCT01877642|Loxapine|loxapine|mesh-list
19977379|NCT01877642|Anticonvulsants|anticonvulsants|mesh-ancestor
19977380|NCT01877642|Antiemetics|antiemetics|mesh-ancestor
19977381|NCT01877642|Autonomic Agents|autonomic agents|mesh-ancestor
19977382|NCT01877642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977383|NCT01877642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977384|NCT01877642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19977385|NCT01877642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19977386|NCT01877642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19977387|NCT01877642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19977388|NCT01877642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19977389|NCT01877642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19977390|NCT01877642|GABA Modulators|gaba modulators|mesh-ancestor
19977391|NCT01877642|GABA Agents|gaba agents|mesh-ancestor
19977392|NCT01877642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19977393|NCT01877642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977394|NCT01877642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19977395|NCT01877642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19977396|NCT01877642|Dopamine Agents|dopamine agents|mesh-ancestor
19977397|NCT01877668|Adalimumab|adalimumab|mesh-list
19977398|NCT01877668|Tofacitinib|tofacitinib|mesh-list
19977399|NCT01877668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19977400|NCT01877668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19977401|NCT01877668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19977402|NCT01877668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977403|NCT01877668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977404|NCT01877915|Rivaroxaban|rivaroxaban|mesh-list
19977405|NCT01877915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19977406|NCT01877915|Antithrombins|antithrombins|mesh-ancestor
19977407|NCT01877915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19977408|NCT01877915|Protease Inhibitors|protease inhibitors|mesh-ancestor
19977409|NCT01877915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977410|NCT01877915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977411|NCT01877915|Anticoagulants|anticoagulants|mesh-ancestor
19977412|NCT01878006|Morphine|morphine|mesh-list
19977413|NCT01878006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19977414|NCT01878006|Narcotics|narcotics|mesh-ancestor
19977415|NCT01878006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19977416|NCT01878006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977417|NCT01878006|Analgesics|analgesics|mesh-ancestor
19977418|NCT01878006|Sensory System Agents|sensory system agents|mesh-ancestor
19977419|NCT01878006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977420|NCT01878292|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
19977421|NCT01878292|Antidepressive Agents|antidepressive agents|mesh-ancestor
19977422|NCT01878292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19977423|NCT01878292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19977424|NCT01878292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19977425|NCT01878292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19977426|NCT01878292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977427|NCT01878292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19977428|NCT01878292|Serotonin Agents|serotonin agents|mesh-ancestor
19977429|NCT01878292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977430|NCT01878292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19977431|NCT01878292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19977432|NCT01878526|Domperidone|domperidone|mesh-list
19977433|NCT01878526|Antiemetics|antiemetics|mesh-ancestor
19977434|NCT01878526|Autonomic Agents|autonomic agents|mesh-ancestor
19977435|NCT01878526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977436|NCT01878526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977437|NCT01878526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19977438|NCT01878526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19977439|NCT01878526|Dopamine Agents|dopamine agents|mesh-ancestor
19977440|NCT01878526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19977441|NCT01878526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977442|NCT01878604|Hypolipidemic Agents|hypolipidemic agents|mesh-list
19977443|NCT01878604|Antimetabolites|antimetabolites|mesh-ancestor
19977444|NCT01878604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977445|NCT01878604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19977446|NCT01878656|Sevoflurane|sevoflurane|mesh-list
19977447|NCT01878656|Desflurane|desflurane|mesh-list
19977448|NCT01878656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19977449|NCT01878656|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19977450|NCT01878656|Anesthetics, General|anesthetics, general|mesh-ancestor
19977451|NCT01878656|Anesthetics|anesthetics|mesh-ancestor
19977452|NCT01878656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19977453|NCT01878656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977454|NCT01878799|Sofosbuvir|sofosbuvir|mesh-list
19977455|NCT01878799|Ledipasvir|ledipasvir|mesh-list
19977456|NCT01878799|Antiviral Agents|antiviral agents|mesh-ancestor
19977457|NCT01878799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19977458|NCT01878890|Efavirenz|efavirenz|mesh-list
19977459|NCT01878890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19977460|NCT01878890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19977461|NCT01878890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977462|NCT01878890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977463|NCT01878890|Antiviral Agents|antiviral agents|mesh-ancestor
19977464|NCT01878890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19977465|NCT01878890|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19977466|NCT01878890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19977467|NCT01878890|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19977468|NCT01878890|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19977469|NCT01878890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19977470|NCT01878890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19977471|NCT01879319|Evolocumab|evolocumab|mesh-list
19977472|NCT01879319|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19977473|NCT01879319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19977474|NCT01879319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19977475|NCT01879319|Antimetabolites|antimetabolites|mesh-ancestor
19977476|NCT01879319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977477|NCT01879319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19977478|NCT01879319|Immunologic Factors|immunologic factors|mesh-ancestor
19977479|NCT01879319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977480|NCT01879332|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19977481|NCT01879332|Anticonvulsants|anticonvulsants|mesh-ancestor
19977482|NCT01879332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19977483|NCT01879332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19977484|NCT01879332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19977485|NCT01879332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977486|NCT01879345|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19977487|NCT01879345|Anticonvulsants|anticonvulsants|mesh-ancestor
19977488|NCT01879345|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19977489|NCT01879345|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19977490|NCT01879345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19977491|NCT01879345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977492|NCT01879371|Ibuprofen|ibuprofen|mesh-list
19977493|NCT01879371|Caffeine|caffeine|mesh-list
19977494|NCT01879371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19977495|NCT01879371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19977496|NCT01879371|Analgesics|analgesics|mesh-ancestor
19977497|NCT01879371|Sensory System Agents|sensory system agents|mesh-ancestor
19977498|NCT01879371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977499|NCT01879371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977500|NCT01879371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19977501|NCT01879371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19977502|NCT01879371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19977503|NCT01879371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977504|NCT01879371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977505|NCT01879371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19977506|NCT01879371|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19977507|NCT01879371|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19977508|NCT01879371|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19977509|NCT01879371|Purinergic Agents|purinergic agents|mesh-ancestor
19977510|NCT01879371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19977511|NCT01879579|Insulin|insulin|mesh-list
19977512|NCT01879579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19977513|NCT01879579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977514|NCT01879618|Dalteparin|dalteparin|mesh-list
19977515|NCT01879618|Anticoagulants|anticoagulants|mesh-ancestor
19977516|NCT01879618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19977517|NCT01879618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19977518|NCT01879618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977519|NCT05329116|Lidocaine|lidocaine|mesh-list
19977520|NCT05329116|Pentoxifylline|pentoxifylline|mesh-list
19977521|NCT05329116|Anesthetics, Local|anesthetics, local|mesh-ancestor
19977522|NCT05329116|Anesthetics|anesthetics|mesh-ancestor
19977523|NCT05329116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19977524|NCT05329116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977525|NCT05329116|Sensory System Agents|sensory system agents|mesh-ancestor
19977526|NCT05329116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977527|NCT05329116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19977528|NCT05329116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19977529|NCT05329116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19977530|NCT05329116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19977531|NCT05329116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977532|NCT05329116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19977533|NCT05329116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977534|NCT05329116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19977535|NCT05329116|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19977536|NCT05329116|Protective Agents|protective agents|mesh-ancestor
19977537|NCT05329116|Vasodilator Agents|vasodilator agents|mesh-ancestor
19977538|NCT05329116|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19977539|NCT05329116|Antioxidants|antioxidants|mesh-ancestor
19977540|NCT05329090|Rituximab|rituximab|mesh-list
19977541|NCT05329090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19977542|NCT05329090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977543|NCT05329090|Immunologic Factors|immunologic factors|mesh-ancestor
19977544|NCT05329090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977545|NCT05329090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19977546|NCT05328921|Antihypertensive Agents|antihypertensive agents|mesh-list
19977547|NCT05328817|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19977548|NCT05328817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19977549|NCT05328817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19977550|NCT05328817|Antitubercular Agents|antitubercular agents|mesh-ancestor
20288732|NCT05225610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20288733|NCT05225610|Analgesics|analgesics|mesh-ancestor
20288734|NCT05225610|Sensory System Agents|sensory system agents|mesh-ancestor
20288735|NCT05225610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20288736|NCT05225610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20288737|NCT05225610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20288738|NCT05225610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20288739|NCT05225610|Adrenergic Agents|adrenergic agents|mesh-ancestor
20288740|NCT05225610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20288741|NCT05225610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288742|NCT05220358|Fostemsavir|fostemsavir|mesh-list
20288743|NCT05220358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19977551|NCT05328674|Mitogens|mitogens|mesh-list
19977552|NCT05328674|Mitosis Modulators|mitosis modulators|mesh-ancestor
19977553|NCT05328674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977554|NCT05328635|Candesartan|candesartan|mesh-list
19977555|NCT05328635|Gabapentin|gabapentin|mesh-list
19977556|NCT05328635|Analgesics|analgesics|mesh-ancestor
19977557|NCT05328635|Sensory System Agents|sensory system agents|mesh-ancestor
19977558|NCT05328635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977559|NCT05328635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977560|NCT05328635|Anticonvulsants|anticonvulsants|mesh-ancestor
19977561|NCT05328635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19977562|NCT05328635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19977563|NCT05328635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19977564|NCT05328635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19977565|NCT05328635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19977566|NCT05328635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19977567|NCT05328635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19977568|NCT05328635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977569|NCT05328635|Antimanic Agents|antimanic agents|mesh-ancestor
20555407|NCT01940250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555408|NCT01940250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20555409|NCT01940250|Tocolytic Agents|tocolytic agents|mesh-ancestor
19977570|NCT05328635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19977571|NCT05328635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19977572|NCT05328635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19977573|NCT05328427|Tin Fluorides|tin fluorides|mesh-list
19977574|NCT05328427|Cariostatic Agents|cariostatic agents|mesh-ancestor
19977575|NCT05328427|Protective Agents|protective agents|mesh-ancestor
19977576|NCT05328427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977577|NCT05328414|Prednisolone|prednisolone|mesh-list
19977578|NCT05328414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19977579|NCT05328414|Glucocorticoids|glucocorticoids|mesh-ancestor
19977580|NCT05328414|Hormones|hormones|mesh-ancestor
20555410|NCT01940250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20555411|NCT01940393|Cetirizine|cetirizine|mesh-list
20555412|NCT01940393|Fexofenadine|fexofenadine|mesh-list
20555413|NCT01940393|Desloratadine|desloratadine|mesh-list
20555414|NCT01940393|Ebastine|ebastine|mesh-list
20555415|NCT01940393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20555416|NCT01940393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20555417|NCT01940393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20555418|NCT01940393|Histamine Antagonists|histamine antagonists|mesh-ancestor
20555419|NCT01940393|Histamine Agents|histamine agents|mesh-ancestor
20555420|NCT01940393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20555421|NCT01940393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555422|NCT01940393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555423|NCT01940393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20555424|NCT01940393|Cholinergic Agents|cholinergic agents|mesh-ancestor
20555425|NCT01940419|Tranexamic Acid|tranexamic acid|mesh-list
19977581|NCT05328414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19977582|NCT05328414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977583|NCT05328414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19977584|NCT05328414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977585|NCT05328336|Paclitaxel|paclitaxel|mesh-list
19977586|NCT05328336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19977587|NCT05328336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977588|NCT05328336|Tubulin Modulators|tubulin modulators|mesh-ancestor
19977589|NCT05328336|Antimitotic Agents|antimitotic agents|mesh-ancestor
19977590|NCT05328336|Mitosis Modulators|mitosis modulators|mesh-ancestor
19977591|NCT05328336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977592|NCT05328310|Nebivolol|nebivolol|mesh-list
19977593|NCT05328310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19977594|NCT05328310|Vasodilator Agents|vasodilator agents|mesh-ancestor
19977595|NCT05328310|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20555426|NCT01940419|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20555427|NCT01940419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19977596|NCT05328310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19977597|NCT05328310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19977598|NCT05328310|Adrenergic Agents|adrenergic agents|mesh-ancestor
19977599|NCT05328310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19977600|NCT05328310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977601|NCT05328310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977602|NCT05328258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19977603|NCT05328258|Luteolytic Agents|luteolytic agents|mesh-ancestor
19977604|NCT05328258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19977605|NCT05328258|Contraceptive Agents|contraceptive agents|mesh-ancestor
19977606|NCT05328258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19977607|NCT05328258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977608|NCT05328258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19977609|NCT05328258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19977610|NCT05328258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977611|NCT05328154|Diphosphonates|diphosphonates|mesh-list
19977612|NCT05328154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19977613|NCT05328154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977614|NCT05328141|Ascorbic Acid|ascorbic acid|mesh-list
19977615|NCT05328141|Antioxidants|antioxidants|mesh-ancestor
19977616|NCT05328141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977617|NCT05328141|Protective Agents|protective agents|mesh-ancestor
19977618|NCT05328141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977619|NCT05328141|Vitamins|vitamins|mesh-ancestor
19977620|NCT05328141|Micronutrients|micronutrients|mesh-ancestor
19977621|NCT05328102|Lenalidomide|lenalidomide|mesh-list
19977622|NCT05328102|Immunologic Factors|immunologic factors|mesh-ancestor
19977623|NCT05328102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977624|NCT05328102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20555428|NCT01940419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555429|NCT01940419|Hemostatics|hemostatics|mesh-ancestor
20555430|NCT01940419|Coagulants|coagulants|mesh-ancestor
20555431|NCT01940536|Tranexamic Acid|tranexamic acid|mesh-list
20555432|NCT01940536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19977625|NCT05328102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19977626|NCT05328102|Growth Substances|growth substances|mesh-ancestor
19977627|NCT05328102|Growth Inhibitors|growth inhibitors|mesh-ancestor
19977628|NCT05328102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977629|NCT05327972|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19977630|NCT05327972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19977631|NCT05327972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977632|NCT05327972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977633|NCT05327972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19977634|NCT05327972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19977635|NCT05327972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977636|NCT05327972|Cholinergic Agents|cholinergic agents|mesh-ancestor
19977637|NCT05327972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19977638|NCT05327894|Blinatumomab|blinatumomab|mesh-list
19977639|NCT05327894|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19977640|NCT05327894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977641|NCT05327894|Immunologic Factors|immunologic factors|mesh-ancestor
19977642|NCT05327894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977643|NCT05327777|Oxycodone|oxycodone|mesh-list
19977644|NCT05327777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19977645|NCT05327777|Narcotics|narcotics|mesh-ancestor
19977646|NCT05327777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19977647|NCT05327777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977648|NCT05327777|Analgesics|analgesics|mesh-ancestor
19977649|NCT05327777|Sensory System Agents|sensory system agents|mesh-ancestor
19977650|NCT05327777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977651|NCT05327751|Celecoxib|celecoxib|mesh-list
19977652|NCT05327751|Capecitabine|capecitabine|mesh-list
19977653|NCT05327751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19977654|NCT05327751|Antimetabolites|antimetabolites|mesh-ancestor
20555433|NCT01940536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20555434|NCT01940536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555435|NCT01940536|Hemostatics|hemostatics|mesh-ancestor
20555436|NCT01940536|Coagulants|coagulants|mesh-ancestor
20555437|NCT01940601|Lenograstim|lenograstim|mesh-list
19977655|NCT05327751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977656|NCT05327751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977657|NCT05327751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19977658|NCT05327751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19977659|NCT05327751|Analgesics|analgesics|mesh-ancestor
19977660|NCT05327751|Sensory System Agents|sensory system agents|mesh-ancestor
19977661|NCT05327751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977662|NCT05327751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977663|NCT05327751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19977664|NCT05327751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20555438|NCT01940601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20555439|NCT01940601|Immunologic Factors|immunologic factors|mesh-ancestor
20555440|NCT01940601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555441|NCT01940627|Ubiquinone|ubiquinone|mesh-list
20555442|NCT01940627|Coenzyme Q10|coenzyme q10|mesh-list
20555443|NCT01940627|Micronutrients|micronutrients|mesh-ancestor
19977665|NCT05327751|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19977666|NCT05327751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19977667|NCT05327751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977668|NCT05327738|Atezolizumab|atezolizumab|mesh-list
19977669|NCT05327738|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19977670|NCT05327738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977671|NCT05327738|Immunologic Factors|immunologic factors|mesh-ancestor
19977672|NCT05327738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977673|NCT05327699|Ketamine|ketamine|mesh-list
19977674|NCT05327699|Analgesics|analgesics|mesh-ancestor
19977675|NCT05327699|Sensory System Agents|sensory system agents|mesh-ancestor
19977676|NCT05327699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977677|NCT05327699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977678|NCT05327699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19977679|NCT05327699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19977680|NCT05327699|Anesthetics, General|anesthetics, general|mesh-ancestor
19977681|NCT05327699|Anesthetics|anesthetics|mesh-ancestor
19977682|NCT05327699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19977683|NCT05327699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19977684|NCT05327699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19977685|NCT05327699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19977686|NCT05327699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977687|NCT05327660|Carbon Monoxide|carbon monoxide|mesh-list
19977688|NCT05327660|Antimetabolites|antimetabolites|mesh-ancestor
19977689|NCT05327660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977690|NCT05327660|Gasotransmitters|gasotransmitters|mesh-ancestor
19977691|NCT05327660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19977692|NCT05327660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977693|NCT05327582|Paclitaxel|paclitaxel|mesh-list
19977694|NCT05327582|Durvalumab|durvalumab|mesh-list
19977695|NCT05327582|Lenvatinib|lenvatinib|mesh-list
19977696|NCT05327582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19977697|NCT05327582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977698|NCT05327582|Tubulin Modulators|tubulin modulators|mesh-ancestor
19977699|NCT05327582|Antimitotic Agents|antimitotic agents|mesh-ancestor
19977700|NCT05327582|Mitosis Modulators|mitosis modulators|mesh-ancestor
19977701|NCT05327582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977702|NCT05327582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20555444|NCT01940627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555445|NCT01940627|Vitamins|vitamins|mesh-ancestor
20555446|NCT01940653|Estradiol|estradiol|mesh-list
20555447|NCT01940653|Progesterone|progesterone|mesh-list
20555448|NCT01940653|Estrogens|estrogens|mesh-ancestor
20555449|NCT01940653|Hormones|hormones|mesh-ancestor
20555450|NCT01940653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20555451|NCT01940653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555452|NCT01940653|Progestins|progestins|mesh-ancestor
20555453|NCT01940692|Tranexamic Acid|tranexamic acid|mesh-list
20555454|NCT01940692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20555455|NCT01940692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20555456|NCT01940692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555457|NCT01940692|Hemostatics|hemostatics|mesh-ancestor
20555458|NCT01940692|Coagulants|coagulants|mesh-ancestor
20555459|NCT01940718|Methyltestosterone|methyltestosterone|mesh-list
20555460|NCT01940718|Testosterone|testosterone|mesh-list
19736052|NCT04533867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19736053|NCT04533685|Vaccines|vaccines|mesh-list
19736054|NCT04533685|Immunologic Factors|immunologic factors|mesh-ancestor
19736055|NCT04533685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736056|NCT04533906|Povidone-Iodine|povidone-iodine|mesh-list
19977703|NCT05327582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19977704|NCT05327582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977705|NCT05327556|Epinephrine|epinephrine|mesh-list
19977706|NCT05327556|Racepinephrine|racepinephrine|mesh-list
19977707|NCT05327556|Epinephryl borate|epinephryl borate|mesh-list
19977708|NCT05327556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19977709|NCT05327556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19977710|NCT05327556|Adrenergic Agents|adrenergic agents|mesh-ancestor
19977711|NCT05327556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19977712|NCT05327556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977713|NCT05327556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977714|NCT05327556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19977715|NCT05327556|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19977716|NCT05327556|Autonomic Agents|autonomic agents|mesh-ancestor
19977717|NCT05327556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977718|NCT05327556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19977719|NCT05327556|Respiratory System Agents|respiratory system agents|mesh-ancestor
19977720|NCT05327556|Mydriatics|mydriatics|mesh-ancestor
19977721|NCT05327556|Sympathomimetics|sympathomimetics|mesh-ancestor
19977722|NCT05327556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19977723|NCT05327530|Avelumab|avelumab|mesh-list
19977724|NCT05327530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19977725|NCT05327530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977726|NCT05327439|Nicotine|nicotine|mesh-list
19977727|NCT05327439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19977728|NCT05327439|Autonomic Agents|autonomic agents|mesh-ancestor
19977729|NCT05327439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977730|NCT05327439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977731|NCT05327439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19977732|NCT05327439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19977733|NCT05327439|Cholinergic Agents|cholinergic agents|mesh-ancestor
19977734|NCT05327439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19977735|NCT05327439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977736|NCT05327426|Vaccines|vaccines|mesh-list
19977737|NCT05327426|Immunologic Factors|immunologic factors|mesh-ancestor
19977738|NCT05327426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977739|NCT05327361|Sunscreening Agents|sunscreening agents|mesh-list
19977740|NCT05327361|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19977741|NCT05327361|Protective Agents|protective agents|mesh-ancestor
19977742|NCT05327361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977743|NCT05327361|Dermatologic Agents|dermatologic agents|mesh-ancestor
19977744|NCT05327309|Bleomycin|bleomycin|mesh-list
19977745|NCT05327309|Propranolol|propranolol|mesh-list
19977746|NCT05327309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19977747|NCT05327309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19977748|NCT05327309|Adrenergic Agents|adrenergic agents|mesh-ancestor
19977749|NCT05327309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19977750|NCT05327309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977751|NCT05327309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977752|NCT05327309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19977753|NCT05327309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19977754|NCT05327309|Vasodilator Agents|vasodilator agents|mesh-ancestor
19736057|NCT04533906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19977755|NCT05327309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19736058|NCT04533906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19977756|NCT05327309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977757|NCT05327296|Propofol|propofol|mesh-list
19977758|NCT05327296|Isoflurane|isoflurane|mesh-list
19977759|NCT05327296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19977760|NCT05327296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19977761|NCT05327296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977762|NCT05327296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19977763|NCT05327296|Anesthetics, General|anesthetics, general|mesh-ancestor
19977764|NCT05327296|Anesthetics|anesthetics|mesh-ancestor
19977765|NCT05327296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19977766|NCT05327231|Docetaxel|docetaxel|mesh-list
19977767|NCT05327231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977768|NCT05327231|Tubulin Modulators|tubulin modulators|mesh-ancestor
19977769|NCT05327231|Antimitotic Agents|antimitotic agents|mesh-ancestor
19977770|NCT05327231|Mitosis Modulators|mitosis modulators|mesh-ancestor
19977771|NCT05327231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977772|NCT05327127|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
19977773|NCT05327127|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19977774|NCT05327127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977775|NCT05327127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19977776|NCT05327127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977777|NCT05327088|Dexmedetomidine|dexmedetomidine|mesh-list
19977778|NCT05327088|Nalbuphine|nalbuphine|mesh-list
19977779|NCT05327088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19977780|NCT05327088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19977781|NCT05327088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977782|NCT05327088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19977783|NCT05327088|Analgesics|analgesics|mesh-ancestor
19977784|NCT05327088|Sensory System Agents|sensory system agents|mesh-ancestor
19977785|NCT05327088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977786|NCT05327088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19977787|NCT05327088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19977788|NCT05327088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19977789|NCT05327088|Adrenergic Agents|adrenergic agents|mesh-ancestor
19977790|NCT05327088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19977791|NCT05327088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977792|NCT05327088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19977793|NCT05327088|Narcotics|narcotics|mesh-ancestor
19977794|NCT05327010|Talazoparib|talazoparib|mesh-list
19977795|NCT05327010|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19977796|NCT05327010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977797|NCT05327010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977798|NCT05327010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977799|NCT05326997|Tranexamic Acid|tranexamic acid|mesh-list
19977800|NCT05326997|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19977801|NCT05326997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19977802|NCT05326997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977803|NCT05326997|Hemostatics|hemostatics|mesh-ancestor
19977804|NCT05326997|Coagulants|coagulants|mesh-ancestor
19977805|NCT05326984|Metformin|metformin|mesh-list
19977806|NCT05326984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19977807|NCT05326984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977808|NCT05326867|Lidocaine|lidocaine|mesh-list
19977809|NCT05326867|Anesthetics, Local|anesthetics, local|mesh-ancestor
19977810|NCT05326867|Anesthetics|anesthetics|mesh-ancestor
19977811|NCT05326867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19977812|NCT05326867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977813|NCT05326867|Sensory System Agents|sensory system agents|mesh-ancestor
19977814|NCT05326867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977815|NCT05326867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19977816|NCT05326867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19977817|NCT05326867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19977818|NCT05326867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19977819|NCT05326867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977820|NCT05326841|Vitamin D|vitamin d|mesh-list
19977821|NCT05326841|Cholecalciferol|cholecalciferol|mesh-list
19977822|NCT05326841|Vitamins|vitamins|mesh-ancestor
19977823|NCT05326841|Micronutrients|micronutrients|mesh-ancestor
19977824|NCT05326841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977825|NCT05326841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19977826|NCT05326841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20288744|NCT05220358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20288745|NCT05220358|Antiviral Agents|antiviral agents|mesh-ancestor
20288746|NCT05220358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20288747|NCT05220358|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20288748|NCT05220358|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20288749|NCT05220358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288750|NCT05217589|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20288751|NCT05217589|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
20288752|NCT05217589|beta-Endorphin|beta-endorphin|mesh-list
20288753|NCT05217589|Hormones|hormones|mesh-ancestor
20288754|NCT05217589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20288755|NCT05217589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288756|NCT05217589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20288757|NCT05217589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288758|NCT05210764|Ketamine|ketamine|mesh-list
20288759|NCT05210764|Anesthetics|anesthetics|mesh-list
20288760|NCT05210764|Propofol|propofol|mesh-list
20288761|NCT05210764|Sevoflurane|sevoflurane|mesh-list
20288762|NCT05210764|Esketamine|esketamine|mesh-list
20288763|NCT05210764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20288764|NCT05210764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288765|NCT05210764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20288766|NCT05210764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20288767|NCT05210764|Anesthetics, General|anesthetics, general|mesh-ancestor
20288768|NCT05210764|Analgesics|analgesics|mesh-ancestor
20288769|NCT05210764|Sensory System Agents|sensory system agents|mesh-ancestor
20288770|NCT05210764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20288771|NCT05210764|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20288772|NCT05210764|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20288773|NCT05210764|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20288774|NCT05210764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20288775|NCT05210764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288776|NCT05210764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20288777|NCT05210764|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20288778|NCT05210764|Antidepressive Agents|antidepressive agents|mesh-ancestor
20288779|NCT05210764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19977827|NCT05326776|Oxytocin|oxytocin|mesh-list
19977828|NCT05326776|Oxytocics|oxytocics|mesh-ancestor
19977829|NCT05326776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19977830|NCT05326776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977831|NCT05324995|Celecoxib|celecoxib|mesh-list
19977832|NCT05324995|Epinephrine|epinephrine|mesh-list
19977833|NCT05324995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19977834|NCT05324995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19977835|NCT05324995|Adrenergic Agents|adrenergic agents|mesh-ancestor
19977836|NCT05324995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19977837|NCT05324995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977838|NCT05324995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977839|NCT05324995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19977840|NCT05324995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19977841|NCT05324995|Autonomic Agents|autonomic agents|mesh-ancestor
19977842|NCT05324995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977843|NCT05324995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19977844|NCT05324995|Respiratory System Agents|respiratory system agents|mesh-ancestor
19977845|NCT05324995|Mydriatics|mydriatics|mesh-ancestor
19977846|NCT05324995|Sympathomimetics|sympathomimetics|mesh-ancestor
19977847|NCT05324995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19977848|NCT05324995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19977849|NCT05324995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19977850|NCT05324995|Analgesics|analgesics|mesh-ancestor
19977851|NCT05324995|Sensory System Agents|sensory system agents|mesh-ancestor
19977852|NCT05324995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19977853|NCT05324995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19977854|NCT05324995|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19977855|NCT05324995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19977856|NCT05324995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977857|NCT05318521|Ibuprofen|ibuprofen|mesh-list
19977858|NCT05318521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19977859|NCT05318521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19977860|NCT05318521|Analgesics|analgesics|mesh-ancestor
19977861|NCT05318521|Sensory System Agents|sensory system agents|mesh-ancestor
19977862|NCT05318521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977863|NCT05318521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977864|NCT05318521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19977865|NCT05318521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19977866|NCT05318521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19977867|NCT05318521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977868|NCT05318521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977869|NCT05317546|Cannabidiol|cannabidiol|mesh-list
19977870|NCT05317546|Anticonvulsants|anticonvulsants|mesh-ancestor
19977871|NCT05311475|Mometasone Furoate|mometasone furoate|mesh-list
19977872|NCT05311475|Azelastine|azelastine|mesh-list
19977873|NCT05311475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19977874|NCT05311475|Dermatologic Agents|dermatologic agents|mesh-ancestor
19977875|NCT05311475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19977876|NCT05311475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19977877|NCT05311475|Autonomic Agents|autonomic agents|mesh-ancestor
19977878|NCT05311475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977879|NCT05311475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977880|NCT05311475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19977881|NCT05311475|Respiratory System Agents|respiratory system agents|mesh-ancestor
19977882|NCT05311475|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19977883|NCT05311475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977884|NCT05311475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977885|NCT05311475|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19977886|NCT05311475|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19977887|NCT05311475|Histamine Antagonists|histamine antagonists|mesh-ancestor
19977888|NCT05311475|Histamine Agents|histamine agents|mesh-ancestor
19977889|NCT05311475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19977890|NCT05304364|Naltrexone|naltrexone|mesh-list
19977891|NCT05304364|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19977892|NCT05304364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19977893|NCT05304364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977894|NCT05304364|Sensory System Agents|sensory system agents|mesh-ancestor
19977895|NCT05304364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977896|NCT05302336|Cyclophosphamide|cyclophosphamide|mesh-list
19977897|NCT05302336|Docetaxel|docetaxel|mesh-list
19977898|NCT05302336|Doxorubicin|doxorubicin|mesh-list
19977899|NCT05302336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19977900|NCT05302336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19977901|NCT05302336|Immunologic Factors|immunologic factors|mesh-ancestor
19977902|NCT05302336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977903|NCT05302336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19977904|NCT05302336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19977905|NCT05302336|Alkylating Agents|alkylating agents|mesh-ancestor
19977906|NCT05302336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977907|NCT05302336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977908|NCT05302336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19977909|NCT05302336|Tubulin Modulators|tubulin modulators|mesh-ancestor
19977910|NCT05302336|Antimitotic Agents|antimitotic agents|mesh-ancestor
19977911|NCT05302336|Mitosis Modulators|mitosis modulators|mesh-ancestor
19977912|NCT05302336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19977913|NCT05302336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19977914|NCT05302336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19977915|NCT05302336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977916|NCT05301712|Naloxone|naloxone|mesh-list
19977917|NCT05301712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19977918|NCT05301712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977919|NCT05301712|Sensory System Agents|sensory system agents|mesh-ancestor
19977920|NCT05301712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977921|NCT05300841|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19977922|NCT05300841|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19977923|NCT05300841|Estradiol|estradiol|mesh-list
19977924|NCT05300841|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19977925|NCT05300841|Dydrogesterone|dydrogesterone|mesh-list
19977926|NCT05300841|Estrogens|estrogens|mesh-ancestor
19977927|NCT05300841|Hormones|hormones|mesh-ancestor
19977928|NCT05300841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19977929|NCT05300841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977930|NCT05300841|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19977931|NCT05300841|Contraceptive Agents|contraceptive agents|mesh-ancestor
19977932|NCT05300841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19977933|NCT05300841|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19977934|NCT05300841|Progestins|progestins|mesh-ancestor
19977935|NCT05290194|Capecitabine|capecitabine|mesh-list
19977936|NCT05290194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19977937|NCT05290194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19977938|NCT05290194|Antimetabolites|antimetabolites|mesh-ancestor
19977939|NCT05290194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555461|NCT01940718|Testosterone undecanoate|testosterone undecanoate|mesh-list
20555462|NCT01940718|Testosterone enanthate|testosterone enanthate|mesh-list
20555463|NCT01940718|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20555464|NCT01940718|Androgens|androgens|mesh-ancestor
20555465|NCT01940718|Hormones|hormones|mesh-ancestor
20555466|NCT01940718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20555467|NCT01940718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977940|NCT05290194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977941|NCT05287893|Pyronaridine|pyronaridine|mesh-list
19977942|NCT05287893|Antimalarials|antimalarials|mesh-ancestor
19977943|NCT05287893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20555468|NCT01940718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20555469|NCT01940718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555470|NCT01940718|Anabolic Agents|anabolic agents|mesh-ancestor
19977944|NCT05287893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19977945|NCT05287893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19977946|NCT05285358|Gemcitabine|gemcitabine|mesh-list
19977947|NCT05285358|Paclitaxel|paclitaxel|mesh-list
19977948|NCT05285358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19977949|NCT05285358|Cisplatin|cisplatin|mesh-list
19977950|NCT05285358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19977951|NCT05285358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977952|NCT05285358|Tubulin Modulators|tubulin modulators|mesh-ancestor
19977953|NCT05285358|Antimitotic Agents|antimitotic agents|mesh-ancestor
19977954|NCT05285358|Mitosis Modulators|mitosis modulators|mesh-ancestor
19977955|NCT05285358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977956|NCT05285358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19977957|NCT05285358|Antimetabolites|antimetabolites|mesh-ancestor
19977958|NCT05285358|Antiviral Agents|antiviral agents|mesh-ancestor
19977959|NCT05285358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19977960|NCT05285358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977961|NCT05285358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19977962|NCT05285358|Immunologic Factors|immunologic factors|mesh-ancestor
19977963|NCT05285358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977964|NCT05284591|Daratumumab|daratumumab|mesh-list
19977965|NCT05284591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977966|NCT05277337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19977967|NCT05277337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19977968|NCT05277337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19977969|NCT05277337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977970|NCT05277337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19977971|NCT05277337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19977972|NCT05277337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977973|NCT05277337|Cholinergic Agents|cholinergic agents|mesh-ancestor
19977974|NCT05277337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19977975|NCT05270057|Prednisone|prednisone|mesh-list
19977976|NCT05270057|Cyclophosphamide|cyclophosphamide|mesh-list
19977977|NCT05270057|Rituximab|rituximab|mesh-list
19977978|NCT05270057|Doxorubicin|doxorubicin|mesh-list
19977979|NCT05270057|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19977980|NCT05270057|Etoposide|etoposide|mesh-list
19977981|NCT05270057|Vincristine|vincristine|mesh-list
19977982|NCT05270057|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
19977983|NCT05270057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19977984|NCT05270057|Immunologic Factors|immunologic factors|mesh-ancestor
19977985|NCT05270057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19977986|NCT05270057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19977987|NCT05270057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19977988|NCT05270057|Alkylating Agents|alkylating agents|mesh-ancestor
19977989|NCT05270057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19977990|NCT05270057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19977991|NCT05270057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19977992|NCT05270057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19977993|NCT05270057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19977994|NCT05270057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19977995|NCT05270057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19977996|NCT05270057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19977997|NCT05270057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19977998|NCT05270057|Glucocorticoids|glucocorticoids|mesh-ancestor
19977999|NCT05270057|Hormones|hormones|mesh-ancestor
19978000|NCT05270057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19978001|NCT05270057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19978002|NCT05270057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19978003|NCT05270057|Tubulin Modulators|tubulin modulators|mesh-ancestor
19978004|NCT05270057|Antimitotic Agents|antimitotic agents|mesh-ancestor
19978005|NCT05270057|Mitosis Modulators|mitosis modulators|mesh-ancestor
19978006|NCT05261490|Doxorubicin|doxorubicin|mesh-list
19978007|NCT05261490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19978008|NCT05261490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19978009|NCT05261490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978010|NCT05261490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19978011|NCT05261490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19978012|NCT05261490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978013|NCT05261490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978014|NCT05251129|Atorvastatin|atorvastatin|mesh-list
19978015|NCT05251129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19978016|NCT05251129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19978017|NCT05251129|Antimetabolites|antimetabolites|mesh-ancestor
19978018|NCT05251129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978019|NCT05251129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19978020|NCT05251129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19978021|NCT05251129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978022|NCT05244226|Fentanyl|fentanyl|mesh-list
19978023|NCT05244226|Methadone|methadone|mesh-list
19978024|NCT05244226|Hydromorphone|hydromorphone|mesh-list
19978025|NCT05244226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19978026|NCT05244226|Narcotics|narcotics|mesh-ancestor
19978027|NCT05244226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19978028|NCT05244226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978029|NCT05244226|Analgesics|analgesics|mesh-ancestor
19978030|NCT05244226|Sensory System Agents|sensory system agents|mesh-ancestor
19978031|NCT05244226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978032|NCT05244226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19978033|NCT05244226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19736059|NCT04533347|Tafenoquine|tafenoquine|mesh-list
19736060|NCT04533347|Antimalarials|antimalarials|mesh-ancestor
19736061|NCT04533347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19736062|NCT04533347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19736063|NCT04533347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736064|NCT04533243|Fentanyl|fentanyl|mesh-list
19736065|NCT04533243|Morphine|morphine|mesh-list
19736066|NCT04533243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19736067|NCT04533243|Narcotics|narcotics|mesh-ancestor
19736068|NCT04533243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19978034|NCT05244226|Anesthetics, General|anesthetics, general|mesh-ancestor
19978035|NCT05244226|Anesthetics|anesthetics|mesh-ancestor
19978036|NCT05244226|Antitussive Agents|antitussive agents|mesh-ancestor
19978037|NCT05244226|Respiratory System Agents|respiratory system agents|mesh-ancestor
19978038|NCT05242471|Golimumab|golimumab|mesh-list
19978039|NCT05242471|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19978040|NCT05242471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19978041|NCT05242471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19978042|NCT05242471|Immunologic Factors|immunologic factors|mesh-ancestor
19978043|NCT05242471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978044|NCT05229653|Ketamine|ketamine|mesh-list
19978045|NCT05229653|Analgesics|analgesics|mesh-ancestor
19978046|NCT05229653|Sensory System Agents|sensory system agents|mesh-ancestor
19978047|NCT05229653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978048|NCT05229653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978049|NCT05229653|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19978050|NCT05229653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19978051|NCT05229653|Anesthetics, General|anesthetics, general|mesh-ancestor
19978052|NCT05229653|Anesthetics|anesthetics|mesh-ancestor
19978053|NCT05229653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19978054|NCT05229653|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19978055|NCT05229653|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19978056|NCT05229653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19978057|NCT05229653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978058|NCT05228574|Amiloride|amiloride|mesh-list
19978059|NCT05228574|Diuretics|diuretics|mesh-ancestor
19978060|NCT05228574|Natriuretic Agents|natriuretic agents|mesh-ancestor
19978061|NCT05228574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978062|NCT05228574|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
19978063|NCT05228574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19978064|NCT05228574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19978065|NCT05228574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978066|NCT05228574|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19978067|NCT05228574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20288780|NCT05210725|Rivaroxaban|rivaroxaban|mesh-list
20288781|NCT05210725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20288782|NCT05210725|Antithrombins|antithrombins|mesh-ancestor
20288783|NCT05210725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20288784|NCT05210725|Protease Inhibitors|protease inhibitors|mesh-ancestor
20288785|NCT05210725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288786|NCT05210725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288787|NCT05210725|Anticoagulants|anticoagulants|mesh-ancestor
20288788|NCT05210374|Copper|copper|mesh-list
20288789|NCT05210374|Doxorubicin|doxorubicin|mesh-list
20288790|NCT05210374|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20288791|NCT05210374|Disulfiram|disulfiram|mesh-list
20288792|NCT05210374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20288793|NCT05210374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736069|NCT04533243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978068|NCT05192850|Metformin|metformin|mesh-list
19978069|NCT05192850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19978070|NCT05192850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978071|NCT05192200|Interferons|interferons|mesh-list
19978072|NCT05192200|Interferon-beta|interferon-beta|mesh-list
19978073|NCT05192200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978074|NCT05192200|Antiviral Agents|antiviral agents|mesh-ancestor
19978075|NCT05192200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19978076|NCT05192200|Immunologic Factors|immunologic factors|mesh-ancestor
19978077|NCT05192200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978078|NCT05180942|Atorvastatin|atorvastatin|mesh-list
19978079|NCT05180942|Calcium|calcium|mesh-list
19978080|NCT05180942|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19978081|NCT05180942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978082|NCT05180942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19978083|NCT05180942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19978084|NCT05180942|Antimetabolites|antimetabolites|mesh-ancestor
19978085|NCT05180942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978086|NCT05180942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19978087|NCT05180942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19978088|NCT05180942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978089|NCT05177263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19978090|NCT05177146|Ketamine|ketamine|mesh-list
19978091|NCT05177146|Analgesics|analgesics|mesh-ancestor
19978092|NCT05177146|Sensory System Agents|sensory system agents|mesh-ancestor
19978093|NCT05177146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978094|NCT05177146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978095|NCT05177146|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19978096|NCT05177146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19978097|NCT05177146|Anesthetics, General|anesthetics, general|mesh-ancestor
19978098|NCT05177146|Anesthetics|anesthetics|mesh-ancestor
19978099|NCT05177146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19978100|NCT05177146|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19978101|NCT05177146|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19978102|NCT05177146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19978103|NCT05177146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978104|NCT05158140|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19978105|NCT05158140|Immunologic Factors|immunologic factors|mesh-ancestor
19978106|NCT05158140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978107|NCT05131919|Pembrolizumab|pembrolizumab|mesh-list
19978108|NCT05131919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19978109|NCT05131919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978110|NCT05105282|Anesthetics|anesthetics|mesh-list
19978111|NCT05105282|Anesthetics, Local|anesthetics, local|mesh-list
19978112|NCT05105282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19978113|NCT05105282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978114|NCT05105282|Sensory System Agents|sensory system agents|mesh-ancestor
19978115|NCT05105282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978116|NCT05100160|Gabapentin|gabapentin|mesh-list
19978117|NCT05100160|Analgesics|analgesics|mesh-ancestor
19978118|NCT05100160|Sensory System Agents|sensory system agents|mesh-ancestor
19978119|NCT05100160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978120|NCT05100160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978121|NCT05100160|Anticonvulsants|anticonvulsants|mesh-ancestor
19978122|NCT05100160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19978123|NCT05100160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19978124|NCT05100160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19978125|NCT05100160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19978126|NCT05100160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19978127|NCT05100160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19978128|NCT05100160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19978129|NCT05100160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978130|NCT05100160|Antimanic Agents|antimanic agents|mesh-ancestor
19978131|NCT05071716|Rifaximin|rifaximin|mesh-list
19978132|NCT05071716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19978133|NCT05071716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19978134|NCT05071716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19978135|NCT05063786|Capecitabine|capecitabine|mesh-list
19978136|NCT05063786|Trastuzumab|trastuzumab|mesh-list
19978137|NCT05063786|Vinorelbine|vinorelbine|mesh-list
19978138|NCT05063786|Fulvestrant|fulvestrant|mesh-list
19978139|NCT05063786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19978140|NCT05063786|Antimetabolites|antimetabolites|mesh-ancestor
19978141|NCT05063786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978142|NCT05063786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978143|NCT05063786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19978144|NCT05063786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19978145|NCT05063786|Tubulin Modulators|tubulin modulators|mesh-ancestor
19978146|NCT05063786|Antimitotic Agents|antimitotic agents|mesh-ancestor
19978147|NCT05063786|Mitosis Modulators|mitosis modulators|mesh-ancestor
19978148|NCT05063786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19978149|NCT05063786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19978150|NCT05063786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19978151|NCT05063786|Hormone Antagonists|hormone antagonists|mesh-ancestor
19978152|NCT05063786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19978153|NCT05063786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978154|NCT05058287|Methylprednisolone|methylprednisolone|mesh-list
19978155|NCT05058287|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19978156|NCT05058287|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19978157|NCT05058287|Prednisolone|prednisolone|mesh-list
19978158|NCT05058287|Prednisolone acetate|prednisolone acetate|mesh-list
19978159|NCT05058287|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19978160|NCT05058287|Prednisolone phosphate|prednisolone phosphate|mesh-list
19978161|NCT05058287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19978162|NCT05058287|Antiemetics|antiemetics|mesh-ancestor
19978163|NCT05058287|Autonomic Agents|autonomic agents|mesh-ancestor
19978164|NCT05058287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978165|NCT05058287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978166|NCT05058287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19978167|NCT05058287|Glucocorticoids|glucocorticoids|mesh-ancestor
19978168|NCT05058287|Hormones|hormones|mesh-ancestor
19978169|NCT05058287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19978170|NCT05058287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19978171|NCT05058287|Protective Agents|protective agents|mesh-ancestor
19978172|NCT05058287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19978173|NCT05058287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978174|NCT05041257|Maytansine|maytansine|mesh-list
19978175|NCT05041257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19978176|NCT05041257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978177|NCT05041257|Tubulin Modulators|tubulin modulators|mesh-ancestor
19978178|NCT05041257|Antimitotic Agents|antimitotic agents|mesh-ancestor
19978179|NCT05041257|Mitosis Modulators|mitosis modulators|mesh-ancestor
19978180|NCT05041257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978181|NCT04999241|Mesalamine|mesalamine|mesh-list
19978182|NCT04999241|Infliximab|infliximab|mesh-list
19978183|NCT04999241|Dermatologic Agents|dermatologic agents|mesh-ancestor
19978184|NCT04999241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19978185|NCT04999241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19978186|NCT04999241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19978187|NCT04999241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19978188|NCT04999241|Analgesics|analgesics|mesh-ancestor
19978189|NCT04999241|Sensory System Agents|sensory system agents|mesh-ancestor
19978190|NCT04999241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978191|NCT04999241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978192|NCT04999241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19978193|NCT04999020|Ravulizumab|ravulizumab|mesh-list
19978194|NCT04999020|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19978195|NCT04999020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19978196|NCT04999020|Immunologic Factors|immunologic factors|mesh-ancestor
19978197|NCT04999020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978198|NCT04986072|Nitroprusside|nitroprusside|mesh-list
19978199|NCT04986072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19978200|NCT04986072|Vasodilator Agents|vasodilator agents|mesh-ancestor
19978201|NCT04986072|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19978202|NCT04986072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978203|NCT04981678|Buprenorphine|buprenorphine|mesh-list
19978204|NCT04981678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19978205|NCT04981678|Narcotics|narcotics|mesh-ancestor
19978206|NCT04981678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19978207|NCT04981678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978208|NCT04981678|Analgesics|analgesics|mesh-ancestor
19978209|NCT04981678|Sensory System Agents|sensory system agents|mesh-ancestor
19978210|NCT04981678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978211|NCT04981678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19978212|NCT04969627|Metformin|metformin|mesh-list
19978213|NCT04969627|Exenatide|exenatide|mesh-list
19978214|NCT04969627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19978215|NCT04969627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978216|NCT04969627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19978217|NCT04969627|Incretins|incretins|mesh-ancestor
19978218|NCT04969627|Hormones|hormones|mesh-ancestor
19978219|NCT04969627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19978220|NCT04956575|Vaccines|vaccines|mesh-list
19978221|NCT04956575|Immunologic Factors|immunologic factors|mesh-ancestor
20555471|NCT01940796|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20555472|NCT01940796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20555473|NCT01940796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555474|NCT01940952|Donepezil|donepezil|mesh-list
19978222|NCT04956575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555475|NCT01940952|Udenafil|udenafil|mesh-list
20555476|NCT01940952|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20555477|NCT01940952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555478|NCT01940952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555479|NCT01940952|Cholinergic Agents|cholinergic agents|mesh-ancestor
20555480|NCT01940952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20555481|NCT01940952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555482|NCT01940952|Nootropic Agents|nootropic agents|mesh-ancestor
20555483|NCT01940952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20555484|NCT01940952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20555485|NCT01940965|Lixisenatide|lixisenatide|mesh-list
20555486|NCT01940965|Biguanides|biguanides|mesh-list
20555487|NCT01940965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20555488|NCT01940965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555489|NCT01940978|Cyproheptadine|cyproheptadine|mesh-list
20555490|NCT01940978|Methylphenidate|methylphenidate|mesh-list
20555491|NCT01940978|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20555492|NCT01940978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555493|NCT01940978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20555494|NCT01940978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19978223|NCT04953325|Vaccines|vaccines|mesh-list
19978224|NCT04953325|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19978225|NCT04953325|Immunologic Factors|immunologic factors|mesh-ancestor
19978226|NCT04953325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978227|NCT04941196|Ticagrelor|ticagrelor|mesh-list
20555495|NCT01940978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20555496|NCT01940978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555497|NCT01940978|Dopamine Agents|dopamine agents|mesh-ancestor
20555498|NCT01940978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20555499|NCT01940978|Antipruritics|antipruritics|mesh-ancestor
20555500|NCT01940978|Dermatologic Agents|dermatologic agents|mesh-ancestor
19978228|NCT04941196|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19978229|NCT04941196|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19978230|NCT04941196|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19978231|NCT04941196|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19978232|NCT04941196|Purinergic Agents|purinergic agents|mesh-ancestor
19978233|NCT04941196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19978234|NCT04941196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978235|NCT04941196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978236|NCT04938856|Lamotrigine|lamotrigine|mesh-list
19978237|NCT04938856|Anticonvulsants|anticonvulsants|mesh-ancestor
19978238|NCT04938856|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19978239|NCT04938856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19978240|NCT04938856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978241|NCT04938856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19978242|NCT04938856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978243|NCT04938856|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19978244|NCT04938856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19978245|NCT04938856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19978246|NCT04938856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19978247|NCT04938856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19978248|NCT04935177|Antibodies|antibodies|mesh-list
19978249|NCT04935177|Immunoglobulins|immunoglobulins|mesh-list
19978250|NCT04935177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19978251|NCT04935177|gamma-Globulins|gamma-globulins|mesh-list
19978252|NCT04935177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19978253|NCT04935177|Eculizumab|eculizumab|mesh-list
19978254|NCT04935177|Immunologic Factors|immunologic factors|mesh-ancestor
19978255|NCT04935177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978256|NCT04935177|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19978257|NCT04935177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20288794|NCT05210374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20288795|NCT05210374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20288796|NCT05210374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288797|NCT05210374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288798|NCT05210374|Trace Elements|trace elements|mesh-ancestor
20288799|NCT05210374|Micronutrients|micronutrients|mesh-ancestor
20288800|NCT05210374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288801|NCT05210374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20288802|NCT05210374|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
20288803|NCT05208333|Albendazole|albendazole|mesh-list
20288804|NCT05208333|Anthelmintics|anthelmintics|mesh-ancestor
20288805|NCT05208333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20288806|NCT05208333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20288807|NCT05208333|Anticestodal Agents|anticestodal agents|mesh-ancestor
20288808|NCT05208333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20288809|NCT05208333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20288810|NCT05208333|Tubulin Modulators|tubulin modulators|mesh-ancestor
20288811|NCT05208333|Antimitotic Agents|antimitotic agents|mesh-ancestor
20288812|NCT05208333|Mitosis Modulators|mitosis modulators|mesh-ancestor
20288813|NCT05208333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288814|NCT05208333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288815|NCT05207137|Vaccines|vaccines|mesh-list
20288816|NCT05207137|Immunologic Factors|immunologic factors|mesh-ancestor
20288817|NCT05207137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288818|NCT05201001|Carboplatin|carboplatin|mesh-list
20288819|NCT05201001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288820|NCT05199662|Tenecteplase|tenecteplase|mesh-list
20288821|NCT05199662|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20288822|NCT05199662|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20288823|NCT05199662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288824|NCT05199194|Tenecteplase|tenecteplase|mesh-list
20288825|NCT05199194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20288826|NCT05199194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19978258|NCT04927780|Leucovorin|leucovorin|mesh-list
19978259|NCT04927780|Fluorouracil|fluorouracil|mesh-list
19978260|NCT04927780|Oxaliplatin|oxaliplatin|mesh-list
19978261|NCT04927780|Irinotecan|irinotecan|mesh-list
19978262|NCT04927780|Calcium|calcium|mesh-list
19978263|NCT04927780|Levoleucovorin|levoleucovorin|mesh-list
19978264|NCT04927780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19978265|NCT04927780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978266|NCT04927780|Antimetabolites|antimetabolites|mesh-ancestor
19978267|NCT04927780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978268|NCT04927780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19978269|NCT04927780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978270|NCT04927780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19978271|NCT04927780|Immunologic Factors|immunologic factors|mesh-ancestor
19978272|NCT04927780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19978273|NCT04927780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19978274|NCT04927780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978275|NCT04927780|Antidotes|antidotes|mesh-ancestor
19978276|NCT04927780|Protective Agents|protective agents|mesh-ancestor
19978277|NCT04927780|Vitamin B Complex|vitamin b complex|mesh-ancestor
19978278|NCT04927780|Vitamins|vitamins|mesh-ancestor
19978279|NCT04927780|Micronutrients|micronutrients|mesh-ancestor
19978280|NCT04923776|Carboplatin|carboplatin|mesh-list
19978281|NCT04923776|Etoposide|etoposide|mesh-list
19978282|NCT04923776|Atezolizumab|atezolizumab|mesh-list
19978283|NCT04923776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978284|NCT04923776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19978285|NCT04923776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19978286|NCT04923776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19978287|NCT04923776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978288|NCT04923776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978289|NCT04885712|Metformin|metformin|mesh-list
19978290|NCT04885712|Pioglitazone|pioglitazone|mesh-list
19978291|NCT04885712|Dapagliflozin|dapagliflozin|mesh-list
19978292|NCT04885712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19978293|NCT04885712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978294|NCT04885712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19978295|NCT04885712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978296|NCT04871061|Fentanyl|fentanyl|mesh-list
19978297|NCT04871061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19736070|NCT04533243|Analgesics|analgesics|mesh-ancestor
19736071|NCT04533243|Sensory System Agents|sensory system agents|mesh-ancestor
19736072|NCT04533243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19736073|NCT04533243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19736074|NCT04533243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19736075|NCT04533243|Anesthetics, General|anesthetics, general|mesh-ancestor
19736076|NCT04533243|Anesthetics|anesthetics|mesh-ancestor
19736077|NCT04533321|Afatinib|afatinib|mesh-list
19736078|NCT04533321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736079|NCT04533321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19736080|NCT04533321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736081|NCT04533321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736082|NCT04532931|Acetaminophen|acetaminophen|mesh-list
19736083|NCT04532931|Sofosbuvir|sofosbuvir|mesh-list
19736084|NCT04532931|Artesunate|artesunate|mesh-list
19978298|NCT04871061|Narcotics|narcotics|mesh-ancestor
19978299|NCT04871061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19978300|NCT04871061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978301|NCT04871061|Analgesics|analgesics|mesh-ancestor
19978302|NCT04871061|Sensory System Agents|sensory system agents|mesh-ancestor
19978303|NCT04871061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978304|NCT04871061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19978305|NCT04871061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19978306|NCT04871061|Anesthetics, General|anesthetics, general|mesh-ancestor
19978307|NCT04871061|Anesthetics|anesthetics|mesh-ancestor
19978308|NCT04867707|Zanamivir|zanamivir|mesh-list
19978309|NCT04867707|Antiviral Agents|antiviral agents|mesh-ancestor
19978310|NCT04867707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19978311|NCT04867707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978312|NCT04867707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978313|NCT04838054|Chlorine dioxide|chlorine dioxide|mesh-list
19978314|NCT04838054|Dental Disinfectants|dental disinfectants|mesh-ancestor
19978315|NCT04838054|Disinfectants|disinfectants|mesh-ancestor
19978316|NCT04838054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19978317|NCT04837209|Niraparib|niraparib|mesh-list
19978318|NCT04837209|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19978319|NCT04837209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978320|NCT04837209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978321|NCT04837209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978322|NCT04837066|Imidacloprid|imidacloprid|mesh-list
19978323|NCT04837066|Cholinergic Agents|cholinergic agents|mesh-ancestor
19978324|NCT04837066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19978325|NCT04837066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978326|NCT04837066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978327|NCT04827537|Metronidazole|metronidazole|mesh-list
19978328|NCT04827537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19978329|NCT04827537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19978330|NCT04827537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19978331|NCT04827537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19978332|NCT04814927|Copper|copper|mesh-list
19978333|NCT04814927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19978334|NCT04814927|Levonorgestrel|levonorgestrel|mesh-list
19978335|NCT04814927|Medroxyprogesterone|medroxyprogesterone|mesh-list
19978336|NCT04814927|Etonogestrel|etonogestrel|mesh-list
19978337|NCT04814927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19978338|NCT04814927|Contraceptive Agents|contraceptive agents|mesh-ancestor
19978339|NCT04814927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19978340|NCT04814927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978341|NCT04814927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19978342|NCT04814927|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19978343|NCT04814927|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19978344|NCT04814927|Trace Elements|trace elements|mesh-ancestor
19978345|NCT04814927|Micronutrients|micronutrients|mesh-ancestor
19978346|NCT04814927|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19978347|NCT04814927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19978348|NCT04814927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19978349|NCT04814927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978350|NCT04810949|Vitamin D|vitamin d|mesh-list
19978351|NCT04810949|Cholecalciferol|cholecalciferol|mesh-list
19978352|NCT04810949|Vitamins|vitamins|mesh-ancestor
19978353|NCT04810949|Micronutrients|micronutrients|mesh-ancestor
19978354|NCT04810949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978355|NCT04810949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19978356|NCT04810949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19978357|NCT04807894|Testosterone|testosterone|mesh-list
19978358|NCT04807894|Androgens|androgens|mesh-ancestor
19978359|NCT04807894|Hormones|hormones|mesh-ancestor
19978360|NCT04807894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19736085|NCT04532931|Favipiravir|favipiravir|mesh-list
19736086|NCT04532931|Amodiaquine|amodiaquine|mesh-list
19736087|NCT04532931|Nitazoxanide|nitazoxanide|mesh-list
19736088|NCT04532931|Pyronaridine|pyronaridine|mesh-list
19736089|NCT04532931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19736090|NCT04532931|Analgesics|analgesics|mesh-ancestor
19736091|NCT04532931|Sensory System Agents|sensory system agents|mesh-ancestor
19736092|NCT04532931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19736093|NCT04532931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736094|NCT04532931|Antipyretics|antipyretics|mesh-ancestor
19736095|NCT04532931|Antiviral Agents|antiviral agents|mesh-ancestor
19978361|NCT04807894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978362|NCT04795583|Prednisone|prednisone|mesh-list
19978363|NCT04795583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19978364|NCT04795583|Glucocorticoids|glucocorticoids|mesh-ancestor
19978365|NCT04795583|Hormones|hormones|mesh-ancestor
19978366|NCT04795583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19978367|NCT04795583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978368|NCT04795583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19978369|NCT04795583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978370|NCT04775173|Sirolimus|sirolimus|mesh-list
19978371|NCT04775173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19978372|NCT04775173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19978373|NCT04775173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19978374|NCT04775173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978375|NCT04775173|Antifungal Agents|antifungal agents|mesh-ancestor
19978376|NCT04775173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19978377|NCT04775173|Immunologic Factors|immunologic factors|mesh-ancestor
19978378|NCT04775173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978379|NCT04774068|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19978380|NCT04774068|Romidepsin|romidepsin|mesh-list
19978381|NCT04774068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19978382|NCT04774068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19978383|NCT04774068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978384|NCT04767191|Lumefantrine|lumefantrine|mesh-list
19978385|NCT04767191|Artemether|artemether|mesh-list
19978386|NCT04767191|Piperaquine|piperaquine|mesh-list
19978387|NCT04767191|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19978388|NCT04767191|Artenimol|artenimol|mesh-list
19978389|NCT04767191|Antimalarials|antimalarials|mesh-ancestor
19978390|NCT04767191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19978391|NCT04767191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19978392|NCT04767191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19978393|NCT04744831|Camptothecin|camptothecin|mesh-list
19978394|NCT04744831|Immunoconjugates|immunoconjugates|mesh-list
19978395|NCT04744831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19978396|NCT04744831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978397|NCT04744831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19978398|NCT04744831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19978399|NCT04744831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555501|NCT01940978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20555502|NCT01940978|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20555503|NCT01940978|Histamine Antagonists|histamine antagonists|mesh-ancestor
20555504|NCT01940978|Histamine Agents|histamine agents|mesh-ancestor
20555505|NCT01940978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20555506|NCT01940978|Serotonin Agents|serotonin agents|mesh-ancestor
20555507|NCT01940978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20555508|NCT01941004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20555509|NCT01941004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20555510|NCT01941004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555511|NCT01941004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20555512|NCT01941004|Immunologic Factors|immunologic factors|mesh-ancestor
20555513|NCT01941004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555514|NCT01941056|Vaccines|vaccines|mesh-list
20555515|NCT01941056|Immunologic Factors|immunologic factors|mesh-ancestor
20555516|NCT01941056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555517|NCT01941134|Levonorgestrel|levonorgestrel|mesh-list
20555518|NCT01941134|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20555519|NCT01941134|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
20555520|NCT01941134|Contraceptive Agents|contraceptive agents|mesh-list
19978400|NCT04744831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978401|NCT04744831|Immunologic Factors|immunologic factors|mesh-ancestor
19978402|NCT04744831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978403|NCT04728087|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
19978404|NCT04728087|Hemostatics|hemostatics|mesh-ancestor
19978405|NCT04728087|Coagulants|coagulants|mesh-ancestor
19978406|NCT04711252|Palbociclib|palbociclib|mesh-list
19978407|NCT04711252|Anastrozole|anastrozole|mesh-list
19978408|NCT04711252|Hormones|hormones|mesh-list
19978409|NCT04711252|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19978410|NCT04711252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19978411|NCT04711252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978412|NCT04711252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978413|NCT04711252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19978414|NCT04711252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978415|NCT04711252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978416|NCT04711252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19978417|NCT04711252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19978418|NCT04711252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19978419|NCT04711252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19978420|NCT04711252|Hormone Antagonists|hormone antagonists|mesh-ancestor
19978421|NCT04689919|Rivaroxaban|rivaroxaban|mesh-list
19978422|NCT04689919|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19978423|NCT04689919|Antithrombins|antithrombins|mesh-ancestor
19978424|NCT04689919|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19978425|NCT04689919|Protease Inhibitors|protease inhibitors|mesh-ancestor
19978426|NCT04689919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978427|NCT04689919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978428|NCT04689919|Anticoagulants|anticoagulants|mesh-ancestor
19978429|NCT04663347|Gemcitabine|gemcitabine|mesh-list
19978430|NCT04663347|Cytarabine|cytarabine|mesh-list
19978431|NCT04663347|Dexamethasone|dexamethasone|mesh-list
19978432|NCT04663347|Prednisone|prednisone|mesh-list
19978433|NCT04663347|Cyclophosphamide|cyclophosphamide|mesh-list
19978434|NCT04663347|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19978435|NCT04663347|Rituximab|rituximab|mesh-list
19978436|NCT04663347|Carboplatin|carboplatin|mesh-list
19978437|NCT04663347|Doxorubicin|doxorubicin|mesh-list
19978438|NCT04663347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19978439|NCT04663347|Oxaliplatin|oxaliplatin|mesh-list
19978440|NCT04663347|Vincristine|vincristine|mesh-list
19978441|NCT04663347|Lenalidomide|lenalidomide|mesh-list
19978442|NCT04663347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19978443|NCT04663347|Immunologic Factors|immunologic factors|mesh-ancestor
19978444|NCT04663347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978445|NCT04663347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19978446|NCT04663347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19978447|NCT04663347|Alkylating Agents|alkylating agents|mesh-ancestor
19978448|NCT04663347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978449|NCT04663347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978450|NCT04663347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19978451|NCT04663347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19978452|NCT04663347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19978453|NCT04663347|Antiemetics|antiemetics|mesh-ancestor
19978454|NCT04663347|Autonomic Agents|autonomic agents|mesh-ancestor
19978455|NCT04663347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978456|NCT04663347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19978457|NCT04663347|Glucocorticoids|glucocorticoids|mesh-ancestor
19978458|NCT04663347|Hormones|hormones|mesh-ancestor
19978459|NCT04663347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19978460|NCT04663347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19978461|NCT04663347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19978462|NCT04663347|Antimetabolites|antimetabolites|mesh-ancestor
19978463|NCT04663347|Antiviral Agents|antiviral agents|mesh-ancestor
19978464|NCT04663347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19978465|NCT04663347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978466|NCT04663347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19978467|NCT04663347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19978468|NCT04663347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19978469|NCT04663347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19978470|NCT04663347|Tubulin Modulators|tubulin modulators|mesh-ancestor
19978471|NCT04663347|Antimitotic Agents|antimitotic agents|mesh-ancestor
19978472|NCT04663347|Mitosis Modulators|mitosis modulators|mesh-ancestor
19978473|NCT04663347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19978474|NCT04663347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19978475|NCT04663347|Growth Substances|growth substances|mesh-ancestor
19978476|NCT04663347|Growth Inhibitors|growth inhibitors|mesh-ancestor
19978477|NCT04654507|Dexamethasone|dexamethasone|mesh-list
19978478|NCT04654507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19978479|NCT04654507|Antiemetics|antiemetics|mesh-ancestor
19978480|NCT04654507|Autonomic Agents|autonomic agents|mesh-ancestor
19978481|NCT04654507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978482|NCT04654507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978483|NCT04654507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19978484|NCT04654507|Glucocorticoids|glucocorticoids|mesh-ancestor
19978485|NCT04654507|Hormones|hormones|mesh-ancestor
19978486|NCT04654507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19978487|NCT04654507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19978488|NCT04654507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978489|NCT04630834|Acetaminophen|acetaminophen|mesh-list
19978490|NCT04630834|Ibuprofen|ibuprofen|mesh-list
19978491|NCT04630834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19978492|NCT04630834|Analgesics|analgesics|mesh-ancestor
19978493|NCT04630834|Sensory System Agents|sensory system agents|mesh-ancestor
19978494|NCT04630834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978495|NCT04630834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978496|NCT04630834|Antipyretics|antipyretics|mesh-ancestor
19978497|NCT04630834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19978498|NCT04630834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19978499|NCT04630834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19978500|NCT04630834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19978501|NCT04630834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978502|NCT04630834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978503|NCT04630769|Interleukin-2|interleukin-2|mesh-list
19978504|NCT04630769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978505|NCT04630769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19978506|NCT04630769|Analgesics|analgesics|mesh-ancestor
19978507|NCT04630769|Sensory System Agents|sensory system agents|mesh-ancestor
19978508|NCT04630769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978509|NCT04630769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978510|NCT04624854|Aspirin|aspirin|mesh-list
19978511|NCT04624854|Clopidogrel|clopidogrel|mesh-list
19978512|NCT04624854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19978513|NCT04624854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19978514|NCT04624854|Analgesics|analgesics|mesh-ancestor
19978515|NCT04624854|Sensory System Agents|sensory system agents|mesh-ancestor
19978516|NCT04624854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978517|NCT04624854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978518|NCT04624854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19978519|NCT04624854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19978520|NCT04624854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19978521|NCT04624854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19978522|NCT04624854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978523|NCT04624854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19978524|NCT04624854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19978525|NCT04624854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978526|NCT04624854|Antipyretics|antipyretics|mesh-ancestor
19978527|NCT04624854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19978528|NCT04624854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19978529|NCT04624854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19978530|NCT04624854|Purinergic Agents|purinergic agents|mesh-ancestor
19978531|NCT04624854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19978532|NCT04619706|Palmidrol|palmidrol|mesh-list
19978533|NCT04619706|Analgesics|analgesics|mesh-ancestor
19978534|NCT04619706|Sensory System Agents|sensory system agents|mesh-ancestor
19978535|NCT04619706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978536|NCT04619706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978537|NCT04619706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19978538|NCT04619706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19978539|NCT04619706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19978540|NCT04619706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19978541|NCT04619706|Antiviral Agents|antiviral agents|mesh-ancestor
19978542|NCT04619706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19978543|NCT04619706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19978544|NCT04619706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19978545|NCT04619706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19978546|NCT04619706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978547|NCT04619706|Hormones|hormones|mesh-ancestor
19978548|NCT04619706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19978549|NCT04619680|Nintedanib|nintedanib|mesh-list
19978550|NCT04619680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978551|NCT04619680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19978552|NCT04619680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978553|NCT04619680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978554|NCT04615949|Cannabidiol|cannabidiol|mesh-list
19978555|NCT04615949|Anticonvulsants|anticonvulsants|mesh-ancestor
19978556|NCT04607421|Leucovorin|leucovorin|mesh-list
19978557|NCT04607421|Bevacizumab|bevacizumab|mesh-list
19978558|NCT04607421|Cetuximab|cetuximab|mesh-list
19978559|NCT04607421|Fluorouracil|fluorouracil|mesh-list
19978560|NCT04607421|Capecitabine|capecitabine|mesh-list
19978561|NCT04607421|Oxaliplatin|oxaliplatin|mesh-list
19978562|NCT04607421|Irinotecan|irinotecan|mesh-list
19978563|NCT04607421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19978564|NCT04607421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978565|NCT04607421|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19978566|NCT04607421|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20555521|NCT01941134|Contraceptives, Oral|contraceptives, oral|mesh-list
20555522|NCT01941134|Estradiol|estradiol|mesh-list
20555523|NCT01941134|Estrogens|estrogens|mesh-ancestor
20555524|NCT01941134|Hormones|hormones|mesh-ancestor
20555525|NCT01941134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20555526|NCT01941134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555527|NCT01941134|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20555528|NCT01941134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20555529|NCT01941134|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20555530|NCT01941134|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20555531|NCT01941134|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20555532|NCT01941134|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20555533|NCT01941173|Leucovorin|leucovorin|mesh-list
20555534|NCT01941173|Fluorouracil|fluorouracil|mesh-list
20555535|NCT01941173|Irinotecan|irinotecan|mesh-list
20555536|NCT01941173|Aflibercept|aflibercept|mesh-list
20555537|NCT01941173|Calcium|calcium|mesh-list
20555538|NCT01941173|Levoleucovorin|levoleucovorin|mesh-list
20555539|NCT01941173|Endothelial Growth Factors|endothelial growth factors|mesh-list
20555540|NCT01941173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20555541|NCT01941173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555542|NCT01941173|Antimetabolites|antimetabolites|mesh-ancestor
20555543|NCT01941173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555544|NCT01941173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20555545|NCT01941173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555546|NCT01941173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20555547|NCT01941173|Immunologic Factors|immunologic factors|mesh-ancestor
20555548|NCT01941173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20555549|NCT01941173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20555550|NCT01941173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555551|NCT01941173|Antidotes|antidotes|mesh-ancestor
20555552|NCT01941173|Protective Agents|protective agents|mesh-ancestor
20555553|NCT01941173|Vitamin B Complex|vitamin b complex|mesh-ancestor
20555554|NCT01941173|Vitamins|vitamins|mesh-ancestor
20555555|NCT01941173|Micronutrients|micronutrients|mesh-ancestor
20555556|NCT01941173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20555557|NCT01941173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20555558|NCT01941173|Growth Substances|growth substances|mesh-ancestor
20555559|NCT01941173|Growth Inhibitors|growth inhibitors|mesh-ancestor
20555560|NCT01941199|Metformin|metformin|mesh-list
20555561|NCT01941199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20555562|NCT01941199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555563|NCT01941225|Iloprost|iloprost|mesh-list
20555564|NCT01941225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20555565|NCT01941225|Vasodilator Agents|vasodilator agents|mesh-ancestor
20555566|NCT01941264|Lumefantrine|lumefantrine|mesh-list
19978567|NCT04607421|Growth Substances|growth substances|mesh-ancestor
20555567|NCT01941264|Artemether|artemether|mesh-list
20555568|NCT01941264|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20555569|NCT01941264|Antimalarials|antimalarials|mesh-ancestor
19978568|NCT04607421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978569|NCT04607421|Growth Inhibitors|growth inhibitors|mesh-ancestor
19978570|NCT04607421|Antimetabolites|antimetabolites|mesh-ancestor
19978571|NCT04607421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978572|NCT04607421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19978573|NCT04607421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19978574|NCT04607421|Immunologic Factors|immunologic factors|mesh-ancestor
19978575|NCT04607421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19978576|NCT04607421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19978577|NCT04607421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978578|NCT04607421|Antidotes|antidotes|mesh-ancestor
19978579|NCT04607421|Protective Agents|protective agents|mesh-ancestor
19978580|NCT04607421|Vitamin B Complex|vitamin b complex|mesh-ancestor
19978581|NCT04607421|Vitamins|vitamins|mesh-ancestor
19978582|NCT04607421|Micronutrients|micronutrients|mesh-ancestor
20288827|NCT05199194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555570|NCT01941264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20555571|NCT01941264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20555572|NCT01941264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20555573|NCT01941316|Irinotecan|irinotecan|mesh-list
20555574|NCT01941316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20555575|NCT01941316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20555576|NCT01941316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555577|NCT01941316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555578|NCT01941316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978583|NCT04550377|Cannabidiol|cannabidiol|mesh-list
19978584|NCT04550377|Anticonvulsants|anticonvulsants|mesh-ancestor
19978585|NCT04479306|Osimertinib|osimertinib|mesh-list
19978586|NCT04479306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978587|NCT04479306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19978588|NCT04479306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978589|NCT04479306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978590|NCT04476212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19978591|NCT04476212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19978592|NCT04458922|Atezolizumab|atezolizumab|mesh-list
19978593|NCT04458922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19978594|NCT04458922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978595|NCT04458922|Immunologic Factors|immunologic factors|mesh-ancestor
19978596|NCT04458922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978597|NCT04457219|Hemostatics|hemostatics|mesh-list
19978598|NCT04457219|Coagulants|coagulants|mesh-ancestor
19978599|NCT04443010|Temozolomide|temozolomide|mesh-list
19978600|NCT04443010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19978601|NCT04443010|Alkylating Agents|alkylating agents|mesh-ancestor
19978602|NCT04443010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978603|NCT04443010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978604|NCT04439357|Trametinib|trametinib|mesh-list
19978605|NCT04439357|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
19978606|NCT04439357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978607|NCT04439357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19978608|NCT04439357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978609|NCT04439357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978610|NCT04439357|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19978611|NCT04439357|Protective Agents|protective agents|mesh-ancestor
19978612|NCT04439357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978613|NCT04439357|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19978614|NCT04439357|Antioxidants|antioxidants|mesh-ancestor
19978615|NCT04294160|Trametinib|trametinib|mesh-list
19978616|NCT04294160|Dabrafenib|dabrafenib|mesh-list
19978617|NCT04294160|Spartalizumab|spartalizumab|mesh-list
19978618|NCT04294160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978619|NCT04294160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19978620|NCT04294160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978621|NCT04294160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978622|NCT04294160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19978623|NCT04281108|Fluticasone|fluticasone|mesh-list
19978624|NCT04281108|Xhance|xhance|mesh-list
19978625|NCT04281108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19978626|NCT04281108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19978627|NCT04281108|Autonomic Agents|autonomic agents|mesh-ancestor
19978628|NCT04281108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978629|NCT04281108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978630|NCT04281108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19978631|NCT04281108|Respiratory System Agents|respiratory system agents|mesh-ancestor
19978632|NCT04281108|Dermatologic Agents|dermatologic agents|mesh-ancestor
19978633|NCT04281108|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19978634|NCT04272333|Nivolumab|nivolumab|mesh-list
19978635|NCT04272333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19978636|NCT04272333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978637|NCT04272333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19978638|NCT04272333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978639|NCT04226495|Sufentanil|sufentanil|mesh-list
19978640|NCT04226495|Dsuvia|dsuvia|mesh-list
19978641|NCT04226495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19978642|NCT04226495|Narcotics|narcotics|mesh-ancestor
19978643|NCT04226495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19978644|NCT04226495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978645|NCT04226495|Analgesics|analgesics|mesh-ancestor
19978646|NCT04226495|Sensory System Agents|sensory system agents|mesh-ancestor
19978647|NCT04226495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978648|NCT04226495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19978649|NCT04226495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19978650|NCT04226495|Anesthetics, General|anesthetics, general|mesh-ancestor
19978651|NCT04226495|Anesthetics|anesthetics|mesh-ancestor
19978652|NCT04218825|Mechlorethamine|mechlorethamine|mesh-list
19978653|NCT04218825|Alkylating Agents|alkylating agents|mesh-ancestor
19978654|NCT04218825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978655|NCT04218825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19978656|NCT04218825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978657|NCT04172246|Zanubrutinib|zanubrutinib|mesh-list
19978658|NCT04172246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978659|NCT04172246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19978660|NCT04172246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978661|NCT04172246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978662|NCT04159519|Budesonide|budesonide|mesh-list
19978663|NCT04159519|Albuterol|albuterol|mesh-list
19978664|NCT04159519|Formoterol Fumarate|formoterol fumarate|mesh-list
19978665|NCT04159519|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19978666|NCT04159519|Benralizumab|benralizumab|mesh-list
19978667|NCT04159519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19978668|NCT04159519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19978669|NCT04159519|Autonomic Agents|autonomic agents|mesh-ancestor
19978670|NCT04159519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978671|NCT04159519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978672|NCT04159519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19978673|NCT04159519|Respiratory System Agents|respiratory system agents|mesh-ancestor
19978674|NCT04159519|Glucocorticoids|glucocorticoids|mesh-ancestor
19978675|NCT04159519|Hormones|hormones|mesh-ancestor
19978676|NCT04159519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19978677|NCT04159519|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19978678|NCT04159519|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19978679|NCT04159519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19978680|NCT04159519|Adrenergic Agents|adrenergic agents|mesh-ancestor
19978681|NCT04159519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19978682|NCT04159519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978683|NCT04159519|Tocolytic Agents|tocolytic agents|mesh-ancestor
19978684|NCT04159519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19978685|NCT04157517|Pembrolizumab|pembrolizumab|mesh-list
19978686|NCT04157517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19978687|NCT04157517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978688|NCT04130516|Pembrolizumab|pembrolizumab|mesh-list
19978689|NCT04130516|Antibodies|antibodies|mesh-list
19978690|NCT04130516|Immunologic Factors|immunologic factors|mesh-ancestor
19978691|NCT04130516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978692|NCT04130516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19978693|NCT04130516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978694|NCT04103034|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19978695|NCT04103034|Hemostatics|hemostatics|mesh-ancestor
19978696|NCT04103034|Coagulants|coagulants|mesh-ancestor
19978697|NCT04103034|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19978698|NCT04103034|Natriuretic Agents|natriuretic agents|mesh-ancestor
19978699|NCT04103034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978700|NCT04095364|Paclitaxel|paclitaxel|mesh-list
19978701|NCT04095364|Carboplatin|carboplatin|mesh-list
19978702|NCT04095364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19978703|NCT04095364|Letrozole|letrozole|mesh-list
19978704|NCT04095364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19978705|NCT04095364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978706|NCT04095364|Tubulin Modulators|tubulin modulators|mesh-ancestor
19978707|NCT04095364|Antimitotic Agents|antimitotic agents|mesh-ancestor
19978708|NCT04095364|Mitosis Modulators|mitosis modulators|mesh-ancestor
19978709|NCT04095364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978710|NCT04095364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19978711|NCT04095364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19978712|NCT04095364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978713|NCT04095364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19978714|NCT04095364|Hormone Antagonists|hormone antagonists|mesh-ancestor
19978715|NCT04095364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19978716|NCT04095364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978717|NCT04082364|Trastuzumab|trastuzumab|mesh-list
19978718|NCT04082364|Margetuximab|margetuximab|mesh-list
19978719|NCT04082364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19978720|NCT04082364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978721|NCT04060108|Methamphetamine|methamphetamine|mesh-list
19978722|NCT04060108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19978723|NCT04060108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978724|NCT04060108|Sympathomimetics|sympathomimetics|mesh-ancestor
19978725|NCT04060108|Autonomic Agents|autonomic agents|mesh-ancestor
19978726|NCT04060108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978727|NCT04060108|Dopamine Agents|dopamine agents|mesh-ancestor
19978728|NCT04060108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19978729|NCT04060108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978730|NCT04060108|Adrenergic Agents|adrenergic agents|mesh-ancestor
19978731|NCT04060108|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19978732|NCT04060108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19978733|NCT04060108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19978734|NCT04060108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19978735|NCT04058470|Prednisone|prednisone|mesh-list
19978736|NCT04058470|Cyclophosphamide|cyclophosphamide|mesh-list
19978737|NCT04058470|Rituximab|rituximab|mesh-list
19978738|NCT04058470|Doxorubicin|doxorubicin|mesh-list
19978739|NCT04058470|Vincristine|vincristine|mesh-list
19978740|NCT04058470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19978741|NCT04058470|Immunologic Factors|immunologic factors|mesh-ancestor
19978742|NCT04058470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978743|NCT04058470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19978744|NCT04058470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19978745|NCT04058470|Alkylating Agents|alkylating agents|mesh-ancestor
19978746|NCT04058470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978747|NCT04058470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978748|NCT04058470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19978749|NCT04058470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19978750|NCT04058470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19978751|NCT04058470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19978752|NCT04058470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19978753|NCT04058470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978754|NCT04058470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19978755|NCT04058470|Glucocorticoids|glucocorticoids|mesh-ancestor
19978756|NCT04058470|Hormones|hormones|mesh-ancestor
19978757|NCT04058470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19978758|NCT04058470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20555579|NCT01941329|Ranibizumab|ranibizumab|mesh-list
20555580|NCT01941329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20555581|NCT01941329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20555582|NCT01941329|Growth Substances|growth substances|mesh-ancestor
20555583|NCT01941329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555584|NCT01941329|Growth Inhibitors|growth inhibitors|mesh-ancestor
20555585|NCT01941329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555586|NCT01941407|Bevacizumab|bevacizumab|mesh-list
20555587|NCT01941407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20555588|NCT01941407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555589|NCT01941407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20555590|NCT01941407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20555591|NCT01941407|Growth Substances|growth substances|mesh-ancestor
20555592|NCT01941407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555593|NCT01941407|Growth Inhibitors|growth inhibitors|mesh-ancestor
20555594|NCT01941524|Poractant alfa|poractant alfa|mesh-list
20555595|NCT01941524|Beractant|beractant|mesh-list
20555596|NCT01941524|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
20555597|NCT01941524|Respiratory System Agents|respiratory system agents|mesh-ancestor
20555598|NCT01941576|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20555599|NCT01941576|Natriuretic Agents|natriuretic agents|mesh-ancestor
20555600|NCT01941576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555601|NCT01941602|Enoxaparin|enoxaparin|mesh-list
20555602|NCT01941602|Anticoagulants|anticoagulants|mesh-ancestor
20555603|NCT01941602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20555604|NCT01941602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20555605|NCT01941602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555606|NCT01941732|Sildenafil Citrate|sildenafil citrate|mesh-list
20555607|NCT01941732|Vasodilator Agents|vasodilator agents|mesh-ancestor
20555608|NCT01941732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20555609|NCT01941732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20555610|NCT01941732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555611|NCT01941732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555612|NCT01941732|Urological Agents|urological agents|mesh-ancestor
20555613|NCT01941758|Vaccines|vaccines|mesh-list
19978759|NCT04058470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19978760|NCT04058470|Tubulin Modulators|tubulin modulators|mesh-ancestor
19978761|NCT04058470|Antimitotic Agents|antimitotic agents|mesh-ancestor
19978762|NCT04058470|Mitosis Modulators|mitosis modulators|mesh-ancestor
19978763|NCT04046887|Gemcitabine|gemcitabine|mesh-list
19978764|NCT04046887|Paclitaxel|paclitaxel|mesh-list
19978765|NCT04046887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19978766|NCT04046887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978767|NCT04046887|Tubulin Modulators|tubulin modulators|mesh-ancestor
19978768|NCT04046887|Antimitotic Agents|antimitotic agents|mesh-ancestor
20555614|NCT01941758|Immunologic Factors|immunologic factors|mesh-ancestor
19978769|NCT04046887|Mitosis Modulators|mitosis modulators|mesh-ancestor
20555615|NCT01941758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978770|NCT04046887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978771|NCT04046887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19978772|NCT04046887|Antimetabolites|antimetabolites|mesh-ancestor
19978773|NCT04046887|Antiviral Agents|antiviral agents|mesh-ancestor
19978774|NCT04046887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19978775|NCT04046887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978776|NCT04046887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19978777|NCT04046887|Immunologic Factors|immunologic factors|mesh-ancestor
19978778|NCT04046887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978779|NCT03956056|Poly I-C|poly i-c|mesh-list
19978780|NCT03956056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19978781|NCT03956056|Poly ICLC|poly iclc|mesh-list
19978782|NCT03956056|Interferon Inducers|interferon inducers|mesh-ancestor
19978783|NCT03956056|Immunologic Factors|immunologic factors|mesh-ancestor
19978784|NCT03956056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978785|NCT03956056|Laxatives|laxatives|mesh-ancestor
19978786|NCT03956056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19978787|NCT03956056|Antiviral Agents|antiviral agents|mesh-ancestor
19978788|NCT03956056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20288828|NCT05174832|Paclitaxel|paclitaxel|mesh-list
20288829|NCT05174832|Pembrolizumab|pembrolizumab|mesh-list
20288830|NCT05174832|Olaparib|olaparib|mesh-list
20288831|NCT05174832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20288832|NCT05174832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288833|NCT05174832|Tubulin Modulators|tubulin modulators|mesh-ancestor
20288834|NCT05174832|Antimitotic Agents|antimitotic agents|mesh-ancestor
20288835|NCT05174832|Mitosis Modulators|mitosis modulators|mesh-ancestor
20288836|NCT05174832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288837|NCT05174832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20288838|NCT05174832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20288839|NCT05174832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288840|NCT05174507|Empagliflozin|empagliflozin|mesh-list
20288841|NCT05174507|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20288842|NCT05174507|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20288843|NCT05174507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288844|NCT05174507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20288845|NCT05174507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288846|NCT05174507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20288847|NCT05168657|Pancrelipase|pancrelipase|mesh-list
20288848|NCT05168657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20288849|NCT05133895|Prednisone|prednisone|mesh-list
20288850|NCT05133895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20288851|NCT05133895|Glucocorticoids|glucocorticoids|mesh-ancestor
20288852|NCT05133895|Hormones|hormones|mesh-ancestor
20288853|NCT05133895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20288854|NCT05133895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288855|NCT05133895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20288856|NCT05133895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288857|NCT05131828|Metformin|metformin|mesh-list
20288858|NCT05131828|Clemastine|clemastine|mesh-list
20288859|NCT05131828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20288860|NCT05131828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288861|NCT05131828|Antipruritics|antipruritics|mesh-ancestor
20288862|NCT05131828|Dermatologic Agents|dermatologic agents|mesh-ancestor
20288863|NCT05131828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20288864|NCT05131828|Histamine Antagonists|histamine antagonists|mesh-ancestor
20288865|NCT05131828|Histamine Agents|histamine agents|mesh-ancestor
20288866|NCT05131828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20288867|NCT05131828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288868|NCT05131828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20288869|NCT05127044|Bilirubin|bilirubin|mesh-list
20555616|NCT01941771|Capecitabine|capecitabine|mesh-list
20288870|NCT05127044|Antioxidants|antioxidants|mesh-ancestor
20288871|NCT05127044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288872|NCT05127044|Protective Agents|protective agents|mesh-ancestor
20288873|NCT05127044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288874|NCT05122208|Famotidine|famotidine|mesh-list
20288875|NCT05122208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20288876|NCT05122208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20288877|NCT05122208|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20288878|NCT05122208|Histamine Antagonists|histamine antagonists|mesh-ancestor
20288879|NCT05122208|Histamine Agents|histamine agents|mesh-ancestor
20288880|NCT05122208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20288881|NCT05122208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288882|NCT05122208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978789|NCT03921060|Denosumab|denosumab|mesh-list
19978790|NCT03921060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19978791|NCT03921060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978792|NCT03904550|Rocuronium|rocuronium|mesh-list
19978793|NCT03904550|Cisatracurium|cisatracurium|mesh-list
19978794|NCT03904550|Neostigmine|neostigmine|mesh-list
19978795|NCT03904550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19978796|NCT03904550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19978797|NCT03904550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19978798|NCT03904550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978799|NCT03904550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978800|NCT03904550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19978801|NCT03904550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978802|NCT03904550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978803|NCT03904550|Cholinergic Agents|cholinergic agents|mesh-ancestor
19978804|NCT03904550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19978805|NCT03904550|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19978806|NCT03904550|Autonomic Agents|autonomic agents|mesh-ancestor
19978807|NCT03868657|Moxifloxacin|moxifloxacin|mesh-list
19978808|NCT03868657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19978809|NCT03868657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19978810|NCT03868657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19978811|NCT03868657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19978812|NCT03868657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978813|NCT03868657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978814|NCT03868657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978815|NCT03867500|Niacin|niacin|mesh-list
19978816|NCT03867500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19978817|NCT03867500|Antimetabolites|antimetabolites|mesh-ancestor
19978818|NCT03867500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978819|NCT03867500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19978820|NCT03867500|Vasodilator Agents|vasodilator agents|mesh-ancestor
19978821|NCT03867500|Vitamin B Complex|vitamin b complex|mesh-ancestor
19978822|NCT03867500|Vitamins|vitamins|mesh-ancestor
19978823|NCT03867500|Micronutrients|micronutrients|mesh-ancestor
19978824|NCT03867500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978825|NCT03866174|Niacin|niacin|mesh-list
19978826|NCT03866174|Psilocybin|psilocybin|mesh-list
19978827|NCT03866174|Vitamins|vitamins|mesh-ancestor
19978828|NCT03866174|Micronutrients|micronutrients|mesh-ancestor
19978829|NCT03866174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978830|NCT03866174|Vitamin B Complex|vitamin b complex|mesh-ancestor
19978831|NCT03866174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19978832|NCT03866174|Antimetabolites|antimetabolites|mesh-ancestor
19978833|NCT03866174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978834|NCT03866174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19978835|NCT03866174|Vasodilator Agents|vasodilator agents|mesh-ancestor
19978836|NCT03866174|Hallucinogens|hallucinogens|mesh-ancestor
19978837|NCT03866174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19978838|NCT03861052|Dulaglutide|dulaglutide|mesh-list
19978839|NCT03861052|Tirzepatide|tirzepatide|mesh-list
19978840|NCT03861052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19978841|NCT03861052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978842|NCT03861052|Incretins|incretins|mesh-ancestor
19978843|NCT03861052|Hormones|hormones|mesh-ancestor
19978844|NCT03861052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19978845|NCT03858231|Acetaminophen|acetaminophen|mesh-list
19978846|NCT03858231|Ibuprofen|ibuprofen|mesh-list
19978847|NCT03858231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19978848|NCT03858231|Analgesics|analgesics|mesh-ancestor
19736096|NCT04532931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736097|NCT04532931|Antimalarials|antimalarials|mesh-ancestor
19736098|NCT04532931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19736099|NCT04532931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19736100|NCT04532931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736101|NCT04532931|Schistosomicides|schistosomicides|mesh-ancestor
19736102|NCT04532931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19978849|NCT03858231|Sensory System Agents|sensory system agents|mesh-ancestor
19736103|NCT04532931|Anthelmintics|anthelmintics|mesh-ancestor
19736104|NCT04532918|Cyclosporine|cyclosporine|mesh-list
19736105|NCT04532918|Rifampin|rifampin|mesh-list
19736106|NCT04532918|Allopurinol|allopurinol|mesh-list
19978850|NCT03858231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978851|NCT03858231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978852|NCT03858231|Antipyretics|antipyretics|mesh-ancestor
19978853|NCT03858231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19978854|NCT03858231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19978855|NCT03858231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19978856|NCT03858231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19978857|NCT03858231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978858|NCT03858231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978859|NCT03846453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19978860|NCT03846453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19978861|NCT03829683|Ascorbic Acid|ascorbic acid|mesh-list
19978862|NCT03829683|Vitamins|vitamins|mesh-ancestor
19978863|NCT03829683|Micronutrients|micronutrients|mesh-ancestor
19978864|NCT03829683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978865|NCT03829683|Antioxidants|antioxidants|mesh-ancestor
19978866|NCT03829683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978867|NCT03829683|Protective Agents|protective agents|mesh-ancestor
19978868|NCT03818178|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19978869|NCT03818178|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19978870|NCT03818178|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19978871|NCT03818178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19978872|NCT03802799|Cannabidiol|cannabidiol|mesh-list
19978873|NCT03802799|Anticonvulsants|anticonvulsants|mesh-ancestor
19978874|NCT03799731|Trifluridine|trifluridine|mesh-list
19978875|NCT03799731|Antimetabolites|antimetabolites|mesh-ancestor
19978876|NCT03799731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978877|NCT03799731|Antiviral Agents|antiviral agents|mesh-ancestor
19978878|NCT03799731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19978879|NCT03776760|Sofosbuvir|sofosbuvir|mesh-list
19978880|NCT03776760|Antiviral Agents|antiviral agents|mesh-ancestor
19978881|NCT03776760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19978882|NCT03669718|Cemiplimab|cemiplimab|mesh-list
19978883|NCT03669718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19978884|NCT03669718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978885|NCT03643796|Dexmedetomidine|dexmedetomidine|mesh-list
19978886|NCT03643796|Ketamine|ketamine|mesh-list
19978887|NCT03643796|Remifentanil|remifentanil|mesh-list
19978888|NCT03643796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19978889|NCT03643796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19978890|NCT03643796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978891|NCT03643796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19978892|NCT03643796|Analgesics|analgesics|mesh-ancestor
19978893|NCT03643796|Sensory System Agents|sensory system agents|mesh-ancestor
19978894|NCT03643796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978895|NCT03643796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19978896|NCT03643796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19978897|NCT03643796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19978898|NCT03643796|Adrenergic Agents|adrenergic agents|mesh-ancestor
19978899|NCT03643796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19978900|NCT03643796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978901|NCT03643796|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19978902|NCT03643796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19978903|NCT03643796|Anesthetics, General|anesthetics, general|mesh-ancestor
19978904|NCT03643796|Anesthetics|anesthetics|mesh-ancestor
19978905|NCT03643796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19978906|NCT03643796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19978907|NCT03643796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19978908|NCT03643796|Narcotics|narcotics|mesh-ancestor
19978909|NCT03605862|Nitazoxanide|nitazoxanide|mesh-list
19978910|NCT03605862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19978911|NCT03605862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19978912|NCT03605342|Buprenorphine|buprenorphine|mesh-list
19736107|NCT04532918|Verinurad|verinurad|mesh-list
19736108|NCT04532918|Cyclosporins|cyclosporins|mesh-list
19736109|NCT04532918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736110|NCT04532918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736111|NCT04532918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19736112|NCT04532918|Immunologic Factors|immunologic factors|mesh-ancestor
19736113|NCT04532918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736114|NCT04532918|Antifungal Agents|antifungal agents|mesh-ancestor
19736115|NCT04532918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736116|NCT04532918|Dermatologic Agents|dermatologic agents|mesh-ancestor
19736117|NCT04532918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19736118|NCT04532918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19978913|NCT03605342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19978914|NCT03605342|Narcotics|narcotics|mesh-ancestor
19978915|NCT03605342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19978916|NCT03605342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978917|NCT03605342|Analgesics|analgesics|mesh-ancestor
19978918|NCT03605342|Sensory System Agents|sensory system agents|mesh-ancestor
19978919|NCT03605342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978920|NCT03605342|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19978921|NCT03575052|Pimavanserin|pimavanserin|mesh-list
19978922|NCT03575052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19978923|NCT03575052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19978924|NCT03575052|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19978925|NCT03575052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19978926|NCT03575052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19978927|NCT03575052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978928|NCT03575052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19978929|NCT03575052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19978930|NCT03575052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19978931|NCT03575052|Serotonin Agents|serotonin agents|mesh-ancestor
19978932|NCT03575052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19978933|NCT03575052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978934|NCT03550391|Memantine|memantine|mesh-list
19978935|NCT03550391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19978936|NCT03550391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19978937|NCT03550391|Dopamine Agents|dopamine agents|mesh-ancestor
19978938|NCT03550391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19978939|NCT03550391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978940|NCT03550391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978941|NCT03550391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19978942|NCT03550391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19978943|NCT03541252|Cisplatin|cisplatin|mesh-list
19978944|NCT03541252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978945|NCT03475277|Ketamine|ketamine|mesh-list
19978946|NCT03475277|Analgesics|analgesics|mesh-ancestor
19978947|NCT03475277|Sensory System Agents|sensory system agents|mesh-ancestor
19978948|NCT03475277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19978949|NCT03475277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978950|NCT03475277|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19978951|NCT03475277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19978952|NCT03475277|Anesthetics, General|anesthetics, general|mesh-ancestor
19978953|NCT03475277|Anesthetics|anesthetics|mesh-ancestor
19978954|NCT03475277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19978955|NCT03475277|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19978956|NCT03475277|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19978957|NCT03475277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19978958|NCT03475277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978959|NCT03471364|Ketoconazole|ketoconazole|mesh-list
19978960|NCT03471364|Antifungal Agents|antifungal agents|mesh-ancestor
19978961|NCT03471364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19978962|NCT03471364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19978963|NCT03471364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19978964|NCT03471364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978965|NCT03471364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978966|NCT03471364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19978967|NCT03471364|Hormone Antagonists|hormone antagonists|mesh-ancestor
19978968|NCT03471364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19978969|NCT03471364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978970|NCT03471364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19978971|NCT03440450|Gemcitabine|gemcitabine|mesh-list
19978972|NCT03440450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19978973|NCT03440450|Antimetabolites|antimetabolites|mesh-ancestor
19978974|NCT03440450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978975|NCT03440450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736119|NCT04532918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19736120|NCT04532918|Antitubercular Agents|antitubercular agents|mesh-ancestor
19736121|NCT04532918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19736122|NCT04532918|Leprostatic Agents|leprostatic agents|mesh-ancestor
19736123|NCT04532918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19736124|NCT04532918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19736125|NCT04532918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19978976|NCT03440450|Antiviral Agents|antiviral agents|mesh-ancestor
19978977|NCT03440450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19978978|NCT03440450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978979|NCT03440450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19978980|NCT03440450|Immunologic Factors|immunologic factors|mesh-ancestor
19978981|NCT03440450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19978982|NCT03434028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
19978983|NCT03420014|Doxorubicin|doxorubicin|mesh-list
19978984|NCT03420014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19978985|NCT03420014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19978986|NCT03420014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978987|NCT03420014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19978988|NCT03420014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19978989|NCT03420014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19978990|NCT03420014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19978995|NCT03360890|Docetaxel|docetaxel|mesh-list
19978996|NCT03360890|Pembrolizumab|pembrolizumab|mesh-list
19978997|NCT03360890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19978998|NCT03360890|Tubulin Modulators|tubulin modulators|mesh-ancestor
19978999|NCT03360890|Antimitotic Agents|antimitotic agents|mesh-ancestor
19979000|NCT03360890|Mitosis Modulators|mitosis modulators|mesh-ancestor
19979001|NCT03360890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979002|NCT03360890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19979003|NCT03252600|Dexamethasone|dexamethasone|mesh-list
19979004|NCT03252600|Dexamethasone acetate|dexamethasone acetate|mesh-list
19979005|NCT03252600|Cyclophosphamide|cyclophosphamide|mesh-list
19979006|NCT03252600|Lenalidomide|lenalidomide|mesh-list
19979007|NCT03252600|Elotuzumab|elotuzumab|mesh-list
19979008|NCT03252600|Ichthammol|ichthammol|mesh-list
19979009|NCT03252600|BB 1101|bb 1101|mesh-list
19979010|NCT03252600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19979011|NCT03252600|Immunologic Factors|immunologic factors|mesh-ancestor
19979012|NCT03252600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979013|NCT03252600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19979014|NCT03252600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19979015|NCT03252600|Alkylating Agents|alkylating agents|mesh-ancestor
19979016|NCT03252600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979017|NCT03252600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979018|NCT03252600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19979019|NCT03252600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19979020|NCT03252600|Antiemetics|antiemetics|mesh-ancestor
19979021|NCT03252600|Autonomic Agents|autonomic agents|mesh-ancestor
19979022|NCT03252600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19979023|NCT03252600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19979024|NCT03252600|Glucocorticoids|glucocorticoids|mesh-ancestor
19979025|NCT03252600|Hormones|hormones|mesh-ancestor
19979026|NCT03252600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19979027|NCT03252600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19979028|NCT03252600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19979029|NCT03252600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19979030|NCT03252600|Growth Substances|growth substances|mesh-ancestor
19979031|NCT03252600|Growth Inhibitors|growth inhibitors|mesh-ancestor
19979032|NCT03252600|Protease Inhibitors|protease inhibitors|mesh-ancestor
19979033|NCT03252600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979034|NCT03252600|Dermatologic Agents|dermatologic agents|mesh-ancestor
19979035|NCT03222570|Serotonin|serotonin|mesh-list
19979036|NCT03222570|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19979037|NCT03222570|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19979038|NCT03222570|Serotonin Agents|serotonin agents|mesh-ancestor
19979039|NCT03222570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19979040|NCT03222570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979041|NCT03222570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979042|NCT03222570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20288883|NCT05116826|Nitazoxanide|nitazoxanide|mesh-list
20288884|NCT05116826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20288885|NCT05116826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20288886|NCT05113368|Fulvestrant|fulvestrant|mesh-list
20288887|NCT05113368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20288888|NCT05113368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288889|NCT05113368|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20288890|NCT05113368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20288891|NCT05113368|Hormone Antagonists|hormone antagonists|mesh-ancestor
19979043|NCT03222570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19979044|NCT03212989|Vorinostat|vorinostat|mesh-list
19979045|NCT03212989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979046|NCT03212989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19979047|NCT03212989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979048|NCT03212989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979049|NCT03191526|Mogamulizumab|mogamulizumab|mesh-list
19979050|NCT03191526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288892|NCT05113368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20288893|NCT05113368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288894|NCT05112263|Cyclosporine|cyclosporine|mesh-list
20288895|NCT05112263|Cyclosporins|cyclosporins|mesh-list
20288896|NCT05112263|Tofacitinib|tofacitinib|mesh-list
20288897|NCT05112263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288898|NCT05112263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288899|NCT05112263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20288900|NCT05112263|Immunologic Factors|immunologic factors|mesh-ancestor
20288901|NCT05112263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288902|NCT05112263|Antifungal Agents|antifungal agents|mesh-ancestor
20288903|NCT05112263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20288904|NCT05112263|Dermatologic Agents|dermatologic agents|mesh-ancestor
20288905|NCT05112263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20288906|NCT05112263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20288907|NCT05112263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20288908|NCT05112081|Botulinum Toxins|botulinum toxins|mesh-list
20288909|NCT05112081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20288910|NCT05112081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20288911|NCT05112081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20288912|NCT05112081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20288913|NCT05112081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288914|NCT05112081|Cholinergic Agents|cholinergic agents|mesh-ancestor
20288915|NCT05112081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20288916|NCT05112081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288917|NCT05112081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20288918|NCT05112081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20288919|NCT05108935|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20288920|NCT05108935|Buprenorphine|buprenorphine|mesh-list
20288921|NCT05108935|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20288922|NCT05108935|Naloxone|naloxone|mesh-list
20288923|NCT05108935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20288924|NCT05108935|Narcotics|narcotics|mesh-ancestor
20288925|NCT05108935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20288926|NCT05108935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288927|NCT05108935|Analgesics|analgesics|mesh-ancestor
20288928|NCT05108935|Sensory System Agents|sensory system agents|mesh-ancestor
20288929|NCT05108935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20288930|NCT05108935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20288931|NCT05108935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20288932|NCT05108935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20288933|NCT05108935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288934|NCT05108935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288935|NCT05108935|Antiviral Agents|antiviral agents|mesh-ancestor
20288936|NCT05108935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20288937|NCT05108935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20288938|NCT05108935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20288939|NCT05105841|Venetoclax|venetoclax|mesh-list
20288940|NCT05105841|Obinutuzumab|obinutuzumab|mesh-list
20288941|NCT05105841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288942|NCT05105841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20288943|NCT05104983|Sirolimus|sirolimus|mesh-list
20288944|NCT05104983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20288945|NCT05104983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20288946|NCT05104983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20288947|NCT05104983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288948|NCT05104983|Antifungal Agents|antifungal agents|mesh-ancestor
20288949|NCT05104983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20288950|NCT05104983|Immunologic Factors|immunologic factors|mesh-ancestor
20288951|NCT05104983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288952|NCT05104554|Folic Acid|folic acid|mesh-list
20288953|NCT05104554|Micronutrients|micronutrients|mesh-list
20288954|NCT05104554|Trace Elements|trace elements|mesh-list
20288955|NCT05104554|Hematinics|hematinics|mesh-ancestor
20288956|NCT05104554|Vitamin B Complex|vitamin b complex|mesh-ancestor
20288957|NCT05104554|Vitamins|vitamins|mesh-ancestor
20288958|NCT05104554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979051|NCT03169361|Ixazomib|ixazomib|mesh-list
19979052|NCT03169361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979053|NCT03169361|Protease Inhibitors|protease inhibitors|mesh-ancestor
19979054|NCT03169361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979055|NCT03169361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979056|NCT03093155|Bevacizumab|bevacizumab|mesh-list
19979057|NCT03093155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19979058|NCT03093155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979059|NCT03093155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19979060|NCT03093155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19979061|NCT03093155|Growth Substances|growth substances|mesh-ancestor
19979062|NCT03093155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979063|NCT03093155|Growth Inhibitors|growth inhibitors|mesh-ancestor
19979064|NCT03062059|Gemcitabine|gemcitabine|mesh-list
19979065|NCT03062059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19979066|NCT03062059|Antimetabolites|antimetabolites|mesh-ancestor
19979067|NCT03062059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979068|NCT03062059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979069|NCT03062059|Antiviral Agents|antiviral agents|mesh-ancestor
19979070|NCT03062059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19979071|NCT03062059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979072|NCT03062059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19979073|NCT03062059|Immunologic Factors|immunologic factors|mesh-ancestor
19979074|NCT03062059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979075|NCT03054038|Afatinib|afatinib|mesh-list
19979076|NCT03054038|Necitumumab|necitumumab|mesh-list
19979077|NCT03054038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979078|NCT03054038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19979079|NCT03054038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979080|NCT03054038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979081|NCT03054038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19979082|NCT03041701|Dasatinib|dasatinib|mesh-list
19979083|NCT03041701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979084|NCT03041701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979085|NCT03041701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19979086|NCT03041701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979087|NCT03021083|Fentanyl|fentanyl|mesh-list
19979088|NCT03021083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19979089|NCT03021083|Narcotics|narcotics|mesh-ancestor
19979090|NCT03021083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19979091|NCT03021083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979092|NCT03021083|Analgesics|analgesics|mesh-ancestor
19979093|NCT03021083|Sensory System Agents|sensory system agents|mesh-ancestor
19979094|NCT03021083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19979095|NCT03021083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19979096|NCT03021083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19979097|NCT03021083|Anesthetics, General|anesthetics, general|mesh-ancestor
19979098|NCT03021083|Anesthetics|anesthetics|mesh-ancestor
19979099|NCT03000257|Venetoclax|venetoclax|mesh-list
19979100|NCT03000257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979101|NCT03000179|Avelumab|avelumab|mesh-list
19979102|NCT03000179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19979103|NCT03000179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979104|NCT02990533|Methyltestosterone|methyltestosterone|mesh-list
19979105|NCT02990533|Testosterone|testosterone|mesh-list
19979106|NCT02990533|Testosterone undecanoate|testosterone undecanoate|mesh-list
19979107|NCT02990533|Testosterone enanthate|testosterone enanthate|mesh-list
19979108|NCT02990533|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19979109|NCT02990533|Androgens|androgens|mesh-ancestor
19979110|NCT02990533|Hormones|hormones|mesh-ancestor
19979111|NCT02990533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19979112|NCT02990533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979113|NCT02990533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20555617|NCT01941771|Vinorelbine|vinorelbine|mesh-list
20555618|NCT01941771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20555619|NCT01941771|Antimetabolites|antimetabolites|mesh-ancestor
20555620|NCT01941771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555621|NCT01941771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555622|NCT01941771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20555623|NCT01941771|Tubulin Modulators|tubulin modulators|mesh-ancestor
20555624|NCT01941771|Antimitotic Agents|antimitotic agents|mesh-ancestor
20555625|NCT01941771|Mitosis Modulators|mitosis modulators|mesh-ancestor
20555626|NCT01941810|Lactoferrin|lactoferrin|mesh-list
19979114|NCT02990533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979115|NCT02990533|Anabolic Agents|anabolic agents|mesh-ancestor
19979116|NCT02979327|Adderall|adderall|mesh-list
19979117|NCT02979327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19979118|NCT02979327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979119|NCT02977780|Temozolomide|temozolomide|mesh-list
19979120|NCT02977780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19979121|NCT02977780|Alkylating Agents|alkylating agents|mesh-ancestor
19979122|NCT02977780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979123|NCT02977780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979124|NCT02945813|Metformin|metformin|mesh-list
19979125|NCT02945813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20555627|NCT01941810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20555628|NCT01941875|Progesterone|progesterone|mesh-list
20555629|NCT01941875|Progestins|progestins|mesh-ancestor
20555630|NCT01941875|Hormones|hormones|mesh-ancestor
20555631|NCT01941875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20555632|NCT01941875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555633|NCT01941888|Midazolam|midazolam|mesh-list
20555634|NCT01941888|Propofol|propofol|mesh-list
20555635|NCT01941888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20555636|NCT01941888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20555637|NCT01941888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555638|NCT01941888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20555639|NCT01941888|Anesthetics, General|anesthetics, general|mesh-ancestor
20555640|NCT01941888|Anesthetics|anesthetics|mesh-ancestor
20555641|NCT01941888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20555642|NCT01941888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19979126|NCT02945813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979127|NCT02909322|Hydromorphone|hydromorphone|mesh-list
19979128|NCT02909322|Bupivacaine|bupivacaine|mesh-list
19979129|NCT02909322|Ropivacaine|ropivacaine|mesh-list
19979130|NCT02909322|Anesthetics, Local|anesthetics, local|mesh-ancestor
19979131|NCT02909322|Anesthetics|anesthetics|mesh-ancestor
19979132|NCT02909322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19979133|NCT02909322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979134|NCT02909322|Sensory System Agents|sensory system agents|mesh-ancestor
19979135|NCT02909322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19979136|NCT02909322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19979137|NCT02909322|Narcotics|narcotics|mesh-ancestor
19979138|NCT02909322|Analgesics|analgesics|mesh-ancestor
19979139|NCT02891447|Cisplatin|cisplatin|mesh-list
19979140|NCT02891447|Mitomycins|mitomycins|mesh-list
19979141|NCT02891447|Mitomycin|mitomycin|mesh-list
19979142|NCT02891447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979143|NCT02891447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19979144|NCT02891447|Alkylating Agents|alkylating agents|mesh-ancestor
19979145|NCT02891447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979146|NCT02891447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19979147|NCT02891447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979148|NCT02876835|Darbepoetin alfa|darbepoetin alfa|mesh-list
19979149|NCT02876835|Hematinics|hematinics|mesh-ancestor
19979150|NCT02860039|Vaccines|vaccines|mesh-list
19979151|NCT02860039|Immunologic Factors|immunologic factors|mesh-ancestor
19979152|NCT02860039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979153|NCT02841748|Pembrolizumab|pembrolizumab|mesh-list
19979154|NCT02841748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19979155|NCT02841748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979156|NCT02815033|Choline|choline|mesh-list
19979157|NCT02815033|Lipotropic Agents|lipotropic agents|mesh-ancestor
19979158|NCT02815033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19979159|NCT02815033|Antimetabolites|antimetabolites|mesh-ancestor
19979160|NCT02815033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979161|NCT02815033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19979162|NCT02815033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19979163|NCT02815033|Nootropic Agents|nootropic agents|mesh-ancestor
19979164|NCT02814968|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19979165|NCT02814968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19979166|NCT02814968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979167|NCT02813642|Mitogens|mitogens|mesh-list
19979168|NCT02813642|Mitosis Modulators|mitosis modulators|mesh-ancestor
19979169|NCT02813642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979170|NCT02781792|Temozolomide|temozolomide|mesh-list
19979171|NCT02781792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19979172|NCT02781792|Alkylating Agents|alkylating agents|mesh-ancestor
20555643|NCT01941888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20555644|NCT01941888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20555645|NCT01941888|GABA Modulators|gaba modulators|mesh-ancestor
20555646|NCT01941888|GABA Agents|gaba agents|mesh-ancestor
20555647|NCT01941888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20555648|NCT01941888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555649|NCT01941901|Calcium, Dietary|calcium, dietary|mesh-list
20555650|NCT01941901|Bleomycin|bleomycin|mesh-list
19979173|NCT02781792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979174|NCT02781792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979175|NCT02766582|Paclitaxel|paclitaxel|mesh-list
19979176|NCT02766582|Carboplatin|carboplatin|mesh-list
19979177|NCT02766582|Pembrolizumab|pembrolizumab|mesh-list
19979178|NCT02766582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19979179|NCT02766582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979180|NCT02766582|Tubulin Modulators|tubulin modulators|mesh-ancestor
19979181|NCT02766582|Antimitotic Agents|antimitotic agents|mesh-ancestor
19979182|NCT02766582|Mitosis Modulators|mitosis modulators|mesh-ancestor
19979183|NCT02766582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979184|NCT02766582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19979185|NCT02734602|Ketamine|ketamine|mesh-list
19979186|NCT02734602|Analgesics|analgesics|mesh-ancestor
19979187|NCT02734602|Sensory System Agents|sensory system agents|mesh-ancestor
19979188|NCT02734602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19979189|NCT02734602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979190|NCT02734602|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19979191|NCT02734602|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19979192|NCT02734602|Anesthetics, General|anesthetics, general|mesh-ancestor
19979193|NCT02734602|Anesthetics|anesthetics|mesh-ancestor
19979194|NCT02734602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19979195|NCT02734602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19979196|NCT02734602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19979197|NCT02734602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19979198|NCT02734602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979199|NCT02727803|Cyclophosphamide|cyclophosphamide|mesh-list
19979200|NCT02727803|Melphalan|melphalan|mesh-list
19979201|NCT02727803|Busulfan|busulfan|mesh-list
19979202|NCT02727803|Mechlorethamine|mechlorethamine|mesh-list
19979203|NCT02727803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19979204|NCT02727803|Rituximab|rituximab|mesh-list
19979205|NCT02727803|Fludarabine|fludarabine|mesh-list
19979206|NCT02727803|Fludarabine phosphate|fludarabine phosphate|mesh-list
19979207|NCT02727803|Clofarabine|clofarabine|mesh-list
19979208|NCT02727803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19979209|NCT02727803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19979210|NCT02727803|Antibodies|antibodies|mesh-list
19979211|NCT02727803|Immunoglobulins|immunoglobulins|mesh-list
19979212|NCT02727803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19979213|NCT02727803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19979214|NCT02727803|Immunologic Factors|immunologic factors|mesh-ancestor
19979215|NCT02727803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979216|NCT02727803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19979217|NCT02727803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19979218|NCT02727803|Alkylating Agents|alkylating agents|mesh-ancestor
19979219|NCT02727803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979220|NCT02727803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979221|NCT02727803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19979222|NCT02727803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19979223|NCT02727803|Antimetabolites|antimetabolites|mesh-ancestor
19979224|NCT02647099|Aspirin|aspirin|mesh-list
19979225|NCT02647099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19979226|NCT02647099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19979227|NCT02647099|Analgesics|analgesics|mesh-ancestor
19979228|NCT02647099|Sensory System Agents|sensory system agents|mesh-ancestor
19979229|NCT02647099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19979230|NCT02647099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979231|NCT02647099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19979232|NCT02647099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19979233|NCT02647099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19979234|NCT02647099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19979235|NCT02647099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979236|NCT02647099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19979237|NCT02647099|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19979238|NCT02647099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979239|NCT02647099|Antipyretics|antipyretics|mesh-ancestor
19979240|NCT02506192|Prednisone|prednisone|mesh-list
19979241|NCT02506192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19979242|NCT02506192|Glucocorticoids|glucocorticoids|mesh-ancestor
19979243|NCT02506192|Hormones|hormones|mesh-ancestor
19979244|NCT02506192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19979245|NCT02506192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979246|NCT02506192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19979247|NCT02506192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979248|NCT02464969|Apixaban|apixaban|mesh-list
19979249|NCT02464969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19979250|NCT02464969|Antithrombins|antithrombins|mesh-ancestor
19979251|NCT02464969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19979252|NCT02464969|Protease Inhibitors|protease inhibitors|mesh-ancestor
19979253|NCT02464969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979254|NCT02464969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979255|NCT02464969|Anticoagulants|anticoagulants|mesh-ancestor
19979256|NCT02281838|Enalapril|enalapril|mesh-list
19979257|NCT02281838|Hydralazine|hydralazine|mesh-list
19979258|NCT02281838|Labetalol|labetalol|mesh-list
19979259|NCT02281838|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19979260|NCT02281838|Protease Inhibitors|protease inhibitors|mesh-ancestor
19979261|NCT02281838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979262|NCT02281838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979263|NCT02281838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19979264|NCT02281838|Vasodilator Agents|vasodilator agents|mesh-ancestor
19979265|NCT02281838|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19979266|NCT02281838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19979267|NCT02281838|Adrenergic Agents|adrenergic agents|mesh-ancestor
19979268|NCT02281838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19979269|NCT02281838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979270|NCT02281838|Sympathomimetics|sympathomimetics|mesh-ancestor
19979271|NCT02281838|Autonomic Agents|autonomic agents|mesh-ancestor
19979272|NCT02281838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19979273|NCT02281838|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19979274|NCT02281838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19979275|NCT02270632|Methotrexate|methotrexate|mesh-list
19979276|NCT02270632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19979277|NCT02270632|Abortifacient Agents|abortifacient agents|mesh-ancestor
19979278|NCT02270632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19979279|NCT02270632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979280|NCT02270632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19979281|NCT02270632|Antimetabolites|antimetabolites|mesh-ancestor
19979282|NCT02270632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979283|NCT02270632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979284|NCT02270632|Dermatologic Agents|dermatologic agents|mesh-ancestor
19979285|NCT02270632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979286|NCT02270632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19979287|NCT02270632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19979288|NCT02270632|Immunologic Factors|immunologic factors|mesh-ancestor
19979289|NCT02270632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19979290|NCT02270632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19979291|NCT02261883|Treprostinil|treprostinil|mesh-list
19979292|NCT02261883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19979293|NCT02157974|Exenatide|exenatide|mesh-list
19979294|NCT02157974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19979295|NCT02157974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979296|NCT02157974|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19979297|NCT02157974|Incretins|incretins|mesh-ancestor
19979298|NCT02157974|Hormones|hormones|mesh-ancestor
19979299|NCT02157974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19979300|NCT02076646|Interleukin-2|interleukin-2|mesh-list
19979301|NCT02076646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979302|NCT02076646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19979303|NCT02076646|Analgesics|analgesics|mesh-ancestor
19979304|NCT02076646|Sensory System Agents|sensory system agents|mesh-ancestor
19979305|NCT02076646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19979306|NCT02076646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979307|NCT02029443|Acalabrutinib|acalabrutinib|mesh-list
19979308|NCT02029443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979309|NCT02007122|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
19979310|NCT02007122|Cephalosporins|cephalosporins|mesh-list
19979311|NCT02007122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19979312|NCT02007122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19979313|NCT01919086|Dexamethasone|dexamethasone|mesh-list
19979314|NCT01919086|Lenalidomide|lenalidomide|mesh-list
19979315|NCT01919086|Bortezomib|bortezomib|mesh-list
19979316|NCT01919086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19979317|NCT01919086|Antiemetics|antiemetics|mesh-ancestor
19979318|NCT01919086|Autonomic Agents|autonomic agents|mesh-ancestor
19979319|NCT01919086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20555651|NCT01941901|Calcium|calcium|mesh-list
20555652|NCT01941901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20555653|NCT01941901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555654|NCT01941901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20555655|NCT01941901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20555656|NCT01941901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555657|NCT01941914|Calcium, Dietary|calcium, dietary|mesh-list
20555658|NCT01941914|Calcium|calcium|mesh-list
20555659|NCT01941914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20555660|NCT01941914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555661|NCT01941914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20555662|NCT01941953|Metformin|metformin|mesh-list
20555663|NCT01941953|Fluorouracil|fluorouracil|mesh-list
20555664|NCT01941953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20555665|NCT01941953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555666|NCT01941953|Antimetabolites|antimetabolites|mesh-ancestor
20555667|NCT01941953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555668|NCT01941953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20555669|NCT01941953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555670|NCT01941953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20555671|NCT01941953|Immunologic Factors|immunologic factors|mesh-ancestor
20555672|NCT01941966|Capecitabine|capecitabine|mesh-list
20555673|NCT01941966|Mitomycins|mitomycins|mesh-list
20555674|NCT01941966|Mitomycin|mitomycin|mesh-list
20555675|NCT01941966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20555676|NCT01941966|Antimetabolites|antimetabolites|mesh-ancestor
20555677|NCT01941966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555678|NCT01941966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555679|NCT01941966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20555680|NCT01941966|Alkylating Agents|alkylating agents|mesh-ancestor
19979320|NCT01919086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979321|NCT01919086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19979322|NCT01919086|Glucocorticoids|glucocorticoids|mesh-ancestor
19979323|NCT01919086|Hormones|hormones|mesh-ancestor
19979324|NCT01919086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19979325|NCT01919086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19979326|NCT01919086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979327|NCT01919086|Immunologic Factors|immunologic factors|mesh-ancestor
19979328|NCT01919086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19979329|NCT01919086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19979330|NCT01919086|Growth Substances|growth substances|mesh-ancestor
19979331|NCT01919086|Growth Inhibitors|growth inhibitors|mesh-ancestor
19979332|NCT01794143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19979333|NCT01794143|Liraglutide|liraglutide|mesh-list
19979334|NCT01794143|Glimepiride|glimepiride|mesh-list
19979335|NCT01794143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19979336|NCT01794143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19979337|NCT01794143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979338|NCT01794143|Incretins|incretins|mesh-ancestor
19979339|NCT01794143|Hormones|hormones|mesh-ancestor
19979340|NCT01794143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19979341|NCT01794143|Protease Inhibitors|protease inhibitors|mesh-ancestor
19979342|NCT01794143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979343|NCT01794143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979344|NCT01794143|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19979345|NCT01794143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19979346|NCT01794143|Immunologic Factors|immunologic factors|mesh-ancestor
19979347|NCT01766128|Zonisamide|zonisamide|mesh-list
19979348|NCT01766128|Anticonvulsants|anticonvulsants|mesh-ancestor
19979349|NCT01766128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19979350|NCT01766128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19979351|NCT01766128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979352|NCT01766128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19979353|NCT01766128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979354|NCT01728259|Dexamethasone|dexamethasone|mesh-list
19979355|NCT01728259|Bortezomib|bortezomib|mesh-list
19979356|NCT01728259|Pomalidomide|pomalidomide|mesh-list
19979357|NCT01728259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19979358|NCT01728259|Antiemetics|antiemetics|mesh-ancestor
19979359|NCT01728259|Autonomic Agents|autonomic agents|mesh-ancestor
19979360|NCT01728259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19979361|NCT01728259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979362|NCT01728259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19979363|NCT01728259|Glucocorticoids|glucocorticoids|mesh-ancestor
19979364|NCT01728259|Hormones|hormones|mesh-ancestor
19979365|NCT01728259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19979366|NCT01728259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19979367|NCT01728259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979368|NCT01728259|Immunologic Factors|immunologic factors|mesh-ancestor
19979369|NCT01728259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19979370|NCT01728259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19979371|NCT01728259|Growth Substances|growth substances|mesh-ancestor
19979372|NCT01728259|Growth Inhibitors|growth inhibitors|mesh-ancestor
19979373|NCT01727193|Azathioprine|azathioprine|mesh-list
19979374|NCT01727193|Leflunomide|leflunomide|mesh-list
19979375|NCT01727193|Antimetabolites|antimetabolites|mesh-ancestor
19979376|NCT01727193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979377|NCT01727193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19979378|NCT01727193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979379|NCT01727193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19979380|NCT01727193|Immunologic Factors|immunologic factors|mesh-ancestor
19979381|NCT01727193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979382|NCT01727193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19979383|NCT01727193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288959|NCT05100199|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20288960|NCT05100199|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20288961|NCT05100199|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20288962|NCT05100199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20288963|NCT05100199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288964|NCT05100199|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20288965|NCT05100199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20288966|NCT05100199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979384|NCT01643460|Ethanol|ethanol|mesh-list
19979385|NCT01643460|Paclitaxel|paclitaxel|mesh-list
19979386|NCT01643460|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19979387|NCT01643460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19979388|NCT01643460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979389|NCT01643460|Tubulin Modulators|tubulin modulators|mesh-ancestor
19979390|NCT01643460|Antimitotic Agents|antimitotic agents|mesh-ancestor
19979391|NCT01643460|Mitosis Modulators|mitosis modulators|mesh-ancestor
19979392|NCT01643460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979393|NCT01643460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19979394|NCT01643460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19979395|NCT01643460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19979396|NCT01643460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979397|NCT01547741|Paclitaxel|paclitaxel|mesh-list
19979398|NCT01547741|Docetaxel|docetaxel|mesh-list
19979399|NCT01547741|Cyclophosphamide|cyclophosphamide|mesh-list
19979400|NCT01547741|Doxorubicin|doxorubicin|mesh-list
19979401|NCT01547741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19979402|NCT01547741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979403|NCT01547741|Tubulin Modulators|tubulin modulators|mesh-ancestor
19979404|NCT01547741|Antimitotic Agents|antimitotic agents|mesh-ancestor
19979405|NCT01547741|Mitosis Modulators|mitosis modulators|mesh-ancestor
19979406|NCT01547741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979407|NCT01547741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19979408|NCT01547741|Immunologic Factors|immunologic factors|mesh-ancestor
19979409|NCT01547741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979410|NCT01547741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19979411|NCT01547741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19979412|NCT01547741|Alkylating Agents|alkylating agents|mesh-ancestor
19979413|NCT01547741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19979414|NCT01547741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19979415|NCT01547741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19979416|NCT01547741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19979417|NCT01547741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979418|NCT01492361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
19979419|NCT01492361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19979420|NCT01492361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19979421|NCT00954876|Capecitabine|capecitabine|mesh-list
19979422|NCT00954876|Cetuximab|cetuximab|mesh-list
19979423|NCT00954876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19979424|NCT00954876|Antimetabolites|antimetabolites|mesh-ancestor
19979425|NCT00954876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979426|NCT00954876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979427|NCT00954876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19979428|NCT00181701|Paclitaxel|paclitaxel|mesh-list
19979429|NCT00181701|Carboplatin|carboplatin|mesh-list
19979430|NCT00181701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19979431|NCT00181701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979432|NCT00181701|Tubulin Modulators|tubulin modulators|mesh-ancestor
19979433|NCT00181701|Antimitotic Agents|antimitotic agents|mesh-ancestor
19979434|NCT00181701|Mitosis Modulators|mitosis modulators|mesh-ancestor
19979435|NCT00181701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979436|NCT00084656|Ipilimumab|ipilimumab|mesh-list
19979437|NCT00084656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19979438|NCT00084656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979439|NCT00084656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19979440|NCT00084656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979441|NCT01879735|Cholylsarcosine|cholylsarcosine|mesh-list
19979442|NCT01879735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19979443|NCT01880086|Clomiphene|clomiphene|mesh-list
19979444|NCT01880086|Enclomiphene|enclomiphene|mesh-list
19979445|NCT01880086|Zuclomiphene|zuclomiphene|mesh-list
19979446|NCT01880086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19979447|NCT01880086|Hormone Antagonists|hormone antagonists|mesh-ancestor
19979448|NCT01880086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19979449|NCT01880086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979450|NCT01880086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19979451|NCT01880086|Fertility Agents|fertility agents|mesh-ancestor
19979452|NCT01880086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19979453|NCT01880086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19979454|NCT01880086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19979455|NCT01880099|Galantamine|galantamine|mesh-list
19979456|NCT01880099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
19979457|NCT01880099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979458|NCT01880099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979459|NCT01880099|Cholinergic Agents|cholinergic agents|mesh-ancestor
19979460|NCT01880099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19979461|NCT01880099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979462|NCT01880099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19979463|NCT01880099|Autonomic Agents|autonomic agents|mesh-ancestor
19979464|NCT01880099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19979465|NCT01880099|Nootropic Agents|nootropic agents|mesh-ancestor
19979466|NCT01880424|Linaclotide|linaclotide|mesh-list
19979467|NCT01880424|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19979468|NCT01880424|Enzyme Activators|enzyme activators|mesh-ancestor
19979469|NCT01880424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979470|NCT01880424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19979471|NCT01880437|Cytarabine|cytarabine|mesh-list
19979472|NCT01880437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19979473|NCT01880437|Antimetabolites|antimetabolites|mesh-ancestor
19979474|NCT01880437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979475|NCT01880437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979476|NCT01880437|Antiviral Agents|antiviral agents|mesh-ancestor
19979477|NCT01880437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19979478|NCT01880437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19979479|NCT01880437|Immunologic Factors|immunologic factors|mesh-ancestor
19979480|NCT01880437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979481|NCT01880515|Tetracycline|tetracycline|mesh-list
19979482|NCT01880515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19979483|NCT01880515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19979484|NCT01880515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19979485|NCT01880515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979486|NCT01880515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979487|NCT01880528|Lisinopril|lisinopril|mesh-list
19979488|NCT01880528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19979489|NCT01880528|Protease Inhibitors|protease inhibitors|mesh-ancestor
20555681|NCT01941966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20555682|NCT01941966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555683|NCT01941979|Leucovorin|leucovorin|mesh-list
20555684|NCT01941979|Capecitabine|capecitabine|mesh-list
20555685|NCT01941979|Oxaliplatin|oxaliplatin|mesh-list
20555686|NCT01941979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20555687|NCT01941979|Antimetabolites|antimetabolites|mesh-ancestor
20555688|NCT01941979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979490|NCT01880528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979491|NCT01880528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979492|NCT01880528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19979493|NCT01880528|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19979494|NCT01880528|Protective Agents|protective agents|mesh-ancestor
19979495|NCT01880528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979496|NCT01880593|Ketamine|ketamine|mesh-list
19979497|NCT01880593|Lithium Carbonate|lithium carbonate|mesh-list
19979498|NCT01880593|Analgesics|analgesics|mesh-ancestor
19979499|NCT01880593|Sensory System Agents|sensory system agents|mesh-ancestor
19979500|NCT01880593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19979501|NCT01880593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979502|NCT01880593|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19979503|NCT01880593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19979504|NCT01880593|Anesthetics, General|anesthetics, general|mesh-ancestor
19979505|NCT01880593|Anesthetics|anesthetics|mesh-ancestor
19979506|NCT01880593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19979507|NCT01880593|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19979508|NCT01880593|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19979509|NCT01880593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19979510|NCT01880593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979511|NCT01880593|Antidepressive Agents|antidepressive agents|mesh-ancestor
19979512|NCT01880593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19979513|NCT01880593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555689|NCT01941979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555690|NCT01941979|Antidotes|antidotes|mesh-ancestor
20555691|NCT01941979|Protective Agents|protective agents|mesh-ancestor
20555692|NCT01941979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555693|NCT01941979|Vitamin B Complex|vitamin b complex|mesh-ancestor
20555694|NCT01941979|Vitamins|vitamins|mesh-ancestor
20555695|NCT01941979|Micronutrients|micronutrients|mesh-ancestor
20555696|NCT01942070|Everolimus|everolimus|mesh-list
20555697|NCT01942070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555698|NCT01942070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20555699|NCT01942070|Immunologic Factors|immunologic factors|mesh-ancestor
20555700|NCT01942070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555701|NCT01942109|Torsemide|torsemide|mesh-list
20555702|NCT01942109|Furosemide|furosemide|mesh-list
20555703|NCT01942109|Diuretics|diuretics|mesh-ancestor
20555704|NCT01942109|Natriuretic Agents|natriuretic agents|mesh-ancestor
20555705|NCT01942109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555706|NCT01942109|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19979514|NCT01880593|Antimanic Agents|antimanic agents|mesh-ancestor
19979515|NCT01880593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19979516|NCT01880723|Albuterol|albuterol|mesh-list
19979517|NCT01880723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19979518|NCT01880723|Autonomic Agents|autonomic agents|mesh-ancestor
19979519|NCT01880723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19979520|NCT01880723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979521|NCT01880723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19979522|NCT01880723|Respiratory System Agents|respiratory system agents|mesh-ancestor
19979523|NCT01880723|Tocolytic Agents|tocolytic agents|mesh-ancestor
19979524|NCT01880723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19979525|NCT01880723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19979526|NCT01880723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19979527|NCT01880723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19979528|NCT01880723|Adrenergic Agents|adrenergic agents|mesh-ancestor
19979529|NCT01880723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19979530|NCT01880723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979531|NCT01880736|Insulin|insulin|mesh-list
19979532|NCT01880736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19979533|NCT01880736|Insulin, Long-Acting|insulin, long-acting|mesh-list
19979534|NCT01880736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19979535|NCT01880736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979536|NCT01880840|Azelastine|azelastine|mesh-list
19979537|NCT01880840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19979538|NCT01880840|Autonomic Agents|autonomic agents|mesh-ancestor
19979539|NCT01880840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19979540|NCT01880840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979541|NCT01880840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19979542|NCT01880840|Respiratory System Agents|respiratory system agents|mesh-ancestor
19979543|NCT01880840|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19979544|NCT01880840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979545|NCT01880840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979546|NCT01880840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19979547|NCT01880840|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19979548|NCT01880840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19979549|NCT01880840|Histamine Antagonists|histamine antagonists|mesh-ancestor
19979550|NCT01880840|Histamine Agents|histamine agents|mesh-ancestor
19979551|NCT01880840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19979552|NCT01881087|Levobupivacaine|levobupivacaine|mesh-list
19979553|NCT01881087|Anesthetics, Local|anesthetics, local|mesh-ancestor
19979554|NCT01881087|Anesthetics|anesthetics|mesh-ancestor
19979555|NCT01881087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19979556|NCT01881087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979557|NCT01881087|Sensory System Agents|sensory system agents|mesh-ancestor
19979558|NCT01881087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19979559|NCT01881113|Cetirizine|cetirizine|mesh-list
19979560|NCT01881113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19979561|NCT01881113|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19979562|NCT01881113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19979563|NCT01881113|Histamine Antagonists|histamine antagonists|mesh-ancestor
19979564|NCT01881113|Histamine Agents|histamine agents|mesh-ancestor
19979565|NCT01881113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19979566|NCT01881113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979567|NCT01881113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979568|NCT01881126|Timolol|timolol|mesh-list
19979569|NCT01881126|Bimatoprost|bimatoprost|mesh-list
19979570|NCT01881126|Travoprost|travoprost|mesh-list
19979571|NCT01881126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19979572|NCT01881126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19979573|NCT01881126|Adrenergic Agents|adrenergic agents|mesh-ancestor
19979574|NCT01881126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19979575|NCT01881126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979576|NCT01881126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979577|NCT01881126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19979578|NCT01881126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19979579|NCT01881230|Gemcitabine|gemcitabine|mesh-list
19979580|NCT01881230|Paclitaxel|paclitaxel|mesh-list
19979581|NCT01881230|Carboplatin|carboplatin|mesh-list
19979582|NCT01881230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19979583|NCT01881230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979584|NCT01881230|Tubulin Modulators|tubulin modulators|mesh-ancestor
19979585|NCT01881230|Antimitotic Agents|antimitotic agents|mesh-ancestor
19979586|NCT01881230|Mitosis Modulators|mitosis modulators|mesh-ancestor
19979587|NCT01881230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979588|NCT01881230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19979589|NCT01881230|Antimetabolites|antimetabolites|mesh-ancestor
19979590|NCT01881230|Antiviral Agents|antiviral agents|mesh-ancestor
19979591|NCT01881230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19979592|NCT01881230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979593|NCT01881230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19979594|NCT01881230|Immunologic Factors|immunologic factors|mesh-ancestor
19979595|NCT01881230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979596|NCT01881412|Fluticasone|fluticasone|mesh-list
20555707|NCT01942109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20555708|NCT01942109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555709|NCT01942109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20555710|NCT01942174|Methotrexate|methotrexate|mesh-list
20555711|NCT01942174|Vaccines|vaccines|mesh-list
20555712|NCT01942174|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20555713|NCT01942174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20555714|NCT01942174|Abortifacient Agents|abortifacient agents|mesh-ancestor
20555715|NCT01942174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20555716|NCT01942174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979597|NCT01881412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19979598|NCT01881412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19979599|NCT01881412|Autonomic Agents|autonomic agents|mesh-ancestor
19979600|NCT01881412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19979601|NCT01881412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979602|NCT01881412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19979603|NCT01881412|Respiratory System Agents|respiratory system agents|mesh-ancestor
19979604|NCT01881412|Dermatologic Agents|dermatologic agents|mesh-ancestor
19979605|NCT01881412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19979606|NCT01881789|Dexamethasone|dexamethasone|mesh-list
19979607|NCT01881789|Cyclophosphamide|cyclophosphamide|mesh-list
19979608|NCT01881789|Lenalidomide|lenalidomide|mesh-list
19979609|NCT01881789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19979610|NCT01881789|Immunologic Factors|immunologic factors|mesh-ancestor
19979611|NCT01881789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979612|NCT01881789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19979613|NCT01881789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19979614|NCT01881789|Alkylating Agents|alkylating agents|mesh-ancestor
19979615|NCT01881789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979616|NCT01881789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979617|NCT01881789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19979618|NCT01881789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19979619|NCT01881789|Antiemetics|antiemetics|mesh-ancestor
19979620|NCT01881789|Autonomic Agents|autonomic agents|mesh-ancestor
19979621|NCT01881789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19979622|NCT01881789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19979623|NCT01881789|Glucocorticoids|glucocorticoids|mesh-ancestor
19979624|NCT01881789|Hormones|hormones|mesh-ancestor
19979625|NCT01881789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19979626|NCT01881789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19979627|NCT01881789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19979628|NCT01881789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19979629|NCT01881789|Growth Substances|growth substances|mesh-ancestor
19979630|NCT01881789|Growth Inhibitors|growth inhibitors|mesh-ancestor
19979631|NCT01881828|Metformin|metformin|mesh-list
19979632|NCT01881828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19979633|NCT01881828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979634|NCT01882088|Psyllium|psyllium|mesh-list
19979635|NCT01882088|Cathartics|cathartics|mesh-ancestor
19979636|NCT01882088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19979637|NCT01882439|Tofacitinib|tofacitinib|mesh-list
19979638|NCT01882439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19979639|NCT01882439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979640|NCT01882439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979641|NCT01882829|Quinidine|quinidine|mesh-list
19979642|NCT01882829|Dextromethorphan|dextromethorphan|mesh-list
19979643|NCT01882829|Antitussive Agents|antitussive agents|mesh-ancestor
19979644|NCT01882829|Respiratory System Agents|respiratory system agents|mesh-ancestor
19979645|NCT01882829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19979646|NCT01882829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19979647|NCT01882829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19979648|NCT01882829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979649|NCT01882829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979650|NCT01882829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19979651|NCT01882829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19979652|NCT01882829|Adrenergic Agents|adrenergic agents|mesh-ancestor
19979653|NCT01882829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19979654|NCT01882829|Antimalarials|antimalarials|mesh-ancestor
19979655|NCT01882829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19979656|NCT01882829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19979657|NCT01882829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19979658|NCT01882829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979659|NCT01882829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19979660|NCT01882829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19979661|NCT01882829|Cholinergic Agents|cholinergic agents|mesh-ancestor
19979662|NCT01882829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19979663|NCT01882829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19979664|NCT01882829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19979665|NCT01882829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19979666|NCT01882829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19979667|NCT01882868|Leucovorin|leucovorin|mesh-list
19979668|NCT01882868|Irinotecan|irinotecan|mesh-list
19979669|NCT01882868|Aflibercept|aflibercept|mesh-list
19979670|NCT01882868|Levoleucovorin|levoleucovorin|mesh-list
19979671|NCT01882868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19979672|NCT01882868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19979673|NCT01882868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979674|NCT01882868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979675|NCT01882868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979676|NCT01882868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19979677|NCT01882868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19979678|NCT01882868|Growth Substances|growth substances|mesh-ancestor
19979679|NCT01882868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979680|NCT01882868|Growth Inhibitors|growth inhibitors|mesh-ancestor
19979681|NCT01882868|Antidotes|antidotes|mesh-ancestor
19979682|NCT01882868|Protective Agents|protective agents|mesh-ancestor
19979683|NCT01882868|Vitamin B Complex|vitamin b complex|mesh-ancestor
19979684|NCT01882868|Vitamins|vitamins|mesh-ancestor
19979685|NCT01882868|Micronutrients|micronutrients|mesh-ancestor
19979686|NCT01882907|Pioglitazone|pioglitazone|mesh-list
19979687|NCT01882907|Vildagliptin|vildagliptin|mesh-list
19979688|NCT01882907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19979689|NCT01882907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979690|NCT01882907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19979691|NCT01882907|Protease Inhibitors|protease inhibitors|mesh-ancestor
19979692|NCT01882907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979693|NCT01882907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979694|NCT01882985|Lycopene|lycopene|mesh-list
19979695|NCT01882985|Docetaxel|docetaxel|mesh-list
19979696|NCT01882985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979697|NCT01882985|Tubulin Modulators|tubulin modulators|mesh-ancestor
19979698|NCT01882985|Antimitotic Agents|antimitotic agents|mesh-ancestor
19979699|NCT01882985|Mitosis Modulators|mitosis modulators|mesh-ancestor
19979700|NCT01882985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979701|NCT01882985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19979702|NCT01882985|Antioxidants|antioxidants|mesh-ancestor
19979703|NCT01882985|Protective Agents|protective agents|mesh-ancestor
19979704|NCT01882985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979705|NCT01882985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19979706|NCT01882985|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19979707|NCT01883362|Midostaurin|midostaurin|mesh-list
19979708|NCT01883362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979709|NCT01883362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19979710|NCT01883362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979711|NCT01883362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979712|NCT01884337|Apixaban|apixaban|mesh-list
19979713|NCT01884337|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19979714|NCT01884337|Antithrombins|antithrombins|mesh-ancestor
19979715|NCT01884337|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19979716|NCT01884337|Protease Inhibitors|protease inhibitors|mesh-ancestor
19979717|NCT01884337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979718|NCT01884337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979719|NCT01884337|Anticoagulants|anticoagulants|mesh-ancestor
19979720|NCT01884350|Apixaban|apixaban|mesh-list
19979721|NCT01884350|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19979722|NCT01884350|Antithrombins|antithrombins|mesh-ancestor
19979723|NCT01884350|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19979724|NCT01884350|Protease Inhibitors|protease inhibitors|mesh-ancestor
19979725|NCT01884350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979726|NCT01884350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979727|NCT01884350|Anticoagulants|anticoagulants|mesh-ancestor
19979728|NCT01884571|Mycophenolic Acid|mycophenolic acid|mesh-list
19979729|NCT01884571|Prednisone|prednisone|mesh-list
19979730|NCT01884571|Methylprednisolone|methylprednisolone|mesh-list
19979731|NCT01884571|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19979732|NCT01884571|Tacrolimus|tacrolimus|mesh-list
19453043|NCT03406988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19979733|NCT01884571|Basiliximab|basiliximab|mesh-list
19979734|NCT01884571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19979735|NCT01884571|Glucocorticoids|glucocorticoids|mesh-ancestor
19979736|NCT01884571|Hormones|hormones|mesh-ancestor
19979737|NCT01884571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19979738|NCT01884571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979739|NCT01884571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19979740|NCT01884571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979741|NCT01884571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19979742|NCT01884571|Immunologic Factors|immunologic factors|mesh-ancestor
19979743|NCT01884571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19979744|NCT01884571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979745|NCT01884571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979746|NCT01884571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19979747|NCT01884571|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19979748|NCT01884571|Antitubercular Agents|antitubercular agents|mesh-ancestor
19979749|NCT01884571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19979750|NCT01884571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19979751|NCT01884571|Antiemetics|antiemetics|mesh-ancestor
19979752|NCT01884571|Autonomic Agents|autonomic agents|mesh-ancestor
19979753|NCT01884571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19979754|NCT01884571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19979755|NCT01884571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19979756|NCT01884571|Protective Agents|protective agents|mesh-ancestor
19979757|NCT01884597|Ranibizumab|ranibizumab|mesh-list
19979758|NCT01884597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19979759|NCT01884597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19979760|NCT01884597|Growth Substances|growth substances|mesh-ancestor
19979761|NCT01884597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979762|NCT01884597|Growth Inhibitors|growth inhibitors|mesh-ancestor
19979763|NCT01884597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979764|NCT01884675|Ambrisentan|ambrisentan|mesh-list
19979765|NCT01884675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19979766|NCT01884844|Vitamin D|vitamin d|mesh-list
19979767|NCT01884844|Cholecalciferol|cholecalciferol|mesh-list
19979768|NCT01884844|Vitamins|vitamins|mesh-ancestor
19979769|NCT01884844|Micronutrients|micronutrients|mesh-ancestor
19979770|NCT01884844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979771|NCT01884844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19979772|NCT01884844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19979773|NCT01885000|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19979774|NCT01885000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19979775|NCT01885000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19979776|NCT01885000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19979777|NCT01885000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19979778|NCT01885000|Adrenergic Agents|adrenergic agents|mesh-ancestor
19979779|NCT01885000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19979780|NCT01885000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979781|NCT01885000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979782|NCT01885104|Bisacodyl|bisacodyl|mesh-list
19979783|NCT01885104|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
19979784|NCT01885104|Laxatives|laxatives|mesh-list
19979785|NCT01885104|Cathartics|cathartics|mesh-ancestor
19979786|NCT01885104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19979787|NCT01885182|Oxycodone|oxycodone|mesh-list
19979788|NCT01885182|Naloxone|naloxone|mesh-list
19453044|NCT03406988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453045|NCT03406988|Vasodilator Agents|vasodilator agents|mesh-ancestor
19453046|NCT03406988|Tocolytic Agents|tocolytic agents|mesh-ancestor
19453047|NCT03406988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19453048|NCT03406988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19453049|NCT03406936|Midazolam|midazolam|mesh-list
19453050|NCT03406936|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19453051|NCT03406936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19453052|NCT03406936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19453053|NCT03406936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453054|NCT03406936|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19453055|NCT03406936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19453056|NCT03406936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19453057|NCT03406936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19453058|NCT03406936|Anesthetics, General|anesthetics, general|mesh-ancestor
19453059|NCT03406936|Anesthetics|anesthetics|mesh-ancestor
19453060|NCT03406936|GABA Modulators|gaba modulators|mesh-ancestor
19453061|NCT03406936|GABA Agents|gaba agents|mesh-ancestor
19453062|NCT03406936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19453063|NCT03406936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453064|NCT03406871|Nivolumab|nivolumab|mesh-list
19453065|NCT03406871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19453066|NCT03406871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453067|NCT03406871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19453068|NCT03406871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453069|NCT03406858|Pembrolizumab|pembrolizumab|mesh-list
19453070|NCT03406858|Antibodies, Bispecific|antibodies, bispecific|mesh-list
19453071|NCT03406858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19453072|NCT03406858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453073|NCT03406858|Immunologic Factors|immunologic factors|mesh-ancestor
19453074|NCT03406858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979789|NCT01885182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19979790|NCT01885182|Narcotics|narcotics|mesh-ancestor
19979791|NCT01885182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19979792|NCT01885182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979793|NCT01885182|Analgesics|analgesics|mesh-ancestor
19979794|NCT01885182|Sensory System Agents|sensory system agents|mesh-ancestor
19979795|NCT01885182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19979796|NCT01885182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19979797|NCT01885208|Exenatide|exenatide|mesh-list
19979798|NCT01885208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19979799|NCT01885208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979800|NCT01885208|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19979801|NCT01885208|Incretins|incretins|mesh-ancestor
19979802|NCT01885208|Hormones|hormones|mesh-ancestor
19979803|NCT01885208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19979804|NCT01885559|Telmisartan|telmisartan|mesh-list
19453075|NCT03406832|Nitroprusside|nitroprusside|mesh-list
19979805|NCT01885559|Lisinopril|lisinopril|mesh-list
19979806|NCT01885559|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19979807|NCT01885559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19979808|NCT01885559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19979809|NCT01885559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19979810|NCT01885559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979811|NCT01885559|Protease Inhibitors|protease inhibitors|mesh-ancestor
19979812|NCT01885559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979813|NCT01885559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19979814|NCT01885559|Protective Agents|protective agents|mesh-ancestor
19979815|NCT01885559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979816|NCT01885910|Doxycycline|doxycycline|mesh-list
19979817|NCT01885910|Dapsone|dapsone|mesh-list
19979818|NCT01885910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19979819|NCT01885910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19979820|NCT01885910|Antimalarials|antimalarials|mesh-ancestor
19979821|NCT01885910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19979822|NCT01885910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19979823|NCT01885910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19979824|NCT01885910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979825|NCT01885910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979826|NCT01885910|Leprostatic Agents|leprostatic agents|mesh-ancestor
19979827|NCT01885936|Albuterol|albuterol|mesh-list
19979828|NCT01885936|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19979829|NCT01885936|Autonomic Agents|autonomic agents|mesh-ancestor
19979830|NCT01885936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19979831|NCT01885936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979832|NCT01885936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19979833|NCT01885936|Respiratory System Agents|respiratory system agents|mesh-ancestor
19979834|NCT01885936|Tocolytic Agents|tocolytic agents|mesh-ancestor
19979835|NCT01885936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19979836|NCT01885936|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19979837|NCT01885936|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19979838|NCT01885936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19979839|NCT01885936|Adrenergic Agents|adrenergic agents|mesh-ancestor
19979840|NCT01885936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19979841|NCT01885936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979842|NCT01886105|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
19979843|NCT01886105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19979844|NCT01886105|Analgesics|analgesics|mesh-ancestor
19979845|NCT01886105|Sensory System Agents|sensory system agents|mesh-ancestor
19979846|NCT01886105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19979847|NCT01886105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979848|NCT01886287|Octreotide|octreotide|mesh-list
19979849|NCT01886287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19979850|NCT01886287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19979851|NCT01886287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288967|NCT05100199|Cholinergic Agents|cholinergic agents|mesh-ancestor
20288968|NCT05100199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20288969|NCT05088980|Lidocaine|lidocaine|mesh-list
20555717|NCT01942174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20555718|NCT01942174|Antimetabolites|antimetabolites|mesh-ancestor
20555719|NCT01942174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555720|NCT01942174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555721|NCT01942174|Dermatologic Agents|dermatologic agents|mesh-ancestor
20555722|NCT01942174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555723|NCT01942174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20555724|NCT01942174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20288970|NCT05088980|Anesthetics, Local|anesthetics, local|mesh-ancestor
20288971|NCT05088980|Anesthetics|anesthetics|mesh-ancestor
20288972|NCT05088980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20288973|NCT05088980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288974|NCT05088980|Sensory System Agents|sensory system agents|mesh-ancestor
20288975|NCT05088980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20288976|NCT05088980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19979852|NCT01886690|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19979853|NCT01886690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19979854|NCT01886690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19979855|NCT01886690|Laxatives|laxatives|mesh-ancestor
19979856|NCT01886690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19979857|NCT01886937|Phentermine|phentermine|mesh-list
19979858|NCT01886937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19979859|NCT01886937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979860|NCT01886937|Appetite Depressants|appetite depressants|mesh-ancestor
19979861|NCT01886937|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19979862|NCT01886937|Sympathomimetics|sympathomimetics|mesh-ancestor
19979863|NCT01886937|Autonomic Agents|autonomic agents|mesh-ancestor
19979864|NCT01886937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19979865|NCT01886937|Adrenergic Agents|adrenergic agents|mesh-ancestor
19979866|NCT01886937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19979867|NCT01886937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979868|NCT01887132|Donepezil|donepezil|mesh-list
19979869|NCT01887132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19979870|NCT01887132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979871|NCT01887132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979872|NCT01887132|Cholinergic Agents|cholinergic agents|mesh-ancestor
19979873|NCT01887132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19979874|NCT01887132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979875|NCT01887132|Nootropic Agents|nootropic agents|mesh-ancestor
19979876|NCT01887171|Tacrolimus|tacrolimus|mesh-list
19979877|NCT01887171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19979878|NCT01887171|Immunologic Factors|immunologic factors|mesh-ancestor
19979879|NCT01887171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979880|NCT01887171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19979881|NCT01887171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979882|NCT01887171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979883|NCT01887327|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
19979884|NCT01887327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979885|NCT01887327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979886|NCT01887353|Ranolazine|ranolazine|mesh-list
19979887|NCT01887353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19979888|NCT01887353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19979889|NCT01887353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979890|NCT01887418|Methyltestosterone|methyltestosterone|mesh-list
19979891|NCT01887418|Testosterone|testosterone|mesh-list
19979892|NCT01887418|Testosterone undecanoate|testosterone undecanoate|mesh-list
19979893|NCT01887418|Testosterone enanthate|testosterone enanthate|mesh-list
19979894|NCT01887418|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19979895|NCT01887418|Androgens|androgens|mesh-ancestor
19979896|NCT01887418|Hormones|hormones|mesh-ancestor
19979897|NCT01887418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19979898|NCT01887418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979899|NCT01887418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19979900|NCT01887418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979901|NCT01887418|Anabolic Agents|anabolic agents|mesh-ancestor
19979902|NCT01887587|Dexamethasone|dexamethasone|mesh-list
19979903|NCT01887587|Doxorubicin|doxorubicin|mesh-list
19979904|NCT01887587|Vincristine|vincristine|mesh-list
19979905|NCT01887587|Ixazomib|ixazomib|mesh-list
19979906|NCT01887587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19979907|NCT01887587|Antiemetics|antiemetics|mesh-ancestor
19979908|NCT01887587|Autonomic Agents|autonomic agents|mesh-ancestor
19979909|NCT01887587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19979910|NCT01887587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979911|NCT01887587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19979912|NCT01887587|Glucocorticoids|glucocorticoids|mesh-ancestor
19979913|NCT01887587|Hormones|hormones|mesh-ancestor
19979914|NCT01887587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19979915|NCT01887587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19979916|NCT01887587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979917|NCT01887587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19979918|NCT01887587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19979919|NCT01887587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19979920|NCT01887587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979921|NCT01887587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979922|NCT01887587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19979923|NCT01887587|Tubulin Modulators|tubulin modulators|mesh-ancestor
19979924|NCT01887587|Antimitotic Agents|antimitotic agents|mesh-ancestor
19979925|NCT01887587|Mitosis Modulators|mitosis modulators|mesh-ancestor
19979926|NCT01887587|Protease Inhibitors|protease inhibitors|mesh-ancestor
19979927|NCT01887717|Sorafenib|sorafenib|mesh-list
19979928|NCT01887717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979929|NCT01887717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19979930|NCT01887717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979931|NCT01887717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979932|NCT01887990|Ketamine|ketamine|mesh-list
19979933|NCT01887990|Analgesics|analgesics|mesh-ancestor
19979934|NCT01887990|Sensory System Agents|sensory system agents|mesh-ancestor
19979935|NCT01887990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19979936|NCT01887990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979937|NCT01887990|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19979938|NCT01887990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19979939|NCT01887990|Anesthetics, General|anesthetics, general|mesh-ancestor
19979940|NCT01887990|Anesthetics|anesthetics|mesh-ancestor
19979941|NCT01887990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19979942|NCT01887990|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19979943|NCT01887990|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19979944|NCT01887990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19979945|NCT01887990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979946|NCT01888003|Epoetin Alfa|epoetin alfa|mesh-list
19979947|NCT01888003|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19979948|NCT01888003|Hematinics|hematinics|mesh-ancestor
19979949|NCT01888367|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19979950|NCT01888367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19979951|NCT01888432|Everolimus|everolimus|mesh-list
19979952|NCT01888432|Tacrolimus|tacrolimus|mesh-list
19979953|NCT01888432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19979954|NCT01888432|Immunologic Factors|immunologic factors|mesh-ancestor
19979955|NCT01888432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979956|NCT01888432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19979957|NCT01888432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19979958|NCT01888432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979959|NCT01888432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19979960|NCT01888497|Diphenhydramine|diphenhydramine|mesh-list
19979961|NCT01888497|Promethazine|promethazine|mesh-list
20555725|NCT01942174|Immunologic Factors|immunologic factors|mesh-ancestor
20555726|NCT01942174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20555727|NCT01942174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20555728|NCT01942187|Aripiprazole|aripiprazole|mesh-list
20555729|NCT01942187|Bupropion|bupropion|mesh-list
20555730|NCT01942187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20555731|NCT01942187|Antidepressive Agents|antidepressive agents|mesh-ancestor
20555732|NCT01942187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19979962|NCT01888497|Triazolam|triazolam|mesh-list
19979963|NCT01888497|Gabapentin|gabapentin|mesh-list
19979964|NCT01888497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19979965|NCT01888497|Analgesics|analgesics|mesh-ancestor
19979966|NCT01888497|Sensory System Agents|sensory system agents|mesh-ancestor
19979967|NCT01888497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19979968|NCT01888497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19979969|NCT01888497|Anticonvulsants|anticonvulsants|mesh-ancestor
19979970|NCT01888497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19979971|NCT01888497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19979972|NCT01888497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19979973|NCT01888497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19979974|NCT01888497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19979975|NCT01888497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19979976|NCT01888497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19979977|NCT01888497|Antimanic Agents|antimanic agents|mesh-ancestor
19979978|NCT01888497|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19979979|NCT01888497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19979980|NCT01888497|Anesthetics, Local|anesthetics, local|mesh-ancestor
19979981|NCT01888497|Anesthetics|anesthetics|mesh-ancestor
19979982|NCT01888497|Antiemetics|antiemetics|mesh-ancestor
19979983|NCT01888497|Autonomic Agents|autonomic agents|mesh-ancestor
19979984|NCT01888497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19979985|NCT01888497|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19979986|NCT01888497|Histamine Antagonists|histamine antagonists|mesh-ancestor
19979987|NCT01888497|Histamine Agents|histamine agents|mesh-ancestor
19979988|NCT01888497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19979989|NCT01888497|Antipruritics|antipruritics|mesh-ancestor
19979990|NCT01888497|Dermatologic Agents|dermatologic agents|mesh-ancestor
19979991|NCT01888497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19979992|NCT01888497|GABA Modulators|gaba modulators|mesh-ancestor
19979993|NCT01888497|GABA Agents|gaba agents|mesh-ancestor
19979994|NCT01888952|Prednisone|prednisone|mesh-list
19979995|NCT01888952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19979996|NCT01888952|Glucocorticoids|glucocorticoids|mesh-ancestor
19979997|NCT01888952|Hormones|hormones|mesh-ancestor
19979998|NCT01888952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19979999|NCT01888952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980000|NCT01888952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19980001|NCT01888952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980002|NCT01889069|Prednisone|prednisone|mesh-list
19980003|NCT01889069|Cyclophosphamide|cyclophosphamide|mesh-list
19980004|NCT01889069|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19980005|NCT01889069|Rituximab|rituximab|mesh-list
19980006|NCT01889069|Doxorubicin|doxorubicin|mesh-list
19980007|NCT01889069|Vincristine|vincristine|mesh-list
19980008|NCT01889069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19980009|NCT01889069|Immunologic Factors|immunologic factors|mesh-ancestor
19980010|NCT01889069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980011|NCT01889069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19980012|NCT01889069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19980013|NCT01889069|Alkylating Agents|alkylating agents|mesh-ancestor
19980014|NCT01889069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453076|NCT03406832|Tirofiban|tirofiban|mesh-list
19980015|NCT01889069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980016|NCT01889069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19980017|NCT01889069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19980018|NCT01889069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19980019|NCT01889069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19980020|NCT01889069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19980021|NCT01889069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980022|NCT01889069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19980023|NCT01889069|Glucocorticoids|glucocorticoids|mesh-ancestor
19980024|NCT01889069|Hormones|hormones|mesh-ancestor
19980025|NCT01889069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19980026|NCT01889069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19980027|NCT01889069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19980028|NCT01889069|Tubulin Modulators|tubulin modulators|mesh-ancestor
20555733|NCT01942187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20555734|NCT01942187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20555735|NCT01942187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20555736|NCT01942187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555737|NCT01942187|Dopamine Agents|dopamine agents|mesh-ancestor
20555738|NCT01942187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20555739|NCT01942187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555740|NCT01942187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20555741|NCT01942187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20555742|NCT01942187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555743|NCT01942187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20555744|NCT01942187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20555745|NCT01942187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20555746|NCT01942187|Dopamine Agonists|dopamine agonists|mesh-ancestor
20555747|NCT01942187|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20555748|NCT01942187|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20555749|NCT01942187|Serotonin Agents|serotonin agents|mesh-ancestor
20555750|NCT01942187|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20555751|NCT01942187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20555752|NCT01942187|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20555753|NCT01942187|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20555754|NCT01942291|Niacin|niacin|mesh-list
20555755|NCT01942291|Nicotinic Acids|nicotinic acids|mesh-list
20555756|NCT01942291|Vitamins|vitamins|mesh-ancestor
20555757|NCT01942291|Micronutrients|micronutrients|mesh-ancestor
20555758|NCT01942291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555759|NCT01942291|Vitamin B Complex|vitamin b complex|mesh-ancestor
20555760|NCT01942291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20555761|NCT01942291|Antimetabolites|antimetabolites|mesh-ancestor
20555762|NCT01942291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555763|NCT01942291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20555764|NCT01942291|Vasodilator Agents|vasodilator agents|mesh-ancestor
20555765|NCT01942304|Calcium|calcium|mesh-list
20555766|NCT01942304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20555767|NCT01942304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555768|NCT01942343|Droperidol|droperidol|mesh-list
20555769|NCT01942343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20555770|NCT01942343|Antiemetics|antiemetics|mesh-ancestor
20555771|NCT01942343|Autonomic Agents|autonomic agents|mesh-ancestor
20555772|NCT01942343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20555773|NCT01942343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555774|NCT01942343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20555775|NCT01942343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20555776|NCT01942343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20555777|NCT01942343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20555778|NCT01942343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20555779|NCT01942343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20555780|NCT01942343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20555781|NCT01942343|Dopamine Agents|dopamine agents|mesh-ancestor
20555782|NCT01942343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20555783|NCT01942343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555784|NCT01942369|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20555785|NCT01942369|Luteolytic Agents|luteolytic agents|mesh-ancestor
20555786|NCT01942369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20555787|NCT01942369|Contraceptive Agents|contraceptive agents|mesh-ancestor
20555788|NCT01942369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20555789|NCT01942369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555790|NCT01942369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20555791|NCT01942369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20555792|NCT01942369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980029|NCT01889069|Antimitotic Agents|antimitotic agents|mesh-ancestor
19980030|NCT01889069|Mitosis Modulators|mitosis modulators|mesh-ancestor
19980031|NCT01889602|Topiramate|topiramate|mesh-list
19980032|NCT01889602|Lorazepam|lorazepam|mesh-list
19980033|NCT01889602|Anticonvulsants|anticonvulsants|mesh-ancestor
19980034|NCT01889602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19980035|NCT01889602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980036|NCT01889602|Antiemetics|antiemetics|mesh-ancestor
19980037|NCT01889602|Autonomic Agents|autonomic agents|mesh-ancestor
19980038|NCT01889602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980039|NCT01889602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19980040|NCT01889602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19980041|NCT01889602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19980042|NCT01889602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19980043|NCT01889602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19980044|NCT01889602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19980045|NCT01889602|GABA Modulators|gaba modulators|mesh-ancestor
19980046|NCT01889602|GABA Agents|gaba agents|mesh-ancestor
19980047|NCT01889602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20555793|NCT01942382|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20555794|NCT01942382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20555795|NCT01942382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20555796|NCT01942382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20555797|NCT01942382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555798|NCT01942382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20555799|NCT01942382|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20555800|NCT01942382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20555801|NCT01942382|Serotonin Agents|serotonin agents|mesh-ancestor
20555802|NCT01942382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20555803|NCT01942382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555804|NCT01942382|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20555805|NCT01942382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20555806|NCT01942382|Dopamine Agents|dopamine agents|mesh-ancestor
19980048|NCT01889602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980049|NCT01889667|Insulin|insulin|mesh-list
19980050|NCT01889667|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19980051|NCT01889667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19980052|NCT01889667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980053|NCT01889797|Rituximab|rituximab|mesh-list
19980054|NCT01889797|Obinutuzumab|obinutuzumab|mesh-list
19980055|NCT01889797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19980056|NCT01889797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980057|NCT01889797|Immunologic Factors|immunologic factors|mesh-ancestor
19980058|NCT01889797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980059|NCT01889797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19980060|NCT01889862|Dextrans|dextrans|mesh-list
19980061|NCT01889862|Anticoagulants|anticoagulants|mesh-ancestor
19980062|NCT01889862|Plasma Substitutes|plasma substitutes|mesh-ancestor
19980063|NCT01889862|Blood Substitutes|blood substitutes|mesh-ancestor
19980064|NCT01890109|Erenumab|erenumab|mesh-list
19980065|NCT01890109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19980066|NCT01890109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980067|NCT01890109|Analgesics|analgesics|mesh-ancestor
19980068|NCT01890109|Sensory System Agents|sensory system agents|mesh-ancestor
19980069|NCT01890109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980070|NCT01890109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980071|NCT01890122|Metformin|metformin|mesh-list
19980072|NCT01890122|Alogliptin|alogliptin|mesh-list
19980073|NCT01890122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19980074|NCT01890122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980075|NCT01890122|Incretins|incretins|mesh-ancestor
19980076|NCT01890122|Hormones|hormones|mesh-ancestor
19980077|NCT01890122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19980078|NCT01890122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19980079|NCT01890122|Protease Inhibitors|protease inhibitors|mesh-ancestor
19980080|NCT01890122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980081|NCT01890122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980082|NCT01890265|Pirfenidone|pirfenidone|mesh-list
19980083|NCT01890265|Nintedanib|nintedanib|mesh-list
19980084|NCT01890265|Immunoglobulins|immunoglobulins|mesh-list
19980085|NCT01890265|Antibodies|antibodies|mesh-list
19980086|NCT01890265|Immunoglobulin G|immunoglobulin g|mesh-list
19980087|NCT01890265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19980088|NCT01890265|Immunologic Factors|immunologic factors|mesh-ancestor
19980089|NCT01890265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980090|NCT01890265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980091|NCT01890265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19980092|NCT01890265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980093|NCT01890265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980094|NCT01890265|Analgesics|analgesics|mesh-ancestor
19980095|NCT01890265|Sensory System Agents|sensory system agents|mesh-ancestor
19980096|NCT01890265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980097|NCT01890265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19980098|NCT01890265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19980099|NCT01890265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19980100|NCT01890265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19980101|NCT01890343|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19980102|NCT01890343|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20555807|NCT01942447|Vancomycin|vancomycin|mesh-list
20555808|NCT01942447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20555809|NCT01942447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20555810|NCT01942460|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20555811|NCT01942460|Hematinics|hematinics|mesh-ancestor
20555812|NCT01942460|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20555813|NCT01942460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20555814|NCT01942551|Tadalafil|tadalafil|mesh-list
20555815|NCT01942551|Dutasteride|dutasteride|mesh-list
20555816|NCT01942551|Vasodilator Agents|vasodilator agents|mesh-ancestor
19980103|NCT01890343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980104|NCT01890473|Abatacept|abatacept|mesh-list
19980105|NCT01890473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19980106|NCT01890473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980107|NCT01890473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980108|NCT01890473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19980109|NCT01890473|Immunologic Factors|immunologic factors|mesh-ancestor
19980110|NCT01890473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980111|NCT01890473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19980112|NCT01890642|Lidocaine|lidocaine|mesh-list
19980113|NCT01890642|Anesthetics, Local|anesthetics, local|mesh-ancestor
19980114|NCT01890642|Anesthetics|anesthetics|mesh-ancestor
19980115|NCT01890642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19980116|NCT01890642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980117|NCT01890642|Sensory System Agents|sensory system agents|mesh-ancestor
19980118|NCT01890642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980119|NCT01890642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19980120|NCT01890642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19980121|NCT01890642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19980122|NCT01890642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19980123|NCT01890642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980124|NCT01890707|Anesthetics|anesthetics|mesh-list
19980125|NCT01890707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19980126|NCT01890707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980127|NCT01890746|Cytarabine|cytarabine|mesh-list
19980128|NCT01890746|Daunorubicin|daunorubicin|mesh-list
19980129|NCT01890746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19980130|NCT01890746|Antimetabolites|antimetabolites|mesh-ancestor
19980131|NCT01890746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980132|NCT01890746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980133|NCT01890746|Antiviral Agents|antiviral agents|mesh-ancestor
19980134|NCT01890746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19980135|NCT01890746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19980136|NCT01890746|Immunologic Factors|immunologic factors|mesh-ancestor
19980137|NCT01890746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980138|NCT01890746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19980139|NCT01890746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19980140|NCT01890746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19980141|NCT01890746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980142|NCT01890785|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19980143|NCT01890785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19980144|NCT01890785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980145|NCT01890785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19980146|NCT01890785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19980147|NCT01890785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19980148|NCT01890785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980149|NCT01890785|Dopamine Agents|dopamine agents|mesh-ancestor
19980150|NCT01890785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19980151|NCT01890967|Atorvastatin|atorvastatin|mesh-list
19980152|NCT01890967|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19980153|NCT01890967|Simvastatin|simvastatin|mesh-list
19980154|NCT01890967|Ezetimibe|ezetimibe|mesh-list
19980155|NCT01890967|Pravastatin|pravastatin|mesh-list
19980156|NCT01890967|Pitavastatin|pitavastatin|mesh-list
19980157|NCT01890967|Lovastatin|lovastatin|mesh-list
19980158|NCT01890967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19980159|NCT01890967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19980160|NCT01890967|Antimetabolites|antimetabolites|mesh-ancestor
19980161|NCT01890967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980162|NCT01890967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19980163|NCT01890967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19980164|NCT01890967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980165|NCT01891331|Fluconazole|fluconazole|mesh-list
19980166|NCT01891331|Antifungal Agents|antifungal agents|mesh-ancestor
19980167|NCT01891331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19980168|NCT01891331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19980169|NCT01891331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19980170|NCT01891331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980171|NCT01891331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980172|NCT01891331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19980173|NCT01891331|Hormone Antagonists|hormone antagonists|mesh-ancestor
19980174|NCT01891331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19980175|NCT01891331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980176|NCT01891331|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19980177|NCT01891331|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19980178|NCT01891357|Paclitaxel|paclitaxel|mesh-list
19980179|NCT01891357|Trastuzumab|trastuzumab|mesh-list
19980180|NCT01891357|Lapatinib|lapatinib|mesh-list
19980181|NCT01891357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19980182|NCT01891357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980183|NCT01891357|Tubulin Modulators|tubulin modulators|mesh-ancestor
19980184|NCT01891357|Antimitotic Agents|antimitotic agents|mesh-ancestor
19980185|NCT01891357|Mitosis Modulators|mitosis modulators|mesh-ancestor
19980186|NCT01891357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980187|NCT01891357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19980188|NCT01891357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19980189|NCT01891357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980190|NCT01891669|PF-06263507|pf-06263507|mesh-list
19980191|NCT01891669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19980192|NCT01891669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980193|NCT01891669|Antimitotic Agents|antimitotic agents|mesh-ancestor
19980194|NCT01891669|Mitosis Modulators|mitosis modulators|mesh-ancestor
19980195|NCT01891669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980196|NCT01891864|Etanercept|etanercept|mesh-list
19980197|NCT01891864|GP2015|gp2015|mesh-list
19980198|NCT01891864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19980199|NCT01891864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19980200|NCT01891864|Analgesics|analgesics|mesh-ancestor
19980201|NCT01891864|Sensory System Agents|sensory system agents|mesh-ancestor
19980202|NCT01891864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980203|NCT01891864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980204|NCT01891864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19980205|NCT01891864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19980206|NCT01891864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19980207|NCT01891864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19980208|NCT01891864|Immunologic Factors|immunologic factors|mesh-ancestor
19980209|NCT01891864|Dermatologic Agents|dermatologic agents|mesh-ancestor
19980210|NCT01891890|Lamotrigine|lamotrigine|mesh-list
19980211|NCT01891890|Oxcarbazepine|oxcarbazepine|mesh-list
19980212|NCT01891890|Levetiracetam|levetiracetam|mesh-list
19980213|NCT01891890|Anticonvulsants|anticonvulsants|mesh-ancestor
19980214|NCT01891890|Nootropic Agents|nootropic agents|mesh-ancestor
19980215|NCT01891890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19980216|NCT01891890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19980217|NCT01891890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980218|NCT01891890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19980219|NCT01891890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980220|NCT01891890|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19980221|NCT01891890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19980222|NCT01891890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19980223|NCT01891890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19980224|NCT01891890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19980225|NCT01891890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19980226|NCT01891890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19980227|NCT01891890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19980228|NCT01891968|Bortezomib|bortezomib|mesh-list
19980229|NCT01891968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980230|NCT01892020|Insulin|insulin|mesh-list
19980231|NCT01892020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19980232|NCT01892020|Insulin Aspart|insulin aspart|mesh-list
19980233|NCT01892020|Biphasic Insulins|biphasic insulins|mesh-list
19980234|NCT01892020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19980235|NCT01892020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980236|NCT01892163|Dexamethasone|dexamethasone|mesh-list
19980237|NCT01892163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19980238|NCT01892163|Antiemetics|antiemetics|mesh-ancestor
19980239|NCT01892163|Autonomic Agents|autonomic agents|mesh-ancestor
19980240|NCT01892163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980241|NCT01892163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980242|NCT01892163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20555817|NCT01942551|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20555818|NCT01942551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20555819|NCT01942551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555820|NCT01942551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555821|NCT01942551|Urological Agents|urological agents|mesh-ancestor
20555822|NCT01942551|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20555823|NCT01942551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19980243|NCT01892163|Glucocorticoids|glucocorticoids|mesh-ancestor
20555824|NCT01942551|Hormone Antagonists|hormone antagonists|mesh-ancestor
20555825|NCT01942551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20555826|NCT01942551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555827|NCT01942577|Protective Agents|protective agents|mesh-list
20555828|NCT01942577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555829|NCT01942681|Propiverine|propiverine|mesh-list
20555830|NCT01942681|Parasympatholytics|parasympatholytics|mesh-ancestor
20555831|NCT01942681|Autonomic Agents|autonomic agents|mesh-ancestor
20555832|NCT01942681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20555833|NCT01942681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555834|NCT01942681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19980244|NCT01892163|Hormones|hormones|mesh-ancestor
19980245|NCT01892163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19980246|NCT01892163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19980247|NCT01892163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980248|NCT01892189|Ketamine|ketamine|mesh-list
19980249|NCT01892189|Analgesics|analgesics|mesh-ancestor
19980250|NCT01892189|Sensory System Agents|sensory system agents|mesh-ancestor
19980251|NCT01892189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980252|NCT01892189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980253|NCT01892189|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19980254|NCT01892189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19980255|NCT01892189|Anesthetics, General|anesthetics, general|mesh-ancestor
19980256|NCT01892189|Anesthetics|anesthetics|mesh-ancestor
19980257|NCT01892189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19980258|NCT01892189|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19980259|NCT01892189|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19980260|NCT01892189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19980261|NCT01892189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980262|NCT01892345|Eculizumab|eculizumab|mesh-list
19980263|NCT01892345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19980264|NCT01892345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19980265|NCT01892345|Immunologic Factors|immunologic factors|mesh-ancestor
19980266|NCT01892345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980267|NCT01892709|Hydromorphone|hydromorphone|mesh-list
19980268|NCT01892709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19980269|NCT01892709|Narcotics|narcotics|mesh-ancestor
19980270|NCT01892709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19980271|NCT01892709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980272|NCT01892709|Analgesics|analgesics|mesh-ancestor
19980273|NCT01892709|Sensory System Agents|sensory system agents|mesh-ancestor
19980274|NCT01892709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980275|NCT01893203|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19980276|NCT01893203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19980277|NCT01893203|Dermatologic Agents|dermatologic agents|mesh-ancestor
19980278|NCT01893281|Methyltestosterone|methyltestosterone|mesh-list
19980279|NCT01893281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19980280|NCT01893281|Testosterone|testosterone|mesh-list
19980281|NCT01893281|Testosterone undecanoate|testosterone undecanoate|mesh-list
19980282|NCT01893281|Testosterone enanthate|testosterone enanthate|mesh-list
19980283|NCT01893281|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19980284|NCT01893281|Androgens|androgens|mesh-ancestor
19980285|NCT01893281|Hormones|hormones|mesh-ancestor
19980286|NCT01893281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19980287|NCT01893281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980288|NCT01893281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19980289|NCT01893281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980290|NCT01893281|Anabolic Agents|anabolic agents|mesh-ancestor
19980291|NCT01893411|Botulinum Toxins|botulinum toxins|mesh-list
19980292|NCT01893411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19980293|NCT01893411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19980294|NCT01893411|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19980295|NCT01893411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19980296|NCT01893411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19980297|NCT01893411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980298|NCT01893411|Cholinergic Agents|cholinergic agents|mesh-ancestor
19980299|NCT01893411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19980300|NCT01893411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980301|NCT01893411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19980302|NCT01893411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980303|NCT01893567|Clobetasol|clobetasol|mesh-list
19980304|NCT01893567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19980305|NCT01893567|Glucocorticoids|glucocorticoids|mesh-ancestor
19980306|NCT01893567|Hormones|hormones|mesh-ancestor
19980307|NCT01893567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19980308|NCT01893567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980309|NCT01893632|Gabapentin|gabapentin|mesh-list
19980310|NCT01893632|Analgesics|analgesics|mesh-ancestor
19980311|NCT01893632|Sensory System Agents|sensory system agents|mesh-ancestor
19980312|NCT01893632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980313|NCT01893632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980314|NCT01893632|Anticonvulsants|anticonvulsants|mesh-ancestor
19980315|NCT01893632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19980316|NCT01893632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19980317|NCT01893632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19980318|NCT01893632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19980319|NCT01893632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19980320|NCT01893632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19980321|NCT01893632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19980322|NCT01893632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980323|NCT01893632|Antimanic Agents|antimanic agents|mesh-ancestor
19980324|NCT01893801|Gemcitabine|gemcitabine|mesh-list
19980325|NCT01893801|Paclitaxel|paclitaxel|mesh-list
19980326|NCT01893801|Cisplatin|cisplatin|mesh-list
19980327|NCT01893801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19980328|NCT01893801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980329|NCT01893801|Tubulin Modulators|tubulin modulators|mesh-ancestor
19980330|NCT01893801|Antimitotic Agents|antimitotic agents|mesh-ancestor
19980331|NCT01893801|Mitosis Modulators|mitosis modulators|mesh-ancestor
19980332|NCT01893801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980333|NCT01893801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19980334|NCT01893801|Antimetabolites|antimetabolites|mesh-ancestor
19980335|NCT01893801|Antiviral Agents|antiviral agents|mesh-ancestor
19980336|NCT01893801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19980337|NCT01893801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980338|NCT01893801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19980339|NCT01893801|Immunologic Factors|immunologic factors|mesh-ancestor
19980340|NCT01893801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980341|NCT01893827|Naltrexone|naltrexone|mesh-list
19980342|NCT01893827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19980343|NCT01893827|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19980344|NCT01893827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980345|NCT01893827|Sensory System Agents|sensory system agents|mesh-ancestor
19980346|NCT01893827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980347|NCT01893879|Ketoprofen|ketoprofen|mesh-list
19980348|NCT01893879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19980349|NCT01893879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19980350|NCT01893879|Analgesics|analgesics|mesh-ancestor
19980351|NCT01893879|Sensory System Agents|sensory system agents|mesh-ancestor
19980352|NCT01893879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980353|NCT01893879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980354|NCT01893879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19980355|NCT01893879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19980356|NCT01893879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19980357|NCT01893879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980358|NCT01893879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980359|NCT01894022|Ambrisentan|ambrisentan|mesh-list
19980360|NCT01894022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19980361|NCT01894152|Everolimus|everolimus|mesh-list
19980362|NCT01894152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980363|NCT01894152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19980364|NCT01894152|Immunologic Factors|immunologic factors|mesh-ancestor
19980365|NCT01894152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980366|NCT01894243|Olaparib|olaparib|mesh-list
19980367|NCT01894243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19980368|NCT01894243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980369|NCT01894243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980370|NCT01894243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288977|NCT05088980|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20288978|NCT05088980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20288979|NCT05088980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20288980|NCT05088980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555835|NCT01942681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20555836|NCT01942681|Cholinergic Agents|cholinergic agents|mesh-ancestor
20555837|NCT01942681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20555838|NCT01942681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555839|NCT01942681|Urological Agents|urological agents|mesh-ancestor
20555840|NCT01942889|Antioxidants|antioxidants|mesh-list
20555841|NCT01942889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555842|NCT01942889|Protective Agents|protective agents|mesh-ancestor
19980371|NCT01894256|Olaparib|olaparib|mesh-list
19980372|NCT01894256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19980373|NCT01894256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980374|NCT01894256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980375|NCT01894256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980376|NCT01894477|Fludarabine|fludarabine|mesh-list
19980377|NCT01894477|Fludarabine phosphate|fludarabine phosphate|mesh-list
19980378|NCT01894477|Treosulfan|treosulfan|mesh-list
19980379|NCT01894477|Busulfan|busulfan|mesh-list
19980380|NCT01894477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980381|NCT01894477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19980382|NCT01894477|Antimetabolites|antimetabolites|mesh-ancestor
19980383|NCT01894477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980384|NCT01894477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19980385|NCT01894477|Immunologic Factors|immunologic factors|mesh-ancestor
19980386|NCT01894477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980387|NCT01894477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19980388|NCT01894477|Alkylating Agents|alkylating agents|mesh-ancestor
19980389|NCT01894477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19980390|NCT01894503|Mometasone Furoate|mometasone furoate|mesh-list
19980391|NCT01894503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19980392|NCT01894503|Dermatologic Agents|dermatologic agents|mesh-ancestor
19980393|NCT01894503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19980394|NCT01894555|Aspirin|aspirin|mesh-list
19980395|NCT01894555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19980396|NCT01894555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19980397|NCT01894555|Analgesics|analgesics|mesh-ancestor
19980398|NCT01894555|Sensory System Agents|sensory system agents|mesh-ancestor
19980399|NCT01894555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980400|NCT01894555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980401|NCT01894555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19980402|NCT01894555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19980403|NCT01894555|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19980404|NCT01894555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19980405|NCT01894555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980406|NCT01894555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19980407|NCT01894555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19980408|NCT01894555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980409|NCT01894555|Antipyretics|antipyretics|mesh-ancestor
19980410|NCT01894568|Insulin|insulin|mesh-list
19980411|NCT01894568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19980412|NCT01894568|Insulin Glargine|insulin glargine|mesh-list
19980413|NCT01894568|Pioglitazone|pioglitazone|mesh-list
19980414|NCT01894568|Biguanides|biguanides|mesh-list
19980415|NCT01894568|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19980416|NCT01894568|Meglitinide|meglitinide|mesh-list
19453077|NCT03406832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19453078|NCT03406832|Vasodilator Agents|vasodilator agents|mesh-ancestor
19453079|NCT03406832|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19453080|NCT03406832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453081|NCT03406832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19980417|NCT01894568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980418|NCT01894581|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19980419|NCT01894581|Hormones|hormones|mesh-ancestor
19980420|NCT01894581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19980421|NCT01894581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980422|NCT01894776|Maraviroc|maraviroc|mesh-list
19980423|NCT01894776|Rifabutin|rifabutin|mesh-list
19980424|NCT01894776|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19980425|NCT01894776|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19980426|NCT01894776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980427|NCT01894776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19980428|NCT01894776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19980429|NCT01894776|Antiviral Agents|antiviral agents|mesh-ancestor
19980430|NCT01894776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19980431|NCT01894776|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19980432|NCT01894776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19980433|NCT01894776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19980434|NCT01894776|Antitubercular Agents|antitubercular agents|mesh-ancestor
19980435|NCT01894919|Vaccines|vaccines|mesh-list
19980436|NCT01894919|Immunologic Factors|immunologic factors|mesh-ancestor
19980437|NCT01894919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980438|NCT01894984|Risperidone|risperidone|mesh-list
19980439|NCT01894984|Antipsychotic Agents|antipsychotic agents|mesh-list
19980440|NCT01894984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19980441|NCT01894984|Serotonin Agents|serotonin agents|mesh-ancestor
19980442|NCT01894984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19980443|NCT01894984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980444|NCT01894984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980445|NCT01894984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19980446|NCT01894984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19980447|NCT01894984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19980448|NCT01894984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19980449|NCT01894984|Dopamine Agents|dopamine agents|mesh-ancestor
19980450|NCT01895036|Naltrexone|naltrexone|mesh-list
19980451|NCT01895036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19980452|NCT01895036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19980453|NCT01895036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980454|NCT01895036|Sensory System Agents|sensory system agents|mesh-ancestor
19980455|NCT01895036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980456|NCT01895101|Tranexamic Acid|tranexamic acid|mesh-list
19980457|NCT01895101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19980458|NCT01895101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19980459|NCT01895101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980460|NCT01895101|Hemostatics|hemostatics|mesh-ancestor
19980461|NCT01895101|Coagulants|coagulants|mesh-ancestor
19980462|NCT01895127|Immunoglobulins|immunoglobulins|mesh-list
19980463|NCT01895127|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19980464|NCT01895127|Antibodies|antibodies|mesh-list
19980465|NCT01895127|Eculizumab|eculizumab|mesh-list
19980466|NCT01895127|Immunologic Factors|immunologic factors|mesh-ancestor
19980467|NCT01895127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980468|NCT01895127|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19980469|NCT01895127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19980470|NCT01895270|Isradipine|isradipine|mesh-list
19980471|NCT01895270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19980472|NCT01895270|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19980473|NCT01895270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19980474|NCT01895270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980475|NCT01895270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19980476|NCT01895270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980477|NCT01895270|Vasodilator Agents|vasodilator agents|mesh-ancestor
19980478|NCT01895309|Etanercept|etanercept|mesh-list
19980479|NCT01895309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19980480|NCT01895309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19980481|NCT01895309|Analgesics|analgesics|mesh-ancestor
19980482|NCT01895309|Sensory System Agents|sensory system agents|mesh-ancestor
19980483|NCT01895309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980484|NCT01895309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980485|NCT01895309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19980486|NCT01895309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19980487|NCT01895309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19980488|NCT01895309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19980489|NCT01895309|Immunologic Factors|immunologic factors|mesh-ancestor
19980490|NCT01895322|Tolvaptan|tolvaptan|mesh-list
19980491|NCT01895322|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19980492|NCT01895322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980493|NCT01895322|Natriuretic Agents|natriuretic agents|mesh-ancestor
19980494|NCT01895322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980495|NCT01895335|Teriflunomide|teriflunomide|mesh-list
19980496|NCT01895335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19980497|NCT01895335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20555843|NCT01942889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980498|NCT01895335|Analgesics|analgesics|mesh-ancestor
19980499|NCT01895335|Sensory System Agents|sensory system agents|mesh-ancestor
19980500|NCT01895335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980501|NCT01895335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980502|NCT01895335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19980503|NCT01895335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19980504|NCT01895335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19980505|NCT01895335|Immunologic Factors|immunologic factors|mesh-ancestor
19980506|NCT01895777|Dabigatran|dabigatran|mesh-list
19980507|NCT01895777|Antithrombins|antithrombins|mesh-ancestor
19980508|NCT01895777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19980509|NCT01895777|Protease Inhibitors|protease inhibitors|mesh-ancestor
19980510|NCT01895777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980511|NCT01895777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980512|NCT01895777|Anticoagulants|anticoagulants|mesh-ancestor
19980513|NCT01896050|Tamoxifen|tamoxifen|mesh-list
19980514|NCT01896050|Letrozole|letrozole|mesh-list
19980515|NCT01896050|Anastrozole|anastrozole|mesh-list
19980516|NCT01896050|Exemestane|exemestane|mesh-list
19980517|NCT01896050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980518|NCT01896050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19980519|NCT01896050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19980520|NCT01896050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980521|NCT01896050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980522|NCT01896050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19980523|NCT01896050|Hormone Antagonists|hormone antagonists|mesh-ancestor
19980524|NCT01896050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20288981|NCT05074355|Azacitidine|azacitidine|mesh-list
19980525|NCT01896050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980526|NCT01896050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19980527|NCT01896050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19980528|NCT01896050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19980529|NCT01896050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19980530|NCT01896128|Modafinil|modafinil|mesh-list
19980531|NCT01896128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19980532|NCT01896128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980533|NCT01896128|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19980534|NCT01896128|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19980535|NCT01896128|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19980536|NCT01896128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980537|NCT01896193|Sofosbuvir|sofosbuvir|mesh-list
19980538|NCT01896193|Antiviral Agents|antiviral agents|mesh-ancestor
19980539|NCT01896193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19980540|NCT01896232|Cinacalcet|cinacalcet|mesh-list
19980541|NCT01896232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19980542|NCT01896232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980543|NCT01896232|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19980544|NCT01896232|Hormone Antagonists|hormone antagonists|mesh-ancestor
19980545|NCT01896232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19980546|NCT01896297|Dabigatran|dabigatran|mesh-list
19980547|NCT01896297|Antithrombins|antithrombins|mesh-ancestor
19980548|NCT01896297|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19980549|NCT01896297|Protease Inhibitors|protease inhibitors|mesh-ancestor
19980550|NCT01896297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980551|NCT01896297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980552|NCT01896297|Anticoagulants|anticoagulants|mesh-ancestor
19980553|NCT01896544|Cholecalciferol|cholecalciferol|mesh-list
19980554|NCT01896544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19980555|NCT01896544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980556|NCT01896544|Vitamins|vitamins|mesh-ancestor
19980557|NCT01896544|Micronutrients|micronutrients|mesh-ancestor
19980558|NCT01896544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19980559|NCT01896557|Omeprazole|omeprazole|mesh-list
19980560|NCT01896557|Ranitidine|ranitidine|mesh-list
19980561|NCT01896557|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
19980562|NCT01896557|Clopidogrel|clopidogrel|mesh-list
19980563|NCT01896557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
19980564|NCT01896557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19980565|NCT01896557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19980566|NCT01896557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19980567|NCT01896557|Purinergic Agents|purinergic agents|mesh-ancestor
19980568|NCT01896557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19980569|NCT01896557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980570|NCT01896557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980571|NCT01896557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19980572|NCT01896557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19980573|NCT01896557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19980574|NCT01896557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980575|NCT01896557|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19980576|NCT01896557|Histamine Antagonists|histamine antagonists|mesh-ancestor
19980577|NCT01896557|Histamine Agents|histamine agents|mesh-ancestor
19980578|NCT01896700|Methylphenidate|methylphenidate|mesh-list
19980579|NCT01896700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19980580|NCT01896700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980581|NCT01896700|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19980582|NCT01896700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19980583|NCT01896700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19980584|NCT01896700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980585|NCT01896700|Dopamine Agents|dopamine agents|mesh-ancestor
19980586|NCT01896700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19980587|NCT01896726|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19980588|NCT01896726|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
19980589|NCT01896726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19980590|NCT01896726|Contraceptive Agents|contraceptive agents|mesh-ancestor
19980591|NCT01896726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19980592|NCT01896726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980593|NCT01896726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19980594|NCT01896726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19980595|NCT01896726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19980596|NCT01896726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19980597|NCT01896726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19980598|NCT01896726|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
19980599|NCT01896726|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19980600|NCT01896726|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19980601|NCT01896856|Trifluridine|trifluridine|mesh-list
19980602|NCT01896856|Irinotecan|irinotecan|mesh-list
19980603|NCT01896856|Guadecitabine|guadecitabine|mesh-list
19980604|NCT01896856|Azacitidine|azacitidine|mesh-list
19980605|NCT01896856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19980606|NCT01896856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19980607|NCT01896856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980608|NCT01896856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980609|NCT01896856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980610|NCT01896856|Antimetabolites|antimetabolites|mesh-ancestor
19980611|NCT01896856|Antiviral Agents|antiviral agents|mesh-ancestor
19980612|NCT01896856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19980613|NCT01896856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19980614|NCT01896869|Ipilimumab|ipilimumab|mesh-list
19980615|NCT01896869|Folfirinox|folfirinox|mesh-list
19980616|NCT01896869|Vaccines|vaccines|mesh-list
20555844|NCT01943019|Linagliptin|linagliptin|mesh-list
20555845|NCT01943019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20555846|NCT01943019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555847|NCT01943019|Incretins|incretins|mesh-ancestor
20555848|NCT01943019|Hormones|hormones|mesh-ancestor
19980617|NCT01896869|Immunologic Factors|immunologic factors|mesh-ancestor
19980618|NCT01896869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980619|NCT01896869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19980620|NCT01896869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980621|NCT01896869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19980622|NCT01896869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980623|NCT01896895|Botulinum Toxins|botulinum toxins|mesh-list
19980624|NCT01896895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19980625|NCT01896895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19980626|NCT01896895|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19980627|NCT01896895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19980628|NCT01896895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19980629|NCT01896895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980630|NCT01896895|Cholinergic Agents|cholinergic agents|mesh-ancestor
19980631|NCT01896895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19980632|NCT01896895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980633|NCT01896895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19980634|NCT01896895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980635|NCT01896921|Raltegravir Potassium|raltegravir potassium|mesh-list
19980636|NCT01896921|Maraviroc|maraviroc|mesh-list
19980637|NCT01896921|Dolutegravir|dolutegravir|mesh-list
19980638|NCT01896921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19980639|NCT01896921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19980640|NCT01896921|Antiviral Agents|antiviral agents|mesh-ancestor
19980641|NCT01896921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19980642|NCT01896921|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19980643|NCT01896921|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19980644|NCT01896921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980645|NCT01896921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555849|NCT01943019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20555850|NCT01943019|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20555851|NCT01943019|Protease Inhibitors|protease inhibitors|mesh-ancestor
20555852|NCT01943019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555853|NCT01943019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980646|NCT01896921|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20555854|NCT01943058|Megestrol|megestrol|mesh-list
20555855|NCT01943058|Megestrol Acetate|megestrol acetate|mesh-list
20555856|NCT01943058|Levonorgestrel|levonorgestrel|mesh-list
20555857|NCT01943058|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20555858|NCT01943058|Contraceptive Agents|contraceptive agents|mesh-ancestor
20555859|NCT01943058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20555860|NCT01943058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555861|NCT01943058|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20555862|NCT01943058|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20555863|NCT01943058|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20555864|NCT01943058|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20555865|NCT01943058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20555866|NCT01943058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555867|NCT01943058|Appetite Stimulants|appetite stimulants|mesh-ancestor
20555868|NCT01943058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20555869|NCT01943136|Mupirocin|mupirocin|mesh-list
20555870|NCT01943136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20555871|NCT01943136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20555872|NCT01943136|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20555873|NCT01943136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980647|NCT01896921|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19980648|NCT01896921|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19980649|NCT01896934|Sertraline|sertraline|mesh-list
19980650|NCT01896934|Antidepressive Agents|antidepressive agents|mesh-ancestor
19980651|NCT01896934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19980652|NCT01896934|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19980653|NCT01896934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19453082|NCT03406832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19453083|NCT03406832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19453084|NCT03406819|Nitroprusside|nitroprusside|mesh-list
19453085|NCT03406819|Tirofiban|tirofiban|mesh-list
19453086|NCT03406819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19453087|NCT03406819|Vasodilator Agents|vasodilator agents|mesh-ancestor
19453088|NCT03406819|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19453089|NCT03406819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453090|NCT03406819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19453091|NCT03406819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19453092|NCT03406819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19453093|NCT03406793|Iron|iron|mesh-list
19453094|NCT03406793|Zinc|zinc|mesh-list
19453095|NCT03406793|Trace Elements|trace elements|mesh-ancestor
19453096|NCT03406793|Micronutrients|micronutrients|mesh-ancestor
19453097|NCT03406793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453098|NCT03406689|Nepafenac|nepafenac|mesh-list
19453099|NCT03406689|Lubricant Eye Drops|lubricant eye drops|mesh-list
19453100|NCT03406689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19453101|NCT03406689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19980654|NCT01896934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19980655|NCT01896934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980656|NCT01896934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19980657|NCT01896934|Serotonin Agents|serotonin agents|mesh-ancestor
19980658|NCT01896934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980659|NCT01897233|Ivacaftor|ivacaftor|mesh-list
19980660|NCT01897233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19980661|NCT01897233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19980662|NCT01897233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980663|NCT01897285|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19980664|NCT01897285|Laxatives|laxatives|mesh-ancestor
19980665|NCT01897285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19980666|NCT01897402|Vaccines|vaccines|mesh-list
19980667|NCT01897402|Immunologic Factors|immunologic factors|mesh-ancestor
19980668|NCT01897402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980669|NCT01897493|Digoxin|digoxin|mesh-list
19980670|NCT01897493|Evacetrapib|evacetrapib|mesh-list
19980671|NCT01897493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19980672|NCT01897493|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19453102|NCT03406689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19980673|NCT01897493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980674|NCT01897493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980675|NCT01897493|Protective Agents|protective agents|mesh-ancestor
19980676|NCT01897493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980677|NCT01897493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19980678|NCT01897493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19980679|NCT01897493|Antimetabolites|antimetabolites|mesh-ancestor
19980680|NCT01897493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19980681|NCT01897532|Linagliptin|linagliptin|mesh-list
19980682|NCT01897532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19980683|NCT01897532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980684|NCT01897532|Incretins|incretins|mesh-ancestor
19980685|NCT01897532|Hormones|hormones|mesh-ancestor
19980686|NCT01897532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19980687|NCT01897532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19980688|NCT01897532|Protease Inhibitors|protease inhibitors|mesh-ancestor
19980689|NCT01897532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980690|NCT01897532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980691|NCT01897714|Dexamethasone|dexamethasone|mesh-list
19980692|NCT01897714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19980693|NCT01897714|Antiemetics|antiemetics|mesh-ancestor
19980694|NCT01897714|Autonomic Agents|autonomic agents|mesh-ancestor
19980695|NCT01897714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980696|NCT01897714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980697|NCT01897714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19980698|NCT01897714|Glucocorticoids|glucocorticoids|mesh-ancestor
19980699|NCT01897714|Hormones|hormones|mesh-ancestor
19980700|NCT01897714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19980701|NCT01897714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19980702|NCT01897714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980703|NCT01897727|Spironolactone|spironolactone|mesh-list
19980704|NCT01897727|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19980705|NCT01897727|Hormone Antagonists|hormone antagonists|mesh-ancestor
19980706|NCT01897727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19980707|NCT01897727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980708|NCT01897727|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19980709|NCT01897727|Diuretics|diuretics|mesh-ancestor
19980710|NCT01897727|Natriuretic Agents|natriuretic agents|mesh-ancestor
19980711|NCT01897792|Vitamins|vitamins|mesh-list
19980712|NCT01897792|Ascorbic Acid|ascorbic acid|mesh-list
19980713|NCT01897792|Vitamin E|vitamin e|mesh-list
19980714|NCT01897792|Tocopherols|tocopherols|mesh-list
19980715|NCT01897792|Tocotrienols|tocotrienols|mesh-list
19980716|NCT01897792|alpha-Tocopherol|alpha-tocopherol|mesh-list
19980717|NCT01897792|Micronutrients|micronutrients|mesh-ancestor
19980718|NCT01897792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980719|NCT01897792|Antioxidants|antioxidants|mesh-ancestor
19980720|NCT01897792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980721|NCT01897792|Protective Agents|protective agents|mesh-ancestor
19980722|NCT01898091|Ascorbic Acid|ascorbic acid|mesh-list
19980723|NCT01898091|Glycerol|glycerol|mesh-list
19980724|NCT01898091|Antioxidants|antioxidants|mesh-ancestor
20288982|NCT05074355|Venetoclax|venetoclax|mesh-list
19980725|NCT01898091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980726|NCT01898091|Protective Agents|protective agents|mesh-ancestor
19980727|NCT01898091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980728|NCT01898091|Vitamins|vitamins|mesh-ancestor
19980729|NCT01898091|Micronutrients|micronutrients|mesh-ancestor
19980730|NCT01898091|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19980731|NCT01898130|Bevacizumab|bevacizumab|mesh-list
19980732|NCT01898130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19980733|NCT01898130|Antibodies|antibodies|mesh-list
19980734|NCT01898130|Immunoglobulins|immunoglobulins|mesh-list
19980735|NCT01898130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19980736|NCT01898130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980737|NCT01898130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19980738|NCT01898130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19980739|NCT01898130|Growth Substances|growth substances|mesh-ancestor
19980740|NCT01898130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980741|NCT01898130|Growth Inhibitors|growth inhibitors|mesh-ancestor
19980742|NCT01898130|Immunologic Factors|immunologic factors|mesh-ancestor
19980743|NCT01898195|Varenicline|varenicline|mesh-list
19980744|NCT01898195|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19980745|NCT01898195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19980746|NCT01898195|Cholinergic Agents|cholinergic agents|mesh-ancestor
19980747|NCT01898195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19980748|NCT01898195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980749|NCT01898195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980750|NCT01898208|Anti-Infective Agents|anti-infective agents|mesh-list
19980751|NCT01898208|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19980752|NCT01898403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19980753|NCT01898442|Ticagrelor|ticagrelor|mesh-list
19980754|NCT01898442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19980755|NCT01898442|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19980756|NCT01898442|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19980757|NCT01898442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19980758|NCT01898442|Purinergic Agents|purinergic agents|mesh-ancestor
20555874|NCT01943136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555875|NCT01943188|Cyclophosphamide|cyclophosphamide|mesh-list
20555876|NCT01943188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20555877|NCT01943188|Immunologic Factors|immunologic factors|mesh-ancestor
20555878|NCT01943188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555879|NCT01943188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20555880|NCT01943188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20555881|NCT01943188|Alkylating Agents|alkylating agents|mesh-ancestor
20555882|NCT01943188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555883|NCT01943188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555884|NCT01943188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20555885|NCT01943240|Ropivacaine|ropivacaine|mesh-list
20555886|NCT01943240|Anesthetics, Local|anesthetics, local|mesh-ancestor
20555887|NCT01943240|Anesthetics|anesthetics|mesh-ancestor
20555888|NCT01943240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20555889|NCT01943240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555890|NCT01943240|Sensory System Agents|sensory system agents|mesh-ancestor
19980759|NCT01898442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19980760|NCT01898442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980761|NCT01898442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980762|NCT01898689|Ropivacaine|ropivacaine|mesh-list
19980763|NCT01898689|Anesthetics, Local|anesthetics, local|mesh-ancestor
19980764|NCT01898689|Anesthetics|anesthetics|mesh-ancestor
19980765|NCT01898689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19980766|NCT01898689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980767|NCT01898689|Sensory System Agents|sensory system agents|mesh-ancestor
19980768|NCT01898689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980769|NCT01898806|Triamcinolone|triamcinolone|mesh-list
19980770|NCT01898806|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19980771|NCT01898806|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19980772|NCT01898806|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19980773|NCT01898806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19980774|NCT01898806|Glucocorticoids|glucocorticoids|mesh-ancestor
19980775|NCT01898806|Hormones|hormones|mesh-ancestor
19980776|NCT01898806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19980777|NCT01898806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980778|NCT01898806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19980779|NCT01898806|Immunologic Factors|immunologic factors|mesh-ancestor
19980780|NCT01898806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980781|NCT01898806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980782|NCT01898923|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19980783|NCT01898923|Laxatives|laxatives|mesh-ancestor
19980784|NCT01898923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19980785|NCT01899053|Serabelisib|serabelisib|mesh-list
19980786|NCT01899053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980787|NCT01899053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980788|NCT01899742|Tiotropium Bromide|tiotropium bromide|mesh-list
19980789|NCT01899742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19980790|NCT01899742|Autonomic Agents|autonomic agents|mesh-ancestor
19980791|NCT01899742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980792|NCT01899742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980793|NCT01899742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19980794|NCT01899742|Respiratory System Agents|respiratory system agents|mesh-ancestor
19980795|NCT01899742|Parasympatholytics|parasympatholytics|mesh-ancestor
19980796|NCT01899742|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19980797|NCT01899742|Cholinergic Agents|cholinergic agents|mesh-ancestor
19980798|NCT01899742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19980799|NCT01899742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980800|NCT01900054|Bepotastine besilate|bepotastine besilate|mesh-list
19980801|NCT01900054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19980802|NCT01900249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19980803|NCT01900249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19980804|NCT01900431|Leucovorin|leucovorin|mesh-list
19980805|NCT01900431|Folic Acid|folic acid|mesh-list
19980806|NCT01900431|Prednisone|prednisone|mesh-list
19980807|NCT01900431|Methotrexate|methotrexate|mesh-list
19980808|NCT01900431|Levoleucovorin|levoleucovorin|mesh-list
19980809|NCT01900431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19980810|NCT01900431|Glucocorticoids|glucocorticoids|mesh-ancestor
19980811|NCT01900431|Hormones|hormones|mesh-ancestor
19980812|NCT01900431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19980813|NCT01900431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980814|NCT01900431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19980815|NCT01900431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980816|NCT01900431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19980817|NCT01900431|Abortifacient Agents|abortifacient agents|mesh-ancestor
19980818|NCT01900431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19980819|NCT01900431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19980820|NCT01900431|Antimetabolites|antimetabolites|mesh-ancestor
19980821|NCT01900431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980822|NCT01900431|Dermatologic Agents|dermatologic agents|mesh-ancestor
19980823|NCT01900431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980824|NCT01900431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19980825|NCT01900431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19980826|NCT01900431|Immunologic Factors|immunologic factors|mesh-ancestor
19980827|NCT01900431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19980828|NCT01900431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19980829|NCT01900431|Antidotes|antidotes|mesh-ancestor
19980830|NCT01900431|Protective Agents|protective agents|mesh-ancestor
19980831|NCT01900431|Vitamin B Complex|vitamin b complex|mesh-ancestor
19980832|NCT01900431|Vitamins|vitamins|mesh-ancestor
19980833|NCT01900431|Micronutrients|micronutrients|mesh-ancestor
19980834|NCT01900431|Hematinics|hematinics|mesh-ancestor
19980835|NCT01900652|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19980836|NCT01900652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980837|NCT01900652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19980838|NCT01900652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980839|NCT01900652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555891|NCT01943240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20555892|NCT01943305|Vaccines|vaccines|mesh-list
20555893|NCT01943305|Immunologic Factors|immunologic factors|mesh-ancestor
20555894|NCT01943305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555895|NCT01943409|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20555896|NCT01943409|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20555897|NCT01943409|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19980840|NCT01901146|Paclitaxel|paclitaxel|mesh-list
19980841|NCT01901146|Trastuzumab|trastuzumab|mesh-list
19980842|NCT01901146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19980843|NCT01901146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19980844|NCT01901146|Tubulin Modulators|tubulin modulators|mesh-ancestor
19980845|NCT01901146|Antimitotic Agents|antimitotic agents|mesh-ancestor
19980846|NCT01901146|Mitosis Modulators|mitosis modulators|mesh-ancestor
19980847|NCT01901146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980848|NCT01901146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19980849|NCT01901185|Etanercept|etanercept|mesh-list
19980850|NCT01901185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19980851|NCT01901185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19980852|NCT01901185|Analgesics|analgesics|mesh-ancestor
19980853|NCT01901185|Sensory System Agents|sensory system agents|mesh-ancestor
19980854|NCT01901185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980855|NCT01901185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980856|NCT01901185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19980857|NCT01901185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19980858|NCT01901185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19980859|NCT01901185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19980860|NCT01901185|Immunologic Factors|immunologic factors|mesh-ancestor
19980861|NCT01901250|Fluorides|fluorides|mesh-list
19980862|NCT01901250|Fluorides, Topical|fluorides, topical|mesh-list
19980863|NCT01901250|Cariostatic Agents|cariostatic agents|mesh-ancestor
19980864|NCT01901250|Protective Agents|protective agents|mesh-ancestor
19980865|NCT01901250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980866|NCT01901393|Ibuprofen|ibuprofen|mesh-list
19980867|NCT01901393|Ketorolac|ketorolac|mesh-list
19980868|NCT01901393|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19980869|NCT01901393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19980870|NCT01901393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19980871|NCT01901393|Analgesics|analgesics|mesh-ancestor
19980872|NCT01901393|Sensory System Agents|sensory system agents|mesh-ancestor
19980873|NCT01901393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980874|NCT01901393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980875|NCT01901393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19980876|NCT01901393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19980877|NCT01901393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19980878|NCT01901393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980879|NCT01901393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980880|NCT01901419|Nitroglycerin|nitroglycerin|mesh-list
19980881|NCT01901419|Vasodilator Agents|vasodilator agents|mesh-ancestor
19980882|NCT01901575|Remifentanil|remifentanil|mesh-list
19980883|NCT01901575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19980884|NCT01901575|Narcotics|narcotics|mesh-ancestor
19980885|NCT01901575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19980886|NCT01901575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980887|NCT01901575|Analgesics|analgesics|mesh-ancestor
19980888|NCT01901575|Sensory System Agents|sensory system agents|mesh-ancestor
19980889|NCT01901575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980890|NCT01901588|Dexmedetomidine|dexmedetomidine|mesh-list
19980891|NCT01901588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19980892|NCT01901588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19980893|NCT01901588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980894|NCT01901588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19980895|NCT01901588|Analgesics|analgesics|mesh-ancestor
19980896|NCT01901588|Sensory System Agents|sensory system agents|mesh-ancestor
19980897|NCT01901588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980898|NCT01901588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19980899|NCT01901588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19980900|NCT01901588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19980901|NCT01901588|Adrenergic Agents|adrenergic agents|mesh-ancestor
19980902|NCT01901588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19980903|NCT01901588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980904|NCT01901614|Anesthetics|anesthetics|mesh-list
19980905|NCT01901614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19980906|NCT01901614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980907|NCT01901809|Dopamine|dopamine|mesh-list
19980908|NCT01901809|Furosemide|furosemide|mesh-list
19980909|NCT01901809|Diuretics|diuretics|mesh-ancestor
19980910|NCT01901809|Natriuretic Agents|natriuretic agents|mesh-ancestor
19980911|NCT01901809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980912|NCT01901809|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19980913|NCT01901809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19980914|NCT01901809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980915|NCT01901809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19980916|NCT01901809|Sympathomimetics|sympathomimetics|mesh-ancestor
19980917|NCT01901809|Autonomic Agents|autonomic agents|mesh-ancestor
19980918|NCT01901809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980919|NCT01901809|Dopamine Agents|dopamine agents|mesh-ancestor
19980920|NCT01901809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19980921|NCT01901809|Protective Agents|protective agents|mesh-ancestor
19980922|NCT01901848|Bupropion|bupropion|mesh-list
19980923|NCT01901848|Nicotine|nicotine|mesh-list
19980924|NCT01901848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19980925|NCT01901848|Autonomic Agents|autonomic agents|mesh-ancestor
19980926|NCT01901848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980927|NCT01901848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980928|NCT01901848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19980929|NCT01901848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19980930|NCT01901848|Cholinergic Agents|cholinergic agents|mesh-ancestor
20555898|NCT01943409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20555899|NCT01943422|Interferons|interferons|mesh-list
20555900|NCT01943422|Interferon-alpha|interferon-alpha|mesh-list
20555901|NCT01943422|Interferon alpha-2|interferon alpha-2|mesh-list
20555902|NCT01943422|Vemurafenib|vemurafenib|mesh-list
20555903|NCT01943422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555904|NCT01943422|Antiviral Agents|antiviral agents|mesh-ancestor
20555905|NCT01943422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20555906|NCT01943422|Immunologic Factors|immunologic factors|mesh-ancestor
20555907|NCT01943422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555908|NCT01943422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20555909|NCT01943422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555910|NCT01943422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555911|NCT01943487|Verapamil|verapamil|mesh-list
20555912|NCT01943487|Tamsulosin|tamsulosin|mesh-list
20555913|NCT01943487|Solifenacin Succinate|solifenacin succinate|mesh-list
20555914|NCT01943487|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20555915|NCT01943487|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20555916|NCT01943487|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20555917|NCT01943487|Adrenergic Agents|adrenergic agents|mesh-ancestor
20555918|NCT01943487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20555919|NCT01943487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555920|NCT01943487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555921|NCT01943487|Urological Agents|urological agents|mesh-ancestor
20555922|NCT01943487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20555923|NCT01943487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20555924|NCT01943487|Cholinergic Agents|cholinergic agents|mesh-ancestor
20555925|NCT01943487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20555926|NCT01943487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20555927|NCT01943487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20555928|NCT01943487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20555929|NCT01943487|Vasodilator Agents|vasodilator agents|mesh-ancestor
20555930|NCT01943526|Natalizumab|natalizumab|mesh-list
20555931|NCT01943526|Immunologic Factors|immunologic factors|mesh-ancestor
20555932|NCT01943526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555933|NCT01943617|Entecavir|entecavir|mesh-list
20555934|NCT01943617|Antiviral Agents|antiviral agents|mesh-ancestor
20555935|NCT01943617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20555936|NCT01943630|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
20555937|NCT01943630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20555938|NCT01943630|Immunologic Factors|immunologic factors|mesh-ancestor
20555939|NCT01943630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555940|NCT01943630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555941|NCT01943630|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20555942|NCT01943630|Protective Agents|protective agents|mesh-ancestor
20555943|NCT01943630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20555944|NCT01943630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19980931|NCT01901848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19980932|NCT01901848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980933|NCT01901848|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19980934|NCT01901848|Antidepressive Agents|antidepressive agents|mesh-ancestor
19980935|NCT01901848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19980936|NCT01901848|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19980937|NCT01901848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19980938|NCT01901848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19980939|NCT01901848|Dopamine Agents|dopamine agents|mesh-ancestor
19980940|NCT01901848|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19980941|NCT01901848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19980942|NCT01901848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980943|NCT01902004|Memantine|memantine|mesh-list
19980944|NCT01902004|Citalopram|citalopram|mesh-list
19980945|NCT01902004|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19980946|NCT01902004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19980947|NCT01902004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19980948|NCT01902004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980949|NCT01902004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19980950|NCT01902004|Serotonin Agents|serotonin agents|mesh-ancestor
19980951|NCT01902004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980952|NCT01902004|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19980953|NCT01902004|Antidepressive Agents|antidepressive agents|mesh-ancestor
19980954|NCT01902004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19980955|NCT01902004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19980956|NCT01902004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19980957|NCT01902004|Dopamine Agents|dopamine agents|mesh-ancestor
19980958|NCT01902004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19980959|NCT01902004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19453103|NCT03406689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19453104|NCT03406689|Analgesics|analgesics|mesh-ancestor
19453105|NCT03406689|Sensory System Agents|sensory system agents|mesh-ancestor
19453106|NCT03406689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19453107|NCT03406689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453108|NCT03406689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19453109|NCT03406689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19453110|NCT03406676|Methylene Blue|methylene blue|mesh-list
19453111|NCT03406676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453112|NCT03406676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736126|NCT04532918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19736127|NCT04532918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19736128|NCT04532918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19736129|NCT04532918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19736130|NCT04532918|Antimetabolites|antimetabolites|mesh-ancestor
19736131|NCT04532918|Gout Suppressants|gout suppressants|mesh-ancestor
19736132|NCT04532918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19736133|NCT04532918|Antioxidants|antioxidants|mesh-ancestor
19980960|NCT01902134|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19980961|NCT01902134|Tramadol|tramadol|mesh-list
19980962|NCT01902134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19980963|NCT01902134|Narcotics|narcotics|mesh-ancestor
19980964|NCT01902134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19980965|NCT01902134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980966|NCT01902134|Analgesics|analgesics|mesh-ancestor
19980967|NCT01902134|Sensory System Agents|sensory system agents|mesh-ancestor
19980968|NCT01902134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980969|NCT01902134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19980970|NCT01902134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19980971|NCT01902134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19980972|NCT01902134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19980973|NCT01902459|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19980974|NCT01902459|Hemostatics|hemostatics|mesh-ancestor
19980975|NCT01902459|Coagulants|coagulants|mesh-ancestor
19980976|NCT01902758|Ambrisentan|ambrisentan|mesh-list
19736134|NCT04532918|Protective Agents|protective agents|mesh-ancestor
19736135|NCT04532775|Methylprednisolone|methylprednisolone|mesh-list
19736136|NCT04532775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19736137|NCT04532775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19736138|NCT04532775|Prednisolone|prednisolone|mesh-list
19736139|NCT04532775|Prednisolone acetate|prednisolone acetate|mesh-list
19736140|NCT04532775|Magnesium Sulfate|magnesium sulfate|mesh-list
19736141|NCT04532775|Bupivacaine|bupivacaine|mesh-list
19736142|NCT04532775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19736143|NCT04532775|Prednisolone phosphate|prednisolone phosphate|mesh-list
19736144|NCT04532775|Anesthetics, Local|anesthetics, local|mesh-ancestor
19736145|NCT04532775|Anesthetics|anesthetics|mesh-ancestor
19736146|NCT04532775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19736147|NCT04532775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736148|NCT04532775|Sensory System Agents|sensory system agents|mesh-ancestor
19736149|NCT04532775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980977|NCT01902758|Theophylline|theophylline|mesh-list
19736150|NCT04532775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19736151|NCT04532775|Antiemetics|antiemetics|mesh-ancestor
19980978|NCT01902758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19980979|NCT01902758|Autonomic Agents|autonomic agents|mesh-ancestor
19980980|NCT01902758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19980981|NCT01902758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19980982|NCT01902758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19980983|NCT01902758|Respiratory System Agents|respiratory system agents|mesh-ancestor
19980984|NCT01902758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19980985|NCT01902758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19980986|NCT01902758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19980987|NCT01902758|Vasodilator Agents|vasodilator agents|mesh-ancestor
19980988|NCT01902758|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19980989|NCT01902758|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19980990|NCT01902758|Purinergic Agents|purinergic agents|mesh-ancestor
19980991|NCT01902758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19980992|NCT01902758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19980993|NCT01903005|Buprenorphine|buprenorphine|mesh-list
19980994|NCT01903005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19980995|NCT01903005|Naloxone|naloxone|mesh-list
19980996|NCT01903005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19980997|NCT01903005|Narcotics|narcotics|mesh-ancestor
19980998|NCT01903005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19980999|NCT01903005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981000|NCT01903005|Analgesics|analgesics|mesh-ancestor
19981001|NCT01903005|Sensory System Agents|sensory system agents|mesh-ancestor
19981002|NCT01903005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981003|NCT01903005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19981004|NCT01903031|Ritonavir|ritonavir|mesh-list
19981005|NCT01903031|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19981006|NCT01903031|Tenofovir|tenofovir|mesh-list
19981007|NCT01903031|Efavirenz|efavirenz|mesh-list
19981008|NCT01903031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
19981009|NCT01903031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19981010|NCT01903031|Etonogestrel|etonogestrel|mesh-list
19981011|NCT01903031|NuvaRing|nuvaring|mesh-list
19981012|NCT01903031|Estradiol|estradiol|mesh-list
19981013|NCT01903031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19981014|NCT01903031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19981015|NCT01903031|Protease Inhibitors|protease inhibitors|mesh-ancestor
19981016|NCT01903031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19981017|NCT01903031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981018|NCT01903031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19981019|NCT01903031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19981020|NCT01903031|Antiviral Agents|antiviral agents|mesh-ancestor
19981021|NCT01903031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19981022|NCT01903031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19981023|NCT01903031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19981024|NCT01903031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19981025|NCT01903031|Estrogens|estrogens|mesh-ancestor
19981026|NCT01903031|Hormones|hormones|mesh-ancestor
20555945|NCT01943630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20555946|NCT01943630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555947|NCT01943630|Antiviral Agents|antiviral agents|mesh-ancestor
20555948|NCT01943630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20555949|NCT01943760|Tramadol|tramadol|mesh-list
20555950|NCT01943760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20555951|NCT01943760|Narcotics|narcotics|mesh-ancestor
20555952|NCT01943760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20555953|NCT01943760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555954|NCT01943760|Analgesics|analgesics|mesh-ancestor
20555955|NCT01943760|Sensory System Agents|sensory system agents|mesh-ancestor
20555956|NCT01943760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981027|NCT01903031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19981028|NCT01903031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981029|NCT01903031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19981030|NCT01903031|Contraceptive Agents|contraceptive agents|mesh-ancestor
19981031|NCT01903031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19981032|NCT01903031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19981033|NCT01903031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19981034|NCT01903031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19981035|NCT01903031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19981036|NCT01903031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19981037|NCT01903031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19981038|NCT01903031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19981039|NCT01903031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19981040|NCT01903252|Mesalamine|mesalamine|mesh-list
19981041|NCT01903252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19981042|NCT01903252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19981043|NCT01903252|Analgesics|analgesics|mesh-ancestor
19981044|NCT01903252|Sensory System Agents|sensory system agents|mesh-ancestor
19981045|NCT01903252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981046|NCT01903252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981047|NCT01903252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19981048|NCT01903252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19981049|NCT01903265|Cyclobenzaprine|cyclobenzaprine|mesh-list
19981050|NCT01903265|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19981051|NCT01903265|Antidepressive Agents|antidepressive agents|mesh-ancestor
19981052|NCT01903265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19981053|NCT01903265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19981054|NCT01903265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981055|NCT01903265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19981056|NCT01903265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981057|NCT01903265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19981058|NCT01903265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19981059|NCT01903356|Linagliptin|linagliptin|mesh-list
19981060|NCT01903356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19981061|NCT01903356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981062|NCT01903356|Incretins|incretins|mesh-ancestor
19981063|NCT01903356|Hormones|hormones|mesh-ancestor
20288983|NCT05074355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19981064|NCT01903356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19981065|NCT01903356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19981066|NCT01903356|Protease Inhibitors|protease inhibitors|mesh-ancestor
19981067|NCT01903356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19981068|NCT01903356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981069|NCT01903434|Evacetrapib|evacetrapib|mesh-list
19981070|NCT01903434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19981071|NCT01903434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19981072|NCT01903434|Antimetabolites|antimetabolites|mesh-ancestor
19981073|NCT01903434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981074|NCT01903434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19981075|NCT01903720|Dexamethasone|dexamethasone|mesh-list
19981076|NCT01903720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19981077|NCT01903720|Antiemetics|antiemetics|mesh-ancestor
19981078|NCT01903720|Autonomic Agents|autonomic agents|mesh-ancestor
19981079|NCT01903720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981080|NCT01903720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981081|NCT01903720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19981082|NCT01903720|Glucocorticoids|glucocorticoids|mesh-ancestor
19981083|NCT01903720|Hormones|hormones|mesh-ancestor
19981084|NCT01903720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19981085|NCT01903720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19981086|NCT01903720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981087|NCT01903798|Mycophenolic Acid|mycophenolic acid|mesh-list
19981088|NCT01903798|Prednisolone|prednisolone|mesh-list
19981089|NCT01903798|Rilonacept|rilonacept|mesh-list
19981090|NCT01903798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19981091|NCT01903798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981092|NCT01903798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19981093|NCT01903798|Antitubercular Agents|antitubercular agents|mesh-ancestor
19981094|NCT01903798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19981095|NCT01903798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19981096|NCT01903798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19981097|NCT01903798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981098|NCT01903798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19981099|NCT01903798|Glucocorticoids|glucocorticoids|mesh-ancestor
19981100|NCT01903798|Hormones|hormones|mesh-ancestor
19981101|NCT01903798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19981102|NCT01903798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981103|NCT01903798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19981104|NCT01903811|Dexamethasone|dexamethasone|mesh-list
19981105|NCT01903811|Dexamethasone acetate|dexamethasone acetate|mesh-list
19981106|NCT01903811|Ichthammol|ichthammol|mesh-list
19981107|NCT01903811|BB 1101|bb 1101|mesh-list
19981108|NCT01903811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19981109|NCT01903811|Antiemetics|antiemetics|mesh-ancestor
19981110|NCT01903811|Autonomic Agents|autonomic agents|mesh-ancestor
19981111|NCT01903811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981112|NCT01903811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981113|NCT01903811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19981114|NCT01903811|Glucocorticoids|glucocorticoids|mesh-ancestor
19981115|NCT01903811|Hormones|hormones|mesh-ancestor
19981116|NCT01903811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19981117|NCT01903811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19981118|NCT01903811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981119|NCT01903811|Protease Inhibitors|protease inhibitors|mesh-ancestor
19981120|NCT01903811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19981121|NCT01903811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981122|NCT01903811|Dermatologic Agents|dermatologic agents|mesh-ancestor
19981123|NCT01903837|Naltrexone|naltrexone|mesh-list
19981124|NCT01903837|Olanzapine|olanzapine|mesh-list
19981125|NCT01903837|ALKS-33|alks-33|mesh-list
19981126|NCT01903837|Antiemetics|antiemetics|mesh-ancestor
19981127|NCT01903837|Autonomic Agents|autonomic agents|mesh-ancestor
19981128|NCT01903837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981129|NCT01903837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981130|NCT01903837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19981131|NCT01903837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19981132|NCT01903837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19981133|NCT01903837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19981134|NCT01903837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19981135|NCT01903837|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19981136|NCT01903837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19981137|NCT01903837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19981138|NCT01903837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981139|NCT01903837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19981140|NCT01903837|Serotonin Agents|serotonin agents|mesh-ancestor
19981141|NCT01903837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19981142|NCT01903837|Sensory System Agents|sensory system agents|mesh-ancestor
19981143|NCT01903837|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19981144|NCT01903993|Docetaxel|docetaxel|mesh-list
19981145|NCT01903993|Atezolizumab|atezolizumab|mesh-list
19981146|NCT01903993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981147|NCT01903993|Tubulin Modulators|tubulin modulators|mesh-ancestor
19981148|NCT01903993|Antimitotic Agents|antimitotic agents|mesh-ancestor
20555957|NCT01943786|Cetuximab|cetuximab|mesh-list
20555958|NCT01943786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20555959|NCT01943786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20555960|NCT01943812|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20555961|NCT01943812|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20555962|NCT01943812|Estradiol|estradiol|mesh-list
20555963|NCT01943812|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20555964|NCT01943812|Progesterone|progesterone|mesh-list
20555965|NCT01943812|Estrogens|estrogens|mesh-ancestor
20555966|NCT01943812|Hormones|hormones|mesh-ancestor
20555967|NCT01943812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20555968|NCT01943812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555969|NCT01943812|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20555970|NCT01943812|Contraceptive Agents|contraceptive agents|mesh-ancestor
20555971|NCT01943812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20555972|NCT01943812|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20555973|NCT01943812|Progestins|progestins|mesh-ancestor
20555974|NCT01943877|Propolis|propolis|mesh-list
20555975|NCT01943877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20555976|NCT01943942|Montelukast|montelukast|mesh-list
20555977|NCT01943942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20555978|NCT01943942|Respiratory System Agents|respiratory system agents|mesh-ancestor
20555979|NCT01943942|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20555980|NCT01943942|Hormone Antagonists|hormone antagonists|mesh-ancestor
20555981|NCT01943942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20555982|NCT01943942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555983|NCT01943942|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20555984|NCT01943942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20555985|NCT01943942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20555986|NCT01943994|Psilocybin|psilocybin|mesh-list
20555987|NCT01943994|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
20555988|NCT01943994|Nicotine|nicotine|mesh-list
20555989|NCT01943994|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20555990|NCT01943994|Autonomic Agents|autonomic agents|mesh-ancestor
20555991|NCT01943994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20555992|NCT01943994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20555993|NCT01943994|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20555994|NCT01943994|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20555995|NCT01943994|Cholinergic Agents|cholinergic agents|mesh-ancestor
19453113|NCT03406650|Durvalumab|durvalumab|mesh-list
20555996|NCT01943994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20555997|NCT01943994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981149|NCT01903993|Mitosis Modulators|mitosis modulators|mesh-ancestor
19981150|NCT01903993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981151|NCT01904058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19981152|NCT01904058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19981153|NCT01904058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19981154|NCT01904071|Morphine|morphine|mesh-list
19981155|NCT01904071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19981156|NCT01904071|Narcotics|narcotics|mesh-ancestor
19981157|NCT01904071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19981158|NCT01904071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981159|NCT01904071|Analgesics|analgesics|mesh-ancestor
19981160|NCT01904071|Sensory System Agents|sensory system agents|mesh-ancestor
19981161|NCT01904071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981162|NCT01904149|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19981163|NCT01904149|Tramadol|tramadol|mesh-list
19981164|NCT01904149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19981165|NCT01904149|Narcotics|narcotics|mesh-ancestor
19981166|NCT01904149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19981167|NCT01904149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981168|NCT01904149|Analgesics|analgesics|mesh-ancestor
19981169|NCT01904149|Sensory System Agents|sensory system agents|mesh-ancestor
19981170|NCT01904149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981171|NCT01904149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19981172|NCT01904149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19981173|NCT01904149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19981174|NCT01904149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19981175|NCT01904526|Guanfacine|guanfacine|mesh-list
19981176|NCT01904526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19981177|NCT01904526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19981178|NCT01904526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19981179|NCT01904526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19981180|NCT01904526|Adrenergic Agents|adrenergic agents|mesh-ancestor
19981181|NCT01904526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19981182|NCT01904526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981183|NCT01904526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981184|NCT01904721|Bimatoprost|bimatoprost|mesh-list
19981185|NCT01904721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19981186|NCT01904721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19981187|NCT01904760|Dexmedetomidine|dexmedetomidine|mesh-list
19981188|NCT01904760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19981189|NCT01904760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19981190|NCT01904760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981191|NCT01904760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19981192|NCT01904760|Analgesics|analgesics|mesh-ancestor
19981193|NCT01904760|Sensory System Agents|sensory system agents|mesh-ancestor
19981194|NCT01904760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981195|NCT01904760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19981196|NCT01904760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19736152|NCT04532775|Autonomic Agents|autonomic agents|mesh-ancestor
19736153|NCT04532775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19736154|NCT04532775|Glucocorticoids|glucocorticoids|mesh-ancestor
19736155|NCT04532775|Hormones|hormones|mesh-ancestor
19736156|NCT04532775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19736157|NCT04532775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19736158|NCT04532775|Protective Agents|protective agents|mesh-ancestor
19736159|NCT04532775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19736160|NCT04532775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736161|NCT04532775|Analgesics|analgesics|mesh-ancestor
19736162|NCT04532775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19736163|NCT04532775|Anticonvulsants|anticonvulsants|mesh-ancestor
19736164|NCT04532775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19736165|NCT04532775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19736166|NCT04532775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736167|NCT04532775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19736168|NCT04532775|Tocolytic Agents|tocolytic agents|mesh-ancestor
19736169|NCT04532775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19736170|NCT04532671|Ether|ether|mesh-list
19736171|NCT04532671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19736172|NCT04532671|Anesthetics, General|anesthetics, general|mesh-ancestor
19736173|NCT04532671|Anesthetics|anesthetics|mesh-ancestor
19736174|NCT04532671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19981197|NCT01904760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19981198|NCT01904760|Adrenergic Agents|adrenergic agents|mesh-ancestor
19981199|NCT01904760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19981200|NCT01904760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981201|NCT01904864|Iron|iron|mesh-list
19981202|NCT01904864|Micronutrients|micronutrients|mesh-ancestor
19981203|NCT01904864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981204|NCT01904864|Trace Elements|trace elements|mesh-ancestor
19981205|NCT01905423|Albendazole|albendazole|mesh-list
19981206|NCT01905423|Diethylcarbamazine|diethylcarbamazine|mesh-list
19981207|NCT01905423|Piperazine|piperazine|mesh-list
19981208|NCT01905423|Mebendazole|mebendazole|mesh-list
19981209|NCT01905423|Piperazine citrate|piperazine citrate|mesh-list
19981210|NCT01905423|Citric Acid|citric acid|mesh-list
19981211|NCT01905423|Sodium Citrate|sodium citrate|mesh-list
19981212|NCT01905423|DMP 777|dmp 777|mesh-list
19981213|NCT01905423|Anticoagulants|anticoagulants|mesh-ancestor
19981214|NCT01905423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19981215|NCT01905423|Chelating Agents|chelating agents|mesh-ancestor
19981216|NCT01905423|Sequestering Agents|sequestering agents|mesh-ancestor
19981217|NCT01905423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981218|NCT01905423|Anthelmintics|anthelmintics|mesh-ancestor
19981219|NCT01905423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19981220|NCT01905423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19981221|NCT01905423|Anticestodal Agents|anticestodal agents|mesh-ancestor
19981222|NCT01905423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19981223|NCT01905423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19981224|NCT01905423|Tubulin Modulators|tubulin modulators|mesh-ancestor
19981225|NCT01905423|Antimitotic Agents|antimitotic agents|mesh-ancestor
19981226|NCT01905423|Mitosis Modulators|mitosis modulators|mesh-ancestor
19981227|NCT01905423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981228|NCT01905423|Filaricides|filaricides|mesh-ancestor
19981229|NCT01905423|Antinematodal Agents|antinematodal agents|mesh-ancestor
19981230|NCT01905423|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19981231|NCT01905423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19981232|NCT01905592|Niraparib|niraparib|mesh-list
19981233|NCT01905592|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19981234|NCT01905592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19981235|NCT01905592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981236|NCT01905592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981237|NCT01905657|Docetaxel|docetaxel|mesh-list
19981238|NCT01905657|Pembrolizumab|pembrolizumab|mesh-list
19981239|NCT01905657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981240|NCT01905657|Tubulin Modulators|tubulin modulators|mesh-ancestor
19981241|NCT01905657|Antimitotic Agents|antimitotic agents|mesh-ancestor
19981242|NCT01905657|Mitosis Modulators|mitosis modulators|mesh-ancestor
19981243|NCT01905657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981244|NCT01905657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19981245|NCT01905683|Botulinum Toxins|botulinum toxins|mesh-list
19981246|NCT01905683|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19981247|NCT01905683|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19981248|NCT01905683|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19981249|NCT01905683|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19981250|NCT01905683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19981251|NCT01905683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981252|NCT01905683|Cholinergic Agents|cholinergic agents|mesh-ancestor
19981253|NCT01905683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19981254|NCT01905683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981255|NCT01905683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19981256|NCT01905683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981257|NCT01905943|Cyclophosphamide|cyclophosphamide|mesh-list
19981258|NCT01905943|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19981259|NCT01905943|Chlorambucil|chlorambucil|mesh-list
19981260|NCT01905943|Fludarabine|fludarabine|mesh-list
19981261|NCT01905943|Obinutuzumab|obinutuzumab|mesh-list
19981262|NCT01905943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19981263|NCT01905943|Immunologic Factors|immunologic factors|mesh-ancestor
19981264|NCT01905943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981265|NCT01905943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19981266|NCT01905943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19981267|NCT01905943|Alkylating Agents|alkylating agents|mesh-ancestor
19981268|NCT01905943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981269|NCT01905943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981270|NCT01905943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19981271|NCT01905943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19981272|NCT01906008|Minocycline|minocycline|mesh-list
19981273|NCT01906008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19981274|NCT01906008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19981275|NCT01906346|Cocaine|cocaine|mesh-list
19981276|NCT01906346|Anesthetics, Local|anesthetics, local|mesh-ancestor
19981277|NCT01906346|Anesthetics|anesthetics|mesh-ancestor
19981278|NCT01906346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19981279|NCT01906346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981280|NCT01906346|Sensory System Agents|sensory system agents|mesh-ancestor
19981281|NCT01906346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981282|NCT01906346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19981283|NCT01906346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19981284|NCT01906346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19981285|NCT01906346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19981286|NCT01906346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981287|NCT01906346|Dopamine Agents|dopamine agents|mesh-ancestor
19981288|NCT01906346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19981289|NCT01906372|Hormones|hormones|mesh-list
19981290|NCT01906372|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19981291|NCT01906372|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19981292|NCT01906372|beta-Endorphin|beta-endorphin|mesh-list
19981293|NCT01906372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19981294|NCT01906372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981295|NCT01906372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19981296|NCT01906372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981297|NCT01906658|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19981298|NCT01906658|Hormones|hormones|mesh-ancestor
19981299|NCT01906658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19981300|NCT01906658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981301|NCT01906866|Melatonin|melatonin|mesh-list
19981302|NCT01906866|Antioxidants|antioxidants|mesh-ancestor
19981303|NCT01906866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981304|NCT01906866|Protective Agents|protective agents|mesh-ancestor
19981305|NCT01906866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981306|NCT01906866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19981307|NCT01907100|Cisplatin|cisplatin|mesh-list
19981308|NCT01907100|Pemetrexed|pemetrexed|mesh-list
19981309|NCT01907100|Nintedanib|nintedanib|mesh-list
19981310|NCT01907100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981311|NCT01907100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19981312|NCT01907100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981313|NCT01907100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19981314|NCT01907100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19981315|NCT01907100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19981316|NCT01907113|Empagliflozin|empagliflozin|mesh-list
19981317|NCT01907113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19981318|NCT01907113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981319|NCT01907113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19981320|NCT01907113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981321|NCT01907217|Methohexital|methohexital|mesh-list
19981322|NCT01907217|Succinylcholine|succinylcholine|mesh-list
19981323|NCT01907217|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19981324|NCT01907217|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19981325|NCT01907217|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19981326|NCT01907217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981327|NCT01907217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981328|NCT01907217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19981329|NCT01907217|Anesthetics, General|anesthetics, general|mesh-ancestor
19981330|NCT01907217|Anesthetics|anesthetics|mesh-ancestor
19981331|NCT01907217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19981332|NCT01907321|Capsaicin|capsaicin|mesh-list
19981333|NCT01907321|Antipruritics|antipruritics|mesh-ancestor
19981334|NCT01907321|Dermatologic Agents|dermatologic agents|mesh-ancestor
19981335|NCT01907321|Sensory System Agents|sensory system agents|mesh-ancestor
19981336|NCT01907321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981337|NCT01907321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981338|NCT01907334|Fluticasone|fluticasone|mesh-list
19981339|NCT01907334|Xhance|xhance|mesh-list
19981340|NCT01907334|Albuterol|albuterol|mesh-list
19981341|NCT01907334|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19981342|NCT01907334|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19981343|NCT01907334|Methacholine Chloride|methacholine chloride|mesh-list
19981344|NCT01907334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19981345|NCT01907334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19453114|NCT03406650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19453115|NCT03406650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981346|NCT01907334|Autonomic Agents|autonomic agents|mesh-ancestor
19453116|NCT03406546|Dexmedetomidine|dexmedetomidine|mesh-list
19981347|NCT01907334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981348|NCT01907334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981349|NCT01907334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20288984|NCT05074355|Antimetabolites|antimetabolites|mesh-ancestor
20288985|NCT05074355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288986|NCT05074355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288987|NCT05074355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288988|NCT05063565|Durvalumab|durvalumab|mesh-list
20288989|NCT05063565|Tremelimumab|tremelimumab|mesh-list
19981350|NCT01907334|Respiratory System Agents|respiratory system agents|mesh-ancestor
19981351|NCT01907334|Dermatologic Agents|dermatologic agents|mesh-ancestor
19981352|NCT01907334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19981353|NCT01907334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19981354|NCT01907334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19981355|NCT01907334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19981356|NCT01907334|Adrenergic Agents|adrenergic agents|mesh-ancestor
19981357|NCT01907334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19981358|NCT01907334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981359|NCT01907334|Tocolytic Agents|tocolytic agents|mesh-ancestor
19981360|NCT01907334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19981361|NCT01907334|Glucocorticoids|glucocorticoids|mesh-ancestor
19981362|NCT01907334|Hormones|hormones|mesh-ancestor
19981363|NCT01907334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19981364|NCT01907334|Sympathomimetics|sympathomimetics|mesh-ancestor
19981365|NCT01907334|Miotics|miotics|mesh-ancestor
19981366|NCT01907334|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19981367|NCT01907334|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
19981368|NCT01907334|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19981369|NCT01907334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19981370|NCT01907334|Cholinergic Agents|cholinergic agents|mesh-ancestor
19981371|NCT01907490|Benzyl Alcohol|benzyl alcohol|mesh-list
19981372|NCT01907490|Anesthetics, Local|anesthetics, local|mesh-ancestor
19981373|NCT01907490|Anesthetics|anesthetics|mesh-ancestor
19981374|NCT01907490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19981375|NCT01907490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981376|NCT01907490|Sensory System Agents|sensory system agents|mesh-ancestor
19981377|NCT01907490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981378|NCT01907607|Palbociclib|palbociclib|mesh-list
19981379|NCT01907607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981380|NCT01907607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19981381|NCT01907607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19981382|NCT01907607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981383|NCT01907815|Trametinib|trametinib|mesh-list
19981384|NCT01907815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981385|NCT01907815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19981386|NCT01907815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19981387|NCT01907815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981388|NCT01907854|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19981389|NCT01907854|Liraglutide|liraglutide|mesh-list
19981390|NCT01907854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19981391|NCT01907854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981392|NCT01907854|Incretins|incretins|mesh-ancestor
19981393|NCT01907854|Hormones|hormones|mesh-ancestor
19981394|NCT01907854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19981395|NCT01907854|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19981396|NCT01907854|Protease Inhibitors|protease inhibitors|mesh-ancestor
19981397|NCT01907854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19981398|NCT01907854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981399|NCT01908062|Naltrexone|naltrexone|mesh-list
19981400|NCT01908062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19981401|NCT01908062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19981402|NCT01908062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981403|NCT01908062|Sensory System Agents|sensory system agents|mesh-ancestor
19453117|NCT03406546|Remifentanil|remifentanil|mesh-list
19981404|NCT01908062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981405|NCT01908101|Halichondrin B|halichondrin b|mesh-list
19981406|NCT01908101|Tubulin Modulators|tubulin modulators|mesh-ancestor
19981407|NCT01908101|Antimitotic Agents|antimitotic agents|mesh-ancestor
19981408|NCT01908101|Mitosis Modulators|mitosis modulators|mesh-ancestor
19981409|NCT01908101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981410|NCT01908101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981411|NCT01908127|Salicylic Acid|salicylic acid|mesh-list
19981412|NCT01908127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19981413|NCT01908127|Antifungal Agents|antifungal agents|mesh-ancestor
19981414|NCT01908127|Keratolytic Agents|keratolytic agents|mesh-ancestor
19981415|NCT01908127|Dermatologic Agents|dermatologic agents|mesh-ancestor
19981416|NCT01908140|Fluticasone|fluticasone|mesh-list
19981417|NCT01908140|Bromides|bromides|mesh-list
19981418|NCT01908140|Formoterol Fumarate|formoterol fumarate|mesh-list
19981419|NCT01908140|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19981420|NCT01908140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19981421|NCT01908140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19981422|NCT01908140|Autonomic Agents|autonomic agents|mesh-ancestor
20288990|NCT05063565|Immunologic Factors|immunologic factors|mesh-list
19981423|NCT01908140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981424|NCT01908140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981425|NCT01908140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19981426|NCT01908140|Respiratory System Agents|respiratory system agents|mesh-ancestor
19981427|NCT01908140|Dermatologic Agents|dermatologic agents|mesh-ancestor
19981428|NCT01908140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19981429|NCT01908140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19981430|NCT01908140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19981431|NCT01908140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19981432|NCT01908140|Adrenergic Agents|adrenergic agents|mesh-ancestor
19981433|NCT01908140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19981434|NCT01908140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981435|NCT01908140|Anticonvulsants|anticonvulsants|mesh-ancestor
19981436|NCT01908205|Oxytocin|oxytocin|mesh-list
19981437|NCT01908205|Oxytocics|oxytocics|mesh-ancestor
19981438|NCT01908205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19981439|NCT01908205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981440|NCT01908582|Rifampin|rifampin|mesh-list
19981441|NCT01908582|Evacetrapib|evacetrapib|mesh-list
19981442|NCT01908582|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19981443|NCT01908582|Antitubercular Agents|antitubercular agents|mesh-ancestor
19981444|NCT01908582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19981445|NCT01908582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19981446|NCT01908582|Leprostatic Agents|leprostatic agents|mesh-ancestor
19981447|NCT01908582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19981448|NCT01908582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19981449|NCT01908582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981450|NCT01908582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19981451|NCT01908582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19981452|NCT01908582|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19981453|NCT01908582|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19981454|NCT01908582|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19981455|NCT01908582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19981456|NCT01908582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19981457|NCT01908582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19981458|NCT01908582|Antimetabolites|antimetabolites|mesh-ancestor
19981459|NCT01908582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19981460|NCT01908699|Beraprost|beraprost|mesh-list
19981461|NCT01908699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19981462|NCT01908699|Vasodilator Agents|vasodilator agents|mesh-ancestor
19981463|NCT01908751|Vitamin D|vitamin d|mesh-list
19981464|NCT01908751|Ergocalciferols|ergocalciferols|mesh-list
19981465|NCT01908751|Vitamins|vitamins|mesh-list
19981466|NCT01908751|Micronutrients|micronutrients|mesh-ancestor
19981467|NCT01908751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981468|NCT01908751|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19981469|NCT01908751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20288991|NCT05063565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20288992|NCT05063565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288993|NCT05063565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20288994|NCT05053971|Entinostat|entinostat|mesh-list
20288995|NCT05053971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
20288996|NCT05053971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20288997|NCT05053971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20288998|NCT05053971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20288999|NCT05053334|Omalizumab|omalizumab|mesh-list
20289000|NCT05053334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20289001|NCT05053334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20289002|NCT05053334|Respiratory System Agents|respiratory system agents|mesh-ancestor
20289003|NCT05048212|Nivolumab|nivolumab|mesh-list
20289004|NCT05048212|Ipilimumab|ipilimumab|mesh-list
20289005|NCT05048212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20289006|NCT05048212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289007|NCT05048212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20289008|NCT05048212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289009|NCT05037045|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20289010|NCT05037045|Incretins|incretins|mesh-ancestor
20289011|NCT05037045|Hormones|hormones|mesh-ancestor
20289012|NCT05037045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19981470|NCT01908803|Ciprofloxacin|ciprofloxacin|mesh-list
19981471|NCT01908803|Dexamethasone|dexamethasone|mesh-list
19981472|NCT01908803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19981473|NCT01908803|Antiemetics|antiemetics|mesh-ancestor
19981474|NCT01908803|Autonomic Agents|autonomic agents|mesh-ancestor
19981475|NCT01908803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981476|NCT01908803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981477|NCT01908803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19981478|NCT01908803|Glucocorticoids|glucocorticoids|mesh-ancestor
19981479|NCT01908803|Hormones|hormones|mesh-ancestor
19981480|NCT01908803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19981481|NCT01908803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19981482|NCT01908803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981483|NCT01908803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19981484|NCT01908803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19981485|NCT01908803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20555998|NCT01943994|Hallucinogens|hallucinogens|mesh-ancestor
20555999|NCT01943994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20556000|NCT01943994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20556001|NCT01943994|Serotonin Agents|serotonin agents|mesh-ancestor
20556002|NCT01943994|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20556003|NCT01944033|Terbutaline|terbutaline|mesh-list
19981486|NCT01908803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20556004|NCT01944033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20556005|NCT01944033|Autonomic Agents|autonomic agents|mesh-ancestor
20556006|NCT01944033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19453118|NCT03406546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19453119|NCT03406546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19453120|NCT03406546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453121|NCT03406546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19453122|NCT03406546|Analgesics|analgesics|mesh-ancestor
19453123|NCT03406546|Sensory System Agents|sensory system agents|mesh-ancestor
19453124|NCT03406546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19453125|NCT03406546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19453126|NCT03406546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19453127|NCT03406546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19453128|NCT03406546|Adrenergic Agents|adrenergic agents|mesh-ancestor
19453129|NCT03406546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19453130|NCT03406546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453131|NCT03406546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19453132|NCT03406546|Narcotics|narcotics|mesh-ancestor
19453133|NCT03406533|Fentanyl|fentanyl|mesh-list
19453134|NCT03406533|Midazolam|midazolam|mesh-list
19453135|NCT03406533|Dexmedetomidine|dexmedetomidine|mesh-list
19453136|NCT03406533|Remifentanil|remifentanil|mesh-list
19453137|NCT03406533|Propofol|propofol|mesh-list
19453138|NCT03406533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19453139|NCT03406533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19453140|NCT03406533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453141|NCT03406533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19453142|NCT03406533|Anesthetics, General|anesthetics, general|mesh-ancestor
19453143|NCT03406533|Anesthetics|anesthetics|mesh-ancestor
19453144|NCT03406533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19453145|NCT03406533|Analgesics|analgesics|mesh-ancestor
19453146|NCT03406533|Sensory System Agents|sensory system agents|mesh-ancestor
19453147|NCT03406533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19453148|NCT03406533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19453149|NCT03406533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19453150|NCT03406533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19453151|NCT03406533|Adrenergic Agents|adrenergic agents|mesh-ancestor
19453152|NCT03406533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19453153|NCT03406533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453154|NCT03406533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19981487|NCT01908803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19981488|NCT01908803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981489|NCT01908803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19981490|NCT01908803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19981491|NCT01908816|Ranibizumab|ranibizumab|mesh-list
19981492|NCT01908816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19981493|NCT01908816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19981494|NCT01908816|Growth Substances|growth substances|mesh-ancestor
19981495|NCT01908816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981496|NCT01908816|Growth Inhibitors|growth inhibitors|mesh-ancestor
19981497|NCT01908816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981498|NCT01908829|Solifenacin Succinate|solifenacin succinate|mesh-list
19981499|NCT01908829|Mirabegron|mirabegron|mesh-list
19981500|NCT01908829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19981501|NCT01908829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19981502|NCT01908829|Cholinergic Agents|cholinergic agents|mesh-ancestor
19981503|NCT01908829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19981504|NCT01908829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981505|NCT01908829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981506|NCT01908829|Urological Agents|urological agents|mesh-ancestor
19981507|NCT01908829|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19981508|NCT01908829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19981509|NCT01908829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19981510|NCT01908829|Adrenergic Agents|adrenergic agents|mesh-ancestor
19981511|NCT01908842|Buprenorphine|buprenorphine|mesh-list
19981512|NCT01908842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19981513|NCT01908842|Narcotics|narcotics|mesh-ancestor
19981514|NCT01908842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19981515|NCT01908842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981516|NCT01908842|Analgesics|analgesics|mesh-ancestor
19981517|NCT01908842|Sensory System Agents|sensory system agents|mesh-ancestor
19981518|NCT01908842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981519|NCT01908842|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19981520|NCT01908972|Prednisolone|prednisolone|mesh-list
19981521|NCT01908972|Propranolol|propranolol|mesh-list
19981522|NCT01908972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19981523|NCT01908972|Glucocorticoids|glucocorticoids|mesh-ancestor
19981524|NCT01908972|Hormones|hormones|mesh-ancestor
19981525|NCT01908972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19981526|NCT01908972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981527|NCT01908972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19981528|NCT01908972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981529|NCT01908972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19981530|NCT01908972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19981531|NCT01908972|Adrenergic Agents|adrenergic agents|mesh-ancestor
19981532|NCT01908972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19981533|NCT01908972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981534|NCT01908972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19981535|NCT01908972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19981536|NCT01908972|Vasodilator Agents|vasodilator agents|mesh-ancestor
19981537|NCT01909141|Metformin|metformin|mesh-list
19981538|NCT01909141|Pioglitazone|pioglitazone|mesh-list
19981539|NCT01909141|Carbamide Peroxide|carbamide peroxide|mesh-list
19981540|NCT01909141|Letrozole|letrozole|mesh-list
19981541|NCT01909141|Clomiphene|clomiphene|mesh-list
19981542|NCT01909141|Enclomiphene|enclomiphene|mesh-list
19981543|NCT01909141|Zuclomiphene|zuclomiphene|mesh-list
19981544|NCT01909141|Hormones|hormones|mesh-list
19981545|NCT01909141|Estradiol|estradiol|mesh-list
19981546|NCT01909141|Testosterone|testosterone|mesh-list
19981547|NCT01909141|Progesterone|progesterone|mesh-list
19981548|NCT01909141|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19981549|NCT01909141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19981550|NCT01909141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981551|NCT01909141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981552|NCT01909141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19981553|NCT01909141|Estrogens|estrogens|mesh-ancestor
20556007|NCT01944033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556008|NCT01944033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20556009|NCT01944033|Respiratory System Agents|respiratory system agents|mesh-ancestor
20556010|NCT01944033|Sympathomimetics|sympathomimetics|mesh-ancestor
20556011|NCT01944033|Tocolytic Agents|tocolytic agents|mesh-ancestor
20556012|NCT01944033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19981554|NCT01909141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19981555|NCT01909141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981556|NCT01909141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19981557|NCT01909141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19981558|NCT01909141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19981559|NCT01909141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19981560|NCT01909141|Hormone Antagonists|hormone antagonists|mesh-ancestor
19981561|NCT01909141|Androgens|androgens|mesh-ancestor
19981562|NCT01909141|Progestins|progestins|mesh-ancestor
19981563|NCT01909141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19981564|NCT01909141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19981565|NCT01909141|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19981566|NCT01909141|Fertility Agents|fertility agents|mesh-ancestor
19981567|NCT01909141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19981568|NCT01909141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19981569|NCT01909336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19981570|NCT01909466|Aripiprazole|aripiprazole|mesh-list
19981571|NCT01909466|Antidepressive Agents|antidepressive agents|mesh-ancestor
19981572|NCT01909466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19981573|NCT01909466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19981574|NCT01909466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19981575|NCT01909466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19981576|NCT01909466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981577|NCT01909466|Dopamine Agonists|dopamine agonists|mesh-ancestor
19981578|NCT01909466|Dopamine Agents|dopamine agents|mesh-ancestor
19981579|NCT01909466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19981580|NCT01909466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981581|NCT01909466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19981582|NCT01909466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19981583|NCT01909466|Serotonin Agents|serotonin agents|mesh-ancestor
19981584|NCT01909466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19981585|NCT01909466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19981586|NCT01909466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19981587|NCT01909466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19981588|NCT01909791|Bevacizumab|bevacizumab|mesh-list
19981589|NCT01909791|Aflibercept|aflibercept|mesh-list
19981590|NCT01909791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19981591|NCT01909791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981592|NCT01909791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19981593|NCT01909791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19981594|NCT01909791|Growth Substances|growth substances|mesh-ancestor
19981595|NCT01909791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981596|NCT01909791|Growth Inhibitors|growth inhibitors|mesh-ancestor
19981597|NCT01909804|Ribavirin|ribavirin|mesh-list
19981598|NCT01909804|Antiviral Agents|antiviral agents|mesh-ancestor
19981599|NCT01909804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19981600|NCT01909804|Antimetabolites|antimetabolites|mesh-ancestor
19981601|NCT01909804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981602|NCT01910064|Adapalene|adapalene|mesh-list
19981603|NCT01910064|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19981604|NCT01910064|Dermatologic Agents|dermatologic agents|mesh-ancestor
19981605|NCT01910064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19981606|NCT01910064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19981607|NCT01910064|Analgesics|analgesics|mesh-ancestor
19981608|NCT01910064|Sensory System Agents|sensory system agents|mesh-ancestor
19981609|NCT01910064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981610|NCT01910064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981611|NCT01910064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19981612|NCT01910064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19981613|NCT01910181|Vemurafenib|vemurafenib|mesh-list
19981614|NCT01910181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981615|NCT01910181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19981616|NCT01910181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19981617|NCT01910181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981618|NCT01910311|Rifampin|rifampin|mesh-list
19981619|NCT01910311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19981620|NCT01910311|Antitubercular Agents|antitubercular agents|mesh-ancestor
19981621|NCT01910311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19981622|NCT01910311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19981623|NCT01910311|Leprostatic Agents|leprostatic agents|mesh-ancestor
19981624|NCT01910311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19981625|NCT01910311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19981626|NCT01910311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981627|NCT01910311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19981628|NCT01910311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19981629|NCT01910311|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19981630|NCT01910311|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19981631|NCT01910311|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19981632|NCT01910311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19981633|NCT01910519|Vaccines|vaccines|mesh-list
19981634|NCT01910519|Immunologic Factors|immunologic factors|mesh-ancestor
19981635|NCT01910519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981636|NCT01910636|Sofosbuvir|sofosbuvir|mesh-list
19981637|NCT01910636|Antiviral Agents|antiviral agents|mesh-ancestor
19981638|NCT01910636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19981639|NCT01911065|Vaccines|vaccines|mesh-list
19981640|NCT01911065|Immunologic Factors|immunologic factors|mesh-ancestor
19981641|NCT01911065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981642|NCT01911169|Vitamin D|vitamin d|mesh-list
19981643|NCT01911169|Cholecalciferol|cholecalciferol|mesh-list
19981644|NCT01911169|Vitamins|vitamins|mesh-list
19981645|NCT01911169|Micronutrients|micronutrients|mesh-ancestor
19981646|NCT01911169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981647|NCT01911169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19981648|NCT01911169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19981649|NCT01911260|Chelating Agents|chelating agents|mesh-list
19981650|NCT01911260|Sequestering Agents|sequestering agents|mesh-ancestor
19981651|NCT01911260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981652|NCT01911351|Nitrous Oxide|nitrous oxide|mesh-list
19981653|NCT01911351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19981654|NCT01911351|Anesthetics, General|anesthetics, general|mesh-ancestor
19981655|NCT01911351|Anesthetics|anesthetics|mesh-ancestor
19981656|NCT01911351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19981657|NCT01911351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981658|NCT01911351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19981659|NCT01911351|Analgesics|analgesics|mesh-ancestor
19981660|NCT01911351|Sensory System Agents|sensory system agents|mesh-ancestor
19981661|NCT01911351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981662|NCT01911429|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19981663|NCT01911429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19981664|NCT01911429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19981665|NCT01911429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19981666|NCT01911429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981667|NCT01911429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19981668|NCT01911429|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19981669|NCT01911429|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19981670|NCT01911429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19981671|NCT01911429|Adrenergic Agents|adrenergic agents|mesh-ancestor
19981672|NCT01911429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19981673|NCT01911429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981674|NCT01911429|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19981675|NCT01911429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19981676|NCT01911429|Serotonin Agents|serotonin agents|mesh-ancestor
19981677|NCT01911429|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19981678|NCT01911429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19981679|NCT01911429|Dopamine Agents|dopamine agents|mesh-ancestor
19981680|NCT01911442|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19981681|NCT01911442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19981682|NCT01911442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19981683|NCT01911442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19981684|NCT01911442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981685|NCT01911442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19981686|NCT01911442|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19981687|NCT01911442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19981688|NCT01911442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19981689|NCT01911442|Adrenergic Agents|adrenergic agents|mesh-ancestor
19981690|NCT01911442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19981691|NCT01911442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981692|NCT01911442|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19981693|NCT01911442|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19981694|NCT01911442|Serotonin Agents|serotonin agents|mesh-ancestor
19981695|NCT01911442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19981696|NCT01911442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19981697|NCT01911442|Dopamine Agents|dopamine agents|mesh-ancestor
19981698|NCT01911546|Everolimus|everolimus|mesh-list
19981699|NCT01911546|Tacrolimus|tacrolimus|mesh-list
19981700|NCT01911546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19981701|NCT01911546|Immunologic Factors|immunologic factors|mesh-ancestor
19981702|NCT01911546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981703|NCT01911546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19981704|NCT01911546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19981705|NCT01911546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981706|NCT01911546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981707|NCT01911780|Amlodipine|amlodipine|mesh-list
19981708|NCT01911780|Telmisartan|telmisartan|mesh-list
19981709|NCT01911780|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19981710|NCT01911780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19981711|NCT01911780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19981712|NCT01911780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19981713|NCT01911780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981714|NCT01911780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19981715|NCT01911780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556013|NCT01944033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20556014|NCT01944033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20556015|NCT01944033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20556016|NCT01944033|Adrenergic Agents|adrenergic agents|mesh-ancestor
20556017|NCT01944033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20556018|NCT01944033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556019|NCT01944085|Acetaminophen|acetaminophen|mesh-list
20556020|NCT01944085|Ascorbic Acid|ascorbic acid|mesh-list
20556021|NCT01944085|Ibuprofen|ibuprofen|mesh-list
20556022|NCT01944085|Vitamins|vitamins|mesh-ancestor
20556023|NCT01944085|Micronutrients|micronutrients|mesh-ancestor
20556024|NCT01944085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556025|NCT01944085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20556026|NCT01944085|Analgesics|analgesics|mesh-ancestor
20556027|NCT01944085|Sensory System Agents|sensory system agents|mesh-ancestor
20556028|NCT01944085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556029|NCT01944085|Antipyretics|antipyretics|mesh-ancestor
20556030|NCT01944085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19981716|NCT01911780|Vasodilator Agents|vasodilator agents|mesh-ancestor
19981717|NCT01911780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19981718|NCT01911780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19981719|NCT01911780|Diuretics|diuretics|mesh-ancestor
19981720|NCT01911780|Natriuretic Agents|natriuretic agents|mesh-ancestor
19981721|NCT01911780|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19981722|NCT01911845|Ribavirin|ribavirin|mesh-list
19981723|NCT01911845|Antimetabolites|antimetabolites|mesh-ancestor
19981724|NCT01911845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981725|NCT01911845|Antiviral Agents|antiviral agents|mesh-ancestor
19981726|NCT01911845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19981727|NCT01912222|Ixazomib|ixazomib|mesh-list
19981728|NCT01912222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981729|NCT01912222|Protease Inhibitors|protease inhibitors|mesh-ancestor
19981730|NCT01912222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19981731|NCT01912222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981732|NCT01912274|Azacitidine|azacitidine|mesh-list
19981733|NCT01912274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19981734|NCT01912274|Antimetabolites|antimetabolites|mesh-ancestor
19981735|NCT01912274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453155|NCT03406533|Narcotics|narcotics|mesh-ancestor
19453156|NCT03406533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19453157|NCT03406533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19453158|NCT03406533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19453159|NCT03406533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19453160|NCT03406533|GABA Modulators|gaba modulators|mesh-ancestor
19453161|NCT03406533|GABA Agents|gaba agents|mesh-ancestor
19453162|NCT03406520|Chlorhexidine|chlorhexidine|mesh-list
19453163|NCT03406520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19453164|NCT03406520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19453165|NCT03406520|Disinfectants|disinfectants|mesh-ancestor
19453166|NCT03406403|Anesthetics|anesthetics|mesh-list
19453167|NCT03406403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19453168|NCT03406403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453169|NCT03406299|Leucovorin|leucovorin|mesh-list
19453170|NCT03406299|Gemcitabine|gemcitabine|mesh-list
19453171|NCT03406299|Oxaliplatin|oxaliplatin|mesh-list
19453172|NCT03406299|Tegafur|tegafur|mesh-list
19453173|NCT03406299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981736|NCT01912274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981737|NCT01912274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19981738|NCT01912352|Methylphenidate|methylphenidate|mesh-list
19981739|NCT01912352|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19981740|NCT01912352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981741|NCT01912352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19981742|NCT01912352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19981743|NCT01912352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19981744|NCT01912352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981745|NCT01912352|Dopamine Agents|dopamine agents|mesh-ancestor
19981746|NCT01912352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19981747|NCT01912456|Complement C1s|complement c1s|mesh-list
19981748|NCT01912456|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19453174|NCT03406299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19453175|NCT03406299|Antimetabolites|antimetabolites|mesh-ancestor
19453176|NCT03406299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453177|NCT03406299|Antiviral Agents|antiviral agents|mesh-ancestor
19453178|NCT03406299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19453179|NCT03406299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453180|NCT03406299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19453181|NCT03406299|Immunologic Factors|immunologic factors|mesh-ancestor
19981749|NCT01912456|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
19981750|NCT01912456|Immunologic Factors|immunologic factors|mesh-ancestor
19981751|NCT01912456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453182|NCT03406299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981752|NCT01912456|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19981753|NCT01912456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19981754|NCT01912612|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19981755|NCT01912612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19981756|NCT01912612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19981757|NCT01912612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19981758|NCT01912612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981759|NCT01912612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19981760|NCT01912612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981761|NCT01912612|Analgesics|analgesics|mesh-ancestor
19981762|NCT01912612|Sensory System Agents|sensory system agents|mesh-ancestor
19981763|NCT01912612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19736175|NCT04532671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736176|NCT04532684|Pregabalin|pregabalin|mesh-list
19736177|NCT04532684|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19981764|NCT01912612|Antidepressive Agents|antidepressive agents|mesh-ancestor
19981765|NCT01912612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19981766|NCT01912612|Dopamine Agents|dopamine agents|mesh-ancestor
19981767|NCT01912716|Indomethacin|indomethacin|mesh-list
19981768|NCT01912716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19981769|NCT01912716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19981770|NCT01912716|Analgesics|analgesics|mesh-ancestor
19981771|NCT01912716|Sensory System Agents|sensory system agents|mesh-ancestor
19981772|NCT01912716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556031|NCT01944085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20556032|NCT01944085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20556033|NCT01944085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20556034|NCT01944085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556035|NCT01944085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556036|NCT01944085|Antioxidants|antioxidants|mesh-ancestor
20556037|NCT01944085|Protective Agents|protective agents|mesh-ancestor
20556038|NCT01944176|Simvastatin|simvastatin|mesh-list
20556039|NCT01944176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20556040|NCT01944176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19736178|NCT04532684|Analgesics|analgesics|mesh-ancestor
19736179|NCT04532684|Sensory System Agents|sensory system agents|mesh-ancestor
19736180|NCT04532684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19736181|NCT04532684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736182|NCT04532684|Anticonvulsants|anticonvulsants|mesh-ancestor
19736183|NCT04532684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20556041|NCT01944176|Antimetabolites|antimetabolites|mesh-ancestor
20556042|NCT01944176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981773|NCT01912716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981774|NCT01912716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19981775|NCT01912716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19981776|NCT01912716|Gout Suppressants|gout suppressants|mesh-ancestor
19981777|NCT01912716|Tocolytic Agents|tocolytic agents|mesh-ancestor
19981778|NCT01912716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19981779|NCT01912716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19981780|NCT01912716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19981781|NCT01912716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981782|NCT01912768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19981783|NCT01912781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19981784|NCT01912807|Ondansetron|ondansetron|mesh-list
19981785|NCT01912807|Antiemetics|antiemetics|mesh-ancestor
19981786|NCT01912807|Autonomic Agents|autonomic agents|mesh-ancestor
19981787|NCT01912807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981788|NCT01912807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981789|NCT01912807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19981790|NCT01912807|Antipruritics|antipruritics|mesh-ancestor
19981791|NCT01912807|Dermatologic Agents|dermatologic agents|mesh-ancestor
19981792|NCT01912807|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19981793|NCT01912807|Serotonin Agents|serotonin agents|mesh-ancestor
19981794|NCT01912807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19981795|NCT01912807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981796|NCT01912807|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19981797|NCT01912807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19981798|NCT01912807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19981799|NCT01912807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19981800|NCT01912807|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19981801|NCT01912872|Omalizumab|omalizumab|mesh-list
19981802|NCT01912872|Budesonide|budesonide|mesh-list
19981803|NCT01912872|Formoterol Fumarate|formoterol fumarate|mesh-list
19981804|NCT01912872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19981805|NCT01912872|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19981806|NCT01912872|Autonomic Agents|autonomic agents|mesh-ancestor
19981807|NCT01912872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981808|NCT01912872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981809|NCT01912872|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19981810|NCT01912872|Respiratory System Agents|respiratory system agents|mesh-ancestor
19981811|NCT01912872|Glucocorticoids|glucocorticoids|mesh-ancestor
19981812|NCT01912872|Hormones|hormones|mesh-ancestor
19981813|NCT01912872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19981814|NCT01912872|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19981815|NCT01912872|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19981816|NCT01912872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19981817|NCT01912872|Adrenergic Agents|adrenergic agents|mesh-ancestor
19981818|NCT01912872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19981819|NCT01912872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981820|NCT01912872|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19981821|NCT01912963|Trastuzumab|trastuzumab|mesh-list
19981822|NCT01912963|Pertuzumab|pertuzumab|mesh-list
19981823|NCT01912963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19981824|NCT01912963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981825|NCT01913340|Epoetin Alfa|epoetin alfa|mesh-list
19981826|NCT01913340|Hematinics|hematinics|mesh-ancestor
19981827|NCT01913405|Factor VIII|factor viii|mesh-list
19981828|NCT01913405|BAX 855|bax 855|mesh-list
19981829|NCT01913405|Coagulants|coagulants|mesh-ancestor
19981830|NCT01913470|Losartan|losartan|mesh-list
19981831|NCT01913470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19981832|NCT01913470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19981833|NCT01913470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19981834|NCT01913470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19981835|NCT01913470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981836|NCT01913483|Heparin|heparin|mesh-list
19981837|NCT01913483|Calcium heparin|calcium heparin|mesh-list
19981838|NCT01913483|Bivalirudin|bivalirudin|mesh-list
19981839|NCT01913483|Anticoagulants|anticoagulants|mesh-ancestor
19981840|NCT01913483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19981841|NCT01913483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19981842|NCT01913483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981843|NCT01913483|Antithrombins|antithrombins|mesh-ancestor
19981844|NCT01913483|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19981845|NCT01913483|Protease Inhibitors|protease inhibitors|mesh-ancestor
19981846|NCT01913483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19981847|NCT01913535|Aticaprant|aticaprant|mesh-list
19981848|NCT01913535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19981849|NCT01913535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981850|NCT01913535|Sensory System Agents|sensory system agents|mesh-ancestor
19981851|NCT01913535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981852|NCT01913639|Leucovorin|leucovorin|mesh-list
19981853|NCT01913639|Fluorouracil|fluorouracil|mesh-list
19453183|NCT03406299|Antidotes|antidotes|mesh-ancestor
19453184|NCT03406299|Protective Agents|protective agents|mesh-ancestor
19453185|NCT03406299|Vitamin B Complex|vitamin b complex|mesh-ancestor
19453186|NCT03406299|Vitamins|vitamins|mesh-ancestor
19453187|NCT03406299|Micronutrients|micronutrients|mesh-ancestor
19453188|NCT03406169|Sildenafil Citrate|sildenafil citrate|mesh-list
19453189|NCT03406169|Pentoxifylline|pentoxifylline|mesh-list
19453190|NCT03406169|Vasodilator Agents|vasodilator agents|mesh-ancestor
19453191|NCT03406169|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19453192|NCT03406169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19453193|NCT03406169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453194|NCT03406169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453195|NCT03406169|Urological Agents|urological agents|mesh-ancestor
19453196|NCT03406169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19453197|NCT03406169|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19453198|NCT03406169|Protective Agents|protective agents|mesh-ancestor
19453199|NCT03406169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453200|NCT03406169|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19453201|NCT03406169|Antioxidants|antioxidants|mesh-ancestor
19453202|NCT03406091|Plerixafor|plerixafor|mesh-list
19453203|NCT03406091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19453204|NCT03406091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19453205|NCT03406091|Antiviral Agents|antiviral agents|mesh-ancestor
19981854|NCT01913639|Oxaliplatin|oxaliplatin|mesh-list
19981855|NCT01913639|Antimetabolites|antimetabolites|mesh-ancestor
19981856|NCT01913639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981857|NCT01913639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19981858|NCT01913639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981859|NCT01913639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19981860|NCT01913639|Immunologic Factors|immunologic factors|mesh-ancestor
19981861|NCT01913639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981862|NCT01913639|Antidotes|antidotes|mesh-ancestor
19981863|NCT01913639|Protective Agents|protective agents|mesh-ancestor
19981864|NCT01913639|Vitamin B Complex|vitamin b complex|mesh-ancestor
19981865|NCT01913639|Vitamins|vitamins|mesh-ancestor
19981866|NCT01913639|Micronutrients|micronutrients|mesh-ancestor
19981867|NCT01914159|Ranibizumab|ranibizumab|mesh-list
19981868|NCT01914159|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19981869|NCT01914159|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19981870|NCT01914159|Growth Substances|growth substances|mesh-ancestor
19981871|NCT01914159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981872|NCT01914159|Growth Inhibitors|growth inhibitors|mesh-ancestor
19981873|NCT01914159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19981874|NCT01914393|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19981875|NCT01914393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19981876|NCT01914393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19981877|NCT01914393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19981878|NCT01914393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981879|NCT01914393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19981880|NCT01914393|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19981881|NCT01914393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19981882|NCT01914393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19981883|NCT01914393|Adrenergic Agents|adrenergic agents|mesh-ancestor
19981884|NCT01914393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19981885|NCT01914393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981886|NCT01914393|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19981887|NCT01914393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19981888|NCT01914393|Serotonin Agents|serotonin agents|mesh-ancestor
19981889|NCT01914393|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19981890|NCT01914393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19981891|NCT01914393|Dopamine Agents|dopamine agents|mesh-ancestor
19981892|NCT01914666|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19981893|NCT01914666|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19981894|NCT01914666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19981895|NCT01914666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19981896|NCT01914666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981897|NCT01914666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19981898|NCT01914666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981899|NCT01914666|Analgesics|analgesics|mesh-ancestor
19981900|NCT01914666|Sensory System Agents|sensory system agents|mesh-ancestor
19981901|NCT01914666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981902|NCT01914666|Antidepressive Agents|antidepressive agents|mesh-ancestor
19981903|NCT01914666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19981904|NCT01914666|Dopamine Agents|dopamine agents|mesh-ancestor
19981905|NCT01914757|Benralizumab|benralizumab|mesh-list
19981906|NCT01914757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19981907|NCT01914757|Respiratory System Agents|respiratory system agents|mesh-ancestor
19981908|NCT01914926|Metoprolol|metoprolol|mesh-list
19981909|NCT01914926|Diltiazem|diltiazem|mesh-list
19981910|NCT01914926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19981911|NCT01914926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19981912|NCT01914926|Sympatholytics|sympatholytics|mesh-ancestor
19981913|NCT01914926|Autonomic Agents|autonomic agents|mesh-ancestor
20556043|NCT01944176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20556044|NCT01944176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20556045|NCT01944176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19981914|NCT01914926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556046|NCT01944189|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20556047|NCT01944189|Antimalarials|antimalarials|mesh-ancestor
20556048|NCT01944189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20556049|NCT01944189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20556050|NCT01944189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20556051|NCT01944215|Caffeine|caffeine|mesh-list
19981915|NCT01914926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981916|NCT01914926|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19981917|NCT01914926|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19981918|NCT01914926|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19981919|NCT01914926|Adrenergic Agents|adrenergic agents|mesh-ancestor
19981920|NCT01914926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19981921|NCT01914926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981922|NCT01914926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19981923|NCT01914926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19981924|NCT01914926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19981925|NCT01914926|Vasodilator Agents|vasodilator agents|mesh-ancestor
19981926|NCT01915108|Remifentanil|remifentanil|mesh-list
19981927|NCT01915108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19981928|NCT01915108|Narcotics|narcotics|mesh-ancestor
19981929|NCT01915108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19981930|NCT01915108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981931|NCT01915108|Analgesics|analgesics|mesh-ancestor
19981932|NCT01915108|Sensory System Agents|sensory system agents|mesh-ancestor
19981933|NCT01915108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981934|NCT01915303|Cabergoline|cabergoline|mesh-list
19981935|NCT01915303|Pasireotide|pasireotide|mesh-list
19981936|NCT01915303|Hormones|hormones|mesh-ancestor
19981937|NCT01915303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19981938|NCT01915303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981939|NCT01915303|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19981940|NCT01915303|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19981941|NCT01915303|Dopamine Agonists|dopamine agonists|mesh-ancestor
19981942|NCT01915303|Dopamine Agents|dopamine agents|mesh-ancestor
19981943|NCT01915303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19981944|NCT01915303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981945|NCT01915732|Clindamycin|clindamycin|mesh-list
19981946|NCT01915732|Clindamycin palmitate|clindamycin palmitate|mesh-list
19981947|NCT01915732|Clindamycin phosphate|clindamycin phosphate|mesh-list
19981948|NCT01915732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19981949|NCT01915732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19981950|NCT01915732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19981951|NCT01915732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19981952|NCT01915732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981953|NCT01915823|Fluticasone|fluticasone|mesh-list
19981954|NCT01915823|Xhance|xhance|mesh-list
19981955|NCT01915823|Azelastine|azelastine|mesh-list
19981956|NCT01915823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19981957|NCT01915823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19981958|NCT01915823|Autonomic Agents|autonomic agents|mesh-ancestor
19981959|NCT01915823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981960|NCT01915823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981961|NCT01915823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19981962|NCT01915823|Respiratory System Agents|respiratory system agents|mesh-ancestor
19981963|NCT01915823|Dermatologic Agents|dermatologic agents|mesh-ancestor
19981964|NCT01915823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19981965|NCT01915823|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
19981966|NCT01915823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19981967|NCT01915823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981968|NCT01915823|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19981969|NCT01915823|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19981970|NCT01915823|Histamine Antagonists|histamine antagonists|mesh-ancestor
19981971|NCT01915823|Histamine Agents|histamine agents|mesh-ancestor
19981972|NCT01915823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19981973|NCT01915849|Licogliflozin|licogliflozin|mesh-list
19981974|NCT01915849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19981975|NCT01915849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981976|NCT01915849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19981977|NCT01915849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981978|NCT01915914|Fluticasone|fluticasone|mesh-list
19981979|NCT01915914|Xhance|xhance|mesh-list
19981980|NCT01915914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19981981|NCT01915914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19981982|NCT01915914|Autonomic Agents|autonomic agents|mesh-ancestor
19981983|NCT01915914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19981984|NCT01915914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981985|NCT01915914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19981986|NCT01915914|Respiratory System Agents|respiratory system agents|mesh-ancestor
19981987|NCT01915914|Dermatologic Agents|dermatologic agents|mesh-ancestor
19981988|NCT01915914|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19981989|NCT01915940|Timolol|timolol|mesh-list
19981990|NCT01915940|Bimatoprost|bimatoprost|mesh-list
19981991|NCT01915940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19981992|NCT01915940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19981993|NCT01915940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19981994|NCT01915940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19981995|NCT01915940|Adrenergic Agents|adrenergic agents|mesh-ancestor
19981996|NCT01915940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19981997|NCT01915940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19981998|NCT01915940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19981999|NCT01915940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19982000|NCT01915940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19982001|NCT01916109|Gemcitabine|gemcitabine|mesh-list
19982002|NCT01916109|Carboplatin|carboplatin|mesh-list
19982003|NCT01916109|Panitumumab|panitumumab|mesh-list
19982004|NCT01916109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982005|NCT01916109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19982006|NCT01916109|Antimetabolites|antimetabolites|mesh-ancestor
19982007|NCT01916109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982008|NCT01916109|Antiviral Agents|antiviral agents|mesh-ancestor
19982009|NCT01916109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19982010|NCT01916109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982011|NCT01916109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19982012|NCT01916109|Immunologic Factors|immunologic factors|mesh-ancestor
19982013|NCT01916109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982014|NCT01916109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19982015|NCT01916226|Cetirizine|cetirizine|mesh-list
19982016|NCT01916226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19982017|NCT01916226|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19982018|NCT01916226|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19982019|NCT01916226|Histamine Antagonists|histamine antagonists|mesh-ancestor
19982020|NCT01916226|Histamine Agents|histamine agents|mesh-ancestor
19982021|NCT01916226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19982022|NCT01916226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982023|NCT01916226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982024|NCT01916629|Sunscreening Agents|sunscreening agents|mesh-list
19982025|NCT01916629|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19982026|NCT01916629|Protective Agents|protective agents|mesh-ancestor
19982027|NCT01916629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982028|NCT01916629|Dermatologic Agents|dermatologic agents|mesh-ancestor
19982029|NCT01916681|Misoprostol|misoprostol|mesh-list
19982030|NCT01916681|Oxytocin|oxytocin|mesh-list
19982031|NCT01916681|Oxytocics|oxytocics|mesh-ancestor
19982032|NCT01916681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19982033|NCT01916681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982034|NCT01916681|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19982035|NCT01916681|Abortifacient Agents|abortifacient agents|mesh-ancestor
19982036|NCT01916681|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19982037|NCT01916681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19982038|NCT01916824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19982039|NCT01916824|Mirtazapine|mirtazapine|mesh-list
19982040|NCT01916824|Citalopram|citalopram|mesh-list
19982041|NCT01916824|Bupropion|bupropion|mesh-list
19982042|NCT01916824|Fluoxetine|fluoxetine|mesh-list
19982043|NCT01916824|Paroxetine|paroxetine|mesh-list
19982044|NCT01916824|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19982045|NCT01916824|Sertraline|sertraline|mesh-list
19982046|NCT01916824|Antidepressive Agents|antidepressive agents|mesh-list
19982047|NCT01916824|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19982048|NCT01916824|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19982049|NCT01916824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19982050|NCT01916824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19982051|NCT01916824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982052|NCT01916824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19982053|NCT01916824|Serotonin Agents|serotonin agents|mesh-ancestor
19982054|NCT01916824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982055|NCT01916824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19982056|NCT01916824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19982057|NCT01916824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982058|NCT01916824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19982059|NCT01916824|Dopamine Agents|dopamine agents|mesh-ancestor
19982060|NCT01916824|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19982061|NCT01916824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19982062|NCT01916824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982063|NCT01916824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19982064|NCT01916824|Analgesics|analgesics|mesh-ancestor
19982065|NCT01916824|Sensory System Agents|sensory system agents|mesh-ancestor
20556052|NCT01944215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20556053|NCT01944215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556054|NCT01944215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20556055|NCT01944215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556056|NCT01944215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556057|NCT01944215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20556058|NCT01944215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20556059|NCT01944215|Purinergic Agents|purinergic agents|mesh-ancestor
20556060|NCT01944215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20556061|NCT01944384|Spironolactone|spironolactone|mesh-list
20556062|NCT01944384|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20556063|NCT01944384|Hormone Antagonists|hormone antagonists|mesh-ancestor
20556064|NCT01944384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20556065|NCT01944384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556066|NCT01944384|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20556067|NCT01944384|Diuretics|diuretics|mesh-ancestor
20556068|NCT01944384|Natriuretic Agents|natriuretic agents|mesh-ancestor
20556069|NCT01944410|Mitogens|mitogens|mesh-list
20556070|NCT01944410|Mitosis Modulators|mitosis modulators|mesh-ancestor
20556071|NCT01944410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556072|NCT01944436|Rivastigmine|rivastigmine|mesh-list
20556073|NCT01944436|Donepezil|donepezil|mesh-list
20556074|NCT01944436|Galantamine|galantamine|mesh-list
20556075|NCT01944436|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
20556076|NCT01944436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556077|NCT01944436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556078|NCT01944436|Cholinergic Agents|cholinergic agents|mesh-ancestor
20556079|NCT01944436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20556080|NCT01944436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556081|NCT01944436|Nootropic Agents|nootropic agents|mesh-ancestor
20556082|NCT01944436|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20556083|NCT01944436|Autonomic Agents|autonomic agents|mesh-ancestor
20556084|NCT01944436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556085|NCT01944436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20556086|NCT01944436|Protective Agents|protective agents|mesh-ancestor
20556087|NCT01944618|Dapagliflozin|dapagliflozin|mesh-list
19982066|NCT01916824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19982067|NCT01916824|Histamine Antagonists|histamine antagonists|mesh-ancestor
19982068|NCT01916824|Histamine Agents|histamine agents|mesh-ancestor
19982069|NCT01916824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19982070|NCT01916824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19982071|NCT01916824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19982072|NCT01916824|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19982073|NCT01916824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19982074|NCT01916824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19982075|NCT01916824|Adrenergic Agents|adrenergic agents|mesh-ancestor
19982076|NCT01916824|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19982077|NCT01916824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19982078|NCT01916824|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19982079|NCT01916941|Prazosin|prazosin|mesh-list
19982080|NCT01916941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19982081|NCT01916941|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19982082|NCT01916941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19982083|NCT01916941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19982084|NCT01916941|Adrenergic Agents|adrenergic agents|mesh-ancestor
19982085|NCT01916941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19982086|NCT01916941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982087|NCT01916941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289013|NCT05037045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289014|NCT05032807|Cannabidiol|cannabidiol|mesh-list
20289015|NCT05032807|Anticonvulsants|anticonvulsants|mesh-ancestor
20289016|NCT05030506|Pembrolizumab|pembrolizumab|mesh-list
20289017|NCT05030506|Lenvatinib|lenvatinib|mesh-list
20289018|NCT05030506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20289019|NCT05030506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289020|NCT05030506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20289021|NCT05030506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289022|NCT05030506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289023|NCT05018520|Prednisone|prednisone|mesh-list
20289024|NCT05018520|Rituximab|rituximab|mesh-list
20289025|NCT05018520|Cyclophosphamide|cyclophosphamide|mesh-list
20289026|NCT05018520|Vincristine|vincristine|mesh-list
20289027|NCT05018520|Doxorubicin|doxorubicin|mesh-list
20289028|NCT05018520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20289029|NCT05018520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289030|NCT05018520|Immunologic Factors|immunologic factors|mesh-ancestor
20289031|NCT05018520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289032|NCT05018520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20289033|NCT05018520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20289034|NCT05018520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20289035|NCT05018520|Alkylating Agents|alkylating agents|mesh-ancestor
20289036|NCT05018520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289037|NCT05018520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20289038|NCT05018520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20289039|NCT05018520|Glucocorticoids|glucocorticoids|mesh-ancestor
20289040|NCT05018520|Hormones|hormones|mesh-ancestor
19453206|NCT03406091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19453207|NCT03405974|Aspirin|aspirin|mesh-list
19453208|NCT03405974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19453209|NCT03405974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19453210|NCT03405974|Analgesics|analgesics|mesh-ancestor
19453211|NCT03405974|Sensory System Agents|sensory system agents|mesh-ancestor
19453212|NCT03405974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982088|NCT01917006|Botulinum Toxins|botulinum toxins|mesh-list
19982089|NCT01917006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19982090|NCT01917006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19982091|NCT01917006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19982092|NCT01917006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19982093|NCT01917006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982094|NCT01917006|Cholinergic Agents|cholinergic agents|mesh-ancestor
19982095|NCT01917006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19982096|NCT01917006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982097|NCT01917006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19982098|NCT01917006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982099|NCT01917136|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19982100|NCT01917136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19982101|NCT01917136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982102|NCT01917214|Sunitinib|sunitinib|mesh-list
19982103|NCT01917214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982104|NCT01917214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19982105|NCT01917214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19982106|NCT01917214|Growth Substances|growth substances|mesh-ancestor
19982107|NCT01917214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982108|NCT01917214|Growth Inhibitors|growth inhibitors|mesh-ancestor
19982109|NCT01917214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19982110|NCT01917214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982111|NCT01917214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982112|NCT01917656|Metformin|metformin|mesh-list
19982113|NCT01917656|Liraglutide|liraglutide|mesh-list
19982114|NCT01917656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19982115|NCT01917656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982116|NCT01917656|Incretins|incretins|mesh-ancestor
19982117|NCT01917656|Hormones|hormones|mesh-ancestor
19982118|NCT01917656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19982119|NCT01917773|Octreotide|octreotide|mesh-list
19982120|NCT01917773|Bisacodyl|bisacodyl|mesh-list
19982121|NCT01917773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19982122|NCT01917773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19982123|NCT01917773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982124|NCT01917773|Cathartics|cathartics|mesh-ancestor
19982125|NCT01917773|Laxatives|laxatives|mesh-ancestor
19982126|NCT01918306|Cisplatin|cisplatin|mesh-list
19982127|NCT01918306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982128|NCT01918332|Valsartan|valsartan|mesh-list
19982129|NCT01918332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19982130|NCT01918332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19982131|NCT01918332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19982132|NCT01918332|Antimetabolites|antimetabolites|mesh-ancestor
19982133|NCT01918332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982134|NCT01918332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19982135|NCT01918332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19982136|NCT01918332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982137|NCT01918332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19982138|NCT01918332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19982139|NCT01918332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19982140|NCT01918371|Bevacizumab|bevacizumab|mesh-list
19982141|NCT01918371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19982142|NCT01918371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982143|NCT01918371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19982144|NCT01918371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19982145|NCT01918371|Growth Substances|growth substances|mesh-ancestor
19982146|NCT01918371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982147|NCT01918371|Growth Inhibitors|growth inhibitors|mesh-ancestor
19982148|NCT01918761|Pemetrexed|pemetrexed|mesh-list
19982149|NCT01918761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982150|NCT01918761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982151|NCT01918761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982152|NCT01918761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19982153|NCT01918761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19982154|NCT01919164|Mitogens|mitogens|mesh-list
19982155|NCT01919164|Mitosis Modulators|mitosis modulators|mesh-ancestor
19982156|NCT01919164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982157|NCT01919190|Bupivacaine|bupivacaine|mesh-list
19982158|NCT01919190|Anesthetics, Local|anesthetics, local|mesh-ancestor
19982159|NCT01919190|Anesthetics|anesthetics|mesh-ancestor
19982160|NCT01919190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19982161|NCT01919190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982162|NCT01919190|Sensory System Agents|sensory system agents|mesh-ancestor
19982163|NCT01919190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982164|NCT01919216|Citalopram|citalopram|mesh-list
19982165|NCT01919216|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19982166|NCT01919216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19982167|NCT01919216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19982168|NCT01919216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982169|NCT01919216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19982170|NCT01919216|Serotonin Agents|serotonin agents|mesh-ancestor
19982171|NCT01919216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982172|NCT01919216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19982173|NCT01919216|Antidepressive Agents|antidepressive agents|mesh-ancestor
19982174|NCT01919216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19982175|NCT01919229|Letrozole|letrozole|mesh-list
19982176|NCT01919229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982177|NCT01919229|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19982178|NCT01919229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19982179|NCT01919229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556088|NCT01944618|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20556089|NCT01944618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556090|NCT01944618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20556091|NCT01944618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556092|NCT01944657|Antidepressive Agents|antidepressive agents|mesh-list
20556093|NCT01944657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20556094|NCT01944683|Midazolam|midazolam|mesh-list
20556095|NCT01944683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20556096|NCT01944683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20556097|NCT01944683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20556098|NCT01944683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556099|NCT01944683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20556100|NCT01944683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20556101|NCT01944683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20556102|NCT01944683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20556103|NCT01944683|Anesthetics, General|anesthetics, general|mesh-ancestor
20556104|NCT01944683|Anesthetics|anesthetics|mesh-ancestor
20556105|NCT01944683|GABA Modulators|gaba modulators|mesh-ancestor
20556106|NCT01944683|GABA Agents|gaba agents|mesh-ancestor
20556107|NCT01944683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20556108|NCT01944683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556109|NCT01944735|Mannitol|mannitol|mesh-list
19982180|NCT01919229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982181|NCT01919229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19982182|NCT01919229|Hormone Antagonists|hormone antagonists|mesh-ancestor
19982183|NCT01919229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19982184|NCT01919229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982185|NCT01919411|Amoxicillin|amoxicillin|mesh-list
19982186|NCT01919411|Clavulanic Acid|clavulanic acid|mesh-list
19982187|NCT01919411|Clavulanic Acids|clavulanic acids|mesh-list
19982188|NCT01919411|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19982189|NCT01919411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19982190|NCT01919411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19982191|NCT01919411|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19982192|NCT01919411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982193|NCT01919411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982194|NCT01919450|Regadenoson|regadenoson|mesh-list
19982195|NCT01919450|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19982196|NCT01919450|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19982197|NCT01919450|Purinergic Agonists|purinergic agonists|mesh-ancestor
19982198|NCT01919450|Purinergic Agents|purinergic agents|mesh-ancestor
19982199|NCT01919450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19982200|NCT01919450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982201|NCT01919450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982202|NCT01919489|Insulin Glargine|insulin glargine|mesh-list
19982203|NCT01919489|Liraglutide|liraglutide|mesh-list
19982204|NCT01919489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19982205|NCT01919489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982206|NCT01919489|Incretins|incretins|mesh-ancestor
19982207|NCT01919489|Hormones|hormones|mesh-ancestor
19982208|NCT01919489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19982209|NCT01919606|Bupivacaine|bupivacaine|mesh-list
19982210|NCT01919606|Anesthetics, Local|anesthetics, local|mesh-ancestor
19982211|NCT01919606|Anesthetics|anesthetics|mesh-ancestor
19982212|NCT01919606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19982213|NCT01919606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982214|NCT01919606|Sensory System Agents|sensory system agents|mesh-ancestor
19982215|NCT01919606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982216|NCT01919697|Plecanatide|plecanatide|mesh-list
19982217|NCT01919697|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19982218|NCT01919697|Enzyme Activators|enzyme activators|mesh-ancestor
19982219|NCT01919697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982220|NCT01919697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19982221|NCT01919723|Ticagrelor|ticagrelor|mesh-list
19982222|NCT01919723|Eptifibatide|eptifibatide|mesh-list
19982223|NCT01919723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19982224|NCT01919723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19982225|NCT01919723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19982226|NCT01919723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19982227|NCT01919723|Purinergic Agents|purinergic agents|mesh-ancestor
19982228|NCT01919723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19982229|NCT01919723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982230|NCT01919723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982231|NCT01919801|Icatibant|icatibant|mesh-list
19982232|NCT01919801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19982233|NCT01919801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19982234|NCT01919801|Analgesics|analgesics|mesh-ancestor
19982235|NCT01919801|Sensory System Agents|sensory system agents|mesh-ancestor
19982236|NCT01919801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982237|NCT01919801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556110|NCT01944735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20556111|NCT01944735|Diuretics|diuretics|mesh-ancestor
20556112|NCT01944735|Natriuretic Agents|natriuretic agents|mesh-ancestor
20556113|NCT01944735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982238|NCT01919801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19982239|NCT01919801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19982240|NCT01919801|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
19982241|NCT01919801|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
19982242|NCT01919801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982243|NCT01919801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19982244|NCT01919801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19982245|NCT01919801|Immunologic Factors|immunologic factors|mesh-ancestor
19982246|NCT01919996|Azithromycin|azithromycin|mesh-list
19982247|NCT01919996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19982248|NCT01919996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19982249|NCT01920061|Docetaxel|docetaxel|mesh-list
19982250|NCT01920061|Gedatolisib|gedatolisib|mesh-list
19982251|NCT01920061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982252|NCT01920061|Tubulin Modulators|tubulin modulators|mesh-ancestor
19982253|NCT01920061|Antimitotic Agents|antimitotic agents|mesh-ancestor
19982254|NCT01920061|Mitosis Modulators|mitosis modulators|mesh-ancestor
19982255|NCT01920061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982256|NCT01920061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19982257|NCT01920061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982258|NCT01920152|Hyaluronic Acid|hyaluronic acid|mesh-list
19982259|NCT01920152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19982260|NCT01920152|Immunologic Factors|immunologic factors|mesh-ancestor
19982261|NCT01920152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982262|NCT01920152|Viscosupplements|viscosupplements|mesh-ancestor
19982263|NCT01920152|Protective Agents|protective agents|mesh-ancestor
19982264|NCT01920282|Nebivolol|nebivolol|mesh-list
19982265|NCT01920282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19982266|NCT01920282|Vasodilator Agents|vasodilator agents|mesh-ancestor
19982267|NCT01920282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19982268|NCT01920282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19982269|NCT01920282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19982270|NCT01920282|Adrenergic Agents|adrenergic agents|mesh-ancestor
19982271|NCT01920282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19982272|NCT01920282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982273|NCT01920282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982274|NCT01920477|Ofatumumab|ofatumumab|mesh-list
19982275|NCT01920477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982276|NCT01920555|Midazolam|midazolam|mesh-list
19982277|NCT01920555|Ketamine|ketamine|mesh-list
19982278|NCT01920555|Analgesics|analgesics|mesh-ancestor
19982279|NCT01920555|Sensory System Agents|sensory system agents|mesh-ancestor
19982280|NCT01920555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982281|NCT01920555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982282|NCT01920555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19982283|NCT01920555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19982284|NCT01920555|Anesthetics, General|anesthetics, general|mesh-ancestor
19982285|NCT01920555|Anesthetics|anesthetics|mesh-ancestor
19982286|NCT01920555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19982287|NCT01920555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19982288|NCT01920555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19982289|NCT01920555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19982290|NCT01920555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982291|NCT01920555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19982292|NCT01920555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19982293|NCT01920555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19982294|NCT01920555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19982295|NCT01920555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19982296|NCT01920555|GABA Modulators|gaba modulators|mesh-ancestor
19982297|NCT01920555|GABA Agents|gaba agents|mesh-ancestor
19982298|NCT01920568|Vitamin D|vitamin d|mesh-list
19982299|NCT01920568|Zoledronic Acid|zoledronic acid|mesh-list
19982300|NCT01920568|Denosumab|denosumab|mesh-list
19982301|NCT01920568|Calcium|calcium|mesh-list
19982302|NCT01920568|Vitamins|vitamins|mesh-ancestor
19982303|NCT01920568|Micronutrients|micronutrients|mesh-ancestor
19982304|NCT01920568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982305|NCT01920568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19982306|NCT01920568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19982307|NCT01920711|Valsartan|valsartan|mesh-list
19982308|NCT01920711|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19982309|NCT01920711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19982310|NCT01920711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19982311|NCT01920711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19982312|NCT01920711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982313|NCT01920802|Olanzapine|olanzapine|mesh-list
19982314|NCT01920802|Iloperidone|iloperidone|mesh-list
19982315|NCT01920802|Antiemetics|antiemetics|mesh-ancestor
19982316|NCT01920802|Autonomic Agents|autonomic agents|mesh-ancestor
19982317|NCT01920802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982318|NCT01920802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982319|NCT01920802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19982320|NCT01920802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19982321|NCT01920802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19982322|NCT01920802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19453213|NCT03405974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453214|NCT03405974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19453215|NCT03405974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19453216|NCT03405974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19453217|NCT03405974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19453218|NCT03405974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453219|NCT03405974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19453220|NCT03405974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19453221|NCT03405974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453222|NCT03405974|Antipyretics|antipyretics|mesh-ancestor
19982323|NCT01920802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19982324|NCT01920802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19982325|NCT01920802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19982326|NCT01920802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19982327|NCT01920802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982328|NCT01920802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19982329|NCT01920802|Serotonin Agents|serotonin agents|mesh-ancestor
19982330|NCT01920893|Mometasone Furoate|mometasone furoate|mesh-list
19982331|NCT01920893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19982332|NCT01920893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19982333|NCT01920893|Dermatologic Agents|dermatologic agents|mesh-ancestor
19982334|NCT01920893|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19982335|NCT01920893|Immunologic Factors|immunologic factors|mesh-ancestor
19982336|NCT01920893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982337|NCT01921205|Lacosamide|lacosamide|mesh-list
19982338|NCT01921205|Anticonvulsants|anticonvulsants|mesh-ancestor
19982339|NCT01921205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19982340|NCT01921205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19982341|NCT01921205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19982342|NCT01921205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982343|NCT01921270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19982344|NCT01921270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19982345|NCT01921270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19982346|NCT01921270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19982347|NCT01921270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982348|NCT01921270|Cholinergic Agents|cholinergic agents|mesh-ancestor
19982349|NCT01921270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19982350|NCT01921270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982351|NCT01921270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19982352|NCT01921270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982353|NCT01921296|Cyclobenzaprine|cyclobenzaprine|mesh-list
19982354|NCT01921296|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19982355|NCT01921296|Antidepressive Agents|antidepressive agents|mesh-ancestor
19982356|NCT01921296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19982357|NCT01921296|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19982358|NCT01921296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982359|NCT01921296|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19982360|NCT01921296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982361|NCT01921296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19982362|NCT01921296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19982363|NCT01921387|Cytarabine|cytarabine|mesh-list
19982364|NCT01921387|Etoposide|etoposide|mesh-list
19982365|NCT01921387|Podophyllotoxin|podophyllotoxin|mesh-list
19982366|NCT01921387|Etoposide phosphate|etoposide phosphate|mesh-list
19982367|NCT01921387|Melphalan|melphalan|mesh-list
19982368|NCT01921387|Mechlorethamine|mechlorethamine|mesh-list
19982369|NCT01921387|Carmustine|carmustine|mesh-list
19982370|NCT01921387|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19982371|NCT01921387|Antibodies|antibodies|mesh-list
19982372|NCT01921387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19982373|NCT01921387|Immunologic Factors|immunologic factors|mesh-ancestor
19982374|NCT01921387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982375|NCT01921387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19982376|NCT01921387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982377|NCT01921387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19982378|NCT01921387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19982379|NCT01921387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982380|NCT01921387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453223|NCT03405948|Botulinum Toxins|botulinum toxins|mesh-list
19453224|NCT03405948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19982381|NCT01921387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19982382|NCT01921387|Antimetabolites|antimetabolites|mesh-ancestor
19982383|NCT01921387|Antiviral Agents|antiviral agents|mesh-ancestor
19982384|NCT01921387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19982385|NCT01921387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19982386|NCT01921387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19453225|NCT03405948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19453226|NCT03405948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453227|NCT03405948|Cholinergic Agents|cholinergic agents|mesh-ancestor
19453228|NCT03405948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19453229|NCT03405948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453230|NCT03405805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19453231|NCT03405805|Immunologic Factors|immunologic factors|mesh-ancestor
19453232|NCT03405805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453233|NCT03405584|Amoxicillin|amoxicillin|mesh-list
19453234|NCT03405584|Potassium Citrate|potassium citrate|mesh-list
19453235|NCT03405584|Esomeprazole|esomeprazole|mesh-list
19453236|NCT03405584|Bismuth|bismuth|mesh-list
19453237|NCT03405584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453238|NCT03405584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19453239|NCT03405584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19453240|NCT03405584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19982387|NCT01921387|Alkylating Agents|alkylating agents|mesh-ancestor
19453241|NCT03405584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19982388|NCT01921387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19982389|NCT01921387|Keratolytic Agents|keratolytic agents|mesh-ancestor
19982390|NCT01921387|Dermatologic Agents|dermatologic agents|mesh-ancestor
19982391|NCT01921387|Tubulin Modulators|tubulin modulators|mesh-ancestor
19982392|NCT01921387|Antimitotic Agents|antimitotic agents|mesh-ancestor
19982393|NCT01921387|Mitosis Modulators|mitosis modulators|mesh-ancestor
19982394|NCT01921751|Gemcitabine|gemcitabine|mesh-list
19982395|NCT01921751|Paclitaxel|paclitaxel|mesh-list
19982396|NCT01921751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19982397|NCT01921751|Capecitabine|capecitabine|mesh-list
19982398|NCT01921751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19982399|NCT01921751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982400|NCT01921751|Tubulin Modulators|tubulin modulators|mesh-ancestor
19982401|NCT01921751|Antimitotic Agents|antimitotic agents|mesh-ancestor
19982402|NCT01921751|Mitosis Modulators|mitosis modulators|mesh-ancestor
19982403|NCT01921751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982404|NCT01921751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19982405|NCT01921751|Antimetabolites|antimetabolites|mesh-ancestor
19982406|NCT01921751|Antiviral Agents|antiviral agents|mesh-ancestor
19982407|NCT01921751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19982408|NCT01921751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982409|NCT01921751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19982410|NCT01921751|Immunologic Factors|immunologic factors|mesh-ancestor
19982411|NCT01921751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982412|NCT01921829|Diuretics|diuretics|mesh-list
19982413|NCT01921829|Natriuretic Agents|natriuretic agents|mesh-ancestor
19982414|NCT01921829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982415|NCT01921894|Vitamin D|vitamin d|mesh-list
19982416|NCT01921894|Cholecalciferol|cholecalciferol|mesh-list
19982417|NCT01921894|Vitamins|vitamins|mesh-ancestor
19982418|NCT01921894|Micronutrients|micronutrients|mesh-ancestor
19982419|NCT01921894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982420|NCT01921894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19982421|NCT01921894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19982422|NCT01922011|Vancomycin|vancomycin|mesh-list
19982423|NCT01922011|Daptomycin|daptomycin|mesh-list
19982424|NCT01922011|Nafcillin|nafcillin|mesh-list
19982425|NCT01922011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19982426|NCT01922011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19982427|NCT01922037|Omalizumab|omalizumab|mesh-list
19982428|NCT01922037|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19982429|NCT01922037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19982430|NCT01922037|Respiratory System Agents|respiratory system agents|mesh-ancestor
19982431|NCT01922089|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19982432|NCT01922089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19982433|NCT01922089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982434|NCT01922102|Ranibizumab|ranibizumab|mesh-list
19982435|NCT01922102|Verteporfin|verteporfin|mesh-list
19982436|NCT01922102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19982437|NCT01922102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19982438|NCT01922102|Growth Substances|growth substances|mesh-ancestor
19982439|NCT01922102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982440|NCT01922102|Growth Inhibitors|growth inhibitors|mesh-ancestor
19982441|NCT01922102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982442|NCT01922102|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19982443|NCT01922102|Dermatologic Agents|dermatologic agents|mesh-ancestor
19982444|NCT01922115|Trospium chloride|trospium chloride|mesh-list
20556114|NCT01944800|Ticagrelor|ticagrelor|mesh-list
19982445|NCT01922115|Parasympatholytics|parasympatholytics|mesh-ancestor
19982446|NCT01922115|Autonomic Agents|autonomic agents|mesh-ancestor
19982447|NCT01922115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556115|NCT01944800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20556116|NCT01944800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20556117|NCT01944800|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20556118|NCT01944800|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20556119|NCT01944800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20556120|NCT01944800|Purinergic Agents|purinergic agents|mesh-ancestor
19982448|NCT01922115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982449|NCT01922115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19982450|NCT01922115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19982451|NCT01922115|Cholinergic Agents|cholinergic agents|mesh-ancestor
19982452|NCT01922115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19982453|NCT01922115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982454|NCT01922115|Urological Agents|urological agents|mesh-ancestor
19982455|NCT01922258|Brexpiprazole|brexpiprazole|mesh-list
19982456|NCT01922258|Serotonin Agents|serotonin agents|mesh-ancestor
19982457|NCT01922258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20556121|NCT01944800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20556122|NCT01944800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556123|NCT01944800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556124|NCT01944852|Icodextrin|icodextrin|mesh-list
20556125|NCT01944852|Dialysis Solutions|dialysis solutions|mesh-ancestor
20556126|NCT01944852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20556127|NCT01945021|Crizotinib|crizotinib|mesh-list
20556128|NCT01945021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556129|NCT01945021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19982458|NCT01922258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982459|NCT01922258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982460|NCT01922258|Dopamine Agonists|dopamine agonists|mesh-ancestor
19982461|NCT01922258|Dopamine Agents|dopamine agents|mesh-ancestor
19982462|NCT01922271|Glycopyrrolate|glycopyrrolate|mesh-list
19982463|NCT01922271|Albuterol|albuterol|mesh-list
19982464|NCT01922271|Tiotropium Bromide|tiotropium bromide|mesh-list
19982465|NCT01922271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19982466|NCT01922271|Autonomic Agents|autonomic agents|mesh-ancestor
19982467|NCT01922271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982468|NCT01922271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982469|NCT01922271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19982470|NCT01922271|Respiratory System Agents|respiratory system agents|mesh-ancestor
19982471|NCT01922271|Parasympatholytics|parasympatholytics|mesh-ancestor
19982472|NCT01922271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19982473|NCT01922271|Cholinergic Agents|cholinergic agents|mesh-ancestor
19982474|NCT01922271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19982475|NCT01922271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982476|NCT01922271|Tocolytic Agents|tocolytic agents|mesh-ancestor
19982477|NCT01922271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19982478|NCT01922271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19982479|NCT01922271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19982480|NCT01922271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19982481|NCT01922271|Adrenergic Agents|adrenergic agents|mesh-ancestor
19982482|NCT01922271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19982483|NCT01922271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19982484|NCT01922336|Infliximab|infliximab|mesh-list
19982485|NCT01922336|Dermatologic Agents|dermatologic agents|mesh-ancestor
19982486|NCT01922336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19982487|NCT01922336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19982488|NCT01922739|Hydrocodone|hydrocodone|mesh-list
19982489|NCT01922739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19982490|NCT01922739|Narcotics|narcotics|mesh-ancestor
19982491|NCT01922739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19982492|NCT01922739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982493|NCT01922739|Analgesics|analgesics|mesh-ancestor
19982494|NCT01922739|Sensory System Agents|sensory system agents|mesh-ancestor
19982495|NCT01922739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982496|NCT01922739|Antitussive Agents|antitussive agents|mesh-ancestor
19982497|NCT01922739|Respiratory System Agents|respiratory system agents|mesh-ancestor
19982498|NCT01922934|Topiramate|topiramate|mesh-list
19982499|NCT01922934|Phentermine|phentermine|mesh-list
19982500|NCT01922934|Anticonvulsants|anticonvulsants|mesh-ancestor
19982501|NCT01922934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19982502|NCT01922934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982503|NCT01922934|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19982504|NCT01922934|Appetite Depressants|appetite depressants|mesh-ancestor
19982505|NCT01922934|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19982506|NCT01922934|Sympathomimetics|sympathomimetics|mesh-ancestor
19982507|NCT01922934|Autonomic Agents|autonomic agents|mesh-ancestor
19982508|NCT01922934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982509|NCT01922934|Adrenergic Agents|adrenergic agents|mesh-ancestor
19982510|NCT01922934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19982511|NCT01922934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982512|NCT01923129|Prazosin|prazosin|mesh-list
19982513|NCT01923129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19982514|NCT01923129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19982515|NCT01923129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19982516|NCT01923129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19453242|NCT03405584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19982517|NCT01923129|Adrenergic Agents|adrenergic agents|mesh-ancestor
19453243|NCT03405584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453244|NCT03405584|Antacids|antacids|mesh-ancestor
19453245|NCT03405584|Diuretics|diuretics|mesh-ancestor
19453246|NCT03405584|Natriuretic Agents|natriuretic agents|mesh-ancestor
19453247|NCT03405584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453248|NCT03405584|Expectorants|expectorants|mesh-ancestor
19453249|NCT03405584|Respiratory System Agents|respiratory system agents|mesh-ancestor
19453250|NCT03405454|Durvalumab|durvalumab|mesh-list
19453251|NCT03405454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19453252|NCT03405454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453253|NCT03405376|Aflibercept|aflibercept|mesh-list
19453254|NCT03405376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19453255|NCT03405376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19453256|NCT03405376|Growth Substances|growth substances|mesh-ancestor
19453257|NCT03405376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453258|NCT03405376|Growth Inhibitors|growth inhibitors|mesh-ancestor
19453259|NCT03405376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453260|NCT03405337|Factor VIII|factor viii|mesh-list
19453261|NCT03405337|Coagulants|coagulants|mesh-ancestor
19453262|NCT03405272|Cetuximab|cetuximab|mesh-list
19453263|NCT03405272|Antibodies|antibodies|mesh-list
19453264|NCT03405272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19453265|NCT03405272|Immunologic Factors|immunologic factors|mesh-ancestor
19453266|NCT03405272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453267|NCT03405272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19453268|NCT03405272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453269|NCT03405207|Vitamin D|vitamin d|mesh-list
19453270|NCT03405207|Cholecalciferol|cholecalciferol|mesh-list
19453271|NCT03405207|Vitamins|vitamins|mesh-ancestor
19453272|NCT03405207|Micronutrients|micronutrients|mesh-ancestor
19453273|NCT03405207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453274|NCT03405207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19453275|NCT03405207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19453276|NCT03405194|Efavirenz|efavirenz|mesh-list
19453277|NCT03405194|Cobicistat|cobicistat|mesh-list
19453278|NCT03405194|Elvitegravir|elvitegravir|mesh-list
19453279|NCT03405194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19453280|NCT03405194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19453281|NCT03405194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453282|NCT03405194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453283|NCT03405194|Antiviral Agents|antiviral agents|mesh-ancestor
19453284|NCT03405194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19453285|NCT03405194|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19453286|NCT03405194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19453287|NCT03405194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19453288|NCT03405194|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19453289|NCT03405194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19453290|NCT03405194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19453291|NCT03405194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19453292|NCT03405194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19453293|NCT03405194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19453294|NCT03405194|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19453295|NCT03405168|Moxifloxacin|moxifloxacin|mesh-list
19453296|NCT03405168|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19453297|NCT03405168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19453298|NCT03405168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19982518|NCT01923129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19982519|NCT01923129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982520|NCT01923129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982521|NCT01923311|Elvitegravir|elvitegravir|mesh-list
19982522|NCT01923311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19982523|NCT01923311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19982524|NCT01923311|Antiviral Agents|antiviral agents|mesh-ancestor
19982525|NCT01923311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19982526|NCT01923311|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19982527|NCT01923311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982528|NCT01923311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982529|NCT01923363|Tazobactam|tazobactam|mesh-list
19982530|NCT01923363|Piperacillin|piperacillin|mesh-list
19982531|NCT01923363|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19982532|NCT01923363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19982533|NCT01923363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20556130|NCT01945021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982534|NCT01923363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19982535|NCT01923363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982536|NCT01923363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982537|NCT01923467|Nicotine|nicotine|mesh-list
19982538|NCT01923467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19982539|NCT01923467|Autonomic Agents|autonomic agents|mesh-ancestor
19982540|NCT01923467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982541|NCT01923467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982542|NCT01923467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19982543|NCT01923467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19982544|NCT01923467|Cholinergic Agents|cholinergic agents|mesh-ancestor
19982545|NCT01923467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19982546|NCT01923467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982547|NCT01923896|Cycloserine|cycloserine|mesh-list
19982548|NCT01923896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19982549|NCT01923896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19982550|NCT01923896|Renal Agents|renal agents|mesh-ancestor
19982551|NCT01923896|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19982552|NCT01923896|Antitubercular Agents|antitubercular agents|mesh-ancestor
19982553|NCT01923896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19982554|NCT01923896|Antimetabolites|antimetabolites|mesh-ancestor
19982555|NCT01923896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982556|NCT01924169|Lenalidomide|lenalidomide|mesh-list
19982557|NCT01924169|Vaccines|vaccines|mesh-list
19982558|NCT01924169|Immunologic Factors|immunologic factors|mesh-ancestor
19982559|NCT01924169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982560|NCT01924169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19982561|NCT01924169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19982562|NCT01924169|Growth Substances|growth substances|mesh-ancestor
19982563|NCT01924169|Growth Inhibitors|growth inhibitors|mesh-ancestor
19982564|NCT01924169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982565|NCT01924182|Morphine|morphine|mesh-list
19982566|NCT01924182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19982567|NCT01924182|Narcotics|narcotics|mesh-ancestor
19982568|NCT01924182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19982569|NCT01924182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982570|NCT01924182|Analgesics|analgesics|mesh-ancestor
19982571|NCT01924182|Sensory System Agents|sensory system agents|mesh-ancestor
19982572|NCT01924182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982573|NCT01924299|Fluconazole|fluconazole|mesh-list
19982574|NCT01924299|Ketoconazole|ketoconazole|mesh-list
19982575|NCT01924299|Antifungal Agents|antifungal agents|mesh-ancestor
19982576|NCT01924299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19982577|NCT01924299|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19982578|NCT01924299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19982579|NCT01924299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982580|NCT01924299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982581|NCT01924299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19982582|NCT01924299|Hormone Antagonists|hormone antagonists|mesh-ancestor
19982583|NCT01924299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19982584|NCT01924299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982585|NCT01924299|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19982586|NCT01924299|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19982587|NCT01924299|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20289041|NCT05018520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20289042|NCT05018520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20289043|NCT05018520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20289044|NCT05018520|Tubulin Modulators|tubulin modulators|mesh-ancestor
20289045|NCT05018520|Antimitotic Agents|antimitotic agents|mesh-ancestor
20289046|NCT05018520|Mitosis Modulators|mitosis modulators|mesh-ancestor
20289047|NCT05018520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20289048|NCT05018520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20289049|NCT05018520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20289050|NCT05018520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289051|NCT05013632|Remdesivir|remdesivir|mesh-list
20289052|NCT05013632|Antibodies|antibodies|mesh-list
20289053|NCT05013632|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20289054|NCT05013632|Immunologic Factors|immunologic factors|mesh-ancestor
20289055|NCT05013632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289056|NCT05013632|Antimetabolites|antimetabolites|mesh-ancestor
20289057|NCT05013632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289058|NCT05013632|Antiviral Agents|antiviral agents|mesh-ancestor
20289059|NCT05013632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20289060|NCT05011266|Buprenorphine|buprenorphine|mesh-list
20289061|NCT05011266|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20289062|NCT05011266|Naloxone|naloxone|mesh-list
20289063|NCT05011266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20289064|NCT05011266|Narcotics|narcotics|mesh-ancestor
20289065|NCT05011266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20289066|NCT05011266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982588|NCT01924429|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19982589|NCT01924429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19982590|NCT01924429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982591|NCT01924429|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19982592|NCT01924429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19982593|NCT01924429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19982594|NCT01924429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982595|NCT01924429|Dopamine Agents|dopamine agents|mesh-ancestor
19982596|NCT01924429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19982597|NCT01924767|Empagliflozin|empagliflozin|mesh-list
20556131|NCT01945021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556132|NCT01945047|Midazolam|midazolam|mesh-list
20556133|NCT01945047|Ketamine|ketamine|mesh-list
20556134|NCT01945047|Analgesics|analgesics|mesh-ancestor
20556135|NCT01945047|Sensory System Agents|sensory system agents|mesh-ancestor
20556136|NCT01945047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556137|NCT01945047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556138|NCT01945047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19453299|NCT03405168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19453300|NCT03405168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19453301|NCT03405168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453302|NCT03405168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453303|NCT03405168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453304|NCT03405168|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19453305|NCT03405168|Contraceptive Agents|contraceptive agents|mesh-ancestor
19453306|NCT03405168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19453307|NCT03405168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453308|NCT03405168|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19453309|NCT03405168|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19453310|NCT03405168|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19453311|NCT03405155|Nivolumab|nivolumab|mesh-list
19453312|NCT03405155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19453313|NCT03405155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453314|NCT03405155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19736184|NCT04532684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19982598|NCT01924767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19982599|NCT01924767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982600|NCT01924767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19982601|NCT01924767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982602|NCT01924871|Remifentanil|remifentanil|mesh-list
19982603|NCT01924871|Desflurane|desflurane|mesh-list
19982604|NCT01924871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19982605|NCT01924871|Narcotics|narcotics|mesh-ancestor
19982606|NCT01924871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19982607|NCT01924871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982608|NCT01924871|Analgesics|analgesics|mesh-ancestor
19982609|NCT01924871|Sensory System Agents|sensory system agents|mesh-ancestor
19982610|NCT01924871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982611|NCT01924871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19982612|NCT01924871|Anesthetics, General|anesthetics, general|mesh-ancestor
19982613|NCT01924871|Anesthetics|anesthetics|mesh-ancestor
19982614|NCT01924949|Sofosbuvir|sofosbuvir|mesh-list
19982615|NCT01924949|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19982616|NCT01924949|Ledipasvir|ledipasvir|mesh-list
19982617|NCT01924949|Antiviral Agents|antiviral agents|mesh-ancestor
19982618|NCT01924949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19982619|NCT01925144|Omeprazole|omeprazole|mesh-list
19982620|NCT01925144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19982621|NCT01925144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19982622|NCT01925144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19982623|NCT01925144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982624|NCT01925144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982625|NCT01925170|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
19982626|NCT01925170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19982627|NCT01925170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982628|NCT01925183|Interferons|interferons|mesh-list
19982629|NCT01925183|Ribavirin|ribavirin|mesh-list
19982630|NCT01925183|Interferon-alpha|interferon-alpha|mesh-list
19982631|NCT01925183|Interferon alpha-2|interferon alpha-2|mesh-list
19982632|NCT01925183|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19982633|NCT01925183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982634|NCT01925183|Antiviral Agents|antiviral agents|mesh-ancestor
19982635|NCT01925183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19982636|NCT01925183|Antimetabolites|antimetabolites|mesh-ancestor
19982637|NCT01925183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982638|NCT01925183|Immunologic Factors|immunologic factors|mesh-ancestor
19982639|NCT01925183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982640|NCT01925274|Irinotecan|irinotecan|mesh-list
19982641|NCT01925274|Cetuximab|cetuximab|mesh-list
19982642|NCT01925274|Gedatolisib|gedatolisib|mesh-list
19982643|NCT01925274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19982644|NCT01925274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19982645|NCT01925274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982646|NCT01925274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982647|NCT01925274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982648|NCT01925274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19982649|NCT01925274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19982650|NCT01925469|Benzocaine|benzocaine|mesh-list
19982651|NCT01925469|Anesthetics, Local|anesthetics, local|mesh-ancestor
19982652|NCT01925469|Anesthetics|anesthetics|mesh-ancestor
19982653|NCT01925469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19982654|NCT01925469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982655|NCT01925469|Sensory System Agents|sensory system agents|mesh-ancestor
19982656|NCT01925469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982657|NCT01925612|Prednisone|prednisone|mesh-list
19982658|NCT01925612|Cyclophosphamide|cyclophosphamide|mesh-list
19982659|NCT01925612|Rituximab|rituximab|mesh-list
19982660|NCT01925612|Doxorubicin|doxorubicin|mesh-list
19982661|NCT01925612|Vincristine|vincristine|mesh-list
19982662|NCT01925612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19982663|NCT01925612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19982664|NCT01925612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19982665|NCT01925612|Immunologic Factors|immunologic factors|mesh-ancestor
19982666|NCT01925612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982667|NCT01925612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19982668|NCT01925612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19982669|NCT01925612|Alkylating Agents|alkylating agents|mesh-ancestor
19982670|NCT01925612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982671|NCT01925612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982672|NCT01925612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19982673|NCT01925612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19982674|NCT01925612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19982675|NCT01925612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19982676|NCT01925612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19982677|NCT01925612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982678|NCT01925612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19982679|NCT01925612|Glucocorticoids|glucocorticoids|mesh-ancestor
19982680|NCT01925612|Hormones|hormones|mesh-ancestor
19982681|NCT01925612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19982682|NCT01925612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19982683|NCT01925612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19982684|NCT01925612|Tubulin Modulators|tubulin modulators|mesh-ancestor
19982685|NCT01925612|Antimitotic Agents|antimitotic agents|mesh-ancestor
19982686|NCT01925612|Mitosis Modulators|mitosis modulators|mesh-ancestor
19982687|NCT01925703|Ferric gluconate|ferric gluconate|mesh-list
19982688|NCT01925703|Hematinics|hematinics|mesh-ancestor
19982689|NCT01925768|Apremilast|apremilast|mesh-list
19982690|NCT01925768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19982691|NCT01925768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19982692|NCT01925768|Analgesics|analgesics|mesh-ancestor
19982693|NCT01925768|Sensory System Agents|sensory system agents|mesh-ancestor
19982694|NCT01925768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982695|NCT01925768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982696|NCT01925768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19982697|NCT01925768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19982698|NCT01925768|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19982699|NCT01925768|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19982700|NCT01925768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982701|NCT01925768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982702|NCT01925781|Nicotine|nicotine|mesh-list
19982703|NCT01925781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19982704|NCT01925781|Autonomic Agents|autonomic agents|mesh-ancestor
19982705|NCT01925781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982706|NCT01925781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982707|NCT01925781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19982708|NCT01925781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19982709|NCT01925781|Cholinergic Agents|cholinergic agents|mesh-ancestor
19982710|NCT01925781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19982711|NCT01925781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982712|NCT01925950|Beclomethasone|beclomethasone|mesh-list
19982713|NCT01925950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19982714|NCT01925950|Glucocorticoids|glucocorticoids|mesh-ancestor
19982715|NCT01925950|Hormones|hormones|mesh-ancestor
19982716|NCT01925950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19982717|NCT01925950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982718|NCT01925950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19982719|NCT01925950|Respiratory System Agents|respiratory system agents|mesh-ancestor
19982720|NCT01925989|Insulin Glargine|insulin glargine|mesh-list
19982721|NCT01925989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19982722|NCT01925989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982723|NCT01926444|Trimebutine|trimebutine|mesh-list
19982724|NCT01926444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19982725|NCT01926444|Parasympatholytics|parasympatholytics|mesh-ancestor
19982726|NCT01926444|Autonomic Agents|autonomic agents|mesh-ancestor
19982727|NCT01926444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982728|NCT01926444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982729|NCT01926496|Imiquimod|imiquimod|mesh-list
19982730|NCT01926496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19982731|NCT01926496|Immunologic Factors|immunologic factors|mesh-ancestor
19982732|NCT01926496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982733|NCT01926496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982734|NCT01926496|Interferon Inducers|interferon inducers|mesh-ancestor
19982735|NCT01926626|Moclobemide|moclobemide|mesh-list
19982736|NCT01926626|Nicotine|nicotine|mesh-list
19982737|NCT01926626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19982738|NCT01926626|Autonomic Agents|autonomic agents|mesh-ancestor
19982739|NCT01926626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982740|NCT01926626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982741|NCT01926626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19982742|NCT01926626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19982743|NCT01926626|Cholinergic Agents|cholinergic agents|mesh-ancestor
19982744|NCT01926626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19982745|NCT01926626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982746|NCT01926626|Antidepressive Agents|antidepressive agents|mesh-ancestor
19982747|NCT01926626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19982748|NCT01926626|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19982749|NCT01926626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982750|NCT01926782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19982751|NCT01926782|Immunologic Factors|immunologic factors|mesh-ancestor
19982752|NCT01926782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982753|NCT01926886|Trastuzumab|trastuzumab|mesh-list
19453315|NCT03405155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453316|NCT03405142|Panitumumab|panitumumab|mesh-list
19453317|NCT03405142|Diethylenetriamine|diethylenetriamine|mesh-list
19453318|NCT03405142|Dextrans|dextrans|mesh-list
19453319|NCT03405142|Edetic Acid|edetic acid|mesh-list
19453320|NCT03405142|Pentetic Acid|pentetic acid|mesh-list
19453321|NCT03405142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19453322|NCT03405142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453323|NCT03405142|Anticoagulants|anticoagulants|mesh-ancestor
19453324|NCT03405142|Plasma Substitutes|plasma substitutes|mesh-ancestor
19453325|NCT03405142|Blood Substitutes|blood substitutes|mesh-ancestor
19453326|NCT03405142|Antidotes|antidotes|mesh-ancestor
19453327|NCT03405142|Protective Agents|protective agents|mesh-ancestor
19453328|NCT03405142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453329|NCT03405142|Chelating Agents|chelating agents|mesh-ancestor
19453330|NCT03405142|Sequestering Agents|sequestering agents|mesh-ancestor
19453331|NCT03405142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453332|NCT03405142|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19453333|NCT03405142|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19453334|NCT03405142|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19453335|NCT03405064|Linezolid|linezolid|mesh-list
19453336|NCT03405064|Levonadifloxacin|levonadifloxacin|mesh-list
19453337|NCT03405064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19453338|NCT03405064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19453339|NCT03405064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19453340|NCT03405064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453341|NCT03405064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736185|NCT04532684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736186|NCT04532684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19736187|NCT04532684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19736188|NCT04532684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19736189|NCT04532684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19736190|NCT04532684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19736191|NCT04532684|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19736192|NCT04532684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19736193|NCT04532684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19736194|NCT04532684|Antidepressive Agents|antidepressive agents|mesh-ancestor
19736195|NCT04532684|Dopamine Agents|dopamine agents|mesh-ancestor
19736196|NCT04532736|Mometasone Furoate|mometasone furoate|mesh-list
19736197|NCT04532736|Methylprednisolone|methylprednisolone|mesh-list
19736198|NCT04532736|Methotrexate|methotrexate|mesh-list
19736199|NCT04532736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19736200|NCT04532736|Abortifacient Agents|abortifacient agents|mesh-ancestor
19736201|NCT04532736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19736202|NCT04532736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736203|NCT04532736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20289067|NCT05011266|Analgesics|analgesics|mesh-ancestor
19736204|NCT04532736|Antimetabolites|antimetabolites|mesh-ancestor
19982754|NCT01926886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19982755|NCT01926886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982756|NCT01926977|Ranibizumab|ranibizumab|mesh-list
19982757|NCT01926977|Aflibercept|aflibercept|mesh-list
19982758|NCT01926977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19982759|NCT01926977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19982760|NCT01926977|Growth Substances|growth substances|mesh-ancestor
19982761|NCT01926977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982762|NCT01926977|Growth Inhibitors|growth inhibitors|mesh-ancestor
19982763|NCT01926977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982764|NCT01927055|Mannitol|mannitol|mesh-list
19982765|NCT01927055|Droxidopa|droxidopa|mesh-list
19982766|NCT01927055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20556139|NCT01945047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20556140|NCT01945047|Anesthetics, General|anesthetics, general|mesh-ancestor
20556141|NCT01945047|Anesthetics|anesthetics|mesh-ancestor
20556142|NCT01945047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20556143|NCT01945047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20556144|NCT01945047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20556145|NCT01945047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20556146|NCT01945047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556147|NCT01945047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20556148|NCT01945047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20556149|NCT01945047|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20556150|NCT01945047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20556151|NCT01945047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20556152|NCT01945047|GABA Modulators|gaba modulators|mesh-ancestor
20556153|NCT01945047|GABA Agents|gaba agents|mesh-ancestor
20556154|NCT01945099|Insulin|insulin|mesh-list
20556155|NCT01945099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20556156|NCT01945099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556157|NCT01945268|Vaccines|vaccines|mesh-list
20556158|NCT01945268|Immunologic Factors|immunologic factors|mesh-ancestor
19453342|NCT03404947|Ethanol|ethanol|mesh-list
19453343|NCT03404947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19453344|NCT03404947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19453345|NCT03404947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19453346|NCT03404947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453347|NCT03404908|Acetaminophen|acetaminophen|mesh-list
19453348|NCT03404908|Dipyrone|dipyrone|mesh-list
19453349|NCT03404908|Ketoprofen|ketoprofen|mesh-list
19453350|NCT03404908|Morphine|morphine|mesh-list
19453351|NCT03404908|Ropivacaine|ropivacaine|mesh-list
19453352|NCT03404908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19453353|NCT03404908|Narcotics|narcotics|mesh-ancestor
19453354|NCT03404908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19453355|NCT03404908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453356|NCT03404908|Analgesics|analgesics|mesh-ancestor
19453357|NCT03404908|Sensory System Agents|sensory system agents|mesh-ancestor
19453358|NCT03404908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19453359|NCT03404908|Anesthetics, Local|anesthetics, local|mesh-ancestor
19453360|NCT03404908|Anesthetics|anesthetics|mesh-ancestor
19982767|NCT01927055|Diuretics|diuretics|mesh-ancestor
19982768|NCT01927055|Natriuretic Agents|natriuretic agents|mesh-ancestor
19982769|NCT01927055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982770|NCT01927055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19982771|NCT01927055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19982772|NCT01927120|Sirolimus|sirolimus|mesh-list
19982773|NCT01927120|Aldesleukin|aldesleukin|mesh-list
19982774|NCT01927120|Tacrolimus|tacrolimus|mesh-list
19982775|NCT01927120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19982776|NCT01927120|Immunologic Factors|immunologic factors|mesh-ancestor
19982777|NCT01927120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982778|NCT01927120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19982779|NCT01927120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982780|NCT01927120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982781|NCT01927120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19982782|NCT01927120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19982783|NCT01927120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19982784|NCT01927120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982785|NCT01927120|Antifungal Agents|antifungal agents|mesh-ancestor
19982786|NCT01927120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19982787|NCT01927120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19982788|NCT01927120|Antiviral Agents|antiviral agents|mesh-ancestor
19982789|NCT01927341|Panitumumab|panitumumab|mesh-list
19982790|NCT01927341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19982791|NCT01927341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982792|NCT01927718|Thalidomide|thalidomide|mesh-list
19982793|NCT01927718|Lenalidomide|lenalidomide|mesh-list
19982794|NCT01927718|Immunologic Factors|immunologic factors|mesh-ancestor
19982795|NCT01927718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982796|NCT01927718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19982797|NCT01927718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19982798|NCT01927718|Growth Substances|growth substances|mesh-ancestor
19982799|NCT01927718|Growth Inhibitors|growth inhibitors|mesh-ancestor
19982800|NCT01927718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982801|NCT01927718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19982802|NCT01927718|Leprostatic Agents|leprostatic agents|mesh-ancestor
19982803|NCT01927718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19982804|NCT01927718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19982805|NCT01927757|Etanercept|etanercept|mesh-list
19982806|NCT01927757|Methotrexate|methotrexate|mesh-list
19982807|NCT01927757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19982808|NCT01927757|Abortifacient Agents|abortifacient agents|mesh-ancestor
19982809|NCT01927757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19982810|NCT01927757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982811|NCT01927757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19982812|NCT01927757|Antimetabolites|antimetabolites|mesh-ancestor
19453361|NCT03404908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19453362|NCT03404908|Antipyretics|antipyretics|mesh-ancestor
19453363|NCT03404908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19453364|NCT03404908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19453365|NCT03404908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19453366|NCT03404908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19453367|NCT03404908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453368|NCT03404908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453369|NCT03404804|Amoxicillin|amoxicillin|mesh-list
19453370|NCT03404804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19453371|NCT03404804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19453372|NCT03404752|Lenograstim|lenograstim|mesh-list
19453373|NCT03404752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19453374|NCT03404752|Immunologic Factors|immunologic factors|mesh-ancestor
19453375|NCT03404752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453376|NCT03404739|Ceftazidime|ceftazidime|mesh-list
19453377|NCT03404739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19453378|NCT03404739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20289068|NCT05011266|Sensory System Agents|sensory system agents|mesh-ancestor
20289069|NCT05011266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20289070|NCT05011266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20289071|NCT05001828|Azacitidine|azacitidine|mesh-list
20289072|NCT05001828|Venetoclax|venetoclax|mesh-list
19453384|NCT03404635|Rivaroxaban|rivaroxaban|mesh-list
19453385|NCT03404635|Apixaban|apixaban|mesh-list
19453386|NCT03404635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19453387|NCT03404635|Antithrombins|antithrombins|mesh-ancestor
19453388|NCT03404635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19453389|NCT03404635|Protease Inhibitors|protease inhibitors|mesh-ancestor
19453390|NCT03404635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453391|NCT03404635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453392|NCT03404635|Anticoagulants|anticoagulants|mesh-ancestor
19453393|NCT03404544|Carbetocin|carbetocin|mesh-list
19453394|NCT03404544|Oxytocin|oxytocin|mesh-list
19453395|NCT03404544|Oxytocics|oxytocics|mesh-ancestor
19453396|NCT03404544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19453397|NCT03404544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453398|NCT03404479|Celecoxib|celecoxib|mesh-list
19453399|NCT03404479|Diacetylrhein|diacetylrhein|mesh-list
19453400|NCT03404479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19453401|NCT03404479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19453402|NCT03404479|Analgesics|analgesics|mesh-ancestor
19453403|NCT03404479|Sensory System Agents|sensory system agents|mesh-ancestor
19453404|NCT03404479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19453405|NCT03404479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453406|NCT03404479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19453407|NCT03404479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19982813|NCT01927757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982814|NCT01927757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982815|NCT01927757|Dermatologic Agents|dermatologic agents|mesh-ancestor
19982816|NCT01927757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982817|NCT01927757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19453408|NCT03404479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19453409|NCT03404479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19453410|NCT03404479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453411|NCT03404479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453412|NCT03404414|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19453413|NCT03404414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19453414|NCT03404414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453415|NCT03404310|Zinc Sulfate|zinc sulfate|mesh-list
19453416|NCT03404310|Astringents|astringents|mesh-ancestor
19453417|NCT03404310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736205|NCT04532736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736206|NCT04532736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736207|NCT04532736|Dermatologic Agents|dermatologic agents|mesh-ancestor
19736208|NCT04532736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736209|NCT04532736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19736210|NCT04532736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19736211|NCT04532736|Immunologic Factors|immunologic factors|mesh-ancestor
19736212|NCT04532736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19736213|NCT04532736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19736214|NCT04532736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19736215|NCT04532736|Antiemetics|antiemetics|mesh-ancestor
19736216|NCT04532736|Autonomic Agents|autonomic agents|mesh-ancestor
19736217|NCT04532736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19736218|NCT04532736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19736219|NCT04532736|Glucocorticoids|glucocorticoids|mesh-ancestor
19736220|NCT04532736|Hormones|hormones|mesh-ancestor
19736221|NCT04532736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19736222|NCT04532736|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19736223|NCT04532736|Protective Agents|protective agents|mesh-ancestor
19736224|NCT04532736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19736225|NCT04532710|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19736226|NCT04532710|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19736227|NCT04532606|Anesthetics|anesthetics|mesh-list
19736228|NCT04532606|Propofol|propofol|mesh-list
19736229|NCT04532606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19736230|NCT04532606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736231|NCT04532606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19736232|NCT04532606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19736233|NCT04532606|Anesthetics, General|anesthetics, general|mesh-ancestor
19736234|NCT04532554|Hormones|hormones|mesh-list
19453418|NCT03404310|Dermatologic Agents|dermatologic agents|mesh-ancestor
19453419|NCT03404284|Vaccines|vaccines|mesh-list
19453420|NCT03404284|Immunologic Factors|immunologic factors|mesh-ancestor
19453421|NCT03404284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453422|NCT03404037|Endostatins|endostatins|mesh-list
19453423|NCT03404037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453424|NCT03404037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19453425|NCT03404037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19982818|NCT01927757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19982819|NCT01927757|Immunologic Factors|immunologic factors|mesh-ancestor
19982820|NCT01927757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19982821|NCT01927757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19982822|NCT01927757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19982823|NCT01927757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19982824|NCT01927757|Analgesics|analgesics|mesh-ancestor
19982825|NCT01927757|Sensory System Agents|sensory system agents|mesh-ancestor
19982826|NCT01927757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982827|NCT01927757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19982828|NCT01927757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19982829|NCT01927887|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19453426|NCT03404037|Growth Substances|growth substances|mesh-ancestor
19453427|NCT03404037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453428|NCT03404037|Growth Inhibitors|growth inhibitors|mesh-ancestor
19982830|NCT01927887|Hematinics|hematinics|mesh-ancestor
19982831|NCT01927887|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19982832|NCT01927887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19982833|NCT01928186|Alovudine|alovudine|mesh-list
19982834|NCT01928186|Antiviral Agents|antiviral agents|mesh-ancestor
19982835|NCT01928186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19982836|NCT01928199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19982837|NCT01928199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19982838|NCT01928199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982839|NCT01928199|Incretins|incretins|mesh-ancestor
19982840|NCT01928199|Hormones|hormones|mesh-ancestor
19982841|NCT01928199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19982842|NCT01928199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19982843|NCT01928199|Protease Inhibitors|protease inhibitors|mesh-ancestor
19982844|NCT01928199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982845|NCT01928199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982846|NCT01928225|Vaccines|vaccines|mesh-list
19982847|NCT01928225|Immunologic Factors|immunologic factors|mesh-ancestor
19982848|NCT01928225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982849|NCT01928290|Leucovorin|leucovorin|mesh-list
19982850|NCT01928290|Tetrahydrofolates|tetrahydrofolates|mesh-list
19982851|NCT01928290|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
19982852|NCT01928290|Fluorouracil|fluorouracil|mesh-list
19982853|NCT01928290|Oxaliplatin|oxaliplatin|mesh-list
19982854|NCT01928290|Trastuzumab|trastuzumab|mesh-list
19982855|NCT01928290|Irinotecan|irinotecan|mesh-list
19982856|NCT01928290|Levoleucovorin|levoleucovorin|mesh-list
19982857|NCT01928290|Antimetabolites|antimetabolites|mesh-ancestor
19982858|NCT01928290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982859|NCT01928290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19982860|NCT01928290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453429|NCT03404024|Mitogens|mitogens|mesh-list
19453430|NCT03404024|Mitosis Modulators|mitosis modulators|mesh-ancestor
19982861|NCT01928290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19453431|NCT03404024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453432|NCT03404011|Glycerol|glycerol|mesh-list
19453433|NCT03404011|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19453434|NCT03404011|Protective Agents|protective agents|mesh-ancestor
19453435|NCT03404011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453436|NCT03403985|Calcium|calcium|mesh-list
19453437|NCT03403985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19453438|NCT03403985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453439|NCT03403972|Vancomycin|vancomycin|mesh-list
19453440|NCT03403972|Simvastatin|simvastatin|mesh-list
19453441|NCT03403972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19453442|NCT03403972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19453443|NCT03403972|Antimetabolites|antimetabolites|mesh-ancestor
19453444|NCT03403972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453445|NCT03403972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19453446|NCT03403972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19453447|NCT03403972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453448|NCT03403972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19453449|NCT03403972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19453450|NCT03403946|Pyrithione zinc|pyrithione zinc|mesh-list
19453451|NCT03403946|Keratolytic Agents|keratolytic agents|mesh-ancestor
19453452|NCT03403946|Dermatologic Agents|dermatologic agents|mesh-ancestor
19453453|NCT03403842|Sufentanil|sufentanil|mesh-list
19453454|NCT03403842|Morphine|morphine|mesh-list
19453455|NCT03403842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19453456|NCT03403842|Narcotics|narcotics|mesh-ancestor
19453457|NCT03403842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19453458|NCT03403842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453459|NCT03403842|Analgesics|analgesics|mesh-ancestor
19453460|NCT03403842|Sensory System Agents|sensory system agents|mesh-ancestor
19453461|NCT03403842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19453462|NCT03403842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19453463|NCT03403842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19453464|NCT03403842|Anesthetics, General|anesthetics, general|mesh-ancestor
19453465|NCT03403842|Anesthetics|anesthetics|mesh-ancestor
19453466|NCT03403829|Gemcitabine|gemcitabine|mesh-list
19453467|NCT03403829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19453468|NCT03403829|Antimetabolites|antimetabolites|mesh-ancestor
19453469|NCT03403829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453470|NCT03403829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453471|NCT03403829|Antiviral Agents|antiviral agents|mesh-ancestor
19453472|NCT03403829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19453473|NCT03403829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453474|NCT03403829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19453475|NCT03403829|Immunologic Factors|immunologic factors|mesh-ancestor
19453476|NCT03403829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453477|NCT03403790|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19453478|NCT03403790|Antidepressive Agents|antidepressive agents|mesh-ancestor
19453479|NCT03403790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19453480|NCT03403790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19453481|NCT03403790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19453482|NCT03403790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19453483|NCT03403790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982862|NCT01928290|Immunologic Factors|immunologic factors|mesh-ancestor
19982863|NCT01928290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982864|NCT01928290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19982865|NCT01928290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19982866|NCT01928290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19982867|NCT01928290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982868|NCT01928290|Antidotes|antidotes|mesh-ancestor
19982869|NCT01928290|Protective Agents|protective agents|mesh-ancestor
19982870|NCT01928290|Vitamin B Complex|vitamin b complex|mesh-ancestor
19982871|NCT01928290|Vitamins|vitamins|mesh-ancestor
19982872|NCT01928290|Micronutrients|micronutrients|mesh-ancestor
19982873|NCT01928329|Exenatide|exenatide|mesh-list
19982874|NCT01928329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19982875|NCT01928329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982876|NCT01928329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19982877|NCT01928329|Incretins|incretins|mesh-ancestor
19982878|NCT01928329|Hormones|hormones|mesh-ancestor
19453484|NCT03403777|Avelumab|avelumab|mesh-list
19982879|NCT01928329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19982880|NCT01928381|Pregabalin|pregabalin|mesh-list
19982881|NCT01928381|Analgesics|analgesics|mesh-ancestor
19982882|NCT01928381|Sensory System Agents|sensory system agents|mesh-ancestor
19982883|NCT01928381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982884|NCT01928381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982885|NCT01928381|Anticonvulsants|anticonvulsants|mesh-ancestor
19982886|NCT01928381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19982887|NCT01928381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19982888|NCT01928381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982889|NCT01928381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19982890|NCT01928381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19453485|NCT03403777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19453486|NCT03403777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453487|NCT03403647|Vitamin D|vitamin d|mesh-list
19453488|NCT03403647|Vitamins|vitamins|mesh-ancestor
19453489|NCT03403647|Micronutrients|micronutrients|mesh-ancestor
19453490|NCT03403647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453491|NCT03403647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19982891|NCT01928381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19982892|NCT01928381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19982893|NCT01928381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19982894|NCT01928433|Ciprofloxacin|ciprofloxacin|mesh-list
19982895|NCT01928433|Finafloxacin|finafloxacin|mesh-list
19982896|NCT01928433|Fluoroquinolones|fluoroquinolones|mesh-list
19982897|NCT01928433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19982898|NCT01928433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19982899|NCT01928433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19982900|NCT01928433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19453492|NCT03403595|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
19453493|NCT03403595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19453494|NCT03403595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453495|NCT03403452|Apatinib|apatinib|mesh-list
19453496|NCT03403452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982901|NCT01928433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982902|NCT01928433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982903|NCT01928433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982904|NCT01928433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19982905|NCT01928433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19982906|NCT01928433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19982907|NCT01928433|Renal Agents|renal agents|mesh-ancestor
19982908|NCT01928433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19982909|NCT01928446|Lithium Carbonate|lithium carbonate|mesh-list
19453497|NCT03403452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19453498|NCT03403452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982910|NCT01928446|Antidepressive Agents|antidepressive agents|mesh-ancestor
19982911|NCT01928446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19982912|NCT01928446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982913|NCT01928446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982914|NCT01928446|Antimanic Agents|antimanic agents|mesh-ancestor
19982915|NCT01928446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19982916|NCT01928446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19982917|NCT01928446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982918|NCT01928680|Capecitabine|capecitabine|mesh-list
19982919|NCT01928680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982920|NCT01928680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19982921|NCT01928680|Antimetabolites|antimetabolites|mesh-ancestor
19982922|NCT01928680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982923|NCT01928693|Moxifloxacin|moxifloxacin|mesh-list
19982924|NCT01928693|Gatifloxacin|gatifloxacin|mesh-list
19982925|NCT01928693|Besifloxacin|besifloxacin|mesh-list
19982926|NCT01928693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19982927|NCT01928693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19982928|NCT01928693|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19982929|NCT01928693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19982930|NCT01928693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19982931|NCT01928693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19982932|NCT01928693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19982933|NCT01928693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982934|NCT01928693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982935|NCT01928693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982936|NCT01928693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19982937|NCT01928693|Contraceptive Agents|contraceptive agents|mesh-ancestor
19982938|NCT01928693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19982939|NCT01928693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982940|NCT01928693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19982941|NCT01928693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19982942|NCT01928693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19982943|NCT01928719|Nicotine|nicotine|mesh-list
19982944|NCT01928719|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19982945|NCT01928719|Autonomic Agents|autonomic agents|mesh-ancestor
19982946|NCT01928719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982947|NCT01928719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982948|NCT01928719|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19982949|NCT01928719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19982950|NCT01928719|Cholinergic Agents|cholinergic agents|mesh-ancestor
19982951|NCT01928719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19453499|NCT03403452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453500|NCT03403439|Itraconazole|itraconazole|mesh-list
19453501|NCT03403439|Antifungal Agents|antifungal agents|mesh-ancestor
19453502|NCT03403439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19453503|NCT03403439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19453504|NCT03403439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19453505|NCT03403439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453506|NCT03403439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453507|NCT03403439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19453508|NCT03403439|Hormone Antagonists|hormone antagonists|mesh-ancestor
19453509|NCT03403439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19453510|NCT03403439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453511|NCT03403439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19453512|NCT03403140|Etanercept|etanercept|mesh-list
19453513|NCT03403140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19453514|NCT03403140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19453515|NCT03403140|Analgesics|analgesics|mesh-ancestor
19453516|NCT03403140|Sensory System Agents|sensory system agents|mesh-ancestor
19453517|NCT03403140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19453518|NCT03403140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453519|NCT03403140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19453520|NCT03403140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19453521|NCT03403140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19453522|NCT03403140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19453523|NCT03403140|Immunologic Factors|immunologic factors|mesh-ancestor
19453524|NCT03403101|Oxaliplatin|oxaliplatin|mesh-list
19453525|NCT03403101|Irinotecan|irinotecan|mesh-list
19982952|NCT01928719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982953|NCT01928758|Nicotine|nicotine|mesh-list
19982954|NCT01928758|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19982955|NCT01928758|Autonomic Agents|autonomic agents|mesh-ancestor
19982956|NCT01928758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982957|NCT01928758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982958|NCT01928758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19982959|NCT01928758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19982960|NCT01928758|Cholinergic Agents|cholinergic agents|mesh-ancestor
19982961|NCT01928758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19982962|NCT01928758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982963|NCT01928771|Benralizumab|benralizumab|mesh-list
19982964|NCT01928771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19982965|NCT01928771|Respiratory System Agents|respiratory system agents|mesh-ancestor
19982966|NCT01928849|Valproic Acid|valproic acid|mesh-list
19982967|NCT01928849|Anticonvulsants|anticonvulsants|mesh-ancestor
19982968|NCT01928849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453526|NCT03403101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453527|NCT03403101|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19453528|NCT03403101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19453529|NCT03403101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453530|NCT03403101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736235|NCT04532554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19736236|NCT04532554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736237|NCT04532229|Nimotuzumab|nimotuzumab|mesh-list
19736238|NCT04532229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19736239|NCT04532229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736240|NCT04532060|Anti-Infective Agents|anti-infective agents|mesh-list
19736241|NCT04532060|Nystatin|nystatin|mesh-list
19736242|NCT04532060|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19736243|NCT04532060|Antifungal Agents|antifungal agents|mesh-ancestor
19736244|NCT04532060|Ionophores|ionophores|mesh-ancestor
19736245|NCT04532060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19736246|NCT04532060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736247|NCT04532281|Carbamide Peroxide|carbamide peroxide|mesh-list
19736248|NCT04532281|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19736249|NCT04532281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736250|NCT04532164|Antifungal Agents|antifungal agents|mesh-list
19736251|NCT04532164|Clotrimazole|clotrimazole|mesh-list
19736252|NCT04532164|Miconazole|miconazole|mesh-list
19736253|NCT04532164|Butenafine|butenafine|mesh-list
19736254|NCT04532164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736255|NCT04532164|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19736256|NCT04532164|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19736257|NCT04532164|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19736258|NCT04532164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736259|NCT04532164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736260|NCT04532164|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19736261|NCT04532164|Hormone Antagonists|hormone antagonists|mesh-ancestor
19736262|NCT04532164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19736263|NCT04532164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736264|NCT04532164|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19736265|NCT04532164|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19736266|NCT04532333|Heparin|heparin|mesh-list
19736267|NCT04532333|Bivalirudin|bivalirudin|mesh-list
19736268|NCT04532333|Anticoagulants|anticoagulants|mesh-ancestor
19736269|NCT04532333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19736270|NCT04532333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19736271|NCT04532333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736272|NCT04532333|Antithrombins|antithrombins|mesh-ancestor
19736273|NCT04532333|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19736274|NCT04532333|Protease Inhibitors|protease inhibitors|mesh-ancestor
19736275|NCT04532333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736276|NCT04531878|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
19736277|NCT04531878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736278|NCT04531865|Mycophenolic Acid|mycophenolic acid|mesh-list
19736279|NCT04531865|Rituximab|rituximab|mesh-list
19736280|NCT04531865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19736281|NCT04531865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736282|NCT04531865|Immunologic Factors|immunologic factors|mesh-ancestor
19736283|NCT04531865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736284|NCT04531865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19736285|NCT04531865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19736286|NCT04531865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19736287|NCT04531865|Antitubercular Agents|antitubercular agents|mesh-ancestor
19736288|NCT04531865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19736289|NCT04531865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736290|NCT04531865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736291|NCT04531865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736292|NCT04531800|Mitogens|mitogens|mesh-list
19736293|NCT04531800|Mitosis Modulators|mitosis modulators|mesh-ancestor
19736294|NCT04531800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736295|NCT04531813|Butenafine|butenafine|mesh-list
19736296|NCT04531813|Antifungal Agents|antifungal agents|mesh-ancestor
20289073|NCT05001828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19736297|NCT04531813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736298|NCT04531748|Toremifene|toremifene|mesh-list
19453531|NCT03403049|Gemcitabine|gemcitabine|mesh-list
19453532|NCT03403049|Capecitabine|capecitabine|mesh-list
19453533|NCT03403049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19453534|NCT03403049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453535|NCT03403049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19453536|NCT03403049|Antimetabolites|antimetabolites|mesh-ancestor
19453537|NCT03403049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453538|NCT03403049|Antiviral Agents|antiviral agents|mesh-ancestor
19453539|NCT03403049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19453540|NCT03403049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453541|NCT03403049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19453542|NCT03403049|Immunologic Factors|immunologic factors|mesh-ancestor
19453543|NCT03403049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453544|NCT03403049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19453545|NCT03403023|Cyclosporine|cyclosporine|mesh-list
19453546|NCT03403023|Cyclosporins|cyclosporins|mesh-list
19453547|NCT03403023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453548|NCT03403023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453549|NCT03403023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19453550|NCT03403023|Immunologic Factors|immunologic factors|mesh-ancestor
19453551|NCT03403023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453552|NCT03403023|Antifungal Agents|antifungal agents|mesh-ancestor
19453553|NCT03403023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19453554|NCT03403023|Dermatologic Agents|dermatologic agents|mesh-ancestor
19453555|NCT03403023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19453556|NCT03403023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19453557|NCT03402984|Z 338|z 338|mesh-list
19453558|NCT03402984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19453559|NCT03402984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736299|NCT04531748|Melatonin|melatonin|mesh-list
19982969|NCT01928849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982970|NCT01928849|GABA Agents|gaba agents|mesh-ancestor
19982971|NCT01928849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19982972|NCT01928849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982973|NCT01928849|Antimanic Agents|antimanic agents|mesh-ancestor
19982974|NCT01928849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19982975|NCT01928849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19982976|NCT01928849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19982977|NCT01928927|Telmisartan|telmisartan|mesh-list
19982978|NCT01928927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19982979|NCT01928927|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19982980|NCT01928927|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20289074|NCT05001828|Antimetabolites|antimetabolites|mesh-ancestor
19736300|NCT04531748|Antioxidants|antioxidants|mesh-ancestor
19453560|NCT03402984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453561|NCT03402984|Cholinergic Agents|cholinergic agents|mesh-ancestor
19453562|NCT03402984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19453563|NCT03402984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453564|NCT03402984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19453565|NCT03402880|Pembrolizumab|pembrolizumab|mesh-list
19453566|NCT03402880|Immunoglobulins|immunoglobulins|mesh-list
19453567|NCT03402880|Immunoglobulin G|immunoglobulin g|mesh-list
19453568|NCT03402880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19453569|NCT03402880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453570|NCT03402880|Immunologic Factors|immunologic factors|mesh-ancestor
19453571|NCT03402880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453572|NCT03402815|Maraviroc|maraviroc|mesh-list
19453573|NCT03402815|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19453574|NCT03402815|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19453575|NCT03402815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453576|NCT03402815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19453577|NCT03402815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19453578|NCT03402815|Antiviral Agents|antiviral agents|mesh-ancestor
19453579|NCT03402815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19453580|NCT03402815|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19453581|NCT03402698|Cholecalciferol|cholecalciferol|mesh-list
19453582|NCT03402698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19453583|NCT03402698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982981|NCT01928927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982982|NCT01928940|Trametinib|trametinib|mesh-list
19982983|NCT01928940|Dabrafenib|dabrafenib|mesh-list
19982984|NCT01928940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19982985|NCT01928940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19982986|NCT01928940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19982987|NCT01928940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19982988|NCT01929031|Ibuprofen|ibuprofen|mesh-list
19982989|NCT01929031|Caffeine|caffeine|mesh-list
19982990|NCT01929031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19982991|NCT01929031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19982992|NCT01929031|Analgesics|analgesics|mesh-ancestor
19982993|NCT01929031|Sensory System Agents|sensory system agents|mesh-ancestor
19982994|NCT01929031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19982995|NCT01929031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19982996|NCT01929031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19982997|NCT01929031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19982998|NCT01929031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20556159|NCT01945268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556160|NCT01945437|Magnesium Sulfate|magnesium sulfate|mesh-list
20556161|NCT01945437|Analgesics|analgesics|mesh-ancestor
20556162|NCT01945437|Sensory System Agents|sensory system agents|mesh-ancestor
20556163|NCT01945437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556164|NCT01945437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556165|NCT01945437|Anesthetics|anesthetics|mesh-ancestor
20556166|NCT01945437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20556167|NCT01945437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20556168|NCT01945437|Anticonvulsants|anticonvulsants|mesh-ancestor
20556169|NCT01945437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20556170|NCT01945437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20556171|NCT01945437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556172|NCT01945437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20556173|NCT01945437|Tocolytic Agents|tocolytic agents|mesh-ancestor
20556174|NCT01945437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20556175|NCT01945450|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20556176|NCT01945450|Clindamycin|clindamycin|mesh-list
20556177|NCT01945450|Clindamycin palmitate|clindamycin palmitate|mesh-list
20556178|NCT01945450|Clindamycin phosphate|clindamycin phosphate|mesh-list
20556179|NCT01945450|Gentamicins|gentamicins|mesh-list
20556180|NCT01945450|Ampicillin|ampicillin|mesh-list
20556181|NCT01945450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20556182|NCT01945450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20556183|NCT01945450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556184|NCT01945450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556185|NCT01945476|Midazolam|midazolam|mesh-list
20556186|NCT01945476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20556187|NCT01945476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20556188|NCT01945476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19982999|NCT01929031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983000|NCT01929031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983001|NCT01929031|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19983002|NCT01929031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19983003|NCT01929031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19983004|NCT01929031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19983005|NCT01929031|Purinergic Agents|purinergic agents|mesh-ancestor
19983006|NCT01929031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983007|NCT01929044|Anisodamine|anisodamine|mesh-list
19983008|NCT01929044|Scopolamine|scopolamine|mesh-list
19983009|NCT01929044|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19983010|NCT01929044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19983011|NCT01929044|Antiemetics|antiemetics|mesh-ancestor
19983012|NCT01929044|Autonomic Agents|autonomic agents|mesh-ancestor
19983013|NCT01929044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983014|NCT01929044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983015|NCT01929044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19983016|NCT01929044|Mydriatics|mydriatics|mesh-ancestor
19983017|NCT01929044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19983018|NCT01929044|Cholinergic Agents|cholinergic agents|mesh-ancestor
19983019|NCT01929044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983020|NCT01929044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983021|NCT01929044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19983022|NCT01929044|Parasympatholytics|parasympatholytics|mesh-ancestor
19983023|NCT01929044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19983024|NCT01929044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19983025|NCT01929044|Adrenergic Agents|adrenergic agents|mesh-ancestor
19983026|NCT01929044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19453584|NCT03402698|Vitamins|vitamins|mesh-ancestor
19983027|NCT01929044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19983028|NCT01929044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19983029|NCT01929044|Analgesics|analgesics|mesh-ancestor
19983030|NCT01929044|Sensory System Agents|sensory system agents|mesh-ancestor
19983031|NCT01929044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19983032|NCT01929044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19983033|NCT01929044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19983034|NCT01929044|Vasodilator Agents|vasodilator agents|mesh-ancestor
19983035|NCT01929044|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19983036|NCT01929044|Antioxidants|antioxidants|mesh-ancestor
19983037|NCT01929044|Protective Agents|protective agents|mesh-ancestor
19983038|NCT01929083|Ibutilide|ibutilide|mesh-list
19983039|NCT01929083|Progesterone|progesterone|mesh-list
19983040|NCT01929083|Progestins|progestins|mesh-ancestor
19983041|NCT01929083|Hormones|hormones|mesh-ancestor
19983042|NCT01929083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19453585|NCT03402698|Micronutrients|micronutrients|mesh-ancestor
19453586|NCT03402698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19453587|NCT03402503|Montelukast|montelukast|mesh-list
19453588|NCT03402503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19453589|NCT03402503|Respiratory System Agents|respiratory system agents|mesh-ancestor
19453590|NCT03402503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19453591|NCT03402503|Hormone Antagonists|hormone antagonists|mesh-ancestor
19453592|NCT03402503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19453593|NCT03402503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453594|NCT03402503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19453595|NCT03402503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19453596|NCT03402503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453597|NCT03402438|Fulacimstat|fulacimstat|mesh-list
19453598|NCT03402438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453599|NCT03402438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453600|NCT03402321|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
19453601|NCT03402321|Hemostatics|hemostatics|mesh-ancestor
19453602|NCT03402321|Coagulants|coagulants|mesh-ancestor
19453603|NCT03402295|Thalidomide|thalidomide|mesh-list
19453604|NCT03402295|Dexamethasone|dexamethasone|mesh-list
19453605|NCT03402295|Cyclophosphamide|cyclophosphamide|mesh-list
19453606|NCT03402295|Bortezomib|bortezomib|mesh-list
19453607|NCT03402295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19453608|NCT03402295|Immunologic Factors|immunologic factors|mesh-ancestor
19453609|NCT03402295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453610|NCT03402295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19453611|NCT03402295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19453612|NCT03402295|Alkylating Agents|alkylating agents|mesh-ancestor
19453613|NCT03402295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453614|NCT03402295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453615|NCT03402295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19453616|NCT03402295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19453617|NCT03402295|Antiemetics|antiemetics|mesh-ancestor
19453618|NCT03402295|Autonomic Agents|autonomic agents|mesh-ancestor
19453619|NCT03402295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19453620|NCT03402295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19453621|NCT03402295|Glucocorticoids|glucocorticoids|mesh-ancestor
19453622|NCT03402295|Hormones|hormones|mesh-ancestor
19453623|NCT03402295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19453624|NCT03402295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19453625|NCT03402295|Leprostatic Agents|leprostatic agents|mesh-ancestor
19453626|NCT03402295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19453627|NCT03402295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19453628|NCT03402295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19453629|NCT03402295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19453630|NCT03402295|Growth Substances|growth substances|mesh-ancestor
19453631|NCT03402295|Growth Inhibitors|growth inhibitors|mesh-ancestor
19453632|NCT03402204|Ubenimex|ubenimex|mesh-list
19453633|NCT03402204|Simvastatin|simvastatin|mesh-list
19453634|NCT03402204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19453635|NCT03402204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19983043|NCT01929083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983044|NCT01929083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19983045|NCT01929135|Atorvastatin|atorvastatin|mesh-list
19983046|NCT01929135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19983047|NCT01929135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19983048|NCT01929135|Antimetabolites|antimetabolites|mesh-ancestor
19983049|NCT01929135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983050|NCT01929135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19983051|NCT01929135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19983052|NCT01929135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983053|NCT01929291|Vaccines|vaccines|mesh-list
19983054|NCT01929291|Immunologic Factors|immunologic factors|mesh-ancestor
19983055|NCT01929291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983056|NCT01929317|Ropinirole|ropinirole|mesh-list
19983057|NCT01929317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19983058|NCT01929317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19983059|NCT01929317|Dopamine Agonists|dopamine agonists|mesh-ancestor
19983060|NCT01929317|Dopamine Agents|dopamine agents|mesh-ancestor
19983061|NCT01929317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983062|NCT01929317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983063|NCT01929317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983064|NCT01929343|Lidocaine|lidocaine|mesh-list
19983065|NCT01929343|Anesthetics, Local|anesthetics, local|mesh-ancestor
19983066|NCT01929343|Anesthetics|anesthetics|mesh-ancestor
19983067|NCT01929343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19983068|NCT01929343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983069|NCT01929343|Sensory System Agents|sensory system agents|mesh-ancestor
19983070|NCT01929343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983071|NCT01929343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19983072|NCT01929343|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19983073|NCT01929343|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19983074|NCT01929343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19983075|NCT01929343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983076|NCT01929460|Ciprofloxacin|ciprofloxacin|mesh-list
19983077|NCT01929460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19983078|NCT01929460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19983079|NCT01929460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19983080|NCT01929460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19983081|NCT01929460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983082|NCT01929460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453636|NCT03402204|Antimetabolites|antimetabolites|mesh-ancestor
19453637|NCT03402204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453638|NCT03402204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19453639|NCT03402204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19453640|NCT03402204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453641|NCT03402204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19453642|NCT03402204|Immunologic Factors|immunologic factors|mesh-ancestor
19453643|NCT03402204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453644|NCT03402204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19453645|NCT03402204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736301|NCT04531748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736302|NCT04531748|Protective Agents|protective agents|mesh-ancestor
19736303|NCT04531748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736304|NCT04531748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19736305|NCT04531748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19736306|NCT04531748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736307|NCT04531748|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19736308|NCT04531748|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19736309|NCT04531748|Hormone Antagonists|hormone antagonists|mesh-ancestor
19736310|NCT04531748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19736311|NCT04531748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19736312|NCT04531527|Butenafine|butenafine|mesh-list
19736313|NCT04531527|Antifungal Agents|antifungal agents|mesh-ancestor
19736314|NCT04531527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19983083|NCT01929460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983084|NCT01929460|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19983085|NCT01929460|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19983086|NCT01929642|Sirolimus|sirolimus|mesh-list
19983087|NCT01929642|Everolimus|everolimus|mesh-list
19983088|NCT01929642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983089|NCT01929642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19983090|NCT01929642|Immunologic Factors|immunologic factors|mesh-ancestor
19983091|NCT01929642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983092|NCT01929642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19736315|NCT04531371|Dexmedetomidine|dexmedetomidine|mesh-list
19983093|NCT01929642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19983094|NCT01929642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19983095|NCT01929642|Antifungal Agents|antifungal agents|mesh-ancestor
19983096|NCT01929759|Tenofovir|tenofovir|mesh-list
19983097|NCT01929759|Emtricitabine|emtricitabine|mesh-list
19983098|NCT01929759|Cobicistat|cobicistat|mesh-list
19983099|NCT01929759|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19983100|NCT01929759|Elvitegravir|elvitegravir|mesh-list
19983101|NCT01929759|Antiviral Agents|antiviral agents|mesh-ancestor
19983102|NCT01929759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19983103|NCT01929759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19983104|NCT01929759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19983105|NCT01929759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983106|NCT01929759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983107|NCT01929759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19983108|NCT01929759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19983109|NCT01929759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19983110|NCT01929759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19983111|NCT01929759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19983112|NCT01929863|Metformin|metformin|mesh-list
19983113|NCT01929863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19983114|NCT01929863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983115|NCT01929876|Itraconazole|itraconazole|mesh-list
19453646|NCT03402204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19453647|NCT03402204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453648|NCT03402204|Protease Inhibitors|protease inhibitors|mesh-ancestor
19453649|NCT03402204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19453650|NCT03402204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19453651|NCT03402204|Antiviral Agents|antiviral agents|mesh-ancestor
19983116|NCT01929876|Antifungal Agents|antifungal agents|mesh-ancestor
19983117|NCT01929876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19983118|NCT01929876|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19983119|NCT01929876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19453652|NCT03402191|Sildenafil Citrate|sildenafil citrate|mesh-list
19453653|NCT03402191|Vasodilator Agents|vasodilator agents|mesh-ancestor
19453654|NCT03402191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19453655|NCT03402191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19453656|NCT03402191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453657|NCT03402191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453658|NCT03402191|Urological Agents|urological agents|mesh-ancestor
19453659|NCT03402165|Sofosbuvir|sofosbuvir|mesh-list
19453660|NCT03402165|Ledipasvir|ledipasvir|mesh-list
19453661|NCT03402165|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19453662|NCT03402165|Antiviral Agents|antiviral agents|mesh-ancestor
19453663|NCT03402165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19453664|NCT03402152|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19453665|NCT03402152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19453666|NCT03402152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19453667|NCT03402152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19453668|NCT03402152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453669|NCT03402152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19453670|NCT03402152|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19453671|NCT03402152|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19453672|NCT03402152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19453673|NCT03402152|Adrenergic Agents|adrenergic agents|mesh-ancestor
19453674|NCT03402152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19453675|NCT03402152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453676|NCT03402152|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19453677|NCT03402152|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19453678|NCT03402152|Serotonin Agents|serotonin agents|mesh-ancestor
19453679|NCT03402152|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19453680|NCT03402152|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19453681|NCT03402152|Dopamine Agents|dopamine agents|mesh-ancestor
19453682|NCT03402113|Midazolam|midazolam|mesh-list
19453683|NCT03402113|Dexmedetomidine|dexmedetomidine|mesh-list
19453684|NCT03402113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19453685|NCT03402113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19453686|NCT03402113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453687|NCT03402113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19453688|NCT03402113|Analgesics|analgesics|mesh-ancestor
19453689|NCT03402113|Sensory System Agents|sensory system agents|mesh-ancestor
19453690|NCT03402113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19453691|NCT03402113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19453692|NCT03402113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19983120|NCT01929876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983121|NCT01929876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983122|NCT01929876|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19983123|NCT01929876|Hormone Antagonists|hormone antagonists|mesh-ancestor
19736316|NCT04531371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19736317|NCT04531371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19736318|NCT04531371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736319|NCT04531371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19736320|NCT04531371|Analgesics|analgesics|mesh-ancestor
19736321|NCT04531371|Sensory System Agents|sensory system agents|mesh-ancestor
19736322|NCT04531371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19736323|NCT04531371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19736324|NCT04531371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19736325|NCT04531371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19736326|NCT04531371|Adrenergic Agents|adrenergic agents|mesh-ancestor
19736327|NCT04531371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19736328|NCT04531371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736329|NCT04531540|Butenafine|butenafine|mesh-list
19736330|NCT04531540|Antifungal Agents|antifungal agents|mesh-ancestor
19736331|NCT04531540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736332|NCT04531423|Golimumab|golimumab|mesh-list
19736333|NCT04531423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19736334|NCT04531423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19736335|NCT04531423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19736336|NCT04531423|Immunologic Factors|immunologic factors|mesh-ancestor
19736337|NCT04531423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736338|NCT04531397|Dapagliflozin|dapagliflozin|mesh-list
19736339|NCT04531397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19736340|NCT04531397|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19736341|NCT04531397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736342|NCT04531397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19736343|NCT04531397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736344|NCT04531397|Protease Inhibitors|protease inhibitors|mesh-ancestor
19736345|NCT04531397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736346|NCT04531267|Calcium|calcium|mesh-list
19736347|NCT04531267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19736348|NCT04531267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736349|NCT04531475|Lansoprazole|lansoprazole|mesh-list
19736350|NCT04531475|Dexlansoprazole|dexlansoprazole|mesh-list
19736351|NCT04531475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19983124|NCT01929876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19983125|NCT01929876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983126|NCT01929876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19983127|NCT01929889|Iloperidone|iloperidone|mesh-list
19983128|NCT01929889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19983129|NCT01929889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19983130|NCT01929889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19983131|NCT01929889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983132|NCT01929889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19983133|NCT01929980|Bortezomib|bortezomib|mesh-list
19983134|NCT01929980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983135|NCT01930045|Raltegravir Potassium|raltegravir potassium|mesh-list
19983136|NCT01930045|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
19983137|NCT01930045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19983138|NCT01930045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19453693|NCT03402113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19453694|NCT03402113|Adrenergic Agents|adrenergic agents|mesh-ancestor
19453695|NCT03402113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19453696|NCT03402113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736352|NCT04531475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19736353|NCT04531475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19736354|NCT04531475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736355|NCT04531475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736356|NCT04531228|Lenvatinib|lenvatinib|mesh-list
19736357|NCT04531228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736358|NCT04531228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19736359|NCT04531228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736360|NCT04531228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736361|NCT04531332|Linezolid|linezolid|mesh-list
19736362|NCT04531332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19736363|NCT04531332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736364|NCT04531332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19736365|NCT04531332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736366|NCT04531332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736367|NCT04530877|Infliximab|infliximab|mesh-list
19736368|NCT04530877|Dermatologic Agents|dermatologic agents|mesh-ancestor
19736369|NCT04530877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19736370|NCT04530877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19736371|NCT04531163|Acetylcysteine|acetylcysteine|mesh-list
19736372|NCT04531163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19736373|NCT04531163|Antiviral Agents|antiviral agents|mesh-ancestor
19736374|NCT04531163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736375|NCT04531163|Expectorants|expectorants|mesh-ancestor
19736376|NCT04531163|Respiratory System Agents|respiratory system agents|mesh-ancestor
19736377|NCT04531163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19736378|NCT04531163|Antioxidants|antioxidants|mesh-ancestor
19736379|NCT04531163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736380|NCT04531163|Protective Agents|protective agents|mesh-ancestor
19736381|NCT04531163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736382|NCT04531163|Antidotes|antidotes|mesh-ancestor
19736383|NCT04531072|Ritonavir|ritonavir|mesh-list
19736384|NCT04531072|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19736385|NCT04531072|Lumefantrine|lumefantrine|mesh-list
19736386|NCT04531072|Artemether|artemether|mesh-list
19736387|NCT04531072|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19736388|NCT04531072|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19736389|NCT04531072|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19736390|NCT04531072|Protease Inhibitors|protease inhibitors|mesh-ancestor
19736391|NCT04531072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736392|NCT04531072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736393|NCT04531072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19736394|NCT04531072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19736395|NCT04531072|Antiviral Agents|antiviral agents|mesh-ancestor
19736396|NCT04531072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736397|NCT04531072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19736398|NCT04531072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19736399|NCT04531072|Antimalarials|antimalarials|mesh-ancestor
19453697|NCT03402113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19453698|NCT03402113|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19453699|NCT03402113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19453700|NCT03402113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19453701|NCT03402113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19453702|NCT03402113|Anesthetics, General|anesthetics, general|mesh-ancestor
19453703|NCT03402113|Anesthetics|anesthetics|mesh-ancestor
19453704|NCT03402113|GABA Modulators|gaba modulators|mesh-ancestor
19453705|NCT03402113|GABA Agents|gaba agents|mesh-ancestor
19453706|NCT03402100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19453707|NCT03402100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19453708|NCT03402087|Leucovorin|leucovorin|mesh-list
19453709|NCT03402087|Methotrexate|methotrexate|mesh-list
19453710|NCT03402087|BMS-986165|bms-986165|mesh-list
19453711|NCT03402087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19453712|NCT03402087|Abortifacient Agents|abortifacient agents|mesh-ancestor
19453713|NCT03402087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19453714|NCT03402087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453715|NCT03402087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19453716|NCT03402087|Antimetabolites|antimetabolites|mesh-ancestor
19453717|NCT03402087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453718|NCT03402087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453719|NCT03402087|Dermatologic Agents|dermatologic agents|mesh-ancestor
19453720|NCT03402087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453721|NCT03402087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19453722|NCT03402087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19453723|NCT03402087|Immunologic Factors|immunologic factors|mesh-ancestor
19453724|NCT03402087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19453725|NCT03402087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19453726|NCT03402087|Antidotes|antidotes|mesh-ancestor
19453727|NCT03402087|Protective Agents|protective agents|mesh-ancestor
19453728|NCT03402087|Vitamin B Complex|vitamin b complex|mesh-ancestor
19453729|NCT03402087|Vitamins|vitamins|mesh-ancestor
19453730|NCT03402087|Micronutrients|micronutrients|mesh-ancestor
19453731|NCT03402087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19453732|NCT03402048|Gemcitabine|gemcitabine|mesh-list
19453733|NCT03402048|Carboplatin|carboplatin|mesh-list
19453734|NCT03402048|Docetaxel|docetaxel|mesh-list
19453735|NCT03402048|Pemetrexed|pemetrexed|mesh-list
19983139|NCT01930045|Antiviral Agents|antiviral agents|mesh-ancestor
19983140|NCT01930045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19983141|NCT01930045|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19983142|NCT01930045|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19983143|NCT01930045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556189|NCT01945476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556190|NCT01945476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20556191|NCT01945476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20556192|NCT01945476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20556193|NCT01945476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20556194|NCT01945476|Anesthetics, General|anesthetics, general|mesh-ancestor
20556195|NCT01945476|Anesthetics|anesthetics|mesh-ancestor
20556196|NCT01945476|GABA Modulators|gaba modulators|mesh-ancestor
20556197|NCT01945476|GABA Agents|gaba agents|mesh-ancestor
20556198|NCT01945476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20556199|NCT01945476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556200|NCT01945528|Lidocaine|lidocaine|mesh-list
20556201|NCT01945528|Anesthetics, Local|anesthetics, local|mesh-list
20556202|NCT01945528|Anesthetics|anesthetics|mesh-list
20556203|NCT01945528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20556204|NCT01945528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556205|NCT01945528|Sensory System Agents|sensory system agents|mesh-ancestor
20556206|NCT01945528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556207|NCT01945528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20556208|NCT01945528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20556209|NCT01945528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20556210|NCT01945528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20556211|NCT01945528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556212|NCT01945554|Bupivacaine|bupivacaine|mesh-list
20556213|NCT01945554|Anesthetics, Local|anesthetics, local|mesh-ancestor
20556214|NCT01945554|Anesthetics|anesthetics|mesh-ancestor
20556215|NCT01945554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19736400|NCT04531072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19736401|NCT04531072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19736402|NCT04530864|Dexamethasone|dexamethasone|mesh-list
19736403|NCT04530864|Dexamethasone acetate|dexamethasone acetate|mesh-list
19736404|NCT04530864|BB 1101|bb 1101|mesh-list
19736405|NCT04530864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19736406|NCT04530864|Antiemetics|antiemetics|mesh-ancestor
19736407|NCT04530864|Autonomic Agents|autonomic agents|mesh-ancestor
19736408|NCT04530864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19736409|NCT04530864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736410|NCT04530864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19736411|NCT04530864|Glucocorticoids|glucocorticoids|mesh-ancestor
19736412|NCT04530864|Hormones|hormones|mesh-ancestor
19736413|NCT04530864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19736414|NCT04530864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19736415|NCT04530864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736416|NCT04530864|Protease Inhibitors|protease inhibitors|mesh-ancestor
19736417|NCT04530864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736418|NCT04530864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736419|NCT04531098|Vaccines|vaccines|mesh-list
19736420|NCT04531098|Immunologic Factors|immunologic factors|mesh-ancestor
19736421|NCT04531098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736422|NCT04530903|Clonidine|clonidine|mesh-list
19736423|NCT04530903|Levobupivacaine|levobupivacaine|mesh-list
19736424|NCT04530903|Analgesics|analgesics|mesh-ancestor
19736425|NCT04530903|Sensory System Agents|sensory system agents|mesh-ancestor
19736426|NCT04530903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19736427|NCT04530903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736428|NCT04530903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19736429|NCT04530903|Sympatholytics|sympatholytics|mesh-ancestor
19736430|NCT04530903|Autonomic Agents|autonomic agents|mesh-ancestor
19736431|NCT04530903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19736432|NCT04530903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19736433|NCT04530903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19736434|NCT04530903|Adrenergic Agents|adrenergic agents|mesh-ancestor
19736435|NCT04530903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19736436|NCT04530903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983144|NCT01930045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983145|NCT01930045|Antacids|antacids|mesh-ancestor
19983146|NCT01930045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20289075|NCT05001828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289076|NCT05001828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289077|NCT05001828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289078|NCT04997993|Leflunomide|leflunomide|mesh-list
20289079|NCT04997993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289080|NCT04997993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289081|NCT04997993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20289082|NCT04997993|Immunologic Factors|immunologic factors|mesh-ancestor
20289083|NCT04997993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289084|NCT04991493|Tramadol|tramadol|mesh-list
20289085|NCT04991493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20289086|NCT04991493|Narcotics|narcotics|mesh-ancestor
20289087|NCT04991493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20289088|NCT04991493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289089|NCT04991493|Analgesics|analgesics|mesh-ancestor
20289090|NCT04991493|Sensory System Agents|sensory system agents|mesh-ancestor
20289091|NCT04991493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20289092|NCT04989283|Paclitaxel|paclitaxel|mesh-list
20289093|NCT04989283|Etoposide|etoposide|mesh-list
20289094|NCT04989283|Podophyllotoxin|podophyllotoxin|mesh-list
20289095|NCT04989283|Cisplatin|cisplatin|mesh-list
20289096|NCT04989283|Carboplatin|carboplatin|mesh-list
19453736|NCT03402048|Vinorelbine|vinorelbine|mesh-list
19983147|NCT01930188|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19983148|NCT01930188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19983149|NCT01930188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983150|NCT01930188|Incretins|incretins|mesh-ancestor
19983151|NCT01930188|Hormones|hormones|mesh-ancestor
19983152|NCT01930188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19983153|NCT01930188|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19983154|NCT01930188|Protease Inhibitors|protease inhibitors|mesh-ancestor
19983155|NCT01930188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983156|NCT01930188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983157|NCT01930487|Antioxidants|antioxidants|mesh-list
19983158|NCT01930487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983159|NCT01930487|Protective Agents|protective agents|mesh-ancestor
19983160|NCT01930487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983161|NCT01930747|Remifentanil|remifentanil|mesh-list
19983162|NCT01930747|Sevoflurane|sevoflurane|mesh-list
19983163|NCT01930747|Rocuronium|rocuronium|mesh-list
19983164|NCT01930747|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19983165|NCT01930747|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19983166|NCT01930747|Anesthetics, General|anesthetics, general|mesh-ancestor
19983167|NCT01930747|Anesthetics|anesthetics|mesh-ancestor
19983168|NCT01930747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19983169|NCT01930747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983170|NCT01930747|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19983171|NCT01930747|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19983172|NCT01930747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19983173|NCT01930747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983174|NCT01930747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19983175|NCT01930747|Narcotics|narcotics|mesh-ancestor
19983176|NCT01930747|Analgesics|analgesics|mesh-ancestor
19983177|NCT01930747|Sensory System Agents|sensory system agents|mesh-ancestor
19983178|NCT01930890|Mycophenolic Acid|mycophenolic acid|mesh-list
19983179|NCT01930890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19453737|NCT03402048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453738|NCT03402048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19453739|NCT03402048|Antimetabolites|antimetabolites|mesh-ancestor
19453740|NCT03402048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453741|NCT03402048|Antiviral Agents|antiviral agents|mesh-ancestor
19453742|NCT03402048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19453743|NCT03402048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453744|NCT03402048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19453745|NCT03402048|Immunologic Factors|immunologic factors|mesh-ancestor
19453746|NCT03402048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453747|NCT03402048|Tubulin Modulators|tubulin modulators|mesh-ancestor
19453748|NCT03402048|Antimitotic Agents|antimitotic agents|mesh-ancestor
19453749|NCT03402048|Mitosis Modulators|mitosis modulators|mesh-ancestor
19453750|NCT03402048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19453751|NCT03402048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19453752|NCT03402048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19453753|NCT03401957|Cetuximab|cetuximab|mesh-list
19453754|NCT03401957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19453755|NCT03401957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453756|NCT03401827|Gemcitabine|gemcitabine|mesh-list
19453757|NCT03401827|Paclitaxel|paclitaxel|mesh-list
19453758|NCT03401827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19453759|NCT03401827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453760|NCT03401827|Tubulin Modulators|tubulin modulators|mesh-ancestor
19453761|NCT03401827|Antimitotic Agents|antimitotic agents|mesh-ancestor
19453762|NCT03401827|Mitosis Modulators|mitosis modulators|mesh-ancestor
19453763|NCT03401827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453764|NCT03401827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19453765|NCT03401827|Antimetabolites|antimetabolites|mesh-ancestor
19453766|NCT03401827|Antiviral Agents|antiviral agents|mesh-ancestor
19453767|NCT03401827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19453768|NCT03401827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453769|NCT03401827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19453770|NCT03401827|Immunologic Factors|immunologic factors|mesh-ancestor
19453771|NCT03401827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453772|NCT03401736|Midazolam|midazolam|mesh-list
19453773|NCT03401736|Dexmedetomidine|dexmedetomidine|mesh-list
19453774|NCT03401736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19453775|NCT03401736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19453776|NCT03401736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453777|NCT03401736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19453778|NCT03401736|Analgesics|analgesics|mesh-ancestor
19453779|NCT03401736|Sensory System Agents|sensory system agents|mesh-ancestor
19453780|NCT03401736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19453781|NCT03401736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19453782|NCT03401736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19453783|NCT03401736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19983180|NCT01930890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983181|NCT01930890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19983182|NCT01930890|Antitubercular Agents|antitubercular agents|mesh-ancestor
19983183|NCT01930890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19983184|NCT01930890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19983185|NCT01930890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983186|NCT01930890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983187|NCT01931059|Risperidone|risperidone|mesh-list
19983188|NCT01931059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19983189|NCT01931059|Serotonin Agents|serotonin agents|mesh-ancestor
19983190|NCT01931059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983191|NCT01931059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983192|NCT01931059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983193|NCT01931059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19983194|NCT01931059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19983195|NCT01931059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19983196|NCT01931059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19983197|NCT01931059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19983198|NCT01931059|Dopamine Agents|dopamine agents|mesh-ancestor
19983199|NCT01931150|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19983200|NCT01931150|Dapsone|dapsone|mesh-list
19983201|NCT01931150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19983202|NCT01931150|Antimalarials|antimalarials|mesh-ancestor
19983203|NCT01931150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19983204|NCT01931150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19983205|NCT01931150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19983206|NCT01931150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983207|NCT01931150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983208|NCT01931150|Leprostatic Agents|leprostatic agents|mesh-ancestor
19983209|NCT01931163|Everolimus|everolimus|mesh-list
19983210|NCT01931163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983211|NCT01931163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19983212|NCT01931163|Immunologic Factors|immunologic factors|mesh-ancestor
19983213|NCT01931163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983214|NCT01931202|Citalopram|citalopram|mesh-list
19983215|NCT01931202|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19983216|NCT01931202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19736437|NCT04530903|Anesthetics, Local|anesthetics, local|mesh-ancestor
19736438|NCT04530903|Anesthetics|anesthetics|mesh-ancestor
19736439|NCT04530903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19736440|NCT04530474|Ivermectin|ivermectin|mesh-list
19736441|NCT04530474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19736442|NCT04530474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736443|NCT04530500|Androgens|androgens|mesh-list
19736444|NCT04530500|Hormones|hormones|mesh-ancestor
19736445|NCT04530500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19736446|NCT04530500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736447|NCT04530578|Heparin|heparin|mesh-list
19736448|NCT04530578|Calcium heparin|calcium heparin|mesh-list
19736449|NCT04530578|Enoxaparin|enoxaparin|mesh-list
19736450|NCT04530578|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19453784|NCT03401736|Adrenergic Agents|adrenergic agents|mesh-ancestor
19453785|NCT03401736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19453786|NCT03401736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453787|NCT03401736|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19453788|NCT03401736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19453789|NCT03401736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19453790|NCT03401736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19453791|NCT03401736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19453792|NCT03401736|Anesthetics, General|anesthetics, general|mesh-ancestor
19453793|NCT03401736|Anesthetics|anesthetics|mesh-ancestor
19453794|NCT03401736|GABA Modulators|gaba modulators|mesh-ancestor
19453795|NCT03401736|GABA Agents|gaba agents|mesh-ancestor
19453796|NCT03401619|Vitamin D|vitamin d|mesh-list
19453797|NCT03401619|Calcitonin|calcitonin|mesh-list
19453798|NCT03401619|Salmon calcitonin|salmon calcitonin|mesh-list
19453799|NCT03401619|Diphosphonates|diphosphonates|mesh-list
19453800|NCT03401619|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
19453801|NCT03401619|Katacalcin|katacalcin|mesh-list
19453802|NCT03401619|Vitamins|vitamins|mesh-ancestor
19453803|NCT03401619|Micronutrients|micronutrients|mesh-ancestor
19453804|NCT03401619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453805|NCT03401619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19983217|NCT01931202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19983218|NCT01931202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983219|NCT01931202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983220|NCT01931202|Serotonin Agents|serotonin agents|mesh-ancestor
19983221|NCT01931202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983222|NCT01931202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19983223|NCT01931202|Antidepressive Agents|antidepressive agents|mesh-ancestor
19983224|NCT01931202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19983225|NCT01931475|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19983226|NCT01931475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19983227|NCT01931475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19983228|NCT01931475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19983229|NCT01931475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983230|NCT01931475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983231|NCT01931475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983232|NCT01931475|Analgesics|analgesics|mesh-ancestor
19983233|NCT01931475|Sensory System Agents|sensory system agents|mesh-ancestor
19983234|NCT01931475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983235|NCT01931475|Antidepressive Agents|antidepressive agents|mesh-ancestor
19453806|NCT03401619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19736451|NCT04530578|Tinzaparin|tinzaparin|mesh-list
19736452|NCT04530578|Dalteparin|dalteparin|mesh-list
19736453|NCT04530578|Anticoagulants|anticoagulants|mesh-ancestor
19736454|NCT04530578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19736455|NCT04530578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19736456|NCT04530578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736457|NCT04530422|Azithromycin|azithromycin|mesh-list
19736458|NCT04530422|Hydroxychloroquine|hydroxychloroquine|mesh-list
19736459|NCT04530422|Sofosbuvir|sofosbuvir|mesh-list
19736460|NCT04530422|Oseltamivir|oseltamivir|mesh-list
19736461|NCT04530422|Ledipasvir|ledipasvir|mesh-list
19736462|NCT04530422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19736463|NCT04530422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736464|NCT04530422|Antimalarials|antimalarials|mesh-ancestor
19736465|NCT04530422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19736466|NCT04530422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19736467|NCT04530422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736468|NCT04530422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736469|NCT04530422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19736470|NCT04530422|Antiviral Agents|antiviral agents|mesh-ancestor
19736471|NCT04530617|Camostat|camostat|mesh-list
19736472|NCT04530617|Protease Inhibitors|protease inhibitors|mesh-ancestor
19736473|NCT04530617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736474|NCT04530617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736475|NCT04530617|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19736476|NCT04530617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19736477|NCT04530487|Cyclosporine|cyclosporine|mesh-list
19736478|NCT04530487|Mycophenolic Acid|mycophenolic acid|mesh-list
19736479|NCT04530487|Fludarabine|fludarabine|mesh-list
19736480|NCT04530487|Fludarabine phosphate|fludarabine phosphate|mesh-list
19736481|NCT04530487|Etoposide|etoposide|mesh-list
19736482|NCT04530487|Etoposide phosphate|etoposide phosphate|mesh-list
19736483|NCT04530487|Melphalan|melphalan|mesh-list
19736484|NCT04530487|Mechlorethamine|mechlorethamine|mesh-list
19736485|NCT04530487|Thiotepa|thiotepa|mesh-list
19736486|NCT04530487|Podophyllotoxin|podophyllotoxin|mesh-list
19736487|NCT04530487|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19736488|NCT04530487|Tacrolimus|tacrolimus|mesh-list
19736489|NCT04530487|Cyclosporins|cyclosporins|mesh-list
19736490|NCT04530487|Thymoglobulin|thymoglobulin|mesh-list
19736491|NCT04530487|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19736492|NCT04530487|Immunoglobulins|immunoglobulins|mesh-list
19983236|NCT01931475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19983237|NCT01931475|Dopamine Agents|dopamine agents|mesh-ancestor
19983238|NCT01931527|Rasburicase|rasburicase|mesh-list
19983239|NCT01931527|Gout Suppressants|gout suppressants|mesh-ancestor
19983240|NCT01931527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19983241|NCT01931566|Pioglitazone|pioglitazone|mesh-list
19983242|NCT01931566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19983243|NCT01931566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983244|NCT01931709|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19983245|NCT01931709|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19983246|NCT01931709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983247|NCT01931839|Ivacaftor|ivacaftor|mesh-list
19983248|NCT01931839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19983249|NCT01931839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19983250|NCT01931839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983251|NCT01931865|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19983252|NCT01931865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19983253|NCT01931865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983254|NCT01931865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983255|NCT01931865|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19983256|NCT01931865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19983257|NCT01931865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983258|NCT01931865|Cholinergic Agents|cholinergic agents|mesh-ancestor
19983259|NCT01931865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983260|NCT01931878|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19983261|NCT01931878|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19983262|NCT01931878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983263|NCT01931878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983264|NCT01931878|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19983265|NCT01931878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19983266|NCT01931878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983267|NCT01931878|Cholinergic Agents|cholinergic agents|mesh-ancestor
19983268|NCT01931878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983269|NCT01932060|Oxytocin|oxytocin|mesh-list
19983270|NCT01932060|Oxytocics|oxytocics|mesh-ancestor
19983271|NCT01932060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19983272|NCT01932060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983273|NCT01932112|Adenosine|adenosine|mesh-list
19983274|NCT01932112|Analgesics|analgesics|mesh-ancestor
19983275|NCT01932112|Sensory System Agents|sensory system agents|mesh-ancestor
19983276|NCT01932112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983277|NCT01932112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983278|NCT01932112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19983279|NCT01932112|Vasodilator Agents|vasodilator agents|mesh-ancestor
19983280|NCT01932112|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19983281|NCT01932112|Purinergic Agonists|purinergic agonists|mesh-ancestor
19983282|NCT01932112|Purinergic Agents|purinergic agents|mesh-ancestor
19983283|NCT01932112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983284|NCT01932112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983285|NCT01932697|Docetaxel|docetaxel|mesh-list
19983286|NCT01932697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983287|NCT01932697|Tubulin Modulators|tubulin modulators|mesh-ancestor
19983288|NCT01932697|Antimitotic Agents|antimitotic agents|mesh-ancestor
19983289|NCT01932697|Mitosis Modulators|mitosis modulators|mesh-ancestor
19983290|NCT01932697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983291|NCT01932762|Ribavirin|ribavirin|mesh-list
19983292|NCT01932762|Grazoprevir|grazoprevir|mesh-list
19983293|NCT01932762|Antimetabolites|antimetabolites|mesh-ancestor
19983294|NCT01932762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983295|NCT01932762|Antiviral Agents|antiviral agents|mesh-ancestor
19983296|NCT01932762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19983297|NCT01932788|Vitamin D|vitamin d|mesh-list
19983298|NCT01932788|Cholecalciferol|cholecalciferol|mesh-list
19453807|NCT03401619|Vasodilator Agents|vasodilator agents|mesh-ancestor
19453808|NCT03401606|Dexmedetomidine|dexmedetomidine|mesh-list
19453809|NCT03401606|Remifentanil|remifentanil|mesh-list
19453810|NCT03401606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19453811|NCT03401606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19453812|NCT03401606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453813|NCT03401606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19453814|NCT03401606|Analgesics|analgesics|mesh-ancestor
19453815|NCT03401606|Sensory System Agents|sensory system agents|mesh-ancestor
19453816|NCT03401606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19453817|NCT03401606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19453818|NCT03401606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19453819|NCT03401606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19453820|NCT03401606|Adrenergic Agents|adrenergic agents|mesh-ancestor
19453821|NCT03401606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19453822|NCT03401606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453823|NCT03401606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19453824|NCT03401606|Narcotics|narcotics|mesh-ancestor
19453825|NCT03401593|Fentanyl|fentanyl|mesh-list
19453826|NCT03401593|Midazolam|midazolam|mesh-list
19453827|NCT03401593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19453828|NCT03401593|Narcotics|narcotics|mesh-ancestor
19453829|NCT03401593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19453830|NCT03401593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453831|NCT03401593|Analgesics|analgesics|mesh-ancestor
19453832|NCT03401593|Sensory System Agents|sensory system agents|mesh-ancestor
19453833|NCT03401593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19453834|NCT03401593|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19453835|NCT03401593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19453836|NCT03401593|Anesthetics, General|anesthetics, general|mesh-ancestor
19453837|NCT03401593|Anesthetics|anesthetics|mesh-ancestor
19453838|NCT03401593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19453839|NCT03401593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19453840|NCT03401593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19453841|NCT03401593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19453842|NCT03401593|GABA Modulators|gaba modulators|mesh-ancestor
19453843|NCT03401593|GABA Agents|gaba agents|mesh-ancestor
19453844|NCT03401593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19453845|NCT03401593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453846|NCT03401541|Vitamin D|vitamin d|mesh-list
19453847|NCT03401541|Calcifediol|calcifediol|mesh-list
19453848|NCT03401541|Ergocalciferols|ergocalciferols|mesh-list
19453849|NCT03401541|Vitamins|vitamins|mesh-ancestor
19453850|NCT03401541|Micronutrients|micronutrients|mesh-ancestor
19453851|NCT03401541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453852|NCT03401541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19453853|NCT03401541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19453854|NCT03401515|Propranolol|propranolol|mesh-list
19453855|NCT03401515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19453856|NCT03401515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19453857|NCT03401515|Adrenergic Agents|adrenergic agents|mesh-ancestor
19453858|NCT03401515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19453859|NCT03401515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453860|NCT03401515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453861|NCT03401515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19453862|NCT03401515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19453863|NCT03401515|Vasodilator Agents|vasodilator agents|mesh-ancestor
19453864|NCT03401502|Ranolazine|ranolazine|mesh-list
19453865|NCT03401502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19453866|NCT03401502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19453867|NCT03401502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453868|NCT03401476|Morphine|morphine|mesh-list
19453869|NCT03401476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19453870|NCT03401476|Narcotics|narcotics|mesh-ancestor
19983299|NCT01932788|Vitamins|vitamins|mesh-list
19983300|NCT01932788|Micronutrients|micronutrients|mesh-ancestor
19736493|NCT04530487|Antibodies|antibodies|mesh-list
19736494|NCT04530487|gamma-Globulins|gamma-globulins|mesh-list
19736495|NCT04530487|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19736496|NCT04530487|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19736497|NCT04530487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736498|NCT04530487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19736499|NCT04530487|Antimetabolites|antimetabolites|mesh-ancestor
19736500|NCT04530487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736501|NCT04530487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19736502|NCT04530487|Immunologic Factors|immunologic factors|mesh-ancestor
19736503|NCT04530487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736504|NCT04530487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19736505|NCT04530487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19736506|NCT04530487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19736507|NCT04530487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736508|NCT04530487|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19736509|NCT04530487|Antifungal Agents|antifungal agents|mesh-ancestor
19736510|NCT04530487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736511|NCT04530487|Dermatologic Agents|dermatologic agents|mesh-ancestor
19736512|NCT04530487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19736513|NCT04530487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19736514|NCT04530487|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19736515|NCT04530487|Antitubercular Agents|antitubercular agents|mesh-ancestor
19736516|NCT04530487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19736517|NCT04530487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19736518|NCT04530487|Alkylating Agents|alkylating agents|mesh-ancestor
19736519|NCT04530487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19736520|NCT04530487|Keratolytic Agents|keratolytic agents|mesh-ancestor
19736521|NCT04530487|Tubulin Modulators|tubulin modulators|mesh-ancestor
19736522|NCT04530487|Antimitotic Agents|antimitotic agents|mesh-ancestor
19736523|NCT04530487|Mitosis Modulators|mitosis modulators|mesh-ancestor
19736524|NCT04529954|Valproic Acid|valproic acid|mesh-list
19736525|NCT04529954|Anticonvulsants|anticonvulsants|mesh-ancestor
19736526|NCT04529954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736527|NCT04529954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736528|NCT04529954|GABA Agents|gaba agents|mesh-ancestor
19736529|NCT04529954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19736530|NCT04529954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736531|NCT04529954|Antimanic Agents|antimanic agents|mesh-ancestor
19736532|NCT04529954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19736533|NCT04529954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19736534|NCT04529954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19736535|NCT04530045|Piperacillin|piperacillin|mesh-list
19736536|NCT04530045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19736537|NCT04530045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736538|NCT04530136|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
20289097|NCT04989283|Pemetrexed|pemetrexed|mesh-list
19983301|NCT01932788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983302|NCT01932788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19983303|NCT01932788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19983304|NCT01932996|Nicotine|nicotine|mesh-list
19983305|NCT01932996|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19983306|NCT01932996|Autonomic Agents|autonomic agents|mesh-ancestor
19983307|NCT01932996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983308|NCT01932996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983309|NCT01932996|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19983310|NCT01932996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19983311|NCT01932996|Cholinergic Agents|cholinergic agents|mesh-ancestor
19983312|NCT01932996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983313|NCT01932996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983314|NCT01933048|Vaccines|vaccines|mesh-list
19983315|NCT01933048|Immunologic Factors|immunologic factors|mesh-ancestor
19983316|NCT01933048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983317|NCT01933217|Methylphenidate|methylphenidate|mesh-list
19983318|NCT01933217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19983319|NCT01933217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983320|NCT01933217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19983321|NCT01933217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19983322|NCT01933217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19983323|NCT01933217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983324|NCT01933217|Dopamine Agents|dopamine agents|mesh-ancestor
19983325|NCT01933217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983326|NCT01933334|Pirfenidone|pirfenidone|mesh-list
19983327|NCT01933334|Analgesics|analgesics|mesh-ancestor
19983328|NCT01933334|Sensory System Agents|sensory system agents|mesh-ancestor
19453871|NCT03401476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19453872|NCT03401476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453873|NCT03401476|Analgesics|analgesics|mesh-ancestor
19453874|NCT03401476|Sensory System Agents|sensory system agents|mesh-ancestor
19453875|NCT03401476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19736539|NCT04530136|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19736540|NCT04530136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19736541|NCT04530136|Immunologic Factors|immunologic factors|mesh-ancestor
19736542|NCT04530136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736543|NCT04530188|Propofol|propofol|mesh-list
19736544|NCT04530188|Sevoflurane|sevoflurane|mesh-list
19736545|NCT04530188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19736546|NCT04530188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19736547|NCT04530188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736548|NCT04530188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19736549|NCT04530188|Anesthetics, General|anesthetics, general|mesh-ancestor
19736550|NCT04530188|Anesthetics|anesthetics|mesh-ancestor
19736551|NCT04530188|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19736552|NCT04530188|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19736553|NCT04530227|Paclitaxel|paclitaxel|mesh-list
19736554|NCT04530227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19736555|NCT04530227|Pemetrexed|pemetrexed|mesh-list
19736556|NCT04530227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19736557|NCT04530227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736558|NCT04530227|Tubulin Modulators|tubulin modulators|mesh-ancestor
19736559|NCT04530227|Antimitotic Agents|antimitotic agents|mesh-ancestor
19736560|NCT04530227|Mitosis Modulators|mitosis modulators|mesh-ancestor
19736561|NCT04530227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736562|NCT04530227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736563|NCT04530227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19736564|NCT04530227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19736565|NCT04529811|Rifaximin|rifaximin|mesh-list
19736566|NCT04529811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19736567|NCT04529811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736568|NCT04529811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19736569|NCT04529785|Ethanol|ethanol|mesh-list
19736570|NCT04529785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19736571|NCT04529785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736572|NCT04529785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19736573|NCT04529785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736574|NCT04529668|Vitamin D|vitamin d|mesh-list
19736575|NCT04529668|Vitamins|vitamins|mesh-ancestor
19736576|NCT04529668|Micronutrients|micronutrients|mesh-ancestor
19736577|NCT04529668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736578|NCT04529668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19736579|NCT04529525|Ivermectin|ivermectin|mesh-list
19736580|NCT04529525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19736581|NCT04529525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736582|NCT04529512|Dexamethasone|dexamethasone|mesh-list
19736583|NCT04529512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19736584|NCT04529512|Antiemetics|antiemetics|mesh-ancestor
19736585|NCT04529512|Autonomic Agents|autonomic agents|mesh-ancestor
19736586|NCT04529512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19736587|NCT04529512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736588|NCT04529512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19736589|NCT04529512|Glucocorticoids|glucocorticoids|mesh-ancestor
19736590|NCT04529512|Hormones|hormones|mesh-ancestor
19736591|NCT04529512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19736592|NCT04529512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19736593|NCT04529512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983329|NCT01933334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983330|NCT01933334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983331|NCT01933334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19983332|NCT01933334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19983333|NCT01933334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19983334|NCT01933334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19983335|NCT01933334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983336|NCT01933425|Rocuronium|rocuronium|mesh-list
19983337|NCT01933425|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19983338|NCT01933425|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19983339|NCT01933425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19983340|NCT01933425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983341|NCT01933425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983342|NCT01933464|Cromolyn Sodium|cromolyn sodium|mesh-list
19983343|NCT01933464|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
19983344|NCT01933464|Immunologic Factors|immunologic factors|mesh-ancestor
19983345|NCT01933464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983346|NCT01933464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19983347|NCT01933464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19983348|NCT01933464|Respiratory System Agents|respiratory system agents|mesh-ancestor
19983349|NCT01933594|Romidepsin|romidepsin|mesh-list
19983350|NCT01933594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19983351|NCT01933594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983352|NCT01933672|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19453876|NCT03401372|Doxycycline|doxycycline|mesh-list
19983353|NCT01933672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19453877|NCT03401372|Dexamethasone|dexamethasone|mesh-list
19453878|NCT03401372|Cyclophosphamide|cyclophosphamide|mesh-list
19453879|NCT03401372|Bortezomib|bortezomib|mesh-list
19453880|NCT03401372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19453881|NCT03401372|Immunologic Factors|immunologic factors|mesh-ancestor
19453882|NCT03401372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453883|NCT03401372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19453884|NCT03401372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19453885|NCT03401372|Alkylating Agents|alkylating agents|mesh-ancestor
19453886|NCT03401372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453887|NCT03401372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453888|NCT03401372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19453889|NCT03401372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19453890|NCT03401372|Antiemetics|antiemetics|mesh-ancestor
19453891|NCT03401372|Autonomic Agents|autonomic agents|mesh-ancestor
19453892|NCT03401372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19453893|NCT03401372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19453894|NCT03401372|Glucocorticoids|glucocorticoids|mesh-ancestor
19453895|NCT03401372|Hormones|hormones|mesh-ancestor
19453896|NCT03401372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19453897|NCT03401372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19453898|NCT03401372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19453899|NCT03401372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19453900|NCT03401372|Antimalarials|antimalarials|mesh-ancestor
19453901|NCT03401372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19453902|NCT03401372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19453903|NCT03401346|Dihydroergotamine|dihydroergotamine|mesh-list
19453904|NCT03401346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19453905|NCT03401346|Dopamine Agonists|dopamine agonists|mesh-ancestor
19453906|NCT03401346|Dopamine Agents|dopamine agents|mesh-ancestor
19453907|NCT03401346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19453908|NCT03401346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453909|NCT03401346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453910|NCT03401346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19453911|NCT03401346|Analgesics|analgesics|mesh-ancestor
19453912|NCT03401346|Sensory System Agents|sensory system agents|mesh-ancestor
19453913|NCT03401346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19453914|NCT03401294|Leucovorin|leucovorin|mesh-list
19453915|NCT03401294|Bevacizumab|bevacizumab|mesh-list
19453916|NCT03401294|Oxaliplatin|oxaliplatin|mesh-list
19453917|NCT03401294|Irinotecan|irinotecan|mesh-list
19453918|NCT03401294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19453919|NCT03401294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19453920|NCT03401294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19453921|NCT03401294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19453922|NCT03401294|Growth Substances|growth substances|mesh-ancestor
19983354|NCT01933672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983355|NCT01933672|Incretins|incretins|mesh-ancestor
19983356|NCT01933672|Hormones|hormones|mesh-ancestor
19983357|NCT01933672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19983358|NCT01933672|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19983359|NCT01933672|Protease Inhibitors|protease inhibitors|mesh-ancestor
19983360|NCT01933672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983361|NCT01933672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983362|NCT01933776|Vaccines|vaccines|mesh-list
19983363|NCT01933776|Immunologic Factors|immunologic factors|mesh-ancestor
19983364|NCT01933776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983365|NCT01933880|Methylphenidate|methylphenidate|mesh-list
19983366|NCT01933880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19983367|NCT01933880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983368|NCT01933880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19983369|NCT01933880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19983370|NCT01933880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19983371|NCT01933880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983372|NCT01933880|Dopamine Agents|dopamine agents|mesh-ancestor
19983373|NCT01933880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983374|NCT01933919|Fluvoxamine|fluvoxamine|mesh-list
19983375|NCT01933919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983376|NCT01933919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983377|NCT01933919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19736594|NCT04529356|Acetaminophen|acetaminophen|mesh-list
19736595|NCT04529356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19736596|NCT04529356|Analgesics|analgesics|mesh-ancestor
19736597|NCT04529356|Sensory System Agents|sensory system agents|mesh-ancestor
19736598|NCT04529356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19736599|NCT04529356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736600|NCT04529356|Antipyretics|antipyretics|mesh-ancestor
19736601|NCT04529044|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
19736602|NCT04529044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736603|NCT04529044|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19736604|NCT04529135|Dexmedetomidine|dexmedetomidine|mesh-list
19453923|NCT03401294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453924|NCT03401294|Growth Inhibitors|growth inhibitors|mesh-ancestor
19453925|NCT03401294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19453926|NCT03401294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19453927|NCT03401294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453928|NCT03401294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453929|NCT03401294|Antidotes|antidotes|mesh-ancestor
19453930|NCT03401294|Protective Agents|protective agents|mesh-ancestor
19453931|NCT03401294|Vitamin B Complex|vitamin b complex|mesh-ancestor
19453932|NCT03401294|Vitamins|vitamins|mesh-ancestor
19453933|NCT03401294|Micronutrients|micronutrients|mesh-ancestor
19453934|NCT03401268|Immunoglobulins|immunoglobulins|mesh-list
19453935|NCT03401268|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19453936|NCT03401268|Antibodies|antibodies|mesh-list
19453937|NCT03401268|Immunologic Factors|immunologic factors|mesh-ancestor
19453938|NCT03401268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453939|NCT03401177|Naproxen|naproxen|mesh-list
19453940|NCT03401177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19453941|NCT03401177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19453942|NCT03401177|Analgesics|analgesics|mesh-ancestor
19453943|NCT03401177|Sensory System Agents|sensory system agents|mesh-ancestor
19453944|NCT03401177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19453945|NCT03401177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983378|NCT01933919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19983379|NCT01933919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19983380|NCT01933919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983381|NCT01933919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19983382|NCT01933919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19983383|NCT01933919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19983384|NCT01933919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19983385|NCT01933919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983386|NCT01933919|Serotonin Agents|serotonin agents|mesh-ancestor
19983387|NCT01933919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19983388|NCT01933919|Antidepressive Agents|antidepressive agents|mesh-ancestor
19983389|NCT01933919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19983390|NCT01933919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19983391|NCT01933919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19983392|NCT01933984|Fluticasone|fluticasone|mesh-list
19983393|NCT01933984|Fenoterol|fenoterol|mesh-list
19983394|NCT01933984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19983395|NCT01933984|Bronchodilator Agents|bronchodilator agents|mesh-list
19983396|NCT01933984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19983397|NCT01933984|Autonomic Agents|autonomic agents|mesh-ancestor
19983398|NCT01933984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983399|NCT01933984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983400|NCT01933984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19983401|NCT01933984|Respiratory System Agents|respiratory system agents|mesh-ancestor
19983402|NCT01933984|Dermatologic Agents|dermatologic agents|mesh-ancestor
19983403|NCT01933984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19983404|NCT01933984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19453946|NCT03401177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19453947|NCT03401177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19453948|NCT03401177|Gout Suppressants|gout suppressants|mesh-ancestor
19453949|NCT03401177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19453950|NCT03401177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453951|NCT03401177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453952|NCT03401073|Immunoglobulins|immunoglobulins|mesh-list
19453953|NCT03401073|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19453954|NCT03401073|Antibodies|antibodies|mesh-list
19453955|NCT03401073|gamma-Globulins|gamma-globulins|mesh-list
19453956|NCT03401073|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19453957|NCT03401073|Immunologic Factors|immunologic factors|mesh-ancestor
19453958|NCT03401073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453959|NCT03401060|Denosumab|denosumab|mesh-list
19453960|NCT03401060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19453961|NCT03401060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453962|NCT03400995|Ziresovir|ziresovir|mesh-list
19453963|NCT03400995|Antiviral Agents|antiviral agents|mesh-ancestor
19453964|NCT03400995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19453965|NCT03400969|Glycerol|glycerol|mesh-list
19453966|NCT03400969|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19736605|NCT04529135|Remifentanil|remifentanil|mesh-list
19983405|NCT01933984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19983406|NCT01933984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19983407|NCT01933984|Adrenergic Agents|adrenergic agents|mesh-ancestor
19983408|NCT01933984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983409|NCT01933984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983410|NCT01933984|Sympathomimetics|sympathomimetics|mesh-ancestor
19983411|NCT01933984|Tocolytic Agents|tocolytic agents|mesh-ancestor
19736606|NCT04529135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19736607|NCT04529135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19736608|NCT04529135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736609|NCT04529135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19736610|NCT04529135|Analgesics|analgesics|mesh-ancestor
19736611|NCT04529135|Sensory System Agents|sensory system agents|mesh-ancestor
19736612|NCT04529135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19736613|NCT04529135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19736614|NCT04529135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19736615|NCT04529135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19736616|NCT04529135|Adrenergic Agents|adrenergic agents|mesh-ancestor
19453967|NCT03400969|Protective Agents|protective agents|mesh-ancestor
19453968|NCT03400969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453969|NCT03400826|Simvastatin|simvastatin|mesh-list
19453970|NCT03400826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19453971|NCT03400826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19453972|NCT03400826|Antimetabolites|antimetabolites|mesh-ancestor
19453973|NCT03400826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19453974|NCT03400826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19453975|NCT03400826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19453976|NCT03400826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19453977|NCT03400735|Cefdinir|cefdinir|mesh-list
19453978|NCT03400735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19453979|NCT03400735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19453980|NCT03400722|Clomiphene|clomiphene|mesh-list
19453981|NCT03400722|Hormones|hormones|mesh-list
19453982|NCT03400722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19453983|NCT03400722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19453984|NCT03400722|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19453985|NCT03400722|Hormone Antagonists|hormone antagonists|mesh-ancestor
19453986|NCT03400722|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19453987|NCT03400722|Fertility Agents|fertility agents|mesh-ancestor
19453988|NCT03400722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19453989|NCT03400722|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19453990|NCT03400722|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19453991|NCT03400709|Acetylcysteine|acetylcysteine|mesh-list
19453992|NCT03400709|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19453993|NCT03400709|Antiviral Agents|antiviral agents|mesh-ancestor
19453994|NCT03400709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19453995|NCT03400709|Expectorants|expectorants|mesh-ancestor
19453996|NCT03400709|Respiratory System Agents|respiratory system agents|mesh-ancestor
19453997|NCT03400709|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19453998|NCT03400709|Antioxidants|antioxidants|mesh-ancestor
19453999|NCT03400709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454000|NCT03400709|Protective Agents|protective agents|mesh-ancestor
19983412|NCT01933984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19983413|NCT01934192|Metoclopramide|metoclopramide|mesh-list
19983414|NCT01934192|Antiemetics|antiemetics|mesh-ancestor
19983415|NCT01934192|Autonomic Agents|autonomic agents|mesh-ancestor
19983416|NCT01934192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983417|NCT01934192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983418|NCT01934192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19983419|NCT01934192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19983420|NCT01934192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19983421|NCT01934192|Dopamine Agents|dopamine agents|mesh-ancestor
19983422|NCT01934192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20556216|NCT01945554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556217|NCT01945554|Sensory System Agents|sensory system agents|mesh-ancestor
20556218|NCT01945554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556219|NCT01945684|Botulinum Toxins|botulinum toxins|mesh-list
20556220|NCT01945684|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20556221|NCT01945684|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20556222|NCT01945684|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20556223|NCT01945684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20556224|NCT01945684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983423|NCT01934192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983424|NCT01934218|Hyaluronic Acid|hyaluronic acid|mesh-list
19983425|NCT01934218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19983426|NCT01934218|Immunologic Factors|immunologic factors|mesh-ancestor
19983427|NCT01934218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983428|NCT01934218|Viscosupplements|viscosupplements|mesh-ancestor
19983429|NCT01934218|Protective Agents|protective agents|mesh-ancestor
19983430|NCT01934231|Amoxicillin|amoxicillin|mesh-list
19983431|NCT01934231|Clavulanic Acid|clavulanic acid|mesh-list
19454001|NCT03400709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736617|NCT04529135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19736618|NCT04529135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736619|NCT04529135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19736620|NCT04529135|Narcotics|narcotics|mesh-ancestor
19736621|NCT04529187|Midazolam|midazolam|mesh-list
19736622|NCT04529187|Dexmedetomidine|dexmedetomidine|mesh-list
19983432|NCT01934231|Clavulanic Acids|clavulanic acids|mesh-list
19983433|NCT01934231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19983434|NCT01934231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19983435|NCT01934231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19983436|NCT01934231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19983437|NCT01934231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983438|NCT01934231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983439|NCT01934556|Ranibizumab|ranibizumab|mesh-list
19983440|NCT01934556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19983441|NCT01934556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19983442|NCT01934556|Growth Substances|growth substances|mesh-ancestor
19983443|NCT01934556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983444|NCT01934556|Growth Inhibitors|growth inhibitors|mesh-ancestor
19983445|NCT01934556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983446|NCT01934582|Treprostinil|treprostinil|mesh-list
19983447|NCT01934582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19983448|NCT01934790|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19983449|NCT01934790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983450|NCT01934894|Lapatinib|lapatinib|mesh-list
19983451|NCT01934894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983452|NCT01934894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19983453|NCT01934894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983454|NCT01934894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983455|NCT01934972|Cycloserine|cycloserine|mesh-list
19983456|NCT01934972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19983457|NCT01934972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19983458|NCT01934972|Renal Agents|renal agents|mesh-ancestor
19983459|NCT01934972|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19983460|NCT01934972|Antitubercular Agents|antitubercular agents|mesh-ancestor
19983461|NCT01934972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19983462|NCT01934972|Antimetabolites|antimetabolites|mesh-ancestor
19983463|NCT01934972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983464|NCT01935622|Doxycycline|doxycycline|mesh-list
19983465|NCT01935622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19983466|NCT01935622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19983467|NCT01935622|Antimalarials|antimalarials|mesh-ancestor
19983468|NCT01935622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19983469|NCT01935622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19983470|NCT01935700|Colchicine|colchicine|mesh-list
19983471|NCT01935700|Gout Suppressants|gout suppressants|mesh-ancestor
19983472|NCT01935700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19983473|NCT01935700|Tubulin Modulators|tubulin modulators|mesh-ancestor
19983474|NCT01935700|Antimitotic Agents|antimitotic agents|mesh-ancestor
19454002|NCT03400709|Antidotes|antidotes|mesh-ancestor
19454003|NCT03400683|Letrozole|letrozole|mesh-list
19454004|NCT03400683|Misoprostol|misoprostol|mesh-list
19454005|NCT03400683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454006|NCT03400683|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19454007|NCT03400683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19454008|NCT03400683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454009|NCT03400683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454010|NCT03400683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19454011|NCT03400683|Hormone Antagonists|hormone antagonists|mesh-ancestor
19454012|NCT03400683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19454013|NCT03400683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454014|NCT03400683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19454015|NCT03400683|Abortifacient Agents|abortifacient agents|mesh-ancestor
19454016|NCT03400683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19454017|NCT03400683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19454018|NCT03400683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19454019|NCT03400683|Oxytocics|oxytocics|mesh-ancestor
19454020|NCT03400592|Irinotecan|irinotecan|mesh-list
19454021|NCT03400592|Nimotuzumab|nimotuzumab|mesh-list
19454022|NCT03400592|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19454023|NCT03400592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19454024|NCT03400592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454025|NCT03400592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454026|NCT03400592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454027|NCT03400592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19454028|NCT03400423|Caffeine|caffeine|mesh-list
19454029|NCT03400423|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19454030|NCT03400423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454031|NCT03400423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19454032|NCT03400423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454033|NCT03400423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454034|NCT03400423|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19454035|NCT03400423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19454036|NCT03400423|Purinergic Agents|purinergic agents|mesh-ancestor
19454037|NCT03400423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983475|NCT01935700|Mitosis Modulators|mitosis modulators|mesh-ancestor
19983476|NCT01935700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983477|NCT01935700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983478|NCT01935791|Glucagon|glucagon|mesh-list
19983479|NCT01935791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19983480|NCT01935791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19983481|NCT01935791|Hormones|hormones|mesh-ancestor
19983482|NCT01935791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19983483|NCT01935791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983484|NCT01935791|Incretins|incretins|mesh-ancestor
19983485|NCT01936181|Infliximab|infliximab|mesh-list
19983486|NCT01936181|Dermatologic Agents|dermatologic agents|mesh-ancestor
19983487|NCT01936181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19983488|NCT01936181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19983489|NCT01936363|Niacinamide|niacinamide|mesh-list
19983490|NCT01936363|Vitamin B Complex|vitamin b complex|mesh-ancestor
19983491|NCT01936363|Vitamins|vitamins|mesh-ancestor
19983492|NCT01936363|Micronutrients|micronutrients|mesh-ancestor
19983493|NCT01936363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983494|NCT01936519|Cyclosporine|cyclosporine|mesh-list
19983495|NCT01936519|Mycophenolic Acid|mycophenolic acid|mesh-list
19983496|NCT01936519|Everolimus|everolimus|mesh-list
19736623|NCT04529187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19736624|NCT04529187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19736625|NCT04529187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736626|NCT04529187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19736627|NCT04529187|Analgesics|analgesics|mesh-ancestor
19736628|NCT04529187|Sensory System Agents|sensory system agents|mesh-ancestor
19736629|NCT04529187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19736630|NCT04529187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19736631|NCT04529187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19736632|NCT04529187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19736633|NCT04529187|Adrenergic Agents|adrenergic agents|mesh-ancestor
19454038|NCT03400267|Acetaminophen|acetaminophen|mesh-list
19454039|NCT03400267|Fentanyl|fentanyl|mesh-list
19454040|NCT03400267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19454041|NCT03400267|Narcotics|narcotics|mesh-ancestor
19454042|NCT03400267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19454043|NCT03400267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454044|NCT03400267|Analgesics|analgesics|mesh-ancestor
19454045|NCT03400267|Sensory System Agents|sensory system agents|mesh-ancestor
19454046|NCT03400267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454047|NCT03400267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19454048|NCT03400267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19454049|NCT03400267|Anesthetics, General|anesthetics, general|mesh-ancestor
19454050|NCT03400267|Anesthetics|anesthetics|mesh-ancestor
19454051|NCT03400267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19454052|NCT03400267|Antipyretics|antipyretics|mesh-ancestor
19454053|NCT03400254|Hydroxychloroquine|hydroxychloroquine|mesh-list
19454054|NCT03400254|Gedatolisib|gedatolisib|mesh-list
19454055|NCT03400254|Antimalarials|antimalarials|mesh-ancestor
19454056|NCT03400254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19454057|NCT03400254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19454058|NCT03400254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19454059|NCT03400254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454060|NCT03400254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454061|NCT03400254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19454062|NCT03400254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19454063|NCT03400241|Bromides|bromides|mesh-list
19454064|NCT03400241|Tiotropium Bromide|tiotropium bromide|mesh-list
19454065|NCT03400241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19454066|NCT03400241|Autonomic Agents|autonomic agents|mesh-ancestor
19454067|NCT03400241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454068|NCT03400241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454069|NCT03400241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19454070|NCT03400241|Respiratory System Agents|respiratory system agents|mesh-ancestor
19454071|NCT03400241|Parasympatholytics|parasympatholytics|mesh-ancestor
19454072|NCT03400241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19454073|NCT03400241|Cholinergic Agents|cholinergic agents|mesh-ancestor
19454074|NCT03400241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19454075|NCT03400241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454076|NCT03400241|Anticonvulsants|anticonvulsants|mesh-ancestor
19454077|NCT03400189|Sulthiame|sulthiame|mesh-list
19454078|NCT03400189|Anticonvulsants|anticonvulsants|mesh-ancestor
19454079|NCT03400111|Acetaminophen|acetaminophen|mesh-list
19454080|NCT03400111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19454081|NCT03400111|Analgesics|analgesics|mesh-ancestor
19454082|NCT03400111|Sensory System Agents|sensory system agents|mesh-ancestor
19454083|NCT03400111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454084|NCT03400111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454085|NCT03400111|Antipyretics|antipyretics|mesh-ancestor
19454086|NCT03400020|Ascorbic Acid|ascorbic acid|mesh-list
19983497|NCT01936519|Tacrolimus|tacrolimus|mesh-list
19983498|NCT01936519|Cyclosporins|cyclosporins|mesh-list
19983499|NCT01936519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
19983500|NCT01936519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19983501|NCT01936519|Immunologic Factors|immunologic factors|mesh-ancestor
19983502|NCT01936519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983503|NCT01936519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983504|NCT01936519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983505|NCT01936519|Antifungal Agents|antifungal agents|mesh-ancestor
19983506|NCT01936519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19983507|NCT01936519|Dermatologic Agents|dermatologic agents|mesh-ancestor
19983508|NCT01936519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19983509|NCT01936519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983510|NCT01936519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19983511|NCT01936519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19983512|NCT01936519|Antitubercular Agents|antitubercular agents|mesh-ancestor
19983513|NCT01936519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19983514|NCT01936649|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19983515|NCT01936649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983516|NCT01936649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983517|NCT01936649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454087|NCT03400020|Vitamins|vitamins|mesh-ancestor
19736634|NCT04529187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19736635|NCT04529187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736636|NCT04529187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19736637|NCT04529187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19736638|NCT04529187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19736639|NCT04529187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19736640|NCT04529187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19736641|NCT04529187|Anesthetics, General|anesthetics, general|mesh-ancestor
19736642|NCT04529187|Anesthetics|anesthetics|mesh-ancestor
19736643|NCT04529187|GABA Modulators|gaba modulators|mesh-ancestor
19736644|NCT04529187|GABA Agents|gaba agents|mesh-ancestor
19736645|NCT04529005|Angiotensin II|angiotensin ii|mesh-list
19736646|NCT04529005|Giapreza|giapreza|mesh-list
19736647|NCT04529005|Angiotensinogen|angiotensinogen|mesh-list
19736648|NCT04529005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19736649|NCT04529005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19736650|NCT04529005|Protease Inhibitors|protease inhibitors|mesh-ancestor
19736651|NCT04529005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736652|NCT04529005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736653|NCT04529226|Haloperidol|haloperidol|mesh-list
19736654|NCT04529226|Pimozide|pimozide|mesh-list
19736655|NCT04529226|Olanzapine|olanzapine|mesh-list
19736656|NCT04529226|Risperidone|risperidone|mesh-list
19736657|NCT04529226|Haloperidol decanoate|haloperidol decanoate|mesh-list
19736658|NCT04529226|Clozapine|clozapine|mesh-list
19736659|NCT04529226|Amisulpride|amisulpride|mesh-list
19736660|NCT04529226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19736661|NCT04529226|Serotonin Agents|serotonin agents|mesh-ancestor
19736662|NCT04529226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19736663|NCT04529226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736664|NCT04529226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736665|NCT04529226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19736666|NCT04529226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19736667|NCT04529226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19736668|NCT04529226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19736669|NCT04529226|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19736670|NCT04529226|Dopamine Agents|dopamine agents|mesh-ancestor
19736671|NCT04529226|Antiemetics|antiemetics|mesh-ancestor
19736672|NCT04529226|Autonomic Agents|autonomic agents|mesh-ancestor
19736673|NCT04529226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19736674|NCT04529226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19736675|NCT04529226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19736676|NCT04529226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19736677|NCT04529226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19736678|NCT04529226|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19736679|NCT04529226|GABA Antagonists|gaba antagonists|mesh-ancestor
19736680|NCT04529226|GABA Agents|gaba agents|mesh-ancestor
19736681|NCT04529226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19736682|NCT04529226|Antidepressive Agents|antidepressive agents|mesh-ancestor
19736683|NCT04528628|Norepinephrine|norepinephrine|mesh-list
19736684|NCT04528628|Serotonin|serotonin|mesh-list
19736685|NCT04528628|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19736686|NCT04528628|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
19736687|NCT04528628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19736688|NCT04528628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19736689|NCT04528628|Adrenergic Agents|adrenergic agents|mesh-ancestor
19736690|NCT04528628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19736691|NCT04528628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736692|NCT04528628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736693|NCT04528628|Sympathomimetics|sympathomimetics|mesh-ancestor
19736694|NCT04528628|Autonomic Agents|autonomic agents|mesh-ancestor
19736695|NCT04528628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19736696|NCT04528628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19983518|NCT01936649|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19983519|NCT01936844|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19454088|NCT03400020|Micronutrients|micronutrients|mesh-ancestor
19454089|NCT03400020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454090|NCT03400020|Antioxidants|antioxidants|mesh-ancestor
19454091|NCT03400020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454092|NCT03400020|Protective Agents|protective agents|mesh-ancestor
19454093|NCT03399955|Amphotericin B|amphotericin b|mesh-list
19454094|NCT03399955|Paromomycin|paromomycin|mesh-list
19454095|NCT03399955|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19454096|NCT03399955|Miltefosine|miltefosine|mesh-list
19454097|NCT03399955|Amebicides|amebicides|mesh-ancestor
19983520|NCT01936844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19983521|NCT01936870|Fesoterodine|fesoterodine|mesh-list
19983522|NCT01936870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19983523|NCT01936870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19983524|NCT01936870|Cholinergic Agents|cholinergic agents|mesh-ancestor
19983525|NCT01936870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983526|NCT01936870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983527|NCT01936870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983528|NCT01936870|Urological Agents|urological agents|mesh-ancestor
19983529|NCT01936896|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19983530|NCT01936896|Protein C Inhibitor|protein c inhibitor|mesh-list
19983531|NCT01936896|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19983532|NCT01936896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19983533|NCT01936896|Protease Inhibitors|protease inhibitors|mesh-ancestor
19983534|NCT01936896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454098|NCT03399955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19454099|NCT03399955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19454100|NCT03399955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19454101|NCT03399955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19454102|NCT03399955|Antifungal Agents|antifungal agents|mesh-ancestor
19454103|NCT03399955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454104|NCT03399903|Mesalamine|mesalamine|mesh-list
19454105|NCT03399903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19454106|NCT03399903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19454107|NCT03399903|Analgesics|analgesics|mesh-ancestor
19454108|NCT03399903|Sensory System Agents|sensory system agents|mesh-ancestor
19454109|NCT03399903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454110|NCT03399903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454111|NCT03399903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19454112|NCT03399903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19454113|NCT03399838|Midazolam|midazolam|mesh-list
19454114|NCT03399838|Dexmedetomidine|dexmedetomidine|mesh-list
19454115|NCT03399838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19454116|NCT03399838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19454117|NCT03399838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454118|NCT03399838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19454119|NCT03399838|Analgesics|analgesics|mesh-ancestor
19454120|NCT03399838|Sensory System Agents|sensory system agents|mesh-ancestor
19454121|NCT03399838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454122|NCT03399838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19454123|NCT03399838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19983535|NCT01936896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454124|NCT03399838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19454125|NCT03399838|Adrenergic Agents|adrenergic agents|mesh-ancestor
19454126|NCT03399838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19736697|NCT04528628|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19983536|NCT01936909|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19983537|NCT01936909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19983538|NCT01937026|Probenecid|probenecid|mesh-list
19983539|NCT01937026|Uricosuric Agents|uricosuric agents|mesh-ancestor
19983540|NCT01937026|Gout Suppressants|gout suppressants|mesh-ancestor
19983541|NCT01937026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19983542|NCT01937026|Renal Agents|renal agents|mesh-ancestor
19983543|NCT01937117|Trastuzumab|trastuzumab|mesh-list
19983544|NCT01937117|Pertuzumab|pertuzumab|mesh-list
19983545|NCT01937117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19983546|NCT01937117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983547|NCT01937260|Brodalumab|brodalumab|mesh-list
19983548|NCT01937260|Dermatologic Agents|dermatologic agents|mesh-ancestor
19983549|NCT01937299|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19983550|NCT01937299|Travoprost|travoprost|mesh-list
19983551|NCT01937299|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19983552|NCT01937299|Brinzolamide|brinzolamide|mesh-list
19983553|NCT01937299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19983554|NCT01937299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19736698|NCT04528628|Serotonin Agents|serotonin agents|mesh-ancestor
19736699|NCT04528628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19736700|NCT04528628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19736701|NCT04528758|Rhodamine 6G|rhodamine 6g|mesh-list
19736702|NCT04528758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736703|NCT04528797|Methylprednisolone|methylprednisolone|mesh-list
19736704|NCT04528797|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19736705|NCT04528797|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19736706|NCT04528797|Prednisolone|prednisolone|mesh-list
19736707|NCT04528797|Prednisolone acetate|prednisolone acetate|mesh-list
19736708|NCT04528797|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19736709|NCT04528797|Prednisolone phosphate|prednisolone phosphate|mesh-list
19736710|NCT04528797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19736711|NCT04528797|Antiemetics|antiemetics|mesh-ancestor
19736712|NCT04528797|Autonomic Agents|autonomic agents|mesh-ancestor
19736713|NCT04528797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19736714|NCT04528797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736715|NCT04528797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19736716|NCT04528797|Glucocorticoids|glucocorticoids|mesh-ancestor
19736717|NCT04528797|Hormones|hormones|mesh-ancestor
19736718|NCT04528797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19736719|NCT04528797|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19736720|NCT04528797|Protective Agents|protective agents|mesh-ancestor
20556225|NCT01945684|Cholinergic Agents|cholinergic agents|mesh-ancestor
19736721|NCT04528797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19454127|NCT03399838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454128|NCT03399838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19454129|NCT03399838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19454130|NCT03399838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19454131|NCT03399838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19454132|NCT03399838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19454133|NCT03399838|Anesthetics, General|anesthetics, general|mesh-ancestor
19736722|NCT04528797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736723|NCT04528888|Methylprednisolone|methylprednisolone|mesh-list
19454134|NCT03399838|Anesthetics|anesthetics|mesh-ancestor
19454135|NCT03399838|GABA Modulators|gaba modulators|mesh-ancestor
19983555|NCT01937299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19983556|NCT01937299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19983557|NCT01937299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19983558|NCT01937299|Adrenergic Agents|adrenergic agents|mesh-ancestor
19983559|NCT01937299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983560|NCT01937299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983561|NCT01937299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983562|NCT01937299|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19983563|NCT01937299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983564|NCT01937312|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19983565|NCT01937312|Travoprost|travoprost|mesh-list
19983566|NCT01937312|Brinzolamide|brinzolamide|mesh-list
19983567|NCT01937312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19736724|NCT04528888|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19736725|NCT04528888|Heparin|heparin|mesh-list
19736726|NCT04528888|Enoxaparin|enoxaparin|mesh-list
19736727|NCT04528888|Calcium heparin|calcium heparin|mesh-list
19736728|NCT04528888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19736729|NCT04528888|Antiemetics|antiemetics|mesh-ancestor
19736730|NCT04528888|Autonomic Agents|autonomic agents|mesh-ancestor
19736731|NCT04528888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19736732|NCT04528888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736733|NCT04528888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19736734|NCT04528888|Glucocorticoids|glucocorticoids|mesh-ancestor
19736735|NCT04528888|Hormones|hormones|mesh-ancestor
19736736|NCT04528888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19736737|NCT04528888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19736738|NCT04528888|Protective Agents|protective agents|mesh-ancestor
19736739|NCT04528888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19736740|NCT04528888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736741|NCT04528888|Anticoagulants|anticoagulants|mesh-ancestor
19736742|NCT04528888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19736743|NCT04528888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19736744|NCT04528888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736745|NCT04528927|Azithromycin|azithromycin|mesh-list
19736746|NCT04528927|Doxycycline|doxycycline|mesh-list
19736747|NCT04528927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19736748|NCT04528927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736749|NCT04528927|Antimalarials|antimalarials|mesh-ancestor
19736750|NCT04528927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19736751|NCT04528927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19736752|NCT04528277|Isoniazid|isoniazid|mesh-list
19736753|NCT04528277|Rifapentine|rifapentine|mesh-list
19454136|NCT03399838|GABA Agents|gaba agents|mesh-ancestor
19454137|NCT03399708|Apremilast|apremilast|mesh-list
19454138|NCT03399708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19454139|NCT03399708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19454140|NCT03399708|Analgesics|analgesics|mesh-ancestor
19454141|NCT03399708|Sensory System Agents|sensory system agents|mesh-ancestor
19454142|NCT03399708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454143|NCT03399708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454144|NCT03399708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19454145|NCT03399708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19454146|NCT03399708|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19454147|NCT03399708|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19454148|NCT03399708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454149|NCT03399708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454150|NCT03399669|Gefitinib|gefitinib|mesh-list
19454151|NCT03399669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454152|NCT03399669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19454153|NCT03399669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454154|NCT03399669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454155|NCT03399643|Atezolizumab|atezolizumab|mesh-list
19454156|NCT03399643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454157|NCT03399604|Treprostinil|treprostinil|mesh-list
19454158|NCT03399604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19736754|NCT04528277|Antitubercular Agents|antitubercular agents|mesh-ancestor
19736755|NCT04528277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19736756|NCT04528277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736757|NCT04528277|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19736758|NCT04528277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19736759|NCT04528277|Antimetabolites|antimetabolites|mesh-ancestor
19736760|NCT04528277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736761|NCT04528277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19736762|NCT04528277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19736763|NCT04528277|Leprostatic Agents|leprostatic agents|mesh-ancestor
19736764|NCT04528290|Ozanimod|ozanimod|mesh-list
19736765|NCT04528290|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19736766|NCT04528290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736767|NCT04528290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19736768|NCT04528290|Immunologic Factors|immunologic factors|mesh-ancestor
19736769|NCT04528290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736770|NCT04528173|Ketorolac|ketorolac|mesh-list
19736771|NCT04528173|Fentanyl|fentanyl|mesh-list
19736772|NCT04528173|Dexmedetomidine|dexmedetomidine|mesh-list
19736773|NCT04528173|Morphine|morphine|mesh-list
19736774|NCT04528173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19736775|NCT04528173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19736776|NCT04528173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736777|NCT04528173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19736778|NCT04528173|Analgesics|analgesics|mesh-ancestor
19736779|NCT04528173|Sensory System Agents|sensory system agents|mesh-ancestor
19736780|NCT04528173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19736781|NCT04528173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19736782|NCT04528173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19736783|NCT04528173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19736784|NCT04528173|Adrenergic Agents|adrenergic agents|mesh-ancestor
19736785|NCT04528173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19736786|NCT04528173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983568|NCT01937312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19983569|NCT01937312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19983570|NCT01937312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19983571|NCT01937312|Adrenergic Agents|adrenergic agents|mesh-ancestor
19983572|NCT01937312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20556226|NCT01945684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20556227|NCT01945684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556228|NCT01945684|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20556229|NCT01945684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983573|NCT01937312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983574|NCT01937312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983575|NCT01937312|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19983576|NCT01937312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983577|NCT01937364|Baclofen|baclofen|mesh-list
19983578|NCT01937364|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19983579|NCT01937364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983580|NCT01937364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19983581|NCT01937364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983582|NCT01937364|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19983583|NCT01937364|GABA Agonists|gaba agonists|mesh-ancestor
19983584|NCT01937364|GABA Agents|gaba agents|mesh-ancestor
19983585|NCT01937364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983586|NCT01937364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983587|NCT01937390|Bromides|bromides|mesh-list
19983588|NCT01937390|Tiotropium Bromide|tiotropium bromide|mesh-list
19983589|NCT01937390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19983590|NCT01937390|Autonomic Agents|autonomic agents|mesh-ancestor
19983591|NCT01937390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983592|NCT01937390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983593|NCT01937390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19983594|NCT01937390|Respiratory System Agents|respiratory system agents|mesh-ancestor
19983595|NCT01937390|Parasympatholytics|parasympatholytics|mesh-ancestor
19983596|NCT01937390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19983597|NCT01937390|Cholinergic Agents|cholinergic agents|mesh-ancestor
19983598|NCT01937390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983599|NCT01937390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983600|NCT01937390|Anticonvulsants|anticonvulsants|mesh-ancestor
19983601|NCT01937559|Tranexamic Acid|tranexamic acid|mesh-list
19983602|NCT01937559|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19983603|NCT01937559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19983604|NCT01937559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983605|NCT01937559|Hemostatics|hemostatics|mesh-ancestor
19983606|NCT01937559|Coagulants|coagulants|mesh-ancestor
19983607|NCT01937598|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19983608|NCT01937598|Liraglutide|liraglutide|mesh-list
19983609|NCT01937598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19983610|NCT01937598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983611|NCT01937598|Incretins|incretins|mesh-ancestor
19983612|NCT01937598|Hormones|hormones|mesh-ancestor
19983613|NCT01937598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19983614|NCT01937598|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19983615|NCT01937598|Protease Inhibitors|protease inhibitors|mesh-ancestor
19983616|NCT01937598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454159|NCT03399526|Calcitriol|calcitriol|mesh-list
19454160|NCT03399526|Betamethasone|betamethasone|mesh-list
19454161|NCT03399526|Betamethasone Valerate|betamethasone valerate|mesh-list
19454162|NCT03399526|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19454163|NCT03399526|Betamethasone benzoate|betamethasone benzoate|mesh-list
19454164|NCT03399526|Clobetasol|clobetasol|mesh-list
19454165|NCT03399526|Prednicarbate|prednicarbate|mesh-list
19454166|NCT03399526|Calcipotriene|calcipotriene|mesh-list
19454167|NCT03399526|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19454168|NCT03399526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19454169|NCT03399526|Glucocorticoids|glucocorticoids|mesh-ancestor
19454170|NCT03399526|Hormones|hormones|mesh-ancestor
19454171|NCT03399526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19454172|NCT03399526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454173|NCT03399526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19454174|NCT03399526|Respiratory System Agents|respiratory system agents|mesh-ancestor
19454175|NCT03399526|Dermatologic Agents|dermatologic agents|mesh-ancestor
19454176|NCT03399526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19454177|NCT03399526|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19454178|NCT03399526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19454179|NCT03399526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454180|NCT03399526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19454181|NCT03399526|Vitamins|vitamins|mesh-ancestor
19454182|NCT03399526|Micronutrients|micronutrients|mesh-ancestor
19454183|NCT03399526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19454184|NCT03399487|Ceritinib|ceritinib|mesh-list
19454185|NCT03399487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454186|NCT03399487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19454187|NCT03399487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454188|NCT03399487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454189|NCT03399474|Lidocaine|lidocaine|mesh-list
19454190|NCT03399474|Dexmedetomidine|dexmedetomidine|mesh-list
19454191|NCT03399474|Anesthetics, Local|anesthetics, local|mesh-ancestor
19454192|NCT03399474|Anesthetics|anesthetics|mesh-ancestor
19454193|NCT03399474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19454194|NCT03399474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454195|NCT03399474|Sensory System Agents|sensory system agents|mesh-ancestor
19454196|NCT03399474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454197|NCT03399474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19454198|NCT03399474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19454199|NCT03399474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19454200|NCT03399474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19454201|NCT03399474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454202|NCT03399474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19454203|NCT03399474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19454204|NCT03399474|Analgesics|analgesics|mesh-ancestor
19454205|NCT03399474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19454206|NCT03399474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19454207|NCT03399474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19454208|NCT03399474|Adrenergic Agents|adrenergic agents|mesh-ancestor
19454209|NCT03399474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19454210|NCT03399448|Cyclophosphamide|cyclophosphamide|mesh-list
19454211|NCT03399448|Fludarabine|fludarabine|mesh-list
19454212|NCT03399448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19454213|NCT03399448|Immunologic Factors|immunologic factors|mesh-ancestor
19454214|NCT03399448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454215|NCT03399448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19454216|NCT03399448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19454217|NCT03399448|Alkylating Agents|alkylating agents|mesh-ancestor
19736787|NCT04528173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19736788|NCT04528173|Narcotics|narcotics|mesh-ancestor
19454218|NCT03399448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454219|NCT03399448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454220|NCT03399448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19454221|NCT03399435|Epinephrine|epinephrine|mesh-list
19454222|NCT03399435|Racepinephrine|racepinephrine|mesh-list
19454223|NCT03399435|Bupivacaine|bupivacaine|mesh-list
19454224|NCT03399435|Epinephryl borate|epinephryl borate|mesh-list
19454225|NCT03399435|Neosaxitoxin|neosaxitoxin|mesh-list
19454226|NCT03399435|Anesthetics, Local|anesthetics, local|mesh-ancestor
19454227|NCT03399435|Anesthetics|anesthetics|mesh-ancestor
19454228|NCT03399435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19454229|NCT03399435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454230|NCT03399435|Sensory System Agents|sensory system agents|mesh-ancestor
19454231|NCT03399435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454232|NCT03399435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19454233|NCT03399435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19454234|NCT03399435|Adrenergic Agents|adrenergic agents|mesh-ancestor
19454235|NCT03399435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19454236|NCT03399435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454237|NCT03399435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19454238|NCT03399435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19454239|NCT03399435|Autonomic Agents|autonomic agents|mesh-ancestor
19454240|NCT03399435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19454241|NCT03399435|Respiratory System Agents|respiratory system agents|mesh-ancestor
19454242|NCT03399435|Mydriatics|mydriatics|mesh-ancestor
19454243|NCT03399435|Sympathomimetics|sympathomimetics|mesh-ancestor
19454244|NCT03399435|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19454245|NCT03399435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19454246|NCT03399435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19454247|NCT03399409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19454248|NCT03399318|Acetaminophen|acetaminophen|mesh-list
19454249|NCT03399318|Ibuprofen|ibuprofen|mesh-list
19454250|NCT03399318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19454251|NCT03399318|Analgesics|analgesics|mesh-ancestor
19454252|NCT03399318|Sensory System Agents|sensory system agents|mesh-ancestor
19454253|NCT03399318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454254|NCT03399318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454255|NCT03399318|Antipyretics|antipyretics|mesh-ancestor
19454256|NCT03399318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19454257|NCT03399318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19454258|NCT03399318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19454259|NCT03399318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19454260|NCT03399318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454261|NCT03399318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454262|NCT03399201|Anesthetics|anesthetics|mesh-list
19454263|NCT03399201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19454264|NCT03399201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454265|NCT03399110|Capecitabine|capecitabine|mesh-list
19454266|NCT03399110|Oxaliplatin|oxaliplatin|mesh-list
19454267|NCT03399110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19454268|NCT03399110|Antimetabolites|antimetabolites|mesh-ancestor
19454269|NCT03399110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454270|NCT03399110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454271|NCT03399032|Caspofungin|caspofungin|mesh-list
19454272|NCT03399032|Antifungal Agents|antifungal agents|mesh-ancestor
19454273|NCT03399032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19454274|NCT03399032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454275|NCT03399032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454276|NCT03399019|Midazolam|midazolam|mesh-list
19454277|NCT03399019|Dexmedetomidine|dexmedetomidine|mesh-list
19454278|NCT03399019|Propofol|propofol|mesh-list
19454279|NCT03399019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19454280|NCT03399019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19454281|NCT03399019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454282|NCT03399019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19454283|NCT03399019|Anesthetics, General|anesthetics, general|mesh-ancestor
19454284|NCT03399019|Anesthetics|anesthetics|mesh-ancestor
19454285|NCT03399019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19454286|NCT03399019|Analgesics|analgesics|mesh-ancestor
19454287|NCT03399019|Sensory System Agents|sensory system agents|mesh-ancestor
19454288|NCT03399019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454289|NCT03399019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19454290|NCT03399019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19454291|NCT03399019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19454292|NCT03399019|Adrenergic Agents|adrenergic agents|mesh-ancestor
19454293|NCT03399019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19454294|NCT03399019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454295|NCT03399019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19454296|NCT03399019|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19454297|NCT03399019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19454298|NCT03399019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19454299|NCT03399019|GABA Modulators|gaba modulators|mesh-ancestor
19454300|NCT03399019|GABA Agents|gaba agents|mesh-ancestor
19454301|NCT03398993|Clomiphene|clomiphene|mesh-list
19454302|NCT03398993|Enclomiphene|enclomiphene|mesh-list
19454303|NCT03398993|Zuclomiphene|zuclomiphene|mesh-list
19454304|NCT03398993|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19454305|NCT03398993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19454306|NCT03398993|Hormone Antagonists|hormone antagonists|mesh-ancestor
19454307|NCT03398993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19454308|NCT03398993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454309|NCT03398993|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19454310|NCT03398993|Fertility Agents|fertility agents|mesh-ancestor
19454311|NCT03398993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19454312|NCT03398993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19454313|NCT03398993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19454314|NCT03398941|Octreotide|octreotide|mesh-list
19454315|NCT03398941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19454316|NCT03398941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19454317|NCT03398941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454318|NCT03398876|Nicotine|nicotine|mesh-list
19454319|NCT03398876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19454320|NCT03398876|Autonomic Agents|autonomic agents|mesh-ancestor
19454321|NCT03398876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454322|NCT03398876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454323|NCT03398876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19454324|NCT03398876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19454325|NCT03398876|Cholinergic Agents|cholinergic agents|mesh-ancestor
19454326|NCT03398876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19454327|NCT03398876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454328|NCT03398824|Metformin|metformin|mesh-list
19454329|NCT03398824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19454330|NCT03398824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454331|NCT03398811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19454332|NCT03398811|Etonogestrel|etonogestrel|mesh-list
19454333|NCT03398811|Desogestrel|desogestrel|mesh-list
19454334|NCT03398811|Medroxyprogesterone|medroxyprogesterone|mesh-list
19454335|NCT03398811|Progesterone|progesterone|mesh-list
19454336|NCT03398811|Progestins|progestins|mesh-ancestor
19454337|NCT03398811|Hormones|hormones|mesh-ancestor
19454338|NCT03398811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19454339|NCT03398811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454340|NCT03398811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19454341|NCT03398811|Contraceptive Agents|contraceptive agents|mesh-ancestor
19454342|NCT03398811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19454343|NCT03398811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19454344|NCT03398811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19454345|NCT03398811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19454346|NCT03398811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19454347|NCT03398811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19454348|NCT03398811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19454349|NCT03398811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454350|NCT03398785|Epinephrine|epinephrine|mesh-list
19454351|NCT03398785|Racepinephrine|racepinephrine|mesh-list
19454352|NCT03398785|Epinephryl borate|epinephryl borate|mesh-list
19454353|NCT03398785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19454354|NCT03398785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19454355|NCT03398785|Adrenergic Agents|adrenergic agents|mesh-ancestor
19454356|NCT03398785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19454357|NCT03398785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454358|NCT03398785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454359|NCT03398785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19454360|NCT03398785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19454361|NCT03398785|Autonomic Agents|autonomic agents|mesh-ancestor
19454362|NCT03398785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454363|NCT03398785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19454364|NCT03398785|Respiratory System Agents|respiratory system agents|mesh-ancestor
19454365|NCT03398785|Mydriatics|mydriatics|mesh-ancestor
19454366|NCT03398785|Sympathomimetics|sympathomimetics|mesh-ancestor
19454367|NCT03398785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19454368|NCT03398759|Butorphanol|butorphanol|mesh-list
19454369|NCT03398759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19454370|NCT03398759|Narcotics|narcotics|mesh-ancestor
19454371|NCT03398759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19454372|NCT03398759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454373|NCT03398759|Analgesics|analgesics|mesh-ancestor
19454374|NCT03398759|Sensory System Agents|sensory system agents|mesh-ancestor
19454375|NCT03398759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454376|NCT03398759|Antitussive Agents|antitussive agents|mesh-ancestor
19454377|NCT03398759|Respiratory System Agents|respiratory system agents|mesh-ancestor
19454378|NCT03398759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19454379|NCT03398577|Dapagliflozin|dapagliflozin|mesh-list
19454380|NCT03398577|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19454381|NCT03398577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454382|NCT03398577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19454383|NCT03398577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454384|NCT03398473|Epoetin Alfa|epoetin alfa|mesh-list
19454385|NCT03398473|Hematinics|hematinics|mesh-ancestor
19454386|NCT03398434|Apixaban|apixaban|mesh-list
19983617|NCT01937598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983618|NCT01937715|Bevacizumab|bevacizumab|mesh-list
19983619|NCT01937715|Gedatolisib|gedatolisib|mesh-list
19983620|NCT01937715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19983621|NCT01937715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983622|NCT01937715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19983623|NCT01937715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19983624|NCT01937715|Growth Substances|growth substances|mesh-ancestor
19983625|NCT01937715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983626|NCT01937715|Growth Inhibitors|growth inhibitors|mesh-ancestor
19983627|NCT01937715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19983628|NCT01937715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983629|NCT01937715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289098|NCT04989283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20289099|NCT04989283|Etoposide phosphate|etoposide phosphate|mesh-list
19454387|NCT03398434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19454388|NCT03398434|Antithrombins|antithrombins|mesh-ancestor
19454389|NCT03398434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19454390|NCT03398434|Protease Inhibitors|protease inhibitors|mesh-ancestor
19454391|NCT03398434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736789|NCT04528173|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19736790|NCT04528173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19736791|NCT04528173|Anesthetics, General|anesthetics, general|mesh-ancestor
19736792|NCT04528173|Anesthetics|anesthetics|mesh-ancestor
19736793|NCT04528173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19736794|NCT04528173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19736795|NCT04528173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19736796|NCT04528173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19736797|NCT04528173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736798|NCT04528095|Clozapine|clozapine|mesh-list
19736799|NCT04528095|Amisulpride|amisulpride|mesh-list
19736800|NCT04528095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19736801|NCT04528095|Serotonin Agents|serotonin agents|mesh-ancestor
19736802|NCT04528095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19736803|NCT04528095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736804|NCT04528095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736805|NCT04528095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19983630|NCT01937871|Tadalafil|tadalafil|mesh-list
19983631|NCT01937871|Tamsulosin|tamsulosin|mesh-list
19983632|NCT01937871|Vasodilator Agents|vasodilator agents|mesh-ancestor
19983633|NCT01937871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19983634|NCT01937871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19983635|NCT01937871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983636|NCT01937871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983637|NCT01937871|Urological Agents|urological agents|mesh-ancestor
19983638|NCT01937871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19983639|NCT01937871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19983640|NCT01937871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19983641|NCT01937871|Adrenergic Agents|adrenergic agents|mesh-ancestor
19983642|NCT01937871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983643|NCT01937871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983644|NCT01937975|Grazoprevir|grazoprevir|mesh-list
19983645|NCT01937975|Antiviral Agents|antiviral agents|mesh-ancestor
19983646|NCT01937975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19983647|NCT01938001|Rituximab|rituximab|mesh-list
19983648|NCT01938001|Lenalidomide|lenalidomide|mesh-list
19983649|NCT01938001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19983650|NCT01938001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983651|NCT01938001|Immunologic Factors|immunologic factors|mesh-ancestor
19983652|NCT01938001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983653|NCT01938001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19983654|NCT01938001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19983655|NCT01938001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19983656|NCT01938001|Growth Substances|growth substances|mesh-ancestor
19983657|NCT01938001|Growth Inhibitors|growth inhibitors|mesh-ancestor
19983658|NCT01938040|Ibuprofen|ibuprofen|mesh-list
19983659|NCT01938040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19983660|NCT01938040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19983661|NCT01938040|Analgesics|analgesics|mesh-ancestor
19983662|NCT01938040|Sensory System Agents|sensory system agents|mesh-ancestor
19983663|NCT01938040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983664|NCT01938040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983665|NCT01938040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19454392|NCT03398434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454393|NCT03398434|Anticoagulants|anticoagulants|mesh-ancestor
19454394|NCT03398252|Doxazosin|doxazosin|mesh-list
19454395|NCT03398252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19454396|NCT03398252|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19454397|NCT03398252|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19454398|NCT03398252|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19454399|NCT03398252|Adrenergic Agents|adrenergic agents|mesh-ancestor
19454400|NCT03398252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19454401|NCT03398252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454402|NCT03398252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454406|NCT03398122|Apatinib|apatinib|mesh-list
19454407|NCT03398122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454408|NCT03398122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19454409|NCT03398122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454410|NCT03398122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454411|NCT03398083|Alprazolam|alprazolam|mesh-list
19454412|NCT03398083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19454413|NCT03398083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19454414|NCT03398083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454415|NCT03398083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19454416|NCT03398083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19454417|NCT03398083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19454418|NCT03398083|GABA Modulators|gaba modulators|mesh-ancestor
19454419|NCT03398083|GABA Agents|gaba agents|mesh-ancestor
19454420|NCT03398083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19454421|NCT03398083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454422|NCT03398044|Dexamethasone|dexamethasone|mesh-list
19454423|NCT03398044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19454424|NCT03398044|Antiemetics|antiemetics|mesh-ancestor
19454425|NCT03398044|Autonomic Agents|autonomic agents|mesh-ancestor
19454426|NCT03398044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454427|NCT03398044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454428|NCT03398044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19454429|NCT03398044|Glucocorticoids|glucocorticoids|mesh-ancestor
19454430|NCT03398044|Hormones|hormones|mesh-ancestor
19454431|NCT03398044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19454432|NCT03398044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19454433|NCT03398044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454434|NCT03398031|Magnesium Oxide|magnesium oxide|mesh-list
19454435|NCT03398031|Antacids|antacids|mesh-ancestor
19454436|NCT03398031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454437|NCT03398031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19454438|NCT03398018|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19454439|NCT03398018|Hormones|hormones|mesh-ancestor
19454440|NCT03398018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19454441|NCT03398018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454442|NCT03397992|Dialysis Solutions|dialysis solutions|mesh-list
19454443|NCT03397992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19454444|NCT03397953|Vinorelbine|vinorelbine|mesh-list
19454445|NCT03397953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19454446|NCT03397953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454447|NCT03397953|Tubulin Modulators|tubulin modulators|mesh-ancestor
19454448|NCT03397953|Antimitotic Agents|antimitotic agents|mesh-ancestor
19454449|NCT03397953|Mitosis Modulators|mitosis modulators|mesh-ancestor
19454450|NCT03397953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454451|NCT03397914|Colistin|colistin|mesh-list
19454452|NCT03397914|Polymyxins|polymyxins|mesh-list
19454453|NCT03397914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19454454|NCT03397914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736806|NCT04528095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19736807|NCT04528095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19736808|NCT04528095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19736809|NCT04528095|GABA Antagonists|gaba antagonists|mesh-ancestor
19736810|NCT04528095|GABA Agents|gaba agents|mesh-ancestor
19736811|NCT04528095|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19736812|NCT04528095|Dopamine Agents|dopamine agents|mesh-ancestor
19736813|NCT04528095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19454455|NCT03397888|Betrixaban|betrixaban|mesh-list
19454456|NCT03397888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19454457|NCT03397888|Antithrombins|antithrombins|mesh-ancestor
19454458|NCT03397888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19454459|NCT03397888|Protease Inhibitors|protease inhibitors|mesh-ancestor
19454460|NCT03397888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454461|NCT03397888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454462|NCT03397888|Anticoagulants|anticoagulants|mesh-ancestor
19454463|NCT03397875|Zinc Oxide|zinc oxide|mesh-list
19454464|NCT03397875|Dermatologic Agents|dermatologic agents|mesh-ancestor
19454465|NCT03397875|Sunscreening Agents|sunscreening agents|mesh-ancestor
19454466|NCT03397875|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19454467|NCT03397875|Protective Agents|protective agents|mesh-ancestor
19454468|NCT03397875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454469|NCT03397862|Donepezil|donepezil|mesh-list
19454470|NCT03397862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19454471|NCT03397862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454472|NCT03397862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454473|NCT03397862|Cholinergic Agents|cholinergic agents|mesh-ancestor
19454474|NCT03397862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19454475|NCT03397862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454476|NCT03397862|Nootropic Agents|nootropic agents|mesh-ancestor
19454477|NCT03397797|Rocuronium|rocuronium|mesh-list
19454478|NCT03397797|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19454479|NCT03397797|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19454480|NCT03397797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19454481|NCT03397797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454482|NCT03397797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454483|NCT03397706|Valganciclovir|valganciclovir|mesh-list
19454484|NCT03397706|Antiviral Agents|antiviral agents|mesh-ancestor
19454485|NCT03397706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19454486|NCT03397654|Pembrolizumab|pembrolizumab|mesh-list
19454487|NCT03397654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19454488|NCT03397654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454489|NCT03397615|Povidone-Iodine|povidone-iodine|mesh-list
19454490|NCT03397615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19454491|NCT03397615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19454492|NCT03397537|Letrozole|letrozole|mesh-list
19454493|NCT03397537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454494|NCT03397537|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19454495|NCT03397537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19454496|NCT03397537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454497|NCT03397537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454498|NCT03397537|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19454499|NCT03397537|Hormone Antagonists|hormone antagonists|mesh-ancestor
19454500|NCT03397537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19454501|NCT03397537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454502|NCT03397446|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19454503|NCT03397446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19454504|NCT03397446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454505|NCT03397446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19454506|NCT03397446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19454507|NCT03397446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19454508|NCT03397446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454509|NCT03397446|Dopamine Agents|dopamine agents|mesh-ancestor
19454510|NCT03397446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19454511|NCT03397264|Aflibercept|aflibercept|mesh-list
19454512|NCT03397264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19454513|NCT03397264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19454514|NCT03397264|Growth Substances|growth substances|mesh-ancestor
19454515|NCT03397264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454516|NCT03397264|Growth Inhibitors|growth inhibitors|mesh-ancestor
19454517|NCT03397264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454518|NCT03397199|Apatinib|apatinib|mesh-list
19454519|NCT03397199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454520|NCT03397199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19454521|NCT03397199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454522|NCT03397199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454523|NCT03397186|Trabectedin|trabectedin|mesh-list
19454524|NCT03397186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19454525|NCT03397186|Alkylating Agents|alkylating agents|mesh-ancestor
19454526|NCT03397186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454527|NCT03397186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454528|NCT03397173|Ascorbic Acid|ascorbic acid|mesh-list
19983666|NCT01938040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19983667|NCT01938040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19983668|NCT01938040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983669|NCT01938040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983670|NCT01938079|Ketamine|ketamine|mesh-list
19454529|NCT03397173|Azacitidine|azacitidine|mesh-list
19454530|NCT03397173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19454531|NCT03397173|Antimetabolites|antimetabolites|mesh-ancestor
19454532|NCT03397173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454533|NCT03397173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454534|NCT03397173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454535|NCT03397173|Antioxidants|antioxidants|mesh-ancestor
19454536|NCT03397173|Protective Agents|protective agents|mesh-ancestor
19454537|NCT03397173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454538|NCT03397173|Vitamins|vitamins|mesh-ancestor
19454539|NCT03397173|Micronutrients|micronutrients|mesh-ancestor
19454540|NCT03397082|Lidocaine|lidocaine|mesh-list
19983671|NCT01938079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19983672|NCT01938079|Analgesics|analgesics|mesh-ancestor
19983673|NCT01938079|Sensory System Agents|sensory system agents|mesh-ancestor
19983674|NCT01938079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983675|NCT01938079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983676|NCT01938079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19983677|NCT01938079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19983678|NCT01938079|Anesthetics, General|anesthetics, general|mesh-ancestor
19983679|NCT01938079|Anesthetics|anesthetics|mesh-ancestor
19983680|NCT01938079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19983681|NCT01938079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19983682|NCT01938079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19983683|NCT01938079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983684|NCT01938079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983685|NCT01938430|Sofosbuvir|sofosbuvir|mesh-list
19983686|NCT01938430|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19983687|NCT01938430|Ledipasvir|ledipasvir|mesh-list
19983688|NCT01938430|Antiviral Agents|antiviral agents|mesh-ancestor
19983689|NCT01938430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19983690|NCT01938573|Gemcitabine|gemcitabine|mesh-list
19983691|NCT01938573|Sirolimus|sirolimus|mesh-list
19983692|NCT01938573|Cisplatin|cisplatin|mesh-list
19983693|NCT01938573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983694|NCT01938573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19983695|NCT01938573|Antimetabolites|antimetabolites|mesh-ancestor
19983696|NCT01938573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983697|NCT01938573|Antiviral Agents|antiviral agents|mesh-ancestor
19983698|NCT01938573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19983699|NCT01938573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983700|NCT01938573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19983701|NCT01938573|Immunologic Factors|immunologic factors|mesh-ancestor
19983702|NCT01938573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983703|NCT01938573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19983704|NCT01938573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19983705|NCT01938573|Antifungal Agents|antifungal agents|mesh-ancestor
19983706|NCT01938625|Cyclosporine|cyclosporine|mesh-list
19983707|NCT01938625|Ribavirin|ribavirin|mesh-list
19983708|NCT01938625|Simeprevir|simeprevir|mesh-list
19454541|NCT03397082|Anesthetics, Local|anesthetics, local|mesh-ancestor
19454542|NCT03397082|Anesthetics|anesthetics|mesh-ancestor
19454543|NCT03397082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19454544|NCT03397082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454545|NCT03397082|Sensory System Agents|sensory system agents|mesh-ancestor
19454546|NCT03397082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454547|NCT03397082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19454548|NCT03397082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19454549|NCT03397082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19454550|NCT03397082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19454551|NCT03397082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454552|NCT03397069|Midazolam|midazolam|mesh-list
19454553|NCT03397069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19454554|NCT03397069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19454555|NCT03397069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19454556|NCT03397069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454557|NCT03397069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19983709|NCT01938625|Tacrolimus|tacrolimus|mesh-list
19454558|NCT03397069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19454559|NCT03397069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19454560|NCT03397069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19454561|NCT03397069|Anesthetics, General|anesthetics, general|mesh-ancestor
19454562|NCT03397069|Anesthetics|anesthetics|mesh-ancestor
19454563|NCT03397069|GABA Modulators|gaba modulators|mesh-ancestor
19454564|NCT03397069|GABA Agents|gaba agents|mesh-ancestor
19454565|NCT03397069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19454566|NCT03397069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454567|NCT03396861|Aflibercept|aflibercept|mesh-list
19454568|NCT03396861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19454569|NCT03396861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19454570|NCT03396861|Growth Substances|growth substances|mesh-ancestor
19454571|NCT03396861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454572|NCT03396861|Growth Inhibitors|growth inhibitors|mesh-ancestor
19454573|NCT03396861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454574|NCT03396601|Ketamine|ketamine|mesh-list
19454575|NCT03396601|Analgesics|analgesics|mesh-ancestor
19454576|NCT03396601|Sensory System Agents|sensory system agents|mesh-ancestor
19454577|NCT03396601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454578|NCT03396601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454579|NCT03396601|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19454580|NCT03396601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19454581|NCT03396601|Anesthetics, General|anesthetics, general|mesh-ancestor
19454582|NCT03396601|Anesthetics|anesthetics|mesh-ancestor
19454583|NCT03396601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19454584|NCT03396601|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19454585|NCT03396601|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19454586|NCT03396601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19454587|NCT03396601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454588|NCT03396588|Clonidine|clonidine|mesh-list
19454589|NCT03396588|Morphine|morphine|mesh-list
19454590|NCT03396588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19454591|NCT03396588|Narcotics|narcotics|mesh-ancestor
19454592|NCT03396588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19454593|NCT03396588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454594|NCT03396588|Analgesics|analgesics|mesh-ancestor
19454595|NCT03396588|Sensory System Agents|sensory system agents|mesh-ancestor
19454596|NCT03396588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454597|NCT03396588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19454598|NCT03396588|Sympatholytics|sympatholytics|mesh-ancestor
19454599|NCT03396588|Autonomic Agents|autonomic agents|mesh-ancestor
19454600|NCT03396588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19454601|NCT03396588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19454602|NCT03396588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19454603|NCT03396588|Adrenergic Agents|adrenergic agents|mesh-ancestor
19454604|NCT03396588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19454605|NCT03396588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454606|NCT03396523|Losartan|losartan|mesh-list
19454607|NCT03396523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19454608|NCT03396523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19454609|NCT03396523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19454610|NCT03396523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19454611|NCT03396523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454612|NCT03396497|Pembrolizumab|pembrolizumab|mesh-list
19454613|NCT03396497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19454614|NCT03396497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454615|NCT03396484|Methyldopa|methyldopa|mesh-list
19454616|NCT03396484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19454617|NCT03396484|Sympatholytics|sympatholytics|mesh-ancestor
19454618|NCT03396484|Autonomic Agents|autonomic agents|mesh-ancestor
19454619|NCT03396484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454620|NCT03396484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454621|NCT03396484|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19454622|NCT03396484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19454623|NCT03396484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19454624|NCT03396484|Adrenergic Agents|adrenergic agents|mesh-ancestor
19454625|NCT03396484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19454626|NCT03396484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454627|NCT03396393|Artenimol|artenimol|mesh-list
19454628|NCT03396393|Antimalarials|antimalarials|mesh-ancestor
19454629|NCT03396393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19454630|NCT03396393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19454631|NCT03396393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19454632|NCT03396380|Calcium, Dietary|calcium, dietary|mesh-list
19454633|NCT03396380|Vitamin D|vitamin d|mesh-list
19454634|NCT03396380|Citric Acid|citric acid|mesh-list
19454635|NCT03396380|Sodium Citrate|sodium citrate|mesh-list
19454636|NCT03396380|Clomiphene|clomiphene|mesh-list
19454637|NCT03396380|Enclomiphene|enclomiphene|mesh-list
19454638|NCT03396380|Zuclomiphene|zuclomiphene|mesh-list
19454639|NCT03396380|Calcium|calcium|mesh-list
19454640|NCT03396380|Vitamins|vitamins|mesh-ancestor
19454641|NCT03396380|Micronutrients|micronutrients|mesh-ancestor
19454642|NCT03396380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454643|NCT03396380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19454644|NCT03396380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19454645|NCT03396380|Anticoagulants|anticoagulants|mesh-ancestor
19454646|NCT03396380|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19454647|NCT03396380|Chelating Agents|chelating agents|mesh-ancestor
19454648|NCT03396380|Sequestering Agents|sequestering agents|mesh-ancestor
19454649|NCT03396380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454650|NCT03396380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19454651|NCT03396380|Hormone Antagonists|hormone antagonists|mesh-ancestor
19454652|NCT03396380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19454653|NCT03396380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19454654|NCT03396380|Fertility Agents|fertility agents|mesh-ancestor
19454655|NCT03396380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19454656|NCT03396380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19454657|NCT03396380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19454658|NCT03396315|Zoledronic Acid|zoledronic acid|mesh-list
19454659|NCT03396315|Alendronate|alendronate|mesh-list
19454660|NCT03396315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19454661|NCT03396315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454662|NCT03396250|Diphenhydramine|diphenhydramine|mesh-list
19454663|NCT03396250|Promethazine|promethazine|mesh-list
19454664|NCT03396250|Naproxen|naproxen|mesh-list
19454665|NCT03396250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19454666|NCT03396250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19454667|NCT03396250|Analgesics|analgesics|mesh-ancestor
19454668|NCT03396250|Sensory System Agents|sensory system agents|mesh-ancestor
19454669|NCT03396250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454670|NCT03396250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454671|NCT03396250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19454672|NCT03396250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19454673|NCT03396250|Gout Suppressants|gout suppressants|mesh-ancestor
19454674|NCT03396250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19454675|NCT03396250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454676|NCT03396250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454677|NCT03396250|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19454678|NCT03396250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19454679|NCT03396250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19454680|NCT03396250|Anesthetics, Local|anesthetics, local|mesh-ancestor
19454681|NCT03396250|Anesthetics|anesthetics|mesh-ancestor
19454682|NCT03396250|Antiemetics|antiemetics|mesh-ancestor
19454683|NCT03396250|Autonomic Agents|autonomic agents|mesh-ancestor
19454684|NCT03396250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19454685|NCT03396250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19454686|NCT03396250|Histamine Antagonists|histamine antagonists|mesh-ancestor
19454687|NCT03396250|Histamine Agents|histamine agents|mesh-ancestor
19454688|NCT03396250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19454689|NCT03396250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19454690|NCT03396250|Antipruritics|antipruritics|mesh-ancestor
19454691|NCT03396250|Dermatologic Agents|dermatologic agents|mesh-ancestor
19736814|NCT04528095|Antidepressive Agents|antidepressive agents|mesh-ancestor
19736815|NCT04528056|Sulfasalazine|sulfasalazine|mesh-list
19736816|NCT04528056|Ambrisentan|ambrisentan|mesh-list
19736817|NCT04528056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736818|NCT04528056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19736819|NCT04528056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19736820|NCT04528056|Analgesics|analgesics|mesh-ancestor
19736821|NCT04528056|Sensory System Agents|sensory system agents|mesh-ancestor
19736822|NCT04528056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19736823|NCT04528056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736824|NCT04528056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19736825|NCT04528056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19736826|NCT04528056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19736827|NCT04528056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19736828|NCT04528004|Niacinamide|niacinamide|mesh-list
19736829|NCT04528004|Niacin|niacin|mesh-list
19736830|NCT04528004|Nicotinic Acids|nicotinic acids|mesh-list
19736831|NCT04528004|Vitamin B Complex|vitamin b complex|mesh-ancestor
19736832|NCT04528004|Vitamins|vitamins|mesh-ancestor
19736833|NCT04528004|Micronutrients|micronutrients|mesh-ancestor
19736834|NCT04528004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454692|NCT03396107|Dexamethasone|dexamethasone|mesh-list
19454693|NCT03396107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19454694|NCT03396107|Antiemetics|antiemetics|mesh-ancestor
19454695|NCT03396107|Autonomic Agents|autonomic agents|mesh-ancestor
19454696|NCT03396107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454697|NCT03396107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454698|NCT03396107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19454699|NCT03396107|Glucocorticoids|glucocorticoids|mesh-ancestor
19454700|NCT03396107|Hormones|hormones|mesh-ancestor
19454701|NCT03396107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19454702|NCT03396107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19454703|NCT03396107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454704|NCT03396068|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19454705|NCT03396068|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19454706|NCT03396068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19454707|NCT03396068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19454708|NCT03396068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454709|NCT03396068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19454710|NCT03396068|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19454711|NCT03396068|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19454712|NCT03396068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19454713|NCT03396068|Adrenergic Agents|adrenergic agents|mesh-ancestor
19454714|NCT03396068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19454715|NCT03396068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454716|NCT03396068|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19454717|NCT03396068|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19454718|NCT03396068|Serotonin Agents|serotonin agents|mesh-ancestor
19454719|NCT03396068|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19454720|NCT03396068|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19454721|NCT03396068|Dopamine Agents|dopamine agents|mesh-ancestor
19454722|NCT03395977|Febuxostat|febuxostat|mesh-list
19454723|NCT03395977|Rasburicase|rasburicase|mesh-list
19454724|NCT03395977|Gout Suppressants|gout suppressants|mesh-ancestor
19454725|NCT03395977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19454726|NCT03395951|Diuretics|diuretics|mesh-list
19454727|NCT03395951|Natriuretic Agents|natriuretic agents|mesh-ancestor
19454728|NCT03395951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454729|NCT03395912|Anesthetics|anesthetics|mesh-list
19454730|NCT03395912|Anesthetics, Local|anesthetics, local|mesh-list
19454731|NCT03395912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19454732|NCT03395912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454733|NCT03395912|Sensory System Agents|sensory system agents|mesh-ancestor
19454734|NCT03395912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454735|NCT03395899|Bevacizumab|bevacizumab|mesh-list
19454736|NCT03395899|Atezolizumab|atezolizumab|mesh-list
19454737|NCT03395899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19454738|NCT03395899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454739|NCT03395899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19454740|NCT03395899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19454741|NCT03395899|Growth Substances|growth substances|mesh-ancestor
19454742|NCT03395899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454743|NCT03395899|Growth Inhibitors|growth inhibitors|mesh-ancestor
19454744|NCT03395873|Decitabine|decitabine|mesh-list
19454745|NCT03395873|Avelumab|avelumab|mesh-list
19454746|NCT03395873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19454747|NCT03395873|Antimetabolites|antimetabolites|mesh-ancestor
19454748|NCT03395873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454749|NCT03395873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454750|NCT03395873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454751|NCT03395873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19454752|NCT03395847|Pembrolizumab|pembrolizumab|mesh-list
19454753|NCT03395847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19454754|NCT03395847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454755|NCT03395756|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19454756|NCT03395756|Medroxyprogesterone|medroxyprogesterone|mesh-list
19454757|NCT03395756|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19454758|NCT03395756|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19454759|NCT03395756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19454760|NCT03395756|Contraceptive Agents|contraceptive agents|mesh-ancestor
19454761|NCT03395756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19454762|NCT03395756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454763|NCT03395756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19454764|NCT03395756|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19454765|NCT03395756|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19454766|NCT03395756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19454767|NCT03395756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454768|NCT03395730|Oxytocin|oxytocin|mesh-list
19454769|NCT03395730|Oxytocics|oxytocics|mesh-ancestor
19454770|NCT03395730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19454771|NCT03395730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454772|NCT03395704|Hepcidins|hepcidins|mesh-list
19454773|NCT03395704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19454774|NCT03395665|Estradiol|estradiol|mesh-list
19454775|NCT03395665|Progesterone|progesterone|mesh-list
19454776|NCT03395665|Estrogens|estrogens|mesh-ancestor
19454777|NCT03395665|Hormones|hormones|mesh-ancestor
19454778|NCT03395665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19454779|NCT03395665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454780|NCT03395665|Progestins|progestins|mesh-ancestor
19454781|NCT03395587|Temozolomide|temozolomide|mesh-list
19454782|NCT03395587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19454783|NCT03395587|Alkylating Agents|alkylating agents|mesh-ancestor
19454784|NCT03395587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454785|NCT03395587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454786|NCT03395574|Terlipressin|terlipressin|mesh-list
19454787|NCT03395574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19454788|NCT03395574|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19454789|NCT03395470|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19454790|NCT03395470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19454791|NCT03395470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19454792|NCT03395470|Antimetabolites|antimetabolites|mesh-ancestor
19454793|NCT03395470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454794|NCT03395470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19454795|NCT03395470|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19454796|NCT03395470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454797|NCT03395405|Nitazoxanide|nitazoxanide|mesh-list
19454798|NCT03395405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19454799|NCT03395405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19454800|NCT03395262|Caffeine|caffeine|mesh-list
19454801|NCT03395262|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19454802|NCT03395262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454803|NCT03395262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19454804|NCT03395262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454805|NCT03395262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454806|NCT03395262|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19454807|NCT03395262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19454808|NCT03395262|Purinergic Agents|purinergic agents|mesh-ancestor
19454809|NCT03395262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19454810|NCT03395223|Methylene Blue|methylene blue|mesh-list
19454811|NCT03395223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454812|NCT03395223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454813|NCT03395171|Vitamin D|vitamin d|mesh-list
19454814|NCT03395171|Cholecalciferol|cholecalciferol|mesh-list
19454815|NCT03395171|Vitamins|vitamins|mesh-ancestor
19454816|NCT03395171|Micronutrients|micronutrients|mesh-ancestor
19454817|NCT03395171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454818|NCT03395171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19454819|NCT03395171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19454820|NCT03395132|Fusidic Acid|fusidic acid|mesh-list
19454821|NCT03395132|Betamethasone|betamethasone|mesh-list
19454822|NCT03395132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19454823|NCT03395132|Glucocorticoids|glucocorticoids|mesh-ancestor
19454824|NCT03395132|Hormones|hormones|mesh-ancestor
19454825|NCT03395132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19454826|NCT03395132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454827|NCT03395132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19454828|NCT03395132|Respiratory System Agents|respiratory system agents|mesh-ancestor
19454829|NCT03395132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19454830|NCT03395132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19454831|NCT03395132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19454832|NCT03395132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454833|NCT03395132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454834|NCT03395093|Fentanyl|fentanyl|mesh-list
19454835|NCT03395093|Midazolam|midazolam|mesh-list
19454836|NCT03395093|Propofol|propofol|mesh-list
19454837|NCT03395093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19454838|NCT03395093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19454839|NCT03395093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454840|NCT03395093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19454841|NCT03395093|Anesthetics, General|anesthetics, general|mesh-ancestor
19454842|NCT03395093|Anesthetics|anesthetics|mesh-ancestor
19454843|NCT03395093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19454844|NCT03395093|Narcotics|narcotics|mesh-ancestor
19454845|NCT03395093|Analgesics|analgesics|mesh-ancestor
19454846|NCT03395093|Sensory System Agents|sensory system agents|mesh-ancestor
19454847|NCT03395093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454848|NCT03395093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19454849|NCT03395093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19454850|NCT03395093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19454851|NCT03395093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19454852|NCT03395093|GABA Modulators|gaba modulators|mesh-ancestor
19454853|NCT03395093|GABA Agents|gaba agents|mesh-ancestor
19454854|NCT03395093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19454855|NCT03395093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454856|NCT03395080|Paclitaxel|paclitaxel|mesh-list
19454857|NCT03395080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19454858|NCT03395080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454859|NCT03395080|Tubulin Modulators|tubulin modulators|mesh-ancestor
19454860|NCT03395080|Antimitotic Agents|antimitotic agents|mesh-ancestor
19454861|NCT03395080|Mitosis Modulators|mitosis modulators|mesh-ancestor
19454862|NCT03395080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454863|NCT03395028|Sargramostim|sargramostim|mesh-list
19454864|NCT03395028|Lenograstim|lenograstim|mesh-list
19454865|NCT03395028|Immunologic Factors|immunologic factors|mesh-ancestor
19454866|NCT03395028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454867|NCT03395028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19454868|NCT03395002|Fluticasone|fluticasone|mesh-list
19736835|NCT04528004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19736836|NCT04528004|Antimetabolites|antimetabolites|mesh-ancestor
19736837|NCT04528004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736838|NCT04528004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19736839|NCT04528004|Vasodilator Agents|vasodilator agents|mesh-ancestor
19736840|NCT04527562|Colchicine|colchicine|mesh-list
19736841|NCT04527562|Gout Suppressants|gout suppressants|mesh-ancestor
19736842|NCT04527562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19736843|NCT04527562|Tubulin Modulators|tubulin modulators|mesh-ancestor
19736844|NCT04527562|Antimitotic Agents|antimitotic agents|mesh-ancestor
19736845|NCT04527562|Mitosis Modulators|mitosis modulators|mesh-ancestor
19983710|NCT01938625|Cyclosporins|cyclosporins|mesh-list
19983711|NCT01938625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19983712|NCT01938625|Immunologic Factors|immunologic factors|mesh-ancestor
20556230|NCT01945736|Methadone|methadone|mesh-list
20556231|NCT01945736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20556232|NCT01945736|Narcotics|narcotics|mesh-ancestor
20556233|NCT01945736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20556234|NCT01945736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556235|NCT01945736|Analgesics|analgesics|mesh-ancestor
20556236|NCT01945736|Sensory System Agents|sensory system agents|mesh-ancestor
20556237|NCT01945736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556238|NCT01945736|Antitussive Agents|antitussive agents|mesh-ancestor
20556239|NCT01945736|Respiratory System Agents|respiratory system agents|mesh-ancestor
20556240|NCT01945788|Teriparatide|teriparatide|mesh-list
20556241|NCT01945788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20556242|NCT01945788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556243|NCT01945788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20556244|NCT01945801|Furosemide|furosemide|mesh-list
20556245|NCT01945801|Spironolactone|spironolactone|mesh-list
20556246|NCT01945801|Diuretics|diuretics|mesh-ancestor
20556247|NCT01945801|Natriuretic Agents|natriuretic agents|mesh-ancestor
20556248|NCT01945801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556249|NCT01945801|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20556250|NCT01945801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20556251|NCT01945801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556252|NCT01945801|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20556253|NCT01945801|Hormone Antagonists|hormone antagonists|mesh-ancestor
20556254|NCT01945801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20556255|NCT01945801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20556256|NCT01945840|Hormones|hormones|mesh-list
20556257|NCT01945840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20556258|NCT01945840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454869|NCT03395002|Xhance|xhance|mesh-list
19454870|NCT03395002|Tiotropium Bromide|tiotropium bromide|mesh-list
19454871|NCT03395002|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19983713|NCT01938625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454872|NCT03395002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19454873|NCT03395002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19454874|NCT03395002|Autonomic Agents|autonomic agents|mesh-ancestor
19454875|NCT03395002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454876|NCT03395002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454877|NCT03395002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19454878|NCT03395002|Respiratory System Agents|respiratory system agents|mesh-ancestor
19454879|NCT03395002|Dermatologic Agents|dermatologic agents|mesh-ancestor
19454880|NCT03395002|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19454881|NCT03395002|Parasympatholytics|parasympatholytics|mesh-ancestor
19454882|NCT03395002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19454883|NCT03395002|Cholinergic Agents|cholinergic agents|mesh-ancestor
19454884|NCT03395002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19454885|NCT03395002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454886|NCT03395002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19454887|NCT03395002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19454888|NCT03395002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19454889|NCT03395002|Adrenergic Agents|adrenergic agents|mesh-ancestor
19454890|NCT03394989|Fluticasone|fluticasone|mesh-list
19454891|NCT03394989|Xhance|xhance|mesh-list
19454892|NCT03394989|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19454893|NCT03394989|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19454894|NCT03394989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19454895|NCT03394989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19454896|NCT03394989|Autonomic Agents|autonomic agents|mesh-ancestor
19454897|NCT03394989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454898|NCT03394989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454899|NCT03394989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19454900|NCT03394989|Respiratory System Agents|respiratory system agents|mesh-ancestor
19454901|NCT03394989|Dermatologic Agents|dermatologic agents|mesh-ancestor
19454902|NCT03394989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19454903|NCT03394989|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19454904|NCT03394989|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19454905|NCT03394989|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19454906|NCT03394989|Adrenergic Agents|adrenergic agents|mesh-ancestor
19454907|NCT03394989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19454908|NCT03394989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454909|NCT03394989|Glucocorticoids|glucocorticoids|mesh-ancestor
19454910|NCT03394989|Hormones|hormones|mesh-ancestor
19454911|NCT03394989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19454912|NCT03394989|Sympathomimetics|sympathomimetics|mesh-ancestor
19454913|NCT03394950|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19454914|NCT03394950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19454915|NCT03394950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19454916|NCT03394950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454917|NCT03394833|Polygeline|polygeline|mesh-list
19454918|NCT03394833|Plasma Substitutes|plasma substitutes|mesh-ancestor
19454919|NCT03394833|Blood Substitutes|blood substitutes|mesh-ancestor
19454920|NCT03394820|Dexamethasone|dexamethasone|mesh-list
19454921|NCT03394820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19454922|NCT03394820|Antiemetics|antiemetics|mesh-ancestor
19454923|NCT03394820|Autonomic Agents|autonomic agents|mesh-ancestor
19454924|NCT03394820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454925|NCT03394820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454926|NCT03394820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19454927|NCT03394820|Glucocorticoids|glucocorticoids|mesh-ancestor
19454928|NCT03394820|Hormones|hormones|mesh-ancestor
19454929|NCT03394820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19454930|NCT03394820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19454931|NCT03394820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454932|NCT03394807|Levobupivacaine|levobupivacaine|mesh-list
19454933|NCT03394807|Anesthetics, Local|anesthetics, local|mesh-ancestor
19454934|NCT03394807|Anesthetics|anesthetics|mesh-ancestor
19454935|NCT03394807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19454936|NCT03394807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454937|NCT03394807|Sensory System Agents|sensory system agents|mesh-ancestor
19454938|NCT03394807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454939|NCT03394729|Propolis|propolis|mesh-list
19454940|NCT03394729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19454941|NCT03394586|Golimumab|golimumab|mesh-list
19454942|NCT03394586|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19454943|NCT03394586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19454944|NCT03394586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19454945|NCT03394586|Immunologic Factors|immunologic factors|mesh-ancestor
19454946|NCT03394586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454947|NCT03394573|Aflibercept|aflibercept|mesh-list
19454948|NCT03394573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19454949|NCT03394573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19454950|NCT03394573|Growth Substances|growth substances|mesh-ancestor
19454951|NCT03394573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983714|NCT01938625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19983715|NCT01938625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983716|NCT01938625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983717|NCT01938625|Antifungal Agents|antifungal agents|mesh-ancestor
19983718|NCT01938625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19983719|NCT01938625|Dermatologic Agents|dermatologic agents|mesh-ancestor
19983720|NCT01938625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19983721|NCT01938625|Antimetabolites|antimetabolites|mesh-ancestor
19454952|NCT03394573|Growth Inhibitors|growth inhibitors|mesh-ancestor
19454953|NCT03394573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736846|NCT04527562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736847|NCT04527562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736848|NCT04527679|Lenvatinib|lenvatinib|mesh-list
19736849|NCT04527679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736850|NCT04527679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19736851|NCT04527679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736852|NCT04527679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736853|NCT04527276|Chlorhexidine|chlorhexidine|mesh-list
19736854|NCT04527276|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19736855|NCT04527276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736856|NCT04527276|Disinfectants|disinfectants|mesh-ancestor
19983722|NCT01938625|Antiviral Agents|antiviral agents|mesh-ancestor
19983723|NCT01938625|Protease Inhibitors|protease inhibitors|mesh-ancestor
19983724|NCT01938664|Candesartan|candesartan|mesh-list
19983725|NCT01938664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19983726|NCT01938664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19983727|NCT01938664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19983728|NCT01938664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983729|NCT01938846|Paclitaxel|paclitaxel|mesh-list
19983730|NCT01938846|Exemestane|exemestane|mesh-list
19983731|NCT01938846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19983732|NCT01938846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983733|NCT01938846|Tubulin Modulators|tubulin modulators|mesh-ancestor
19983734|NCT01938846|Antimitotic Agents|antimitotic agents|mesh-ancestor
19983735|NCT01938846|Mitosis Modulators|mitosis modulators|mesh-ancestor
19983736|NCT01938846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983737|NCT01938846|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19983738|NCT01938846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19983739|NCT01938846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983740|NCT01938846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19983741|NCT01938846|Hormone Antagonists|hormone antagonists|mesh-ancestor
19983742|NCT01938846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19983743|NCT01938846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983744|NCT01938989|Methamphetamine|methamphetamine|mesh-list
19983745|NCT01938989|beta-Endorphin|beta-endorphin|mesh-list
19983746|NCT01938989|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19983747|NCT01938989|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19983748|NCT01938989|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19983749|NCT01938989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983750|NCT01938989|Sympathomimetics|sympathomimetics|mesh-ancestor
19983751|NCT01938989|Autonomic Agents|autonomic agents|mesh-ancestor
19983752|NCT01938989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983753|NCT01938989|Dopamine Agents|dopamine agents|mesh-ancestor
19983754|NCT01938989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983755|NCT01938989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983756|NCT01938989|Adrenergic Agents|adrenergic agents|mesh-ancestor
19983757|NCT01938989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19983758|NCT01938989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19983759|NCT01938989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19983760|NCT01938989|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19983761|NCT01938989|Hormones|hormones|mesh-ancestor
19983762|NCT01938989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19983763|NCT01939002|Interferons|interferons|mesh-list
19983764|NCT01939002|Interferon-beta|interferon-beta|mesh-list
19983765|NCT01939002|Interferon beta-1a|interferon beta-1a|mesh-list
19454954|NCT03394430|Midazolam|midazolam|mesh-list
19454955|NCT03394430|Dexmedetomidine|dexmedetomidine|mesh-list
19454956|NCT03394430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19454957|NCT03394430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19454958|NCT03394430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454959|NCT03394430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19454960|NCT03394430|Analgesics|analgesics|mesh-ancestor
19454961|NCT03394430|Sensory System Agents|sensory system agents|mesh-ancestor
19454962|NCT03394430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454963|NCT03394430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19454964|NCT03394430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19454965|NCT03394430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19454966|NCT03394430|Adrenergic Agents|adrenergic agents|mesh-ancestor
19454967|NCT03394430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19454968|NCT03394430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454969|NCT03394430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19454970|NCT03394430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19454971|NCT03394430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19454972|NCT03394430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19454973|NCT03394430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19454974|NCT03394430|Anesthetics, General|anesthetics, general|mesh-ancestor
19454975|NCT03394430|Anesthetics|anesthetics|mesh-ancestor
19454976|NCT03394430|GABA Modulators|gaba modulators|mesh-ancestor
19454977|NCT03394430|GABA Agents|gaba agents|mesh-ancestor
19454978|NCT03394287|Apatinib|apatinib|mesh-list
19454979|NCT03394287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19454980|NCT03394287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19454981|NCT03394287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454982|NCT03394287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19454983|NCT03394222|Budesonide|budesonide|mesh-list
19454984|NCT03394222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19454985|NCT03394222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19454986|NCT03394222|Autonomic Agents|autonomic agents|mesh-ancestor
19454987|NCT03394222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19454988|NCT03394222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19454989|NCT03394222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19454990|NCT03394222|Respiratory System Agents|respiratory system agents|mesh-ancestor
19454991|NCT03394222|Glucocorticoids|glucocorticoids|mesh-ancestor
19454992|NCT03394222|Hormones|hormones|mesh-ancestor
19454993|NCT03394222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19454994|NCT03394209|Oseltamivir|oseltamivir|mesh-list
19454995|NCT03394209|Favipiravir|favipiravir|mesh-list
19454996|NCT03394209|Antiviral Agents|antiviral agents|mesh-ancestor
19454997|NCT03394209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19454998|NCT03394209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19454999|NCT03394209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455000|NCT03394196|Ritonavir|ritonavir|mesh-list
19455001|NCT03394196|Lopinavir|lopinavir|mesh-list
19455002|NCT03394196|Darunavir|darunavir|mesh-list
19455003|NCT03394196|Tenofovir|tenofovir|mesh-list
19455004|NCT03394196|Lamivudine|lamivudine|mesh-list
19455005|NCT03394196|Zidovudine|zidovudine|mesh-list
19455006|NCT03394196|Emtricitabine|emtricitabine|mesh-list
19983766|NCT01939002|Naproxen|naproxen|mesh-list
19983767|NCT01939002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19983768|NCT01939002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19983769|NCT01939002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983770|NCT01939002|Antiviral Agents|antiviral agents|mesh-ancestor
19983771|NCT01939002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19983772|NCT01939002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19983773|NCT01939002|Analgesics|analgesics|mesh-ancestor
19983774|NCT01939002|Sensory System Agents|sensory system agents|mesh-ancestor
19983775|NCT01939002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983776|NCT01939002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983777|NCT01939002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19983778|NCT01939002|Gout Suppressants|gout suppressants|mesh-ancestor
19983779|NCT01939002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19983780|NCT01939002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983781|NCT01939002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983782|NCT01939002|Immunologic Factors|immunologic factors|mesh-ancestor
19983783|NCT01939002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19983784|NCT01939028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19455007|NCT03394196|Raltegravir Potassium|raltegravir potassium|mesh-list
19455008|NCT03394196|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19455009|NCT03394196|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19455010|NCT03394196|Protease Inhibitors|protease inhibitors|mesh-ancestor
19455011|NCT03394196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289100|NCT04989283|Atezolizumab|atezolizumab|mesh-list
19455012|NCT03394196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455013|NCT03394196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19455014|NCT03394196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19455015|NCT03394196|Antiviral Agents|antiviral agents|mesh-ancestor
19455016|NCT03394196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19455017|NCT03394196|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19455018|NCT03394196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19455019|NCT03394196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19455020|NCT03394196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19455021|NCT03394196|Antimetabolites|antimetabolites|mesh-ancestor
19455022|NCT03394196|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19455023|NCT03394196|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19455024|NCT03394144|Durvalumab|durvalumab|mesh-list
19455025|NCT03394144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19455026|NCT03394144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455027|NCT03394131|Insulin|insulin|mesh-list
19455028|NCT03394131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19455029|NCT03394131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19455030|NCT03394131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455031|NCT03394118|Osimertinib|osimertinib|mesh-list
19455032|NCT03394118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455033|NCT03394118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19455034|NCT03394118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455035|NCT03394118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455036|NCT03394105|Docetaxel|docetaxel|mesh-list
19455037|NCT03394105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455038|NCT03394105|Tubulin Modulators|tubulin modulators|mesh-ancestor
19455039|NCT03394105|Antimitotic Agents|antimitotic agents|mesh-ancestor
19455040|NCT03394105|Mitosis Modulators|mitosis modulators|mesh-ancestor
19455041|NCT03394105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455042|NCT03394001|Ketorolac|ketorolac|mesh-list
19455043|NCT03394001|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19455044|NCT03394001|Lidocaine|lidocaine|mesh-list
19455045|NCT03394001|Anesthetics, Local|anesthetics, local|mesh-ancestor
19455046|NCT03394001|Anesthetics|anesthetics|mesh-ancestor
19455047|NCT03394001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455048|NCT03394001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455049|NCT03394001|Sensory System Agents|sensory system agents|mesh-ancestor
19455050|NCT03394001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19455051|NCT03394001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19455052|NCT03394001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19455053|NCT03394001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19455054|NCT03394001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19455055|NCT03394001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455056|NCT03394001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19455057|NCT03394001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19455058|NCT03394001|Analgesics|analgesics|mesh-ancestor
19455059|NCT03394001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19455060|NCT03394001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19455061|NCT03394001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19455062|NCT03394001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455063|NCT03393988|Fentanyl|fentanyl|mesh-list
19455064|NCT03393988|Dexmedetomidine|dexmedetomidine|mesh-list
19455065|NCT03393988|Sympathomimetics|sympathomimetics|mesh-list
19455066|NCT03393988|Anesthetics|anesthetics|mesh-ancestor
19455067|NCT03393988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455068|NCT03393988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455069|NCT03393988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19455070|NCT03393988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19455071|NCT03393988|Analgesics|analgesics|mesh-ancestor
19455072|NCT03393988|Sensory System Agents|sensory system agents|mesh-ancestor
19455073|NCT03393988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19455074|NCT03393988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19455075|NCT03393988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19455076|NCT03393988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19455077|NCT03393988|Adrenergic Agents|adrenergic agents|mesh-ancestor
19455078|NCT03393988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19455079|NCT03393988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455080|NCT03393988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19455081|NCT03393988|Narcotics|narcotics|mesh-ancestor
19455082|NCT03393988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19455083|NCT03393988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19455084|NCT03393988|Anesthetics, General|anesthetics, general|mesh-ancestor
19455085|NCT03393988|Autonomic Agents|autonomic agents|mesh-ancestor
19455086|NCT03393949|Methylprednisolone|methylprednisolone|mesh-list
19455087|NCT03393949|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19455088|NCT03393949|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19455089|NCT03393949|Prednisolone|prednisolone|mesh-list
19455090|NCT03393949|Prednisolone acetate|prednisolone acetate|mesh-list
19455091|NCT03393949|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19455092|NCT03393949|Prednisolone phosphate|prednisolone phosphate|mesh-list
19455093|NCT03393949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19455094|NCT03393949|Antiemetics|antiemetics|mesh-ancestor
19455095|NCT03393949|Autonomic Agents|autonomic agents|mesh-ancestor
19455096|NCT03393949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19455097|NCT03393949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455098|NCT03393949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19455099|NCT03393949|Glucocorticoids|glucocorticoids|mesh-ancestor
19455100|NCT03393949|Hormones|hormones|mesh-ancestor
19455101|NCT03393949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19455102|NCT03393949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19455103|NCT03393949|Protective Agents|protective agents|mesh-ancestor
19455104|NCT03393949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19455105|NCT03393949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455106|NCT03393858|Antibodies|antibodies|mesh-list
19455107|NCT03393858|Immunologic Factors|immunologic factors|mesh-ancestor
19455108|NCT03393858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455109|NCT03393819|Ethanol|ethanol|mesh-list
19455110|NCT03393819|Chlorhexidine|chlorhexidine|mesh-list
19455111|NCT03393819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19455112|NCT03393819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19455113|NCT03393819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455114|NCT03393819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455115|NCT03393819|Disinfectants|disinfectants|mesh-ancestor
19455116|NCT03393780|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19455117|NCT03393780|Hormones|hormones|mesh-ancestor
19455118|NCT03393780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19455119|NCT03393780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455120|NCT03393767|Ranibizumab|ranibizumab|mesh-list
19455121|NCT03393767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19455122|NCT03393767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19455123|NCT03393767|Growth Substances|growth substances|mesh-ancestor
19455124|NCT03393767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455125|NCT03393767|Growth Inhibitors|growth inhibitors|mesh-ancestor
19455126|NCT03393767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455127|NCT03393728|Propranolol|propranolol|mesh-list
19455128|NCT03393728|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19455129|NCT03393728|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19455130|NCT03393728|Adrenergic Agents|adrenergic agents|mesh-ancestor
19736857|NCT04527666|Anticoagulants|anticoagulants|mesh-list
19736858|NCT04527211|Ivermectin|ivermectin|mesh-list
19983785|NCT01939158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19983786|NCT01939158|Immunologic Factors|immunologic factors|mesh-ancestor
19983787|NCT01939158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983788|NCT01939197|Ritonavir|ritonavir|mesh-list
19983789|NCT01939197|Ribavirin|ribavirin|mesh-list
19983790|NCT01939197|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19983791|NCT01939197|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19983792|NCT01939197|Protease Inhibitors|protease inhibitors|mesh-ancestor
19983793|NCT01939197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983794|NCT01939197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983795|NCT01939197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19983796|NCT01939197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19983797|NCT01939197|Antiviral Agents|antiviral agents|mesh-ancestor
19983798|NCT01939197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19983799|NCT01939197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19983800|NCT01939197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19983801|NCT01939197|Antimetabolites|antimetabolites|mesh-ancestor
19455131|NCT03393728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19736859|NCT04527211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19736860|NCT04527211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736861|NCT05140811|Azacitidine|azacitidine|mesh-list
19736862|NCT05140811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19736863|NCT05140811|Antimetabolites|antimetabolites|mesh-ancestor
19736864|NCT05140811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736865|NCT05140811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736866|NCT05140811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736867|NCT05140746|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19736868|NCT05140746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19455132|NCT03393728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455133|NCT03393728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455134|NCT03393728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19455135|NCT03393728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19455136|NCT03393728|Vasodilator Agents|vasodilator agents|mesh-ancestor
19455137|NCT03393715|Perindopril|perindopril|mesh-list
19455138|NCT03393715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19455139|NCT03393715|Protease Inhibitors|protease inhibitors|mesh-ancestor
19455140|NCT03393715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455141|NCT03393715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455142|NCT03393715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19455143|NCT03393702|Gabapentin|gabapentin|mesh-list
19455144|NCT03393702|Analgesics|analgesics|mesh-ancestor
19455145|NCT03393702|Sensory System Agents|sensory system agents|mesh-ancestor
19455146|NCT03393702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19455147|NCT03393702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455148|NCT03393702|Anticonvulsants|anticonvulsants|mesh-ancestor
19455149|NCT03393702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19455150|NCT03393702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19455151|NCT03393702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455152|NCT03393702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19455153|NCT03393702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19455154|NCT03393702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19455155|NCT03393702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19455156|NCT03393702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455157|NCT03393702|Antimanic Agents|antimanic agents|mesh-ancestor
19455158|NCT03393572|Magnesium Sulfate|magnesium sulfate|mesh-list
19455159|NCT03393572|Nalbuphine|nalbuphine|mesh-list
19455160|NCT03393572|Bupivacaine|bupivacaine|mesh-list
19455161|NCT03393572|Anesthetics, Local|anesthetics, local|mesh-ancestor
19455162|NCT03393572|Anesthetics|anesthetics|mesh-ancestor
19455163|NCT03393572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455164|NCT03393572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455165|NCT03393572|Sensory System Agents|sensory system agents|mesh-ancestor
19455166|NCT03393572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19455167|NCT03393572|Analgesics|analgesics|mesh-ancestor
19455168|NCT03393572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19455169|NCT03393572|Anticonvulsants|anticonvulsants|mesh-ancestor
19455170|NCT03393572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19455171|NCT03393572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19455172|NCT03393572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455173|NCT03393572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19455174|NCT03393572|Tocolytic Agents|tocolytic agents|mesh-ancestor
19455175|NCT03393572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19455176|NCT03393572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19455177|NCT03393572|Narcotics|narcotics|mesh-ancestor
19455178|NCT03393507|Apatinib|apatinib|mesh-list
19455179|NCT03393507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455180|NCT03393507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19455181|NCT03393507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455182|NCT03393507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455183|NCT03393481|Enoxaparin|enoxaparin|mesh-list
19455184|NCT03393481|Anticoagulants|anticoagulants|mesh-ancestor
19455185|NCT03393481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19455186|NCT03393481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19455187|NCT03393481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455188|NCT03393416|Antibodies|antibodies|mesh-list
19455189|NCT03393416|Immunologic Factors|immunologic factors|mesh-ancestor
19455190|NCT03393416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455191|NCT03393403|Dexmedetomidine|dexmedetomidine|mesh-list
19455192|NCT03393403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19455193|NCT03393403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455194|NCT03393403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455195|NCT03393403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19455196|NCT03393403|Analgesics|analgesics|mesh-ancestor
19455197|NCT03393403|Sensory System Agents|sensory system agents|mesh-ancestor
19455198|NCT03393403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19455199|NCT03393403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19455200|NCT03393403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19455201|NCT03393403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19455202|NCT03393403|Adrenergic Agents|adrenergic agents|mesh-ancestor
19455203|NCT03393403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19455204|NCT03393403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455205|NCT03393377|Valsartan|valsartan|mesh-list
19455206|NCT03393377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19455207|NCT03393377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19455208|NCT03393377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19455209|NCT03393377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455210|NCT03393364|Ketorolac|ketorolac|mesh-list
19455211|NCT03393364|Oxycodone|oxycodone|mesh-list
19455212|NCT03393364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19455213|NCT03393364|Narcotics|narcotics|mesh-ancestor
19455214|NCT03393364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455215|NCT03393364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455216|NCT03393364|Analgesics|analgesics|mesh-ancestor
19455217|NCT03393364|Sensory System Agents|sensory system agents|mesh-ancestor
19455218|NCT03393364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19455219|NCT03393364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19455220|NCT03393364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19455221|NCT03393364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19455222|NCT03393364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19455223|NCT03393364|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19455224|NCT03393364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455225|NCT03393364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455226|NCT03393325|Tadalafil|tadalafil|mesh-list
19455227|NCT03393325|Vasodilator Agents|vasodilator agents|mesh-ancestor
19455228|NCT03393325|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19455229|NCT03393325|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19455230|NCT03393325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455231|NCT03393325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983802|NCT01939301|Nitric Oxide|nitric oxide|mesh-list
19983803|NCT01939301|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19983804|NCT01939301|Autonomic Agents|autonomic agents|mesh-ancestor
19983805|NCT01939301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983806|NCT01939301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983807|NCT01939301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19983808|NCT01939301|Respiratory System Agents|respiratory system agents|mesh-ancestor
19983809|NCT01939301|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19983810|NCT01939301|Antioxidants|antioxidants|mesh-ancestor
19983811|NCT01939301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983812|NCT01939301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983813|NCT01939301|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19983814|NCT01939301|Vasodilator Agents|vasodilator agents|mesh-ancestor
19983815|NCT01939301|Gasotransmitters|gasotransmitters|mesh-ancestor
19983816|NCT01939301|Protective Agents|protective agents|mesh-ancestor
19983817|NCT01939314|Bupivacaine|bupivacaine|mesh-list
19983818|NCT01939314|Anesthetics, Local|anesthetics, local|mesh-ancestor
19983819|NCT01939314|Anesthetics|anesthetics|mesh-ancestor
19983820|NCT01939314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19983821|NCT01939314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455232|NCT03393325|Urological Agents|urological agents|mesh-ancestor
19455233|NCT03393273|Elotuzumab|elotuzumab|mesh-list
19455234|NCT03393273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455235|NCT03393247|Azathioprine|azathioprine|mesh-list
19455236|NCT03393247|Infliximab|infliximab|mesh-list
19455237|NCT03393247|Dermatologic Agents|dermatologic agents|mesh-ancestor
19455238|NCT03393247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19983822|NCT01939314|Sensory System Agents|sensory system agents|mesh-ancestor
19983823|NCT01939314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983824|NCT01939366|Pregabalin|pregabalin|mesh-list
19983825|NCT01939366|Analgesics|analgesics|mesh-ancestor
19983826|NCT01939366|Sensory System Agents|sensory system agents|mesh-ancestor
19983827|NCT01939366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983828|NCT01939366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983829|NCT01939366|Anticonvulsants|anticonvulsants|mesh-ancestor
19983830|NCT01939366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19983831|NCT01939366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19983832|NCT01939366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983833|NCT01939366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19983834|NCT01939366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19983835|NCT01939366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19983836|NCT01939366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19983837|NCT01939366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19983838|NCT01939496|Canagliflozin|canagliflozin|mesh-list
19983839|NCT01939496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19983840|NCT01939496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455239|NCT03393247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19455240|NCT03393247|Antimetabolites|antimetabolites|mesh-ancestor
19455241|NCT03393247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455242|NCT03393247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19455243|NCT03393247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455244|NCT03393247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19455245|NCT03393247|Immunologic Factors|immunologic factors|mesh-ancestor
19455246|NCT03393247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455247|NCT03393117|Narcotics|narcotics|mesh-list
19455248|NCT03393117|Bupivacaine|bupivacaine|mesh-list
19455249|NCT03393117|Anesthetics, Local|anesthetics, local|mesh-ancestor
19455250|NCT03393117|Anesthetics|anesthetics|mesh-ancestor
19455251|NCT03393117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455252|NCT03393117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455253|NCT03393117|Sensory System Agents|sensory system agents|mesh-ancestor
19455254|NCT03393117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19455255|NCT03393117|Analgesics|analgesics|mesh-ancestor
19455256|NCT03393026|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19455257|NCT03393026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19455258|NCT03393026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19455259|NCT03393026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455260|NCT03393026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455261|NCT03393026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19455262|NCT03393026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19455263|NCT03393026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19455264|NCT03393026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19455265|NCT03393026|Adrenergic Agents|adrenergic agents|mesh-ancestor
19455266|NCT03393026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19455267|NCT03393026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455268|NCT03393026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19455269|NCT03393026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19455270|NCT03393026|Serotonin Agents|serotonin agents|mesh-ancestor
19455271|NCT03393026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19455272|NCT03393026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19455273|NCT03393026|Dopamine Agents|dopamine agents|mesh-ancestor
19455274|NCT03392961|Insulin|insulin|mesh-list
19455275|NCT03392961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19455276|NCT03392961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455277|NCT03392909|Gentamicins|gentamicins|mesh-list
19455278|NCT03392909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19455279|NCT03392909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19455280|NCT03392909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19455281|NCT03392909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455282|NCT03392909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455283|NCT03392792|Plasminogen|plasminogen|mesh-list
19455284|NCT03392792|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19455285|NCT03392792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19455286|NCT03392792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19455287|NCT03392792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736869|NCT05140746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736870|NCT05140655|Fulvestrant|fulvestrant|mesh-list
19736871|NCT05140655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19736872|NCT05140655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736873|NCT05140655|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19736874|NCT05140655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19736875|NCT05140655|Hormone Antagonists|hormone antagonists|mesh-ancestor
19736876|NCT05140655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19736877|NCT05140655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736878|NCT05140525|Macitentan|macitentan|mesh-list
19736879|NCT05140525|Riociguat|riociguat|mesh-list
19736880|NCT05140525|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19736881|NCT05140525|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19736882|NCT05140525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736883|NCT05140525|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19736884|NCT05140525|Enzyme Activators|enzyme activators|mesh-ancestor
19736885|NCT05140512|Goserelin|goserelin|mesh-list
19736886|NCT05140512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19736887|NCT05140512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736888|NCT05140096|Fluconazole|fluconazole|mesh-list
19736889|NCT05140096|Isavuconazole|isavuconazole|mesh-list
19736890|NCT05140096|Acalabrutinib|acalabrutinib|mesh-list
19736891|NCT05140096|Antifungal Agents|antifungal agents|mesh-ancestor
19736892|NCT05140096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736893|NCT05140096|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19736894|NCT05140096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19455288|NCT03392740|Lisinopril|lisinopril|mesh-list
19455289|NCT03392740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19455290|NCT03392740|Protease Inhibitors|protease inhibitors|mesh-ancestor
19455291|NCT03392740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455292|NCT03392740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455293|NCT03392740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19455294|NCT03392740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19455295|NCT03392740|Protective Agents|protective agents|mesh-ancestor
19455296|NCT03392740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455297|NCT03392623|Niacinamide|niacinamide|mesh-list
19455298|NCT03392623|Niacin|niacin|mesh-list
19455299|NCT03392623|Nicotinic Acids|nicotinic acids|mesh-list
19455300|NCT03392623|Tretinoin|tretinoin|mesh-list
19455301|NCT03392623|Sunscreening Agents|sunscreening agents|mesh-list
19455302|NCT03392623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455303|NCT03392623|Keratolytic Agents|keratolytic agents|mesh-ancestor
19455304|NCT03392623|Dermatologic Agents|dermatologic agents|mesh-ancestor
19455305|NCT03392623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19455306|NCT03392623|Protective Agents|protective agents|mesh-ancestor
19455307|NCT03392623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455308|NCT03392623|Vitamin B Complex|vitamin b complex|mesh-ancestor
19455309|NCT03392623|Vitamins|vitamins|mesh-ancestor
19455310|NCT03392623|Micronutrients|micronutrients|mesh-ancestor
19455311|NCT03392623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19455312|NCT03392623|Antimetabolites|antimetabolites|mesh-ancestor
19455313|NCT03392623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455314|NCT03392623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19455315|NCT03392623|Vasodilator Agents|vasodilator agents|mesh-ancestor
19455316|NCT03392571|Gemcitabine|gemcitabine|mesh-list
19455317|NCT03392571|Paclitaxel|paclitaxel|mesh-list
19455318|NCT03392571|Cisplatin|cisplatin|mesh-list
19455319|NCT03392571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19455320|NCT03392571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455321|NCT03392571|Tubulin Modulators|tubulin modulators|mesh-ancestor
19455322|NCT03392571|Antimitotic Agents|antimitotic agents|mesh-ancestor
19455323|NCT03392571|Mitosis Modulators|mitosis modulators|mesh-ancestor
19455324|NCT03392571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455325|NCT03392571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19455326|NCT03392571|Antimetabolites|antimetabolites|mesh-ancestor
19455327|NCT03392571|Antiviral Agents|antiviral agents|mesh-ancestor
19455328|NCT03392571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19455329|NCT03392571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455330|NCT03392571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19455331|NCT03392571|Immunologic Factors|immunologic factors|mesh-ancestor
19455332|NCT03392571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455333|NCT03392545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
19455334|NCT03392545|Immunologic Factors|immunologic factors|mesh-ancestor
19455335|NCT03392545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455336|NCT03392428|177Lu-PSMA-617|177lu-psma-617|mesh-list
19455337|NCT03392428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19455338|NCT03392428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455339|NCT03392311|Calcipotriene|calcipotriene|mesh-list
19455340|NCT03392311|Dermatologic Agents|dermatologic agents|mesh-ancestor
19455341|NCT03392272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19455342|NCT03392272|Hemostatics|hemostatics|mesh-ancestor
19455343|NCT03392272|Coagulants|coagulants|mesh-ancestor
19455344|NCT03392103|Raltitrexed|raltitrexed|mesh-list
19455345|NCT03392103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19455346|NCT03392103|Antimetabolites|antimetabolites|mesh-ancestor
19455347|NCT03392103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455348|NCT03392103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455349|NCT03392103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19455350|NCT03392103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455351|NCT03392051|Clopidogrel|clopidogrel|mesh-list
19455352|NCT03392051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19455353|NCT03392051|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19455354|NCT03392051|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19455355|NCT03392051|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19455356|NCT03392051|Purinergic Agents|purinergic agents|mesh-ancestor
19455357|NCT03392051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19455358|NCT03392051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455359|NCT03392051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455360|NCT03391934|Leucovorin|leucovorin|mesh-list
19455361|NCT03391934|Fluorouracil|fluorouracil|mesh-list
19455362|NCT03391934|Irinotecan|irinotecan|mesh-list
19455363|NCT03391934|Cetuximab|cetuximab|mesh-list
19455364|NCT03391934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455365|NCT03391934|Antimetabolites|antimetabolites|mesh-ancestor
19455366|NCT03391934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455367|NCT03391934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19455368|NCT03391934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455369|NCT03391934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19455370|NCT03391934|Immunologic Factors|immunologic factors|mesh-ancestor
19455371|NCT03391934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19455372|NCT03391934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19455373|NCT03391934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455374|NCT03391934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19455375|NCT03391934|Antidotes|antidotes|mesh-ancestor
19455376|NCT03391934|Protective Agents|protective agents|mesh-ancestor
19455377|NCT03391934|Vitamin B Complex|vitamin b complex|mesh-ancestor
19455378|NCT03391934|Vitamins|vitamins|mesh-ancestor
19455379|NCT03391934|Micronutrients|micronutrients|mesh-ancestor
19455380|NCT03391856|Acetylcysteine|acetylcysteine|mesh-list
19455381|NCT03391856|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19455382|NCT03391856|Antiviral Agents|antiviral agents|mesh-ancestor
19455383|NCT03391856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19455384|NCT03391856|Expectorants|expectorants|mesh-ancestor
19455385|NCT03391856|Respiratory System Agents|respiratory system agents|mesh-ancestor
19455386|NCT03391856|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19455387|NCT03391856|Antioxidants|antioxidants|mesh-ancestor
19455388|NCT03391856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455389|NCT03391856|Protective Agents|protective agents|mesh-ancestor
19455390|NCT03391856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455391|NCT03391856|Antidotes|antidotes|mesh-ancestor
19455392|NCT03391843|Cetuximab|cetuximab|mesh-list
19455393|NCT03391843|Oxaliplatin|oxaliplatin|mesh-list
19455394|NCT03391843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19455395|NCT03391843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455396|NCT03391830|Ascorbic Acid|ascorbic acid|mesh-list
19455397|NCT03391830|Atorvastatin|atorvastatin|mesh-list
19455398|NCT03391830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19455399|NCT03391830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19455400|NCT03391830|Antimetabolites|antimetabolites|mesh-ancestor
19455401|NCT03391830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455402|NCT03391830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19455403|NCT03391830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19455404|NCT03391830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455405|NCT03391830|Antioxidants|antioxidants|mesh-ancestor
19455406|NCT03391830|Protective Agents|protective agents|mesh-ancestor
19455407|NCT03391830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455408|NCT03391830|Vitamins|vitamins|mesh-ancestor
19455409|NCT03391830|Micronutrients|micronutrients|mesh-ancestor
19455410|NCT03391700|Rocuronium|rocuronium|mesh-list
19455411|NCT03391700|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19455412|NCT03391700|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19455413|NCT03391700|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19455414|NCT03391700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19455415|NCT03391700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455416|NCT03391609|Dexmedetomidine|dexmedetomidine|mesh-list
19455417|NCT03391609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19455418|NCT03391609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455419|NCT03391609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455420|NCT03391609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19455421|NCT03391609|Analgesics|analgesics|mesh-ancestor
19455422|NCT03391609|Sensory System Agents|sensory system agents|mesh-ancestor
19455423|NCT03391609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19455424|NCT03391609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19455425|NCT03391609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19455426|NCT03391609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19455427|NCT03391609|Adrenergic Agents|adrenergic agents|mesh-ancestor
19455428|NCT03391609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19455429|NCT03391609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455430|NCT03391570|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
19455431|NCT03391570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19455432|NCT03391570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455433|NCT03391570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455434|NCT03391570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19455435|NCT03391570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19455436|NCT03391570|Analgesics|analgesics|mesh-ancestor
19455437|NCT03391570|Sensory System Agents|sensory system agents|mesh-ancestor
19455438|NCT03391570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19455439|NCT03391570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455440|NCT03391570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19455441|NCT03391570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19455442|NCT03391427|Lidocaine|lidocaine|mesh-list
19455443|NCT03391427|Ketamine|ketamine|mesh-list
19455444|NCT03391427|Anesthetics, Local|anesthetics, local|mesh-ancestor
19455445|NCT03391427|Anesthetics|anesthetics|mesh-ancestor
19455446|NCT03391427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455447|NCT03391427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455448|NCT03391427|Sensory System Agents|sensory system agents|mesh-ancestor
19455449|NCT03391427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19455450|NCT03391427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19455451|NCT03391427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19455452|NCT03391427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19983841|NCT01939496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19983842|NCT01939496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983843|NCT01939899|Ixazomib|ixazomib|mesh-list
19983844|NCT01939899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983845|NCT01939899|Protease Inhibitors|protease inhibitors|mesh-ancestor
19983846|NCT01939899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983847|NCT01939899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983848|NCT01939977|Calcifediol|calcifediol|mesh-list
19983849|NCT01939977|Vitamins|vitamins|mesh-ancestor
19983850|NCT01939977|Micronutrients|micronutrients|mesh-ancestor
19983851|NCT01939977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983852|NCT01939977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19983853|NCT01940276|Prednisone|prednisone|mesh-list
19983854|NCT01940276|Abiraterone Acetate|abiraterone acetate|mesh-list
19983855|NCT01940276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19983856|NCT01940276|Glucocorticoids|glucocorticoids|mesh-ancestor
19983857|NCT01940276|Hormones|hormones|mesh-ancestor
19983858|NCT01940276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19983859|NCT01940276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983860|NCT01940276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19983861|NCT01940276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983862|NCT01940276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19983863|NCT01940276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983864|NCT01940276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983865|NCT01940276|Hormone Antagonists|hormone antagonists|mesh-ancestor
19983866|NCT01940276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19983867|NCT01940484|Epoetin Alfa|epoetin alfa|mesh-list
19983868|NCT01940484|Hematinics|hematinics|mesh-ancestor
19983869|NCT01940497|Paclitaxel|paclitaxel|mesh-list
19983870|NCT01940497|Docetaxel|docetaxel|mesh-list
19983871|NCT01940497|Doxorubicin|doxorubicin|mesh-list
19983872|NCT01940497|Trastuzumab|trastuzumab|mesh-list
19983873|NCT01940497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19983874|NCT01940497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983875|NCT01940497|Tubulin Modulators|tubulin modulators|mesh-ancestor
19983876|NCT01940497|Antimitotic Agents|antimitotic agents|mesh-ancestor
19983877|NCT01940497|Mitosis Modulators|mitosis modulators|mesh-ancestor
19983878|NCT01940497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983879|NCT01940497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19983880|NCT01940497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19983881|NCT01940497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19983882|NCT01940497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983883|NCT01940497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19983884|NCT01940510|Rifampin|rifampin|mesh-list
19983885|NCT01940510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19983886|NCT01940510|Antitubercular Agents|antitubercular agents|mesh-ancestor
19983887|NCT01940510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19983888|NCT01940510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19455453|NCT03391427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19455454|NCT03391427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455455|NCT03391427|Analgesics|analgesics|mesh-ancestor
19455456|NCT03391427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19455457|NCT03391427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19455458|NCT03391427|Anesthetics, General|anesthetics, general|mesh-ancestor
19455459|NCT03391427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19455460|NCT03391427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19455461|NCT03391427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19455462|NCT03391245|Vitamin D|vitamin d|mesh-list
19983889|NCT01940510|Leprostatic Agents|leprostatic agents|mesh-ancestor
19983890|NCT01940510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19983891|NCT01940510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983892|NCT01940510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455463|NCT03391245|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19455464|NCT03391245|Calcifediol|calcifediol|mesh-list
19455465|NCT03391245|Vitamins|vitamins|mesh-ancestor
19455466|NCT03391245|Micronutrients|micronutrients|mesh-ancestor
19455467|NCT03391245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455468|NCT03391245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19455469|NCT03391219|Bevacizumab|bevacizumab|mesh-list
19455470|NCT03391219|Fasudil|fasudil|mesh-list
19455471|NCT03391219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19455472|NCT03391219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455473|NCT03391219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19455474|NCT03391219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19455475|NCT03391219|Growth Substances|growth substances|mesh-ancestor
19455476|NCT03391219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455477|NCT03391219|Growth Inhibitors|growth inhibitors|mesh-ancestor
19455478|NCT03391219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19455479|NCT03391219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19455480|NCT03391219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455481|NCT03391219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19455482|NCT03391219|Vasodilator Agents|vasodilator agents|mesh-ancestor
19455483|NCT03391219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19455484|NCT03391219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736895|NCT05140096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736896|NCT05140096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736897|NCT05140096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19736898|NCT05140096|Hormone Antagonists|hormone antagonists|mesh-ancestor
19736899|NCT05140096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19736900|NCT05140096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736901|NCT05140096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19736902|NCT05140096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19736903|NCT05140096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736904|NCT05139966|Fluorides|fluorides|mesh-list
19736905|NCT05139966|Cariostatic Agents|cariostatic agents|mesh-ancestor
19736906|NCT05139966|Protective Agents|protective agents|mesh-ancestor
19736907|NCT05139966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736908|NCT05139667|Tacrolimus|tacrolimus|mesh-list
19983893|NCT01940510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19983894|NCT01940510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19983895|NCT01940510|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19983896|NCT01940510|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19983897|NCT01940510|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19983898|NCT01940510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19983899|NCT01940523|Tranexamic Acid|tranexamic acid|mesh-list
19983900|NCT01940523|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19983901|NCT01940523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19983902|NCT01940523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983903|NCT01940523|Hemostatics|hemostatics|mesh-ancestor
19983904|NCT01940523|Coagulants|coagulants|mesh-ancestor
19983905|NCT01940887|Bevacizumab|bevacizumab|mesh-list
19983906|NCT01940887|Aflibercept|aflibercept|mesh-list
19983907|NCT01940887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19983908|NCT01940887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983909|NCT01940887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19983910|NCT01940887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19983911|NCT01940887|Growth Substances|growth substances|mesh-ancestor
19983912|NCT01940887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983913|NCT01940887|Growth Inhibitors|growth inhibitors|mesh-ancestor
19983914|NCT01940900|Ranibizumab|ranibizumab|mesh-list
19736909|NCT05139667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19736910|NCT05139667|Immunologic Factors|immunologic factors|mesh-ancestor
19736911|NCT05139667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736912|NCT05139667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19736913|NCT05139667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736914|NCT05139667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736915|NCT05139524|Immunoglobulin G|immunoglobulin g|mesh-list
19736916|NCT05139524|Immunologic Factors|immunologic factors|mesh-ancestor
19736917|NCT05139524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736918|NCT05139472|Empagliflozin|empagliflozin|mesh-list
19736919|NCT05139472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19736920|NCT05139472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736921|NCT05139472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19983915|NCT01940900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19455485|NCT03391050|Dabrafenib|dabrafenib|mesh-list
19455486|NCT03391050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455487|NCT03391050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19455488|NCT03391050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455489|NCT03391050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455490|NCT03390972|Dexmedetomidine|dexmedetomidine|mesh-list
19455491|NCT03390972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19455492|NCT03390972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455493|NCT03390972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455494|NCT03390972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19455495|NCT03390972|Analgesics|analgesics|mesh-ancestor
19455496|NCT03390972|Sensory System Agents|sensory system agents|mesh-ancestor
19455497|NCT03390972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19455498|NCT03390972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19455499|NCT03390972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19455500|NCT03390972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19455501|NCT03390972|Adrenergic Agents|adrenergic agents|mesh-ancestor
19455502|NCT03390972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19455503|NCT03390972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455504|NCT03390933|Fluoxetine|fluoxetine|mesh-list
19455505|NCT03390933|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19455506|NCT03390933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19455507|NCT03390933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19455508|NCT03390933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455509|NCT03390933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19455510|NCT03390933|Serotonin Agents|serotonin agents|mesh-ancestor
19455511|NCT03390933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455512|NCT03390933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19455513|NCT03390933|Antidepressive Agents|antidepressive agents|mesh-ancestor
19455514|NCT03390933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19455515|NCT03390933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19455516|NCT03390933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19455517|NCT03390933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455518|NCT03390790|Lidocaine|lidocaine|mesh-list
19455519|NCT03390790|Anesthetics, Local|anesthetics, local|mesh-ancestor
19455520|NCT03390790|Anesthetics|anesthetics|mesh-ancestor
19455521|NCT03390790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455522|NCT03390790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455523|NCT03390790|Sensory System Agents|sensory system agents|mesh-ancestor
19455524|NCT03390790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19455525|NCT03390790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19455526|NCT03390790|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19455527|NCT03390790|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19455528|NCT03390790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19455529|NCT03390790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455530|NCT03390738|Nivolumab|nivolumab|mesh-list
19455531|NCT03390738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19455532|NCT03390738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455533|NCT03390738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19455534|NCT03390738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455535|NCT03390712|Risperidone|risperidone|mesh-list
19455536|NCT03390712|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19455537|NCT03390712|Antipsychotic Agents|antipsychotic agents|mesh-list
19455538|NCT03390712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19455539|NCT03390712|Serotonin Agents|serotonin agents|mesh-ancestor
19455540|NCT03390712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19455541|NCT03390712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455542|NCT03390712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455543|NCT03390712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19455544|NCT03390712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455545|NCT03390712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19455546|NCT03390712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19455547|NCT03390712|Dopamine Agents|dopamine agents|mesh-ancestor
19455548|NCT03390712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19455549|NCT03390712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19455550|NCT03390686|Paclitaxel|paclitaxel|mesh-list
19455551|NCT03390686|Bevacizumab|bevacizumab|mesh-list
19455552|NCT03390686|Carboplatin|carboplatin|mesh-list
19455553|NCT03390686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19455554|NCT03390686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455555|NCT03390686|Tubulin Modulators|tubulin modulators|mesh-ancestor
19455556|NCT03390686|Antimitotic Agents|antimitotic agents|mesh-ancestor
19455557|NCT03390686|Mitosis Modulators|mitosis modulators|mesh-ancestor
19455558|NCT03390686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455559|NCT03390686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19455560|NCT03390686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19455561|NCT03390686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19455562|NCT03390686|Growth Substances|growth substances|mesh-ancestor
19455563|NCT03390686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455564|NCT03390686|Growth Inhibitors|growth inhibitors|mesh-ancestor
19455565|NCT03390673|Bevacizumab|bevacizumab|mesh-list
19455566|NCT03390673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19455567|NCT03390673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455568|NCT03390673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19455569|NCT03390673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19455570|NCT03390673|Growth Substances|growth substances|mesh-ancestor
19455571|NCT03390673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455572|NCT03390673|Growth Inhibitors|growth inhibitors|mesh-ancestor
19455573|NCT03390608|Trastuzumab|trastuzumab|mesh-list
19455574|NCT03390608|Estrogens|estrogens|mesh-list
19455575|NCT03390608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19455576|NCT03390608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455577|NCT03390608|Hormones|hormones|mesh-ancestor
19455578|NCT03390608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19455579|NCT03390608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455580|NCT03390595|Gemcitabine|gemcitabine|mesh-list
19455581|NCT03390595|Carboplatin|carboplatin|mesh-list
19455582|NCT03390595|Avelumab|avelumab|mesh-list
19455583|NCT03390595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455584|NCT03390595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19455585|NCT03390595|Antimetabolites|antimetabolites|mesh-ancestor
19455586|NCT03390595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455587|NCT03390595|Antiviral Agents|antiviral agents|mesh-ancestor
19455588|NCT03390595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19455589|NCT03390595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455590|NCT03390595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19455591|NCT03390595|Immunologic Factors|immunologic factors|mesh-ancestor
19455592|NCT03390595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455593|NCT03390595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19455594|NCT03390582|Methimazole|methimazole|mesh-list
19455595|NCT03390582|Antithyroid Agents|antithyroid agents|mesh-ancestor
19455596|NCT03390582|Hormone Antagonists|hormone antagonists|mesh-ancestor
19455597|NCT03390582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19455598|NCT03390582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455599|NCT03390465|Amlodipine|amlodipine|mesh-list
19455600|NCT03390465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19455601|NCT03390465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19455602|NCT03390465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19455603|NCT03390465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19455604|NCT03390465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455605|NCT03390465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19455606|NCT03390465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455607|NCT03390465|Vasodilator Agents|vasodilator agents|mesh-ancestor
19455608|NCT03390465|Diuretics|diuretics|mesh-ancestor
19455609|NCT03390465|Natriuretic Agents|natriuretic agents|mesh-ancestor
19455610|NCT03390465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19455611|NCT03390387|Dexamethasone|dexamethasone|mesh-list
19455612|NCT03390387|Dexamethasone acetate|dexamethasone acetate|mesh-list
19455613|NCT03390387|Methylprednisolone|methylprednisolone|mesh-list
19455614|NCT03390387|Bortezomib|bortezomib|mesh-list
19455615|NCT03390387|Daunorubicin|daunorubicin|mesh-list
19455616|NCT03390387|Idarubicin|idarubicin|mesh-list
19455617|NCT03390387|BB 1101|bb 1101|mesh-list
19455618|NCT03390387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19455619|NCT03390387|Antiemetics|antiemetics|mesh-ancestor
19455620|NCT03390387|Autonomic Agents|autonomic agents|mesh-ancestor
19455621|NCT03390387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19455622|NCT03390387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736922|NCT05139472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736923|NCT05139238|Labetalol|labetalol|mesh-list
19736924|NCT05139238|Nifedipine|nifedipine|mesh-list
19736925|NCT05139238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19736926|NCT05139238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19455623|NCT03390387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19455624|NCT03390387|Glucocorticoids|glucocorticoids|mesh-ancestor
19455625|NCT03390387|Hormones|hormones|mesh-ancestor
19736927|NCT05139238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455626|NCT03390387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19455627|NCT03390387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19455628|NCT03390387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455629|NCT03390387|Protease Inhibitors|protease inhibitors|mesh-ancestor
19455630|NCT03390387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455631|NCT03390387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455632|NCT03390387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19455633|NCT03390387|Protective Agents|protective agents|mesh-ancestor
19455634|NCT03390387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19455635|NCT03390387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19455636|NCT03390387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19455637|NCT03390374|Nystatin|nystatin|mesh-list
19455638|NCT03390374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19455639|NCT03390374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19455640|NCT03390374|Antifungal Agents|antifungal agents|mesh-ancestor
19455641|NCT03390374|Ionophores|ionophores|mesh-ancestor
19455642|NCT03390374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19455643|NCT03390374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455644|NCT03390062|Apatinib|apatinib|mesh-list
19455645|NCT03390062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455646|NCT03390062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19455647|NCT03390062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455648|NCT03390062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455649|NCT03390036|Triamcinolone|triamcinolone|mesh-list
19455650|NCT03390036|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19455651|NCT03390036|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19455652|NCT03390036|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19455653|NCT03390036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19455654|NCT03390036|Glucocorticoids|glucocorticoids|mesh-ancestor
19455655|NCT03390036|Hormones|hormones|mesh-ancestor
19455656|NCT03390036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19455657|NCT03390036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455658|NCT03390036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19455659|NCT03390036|Immunologic Factors|immunologic factors|mesh-ancestor
19455660|NCT03390036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455661|NCT03390036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455662|NCT03390010|Misoprostol|misoprostol|mesh-list
19455663|NCT03390010|Oxytocin|oxytocin|mesh-list
19455664|NCT03390010|Methylergonovine|methylergonovine|mesh-list
19455665|NCT03390010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19455666|NCT03390010|Abortifacient Agents|abortifacient agents|mesh-ancestor
19455667|NCT03390010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19455668|NCT03390010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455669|NCT03390010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19455670|NCT03390010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19455671|NCT03390010|Oxytocics|oxytocics|mesh-ancestor
19455672|NCT03389958|Copper|copper|mesh-list
19455673|NCT03389958|Trace Elements|trace elements|mesh-ancestor
19455674|NCT03389958|Micronutrients|micronutrients|mesh-ancestor
19455675|NCT03389958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455676|NCT03389789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19455677|NCT03389776|Anesthetics|anesthetics|mesh-list
19455678|NCT03389776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455679|NCT03389776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455680|NCT03389763|Remifentanil|remifentanil|mesh-list
19455681|NCT03389763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19455682|NCT03389763|Narcotics|narcotics|mesh-ancestor
19455683|NCT03389763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455684|NCT03389763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455685|NCT03389763|Analgesics|analgesics|mesh-ancestor
19455686|NCT03389763|Sensory System Agents|sensory system agents|mesh-ancestor
19455687|NCT03389763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19455688|NCT03389750|Oxymorphone|oxymorphone|mesh-list
19455689|NCT03389750|Morphine|morphine|mesh-list
19455690|NCT03389750|Oxycodone|oxycodone|mesh-list
19455691|NCT03389750|Hydromorphone|hydromorphone|mesh-list
19455692|NCT03389750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19455693|NCT03389750|Narcotics|narcotics|mesh-ancestor
19455694|NCT03389750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455695|NCT03389750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455696|NCT03389750|Analgesics|analgesics|mesh-ancestor
19455697|NCT03389750|Sensory System Agents|sensory system agents|mesh-ancestor
19455698|NCT03389750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19455699|NCT03389750|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19455700|NCT03389724|Captopril|captopril|mesh-list
19455701|NCT03389724|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19455702|NCT03389724|Protease Inhibitors|protease inhibitors|mesh-ancestor
19455703|NCT03389724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455704|NCT03389724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455705|NCT03389724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19455706|NCT03389672|Anesthetics|anesthetics|mesh-list
19455707|NCT03389672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455708|NCT03389672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455709|NCT03389659|Vitamin D|vitamin d|mesh-list
19455710|NCT03389659|Cholecalciferol|cholecalciferol|mesh-list
19455711|NCT03389659|Vitamins|vitamins|mesh-ancestor
19455712|NCT03389659|Micronutrients|micronutrients|mesh-ancestor
19455713|NCT03389659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983916|NCT01940900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19983917|NCT01940900|Growth Substances|growth substances|mesh-ancestor
19983918|NCT01940900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983919|NCT01940900|Growth Inhibitors|growth inhibitors|mesh-ancestor
19983920|NCT01940900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983921|NCT01941095|Hydroxychloroquine|hydroxychloroquine|mesh-list
19983922|NCT01941095|Chloroquine|chloroquine|mesh-list
19455714|NCT03389659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19455715|NCT03389659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19983923|NCT01941095|Sulfasalazine|sulfasalazine|mesh-list
19983924|NCT01941095|Methotrexate|methotrexate|mesh-list
19983925|NCT01941095|Azathioprine|azathioprine|mesh-list
19983926|NCT01941095|Leflunomide|leflunomide|mesh-list
19983927|NCT01941095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19983928|NCT01941095|Abortifacient Agents|abortifacient agents|mesh-ancestor
19983929|NCT01941095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19983930|NCT01941095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983931|NCT01941095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19983932|NCT01941095|Antimetabolites|antimetabolites|mesh-ancestor
19983933|NCT01941095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983934|NCT01941095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983935|NCT01941095|Dermatologic Agents|dermatologic agents|mesh-ancestor
19983936|NCT01941095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983937|NCT01941095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19983938|NCT01941095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19455716|NCT03389607|Anesthetics|anesthetics|mesh-list
19455717|NCT03389607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455718|NCT03389607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736928|NCT05139238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19736929|NCT05139238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736930|NCT05139238|Vasodilator Agents|vasodilator agents|mesh-ancestor
19736931|NCT05139238|Tocolytic Agents|tocolytic agents|mesh-ancestor
19736932|NCT05139238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19736933|NCT05139238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19736934|NCT05139238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19736935|NCT05139238|Adrenergic Agents|adrenergic agents|mesh-ancestor
19736936|NCT05139238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19736937|NCT05139238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19736938|NCT05139238|Sympathomimetics|sympathomimetics|mesh-ancestor
19736939|NCT05139238|Autonomic Agents|autonomic agents|mesh-ancestor
19983939|NCT01941095|Immunologic Factors|immunologic factors|mesh-ancestor
19455719|NCT03389490|Insulin|insulin|mesh-list
19455720|NCT03389490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19455721|NCT03389490|Insulin Glargine|insulin glargine|mesh-list
19455722|NCT03389490|Insulin, Isophane|insulin, isophane|mesh-list
19455723|NCT03389490|Isophane Insulin, Human|isophane insulin, human|mesh-list
19455724|NCT03389490|Isophane insulin, beef|isophane insulin, beef|mesh-list
19455725|NCT03389490|Protamines|protamines|mesh-list
19455726|NCT03389490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19455727|NCT03389490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455728|NCT03389490|Heparin Antagonists|heparin antagonists|mesh-ancestor
19455729|NCT03389490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455730|NCT03389490|Coagulants|coagulants|mesh-ancestor
19455731|NCT03389451|Edetic Acid|edetic acid|mesh-list
19455732|NCT03389451|Chelating Agents|chelating agents|mesh-ancestor
19455733|NCT03389451|Sequestering Agents|sequestering agents|mesh-ancestor
19455734|NCT03389451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455735|NCT03389451|Anticoagulants|anticoagulants|mesh-ancestor
19455736|NCT03389451|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19455737|NCT03389412|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19455738|NCT03389412|Hemostatics|hemostatics|mesh-ancestor
19455739|NCT03389412|Coagulants|coagulants|mesh-ancestor
19455740|NCT03389412|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19455741|NCT03389412|Natriuretic Agents|natriuretic agents|mesh-ancestor
19455742|NCT03389412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455743|NCT03389321|Macitentan|macitentan|mesh-list
19455744|NCT03389321|Riociguat|riociguat|mesh-list
19455745|NCT03389321|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19455746|NCT03389321|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19455747|NCT03389321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455748|NCT03389321|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19455749|NCT03389321|Enzyme Activators|enzyme activators|mesh-ancestor
19455750|NCT03389295|Cisplatin|cisplatin|mesh-list
19455751|NCT03389295|Docetaxel|docetaxel|mesh-list
19455752|NCT03389295|Fluorouracil|fluorouracil|mesh-list
19455753|NCT03389295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455754|NCT03389295|Tubulin Modulators|tubulin modulators|mesh-ancestor
19455755|NCT03389295|Antimitotic Agents|antimitotic agents|mesh-ancestor
19455756|NCT03389295|Mitosis Modulators|mitosis modulators|mesh-ancestor
19455757|NCT03389295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455758|NCT03389295|Antimetabolites|antimetabolites|mesh-ancestor
19455759|NCT03389295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19455760|NCT03389295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19455761|NCT03389295|Immunologic Factors|immunologic factors|mesh-ancestor
19455762|NCT03389295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455763|NCT03389256|Apatinib|apatinib|mesh-list
19455764|NCT03389256|Gefitinib|gefitinib|mesh-list
19455765|NCT03389256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455766|NCT03389256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19455767|NCT03389256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455768|NCT03389256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455769|NCT03389191|Acyclovir|acyclovir|mesh-list
19455770|NCT03389191|Antiviral Agents|antiviral agents|mesh-ancestor
19455771|NCT03389191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19455772|NCT03389139|Anesthetics|anesthetics|mesh-list
19455773|NCT03389139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455774|NCT03389139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455775|NCT03389126|Avelumab|avelumab|mesh-list
19455776|NCT03389126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19455777|NCT03389126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455778|NCT03389087|Etoposide|etoposide|mesh-list
19455779|NCT03389087|Apatinib|apatinib|mesh-list
19455780|NCT03389087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19455781|NCT03389087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455782|NCT03389087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19455783|NCT03389087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19455784|NCT03389087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455785|NCT03389087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455786|NCT03389087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19455787|NCT03389061|Sofosbuvir|sofosbuvir|mesh-list
19455788|NCT03389061|Velpatasvir|velpatasvir|mesh-list
19455789|NCT03389061|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
19455790|NCT03389061|Antiviral Agents|antiviral agents|mesh-ancestor
19455791|NCT03389061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19455792|NCT03388970|Vitamin K|vitamin k|mesh-list
19455793|NCT03388970|Vitamin K 1|vitamin k 1|mesh-list
19455794|NCT03388970|Vitamins|vitamins|mesh-ancestor
19455795|NCT03388970|Micronutrients|micronutrients|mesh-ancestor
19455796|NCT03388970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455797|NCT03388970|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19455798|NCT03388970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19455799|NCT03388970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455800|NCT03388970|Hemostatics|hemostatics|mesh-ancestor
19455801|NCT03388970|Coagulants|coagulants|mesh-ancestor
19455802|NCT03388957|Propranolol|propranolol|mesh-list
19455803|NCT03388957|Midazolam|midazolam|mesh-list
19455804|NCT03388957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19455805|NCT03388957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19455806|NCT03388957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455807|NCT03388957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455808|NCT03388957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19455809|NCT03388957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19455810|NCT03388957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19455811|NCT03388957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19455812|NCT03388957|Anesthetics, General|anesthetics, general|mesh-ancestor
19455813|NCT03388957|Anesthetics|anesthetics|mesh-ancestor
19455814|NCT03388957|GABA Modulators|gaba modulators|mesh-ancestor
19455815|NCT03388957|GABA Agents|gaba agents|mesh-ancestor
19455816|NCT03388957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19455817|NCT03388957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455818|NCT03388957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19455819|NCT03388957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19455820|NCT03388957|Adrenergic Agents|adrenergic agents|mesh-ancestor
19455821|NCT03388957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19455822|NCT03388957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19455823|NCT03388957|Vasodilator Agents|vasodilator agents|mesh-ancestor
19455824|NCT03388892|Paclitaxel|paclitaxel|mesh-list
19455825|NCT03388892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19455826|NCT03388892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455827|NCT03388892|Tubulin Modulators|tubulin modulators|mesh-ancestor
19455828|NCT03388892|Antimitotic Agents|antimitotic agents|mesh-ancestor
19455829|NCT03388892|Mitosis Modulators|mitosis modulators|mesh-ancestor
19455830|NCT03388892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455831|NCT03388866|Immunologic Factors|immunologic factors|mesh-list
19455832|NCT03388866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455833|NCT03388853|Acetylcysteine|acetylcysteine|mesh-list
19455834|NCT03388853|Doxofylline|doxofylline|mesh-list
19455835|NCT03388853|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19455836|NCT03388853|Antiviral Agents|antiviral agents|mesh-ancestor
19455837|NCT03388853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19455838|NCT03388853|Expectorants|expectorants|mesh-ancestor
19455839|NCT03388853|Respiratory System Agents|respiratory system agents|mesh-ancestor
19455840|NCT03388853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19455841|NCT03388853|Antioxidants|antioxidants|mesh-ancestor
19455842|NCT03388853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455843|NCT03388853|Protective Agents|protective agents|mesh-ancestor
19455844|NCT03388853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455845|NCT03388853|Antidotes|antidotes|mesh-ancestor
19455846|NCT03388853|Antitussive Agents|antitussive agents|mesh-ancestor
19455847|NCT03388853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19455848|NCT03388853|Autonomic Agents|autonomic agents|mesh-ancestor
19455849|NCT03388853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19455850|NCT03388853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19455851|NCT03388853|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19455852|NCT03388853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455853|NCT03388827|Misoprostol|misoprostol|mesh-list
19455854|NCT03388827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19455855|NCT03388827|Abortifacient Agents|abortifacient agents|mesh-ancestor
19455856|NCT03388827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19455857|NCT03388827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455858|NCT03388827|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19455859|NCT03388827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19455860|NCT03388827|Oxytocics|oxytocics|mesh-ancestor
19455861|NCT03388814|Bupivacaine|bupivacaine|mesh-list
19455862|NCT03388814|Anesthetics, Local|anesthetics, local|mesh-ancestor
19455863|NCT03388814|Anesthetics|anesthetics|mesh-ancestor
19455864|NCT03388814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455865|NCT03388814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455866|NCT03388814|Sensory System Agents|sensory system agents|mesh-ancestor
19455867|NCT03388814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19455868|NCT03388697|Insulin|insulin|mesh-list
19983940|NCT01941095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19455869|NCT03388697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19455870|NCT03388697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455871|NCT03388671|Bupivacaine|bupivacaine|mesh-list
19455872|NCT03388671|Anesthetics, Local|anesthetics, local|mesh-ancestor
19455873|NCT03388671|Anesthetics|anesthetics|mesh-ancestor
19455874|NCT03388671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455875|NCT03388671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455876|NCT03388671|Sensory System Agents|sensory system agents|mesh-ancestor
19455877|NCT03388671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19455878|NCT03388541|Dexmedetomidine|dexmedetomidine|mesh-list
19455879|NCT03388541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19455880|NCT03388541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455881|NCT03388541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455882|NCT03388541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19455883|NCT03388541|Analgesics|analgesics|mesh-ancestor
19455884|NCT03388541|Sensory System Agents|sensory system agents|mesh-ancestor
19455885|NCT03388541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19455886|NCT03388541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19455887|NCT03388541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19455888|NCT03388541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19455889|NCT03388541|Adrenergic Agents|adrenergic agents|mesh-ancestor
19455890|NCT03388541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19455891|NCT03388541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455892|NCT03388463|Omeprazole|omeprazole|mesh-list
19455893|NCT03388463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19455894|NCT03388463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19455895|NCT03388463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19455896|NCT03388463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455897|NCT03388463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455898|NCT03388372|Temozolomide|temozolomide|mesh-list
19455899|NCT03388372|Nimotuzumab|nimotuzumab|mesh-list
19455900|NCT03388372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19455901|NCT03388372|Alkylating Agents|alkylating agents|mesh-ancestor
19455902|NCT03388372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455903|NCT03388372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455904|NCT03388372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19455905|NCT03388346|Edetic Acid|edetic acid|mesh-list
19455906|NCT03388346|Chelating Agents|chelating agents|mesh-ancestor
19455907|NCT03388346|Sequestering Agents|sequestering agents|mesh-ancestor
19455908|NCT03388346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455909|NCT03388346|Anticoagulants|anticoagulants|mesh-ancestor
19455910|NCT03388346|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19455911|NCT03388151|Midazolam|midazolam|mesh-list
19455912|NCT03388151|Propofol|propofol|mesh-list
19455913|NCT03388151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19455914|NCT03388151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455915|NCT03388151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455916|NCT03388151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19455917|NCT03388151|Anesthetics, General|anesthetics, general|mesh-ancestor
19455918|NCT03388151|Anesthetics|anesthetics|mesh-ancestor
19455919|NCT03388151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19455920|NCT03388151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19455921|NCT03388151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19455922|NCT03388151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19455923|NCT03388151|GABA Modulators|gaba modulators|mesh-ancestor
19455924|NCT03388151|GABA Agents|gaba agents|mesh-ancestor
19455925|NCT03388151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19455926|NCT03388151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455927|NCT03388125|Ethanolamine oleate|ethanolamine oleate|mesh-list
19455928|NCT03388125|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19455929|NCT03388125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19455930|NCT03387956|Dexamethasone|dexamethasone|mesh-list
19455931|NCT03387956|Atropine|atropine|mesh-list
19455932|NCT03387956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19455933|NCT03387956|Antiemetics|antiemetics|mesh-ancestor
19455934|NCT03387956|Autonomic Agents|autonomic agents|mesh-ancestor
19455935|NCT03387956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19455936|NCT03387956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455937|NCT03387956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19455938|NCT03387956|Glucocorticoids|glucocorticoids|mesh-ancestor
19455939|NCT03387956|Hormones|hormones|mesh-ancestor
19455940|NCT03387956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19455941|NCT03387956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19455942|NCT03387956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455943|NCT03387956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19455944|NCT03387956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19455945|NCT03387956|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19455946|NCT03387956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19455947|NCT03387956|Respiratory System Agents|respiratory system agents|mesh-ancestor
19455948|NCT03387956|Mydriatics|mydriatics|mesh-ancestor
19455949|NCT03387956|Parasympatholytics|parasympatholytics|mesh-ancestor
19455950|NCT03387956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19455951|NCT03387956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19455952|NCT03387956|Cholinergic Agents|cholinergic agents|mesh-ancestor
19455953|NCT03387956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19455954|NCT03387956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455955|NCT03387943|Cisplatin|cisplatin|mesh-list
19455956|NCT03387943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19455957|NCT03387904|Irinotecan|irinotecan|mesh-list
19455958|NCT03387904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19455959|NCT03387904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19455960|NCT03387904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455961|NCT03387904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455962|NCT03387904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736940|NCT05139238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19736941|NCT05139238|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19736942|NCT05139238|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19736948|NCT05138978|Listerine|listerine|mesh-list
19736949|NCT05138978|Sodium Fluoride|sodium fluoride|mesh-list
19736950|NCT05138978|Cariostatic Agents|cariostatic agents|mesh-ancestor
19736951|NCT05138978|Protective Agents|protective agents|mesh-ancestor
19736952|NCT05138978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19736953|NCT05138978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19736954|NCT05138978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736955|NCT05138861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19736956|NCT05138861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19736957|NCT05138718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19736958|NCT05138718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19736959|NCT05138718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736960|NCT05138484|Chlorhexidine|chlorhexidine|mesh-list
19736961|NCT05138484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19736962|NCT05138484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19736963|NCT05138484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736964|NCT05138484|Disinfectants|disinfectants|mesh-ancestor
19736965|NCT05138484|Dermatologic Agents|dermatologic agents|mesh-ancestor
19736966|NCT05126121|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19736967|NCT05126121|Amoxicillin|amoxicillin|mesh-list
19736968|NCT05126121|Clarithromycin|clarithromycin|mesh-list
19736969|NCT05126121|Levofloxacin|levofloxacin|mesh-list
19736970|NCT05126121|Ofloxacin|ofloxacin|mesh-list
19736971|NCT05126121|Tetracycline|tetracycline|mesh-list
19736972|NCT05126121|Tinidazole|tinidazole|mesh-list
19736973|NCT05126121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19736974|NCT05126121|Furazolidone|furazolidone|mesh-list
19736975|NCT05126121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19736976|NCT05126121|Antitubercular Agents|antitubercular agents|mesh-ancestor
19736977|NCT05126121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19736978|NCT05126121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19736979|NCT05126121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19736980|NCT05126121|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19736981|NCT05126121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19736982|NCT05126121|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19736983|NCT05126121|Renal Agents|renal agents|mesh-ancestor
19736984|NCT05126121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19736985|NCT05126121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19736986|NCT05126121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19736987|NCT05126121|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19736988|NCT05126121|Alkylating Agents|alkylating agents|mesh-ancestor
19736989|NCT05126121|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19736990|NCT05126121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19736991|NCT05126121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19736992|NCT05126121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19736993|NCT05126121|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19736994|NCT05108688|Sumatriptan|sumatriptan|mesh-list
19736995|NCT05108688|Mirtazapine|mirtazapine|mesh-list
19736996|NCT05108688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19736997|NCT05108688|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19736998|NCT05108688|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19736999|NCT05108688|Serotonin Agents|serotonin agents|mesh-ancestor
19737000|NCT05108688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983941|NCT01941095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19983942|NCT01941095|Antimalarials|antimalarials|mesh-ancestor
19983943|NCT01941095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19983944|NCT01941095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19983945|NCT01941095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19983946|NCT01941095|Amebicides|amebicides|mesh-ancestor
19983947|NCT01941095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19983948|NCT01941095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19983949|NCT01941095|Analgesics|analgesics|mesh-ancestor
19983950|NCT01941095|Sensory System Agents|sensory system agents|mesh-ancestor
19983951|NCT01941095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556259|NCT01945879|Heparin|heparin|mesh-list
20556260|NCT01945879|Enoxaparin|enoxaparin|mesh-list
20556261|NCT01945879|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
20556262|NCT01945879|Tinzaparin|tinzaparin|mesh-list
20556263|NCT01945879|Dalteparin|dalteparin|mesh-list
20556264|NCT01945879|Anticoagulants|anticoagulants|mesh-ancestor
20556265|NCT01945879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20556266|NCT01945879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20556267|NCT01945879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556268|NCT01945892|Dexamethasone|dexamethasone|mesh-list
20556269|NCT01945892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20556270|NCT01945892|Antiemetics|antiemetics|mesh-ancestor
19983952|NCT01941095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19983953|NCT01941095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20556271|NCT01945892|Autonomic Agents|autonomic agents|mesh-ancestor
19455963|NCT03387826|Ticagrelor|ticagrelor|mesh-list
19455964|NCT03387826|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19455965|NCT03387826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19455966|NCT03387826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19455967|NCT03387826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19455968|NCT03387826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19455969|NCT03387826|Purinergic Agents|purinergic agents|mesh-ancestor
19455970|NCT03387826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19455971|NCT03387826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455972|NCT03387826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455973|NCT03387787|Insulin|insulin|mesh-list
19455974|NCT03387787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19455975|NCT03387787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455976|NCT03387670|Simvastatin|simvastatin|mesh-list
19455977|NCT03387670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19455978|NCT03387670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19455979|NCT03387670|Antimetabolites|antimetabolites|mesh-ancestor
19455980|NCT03387670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455981|NCT03387670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19455982|NCT03387670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19455983|NCT03387670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19455984|NCT03387644|Pregabalin|pregabalin|mesh-list
19455985|NCT03387644|Analgesics|analgesics|mesh-ancestor
19455986|NCT03387644|Sensory System Agents|sensory system agents|mesh-ancestor
19455987|NCT03387644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19455988|NCT03387644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19455989|NCT03387644|Anticonvulsants|anticonvulsants|mesh-ancestor
19455990|NCT03387644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19455991|NCT03387644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19455992|NCT03387644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19455993|NCT03387644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19455994|NCT03387644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19455995|NCT03387644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19455996|NCT03387644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19455997|NCT03387644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19455998|NCT03387631|Lumefantrine|lumefantrine|mesh-list
19455999|NCT03387631|Artemether|artemether|mesh-list
19456000|NCT03387631|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
19456001|NCT03387631|Antimalarials|antimalarials|mesh-ancestor
19456002|NCT03387631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19456003|NCT03387631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19456004|NCT03387631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19456005|NCT03387592|Leucovorin|leucovorin|mesh-list
19456006|NCT03387592|Fluorouracil|fluorouracil|mesh-list
19983954|NCT01941537|Fezakinumab|fezakinumab|mesh-list
19983955|NCT01941537|Dermatologic Agents|dermatologic agents|mesh-ancestor
19983956|NCT01941628|Rocuronium|rocuronium|mesh-list
19983957|NCT01941628|Succinylcholine|succinylcholine|mesh-list
19983958|NCT01941628|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19983959|NCT01941628|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19456007|NCT03387592|Capecitabine|capecitabine|mesh-list
19456008|NCT03387592|Temozolomide|temozolomide|mesh-list
19456009|NCT03387592|Levoleucovorin|levoleucovorin|mesh-list
19456010|NCT03387592|Antimetabolites|antimetabolites|mesh-ancestor
19456011|NCT03387592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456012|NCT03387592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19456013|NCT03387592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456014|NCT03387592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19456015|NCT03387592|Immunologic Factors|immunologic factors|mesh-ancestor
19456016|NCT03387592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456017|NCT03387592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19456018|NCT03387592|Alkylating Agents|alkylating agents|mesh-ancestor
19456019|NCT03387592|Antidotes|antidotes|mesh-ancestor
19456020|NCT03387592|Protective Agents|protective agents|mesh-ancestor
19456021|NCT03387592|Vitamin B Complex|vitamin b complex|mesh-ancestor
19456022|NCT03387592|Vitamins|vitamins|mesh-ancestor
19456023|NCT03387592|Micronutrients|micronutrients|mesh-ancestor
19456024|NCT03387566|Immunoglobulins|immunoglobulins|mesh-list
19456025|NCT03387566|Endothelial Growth Factors|endothelial growth factors|mesh-list
19456026|NCT03387566|Immunologic Factors|immunologic factors|mesh-ancestor
19456027|NCT03387566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983960|NCT01941628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19456028|NCT03387566|Growth Substances|growth substances|mesh-ancestor
19456029|NCT03387501|Mitogens|mitogens|mesh-list
19456030|NCT03387501|Mitosis Modulators|mitosis modulators|mesh-ancestor
19456031|NCT03387501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456032|NCT03387241|Fluticasone|fluticasone|mesh-list
19456033|NCT03387241|Xhance|xhance|mesh-list
19456034|NCT03387241|Formoterol Fumarate|formoterol fumarate|mesh-list
19456035|NCT03387241|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19456036|NCT03387241|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19456037|NCT03387241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19456038|NCT03387241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19456039|NCT03387241|Autonomic Agents|autonomic agents|mesh-ancestor
19456040|NCT03387241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19456041|NCT03387241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456042|NCT03387241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19456043|NCT03387241|Respiratory System Agents|respiratory system agents|mesh-ancestor
19456044|NCT03387241|Dermatologic Agents|dermatologic agents|mesh-ancestor
19456045|NCT03387241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19456046|NCT03387241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19456047|NCT03387241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19456048|NCT03387241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19456049|NCT03387241|Adrenergic Agents|adrenergic agents|mesh-ancestor
19456050|NCT03387241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19456051|NCT03387241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456052|NCT03387241|Glucocorticoids|glucocorticoids|mesh-ancestor
19456053|NCT03387241|Hormones|hormones|mesh-ancestor
19456054|NCT03387241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19456055|NCT03387241|Sympathomimetics|sympathomimetics|mesh-ancestor
19456056|NCT03387163|Valsartan|valsartan|mesh-list
19456057|NCT03387163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19456058|NCT03387163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19456059|NCT03387163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19456060|NCT03387163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456061|NCT03387111|Leucovorin|leucovorin|mesh-list
19456062|NCT03387111|Paclitaxel|paclitaxel|mesh-list
19456063|NCT03387111|Cyclophosphamide|cyclophosphamide|mesh-list
19456064|NCT03387111|Bevacizumab|bevacizumab|mesh-list
19456065|NCT03387111|Fluorouracil|fluorouracil|mesh-list
19456066|NCT03387111|Capecitabine|capecitabine|mesh-list
19456067|NCT03387111|Cetuximab|cetuximab|mesh-list
19456068|NCT03387111|Avelumab|avelumab|mesh-list
19456069|NCT03387111|Necitumumab|necitumumab|mesh-list
19456070|NCT03387111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19456071|NCT03387111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456072|NCT03387111|Tubulin Modulators|tubulin modulators|mesh-ancestor
19456073|NCT03387111|Antimitotic Agents|antimitotic agents|mesh-ancestor
19456074|NCT03387111|Mitosis Modulators|mitosis modulators|mesh-ancestor
19456075|NCT03387111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456076|NCT03387111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19456077|NCT03387111|Immunologic Factors|immunologic factors|mesh-ancestor
19456078|NCT03387111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456079|NCT03387111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19456080|NCT03387111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19456081|NCT03387111|Alkylating Agents|alkylating agents|mesh-ancestor
19456082|NCT03387111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19456083|NCT03387111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19456084|NCT03387111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19456085|NCT03387111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19456086|NCT03387111|Growth Substances|growth substances|mesh-ancestor
19456087|NCT03387111|Growth Inhibitors|growth inhibitors|mesh-ancestor
19456088|NCT03387111|Antimetabolites|antimetabolites|mesh-ancestor
19456089|NCT03387111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19456090|NCT03387111|Antidotes|antidotes|mesh-ancestor
19456091|NCT03387111|Protective Agents|protective agents|mesh-ancestor
19456092|NCT03387111|Vitamin B Complex|vitamin b complex|mesh-ancestor
19456093|NCT03387111|Vitamins|vitamins|mesh-ancestor
19456094|NCT03387111|Micronutrients|micronutrients|mesh-ancestor
19456095|NCT03387098|Leucovorin|leucovorin|mesh-list
19456096|NCT03387098|Paclitaxel|paclitaxel|mesh-list
19456097|NCT03387098|Cyclophosphamide|cyclophosphamide|mesh-list
19456098|NCT03387098|Bevacizumab|bevacizumab|mesh-list
19456099|NCT03387098|Fluorouracil|fluorouracil|mesh-list
19456100|NCT03387098|Capecitabine|capecitabine|mesh-list
19456101|NCT03387098|Oxaliplatin|oxaliplatin|mesh-list
19456102|NCT03387098|Avelumab|avelumab|mesh-list
19456103|NCT03387098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19456104|NCT03387098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456105|NCT03387098|Tubulin Modulators|tubulin modulators|mesh-ancestor
19456106|NCT03387098|Antimitotic Agents|antimitotic agents|mesh-ancestor
19456107|NCT03387098|Mitosis Modulators|mitosis modulators|mesh-ancestor
19456108|NCT03387098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456109|NCT03387098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19456110|NCT03387098|Immunologic Factors|immunologic factors|mesh-ancestor
19456111|NCT03387098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456112|NCT03387098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19456113|NCT03387098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19456114|NCT03387098|Alkylating Agents|alkylating agents|mesh-ancestor
19456115|NCT03387098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19456116|NCT03387098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19456117|NCT03387098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19456118|NCT03387098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19456119|NCT03387098|Growth Substances|growth substances|mesh-ancestor
19456120|NCT03387098|Growth Inhibitors|growth inhibitors|mesh-ancestor
19456121|NCT03387098|Antimetabolites|antimetabolites|mesh-ancestor
19456122|NCT03387098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19456123|NCT03387098|Antidotes|antidotes|mesh-ancestor
19456124|NCT03387098|Protective Agents|protective agents|mesh-ancestor
19456125|NCT03387098|Vitamin B Complex|vitamin b complex|mesh-ancestor
19456126|NCT03387098|Vitamins|vitamins|mesh-ancestor
19456127|NCT03387098|Micronutrients|micronutrients|mesh-ancestor
19456128|NCT03386929|Palbociclib|palbociclib|mesh-list
19456129|NCT03386929|Avelumab|avelumab|mesh-list
19456130|NCT03386929|Axitinib|axitinib|mesh-list
19456131|NCT03386929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456132|NCT03386929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19456133|NCT03386929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456134|NCT03386929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456135|NCT03386929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19456136|NCT03386838|Carboplatin|carboplatin|mesh-list
19456137|NCT03386838|Fluorouracil|fluorouracil|mesh-list
19456138|NCT03386838|Nivolumab|nivolumab|mesh-list
19456139|NCT03386838|Cetuximab|cetuximab|mesh-list
19456140|NCT03386838|Linrodostat|linrodostat|mesh-list
19456141|NCT03386838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456142|NCT03386838|Antimetabolites|antimetabolites|mesh-ancestor
19456143|NCT03386838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456144|NCT03386838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19456145|NCT03386838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19456146|NCT03386838|Immunologic Factors|immunologic factors|mesh-ancestor
19456147|NCT03386838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456148|NCT03386838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19456149|NCT03386838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19456150|NCT03386838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456151|NCT03386656|Tranexamic Acid|tranexamic acid|mesh-list
19456152|NCT03386656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19456153|NCT03386656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19456154|NCT03386656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456155|NCT03386656|Hemostatics|hemostatics|mesh-ancestor
19456156|NCT03386656|Coagulants|coagulants|mesh-ancestor
19456157|NCT03386643|Clobetasol|clobetasol|mesh-list
19456158|NCT03386643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19456159|NCT03386643|Glucocorticoids|glucocorticoids|mesh-ancestor
19456160|NCT03386643|Hormones|hormones|mesh-ancestor
19456161|NCT03386643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19456162|NCT03386643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456163|NCT03386630|Sufentanil|sufentanil|mesh-list
19456164|NCT03386630|Morphine|morphine|mesh-list
19456165|NCT03386630|Dsuvia|dsuvia|mesh-list
19456166|NCT03386630|Bupivacaine|bupivacaine|mesh-list
19456167|NCT03386630|Anesthetics, Local|anesthetics, local|mesh-ancestor
19456168|NCT03386630|Anesthetics|anesthetics|mesh-ancestor
19456169|NCT03386630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19456170|NCT03386630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456171|NCT03386630|Sensory System Agents|sensory system agents|mesh-ancestor
19456172|NCT03386630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19456173|NCT03386630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19456174|NCT03386630|Narcotics|narcotics|mesh-ancestor
19456175|NCT03386630|Analgesics|analgesics|mesh-ancestor
19456176|NCT03386630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19456177|NCT03386630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19456178|NCT03386630|Anesthetics, General|anesthetics, general|mesh-ancestor
19456179|NCT03386591|Naloxone|naloxone|mesh-list
19456180|NCT03386591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19456181|NCT03386591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456182|NCT03386591|Sensory System Agents|sensory system agents|mesh-ancestor
19983961|NCT01941628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983962|NCT01941628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983963|NCT01941628|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
19983964|NCT01941927|Trametinib|trametinib|mesh-list
19983965|NCT01941927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19983966|NCT01941927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19983967|NCT01941927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19983968|NCT01941927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983969|NCT01942148|Aripiprazole|aripiprazole|mesh-list
19983970|NCT01942148|Antidepressive Agents|antidepressive agents|mesh-ancestor
19983971|NCT01942148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19983972|NCT01942148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19983973|NCT01942148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19983974|NCT01942148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19983975|NCT01942148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983976|NCT01942148|Dopamine Agonists|dopamine agonists|mesh-ancestor
19983977|NCT01942148|Dopamine Agents|dopamine agents|mesh-ancestor
19983978|NCT01942148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983979|NCT01942148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983980|NCT01942148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19983981|NCT01942148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19983982|NCT01942148|Serotonin Agents|serotonin agents|mesh-ancestor
19983983|NCT01942148|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19983984|NCT01942148|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19983985|NCT01942148|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19983986|NCT01942148|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19983987|NCT01942161|Aripiprazole|aripiprazole|mesh-list
19983988|NCT01942161|Antidepressive Agents|antidepressive agents|mesh-ancestor
19983989|NCT01942161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19456183|NCT03386591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19456184|NCT03386565|Lidocaine|lidocaine|mesh-list
19456185|NCT03386565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19983990|NCT01942161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19983991|NCT01942161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19983992|NCT01942161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19983993|NCT01942161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19983994|NCT01942161|Dopamine Agonists|dopamine agonists|mesh-ancestor
19983995|NCT01942161|Dopamine Agents|dopamine agents|mesh-ancestor
19456186|NCT03386565|Anesthetics, Local|anesthetics, local|mesh-ancestor
19456187|NCT03386565|Anesthetics|anesthetics|mesh-ancestor
19456188|NCT03386565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19456189|NCT03386565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456190|NCT03386565|Sensory System Agents|sensory system agents|mesh-ancestor
19456191|NCT03386565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19983996|NCT01942161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19983997|NCT01942161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19983998|NCT01942161|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19983999|NCT01942161|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19984000|NCT01942161|Serotonin Agents|serotonin agents|mesh-ancestor
19984001|NCT01942161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19984002|NCT01942161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19984003|NCT01942161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19984004|NCT01942161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19984005|NCT01942590|Clenbuterol|clenbuterol|mesh-list
19984006|NCT01942590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19984007|NCT01942590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19984008|NCT01942590|Adrenergic Agents|adrenergic agents|mesh-ancestor
19984009|NCT01942590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19984010|NCT01942590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984011|NCT01942590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984012|NCT01942590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19984013|NCT01942590|Autonomic Agents|autonomic agents|mesh-ancestor
19984014|NCT01942590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19984015|NCT01942590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19984016|NCT01942590|Respiratory System Agents|respiratory system agents|mesh-ancestor
19984017|NCT01942590|Sympathomimetics|sympathomimetics|mesh-ancestor
19456192|NCT03386565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19456193|NCT03386565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19456194|NCT03386565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19456195|NCT03386565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19456196|NCT03386565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456197|NCT03386539|Mycophenolic Acid|mycophenolic acid|mesh-list
19456198|NCT03386539|Everolimus|everolimus|mesh-list
19456199|NCT03386539|Tacrolimus|tacrolimus|mesh-list
19456200|NCT03386539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19456201|NCT03386539|Immunologic Factors|immunologic factors|mesh-ancestor
19456202|NCT03386539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456203|NCT03386539|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19456204|NCT03386539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456205|NCT03386539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456206|NCT03386539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456207|NCT03386539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19456208|NCT03386539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19456209|NCT03386539|Antitubercular Agents|antitubercular agents|mesh-ancestor
19456210|NCT03386539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19456211|NCT03386539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19456212|NCT03386357|Pembrolizumab|pembrolizumab|mesh-list
19456213|NCT03386357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19456214|NCT03386357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984018|NCT01942668|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19984019|NCT01942668|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19984020|NCT01942668|Estradiol|estradiol|mesh-list
19456215|NCT03386318|Oxycodone|oxycodone|mesh-list
19456216|NCT03386318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19456217|NCT03386318|Narcotics|narcotics|mesh-ancestor
19456218|NCT03386318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19456219|NCT03386318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456220|NCT03386318|Analgesics|analgesics|mesh-ancestor
19456221|NCT03386318|Sensory System Agents|sensory system agents|mesh-ancestor
19456222|NCT03386318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19984021|NCT01942668|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19984022|NCT01942668|Progesterone|progesterone|mesh-list
19984023|NCT01942668|Estrogens|estrogens|mesh-ancestor
19984024|NCT01942668|Hormones|hormones|mesh-ancestor
19984025|NCT01942668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19984026|NCT01942668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984027|NCT01942668|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19984028|NCT01942668|Contraceptive Agents|contraceptive agents|mesh-ancestor
19984029|NCT01942668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19984030|NCT01942668|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19984031|NCT01942668|Progestins|progestins|mesh-ancestor
19984032|NCT01942694|Vitamin D|vitamin d|mesh-list
19984033|NCT01942694|Cholecalciferol|cholecalciferol|mesh-list
19984034|NCT01942694|Vitamins|vitamins|mesh-ancestor
19984035|NCT01942694|Micronutrients|micronutrients|mesh-ancestor
19984036|NCT01942694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984037|NCT01942694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19984038|NCT01942694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19984039|NCT01942733|Brexpiprazole|brexpiprazole|mesh-list
19984040|NCT01942733|Serotonin Agents|serotonin agents|mesh-ancestor
19984041|NCT01942733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19984042|NCT01942733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984043|NCT01942733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984044|NCT01942733|Dopamine Agonists|dopamine agonists|mesh-ancestor
19984045|NCT01942733|Dopamine Agents|dopamine agents|mesh-ancestor
19984046|NCT01942785|Brexpiprazole|brexpiprazole|mesh-list
19456223|NCT03386305|Tacrolimus|tacrolimus|mesh-list
19456224|NCT03386305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19456225|NCT03386305|Immunologic Factors|immunologic factors|mesh-ancestor
19984047|NCT01942785|Serotonin Agents|serotonin agents|mesh-ancestor
19984048|NCT01942785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19456226|NCT03386305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456227|NCT03386305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19456228|NCT03386305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456229|NCT03386305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456230|NCT03386279|Moxifloxacin|moxifloxacin|mesh-list
19456231|NCT03386279|Abrocitinib|abrocitinib|mesh-list
19456232|NCT03386279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19456233|NCT03386279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19456234|NCT03386279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19456235|NCT03386279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19456236|NCT03386279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456237|NCT03386279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456238|NCT03386279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456239|NCT03386279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19456240|NCT03386227|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19456241|NCT03386227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19456242|NCT03386201|Methylene Blue|methylene blue|mesh-list
19456243|NCT03386201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456244|NCT03386201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456245|NCT03386149|Loxoprofen|loxoprofen|mesh-list
19456246|NCT03386149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19456247|NCT03386149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19456248|NCT03386149|Analgesics|analgesics|mesh-ancestor
19456249|NCT03386149|Sensory System Agents|sensory system agents|mesh-ancestor
19456250|NCT03386149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19456251|NCT03386149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456252|NCT03386149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19456253|NCT03386149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19456254|NCT03386071|Trametinib|trametinib|mesh-list
19456255|NCT03386071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456256|NCT03386071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19456257|NCT03386071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456258|NCT03386071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737001|NCT05108688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737002|NCT05108688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737003|NCT05108688|Antidepressive Agents|antidepressive agents|mesh-ancestor
19737004|NCT05108688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19737005|NCT05108688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19737006|NCT05108688|Histamine Antagonists|histamine antagonists|mesh-ancestor
19737007|NCT05108688|Histamine Agents|histamine agents|mesh-ancestor
19737008|NCT05108688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19737009|NCT05108688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19737010|NCT05108688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19737011|NCT05108688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19737012|NCT05108688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19737013|NCT05108688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19737014|NCT05108688|Adrenergic Agents|adrenergic agents|mesh-ancestor
19737015|NCT05108688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19737016|NCT05108688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19737017|NCT05108688|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19984049|NCT01942785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984050|NCT01942785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984051|NCT01942785|Dopamine Agonists|dopamine agonists|mesh-ancestor
19984052|NCT01942785|Dopamine Agents|dopamine agents|mesh-ancestor
19984053|NCT01942993|Vemurafenib|vemurafenib|mesh-list
19984054|NCT01942993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984055|NCT01942993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19984056|NCT01942993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984057|NCT01942993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984058|NCT01943435|Acetaminophen|acetaminophen|mesh-list
19984059|NCT01943435|Ibuprofen|ibuprofen|mesh-list
19984060|NCT01943435|Celecoxib|celecoxib|mesh-list
19984061|NCT01943435|Diclofenac|diclofenac|mesh-list
19984062|NCT01943435|Gabapentin|gabapentin|mesh-list
19984063|NCT01943435|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19984064|NCT01943435|Tramadol|tramadol|mesh-list
19984065|NCT01943435|Analgesics|analgesics|mesh-list
19984066|NCT01943435|Mirtazapine|mirtazapine|mesh-list
19984067|NCT01943435|Trazodone|trazodone|mesh-list
19984068|NCT01943435|Sertraline|sertraline|mesh-list
19984069|NCT01943435|Nortriptyline|nortriptyline|mesh-list
19984070|NCT01943435|Antidepressive Agents|antidepressive agents|mesh-list
19984071|NCT01943435|Misoprostol|misoprostol|mesh-list
19984072|NCT01943435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19984073|NCT01943435|Sensory System Agents|sensory system agents|mesh-ancestor
19984074|NCT01943435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19456259|NCT03385967|Dexmedetomidine|dexmedetomidine|mesh-list
19456260|NCT03385967|Ropivacaine|ropivacaine|mesh-list
19456261|NCT03385967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19456262|NCT03385967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19456263|NCT03385967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456264|NCT03385967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19456265|NCT03385967|Analgesics|analgesics|mesh-ancestor
19456266|NCT03385967|Sensory System Agents|sensory system agents|mesh-ancestor
19456267|NCT03385967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19456268|NCT03385967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19456269|NCT03385967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19456270|NCT03385967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19456271|NCT03385967|Adrenergic Agents|adrenergic agents|mesh-ancestor
19456272|NCT03385967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19456273|NCT03385967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456274|NCT03385967|Anesthetics, Local|anesthetics, local|mesh-ancestor
19456275|NCT03385967|Anesthetics|anesthetics|mesh-ancestor
19456276|NCT03385863|Pulmonary Surfactants|pulmonary surfactants|mesh-list
19456277|NCT03385863|Poractant alfa|poractant alfa|mesh-list
19456278|NCT03385863|Respiratory System Agents|respiratory system agents|mesh-ancestor
19456279|NCT03385668|Pirfenidone|pirfenidone|mesh-list
19456280|NCT03385668|Analgesics|analgesics|mesh-ancestor
19456281|NCT03385668|Sensory System Agents|sensory system agents|mesh-ancestor
19456282|NCT03385668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19456283|NCT03385668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456284|NCT03385668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19456285|NCT03385668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19456286|NCT03385668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19456287|NCT03385668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19456288|NCT03385668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456289|NCT03385551|Estradiol|estradiol|mesh-list
19456290|NCT03385551|Estrogens|estrogens|mesh-ancestor
19456291|NCT03385551|Hormones|hormones|mesh-ancestor
19456292|NCT03385551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19456293|NCT03385551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456294|NCT03385538|Clopidogrel|clopidogrel|mesh-list
19456295|NCT03385538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19456296|NCT03385538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19456297|NCT03385538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19456298|NCT03385538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19456299|NCT03385538|Purinergic Agents|purinergic agents|mesh-ancestor
19456300|NCT03385538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19456301|NCT03385538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456302|NCT03385538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456303|NCT03385525|Valproic Acid|valproic acid|mesh-list
19456304|NCT03385525|Anticonvulsants|anticonvulsants|mesh-ancestor
19456305|NCT03385525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456306|NCT03385525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456307|NCT03385525|GABA Agents|gaba agents|mesh-ancestor
19456308|NCT03385525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19456309|NCT03385525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456310|NCT03385525|Antimanic Agents|antimanic agents|mesh-ancestor
19456311|NCT03385525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19456312|NCT03385525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19456313|NCT03385525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19456314|NCT03385395|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19456315|NCT03385395|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19456316|NCT03385395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19456317|NCT03385395|Protease Inhibitors|protease inhibitors|mesh-ancestor
19456318|NCT03385395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456319|NCT03385395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456320|NCT03385382|Dexamethasone|dexamethasone|mesh-list
19456321|NCT03385382|Ranibizumab|ranibizumab|mesh-list
19456322|NCT03385382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19456323|NCT03385382|Antiemetics|antiemetics|mesh-ancestor
19456324|NCT03385382|Autonomic Agents|autonomic agents|mesh-ancestor
19456325|NCT03385382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19456326|NCT03385382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456327|NCT03385382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19456328|NCT03385382|Glucocorticoids|glucocorticoids|mesh-ancestor
19456329|NCT03385382|Hormones|hormones|mesh-ancestor
19456330|NCT03385382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19456331|NCT03385382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19456332|NCT03385382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456333|NCT03385382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19456334|NCT03385382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19456335|NCT03385382|Growth Substances|growth substances|mesh-ancestor
19456336|NCT03385382|Growth Inhibitors|growth inhibitors|mesh-ancestor
19456337|NCT03385356|Vitamin D|vitamin d|mesh-list
19456338|NCT03385356|Vitamins|vitamins|mesh-ancestor
19456339|NCT03385356|Micronutrients|micronutrients|mesh-ancestor
19456340|NCT03385356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456341|NCT03385356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19456342|NCT03385304|Iodine|iodine|mesh-list
19456343|NCT03385304|Chlorhexidine|chlorhexidine|mesh-list
19456344|NCT03385304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19456345|NCT03385304|Povidone-Iodine|povidone-iodine|mesh-list
19456346|NCT03385304|Povidone|povidone|mesh-list
19456347|NCT03385304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19456348|NCT03385304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19456349|NCT03385304|Disinfectants|disinfectants|mesh-ancestor
19456350|NCT03385304|Dermatologic Agents|dermatologic agents|mesh-ancestor
19456351|NCT03385304|Trace Elements|trace elements|mesh-ancestor
19737018|NCT05080790|Zoledronic Acid|zoledronic acid|mesh-list
19737019|NCT05080790|Interleukin-2|interleukin-2|mesh-list
19737020|NCT05080790|Dinutuximab|dinutuximab|mesh-list
19737021|NCT05080790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737022|NCT05080790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19737023|NCT05080790|Analgesics|analgesics|mesh-ancestor
19737024|NCT05080790|Sensory System Agents|sensory system agents|mesh-ancestor
19737025|NCT05080790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19737026|NCT05080790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737027|NCT05080790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19737028|NCT04918017|Esomeprazole|esomeprazole|mesh-list
19737029|NCT04918017|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
19737030|NCT04918017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19737031|NCT04918017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19737032|NCT04918017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737033|NCT04918017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737034|NCT04590248|Adavosertib|adavosertib|mesh-list
19737035|NCT04590248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737036|NCT04590248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737037|NCT04505254|Obinutuzumab|obinutuzumab|mesh-list
19737038|NCT04505254|Acalabrutinib|acalabrutinib|mesh-list
19737039|NCT04505254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19737040|NCT04505254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737041|NCT04502693|Vaccines|vaccines|mesh-list
19737042|NCT04502693|Immunologic Factors|immunologic factors|mesh-ancestor
19737043|NCT04502693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737044|NCT04459871|Thrombin|thrombin|mesh-list
19737045|NCT04459871|Hemostatics|hemostatics|mesh-ancestor
19737046|NCT04459871|Coagulants|coagulants|mesh-ancestor
19737047|NCT04455139|Melphalan|melphalan|mesh-list
19737048|NCT04455139|Topotecan|topotecan|mesh-list
19737049|NCT04455139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19737050|NCT04455139|Alkylating Agents|alkylating agents|mesh-ancestor
19737051|NCT04455139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737052|NCT04455139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737053|NCT04455139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19737054|NCT04455139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19737055|NCT04455139|Immunologic Factors|immunologic factors|mesh-ancestor
19737056|NCT04455139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737057|NCT04455139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19737058|NCT04455139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19737059|NCT04455139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737060|NCT04447183|Iodine|iodine|mesh-list
19737061|NCT04447183|Hormones|hormones|mesh-list
19737062|NCT04447183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19737063|NCT04447183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737064|NCT04447183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19737065|NCT04447183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19737066|NCT04447183|Trace Elements|trace elements|mesh-ancestor
19737067|NCT04447183|Micronutrients|micronutrients|mesh-ancestor
19737068|NCT04417088|Carboplatin|carboplatin|mesh-list
19737069|NCT04417088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737070|NCT04380545|Interferons|interferons|mesh-list
19737071|NCT04380545|Interferon-alpha|interferon-alpha|mesh-list
19737072|NCT04380545|Interferon alpha-2|interferon alpha-2|mesh-list
19456352|NCT03385304|Micronutrients|micronutrients|mesh-ancestor
19456353|NCT03385304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737073|NCT04380545|Fluorouracil|fluorouracil|mesh-list
19737074|NCT04380545|Nivolumab|nivolumab|mesh-list
19737075|NCT04380545|Antimetabolites|antimetabolites|mesh-ancestor
19984075|NCT01943435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456354|NCT03385304|Plasma Substitutes|plasma substitutes|mesh-ancestor
19456355|NCT03385304|Blood Substitutes|blood substitutes|mesh-ancestor
19456356|NCT03385226|Pembrolizumab|pembrolizumab|mesh-list
19456357|NCT03385226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19456358|NCT03385226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456359|NCT03385174|Carbon Monoxide|carbon monoxide|mesh-list
19456360|NCT03385174|Antimetabolites|antimetabolites|mesh-ancestor
19456361|NCT03385174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456362|NCT03385174|Gasotransmitters|gasotransmitters|mesh-ancestor
19456363|NCT03385174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19456364|NCT03385174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456365|NCT03385161|Ethanol|ethanol|mesh-list
19456366|NCT03385161|Botulinum Toxins|botulinum toxins|mesh-list
19456367|NCT03385161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19456368|NCT03385161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19456369|NCT03385161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19456370|NCT03385161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19456371|NCT03385161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456372|NCT03385161|Cholinergic Agents|cholinergic agents|mesh-ancestor
19456373|NCT03385161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19456374|NCT03385161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456375|NCT03385161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19456376|NCT03385161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19456377|NCT03385161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19456378|NCT03385161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19456379|NCT03385161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19456380|NCT03385135|Allopurinol|allopurinol|mesh-list
19456381|NCT03385135|Antimetabolites|antimetabolites|mesh-ancestor
19456382|NCT03385135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456383|NCT03385135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456384|NCT03385135|Gout Suppressants|gout suppressants|mesh-ancestor
19456385|NCT03385135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19456386|NCT03385135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19456387|NCT03385135|Antioxidants|antioxidants|mesh-ancestor
19456388|NCT03385135|Protective Agents|protective agents|mesh-ancestor
19456389|NCT03385135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456390|NCT03385096|Cyclophosphamide|cyclophosphamide|mesh-list
19456391|NCT03385096|Melphalan|melphalan|mesh-list
19456392|NCT03385096|Busulfan|busulfan|mesh-list
19456393|NCT03385096|Etoposide|etoposide|mesh-list
19456394|NCT03385096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19456395|NCT03385096|Immunologic Factors|immunologic factors|mesh-ancestor
19456396|NCT03385096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456397|NCT03385096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19456398|NCT03385096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19456399|NCT03385096|Alkylating Agents|alkylating agents|mesh-ancestor
19456400|NCT03385096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456401|NCT03385096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456402|NCT03385096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19456403|NCT03385096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19456404|NCT03385096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19456405|NCT03385096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19456406|NCT03385096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456407|NCT03385057|Acetaminophen|acetaminophen|mesh-list
19456408|NCT03385057|Ibuprofen|ibuprofen|mesh-list
19456409|NCT03385057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19456410|NCT03385057|Analgesics|analgesics|mesh-ancestor
19456411|NCT03385057|Sensory System Agents|sensory system agents|mesh-ancestor
19456412|NCT03385057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19456413|NCT03385057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456414|NCT03385057|Antipyretics|antipyretics|mesh-ancestor
19456415|NCT03385057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19456416|NCT03385057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19456417|NCT03385057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19456418|NCT03385057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19456419|NCT03385057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456420|NCT03385057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456421|NCT03384862|Folic Acid|folic acid|mesh-list
19456422|NCT03384862|Vitamin B 12|vitamin b 12|mesh-list
19456423|NCT03384862|Hydroxocobalamin|hydroxocobalamin|mesh-list
19456424|NCT03384862|Vitamins|vitamins|mesh-ancestor
19456425|NCT03384862|Micronutrients|micronutrients|mesh-ancestor
19984076|NCT01943435|Antipyretics|antipyretics|mesh-ancestor
19456426|NCT03384862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456427|NCT03384862|Hematinics|hematinics|mesh-ancestor
19456428|NCT03384862|Vitamin B Complex|vitamin b complex|mesh-ancestor
19456429|NCT03384537|Chlorhexidine|chlorhexidine|mesh-list
19456430|NCT03384537|Listerine|listerine|mesh-list
19456431|NCT03384537|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19456432|NCT03384537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19456433|NCT03384537|Disinfectants|disinfectants|mesh-ancestor
19456434|NCT03384524|Metoprolol|metoprolol|mesh-list
19456435|NCT03384524|Bromocriptine|bromocriptine|mesh-list
19456436|NCT03384524|Tamsulosin|tamsulosin|mesh-list
19456437|NCT03384524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19456438|NCT03384524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19456439|NCT03384524|Sympatholytics|sympatholytics|mesh-ancestor
19456440|NCT03384524|Autonomic Agents|autonomic agents|mesh-ancestor
19456441|NCT03384524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19456442|NCT03384524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456443|NCT03384524|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19456444|NCT03384524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19456445|NCT03384524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19456446|NCT03384524|Adrenergic Agents|adrenergic agents|mesh-ancestor
19456447|NCT03384524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19456448|NCT03384524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456449|NCT03384524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19456450|NCT03384524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19456451|NCT03384524|Urological Agents|urological agents|mesh-ancestor
19456452|NCT03384524|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19456453|NCT03384524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19456454|NCT03384524|Hormone Antagonists|hormone antagonists|mesh-ancestor
19456455|NCT03384524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19456456|NCT03384524|Dopamine Agonists|dopamine agonists|mesh-ancestor
19456457|NCT03384524|Dopamine Agents|dopamine agents|mesh-ancestor
19456458|NCT03384511|Apatinib|apatinib|mesh-list
19456459|NCT03384511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456460|NCT03384511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19456461|NCT03384511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456462|NCT03384511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737076|NCT04380545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737077|NCT04380545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19737078|NCT04380545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737079|NCT04380545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19737080|NCT04380545|Immunologic Factors|immunologic factors|mesh-ancestor
19737081|NCT04380545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737082|NCT04380545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19737083|NCT04380545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19737084|NCT04380545|Antiviral Agents|antiviral agents|mesh-ancestor
19737085|NCT04380545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19737086|NCT04312594|Acetylcysteine|acetylcysteine|mesh-list
19737087|NCT04312594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19737088|NCT04312594|Antiviral Agents|antiviral agents|mesh-ancestor
19737089|NCT04312594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19737090|NCT04312594|Expectorants|expectorants|mesh-ancestor
19737091|NCT04312594|Respiratory System Agents|respiratory system agents|mesh-ancestor
19737092|NCT04312594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19737093|NCT04312594|Antioxidants|antioxidants|mesh-ancestor
19737094|NCT04312594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737095|NCT04312594|Protective Agents|protective agents|mesh-ancestor
19737096|NCT04312594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737097|NCT04312594|Antidotes|antidotes|mesh-ancestor
19737098|NCT04282018|Zanubrutinib|zanubrutinib|mesh-list
19737099|NCT04282018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737100|NCT04282018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19737101|NCT04282018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737102|NCT04282018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737103|NCT04265755|Erenumab|erenumab|mesh-list
19737104|NCT04265755|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19737105|NCT04265755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737106|NCT04265755|Analgesics|analgesics|mesh-ancestor
19737107|NCT04265755|Sensory System Agents|sensory system agents|mesh-ancestor
19737108|NCT04265755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19737109|NCT04265755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737110|NCT04238416|Lactulose|lactulose|mesh-list
19737111|NCT04238416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19737112|NCT04201496|Empagliflozin|empagliflozin|mesh-list
19456463|NCT03384277|Cyclophosphamide|cyclophosphamide|mesh-list
19456464|NCT03384277|Rituximab|rituximab|mesh-list
19456465|NCT03384277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19456466|NCT03384277|Immunologic Factors|immunologic factors|mesh-ancestor
19456467|NCT03384277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456468|NCT03384277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19456469|NCT03384277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19456470|NCT03384277|Alkylating Agents|alkylating agents|mesh-ancestor
19456471|NCT03384277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456472|NCT03384277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456473|NCT03384277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19456474|NCT03384277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19456475|NCT03384238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19456476|NCT03384238|Panitumumab|panitumumab|mesh-list
19456477|NCT03384238|Antibodies|antibodies|mesh-list
19456478|NCT03384238|Immunoglobulins|immunoglobulins|mesh-list
19456479|NCT03384238|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19456480|NCT03384238|Immunologic Factors|immunologic factors|mesh-ancestor
19456481|NCT03384238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456482|NCT03384238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456483|NCT03384121|Rifampin|rifampin|mesh-list
19456484|NCT03384121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19456485|NCT03384121|Antitubercular Agents|antitubercular agents|mesh-ancestor
19456486|NCT03384121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19456487|NCT03384121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19456488|NCT03384121|Leprostatic Agents|leprostatic agents|mesh-ancestor
19456489|NCT03384121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19456490|NCT03384121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456491|NCT03384121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456492|NCT03384121|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19456493|NCT03384121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19456494|NCT03384121|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19456495|NCT03384121|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19456496|NCT03384121|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19456497|NCT03384121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19456498|NCT03384095|Hyaluronic Acid|hyaluronic acid|mesh-list
19456499|NCT03384095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19456500|NCT03384095|Immunologic Factors|immunologic factors|mesh-ancestor
19456501|NCT03384095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456502|NCT03384095|Viscosupplements|viscosupplements|mesh-ancestor
19456503|NCT03384095|Protective Agents|protective agents|mesh-ancestor
19984077|NCT01943435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19984078|NCT01943435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19984079|NCT01943435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19984080|NCT01943435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19984081|NCT01943435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984082|NCT01943435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984083|NCT01943435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19984084|NCT01943435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19984085|NCT01943435|Abortifacient Agents|abortifacient agents|mesh-ancestor
19984086|NCT01943435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19984087|NCT01943435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19984088|NCT01943435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19984089|NCT01943435|Oxytocics|oxytocics|mesh-ancestor
19984090|NCT01943435|Anticonvulsants|anticonvulsants|mesh-ancestor
19984091|NCT01943435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19984092|NCT01943435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19984093|NCT01943435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19984094|NCT01943435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19984095|NCT01943435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19984096|NCT01943435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19456504|NCT03383939|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19456505|NCT03383939|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19456506|NCT03383939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19456507|NCT03383939|Protease Inhibitors|protease inhibitors|mesh-ancestor
19456508|NCT03383939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456509|NCT03383939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456510|NCT03383822|Insulin|insulin|mesh-list
19456511|NCT03383822|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19456512|NCT03383822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19456513|NCT03383822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456514|NCT03383744|Vitamin A|vitamin a|mesh-list
19456515|NCT03383744|Vitamins|vitamins|mesh-ancestor
19456516|NCT03383744|Micronutrients|micronutrients|mesh-ancestor
19456517|NCT03383744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456518|NCT03383406|Cytarabine|cytarabine|mesh-list
19456519|NCT03383406|Methotrexate|methotrexate|mesh-list
19456520|NCT03383406|Etoposide|etoposide|mesh-list
19456521|NCT03383406|Ifosfamide|ifosfamide|mesh-list
19456522|NCT03383406|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19456523|NCT03383406|Abortifacient Agents|abortifacient agents|mesh-ancestor
19456524|NCT03383406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19456525|NCT03383406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456526|NCT03383406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19456527|NCT03383406|Antimetabolites|antimetabolites|mesh-ancestor
19456528|NCT03383406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456529|NCT03383406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456530|NCT03383406|Dermatologic Agents|dermatologic agents|mesh-ancestor
19456531|NCT03383406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456532|NCT03383406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19456533|NCT03383406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19456534|NCT03383406|Immunologic Factors|immunologic factors|mesh-ancestor
19456535|NCT03383406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19456536|NCT03383406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19456537|NCT03383406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19456538|NCT03383406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19456539|NCT03383406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19456540|NCT03383406|Antiviral Agents|antiviral agents|mesh-ancestor
19456541|NCT03383406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19456542|NCT03383406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19456543|NCT03383406|Alkylating Agents|alkylating agents|mesh-ancestor
19456544|NCT03383393|Adenosine|adenosine|mesh-list
19456545|NCT03383393|Eptifibatide|eptifibatide|mesh-list
19456546|NCT03383393|Analgesics|analgesics|mesh-ancestor
19456547|NCT03383393|Sensory System Agents|sensory system agents|mesh-ancestor
19456548|NCT03383393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19456549|NCT03383393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456550|NCT03383393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19456551|NCT03383393|Vasodilator Agents|vasodilator agents|mesh-ancestor
19456552|NCT03383393|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19456553|NCT03383393|Purinergic Agonists|purinergic agonists|mesh-ancestor
19456554|NCT03383393|Purinergic Agents|purinergic agents|mesh-ancestor
19456555|NCT03383393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19456556|NCT03383393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456557|NCT03383393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19456558|NCT03383367|TEMPO|tempo|mesh-list
19456559|NCT03383367|Antioxidants|antioxidants|mesh-ancestor
19456560|NCT03383367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456561|NCT03383367|Protective Agents|protective agents|mesh-ancestor
19456562|NCT03383367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456563|NCT03383328|Prednisolone|prednisolone|mesh-list
19456564|NCT03383328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19456565|NCT03383328|Methylprednisolone|methylprednisolone|mesh-list
19456566|NCT03383328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19456567|NCT03383328|Prednisolone acetate|prednisolone acetate|mesh-list
19456568|NCT03383328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19456569|NCT03383328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19456570|NCT03383328|Prednisolone phosphate|prednisolone phosphate|mesh-list
19456571|NCT03383328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19456572|NCT03383328|Glucocorticoids|glucocorticoids|mesh-ancestor
19456573|NCT03383328|Hormones|hormones|mesh-ancestor
19456574|NCT03383328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19456575|NCT03383328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456576|NCT03383328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19456577|NCT03383328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456578|NCT03383328|Antiemetics|antiemetics|mesh-ancestor
19456579|NCT03383328|Autonomic Agents|autonomic agents|mesh-ancestor
19456580|NCT03383328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19456581|NCT03383328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19456582|NCT03383328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19456583|NCT03383328|Protective Agents|protective agents|mesh-ancestor
19456584|NCT03383328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19456585|NCT03383328|Analgesics|analgesics|mesh-ancestor
19456586|NCT03383328|Sensory System Agents|sensory system agents|mesh-ancestor
19456587|NCT03383328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19456588|NCT03383315|Tramadol|tramadol|mesh-list
19456589|NCT03383315|Metoclopramide|metoclopramide|mesh-list
19456590|NCT03383315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19456591|NCT03383315|Narcotics|narcotics|mesh-ancestor
19456592|NCT03383315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19456593|NCT03383315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456594|NCT03383315|Analgesics|analgesics|mesh-ancestor
19456595|NCT03383315|Sensory System Agents|sensory system agents|mesh-ancestor
19456596|NCT03383315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19456597|NCT03383315|Antiemetics|antiemetics|mesh-ancestor
19456598|NCT03383315|Autonomic Agents|autonomic agents|mesh-ancestor
19456599|NCT03383315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19456600|NCT03383315|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19456601|NCT03383315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19456602|NCT03383315|Dopamine Agents|dopamine agents|mesh-ancestor
19456603|NCT03383315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19984097|NCT01943435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19984098|NCT01943435|Antimanic Agents|antimanic agents|mesh-ancestor
19984099|NCT01943435|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19984100|NCT01943435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19984101|NCT01943435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19984102|NCT01943435|Dopamine Agents|dopamine agents|mesh-ancestor
19984103|NCT01943435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19984104|NCT01943435|Narcotics|narcotics|mesh-ancestor
19984105|NCT01943435|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19984106|NCT01943435|Serotonin Agents|serotonin agents|mesh-ancestor
19984107|NCT01943435|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19984108|NCT01943435|Histamine Antagonists|histamine antagonists|mesh-ancestor
19984109|NCT01943435|Histamine Agents|histamine agents|mesh-ancestor
19984110|NCT01943435|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19984111|NCT01943435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19984112|NCT01943435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19984113|NCT01943435|Adrenergic Agents|adrenergic agents|mesh-ancestor
19984114|NCT01943435|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19984115|NCT01943435|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19984116|NCT01943435|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19984117|NCT01943435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19984118|NCT01943435|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19984119|NCT01943435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19984120|NCT01943461|Avelumab|avelumab|mesh-list
19984121|NCT01943461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19984122|NCT01943461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19984123|NCT01943461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984124|NCT01943461|Immunologic Factors|immunologic factors|mesh-ancestor
19984125|NCT01943461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984126|NCT01943552|Bromides|bromides|mesh-list
19984127|NCT01943552|Ipratropium|ipratropium|mesh-list
19984128|NCT01943552|Anticonvulsants|anticonvulsants|mesh-ancestor
19984129|NCT01943552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19984130|NCT01943552|Autonomic Agents|autonomic agents|mesh-ancestor
19984131|NCT01943552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19984132|NCT01943552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984133|NCT01943552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19984134|NCT01943552|Respiratory System Agents|respiratory system agents|mesh-ancestor
19984135|NCT01943552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19984136|NCT01943552|Cholinergic Agents|cholinergic agents|mesh-ancestor
19984137|NCT01943552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19984138|NCT01943552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984139|NCT01943565|Hydromorphone|hydromorphone|mesh-list
19984140|NCT01943565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20556272|NCT01945892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556273|NCT01945892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556274|NCT01945892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20556275|NCT01945892|Glucocorticoids|glucocorticoids|mesh-ancestor
20556276|NCT01945892|Hormones|hormones|mesh-ancestor
19456604|NCT03383315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456605|NCT03383302|Nivolumab|nivolumab|mesh-list
19456606|NCT03383302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19456607|NCT03383302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456608|NCT03383302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19456609|NCT03383302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456610|NCT03383276|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19456611|NCT03383276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19456612|NCT03383237|Apatinib|apatinib|mesh-list
19456613|NCT03383237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456614|NCT03383237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19456615|NCT03383237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456616|NCT03383237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456617|NCT03383185|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19456618|NCT03383185|Contraceptive Agents|contraceptive agents|mesh-list
19456619|NCT03383185|Medroxyprogesterone|medroxyprogesterone|mesh-list
19456620|NCT03383185|Contraceptives, Oral|contraceptives, oral|mesh-list
19456621|NCT03383185|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19456622|NCT03383185|Progestins|progestins|mesh-list
19456623|NCT03383185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19456624|NCT03383185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456625|NCT03383185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19456626|NCT03383185|Hormones|hormones|mesh-ancestor
19456627|NCT03383185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19456628|NCT03383185|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19456629|NCT03383185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19456630|NCT03383185|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19456631|NCT03383185|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19456632|NCT03383185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19456633|NCT03383185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456634|NCT03383120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19456635|NCT03383120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19456636|NCT03383094|Pembrolizumab|pembrolizumab|mesh-list
19456637|NCT03383094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456638|NCT03383094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19456639|NCT03383068|Metformin|metformin|mesh-list
19456640|NCT03383068|Exenatide|exenatide|mesh-list
19456641|NCT03383068|Acarbose|acarbose|mesh-list
19456642|NCT03383068|Orlistat|orlistat|mesh-list
19456643|NCT03383068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19456644|NCT03383068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456645|NCT03383068|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19456646|NCT03383068|Incretins|incretins|mesh-ancestor
19456647|NCT03383068|Hormones|hormones|mesh-ancestor
19456648|NCT03383068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19456649|NCT03383068|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19456650|NCT03383068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456651|NCT03383068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456652|NCT03383068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19456653|NCT03383003|Amoxicillin|amoxicillin|mesh-list
19456654|NCT03383003|Metronidazole|metronidazole|mesh-list
19456655|NCT03383003|Clarithromycin|clarithromycin|mesh-list
19456656|NCT03383003|Esomeprazole|esomeprazole|mesh-list
19456657|NCT03383003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19456658|NCT03383003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19456659|NCT03383003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19456660|NCT03383003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19456661|NCT03383003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19456662|NCT03383003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19456663|NCT03383003|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19456664|NCT03383003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456665|NCT03383003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456666|NCT03383003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19456667|NCT03383003|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19984141|NCT01943565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984142|NCT01943565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19984143|NCT01943565|Narcotics|narcotics|mesh-ancestor
19984144|NCT01943565|Analgesics|analgesics|mesh-ancestor
19984145|NCT01943565|Sensory System Agents|sensory system agents|mesh-ancestor
19984146|NCT01943565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19984147|NCT01943864|Trametinib|trametinib|mesh-list
19984148|NCT01943864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984149|NCT01943864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19456668|NCT03383003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19456669|NCT03382938|Dexmedetomidine|dexmedetomidine|mesh-list
19456670|NCT03382938|Ropivacaine|ropivacaine|mesh-list
19984150|NCT01943864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456671|NCT03382938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19456672|NCT03382938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19456673|NCT03382938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456674|NCT03382938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19456675|NCT03382938|Analgesics|analgesics|mesh-ancestor
19456676|NCT03382938|Sensory System Agents|sensory system agents|mesh-ancestor
19456677|NCT03382938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19456678|NCT03382938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19456679|NCT03382938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19456680|NCT03382938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19456681|NCT03382938|Adrenergic Agents|adrenergic agents|mesh-ancestor
19456682|NCT03382938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19456683|NCT03382938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456684|NCT03382938|Anesthetics, Local|anesthetics, local|mesh-ancestor
19456685|NCT03382938|Anesthetics|anesthetics|mesh-ancestor
19456686|NCT03382886|Bevacizumab|bevacizumab|mesh-list
19984151|NCT01943864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984152|NCT01944046|Oxytocin|oxytocin|mesh-list
19984153|NCT01944046|Oxytocics|oxytocics|mesh-ancestor
19984154|NCT01944046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19984155|NCT01944046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984156|NCT01944098|Lidocaine|lidocaine|mesh-list
19984157|NCT01944098|Anesthetics, Local|anesthetics, local|mesh-ancestor
19984158|NCT01944098|Anesthetics|anesthetics|mesh-ancestor
19984159|NCT01944098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19984160|NCT01944098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984161|NCT01944098|Sensory System Agents|sensory system agents|mesh-ancestor
19984162|NCT01944098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19984163|NCT01944098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19984164|NCT01944098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19984165|NCT01944098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19984166|NCT01944098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19984167|NCT01944098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984168|NCT01944293|Midazolam|midazolam|mesh-list
19984169|NCT01944293|Ketamine|ketamine|mesh-list
19984170|NCT01944293|Analgesics|analgesics|mesh-ancestor
19984171|NCT01944293|Sensory System Agents|sensory system agents|mesh-ancestor
19984172|NCT01944293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19984173|NCT01944293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984174|NCT01944293|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19984175|NCT01944293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19984176|NCT01944293|Anesthetics, General|anesthetics, general|mesh-ancestor
19984177|NCT01944293|Anesthetics|anesthetics|mesh-ancestor
19984178|NCT01944293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19984179|NCT01944293|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19984180|NCT01944293|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19984181|NCT01944293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19984182|NCT01944293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984183|NCT01944293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19984184|NCT01944293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19984185|NCT01944293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19984186|NCT01944293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19984187|NCT01944293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19984188|NCT01944293|GABA Modulators|gaba modulators|mesh-ancestor
19984189|NCT01944293|GABA Agents|gaba agents|mesh-ancestor
19984190|NCT01944319|Meropenem|meropenem|mesh-list
19984191|NCT01944319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19984192|NCT01944319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19984193|NCT01944371|Disulfiram|disulfiram|mesh-list
19984194|NCT01944371|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19456687|NCT03382886|Nivolumab|nivolumab|mesh-list
19456688|NCT03382886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19456689|NCT03382886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456690|NCT03382886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19456691|NCT03382886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19456692|NCT03382886|Growth Substances|growth substances|mesh-ancestor
19456693|NCT03382886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456694|NCT03382886|Growth Inhibitors|growth inhibitors|mesh-ancestor
19456695|NCT03382886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19456696|NCT03382886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456697|NCT03382756|Choline|choline|mesh-list
19456698|NCT03382756|Atorvastatin|atorvastatin|mesh-list
19456699|NCT03382756|Fenofibrate|fenofibrate|mesh-list
19456700|NCT03382756|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19456701|NCT03382756|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19456702|NCT03382756|Antimetabolites|antimetabolites|mesh-ancestor
19456703|NCT03382756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456704|NCT03382756|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19456705|NCT03382756|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19456706|NCT03382756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456707|NCT03382756|Lipotropic Agents|lipotropic agents|mesh-ancestor
19456708|NCT03382756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19456709|NCT03382756|Nootropic Agents|nootropic agents|mesh-ancestor
19456710|NCT03382743|Lidocaine|lidocaine|mesh-list
19456711|NCT03382743|Anesthetics, Local|anesthetics, local|mesh-ancestor
19456712|NCT03382743|Anesthetics|anesthetics|mesh-ancestor
19456713|NCT03382743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19456714|NCT03382743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456715|NCT03382743|Sensory System Agents|sensory system agents|mesh-ancestor
19456716|NCT03382743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19456717|NCT03382743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19456718|NCT03382743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19456719|NCT03382743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19456720|NCT03382743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19456721|NCT03382743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456722|NCT03382717|Amorolfine|amorolfine|mesh-list
19456723|NCT03382717|Antifungal Agents|antifungal agents|mesh-ancestor
19456724|NCT03382717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19456725|NCT03382600|Pembrolizumab|pembrolizumab|mesh-list
19456726|NCT03382600|Oxaliplatin|oxaliplatin|mesh-list
19456727|NCT03382600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456728|NCT03382600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19456729|NCT03382587|Aflibercept|aflibercept|mesh-list
19456730|NCT03382587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19456731|NCT03382587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19456732|NCT03382587|Growth Substances|growth substances|mesh-ancestor
19456733|NCT03382587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456734|NCT03382587|Growth Inhibitors|growth inhibitors|mesh-ancestor
19456735|NCT03382587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456736|NCT03382548|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19456737|NCT03382548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19456738|NCT03382548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19456739|NCT03382548|Antitubercular Agents|antitubercular agents|mesh-ancestor
19456740|NCT03382470|Anti-Infective Agents|anti-infective agents|mesh-list
19456741|NCT03382470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19456742|NCT03382431|PC-786|pc-786|mesh-list
19456743|NCT03382431|Antiviral Agents|antiviral agents|mesh-ancestor
19456744|NCT03382431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19456745|NCT03382431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456746|NCT03382431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737113|NCT04201496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19737114|NCT04201496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737115|NCT04201496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19737116|NCT04201496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737117|NCT04129216|Tamoxifen|tamoxifen|mesh-list
19737118|NCT04129216|Letrozole|letrozole|mesh-list
19737119|NCT04129216|Exemestane|exemestane|mesh-list
19737120|NCT04129216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737121|NCT04129216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737122|NCT04129216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19737123|NCT04129216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19737124|NCT04129216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737125|NCT04129216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19737126|NCT04129216|Hormone Antagonists|hormone antagonists|mesh-ancestor
20289101|NCT04989283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19456747|NCT03382314|Cholecalciferol|cholecalciferol|mesh-list
19456748|NCT03382314|Bazedoxifene|bazedoxifene|mesh-list
19456749|NCT03382314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19456750|NCT03382314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456751|NCT03382314|Vitamins|vitamins|mesh-ancestor
19456752|NCT03382314|Micronutrients|micronutrients|mesh-ancestor
19456753|NCT03382314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19456754|NCT03382314|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19456755|NCT03382314|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19456756|NCT03382314|Hormone Antagonists|hormone antagonists|mesh-ancestor
19456757|NCT03382314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19456758|NCT03382275|Iron|iron|mesh-list
19456759|NCT03382275|Ferric maltol|ferric maltol|mesh-list
19456760|NCT03382275|Trace Elements|trace elements|mesh-ancestor
19456761|NCT03382275|Micronutrients|micronutrients|mesh-ancestor
19456762|NCT03382275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456763|NCT03382275|Hematinics|hematinics|mesh-ancestor
19456764|NCT03382106|Sildenafil Citrate|sildenafil citrate|mesh-list
19456765|NCT03382106|Vasodilator Agents|vasodilator agents|mesh-ancestor
19456766|NCT03382106|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19456767|NCT03382106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19456768|NCT03382106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456769|NCT03382106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456770|NCT03382106|Urological Agents|urological agents|mesh-ancestor
19456771|NCT03381859|Grazoprevir|grazoprevir|mesh-list
19456772|NCT03381859|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
19456773|NCT03381859|Antiviral Agents|antiviral agents|mesh-ancestor
19456774|NCT03381859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19456775|NCT03381833|Hepcidins|hepcidins|mesh-list
19456776|NCT03381833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19456777|NCT03381781|Cytarabine|cytarabine|mesh-list
19456778|NCT03381781|Decitabine|decitabine|mesh-list
19456779|NCT03381781|Arsenic Trioxide|arsenic trioxide|mesh-list
19456780|NCT03381781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19456781|NCT03381781|Antimetabolites|antimetabolites|mesh-ancestor
19456782|NCT03381781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456783|NCT03381781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456784|NCT03381781|Antiviral Agents|antiviral agents|mesh-ancestor
19456785|NCT03381781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19456786|NCT03381781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19456787|NCT03381781|Immunologic Factors|immunologic factors|mesh-ancestor
19456788|NCT03381781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456789|NCT03381781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456790|NCT03381755|Ticagrelor|ticagrelor|mesh-list
19456791|NCT03381755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19456792|NCT03381755|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19456793|NCT03381755|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19456794|NCT03381755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19456795|NCT03381755|Purinergic Agents|purinergic agents|mesh-ancestor
19456796|NCT03381755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19456797|NCT03381755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456798|NCT03381755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456799|NCT03381703|YH12852|yh12852|mesh-list
19456800|NCT03381703|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19456801|NCT03381703|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19456802|NCT03381703|Serotonin Agents|serotonin agents|mesh-ancestor
19456803|NCT03381703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19456804|NCT03381703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456805|NCT03381703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456806|NCT03381664|Quinidine|quinidine|mesh-list
19456807|NCT03381664|Dextromethorphan|dextromethorphan|mesh-list
19456808|NCT03381664|Antitussive Agents|antitussive agents|mesh-ancestor
19456809|NCT03381664|Respiratory System Agents|respiratory system agents|mesh-ancestor
19456810|NCT03381664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19456811|NCT03381664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19456812|NCT03381664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19456813|NCT03381664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456814|NCT03381664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456815|NCT03381664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19456816|NCT03381664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19456817|NCT03381664|Adrenergic Agents|adrenergic agents|mesh-ancestor
19456818|NCT03381664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19456819|NCT03381664|Antimalarials|antimalarials|mesh-ancestor
19456820|NCT03381664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19456821|NCT03381664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19456822|NCT03381664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19456823|NCT03381664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456824|NCT03381664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19456825|NCT03381664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19456826|NCT03381664|Cholinergic Agents|cholinergic agents|mesh-ancestor
19456827|NCT03381664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19456828|NCT03381664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19456829|NCT03381664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19456830|NCT03381664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19456831|NCT03381664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19456832|NCT03381599|Lenograstim|lenograstim|mesh-list
19456833|NCT03381599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19456834|NCT03381599|Immunologic Factors|immunologic factors|mesh-ancestor
19456835|NCT03381599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456836|NCT03381495|Sufentanil|sufentanil|mesh-list
19456837|NCT03381495|Ropivacaine|ropivacaine|mesh-list
19456838|NCT03381495|Anesthetics, Local|anesthetics, local|mesh-ancestor
19456839|NCT03381495|Anesthetics|anesthetics|mesh-ancestor
19456840|NCT03381495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19456841|NCT03381495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456842|NCT03381495|Sensory System Agents|sensory system agents|mesh-ancestor
19456843|NCT03381495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19456844|NCT03381495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19456845|NCT03381495|Narcotics|narcotics|mesh-ancestor
19456846|NCT03381495|Analgesics|analgesics|mesh-ancestor
19456847|NCT03381495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19456848|NCT03381495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19456849|NCT03381495|Anesthetics, General|anesthetics, general|mesh-ancestor
19456850|NCT03381482|Anesthetics|anesthetics|mesh-list
19737127|NCT04129216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19737128|NCT04129216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737129|NCT04129216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19737130|NCT04129216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19737131|NCT04129216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19737132|NCT04129216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19737133|NCT04106414|Nivolumab|nivolumab|mesh-list
19737134|NCT04106414|Linrodostat|linrodostat|mesh-list
19737135|NCT04106414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19737136|NCT04106414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737137|NCT04106414|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19737138|NCT04106414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737139|NCT04106414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737140|NCT04102618|Trastuzumab|trastuzumab|mesh-list
19737141|NCT04102618|Atezolizumab|atezolizumab|mesh-list
19737142|NCT04102618|Letrozole|letrozole|mesh-list
19737143|NCT04102618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19737144|NCT04102618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737145|NCT04102618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19737146|NCT04102618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19737147|NCT04102618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737148|NCT04102618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737149|NCT04102618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19737150|NCT04102618|Hormone Antagonists|hormone antagonists|mesh-ancestor
19737151|NCT04102618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19737152|NCT04102618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984195|NCT01944371|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19984196|NCT01944371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984197|NCT01944371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984198|NCT01944423|Cycloserine|cycloserine|mesh-list
19984199|NCT01944423|Nicotine|nicotine|mesh-list
19984200|NCT01944423|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19984201|NCT01944423|Autonomic Agents|autonomic agents|mesh-ancestor
19456851|NCT03381482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19456852|NCT03381482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456853|NCT03381430|Gefitinib|gefitinib|mesh-list
19456854|NCT03381430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456855|NCT03381430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19456856|NCT03381430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456857|NCT03381430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456858|NCT03381352|Capecitabine|capecitabine|mesh-list
19456859|NCT03381352|Mitomycins|mitomycins|mesh-list
19456860|NCT03381352|Mitomycin|mitomycin|mesh-list
19456861|NCT03381352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19456862|NCT03381352|Antimetabolites|antimetabolites|mesh-ancestor
19456863|NCT03381352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456864|NCT03381352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456865|NCT03381352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19456866|NCT03381352|Alkylating Agents|alkylating agents|mesh-ancestor
19456867|NCT03381352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19456868|NCT03381352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456869|NCT03381261|Botulinum Toxins|botulinum toxins|mesh-list
19456870|NCT03381261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19456871|NCT03381261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19456872|NCT03381261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19456873|NCT03381261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19456874|NCT03381261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456875|NCT03381261|Cholinergic Agents|cholinergic agents|mesh-ancestor
19456876|NCT03381261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19456877|NCT03381261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456878|NCT03381261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19456879|NCT03381261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19456880|NCT03381118|Cytarabine|cytarabine|mesh-list
19456881|NCT03381118|Nivolumab|nivolumab|mesh-list
19456882|NCT03381118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19456883|NCT03381118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456884|NCT03381118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19456885|NCT03381118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456886|NCT03381118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19456887|NCT03381118|Antimetabolites|antimetabolites|mesh-ancestor
19456888|NCT03381118|Antiviral Agents|antiviral agents|mesh-ancestor
19456889|NCT03381118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19456890|NCT03381118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19456891|NCT03381118|Immunologic Factors|immunologic factors|mesh-ancestor
19456892|NCT03381118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456893|NCT03381066|Cisplatin|cisplatin|mesh-list
19456894|NCT03381066|Pemetrexed|pemetrexed|mesh-list
19456895|NCT03381066|Vinorelbine|vinorelbine|mesh-list
19456896|NCT03381066|Gefitinib|gefitinib|mesh-list
19456897|NCT03381066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456898|NCT03381066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456899|NCT03381066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456900|NCT03381066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19456901|NCT03381066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19456902|NCT03381066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19456903|NCT03381066|Tubulin Modulators|tubulin modulators|mesh-ancestor
19456904|NCT03381066|Antimitotic Agents|antimitotic agents|mesh-ancestor
19456905|NCT03381066|Mitosis Modulators|mitosis modulators|mesh-ancestor
19456906|NCT03381066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19456907|NCT03381053|Imatinib Mesylate|imatinib mesylate|mesh-list
19456908|NCT03381053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456909|NCT03381053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19456910|NCT03381053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456911|NCT03381053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456912|NCT03381040|Hyaluronic Acid|hyaluronic acid|mesh-list
19456913|NCT03381040|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19456914|NCT03381040|Immunologic Factors|immunologic factors|mesh-ancestor
19456915|NCT03381040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456916|NCT03381040|Viscosupplements|viscosupplements|mesh-ancestor
19456917|NCT03381040|Protective Agents|protective agents|mesh-ancestor
19456918|NCT03380975|Montelukast|montelukast|mesh-list
19456919|NCT03380975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19456920|NCT03380975|Respiratory System Agents|respiratory system agents|mesh-ancestor
19456921|NCT03380975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19456922|NCT03380975|Hormone Antagonists|hormone antagonists|mesh-ancestor
19456923|NCT03380975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19456924|NCT03380975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456925|NCT03380975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19984202|NCT01944423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19456926|NCT03380975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19456927|NCT03380975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456928|NCT03380949|Remifentanil|remifentanil|mesh-list
19456929|NCT03380949|Analgesics, Opioid|analgesics, opioid|mesh-list
19456930|NCT03380949|Narcotics|narcotics|mesh-ancestor
19456931|NCT03380949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19456932|NCT03380949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456933|NCT03380949|Analgesics|analgesics|mesh-ancestor
19456934|NCT03380949|Sensory System Agents|sensory system agents|mesh-ancestor
19456935|NCT03380949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19456936|NCT03380936|Tacrolimus|tacrolimus|mesh-list
19456937|NCT03380936|Immunoglobulins|immunoglobulins|mesh-list
19456938|NCT03380936|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19456939|NCT03380936|Antibodies|antibodies|mesh-list
19456940|NCT03380936|gamma-Globulins|gamma-globulins|mesh-list
19456941|NCT03380936|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19456942|NCT03380936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19456943|NCT03380936|Immunologic Factors|immunologic factors|mesh-ancestor
19456944|NCT03380936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456945|NCT03380936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19456946|NCT03380936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456947|NCT03380936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456948|NCT03380871|Carboplatin|carboplatin|mesh-list
19456949|NCT03380871|Pembrolizumab|pembrolizumab|mesh-list
19456950|NCT03380871|Pemetrexed|pemetrexed|mesh-list
19456951|NCT03380871|Poly ICLC|poly iclc|mesh-list
19456952|NCT03380871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456953|NCT03380871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19456954|NCT03380871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456955|NCT03380871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456956|NCT03380871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19456957|NCT03380871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19456958|NCT03380871|Interferon Inducers|interferon inducers|mesh-ancestor
19456959|NCT03380871|Immunologic Factors|immunologic factors|mesh-ancestor
19456960|NCT03380871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737153|NCT04052880|Dexamethasone|dexamethasone|mesh-list
19737154|NCT04052880|Lenalidomide|lenalidomide|mesh-list
19737155|NCT04052880|Bortezomib|bortezomib|mesh-list
19737156|NCT04052880|Daratumumab|daratumumab|mesh-list
19737157|NCT04052880|Ixazomib|ixazomib|mesh-list
19737158|NCT04052880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19737159|NCT04052880|Antiemetics|antiemetics|mesh-ancestor
19737160|NCT04052880|Autonomic Agents|autonomic agents|mesh-ancestor
19737161|NCT04052880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19737162|NCT04052880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737163|NCT04052880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19737164|NCT04052880|Glucocorticoids|glucocorticoids|mesh-ancestor
19737165|NCT04052880|Hormones|hormones|mesh-ancestor
19737166|NCT04052880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19984203|NCT01944423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984204|NCT01944423|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19984205|NCT01944423|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19984206|NCT01944423|Cholinergic Agents|cholinergic agents|mesh-ancestor
19984207|NCT01944423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19984208|NCT01944423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984209|NCT01944423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19984210|NCT01944423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19984211|NCT01944423|Renal Agents|renal agents|mesh-ancestor
19984212|NCT01944423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19984213|NCT01944423|Antitubercular Agents|antitubercular agents|mesh-ancestor
19984214|NCT01944423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19737167|NCT04052880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19737168|NCT04052880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737169|NCT04052880|Immunologic Factors|immunologic factors|mesh-ancestor
19737170|NCT04052880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19737171|NCT04052880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19737172|NCT04052880|Growth Substances|growth substances|mesh-ancestor
19984215|NCT01944423|Antimetabolites|antimetabolites|mesh-ancestor
19984216|NCT01944462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19984217|NCT01944462|Immunologic Factors|immunologic factors|mesh-ancestor
19984218|NCT01944462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737173|NCT04052880|Growth Inhibitors|growth inhibitors|mesh-ancestor
19737174|NCT04052880|Protease Inhibitors|protease inhibitors|mesh-ancestor
19737175|NCT04052880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737176|NCT04052880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456961|NCT03380728|Ibogaine|ibogaine|mesh-list
19456962|NCT03380728|Hallucinogens|hallucinogens|mesh-ancestor
19456963|NCT03380728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456964|NCT03380728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19456965|NCT03380728|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19456966|NCT03380728|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19456967|NCT03380728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19456968|NCT03380728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456969|NCT03380689|Bevacizumab|bevacizumab|mesh-list
19456970|NCT03380689|Irinotecan|irinotecan|mesh-list
19456971|NCT03380689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19456972|NCT03380689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19456973|NCT03380689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19456974|NCT03380689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19456975|NCT03380689|Growth Substances|growth substances|mesh-ancestor
19456976|NCT03380689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456977|NCT03380689|Growth Inhibitors|growth inhibitors|mesh-ancestor
19456978|NCT03380689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19456979|NCT03380689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19456980|NCT03380689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456981|NCT03380689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456982|NCT03380546|Insulin|insulin|mesh-list
19456983|NCT03380546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19456984|NCT03380546|Acarbose|acarbose|mesh-list
19456985|NCT03380546|Insulin, Short-Acting|insulin, short-acting|mesh-list
19456986|NCT03380546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19456987|NCT03380546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456988|NCT03380546|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19456989|NCT03380546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19456990|NCT03380546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19456991|NCT03380533|Buprenorphine|buprenorphine|mesh-list
19456992|NCT03380533|Tramadol|tramadol|mesh-list
19456993|NCT03380533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19456994|NCT03380533|Narcotics|narcotics|mesh-ancestor
19456995|NCT03380533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19456996|NCT03380533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19456997|NCT03380533|Analgesics|analgesics|mesh-ancestor
19456998|NCT03380533|Sensory System Agents|sensory system agents|mesh-ancestor
19456999|NCT03380533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457000|NCT03380533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19737177|NCT04018755|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19737178|NCT04018755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19737179|NCT03993379|Ipilimumab|ipilimumab|mesh-list
19737180|NCT03993379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19737181|NCT03993379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737182|NCT03993379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19737183|NCT03993379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737184|NCT03921866|Palbociclib|palbociclib|mesh-list
19737185|NCT03921866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737186|NCT03921866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19737187|NCT03921866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737188|NCT03921866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737189|NCT03772158|Cetirizine|cetirizine|mesh-list
19737190|NCT03772158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19737191|NCT03772158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19737192|NCT03772158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19737193|NCT03772158|Histamine Antagonists|histamine antagonists|mesh-ancestor
19737194|NCT03772158|Histamine Agents|histamine agents|mesh-ancestor
19737195|NCT03772158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19737196|NCT03772158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737197|NCT03772158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737198|NCT03723590|Hyaluronic Acid|hyaluronic acid|mesh-list
19737199|NCT03723590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19457001|NCT03380468|Pemetrexed|pemetrexed|mesh-list
19457002|NCT03380468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457003|NCT03380468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457004|NCT03380468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457005|NCT03380468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19457006|NCT03380468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19457007|NCT03380455|Cimetidine|cimetidine|mesh-list
19457008|NCT03380455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19457009|NCT03380455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19457010|NCT03380455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19457011|NCT03380455|Histamine Antagonists|histamine antagonists|mesh-ancestor
19457012|NCT03380455|Histamine Agents|histamine agents|mesh-ancestor
19457013|NCT03380455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19457014|NCT03380455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457015|NCT03380455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457016|NCT03380455|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19457017|NCT03380455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19457018|NCT03380455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457019|NCT03380442|Ketamine|ketamine|mesh-list
19457020|NCT03380442|Psilocybin|psilocybin|mesh-list
19457021|NCT03380442|Analgesics|analgesics|mesh-ancestor
19457022|NCT03380442|Sensory System Agents|sensory system agents|mesh-ancestor
19457023|NCT03380442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457024|NCT03380442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457025|NCT03380442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19457026|NCT03380442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19457027|NCT03380442|Anesthetics, General|anesthetics, general|mesh-ancestor
19457028|NCT03380442|Anesthetics|anesthetics|mesh-ancestor
19457029|NCT03380442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19457030|NCT03380442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19457031|NCT03380442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19457032|NCT03380442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19457033|NCT03380442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457034|NCT03380442|Hallucinogens|hallucinogens|mesh-ancestor
19457035|NCT03380442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19457036|NCT03380403|Ciprofloxacin|ciprofloxacin|mesh-list
19984219|NCT01944774|Moxifloxacin|moxifloxacin|mesh-list
19984220|NCT01944774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19984221|NCT01944774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19984222|NCT01944774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19984223|NCT01944774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19984224|NCT01944774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984225|NCT01944774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984226|NCT01944774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984227|NCT01944839|Ranibizumab|ranibizumab|mesh-list
19984228|NCT01944839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19984229|NCT01944839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19984230|NCT01944839|Growth Substances|growth substances|mesh-ancestor
19984231|NCT01944839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984232|NCT01944839|Growth Inhibitors|growth inhibitors|mesh-ancestor
19984233|NCT01944839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984234|NCT01944969|Brexpiprazole|brexpiprazole|mesh-list
19457037|NCT03380403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19457038|NCT03380403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19457039|NCT03380403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19457040|NCT03380403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19457041|NCT03380403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457042|NCT03380403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457043|NCT03380403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457044|NCT03380403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19457045|NCT03380403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19457046|NCT03380325|Iloprost|iloprost|mesh-list
19457047|NCT03380325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19457048|NCT03380325|Vasodilator Agents|vasodilator agents|mesh-ancestor
19457049|NCT03380130|Nivolumab|nivolumab|mesh-list
19457050|NCT03380130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19457051|NCT03380130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457052|NCT03380130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19457053|NCT03380130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457054|NCT03380039|Cyclophosphamide|cyclophosphamide|mesh-list
19457055|NCT03380039|Fludarabine|fludarabine|mesh-list
19457056|NCT03380039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19457057|NCT03380039|Immunologic Factors|immunologic factors|mesh-ancestor
19457058|NCT03380039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457059|NCT03380039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19457060|NCT03380039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19457061|NCT03380039|Alkylating Agents|alkylating agents|mesh-ancestor
19457062|NCT03380039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457063|NCT03380039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457064|NCT03380039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19457065|NCT03379987|Morphine|morphine|mesh-list
19457066|NCT03379987|Bupivacaine|bupivacaine|mesh-list
19457067|NCT03379987|Anesthetics, Local|anesthetics, local|mesh-ancestor
19457068|NCT03379987|Anesthetics|anesthetics|mesh-ancestor
19457069|NCT03379987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19457070|NCT03379987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457071|NCT03379987|Sensory System Agents|sensory system agents|mesh-ancestor
19457072|NCT03379987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457073|NCT03379987|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19457074|NCT03379987|Narcotics|narcotics|mesh-ancestor
19457075|NCT03379987|Analgesics|analgesics|mesh-ancestor
19457076|NCT03379974|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19457077|NCT03379974|Hemostatics|hemostatics|mesh-ancestor
19457078|NCT03379974|Coagulants|coagulants|mesh-ancestor
19457079|NCT03379974|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19457080|NCT03379974|Natriuretic Agents|natriuretic agents|mesh-ancestor
19457081|NCT03379974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457082|NCT03379909|Metformin|metformin|mesh-list
19457083|NCT03379909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19457084|NCT03379909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457085|NCT03379441|Pembrolizumab|pembrolizumab|mesh-list
19457086|NCT03379441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19457087|NCT03379441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457088|NCT03379194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19457089|NCT03379194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19984235|NCT01944969|Serotonin Agents|serotonin agents|mesh-ancestor
19984236|NCT01944969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19984237|NCT01944969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457090|NCT03379181|Propranolol|propranolol|mesh-list
19457091|NCT03379181|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19737200|NCT03723590|Immunologic Factors|immunologic factors|mesh-ancestor
19737201|NCT03723590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737202|NCT03723590|Viscosupplements|viscosupplements|mesh-ancestor
19737203|NCT03723590|Protective Agents|protective agents|mesh-ancestor
19737204|NCT03613727|Ascorbic Acid|ascorbic acid|mesh-list
19984238|NCT01944969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984239|NCT01944969|Dopamine Agonists|dopamine agonists|mesh-ancestor
19984240|NCT01944969|Dopamine Agents|dopamine agents|mesh-ancestor
19984241|NCT01945086|Ustekinumab|ustekinumab|mesh-list
19984242|NCT01945086|Dermatologic Agents|dermatologic agents|mesh-ancestor
19457092|NCT03379181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19457093|NCT03379181|Adrenergic Agents|adrenergic agents|mesh-ancestor
19457094|NCT03379181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19457095|NCT03379181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457096|NCT03379181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457097|NCT03379181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19457098|NCT03379181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19457099|NCT03379181|Vasodilator Agents|vasodilator agents|mesh-ancestor
19457100|NCT03379103|Propofol|propofol|mesh-list
19457101|NCT03379103|Sevoflurane|sevoflurane|mesh-list
19457102|NCT03379103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19457103|NCT03379103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19457104|NCT03379103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457105|NCT03379103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19457106|NCT03379103|Anesthetics, General|anesthetics, general|mesh-ancestor
19457107|NCT03379103|Anesthetics|anesthetics|mesh-ancestor
19457108|NCT03379103|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19457109|NCT03379103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19737205|NCT03613727|Vitamins|vitamins|mesh-ancestor
19737206|NCT03613727|Micronutrients|micronutrients|mesh-ancestor
19737207|NCT03613727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737208|NCT03613727|Antioxidants|antioxidants|mesh-ancestor
19737209|NCT03613727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737210|NCT03613727|Protective Agents|protective agents|mesh-ancestor
19737211|NCT03558854|Aspirin|aspirin|mesh-list
19737212|NCT03558854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19737213|NCT03558854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19737214|NCT03558854|Analgesics|analgesics|mesh-ancestor
19737215|NCT03558854|Sensory System Agents|sensory system agents|mesh-ancestor
19737216|NCT03558854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19737217|NCT03558854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737218|NCT03558854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19737219|NCT03558854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19737220|NCT03558854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19737221|NCT03558854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19737222|NCT03558854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737223|NCT03558854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19737224|NCT03558854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19737225|NCT03558854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737226|NCT03558854|Antipyretics|antipyretics|mesh-ancestor
19737227|NCT03486301|Pembrolizumab|pembrolizumab|mesh-list
19737228|NCT03486301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19737229|NCT03486301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737230|NCT03430895|Durvalumab|durvalumab|mesh-list
19737231|NCT03430895|Tremelimumab|tremelimumab|mesh-list
19737232|NCT03430895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19737233|NCT03430895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737234|NCT03409458|Avelumab|avelumab|mesh-list
19737235|NCT03409458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19737236|NCT03409458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289102|NCT04989283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20289103|NCT04989283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289104|NCT04989283|Tubulin Modulators|tubulin modulators|mesh-ancestor
20289105|NCT04989283|Antimitotic Agents|antimitotic agents|mesh-ancestor
20289106|NCT04989283|Mitosis Modulators|mitosis modulators|mesh-ancestor
20289107|NCT04989283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289108|NCT04989283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20289109|NCT04989283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19457110|NCT03379012|Sunitinib|sunitinib|mesh-list
19457111|NCT03379012|Methyltestosterone|methyltestosterone|mesh-list
19457112|NCT03379012|Testosterone|testosterone|mesh-list
19457113|NCT03379012|Testosterone undecanoate|testosterone undecanoate|mesh-list
19457114|NCT03379012|Testosterone enanthate|testosterone enanthate|mesh-list
19457115|NCT03379012|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19457116|NCT03379012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457117|NCT03379012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19457118|NCT03379012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19457119|NCT03379012|Growth Substances|growth substances|mesh-ancestor
19457120|NCT03379012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457121|NCT03379012|Growth Inhibitors|growth inhibitors|mesh-ancestor
19457122|NCT03379012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19457123|NCT03379012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457124|NCT03379012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457125|NCT03379012|Androgens|androgens|mesh-ancestor
19457126|NCT03379012|Hormones|hormones|mesh-ancestor
19457127|NCT03379012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19457128|NCT03379012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19457129|NCT03379012|Anabolic Agents|anabolic agents|mesh-ancestor
19457130|NCT03378960|Omeprazole|omeprazole|mesh-list
19457131|NCT03378960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19457132|NCT03378960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19457133|NCT03378960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19457134|NCT03378960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457135|NCT03378960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457136|NCT03378934|Aspirin|aspirin|mesh-list
19457137|NCT03378934|Clopidogrel|clopidogrel|mesh-list
19457138|NCT03378934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19457139|NCT03378934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19457140|NCT03378934|Analgesics|analgesics|mesh-ancestor
19457141|NCT03378934|Sensory System Agents|sensory system agents|mesh-ancestor
19457142|NCT03378934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457143|NCT03378934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457144|NCT03378934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19457145|NCT03378934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19457146|NCT03378934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19457147|NCT03378934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19457148|NCT03378934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457149|NCT03378934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19457150|NCT03378934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19457151|NCT03378934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457152|NCT03378934|Antipyretics|antipyretics|mesh-ancestor
19457153|NCT03378934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19457154|NCT03378934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19457155|NCT03378934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19457156|NCT03378934|Purinergic Agents|purinergic agents|mesh-ancestor
19457157|NCT03378934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19457158|NCT03378791|Ferrous fumarate|ferrous fumarate|mesh-list
19457159|NCT03378791|Trace Elements|trace elements|mesh-ancestor
19457160|NCT03378791|Micronutrients|micronutrients|mesh-ancestor
19457161|NCT03378791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457162|NCT03378726|Micronutrients|micronutrients|mesh-list
19457163|NCT03378726|Trace Elements|trace elements|mesh-list
19457164|NCT03378726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984243|NCT01945138|Insulin|insulin|mesh-list
19984244|NCT01945138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19984245|NCT01945138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19984246|NCT01945138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984247|NCT01945216|Alogliptin|alogliptin|mesh-list
19984248|NCT01945216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19984249|NCT01945216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984250|NCT01945216|Incretins|incretins|mesh-ancestor
19984251|NCT01945216|Hormones|hormones|mesh-ancestor
19984252|NCT01945216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19984253|NCT01945216|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19984254|NCT01945216|Protease Inhibitors|protease inhibitors|mesh-ancestor
19984255|NCT01945216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984256|NCT01945216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984257|NCT01945242|Alogliptin|alogliptin|mesh-list
19984258|NCT01945242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19984259|NCT01945242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984260|NCT01945242|Incretins|incretins|mesh-ancestor
19457165|NCT03378713|Methyltestosterone|methyltestosterone|mesh-list
19984261|NCT01945242|Hormones|hormones|mesh-ancestor
20289110|NCT04989283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457166|NCT03378713|Testosterone|testosterone|mesh-list
19457167|NCT03378713|Testosterone undecanoate|testosterone undecanoate|mesh-list
19457168|NCT03378713|Testosterone enanthate|testosterone enanthate|mesh-list
19457169|NCT03378713|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19457170|NCT03378713|Androgens|androgens|mesh-ancestor
19457171|NCT03378713|Hormones|hormones|mesh-ancestor
19457172|NCT03378713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19457173|NCT03378713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457174|NCT03378713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19457175|NCT03378713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457176|NCT03378713|Anabolic Agents|anabolic agents|mesh-ancestor
19457177|NCT03378674|Remifentanil|remifentanil|mesh-list
19457178|NCT03378674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19457179|NCT03378674|Narcotics|narcotics|mesh-ancestor
19457180|NCT03378674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19457181|NCT03378674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457182|NCT03378674|Analgesics|analgesics|mesh-ancestor
19457183|NCT03378674|Sensory System Agents|sensory system agents|mesh-ancestor
19457184|NCT03378674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457185|NCT03378661|Benzonidazole|benzonidazole|mesh-list
19457186|NCT03378661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19457187|NCT03378661|Immunologic Factors|immunologic factors|mesh-ancestor
19457188|NCT03378661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457189|NCT03378661|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19457190|NCT03378661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19457191|NCT03378661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19457192|NCT03378661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19984262|NCT01945242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19984263|NCT01945242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19984264|NCT01945242|Protease Inhibitors|protease inhibitors|mesh-ancestor
19984265|NCT01945242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984266|NCT01945242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984267|NCT01945281|Amphotericin B|amphotericin b|mesh-list
19984268|NCT01945281|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19984269|NCT01945281|Caspofungin|caspofungin|mesh-list
19984270|NCT01945281|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
19984271|NCT01945281|Deoxycholic Acid|deoxycholic acid|mesh-list
19984272|NCT01945281|Amebicides|amebicides|mesh-ancestor
19984273|NCT01945281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19457193|NCT03378648|Bromides|bromides|mesh-list
19457194|NCT03378648|Anticonvulsants|anticonvulsants|mesh-ancestor
19457195|NCT03378479|Posaconazole|posaconazole|mesh-list
19457196|NCT03378479|Antifungal Agents|antifungal agents|mesh-ancestor
19457197|NCT03378479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19457198|NCT03378479|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19457199|NCT03378479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19457200|NCT03378479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19457201|NCT03378479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19457202|NCT03378479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19984274|NCT01945281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19984275|NCT01945281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19984276|NCT01945281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19984277|NCT01945281|Antifungal Agents|antifungal agents|mesh-ancestor
19984278|NCT01945281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457203|NCT03378479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457204|NCT03378479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457205|NCT03378479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19457206|NCT03378479|Hormone Antagonists|hormone antagonists|mesh-ancestor
19457207|NCT03378479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19457208|NCT03378479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457209|NCT03378427|Doxycycline|doxycycline|mesh-list
19457210|NCT03378427|Ciprofloxacin|ciprofloxacin|mesh-list
19457211|NCT03378427|Levofloxacin|levofloxacin|mesh-list
19457212|NCT03378427|Ofloxacin|ofloxacin|mesh-list
19457213|NCT03378427|Minocycline|minocycline|mesh-list
19457214|NCT03378427|Rifampin|rifampin|mesh-list
19457215|NCT03378427|Clindamycin|clindamycin|mesh-list
19457216|NCT03378427|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19457217|NCT03378427|Tedizolid|tedizolid|mesh-list
19457218|NCT03378427|Teicoplanin|teicoplanin|mesh-list
19457219|NCT03378427|Tedizolid phosphate|tedizolid phosphate|mesh-list
19457220|NCT03378427|Fusidic Acid|fusidic acid|mesh-list
19984279|NCT01945281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984280|NCT01945281|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19457221|NCT03378427|Trimethoprim|trimethoprim|mesh-list
19457222|NCT03378427|Sulfamethoxazole|sulfamethoxazole|mesh-list
19457223|NCT03378427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19457224|NCT03378427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19457225|NCT03378427|Antimalarials|antimalarials|mesh-ancestor
19457226|NCT03378427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19457227|NCT03378427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19457228|NCT03378427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19457229|NCT03378427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19457230|NCT03378427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457231|NCT03378427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457232|NCT03378427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457233|NCT03378427|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19457234|NCT03378427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19457235|NCT03378427|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19457236|NCT03378427|Renal Agents|renal agents|mesh-ancestor
19457237|NCT03378427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19457238|NCT03378427|Antitubercular Agents|antitubercular agents|mesh-ancestor
19457239|NCT03378427|Leprostatic Agents|leprostatic agents|mesh-ancestor
19457240|NCT03378427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19457241|NCT03378427|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19457242|NCT03378427|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19457243|NCT03378427|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19457244|NCT03378427|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19457245|NCT03378427|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19457246|NCT03378427|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19457247|NCT03378427|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19457248|NCT03378427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19457249|NCT03378427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19457250|NCT03378427|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19457251|NCT03378401|Octenidine|octenidine|mesh-list
19457252|NCT03378401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19457253|NCT03378401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19457254|NCT03378323|Anesthetics|anesthetics|mesh-list
19457255|NCT03378323|Anesthetics, Local|anesthetics, local|mesh-list
19457256|NCT03378323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19457257|NCT03378323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457258|NCT03378323|Sensory System Agents|sensory system agents|mesh-ancestor
19457259|NCT03378323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457260|NCT03378310|Linrodostat|linrodostat|mesh-list
19457261|NCT03378310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457262|NCT03378310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457263|NCT03378297|Aspirin|aspirin|mesh-list
19457264|NCT03378297|Metformin|metformin|mesh-list
19457265|NCT03378297|Letrozole|letrozole|mesh-list
19457266|NCT03378297|Olaparib|olaparib|mesh-list
19457267|NCT03378297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19457268|NCT03378297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457269|NCT03378297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457270|NCT03378297|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19457271|NCT03378297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19457272|NCT03378297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457273|NCT03378297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457274|NCT03378297|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19457275|NCT03378297|Hormone Antagonists|hormone antagonists|mesh-ancestor
19457276|NCT03378297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19457277|NCT03378297|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19457278|NCT03378297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19457279|NCT03378297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19457280|NCT03378297|Analgesics|analgesics|mesh-ancestor
19457281|NCT03378297|Sensory System Agents|sensory system agents|mesh-ancestor
19457282|NCT03378297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457283|NCT03378297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19457284|NCT03378297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19457285|NCT03378297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19457286|NCT03378297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19457287|NCT03378297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19457288|NCT03378297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19457289|NCT03378297|Antipyretics|antipyretics|mesh-ancestor
19457290|NCT03377907|Lidocaine|lidocaine|mesh-list
19457291|NCT03377907|Ketamine|ketamine|mesh-list
19457292|NCT03377907|Anesthetics, Local|anesthetics, local|mesh-ancestor
19457293|NCT03377907|Anesthetics|anesthetics|mesh-ancestor
19457294|NCT03377907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19457295|NCT03377907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984281|NCT01945281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19457296|NCT03377907|Sensory System Agents|sensory system agents|mesh-ancestor
19457297|NCT03377907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457298|NCT03377907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19457299|NCT03377907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19457300|NCT03377907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19457301|NCT03377907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19457302|NCT03377907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457303|NCT03377907|Analgesics|analgesics|mesh-ancestor
19457304|NCT03377907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19457305|NCT03377907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19457306|NCT03377907|Anesthetics, General|anesthetics, general|mesh-ancestor
19457307|NCT03377907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19457308|NCT03377907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19457309|NCT03377907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19457310|NCT03377842|Leucovorin|leucovorin|mesh-list
19457311|NCT03377842|Apatinib|apatinib|mesh-list
19457312|NCT03377842|Fluorouracil|fluorouracil|mesh-list
19457313|NCT03377842|Oxaliplatin|oxaliplatin|mesh-list
19457314|NCT03377842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457315|NCT03377842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19457316|NCT03377842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457317|NCT03377842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457318|NCT03377842|Antimetabolites|antimetabolites|mesh-ancestor
19457319|NCT03377842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19457320|NCT03377842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19457321|NCT03377842|Immunologic Factors|immunologic factors|mesh-ancestor
19457322|NCT03377842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457323|NCT03377842|Antidotes|antidotes|mesh-ancestor
19457324|NCT03377842|Protective Agents|protective agents|mesh-ancestor
19457325|NCT03377842|Vitamin B Complex|vitamin b complex|mesh-ancestor
19457326|NCT03377842|Vitamins|vitamins|mesh-ancestor
19457327|NCT03377842|Micronutrients|micronutrients|mesh-ancestor
19457328|NCT03377725|Decitabine|decitabine|mesh-list
19457329|NCT03377725|Arsenic Trioxide|arsenic trioxide|mesh-list
19457330|NCT03377725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19457331|NCT03377725|Antimetabolites|antimetabolites|mesh-ancestor
19457332|NCT03377725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457333|NCT03377725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457334|NCT03377725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457335|NCT03377608|Tenofovir|tenofovir|mesh-list
19457336|NCT03377608|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19457337|NCT03377608|Medroxyprogesterone|medroxyprogesterone|mesh-list
19457338|NCT03377608|Antiviral Agents|antiviral agents|mesh-ancestor
19457339|NCT03377608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19737237|NCT03366272|Gemcitabine|gemcitabine|mesh-list
19737238|NCT03366272|Rituximab|rituximab|mesh-list
19737239|NCT03366272|Nivolumab|nivolumab|mesh-list
19737240|NCT03366272|Oxaliplatin|oxaliplatin|mesh-list
19737241|NCT03366272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19737242|NCT03366272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737243|NCT03366272|Immunologic Factors|immunologic factors|mesh-ancestor
19737244|NCT03366272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737245|NCT03366272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19737246|NCT03366272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19737247|NCT03366272|Antimetabolites|antimetabolites|mesh-ancestor
19737248|NCT03366272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737249|NCT03366272|Antiviral Agents|antiviral agents|mesh-ancestor
19737250|NCT03366272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19737251|NCT03366272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737252|NCT03366272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19737253|NCT03366272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19737254|NCT03243058|Aldesleukin|aldesleukin|mesh-list
19737255|NCT03243058|Interleukin-2|interleukin-2|mesh-list
19737256|NCT03243058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737257|NCT03243058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19737258|NCT03243058|Analgesics|analgesics|mesh-ancestor
19737259|NCT03243058|Sensory System Agents|sensory system agents|mesh-ancestor
19737260|NCT03243058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19737261|NCT03243058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737262|NCT03243058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19737263|NCT03243058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19737264|NCT03243058|Antiviral Agents|antiviral agents|mesh-ancestor
19737265|NCT03243058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19737266|NCT03230838|Meropenem|meropenem|mesh-list
19457340|NCT03377608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19457341|NCT03377608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19737267|NCT03230838|Tazobactam|tazobactam|mesh-list
19457342|NCT03377608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457343|NCT03377608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457344|NCT03377608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19457345|NCT03377608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19457346|NCT03377608|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19457347|NCT03377608|Contraceptive Agents|contraceptive agents|mesh-ancestor
19457348|NCT03377608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19457349|NCT03377608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457350|NCT03377608|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19457351|NCT03377608|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19457352|NCT03377608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19457353|NCT03377608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457354|NCT03377608|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19457355|NCT03377608|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19457356|NCT03377608|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19457357|NCT03377543|Aspirin|aspirin|mesh-list
19457358|NCT03377543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19457359|NCT03377543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19457360|NCT03377543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19457361|NCT03377543|Analgesics|analgesics|mesh-ancestor
19457362|NCT03377543|Sensory System Agents|sensory system agents|mesh-ancestor
19457363|NCT03377543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457364|NCT03377543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457365|NCT03377543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19457366|NCT03377543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19457367|NCT03377543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19457368|NCT03377543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457369|NCT03377543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19457370|NCT03377543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19457371|NCT03377543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457372|NCT03377543|Antipyretics|antipyretics|mesh-ancestor
19457373|NCT03377478|Sofosbuvir|sofosbuvir|mesh-list
19457374|NCT03377478|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
19457375|NCT03377478|Velpatasvir|velpatasvir|mesh-list
19457376|NCT03377478|Antiviral Agents|antiviral agents|mesh-ancestor
19457377|NCT03377478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19457378|NCT03377465|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19457379|NCT03377465|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
19457380|NCT03377465|Natriuretic Agents|natriuretic agents|mesh-ancestor
19457381|NCT03377465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457382|NCT03377465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457383|NCT03377465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457384|NCT03377400|Cisplatin|cisplatin|mesh-list
19457385|NCT03377400|Durvalumab|durvalumab|mesh-list
19457386|NCT03377400|Tremelimumab|tremelimumab|mesh-list
19457387|NCT03377400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457388|NCT03377400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19737268|NCT03230838|Ceftolozane|ceftolozane|mesh-list
19737269|NCT03230838|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
19737270|NCT03230838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19737271|NCT03230838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19737272|NCT03230838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19737273|NCT03230838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737274|NCT03230838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737275|NCT03230838|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19737276|NCT03230838|Renal Agents|renal agents|mesh-ancestor
19737277|NCT03113955|Epirubicin|epirubicin|mesh-list
19737278|NCT03113955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19737279|NCT03113955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737280|NCT03113955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19737281|NCT03113955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19737282|NCT03113955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737283|NCT03113955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737284|NCT03034096|Propofol|propofol|mesh-list
19737285|NCT03034096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19737286|NCT03034096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19737287|NCT03034096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737288|NCT03034096|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19737289|NCT03034096|Anesthetics, General|anesthetics, general|mesh-ancestor
19737290|NCT03034096|Anesthetics|anesthetics|mesh-ancestor
19737291|NCT03016338|Niraparib|niraparib|mesh-list
19737292|NCT03016338|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19737293|NCT03016338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984282|NCT01945294|Interferons|interferons|mesh-list
19457389|NCT03377348|Triamcinolone|triamcinolone|mesh-list
19457390|NCT03377348|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19457391|NCT03377348|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19457392|NCT03377348|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19457393|NCT03377348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19457394|NCT03377348|Glucocorticoids|glucocorticoids|mesh-ancestor
19457395|NCT03377348|Hormones|hormones|mesh-ancestor
19457396|NCT03377348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19457397|NCT03377348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457398|NCT03377348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19457399|NCT03377348|Immunologic Factors|immunologic factors|mesh-ancestor
19457400|NCT03377348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457401|NCT03377348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457402|NCT03377335|Metformin|metformin|mesh-list
19457403|NCT03377335|Dapagliflozin|dapagliflozin|mesh-list
19457404|NCT03377335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19457405|NCT03377335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457406|NCT03377335|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19457407|NCT03377335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457408|NCT03377283|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19457409|NCT03377283|Thymoglobulin|thymoglobulin|mesh-list
19457410|NCT03377283|Immunologic Factors|immunologic factors|mesh-ancestor
19457411|NCT03377283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457412|NCT03377283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19457413|NCT03377257|Oxazolidinones|oxazolidinones|mesh-list
19457414|NCT03377257|Zolmitriptan|zolmitriptan|mesh-list
19457415|NCT03377257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19457416|NCT03377257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19457417|NCT03377257|Serotonin Agents|serotonin agents|mesh-ancestor
19457418|NCT03377257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19457419|NCT03377257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457420|NCT03377257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457421|NCT03377257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19457422|NCT03377257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19457423|NCT03377257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457424|NCT03377218|Iodine|iodine|mesh-list
19457425|NCT03377218|Selenium|selenium|mesh-list
19457426|NCT03377218|Cadexomer iodine|cadexomer iodine|mesh-list
19457427|NCT03377218|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19457428|NCT03377218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19457429|NCT03377218|Trace Elements|trace elements|mesh-ancestor
19457430|NCT03377218|Micronutrients|micronutrients|mesh-ancestor
19457431|NCT03377218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457432|NCT03377218|Antioxidants|antioxidants|mesh-ancestor
19457433|NCT03377218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457434|NCT03377218|Protective Agents|protective agents|mesh-ancestor
19457435|NCT03377101|Fulvestrant|fulvestrant|mesh-list
19457436|NCT03377101|Palbociclib|palbociclib|mesh-list
19457437|NCT03377101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19457438|NCT03377101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457439|NCT03377101|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19457440|NCT03377101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19457441|NCT03377101|Hormone Antagonists|hormone antagonists|mesh-ancestor
19457442|NCT03377101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19457443|NCT03377101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457444|NCT03377101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19457445|NCT03377101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457446|NCT03377101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457447|NCT03376958|Apatinib|apatinib|mesh-list
19457448|NCT03376958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457449|NCT03376958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19457450|NCT03376958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457451|NCT03376958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457452|NCT03376932|Albuterol|albuterol|mesh-list
19457453|NCT03376932|Tiotropium Bromide|tiotropium bromide|mesh-list
19457454|NCT03376932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19457455|NCT03376932|Autonomic Agents|autonomic agents|mesh-ancestor
19457456|NCT03376932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457457|NCT03376932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457458|NCT03376932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19457459|NCT03376932|Respiratory System Agents|respiratory system agents|mesh-ancestor
19457460|NCT03376932|Parasympatholytics|parasympatholytics|mesh-ancestor
19457461|NCT03376932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19984283|NCT01945294|Ribavirin|ribavirin|mesh-list
19984284|NCT01945294|Interferon-alpha|interferon-alpha|mesh-list
19984285|NCT01945294|Interferon alpha-2|interferon alpha-2|mesh-list
19984286|NCT01945294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19984287|NCT01945294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984288|NCT01945294|Antiviral Agents|antiviral agents|mesh-ancestor
19984289|NCT01945294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19984290|NCT01945294|Antimetabolites|antimetabolites|mesh-ancestor
19984291|NCT01945294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457462|NCT03376932|Cholinergic Agents|cholinergic agents|mesh-ancestor
19457463|NCT03376932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19457464|NCT03376932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457465|NCT03376932|Tocolytic Agents|tocolytic agents|mesh-ancestor
19457466|NCT03376932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19457467|NCT03376932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19457468|NCT03376932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19457469|NCT03376932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19457470|NCT03376932|Adrenergic Agents|adrenergic agents|mesh-ancestor
19457471|NCT03376854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
19457472|NCT03376854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19457473|NCT03376854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457474|NCT03376854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457475|NCT03376841|Cenicriviroc|cenicriviroc|mesh-list
19457476|NCT03376841|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19457477|NCT03376841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457478|NCT03376841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19457479|NCT03376841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19457480|NCT03376841|Antiviral Agents|antiviral agents|mesh-ancestor
19457481|NCT03376841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19457482|NCT03376789|MYL-1501D|myl-1501d|mesh-list
19457483|NCT03376789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19457484|NCT03376789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457485|NCT03376737|Pemetrexed|pemetrexed|mesh-list
19457486|NCT03376737|Apatinib|apatinib|mesh-list
19457487|NCT03376737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457488|NCT03376737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457489|NCT03376737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457490|NCT03376737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19457491|NCT03376737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19457492|NCT03376737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19457493|NCT03376594|Loratadine|loratadine|mesh-list
19984292|NCT01945294|Immunologic Factors|immunologic factors|mesh-ancestor
19984293|NCT01945294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984294|NCT01945489|Botulinum Toxins|botulinum toxins|mesh-list
19984295|NCT01945489|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19984296|NCT01945489|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19984297|NCT01945489|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19984298|NCT01945489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19984299|NCT01945489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984300|NCT01945489|Cholinergic Agents|cholinergic agents|mesh-ancestor
19984301|NCT01945489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19984302|NCT01945489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984303|NCT01945489|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19984304|NCT01945489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19984305|NCT01945593|Factor VIII|factor viii|mesh-list
19984306|NCT01945593|BAX 855|bax 855|mesh-list
19984307|NCT01945593|Coagulants|coagulants|mesh-ancestor
19984308|NCT01945866|Dexamethasone|dexamethasone|mesh-list
19984309|NCT01945866|Ranibizumab|ranibizumab|mesh-list
19984310|NCT01945866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19457494|NCT03376594|Antipruritics|antipruritics|mesh-ancestor
19457495|NCT03376594|Dermatologic Agents|dermatologic agents|mesh-ancestor
19457496|NCT03376594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19457497|NCT03376594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19457498|NCT03376594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19984311|NCT01945866|Antiemetics|antiemetics|mesh-ancestor
19984312|NCT01945866|Autonomic Agents|autonomic agents|mesh-ancestor
19984313|NCT01945866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19984314|NCT01945866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457499|NCT03376594|Histamine Antagonists|histamine antagonists|mesh-ancestor
19457500|NCT03376594|Histamine Agents|histamine agents|mesh-ancestor
19457501|NCT03376594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19457502|NCT03376594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457503|NCT03376594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457504|NCT03376555|Nitroglycerin|nitroglycerin|mesh-list
19457505|NCT03376555|Acetylcholine|acetylcholine|mesh-list
19457506|NCT03376555|Vasodilator Agents|vasodilator agents|mesh-ancestor
19457507|NCT03376555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19457508|NCT03376555|Cholinergic Agents|cholinergic agents|mesh-ancestor
19457509|NCT03376555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19457510|NCT03376555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457511|NCT03376555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457512|NCT03376529|Tazobactam|tazobactam|mesh-list
19457513|NCT03376529|Piperacillin|piperacillin|mesh-list
19457514|NCT03376529|Ceftazidime|ceftazidime|mesh-list
19457515|NCT03376529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19457516|NCT03376529|Aztreonam|aztreonam|mesh-list
19457517|NCT03376529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19457518|NCT03376529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19457519|NCT03376529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19457520|NCT03376529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457521|NCT03376529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457522|NCT03376464|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19457523|NCT03376464|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19457524|NCT03376464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457525|NCT03376464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457526|NCT03376464|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19457527|NCT03376464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19457528|NCT03376464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457529|NCT03376464|Cholinergic Agents|cholinergic agents|mesh-ancestor
19457530|NCT03376464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19457531|NCT03376438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19457532|NCT03376243|Emollients|emollients|mesh-list
19457533|NCT03376243|Dermatologic Agents|dermatologic agents|mesh-ancestor
19457534|NCT03376191|Apatinib|apatinib|mesh-list
19457535|NCT03376191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457536|NCT03376191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19457537|NCT03376191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457538|NCT03376191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457539|NCT03376178|Lidocaine|lidocaine|mesh-list
19457540|NCT03376178|Ropivacaine|ropivacaine|mesh-list
19457541|NCT03376178|Anesthetics, Local|anesthetics, local|mesh-ancestor
19457542|NCT03376178|Anesthetics|anesthetics|mesh-ancestor
19457543|NCT03376178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19457544|NCT03376178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457545|NCT03376178|Sensory System Agents|sensory system agents|mesh-ancestor
19457546|NCT03376178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457547|NCT03376178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19457548|NCT03376178|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19457549|NCT03376178|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19457550|NCT03376178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19457551|NCT03376178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457552|NCT03376139|Zonisamide|zonisamide|mesh-list
19457553|NCT03376139|Anticonvulsants|anticonvulsants|mesh-ancestor
19457554|NCT03376139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19457555|NCT03376139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19457556|NCT03376139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457557|NCT03376139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19457558|NCT03376139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457559|NCT03376048|Ropivacaine|ropivacaine|mesh-list
19457560|NCT03376048|Anesthetics, Local|anesthetics, local|mesh-ancestor
19457561|NCT03376048|Anesthetics|anesthetics|mesh-ancestor
19457562|NCT03376048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19457563|NCT03376048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457564|NCT03376048|Sensory System Agents|sensory system agents|mesh-ancestor
19457565|NCT03376048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457566|NCT03375996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19457567|NCT03375996|Cyclopentolate|cyclopentolate|mesh-list
19457568|NCT03375996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19457569|NCT03375996|Mydriatics|mydriatics|mesh-ancestor
19457570|NCT03375996|Autonomic Agents|autonomic agents|mesh-ancestor
19457571|NCT03375996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457572|NCT03375996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457573|NCT03375996|Parasympatholytics|parasympatholytics|mesh-ancestor
19457574|NCT03375996|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19457575|NCT03375996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19457576|NCT03375996|Cholinergic Agents|cholinergic agents|mesh-ancestor
19457577|NCT03375996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19457578|NCT03375996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457579|NCT03375788|Hormones|hormones|mesh-list
19457580|NCT03375788|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
19457581|NCT03375788|Tesamorelin|tesamorelin|mesh-list
19457582|NCT03375788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19457583|NCT03375788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457584|NCT03375788|Growth Substances|growth substances|mesh-ancestor
19457585|NCT03375775|Immunologic Factors|immunologic factors|mesh-list
19457586|NCT03375775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457587|NCT03375671|Midazolam|midazolam|mesh-list
19457588|NCT03375671|Ketamine|ketamine|mesh-list
19457589|NCT03375671|Haloperidol|haloperidol|mesh-list
19457590|NCT03375671|Haloperidol decanoate|haloperidol decanoate|mesh-list
19457591|NCT03375671|Analgesics|analgesics|mesh-ancestor
19457592|NCT03375671|Sensory System Agents|sensory system agents|mesh-ancestor
19457593|NCT03375671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457594|NCT03375671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457595|NCT03375671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19457596|NCT03375671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19457597|NCT03375671|Anesthetics, General|anesthetics, general|mesh-ancestor
19457598|NCT03375671|Anesthetics|anesthetics|mesh-ancestor
19457599|NCT03375671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19457600|NCT03375671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19457601|NCT03375671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19984315|NCT01945866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19984316|NCT01945866|Glucocorticoids|glucocorticoids|mesh-ancestor
19984317|NCT01945866|Hormones|hormones|mesh-ancestor
19984318|NCT01945866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19984319|NCT01945866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19984320|NCT01945866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984321|NCT01945866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19984322|NCT01945866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19984323|NCT01945866|Growth Substances|growth substances|mesh-ancestor
19984324|NCT01945866|Growth Inhibitors|growth inhibitors|mesh-ancestor
19984325|NCT01946152|Dexamethasone|dexamethasone|mesh-list
19984326|NCT01946152|Dexamethasone acetate|dexamethasone acetate|mesh-list
19984327|NCT01946152|Pomalidomide|pomalidomide|mesh-list
19984328|NCT01946152|Ichthammol|ichthammol|mesh-list
19984329|NCT01946152|Lenograstim|lenograstim|mesh-list
19984330|NCT01946152|BB 1101|bb 1101|mesh-list
19984331|NCT01946152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19984332|NCT01946152|Antiemetics|antiemetics|mesh-ancestor
19984333|NCT01946152|Autonomic Agents|autonomic agents|mesh-ancestor
19457602|NCT03375671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19457603|NCT03375671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457604|NCT03375671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19457605|NCT03375671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19984334|NCT01946152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19984335|NCT01946152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984336|NCT01946152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19984337|NCT01946152|Glucocorticoids|glucocorticoids|mesh-ancestor
19984338|NCT01946152|Hormones|hormones|mesh-ancestor
19984339|NCT01946152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19984340|NCT01946152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19984341|NCT01946152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984342|NCT01946152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19984343|NCT01946152|Immunologic Factors|immunologic factors|mesh-ancestor
19984344|NCT01946152|Protease Inhibitors|protease inhibitors|mesh-ancestor
19984345|NCT01946152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984346|NCT01946152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984347|NCT01946152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19984348|NCT01946152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19984349|NCT01946152|Growth Substances|growth substances|mesh-ancestor
19984350|NCT01946152|Growth Inhibitors|growth inhibitors|mesh-ancestor
19984351|NCT01946152|Dermatologic Agents|dermatologic agents|mesh-ancestor
19984352|NCT01946165|Prednisone|prednisone|mesh-list
19984353|NCT01946165|Abiraterone Acetate|abiraterone acetate|mesh-list
19984354|NCT01946165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19457606|NCT03375671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19984355|NCT01946165|Glucocorticoids|glucocorticoids|mesh-ancestor
19457607|NCT03375671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19457608|NCT03375671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19457609|NCT03375671|GABA Modulators|gaba modulators|mesh-ancestor
19457610|NCT03375671|GABA Agents|gaba agents|mesh-ancestor
19457611|NCT03375671|Antiemetics|antiemetics|mesh-ancestor
19457612|NCT03375671|Autonomic Agents|autonomic agents|mesh-ancestor
19457613|NCT03375671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19457614|NCT03375671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19457615|NCT03375671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19457616|NCT03375671|Dopamine Agents|dopamine agents|mesh-ancestor
19457617|NCT03375671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19737294|NCT03016338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737295|NCT03016338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737296|NCT02995694|Estradiol|estradiol|mesh-list
19737297|NCT02995694|Estrogens|estrogens|mesh-ancestor
19737298|NCT02995694|Hormones|hormones|mesh-ancestor
19737299|NCT02995694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19737300|NCT02995694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737301|NCT02698865|Hyaluronic Acid|hyaluronic acid|mesh-list
19737302|NCT02698865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19737303|NCT02698865|Immunologic Factors|immunologic factors|mesh-ancestor
19737304|NCT02698865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737305|NCT02698865|Viscosupplements|viscosupplements|mesh-ancestor
19737306|NCT02698865|Protective Agents|protective agents|mesh-ancestor
19737307|NCT02535325|Cisplatin|cisplatin|mesh-list
19737308|NCT02535325|Pemetrexed|pemetrexed|mesh-list
19737309|NCT02535325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737310|NCT02535325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737311|NCT02535325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737312|NCT02535325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19737313|NCT02535325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19737314|NCT02498951|Obinutuzumab|obinutuzumab|mesh-list
19737315|NCT02498951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19737316|NCT02498951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737317|NCT02257567|Rituximab|rituximab|mesh-list
19737318|NCT02257567|Obinutuzumab|obinutuzumab|mesh-list
19737319|NCT02257567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19737320|NCT02257567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19737321|NCT02257567|Immunoconjugates|immunoconjugates|mesh-list
19737322|NCT02257567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19737323|NCT02257567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737324|NCT02257567|Immunologic Factors|immunologic factors|mesh-ancestor
19737325|NCT02257567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737326|NCT02257567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19737327|NCT02257567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19737328|NCT02257567|Alkylating Agents|alkylating agents|mesh-ancestor
19737329|NCT02257567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737330|NCT02149537|Hydroxyurea|hydroxyurea|mesh-list
19737331|NCT02149537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737332|NCT02149537|Antisickling Agents|antisickling agents|mesh-ancestor
19737333|NCT02149537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737334|NCT02149537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737335|NCT02149537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19737336|NCT02129647|Axitinib|axitinib|mesh-list
19737337|NCT02129647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737338|NCT02129647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19737339|NCT02129647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737340|NCT02129647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737341|NCT01959139|Leucovorin|leucovorin|mesh-list
19737342|NCT01959139|Fluorouracil|fluorouracil|mesh-list
19737343|NCT01959139|Oxaliplatin|oxaliplatin|mesh-list
19737344|NCT01959139|Irinotecan|irinotecan|mesh-list
19737345|NCT01959139|Levoleucovorin|levoleucovorin|mesh-list
19737346|NCT01959139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737347|NCT01959139|Antimetabolites|antimetabolites|mesh-ancestor
19737348|NCT01959139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737349|NCT01959139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19737350|NCT01959139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737351|NCT01959139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19737352|NCT01959139|Immunologic Factors|immunologic factors|mesh-ancestor
19737353|NCT01959139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19737354|NCT01959139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19737355|NCT01959139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737356|NCT01959139|Antidotes|antidotes|mesh-ancestor
19737357|NCT01959139|Protective Agents|protective agents|mesh-ancestor
19737358|NCT01959139|Vitamin B Complex|vitamin b complex|mesh-ancestor
19737359|NCT01959139|Vitamins|vitamins|mesh-ancestor
19457618|NCT03375632|Dotinurad|dotinurad|mesh-list
19457619|NCT03375632|Uricosuric Agents|uricosuric agents|mesh-ancestor
19457620|NCT03375632|Gout Suppressants|gout suppressants|mesh-ancestor
19457621|NCT03375632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19457622|NCT03375632|Renal Agents|renal agents|mesh-ancestor
19457623|NCT03375593|Acetaminophen|acetaminophen|mesh-list
19457624|NCT03375593|Ibuprofen|ibuprofen|mesh-list
19457625|NCT03375593|Oxycodone|oxycodone|mesh-list
19457626|NCT03375593|Hydrocodone|hydrocodone|mesh-list
19457627|NCT03375593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19457628|NCT03375593|Analgesics|analgesics|mesh-ancestor
19457629|NCT03375593|Sensory System Agents|sensory system agents|mesh-ancestor
19457630|NCT03375593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457631|NCT03375593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457632|NCT03375593|Antipyretics|antipyretics|mesh-ancestor
19457633|NCT03375593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19457634|NCT03375593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19457635|NCT03375593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19457636|NCT03375593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19457637|NCT03375593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457638|NCT03375593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457639|NCT03375593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19457640|NCT03375593|Narcotics|narcotics|mesh-ancestor
19457641|NCT03375593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19457642|NCT03375593|Antitussive Agents|antitussive agents|mesh-ancestor
19457643|NCT03375593|Respiratory System Agents|respiratory system agents|mesh-ancestor
19457644|NCT03375580|Metformin|metformin|mesh-list
19457645|NCT03375580|Simvastatin|simvastatin|mesh-list
19457646|NCT03375580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19457647|NCT03375580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457648|NCT03375580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19457649|NCT03375580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19457650|NCT03375580|Antimetabolites|antimetabolites|mesh-ancestor
19457651|NCT03375580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457652|NCT03375580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19457653|NCT03375580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19457654|NCT03375580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457655|NCT03375515|Hydromorphone|hydromorphone|mesh-list
19457656|NCT03375515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19457657|NCT03375515|Narcotics|narcotics|mesh-ancestor
19457658|NCT03375515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19457659|NCT03375515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457660|NCT03375515|Analgesics|analgesics|mesh-ancestor
19457661|NCT03375515|Sensory System Agents|sensory system agents|mesh-ancestor
19457662|NCT03375515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457663|NCT03375502|Vaccines|vaccines|mesh-list
19457664|NCT03375502|Immunologic Factors|immunologic factors|mesh-ancestor
19457665|NCT03375502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457666|NCT03375463|Tirzepatide|tirzepatide|mesh-list
19457667|NCT03375463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19457668|NCT03375463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457669|NCT03375463|Incretins|incretins|mesh-ancestor
19457670|NCT03375463|Hormones|hormones|mesh-ancestor
19457671|NCT03375463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19457672|NCT03375424|Vedolizumab|vedolizumab|mesh-list
19457673|NCT03375424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19457674|NCT03375398|PAZ320|paz320|mesh-list
19457675|NCT03375398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19457676|NCT03375398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457677|NCT03375242|Crizotinib|crizotinib|mesh-list
19457678|NCT03375242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457679|NCT03375242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19457680|NCT03375242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457681|NCT03375242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457682|NCT03375138|Abatacept|abatacept|mesh-list
19457683|NCT03375138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19457684|NCT03375138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457685|NCT03375138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457686|NCT03375138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19457687|NCT03375138|Immunologic Factors|immunologic factors|mesh-ancestor
19457688|NCT03375138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457689|NCT03375138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19457690|NCT03375112|Bupivacaine|bupivacaine|mesh-list
19737360|NCT01959139|Micronutrients|micronutrients|mesh-ancestor
19457691|NCT03375112|Anesthetics, Local|anesthetics, local|mesh-ancestor
19457692|NCT03375112|Anesthetics|anesthetics|mesh-ancestor
19457693|NCT03375112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19737361|NCT01870193|Acetylcysteine|acetylcysteine|mesh-list
19457694|NCT03375112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457695|NCT03375112|Sensory System Agents|sensory system agents|mesh-ancestor
19457696|NCT03375112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457697|NCT03375034|Clonazepam|clonazepam|mesh-list
19457698|NCT03375034|Anticonvulsants|anticonvulsants|mesh-ancestor
19457699|NCT03375034|GABA Modulators|gaba modulators|mesh-ancestor
19457700|NCT03375034|GABA Agents|gaba agents|mesh-ancestor
19457701|NCT03375034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19457702|NCT03375034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457703|NCT03375034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457704|NCT03374878|Contraceptive Agents|contraceptive agents|mesh-list
19457705|NCT03374878|Contraceptives, Oral|contraceptives, oral|mesh-list
19457706|NCT03374878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19457707|NCT03374878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457708|NCT03374878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19457709|NCT03374774|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19457710|NCT03374774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19457711|NCT03374774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457712|NCT03374722|Analgesics, Opioid|analgesics, opioid|mesh-list
19984356|NCT01946165|Hormones|hormones|mesh-ancestor
19984357|NCT01946165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19984358|NCT01946165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984359|NCT01946165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19457713|NCT03374722|Narcotics|narcotics|mesh-ancestor
19457714|NCT03374722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19457715|NCT03374722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457716|NCT03374722|Analgesics|analgesics|mesh-ancestor
19457717|NCT03374722|Sensory System Agents|sensory system agents|mesh-ancestor
19457718|NCT03374722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457719|NCT03374709|Oxcarbazepine|oxcarbazepine|mesh-list
19457720|NCT03374709|Anticonvulsants|anticonvulsants|mesh-ancestor
19457721|NCT03374709|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19457722|NCT03374709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19457723|NCT03374709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19457724|NCT03374709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737362|NCT01870193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19737363|NCT01870193|Glycine|glycine|mesh-list
19737364|NCT01870193|Antiviral Agents|antiviral agents|mesh-ancestor
19737365|NCT01870193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19737366|NCT01870193|Expectorants|expectorants|mesh-ancestor
19737367|NCT01870193|Respiratory System Agents|respiratory system agents|mesh-ancestor
19737368|NCT01870193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19737369|NCT01870193|Antioxidants|antioxidants|mesh-ancestor
19737370|NCT01870193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737371|NCT01870193|Protective Agents|protective agents|mesh-ancestor
19737372|NCT01870193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737373|NCT01870193|Antidotes|antidotes|mesh-ancestor
19737374|NCT01870193|Glycine Agents|glycine agents|mesh-ancestor
19737375|NCT01870193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19737376|NCT01805284|Linezolid|linezolid|mesh-list
19737377|NCT01805284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19737378|NCT01805284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19737379|NCT01805284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19737380|NCT01805284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737381|NCT01805284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737382|NCT01522976|Lenalidomide|lenalidomide|mesh-list
19737383|NCT01522976|Azacitidine|azacitidine|mesh-list
19737384|NCT01522976|Vorinostat|vorinostat|mesh-list
19737385|NCT01522976|Immunologic Factors|immunologic factors|mesh-ancestor
19737386|NCT01522976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737387|NCT01522976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19737388|NCT01522976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19737389|NCT01522976|Growth Substances|growth substances|mesh-ancestor
19737390|NCT01522976|Growth Inhibitors|growth inhibitors|mesh-ancestor
19737391|NCT01522976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984360|NCT01946165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984361|NCT01946165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19984362|NCT01946165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984363|NCT01946165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984364|NCT01946165|Hormone Antagonists|hormone antagonists|mesh-ancestor
19984365|NCT01946165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19984366|NCT01946412|Ivacaftor|ivacaftor|mesh-list
19737392|NCT01522976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19737393|NCT01522976|Antimetabolites|antimetabolites|mesh-ancestor
19457725|NCT03374709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19457726|NCT03374709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19457727|NCT03374670|Aflibercept|aflibercept|mesh-list
19457728|NCT03374670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19457729|NCT03374670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19457730|NCT03374670|Growth Substances|growth substances|mesh-ancestor
19457731|NCT03374670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457732|NCT03374670|Growth Inhibitors|growth inhibitors|mesh-ancestor
19457733|NCT03374670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457734|NCT03374540|Vitamin K|vitamin k|mesh-list
19457735|NCT03374540|Rivaroxaban|rivaroxaban|mesh-list
19457736|NCT03374540|Vitamins|vitamins|mesh-ancestor
19457737|NCT03374540|Micronutrients|micronutrients|mesh-ancestor
19457738|NCT03374540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457739|NCT03374540|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19457740|NCT03374540|Antithrombins|antithrombins|mesh-ancestor
19457741|NCT03374540|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19457742|NCT03374540|Protease Inhibitors|protease inhibitors|mesh-ancestor
19457743|NCT03374540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457744|NCT03374540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457745|NCT03374540|Anticoagulants|anticoagulants|mesh-ancestor
19457746|NCT03374540|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19457747|NCT03374540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19457748|NCT03374540|Hemostatics|hemostatics|mesh-ancestor
19457749|NCT03374540|Coagulants|coagulants|mesh-ancestor
19457750|NCT03374514|Dexamethasone|dexamethasone|mesh-list
19457751|NCT03374514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19457752|NCT03374514|Antiemetics|antiemetics|mesh-ancestor
19457753|NCT03374514|Autonomic Agents|autonomic agents|mesh-ancestor
19457754|NCT03374514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457755|NCT03374514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457756|NCT03374514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19457757|NCT03374514|Glucocorticoids|glucocorticoids|mesh-ancestor
19457758|NCT03374514|Hormones|hormones|mesh-ancestor
19457759|NCT03374514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19457760|NCT03374514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19457761|NCT03374514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457762|NCT03374501|PAZ320|paz320|mesh-list
19457763|NCT03374501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19457764|NCT03374501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457765|NCT03374345|Juzentaihoto|juzentaihoto|mesh-list
19457766|NCT03374345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457767|NCT03374345|Mitogens|mitogens|mesh-ancestor
19457768|NCT03374345|Mitosis Modulators|mitosis modulators|mesh-ancestor
19457769|NCT03374345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457770|NCT03374306|Atropine|atropine|mesh-list
19457771|NCT03374306|Lubricant Eye Drops|lubricant eye drops|mesh-list
19457772|NCT03374306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19457773|NCT03374306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19457774|NCT03374306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19457775|NCT03374306|Autonomic Agents|autonomic agents|mesh-ancestor
19457776|NCT03374306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457777|NCT03374306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457778|NCT03374306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19457779|NCT03374306|Respiratory System Agents|respiratory system agents|mesh-ancestor
19457780|NCT03374306|Mydriatics|mydriatics|mesh-ancestor
19457781|NCT03374306|Parasympatholytics|parasympatholytics|mesh-ancestor
19457782|NCT03374306|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19457783|NCT03374306|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19457784|NCT03374306|Cholinergic Agents|cholinergic agents|mesh-ancestor
19457785|NCT03374306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19457786|NCT03374306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457787|NCT03374306|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19457788|NCT03374306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19457789|NCT03374293|Antibodies|antibodies|mesh-list
19457790|NCT03374293|Immunologic Factors|immunologic factors|mesh-ancestor
19457791|NCT03374293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457792|NCT03374280|Cisplatin|cisplatin|mesh-list
19457793|NCT03374280|Pemetrexed|pemetrexed|mesh-list
19457794|NCT03374280|Gefitinib|gefitinib|mesh-list
19457795|NCT03374280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457796|NCT03374280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457797|NCT03374280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457798|NCT03374280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19457799|NCT03374280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19457800|NCT03374280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19457801|NCT03374254|Leucovorin|leucovorin|mesh-list
19457802|NCT03374254|Pembrolizumab|pembrolizumab|mesh-list
19457803|NCT03374254|Fluorouracil|fluorouracil|mesh-list
19457804|NCT03374254|Oxaliplatin|oxaliplatin|mesh-list
19457805|NCT03374254|Irinotecan|irinotecan|mesh-list
19457806|NCT03374254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457807|NCT03374254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19457808|NCT03374254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457809|NCT03374254|Antimetabolites|antimetabolites|mesh-ancestor
19457810|NCT03374254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457811|NCT03374254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19457812|NCT03374254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19457813|NCT03374254|Immunologic Factors|immunologic factors|mesh-ancestor
19457814|NCT03374254|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19457815|NCT03374254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19457816|NCT03374254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457817|NCT03374254|Antidotes|antidotes|mesh-ancestor
19457818|NCT03374254|Protective Agents|protective agents|mesh-ancestor
19457819|NCT03374254|Vitamin B Complex|vitamin b complex|mesh-ancestor
19457820|NCT03374254|Vitamins|vitamins|mesh-ancestor
19457821|NCT03374254|Micronutrients|micronutrients|mesh-ancestor
19457822|NCT03374228|Linrodostat|linrodostat|mesh-list
19457823|NCT03374228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457824|NCT03374228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457825|NCT03374163|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19457826|NCT03374163|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19457827|NCT03374163|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19457828|NCT03374163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19457829|NCT03374085|Dexamethasone|dexamethasone|mesh-list
19457830|NCT03374085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19457831|NCT03374085|Antiemetics|antiemetics|mesh-ancestor
19457832|NCT03374085|Autonomic Agents|autonomic agents|mesh-ancestor
19457833|NCT03374085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457834|NCT03374085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457835|NCT03374085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19457836|NCT03374085|Glucocorticoids|glucocorticoids|mesh-ancestor
19457837|NCT03374085|Hormones|hormones|mesh-ancestor
19457838|NCT03374085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19457839|NCT03374085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19457840|NCT03374085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457841|NCT03374007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19457842|NCT03374007|Antibodies|antibodies|mesh-list
19457843|NCT03374007|Immunoglobulins|immunoglobulins|mesh-list
19457844|NCT03374007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19457845|NCT03374007|Immunologic Factors|immunologic factors|mesh-ancestor
19457846|NCT03374007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457847|NCT03374007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457848|NCT03373994|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19457849|NCT03373994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19457850|NCT03373994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457851|NCT03373955|Pembrolizumab|pembrolizumab|mesh-list
19457852|NCT03373955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19457853|NCT03373955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457854|NCT03373903|Everolimus|everolimus|mesh-list
19457855|NCT03373903|Dactolisib|dactolisib|mesh-list
19457856|NCT03373903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457857|NCT03373903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19457858|NCT03373903|Immunologic Factors|immunologic factors|mesh-ancestor
19457859|NCT03373903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737394|NCT01522976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737395|NCT01522976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737396|NCT01522976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19737397|NCT01286272|Deoxyglucose|deoxyglucose|mesh-list
19737398|NCT01286272|Bortezomib|bortezomib|mesh-list
19737399|NCT01286272|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19737400|NCT01286272|Ofatumumab|ofatumumab|mesh-list
19737401|NCT01286272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19737402|NCT01286272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19737403|NCT01286272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737404|NCT01286272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19737405|NCT01286272|Alkylating Agents|alkylating agents|mesh-ancestor
19737406|NCT01286272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737407|NCT01286272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19737408|NCT01286272|Antimetabolites|antimetabolites|mesh-ancestor
19737409|NCT01286272|Antiviral Agents|antiviral agents|mesh-ancestor
19737410|NCT01286272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19737411|NCT01286272|Immunologic Factors|immunologic factors|mesh-ancestor
19737412|NCT01286272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457860|NCT03373877|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
19457861|NCT03373877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457862|NCT03373864|Anesthetics|anesthetics|mesh-list
19457863|NCT03373864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19457864|NCT03373864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457865|NCT03373851|Sufentanil|sufentanil|mesh-list
19457866|NCT03373851|Dsuvia|dsuvia|mesh-list
19457867|NCT03373851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19457868|NCT03373851|Narcotics|narcotics|mesh-ancestor
19457869|NCT03373851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19457870|NCT03373851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457871|NCT03373851|Analgesics|analgesics|mesh-ancestor
19457872|NCT03373851|Sensory System Agents|sensory system agents|mesh-ancestor
19457873|NCT03373851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457874|NCT03373851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19457875|NCT03373851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19457876|NCT03373851|Anesthetics, General|anesthetics, general|mesh-ancestor
19457877|NCT03373851|Anesthetics|anesthetics|mesh-ancestor
19457878|NCT03373825|Fentanyl|fentanyl|mesh-list
19457879|NCT03373825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19457880|NCT03373825|Narcotics|narcotics|mesh-ancestor
19457881|NCT03373825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19457882|NCT03373825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457883|NCT03373825|Analgesics|analgesics|mesh-ancestor
19457884|NCT03373825|Sensory System Agents|sensory system agents|mesh-ancestor
19457885|NCT03373825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457886|NCT03373825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19457887|NCT03373825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19457888|NCT03373825|Anesthetics, General|anesthetics, general|mesh-ancestor
19457889|NCT03373825|Anesthetics|anesthetics|mesh-ancestor
19457890|NCT03373708|Tamoxifen|tamoxifen|mesh-list
19457891|NCT03373708|Cyclophosphamide|cyclophosphamide|mesh-list
19457892|NCT03373708|Docetaxel|docetaxel|mesh-list
19457893|NCT03373708|Letrozole|letrozole|mesh-list
19457894|NCT03373708|Epirubicin|epirubicin|mesh-list
19457895|NCT03373708|Goserelin|goserelin|mesh-list
19457896|NCT03373708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19457897|NCT03373708|Immunologic Factors|immunologic factors|mesh-ancestor
19457898|NCT03373708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457899|NCT03373708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19457900|NCT03373708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19457901|NCT03373708|Alkylating Agents|alkylating agents|mesh-ancestor
19457902|NCT03373708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457903|NCT03373708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457904|NCT03373708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19457905|NCT03373708|Tubulin Modulators|tubulin modulators|mesh-ancestor
19457906|NCT03373708|Antimitotic Agents|antimitotic agents|mesh-ancestor
19457907|NCT03373708|Mitosis Modulators|mitosis modulators|mesh-ancestor
19457908|NCT03373708|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19457909|NCT03373708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19457910|NCT03373708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457911|NCT03373708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19457912|NCT03373708|Hormone Antagonists|hormone antagonists|mesh-ancestor
19457913|NCT03373708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19457914|NCT03373708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19457915|NCT03373708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19457916|NCT03373708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19457917|NCT03373708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19737413|NCT01139970|Temozolomide|temozolomide|mesh-list
19737414|NCT01139970|Veliparib|veliparib|mesh-list
19737415|NCT01139970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19737416|NCT01139970|Alkylating Agents|alkylating agents|mesh-ancestor
19737417|NCT01139970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737418|NCT01139970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737419|NCT01139970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19737420|NCT01139970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737421|NCT01134601|Capecitabine|capecitabine|mesh-list
19737422|NCT01134601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19737423|NCT01134601|Antimetabolites|antimetabolites|mesh-ancestor
19737424|NCT01134601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737425|NCT01134601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737426|NCT00731731|Temozolomide|temozolomide|mesh-list
19457918|NCT03373708|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19457919|NCT03373708|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19457920|NCT03373708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19457921|NCT03373669|Vaccines|vaccines|mesh-list
19457922|NCT03373669|Immunologic Factors|immunologic factors|mesh-ancestor
19457923|NCT03373669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457924|NCT03373656|Vaccines|vaccines|mesh-list
19457925|NCT03373656|Immunologic Factors|immunologic factors|mesh-ancestor
19457926|NCT03373656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457927|NCT03373409|Albuterol|albuterol|mesh-list
19457928|NCT03373409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19457929|NCT03373409|Autonomic Agents|autonomic agents|mesh-ancestor
19457930|NCT03373409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19457931|NCT03373409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457932|NCT03373409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19457933|NCT03373409|Respiratory System Agents|respiratory system agents|mesh-ancestor
19457934|NCT03373409|Tocolytic Agents|tocolytic agents|mesh-ancestor
19457935|NCT03373409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19457936|NCT03373409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19457937|NCT03373409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19457938|NCT03373409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19457939|NCT03373409|Adrenergic Agents|adrenergic agents|mesh-ancestor
19457940|NCT03373409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19457941|NCT03373409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457942|NCT03373318|Plasma-lyte 148|plasma-lyte 148|mesh-list
19457943|NCT03373318|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19457944|NCT03373318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19457945|NCT03373305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19457946|NCT03373305|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19457947|NCT03373305|Lenalidomide|lenalidomide|mesh-list
19457948|NCT03373305|Piperidine|piperidine|mesh-list
19457949|NCT03373305|Antibodies|antibodies|mesh-list
19457950|NCT03373305|Immunoglobulins|immunoglobulins|mesh-list
19457951|NCT03373305|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19457952|NCT03373305|Immunoconjugates|immunoconjugates|mesh-list
19457953|NCT03373305|Immunologic Factors|immunologic factors|mesh-ancestor
19457954|NCT03373305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457955|NCT03373305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457956|NCT03373305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19457957|NCT03373305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19457958|NCT03373305|Growth Substances|growth substances|mesh-ancestor
19457959|NCT03373305|Growth Inhibitors|growth inhibitors|mesh-ancestor
19457960|NCT03373305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19457961|NCT03373305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19457962|NCT03373305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457963|NCT03373305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19457964|NCT03373266|Sevoflurane|sevoflurane|mesh-list
19457965|NCT03373266|Isoflurane|isoflurane|mesh-list
19457966|NCT03373266|Anesthetics|anesthetics|mesh-list
19457967|NCT03373266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19457968|NCT03373266|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19457969|NCT03373266|Anesthetics, General|anesthetics, general|mesh-ancestor
19457970|NCT03373266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19457971|NCT03373266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457972|NCT03373227|Tacrolimus|tacrolimus|mesh-list
19457973|NCT03373227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19457974|NCT03373227|Immunologic Factors|immunologic factors|mesh-ancestor
19457975|NCT03373227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457976|NCT03373227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19457977|NCT03373227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457978|NCT03373227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457979|NCT03373149|Hormones|hormones|mesh-list
19457980|NCT03373149|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19457981|NCT03373149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19457982|NCT03373149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457983|NCT03372967|Vaccines|vaccines|mesh-list
19457984|NCT03372967|Immunologic Factors|immunologic factors|mesh-ancestor
19457985|NCT03372967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457986|NCT03372850|Esomeprazole|esomeprazole|mesh-list
19457987|NCT03372850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19457988|NCT03372850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19457989|NCT03372850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19457990|NCT03372850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19457991|NCT03372850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19457992|NCT03372837|Rituximab|rituximab|mesh-list
19457993|NCT03372837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19457994|NCT03372837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19457995|NCT03372837|Immunologic Factors|immunologic factors|mesh-ancestor
19457996|NCT03372837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19457997|NCT03372837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19457998|NCT03372785|Aspirin|aspirin|mesh-list
19457999|NCT03372785|Metoprolol|metoprolol|mesh-list
19458000|NCT03372785|Clopidogrel|clopidogrel|mesh-list
19458001|NCT03372785|Ticagrelor|ticagrelor|mesh-list
19458002|NCT03372785|Atorvastatin|atorvastatin|mesh-list
19458003|NCT03372785|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19458004|NCT03372785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19458005|NCT03372785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19458006|NCT03372785|Analgesics|analgesics|mesh-ancestor
19458007|NCT03372785|Sensory System Agents|sensory system agents|mesh-ancestor
19458008|NCT03372785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458009|NCT03372785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458010|NCT03372785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19458011|NCT03372785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19458012|NCT03372785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19458013|NCT03372785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19458014|NCT03372785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458015|NCT03372785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19458016|NCT03372785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19458017|NCT03372785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19458018|NCT03372785|Antipyretics|antipyretics|mesh-ancestor
19458019|NCT03372785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19458020|NCT03372785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19458021|NCT03372785|Antimetabolites|antimetabolites|mesh-ancestor
19458022|NCT03372785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19458023|NCT03372785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19458024|NCT03372785|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19458025|NCT03372785|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19458026|NCT03372785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19458027|NCT03372785|Purinergic Agents|purinergic agents|mesh-ancestor
19458028|NCT03372785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19458029|NCT03372785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19458030|NCT03372785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19458031|NCT03372785|Sympatholytics|sympatholytics|mesh-ancestor
19458032|NCT03372785|Autonomic Agents|autonomic agents|mesh-ancestor
19458033|NCT03372785|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19458034|NCT03372785|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19458035|NCT03372785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19458036|NCT03372785|Adrenergic Agents|adrenergic agents|mesh-ancestor
19458037|NCT03372681|Antidiarrheals|antidiarrheals|mesh-list
19458038|NCT03372681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19458039|NCT03372486|Bupivacaine|bupivacaine|mesh-list
19458040|NCT03372486|Naloxone|naloxone|mesh-list
19458041|NCT03372486|Anesthetics, Local|anesthetics, local|mesh-ancestor
19458042|NCT03372486|Anesthetics|anesthetics|mesh-ancestor
19458043|NCT03372486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19458044|NCT03372486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458045|NCT03372486|Sensory System Agents|sensory system agents|mesh-ancestor
19458046|NCT03372486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458047|NCT03372486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19458048|NCT03372473|Loratadine|loratadine|mesh-list
19458049|NCT03372473|Montelukast|montelukast|mesh-list
19458050|NCT03372473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19458051|NCT03372473|Respiratory System Agents|respiratory system agents|mesh-ancestor
19458052|NCT03372473|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19458053|NCT03372473|Hormone Antagonists|hormone antagonists|mesh-ancestor
19458054|NCT03372473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19458055|NCT03372473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458056|NCT03372473|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19458057|NCT03372473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19458058|NCT03372473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458059|NCT03372473|Antipruritics|antipruritics|mesh-ancestor
19458060|NCT03372473|Dermatologic Agents|dermatologic agents|mesh-ancestor
19458061|NCT03372473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19458062|NCT03372473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19458063|NCT03372473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19458064|NCT03372473|Histamine Antagonists|histamine antagonists|mesh-ancestor
19458065|NCT03372473|Histamine Agents|histamine agents|mesh-ancestor
19458066|NCT03372473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19458067|NCT03372447|Thiamine|thiamine|mesh-list
19458068|NCT03372447|Pyridoxine|pyridoxine|mesh-list
19458069|NCT03372447|Hydroxocobalamin|hydroxocobalamin|mesh-list
19458070|NCT03372447|Vitamin B 12|vitamin b 12|mesh-list
19458071|NCT03372447|Vitamin B Complex|vitamin b complex|mesh-ancestor
19458072|NCT03372447|Vitamins|vitamins|mesh-ancestor
19458073|NCT03372447|Micronutrients|micronutrients|mesh-ancestor
19458074|NCT03372447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458075|NCT03372447|Hematinics|hematinics|mesh-ancestor
19458076|NCT03372304|Ropivacaine|ropivacaine|mesh-list
19458077|NCT03372304|Anesthetics, Local|anesthetics, local|mesh-ancestor
19458078|NCT03372304|Anesthetics|anesthetics|mesh-ancestor
19458079|NCT03372304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19458080|NCT03372304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458081|NCT03372304|Sensory System Agents|sensory system agents|mesh-ancestor
19458082|NCT03372304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458083|NCT03372265|Ropivacaine|ropivacaine|mesh-list
19458084|NCT03372265|Anesthetics, Local|anesthetics, local|mesh-ancestor
19458085|NCT03372265|Anesthetics|anesthetics|mesh-ancestor
19458086|NCT03372265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19458087|NCT03372265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458088|NCT03372265|Sensory System Agents|sensory system agents|mesh-ancestor
19458089|NCT03372265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458090|NCT03372239|Tryptophan|tryptophan|mesh-list
19458091|NCT03372239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19458092|NCT03372239|Antidepressive Agents|antidepressive agents|mesh-ancestor
19458093|NCT03372239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19458094|NCT03372200|Febuxostat|febuxostat|mesh-list
19458095|NCT03372200|Dotinurad|dotinurad|mesh-list
19458096|NCT03372200|Gout Suppressants|gout suppressants|mesh-ancestor
19458097|NCT03372200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19458098|NCT03372200|Uricosuric Agents|uricosuric agents|mesh-ancestor
19458099|NCT03372200|Renal Agents|renal agents|mesh-ancestor
19458100|NCT03372122|Chlorhexidine|chlorhexidine|mesh-list
19458101|NCT03372122|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19458102|NCT03372122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19458103|NCT03372122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19458104|NCT03372122|Disinfectants|disinfectants|mesh-ancestor
19458105|NCT03372122|Dermatologic Agents|dermatologic agents|mesh-ancestor
19458106|NCT03372109|Calcium|calcium|mesh-list
19458107|NCT03372109|Turmeric extract|turmeric extract|mesh-list
19458108|NCT03372109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19458109|NCT03372109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458110|NCT03372109|Antioxidants|antioxidants|mesh-ancestor
19458111|NCT03372109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458112|NCT03372109|Protective Agents|protective agents|mesh-ancestor
19737427|NCT00731731|Vorinostat|vorinostat|mesh-list
19737428|NCT00731731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19737429|NCT00731731|Alkylating Agents|alkylating agents|mesh-ancestor
19737430|NCT00731731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737431|NCT00731731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737432|NCT00731731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19737433|NCT00731731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737434|NCT00588991|Carboplatin|carboplatin|mesh-list
19737435|NCT00588991|Topotecan|topotecan|mesh-list
19737436|NCT00588991|Veliparib|veliparib|mesh-list
19737437|NCT00588991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737438|NCT00588991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19737439|NCT00588991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19737440|NCT00588991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737441|NCT00588991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737442|NCT00588991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19737443|NCT00336063|Azacitidine|azacitidine|mesh-list
19737444|NCT00336063|Vorinostat|vorinostat|mesh-list
19737445|NCT00336063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19737446|NCT00336063|Antimetabolites|antimetabolites|mesh-ancestor
19737447|NCT00336063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737448|NCT00336063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737449|NCT00336063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737450|NCT00336063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19737451|NCT00095784|Decitabine|decitabine|mesh-list
19737452|NCT00095784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19737453|NCT00095784|Antimetabolites|antimetabolites|mesh-ancestor
19737454|NCT00095784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737455|NCT00095784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737456|NCT00095784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737457|NCT00070499|Imatinib Mesylate|imatinib mesylate|mesh-list
19737458|NCT00070499|Dasatinib|dasatinib|mesh-list
19737459|NCT00070499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737460|NCT00070499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19737461|NCT00070499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737462|NCT00070499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458113|NCT03371992|Pembrolizumab|pembrolizumab|mesh-list
19458114|NCT03371992|Nivolumab|nivolumab|mesh-list
19458115|NCT03371992|Atezolizumab|atezolizumab|mesh-list
19458116|NCT03371992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19458117|NCT03371992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458118|NCT03371992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19458119|NCT03371992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458120|NCT03371953|Atracurium|atracurium|mesh-list
19458121|NCT03371953|Vecuronium Bromide|vecuronium bromide|mesh-list
19458122|NCT03371953|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19458123|NCT03371953|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19458124|NCT03371953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19458125|NCT03371953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458126|NCT03371953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458127|NCT03371953|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19458128|NCT03371953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19458129|NCT03371953|Cholinergic Agents|cholinergic agents|mesh-ancestor
19458130|NCT03371953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19458131|NCT03371953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458132|NCT03371862|Liraglutide|liraglutide|mesh-list
19458133|NCT03371862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19458134|NCT03371862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458135|NCT03371862|Incretins|incretins|mesh-ancestor
19458136|NCT03371862|Hormones|hormones|mesh-ancestor
19458137|NCT03371862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19737463|NCT04512118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19737464|NCT04512118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19737465|NCT04512118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984367|NCT01946412|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19984368|NCT01946412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19984369|NCT01946412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984370|NCT01946425|Vaccines|vaccines|mesh-list
19984371|NCT01946425|Immunologic Factors|immunologic factors|mesh-ancestor
19984372|NCT01946425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984373|NCT01946438|Vaccines|vaccines|mesh-list
19984374|NCT01946438|Immunologic Factors|immunologic factors|mesh-ancestor
19984375|NCT01946438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984376|NCT01946529|Sirolimus|sirolimus|mesh-list
19984377|NCT01946529|Cyclophosphamide|cyclophosphamide|mesh-list
19984378|NCT01946529|Temozolomide|temozolomide|mesh-list
19984379|NCT01946529|Ifosfamide|ifosfamide|mesh-list
19984380|NCT01946529|Bevacizumab|bevacizumab|mesh-list
19984381|NCT01946529|Doxorubicin|doxorubicin|mesh-list
19984382|NCT01946529|Etoposide|etoposide|mesh-list
19984383|NCT01946529|Vincristine|vincristine|mesh-list
19984384|NCT01946529|Sorafenib|sorafenib|mesh-list
19984385|NCT01946529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19984386|NCT01946529|Immunologic Factors|immunologic factors|mesh-ancestor
19984387|NCT01946529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984388|NCT01946529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19984389|NCT01946529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19984390|NCT01946529|Alkylating Agents|alkylating agents|mesh-ancestor
19984391|NCT01946529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984392|NCT01946529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984393|NCT01946529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19984394|NCT01946529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19984395|NCT01946529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19984396|NCT01946529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19984397|NCT01946529|Growth Substances|growth substances|mesh-ancestor
19984398|NCT01946529|Growth Inhibitors|growth inhibitors|mesh-ancestor
19984399|NCT01946529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19984400|NCT01946529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19984401|NCT01946529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19984402|NCT01946529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984403|NCT01946529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19984404|NCT01946529|Tubulin Modulators|tubulin modulators|mesh-ancestor
19984405|NCT01946529|Antimitotic Agents|antimitotic agents|mesh-ancestor
19984406|NCT01946529|Mitosis Modulators|mitosis modulators|mesh-ancestor
19984407|NCT01946529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19984408|NCT01946529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19984409|NCT01946529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19984410|NCT01946529|Antifungal Agents|antifungal agents|mesh-ancestor
19984411|NCT01946880|Mycophenolic Acid|mycophenolic acid|mesh-list
19984412|NCT01946880|Hydroxychloroquine|hydroxychloroquine|mesh-list
19458138|NCT03371849|Montelukast|montelukast|mesh-list
19458139|NCT03371849|Levocetirizine|levocetirizine|mesh-list
19458140|NCT03371849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19458141|NCT03371849|Respiratory System Agents|respiratory system agents|mesh-ancestor
19458142|NCT03371849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19458143|NCT03371849|Hormone Antagonists|hormone antagonists|mesh-ancestor
19458144|NCT03371849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19458145|NCT03371849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458146|NCT03371849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19458147|NCT03371849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19458148|NCT03371849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458149|NCT03371849|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19458150|NCT03371849|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19458151|NCT03371849|Histamine Antagonists|histamine antagonists|mesh-ancestor
19458152|NCT03371849|Histamine Agents|histamine agents|mesh-ancestor
19458153|NCT03371849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19458154|NCT03371797|Amlodipine|amlodipine|mesh-list
19458155|NCT03371797|Valsartan|valsartan|mesh-list
19458156|NCT03371797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19458157|NCT03371797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19458158|NCT03371797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19458159|NCT03371797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458160|NCT03371797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19458161|NCT03371797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458162|NCT03371797|Vasodilator Agents|vasodilator agents|mesh-ancestor
19458163|NCT03371797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19458164|NCT03371797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19458165|NCT03371784|Hydrocortisone|hydrocortisone|mesh-list
19458166|NCT03371784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19458167|NCT03371589|Dexamethasone|dexamethasone|mesh-list
19458168|NCT03371589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19458169|NCT03371589|Antiemetics|antiemetics|mesh-ancestor
19458170|NCT03371589|Autonomic Agents|autonomic agents|mesh-ancestor
19458171|NCT03371589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458172|NCT03371589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458173|NCT03371589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19458174|NCT03371589|Glucocorticoids|glucocorticoids|mesh-ancestor
19458175|NCT03371589|Hormones|hormones|mesh-ancestor
19458176|NCT03371589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19458177|NCT03371589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19458178|NCT03371589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458179|NCT03371563|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19458180|NCT03371563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19458181|NCT03371550|Docetaxel|docetaxel|mesh-list
19458182|NCT03371550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458183|NCT03371550|Tubulin Modulators|tubulin modulators|mesh-ancestor
19458184|NCT03371550|Antimitotic Agents|antimitotic agents|mesh-ancestor
19458185|NCT03371550|Mitosis Modulators|mitosis modulators|mesh-ancestor
19458186|NCT03371550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458187|NCT03371498|Methylprednisolone|methylprednisolone|mesh-list
19458188|NCT03371498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19458189|NCT03371498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19458190|NCT03371498|Prednisolone|prednisolone|mesh-list
19458191|NCT03371498|Prednisolone acetate|prednisolone acetate|mesh-list
19458192|NCT03371498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19458193|NCT03371498|Prednisolone phosphate|prednisolone phosphate|mesh-list
19458194|NCT03371498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19458195|NCT03371498|Antiemetics|antiemetics|mesh-ancestor
19458196|NCT03371498|Autonomic Agents|autonomic agents|mesh-ancestor
19458197|NCT03371498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458198|NCT03371498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458199|NCT03371498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19458200|NCT03371498|Glucocorticoids|glucocorticoids|mesh-ancestor
19458201|NCT03371498|Hormones|hormones|mesh-ancestor
19458202|NCT03371498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19458203|NCT03371498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19458204|NCT03371498|Protective Agents|protective agents|mesh-ancestor
19458205|NCT03371498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19458206|NCT03371498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458207|NCT03371342|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19458208|NCT03371342|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19458209|NCT03371342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458210|NCT03371342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458211|NCT03371342|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19737466|NCT04497519|Hydroxychloroquine|hydroxychloroquine|mesh-list
19458212|NCT03371342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19458213|NCT03371342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458214|NCT03371342|Cholinergic Agents|cholinergic agents|mesh-ancestor
19458215|NCT03371342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19458216|NCT03371186|Contraceptive Agents|contraceptive agents|mesh-list
19458217|NCT03371186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19458218|NCT03371186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458219|NCT03371173|Ferric maltol|ferric maltol|mesh-list
19458220|NCT03371173|Hematinics|hematinics|mesh-ancestor
19458221|NCT03371095|Cyclophosphamide|cyclophosphamide|mesh-list
19458222|NCT03371095|Infliximab|infliximab|mesh-list
19458223|NCT03371095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19458224|NCT03371095|Immunologic Factors|immunologic factors|mesh-ancestor
19458225|NCT03371095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458226|NCT03371095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19458227|NCT03371095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19458228|NCT03371095|Alkylating Agents|alkylating agents|mesh-ancestor
19458229|NCT03371095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458230|NCT03371095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458231|NCT03371095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19458232|NCT03371095|Dermatologic Agents|dermatologic agents|mesh-ancestor
19458233|NCT03371095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19458234|NCT03371069|Methylphenidate|methylphenidate|mesh-list
19458235|NCT03371069|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19458236|NCT03371069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458237|NCT03371069|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19458238|NCT03371069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19458239|NCT03371069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19458240|NCT03371069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458241|NCT03371069|Dopamine Agents|dopamine agents|mesh-ancestor
19458242|NCT03371069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19458243|NCT03371043|Analgesics|analgesics|mesh-list
19458244|NCT03371043|Sensory System Agents|sensory system agents|mesh-ancestor
19458245|NCT03371043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458246|NCT03371043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458247|NCT03370848|Aspirin|aspirin|mesh-list
19458248|NCT03370848|Psyllium|psyllium|mesh-list
19458249|NCT03370848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19458250|NCT03370848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19458251|NCT03370848|Analgesics|analgesics|mesh-ancestor
19458252|NCT03370848|Sensory System Agents|sensory system agents|mesh-ancestor
19458253|NCT03370848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458254|NCT03370848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458255|NCT03370848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19458256|NCT03370848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19458257|NCT03370848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19458258|NCT03370848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19458259|NCT03370848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458260|NCT03370848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19458261|NCT03370848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19458262|NCT03370848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19458263|NCT03370848|Antipyretics|antipyretics|mesh-ancestor
19458264|NCT03370848|Cathartics|cathartics|mesh-ancestor
19458265|NCT03370848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19458266|NCT03370835|Metoprolol|metoprolol|mesh-list
19458267|NCT03370835|Carvedilol|carvedilol|mesh-list
19458268|NCT03370835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19458269|NCT03370835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19458270|NCT03370835|Sympatholytics|sympatholytics|mesh-ancestor
19458271|NCT03370835|Autonomic Agents|autonomic agents|mesh-ancestor
19458272|NCT03370835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458273|NCT03370835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458274|NCT03370835|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19458275|NCT03370835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19458276|NCT03370835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19458277|NCT03370835|Adrenergic Agents|adrenergic agents|mesh-ancestor
19458278|NCT03370835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19458279|NCT03370835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458280|NCT03370835|Antioxidants|antioxidants|mesh-ancestor
19458281|NCT03370835|Protective Agents|protective agents|mesh-ancestor
19458282|NCT03370835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19458283|NCT03370835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19458284|NCT03370835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19458285|NCT03370835|Vasodilator Agents|vasodilator agents|mesh-ancestor
19458286|NCT03370835|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19458287|NCT03370835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19458288|NCT03370783|Ethanol|ethanol|mesh-list
19458289|NCT03370783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19458290|NCT03370783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19458291|NCT03370783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19458292|NCT03370783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458293|NCT03370705|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
19458294|NCT03370705|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
19458295|NCT03370705|Captopril|captopril|mesh-list
19458296|NCT03370705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
19458297|NCT03370705|Atorvastatin|atorvastatin|mesh-list
19458298|NCT03370705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
19458299|NCT03370705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19458300|NCT03370705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19458301|NCT03370705|Antimetabolites|antimetabolites|mesh-ancestor
19458302|NCT03370705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458303|NCT03370705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19458304|NCT03370705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19458305|NCT03370705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19458306|NCT03370705|Protease Inhibitors|protease inhibitors|mesh-ancestor
19458307|NCT03370705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19458308|NCT03370705|Anticoagulants|anticoagulants|mesh-ancestor
19458309|NCT03370705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19458310|NCT03370705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19458311|NCT03370705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19458312|NCT03370705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458313|NCT03370705|Analgesics|analgesics|mesh-ancestor
19458314|NCT03370705|Sensory System Agents|sensory system agents|mesh-ancestor
19458315|NCT03370705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458316|NCT03370705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19458317|NCT03370705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19458318|NCT03370705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19458319|NCT03370705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19458320|NCT03370705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19458321|NCT03370627|Antibodies|antibodies|mesh-list
19458322|NCT03370627|Immunologic Factors|immunologic factors|mesh-ancestor
19458323|NCT03370627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458324|NCT03370601|Mercaptopurine|mercaptopurine|mesh-list
19458325|NCT03370601|Azathioprine|azathioprine|mesh-list
19458326|NCT03370601|Infliximab|infliximab|mesh-list
19458327|NCT03370601|Dermatologic Agents|dermatologic agents|mesh-ancestor
19458328|NCT03370601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19458329|NCT03370601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19458330|NCT03370601|Antimetabolites|antimetabolites|mesh-ancestor
19458331|NCT03370601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458332|NCT03370601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19458333|NCT03370601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458334|NCT03370601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19458335|NCT03370601|Immunologic Factors|immunologic factors|mesh-ancestor
19458336|NCT03370601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458337|NCT03370601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19458338|NCT03370601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19458339|NCT03370588|Dexmedetomidine|dexmedetomidine|mesh-list
19458340|NCT03370588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19458341|NCT03370588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19458342|NCT03370588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458343|NCT03370588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19458344|NCT03370588|Analgesics|analgesics|mesh-ancestor
19458345|NCT03370588|Sensory System Agents|sensory system agents|mesh-ancestor
19458346|NCT03370588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458347|NCT03370588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19458348|NCT03370588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19458349|NCT03370588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19458350|NCT03370588|Adrenergic Agents|adrenergic agents|mesh-ancestor
19458351|NCT03370588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19458352|NCT03370588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458353|NCT03370562|Dexmedetomidine|dexmedetomidine|mesh-list
19458354|NCT03370562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19458355|NCT03370562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19458356|NCT03370562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458357|NCT03370562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19458358|NCT03370562|Analgesics|analgesics|mesh-ancestor
19458359|NCT03370562|Sensory System Agents|sensory system agents|mesh-ancestor
19458360|NCT03370562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458361|NCT03370562|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19458362|NCT03370562|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19737467|NCT04497519|Antimalarials|antimalarials|mesh-ancestor
19737468|NCT04497519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19737469|NCT04497519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19737470|NCT04497519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19737471|NCT04497519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737472|NCT04497519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737473|NCT04497519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19737474|NCT04489433|Trametinib|trametinib|mesh-list
19737475|NCT04489433|Dabrafenib|dabrafenib|mesh-list
19737476|NCT04489433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737477|NCT04489433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19737478|NCT04489433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737479|NCT04489433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737480|NCT04488237|Vitamin D|vitamin d|mesh-list
19737481|NCT04488237|Vitamins|vitamins|mesh-ancestor
19737482|NCT04488237|Micronutrients|micronutrients|mesh-ancestor
19737483|NCT04488237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737484|NCT04488237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19737485|NCT04484363|Azacitidine|azacitidine|mesh-list
19737486|NCT04484363|Pevonedistat|pevonedistat|mesh-list
19737487|NCT04484363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19737488|NCT04484363|Antimetabolites|antimetabolites|mesh-ancestor
19737489|NCT04484363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737490|NCT04484363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737491|NCT04484363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737492|NCT04482361|Antibodies|antibodies|mesh-list
19737493|NCT04482361|Immunologic Factors|immunologic factors|mesh-ancestor
19737494|NCT04482361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984413|NCT01946880|Chloroquine|chloroquine|mesh-list
19984414|NCT01946880|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
19984415|NCT01946880|Prednisone|prednisone|mesh-list
19984416|NCT01946880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19984417|NCT01946880|Glucocorticoids|glucocorticoids|mesh-ancestor
19984418|NCT01946880|Hormones|hormones|mesh-ancestor
19984419|NCT01946880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19984420|NCT01946880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984421|NCT01946880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19984422|NCT01946880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984423|NCT01946880|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19984424|NCT01946880|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19984425|NCT01946880|Antitubercular Agents|antitubercular agents|mesh-ancestor
19984426|NCT01946880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19984427|NCT01946880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19984428|NCT01946880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984429|NCT01946880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984430|NCT01946880|Antimalarials|antimalarials|mesh-ancestor
19984431|NCT01946880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19984432|NCT01946880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19984433|NCT01946880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19984434|NCT01946880|Amebicides|amebicides|mesh-ancestor
19984435|NCT01946880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19984436|NCT01946880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19984437|NCT01946880|Analgesics|analgesics|mesh-ancestor
19984438|NCT01946880|Sensory System Agents|sensory system agents|mesh-ancestor
19984439|NCT01946880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19984440|NCT01946880|Filaricides|filaricides|mesh-ancestor
19984441|NCT01946880|Antinematodal Agents|antinematodal agents|mesh-ancestor
19984442|NCT01946880|Anthelmintics|anthelmintics|mesh-ancestor
19984443|NCT01947153|Metformin|metformin|mesh-list
19984444|NCT01947153|Linagliptin|linagliptin|mesh-list
19984445|NCT01947153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19984446|NCT01947153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984447|NCT01947153|Incretins|incretins|mesh-ancestor
19984448|NCT01947153|Hormones|hormones|mesh-ancestor
19984449|NCT01947153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19458363|NCT03370562|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19458364|NCT03370562|Adrenergic Agents|adrenergic agents|mesh-ancestor
19458365|NCT03370562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19458366|NCT03370562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458367|NCT03370406|Fluorouracil|fluorouracil|mesh-list
19458368|NCT03370406|Imiquimod|imiquimod|mesh-list
19458369|NCT03370406|Antimetabolites|antimetabolites|mesh-ancestor
19458370|NCT03370406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458371|NCT03370406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19458372|NCT03370406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458373|NCT03370406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19458374|NCT03370406|Immunologic Factors|immunologic factors|mesh-ancestor
19458375|NCT03370406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458376|NCT03370406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19458377|NCT03370406|Interferon Inducers|interferon inducers|mesh-ancestor
19458378|NCT03370380|Aflibercept|aflibercept|mesh-list
19458379|NCT03370380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19458380|NCT03370380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19458381|NCT03370380|Growth Substances|growth substances|mesh-ancestor
19458382|NCT03370380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458383|NCT03370380|Growth Inhibitors|growth inhibitors|mesh-ancestor
19458384|NCT03370380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458385|NCT03370367|Tretinoin|tretinoin|mesh-list
19458386|NCT03370367|Isotretinoin|isotretinoin|mesh-list
19458387|NCT03370367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458388|NCT03370367|Keratolytic Agents|keratolytic agents|mesh-ancestor
19458389|NCT03370367|Dermatologic Agents|dermatologic agents|mesh-ancestor
19458390|NCT03370328|Peppermint oil|peppermint oil|mesh-list
19458391|NCT03370328|Antiemetics|antiemetics|mesh-ancestor
19458392|NCT03370328|Autonomic Agents|autonomic agents|mesh-ancestor
19458393|NCT03370328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458394|NCT03370328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458395|NCT03370328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19458396|NCT03370328|Parasympatholytics|parasympatholytics|mesh-ancestor
19737495|NCT04477382|Tretinoin|tretinoin|mesh-list
19737496|NCT04477382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737497|NCT04477382|Keratolytic Agents|keratolytic agents|mesh-ancestor
19737498|NCT04477382|Dermatologic Agents|dermatologic agents|mesh-ancestor
19984450|NCT01947153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19984451|NCT01947153|Protease Inhibitors|protease inhibitors|mesh-ancestor
19984452|NCT01947153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984453|NCT01947153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984454|NCT01947855|Empagliflozin|empagliflozin|mesh-list
19984455|NCT01947855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19984456|NCT01947855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984457|NCT01947855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19984458|NCT01947855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984459|NCT01947907|Hormones|hormones|mesh-list
19984460|NCT01947907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19984461|NCT01947907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984462|NCT01947946|Benralizumab|benralizumab|mesh-list
19984463|NCT01947946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19984464|NCT01947946|Respiratory System Agents|respiratory system agents|mesh-ancestor
19984465|NCT01948141|Nintedanib|nintedanib|mesh-list
19984466|NCT01948141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984467|NCT01948141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19984468|NCT01948141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984469|NCT01948141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984470|NCT01948310|Ranolazine|ranolazine|mesh-list
19984471|NCT01948310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19984472|NCT01948310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19984473|NCT01948310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984474|NCT01948388|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19984475|NCT01948388|Hormones|hormones|mesh-ancestor
19984476|NCT01948388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19984477|NCT01948388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984478|NCT01948518|Sildenafil Citrate|sildenafil citrate|mesh-list
19984479|NCT01948518|Vasodilator Agents|vasodilator agents|mesh-ancestor
19984480|NCT01948518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19984481|NCT01948518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19984482|NCT01948518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984483|NCT01948518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984484|NCT01948518|Urological Agents|urological agents|mesh-ancestor
19984485|NCT01948791|Rivastigmine|rivastigmine|mesh-list
19984486|NCT01948791|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19984487|NCT01948791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984488|NCT01948791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984489|NCT01948791|Cholinergic Agents|cholinergic agents|mesh-ancestor
19984490|NCT01948791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19984491|NCT01948791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458397|NCT03370276|Nivolumab|nivolumab|mesh-list
19458398|NCT03370276|Cetuximab|cetuximab|mesh-list
19458399|NCT03370276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19458400|NCT03370276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458401|NCT03370276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19458402|NCT03370276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458403|NCT03370159|Thioctic Acid|thioctic acid|mesh-list
19458404|NCT03370159|Docetaxel|docetaxel|mesh-list
19458405|NCT03370159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458406|NCT03370159|Tubulin Modulators|tubulin modulators|mesh-ancestor
19458407|NCT03370159|Antimitotic Agents|antimitotic agents|mesh-ancestor
19458408|NCT03370159|Mitosis Modulators|mitosis modulators|mesh-ancestor
19458409|NCT03370159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458410|NCT03370159|Antioxidants|antioxidants|mesh-ancestor
19458411|NCT03370159|Protective Agents|protective agents|mesh-ancestor
19458412|NCT03370159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458413|NCT03370159|Vitamin B Complex|vitamin b complex|mesh-ancestor
19458414|NCT03370159|Vitamins|vitamins|mesh-ancestor
19458415|NCT03370159|Micronutrients|micronutrients|mesh-ancestor
19458416|NCT03369990|Botulinum Toxins|botulinum toxins|mesh-list
19458417|NCT03369990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19458418|NCT03369990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19458419|NCT03369990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19458420|NCT03369990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19458421|NCT03369990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458422|NCT03369990|Cholinergic Agents|cholinergic agents|mesh-ancestor
19458423|NCT03369990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19458424|NCT03369990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458425|NCT03369990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19458426|NCT03369990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458427|NCT03369964|Atezolizumab|atezolizumab|mesh-list
19458428|NCT03369964|Obinutuzumab|obinutuzumab|mesh-list
19458429|NCT03369964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458430|NCT03369964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19458431|NCT03369925|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19458432|NCT03369925|Nootropic Agents|nootropic agents|mesh-ancestor
19458433|NCT03369847|Budesonide|budesonide|mesh-list
19458434|NCT03369847|Beclomethasone|beclomethasone|mesh-list
19458435|NCT03369847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19458436|NCT03369847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19458437|NCT03369847|Autonomic Agents|autonomic agents|mesh-ancestor
19458438|NCT03369847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458439|NCT03369847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458440|NCT03369847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19458441|NCT03369847|Respiratory System Agents|respiratory system agents|mesh-ancestor
19458442|NCT03369847|Glucocorticoids|glucocorticoids|mesh-ancestor
19458443|NCT03369847|Hormones|hormones|mesh-ancestor
19458444|NCT03369847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19458445|NCT03369808|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19458446|NCT03369808|Vaccines|vaccines|mesh-list
19458447|NCT03369808|Immunologic Factors|immunologic factors|mesh-ancestor
19458448|NCT03369808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458449|NCT03369808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19458450|NCT03369808|Antacids|antacids|mesh-ancestor
19458451|NCT03369808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458452|NCT03369808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19458453|NCT03369795|Methotrexate|methotrexate|mesh-list
19458454|NCT03369795|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19458455|NCT03369795|Abortifacient Agents|abortifacient agents|mesh-ancestor
19458456|NCT03369795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19458457|NCT03369795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458458|NCT03369795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19458459|NCT03369795|Antimetabolites|antimetabolites|mesh-ancestor
19458460|NCT03369795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458461|NCT03369795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458462|NCT03369795|Dermatologic Agents|dermatologic agents|mesh-ancestor
19458463|NCT03369795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19458464|NCT03369795|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19458465|NCT03369795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19458466|NCT03369795|Immunologic Factors|immunologic factors|mesh-ancestor
19458467|NCT03369795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19458468|NCT03369795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19458469|NCT03369782|Rocuronium|rocuronium|mesh-list
19458470|NCT03369782|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19458471|NCT03369782|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19458472|NCT03369782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19458473|NCT03369782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458474|NCT03369782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458475|NCT03369574|Reslizumab|reslizumab|mesh-list
19458476|NCT03369574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19458477|NCT03369574|Respiratory System Agents|respiratory system agents|mesh-ancestor
19458478|NCT03369379|Cholecalciferol|cholecalciferol|mesh-list
19458479|NCT03369379|Vitamins|vitamins|mesh-ancestor
19458480|NCT03369379|Micronutrients|micronutrients|mesh-ancestor
19458481|NCT03369379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458482|NCT03369379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19458483|NCT03369379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19458484|NCT03369327|Sofosbuvir|sofosbuvir|mesh-list
19458485|NCT03369327|Antiviral Agents|antiviral agents|mesh-ancestor
19458486|NCT03369327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19458487|NCT03369262|Atosiban|atosiban|mesh-list
19458488|NCT03369262|Hormone Antagonists|hormone antagonists|mesh-ancestor
19458489|NCT03369262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19458490|NCT03369262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458491|NCT03369262|Tocolytic Agents|tocolytic agents|mesh-ancestor
19458492|NCT03369262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19458493|NCT03369119|Montelukast|montelukast|mesh-list
19458494|NCT03369119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19458495|NCT03369119|Respiratory System Agents|respiratory system agents|mesh-ancestor
19458496|NCT03369119|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19458497|NCT03369119|Hormone Antagonists|hormone antagonists|mesh-ancestor
19458498|NCT03369119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19458499|NCT03369119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458500|NCT03369119|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19458501|NCT03369119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19458502|NCT03369119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458503|NCT03369093|Amoxicillin|amoxicillin|mesh-list
19458504|NCT03369093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19458505|NCT03369093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19458506|NCT03369067|Insulin|insulin|mesh-list
19458507|NCT03369067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19737499|NCT04455776|Propofol|propofol|mesh-list
19737500|NCT04455776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19737501|NCT04455776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19737502|NCT04455776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737503|NCT04455776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19737504|NCT04455776|Anesthetics, General|anesthetics, general|mesh-ancestor
19737505|NCT04455776|Anesthetics|anesthetics|mesh-ancestor
19737506|NCT04446793|Bevacizumab|bevacizumab|mesh-list
19737507|NCT04446793|Onvansertib|onvansertib|mesh-list
19737508|NCT04446793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19737509|NCT04446793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737510|NCT04446793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19737511|NCT04446793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19737512|NCT04446793|Growth Substances|growth substances|mesh-ancestor
19737513|NCT04446793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984492|NCT01948791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19984493|NCT01948791|Protective Agents|protective agents|mesh-ancestor
19984494|NCT01948830|Ranibizumab|ranibizumab|mesh-list
19984495|NCT01948830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19984496|NCT01948830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19984497|NCT01948830|Growth Substances|growth substances|mesh-ancestor
19984498|NCT01948830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984499|NCT01948830|Growth Inhibitors|growth inhibitors|mesh-ancestor
19984500|NCT01948830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984501|NCT01948908|Midazolam|midazolam|mesh-list
19984502|NCT01948908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19984503|NCT01948908|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19984504|NCT01948908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19984505|NCT01948908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984506|NCT01948908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19984507|NCT01948908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19984508|NCT01948908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19984509|NCT01948908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19984510|NCT01948908|Anesthetics, General|anesthetics, general|mesh-ancestor
19984511|NCT01948908|Anesthetics|anesthetics|mesh-ancestor
19984512|NCT01948908|GABA Modulators|gaba modulators|mesh-ancestor
19984513|NCT01948908|GABA Agents|gaba agents|mesh-ancestor
19984514|NCT01948908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19984515|NCT01948908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458508|NCT03369067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19458509|NCT03369067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458510|NCT03369015|Amphetamine|amphetamine|mesh-list
19458511|NCT03369015|Dextroamphetamine|dextroamphetamine|mesh-list
19458512|NCT03369015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19458513|NCT03369015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458514|NCT03369015|Sympathomimetics|sympathomimetics|mesh-ancestor
19458515|NCT03369015|Autonomic Agents|autonomic agents|mesh-ancestor
19458516|NCT03369015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458517|NCT03369015|Dopamine Agents|dopamine agents|mesh-ancestor
19458518|NCT03369015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19458519|NCT03369015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458520|NCT03369015|Adrenergic Agents|adrenergic agents|mesh-ancestor
19458521|NCT03369015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19458522|NCT03369015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19458523|NCT03369015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19458524|NCT03369015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19458525|NCT03369002|Seladelpar|seladelpar|mesh-list
19458526|NCT03369002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19458527|NCT03369002|Antimetabolites|antimetabolites|mesh-ancestor
19458528|NCT03369002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458529|NCT03369002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19458530|NCT03368989|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19458531|NCT03368989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458532|NCT03368794|Analgesics, Opioid|analgesics, opioid|mesh-list
19458533|NCT03368794|Narcotics|narcotics|mesh-ancestor
19458534|NCT03368794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19458535|NCT03368794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458536|NCT03368794|Analgesics|analgesics|mesh-ancestor
19458537|NCT03368794|Sensory System Agents|sensory system agents|mesh-ancestor
19458538|NCT03368794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458539|NCT03368664|Interferons|interferons|mesh-list
19458540|NCT03368664|Acyclovir|acyclovir|mesh-list
19458541|NCT03368664|Interferon-beta|interferon-beta|mesh-list
19458542|NCT03368664|Methylprednisolone|methylprednisolone|mesh-list
19458543|NCT03368664|Prednisolone|prednisolone|mesh-list
19458544|NCT03368664|Alemtuzumab|alemtuzumab|mesh-list
19458545|NCT03368664|Glatiramer Acetate|glatiramer acetate|mesh-list
19458546|NCT03368664|Ranitidine|ranitidine|mesh-list
19458547|NCT03368664|(T,G)-A-L|(t,g)-a-l|mesh-list
19458548|NCT03368664|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
19458549|NCT03368664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458550|NCT03368664|Antiviral Agents|antiviral agents|mesh-ancestor
19458551|NCT03368664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19458552|NCT03368664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19458553|NCT03368664|Antiemetics|antiemetics|mesh-ancestor
19458554|NCT03368664|Autonomic Agents|autonomic agents|mesh-ancestor
19458555|NCT03368664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458556|NCT03368664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458557|NCT03368664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19458558|NCT03368664|Glucocorticoids|glucocorticoids|mesh-ancestor
19458559|NCT03368664|Hormones|hormones|mesh-ancestor
19458560|NCT03368664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19458561|NCT03368664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19458562|NCT03368664|Protective Agents|protective agents|mesh-ancestor
19458563|NCT03368664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19458564|NCT03368664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19458565|NCT03368664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19458566|NCT03368664|Immunologic Factors|immunologic factors|mesh-ancestor
19458567|NCT03368664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19458568|NCT03368664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19458569|NCT03368664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19458570|NCT03368664|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19458571|NCT03368664|Histamine Antagonists|histamine antagonists|mesh-ancestor
19458572|NCT03368664|Histamine Agents|histamine agents|mesh-ancestor
19458573|NCT03368664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19458574|NCT03368664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458575|NCT03368664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19458576|NCT03368547|Edetic Acid|edetic acid|mesh-list
19458577|NCT03368547|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19458578|NCT03368547|Chelating Agents|chelating agents|mesh-ancestor
19458579|NCT03368547|Sequestering Agents|sequestering agents|mesh-ancestor
19458580|NCT03368547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458581|NCT03368547|Anticoagulants|anticoagulants|mesh-ancestor
19458582|NCT03368547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19458583|NCT03368547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19737514|NCT04446793|Growth Inhibitors|growth inhibitors|mesh-ancestor
19458584|NCT03368430|Melatonin|melatonin|mesh-list
19458585|NCT03368430|Antioxidants|antioxidants|mesh-ancestor
19458586|NCT03368430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458587|NCT03368430|Protective Agents|protective agents|mesh-ancestor
19458588|NCT03368430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458589|NCT03368430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19458590|NCT03368404|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19458591|NCT03368404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19458592|NCT03368391|Lidocaine|lidocaine|mesh-list
19458593|NCT03368391|Phenylephrine|phenylephrine|mesh-list
19458594|NCT03368391|Epinephrine|epinephrine|mesh-list
19458595|NCT03368391|Racepinephrine|racepinephrine|mesh-list
19458596|NCT03368391|Oxymetazoline|oxymetazoline|mesh-list
19458597|NCT03368391|Tetracaine|tetracaine|mesh-list
19458598|NCT03368391|Mepivacaine|mepivacaine|mesh-list
19458599|NCT03368391|Epinephryl borate|epinephryl borate|mesh-list
19458600|NCT03368391|Anesthetics, Local|anesthetics, local|mesh-ancestor
19458601|NCT03368391|Anesthetics|anesthetics|mesh-ancestor
19458602|NCT03368391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19458603|NCT03368391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458604|NCT03368391|Sensory System Agents|sensory system agents|mesh-ancestor
19458605|NCT03368391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458606|NCT03368391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19458607|NCT03368391|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19458608|NCT03368391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19458609|NCT03368391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19458610|NCT03368391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458611|NCT03368391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19458612|NCT03368391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19458613|NCT03368391|Adrenergic Agents|adrenergic agents|mesh-ancestor
19458614|NCT03368391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19458615|NCT03368391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19458616|NCT03368391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19458617|NCT03368391|Autonomic Agents|autonomic agents|mesh-ancestor
19458618|NCT03368391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19458619|NCT03368391|Respiratory System Agents|respiratory system agents|mesh-ancestor
19458620|NCT03368391|Mydriatics|mydriatics|mesh-ancestor
19458621|NCT03368391|Sympathomimetics|sympathomimetics|mesh-ancestor
19458622|NCT03368391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19458623|NCT03368391|Nasal Decongestants|nasal decongestants|mesh-ancestor
19458624|NCT03368391|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19458625|NCT03368391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19458626|NCT03368391|Protective Agents|protective agents|mesh-ancestor
19458627|NCT03368352|Melatonin|melatonin|mesh-list
19458628|NCT03368352|Antioxidants|antioxidants|mesh-ancestor
19458629|NCT03368352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458630|NCT03368352|Protective Agents|protective agents|mesh-ancestor
19458631|NCT03368352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458632|NCT03368352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19458633|NCT03368274|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
19458634|NCT03368274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19458635|NCT03368274|Glucocorticoids|glucocorticoids|mesh-ancestor
19458636|NCT03368274|Hormones|hormones|mesh-ancestor
19458637|NCT03368274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19458638|NCT03368274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458639|NCT03368131|Capecitabine|capecitabine|mesh-list
19458640|NCT03368131|Oxaliplatin|oxaliplatin|mesh-list
19458641|NCT03368131|Trastuzumab|trastuzumab|mesh-list
19458642|NCT03368131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19458643|NCT03368131|Antimetabolites|antimetabolites|mesh-ancestor
19458644|NCT03368131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458645|NCT03368131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458646|NCT03368131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19458647|NCT03367728|Ropivacaine|ropivacaine|mesh-list
19458648|NCT03367728|Anesthetics, Local|anesthetics, local|mesh-ancestor
19458649|NCT03367728|Anesthetics|anesthetics|mesh-ancestor
19458650|NCT03367728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19458651|NCT03367728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458652|NCT03367728|Sensory System Agents|sensory system agents|mesh-ancestor
19458653|NCT03367728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458654|NCT03367676|Docetaxel|docetaxel|mesh-list
19458655|NCT03367676|Trastuzumab|trastuzumab|mesh-list
19458656|NCT03367676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458657|NCT03367676|Tubulin Modulators|tubulin modulators|mesh-ancestor
19458658|NCT03367676|Antimitotic Agents|antimitotic agents|mesh-ancestor
19458659|NCT03367676|Mitosis Modulators|mitosis modulators|mesh-ancestor
19458660|NCT03367676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458661|NCT03367676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19458662|NCT03367663|Prednisone|prednisone|mesh-list
19458663|NCT03367663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19458664|NCT03367663|Glucocorticoids|glucocorticoids|mesh-ancestor
19458665|NCT03367663|Hormones|hormones|mesh-ancestor
19458666|NCT03367663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19458667|NCT03367663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458668|NCT03367663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19458669|NCT03367663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458670|NCT03367585|Vitamin D|vitamin d|mesh-list
19458671|NCT03367585|Cholecalciferol|cholecalciferol|mesh-list
19458672|NCT03367585|Vitamins|vitamins|mesh-ancestor
19458673|NCT03367585|Micronutrients|micronutrients|mesh-ancestor
19458674|NCT03367585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458675|NCT03367585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19458676|NCT03367585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19984516|NCT01948986|Ertugliflozin|ertugliflozin|mesh-list
19984517|NCT01948986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19984518|NCT01948986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984519|NCT01948986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19984520|NCT01948986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984521|NCT01949051|Levocabastine|levocabastine|mesh-list
19984522|NCT01949051|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19984523|NCT01949051|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19984524|NCT01949051|Histamine Antagonists|histamine antagonists|mesh-ancestor
19984525|NCT01949051|Histamine Agents|histamine agents|mesh-ancestor
19984526|NCT01949051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19984527|NCT01949051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984528|NCT01949051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984529|NCT01949116|Folic Acid|folic acid|mesh-list
19458691|NCT03367494|Bromides|bromides|mesh-list
19458692|NCT03367494|Anticonvulsants|anticonvulsants|mesh-ancestor
19458693|NCT03367390|Insulin Lispro|insulin lispro|mesh-list
19458694|NCT03367390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19458695|NCT03367390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458696|NCT03367377|Insulin Glargine|insulin glargine|mesh-list
19458697|NCT03367377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19458698|NCT03367377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458699|NCT03367195|Omeprazole|omeprazole|mesh-list
19458700|NCT03367195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19458701|NCT03367195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19458702|NCT03367195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19458703|NCT03367195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19458704|NCT03367195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458705|NCT03367182|Paclitaxel|paclitaxel|mesh-list
19458706|NCT03367182|Bevacizumab|bevacizumab|mesh-list
19458707|NCT03367182|Doxorubicin|doxorubicin|mesh-list
19458708|NCT03367182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19458709|NCT03367182|Topotecan|topotecan|mesh-list
19458710|NCT03367182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19458711|NCT03367182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458712|NCT03367182|Tubulin Modulators|tubulin modulators|mesh-ancestor
19458713|NCT03367182|Antimitotic Agents|antimitotic agents|mesh-ancestor
19458714|NCT03367182|Mitosis Modulators|mitosis modulators|mesh-ancestor
19458715|NCT03367182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458716|NCT03367182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19458717|NCT03367182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19458718|NCT03367182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19458719|NCT03367182|Growth Substances|growth substances|mesh-ancestor
19458720|NCT03367182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458721|NCT03367182|Growth Inhibitors|growth inhibitors|mesh-ancestor
19458722|NCT03367182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19458723|NCT03367182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19458724|NCT03367182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19458725|NCT03367182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19458726|NCT03367182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19458727|NCT03367143|Carboplatin|carboplatin|mesh-list
19458728|NCT03367143|Etoposide|etoposide|mesh-list
19458729|NCT03367143|Lenalidomide|lenalidomide|mesh-list
19458730|NCT03367143|Ifosfamide|ifosfamide|mesh-list
19984530|NCT01949116|Methotrexate|methotrexate|mesh-list
19458731|NCT03367143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458732|NCT03367143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19458733|NCT03367143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19458734|NCT03367143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19458735|NCT03367143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19458736|NCT03367143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458737|NCT03367143|Immunologic Factors|immunologic factors|mesh-ancestor
19458738|NCT03367143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458739|NCT03367143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19458740|NCT03367143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19458741|NCT03367143|Growth Substances|growth substances|mesh-ancestor
19458742|NCT03367143|Growth Inhibitors|growth inhibitors|mesh-ancestor
19458743|NCT03367143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19458744|NCT03367143|Alkylating Agents|alkylating agents|mesh-ancestor
19458745|NCT03367013|Lactoferrin|lactoferrin|mesh-list
19458746|NCT03367013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19458747|NCT03366974|Clarithromycin|clarithromycin|mesh-list
19458748|NCT03366974|Midazolam|midazolam|mesh-list
19458749|NCT03366974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19458750|NCT03366974|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19458751|NCT03366974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19458752|NCT03366974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737515|NCT04446793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19737516|NCT04446793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737517|NCT04446793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737518|NCT04445415|Antibodies|antibodies|mesh-list
19737519|NCT04445415|Immunologic Factors|immunologic factors|mesh-ancestor
19737520|NCT04445415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984531|NCT01949116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19984532|NCT01949116|Abortifacient Agents|abortifacient agents|mesh-ancestor
19984533|NCT01949116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19984534|NCT01949116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984535|NCT01949116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19984536|NCT01949116|Antimetabolites|antimetabolites|mesh-ancestor
19984537|NCT01949116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984538|NCT01949116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984539|NCT01949116|Dermatologic Agents|dermatologic agents|mesh-ancestor
19984540|NCT01949116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984541|NCT01949116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19984542|NCT01949116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19984543|NCT01949116|Immunologic Factors|immunologic factors|mesh-ancestor
19984544|NCT01949116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19984545|NCT01949116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19984546|NCT01949116|Hematinics|hematinics|mesh-ancestor
19984547|NCT01949116|Vitamin B Complex|vitamin b complex|mesh-ancestor
19984548|NCT01949116|Vitamins|vitamins|mesh-ancestor
19984549|NCT01949116|Micronutrients|micronutrients|mesh-ancestor
19984550|NCT01949337|Prednisone|prednisone|mesh-list
19984551|NCT01949337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19984552|NCT01949337|Glucocorticoids|glucocorticoids|mesh-ancestor
19984553|NCT01949337|Hormones|hormones|mesh-ancestor
19984554|NCT01949337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19984555|NCT01949337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984556|NCT01949337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19984557|NCT01949337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984558|NCT01949662|Lorazepam|lorazepam|mesh-list
19984559|NCT01949662|Haloperidol|haloperidol|mesh-list
19984560|NCT01949662|Haloperidol decanoate|haloperidol decanoate|mesh-list
19984561|NCT01949662|Antiemetics|antiemetics|mesh-ancestor
19984562|NCT01949662|Autonomic Agents|autonomic agents|mesh-ancestor
19984563|NCT01949662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19984564|NCT01949662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984565|NCT01949662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19984566|NCT01949662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19984567|NCT01949662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19984568|NCT01949662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19984569|NCT01949662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19984570|NCT01949662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19984571|NCT01949662|Dopamine Agents|dopamine agents|mesh-ancestor
19984572|NCT01949662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19984573|NCT01949662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984574|NCT01949662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19984575|NCT01949662|Anticonvulsants|anticonvulsants|mesh-ancestor
19984576|NCT01949662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19984577|NCT01949662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19984578|NCT01949662|GABA Modulators|gaba modulators|mesh-ancestor
19458753|NCT03366974|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19458754|NCT03366974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19458755|NCT03366974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19458756|NCT03366974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19458757|NCT03366974|Anesthetics, General|anesthetics, general|mesh-ancestor
19458758|NCT03366974|Anesthetics|anesthetics|mesh-ancestor
19458759|NCT03366974|GABA Modulators|gaba modulators|mesh-ancestor
19458760|NCT03366974|GABA Agents|gaba agents|mesh-ancestor
19458761|NCT03366974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19458762|NCT03366974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458763|NCT03366974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19458764|NCT03366974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19458765|NCT03366974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19458766|NCT03366974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19458767|NCT03366974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19458768|NCT03366974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19458769|NCT03366883|Paclitaxel|paclitaxel|mesh-list
19458770|NCT03366883|Cisplatin|cisplatin|mesh-list
19458771|NCT03366883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19458772|NCT03366883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458773|NCT03366883|Tubulin Modulators|tubulin modulators|mesh-ancestor
19458774|NCT03366883|Antimitotic Agents|antimitotic agents|mesh-ancestor
19458775|NCT03366883|Mitosis Modulators|mitosis modulators|mesh-ancestor
19458776|NCT03366883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458777|NCT03366766|Gemcitabine|gemcitabine|mesh-list
19458778|NCT03366766|Cisplatin|cisplatin|mesh-list
19458779|NCT03366766|Nivolumab|nivolumab|mesh-list
19458780|NCT03366766|Pemetrexed|pemetrexed|mesh-list
19458781|NCT03366766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458782|NCT03366766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19458783|NCT03366766|Antimetabolites|antimetabolites|mesh-ancestor
19458784|NCT03366766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458785|NCT03366766|Antiviral Agents|antiviral agents|mesh-ancestor
19458786|NCT03366766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19458787|NCT03366766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19458788|NCT03366766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19458789|NCT03366766|Immunologic Factors|immunologic factors|mesh-ancestor
19458790|NCT03366766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458791|NCT03366766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19458792|NCT03366766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19458793|NCT03366766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19458794|NCT03366766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19737521|NCT04433026|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
19737522|NCT04433026|Natriuretic Agents|natriuretic agents|mesh-ancestor
19737523|NCT04433026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737524|NCT04426084|Antihypertensive Agents|antihypertensive agents|mesh-list
19984579|NCT01949662|GABA Agents|gaba agents|mesh-ancestor
19984580|NCT01949844|Regadenoson|regadenoson|mesh-list
19984581|NCT01949844|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19984582|NCT01949844|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19984583|NCT01949844|Purinergic Agonists|purinergic agonists|mesh-ancestor
19984584|NCT01949844|Purinergic Agents|purinergic agents|mesh-ancestor
19984585|NCT01949844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19984586|NCT01949844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984587|NCT01949844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984588|NCT01949870|Gemcitabine|gemcitabine|mesh-list
19984589|NCT01949870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984590|NCT01949870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19984591|NCT01949870|Antimetabolites|antimetabolites|mesh-ancestor
19984592|NCT01949870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984593|NCT01949870|Antiviral Agents|antiviral agents|mesh-ancestor
19984594|NCT01949870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19984595|NCT01949870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984596|NCT01949870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19984597|NCT01949870|Immunologic Factors|immunologic factors|mesh-ancestor
19984598|NCT01949870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984599|NCT01950039|Betaine|betaine|mesh-list
19984600|NCT01950039|Glycine|glycine|mesh-list
19984601|NCT01950039|Glycine Agents|glycine agents|mesh-ancestor
19984602|NCT01950039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19984603|NCT01950039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984604|NCT01950039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984605|NCT01950039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19984606|NCT01950039|Lipotropic Agents|lipotropic agents|mesh-ancestor
19984607|NCT01950039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19984608|NCT01950039|Antimetabolites|antimetabolites|mesh-ancestor
19458795|NCT03366597|Sevoflurane|sevoflurane|mesh-list
19458796|NCT03366597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19458797|NCT03366597|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19458798|NCT03366597|Anesthetics, General|anesthetics, general|mesh-ancestor
19458799|NCT03366597|Anesthetics|anesthetics|mesh-ancestor
19458800|NCT03366597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19458801|NCT03366597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458802|NCT03366584|Vitamin D|vitamin d|mesh-list
19458803|NCT03366584|Cholecalciferol|cholecalciferol|mesh-list
19458804|NCT03366584|Beta Carotene|beta carotene|mesh-list
19458805|NCT03366584|Zinc|zinc|mesh-list
19458806|NCT03366584|Dexamethasone|dexamethasone|mesh-list
19458807|NCT03366584|Carotenoids|carotenoids|mesh-list
19458808|NCT03366584|Picolinic acid|picolinic acid|mesh-list
19458809|NCT03366584|Vitamins|vitamins|mesh-ancestor
19458810|NCT03366584|Micronutrients|micronutrients|mesh-ancestor
19458811|NCT03366584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458812|NCT03366584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19458813|NCT03366584|Antiemetics|antiemetics|mesh-ancestor
19458814|NCT03366584|Autonomic Agents|autonomic agents|mesh-ancestor
19458815|NCT03366584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458816|NCT03366584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19458817|NCT03366584|Glucocorticoids|glucocorticoids|mesh-ancestor
19458818|NCT03366584|Hormones|hormones|mesh-ancestor
19458819|NCT03366584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19458820|NCT03366584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19458821|NCT03366584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458822|NCT03366584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19458823|NCT03366584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19458824|NCT03366584|Trace Elements|trace elements|mesh-ancestor
19458825|NCT03366584|Antioxidants|antioxidants|mesh-ancestor
19458826|NCT03366584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458827|NCT03366584|Protective Agents|protective agents|mesh-ancestor
19458828|NCT03366584|Provitamins|provitamins|mesh-ancestor
19458829|NCT03366584|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19458830|NCT03366584|Chelating Agents|chelating agents|mesh-ancestor
19458831|NCT03366584|Sequestering Agents|sequestering agents|mesh-ancestor
19458832|NCT03366571|Entecavir|entecavir|mesh-list
19458833|NCT03366571|Antiviral Agents|antiviral agents|mesh-ancestor
19458834|NCT03366571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19458835|NCT03366480|Paclitaxel|paclitaxel|mesh-list
19458836|NCT03366480|Carboplatin|carboplatin|mesh-list
19458837|NCT03366480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19458838|NCT03366480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458839|NCT03366480|Tubulin Modulators|tubulin modulators|mesh-ancestor
19458840|NCT03366480|Antimitotic Agents|antimitotic agents|mesh-ancestor
19458841|NCT03366480|Mitosis Modulators|mitosis modulators|mesh-ancestor
19458842|NCT03366480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458843|NCT03366259|Misoprostol|misoprostol|mesh-list
19458844|NCT03366259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19458845|NCT03366259|Abortifacient Agents|abortifacient agents|mesh-ancestor
19458846|NCT03366259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19458847|NCT03366259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458848|NCT03366259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19458849|NCT03366259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19458850|NCT03366259|Oxytocics|oxytocics|mesh-ancestor
19458851|NCT03366246|Lidocaine|lidocaine|mesh-list
19458852|NCT03366246|Prilocaine|prilocaine|mesh-list
19458853|NCT03366246|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19458854|NCT03366246|Anesthetics, Local|anesthetics, local|mesh-ancestor
19458855|NCT03366246|Anesthetics|anesthetics|mesh-ancestor
19458856|NCT03366246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19458857|NCT03366246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458858|NCT03366246|Sensory System Agents|sensory system agents|mesh-ancestor
19458859|NCT03366246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458860|NCT03366246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19458861|NCT03366246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19458862|NCT03366246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19458863|NCT03366246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19458864|NCT03366246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458865|NCT03366246|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19458866|NCT03366064|Pemetrexed|pemetrexed|mesh-list
19458867|NCT03366064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458868|NCT03366064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19458869|NCT03366064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737525|NCT04407572|Vitamin D|vitamin d|mesh-list
19458870|NCT03366064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19737526|NCT04407572|Vitamins|vitamins|mesh-list
19458871|NCT03366064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19458872|NCT03366025|Progesterone|progesterone|mesh-list
19458873|NCT03366025|Progestins|progestins|mesh-ancestor
19458874|NCT03366025|Hormones|hormones|mesh-ancestor
19458875|NCT03366025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19458876|NCT03366025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458877|NCT03365999|Tranexamic Acid|tranexamic acid|mesh-list
19458878|NCT03365999|Aminocaproic Acid|aminocaproic acid|mesh-list
19458879|NCT03365999|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19458880|NCT03365999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19458881|NCT03365999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458882|NCT03365999|Hemostatics|hemostatics|mesh-ancestor
19458883|NCT03365999|Coagulants|coagulants|mesh-ancestor
19458884|NCT03365869|Sirolimus|sirolimus|mesh-list
19458885|NCT03365869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19458886|NCT03365869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19458887|NCT03365869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19458888|NCT03365869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458889|NCT03365869|Antifungal Agents|antifungal agents|mesh-ancestor
19458890|NCT03365869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19458891|NCT03365869|Immunologic Factors|immunologic factors|mesh-ancestor
19458892|NCT03365869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458893|NCT03365817|Fentanyl|fentanyl|mesh-list
19458894|NCT03365817|Morphine|morphine|mesh-list
19458895|NCT03365817|Oxycodone|oxycodone|mesh-list
19458896|NCT03365817|Analgesics, Opioid|analgesics, opioid|mesh-list
19458897|NCT03365817|Tramadol|tramadol|mesh-list
19458898|NCT03365817|Methadone|methadone|mesh-list
19458899|NCT03365817|Narcotics|narcotics|mesh-ancestor
19458900|NCT03365817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19458901|NCT03365817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458902|NCT03365817|Analgesics|analgesics|mesh-ancestor
19458903|NCT03365817|Sensory System Agents|sensory system agents|mesh-ancestor
19458904|NCT03365817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458905|NCT03365817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19458906|NCT03365817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19458907|NCT03365817|Anesthetics, General|anesthetics, general|mesh-ancestor
19458908|NCT03365817|Anesthetics|anesthetics|mesh-ancestor
19458909|NCT03365817|Antitussive Agents|antitussive agents|mesh-ancestor
19458910|NCT03365817|Respiratory System Agents|respiratory system agents|mesh-ancestor
19458911|NCT03365765|Fluorouracil|fluorouracil|mesh-list
19458912|NCT03365765|Oxaliplatin|oxaliplatin|mesh-list
19458913|NCT03365765|Apatinib|apatinib|mesh-list
19458914|NCT03365765|Antimetabolites|antimetabolites|mesh-ancestor
19458915|NCT03365765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458916|NCT03365765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19458917|NCT03365765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19458918|NCT03365765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19737527|NCT04407572|Vitamin B 12|vitamin b 12|mesh-list
19737528|NCT04407572|Hydroxocobalamin|hydroxocobalamin|mesh-list
19737529|NCT04407572|Micronutrients|micronutrients|mesh-ancestor
19737530|NCT04407572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737531|NCT04407572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19737532|NCT04407572|Vitamin B Complex|vitamin b complex|mesh-ancestor
19737533|NCT04407572|Hematinics|hematinics|mesh-ancestor
19737534|NCT04405284|Disinfectants|disinfectants|mesh-list
19737535|NCT04405284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19984609|NCT01950039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19984610|NCT01950169|Vitamin D|vitamin d|mesh-list
19984611|NCT01950169|Cholecalciferol|cholecalciferol|mesh-list
19984612|NCT01950169|Risedronic Acid|risedronic acid|mesh-list
19984613|NCT01950169|Diphosphonates|diphosphonates|mesh-list
19984614|NCT01950169|Calcium|calcium|mesh-list
19984615|NCT01950169|Vitamins|vitamins|mesh-ancestor
19984616|NCT01950169|Micronutrients|micronutrients|mesh-ancestor
19984617|NCT01950169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984618|NCT01950169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19984619|NCT01950169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19984620|NCT01950169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19984621|NCT01950169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19984622|NCT01950169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984623|NCT01950260|Hormones|hormones|mesh-list
19984624|NCT01950260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19984625|NCT01950260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984626|NCT01950273|Rituximab|rituximab|mesh-list
19458919|NCT03365765|Immunologic Factors|immunologic factors|mesh-ancestor
19458920|NCT03365765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458921|NCT03365765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19458922|NCT03365765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19458923|NCT03365726|Dobutamine|dobutamine|mesh-list
19458924|NCT03365726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19458925|NCT03365726|Sympathomimetics|sympathomimetics|mesh-ancestor
19458926|NCT03365726|Autonomic Agents|autonomic agents|mesh-ancestor
19458927|NCT03365726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458928|NCT03365726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458929|NCT03365726|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19458930|NCT03365726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19458931|NCT03365726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19458932|NCT03365726|Adrenergic Agents|adrenergic agents|mesh-ancestor
19458933|NCT03365726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19458934|NCT03365726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458935|NCT03365726|Protective Agents|protective agents|mesh-ancestor
19458936|NCT03365479|Iloprost|iloprost|mesh-list
19458937|NCT03365479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19458938|NCT03365479|Vasodilator Agents|vasodilator agents|mesh-ancestor
19458939|NCT03365466|Aspirin|aspirin|mesh-list
19458940|NCT03365466|Heparin|heparin|mesh-list
19458941|NCT03365466|Calcium heparin|calcium heparin|mesh-list
19458942|NCT03365466|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19458943|NCT03365466|Tinzaparin|tinzaparin|mesh-list
19458944|NCT03365466|Dalteparin|dalteparin|mesh-list
19458945|NCT03365466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19458946|NCT03365466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19458947|NCT03365466|Analgesics|analgesics|mesh-ancestor
19458948|NCT03365466|Sensory System Agents|sensory system agents|mesh-ancestor
19458949|NCT03365466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458950|NCT03365466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458951|NCT03365466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19458952|NCT03365466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19458953|NCT03365466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19458954|NCT03365466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19458955|NCT03365466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458956|NCT03365466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19458957|NCT03365466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19458958|NCT03365466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19458959|NCT03365466|Antipyretics|antipyretics|mesh-ancestor
19458960|NCT03365466|Anticoagulants|anticoagulants|mesh-ancestor
19458961|NCT03365414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19458962|NCT03365388|Hyaluronic Acid|hyaluronic acid|mesh-list
19458963|NCT03365388|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19458964|NCT03365388|Immunologic Factors|immunologic factors|mesh-ancestor
19458965|NCT03365388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458966|NCT03365388|Viscosupplements|viscosupplements|mesh-ancestor
19458967|NCT03365388|Protective Agents|protective agents|mesh-ancestor
19458968|NCT03365336|Oseltamivir|oseltamivir|mesh-list
19458969|NCT03365336|Antiviral Agents|antiviral agents|mesh-ancestor
19458970|NCT03365336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19458971|NCT03365336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19458972|NCT03365336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458973|NCT03365141|Triamcinolone|triamcinolone|mesh-list
19458974|NCT03365141|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19458975|NCT03365141|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19458976|NCT03365141|Tacrolimus|tacrolimus|mesh-list
19458977|NCT03365141|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19458978|NCT03365141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19458979|NCT03365141|Immunologic Factors|immunologic factors|mesh-ancestor
19458980|NCT03365141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458981|NCT03365141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19458982|NCT03365141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19458983|NCT03365141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19458984|NCT03365141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19458985|NCT03365141|Glucocorticoids|glucocorticoids|mesh-ancestor
19458986|NCT03365141|Hormones|hormones|mesh-ancestor
19458987|NCT03365141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19458988|NCT03365115|Fentanyl|fentanyl|mesh-list
19458989|NCT03365115|Morphine|morphine|mesh-list
19458990|NCT03365115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19458991|NCT03365115|Narcotics|narcotics|mesh-ancestor
19458992|NCT03365115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19458993|NCT03365115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19458994|NCT03365115|Analgesics|analgesics|mesh-ancestor
19458995|NCT03365115|Sensory System Agents|sensory system agents|mesh-ancestor
19458996|NCT03365115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19458997|NCT03365115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19458998|NCT03365115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19458999|NCT03365115|Anesthetics, General|anesthetics, general|mesh-ancestor
19459000|NCT03365115|Anesthetics|anesthetics|mesh-ancestor
19459001|NCT03364998|Factor VIII|factor viii|mesh-list
19459002|NCT03364998|Coagulants|coagulants|mesh-ancestor
19459003|NCT03364985|Dapagliflozin|dapagliflozin|mesh-list
19459004|NCT03364985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19459005|NCT03364985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459006|NCT03364985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19459007|NCT03364985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737536|NCT04397302|Valsartan|valsartan|mesh-list
19737537|NCT04397302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19737538|NCT04397302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19737539|NCT04397302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19737540|NCT04397302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737541|NCT04396587|Sufentanil|sufentanil|mesh-list
19737542|NCT04396587|Oxycodone|oxycodone|mesh-list
19737543|NCT04396587|Hydromorphone|hydromorphone|mesh-list
19737544|NCT04396587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19737545|NCT04396587|Narcotics|narcotics|mesh-ancestor
19737546|NCT04396587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19737547|NCT04396587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737548|NCT04396587|Analgesics|analgesics|mesh-ancestor
19737549|NCT04396587|Sensory System Agents|sensory system agents|mesh-ancestor
19737550|NCT04396587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19737551|NCT04396587|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19737552|NCT04396587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19737553|NCT04396587|Anesthetics, General|anesthetics, general|mesh-ancestor
19737554|NCT04396587|Anesthetics|anesthetics|mesh-ancestor
19737555|NCT04390802|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19737556|NCT04390802|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19737557|NCT04390802|Dermatologic Agents|dermatologic agents|mesh-ancestor
19737558|NCT04389294|Antibodies|antibodies|mesh-list
19737559|NCT04389294|Immunologic Factors|immunologic factors|mesh-ancestor
19737560|NCT04389294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984627|NCT01950273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19984628|NCT01950273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984629|NCT01950273|Immunologic Factors|immunologic factors|mesh-ancestor
19984630|NCT01950273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984631|NCT01950273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19984632|NCT01950299|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19984633|NCT01950299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19984634|NCT01950364|Rifampin|rifampin|mesh-list
19984635|NCT01950364|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19984636|NCT01950364|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19984637|NCT01950364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19984638|NCT01950364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984639|NCT01950364|Immunologic Factors|immunologic factors|mesh-ancestor
19984640|NCT01950364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984641|NCT01950364|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19984642|NCT01950364|Antitubercular Agents|antitubercular agents|mesh-ancestor
19984643|NCT01950364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19984644|NCT01950364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19984645|NCT01950364|Leprostatic Agents|leprostatic agents|mesh-ancestor
19984646|NCT01950364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19984647|NCT01950364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984648|NCT01950364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984649|NCT01950364|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19984650|NCT01950364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19984651|NCT01950364|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19984652|NCT01950364|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19984653|NCT01950364|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19984654|NCT01950364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19984655|NCT01950741|Aflibercept|aflibercept|mesh-list
19984656|NCT01950741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19984657|NCT01950741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19984658|NCT01950741|Growth Substances|growth substances|mesh-ancestor
19984659|NCT01950741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984660|NCT01950741|Growth Inhibitors|growth inhibitors|mesh-ancestor
19984661|NCT01950741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984662|NCT01950819|Cyclosporine|cyclosporine|mesh-list
19984663|NCT01950819|Prednisone|prednisone|mesh-list
19984664|NCT01950819|Methylprednisolone|methylprednisolone|mesh-list
19984665|NCT01950819|Tacrolimus|tacrolimus|mesh-list
19984666|NCT01950819|Thymoglobulin|thymoglobulin|mesh-list
19984667|NCT01950819|Cyclosporins|cyclosporins|mesh-list
19984668|NCT01950819|Basiliximab|basiliximab|mesh-list
19459008|NCT03364842|Furosemide|furosemide|mesh-list
19459009|NCT03364842|Diuretics|diuretics|mesh-ancestor
19459010|NCT03364842|Natriuretic Agents|natriuretic agents|mesh-ancestor
19459011|NCT03364842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459012|NCT03364842|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19459013|NCT03364842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19459014|NCT03364842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459015|NCT03364829|Glycopyrrolate|glycopyrrolate|mesh-list
19459016|NCT03364829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19459017|NCT03364829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19459018|NCT03364829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19459019|NCT03364829|Cholinergic Agents|cholinergic agents|mesh-ancestor
19459020|NCT03364829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19459021|NCT03364829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459022|NCT03364829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459023|NCT03364764|Sirolimus|sirolimus|mesh-list
19459024|NCT03364764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19459025|NCT03364764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19459026|NCT03364764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19459027|NCT03364764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459028|NCT03364764|Antifungal Agents|antifungal agents|mesh-ancestor
19459029|NCT03364764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19459030|NCT03364764|Immunologic Factors|immunologic factors|mesh-ancestor
19459031|NCT03364764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459032|NCT03364569|Tranexamic Acid|tranexamic acid|mesh-list
19459033|NCT03364569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19459034|NCT03364569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19459035|NCT03364569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459036|NCT03364569|Hemostatics|hemostatics|mesh-ancestor
19459037|NCT03364569|Coagulants|coagulants|mesh-ancestor
19459038|NCT03364530|Gemcitabine|gemcitabine|mesh-list
19459039|NCT03364530|Oxaliplatin|oxaliplatin|mesh-list
19459040|NCT03364530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19459041|NCT03364530|Antimetabolites|antimetabolites|mesh-ancestor
19459042|NCT03364530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459043|NCT03364530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459044|NCT03364530|Antiviral Agents|antiviral agents|mesh-ancestor
19459045|NCT03364530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19459046|NCT03364530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459047|NCT03364530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19459048|NCT03364530|Immunologic Factors|immunologic factors|mesh-ancestor
19459049|NCT03364530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459050|NCT03364348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19459051|NCT03364348|Trastuzumab|trastuzumab|mesh-list
19459052|NCT03364348|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19459053|NCT03364348|Maytansine|maytansine|mesh-list
19459054|NCT03364348|Antibodies|antibodies|mesh-list
19459055|NCT03364348|Immunoglobulins|immunoglobulins|mesh-list
19459056|NCT03364348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19459057|NCT03364348|Immunoconjugates|immunoconjugates|mesh-list
19737561|NCT04381091|Idebenone|idebenone|mesh-list
19737562|NCT04381091|Antioxidants|antioxidants|mesh-ancestor
19737563|NCT04381091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737564|NCT04381091|Protective Agents|protective agents|mesh-ancestor
19737565|NCT04381091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737566|NCT04377295|Ranibizumab|ranibizumab|mesh-list
19737567|NCT04377295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19737568|NCT04377295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19737569|NCT04377295|Growth Substances|growth substances|mesh-ancestor
19737570|NCT04377295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737571|NCT04377295|Growth Inhibitors|growth inhibitors|mesh-ancestor
19737572|NCT04377295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737573|NCT04374123|Antibodies|antibodies|mesh-list
19737574|NCT04374123|Immunoglobulin M|immunoglobulin m|mesh-list
19737575|NCT04374123|Immunologic Factors|immunologic factors|mesh-ancestor
19737576|NCT04374123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737577|NCT04367688|Tenofovir|tenofovir|mesh-list
19737578|NCT04367688|Emtricitabine|emtricitabine|mesh-list
19737579|NCT04367688|Antiviral Agents|antiviral agents|mesh-ancestor
19737580|NCT04367688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19737581|NCT04367688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19459058|NCT03364348|Immunoglobulin G|immunoglobulin g|mesh-list
19459059|NCT03364348|Immunologic Factors|immunologic factors|mesh-ancestor
19737582|NCT04367688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19459060|NCT03364348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459061|NCT03364348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737583|NCT04367688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459062|NCT03364348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19459063|NCT03364348|Tubulin Modulators|tubulin modulators|mesh-ancestor
19459064|NCT03364348|Antimitotic Agents|antimitotic agents|mesh-ancestor
19459065|NCT03364348|Mitosis Modulators|mitosis modulators|mesh-ancestor
19459066|NCT03364348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459067|NCT03364218|Acetylcysteine|acetylcysteine|mesh-list
19459068|NCT03364218|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19459069|NCT03364218|Antiviral Agents|antiviral agents|mesh-ancestor
19459070|NCT03364218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19459071|NCT03364218|Expectorants|expectorants|mesh-ancestor
19459072|NCT03364218|Respiratory System Agents|respiratory system agents|mesh-ancestor
19459073|NCT03364218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19459074|NCT03364218|Antioxidants|antioxidants|mesh-ancestor
19459075|NCT03364218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459076|NCT03364218|Protective Agents|protective agents|mesh-ancestor
19459077|NCT03364218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459078|NCT03364218|Antidotes|antidotes|mesh-ancestor
19459079|NCT03364088|Oxycodone|oxycodone|mesh-list
19459080|NCT03364088|Anesthetics|anesthetics|mesh-list
19459081|NCT03364088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19459082|NCT03364088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459083|NCT03364088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19459084|NCT03364088|Narcotics|narcotics|mesh-ancestor
19459085|NCT03364088|Analgesics|analgesics|mesh-ancestor
19459086|NCT03364088|Sensory System Agents|sensory system agents|mesh-ancestor
19459087|NCT03364088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19459088|NCT03364075|Propranolol|propranolol|mesh-list
19459089|NCT03364075|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19459090|NCT03364075|Serotonin|serotonin|mesh-list
19459091|NCT03364075|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19459092|NCT03364075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19459093|NCT03364075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19459094|NCT03364075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459095|NCT03364075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19459096|NCT03364075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459097|NCT03364075|Analgesics|analgesics|mesh-ancestor
19459098|NCT03364075|Sensory System Agents|sensory system agents|mesh-ancestor
19459099|NCT03364075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19459100|NCT03364075|Antidepressive Agents|antidepressive agents|mesh-ancestor
19459101|NCT03364075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19459102|NCT03364075|Dopamine Agents|dopamine agents|mesh-ancestor
19459103|NCT03364075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19459104|NCT03364075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19459105|NCT03364075|Adrenergic Agents|adrenergic agents|mesh-ancestor
19459106|NCT03364075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19459107|NCT03364075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19459108|NCT03364075|Vasodilator Agents|vasodilator agents|mesh-ancestor
19459109|NCT03364075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19459110|NCT03364075|Serotonin Agents|serotonin agents|mesh-ancestor
19459111|NCT03363984|Midazolam|midazolam|mesh-list
19459112|NCT03363984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19459113|NCT03363984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19459114|NCT03363984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19459115|NCT03363984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459116|NCT03363984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19459117|NCT03363984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19459118|NCT03363984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19459119|NCT03363984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19459120|NCT03363984|Anesthetics, General|anesthetics, general|mesh-ancestor
19459121|NCT03363984|Anesthetics|anesthetics|mesh-ancestor
19459122|NCT03363984|GABA Modulators|gaba modulators|mesh-ancestor
19459123|NCT03363984|GABA Agents|gaba agents|mesh-ancestor
19459124|NCT03363984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19459125|NCT03363984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459126|NCT03363867|Bevacizumab|bevacizumab|mesh-list
19459127|NCT03363867|Atezolizumab|atezolizumab|mesh-list
19459128|NCT03363867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19459129|NCT03363867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459130|NCT03363867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19459131|NCT03363867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19459132|NCT03363867|Growth Substances|growth substances|mesh-ancestor
19459133|NCT03363867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459134|NCT03363867|Growth Inhibitors|growth inhibitors|mesh-ancestor
19459135|NCT03363841|Ibrexafungerp|ibrexafungerp|mesh-list
19459136|NCT03363841|Antifungal Agents|antifungal agents|mesh-ancestor
19459137|NCT03363841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19459138|NCT03363815|Vitamin K|vitamin k|mesh-list
19459139|NCT03363815|Metformin|metformin|mesh-list
19459140|NCT03363815|Nintedanib|nintedanib|mesh-list
19459141|NCT03363815|Digoxin|digoxin|mesh-list
19459142|NCT03363815|Midazolam|midazolam|mesh-list
19459143|NCT03363815|Omeprazole|omeprazole|mesh-list
19459144|NCT03363815|Warfarin|warfarin|mesh-list
19459145|NCT03363815|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19459146|NCT03363815|Vitamins|vitamins|mesh-ancestor
19459147|NCT03363815|Micronutrients|micronutrients|mesh-ancestor
19459148|NCT03363815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459149|NCT03363815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19459150|NCT03363815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19459151|NCT03363815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19459152|NCT03363815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19459153|NCT03363815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19459154|NCT03363815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19459155|NCT03363815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19459156|NCT03363815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19459157|NCT03363815|Anesthetics, General|anesthetics, general|mesh-ancestor
19459158|NCT03363815|Anesthetics|anesthetics|mesh-ancestor
19459159|NCT03363815|GABA Modulators|gaba modulators|mesh-ancestor
19459160|NCT03363815|GABA Agents|gaba agents|mesh-ancestor
19459161|NCT03363815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19459162|NCT03363815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459163|NCT03363815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19459164|NCT03363815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19459165|NCT03363815|Antimetabolites|antimetabolites|mesh-ancestor
19459166|NCT03363815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19459167|NCT03363815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19459168|NCT03363815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459169|NCT03363815|Anticoagulants|anticoagulants|mesh-ancestor
19459170|NCT03363815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19459171|NCT03363815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19459172|NCT03363815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19459173|NCT03363815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19459174|NCT03363815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19459175|NCT03363815|Protective Agents|protective agents|mesh-ancestor
19459176|NCT03363815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19459177|NCT03363815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19459178|NCT03363815|Hemostatics|hemostatics|mesh-ancestor
19459179|NCT03363815|Coagulants|coagulants|mesh-ancestor
19459180|NCT03363815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459181|NCT03363815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19459182|NCT03363659|Copper|copper|mesh-list
19459183|NCT03363659|Temozolomide|temozolomide|mesh-list
19459184|NCT03363659|Disulfiram|disulfiram|mesh-list
19459185|NCT03363659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19459186|NCT03363659|Alkylating Agents|alkylating agents|mesh-ancestor
19459187|NCT03363659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459188|NCT03363659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459189|NCT03363659|Trace Elements|trace elements|mesh-ancestor
19459190|NCT03363659|Micronutrients|micronutrients|mesh-ancestor
19459191|NCT03363659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459192|NCT03363659|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19459193|NCT03363659|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19459194|NCT03363659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459195|NCT03363477|Enoxaparin|enoxaparin|mesh-list
19459196|NCT03363477|Enoxaparin sodium|enoxaparin sodium|mesh-list
19459197|NCT03363477|Anticoagulants|anticoagulants|mesh-ancestor
19459198|NCT03363477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19459199|NCT03363477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19459200|NCT03363477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459201|NCT03363451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19459202|NCT03363451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19459203|NCT03363425|Lidocaine|lidocaine|mesh-list
19459204|NCT03363425|Dexmedetomidine|dexmedetomidine|mesh-list
19459205|NCT03363425|Anesthetics, Local|anesthetics, local|mesh-ancestor
19459206|NCT03363425|Anesthetics|anesthetics|mesh-ancestor
19459207|NCT03363425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19459208|NCT03363425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459209|NCT03363425|Sensory System Agents|sensory system agents|mesh-ancestor
19459210|NCT03363425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19459211|NCT03363425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19459212|NCT03363425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19459213|NCT03363425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19459214|NCT03363425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19459215|NCT03363425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459216|NCT03363425|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19459217|NCT03363425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19459218|NCT03363425|Analgesics|analgesics|mesh-ancestor
19459219|NCT03363425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19459220|NCT03363425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19459221|NCT03363425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19459222|NCT03363425|Adrenergic Agents|adrenergic agents|mesh-ancestor
19459223|NCT03363425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19459224|NCT03363295|Moxifloxacin|moxifloxacin|mesh-list
19459225|NCT03363295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19459226|NCT03363295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19459227|NCT03363295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19459228|NCT03363295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19459229|NCT03363295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459230|NCT03363295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459231|NCT03363295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459232|NCT03363204|Salicylic Acid|salicylic acid|mesh-list
19459233|NCT03363204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19459234|NCT03363204|Antifungal Agents|antifungal agents|mesh-ancestor
19459235|NCT03363204|Keratolytic Agents|keratolytic agents|mesh-ancestor
19459236|NCT03363204|Dermatologic Agents|dermatologic agents|mesh-ancestor
19459237|NCT03363191|Fluticasone|fluticasone|mesh-list
19459238|NCT03363191|Xhance|xhance|mesh-list
19459239|NCT03363191|Albuterol|albuterol|mesh-list
19459240|NCT03363191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19459241|NCT03363191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19459242|NCT03363191|Autonomic Agents|autonomic agents|mesh-ancestor
19459243|NCT03363191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19459244|NCT03363191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459245|NCT03363191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19459246|NCT03363191|Respiratory System Agents|respiratory system agents|mesh-ancestor
19459247|NCT03363191|Dermatologic Agents|dermatologic agents|mesh-ancestor
19459248|NCT03363191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19459249|NCT03363191|Tocolytic Agents|tocolytic agents|mesh-ancestor
19459250|NCT03363191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19459251|NCT03363191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19459252|NCT03363191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19459253|NCT03363191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19459254|NCT03363191|Adrenergic Agents|adrenergic agents|mesh-ancestor
19459255|NCT03363191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19459256|NCT03363191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737584|NCT04367688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737585|NCT04367688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19737586|NCT04367688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19737587|NCT04366830|Remestemcel-l|remestemcel-l|mesh-list
19737588|NCT04366830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19737589|NCT04366830|Antiviral Agents|antiviral agents|mesh-ancestor
19737590|NCT04366830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19984669|NCT01950819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19984670|NCT01950819|Glucocorticoids|glucocorticoids|mesh-ancestor
19984671|NCT01950819|Hormones|hormones|mesh-ancestor
19984672|NCT01950819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19984673|NCT01950819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984674|NCT01950819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19984675|NCT01950819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984676|NCT01950819|Antiemetics|antiemetics|mesh-ancestor
19984677|NCT01950819|Autonomic Agents|autonomic agents|mesh-ancestor
19984678|NCT01950819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19984679|NCT01950819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19984680|NCT01950819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19984681|NCT01950819|Protective Agents|protective agents|mesh-ancestor
19984682|NCT01950819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19984683|NCT01950819|Immunologic Factors|immunologic factors|mesh-ancestor
19984684|NCT01950819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19984685|NCT01950819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984686|NCT01950819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984687|NCT01950819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19984688|NCT01950819|Antifungal Agents|antifungal agents|mesh-ancestor
19984689|NCT01950819|Dermatologic Agents|dermatologic agents|mesh-ancestor
19984690|NCT01950819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19984691|NCT01951066|Dexamethasone|dexamethasone|mesh-list
19984692|NCT01951066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19984693|NCT01951066|Antiemetics|antiemetics|mesh-ancestor
19984694|NCT01951066|Autonomic Agents|autonomic agents|mesh-ancestor
19984695|NCT01951066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19984696|NCT01951066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459257|NCT03363113|Botulinum Toxins|botulinum toxins|mesh-list
19459258|NCT03363113|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19459259|NCT03363113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19459260|NCT03363113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459261|NCT03363113|Cholinergic Agents|cholinergic agents|mesh-ancestor
19459262|NCT03363113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19459263|NCT03363113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459264|NCT03362905|Lidocaine|lidocaine|mesh-list
19459265|NCT03362905|Anesthetics, Local|anesthetics, local|mesh-ancestor
19459266|NCT03362905|Anesthetics|anesthetics|mesh-ancestor
19459267|NCT03362905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19459268|NCT03362905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459269|NCT03362905|Sensory System Agents|sensory system agents|mesh-ancestor
19459270|NCT03362905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19459271|NCT03362905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19459272|NCT03362905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19459273|NCT03362905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19459274|NCT03362905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19459275|NCT03362905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459276|NCT03362853|Moxifloxacin|moxifloxacin|mesh-list
19459277|NCT03362853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19459278|NCT03362853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19459279|NCT03362853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19459280|NCT03362853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19459281|NCT03362853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459282|NCT03362853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459283|NCT03362853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459284|NCT03362814|Ritonavir|ritonavir|mesh-list
19459285|NCT03362814|Ribavirin|ribavirin|mesh-list
19459286|NCT03362814|Lactams|lactams|mesh-list
19459287|NCT03362814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19459288|NCT03362814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19459289|NCT03362814|Protease Inhibitors|protease inhibitors|mesh-ancestor
19459290|NCT03362814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459291|NCT03362814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459292|NCT03362814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19459293|NCT03362814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19459294|NCT03362814|Antiviral Agents|antiviral agents|mesh-ancestor
19459295|NCT03362814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19459296|NCT03362814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19459297|NCT03362814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19459298|NCT03362814|Antimetabolites|antimetabolites|mesh-ancestor
19459299|NCT03362814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19459300|NCT03362788|Vitamin K|vitamin k|mesh-list
19459301|NCT03362788|Anticoagulants|anticoagulants|mesh-list
19459302|NCT03362788|Vitamins|vitamins|mesh-ancestor
19459303|NCT03362788|Micronutrients|micronutrients|mesh-ancestor
19459304|NCT03362788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459305|NCT03362788|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19459306|NCT03362788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19459307|NCT03362788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459308|NCT03362788|Hemostatics|hemostatics|mesh-ancestor
19459309|NCT03362788|Coagulants|coagulants|mesh-ancestor
19459310|NCT03362775|Propofol|propofol|mesh-list
19459311|NCT03362775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19459312|NCT03362775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19459313|NCT03362775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459314|NCT03362775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19459315|NCT03362775|Anesthetics, General|anesthetics, general|mesh-ancestor
19459316|NCT03362775|Anesthetics|anesthetics|mesh-ancestor
19459317|NCT03362736|Ustekinumab|ustekinumab|mesh-list
19459318|NCT03362736|Dermatologic Agents|dermatologic agents|mesh-ancestor
19459319|NCT03362697|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19459320|NCT03362697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19459321|NCT03362684|Cetuximab|cetuximab|mesh-list
19459322|NCT03362684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19459323|NCT03362684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459324|NCT03362632|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19459325|NCT03362632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19459326|NCT03362515|Furosemide|furosemide|mesh-list
19459327|NCT03362515|Diuretics|diuretics|mesh-ancestor
19459328|NCT03362515|Natriuretic Agents|natriuretic agents|mesh-ancestor
19459329|NCT03362515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459330|NCT03362515|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19459331|NCT03362515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19459332|NCT03362515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459333|NCT03362411|Linrodostat|linrodostat|mesh-list
19459334|NCT03362411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459335|NCT03362411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459336|NCT03362359|Edetic Acid|edetic acid|mesh-list
19459337|NCT03362359|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19459338|NCT03362359|Chelating Agents|chelating agents|mesh-ancestor
19459339|NCT03362359|Sequestering Agents|sequestering agents|mesh-ancestor
19459340|NCT03362359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459341|NCT03362359|Anticoagulants|anticoagulants|mesh-ancestor
19459342|NCT03362359|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19459343|NCT03362359|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19459344|NCT03362281|Amoxicillin|amoxicillin|mesh-list
19459345|NCT03362281|Clarithromycin|clarithromycin|mesh-list
19459346|NCT03362281|Omeprazole|omeprazole|mesh-list
19459347|NCT03362281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19459348|NCT03362281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19459349|NCT03362281|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19459350|NCT03362281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19459351|NCT03362281|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19459352|NCT03362281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459353|NCT03362281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459354|NCT03362281|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19459355|NCT03362281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19459356|NCT03362281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19459357|NCT03362268|Omeprazole|omeprazole|mesh-list
19459358|NCT03362268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19459359|NCT03362268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19459360|NCT03362268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19459361|NCT03362268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459362|NCT03362268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459363|NCT03362216|Diclofenac|diclofenac|mesh-list
19459364|NCT03362216|Salicylates|salicylates|mesh-list
19459365|NCT03362216|Methyl salicylate|methyl salicylate|mesh-list
19459366|NCT03362216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19459367|NCT03362216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19459368|NCT03362216|Analgesics|analgesics|mesh-ancestor
19459369|NCT03362216|Sensory System Agents|sensory system agents|mesh-ancestor
19459370|NCT03362216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19459371|NCT03362216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459372|NCT03362216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19459373|NCT03362216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19459374|NCT03362216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19459375|NCT03362216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459376|NCT03362216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459377|NCT03362073|Ketamine|ketamine|mesh-list
19459378|NCT03362073|Analgesics|analgesics|mesh-ancestor
19459379|NCT03362073|Sensory System Agents|sensory system agents|mesh-ancestor
19459380|NCT03362073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19459381|NCT03362073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459382|NCT03362073|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19459383|NCT03362073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19459384|NCT03362073|Anesthetics, General|anesthetics, general|mesh-ancestor
19459385|NCT03362073|Anesthetics|anesthetics|mesh-ancestor
19459386|NCT03362073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19459387|NCT03362073|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19459388|NCT03362073|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19459389|NCT03362073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19459390|NCT03362073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459391|NCT03362060|Pembrolizumab|pembrolizumab|mesh-list
19459392|NCT03362060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19459393|NCT03362060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459394|NCT03362047|Macitentan|macitentan|mesh-list
19459395|NCT03362047|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19459396|NCT03362047|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19459397|NCT03362047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459398|NCT03362047|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19459399|NCT03362008|Varenicline|varenicline|mesh-list
19459400|NCT03362008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19459401|NCT03362008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19459402|NCT03362008|Cholinergic Agents|cholinergic agents|mesh-ancestor
19459403|NCT03362008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19984697|NCT01951066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19984698|NCT01951066|Glucocorticoids|glucocorticoids|mesh-ancestor
19459404|NCT03362008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459405|NCT03362008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459406|NCT03361878|Metformin|metformin|mesh-list
19459407|NCT03361878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19459408|NCT03361878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737591|NCT04365725|Remdesivir|remdesivir|mesh-list
19737592|NCT04365725|Antimetabolites|antimetabolites|mesh-ancestor
19737593|NCT04365725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737594|NCT04365725|Antiviral Agents|antiviral agents|mesh-ancestor
19737595|NCT04365725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19737596|NCT04358588|Nitric Oxide|nitric oxide|mesh-list
19737597|NCT04358588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19737598|NCT04358588|Autonomic Agents|autonomic agents|mesh-ancestor
19737599|NCT04358588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19737600|NCT04358588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737601|NCT04358588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19737602|NCT04358588|Respiratory System Agents|respiratory system agents|mesh-ancestor
19737603|NCT04358588|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19737604|NCT04358588|Antioxidants|antioxidants|mesh-ancestor
19737605|NCT04358588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737606|NCT04358588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19737607|NCT04358588|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19737608|NCT04358588|Vasodilator Agents|vasodilator agents|mesh-ancestor
19737609|NCT04358588|Gasotransmitters|gasotransmitters|mesh-ancestor
19737610|NCT04358588|Protective Agents|protective agents|mesh-ancestor
19737611|NCT04350021|Cyclophosphamide|cyclophosphamide|mesh-list
19737612|NCT04350021|Capecitabine|capecitabine|mesh-list
19737613|NCT04350021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19737614|NCT04350021|Immunologic Factors|immunologic factors|mesh-ancestor
19737615|NCT04350021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737616|NCT04350021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19737617|NCT04350021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19737618|NCT04350021|Alkylating Agents|alkylating agents|mesh-ancestor
19737619|NCT04350021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737620|NCT04350021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737621|NCT04350021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19737622|NCT04350021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19737623|NCT04350021|Antimetabolites|antimetabolites|mesh-ancestor
19737624|NCT04348448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19737625|NCT04348448|Immunologic Factors|immunologic factors|mesh-ancestor
19737626|NCT04348448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984699|NCT01951066|Hormones|hormones|mesh-ancestor
19984700|NCT01951066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19984701|NCT01951066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19984702|NCT01951066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984703|NCT01951105|Naproxen|naproxen|mesh-list
19984704|NCT01951105|Levodopa|levodopa|mesh-list
19984705|NCT01951105|Carbidopa|carbidopa|mesh-list
19984706|NCT01951105|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19984707|NCT01951105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19984708|NCT01951105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19984709|NCT01951105|Analgesics|analgesics|mesh-ancestor
19984710|NCT01951105|Sensory System Agents|sensory system agents|mesh-ancestor
19984711|NCT01951105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19984712|NCT01951105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984713|NCT01951105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19984714|NCT01951105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19984715|NCT01951105|Gout Suppressants|gout suppressants|mesh-ancestor
19984716|NCT01951105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19984717|NCT01951105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984718|NCT01951105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984719|NCT01951105|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19984720|NCT01951105|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19984721|NCT01951105|Dopamine Agents|dopamine agents|mesh-ancestor
19984722|NCT01951105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19984723|NCT01951105|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19984724|NCT01951105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19984725|NCT01951105|Immunologic Factors|immunologic factors|mesh-ancestor
19984726|NCT01951105|Dopamine Agonists|dopamine agonists|mesh-ancestor
19984727|NCT01951118|Donepezil|donepezil|mesh-list
19984728|NCT01951118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19459409|NCT03361800|Entinostat|entinostat|mesh-list
19459410|NCT03361800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459411|NCT03361800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19459412|NCT03361800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459413|NCT03361800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459414|NCT03361774|Fluorides|fluorides|mesh-list
19459415|NCT03361774|Cariostatic Agents|cariostatic agents|mesh-ancestor
19459416|NCT03361774|Protective Agents|protective agents|mesh-ancestor
19459417|NCT03361774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459418|NCT03361735|Leuprolide|leuprolide|mesh-list
19459419|NCT03361735|Goserelin|goserelin|mesh-list
19459420|NCT03361735|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19459421|NCT03361735|Hormones|hormones|mesh-list
19459422|NCT03361735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19459423|NCT03361735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459424|NCT03361735|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19459425|NCT03361735|Fertility Agents|fertility agents|mesh-ancestor
19459426|NCT03361735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19459427|NCT03361735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19459428|NCT03361735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459429|NCT03361709|Dexamethasone|dexamethasone|mesh-list
19459430|NCT03361709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19459431|NCT03361709|Antiemetics|antiemetics|mesh-ancestor
19459432|NCT03361709|Autonomic Agents|autonomic agents|mesh-ancestor
19459433|NCT03361709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19459434|NCT03361709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459435|NCT03361709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19459436|NCT03361709|Glucocorticoids|glucocorticoids|mesh-ancestor
19459437|NCT03361709|Hormones|hormones|mesh-ancestor
19459438|NCT03361709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19459439|NCT03361709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19459440|NCT03361709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459441|NCT03361618|Zinc Sulfate|zinc sulfate|mesh-list
19459442|NCT03361618|Astringents|astringents|mesh-ancestor
19459443|NCT03361618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459444|NCT03361618|Dermatologic Agents|dermatologic agents|mesh-ancestor
19737627|NCT04334837|Copper|copper|mesh-list
19737628|NCT04334837|Trace Elements|trace elements|mesh-ancestor
19737629|NCT04334837|Micronutrients|micronutrients|mesh-ancestor
19737630|NCT04334837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984729|NCT01951118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984730|NCT01951118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984731|NCT01951118|Cholinergic Agents|cholinergic agents|mesh-ancestor
19984732|NCT01951118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19984733|NCT01951118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984734|NCT01951118|Nootropic Agents|nootropic agents|mesh-ancestor
19984735|NCT01951157|Gemcitabine|gemcitabine|mesh-list
19984736|NCT01951157|Docetaxel|docetaxel|mesh-list
19984737|NCT01951157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19984738|NCT01951157|Antimetabolites|antimetabolites|mesh-ancestor
19984739|NCT01951157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984740|NCT01951157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984741|NCT01951157|Antiviral Agents|antiviral agents|mesh-ancestor
19984742|NCT01951157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19984743|NCT01951157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984744|NCT01951157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19984745|NCT01951157|Immunologic Factors|immunologic factors|mesh-ancestor
19984746|NCT01951157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984747|NCT01951157|Tubulin Modulators|tubulin modulators|mesh-ancestor
19984748|NCT01951157|Antimitotic Agents|antimitotic agents|mesh-ancestor
19984749|NCT01951157|Mitosis Modulators|mitosis modulators|mesh-ancestor
19984750|NCT01951339|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19984751|NCT01951339|Glimepiride|glimepiride|mesh-list
19984752|NCT01951339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19984753|NCT01951339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984754|NCT01951339|Incretins|incretins|mesh-ancestor
19984755|NCT01951339|Hormones|hormones|mesh-ancestor
19984756|NCT01951339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19984757|NCT01951339|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19984758|NCT01951339|Protease Inhibitors|protease inhibitors|mesh-ancestor
19984759|NCT01951339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984760|NCT01951339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984761|NCT01951339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19984762|NCT01951339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19984763|NCT01951339|Immunologic Factors|immunologic factors|mesh-ancestor
19984764|NCT01951391|Benzalkonium Compounds|benzalkonium compounds|mesh-list
19984765|NCT01951391|Triclocarban|triclocarban|mesh-list
19984766|NCT01951391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19459445|NCT03361397|Lidocaine|lidocaine|mesh-list
19459446|NCT03361397|Anesthetics, Local|anesthetics, local|mesh-ancestor
19459447|NCT03361397|Anesthetics|anesthetics|mesh-ancestor
19459448|NCT03361397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19459449|NCT03361397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459450|NCT03361397|Sensory System Agents|sensory system agents|mesh-ancestor
19459451|NCT03361397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19459452|NCT03361397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19459453|NCT03361397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19737631|NCT04327752|Dermatologic Agents|dermatologic agents|mesh-list
19737632|NCT04326023|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19737633|NCT04326023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737634|NCT04326023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737635|NCT04326023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737636|NCT04321733|Amoxicillin|amoxicillin|mesh-list
19737637|NCT04321733|Clavulanic Acid|clavulanic acid|mesh-list
19737638|NCT04321733|Clavulanic Acids|clavulanic acids|mesh-list
19737639|NCT04321733|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19737640|NCT04321733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19737641|NCT04321733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19737642|NCT04321733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19737643|NCT04321733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737644|NCT04321733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737645|NCT04319341|Autoantibodies|autoantibodies|mesh-list
19737646|NCT04319341|Immunologic Factors|immunologic factors|mesh-ancestor
19737647|NCT04319341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737648|NCT04318405|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19737649|NCT04318405|Hematinics|hematinics|mesh-ancestor
19737650|NCT04314336|Coal Tar|coal tar|mesh-list
19737651|NCT04314336|Keratolytic Agents|keratolytic agents|mesh-ancestor
19737652|NCT04314336|Dermatologic Agents|dermatologic agents|mesh-ancestor
19737653|NCT04312555|Alprostadil|alprostadil|mesh-list
19737654|NCT04312555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19737655|NCT04312555|Vasodilator Agents|vasodilator agents|mesh-ancestor
19737656|NCT04312555|Urological Agents|urological agents|mesh-ancestor
19737657|NCT04310631|Ranibizumab|ranibizumab|mesh-list
19737658|NCT04310631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19737659|NCT04310631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19737660|NCT04310631|Growth Substances|growth substances|mesh-ancestor
19737661|NCT04310631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737662|NCT04310631|Growth Inhibitors|growth inhibitors|mesh-ancestor
19737663|NCT04310631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984767|NCT01951391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19984768|NCT01951417|Adapalene|adapalene|mesh-list
19984769|NCT01951417|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19984770|NCT01951417|Dermatologic Agents|dermatologic agents|mesh-ancestor
19984771|NCT01951417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19984772|NCT01951417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19984773|NCT01951417|Analgesics|analgesics|mesh-ancestor
19984774|NCT01951417|Sensory System Agents|sensory system agents|mesh-ancestor
19984775|NCT01951417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19984776|NCT01951417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984777|NCT01951417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19984778|NCT01951417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19984779|NCT01951586|Zoledronic Acid|zoledronic acid|mesh-list
19984780|NCT01951586|Denosumab|denosumab|mesh-list
19984781|NCT01951586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19984782|NCT01951586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984783|NCT01951651|Exenatide|exenatide|mesh-list
19984784|NCT01951651|Glipizide|glipizide|mesh-list
19984785|NCT01951651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19984786|NCT01951651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984787|NCT01951651|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19984788|NCT01951651|Incretins|incretins|mesh-ancestor
19984789|NCT01951651|Hormones|hormones|mesh-ancestor
19984790|NCT01951651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20289111|NCT04989283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20289112|NCT04989283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20289113|NCT04989283|Immunologic Factors|immunologic factors|mesh-ancestor
20289114|NCT04989283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289115|NCT04989283|Keratolytic Agents|keratolytic agents|mesh-ancestor
20289116|NCT04989283|Dermatologic Agents|dermatologic agents|mesh-ancestor
20289117|NCT04980495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20289118|NCT04958538|Methotrexate|methotrexate|mesh-list
20289119|NCT04958538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20289120|NCT04958538|Abortifacient Agents|abortifacient agents|mesh-ancestor
19737664|NCT04302012|Mydriatics|mydriatics|mesh-list
19737665|NCT04302012|Autonomic Agents|autonomic agents|mesh-ancestor
19737666|NCT04302012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19984791|NCT01951768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19984792|NCT01951768|Gentamicins|gentamicins|mesh-list
19984793|NCT01951768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19984794|NCT01951768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19984795|NCT01951768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984796|NCT01951768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984797|NCT01951820|Lidocaine|lidocaine|mesh-list
19984798|NCT01951820|Tetracaine|tetracaine|mesh-list
19984799|NCT01951820|Carticaine|carticaine|mesh-list
19984800|NCT01951820|Benzocaine|benzocaine|mesh-list
19984801|NCT01951820|Anesthetics, Local|anesthetics, local|mesh-ancestor
19984802|NCT01951820|Anesthetics|anesthetics|mesh-ancestor
19984803|NCT01951820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19984804|NCT01951820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984805|NCT01951820|Sensory System Agents|sensory system agents|mesh-ancestor
19984806|NCT01951820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19984807|NCT01951820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19984808|NCT01951820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19984809|NCT01951820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19984810|NCT01951820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19984811|NCT01951820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984812|NCT01951950|Nicardipine|nicardipine|mesh-list
19984813|NCT01951950|Esmolol|esmolol|mesh-list
19984814|NCT01951950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19984815|NCT01951950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19984816|NCT01951950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19984817|NCT01951950|Adrenergic Agents|adrenergic agents|mesh-ancestor
19984818|NCT01951950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19984819|NCT01951950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984820|NCT01951950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984821|NCT01951950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19984822|NCT01951950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19984823|NCT01951950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19984824|NCT01951950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19984825|NCT01951950|Vasodilator Agents|vasodilator agents|mesh-ancestor
19984826|NCT01951963|Ketamine|ketamine|mesh-list
19984827|NCT01951963|Morphine|morphine|mesh-list
19984828|NCT01951963|Analgesics|analgesics|mesh-ancestor
19984829|NCT01951963|Sensory System Agents|sensory system agents|mesh-ancestor
19984830|NCT01951963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19984831|NCT01951963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984832|NCT01951963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19984833|NCT01951963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19459454|NCT03361397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19459455|NCT03361397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19459456|NCT03361397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459457|NCT03361319|Paclitaxel|paclitaxel|mesh-list
19459458|NCT03361319|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19459459|NCT03361319|Nintedanib|nintedanib|mesh-list
19459460|NCT03361319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19459461|NCT03361319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459462|NCT03361319|Tubulin Modulators|tubulin modulators|mesh-ancestor
19459463|NCT03361319|Antimitotic Agents|antimitotic agents|mesh-ancestor
19459464|NCT03361319|Mitosis Modulators|mitosis modulators|mesh-ancestor
19459465|NCT03361319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459466|NCT03361319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19459467|NCT03361319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459468|NCT03361280|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19459469|NCT03361280|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19459470|NCT03361280|Adrenergic Agents|adrenergic agents|mesh-ancestor
19459471|NCT03361280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19459472|NCT03361280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459473|NCT03361280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459474|NCT03361163|Bromoacetylalprenololmenthane|bromoacetylalprenololmenthane|mesh-list
19737667|NCT04302012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737668|NCT04296253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19737669|NCT04296253|Mitogens|mitogens|mesh-list
19737670|NCT04296253|Mitosis Modulators|mitosis modulators|mesh-ancestor
19737671|NCT04296253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737672|NCT04288713|Eculizumab|eculizumab|mesh-list
19737673|NCT04288713|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19737674|NCT04288713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19737675|NCT04288713|Immunologic Factors|immunologic factors|mesh-ancestor
19737676|NCT04288713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737677|NCT04286230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19737678|NCT04286230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19737679|NCT04286230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19737680|NCT04286230|Antitubercular Agents|antitubercular agents|mesh-ancestor
19984834|NCT01951963|Anesthetics, General|anesthetics, general|mesh-ancestor
19984835|NCT01951963|Anesthetics|anesthetics|mesh-ancestor
19984836|NCT01951963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19984837|NCT01951963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19984838|NCT01951963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19984839|NCT01951963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19984840|NCT01951963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984841|NCT01951963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19984842|NCT01951963|Narcotics|narcotics|mesh-ancestor
19984843|NCT01952054|Denosumab|denosumab|mesh-list
19984844|NCT01952054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19984845|NCT01952054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984846|NCT01952080|Teduglutide|teduglutide|mesh-list
19984847|NCT01952080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19984848|NCT01952080|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19984849|NCT01952080|Protective Agents|protective agents|mesh-ancestor
19984850|NCT01952080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984851|NCT01952145|Insulin|insulin|mesh-list
19984852|NCT01952145|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19984853|NCT01952145|Insulin Glargine|insulin glargine|mesh-list
19984854|NCT01952145|Liraglutide|liraglutide|mesh-list
19984855|NCT01952145|Xultophy|xultophy|mesh-list
19984856|NCT01952145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19984857|NCT01952145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984858|NCT01952145|Incretins|incretins|mesh-ancestor
19984859|NCT01952145|Hormones|hormones|mesh-ancestor
19984860|NCT01952145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19984861|NCT01952444|Ciprofloxacin|ciprofloxacin|mesh-list
19984862|NCT01952444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19984863|NCT01952444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19984864|NCT01952444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19984865|NCT01952444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19984866|NCT01952444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984867|NCT01952444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984868|NCT01952444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984869|NCT01952444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19984870|NCT01952444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19984871|NCT01952834|Vancomycin|vancomycin|mesh-list
19984872|NCT01952834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19984873|NCT01952834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19984874|NCT01953003|Capecitabine|capecitabine|mesh-list
19984875|NCT01953003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19984876|NCT01953003|Antimetabolites|antimetabolites|mesh-ancestor
19984877|NCT01953003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984878|NCT01953003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984879|NCT01953081|Metoclopramide|metoclopramide|mesh-list
19984880|NCT01953081|Antiemetics|antiemetics|mesh-ancestor
19984881|NCT01953081|Autonomic Agents|autonomic agents|mesh-ancestor
19984882|NCT01953081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19984883|NCT01953081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984884|NCT01953081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19984885|NCT01953081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19984886|NCT01953081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19984887|NCT01953081|Dopamine Agents|dopamine agents|mesh-ancestor
19984888|NCT01953081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19984889|NCT01953081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984890|NCT01953211|Contraceptive Agents|contraceptive agents|mesh-list
19984891|NCT01953211|Norinyl|norinyl|mesh-list
19984892|NCT01953211|Contraceptives, Oral|contraceptives, oral|mesh-list
19984893|NCT01953211|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19984894|NCT01953211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19984895|NCT01953211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984896|NCT01953211|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19984897|NCT01953211|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19984898|NCT01953211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19737681|NCT04267601|Anagliptin|anagliptin|mesh-list
19737682|NCT04267601|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19737683|NCT04267601|Protease Inhibitors|protease inhibitors|mesh-ancestor
19737684|NCT04267601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737685|NCT04267601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737686|NCT04267601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19737687|NCT04267601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984899|NCT01953328|Atorvastatin|atorvastatin|mesh-list
19984900|NCT01953328|Evolocumab|evolocumab|mesh-list
19984901|NCT01953328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19984902|NCT01953328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19984903|NCT01953328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19984904|NCT01953328|Antimetabolites|antimetabolites|mesh-ancestor
19984905|NCT01953328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984906|NCT01953328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19984907|NCT01953328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19984908|NCT01953328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984909|NCT01953328|Immunologic Factors|immunologic factors|mesh-ancestor
19984910|NCT01953328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984911|NCT01953432|Doxazosin|doxazosin|mesh-list
19984912|NCT01953432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19984913|NCT01953432|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19984914|NCT01953432|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19984915|NCT01953432|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19984916|NCT01953432|Adrenergic Agents|adrenergic agents|mesh-ancestor
19984917|NCT01953432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19984918|NCT01953432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984919|NCT01953432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984920|NCT01953692|Pembrolizumab|pembrolizumab|mesh-list
19984921|NCT01953692|Lenalidomide|lenalidomide|mesh-list
19984922|NCT01953692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19984923|NCT01953692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984924|NCT01953692|Immunologic Factors|immunologic factors|mesh-ancestor
19984925|NCT01953692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984926|NCT01953692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19984927|NCT01953692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19984928|NCT01953692|Growth Substances|growth substances|mesh-ancestor
19984929|NCT01953692|Growth Inhibitors|growth inhibitors|mesh-ancestor
19984930|NCT01953783|Ixazomib|ixazomib|mesh-list
19984931|NCT01953783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984932|NCT01953783|Protease Inhibitors|protease inhibitors|mesh-ancestor
19984933|NCT01953783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984934|NCT01953783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984935|NCT01953913|Afatinib|afatinib|mesh-list
19984936|NCT01953913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984937|NCT01953913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19984938|NCT01953913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19984939|NCT01953913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984940|NCT01954056|Hydrocortisone|hydrocortisone|mesh-list
19984941|NCT01954056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19984942|NCT01954082|Inositol|inositol|mesh-list
19984943|NCT01954082|Vitamin B Complex|vitamin b complex|mesh-ancestor
19984944|NCT01954082|Vitamins|vitamins|mesh-ancestor
19984945|NCT01954082|Micronutrients|micronutrients|mesh-ancestor
19984946|NCT01954082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984947|NCT01954121|Carbamazepine|carbamazepine|mesh-list
19984948|NCT01954121|Levetiracetam|levetiracetam|mesh-list
19984949|NCT01954121|Anticonvulsants|anticonvulsants|mesh-ancestor
19984950|NCT01954121|Nootropic Agents|nootropic agents|mesh-ancestor
19984951|NCT01954121|Antimanic Agents|antimanic agents|mesh-ancestor
19984952|NCT01954121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19984953|NCT01954121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19984954|NCT01954121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984955|NCT01954121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19984956|NCT01954121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19984957|NCT01954121|Analgesics|analgesics|mesh-ancestor
19984958|NCT01954121|Sensory System Agents|sensory system agents|mesh-ancestor
19984959|NCT01954121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19984960|NCT01954121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19984961|NCT01954121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19984962|NCT01954121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984963|NCT01954121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19984964|NCT01954121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19984965|NCT01954251|Vaccines|vaccines|mesh-list
19984966|NCT01954251|Immunologic Factors|immunologic factors|mesh-ancestor
19737688|NCT04264884|Daratumumab|daratumumab|mesh-list
19737689|NCT04264884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737690|NCT04261231|Anesthetics|anesthetics|mesh-list
19737691|NCT04261231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19737692|NCT04261231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737693|NCT04260139|Metronidazole|metronidazole|mesh-list
19737694|NCT04260139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19737695|NCT04260139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19737696|NCT04260139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19737697|NCT04260139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19737698|NCT04256265|Risdiplam|risdiplam|mesh-list
19737699|NCT04256265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19737700|NCT04256265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19737701|NCT04256265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737702|NCT04253119|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19737703|NCT04253119|Antiviral Agents|antiviral agents|mesh-ancestor
19737704|NCT04253119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19984967|NCT01954251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984968|NCT01954927|Gabapentin|gabapentin|mesh-list
19984969|NCT01954927|Analgesics|analgesics|mesh-ancestor
19984970|NCT01954927|Sensory System Agents|sensory system agents|mesh-ancestor
19984971|NCT01954927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19984972|NCT01954927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984973|NCT01954927|Anticonvulsants|anticonvulsants|mesh-ancestor
19984974|NCT01954927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19984975|NCT01954927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19984976|NCT01954927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19984977|NCT01954927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19984978|NCT01954927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19984979|NCT01954927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19984980|NCT01954927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19984981|NCT01954927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19984982|NCT01954927|Antimanic Agents|antimanic agents|mesh-ancestor
19984983|NCT01955382|Artesunate|artesunate|mesh-list
19984984|NCT01955382|Amodiaquine|amodiaquine|mesh-list
19984985|NCT01955382|Charcoal|charcoal|mesh-list
19984986|NCT01955382|Antimalarials|antimalarials|mesh-ancestor
19984987|NCT01955382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19984988|NCT01955382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19984989|NCT01955382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19984990|NCT01955382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19984991|NCT01955382|Antiviral Agents|antiviral agents|mesh-ancestor
19984992|NCT01955382|Schistosomicides|schistosomicides|mesh-ancestor
19984993|NCT01955382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
19984994|NCT01955382|Anthelmintics|anthelmintics|mesh-ancestor
19984995|NCT01955382|Antidotes|antidotes|mesh-ancestor
19984996|NCT01955382|Protective Agents|protective agents|mesh-ancestor
19984997|NCT01955382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19984998|NCT01955434|Cyclophosphamide|cyclophosphamide|mesh-list
19984999|NCT01955434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19985000|NCT01955434|Immunologic Factors|immunologic factors|mesh-ancestor
19985001|NCT01955434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985002|NCT01955434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19985003|NCT01955434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19985004|NCT01955434|Alkylating Agents|alkylating agents|mesh-ancestor
19985005|NCT01955434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985006|NCT01955434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985007|NCT01955434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19985008|NCT01955629|Capecitabine|capecitabine|mesh-list
19985009|NCT01955629|Oxaliplatin|oxaliplatin|mesh-list
19985010|NCT01955629|Aflibercept|aflibercept|mesh-list
19985011|NCT01955629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19985012|NCT01955629|Antimetabolites|antimetabolites|mesh-ancestor
19985013|NCT01955629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985014|NCT01955629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459475|NCT03361163|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19459476|NCT03361163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19459477|NCT03361163|Adrenergic Agents|adrenergic agents|mesh-ancestor
19459478|NCT03361163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19459479|NCT03361163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459480|NCT03361163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459481|NCT03361163|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19459482|NCT03361163|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19459483|NCT03361124|Oxytocin|oxytocin|mesh-list
19459484|NCT03361124|Oxytocics|oxytocics|mesh-ancestor
19459485|NCT03361124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19985015|NCT01955629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19737705|NCT04240509|Tenofovir|tenofovir|mesh-list
19737706|NCT04240509|Emtricitabine|emtricitabine|mesh-list
19737707|NCT04240509|Antiviral Agents|antiviral agents|mesh-ancestor
19737708|NCT04240509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19737709|NCT04240509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19737710|NCT04240509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19737711|NCT04240509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737712|NCT04240509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737713|NCT04240509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19737714|NCT04240509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19737715|NCT04238741|Anesthetics|anesthetics|mesh-list
19737716|NCT04238741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19737717|NCT04238741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737718|NCT04233047|Fostemsavir|fostemsavir|mesh-list
19737719|NCT04233047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19737720|NCT04233047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19737721|NCT04233047|Antiviral Agents|antiviral agents|mesh-ancestor
19737722|NCT04233047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19737723|NCT04233047|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19737724|NCT04233047|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19737725|NCT04233047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737726|NCT04230707|Melatonin|melatonin|mesh-list
19737727|NCT04230707|Antioxidants|antioxidants|mesh-ancestor
19737728|NCT04230707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737729|NCT04230707|Protective Agents|protective agents|mesh-ancestor
19737730|NCT04230707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737731|NCT04230707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19737732|NCT04221568|Fentanyl|fentanyl|mesh-list
19737733|NCT04221568|Bupivacaine|bupivacaine|mesh-list
19737734|NCT04221568|Levobupivacaine|levobupivacaine|mesh-list
19737735|NCT04221568|Anesthetics, Local|anesthetics, local|mesh-ancestor
19737736|NCT04221568|Anesthetics|anesthetics|mesh-ancestor
19737737|NCT04221568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19737738|NCT04221568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737739|NCT04221568|Sensory System Agents|sensory system agents|mesh-ancestor
19737740|NCT04221568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19737741|NCT04221568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19737742|NCT04221568|Narcotics|narcotics|mesh-ancestor
19737743|NCT04221568|Analgesics|analgesics|mesh-ancestor
19737744|NCT04221568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19737745|NCT04221568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19737746|NCT04221568|Anesthetics, General|anesthetics, general|mesh-ancestor
19737747|NCT04220203|Capecitabine|capecitabine|mesh-list
19737748|NCT04220203|Trastuzumab|trastuzumab|mesh-list
19737749|NCT04220203|Tucatinib|tucatinib|mesh-list
19737750|NCT04220203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19737751|NCT04220203|Antimetabolites|antimetabolites|mesh-ancestor
19737752|NCT04220203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737753|NCT04220203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737754|NCT04220203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19737755|NCT04220203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19737756|NCT04220203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985016|NCT01955629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19985017|NCT01955629|Growth Substances|growth substances|mesh-ancestor
19985018|NCT01955629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985019|NCT01955629|Growth Inhibitors|growth inhibitors|mesh-ancestor
19985020|NCT01955707|Natalizumab|natalizumab|mesh-list
19985021|NCT01955707|Immunologic Factors|immunologic factors|mesh-ancestor
19985022|NCT01955707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985023|NCT01956123|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19985024|NCT01956123|Hormones|hormones|mesh-ancestor
19985025|NCT01956123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19985026|NCT01956123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985027|NCT01957150|Fluticasone|fluticasone|mesh-list
19985028|NCT01957150|Xhance|xhance|mesh-list
19985029|NCT01957150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19985030|NCT01957150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19985031|NCT01957150|Autonomic Agents|autonomic agents|mesh-ancestor
19985032|NCT01957150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19985033|NCT01957150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985034|NCT01957150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19985035|NCT01957150|Respiratory System Agents|respiratory system agents|mesh-ancestor
19985036|NCT01957150|Dermatologic Agents|dermatologic agents|mesh-ancestor
19985037|NCT01957150|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19985038|NCT01957202|Levocabastine|levocabastine|mesh-list
19985039|NCT01957202|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19737757|NCT04204928|Pralsetinib|pralsetinib|mesh-list
19737758|NCT04204928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737759|NCT04195009|Anesthetics|anesthetics|mesh-list
19737760|NCT04195009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19737761|NCT04195009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985040|NCT01957202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19985041|NCT01957202|Histamine Antagonists|histamine antagonists|mesh-ancestor
19985042|NCT01957202|Histamine Agents|histamine agents|mesh-ancestor
19985043|NCT01957202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19985044|NCT01957202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985045|NCT01957202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985046|NCT01957215|Indomethacin|indomethacin|mesh-list
19985047|NCT01957215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19985048|NCT01957215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19985049|NCT01957215|Analgesics|analgesics|mesh-ancestor
19985050|NCT01957215|Sensory System Agents|sensory system agents|mesh-ancestor
19985051|NCT01957215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19985052|NCT01957215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985053|NCT01957215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19985054|NCT01957215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19985055|NCT01957215|Gout Suppressants|gout suppressants|mesh-ancestor
19985056|NCT01957215|Tocolytic Agents|tocolytic agents|mesh-ancestor
19985057|NCT01957215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19985058|NCT01957215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19985059|NCT01957215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985060|NCT01957215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985061|NCT01957410|Ketamine|ketamine|mesh-list
19985062|NCT01957410|Analgesics|analgesics|mesh-ancestor
19985063|NCT01957410|Sensory System Agents|sensory system agents|mesh-ancestor
19985064|NCT01957410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19985065|NCT01957410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985066|NCT01957410|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19985067|NCT01957410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19985068|NCT01957410|Anesthetics, General|anesthetics, general|mesh-ancestor
19985069|NCT01957410|Anesthetics|anesthetics|mesh-ancestor
19985070|NCT01957410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19985071|NCT01957410|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19985072|NCT01957410|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19985073|NCT01957410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19985074|NCT01957410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985075|NCT01957644|Azacitidine|azacitidine|mesh-list
19985076|NCT01957644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19985077|NCT01957644|Antimetabolites|antimetabolites|mesh-ancestor
19985078|NCT01957644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985079|NCT01957644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985080|NCT01957644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985081|NCT01957709|Interferons|interferons|mesh-list
19985082|NCT01957709|Interferon-gamma|interferon-gamma|mesh-list
19985083|NCT01957709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985084|NCT01957709|Antiviral Agents|antiviral agents|mesh-ancestor
19985085|NCT01957709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19985086|NCT01957930|Insulin|insulin|mesh-list
19985087|NCT01957930|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19985088|NCT01957930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19985089|NCT01957930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985090|NCT01958073|Estradiol|estradiol|mesh-list
19985091|NCT01958073|Estrogens|estrogens|mesh-list
19985092|NCT01958073|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
19985093|NCT01958073|Hormones|hormones|mesh-ancestor
19985094|NCT01958073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19985095|NCT01958073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985096|NCT01958112|Trametinib|trametinib|mesh-list
19985097|NCT01958112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985098|NCT01958112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19985099|NCT01958112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985100|NCT01958112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985101|NCT01958164|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19985102|NCT01958164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19985103|NCT01958164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19985104|NCT01958164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985105|NCT01958281|Sofosbuvir|sofosbuvir|mesh-list
19985106|NCT01958281|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19985107|NCT01958281|Antiviral Agents|antiviral agents|mesh-ancestor
19985108|NCT01958281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19737762|NCT04187248|Asparaginase|asparaginase|mesh-list
19737763|NCT04187248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737764|NCT04179266|Ketamine|ketamine|mesh-list
19737765|NCT04179266|Analgesics|analgesics|mesh-ancestor
19737766|NCT04179266|Sensory System Agents|sensory system agents|mesh-ancestor
19737767|NCT04179266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19737768|NCT04179266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737769|NCT04179266|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19737770|NCT04179266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19737771|NCT04179266|Anesthetics, General|anesthetics, general|mesh-ancestor
19737772|NCT04179266|Anesthetics|anesthetics|mesh-ancestor
19737773|NCT04179266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19737774|NCT04179266|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19737775|NCT04179266|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19737776|NCT04179266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19737777|NCT04179266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737778|NCT04171128|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19737779|NCT04171128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19985109|NCT01958476|Morphine|morphine|mesh-list
19985110|NCT01958476|Methadone|methadone|mesh-list
19985111|NCT01958476|Phenobarbital|phenobarbital|mesh-list
19985112|NCT01958476|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19985113|NCT01958476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19985114|NCT01958476|Narcotics|narcotics|mesh-ancestor
19985115|NCT01958476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19985116|NCT01958476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985117|NCT01958476|Analgesics|analgesics|mesh-ancestor
19985118|NCT01958476|Sensory System Agents|sensory system agents|mesh-ancestor
19985119|NCT01958476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19985120|NCT01958476|Antitussive Agents|antitussive agents|mesh-ancestor
19985121|NCT01958476|Respiratory System Agents|respiratory system agents|mesh-ancestor
19985122|NCT01958476|Anticonvulsants|anticonvulsants|mesh-ancestor
19985123|NCT01958476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19985124|NCT01958476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19985125|NCT01958476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19985126|NCT01958476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19985127|NCT01958476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985128|NCT01958476|GABA Modulators|gaba modulators|mesh-ancestor
19985129|NCT01958476|GABA Agents|gaba agents|mesh-ancestor
19985130|NCT01958476|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19985131|NCT01958476|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19985132|NCT01958476|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19985133|NCT01958489|Pravastatin|pravastatin|mesh-list
19985134|NCT01958489|Evacetrapib|evacetrapib|mesh-list
19985135|NCT01958489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19985136|NCT01958489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19985137|NCT01958489|Antimetabolites|antimetabolites|mesh-ancestor
19985138|NCT01958489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985139|NCT01958489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19985140|NCT01958489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19985141|NCT01958489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985142|NCT01958619|Artefenomel|artefenomel|mesh-list
19985143|NCT01958619|Antimalarials|antimalarials|mesh-ancestor
19985144|NCT01958619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19985145|NCT01958619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19985146|NCT01958619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19985147|NCT01958671|Metformin|metformin|mesh-list
19985148|NCT01958671|Glimepiride|glimepiride|mesh-list
19985149|NCT01958671|Ertugliflozin|ertugliflozin|mesh-list
19985150|NCT01958671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19985151|NCT01958671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985152|NCT01958671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19985153|NCT01958671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19985154|NCT01958671|Immunologic Factors|immunologic factors|mesh-ancestor
19985155|NCT01958671|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19985156|NCT01958671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985157|NCT01958827|Adalimumab|adalimumab|mesh-list
19985158|NCT01958827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19985159|NCT01958827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19985160|NCT01958918|Ranibizumab|ranibizumab|mesh-list
19985161|NCT01958918|Aflibercept|aflibercept|mesh-list
19985162|NCT01958918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19985163|NCT01958918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19985164|NCT01958918|Growth Substances|growth substances|mesh-ancestor
19985165|NCT01958918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985166|NCT01958918|Growth Inhibitors|growth inhibitors|mesh-ancestor
19737780|NCT04163224|Imidacloprid|imidacloprid|mesh-list
19737781|NCT04163224|Cholinergic Agents|cholinergic agents|mesh-ancestor
19737782|NCT04163224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19737783|NCT04163224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737784|NCT04163224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737785|NCT04152941|Olaparib|olaparib|mesh-list
19737786|NCT04152941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19737787|NCT04152941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737788|NCT04152941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737789|NCT04152941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737790|NCT04138641|Cangrelor|cangrelor|mesh-list
19737791|NCT04138641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19737792|NCT04138641|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19737793|NCT04138641|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19737794|NCT04138641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19737795|NCT04138641|Purinergic Agents|purinergic agents|mesh-ancestor
19737796|NCT04138641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19737797|NCT04138641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737798|NCT04138641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985167|NCT01958918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985168|NCT01959035|Aripiprazole|aripiprazole|mesh-list
19985169|NCT01959035|Antidepressive Agents|antidepressive agents|mesh-ancestor
19985170|NCT01959035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19985171|NCT01959035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19985172|NCT01959035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19985173|NCT01959035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19985174|NCT01959035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985175|NCT01959035|Dopamine Agonists|dopamine agonists|mesh-ancestor
19985176|NCT01959035|Dopamine Agents|dopamine agents|mesh-ancestor
19985177|NCT01959035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19985178|NCT01959035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985179|NCT01959035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19985180|NCT01959035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19985181|NCT01959035|Serotonin Agents|serotonin agents|mesh-ancestor
19985182|NCT01959035|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19985183|NCT01959035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19985184|NCT01959035|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19985185|NCT01959035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19985186|NCT01959230|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19985187|NCT01959230|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19985188|NCT01959230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19985189|NCT01959230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19985190|NCT01959230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19985191|NCT01959230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19985192|NCT01959230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19985193|NCT01959230|Adrenergic Agents|adrenergic agents|mesh-ancestor
19985194|NCT01959230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19985195|NCT01959230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985196|NCT01959230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985197|NCT01959243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19985198|NCT01959243|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19985199|NCT01959243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19985200|NCT01959243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19985201|NCT01959243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19985202|NCT01959243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19985203|NCT01959243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19985204|NCT01959243|Adrenergic Agents|adrenergic agents|mesh-ancestor
19985205|NCT01959243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19985206|NCT01959243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985207|NCT01959243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985208|NCT01959334|Glucagon|glucagon|mesh-list
19985209|NCT01959334|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19985210|NCT01959334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19985211|NCT01959334|Hormones|hormones|mesh-ancestor
19985212|NCT01959334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19985213|NCT01959334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985214|NCT01959334|Incretins|incretins|mesh-ancestor
19985215|NCT01959490|Paclitaxel|paclitaxel|mesh-list
19985216|NCT01959490|Docetaxel|docetaxel|mesh-list
19985217|NCT01959490|Cyclophosphamide|cyclophosphamide|mesh-list
19985218|NCT01959490|Bevacizumab|bevacizumab|mesh-list
19985219|NCT01959490|Carboplatin|carboplatin|mesh-list
19985220|NCT01959490|Doxorubicin|doxorubicin|mesh-list
19459486|NCT03361124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459487|NCT03361098|Dapagliflozin|dapagliflozin|mesh-list
19459488|NCT03361098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
19459489|NCT03361098|Exenatide|exenatide|mesh-list
19737799|NCT04135092|Aldesleukin|aldesleukin|mesh-list
19737800|NCT04135092|Cyclophosphamide|cyclophosphamide|mesh-list
19737801|NCT04135092|Pembrolizumab|pembrolizumab|mesh-list
19737802|NCT04135092|Fludarabine|fludarabine|mesh-list
19737803|NCT04135092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19737804|NCT04135092|Immunologic Factors|immunologic factors|mesh-ancestor
19737805|NCT04135092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737806|NCT04135092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19737807|NCT04135092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19737808|NCT04135092|Alkylating Agents|alkylating agents|mesh-ancestor
19737809|NCT04135092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737810|NCT04135092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737811|NCT04135092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19737812|NCT04135092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19737813|NCT04135092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19737814|NCT04135092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19737815|NCT04135092|Antiviral Agents|antiviral agents|mesh-ancestor
19737816|NCT04135092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19737817|NCT04132882|Sodium thiosulfate|sodium thiosulfate|mesh-list
19737818|NCT04132882|Antidotes|antidotes|mesh-ancestor
19737819|NCT04132882|Protective Agents|protective agents|mesh-ancestor
19737820|NCT04132882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737821|NCT04132882|Antioxidants|antioxidants|mesh-ancestor
19737822|NCT04132882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737823|NCT04132882|Antitubercular Agents|antitubercular agents|mesh-ancestor
19737824|NCT04132882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19737825|NCT04132882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19737826|NCT04132882|Chelating Agents|chelating agents|mesh-ancestor
19737827|NCT04132882|Sequestering Agents|sequestering agents|mesh-ancestor
19737828|NCT04130776|Kallikreins|kallikreins|mesh-list
19737829|NCT04130776|Coagulants|coagulants|mesh-ancestor
19737830|NCT04130776|Fertility Agents, Male|fertility agents, male|mesh-ancestor
19737831|NCT04130776|Fertility Agents|fertility agents|mesh-ancestor
19737832|NCT04130776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19737833|NCT04130776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737834|NCT04124562|Nitrous Oxide|nitrous oxide|mesh-list
19737835|NCT04124562|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19737836|NCT04124562|Anesthetics, General|anesthetics, general|mesh-ancestor
19737837|NCT04124562|Anesthetics|anesthetics|mesh-ancestor
19737838|NCT04124562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19737839|NCT04124562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737840|NCT04124562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19737841|NCT04124562|Analgesics|analgesics|mesh-ancestor
19737842|NCT04124562|Sensory System Agents|sensory system agents|mesh-ancestor
19737843|NCT04124562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19737844|NCT04124133|Hyaluronic Acid|hyaluronic acid|mesh-list
19737845|NCT04124133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19737846|NCT04124133|Immunologic Factors|immunologic factors|mesh-ancestor
19737847|NCT04124133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737848|NCT04124133|Viscosupplements|viscosupplements|mesh-ancestor
19737849|NCT04124133|Protective Agents|protective agents|mesh-ancestor
19985221|NCT01959490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19459490|NCT03361098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459491|NCT03361098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19459492|NCT03361098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459493|NCT03361098|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19459494|NCT03361098|Incretins|incretins|mesh-ancestor
19459495|NCT03361098|Hormones|hormones|mesh-ancestor
19459496|NCT03361098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19459497|NCT03360981|Incretins|incretins|mesh-list
19459498|NCT03360981|Hormones|hormones|mesh-ancestor
19459499|NCT03360981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19459500|NCT03360981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459501|NCT03360955|Anesthetics|anesthetics|mesh-list
19459502|NCT03360955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19459503|NCT03360955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459504|NCT03360760|Doxorubicin|doxorubicin|mesh-list
19459505|NCT03360760|Methotrexate|methotrexate|mesh-list
19459506|NCT03360760|Ifosfamide|ifosfamide|mesh-list
19985222|NCT01959490|Trastuzumab|trastuzumab|mesh-list
19985223|NCT01959490|Pertuzumab|pertuzumab|mesh-list
19985224|NCT01959490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19737850|NCT04114500|Estradiol|estradiol|mesh-list
19737851|NCT04114500|Progesterone|progesterone|mesh-list
19737852|NCT04114500|Estrogens|estrogens|mesh-ancestor
19737853|NCT04114500|Hormones|hormones|mesh-ancestor
19737854|NCT04114500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19737855|NCT04114500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737856|NCT04114500|Progestins|progestins|mesh-ancestor
19737857|NCT04112277|Morphine|morphine|mesh-list
19737858|NCT04112277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19737859|NCT04112277|Narcotics|narcotics|mesh-ancestor
19985225|NCT01959490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985226|NCT01959490|Tubulin Modulators|tubulin modulators|mesh-ancestor
19985227|NCT01959490|Antimitotic Agents|antimitotic agents|mesh-ancestor
19985228|NCT01959490|Mitosis Modulators|mitosis modulators|mesh-ancestor
19985229|NCT01959490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985230|NCT01959490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19985231|NCT01959490|Immunologic Factors|immunologic factors|mesh-ancestor
19985232|NCT01959490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985233|NCT01959490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19985234|NCT01959490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19985235|NCT01959490|Alkylating Agents|alkylating agents|mesh-ancestor
19985236|NCT01959490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19985237|NCT01959490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19985238|NCT01959490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19985239|NCT01959490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19985240|NCT01959490|Growth Substances|growth substances|mesh-ancestor
19985241|NCT01959490|Growth Inhibitors|growth inhibitors|mesh-ancestor
19985242|NCT01959490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19985243|NCT01959490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19985244|NCT01959490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19985245|NCT01959490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985246|NCT01959503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
19985247|NCT01959503|Hemostatics|hemostatics|mesh-ancestor
19985248|NCT01959503|Coagulants|coagulants|mesh-ancestor
19985249|NCT01959516|Glycopyrrolate|glycopyrrolate|mesh-list
19985250|NCT01959516|Tiotropium Bromide|tiotropium bromide|mesh-list
19985251|NCT01959516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19985252|NCT01959516|Autonomic Agents|autonomic agents|mesh-ancestor
19985253|NCT01959516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19985254|NCT01959516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985255|NCT01959516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19985256|NCT01959516|Respiratory System Agents|respiratory system agents|mesh-ancestor
19985257|NCT01959516|Parasympatholytics|parasympatholytics|mesh-ancestor
19985258|NCT01959516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19985259|NCT01959516|Cholinergic Agents|cholinergic agents|mesh-ancestor
19985260|NCT01959516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19985261|NCT01959516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985262|NCT01959516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19985263|NCT01959516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19985264|NCT01959529|Insulin|insulin|mesh-list
19459507|NCT03360760|Isophosphamide mustard|isophosphamide mustard|mesh-list
19459508|NCT03360760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459509|NCT03360760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19459510|NCT03360760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19459511|NCT03360760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19459512|NCT03360760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459513|NCT03360760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459514|NCT03360760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19459515|NCT03360760|Abortifacient Agents|abortifacient agents|mesh-ancestor
19459516|NCT03360760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19459517|NCT03360760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737860|NCT04112277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19737861|NCT04112277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737862|NCT04112277|Analgesics|analgesics|mesh-ancestor
19737863|NCT04112277|Sensory System Agents|sensory system agents|mesh-ancestor
19737864|NCT04112277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19737865|NCT04102319|Hepcidins|hepcidins|mesh-list
19737866|NCT04102319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19985265|NCT01959529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19985266|NCT01959529|Insulin Glargine|insulin glargine|mesh-list
19985267|NCT01959529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19985268|NCT01959529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985269|NCT01959672|Calcium, Dietary|calcium, dietary|mesh-list
19985270|NCT01959672|Leucovorin|leucovorin|mesh-list
19985271|NCT01959672|Folic Acid|folic acid|mesh-list
19985272|NCT01959672|Gemcitabine|gemcitabine|mesh-list
19985273|NCT01959672|Nelfinavir|nelfinavir|mesh-list
19985274|NCT01959672|Fluorouracil|fluorouracil|mesh-list
19985275|NCT01959672|Oregovomab|oregovomab|mesh-list
19985276|NCT01959672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19985277|NCT01959672|Antibodies|antibodies|mesh-list
19985278|NCT01959672|Immunoglobulins|immunoglobulins|mesh-list
19985279|NCT01959672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19985280|NCT01959672|Calcium|calcium|mesh-list
19985281|NCT01959672|Levoleucovorin|levoleucovorin|mesh-list
19985282|NCT01959672|Immunologic Factors|immunologic factors|mesh-ancestor
19985283|NCT01959672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985284|NCT01959672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19985285|NCT01959672|Antimetabolites|antimetabolites|mesh-ancestor
19985286|NCT01959672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985287|NCT01959672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985288|NCT01959672|Antiviral Agents|antiviral agents|mesh-ancestor
19985289|NCT01959672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19985290|NCT01959672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985291|NCT01959672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19985292|NCT01959672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19985293|NCT01959672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19985294|NCT01959672|Antidotes|antidotes|mesh-ancestor
19985295|NCT01959672|Protective Agents|protective agents|mesh-ancestor
19985296|NCT01959672|Vitamin B Complex|vitamin b complex|mesh-ancestor
19985297|NCT01959672|Vitamins|vitamins|mesh-ancestor
19985298|NCT01959672|Micronutrients|micronutrients|mesh-ancestor
19985299|NCT01959672|Hematinics|hematinics|mesh-ancestor
19985300|NCT01959672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19985301|NCT01959672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19985302|NCT01959672|Protease Inhibitors|protease inhibitors|mesh-ancestor
19985303|NCT01959672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19985304|NCT01959672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19985305|NCT01959685|Enclomiphene|enclomiphene|mesh-list
19985306|NCT01959685|Clomiphene|clomiphene|mesh-list
19985307|NCT01959685|Zuclomiphene|zuclomiphene|mesh-list
19985308|NCT01959685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19985309|NCT01959685|Hormone Antagonists|hormone antagonists|mesh-ancestor
19985310|NCT01959685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19985311|NCT01959685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985312|NCT01959685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19985313|NCT01959685|Fertility Agents|fertility agents|mesh-ancestor
19985314|NCT01959685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19985315|NCT01959685|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19985316|NCT01959685|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19985317|NCT01959698|Rituximab|rituximab|mesh-list
19985318|NCT01959698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19985319|NCT01959698|Carboplatin|carboplatin|mesh-list
19985320|NCT01959698|Etoposide|etoposide|mesh-list
19985321|NCT01959698|Etoposide phosphate|etoposide phosphate|mesh-list
19985322|NCT01959698|Ifosfamide|ifosfamide|mesh-list
19985323|NCT01959698|Isophosphamide mustard|isophosphamide mustard|mesh-list
19985324|NCT01959698|Podophyllotoxin|podophyllotoxin|mesh-list
19985325|NCT01959698|Antibodies|antibodies|mesh-list
19985326|NCT01959698|Immunoglobulins|immunoglobulins|mesh-list
19985327|NCT01959698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19985328|NCT01959698|Immunologic Factors|immunologic factors|mesh-ancestor
19985329|NCT01959698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985330|NCT01959698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985331|NCT01959698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19985332|NCT01959698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19985333|NCT01959698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19985334|NCT01959698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19985335|NCT01959698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985336|NCT01959698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737867|NCT04095494|Nitrous Oxide|nitrous oxide|mesh-list
19737868|NCT04095494|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19737869|NCT04095494|Anesthetics, General|anesthetics, general|mesh-ancestor
19737870|NCT04095494|Anesthetics|anesthetics|mesh-ancestor
19737871|NCT04095494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19737872|NCT04095494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737873|NCT04095494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19737874|NCT04095494|Analgesics|analgesics|mesh-ancestor
19737875|NCT04095494|Sensory System Agents|sensory system agents|mesh-ancestor
19737876|NCT04095494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19737877|NCT04080271|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19737878|NCT04080271|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19737879|NCT04080271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985337|NCT01959698|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19985338|NCT01959698|Alkylating Agents|alkylating agents|mesh-ancestor
19985339|NCT01959698|Keratolytic Agents|keratolytic agents|mesh-ancestor
19985340|NCT01959698|Dermatologic Agents|dermatologic agents|mesh-ancestor
19985341|NCT01959698|Tubulin Modulators|tubulin modulators|mesh-ancestor
19985342|NCT01959698|Antimitotic Agents|antimitotic agents|mesh-ancestor
19985343|NCT01959698|Mitosis Modulators|mitosis modulators|mesh-ancestor
19985344|NCT01959841|Valacyclovir|valacyclovir|mesh-list
19985345|NCT01959841|Antiviral Agents|antiviral agents|mesh-ancestor
19985346|NCT01959841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19985347|NCT01959919|Factor VIII|factor viii|mesh-list
19985348|NCT01959919|Coagulants|coagulants|mesh-ancestor
19985349|NCT01959945|Vaccines|vaccines|mesh-list
19985350|NCT01959945|Hemagglutinins|hemagglutinins|mesh-list
19985351|NCT01959945|Immunologic Factors|immunologic factors|mesh-ancestor
19985352|NCT01959945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985353|NCT01959945|Agglutinins|agglutinins|mesh-ancestor
19985354|NCT01960075|Fosphenytoin|fosphenytoin|mesh-list
19985355|NCT01960075|Levetiracetam|levetiracetam|mesh-list
19985356|NCT01960075|Valproic Acid|valproic acid|mesh-list
19985357|NCT01960075|Anticonvulsants|anticonvulsants|mesh-ancestor
19985358|NCT01960075|Nootropic Agents|nootropic agents|mesh-ancestor
19985359|NCT01960075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985360|NCT01960075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985361|NCT01960075|GABA Agents|gaba agents|mesh-ancestor
19985362|NCT01960075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19985363|NCT01960075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985364|NCT01960075|Antimanic Agents|antimanic agents|mesh-ancestor
19985365|NCT01960075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19985366|NCT01960075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19985367|NCT01960075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19985368|NCT01960075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19985369|NCT01960075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19985370|NCT01960114|Acetaminophen|acetaminophen|mesh-list
19985371|NCT01960114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19985372|NCT01960114|Analgesics|analgesics|mesh-ancestor
19985373|NCT01960114|Sensory System Agents|sensory system agents|mesh-ancestor
19985374|NCT01960114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19985375|NCT01960114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985376|NCT01960114|Antipyretics|antipyretics|mesh-ancestor
19985377|NCT01960140|Simvastatin|simvastatin|mesh-list
19985378|NCT01960140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19985379|NCT01960140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19985380|NCT01960140|Antimetabolites|antimetabolites|mesh-ancestor
19985381|NCT01960140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985382|NCT01960140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19985383|NCT01960140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19985384|NCT01960140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985385|NCT01960296|Clopidogrel|clopidogrel|mesh-list
19985386|NCT01960296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19985387|NCT01960296|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19985388|NCT01960296|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19985389|NCT01960296|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19985390|NCT01960296|Purinergic Agents|purinergic agents|mesh-ancestor
19985391|NCT01960296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19985392|NCT01960296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985393|NCT01960296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985394|NCT01960387|Cytarabine|cytarabine|mesh-list
19985395|NCT01960387|Clofarabine|clofarabine|mesh-list
19985396|NCT01960387|Antimetabolites|antimetabolites|mesh-list
19985397|NCT01960387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19985398|NCT01960387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985399|NCT01960387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985400|NCT01960387|Antiviral Agents|antiviral agents|mesh-ancestor
19737880|NCT04064476|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19737881|NCT04064476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19737882|NCT04064476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19737883|NCT04064476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19737884|NCT04064476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737885|NCT04064476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19737886|NCT04064476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19737887|NCT04064476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19737888|NCT04064476|Serotonin Agents|serotonin agents|mesh-ancestor
19985401|NCT01960387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19985402|NCT01960387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19985403|NCT01960387|Immunologic Factors|immunologic factors|mesh-ancestor
19985404|NCT01960387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985405|NCT01960413|Hydroxyurea|hydroxyurea|mesh-list
19985406|NCT01960413|Montelukast|montelukast|mesh-list
19985407|NCT01960413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19985408|NCT01960413|Respiratory System Agents|respiratory system agents|mesh-ancestor
19985409|NCT01960413|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19985410|NCT01960413|Hormone Antagonists|hormone antagonists|mesh-ancestor
19985411|NCT01960413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19985412|NCT01960413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985413|NCT01960413|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19985414|NCT01960413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19985415|NCT01960413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985416|NCT01960413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985417|NCT01960413|Antisickling Agents|antisickling agents|mesh-ancestor
19985418|NCT01960413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985419|NCT01960413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19985420|NCT01960842|Levodopa|levodopa|mesh-list
19985421|NCT01960842|Carbidopa|carbidopa|mesh-list
19985422|NCT01960842|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19985423|NCT01960842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19985424|NCT01960842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19985425|NCT01960842|Dopamine Agents|dopamine agents|mesh-ancestor
19985426|NCT01960842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19985427|NCT01960842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985428|NCT01960842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985429|NCT01960842|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19985430|NCT01960842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985431|NCT01960842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19985432|NCT01960842|Immunologic Factors|immunologic factors|mesh-ancestor
19985433|NCT01960842|Dopamine Agonists|dopamine agonists|mesh-ancestor
19985434|NCT01960855|Upadacitinib|upadacitinib|mesh-list
19985435|NCT01960855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19985436|NCT01960855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19985437|NCT01960855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985438|NCT01960855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985439|NCT01960855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19985440|NCT01961271|Buprenorphine|buprenorphine|mesh-list
19985441|NCT01961271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19985442|NCT01961271|Narcotics|narcotics|mesh-ancestor
19985443|NCT01961271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19985444|NCT01961271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985445|NCT01961271|Analgesics|analgesics|mesh-ancestor
19985446|NCT01961271|Sensory System Agents|sensory system agents|mesh-ancestor
19985447|NCT01961271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19985448|NCT01961271|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19985449|NCT01961297|Sodium Oxybate|sodium oxybate|mesh-list
19985450|NCT01961297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19985451|NCT01961297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19985452|NCT01961297|Anesthetics, General|anesthetics, general|mesh-ancestor
19985453|NCT01961297|Anesthetics|anesthetics|mesh-ancestor
19985454|NCT01961297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19985455|NCT01961297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985456|NCT01961323|Nebivolol|nebivolol|mesh-list
19985457|NCT01961323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19985458|NCT01961323|Vasodilator Agents|vasodilator agents|mesh-ancestor
19985459|NCT01961323|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19985460|NCT01961323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19985461|NCT01961323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19985462|NCT01961323|Adrenergic Agents|adrenergic agents|mesh-ancestor
19985463|NCT01961323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19985464|NCT01961323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985465|NCT01961323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737889|NCT04064476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19737890|NCT04064476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737891|NCT04064476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19737892|NCT04064476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19737893|NCT04064476|Dopamine Agents|dopamine agents|mesh-ancestor
19737894|NCT04059991|Vaccines|vaccines|mesh-list
19737895|NCT04059991|Immunologic Factors|immunologic factors|mesh-ancestor
19737896|NCT04059991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985466|NCT01961349|Propofol|propofol|mesh-list
19985467|NCT01961349|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
19985468|NCT01961349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19985469|NCT01961349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19985470|NCT01961349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985471|NCT01961349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19985472|NCT01961349|Anesthetics, General|anesthetics, general|mesh-ancestor
19985473|NCT01961349|Anesthetics|anesthetics|mesh-ancestor
19985474|NCT01961349|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
19985475|NCT01961349|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19985476|NCT01961349|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19985477|NCT01962103|Paclitaxel|paclitaxel|mesh-list
19985478|NCT01962103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19985479|NCT01962103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19985480|NCT01962103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985481|NCT01962103|Tubulin Modulators|tubulin modulators|mesh-ancestor
19985482|NCT01962103|Antimitotic Agents|antimitotic agents|mesh-ancestor
19985483|NCT01962103|Mitosis Modulators|mitosis modulators|mesh-ancestor
19985484|NCT01962103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985485|NCT01962298|Rocuronium|rocuronium|mesh-list
19985486|NCT01962298|Neostigmine|neostigmine|mesh-list
19985487|NCT01962298|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19985488|NCT01962298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19985489|NCT01962298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19985490|NCT01962298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19985491|NCT01962298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985492|NCT01962298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19985493|NCT01962298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985494|NCT01962298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985495|NCT01962298|Cholinergic Agents|cholinergic agents|mesh-ancestor
19985496|NCT01962298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19985497|NCT01962298|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19985498|NCT01962298|Autonomic Agents|autonomic agents|mesh-ancestor
19985499|NCT01962428|Ticagrelor|ticagrelor|mesh-list
19985500|NCT01962428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19985501|NCT01962428|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19985502|NCT01962428|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19985503|NCT01962428|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19985504|NCT01962428|Purinergic Agents|purinergic agents|mesh-ancestor
19985505|NCT01962428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19985506|NCT01962428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985507|NCT01962428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985508|NCT01962441|Sofosbuvir|sofosbuvir|mesh-list
19985509|NCT01962441|Antiviral Agents|antiviral agents|mesh-ancestor
19985510|NCT01962441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19985511|NCT01962493|Chlorhexidine|chlorhexidine|mesh-list
19985512|NCT01962493|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19985513|NCT01962493|Listerine|listerine|mesh-list
19985514|NCT01962493|Fluorides|fluorides|mesh-list
19985515|NCT01962493|Sodium Fluoride|sodium fluoride|mesh-list
19985516|NCT01962493|Cariostatic Agents|cariostatic agents|mesh-ancestor
19985517|NCT01962493|Protective Agents|protective agents|mesh-ancestor
19985518|NCT01962493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985519|NCT01962493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19985520|NCT01962493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19985521|NCT01962493|Disinfectants|disinfectants|mesh-ancestor
19985522|NCT01962493|Dermatologic Agents|dermatologic agents|mesh-ancestor
19985523|NCT01962688|Diuretics|diuretics|mesh-list
19985524|NCT01962688|Natriuretic Agents|natriuretic agents|mesh-ancestor
19985525|NCT01962688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985526|NCT01962870|Vasopressins|vasopressins|mesh-list
19985527|NCT01962870|Arginine Vasopressin|arginine vasopressin|mesh-list
19985528|NCT01962870|Hemostatics|hemostatics|mesh-ancestor
19985529|NCT01962870|Coagulants|coagulants|mesh-ancestor
19985530|NCT01962870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19985531|NCT01962870|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19985532|NCT01962870|Natriuretic Agents|natriuretic agents|mesh-ancestor
19985533|NCT01962870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737897|NCT04045171|Tacrolimus|tacrolimus|mesh-list
19737898|NCT04045171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19737899|NCT04045171|Immunologic Factors|immunologic factors|mesh-ancestor
19737900|NCT04045171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737901|NCT04045171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19737902|NCT04045171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737903|NCT04045171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985534|NCT01962896|Sirolimus|sirolimus|mesh-list
19985535|NCT01962896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19985536|NCT01962896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985537|NCT01962896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19985538|NCT01962896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985539|NCT01962896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985540|NCT01962896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19985541|NCT01962896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19985542|NCT01962896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19985543|NCT01962896|Antifungal Agents|antifungal agents|mesh-ancestor
19985544|NCT01962896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19985545|NCT01962896|Immunologic Factors|immunologic factors|mesh-ancestor
19985546|NCT01962896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985547|NCT01962922|Tacrolimus|tacrolimus|mesh-list
19985548|NCT01962922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19985549|NCT01962922|Immunologic Factors|immunologic factors|mesh-ancestor
19985550|NCT01962922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985551|NCT01962922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19985552|NCT01962922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985553|NCT01962922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985554|NCT01962961|Acetylcysteine|acetylcysteine|mesh-list
19985555|NCT01962961|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19985556|NCT01962961|Antiviral Agents|antiviral agents|mesh-ancestor
19985557|NCT01962961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19985558|NCT01962961|Expectorants|expectorants|mesh-ancestor
19985559|NCT01962961|Respiratory System Agents|respiratory system agents|mesh-ancestor
19985560|NCT01962961|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19985561|NCT01962961|Antioxidants|antioxidants|mesh-ancestor
19985562|NCT01962961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985563|NCT01962961|Protective Agents|protective agents|mesh-ancestor
19985564|NCT01962961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985565|NCT01962961|Antidotes|antidotes|mesh-ancestor
19985566|NCT01962987|Diclofenac|diclofenac|mesh-list
19985567|NCT01962987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19985568|NCT01962987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19985569|NCT01962987|Analgesics|analgesics|mesh-ancestor
19985570|NCT01962987|Sensory System Agents|sensory system agents|mesh-ancestor
19985571|NCT01962987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19985572|NCT01962987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985573|NCT01962987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19985574|NCT01962987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19985575|NCT01962987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19985576|NCT01962987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985577|NCT01962987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985578|NCT01963078|Oxytocin|oxytocin|mesh-list
19985579|NCT01963078|Oxytocics|oxytocics|mesh-ancestor
19985580|NCT01963078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19985581|NCT01963078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985582|NCT01963091|Oxytocin|oxytocin|mesh-list
19985583|NCT01963091|Oxytocics|oxytocics|mesh-ancestor
19985584|NCT01963091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19985585|NCT01963091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985586|NCT01963143|gamma-Globulins|gamma-globulins|mesh-list
19985587|NCT01963143|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19985588|NCT01963143|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19985589|NCT01963143|Immunologic Factors|immunologic factors|mesh-ancestor
19985590|NCT01963143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985591|NCT01963481|Cyclophosphamide|cyclophosphamide|mesh-list
19985592|NCT01963481|Exemestane|exemestane|mesh-list
19985593|NCT01963481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19985594|NCT01963481|Immunologic Factors|immunologic factors|mesh-ancestor
19985595|NCT01963481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985596|NCT01963481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19985597|NCT01963481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19985598|NCT01963481|Alkylating Agents|alkylating agents|mesh-ancestor
19985599|NCT01963481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737904|NCT04002258|Antipsychotic Agents|antipsychotic agents|mesh-list
19737905|NCT04002258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19737906|NCT04002258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19737907|NCT04002258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737908|NCT04002258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19737909|NCT03998774|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
19737910|NCT03998774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19737911|NCT03998774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19737912|NCT03998774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737913|NCT03998774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19737956|NCT03947099|Ketamine|ketamine|mesh-list
19737957|NCT03947099|Analgesics|analgesics|mesh-ancestor
19737958|NCT03947099|Sensory System Agents|sensory system agents|mesh-ancestor
19737959|NCT03947099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19737960|NCT03947099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737961|NCT03947099|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19737962|NCT03947099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19737963|NCT03947099|Anesthetics, General|anesthetics, general|mesh-ancestor
19737964|NCT03947099|Anesthetics|anesthetics|mesh-ancestor
19737965|NCT03947099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19737966|NCT03947099|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19737967|NCT03947099|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19737968|NCT03947099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19737969|NCT03947099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737970|NCT03930017|Vaccines|vaccines|mesh-list
19737971|NCT03930017|Immunologic Factors|immunologic factors|mesh-ancestor
19737972|NCT03930017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738027|NCT03881917|Cystatins|cystatins|mesh-list
19738028|NCT03881917|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19738029|NCT03881917|Protease Inhibitors|protease inhibitors|mesh-ancestor
19738030|NCT03881917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738031|NCT03881917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738032|NCT03851965|Plasminogen|plasminogen|mesh-list
19738033|NCT03851965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19738034|NCT03851965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19738035|NCT03851965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738036|NCT03839511|Hypoglycemic Agents|hypoglycemic agents|mesh-list
19738037|NCT03839511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738038|NCT05278897|Hyaluronic Acid|hyaluronic acid|mesh-list
19738039|NCT05278897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19738040|NCT05278897|Immunologic Factors|immunologic factors|mesh-ancestor
19738041|NCT05278897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738042|NCT05278897|Viscosupplements|viscosupplements|mesh-ancestor
19738043|NCT05278897|Protective Agents|protective agents|mesh-ancestor
19738044|NCT05278884|Anesthetics|anesthetics|mesh-list
19738045|NCT05278884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19738046|NCT05278884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985600|NCT01963481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985601|NCT01963481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19985602|NCT01963481|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19985603|NCT01963481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19985604|NCT01963481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985605|NCT01963481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19985606|NCT01963481|Hormone Antagonists|hormone antagonists|mesh-ancestor
19985607|NCT01963481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19985608|NCT01963611|Glatiramer Acetate|glatiramer acetate|mesh-list
19985609|NCT01963611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19985610|NCT01963611|Immunologic Factors|immunologic factors|mesh-ancestor
19985611|NCT01963611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985612|NCT01963611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19985613|NCT01963611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19985614|NCT01963793|Aprepitant|aprepitant|mesh-list
19985615|NCT01963793|Fosaprepitant|fosaprepitant|mesh-list
19985616|NCT01963793|Antiemetics|antiemetics|mesh-ancestor
19985617|NCT01963793|Autonomic Agents|autonomic agents|mesh-ancestor
19985618|NCT01963793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19985619|NCT01963793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985620|NCT01963793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19985621|NCT01963793|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19985622|NCT01963793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19985623|NCT01963793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985624|NCT01963845|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19985625|NCT01963845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19985626|NCT01963845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737914|NCT03994419|Anesthetics|anesthetics|mesh-list
19737915|NCT03994419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19737916|NCT03994419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737917|NCT03988179|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
19737918|NCT03988179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737919|NCT03988179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737920|NCT03988179|Cholinergic Agents|cholinergic agents|mesh-ancestor
19737921|NCT03988179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19737922|NCT03988179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737923|NCT03979625|Heparin|heparin|mesh-list
19737924|NCT03979625|Antibodies|antibodies|mesh-list
19737925|NCT03979625|Immunologic Factors|immunologic factors|mesh-ancestor
19737926|NCT03979625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737927|NCT03979625|Anticoagulants|anticoagulants|mesh-ancestor
19737928|NCT03979625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19737929|NCT03979625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19737930|NCT03979625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737931|NCT03974464|Arginine Vasopressin|arginine vasopressin|mesh-list
19737932|NCT03974464|Hemostatics|hemostatics|mesh-ancestor
19737933|NCT03974464|Coagulants|coagulants|mesh-ancestor
19737934|NCT03974464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19737935|NCT03974464|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19737936|NCT03974464|Natriuretic Agents|natriuretic agents|mesh-ancestor
19737937|NCT03974464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737973|NCT03920566|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19737974|NCT03920566|Dalteparin|dalteparin|mesh-list
19737975|NCT03920566|Anticoagulants|anticoagulants|mesh-ancestor
19737976|NCT03920566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19737977|NCT03920566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19737978|NCT03920566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737979|NCT03914170|Cetuximab|cetuximab|mesh-list
19737980|NCT03914170|Folfirinox|folfirinox|mesh-list
19737981|NCT03914170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19737982|NCT03914170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19737983|NCT03910985|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
19737984|NCT03910985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19737985|NCT03910985|Autonomic Agents|autonomic agents|mesh-ancestor
19737986|NCT03910985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19737987|NCT03910985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737988|NCT03910985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19737989|NCT03910985|Respiratory System Agents|respiratory system agents|mesh-ancestor
19738047|NCT05278793|Ferrous fumarate|ferrous fumarate|mesh-list
19738048|NCT05278793|Trace Elements|trace elements|mesh-ancestor
19738049|NCT05278793|Micronutrients|micronutrients|mesh-ancestor
19738050|NCT05278793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738051|NCT05278728|Irinotecan|irinotecan|mesh-list
19738052|NCT05278728|Nimotuzumab|nimotuzumab|mesh-list
19738053|NCT05278728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19738054|NCT05278728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19738055|NCT05278728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738056|NCT05278728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738057|NCT05278728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738058|NCT05278728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19738059|NCT05278715|Carboplatin|carboplatin|mesh-list
19738060|NCT05278715|Vincristine|vincristine|mesh-list
19738061|NCT05278715|Endostatins|endostatins|mesh-list
19738062|NCT05278715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738063|NCT05278715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19738064|NCT05278715|Tubulin Modulators|tubulin modulators|mesh-ancestor
19738065|NCT05278715|Antimitotic Agents|antimitotic agents|mesh-ancestor
19738066|NCT05278715|Mitosis Modulators|mitosis modulators|mesh-ancestor
19738067|NCT05278715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738068|NCT05278715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19738069|NCT05278715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19738070|NCT05278715|Growth Substances|growth substances|mesh-ancestor
19738071|NCT05278715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738072|NCT05278715|Growth Inhibitors|growth inhibitors|mesh-ancestor
19738073|NCT05278637|Aspirin|aspirin|mesh-list
19738074|NCT05278637|Ticagrelor|ticagrelor|mesh-list
19738075|NCT05278637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19738076|NCT05278637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19738077|NCT05278637|Analgesics|analgesics|mesh-ancestor
19738078|NCT05278637|Sensory System Agents|sensory system agents|mesh-ancestor
19738079|NCT05278637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19738080|NCT05278637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738081|NCT05278637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19737938|NCT03970265|Meropenem|meropenem|mesh-list
19737939|NCT03970265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19737940|NCT03970265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19737941|NCT03967483|Indomethacin|indomethacin|mesh-list
19737942|NCT03967483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19737943|NCT03967483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19737944|NCT03967483|Analgesics|analgesics|mesh-ancestor
19737945|NCT03967483|Sensory System Agents|sensory system agents|mesh-ancestor
19737946|NCT03967483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19737947|NCT03967483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737948|NCT03967483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19737949|NCT03967483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19737950|NCT03967483|Gout Suppressants|gout suppressants|mesh-ancestor
19737951|NCT03967483|Tocolytic Agents|tocolytic agents|mesh-ancestor
19737952|NCT03967483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19737953|NCT03967483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19737954|NCT03967483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19737955|NCT03967483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19737990|NCT03907605|Hormones|hormones|mesh-list
19737991|NCT03907605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19737992|NCT03907605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19737993|NCT03903406|Dexamethasone|dexamethasone|mesh-list
19737994|NCT03903406|Lenalidomide|lenalidomide|mesh-list
19737995|NCT03903406|Ixazomib|ixazomib|mesh-list
19737996|NCT03903406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19737997|NCT03903406|Antiemetics|antiemetics|mesh-ancestor
19737998|NCT03903406|Autonomic Agents|autonomic agents|mesh-ancestor
19737999|NCT03903406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19738000|NCT03903406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738001|NCT03903406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19738002|NCT03903406|Glucocorticoids|glucocorticoids|mesh-ancestor
19738003|NCT03903406|Hormones|hormones|mesh-ancestor
19738004|NCT03903406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19738005|NCT03903406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19738006|NCT03903406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738007|NCT03903406|Immunologic Factors|immunologic factors|mesh-ancestor
19738008|NCT03903406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19738009|NCT03903406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19738010|NCT03903406|Growth Substances|growth substances|mesh-ancestor
19738011|NCT03903406|Growth Inhibitors|growth inhibitors|mesh-ancestor
19738012|NCT03903406|Protease Inhibitors|protease inhibitors|mesh-ancestor
19738013|NCT03903406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738014|NCT03903406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738015|NCT03897192|Bevacizumab|bevacizumab|mesh-list
19738016|NCT03897192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19738017|NCT03897192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738018|NCT03897192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19738019|NCT03897192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19738020|NCT03897192|Growth Substances|growth substances|mesh-ancestor
19738021|NCT03897192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738022|NCT03897192|Growth Inhibitors|growth inhibitors|mesh-ancestor
19738023|NCT03896815|INCB054329|incb054329|mesh-list
19738024|NCT03896815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738025|NCT03894696|Antiviral Agents|antiviral agents|mesh-list
19738026|NCT03894696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19738082|NCT05278637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19738083|NCT05278637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19738084|NCT05278637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19738085|NCT05278637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738086|NCT05278637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19738087|NCT05278637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19738088|NCT05278637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738089|NCT05278637|Antipyretics|antipyretics|mesh-ancestor
19738090|NCT05278637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19738091|NCT05278637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19738092|NCT05278637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19738093|NCT05278637|Purinergic Agents|purinergic agents|mesh-ancestor
19738094|NCT05278637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19738095|NCT05278494|Dextromethorphan|dextromethorphan|mesh-list
19738096|NCT05278494|Antitussive Agents|antitussive agents|mesh-ancestor
19738097|NCT05278494|Respiratory System Agents|respiratory system agents|mesh-ancestor
19738098|NCT05278494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19738099|NCT05278494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19738100|NCT05278494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19738101|NCT05278494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738102|NCT05278494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738103|NCT05278338|Denosumab|denosumab|mesh-list
19738104|NCT05278338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19738105|NCT05278338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738106|NCT05278065|Nicotine|nicotine|mesh-list
19738107|NCT05278065|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19738108|NCT05278065|Autonomic Agents|autonomic agents|mesh-ancestor
19738109|NCT05278065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19738110|NCT05278065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738111|NCT05278065|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19985627|NCT01963845|Incretins|incretins|mesh-ancestor
19985628|NCT01963845|Hormones|hormones|mesh-ancestor
19985629|NCT01963845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19985630|NCT01963845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19985631|NCT01963845|Protease Inhibitors|protease inhibitors|mesh-ancestor
19985632|NCT01963845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985633|NCT01963845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289121|NCT04958538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20289122|NCT04958538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289123|NCT04958538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20289124|NCT04958538|Antimetabolites|antimetabolites|mesh-ancestor
20289125|NCT04958538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289126|NCT04958538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289127|NCT04958538|Dermatologic Agents|dermatologic agents|mesh-ancestor
20289128|NCT04958538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289129|NCT04958538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20289130|NCT04958538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20289131|NCT04958538|Immunologic Factors|immunologic factors|mesh-ancestor
20289132|NCT04958538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20289133|NCT04958538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20289134|NCT04951388|Somatomedin B|somatomedin b|mesh-list
20289135|NCT04951388|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20289136|NCT04951388|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20289137|NCT04951388|Protease Inhibitors|protease inhibitors|mesh-ancestor
20289138|NCT04951388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289139|NCT04951388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289140|NCT04939844|Lenalidomide|lenalidomide|mesh-list
20289141|NCT04939844|Bortezomib|bortezomib|mesh-list
20289142|NCT04939844|Immunologic Factors|immunologic factors|mesh-ancestor
20289143|NCT04939844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289144|NCT04939844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20289145|NCT04939844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20289146|NCT04939844|Growth Substances|growth substances|mesh-ancestor
20289147|NCT04939844|Growth Inhibitors|growth inhibitors|mesh-ancestor
20289148|NCT04939844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289149|NCT04931602|Vitamin D|vitamin d|mesh-list
20289150|NCT04931602|Vitamins|vitamins|mesh-ancestor
20556277|NCT01945892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20556278|NCT01945892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20556279|NCT01945892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556280|NCT01945957|Oxytocin|oxytocin|mesh-list
20556281|NCT01945957|Oxytocics|oxytocics|mesh-ancestor
20556282|NCT01945957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20556283|NCT01945957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556284|NCT01945983|Norepinephrine|norepinephrine|mesh-list
20556285|NCT01945983|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20556286|NCT01945983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20556287|NCT01945983|Adrenergic Agents|adrenergic agents|mesh-ancestor
20556288|NCT01945983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20556289|NCT01945983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556290|NCT01945983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556291|NCT01945983|Sympathomimetics|sympathomimetics|mesh-ancestor
20556292|NCT01945983|Autonomic Agents|autonomic agents|mesh-ancestor
20556293|NCT01945983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556294|NCT01945983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20556295|NCT01946009|Cidofovir|cidofovir|mesh-list
20556296|NCT01946009|Antiviral Agents|antiviral agents|mesh-ancestor
20556297|NCT01946009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20556298|NCT01946009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556299|NCT01946009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556300|NCT01946035|Doxazosin|doxazosin|mesh-list
20556301|NCT01946035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19738112|NCT05278065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19738113|NCT05278065|Cholinergic Agents|cholinergic agents|mesh-ancestor
19738114|NCT05278065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19738115|NCT05278065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738116|NCT05277974|Dexamethasone|dexamethasone|mesh-list
19738117|NCT05277974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19738118|NCT05277974|Antiemetics|antiemetics|mesh-ancestor
19738119|NCT05277974|Autonomic Agents|autonomic agents|mesh-ancestor
19738120|NCT05277974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19738121|NCT05277974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738122|NCT05277974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19738123|NCT05277974|Glucocorticoids|glucocorticoids|mesh-ancestor
19738124|NCT05277974|Hormones|hormones|mesh-ancestor
19738125|NCT05277974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19738126|NCT05277974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19738127|NCT05277974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738128|NCT05277701|Lazertinib|lazertinib|mesh-list
19738129|NCT05277701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19738130|NCT05277701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738131|NCT05277701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738132|NCT05277675|Bevacizumab|bevacizumab|mesh-list
19738133|NCT05277675|Lenvatinib|lenvatinib|mesh-list
19738134|NCT05277675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19738135|NCT05277675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738136|NCT05277675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19738137|NCT05277675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19738138|NCT05277675|Growth Substances|growth substances|mesh-ancestor
19738139|NCT05277675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738140|NCT05277675|Growth Inhibitors|growth inhibitors|mesh-ancestor
19738141|NCT05277675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19738142|NCT05277675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738143|NCT05277675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738144|NCT05277038|Clonidine|clonidine|mesh-list
19738145|NCT05277038|Zopiclone|zopiclone|mesh-list
19738146|NCT05277038|Analgesics|analgesics|mesh-ancestor
19738147|NCT05277038|Sensory System Agents|sensory system agents|mesh-ancestor
19738148|NCT05277038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19738149|NCT05277038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738150|NCT05277038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19738151|NCT05277038|Sympatholytics|sympatholytics|mesh-ancestor
19738152|NCT05277038|Autonomic Agents|autonomic agents|mesh-ancestor
19738153|NCT05277038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19738154|NCT05277038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19738155|NCT05277038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19738156|NCT05277038|Adrenergic Agents|adrenergic agents|mesh-ancestor
19738157|NCT05277038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19738158|NCT05277038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738159|NCT05277038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19738160|NCT05277038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19738161|NCT05276960|Cholecalciferol|cholecalciferol|mesh-list
19738162|NCT05276960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19738163|NCT05276960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738164|NCT05276960|Vitamins|vitamins|mesh-ancestor
19738165|NCT05276960|Micronutrients|micronutrients|mesh-ancestor
19738166|NCT05276960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19738167|NCT05276908|Bupivacaine|bupivacaine|mesh-list
19738168|NCT05276908|Anesthetics|anesthetics|mesh-list
19738169|NCT05276908|Anesthetics, Local|anesthetics, local|mesh-ancestor
19738170|NCT05276908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19738171|NCT05276908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738172|NCT05276908|Sensory System Agents|sensory system agents|mesh-ancestor
19738173|NCT05276908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19738174|NCT05276895|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
19738175|NCT05276895|Quercetin|quercetin|mesh-list
19738176|NCT05276895|Antioxidants|antioxidants|mesh-ancestor
19738177|NCT05276895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738178|NCT05276895|Protective Agents|protective agents|mesh-ancestor
19738179|NCT05276895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738180|NCT05276895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19738193|NCT05258851|Ceftazidime|ceftazidime|mesh-list
19738194|NCT05258851|Colistin|colistin|mesh-list
19738195|NCT05258851|Avibactam|avibactam|mesh-list
19738196|NCT05258851|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
19738197|NCT05258851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19738198|NCT05258851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19738199|NCT05258851|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19738200|NCT05258851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738201|NCT05258851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985634|NCT01964300|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19985635|NCT01964300|Antiviral Agents|antiviral agents|mesh-ancestor
19985636|NCT01964300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19985637|NCT01964326|Atorvastatin|atorvastatin|mesh-list
19985638|NCT01964326|Calcium|calcium|mesh-list
19985639|NCT01964326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19985640|NCT01964326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985641|NCT01964326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19985642|NCT01964326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19985643|NCT01964326|Antimetabolites|antimetabolites|mesh-ancestor
19985644|NCT01964326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985645|NCT01964326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19985646|NCT01964326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19985647|NCT01964326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985648|NCT01964352|Tiotropium Bromide|tiotropium bromide|mesh-list
19985649|NCT01964352|Olodaterol|olodaterol|mesh-list
19985650|NCT01964352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19985651|NCT01964352|Autonomic Agents|autonomic agents|mesh-ancestor
19985652|NCT01964352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19985653|NCT01964352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985654|NCT01964352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19985655|NCT01964352|Respiratory System Agents|respiratory system agents|mesh-ancestor
19985656|NCT01964352|Parasympatholytics|parasympatholytics|mesh-ancestor
19985657|NCT01964352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19985658|NCT01964352|Cholinergic Agents|cholinergic agents|mesh-ancestor
19985659|NCT01964352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19985660|NCT01964352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985661|NCT01964378|Morphine|morphine|mesh-list
19985662|NCT01964378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19985663|NCT01964378|Narcotics|narcotics|mesh-ancestor
19985664|NCT01964378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19985665|NCT01964378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985666|NCT01964378|Analgesics|analgesics|mesh-ancestor
19985667|NCT01964378|Sensory System Agents|sensory system agents|mesh-ancestor
19985668|NCT01964378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19985669|NCT01964430|Gemcitabine|gemcitabine|mesh-list
19985670|NCT01964430|Paclitaxel|paclitaxel|mesh-list
19985671|NCT01964430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19985672|NCT01964430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985673|NCT01964430|Tubulin Modulators|tubulin modulators|mesh-ancestor
19985674|NCT01964430|Antimitotic Agents|antimitotic agents|mesh-ancestor
19985675|NCT01964430|Mitosis Modulators|mitosis modulators|mesh-ancestor
19985676|NCT01964430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985677|NCT01964430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19985678|NCT01964430|Antimetabolites|antimetabolites|mesh-ancestor
19985679|NCT01964430|Antiviral Agents|antiviral agents|mesh-ancestor
19985680|NCT01964430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19985681|NCT01964430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985682|NCT01964430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19985683|NCT01964430|Immunologic Factors|immunologic factors|mesh-ancestor
19985684|NCT01964430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985685|NCT01964547|Nabiximols|nabiximols|mesh-list
19985686|NCT01964547|Analgesics|analgesics|mesh-ancestor
19985687|NCT01964547|Sensory System Agents|sensory system agents|mesh-ancestor
19985688|NCT01964547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19985689|NCT01964547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985690|NCT01964716|Vaccines|vaccines|mesh-list
19985691|NCT01964716|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19985692|NCT01964716|Immunologic Factors|immunologic factors|mesh-ancestor
19985693|NCT01964716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985694|NCT01964755|Leucovorin|leucovorin|mesh-list
19985695|NCT01964755|Tetrahydrofolates|tetrahydrofolates|mesh-list
19738202|NCT05257213|Heparin|heparin|mesh-list
19738203|NCT05257213|Anticoagulants|anticoagulants|mesh-ancestor
19738204|NCT05257213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19738205|NCT05257213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19738206|NCT05257213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738207|NCT05255107|Riboflavin|riboflavin|mesh-list
19738208|NCT05255107|Lubricant Eye Drops|lubricant eye drops|mesh-list
19738209|NCT05255107|Vitamin B Complex|vitamin b complex|mesh-ancestor
19738210|NCT05255107|Vitamins|vitamins|mesh-ancestor
19738211|NCT05255107|Micronutrients|micronutrients|mesh-ancestor
19738212|NCT05255107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738213|NCT05255107|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19738214|NCT05255107|Dermatologic Agents|dermatologic agents|mesh-ancestor
19738215|NCT05255107|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19738216|NCT05255107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19738217|NCT05255016|Riboflavin|riboflavin|mesh-list
19738218|NCT05255016|Lubricant Eye Drops|lubricant eye drops|mesh-list
19738219|NCT05255016|Vitamin B Complex|vitamin b complex|mesh-ancestor
19738220|NCT05255016|Vitamins|vitamins|mesh-ancestor
19738221|NCT05255016|Micronutrients|micronutrients|mesh-ancestor
19738222|NCT05255016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738223|NCT05255016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19738224|NCT05255016|Dermatologic Agents|dermatologic agents|mesh-ancestor
19738225|NCT05255016|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19738226|NCT05255016|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19738227|NCT05232851|Pembrolizumab|pembrolizumab|mesh-list
19738228|NCT05232851|Vaccines|vaccines|mesh-list
19738229|NCT05232851|Immunologic Factors|immunologic factors|mesh-ancestor
19738230|NCT05232851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738231|NCT05232851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19738232|NCT05232851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738233|NCT05230368|Decitabine|decitabine|mesh-list
19738234|NCT05230368|Romidepsin|romidepsin|mesh-list
19738235|NCT05230368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19738236|NCT05230368|Antimetabolites|antimetabolites|mesh-ancestor
19738237|NCT05230368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738238|NCT05230368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738239|NCT05230368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738240|NCT05230368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19738241|NCT05212454|Capecitabine|capecitabine|mesh-list
19738242|NCT05212454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19738243|NCT05212454|Antimetabolites|antimetabolites|mesh-ancestor
19738244|NCT05212454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738245|NCT05212454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738246|NCT05198843|Dasatinib|dasatinib|mesh-list
19738247|NCT05198843|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
19738248|NCT05198843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738249|NCT05198843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19738250|NCT05198843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738251|NCT05198843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738252|NCT05198843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19738253|NCT05198843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19738254|NCT05198544|Hyaluronic Acid|hyaluronic acid|mesh-list
19738255|NCT05198544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19738256|NCT05198544|Immunologic Factors|immunologic factors|mesh-ancestor
19985696|NCT01964755|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
19985697|NCT01964755|Zidovudine|zidovudine|mesh-list
19985698|NCT01964755|Rituximab|rituximab|mesh-list
19985699|NCT01964755|Doxorubicin|doxorubicin|mesh-list
19985700|NCT01964755|Methotrexate|methotrexate|mesh-list
19738257|NCT05198544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738258|NCT05198544|Viscosupplements|viscosupplements|mesh-ancestor
19985701|NCT01964755|Hydroxyurea|hydroxyurea|mesh-list
19738259|NCT05198544|Protective Agents|protective agents|mesh-ancestor
19738260|NCT05176223|Edetic Acid|edetic acid|mesh-list
19738261|NCT05176223|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19738262|NCT05176223|Chelating Agents|chelating agents|mesh-ancestor
19738263|NCT05176223|Sequestering Agents|sequestering agents|mesh-ancestor
19738264|NCT05176223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738265|NCT05176223|Anticoagulants|anticoagulants|mesh-ancestor
19738266|NCT05176223|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19738267|NCT05176223|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19738268|NCT05174884|Etonogestrel|etonogestrel|mesh-list
19738269|NCT05174884|Desogestrel|desogestrel|mesh-list
19738270|NCT05174884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19738271|NCT05174884|Contraceptive Agents|contraceptive agents|mesh-ancestor
19738272|NCT05174884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19738273|NCT05174884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738274|NCT05174884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19738275|NCT05174884|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19738276|NCT05174884|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19738277|NCT05174884|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19738278|NCT05174884|Progestins|progestins|mesh-ancestor
19738279|NCT05174884|Hormones|hormones|mesh-ancestor
19738280|NCT05174884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19738281|NCT05173493|Amoxicillin|amoxicillin|mesh-list
19738282|NCT05173493|Levofloxacin|levofloxacin|mesh-list
19738283|NCT05173493|Ofloxacin|ofloxacin|mesh-list
19738284|NCT05173493|Tetracycline|tetracycline|mesh-list
19738285|NCT05173493|Furazolidone|furazolidone|mesh-list
19738286|NCT05173493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19738287|NCT05173493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19738288|NCT05173493|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19738289|NCT05173493|Renal Agents|renal agents|mesh-ancestor
19738290|NCT05173493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19738291|NCT05173493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19738292|NCT05173493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738293|NCT05173493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738294|NCT05173493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738295|NCT05173493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19738296|NCT05173493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19738297|NCT05173493|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19738298|NCT05173493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19738299|NCT05173493|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
19738300|NCT05173493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19738301|NCT05173493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19738302|NCT05173493|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19738303|NCT05168618|Atezolizumab|atezolizumab|mesh-list
19738304|NCT05168618|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19738305|NCT05168618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738306|NCT05168618|Immunologic Factors|immunologic factors|mesh-ancestor
19738307|NCT05168618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738308|NCT05168202|Azacitidine|azacitidine|mesh-list
19738309|NCT05168202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19738310|NCT05168202|Antimetabolites|antimetabolites|mesh-ancestor
19738311|NCT05168202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738312|NCT05168202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738313|NCT05168202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738314|NCT05326555|Imidacloprid|imidacloprid|mesh-list
19738315|NCT05326555|Cholinergic Agents|cholinergic agents|mesh-ancestor
19738316|NCT05326555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19738317|NCT05326555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738318|NCT05326555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738319|NCT05326464|Tofacitinib|tofacitinib|mesh-list
19738320|NCT05326464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19738321|NCT05326464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738322|NCT05326464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738323|NCT05326347|Brexpiprazole|brexpiprazole|mesh-list
19738324|NCT05326347|Serotonin Agents|serotonin agents|mesh-ancestor
19738325|NCT05326347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19738326|NCT05326347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738327|NCT05326347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738328|NCT05326347|Dopamine Agonists|dopamine agonists|mesh-ancestor
19738329|NCT05326347|Dopamine Agents|dopamine agents|mesh-ancestor
19738330|NCT05326269|Terbutaline|terbutaline|mesh-list
19738331|NCT05326269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19738332|NCT05326269|Autonomic Agents|autonomic agents|mesh-ancestor
19738333|NCT05326269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19738334|NCT05326269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738335|NCT05326269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19738336|NCT05326269|Respiratory System Agents|respiratory system agents|mesh-ancestor
19738337|NCT05326269|Sympathomimetics|sympathomimetics|mesh-ancestor
19738338|NCT05326269|Tocolytic Agents|tocolytic agents|mesh-ancestor
19738339|NCT05326269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19738340|NCT05326269|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19738341|NCT05326269|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19738342|NCT05326269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19738343|NCT05326269|Adrenergic Agents|adrenergic agents|mesh-ancestor
19738344|NCT05326269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19738345|NCT05326269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738346|NCT05326139|Tranexamic Acid|tranexamic acid|mesh-list
19738347|NCT05326139|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19738348|NCT05326139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19738349|NCT05326139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738350|NCT05326139|Hemostatics|hemostatics|mesh-ancestor
19738351|NCT05326139|Coagulants|coagulants|mesh-ancestor
19738352|NCT05326087|Cetrorelix|cetrorelix|mesh-list
19738353|NCT05326087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19738354|NCT05326087|Fertility Agents|fertility agents|mesh-ancestor
19738355|NCT05326087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19738356|NCT05326087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738357|NCT05326087|Hormone Antagonists|hormone antagonists|mesh-ancestor
19738358|NCT05326087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19738359|NCT05325866|Bemarituzumab|bemarituzumab|mesh-list
19738360|NCT05325866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19738361|NCT05325866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738362|NCT05325762|Dexmedetomidine|dexmedetomidine|mesh-list
19738363|NCT05325762|Propofol|propofol|mesh-list
19738364|NCT05325762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19738365|NCT05325762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19738366|NCT05325762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738367|NCT05325762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19738368|NCT05325762|Anesthetics, General|anesthetics, general|mesh-ancestor
19738369|NCT05325762|Anesthetics|anesthetics|mesh-ancestor
19738370|NCT05325762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19738371|NCT05325762|Analgesics|analgesics|mesh-ancestor
19738372|NCT05325762|Sensory System Agents|sensory system agents|mesh-ancestor
19738373|NCT05325762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19738374|NCT05325762|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19738375|NCT05325762|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19738376|NCT05325762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19738377|NCT05325762|Adrenergic Agents|adrenergic agents|mesh-ancestor
19738378|NCT05325762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19738379|NCT05325762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738380|NCT05325684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19738381|NCT05325684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738382|NCT05325684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985702|NCT01964755|Levoleucovorin|levoleucovorin|mesh-list
19985703|NCT01964755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19985704|NCT01964755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985705|NCT01964755|Immunologic Factors|immunologic factors|mesh-ancestor
19985706|NCT01964755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985707|NCT01964755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19985708|NCT01964755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19985709|NCT01964755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19985710|NCT01964755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19985711|NCT01964755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985712|NCT01964755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985713|NCT01964755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19985714|NCT01964755|Abortifacient Agents|abortifacient agents|mesh-ancestor
19985715|NCT01964755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19985716|NCT01964755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19985717|NCT01964755|Antimetabolites|antimetabolites|mesh-ancestor
19985718|NCT01964755|Dermatologic Agents|dermatologic agents|mesh-ancestor
19985719|NCT01964755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19985720|NCT01964755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19985721|NCT01964755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19985722|NCT01964755|Antidotes|antidotes|mesh-ancestor
19985723|NCT01964755|Protective Agents|protective agents|mesh-ancestor
19985724|NCT01964755|Vitamin B Complex|vitamin b complex|mesh-ancestor
19985725|NCT01964755|Vitamins|vitamins|mesh-ancestor
19985726|NCT01964755|Micronutrients|micronutrients|mesh-ancestor
19738383|NCT05325645|Brexpiprazole|brexpiprazole|mesh-list
19738384|NCT05325645|Serotonin Agents|serotonin agents|mesh-ancestor
19738385|NCT05325645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19738386|NCT05325645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738387|NCT05325645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738388|NCT05325645|Dopamine Agonists|dopamine agonists|mesh-ancestor
19738389|NCT05325645|Dopamine Agents|dopamine agents|mesh-ancestor
19738390|NCT05325632|Paclitaxel|paclitaxel|mesh-list
19738391|NCT05325632|Trastuzumab|trastuzumab|mesh-list
19738392|NCT05325632|Pertuzumab|pertuzumab|mesh-list
19738393|NCT05325632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19738394|NCT05325632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738395|NCT05325632|Tubulin Modulators|tubulin modulators|mesh-ancestor
19738396|NCT05325632|Antimitotic Agents|antimitotic agents|mesh-ancestor
19738397|NCT05325632|Mitosis Modulators|mitosis modulators|mesh-ancestor
19738398|NCT05325632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738399|NCT05325632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19738400|NCT05325593|Dexamethasone|dexamethasone|mesh-list
19738401|NCT05325593|Dexamethasone acetate|dexamethasone acetate|mesh-list
19738402|NCT05325593|BB 1101|bb 1101|mesh-list
19738403|NCT05325593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19738404|NCT05325593|Antiemetics|antiemetics|mesh-ancestor
19738405|NCT05325593|Autonomic Agents|autonomic agents|mesh-ancestor
19738406|NCT05325593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19738407|NCT05325593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738408|NCT05325593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19738409|NCT05325593|Glucocorticoids|glucocorticoids|mesh-ancestor
19738410|NCT05325593|Hormones|hormones|mesh-ancestor
19738411|NCT05325593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19738412|NCT05325593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19738413|NCT05325593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738414|NCT05325593|Protease Inhibitors|protease inhibitors|mesh-ancestor
19738415|NCT05325593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738416|NCT05325593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738417|NCT05325580|Magnesium Sulfate|magnesium sulfate|mesh-list
19738418|NCT05325580|Analgesics|analgesics|mesh-ancestor
19738419|NCT05325580|Sensory System Agents|sensory system agents|mesh-ancestor
19738420|NCT05325580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19738421|NCT05325580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738422|NCT05325580|Anesthetics|anesthetics|mesh-ancestor
19738423|NCT05325580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19738424|NCT05325580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19738425|NCT05325580|Anticonvulsants|anticonvulsants|mesh-ancestor
19738426|NCT05325580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19738427|NCT05325580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19738428|NCT05325580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738429|NCT05325580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19738430|NCT05325580|Tocolytic Agents|tocolytic agents|mesh-ancestor
19738431|NCT05325580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19459518|NCT03360760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19459519|NCT03360760|Antimetabolites|antimetabolites|mesh-ancestor
19459520|NCT03360760|Dermatologic Agents|dermatologic agents|mesh-ancestor
19459521|NCT03360760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19459522|NCT03360760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19459523|NCT03360760|Immunologic Factors|immunologic factors|mesh-ancestor
19738432|NCT05325528|Oxaliplatin|oxaliplatin|mesh-list
19738433|NCT05325528|Tegafur|tegafur|mesh-list
19738434|NCT05325528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738435|NCT05325528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19738436|NCT05325528|Antimetabolites|antimetabolites|mesh-ancestor
19738437|NCT05325528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738438|NCT05325515|Alendronate|alendronate|mesh-list
19738439|NCT05325515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19738440|NCT05325515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738441|NCT05325346|Argatroban|argatroban|mesh-list
19738442|NCT05325346|Antithrombins|antithrombins|mesh-ancestor
19738443|NCT05325346|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19738444|NCT05325346|Protease Inhibitors|protease inhibitors|mesh-ancestor
19738445|NCT05325346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459524|NCT03360760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19459525|NCT03360760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19459526|NCT03360760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19459527|NCT03360760|Alkylating Agents|alkylating agents|mesh-ancestor
19459528|NCT03360734|Cetuximab|cetuximab|mesh-list
19459529|NCT03360734|Panitumumab|panitumumab|mesh-list
19459530|NCT03360734|Necitumumab|necitumumab|mesh-list
19738446|NCT05325346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738447|NCT05325346|Anticoagulants|anticoagulants|mesh-ancestor
19738448|NCT05325346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19738449|NCT05325229|Bevacizumab|bevacizumab|mesh-list
19985727|NCT01964755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19985728|NCT01964755|Antiviral Agents|antiviral agents|mesh-ancestor
19985729|NCT01964755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19985730|NCT01964755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19985731|NCT01964755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19985732|NCT01964755|Antisickling Agents|antisickling agents|mesh-ancestor
19985733|NCT01964898|Nicotine|nicotine|mesh-list
19985734|NCT01964898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19985735|NCT01964898|Autonomic Agents|autonomic agents|mesh-ancestor
19985736|NCT01964898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19985737|NCT01964898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985738|NCT01964898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19985739|NCT01964898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19985740|NCT01964898|Cholinergic Agents|cholinergic agents|mesh-ancestor
19985741|NCT01964898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19985742|NCT01964898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985743|NCT01964924|Trametinib|trametinib|mesh-list
19985744|NCT01964924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985745|NCT01964924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19985746|NCT01964924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985747|NCT01964924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985748|NCT01964963|Alogliptin|alogliptin|mesh-list
19985749|NCT01964963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19985750|NCT01964963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985751|NCT01964963|Incretins|incretins|mesh-ancestor
19985752|NCT01964963|Hormones|hormones|mesh-ancestor
19985753|NCT01964963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19985754|NCT01964963|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19985755|NCT01964963|Protease Inhibitors|protease inhibitors|mesh-ancestor
19985756|NCT01964963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985757|NCT01964963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985758|NCT01965002|Aspirin|aspirin|mesh-list
19985759|NCT01965002|Enoxaparin|enoxaparin|mesh-list
19985760|NCT01965002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19985761|NCT01965002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19985762|NCT01965002|Analgesics|analgesics|mesh-ancestor
19985763|NCT01965002|Sensory System Agents|sensory system agents|mesh-ancestor
19985764|NCT01965002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19985765|NCT01965002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985766|NCT01965002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19985767|NCT01965002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19985768|NCT01965002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19985769|NCT01965002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19985770|NCT01965002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985771|NCT01965002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19985772|NCT01965002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19985773|NCT01965002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985774|NCT01965002|Antipyretics|antipyretics|mesh-ancestor
19985775|NCT01965002|Anticoagulants|anticoagulants|mesh-ancestor
19985776|NCT01965327|Interferons|interferons|mesh-list
19985777|NCT01965327|Interferon-gamma|interferon-gamma|mesh-list
19985778|NCT01965327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985779|NCT01965327|Antiviral Agents|antiviral agents|mesh-ancestor
19985780|NCT01965327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19985781|NCT01965366|Dexamethasone|dexamethasone|mesh-list
19985782|NCT01965366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19985783|NCT01965366|Antiemetics|antiemetics|mesh-ancestor
19985784|NCT01965366|Autonomic Agents|autonomic agents|mesh-ancestor
19738450|NCT05325229|Docetaxel|docetaxel|mesh-list
19738451|NCT05325229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19738452|NCT05325229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738453|NCT05325229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19738454|NCT05325229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19738455|NCT05325229|Growth Substances|growth substances|mesh-ancestor
19738456|NCT05325229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738457|NCT05325229|Growth Inhibitors|growth inhibitors|mesh-ancestor
19738458|NCT05325229|Tubulin Modulators|tubulin modulators|mesh-ancestor
19738459|NCT05325229|Antimitotic Agents|antimitotic agents|mesh-ancestor
19738460|NCT05325229|Mitosis Modulators|mitosis modulators|mesh-ancestor
19738461|NCT05325229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738462|NCT05325190|Granisetron|granisetron|mesh-list
19738463|NCT05325190|Antiemetics|antiemetics|mesh-ancestor
19738464|NCT05325190|Autonomic Agents|autonomic agents|mesh-ancestor
19738465|NCT05325190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19738466|NCT05325190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738467|NCT05325190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19738468|NCT05325190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19738469|NCT05325190|Serotonin Agents|serotonin agents|mesh-ancestor
19738470|NCT05325190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19738471|NCT05325190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738472|NCT05325073|Epoetin Alfa|epoetin alfa|mesh-list
19738473|NCT05325073|Hematinics|hematinics|mesh-ancestor
19738474|NCT05325008|Immunoglobulins|immunoglobulins|mesh-list
19738475|NCT05325008|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19738476|NCT05325008|Antibodies|antibodies|mesh-list
19738477|NCT05325008|gamma-Globulins|gamma-globulins|mesh-list
19738478|NCT05325008|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19738479|NCT05325008|Immunologic Factors|immunologic factors|mesh-ancestor
19738480|NCT05325008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738481|NCT05324917|Rituximab|rituximab|mesh-list
19738482|NCT05324917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19738483|NCT05324917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738484|NCT05324917|Immunologic Factors|immunologic factors|mesh-ancestor
19738485|NCT05324917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738486|NCT05324917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19738487|NCT05324904|Vitamin D|vitamin d|mesh-list
19738488|NCT05324904|Acyclovir|acyclovir|mesh-list
19738489|NCT05324904|Vitamins|vitamins|mesh-ancestor
19738490|NCT05324904|Micronutrients|micronutrients|mesh-ancestor
19738491|NCT05324904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738492|NCT05324904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19738493|NCT05324904|Antiviral Agents|antiviral agents|mesh-ancestor
19738494|NCT05324904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19738495|NCT05324891|Fentanyl|fentanyl|mesh-list
19738496|NCT05324891|Dexmedetomidine|dexmedetomidine|mesh-list
19738497|NCT05324891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19738498|NCT05324891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19738499|NCT05324891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738500|NCT05324891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19738501|NCT05324891|Analgesics|analgesics|mesh-ancestor
19738502|NCT05324891|Sensory System Agents|sensory system agents|mesh-ancestor
19738503|NCT05324891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19738504|NCT05324891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19738505|NCT05324891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19738506|NCT05324891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19738507|NCT05324891|Adrenergic Agents|adrenergic agents|mesh-ancestor
19738508|NCT05324891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19738509|NCT05324891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738510|NCT05324891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19738511|NCT05324891|Narcotics|narcotics|mesh-ancestor
19738512|NCT05324891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19738513|NCT05324891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19738514|NCT05324891|Anesthetics, General|anesthetics, general|mesh-ancestor
19738515|NCT05324891|Anesthetics|anesthetics|mesh-ancestor
19738516|NCT05323058|Benzydamine|benzydamine|mesh-list
19738517|NCT05323058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19738518|NCT05317403|Cytarabine|cytarabine|mesh-list
19738519|NCT05317403|Fludarabine|fludarabine|mesh-list
19738520|NCT05317403|Venetoclax|venetoclax|mesh-list
19738521|NCT05317403|Vorinostat|vorinostat|mesh-list
19738522|NCT05317403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738523|NCT05317403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19738524|NCT05317403|Antimetabolites|antimetabolites|mesh-ancestor
19738525|NCT05317403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738526|NCT05317403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19738527|NCT05317403|Immunologic Factors|immunologic factors|mesh-ancestor
19738528|NCT05317403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738529|NCT05317403|Antiviral Agents|antiviral agents|mesh-ancestor
19738530|NCT05317403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19738531|NCT05317403|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19738532|NCT05317403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738533|NCT05311579|Niraparib|niraparib|mesh-list
19738534|NCT05311579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19738535|NCT05311579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738536|NCT05311579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738537|NCT05311579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289151|NCT04931602|Micronutrients|micronutrients|mesh-ancestor
19738538|NCT05307081|Lubricant Eye Drops|lubricant eye drops|mesh-list
19738539|NCT05307081|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19738540|NCT05307081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19738541|NCT05306873|Mycophenolic Acid|mycophenolic acid|mesh-list
19738542|NCT05306873|Cyclosporine|cyclosporine|mesh-list
19738543|NCT05306873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19738544|NCT05306873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738545|NCT05306873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19738546|NCT05306873|Antitubercular Agents|antitubercular agents|mesh-ancestor
19738547|NCT05306873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19738548|NCT05306873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19738549|NCT05306873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738550|NCT05306873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738551|NCT05306873|Antifungal Agents|antifungal agents|mesh-ancestor
19738552|NCT05306873|Dermatologic Agents|dermatologic agents|mesh-ancestor
19738553|NCT05306873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19738554|NCT05306873|Immunologic Factors|immunologic factors|mesh-ancestor
19738555|NCT05306873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738556|NCT05306873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19738557|NCT05306873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19738558|NCT05294328|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19738559|NCT05294328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19738560|NCT05294328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19738561|NCT05294328|Aceclidine|aceclidine|mesh-list
19738562|NCT05294328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19738563|NCT05294328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19738564|NCT05294328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19738565|NCT05294328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19738566|NCT05294328|Adrenergic Agents|adrenergic agents|mesh-ancestor
19738567|NCT05294328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19738568|NCT05294328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738569|NCT05294328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738570|NCT05294328|Miotics|miotics|mesh-ancestor
19738571|NCT05294328|Autonomic Agents|autonomic agents|mesh-ancestor
19738572|NCT05294328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19738573|NCT05294328|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19738574|NCT05285683|Levodopa|levodopa|mesh-list
19738575|NCT05285683|Carbidopa|carbidopa|mesh-list
19738576|NCT05285683|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19738577|NCT05285683|Methylphenidate|methylphenidate|mesh-list
19738578|NCT05285683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19738579|NCT05285683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738580|NCT05285683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19738581|NCT05285683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19738582|NCT05285683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19738583|NCT05285683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738584|NCT05285683|Dopamine Agents|dopamine agents|mesh-ancestor
19738585|NCT05285683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19738586|NCT05285683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19738587|NCT05285683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19738588|NCT05285683|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19738589|NCT05285683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738590|NCT05285683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19738591|NCT05285683|Immunologic Factors|immunologic factors|mesh-ancestor
19738592|NCT05285683|Dopamine Agonists|dopamine agonists|mesh-ancestor
19738593|NCT05275023|Tenofovir|tenofovir|mesh-list
19738594|NCT05275023|Entecavir|entecavir|mesh-list
19738595|NCT05275023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19738596|NCT05275023|Antiviral Agents|antiviral agents|mesh-ancestor
19738597|NCT05275023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19738598|NCT05275023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19738599|NCT05275023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19738600|NCT05275023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738601|NCT05275023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738602|NCT05275023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19738603|NCT05275023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19738604|NCT05275023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738605|NCT05272254|Povidone-Iodine|povidone-iodine|mesh-list
19738606|NCT05272254|Povidone|povidone|mesh-list
19738607|NCT05272254|Plasma Substitutes|plasma substitutes|mesh-ancestor
19738608|NCT05272254|Blood Substitutes|blood substitutes|mesh-ancestor
19738609|NCT05272254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19738610|NCT05272254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19738611|NCT05263492|Pembrolizumab|pembrolizumab|mesh-list
19738612|NCT05263492|Lenvatinib|lenvatinib|mesh-list
19738613|NCT05263492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20556302|NCT01946035|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19738614|NCT05263492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738615|NCT05263492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19738616|NCT05263492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738617|NCT05263492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738618|NCT05253937|Epinephrine|epinephrine|mesh-list
19738619|NCT05253937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19738620|NCT05253937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19738621|NCT05253937|Adrenergic Agents|adrenergic agents|mesh-ancestor
19738622|NCT05253937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19738623|NCT05253937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738624|NCT05253937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738625|NCT05253937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19738626|NCT05253937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19738627|NCT05253937|Autonomic Agents|autonomic agents|mesh-ancestor
19738628|NCT05253937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19738629|NCT05253937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19738630|NCT05253937|Respiratory System Agents|respiratory system agents|mesh-ancestor
19738631|NCT05253937|Mydriatics|mydriatics|mesh-ancestor
19738632|NCT05253937|Sympathomimetics|sympathomimetics|mesh-ancestor
19738633|NCT05253937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19738634|NCT05236673|Empagliflozin|empagliflozin|mesh-list
19738635|NCT05236673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19738636|NCT05236673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738637|NCT05236673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19738638|NCT05236673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738639|NCT05204160|Pembrolizumab|pembrolizumab|mesh-list
19738640|NCT05204160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19738641|NCT05204160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738642|NCT05204147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19738643|NCT05204147|Antibodies|antibodies|mesh-list
19738644|NCT05204147|Immunoglobulins|immunoglobulins|mesh-list
19738645|NCT05204147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19738646|NCT05204147|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
19738647|NCT05204147|Immunologic Factors|immunologic factors|mesh-ancestor
19738648|NCT05204147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738649|NCT05204147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738650|NCT05204147|Chelating Agents|chelating agents|mesh-ancestor
19738651|NCT05204147|Sequestering Agents|sequestering agents|mesh-ancestor
19738652|NCT05204147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738653|NCT05202860|Vaccines|vaccines|mesh-list
19738654|NCT05202860|Immunologic Factors|immunologic factors|mesh-ancestor
19738655|NCT05202860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985785|NCT01965366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19985786|NCT01965366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985787|NCT01965366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19985788|NCT01965366|Glucocorticoids|glucocorticoids|mesh-ancestor
19985789|NCT01965366|Hormones|hormones|mesh-ancestor
19985790|NCT01965366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19985791|NCT01965366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19985792|NCT01965366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985793|NCT01965431|Moxifloxacin|moxifloxacin|mesh-list
19985794|NCT01965431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19985795|NCT01965431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19985796|NCT01965431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19985797|NCT01965431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19985798|NCT01965431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985799|NCT01965431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985800|NCT01965431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985801|NCT01965535|Sofosbuvir|sofosbuvir|mesh-list
19985802|NCT01965535|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19985803|NCT01965535|Ledipasvir|ledipasvir|mesh-list
19985804|NCT01965535|Antiviral Agents|antiviral agents|mesh-ancestor
19985805|NCT01965535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19985806|NCT01965756|Metformin|metformin|mesh-list
19985807|NCT01965756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19985808|NCT01965756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985809|NCT01965834|Fenofibrate|fenofibrate|mesh-list
19985810|NCT01965834|Fenofibric acid|fenofibric acid|mesh-list
19985811|NCT01965834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19985812|NCT01965834|Antimetabolites|antimetabolites|mesh-ancestor
19985813|NCT01965834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985814|NCT01965834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19985815|NCT01965834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19985816|NCT01966003|Paclitaxel|paclitaxel|mesh-list
19738656|NCT05197075|Darunavir|darunavir|mesh-list
19738657|NCT05197075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19738658|NCT05197075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19738659|NCT05197075|Protease Inhibitors|protease inhibitors|mesh-ancestor
19738660|NCT05197075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738661|NCT05197075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738662|NCT05197075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19738663|NCT05197075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19738664|NCT05197075|Antiviral Agents|antiviral agents|mesh-ancestor
19738665|NCT05197075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19738666|NCT05185739|Pembrolizumab|pembrolizumab|mesh-list
19738667|NCT05185739|Lenvatinib|lenvatinib|mesh-list
19738668|NCT05185739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19738669|NCT05185739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738670|NCT05185739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19738671|NCT05185739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738672|NCT05185739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738673|NCT05176418|Nicotine|nicotine|mesh-list
19738674|NCT05176418|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19738675|NCT05176418|Autonomic Agents|autonomic agents|mesh-ancestor
19738676|NCT05176418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19738677|NCT05176418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738678|NCT05176418|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19738679|NCT05176418|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19738680|NCT05176418|Cholinergic Agents|cholinergic agents|mesh-ancestor
19738681|NCT05176418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19738682|NCT05176418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738683|NCT05165550|Elsulfavirine|elsulfavirine|mesh-list
19738684|NCT05165550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19738685|NCT05165550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19738686|NCT05165550|Antiviral Agents|antiviral agents|mesh-ancestor
19738687|NCT05165550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19738688|NCT05153239|Irinotecan|irinotecan|mesh-list
19738689|NCT05153239|Topotecan|topotecan|mesh-list
19738690|NCT05153239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19738691|NCT05153239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19738692|NCT05153239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738693|NCT05153239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738694|NCT05153239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738695|NCT05146804|Sulforaphane|sulforaphane|mesh-list
19738696|NCT05146804|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19738697|NCT05146804|Protective Agents|protective agents|mesh-ancestor
19738698|NCT05146804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738699|NCT05146804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738700|NCT05140941|Sofosbuvir|sofosbuvir|mesh-list
19738701|NCT05140941|Velpatasvir|velpatasvir|mesh-list
19738702|NCT05140941|Antiviral Agents|antiviral agents|mesh-ancestor
19738703|NCT05140941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19738704|NCT05134441|Calcium, Dietary|calcium, dietary|mesh-list
19738705|NCT05134441|Calcium|calcium|mesh-list
19738706|NCT05134441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19738707|NCT05134441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738708|NCT05134441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19738709|NCT05112939|Cabotegravir|cabotegravir|mesh-list
19738710|NCT05112939|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19738711|NCT05112939|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19738712|NCT05112939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738713|NCT05112939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738714|NCT05112939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19738715|NCT05112939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19738716|NCT05112939|Antiviral Agents|antiviral agents|mesh-ancestor
19738717|NCT05112939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19738718|NCT05102734|Nitroglycerin|nitroglycerin|mesh-list
19738719|NCT05102734|Vasodilator Agents|vasodilator agents|mesh-ancestor
19738720|NCT05094128|Upadacitinib|upadacitinib|mesh-list
19738721|NCT05094128|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19738722|NCT05094128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19738723|NCT05094128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738724|NCT05094128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738725|NCT05094128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19985817|NCT01966003|Bevacizumab|bevacizumab|mesh-list
19985818|NCT01966003|Carboplatin|carboplatin|mesh-list
19985819|NCT01966003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19985820|NCT01966003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985821|NCT01966003|Tubulin Modulators|tubulin modulators|mesh-ancestor
19985822|NCT01966003|Antimitotic Agents|antimitotic agents|mesh-ancestor
19985823|NCT01966003|Mitosis Modulators|mitosis modulators|mesh-ancestor
19738726|NCT05071313|Vaccines|vaccines|mesh-list
19738727|NCT05071313|Immunologic Factors|immunologic factors|mesh-ancestor
19738728|NCT05071313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738729|NCT05067998|Vitamins|vitamins|mesh-list
19738730|NCT05067998|Micronutrients|micronutrients|mesh-ancestor
19738731|NCT05067998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738732|NCT05054140|Calcium|calcium|mesh-list
19738733|NCT05054140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19738734|NCT05054140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738735|NCT05036980|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
19738736|NCT05036980|Antioxidants|antioxidants|mesh-ancestor
19738737|NCT05036980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738738|NCT05036980|Protective Agents|protective agents|mesh-ancestor
19738739|NCT05036980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738740|NCT05036980|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19738741|NCT05036980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738742|NCT05029622|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19738743|NCT05029622|Luteolytic Agents|luteolytic agents|mesh-ancestor
19738744|NCT05029622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19738745|NCT05029622|Contraceptive Agents|contraceptive agents|mesh-ancestor
19738746|NCT05029622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19738747|NCT05029622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738748|NCT05029622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19738749|NCT05029622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19738750|NCT05029622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738751|NCT05014646|Cholestyramine Resin|cholestyramine resin|mesh-list
19738752|NCT05014646|Leflunomide|leflunomide|mesh-list
19738753|NCT05014646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738754|NCT05014646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738755|NCT05014646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19738756|NCT05014646|Immunologic Factors|immunologic factors|mesh-ancestor
19738757|NCT05014646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738758|NCT05014646|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19738759|NCT05014646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19738760|NCT05014646|Antimetabolites|antimetabolites|mesh-ancestor
19738761|NCT05014646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19738762|NCT05011513|Ritonavir|ritonavir|mesh-list
19738763|NCT05011513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19738764|NCT05011513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19738765|NCT05011513|Protease Inhibitors|protease inhibitors|mesh-ancestor
19738766|NCT05011513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738767|NCT05011513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738768|NCT05011513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19738769|NCT05011513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19738770|NCT05011513|Antiviral Agents|antiviral agents|mesh-ancestor
19738771|NCT05011513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19985824|NCT01966003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985825|NCT01966003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19985826|NCT01966003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19985827|NCT01966003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19985828|NCT01966003|Growth Substances|growth substances|mesh-ancestor
19985829|NCT01966003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985830|NCT01966003|Growth Inhibitors|growth inhibitors|mesh-ancestor
19985831|NCT01966107|Bromides|bromides|mesh-list
19985832|NCT01966107|Anticonvulsants|anticonvulsants|mesh-ancestor
19985833|NCT01966120|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19985834|NCT01966120|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19985835|NCT01966120|Dermatologic Agents|dermatologic agents|mesh-ancestor
19459531|NCT03360734|Antibodies|antibodies|mesh-list
19459532|NCT03360734|Immunologic Factors|immunologic factors|mesh-ancestor
19459533|NCT03360734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459534|NCT03360734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19459535|NCT03360734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459536|NCT03360682|Tenofovir|tenofovir|mesh-list
19459537|NCT03360682|Lamivudine|lamivudine|mesh-list
19459538|NCT03360682|Emtricitabine|emtricitabine|mesh-list
19459539|NCT03360682|Abacavir|abacavir|mesh-list
19459540|NCT03360682|Dolutegravir|dolutegravir|mesh-list
19459541|NCT03360682|Antiviral Agents|antiviral agents|mesh-ancestor
19459542|NCT03360682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19459543|NCT03360682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19459544|NCT03360682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19459545|NCT03360682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459546|NCT03360682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459547|NCT03360682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19738772|NCT05011513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19738773|NCT05011513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19738774|NCT04973566|Hydroxychloroquine|hydroxychloroquine|mesh-list
19738775|NCT04973566|Etanercept|etanercept|mesh-list
19738776|NCT04973566|Antimalarials|antimalarials|mesh-ancestor
19738777|NCT04973566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19738778|NCT04973566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19738779|NCT04973566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19738780|NCT04973566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738781|NCT04973566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738782|NCT04973566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19738783|NCT04973566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19738784|NCT04973566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19738785|NCT04973566|Analgesics|analgesics|mesh-ancestor
19738786|NCT04973566|Sensory System Agents|sensory system agents|mesh-ancestor
19738787|NCT04973566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19738788|NCT04973566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738789|NCT04973566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19738790|NCT04973566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19738791|NCT04973566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19738792|NCT04973566|Immunologic Factors|immunologic factors|mesh-ancestor
19738793|NCT04931615|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19738794|NCT04931615|Thrombin|thrombin|mesh-list
19738795|NCT04931615|Hemostatics|hemostatics|mesh-ancestor
19738796|NCT04931615|Coagulants|coagulants|mesh-ancestor
19738797|NCT04907968|Carboplatin|carboplatin|mesh-list
19738798|NCT04907968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738799|NCT04754334|Insulin|insulin|mesh-list
19738800|NCT04754334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19738801|NCT04754334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738802|NCT04722575|Atezolizumab|atezolizumab|mesh-list
19738803|NCT04722575|Vemurafenib|vemurafenib|mesh-list
19738804|NCT04722575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738805|NCT04722575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19738806|NCT04722575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738807|NCT04722575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738808|NCT04717375|Pembrolizumab|pembrolizumab|mesh-list
19738809|NCT04717375|Cetuximab|cetuximab|mesh-list
19738810|NCT04717375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19738811|NCT04717375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985836|NCT01966419|Phenylacetic acid|phenylacetic acid|mesh-list
19985837|NCT01966419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19985838|NCT01966419|Antimetabolites|antimetabolites|mesh-ancestor
19985839|NCT01966419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985840|NCT01966419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985841|NCT01966718|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19985842|NCT01966718|Hormones|hormones|mesh-ancestor
19985843|NCT01966718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19985844|NCT01966718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985845|NCT01966809|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
19985846|NCT01966809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459548|NCT03360682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19459549|NCT03360682|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19459550|NCT03360682|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19459551|NCT03360279|Paclitaxel|paclitaxel|mesh-list
19459552|NCT03360279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19459553|NCT03360279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459554|NCT03360279|Tubulin Modulators|tubulin modulators|mesh-ancestor
19459555|NCT03360279|Antimitotic Agents|antimitotic agents|mesh-ancestor
19459556|NCT03360279|Mitosis Modulators|mitosis modulators|mesh-ancestor
19459557|NCT03360279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459558|NCT03360266|Listerine|listerine|mesh-list
19459559|NCT03360266|Fluorides|fluorides|mesh-list
19459560|NCT03360266|Sodium Fluoride|sodium fluoride|mesh-list
19459561|NCT03360266|Fluorides, Topical|fluorides, topical|mesh-list
19459562|NCT03360266|Cariostatic Agents|cariostatic agents|mesh-ancestor
19459563|NCT03360266|Protective Agents|protective agents|mesh-ancestor
19459564|NCT03360266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459565|NCT03360266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19459566|NCT03360266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19459567|NCT03360123|Midazolam|midazolam|mesh-list
19459568|NCT03360123|Triazolam|triazolam|mesh-list
19459569|NCT03360123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19459570|NCT03360123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19985847|NCT01966809|Dermatologic Agents|dermatologic agents|mesh-ancestor
19985848|NCT01966809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19738812|NCT04667312|Durvalumab|durvalumab|mesh-list
19738813|NCT04667312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19738814|NCT04667312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738815|NCT04667104|Tenofovir|tenofovir|mesh-list
19738816|NCT04667104|Entecavir|entecavir|mesh-list
19738817|NCT04667104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19738818|NCT04667104|Antiviral Agents|antiviral agents|mesh-ancestor
19738819|NCT04667104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19738820|NCT04667104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19738821|NCT04667104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19738822|NCT04667104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738823|NCT04667104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738824|NCT04667104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19738825|NCT04667104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19738826|NCT04641975|Mirabegron|mirabegron|mesh-list
19738827|NCT04641975|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19738828|NCT04641975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19738829|NCT04641975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19738830|NCT04641975|Adrenergic Agents|adrenergic agents|mesh-ancestor
19738831|NCT04641975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19738832|NCT04641975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738833|NCT04641975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738834|NCT04641975|Urological Agents|urological agents|mesh-ancestor
19738835|NCT04630145|Clarithromycin|clarithromycin|mesh-list
19738836|NCT04630145|Rifampin|rifampin|mesh-list
19738837|NCT04630145|Ethambutol|ethambutol|mesh-list
19738838|NCT04630145|Rifabutin|rifabutin|mesh-list
19738839|NCT04630145|Bedaquiline|bedaquiline|mesh-list
19738840|NCT04630145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19738841|NCT04630145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19738842|NCT04630145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19738843|NCT04630145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738844|NCT04630145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738845|NCT04630145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19738846|NCT04630145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19738847|NCT04630145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19738848|NCT04630145|Antitubercular Agents|antitubercular agents|mesh-ancestor
19738849|NCT04630145|Leprostatic Agents|leprostatic agents|mesh-ancestor
19738850|NCT04630145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19738851|NCT04630145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19738852|NCT04630145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19738853|NCT04630145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19738854|NCT04630145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19738855|NCT04630145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19738856|NCT04630145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19738857|NCT04629872|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19738858|NCT04629872|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19738859|NCT04629872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738860|NCT04629872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19738861|NCT04629872|Immunologic Factors|immunologic factors|mesh-ancestor
19738862|NCT04629872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738863|NCT04585789|Tenofovir|tenofovir|mesh-list
19738864|NCT04585789|Entecavir|entecavir|mesh-list
19738865|NCT04585789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19738866|NCT04585789|Antiviral Agents|antiviral agents|mesh-ancestor
19738867|NCT04585789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19738868|NCT04585789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19738869|NCT04585789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19738870|NCT04585789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738871|NCT04585789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738872|NCT04585789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19738873|NCT04585789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19738874|NCT04535544|Tenofovir|tenofovir|mesh-list
19738875|NCT04535544|Entecavir|entecavir|mesh-list
19738876|NCT04535544|Antiviral Agents|antiviral agents|mesh-ancestor
19738877|NCT04535544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19738878|NCT04535544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19738879|NCT04535544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19738880|NCT04535544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738881|NCT04535544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738882|NCT04535544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19985849|NCT01966978|Insulin|insulin|mesh-list
19985850|NCT01966978|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19985851|NCT01966978|Metformin|metformin|mesh-list
19985852|NCT01966978|Insulin Aspart|insulin aspart|mesh-list
19738883|NCT04535544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19738884|NCT04510038|Colchicine|colchicine|mesh-list
19738885|NCT04510038|Gout Suppressants|gout suppressants|mesh-ancestor
19738886|NCT04510038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19738887|NCT04510038|Tubulin Modulators|tubulin modulators|mesh-ancestor
19738888|NCT04510038|Antimitotic Agents|antimitotic agents|mesh-ancestor
19738889|NCT04510038|Mitosis Modulators|mitosis modulators|mesh-ancestor
19738890|NCT04510038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738891|NCT04510038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738892|NCT04498923|Dexamethasone|dexamethasone|mesh-list
19738893|NCT04498923|Epinephrine|epinephrine|mesh-list
19738894|NCT04498923|Bupivacaine|bupivacaine|mesh-list
19738895|NCT04498923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19738896|NCT04498923|Antiemetics|antiemetics|mesh-ancestor
19738897|NCT04498923|Autonomic Agents|autonomic agents|mesh-ancestor
19738898|NCT04498923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19738899|NCT04498923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738900|NCT04498923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19738901|NCT04498923|Glucocorticoids|glucocorticoids|mesh-ancestor
19738902|NCT04498923|Hormones|hormones|mesh-ancestor
19738903|NCT04498923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19738904|NCT04498923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19738905|NCT04498923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738906|NCT04498923|Anesthetics, Local|anesthetics, local|mesh-ancestor
19738907|NCT04498923|Anesthetics|anesthetics|mesh-ancestor
19738908|NCT04498923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19738909|NCT04498923|Sensory System Agents|sensory system agents|mesh-ancestor
19738910|NCT04498923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19738911|NCT04498923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19738912|NCT04498923|Adrenergic Agents|adrenergic agents|mesh-ancestor
19738913|NCT04498923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19738914|NCT04498923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738915|NCT04498923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19738916|NCT04498923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19738917|NCT04498923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19738918|NCT04498923|Respiratory System Agents|respiratory system agents|mesh-ancestor
19738919|NCT04498923|Mydriatics|mydriatics|mesh-ancestor
19738920|NCT04498923|Sympathomimetics|sympathomimetics|mesh-ancestor
19738921|NCT04498923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19738922|NCT04469556|Leucovorin|leucovorin|mesh-list
19738923|NCT04469556|Gemcitabine|gemcitabine|mesh-list
19738924|NCT04469556|Paclitaxel|paclitaxel|mesh-list
19738925|NCT04469556|Oxaliplatin|oxaliplatin|mesh-list
19738926|NCT04469556|Irinotecan|irinotecan|mesh-list
19738927|NCT04469556|Folfirinox|folfirinox|mesh-list
19738928|NCT04469556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19738929|NCT04469556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738930|NCT04469556|Tubulin Modulators|tubulin modulators|mesh-ancestor
19738931|NCT04469556|Antimitotic Agents|antimitotic agents|mesh-ancestor
19738932|NCT04469556|Mitosis Modulators|mitosis modulators|mesh-ancestor
19738933|NCT04469556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738934|NCT04469556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19738935|NCT04469556|Antimetabolites|antimetabolites|mesh-ancestor
19738936|NCT04469556|Antiviral Agents|antiviral agents|mesh-ancestor
19738937|NCT04469556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19738938|NCT04469556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738939|NCT04469556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19738940|NCT04469556|Immunologic Factors|immunologic factors|mesh-ancestor
19738941|NCT04469556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738942|NCT04469556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19738943|NCT04469556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19738944|NCT04469556|Antidotes|antidotes|mesh-ancestor
19738945|NCT04469556|Protective Agents|protective agents|mesh-ancestor
19738946|NCT04469556|Vitamin B Complex|vitamin b complex|mesh-ancestor
19738947|NCT04469556|Vitamins|vitamins|mesh-ancestor
19738948|NCT04469556|Micronutrients|micronutrients|mesh-ancestor
19738949|NCT04461795|Erenumab|erenumab|mesh-list
19738950|NCT04461795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19738951|NCT04461795|Immunologic Factors|immunologic factors|mesh-ancestor
19738952|NCT04461795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738953|NCT04461795|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
19738954|NCT04461795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738955|NCT04461795|Analgesics|analgesics|mesh-ancestor
19738956|NCT04461795|Sensory System Agents|sensory system agents|mesh-ancestor
19738957|NCT04461795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19738958|NCT04439539|Tenofovir|tenofovir|mesh-list
19738959|NCT04439539|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19738960|NCT04439539|Antiviral Agents|antiviral agents|mesh-ancestor
19738961|NCT04439539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19738962|NCT04439539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19738963|NCT04439539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19738964|NCT04439539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738965|NCT04439539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738966|NCT04439539|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19738967|NCT04439539|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19738968|NCT04439188|GSK2636771|gsk2636771|mesh-list
19738969|NCT04439188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985853|NCT01966978|Insulin, Long-Acting|insulin, long-acting|mesh-list
19985854|NCT01966978|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19985855|NCT01966978|Liraglutide|liraglutide|mesh-list
19985856|NCT01966978|Insulin Detemir|insulin detemir|mesh-list
19985857|NCT01966978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19985858|NCT01966978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985859|NCT01966978|Incretins|incretins|mesh-ancestor
19985860|NCT01966978|Hormones|hormones|mesh-ancestor
19985861|NCT01966978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19985862|NCT01967147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19985863|NCT01967147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19985864|NCT01967173|Fluticasone|fluticasone|mesh-list
19985865|NCT01967173|Xhance|xhance|mesh-list
19985866|NCT01967173|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19985867|NCT01967173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19985868|NCT01967173|Autonomic Agents|autonomic agents|mesh-ancestor
19985869|NCT01967173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19985870|NCT01967173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985871|NCT01967173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19985872|NCT01967173|Respiratory System Agents|respiratory system agents|mesh-ancestor
19985873|NCT01967173|Glucocorticoids|glucocorticoids|mesh-ancestor
19985874|NCT01967173|Hormones|hormones|mesh-ancestor
19985875|NCT01967173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19985876|NCT01967173|Sympathomimetics|sympathomimetics|mesh-ancestor
19985877|NCT01967173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19985878|NCT01967173|Dermatologic Agents|dermatologic agents|mesh-ancestor
19985879|NCT01967173|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19985880|NCT01967225|Linezolid|linezolid|mesh-list
19985881|NCT01967225|Tedizolid|tedizolid|mesh-list
19985882|NCT01967225|Tedizolid phosphate|tedizolid phosphate|mesh-list
19985883|NCT01967225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19985884|NCT01967225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19985885|NCT01967225|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19985886|NCT01967225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985887|NCT01967225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985888|NCT01967433|Diphenhydramine|diphenhydramine|mesh-list
19985889|NCT01967433|Promethazine|promethazine|mesh-list
19985890|NCT01967433|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19985891|NCT01967433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19985892|NCT01967433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19985893|NCT01967433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985894|NCT01967433|Anesthetics, Local|anesthetics, local|mesh-ancestor
19985895|NCT01967433|Anesthetics|anesthetics|mesh-ancestor
19985896|NCT01967433|Sensory System Agents|sensory system agents|mesh-ancestor
19985897|NCT01967433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19985898|NCT01967433|Antiemetics|antiemetics|mesh-ancestor
19985899|NCT01967433|Autonomic Agents|autonomic agents|mesh-ancestor
19985900|NCT01967433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19985901|NCT01967433|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19985902|NCT01967433|Histamine Antagonists|histamine antagonists|mesh-ancestor
19985903|NCT01967433|Histamine Agents|histamine agents|mesh-ancestor
19985904|NCT01967433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19985905|NCT01967433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985906|NCT01967433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19985907|NCT01967433|Antipruritics|antipruritics|mesh-ancestor
19985908|NCT01967433|Dermatologic Agents|dermatologic agents|mesh-ancestor
19985909|NCT01967550|Diclofenac|diclofenac|mesh-list
19985910|NCT01967550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19985911|NCT01967550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19985912|NCT01967550|Analgesics|analgesics|mesh-ancestor
19985913|NCT01967550|Sensory System Agents|sensory system agents|mesh-ancestor
19985914|NCT01967550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19985915|NCT01967550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985916|NCT01967550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19985917|NCT01967550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19985918|NCT01967550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19985919|NCT01967550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556303|NCT01946035|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20556304|NCT01946035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20556305|NCT01946035|Adrenergic Agents|adrenergic agents|mesh-ancestor
20556306|NCT01946035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19738970|NCT04439188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19738971|NCT04439188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738972|NCT04439188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738973|NCT04439149|GSK2636771|gsk2636771|mesh-list
19738974|NCT04439149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19738975|NCT04439149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19738976|NCT04439149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738977|NCT04439149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738978|NCT04421664|Hydroxychloroquine|hydroxychloroquine|mesh-list
19738979|NCT04421664|Antimalarials|antimalarials|mesh-ancestor
19738980|NCT04421664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19738981|NCT04421664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19738982|NCT04421664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19738983|NCT04421664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19738984|NCT04421664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738985|NCT04421664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19738986|NCT04416386|Ascorbic Acid|ascorbic acid|mesh-list
19738987|NCT04416386|Vitamins|vitamins|mesh-ancestor
19738988|NCT04416386|Micronutrients|micronutrients|mesh-ancestor
19738989|NCT04416386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19738990|NCT04416386|Antioxidants|antioxidants|mesh-ancestor
19738991|NCT04416386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19738992|NCT04416386|Protective Agents|protective agents|mesh-ancestor
19738993|NCT04410965|Teriflunomide|teriflunomide|mesh-list
19738994|NCT04410965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19738995|NCT04410965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19738996|NCT04410965|Analgesics|analgesics|mesh-ancestor
19738997|NCT04410965|Sensory System Agents|sensory system agents|mesh-ancestor
19738998|NCT04410965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19738999|NCT04410965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739000|NCT04410965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19739001|NCT04410965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19739002|NCT04410965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19739003|NCT04410965|Immunologic Factors|immunologic factors|mesh-ancestor
19739004|NCT04405999|Bromhexine|bromhexine|mesh-list
19739005|NCT04405999|Expectorants|expectorants|mesh-ancestor
19739006|NCT04405999|Respiratory System Agents|respiratory system agents|mesh-ancestor
19739007|NCT04364555|Clobetasol|clobetasol|mesh-list
19739008|NCT04364555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19739009|NCT04364555|Glucocorticoids|glucocorticoids|mesh-ancestor
19739010|NCT04364555|Hormones|hormones|mesh-ancestor
19739011|NCT04364555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19739012|NCT04364555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739013|NCT04353778|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
19739014|NCT04353778|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19739015|NCT04353778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739016|NCT04353778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739017|NCT04353778|Cholinergic Agents|cholinergic agents|mesh-ancestor
19739018|NCT04353778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19739019|NCT04353778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739020|NCT04280536|Trifluridine|trifluridine|mesh-list
19739021|NCT04280536|Antimetabolites|antimetabolites|mesh-ancestor
19739022|NCT04280536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739023|NCT04280536|Antiviral Agents|antiviral agents|mesh-ancestor
19739024|NCT04280536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19739025|NCT04277858|Cisplatin|cisplatin|mesh-list
19739026|NCT04277858|Docetaxel|docetaxel|mesh-list
19739027|NCT04277858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739028|NCT04277858|Tubulin Modulators|tubulin modulators|mesh-ancestor
19739029|NCT04277858|Antimitotic Agents|antimitotic agents|mesh-ancestor
19739030|NCT04277858|Mitosis Modulators|mitosis modulators|mesh-ancestor
19739031|NCT04277858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739032|NCT04232657|Denosumab|denosumab|mesh-list
19739033|NCT04232657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19739034|NCT04232657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739035|NCT04216043|Caseins|caseins|mesh-list
19739036|NCT04216043|Chelating Agents|chelating agents|mesh-ancestor
19739037|NCT04216043|Sequestering Agents|sequestering agents|mesh-ancestor
19739038|NCT04216043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739039|NCT04206059|Dexmedetomidine|dexmedetomidine|mesh-list
19739040|NCT04206059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19739041|NCT04206059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19739042|NCT04206059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739043|NCT04206059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19739044|NCT04206059|Analgesics|analgesics|mesh-ancestor
19739045|NCT04206059|Sensory System Agents|sensory system agents|mesh-ancestor
19739046|NCT04206059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19739047|NCT04206059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19739048|NCT04206059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19739049|NCT04206059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19739050|NCT04206059|Adrenergic Agents|adrenergic agents|mesh-ancestor
19739051|NCT04206059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19739052|NCT04206059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739053|NCT04184622|Tirzepatide|tirzepatide|mesh-list
19739054|NCT04184622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19739055|NCT04184622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739056|NCT04184622|Incretins|incretins|mesh-ancestor
19739057|NCT04184622|Hormones|hormones|mesh-ancestor
19739058|NCT04184622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19739059|NCT04170738|Amphetamine|amphetamine|mesh-list
19739060|NCT04170738|Adderall|adderall|mesh-list
19739061|NCT04170738|Dextroamphetamine|dextroamphetamine|mesh-list
19739062|NCT04170738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19739063|NCT04170738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739064|NCT04170738|Sympathomimetics|sympathomimetics|mesh-ancestor
19739065|NCT04170738|Autonomic Agents|autonomic agents|mesh-ancestor
19739066|NCT04170738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19739067|NCT04170738|Dopamine Agents|dopamine agents|mesh-ancestor
19739068|NCT04170738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19739069|NCT04170738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556307|NCT01946035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556308|NCT01946035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556309|NCT01946061|Oxaliplatin|oxaliplatin|mesh-list
20556310|NCT01946061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556311|NCT01946256|Amoxicillin|amoxicillin|mesh-list
20556312|NCT01946256|Erythromycin|erythromycin|mesh-list
19739070|NCT04170738|Adrenergic Agents|adrenergic agents|mesh-ancestor
19739071|NCT04170738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19739072|NCT04170738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19739073|NCT04170738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19739074|NCT04170738|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19739075|NCT04155424|Eculizumab|eculizumab|mesh-list
19739076|NCT04155424|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19739077|NCT04155424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19739078|NCT04155424|Immunologic Factors|immunologic factors|mesh-ancestor
19739079|NCT04155424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739080|NCT04147325|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19739081|NCT04147325|Antiviral Agents|antiviral agents|mesh-ancestor
20556313|NCT01946256|Erythromycin Estolate|erythromycin estolate|mesh-list
20556314|NCT01946256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20556315|NCT01946256|Erythromycin stearate|erythromycin stearate|mesh-list
20556316|NCT01946256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19739082|NCT04147325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19739083|NCT04133792|Simvastatin|simvastatin|mesh-list
19739084|NCT04133792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19739085|NCT04133792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19739086|NCT04133792|Antimetabolites|antimetabolites|mesh-ancestor
19739087|NCT04133792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739088|NCT04133792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19739089|NCT04133792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19739090|NCT04133792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739091|NCT04129554|Tenofovir|tenofovir|mesh-list
19739092|NCT04129554|Entecavir|entecavir|mesh-list
19739093|NCT04129554|Antiviral Agents|antiviral agents|mesh-ancestor
19739094|NCT04129554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19739095|NCT04129554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19739096|NCT04129554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19739097|NCT04129554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739098|NCT04129554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739099|NCT04129554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19739100|NCT04129554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19739101|NCT04099849|Zinc|zinc|mesh-list
19739102|NCT04099849|Trace Elements|trace elements|mesh-ancestor
19739103|NCT04099849|Micronutrients|micronutrients|mesh-ancestor
19739104|NCT04099849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739105|NCT04095442|Benzocaine|benzocaine|mesh-list
19739106|NCT04095442|Anesthetics, Local|anesthetics, local|mesh-ancestor
19739107|NCT04095442|Anesthetics|anesthetics|mesh-ancestor
19739108|NCT04095442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19739109|NCT04095442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739110|NCT04095442|Sensory System Agents|sensory system agents|mesh-ancestor
19739111|NCT04095442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19739112|NCT04091867|Cetuximab|cetuximab|mesh-list
19739113|NCT04091867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19739114|NCT04091867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739115|NCT04082910|Etanercept|etanercept|mesh-list
19739116|NCT04082910|Infliximab|infliximab|mesh-list
19739117|NCT04082910|Metoprolol|metoprolol|mesh-list
19739118|NCT04082910|Dermatologic Agents|dermatologic agents|mesh-ancestor
19739119|NCT04082910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19739120|NCT04082910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19739121|NCT04082910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19739122|NCT04082910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19739123|NCT04082910|Analgesics|analgesics|mesh-ancestor
19739124|NCT04082910|Sensory System Agents|sensory system agents|mesh-ancestor
19739125|NCT04082910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19739126|NCT04082910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739127|NCT04082910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19739128|NCT04082910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19739129|NCT04082910|Immunologic Factors|immunologic factors|mesh-ancestor
19739130|NCT04082910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19739131|NCT04082910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19739132|NCT04082910|Sympatholytics|sympatholytics|mesh-ancestor
19739133|NCT04082910|Autonomic Agents|autonomic agents|mesh-ancestor
19739134|NCT04082910|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19739135|NCT04082910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19739136|NCT04082910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19739137|NCT04082910|Adrenergic Agents|adrenergic agents|mesh-ancestor
19739138|NCT04082910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19739139|NCT04082910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739140|NCT04035473|Paclitaxel|paclitaxel|mesh-list
19739141|NCT04035473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19739142|NCT04035473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739143|NCT04035473|Tubulin Modulators|tubulin modulators|mesh-ancestor
19739144|NCT04035473|Antimitotic Agents|antimitotic agents|mesh-ancestor
19739145|NCT04035473|Mitosis Modulators|mitosis modulators|mesh-ancestor
19739146|NCT04035473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985920|NCT01967550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985921|NCT01967576|Axitinib|axitinib|mesh-list
19985922|NCT01967576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19985923|NCT01967576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19985924|NCT01967576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985925|NCT01967576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985926|NCT01967628|Vitamin D|vitamin d|mesh-list
19985927|NCT01967628|Cholecalciferol|cholecalciferol|mesh-list
19985928|NCT01967628|Vitamins|vitamins|mesh-ancestor
19985929|NCT01967628|Micronutrients|micronutrients|mesh-ancestor
19985930|NCT01967628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985931|NCT01967628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19985932|NCT01967628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19985933|NCT01967641|Buprenorphine|buprenorphine|mesh-list
19985934|NCT01967641|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19985935|NCT01967641|Naloxone|naloxone|mesh-list
19985936|NCT01967641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19985937|NCT01967641|Narcotics|narcotics|mesh-ancestor
19985938|NCT01967641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19985939|NCT01967641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985940|NCT01967641|Analgesics|analgesics|mesh-ancestor
19985941|NCT01967641|Sensory System Agents|sensory system agents|mesh-ancestor
19985942|NCT01967641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19985943|NCT01967641|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19985944|NCT01967862|Listerine|listerine|mesh-list
19985945|NCT01967862|Fluorides|fluorides|mesh-list
19985946|NCT01967862|Sodium Fluoride|sodium fluoride|mesh-list
19985947|NCT01967862|Cariostatic Agents|cariostatic agents|mesh-ancestor
19985948|NCT01967862|Protective Agents|protective agents|mesh-ancestor
19985949|NCT01967862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985950|NCT01967862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19985951|NCT01967862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19985952|NCT01967940|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19985953|NCT01967940|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19739147|NCT04035382|Misoprostol|misoprostol|mesh-list
19739148|NCT04035382|Oxytocin|oxytocin|mesh-list
19739149|NCT04035382|Oxytocics|oxytocics|mesh-ancestor
19739150|NCT04035382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19739151|NCT04035382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739152|NCT04035382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19739153|NCT04035382|Abortifacient Agents|abortifacient agents|mesh-ancestor
19739154|NCT04035382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19739155|NCT04035382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19739156|NCT04012931|Rilpivirine|rilpivirine|mesh-list
19739157|NCT04012931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19739158|NCT04012931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19739159|NCT04012931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739160|NCT04012931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739161|NCT04012931|Antiviral Agents|antiviral agents|mesh-ancestor
19739162|NCT04012931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19739163|NCT04012931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19739164|NCT04012931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19739165|NCT03993457|Citalopram|citalopram|mesh-list
19739166|NCT03993457|Bupropion|bupropion|mesh-list
19985954|NCT01967940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19985955|NCT01967940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19985956|NCT01967940|Protease Inhibitors|protease inhibitors|mesh-ancestor
19985957|NCT01967940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985958|NCT01967940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985959|NCT01967940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19985960|NCT01967940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19985961|NCT01967940|Antiviral Agents|antiviral agents|mesh-ancestor
19985962|NCT01967940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19985963|NCT01968031|Istradefylline|istradefylline|mesh-list
19985964|NCT01968031|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
19985965|NCT01968031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19985966|NCT01968031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19985967|NCT01968031|Purinergic Agents|purinergic agents|mesh-ancestor
19985968|NCT01968031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19985969|NCT01968031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985970|NCT01968031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985971|NCT01968057|Cyclosporine|cyclosporine|mesh-list
19985972|NCT01968057|Cyclosporins|cyclosporins|mesh-list
19985973|NCT01968057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985974|NCT01968057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985975|NCT01968057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19985976|NCT01968057|Immunologic Factors|immunologic factors|mesh-ancestor
19985977|NCT01968057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985978|NCT01968057|Antifungal Agents|antifungal agents|mesh-ancestor
19985979|NCT01968057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19985980|NCT01968057|Dermatologic Agents|dermatologic agents|mesh-ancestor
19985981|NCT01968057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19985982|NCT01968057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19985983|NCT01968070|Celecoxib|celecoxib|mesh-list
19985984|NCT01968070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19985985|NCT01968070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19985986|NCT01968070|Analgesics|analgesics|mesh-ancestor
19985987|NCT01968070|Sensory System Agents|sensory system agents|mesh-ancestor
19985988|NCT01968070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19985989|NCT01968070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19985990|NCT01968070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19985991|NCT01968070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19985992|NCT01968070|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19985993|NCT01968070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19985994|NCT01968070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19985995|NCT01968070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19985996|NCT01968135|Contraceptive Agents|contraceptive agents|mesh-list
19985997|NCT01968135|Contraceptives, Oral|contraceptives, oral|mesh-list
19985998|NCT01968135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19985999|NCT01968135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19986000|NCT01968135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986001|NCT01968135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19986002|NCT01968213|Rucaparib|rucaparib|mesh-list
19986003|NCT01968213|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19986004|NCT01968213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986005|NCT01968213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986006|NCT01968213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739167|NCT03993457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19739168|NCT03993457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19739169|NCT03993457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19739170|NCT03993457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739171|NCT03993457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19739172|NCT03993457|Serotonin Agents|serotonin agents|mesh-ancestor
19739173|NCT03993457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739174|NCT03993457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19739175|NCT03993457|Antidepressive Agents|antidepressive agents|mesh-ancestor
19739176|NCT03993457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19739177|NCT03993457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19739178|NCT03993457|Dopamine Agents|dopamine agents|mesh-ancestor
19739179|NCT03993457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19739180|NCT03993457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19739181|NCT03993457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739182|NCT03860428|Acetaminophen|acetaminophen|mesh-list
19739183|NCT03860428|Ibuprofen|ibuprofen|mesh-list
19739184|NCT03860428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
19739185|NCT03860428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19739186|NCT03860428|Analgesics|analgesics|mesh-ancestor
19739187|NCT03860428|Sensory System Agents|sensory system agents|mesh-ancestor
19739188|NCT03860428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19739189|NCT03860428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739190|NCT03860428|Antipyretics|antipyretics|mesh-ancestor
19739191|NCT03860428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19739192|NCT03860428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19739193|NCT03860428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19739194|NCT03860428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739195|NCT03860428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739196|NCT03823131|Pembrolizumab|pembrolizumab|mesh-list
19739197|NCT03823131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19739198|NCT03823131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739199|NCT03819049|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19739200|NCT03819049|Immunologic Factors|immunologic factors|mesh-ancestor
19986007|NCT01968317|Metformin|metformin|mesh-list
19986008|NCT01968317|Megestrol|megestrol|mesh-list
19986009|NCT01968317|Megestrol Acetate|megestrol acetate|mesh-list
19986010|NCT01968317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19986011|NCT01968317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986012|NCT01968317|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19986013|NCT01968317|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19986014|NCT01968317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19986015|NCT01968317|Contraceptive Agents|contraceptive agents|mesh-ancestor
19986016|NCT01968317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19986017|NCT01968317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19986018|NCT01968317|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19986019|NCT01968317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19986020|NCT01968317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986021|NCT01968317|Appetite Stimulants|appetite stimulants|mesh-ancestor
19986022|NCT01968317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19986023|NCT01968356|Ethanol|ethanol|mesh-list
19986024|NCT01968356|Chlorhexidine|chlorhexidine|mesh-list
19986025|NCT01968356|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19986026|NCT01968356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19986027|NCT01968356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19986028|NCT01968356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19986029|NCT01968356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986030|NCT01968356|Disinfectants|disinfectants|mesh-ancestor
19986031|NCT01968356|Dermatologic Agents|dermatologic agents|mesh-ancestor
19986032|NCT01968421|Broncho-Vaxom|broncho-vaxom|mesh-list
19986033|NCT01968421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19986034|NCT01968421|Immunologic Factors|immunologic factors|mesh-ancestor
19986035|NCT01968421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986036|NCT01968434|Carbocysteine|carbocysteine|mesh-list
19986037|NCT01968434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19986038|NCT01968434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19986039|NCT01968434|Expectorants|expectorants|mesh-ancestor
19986040|NCT01968434|Respiratory System Agents|respiratory system agents|mesh-ancestor
19986041|NCT01968551|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19986042|NCT01968551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19986043|NCT01968551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19986044|NCT01968551|Antiviral Agents|antiviral agents|mesh-ancestor
19986045|NCT01968551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19986046|NCT01968694|Diphenhydramine|diphenhydramine|mesh-list
19986047|NCT01968694|Promethazine|promethazine|mesh-list
19739201|NCT03819049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739202|NCT03796676|Abrocitinib|abrocitinib|mesh-list
19739203|NCT03796676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19739204|NCT03796676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739205|NCT03796676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739206|NCT03796273|Ketoconazole|ketoconazole|mesh-list
19739207|NCT03796273|Antifungal Agents|antifungal agents|mesh-ancestor
19739208|NCT03796273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19739209|NCT03796273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19739210|NCT03796273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19739211|NCT03796273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739212|NCT03796273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739213|NCT03796273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19739214|NCT03796273|Hormone Antagonists|hormone antagonists|mesh-ancestor
19739215|NCT03796273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19739216|NCT03796273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739217|NCT03796273|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19739218|NCT03702270|Penicillins|penicillins|mesh-list
19739219|NCT03702270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19739220|NCT03702270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19739221|NCT03691610|Vaccines|vaccines|mesh-list
19739222|NCT03691610|Immunoglobulins|immunoglobulins|mesh-list
19739223|NCT03691610|Immunologic Factors|immunologic factors|mesh-ancestor
19739224|NCT03691610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739225|NCT03667443|Inositol|inositol|mesh-list
19739226|NCT03667443|Vitamin B Complex|vitamin b complex|mesh-ancestor
19739227|NCT03667443|Vitamins|vitamins|mesh-ancestor
19739228|NCT03667443|Micronutrients|micronutrients|mesh-ancestor
19739229|NCT03667443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739230|NCT03622515|Anesthetics|anesthetics|mesh-list
19739231|NCT03622515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19739232|NCT03622515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739233|NCT03556332|Dexamethasone|dexamethasone|mesh-list
19739234|NCT03556332|Lenalidomide|lenalidomide|mesh-list
19739235|NCT03556332|Daratumumab|daratumumab|mesh-list
19739236|NCT03556332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19739237|NCT03556332|Antiemetics|antiemetics|mesh-ancestor
19739238|NCT03556332|Autonomic Agents|autonomic agents|mesh-ancestor
19739239|NCT03556332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19739240|NCT03556332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739241|NCT03556332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19739242|NCT03556332|Glucocorticoids|glucocorticoids|mesh-ancestor
19739243|NCT03556332|Hormones|hormones|mesh-ancestor
19739244|NCT03556332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19739245|NCT03556332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19739246|NCT03556332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739247|NCT03556332|Immunologic Factors|immunologic factors|mesh-ancestor
19739248|NCT03556332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19739249|NCT03556332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19739250|NCT03556332|Growth Substances|growth substances|mesh-ancestor
19739251|NCT03556332|Growth Inhibitors|growth inhibitors|mesh-ancestor
19739252|NCT03544099|Pembrolizumab|pembrolizumab|mesh-list
19739253|NCT03544099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19739254|NCT03544099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739255|NCT03519074|Cisplatin|cisplatin|mesh-list
19739256|NCT03519074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739257|NCT03498612|Pembrolizumab|pembrolizumab|mesh-list
19739258|NCT03498612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19739259|NCT03498612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739260|NCT03441048|Cytarabine|cytarabine|mesh-list
19739261|NCT03441048|Mitoxantrone|mitoxantrone|mesh-list
19739262|NCT03441048|Cladribine|cladribine|mesh-list
19739263|NCT03441048|Lintuzumab|lintuzumab|mesh-list
19739264|NCT03441048|Sargramostim|sargramostim|mesh-list
19739265|NCT03441048|Lenograstim|lenograstim|mesh-list
19739266|NCT03441048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19739267|NCT03441048|Antimetabolites|antimetabolites|mesh-ancestor
19739268|NCT03441048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739269|NCT03441048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739270|NCT03441048|Antiviral Agents|antiviral agents|mesh-ancestor
19739271|NCT03441048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19739272|NCT03441048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19739273|NCT03441048|Immunologic Factors|immunologic factors|mesh-ancestor
19739274|NCT03441048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739275|NCT03441048|Analgesics|analgesics|mesh-ancestor
19739276|NCT03441048|Sensory System Agents|sensory system agents|mesh-ancestor
19739277|NCT03441048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19739278|NCT03441048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19739279|NCT03441048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19739280|NCT03441048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739281|NCT03441048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19739282|NCT03441048|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19739283|NCT03384641|Bedaquiline|bedaquiline|mesh-list
19739284|NCT03384641|Antitubercular Agents|antitubercular agents|mesh-ancestor
19739285|NCT03384641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19739286|NCT03384641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19739287|NCT03345576|Methyltestosterone|methyltestosterone|mesh-list
19739288|NCT03345576|Testosterone|testosterone|mesh-list
19739289|NCT03345576|Testosterone undecanoate|testosterone undecanoate|mesh-list
19739290|NCT03345576|Testosterone enanthate|testosterone enanthate|mesh-list
19739291|NCT03345576|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19739292|NCT03345576|Androgens|androgens|mesh-ancestor
19739293|NCT03345576|Hormones|hormones|mesh-ancestor
19739294|NCT03345576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19739295|NCT03345576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739296|NCT03345576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19739297|NCT03345576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739298|NCT03345576|Anabolic Agents|anabolic agents|mesh-ancestor
19739299|NCT03338959|Pembrolizumab|pembrolizumab|mesh-list
19739300|NCT03338959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19739301|NCT03338959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739302|NCT03333486|Cyclophosphamide|cyclophosphamide|mesh-list
19739303|NCT03333486|Fludarabine|fludarabine|mesh-list
19739304|NCT03333486|Fludarabine phosphate|fludarabine phosphate|mesh-list
19739305|NCT03333486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19739306|NCT03333486|Immunologic Factors|immunologic factors|mesh-ancestor
19739307|NCT03333486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739308|NCT03333486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19739309|NCT03333486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19739310|NCT03333486|Alkylating Agents|alkylating agents|mesh-ancestor
19739311|NCT03333486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739312|NCT03333486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739313|NCT03333486|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19739314|NCT03333486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19739315|NCT03333486|Antimetabolites|antimetabolites|mesh-ancestor
19739316|NCT03310944|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
19739317|NCT03310944|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19739318|NCT03310944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739319|NCT03310944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19739320|NCT03310944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739321|NCT03283878|Cefazolin|cefazolin|mesh-list
19739322|NCT03283878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19739323|NCT03283878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19739324|NCT03259503|Gemcitabine|gemcitabine|mesh-list
19739325|NCT03259503|Rituximab|rituximab|mesh-list
19739326|NCT03259503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19739327|NCT03259503|Melphalan|melphalan|mesh-list
19739328|NCT03259503|Busulfan|busulfan|mesh-list
19739329|NCT03259503|Olaparib|olaparib|mesh-list
19739330|NCT03259503|Mechlorethamine|mechlorethamine|mesh-list
19739331|NCT03259503|Vorinostat|vorinostat|mesh-list
19739332|NCT03259503|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
19739333|NCT03259503|Antibodies|antibodies|mesh-list
19739334|NCT03259503|Immunoglobulins|immunoglobulins|mesh-list
19739335|NCT03259503|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19739336|NCT03259503|Immunologic Factors|immunologic factors|mesh-ancestor
19739337|NCT03259503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739338|NCT03259503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739339|NCT03259503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19739340|NCT03259503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19739341|NCT03259503|Antimetabolites|antimetabolites|mesh-ancestor
19739342|NCT03259503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739343|NCT03259503|Antiviral Agents|antiviral agents|mesh-ancestor
19739344|NCT03259503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19739345|NCT03259503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739346|NCT03259503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19739347|NCT03259503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19739348|NCT03259503|Alkylating Agents|alkylating agents|mesh-ancestor
19739349|NCT03259503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19739350|NCT03259503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19739351|NCT03259503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19739352|NCT03235739|Naloxegol|naloxegol|mesh-list
19739353|NCT03235739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19739354|NCT03235739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739355|NCT03235739|Sensory System Agents|sensory system agents|mesh-ancestor
19739356|NCT03235739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19739357|NCT03215810|Cyclophosphamide|cyclophosphamide|mesh-list
19739358|NCT03215810|Nivolumab|nivolumab|mesh-list
19739359|NCT03215810|Fludarabine|fludarabine|mesh-list
19739360|NCT03215810|Interleukin-2|interleukin-2|mesh-list
19739361|NCT03215810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19739362|NCT03215810|Immunologic Factors|immunologic factors|mesh-ancestor
19739363|NCT03215810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739364|NCT03215810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19986048|NCT01968694|Lidocaine|lidocaine|mesh-list
19986049|NCT01968694|Anesthetics, Local|anesthetics, local|mesh-ancestor
19986050|NCT01968694|Anesthetics|anesthetics|mesh-ancestor
19986051|NCT01968694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19986052|NCT01968694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986053|NCT01968694|Sensory System Agents|sensory system agents|mesh-ancestor
19986054|NCT01968694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19986055|NCT01968694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19986056|NCT01968694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19986057|NCT01968694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19986058|NCT01968694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19986059|NCT01968694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986060|NCT01968694|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19986061|NCT01968694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19986062|NCT01968694|Antiemetics|antiemetics|mesh-ancestor
19986063|NCT01968694|Autonomic Agents|autonomic agents|mesh-ancestor
19986064|NCT01968694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19986065|NCT01968694|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19986066|NCT01968694|Histamine Antagonists|histamine antagonists|mesh-ancestor
19986067|NCT01968694|Histamine Agents|histamine agents|mesh-ancestor
19986068|NCT01968694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19986069|NCT01968694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19986070|NCT01968694|Antipruritics|antipruritics|mesh-ancestor
19986071|NCT01968694|Dermatologic Agents|dermatologic agents|mesh-ancestor
19986072|NCT01968707|Ethanol|ethanol|mesh-list
19986073|NCT01968707|Chlorhexidine|chlorhexidine|mesh-list
19986074|NCT01968707|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19986075|NCT01968707|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19986076|NCT01968707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19986077|NCT01968707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19986078|NCT01968707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986079|NCT01968707|Disinfectants|disinfectants|mesh-ancestor
19986080|NCT01968707|Dermatologic Agents|dermatologic agents|mesh-ancestor
19986081|NCT01968954|Bococizumab|bococizumab|mesh-list
19986082|NCT01968954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19986083|NCT01968954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19986084|NCT01968954|Antimetabolites|antimetabolites|mesh-ancestor
19739365|NCT03215810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19739366|NCT03215810|Alkylating Agents|alkylating agents|mesh-ancestor
19739367|NCT03215810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739368|NCT03215810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739369|NCT03215810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19739370|NCT03215810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19739371|NCT03215810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19739372|NCT03215810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19739373|NCT03215810|Analgesics|analgesics|mesh-ancestor
19739374|NCT03215810|Sensory System Agents|sensory system agents|mesh-ancestor
19739375|NCT03215810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19739376|NCT03179761|Vaccines|vaccines|mesh-list
19739377|NCT03179761|Immunologic Factors|immunologic factors|mesh-ancestor
19739378|NCT03179761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739379|NCT03176277|Venetoclax|venetoclax|mesh-list
19739380|NCT03176277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739381|NCT03150004|Cytarabine|cytarabine|mesh-list
19739382|NCT03150004|Mitoxantrone|mitoxantrone|mesh-list
19739383|NCT03150004|Cladribine|cladribine|mesh-list
19739384|NCT03150004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19739385|NCT03150004|Antimetabolites|antimetabolites|mesh-ancestor
19739386|NCT03150004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739387|NCT03150004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739388|NCT03150004|Antiviral Agents|antiviral agents|mesh-ancestor
19739389|NCT03150004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19739390|NCT03150004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19739391|NCT03150004|Immunologic Factors|immunologic factors|mesh-ancestor
19739392|NCT03150004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739393|NCT03150004|Analgesics|analgesics|mesh-ancestor
19739394|NCT03150004|Sensory System Agents|sensory system agents|mesh-ancestor
19739395|NCT03150004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19739396|NCT03150004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19739397|NCT03150004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19739398|NCT03150004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986085|NCT01968954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986086|NCT01968954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19986087|NCT01968967|Bococizumab|bococizumab|mesh-list
19986088|NCT01968967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19986089|NCT01968967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19986090|NCT01968967|Antimetabolites|antimetabolites|mesh-ancestor
19986091|NCT01968967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986092|NCT01968967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19986093|NCT01968980|Bococizumab|bococizumab|mesh-list
19986094|NCT01968980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19986095|NCT01968980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19986096|NCT01968980|Antimetabolites|antimetabolites|mesh-ancestor
19986097|NCT01968980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986098|NCT01968980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19986099|NCT01969058|Isotretinoin|isotretinoin|mesh-list
19986100|NCT01969058|Dermatologic Agents|dermatologic agents|mesh-ancestor
19986101|NCT01969084|Linagliptin|linagliptin|mesh-list
19986102|NCT01969084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19986103|NCT01969084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986104|NCT01969084|Incretins|incretins|mesh-ancestor
19986105|NCT01969084|Hormones|hormones|mesh-ancestor
19986106|NCT01969084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19986107|NCT01969084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19986108|NCT01969084|Protease Inhibitors|protease inhibitors|mesh-ancestor
19986109|NCT01969084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986110|NCT01969084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986111|NCT01969201|Hormones|hormones|mesh-list
19986112|NCT01969201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19986113|NCT01969201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986114|NCT01969435|Cytarabine|cytarabine|mesh-list
19986115|NCT01969435|Etoposide|etoposide|mesh-list
19986116|NCT01969435|Melphalan|melphalan|mesh-list
19986117|NCT01969435|Carmustine|carmustine|mesh-list
19986118|NCT01969435|Etoposide phosphate|etoposide phosphate|mesh-list
19986119|NCT01969435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19986120|NCT01969435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986121|NCT01969435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19986122|NCT01969435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19986123|NCT01969435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986124|NCT01969435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986125|NCT01969435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19986126|NCT01969435|Antimetabolites|antimetabolites|mesh-ancestor
19986127|NCT01969435|Antiviral Agents|antiviral agents|mesh-ancestor
19986128|NCT01969435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19986129|NCT01969435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19986130|NCT01969435|Immunologic Factors|immunologic factors|mesh-ancestor
19986131|NCT01969435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986132|NCT01969435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19986133|NCT01969435|Alkylating Agents|alkylating agents|mesh-ancestor
19986134|NCT01969435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20289152|NCT04931602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289153|NCT04931602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19739399|NCT03125811|Ethanol|ethanol|mesh-list
19739400|NCT03125811|Ondansetron|ondansetron|mesh-list
19739401|NCT03125811|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19739402|NCT03125811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19739403|NCT03125811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19739404|NCT03125811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739405|NCT03125811|Antiemetics|antiemetics|mesh-ancestor
19739406|NCT03125811|Autonomic Agents|autonomic agents|mesh-ancestor
19739407|NCT03125811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19739408|NCT03125811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19739409|NCT03125811|Antipruritics|antipruritics|mesh-ancestor
19739410|NCT03125811|Dermatologic Agents|dermatologic agents|mesh-ancestor
19739411|NCT03125811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19739412|NCT03125811|Serotonin Agents|serotonin agents|mesh-ancestor
19739413|NCT03125811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19739414|NCT03125811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739415|NCT03125811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19739416|NCT03125811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19739417|NCT03125811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19739418|NCT03125811|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19739419|NCT03036930|Vaccines|vaccines|mesh-list
19739420|NCT03036930|Immunologic Factors|immunologic factors|mesh-ancestor
19739421|NCT03036930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739422|NCT02989857|Ivosidenib|ivosidenib|mesh-list
19739423|NCT02989857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739424|NCT02989857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739425|NCT02989857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739426|NCT02983799|Olaparib|olaparib|mesh-list
19739427|NCT02983799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19739428|NCT02983799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739429|NCT02983799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739430|NCT02983799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739431|NCT02974725|Trametinib|trametinib|mesh-list
19739432|NCT02974725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739433|NCT02974725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19739434|NCT02974725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739435|NCT02974725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739436|NCT02971683|Abatacept|abatacept|mesh-list
19739437|NCT02971683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19739438|NCT02971683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739439|NCT02971683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739440|NCT02971683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19739441|NCT02971683|Immunologic Factors|immunologic factors|mesh-ancestor
19739442|NCT02971683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739443|NCT02971683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19739444|NCT02845271|Acetaminophen|acetaminophen|mesh-list
19739445|NCT02845271|Tramadol|tramadol|mesh-list
19739446|NCT02845271|Codeine|codeine|mesh-list
19739447|NCT02845271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19739448|NCT02845271|Analgesics|analgesics|mesh-ancestor
19739449|NCT02845271|Sensory System Agents|sensory system agents|mesh-ancestor
19739450|NCT02845271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19739451|NCT02845271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739452|NCT02845271|Antipyretics|antipyretics|mesh-ancestor
19739453|NCT02845271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19739454|NCT02845271|Narcotics|narcotics|mesh-ancestor
19739455|NCT02845271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19739456|NCT02845271|Antitussive Agents|antitussive agents|mesh-ancestor
19739457|NCT02845271|Respiratory System Agents|respiratory system agents|mesh-ancestor
19739458|NCT02842359|Irbesartan|irbesartan|mesh-list
19986135|NCT01969708|Bevacizumab|bevacizumab|mesh-list
19986136|NCT01969708|Aflibercept|aflibercept|mesh-list
19986137|NCT01969708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19986138|NCT01969708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986139|NCT01969708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19986140|NCT01969708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19986141|NCT01969708|Growth Substances|growth substances|mesh-ancestor
19986142|NCT01969708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986143|NCT01969708|Growth Inhibitors|growth inhibitors|mesh-ancestor
19986144|NCT01969721|Fluticasone|fluticasone|mesh-list
19986145|NCT01969721|Xhance|xhance|mesh-list
19986146|NCT01969721|Tiotropium Bromide|tiotropium bromide|mesh-list
19986147|NCT01969721|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19986148|NCT01969721|Olodaterol|olodaterol|mesh-list
19986149|NCT01969721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19739459|NCT02842359|Atorvastatin|atorvastatin|mesh-list
19739460|NCT02842359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19986150|NCT01969721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19739461|NCT02842359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19739462|NCT02842359|Antimetabolites|antimetabolites|mesh-ancestor
19739463|NCT02842359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739464|NCT02842359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19739465|NCT02842359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19739466|NCT02842359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739467|NCT02842359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19739468|NCT02842359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19739469|NCT02842359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19739470|NCT02796937|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19739471|NCT02796937|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19739472|NCT02796937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19739473|NCT02796937|Protease Inhibitors|protease inhibitors|mesh-ancestor
19739474|NCT02796937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739475|NCT02796937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739476|NCT02679508|Lansoprazole|lansoprazole|mesh-list
19739477|NCT02679508|Dexlansoprazole|dexlansoprazole|mesh-list
19739478|NCT02679508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19739479|NCT02679508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19739480|NCT02679508|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19739481|NCT02679508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739482|NCT02679508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739483|NCT02678312|Enalapril|enalapril|mesh-list
19739484|NCT02678312|Enalaprilat|enalaprilat|mesh-list
19739485|NCT02678312|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19739486|NCT02678312|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19739487|NCT02678312|Protease Inhibitors|protease inhibitors|mesh-ancestor
19739488|NCT02678312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739489|NCT02678312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739490|NCT02678312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19739491|NCT02678312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19739492|NCT02633059|Dexamethasone|dexamethasone|mesh-list
19739493|NCT02633059|Dexamethasone acetate|dexamethasone acetate|mesh-list
19739494|NCT02633059|Ixazomib|ixazomib|mesh-list
19739495|NCT02633059|Ichthammol|ichthammol|mesh-list
19739496|NCT02633059|BB 1101|bb 1101|mesh-list
19739497|NCT02633059|Glycine|glycine|mesh-list
19739498|NCT02633059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19739499|NCT02633059|Antiemetics|antiemetics|mesh-ancestor
19739500|NCT02633059|Autonomic Agents|autonomic agents|mesh-ancestor
19739501|NCT02633059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19739502|NCT02633059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739503|NCT02633059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19739504|NCT02633059|Glucocorticoids|glucocorticoids|mesh-ancestor
19739505|NCT02633059|Hormones|hormones|mesh-ancestor
19739506|NCT02633059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19739507|NCT02633059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19739508|NCT02633059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739509|NCT02633059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739510|NCT02633059|Protease Inhibitors|protease inhibitors|mesh-ancestor
19739511|NCT02633059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739512|NCT02633059|Dermatologic Agents|dermatologic agents|mesh-ancestor
19739513|NCT02633059|Glycine Agents|glycine agents|mesh-ancestor
19739514|NCT02633059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19739515|NCT02631577|Lenalidomide|lenalidomide|mesh-list
19739516|NCT02631577|Atezolizumab|atezolizumab|mesh-list
19739517|NCT02631577|Obinutuzumab|obinutuzumab|mesh-list
19739518|NCT02631577|Immunologic Factors|immunologic factors|mesh-ancestor
19739519|NCT02631577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739520|NCT02631577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19739521|NCT02631577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19739522|NCT02631577|Growth Substances|growth substances|mesh-ancestor
19739523|NCT02631577|Growth Inhibitors|growth inhibitors|mesh-ancestor
19739524|NCT02631577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739525|NCT02631577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19739526|NCT02494986|Rilpivirine|rilpivirine|mesh-list
19739527|NCT02494986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19739528|NCT02494986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19739529|NCT02494986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739530|NCT02494986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739531|NCT02494986|Antiviral Agents|antiviral agents|mesh-ancestor
19739532|NCT02494986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19739533|NCT02494986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19739534|NCT02494986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19739535|NCT02408315|Misoprostol|misoprostol|mesh-list
19739536|NCT02408315|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19739537|NCT02408315|Abortifacient Agents|abortifacient agents|mesh-ancestor
19739538|NCT02408315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19739539|NCT02408315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739540|NCT02408315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19739541|NCT02408315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19739542|NCT02408315|Oxytocics|oxytocics|mesh-ancestor
19739543|NCT02354014|Bedaquiline|bedaquiline|mesh-list
19739544|NCT02354014|Diarylquinolines|diarylquinolines|mesh-list
19739545|NCT02354014|Antitubercular Agents|antitubercular agents|mesh-ancestor
19739546|NCT02354014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19986151|NCT01969721|Autonomic Agents|autonomic agents|mesh-ancestor
19986152|NCT01969721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19986153|NCT01969721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986154|NCT01969721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19739547|NCT02354014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19739548|NCT02125461|Durvalumab|durvalumab|mesh-list
19739549|NCT02125461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19739550|NCT02125461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739551|NCT02022592|Midazolam|midazolam|mesh-list
19739552|NCT02022592|Lormetazepam|lormetazepam|mesh-list
19739553|NCT02022592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19739554|NCT02022592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19739555|NCT02022592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19739556|NCT02022592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739557|NCT02022592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19739558|NCT02022592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19739559|NCT02022592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19739560|NCT02022592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19739561|NCT02022592|Anesthetics, General|anesthetics, general|mesh-ancestor
19739562|NCT02022592|Anesthetics|anesthetics|mesh-ancestor
19739563|NCT02022592|GABA Modulators|gaba modulators|mesh-ancestor
19739564|NCT02022592|GABA Agents|gaba agents|mesh-ancestor
19739565|NCT02022592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19739566|NCT02022592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739567|NCT01854814|Mycophenolic Acid|mycophenolic acid|mesh-list
19739568|NCT01854814|Losartan|losartan|mesh-list
19739569|NCT01854814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19739570|NCT01854814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739571|NCT01854814|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19739572|NCT01854814|Antitubercular Agents|antitubercular agents|mesh-ancestor
19739573|NCT01854814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19739574|NCT01854814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19739575|NCT01854814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739576|NCT01854814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739577|NCT01854814|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19739578|NCT01854814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19739579|NCT01854814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19739580|NCT01854814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19739581|NCT01837862|Mebendazole|mebendazole|mesh-list
19739582|NCT01837862|Piperazine|piperazine|mesh-list
19739583|NCT01837862|Piperazine citrate|piperazine citrate|mesh-list
19739584|NCT01837862|Bevacizumab|bevacizumab|mesh-list
19739585|NCT01837862|Carboplatin|carboplatin|mesh-list
19739586|NCT01837862|Irinotecan|irinotecan|mesh-list
19739587|NCT01837862|Vincristine|vincristine|mesh-list
19739588|NCT01837862|Temozolomide|temozolomide|mesh-list
19739589|NCT01837862|DMP 777|dmp 777|mesh-list
19739590|NCT01837862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19739591|NCT01837862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739592|NCT01837862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19739593|NCT01837862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19739594|NCT01837862|Growth Substances|growth substances|mesh-ancestor
19739595|NCT01837862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739596|NCT01837862|Growth Inhibitors|growth inhibitors|mesh-ancestor
19739597|NCT01837862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19739598|NCT01837862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19739599|NCT01837862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739600|NCT01837862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739601|NCT01837862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19739602|NCT01837862|Tubulin Modulators|tubulin modulators|mesh-ancestor
19739603|NCT01837862|Antimitotic Agents|antimitotic agents|mesh-ancestor
19739604|NCT01837862|Mitosis Modulators|mitosis modulators|mesh-ancestor
19739605|NCT01837862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19739606|NCT01837862|Alkylating Agents|alkylating agents|mesh-ancestor
19739607|NCT01837862|Antinematodal Agents|antinematodal agents|mesh-ancestor
19739608|NCT01837862|Anthelmintics|anthelmintics|mesh-ancestor
19739609|NCT01837862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19739610|NCT01837862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19739611|NCT01813227|Dexamethasone|dexamethasone|mesh-list
19739612|NCT01813227|Rituximab|rituximab|mesh-list
19739613|NCT01813227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19739614|NCT01813227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739615|NCT01813227|Immunologic Factors|immunologic factors|mesh-ancestor
19739616|NCT01813227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739617|NCT01813227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19739618|NCT01813227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19739619|NCT01813227|Antiemetics|antiemetics|mesh-ancestor
19739620|NCT01813227|Autonomic Agents|autonomic agents|mesh-ancestor
19739621|NCT01813227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19739622|NCT01813227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19739623|NCT01813227|Glucocorticoids|glucocorticoids|mesh-ancestor
19739624|NCT01813227|Hormones|hormones|mesh-ancestor
19739625|NCT01813227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19739626|NCT01813227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19739627|NCT01791478|Letrozole|letrozole|mesh-list
19739628|NCT01791478|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
19739629|NCT01791478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739630|NCT01791478|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19739631|NCT01791478|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19739632|NCT01791478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739633|NCT01791478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739634|NCT01791478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19739635|NCT01791478|Hormone Antagonists|hormone antagonists|mesh-ancestor
19986155|NCT01969721|Respiratory System Agents|respiratory system agents|mesh-ancestor
19986156|NCT01969721|Dermatologic Agents|dermatologic agents|mesh-ancestor
19986157|NCT01969721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19986158|NCT01969721|Parasympatholytics|parasympatholytics|mesh-ancestor
19986159|NCT01969721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19986160|NCT01969721|Cholinergic Agents|cholinergic agents|mesh-ancestor
19986161|NCT01969721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19986162|NCT01969721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986163|NCT01969721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19986164|NCT01969721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19986165|NCT01969721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19986166|NCT01969721|Adrenergic Agents|adrenergic agents|mesh-ancestor
19986167|NCT01969747|Empagliflozin|empagliflozin|mesh-list
19986168|NCT01969747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19986169|NCT01969747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986170|NCT01969747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19986171|NCT01969747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986172|NCT01969799|Amikacin|amikacin|mesh-list
19986173|NCT01969799|Fosfomycin|fosfomycin|mesh-list
19986174|NCT01969799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19986175|NCT01969799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19986176|NCT01969851|Lacosamide|lacosamide|mesh-list
19986177|NCT01969851|Anticonvulsants|anticonvulsants|mesh-ancestor
19986178|NCT01969851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19986179|NCT01969851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19986180|NCT01969851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19986181|NCT01969851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986182|NCT01969916|Regadenoson|regadenoson|mesh-list
19986183|NCT01969916|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19986184|NCT01969916|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19986185|NCT01969916|Purinergic Agonists|purinergic agonists|mesh-ancestor
19459571|NCT03360123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19459572|NCT03360123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459573|NCT03360123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19459574|NCT03360123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19459575|NCT03360123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19459576|NCT03360123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19459577|NCT03360123|Anesthetics, General|anesthetics, general|mesh-ancestor
19459578|NCT03360123|Anesthetics|anesthetics|mesh-ancestor
19459579|NCT03360123|GABA Modulators|gaba modulators|mesh-ancestor
19459580|NCT03360123|GABA Agents|gaba agents|mesh-ancestor
19739636|NCT01791478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19739637|NCT01791478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739638|NCT01698840|Vitamin D|vitamin d|mesh-list
19739639|NCT01698840|Vitamins|vitamins|mesh-ancestor
19739640|NCT01698840|Micronutrients|micronutrients|mesh-ancestor
19739641|NCT01698840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739642|NCT01698840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19739643|NCT01695317|Acetylcarnitine|acetylcarnitine|mesh-list
19739644|NCT01695317|Vitamin B Complex|vitamin b complex|mesh-ancestor
19739645|NCT01695317|Vitamins|vitamins|mesh-ancestor
19739646|NCT01695317|Micronutrients|micronutrients|mesh-ancestor
19739647|NCT01695317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739648|NCT01695317|Nootropic Agents|nootropic agents|mesh-ancestor
19739649|NCT01652092|Vidarabine|vidarabine|mesh-list
19739650|NCT01652092|Cyclophosphamide|cyclophosphamide|mesh-list
19739651|NCT01652092|Melphalan|melphalan|mesh-list
19739652|NCT01652092|Busulfan|busulfan|mesh-list
19739653|NCT01652092|Fludarabine|fludarabine|mesh-list
19739654|NCT01652092|Fludarabine phosphate|fludarabine phosphate|mesh-list
19739655|NCT01652092|Alemtuzumab|alemtuzumab|mesh-list
19739656|NCT01652092|Mesna|mesna|mesh-list
19739657|NCT01652092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19739658|NCT01652092|Immunologic Factors|immunologic factors|mesh-ancestor
19739659|NCT01652092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739660|NCT01652092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19739661|NCT01652092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19739662|NCT01652092|Alkylating Agents|alkylating agents|mesh-ancestor
19739663|NCT01652092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739664|NCT01652092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739665|NCT01652092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19739666|NCT01652092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19739667|NCT01652092|Antimetabolites|antimetabolites|mesh-ancestor
19739668|NCT01652092|Antiviral Agents|antiviral agents|mesh-ancestor
19739669|NCT01652092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19739670|NCT01652092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19739671|NCT01652092|Protective Agents|protective agents|mesh-ancestor
19739672|NCT01505569|Etoposide|etoposide|mesh-list
19739673|NCT01505569|Carboplatin|carboplatin|mesh-list
19739674|NCT01505569|Melphalan|melphalan|mesh-list
19739675|NCT01505569|Busulfan|busulfan|mesh-list
19739676|NCT01505569|Ifosfamide|ifosfamide|mesh-list
19739677|NCT01505569|Thiotepa|thiotepa|mesh-list
19739678|NCT01505569|Lenograstim|lenograstim|mesh-list
19739679|NCT01505569|Mesna|mesna|mesh-list
19739680|NCT01505569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19739681|NCT01505569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739682|NCT01505569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739683|NCT01505569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19739684|NCT01505569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19739685|NCT01505569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739686|NCT01505569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19739687|NCT01505569|Alkylating Agents|alkylating agents|mesh-ancestor
19739688|NCT01505569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19739689|NCT01505569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19739690|NCT01505569|Immunologic Factors|immunologic factors|mesh-ancestor
19739691|NCT01505569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739692|NCT01505569|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19739693|NCT01505569|Protective Agents|protective agents|mesh-ancestor
19739694|NCT01196936|Tamoxifen|tamoxifen|mesh-list
19739695|NCT01196936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19739696|NCT01196936|Hormone Antagonists|hormone antagonists|mesh-ancestor
19739697|NCT01196936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19739698|NCT01196936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739699|NCT01196936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19739700|NCT01196936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739701|NCT01196936|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19739702|NCT01196936|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19739703|NCT01196936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19739704|NCT01127451|Denileukin diftitox|denileukin diftitox|mesh-list
19739705|NCT01127451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739706|NCT01068249|Everolimus|everolimus|mesh-list
19739707|NCT01068249|Letrozole|letrozole|mesh-list
19739708|NCT01068249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739709|NCT01068249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19739710|NCT01068249|Immunologic Factors|immunologic factors|mesh-ancestor
19739711|NCT01068249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739712|NCT01068249|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19739713|NCT01068249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19739714|NCT01068249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739715|NCT01068249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739716|NCT01068249|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19739717|NCT01068249|Hormone Antagonists|hormone antagonists|mesh-ancestor
19739718|NCT01068249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19739719|NCT01054196|Lenalidomide|lenalidomide|mesh-list
19739720|NCT01054196|Melphalan|melphalan|mesh-list
19739721|NCT01054196|Immunologic Factors|immunologic factors|mesh-ancestor
19739722|NCT01054196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739723|NCT01054196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19739724|NCT01054196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19739725|NCT01054196|Growth Substances|growth substances|mesh-ancestor
19739726|NCT01054196|Growth Inhibitors|growth inhibitors|mesh-ancestor
19739727|NCT01054196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739728|NCT01054196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19739729|NCT01054196|Alkylating Agents|alkylating agents|mesh-ancestor
19739730|NCT01054196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739731|NCT01054196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19739732|NCT01054196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19739733|NCT01004874|Bevacizumab|bevacizumab|mesh-list
19739734|NCT01004874|Temozolomide|temozolomide|mesh-list
19739735|NCT01004874|Topotecan|topotecan|mesh-list
19739736|NCT01004874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19739737|NCT01004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739738|NCT01004874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19739739|NCT01004874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19739740|NCT01004874|Growth Substances|growth substances|mesh-ancestor
19739741|NCT01004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739742|NCT01004874|Growth Inhibitors|growth inhibitors|mesh-ancestor
19739743|NCT01004874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19739744|NCT01004874|Alkylating Agents|alkylating agents|mesh-ancestor
19739745|NCT01004874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739746|NCT01004874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19739747|NCT01004874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19739748|NCT01004874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739749|NCT00799864|Tenofovir|tenofovir|mesh-list
19739750|NCT00799864|Lamivudine|lamivudine|mesh-list
19739751|NCT00799864|Zidovudine|zidovudine|mesh-list
19739752|NCT00799864|Emtricitabine|emtricitabine|mesh-list
19739753|NCT00799864|Abacavir|abacavir|mesh-list
19739754|NCT00799864|Rilpivirine|rilpivirine|mesh-list
19739755|NCT00799864|Antiviral Agents|antiviral agents|mesh-ancestor
19739756|NCT00799864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19739757|NCT00799864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19739758|NCT00799864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19739759|NCT00799864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739760|NCT00799864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739761|NCT00799864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19739762|NCT00799864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19739763|NCT00799864|Antimetabolites|antimetabolites|mesh-ancestor
19739764|NCT00268476|Zoledronic Acid|zoledronic acid|mesh-list
19739765|NCT00268476|Metformin|metformin|mesh-list
19739766|NCT00268476|Prednisone|prednisone|mesh-list
19739767|NCT00268476|Prednisolone|prednisolone|mesh-list
19739768|NCT00268476|Celecoxib|celecoxib|mesh-list
19739769|NCT00268476|Docetaxel|docetaxel|mesh-list
19739770|NCT00268476|Estradiol|estradiol|mesh-list
19739771|NCT00268476|Androgens|androgens|mesh-list
19739772|NCT00268476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19739773|NCT00268476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739774|NCT00268476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739775|NCT00268476|Tubulin Modulators|tubulin modulators|mesh-ancestor
19739776|NCT00268476|Antimitotic Agents|antimitotic agents|mesh-ancestor
19739777|NCT00268476|Mitosis Modulators|mitosis modulators|mesh-ancestor
19739778|NCT00268476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739779|NCT00268476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19739780|NCT00268476|Glucocorticoids|glucocorticoids|mesh-ancestor
19739781|NCT00268476|Hormones|hormones|mesh-ancestor
19739782|NCT00268476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19739783|NCT00268476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19739784|NCT00268476|Estrogens|estrogens|mesh-ancestor
19739785|NCT00268476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19739786|NCT00268476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19739787|NCT00268476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19739788|NCT00268476|Analgesics|analgesics|mesh-ancestor
19739789|NCT00268476|Sensory System Agents|sensory system agents|mesh-ancestor
19739790|NCT00268476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19739791|NCT00268476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19739792|NCT00268476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19739793|NCT00268476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739794|NCT00268476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19739795|NCT05127304|Bromides|bromides|mesh-list
19739796|NCT05127304|Tiotropium Bromide|tiotropium bromide|mesh-list
19739797|NCT05127304|Olodaterol|olodaterol|mesh-list
19739798|NCT05127304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19739799|NCT05127304|Autonomic Agents|autonomic agents|mesh-ancestor
19739800|NCT05127304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19739801|NCT05127304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739802|NCT05127304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19739803|NCT05127304|Respiratory System Agents|respiratory system agents|mesh-ancestor
19739804|NCT05127304|Parasympatholytics|parasympatholytics|mesh-ancestor
19739805|NCT05127304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19739806|NCT05127304|Cholinergic Agents|cholinergic agents|mesh-ancestor
19739807|NCT05127304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19739808|NCT05127304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739809|NCT05127304|Anticonvulsants|anticonvulsants|mesh-ancestor
19739810|NCT05102162|Meropenem|meropenem|mesh-list
19739811|NCT05102162|Tazobactam|tazobactam|mesh-list
19739812|NCT05102162|Piperacillin|piperacillin|mesh-list
19739813|NCT05102162|Cefepime|cefepime|mesh-list
19739814|NCT05102162|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19739815|NCT05102162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19739816|NCT05102162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19739817|NCT05102162|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19739818|NCT05102162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739819|NCT05102162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986186|NCT01969916|Purinergic Agents|purinergic agents|mesh-ancestor
19986187|NCT01969916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19986188|NCT01969916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986189|NCT01969916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986190|NCT01970176|Tadalafil|tadalafil|mesh-list
19986191|NCT01970176|Vasodilator Agents|vasodilator agents|mesh-ancestor
19986192|NCT01970176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19986193|NCT01970176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19986194|NCT01970176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986195|NCT01970176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986196|NCT01970176|Urological Agents|urological agents|mesh-ancestor
19986197|NCT01970241|Insulin|insulin|mesh-list
19986198|NCT01970241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19986199|NCT01970241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19986200|NCT01970241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986201|NCT01970371|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19986202|NCT01970371|Meropenem|meropenem|mesh-list
19986203|NCT01970371|Colistin|colistin|mesh-list
19986204|NCT01970371|Tigecycline|tigecycline|mesh-list
19986205|NCT01970371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19986206|NCT01970371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19986207|NCT01970371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986208|NCT01970371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986209|NCT01970397|Hyaluronic Acid|hyaluronic acid|mesh-list
19986210|NCT01970397|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19986211|NCT01970397|Immunologic Factors|immunologic factors|mesh-ancestor
19986212|NCT01970397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986213|NCT01970397|Viscosupplements|viscosupplements|mesh-ancestor
19986214|NCT01970397|Protective Agents|protective agents|mesh-ancestor
19986215|NCT01970475|Adalimumab|adalimumab|mesh-list
19986216|NCT01970475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19986217|NCT01970475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19986218|NCT01970488|Adalimumab|adalimumab|mesh-list
19986219|NCT01970488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19986220|NCT01970488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19986221|NCT01970527|Ipilimumab|ipilimumab|mesh-list
19986222|NCT01970527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19986223|NCT01970527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986224|NCT01970527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19739820|NCT05050214|Obinutuzumab|obinutuzumab|mesh-list
19739821|NCT05050214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19739822|NCT05050214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739823|NCT05049980|Mifepristone|mifepristone|mesh-list
19739824|NCT05049980|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19739825|NCT05049980|Abortifacient Agents|abortifacient agents|mesh-ancestor
19739826|NCT05049980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19739827|NCT05049980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739828|NCT05049980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19739829|NCT05049980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19739830|NCT05049980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19739831|NCT05049980|Contraceptive Agents|contraceptive agents|mesh-ancestor
19739832|NCT05049980|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19739833|NCT05049980|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19739834|NCT05049980|Hormone Antagonists|hormone antagonists|mesh-ancestor
19739835|NCT05049980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19739836|NCT05049980|Luteolytic Agents|luteolytic agents|mesh-ancestor
19739837|NCT05049980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19739838|NCT05049980|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19739839|NCT05003258|Dexamethasone|dexamethasone|mesh-list
19739840|NCT05003258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19739841|NCT05003258|Antiemetics|antiemetics|mesh-ancestor
19739842|NCT05003258|Autonomic Agents|autonomic agents|mesh-ancestor
19739843|NCT05003258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19739844|NCT05003258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739845|NCT05003258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19739846|NCT05003258|Glucocorticoids|glucocorticoids|mesh-ancestor
19739847|NCT05003258|Hormones|hormones|mesh-ancestor
19739848|NCT05003258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19739849|NCT05003258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19739850|NCT05003258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739851|NCT04986631|Topiramate|topiramate|mesh-list
19739852|NCT04986631|Anticonvulsants|anticonvulsants|mesh-ancestor
19739853|NCT04986631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19739854|NCT04986631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739855|NCT04961190|Paroxetine|paroxetine|mesh-list
19739856|NCT04961190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
19739857|NCT04961190|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19739858|NCT04961190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19986225|NCT01970527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986226|NCT01970540|Doxorubicin|doxorubicin|mesh-list
19986227|NCT01970540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19986228|NCT01970540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986229|NCT01970540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19986230|NCT01970540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19986231|NCT01970540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986232|NCT01970540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986233|NCT01970878|Bromides|bromides|mesh-list
19986234|NCT01970878|Tiotropium Bromide|tiotropium bromide|mesh-list
19986235|NCT01970878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19986236|NCT01970878|Autonomic Agents|autonomic agents|mesh-ancestor
19986237|NCT01970878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19986238|NCT01970878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986239|NCT01970878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19986240|NCT01970878|Respiratory System Agents|respiratory system agents|mesh-ancestor
19986241|NCT01970878|Parasympatholytics|parasympatholytics|mesh-ancestor
19986242|NCT01970878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19986243|NCT01970878|Cholinergic Agents|cholinergic agents|mesh-ancestor
19986244|NCT01970878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19986245|NCT01970878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986246|NCT01970878|Anticonvulsants|anticonvulsants|mesh-ancestor
19986247|NCT01970995|Menthol|menthol|mesh-list
19986248|NCT01970995|Antipruritics|antipruritics|mesh-ancestor
19986249|NCT01970995|Dermatologic Agents|dermatologic agents|mesh-ancestor
19986250|NCT01971203|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19986251|NCT01971203|Antidepressive Agents|antidepressive agents|mesh-ancestor
19986252|NCT01971203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19986253|NCT01971203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19986254|NCT01971203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19986255|NCT01971203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19986256|NCT01971203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986257|NCT01971346|Etanercept|etanercept|mesh-list
19986258|NCT01971346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19986259|NCT01971346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19739859|NCT04961190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19739860|NCT04961190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739861|NCT04961190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19986260|NCT01971346|Analgesics|analgesics|mesh-ancestor
19986261|NCT01971346|Sensory System Agents|sensory system agents|mesh-ancestor
19986262|NCT01971346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19986263|NCT01971346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986264|NCT01971346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19986265|NCT01971346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19986266|NCT01971346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19986267|NCT01971346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19986268|NCT01971346|Immunologic Factors|immunologic factors|mesh-ancestor
19986269|NCT01971385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19986270|NCT01971385|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
19986271|NCT01971385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19986272|NCT01971385|Immunologic Factors|immunologic factors|mesh-ancestor
19986273|NCT01971385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986274|NCT01971580|Ambrisentan|ambrisentan|mesh-list
19986275|NCT01971580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19986276|NCT01971593|Eplerenone|eplerenone|mesh-list
19986277|NCT01971593|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19986278|NCT01971593|Hormone Antagonists|hormone antagonists|mesh-ancestor
19986279|NCT01971593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19986280|NCT01971593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986281|NCT01971593|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19986282|NCT01971593|Diuretics|diuretics|mesh-ancestor
19986283|NCT01971593|Natriuretic Agents|natriuretic agents|mesh-ancestor
19986284|NCT01971593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19986285|NCT01971645|Dexamethasone|dexamethasone|mesh-list
19986286|NCT01971645|Ropivacaine|ropivacaine|mesh-list
19986287|NCT01971645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19986288|NCT01971645|Antiemetics|antiemetics|mesh-ancestor
19986289|NCT01971645|Autonomic Agents|autonomic agents|mesh-ancestor
19986290|NCT01971645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19986291|NCT01971645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986292|NCT01971645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19986293|NCT01971645|Glucocorticoids|glucocorticoids|mesh-ancestor
19986294|NCT01971645|Hormones|hormones|mesh-ancestor
19986295|NCT01971645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19986296|NCT01971645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19986297|NCT01971645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986298|NCT01971645|Anesthetics, Local|anesthetics, local|mesh-ancestor
19986299|NCT01971645|Anesthetics|anesthetics|mesh-ancestor
19986300|NCT01971645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19986301|NCT01971645|Sensory System Agents|sensory system agents|mesh-ancestor
19986302|NCT01972074|Memantine|memantine|mesh-list
19986303|NCT01972074|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19986304|NCT01972074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19986305|NCT01972074|Dopamine Agents|dopamine agents|mesh-ancestor
19986306|NCT01972074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19986307|NCT01972074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986308|NCT01972074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986309|NCT01972074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19986310|NCT01972074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19986311|NCT01972152|Glucagon|glucagon|mesh-list
19986312|NCT01972152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19986313|NCT01972152|Hormones|hormones|mesh-ancestor
19986314|NCT01972152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19986315|NCT01972152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986316|NCT01972464|Progesterone|progesterone|mesh-list
19986317|NCT01972464|Progestins|progestins|mesh-ancestor
19986318|NCT01972464|Hormones|hormones|mesh-ancestor
19986319|NCT01972464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19986320|NCT01972464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986321|NCT01972659|Magnesium Sulfate|magnesium sulfate|mesh-list
19986322|NCT01972659|Analgesics|analgesics|mesh-ancestor
19986323|NCT01972659|Sensory System Agents|sensory system agents|mesh-ancestor
19986324|NCT01972659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19986325|NCT01972659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739862|NCT04961190|Serotonin Agents|serotonin agents|mesh-ancestor
19739863|NCT04961190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739864|NCT04961190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19739865|NCT04961190|Antidepressive Agents|antidepressive agents|mesh-ancestor
19739866|NCT04961190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19739867|NCT04961190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19739868|NCT04961190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19739869|NCT04961190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739870|NCT04961190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19739871|NCT04938323|BCG Vaccine|bcg vaccine|mesh-list
19739872|NCT04938323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19739873|NCT04938323|Immunologic Factors|immunologic factors|mesh-ancestor
19739874|NCT04938323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739875|NCT04929080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19739876|NCT04929080|Antibodies|antibodies|mesh-list
19739877|NCT04929080|Immunoglobulins|immunoglobulins|mesh-list
19739878|NCT04929080|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19739879|NCT04929080|Immunoglobulin G|immunoglobulin g|mesh-list
19739880|NCT04929080|Immunologic Factors|immunologic factors|mesh-ancestor
19739881|NCT04929080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739882|NCT04929080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739883|NCT04909801|Adalimumab|adalimumab|mesh-list
19739884|NCT04909801|Methotrexate|methotrexate|mesh-list
19739885|NCT04909801|Abatacept|abatacept|mesh-list
19739886|NCT04909801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19739887|NCT04909801|Abortifacient Agents|abortifacient agents|mesh-ancestor
19739888|NCT04909801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19739889|NCT04909801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739890|NCT04909801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19739891|NCT04909801|Antimetabolites|antimetabolites|mesh-ancestor
19739892|NCT04909801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739893|NCT04909801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739894|NCT04909801|Dermatologic Agents|dermatologic agents|mesh-ancestor
19739895|NCT04909801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739896|NCT04909801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19739897|NCT04909801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19739898|NCT04909801|Immunologic Factors|immunologic factors|mesh-ancestor
19739899|NCT04909801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19739900|NCT04909801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19739901|NCT04909801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19739902|NCT04909801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19739903|NCT04903353|Risperidone|risperidone|mesh-list
19739904|NCT04903353|Aripiprazole|aripiprazole|mesh-list
19739905|NCT04903353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19739906|NCT04903353|Serotonin Agents|serotonin agents|mesh-ancestor
19739907|NCT04903353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19739908|NCT04903353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739909|NCT04903353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739910|NCT04903353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19739911|NCT04903353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19739912|NCT04903353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19739913|NCT04903353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19739914|NCT04903353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19739915|NCT04903353|Dopamine Agents|dopamine agents|mesh-ancestor
19739916|NCT04903353|Antidepressive Agents|antidepressive agents|mesh-ancestor
19739917|NCT04903353|Dopamine Agonists|dopamine agonists|mesh-ancestor
19739918|NCT04903353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19739919|NCT04903353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19739920|NCT04903353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19739921|NCT04903353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19739922|NCT04850599|Pomalidomide|pomalidomide|mesh-list
19739923|NCT04850599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19739924|NCT04850599|Immunologic Factors|immunologic factors|mesh-ancestor
19739925|NCT04850599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739926|NCT04850599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19739927|NCT04850599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19739928|NCT04850599|Growth Substances|growth substances|mesh-ancestor
19739929|NCT04850599|Growth Inhibitors|growth inhibitors|mesh-ancestor
19739930|NCT04850599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739931|NCT04844762|Menthol|menthol|mesh-list
19739932|NCT04844762|Antipruritics|antipruritics|mesh-ancestor
19739933|NCT04844762|Dermatologic Agents|dermatologic agents|mesh-ancestor
19739934|NCT04829903|Liraglutide|liraglutide|mesh-list
19739935|NCT04829903|Dulaglutide|dulaglutide|mesh-list
19739936|NCT04829903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19739937|NCT04829903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739938|NCT04829903|Incretins|incretins|mesh-ancestor
19739939|NCT04829903|Hormones|hormones|mesh-ancestor
19739940|NCT04829903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19739941|NCT04813822|Miconazole|miconazole|mesh-list
19739942|NCT04813822|Clotrimazole|clotrimazole|mesh-list
19739943|NCT04813822|Bromides|bromides|mesh-list
19739944|NCT04813822|Anticonvulsants|anticonvulsants|mesh-ancestor
19739945|NCT04813822|Antifungal Agents|antifungal agents|mesh-ancestor
19739946|NCT04813822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19739947|NCT04813822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19739948|NCT04813822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19739949|NCT04813822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739950|NCT04813822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739951|NCT04813822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19739952|NCT04813822|Hormone Antagonists|hormone antagonists|mesh-ancestor
19739953|NCT04813822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19739954|NCT04813822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739955|NCT04813822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19739956|NCT04813822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19739957|NCT04813822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19739958|NCT04791228|Doxorubicin|doxorubicin|mesh-list
19739959|NCT04791228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19739960|NCT04791228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19739961|NCT04791228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739962|NCT04791228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19739963|NCT04791228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19739964|NCT04791228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19739965|NCT04791228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739966|NCT04784754|Melatonin|melatonin|mesh-list
19739967|NCT04784754|Antioxidants|antioxidants|mesh-ancestor
19739968|NCT04784754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739969|NCT04784754|Protective Agents|protective agents|mesh-ancestor
19739970|NCT04784754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739971|NCT04784754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19739972|NCT04762771|Colchicine|colchicine|mesh-list
19739973|NCT04762771|Gout Suppressants|gout suppressants|mesh-ancestor
19739974|NCT04762771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19739975|NCT04762771|Tubulin Modulators|tubulin modulators|mesh-ancestor
19739976|NCT04762771|Antimitotic Agents|antimitotic agents|mesh-ancestor
19739977|NCT04762771|Mitosis Modulators|mitosis modulators|mesh-ancestor
19739978|NCT04762771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739979|NCT04762771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739980|NCT04732845|Cyclophosphamide|cyclophosphamide|mesh-list
19739981|NCT04732845|Fludarabine|fludarabine|mesh-list
19739982|NCT04732845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19739983|NCT04732845|Immunologic Factors|immunologic factors|mesh-ancestor
19739984|NCT04732845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739985|NCT04732845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19739986|NCT04732845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19739987|NCT04732845|Alkylating Agents|alkylating agents|mesh-ancestor
19739988|NCT04732845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739989|NCT04732845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19739990|NCT04732845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19739991|NCT04718389|Benralizumab|benralizumab|mesh-list
19739992|NCT04718389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19739993|NCT04718389|Respiratory System Agents|respiratory system agents|mesh-ancestor
19739994|NCT04715022|Ascorbic Acid|ascorbic acid|mesh-list
19739995|NCT04715022|Antioxidants|antioxidants|mesh-ancestor
19739996|NCT04715022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19739997|NCT04715022|Protective Agents|protective agents|mesh-ancestor
19739998|NCT04715022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19739999|NCT04715022|Vitamins|vitamins|mesh-ancestor
19740000|NCT04715022|Micronutrients|micronutrients|mesh-ancestor
19740001|NCT04693715|RNS60|rns60|mesh-list
19740002|NCT04693715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19740003|NCT04693715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19740004|NCT04693715|Analgesics|analgesics|mesh-ancestor
19740005|NCT04693715|Sensory System Agents|sensory system agents|mesh-ancestor
19740006|NCT04693715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19740007|NCT04693715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740008|NCT04693715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19740009|NCT04693715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19740010|NCT04693715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19740011|NCT04683575|Selenium|selenium|mesh-list
19740012|NCT04683575|Antioxidants|antioxidants|mesh-ancestor
19740013|NCT04683575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740014|NCT04683575|Protective Agents|protective agents|mesh-ancestor
19740015|NCT04683575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740016|NCT04683575|Trace Elements|trace elements|mesh-ancestor
19740017|NCT04683575|Micronutrients|micronutrients|mesh-ancestor
19740018|NCT04609878|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19740019|NCT04609878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19740020|NCT04609878|Respiratory System Agents|respiratory system agents|mesh-ancestor
19740021|NCT04566380|Capecitabine|capecitabine|mesh-list
19740022|NCT04566380|Oxaliplatin|oxaliplatin|mesh-list
19740023|NCT04566380|Nivolumab|nivolumab|mesh-list
19740024|NCT04566380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19740025|NCT04566380|Antimetabolites|antimetabolites|mesh-ancestor
19740026|NCT04566380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740027|NCT04566380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740028|NCT04566380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19740029|NCT04566380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19986326|NCT01972659|Anesthetics|anesthetics|mesh-ancestor
19986327|NCT01972659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19986328|NCT01972659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19986329|NCT01972659|Anticonvulsants|anticonvulsants|mesh-ancestor
19986330|NCT01972659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19986331|NCT01972659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19986332|NCT01972659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986333|NCT01972659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19986334|NCT01972659|Tocolytic Agents|tocolytic agents|mesh-ancestor
19986335|NCT01972659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19986336|NCT01972724|Metformin|metformin|mesh-list
19986337|NCT01972724|Pioglitazone|pioglitazone|mesh-list
19986338|NCT01972724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19986339|NCT01972724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986340|NCT01972789|Ranibizumab|ranibizumab|mesh-list
19986341|NCT01972789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19986342|NCT01972789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19986343|NCT01972789|Growth Substances|growth substances|mesh-ancestor
19986344|NCT01972789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986345|NCT01972789|Growth Inhibitors|growth inhibitors|mesh-ancestor
19986346|NCT01972789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986347|NCT01972841|Solifenacin Succinate|solifenacin succinate|mesh-list
19986348|NCT01972841|Mirabegron|mirabegron|mesh-list
19986349|NCT01972841|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19986350|NCT01972841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19986351|NCT01972841|Cholinergic Agents|cholinergic agents|mesh-ancestor
19986352|NCT01972841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19986353|NCT01972841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986354|NCT01972841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986355|NCT01972841|Urological Agents|urological agents|mesh-ancestor
19986356|NCT01972841|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19986357|NCT01972841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19986358|NCT01972841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19986359|NCT01972841|Adrenergic Agents|adrenergic agents|mesh-ancestor
19986360|NCT01973036|Oxytocin|oxytocin|mesh-list
19986361|NCT01973036|Oxytocics|oxytocics|mesh-ancestor
19986362|NCT01973036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19986363|NCT01973036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986364|NCT01973205|Aspirin|aspirin|mesh-list
19986365|NCT01973205|Acetaminophen|acetaminophen|mesh-list
19986366|NCT01973205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19986367|NCT01973205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19986368|NCT01973205|Analgesics|analgesics|mesh-ancestor
19986369|NCT01973205|Sensory System Agents|sensory system agents|mesh-ancestor
19986370|NCT01973205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19986371|NCT01973205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986372|NCT01973205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19986373|NCT01973205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19986374|NCT01973205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19986375|NCT01973205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19986376|NCT01973205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986377|NCT01973205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19986378|NCT01973205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19986379|NCT01973205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986380|NCT01973205|Antipyretics|antipyretics|mesh-ancestor
19986381|NCT01973218|Vaccines|vaccines|mesh-list
19986382|NCT01973218|Immunologic Factors|immunologic factors|mesh-ancestor
19986383|NCT01973218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986384|NCT01973231|Liraglutide|liraglutide|mesh-list
19986385|NCT01973231|Lixisenatide|lixisenatide|mesh-list
19740030|NCT04492475|Interferons|interferons|mesh-list
19740031|NCT04492475|Interferon-beta|interferon-beta|mesh-list
19740032|NCT04492475|Interferon beta-1a|interferon beta-1a|mesh-list
19740033|NCT04492475|Remdesivir|remdesivir|mesh-list
19740034|NCT04492475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740035|NCT04492475|Antiviral Agents|antiviral agents|mesh-ancestor
19740036|NCT04492475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19740037|NCT04492475|Immunologic Factors|immunologic factors|mesh-ancestor
19740038|NCT04492475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740039|NCT04492475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19740040|NCT04492475|Antimetabolites|antimetabolites|mesh-ancestor
19740041|NCT04492475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740042|NCT04491383|Tocovid|tocovid|mesh-list
19740043|NCT04491383|Vitamins|vitamins|mesh-ancestor
19740044|NCT04491383|Micronutrients|micronutrients|mesh-ancestor
19740045|NCT04491383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740046|NCT04486911|Letrozole|letrozole|mesh-list
19740047|NCT04486911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740048|NCT04486911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19740049|NCT04486911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19740050|NCT04486911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740051|NCT04486911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740052|NCT04486911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19986386|NCT01973231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19986387|NCT01973231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986388|NCT01973231|Incretins|incretins|mesh-ancestor
19986389|NCT01973231|Hormones|hormones|mesh-ancestor
19986390|NCT01973231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19986391|NCT01973283|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19986392|NCT01973283|Citalopram|citalopram|mesh-list
19986393|NCT01973283|Antidepressive Agents|antidepressive agents|mesh-list
19986394|NCT01973283|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19986395|NCT01973283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19986396|NCT01973283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19986397|NCT01973283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986398|NCT01973283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19986399|NCT01973283|Serotonin Agents|serotonin agents|mesh-ancestor
19986400|NCT01973283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986401|NCT01973283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19986402|NCT01973283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19986403|NCT01973283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19986404|NCT01973283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19986405|NCT01973283|Analgesics|analgesics|mesh-ancestor
19986406|NCT01973283|Sensory System Agents|sensory system agents|mesh-ancestor
19986407|NCT01973283|Dopamine Agents|dopamine agents|mesh-ancestor
19986408|NCT01973335|Spironolactone|spironolactone|mesh-list
19986409|NCT01973335|Acetazolamide|acetazolamide|mesh-list
19986410|NCT01973335|Bumetanide|bumetanide|mesh-list
19986411|NCT01973335|Diuretics|diuretics|mesh-list
19986412|NCT01973335|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
19986413|NCT01973335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19986414|NCT01973335|Hormone Antagonists|hormone antagonists|mesh-ancestor
19986415|NCT01973335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19986416|NCT01973335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986417|NCT01973335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19986418|NCT01973335|Natriuretic Agents|natriuretic agents|mesh-ancestor
19986419|NCT01973335|Anticonvulsants|anticonvulsants|mesh-ancestor
19986420|NCT01973335|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19986421|NCT01973335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986422|NCT01973335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986423|NCT01973335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19986424|NCT01973348|Methamphetamine|methamphetamine|mesh-list
19986425|NCT01973348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19986426|NCT01973348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986427|NCT01973348|Sympathomimetics|sympathomimetics|mesh-ancestor
19986428|NCT01973348|Autonomic Agents|autonomic agents|mesh-ancestor
19986429|NCT01973348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19986430|NCT01973348|Dopamine Agents|dopamine agents|mesh-ancestor
19986431|NCT01973348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19986432|NCT01973348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986433|NCT01973348|Adrenergic Agents|adrenergic agents|mesh-ancestor
19986434|NCT01973348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19740053|NCT04486911|Hormone Antagonists|hormone antagonists|mesh-ancestor
19740054|NCT04486911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19740055|NCT04486911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740056|NCT04483206|Melphalan|melphalan|mesh-list
19740057|NCT04483206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19740058|NCT04483206|Alkylating Agents|alkylating agents|mesh-ancestor
19740059|NCT04483206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740060|NCT04483206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740061|NCT04483206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19740062|NCT04483206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19740063|NCT04483206|Immunologic Factors|immunologic factors|mesh-ancestor
19740064|NCT04483206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740065|NCT04478838|Olanzapine|olanzapine|mesh-list
19740066|NCT04478838|Risperidone|risperidone|mesh-list
19740067|NCT04478838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19740068|NCT04478838|Serotonin Agents|serotonin agents|mesh-ancestor
19740069|NCT04478838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19740070|NCT04478838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740071|NCT04478838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740072|NCT04478838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19740073|NCT04478838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19740074|NCT04478838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19740075|NCT04478838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19740076|NCT04478838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19740077|NCT04478838|Dopamine Agents|dopamine agents|mesh-ancestor
19740078|NCT04478838|Antiemetics|antiemetics|mesh-ancestor
19740079|NCT04478838|Autonomic Agents|autonomic agents|mesh-ancestor
19740080|NCT04478838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19740081|NCT04478838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19740082|NCT04478838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19740083|NCT04478838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19740084|NCT04478838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19740085|NCT04474483|Melatonin|melatonin|mesh-list
19740086|NCT04474483|Antioxidants|antioxidants|mesh-ancestor
19740087|NCT04474483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740088|NCT04474483|Protective Agents|protective agents|mesh-ancestor
19740089|NCT04474483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740090|NCT04474483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19740091|NCT04452136|Edetic Acid|edetic acid|mesh-list
19740092|NCT04452136|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19740093|NCT04452136|Anticoagulants|anticoagulants|mesh-ancestor
19740094|NCT04452136|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19740095|NCT04452136|Chelating Agents|chelating agents|mesh-ancestor
19740096|NCT04452136|Sequestering Agents|sequestering agents|mesh-ancestor
19740097|NCT04452136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740098|NCT04452136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19740099|NCT04424966|Infigratinib|infigratinib|mesh-list
19740100|NCT04424966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740101|NCT04401579|Remdesivir|remdesivir|mesh-list
19740102|NCT04401579|Antimetabolites|antimetabolites|mesh-ancestor
19740103|NCT04401579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459581|NCT03360123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19459582|NCT03360123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459583|NCT03360045|Tranexamic Acid|tranexamic acid|mesh-list
19459584|NCT03360045|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
19459585|NCT03360045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19459586|NCT03360045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19459587|NCT03360045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459588|NCT03360045|Hemostatics|hemostatics|mesh-ancestor
19740104|NCT04401579|Antiviral Agents|antiviral agents|mesh-ancestor
19740105|NCT04401579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19740106|NCT04383743|Cisplatin|cisplatin|mesh-list
19740107|NCT04383743|Doxorubicin|doxorubicin|mesh-list
19740108|NCT04383743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19740109|NCT04383743|Pembrolizumab|pembrolizumab|mesh-list
19740110|NCT04383743|Methotrexate|methotrexate|mesh-list
19740111|NCT04383743|Daunorubicin|daunorubicin|mesh-list
19740112|NCT04383743|Vinblastine|vinblastine|mesh-list
19740113|NCT04383743|Lenograstim|lenograstim|mesh-list
19740114|NCT04383743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740115|NCT04383743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19740116|NCT04383743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19740117|NCT04383743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19740118|NCT04383743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740119|NCT04383743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740120|NCT04383743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19740121|NCT04383743|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19740122|NCT04383743|Abortifacient Agents|abortifacient agents|mesh-ancestor
19740123|NCT04383743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19740124|NCT04383743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740125|NCT04383743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19740126|NCT04383743|Antimetabolites|antimetabolites|mesh-ancestor
19740127|NCT04383743|Dermatologic Agents|dermatologic agents|mesh-ancestor
19740128|NCT04383743|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19740129|NCT04383743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19740130|NCT04383743|Immunologic Factors|immunologic factors|mesh-ancestor
19740131|NCT04383743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19740132|NCT04383743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19740133|NCT04383743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19740134|NCT04383743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19740135|NCT04383743|Tubulin Modulators|tubulin modulators|mesh-ancestor
19740136|NCT04383743|Antimitotic Agents|antimitotic agents|mesh-ancestor
19740137|NCT04383743|Mitosis Modulators|mitosis modulators|mesh-ancestor
19740138|NCT04344184|Ascorbic Acid|ascorbic acid|mesh-list
19740139|NCT04344184|Vitamins|vitamins|mesh-ancestor
19740140|NCT04344184|Micronutrients|micronutrients|mesh-ancestor
19740141|NCT04344184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740142|NCT04344184|Antioxidants|antioxidants|mesh-ancestor
19740143|NCT04344184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740144|NCT04344184|Protective Agents|protective agents|mesh-ancestor
19740145|NCT04336982|Azacitidine|azacitidine|mesh-list
19740146|NCT04336982|Venetoclax|venetoclax|mesh-list
19740147|NCT04336982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19740148|NCT04336982|Antimetabolites|antimetabolites|mesh-ancestor
19740149|NCT04336982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740150|NCT04336982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740151|NCT04336982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740152|NCT04328727|Cyclosporine|cyclosporine|mesh-list
19740153|NCT04328727|Cyclosporins|cyclosporins|mesh-list
19740154|NCT04328727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19740155|NCT04328727|Thymoglobulin|thymoglobulin|mesh-list
19740156|NCT04328727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740157|NCT04328727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740158|NCT04328727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19740159|NCT04328727|Immunologic Factors|immunologic factors|mesh-ancestor
19740160|NCT04328727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740161|NCT04328727|Antifungal Agents|antifungal agents|mesh-ancestor
19740162|NCT04328727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19740163|NCT04328727|Dermatologic Agents|dermatologic agents|mesh-ancestor
19740164|NCT04328727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19740165|NCT04328727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19740166|NCT04320628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
19740167|NCT04320628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19740168|NCT04280705|Remdesivir|remdesivir|mesh-list
19740169|NCT04280705|Antimetabolites|antimetabolites|mesh-ancestor
19740170|NCT04280705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740171|NCT04280705|Antiviral Agents|antiviral agents|mesh-ancestor
19740172|NCT04280705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19740173|NCT04258046|Trametinib|trametinib|mesh-list
19740174|NCT04258046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740175|NCT04258046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19740176|NCT04258046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740177|NCT04258046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740178|NCT04224493|Rituximab|rituximab|mesh-list
19740179|NCT04224493|Lenalidomide|lenalidomide|mesh-list
19740180|NCT04224493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19740181|NCT04224493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740182|NCT04224493|Immunologic Factors|immunologic factors|mesh-ancestor
19740183|NCT04224493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740184|NCT04224493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19740185|NCT04224493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19740186|NCT04224493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19740187|NCT04224493|Growth Substances|growth substances|mesh-ancestor
19740188|NCT04224493|Growth Inhibitors|growth inhibitors|mesh-ancestor
19740189|NCT04218409|Oxycodone|oxycodone|mesh-list
19740190|NCT04218409|Oxytocin|oxytocin|mesh-list
19740191|NCT04218409|Oxytocics|oxytocics|mesh-ancestor
19740192|NCT04218409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19740193|NCT04218409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740194|NCT04218409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19740195|NCT04218409|Narcotics|narcotics|mesh-ancestor
19740196|NCT04218409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19740197|NCT04218409|Analgesics|analgesics|mesh-ancestor
19740198|NCT04218409|Sensory System Agents|sensory system agents|mesh-ancestor
19986435|NCT01973348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19986436|NCT01973348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19986437|NCT01973348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19986438|NCT01973387|Rituximab|rituximab|mesh-list
19986439|NCT01973387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19986440|NCT01973387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986441|NCT01973387|Immunologic Factors|immunologic factors|mesh-ancestor
19986442|NCT01973387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986443|NCT01973387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19986444|NCT01973413|Insulin|insulin|mesh-list
19986445|NCT01973413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19986446|NCT01973413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986447|NCT01973439|Abacavir|abacavir|mesh-list
19986448|NCT01973439|Dideoxynucleosides|dideoxynucleosides|mesh-list
19986449|NCT01973439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19986450|NCT01973439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19986451|NCT01973439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986452|NCT01973439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986453|NCT01973439|Antiviral Agents|antiviral agents|mesh-ancestor
19986454|NCT01973439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19986455|NCT01973439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19986456|NCT01973439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19986457|NCT01973439|Antimetabolites|antimetabolites|mesh-ancestor
19986458|NCT01973569|Denosumab|denosumab|mesh-list
19986459|NCT01973569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19986460|NCT01973569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986461|NCT01974141|Dapsone|dapsone|mesh-list
19986462|NCT01974141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19986463|NCT01974141|Antimalarials|antimalarials|mesh-ancestor
19986464|NCT01974141|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19986465|NCT01974141|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19986466|NCT01974141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19986467|NCT01974141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986468|NCT01974141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986469|NCT01974141|Leprostatic Agents|leprostatic agents|mesh-ancestor
19986470|NCT01974141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19986471|NCT01974245|Cholecalciferol|cholecalciferol|mesh-list
19986472|NCT01974245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19986473|NCT01974245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986474|NCT01974245|Vitamins|vitamins|mesh-ancestor
19986475|NCT01974245|Micronutrients|micronutrients|mesh-ancestor
19986476|NCT01974245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19986477|NCT01974323|Dapsone|dapsone|mesh-list
19986478|NCT01974323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19986479|NCT01974323|Antimalarials|antimalarials|mesh-ancestor
19986480|NCT01974323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19986481|NCT01974323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19986482|NCT01974323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19986483|NCT01974323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986484|NCT01974323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986485|NCT01974323|Leprostatic Agents|leprostatic agents|mesh-ancestor
19986486|NCT01974323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19986487|NCT01974687|Itraconazole|itraconazole|mesh-list
19986488|NCT01974687|Uprifosbuvir|uprifosbuvir|mesh-list
19986489|NCT01974687|Antifungal Agents|antifungal agents|mesh-ancestor
19986490|NCT01974687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19986491|NCT01974687|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19740199|NCT04218409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19740200|NCT04162210|Dexamethasone|dexamethasone|mesh-list
19740201|NCT04162210|Pomalidomide|pomalidomide|mesh-list
19740202|NCT04162210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19740203|NCT04162210|Antiemetics|antiemetics|mesh-ancestor
19740204|NCT04162210|Autonomic Agents|autonomic agents|mesh-ancestor
19740205|NCT04162210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19740206|NCT04162210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740207|NCT04162210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19740208|NCT04162210|Glucocorticoids|glucocorticoids|mesh-ancestor
19740209|NCT04162210|Hormones|hormones|mesh-ancestor
19740210|NCT04162210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19740211|NCT04162210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19740212|NCT04162210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740213|NCT04162210|Immunologic Factors|immunologic factors|mesh-ancestor
19740214|NCT04162210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19740215|NCT04162210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19740216|NCT04162210|Growth Substances|growth substances|mesh-ancestor
19740217|NCT04162210|Growth Inhibitors|growth inhibitors|mesh-ancestor
19740218|NCT04153565|Pembrolizumab|pembrolizumab|mesh-list
19740219|NCT04153565|Pemetrexed|pemetrexed|mesh-list
19740220|NCT04153565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740221|NCT04153565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19740222|NCT04153565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740223|NCT04153565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740224|NCT04153565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19740225|NCT04153565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19740226|NCT04151017|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19740227|NCT04151017|Hemostatics|hemostatics|mesh-ancestor
19740228|NCT04151017|Coagulants|coagulants|mesh-ancestor
19740229|NCT04116398|Dexamethasone|dexamethasone|mesh-list
19740230|NCT04116398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19740231|NCT04116398|Antiemetics|antiemetics|mesh-ancestor
19740232|NCT04116398|Autonomic Agents|autonomic agents|mesh-ancestor
19740233|NCT04116398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19740234|NCT04116398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740235|NCT04116398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19740236|NCT04116398|Glucocorticoids|glucocorticoids|mesh-ancestor
19740237|NCT04116398|Hormones|hormones|mesh-ancestor
19740238|NCT04116398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19740239|NCT04116398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19740240|NCT04116398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740241|NCT04112589|Cytarabine|cytarabine|mesh-list
19740242|NCT04112589|Fludarabine|fludarabine|mesh-list
19740243|NCT04112589|Idarubicin|idarubicin|mesh-list
19740244|NCT04112589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740245|NCT04112589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19740246|NCT04112589|Antimetabolites|antimetabolites|mesh-ancestor
19740247|NCT04112589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740248|NCT04112589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19740249|NCT04112589|Immunologic Factors|immunologic factors|mesh-ancestor
19740250|NCT04112589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740251|NCT04112589|Antiviral Agents|antiviral agents|mesh-ancestor
19740252|NCT04112589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19740253|NCT04112589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19740254|NCT04112589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19740255|NCT04112589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19740256|NCT04112589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740257|NCT04080427|Dronabinol|dronabinol|mesh-list
19740258|NCT04080427|Hallucinogens|hallucinogens|mesh-ancestor
19740259|NCT04080427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740260|NCT04080427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19740261|NCT04080427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19740262|NCT04080427|Analgesics|analgesics|mesh-ancestor
19740263|NCT04080427|Sensory System Agents|sensory system agents|mesh-ancestor
19740264|NCT04080427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19740265|NCT04080427|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19740266|NCT04080427|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19740267|NCT04080427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19740268|NCT04080427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740269|NCT04080427|Hormones|hormones|mesh-ancestor
19740270|NCT04080427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19740271|NCT04070157|Lofexidine|lofexidine|mesh-list
19740272|NCT04070157|Clonidine|clonidine|mesh-list
19986492|NCT01974687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19740273|NCT04070157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19740274|NCT04070157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19740275|NCT04070157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740276|NCT04070157|Sensory System Agents|sensory system agents|mesh-ancestor
19740277|NCT04070157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19740278|NCT04070157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19740279|NCT04070157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19740280|NCT04070157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19740281|NCT04070157|Adrenergic Agents|adrenergic agents|mesh-ancestor
19740282|NCT04070157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19740283|NCT04070157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740284|NCT04070157|Analgesics|analgesics|mesh-ancestor
19740285|NCT04070157|Sympatholytics|sympatholytics|mesh-ancestor
19740286|NCT04070157|Autonomic Agents|autonomic agents|mesh-ancestor
19986493|NCT01974687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986494|NCT01974687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986495|NCT01974687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19986496|NCT01974687|Hormone Antagonists|hormone antagonists|mesh-ancestor
19986497|NCT01974687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19986498|NCT01974687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986499|NCT01974687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19986500|NCT01974687|Antiviral Agents|antiviral agents|mesh-ancestor
19986501|NCT01974700|Levetiracetam|levetiracetam|mesh-list
19986502|NCT01974700|Anticonvulsants|anticonvulsants|mesh-ancestor
19986503|NCT01974700|Nootropic Agents|nootropic agents|mesh-ancestor
19986504|NCT01974752|Dacarbazine|dacarbazine|mesh-list
19986505|NCT01974752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19986506|NCT01974752|Alkylating Agents|alkylating agents|mesh-ancestor
19986507|NCT01974752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986508|NCT01974752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986509|NCT01974817|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19986510|NCT01974817|Immunologic Factors|immunologic factors|mesh-ancestor
19986511|NCT01974817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986512|NCT01975220|Metformin|metformin|mesh-list
19986513|NCT01975220|Empagliflozin|empagliflozin|mesh-list
19986514|NCT01975220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19986515|NCT01975220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986516|NCT01975220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19986517|NCT01975220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986518|NCT01975246|Amlodipine|amlodipine|mesh-list
19986519|NCT01975246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19986520|NCT01975246|Telmisartan|telmisartan|mesh-list
19986521|NCT01975246|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
19986522|NCT01975246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19986523|NCT01975246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19986524|NCT01975246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19986525|NCT01975246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986526|NCT01975246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19986527|NCT01975246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986528|NCT01975246|Vasodilator Agents|vasodilator agents|mesh-ancestor
19986529|NCT01975246|Diuretics|diuretics|mesh-ancestor
19986530|NCT01975246|Natriuretic Agents|natriuretic agents|mesh-ancestor
19986531|NCT01975246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19986532|NCT01975246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19986533|NCT01975246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19986534|NCT01975285|Dexamethasone|dexamethasone|mesh-list
19986535|NCT01975285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19986536|NCT01975285|Antiemetics|antiemetics|mesh-ancestor
19986537|NCT01975285|Autonomic Agents|autonomic agents|mesh-ancestor
19986538|NCT01975285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19986539|NCT01975285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986540|NCT01975285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19459589|NCT03360045|Coagulants|coagulants|mesh-ancestor
19459590|NCT03359967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
19459591|NCT03359967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19459592|NCT03359967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459593|NCT03359876|Warfarin|warfarin|mesh-list
19459594|NCT03359876|Rivaroxaban|rivaroxaban|mesh-list
19459595|NCT03359876|Anticoagulants|anticoagulants|mesh-ancestor
19459596|NCT03359876|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19459597|NCT03359876|Antithrombins|antithrombins|mesh-ancestor
19459598|NCT03359876|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19740287|NCT04002401|Cyclophosphamide|cyclophosphamide|mesh-list
19740288|NCT04002401|Rituximab|rituximab|mesh-list
19740289|NCT04002401|Fludarabine|fludarabine|mesh-list
19740290|NCT04002401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19740291|NCT04002401|Immunologic Factors|immunologic factors|mesh-ancestor
19740292|NCT04002401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740293|NCT04002401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19740294|NCT04002401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19740295|NCT04002401|Alkylating Agents|alkylating agents|mesh-ancestor
19740296|NCT04002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740297|NCT04002401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740298|NCT04002401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19986541|NCT01975285|Glucocorticoids|glucocorticoids|mesh-ancestor
19986542|NCT01975285|Hormones|hormones|mesh-ancestor
19986543|NCT01975285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19986544|NCT01975285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19986545|NCT01975285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986546|NCT01975376|Bococizumab|bococizumab|mesh-list
19986547|NCT01975376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19986548|NCT01975376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19986549|NCT01975376|Antimetabolites|antimetabolites|mesh-ancestor
19986550|NCT01975376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986551|NCT01975376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19986552|NCT01975389|Bococizumab|bococizumab|mesh-list
19986553|NCT01975389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19986554|NCT01975389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19986555|NCT01975389|Antimetabolites|antimetabolites|mesh-ancestor
19986556|NCT01975389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986557|NCT01975389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19986558|NCT01975519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19986559|NCT01975519|Immunologic Factors|immunologic factors|mesh-ancestor
19986560|NCT01975519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986561|NCT01975675|Sofosbuvir|sofosbuvir|mesh-list
19986562|NCT01975675|Antiviral Agents|antiviral agents|mesh-ancestor
19986563|NCT01975675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19986564|NCT01975701|Infigratinib|infigratinib|mesh-list
19986565|NCT01975701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986566|NCT01975831|Durvalumab|durvalumab|mesh-list
19986567|NCT01975831|Tremelimumab|tremelimumab|mesh-list
19986568|NCT01975831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19986569|NCT01975831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986570|NCT01975935|Amlexanox|amlexanox|mesh-list
19986571|NCT01975935|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19986572|NCT01976312|Ranibizumab|ranibizumab|mesh-list
19986573|NCT01976312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19986574|NCT01976312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19986575|NCT01976312|Growth Substances|growth substances|mesh-ancestor
19986576|NCT01976312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986577|NCT01976312|Growth Inhibitors|growth inhibitors|mesh-ancestor
19986578|NCT01976312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986579|NCT01976338|Ranibizumab|ranibizumab|mesh-list
19986580|NCT01976338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19986581|NCT01976338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19986582|NCT01976338|Growth Substances|growth substances|mesh-ancestor
19986583|NCT01976338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986584|NCT01976338|Growth Inhibitors|growth inhibitors|mesh-ancestor
19986585|NCT01976338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289171|NCT04921358|Docetaxel|docetaxel|mesh-list
20289172|NCT04921358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289173|NCT04921358|Tubulin Modulators|tubulin modulators|mesh-ancestor
20289174|NCT04921358|Antimitotic Agents|antimitotic agents|mesh-ancestor
20289175|NCT04921358|Mitosis Modulators|mitosis modulators|mesh-ancestor
20289176|NCT04921358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289177|NCT04919096|Aflibercept|aflibercept|mesh-list
20289178|NCT04919096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20289179|NCT04919096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20289180|NCT04919096|Growth Substances|growth substances|mesh-ancestor
20289181|NCT04919096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289182|NCT04919096|Growth Inhibitors|growth inhibitors|mesh-ancestor
20289183|NCT04919096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289184|NCT04909697|Sivelestat|sivelestat|mesh-list
20289185|NCT04909697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20289186|NCT04909697|Protease Inhibitors|protease inhibitors|mesh-ancestor
20289187|NCT04909697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740299|NCT04002401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19740300|NCT03976362|Paclitaxel|paclitaxel|mesh-list
19740301|NCT03976362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19740302|NCT03976362|Carboplatin|carboplatin|mesh-list
19740303|NCT03976362|Pembrolizumab|pembrolizumab|mesh-list
19740304|NCT03976362|Olaparib|olaparib|mesh-list
19740305|NCT03976362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19740306|NCT03976362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740307|NCT03976362|Tubulin Modulators|tubulin modulators|mesh-ancestor
19740308|NCT03976362|Antimitotic Agents|antimitotic agents|mesh-ancestor
19740309|NCT03976362|Mitosis Modulators|mitosis modulators|mesh-ancestor
19740310|NCT03976362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740311|NCT03976362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19740312|NCT03976362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19740313|NCT03976362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740314|NCT03973333|Atezolizumab|atezolizumab|mesh-list
19740315|NCT03973333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740316|NCT03971877|Polymyxins|polymyxins|mesh-list
19740317|NCT03971877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19740318|NCT03971877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19740319|NCT03963414|Carboplatin|carboplatin|mesh-list
19740320|NCT03963414|Etoposide|etoposide|mesh-list
19740321|NCT03963414|Etoposide phosphate|etoposide phosphate|mesh-list
19740322|NCT03963414|Durvalumab|durvalumab|mesh-list
19740323|NCT03963414|Tremelimumab|tremelimumab|mesh-list
19740324|NCT03963414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19740325|NCT03963414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740326|NCT03963414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19740327|NCT03963414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19740328|NCT03963414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19740329|NCT03963414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740330|NCT03963414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740331|NCT03963414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19740332|NCT03963414|Immunologic Factors|immunologic factors|mesh-ancestor
19740333|NCT03963414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740334|NCT03955211|Acetaminophen|acetaminophen|mesh-list
19740335|NCT03955211|Ibuprofen|ibuprofen|mesh-list
19740336|NCT03955211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19740337|NCT03955211|Analgesics|analgesics|mesh-ancestor
19740338|NCT03955211|Sensory System Agents|sensory system agents|mesh-ancestor
19740339|NCT03955211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19740340|NCT03955211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740341|NCT03955211|Antipyretics|antipyretics|mesh-ancestor
19740342|NCT03955211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19740343|NCT03955211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19740344|NCT03955211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19740345|NCT03955211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19740346|NCT03955211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740347|NCT03955211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740348|NCT03943927|Metoprolol|metoprolol|mesh-list
19740349|NCT03943927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19740350|NCT03943927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19740351|NCT03943927|Sympatholytics|sympatholytics|mesh-ancestor
19740352|NCT03943927|Autonomic Agents|autonomic agents|mesh-ancestor
19740353|NCT03943927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19740354|NCT03943927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740355|NCT03943927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19740356|NCT03943927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19740357|NCT03943927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19740358|NCT03943927|Adrenergic Agents|adrenergic agents|mesh-ancestor
19740359|NCT03943927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19740360|NCT03943927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740361|NCT03900884|Letrozole|letrozole|mesh-list
19740362|NCT03900884|Venetoclax|venetoclax|mesh-list
19740363|NCT03900884|Palbociclib|palbociclib|mesh-list
19740364|NCT03900884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740365|NCT03900884|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19740366|NCT03900884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19740367|NCT03900884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740368|NCT03900884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740369|NCT03900884|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19740370|NCT03900884|Hormone Antagonists|hormone antagonists|mesh-ancestor
19740371|NCT03900884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19740372|NCT03900884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740373|NCT03900884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19740374|NCT03874897|Antibodies|antibodies|mesh-list
19740375|NCT03874897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19740376|NCT03874897|Immunologic Factors|immunologic factors|mesh-ancestor
19740377|NCT03874897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740378|NCT03853330|Bupivacaine|bupivacaine|mesh-list
19740379|NCT03853330|Anesthetics, Local|anesthetics, local|mesh-ancestor
19740380|NCT03853330|Anesthetics|anesthetics|mesh-ancestor
19740381|NCT03853330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19740382|NCT03853330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740383|NCT03853330|Sensory System Agents|sensory system agents|mesh-ancestor
19740384|NCT03853330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19740385|NCT03850691|Aldesleukin|aldesleukin|mesh-list
19740386|NCT03850691|Nivolumab|nivolumab|mesh-list
19740387|NCT03850691|Ipilimumab|ipilimumab|mesh-list
19740388|NCT03850691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19740389|NCT03850691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740390|NCT03850691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19740391|NCT03850691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740392|NCT03850691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19740393|NCT03850691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19740394|NCT03850691|Antiviral Agents|antiviral agents|mesh-ancestor
19740395|NCT03850691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19740396|NCT03834740|Everolimus|everolimus|mesh-list
19740397|NCT03834740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740398|NCT03834740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19740399|NCT03834740|Immunologic Factors|immunologic factors|mesh-ancestor
19740400|NCT03834740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740401|NCT03805100|Ranibizumab|ranibizumab|mesh-list
19740402|NCT03805100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19740403|NCT03805100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19740404|NCT03805100|Growth Substances|growth substances|mesh-ancestor
19740405|NCT03805100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740406|NCT03805100|Growth Inhibitors|growth inhibitors|mesh-ancestor
19740407|NCT03805100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740408|NCT03769532|Pembrolizumab|pembrolizumab|mesh-list
19740409|NCT03769532|Azacitidine|azacitidine|mesh-list
19740410|NCT03769532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19740411|NCT03769532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740412|NCT03769532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19740413|NCT03769532|Antimetabolites|antimetabolites|mesh-ancestor
19740414|NCT03769532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740415|NCT03769532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740416|NCT03764098|Guanfacine|guanfacine|mesh-list
19740417|NCT03764098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19740418|NCT03764098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19740419|NCT03764098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19740420|NCT03764098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19740421|NCT03764098|Adrenergic Agents|adrenergic agents|mesh-ancestor
19740422|NCT03764098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19740423|NCT03764098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740424|NCT03764098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740425|NCT03739710|Docetaxel|docetaxel|mesh-list
19740426|NCT03739710|Ipilimumab|ipilimumab|mesh-list
19740427|NCT03739710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740428|NCT03739710|Tubulin Modulators|tubulin modulators|mesh-ancestor
19740429|NCT03739710|Antimitotic Agents|antimitotic agents|mesh-ancestor
19740430|NCT03739710|Mitosis Modulators|mitosis modulators|mesh-ancestor
19740431|NCT03739710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740432|NCT03739710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19740433|NCT03739710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19740434|NCT03661645|Dexamethasone|dexamethasone|mesh-list
19740435|NCT03661645|Dexamethasone acetate|dexamethasone acetate|mesh-list
19740436|NCT03661645|Methylprednisolone|methylprednisolone|mesh-list
19740437|NCT03661645|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19740438|NCT03661645|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19740439|NCT03661645|BB 1101|bb 1101|mesh-list
19740440|NCT03661645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19740441|NCT03661645|Antiemetics|antiemetics|mesh-ancestor
19740442|NCT03661645|Autonomic Agents|autonomic agents|mesh-ancestor
19740443|NCT03661645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19740444|NCT03661645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740445|NCT03661645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19740446|NCT03661645|Glucocorticoids|glucocorticoids|mesh-ancestor
19740447|NCT03661645|Hormones|hormones|mesh-ancestor
19740448|NCT03661645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19740449|NCT03661645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19740450|NCT03661645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740451|NCT03661645|Protease Inhibitors|protease inhibitors|mesh-ancestor
19740452|NCT03661645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740453|NCT03661645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740454|NCT03661645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19740455|NCT03661645|Protective Agents|protective agents|mesh-ancestor
19740456|NCT03647566|Listerine|listerine|mesh-list
19740457|NCT03647566|Fluorides|fluorides|mesh-list
19740458|NCT03647566|Sodium Fluoride|sodium fluoride|mesh-list
19740459|NCT03647566|Cariostatic Agents|cariostatic agents|mesh-ancestor
19740460|NCT03647566|Protective Agents|protective agents|mesh-ancestor
19740461|NCT03647566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740462|NCT03647566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19740463|NCT03647566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19740464|NCT03576313|Ivermectin|ivermectin|mesh-list
19740465|NCT03576313|Piperaquine|piperaquine|mesh-list
19740466|NCT03576313|Artenimol|artenimol|mesh-list
19740467|NCT03576313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19740468|NCT03576313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19740469|NCT03576313|Antimalarials|antimalarials|mesh-ancestor
19740470|NCT03576313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19740471|NCT03547908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19740472|NCT03547908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19740473|NCT03547908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19740474|NCT03547908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740475|NCT03547908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740476|NCT03547908|Antiviral Agents|antiviral agents|mesh-ancestor
19740477|NCT03547908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19740478|NCT03547908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19740479|NCT03547908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19740480|NCT03533010|Vitamin D|vitamin d|mesh-list
19740481|NCT03533010|Vitamins|vitamins|mesh-ancestor
19740482|NCT03533010|Micronutrients|micronutrients|mesh-ancestor
19740483|NCT03533010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740484|NCT03533010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19740485|NCT03512275|Antibodies|antibodies|mesh-list
19740486|NCT03512275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19740487|NCT03512275|Immunologic Factors|immunologic factors|mesh-ancestor
19740488|NCT03512275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740489|NCT03485729|TIC10 compound|tic10 compound|mesh-list
19740490|NCT03485729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740491|NCT03435003|Dexamethasone|dexamethasone|mesh-list
19740492|NCT03435003|Fentanyl|fentanyl|mesh-list
19740493|NCT03435003|Scopolamine|scopolamine|mesh-list
19740494|NCT03435003|Dexmedetomidine|dexmedetomidine|mesh-list
19740495|NCT03435003|Ondansetron|ondansetron|mesh-list
19740496|NCT03435003|Aprepitant|aprepitant|mesh-list
19740497|NCT03435003|Metoclopramide|metoclopramide|mesh-list
19740498|NCT03435003|Prochlorperazine|prochlorperazine|mesh-list
19740499|NCT03435003|Propofol|propofol|mesh-list
19740500|NCT03435003|Sevoflurane|sevoflurane|mesh-list
19740501|NCT03435003|Desflurane|desflurane|mesh-list
19740502|NCT03435003|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19740503|NCT03435003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19740504|NCT03435003|Antiemetics|antiemetics|mesh-ancestor
19740505|NCT03435003|Autonomic Agents|autonomic agents|mesh-ancestor
19740506|NCT03435003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19740507|NCT03435003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740508|NCT03435003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19740509|NCT03435003|Glucocorticoids|glucocorticoids|mesh-ancestor
19740510|NCT03435003|Hormones|hormones|mesh-ancestor
19740511|NCT03435003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19740512|NCT03435003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19740513|NCT03435003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459599|NCT03359876|Protease Inhibitors|protease inhibitors|mesh-ancestor
19459600|NCT03359876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459601|NCT03359876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459602|NCT03359837|Insulin|insulin|mesh-list
19459603|NCT03359837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19459604|NCT03359837|Metformin|metformin|mesh-list
19459605|NCT03359837|Insulin Glargine|insulin glargine|mesh-list
19459606|NCT03359837|Insulin Aspart|insulin aspart|mesh-list
19459607|NCT03359837|Biphasic Insulins|biphasic insulins|mesh-list
19459608|NCT03359837|Acarbose|acarbose|mesh-list
19459609|NCT03359837|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
19459610|NCT03359837|Insulin glulisine|insulin glulisine|mesh-list
19459611|NCT03359837|Repaglinide|repaglinide|mesh-list
19459612|NCT03359837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19740514|NCT03435003|Anesthetics|anesthetics|mesh-ancestor
19740515|NCT03435003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19986586|NCT01976364|Methotrexate|methotrexate|mesh-list
19986587|NCT01976364|Tofacitinib|tofacitinib|mesh-list
19986588|NCT01976364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19986589|NCT01976364|Abortifacient Agents|abortifacient agents|mesh-ancestor
19986590|NCT01976364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19986591|NCT01976364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986592|NCT01976364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19986593|NCT01976364|Antimetabolites|antimetabolites|mesh-ancestor
19986594|NCT01976364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986595|NCT01976364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986596|NCT01976364|Dermatologic Agents|dermatologic agents|mesh-ancestor
19986597|NCT01976364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986598|NCT01976364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19986599|NCT01976364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19986600|NCT01976364|Immunologic Factors|immunologic factors|mesh-ancestor
19986601|NCT01976364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19986602|NCT01976364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19986603|NCT01976364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19986604|NCT01976390|Sirolimus|sirolimus|mesh-list
19986605|NCT01976390|Everolimus|everolimus|mesh-list
19986606|NCT01976390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986607|NCT01976390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19986608|NCT01976390|Immunologic Factors|immunologic factors|mesh-ancestor
19986609|NCT01976390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986610|NCT01976390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19986611|NCT01976390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19986612|NCT01976390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19986613|NCT01976390|Antifungal Agents|antifungal agents|mesh-ancestor
19986614|NCT01976416|Hydroxyurea|hydroxyurea|mesh-list
19986615|NCT01976416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986616|NCT01976416|Antisickling Agents|antisickling agents|mesh-ancestor
19986617|NCT01976416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986618|NCT01976416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986619|NCT01976416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19986620|NCT01976507|Dabigatran|dabigatran|mesh-list
19986621|NCT01976507|Antithrombins|antithrombins|mesh-ancestor
19986622|NCT01976507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19986623|NCT01976507|Protease Inhibitors|protease inhibitors|mesh-ancestor
19986624|NCT01976507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986625|NCT01976507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986626|NCT01976507|Anticoagulants|anticoagulants|mesh-ancestor
19986627|NCT01976572|Candesartan|candesartan|mesh-list
19986628|NCT01976572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19986629|NCT01976572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19986630|NCT01976572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19986631|NCT01976572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986632|NCT01976624|Timolol|timolol|mesh-list
19986633|NCT01976624|Bimatoprost|bimatoprost|mesh-list
19986634|NCT01976624|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19986635|NCT01976624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19986636|NCT01976624|Adrenergic Agents|adrenergic agents|mesh-ancestor
19986637|NCT01976624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19986638|NCT01976624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986639|NCT01976624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986640|NCT01976624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19986641|NCT01976624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19986642|NCT01976650|Dexamethasone|dexamethasone|mesh-list
19986643|NCT01976650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19986644|NCT01976650|Antiemetics|antiemetics|mesh-ancestor
19986645|NCT01976650|Autonomic Agents|autonomic agents|mesh-ancestor
19986646|NCT01976650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19986647|NCT01976650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986648|NCT01976650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19986649|NCT01976650|Glucocorticoids|glucocorticoids|mesh-ancestor
19986650|NCT01976650|Hormones|hormones|mesh-ancestor
19986651|NCT01976650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19986652|NCT01976650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19986653|NCT01976650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986654|NCT01976728|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19986655|NCT01976728|Hormones|hormones|mesh-ancestor
19986656|NCT01976728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19986657|NCT01976728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986658|NCT01976806|Aspirin|aspirin|mesh-list
19986659|NCT01976806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19740516|NCT03435003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19740517|NCT03435003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19740518|NCT03435003|Anesthetics, General|anesthetics, general|mesh-ancestor
19740519|NCT03435003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19740520|NCT03435003|Analgesics|analgesics|mesh-ancestor
19740521|NCT03435003|Sensory System Agents|sensory system agents|mesh-ancestor
19740522|NCT03435003|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19740523|NCT03435003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19740524|NCT03435003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19740525|NCT03435003|Adrenergic Agents|adrenergic agents|mesh-ancestor
19740526|NCT03435003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19740527|NCT03435003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740528|NCT03435003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19740529|NCT03435003|Narcotics|narcotics|mesh-ancestor
19740530|NCT03435003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19740531|NCT03435003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19740532|NCT03435003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19740533|NCT03435003|Antipruritics|antipruritics|mesh-ancestor
19740534|NCT03435003|Dermatologic Agents|dermatologic agents|mesh-ancestor
19740535|NCT03435003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19740536|NCT03435003|Serotonin Agents|serotonin agents|mesh-ancestor
19740537|NCT03435003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19740538|NCT03435003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19740539|NCT03435003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19740540|NCT03435003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19740541|NCT03435003|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19740542|NCT03435003|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19740543|NCT03435003|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19740544|NCT03435003|Dopamine Agents|dopamine agents|mesh-ancestor
19740545|NCT03435003|Mydriatics|mydriatics|mesh-ancestor
19740546|NCT03435003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19740547|NCT03435003|Cholinergic Agents|cholinergic agents|mesh-ancestor
19740548|NCT03435003|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19740549|NCT03435003|Parasympatholytics|parasympatholytics|mesh-ancestor
19740550|NCT03434769|Cyclophosphamide|cyclophosphamide|mesh-list
19740551|NCT03434769|Fludarabine|fludarabine|mesh-list
19740552|NCT03434769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19740553|NCT03434769|Immunologic Factors|immunologic factors|mesh-ancestor
19740554|NCT03434769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740555|NCT03434769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19740556|NCT03434769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19740557|NCT03434769|Alkylating Agents|alkylating agents|mesh-ancestor
19740558|NCT03434769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740559|NCT03434769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740560|NCT03434769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19740561|NCT03414983|Leucovorin|leucovorin|mesh-list
19740562|NCT03414983|Bevacizumab|bevacizumab|mesh-list
19740563|NCT03414983|Nivolumab|nivolumab|mesh-list
19740564|NCT03414983|Fluorouracil|fluorouracil|mesh-list
19740565|NCT03414983|Oxaliplatin|oxaliplatin|mesh-list
19740566|NCT03414983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19740567|NCT03414983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740568|NCT03414983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19740569|NCT03414983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19740570|NCT03414983|Growth Substances|growth substances|mesh-ancestor
19740571|NCT03414983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740572|NCT03414983|Growth Inhibitors|growth inhibitors|mesh-ancestor
19740573|NCT03414983|Antimetabolites|antimetabolites|mesh-ancestor
19740574|NCT03414983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740575|NCT03414983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19740576|NCT03414983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19740577|NCT03414983|Immunologic Factors|immunologic factors|mesh-ancestor
19740578|NCT03414983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19740579|NCT03414983|Antidotes|antidotes|mesh-ancestor
19740580|NCT03414983|Protective Agents|protective agents|mesh-ancestor
19740581|NCT03414983|Vitamin B Complex|vitamin b complex|mesh-ancestor
19740582|NCT03414983|Vitamins|vitamins|mesh-ancestor
19740583|NCT03414983|Micronutrients|micronutrients|mesh-ancestor
19740584|NCT03383692|Ritonavir|ritonavir|mesh-list
19740585|NCT03383692|Itraconazole|itraconazole|mesh-list
19740586|NCT03383692|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19740587|NCT03383692|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19740588|NCT03383692|Protease Inhibitors|protease inhibitors|mesh-ancestor
19740589|NCT03383692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740590|NCT03383692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740591|NCT03383692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19740592|NCT03383692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19740593|NCT03383692|Antiviral Agents|antiviral agents|mesh-ancestor
19740594|NCT03383692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19740595|NCT03383692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19740596|NCT03383692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19740597|NCT03383692|Antifungal Agents|antifungal agents|mesh-ancestor
19740598|NCT03383692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19740599|NCT03383692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19740600|NCT03383692|Hormone Antagonists|hormone antagonists|mesh-ancestor
19740601|NCT03383692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19740602|NCT03383692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740603|NCT03349268|Xenon|xenon|mesh-list
19740604|NCT03349268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19740605|NCT03349268|Anesthetics, General|anesthetics, general|mesh-ancestor
19740606|NCT03349268|Anesthetics|anesthetics|mesh-ancestor
19740607|NCT03349268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19740608|NCT03349268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740609|NCT03321656|Tacrolimus|tacrolimus|mesh-list
19740610|NCT03321656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19740611|NCT03321656|Immunologic Factors|immunologic factors|mesh-ancestor
19740612|NCT03321656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740613|NCT03321656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19740614|NCT03321656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740615|NCT03321656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740616|NCT03307785|Paclitaxel|paclitaxel|mesh-list
19740617|NCT03307785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19740618|NCT03307785|Bevacizumab|bevacizumab|mesh-list
19740619|NCT03307785|Carboplatin|carboplatin|mesh-list
19740620|NCT03307785|Pemetrexed|pemetrexed|mesh-list
19740621|NCT03307785|Niraparib|niraparib|mesh-list
19740622|NCT03307785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19740623|NCT03307785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740624|NCT03307785|Tubulin Modulators|tubulin modulators|mesh-ancestor
19740625|NCT03307785|Antimitotic Agents|antimitotic agents|mesh-ancestor
19740626|NCT03307785|Mitosis Modulators|mitosis modulators|mesh-ancestor
19740627|NCT03307785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740628|NCT03307785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19740629|NCT03307785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19740630|NCT03307785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19740631|NCT03307785|Growth Substances|growth substances|mesh-ancestor
19740632|NCT03307785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740633|NCT03307785|Growth Inhibitors|growth inhibitors|mesh-ancestor
19740634|NCT03307785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740635|NCT03307785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19740636|NCT03307785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19740637|NCT03307785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19740638|NCT03277638|Pembrolizumab|pembrolizumab|mesh-list
19740639|NCT03277638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19740640|NCT03277638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740641|NCT03182166|Golimumab|golimumab|mesh-list
19740642|NCT03182166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19740643|NCT03182166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19740644|NCT03182166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19740645|NCT03182166|Immunologic Factors|immunologic factors|mesh-ancestor
19740646|NCT03182166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740647|NCT03161028|Thioctic Acid|thioctic acid|mesh-list
19740648|NCT03161028|Antioxidants|antioxidants|mesh-ancestor
19740649|NCT03161028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740650|NCT03161028|Protective Agents|protective agents|mesh-ancestor
19740651|NCT03161028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740652|NCT03161028|Vitamin B Complex|vitamin b complex|mesh-ancestor
19740653|NCT03161028|Vitamins|vitamins|mesh-ancestor
19740654|NCT03161028|Micronutrients|micronutrients|mesh-ancestor
19986660|NCT01976806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19986661|NCT01976806|Analgesics|analgesics|mesh-ancestor
19986662|NCT01976806|Sensory System Agents|sensory system agents|mesh-ancestor
19740655|NCT03134131|TIC10 compound|tic10 compound|mesh-list
19740656|NCT03134131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740657|NCT03090737|Nivolumab|nivolumab|mesh-list
19740658|NCT03090737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19740659|NCT03090737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740660|NCT03090737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19740661|NCT03090737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740662|NCT03088826|Acetaminophen|acetaminophen|mesh-list
19740663|NCT03088826|Morphine|morphine|mesh-list
19740664|NCT03088826|Oxycodone|oxycodone|mesh-list
19740665|NCT03088826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19740666|NCT03088826|Narcotics|narcotics|mesh-ancestor
19740667|NCT03088826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19740668|NCT03088826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740669|NCT03088826|Analgesics|analgesics|mesh-ancestor
19740670|NCT03088826|Sensory System Agents|sensory system agents|mesh-ancestor
19740671|NCT03088826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19740672|NCT03088826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19740673|NCT03088826|Antipyretics|antipyretics|mesh-ancestor
19740674|NCT03043872|Carboplatin|carboplatin|mesh-list
19740675|NCT03043872|Etoposide|etoposide|mesh-list
19740676|NCT03043872|Durvalumab|durvalumab|mesh-list
19740677|NCT03043872|Tremelimumab|tremelimumab|mesh-list
19740678|NCT03043872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740679|NCT03043872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19740680|NCT03043872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19740681|NCT03043872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19740682|NCT03043872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740683|NCT03043872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740684|NCT03043872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19740685|NCT03034018|Suvorexant|suvorexant|mesh-list
19740686|NCT03034018|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19740687|NCT03034018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19740688|NCT03034018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19740689|NCT03034018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740690|NCT03034018|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
19740691|NCT03034018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19740692|NCT03034018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740693|NCT03024437|Bevacizumab|bevacizumab|mesh-list
19740694|NCT03024437|Atezolizumab|atezolizumab|mesh-list
19740695|NCT03024437|Entinostat|entinostat|mesh-list
19740696|NCT03024437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19740697|NCT03024437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740698|NCT03024437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19740699|NCT03024437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19740700|NCT03024437|Growth Substances|growth substances|mesh-ancestor
19740701|NCT03024437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740702|NCT03024437|Growth Inhibitors|growth inhibitors|mesh-ancestor
19740703|NCT03024437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19740704|NCT03024437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740705|NCT03024437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740706|NCT03021460|Pembrolizumab|pembrolizumab|mesh-list
19740707|NCT03021460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19740708|NCT03021460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740709|NCT02989402|Rivastigmine|rivastigmine|mesh-list
19740710|NCT02989402|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19740711|NCT02989402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740712|NCT02989402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986663|NCT01976806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19986664|NCT01976806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986665|NCT01976806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19986666|NCT01976806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19986667|NCT01976806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19986668|NCT01976806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19986669|NCT01976806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986670|NCT01976806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19986671|NCT01976806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19986672|NCT01976806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986673|NCT01976806|Antipyretics|antipyretics|mesh-ancestor
19986674|NCT01976845|Midazolam|midazolam|mesh-list
19986675|NCT01976845|Propofol|propofol|mesh-list
19986676|NCT01976845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19986677|NCT01976845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19986678|NCT01976845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986679|NCT01976845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19986680|NCT01976845|Anesthetics, General|anesthetics, general|mesh-ancestor
19986681|NCT01976845|Anesthetics|anesthetics|mesh-ancestor
19986682|NCT01976845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19986683|NCT01976845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19986684|NCT01976845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19986685|NCT01976845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19986686|NCT01976845|GABA Modulators|gaba modulators|mesh-ancestor
19986687|NCT01976845|GABA Agents|gaba agents|mesh-ancestor
19986688|NCT01976845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19986689|NCT01976845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986690|NCT01976871|Rotigotine|rotigotine|mesh-list
19986691|NCT01976871|Dopamine Agonists|dopamine agonists|mesh-ancestor
19986692|NCT01976871|Dopamine Agents|dopamine agents|mesh-ancestor
19986693|NCT01976871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19986694|NCT01976871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986695|NCT01976871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986696|NCT01976988|Heparin|heparin|mesh-list
19986697|NCT01976988|Anticoagulants|anticoagulants|mesh-ancestor
19986698|NCT01976988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19986699|NCT01976988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19986700|NCT01976988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986701|NCT01977352|Bupivacaine|bupivacaine|mesh-list
19986702|NCT01977352|Anesthetics, Local|anesthetics, local|mesh-ancestor
19986703|NCT01977352|Anesthetics|anesthetics|mesh-ancestor
19986704|NCT01977352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19986705|NCT01977352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986706|NCT01977352|Sensory System Agents|sensory system agents|mesh-ancestor
19986707|NCT01977352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19986708|NCT01977456|Eptifibatide|eptifibatide|mesh-list
19986709|NCT01977456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19986710|NCT01977625|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19740713|NCT02989402|Cholinergic Agents|cholinergic agents|mesh-ancestor
19740714|NCT02989402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19740715|NCT02989402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740716|NCT02989402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19740717|NCT02989402|Protective Agents|protective agents|mesh-ancestor
19740718|NCT02908750|Fexofenadine|fexofenadine|mesh-list
19740719|NCT02908750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19740720|NCT02908750|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19740721|NCT02908750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19740722|NCT02908750|Histamine Antagonists|histamine antagonists|mesh-ancestor
19740723|NCT02908750|Histamine Agents|histamine agents|mesh-ancestor
19740724|NCT02908750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19740725|NCT02908750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740726|NCT02908750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740727|NCT02892123|Paclitaxel|paclitaxel|mesh-list
19740728|NCT02892123|Vinorelbine|vinorelbine|mesh-list
19740729|NCT02892123|Capecitabine|capecitabine|mesh-list
19740730|NCT02892123|Tucatinib|tucatinib|mesh-list
19740731|NCT02892123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19740732|NCT02892123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740733|NCT02892123|Tubulin Modulators|tubulin modulators|mesh-ancestor
19740734|NCT02892123|Antimitotic Agents|antimitotic agents|mesh-ancestor
19740735|NCT02892123|Mitosis Modulators|mitosis modulators|mesh-ancestor
19740736|NCT02892123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740737|NCT02892123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19740738|NCT02892123|Antimetabolites|antimetabolites|mesh-ancestor
19740739|NCT02892123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19740740|NCT02892123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740741|NCT02819596|Durvalumab|durvalumab|mesh-list
19740742|NCT02819596|Tremelimumab|tremelimumab|mesh-list
19740743|NCT02819596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19740744|NCT02819596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740745|NCT02673333|Pembrolizumab|pembrolizumab|mesh-list
19740746|NCT02673333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19740747|NCT02673333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740748|NCT02639702|Clozapine|clozapine|mesh-list
19740749|NCT02639702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19740750|NCT02639702|Serotonin Agents|serotonin agents|mesh-ancestor
19740751|NCT02639702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19740752|NCT02639702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740753|NCT02639702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740754|NCT02639702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19740755|NCT02639702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19740756|NCT02639702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19740757|NCT02639702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19740758|NCT02639702|GABA Antagonists|gaba antagonists|mesh-ancestor
19740759|NCT02639702|GABA Agents|gaba agents|mesh-ancestor
19740760|NCT02596997|Brincidofovir|brincidofovir|mesh-list
19740761|NCT02596997|Antiviral Agents|antiviral agents|mesh-ancestor
19740762|NCT02596997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19740763|NCT02595879|Cisplatin|cisplatin|mesh-list
19740764|NCT02595879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740765|NCT02555254|Methamphetamine|methamphetamine|mesh-list
19740766|NCT02555254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19740767|NCT02555254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740768|NCT02555254|Sympathomimetics|sympathomimetics|mesh-ancestor
19740769|NCT02555254|Autonomic Agents|autonomic agents|mesh-ancestor
19740770|NCT02555254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19740771|NCT02555254|Dopamine Agents|dopamine agents|mesh-ancestor
19740772|NCT02555254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19740773|NCT02555254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740774|NCT02555254|Adrenergic Agents|adrenergic agents|mesh-ancestor
19740775|NCT02555254|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19740776|NCT02555254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19740777|NCT02555254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19740778|NCT02555254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19740779|NCT02444728|Hydroxychloroquine|hydroxychloroquine|mesh-list
19740780|NCT02444728|Methylprednisolone|methylprednisolone|mesh-list
19740781|NCT02444728|Cyclophosphamide|cyclophosphamide|mesh-list
19740782|NCT02444728|Azathioprine|azathioprine|mesh-list
19740783|NCT02444728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19740784|NCT02444728|Immunologic Factors|immunologic factors|mesh-ancestor
19740785|NCT02444728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740786|NCT02444728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19740787|NCT02444728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19740788|NCT02444728|Alkylating Agents|alkylating agents|mesh-ancestor
19740789|NCT02444728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740790|NCT02444728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740791|NCT02444728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19740792|NCT02444728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19740793|NCT02444728|Antiemetics|antiemetics|mesh-ancestor
19740794|NCT02444728|Autonomic Agents|autonomic agents|mesh-ancestor
19740795|NCT02444728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19740796|NCT02444728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19740797|NCT02444728|Glucocorticoids|glucocorticoids|mesh-ancestor
19740798|NCT02444728|Hormones|hormones|mesh-ancestor
19740799|NCT02444728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19740800|NCT02444728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19740801|NCT02444728|Protective Agents|protective agents|mesh-ancestor
19740802|NCT02444728|Antimalarials|antimalarials|mesh-ancestor
19740803|NCT02444728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19740804|NCT02444728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19740805|NCT02444728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19740806|NCT02444728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740807|NCT02444728|Antimetabolites|antimetabolites|mesh-ancestor
19740808|NCT02444728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19740809|NCT02381353|Bupivacaine|bupivacaine|mesh-list
19740810|NCT02381353|Anesthetics, Local|anesthetics, local|mesh-ancestor
19740811|NCT02381353|Anesthetics|anesthetics|mesh-ancestor
19740812|NCT02381353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19740813|NCT02381353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740814|NCT02381353|Sensory System Agents|sensory system agents|mesh-ancestor
19740815|NCT02381353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19740816|NCT02296918|Rituximab|rituximab|mesh-list
19740817|NCT02296918|Obinutuzumab|obinutuzumab|mesh-list
19740818|NCT02296918|Venetoclax|venetoclax|mesh-list
19740819|NCT02296918|Acalabrutinib|acalabrutinib|mesh-list
19740820|NCT02296918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19740821|NCT02296918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740822|NCT02296918|Immunologic Factors|immunologic factors|mesh-ancestor
19740823|NCT02296918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740824|NCT02296918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19740825|NCT01787409|Vitamin D|vitamin d|mesh-list
19740826|NCT01787409|Cholecalciferol|cholecalciferol|mesh-list
19740827|NCT01787409|Vitamins|vitamins|mesh-ancestor
19740828|NCT01787409|Micronutrients|micronutrients|mesh-ancestor
19740829|NCT01787409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740830|NCT01787409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19740831|NCT01787409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19740832|NCT01750281|Docetaxel|docetaxel|mesh-list
19740833|NCT01750281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740834|NCT01750281|Tubulin Modulators|tubulin modulators|mesh-ancestor
19740835|NCT01750281|Antimitotic Agents|antimitotic agents|mesh-ancestor
19740836|NCT01750281|Mitosis Modulators|mitosis modulators|mesh-ancestor
19740837|NCT01750281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740838|NCT01426529|Norepinephrine|norepinephrine|mesh-list
19740839|NCT01426529|Angiotensin II|angiotensin ii|mesh-list
19740840|NCT01426529|Giapreza|giapreza|mesh-list
19740841|NCT01426529|Angiotensinogen|angiotensinogen|mesh-list
19740842|NCT01426529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19740843|NCT01426529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19740844|NCT01426529|Adrenergic Agents|adrenergic agents|mesh-ancestor
19740845|NCT01426529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19740846|NCT01426529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740847|NCT01426529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740848|NCT01426529|Sympathomimetics|sympathomimetics|mesh-ancestor
19740849|NCT01426529|Autonomic Agents|autonomic agents|mesh-ancestor
19740850|NCT01426529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19740851|NCT01426529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19740852|NCT01426529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19740853|NCT01426529|Protease Inhibitors|protease inhibitors|mesh-ancestor
19740854|NCT01426529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740855|NCT01252953|Oxazolidinones|oxazolidinones|mesh-list
19740856|NCT01252953|Anacetrapib|anacetrapib|mesh-list
19740857|NCT01252953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19740858|NCT01252953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19740859|NCT01252953|Antimetabolites|antimetabolites|mesh-ancestor
19740860|NCT01252953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740861|NCT01252953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19740862|NCT01252953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19740863|NCT01252953|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19740864|NCT01252953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740865|NCT01012609|Irinotecan|irinotecan|mesh-list
19740866|NCT01012609|Cetuximab|cetuximab|mesh-list
19740867|NCT01012609|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19740868|NCT01012609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19740869|NCT01012609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740870|NCT01012609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740871|NCT01012609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740872|NCT01012609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19986711|NCT01977625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19986712|NCT01977625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986713|NCT01977625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19986714|NCT01977625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19986715|NCT01977625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19986716|NCT01977625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986717|NCT01977625|Dopamine Agents|dopamine agents|mesh-ancestor
19986718|NCT01977625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19986719|NCT01977677|Plerixafor|plerixafor|mesh-list
19986720|NCT01977677|Temozolomide|temozolomide|mesh-list
19740873|NCT00920387|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
19740874|NCT00920387|Hallucinogens|hallucinogens|mesh-ancestor
19740875|NCT00920387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740876|NCT00920387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19740877|NCT00920387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19740878|NCT00920387|Serotonin Agents|serotonin agents|mesh-ancestor
19740879|NCT00920387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19740880|NCT00920387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740881|NCT00920387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19740882|NCT00494234|Olaparib|olaparib|mesh-list
19740883|NCT00494234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
19740884|NCT00494234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740885|NCT00494234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740886|NCT00494234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740887|NCT00458835|Ciclesonide|ciclesonide|mesh-list
19740888|NCT00458835|Glucocorticoids|glucocorticoids|mesh-ancestor
19740889|NCT00458835|Hormones|hormones|mesh-ancestor
19740890|NCT00458835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19740891|NCT00458835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740892|NCT00458835|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19740893|NCT00403559|Ketoconazole|ketoconazole|mesh-list
19740894|NCT00403559|Pimecrolimus|pimecrolimus|mesh-list
19740895|NCT00403559|Antifungal Agents|antifungal agents|mesh-ancestor
19740896|NCT00403559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19740897|NCT00403559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19740898|NCT00403559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19740899|NCT00403559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740900|NCT00403559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740901|NCT00403559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19740902|NCT00403559|Hormone Antagonists|hormone antagonists|mesh-ancestor
19740903|NCT00403559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19740904|NCT00403559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740905|NCT00403559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19740906|NCT00403559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19740907|NCT00403559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19740908|NCT00403559|Analgesics|analgesics|mesh-ancestor
19740909|NCT00403559|Sensory System Agents|sensory system agents|mesh-ancestor
19740910|NCT00403559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19740911|NCT00403559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19740912|NCT00403559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19740913|NCT00403559|Dermatologic Agents|dermatologic agents|mesh-ancestor
19740914|NCT00403559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19740915|NCT00403559|Immunologic Factors|immunologic factors|mesh-ancestor
19740916|NCT00403559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19740917|NCT00353938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
19740918|NCT00353938|Hallucinogens|hallucinogens|mesh-ancestor
19740919|NCT00353938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740920|NCT00353938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19740921|NCT00353938|Serotonin Agents|serotonin agents|mesh-ancestor
19740922|NCT00353938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19740923|NCT00353938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740924|NCT00353938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19740925|NCT00353938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19740926|NCT00353938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19740927|NCT00353938|Adrenergic Agents|adrenergic agents|mesh-ancestor
19740928|NCT00006436|Rituximab|rituximab|mesh-list
19740929|NCT00006436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19740930|NCT00006436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740931|NCT00006436|Immunologic Factors|immunologic factors|mesh-ancestor
19740932|NCT00006436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740933|NCT00006436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19740934|NCT05283304|Buprenorphine|buprenorphine|mesh-list
19740935|NCT05283304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19740936|NCT05283304|Narcotics|narcotics|mesh-ancestor
19740937|NCT05283304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19740938|NCT05283304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740939|NCT05283304|Analgesics|analgesics|mesh-ancestor
19740940|NCT05283304|Sensory System Agents|sensory system agents|mesh-ancestor
19740941|NCT05283304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19740942|NCT05283304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19740943|NCT05283278|Lactoferrin|lactoferrin|mesh-list
19740944|NCT05283278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19740945|NCT05283226|Paclitaxel|paclitaxel|mesh-list
19740946|NCT05283226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19740947|NCT05283226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740948|NCT05283226|Tubulin Modulators|tubulin modulators|mesh-ancestor
19740949|NCT05283226|Antimitotic Agents|antimitotic agents|mesh-ancestor
19740950|NCT05283226|Mitosis Modulators|mitosis modulators|mesh-ancestor
19740951|NCT05283226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740952|NCT05283109|Vaccines|vaccines|mesh-list
19740953|NCT05283109|Poly ICLC|poly iclc|mesh-list
19740954|NCT05283109|Immunologic Factors|immunologic factors|mesh-ancestor
19740955|NCT05283109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740956|NCT05283109|Interferon Inducers|interferon inducers|mesh-ancestor
19740957|NCT05283057|Empagliflozin|empagliflozin|mesh-list
19740958|NCT05283057|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19740959|NCT05283057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740960|NCT05283057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19740961|NCT05283057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740962|NCT05282771|Nicotinic Acids|nicotinic acids|mesh-list
19740963|NCT05282771|Clobetasol|clobetasol|mesh-list
19740964|NCT05282771|Halobetasol|halobetasol|mesh-list
19740965|NCT05282771|Tazarotene|tazarotene|mesh-list
19740966|NCT05282771|Dermatologic Agents|dermatologic agents|mesh-ancestor
19740967|NCT05282771|Keratolytic Agents|keratolytic agents|mesh-ancestor
19740968|NCT05282771|Vitamin B Complex|vitamin b complex|mesh-ancestor
19740969|NCT05282771|Vitamins|vitamins|mesh-ancestor
19740970|NCT05282771|Micronutrients|micronutrients|mesh-ancestor
19740971|NCT05282771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740972|NCT05282771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19740973|NCT05282771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19740974|NCT05282771|Glucocorticoids|glucocorticoids|mesh-ancestor
19740975|NCT05282771|Hormones|hormones|mesh-ancestor
19740976|NCT05282771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19986721|NCT01977677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19986722|NCT01977677|Alkylating Agents|alkylating agents|mesh-ancestor
19986723|NCT01977677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986724|NCT01977677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986725|NCT01977677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19986726|NCT01977677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19986727|NCT01977677|Antiviral Agents|antiviral agents|mesh-ancestor
19986728|NCT01977677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19986729|NCT01977781|Methylprednisolone|methylprednisolone|mesh-list
19986730|NCT01977781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19986731|NCT01977781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19986732|NCT01977781|Prednisolone|prednisolone|mesh-list
19986733|NCT01977781|Prednisolone acetate|prednisolone acetate|mesh-list
19986734|NCT01977781|Tacrolimus|tacrolimus|mesh-list
19986735|NCT01977781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19986736|NCT01977781|Prednisolone phosphate|prednisolone phosphate|mesh-list
19986737|NCT01977781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19986738|NCT01977781|Immunologic Factors|immunologic factors|mesh-ancestor
19986739|NCT01977781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986740|NCT01977781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19986741|NCT01977781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986742|NCT01977781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986743|NCT01977781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19986744|NCT01977781|Antiemetics|antiemetics|mesh-ancestor
19986745|NCT01977781|Autonomic Agents|autonomic agents|mesh-ancestor
19986746|NCT01977781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19986747|NCT01977781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19986748|NCT01977781|Glucocorticoids|glucocorticoids|mesh-ancestor
19986749|NCT01977781|Hormones|hormones|mesh-ancestor
19986750|NCT01977781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19986751|NCT01977781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19986752|NCT01977781|Protective Agents|protective agents|mesh-ancestor
19986753|NCT01977781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19986754|NCT01977781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986755|NCT01977794|Amlodipine|amlodipine|mesh-list
19986756|NCT01977794|Bisoprolol|bisoprolol|mesh-list
19986757|NCT01977794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19986758|NCT01977794|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19986759|NCT01977794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19986760|NCT01977794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986761|NCT01977794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19986762|NCT01977794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986763|NCT01977794|Vasodilator Agents|vasodilator agents|mesh-ancestor
19986764|NCT01977794|Sympatholytics|sympatholytics|mesh-ancestor
19986765|NCT01977794|Autonomic Agents|autonomic agents|mesh-ancestor
19986766|NCT01977794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19986767|NCT01977794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19740977|NCT05282719|Azacitidine|azacitidine|mesh-list
19740978|NCT05282719|Venetoclax|venetoclax|mesh-list
19740979|NCT05282719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19740980|NCT05282719|Antimetabolites|antimetabolites|mesh-ancestor
19740981|NCT05282719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740982|NCT05282719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740983|NCT05282719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740984|NCT05282420|Ranibizumab|ranibizumab|mesh-list
19740985|NCT05282420|Aflibercept|aflibercept|mesh-list
19740986|NCT05282420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19740987|NCT05282420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19740988|NCT05282420|Growth Substances|growth substances|mesh-ancestor
19740989|NCT05282420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19740990|NCT05282420|Growth Inhibitors|growth inhibitors|mesh-ancestor
19740991|NCT05282420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19740992|NCT05282407|Tenofovir|tenofovir|mesh-list
19740993|NCT05282407|Antiviral Agents|antiviral agents|mesh-ancestor
19740994|NCT05282407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19740995|NCT05282407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19740996|NCT05282407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19740997|NCT05282407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19740998|NCT05282407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19740999|NCT05282407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19741000|NCT05282407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19741001|NCT05282251|Bupivacaine|bupivacaine|mesh-list
19741002|NCT05282251|Anesthetics, Local|anesthetics, local|mesh-ancestor
19741003|NCT05282251|Anesthetics|anesthetics|mesh-ancestor
19741004|NCT05282251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19741005|NCT05282251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741006|NCT05282251|Sensory System Agents|sensory system agents|mesh-ancestor
19741007|NCT05282251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741008|NCT05281965|Tretinoin|tretinoin|mesh-list
19741009|NCT05281965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741010|NCT05281965|Keratolytic Agents|keratolytic agents|mesh-ancestor
19741011|NCT05281965|Dermatologic Agents|dermatologic agents|mesh-ancestor
19741012|NCT05281926|Nivolumab|nivolumab|mesh-list
19741013|NCT05281926|Poly ICLC|poly iclc|mesh-list
19741014|NCT05281926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19741015|NCT05281926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741016|NCT05281926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19741017|NCT05281926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741018|NCT05281926|Interferon Inducers|interferon inducers|mesh-ancestor
19741019|NCT05281926|Immunologic Factors|immunologic factors|mesh-ancestor
19741020|NCT05281926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741021|NCT05281861|Lithium Carbonate|lithium carbonate|mesh-list
19741022|NCT05281861|Antidepressive Agents|antidepressive agents|mesh-ancestor
19741023|NCT05281861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19741024|NCT05281861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741025|NCT05281861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741026|NCT05281861|Antimanic Agents|antimanic agents|mesh-ancestor
19741027|NCT05281861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19741028|NCT05281861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19741029|NCT05281861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741030|NCT05281614|Etanercept|etanercept|mesh-list
19741031|NCT05281614|Vedolizumab|vedolizumab|mesh-list
19741032|NCT05281614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19741033|NCT05281614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19741034|NCT05281614|Analgesics|analgesics|mesh-ancestor
19741035|NCT05281614|Sensory System Agents|sensory system agents|mesh-ancestor
19741036|NCT05281614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741037|NCT05281614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741038|NCT05281614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19741039|NCT05281614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19741040|NCT05281614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19741041|NCT05281614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19741042|NCT05281614|Immunologic Factors|immunologic factors|mesh-ancestor
19741043|NCT05281419|Triamcinolone|triamcinolone|mesh-list
19741044|NCT05281419|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19741045|NCT05281419|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19741046|NCT05281419|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19741047|NCT05281419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19741048|NCT05281419|Glucocorticoids|glucocorticoids|mesh-ancestor
19741049|NCT05281419|Hormones|hormones|mesh-ancestor
19741050|NCT05281419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19741051|NCT05281419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741052|NCT05281419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19741053|NCT05281419|Immunologic Factors|immunologic factors|mesh-ancestor
19741054|NCT05281419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741055|NCT05281419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741056|NCT05281406|Carboplatin|carboplatin|mesh-list
19741057|NCT05281406|Pemetrexed|pemetrexed|mesh-list
19741058|NCT05281406|Osimertinib|osimertinib|mesh-list
19741059|NCT05281406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741060|NCT05281406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741061|NCT05281406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986768|NCT01977794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19986769|NCT01977794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19986770|NCT01977794|Adrenergic Agents|adrenergic agents|mesh-ancestor
19986771|NCT01977794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19986772|NCT01977898|Morphine|morphine|mesh-list
19986773|NCT01977898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19986774|NCT01977898|Narcotics|narcotics|mesh-ancestor
19986775|NCT01977898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19986776|NCT01977898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986777|NCT01977898|Analgesics|analgesics|mesh-ancestor
19986778|NCT01977898|Sensory System Agents|sensory system agents|mesh-ancestor
19986779|NCT01977898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19986780|NCT01977937|Gabapentin|gabapentin|mesh-list
19986781|NCT01977937|Analgesics|analgesics|mesh-ancestor
19986782|NCT01977937|Sensory System Agents|sensory system agents|mesh-ancestor
19986783|NCT01977937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19986784|NCT01977937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741062|NCT05281406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19741063|NCT05281406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19741064|NCT05281406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19741065|NCT05281328|Octreotide|octreotide|mesh-list
19741066|NCT05281328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19741067|NCT05281328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19741068|NCT05281328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741069|NCT05281276|Celecoxib|celecoxib|mesh-list
19741070|NCT05281276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19741071|NCT05281276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19741072|NCT05281276|Analgesics|analgesics|mesh-ancestor
19741073|NCT05281276|Sensory System Agents|sensory system agents|mesh-ancestor
19741074|NCT05281276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741075|NCT05281276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741076|NCT05281276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19741077|NCT05281276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19741078|NCT05281276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19741079|NCT05281276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19741080|NCT05281276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741081|NCT05281276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741082|NCT05281185|Factor VIII|factor viii|mesh-list
19741083|NCT05281185|Coagulants|coagulants|mesh-ancestor
19741084|NCT05281107|Calcium, Dietary|calcium, dietary|mesh-list
19741085|NCT05281107|Vitamin D|vitamin d|mesh-list
19741086|NCT05281107|Ergocalciferols|ergocalciferols|mesh-list
19741087|NCT05281107|Vitamins|vitamins|mesh-list
19741088|NCT05281107|Calcium|calcium|mesh-list
19741089|NCT05281107|Micronutrients|micronutrients|mesh-ancestor
19741090|NCT05281107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741091|NCT05281107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19741092|NCT05281107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19741093|NCT05281081|Morphine|morphine|mesh-list
19741094|NCT05281081|Levobupivacaine|levobupivacaine|mesh-list
19741095|NCT05281081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19741096|NCT05281081|Narcotics|narcotics|mesh-ancestor
19741097|NCT05281081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19741098|NCT05281081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741099|NCT05281081|Analgesics|analgesics|mesh-ancestor
19741100|NCT05281081|Sensory System Agents|sensory system agents|mesh-ancestor
19741101|NCT05281081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741102|NCT05281081|Anesthetics, Local|anesthetics, local|mesh-ancestor
19741103|NCT05281081|Anesthetics|anesthetics|mesh-ancestor
19741104|NCT05281003|Paclitaxel|paclitaxel|mesh-list
19741105|NCT05281003|Pembrolizumab|pembrolizumab|mesh-list
19741106|NCT05281003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19741107|NCT05281003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741108|NCT05281003|Tubulin Modulators|tubulin modulators|mesh-ancestor
19741109|NCT05281003|Antimitotic Agents|antimitotic agents|mesh-ancestor
19741110|NCT05281003|Mitosis Modulators|mitosis modulators|mesh-ancestor
19741111|NCT05281003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986785|NCT01977937|Anticonvulsants|anticonvulsants|mesh-ancestor
19741112|NCT05281003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19741113|NCT05280873|Methylprednisolone|methylprednisolone|mesh-list
19741114|NCT05280873|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19741115|NCT05280873|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19741116|NCT05280873|Prednisolone|prednisolone|mesh-list
19741117|NCT05280873|Prednisolone acetate|prednisolone acetate|mesh-list
19741118|NCT05280873|Pirfenidone|pirfenidone|mesh-list
19741119|NCT05280873|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19741120|NCT05280873|Prednisolone phosphate|prednisolone phosphate|mesh-list
19741121|NCT05280873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19741122|NCT05280873|Antiemetics|antiemetics|mesh-ancestor
19741123|NCT05280873|Autonomic Agents|autonomic agents|mesh-ancestor
19741124|NCT05280873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741125|NCT05280873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741126|NCT05280873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19741127|NCT05280873|Glucocorticoids|glucocorticoids|mesh-ancestor
19741128|NCT05280873|Hormones|hormones|mesh-ancestor
19741129|NCT05280873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19741130|NCT05280873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19741131|NCT05280873|Protective Agents|protective agents|mesh-ancestor
19741132|NCT05280873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19741133|NCT05280873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741134|NCT05280873|Analgesics|analgesics|mesh-ancestor
19986786|NCT01977937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19986787|NCT01977937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19986788|NCT01977937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19986789|NCT01977937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19986790|NCT01977937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19986791|NCT01977937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19986792|NCT01977937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19986793|NCT01977937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986794|NCT01977937|Antimanic Agents|antimanic agents|mesh-ancestor
19986795|NCT01978093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19986796|NCT01978093|Immunologic Factors|immunologic factors|mesh-ancestor
19986797|NCT01978093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986798|NCT01978184|Gemcitabine|gemcitabine|mesh-list
19986799|NCT01978184|Hydroxychloroquine|hydroxychloroquine|mesh-list
19986800|NCT01978184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19986801|NCT01978184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19986802|NCT01978184|Antimetabolites|antimetabolites|mesh-ancestor
19986803|NCT01978184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986804|NCT01978184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986805|NCT01978184|Antiviral Agents|antiviral agents|mesh-ancestor
19986806|NCT01978184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19986807|NCT01978184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986808|NCT01978184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19986809|NCT01978184|Immunologic Factors|immunologic factors|mesh-ancestor
19986810|NCT01978184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986811|NCT01978184|Antimalarials|antimalarials|mesh-ancestor
19986812|NCT01978184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19986813|NCT01978184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19986814|NCT01978184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19986815|NCT01978236|Trametinib|trametinib|mesh-list
19986816|NCT01978236|Dabrafenib|dabrafenib|mesh-list
19986817|NCT01978236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986818|NCT01978236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19986819|NCT01978236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986820|NCT01978236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986821|NCT01978600|Timolol|timolol|mesh-list
19986822|NCT01978600|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19986823|NCT01978600|Brinzolamide|brinzolamide|mesh-list
19986824|NCT01978600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19986825|NCT01978600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19986826|NCT01978600|Adrenergic Agents|adrenergic agents|mesh-ancestor
19986827|NCT01978600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19986828|NCT01978600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986829|NCT01978600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986830|NCT01978600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19986831|NCT01978600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19986832|NCT01978600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986833|NCT01978600|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19986834|NCT01978600|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19986835|NCT01978600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19986836|NCT01978600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19986837|NCT01978743|Raltegravir Potassium|raltegravir potassium|mesh-list
19741135|NCT05280873|Sensory System Agents|sensory system agents|mesh-ancestor
19741136|NCT05280873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19741137|NCT05280873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19741138|NCT05280873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19741139|NCT05280704|Lidocaine|lidocaine|mesh-list
19741140|NCT05280704|Anesthetics, Local|anesthetics, local|mesh-ancestor
19741141|NCT05280704|Anesthetics|anesthetics|mesh-ancestor
19741142|NCT05280704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19741143|NCT05280704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741144|NCT05280704|Sensory System Agents|sensory system agents|mesh-ancestor
19741145|NCT05280704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741146|NCT05280704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19741147|NCT05280704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19741148|NCT05280704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19741149|NCT05280704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19741150|NCT05280704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986838|NCT01978743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19986839|NCT01978743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19986840|NCT01978743|Antiviral Agents|antiviral agents|mesh-ancestor
19986841|NCT01978743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19986842|NCT01978743|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19986843|NCT01978743|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19986844|NCT01978743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986845|NCT01978743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986846|NCT01979016|Emollients|emollients|mesh-list
19986847|NCT01979016|Dermatologic Agents|dermatologic agents|mesh-ancestor
19986848|NCT01979185|Simvastatin|simvastatin|mesh-list
19986849|NCT01979185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19986850|NCT01979185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19986851|NCT01979185|Antimetabolites|antimetabolites|mesh-ancestor
19986852|NCT01979185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986853|NCT01979185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19986854|NCT01979185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19986855|NCT01979185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986856|NCT01979276|Dexamethasone|dexamethasone|mesh-list
19986857|NCT01979276|Pomalidomide|pomalidomide|mesh-list
19986858|NCT01979276|Romidepsin|romidepsin|mesh-list
19986859|NCT01979276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19986860|NCT01979276|Antiemetics|antiemetics|mesh-ancestor
19986861|NCT01979276|Autonomic Agents|autonomic agents|mesh-ancestor
19986862|NCT01979276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19986863|NCT01979276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986864|NCT01979276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19986865|NCT01979276|Glucocorticoids|glucocorticoids|mesh-ancestor
19986866|NCT01979276|Hormones|hormones|mesh-ancestor
19986867|NCT01979276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19986868|NCT01979276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19986869|NCT01979276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986870|NCT01979276|Immunologic Factors|immunologic factors|mesh-ancestor
19986871|NCT01979276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19986872|NCT01979276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19986873|NCT01979276|Growth Substances|growth substances|mesh-ancestor
19986874|NCT01979276|Growth Inhibitors|growth inhibitors|mesh-ancestor
19986875|NCT01979276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19986876|NCT01979445|Clopidogrel|clopidogrel|mesh-list
19986877|NCT01979445|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19986878|NCT01979445|Cangrelor|cangrelor|mesh-list
19986879|NCT01979445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19986880|NCT01979445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19986881|NCT01979445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19986882|NCT01979445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19986883|NCT01979445|Purinergic Agents|purinergic agents|mesh-ancestor
19986884|NCT01979445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19459613|NCT03359837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459614|NCT03359837|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19459615|NCT03359837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459616|NCT03359837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459617|NCT03359798|Narcotics|narcotics|mesh-list
19459618|NCT03359798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19459619|NCT03359798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459620|NCT03359798|Analgesics|analgesics|mesh-ancestor
19459621|NCT03359798|Sensory System Agents|sensory system agents|mesh-ancestor
19459622|NCT03359798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741151|NCT05280626|Prednisolone|prednisolone|mesh-list
19741152|NCT05280626|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19741153|NCT05280626|Methylprednisolone|methylprednisolone|mesh-list
19741154|NCT05280626|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19741155|NCT05280626|Prednisolone acetate|prednisolone acetate|mesh-list
19741156|NCT05280626|Cyclophosphamide|cyclophosphamide|mesh-list
19741157|NCT05280626|Rituximab|rituximab|mesh-list
19741158|NCT05280626|Doxorubicin|doxorubicin|mesh-list
19741159|NCT05280626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19741160|NCT05280626|Vincristine|vincristine|mesh-list
19741161|NCT05280626|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19741162|NCT05280626|Prednisolone phosphate|prednisolone phosphate|mesh-list
19741163|NCT05280626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19741164|NCT05280626|Immunologic Factors|immunologic factors|mesh-ancestor
19741165|NCT05280626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741166|NCT05280626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19741167|NCT05280626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19741168|NCT05280626|Alkylating Agents|alkylating agents|mesh-ancestor
19741169|NCT05280626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741170|NCT05280626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741171|NCT05280626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19741172|NCT05280626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19741173|NCT05280626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19741174|NCT05280626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19741175|NCT05280626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19741176|NCT05280626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741177|NCT05280626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19741178|NCT05280626|Glucocorticoids|glucocorticoids|mesh-ancestor
19741179|NCT05280626|Hormones|hormones|mesh-ancestor
19741180|NCT05280626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19741181|NCT05280626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19741182|NCT05280626|Antiemetics|antiemetics|mesh-ancestor
19741183|NCT05280626|Autonomic Agents|autonomic agents|mesh-ancestor
19741184|NCT05280626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741185|NCT05280626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19741186|NCT05280626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19741187|NCT05280626|Protective Agents|protective agents|mesh-ancestor
19741188|NCT05280626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19741189|NCT05280626|Tubulin Modulators|tubulin modulators|mesh-ancestor
19741190|NCT05280626|Antimitotic Agents|antimitotic agents|mesh-ancestor
19741191|NCT05280626|Mitosis Modulators|mitosis modulators|mesh-ancestor
19741192|NCT05280496|Metformin|metformin|mesh-list
19741193|NCT05280496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19741194|NCT05280496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741195|NCT05280444|Idarubicin|idarubicin|mesh-list
19741196|NCT05280444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19741197|NCT05280444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741198|NCT05280444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19741199|NCT05280444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19741200|NCT05280444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741201|NCT05280444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741202|NCT05280340|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19741203|NCT05280340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20556317|NCT01946256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20556318|NCT01946256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20556319|NCT01946256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20556320|NCT01946256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556321|NCT01946256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556322|NCT01946295|Famotidine|famotidine|mesh-list
19741204|NCT05280314|Pembrolizumab|pembrolizumab|mesh-list
19741205|NCT05280314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19741206|NCT05280314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741207|NCT05280275|Dexamethasone|dexamethasone|mesh-list
19741208|NCT05280275|Lenalidomide|lenalidomide|mesh-list
19741209|NCT05280275|Daratumumab|daratumumab|mesh-list
19741210|NCT05280275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19741211|NCT05280275|Antiemetics|antiemetics|mesh-ancestor
19741212|NCT05280275|Autonomic Agents|autonomic agents|mesh-ancestor
19741213|NCT05280275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741214|NCT05280275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741215|NCT05280275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19741216|NCT05280275|Glucocorticoids|glucocorticoids|mesh-ancestor
19741217|NCT05280275|Hormones|hormones|mesh-ancestor
19741218|NCT05280275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19741219|NCT05280275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19741220|NCT05280275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741221|NCT05280275|Immunologic Factors|immunologic factors|mesh-ancestor
19741222|NCT05280275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19741223|NCT05280275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19741224|NCT05280275|Growth Substances|growth substances|mesh-ancestor
19741225|NCT05280275|Growth Inhibitors|growth inhibitors|mesh-ancestor
19741226|NCT05280236|Propofol|propofol|mesh-list
19741227|NCT05280236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19741228|NCT05280236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19741229|NCT05280236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741230|NCT05280236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19741231|NCT05280236|Anesthetics, General|anesthetics, general|mesh-ancestor
19741232|NCT05280236|Anesthetics|anesthetics|mesh-ancestor
19741233|NCT05280223|Dexmedetomidine|dexmedetomidine|mesh-list
19741234|NCT05280223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19741235|NCT05280223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19741236|NCT05280223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741237|NCT05280223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19741238|NCT05280223|Analgesics|analgesics|mesh-ancestor
19741239|NCT05280223|Sensory System Agents|sensory system agents|mesh-ancestor
19741240|NCT05280223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741241|NCT05280223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19741242|NCT05280223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19741243|NCT05280223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19741244|NCT05280223|Adrenergic Agents|adrenergic agents|mesh-ancestor
19741245|NCT05280223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19741246|NCT05280223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741247|NCT05280197|Bupivacaine|bupivacaine|mesh-list
19741248|NCT05280197|Anesthetics, Local|anesthetics, local|mesh-ancestor
19741249|NCT05280197|Anesthetics|anesthetics|mesh-ancestor
19741250|NCT05280197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19741251|NCT05280197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741252|NCT05280197|Sensory System Agents|sensory system agents|mesh-ancestor
19741253|NCT05280197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741254|NCT05280132|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19741255|NCT05280132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19741256|NCT05280132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19741257|NCT05280132|Antitubercular Agents|antitubercular agents|mesh-ancestor
19741258|NCT05280054|Probenecid|probenecid|mesh-list
19741259|NCT05280054|Uricosuric Agents|uricosuric agents|mesh-ancestor
19741260|NCT05280054|Gout Suppressants|gout suppressants|mesh-ancestor
19741261|NCT05280054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19741262|NCT05280054|Renal Agents|renal agents|mesh-ancestor
19741263|NCT05280028|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19741264|NCT05280028|Tibolone|tibolone|mesh-list
19741265|NCT05280028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19741266|NCT05280028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19741267|NCT05280028|Medroxyprogesterone|medroxyprogesterone|mesh-list
19741268|NCT05280028|Estradiol|estradiol|mesh-list
19741269|NCT05280028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19741270|NCT05280028|Estrogens|estrogens|mesh-ancestor
19741271|NCT05280028|Hormones|hormones|mesh-ancestor
19741272|NCT05280028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19741273|NCT05280028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741274|NCT05280028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19741275|NCT05280028|Contraceptive Agents|contraceptive agents|mesh-ancestor
19741276|NCT05280028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19741277|NCT05280028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19741278|NCT05280028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19741279|NCT05280028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19741280|NCT05280028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19741281|NCT05280028|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19741282|NCT05280028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19741283|NCT05280028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741284|NCT05280028|Androgen Antagonists|androgen antagonists|mesh-ancestor
19741285|NCT05280028|Hormone Antagonists|hormone antagonists|mesh-ancestor
19741286|NCT05280028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19741287|NCT05280028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19741288|NCT05280028|Anabolic Agents|anabolic agents|mesh-ancestor
19741289|NCT05279898|Dexmedetomidine|dexmedetomidine|mesh-list
19741290|NCT05279898|Ketamine|ketamine|mesh-list
19741291|NCT05279898|Remifentanil|remifentanil|mesh-list
19741292|NCT05279898|Propofol|propofol|mesh-list
19741293|NCT05279898|Ropivacaine|ropivacaine|mesh-list
19741294|NCT05279898|Rocuronium|rocuronium|mesh-list
19741295|NCT05279898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19741296|NCT05279898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20556323|NCT01946295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19741297|NCT05279898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741298|NCT05279898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19741299|NCT05279898|Anesthetics, General|anesthetics, general|mesh-ancestor
19741300|NCT05279898|Anesthetics|anesthetics|mesh-ancestor
19741301|NCT05279898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19741302|NCT05279898|Analgesics|analgesics|mesh-ancestor
19741303|NCT05279898|Sensory System Agents|sensory system agents|mesh-ancestor
19741304|NCT05279898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741305|NCT05279898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19741306|NCT05279898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19741307|NCT05279898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19741308|NCT05279898|Adrenergic Agents|adrenergic agents|mesh-ancestor
19741309|NCT05279898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19741310|NCT05279898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741311|NCT05279898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19741312|NCT05279898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19741313|NCT05279898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19741314|NCT05279898|Anesthetics, Local|anesthetics, local|mesh-ancestor
19741315|NCT05279898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19741316|NCT05279898|Narcotics|narcotics|mesh-ancestor
19741317|NCT05279898|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19741318|NCT05279898|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19741319|NCT05279898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19741320|NCT05279872|Zanubrutinib|zanubrutinib|mesh-list
19741321|NCT05279872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741322|NCT05279872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19741323|NCT05279872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741324|NCT05279872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741325|NCT05279807|Amlodipine|amlodipine|mesh-list
19741326|NCT05279807|Zofenopril|zofenopril|mesh-list
19741327|NCT05279807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19741328|NCT05279807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19741329|NCT05279807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19741330|NCT05279807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741331|NCT05279807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19741332|NCT05279807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741333|NCT05279807|Vasodilator Agents|vasodilator agents|mesh-ancestor
19741334|NCT05279807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19741335|NCT05279807|Protease Inhibitors|protease inhibitors|mesh-ancestor
19741336|NCT05279807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741337|NCT05279716|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19741338|NCT05279716|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19741339|NCT05279703|Epinephrine|epinephrine|mesh-list
19741340|NCT05279703|Racepinephrine|racepinephrine|mesh-list
19741341|NCT05279703|Epinephryl borate|epinephryl borate|mesh-list
19741342|NCT05279703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19741343|NCT05279703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19741344|NCT05279703|Adrenergic Agents|adrenergic agents|mesh-ancestor
19741345|NCT05279703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19741346|NCT05279703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741347|NCT05279703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741348|NCT05279703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19741349|NCT05279703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19741350|NCT05279703|Autonomic Agents|autonomic agents|mesh-ancestor
19741351|NCT05279703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741352|NCT05279703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19741353|NCT05279703|Respiratory System Agents|respiratory system agents|mesh-ancestor
19741354|NCT05279703|Mydriatics|mydriatics|mesh-ancestor
19741355|NCT05279703|Sympathomimetics|sympathomimetics|mesh-ancestor
19741356|NCT05279703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19741357|NCT05279690|Colchicine|colchicine|mesh-list
19741358|NCT05279690|Gout Suppressants|gout suppressants|mesh-ancestor
19741359|NCT05279690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19741360|NCT05279690|Tubulin Modulators|tubulin modulators|mesh-ancestor
19741361|NCT05279690|Antimitotic Agents|antimitotic agents|mesh-ancestor
19741362|NCT05279690|Mitosis Modulators|mitosis modulators|mesh-ancestor
19459623|NCT03359746|Grazoprevir|grazoprevir|mesh-list
19459624|NCT03359746|Antiviral Agents|antiviral agents|mesh-ancestor
19459625|NCT03359746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19459626|NCT03359694|Docetaxel|docetaxel|mesh-list
19459627|NCT03359694|Doxorubicin|doxorubicin|mesh-list
19459628|NCT03359694|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19459629|NCT03359694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459630|NCT03359694|Tubulin Modulators|tubulin modulators|mesh-ancestor
19459631|NCT03359694|Antimitotic Agents|antimitotic agents|mesh-ancestor
19459632|NCT03359694|Mitosis Modulators|mitosis modulators|mesh-ancestor
19741363|NCT05279690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741364|NCT05279690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741365|NCT05279586|Colistin|colistin|mesh-list
19741366|NCT05279586|Lactulose|lactulose|mesh-list
19741367|NCT05279586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19741368|NCT05279586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19741369|NCT05279586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19741370|NCT05279482|Methylprednisolone|methylprednisolone|mesh-list
19986885|NCT01979445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986886|NCT01979445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986887|NCT01979523|Trametinib|trametinib|mesh-list
19986888|NCT01979523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986889|NCT01979523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19986890|NCT01979523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986891|NCT01979523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986892|NCT01979952|Nintedanib|nintedanib|mesh-list
19986893|NCT01979952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986894|NCT01979952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19986895|NCT01979952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986896|NCT01979952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986897|NCT01980485|Carbon Monoxide|carbon monoxide|mesh-list
19986898|NCT01980485|Antimetabolites|antimetabolites|mesh-ancestor
19986899|NCT01980485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986900|NCT01980485|Gasotransmitters|gasotransmitters|mesh-ancestor
19986901|NCT01980485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19986902|NCT01980485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986903|NCT01980524|Acipimox|acipimox|mesh-list
19986904|NCT01980524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19986905|NCT01980524|Antimetabolites|antimetabolites|mesh-ancestor
19986906|NCT01980524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986907|NCT01980524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19986908|NCT01980589|Dexamethasone|dexamethasone|mesh-list
19986909|NCT01980589|Cyclophosphamide|cyclophosphamide|mesh-list
19986910|NCT01980589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19986911|NCT01980589|Immunologic Factors|immunologic factors|mesh-ancestor
19986912|NCT01980589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986913|NCT01980589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19986914|NCT01980589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19986915|NCT01980589|Alkylating Agents|alkylating agents|mesh-ancestor
19986916|NCT01980589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741371|NCT05279482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19741372|NCT05279482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19741373|NCT05279482|Prednisolone|prednisolone|mesh-list
19741374|NCT05279482|Prednisolone acetate|prednisolone acetate|mesh-list
19986917|NCT01980589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986918|NCT01980589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19986919|NCT01980589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19986920|NCT01980589|Antiemetics|antiemetics|mesh-ancestor
19986921|NCT01980589|Autonomic Agents|autonomic agents|mesh-ancestor
19986922|NCT01980589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19986923|NCT01980589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19986924|NCT01980589|Glucocorticoids|glucocorticoids|mesh-ancestor
19986925|NCT01980589|Hormones|hormones|mesh-ancestor
19986926|NCT01980589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19986927|NCT01980589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19986928|NCT01980654|Rituximab|rituximab|mesh-list
19986929|NCT01980654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19986930|NCT01980654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986931|NCT01980654|Immunologic Factors|immunologic factors|mesh-ancestor
19986932|NCT01980654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986933|NCT01980654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19986934|NCT01980706|Baclofen|baclofen|mesh-list
19986935|NCT01980706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19986936|NCT01980706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986937|NCT01980706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19986938|NCT01980706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19986939|NCT01980706|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19986940|NCT01980706|GABA Agonists|gaba agonists|mesh-ancestor
19986941|NCT01980706|GABA Agents|gaba agents|mesh-ancestor
19986942|NCT01980706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19986943|NCT01980706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986944|NCT01980888|Rituximab|rituximab|mesh-list
19986945|NCT01980888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19986946|NCT01980888|Idelalisib|idelalisib|mesh-list
19741375|NCT05279482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19741376|NCT05279482|Prednisolone phosphate|prednisolone phosphate|mesh-list
19741377|NCT05279482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19741378|NCT05279482|Antiemetics|antiemetics|mesh-ancestor
19741379|NCT05279482|Autonomic Agents|autonomic agents|mesh-ancestor
19741380|NCT05279482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741381|NCT05279482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741382|NCT05279482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19741383|NCT05279482|Glucocorticoids|glucocorticoids|mesh-ancestor
19741384|NCT05279482|Hormones|hormones|mesh-ancestor
19741385|NCT05279482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19741386|NCT05279482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19741387|NCT05279482|Protective Agents|protective agents|mesh-ancestor
19741388|NCT05279482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19741389|NCT05279482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741390|NCT05279469|Fibrin fragment D|fibrin fragment d|mesh-list
19741391|NCT05279469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19741392|NCT05279469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19986947|NCT01980888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19986948|NCT01980888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19986949|NCT01980888|Immunologic Factors|immunologic factors|mesh-ancestor
19986950|NCT01980888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986951|NCT01980888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19986952|NCT01980888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19986953|NCT01980888|Alkylating Agents|alkylating agents|mesh-ancestor
19986954|NCT01980888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986955|NCT01980888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19986956|NCT01981473|Infliximab|infliximab|mesh-list
19986957|NCT01981473|Dermatologic Agents|dermatologic agents|mesh-ancestor
19986958|NCT01981473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19986959|NCT01981473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19986960|NCT01981616|Vedolizumab|vedolizumab|mesh-list
19986961|NCT01981616|Vaccines|vaccines|mesh-list
19986962|NCT01981616|Immunologic Factors|immunologic factors|mesh-ancestor
19986963|NCT01981616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986964|NCT01981616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19986965|NCT01981759|Cycloserine|cycloserine|mesh-list
19986966|NCT01981759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19986967|NCT01981759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19986968|NCT01981759|Renal Agents|renal agents|mesh-ancestor
19986969|NCT01981759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19986970|NCT01981759|Antitubercular Agents|antitubercular agents|mesh-ancestor
19986971|NCT01981759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19986972|NCT01981759|Antimetabolites|antimetabolites|mesh-ancestor
19986973|NCT01981759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986974|NCT01981772|Lidocaine|lidocaine|mesh-list
19986975|NCT01981772|Epinephrine|epinephrine|mesh-list
19986976|NCT01981772|Racepinephrine|racepinephrine|mesh-list
19986977|NCT01981772|Epinephryl borate|epinephryl borate|mesh-list
19986978|NCT01981772|Anesthetics, Local|anesthetics, local|mesh-ancestor
19986979|NCT01981772|Anesthetics|anesthetics|mesh-ancestor
19986980|NCT01981772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19986981|NCT01981772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19986982|NCT01981772|Sensory System Agents|sensory system agents|mesh-ancestor
19986983|NCT01981772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19986984|NCT01981772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19986985|NCT01981772|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19986986|NCT01981772|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19986987|NCT01981772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19986988|NCT01981772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19986989|NCT01981772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19986990|NCT01981772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19986991|NCT01981772|Adrenergic Agents|adrenergic agents|mesh-ancestor
19986992|NCT01981772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19986993|NCT01981772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19986994|NCT01981772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19986995|NCT01981772|Autonomic Agents|autonomic agents|mesh-ancestor
19986996|NCT01981772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19986997|NCT01981772|Respiratory System Agents|respiratory system agents|mesh-ancestor
19986998|NCT01981772|Mydriatics|mydriatics|mesh-ancestor
19986999|NCT01981772|Sympathomimetics|sympathomimetics|mesh-ancestor
19987000|NCT01981772|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19987001|NCT01981863|Aminocaproic Acid|aminocaproic acid|mesh-list
19987002|NCT01981863|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19987003|NCT01981863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20556324|NCT01946295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20556325|NCT01946295|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19741393|NCT05279469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741394|NCT05279469|Hemostatics|hemostatics|mesh-ancestor
19741395|NCT05279469|Coagulants|coagulants|mesh-ancestor
19741396|NCT05279417|Methotrexate|methotrexate|mesh-list
19741397|NCT05279417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19741398|NCT05279417|Abortifacient Agents|abortifacient agents|mesh-ancestor
19741399|NCT05279417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19741400|NCT05279417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741401|NCT05279417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19741402|NCT05279417|Antimetabolites|antimetabolites|mesh-ancestor
19741403|NCT05279417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741404|NCT05279417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741405|NCT05279417|Dermatologic Agents|dermatologic agents|mesh-ancestor
19741406|NCT05279417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741407|NCT05279417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19741408|NCT05279417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19741409|NCT05279417|Immunologic Factors|immunologic factors|mesh-ancestor
19741410|NCT05279417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19741411|NCT05279417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19741412|NCT05279391|Dexamethasone|dexamethasone|mesh-list
19741413|NCT05279391|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19741414|NCT05279391|Heparin|heparin|mesh-list
19741415|NCT05279391|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19987004|NCT01981863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987005|NCT01981863|Hemostatics|hemostatics|mesh-ancestor
19987006|NCT01981863|Coagulants|coagulants|mesh-ancestor
19987007|NCT01981954|Solifenacin Succinate|solifenacin succinate|mesh-list
19987008|NCT01981954|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19987009|NCT01981954|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19987010|NCT01981954|Cholinergic Agents|cholinergic agents|mesh-ancestor
19987011|NCT01981954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19987012|NCT01981954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987013|NCT01981954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987014|NCT01981954|Urological Agents|urological agents|mesh-ancestor
19987015|NCT01981967|Vaccines|vaccines|mesh-list
19987016|NCT01981967|Immunologic Factors|immunologic factors|mesh-ancestor
19987017|NCT01981967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987018|NCT01982123|Edetic Acid|edetic acid|mesh-list
19987019|NCT01982123|Pentetic Acid|pentetic acid|mesh-list
19987020|NCT01982123|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
19987021|NCT01982123|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
19987022|NCT01982123|Antidotes|antidotes|mesh-ancestor
19987023|NCT01982123|Protective Agents|protective agents|mesh-ancestor
19987024|NCT01982123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987025|NCT01982123|Chelating Agents|chelating agents|mesh-ancestor
19987026|NCT01982123|Sequestering Agents|sequestering agents|mesh-ancestor
19987027|NCT01982123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987028|NCT01982123|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19987029|NCT01982123|Anticoagulants|anticoagulants|mesh-ancestor
19987030|NCT01982123|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19987031|NCT01982123|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19987032|NCT01982240|Bisacodyl|bisacodyl|mesh-list
19987033|NCT01982240|Plecanatide|plecanatide|mesh-list
19987034|NCT01982240|Cathartics|cathartics|mesh-ancestor
19987035|NCT01982240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19987036|NCT01982240|Laxatives|laxatives|mesh-ancestor
19987037|NCT01982240|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19987038|NCT01982240|Enzyme Activators|enzyme activators|mesh-ancestor
19987039|NCT01982240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987040|NCT01982331|Vaccines|vaccines|mesh-list
19987041|NCT01982331|Immunologic Factors|immunologic factors|mesh-ancestor
19987042|NCT01982331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987043|NCT01982435|Ranibizumab|ranibizumab|mesh-list
19987044|NCT01982435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19987045|NCT01982435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19987046|NCT01982435|Growth Substances|growth substances|mesh-ancestor
19987047|NCT01982435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987048|NCT01982435|Growth Inhibitors|growth inhibitors|mesh-ancestor
19987049|NCT01982435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987050|NCT01982539|Diclofenac|diclofenac|mesh-list
19987051|NCT01982539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19987052|NCT01982539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19741416|NCT05279391|Tinzaparin|tinzaparin|mesh-list
19987053|NCT01982539|Analgesics|analgesics|mesh-ancestor
19987054|NCT01982539|Sensory System Agents|sensory system agents|mesh-ancestor
19987055|NCT01982539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741417|NCT05279391|Dalteparin|dalteparin|mesh-list
19741418|NCT05279391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19741419|NCT05279391|Antiemetics|antiemetics|mesh-ancestor
19741420|NCT05279391|Autonomic Agents|autonomic agents|mesh-ancestor
19741421|NCT05279391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741422|NCT05279391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741423|NCT05279391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19741424|NCT05279391|Glucocorticoids|glucocorticoids|mesh-ancestor
19741425|NCT05279391|Hormones|hormones|mesh-ancestor
19741426|NCT05279391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19741427|NCT05279391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19741428|NCT05279391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741429|NCT05279391|Anticoagulants|anticoagulants|mesh-ancestor
19741430|NCT05279391|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19741431|NCT05279391|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19741432|NCT05279391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741433|NCT05279391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19741434|NCT05279235|Favipiravir|favipiravir|mesh-list
19741435|NCT05279235|Antiviral Agents|antiviral agents|mesh-ancestor
19741436|NCT05279235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19741437|NCT05279040|Ivacaftor|ivacaftor|mesh-list
19741438|NCT05279040|Elexacaftor|elexacaftor|mesh-list
19741439|NCT05279040|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19741440|NCT05279040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19741441|NCT05279040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741442|NCT05278975|Thiostrepton|thiostrepton|mesh-list
19741443|NCT05278975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19741444|NCT05278975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19741445|NCT05267886|Dobutamine|dobutamine|mesh-list
19741446|NCT05267886|Milrinone|milrinone|mesh-list
19741447|NCT05267886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19741448|NCT05267886|Sympathomimetics|sympathomimetics|mesh-ancestor
19741449|NCT05267886|Autonomic Agents|autonomic agents|mesh-ancestor
19741450|NCT05267886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741451|NCT05267886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741452|NCT05267886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19741453|NCT05267886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19741454|NCT05267886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19741455|NCT05267886|Adrenergic Agents|adrenergic agents|mesh-ancestor
19741456|NCT05267886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19741457|NCT05267886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741458|NCT05267886|Protective Agents|protective agents|mesh-ancestor
19741459|NCT05267886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19741460|NCT05267886|Vasodilator Agents|vasodilator agents|mesh-ancestor
19741461|NCT05267886|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19741462|NCT05267886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19741463|NCT05267886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741464|NCT05266586|Ezetimibe|ezetimibe|mesh-list
19741465|NCT05266586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19741466|NCT05266586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19741467|NCT05266586|Antimetabolites|antimetabolites|mesh-ancestor
19741468|NCT05266586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741469|NCT05266586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19987056|NCT01982539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987057|NCT01982539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19987058|NCT01982539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19987059|NCT01982539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19987060|NCT01982539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987061|NCT01982539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987062|NCT01982643|Naltrexone|naltrexone|mesh-list
19987063|NCT01982643|Bupropion|bupropion|mesh-list
19987064|NCT01982643|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19987065|NCT01982643|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19987066|NCT01982643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987067|NCT01982643|Sensory System Agents|sensory system agents|mesh-ancestor
19987068|NCT01982643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19987069|NCT01982643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19987070|NCT01982643|Antidepressive Agents|antidepressive agents|mesh-ancestor
19987071|NCT01982643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19987072|NCT01982643|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19987073|NCT01982643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19987074|NCT01982643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19987075|NCT01982643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987076|NCT01982643|Dopamine Agents|dopamine agents|mesh-ancestor
19741470|NCT05266469|Ofatumumab|ofatumumab|mesh-list
19741471|NCT05266469|Ocrelizumab|ocrelizumab|mesh-list
19741472|NCT05266469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741473|NCT05266469|Immunologic Factors|immunologic factors|mesh-ancestor
19741474|NCT05266469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741475|NCT05262257|Metformin|metformin|mesh-list
19741476|NCT05262257|Dapagliflozin|dapagliflozin|mesh-list
19741477|NCT05262257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19741478|NCT05262257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741479|NCT05262257|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19741480|NCT05262257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741481|NCT05260671|Cetuximab|cetuximab|mesh-list
19741482|NCT05260671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19741483|NCT05260671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741484|NCT05260359|Ethanol|ethanol|mesh-list
19741485|NCT05260359|Sunscreening Agents|sunscreening agents|mesh-list
19741486|NCT05260359|Petrolatum|petrolatum|mesh-list
19741487|NCT05260359|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19741488|NCT05260359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19741489|NCT05260359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19741490|NCT05260359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741491|NCT05260359|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19741492|NCT05260359|Protective Agents|protective agents|mesh-ancestor
19741493|NCT05260359|Dermatologic Agents|dermatologic agents|mesh-ancestor
19741494|NCT05260359|Emollients|emollients|mesh-ancestor
19741495|NCT05254912|Sunscreening Agents|sunscreening agents|mesh-list
19741496|NCT05254912|Petrolatum|petrolatum|mesh-list
19741497|NCT05254912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19741498|NCT05254912|Protective Agents|protective agents|mesh-ancestor
19741499|NCT05254912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741500|NCT05254912|Dermatologic Agents|dermatologic agents|mesh-ancestor
19741501|NCT05254912|Emollients|emollients|mesh-ancestor
19741502|NCT05254808|Fosfomycin|fosfomycin|mesh-list
19741503|NCT05254808|Nitrofurantoin|nitrofurantoin|mesh-list
19741504|NCT05254808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19741505|NCT05254808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19741506|NCT05254808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19741507|NCT05254808|Renal Agents|renal agents|mesh-ancestor
19741508|NCT05250596|Colchicine|colchicine|mesh-list
19741509|NCT05250596|Atorvastatin|atorvastatin|mesh-list
19741510|NCT05250596|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19741511|NCT05250596|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19741512|NCT05250596|Antimetabolites|antimetabolites|mesh-ancestor
19741513|NCT05250596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741514|NCT05250596|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19741515|NCT05250596|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19741516|NCT05250596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741517|NCT05250596|Gout Suppressants|gout suppressants|mesh-ancestor
19741518|NCT05250596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19741519|NCT05250596|Tubulin Modulators|tubulin modulators|mesh-ancestor
19741520|NCT05250596|Antimitotic Agents|antimitotic agents|mesh-ancestor
19741521|NCT05250596|Mitosis Modulators|mitosis modulators|mesh-ancestor
19741522|NCT05250596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741523|NCT05249634|Testosterone|testosterone|mesh-list
19741524|NCT05249634|Androgens|androgens|mesh-ancestor
19741525|NCT05249634|Hormones|hormones|mesh-ancestor
19741526|NCT05249634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19741527|NCT05249634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741528|NCT05247970|Midazolam|midazolam|mesh-list
19741529|NCT05247970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19741530|NCT05247970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19741531|NCT05247970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19741532|NCT05247970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741533|NCT05247970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19741534|NCT05247970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19741535|NCT05247970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19741536|NCT05247970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19741537|NCT05247970|Anesthetics, General|anesthetics, general|mesh-ancestor
19741538|NCT05247970|Anesthetics|anesthetics|mesh-ancestor
19741539|NCT05247970|GABA Modulators|gaba modulators|mesh-ancestor
19741540|NCT05247970|GABA Agents|gaba agents|mesh-ancestor
19741541|NCT05247970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19741542|NCT05247970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741543|NCT05243329|Psilocybin|psilocybin|mesh-list
19741544|NCT05243329|Hallucinogens|hallucinogens|mesh-ancestor
19741545|NCT05243329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741546|NCT05243329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19741547|NCT05241288|Albuterol|albuterol|mesh-list
19741548|NCT05241288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19741549|NCT05241288|Autonomic Agents|autonomic agents|mesh-ancestor
19741550|NCT05241288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741551|NCT05241288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741552|NCT05241288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19741553|NCT05241288|Respiratory System Agents|respiratory system agents|mesh-ancestor
19741554|NCT05241288|Tocolytic Agents|tocolytic agents|mesh-ancestor
19741555|NCT05241288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19741556|NCT05241288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19741557|NCT05241288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19741558|NCT05241288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19741559|NCT05241288|Adrenergic Agents|adrenergic agents|mesh-ancestor
19741560|NCT05241288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19741561|NCT05241288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741562|NCT05239637|Heparin|heparin|mesh-list
19741563|NCT05239637|Calcium heparin|calcium heparin|mesh-list
19741564|NCT05239637|Anticoagulants|anticoagulants|mesh-ancestor
19741565|NCT05239637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19741566|NCT05239637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19741567|NCT05239637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741568|NCT05232630|Fenfluramine|fenfluramine|mesh-list
19741569|NCT05232630|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19741570|NCT05232630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19741571|NCT05232630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19741572|NCT05232630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741573|NCT05232630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19741574|NCT05232630|Serotonin Agents|serotonin agents|mesh-ancestor
19741575|NCT05232630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741576|NCT05232357|Sodium thiosulfate|sodium thiosulfate|mesh-list
19741577|NCT05232357|Methylene Blue|methylene blue|mesh-list
19741578|NCT05232357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741579|NCT05232357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741580|NCT05232357|Antidotes|antidotes|mesh-ancestor
19741581|NCT05232357|Protective Agents|protective agents|mesh-ancestor
19741582|NCT05232357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741583|NCT05232357|Antioxidants|antioxidants|mesh-ancestor
19741584|NCT05232357|Antitubercular Agents|antitubercular agents|mesh-ancestor
19741585|NCT05232357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19741586|NCT05232357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19741587|NCT05232357|Chelating Agents|chelating agents|mesh-ancestor
19741588|NCT05232357|Sequestering Agents|sequestering agents|mesh-ancestor
19741589|NCT05229003|Irinotecan|irinotecan|mesh-list
19741590|NCT05229003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19741591|NCT05229003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19741592|NCT05229003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741593|NCT05229003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741594|NCT05229003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741595|NCT05218668|Fasudil|fasudil|mesh-list
19741596|NCT05218668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19741597|NCT05218668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19741598|NCT05218668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741599|NCT05218668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19741600|NCT05218668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741601|NCT05218668|Vasodilator Agents|vasodilator agents|mesh-ancestor
19741602|NCT05218668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19741603|NCT05218668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741604|NCT05215405|Venetoclax|venetoclax|mesh-list
19741605|NCT05215405|Navitoclax|navitoclax|mesh-list
19741606|NCT05215405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741607|NCT05213221|Lenvatinib|lenvatinib|mesh-list
19741608|NCT05213221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741609|NCT05213221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19741610|NCT05213221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741611|NCT05213221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741612|NCT05212857|Leuprolide|leuprolide|mesh-list
19741613|NCT05212857|Goserelin|goserelin|mesh-list
19741614|NCT05212857|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19741615|NCT05212857|Abiraterone Acetate|abiraterone acetate|mesh-list
19741616|NCT05212857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19741617|NCT05212857|Fertility Agents|fertility agents|mesh-ancestor
19741618|NCT05212857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19741619|NCT05212857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741620|NCT05212857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19741621|NCT05212857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741622|NCT05212857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19741623|NCT05212857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741624|NCT05212857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741625|NCT05212857|Hormone Antagonists|hormone antagonists|mesh-ancestor
19741626|NCT05212857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19741627|NCT05212857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19741628|NCT05212857|Luteolytic Agents|luteolytic agents|mesh-ancestor
19741629|NCT05212857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19741630|NCT05212857|Contraceptive Agents|contraceptive agents|mesh-ancestor
19741631|NCT05212857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19741632|NCT05203822|Itraconazole|itraconazole|mesh-list
19741633|NCT05203822|Tepotinib|tepotinib|mesh-list
19741634|NCT05203822|Antifungal Agents|antifungal agents|mesh-ancestor
19741635|NCT05203822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19987077|NCT01982643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19987078|NCT01982643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19987079|NCT01982643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19987080|NCT01982643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987081|NCT01982682|Mycophenolic Acid|mycophenolic acid|mesh-list
19987082|NCT01982682|Cyclophosphamide|cyclophosphamide|mesh-list
19987083|NCT01982682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19987084|NCT01982682|Immunologic Factors|immunologic factors|mesh-ancestor
19987085|NCT01982682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987086|NCT01982682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19987087|NCT01982682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19987088|NCT01982682|Alkylating Agents|alkylating agents|mesh-ancestor
19987089|NCT01982682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987090|NCT01982682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987091|NCT01982682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19987092|NCT01982682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19987093|NCT01982682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19987094|NCT01982682|Antitubercular Agents|antitubercular agents|mesh-ancestor
19987095|NCT01982682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19987096|NCT01982682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19987097|NCT01982682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987098|NCT01982695|Losartan|losartan|mesh-list
19987099|NCT01982695|Lisinopril|lisinopril|mesh-list
19987100|NCT01982695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19987101|NCT01982695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19987102|NCT01982695|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19987103|NCT01982695|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19987104|NCT01982695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987105|NCT01982695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19987106|NCT01982695|Protease Inhibitors|protease inhibitors|mesh-ancestor
19987107|NCT01982695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987108|NCT01982695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19987109|NCT01982695|Protective Agents|protective agents|mesh-ancestor
19987110|NCT01982695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987111|NCT01982812|Levetiracetam|levetiracetam|mesh-list
19987112|NCT01982812|Anticonvulsants|anticonvulsants|mesh-ancestor
19987113|NCT01982812|Nootropic Agents|nootropic agents|mesh-ancestor
19987114|NCT01982942|Ibudilast|ibudilast|mesh-list
19987115|NCT01982942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19987116|NCT01982942|Autonomic Agents|autonomic agents|mesh-ancestor
19987117|NCT01982942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19987118|NCT01982942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987119|NCT01982942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19987120|NCT01982942|Respiratory System Agents|respiratory system agents|mesh-ancestor
19987121|NCT01982942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19987122|NCT01982942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987123|NCT01982942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987124|NCT01982942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19987125|NCT01982942|Vasodilator Agents|vasodilator agents|mesh-ancestor
19987126|NCT01982955|Carboplatin|carboplatin|mesh-list
19987127|NCT01982955|Pemetrexed|pemetrexed|mesh-list
19987128|NCT01982955|Gefitinib|gefitinib|mesh-list
19987129|NCT01982955|Tepotinib|tepotinib|mesh-list
19987130|NCT01982955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987131|NCT01982955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987132|NCT01982955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987133|NCT01982955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19987134|NCT01982955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19987135|NCT01982955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20289188|NCT04909697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741636|NCT05203822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19741637|NCT05203822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19741638|NCT05203822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741639|NCT05203822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741640|NCT05203822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19741641|NCT05203822|Hormone Antagonists|hormone antagonists|mesh-ancestor
19741642|NCT05203822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19741643|NCT05203822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741644|NCT05203822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19741645|NCT05203822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741646|NCT05193968|Nitroprusside|nitroprusside|mesh-list
19741647|NCT05193968|Norepinephrine|norepinephrine|mesh-list
19741648|NCT05193968|Acetylcholine|acetylcholine|mesh-list
19741649|NCT05193968|Terbutaline|terbutaline|mesh-list
19741650|NCT05193968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19741651|NCT05193968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19741652|NCT05193968|Adrenergic Agents|adrenergic agents|mesh-ancestor
19741653|NCT05193968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19741654|NCT05193968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741655|NCT05193968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741656|NCT05193968|Sympathomimetics|sympathomimetics|mesh-ancestor
19741657|NCT05193968|Autonomic Agents|autonomic agents|mesh-ancestor
19741658|NCT05193968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741659|NCT05193968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19741660|NCT05193968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19741661|NCT05193968|Vasodilator Agents|vasodilator agents|mesh-ancestor
19741662|NCT05193968|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19741663|NCT05193968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19741664|NCT05193968|Cholinergic Agents|cholinergic agents|mesh-ancestor
19741665|NCT05193968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19741666|NCT05193968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19741667|NCT05193968|Respiratory System Agents|respiratory system agents|mesh-ancestor
19741668|NCT05193968|Tocolytic Agents|tocolytic agents|mesh-ancestor
19741669|NCT05193968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19741670|NCT05193968|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19741671|NCT05193968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19741672|NCT05193851|Ricolinostat|ricolinostat|mesh-list
19741673|NCT05193851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741674|NCT05193851|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19741675|NCT05193851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741676|NCT05193851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741677|NCT05191277|Antidepressive Agents|antidepressive agents|mesh-list
19741678|NCT05191277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19741679|NCT05190705|Dexamethasone|dexamethasone|mesh-list
19741680|NCT05190705|Dexamethasone acetate|dexamethasone acetate|mesh-list
19741681|NCT05190705|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
19741682|NCT05190705|BB 1101|bb 1101|mesh-list
19741683|NCT05190705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19741684|NCT05190705|Antiemetics|antiemetics|mesh-ancestor
19741685|NCT05190705|Autonomic Agents|autonomic agents|mesh-ancestor
19741686|NCT05190705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741687|NCT05190705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741688|NCT05190705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19741689|NCT05190705|Glucocorticoids|glucocorticoids|mesh-ancestor
19741690|NCT05190705|Hormones|hormones|mesh-ancestor
19741691|NCT05190705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19741692|NCT05190705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19741693|NCT05190705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741694|NCT05190705|Protease Inhibitors|protease inhibitors|mesh-ancestor
19741695|NCT05190705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741696|NCT05190705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741697|NCT05190705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19741698|NCT05187715|Simvastatin|simvastatin|mesh-list
19741699|NCT05187715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19741700|NCT05187715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19741701|NCT05187715|Antimetabolites|antimetabolites|mesh-ancestor
19741702|NCT05187715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741703|NCT05187715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19741704|NCT05187715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19741705|NCT05187715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987136|NCT01983020|Lidocaine|lidocaine|mesh-list
19987137|NCT01983020|Ketamine|ketamine|mesh-list
19987138|NCT01983020|Anesthetics, Local|anesthetics, local|mesh-ancestor
19987139|NCT01983020|Anesthetics|anesthetics|mesh-ancestor
19741706|NCT05179876|Selexipag|selexipag|mesh-list
19741707|NCT05179876|Tadalafil|tadalafil|mesh-list
19741708|NCT05179876|Macitentan|macitentan|mesh-list
19741709|NCT05179876|Vasodilator Agents|vasodilator agents|mesh-ancestor
19741710|NCT05179876|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19741711|NCT05179876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19741712|NCT05179876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741713|NCT05179876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741714|NCT05179876|Urological Agents|urological agents|mesh-ancestor
19741715|NCT05179876|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19741716|NCT05179876|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19741717|NCT05179876|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19741718|NCT05179876|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19741719|NCT05177731|Cytarabine|cytarabine|mesh-list
19741720|NCT05177731|Decitabine|decitabine|mesh-list
19741721|NCT05177731|Venetoclax|venetoclax|mesh-list
19741722|NCT05177731|Idarubicin|idarubicin|mesh-list
19741723|NCT05177731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19741724|NCT05177731|Antimetabolites|antimetabolites|mesh-ancestor
19741725|NCT05177731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741726|NCT05177731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741727|NCT05177731|Antiviral Agents|antiviral agents|mesh-ancestor
19741728|NCT05177731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19741729|NCT05177731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19741730|NCT05177731|Immunologic Factors|immunologic factors|mesh-ancestor
19741731|NCT05177731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741732|NCT05177731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741733|NCT05177731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19741734|NCT05177731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19741735|NCT05177731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19741736|NCT05159830|Cannabidiol|cannabidiol|mesh-list
19741737|NCT05159830|Anticonvulsants|anticonvulsants|mesh-ancestor
19741738|NCT05158309|Capsaicin|capsaicin|mesh-list
19741739|NCT05158309|Antipruritics|antipruritics|mesh-ancestor
19741740|NCT05158309|Dermatologic Agents|dermatologic agents|mesh-ancestor
19741741|NCT05158309|Sensory System Agents|sensory system agents|mesh-ancestor
19741742|NCT05158309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741743|NCT05158309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741744|NCT05147376|Curcumin|curcumin|mesh-list
19741745|NCT05147376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19741746|NCT05147376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19741747|NCT05147376|Analgesics|analgesics|mesh-ancestor
19741748|NCT05147376|Sensory System Agents|sensory system agents|mesh-ancestor
19741749|NCT05147376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741750|NCT05147376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741751|NCT05147376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19741752|NCT05147376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19741753|NCT05147376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741754|NCT05147376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741755|NCT05147376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987140|NCT01983020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19987141|NCT01983020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987142|NCT01983020|Sensory System Agents|sensory system agents|mesh-ancestor
19987143|NCT01983020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19987144|NCT01983020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19987145|NCT01983020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19987146|NCT01983020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19987147|NCT01983020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19987148|NCT01983020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987149|NCT01983020|Analgesics|analgesics|mesh-ancestor
19987150|NCT01983020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19987151|NCT01983020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19987152|NCT01983020|Anesthetics, General|anesthetics, general|mesh-ancestor
19987153|NCT01983020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19987154|NCT01983020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19987155|NCT01983020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19987156|NCT01983111|Acetaminophen|acetaminophen|mesh-list
19987157|NCT01983111|Buprenorphine|buprenorphine|mesh-list
19987158|NCT01983111|Tramadol|tramadol|mesh-list
19987159|NCT01983111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19987160|NCT01983111|Analgesics|analgesics|mesh-ancestor
19987161|NCT01983111|Sensory System Agents|sensory system agents|mesh-ancestor
19987162|NCT01983111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19987163|NCT01983111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741756|NCT05137587|Ketamine|ketamine|mesh-list
19741757|NCT05137587|Propofol|propofol|mesh-list
19741758|NCT05137587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19741759|NCT05137587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19741760|NCT05137587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741761|NCT05137587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19741762|NCT05137587|Anesthetics, General|anesthetics, general|mesh-ancestor
19741763|NCT05137587|Anesthetics|anesthetics|mesh-ancestor
19741764|NCT05137587|Analgesics|analgesics|mesh-ancestor
19741765|NCT05137587|Sensory System Agents|sensory system agents|mesh-ancestor
19741766|NCT05137587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741767|NCT05137587|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19741768|NCT05137587|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19741769|NCT05137587|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19741770|NCT05137587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19741771|NCT05137587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741772|NCT05137574|Ketamine|ketamine|mesh-list
19741773|NCT05137574|Propofol|propofol|mesh-list
19741774|NCT05137574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19741775|NCT05137574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19741776|NCT05137574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741777|NCT05137574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19741778|NCT05137574|Anesthetics, General|anesthetics, general|mesh-ancestor
19741779|NCT05137574|Anesthetics|anesthetics|mesh-ancestor
19741780|NCT05137574|Analgesics|analgesics|mesh-ancestor
19741781|NCT05137574|Sensory System Agents|sensory system agents|mesh-ancestor
19741782|NCT05137574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741783|NCT05137574|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19741784|NCT05137574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19741785|NCT05137574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19741786|NCT05137574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19741787|NCT05137574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741788|NCT05132829|Azithromycin|azithromycin|mesh-list
19741789|NCT05132829|Cefazolin|cefazolin|mesh-list
19741790|NCT05132829|Indomethacin|indomethacin|mesh-list
19741791|NCT05132829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19741792|NCT05132829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19741793|NCT05132829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19741794|NCT05132829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19741795|NCT05132829|Analgesics|analgesics|mesh-ancestor
19741796|NCT05132829|Sensory System Agents|sensory system agents|mesh-ancestor
19741797|NCT05132829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741798|NCT05132829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741799|NCT05132829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19741800|NCT05132829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19741801|NCT05132829|Gout Suppressants|gout suppressants|mesh-ancestor
19741802|NCT05132829|Tocolytic Agents|tocolytic agents|mesh-ancestor
19741803|NCT05132829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19741804|NCT05132829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19741805|NCT05132829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741806|NCT05132829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741807|NCT05125237|Amiloride|amiloride|mesh-list
19741808|NCT05125237|Triamterene|triamterene|mesh-list
19741809|NCT05125237|Diuretics|diuretics|mesh-ancestor
19741810|NCT05125237|Natriuretic Agents|natriuretic agents|mesh-ancestor
19741811|NCT05125237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741812|NCT05125237|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
19741813|NCT05125237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19741814|NCT05125237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19741815|NCT05125237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741816|NCT05125237|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
19741817|NCT05125237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19741818|NCT05125224|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19741819|NCT05125224|Calcium Channel Blockers|calcium channel blockers|mesh-list
19741820|NCT05125224|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
19741821|NCT05125224|Calcium|calcium|mesh-list
19741822|NCT05125224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19741823|NCT05125224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741824|NCT05125224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19741825|NCT05125224|Diuretics|diuretics|mesh-ancestor
19741826|NCT05125224|Natriuretic Agents|natriuretic agents|mesh-ancestor
19741827|NCT05125224|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19741828|NCT05125224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19741829|NCT05125224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741830|NCT05122819|Anesthetics|anesthetics|mesh-list
19741831|NCT05122819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19741832|NCT05122819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741833|NCT05116917|Nivolumab|nivolumab|mesh-list
19741834|NCT05116917|Ipilimumab|ipilimumab|mesh-list
19741835|NCT05116917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19741836|NCT05116917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741837|NCT05116917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19741838|NCT05116917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741839|NCT05114941|Immunoglobulins|immunoglobulins|mesh-list
19741840|NCT05114941|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19741841|NCT05114941|Antibodies|antibodies|mesh-list
19741842|NCT05114941|gamma-Globulins|gamma-globulins|mesh-list
19741843|NCT05114941|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19741844|NCT05114941|Immunologic Factors|immunologic factors|mesh-ancestor
19741845|NCT05114941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741846|NCT05102591|Ketorolac|ketorolac|mesh-list
19741847|NCT05102591|Metoclopramide|metoclopramide|mesh-list
19741848|NCT05102591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19741849|NCT05102591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19741850|NCT05102591|Analgesics|analgesics|mesh-ancestor
19741851|NCT05102591|Sensory System Agents|sensory system agents|mesh-ancestor
19741852|NCT05102591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741853|NCT05102591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741854|NCT05102591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19741855|NCT05102591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19741856|NCT05102591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19741857|NCT05102591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741858|NCT05102591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741859|NCT05102591|Antiemetics|antiemetics|mesh-ancestor
19987164|NCT01983111|Antipyretics|antipyretics|mesh-ancestor
19987165|NCT01983111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19987166|NCT01983111|Narcotics|narcotics|mesh-ancestor
19987167|NCT01983111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19987168|NCT01983111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19987169|NCT01983566|Omeprazole|omeprazole|mesh-list
19987170|NCT01983566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19987171|NCT01983566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19987172|NCT01983566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19987173|NCT01983566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987174|NCT01983566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987175|NCT01983683|Vancomycin|vancomycin|mesh-list
19987176|NCT01983683|Oxazolidinones|oxazolidinones|mesh-list
19987177|NCT01983683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19987178|NCT01983683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19987179|NCT01983683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19987180|NCT01983683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987181|NCT01983683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741860|NCT05102591|Autonomic Agents|autonomic agents|mesh-ancestor
19741861|NCT05102591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19741862|NCT05102591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19741863|NCT05102591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19741864|NCT05102591|Dopamine Agents|dopamine agents|mesh-ancestor
19741865|NCT05102591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19741866|NCT05088252|Propofol|propofol|mesh-list
19741867|NCT05088252|Desflurane|desflurane|mesh-list
19741868|NCT05088252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19741869|NCT05088252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19741870|NCT05088252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741871|NCT05088252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19741872|NCT05088252|Anesthetics, General|anesthetics, general|mesh-ancestor
19741873|NCT05088252|Anesthetics|anesthetics|mesh-ancestor
19741874|NCT05088252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19741875|NCT05075200|Tranexamic Acid|tranexamic acid|mesh-list
19741876|NCT05075200|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19741877|NCT05075200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19741878|NCT05075200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741879|NCT05075200|Hemostatics|hemostatics|mesh-ancestor
19741880|NCT05075200|Coagulants|coagulants|mesh-ancestor
19741881|NCT05068440|Zanubrutinib|zanubrutinib|mesh-list
19741882|NCT05068440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741883|NCT05068440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19741884|NCT05068440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741885|NCT05068440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741886|NCT05065866|Azacitidine|azacitidine|mesh-list
19741887|NCT05065866|Cc-486|cc-486|mesh-list
19741888|NCT05065866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19741889|NCT05065866|Antimetabolites|antimetabolites|mesh-ancestor
19741890|NCT05065866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741891|NCT05065866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741892|NCT05065866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741893|NCT05063604|Citalopram|citalopram|mesh-list
19741894|NCT05063604|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19741895|NCT05063604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19741896|NCT05063604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19741897|NCT05063604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741898|NCT05063604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19741899|NCT05063604|Serotonin Agents|serotonin agents|mesh-ancestor
19741900|NCT05063604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741901|NCT05063604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19741902|NCT05063604|Antidepressive Agents|antidepressive agents|mesh-ancestor
19741903|NCT05063604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19741904|NCT05060276|Immunoconjugates|immunoconjugates|mesh-list
19741905|NCT05060276|Immunologic Factors|immunologic factors|mesh-ancestor
19741906|NCT05060276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741907|NCT05060003|Atezolizumab|atezolizumab|mesh-list
19741908|NCT05060003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987182|NCT01983878|Ramucirumab|ramucirumab|mesh-list
19459633|NCT03359694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459634|NCT03359694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19459635|NCT03359694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19459636|NCT03359694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19459637|NCT03359694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459638|NCT03359681|Metformin|metformin|mesh-list
19459639|NCT03359681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19459640|NCT03359681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459641|NCT03359655|Scopolamine|scopolamine|mesh-list
19459642|NCT03359655|Bromides|bromides|mesh-list
19459643|NCT03359655|Misoprostol|misoprostol|mesh-list
19459644|NCT03359655|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19459645|NCT03359655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19459646|NCT03359655|Abortifacient Agents|abortifacient agents|mesh-ancestor
19459647|NCT03359655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19459648|NCT03359655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987183|NCT01983878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987184|NCT01983969|Pyridoxine|pyridoxine|mesh-list
19987185|NCT01983969|Gemcitabine|gemcitabine|mesh-list
19987186|NCT01983969|Dexamethasone|dexamethasone|mesh-list
19987187|NCT01983969|Rituximab|rituximab|mesh-list
19987188|NCT01983969|Azacitidine|azacitidine|mesh-list
19987189|NCT01983969|Melphalan|melphalan|mesh-list
19987190|NCT01983969|Busulfan|busulfan|mesh-list
19987191|NCT01983969|Vorinostat|vorinostat|mesh-list
19987192|NCT01983969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19987193|NCT01983969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987194|NCT01983969|Immunologic Factors|immunologic factors|mesh-ancestor
19987195|NCT01983969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987196|NCT01983969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19459649|NCT03359655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19987197|NCT01983969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19987198|NCT01983969|Antiemetics|antiemetics|mesh-ancestor
19741909|NCT05040568|Vidarabine|vidarabine|mesh-list
19741910|NCT05040568|Cyclophosphamide|cyclophosphamide|mesh-list
19741911|NCT05040568|Fludarabine|fludarabine|mesh-list
19741912|NCT05040568|Fludarabine phosphate|fludarabine phosphate|mesh-list
19741913|NCT05040568|Cetuximab|cetuximab|mesh-list
19741914|NCT05040568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19741915|NCT05040568|Immunologic Factors|immunologic factors|mesh-ancestor
19741916|NCT05040568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741917|NCT05040568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19741918|NCT05040568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19741919|NCT05040568|Alkylating Agents|alkylating agents|mesh-ancestor
19741920|NCT05040568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741921|NCT05040568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741922|NCT05040568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19741923|NCT05040568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19741924|NCT05040568|Antimetabolites|antimetabolites|mesh-ancestor
19741925|NCT05040568|Antiviral Agents|antiviral agents|mesh-ancestor
19741926|NCT05040568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19741927|NCT05040568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19741928|NCT05036317|Empagliflozin|empagliflozin|mesh-list
19741929|NCT05036317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19741930|NCT05036317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741931|NCT05036317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19741932|NCT05036317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741933|NCT05034367|Mannitol|mannitol|mesh-list
19741934|NCT05034367|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19741935|NCT05034367|Diuretics|diuretics|mesh-ancestor
19741936|NCT05034367|Natriuretic Agents|natriuretic agents|mesh-ancestor
19741937|NCT05034367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741938|NCT05026905|Leucovorin|leucovorin|mesh-list
19741939|NCT05026905|Gemcitabine|gemcitabine|mesh-list
19741940|NCT05026905|Paclitaxel|paclitaxel|mesh-list
19741941|NCT05026905|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19741942|NCT05026905|Oxaliplatin|oxaliplatin|mesh-list
19741943|NCT05026905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19741944|NCT05026905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741945|NCT05026905|Tubulin Modulators|tubulin modulators|mesh-ancestor
19741946|NCT05026905|Antimitotic Agents|antimitotic agents|mesh-ancestor
19741947|NCT05026905|Mitosis Modulators|mitosis modulators|mesh-ancestor
19741948|NCT05026905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741949|NCT05026905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19741950|NCT05026905|Antimetabolites|antimetabolites|mesh-ancestor
19741951|NCT05026905|Antiviral Agents|antiviral agents|mesh-ancestor
19741952|NCT05026905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19741953|NCT05026905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741954|NCT05026905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19741955|NCT05026905|Immunologic Factors|immunologic factors|mesh-ancestor
19741956|NCT05026905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741957|NCT05026905|Antidotes|antidotes|mesh-ancestor
19741958|NCT05026905|Protective Agents|protective agents|mesh-ancestor
19741959|NCT05026905|Vitamin B Complex|vitamin b complex|mesh-ancestor
19741960|NCT05026905|Vitamins|vitamins|mesh-ancestor
19741961|NCT05026905|Micronutrients|micronutrients|mesh-ancestor
19741962|NCT05020769|Osimertinib|osimertinib|mesh-list
19741963|NCT05020769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19741964|NCT05020769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19741965|NCT05020769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19741966|NCT05020769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741967|NCT05019638|Ketorolac|ketorolac|mesh-list
19741968|NCT05019638|Epinephrine|epinephrine|mesh-list
19741969|NCT05019638|Racepinephrine|racepinephrine|mesh-list
19741970|NCT05019638|Morphine|morphine|mesh-list
19741971|NCT05019638|Bupivacaine|bupivacaine|mesh-list
19741972|NCT05019638|Epinephryl borate|epinephryl borate|mesh-list
19741973|NCT05019638|Anesthetics, Local|anesthetics, local|mesh-ancestor
19741974|NCT05019638|Anesthetics|anesthetics|mesh-ancestor
19741975|NCT05019638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19741976|NCT05019638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19741977|NCT05019638|Sensory System Agents|sensory system agents|mesh-ancestor
19741978|NCT05019638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19741979|NCT05019638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19741980|NCT05019638|Narcotics|narcotics|mesh-ancestor
19741981|NCT05019638|Analgesics|analgesics|mesh-ancestor
19741982|NCT05019638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19741983|NCT05019638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19741984|NCT05019638|Adrenergic Agents|adrenergic agents|mesh-ancestor
19741985|NCT05019638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19741986|NCT05019638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19741987|NCT05019638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19741988|NCT05019638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19741989|NCT05019638|Autonomic Agents|autonomic agents|mesh-ancestor
19741990|NCT05019638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19741991|NCT05019638|Respiratory System Agents|respiratory system agents|mesh-ancestor
19741992|NCT05019638|Mydriatics|mydriatics|mesh-ancestor
19741993|NCT05019638|Sympathomimetics|sympathomimetics|mesh-ancestor
19741994|NCT05019638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19741995|NCT05019638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19741996|NCT05019638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19741997|NCT05019638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19741998|NCT05019638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19741999|NCT05019638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19742000|NCT05019638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742001|NCT05016609|Sofosbuvir|sofosbuvir|mesh-list
19742002|NCT05016609|Velpatasvir|velpatasvir|mesh-list
19742003|NCT05016609|Antibodies|antibodies|mesh-list
19742004|NCT05016609|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
19742005|NCT05016609|Immunologic Factors|immunologic factors|mesh-ancestor
19742006|NCT05016609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742007|NCT05016609|Antiviral Agents|antiviral agents|mesh-ancestor
19742008|NCT05016609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19742009|NCT05013216|Poly ICLC|poly iclc|mesh-list
19742010|NCT05013216|Interferon Inducers|interferon inducers|mesh-ancestor
19742011|NCT05013216|Immunologic Factors|immunologic factors|mesh-ancestor
19742012|NCT05013216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742013|NCT05009927|Imatinib Mesylate|imatinib mesylate|mesh-list
19742014|NCT05009927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742015|NCT05009927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19742016|NCT05009927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742017|NCT05009927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742018|NCT05005559|Myeloma Proteins|myeloma proteins|mesh-list
19742019|NCT05005559|Paraproteins|paraproteins|mesh-list
19742020|NCT05005559|Immunologic Factors|immunologic factors|mesh-ancestor
19742021|NCT05005559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742022|NCT05004259|Daratumumab|daratumumab|mesh-list
19742023|NCT05004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742024|NCT05002816|Elotuzumab|elotuzumab|mesh-list
19742025|NCT05002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742026|NCT04997941|Tamoxifen|tamoxifen|mesh-list
19742027|NCT04997941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19742028|NCT04997941|Hormone Antagonists|hormone antagonists|mesh-ancestor
19742029|NCT04997941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19742030|NCT04997941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742031|NCT04997941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19742032|NCT04997941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742033|NCT04997941|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19742034|NCT04997941|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19742035|NCT04997941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19742036|NCT04994444|Nicotine|nicotine|mesh-list
19742037|NCT04994444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19742038|NCT04994444|Autonomic Agents|autonomic agents|mesh-ancestor
19742039|NCT04994444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19742040|NCT04994444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742041|NCT04994444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19742042|NCT04994444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19742043|NCT04994444|Cholinergic Agents|cholinergic agents|mesh-ancestor
19742044|NCT04994444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19742045|NCT04994444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742046|NCT04979338|Bupivacaine|bupivacaine|mesh-list
19742047|NCT04979338|Anesthetics, Local|anesthetics, local|mesh-list
19742048|NCT04979338|Anesthetics|anesthetics|mesh-list
19987199|NCT01983969|Autonomic Agents|autonomic agents|mesh-ancestor
19742049|NCT04979338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19742050|NCT04979338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742051|NCT04979338|Sensory System Agents|sensory system agents|mesh-ancestor
19742052|NCT04979338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19742053|NCT04979052|Interferons|interferons|mesh-list
19742054|NCT04979052|Interferon-gamma|interferon-gamma|mesh-list
19742055|NCT04979052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742056|NCT04979052|Antiviral Agents|antiviral agents|mesh-ancestor
19742057|NCT04979052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19742058|NCT04973124|Dexmedetomidine|dexmedetomidine|mesh-list
19742059|NCT04973124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19742060|NCT04973124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19742061|NCT04973124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742062|NCT04973124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19742063|NCT04973124|Analgesics|analgesics|mesh-ancestor
19742064|NCT04973124|Sensory System Agents|sensory system agents|mesh-ancestor
19742065|NCT04973124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19742066|NCT04973124|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19742067|NCT04973124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19742068|NCT04973124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19742069|NCT04973124|Adrenergic Agents|adrenergic agents|mesh-ancestor
19742070|NCT04973124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19742071|NCT04973124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742072|NCT04971005|Alemtuzumab|alemtuzumab|mesh-list
19742073|NCT04971005|Ocrelizumab|ocrelizumab|mesh-list
19742074|NCT04971005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19742075|NCT04971005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742076|NCT04971005|Immunologic Factors|immunologic factors|mesh-ancestor
19742077|NCT04971005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742078|NCT04969120|Metoclopramide|metoclopramide|mesh-list
19742079|NCT04969120|Antiemetics|antiemetics|mesh-ancestor
19742080|NCT04969120|Autonomic Agents|autonomic agents|mesh-ancestor
19742081|NCT04969120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19742082|NCT04969120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742083|NCT04969120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19742084|NCT04969120|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19742085|NCT04969120|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19742086|NCT04969120|Dopamine Agents|dopamine agents|mesh-ancestor
19742087|NCT04969120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19742088|NCT04969120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742089|NCT04951947|Lenvatinib|lenvatinib|mesh-list
19742090|NCT04951947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742091|NCT04951947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19742092|NCT04951947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742093|NCT04951947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742094|NCT04914676|Cytarabine|cytarabine|mesh-list
19742095|NCT04914676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19742096|NCT04914676|Antimetabolites|antimetabolites|mesh-ancestor
19742097|NCT04914676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742098|NCT04914676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742099|NCT04914676|Antiviral Agents|antiviral agents|mesh-ancestor
19742100|NCT04914676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19742101|NCT04914676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19742102|NCT04914676|Immunologic Factors|immunologic factors|mesh-ancestor
19742103|NCT04914676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742104|NCT04912505|Aspirin|aspirin|mesh-list
19742105|NCT04912505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19742106|NCT04912505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19742107|NCT04912505|Analgesics|analgesics|mesh-ancestor
19742108|NCT04912505|Sensory System Agents|sensory system agents|mesh-ancestor
19742109|NCT04912505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19742110|NCT04912505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742111|NCT04912505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19742112|NCT04912505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19742113|NCT04912505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19742114|NCT04912505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19742115|NCT04912505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742116|NCT04912505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19742117|NCT04912505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19742118|NCT04912505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742119|NCT04912505|Antipyretics|antipyretics|mesh-ancestor
19742120|NCT04912492|Ethanol|ethanol|mesh-list
19742121|NCT04912492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19742122|NCT04912492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19742123|NCT04912492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19742124|NCT04912492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742125|NCT04910711|Dolutegravir|dolutegravir|mesh-list
19742126|NCT04910711|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19742127|NCT04910711|Levonorgestrel|levonorgestrel|mesh-list
19742128|NCT04910711|Medroxyprogesterone|medroxyprogesterone|mesh-list
19742129|NCT04910711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19742130|NCT04910711|Contraceptive Agents|contraceptive agents|mesh-ancestor
19742131|NCT04910711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19742132|NCT04910711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742133|NCT04910711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19742134|NCT04910711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19742135|NCT04910711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19742136|NCT04910711|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19742137|NCT04910711|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19742138|NCT04910711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742139|NCT04910711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742140|NCT04910711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19742141|NCT04910711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19742142|NCT04910711|Antiviral Agents|antiviral agents|mesh-ancestor
19742143|NCT04910711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19742144|NCT04910711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19742145|NCT04910711|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19742146|NCT04910711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19742147|NCT04910711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742148|NCT04905810|Azacitidine|azacitidine|mesh-list
19742149|NCT04905810|Decitabine|decitabine|mesh-list
19742150|NCT04905810|Venetoclax|venetoclax|mesh-list
19742151|NCT04905810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19742152|NCT04905810|Antimetabolites|antimetabolites|mesh-ancestor
19742153|NCT04905810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742154|NCT04905810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742155|NCT04905810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742156|NCT04904965|Propofol|propofol|mesh-list
19742157|NCT04904965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19742158|NCT04904965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19742159|NCT04904965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742160|NCT04904965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19742161|NCT04904965|Anesthetics, General|anesthetics, general|mesh-ancestor
19742162|NCT04904965|Anesthetics|anesthetics|mesh-ancestor
19987200|NCT01983969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19987201|NCT01983969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19987202|NCT01983969|Glucocorticoids|glucocorticoids|mesh-ancestor
19987203|NCT01983969|Hormones|hormones|mesh-ancestor
19987204|NCT01983969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19987205|NCT01983969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19987206|NCT01983969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19987207|NCT01983969|Antimetabolites|antimetabolites|mesh-ancestor
19987208|NCT01983969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987209|NCT01983969|Antiviral Agents|antiviral agents|mesh-ancestor
19987210|NCT01983969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19987211|NCT01983969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987212|NCT01983969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19987213|NCT01983969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19987214|NCT01983969|Alkylating Agents|alkylating agents|mesh-ancestor
19987215|NCT01983969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19987216|NCT01983969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19987217|NCT01983969|Vitamin B Complex|vitamin b complex|mesh-ancestor
19987218|NCT01983969|Vitamins|vitamins|mesh-ancestor
19987219|NCT01983969|Micronutrients|micronutrients|mesh-ancestor
19987220|NCT01984164|Candesartan|candesartan|mesh-list
19987221|NCT01984164|Lisinopril|lisinopril|mesh-list
19987222|NCT01984164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19987223|NCT01984164|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19987224|NCT01984164|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19987225|NCT01984164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987226|NCT01984164|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19987227|NCT01984164|Protease Inhibitors|protease inhibitors|mesh-ancestor
19987228|NCT01984164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987229|NCT01984164|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19987230|NCT01984164|Protective Agents|protective agents|mesh-ancestor
19987231|NCT01984164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987232|NCT01984229|Posaconazole|posaconazole|mesh-list
19987233|NCT01984229|Antifungal Agents|antifungal agents|mesh-ancestor
19987234|NCT01984229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19987235|NCT01984229|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19987236|NCT01984229|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19987237|NCT01984229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19987238|NCT01984229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19987239|NCT01984229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19742163|NCT04883242|Dexamethasone|dexamethasone|mesh-list
19742164|NCT04883242|Dexamethasone acetate|dexamethasone acetate|mesh-list
19987240|NCT01984229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987241|NCT01984229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987242|NCT01984229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19987243|NCT01984229|Hormone Antagonists|hormone antagonists|mesh-ancestor
19987244|NCT01984229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19987245|NCT01984229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987246|NCT01984242|Bevacizumab|bevacizumab|mesh-list
19987247|NCT01984242|Sunitinib|sunitinib|mesh-list
19987248|NCT01984242|Atezolizumab|atezolizumab|mesh-list
19987249|NCT01984242|Antibodies|antibodies|mesh-list
19987250|NCT01984242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19987251|NCT01984242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19987252|NCT01984242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987253|NCT01984242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19987254|NCT01984242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19987255|NCT01984242|Growth Substances|growth substances|mesh-ancestor
19987256|NCT01984242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987257|NCT01984242|Growth Inhibitors|growth inhibitors|mesh-ancestor
19987258|NCT01984242|Immunologic Factors|immunologic factors|mesh-ancestor
19987259|NCT01984242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19987260|NCT01984242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987261|NCT01984242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987262|NCT01984294|Ribavirin|ribavirin|mesh-list
19987263|NCT01984294|Antiviral Agents|antiviral agents|mesh-ancestor
19987264|NCT01984294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19987265|NCT01984294|Antimetabolites|antimetabolites|mesh-ancestor
19987266|NCT01984294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987267|NCT01984398|Citric Acid|citric acid|mesh-list
19987268|NCT01984398|Sodium Citrate|sodium citrate|mesh-list
19987269|NCT01984398|Enclomiphene|enclomiphene|mesh-list
19987270|NCT01984398|Clomiphene|clomiphene|mesh-list
19987271|NCT01984398|Zuclomiphene|zuclomiphene|mesh-list
19987272|NCT01984398|Anticoagulants|anticoagulants|mesh-ancestor
19987273|NCT01984398|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
19987274|NCT01984398|Chelating Agents|chelating agents|mesh-ancestor
19987275|NCT01984398|Sequestering Agents|sequestering agents|mesh-ancestor
19987276|NCT01984398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987277|NCT01984398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19987278|NCT01984398|Hormone Antagonists|hormone antagonists|mesh-ancestor
19987279|NCT01984398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19987280|NCT01984398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987281|NCT01984398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19987282|NCT01984398|Fertility Agents|fertility agents|mesh-ancestor
19987283|NCT01984398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19987284|NCT01984398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19987285|NCT01984398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19987286|NCT01984424|Atorvastatin|atorvastatin|mesh-list
19987287|NCT01984424|Ezetimibe|ezetimibe|mesh-list
19987288|NCT01984424|Evolocumab|evolocumab|mesh-list
19987289|NCT01984424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19987290|NCT01984424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19987291|NCT01984424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19987292|NCT01984424|Antimetabolites|antimetabolites|mesh-ancestor
19987293|NCT01984424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987294|NCT01984424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19987295|NCT01984424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19987296|NCT01984424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987297|NCT01984424|Immunologic Factors|immunologic factors|mesh-ancestor
19987298|NCT01984424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987299|NCT01984684|Vancomycin|vancomycin|mesh-list
20556326|NCT01946295|Histamine Antagonists|histamine antagonists|mesh-ancestor
20556327|NCT01946295|Histamine Agents|histamine agents|mesh-ancestor
20556328|NCT01946295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20556329|NCT01946295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556330|NCT01946295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742165|NCT04883242|Pomalidomide|pomalidomide|mesh-list
19742166|NCT04883242|Ichthammol|ichthammol|mesh-list
19742167|NCT04883242|BB 1101|bb 1101|mesh-list
19742168|NCT04883242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19742169|NCT04883242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19742170|NCT04883242|Antiemetics|antiemetics|mesh-ancestor
19742171|NCT04883242|Autonomic Agents|autonomic agents|mesh-ancestor
19742172|NCT04883242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19742173|NCT04883242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742174|NCT04883242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19742175|NCT04883242|Glucocorticoids|glucocorticoids|mesh-ancestor
19742176|NCT04883242|Hormones|hormones|mesh-ancestor
20556331|NCT01946373|Vidarabine|vidarabine|mesh-list
20556332|NCT01946373|Cyclophosphamide|cyclophosphamide|mesh-list
20556333|NCT01946373|Fludarabine|fludarabine|mesh-list
20556334|NCT01946373|Fludarabine phosphate|fludarabine phosphate|mesh-list
20556335|NCT01946373|Interleukin-2|interleukin-2|mesh-list
20556336|NCT01946373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19742177|NCT04883242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19742178|NCT04883242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19742179|NCT04883242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742180|NCT04883242|Protease Inhibitors|protease inhibitors|mesh-ancestor
19742181|NCT04883242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742182|NCT04883242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742183|NCT04883242|Immunologic Factors|immunologic factors|mesh-ancestor
19742184|NCT04883242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19742185|NCT04883242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19742186|NCT04883242|Growth Substances|growth substances|mesh-ancestor
19742187|NCT04883242|Growth Inhibitors|growth inhibitors|mesh-ancestor
19742188|NCT04883242|Dermatologic Agents|dermatologic agents|mesh-ancestor
19742189|NCT04880980|Itraconazole|itraconazole|mesh-list
19742190|NCT04880980|Terbinafine|terbinafine|mesh-list
19742191|NCT04880980|Antifungal Agents|antifungal agents|mesh-ancestor
19742192|NCT04880980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19742193|NCT04880980|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19742194|NCT04880980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19742195|NCT04880980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742196|NCT04880980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742197|NCT04880980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19742198|NCT04880980|Hormone Antagonists|hormone antagonists|mesh-ancestor
19742199|NCT04880980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19742200|NCT04880980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742201|NCT04880980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19742202|NCT04872257|Vitamin D|vitamin d|mesh-list
19742203|NCT04872257|Vitamins|vitamins|mesh-ancestor
19742204|NCT04872257|Micronutrients|micronutrients|mesh-ancestor
19742205|NCT04872257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742206|NCT04872257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19742207|NCT04867928|Azacitidine|azacitidine|mesh-list
19742208|NCT04867928|Venetoclax|venetoclax|mesh-list
19742209|NCT04867928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19742210|NCT04867928|Antimetabolites|antimetabolites|mesh-ancestor
19742211|NCT04867928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742212|NCT04867928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742213|NCT04867928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742214|NCT04846348|Diphenhydramine|diphenhydramine|mesh-list
19742215|NCT04846348|Promethazine|promethazine|mesh-list
19742216|NCT04846348|Salicylates|salicylates|mesh-list
19742217|NCT04846348|Cromolyn Sodium|cromolyn sodium|mesh-list
19742218|NCT04846348|Emollients|emollients|mesh-list
19742219|NCT04846348|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19742220|NCT04846348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19742221|NCT04846348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19742222|NCT04846348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742223|NCT04846348|Anesthetics, Local|anesthetics, local|mesh-ancestor
19742224|NCT04846348|Anesthetics|anesthetics|mesh-ancestor
19742225|NCT04846348|Sensory System Agents|sensory system agents|mesh-ancestor
19742226|NCT04846348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19742227|NCT04846348|Antiemetics|antiemetics|mesh-ancestor
19742228|NCT04846348|Autonomic Agents|autonomic agents|mesh-ancestor
19742229|NCT04846348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19742230|NCT04846348|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19742231|NCT04846348|Histamine Antagonists|histamine antagonists|mesh-ancestor
19742232|NCT04846348|Histamine Agents|histamine agents|mesh-ancestor
19742233|NCT04846348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19742234|NCT04846348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742235|NCT04846348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19742236|NCT04846348|Antipruritics|antipruritics|mesh-ancestor
19742237|NCT04846348|Dermatologic Agents|dermatologic agents|mesh-ancestor
19742238|NCT04846348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19742239|NCT04846348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19742240|NCT04846348|Analgesics|analgesics|mesh-ancestor
19742241|NCT04846348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20556337|NCT01946373|Immunologic Factors|immunologic factors|mesh-ancestor
19742242|NCT04846348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19742243|NCT04846348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19742244|NCT04846348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742245|NCT04846348|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
19742246|NCT04846348|Immunologic Factors|immunologic factors|mesh-ancestor
19742247|NCT04846348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19742248|NCT04846348|Respiratory System Agents|respiratory system agents|mesh-ancestor
19742249|NCT04840472|Panitumumab|panitumumab|mesh-list
19742250|NCT04840472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19742251|NCT04840472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742252|NCT04823091|Cyclophosphamide|cyclophosphamide|mesh-list
19742253|NCT04823091|Fludarabine|fludarabine|mesh-list
19742254|NCT04823091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19742255|NCT04823091|Immunologic Factors|immunologic factors|mesh-ancestor
19742256|NCT04823091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742257|NCT04823091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19742258|NCT04823091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19742259|NCT04823091|Alkylating Agents|alkylating agents|mesh-ancestor
19742260|NCT04823091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742261|NCT04823091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742262|NCT04823091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19742263|NCT04815902|Losartan|losartan|mesh-list
19742264|NCT04815902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19742265|NCT04815902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19742266|NCT04815902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19742267|NCT04815902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19742268|NCT04815902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742269|NCT04814602|Proglumide|proglumide|mesh-list
19742270|NCT04814602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19742271|NCT04814602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19742272|NCT04799431|Poly I-C|poly i-c|mesh-list
19987300|NCT01984684|Aztreonam|aztreonam|mesh-list
19987301|NCT01984684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19987302|NCT01984684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19987303|NCT01984892|Poly ICLC|poly iclc|mesh-list
19987304|NCT01984892|Interferon Inducers|interferon inducers|mesh-ancestor
19987305|NCT01984892|Immunologic Factors|immunologic factors|mesh-ancestor
19987306|NCT01984892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987307|NCT01985126|Acetaminophen|acetaminophen|mesh-list
19987308|NCT01985126|Diphenhydramine|diphenhydramine|mesh-list
19987309|NCT01985126|Promethazine|promethazine|mesh-list
19987310|NCT01985126|Methylprednisolone|methylprednisolone|mesh-list
19987311|NCT01985126|Daratumumab|daratumumab|mesh-list
19987312|NCT01985126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19987313|NCT01985126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19987314|NCT01985126|Analgesics|analgesics|mesh-ancestor
19987315|NCT01985126|Sensory System Agents|sensory system agents|mesh-ancestor
19987316|NCT01985126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19987317|NCT01985126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987318|NCT01985126|Antipyretics|antipyretics|mesh-ancestor
19987319|NCT01985126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19987320|NCT01985126|Antiemetics|antiemetics|mesh-ancestor
19987321|NCT01985126|Autonomic Agents|autonomic agents|mesh-ancestor
19987322|NCT01985126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19987323|NCT01985126|Glucocorticoids|glucocorticoids|mesh-ancestor
19987324|NCT01985126|Hormones|hormones|mesh-ancestor
19987325|NCT01985126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19987326|NCT01985126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19987327|NCT01985126|Protective Agents|protective agents|mesh-ancestor
19987328|NCT01985126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987329|NCT01985126|Immunologic Factors|immunologic factors|mesh-ancestor
19987330|NCT01985126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19987331|NCT01985126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19987332|NCT01985126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19987333|NCT01985126|Anesthetics, Local|anesthetics, local|mesh-ancestor
19987334|NCT01985126|Anesthetics|anesthetics|mesh-ancestor
19987335|NCT01985126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19987336|NCT01985126|Histamine Antagonists|histamine antagonists|mesh-ancestor
19987337|NCT01985126|Histamine Agents|histamine agents|mesh-ancestor
19987338|NCT01985126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19987339|NCT01985126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987340|NCT01985126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19987341|NCT01985126|Antipruritics|antipruritics|mesh-ancestor
19987342|NCT01985126|Dermatologic Agents|dermatologic agents|mesh-ancestor
19987343|NCT01985321|Ethanol|ethanol|mesh-list
19987344|NCT01985321|Glycolic acid|glycolic acid|mesh-list
19987345|NCT01985321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19742273|NCT04799431|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20289189|NCT04907279|Aripiprazole|aripiprazole|mesh-list
19742274|NCT04799431|Poly ICLC|poly iclc|mesh-list
19742275|NCT04799431|Interferon Inducers|interferon inducers|mesh-ancestor
19742276|NCT04799431|Immunologic Factors|immunologic factors|mesh-ancestor
19742277|NCT04799431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742278|NCT04799431|Laxatives|laxatives|mesh-ancestor
19742279|NCT04799431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19742280|NCT04799431|Antiviral Agents|antiviral agents|mesh-ancestor
19742281|NCT04799431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19742282|NCT04798755|Adalimumab|adalimumab|mesh-list
19742283|NCT04798755|Methotrexate|methotrexate|mesh-list
19742284|NCT04798755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19742285|NCT04798755|Abortifacient Agents|abortifacient agents|mesh-ancestor
19742286|NCT04798755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19742287|NCT04798755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742288|NCT04798755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19742289|NCT04798755|Antimetabolites|antimetabolites|mesh-ancestor
19742290|NCT04798755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742291|NCT04798755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742292|NCT04798755|Dermatologic Agents|dermatologic agents|mesh-ancestor
19742293|NCT04798755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742294|NCT04798755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19742295|NCT04798755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19742296|NCT04798755|Immunologic Factors|immunologic factors|mesh-ancestor
19742297|NCT04798755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19742298|NCT04798755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19742299|NCT04798755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19742300|NCT04792801|Choline|choline|mesh-list
19742301|NCT04792801|Lipotropic Agents|lipotropic agents|mesh-ancestor
19742302|NCT04792801|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19742303|NCT04792801|Antimetabolites|antimetabolites|mesh-ancestor
19742304|NCT04792801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742305|NCT04792801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19742306|NCT04792801|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19742307|NCT04792801|Nootropic Agents|nootropic agents|mesh-ancestor
19742308|NCT04788108|Dydrogesterone|dydrogesterone|mesh-list
19742309|NCT04788108|Progestins|progestins|mesh-ancestor
19742310|NCT04788108|Hormones|hormones|mesh-ancestor
19742311|NCT04788108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19742312|NCT04788108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742313|NCT04774120|Propofol|propofol|mesh-list
19742314|NCT04774120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19742315|NCT04774120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19742316|NCT04774120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742317|NCT04774120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19742318|NCT04774120|Anesthetics, General|anesthetics, general|mesh-ancestor
19742319|NCT04774120|Anesthetics|anesthetics|mesh-ancestor
19742320|NCT04773002|Anesthetics|anesthetics|mesh-list
19742321|NCT04773002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19742322|NCT04773002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742323|NCT04762472|Montelukast|montelukast|mesh-list
19742324|NCT04762472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19742325|NCT04762472|Respiratory System Agents|respiratory system agents|mesh-ancestor
19742326|NCT04762472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
19742327|NCT04762472|Hormone Antagonists|hormone antagonists|mesh-ancestor
19742328|NCT04762472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19742329|NCT04762472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742330|NCT04762472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
19742331|NCT04762472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19742332|NCT04762472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742333|NCT04753879|Gemcitabine|gemcitabine|mesh-list
19742334|NCT04753879|Paclitaxel|paclitaxel|mesh-list
19742335|NCT04753879|Pembrolizumab|pembrolizumab|mesh-list
19742336|NCT04753879|Capecitabine|capecitabine|mesh-list
19742337|NCT04753879|Irinotecan|irinotecan|mesh-list
19742338|NCT04753879|Olaparib|olaparib|mesh-list
19742339|NCT04753879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19742340|NCT04753879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742341|NCT04753879|Tubulin Modulators|tubulin modulators|mesh-ancestor
19742342|NCT04753879|Antimitotic Agents|antimitotic agents|mesh-ancestor
19742343|NCT04753879|Mitosis Modulators|mitosis modulators|mesh-ancestor
19742344|NCT04753879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742345|NCT04753879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19742346|NCT04753879|Antimetabolites|antimetabolites|mesh-ancestor
19742347|NCT04753879|Antiviral Agents|antiviral agents|mesh-ancestor
19742348|NCT04753879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19742349|NCT04753879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742350|NCT04753879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19742351|NCT04753879|Immunologic Factors|immunologic factors|mesh-ancestor
19742352|NCT04753879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742353|NCT04753879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19742354|NCT04753879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19742355|NCT04753879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19742356|NCT04753879|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19742357|NCT04752540|Olorofim|olorofim|mesh-list
19742358|NCT04752540|Antifungal Agents|antifungal agents|mesh-ancestor
19742359|NCT04752540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19742360|NCT04749459|Sunscreening Agents|sunscreening agents|mesh-list
19742361|NCT04749459|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19742362|NCT04749459|Protective Agents|protective agents|mesh-ancestor
19742363|NCT04749459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742364|NCT04749459|Dermatologic Agents|dermatologic agents|mesh-ancestor
19742365|NCT04746924|Pembrolizumab|pembrolizumab|mesh-list
19742366|NCT04746924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19742367|NCT04746924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742368|NCT04734652|Tenofovir|tenofovir|mesh-list
19742369|NCT04734652|Lamivudine|lamivudine|mesh-list
19742370|NCT04734652|Dolutegravir|dolutegravir|mesh-list
19742371|NCT04734652|Antiviral Agents|antiviral agents|mesh-ancestor
19742372|NCT04734652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19742373|NCT04734652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19742374|NCT04734652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19742375|NCT04734652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742376|NCT04734652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742377|NCT04734652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19742378|NCT04734652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19742379|NCT04734652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19742380|NCT04734652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19742381|NCT04732260|Letermovir|letermovir|mesh-list
19742382|NCT04732260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19742383|NCT04732260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742384|NCT04732260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742385|NCT04732260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742386|NCT04732260|Antiviral Agents|antiviral agents|mesh-ancestor
19742387|NCT04732260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19987346|NCT01985321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19987347|NCT01985321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19987348|NCT01985321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987349|NCT01985321|Keratolytic Agents|keratolytic agents|mesh-ancestor
19987350|NCT01985321|Dermatologic Agents|dermatologic agents|mesh-ancestor
19987351|NCT01985334|Glycopyrrolate|glycopyrrolate|mesh-list
19987352|NCT01985334|Bromides|bromides|mesh-list
19987353|NCT01985334|Anticonvulsants|anticonvulsants|mesh-ancestor
19987354|NCT01985334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987355|NCT01985334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19987356|NCT01985334|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19987357|NCT01985334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19987358|NCT01985334|Cholinergic Agents|cholinergic agents|mesh-ancestor
19987359|NCT01985334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19987360|NCT01985334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987361|NCT01985425|Colchicine|colchicine|mesh-list
19987362|NCT01985425|Gout Suppressants|gout suppressants|mesh-ancestor
19987363|NCT01985425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19987364|NCT01985425|Tubulin Modulators|tubulin modulators|mesh-ancestor
19987365|NCT01985425|Antimitotic Agents|antimitotic agents|mesh-ancestor
19987366|NCT01985425|Mitosis Modulators|mitosis modulators|mesh-ancestor
19987367|NCT01985425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987368|NCT01985425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987369|NCT01985581|Guanfacine|guanfacine|mesh-list
19987370|NCT01985581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19987371|NCT01985581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19987372|NCT01985581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19987373|NCT01985581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19987374|NCT01985581|Adrenergic Agents|adrenergic agents|mesh-ancestor
19987375|NCT01985581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19987376|NCT01985581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987377|NCT01985581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987378|NCT01985685|Thiamine|thiamine|mesh-list
19987379|NCT01985685|Vitamin B Complex|vitamin b complex|mesh-ancestor
19987380|NCT01985685|Vitamins|vitamins|mesh-ancestor
19987381|NCT01985685|Micronutrients|micronutrients|mesh-ancestor
19987382|NCT01985685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987383|NCT01985763|Genistein|genistein|mesh-list
19742388|NCT04716725|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19742389|NCT04716725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19742390|NCT04716725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742391|NCT04713592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19742392|NCT04713592|Immunologic Factors|immunologic factors|mesh-ancestor
19742393|NCT04713592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742394|NCT04701281|Capecitabine|capecitabine|mesh-list
19742395|NCT04701281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19742396|NCT04701281|Antimetabolites|antimetabolites|mesh-ancestor
19742397|NCT04701281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742398|NCT04701281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742399|NCT04690231|Etoposide|etoposide|mesh-list
19742400|NCT04690231|Etoposide phosphate|etoposide phosphate|mesh-list
19742401|NCT04690231|Apatinib|apatinib|mesh-list
19742402|NCT04690231|Ifosfamide|ifosfamide|mesh-list
19742403|NCT04690231|Isophosphamide mustard|isophosphamide mustard|mesh-list
19742404|NCT04690231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19742405|NCT04690231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742406|NCT04690231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19742407|NCT04690231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19742408|NCT04690231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742409|NCT04690231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742410|NCT04690231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19742411|NCT04690231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19742412|NCT04690231|Alkylating Agents|alkylating agents|mesh-ancestor
19742413|NCT04677439|HH-GV-678|hh-gv-678|mesh-list
19742414|NCT04677439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19742415|NCT04677439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742416|NCT04677439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742417|NCT04675827|Trastuzumab|trastuzumab|mesh-list
19742418|NCT04675827|Pertuzumab|pertuzumab|mesh-list
19742419|NCT04675827|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19742420|NCT04675827|Maytansine|maytansine|mesh-list
19742421|NCT04675827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19742422|NCT04675827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742423|NCT04675827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19742424|NCT04675827|Tubulin Modulators|tubulin modulators|mesh-ancestor
19742425|NCT04675827|Antimitotic Agents|antimitotic agents|mesh-ancestor
19742426|NCT04675827|Mitosis Modulators|mitosis modulators|mesh-ancestor
19742427|NCT04675827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742428|NCT04669678|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19742429|NCT04669678|Medroxyprogesterone|medroxyprogesterone|mesh-list
19742430|NCT04669678|Etonogestrel|etonogestrel|mesh-list
19742431|NCT04669678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19742432|NCT04669678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19742433|NCT04669678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19742434|NCT04669678|Contraceptive Agents|contraceptive agents|mesh-ancestor
19742435|NCT04669678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19742436|NCT04669678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742437|NCT04669678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19742438|NCT04669678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19742439|NCT04669678|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19742440|NCT04669678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19742441|NCT04669678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742442|NCT04652700|Tenofovir|tenofovir|mesh-list
19742443|NCT04652700|Emtricitabine|emtricitabine|mesh-list
19742444|NCT04652700|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19742445|NCT04652700|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
19742446|NCT04652700|Antiviral Agents|antiviral agents|mesh-ancestor
19742447|NCT04652700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19742448|NCT04652700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19742449|NCT04652700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19742450|NCT04652700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742451|NCT04652700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742452|NCT04652700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19742453|NCT04652700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19742454|NCT04651439|Lenograstim|lenograstim|mesh-list
19742455|NCT04651439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19742456|NCT04651439|Immunologic Factors|immunologic factors|mesh-ancestor
19742457|NCT04651439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742458|NCT04650087|Apixaban|apixaban|mesh-list
19742459|NCT04650087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19742460|NCT04650087|Antithrombins|antithrombins|mesh-ancestor
19742461|NCT04650087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19742462|NCT04650087|Protease Inhibitors|protease inhibitors|mesh-ancestor
19742463|NCT04650087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742464|NCT04650087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742465|NCT04650087|Anticoagulants|anticoagulants|mesh-ancestor
19742466|NCT04642430|Rivaroxaban|rivaroxaban|mesh-list
19742467|NCT04642430|Apixaban|apixaban|mesh-list
19742468|NCT04642430|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19742469|NCT04642430|Antithrombins|antithrombins|mesh-ancestor
19742470|NCT04642430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19742471|NCT04642430|Protease Inhibitors|protease inhibitors|mesh-ancestor
19742472|NCT04642430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742473|NCT04642430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742474|NCT04642430|Anticoagulants|anticoagulants|mesh-ancestor
19742475|NCT04633564|Bevacizumab|bevacizumab|mesh-list
19742476|NCT04633564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19742477|NCT04633564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742478|NCT04633564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19742479|NCT04633564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19742480|NCT04633564|Growth Substances|growth substances|mesh-ancestor
19742481|NCT04633564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742482|NCT04633564|Growth Inhibitors|growth inhibitors|mesh-ancestor
19742483|NCT04602845|Flurbiprofen|flurbiprofen|mesh-list
19742484|NCT04602845|Fentanyl|fentanyl|mesh-list
19742485|NCT04602845|Midazolam|midazolam|mesh-list
19742486|NCT04602845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19742487|NCT04602845|Narcotics|narcotics|mesh-ancestor
19742488|NCT04602845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19742489|NCT04602845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742490|NCT04602845|Analgesics|analgesics|mesh-ancestor
19742491|NCT04602845|Sensory System Agents|sensory system agents|mesh-ancestor
19742492|NCT04602845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19742493|NCT04602845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19742494|NCT04602845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19742495|NCT04602845|Anesthetics, General|anesthetics, general|mesh-ancestor
19742496|NCT04602845|Anesthetics|anesthetics|mesh-ancestor
19742497|NCT04602845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19742498|NCT04602845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19742499|NCT04602845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19742500|NCT04602845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19742501|NCT04602845|GABA Modulators|gaba modulators|mesh-ancestor
19742502|NCT04602845|GABA Agents|gaba agents|mesh-ancestor
19742503|NCT04602845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19742504|NCT04602845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742505|NCT04602845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19742506|NCT04602845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19742507|NCT04602845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19742508|NCT04602845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19742509|NCT04602845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19742510|NCT04602845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742511|NCT04597476|Fucoidan|fucoidan|mesh-list
19742512|NCT04597476|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19742513|NCT04597476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19742514|NCT04597476|Anticoagulants|anticoagulants|mesh-ancestor
19742515|NCT04597476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742516|NCT04597320|Fentanyl|fentanyl|mesh-list
19742517|NCT04597320|Midazolam|midazolam|mesh-list
19742518|NCT04597320|Esketamine|esketamine|mesh-list
19742519|NCT04597320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19742520|NCT04597320|Narcotics|narcotics|mesh-ancestor
19742521|NCT04597320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19742522|NCT04597320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742523|NCT04597320|Analgesics|analgesics|mesh-ancestor
19742524|NCT04597320|Sensory System Agents|sensory system agents|mesh-ancestor
19742525|NCT04597320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19742526|NCT04597320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19742527|NCT04597320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19742528|NCT04597320|Anesthetics, General|anesthetics, general|mesh-ancestor
19742529|NCT04597320|Anesthetics|anesthetics|mesh-ancestor
19742530|NCT04597320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19742531|NCT04597320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19742532|NCT04597320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19742533|NCT04597320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19742534|NCT04597320|GABA Modulators|gaba modulators|mesh-ancestor
19742535|NCT04597320|GABA Agents|gaba agents|mesh-ancestor
19742536|NCT04597320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19742537|NCT04597320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742538|NCT04597320|Antidepressive Agents|antidepressive agents|mesh-ancestor
19742539|NCT04596189|Mometasone Furoate|mometasone furoate|mesh-list
19742540|NCT04596189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19742541|NCT04596189|Dermatologic Agents|dermatologic agents|mesh-ancestor
19742542|NCT04596189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19742543|NCT04587128|Irinotecan|irinotecan|mesh-list
19742544|NCT04587128|Cetuximab|cetuximab|mesh-list
19742545|NCT04587128|Panitumumab|panitumumab|mesh-list
19742546|NCT04587128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19742547|NCT04587128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19742548|NCT04587128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742549|NCT04587128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742550|NCT04587128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742551|NCT04587128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19742552|NCT04573920|Atrasentan|atrasentan|mesh-list
19742553|NCT04573920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742554|NCT04573920|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19742555|NCT04573920|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19742556|NCT04573920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742557|NCT04568200|Paclitaxel|paclitaxel|mesh-list
19742558|NCT04568200|Carboplatin|carboplatin|mesh-list
19742559|NCT04568200|Durvalumab|durvalumab|mesh-list
19742560|NCT04568200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19742561|NCT04568200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742562|NCT04568200|Tubulin Modulators|tubulin modulators|mesh-ancestor
19742563|NCT04568200|Antimitotic Agents|antimitotic agents|mesh-ancestor
19742564|NCT04568200|Mitosis Modulators|mitosis modulators|mesh-ancestor
19742565|NCT04568200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742566|NCT04568200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19742567|NCT04564339|Ravulizumab|ravulizumab|mesh-list
19742568|NCT04564339|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19742569|NCT04564339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19742570|NCT04564339|Immunologic Factors|immunologic factors|mesh-ancestor
19742571|NCT04564339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742572|NCT04559529|Levetiracetam|levetiracetam|mesh-list
19742573|NCT04559529|Anticonvulsants|anticonvulsants|mesh-ancestor
19742574|NCT04559529|Nootropic Agents|nootropic agents|mesh-ancestor
19742575|NCT04553692|Leucovorin|leucovorin|mesh-list
19742576|NCT04553692|Bevacizumab|bevacizumab|mesh-list
19742577|NCT04553692|Fluorouracil|fluorouracil|mesh-list
19742578|NCT04553692|Irinotecan|irinotecan|mesh-list
19742579|NCT04553692|Venetoclax|venetoclax|mesh-list
19742580|NCT04553692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19742581|NCT04553692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742582|NCT04553692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19742583|NCT04553692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19742584|NCT04553692|Growth Substances|growth substances|mesh-ancestor
19742585|NCT04553692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742586|NCT04553692|Growth Inhibitors|growth inhibitors|mesh-ancestor
19742587|NCT04553692|Antimetabolites|antimetabolites|mesh-ancestor
19742588|NCT04553692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742589|NCT04553692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19742590|NCT04553692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19742591|NCT04553692|Immunologic Factors|immunologic factors|mesh-ancestor
19742592|NCT04553692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19742593|NCT04553692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19742594|NCT04553692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742595|NCT04553692|Antidotes|antidotes|mesh-ancestor
19742596|NCT04553692|Protective Agents|protective agents|mesh-ancestor
19742597|NCT04553692|Vitamin B Complex|vitamin b complex|mesh-ancestor
19742598|NCT04553692|Vitamins|vitamins|mesh-ancestor
19742599|NCT04553692|Micronutrients|micronutrients|mesh-ancestor
19742600|NCT04544995|Niraparib|niraparib|mesh-list
19742601|NCT04544995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19742602|NCT04544995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742603|NCT04544995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742604|NCT04544995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742605|NCT04532346|Hydroxychloroquine|hydroxychloroquine|mesh-list
19742606|NCT04532346|Antimalarials|antimalarials|mesh-ancestor
19742607|NCT04532346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19742608|NCT04532346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19742609|NCT04532346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19742610|NCT04532346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742611|NCT04532346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742612|NCT04532346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19742613|NCT04530747|Metformin|metformin|mesh-list
19742614|NCT04530747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19742615|NCT04530747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742616|NCT04524702|Gemcitabine|gemcitabine|mesh-list
19742617|NCT04524702|Hydroxychloroquine|hydroxychloroquine|mesh-list
19742618|NCT04524702|Paclitaxel|paclitaxel|mesh-list
19742619|NCT04524702|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19742620|NCT04524702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19742621|NCT04524702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19742622|NCT04524702|Tubulin Modulators|tubulin modulators|mesh-ancestor
19742623|NCT04524702|Antimitotic Agents|antimitotic agents|mesh-ancestor
19742624|NCT04524702|Mitosis Modulators|mitosis modulators|mesh-ancestor
19742625|NCT04524702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742626|NCT04524702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19742627|NCT04524702|Antimetabolites|antimetabolites|mesh-ancestor
19742628|NCT04524702|Antiviral Agents|antiviral agents|mesh-ancestor
19742629|NCT04524702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19742630|NCT04524702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19742631|NCT04524702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19742632|NCT04524702|Immunologic Factors|immunologic factors|mesh-ancestor
19742633|NCT04524702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742634|NCT04524702|Antimalarials|antimalarials|mesh-ancestor
19742635|NCT04524702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19742636|NCT04524702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19742637|NCT04524702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19987384|NCT01985763|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19987385|NCT01985763|Protective Agents|protective agents|mesh-ancestor
19987386|NCT01985763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987387|NCT01985763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987388|NCT01985763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19987389|NCT01985763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987390|NCT01985763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987391|NCT01985763|Phytoestrogens|phytoestrogens|mesh-ancestor
19987392|NCT01985763|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19987393|NCT01985763|Estrogens|estrogens|mesh-ancestor
19987394|NCT01985763|Hormones|hormones|mesh-ancestor
19987395|NCT01985763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19987396|NCT01986010|Aluminum phosphate|aluminum phosphate|mesh-list
19987397|NCT01986010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19987398|NCT01986010|Immunologic Factors|immunologic factors|mesh-ancestor
19987399|NCT01986010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987400|NCT01986010|Antacids|antacids|mesh-ancestor
19987401|NCT01986010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987402|NCT01986010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19987403|NCT01986062|Amphetamine|amphetamine|mesh-list
19987404|NCT01986062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19987405|NCT01986062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987406|NCT01986062|Sympathomimetics|sympathomimetics|mesh-ancestor
19987407|NCT01986062|Autonomic Agents|autonomic agents|mesh-ancestor
19987408|NCT01986062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19987409|NCT01986062|Dopamine Agents|dopamine agents|mesh-ancestor
19987410|NCT01986062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19987411|NCT01986062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987412|NCT01986062|Adrenergic Agents|adrenergic agents|mesh-ancestor
19987413|NCT01986062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19987414|NCT01986062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19987415|NCT01986062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19987416|NCT01986062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19987417|NCT01986231|Glucagon|glucagon|mesh-list
19987418|NCT01986231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19987419|NCT01986231|Hormones|hormones|mesh-ancestor
19987420|NCT01986231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19987421|NCT01986231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987422|NCT01986361|Flurbiprofen|flurbiprofen|mesh-list
19987423|NCT01986361|Analgesics|analgesics|mesh-ancestor
19987424|NCT01986361|Sensory System Agents|sensory system agents|mesh-ancestor
19987425|NCT01986361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19987426|NCT01986361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987427|NCT01986361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19987428|NCT01986361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19987429|NCT01986361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19987430|NCT01986361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19987431|NCT01986361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19987432|NCT01986361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987433|NCT01986361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987434|NCT01986855|Ertugliflozin|ertugliflozin|mesh-list
19742638|NCT04509414|Midazolam|midazolam|mesh-list
19742639|NCT04509414|Dexmedetomidine|dexmedetomidine|mesh-list
19742640|NCT04509414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19742641|NCT04509414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19742642|NCT04509414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742643|NCT04509414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19742644|NCT04509414|Analgesics|analgesics|mesh-ancestor
19742645|NCT04509414|Sensory System Agents|sensory system agents|mesh-ancestor
19742646|NCT04509414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19742647|NCT04509414|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19742648|NCT04509414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19742649|NCT04509414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19742650|NCT04509414|Adrenergic Agents|adrenergic agents|mesh-ancestor
19742651|NCT04509414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19742652|NCT04509414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19742653|NCT04509414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19742654|NCT04509414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19742655|NCT04509414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19742656|NCT04509414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19742657|NCT04509414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19742658|NCT04509414|Anesthetics, General|anesthetics, general|mesh-ancestor
19742659|NCT04509414|Anesthetics|anesthetics|mesh-ancestor
19742660|NCT04509414|GABA Modulators|gaba modulators|mesh-ancestor
19742661|NCT04509414|GABA Agents|gaba agents|mesh-ancestor
19742662|NCT04505059|Anesthetics|anesthetics|mesh-list
19742663|NCT04505059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19742664|NCT04505059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19742665|NCT04500574|Latanoprost|latanoprost|mesh-list
19742666|NCT04500574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19742667|NCT04500574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19987435|NCT01986855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19987436|NCT01986855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987437|NCT01986855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19987438|NCT01986855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987439|NCT01986881|Ertugliflozin|ertugliflozin|mesh-list
19987440|NCT01986881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19987441|NCT01986881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987442|NCT01986881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19987443|NCT01986881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987444|NCT01986907|Ranibizumab|ranibizumab|mesh-list
19987445|NCT01986907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19987446|NCT01986907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19987447|NCT01986907|Growth Substances|growth substances|mesh-ancestor
19987448|NCT01986907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987449|NCT01986907|Growth Inhibitors|growth inhibitors|mesh-ancestor
19987450|NCT01986907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987451|NCT01986946|Hydromorphone|hydromorphone|mesh-list
19987452|NCT01986946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19987453|NCT01986946|Narcotics|narcotics|mesh-ancestor
19987454|NCT01986946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19987455|NCT01986946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987456|NCT01986946|Analgesics|analgesics|mesh-ancestor
19987457|NCT01986946|Sensory System Agents|sensory system agents|mesh-ancestor
19987458|NCT01986946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19987459|NCT01987102|Leucovorin|leucovorin|mesh-list
19987460|NCT01987102|Calcium|calcium|mesh-list
19987461|NCT01987102|Levoleucovorin|levoleucovorin|mesh-list
19987462|NCT01987102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19987463|NCT01987102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987464|NCT01987102|Antidotes|antidotes|mesh-ancestor
19987465|NCT01987102|Protective Agents|protective agents|mesh-ancestor
19987466|NCT01987102|Vitamin B Complex|vitamin b complex|mesh-ancestor
19987467|NCT01987102|Vitamins|vitamins|mesh-ancestor
19987468|NCT01987102|Micronutrients|micronutrients|mesh-ancestor
19987469|NCT01987219|Bromides|bromides|mesh-list
19987470|NCT01987219|Albuterol|albuterol|mesh-list
19987471|NCT01987219|Ipratropium|ipratropium|mesh-list
19987472|NCT01987219|Anticonvulsants|anticonvulsants|mesh-ancestor
19987473|NCT01987219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19987474|NCT01987219|Autonomic Agents|autonomic agents|mesh-ancestor
19987475|NCT01987219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19987476|NCT01987219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987477|NCT01987219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19987478|NCT01987219|Respiratory System Agents|respiratory system agents|mesh-ancestor
19987479|NCT01987219|Tocolytic Agents|tocolytic agents|mesh-ancestor
19987480|NCT01987219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19987481|NCT01987219|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19987482|NCT01987219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19987483|NCT01987219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19987484|NCT01987219|Adrenergic Agents|adrenergic agents|mesh-ancestor
19987485|NCT01987219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19987486|NCT01987219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987487|NCT01987219|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19987488|NCT01987219|Cholinergic Agents|cholinergic agents|mesh-ancestor
19987489|NCT01987232|Carboplatin|carboplatin|mesh-list
19987490|NCT01987232|Etoposide|etoposide|mesh-list
19987491|NCT01987232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987492|NCT01987232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19987493|NCT01987232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19987494|NCT01987232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19987495|NCT01987232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987496|NCT01987232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987497|NCT01987427|Phentermine|phentermine|mesh-list
19987498|NCT01987427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19987499|NCT01987427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987500|NCT01987427|Appetite Depressants|appetite depressants|mesh-ancestor
19987501|NCT01987427|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19987502|NCT01987427|Sympathomimetics|sympathomimetics|mesh-ancestor
19987503|NCT01987427|Autonomic Agents|autonomic agents|mesh-ancestor
19987504|NCT01987427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19987505|NCT01987427|Adrenergic Agents|adrenergic agents|mesh-ancestor
19987506|NCT01987427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19987507|NCT01987427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987508|NCT01987453|Sofosbuvir|sofosbuvir|mesh-list
19987509|NCT01987453|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19987510|NCT01987453|Ledipasvir|ledipasvir|mesh-list
19987511|NCT01987453|Antiviral Agents|antiviral agents|mesh-ancestor
19987512|NCT01987453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19987513|NCT01987479|Methotrexate|methotrexate|mesh-list
19987514|NCT01987479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19987515|NCT01987479|Abortifacient Agents|abortifacient agents|mesh-ancestor
19987516|NCT01987479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19987517|NCT01987479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987518|NCT01987479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19987519|NCT01987479|Antimetabolites|antimetabolites|mesh-ancestor
19987520|NCT01987479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987521|NCT01987479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987522|NCT01987479|Dermatologic Agents|dermatologic agents|mesh-ancestor
19987523|NCT01987479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987524|NCT01987479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19987525|NCT01987479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19987526|NCT01987479|Immunologic Factors|immunologic factors|mesh-ancestor
19987527|NCT01987479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19987528|NCT01987479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19987529|NCT01987505|Rituximab|rituximab|mesh-list
19987530|NCT01987505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19987531|NCT01987505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987532|NCT01987505|Immunologic Factors|immunologic factors|mesh-ancestor
19987533|NCT01987505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987534|NCT01987505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19987535|NCT01987596|Lenograstim|lenograstim|mesh-list
19987536|NCT01987596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19987537|NCT01987596|Immunologic Factors|immunologic factors|mesh-ancestor
19987538|NCT01987596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987539|NCT01987752|Timolol|timolol|mesh-list
19987540|NCT01987752|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19987541|NCT01987752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19987542|NCT01987752|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
19987543|NCT01987752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19987544|NCT01987752|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19987545|NCT01987752|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19987546|NCT01987752|Adrenergic Agents|adrenergic agents|mesh-ancestor
19987547|NCT01987752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19987548|NCT01987752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987549|NCT01987752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987550|NCT01987752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19987551|NCT01987752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19987552|NCT01987752|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19987553|NCT01987752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19987554|NCT01987752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19987555|NCT01987765|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19987556|NCT01987765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19987557|NCT01987895|Vancomycin|vancomycin|mesh-list
19987558|NCT01987895|Oxazolidinones|oxazolidinones|mesh-list
19987559|NCT01987895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19987560|NCT01987895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19987561|NCT01987895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19987562|NCT01987895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987563|NCT01987895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987564|NCT01987960|Brexpiprazole|brexpiprazole|mesh-list
19987565|NCT01987960|Serotonin Agents|serotonin agents|mesh-ancestor
19987566|NCT01987960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19987567|NCT01987960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987568|NCT01987960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987569|NCT01987960|Dopamine Agonists|dopamine agonists|mesh-ancestor
19987570|NCT01987960|Dopamine Agents|dopamine agents|mesh-ancestor
19987571|NCT01988090|Vitamin D|vitamin d|mesh-list
19987572|NCT01988090|Ergocalciferols|ergocalciferols|mesh-list
19987573|NCT01988090|Vitamins|vitamins|mesh-list
19987574|NCT01988090|Micronutrients|micronutrients|mesh-ancestor
19987575|NCT01988090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987576|NCT01988090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19987577|NCT01988090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19987578|NCT01988103|Thalidomide|thalidomide|mesh-list
19987579|NCT01988103|Apremilast|apremilast|mesh-list
19987580|NCT01988103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19987581|NCT01988103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19987582|NCT01988103|Analgesics|analgesics|mesh-ancestor
19987583|NCT01988103|Sensory System Agents|sensory system agents|mesh-ancestor
19987584|NCT01988103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19987585|NCT01988103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987586|NCT01988103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19987587|NCT01988103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19987588|NCT01988103|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19987589|NCT01988103|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19987590|NCT01988103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987591|NCT01988103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987592|NCT01988103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19987593|NCT01988103|Immunologic Factors|immunologic factors|mesh-ancestor
19987594|NCT01988103|Leprostatic Agents|leprostatic agents|mesh-ancestor
19987595|NCT01988103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19987596|NCT01988103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19987597|NCT01988103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19987598|NCT01988103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19987599|NCT01988103|Growth Substances|growth substances|mesh-ancestor
19987600|NCT01988103|Growth Inhibitors|growth inhibitors|mesh-ancestor
19987601|NCT01988103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987602|NCT01988246|Aflibercept|aflibercept|mesh-list
19987603|NCT01988246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19987604|NCT01988246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19987605|NCT01988246|Growth Substances|growth substances|mesh-ancestor
19987606|NCT01988246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987607|NCT01988246|Growth Inhibitors|growth inhibitors|mesh-ancestor
19987608|NCT01988246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987609|NCT01988402|Allopurinol|allopurinol|mesh-list
19987610|NCT01988402|Antimetabolites|antimetabolites|mesh-ancestor
19987611|NCT01988402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987612|NCT01988402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987613|NCT01988402|Gout Suppressants|gout suppressants|mesh-ancestor
19987614|NCT01988402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19987615|NCT01988402|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19987616|NCT01988402|Antioxidants|antioxidants|mesh-ancestor
19987617|NCT01988402|Protective Agents|protective agents|mesh-ancestor
19987618|NCT01988402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987619|NCT01988662|Ranibizumab|ranibizumab|mesh-list
19987620|NCT01988662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19987621|NCT01988662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19987622|NCT01988662|Growth Substances|growth substances|mesh-ancestor
19987623|NCT01988662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987624|NCT01988662|Growth Inhibitors|growth inhibitors|mesh-ancestor
19987625|NCT01988662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987626|NCT01988779|Levofloxacin|levofloxacin|mesh-list
19987627|NCT01988779|Ofloxacin|ofloxacin|mesh-list
19987628|NCT01988779|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19987629|NCT01988779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19987630|NCT01988779|Renal Agents|renal agents|mesh-ancestor
19987631|NCT01988779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19987632|NCT01988779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19987633|NCT01988779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19987634|NCT01988779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987635|NCT01988779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987636|NCT01988779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987637|NCT01988779|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19987638|NCT01988779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19987639|NCT01988922|Ketamine|ketamine|mesh-list
19987640|NCT01988922|Analgesics|analgesics|mesh-ancestor
19987641|NCT01988922|Sensory System Agents|sensory system agents|mesh-ancestor
19987642|NCT01988922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19987643|NCT01988922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987644|NCT01988922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19987645|NCT01988922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19987646|NCT01988922|Anesthetics, General|anesthetics, general|mesh-ancestor
19987647|NCT01988922|Anesthetics|anesthetics|mesh-ancestor
19987648|NCT01988922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19987649|NCT01988922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19987650|NCT01988922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19987651|NCT01988922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19987652|NCT01988922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987653|NCT01989156|Menthol|menthol|mesh-list
19987654|NCT01989156|Antipruritics|antipruritics|mesh-ancestor
19987655|NCT01989156|Dermatologic Agents|dermatologic agents|mesh-ancestor
19987656|NCT01989169|Midazolam|midazolam|mesh-list
19987657|NCT01989169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19987658|NCT01989169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19987659|NCT01989169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19987660|NCT01989169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987661|NCT01989169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19987662|NCT01989169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19987663|NCT01989169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19987664|NCT01989169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19987665|NCT01989169|Anesthetics, General|anesthetics, general|mesh-ancestor
19987666|NCT01989169|Anesthetics|anesthetics|mesh-ancestor
19987667|NCT01989169|GABA Modulators|gaba modulators|mesh-ancestor
19987668|NCT01989169|GABA Agents|gaba agents|mesh-ancestor
19987669|NCT01989169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19987670|NCT01989169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987671|NCT01989195|Manganese|manganese|mesh-list
19987672|NCT01989195|Trace Elements|trace elements|mesh-ancestor
19987673|NCT01989195|Micronutrients|micronutrients|mesh-ancestor
19987674|NCT01989195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987675|NCT01989208|Sodium sulfate|sodium sulfate|mesh-list
19987676|NCT01989208|Cathartics|cathartics|mesh-ancestor
19987677|NCT01989208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19987678|NCT01989221|Granisetron|granisetron|mesh-list
19987679|NCT01989221|Antiemetics|antiemetics|mesh-ancestor
19987680|NCT01989221|Autonomic Agents|autonomic agents|mesh-ancestor
19987681|NCT01989221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19987682|NCT01989221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987683|NCT01989221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19987684|NCT01989221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19987685|NCT01989221|Serotonin Agents|serotonin agents|mesh-ancestor
19987686|NCT01989221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19987687|NCT01989221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987688|NCT01989455|Deferiprone|deferiprone|mesh-list
19987689|NCT01989455|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19987690|NCT01989455|Chelating Agents|chelating agents|mesh-ancestor
19987691|NCT01989455|Sequestering Agents|sequestering agents|mesh-ancestor
19987692|NCT01989455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987693|NCT01989468|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19987694|NCT01989468|Immunologic Factors|immunologic factors|mesh-ancestor
19987695|NCT01989468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987696|NCT01989546|Talazoparib|talazoparib|mesh-list
19987697|NCT01989546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19987698|NCT01989546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987699|NCT01989546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987700|NCT01989546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987701|NCT01989572|Sargramostim|sargramostim|mesh-list
19987702|NCT01989572|Immunologic Factors|immunologic factors|mesh-ancestor
19987703|NCT01989572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987704|NCT01989689|Etanercept|etanercept|mesh-list
19987705|NCT01989689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19987706|NCT01989689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19987707|NCT01989689|Analgesics|analgesics|mesh-ancestor
19987708|NCT01989689|Sensory System Agents|sensory system agents|mesh-ancestor
19987709|NCT01989689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19987710|NCT01989689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987711|NCT01989689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19987712|NCT01989689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19987713|NCT01989689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19987714|NCT01989689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19987715|NCT01989689|Immunologic Factors|immunologic factors|mesh-ancestor
19987716|NCT01989754|Canagliflozin|canagliflozin|mesh-list
19987717|NCT01989754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19987718|NCT01989754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987719|NCT01989754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19987720|NCT01989754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987721|NCT01989793|Losartan|losartan|mesh-list
19987722|NCT01989793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19987723|NCT01989793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19987724|NCT01989793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19987725|NCT01989793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19987726|NCT01989793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987727|NCT01989910|Efavirenz|efavirenz|mesh-list
19987728|NCT01989910|Raltegravir Potassium|raltegravir potassium|mesh-list
19987729|NCT01989910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19987730|NCT01989910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19987731|NCT01989910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987732|NCT01989910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987733|NCT01989910|Antiviral Agents|antiviral agents|mesh-ancestor
19987734|NCT01989910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19987735|NCT01989910|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19987736|NCT01989910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19987737|NCT01989910|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19987738|NCT01989910|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19987739|NCT01989910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19987740|NCT01989910|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19987741|NCT01989910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19987742|NCT01989910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19987743|NCT01989910|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19459650|NCT03359655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19459651|NCT03359655|Oxytocics|oxytocics|mesh-ancestor
19459652|NCT03359655|Anticonvulsants|anticonvulsants|mesh-ancestor
19459653|NCT03359655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19459654|NCT03359655|Antiemetics|antiemetics|mesh-ancestor
19459655|NCT03359655|Autonomic Agents|autonomic agents|mesh-ancestor
19459656|NCT03359655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19459657|NCT03359655|Mydriatics|mydriatics|mesh-ancestor
19459658|NCT03359655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19459659|NCT03359655|Cholinergic Agents|cholinergic agents|mesh-ancestor
19459660|NCT03359655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19459661|NCT03359655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459662|NCT03359655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19459663|NCT03359655|Parasympatholytics|parasympatholytics|mesh-ancestor
19459664|NCT03359525|Tranexamic Acid|tranexamic acid|mesh-list
19459665|NCT03359525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19459666|NCT03359525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19459667|NCT03359525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459668|NCT03359525|Hemostatics|hemostatics|mesh-ancestor
19459669|NCT03359525|Coagulants|coagulants|mesh-ancestor
19459670|NCT03359499|Trimebutine|trimebutine|mesh-list
19459671|NCT03359499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19987744|NCT01989910|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20289190|NCT04907279|Antidepressive Agents|antidepressive agents|mesh-ancestor
20289191|NCT04907279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20289192|NCT04907279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20289193|NCT04907279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20289194|NCT04907279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20289195|NCT04907279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289196|NCT04907279|Dopamine Agonists|dopamine agonists|mesh-ancestor
20289197|NCT04907279|Dopamine Agents|dopamine agents|mesh-ancestor
20289198|NCT04907279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19987745|NCT01990261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19987746|NCT01990261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987747|NCT01990261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19987748|NCT01990261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987749|NCT01990261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987750|NCT01990300|Pioglitazone|pioglitazone|mesh-list
19987751|NCT01990300|Alogliptin|alogliptin|mesh-list
19987752|NCT01990300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19987753|NCT01990300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987754|NCT01990300|Incretins|incretins|mesh-ancestor
19987755|NCT01990300|Hormones|hormones|mesh-ancestor
19987756|NCT01990300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19987757|NCT01990300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19987758|NCT01990300|Protease Inhibitors|protease inhibitors|mesh-ancestor
19987759|NCT01990300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987760|NCT01990300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987761|NCT01990339|Lansoprazole|lansoprazole|mesh-list
19987762|NCT01990339|Dexlansoprazole|dexlansoprazole|mesh-list
19987763|NCT01990339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19987764|NCT01990339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19987765|NCT01990339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19987766|NCT01990339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987767|NCT01990339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987768|NCT01990534|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19987769|NCT01990534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19987770|NCT01990534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987771|NCT01990560|Mifepristone|mifepristone|mesh-list
19987772|NCT01990560|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19987773|NCT01990560|Abortifacient Agents|abortifacient agents|mesh-ancestor
19987774|NCT01990560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19987775|NCT01990560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987776|NCT01990560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19987777|NCT01990560|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19987778|NCT01990560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19987779|NCT01990560|Contraceptive Agents|contraceptive agents|mesh-ancestor
19987780|NCT01990560|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19987781|NCT01990560|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19987782|NCT01990560|Hormone Antagonists|hormone antagonists|mesh-ancestor
19987783|NCT01990560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19987784|NCT01990560|Luteolytic Agents|luteolytic agents|mesh-ancestor
19987785|NCT01990560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19987786|NCT01990560|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19987787|NCT01990573|Methadone|methadone|mesh-list
19987788|NCT01990573|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19987789|NCT01990573|Narcotics|narcotics|mesh-ancestor
19987790|NCT01990573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19987791|NCT01990573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987792|NCT01990573|Analgesics|analgesics|mesh-ancestor
19987793|NCT01990573|Sensory System Agents|sensory system agents|mesh-ancestor
19987794|NCT01990573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19987795|NCT01990573|Antitussive Agents|antitussive agents|mesh-ancestor
19987796|NCT01990573|Respiratory System Agents|respiratory system agents|mesh-ancestor
19987797|NCT01990677|Eplerenone|eplerenone|mesh-list
19987798|NCT01990677|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19987799|NCT01990677|Hormone Antagonists|hormone antagonists|mesh-ancestor
19987800|NCT01990677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19987801|NCT01990677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987802|NCT01990677|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19987803|NCT01990677|Diuretics|diuretics|mesh-ancestor
19987804|NCT01990677|Natriuretic Agents|natriuretic agents|mesh-ancestor
19987805|NCT01990677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19987806|NCT01990703|Levonorgestrel|levonorgestrel|mesh-list
19987807|NCT01990703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19987808|NCT01990703|Contraceptive Agents|contraceptive agents|mesh-ancestor
19987809|NCT01990703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19987810|NCT01990703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987811|NCT01990703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19987812|NCT01990703|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19987813|NCT01990703|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19987814|NCT01990768|Tranexamic Acid|tranexamic acid|mesh-list
19987815|NCT01990768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19987816|NCT01990768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19987817|NCT01990768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987818|NCT01990768|Hemostatics|hemostatics|mesh-ancestor
19987819|NCT01990768|Coagulants|coagulants|mesh-ancestor
19987820|NCT01990859|Ipilimumab|ipilimumab|mesh-list
19987821|NCT01990859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19987822|NCT01990859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987823|NCT01990859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19987824|NCT01990859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987825|NCT01990898|Cyclosporine|cyclosporine|mesh-list
19987826|NCT01990898|Cyclosporins|cyclosporins|mesh-list
19987827|NCT01990898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987828|NCT01990898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987829|NCT01990898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19987830|NCT01990898|Immunologic Factors|immunologic factors|mesh-ancestor
19987831|NCT01990898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987832|NCT01990898|Antifungal Agents|antifungal agents|mesh-ancestor
19987833|NCT01990898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19987834|NCT01990898|Dermatologic Agents|dermatologic agents|mesh-ancestor
19987835|NCT01990898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19987836|NCT01990898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19987837|NCT01991197|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19987838|NCT01991197|Gliclazide|gliclazide|mesh-list
19987839|NCT01991197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19987840|NCT01991197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987841|NCT01991197|Incretins|incretins|mesh-ancestor
19987842|NCT01991197|Hormones|hormones|mesh-ancestor
19987843|NCT01991197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19987844|NCT01991197|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19987845|NCT01991197|Protease Inhibitors|protease inhibitors|mesh-ancestor
19987846|NCT01991197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987847|NCT01991197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987848|NCT01991548|Insulin|insulin|mesh-list
19987849|NCT01991548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19987850|NCT01991548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987851|NCT01991743|Bupivacaine|bupivacaine|mesh-list
19987852|NCT01991743|Anesthetics, Local|anesthetics, local|mesh-ancestor
19987853|NCT01991743|Anesthetics|anesthetics|mesh-ancestor
19987854|NCT01991743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19987855|NCT01991743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987856|NCT01991743|Sensory System Agents|sensory system agents|mesh-ancestor
19987857|NCT01991743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19987858|NCT01991795|Ticagrelor|ticagrelor|mesh-list
19987859|NCT01991795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19987860|NCT01991795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19987861|NCT01991795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19987862|NCT01991795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19987863|NCT01991795|Purinergic Agents|purinergic agents|mesh-ancestor
19987864|NCT01991795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19987865|NCT01991795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987866|NCT01991795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987867|NCT01991860|Amisulpride|amisulpride|mesh-list
19987868|NCT01991860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19987869|NCT01991860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19987870|NCT01991860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19987871|NCT01991860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987872|NCT01991860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19987873|NCT01991860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19987874|NCT01991860|Dopamine Agents|dopamine agents|mesh-ancestor
19987875|NCT01991860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19987876|NCT01991860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987877|NCT01991860|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19987878|NCT01991860|Antidepressive Agents|antidepressive agents|mesh-ancestor
19987879|NCT01991977|Temozolomide|temozolomide|mesh-list
19987880|NCT01991977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19987881|NCT01991977|Alkylating Agents|alkylating agents|mesh-ancestor
19987882|NCT01991977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987883|NCT01991977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987884|NCT01992016|Ranolazine|ranolazine|mesh-list
19987885|NCT01992016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19987886|NCT01992016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19987887|NCT01992016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987888|NCT01992172|Sunscreening Agents|sunscreening agents|mesh-list
19987889|NCT01992172|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19987890|NCT01992172|Protective Agents|protective agents|mesh-ancestor
19987891|NCT01992172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987892|NCT01992172|Dermatologic Agents|dermatologic agents|mesh-ancestor
19987893|NCT01992185|Sunscreening Agents|sunscreening agents|mesh-list
19987894|NCT01992185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19987895|NCT01992185|Protective Agents|protective agents|mesh-ancestor
19987896|NCT01992185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987897|NCT01992185|Dermatologic Agents|dermatologic agents|mesh-ancestor
19987898|NCT01992523|Ticagrelor|ticagrelor|mesh-list
19987899|NCT01992523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19987900|NCT01992523|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19987901|NCT01992523|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19987902|NCT01992523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19987903|NCT01992523|Purinergic Agents|purinergic agents|mesh-ancestor
19987904|NCT01992523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19987905|NCT01992523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987906|NCT01992523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987907|NCT01992874|Niacinamide|niacinamide|mesh-list
19987908|NCT01992874|Vitamin B Complex|vitamin b complex|mesh-ancestor
19987909|NCT01992874|Vitamins|vitamins|mesh-ancestor
19987910|NCT01992874|Micronutrients|micronutrients|mesh-ancestor
19987911|NCT01992874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987912|NCT01993017|Bupropion|bupropion|mesh-list
19987913|NCT01993017|Sertraline|sertraline|mesh-list
19987914|NCT01993017|Antidepressive Agents|antidepressive agents|mesh-list
19987915|NCT01993017|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19987916|NCT01993017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19987917|NCT01993017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19987918|NCT01993017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19987919|NCT01993017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19987920|NCT01993017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987921|NCT01993017|Dopamine Agents|dopamine agents|mesh-ancestor
19987922|NCT01993017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19987923|NCT01993017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987924|NCT01993017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19987925|NCT01993017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19987926|NCT01993017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987927|NCT01993017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19987928|NCT01993017|Serotonin Agents|serotonin agents|mesh-ancestor
19987929|NCT01993108|Naltrexone|naltrexone|mesh-list
19987930|NCT01993108|Methylphenidate|methylphenidate|mesh-list
19987931|NCT01993108|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19987932|NCT01993108|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19987933|NCT01993108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987934|NCT01993108|Sensory System Agents|sensory system agents|mesh-ancestor
19987935|NCT01993108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19987936|NCT01993108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19987937|NCT01993108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19987938|NCT01993108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19987939|NCT01993108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19987940|NCT01993108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987941|NCT01993108|Dopamine Agents|dopamine agents|mesh-ancestor
19987942|NCT01993108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19987943|NCT01993186|Glycerol|glycerol|mesh-list
19987944|NCT01993186|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19987945|NCT01993186|Protective Agents|protective agents|mesh-ancestor
19987946|NCT01993186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987947|NCT01993329|Mitomycin|mitomycin|mesh-list
19987948|NCT01993329|Cisplatin|cisplatin|mesh-list
19987949|NCT01993329|Ifosfamide|ifosfamide|mesh-list
19987950|NCT01993329|Mesna|mesna|mesh-list
19987951|NCT01993329|Protective Agents|protective agents|mesh-ancestor
19987952|NCT01993329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987953|NCT01993329|Alkylating Agents|alkylating agents|mesh-ancestor
19987954|NCT01993329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987955|NCT01993329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19987956|NCT01993329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19987957|NCT01993329|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19987958|NCT01993329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987959|NCT01993329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19987960|NCT01993667|Acetazolamide|acetazolamide|mesh-list
19987961|NCT01993667|Anticonvulsants|anticonvulsants|mesh-ancestor
19987962|NCT01993667|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19987963|NCT01993667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987964|NCT01993667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987965|NCT01993667|Diuretics|diuretics|mesh-ancestor
19987966|NCT01993667|Natriuretic Agents|natriuretic agents|mesh-ancestor
19987967|NCT01993667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987968|NCT01993823|Clotrimazole|clotrimazole|mesh-list
19987969|NCT01993823|Miconazole|miconazole|mesh-list
19987970|NCT01993823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19987971|NCT01993823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19987972|NCT01993823|Antifungal Agents|antifungal agents|mesh-ancestor
19987973|NCT01993823|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19987974|NCT01993823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19987975|NCT01993823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19987976|NCT01993823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19987977|NCT01993823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19987978|NCT01993823|Hormone Antagonists|hormone antagonists|mesh-ancestor
19987979|NCT01993823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19987980|NCT01993823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987981|NCT01993823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19987982|NCT01993823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19987983|NCT01993836|Anesthetics|anesthetics|mesh-list
19987984|NCT01993836|Propofol|propofol|mesh-list
19987985|NCT01993836|Isoflurane|isoflurane|mesh-list
19987986|NCT01993836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19987987|NCT01993836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19987988|NCT01993836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19987989|NCT01993836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19987990|NCT01993836|Anesthetics, General|anesthetics, general|mesh-ancestor
19987991|NCT01993836|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19987992|NCT01993849|Acetylcysteine|acetylcysteine|mesh-list
19987993|NCT01993849|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19987994|NCT01993849|Antiviral Agents|antiviral agents|mesh-ancestor
19987995|NCT01993849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19987996|NCT01993849|Expectorants|expectorants|mesh-ancestor
19987997|NCT01993849|Respiratory System Agents|respiratory system agents|mesh-ancestor
19987998|NCT01993849|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19987999|NCT01993849|Antioxidants|antioxidants|mesh-ancestor
19988000|NCT01993849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988001|NCT01993849|Protective Agents|protective agents|mesh-ancestor
19988002|NCT01993849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988003|NCT01993849|Antidotes|antidotes|mesh-ancestor
19988004|NCT01993875|Lubiprostone|lubiprostone|mesh-list
19988005|NCT01993875|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19988006|NCT01993875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19988007|NCT01993875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988008|NCT01993888|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19988009|NCT01993888|Hemostatics|hemostatics|mesh-ancestor
19988010|NCT01993888|Coagulants|coagulants|mesh-ancestor
19988011|NCT01993927|Voglibose|voglibose|mesh-list
19988012|NCT01993927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19988013|NCT01993927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988014|NCT01993927|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19988015|NCT01993927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988016|NCT01993927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988017|NCT01994109|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
19988018|NCT01994109|Botulinum Toxins|botulinum toxins|mesh-list
19988019|NCT01994109|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19988020|NCT01994109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19988021|NCT01994109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988022|NCT01994109|Cholinergic Agents|cholinergic agents|mesh-ancestor
19988023|NCT01994109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19988024|NCT01994109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988025|NCT01994109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19988026|NCT01994226|Naproxen|naproxen|mesh-list
19988027|NCT01994226|Colchicine|colchicine|mesh-list
19988028|NCT01994226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19988029|NCT01994226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19988030|NCT01994226|Analgesics|analgesics|mesh-ancestor
19988031|NCT01994226|Sensory System Agents|sensory system agents|mesh-ancestor
19988032|NCT01994226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988033|NCT01994226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988034|NCT01994226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19988035|NCT01994226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19988036|NCT01994226|Gout Suppressants|gout suppressants|mesh-ancestor
19988037|NCT01994226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19988038|NCT01994226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988039|NCT01994226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988040|NCT01994226|Tubulin Modulators|tubulin modulators|mesh-ancestor
19988041|NCT01994226|Antimitotic Agents|antimitotic agents|mesh-ancestor
19988042|NCT01994226|Mitosis Modulators|mitosis modulators|mesh-ancestor
19988043|NCT01994226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988044|NCT01994291|Ranibizumab|ranibizumab|mesh-list
19988045|NCT01994291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19988046|NCT01994291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19988047|NCT01994291|Growth Substances|growth substances|mesh-ancestor
19988048|NCT01994291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988049|NCT01994291|Growth Inhibitors|growth inhibitors|mesh-ancestor
19988050|NCT01994291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988051|NCT01994486|Sofosbuvir|sofosbuvir|mesh-list
19988052|NCT01994486|Antiviral Agents|antiviral agents|mesh-ancestor
19988053|NCT01994486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19988054|NCT01994538|Oxymetazoline|oxymetazoline|mesh-list
19988055|NCT01994538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19988056|NCT01994538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19988057|NCT01994538|Adrenergic Agents|adrenergic agents|mesh-ancestor
19988058|NCT01994538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19988059|NCT01994538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988060|NCT01994538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988061|NCT01994538|Sympathomimetics|sympathomimetics|mesh-ancestor
19988062|NCT01994538|Autonomic Agents|autonomic agents|mesh-ancestor
19988063|NCT01994538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988064|NCT01994538|Nasal Decongestants|nasal decongestants|mesh-ancestor
19988065|NCT01994538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19988066|NCT01994538|Respiratory System Agents|respiratory system agents|mesh-ancestor
19988067|NCT01994590|Prednisone|prednisone|mesh-list
19988068|NCT01994590|Abiraterone Acetate|abiraterone acetate|mesh-list
19988069|NCT01994590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19988070|NCT01994590|Glucocorticoids|glucocorticoids|mesh-ancestor
19988071|NCT01994590|Hormones|hormones|mesh-ancestor
19988072|NCT01994590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19988073|NCT01994590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988074|NCT01994590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19988075|NCT01994590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988076|NCT01994590|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19988077|NCT01994590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988078|NCT01994590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988079|NCT01994590|Hormone Antagonists|hormone antagonists|mesh-ancestor
19988080|NCT01994590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19988081|NCT01994720|Aspirin|aspirin|mesh-list
19988082|NCT01994720|Ticagrelor|ticagrelor|mesh-list
19988083|NCT01994720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19988084|NCT01994720|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19988085|NCT01994720|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19988086|NCT01994720|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19988087|NCT01994720|Purinergic Agents|purinergic agents|mesh-ancestor
19988088|NCT01994720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19988089|NCT01994720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988090|NCT01994720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988091|NCT01994720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19988092|NCT01994720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19988093|NCT01994720|Analgesics|analgesics|mesh-ancestor
19988094|NCT01994720|Sensory System Agents|sensory system agents|mesh-ancestor
19988095|NCT01994720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988096|NCT01994720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19988097|NCT01994720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19988098|NCT01994720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19988099|NCT01994720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19988100|NCT01994720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19988101|NCT01994720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988102|NCT01994720|Antipyretics|antipyretics|mesh-ancestor
19988103|NCT01994746|Glucagon|glucagon|mesh-list
19988104|NCT01994746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19988105|NCT01994746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19988106|NCT01994746|Hormones|hormones|mesh-ancestor
19988107|NCT01994746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19988108|NCT01994746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988109|NCT01994746|Incretins|incretins|mesh-ancestor
19988110|NCT01994837|Venetoclax|venetoclax|mesh-list
19988111|NCT01994837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988112|NCT01994850|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19988113|NCT01994850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19988114|NCT01994850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988115|NCT01994993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19988116|NCT01994993|Metronidazole|metronidazole|mesh-list
19988117|NCT01994993|Clindamycin|clindamycin|mesh-list
19988118|NCT01994993|Clindamycin palmitate|clindamycin palmitate|mesh-list
19988119|NCT01994993|Clindamycin phosphate|clindamycin phosphate|mesh-list
19988120|NCT01994993|Gentamicins|gentamicins|mesh-list
19988121|NCT01994993|Tazobactam|tazobactam|mesh-list
19988122|NCT01994993|Piperacillin|piperacillin|mesh-list
19988123|NCT01994993|Ampicillin|ampicillin|mesh-list
19988124|NCT01994993|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19988125|NCT01994993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19988126|NCT01994993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19988127|NCT01994993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19988128|NCT01994993|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19988129|NCT01994993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556338|NCT01946373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556339|NCT01946373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19459672|NCT03359499|Parasympatholytics|parasympatholytics|mesh-ancestor
19459673|NCT03359499|Autonomic Agents|autonomic agents|mesh-ancestor
19459674|NCT03359499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19459675|NCT03359499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459676|NCT03359291|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19459677|NCT03359291|Macitentan|macitentan|mesh-list
19459678|NCT03359291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19459679|NCT03359291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19459680|NCT03359291|Antimetabolites|antimetabolites|mesh-ancestor
19988130|NCT01994993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988131|NCT01994993|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19988132|NCT01995045|Triamcinolone|triamcinolone|mesh-list
19988133|NCT01995045|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19988134|NCT01995045|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19988135|NCT01995045|Bupivacaine|bupivacaine|mesh-list
19988136|NCT01995045|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19988137|NCT01995045|Anesthetics, Local|anesthetics, local|mesh-ancestor
19988138|NCT01995045|Anesthetics|anesthetics|mesh-ancestor
19988139|NCT01995045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19988140|NCT01995045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988141|NCT01995045|Sensory System Agents|sensory system agents|mesh-ancestor
19988142|NCT01995045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988143|NCT01995045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19988144|NCT01995045|Glucocorticoids|glucocorticoids|mesh-ancestor
19988145|NCT01995045|Hormones|hormones|mesh-ancestor
19988146|NCT01995045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19988147|NCT01995045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19988148|NCT01995045|Immunologic Factors|immunologic factors|mesh-ancestor
19988149|NCT01995045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988150|NCT01995045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988151|NCT01995071|Ribavirin|ribavirin|mesh-list
19988152|NCT01995071|Antimetabolites|antimetabolites|mesh-ancestor
19988153|NCT01995071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988154|NCT01995071|Antiviral Agents|antiviral agents|mesh-ancestor
19988155|NCT01995071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19988156|NCT01995136|Travoprost|travoprost|mesh-list
19988157|NCT01995136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19988158|NCT01995136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19988159|NCT01995136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19988160|NCT01995201|Methotrexate|methotrexate|mesh-list
19988161|NCT01995201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19988162|NCT01995201|Abortifacient Agents|abortifacient agents|mesh-ancestor
19988163|NCT01995201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19988164|NCT01995201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556340|NCT01946373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20556341|NCT01946373|Alkylating Agents|alkylating agents|mesh-ancestor
20556342|NCT01946373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556343|NCT01946373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556344|NCT01946373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20556345|NCT01946373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20556346|NCT01946373|Antimetabolites|antimetabolites|mesh-ancestor
20556347|NCT01946373|Antiviral Agents|antiviral agents|mesh-ancestor
20556348|NCT01946373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20556349|NCT01946373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20556350|NCT01946373|Analgesics|analgesics|mesh-ancestor
20556351|NCT01946373|Sensory System Agents|sensory system agents|mesh-ancestor
20556352|NCT01946373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556353|NCT01946386|Betamethasone|betamethasone|mesh-list
20556354|NCT01946386|Betamethasone Valerate|betamethasone valerate|mesh-list
20556355|NCT01946386|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20556356|NCT01946386|Betamethasone benzoate|betamethasone benzoate|mesh-list
20556357|NCT01946386|Clobetasol|clobetasol|mesh-list
20556358|NCT01946386|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20556359|NCT01946386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20556360|NCT01946386|Glucocorticoids|glucocorticoids|mesh-ancestor
20556361|NCT01946386|Hormones|hormones|mesh-ancestor
20556362|NCT01946386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20556363|NCT01946386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556364|NCT01946386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20556365|NCT01946386|Respiratory System Agents|respiratory system agents|mesh-ancestor
20556366|NCT01946399|Dexamethasone|dexamethasone|mesh-list
20556367|NCT01946399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20556368|NCT01946399|Antiemetics|antiemetics|mesh-ancestor
20556369|NCT01946399|Autonomic Agents|autonomic agents|mesh-ancestor
20556370|NCT01946399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556371|NCT01946399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556372|NCT01946399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20556373|NCT01946399|Glucocorticoids|glucocorticoids|mesh-ancestor
20556374|NCT01946399|Hormones|hormones|mesh-ancestor
20556375|NCT01946399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20556376|NCT01946399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20556377|NCT01946399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556378|NCT01946555|Fentanyl|fentanyl|mesh-list
19988165|NCT01995201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19988166|NCT01995201|Antimetabolites|antimetabolites|mesh-ancestor
19988167|NCT01995201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988168|NCT01995201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988169|NCT01995201|Dermatologic Agents|dermatologic agents|mesh-ancestor
19988170|NCT01995201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988171|NCT01995201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19988172|NCT01995201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19988173|NCT01995201|Immunologic Factors|immunologic factors|mesh-ancestor
19988174|NCT01995201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19988175|NCT01995201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19988176|NCT01995266|Asunaprevir|asunaprevir|mesh-list
19988177|NCT01995266|Protease Inhibitors|protease inhibitors|mesh-ancestor
19988178|NCT01995266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988179|NCT01995266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988180|NCT01995513|Prednisone|prednisone|mesh-list
19988181|NCT01995513|Prednisolone|prednisolone|mesh-list
19988182|NCT01995513|Abiraterone Acetate|abiraterone acetate|mesh-list
19988183|NCT01995513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19988184|NCT01995513|Glucocorticoids|glucocorticoids|mesh-ancestor
19988185|NCT01995513|Hormones|hormones|mesh-ancestor
19988186|NCT01995513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19988187|NCT01995513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988188|NCT01995513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19988189|NCT01995513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988190|NCT01995513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19988191|NCT01995513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988192|NCT01995513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988193|NCT01995513|Hormone Antagonists|hormone antagonists|mesh-ancestor
19988194|NCT01995513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19988195|NCT01995526|Insulin|insulin|mesh-list
19988196|NCT01995526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19988197|NCT01995526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988198|NCT01995825|Lamotrigine|lamotrigine|mesh-list
19988199|NCT01995825|Anticonvulsants|anticonvulsants|mesh-list
19988200|NCT01995825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19988201|NCT01995825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19988202|NCT01995825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988203|NCT01995825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19988204|NCT01995825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988205|NCT01995825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19988206|NCT01995825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19988207|NCT01995825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19988208|NCT01995825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19988209|NCT01995825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19988210|NCT01996332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19988211|NCT01996332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988212|NCT01996332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19988213|NCT01996332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988214|NCT01996332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289199|NCT04907279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289200|NCT04907279|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20289201|NCT04907279|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20289202|NCT04907279|Serotonin Agents|serotonin agents|mesh-ancestor
20289203|NCT04907279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20289204|NCT04907279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20289205|NCT04907279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20289206|NCT04907279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20556379|NCT01946555|Morphine|morphine|mesh-list
20556380|NCT01946555|Oxycodone|oxycodone|mesh-list
20556381|NCT01946555|Buprenorphine|buprenorphine|mesh-list
20556382|NCT01946555|Methadone|methadone|mesh-list
20556383|NCT01946555|Hydromorphone|hydromorphone|mesh-list
20556384|NCT01946555|Tapentadol|tapentadol|mesh-list
20556385|NCT01946555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20556386|NCT01946555|Narcotics|narcotics|mesh-ancestor
20556387|NCT01946555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20556388|NCT01946555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556389|NCT01946555|Analgesics|analgesics|mesh-ancestor
20556390|NCT01946555|Sensory System Agents|sensory system agents|mesh-ancestor
20556391|NCT01946555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556392|NCT01946555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20556393|NCT01946555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20556394|NCT01946555|Anesthetics, General|anesthetics, general|mesh-ancestor
20556395|NCT01946555|Anesthetics|anesthetics|mesh-ancestor
20556396|NCT01946555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20556397|NCT01946555|Antitussive Agents|antitussive agents|mesh-ancestor
20556398|NCT01946555|Respiratory System Agents|respiratory system agents|mesh-ancestor
20556399|NCT01946555|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20556400|NCT01946555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20556401|NCT01946555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20556402|NCT01946555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556403|NCT01946555|Adrenergic Agents|adrenergic agents|mesh-ancestor
20556404|NCT01946555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19988215|NCT01996657|Warfarin|warfarin|mesh-list
19988216|NCT01996657|Anticoagulants|anticoagulants|mesh-ancestor
19988217|NCT01996709|Hydrogen Peroxide|hydrogen peroxide|mesh-list
19988218|NCT01996709|Contact Lens Solutions|contact lens solutions|mesh-list
19988219|NCT01996709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19988220|NCT01996709|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19988221|NCT01996709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19988222|NCT01996709|Disinfectants|disinfectants|mesh-ancestor
19988223|NCT01996826|Bevacizumab|bevacizumab|mesh-list
19988224|NCT01996826|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19988225|NCT01996826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19988226|NCT01996826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988227|NCT01996826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19988228|NCT01996826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19988229|NCT01996826|Growth Substances|growth substances|mesh-ancestor
19988230|NCT01996826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988231|NCT01996826|Growth Inhibitors|growth inhibitors|mesh-ancestor
19988232|NCT01996826|Laxatives|laxatives|mesh-ancestor
19988233|NCT01996826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19988234|NCT01996839|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19988235|NCT01996839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19988236|NCT01996943|Ethanol|ethanol|mesh-list
19988237|NCT01996943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19988238|NCT01996943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19988239|NCT01996943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19988240|NCT01996943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988241|NCT01997229|Eculizumab|eculizumab|mesh-list
19988242|NCT01997229|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19988243|NCT01997229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19988244|NCT01997229|Immunologic Factors|immunologic factors|mesh-ancestor
19988245|NCT01997229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988246|NCT01997333|Capecitabine|capecitabine|mesh-list
19988247|NCT01997333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19988248|NCT01997333|Antimetabolites|antimetabolites|mesh-ancestor
19988249|NCT01997333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988250|NCT01997333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988251|NCT01997411|Glucagon|glucagon|mesh-list
19988252|NCT01997411|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19988253|NCT01997411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19988254|NCT01997411|Hormones|hormones|mesh-ancestor
19988255|NCT01997411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19988256|NCT01997411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988257|NCT01997411|Incretins|incretins|mesh-ancestor
19988258|NCT01997515|Ketamine|ketamine|mesh-list
19988259|NCT01997515|Analgesics|analgesics|mesh-ancestor
19988260|NCT01997515|Sensory System Agents|sensory system agents|mesh-ancestor
19988261|NCT01997515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988262|NCT01997515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988263|NCT01997515|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19988264|NCT01997515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19988265|NCT01997515|Anesthetics, General|anesthetics, general|mesh-ancestor
19988266|NCT01997515|Anesthetics|anesthetics|mesh-ancestor
19988267|NCT01997515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19988268|NCT01997515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19988269|NCT01997515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19988270|NCT01997515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19988271|NCT01997515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988272|NCT01997905|Protein S|protein s|mesh-list
19988273|NCT01997905|Anticoagulants|anticoagulants|mesh-ancestor
19988274|NCT01998399|Ticagrelor|ticagrelor|mesh-list
19988275|NCT01998399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19988276|NCT01998399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19988277|NCT01998399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19988278|NCT01998399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19988279|NCT01998399|Purinergic Agents|purinergic agents|mesh-ancestor
19988280|NCT01998399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19988281|NCT01998399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988282|NCT01998399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988283|NCT01998438|Tranexamic Acid|tranexamic acid|mesh-list
19988284|NCT01998438|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19988285|NCT01998438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19988286|NCT01998438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988287|NCT01998438|Hemostatics|hemostatics|mesh-ancestor
19988288|NCT01998438|Coagulants|coagulants|mesh-ancestor
19988289|NCT01998880|Rituximab|rituximab|mesh-list
19988290|NCT01998880|Obinutuzumab|obinutuzumab|mesh-list
19988291|NCT01998880|Chlorambucil|chlorambucil|mesh-list
19988292|NCT01998880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19988293|NCT01998880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988294|NCT01998880|Immunologic Factors|immunologic factors|mesh-ancestor
19988295|NCT01998880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988296|NCT01998880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19988297|NCT01998880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19988298|NCT01998880|Alkylating Agents|alkylating agents|mesh-ancestor
19988299|NCT01998880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988300|NCT01998893|Rituximab|rituximab|mesh-list
19988301|NCT01998893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19988302|NCT01998893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988303|NCT01998893|Immunologic Factors|immunologic factors|mesh-ancestor
19988304|NCT01998893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988305|NCT01998893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19988306|NCT01998906|Paclitaxel|paclitaxel|mesh-list
19988307|NCT01998906|Doxorubicin|doxorubicin|mesh-list
19988308|NCT01998906|Trastuzumab|trastuzumab|mesh-list
19988309|NCT01998906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19988310|NCT01998906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988311|NCT01998906|Tubulin Modulators|tubulin modulators|mesh-ancestor
19988312|NCT01998906|Antimitotic Agents|antimitotic agents|mesh-ancestor
19988313|NCT01998906|Mitosis Modulators|mitosis modulators|mesh-ancestor
19988314|NCT01998906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988315|NCT01998906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19988316|NCT01998906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19988317|NCT01998906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19988318|NCT01998906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988319|NCT01998906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19988320|NCT01998919|Gemcitabine|gemcitabine|mesh-list
19988321|NCT01998919|Carboplatin|carboplatin|mesh-list
19988322|NCT01998919|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19988323|NCT01998919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988324|NCT01998919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19988325|NCT01998919|Antimetabolites|antimetabolites|mesh-ancestor
19988326|NCT01998919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988327|NCT01998919|Antiviral Agents|antiviral agents|mesh-ancestor
19988328|NCT01998919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19988329|NCT01998919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988330|NCT01998919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19988331|NCT01998919|Immunologic Factors|immunologic factors|mesh-ancestor
19988332|NCT01998919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988333|NCT01998919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19988334|NCT01998958|Esketamine|esketamine|mesh-list
19988335|NCT01998958|Antidepressive Agents|antidepressive agents|mesh-ancestor
19988336|NCT01998958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19988337|NCT01999114|Moxifloxacin|moxifloxacin|mesh-list
19988338|NCT01999114|Naltrexone|naltrexone|mesh-list
19988339|NCT01999114|Buprenorphine|buprenorphine|mesh-list
19988340|NCT01999114|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
19988341|NCT01999114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19988342|NCT01999114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19988343|NCT01999114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19988344|NCT01999114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19988345|NCT01999114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988346|NCT01999114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988347|NCT01999114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988348|NCT01999114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19988349|NCT01999114|Contraceptive Agents|contraceptive agents|mesh-ancestor
19988350|NCT01999114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19988351|NCT01999114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988352|NCT01999114|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19988353|NCT01999114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19988354|NCT01999114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19988355|NCT01999114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19988356|NCT01999114|Narcotics|narcotics|mesh-ancestor
19988357|NCT01999114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19988358|NCT01999114|Analgesics|analgesics|mesh-ancestor
19988359|NCT01999114|Sensory System Agents|sensory system agents|mesh-ancestor
19988360|NCT01999114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988361|NCT01999114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19988362|NCT01999114|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19988363|NCT01999218|Metformin|metformin|mesh-list
19988364|NCT01999218|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19988365|NCT01999218|Glimepiride|glimepiride|mesh-list
19988366|NCT01999218|Ertugliflozin|ertugliflozin|mesh-list
19988367|NCT01999218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19988368|NCT01999218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988369|NCT01999218|Incretins|incretins|mesh-ancestor
19988370|NCT01999218|Hormones|hormones|mesh-ancestor
19988371|NCT01999218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19988372|NCT01999218|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19988373|NCT01999218|Protease Inhibitors|protease inhibitors|mesh-ancestor
19988374|NCT01999218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988375|NCT01999218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988376|NCT01999218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19988377|NCT01999218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19988378|NCT01999218|Immunologic Factors|immunologic factors|mesh-ancestor
19988379|NCT01999218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19988380|NCT01999322|Insulin|insulin|mesh-list
19988381|NCT01999322|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19988382|NCT01999322|Insulin Aspart|insulin aspart|mesh-list
19988383|NCT01999322|Insulin, Long-Acting|insulin, long-acting|mesh-list
19988384|NCT01999322|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
19988385|NCT01999322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19988386|NCT01999322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988387|NCT01999335|Dexamethasone|dexamethasone|mesh-list
19988388|NCT01999335|Pomalidomide|pomalidomide|mesh-list
19988389|NCT01999335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19988390|NCT01999335|Antiemetics|antiemetics|mesh-ancestor
19988391|NCT01999335|Autonomic Agents|autonomic agents|mesh-ancestor
19988392|NCT01999335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988393|NCT01999335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988394|NCT01999335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19988395|NCT01999335|Glucocorticoids|glucocorticoids|mesh-ancestor
19988396|NCT01999335|Hormones|hormones|mesh-ancestor
19988397|NCT01999335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19988398|NCT01999335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19988399|NCT01999335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988400|NCT01999335|Immunologic Factors|immunologic factors|mesh-ancestor
19988401|NCT01999335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19988402|NCT01999335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19988403|NCT01999335|Growth Substances|growth substances|mesh-ancestor
19988404|NCT01999335|Growth Inhibitors|growth inhibitors|mesh-ancestor
19988405|NCT01999348|Timolol|timolol|mesh-list
19988406|NCT01999348|Bimatoprost|bimatoprost|mesh-list
19988407|NCT01999348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19988408|NCT01999348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19988409|NCT01999348|Adrenergic Agents|adrenergic agents|mesh-ancestor
19988410|NCT01999348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19988411|NCT01999348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988412|NCT01999348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988413|NCT01999348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19988414|NCT01999348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19988415|NCT01999400|Mesalamine|mesalamine|mesh-list
19988416|NCT01999400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19988417|NCT01999400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19988418|NCT01999400|Analgesics|analgesics|mesh-ancestor
19988419|NCT01999400|Sensory System Agents|sensory system agents|mesh-ancestor
19988420|NCT01999400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988421|NCT01999400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988422|NCT01999400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19988423|NCT01999400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19988424|NCT01999517|Nitroglycerin|nitroglycerin|mesh-list
19988425|NCT01999517|Vasodilator Agents|vasodilator agents|mesh-ancestor
19988426|NCT01999530|Prazosin|prazosin|mesh-list
19988427|NCT01999530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19988428|NCT01999530|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19988429|NCT01999530|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19988430|NCT01999530|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19988431|NCT01999530|Adrenergic Agents|adrenergic agents|mesh-ancestor
19988432|NCT01999530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19988433|NCT01999530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988434|NCT01999530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988435|NCT01999868|Abatacept|abatacept|mesh-list
19988436|NCT01999868|Ustekinumab|ustekinumab|mesh-list
19988437|NCT01999868|Immunoglobulins|immunoglobulins|mesh-list
19988438|NCT01999868|Immunologic Factors|immunologic factors|mesh-ancestor
19988439|NCT01999868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988440|NCT01999868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19988441|NCT01999868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988442|NCT01999868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988443|NCT01999868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19988444|NCT01999868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19988445|NCT01999868|Dermatologic Agents|dermatologic agents|mesh-ancestor
19988446|NCT01999894|Memantine|memantine|mesh-list
19988447|NCT01999894|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20556405|NCT01946568|Dalbavancin|dalbavancin|mesh-list
20556406|NCT01946568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19988448|NCT01999894|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19988449|NCT01999894|Dopamine Agents|dopamine agents|mesh-ancestor
19988450|NCT01999894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19988451|NCT01999894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988452|NCT01999894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988453|NCT01999894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19988454|NCT01999894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19988455|NCT01999920|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
19988456|NCT01999920|Antidepressive Agents|antidepressive agents|mesh-ancestor
19988457|NCT01999920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19988458|NCT01999920|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19988459|NCT01999920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19988460|NCT01999920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19988461|NCT01999920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988462|NCT01999920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19988463|NCT01999920|Serotonin Agents|serotonin agents|mesh-ancestor
19988464|NCT01999920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988465|NCT01999920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19988466|NCT01999920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19988467|NCT01999946|Naltrexone|naltrexone|mesh-list
19988468|NCT01999946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19988469|NCT01999946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19988470|NCT01999946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988471|NCT01999946|Sensory System Agents|sensory system agents|mesh-ancestor
19988472|NCT01999946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988473|NCT01999972|Axitinib|axitinib|mesh-list
20556407|NCT01946568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20556408|NCT01946594|Acetaminophen|acetaminophen|mesh-list
20556409|NCT01946594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20556410|NCT01946594|Analgesics|analgesics|mesh-ancestor
20556411|NCT01946594|Sensory System Agents|sensory system agents|mesh-ancestor
20556412|NCT01946594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556413|NCT01946594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556414|NCT01946594|Antipyretics|antipyretics|mesh-ancestor
20556415|NCT01946607|Citalopram|citalopram|mesh-list
20556416|NCT01946607|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20556417|NCT01946607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20556418|NCT01946607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19459681|NCT03359291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459682|NCT03359291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19459683|NCT03359291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19459684|NCT03359291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459685|NCT03359291|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19459686|NCT03359291|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19459687|NCT03359291|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19459688|NCT03359161|Furosemide|furosemide|mesh-list
19459689|NCT03359161|Diuretics|diuretics|mesh-ancestor
19459690|NCT03359161|Natriuretic Agents|natriuretic agents|mesh-ancestor
19988474|NCT01999972|Crizotinib|crizotinib|mesh-list
19988475|NCT01999972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988476|NCT01999972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19988477|NCT01999972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988478|NCT01999972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988479|NCT01999985|Dasatinib|dasatinib|mesh-list
19988480|NCT01999985|Afatinib|afatinib|mesh-list
19988481|NCT01999985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988482|NCT01999985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19988483|NCT01999985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988484|NCT01999985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988485|NCT02000531|Gemcitabine|gemcitabine|mesh-list
19988486|NCT02000531|Cisplatin|cisplatin|mesh-list
19988487|NCT02000531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19988488|NCT02000531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988489|NCT02000531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19988490|NCT02000531|Antimetabolites|antimetabolites|mesh-ancestor
19988491|NCT02000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988492|NCT02000531|Antiviral Agents|antiviral agents|mesh-ancestor
19988493|NCT02000531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19988494|NCT02000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988495|NCT02000531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19988496|NCT02000531|Immunologic Factors|immunologic factors|mesh-ancestor
19988497|NCT02000531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988498|NCT02000531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19988499|NCT02000921|Nicotine|nicotine|mesh-list
19988500|NCT02000921|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19988501|NCT02000921|Autonomic Agents|autonomic agents|mesh-ancestor
19988502|NCT02000921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988503|NCT02000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988504|NCT02000921|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19988505|NCT02000921|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19988506|NCT02000921|Cholinergic Agents|cholinergic agents|mesh-ancestor
19988507|NCT02000921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19988508|NCT02000921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988509|NCT02000973|Lidocaine|lidocaine|mesh-list
19988510|NCT02000973|Bupivacaine|bupivacaine|mesh-list
19988511|NCT02000973|Ropivacaine|ropivacaine|mesh-list
19988512|NCT02000973|Anesthetics, Local|anesthetics, local|mesh-ancestor
19988513|NCT02000973|Anesthetics|anesthetics|mesh-ancestor
19988514|NCT02000973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19988515|NCT02000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988516|NCT02000973|Sensory System Agents|sensory system agents|mesh-ancestor
19988517|NCT02000973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988518|NCT02000973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19988519|NCT02000973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19988520|NCT02000973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19988521|NCT02000973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19988522|NCT02000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988523|NCT02001181|Tofacitinib|tofacitinib|mesh-list
19988524|NCT02001181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19988525|NCT02001181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988526|NCT02001181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988527|NCT02001987|Methotrexate|methotrexate|mesh-list
19988528|NCT02001987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19988529|NCT02001987|Abortifacient Agents|abortifacient agents|mesh-ancestor
19988530|NCT02001987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19988531|NCT02001987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988532|NCT02001987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19988533|NCT02001987|Antimetabolites|antimetabolites|mesh-ancestor
19988534|NCT02001987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988535|NCT02001987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988536|NCT02001987|Dermatologic Agents|dermatologic agents|mesh-ancestor
19988537|NCT02001987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988538|NCT02001987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19988539|NCT02001987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19988540|NCT02001987|Immunologic Factors|immunologic factors|mesh-ancestor
19988541|NCT02001987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19988542|NCT02001987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19988543|NCT02002221|Metformin|metformin|mesh-list
19988544|NCT02002221|Vildagliptin|vildagliptin|mesh-list
19988545|NCT02002221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19988546|NCT02002221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988547|NCT02002221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19988548|NCT02002221|Protease Inhibitors|protease inhibitors|mesh-ancestor
19988549|NCT02002221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988550|NCT02002221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988551|NCT02002650|Indomethacin|indomethacin|mesh-list
19988552|NCT02002650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19988553|NCT02002650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19988554|NCT02002650|Analgesics|analgesics|mesh-ancestor
19988555|NCT02002650|Sensory System Agents|sensory system agents|mesh-ancestor
19988556|NCT02002650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988557|NCT02002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988558|NCT02002650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19988559|NCT02002650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19988560|NCT02002650|Gout Suppressants|gout suppressants|mesh-ancestor
19988561|NCT02002650|Tocolytic Agents|tocolytic agents|mesh-ancestor
19988562|NCT02002650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19988563|NCT02002650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19988564|NCT02002650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988565|NCT02002650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988566|NCT02002767|Velpatasvir|velpatasvir|mesh-list
19988567|NCT02002767|Antiviral Agents|antiviral agents|mesh-ancestor
19988568|NCT02002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19988569|NCT02002832|Risperidone|risperidone|mesh-list
19988570|NCT02002832|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19988571|NCT02002832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19988572|NCT02002832|Serotonin Agents|serotonin agents|mesh-ancestor
19988573|NCT02002832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19988574|NCT02002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988575|NCT02002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988576|NCT02002832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19988577|NCT02002832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19988578|NCT02002832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19988579|NCT02002832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19988580|NCT02002832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19988581|NCT02002832|Dopamine Agents|dopamine agents|mesh-ancestor
19988582|NCT02002832|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19988583|NCT02002832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19988584|NCT02002832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19988585|NCT02002832|Adrenergic Agents|adrenergic agents|mesh-ancestor
19988586|NCT02002832|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19988587|NCT02002832|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19988588|NCT02002884|Botulinum Toxins|botulinum toxins|mesh-list
19988589|NCT02002884|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19988590|NCT02002884|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19988591|NCT02002884|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19988592|NCT02002884|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19988593|NCT02002884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19988594|NCT02002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988595|NCT02002884|Cholinergic Agents|cholinergic agents|mesh-ancestor
19988596|NCT02002884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19988597|NCT02002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988598|NCT02002884|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19988599|NCT02002884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988600|NCT02002975|Pioglitazone|pioglitazone|mesh-list
19988601|NCT02002975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19988602|NCT02002975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988603|NCT02003014|Pioglitazone|pioglitazone|mesh-list
19988604|NCT02003014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19988605|NCT02003014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988606|NCT02003365|Triamcinolone|triamcinolone|mesh-list
19988607|NCT02003365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19988608|NCT02003365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19988609|NCT02003365|FX006|fx006|mesh-list
19988610|NCT02003365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19988611|NCT02003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19988612|NCT02003365|Glucocorticoids|glucocorticoids|mesh-ancestor
19988613|NCT02003365|Hormones|hormones|mesh-ancestor
19988614|NCT02003365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19988615|NCT02003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988616|NCT02003365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19988617|NCT02003365|Immunologic Factors|immunologic factors|mesh-ancestor
19988618|NCT02003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988619|NCT02003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988620|NCT02003391|Timolol|timolol|mesh-list
19988621|NCT02003391|Travoprost|travoprost|mesh-list
19988622|NCT02003391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19988623|NCT02003391|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
19988624|NCT02003391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19988625|NCT02003391|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19988626|NCT02003391|Adrenergic Agents|adrenergic agents|mesh-ancestor
19988627|NCT02003391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19988628|NCT02003391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988629|NCT02003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988630|NCT02003391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19988631|NCT02003391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19988632|NCT02003534|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19988633|NCT02003534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19988634|NCT02003534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19988635|NCT02003534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19988636|NCT02003534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19988637|NCT02003534|Adrenergic Agents|adrenergic agents|mesh-ancestor
19988638|NCT02003534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19988639|NCT02003534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988640|NCT02003534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988641|NCT02003573|Decitabine|decitabine|mesh-list
19988642|NCT02003573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19988643|NCT02003573|Antimetabolites|antimetabolites|mesh-ancestor
19988644|NCT02003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988645|NCT02003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988646|NCT02003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988647|NCT02003625|Meloxicam|meloxicam|mesh-list
19988648|NCT02003625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19988649|NCT02003625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19988650|NCT02003625|Analgesics|analgesics|mesh-ancestor
19988651|NCT02003625|Sensory System Agents|sensory system agents|mesh-ancestor
19988652|NCT02003625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988653|NCT02003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988654|NCT02003625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19988655|NCT02003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19988656|NCT02003625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19988657|NCT02003625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19988658|NCT02003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988659|NCT02003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289207|NCT04898894|Vidarabine|vidarabine|mesh-list
20289208|NCT04898894|Cytarabine|cytarabine|mesh-list
19459691|NCT03359161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459692|NCT03359161|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19459693|NCT03359161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19459694|NCT03359161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459695|NCT03359070|Miconazole|miconazole|mesh-list
19459696|NCT03359070|Clotrimazole|clotrimazole|mesh-list
19459697|NCT03359070|Antifungal Agents|antifungal agents|mesh-ancestor
19459698|NCT03359070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19459699|NCT03359070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19459700|NCT03359070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19459701|NCT03359070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459702|NCT03359070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459703|NCT03359070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19459704|NCT03359070|Hormone Antagonists|hormone antagonists|mesh-ancestor
19459705|NCT03359070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19459706|NCT03359070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459707|NCT03359070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19988660|NCT02003638|Niacin|niacin|mesh-list
19988661|NCT02003638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19988662|NCT02003638|Antimetabolites|antimetabolites|mesh-ancestor
19988663|NCT02003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988664|NCT02003638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19988665|NCT02003638|Vasodilator Agents|vasodilator agents|mesh-ancestor
19988666|NCT02003638|Vitamin B Complex|vitamin b complex|mesh-ancestor
19988667|NCT02003638|Vitamins|vitamins|mesh-ancestor
19988668|NCT02003638|Micronutrients|micronutrients|mesh-ancestor
19988669|NCT02003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988670|NCT02003898|Insulin|insulin|mesh-list
19988671|NCT02003898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19988672|NCT02003898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988673|NCT02003911|Azithromycin|azithromycin|mesh-list
19988674|NCT02003911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19988675|NCT02003911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19988676|NCT02004093|Gemcitabine|gemcitabine|mesh-list
19988677|NCT02004093|Paclitaxel|paclitaxel|mesh-list
19988678|NCT02004093|Carboplatin|carboplatin|mesh-list
19988679|NCT02004093|Pertuzumab|pertuzumab|mesh-list
19988680|NCT02004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19988681|NCT02004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988682|NCT02004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
19988683|NCT02004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
19988684|NCT02004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
19988685|NCT02004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988686|NCT02004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19988687|NCT02004093|Antimetabolites|antimetabolites|mesh-ancestor
19988688|NCT02004093|Antiviral Agents|antiviral agents|mesh-ancestor
19988689|NCT02004093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19988690|NCT02004093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988691|NCT02004093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19988692|NCT02004093|Immunologic Factors|immunologic factors|mesh-ancestor
19988693|NCT02004093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988694|NCT02004093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19988695|NCT02004132|Testosterone|testosterone|mesh-list
19988696|NCT02004132|Androgens|androgens|mesh-ancestor
19988697|NCT02004132|Hormones|hormones|mesh-ancestor
19988698|NCT02004132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19988699|NCT02004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988700|NCT02004262|Cyclophosphamide|cyclophosphamide|mesh-list
19988701|NCT02004262|Pancrelipase|pancrelipase|mesh-list
19988702|NCT02004262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19988703|NCT02004262|Immunologic Factors|immunologic factors|mesh-ancestor
19988704|NCT02004262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988705|NCT02004262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19988706|NCT02004262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19988707|NCT02004262|Alkylating Agents|alkylating agents|mesh-ancestor
19988708|NCT02004262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988709|NCT02004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988710|NCT02004262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19988711|NCT02004262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19988712|NCT02004366|Insulin Glargine|insulin glargine|mesh-list
19988713|NCT02004366|Linagliptin|linagliptin|mesh-list
19988714|NCT02004366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19988715|NCT02004366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988716|NCT02004366|Incretins|incretins|mesh-ancestor
19988717|NCT02004366|Hormones|hormones|mesh-ancestor
19988718|NCT02004366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19988719|NCT02004366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19988720|NCT02004366|Protease Inhibitors|protease inhibitors|mesh-ancestor
19988721|NCT02004366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988722|NCT02004366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988723|NCT02004613|Dexmedetomidine|dexmedetomidine|mesh-list
19988724|NCT02004613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19988725|NCT02004613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19988726|NCT02004613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988727|NCT02004613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19988728|NCT02004613|Analgesics|analgesics|mesh-ancestor
19988729|NCT02004613|Sensory System Agents|sensory system agents|mesh-ancestor
19988730|NCT02004613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988731|NCT02004613|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19988732|NCT02004613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19988733|NCT02004613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19988734|NCT02004613|Adrenergic Agents|adrenergic agents|mesh-ancestor
19988735|NCT02004613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19988736|NCT02004613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988737|NCT02004886|Metformin|metformin|mesh-list
19988738|NCT02004886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19988739|NCT02004886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988740|NCT02004990|Povidone-Iodine|povidone-iodine|mesh-list
19988741|NCT02004990|Povidone|povidone|mesh-list
19988742|NCT02004990|Plasma Substitutes|plasma substitutes|mesh-ancestor
19988743|NCT02004990|Blood Substitutes|blood substitutes|mesh-ancestor
19988744|NCT02004990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19988745|NCT02004990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19988746|NCT02005029|Erythromycin|erythromycin|mesh-list
19988747|NCT02005029|Erythromycin Estolate|erythromycin estolate|mesh-list
19988748|NCT02005029|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
19988749|NCT02005029|Erythromycin stearate|erythromycin stearate|mesh-list
19988750|NCT02005029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19988751|NCT02005029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19988752|NCT02005029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19988753|NCT02005029|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19988754|NCT02005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988755|NCT02005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988756|NCT02005354|Nitrous Oxide|nitrous oxide|mesh-list
19988757|NCT02005354|Anesthetics|anesthetics|mesh-list
19988758|NCT02005354|Anesthetics, Local|anesthetics, local|mesh-list
19988759|NCT02005354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19988760|NCT02005354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988761|NCT02005354|Sensory System Agents|sensory system agents|mesh-ancestor
19988762|NCT02005354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988763|NCT02005354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19988764|NCT02005354|Anesthetics, General|anesthetics, general|mesh-ancestor
19988765|NCT02005354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19988766|NCT02005354|Analgesics|analgesics|mesh-ancestor
19988767|NCT02005484|Trastuzumab|trastuzumab|mesh-list
19988768|NCT02005484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19988769|NCT02005484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988770|NCT02005549|Bevacizumab|bevacizumab|mesh-list
19988771|NCT02005549|Docetaxel|docetaxel|mesh-list
19988772|NCT02005549|Capecitabine|capecitabine|mesh-list
19988773|NCT02005549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19988774|NCT02005549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988775|NCT02005549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19988776|NCT02005549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19988777|NCT02005549|Growth Substances|growth substances|mesh-ancestor
19988778|NCT02005549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988779|NCT02005549|Growth Inhibitors|growth inhibitors|mesh-ancestor
19988780|NCT02005549|Tubulin Modulators|tubulin modulators|mesh-ancestor
19988781|NCT02005549|Antimitotic Agents|antimitotic agents|mesh-ancestor
19988782|NCT02005549|Mitosis Modulators|mitosis modulators|mesh-ancestor
19988783|NCT02005549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988784|NCT02005549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19988785|NCT02005549|Antimetabolites|antimetabolites|mesh-ancestor
19988786|NCT02005562|Cyclosporine|cyclosporine|mesh-list
19988787|NCT02005562|Mycophenolic Acid|mycophenolic acid|mesh-list
19988788|NCT02005562|Methylprednisolone|methylprednisolone|mesh-list
19988789|NCT02005562|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19988790|NCT02005562|Cyclosporins|cyclosporins|mesh-list
19988791|NCT02005562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988792|NCT02005562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988793|NCT02005562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19988794|NCT02005562|Immunologic Factors|immunologic factors|mesh-ancestor
19988795|NCT02005562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988796|NCT02005562|Antifungal Agents|antifungal agents|mesh-ancestor
19988797|NCT02005562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19988798|NCT02005562|Dermatologic Agents|dermatologic agents|mesh-ancestor
19988799|NCT02005562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19988800|NCT02005562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19988801|NCT02005562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19988802|NCT02005562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988803|NCT02005562|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19988804|NCT02005562|Antitubercular Agents|antitubercular agents|mesh-ancestor
19988805|NCT02005562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19988806|NCT02005562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19988807|NCT02005562|Antiemetics|antiemetics|mesh-ancestor
19988808|NCT02005562|Autonomic Agents|autonomic agents|mesh-ancestor
19988809|NCT02005562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988810|NCT02005562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19988811|NCT02005562|Glucocorticoids|glucocorticoids|mesh-ancestor
19988812|NCT02005562|Hormones|hormones|mesh-ancestor
19988813|NCT02005562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19988814|NCT02005562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19988815|NCT02005562|Protective Agents|protective agents|mesh-ancestor
19988816|NCT02005562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19988817|NCT02005601|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19988818|NCT02005601|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19988819|NCT02005601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19988820|NCT02005601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19988821|NCT02005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988822|NCT02005601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20289209|NCT04898894|Hydrocortisone|hydrocortisone|mesh-list
19988823|NCT02005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988824|NCT02005601|Analgesics|analgesics|mesh-ancestor
19988825|NCT02005601|Sensory System Agents|sensory system agents|mesh-ancestor
19988826|NCT02005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988827|NCT02005601|Antidepressive Agents|antidepressive agents|mesh-ancestor
19988828|NCT02005601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19988829|NCT02005601|Dopamine Agents|dopamine agents|mesh-ancestor
19988830|NCT02005627|Immunologic Factors|immunologic factors|mesh-list
19988831|NCT02005627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988832|NCT02005666|Clindamycin|clindamycin|mesh-list
19988833|NCT02005666|Clindamycin palmitate|clindamycin palmitate|mesh-list
19988834|NCT02005666|Clindamycin phosphate|clindamycin phosphate|mesh-list
19988835|NCT02005666|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19988836|NCT02005666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19988837|NCT02005666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19988838|NCT02005666|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19988839|NCT02005666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988840|NCT02005666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988841|NCT02005666|Dermatologic Agents|dermatologic agents|mesh-ancestor
19988842|NCT02005887|Letrozole|letrozole|mesh-list
19988843|NCT02005887|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19988844|NCT02005887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988845|NCT02005887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19988846|NCT02005887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19988847|NCT02005887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988848|NCT02005887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988849|NCT02005887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19988850|NCT02005887|Hormone Antagonists|hormone antagonists|mesh-ancestor
19988851|NCT02005887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19988852|NCT02005887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988853|NCT02005887|Luteolytic Agents|luteolytic agents|mesh-ancestor
19988854|NCT02005887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19988855|NCT02005887|Contraceptive Agents|contraceptive agents|mesh-ancestor
19988856|NCT02005887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19988857|NCT02005887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19988858|NCT02005887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19988859|NCT02006056|Ondansetron|ondansetron|mesh-list
19988860|NCT02006056|Antiemetics|antiemetics|mesh-ancestor
19988861|NCT02006056|Autonomic Agents|autonomic agents|mesh-ancestor
19988862|NCT02006056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988863|NCT02006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988864|NCT02006056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19988865|NCT02006056|Antipruritics|antipruritics|mesh-ancestor
19988866|NCT02006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
19988867|NCT02006056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19988868|NCT02006056|Serotonin Agents|serotonin agents|mesh-ancestor
19988869|NCT02006056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19988870|NCT02006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988871|NCT02006056|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19988872|NCT02006056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19988873|NCT02006056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19988874|NCT02006056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19988875|NCT02006056|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19988876|NCT02006108|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19988877|NCT02006108|Hematinics|hematinics|mesh-ancestor
19988878|NCT02006108|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19988879|NCT02006108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19988880|NCT02006121|Apomorphine|apomorphine|mesh-list
19988881|NCT02006121|Emetics|emetics|mesh-ancestor
19988882|NCT02006121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988883|NCT02006121|Autonomic Agents|autonomic agents|mesh-ancestor
19988884|NCT02006121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988885|NCT02006121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19988886|NCT02006121|Dopamine Agonists|dopamine agonists|mesh-ancestor
19988887|NCT02006121|Dopamine Agents|dopamine agents|mesh-ancestor
19988888|NCT02006121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19988889|NCT02006121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988890|NCT02006160|4-Aminopyridine|4-aminopyridine|mesh-list
19988891|NCT02006160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19988892|NCT02006160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19988893|NCT02006160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988894|NCT02006342|Insulin|insulin|mesh-list
19988895|NCT02006342|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19988896|NCT02006342|Insulin Glargine|insulin glargine|mesh-list
19988897|NCT02006342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19988898|NCT02006342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988899|NCT02006576|Ibuprofen|ibuprofen|mesh-list
19988900|NCT02006576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19988901|NCT02006576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19988902|NCT02006576|Analgesics|analgesics|mesh-ancestor
19988903|NCT02006576|Sensory System Agents|sensory system agents|mesh-ancestor
19988904|NCT02006576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988905|NCT02006576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988906|NCT02006576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19988907|NCT02006576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19988908|NCT02006576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19988909|NCT02006576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988910|NCT02006576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988911|NCT02006628|Cannabidiol|cannabidiol|mesh-list
19988912|NCT02006628|Anticonvulsants|anticonvulsants|mesh-ancestor
19988913|NCT02006667|Gemcitabine|gemcitabine|mesh-list
19988914|NCT02006667|Trastuzumab|trastuzumab|mesh-list
19988915|NCT02006667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988916|NCT02006667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19988917|NCT02006667|Antimetabolites|antimetabolites|mesh-ancestor
19988918|NCT02006667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988919|NCT02006667|Antiviral Agents|antiviral agents|mesh-ancestor
19988920|NCT02006667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19988921|NCT02006667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988922|NCT02006667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19988923|NCT02006667|Immunologic Factors|immunologic factors|mesh-ancestor
19988924|NCT02006667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988925|NCT02006667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19988926|NCT02006706|Methylprednisolone|methylprednisolone|mesh-list
19988927|NCT02006706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19988928|NCT02006706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19988929|NCT02006706|Prednisolone|prednisolone|mesh-list
19988930|NCT02006706|Prednisolone acetate|prednisolone acetate|mesh-list
19988931|NCT02006706|Rituximab|rituximab|mesh-list
19988932|NCT02006706|Methotrexate|methotrexate|mesh-list
19988933|NCT02006706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19988934|NCT02006706|Prednisolone phosphate|prednisolone phosphate|mesh-list
19988935|NCT02006706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19988936|NCT02006706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988937|NCT02006706|Immunologic Factors|immunologic factors|mesh-ancestor
19988938|NCT02006706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988939|NCT02006706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19988940|NCT02006706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19988941|NCT02006706|Abortifacient Agents|abortifacient agents|mesh-ancestor
19988942|NCT02006706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19988943|NCT02006706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19988944|NCT02006706|Antimetabolites|antimetabolites|mesh-ancestor
19988945|NCT02006706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988946|NCT02006706|Dermatologic Agents|dermatologic agents|mesh-ancestor
19988947|NCT02006706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19988948|NCT02006706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19988949|NCT02006706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19988950|NCT02006706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19988951|NCT02006706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19988952|NCT02006706|Antiemetics|antiemetics|mesh-ancestor
19988953|NCT02006706|Autonomic Agents|autonomic agents|mesh-ancestor
19988954|NCT02006706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988955|NCT02006706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19988956|NCT02006706|Glucocorticoids|glucocorticoids|mesh-ancestor
19988957|NCT02006706|Hormones|hormones|mesh-ancestor
19988958|NCT02006706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19988959|NCT02006706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19988960|NCT02006706|Protective Agents|protective agents|mesh-ancestor
19988961|NCT02006706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19988962|NCT02006732|Tiotropium Bromide|tiotropium bromide|mesh-list
19988963|NCT02006732|Olodaterol|olodaterol|mesh-list
19988964|NCT02006732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19988965|NCT02006732|Autonomic Agents|autonomic agents|mesh-ancestor
19988966|NCT02006732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988967|NCT02006732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988968|NCT02006732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19988969|NCT02006732|Respiratory System Agents|respiratory system agents|mesh-ancestor
19988970|NCT02006732|Parasympatholytics|parasympatholytics|mesh-ancestor
19988971|NCT02006732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19988972|NCT02006732|Cholinergic Agents|cholinergic agents|mesh-ancestor
19988973|NCT02006732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19988974|NCT02006732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19988975|NCT02006836|Insulin|insulin|mesh-list
19988976|NCT02006836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19988977|NCT02006836|Metformin|metformin|mesh-list
19988978|NCT02006836|Insulin Aspart|insulin aspart|mesh-list
19988979|NCT02006836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19988980|NCT02006836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988981|NCT02007070|Pembrolizumab|pembrolizumab|mesh-list
19988982|NCT02007070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19988983|NCT02007070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19988984|NCT02007096|Bupivacaine|bupivacaine|mesh-list
19988985|NCT02007096|Anesthetics, Local|anesthetics, local|mesh-ancestor
19988986|NCT02007096|Anesthetics|anesthetics|mesh-ancestor
19988987|NCT02007096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19988988|NCT02007096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988989|NCT02007096|Sensory System Agents|sensory system agents|mesh-ancestor
19988990|NCT02007096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19988991|NCT02007278|Metformin|metformin|mesh-list
19988992|NCT02007278|Glimepiride|glimepiride|mesh-list
19988993|NCT02007278|Vildagliptin|vildagliptin|mesh-list
19988994|NCT02007278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19988995|NCT02007278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19988996|NCT02007278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19988997|NCT02007278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19988998|NCT02007278|Immunologic Factors|immunologic factors|mesh-ancestor
19988999|NCT02007278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19989000|NCT02007278|Protease Inhibitors|protease inhibitors|mesh-ancestor
19989001|NCT02007278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989002|NCT02007278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989003|NCT02007434|Loratadine|loratadine|mesh-list
19989004|NCT02007434|Ibuprofen|ibuprofen|mesh-list
19989005|NCT02007434|Lidocaine|lidocaine|mesh-list
19989006|NCT02007434|Epinephrine|epinephrine|mesh-list
19989007|NCT02007434|Deoxycholic Acid|deoxycholic acid|mesh-list
19989008|NCT02007434|Anesthetics, Local|anesthetics, local|mesh-ancestor
19989009|NCT02007434|Anesthetics|anesthetics|mesh-ancestor
19989010|NCT02007434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19989011|NCT02007434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989012|NCT02007434|Sensory System Agents|sensory system agents|mesh-ancestor
19989013|NCT02007434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19989014|NCT02007434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19989015|NCT02007434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19989016|NCT02007434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19989017|NCT02007434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19989018|NCT02007434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989019|NCT02007434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19989020|NCT02007434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19989021|NCT02007434|Analgesics|analgesics|mesh-ancestor
19989022|NCT02007434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19989023|NCT02007434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19989024|NCT02007434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19989025|NCT02007434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989026|NCT02007434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19989027|NCT02007434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19989028|NCT02007434|Adrenergic Agents|adrenergic agents|mesh-ancestor
19989029|NCT02007434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19989030|NCT02007434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19989031|NCT02007434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19989032|NCT02007434|Autonomic Agents|autonomic agents|mesh-ancestor
19989033|NCT02007434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19989034|NCT02007434|Respiratory System Agents|respiratory system agents|mesh-ancestor
19989035|NCT02007434|Mydriatics|mydriatics|mesh-ancestor
19989036|NCT02007434|Sympathomimetics|sympathomimetics|mesh-ancestor
19989037|NCT02007434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19989038|NCT02007434|Antipruritics|antipruritics|mesh-ancestor
19989039|NCT02007434|Dermatologic Agents|dermatologic agents|mesh-ancestor
19989040|NCT02007434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19989041|NCT02007434|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19989042|NCT02007434|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19989043|NCT02007434|Histamine Antagonists|histamine antagonists|mesh-ancestor
19989044|NCT02007434|Histamine Agents|histamine agents|mesh-ancestor
19989045|NCT02007434|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19989046|NCT02007434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19989047|NCT02007577|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
19989048|NCT02007577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19989049|NCT02007577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19989050|NCT02007577|Analgesics|analgesics|mesh-ancestor
19989051|NCT02007577|Sensory System Agents|sensory system agents|mesh-ancestor
19989052|NCT02007577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19989053|NCT02007577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989054|NCT02007577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19989055|NCT02007577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19989056|NCT02007863|Fludarabine|fludarabine|mesh-list
19989057|NCT02007863|Melphalan|melphalan|mesh-list
19989058|NCT02007863|Busulfan|busulfan|mesh-list
19989059|NCT02007863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989060|NCT02007863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989061|NCT02007863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19989062|NCT02007863|Immunologic Factors|immunologic factors|mesh-ancestor
19989063|NCT02007863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989064|NCT02007863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19989065|NCT02007863|Alkylating Agents|alkylating agents|mesh-ancestor
19989066|NCT02007863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19989067|NCT02008227|Docetaxel|docetaxel|mesh-list
19989068|NCT02008227|Atezolizumab|atezolizumab|mesh-list
19989069|NCT02008227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989070|NCT02008227|Tubulin Modulators|tubulin modulators|mesh-ancestor
19989071|NCT02008227|Antimitotic Agents|antimitotic agents|mesh-ancestor
19989072|NCT02008227|Mitosis Modulators|mitosis modulators|mesh-ancestor
19989073|NCT02008227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989074|NCT02008565|Loperamide|loperamide|mesh-list
19989075|NCT02008565|Antidiarrheals|antidiarrheals|mesh-list
19989076|NCT02008565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19989077|NCT02008617|Bupivacaine|bupivacaine|mesh-list
19989078|NCT02008617|Anesthetics, Local|anesthetics, local|mesh-ancestor
19989079|NCT02008617|Anesthetics|anesthetics|mesh-ancestor
19989080|NCT02008617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19989081|NCT02008617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989082|NCT02008617|Sensory System Agents|sensory system agents|mesh-ancestor
19989083|NCT02008617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19989084|NCT02008682|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19989085|NCT02008682|Liraglutide|liraglutide|mesh-list
19989086|NCT02008682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19989087|NCT02008682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989088|NCT02008682|Incretins|incretins|mesh-ancestor
19989089|NCT02008682|Hormones|hormones|mesh-ancestor
19989090|NCT02008682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19459708|NCT03359070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19459709|NCT03359070|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19459710|NCT03359057|Folic Acid|folic acid|mesh-list
19459711|NCT03359057|Vitamin B Complex|vitamin b complex|mesh-list
19459712|NCT03359057|Levonorgestrel|levonorgestrel|mesh-list
19459713|NCT03359057|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19459714|NCT03359057|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19459715|NCT03359057|Estradiol|estradiol|mesh-list
19459716|NCT03359057|Estrogens|estrogens|mesh-ancestor
19459717|NCT03359057|Hormones|hormones|mesh-ancestor
19459718|NCT03359057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19459719|NCT03359057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459720|NCT03359057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19459721|NCT03359057|Contraceptive Agents|contraceptive agents|mesh-ancestor
19459722|NCT03359057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19459723|NCT03359057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19459724|NCT03359057|Hematinics|hematinics|mesh-ancestor
19459725|NCT03359057|Vitamins|vitamins|mesh-ancestor
19459726|NCT03359057|Micronutrients|micronutrients|mesh-ancestor
19459727|NCT03359057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19459728|NCT03359057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19989091|NCT02008682|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19459729|NCT03359057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19989092|NCT02008682|Protease Inhibitors|protease inhibitors|mesh-ancestor
19989093|NCT02008682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989094|NCT02008682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989095|NCT02008773|Valacyclovir|valacyclovir|mesh-list
19989096|NCT02008773|Antiviral Agents|antiviral agents|mesh-ancestor
19989097|NCT02008773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19989098|NCT02008877|Sirolimus|sirolimus|mesh-list
19989099|NCT02008877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19989100|NCT02008877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19989101|NCT02008877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19989102|NCT02008877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989103|NCT02008877|Antifungal Agents|antifungal agents|mesh-ancestor
19989104|NCT02008877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19989105|NCT02008877|Immunologic Factors|immunologic factors|mesh-ancestor
19989106|NCT02008877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989107|NCT02008890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19989108|NCT02008890|Immunologic Factors|immunologic factors|mesh-ancestor
19989109|NCT02008890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989110|NCT02008916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19989111|NCT02008916|Immunologic Factors|immunologic factors|mesh-ancestor
19459730|NCT03359057|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
20289210|NCT04898894|Methotrexate|methotrexate|mesh-list
19989112|NCT02008916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989113|NCT02008942|Aspirin|aspirin|mesh-list
19989114|NCT02008942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19989115|NCT02008942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19989116|NCT02008942|Analgesics|analgesics|mesh-ancestor
19989117|NCT02008942|Sensory System Agents|sensory system agents|mesh-ancestor
19989118|NCT02008942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19989119|NCT02008942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989120|NCT02008942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19989121|NCT02008942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19989122|NCT02008942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19989123|NCT02008942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19989124|NCT02008942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989125|NCT02008942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19989126|NCT02008942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19989127|NCT02008942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989128|NCT02008942|Antipyretics|antipyretics|mesh-ancestor
19989129|NCT02009163|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19989130|NCT02009163|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19989131|NCT02009163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989132|NCT02009163|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19989133|NCT02009163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19989134|NCT02009163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19989135|NCT02009163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989136|NCT02009163|Dopamine Agents|dopamine agents|mesh-ancestor
19989137|NCT02009163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19989138|NCT02009332|Gemcitabine|gemcitabine|mesh-list
19989139|NCT02009332|Sirolimus|sirolimus|mesh-list
19989140|NCT02009332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19989141|NCT02009332|Antimetabolites|antimetabolites|mesh-ancestor
20289211|NCT04898894|Fludarabine phosphate|fludarabine phosphate|mesh-list
19989142|NCT02009332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989143|NCT02009332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989144|NCT02009332|Antiviral Agents|antiviral agents|mesh-ancestor
19989145|NCT02009332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19989146|NCT02009332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989147|NCT02009332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19989148|NCT02009332|Immunologic Factors|immunologic factors|mesh-ancestor
19989149|NCT02009332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989150|NCT02009332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19989151|NCT02009332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19989152|NCT02009332|Antifungal Agents|antifungal agents|mesh-ancestor
19989153|NCT02009397|Ipilimumab|ipilimumab|mesh-list
19989154|NCT02009397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19989155|NCT02009397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989156|NCT02009397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19989157|NCT02009397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989158|NCT02009722|Morphine|morphine|mesh-list
19989159|NCT02009722|Hydromorphone|hydromorphone|mesh-list
19989160|NCT02009722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19989161|NCT02009722|Narcotics|narcotics|mesh-ancestor
19989162|NCT02009722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19989163|NCT02009722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989164|NCT02009722|Analgesics|analgesics|mesh-ancestor
19989165|NCT02009722|Sensory System Agents|sensory system agents|mesh-ancestor
19989166|NCT02009722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19989167|NCT02009878|Tolvaptan|tolvaptan|mesh-list
19989168|NCT02009878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19989169|NCT02009878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989170|NCT02009878|Natriuretic Agents|natriuretic agents|mesh-ancestor
19989171|NCT02009878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989172|NCT02010021|Letrozole|letrozole|mesh-list
19989173|NCT02010021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989174|NCT02010021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19989175|NCT02010021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19989176|NCT02010021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989177|NCT02010021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989178|NCT02010021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19989179|NCT02010021|Hormone Antagonists|hormone antagonists|mesh-ancestor
19989180|NCT02010021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19989181|NCT02010021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989182|NCT02010203|BCG Vaccine|bcg vaccine|mesh-list
19989183|NCT02010203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19989184|NCT02010203|Immunologic Factors|immunologic factors|mesh-ancestor
19989185|NCT02010203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989186|NCT02010255|Sofosbuvir|sofosbuvir|mesh-list
19989187|NCT02010255|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19989188|NCT02010255|Ledipasvir|ledipasvir|mesh-list
19989189|NCT02010255|Antiviral Agents|antiviral agents|mesh-ancestor
19989190|NCT02010255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19989191|NCT02010567|Capecitabine|capecitabine|mesh-list
19989192|NCT02010567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19989193|NCT02010567|Antimetabolites|antimetabolites|mesh-ancestor
19989194|NCT02010567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989195|NCT02010567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989196|NCT02010632|Clopidogrel|clopidogrel|mesh-list
19989197|NCT02010632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19989198|NCT02010632|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19989199|NCT02010632|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19989200|NCT02010632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19989201|NCT02010632|Purinergic Agents|purinergic agents|mesh-ancestor
19989202|NCT02010632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19989203|NCT02010632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989204|NCT02010632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989205|NCT02010645|Decitabine|decitabine|mesh-list
19989206|NCT02010645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19989207|NCT02010645|Antimetabolites|antimetabolites|mesh-ancestor
19989208|NCT02010645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989209|NCT02010645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989210|NCT02010645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289212|NCT04898894|Fludarabine|fludarabine|mesh-list
20289213|NCT04898894|Venetoclax|venetoclax|mesh-list
20289214|NCT04898894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20289215|NCT04898894|Abortifacient Agents|abortifacient agents|mesh-ancestor
20289216|NCT04898894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20289217|NCT04898894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289218|NCT04898894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20289219|NCT04898894|Antimetabolites|antimetabolites|mesh-ancestor
20289220|NCT04898894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289221|NCT04898894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289222|NCT04898894|Dermatologic Agents|dermatologic agents|mesh-ancestor
20289223|NCT04898894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289224|NCT04898894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20289225|NCT04898894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20289226|NCT04898894|Immunologic Factors|immunologic factors|mesh-ancestor
20289227|NCT04898894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20289228|NCT04898894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20289229|NCT04898894|Antiviral Agents|antiviral agents|mesh-ancestor
19989211|NCT02010775|Botulinum Toxins|botulinum toxins|mesh-list
19989212|NCT02010775|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19989213|NCT02010775|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19989214|NCT02010775|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19989215|NCT02010775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19989216|NCT02010775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989217|NCT02010775|Cholinergic Agents|cholinergic agents|mesh-ancestor
19989218|NCT02010775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19989219|NCT02010775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989220|NCT02010775|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19989221|NCT02010775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19989222|NCT02011113|Dexamethasone|dexamethasone|mesh-list
19989223|NCT02011113|Pomalidomide|pomalidomide|mesh-list
19989224|NCT02011113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19989225|NCT02011113|Antiemetics|antiemetics|mesh-ancestor
19989226|NCT02011113|Autonomic Agents|autonomic agents|mesh-ancestor
19989227|NCT02011113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19989228|NCT02011113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989229|NCT02011113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19989230|NCT02011113|Glucocorticoids|glucocorticoids|mesh-ancestor
19989231|NCT02011113|Hormones|hormones|mesh-ancestor
19989232|NCT02011113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19989233|NCT02011113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19989234|NCT02011113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989235|NCT02011113|Immunologic Factors|immunologic factors|mesh-ancestor
19989236|NCT02011113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19989237|NCT02011113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19989238|NCT02011113|Growth Substances|growth substances|mesh-ancestor
19989239|NCT02011113|Growth Inhibitors|growth inhibitors|mesh-ancestor
19989240|NCT02011386|Golimumab|golimumab|mesh-list
19989241|NCT02011386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19989242|NCT02011386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19989243|NCT02011386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19989244|NCT02011386|Immunologic Factors|immunologic factors|mesh-ancestor
19989245|NCT02011386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989246|NCT02011464|Bupivacaine|bupivacaine|mesh-list
19989247|NCT02011464|Anesthetics, Local|anesthetics, local|mesh-ancestor
19989248|NCT02011464|Anesthetics|anesthetics|mesh-ancestor
19989249|NCT02011464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19989250|NCT02011464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989251|NCT02011464|Sensory System Agents|sensory system agents|mesh-ancestor
19989252|NCT02011464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19989253|NCT02011516|Baclofen|baclofen|mesh-list
19989254|NCT02011516|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19989255|NCT02011516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989256|NCT02011516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19989257|NCT02011516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19989258|NCT02011516|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19989259|NCT02011516|GABA Agonists|gaba agonists|mesh-ancestor
19989260|NCT02011516|GABA Agents|gaba agents|mesh-ancestor
19989261|NCT02011516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19989262|NCT02011516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989263|NCT02011945|Nivolumab|nivolumab|mesh-list
19989264|NCT02011945|Dasatinib|dasatinib|mesh-list
19989265|NCT02011945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19989266|NCT02011945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989267|NCT02011945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19989268|NCT02011945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989269|NCT02011945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19989270|NCT02011945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989271|NCT02012192|Paclitaxel|paclitaxel|mesh-list
19989272|NCT02012192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19989273|NCT02012192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989274|NCT02012192|Tubulin Modulators|tubulin modulators|mesh-ancestor
19989275|NCT02012192|Antimitotic Agents|antimitotic agents|mesh-ancestor
19989276|NCT02012192|Mitosis Modulators|mitosis modulators|mesh-ancestor
19989277|NCT02012192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989278|NCT02012218|Brexpiprazole|brexpiprazole|mesh-list
19989279|NCT02012218|Serotonin Agents|serotonin agents|mesh-ancestor
19989280|NCT02012218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19989281|NCT02012218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989282|NCT02012218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989283|NCT02012218|Dopamine Agonists|dopamine agonists|mesh-ancestor
19989284|NCT02012218|Dopamine Agents|dopamine agents|mesh-ancestor
19989285|NCT02012348|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19989286|NCT02012348|Benzalkonium Compounds|benzalkonium compounds|mesh-list
19989287|NCT02012348|Triclocarban|triclocarban|mesh-list
19989288|NCT02012348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19989289|NCT02012348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19989290|NCT02012491|Misoprostol|misoprostol|mesh-list
19989291|NCT02012491|Mifepristone|mifepristone|mesh-list
19989292|NCT02012491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19989293|NCT02012491|Abortifacient Agents|abortifacient agents|mesh-ancestor
19989294|NCT02012491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19989295|NCT02012491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989296|NCT02012491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19989297|NCT02012491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19989298|NCT02012491|Oxytocics|oxytocics|mesh-ancestor
19989299|NCT02012491|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19989300|NCT02012491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19989301|NCT02012491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19989302|NCT02012491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19989303|NCT02012491|Contraceptive Agents|contraceptive agents|mesh-ancestor
19989304|NCT02012491|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19989305|NCT02012491|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19989306|NCT02012491|Hormone Antagonists|hormone antagonists|mesh-ancestor
19989307|NCT02012491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19989308|NCT02012491|Luteolytic Agents|luteolytic agents|mesh-ancestor
19989309|NCT02012491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19989310|NCT02012491|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
19989311|NCT02012959|Tolvaptan|tolvaptan|mesh-list
19989312|NCT02012959|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19989313|NCT02012959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989314|NCT02012959|Natriuretic Agents|natriuretic agents|mesh-ancestor
19989315|NCT02012959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989316|NCT02013037|Eculizumab|eculizumab|mesh-list
19989317|NCT02013037|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19989318|NCT02013037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19989319|NCT02013037|Immunologic Factors|immunologic factors|mesh-ancestor
19989320|NCT02013037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989321|NCT02013206|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19989322|NCT02013206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989323|NCT02013206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19989324|NCT02013206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989325|NCT02013206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989326|NCT02013245|Vaccines|vaccines|mesh-list
19989327|NCT02013245|Immunoglobulins|immunoglobulins|mesh-list
19989328|NCT02013245|Immunologic Factors|immunologic factors|mesh-ancestor
19989329|NCT02013245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989330|NCT02013375|Sirolimus|sirolimus|mesh-list
19989331|NCT02013375|Cyclophosphamide|cyclophosphamide|mesh-list
19989332|NCT02013375|Alemtuzumab|alemtuzumab|mesh-list
19989333|NCT02013375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19989334|NCT02013375|Immunologic Factors|immunologic factors|mesh-ancestor
19989335|NCT02013375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989336|NCT02013375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19989337|NCT02013375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19989338|NCT02013375|Alkylating Agents|alkylating agents|mesh-ancestor
19989339|NCT02013375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989340|NCT02013375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989341|NCT02013375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19989342|NCT02013375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19989343|NCT02013375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19989344|NCT02013375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19989345|NCT02013375|Antifungal Agents|antifungal agents|mesh-ancestor
19989346|NCT02013375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19989347|NCT02013531|Brexpiprazole|brexpiprazole|mesh-list
19989348|NCT02013531|Serotonin Agents|serotonin agents|mesh-ancestor
19989349|NCT02013531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19989350|NCT02013531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989351|NCT02013531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989352|NCT02013531|Dopamine Agonists|dopamine agonists|mesh-ancestor
19989353|NCT02013531|Dopamine Agents|dopamine agents|mesh-ancestor
19989354|NCT02013544|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
19989355|NCT02013544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19989356|NCT02013544|Immunologic Factors|immunologic factors|mesh-ancestor
19989357|NCT02013544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989358|NCT02013609|Brexpiprazole|brexpiprazole|mesh-list
19989359|NCT02013609|Serotonin Agents|serotonin agents|mesh-ancestor
19989360|NCT02013609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19989361|NCT02013609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989362|NCT02013609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989363|NCT02013609|Dopamine Agonists|dopamine agonists|mesh-ancestor
19989364|NCT02013609|Dopamine Agents|dopamine agents|mesh-ancestor
19989365|NCT02013622|Brexpiprazole|brexpiprazole|mesh-list
19989366|NCT02013622|Serotonin Agents|serotonin agents|mesh-ancestor
19989367|NCT02013622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19989368|NCT02013622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989369|NCT02013622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989370|NCT02013622|Dopamine Agonists|dopamine agonists|mesh-ancestor
19989371|NCT02013622|Dopamine Agents|dopamine agents|mesh-ancestor
19989372|NCT02013674|Remestemcel-l|remestemcel-l|mesh-list
19989373|NCT02013674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19989374|NCT02013674|Antiviral Agents|antiviral agents|mesh-ancestor
19989375|NCT02013674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19989376|NCT02013765|Trastuzumab|trastuzumab|mesh-list
19989377|NCT02013765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19989378|NCT02013765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989379|NCT02013791|Cyclosporine|cyclosporine|mesh-list
19989380|NCT02013791|Cyclosporins|cyclosporins|mesh-list
19989381|NCT02013791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989382|NCT02013791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989383|NCT02013791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19989384|NCT02013791|Immunologic Factors|immunologic factors|mesh-ancestor
19989385|NCT02013791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989386|NCT02013791|Antifungal Agents|antifungal agents|mesh-ancestor
19989387|NCT02013791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19989388|NCT02013791|Dermatologic Agents|dermatologic agents|mesh-ancestor
19989389|NCT02013791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19989390|NCT02013791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19989391|NCT02013817|Cyclophosphamide|cyclophosphamide|mesh-list
19989392|NCT02013817|Rituximab|rituximab|mesh-list
19989393|NCT02013817|Fludarabine|fludarabine|mesh-list
19989394|NCT02013817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19989395|NCT02013817|Immunologic Factors|immunologic factors|mesh-ancestor
19989396|NCT02013817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989397|NCT02013817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19989398|NCT02013817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19989399|NCT02013817|Alkylating Agents|alkylating agents|mesh-ancestor
19989400|NCT02013817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989401|NCT02013817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989402|NCT02013817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19989403|NCT02013817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19989404|NCT02013830|Bevacizumab|bevacizumab|mesh-list
19989405|NCT02013830|Capecitabine|capecitabine|mesh-list
19989406|NCT02013830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19989407|NCT02013830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989408|NCT02013830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19989409|NCT02013830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19989410|NCT02013830|Growth Substances|growth substances|mesh-ancestor
19989411|NCT02013830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989412|NCT02013830|Growth Inhibitors|growth inhibitors|mesh-ancestor
19989413|NCT02013830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19989414|NCT02013830|Antimetabolites|antimetabolites|mesh-ancestor
19989415|NCT02013830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989416|NCT02014363|Amitriptyline|amitriptyline|mesh-list
19989417|NCT02014363|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19989418|NCT02014363|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19989419|NCT02014363|Antidepressive Agents|antidepressive agents|mesh-ancestor
19989420|NCT02014363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19989421|NCT02014363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19989422|NCT02014363|Analgesics|analgesics|mesh-ancestor
19989423|NCT02014363|Sensory System Agents|sensory system agents|mesh-ancestor
19989424|NCT02014363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19989425|NCT02014363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989426|NCT02014363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19989427|NCT02014363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19989428|NCT02014363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19989429|NCT02014363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989430|NCT02014363|Adrenergic Agents|adrenergic agents|mesh-ancestor
19989431|NCT02014363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19989432|NCT02014363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19989433|NCT02014363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19989434|NCT02014363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19989435|NCT02014402|Thrombin|thrombin|mesh-list
19989436|NCT02014402|Hemostatics|hemostatics|mesh-ancestor
19989437|NCT02014402|Coagulants|coagulants|mesh-ancestor
19989438|NCT02014441|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
19989439|NCT02014441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19989440|NCT02014441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989441|NCT02014467|Vitamin D|vitamin d|mesh-list
19989442|NCT02014467|Denosumab|denosumab|mesh-list
19989443|NCT02014467|Calcium|calcium|mesh-list
19989444|NCT02014467|Vitamins|vitamins|mesh-ancestor
19989445|NCT02014467|Micronutrients|micronutrients|mesh-ancestor
19989446|NCT02014467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989447|NCT02014467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19989448|NCT02014467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19989449|NCT02014584|Dutasteride|dutasteride|mesh-list
19989450|NCT02014584|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19989451|NCT02014584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19989452|NCT02014584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989453|NCT02014584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989454|NCT02014584|Hormone Antagonists|hormone antagonists|mesh-ancestor
19989455|NCT02014584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19989456|NCT02014584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989457|NCT02014740|Metformin|metformin|mesh-list
19989458|NCT02014740|Liraglutide|liraglutide|mesh-list
19989459|NCT02014740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19989460|NCT02014740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556419|NCT01946607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556420|NCT01946607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20556421|NCT01946607|Serotonin Agents|serotonin agents|mesh-ancestor
20556422|NCT01946607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556423|NCT01946607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20556424|NCT01946607|Antidepressive Agents|antidepressive agents|mesh-ancestor
20556425|NCT01946607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20556426|NCT01946620|Formoterol Fumarate|formoterol fumarate|mesh-list
19989461|NCT02014740|Incretins|incretins|mesh-ancestor
19989462|NCT02014740|Hormones|hormones|mesh-ancestor
19989463|NCT02014740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19989464|NCT02015104|BCG Vaccine|bcg vaccine|mesh-list
19989465|NCT02015104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19989466|NCT02015104|Immunologic Factors|immunologic factors|mesh-ancestor
19989467|NCT02015104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989468|NCT02015195|Ethanol|ethanol|mesh-list
19989469|NCT02015195|Acetic Acid|acetic acid|mesh-list
19989470|NCT02015195|Retinol acetate|retinol acetate|mesh-list
19989471|NCT02015195|Lidocaine|lidocaine|mesh-list
19989472|NCT02015195|Anesthetics, Local|anesthetics, local|mesh-ancestor
19989473|NCT02015195|Anesthetics|anesthetics|mesh-ancestor
19989474|NCT02015195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19989475|NCT02015195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989476|NCT02015195|Sensory System Agents|sensory system agents|mesh-ancestor
19989477|NCT02015195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19989478|NCT02015195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19989479|NCT02015195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19989480|NCT02015195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19989481|NCT02015195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19989482|NCT02015195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989483|NCT02015195|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19989484|NCT02015195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19989485|NCT02015195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19989486|NCT02015195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19989487|NCT02015195|Immunologic Factors|immunologic factors|mesh-ancestor
19989488|NCT02015195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19989489|NCT02015195|Protective Agents|protective agents|mesh-ancestor
19989490|NCT02015195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989491|NCT02015234|Cyclobenzaprine|cyclobenzaprine|mesh-list
19989492|NCT02015234|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19989493|NCT02015234|Antidepressive Agents|antidepressive agents|mesh-ancestor
19989494|NCT02015234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19989495|NCT02015234|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19989496|NCT02015234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989497|NCT02015234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19989498|NCT02015234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19989499|NCT02015234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19989500|NCT02015234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19989501|NCT02015546|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
19989502|NCT02015546|Antidepressive Agents|antidepressive agents|mesh-ancestor
19989503|NCT02015546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19989504|NCT02015546|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19989505|NCT02015546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19989506|NCT02015546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19989507|NCT02015546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989508|NCT02015546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19989509|NCT02015546|Serotonin Agents|serotonin agents|mesh-ancestor
19989510|NCT02015546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989511|NCT02015546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19989512|NCT02015546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19989513|NCT02015637|Ceftriaxone|ceftriaxone|mesh-list
19989514|NCT02015637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19989515|NCT02015637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19989516|NCT02015676|Paclitaxel|paclitaxel|mesh-list
19989517|NCT02015676|Trastuzumab|trastuzumab|mesh-list
19989518|NCT02015676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19989519|NCT02015676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989520|NCT02015676|Tubulin Modulators|tubulin modulators|mesh-ancestor
19989521|NCT02015676|Antimitotic Agents|antimitotic agents|mesh-ancestor
19989522|NCT02015676|Mitosis Modulators|mitosis modulators|mesh-ancestor
19989523|NCT02015676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989524|NCT02015676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19989525|NCT02015793|Adalimumab|adalimumab|mesh-list
19989526|NCT02015793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19989527|NCT02015793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19989528|NCT02015819|Leucovorin|leucovorin|mesh-list
19989529|NCT02015819|Flucytosine|flucytosine|mesh-list
19989530|NCT02015819|Calcium|calcium|mesh-list
19989531|NCT02015819|Levoleucovorin|levoleucovorin|mesh-list
19989532|NCT02015819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19989533|NCT02015819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989534|NCT02015819|Antidotes|antidotes|mesh-ancestor
19989535|NCT02015819|Protective Agents|protective agents|mesh-ancestor
19989536|NCT02015819|Vitamin B Complex|vitamin b complex|mesh-ancestor
19989537|NCT02015819|Vitamins|vitamins|mesh-ancestor
19989538|NCT02015819|Micronutrients|micronutrients|mesh-ancestor
19989539|NCT02015819|Antifungal Agents|antifungal agents|mesh-ancestor
19989540|NCT02015819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19989541|NCT02015819|Antimetabolites|antimetabolites|mesh-ancestor
19989542|NCT02015819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989543|NCT02016105|Adalimumab|adalimumab|mesh-list
19989544|NCT02016105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19989545|NCT02016105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19989546|NCT02016170|Ticagrelor|ticagrelor|mesh-list
19989547|NCT02016170|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19989548|NCT02016170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19989549|NCT02016170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19989550|NCT02016170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19989551|NCT02016170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19989552|NCT02016170|Purinergic Agents|purinergic agents|mesh-ancestor
19989553|NCT02016170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19989554|NCT02016170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989555|NCT02016170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989556|NCT02016183|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
19989557|NCT02016183|Candesartan|candesartan|mesh-list
19989558|NCT02016183|Candesartan cilexetil|candesartan cilexetil|mesh-list
19989559|NCT02016183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19989560|NCT02016183|Diuretics|diuretics|mesh-ancestor
19989561|NCT02016183|Natriuretic Agents|natriuretic agents|mesh-ancestor
19989562|NCT02016183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989563|NCT02016183|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19989564|NCT02016183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19989565|NCT02016183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989566|NCT02016183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19989567|NCT02016183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19989568|NCT02016482|Adalimumab|adalimumab|mesh-list
19989569|NCT02016482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19989570|NCT02016482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19989571|NCT02016625|Cyclosporine|cyclosporine|mesh-list
19989572|NCT02016625|Tacrolimus|tacrolimus|mesh-list
19989573|NCT02016625|Cyclosporins|cyclosporins|mesh-list
19989574|NCT02016625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19989575|NCT02016625|Immunologic Factors|immunologic factors|mesh-ancestor
19989576|NCT02016625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989577|NCT02016625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19989578|NCT02016625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989579|NCT02016625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989580|NCT02016625|Antifungal Agents|antifungal agents|mesh-ancestor
19989581|NCT02016625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19989582|NCT02016625|Dermatologic Agents|dermatologic agents|mesh-ancestor
19989583|NCT02016625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19989584|NCT02016716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19989585|NCT02016716|Immunologic Factors|immunologic factors|mesh-ancestor
19989586|NCT02016716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989587|NCT02016885|Glycopyrrolate|glycopyrrolate|mesh-list
19989588|NCT02016885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19989589|NCT02016885|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19459731|NCT03359018|Apatinib|apatinib|mesh-list
19459732|NCT03359018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459733|NCT03359018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19459734|NCT03359018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459735|NCT03359018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459736|NCT03359005|Vincristine|vincristine|mesh-list
19459737|NCT03359005|Temozolomide|temozolomide|mesh-list
19459738|NCT03359005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19459739|NCT03359005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459740|NCT03359005|Tubulin Modulators|tubulin modulators|mesh-ancestor
19989590|NCT02016885|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19989591|NCT02016885|Cholinergic Agents|cholinergic agents|mesh-ancestor
19989592|NCT02016885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19989593|NCT02016885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459741|NCT03359005|Antimitotic Agents|antimitotic agents|mesh-ancestor
19989594|NCT02016885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989595|NCT02016898|Mitomycins|mitomycins|mesh-list
19989596|NCT02016898|Mitomycin|mitomycin|mesh-list
19989597|NCT02016898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19989598|NCT02016898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989599|NCT02016898|Alkylating Agents|alkylating agents|mesh-ancestor
19989600|NCT02016898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989601|NCT02016898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19989602|NCT02016898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989603|NCT02017015|Gemcitabine|gemcitabine|mesh-list
19989604|NCT02017015|Paclitaxel|paclitaxel|mesh-list
19989605|NCT02017015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19989606|NCT02017015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989607|NCT02017015|Tubulin Modulators|tubulin modulators|mesh-ancestor
19989608|NCT02017015|Antimitotic Agents|antimitotic agents|mesh-ancestor
19989609|NCT02017015|Mitosis Modulators|mitosis modulators|mesh-ancestor
19989610|NCT02017015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989611|NCT02017015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19989612|NCT02017015|Antimetabolites|antimetabolites|mesh-ancestor
19989613|NCT02017015|Antiviral Agents|antiviral agents|mesh-ancestor
19989614|NCT02017015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19989615|NCT02017015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989616|NCT02017015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19989617|NCT02017015|Immunologic Factors|immunologic factors|mesh-ancestor
19989618|NCT02017015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989619|NCT02017171|Allopurinol|allopurinol|mesh-list
19989620|NCT02017171|Antimetabolites|antimetabolites|mesh-ancestor
19989621|NCT02017171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989622|NCT02017171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989623|NCT02017171|Gout Suppressants|gout suppressants|mesh-ancestor
19989624|NCT02017171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19989625|NCT02017171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19989626|NCT02017171|Antioxidants|antioxidants|mesh-ancestor
19989627|NCT02017171|Protective Agents|protective agents|mesh-ancestor
19989628|NCT02017171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989629|NCT02017327|Bimatoprost|bimatoprost|mesh-list
19989630|NCT02017327|Latanoprost|latanoprost|mesh-list
19989631|NCT02017327|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19989632|NCT02017327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19989633|NCT02017327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19989634|NCT02017535|Fluoxetine|fluoxetine|mesh-list
19989635|NCT02017535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19989636|NCT02017535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19989637|NCT02017535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19989638|NCT02017535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989639|NCT02017535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19989640|NCT02017535|Serotonin Agents|serotonin agents|mesh-ancestor
19989641|NCT02017535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989642|NCT02017535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19989643|NCT02017535|Antidepressive Agents|antidepressive agents|mesh-ancestor
19989644|NCT02017535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19989645|NCT02017535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19989646|NCT02017535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19989647|NCT02017535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989648|NCT02017860|Everolimus|everolimus|mesh-list
19989649|NCT02017860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989650|NCT02017860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19989651|NCT02017860|Immunologic Factors|immunologic factors|mesh-ancestor
19989652|NCT02017860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989653|NCT02017899|Vaccines|vaccines|mesh-list
19989654|NCT02017899|Immunologic Factors|immunologic factors|mesh-ancestor
19989655|NCT02017899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989656|NCT02018042|Abatacept|abatacept|mesh-list
19989657|NCT02018042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19989658|NCT02018042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989659|NCT02018042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989660|NCT02018042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19989661|NCT02018042|Immunologic Factors|immunologic factors|mesh-ancestor
19989662|NCT02018042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989663|NCT02018042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19989664|NCT02018107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19989665|NCT02018107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19989666|NCT02018107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989667|NCT02018458|Paclitaxel|paclitaxel|mesh-list
19989668|NCT02018458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19989669|NCT02018458|Cyclophosphamide|cyclophosphamide|mesh-list
19989670|NCT02018458|Carboplatin|carboplatin|mesh-list
19989671|NCT02018458|Doxorubicin|doxorubicin|mesh-list
19989672|NCT02018458|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19989673|NCT02018458|Vaccines|vaccines|mesh-list
19989674|NCT02018458|Immunologic Factors|immunologic factors|mesh-ancestor
19989675|NCT02018458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989676|NCT02018458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19989677|NCT02018458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989678|NCT02018458|Tubulin Modulators|tubulin modulators|mesh-ancestor
19989679|NCT02018458|Antimitotic Agents|antimitotic agents|mesh-ancestor
19989680|NCT02018458|Mitosis Modulators|mitosis modulators|mesh-ancestor
19989681|NCT02018458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989682|NCT02018458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19989683|NCT02018458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19989684|NCT02018458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19989685|NCT02018458|Alkylating Agents|alkylating agents|mesh-ancestor
19989686|NCT02018458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19989687|NCT02018458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19989688|NCT02018458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19989689|NCT02018458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19989690|NCT02018458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289230|NCT04898894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20289231|NCT04898894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20289232|NCT04892043|Nivolumab|nivolumab|mesh-list
20289233|NCT04892043|Ipilimumab|ipilimumab|mesh-list
20289234|NCT04892043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20289235|NCT04892043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289236|NCT04892043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20289237|NCT04892043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289238|NCT04887298|Annamycin|annamycin|mesh-list
20289239|NCT04887298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20289240|NCT04887298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289241|NCT04876937|Dexmedetomidine|dexmedetomidine|mesh-list
20289242|NCT04876937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20289243|NCT04876937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20289244|NCT04876937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289245|NCT04876937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20289246|NCT04876937|Analgesics|analgesics|mesh-ancestor
20289247|NCT04876937|Sensory System Agents|sensory system agents|mesh-ancestor
19989691|NCT02018627|Glucagon|glucagon|mesh-list
19989692|NCT02018627|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19989693|NCT02018627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19989694|NCT02018627|Hormones|hormones|mesh-ancestor
19989695|NCT02018627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19989696|NCT02018627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989697|NCT02018627|Incretins|incretins|mesh-ancestor
19989698|NCT02018653|Calcium, Dietary|calcium, dietary|mesh-list
19989699|NCT02018653|Antidiarrheals|antidiarrheals|mesh-list
19989700|NCT02018653|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
19989701|NCT02018653|Calcium|calcium|mesh-list
19989702|NCT02018653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19989703|NCT02018653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989704|NCT02018653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19989705|NCT02018653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19989706|NCT02018822|Urethane|urethane|mesh-list
19989707|NCT02018822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989708|NCT02018822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19989709|NCT02018822|Anesthetics, General|anesthetics, general|mesh-ancestor
19989710|NCT02018822|Anesthetics|anesthetics|mesh-ancestor
19989711|NCT02018822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19989712|NCT02018822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989713|NCT02019069|Cytarabine|cytarabine|mesh-list
19989714|NCT02019069|Daunorubicin|daunorubicin|mesh-list
19989715|NCT02019069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19989716|NCT02019069|Antimetabolites|antimetabolites|mesh-ancestor
19989717|NCT02019069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989718|NCT02019069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989719|NCT02019069|Antiviral Agents|antiviral agents|mesh-ancestor
19989720|NCT02019069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19989721|NCT02019069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19989722|NCT02019069|Immunologic Factors|immunologic factors|mesh-ancestor
19989723|NCT02019069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989724|NCT02019069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19989725|NCT02019069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19989726|NCT02019069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19989727|NCT02019069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989728|NCT02019277|Paclitaxel|paclitaxel|mesh-list
19989729|NCT02019277|Docetaxel|docetaxel|mesh-list
19989730|NCT02019277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19989731|NCT02019277|Trastuzumab|trastuzumab|mesh-list
19989732|NCT02019277|Pertuzumab|pertuzumab|mesh-list
19989733|NCT02019277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19989734|NCT02019277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989735|NCT02019277|Tubulin Modulators|tubulin modulators|mesh-ancestor
19989736|NCT02019277|Antimitotic Agents|antimitotic agents|mesh-ancestor
19989737|NCT02019277|Mitosis Modulators|mitosis modulators|mesh-ancestor
19989738|NCT02019277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989739|NCT02019277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19989740|NCT02019420|Linezolid|linezolid|mesh-list
19989741|NCT02019420|Tedizolid|tedizolid|mesh-list
19989742|NCT02019420|Tedizolid phosphate|tedizolid phosphate|mesh-list
19989743|NCT02019420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19989744|NCT02019420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19989745|NCT02019420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19989746|NCT02019420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989747|NCT02019420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989748|NCT02019472|Adalimumab|adalimumab|mesh-list
19989749|NCT02019472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19989750|NCT02019472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19989751|NCT02019472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19989752|NCT02019472|Immunologic Factors|immunologic factors|mesh-ancestor
19989753|NCT02019472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989754|NCT02019602|Certolizumab Pegol|certolizumab pegol|mesh-list
19989755|NCT02019602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19989756|NCT02019602|Immunologic Factors|immunologic factors|mesh-ancestor
19989757|NCT02019602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989758|NCT02019602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19989759|NCT02019667|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
19989760|NCT02019667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19989761|NCT02019667|Protective Agents|protective agents|mesh-ancestor
19989762|NCT02019667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989763|NCT02019667|GABA Antagonists|gaba antagonists|mesh-ancestor
19989764|NCT02019667|GABA Agents|gaba agents|mesh-ancestor
19989765|NCT02019667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19989766|NCT02019667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989767|NCT02019758|Fluticasone|fluticasone|mesh-list
19989768|NCT02019758|Budesonide|budesonide|mesh-list
19989769|NCT02019758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19989770|NCT02019758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19989771|NCT02019758|Autonomic Agents|autonomic agents|mesh-ancestor
19989772|NCT02019758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19989773|NCT02019758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989774|NCT02019758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19989775|NCT02019758|Respiratory System Agents|respiratory system agents|mesh-ancestor
19989776|NCT02019758|Dermatologic Agents|dermatologic agents|mesh-ancestor
19989777|NCT02019758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19989778|NCT02019758|Glucocorticoids|glucocorticoids|mesh-ancestor
19989779|NCT02019758|Hormones|hormones|mesh-ancestor
19989780|NCT02019758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19989781|NCT02019940|Riluzole|riluzole|mesh-list
19989782|NCT02019940|Anticonvulsants|anticonvulsants|mesh-ancestor
19989783|NCT02019940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19989784|NCT02019940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19989785|NCT02019940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19989786|NCT02019940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989787|NCT02019940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989788|NCT02019940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19989789|NCT02019940|Protective Agents|protective agents|mesh-ancestor
19989790|NCT02019979|Metformin|metformin|mesh-list
19989791|NCT02019979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19989792|NCT02019979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989793|NCT02020031|Vancomycin|vancomycin|mesh-list
19989794|NCT02020031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19989795|NCT02020031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19989796|NCT02020278|Tolvaptan|tolvaptan|mesh-list
19989797|NCT02020278|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19989798|NCT02020278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989799|NCT02020278|Natriuretic Agents|natriuretic agents|mesh-ancestor
19989800|NCT02020278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989801|NCT02020408|Raclopride|raclopride|mesh-list
19989802|NCT02020408|Amphetamine|amphetamine|mesh-list
19989803|NCT02020408|Dextroamphetamine|dextroamphetamine|mesh-list
19989804|NCT02020408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19989805|NCT02020408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989806|NCT02020408|Sympathomimetics|sympathomimetics|mesh-ancestor
19989807|NCT02020408|Autonomic Agents|autonomic agents|mesh-ancestor
19989808|NCT02020408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19989809|NCT02020408|Dopamine Agents|dopamine agents|mesh-ancestor
19989810|NCT02020408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19989811|NCT02020408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989812|NCT02020408|Adrenergic Agents|adrenergic agents|mesh-ancestor
19989813|NCT02020408|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19989814|NCT02020408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19989815|NCT02020408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19989816|NCT02020408|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19989817|NCT02020408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19989818|NCT02020408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19989819|NCT02020408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19989820|NCT02020408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19989821|NCT02020408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19989822|NCT02020512|Bimatoprost|bimatoprost|mesh-list
19989823|NCT02020512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19989824|NCT02020577|Cetuximab|cetuximab|mesh-list
19989825|NCT02020577|Afatinib|afatinib|mesh-list
19989826|NCT02020577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19989827|NCT02020577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989828|NCT02020577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19989829|NCT02020577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989830|NCT02020577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989831|NCT02020616|Metformin|metformin|mesh-list
19989832|NCT02020616|Exenatide|exenatide|mesh-list
19989833|NCT02020616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19989834|NCT02020616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989835|NCT02020616|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19989836|NCT02020616|Incretins|incretins|mesh-ancestor
19989837|NCT02020616|Hormones|hormones|mesh-ancestor
19989838|NCT02020616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19989839|NCT02020941|Dexamethasone|dexamethasone|mesh-list
19989840|NCT02020941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19989841|NCT02020941|Antiemetics|antiemetics|mesh-ancestor
19989842|NCT02020941|Autonomic Agents|autonomic agents|mesh-ancestor
19989843|NCT02020941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19989844|NCT02020941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989845|NCT02020941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19989846|NCT02020941|Glucocorticoids|glucocorticoids|mesh-ancestor
19989847|NCT02020941|Hormones|hormones|mesh-ancestor
19989848|NCT02020941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19989849|NCT02020941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19989850|NCT02020941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989851|NCT02021292|Macitentan|macitentan|mesh-list
19989852|NCT02021292|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19989853|NCT02021292|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19989854|NCT02021292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989855|NCT02021292|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19989856|NCT02021318|Darbepoetin alfa|darbepoetin alfa|mesh-list
19989857|NCT02021318|Hematinics|hematinics|mesh-ancestor
19989858|NCT02021331|Ethanol|ethanol|mesh-list
19989859|NCT02021331|Povidone-Iodine|povidone-iodine|mesh-list
19989860|NCT02021331|Cimetidine|cimetidine|mesh-list
19989861|NCT02021331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19989862|NCT02021331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19989863|NCT02021331|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19989864|NCT02021331|Histamine Antagonists|histamine antagonists|mesh-ancestor
19989865|NCT02021331|Histamine Agents|histamine agents|mesh-ancestor
19989866|NCT02021331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19989867|NCT02021331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989868|NCT02021331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989869|NCT02021331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19989870|NCT02021331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19989871|NCT02021331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989872|NCT02021331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19989873|NCT02021331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19989874|NCT02021331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19989875|NCT02021461|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19989876|NCT02021461|Anticonvulsants|anticonvulsants|mesh-ancestor
19989877|NCT02021461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19989878|NCT02021461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19989879|NCT02021461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19989880|NCT02021461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989881|NCT02021643|Sofosbuvir|sofosbuvir|mesh-list
19989882|NCT02021643|Ribavirin|ribavirin|mesh-list
19989883|NCT02021643|Antiviral Agents|antiviral agents|mesh-ancestor
19989884|NCT02021643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19989885|NCT02021643|Antimetabolites|antimetabolites|mesh-ancestor
19989886|NCT02021643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989887|NCT02021656|Sofosbuvir|sofosbuvir|mesh-list
19989888|NCT02021656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19989889|NCT02021656|Ledipasvir|ledipasvir|mesh-list
19989890|NCT02021656|Antiviral Agents|antiviral agents|mesh-ancestor
19989891|NCT02021656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19989892|NCT02021929|Sorafenib|sorafenib|mesh-list
19989893|NCT02021929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989894|NCT02021929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19989895|NCT02021929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989896|NCT02021929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989897|NCT02021942|Pasireotide|pasireotide|mesh-list
19989898|NCT02021942|Hormones|hormones|mesh-ancestor
19989899|NCT02021942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19989900|NCT02021942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989901|NCT02022007|Metformin|metformin|mesh-list
19989902|NCT02022007|Saxagliptin|saxagliptin|mesh-list
19989903|NCT02022007|Biguanides|biguanides|mesh-list
19989904|NCT02022007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
19989905|NCT02022007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19989906|NCT02022007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989907|NCT02022007|Incretins|incretins|mesh-ancestor
19989908|NCT02022007|Hormones|hormones|mesh-ancestor
19989909|NCT02022007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19989910|NCT02022007|Protease Inhibitors|protease inhibitors|mesh-ancestor
19989911|NCT02022007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989912|NCT02022007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989913|NCT02022657|Tenofovir|tenofovir|mesh-list
19989914|NCT02022657|Emtricitabine|emtricitabine|mesh-list
19989915|NCT02022657|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19989916|NCT02022657|Antiviral Agents|antiviral agents|mesh-ancestor
19989917|NCT02022657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19989918|NCT02022657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19989919|NCT02022657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19989920|NCT02022657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989921|NCT02022657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989922|NCT02022657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19989923|NCT02022657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19989924|NCT02022748|Ticagrelor|ticagrelor|mesh-list
19989925|NCT02022748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19989926|NCT02022748|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19989927|NCT02022748|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19989928|NCT02022748|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19989929|NCT02022748|Purinergic Agents|purinergic agents|mesh-ancestor
19989930|NCT02022748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19989931|NCT02022748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989932|NCT02022748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989933|NCT02023099|Ritonavir|ritonavir|mesh-list
19989934|NCT02023099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19989935|NCT02023099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19989936|NCT02023099|Protease Inhibitors|protease inhibitors|mesh-ancestor
19989937|NCT02023099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989938|NCT02023099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989939|NCT02023099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19989940|NCT02023099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19989941|NCT02023099|Antiviral Agents|antiviral agents|mesh-ancestor
19989942|NCT02023099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19989943|NCT02023099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19989944|NCT02023099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19989945|NCT02023112|Ritonavir|ritonavir|mesh-list
19989946|NCT02023112|Ribavirin|ribavirin|mesh-list
19989947|NCT02023112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19989948|NCT02023112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19989949|NCT02023112|Protease Inhibitors|protease inhibitors|mesh-ancestor
19989950|NCT02023112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989951|NCT02023112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989952|NCT02023112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19989953|NCT02023112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19989954|NCT02023112|Antiviral Agents|antiviral agents|mesh-ancestor
19989955|NCT02023112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19989956|NCT02023112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19989957|NCT02023112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19989958|NCT02023112|Antimetabolites|antimetabolites|mesh-ancestor
19989959|NCT02023125|Esomeprazole|esomeprazole|mesh-list
19989960|NCT02023125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19989961|NCT02023125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19989962|NCT02023125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19989963|NCT02023125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989964|NCT02023125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989965|NCT02023151|Omalizumab|omalizumab|mesh-list
19989966|NCT02023151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19989967|NCT02023151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19989968|NCT02023151|Respiratory System Agents|respiratory system agents|mesh-ancestor
19989969|NCT02023411|Teriparatide|teriparatide|mesh-list
19989970|NCT02023411|Hormones|hormones|mesh-list
19989971|NCT02023411|Parathyroid Hormone|parathyroid hormone|mesh-list
19989972|NCT02023411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19989973|NCT02023411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989974|NCT02023411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19989975|NCT02023411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19989976|NCT02023697|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19989977|NCT02023697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989978|NCT02023866|Cysteamine|cysteamine|mesh-list
19989979|NCT02023866|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
19989980|NCT02023866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989981|NCT02023879|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19989982|NCT02023879|Immunologic Factors|immunologic factors|mesh-ancestor
19989983|NCT02023879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989984|NCT02024087|Sorafenib|sorafenib|mesh-list
19989985|NCT02024087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19989986|NCT02024087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19989987|NCT02024087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19989988|NCT02024087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19989989|NCT02024204|Fluticasone|fluticasone|mesh-list
19989990|NCT02024204|Xhance|xhance|mesh-list
19989991|NCT02024204|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19989992|NCT02024204|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19989993|NCT02024204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19989994|NCT02024204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19989995|NCT02024204|Autonomic Agents|autonomic agents|mesh-ancestor
19989996|NCT02024204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19989997|NCT02024204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19989998|NCT02024204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19989999|NCT02024204|Respiratory System Agents|respiratory system agents|mesh-ancestor
19990000|NCT02024204|Dermatologic Agents|dermatologic agents|mesh-ancestor
19990001|NCT02024204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19990002|NCT02024204|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19990003|NCT02024204|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19990004|NCT02024204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19990005|NCT02024204|Adrenergic Agents|adrenergic agents|mesh-ancestor
19990006|NCT02024204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19990007|NCT02024204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990008|NCT02024204|Glucocorticoids|glucocorticoids|mesh-ancestor
19990009|NCT02024204|Hormones|hormones|mesh-ancestor
19990010|NCT02024204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19990011|NCT02024204|Sympathomimetics|sympathomimetics|mesh-ancestor
19990012|NCT02024386|Riociguat|riociguat|mesh-list
19990013|NCT02024386|Enzyme Activators|enzyme activators|mesh-ancestor
19990014|NCT02024386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990015|NCT02024477|Saxagliptin|saxagliptin|mesh-list
19990016|NCT02024477|Incretins|incretins|mesh-ancestor
19990017|NCT02024477|Hormones|hormones|mesh-ancestor
19990018|NCT02024477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19990019|NCT02024477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990020|NCT02024477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19990021|NCT02024477|Protease Inhibitors|protease inhibitors|mesh-ancestor
19990022|NCT02024477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990023|NCT02024477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990024|NCT02024477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19990025|NCT02024646|Brodalumab|brodalumab|mesh-list
19990026|NCT02024646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19990027|NCT02024646|Dermatologic Agents|dermatologic agents|mesh-ancestor
19990028|NCT02024646|Immunologic Factors|immunologic factors|mesh-ancestor
19990029|NCT02024646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990030|NCT02024711|Hyaluronic Acid|hyaluronic acid|mesh-list
19990031|NCT02024711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19990032|NCT02024711|Immunologic Factors|immunologic factors|mesh-ancestor
19990033|NCT02024711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990034|NCT02024711|Viscosupplements|viscosupplements|mesh-ancestor
19990035|NCT02024711|Protective Agents|protective agents|mesh-ancestor
19990036|NCT02024724|Dexamethasone|dexamethasone|mesh-list
19990037|NCT02024724|Triamcinolone|triamcinolone|mesh-list
19990038|NCT02024724|Bupivacaine|bupivacaine|mesh-list
19990039|NCT02024724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19990040|NCT02024724|Antiemetics|antiemetics|mesh-ancestor
19990041|NCT02024724|Autonomic Agents|autonomic agents|mesh-ancestor
19990042|NCT02024724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990043|NCT02024724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990044|NCT02024724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19990045|NCT02024724|Glucocorticoids|glucocorticoids|mesh-ancestor
19990046|NCT02024724|Hormones|hormones|mesh-ancestor
19990047|NCT02024724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19990048|NCT02024724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19990049|NCT02024724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990050|NCT02024724|Anesthetics, Local|anesthetics, local|mesh-ancestor
19990051|NCT02024724|Anesthetics|anesthetics|mesh-ancestor
19990052|NCT02024724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19990053|NCT02024724|Sensory System Agents|sensory system agents|mesh-ancestor
19990054|NCT02024867|Trimethoprim|trimethoprim|mesh-list
19990055|NCT02024867|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19990056|NCT02024867|Sulfamethoxazole|sulfamethoxazole|mesh-list
19990057|NCT02024867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19990058|NCT02024867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19990059|NCT02024867|Renal Agents|renal agents|mesh-ancestor
19990060|NCT02024867|Antimalarials|antimalarials|mesh-ancestor
19990061|NCT02024867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19990062|NCT02024867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19990063|NCT02024867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19990064|NCT02024867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990065|NCT02024867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990066|NCT02024867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19990067|NCT02024867|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19990068|NCT02024867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19990069|NCT02024867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19990070|NCT02024971|Metformin|metformin|mesh-list
19990071|NCT02024971|Pioglitazone|pioglitazone|mesh-list
19990072|NCT02024971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19990073|NCT02024971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990074|NCT02025075|Rocuronium|rocuronium|mesh-list
19990075|NCT02025075|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19990076|NCT02025075|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19990077|NCT02025075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19990078|NCT02025075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990079|NCT02025075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990080|NCT02025179|Teriparatide|teriparatide|mesh-list
19990081|NCT02025179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19990082|NCT02025179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990083|NCT02025179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19990084|NCT02025426|Phenylephrine|phenylephrine|mesh-list
19990085|NCT02025426|Oxymetazoline|oxymetazoline|mesh-list
19990086|NCT02025426|Ephedrine|ephedrine|mesh-list
19990087|NCT02025426|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19990088|NCT02025426|Mydriatics|mydriatics|mesh-ancestor
19990089|NCT02025426|Autonomic Agents|autonomic agents|mesh-ancestor
19990090|NCT02025426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990091|NCT02025426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990092|NCT02025426|Sympathomimetics|sympathomimetics|mesh-ancestor
19990093|NCT02025426|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19990094|NCT02025426|Nasal Decongestants|nasal decongestants|mesh-ancestor
19990095|NCT02025426|Respiratory System Agents|respiratory system agents|mesh-ancestor
19990096|NCT02025426|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19990097|NCT02025426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19990098|NCT02025426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19990099|NCT02025426|Adrenergic Agents|adrenergic agents|mesh-ancestor
19990100|NCT02025426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19990101|NCT02025426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990102|NCT02025426|Protective Agents|protective agents|mesh-ancestor
19990103|NCT02025426|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19990104|NCT02025439|Amantadine|amantadine|mesh-list
19990105|NCT02025439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19990106|NCT02025439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19990107|NCT02025439|Antiviral Agents|antiviral agents|mesh-ancestor
19990108|NCT02025439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19990109|NCT02025439|Dopamine Agents|dopamine agents|mesh-ancestor
19990110|NCT02025439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19990111|NCT02025439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990112|NCT02025439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990113|NCT02025439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19990114|NCT02025439|Analgesics|analgesics|mesh-ancestor
19990115|NCT02025439|Sensory System Agents|sensory system agents|mesh-ancestor
19990116|NCT02025439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990117|NCT02025621|Simendan|simendan|mesh-list
19990118|NCT02025621|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19990119|NCT02025621|Vasodilator Agents|vasodilator agents|mesh-ancestor
19990120|NCT02025621|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
19990121|NCT02025621|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19990122|NCT02025621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990123|NCT02025621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990124|NCT02025621|Protective Agents|protective agents|mesh-ancestor
19990125|NCT02025621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990126|NCT02025634|Acetaminophen|acetaminophen|mesh-list
19990127|NCT02025634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19990128|NCT02025634|Analgesics|analgesics|mesh-ancestor
19990129|NCT02025634|Sensory System Agents|sensory system agents|mesh-ancestor
19990130|NCT02025634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990131|NCT02025634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990132|NCT02025634|Antipyretics|antipyretics|mesh-ancestor
19990133|NCT02025725|Metoclopramide|metoclopramide|mesh-list
19990134|NCT02025725|Antiemetics|antiemetics|mesh-ancestor
19990135|NCT02025725|Autonomic Agents|autonomic agents|mesh-ancestor
19990136|NCT02025725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990137|NCT02025725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990138|NCT02025725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19990139|NCT02025725|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19990140|NCT02025725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19990141|NCT02025725|Dopamine Agents|dopamine agents|mesh-ancestor
19990142|NCT02025725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19990143|NCT02025725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990144|NCT02025751|Metoclopramide|metoclopramide|mesh-list
19990145|NCT02025751|Antiemetics|antiemetics|mesh-ancestor
19990146|NCT02025751|Autonomic Agents|autonomic agents|mesh-ancestor
19990147|NCT02025751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990148|NCT02025751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990149|NCT02025751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19990150|NCT02025751|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19990151|NCT02025751|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19990152|NCT02025751|Dopamine Agents|dopamine agents|mesh-ancestor
19990153|NCT02025751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19990154|NCT02025751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990155|NCT02025907|Canagliflozin|canagliflozin|mesh-list
19990156|NCT02025907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19990157|NCT02025907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990158|NCT02025907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19990159|NCT02025907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990160|NCT02026011|Naltrexone|naltrexone|mesh-list
19990161|NCT02026011|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19990162|NCT02026011|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19990163|NCT02026011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990164|NCT02026011|Sensory System Agents|sensory system agents|mesh-ancestor
19990165|NCT02026011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990166|NCT02026141|Dexmedetomidine|dexmedetomidine|mesh-list
19990167|NCT02026141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19990168|NCT02026141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19990169|NCT02026141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990170|NCT02026141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19990171|NCT02026141|Analgesics|analgesics|mesh-ancestor
19990172|NCT02026141|Sensory System Agents|sensory system agents|mesh-ancestor
19990173|NCT02026141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990174|NCT02026141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19990175|NCT02026141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20556427|NCT01946620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20556428|NCT01946620|Autonomic Agents|autonomic agents|mesh-ancestor
20556429|NCT01946620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556430|NCT01946620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556431|NCT01946620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20556432|NCT01946620|Respiratory System Agents|respiratory system agents|mesh-ancestor
20556433|NCT01946620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20556434|NCT01946620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20556435|NCT01946620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19990176|NCT02026141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19990177|NCT02026141|Adrenergic Agents|adrenergic agents|mesh-ancestor
19990178|NCT02026141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19990179|NCT02026141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990180|NCT02026297|Tranexamic Acid|tranexamic acid|mesh-list
19990181|NCT02026297|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19990182|NCT02026297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19990183|NCT02026297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990184|NCT02026297|Hemostatics|hemostatics|mesh-ancestor
19990185|NCT02026297|Coagulants|coagulants|mesh-ancestor
19990186|NCT02027311|Midazolam|midazolam|mesh-list
19990187|NCT02027311|Meperidine|meperidine|mesh-list
19990188|NCT02027311|Etomidate|etomidate|mesh-list
19990189|NCT02027311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19990190|NCT02027311|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19990191|NCT02027311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19990192|NCT02027311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990193|NCT02027311|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19990194|NCT02027311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19990195|NCT02027311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19990196|NCT02027311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19990197|NCT02027311|Anesthetics, General|anesthetics, general|mesh-ancestor
19990198|NCT02027311|Anesthetics|anesthetics|mesh-ancestor
19990199|NCT02027311|GABA Modulators|gaba modulators|mesh-ancestor
19990200|NCT02027311|GABA Agents|gaba agents|mesh-ancestor
19990201|NCT02027311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19990202|NCT02027311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990203|NCT02027311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19990204|NCT02027311|Narcotics|narcotics|mesh-ancestor
19990205|NCT02027311|Analgesics|analgesics|mesh-ancestor
19990206|NCT02027311|Sensory System Agents|sensory system agents|mesh-ancestor
19990207|NCT02027311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990208|NCT02027376|Docetaxel|docetaxel|mesh-list
19990209|NCT02027376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990210|NCT02027376|Tubulin Modulators|tubulin modulators|mesh-ancestor
19990211|NCT02027376|Antimitotic Agents|antimitotic agents|mesh-ancestor
19990212|NCT02027376|Mitosis Modulators|mitosis modulators|mesh-ancestor
19990213|NCT02027376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990214|NCT02027428|Paclitaxel|paclitaxel|mesh-list
19990215|NCT02027428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19990216|NCT02027428|Carboplatin|carboplatin|mesh-list
19990217|NCT02027428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19990218|NCT02027428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990219|NCT02027428|Tubulin Modulators|tubulin modulators|mesh-ancestor
19990220|NCT02027428|Antimitotic Agents|antimitotic agents|mesh-ancestor
19990221|NCT02027428|Mitosis Modulators|mitosis modulators|mesh-ancestor
19990222|NCT02027428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990223|NCT02028221|Metformin|metformin|mesh-list
19990224|NCT02028221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19990225|NCT02028221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990226|NCT02028676|Lamivudine|lamivudine|mesh-list
19990227|NCT02028676|Zidovudine|zidovudine|mesh-list
19990228|NCT02028676|Efavirenz|efavirenz|mesh-list
19990229|NCT02028676|Nevirapine|nevirapine|mesh-list
19990230|NCT02028676|Abacavir|abacavir|mesh-list
19990231|NCT02028676|Dideoxynucleosides|dideoxynucleosides|mesh-list
19990232|NCT02028676|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
19990233|NCT02028676|Trimethoprim|trimethoprim|mesh-list
19990234|NCT02028676|Sulfamethoxazole|sulfamethoxazole|mesh-list
19990235|NCT02028676|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19990236|NCT02028676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19990237|NCT02028676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19990238|NCT02028676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990239|NCT02028676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990240|NCT02028676|Antiviral Agents|antiviral agents|mesh-ancestor
19990241|NCT02028676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19990242|NCT02028676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19990243|NCT02028676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19990244|NCT02028676|Antimetabolites|antimetabolites|mesh-ancestor
19990245|NCT02028676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19990246|NCT02028676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19990247|NCT02028676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19990248|NCT02028676|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19990249|NCT02028676|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19990250|NCT02028676|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20556436|NCT01946620|Adrenergic Agents|adrenergic agents|mesh-ancestor
20556437|NCT01946620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20556438|NCT01946620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556439|NCT01946815|Atorvastatin|atorvastatin|mesh-list
20556440|NCT01946815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20556441|NCT01946815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20556442|NCT01946815|Antimetabolites|antimetabolites|mesh-ancestor
20556443|NCT01946815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556444|NCT01946815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20556445|NCT01946815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20556446|NCT01946815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556447|NCT01946906|Rifaximin|rifaximin|mesh-list
19990251|NCT02028676|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19990252|NCT02028676|Renal Agents|renal agents|mesh-ancestor
19990253|NCT02028676|Antimalarials|antimalarials|mesh-ancestor
19990254|NCT02028676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19990255|NCT02028676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19990256|NCT02028676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19990257|NCT02028676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19990258|NCT02028676|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19990259|NCT02028676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19990260|NCT02028715|Acetaminophen|acetaminophen|mesh-list
19990261|NCT02028715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19990262|NCT02028715|Analgesics|analgesics|mesh-ancestor
19990263|NCT02028715|Sensory System Agents|sensory system agents|mesh-ancestor
19990264|NCT02028715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990265|NCT02028715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990266|NCT02028715|Antipyretics|antipyretics|mesh-ancestor
19990267|NCT02028754|Levofloxacin|levofloxacin|mesh-list
19990268|NCT02028754|Ofloxacin|ofloxacin|mesh-list
19990269|NCT02028754|Prednisolone|prednisolone|mesh-list
19990270|NCT02028754|Prednisolone acetate|prednisolone acetate|mesh-list
19990271|NCT02028754|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19990272|NCT02028754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19990273|NCT02028754|Glucocorticoids|glucocorticoids|mesh-ancestor
19990274|NCT02028754|Hormones|hormones|mesh-ancestor
19990275|NCT02028754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19990276|NCT02028754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990277|NCT02028754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19990278|NCT02028754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990279|NCT02028754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19990280|NCT02028754|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19990281|NCT02028754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19990282|NCT02028754|Renal Agents|renal agents|mesh-ancestor
19990283|NCT02028754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19990284|NCT02028754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19990285|NCT02028754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19990286|NCT02028754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990287|NCT02028754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990288|NCT02028754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19990289|NCT02028754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19990290|NCT02028754|Laxatives|laxatives|mesh-ancestor
19990291|NCT02028767|Metformin|metformin|mesh-list
19990292|NCT02028767|Empagliflozin|empagliflozin|mesh-list
19990293|NCT02028767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19990294|NCT02028767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990295|NCT02028767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19990296|NCT02028767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990297|NCT02028780|Dabigatran|dabigatran|mesh-list
19990298|NCT02028780|Antithrombins|antithrombins|mesh-ancestor
19990299|NCT02028780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19990300|NCT02028780|Protease Inhibitors|protease inhibitors|mesh-ancestor
19990301|NCT02028780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990302|NCT02028780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990303|NCT02028780|Anticoagulants|anticoagulants|mesh-ancestor
19990304|NCT02028871|Insulin|insulin|mesh-list
19990305|NCT02028871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19990306|NCT02028871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990307|NCT02029235|Acetaminophen|acetaminophen|mesh-list
19990308|NCT02029235|Ibuprofen|ibuprofen|mesh-list
19990309|NCT02029235|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19990310|NCT02029235|Hydrocodone|hydrocodone|mesh-list
19990311|NCT02029235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19990312|NCT02029235|Analgesics|analgesics|mesh-ancestor
19990313|NCT02029235|Sensory System Agents|sensory system agents|mesh-ancestor
19990314|NCT02029235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990315|NCT02029235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990316|NCT02029235|Antipyretics|antipyretics|mesh-ancestor
19990317|NCT02029235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19990318|NCT02029235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19990319|NCT02029235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19990320|NCT02029235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19990321|NCT02029235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990322|NCT02029235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990323|NCT02029235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19990324|NCT02029235|Narcotics|narcotics|mesh-ancestor
19990325|NCT02029235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19990326|NCT02029235|Antitussive Agents|antitussive agents|mesh-ancestor
19990327|NCT02029235|Respiratory System Agents|respiratory system agents|mesh-ancestor
19990328|NCT02029274|Siponimod|siponimod|mesh-list
19990329|NCT02029274|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19990330|NCT02029274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990331|NCT02029274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19990332|NCT02029274|Immunologic Factors|immunologic factors|mesh-ancestor
19990333|NCT02029274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990334|NCT02029417|Cytarabine|cytarabine|mesh-list
19990335|NCT02029417|Decitabine|decitabine|mesh-list
19990336|NCT02029417|Azacitidine|azacitidine|mesh-list
19990337|NCT02029417|Homoharringtonine|homoharringtonine|mesh-list
19990338|NCT02029417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19990339|NCT02029417|Antimetabolites|antimetabolites|mesh-ancestor
19990340|NCT02029417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990341|NCT02029417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990342|NCT02029417|Antiviral Agents|antiviral agents|mesh-ancestor
19990343|NCT02029417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19990344|NCT02029417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19990345|NCT02029417|Immunologic Factors|immunologic factors|mesh-ancestor
19990346|NCT02029417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990347|NCT02029417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990348|NCT02029417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19990349|NCT02029417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19990350|NCT02029495|Brodalumab|brodalumab|mesh-list
19990351|NCT02029495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19990352|NCT02029495|Dermatologic Agents|dermatologic agents|mesh-ancestor
19990353|NCT02029495|Immunologic Factors|immunologic factors|mesh-ancestor
19990354|NCT02029495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990355|NCT02029638|Acetaminophen|acetaminophen|mesh-list
19990356|NCT02029638|Diphenhydramine|diphenhydramine|mesh-list
19990357|NCT02029638|Promethazine|promethazine|mesh-list
19990358|NCT02029638|Mycophenolic Acid|mycophenolic acid|mesh-list
19990359|NCT02029638|Prednisone|prednisone|mesh-list
19990360|NCT02029638|Methylprednisolone|methylprednisolone|mesh-list
19990361|NCT02029638|Cyclophosphamide|cyclophosphamide|mesh-list
19990362|NCT02029638|Fludarabine|fludarabine|mesh-list
19990363|NCT02029638|Thymoglobulin|thymoglobulin|mesh-list
19990364|NCT02029638|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19990365|NCT02029638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19990366|NCT02029638|Immunologic Factors|immunologic factors|mesh-ancestor
19990367|NCT02029638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990368|NCT02029638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19990369|NCT02029638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19990370|NCT02029638|Alkylating Agents|alkylating agents|mesh-ancestor
19990371|NCT02029638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990372|NCT02029638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990373|NCT02029638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19990374|NCT02029638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19990375|NCT02029638|Glucocorticoids|glucocorticoids|mesh-ancestor
19990376|NCT02029638|Hormones|hormones|mesh-ancestor
19990377|NCT02029638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19990378|NCT02029638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19990379|NCT02029638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19990380|NCT02029638|Analgesics|analgesics|mesh-ancestor
19990381|NCT02029638|Sensory System Agents|sensory system agents|mesh-ancestor
19990382|NCT02029638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990383|NCT02029638|Antipyretics|antipyretics|mesh-ancestor
19990384|NCT02029638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19990385|NCT02029638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19990386|NCT02029638|Antitubercular Agents|antitubercular agents|mesh-ancestor
19990387|NCT02029638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19990388|NCT02029638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19990389|NCT02029638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990390|NCT02029638|Antiemetics|antiemetics|mesh-ancestor
19990391|NCT02029638|Autonomic Agents|autonomic agents|mesh-ancestor
19990392|NCT02029638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19990393|NCT02029638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19990394|NCT02029638|Protective Agents|protective agents|mesh-ancestor
19990395|NCT02029638|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19990396|NCT02029638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19990397|NCT02029638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19990398|NCT02029638|Anesthetics, Local|anesthetics, local|mesh-ancestor
19990399|NCT02029638|Anesthetics|anesthetics|mesh-ancestor
19990400|NCT02029638|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19990401|NCT02029638|Histamine Antagonists|histamine antagonists|mesh-ancestor
19990402|NCT02029638|Histamine Agents|histamine agents|mesh-ancestor
19990403|NCT02029638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19990404|NCT02029638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19990405|NCT02029638|Antipruritics|antipruritics|mesh-ancestor
19990406|NCT02029638|Dermatologic Agents|dermatologic agents|mesh-ancestor
19990407|NCT02029703|Hylan|hylan|mesh-list
19990408|NCT02029703|Viscosupplements|viscosupplements|mesh-ancestor
19990409|NCT02029703|Protective Agents|protective agents|mesh-ancestor
19990410|NCT02029703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990411|NCT02029755|Anesthetics|anesthetics|mesh-list
19990412|NCT02029755|Anesthetics, Local|anesthetics, local|mesh-list
19990413|NCT02029755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19990414|NCT02029755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990415|NCT02029755|Sensory System Agents|sensory system agents|mesh-ancestor
19990416|NCT02029755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990417|NCT02029872|Chlorhexidine|chlorhexidine|mesh-list
19990418|NCT02029872|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19990419|NCT02029872|Mupirocin|mupirocin|mesh-list
19990420|NCT02029872|Calcium|calcium|mesh-list
19990421|NCT02029872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19990422|NCT02029872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990423|NCT02029872|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19990424|NCT02029872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19990425|NCT02029872|Disinfectants|disinfectants|mesh-ancestor
19990426|NCT02029872|Dermatologic Agents|dermatologic agents|mesh-ancestor
19990427|NCT02029872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19990428|NCT02029872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19990429|NCT02029872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990430|NCT02029872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990431|NCT02030041|Vitamin D|vitamin d|mesh-list
19990432|NCT02030041|Cholecalciferol|cholecalciferol|mesh-list
19990433|NCT02030041|Simvastatin|simvastatin|mesh-list
19990434|NCT02030041|Vitamins|vitamins|mesh-ancestor
19990435|NCT02030041|Micronutrients|micronutrients|mesh-ancestor
19990436|NCT02030041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990437|NCT02030041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19990438|NCT02030041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19990439|NCT02030041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19990440|NCT02030041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19990441|NCT02030041|Antimetabolites|antimetabolites|mesh-ancestor
19990442|NCT02030041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990443|NCT02030041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19990444|NCT02030041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19990445|NCT02030041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990446|NCT02030405|Ixazomib|ixazomib|mesh-list
19990447|NCT02030405|Proteasome Inhibitors|proteasome inhibitors|mesh-list
19990448|NCT02030405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990449|NCT02030405|Protease Inhibitors|protease inhibitors|mesh-ancestor
19990450|NCT02030405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990451|NCT02030405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990452|NCT02030535|Tiotropium Bromide|tiotropium bromide|mesh-list
19990453|NCT02030535|Olodaterol|olodaterol|mesh-list
19990454|NCT02030535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19990455|NCT02030535|Autonomic Agents|autonomic agents|mesh-ancestor
19990456|NCT02030535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990457|NCT02030535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990458|NCT02030535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19990459|NCT02030535|Respiratory System Agents|respiratory system agents|mesh-ancestor
19990460|NCT02030535|Parasympatholytics|parasympatholytics|mesh-ancestor
19990461|NCT02030535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19990462|NCT02030535|Cholinergic Agents|cholinergic agents|mesh-ancestor
19990463|NCT02030535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19990464|NCT02030535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990465|NCT02030574|Gemcitabine|gemcitabine|mesh-list
19990466|NCT02030574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990467|NCT02030574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19990468|NCT02030574|Antimetabolites|antimetabolites|mesh-ancestor
19990469|NCT02030574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990470|NCT02030574|Antiviral Agents|antiviral agents|mesh-ancestor
19990471|NCT02030574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19990472|NCT02030574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990473|NCT02030574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19990474|NCT02030574|Immunologic Factors|immunologic factors|mesh-ancestor
19990475|NCT02030574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990476|NCT02030600|Insulin|insulin|mesh-list
19990477|NCT02030600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19990478|NCT02030600|Insulin Glargine|insulin glargine|mesh-list
19990479|NCT02030600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19990480|NCT02030600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990481|NCT02030821|Tranexamic Acid|tranexamic acid|mesh-list
19990482|NCT02030821|Aminocaproic Acid|aminocaproic acid|mesh-list
19990483|NCT02030821|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19990484|NCT02030821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19990485|NCT02030821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990486|NCT02030821|Hemostatics|hemostatics|mesh-ancestor
19990487|NCT02030821|Coagulants|coagulants|mesh-ancestor
19990488|NCT02031276|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19990489|NCT02031276|Immunologic Factors|immunologic factors|mesh-ancestor
19990490|NCT02031276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990491|NCT02031458|Atezolizumab|atezolizumab|mesh-list
19990492|NCT02031458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990493|NCT02031536|Everolimus|everolimus|mesh-list
19990494|NCT02031536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990495|NCT02031536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19990496|NCT02031536|Immunologic Factors|immunologic factors|mesh-ancestor
19990497|NCT02031536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990498|NCT02031640|Beclomethasone|beclomethasone|mesh-list
19990499|NCT02031640|Albuterol|albuterol|mesh-list
19990500|NCT02031640|Bronchodilator Agents|bronchodilator agents|mesh-list
19990501|NCT02031640|Autonomic Agents|autonomic agents|mesh-ancestor
19990502|NCT02031640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990503|NCT02031640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990504|NCT02031640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19990505|NCT02031640|Respiratory System Agents|respiratory system agents|mesh-ancestor
19990506|NCT02031640|Tocolytic Agents|tocolytic agents|mesh-ancestor
19990507|NCT02031640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19990508|NCT02031640|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19990509|NCT02031640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19990510|NCT02031640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19990511|NCT02031640|Adrenergic Agents|adrenergic agents|mesh-ancestor
19990512|NCT02031640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19990513|NCT02031640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990514|NCT02031640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19990515|NCT02031640|Glucocorticoids|glucocorticoids|mesh-ancestor
19990516|NCT02031640|Hormones|hormones|mesh-ancestor
19990517|NCT02031640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19990518|NCT02032173|Ranibizumab|ranibizumab|mesh-list
19990519|NCT02032173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19990520|NCT02032173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19990521|NCT02032173|Growth Substances|growth substances|mesh-ancestor
19990522|NCT02032173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990523|NCT02032173|Growth Inhibitors|growth inhibitors|mesh-ancestor
19990524|NCT02032173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990525|NCT02032212|Nicotine|nicotine|mesh-list
19990526|NCT02032212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19990527|NCT02032212|Autonomic Agents|autonomic agents|mesh-ancestor
19990528|NCT02032212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990529|NCT02032212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990530|NCT02032212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19990531|NCT02032212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19990532|NCT02032212|Cholinergic Agents|cholinergic agents|mesh-ancestor
19990533|NCT02032212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19990534|NCT02032212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990535|NCT02032407|Dapsone|dapsone|mesh-list
19990536|NCT02032407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19990537|NCT02032407|Antimalarials|antimalarials|mesh-ancestor
19990538|NCT02032407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19990539|NCT02032407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19990540|NCT02032407|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19990541|NCT02032407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990542|NCT02032407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990543|NCT02032407|Leprostatic Agents|leprostatic agents|mesh-ancestor
19990544|NCT02032407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19990545|NCT02032433|Naltrexone|naltrexone|mesh-list
19990546|NCT02032433|Buprenorphine|buprenorphine|mesh-list
19990547|NCT02032433|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19990548|NCT02032433|Naloxone|naloxone|mesh-list
19990549|NCT02032433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19990550|NCT02032433|Narcotics|narcotics|mesh-ancestor
19990551|NCT02032433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19990552|NCT02032433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990553|NCT02032433|Analgesics|analgesics|mesh-ancestor
19990554|NCT02032433|Sensory System Agents|sensory system agents|mesh-ancestor
19990555|NCT02032433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990556|NCT02032433|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19990557|NCT02032433|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19990558|NCT02032758|Propranolol|propranolol|mesh-list
19990559|NCT02032758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19990560|NCT02032758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19990561|NCT02032758|Adrenergic Agents|adrenergic agents|mesh-ancestor
19990562|NCT02032758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19990563|NCT02032758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990564|NCT02032758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990565|NCT02032758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19990566|NCT02032758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19990567|NCT02032758|Vasodilator Agents|vasodilator agents|mesh-ancestor
19990568|NCT02032875|Ribavirin|ribavirin|mesh-list
19990569|NCT02032875|Sofosbuvir|sofosbuvir|mesh-list
19990570|NCT02032875|Antimetabolites|antimetabolites|mesh-ancestor
19990571|NCT02032875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990572|NCT02032875|Antiviral Agents|antiviral agents|mesh-ancestor
19990573|NCT02032875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19990574|NCT02032888|Sofosbuvir|sofosbuvir|mesh-list
19990575|NCT02032888|Antiviral Agents|antiviral agents|mesh-ancestor
19990576|NCT02032888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19990577|NCT02032901|Sofosbuvir|sofosbuvir|mesh-list
19990578|NCT02032901|Antiviral Agents|antiviral agents|mesh-ancestor
19990579|NCT02032901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19990580|NCT02033369|Pramipexole|pramipexole|mesh-list
19990581|NCT02033369|Antioxidants|antioxidants|mesh-ancestor
19990582|NCT02033369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990583|NCT02033369|Protective Agents|protective agents|mesh-ancestor
19990584|NCT02033369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990585|NCT02033369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19990586|NCT02033369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19990587|NCT02033369|Dopamine Agonists|dopamine agonists|mesh-ancestor
19990588|NCT02033369|Dopamine Agents|dopamine agents|mesh-ancestor
19990589|NCT02033369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20289248|NCT04876937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20289249|NCT04876937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20289250|NCT04876937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19990590|NCT02033876|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
19990591|NCT02033876|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19990592|NCT02033876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19990593|NCT02033889|Insulin|insulin|mesh-list
19990594|NCT02033889|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19990595|NCT02033889|Metformin|metformin|mesh-list
19990596|NCT02033889|Insulin Glargine|insulin glargine|mesh-list
19990597|NCT02033889|Glimepiride|glimepiride|mesh-list
19990598|NCT02033889|Insulin Detemir|insulin detemir|mesh-list
19990599|NCT02033889|Ertugliflozin|ertugliflozin|mesh-list
19990600|NCT02033889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19990601|NCT02033889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990602|NCT02033889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19990603|NCT02033889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19990604|NCT02033889|Immunologic Factors|immunologic factors|mesh-ancestor
19990605|NCT02033889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19990606|NCT02033889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990607|NCT02033993|Paclitaxel|paclitaxel|mesh-list
19990608|NCT02033993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19990609|NCT02033993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19990610|NCT02033993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990611|NCT02033993|Tubulin Modulators|tubulin modulators|mesh-ancestor
19990612|NCT02033993|Antimitotic Agents|antimitotic agents|mesh-ancestor
19990613|NCT02033993|Mitosis Modulators|mitosis modulators|mesh-ancestor
19990614|NCT02033993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990615|NCT02034006|Ranibizumab|ranibizumab|mesh-list
19990616|NCT02034006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19990617|NCT02034006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19990618|NCT02034006|Growth Substances|growth substances|mesh-ancestor
19990619|NCT02034006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990620|NCT02034006|Growth Inhibitors|growth inhibitors|mesh-ancestor
19990621|NCT02034006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990622|NCT02034019|Dexamethasone|dexamethasone|mesh-list
19990623|NCT02034019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19990624|NCT02034019|Antiemetics|antiemetics|mesh-ancestor
19990625|NCT02034019|Autonomic Agents|autonomic agents|mesh-ancestor
19990626|NCT02034019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990627|NCT02034019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990628|NCT02034019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19990629|NCT02034019|Glucocorticoids|glucocorticoids|mesh-ancestor
19990630|NCT02034019|Hormones|hormones|mesh-ancestor
19990631|NCT02034019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19990632|NCT02034019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19990633|NCT02034019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990634|NCT02034162|Mebendazole|mebendazole|mesh-list
19990635|NCT02034162|Piperazine|piperazine|mesh-list
19990636|NCT02034162|Piperazine citrate|piperazine citrate|mesh-list
19990637|NCT02034162|DMP 777|dmp 777|mesh-list
19990638|NCT02034162|Antinematodal Agents|antinematodal agents|mesh-ancestor
19990639|NCT02034162|Anthelmintics|anthelmintics|mesh-ancestor
19990640|NCT02034162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19990641|NCT02034162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19990642|NCT02034162|Tubulin Modulators|tubulin modulators|mesh-ancestor
19990643|NCT02034162|Antimitotic Agents|antimitotic agents|mesh-ancestor
19990644|NCT02034162|Mitosis Modulators|mitosis modulators|mesh-ancestor
19990645|NCT02034162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990646|NCT02034162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990647|NCT02034162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990648|NCT02034435|Amlodipine|amlodipine|mesh-list
19990649|NCT02034435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19990650|NCT02034435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19990651|NCT02034435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19990652|NCT02034435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990653|NCT02034435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19990654|NCT02034435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990655|NCT02034435|Vasodilator Agents|vasodilator agents|mesh-ancestor
19990656|NCT02034513|Insulin|insulin|mesh-list
19990657|NCT02034513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19990658|NCT02034513|Insulin Glargine|insulin glargine|mesh-list
19990659|NCT02034513|Insulin Aspart|insulin aspart|mesh-list
19990660|NCT02034513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19990661|NCT02034513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990662|NCT02034552|Prednisone|prednisone|mesh-list
19990663|NCT02034552|Abiraterone Acetate|abiraterone acetate|mesh-list
19990664|NCT02034552|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19990665|NCT02034552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19990666|NCT02034552|Glucocorticoids|glucocorticoids|mesh-ancestor
19990667|NCT02034552|Hormones|hormones|mesh-ancestor
19990668|NCT02034552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19990669|NCT02034552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990670|NCT02034552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19990671|NCT02034552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990672|NCT02034552|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19990673|NCT02034552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990674|NCT02034552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990675|NCT02034552|Hormone Antagonists|hormone antagonists|mesh-ancestor
19990676|NCT02034552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19990677|NCT02034565|Apixaban|apixaban|mesh-list
19990678|NCT02034565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19990679|NCT02034565|Antithrombins|antithrombins|mesh-ancestor
19990680|NCT02034565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19990681|NCT02034565|Protease Inhibitors|protease inhibitors|mesh-ancestor
19990682|NCT02034565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990683|NCT02034565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990684|NCT02034565|Anticoagulants|anticoagulants|mesh-ancestor
19990685|NCT02034578|Apixaban|apixaban|mesh-list
19990686|NCT02034578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19990687|NCT02034578|Antithrombins|antithrombins|mesh-ancestor
19990688|NCT02034578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19990689|NCT02034578|Protease Inhibitors|protease inhibitors|mesh-ancestor
19990690|NCT02034578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990691|NCT02034578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990692|NCT02034578|Anticoagulants|anticoagulants|mesh-ancestor
19990693|NCT02034591|Apixaban|apixaban|mesh-list
19990694|NCT02034591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19990695|NCT02034591|Antithrombins|antithrombins|mesh-ancestor
19990696|NCT02034591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19990697|NCT02034591|Protease Inhibitors|protease inhibitors|mesh-ancestor
19990698|NCT02034591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990699|NCT02034591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990700|NCT02034591|Anticoagulants|anticoagulants|mesh-ancestor
19990701|NCT02034799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19990702|NCT02034799|Hemostatics|hemostatics|mesh-ancestor
19990703|NCT02034799|Coagulants|coagulants|mesh-ancestor
19990704|NCT02034877|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19990705|NCT02034877|Immunologic Factors|immunologic factors|mesh-ancestor
19990706|NCT02034877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990707|NCT02034916|Talazoparib|talazoparib|mesh-list
19990708|NCT02034916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19990709|NCT02034916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990710|NCT02034916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990711|NCT02034916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990712|NCT02035267|Deoxycholic Acid|deoxycholic acid|mesh-list
19990713|NCT02035267|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19990714|NCT02035267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19990715|NCT02035345|Carboplatin|carboplatin|mesh-list
19990716|NCT02035345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990717|NCT02035553|Pimavanserin|pimavanserin|mesh-list
19990718|NCT02035553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19990719|NCT02035553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19990720|NCT02035553|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19990721|NCT02035553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19990722|NCT02035553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19990723|NCT02035553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990724|NCT02035553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19990725|NCT02035553|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19990726|NCT02035553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19990727|NCT02035553|Serotonin Agents|serotonin agents|mesh-ancestor
19990728|NCT02035553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19990729|NCT02035553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990730|NCT02035696|Vaccines|vaccines|mesh-list
19990731|NCT02035696|Immunologic Factors|immunologic factors|mesh-ancestor
19990732|NCT02035696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990733|NCT02036424|Dexamethasone|dexamethasone|mesh-list
19990734|NCT02036424|Bevacizumab|bevacizumab|mesh-list
19990735|NCT02036424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19990736|NCT02036424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990737|NCT02036424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19990738|NCT02036424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19990739|NCT02036424|Growth Substances|growth substances|mesh-ancestor
19990740|NCT02036424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990741|NCT02036424|Growth Inhibitors|growth inhibitors|mesh-ancestor
19990742|NCT02036424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19990743|NCT02036424|Antiemetics|antiemetics|mesh-ancestor
19990744|NCT02036424|Autonomic Agents|autonomic agents|mesh-ancestor
19990745|NCT02036424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990746|NCT02036424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19990747|NCT02036424|Glucocorticoids|glucocorticoids|mesh-ancestor
19990748|NCT02036424|Hormones|hormones|mesh-ancestor
19990749|NCT02036424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19990750|NCT02036424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19990751|NCT02036502|Dexamethasone|dexamethasone|mesh-list
19990752|NCT02036502|Pembrolizumab|pembrolizumab|mesh-list
19990753|NCT02036502|Lenalidomide|lenalidomide|mesh-list
19990754|NCT02036502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19990755|NCT02036502|Antiemetics|antiemetics|mesh-ancestor
19990756|NCT02036502|Autonomic Agents|autonomic agents|mesh-ancestor
19990757|NCT02036502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990758|NCT02036502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990759|NCT02036502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19990760|NCT02036502|Glucocorticoids|glucocorticoids|mesh-ancestor
19990761|NCT02036502|Hormones|hormones|mesh-ancestor
19990762|NCT02036502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19990763|NCT02036502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19990764|NCT02036502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990765|NCT02036502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19990766|NCT02036502|Immunologic Factors|immunologic factors|mesh-ancestor
19990767|NCT02036502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19990768|NCT02036502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19990769|NCT02036502|Growth Substances|growth substances|mesh-ancestor
19990770|NCT02036502|Growth Inhibitors|growth inhibitors|mesh-ancestor
19990771|NCT02036515|Metformin|metformin|mesh-list
19990772|NCT02036515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19990773|NCT02036515|Glimepiride|glimepiride|mesh-list
19990774|NCT02036515|Ertugliflozin|ertugliflozin|mesh-list
19990775|NCT02036515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19990776|NCT02036515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990777|NCT02036515|Incretins|incretins|mesh-ancestor
19990778|NCT02036515|Hormones|hormones|mesh-ancestor
19990779|NCT02036515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19990780|NCT02036515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19990781|NCT02036515|Protease Inhibitors|protease inhibitors|mesh-ancestor
19990782|NCT02036515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990783|NCT02036515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990784|NCT02036515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19990785|NCT02036515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19990786|NCT02036515|Immunologic Factors|immunologic factors|mesh-ancestor
19990787|NCT02036515|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19990788|NCT02036580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19990789|NCT02036580|Immunologic Factors|immunologic factors|mesh-ancestor
19990790|NCT02036580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990791|NCT02036775|Ambroxol|ambroxol|mesh-list
19990792|NCT02036775|Expectorants|expectorants|mesh-ancestor
19990793|NCT02036775|Respiratory System Agents|respiratory system agents|mesh-ancestor
19990794|NCT02036840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19990795|NCT02036840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19990796|NCT02037061|Bupivacaine|bupivacaine|mesh-list
19990797|NCT02037061|Anesthetics, Local|anesthetics, local|mesh-ancestor
19990798|NCT02037061|Anesthetics|anesthetics|mesh-ancestor
19990799|NCT02037061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19990800|NCT02037061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990801|NCT02037061|Sensory System Agents|sensory system agents|mesh-ancestor
19990802|NCT02037061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990803|NCT02037165|Celecoxib|celecoxib|mesh-list
19990804|NCT02037165|Pregabalin|pregabalin|mesh-list
19990805|NCT02037165|Analgesics|analgesics|mesh-ancestor
19990806|NCT02037165|Sensory System Agents|sensory system agents|mesh-ancestor
19990807|NCT02037165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990808|NCT02037165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990809|NCT02037165|Anticonvulsants|anticonvulsants|mesh-ancestor
19990810|NCT02037165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19990811|NCT02037165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19990812|NCT02037165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990813|NCT02037165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19990814|NCT02037165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19990815|NCT02037165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19990816|NCT02037165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19990817|NCT02037165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19990818|NCT02037165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19990819|NCT02037165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19990820|NCT02037165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19990821|NCT02037165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19990822|NCT02037165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19990823|NCT02037165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19990824|NCT02037165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990825|NCT02037230|Gemcitabine|gemcitabine|mesh-list
19990826|NCT02037230|Adavosertib|adavosertib|mesh-list
19990827|NCT02037230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19990828|NCT02037230|Antimetabolites|antimetabolites|mesh-ancestor
19990829|NCT02037230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990830|NCT02037230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990831|NCT02037230|Antiviral Agents|antiviral agents|mesh-ancestor
19990832|NCT02037230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19990833|NCT02037230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990834|NCT02037230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19990835|NCT02037230|Immunologic Factors|immunologic factors|mesh-ancestor
19990836|NCT02037230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990837|NCT02037256|Bortezomib|bortezomib|mesh-list
19990838|NCT02037256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990839|NCT02037295|Vancomycin|vancomycin|mesh-list
19990840|NCT02037295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19990841|NCT02037295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19990842|NCT02037425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19990843|NCT02037425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19990844|NCT02037425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19990845|NCT02037425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990846|NCT02037425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990847|NCT02037425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19990848|NCT02037425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19990849|NCT02037425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990850|NCT02037425|Cholinergic Agents|cholinergic agents|mesh-ancestor
19990851|NCT02037425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19990852|NCT02037477|Esomeprazole|esomeprazole|mesh-list
19990853|NCT02037477|Rabeprazole|rabeprazole|mesh-list
19990854|NCT02037477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19990855|NCT02037477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19990856|NCT02037477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19990857|NCT02037477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990858|NCT02037477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990859|NCT02037555|Antithrombins|antithrombins|mesh-list
19990860|NCT02037555|Antithrombin III|antithrombin iii|mesh-list
19990861|NCT02037555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19990862|NCT02037555|Protease Inhibitors|protease inhibitors|mesh-ancestor
19990863|NCT02037555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990864|NCT02037555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990865|NCT02037555|Anticoagulants|anticoagulants|mesh-ancestor
19990866|NCT02037893|Antipyrine|antipyrine|mesh-list
19990867|NCT02037893|Benzocaine|benzocaine|mesh-list
19990868|NCT02037893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19990869|NCT02037893|Anesthetics, Local|anesthetics, local|mesh-ancestor
19990870|NCT02037893|Anesthetics|anesthetics|mesh-ancestor
19990871|NCT02037893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19990872|NCT02037893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990873|NCT02037893|Sensory System Agents|sensory system agents|mesh-ancestor
19990874|NCT02037893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990875|NCT02037893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19990876|NCT02037893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19990877|NCT02037893|Analgesics|analgesics|mesh-ancestor
19990878|NCT02037893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19990879|NCT02037893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19990880|NCT02037984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19990881|NCT02037984|Immunologic Factors|immunologic factors|mesh-ancestor
19990882|NCT02037984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990883|NCT02038010|Trastuzumab|trastuzumab|mesh-list
19990884|NCT02038010|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19990885|NCT02038010|Maytansine|maytansine|mesh-list
19990886|NCT02038010|Immunoconjugates|immunoconjugates|mesh-list
19990887|NCT02038010|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
19990888|NCT02038010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19990889|NCT02038010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990890|NCT02038010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19990891|NCT02038010|Tubulin Modulators|tubulin modulators|mesh-ancestor
19990892|NCT02038010|Antimitotic Agents|antimitotic agents|mesh-ancestor
19990893|NCT02038010|Mitosis Modulators|mitosis modulators|mesh-ancestor
19990894|NCT02038010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990895|NCT02038010|Immunologic Factors|immunologic factors|mesh-ancestor
19990896|NCT02038010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990897|NCT02038010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990898|NCT02038023|Iron|iron|mesh-list
19990899|NCT02038023|Dextrans|dextrans|mesh-list
19990900|NCT02038023|Iron-Dextran Complex|iron-dextran complex|mesh-list
19990901|NCT02038023|Trace Elements|trace elements|mesh-ancestor
19990902|NCT02038023|Micronutrients|micronutrients|mesh-ancestor
19990903|NCT02038023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990904|NCT02038023|Anticoagulants|anticoagulants|mesh-ancestor
19990905|NCT02038023|Plasma Substitutes|plasma substitutes|mesh-ancestor
19990906|NCT02038023|Blood Substitutes|blood substitutes|mesh-ancestor
19990907|NCT02038023|Hematinics|hematinics|mesh-ancestor
19990908|NCT02038179|Allopurinol|allopurinol|mesh-list
19990909|NCT02038179|Antimetabolites|antimetabolites|mesh-ancestor
19990910|NCT02038179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990911|NCT02038179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990912|NCT02038179|Gout Suppressants|gout suppressants|mesh-ancestor
19990913|NCT02038179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19990914|NCT02038179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19990915|NCT02038179|Antioxidants|antioxidants|mesh-ancestor
19990916|NCT02038179|Protective Agents|protective agents|mesh-ancestor
19990917|NCT02038179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990918|NCT02038647|Paclitaxel|paclitaxel|mesh-list
19990919|NCT02038647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19990920|NCT02038647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990921|NCT02038647|Tubulin Modulators|tubulin modulators|mesh-ancestor
19990922|NCT02038647|Antimitotic Agents|antimitotic agents|mesh-ancestor
19990923|NCT02038647|Mitosis Modulators|mitosis modulators|mesh-ancestor
19990924|NCT02038647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990925|NCT02038790|Buprenorphine|buprenorphine|mesh-list
19990926|NCT02038790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
19990927|NCT02038790|Naloxone|naloxone|mesh-list
19990928|NCT02038790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19990929|NCT02038790|Narcotics|narcotics|mesh-ancestor
19990930|NCT02038790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19990931|NCT02038790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990932|NCT02038790|Analgesics|analgesics|mesh-ancestor
19990933|NCT02038790|Sensory System Agents|sensory system agents|mesh-ancestor
19990934|NCT02038790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990935|NCT02038790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19990936|NCT02038881|Vaccines|vaccines|mesh-list
19990937|NCT02038881|Immunologic Factors|immunologic factors|mesh-ancestor
19990938|NCT02038881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990939|NCT02038894|Propofol|propofol|mesh-list
19990940|NCT02038894|Sevoflurane|sevoflurane|mesh-list
19990941|NCT02038894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19990942|NCT02038894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19990943|NCT02038894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990944|NCT02038894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19990945|NCT02038894|Anesthetics, General|anesthetics, general|mesh-ancestor
19990946|NCT02038894|Anesthetics|anesthetics|mesh-ancestor
19990947|NCT02038894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19990948|NCT02038894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19990949|NCT02038907|Vaccines|vaccines|mesh-list
19990950|NCT02038907|Immunologic Factors|immunologic factors|mesh-ancestor
19990951|NCT02038907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990952|NCT02038920|Vedolizumab|vedolizumab|mesh-list
19990953|NCT02038920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19990954|NCT02038933|Nivolumab|nivolumab|mesh-list
19990955|NCT02038933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19990956|NCT02038933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990957|NCT02038933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19990958|NCT02038933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990959|NCT02039115|Prednisone|prednisone|mesh-list
19990960|NCT02039115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19990961|NCT02039115|Glucocorticoids|glucocorticoids|mesh-ancestor
19990962|NCT02039115|Hormones|hormones|mesh-ancestor
19990963|NCT02039115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19990964|NCT02039115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990965|NCT02039115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19990966|NCT02039115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990967|NCT02039427|Dexamethasone|dexamethasone|mesh-list
19990968|NCT02039427|Ketorolac|ketorolac|mesh-list
19990969|NCT02039427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19990970|NCT02039427|Antiemetics|antiemetics|mesh-ancestor
19990971|NCT02039427|Autonomic Agents|autonomic agents|mesh-ancestor
19990972|NCT02039427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19990973|NCT02039427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19990974|NCT02039427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19990975|NCT02039427|Glucocorticoids|glucocorticoids|mesh-ancestor
19990976|NCT02039427|Hormones|hormones|mesh-ancestor
19990977|NCT02039427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19990978|NCT02039427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19990979|NCT02039427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19990980|NCT02039427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19990981|NCT02039427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19990982|NCT02039427|Analgesics|analgesics|mesh-ancestor
19990983|NCT02039427|Sensory System Agents|sensory system agents|mesh-ancestor
19990984|NCT02039427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19990985|NCT02039427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19990986|NCT02039427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19990987|NCT02039427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19990988|NCT02039505|Vedolizumab|vedolizumab|mesh-list
19990989|NCT02039505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19990990|NCT02039674|Paclitaxel|paclitaxel|mesh-list
19990991|NCT02039674|Bevacizumab|bevacizumab|mesh-list
19990992|NCT02039674|Carboplatin|carboplatin|mesh-list
19990993|NCT02039674|Pembrolizumab|pembrolizumab|mesh-list
19990994|NCT02039674|Pemetrexed|pemetrexed|mesh-list
19990995|NCT02039674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19990996|NCT02039674|Ipilimumab|ipilimumab|mesh-list
19990997|NCT02039674|Gefitinib|gefitinib|mesh-list
19990998|NCT02039674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19990999|NCT02039674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991000|NCT02039674|Tubulin Modulators|tubulin modulators|mesh-ancestor
19991001|NCT02039674|Antimitotic Agents|antimitotic agents|mesh-ancestor
19991002|NCT02039674|Mitosis Modulators|mitosis modulators|mesh-ancestor
19991003|NCT02039674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991004|NCT02039674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19991005|NCT02039674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19991006|NCT02039674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19991007|NCT02039674|Growth Substances|growth substances|mesh-ancestor
19991008|NCT02039674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991009|NCT02039674|Growth Inhibitors|growth inhibitors|mesh-ancestor
19991010|NCT02039674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991011|NCT02039674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19991012|NCT02039674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19991013|NCT02039674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19459742|NCT03359005|Mitosis Modulators|mitosis modulators|mesh-ancestor
19459743|NCT03359005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991014|NCT02039674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19991015|NCT02039778|Temozolomide|temozolomide|mesh-list
19991016|NCT02039778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19991017|NCT02039778|Alkylating Agents|alkylating agents|mesh-ancestor
19991018|NCT02039778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991019|NCT02039778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991020|NCT02039908|Methylphenidate|methylphenidate|mesh-list
19991021|NCT02039908|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19991022|NCT02039908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991023|NCT02039908|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19991024|NCT02039908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19991025|NCT02039908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19991026|NCT02039908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991027|NCT02039908|Dopamine Agents|dopamine agents|mesh-ancestor
19991028|NCT02039908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19991029|NCT02039947|Trametinib|trametinib|mesh-list
19991030|NCT02039947|Dabrafenib|dabrafenib|mesh-list
19991031|NCT02039947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991032|NCT02039947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19991033|NCT02039947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991034|NCT02039947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991035|NCT02040116|Rituximab|rituximab|mesh-list
19991036|NCT02040116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19991037|NCT02040116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991038|NCT02040116|Immunologic Factors|immunologic factors|mesh-ancestor
19991039|NCT02040116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991040|NCT02040116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19991041|NCT02040298|Clemastine|clemastine|mesh-list
19991042|NCT02040298|Antipruritics|antipruritics|mesh-ancestor
19991043|NCT02040298|Dermatologic Agents|dermatologic agents|mesh-ancestor
19991044|NCT02040298|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19991045|NCT02040298|Histamine Antagonists|histamine antagonists|mesh-ancestor
19991046|NCT02040298|Histamine Agents|histamine agents|mesh-ancestor
19991047|NCT02040298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19991048|NCT02040298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991049|NCT02040298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991050|NCT02040298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19991051|NCT02040428|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19991052|NCT02040428|Hemostatics|hemostatics|mesh-ancestor
19991053|NCT02040428|Coagulants|coagulants|mesh-ancestor
19991054|NCT02040532|Gabapentin|gabapentin|mesh-list
19991055|NCT02040532|Analgesics|analgesics|mesh-ancestor
19991056|NCT02040532|Sensory System Agents|sensory system agents|mesh-ancestor
19991057|NCT02040532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19991058|NCT02040532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991059|NCT02040532|Anticonvulsants|anticonvulsants|mesh-ancestor
19991060|NCT02040532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19991061|NCT02040532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19991062|NCT02040532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19991063|NCT02040532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19991064|NCT02040532|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19991065|NCT02040532|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19991066|NCT02040532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19991067|NCT02040532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991068|NCT02040532|Antimanic Agents|antimanic agents|mesh-ancestor
19991069|NCT02040623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19991070|NCT02040623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19991071|NCT02040766|Beclomethasone|beclomethasone|mesh-list
19991072|NCT02040766|Albuterol|albuterol|mesh-list
19991073|NCT02040766|Bronchodilator Agents|bronchodilator agents|mesh-list
19991074|NCT02040766|Autonomic Agents|autonomic agents|mesh-ancestor
19991075|NCT02040766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19991076|NCT02040766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991077|NCT02040766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19991078|NCT02040766|Respiratory System Agents|respiratory system agents|mesh-ancestor
19991079|NCT02040766|Tocolytic Agents|tocolytic agents|mesh-ancestor
19991080|NCT02040766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19991081|NCT02040766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19991082|NCT02040766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19991083|NCT02040766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19991084|NCT02040766|Adrenergic Agents|adrenergic agents|mesh-ancestor
19991085|NCT02040766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19991086|NCT02040766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991087|NCT02040766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19991088|NCT02040766|Glucocorticoids|glucocorticoids|mesh-ancestor
19991089|NCT02040766|Hormones|hormones|mesh-ancestor
19991090|NCT02040766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19991091|NCT02040779|Beclomethasone|beclomethasone|mesh-list
19991092|NCT02040779|Albuterol|albuterol|mesh-list
19991093|NCT02040779|Bronchodilator Agents|bronchodilator agents|mesh-list
19991094|NCT02040779|Autonomic Agents|autonomic agents|mesh-ancestor
19991095|NCT02040779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19991096|NCT02040779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991097|NCT02040779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19991098|NCT02040779|Respiratory System Agents|respiratory system agents|mesh-ancestor
19991099|NCT02040779|Tocolytic Agents|tocolytic agents|mesh-ancestor
19991100|NCT02040779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19991101|NCT02040779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19991102|NCT02040779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19991103|NCT02040779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19991104|NCT02040779|Adrenergic Agents|adrenergic agents|mesh-ancestor
19991105|NCT02040779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19991106|NCT02040779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991107|NCT02040779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19991108|NCT02040779|Glucocorticoids|glucocorticoids|mesh-ancestor
19991109|NCT02040779|Hormones|hormones|mesh-ancestor
19991110|NCT02040779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20289251|NCT04876937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20289252|NCT04876937|Adrenergic Agents|adrenergic agents|mesh-ancestor
20289253|NCT04876937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20289254|NCT04876937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289255|NCT04874025|Palbociclib|palbociclib|mesh-list
20289256|NCT04874025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991111|NCT02040870|Ceritinib|ceritinib|mesh-list
19991112|NCT02040870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991113|NCT02040870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19991114|NCT02040870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991115|NCT02040870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991116|NCT02041091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19991117|NCT02041091|Immunologic Factors|immunologic factors|mesh-ancestor
19991118|NCT02041091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991119|NCT02041299|Deferiprone|deferiprone|mesh-list
19991120|NCT02041299|Deferoxamine|deferoxamine|mesh-list
19991121|NCT02041299|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19991122|NCT02041299|Chelating Agents|chelating agents|mesh-ancestor
19991123|NCT02041299|Sequestering Agents|sequestering agents|mesh-ancestor
19991124|NCT02041299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991125|NCT02041299|Siderophores|siderophores|mesh-ancestor
19991126|NCT02041325|Lenalidomide|lenalidomide|mesh-list
19991127|NCT02041325|Immunologic Factors|immunologic factors|mesh-ancestor
19991128|NCT02041325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991129|NCT02041325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19991130|NCT02041325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19991131|NCT02041325|Growth Substances|growth substances|mesh-ancestor
19991132|NCT02041325|Growth Inhibitors|growth inhibitors|mesh-ancestor
19991133|NCT02041325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991134|NCT02041429|Paclitaxel|paclitaxel|mesh-list
19991135|NCT02041429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19991136|NCT02041429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991137|NCT02041429|Tubulin Modulators|tubulin modulators|mesh-ancestor
19991138|NCT02041429|Antimitotic Agents|antimitotic agents|mesh-ancestor
19991139|NCT02041429|Mitosis Modulators|mitosis modulators|mesh-ancestor
19991140|NCT02041429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991141|NCT02042183|Lubiprostone|lubiprostone|mesh-list
19991142|NCT02042183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19991143|NCT02042183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19991144|NCT02042183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991145|NCT02042443|Calcium, Dietary|calcium, dietary|mesh-list
19991146|NCT02042443|Leucovorin|leucovorin|mesh-list
19991147|NCT02042443|Folic Acid|folic acid|mesh-list
19991148|NCT02042443|Fluorouracil|fluorouracil|mesh-list
19991149|NCT02042443|Capecitabine|capecitabine|mesh-list
19991150|NCT02042443|Trametinib|trametinib|mesh-list
19991151|NCT02042443|Calcium|calcium|mesh-list
19991152|NCT02042443|Levoleucovorin|levoleucovorin|mesh-list
19991153|NCT02042443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19991154|NCT02042443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991155|NCT02042443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19991156|NCT02042443|Antimetabolites|antimetabolites|mesh-ancestor
19991157|NCT02042443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991158|NCT02042443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19991159|NCT02042443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991160|NCT02042443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19991161|NCT02042443|Immunologic Factors|immunologic factors|mesh-ancestor
19991162|NCT02042443|Antidotes|antidotes|mesh-ancestor
19991163|NCT02042443|Protective Agents|protective agents|mesh-ancestor
19991164|NCT02042443|Vitamin B Complex|vitamin b complex|mesh-ancestor
19991165|NCT02042443|Vitamins|vitamins|mesh-ancestor
19991166|NCT02042443|Micronutrients|micronutrients|mesh-ancestor
19991167|NCT02042443|Hematinics|hematinics|mesh-ancestor
19991168|NCT02042443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19991169|NCT02042443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991170|NCT02042534|Warfarin|warfarin|mesh-list
19991171|NCT02042534|Rivaroxaban|rivaroxaban|mesh-list
19991172|NCT02042534|Anticoagulants|anticoagulants|mesh-ancestor
19991173|NCT02042534|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19991174|NCT02042534|Antithrombins|antithrombins|mesh-ancestor
19991175|NCT02042534|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19991176|NCT02042534|Protease Inhibitors|protease inhibitors|mesh-ancestor
19991177|NCT02042534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991178|NCT02042534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991179|NCT02042872|Zoledronic Acid|zoledronic acid|mesh-list
19991180|NCT02042872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19991181|NCT02042872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991182|NCT02043132|Tranexamic Acid|tranexamic acid|mesh-list
19991183|NCT02043132|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
19991184|NCT02043132|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19991185|NCT02043132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991186|NCT02043132|Hemostatics|hemostatics|mesh-ancestor
19991187|NCT02043132|Coagulants|coagulants|mesh-ancestor
19991188|NCT02043145|Botulinum Toxins|botulinum toxins|mesh-list
19991189|NCT02043145|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19991190|NCT02043145|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19991191|NCT02043145|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19991192|NCT02043145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19991193|NCT02043145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991194|NCT02043145|Cholinergic Agents|cholinergic agents|mesh-ancestor
19991195|NCT02043145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19991196|NCT02043145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991197|NCT02043145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19991198|NCT02043145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19991199|NCT02043301|Bococizumab|bococizumab|mesh-list
19991200|NCT02043301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19991201|NCT02043301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19991202|NCT02043301|Antimetabolites|antimetabolites|mesh-ancestor
19991203|NCT02043301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991204|NCT02043301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19991205|NCT02043366|Flurbiprofen|flurbiprofen|mesh-list
19991206|NCT02043366|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
19991207|NCT02043366|Sufentanil|sufentanil|mesh-list
19991208|NCT02043366|Remifentanil|remifentanil|mesh-list
19991209|NCT02043366|Butorphanol|butorphanol|mesh-list
19991210|NCT02043366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19991211|NCT02043366|Narcotics|narcotics|mesh-ancestor
19991212|NCT02043366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19991213|NCT02043366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991214|NCT02043366|Analgesics|analgesics|mesh-ancestor
19991215|NCT02043366|Sensory System Agents|sensory system agents|mesh-ancestor
19991216|NCT02043366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19991217|NCT02043366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19991218|NCT02043366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19991219|NCT02043366|Anesthetics, General|anesthetics, general|mesh-ancestor
19991220|NCT02043366|Anesthetics|anesthetics|mesh-ancestor
19991221|NCT02043366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19991222|NCT02043366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19991223|NCT02043366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19991224|NCT02043366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19991225|NCT02043366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19991226|NCT02043366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991227|NCT02043366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991228|NCT02043366|Antitussive Agents|antitussive agents|mesh-ancestor
19991229|NCT02043366|Respiratory System Agents|respiratory system agents|mesh-ancestor
19991230|NCT02043366|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19991231|NCT02043379|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19991232|NCT02043379|Immunologic Factors|immunologic factors|mesh-ancestor
19991233|NCT02043379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991234|NCT02043652|Chloroquine|chloroquine|mesh-list
19991235|NCT02043652|Primaquine|primaquine|mesh-list
19991236|NCT02043652|Amebicides|amebicides|mesh-ancestor
19991237|NCT02043652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19991238|NCT02043652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19991239|NCT02043652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19991240|NCT02043652|Antimalarials|antimalarials|mesh-ancestor
19991241|NCT02043652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19991242|NCT02043704|Acetaminophen|acetaminophen|mesh-list
19991243|NCT02043704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19991244|NCT02043704|Analgesics|analgesics|mesh-ancestor
19991245|NCT02043704|Sensory System Agents|sensory system agents|mesh-ancestor
19991246|NCT02043704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19991247|NCT02043704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991248|NCT02043704|Antipyretics|antipyretics|mesh-ancestor
19991249|NCT02043899|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
19991250|NCT02043899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991251|NCT02043899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991252|NCT02043899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991253|NCT02043899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19991254|NCT02044094|Buprenorphine|buprenorphine|mesh-list
19991255|NCT02044094|Hydromorphone|hydromorphone|mesh-list
19991256|NCT02044094|Naloxone|naloxone|mesh-list
19991257|NCT02044094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19991258|NCT02044094|Narcotics|narcotics|mesh-ancestor
19991259|NCT02044094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19991260|NCT02044094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991261|NCT02044094|Analgesics|analgesics|mesh-ancestor
19991262|NCT02044094|Sensory System Agents|sensory system agents|mesh-ancestor
19991263|NCT02044094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19991264|NCT02044094|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19991265|NCT02044159|Hydrocortisone|hydrocortisone|mesh-list
19991266|NCT02044159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19991267|NCT02044159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19991268|NCT02044367|Dabigatran|dabigatran|mesh-list
19991269|NCT02044367|Antithrombins|antithrombins|mesh-ancestor
19991270|NCT02044367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19991271|NCT02044367|Protease Inhibitors|protease inhibitors|mesh-ancestor
19991272|NCT02044367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991273|NCT02044367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991274|NCT02044367|Anticoagulants|anticoagulants|mesh-ancestor
19991275|NCT02044380|Afatinib|afatinib|mesh-list
19991276|NCT02044380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991277|NCT02044380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19991278|NCT02044380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991279|NCT02044380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991280|NCT02044393|Itraconazole|itraconazole|mesh-list
19991281|NCT02044393|Antifungal Agents|antifungal agents|mesh-ancestor
19991282|NCT02044393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19991283|NCT02044393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19991284|NCT02044393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19991285|NCT02044393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991286|NCT02044393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991287|NCT02044393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19991288|NCT02044393|Hormone Antagonists|hormone antagonists|mesh-ancestor
19991289|NCT02044393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19991290|NCT02044393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991291|NCT02044393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19991292|NCT02044510|Mirabegron|mirabegron|mesh-list
19991293|NCT02044510|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19991294|NCT02044510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19991295|NCT02044510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19991296|NCT02044510|Adrenergic Agents|adrenergic agents|mesh-ancestor
19991297|NCT02044510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19991298|NCT02044510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991299|NCT02044510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991300|NCT02044510|Urological Agents|urological agents|mesh-ancestor
19991301|NCT02044796|Cytarabine|cytarabine|mesh-list
19991302|NCT02044796|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
19991303|NCT02044796|Mitoxantrone|mitoxantrone|mesh-list
19991304|NCT02044796|Cladribine|cladribine|mesh-list
19991305|NCT02044796|Lenograstim|lenograstim|mesh-list
19991306|NCT02044796|Sargramostim|sargramostim|mesh-list
19991307|NCT02044796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19991308|NCT02044796|Antimetabolites|antimetabolites|mesh-ancestor
19991309|NCT02044796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991310|NCT02044796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556448|NCT01946906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20556449|NCT01946906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20556450|NCT01946906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20556451|NCT01946971|Lansoprazole|lansoprazole|mesh-list
20556452|NCT01946971|Dexlansoprazole|dexlansoprazole|mesh-list
20556453|NCT01946971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20556454|NCT01946971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20556455|NCT01946971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20556456|NCT01946971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556457|NCT01946971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556458|NCT01946984|Diclofenac|diclofenac|mesh-list
20556459|NCT01946984|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
20556460|NCT01946984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20556461|NCT01946984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20556462|NCT01946984|Analgesics|analgesics|mesh-ancestor
20556463|NCT01946984|Sensory System Agents|sensory system agents|mesh-ancestor
20556464|NCT01946984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556465|NCT01946984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556466|NCT01946984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20556467|NCT01946984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20556468|NCT01946984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20556469|NCT01946984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556470|NCT01946984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556471|NCT01947010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20556472|NCT01947010|Immunologic Factors|immunologic factors|mesh-ancestor
20556473|NCT01947010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556474|NCT01947062|Cyclophosphamide|cyclophosphamide|mesh-list
20556475|NCT01947062|Cisplatin|cisplatin|mesh-list
19991311|NCT02044796|Antiviral Agents|antiviral agents|mesh-ancestor
19991312|NCT02044796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19991313|NCT02044796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19991314|NCT02044796|Immunologic Factors|immunologic factors|mesh-ancestor
19991315|NCT02044796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991316|NCT02044796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19991317|NCT02044796|Analgesics|analgesics|mesh-ancestor
19991318|NCT02044796|Sensory System Agents|sensory system agents|mesh-ancestor
19991319|NCT02044796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19991320|NCT02044796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19991321|NCT02044796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19991322|NCT02044796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991323|NCT02045264|Icatibant|icatibant|mesh-list
19991324|NCT02045264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19991325|NCT02045264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19991326|NCT02045264|Analgesics|analgesics|mesh-ancestor
19991327|NCT02045264|Sensory System Agents|sensory system agents|mesh-ancestor
19991328|NCT02045264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19991329|NCT02045264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991330|NCT02045264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19991331|NCT02045264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19991332|NCT02045264|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
19991333|NCT02045264|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
19991334|NCT02045264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991335|NCT02045264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19991336|NCT02045264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19991337|NCT02045264|Immunologic Factors|immunologic factors|mesh-ancestor
19991338|NCT02045836|Vaccines|vaccines|mesh-list
19991339|NCT02045836|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19991340|NCT02045836|Immunologic Factors|immunologic factors|mesh-ancestor
19991341|NCT02045836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991342|NCT02045862|Solifenacin Succinate|solifenacin succinate|mesh-list
19991343|NCT02045862|Mirabegron|mirabegron|mesh-list
19991344|NCT02045862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19991345|NCT02045862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19991346|NCT02045862|Cholinergic Agents|cholinergic agents|mesh-ancestor
19991347|NCT02045862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19991348|NCT02045862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991349|NCT02045862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991350|NCT02045862|Urological Agents|urological agents|mesh-ancestor
19991351|NCT02045862|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19991352|NCT02045862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19991353|NCT02045862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19991354|NCT02045862|Adrenergic Agents|adrenergic agents|mesh-ancestor
19991355|NCT02045875|Mometasone Furoate|mometasone furoate|mesh-list
19991356|NCT02045875|Formoterol Fumarate|formoterol fumarate|mesh-list
19991357|NCT02045875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19991358|NCT02045875|Autonomic Agents|autonomic agents|mesh-ancestor
19991359|NCT02045875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19991360|NCT02045875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991361|NCT02045875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19991362|NCT02045875|Respiratory System Agents|respiratory system agents|mesh-ancestor
19991363|NCT02045875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19991364|NCT02045875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19991365|NCT02045875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19991366|NCT02045875|Adrenergic Agents|adrenergic agents|mesh-ancestor
19991367|NCT02045875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19991368|NCT02045875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991369|NCT02045875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19991370|NCT02045875|Dermatologic Agents|dermatologic agents|mesh-ancestor
19991371|NCT02045875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19991372|NCT02045979|Adalimumab|adalimumab|mesh-list
19991373|NCT02045979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19991374|NCT02045979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19991375|NCT02046070|Dexamethasone|dexamethasone|mesh-list
19991376|NCT02046070|Cyclophosphamide|cyclophosphamide|mesh-list
19991377|NCT02046070|Ixazomib|ixazomib|mesh-list
19991378|NCT02046070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19991379|NCT02046070|Immunologic Factors|immunologic factors|mesh-ancestor
19991380|NCT02046070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991381|NCT02046070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19991382|NCT02046070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19991383|NCT02046070|Alkylating Agents|alkylating agents|mesh-ancestor
19991384|NCT02046070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991385|NCT02046070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991386|NCT02046070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19991387|NCT02046070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19991388|NCT02046070|Antiemetics|antiemetics|mesh-ancestor
19991389|NCT02046070|Autonomic Agents|autonomic agents|mesh-ancestor
19991390|NCT02046070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19991391|NCT02046070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19991392|NCT02046070|Glucocorticoids|glucocorticoids|mesh-ancestor
19991393|NCT02046070|Hormones|hormones|mesh-ancestor
19991394|NCT02046070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19991395|NCT02046070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19991396|NCT02046070|Protease Inhibitors|protease inhibitors|mesh-ancestor
19991397|NCT02046070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991398|NCT02046122|Cytarabine|cytarabine|mesh-list
19991399|NCT02046122|Idarubicin|idarubicin|mesh-list
19991400|NCT02046122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19991401|NCT02046122|Antimetabolites|antimetabolites|mesh-ancestor
19991402|NCT02046122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991403|NCT02046122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991404|NCT02046122|Antiviral Agents|antiviral agents|mesh-ancestor
19991405|NCT02046122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19991406|NCT02046122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19991407|NCT02046122|Immunologic Factors|immunologic factors|mesh-ancestor
19991408|NCT02046122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991409|NCT02046122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19991410|NCT02046122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19991411|NCT02046122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19991412|NCT02046122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991413|NCT02046200|Ethanol|ethanol|mesh-list
19991414|NCT02046200|Ivermectin|ivermectin|mesh-list
19991415|NCT02046200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19991416|NCT02046200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19991417|NCT02046200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19991418|NCT02046200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991419|NCT02046200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19991420|NCT02046369|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19991421|NCT02046369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19991422|NCT02046369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19991423|NCT02046369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19991424|NCT02046369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991425|NCT02046369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19991426|NCT02046369|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19991427|NCT02046369|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19991428|NCT02046369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19991429|NCT02046369|Adrenergic Agents|adrenergic agents|mesh-ancestor
19991430|NCT02046369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19991431|NCT02046369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991432|NCT02046369|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19991433|NCT02046369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19991434|NCT02046369|Serotonin Agents|serotonin agents|mesh-ancestor
19991435|NCT02046369|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19991436|NCT02046369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19991437|NCT02046369|Dopamine Agents|dopamine agents|mesh-ancestor
19991438|NCT02046382|Acetaminophen|acetaminophen|mesh-list
19991439|NCT02046382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19991440|NCT02046382|Analgesics|analgesics|mesh-ancestor
19991441|NCT02046382|Sensory System Agents|sensory system agents|mesh-ancestor
19991442|NCT02046382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19991443|NCT02046382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991444|NCT02046382|Antipyretics|antipyretics|mesh-ancestor
19991445|NCT02046603|Methotrexate|methotrexate|mesh-list
19991446|NCT02046603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19991447|NCT02046603|Abortifacient Agents|abortifacient agents|mesh-ancestor
19991448|NCT02046603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19991449|NCT02046603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991450|NCT02046603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19991451|NCT02046603|Antimetabolites|antimetabolites|mesh-ancestor
19991452|NCT02046603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991453|NCT02046603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991454|NCT02046603|Dermatologic Agents|dermatologic agents|mesh-ancestor
19991455|NCT02046603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991456|NCT02046603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19991457|NCT02046603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19991458|NCT02046603|Immunologic Factors|immunologic factors|mesh-ancestor
19991459|NCT02046603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20556476|NCT01947062|Etoposide|etoposide|mesh-list
19991460|NCT02046603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19991461|NCT02046616|Methotrexate|methotrexate|mesh-list
19991462|NCT02046616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19991463|NCT02046616|Abortifacient Agents|abortifacient agents|mesh-ancestor
19991464|NCT02046616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19991465|NCT02046616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991466|NCT02046616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19991467|NCT02046616|Antimetabolites|antimetabolites|mesh-ancestor
19991468|NCT02046616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991469|NCT02046616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991470|NCT02046616|Dermatologic Agents|dermatologic agents|mesh-ancestor
19991471|NCT02046616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991472|NCT02046616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19991473|NCT02046616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19991474|NCT02046616|Immunologic Factors|immunologic factors|mesh-ancestor
19991475|NCT02046616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19991476|NCT02046616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19991477|NCT02046772|Morphine|morphine|mesh-list
19991478|NCT02046772|Bupivacaine|bupivacaine|mesh-list
19991479|NCT02046772|Anesthetics, Local|anesthetics, local|mesh-ancestor
19991480|NCT02046772|Anesthetics|anesthetics|mesh-ancestor
19991481|NCT02046772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19991482|NCT02046772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991483|NCT02046772|Sensory System Agents|sensory system agents|mesh-ancestor
19991484|NCT02046772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19991485|NCT02046772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19991486|NCT02046772|Narcotics|narcotics|mesh-ancestor
19991487|NCT02046772|Analgesics|analgesics|mesh-ancestor
19991488|NCT02047032|Solifenacin Succinate|solifenacin succinate|mesh-list
19991489|NCT02047032|Cholinergic Antagonists|cholinergic antagonists|mesh-list
19991490|NCT02047032|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19991491|NCT02047032|Cholinergic Agents|cholinergic agents|mesh-ancestor
19991492|NCT02047032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19991493|NCT02047032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991494|NCT02047032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991495|NCT02047032|Urological Agents|urological agents|mesh-ancestor
19991496|NCT02047045|Prucalopride|prucalopride|mesh-list
19991497|NCT02047045|Serotonin|serotonin|mesh-list
19991498|NCT02047045|Laxatives|laxatives|mesh-ancestor
19991499|NCT02047045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19991500|NCT02047045|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19991501|NCT02047045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19991502|NCT02047045|Serotonin Agents|serotonin agents|mesh-ancestor
19991503|NCT02047045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19991504|NCT02047045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991505|NCT02047045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991506|NCT02047110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19991507|NCT02047110|Immunologic Factors|immunologic factors|mesh-ancestor
19991508|NCT02047110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991509|NCT02047227|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19991510|NCT02047227|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19991511|NCT02047227|Hormones|hormones|mesh-ancestor
19991512|NCT02047227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19991513|NCT02047227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991514|NCT02047227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19991515|NCT02047253|Acyclovir|acyclovir|mesh-list
19991516|NCT02047253|Dexamethasone|dexamethasone|mesh-list
19991517|NCT02047253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19991518|NCT02047253|Antiemetics|antiemetics|mesh-ancestor
19991519|NCT02047253|Autonomic Agents|autonomic agents|mesh-ancestor
19991520|NCT02047253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19991521|NCT02047253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991522|NCT02047253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19991523|NCT02047253|Glucocorticoids|glucocorticoids|mesh-ancestor
19991524|NCT02047253|Hormones|hormones|mesh-ancestor
19991525|NCT02047253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19991526|NCT02047253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19991527|NCT02047253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991528|NCT02047253|Antiviral Agents|antiviral agents|mesh-ancestor
19991529|NCT02047253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19991530|NCT02047500|Gemcitabine|gemcitabine|mesh-list
19991531|NCT02047500|Paclitaxel|paclitaxel|mesh-list
19991532|NCT02047500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19991533|NCT02047500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991534|NCT02047500|Tubulin Modulators|tubulin modulators|mesh-ancestor
19991535|NCT02047500|Antimitotic Agents|antimitotic agents|mesh-ancestor
19991536|NCT02047500|Mitosis Modulators|mitosis modulators|mesh-ancestor
19991537|NCT02047500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991538|NCT02047500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19991539|NCT02047500|Antimetabolites|antimetabolites|mesh-ancestor
19991540|NCT02047500|Antiviral Agents|antiviral agents|mesh-ancestor
19991541|NCT02047500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19991542|NCT02047500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991543|NCT02047500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19991544|NCT02047500|Immunologic Factors|immunologic factors|mesh-ancestor
19991545|NCT02047500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991546|NCT02047734|Interferons|interferons|mesh-list
19991547|NCT02047734|Interferon-beta|interferon-beta|mesh-list
19991548|NCT02047734|Interferon beta-1a|interferon beta-1a|mesh-list
19991549|NCT02047734|Ozanimod|ozanimod|mesh-list
19991550|NCT02047734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991551|NCT02047734|Antiviral Agents|antiviral agents|mesh-ancestor
19991552|NCT02047734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19991553|NCT02047734|Immunologic Factors|immunologic factors|mesh-ancestor
19991554|NCT02047734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991555|NCT02047734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19991556|NCT02047734|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19991557|NCT02047734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991558|NCT02047734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19991559|NCT02047903|Afatinib|afatinib|mesh-list
19991560|NCT02047903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991561|NCT02047903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19991562|NCT02047903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991563|NCT02047903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991564|NCT02047981|Azithromycin|azithromycin|mesh-list
19991565|NCT02047981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19991566|NCT02047981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20289257|NCT04874025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20289258|NCT04874025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289259|NCT04874025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289260|NCT04861181|Niraparib|niraparib|mesh-list
20289261|NCT04861181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20289262|NCT04861181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289263|NCT04861181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289264|NCT04861181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289265|NCT04856631|Cetuximab|cetuximab|mesh-list
20289266|NCT04856631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20289267|NCT04856631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289268|NCT04848597|Paclitaxel|paclitaxel|mesh-list
20289269|NCT04848597|Antibodies|antibodies|mesh-list
20289270|NCT04848597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20289271|NCT04848597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20289272|NCT04848597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289273|NCT04848597|Tubulin Modulators|tubulin modulators|mesh-ancestor
20289274|NCT04848597|Antimitotic Agents|antimitotic agents|mesh-ancestor
20289275|NCT04848597|Mitosis Modulators|mitosis modulators|mesh-ancestor
20289276|NCT04848597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289277|NCT04848597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289278|NCT04848597|Immunologic Factors|immunologic factors|mesh-ancestor
20289279|NCT04840602|Rituximab|rituximab|mesh-list
20289280|NCT04840602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20289281|NCT04840602|Venetoclax|venetoclax|mesh-list
20289282|NCT04840602|Antibodies|antibodies|mesh-list
20289283|NCT04840602|Immunoglobulins|immunoglobulins|mesh-list
20289284|NCT04840602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20289285|NCT04840602|Immunologic Factors|immunologic factors|mesh-ancestor
20289286|NCT04840602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289287|NCT04840602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289288|NCT04840602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20289289|NCT04821869|Albuterol|albuterol|mesh-list
20289290|NCT04821869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20289291|NCT04821869|Autonomic Agents|autonomic agents|mesh-ancestor
20289292|NCT04821869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20289293|NCT04821869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289294|NCT04821869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20289295|NCT04821869|Respiratory System Agents|respiratory system agents|mesh-ancestor
20289296|NCT04821869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20289297|NCT04821869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20289298|NCT04821869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20289299|NCT04821869|Adrenergic Agents|adrenergic agents|mesh-ancestor
19991567|NCT02048072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19991568|NCT02048072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19991569|NCT02048072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991570|NCT02048072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19991571|NCT02048072|Immunologic Factors|immunologic factors|mesh-ancestor
19991572|NCT02048072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991573|NCT02048241|Guanfacine|guanfacine|mesh-list
19991574|NCT02048241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19991575|NCT02048241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19991576|NCT02048241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19991577|NCT02048241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19991578|NCT02048241|Adrenergic Agents|adrenergic agents|mesh-ancestor
19991579|NCT02048241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19991580|NCT02048241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991581|NCT02048241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991582|NCT02048891|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19991583|NCT02048891|Progesterone|progesterone|mesh-list
19991584|NCT02048891|Progestins|progestins|mesh-ancestor
19991585|NCT02048891|Hormones|hormones|mesh-ancestor
19991586|NCT02048891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19991587|NCT02048891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991588|NCT02048891|Luteolytic Agents|luteolytic agents|mesh-ancestor
19991589|NCT02048891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19991590|NCT02048891|Contraceptive Agents|contraceptive agents|mesh-ancestor
19991591|NCT02048891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19991592|NCT02048891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19991593|NCT02048891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19991594|NCT02048891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991595|NCT02049151|Cyclophosphamide|cyclophosphamide|mesh-list
19991596|NCT02049151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19991597|NCT02049151|Immunologic Factors|immunologic factors|mesh-ancestor
19991598|NCT02049151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991599|NCT02049151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19991600|NCT02049151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19991601|NCT02049151|Alkylating Agents|alkylating agents|mesh-ancestor
19991602|NCT02049151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991603|NCT02049151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991604|NCT02049151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19991605|NCT02049307|Losartan|losartan|mesh-list
19991606|NCT02049307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19991607|NCT02049307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19991608|NCT02049307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19991609|NCT02049307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19991610|NCT02049307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991611|NCT02049385|Diazoxide|diazoxide|mesh-list
19991612|NCT02049385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19991613|NCT02049385|Vasodilator Agents|vasodilator agents|mesh-ancestor
19991614|NCT02049476|Dexamethasone|dexamethasone|mesh-list
19991615|NCT02049476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19991616|NCT02049476|Antiemetics|antiemetics|mesh-ancestor
19991617|NCT02049476|Autonomic Agents|autonomic agents|mesh-ancestor
19991618|NCT02049476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19991619|NCT02049476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991620|NCT02049476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19991621|NCT02049476|Glucocorticoids|glucocorticoids|mesh-ancestor
19991622|NCT02049476|Hormones|hormones|mesh-ancestor
19991623|NCT02049476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19991624|NCT02049476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19991625|NCT02049476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991626|NCT02049814|Metformin|metformin|mesh-list
19991627|NCT02049814|Acarbose|acarbose|mesh-list
19991628|NCT02049814|Voglibose|voglibose|mesh-list
19991629|NCT02049814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19991630|NCT02049814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991631|NCT02049814|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19991632|NCT02049814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991633|NCT02049814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991634|NCT02049866|Denosumab|denosumab|mesh-list
19991635|NCT02049866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19991636|NCT02049866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991637|NCT02049944|Cefazolin|cefazolin|mesh-list
19991638|NCT02049944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19991639|NCT02049944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19991640|NCT02049957|Fulvestrant|fulvestrant|mesh-list
19991641|NCT02049957|Exemestane|exemestane|mesh-list
19991642|NCT02049957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19991643|NCT02049957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991644|NCT02049957|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19991645|NCT02049957|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19991646|NCT02049957|Hormone Antagonists|hormone antagonists|mesh-ancestor
19991647|NCT02049957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19991648|NCT02049957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991649|NCT02049957|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19991650|NCT02049957|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19991651|NCT02049957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991652|NCT02049957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991653|NCT02050321|Vemurafenib|vemurafenib|mesh-list
19991654|NCT02050321|Acitretin|acitretin|mesh-list
19991655|NCT02050321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991656|NCT02050321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19991657|NCT02050321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991658|NCT02050321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991659|NCT02050321|Keratolytic Agents|keratolytic agents|mesh-ancestor
19991660|NCT02050321|Dermatologic Agents|dermatologic agents|mesh-ancestor
19991661|NCT02050334|Caffeic acid|caffeic acid|mesh-list
19991662|NCT02050334|Antioxidants|antioxidants|mesh-ancestor
19991663|NCT02050334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991664|NCT02050334|Protective Agents|protective agents|mesh-ancestor
19991665|NCT02050334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991666|NCT02051296|Minocycline|minocycline|mesh-list
19991667|NCT02051296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19991668|NCT02051296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19991669|NCT02051335|Scopolamine|scopolamine|mesh-list
19991670|NCT02051335|Donepezil|donepezil|mesh-list
19991671|NCT02051335|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19991672|NCT02051335|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19991673|NCT02051335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991674|NCT02051335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991675|NCT02051335|Cholinergic Agents|cholinergic agents|mesh-ancestor
19991676|NCT02051335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19991677|NCT02051335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991678|NCT02051335|Nootropic Agents|nootropic agents|mesh-ancestor
19991679|NCT02051335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19991680|NCT02051335|Antiemetics|antiemetics|mesh-ancestor
19991681|NCT02051335|Autonomic Agents|autonomic agents|mesh-ancestor
19991682|NCT02051335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19991683|NCT02051335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19991684|NCT02051335|Mydriatics|mydriatics|mesh-ancestor
19991685|NCT02051335|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19991686|NCT02051335|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19991687|NCT02051335|Parasympatholytics|parasympatholytics|mesh-ancestor
19991688|NCT02051452|Methylphenidate|methylphenidate|mesh-list
19991689|NCT02051452|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19991690|NCT02051452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991691|NCT02051452|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19991692|NCT02051452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19991693|NCT02051452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19991694|NCT02051452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991695|NCT02051452|Dopamine Agents|dopamine agents|mesh-ancestor
19991696|NCT02051452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19991697|NCT02051595|Vancomycin|vancomycin|mesh-list
19991698|NCT02051595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19991699|NCT02051595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19991700|NCT02051686|Tranexamic Acid|tranexamic acid|mesh-list
19991701|NCT02051686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19991702|NCT02051686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19991703|NCT02051686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991704|NCT02051686|Hemostatics|hemostatics|mesh-ancestor
19991705|NCT02051686|Coagulants|coagulants|mesh-ancestor
19991706|NCT02052011|Ranolazine|ranolazine|mesh-list
19991707|NCT02052011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19991708|NCT02052011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19991709|NCT02052011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991710|NCT02052141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19991711|NCT02052141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19991712|NCT02052141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19991713|NCT02052141|Immunologic Factors|immunologic factors|mesh-ancestor
19991714|NCT02052141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991715|NCT02052310|Epoetin Alfa|epoetin alfa|mesh-list
19991716|NCT02052310|Hematinics|hematinics|mesh-ancestor
19991717|NCT02052414|Gabapentin|gabapentin|mesh-list
19991718|NCT02052414|Analgesics|analgesics|mesh-ancestor
19991719|NCT02052414|Sensory System Agents|sensory system agents|mesh-ancestor
19991720|NCT02052414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19991721|NCT02052414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991722|NCT02052414|Anticonvulsants|anticonvulsants|mesh-ancestor
19991723|NCT02052414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19991724|NCT02052414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19991725|NCT02052414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19991726|NCT02052414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19991727|NCT02052414|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19991728|NCT02052414|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19991729|NCT02052414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19991730|NCT02052414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991731|NCT02052414|Antimanic Agents|antimanic agents|mesh-ancestor
19991732|NCT02052440|Baclofen|baclofen|mesh-list
19991733|NCT02052440|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19991734|NCT02052440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991735|NCT02052440|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19991736|NCT02052440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19991737|NCT02052440|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19991738|NCT02052440|GABA Agonists|gaba agonists|mesh-ancestor
19991739|NCT02052440|GABA Agents|gaba agents|mesh-ancestor
19991740|NCT02052440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19991741|NCT02052440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991742|NCT02052557|Bupivacaine|bupivacaine|mesh-list
19991743|NCT02052557|Anesthetics, Local|anesthetics, local|mesh-ancestor
19991744|NCT02052557|Anesthetics|anesthetics|mesh-ancestor
19991745|NCT02052557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19991746|NCT02052557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991747|NCT02052557|Sensory System Agents|sensory system agents|mesh-ancestor
19991748|NCT02052557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19991749|NCT02052635|Clopidogrel|clopidogrel|mesh-list
19991750|NCT02052635|Ticagrelor|ticagrelor|mesh-list
19991751|NCT02052635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19991752|NCT02052635|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19991753|NCT02052635|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19991754|NCT02052635|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19991755|NCT02052635|Purinergic Agents|purinergic agents|mesh-ancestor
19991756|NCT02052635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19991757|NCT02052635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991758|NCT02052635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991759|NCT02052752|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19991760|NCT02052752|Dermatologic Agents|dermatologic agents|mesh-ancestor
19991761|NCT02052960|Cisplatin|cisplatin|mesh-list
19991762|NCT02052960|Fluorouracil|fluorouracil|mesh-list
19991763|NCT02052960|Cetuximab|cetuximab|mesh-list
19991764|NCT02052960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991765|NCT02052960|Antimetabolites|antimetabolites|mesh-ancestor
19991766|NCT02052960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991767|NCT02052960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19991768|NCT02052960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19991769|NCT02052960|Immunologic Factors|immunologic factors|mesh-ancestor
19991770|NCT02052960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991771|NCT02052960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19991772|NCT02053493|Isosorbide|isosorbide|mesh-list
19991773|NCT02053493|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
19991774|NCT02053493|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
19991775|NCT02053493|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19991776|NCT02053493|Diuretics|diuretics|mesh-ancestor
19991777|NCT02053493|Natriuretic Agents|natriuretic agents|mesh-ancestor
19991778|NCT02053493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991779|NCT02053493|Vasodilator Agents|vasodilator agents|mesh-ancestor
19991780|NCT02053493|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19991781|NCT02053493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991782|NCT02053610|Rituximab|rituximab|mesh-list
19991783|NCT02053610|Obinutuzumab|obinutuzumab|mesh-list
19991784|NCT02053610|Chlorambucil|chlorambucil|mesh-list
19991785|NCT02053610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19991786|NCT02053610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991787|NCT02053610|Immunologic Factors|immunologic factors|mesh-ancestor
19991788|NCT02053610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991789|NCT02053610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19991790|NCT02053610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19991791|NCT02053610|Alkylating Agents|alkylating agents|mesh-ancestor
19991792|NCT02053610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991793|NCT02053753|Denosumab|denosumab|mesh-list
19991794|NCT02053753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19991795|NCT02053753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991796|NCT02054156|Azithromycin|azithromycin|mesh-list
19991797|NCT02054156|Tobramycin|tobramycin|mesh-list
19991798|NCT02054156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19991799|NCT02054156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19991800|NCT02054325|Polidocanol|polidocanol|mesh-list
19991801|NCT02054325|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
19991802|NCT02054325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19991803|NCT02054338|Gemcitabine|gemcitabine|mesh-list
19991804|NCT02054338|Paclitaxel|paclitaxel|mesh-list
19991805|NCT02054338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19991806|NCT02054338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991807|NCT02054338|Tubulin Modulators|tubulin modulators|mesh-ancestor
19991808|NCT02054338|Antimitotic Agents|antimitotic agents|mesh-ancestor
19991809|NCT02054338|Mitosis Modulators|mitosis modulators|mesh-ancestor
19991810|NCT02054338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991811|NCT02054338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19991812|NCT02054338|Antimetabolites|antimetabolites|mesh-ancestor
19991813|NCT02054338|Antiviral Agents|antiviral agents|mesh-ancestor
19991814|NCT02054338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19991815|NCT02054338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991816|NCT02054338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19991817|NCT02054338|Immunologic Factors|immunologic factors|mesh-ancestor
19991818|NCT02054338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991819|NCT02054481|Ustekinumab|ustekinumab|mesh-list
19991820|NCT02054481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19991821|NCT02054481|Dermatologic Agents|dermatologic agents|mesh-ancestor
19991822|NCT02054481|Immunologic Factors|immunologic factors|mesh-ancestor
19991823|NCT02054481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991824|NCT02054520|Pembrolizumab|pembrolizumab|mesh-list
19991825|NCT02054520|Nivolumab|nivolumab|mesh-list
19991826|NCT02054520|Ipilimumab|ipilimumab|mesh-list
19991827|NCT02054520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19991828|NCT02054520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991829|NCT02054520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19991830|NCT02054520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991831|NCT02054702|Aripiprazole|aripiprazole|mesh-list
19991832|NCT02054702|Brexpiprazole|brexpiprazole|mesh-list
19991833|NCT02054702|Antidepressive Agents|antidepressive agents|mesh-ancestor
19991834|NCT02054702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19991835|NCT02054702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19991836|NCT02054702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19991837|NCT02054702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19991838|NCT02054702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991839|NCT02054702|Dopamine Agonists|dopamine agonists|mesh-ancestor
19991840|NCT02054702|Dopamine Agents|dopamine agents|mesh-ancestor
19991841|NCT02054702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19991842|NCT02054702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991843|NCT02054702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19991844|NCT02054702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19991845|NCT02054702|Serotonin Agents|serotonin agents|mesh-ancestor
19991846|NCT02054702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19991847|NCT02054702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19991848|NCT02054702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19991849|NCT02054702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19991850|NCT02054754|HU 211|hu 211|mesh-list
19991851|NCT02054754|Dronabinol|dronabinol|mesh-list
19991852|NCT02054754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19991853|NCT02054754|Antiemetics|antiemetics|mesh-ancestor
19991854|NCT02054754|Autonomic Agents|autonomic agents|mesh-ancestor
19991855|NCT02054754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19991856|NCT02054754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991857|NCT02054754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19991858|NCT02054754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19991859|NCT02054754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19991860|NCT02054754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19991861|NCT02054754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991862|NCT02054754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19991863|NCT02054754|Protective Agents|protective agents|mesh-ancestor
19991864|NCT02054754|Hallucinogens|hallucinogens|mesh-ancestor
19991865|NCT02054754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19991866|NCT02054754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19991867|NCT02054754|Analgesics|analgesics|mesh-ancestor
19991868|NCT02054754|Sensory System Agents|sensory system agents|mesh-ancestor
19991869|NCT02054754|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19991870|NCT02054754|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19991871|NCT02054754|Hormones|hormones|mesh-ancestor
19991872|NCT02054754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19991873|NCT02055157|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
19991874|NCT02055157|Natriuretic Agents|natriuretic agents|mesh-ancestor
19991875|NCT02055157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991876|NCT02055352|Fluticasone|fluticasone|mesh-list
19991877|NCT02055352|Budesonide|budesonide|mesh-list
19991878|NCT02055352|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19991879|NCT02055352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19991880|NCT02055352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19991881|NCT02055352|Autonomic Agents|autonomic agents|mesh-ancestor
19991882|NCT02055352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19991883|NCT02055352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991884|NCT02055352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19991885|NCT02055352|Respiratory System Agents|respiratory system agents|mesh-ancestor
19991886|NCT02055352|Dermatologic Agents|dermatologic agents|mesh-ancestor
19991887|NCT02055352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19991888|NCT02055352|Glucocorticoids|glucocorticoids|mesh-ancestor
19991889|NCT02055352|Hormones|hormones|mesh-ancestor
19991890|NCT02055352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19991891|NCT02055352|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19991892|NCT02055352|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19991893|NCT02055352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19991894|NCT02055352|Adrenergic Agents|adrenergic agents|mesh-ancestor
19991895|NCT02055352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19991896|NCT02055352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991897|NCT02055638|SRX246|srx246|mesh-list
19991898|NCT02055638|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19991899|NCT02055638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991900|NCT02055638|Natriuretic Agents|natriuretic agents|mesh-ancestor
19991901|NCT02055638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991902|NCT02055820|Prednisone|prednisone|mesh-list
19991903|NCT02055820|Cyclophosphamide|cyclophosphamide|mesh-list
19991904|NCT02055820|Rituximab|rituximab|mesh-list
19991905|NCT02055820|Doxorubicin|doxorubicin|mesh-list
19991906|NCT02055820|Vincristine|vincristine|mesh-list
19991907|NCT02055820|Venetoclax|venetoclax|mesh-list
19991908|NCT02055820|Obinutuzumab|obinutuzumab|mesh-list
19991909|NCT02055820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19991910|NCT02055820|Immunologic Factors|immunologic factors|mesh-ancestor
19991911|NCT02055820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991912|NCT02055820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19991913|NCT02055820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19991914|NCT02055820|Alkylating Agents|alkylating agents|mesh-ancestor
19991915|NCT02055820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991916|NCT02055820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991917|NCT02055820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19991918|NCT02055820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19991919|NCT02055820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19991920|NCT02055820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19991921|NCT02055820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19991922|NCT02055820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991923|NCT02055820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19991924|NCT02055820|Glucocorticoids|glucocorticoids|mesh-ancestor
19991925|NCT02055820|Hormones|hormones|mesh-ancestor
19991926|NCT02055820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19991927|NCT02055820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19991928|NCT02055820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19991929|NCT02055820|Tubulin Modulators|tubulin modulators|mesh-ancestor
19991930|NCT02055820|Antimitotic Agents|antimitotic agents|mesh-ancestor
19991931|NCT02055820|Mitosis Modulators|mitosis modulators|mesh-ancestor
19991932|NCT02055898|Sodium Oxybate|sodium oxybate|mesh-list
19991933|NCT02055898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19991934|NCT02055898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19991935|NCT02055898|Anesthetics, General|anesthetics, general|mesh-ancestor
19991936|NCT02055898|Anesthetics|anesthetics|mesh-ancestor
19991937|NCT02055898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19991938|NCT02055898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991939|NCT02055976|Ezetimibe|ezetimibe|mesh-list
19991940|NCT02055976|Bococizumab|bococizumab|mesh-list
19991941|NCT02055976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19991942|NCT02055976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19991943|NCT02055976|Antimetabolites|antimetabolites|mesh-ancestor
19991944|NCT02055976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991945|NCT02055976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19991946|NCT02056171|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19991947|NCT02056171|Antidepressive Agents|antidepressive agents|mesh-ancestor
19991948|NCT02056171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19991949|NCT02056171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19991950|NCT02056171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19991951|NCT02056171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19991952|NCT02056171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991953|NCT02056288|Fentanyl|fentanyl|mesh-list
19991954|NCT02056288|Ropivacaine|ropivacaine|mesh-list
19991955|NCT02056288|Anesthetics, Local|anesthetics, local|mesh-ancestor
19991956|NCT02056288|Anesthetics|anesthetics|mesh-ancestor
19991957|NCT02056288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19991958|NCT02056288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991959|NCT02056288|Sensory System Agents|sensory system agents|mesh-ancestor
19991960|NCT02056288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19991961|NCT02056288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19991962|NCT02056288|Narcotics|narcotics|mesh-ancestor
19991963|NCT02056288|Analgesics|analgesics|mesh-ancestor
19991964|NCT02056288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19991965|NCT02056288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19991966|NCT02056288|Anesthetics, General|anesthetics, general|mesh-ancestor
19991967|NCT02056301|Morphine|morphine|mesh-list
19991968|NCT02056301|Hydromorphone|hydromorphone|mesh-list
19991969|NCT02056301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19991970|NCT02056301|Narcotics|narcotics|mesh-ancestor
19991971|NCT02056301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19991972|NCT02056301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991973|NCT02056301|Analgesics|analgesics|mesh-ancestor
19991974|NCT02056301|Sensory System Agents|sensory system agents|mesh-ancestor
19991975|NCT02056301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19991976|NCT02056340|Atorvastatin|atorvastatin|mesh-list
19991977|NCT02056340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19991978|NCT02056340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19991979|NCT02056340|Antimetabolites|antimetabolites|mesh-ancestor
19991980|NCT02056340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991981|NCT02056340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19991982|NCT02056340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19991983|NCT02056340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991984|NCT02056392|Moxifloxacin|moxifloxacin|mesh-list
19991985|NCT02056392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19991986|NCT02056392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19991987|NCT02056392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19991988|NCT02056392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19991989|NCT02056392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19991990|NCT02056392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991991|NCT02056392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19991992|NCT02056626|Carvedilol|carvedilol|mesh-list
19991993|NCT02056626|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19991994|NCT02056626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19991995|NCT02056626|Adrenergic Agents|adrenergic agents|mesh-ancestor
19991996|NCT02056626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19991997|NCT02056626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19991998|NCT02056626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19991999|NCT02056626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19992000|NCT02056626|Antioxidants|antioxidants|mesh-ancestor
19992001|NCT02056626|Protective Agents|protective agents|mesh-ancestor
19992002|NCT02056626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19992003|NCT02056626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19992004|NCT02056626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19992005|NCT02056626|Vasodilator Agents|vasodilator agents|mesh-ancestor
19992006|NCT02056626|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19992007|NCT02056626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19992008|NCT02057198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19992009|NCT02057198|Metronidazole|metronidazole|mesh-list
19992010|NCT02057198|Vancomycin|vancomycin|mesh-list
19992011|NCT02057198|Fidaxomicin|fidaxomicin|mesh-list
19992012|NCT02057198|Amebicides|amebicides|mesh-list
19992013|NCT02057198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19992014|NCT02057198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19992015|NCT02057198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19992016|NCT02057250|Hydroxychloroquine|hydroxychloroquine|mesh-list
19992017|NCT02057250|Sulfasalazine|sulfasalazine|mesh-list
19992018|NCT02057250|Methotrexate|methotrexate|mesh-list
19992019|NCT02057250|Leflunomide|leflunomide|mesh-list
19992020|NCT02057250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19992021|NCT02057250|Abortifacient Agents|abortifacient agents|mesh-ancestor
19992022|NCT02057250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19992023|NCT02057250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992024|NCT02057250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19992025|NCT02057250|Antimetabolites|antimetabolites|mesh-ancestor
19992026|NCT02057250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992027|NCT02057250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19992028|NCT02057250|Dermatologic Agents|dermatologic agents|mesh-ancestor
19992029|NCT02057250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992030|NCT02057250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19992031|NCT02057250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19992032|NCT02057250|Immunologic Factors|immunologic factors|mesh-ancestor
19992033|NCT02057250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19992034|NCT02057250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19992035|NCT02057250|Antimalarials|antimalarials|mesh-ancestor
19992036|NCT02057250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19992037|NCT02057250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19992038|NCT02057250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19992039|NCT02057250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19992040|NCT02057250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19992041|NCT02057250|Analgesics|analgesics|mesh-ancestor
19992042|NCT02057250|Sensory System Agents|sensory system agents|mesh-ancestor
19992043|NCT02057250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992044|NCT02057250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19992045|NCT02057250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19992046|NCT02057393|Methylene Blue|methylene blue|mesh-list
19992047|NCT02057393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992048|NCT02057393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992049|NCT02057458|Sildenafil Citrate|sildenafil citrate|mesh-list
19992050|NCT02057458|Vasodilator Agents|vasodilator agents|mesh-ancestor
19992051|NCT02057458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19992052|NCT02057458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19992053|NCT02057458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992054|NCT02057458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992055|NCT02057458|Urological Agents|urological agents|mesh-ancestor
19992056|NCT02057523|Hormones|hormones|mesh-list
19992057|NCT02057523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19992058|NCT02057523|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19992059|NCT02057523|beta-Endorphin|beta-endorphin|mesh-list
19992060|NCT02057523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19992061|NCT02057523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992062|NCT02057523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19992063|NCT02057523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992064|NCT02057549|Haloperidol|haloperidol|mesh-list
19992065|NCT02057549|Haloperidol decanoate|haloperidol decanoate|mesh-list
19992066|NCT02057549|Antiemetics|antiemetics|mesh-ancestor
19992067|NCT02057549|Autonomic Agents|autonomic agents|mesh-ancestor
19992068|NCT02057549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992069|NCT02057549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992070|NCT02057549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19992071|NCT02057549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19992072|NCT02057549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19992073|NCT02057549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19992074|NCT02057549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19992075|NCT02057549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19992076|NCT02057549|Dopamine Agents|dopamine agents|mesh-ancestor
19992077|NCT02057549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19992078|NCT02057549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992079|NCT02057549|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19992080|NCT02057575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19992081|NCT02057575|Latanoprost|latanoprost|mesh-list
19992082|NCT02057575|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19992083|NCT02057640|Dexamethasone|dexamethasone|mesh-list
19992084|NCT02057640|Ixazomib|ixazomib|mesh-list
19992085|NCT02057640|Panobinostat|panobinostat|mesh-list
19992086|NCT02057640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19992087|NCT02057640|Antiemetics|antiemetics|mesh-ancestor
19992088|NCT02057640|Autonomic Agents|autonomic agents|mesh-ancestor
19992089|NCT02057640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992090|NCT02057640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556477|NCT01947062|Etoposide phosphate|etoposide phosphate|mesh-list
19992091|NCT02057640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19992092|NCT02057640|Glucocorticoids|glucocorticoids|mesh-ancestor
19992093|NCT02057640|Hormones|hormones|mesh-ancestor
19992094|NCT02057640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19992095|NCT02057640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19992096|NCT02057640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19992097|NCT02057640|Protease Inhibitors|protease inhibitors|mesh-ancestor
19992098|NCT02057640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992099|NCT02057640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992100|NCT02057640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20289300|NCT04821869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20289301|NCT04821869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289302|NCT04821869|Tocolytic Agents|tocolytic agents|mesh-ancestor
20289303|NCT04821869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20289304|NCT04809766|Cyclophosphamide|cyclophosphamide|mesh-list
20289305|NCT04809766|Fludarabine|fludarabine|mesh-list
20289306|NCT04809766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20289307|NCT04809766|Immunologic Factors|immunologic factors|mesh-ancestor
20289308|NCT04809766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289309|NCT04809766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20289310|NCT04809766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20289311|NCT04809766|Alkylating Agents|alkylating agents|mesh-ancestor
20289312|NCT04809766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289313|NCT04809766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289314|NCT04809766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20289315|NCT04809220|Dulaglutide|dulaglutide|mesh-list
20289316|NCT04809220|Biguanides|biguanides|mesh-list
20289317|NCT04809220|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
20289318|NCT04809220|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
20289319|NCT04809220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20289320|NCT04809220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289321|NCT04809220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289322|NCT04809220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289323|NCT04803201|Prednisone|prednisone|mesh-list
20289324|NCT04803201|Cyclophosphamide|cyclophosphamide|mesh-list
20289325|NCT04803201|Doxorubicin|doxorubicin|mesh-list
20289326|NCT04803201|Etoposide|etoposide|mesh-list
20289327|NCT04803201|Vincristine|vincristine|mesh-list
20289328|NCT04803201|Azacitidine|azacitidine|mesh-list
20289329|NCT04803201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20289330|NCT04803201|Immunologic Factors|immunologic factors|mesh-ancestor
20289331|NCT04803201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289332|NCT04803201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20289333|NCT04803201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20289334|NCT04803201|Alkylating Agents|alkylating agents|mesh-ancestor
20289335|NCT04803201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289336|NCT04803201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289337|NCT04803201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20289338|NCT04803201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20289339|NCT04803201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20289340|NCT04803201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20289341|NCT04803201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289342|NCT04803201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20289343|NCT04803201|Glucocorticoids|glucocorticoids|mesh-ancestor
20289344|NCT04803201|Hormones|hormones|mesh-ancestor
20289345|NCT04803201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20289346|NCT04803201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20289347|NCT04803201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20289348|NCT04803201|Tubulin Modulators|tubulin modulators|mesh-ancestor
20289349|NCT04803201|Antimitotic Agents|antimitotic agents|mesh-ancestor
20289350|NCT04803201|Mitosis Modulators|mitosis modulators|mesh-ancestor
20289351|NCT04803201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20289352|NCT04803201|Antimetabolites|antimetabolites|mesh-ancestor
20289353|NCT04791059|Sufentanil|sufentanil|mesh-list
20289354|NCT04791059|Dexmedetomidine|dexmedetomidine|mesh-list
20289355|NCT04791059|Ketamine|ketamine|mesh-list
20289356|NCT04791059|Esketamine|esketamine|mesh-list
20289357|NCT04791059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20289358|NCT04791059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20289359|NCT04791059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289360|NCT04791059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20289361|NCT04791059|Analgesics|analgesics|mesh-ancestor
20289362|NCT04791059|Sensory System Agents|sensory system agents|mesh-ancestor
20289363|NCT04791059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20289364|NCT04791059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20289365|NCT04791059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20289366|NCT04791059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19992101|NCT02057757|Nitazoxanide|nitazoxanide|mesh-list
19992102|NCT02057757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19992103|NCT02057757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19992104|NCT02057939|Leuprolide|leuprolide|mesh-list
19992105|NCT02057939|Androgens|androgens|mesh-list
19992106|NCT02057939|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19992107|NCT02057939|Fertility Agents|fertility agents|mesh-ancestor
19992108|NCT02057939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19992109|NCT02057939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992110|NCT02057939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19992111|NCT02057939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19992112|NCT02057939|Hormones|hormones|mesh-ancestor
19992113|NCT02057939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19992114|NCT02058095|Tadalafil|tadalafil|mesh-list
19992115|NCT02058095|Vasodilator Agents|vasodilator agents|mesh-ancestor
19992116|NCT02058095|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19992117|NCT02058095|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19992118|NCT02058095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992119|NCT02058095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992120|NCT02058095|Urological Agents|urological agents|mesh-ancestor
19992121|NCT02058108|Telbivudine|telbivudine|mesh-list
19992122|NCT02058108|Antiviral Agents|antiviral agents|mesh-ancestor
19992123|NCT02058108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19992124|NCT02058108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19992125|NCT02058108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992126|NCT02058108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992127|NCT02058147|Insulin|insulin|mesh-list
19992128|NCT02058147|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19992129|NCT02058147|Metformin|metformin|mesh-list
19992130|NCT02058147|Insulin Glargine|insulin glargine|mesh-list
19992131|NCT02058147|Lixisenatide|lixisenatide|mesh-list
19992132|NCT02058147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19992133|NCT02058147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992134|NCT02058160|Insulin|insulin|mesh-list
19992135|NCT02058160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19992136|NCT02058160|Metformin|metformin|mesh-list
19992137|NCT02058160|Insulin Glargine|insulin glargine|mesh-list
19992138|NCT02058160|Lixisenatide|lixisenatide|mesh-list
19992139|NCT02058160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19992140|NCT02058160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992141|NCT02058251|Oxytocin|oxytocin|mesh-list
19992142|NCT02058251|Oxytocics|oxytocics|mesh-ancestor
19992143|NCT02058251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19992144|NCT02058251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992145|NCT02058290|Morphine|morphine|mesh-list
19992146|NCT02058290|Bupivacaine|bupivacaine|mesh-list
19992147|NCT02058290|Anesthetics, Local|anesthetics, local|mesh-ancestor
19992148|NCT02058290|Anesthetics|anesthetics|mesh-ancestor
19992149|NCT02058290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19992150|NCT02058290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992151|NCT02058290|Sensory System Agents|sensory system agents|mesh-ancestor
19992152|NCT02058290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992153|NCT02058290|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19992154|NCT02058290|Narcotics|narcotics|mesh-ancestor
19992155|NCT02058290|Analgesics|analgesics|mesh-ancestor
19992156|NCT02058368|Tamsulosin|tamsulosin|mesh-list
19992157|NCT02058368|Dutasteride|dutasteride|mesh-list
19992158|NCT02058368|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19992159|NCT02058368|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19992160|NCT02058368|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19992161|NCT02058368|Adrenergic Agents|adrenergic agents|mesh-ancestor
19992162|NCT02058368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19992163|NCT02058368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992164|NCT02058368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992165|NCT02058368|Urological Agents|urological agents|mesh-ancestor
20556478|NCT01947062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20556479|NCT01947062|Immunologic Factors|immunologic factors|mesh-ancestor
20556480|NCT01947062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556481|NCT01947062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20556482|NCT01947062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20556483|NCT01947062|Alkylating Agents|alkylating agents|mesh-ancestor
20556484|NCT01947062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992166|NCT02058368|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19992167|NCT02058368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19992168|NCT02058368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992169|NCT02058368|Hormone Antagonists|hormone antagonists|mesh-ancestor
19992170|NCT02058368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19992171|NCT02058511|Anesthetics|anesthetics|mesh-list
19992172|NCT02058511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19992173|NCT02058511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992174|NCT02058628|Clindamycin|clindamycin|mesh-list
19992175|NCT02058628|Clindamycin palmitate|clindamycin palmitate|mesh-list
19992176|NCT02058628|Clindamycin phosphate|clindamycin phosphate|mesh-list
19992177|NCT02058628|Azelaic acid|azelaic acid|mesh-list
19992178|NCT02058628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19992179|NCT02058628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19992180|NCT02058628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19992181|NCT02058628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992182|NCT02058628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992183|NCT02058628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19992184|NCT02058628|Dermatologic Agents|dermatologic agents|mesh-ancestor
19992185|NCT02058836|Botulinum Toxins|botulinum toxins|mesh-list
19992186|NCT02058836|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19992187|NCT02058836|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19992188|NCT02058836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19992189|NCT02058836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992190|NCT02058836|Cholinergic Agents|cholinergic agents|mesh-ancestor
19992191|NCT02058836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19992192|NCT02058836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992193|NCT02058836|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19992194|NCT02058836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992195|NCT02058940|Exenatide|exenatide|mesh-list
19992196|NCT02058940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19992197|NCT02058940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992198|NCT02058940|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19992199|NCT02058940|Incretins|incretins|mesh-ancestor
19992200|NCT02058940|Hormones|hormones|mesh-ancestor
19992201|NCT02058940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19992202|NCT02058966|Entacapone|entacapone|mesh-list
19992203|NCT02058966|Methamphetamine|methamphetamine|mesh-list
19992204|NCT02058966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19992205|NCT02058966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19992206|NCT02058966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19992207|NCT02058966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992208|NCT02058966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992209|NCT02058966|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19992210|NCT02058966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992211|NCT02058966|Sympathomimetics|sympathomimetics|mesh-ancestor
19992212|NCT02058966|Autonomic Agents|autonomic agents|mesh-ancestor
19992213|NCT02058966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992214|NCT02058966|Dopamine Agents|dopamine agents|mesh-ancestor
19992215|NCT02058966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19992216|NCT02058966|Adrenergic Agents|adrenergic agents|mesh-ancestor
19992217|NCT02058966|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19992218|NCT02058966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19992219|NCT02058966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19992220|NCT02058966|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19992221|NCT02059070|Bupivacaine|bupivacaine|mesh-list
19992222|NCT02059070|Ropivacaine|ropivacaine|mesh-list
19992223|NCT02059070|Anesthetics, Local|anesthetics, local|mesh-ancestor
19992224|NCT02059070|Anesthetics|anesthetics|mesh-ancestor
19992225|NCT02059070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19992226|NCT02059070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992227|NCT02059070|Sensory System Agents|sensory system agents|mesh-ancestor
19992228|NCT02059070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992229|NCT02059135|Antithrombins|antithrombins|mesh-list
19992230|NCT02059135|Antithrombin III|antithrombin iii|mesh-list
19992231|NCT02059135|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19992232|NCT02059135|Protease Inhibitors|protease inhibitors|mesh-ancestor
19992233|NCT02059135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992234|NCT02059135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992235|NCT02059135|Anticoagulants|anticoagulants|mesh-ancestor
19992236|NCT02059161|Insulin|insulin|mesh-list
19992237|NCT02059161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19992238|NCT02059161|Insulin Glargine|insulin glargine|mesh-list
19992239|NCT02059161|MK-1293|mk-1293|mesh-list
19992240|NCT02059161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19992241|NCT02059161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992242|NCT02059161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19992243|NCT02059161|Antimetabolites|antimetabolites|mesh-ancestor
20289367|NCT04791059|Adrenergic Agents|adrenergic agents|mesh-ancestor
19992244|NCT02059161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992245|NCT02059161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19992246|NCT02059174|Insulin Aspart|insulin aspart|mesh-list
19992247|NCT02059174|MK-1293|mk-1293|mesh-list
19992248|NCT02059174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19992249|NCT02059174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992250|NCT02059174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19992251|NCT02059174|Antimetabolites|antimetabolites|mesh-ancestor
19992252|NCT02059174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992253|NCT02059174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19992254|NCT02059187|Insulin|insulin|mesh-list
19992255|NCT02059187|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19992256|NCT02059187|Insulin Glargine|insulin glargine|mesh-list
19992257|NCT02059187|MK-1293|mk-1293|mesh-list
19992258|NCT02059187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19992259|NCT02059187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992260|NCT02059187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19992261|NCT02059187|Antimetabolites|antimetabolites|mesh-ancestor
19992262|NCT02059187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992263|NCT02059187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19992264|NCT02059213|Palbociclib|palbociclib|mesh-list
19992265|NCT02059213|Leuprolide|leuprolide|mesh-list
19992266|NCT02059213|Goserelin|goserelin|mesh-list
19992267|NCT02059213|Bicalutamide|bicalutamide|mesh-list
19992268|NCT02059213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19992269|NCT02059213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19992270|NCT02059213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992271|NCT02059213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992272|NCT02059213|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19992273|NCT02059213|Fertility Agents|fertility agents|mesh-ancestor
19992274|NCT02059213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19992275|NCT02059213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992276|NCT02059213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19992277|NCT02059213|Androgen Antagonists|androgen antagonists|mesh-ancestor
19992278|NCT02059213|Hormone Antagonists|hormone antagonists|mesh-ancestor
19992279|NCT02059213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19992280|NCT02059239|Cytarabine|cytarabine|mesh-list
19992281|NCT02059239|Rituximab|rituximab|mesh-list
19992282|NCT02059239|Alemtuzumab|alemtuzumab|mesh-list
19992283|NCT02059239|Etoposide|etoposide|mesh-list
19992284|NCT02059239|Melphalan|melphalan|mesh-list
19992285|NCT02059239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19992286|NCT02059239|Carmustine|carmustine|mesh-list
19992287|NCT02059239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19992288|NCT02059239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19992289|NCT02059239|Immunologic Factors|immunologic factors|mesh-ancestor
19992290|NCT02059239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992291|NCT02059239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19992292|NCT02059239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19992293|NCT02059239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19992294|NCT02059239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19992295|NCT02059239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992296|NCT02059239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992297|NCT02059239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19992298|NCT02059239|Antimetabolites|antimetabolites|mesh-ancestor
19992299|NCT02059239|Antiviral Agents|antiviral agents|mesh-ancestor
19992300|NCT02059239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19992301|NCT02059239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19992302|NCT02059239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19992303|NCT02059239|Alkylating Agents|alkylating agents|mesh-ancestor
19992304|NCT02059239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19992305|NCT02059278|Latanoprost|latanoprost|mesh-list
19992306|NCT02059278|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19992307|NCT02059278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19992308|NCT02059434|Tiotropium Bromide|tiotropium bromide|mesh-list
19992309|NCT02059434|LAS190792|las190792|mesh-list
19992310|NCT02059434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19992311|NCT02059434|Autonomic Agents|autonomic agents|mesh-ancestor
19992312|NCT02059434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992313|NCT02059434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992314|NCT02059434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19992315|NCT02059434|Respiratory System Agents|respiratory system agents|mesh-ancestor
19992316|NCT02059434|Parasympatholytics|parasympatholytics|mesh-ancestor
19992317|NCT02059434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19992318|NCT02059434|Cholinergic Agents|cholinergic agents|mesh-ancestor
19992319|NCT02059434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20289368|NCT04791059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19992320|NCT02059434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992321|NCT02059434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19992322|NCT02059434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19992323|NCT02059434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19992324|NCT02059434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19992325|NCT02059434|Adrenergic Agents|adrenergic agents|mesh-ancestor
19992326|NCT02059642|Metadoxine|metadoxine|mesh-list
19992327|NCT02059642|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19992328|NCT02059902|Lidocaine|lidocaine|mesh-list
19992329|NCT02059902|Anesthetics, Local|anesthetics, local|mesh-ancestor
19992330|NCT02059902|Anesthetics|anesthetics|mesh-ancestor
19992331|NCT02059902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19992332|NCT02059902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992333|NCT02059902|Sensory System Agents|sensory system agents|mesh-ancestor
19992334|NCT02059902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992335|NCT02059902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19992336|NCT02059902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19992337|NCT02059902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19992338|NCT02059902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19992339|NCT02059902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992340|NCT02060370|Sunitinib|sunitinib|mesh-list
19992341|NCT02060370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19992342|NCT02060370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19992343|NCT02060370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19992344|NCT02060370|Growth Substances|growth substances|mesh-ancestor
19992345|NCT02060370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992346|NCT02060370|Growth Inhibitors|growth inhibitors|mesh-ancestor
19992347|NCT02060370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19992348|NCT02060370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992349|NCT02060370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992350|NCT02060383|Metformin|metformin|mesh-list
19992351|NCT02060383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19992352|NCT02060383|Liraglutide|liraglutide|mesh-list
19992353|NCT02060383|Pasireotide|pasireotide|mesh-list
19992354|NCT02060383|Somatostatin|somatostatin|mesh-list
19992355|NCT02060383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19992356|NCT02060383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992357|NCT02060383|Incretins|incretins|mesh-ancestor
19992358|NCT02060383|Hormones|hormones|mesh-ancestor
19992359|NCT02060383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19992360|NCT02060383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19992361|NCT02060383|Protease Inhibitors|protease inhibitors|mesh-ancestor
19992362|NCT02060383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992363|NCT02060383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992364|NCT02061202|Mometasone Furoate|mometasone furoate|mesh-list
19992365|NCT02061202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19992366|NCT02061202|Dermatologic Agents|dermatologic agents|mesh-ancestor
19992367|NCT02061202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19992368|NCT02061280|Fluticasone|fluticasone|mesh-list
19992369|NCT02061280|Xhance|xhance|mesh-list
19992370|NCT02061280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19992371|NCT02061280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
19992372|NCT02061280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19992373|NCT02061280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19992374|NCT02061280|Autonomic Agents|autonomic agents|mesh-ancestor
19992375|NCT02061280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992376|NCT02061280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992377|NCT02061280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19992378|NCT02061280|Respiratory System Agents|respiratory system agents|mesh-ancestor
19992379|NCT02061280|Dermatologic Agents|dermatologic agents|mesh-ancestor
19992380|NCT02061280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19992381|NCT02061280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19992382|NCT02061280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19992383|NCT02061280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19992384|NCT02061280|Adrenergic Agents|adrenergic agents|mesh-ancestor
19992385|NCT02061280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19992386|NCT02061280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992387|NCT02061280|Glucocorticoids|glucocorticoids|mesh-ancestor
19992388|NCT02061280|Hormones|hormones|mesh-ancestor
19992389|NCT02061280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19992390|NCT02061280|Sympathomimetics|sympathomimetics|mesh-ancestor
19992391|NCT02061384|Calcitriol|calcitriol|mesh-list
19992392|NCT02061384|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
19992393|NCT02061384|Tretinoin|tretinoin|mesh-list
19992394|NCT02061384|Isotretinoin|isotretinoin|mesh-list
19992395|NCT02061384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19992396|NCT02061384|Keratolytic Agents|keratolytic agents|mesh-ancestor
19992397|NCT02061384|Dermatologic Agents|dermatologic agents|mesh-ancestor
19992398|NCT02061384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19992399|NCT02061384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992400|NCT02061384|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
19992401|NCT02061384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19992402|NCT02061384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992403|NCT02061384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19992404|NCT02061384|Vitamins|vitamins|mesh-ancestor
19992405|NCT02061384|Micronutrients|micronutrients|mesh-ancestor
19992406|NCT02061384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19992407|NCT02061397|Sirolimus|sirolimus|mesh-list
19992408|NCT02061397|Everolimus|everolimus|mesh-list
19992409|NCT02061397|Simvastatin|simvastatin|mesh-list
19992410|NCT02061397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19992411|NCT02061397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19992412|NCT02061397|Immunologic Factors|immunologic factors|mesh-ancestor
19992413|NCT02061397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992414|NCT02061397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19992415|NCT02061397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19992416|NCT02061397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19992417|NCT02061397|Antifungal Agents|antifungal agents|mesh-ancestor
19992418|NCT02061397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19992419|NCT02061397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19992420|NCT02061397|Antimetabolites|antimetabolites|mesh-ancestor
19992421|NCT02061397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992422|NCT02061397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19992423|NCT02061397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19992424|NCT02061397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992425|NCT02061683|Bimatoprost|bimatoprost|mesh-list
19992426|NCT02061683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19992427|NCT02061774|Acetaminophen|acetaminophen|mesh-list
19992428|NCT02061774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19992429|NCT02061774|Analgesics|analgesics|mesh-ancestor
19992430|NCT02061774|Sensory System Agents|sensory system agents|mesh-ancestor
19992431|NCT02061774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992432|NCT02061774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992433|NCT02061774|Antipyretics|antipyretics|mesh-ancestor
19992434|NCT02061969|Insulin Glargine|insulin glargine|mesh-list
19992435|NCT02061969|Linagliptin|linagliptin|mesh-list
19992436|NCT02061969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19992437|NCT02061969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992438|NCT02061969|Incretins|incretins|mesh-ancestor
19992439|NCT02061969|Hormones|hormones|mesh-ancestor
19992440|NCT02061969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19992441|NCT02061969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19992442|NCT02061969|Protease Inhibitors|protease inhibitors|mesh-ancestor
19992443|NCT02061969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992444|NCT02061969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992445|NCT02062177|Midazolam|midazolam|mesh-list
19992446|NCT02062177|Propofol|propofol|mesh-list
19992447|NCT02062177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19992448|NCT02062177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19992449|NCT02062177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992450|NCT02062177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19992451|NCT02062177|Anesthetics, General|anesthetics, general|mesh-ancestor
19992452|NCT02062177|Anesthetics|anesthetics|mesh-ancestor
19992453|NCT02062177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19992454|NCT02062177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19992455|NCT02062177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19992456|NCT02062177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19992457|NCT02062177|GABA Modulators|gaba modulators|mesh-ancestor
19992458|NCT02062177|GABA Agents|gaba agents|mesh-ancestor
19992459|NCT02062177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19992460|NCT02062177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992461|NCT02062359|Aldesleukin|aldesleukin|mesh-list
19992462|NCT02062359|Cyclophosphamide|cyclophosphamide|mesh-list
19992463|NCT02062359|Fludarabine|fludarabine|mesh-list
19992464|NCT02062359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19992465|NCT02062359|Immunologic Factors|immunologic factors|mesh-ancestor
19992466|NCT02062359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992467|NCT02062359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19992468|NCT02062359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19992469|NCT02062359|Alkylating Agents|alkylating agents|mesh-ancestor
19992470|NCT02062359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992471|NCT02062359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19992472|NCT02062359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19992473|NCT02062359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19992474|NCT02062359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19992475|NCT02062359|Antiviral Agents|antiviral agents|mesh-ancestor
19992476|NCT02062359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19992477|NCT02062632|Doxepin|doxepin|mesh-list
19992478|NCT02062632|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19992479|NCT02062632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19992480|NCT02062632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19992481|NCT02062632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992482|NCT02062632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19992483|NCT02062632|Antidepressive Agents|antidepressive agents|mesh-ancestor
19992484|NCT02062632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19992485|NCT02062632|Histamine Antagonists|histamine antagonists|mesh-ancestor
19992486|NCT02062632|Histamine Agents|histamine agents|mesh-ancestor
19992487|NCT02062632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19992488|NCT02062632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992489|NCT02062645|Amlodipine|amlodipine|mesh-list
19992490|NCT02062645|Valsartan|valsartan|mesh-list
19992491|NCT02062645|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
19992492|NCT02062645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19992493|NCT02062645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19992494|NCT02062645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19992495|NCT02062645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992496|NCT02062645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19992497|NCT02062645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992498|NCT02062645|Vasodilator Agents|vasodilator agents|mesh-ancestor
19992499|NCT02062645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19992500|NCT02062645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19992501|NCT02062658|Ketamine|ketamine|mesh-list
19992502|NCT02062658|Analgesics|analgesics|mesh-ancestor
19992503|NCT02062658|Sensory System Agents|sensory system agents|mesh-ancestor
19992504|NCT02062658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992505|NCT02062658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992506|NCT02062658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19992507|NCT02062658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19992508|NCT02062658|Anesthetics, General|anesthetics, general|mesh-ancestor
19992509|NCT02062658|Anesthetics|anesthetics|mesh-ancestor
19992510|NCT02062658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19992511|NCT02062658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19992512|NCT02062658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19992513|NCT02062658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19992514|NCT02062658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992515|NCT02062710|Diphenhydramine|diphenhydramine|mesh-list
19992516|NCT02062710|Promethazine|promethazine|mesh-list
19992517|NCT02062710|Phenylephrine|phenylephrine|mesh-list
19992518|NCT02062710|Oxymetazoline|oxymetazoline|mesh-list
19992519|NCT02062710|Dextromethorphan|dextromethorphan|mesh-list
19992520|NCT02062710|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19992521|NCT02062710|Mydriatics|mydriatics|mesh-ancestor
19992522|NCT02062710|Autonomic Agents|autonomic agents|mesh-ancestor
19992523|NCT02062710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992524|NCT02062710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992525|NCT02062710|Sympathomimetics|sympathomimetics|mesh-ancestor
19992526|NCT02062710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19992527|NCT02062710|Nasal Decongestants|nasal decongestants|mesh-ancestor
19992528|NCT02062710|Respiratory System Agents|respiratory system agents|mesh-ancestor
19992529|NCT02062710|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19992530|NCT02062710|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19992531|NCT02062710|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19992532|NCT02062710|Adrenergic Agents|adrenergic agents|mesh-ancestor
19992533|NCT02062710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19992534|NCT02062710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992535|NCT02062710|Protective Agents|protective agents|mesh-ancestor
19992536|NCT02062710|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19992537|NCT02062710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19992538|NCT02062710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19992539|NCT02062710|Anesthetics, Local|anesthetics, local|mesh-ancestor
19992540|NCT02062710|Anesthetics|anesthetics|mesh-ancestor
19992541|NCT02062710|Sensory System Agents|sensory system agents|mesh-ancestor
19992542|NCT02062710|Antiemetics|antiemetics|mesh-ancestor
19992543|NCT02062710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19992544|NCT02062710|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19992545|NCT02062710|Histamine Antagonists|histamine antagonists|mesh-ancestor
19992546|NCT02062710|Histamine Agents|histamine agents|mesh-ancestor
19992547|NCT02062710|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19992548|NCT02062710|Antipruritics|antipruritics|mesh-ancestor
19992549|NCT02062710|Dermatologic Agents|dermatologic agents|mesh-ancestor
19992550|NCT02062710|Antitussive Agents|antitussive agents|mesh-ancestor
19992551|NCT02062710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19992552|NCT02062710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19992553|NCT02062801|Ephedrine|ephedrine|mesh-list
19992554|NCT02062801|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19992555|NCT02062801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992556|NCT02062801|Sympathomimetics|sympathomimetics|mesh-ancestor
19992557|NCT02062801|Autonomic Agents|autonomic agents|mesh-ancestor
19992558|NCT02062801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992559|NCT02062801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19992560|NCT02062801|Adrenergic Agents|adrenergic agents|mesh-ancestor
19992561|NCT02062801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19992562|NCT02062801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992563|NCT02062879|Ketamine|ketamine|mesh-list
19992564|NCT02062879|Hydromorphone|hydromorphone|mesh-list
19992565|NCT02062879|Analgesics|analgesics|mesh-ancestor
19992566|NCT02062879|Sensory System Agents|sensory system agents|mesh-ancestor
19992567|NCT02062879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992568|NCT02062879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992569|NCT02062879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19992570|NCT02062879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19992571|NCT02062879|Anesthetics, General|anesthetics, general|mesh-ancestor
19992572|NCT02062879|Anesthetics|anesthetics|mesh-ancestor
19992573|NCT02062879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19992574|NCT02062879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19992575|NCT02062879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19992576|NCT02062879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19992577|NCT02062879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992578|NCT02062879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19992579|NCT02062879|Narcotics|narcotics|mesh-ancestor
19992580|NCT02062905|Dexamethasone|dexamethasone|mesh-list
19992581|NCT02062905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19992582|NCT02062905|Antiemetics|antiemetics|mesh-ancestor
19992583|NCT02062905|Autonomic Agents|autonomic agents|mesh-ancestor
19992584|NCT02062905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992585|NCT02062905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992586|NCT02062905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19992587|NCT02062905|Glucocorticoids|glucocorticoids|mesh-ancestor
19992588|NCT02062905|Hormones|hormones|mesh-ancestor
19992589|NCT02062905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19992590|NCT02062905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19992591|NCT02062905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19992592|NCT02063035|Tranexamic Acid|tranexamic acid|mesh-list
19992593|NCT02063035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19992594|NCT02063035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19992595|NCT02063035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992596|NCT02063035|Hemostatics|hemostatics|mesh-ancestor
19992597|NCT02063035|Coagulants|coagulants|mesh-ancestor
19992598|NCT02063217|Sodium Oxybate|sodium oxybate|mesh-list
19992599|NCT02063217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19992600|NCT02063217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19992601|NCT02063217|Anesthetics, General|anesthetics, general|mesh-ancestor
19992602|NCT02063217|Anesthetics|anesthetics|mesh-ancestor
19992603|NCT02063217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19992604|NCT02063217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992605|NCT02063698|Auranofin|auranofin|mesh-list
19992606|NCT02063698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19992607|NCT02063854|Risedronic Acid|risedronic acid|mesh-list
19992608|NCT02063854|Etidronic Acid|etidronic acid|mesh-list
19992609|NCT02063854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19992610|NCT02063854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19992611|NCT02063854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992612|NCT02063854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19992613|NCT02063854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992614|NCT02063854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20289369|NCT04791059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289370|NCT04791059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20289371|NCT04791059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19992615|NCT02064166|Insulin|insulin|mesh-list
19992616|NCT02064166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19992617|NCT02064166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992618|NCT02064439|Rivaroxaban|rivaroxaban|mesh-list
19992619|NCT02064439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19992620|NCT02064439|Antithrombins|antithrombins|mesh-ancestor
19992621|NCT02064439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19992622|NCT02064439|Protease Inhibitors|protease inhibitors|mesh-ancestor
19992623|NCT02064439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992624|NCT02064439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992625|NCT02064439|Anticoagulants|anticoagulants|mesh-ancestor
19992626|NCT02064582|Leuprolide|leuprolide|mesh-list
19992627|NCT02064582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19992628|NCT02064582|Fertility Agents|fertility agents|mesh-ancestor
19992629|NCT02064582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19992630|NCT02064582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992631|NCT02064582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19992632|NCT02064582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19992633|NCT02064816|Interferon beta-1a|interferon beta-1a|mesh-list
19992634|NCT02064816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19992635|NCT02064816|Immunologic Factors|immunologic factors|mesh-ancestor
19992636|NCT02064816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992637|NCT02064816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19992638|NCT02064816|Antiviral Agents|antiviral agents|mesh-ancestor
19992639|NCT02064816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19992640|NCT02064894|Ibuprofen|ibuprofen|mesh-list
19992641|NCT02064894|Morphine|morphine|mesh-list
19992642|NCT02064894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19992643|NCT02064894|Narcotics|narcotics|mesh-ancestor
19992644|NCT02064894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19992645|NCT02064894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992646|NCT02064894|Analgesics|analgesics|mesh-ancestor
19992647|NCT02064894|Sensory System Agents|sensory system agents|mesh-ancestor
19992648|NCT02064894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992649|NCT02064894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19992650|NCT02064894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19992651|NCT02064894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19992652|NCT02064894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19992653|NCT02064894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19992654|NCT02064894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992655|NCT02064894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992656|NCT02064907|Dexlansoprazole|dexlansoprazole|mesh-list
19992657|NCT02064907|Lansoprazole|lansoprazole|mesh-list
19992658|NCT02064907|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19992659|NCT02064907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19992660|NCT02064907|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19992661|NCT02064907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992662|NCT02064907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992663|NCT02064920|Donepezil|donepezil|mesh-list
19992664|NCT02064920|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19992665|NCT02064920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992666|NCT02064920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992667|NCT02064920|Cholinergic Agents|cholinergic agents|mesh-ancestor
19992668|NCT02064920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19992669|NCT02064920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992670|NCT02064920|Nootropic Agents|nootropic agents|mesh-ancestor
19992671|NCT02064985|Ticagrelor|ticagrelor|mesh-list
19992672|NCT02064985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19992673|NCT02064985|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19992674|NCT02064985|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19992675|NCT02064985|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19992676|NCT02064985|Purinergic Agents|purinergic agents|mesh-ancestor
19992677|NCT02064985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19992678|NCT02064985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992679|NCT02064985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992680|NCT02065245|Penicillins|penicillins|mesh-list
19992681|NCT02065245|Streptomycin|streptomycin|mesh-list
19992682|NCT02065245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19992683|NCT02065245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19992684|NCT02065245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19992685|NCT02065245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992686|NCT02065245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992687|NCT02065336|Chlorpheniramine|chlorpheniramine|mesh-list
19992688|NCT02065336|Entecavir|entecavir|mesh-list
19992689|NCT02065336|Antiviral Agents|antiviral agents|mesh-ancestor
20289372|NCT04791059|Anesthetics, General|anesthetics, general|mesh-ancestor
19992690|NCT02065336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19992691|NCT02065336|Antipruritics|antipruritics|mesh-ancestor
19992692|NCT02065336|Dermatologic Agents|dermatologic agents|mesh-ancestor
19992693|NCT02065336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19992694|NCT02065336|Histamine Antagonists|histamine antagonists|mesh-ancestor
19992695|NCT02065336|Histamine Agents|histamine agents|mesh-ancestor
19992696|NCT02065336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19992697|NCT02065336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992698|NCT02065336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992699|NCT02065336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19992700|NCT02065479|Ticagrelor|ticagrelor|mesh-list
19992701|NCT02065479|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19992702|NCT02065479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19992703|NCT02065479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19992704|NCT02065479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19992705|NCT02065479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19992706|NCT02065479|Purinergic Agents|purinergic agents|mesh-ancestor
19992707|NCT02065479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19992708|NCT02065479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992709|NCT02065479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992710|NCT02065557|Adalimumab|adalimumab|mesh-list
19992711|NCT02065557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19992712|NCT02065557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19992713|NCT02065570|Adalimumab|adalimumab|mesh-list
19992714|NCT02065570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19992715|NCT02065570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19992716|NCT02065622|Adalimumab|adalimumab|mesh-list
19992717|NCT02065622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19992718|NCT02065622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19992719|NCT02065687|Metformin|metformin|mesh-list
19992720|NCT02065687|Paclitaxel|paclitaxel|mesh-list
19992721|NCT02065687|Carboplatin|carboplatin|mesh-list
19992722|NCT02065687|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19992723|NCT02065687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19992724|NCT02065687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19992725|NCT02065687|Tubulin Modulators|tubulin modulators|mesh-ancestor
19992726|NCT02065687|Antimitotic Agents|antimitotic agents|mesh-ancestor
19992727|NCT02065687|Mitosis Modulators|mitosis modulators|mesh-ancestor
19992728|NCT02065687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992729|NCT02065687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19992730|NCT02065687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992731|NCT02065713|Golimumab|golimumab|mesh-list
19992732|NCT02065713|Methotrexate|methotrexate|mesh-list
19992733|NCT02065713|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19992734|NCT02065713|Abortifacient Agents|abortifacient agents|mesh-ancestor
19992735|NCT02065713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19992736|NCT02065713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992737|NCT02065713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19992738|NCT02065713|Antimetabolites|antimetabolites|mesh-ancestor
19992739|NCT02065713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992740|NCT02065713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19992741|NCT02065713|Dermatologic Agents|dermatologic agents|mesh-ancestor
19992742|NCT02065713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992743|NCT02065713|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19992744|NCT02065713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19992745|NCT02065713|Immunologic Factors|immunologic factors|mesh-ancestor
19992746|NCT02065713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19992747|NCT02065713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19992748|NCT02065713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19992749|NCT02065713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19992750|NCT02065791|Canagliflozin|canagliflozin|mesh-list
19992751|NCT02065791|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19992752|NCT02065791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992753|NCT02065791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19992754|NCT02065791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992755|NCT02066129|Fluticasone|fluticasone|mesh-list
19992756|NCT02066129|Xhance|xhance|mesh-list
19992757|NCT02066129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19992758|NCT02066129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19992759|NCT02066129|Autonomic Agents|autonomic agents|mesh-ancestor
19992760|NCT02066129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992761|NCT02066129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992762|NCT02066129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19992763|NCT02066129|Respiratory System Agents|respiratory system agents|mesh-ancestor
19992764|NCT02066129|Dermatologic Agents|dermatologic agents|mesh-ancestor
19992765|NCT02066129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19992766|NCT02066298|Mometasone Furoate|mometasone furoate|mesh-list
19992767|NCT02066298|Tiotropium Bromide|tiotropium bromide|mesh-list
19992768|NCT02066298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19992769|NCT02066298|Autonomic Agents|autonomic agents|mesh-ancestor
19992770|NCT02066298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992771|NCT02066298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992772|NCT02066298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19992773|NCT02066298|Respiratory System Agents|respiratory system agents|mesh-ancestor
19992774|NCT02066298|Parasympatholytics|parasympatholytics|mesh-ancestor
19992775|NCT02066298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19992776|NCT02066298|Cholinergic Agents|cholinergic agents|mesh-ancestor
19992777|NCT02066298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19992778|NCT02066298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992779|NCT02066298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19992780|NCT02066298|Dermatologic Agents|dermatologic agents|mesh-ancestor
19992781|NCT02066298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19992782|NCT02066311|Nelfinavir|nelfinavir|mesh-list
19992783|NCT02066311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19992784|NCT02066311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19992785|NCT02066311|Protease Inhibitors|protease inhibitors|mesh-ancestor
19992786|NCT02066311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992787|NCT02066311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992788|NCT02066311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19992789|NCT02066311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19992790|NCT02066311|Antiviral Agents|antiviral agents|mesh-ancestor
19992791|NCT02066311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19992792|NCT02066389|Upadacitinib|upadacitinib|mesh-list
19992793|NCT02066389|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19992794|NCT02066389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19992795|NCT02066389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992796|NCT02066389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992797|NCT02066389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19992798|NCT02066402|Linezolid|linezolid|mesh-list
19992799|NCT02066402|Tedizolid|tedizolid|mesh-list
19992800|NCT02066402|Oxazolidinones|oxazolidinones|mesh-list
19992801|NCT02066402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19992802|NCT02066402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19992803|NCT02066402|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19992804|NCT02066402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992805|NCT02066402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992806|NCT02066727|Dexmedetomidine|dexmedetomidine|mesh-list
19992807|NCT02066727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19992808|NCT02066727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19992809|NCT02066727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992810|NCT02066727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19992811|NCT02066727|Analgesics|analgesics|mesh-ancestor
19992812|NCT02066727|Sensory System Agents|sensory system agents|mesh-ancestor
19992813|NCT02066727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992814|NCT02066727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19992815|NCT02066727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19992816|NCT02066727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19992817|NCT02066727|Adrenergic Agents|adrenergic agents|mesh-ancestor
19992818|NCT02066727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19992819|NCT02066727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992820|NCT02066792|Cycloserine|cycloserine|mesh-list
19992821|NCT02066792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19992822|NCT02066792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19992823|NCT02066792|Renal Agents|renal agents|mesh-ancestor
19992824|NCT02066792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19992825|NCT02066792|Antitubercular Agents|antitubercular agents|mesh-ancestor
19992826|NCT02066792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19992827|NCT02066792|Antimetabolites|antimetabolites|mesh-ancestor
19992828|NCT02066792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992829|NCT02067663|Levonorgestrel|levonorgestrel|mesh-list
19992830|NCT02067663|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19992831|NCT02067663|Contraceptive Agents|contraceptive agents|mesh-ancestor
19992832|NCT02067663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19992833|NCT02067663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992834|NCT02067663|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19992835|NCT02067663|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19992836|NCT02067663|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19992837|NCT02067676|Aluminum Hydroxide|aluminum hydroxide|mesh-list
19992838|NCT02067676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19992839|NCT02067676|Immunologic Factors|immunologic factors|mesh-ancestor
19992840|NCT02067676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992841|NCT02067676|Antacids|antacids|mesh-ancestor
19992842|NCT02067676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992843|NCT02067676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19992844|NCT02067806|Chloroprocaine|chloroprocaine|mesh-list
19992845|NCT02067806|Anesthetics, Local|anesthetics, local|mesh-ancestor
19992846|NCT02067806|Anesthetics|anesthetics|mesh-ancestor
19992847|NCT02067806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19992848|NCT02067806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992849|NCT02067806|Sensory System Agents|sensory system agents|mesh-ancestor
19992850|NCT02067806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992851|NCT02068027|Clonidine|clonidine|mesh-list
19992852|NCT02068027|Analgesics|analgesics|mesh-ancestor
19992853|NCT02068027|Sensory System Agents|sensory system agents|mesh-ancestor
19992854|NCT02068027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992855|NCT02068027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992856|NCT02068027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19992857|NCT02068027|Sympatholytics|sympatholytics|mesh-ancestor
19992858|NCT02068027|Autonomic Agents|autonomic agents|mesh-ancestor
19992859|NCT02068027|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19992860|NCT02068027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19992861|NCT02068027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19992862|NCT02068027|Adrenergic Agents|adrenergic agents|mesh-ancestor
19992863|NCT02068027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19992864|NCT02068027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992865|NCT02068157|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
19992866|NCT02068157|Trioxsalen|trioxsalen|mesh-list
19992867|NCT02068157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19992868|NCT02068157|Dermatologic Agents|dermatologic agents|mesh-ancestor
19992869|NCT02068157|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19992870|NCT02068222|Ritonavir|ritonavir|mesh-list
19992871|NCT02068222|Ribavirin|ribavirin|mesh-list
19992872|NCT02068222|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19992873|NCT02068222|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19992874|NCT02068222|Protease Inhibitors|protease inhibitors|mesh-ancestor
19992875|NCT02068222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992876|NCT02068222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992877|NCT02068222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19992878|NCT02068222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19992879|NCT02068222|Antiviral Agents|antiviral agents|mesh-ancestor
19992880|NCT02068222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19992881|NCT02068222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19992882|NCT02068222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19992883|NCT02068222|Antimetabolites|antimetabolites|mesh-ancestor
19992884|NCT02068443|Metformin|metformin|mesh-list
19992885|NCT02068443|Alogliptin|alogliptin|mesh-list
19992886|NCT02068443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19992887|NCT02068443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992888|NCT02068443|Incretins|incretins|mesh-ancestor
19992889|NCT02068443|Hormones|hormones|mesh-ancestor
19992890|NCT02068443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19992891|NCT02068443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19992892|NCT02068443|Protease Inhibitors|protease inhibitors|mesh-ancestor
19992893|NCT02068443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992894|NCT02068443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992895|NCT02068495|Amlodipine|amlodipine|mesh-list
19992896|NCT02068495|Candesartan|candesartan|mesh-list
19992897|NCT02068495|Candesartan cilexetil|candesartan cilexetil|mesh-list
19992898|NCT02068495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19992899|NCT02068495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19992900|NCT02068495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19992901|NCT02068495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992902|NCT02068495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19992903|NCT02068495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992904|NCT02068495|Vasodilator Agents|vasodilator agents|mesh-ancestor
19992905|NCT02068495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19992906|NCT02068495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19992907|NCT02068508|Pioglitazone|pioglitazone|mesh-list
19992908|NCT02068508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19992909|NCT02068508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992910|NCT02068820|Fluorophosphate|fluorophosphate|mesh-list
19992911|NCT02068820|Cariostatic Agents|cariostatic agents|mesh-ancestor
19992912|NCT02068820|Protective Agents|protective agents|mesh-ancestor
19992913|NCT02068820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992914|NCT02068846|Ciprofloxacin|ciprofloxacin|mesh-list
19992915|NCT02068846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19992916|NCT02068846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19992917|NCT02068846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19992918|NCT02068846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19992919|NCT02068846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992920|NCT02068846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992921|NCT02068846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19992922|NCT02068846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19992923|NCT02068846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19992924|NCT02069041|Leucovorin|leucovorin|mesh-list
19992925|NCT02069041|Fluorouracil|fluorouracil|mesh-list
19992926|NCT02069041|Oxaliplatin|oxaliplatin|mesh-list
19992927|NCT02069041|Ramucirumab|ramucirumab|mesh-list
19992928|NCT02069041|Antimetabolites|antimetabolites|mesh-ancestor
19992929|NCT02069041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992930|NCT02069041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19992931|NCT02069041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19992932|NCT02069041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19992933|NCT02069041|Immunologic Factors|immunologic factors|mesh-ancestor
19992934|NCT02069041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992935|NCT02069041|Antidotes|antidotes|mesh-ancestor
19992936|NCT02069041|Protective Agents|protective agents|mesh-ancestor
19992937|NCT02069041|Vitamin B Complex|vitamin b complex|mesh-ancestor
19992938|NCT02069041|Vitamins|vitamins|mesh-ancestor
19992939|NCT02069041|Micronutrients|micronutrients|mesh-ancestor
19992940|NCT02069093|Dexamethasone|dexamethasone|mesh-list
19992941|NCT02069093|Everolimus|everolimus|mesh-list
19992942|NCT02069093|Exemestane|exemestane|mesh-list
19992943|NCT02069093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19992944|NCT02069093|Antiemetics|antiemetics|mesh-ancestor
19992945|NCT02069093|Autonomic Agents|autonomic agents|mesh-ancestor
19992946|NCT02069093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992947|NCT02069093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992948|NCT02069093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19992949|NCT02069093|Glucocorticoids|glucocorticoids|mesh-ancestor
19992950|NCT02069093|Hormones|hormones|mesh-ancestor
19992951|NCT02069093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19992952|NCT02069093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19992953|NCT02069093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19992954|NCT02069093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19992955|NCT02069093|Immunologic Factors|immunologic factors|mesh-ancestor
19992956|NCT02069093|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19992957|NCT02069093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19992958|NCT02069093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19992959|NCT02069093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992960|NCT02069093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19992961|NCT02069093|Hormone Antagonists|hormone antagonists|mesh-ancestor
19992962|NCT02069184|Acetaminophen|acetaminophen|mesh-list
19992963|NCT02069184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19992964|NCT02069184|Analgesics|analgesics|mesh-ancestor
19992965|NCT02069184|Sensory System Agents|sensory system agents|mesh-ancestor
19992966|NCT02069184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992967|NCT02069184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992968|NCT02069184|Antipyretics|antipyretics|mesh-ancestor
19992969|NCT02069379|Metformin|metformin|mesh-list
19992970|NCT02069379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19992971|NCT02069379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992972|NCT02069392|Nicotine|nicotine|mesh-list
19992973|NCT02069392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19992974|NCT02069392|Autonomic Agents|autonomic agents|mesh-ancestor
19992975|NCT02069392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19992976|NCT02069392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992977|NCT02069392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19992978|NCT02069392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19992979|NCT02069392|Cholinergic Agents|cholinergic agents|mesh-ancestor
19992980|NCT02069392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19992981|NCT02069392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992982|NCT02069704|Leucovorin|leucovorin|mesh-list
19992983|NCT02069704|Folic Acid|folic acid|mesh-list
19992984|NCT02069704|Bevacizumab|bevacizumab|mesh-list
19992985|NCT02069704|Fluorouracil|fluorouracil|mesh-list
19992986|NCT02069704|Oxaliplatin|oxaliplatin|mesh-list
19992987|NCT02069704|Irinotecan|irinotecan|mesh-list
19992988|NCT02069704|Levoleucovorin|levoleucovorin|mesh-list
19992989|NCT02069704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19992990|NCT02069704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19992991|NCT02069704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19992992|NCT02069704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19992993|NCT02069704|Growth Substances|growth substances|mesh-ancestor
19992994|NCT02069704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19992995|NCT02069704|Growth Inhibitors|growth inhibitors|mesh-ancestor
19992996|NCT02069704|Antimetabolites|antimetabolites|mesh-ancestor
19992997|NCT02069704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19992998|NCT02069704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19992999|NCT02069704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19993000|NCT02069704|Immunologic Factors|immunologic factors|mesh-ancestor
19993001|NCT02069704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19993002|NCT02069704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19993003|NCT02069704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993004|NCT02069704|Antidotes|antidotes|mesh-ancestor
19993005|NCT02069704|Protective Agents|protective agents|mesh-ancestor
19993006|NCT02069704|Vitamin B Complex|vitamin b complex|mesh-ancestor
19993007|NCT02069704|Vitamins|vitamins|mesh-ancestor
19993008|NCT02069704|Micronutrients|micronutrients|mesh-ancestor
19993009|NCT02069704|Hematinics|hematinics|mesh-ancestor
19993010|NCT02069847|Budesonide|budesonide|mesh-list
19993011|NCT02069847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19993012|NCT02069847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19993013|NCT02069847|Autonomic Agents|autonomic agents|mesh-ancestor
19993014|NCT02069847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19993015|NCT02069847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993016|NCT02069847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19993017|NCT02069847|Respiratory System Agents|respiratory system agents|mesh-ancestor
19993018|NCT02069847|Glucocorticoids|glucocorticoids|mesh-ancestor
19993019|NCT02069847|Hormones|hormones|mesh-ancestor
19993020|NCT02069847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19993021|NCT02070237|Enoxaparin|enoxaparin|mesh-list
19993022|NCT02070237|Anticoagulants|anticoagulants|mesh-ancestor
19993023|NCT02070237|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19993024|NCT02070237|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19993025|NCT02070237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993026|NCT02070302|Botulinum Toxins|botulinum toxins|mesh-list
19993027|NCT02070302|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19993028|NCT02070302|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19993029|NCT02070302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19993030|NCT02070302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19993031|NCT02070302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993032|NCT02070302|Cholinergic Agents|cholinergic agents|mesh-ancestor
19993033|NCT02070302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19993034|NCT02070302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993035|NCT02070302|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19993036|NCT02070302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19993037|NCT02070692|Tamoxifen|tamoxifen|mesh-list
19993038|NCT02070692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19993039|NCT02070692|Hormone Antagonists|hormone antagonists|mesh-ancestor
19993040|NCT02070692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19993041|NCT02070692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993042|NCT02070692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19993043|NCT02070692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993044|NCT02070692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19993045|NCT02070692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19993046|NCT02070692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19993047|NCT02070744|Ivacaftor|ivacaftor|mesh-list
19993048|NCT02070744|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19993049|NCT02070744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19993050|NCT02070744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993051|NCT02070757|Meropenem|meropenem|mesh-list
19993052|NCT02070757|Tazobactam|tazobactam|mesh-list
19993053|NCT02070757|Ceftolozane|ceftolozane|mesh-list
19993054|NCT02070757|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
19993055|NCT02070757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19993056|NCT02070757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19993057|NCT02070757|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19993058|NCT02070757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993059|NCT02070757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993060|NCT02070757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19993061|NCT02070757|Renal Agents|renal agents|mesh-ancestor
19993062|NCT02070991|Macitentan|macitentan|mesh-list
19993063|NCT02070991|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19993064|NCT02070991|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19993065|NCT02070991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993066|NCT02070991|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19993067|NCT02071082|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19993068|NCT02071082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19993069|NCT02071082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19993070|NCT02071082|Antiviral Agents|antiviral agents|mesh-ancestor
19993071|NCT02071082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19993072|NCT02071095|Poly I-C|poly i-c|mesh-list
19993073|NCT02071095|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19993074|NCT02071095|Poly ICLC|poly iclc|mesh-list
19993075|NCT02071095|Interferon Inducers|interferon inducers|mesh-ancestor
19993076|NCT02071095|Immunologic Factors|immunologic factors|mesh-ancestor
19993077|NCT02071095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993078|NCT02071095|Laxatives|laxatives|mesh-ancestor
19993079|NCT02071095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19993080|NCT02071095|Antiviral Agents|antiviral agents|mesh-ancestor
19993081|NCT02071095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19993082|NCT02071225|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19993083|NCT02071225|Obinutuzumab|obinutuzumab|mesh-list
19993084|NCT02071225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19993085|NCT02071225|Alkylating Agents|alkylating agents|mesh-ancestor
19993086|NCT02071225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993087|NCT02071225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993088|NCT02071225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19993089|NCT02071810|Opicapone|opicapone|mesh-list
19993090|NCT02071810|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19993091|NCT02071810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993092|NCT02071810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993093|NCT02071810|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19993094|NCT02071810|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19993095|NCT02071823|Opicapone|opicapone|mesh-list
19993096|NCT02071823|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19993097|NCT02071823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993098|NCT02071823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993099|NCT02071823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19993100|NCT02071823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20289373|NCT04791059|Anesthetics|anesthetics|mesh-ancestor
20289374|NCT04791059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20289375|NCT04791059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20289376|NCT04791059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20289377|NCT04791059|Narcotics|narcotics|mesh-ancestor
20289378|NCT04791059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20289379|NCT04791059|Antidepressive Agents|antidepressive agents|mesh-ancestor
20289380|NCT04791059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20289381|NCT04769050|Docetaxel|docetaxel|mesh-list
20289382|NCT04769050|Capecitabine|capecitabine|mesh-list
20289383|NCT04769050|Trastuzumab|trastuzumab|mesh-list
20289384|NCT04769050|Pertuzumab|pertuzumab|mesh-list
20289385|NCT04769050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289386|NCT04769050|Tubulin Modulators|tubulin modulators|mesh-ancestor
20289387|NCT04769050|Antimitotic Agents|antimitotic agents|mesh-ancestor
20289388|NCT04769050|Mitosis Modulators|mitosis modulators|mesh-ancestor
20289389|NCT04769050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289390|NCT04769050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20289391|NCT04769050|Antimetabolites|antimetabolites|mesh-ancestor
20289392|NCT04769050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20289393|NCT04763135|Mirtazapine|mirtazapine|mesh-list
20556485|NCT01947062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556486|NCT01947062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20556487|NCT01947062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20556488|NCT01947062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20556489|NCT01947062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20556490|NCT01947062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556491|NCT01947114|Ketamine|ketamine|mesh-list
20556492|NCT01947114|Remifentanil|remifentanil|mesh-list
20556493|NCT01947114|Propofol|propofol|mesh-list
20556494|NCT01947114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20556495|NCT01947114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20556496|NCT01947114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556497|NCT01947114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20556498|NCT01947114|Anesthetics, General|anesthetics, general|mesh-ancestor
20556499|NCT01947114|Anesthetics|anesthetics|mesh-ancestor
20556500|NCT01947114|Analgesics|analgesics|mesh-ancestor
20289394|NCT04763135|Citalopram|citalopram|mesh-list
20556501|NCT01947114|Sensory System Agents|sensory system agents|mesh-ancestor
20556502|NCT01947114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556503|NCT01947114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19993101|NCT02072096|Metformin|metformin|mesh-list
19993102|NCT02072096|Insulin Glargine|insulin glargine|mesh-list
19993103|NCT02072096|Pioglitazone|pioglitazone|mesh-list
19993104|NCT02072096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19993105|NCT02072096|Liraglutide|liraglutide|mesh-list
19993106|NCT02072096|Exenatide|exenatide|mesh-list
19993107|NCT02072096|Glimepiride|glimepiride|mesh-list
19993108|NCT02072096|Linagliptin|linagliptin|mesh-list
19993109|NCT02072096|Acarbose|acarbose|mesh-list
19993110|NCT02072096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19993111|NCT02072096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993112|NCT02072096|Incretins|incretins|mesh-ancestor
19993113|NCT02072096|Hormones|hormones|mesh-ancestor
19993114|NCT02072096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19993115|NCT02072096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19993116|NCT02072096|Protease Inhibitors|protease inhibitors|mesh-ancestor
19993117|NCT02072096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993118|NCT02072096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993119|NCT02072096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19993120|NCT02072096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19993121|NCT02072096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19993122|NCT02072096|Immunologic Factors|immunologic factors|mesh-ancestor
19993123|NCT02072096|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19993124|NCT02072200|Prednisone|prednisone|mesh-list
19993125|NCT02072200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19993126|NCT02072200|Glucocorticoids|glucocorticoids|mesh-ancestor
19993127|NCT02072200|Hormones|hormones|mesh-ancestor
19993128|NCT02072200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19993129|NCT02072200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993130|NCT02072200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19993131|NCT02072200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993132|NCT02072226|Aspirin|aspirin|mesh-list
19993133|NCT02072226|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19993134|NCT02072226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19993135|NCT02072226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19993136|NCT02072226|Analgesics|analgesics|mesh-ancestor
19993137|NCT02072226|Sensory System Agents|sensory system agents|mesh-ancestor
19993138|NCT02072226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19993139|NCT02072226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993140|NCT02072226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19993141|NCT02072226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19993142|NCT02072226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19993143|NCT02072226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19993144|NCT02072226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993145|NCT02072226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19993146|NCT02072226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19993147|NCT02072226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993148|NCT02072226|Antipyretics|antipyretics|mesh-ancestor
19993149|NCT02072434|Enoxaparin|enoxaparin|mesh-list
19993150|NCT02072434|Warfarin|warfarin|mesh-list
19993151|NCT02072434|Edoxaban|edoxaban|mesh-list
19993152|NCT02072434|Anticoagulants|anticoagulants|mesh-ancestor
19993153|NCT02072434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19993154|NCT02072434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19993155|NCT02072434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993156|NCT02072434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19993157|NCT02072434|Antithrombins|antithrombins|mesh-ancestor
19993158|NCT02072434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19993159|NCT02072434|Protease Inhibitors|protease inhibitors|mesh-ancestor
19993160|NCT02072434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993161|NCT02072668|Rivaroxaban|rivaroxaban|mesh-list
19993162|NCT02072668|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19993163|NCT02072668|Antithrombins|antithrombins|mesh-ancestor
19993164|NCT02072668|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19993165|NCT02072668|Protease Inhibitors|protease inhibitors|mesh-ancestor
19993166|NCT02072668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993167|NCT02072668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993168|NCT02072668|Anticoagulants|anticoagulants|mesh-ancestor
19993169|NCT02072824|Pregabalin|pregabalin|mesh-list
19993170|NCT02072824|Analgesics|analgesics|mesh-ancestor
19993171|NCT02072824|Sensory System Agents|sensory system agents|mesh-ancestor
19993172|NCT02072824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19993173|NCT02072824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993174|NCT02072824|Anticonvulsants|anticonvulsants|mesh-ancestor
19993175|NCT02072824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19993176|NCT02072824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19993177|NCT02072824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993178|NCT02072824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19993179|NCT02072824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19993180|NCT02072824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19993181|NCT02072824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19993182|NCT02072824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19993183|NCT02072928|Botulinum Toxins|botulinum toxins|mesh-list
19993184|NCT02072928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19993185|NCT02072928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19993186|NCT02072928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19993187|NCT02072928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19993188|NCT02072928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993189|NCT02072928|Cholinergic Agents|cholinergic agents|mesh-ancestor
19993190|NCT02072928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19993191|NCT02072928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993192|NCT02072928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19993193|NCT02072928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19993194|NCT02073448|Adapalene|adapalene|mesh-list
19993195|NCT02073448|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19993196|NCT02073448|Dermatologic Agents|dermatologic agents|mesh-ancestor
19993197|NCT02073448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19993198|NCT02073448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19993199|NCT02073448|Analgesics|analgesics|mesh-ancestor
19993200|NCT02073448|Sensory System Agents|sensory system agents|mesh-ancestor
19993201|NCT02073448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19993202|NCT02073448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993203|NCT02073448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19993204|NCT02073448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19993205|NCT02073461|Benzoyl Peroxide|benzoyl peroxide|mesh-list
19993206|NCT02073461|Dermatologic Agents|dermatologic agents|mesh-ancestor
19993207|NCT02073487|Paclitaxel|paclitaxel|mesh-list
19993208|NCT02073487|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19993209|NCT02073487|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19993210|NCT02073487|Trastuzumab|trastuzumab|mesh-list
19993211|NCT02073487|Lapatinib|lapatinib|mesh-list
19993212|NCT02073487|Pertuzumab|pertuzumab|mesh-list
19993213|NCT02073487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19993214|NCT02073487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993215|NCT02073487|Tubulin Modulators|tubulin modulators|mesh-ancestor
19993216|NCT02073487|Antimitotic Agents|antimitotic agents|mesh-ancestor
19993217|NCT02073487|Mitosis Modulators|mitosis modulators|mesh-ancestor
19993218|NCT02073487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993219|NCT02073487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19993220|NCT02073487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19993221|NCT02073487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993222|NCT02073656|Sofosbuvir|sofosbuvir|mesh-list
19993223|NCT02073656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19993224|NCT02073656|Ledipasvir|ledipasvir|mesh-list
19993225|NCT02073656|Antiviral Agents|antiviral agents|mesh-ancestor
19993226|NCT02073656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19993227|NCT02073682|Heparin|heparin|mesh-list
19993228|NCT02073682|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19993229|NCT02073682|Tinzaparin|tinzaparin|mesh-list
19993230|NCT02073682|Dalteparin|dalteparin|mesh-list
19993231|NCT02073682|Edoxaban|edoxaban|mesh-list
19993232|NCT02073682|Anticoagulants|anticoagulants|mesh-ancestor
19993233|NCT02073682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19993234|NCT02073682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19993235|NCT02073682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993236|NCT02073682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19993237|NCT02073682|Antithrombins|antithrombins|mesh-ancestor
19993238|NCT02073682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19993239|NCT02073682|Protease Inhibitors|protease inhibitors|mesh-ancestor
19993240|NCT02073682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993241|NCT02073747|Albuterol|albuterol|mesh-list
19993242|NCT02073747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19993243|NCT02073747|Autonomic Agents|autonomic agents|mesh-ancestor
19993244|NCT02073747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19993245|NCT02073747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993246|NCT02073747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19993247|NCT02073747|Respiratory System Agents|respiratory system agents|mesh-ancestor
19993248|NCT02073747|Tocolytic Agents|tocolytic agents|mesh-ancestor
19993249|NCT02073747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19993250|NCT02073747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19993251|NCT02073747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19993252|NCT02073747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19993253|NCT02073747|Adrenergic Agents|adrenergic agents|mesh-ancestor
19993254|NCT02073747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19993255|NCT02073747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993256|NCT02073929|Liraglutide|liraglutide|mesh-list
19993257|NCT02073929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19993258|NCT02073929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993259|NCT02073929|Incretins|incretins|mesh-ancestor
19993260|NCT02073929|Hormones|hormones|mesh-ancestor
19993261|NCT02073929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19993262|NCT02074358|Apixaban|apixaban|mesh-list
19993263|NCT02074358|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19993264|NCT02074358|Antithrombins|antithrombins|mesh-ancestor
19993265|NCT02074358|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19993266|NCT02074358|Protease Inhibitors|protease inhibitors|mesh-ancestor
19993267|NCT02074358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993268|NCT02074358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993269|NCT02074358|Anticoagulants|anticoagulants|mesh-ancestor
19993270|NCT02074514|Sofosbuvir|sofosbuvir|mesh-list
19993271|NCT02074514|Antiviral Agents|antiviral agents|mesh-ancestor
19993272|NCT02074514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19993273|NCT02074709|Bupivacaine|bupivacaine|mesh-list
19993274|NCT02074709|Anesthetics, Local|anesthetics, local|mesh-ancestor
19993275|NCT02074709|Anesthetics|anesthetics|mesh-ancestor
19993276|NCT02074709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19993277|NCT02074709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993278|NCT02074709|Sensory System Agents|sensory system agents|mesh-ancestor
19993279|NCT02074709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19993280|NCT02074735|Choline|choline|mesh-list
19993281|NCT02074735|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
19993282|NCT02074735|Lipotropic Agents|lipotropic agents|mesh-ancestor
19993283|NCT02074735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19993284|NCT02074735|Antimetabolites|antimetabolites|mesh-ancestor
19993285|NCT02074735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993286|NCT02074735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19993287|NCT02074735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19993288|NCT02074735|Nootropic Agents|nootropic agents|mesh-ancestor
19993289|NCT02074982|Ustekinumab|ustekinumab|mesh-list
19993290|NCT02074982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19993291|NCT02074982|Immunologic Factors|immunologic factors|mesh-ancestor
19993292|NCT02074982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993293|NCT02074982|Dermatologic Agents|dermatologic agents|mesh-ancestor
19993294|NCT02075047|Ziprasidone|ziprasidone|mesh-list
19993295|NCT02075047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19993296|NCT02075047|Serotonin Agents|serotonin agents|mesh-ancestor
19993297|NCT02075047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19993298|NCT02075047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993299|NCT02075047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993300|NCT02075047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19993301|NCT02075047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19993302|NCT02075047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19993303|NCT02075047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19993304|NCT02075047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19993305|NCT02075047|Dopamine Agents|dopamine agents|mesh-ancestor
19993306|NCT02075073|Trastuzumab|trastuzumab|mesh-list
19993307|NCT02075073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19993308|NCT02075073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993309|NCT02075125|Ticagrelor|ticagrelor|mesh-list
19993310|NCT02075125|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19993311|NCT02075125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19993312|NCT02075125|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19993313|NCT02075125|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19993314|NCT02075125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19993315|NCT02075125|Purinergic Agents|purinergic agents|mesh-ancestor
19993316|NCT02075125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19993317|NCT02075125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993318|NCT02075125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993319|NCT02075203|BCG Vaccine|bcg vaccine|mesh-list
19993320|NCT02075203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19993321|NCT02075203|Immunologic Factors|immunologic factors|mesh-ancestor
19993322|NCT02075203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993323|NCT02075255|Benralizumab|benralizumab|mesh-list
19993324|NCT02075255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19993325|NCT02075255|Respiratory System Agents|respiratory system agents|mesh-ancestor
19993326|NCT02075515|Vaccines|vaccines|mesh-list
19993327|NCT02075515|Immunologic Factors|immunologic factors|mesh-ancestor
19993328|NCT02075515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993329|NCT02075606|Lanreotide|lanreotide|mesh-list
19993330|NCT02075606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993331|NCT02075632|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
19993332|NCT02075632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19993333|NCT02075632|Glucocorticoids|glucocorticoids|mesh-ancestor
19993334|NCT02075632|Hormones|hormones|mesh-ancestor
19993335|NCT02075632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19993336|NCT02075632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993337|NCT02076100|Ruzasvir|ruzasvir|mesh-list
19993338|NCT02076100|Antiviral Agents|antiviral agents|mesh-ancestor
19993339|NCT02076100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19993340|NCT02076152|Bevacizumab|bevacizumab|mesh-list
19993341|NCT02076152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19993342|NCT02076152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993343|NCT02076152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19993344|NCT02076152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19993345|NCT02076152|Growth Substances|growth substances|mesh-ancestor
19993346|NCT02076152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993347|NCT02076152|Growth Inhibitors|growth inhibitors|mesh-ancestor
19993348|NCT02076243|Paclitaxel|paclitaxel|mesh-list
19993349|NCT02076243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19993350|NCT02076243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993351|NCT02076243|Tubulin Modulators|tubulin modulators|mesh-ancestor
19993352|NCT02076243|Antimitotic Agents|antimitotic agents|mesh-ancestor
19993353|NCT02076243|Mitosis Modulators|mitosis modulators|mesh-ancestor
19993354|NCT02076243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993355|NCT02076321|Acetaminophen|acetaminophen|mesh-list
19993356|NCT02076321|Ibuprofen|ibuprofen|mesh-list
19993357|NCT02076321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19993358|NCT02076321|Analgesics|analgesics|mesh-ancestor
19993359|NCT02076321|Sensory System Agents|sensory system agents|mesh-ancestor
19993360|NCT02076321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19993361|NCT02076321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993362|NCT02076321|Antipyretics|antipyretics|mesh-ancestor
19993363|NCT02076321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19993364|NCT02076321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19993365|NCT02076321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19993366|NCT02076321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19993367|NCT02076321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993368|NCT02076321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993369|NCT02076919|Acrizanib|acrizanib|mesh-list
19993370|NCT02076919|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19993371|NCT02076919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19993372|NCT02076919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19993373|NCT02076919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993374|NCT02076919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993375|NCT02076997|Methotrexate|methotrexate|mesh-list
19993376|NCT02076997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19993377|NCT02076997|Abortifacient Agents|abortifacient agents|mesh-ancestor
19993378|NCT02076997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19993379|NCT02076997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993380|NCT02076997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19993381|NCT02076997|Antimetabolites|antimetabolites|mesh-ancestor
19993382|NCT02076997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993383|NCT02076997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993384|NCT02076997|Dermatologic Agents|dermatologic agents|mesh-ancestor
19993385|NCT02076997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993386|NCT02076997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19993387|NCT02076997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19993388|NCT02076997|Immunologic Factors|immunologic factors|mesh-ancestor
19993389|NCT02076997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19993390|NCT02076997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19993391|NCT02077465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19993392|NCT02077465|Immunologic Factors|immunologic factors|mesh-ancestor
19993393|NCT02077465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993394|NCT02078102|Meloxicam|meloxicam|mesh-list
19993395|NCT02078102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993396|NCT02078102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19993397|NCT02078102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19993398|NCT02078102|Analgesics|analgesics|mesh-ancestor
19993399|NCT02078102|Sensory System Agents|sensory system agents|mesh-ancestor
19993400|NCT02078102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19993401|NCT02078102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19993402|NCT02078102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19993403|NCT02078102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19993404|NCT02078102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19993405|NCT02078102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993406|NCT02078102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993407|NCT02078180|Bupropion|bupropion|mesh-list
19993408|NCT02078180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19993409|NCT02078180|Antidepressive Agents|antidepressive agents|mesh-ancestor
19993410|NCT02078180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19993411|NCT02078180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19993412|NCT02078180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19993413|NCT02078180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19993414|NCT02078180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993415|NCT02078180|Dopamine Agents|dopamine agents|mesh-ancestor
19993416|NCT02078180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19993417|NCT02078180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993418|NCT02078180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19993419|NCT02078180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19993420|NCT02078180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993421|NCT02078193|Abatacept|abatacept|mesh-list
19993422|NCT02078193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19993423|NCT02078193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993424|NCT02078193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993425|NCT02078193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19993426|NCT02078193|Immunologic Factors|immunologic factors|mesh-ancestor
19993427|NCT02078193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993428|NCT02078193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19993429|NCT02078219|Allopurinol|allopurinol|mesh-list
19993430|NCT02078219|Verinurad|verinurad|mesh-list
19993431|NCT02078219|Antimetabolites|antimetabolites|mesh-ancestor
19993432|NCT02078219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993433|NCT02078219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993434|NCT02078219|Gout Suppressants|gout suppressants|mesh-ancestor
19993435|NCT02078219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19993436|NCT02078219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19993437|NCT02078219|Antioxidants|antioxidants|mesh-ancestor
19993438|NCT02078219|Protective Agents|protective agents|mesh-ancestor
19993439|NCT02078219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993440|NCT02078284|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
19993441|NCT02078284|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19993442|NCT02078284|Protective Agents|protective agents|mesh-ancestor
19993443|NCT02078284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993444|NCT02078284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19993445|NCT02078284|Antioxidants|antioxidants|mesh-ancestor
19993446|NCT02078284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993447|NCT02078492|Ketorolac|ketorolac|mesh-list
19993448|NCT02078492|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19993449|NCT02078492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19993450|NCT02078492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19993451|NCT02078492|Analgesics|analgesics|mesh-ancestor
19993452|NCT02078492|Sensory System Agents|sensory system agents|mesh-ancestor
19993453|NCT02078492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19993454|NCT02078492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993455|NCT02078492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19993456|NCT02078492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19993457|NCT02078492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19993458|NCT02078492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993459|NCT02078492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993460|NCT02078713|Contraceptive Agents|contraceptive agents|mesh-list
19993461|NCT02078713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19993462|NCT02078713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993463|NCT02078726|Glucagon|glucagon|mesh-list
19993464|NCT02078726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19993465|NCT02078726|Hormones|hormones|mesh-ancestor
19993466|NCT02078726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19993467|NCT02078726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993468|NCT02078817|Ketamine|ketamine|mesh-list
19993469|NCT02078817|Analgesics|analgesics|mesh-ancestor
19993470|NCT02078817|Sensory System Agents|sensory system agents|mesh-ancestor
19993471|NCT02078817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19993472|NCT02078817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993473|NCT02078817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19993474|NCT02078817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19993475|NCT02078817|Anesthetics, General|anesthetics, general|mesh-ancestor
19993476|NCT02078817|Anesthetics|anesthetics|mesh-ancestor
19993477|NCT02078817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19993478|NCT02078817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19993479|NCT02078817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19993480|NCT02078817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19993481|NCT02078817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993482|NCT02078882|Abatacept|abatacept|mesh-list
19993483|NCT02078882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19993484|NCT02078882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993485|NCT02078882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993486|NCT02078882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20556504|NCT01947114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20556505|NCT01947114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20556506|NCT01947114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20556507|NCT01947114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556508|NCT01947114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20556509|NCT01947114|Narcotics|narcotics|mesh-ancestor
20556510|NCT01947140|Romidepsin|romidepsin|mesh-list
20556511|NCT01947140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20556512|NCT01947140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556513|NCT01947192|Chlorhexidine|chlorhexidine|mesh-list
20556514|NCT01947192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20556515|NCT01947192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20556516|NCT01947192|Disinfectants|disinfectants|mesh-ancestor
19993487|NCT02078882|Immunologic Factors|immunologic factors|mesh-ancestor
19993488|NCT02078882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993489|NCT02078882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19993490|NCT02078960|Homoharringtonine|homoharringtonine|mesh-list
19993491|NCT02078960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19993492|NCT02078960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993493|NCT02078960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19993494|NCT02078960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993495|NCT02078960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993496|NCT02079077|Aspirin|aspirin|mesh-list
19993497|NCT02079077|Hydroxychloroquine|hydroxychloroquine|mesh-list
19993498|NCT02079077|Antimalarials|antimalarials|mesh-ancestor
19993499|NCT02079077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19993500|NCT02079077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19993501|NCT02079077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19993502|NCT02079077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993503|NCT02079077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993504|NCT02079077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19993505|NCT02079077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19993506|NCT02079077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19993507|NCT02079077|Analgesics|analgesics|mesh-ancestor
19993508|NCT02079077|Sensory System Agents|sensory system agents|mesh-ancestor
19993509|NCT02079077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19993510|NCT02079077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993511|NCT02079077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19993512|NCT02079077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19993513|NCT02079077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19993514|NCT02079077|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19993515|NCT02079077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19993516|NCT02079077|Antipyretics|antipyretics|mesh-ancestor
19993517|NCT02079519|Bevacizumab|bevacizumab|mesh-list
19993518|NCT02079519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19993519|NCT02079519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993520|NCT02079519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19993521|NCT02079519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19993522|NCT02079519|Growth Substances|growth substances|mesh-ancestor
19993523|NCT02079519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993524|NCT02079519|Growth Inhibitors|growth inhibitors|mesh-ancestor
19993525|NCT02079532|Rituximab|rituximab|mesh-list
19993526|NCT02079532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19993527|NCT02079532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993528|NCT02079532|Immunologic Factors|immunologic factors|mesh-ancestor
19993529|NCT02079532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993530|NCT02079532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19993531|NCT02079636|Gemcitabine|gemcitabine|mesh-list
19993532|NCT02079636|Pembrolizumab|pembrolizumab|mesh-list
19993533|NCT02079636|Pemetrexed|pemetrexed|mesh-list
19993534|NCT02079636|Ramucirumab|ramucirumab|mesh-list
19993535|NCT02079636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19993536|NCT02079636|Antimetabolites|antimetabolites|mesh-ancestor
19993537|NCT02079636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993538|NCT02079636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993539|NCT02079636|Antiviral Agents|antiviral agents|mesh-ancestor
19993540|NCT02079636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19993541|NCT02079636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993542|NCT02079636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19993543|NCT02079636|Immunologic Factors|immunologic factors|mesh-ancestor
19993544|NCT02079636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993545|NCT02079636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19993546|NCT02079636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19993547|NCT02079636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19993548|NCT02079649|Dexamethasone|dexamethasone|mesh-list
19993549|NCT02079649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19993550|NCT02079649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19993551|NCT02079649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19993552|NCT02079649|Antiemetics|antiemetics|mesh-ancestor
19993553|NCT02079649|Autonomic Agents|autonomic agents|mesh-ancestor
19993554|NCT02079649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19993555|NCT02079649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993556|NCT02079649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19993557|NCT02079649|Glucocorticoids|glucocorticoids|mesh-ancestor
19993558|NCT02079649|Hormones|hormones|mesh-ancestor
19993559|NCT02079649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19993560|NCT02079649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19993561|NCT02079649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993562|NCT02079805|Telmisartan|telmisartan|mesh-list
19993563|NCT02079805|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19993564|NCT02079805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19993565|NCT02079805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19993566|NCT02079805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19993567|NCT02079805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993568|NCT02079844|Antipsychotic Agents|antipsychotic agents|mesh-list
19993569|NCT02079844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19993570|NCT02079844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19993571|NCT02079844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993572|NCT02079844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19993573|NCT02080195|Mycophenolic Acid|mycophenolic acid|mesh-list
19993574|NCT02080195|Cyclophosphamide|cyclophosphamide|mesh-list
19993575|NCT02080195|Fludarabine|fludarabine|mesh-list
19993576|NCT02080195|Tacrolimus|tacrolimus|mesh-list
19993577|NCT02080195|Thymoglobulin|thymoglobulin|mesh-list
19993578|NCT02080195|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19993579|NCT02080195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19993580|NCT02080195|Immunologic Factors|immunologic factors|mesh-ancestor
19993581|NCT02080195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993582|NCT02080195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19993583|NCT02080195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19993584|NCT02080195|Alkylating Agents|alkylating agents|mesh-ancestor
19993585|NCT02080195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993586|NCT02080195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993587|NCT02080195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19993588|NCT02080195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19993589|NCT02080195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993590|NCT02080195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19993591|NCT02080195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19993592|NCT02080195|Antitubercular Agents|antitubercular agents|mesh-ancestor
19993593|NCT02080195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19993594|NCT02080195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19993595|NCT02080221|Leucovorin|leucovorin|mesh-list
19993596|NCT02080221|Oxaliplatin|oxaliplatin|mesh-list
19993597|NCT02080221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993598|NCT02080221|Antidotes|antidotes|mesh-ancestor
19993599|NCT02080221|Protective Agents|protective agents|mesh-ancestor
19993600|NCT02080221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993601|NCT02080221|Vitamin B Complex|vitamin b complex|mesh-ancestor
19993602|NCT02080221|Vitamins|vitamins|mesh-ancestor
19993603|NCT02080221|Micronutrients|micronutrients|mesh-ancestor
19993604|NCT02080273|Listerine|listerine|mesh-list
19993605|NCT02080273|Sodium Fluoride|sodium fluoride|mesh-list
19993606|NCT02080273|Cariostatic Agents|cariostatic agents|mesh-ancestor
19993607|NCT02080273|Protective Agents|protective agents|mesh-ancestor
19993608|NCT02080273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993609|NCT02080273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19993610|NCT02080273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19993611|NCT02080403|Chlorhexidine|chlorhexidine|mesh-list
19993612|NCT02080403|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19993613|NCT02080403|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19993614|NCT02080403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19993615|NCT02080403|Disinfectants|disinfectants|mesh-ancestor
19993616|NCT02080403|Dermatologic Agents|dermatologic agents|mesh-ancestor
19993617|NCT02080455|Atorvastatin|atorvastatin|mesh-list
19993618|NCT02080455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19993619|NCT02080455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19993620|NCT02080455|Antimetabolites|antimetabolites|mesh-ancestor
19993621|NCT02080455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993622|NCT02080455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19993623|NCT02080455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19993624|NCT02080455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289395|NCT04763135|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20289396|NCT04763135|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20289397|NCT04763135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20289398|NCT04763135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289399|NCT04763135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20289400|NCT04763135|Serotonin Agents|serotonin agents|mesh-ancestor
20289401|NCT04763135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289402|NCT04763135|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20289403|NCT04763135|Antidepressive Agents|antidepressive agents|mesh-ancestor
20289404|NCT04763135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20289405|NCT04763135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20289406|NCT04763135|Histamine Antagonists|histamine antagonists|mesh-ancestor
20289407|NCT04763135|Histamine Agents|histamine agents|mesh-ancestor
20289408|NCT04763135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20289409|NCT04763135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20289410|NCT04763135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20289411|NCT04763135|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20289412|NCT04763135|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20289413|NCT04763135|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20289414|NCT04763135|Adrenergic Agents|adrenergic agents|mesh-ancestor
20289415|NCT04763135|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20289416|NCT04763135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20289417|NCT04763135|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20289418|NCT04762875|Plerixafor|plerixafor|mesh-list
20289419|NCT04762875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20289420|NCT04762875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20289421|NCT04762875|Antiviral Agents|antiviral agents|mesh-ancestor
20289422|NCT04762875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20289423|NCT04758416|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20289424|NCT04758416|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19993625|NCT02080468|Norgestimate|norgestimate|mesh-list
19993626|NCT02080468|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19993627|NCT02080468|Contraceptive Agents|contraceptive agents|mesh-ancestor
19993628|NCT02080468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19993629|NCT02080468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993630|NCT02080468|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19993631|NCT02080468|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19993632|NCT02080468|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19993633|NCT02080637|Ambrisentan|ambrisentan|mesh-list
19993634|NCT02080637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19993635|NCT02080780|Clarithromycin|clarithromycin|mesh-list
19993636|NCT02080780|Diltiazem|diltiazem|mesh-list
19993637|NCT02080780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19993638|NCT02080780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19993639|NCT02080780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19993640|NCT02080780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993641|NCT02080780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993642|NCT02080780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19993643|NCT02080780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19993644|NCT02080780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19993645|NCT02080780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19993646|NCT02080780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19993647|NCT02080780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19993648|NCT02080780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993649|NCT02080780|Vasodilator Agents|vasodilator agents|mesh-ancestor
19993650|NCT02080819|Levodopa|levodopa|mesh-list
19993651|NCT02080819|Carbidopa|carbidopa|mesh-list
19993652|NCT02080819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19993653|NCT02080819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19993654|NCT02080819|Dopamine Agents|dopamine agents|mesh-ancestor
19993655|NCT02080819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19993656|NCT02080819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993657|NCT02080819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993658|NCT02080819|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19993659|NCT02080819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993660|NCT02080832|Dexetimide|dexetimide|mesh-list
19993661|NCT02080832|Citalopram|citalopram|mesh-list
19993662|NCT02080832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19993663|NCT02080832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19993664|NCT02080832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19993665|NCT02080832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993666|NCT02080832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19993667|NCT02080832|Serotonin Agents|serotonin agents|mesh-ancestor
19993668|NCT02080832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993669|NCT02080832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19993670|NCT02080832|Antidepressive Agents|antidepressive agents|mesh-ancestor
19993671|NCT02080832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19993672|NCT02080832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19993673|NCT02080832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19993674|NCT02080832|Parasympatholytics|parasympatholytics|mesh-ancestor
19993675|NCT02080832|Autonomic Agents|autonomic agents|mesh-ancestor
19993676|NCT02080832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19993677|NCT02080832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19993678|NCT02080832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19993679|NCT02080832|Cholinergic Agents|cholinergic agents|mesh-ancestor
19993680|NCT02081001|Glucagon|glucagon|mesh-list
19993681|NCT02081001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19993682|NCT02081001|Hormones|hormones|mesh-ancestor
19993683|NCT02081001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19993684|NCT02081001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993685|NCT02081014|Glucagon|glucagon|mesh-list
19993686|NCT02081014|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19993687|NCT02081014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19993688|NCT02081014|Hormones|hormones|mesh-ancestor
19993689|NCT02081014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19993690|NCT02081014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993691|NCT02081014|Incretins|incretins|mesh-ancestor
19993692|NCT02081079|Sofosbuvir|sofosbuvir|mesh-list
19993693|NCT02081079|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19993694|NCT02081079|Ledipasvir|ledipasvir|mesh-list
19993695|NCT02081079|Antiviral Agents|antiviral agents|mesh-ancestor
19993696|NCT02081079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19993697|NCT02081443|Ticagrelor|ticagrelor|mesh-list
19993698|NCT02081443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19993699|NCT02081443|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19993700|NCT02081443|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19993701|NCT02081443|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19993702|NCT02081443|Purinergic Agents|purinergic agents|mesh-ancestor
19993703|NCT02081443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19993704|NCT02081443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993705|NCT02081443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993706|NCT02081599|Insulin|insulin|mesh-list
19993707|NCT02081599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19993708|NCT02081599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993709|NCT02081638|Aspirin|aspirin|mesh-list
19993710|NCT02081638|Atorvastatin|atorvastatin|mesh-list
19993711|NCT02081638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19993712|NCT02081638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19993713|NCT02081638|Analgesics|analgesics|mesh-ancestor
19993714|NCT02081638|Sensory System Agents|sensory system agents|mesh-ancestor
19993715|NCT02081638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19993716|NCT02081638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993717|NCT02081638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19993718|NCT02081638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19993719|NCT02081638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19993720|NCT02081638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19993721|NCT02081638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993722|NCT02081638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19993723|NCT02081638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19993724|NCT02081638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993725|NCT02081638|Antipyretics|antipyretics|mesh-ancestor
19993726|NCT02081638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19993727|NCT02081638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19993728|NCT02081638|Antimetabolites|antimetabolites|mesh-ancestor
19993729|NCT02081638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19993730|NCT02081638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19993731|NCT02081690|Macitentan|macitentan|mesh-list
19993732|NCT02081690|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19993733|NCT02081690|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19993734|NCT02081690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993735|NCT02081690|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
19993736|NCT02081950|Enoxaparin|enoxaparin|mesh-list
19993737|NCT02081950|Enoxaparin sodium|enoxaparin sodium|mesh-list
19993738|NCT02081950|Anticoagulants|anticoagulants|mesh-ancestor
19993739|NCT02081950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19993740|NCT02081950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19993741|NCT02081950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993742|NCT02081963|Amikacin|amikacin|mesh-list
19993743|NCT02081963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19993744|NCT02081963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19993745|NCT02082210|Ramucirumab|ramucirumab|mesh-list
19993746|NCT02082210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993747|NCT02082392|Citalopram|citalopram|mesh-list
19993748|NCT02082392|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19993749|NCT02082392|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19993750|NCT02082392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19993751|NCT02082392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993752|NCT02082392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19993753|NCT02082392|Serotonin Agents|serotonin agents|mesh-ancestor
19993754|NCT02082392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993755|NCT02082392|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19993756|NCT02082392|Antidepressive Agents|antidepressive agents|mesh-ancestor
19993757|NCT02082392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19993758|NCT02082522|Gemcitabine|gemcitabine|mesh-list
19993759|NCT02082522|Cisplatin|cisplatin|mesh-list
19993760|NCT02082522|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
19993761|NCT02082522|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
19993762|NCT02082522|Trioxsalen|trioxsalen|mesh-list
19993763|NCT02082522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993764|NCT02082522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19993765|NCT02082522|Antimetabolites|antimetabolites|mesh-ancestor
19993766|NCT02082522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993767|NCT02082522|Antiviral Agents|antiviral agents|mesh-ancestor
19993768|NCT02082522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19993769|NCT02082522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993770|NCT02082522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19993771|NCT02082522|Immunologic Factors|immunologic factors|mesh-ancestor
20556517|NCT01947205|Acetaminophen|acetaminophen|mesh-list
19993772|NCT02082522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993773|NCT02082522|Dermatologic Agents|dermatologic agents|mesh-ancestor
19993774|NCT02082522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19993775|NCT02082678|Ondansetron|ondansetron|mesh-list
19993776|NCT02082678|Antiemetics|antiemetics|mesh-ancestor
19993777|NCT02082678|Autonomic Agents|autonomic agents|mesh-ancestor
19993778|NCT02082678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19993779|NCT02082678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993780|NCT02082678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19993781|NCT02082678|Antipruritics|antipruritics|mesh-ancestor
19993782|NCT02082678|Dermatologic Agents|dermatologic agents|mesh-ancestor
19993783|NCT02082678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19993784|NCT02082678|Serotonin Agents|serotonin agents|mesh-ancestor
19993785|NCT02082678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19993786|NCT02082678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993787|NCT02082678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19993788|NCT02082678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19993789|NCT02082678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19993790|NCT02082678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19993791|NCT02082678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19993792|NCT02082769|Allopurinol|allopurinol|mesh-list
19993793|NCT02082769|Febuxostat|febuxostat|mesh-list
19993794|NCT02082769|Antimetabolites|antimetabolites|mesh-ancestor
19993795|NCT02082769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993796|NCT02082769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993797|NCT02082769|Gout Suppressants|gout suppressants|mesh-ancestor
19993798|NCT02082769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19993799|NCT02082769|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19993800|NCT02082769|Antioxidants|antioxidants|mesh-ancestor
19993801|NCT02082769|Protective Agents|protective agents|mesh-ancestor
19993802|NCT02082769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993803|NCT02082912|Cycloserine|cycloserine|mesh-list
19993804|NCT02082912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19993805|NCT02082912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19993806|NCT02082912|Renal Agents|renal agents|mesh-ancestor
19993807|NCT02082912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19993808|NCT02082912|Antitubercular Agents|antitubercular agents|mesh-ancestor
19993809|NCT02082912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19993810|NCT02082912|Antimetabolites|antimetabolites|mesh-ancestor
19993811|NCT02082912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993812|NCT02083107|Misoprostol|misoprostol|mesh-list
19993813|NCT02083107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19993814|NCT02083107|Abortifacient Agents|abortifacient agents|mesh-ancestor
19993815|NCT02083107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19993816|NCT02083107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993817|NCT02083107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19993818|NCT02083107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19993819|NCT02083107|Oxytocics|oxytocics|mesh-ancestor
19993820|NCT02083185|Leuprolide|leuprolide|mesh-list
19993821|NCT02083185|Relugolix|relugolix|mesh-list
19993822|NCT02083185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19993823|NCT02083185|Fertility Agents|fertility agents|mesh-ancestor
19993824|NCT02083185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19993825|NCT02083185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993826|NCT02083185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19993827|NCT02083185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993828|NCT02083185|Androgen Antagonists|androgen antagonists|mesh-ancestor
19993829|NCT02083185|Hormone Antagonists|hormone antagonists|mesh-ancestor
19993830|NCT02083185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19993831|NCT02083380|Piperaquine|piperaquine|mesh-list
19993832|NCT02083380|Artefenomel|artefenomel|mesh-list
19993833|NCT02083380|Antimalarials|antimalarials|mesh-ancestor
19993834|NCT02083380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19993835|NCT02083380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19993836|NCT02083380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19993837|NCT02083406|Artefenomel|artefenomel|mesh-list
19993838|NCT02083406|Antimalarials|antimalarials|mesh-ancestor
19993839|NCT02083406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19993840|NCT02083406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19993841|NCT02083406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19993842|NCT02083653|Fluorouracil|fluorouracil|mesh-list
19993843|NCT02083653|Capecitabine|capecitabine|mesh-list
19993844|NCT02083653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19993845|NCT02083653|Antimetabolites|antimetabolites|mesh-ancestor
19993846|NCT02083653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993847|NCT02083653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19993848|NCT02083653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993849|NCT02083653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19993850|NCT02083653|Immunologic Factors|immunologic factors|mesh-ancestor
19993851|NCT02083653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993852|NCT02083679|Gemcitabine|gemcitabine|mesh-list
19993853|NCT02083679|Paclitaxel|paclitaxel|mesh-list
19993854|NCT02083679|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19993855|NCT02083679|Cisplatin|cisplatin|mesh-list
19993856|NCT02083679|Carboplatin|carboplatin|mesh-list
19993857|NCT02083679|Pemetrexed|pemetrexed|mesh-list
19993858|NCT02083679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19993859|NCT02083679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19993860|NCT02083679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993861|NCT02083679|Tubulin Modulators|tubulin modulators|mesh-ancestor
19993862|NCT02083679|Antimitotic Agents|antimitotic agents|mesh-ancestor
19993863|NCT02083679|Mitosis Modulators|mitosis modulators|mesh-ancestor
19993864|NCT02083679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993865|NCT02083679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19993866|NCT02083679|Antimetabolites|antimetabolites|mesh-ancestor
19993867|NCT02083679|Antiviral Agents|antiviral agents|mesh-ancestor
19993868|NCT02083679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19993869|NCT02083679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993870|NCT02083679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19993871|NCT02083679|Immunologic Factors|immunologic factors|mesh-ancestor
19993872|NCT02083679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993873|NCT02083679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19993874|NCT02083679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19993875|NCT02083783|Amphetamine|amphetamine|mesh-list
19993876|NCT02083783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19993877|NCT02083783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993878|NCT02083783|Sympathomimetics|sympathomimetics|mesh-ancestor
19993879|NCT02083783|Autonomic Agents|autonomic agents|mesh-ancestor
19993880|NCT02083783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19993881|NCT02083783|Dopamine Agents|dopamine agents|mesh-ancestor
19993882|NCT02083783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19993883|NCT02083783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993884|NCT02083783|Adrenergic Agents|adrenergic agents|mesh-ancestor
19993885|NCT02083783|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19993886|NCT02083783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19993887|NCT02083783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19993888|NCT02083783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19993889|NCT02083809|Oxytocin|oxytocin|mesh-list
19993890|NCT02083809|Oxytocics|oxytocics|mesh-ancestor
19993891|NCT02083809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19993892|NCT02083809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993893|NCT02083861|Oxymetazoline|oxymetazoline|mesh-list
19993894|NCT02083861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19993895|NCT02083861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19993896|NCT02083861|Adrenergic Agents|adrenergic agents|mesh-ancestor
19993897|NCT02083861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19993898|NCT02083861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993899|NCT02083861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993900|NCT02083861|Sympathomimetics|sympathomimetics|mesh-ancestor
19993901|NCT02083861|Autonomic Agents|autonomic agents|mesh-ancestor
19993902|NCT02083861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19993903|NCT02083861|Nasal Decongestants|nasal decongestants|mesh-ancestor
19993904|NCT02083861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19993905|NCT02083861|Respiratory System Agents|respiratory system agents|mesh-ancestor
19993906|NCT02083926|Ketamine|ketamine|mesh-list
19993907|NCT02083926|Analgesics|analgesics|mesh-ancestor
19993908|NCT02083926|Sensory System Agents|sensory system agents|mesh-ancestor
19993909|NCT02083926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19993910|NCT02083926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993911|NCT02083926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19993912|NCT02083926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19993913|NCT02083926|Anesthetics, General|anesthetics, general|mesh-ancestor
19993914|NCT02083926|Anesthetics|anesthetics|mesh-ancestor
19993915|NCT02083926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19993916|NCT02083926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19993917|NCT02083926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19993918|NCT02083926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19993919|NCT02083926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993920|NCT02083965|Factor VIII|factor viii|mesh-list
19993921|NCT02083965|Coagulants|coagulants|mesh-ancestor
19993922|NCT02084056|Metformin|metformin|mesh-list
19993923|NCT02084056|Linagliptin|linagliptin|mesh-list
19993924|NCT02084056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19993925|NCT02084056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993926|NCT02084056|Incretins|incretins|mesh-ancestor
19993927|NCT02084056|Hormones|hormones|mesh-ancestor
19993928|NCT02084056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19993929|NCT02084056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19993930|NCT02084056|Protease Inhibitors|protease inhibitors|mesh-ancestor
19993931|NCT02084056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993932|NCT02084056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993933|NCT02084069|Atorvastatin|atorvastatin|mesh-list
19993934|NCT02084069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19993935|NCT02084069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19993936|NCT02084069|Antimetabolites|antimetabolites|mesh-ancestor
19993937|NCT02084069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993938|NCT02084069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19993939|NCT02084069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19993940|NCT02084069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993941|NCT02084082|Metformin|metformin|mesh-list
19993942|NCT02084082|Linagliptin|linagliptin|mesh-list
19993943|NCT02084082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19993944|NCT02084082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993945|NCT02084082|Incretins|incretins|mesh-ancestor
19993946|NCT02084082|Hormones|hormones|mesh-ancestor
19993947|NCT02084082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19993948|NCT02084082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19993949|NCT02084082|Protease Inhibitors|protease inhibitors|mesh-ancestor
19993950|NCT02084082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993951|NCT02084082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993952|NCT02084134|Dexamethasone|dexamethasone|mesh-list
19993953|NCT02084134|Dexamethasone acetate|dexamethasone acetate|mesh-list
19993954|NCT02084134|Hydrocortisone|hydrocortisone|mesh-list
19993955|NCT02084134|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19993956|NCT02084134|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19993957|NCT02084134|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19993958|NCT02084134|BB 1101|bb 1101|mesh-list
19993959|NCT02084134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19993960|NCT02084134|Antiemetics|antiemetics|mesh-ancestor
19993961|NCT02084134|Autonomic Agents|autonomic agents|mesh-ancestor
19993962|NCT02084134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19993963|NCT02084134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993964|NCT02084134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19993965|NCT02084134|Glucocorticoids|glucocorticoids|mesh-ancestor
19993966|NCT02084134|Hormones|hormones|mesh-ancestor
19993967|NCT02084134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19993968|NCT02084134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19993969|NCT02084134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993970|NCT02084134|Protease Inhibitors|protease inhibitors|mesh-ancestor
19993971|NCT02084134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993972|NCT02084134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993973|NCT02084238|Interleukin-2|interleukin-2|mesh-list
19993974|NCT02084238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19993975|NCT02084238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19993976|NCT02084238|Analgesics|analgesics|mesh-ancestor
19993977|NCT02084238|Sensory System Agents|sensory system agents|mesh-ancestor
19993978|NCT02084238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19993979|NCT02084238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993980|NCT02084511|Celecoxib|celecoxib|mesh-list
19993981|NCT02084511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19993982|NCT02084511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19993983|NCT02084511|Analgesics|analgesics|mesh-ancestor
19993984|NCT02084511|Sensory System Agents|sensory system agents|mesh-ancestor
19993985|NCT02084511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19993986|NCT02084511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19993987|NCT02084511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19993988|NCT02084511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19993989|NCT02084511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19993990|NCT02084511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19993991|NCT02084511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19993992|NCT02084511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19993993|NCT02084706|Triamcinolone|triamcinolone|mesh-list
19993994|NCT02084706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19993995|NCT02084706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19993996|NCT02084706|Lidocaine|lidocaine|mesh-list
19993997|NCT02084706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19993998|NCT02084706|Anesthetics, Local|anesthetics, local|mesh-ancestor
19993999|NCT02084706|Anesthetics|anesthetics|mesh-ancestor
19994000|NCT02084706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19994001|NCT02084706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994002|NCT02084706|Sensory System Agents|sensory system agents|mesh-ancestor
19994003|NCT02084706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994004|NCT02084706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19994005|NCT02084706|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19994006|NCT02084706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19994007|NCT02084706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19994008|NCT02084706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994009|NCT02084706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19994010|NCT02084706|Glucocorticoids|glucocorticoids|mesh-ancestor
19994011|NCT02084706|Hormones|hormones|mesh-ancestor
19994012|NCT02084706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19994013|NCT02084706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19994014|NCT02084706|Immunologic Factors|immunologic factors|mesh-ancestor
19994015|NCT02084706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994016|NCT02084797|Tolvaptan|tolvaptan|mesh-list
19994017|NCT02084797|Vasopressins|vasopressins|mesh-list
19994018|NCT02084797|Arginine Vasopressin|arginine vasopressin|mesh-list
19994019|NCT02084797|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19994020|NCT02084797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994021|NCT02084797|Natriuretic Agents|natriuretic agents|mesh-ancestor
19994022|NCT02084797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994023|NCT02084797|Hemostatics|hemostatics|mesh-ancestor
19994024|NCT02084797|Coagulants|coagulants|mesh-ancestor
19994025|NCT02084797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19994026|NCT02084797|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19994027|NCT02085070|Pembrolizumab|pembrolizumab|mesh-list
19994028|NCT02085070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19994029|NCT02085070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994030|NCT02085161|Tiotropium Bromide|tiotropium bromide|mesh-list
19994031|NCT02085161|Olodaterol|olodaterol|mesh-list
19994032|NCT02085161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19994033|NCT02085161|Autonomic Agents|autonomic agents|mesh-ancestor
19994034|NCT02085161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994035|NCT02085161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994036|NCT02085161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19994037|NCT02085161|Respiratory System Agents|respiratory system agents|mesh-ancestor
19994038|NCT02085161|Parasympatholytics|parasympatholytics|mesh-ancestor
19994039|NCT02085161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19994040|NCT02085161|Cholinergic Agents|cholinergic agents|mesh-ancestor
19994041|NCT02085161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19994042|NCT02085161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994043|NCT02085252|Bicalutamide|bicalutamide|mesh-list
19994044|NCT02085252|Leuprolide|leuprolide|mesh-list
19994045|NCT02085252|Androgen Antagonists|androgen antagonists|mesh-ancestor
19994046|NCT02085252|Hormone Antagonists|hormone antagonists|mesh-ancestor
19994047|NCT02085252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19994048|NCT02085252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994049|NCT02085252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994050|NCT02085252|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19994051|NCT02085252|Fertility Agents|fertility agents|mesh-ancestor
19994052|NCT02085252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19994053|NCT02085252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19994054|NCT02085447|Haloperidol|haloperidol|mesh-list
19994055|NCT02085447|Paliperidone Palmitate|paliperidone palmitate|mesh-list
19994056|NCT02085447|Haloperidol decanoate|haloperidol decanoate|mesh-list
19994057|NCT02085447|Antipsychotic Agents|antipsychotic agents|mesh-list
19994058|NCT02085447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19994059|NCT02085447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19994060|NCT02085447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994061|NCT02085447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19994062|NCT02085447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19994063|NCT02085447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19994064|NCT02085447|Serotonin Agents|serotonin agents|mesh-ancestor
19994065|NCT02085447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19994066|NCT02085447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994067|NCT02085447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19994068|NCT02085447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19994069|NCT02085447|Dopamine Agents|dopamine agents|mesh-ancestor
19994070|NCT02085447|Antiemetics|antiemetics|mesh-ancestor
19994071|NCT02085447|Autonomic Agents|autonomic agents|mesh-ancestor
19994072|NCT02085447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994073|NCT02085447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19994074|NCT02085447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19994075|NCT02085460|Rebamipide|rebamipide|mesh-list
19994076|NCT02085460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19994077|NCT02085460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19994078|NCT02085460|Antioxidants|antioxidants|mesh-ancestor
19994079|NCT02085460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994080|NCT02085460|Protective Agents|protective agents|mesh-ancestor
19994081|NCT02085460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994082|NCT02085460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994083|NCT02086500|Tranexamic Acid|tranexamic acid|mesh-list
19994084|NCT02086500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19994085|NCT02086500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19994086|NCT02086500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994087|NCT02086500|Hemostatics|hemostatics|mesh-ancestor
19994088|NCT02086500|Coagulants|coagulants|mesh-ancestor
19994089|NCT02086591|Doxycycline|doxycycline|mesh-list
19994090|NCT02086591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19994091|NCT02086591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19994092|NCT02086591|Antimalarials|antimalarials|mesh-ancestor
19994093|NCT02086591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19994094|NCT02086591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19994095|NCT02086786|Risperidone|risperidone|mesh-list
19994096|NCT02086786|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19994097|NCT02086786|Serotonin Agents|serotonin agents|mesh-ancestor
19994098|NCT02086786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19994099|NCT02086786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994100|NCT02086786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994101|NCT02086786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19994102|NCT02086786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19994103|NCT02086786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19994104|NCT02086786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19994105|NCT02086786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19994106|NCT02086786|Dopamine Agents|dopamine agents|mesh-ancestor
19994107|NCT02087085|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19994108|NCT02087085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19994109|NCT02087085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19994110|NCT02087085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19994111|NCT02087085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19994112|NCT02087085|Adrenergic Agents|adrenergic agents|mesh-ancestor
19994113|NCT02087085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19994114|NCT02087085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994115|NCT02087085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994116|NCT02087176|Antimitotic Agents|antimitotic agents|mesh-list
19994117|NCT02087176|Adavosertib|adavosertib|mesh-list
19994118|NCT02087176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994119|NCT02087176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994120|NCT02087176|Mitosis Modulators|mitosis modulators|mesh-ancestor
19994121|NCT02087176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994122|NCT02087241|Carboplatin|carboplatin|mesh-list
19994123|NCT02087241|Pemetrexed|pemetrexed|mesh-list
19994124|NCT02087241|Adavosertib|adavosertib|mesh-list
19994125|NCT02087241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994126|NCT02087241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994127|NCT02087241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994128|NCT02087241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19994129|NCT02087241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19994130|NCT02087306|Brincidofovir|brincidofovir|mesh-list
19994131|NCT02087306|Antiviral Agents|antiviral agents|mesh-ancestor
19994132|NCT02087306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20289425|NCT04758416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289426|NCT04756726|Dexamethasone|dexamethasone|mesh-list
20289427|NCT04756726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20289428|NCT04756726|Antiemetics|antiemetics|mesh-ancestor
20289429|NCT04756726|Autonomic Agents|autonomic agents|mesh-ancestor
20289430|NCT04756726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20289431|NCT04756726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289432|NCT04756726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20289433|NCT04756726|Glucocorticoids|glucocorticoids|mesh-ancestor
20289434|NCT04756726|Hormones|hormones|mesh-ancestor
20289435|NCT04756726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20289436|NCT04756726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20289437|NCT04756726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556518|NCT01947205|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
20556519|NCT01947205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20556520|NCT01947205|Analgesics|analgesics|mesh-ancestor
19994133|NCT02087748|Diclofenac|diclofenac|mesh-list
19994134|NCT02087748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19994135|NCT02087748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19994136|NCT02087748|Analgesics|analgesics|mesh-ancestor
19994137|NCT02087748|Sensory System Agents|sensory system agents|mesh-ancestor
19994138|NCT02087748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994139|NCT02087748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994140|NCT02087748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19994141|NCT02087748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19994142|NCT02087748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19994143|NCT02087748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994144|NCT02087748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994145|NCT02087943|Thalidomide|thalidomide|mesh-list
19994146|NCT02087943|Apremilast|apremilast|mesh-list
19994147|NCT02087943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19994148|NCT02087943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19994149|NCT02087943|Analgesics|analgesics|mesh-ancestor
19994150|NCT02087943|Sensory System Agents|sensory system agents|mesh-ancestor
19994151|NCT02087943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994152|NCT02087943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994153|NCT02087943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19994154|NCT02087943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19994155|NCT02087943|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
19994156|NCT02087943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19994157|NCT02087943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994158|NCT02087943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994159|NCT02087943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19994160|NCT02087943|Immunologic Factors|immunologic factors|mesh-ancestor
19994161|NCT02087943|Leprostatic Agents|leprostatic agents|mesh-ancestor
19994162|NCT02087943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19994163|NCT02087943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19994164|NCT02087943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19994165|NCT02087943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19994166|NCT02087943|Growth Substances|growth substances|mesh-ancestor
19994167|NCT02087943|Growth Inhibitors|growth inhibitors|mesh-ancestor
19994168|NCT02087943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994169|NCT02088034|Metformin|metformin|mesh-list
19994170|NCT02088034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19994171|NCT02088034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994172|NCT02088177|Naltrexone|naltrexone|mesh-list
19994173|NCT02088177|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19994174|NCT02088177|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19994175|NCT02088177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994176|NCT02088177|Sensory System Agents|sensory system agents|mesh-ancestor
19994177|NCT02088177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994178|NCT02088216|Acetylcysteine|acetylcysteine|mesh-list
19994179|NCT02088216|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19994180|NCT02088216|Antiviral Agents|antiviral agents|mesh-ancestor
19994181|NCT02088216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19994182|NCT02088216|Expectorants|expectorants|mesh-ancestor
19994183|NCT02088216|Respiratory System Agents|respiratory system agents|mesh-ancestor
19994184|NCT02088216|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19994185|NCT02088216|Antioxidants|antioxidants|mesh-ancestor
19994186|NCT02088216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994187|NCT02088216|Protective Agents|protective agents|mesh-ancestor
19994188|NCT02088216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994189|NCT02088216|Antidotes|antidotes|mesh-ancestor
19994190|NCT02088541|Cytarabine|cytarabine|mesh-list
19994191|NCT02088541|Hydroxyurea|hydroxyurea|mesh-list
19994192|NCT02088541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19994193|NCT02088541|Antimetabolites|antimetabolites|mesh-ancestor
19994194|NCT02088541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994195|NCT02088541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994196|NCT02088541|Antiviral Agents|antiviral agents|mesh-ancestor
19994197|NCT02088541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19994198|NCT02088541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19994199|NCT02088541|Immunologic Factors|immunologic factors|mesh-ancestor
19994200|NCT02088541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994201|NCT02088541|Antisickling Agents|antisickling agents|mesh-ancestor
19994202|NCT02088541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994203|NCT02088541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19994204|NCT02089113|Dexamethasone|dexamethasone|mesh-list
19994205|NCT02089113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19994206|NCT02089113|Antiemetics|antiemetics|mesh-ancestor
19994207|NCT02089113|Autonomic Agents|autonomic agents|mesh-ancestor
19994208|NCT02089113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994209|NCT02089113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994210|NCT02089113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19994211|NCT02089113|Glucocorticoids|glucocorticoids|mesh-ancestor
19994212|NCT02089113|Hormones|hormones|mesh-ancestor
19994213|NCT02089113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19994214|NCT02089113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19994215|NCT02089113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994216|NCT02089347|Vaccines|vaccines|mesh-list
19994217|NCT02089347|Immunologic Factors|immunologic factors|mesh-ancestor
19994218|NCT02089347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994219|NCT02089737|Panitumumab|panitumumab|mesh-list
19994220|NCT02089737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19994221|NCT02089737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994222|NCT02089997|Risedronic Acid|risedronic acid|mesh-list
19994223|NCT02089997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19994224|NCT02089997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19994225|NCT02089997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994226|NCT02089997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19994227|NCT02089997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994228|NCT02089997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19994229|NCT02090075|Warfarin|warfarin|mesh-list
19994230|NCT02090075|Apixaban|apixaban|mesh-list
19994231|NCT02090075|Anticoagulants|anticoagulants|mesh-ancestor
19994232|NCT02090075|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19994233|NCT02090075|Antithrombins|antithrombins|mesh-ancestor
19994234|NCT02090075|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19994235|NCT02090075|Protease Inhibitors|protease inhibitors|mesh-ancestor
19994236|NCT02090075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994237|NCT02090075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994238|NCT02090374|Vitamin D|vitamin d|mesh-list
19994239|NCT02090374|Poly ICLC|poly iclc|mesh-list
19994240|NCT02090374|Vitamins|vitamins|mesh-ancestor
19994241|NCT02090374|Micronutrients|micronutrients|mesh-ancestor
19994242|NCT02090374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994243|NCT02090374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19994244|NCT02090374|Interferon Inducers|interferon inducers|mesh-ancestor
19994245|NCT02090374|Immunologic Factors|immunologic factors|mesh-ancestor
19994246|NCT02090413|Aspirin|aspirin|mesh-list
19994247|NCT02090413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19994248|NCT02090413|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19994249|NCT02090413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19994250|NCT02090413|Analgesics|analgesics|mesh-ancestor
19994251|NCT02090413|Sensory System Agents|sensory system agents|mesh-ancestor
19994252|NCT02090413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994253|NCT02090413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994254|NCT02090413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19994255|NCT02090413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19994256|NCT02090413|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19994257|NCT02090413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19994258|NCT02090413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994259|NCT02090413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19994260|NCT02090413|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19994261|NCT02090413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994262|NCT02090413|Antipyretics|antipyretics|mesh-ancestor
19994263|NCT02090413|Dermatologic Agents|dermatologic agents|mesh-ancestor
19994264|NCT02090413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19994265|NCT02090413|Immunologic Factors|immunologic factors|mesh-ancestor
19994266|NCT02091206|Cannabidiol|cannabidiol|mesh-list
19994267|NCT02091206|Anticonvulsants|anticonvulsants|mesh-ancestor
19994268|NCT02091362|Metformin|metformin|mesh-list
19994269|NCT02091362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19994270|NCT02091362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994271|NCT02091375|Cannabidiol|cannabidiol|mesh-list
19994272|NCT02091375|Anticonvulsants|anticonvulsants|mesh-ancestor
19994273|NCT02091414|Cyclosporine|cyclosporine|mesh-list
19994274|NCT02091414|Mycophenolic Acid|mycophenolic acid|mesh-list
19994275|NCT02091414|Cyclosporins|cyclosporins|mesh-list
19994276|NCT02091414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994277|NCT02091414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994278|NCT02091414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19994279|NCT02091414|Immunologic Factors|immunologic factors|mesh-ancestor
19994280|NCT02091414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994281|NCT02091414|Antifungal Agents|antifungal agents|mesh-ancestor
19994282|NCT02091414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19994283|NCT02091414|Dermatologic Agents|dermatologic agents|mesh-ancestor
19994284|NCT02091414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19994285|NCT02091414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19994286|NCT02091414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19994287|NCT02091414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994288|NCT02091414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19994289|NCT02091414|Antitubercular Agents|antitubercular agents|mesh-ancestor
19994290|NCT02091414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19994291|NCT02091739|Botulinum Toxins|botulinum toxins|mesh-list
19994292|NCT02091739|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19994293|NCT02091739|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19994294|NCT02091739|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19994295|NCT02091739|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19994296|NCT02091739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19994297|NCT02091739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994298|NCT02091739|Cholinergic Agents|cholinergic agents|mesh-ancestor
19994299|NCT02091739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19994300|NCT02091739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994301|NCT02091739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19994302|NCT02091739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994303|NCT02091882|Aripiprazole|aripiprazole|mesh-list
19994304|NCT02091882|Antidepressive Agents|antidepressive agents|mesh-ancestor
19994305|NCT02091882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19994306|NCT02091882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19994307|NCT02091882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19994308|NCT02091882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19994309|NCT02091882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994310|NCT02091882|Dopamine Agonists|dopamine agonists|mesh-ancestor
19994311|NCT02091882|Dopamine Agents|dopamine agents|mesh-ancestor
19994312|NCT02091882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19994313|NCT02091882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994314|NCT02091882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19994315|NCT02091882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19994316|NCT02091882|Serotonin Agents|serotonin agents|mesh-ancestor
19994317|NCT02091882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19994318|NCT02091882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19994319|NCT02091882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19994320|NCT02091882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19994321|NCT02091921|Ticagrelor|ticagrelor|mesh-list
19994322|NCT02091921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19994323|NCT02091921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19994324|NCT02091921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19994325|NCT02091921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19994326|NCT02091921|Purinergic Agents|purinergic agents|mesh-ancestor
19994327|NCT02091921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19994328|NCT02091921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994329|NCT02091921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994330|NCT02091986|Budesonide|budesonide|mesh-list
19994331|NCT02091986|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19994332|NCT02091986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19994333|NCT02091986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19994334|NCT02091986|Autonomic Agents|autonomic agents|mesh-ancestor
19994335|NCT02091986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994336|NCT02091986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994337|NCT02091986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19994338|NCT02091986|Respiratory System Agents|respiratory system agents|mesh-ancestor
19994339|NCT02091986|Glucocorticoids|glucocorticoids|mesh-ancestor
19994340|NCT02091986|Hormones|hormones|mesh-ancestor
19994341|NCT02091986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19994342|NCT02092025|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19994343|NCT02092025|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19994344|NCT02092025|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19994345|NCT02092025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994346|NCT02092116|Romidepsin|romidepsin|mesh-list
19994347|NCT02092116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19994348|NCT02092116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994349|NCT02092168|Opicapone|opicapone|mesh-list
19994350|NCT02092168|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19994351|NCT02092168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994352|NCT02092168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994353|NCT02092168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19994354|NCT02092168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19994355|NCT02092181|Mirabegron|mirabegron|mesh-list
19994356|NCT02092181|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19994357|NCT02092181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19994358|NCT02092181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19994359|NCT02092181|Adrenergic Agents|adrenergic agents|mesh-ancestor
19994360|NCT02092181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19994361|NCT02092181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994362|NCT02092181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994363|NCT02092181|Urological Agents|urological agents|mesh-ancestor
19994364|NCT02092220|Pancrelipase|pancrelipase|mesh-list
19994365|NCT02092220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19994366|NCT02092285|Golimumab|golimumab|mesh-list
19994367|NCT02092285|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19994368|NCT02092285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19994369|NCT02092285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19994370|NCT02092285|Immunologic Factors|immunologic factors|mesh-ancestor
19994371|NCT02092285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994372|NCT02092298|Sodium thiosulfate|sodium thiosulfate|mesh-list
19994373|NCT02092298|Cisplatin|cisplatin|mesh-list
19994374|NCT02092298|Mitomycins|mitomycins|mesh-list
19994375|NCT02092298|Mitomycin|mitomycin|mesh-list
19994376|NCT02092298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994377|NCT02092298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19994378|NCT02092298|Alkylating Agents|alkylating agents|mesh-ancestor
19994379|NCT02092298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994380|NCT02092298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19994381|NCT02092298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994382|NCT02092298|Antidotes|antidotes|mesh-ancestor
19994383|NCT02092298|Protective Agents|protective agents|mesh-ancestor
19994384|NCT02092298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994385|NCT02092298|Antioxidants|antioxidants|mesh-ancestor
19994386|NCT02092298|Antitubercular Agents|antitubercular agents|mesh-ancestor
19994387|NCT02092298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19994388|NCT02092298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19994389|NCT02092298|Chelating Agents|chelating agents|mesh-ancestor
19994390|NCT02092298|Sequestering Agents|sequestering agents|mesh-ancestor
19994391|NCT02092350|Grazoprevir|grazoprevir|mesh-list
19994392|NCT02092350|Antiviral Agents|antiviral agents|mesh-ancestor
19994393|NCT02092350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19994394|NCT02092467|Adalimumab|adalimumab|mesh-list
19994395|NCT02092467|Etanercept|etanercept|mesh-list
19994396|NCT02092467|Tofacitinib|tofacitinib|mesh-list
19994397|NCT02092467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19994398|NCT02092467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19994399|NCT02092467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19994400|NCT02092467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19994401|NCT02092467|Analgesics|analgesics|mesh-ancestor
19994402|NCT02092467|Sensory System Agents|sensory system agents|mesh-ancestor
19994403|NCT02092467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994404|NCT02092467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994405|NCT02092467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19994406|NCT02092467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19994407|NCT02092467|Immunologic Factors|immunologic factors|mesh-ancestor
19994408|NCT02092467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19994409|NCT02092467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994410|NCT02092467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994411|NCT02092961|Adalimumab|adalimumab|mesh-list
19994412|NCT02092961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19994413|NCT02092961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19994414|NCT02093026|Folic Acid|folic acid|mesh-list
19994415|NCT02093026|Methylprednisolone|methylprednisolone|mesh-list
19994416|NCT02093026|Rituximab|rituximab|mesh-list
19994417|NCT02093026|Methotrexate|methotrexate|mesh-list
19994418|NCT02093026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19994419|NCT02093026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994420|NCT02093026|Immunologic Factors|immunologic factors|mesh-ancestor
19994421|NCT02093026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994422|NCT02093026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19994423|NCT02093026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19994424|NCT02093026|Abortifacient Agents|abortifacient agents|mesh-ancestor
19994425|NCT02093026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19994426|NCT02093026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19994427|NCT02093026|Antimetabolites|antimetabolites|mesh-ancestor
19994428|NCT02093026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994429|NCT02093026|Dermatologic Agents|dermatologic agents|mesh-ancestor
19994430|NCT02093026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994431|NCT02093026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19994432|NCT02093026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19994433|NCT02093026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19994434|NCT02093026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19994435|NCT02093026|Antiemetics|antiemetics|mesh-ancestor
19994436|NCT02093026|Autonomic Agents|autonomic agents|mesh-ancestor
19994437|NCT02093026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994438|NCT02093026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19994439|NCT02093026|Glucocorticoids|glucocorticoids|mesh-ancestor
19994440|NCT02093026|Hormones|hormones|mesh-ancestor
19994441|NCT02093026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19994442|NCT02093026|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19994443|NCT02093026|Protective Agents|protective agents|mesh-ancestor
19994444|NCT02093026|Hematinics|hematinics|mesh-ancestor
19994445|NCT02093026|Vitamin B Complex|vitamin b complex|mesh-ancestor
19994446|NCT02093026|Vitamins|vitamins|mesh-ancestor
19994447|NCT02093026|Micronutrients|micronutrients|mesh-ancestor
19994448|NCT02093221|Protease Inhibitors|protease inhibitors|mesh-list
19994449|NCT02093221|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19994450|NCT02093221|Protein C Inhibitor|protein c inhibitor|mesh-list
19994451|NCT02093221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994452|NCT02093221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994453|NCT02093221|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
19994454|NCT02093221|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19994455|NCT02093351|Tamoxifen|tamoxifen|mesh-list
19994456|NCT02093351|Letrozole|letrozole|mesh-list
19994457|NCT02093351|Olaparib|olaparib|mesh-list
19994458|NCT02093351|Anastrozole|anastrozole|mesh-list
19994459|NCT02093351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994460|NCT02093351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19994461|NCT02093351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19994462|NCT02093351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994463|NCT02093351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994464|NCT02093351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19994465|NCT02093351|Hormone Antagonists|hormone antagonists|mesh-ancestor
19994466|NCT02093351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19994467|NCT02093351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994468|NCT02093351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20556521|NCT01947205|Sensory System Agents|sensory system agents|mesh-ancestor
20556522|NCT01947205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556523|NCT01947205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556524|NCT01947205|Antipyretics|antipyretics|mesh-ancestor
20556525|NCT01947205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20556526|NCT01947205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20556527|NCT01947205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20556528|NCT01947309|Lenalidomide|lenalidomide|mesh-list
20556529|NCT01947309|Immunologic Factors|immunologic factors|mesh-ancestor
20556530|NCT01947309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556531|NCT01947309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20556532|NCT01947309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20556533|NCT01947309|Growth Substances|growth substances|mesh-ancestor
20556534|NCT01947309|Growth Inhibitors|growth inhibitors|mesh-ancestor
20556535|NCT01947309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556536|NCT01947465|Vaccines|vaccines|mesh-list
20556537|NCT01947465|Immunologic Factors|immunologic factors|mesh-ancestor
20556538|NCT01947465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556539|NCT01947556|Insulin Aspart|insulin aspart|mesh-list
20556540|NCT01947556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20556541|NCT01947556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556542|NCT01947608|Ceritinib|ceritinib|mesh-list
20556543|NCT01947608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556544|NCT01947608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20556545|NCT01947608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556546|NCT01947608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556547|NCT01947660|Anesthetics|anesthetics|mesh-list
20556548|NCT01947660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20556549|NCT01947660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556550|NCT01947699|Glyburide|glyburide|mesh-list
20556551|NCT01947699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20556552|NCT01947699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556553|NCT01947777|Rifampin|rifampin|mesh-list
20556554|NCT01947777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20556555|NCT01947777|Antitubercular Agents|antitubercular agents|mesh-ancestor
20556556|NCT01947777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20556557|NCT01947777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20556558|NCT01947777|Leprostatic Agents|leprostatic agents|mesh-ancestor
20556559|NCT01947777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19994469|NCT02093351|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19994470|NCT02093351|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19994471|NCT02093351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19994472|NCT02093351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19994473|NCT02093390|Fluconazole|fluconazole|mesh-list
19994474|NCT02093390|Atorvastatin|atorvastatin|mesh-list
19994475|NCT02093390|Relugolix|relugolix|mesh-list
19994476|NCT02093390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19994477|NCT02093390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19994478|NCT02093390|Antimetabolites|antimetabolites|mesh-ancestor
19994479|NCT02093390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994480|NCT02093390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19994481|NCT02093390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19994482|NCT02093390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994483|NCT02093390|Antifungal Agents|antifungal agents|mesh-ancestor
19994484|NCT02093390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19994485|NCT02093390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19994486|NCT02093390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19994487|NCT02093390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19994488|NCT02093390|Hormone Antagonists|hormone antagonists|mesh-ancestor
19994489|NCT02093390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19994490|NCT02093390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994491|NCT02093390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19994492|NCT02093390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19994493|NCT02093390|Androgen Antagonists|androgen antagonists|mesh-ancestor
19994494|NCT02093663|Mesalamine|mesalamine|mesh-list
19994495|NCT02093663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19994496|NCT02093663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19994497|NCT02093663|Analgesics|analgesics|mesh-ancestor
19994498|NCT02093663|Sensory System Agents|sensory system agents|mesh-ancestor
19994499|NCT02093663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994500|NCT02093663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994501|NCT02093663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19994502|NCT02093663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19994503|NCT02093897|Factor VIII|factor viii|mesh-list
19994504|NCT02093897|Coagulants|coagulants|mesh-ancestor
19994505|NCT02093962|Pemetrexed|pemetrexed|mesh-list
19994506|NCT02093962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994507|NCT02093962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994508|NCT02093962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994509|NCT02093962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19994510|NCT02093962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19994511|NCT02094443|Ribavirin|ribavirin|mesh-list
19994512|NCT02094443|Antimetabolites|antimetabolites|mesh-ancestor
19994513|NCT02094443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994514|NCT02094443|Antiviral Agents|antiviral agents|mesh-ancestor
19994515|NCT02094443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19994516|NCT02094534|Insulin|insulin|mesh-list
19994517|NCT02094534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19994518|NCT02094534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289438|NCT04745975|Gemcitabine|gemcitabine|mesh-list
20289439|NCT04745975|Paclitaxel|paclitaxel|mesh-list
20289440|NCT04745975|Vinorelbine|vinorelbine|mesh-list
20289441|NCT04745975|Capecitabine|capecitabine|mesh-list
20289442|NCT04745975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20289443|NCT04745975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289444|NCT04745975|Tubulin Modulators|tubulin modulators|mesh-ancestor
20289445|NCT04745975|Antimitotic Agents|antimitotic agents|mesh-ancestor
20289446|NCT04745975|Mitosis Modulators|mitosis modulators|mesh-ancestor
20289447|NCT04745975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289448|NCT04745975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20289449|NCT04745975|Antimetabolites|antimetabolites|mesh-ancestor
20289450|NCT04745975|Antiviral Agents|antiviral agents|mesh-ancestor
20289451|NCT04745975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20289452|NCT04745975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289453|NCT04745975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20289454|NCT04745975|Immunologic Factors|immunologic factors|mesh-ancestor
20289455|NCT04745975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289456|NCT04745728|Prednisone|prednisone|mesh-list
20289457|NCT04745728|Cyclophosphamide|cyclophosphamide|mesh-list
20289458|NCT04745728|Rituximab|rituximab|mesh-list
20289459|NCT04745728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20289460|NCT04745728|Immunologic Factors|immunologic factors|mesh-ancestor
20289461|NCT04745728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289462|NCT04745728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20289463|NCT04745728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20289464|NCT04745728|Alkylating Agents|alkylating agents|mesh-ancestor
19994519|NCT02094885|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19994520|NCT02094885|Hemostatics|hemostatics|mesh-ancestor
19994521|NCT02094885|Coagulants|coagulants|mesh-ancestor
19994522|NCT02094898|Ketamine|ketamine|mesh-list
19994523|NCT02094898|Analgesics|analgesics|mesh-ancestor
19994524|NCT02094898|Sensory System Agents|sensory system agents|mesh-ancestor
19994525|NCT02094898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994526|NCT02094898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994527|NCT02094898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19994528|NCT02094898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19994529|NCT02094898|Anesthetics, General|anesthetics, general|mesh-ancestor
19994530|NCT02094898|Anesthetics|anesthetics|mesh-ancestor
19994531|NCT02094898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19994532|NCT02094898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19994533|NCT02094898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19994534|NCT02094898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19994535|NCT02094898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994536|NCT02094937|Fluticasone|fluticasone|mesh-list
19994537|NCT02094937|Xhance|xhance|mesh-list
19994538|NCT02094937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19994539|NCT02094937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19994540|NCT02094937|Autonomic Agents|autonomic agents|mesh-ancestor
19994541|NCT02094937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994542|NCT02094937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994543|NCT02094937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19994544|NCT02094937|Respiratory System Agents|respiratory system agents|mesh-ancestor
19994545|NCT02094937|Dermatologic Agents|dermatologic agents|mesh-ancestor
19994546|NCT02094937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19994547|NCT02095106|Calpastatin|calpastatin|mesh-list
19994548|NCT02095106|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
19994549|NCT02095106|Protease Inhibitors|protease inhibitors|mesh-ancestor
19994550|NCT02095106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994551|NCT02095106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994552|NCT02095158|Phenylephrine|phenylephrine|mesh-list
19994553|NCT02095158|Oxymetazoline|oxymetazoline|mesh-list
19994554|NCT02095158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19994555|NCT02095158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19994556|NCT02095158|Adrenergic Agents|adrenergic agents|mesh-ancestor
19994557|NCT02095158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19994558|NCT02095158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994559|NCT02095158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994560|NCT02095158|Sympathomimetics|sympathomimetics|mesh-ancestor
19994561|NCT02095158|Autonomic Agents|autonomic agents|mesh-ancestor
19994562|NCT02095158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994563|NCT02095158|Nasal Decongestants|nasal decongestants|mesh-ancestor
19994564|NCT02095158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19994565|NCT02095158|Respiratory System Agents|respiratory system agents|mesh-ancestor
19994566|NCT02095158|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19994567|NCT02095158|Mydriatics|mydriatics|mesh-ancestor
19994568|NCT02095158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19994569|NCT02095158|Protective Agents|protective agents|mesh-ancestor
19994570|NCT02095197|Triamcinolone|triamcinolone|mesh-list
19994571|NCT02095197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19994572|NCT02095197|Glucocorticoids|glucocorticoids|mesh-ancestor
19994573|NCT02095197|Hormones|hormones|mesh-ancestor
19994574|NCT02095197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19994575|NCT02095197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994576|NCT02095535|Chlorhexidine|chlorhexidine|mesh-list
19994577|NCT02095535|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19994578|NCT02095535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19994579|NCT02095535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19994580|NCT02095535|Disinfectants|disinfectants|mesh-ancestor
19994581|NCT02095535|Dermatologic Agents|dermatologic agents|mesh-ancestor
19994582|NCT02095873|Resveratrol|resveratrol|mesh-list
19994583|NCT02095873|Antioxidants|antioxidants|mesh-ancestor
19994584|NCT02095873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994585|NCT02095873|Protective Agents|protective agents|mesh-ancestor
19994586|NCT02095873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994587|NCT02095873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994588|NCT02095873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19994589|NCT02095951|Ethanol|ethanol|mesh-list
19994590|NCT02095951|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19994591|NCT02095951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19994592|NCT02095951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19994593|NCT02095951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994594|NCT02096003|Morphine|morphine|mesh-list
19994595|NCT02096003|Hydromorphone|hydromorphone|mesh-list
19994596|NCT02096003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19994597|NCT02096003|Narcotics|narcotics|mesh-ancestor
19994598|NCT02096003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19994599|NCT02096003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994600|NCT02096003|Analgesics|analgesics|mesh-ancestor
19994601|NCT02096003|Sensory System Agents|sensory system agents|mesh-ancestor
19994602|NCT02096003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994603|NCT02096029|Nicotine|nicotine|mesh-list
19994604|NCT02096029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19994605|NCT02096029|Autonomic Agents|autonomic agents|mesh-ancestor
19994606|NCT02096029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994607|NCT02096029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994608|NCT02096029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19994609|NCT02096029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19994610|NCT02096029|Cholinergic Agents|cholinergic agents|mesh-ancestor
19994611|NCT02096029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19994612|NCT02096029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994613|NCT02096081|Botulinum Toxins|botulinum toxins|mesh-list
19994614|NCT02096081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19994615|NCT02096081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19994616|NCT02096081|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
19994617|NCT02096081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19994618|NCT02096081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19994619|NCT02096081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994620|NCT02096081|Cholinergic Agents|cholinergic agents|mesh-ancestor
19994621|NCT02096081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19994622|NCT02096081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994623|NCT02096081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19994624|NCT02096081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994625|NCT02096107|Everolimus|everolimus|mesh-list
19994626|NCT02096107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994627|NCT02096107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19994628|NCT02096107|Immunologic Factors|immunologic factors|mesh-ancestor
19994629|NCT02096107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994630|NCT02096263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19994631|NCT02096263|Immunologic Factors|immunologic factors|mesh-ancestor
19994632|NCT02096263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994633|NCT02096458|Dexlansoprazole|dexlansoprazole|mesh-list
19994634|NCT02096458|Lansoprazole|lansoprazole|mesh-list
19994635|NCT02096458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19994636|NCT02096458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19994637|NCT02096458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19994638|NCT02096458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994639|NCT02096458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994640|NCT02096575|Nitrous Oxide|nitrous oxide|mesh-list
19994641|NCT02096575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19994642|NCT02096575|Anesthetics, General|anesthetics, general|mesh-ancestor
19994643|NCT02096575|Anesthetics|anesthetics|mesh-ancestor
19994644|NCT02096575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19994645|NCT02096575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994646|NCT02096575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19994647|NCT02096575|Analgesics|analgesics|mesh-ancestor
19994648|NCT02096575|Sensory System Agents|sensory system agents|mesh-ancestor
19994649|NCT02096575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994650|NCT02096588|Cyclophosphamide|cyclophosphamide|mesh-list
19994651|NCT02096588|Doxorubicin|doxorubicin|mesh-list
19994652|NCT02096588|Simvastatin|simvastatin|mesh-list
19994653|NCT02096588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19994654|NCT02096588|Immunologic Factors|immunologic factors|mesh-ancestor
19994655|NCT02096588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994656|NCT02096588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19994657|NCT02096588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19994658|NCT02096588|Alkylating Agents|alkylating agents|mesh-ancestor
19994659|NCT02096588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994660|NCT02096588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994661|NCT02096588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19994662|NCT02096588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19994663|NCT02096588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19994664|NCT02096588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19994665|NCT02096588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994666|NCT02096588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19994667|NCT02096588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19994668|NCT02096588|Antimetabolites|antimetabolites|mesh-ancestor
19994669|NCT02096588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19994670|NCT02096588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19994671|NCT02096679|Osimertinib|osimertinib|mesh-list
19994672|NCT02096679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994673|NCT02096679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19994674|NCT02096679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994675|NCT02096679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994676|NCT02096705|Dapagliflozin|dapagliflozin|mesh-list
19994677|NCT02096705|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19994678|NCT02096705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994679|NCT02096705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19994680|NCT02096705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994681|NCT02096718|Afatinib|afatinib|mesh-list
19994682|NCT02096718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994683|NCT02096718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19994684|NCT02096718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994685|NCT02096718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994686|NCT02096744|Clonidine|clonidine|mesh-list
19994687|NCT02096744|Analgesics|analgesics|mesh-ancestor
19994688|NCT02096744|Sensory System Agents|sensory system agents|mesh-ancestor
19994689|NCT02096744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994690|NCT02096744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994691|NCT02096744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19994692|NCT02096744|Sympatholytics|sympatholytics|mesh-ancestor
19994693|NCT02096744|Autonomic Agents|autonomic agents|mesh-ancestor
19994694|NCT02096744|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19994695|NCT02096744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19994696|NCT02096744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19994697|NCT02096744|Adrenergic Agents|adrenergic agents|mesh-ancestor
19994698|NCT02096744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19994699|NCT02096744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994700|NCT02096835|Dexamethasone|dexamethasone|mesh-list
19994701|NCT02096835|Tropisetron|tropisetron|mesh-list
19994702|NCT02096835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19994703|NCT02096835|Antiemetics|antiemetics|mesh-ancestor
19994704|NCT02096835|Autonomic Agents|autonomic agents|mesh-ancestor
19994705|NCT02096835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994706|NCT02096835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994707|NCT02096835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19994708|NCT02096835|Glucocorticoids|glucocorticoids|mesh-ancestor
19994709|NCT02096835|Hormones|hormones|mesh-ancestor
19994710|NCT02096835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19994711|NCT02096835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19994712|NCT02096835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994713|NCT02096835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19994714|NCT02096835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19994715|NCT02096835|Serotonin Agents|serotonin agents|mesh-ancestor
19994716|NCT02096835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19994717|NCT02096835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994718|NCT02096861|Infliximab|infliximab|mesh-list
19994719|NCT02096861|Dermatologic Agents|dermatologic agents|mesh-ancestor
19994720|NCT02096861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19994721|NCT02096861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19994722|NCT02096900|Midazolam|midazolam|mesh-list
19994723|NCT02096900|Zolpidem|zolpidem|mesh-list
19994724|NCT02096900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19994725|NCT02096900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19994726|NCT02096900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19994727|NCT02096900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994728|NCT02096900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19994729|NCT02096900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19994730|NCT02096900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19994731|NCT02096900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19994732|NCT02096900|Anesthetics, General|anesthetics, general|mesh-ancestor
19994733|NCT02096900|Anesthetics|anesthetics|mesh-ancestor
19994734|NCT02096900|GABA Modulators|gaba modulators|mesh-ancestor
19994735|NCT02096900|GABA Agents|gaba agents|mesh-ancestor
19994736|NCT02096900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19994737|NCT02096900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994738|NCT02096900|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19994739|NCT02096900|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
19994740|NCT02096900|GABA Agonists|gaba agonists|mesh-ancestor
19994741|NCT02096952|Methylphenidate|methylphenidate|mesh-list
19994742|NCT02096952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19994743|NCT02096952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994744|NCT02096952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19994745|NCT02096952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19994746|NCT02096952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19994747|NCT02096952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994748|NCT02096952|Dopamine Agents|dopamine agents|mesh-ancestor
19994749|NCT02096952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19994750|NCT02097056|Donepezil|donepezil|mesh-list
19994751|NCT02097056|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19994752|NCT02097056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994753|NCT02097056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994754|NCT02097056|Cholinergic Agents|cholinergic agents|mesh-ancestor
19994755|NCT02097056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19994756|NCT02097056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994757|NCT02097056|Nootropic Agents|nootropic agents|mesh-ancestor
19994758|NCT02097108|Raltegravir Potassium|raltegravir potassium|mesh-list
19994759|NCT02097108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19994760|NCT02097108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19994761|NCT02097108|Antiviral Agents|antiviral agents|mesh-ancestor
19994762|NCT02097108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19994763|NCT02097108|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19994764|NCT02097108|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19994765|NCT02097108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994766|NCT02097108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994767|NCT02097238|Halichondrin B|halichondrin b|mesh-list
19994768|NCT02097238|Tubulin Modulators|tubulin modulators|mesh-ancestor
19994769|NCT02097238|Antimitotic Agents|antimitotic agents|mesh-ancestor
19994770|NCT02097238|Mitosis Modulators|mitosis modulators|mesh-ancestor
19994771|NCT02097238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994772|NCT02097238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994773|NCT02097303|Prednisone|prednisone|mesh-list
19994774|NCT02097303|Abiraterone Acetate|abiraterone acetate|mesh-list
19994775|NCT02097303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19994776|NCT02097303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19994777|NCT02097303|Glucocorticoids|glucocorticoids|mesh-ancestor
19994778|NCT02097303|Hormones|hormones|mesh-ancestor
19994779|NCT02097303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19994780|NCT02097303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994781|NCT02097303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19994782|NCT02097303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994783|NCT02097303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19994784|NCT02097303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994785|NCT02097303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994786|NCT02097303|Hormone Antagonists|hormone antagonists|mesh-ancestor
19994787|NCT02097303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19994788|NCT02097472|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19994789|NCT02097472|Immunologic Factors|immunologic factors|mesh-ancestor
19994790|NCT02097472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994791|NCT02097537|Methacholine Chloride|methacholine chloride|mesh-list
19994792|NCT02097537|Miotics|miotics|mesh-ancestor
19994793|NCT02097537|Autonomic Agents|autonomic agents|mesh-ancestor
19994794|NCT02097537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994795|NCT02097537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994796|NCT02097537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19994797|NCT02097537|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
19994798|NCT02097537|Respiratory System Agents|respiratory system agents|mesh-ancestor
19994799|NCT02097537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
19994800|NCT02097537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19994801|NCT02097537|Cholinergic Agents|cholinergic agents|mesh-ancestor
19994802|NCT02097537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19994803|NCT02097537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994804|NCT02097641|Plasma-lyte 148|plasma-lyte 148|mesh-list
19994805|NCT02097641|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19994806|NCT02097641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19994807|NCT02097719|Timolol|timolol|mesh-list
19994808|NCT02097719|Bimatoprost|bimatoprost|mesh-list
19994809|NCT02097719|Travoprost|travoprost|mesh-list
19994810|NCT02097719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19994811|NCT02097719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19994812|NCT02097719|Adrenergic Agents|adrenergic agents|mesh-ancestor
19994813|NCT02097719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19994814|NCT02097719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994815|NCT02097719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994816|NCT02097719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19994817|NCT02097719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19994818|NCT02097732|Ipilimumab|ipilimumab|mesh-list
19994819|NCT02097732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19994820|NCT02097732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994821|NCT02097732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19994822|NCT02097732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994823|NCT02097745|Rituximab|rituximab|mesh-list
19994824|NCT02097745|Methotrexate|methotrexate|mesh-list
19994825|NCT02097745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19994826|NCT02097745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994827|NCT02097745|Immunologic Factors|immunologic factors|mesh-ancestor
19994828|NCT02097745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994829|NCT02097745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19994830|NCT02097745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19994831|NCT02097745|Abortifacient Agents|abortifacient agents|mesh-ancestor
19994832|NCT02097745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19994833|NCT02097745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19994834|NCT02097745|Antimetabolites|antimetabolites|mesh-ancestor
19994835|NCT02097745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994836|NCT02097745|Dermatologic Agents|dermatologic agents|mesh-ancestor
19994837|NCT02097745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994838|NCT02097745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19994839|NCT02097745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19994840|NCT02097745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19994841|NCT02097823|Olanzapine|olanzapine|mesh-list
19994842|NCT02097823|Aprepitant|aprepitant|mesh-list
19994843|NCT02097823|Antiemetics|antiemetics|mesh-ancestor
19994844|NCT02097823|Autonomic Agents|autonomic agents|mesh-ancestor
19994845|NCT02097823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994846|NCT02097823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994847|NCT02097823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20556560|NCT01947777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556561|NCT01947777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556562|NCT01947777|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20556563|NCT01947777|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20556564|NCT01947777|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20556565|NCT01947777|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20556566|NCT01947777|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20556567|NCT01947777|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20556568|NCT01947790|Metformin|metformin|mesh-list
20556569|NCT01947790|Pioglitazone|pioglitazone|mesh-list
20556570|NCT01947790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20556571|NCT01947790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556572|NCT01947803|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20556573|NCT01947803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20556574|NCT01947803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20556575|NCT01947803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20556576|NCT01947803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556577|NCT01947803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20556578|NCT01947803|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20556579|NCT01947803|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20556580|NCT01947803|Serotonin Agents|serotonin agents|mesh-ancestor
20556581|NCT01947803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20556582|NCT01947803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556583|NCT01947803|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20556584|NCT01947803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20556585|NCT01947803|Dopamine Agents|dopamine agents|mesh-ancestor
20556586|NCT01947920|Tramadol|tramadol|mesh-list
20556587|NCT01947920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19994848|NCT02097823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19994849|NCT02097823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19994850|NCT02097823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19994851|NCT02097823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19994852|NCT02097823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19994853|NCT02097823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19994854|NCT02097823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19994855|NCT02097823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994856|NCT02097823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19994857|NCT02097823|Serotonin Agents|serotonin agents|mesh-ancestor
19994858|NCT02097823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20556588|NCT01947920|Narcotics|narcotics|mesh-ancestor
20556589|NCT01947920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20556590|NCT01947920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556591|NCT01947920|Analgesics|analgesics|mesh-ancestor
19994859|NCT02097849|Interferons|interferons|mesh-list
19994860|NCT02097849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19994861|NCT02097849|Vaccines|vaccines|mesh-list
19994862|NCT02097849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19994863|NCT02097849|Immunologic Factors|immunologic factors|mesh-ancestor
19994864|NCT02097849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994865|NCT02097849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19994866|NCT02097849|Antiviral Agents|antiviral agents|mesh-ancestor
19994867|NCT02097849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19994868|NCT02097849|Dermatologic Agents|dermatologic agents|mesh-ancestor
19994869|NCT02097849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19994870|NCT02098109|Plerixafor|plerixafor|mesh-list
19994871|NCT02098109|Lenograstim|lenograstim|mesh-list
19994872|NCT02098109|Sargramostim|sargramostim|mesh-list
19994873|NCT02098109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19994874|NCT02098109|Immunologic Factors|immunologic factors|mesh-ancestor
19994875|NCT02098109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994876|NCT02098109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19994877|NCT02098109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19994878|NCT02098109|Antiviral Agents|antiviral agents|mesh-ancestor
19994879|NCT02098109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19994880|NCT02098395|Liraglutide|liraglutide|mesh-list
19994881|NCT02098395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19994882|NCT02098395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994883|NCT02098395|Incretins|incretins|mesh-ancestor
19994884|NCT02098395|Hormones|hormones|mesh-ancestor
19994885|NCT02098395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19994886|NCT02098733|Pioglitazone|pioglitazone|mesh-list
19994887|NCT02098733|Glimepiride|glimepiride|mesh-list
19994888|NCT02098733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19994889|NCT02098733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994890|NCT02098733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19994891|NCT02098733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19994892|NCT02098733|Immunologic Factors|immunologic factors|mesh-ancestor
19994893|NCT02098746|Pioglitazone|pioglitazone|mesh-list
19994894|NCT02098746|Glimepiride|glimepiride|mesh-list
19994895|NCT02098746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19994896|NCT02098746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994897|NCT02098746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19994898|NCT02098746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19994899|NCT02098746|Immunologic Factors|immunologic factors|mesh-ancestor
19994900|NCT02098993|Heparin|heparin|mesh-list
19994901|NCT02098993|Calcium heparin|calcium heparin|mesh-list
19994902|NCT02098993|Anticoagulants|anticoagulants|mesh-ancestor
19994903|NCT02098993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19994904|NCT02098993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19994905|NCT02098993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994906|NCT02099006|Ketoprofen|ketoprofen|mesh-list
19994907|NCT02099006|Ketamine|ketamine|mesh-list
19994908|NCT02099006|Gabapentin|gabapentin|mesh-list
20556592|NCT01947920|Sensory System Agents|sensory system agents|mesh-ancestor
19994909|NCT02099006|Amitriptyline|amitriptyline|mesh-list
19994910|NCT02099006|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
19994911|NCT02099006|Baclofen|baclofen|mesh-list
19994912|NCT02099006|Loperamide|loperamide|mesh-list
19994913|NCT02099006|Antidiarrheals|antidiarrheals|mesh-list
19994914|NCT02099006|Analgesics|analgesics|mesh-ancestor
19994915|NCT02099006|Sensory System Agents|sensory system agents|mesh-ancestor
19994916|NCT02099006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19994917|NCT02099006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994918|NCT02099006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19994919|NCT02099006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19994920|NCT02099006|Anesthetics, General|anesthetics, general|mesh-ancestor
19994921|NCT02099006|Anesthetics|anesthetics|mesh-ancestor
19994922|NCT02099006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19994923|NCT02099006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19994924|NCT02099006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19994925|NCT02099006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19994926|NCT02099006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994927|NCT02099006|Anticonvulsants|anticonvulsants|mesh-ancestor
19994928|NCT02099006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19994929|NCT02099006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19994930|NCT02099006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19994931|NCT02099006|Antimanic Agents|antimanic agents|mesh-ancestor
19994932|NCT02099006|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19994933|NCT02099006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19994934|NCT02099006|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19994935|NCT02099006|GABA Agonists|gaba agonists|mesh-ancestor
19994936|NCT02099006|GABA Agents|gaba agents|mesh-ancestor
19994937|NCT02099006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19994938|NCT02099006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19994939|NCT02099006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19994940|NCT02099006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19994941|NCT02099006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19994942|NCT02099006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994943|NCT02099006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
19994944|NCT02099006|Antidepressive Agents|antidepressive agents|mesh-ancestor
19994945|NCT02099006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19994946|NCT02099006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19994947|NCT02099006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19994948|NCT02099006|Adrenergic Agents|adrenergic agents|mesh-ancestor
19994949|NCT02099006|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19994950|NCT02099006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19994951|NCT02099084|Teduglutide|teduglutide|mesh-list
19994952|NCT02099084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19994953|NCT02099084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19994954|NCT02099084|Protective Agents|protective agents|mesh-ancestor
19994955|NCT02099084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994956|NCT02099110|Metformin|metformin|mesh-list
19994957|NCT02099110|Insulin Glargine|insulin glargine|mesh-list
19994958|NCT02099110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19994959|NCT02099110|Glimepiride|glimepiride|mesh-list
19994960|NCT02099110|Ertugliflozin|ertugliflozin|mesh-list
19994961|NCT02099110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19994962|NCT02099110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994963|NCT02099110|Incretins|incretins|mesh-ancestor
19994964|NCT02099110|Hormones|hormones|mesh-ancestor
19994965|NCT02099110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19994966|NCT02099110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19994967|NCT02099110|Protease Inhibitors|protease inhibitors|mesh-ancestor
19994968|NCT02099110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994969|NCT02099110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994970|NCT02099110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19994971|NCT02099110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19994972|NCT02099110|Immunologic Factors|immunologic factors|mesh-ancestor
19994973|NCT02099110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19994974|NCT02099461|Denosumab|denosumab|mesh-list
19994975|NCT02099461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19994976|NCT02099461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994977|NCT02099682|Lansoprazole|lansoprazole|mesh-list
19994978|NCT02099682|Dexlansoprazole|dexlansoprazole|mesh-list
19994979|NCT02099682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19994980|NCT02099682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19994981|NCT02099682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19994982|NCT02099682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994983|NCT02099682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994984|NCT02099708|Lansoprazole|lansoprazole|mesh-list
19994985|NCT02099708|Dexlansoprazole|dexlansoprazole|mesh-list
19994986|NCT02099708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19994987|NCT02099708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19994988|NCT02099708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19994989|NCT02099708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994990|NCT02099708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19994991|NCT02099838|Metformin|metformin|mesh-list
19994992|NCT02099838|Pioglitazone|pioglitazone|mesh-list
19994993|NCT02099838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19994994|NCT02099838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19994995|NCT02100007|Topotecan|topotecan|mesh-list
19994996|NCT02100007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19994997|NCT02100007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19994998|NCT02100007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19994999|NCT02100007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995000|NCT02100007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995001|NCT02100124|Contraceptive Agents|contraceptive agents|mesh-list
19995002|NCT02100124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19995003|NCT02100124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995004|NCT02100228|Vitamin K|vitamin k|mesh-list
19995005|NCT02100228|Heparin|heparin|mesh-list
19995006|NCT02100228|Apixaban|apixaban|mesh-list
19995007|NCT02100228|Vitamins|vitamins|mesh-ancestor
19995008|NCT02100228|Micronutrients|micronutrients|mesh-ancestor
19995009|NCT02100228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995010|NCT02100228|Anticoagulants|anticoagulants|mesh-ancestor
19995011|NCT02100228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19995012|NCT02100228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19995013|NCT02100228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995014|NCT02100228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19995015|NCT02100228|Antithrombins|antithrombins|mesh-ancestor
19995016|NCT02100228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19995017|NCT02100228|Protease Inhibitors|protease inhibitors|mesh-ancestor
19995018|NCT02100228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995019|NCT02100228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19995020|NCT02100228|Hemostatics|hemostatics|mesh-ancestor
19995021|NCT02100228|Coagulants|coagulants|mesh-ancestor
19995022|NCT02100319|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
19995023|NCT02100319|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19995024|NCT02100319|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19995025|NCT02100319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995026|NCT02100475|Insulin|insulin|mesh-list
20556593|NCT01947920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556594|NCT01947933|Mirikizumab|mirikizumab|mesh-list
20556595|NCT01947933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20556596|NCT01947933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20556597|NCT01947933|Analgesics|analgesics|mesh-ancestor
20556598|NCT01947933|Sensory System Agents|sensory system agents|mesh-ancestor
20556599|NCT01947933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556600|NCT01947933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556601|NCT01947933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20556602|NCT01947933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20556603|NCT01947933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20556604|NCT01947933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20556605|NCT01947959|Rivaroxaban|rivaroxaban|mesh-list
20556606|NCT01947959|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20556607|NCT01947959|Antithrombins|antithrombins|mesh-ancestor
20556608|NCT01947959|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20556609|NCT01947959|Protease Inhibitors|protease inhibitors|mesh-ancestor
20556610|NCT01947959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556611|NCT01947959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556612|NCT01947959|Anticoagulants|anticoagulants|mesh-ancestor
20556613|NCT01947985|Rivaroxaban|rivaroxaban|mesh-list
20556614|NCT01947985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20556615|NCT01947985|Antithrombins|antithrombins|mesh-ancestor
20556616|NCT01947985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20556617|NCT01947985|Protease Inhibitors|protease inhibitors|mesh-ancestor
19995027|NCT02100475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19995028|NCT02100475|Insulin Aspart|insulin aspart|mesh-list
19995029|NCT02100475|Liraglutide|liraglutide|mesh-list
19995030|NCT02100475|Xultophy|xultophy|mesh-list
19995031|NCT02100475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19995032|NCT02100475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995033|NCT02100475|Incretins|incretins|mesh-ancestor
19995034|NCT02100475|Hormones|hormones|mesh-ancestor
19995035|NCT02100475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19995036|NCT02100514|Bococizumab|bococizumab|mesh-list
19995037|NCT02100514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19995038|NCT02100514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19995039|NCT02100514|Antimetabolites|antimetabolites|mesh-ancestor
19995040|NCT02100514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995041|NCT02100514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19995042|NCT02100579|Bupivacaine|bupivacaine|mesh-list
19995043|NCT02100579|Anesthetics, Local|anesthetics, local|mesh-ancestor
19995044|NCT02100579|Anesthetics|anesthetics|mesh-ancestor
19995045|NCT02100579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19995046|NCT02100579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995047|NCT02100579|Sensory System Agents|sensory system agents|mesh-ancestor
19995048|NCT02100579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995049|NCT02100644|Lamotrigine|lamotrigine|mesh-list
19995050|NCT02100644|Anticonvulsants|anticonvulsants|mesh-ancestor
19995051|NCT02100644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19995052|NCT02100644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20556618|NCT01947985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556619|NCT01947985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556620|NCT01947985|Anticoagulants|anticoagulants|mesh-ancestor
20556621|NCT01947998|Warfarin|warfarin|mesh-list
20556622|NCT01947998|Rivaroxaban|rivaroxaban|mesh-list
20556623|NCT01947998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
20556624|NCT01947998|Anticoagulants|anticoagulants|mesh-ancestor
20556625|NCT01947998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20556626|NCT01947998|Antithrombins|antithrombins|mesh-ancestor
20556627|NCT01947998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20556628|NCT01947998|Protease Inhibitors|protease inhibitors|mesh-ancestor
20556629|NCT01947998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556630|NCT01947998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556631|NCT01948011|Racecadotril|racecadotril|mesh-list
20556632|NCT01948011|Thiorphan|thiorphan|mesh-list
20556633|NCT01948011|Antidiarrheals|antidiarrheals|mesh-ancestor
20556634|NCT01948011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20556635|NCT01948011|Protease Inhibitors|protease inhibitors|mesh-ancestor
20556636|NCT01948011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556637|NCT01948011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556638|NCT01948024|Asenapine|asenapine|mesh-list
20556639|NCT01948024|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20556640|NCT01948024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20556641|NCT01948024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20556642|NCT01948024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556643|NCT01948024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20556644|NCT01948115|Nitrous Oxide|nitrous oxide|mesh-list
19995053|NCT02100644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995054|NCT02100644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19995055|NCT02100644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995056|NCT02100644|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19995057|NCT02100644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19995058|NCT02100644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19995059|NCT02100644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19995060|NCT02100644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19995061|NCT02100657|Dexamethasone|dexamethasone|mesh-list
19995062|NCT02100657|Bortezomib|bortezomib|mesh-list
19995063|NCT02100657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19995064|NCT02100657|Antiemetics|antiemetics|mesh-ancestor
19995065|NCT02100657|Autonomic Agents|autonomic agents|mesh-ancestor
19995066|NCT02100657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995067|NCT02100657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995068|NCT02100657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19995069|NCT02100657|Glucocorticoids|glucocorticoids|mesh-ancestor
19995070|NCT02100657|Hormones|hormones|mesh-ancestor
19995071|NCT02100657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19995072|NCT02100657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19995073|NCT02100657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995074|NCT02100670|Diclofenac|diclofenac|mesh-list
19995075|NCT02100670|Menthol|menthol|mesh-list
19995076|NCT02100670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19995077|NCT02100670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20556645|NCT01948115|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19995078|NCT02100670|Analgesics|analgesics|mesh-ancestor
19995079|NCT02100670|Sensory System Agents|sensory system agents|mesh-ancestor
19995080|NCT02100670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995081|NCT02100670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995082|NCT02100670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19995083|NCT02100670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19995084|NCT02100670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19995085|NCT02100670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995086|NCT02100670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995087|NCT02100670|Antipruritics|antipruritics|mesh-ancestor
19995088|NCT02100670|Dermatologic Agents|dermatologic agents|mesh-ancestor
19995089|NCT02100696|Etrolizumab|etrolizumab|mesh-list
19995090|NCT02100696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19995091|NCT02100696|Immunologic Factors|immunologic factors|mesh-ancestor
19995092|NCT02100696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995093|NCT02100748|Morphine|morphine|mesh-list
19995094|NCT02100748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19995095|NCT02100748|Narcotics|narcotics|mesh-ancestor
19995096|NCT02100748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19995097|NCT02100748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995098|NCT02100748|Analgesics|analgesics|mesh-ancestor
19995099|NCT02100748|Sensory System Agents|sensory system agents|mesh-ancestor
19995100|NCT02100748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995101|NCT02100826|Cephalexin|cephalexin|mesh-list
19995102|NCT02100826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19995103|NCT02100826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19995104|NCT02100930|Molgramostim|molgramostim|mesh-list
19995105|NCT02100930|Isotretinoin|isotretinoin|mesh-list
19995106|NCT02100930|Antibodies|antibodies|mesh-list
19995107|NCT02100930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19995108|NCT02100930|Sargramostim|sargramostim|mesh-list
19995109|NCT02100930|Immunologic Factors|immunologic factors|mesh-ancestor
19995110|NCT02100930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995111|NCT02100930|Dermatologic Agents|dermatologic agents|mesh-ancestor
19995112|NCT02100930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995113|NCT02100969|Immunoglobulins|immunoglobulins|mesh-list
19995114|NCT02100969|gamma-Globulins|gamma-globulins|mesh-list
19995115|NCT02100969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19995116|NCT02100969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19995117|NCT02100969|Immunologic Factors|immunologic factors|mesh-ancestor
19995118|NCT02100969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995119|NCT02101008|Disulfiram|disulfiram|mesh-list
19995120|NCT02101008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19995121|NCT02101008|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19995122|NCT02101008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995123|NCT02101008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995124|NCT02101021|Gemcitabine|gemcitabine|mesh-list
19995125|NCT02101021|Paclitaxel|paclitaxel|mesh-list
19995126|NCT02101021|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
19995127|NCT02101021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19995128|NCT02101021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995129|NCT02101021|Tubulin Modulators|tubulin modulators|mesh-ancestor
19995130|NCT02101021|Antimitotic Agents|antimitotic agents|mesh-ancestor
19995131|NCT02101021|Mitosis Modulators|mitosis modulators|mesh-ancestor
19995132|NCT02101021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995133|NCT02101021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19995134|NCT02101021|Antimetabolites|antimetabolites|mesh-ancestor
19995135|NCT02101021|Antiviral Agents|antiviral agents|mesh-ancestor
19995136|NCT02101021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19995137|NCT02101021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995138|NCT02101021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19995139|NCT02101021|Immunologic Factors|immunologic factors|mesh-ancestor
19995140|NCT02101021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995141|NCT02101021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20289465|NCT04745728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289466|NCT04745728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289467|NCT04745728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20289468|NCT04745728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20289469|NCT04745728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20289470|NCT04745728|Glucocorticoids|glucocorticoids|mesh-ancestor
20289471|NCT04745728|Hormones|hormones|mesh-ancestor
20289472|NCT04745728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20289473|NCT04745728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20289474|NCT04742075|Durvalumab|durvalumab|mesh-list
20289475|NCT04742075|Olaparib|olaparib|mesh-list
19995142|NCT02101112|Apixaban|apixaban|mesh-list
19995143|NCT02101112|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19995144|NCT02101112|Antithrombins|antithrombins|mesh-ancestor
19995145|NCT02101112|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19995146|NCT02101112|Protease Inhibitors|protease inhibitors|mesh-ancestor
19995147|NCT02101112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995148|NCT02101112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995149|NCT02101112|Anticoagulants|anticoagulants|mesh-ancestor
19995150|NCT02101190|Opicapone|opicapone|mesh-list
19995151|NCT02101190|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19995152|NCT02101190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995153|NCT02101190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995154|NCT02101190|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19995155|NCT02101190|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19995156|NCT02101281|Mitogens|mitogens|mesh-list
19995157|NCT02101281|Mitosis Modulators|mitosis modulators|mesh-ancestor
19995158|NCT02101281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995159|NCT02101359|Tetracaine|tetracaine|mesh-list
19995160|NCT02101359|Tropicamide|tropicamide|mesh-list
19995161|NCT02101359|Mydriatics|mydriatics|mesh-list
19995162|NCT02101359|Anesthetics, Local|anesthetics, local|mesh-ancestor
19995163|NCT02101359|Anesthetics|anesthetics|mesh-ancestor
19995164|NCT02101359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19995165|NCT02101359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995166|NCT02101359|Sensory System Agents|sensory system agents|mesh-ancestor
19995167|NCT02101359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995168|NCT02101359|Autonomic Agents|autonomic agents|mesh-ancestor
19995169|NCT02101359|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19995170|NCT02101359|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19995171|NCT02101359|Cholinergic Agents|cholinergic agents|mesh-ancestor
19995172|NCT02101359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19995173|NCT02101359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995174|NCT02101918|Aflibercept|aflibercept|mesh-list
19995175|NCT02101918|Endothelial Growth Factors|endothelial growth factors|mesh-list
19995176|NCT02101918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19995177|NCT02101918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19995178|NCT02101918|Growth Substances|growth substances|mesh-ancestor
19995179|NCT02101918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995180|NCT02101918|Growth Inhibitors|growth inhibitors|mesh-ancestor
19995181|NCT02101918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995182|NCT02101983|Cytarabine|cytarabine|mesh-list
19995183|NCT02101983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19995184|NCT02101983|Antimetabolites|antimetabolites|mesh-ancestor
19995185|NCT02101983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995186|NCT02101983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995187|NCT02101983|Antiviral Agents|antiviral agents|mesh-ancestor
19995188|NCT02101983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19995189|NCT02101983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19995190|NCT02101983|Immunologic Factors|immunologic factors|mesh-ancestor
19995191|NCT02101983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995192|NCT02102100|Menthol|menthol|mesh-list
19995193|NCT02102100|Nicotine|nicotine|mesh-list
19995194|NCT02102100|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19995195|NCT02102100|Autonomic Agents|autonomic agents|mesh-ancestor
19995196|NCT02102100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995197|NCT02102100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995198|NCT02102100|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19995199|NCT02102100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19995200|NCT02102100|Cholinergic Agents|cholinergic agents|mesh-ancestor
19995201|NCT02102100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19995202|NCT02102100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995203|NCT02102100|Antipruritics|antipruritics|mesh-ancestor
19995204|NCT02102100|Dermatologic Agents|dermatologic agents|mesh-ancestor
19995205|NCT02102932|Metformin|metformin|mesh-list
19995206|NCT02102932|Empagliflozin|empagliflozin|mesh-list
19995207|NCT02102932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19995208|NCT02102932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995209|NCT02102932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19995210|NCT02102932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995211|NCT02103062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19995212|NCT02103062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995213|NCT02103114|Antithrombin III|antithrombin iii|mesh-list
19995214|NCT02103114|Antithrombins|antithrombins|mesh-list
19995215|NCT02103114|Thrombin|thrombin|mesh-list
19995216|NCT02103114|Hemostatics|hemostatics|mesh-ancestor
19995217|NCT02103114|Coagulants|coagulants|mesh-ancestor
19995218|NCT02103114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19995219|NCT02103114|Protease Inhibitors|protease inhibitors|mesh-ancestor
19995220|NCT02103114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995221|NCT02103114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995222|NCT02103114|Anticoagulants|anticoagulants|mesh-ancestor
19995223|NCT02103439|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19995224|NCT02103439|Antiviral Agents|antiviral agents|mesh-ancestor
19995225|NCT02103439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19995226|NCT02103478|Decitabine|decitabine|mesh-list
19995227|NCT02103478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19995228|NCT02103478|Antimetabolites|antimetabolites|mesh-ancestor
19995229|NCT02103478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995230|NCT02103478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995231|NCT02103478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995232|NCT02103855|Abatacept|abatacept|mesh-list
19995233|NCT02103855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19995234|NCT02103855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995235|NCT02103855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995236|NCT02103855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19995237|NCT02103855|Immunologic Factors|immunologic factors|mesh-ancestor
19995238|NCT02103855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995239|NCT02103855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19995240|NCT02104414|Epinephrine|epinephrine|mesh-list
19995241|NCT02104414|Bupivacaine|bupivacaine|mesh-list
19995242|NCT02104414|Anesthetics, Local|anesthetics, local|mesh-ancestor
19995243|NCT02104414|Anesthetics|anesthetics|mesh-ancestor
19995244|NCT02104414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19995245|NCT02104414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995246|NCT02104414|Sensory System Agents|sensory system agents|mesh-ancestor
19995247|NCT02104414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995248|NCT02104414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19995249|NCT02104414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19995250|NCT02104414|Adrenergic Agents|adrenergic agents|mesh-ancestor
19995251|NCT02104414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19995252|NCT02104414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995253|NCT02104414|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19995254|NCT02104414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19995255|NCT02104414|Autonomic Agents|autonomic agents|mesh-ancestor
19995256|NCT02104414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19995257|NCT02104414|Respiratory System Agents|respiratory system agents|mesh-ancestor
19995258|NCT02104414|Mydriatics|mydriatics|mesh-ancestor
19995259|NCT02104414|Sympathomimetics|sympathomimetics|mesh-ancestor
19995260|NCT02104414|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19995261|NCT02104505|Tocopherols|tocopherols|mesh-list
19995262|NCT02104505|Vitamin E|vitamin e|mesh-list
19995263|NCT02104505|Tocotrienols|tocotrienols|mesh-list
19995264|NCT02104505|alpha-Tocopherol|alpha-tocopherol|mesh-list
19995265|NCT02104505|gamma-Tocopherol|gamma-tocopherol|mesh-list
19995266|NCT02104505|Antioxidants|antioxidants|mesh-ancestor
19995267|NCT02104505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995268|NCT02104505|Protective Agents|protective agents|mesh-ancestor
19995269|NCT02104505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995270|NCT02104505|Vitamins|vitamins|mesh-ancestor
19995271|NCT02104505|Micronutrients|micronutrients|mesh-ancestor
19995272|NCT02104739|Exenatide|exenatide|mesh-list
19995273|NCT02104739|Saxagliptin|saxagliptin|mesh-list
19995274|NCT02104739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19995275|NCT02104739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995276|NCT02104739|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19995277|NCT02104739|Incretins|incretins|mesh-ancestor
19995278|NCT02104739|Hormones|hormones|mesh-ancestor
19995279|NCT02104739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19995280|NCT02104739|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19995281|NCT02104739|Protease Inhibitors|protease inhibitors|mesh-ancestor
19995282|NCT02104739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995283|NCT02104739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995284|NCT02104752|Curcumin|curcumin|mesh-list
19995285|NCT02104752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19995286|NCT02104752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19995287|NCT02104752|Analgesics|analgesics|mesh-ancestor
19995288|NCT02104752|Sensory System Agents|sensory system agents|mesh-ancestor
19995289|NCT02104752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995290|NCT02104752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995291|NCT02104752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19995292|NCT02104752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19995293|NCT02104752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995294|NCT02104752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995295|NCT02104752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995296|NCT02104804|Insulin|insulin|mesh-list
19995297|NCT02104804|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19995298|NCT02104804|Metformin|metformin|mesh-list
19995299|NCT02104804|Saxagliptin|saxagliptin|mesh-list
19995300|NCT02104804|Insulin, Short-Acting|insulin, short-acting|mesh-list
19995301|NCT02104804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19995302|NCT02104804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995303|NCT02104804|Incretins|incretins|mesh-ancestor
19995304|NCT02104804|Hormones|hormones|mesh-ancestor
19995305|NCT02104804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19995306|NCT02104804|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19995307|NCT02104804|Protease Inhibitors|protease inhibitors|mesh-ancestor
19995308|NCT02104804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995309|NCT02104804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995310|NCT02104830|Lenograstim|lenograstim|mesh-list
19995311|NCT02104830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19995312|NCT02104830|Immunologic Factors|immunologic factors|mesh-ancestor
19995313|NCT02104830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995314|NCT02105272|Carteolol|carteolol|mesh-list
19995315|NCT02105272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19995316|NCT02105272|Latanoprost|latanoprost|mesh-list
19995317|NCT02105272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19995318|NCT02105272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19995319|NCT02105272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19995320|NCT02105272|Adrenergic Agents|adrenergic agents|mesh-ancestor
19995321|NCT02105272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19995322|NCT02105272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995323|NCT02105272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995324|NCT02105272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19995325|NCT02105272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19995326|NCT02105272|Sympatholytics|sympatholytics|mesh-ancestor
19995327|NCT02105272|Autonomic Agents|autonomic agents|mesh-ancestor
19995328|NCT02105272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995329|NCT02105285|Carteolol|carteolol|mesh-list
19995330|NCT02105285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19995331|NCT02105285|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19995332|NCT02105285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19995333|NCT02105285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19995334|NCT02105285|Adrenergic Agents|adrenergic agents|mesh-ancestor
19995335|NCT02105285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19995336|NCT02105285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995337|NCT02105285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995338|NCT02105285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19995339|NCT02105285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19995340|NCT02105285|Sympatholytics|sympatholytics|mesh-ancestor
19995341|NCT02105285|Autonomic Agents|autonomic agents|mesh-ancestor
19995342|NCT02105285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995343|NCT02105324|Pancrelipase|pancrelipase|mesh-list
19995344|NCT02105324|Pancreatin|pancreatin|mesh-list
19995345|NCT02105324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19995346|NCT02105415|Ketamine|ketamine|mesh-list
19995347|NCT02105415|Propofol|propofol|mesh-list
19995348|NCT02105415|Etomidate|etomidate|mesh-list
19995349|NCT02105415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19995350|NCT02105415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19995351|NCT02105415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995352|NCT02105415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19995353|NCT02105415|Anesthetics, General|anesthetics, general|mesh-ancestor
19995354|NCT02105415|Anesthetics|anesthetics|mesh-ancestor
19995355|NCT02105415|Analgesics|analgesics|mesh-ancestor
19995356|NCT02105415|Sensory System Agents|sensory system agents|mesh-ancestor
19995357|NCT02105415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995358|NCT02105415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19995359|NCT02105415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19995360|NCT02105415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19995361|NCT02105415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19995362|NCT02105415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995363|NCT02105454|Ribavirin|ribavirin|mesh-list
19995364|NCT02105454|Grazoprevir|grazoprevir|mesh-list
19995365|NCT02105454|Antimetabolites|antimetabolites|mesh-ancestor
19995366|NCT02105454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995367|NCT02105454|Antiviral Agents|antiviral agents|mesh-ancestor
19995368|NCT02105454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19995369|NCT02105467|Grazoprevir|grazoprevir|mesh-list
19995370|NCT02105467|Antiviral Agents|antiviral agents|mesh-ancestor
20289476|NCT04742075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19995371|NCT02105467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19995372|NCT02105558|Anesthetics|anesthetics|mesh-list
19995373|NCT02105558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19995374|NCT02105558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995375|NCT02105662|Grazoprevir|grazoprevir|mesh-list
19995376|NCT02105662|Antiviral Agents|antiviral agents|mesh-ancestor
19995377|NCT02105662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19995378|NCT02105688|Grazoprevir|grazoprevir|mesh-list
19995379|NCT02105688|Antiviral Agents|antiviral agents|mesh-ancestor
19995380|NCT02105688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19995381|NCT02105701|Ribavirin|ribavirin|mesh-list
19995382|NCT02105701|Grazoprevir|grazoprevir|mesh-list
19995383|NCT02105701|Antimetabolites|antimetabolites|mesh-ancestor
19995384|NCT02105701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995385|NCT02105701|Antiviral Agents|antiviral agents|mesh-ancestor
19995386|NCT02105701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19995387|NCT02105974|Fluticasone|fluticasone|mesh-list
19995388|NCT02105974|Xhance|xhance|mesh-list
19995389|NCT02105974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19995390|NCT02105974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19995391|NCT02105974|Autonomic Agents|autonomic agents|mesh-ancestor
19995392|NCT02105974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995393|NCT02105974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995394|NCT02105974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19995395|NCT02105974|Respiratory System Agents|respiratory system agents|mesh-ancestor
19995396|NCT02105974|Dermatologic Agents|dermatologic agents|mesh-ancestor
19995397|NCT02105974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19995398|NCT02106156|Interferons|interferons|mesh-list
19995399|NCT02106156|Ribavirin|ribavirin|mesh-list
19995400|NCT02106156|Interferon-alpha|interferon-alpha|mesh-list
19995401|NCT02106156|Interferon alpha-2|interferon alpha-2|mesh-list
19995402|NCT02106156|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19995403|NCT02106156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995404|NCT02106156|Antiviral Agents|antiviral agents|mesh-ancestor
19995405|NCT02106156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19995406|NCT02106156|Antimetabolites|antimetabolites|mesh-ancestor
19995407|NCT02106156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995408|NCT02106156|Immunologic Factors|immunologic factors|mesh-ancestor
19995409|NCT02106156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995410|NCT02106325|Diphenhydramine|diphenhydramine|mesh-list
19995411|NCT02106325|Promethazine|promethazine|mesh-list
19995412|NCT02106325|Ketamine|ketamine|mesh-list
19995413|NCT02106325|Analgesics|analgesics|mesh-ancestor
19995414|NCT02106325|Sensory System Agents|sensory system agents|mesh-ancestor
19995415|NCT02106325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995416|NCT02106325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995417|NCT02106325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19995418|NCT02106325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19995419|NCT02106325|Anesthetics, General|anesthetics, general|mesh-ancestor
19995420|NCT02106325|Anesthetics|anesthetics|mesh-ancestor
19995421|NCT02106325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19995422|NCT02106325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19995423|NCT02106325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19995424|NCT02106325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19995425|NCT02106325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995426|NCT02106325|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19995427|NCT02106325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19995428|NCT02106325|Anesthetics, Local|anesthetics, local|mesh-ancestor
19995429|NCT02106325|Antiemetics|antiemetics|mesh-ancestor
19995430|NCT02106325|Autonomic Agents|autonomic agents|mesh-ancestor
19995431|NCT02106325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19995432|NCT02106325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19995433|NCT02106325|Histamine Antagonists|histamine antagonists|mesh-ancestor
19995434|NCT02106325|Histamine Agents|histamine agents|mesh-ancestor
19995435|NCT02106325|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19995436|NCT02106325|Antipruritics|antipruritics|mesh-ancestor
19995437|NCT02106325|Dermatologic Agents|dermatologic agents|mesh-ancestor
19995438|NCT02106351|Botulinum Toxins|botulinum toxins|mesh-list
19995439|NCT02106351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19995440|NCT02106351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19995441|NCT02106351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19995442|NCT02106351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19995443|NCT02106351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995444|NCT02106351|Cholinergic Agents|cholinergic agents|mesh-ancestor
19995445|NCT02106351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19995446|NCT02106351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995447|NCT02106351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20556646|NCT01948115|Anesthetics, General|anesthetics, general|mesh-ancestor
19995448|NCT02106351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995449|NCT02106390|Vaccines|vaccines|mesh-list
19995450|NCT02106390|Immunologic Factors|immunologic factors|mesh-ancestor
19995451|NCT02106390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995452|NCT02106403|Disinfectants|disinfectants|mesh-list
19995453|NCT02106403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19995454|NCT02106442|Risedronic Acid|risedronic acid|mesh-list
19995455|NCT02106442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19995456|NCT02106442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19995457|NCT02106442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995458|NCT02106442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19995459|NCT02106442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995460|NCT02106442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19995461|NCT02106455|Risedronic Acid|risedronic acid|mesh-list
19995462|NCT02106455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19995463|NCT02106455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19995464|NCT02106455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995465|NCT02106455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19995466|NCT02106455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995467|NCT02106455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19995468|NCT02106494|Dexamethasone|dexamethasone|mesh-list
19995469|NCT02106494|Ondansetron|ondansetron|mesh-list
19995470|NCT02106494|Fosaprepitant|fosaprepitant|mesh-list
19995471|NCT02106494|Aprepitant|aprepitant|mesh-list
19995472|NCT02106494|Granisetron|granisetron|mesh-list
19995473|NCT02106494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19995474|NCT02106494|Antiemetics|antiemetics|mesh-ancestor
19995475|NCT02106494|Autonomic Agents|autonomic agents|mesh-ancestor
19995476|NCT02106494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995477|NCT02106494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995478|NCT02106494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19995479|NCT02106494|Glucocorticoids|glucocorticoids|mesh-ancestor
19995480|NCT02106494|Hormones|hormones|mesh-ancestor
19995481|NCT02106494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19995482|NCT02106494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19995483|NCT02106494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995484|NCT02106494|Antipruritics|antipruritics|mesh-ancestor
19995485|NCT02106494|Dermatologic Agents|dermatologic agents|mesh-ancestor
19995486|NCT02106494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19995487|NCT02106494|Serotonin Agents|serotonin agents|mesh-ancestor
19995488|NCT02106494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19995489|NCT02106494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995490|NCT02106494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19995491|NCT02106494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19995492|NCT02106494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19995493|NCT02106494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19995494|NCT02106494|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19995495|NCT02106494|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19995496|NCT02106832|Ciprofloxacin|ciprofloxacin|mesh-list
19995497|NCT02106832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19995498|NCT02106832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19995499|NCT02106832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19995500|NCT02106832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19995501|NCT02106832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995502|NCT02106832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995503|NCT02106832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995504|NCT02106832|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19995505|NCT02106832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19995506|NCT02106884|Gemcitabine|gemcitabine|mesh-list
19995507|NCT02106884|Paclitaxel|paclitaxel|mesh-list
19995508|NCT02106884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19995509|NCT02106884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995510|NCT02106884|Tubulin Modulators|tubulin modulators|mesh-ancestor
19995511|NCT02106884|Antimitotic Agents|antimitotic agents|mesh-ancestor
19995512|NCT02106884|Mitosis Modulators|mitosis modulators|mesh-ancestor
19995513|NCT02106884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995514|NCT02106884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19995515|NCT02106884|Antimetabolites|antimetabolites|mesh-ancestor
19995516|NCT02106884|Antiviral Agents|antiviral agents|mesh-ancestor
19995517|NCT02106884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19995518|NCT02106884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995519|NCT02106884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19995520|NCT02106884|Immunologic Factors|immunologic factors|mesh-ancestor
19995521|NCT02106884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995522|NCT02106923|Metformin|metformin|mesh-list
19995523|NCT02106923|Empagliflozin|empagliflozin|mesh-list
19995524|NCT02106923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19995525|NCT02106923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995526|NCT02106923|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19995527|NCT02106923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995528|NCT02106962|Bacitracin|bacitracin|mesh-list
19995529|NCT02106962|Tranexamic Acid|tranexamic acid|mesh-list
19995530|NCT02106962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19995531|NCT02106962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19995532|NCT02106962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995533|NCT02106962|Hemostatics|hemostatics|mesh-ancestor
19995534|NCT02106962|Coagulants|coagulants|mesh-ancestor
19995535|NCT02106962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19995536|NCT02106962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19995537|NCT02106962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19995538|NCT02106975|Ascorbic Acid|ascorbic acid|mesh-list
19995539|NCT02106975|Vitamins|vitamins|mesh-ancestor
19995540|NCT02106975|Micronutrients|micronutrients|mesh-ancestor
19995541|NCT02106975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995542|NCT02106975|Antioxidants|antioxidants|mesh-ancestor
19995543|NCT02106975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995544|NCT02106975|Protective Agents|protective agents|mesh-ancestor
19995545|NCT02107014|Naltrexone|naltrexone|mesh-list
19995546|NCT02107014|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19995547|NCT02107014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19995548|NCT02107014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995549|NCT02107014|Sensory System Agents|sensory system agents|mesh-ancestor
19995550|NCT02107014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995551|NCT02107131|Ranibizumab|ranibizumab|mesh-list
19995552|NCT02107131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19995553|NCT02107131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19995554|NCT02107131|Growth Substances|growth substances|mesh-ancestor
19995555|NCT02107131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995556|NCT02107131|Growth Inhibitors|growth inhibitors|mesh-ancestor
19995557|NCT02107131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995558|NCT02107274|Azithromycin|azithromycin|mesh-list
19995559|NCT02107274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19995560|NCT02107274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19995561|NCT02107339|Methadone|methadone|mesh-list
19995562|NCT02107339|Hydromorphone|hydromorphone|mesh-list
19995563|NCT02107339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19995564|NCT02107339|Narcotics|narcotics|mesh-ancestor
19995565|NCT02107339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19995566|NCT02107339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995567|NCT02107339|Analgesics|analgesics|mesh-ancestor
19995568|NCT02107339|Sensory System Agents|sensory system agents|mesh-ancestor
19995569|NCT02107339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995570|NCT02107339|Antitussive Agents|antitussive agents|mesh-ancestor
19995571|NCT02107339|Respiratory System Agents|respiratory system agents|mesh-ancestor
19995572|NCT02107703|Fulvestrant|fulvestrant|mesh-list
19995573|NCT02107703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19995574|NCT02107703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995575|NCT02107703|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19995576|NCT02107703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19995577|NCT02107703|Hormone Antagonists|hormone antagonists|mesh-ancestor
19995578|NCT02107703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19995579|NCT02107703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995580|NCT02107898|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19995581|NCT02107898|Immunologic Factors|immunologic factors|mesh-ancestor
19995582|NCT02107898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995583|NCT02108171|Dexmedetomidine|dexmedetomidine|mesh-list
19995584|NCT02108171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19995585|NCT02108171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19995586|NCT02108171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995587|NCT02108171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19995588|NCT02108171|Analgesics|analgesics|mesh-ancestor
19995589|NCT02108171|Sensory System Agents|sensory system agents|mesh-ancestor
19995590|NCT02108171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995591|NCT02108171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19995592|NCT02108171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19995593|NCT02108171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19995594|NCT02108171|Adrenergic Agents|adrenergic agents|mesh-ancestor
19995595|NCT02108171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19995596|NCT02108171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995597|NCT02108288|Carteolol|carteolol|mesh-list
19995598|NCT02108288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19995599|NCT02108288|Latanoprost|latanoprost|mesh-list
19995600|NCT02108288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19995601|NCT02108288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19995602|NCT02108288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19995603|NCT02108288|Adrenergic Agents|adrenergic agents|mesh-ancestor
19995604|NCT02108288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19995605|NCT02108288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995606|NCT02108288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995607|NCT02108288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19995608|NCT02108288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19995609|NCT02108288|Sympatholytics|sympatholytics|mesh-ancestor
19995610|NCT02108288|Autonomic Agents|autonomic agents|mesh-ancestor
19995611|NCT02108288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20289477|NCT04742075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20289478|NCT04742075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289479|NCT04742075|Immunologic Factors|immunologic factors|mesh-ancestor
20289480|NCT04742075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289481|NCT04742075|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20289482|NCT04742075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289483|NCT04742075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289484|NCT04704934|Paclitaxel|paclitaxel|mesh-list
20289485|NCT04704934|Trastuzumab|trastuzumab|mesh-list
20289486|NCT04704934|Ramucirumab|ramucirumab|mesh-list
20289487|NCT04704934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20289488|NCT04704934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289489|NCT04704934|Tubulin Modulators|tubulin modulators|mesh-ancestor
20289490|NCT04704934|Antimitotic Agents|antimitotic agents|mesh-ancestor
20289491|NCT04704934|Mitosis Modulators|mitosis modulators|mesh-ancestor
20289492|NCT04704934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289493|NCT04704934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20289494|NCT04692467|Amlodipine|amlodipine|mesh-list
20289495|NCT04692467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20289496|NCT04692467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20289497|NCT04692467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20289498|NCT04692467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289499|NCT04692467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20289500|NCT04692467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289501|NCT04692467|Vasodilator Agents|vasodilator agents|mesh-ancestor
20289502|NCT04690322|Factor VIII|factor viii|mesh-list
20289503|NCT04690322|BAX 855|bax 855|mesh-list
20289504|NCT04690322|Antibodies, Bispecific|antibodies, bispecific|mesh-list
20289505|NCT04690322|Coagulants|coagulants|mesh-ancestor
20289506|NCT04690322|Immunologic Factors|immunologic factors|mesh-ancestor
20289507|NCT04690322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289508|NCT04673422|Montelukast|montelukast|mesh-list
20289509|NCT04673422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20289510|NCT04673422|Respiratory System Agents|respiratory system agents|mesh-ancestor
20289511|NCT04673422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20289512|NCT04673422|Hormone Antagonists|hormone antagonists|mesh-ancestor
20289513|NCT04673422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20289514|NCT04673422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289515|NCT04673422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20289516|NCT04673422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20289517|NCT04673422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289518|NCT04661930|Fenofibrate|fenofibrate|mesh-list
20289519|NCT04661930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20289520|NCT04661930|Antimetabolites|antimetabolites|mesh-ancestor
20289521|NCT04661930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289522|NCT04661930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20289523|NCT04657068|Gemcitabine|gemcitabine|mesh-list
20289524|NCT04657068|Irinotecan|irinotecan|mesh-list
20289525|NCT04657068|Camptothecin|camptothecin|mesh-list
20289526|NCT04657068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20289527|NCT04657068|Antimetabolites|antimetabolites|mesh-ancestor
20289528|NCT04657068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995612|NCT02109029|Insulin|insulin|mesh-list
19995613|NCT02109029|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19995614|NCT02109029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19995615|NCT02109029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995616|NCT02109133|Rocuronium|rocuronium|mesh-list
19995617|NCT02109133|Atracurium|atracurium|mesh-list
19995618|NCT02109133|Neostigmine|neostigmine|mesh-list
19995619|NCT02109133|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19995620|NCT02109133|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19995621|NCT02109133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19995622|NCT02109133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995623|NCT02109133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995624|NCT02109133|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19995625|NCT02109133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995626|NCT02109133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995627|NCT02109133|Cholinergic Agents|cholinergic agents|mesh-ancestor
19995628|NCT02109133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19995629|NCT02109133|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19995630|NCT02109133|Autonomic Agents|autonomic agents|mesh-ancestor
19995631|NCT02109133|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
19995632|NCT02109133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19995633|NCT02109445|Gemcitabine|gemcitabine|mesh-list
19995634|NCT02109445|Paclitaxel|paclitaxel|mesh-list
19995635|NCT02109445|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19995636|NCT02109445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19995637|NCT02109445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995638|NCT02109445|Tubulin Modulators|tubulin modulators|mesh-ancestor
19995639|NCT02109445|Antimitotic Agents|antimitotic agents|mesh-ancestor
19995640|NCT02109445|Mitosis Modulators|mitosis modulators|mesh-ancestor
19995641|NCT02109445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995642|NCT02109445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19995643|NCT02109445|Antimetabolites|antimetabolites|mesh-ancestor
19995644|NCT02109445|Antiviral Agents|antiviral agents|mesh-ancestor
19995645|NCT02109445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19995646|NCT02109445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995647|NCT02109445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19995648|NCT02109445|Immunologic Factors|immunologic factors|mesh-ancestor
19995649|NCT02109445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995650|NCT02109484|Vaccines|vaccines|mesh-list
19995651|NCT02109484|Immunologic Factors|immunologic factors|mesh-ancestor
19995652|NCT02109484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995653|NCT02109562|Risperidone|risperidone|mesh-list
19995654|NCT02109562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19995655|NCT02109562|Serotonin Agents|serotonin agents|mesh-ancestor
19995656|NCT02109562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19995657|NCT02109562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995658|NCT02109562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995659|NCT02109562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19995660|NCT02109562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19995661|NCT02109562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19995662|NCT02109562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19995663|NCT02109562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19995664|NCT02109562|Dopamine Agents|dopamine agents|mesh-ancestor
19995665|NCT02109640|Oxycodone|oxycodone|mesh-list
19995666|NCT02109640|Naloxone|naloxone|mesh-list
19995667|NCT02109640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19995668|NCT02109640|Narcotics|narcotics|mesh-ancestor
19995669|NCT02109640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19995670|NCT02109640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995671|NCT02109640|Analgesics|analgesics|mesh-ancestor
19995672|NCT02109640|Sensory System Agents|sensory system agents|mesh-ancestor
19995673|NCT02109640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995674|NCT02109640|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19995675|NCT02109939|Psychotropic Drugs|psychotropic drugs|mesh-list
19995676|NCT02110225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19995677|NCT02110225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19995678|NCT02110225|Mitogens|mitogens|mesh-list
19995679|NCT02110225|Mitosis Modulators|mitosis modulators|mesh-ancestor
19995680|NCT02110225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995681|NCT02110238|Hyaluronic Acid|hyaluronic acid|mesh-list
19995682|NCT02110238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19995683|NCT02110238|Immunologic Factors|immunologic factors|mesh-ancestor
19995684|NCT02110238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995685|NCT02110238|Viscosupplements|viscosupplements|mesh-ancestor
19995686|NCT02110238|Protective Agents|protective agents|mesh-ancestor
19995687|NCT02110264|Naltrexone|naltrexone|mesh-list
19995688|NCT02110264|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19995689|NCT02110264|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19995690|NCT02110264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995691|NCT02110264|Sensory System Agents|sensory system agents|mesh-ancestor
19995692|NCT02110264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995693|NCT02110706|Rituximab|rituximab|mesh-list
19995694|NCT02110706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19995695|NCT02110706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995696|NCT02110706|Immunologic Factors|immunologic factors|mesh-ancestor
19995697|NCT02110706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995698|NCT02110706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19995699|NCT02111083|Insulin Lispro|insulin lispro|mesh-list
19995700|NCT02111083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19995701|NCT02111083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995702|NCT02111096|Metformin|metformin|mesh-list
19995703|NCT02111096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19995704|NCT02111096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19995705|NCT02111096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995706|NCT02111096|Incretins|incretins|mesh-ancestor
19995707|NCT02111096|Hormones|hormones|mesh-ancestor
19995708|NCT02111096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19995709|NCT02111096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19995710|NCT02111096|Protease Inhibitors|protease inhibitors|mesh-ancestor
19995711|NCT02111096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995712|NCT02111096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995713|NCT02111200|Sodium Benzoate|sodium benzoate|mesh-list
19995714|NCT02111200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
19995715|NCT02111200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995716|NCT02111200|Antifungal Agents|antifungal agents|mesh-ancestor
19995717|NCT02111200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19995718|NCT02111369|Propranolol|propranolol|mesh-list
19995719|NCT02111369|Botulinum Toxins|botulinum toxins|mesh-list
19995720|NCT02111369|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19995721|NCT02111369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19995722|NCT02111369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995723|NCT02111369|Cholinergic Agents|cholinergic agents|mesh-ancestor
19995724|NCT02111369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19995725|NCT02111369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995726|NCT02111369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19995727|NCT02111369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19995728|NCT02111369|Adrenergic Agents|adrenergic agents|mesh-ancestor
19995729|NCT02111369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19995730|NCT02111369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19995731|NCT02111369|Vasodilator Agents|vasodilator agents|mesh-ancestor
19995732|NCT02111447|Propofol|propofol|mesh-list
19995733|NCT02111447|Sevoflurane|sevoflurane|mesh-list
19995734|NCT02111447|Isoflurane|isoflurane|mesh-list
19995735|NCT02111447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19995736|NCT02111447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19995737|NCT02111447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995738|NCT02111447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19995739|NCT02111447|Anesthetics, General|anesthetics, general|mesh-ancestor
19995740|NCT02111447|Anesthetics|anesthetics|mesh-ancestor
19995741|NCT02111447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19995742|NCT02111447|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19995743|NCT02111564|Rivaroxaban|rivaroxaban|mesh-list
19995744|NCT02111564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19995745|NCT02111564|Antithrombins|antithrombins|mesh-ancestor
19995746|NCT02111564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19995747|NCT02111564|Protease Inhibitors|protease inhibitors|mesh-ancestor
20556647|NCT01948115|Anesthetics|anesthetics|mesh-ancestor
20556648|NCT01948115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20556649|NCT01948115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556650|NCT01948115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20556651|NCT01948115|Analgesics|analgesics|mesh-ancestor
20556652|NCT01948115|Sensory System Agents|sensory system agents|mesh-ancestor
20556653|NCT01948115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556654|NCT01948128|Vitamin D|vitamin d|mesh-list
20556655|NCT01948128|Ergocalciferols|ergocalciferols|mesh-list
19995748|NCT02111564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995749|NCT02111564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995750|NCT02111564|Anticoagulants|anticoagulants|mesh-ancestor
19995751|NCT02111603|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
19995752|NCT02111603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19995753|NCT02111603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19995754|NCT02111603|Antimetabolites|antimetabolites|mesh-ancestor
19995755|NCT02111603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995756|NCT02111603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19995757|NCT02111746|Bupivacaine|bupivacaine|mesh-list
19995758|NCT02111746|Anesthetics, Local|anesthetics, local|mesh-ancestor
19995759|NCT02111746|Anesthetics|anesthetics|mesh-ancestor
19995760|NCT02111746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19995761|NCT02111746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995762|NCT02111746|Sensory System Agents|sensory system agents|mesh-ancestor
19995763|NCT02111746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995764|NCT02111785|Dexamethasone|dexamethasone|mesh-list
19995765|NCT02111785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19995766|NCT02111785|Antiemetics|antiemetics|mesh-ancestor
19995767|NCT02111785|Autonomic Agents|autonomic agents|mesh-ancestor
19995768|NCT02111785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995769|NCT02111785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995770|NCT02111785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19995771|NCT02111785|Glucocorticoids|glucocorticoids|mesh-ancestor
19995772|NCT02111785|Hormones|hormones|mesh-ancestor
19995773|NCT02111785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19995774|NCT02111785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19995775|NCT02111785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995776|NCT02111798|Bupropion|bupropion|mesh-list
19995777|NCT02111798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19995778|NCT02111798|Antidepressive Agents|antidepressive agents|mesh-ancestor
19995779|NCT02111798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19995780|NCT02111798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19995781|NCT02111798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19995782|NCT02111798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19995783|NCT02111798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995784|NCT02111798|Dopamine Agents|dopamine agents|mesh-ancestor
19995785|NCT02111798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19995786|NCT02111798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995787|NCT02111798|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19995788|NCT02111798|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19995789|NCT02111798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995790|NCT02111863|Aldesleukin|aldesleukin|mesh-list
19995791|NCT02111863|Cyclophosphamide|cyclophosphamide|mesh-list
19995792|NCT02111863|Fludarabine|fludarabine|mesh-list
19995793|NCT02111863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19995794|NCT02111863|Immunologic Factors|immunologic factors|mesh-ancestor
19995795|NCT02111863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995796|NCT02111863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19995797|NCT02111863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19995798|NCT02111863|Alkylating Agents|alkylating agents|mesh-ancestor
20556656|NCT01948128|Cholecalciferol|cholecalciferol|mesh-list
20556657|NCT01948128|Vitamins|vitamins|mesh-list
19995799|NCT02111863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995800|NCT02111863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995801|NCT02111863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19995802|NCT02111863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19995803|NCT02111863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19995804|NCT02111863|Antiviral Agents|antiviral agents|mesh-ancestor
19995805|NCT02111863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19995806|NCT02112045|Melphalan|melphalan|mesh-list
19995807|NCT02112045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19995808|NCT02112045|Alkylating Agents|alkylating agents|mesh-ancestor
19995809|NCT02112045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995810|NCT02112045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995811|NCT02112045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19995812|NCT02112045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19995813|NCT02112045|Immunologic Factors|immunologic factors|mesh-ancestor
19995814|NCT02112045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995815|NCT02112370|Epinephrine|epinephrine|mesh-list
19995816|NCT02112370|Racepinephrine|racepinephrine|mesh-list
19995817|NCT02112370|Ropivacaine|ropivacaine|mesh-list
19995818|NCT02112370|Epinephryl borate|epinephryl borate|mesh-list
19995819|NCT02112370|Anesthetics, Local|anesthetics, local|mesh-ancestor
19995820|NCT02112370|Anesthetics|anesthetics|mesh-ancestor
19995821|NCT02112370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19995822|NCT02112370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995823|NCT02112370|Sensory System Agents|sensory system agents|mesh-ancestor
19995824|NCT02112370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995825|NCT02112370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19995826|NCT02112370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19995827|NCT02112370|Adrenergic Agents|adrenergic agents|mesh-ancestor
19995828|NCT02112370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19995829|NCT02112370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995830|NCT02112370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19995831|NCT02112370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19995832|NCT02112370|Autonomic Agents|autonomic agents|mesh-ancestor
19995833|NCT02112370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19995834|NCT02112370|Respiratory System Agents|respiratory system agents|mesh-ancestor
19995835|NCT02112370|Mydriatics|mydriatics|mesh-ancestor
19995836|NCT02112370|Sympathomimetics|sympathomimetics|mesh-ancestor
19995837|NCT02112370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19995838|NCT02112448|Acetaminophen|acetaminophen|mesh-list
19995839|NCT02112448|Ketorolac|ketorolac|mesh-list
19995840|NCT02112448|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
19995841|NCT02112448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19995842|NCT02112448|Analgesics|analgesics|mesh-ancestor
19995843|NCT02112448|Sensory System Agents|sensory system agents|mesh-ancestor
19995844|NCT02112448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995845|NCT02112448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995846|NCT02112448|Antipyretics|antipyretics|mesh-ancestor
19995847|NCT02112448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19995848|NCT02112448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19995849|NCT02112448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19995850|NCT02112448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20556658|NCT01948128|Micronutrients|micronutrients|mesh-ancestor
20556659|NCT01948128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556660|NCT01948128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20556661|NCT01948128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19995851|NCT02112448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995852|NCT02112448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995853|NCT02113007|Rituximab|rituximab|mesh-list
19995854|NCT02113007|Temozolomide|temozolomide|mesh-list
19995855|NCT02113007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19995856|NCT02113007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995857|NCT02113007|Immunologic Factors|immunologic factors|mesh-ancestor
19995858|NCT02113007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995859|NCT02113007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19995860|NCT02113007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19995861|NCT02113007|Alkylating Agents|alkylating agents|mesh-ancestor
19995862|NCT02113007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995863|NCT02113241|Dapagliflozin|dapagliflozin|mesh-list
19995864|NCT02113241|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19995865|NCT02113241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995866|NCT02113241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19995867|NCT02113241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995868|NCT02113579|Fluorides|fluorides|mesh-list
19995869|NCT02113579|Cariostatic Agents|cariostatic agents|mesh-ancestor
19995870|NCT02113579|Protective Agents|protective agents|mesh-ancestor
19995871|NCT02113579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995872|NCT02114151|Sofosbuvir|sofosbuvir|mesh-list
19995873|NCT02114151|Simeprevir|simeprevir|mesh-list
19995874|NCT02114151|Antiviral Agents|antiviral agents|mesh-ancestor
19995875|NCT02114151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19995876|NCT02114151|Protease Inhibitors|protease inhibitors|mesh-ancestor
19995877|NCT02114151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995878|NCT02114151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995879|NCT02114177|Sofosbuvir|sofosbuvir|mesh-list
19995880|NCT02114177|Simeprevir|simeprevir|mesh-list
19995881|NCT02114177|Antiviral Agents|antiviral agents|mesh-ancestor
19995882|NCT02114177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19995883|NCT02114177|Protease Inhibitors|protease inhibitors|mesh-ancestor
19995884|NCT02114177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995885|NCT02114177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995886|NCT02114385|Vaccines|vaccines|mesh-list
19995887|NCT02114385|Immunologic Factors|immunologic factors|mesh-ancestor
19995888|NCT02114385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995889|NCT02114684|Moxifloxacin|moxifloxacin|mesh-list
19995890|NCT02114684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19995891|NCT02114684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19995892|NCT02114684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19995893|NCT02114684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19995894|NCT02114684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995895|NCT02114684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995896|NCT02114684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995897|NCT02114892|Resveratrol|resveratrol|mesh-list
19995898|NCT02114892|Antioxidants|antioxidants|mesh-ancestor
19995899|NCT02114892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995900|NCT02114892|Protective Agents|protective agents|mesh-ancestor
19995901|NCT02114892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995902|NCT02114892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995903|NCT02114892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19995904|NCT02114931|Adalimumab|adalimumab|mesh-list
19995905|NCT02114931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19995906|NCT02114931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19995907|NCT02115048|Letrozole|letrozole|mesh-list
19995908|NCT02115048|Afatinib|afatinib|mesh-list
19995909|NCT02115048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995910|NCT02115048|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19995911|NCT02115048|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19995912|NCT02115048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995913|NCT02115048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995914|NCT02115048|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19995915|NCT02115048|Hormone Antagonists|hormone antagonists|mesh-ancestor
19995916|NCT02115048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19995917|NCT02115048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995918|NCT02115048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19995919|NCT02115113|Everolimus|everolimus|mesh-list
19995920|NCT02115113|Tacrolimus|tacrolimus|mesh-list
19995921|NCT02115113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19995922|NCT02115113|Immunologic Factors|immunologic factors|mesh-ancestor
19995923|NCT02115113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995924|NCT02115113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19995925|NCT02115113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995926|NCT02115113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995927|NCT02115113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995928|NCT02115139|Ipilimumab|ipilimumab|mesh-list
19995929|NCT02115139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19995930|NCT02115139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995931|NCT02115139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19995932|NCT02115139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995933|NCT02115256|Nitroglycerin|nitroglycerin|mesh-list
19995934|NCT02115256|Terbutaline|terbutaline|mesh-list
19995935|NCT02115256|Vasodilator Agents|vasodilator agents|mesh-ancestor
19995936|NCT02115256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19995937|NCT02115256|Autonomic Agents|autonomic agents|mesh-ancestor
19995938|NCT02115256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995939|NCT02115256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995940|NCT02115256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19995941|NCT02115256|Respiratory System Agents|respiratory system agents|mesh-ancestor
19995942|NCT02115256|Sympathomimetics|sympathomimetics|mesh-ancestor
19995943|NCT02115256|Tocolytic Agents|tocolytic agents|mesh-ancestor
19995944|NCT02115256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19995945|NCT02115256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19995946|NCT02115256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19995947|NCT02115256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19995948|NCT02115256|Adrenergic Agents|adrenergic agents|mesh-ancestor
19995949|NCT02115256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19995950|NCT02115256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995951|NCT02115282|Exemestane|exemestane|mesh-list
19995952|NCT02115282|Goserelin|goserelin|mesh-list
19995953|NCT02115282|Entinostat|entinostat|mesh-list
19995954|NCT02115282|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
19995955|NCT02115282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995956|NCT02115282|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19995957|NCT02115282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19995958|NCT02115282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19995959|NCT02115282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995960|NCT02115282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19995961|NCT02115282|Hormone Antagonists|hormone antagonists|mesh-ancestor
19995962|NCT02115282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19995963|NCT02115282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995964|NCT02115282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19995965|NCT02115308|Regadenoson|regadenoson|mesh-list
19995966|NCT02115308|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
19995967|NCT02115308|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19995968|NCT02115308|Purinergic Agonists|purinergic agonists|mesh-ancestor
19995969|NCT02115308|Purinergic Agents|purinergic agents|mesh-ancestor
19995970|NCT02115308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19995971|NCT02115308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995972|NCT02115308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995973|NCT02115321|Grazoprevir|grazoprevir|mesh-list
19995974|NCT02115321|Antiviral Agents|antiviral agents|mesh-ancestor
19995975|NCT02115321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19995976|NCT02115347|Ertugliflozin|ertugliflozin|mesh-list
19995977|NCT02115347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19995978|NCT02115347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19995979|NCT02115347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19995980|NCT02115347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995981|NCT02115373|Tepotinib|tepotinib|mesh-list
19995982|NCT02115373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19995983|NCT02115581|Ubiquinone|ubiquinone|mesh-list
19995984|NCT02115581|Coenzyme Q10|coenzyme q10|mesh-list
19995985|NCT02115581|Micronutrients|micronutrients|mesh-ancestor
19995986|NCT02115581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995987|NCT02115581|Vitamins|vitamins|mesh-ancestor
19995988|NCT02115750|Etanercept|etanercept|mesh-list
19995989|NCT02115750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19995990|NCT02115750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19995991|NCT02115750|Analgesics|analgesics|mesh-ancestor
19995992|NCT02115750|Sensory System Agents|sensory system agents|mesh-ancestor
19995993|NCT02115750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19995994|NCT02115750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19995995|NCT02115750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19995996|NCT02115750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19995997|NCT02115750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19995998|NCT02115750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19995999|NCT02115750|Immunologic Factors|immunologic factors|mesh-ancestor
19996000|NCT02116205|Vaccines|vaccines|mesh-list
19996001|NCT02116205|Immunologic Factors|immunologic factors|mesh-ancestor
19996002|NCT02116205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996003|NCT02116309|Indomethacin|indomethacin|mesh-list
19996004|NCT02116309|Epinephrine|epinephrine|mesh-list
19996005|NCT02116309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19996006|NCT02116309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19996007|NCT02116309|Adrenergic Agents|adrenergic agents|mesh-ancestor
19996008|NCT02116309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19996009|NCT02116309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996010|NCT02116309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996011|NCT02116309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19996012|NCT02116309|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19996013|NCT02116309|Autonomic Agents|autonomic agents|mesh-ancestor
19996014|NCT02116309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19996015|NCT02116309|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19996016|NCT02116309|Respiratory System Agents|respiratory system agents|mesh-ancestor
19996017|NCT02116309|Mydriatics|mydriatics|mesh-ancestor
19996018|NCT02116309|Sympathomimetics|sympathomimetics|mesh-ancestor
19996019|NCT02116309|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19996020|NCT02116309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19996021|NCT02116309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19996022|NCT02116309|Analgesics|analgesics|mesh-ancestor
19996023|NCT02116309|Sensory System Agents|sensory system agents|mesh-ancestor
19996024|NCT02116309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19996025|NCT02116309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19996026|NCT02116309|Gout Suppressants|gout suppressants|mesh-ancestor
19996027|NCT02116309|Tocolytic Agents|tocolytic agents|mesh-ancestor
19996028|NCT02116309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19996029|NCT02116309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19996030|NCT02116309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996031|NCT02116361|Botulinum Toxins|botulinum toxins|mesh-list
19996032|NCT02116361|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19996033|NCT02116361|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19996034|NCT02116361|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19996035|NCT02116361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19996036|NCT02116361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996037|NCT02116361|Cholinergic Agents|cholinergic agents|mesh-ancestor
19996038|NCT02116361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19996039|NCT02116361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996040|NCT02116361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19996041|NCT02116361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19996042|NCT02116530|Dexamethasone|dexamethasone|mesh-list
19996043|NCT02116530|Cyclophosphamide|cyclophosphamide|mesh-list
19996044|NCT02116530|Doxorubicin|doxorubicin|mesh-list
19996045|NCT02116530|Ondansetron|ondansetron|mesh-list
19996046|NCT02116530|Olanzapine|olanzapine|mesh-list
19996047|NCT02116530|Aprepitant|aprepitant|mesh-list
19996048|NCT02116530|Fosaprepitant|fosaprepitant|mesh-list
19996049|NCT02116530|Palonosetron|palonosetron|mesh-list
19996050|NCT02116530|Granisetron|granisetron|mesh-list
19996051|NCT02116530|Antiemetics|antiemetics|mesh-list
19996052|NCT02116530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19996053|NCT02116530|Immunologic Factors|immunologic factors|mesh-ancestor
19996054|NCT02116530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996055|NCT02116530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19996056|NCT02116530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19996057|NCT02116530|Alkylating Agents|alkylating agents|mesh-ancestor
19996058|NCT02116530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996059|NCT02116530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996060|NCT02116530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19996061|NCT02116530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19996062|NCT02116530|Autonomic Agents|autonomic agents|mesh-ancestor
19996063|NCT02116530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19996064|NCT02116530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19996065|NCT02116530|Glucocorticoids|glucocorticoids|mesh-ancestor
19996066|NCT02116530|Hormones|hormones|mesh-ancestor
19996067|NCT02116530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19996068|NCT02116530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19996069|NCT02116530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19996070|NCT02116530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19996071|NCT02116530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19996072|NCT02116530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996073|NCT02116530|Antipruritics|antipruritics|mesh-ancestor
19996074|NCT02116530|Dermatologic Agents|dermatologic agents|mesh-ancestor
19996075|NCT02116530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19996076|NCT02116530|Serotonin Agents|serotonin agents|mesh-ancestor
19996077|NCT02116530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19996078|NCT02116530|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19996079|NCT02116530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19996080|NCT02116530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19996081|NCT02116530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19996082|NCT02116530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19996083|NCT02116530|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19996084|NCT02116530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19996085|NCT02116530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19996086|NCT02116530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
19996087|NCT02116530|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19996088|NCT02116608|Povidone-Iodine|povidone-iodine|mesh-list
19996089|NCT02116608|Silver Nitrate|silver nitrate|mesh-list
19996090|NCT02116608|Hydrocortisone|hydrocortisone|mesh-list
19996091|NCT02116608|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
19996092|NCT02116608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19996093|NCT02116608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19996094|NCT02116608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996095|NCT02116608|Dermatologic Agents|dermatologic agents|mesh-ancestor
19996096|NCT02116660|Ritonavir|ritonavir|mesh-list
19996097|NCT02116660|Lopinavir|lopinavir|mesh-list
19996098|NCT02116660|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19996099|NCT02116660|Darunavir|darunavir|mesh-list
19996100|NCT02116660|Tenofovir|tenofovir|mesh-list
19996101|NCT02116660|Lamivudine|lamivudine|mesh-list
19996102|NCT02116660|Emtricitabine|emtricitabine|mesh-list
19996103|NCT02116660|Raltegravir Potassium|raltegravir potassium|mesh-list
19996104|NCT02116660|Nevirapine|nevirapine|mesh-list
19996105|NCT02116660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19996106|NCT02116660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19996107|NCT02116660|Protease Inhibitors|protease inhibitors|mesh-ancestor
19996108|NCT02116660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996109|NCT02116660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996110|NCT02116660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19996111|NCT02116660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19996112|NCT02116660|Antiviral Agents|antiviral agents|mesh-ancestor
19996113|NCT02116660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996114|NCT02116660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19996115|NCT02116660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19996116|NCT02116660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19996117|NCT02116660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19996118|NCT02116660|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19996119|NCT02116660|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19996120|NCT02116660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19996121|NCT02116660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19996122|NCT02116777|Temozolomide|temozolomide|mesh-list
19996123|NCT02116777|Talazoparib|talazoparib|mesh-list
19996124|NCT02116777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19996125|NCT02116777|Alkylating Agents|alkylating agents|mesh-ancestor
19996126|NCT02116777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996127|NCT02116777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996128|NCT02116777|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19996129|NCT02116777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996130|NCT02116803|Fulvestrant|fulvestrant|mesh-list
19996131|NCT02116803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19996132|NCT02116803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996133|NCT02116803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19996134|NCT02116803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19996135|NCT02116803|Hormone Antagonists|hormone antagonists|mesh-ancestor
19996136|NCT02116803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19996137|NCT02116803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996138|NCT02116972|FX006|fx006|mesh-list
19996139|NCT02116972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19996140|NCT02116972|Glucocorticoids|glucocorticoids|mesh-ancestor
19996141|NCT02116972|Hormones|hormones|mesh-ancestor
19996142|NCT02116972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19996143|NCT02116972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996144|NCT02116972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19996145|NCT02116972|Immunologic Factors|immunologic factors|mesh-ancestor
19996146|NCT02117024|Gemcitabine|gemcitabine|mesh-list
19996147|NCT02117024|Paclitaxel|paclitaxel|mesh-list
19996148|NCT02117024|Vinorelbine|vinorelbine|mesh-list
19996149|NCT02117024|Docetaxel|docetaxel|mesh-list
19996150|NCT02117024|Cyclophosphamide|cyclophosphamide|mesh-list
19996151|NCT02117024|Pemetrexed|pemetrexed|mesh-list
19996152|NCT02117024|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19996153|NCT02117024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19996154|NCT02117024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996155|NCT02117024|Tubulin Modulators|tubulin modulators|mesh-ancestor
19996156|NCT02117024|Antimitotic Agents|antimitotic agents|mesh-ancestor
19996157|NCT02117024|Mitosis Modulators|mitosis modulators|mesh-ancestor
19996158|NCT02117024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996159|NCT02117024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19996160|NCT02117024|Immunologic Factors|immunologic factors|mesh-ancestor
19996161|NCT02117024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996162|NCT02117024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19996163|NCT02117024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19996164|NCT02117024|Alkylating Agents|alkylating agents|mesh-ancestor
19996165|NCT02117024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19996166|NCT02117024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19996167|NCT02117024|Antimetabolites|antimetabolites|mesh-ancestor
19996168|NCT02117024|Antiviral Agents|antiviral agents|mesh-ancestor
19996169|NCT02117024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996170|NCT02117024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996171|NCT02117024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19996172|NCT02117024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19996173|NCT02117024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19996174|NCT02117349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19996175|NCT02117349|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
19996176|NCT02117349|Hemostatics|hemostatics|mesh-ancestor
19996177|NCT02117349|Coagulants|coagulants|mesh-ancestor
19996178|NCT02117479|Capecitabine|capecitabine|mesh-list
19996179|NCT02117479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19996180|NCT02117479|Antimetabolites|antimetabolites|mesh-ancestor
19996181|NCT02117479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996182|NCT02117479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996183|NCT02117570|Vaccines|vaccines|mesh-list
19996184|NCT02117570|Immunologic Factors|immunologic factors|mesh-ancestor
19996185|NCT02117570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996186|NCT02117648|Clarithromycin|clarithromycin|mesh-list
19996187|NCT02117648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19996188|NCT02117648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996189|NCT02117648|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19996190|NCT02117648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996191|NCT02117648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996192|NCT02117648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19996193|NCT02117648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19996194|NCT02117687|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19996195|NCT02117687|Hyaluronic Acid|hyaluronic acid|mesh-list
19996196|NCT02117687|Glycerol|glycerol|mesh-list
19996197|NCT02117687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19996198|NCT02117687|Immunologic Factors|immunologic factors|mesh-ancestor
19996199|NCT02117687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996200|NCT02117687|Viscosupplements|viscosupplements|mesh-ancestor
19996201|NCT02117687|Protective Agents|protective agents|mesh-ancestor
19996202|NCT02117687|Laxatives|laxatives|mesh-ancestor
19996203|NCT02117687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19996204|NCT02117687|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
19996205|NCT02117934|Vaccines|vaccines|mesh-list
19996206|NCT02117934|Immunologic Factors|immunologic factors|mesh-ancestor
19996207|NCT02117934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996208|NCT02118012|Ribavirin|ribavirin|mesh-list
19996209|NCT02118012|Antimetabolites|antimetabolites|mesh-ancestor
19996210|NCT02118012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996211|NCT02118012|Antiviral Agents|antiviral agents|mesh-ancestor
19996212|NCT02118012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996213|NCT02118337|Nivolumab|nivolumab|mesh-list
19996214|NCT02118337|Durvalumab|durvalumab|mesh-list
20556662|NCT01948232|Perindopril|perindopril|mesh-list
19996215|NCT02118337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19996216|NCT02118337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996217|NCT02118337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19996218|NCT02118337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996219|NCT02118597|Interferons|interferons|mesh-list
19996220|NCT02118597|Ribavirin|ribavirin|mesh-list
19996221|NCT02118597|Simeprevir|simeprevir|mesh-list
19996222|NCT02118597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996223|NCT02118597|Antiviral Agents|antiviral agents|mesh-ancestor
19996224|NCT02118597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996225|NCT02118597|Antimetabolites|antimetabolites|mesh-ancestor
19996226|NCT02118597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996227|NCT02118597|Protease Inhibitors|protease inhibitors|mesh-ancestor
19996228|NCT02118597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996229|NCT02118714|Atrasentan|atrasentan|mesh-list
19996230|NCT02118714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996231|NCT02118714|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
19996232|NCT02118714|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
19996233|NCT02118714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996234|NCT02118831|Bevacizumab|bevacizumab|mesh-list
19996235|NCT02118831|Ranibizumab|ranibizumab|mesh-list
19996236|NCT02118831|Aflibercept|aflibercept|mesh-list
19996237|NCT02118831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19996238|NCT02118831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996239|NCT02118831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19996240|NCT02118831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19996241|NCT02118831|Growth Substances|growth substances|mesh-ancestor
19996242|NCT02118831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996243|NCT02118831|Growth Inhibitors|growth inhibitors|mesh-ancestor
19996244|NCT02118896|Tacrolimus|tacrolimus|mesh-list
19996245|NCT02118896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19996246|NCT02118896|Immunologic Factors|immunologic factors|mesh-ancestor
19996247|NCT02118896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996248|NCT02118896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19996249|NCT02118896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996250|NCT02118896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996251|NCT02118961|Vaccines|vaccines|mesh-list
19996252|NCT02118961|Immunologic Factors|immunologic factors|mesh-ancestor
19996253|NCT02118961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996254|NCT02119026|Bevacizumab|bevacizumab|mesh-list
19996255|NCT02119026|Capecitabine|capecitabine|mesh-list
19996256|NCT02119026|Oxaliplatin|oxaliplatin|mesh-list
19996257|NCT02119026|Irinotecan|irinotecan|mesh-list
19996258|NCT02119026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19996259|NCT02119026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996260|NCT02119026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19996261|NCT02119026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19996262|NCT02119026|Growth Substances|growth substances|mesh-ancestor
19996263|NCT02119026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996264|NCT02119026|Growth Inhibitors|growth inhibitors|mesh-ancestor
19996265|NCT02119026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19996266|NCT02119026|Antimetabolites|antimetabolites|mesh-ancestor
19996267|NCT02119026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996268|NCT02119026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19996269|NCT02119026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19996270|NCT02119026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996271|NCT02119104|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19996272|NCT02119104|Immunologic Factors|immunologic factors|mesh-ancestor
19996273|NCT02119104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996274|NCT02119156|Belimumab|belimumab|mesh-list
19996275|NCT02119156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19996276|NCT02119156|Immunologic Factors|immunologic factors|mesh-ancestor
19996277|NCT02119156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996278|NCT02119260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19996279|NCT02119650|Pemetrexed|pemetrexed|mesh-list
19996280|NCT02119650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996281|NCT02119650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996282|NCT02119650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996283|NCT02119650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19996284|NCT02119650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19996285|NCT02119663|Capecitabine|capecitabine|mesh-list
19996286|NCT02119663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19996287|NCT02119663|Antimetabolites|antimetabolites|mesh-ancestor
19996288|NCT02119663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996289|NCT02119663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996290|NCT02119819|Metformin|metformin|mesh-list
19996291|NCT02119819|Exenatide|exenatide|mesh-list
19996292|NCT02119819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19996293|NCT02119819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996294|NCT02119819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19996295|NCT02119819|Incretins|incretins|mesh-ancestor
19996296|NCT02119819|Hormones|hormones|mesh-ancestor
19996297|NCT02119819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19996298|NCT02120157|Mycophenolic Acid|mycophenolic acid|mesh-list
19996299|NCT02120157|Cyclophosphamide|cyclophosphamide|mesh-list
19996300|NCT02120157|Busulfan|busulfan|mesh-list
19996301|NCT02120157|Tacrolimus|tacrolimus|mesh-list
19996302|NCT02120157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19996303|NCT02120157|Immunologic Factors|immunologic factors|mesh-ancestor
19996304|NCT02120157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996305|NCT02120157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19996306|NCT02120157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19996307|NCT02120157|Alkylating Agents|alkylating agents|mesh-ancestor
19996308|NCT02120157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996309|NCT02120157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996310|NCT02120157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19996311|NCT02120157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19996312|NCT02120157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996313|NCT02120157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19996314|NCT02120157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19996315|NCT02120157|Antitubercular Agents|antitubercular agents|mesh-ancestor
19996316|NCT02120157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19996317|NCT02120157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996318|NCT02120261|Triamcinolone|triamcinolone|mesh-list
19996319|NCT02120261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19996320|NCT02120261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19996321|NCT02120261|Lidocaine|lidocaine|mesh-list
19996322|NCT02120261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19996323|NCT02120261|Anesthetics, Local|anesthetics, local|mesh-ancestor
19996324|NCT02120261|Anesthetics|anesthetics|mesh-ancestor
19996325|NCT02120261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19996326|NCT02120261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996327|NCT02120261|Sensory System Agents|sensory system agents|mesh-ancestor
19996328|NCT02120261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19996329|NCT02120261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19996330|NCT02120261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19996331|NCT02120261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19996332|NCT02120261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19996333|NCT02120261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996334|NCT02120261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19996335|NCT02120261|Glucocorticoids|glucocorticoids|mesh-ancestor
19996336|NCT02120261|Hormones|hormones|mesh-ancestor
19996337|NCT02120261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19996338|NCT02120261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19996339|NCT02120261|Immunologic Factors|immunologic factors|mesh-ancestor
19996340|NCT02120261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996341|NCT02120287|Bevacizumab|bevacizumab|mesh-list
19996342|NCT02120287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19996343|NCT02120287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996344|NCT02120287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19996345|NCT02120287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19996346|NCT02120287|Growth Substances|growth substances|mesh-ancestor
19996347|NCT02120287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996348|NCT02120287|Growth Inhibitors|growth inhibitors|mesh-ancestor
19996349|NCT02120300|Sofosbuvir|sofosbuvir|mesh-list
19996350|NCT02120300|Antiviral Agents|antiviral agents|mesh-ancestor
19996351|NCT02120300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996352|NCT02120417|Capecitabine|capecitabine|mesh-list
19996353|NCT02120417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19996354|NCT02120417|Antimetabolites|antimetabolites|mesh-ancestor
19996355|NCT02120417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996356|NCT02120417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996357|NCT02120664|Corticosterone|corticosterone|mesh-list
19996358|NCT02120664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19996359|NCT02120794|Insulin|insulin|mesh-list
19996360|NCT02120794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19996361|NCT02120794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996362|NCT02120833|Decanoic acid|decanoic acid|mesh-list
19996363|NCT02120833|Antifungal Agents|antifungal agents|mesh-ancestor
19996364|NCT02120833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996365|NCT02120898|Imiquimod|imiquimod|mesh-list
19996366|NCT02120898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19996367|NCT02120898|Immunologic Factors|immunologic factors|mesh-ancestor
19996368|NCT02120898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996369|NCT02120898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996370|NCT02120898|Interferon Inducers|interferon inducers|mesh-ancestor
19996371|NCT02120924|Azelaic acid|azelaic acid|mesh-list
19996372|NCT02120924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996373|NCT02120924|Dermatologic Agents|dermatologic agents|mesh-ancestor
19996374|NCT02120950|Aflibercept|aflibercept|mesh-list
19996375|NCT02120950|Verteporfin|verteporfin|mesh-list
19996376|NCT02120950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19996377|NCT02120950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19996378|NCT02120950|Growth Substances|growth substances|mesh-ancestor
19996379|NCT02120950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996380|NCT02120950|Growth Inhibitors|growth inhibitors|mesh-ancestor
19996381|NCT02120950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996382|NCT02120950|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19996383|NCT02120950|Dermatologic Agents|dermatologic agents|mesh-ancestor
19996384|NCT02121002|Diclofenac|diclofenac|mesh-list
19996385|NCT02121002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19996386|NCT02121002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19996387|NCT02121002|Analgesics|analgesics|mesh-ancestor
19996388|NCT02121002|Sensory System Agents|sensory system agents|mesh-ancestor
19996389|NCT02121002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19996390|NCT02121002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996391|NCT02121002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19996392|NCT02121002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19996393|NCT02121002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19996394|NCT02121002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996395|NCT02121002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996396|NCT02121041|Losartan|losartan|mesh-list
19996397|NCT02121041|Amlodipine|amlodipine|mesh-list
19996398|NCT02121041|Chlorthalidone|chlorthalidone|mesh-list
19996399|NCT02121041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19996400|NCT02121041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19996401|NCT02121041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19996402|NCT02121041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996403|NCT02121041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19996404|NCT02121041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996405|NCT02121041|Vasodilator Agents|vasodilator agents|mesh-ancestor
19996406|NCT02121041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19996407|NCT02121041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19996408|NCT02121041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19996409|NCT02121041|Diuretics|diuretics|mesh-ancestor
19996410|NCT02121041|Natriuretic Agents|natriuretic agents|mesh-ancestor
19996411|NCT02121041|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
19996412|NCT02121067|Levonorgestrel|levonorgestrel|mesh-list
19996413|NCT02121067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19996414|NCT02121067|Contraceptive Agents|contraceptive agents|mesh-ancestor
19996415|NCT02121067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19996416|NCT02121067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996417|NCT02121067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19996418|NCT02121067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19996419|NCT02121067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19996420|NCT02121262|Dexamethasone|dexamethasone|mesh-list
19996421|NCT02121262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19996422|NCT02121262|Antiemetics|antiemetics|mesh-ancestor
19996423|NCT02121262|Autonomic Agents|autonomic agents|mesh-ancestor
19996424|NCT02121262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19996425|NCT02121262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996426|NCT02121262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19996427|NCT02121262|Glucocorticoids|glucocorticoids|mesh-ancestor
19996428|NCT02121262|Hormones|hormones|mesh-ancestor
19996429|NCT02121262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19996430|NCT02121262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19996431|NCT02121262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996432|NCT02121301|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19996433|NCT02121301|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19996434|NCT02121392|Bupivacaine|bupivacaine|mesh-list
19996435|NCT02121392|Anesthetics, Local|anesthetics, local|mesh-ancestor
19996436|NCT02121392|Anesthetics|anesthetics|mesh-ancestor
19996437|NCT02121392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19996438|NCT02121392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996439|NCT02121392|Sensory System Agents|sensory system agents|mesh-ancestor
19996440|NCT02121392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19996441|NCT02121418|Cytarabine|cytarabine|mesh-list
19996442|NCT02121418|Decitabine|decitabine|mesh-list
19996443|NCT02121418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19996444|NCT02121418|Antimetabolites|antimetabolites|mesh-ancestor
19996445|NCT02121418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996446|NCT02121418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996447|NCT02121418|Antiviral Agents|antiviral agents|mesh-ancestor
19996448|NCT02121418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996449|NCT02121418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19996450|NCT02121418|Immunologic Factors|immunologic factors|mesh-ancestor
19996451|NCT02121418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996452|NCT02121418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996453|NCT02121483|Empagliflozin|empagliflozin|mesh-list
19996454|NCT02121483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19996455|NCT02121483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996456|NCT02121483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19996457|NCT02121483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996458|NCT02121509|Metformin|metformin|mesh-list
19996459|NCT02121509|Linagliptin|linagliptin|mesh-list
19996460|NCT02121509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19996461|NCT02121509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996462|NCT02121509|Incretins|incretins|mesh-ancestor
19996463|NCT02121509|Hormones|hormones|mesh-ancestor
19996464|NCT02121509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19996465|NCT02121509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19996466|NCT02121509|Protease Inhibitors|protease inhibitors|mesh-ancestor
19996467|NCT02121509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996468|NCT02121509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996469|NCT02121756|Dipyridamole|dipyridamole|mesh-list
19996470|NCT02121756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19996471|NCT02121756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996472|NCT02121756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996473|NCT02121756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19996474|NCT02121756|Vasodilator Agents|vasodilator agents|mesh-ancestor
19996475|NCT02121795|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19996476|NCT02121795|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19996477|NCT02121795|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19996478|NCT02121795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19996479|NCT02121795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996480|NCT02121795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996481|NCT02121795|Antiviral Agents|antiviral agents|mesh-ancestor
19996482|NCT02121795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996483|NCT02121795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19996484|NCT02121847|Cyclosporine|cyclosporine|mesh-list
19996485|NCT02121847|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19996486|NCT02121847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19996487|NCT02121847|Lubricant Eye Drops|lubricant eye drops|mesh-list
19996488|NCT02121847|Cyclosporins|cyclosporins|mesh-list
19996489|NCT02121847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996490|NCT02121847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996491|NCT02121847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19996492|NCT02121847|Immunologic Factors|immunologic factors|mesh-ancestor
19996493|NCT02121847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996494|NCT02121847|Antifungal Agents|antifungal agents|mesh-ancestor
19996495|NCT02121847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996496|NCT02121847|Dermatologic Agents|dermatologic agents|mesh-ancestor
19996497|NCT02121847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19996498|NCT02121847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19996499|NCT02121847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19996500|NCT02121847|Laxatives|laxatives|mesh-ancestor
19996501|NCT02121847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19996502|NCT02122380|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
19996503|NCT02122380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19996504|NCT02122380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996505|NCT02122380|Incretins|incretins|mesh-ancestor
19996506|NCT02122380|Hormones|hormones|mesh-ancestor
19996507|NCT02122380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19996508|NCT02122380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19996509|NCT02122380|Protease Inhibitors|protease inhibitors|mesh-ancestor
19996510|NCT02122380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996511|NCT02122380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289529|NCT04657068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289530|NCT04657068|Antiviral Agents|antiviral agents|mesh-ancestor
20289531|NCT04657068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20289532|NCT04657068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289533|NCT04657068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20289534|NCT04657068|Immunologic Factors|immunologic factors|mesh-ancestor
20289535|NCT04657068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289536|NCT04657068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20289537|NCT04657068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20289538|NCT04657068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20289539|NCT04657003|Tirzepatide|tirzepatide|mesh-list
20289540|NCT04657003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20289541|NCT04657003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289542|NCT04657003|Incretins|incretins|mesh-ancestor
20289543|NCT04657003|Hormones|hormones|mesh-ancestor
20289544|NCT04657003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20289545|NCT04655976|Docetaxel|docetaxel|mesh-list
20289546|NCT04655976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289547|NCT04655976|Tubulin Modulators|tubulin modulators|mesh-ancestor
20289548|NCT04655976|Antimitotic Agents|antimitotic agents|mesh-ancestor
20289549|NCT04655976|Mitosis Modulators|mitosis modulators|mesh-ancestor
20289550|NCT04655976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289551|NCT04647435|Tramadol|tramadol|mesh-list
20289552|NCT04647435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20289553|NCT04647435|Narcotics|narcotics|mesh-ancestor
20289554|NCT04647435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20289555|NCT04647435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289556|NCT04647435|Analgesics|analgesics|mesh-ancestor
20289557|NCT04647435|Sensory System Agents|sensory system agents|mesh-ancestor
20289558|NCT04647435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20289559|NCT04645966|Acetaminophen|acetaminophen|mesh-list
20289560|NCT04645966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20289561|NCT04645966|Analgesics|analgesics|mesh-ancestor
20289562|NCT04645966|Sensory System Agents|sensory system agents|mesh-ancestor
20289563|NCT04645966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20289564|NCT04645966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289565|NCT04645966|Antipyretics|antipyretics|mesh-ancestor
20289566|NCT04644029|Tenofovir|tenofovir|mesh-list
20289567|NCT04644029|Emtricitabine|emtricitabine|mesh-list
20289568|NCT04644029|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20289569|NCT04644029|Islatravir|islatravir|mesh-list
20289570|NCT04644029|Antiviral Agents|antiviral agents|mesh-ancestor
20289571|NCT04644029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20289572|NCT04644029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20289573|NCT04644029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20289574|NCT04644029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289575|NCT04644029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289576|NCT04644029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20289577|NCT04644029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20289578|NCT04642651|Dexmedetomidine|dexmedetomidine|mesh-list
20289579|NCT04642651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20289580|NCT04642651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20289581|NCT04642651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289582|NCT04642651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20289583|NCT04642651|Analgesics|analgesics|mesh-ancestor
20289584|NCT04642651|Sensory System Agents|sensory system agents|mesh-ancestor
20289585|NCT04642651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20289586|NCT04642651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20289587|NCT04642651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20289588|NCT04642651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20289589|NCT04642651|Adrenergic Agents|adrenergic agents|mesh-ancestor
20556663|NCT01948232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
19996512|NCT02122471|Plecanatide|plecanatide|mesh-list
19996513|NCT02122471|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
19996514|NCT02122471|Enzyme Activators|enzyme activators|mesh-ancestor
19996515|NCT02122471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996516|NCT02122471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19996517|NCT02122770|Itraconazole|itraconazole|mesh-list
19996518|NCT02122770|Fluconazole|fluconazole|mesh-list
19996519|NCT02122770|Paclitaxel|paclitaxel|mesh-list
19996520|NCT02122770|Docetaxel|docetaxel|mesh-list
19996521|NCT02122770|Carboplatin|carboplatin|mesh-list
19996522|NCT02122770|Pevonedistat|pevonedistat|mesh-list
19996523|NCT02122770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19996524|NCT02122770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996525|NCT02122770|Tubulin Modulators|tubulin modulators|mesh-ancestor
19996526|NCT02122770|Antimitotic Agents|antimitotic agents|mesh-ancestor
19996527|NCT02122770|Mitosis Modulators|mitosis modulators|mesh-ancestor
19996528|NCT02122770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996529|NCT02122770|Antifungal Agents|antifungal agents|mesh-ancestor
19996530|NCT02122770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996531|NCT02122770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19996532|NCT02122770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19996533|NCT02122770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996534|NCT02122770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19996535|NCT02122770|Hormone Antagonists|hormone antagonists|mesh-ancestor
19996536|NCT02122770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19996537|NCT02122770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996538|NCT02122770|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19996539|NCT02122770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19996540|NCT02122770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19996541|NCT02123017|Lactulose|lactulose|mesh-list
19996542|NCT02123017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19996543|NCT02123134|Deoxycholic Acid|deoxycholic acid|mesh-list
19996544|NCT02123134|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19996545|NCT02123134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19996546|NCT02123446|Cephalexin|cephalexin|mesh-list
19996547|NCT02123446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19996548|NCT02123446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996549|NCT02123459|Cephalexin|cephalexin|mesh-list
19996550|NCT02123459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19996551|NCT02123459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996552|NCT02123472|Cephalexin|cephalexin|mesh-list
19996553|NCT02123472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19996554|NCT02123472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996555|NCT02123511|Acetylcysteine|acetylcysteine|mesh-list
19996556|NCT02123511|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19996557|NCT02123511|Antiviral Agents|antiviral agents|mesh-ancestor
19996558|NCT02123511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996559|NCT02123511|Expectorants|expectorants|mesh-ancestor
19996560|NCT02123511|Respiratory System Agents|respiratory system agents|mesh-ancestor
19996561|NCT02123511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19996562|NCT02123511|Antioxidants|antioxidants|mesh-ancestor
19996563|NCT02123511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996564|NCT02123511|Protective Agents|protective agents|mesh-ancestor
19996565|NCT02123511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996566|NCT02123511|Antidotes|antidotes|mesh-ancestor
19996567|NCT02123576|Pentoxifylline|pentoxifylline|mesh-list
19996568|NCT02123576|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19996569|NCT02123576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996570|NCT02123576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996571|NCT02123576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19996572|NCT02123576|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19996573|NCT02123576|Protective Agents|protective agents|mesh-ancestor
19996574|NCT02123576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996575|NCT02123576|Vasodilator Agents|vasodilator agents|mesh-ancestor
19996576|NCT02123576|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19996577|NCT02123576|Antioxidants|antioxidants|mesh-ancestor
19996578|NCT02123849|Aspirin|aspirin|mesh-list
19996579|NCT02123849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19996580|NCT02123849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19996581|NCT02123849|Analgesics|analgesics|mesh-ancestor
19996582|NCT02123849|Sensory System Agents|sensory system agents|mesh-ancestor
19996583|NCT02123849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19996584|NCT02123849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996585|NCT02123849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19996586|NCT02123849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19996587|NCT02123849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19996588|NCT02123849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19996589|NCT02123849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996590|NCT02123849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19996591|NCT02123849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19996592|NCT02123849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996593|NCT02123849|Antipyretics|antipyretics|mesh-ancestor
19996594|NCT02123966|Sirolimus|sirolimus|mesh-list
19996595|NCT02123966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19996596|NCT02123966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996597|NCT02123966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19996598|NCT02123966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996599|NCT02123966|Antifungal Agents|antifungal agents|mesh-ancestor
19996600|NCT02123966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19996601|NCT02123966|Immunologic Factors|immunologic factors|mesh-ancestor
19996602|NCT02123966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996603|NCT02124044|Asunaprevir|asunaprevir|mesh-list
19996604|NCT02124044|Protease Inhibitors|protease inhibitors|mesh-ancestor
19996605|NCT02124044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996606|NCT02124044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996607|NCT02124083|Vorinostat|vorinostat|mesh-list
19996608|NCT02124083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996609|NCT02124083|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
19996610|NCT02124083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996611|NCT02124083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996612|NCT02124161|Vaccines|vaccines|mesh-list
19996613|NCT02124161|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19996614|NCT02124161|Immunologic Factors|immunologic factors|mesh-ancestor
19996615|NCT02124161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996616|NCT02124512|Rifaximin|rifaximin|mesh-list
19996617|NCT02124512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19996618|NCT02124512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996619|NCT02124512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19996620|NCT02124564|Lacosamide|lacosamide|mesh-list
19996621|NCT02124564|Anticonvulsants|anticonvulsants|mesh-ancestor
19996622|NCT02124564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19996623|NCT02124564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19996624|NCT02124564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19996625|NCT02124564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996626|NCT02124707|Paclitaxel|paclitaxel|mesh-list
19996627|NCT02124707|Carboplatin|carboplatin|mesh-list
19996628|NCT02124707|Cetuximab|cetuximab|mesh-list
19996629|NCT02124707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19996630|NCT02124707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996631|NCT02124707|Tubulin Modulators|tubulin modulators|mesh-ancestor
19996632|NCT02124707|Antimitotic Agents|antimitotic agents|mesh-ancestor
19996633|NCT02124707|Mitosis Modulators|mitosis modulators|mesh-ancestor
19996634|NCT02124707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996635|NCT02124707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19996636|NCT02124746|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
19996637|NCT02124746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19996638|NCT02124746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996639|NCT02124746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996640|NCT02124759|Sevelamer|sevelamer|mesh-list
19996641|NCT02124759|Chelating Agents|chelating agents|mesh-ancestor
19996642|NCT02124759|Sequestering Agents|sequestering agents|mesh-ancestor
19996643|NCT02124759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996644|NCT02124772|Trametinib|trametinib|mesh-list
19996645|NCT02124772|Dabrafenib|dabrafenib|mesh-list
19996646|NCT02124772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996647|NCT02124772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19996648|NCT02124772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996649|NCT02124772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996650|NCT02124798|Belimumab|belimumab|mesh-list
19996651|NCT02124798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19996652|NCT02124798|Immunologic Factors|immunologic factors|mesh-ancestor
19996653|NCT02124798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996654|NCT02124811|Minocycline|minocycline|mesh-list
19996655|NCT02124811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19996656|NCT02124811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996657|NCT02125279|Calcitriol|calcitriol|mesh-list
19996658|NCT02125279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19996659|NCT02125279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996660|NCT02125279|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20556664|NCT01948232|Protease Inhibitors|protease inhibitors|mesh-ancestor
19996661|NCT02125279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19996662|NCT02125279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996663|NCT02125279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19996664|NCT02125279|Vitamins|vitamins|mesh-ancestor
19996665|NCT02125279|Micronutrients|micronutrients|mesh-ancestor
19996666|NCT02125279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19996667|NCT02125292|Mesalamine|mesalamine|mesh-list
19996668|NCT02125292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19996669|NCT02125292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19996670|NCT02125292|Analgesics|analgesics|mesh-ancestor
19996671|NCT02125292|Sensory System Agents|sensory system agents|mesh-ancestor
19996672|NCT02125292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19996673|NCT02125292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996674|NCT02125292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19996675|NCT02125292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19996676|NCT02125604|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19996677|NCT02125604|Dermatologic Agents|dermatologic agents|mesh-ancestor
19996678|NCT02125604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19996679|NCT02125604|Immunologic Factors|immunologic factors|mesh-ancestor
19996680|NCT02125604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996681|NCT02125721|Penicillamine|penicillamine|mesh-list
19996682|NCT02125721|Antidotes|antidotes|mesh-ancestor
19996683|NCT02125721|Protective Agents|protective agents|mesh-ancestor
19996684|NCT02125721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996685|NCT02125721|Chelating Agents|chelating agents|mesh-ancestor
19996686|NCT02125721|Sequestering Agents|sequestering agents|mesh-ancestor
19996687|NCT02125721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996688|NCT02125721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19996689|NCT02125734|Bromides|bromides|mesh-list
19996690|NCT02125734|Tiotropium Bromide|tiotropium bromide|mesh-list
19996691|NCT02125734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19996692|NCT02125734|Autonomic Agents|autonomic agents|mesh-ancestor
19996693|NCT02125734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19996694|NCT02125734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996695|NCT02125734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19996696|NCT02125734|Respiratory System Agents|respiratory system agents|mesh-ancestor
19996697|NCT02125734|Parasympatholytics|parasympatholytics|mesh-ancestor
19996698|NCT02125734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19996699|NCT02125734|Cholinergic Agents|cholinergic agents|mesh-ancestor
19996700|NCT02125734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19996701|NCT02125734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996702|NCT02125734|Anticonvulsants|anticonvulsants|mesh-ancestor
19996703|NCT02125877|Deferasirox|deferasirox|mesh-list
19996704|NCT02125877|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19996705|NCT02125877|Chelating Agents|chelating agents|mesh-ancestor
19996706|NCT02125877|Sequestering Agents|sequestering agents|mesh-ancestor
19996707|NCT02125877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996708|NCT02126839|Albuterol|albuterol|mesh-list
19996709|NCT02126839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19996710|NCT02126839|Autonomic Agents|autonomic agents|mesh-ancestor
19996711|NCT02126839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19996712|NCT02126839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996713|NCT02126839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19996714|NCT02126839|Respiratory System Agents|respiratory system agents|mesh-ancestor
19996715|NCT02126839|Tocolytic Agents|tocolytic agents|mesh-ancestor
19996716|NCT02126839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19996717|NCT02126839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19996718|NCT02126839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19996719|NCT02126839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19996720|NCT02126839|Adrenergic Agents|adrenergic agents|mesh-ancestor
19996721|NCT02126839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19996722|NCT02126839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996723|NCT02126969|Carboplatin|carboplatin|mesh-list
19996724|NCT02126969|Docetaxel|docetaxel|mesh-list
19996725|NCT02126969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996726|NCT02126969|Tubulin Modulators|tubulin modulators|mesh-ancestor
19996727|NCT02126969|Antimitotic Agents|antimitotic agents|mesh-ancestor
19996728|NCT02126969|Mitosis Modulators|mitosis modulators|mesh-ancestor
19996729|NCT02126969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996730|NCT02127125|Sevelamer|sevelamer|mesh-list
19996731|NCT02127125|Chelating Agents|chelating agents|mesh-ancestor
19996732|NCT02127125|Sequestering Agents|sequestering agents|mesh-ancestor
19996733|NCT02127125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996734|NCT02127372|Cisplatin|cisplatin|mesh-list
19996735|NCT02127372|Docetaxel|docetaxel|mesh-list
19996736|NCT02127372|Imatinib Mesylate|imatinib mesylate|mesh-list
19996737|NCT02127372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996738|NCT02127372|Tubulin Modulators|tubulin modulators|mesh-ancestor
19996739|NCT02127372|Antimitotic Agents|antimitotic agents|mesh-ancestor
19996740|NCT02127372|Mitosis Modulators|mitosis modulators|mesh-ancestor
19996741|NCT02127372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996742|NCT02127372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19996743|NCT02127372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996744|NCT02127723|Hyaluronic Acid|hyaluronic acid|mesh-list
19996745|NCT02127723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19996746|NCT02127723|Immunologic Factors|immunologic factors|mesh-ancestor
19996747|NCT02127723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996748|NCT02127723|Viscosupplements|viscosupplements|mesh-ancestor
19996749|NCT02127723|Protective Agents|protective agents|mesh-ancestor
19996750|NCT02127970|Dalbavancin|dalbavancin|mesh-list
19996751|NCT02127970|Teicoplanin|teicoplanin|mesh-list
19996752|NCT02127970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19996753|NCT02127970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996754|NCT02128217|Ribavirin|ribavirin|mesh-list
19996755|NCT02128217|Sofosbuvir|sofosbuvir|mesh-list
19996756|NCT02128217|Ledipasvir|ledipasvir|mesh-list
19996757|NCT02128217|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
19996758|NCT02128217|Antimetabolites|antimetabolites|mesh-ancestor
19996759|NCT02128217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996760|NCT02128217|Antiviral Agents|antiviral agents|mesh-ancestor
19996761|NCT02128217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996762|NCT02128230|Thalidomide|thalidomide|mesh-list
19996763|NCT02128230|Dexamethasone|dexamethasone|mesh-list
19996764|NCT02128230|Dexamethasone acetate|dexamethasone acetate|mesh-list
19996765|NCT02128230|Cyclophosphamide|cyclophosphamide|mesh-list
19996766|NCT02128230|Melphalan|melphalan|mesh-list
19996767|NCT02128230|Cisplatin|cisplatin|mesh-list
19996768|NCT02128230|Doxorubicin|doxorubicin|mesh-list
19996769|NCT02128230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19996770|NCT02128230|Etoposide|etoposide|mesh-list
19996771|NCT02128230|Etoposide phosphate|etoposide phosphate|mesh-list
19996772|NCT02128230|Lenalidomide|lenalidomide|mesh-list
19996773|NCT02128230|Lenograstim|lenograstim|mesh-list
19996774|NCT02128230|BB 1101|bb 1101|mesh-list
19996775|NCT02128230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19996776|NCT02128230|Immunologic Factors|immunologic factors|mesh-ancestor
19996777|NCT02128230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996778|NCT02128230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19996779|NCT02128230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19996780|NCT02128230|Alkylating Agents|alkylating agents|mesh-ancestor
19996781|NCT02128230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996782|NCT02128230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996783|NCT02128230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19996784|NCT02128230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19996785|NCT02128230|Antiemetics|antiemetics|mesh-ancestor
19996786|NCT02128230|Autonomic Agents|autonomic agents|mesh-ancestor
19996787|NCT02128230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19996788|NCT02128230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19996789|NCT02128230|Glucocorticoids|glucocorticoids|mesh-ancestor
19996790|NCT02128230|Hormones|hormones|mesh-ancestor
19996791|NCT02128230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19996792|NCT02128230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20556665|NCT01948232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556666|NCT01948232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556667|NCT01948232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20556668|NCT01948245|Taurolidine|taurolidine|mesh-list
20556669|NCT01948245|Heparin|heparin|mesh-list
20556670|NCT01948245|Calcium heparin|calcium heparin|mesh-list
20556671|NCT01948245|Anticoagulants|anticoagulants|mesh-ancestor
20556672|NCT01948245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556673|NCT01948245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20556674|NCT01948245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20556675|NCT01948245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20556676|NCT01948245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20556677|NCT01948245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556678|NCT01948336|Dexmedetomidine|dexmedetomidine|mesh-list
20556679|NCT01948336|Ketamine|ketamine|mesh-list
20556680|NCT01948336|Propofol|propofol|mesh-list
20556681|NCT01948336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20556682|NCT01948336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19996793|NCT02128230|Protease Inhibitors|protease inhibitors|mesh-ancestor
19996794|NCT02128230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996795|NCT02128230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19996796|NCT02128230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19996797|NCT02128230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19996798|NCT02128230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19996799|NCT02128230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19996800|NCT02128230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19996801|NCT02128230|Growth Substances|growth substances|mesh-ancestor
19996802|NCT02128230|Growth Inhibitors|growth inhibitors|mesh-ancestor
19996803|NCT02128230|Leprostatic Agents|leprostatic agents|mesh-ancestor
19996804|NCT02128230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19996805|NCT02128230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996806|NCT02128230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19996807|NCT02128490|Naproxen|naproxen|mesh-list
19996808|NCT02128490|Colchicine|colchicine|mesh-list
19996809|NCT02128490|Febuxostat|febuxostat|mesh-list
19996810|NCT02128490|Lansoprazole|lansoprazole|mesh-list
19996811|NCT02128490|Dexlansoprazole|dexlansoprazole|mesh-list
19996812|NCT02128490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19996813|NCT02128490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19996814|NCT02128490|Analgesics|analgesics|mesh-ancestor
19996815|NCT02128490|Sensory System Agents|sensory system agents|mesh-ancestor
19996816|NCT02128490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19996817|NCT02128490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996818|NCT02128490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19996819|NCT02128490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19996820|NCT02128490|Gout Suppressants|gout suppressants|mesh-ancestor
19996821|NCT02128490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19996822|NCT02128490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996823|NCT02128490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996824|NCT02128490|Tubulin Modulators|tubulin modulators|mesh-ancestor
19996825|NCT02128490|Antimitotic Agents|antimitotic agents|mesh-ancestor
19996826|NCT02128490|Mitosis Modulators|mitosis modulators|mesh-ancestor
19996827|NCT02128490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996828|NCT02128490|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19996829|NCT02128490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19996830|NCT02128490|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19996831|NCT02128542|Sofosbuvir|sofosbuvir|mesh-list
19996832|NCT02128542|Antiviral Agents|antiviral agents|mesh-ancestor
19996833|NCT02128542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996834|NCT02128828|Cenicriviroc|cenicriviroc|mesh-list
19996835|NCT02128828|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19996836|NCT02128828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996837|NCT02128828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19996838|NCT02128828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19996839|NCT02128828|Antiviral Agents|antiviral agents|mesh-ancestor
19996840|NCT02128828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996841|NCT02128932|Insulin Glargine|insulin glargine|mesh-list
19996842|NCT02128932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19996843|NCT02128932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996844|NCT02129075|Poly I-C|poly i-c|mesh-list
19996845|NCT02129075|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19996846|NCT02129075|Poly ICLC|poly iclc|mesh-list
19996847|NCT02129075|Flt3 ligand protein|flt3 ligand protein|mesh-list
19996848|NCT02129075|Interferon Inducers|interferon inducers|mesh-ancestor
19996849|NCT02129075|Immunologic Factors|immunologic factors|mesh-ancestor
19996850|NCT02129075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996851|NCT02129075|Laxatives|laxatives|mesh-ancestor
19996852|NCT02129075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19996853|NCT02129075|Antiviral Agents|antiviral agents|mesh-ancestor
19996854|NCT02129075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996855|NCT02129075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19996856|NCT02129075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19996857|NCT02129075|Protective Agents|protective agents|mesh-ancestor
19996858|NCT02129192|Amlodipine|amlodipine|mesh-list
19996859|NCT02129192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19996860|NCT02129192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19996861|NCT02129192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19996862|NCT02129192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996863|NCT02129192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19996864|NCT02129192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996865|NCT02129192|Vasodilator Agents|vasodilator agents|mesh-ancestor
19996866|NCT02129426|Midazolam|midazolam|mesh-list
19996867|NCT02129426|Dexmedetomidine|dexmedetomidine|mesh-list
19996868|NCT02129426|Ketamine|ketamine|mesh-list
19996869|NCT02129426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19996870|NCT02129426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19996871|NCT02129426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996872|NCT02129426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19996873|NCT02129426|Analgesics|analgesics|mesh-ancestor
19996874|NCT02129426|Sensory System Agents|sensory system agents|mesh-ancestor
19996875|NCT02129426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19996876|NCT02129426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19996877|NCT02129426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19996878|NCT02129426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19996879|NCT02129426|Adrenergic Agents|adrenergic agents|mesh-ancestor
19996880|NCT02129426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19996881|NCT02129426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996882|NCT02129426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19996883|NCT02129426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19996884|NCT02129426|Anesthetics, General|anesthetics, general|mesh-ancestor
19996885|NCT02129426|Anesthetics|anesthetics|mesh-ancestor
19996886|NCT02129426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19996887|NCT02129426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19996888|NCT02129426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19996889|NCT02129426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19996890|NCT02129426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19996891|NCT02129426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19996892|NCT02129426|GABA Modulators|gaba modulators|mesh-ancestor
19996893|NCT02129426|GABA Agents|gaba agents|mesh-ancestor
19996894|NCT02129478|Olanzapine|olanzapine|mesh-list
19996895|NCT02129478|Antiemetics|antiemetics|mesh-ancestor
19996896|NCT02129478|Autonomic Agents|autonomic agents|mesh-ancestor
19996897|NCT02129478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19996898|NCT02129478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996899|NCT02129478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19996900|NCT02129478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19996901|NCT02129478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19996902|NCT02129478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19996903|NCT02129478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19996904|NCT02129478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19996905|NCT02129478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19996906|NCT02129478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19996907|NCT02129478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996908|NCT02129478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19996909|NCT02129478|Serotonin Agents|serotonin agents|mesh-ancestor
19996910|NCT02129556|Pembrolizumab|pembrolizumab|mesh-list
19996911|NCT02129556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19996912|NCT02129556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996913|NCT02129660|Glycopyrrolate|glycopyrrolate|mesh-list
19996914|NCT02129660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19996915|NCT02129660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19996916|NCT02129660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19996917|NCT02129660|Cholinergic Agents|cholinergic agents|mesh-ancestor
19996918|NCT02129660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19996919|NCT02129660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996920|NCT02129660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996921|NCT02129725|Sildenafil Citrate|sildenafil citrate|mesh-list
19996922|NCT02129725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996923|NCT02129725|Vasodilator Agents|vasodilator agents|mesh-ancestor
19996924|NCT02129725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19996925|NCT02129725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19996926|NCT02129725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996927|NCT02129725|Urological Agents|urological agents|mesh-ancestor
19996928|NCT02130024|Ranibizumab|ranibizumab|mesh-list
19996929|NCT02130024|Aflibercept|aflibercept|mesh-list
19996930|NCT02130024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19996931|NCT02130024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19996932|NCT02130024|Growth Substances|growth substances|mesh-ancestor
19996933|NCT02130024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996934|NCT02130024|Growth Inhibitors|growth inhibitors|mesh-ancestor
19996935|NCT02130024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996936|NCT02130063|Iron|iron|mesh-list
19996937|NCT02130063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19996938|NCT02130063|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
19996939|NCT02130063|Trace Elements|trace elements|mesh-ancestor
19996940|NCT02130063|Micronutrients|micronutrients|mesh-ancestor
19996941|NCT02130063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996942|NCT02130063|Hematinics|hematinics|mesh-ancestor
19996943|NCT02130284|Insulin|insulin|mesh-list
19996944|NCT02130284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19996945|NCT02130284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19996946|NCT02130284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996947|NCT02130557|Imatinib Mesylate|imatinib mesylate|mesh-list
19996948|NCT02130557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996949|NCT02130557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19996950|NCT02130557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996951|NCT02130557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289590|NCT04642651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20289591|NCT04642651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289592|NCT04637594|Pembrolizumab|pembrolizumab|mesh-list
20289593|NCT04637594|Nivolumab|nivolumab|mesh-list
20289594|NCT04637594|Durvalumab|durvalumab|mesh-list
20289595|NCT04637594|Avelumab|avelumab|mesh-list
20289596|NCT04637594|Atezolizumab|atezolizumab|mesh-list
20289597|NCT04637594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20289598|NCT04637594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289599|NCT04637594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20289600|NCT04637594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289601|NCT04637529|Ibuprofen|ibuprofen|mesh-list
20289602|NCT04637529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20289603|NCT04637529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20289604|NCT04637529|Analgesics|analgesics|mesh-ancestor
20289605|NCT04637529|Sensory System Agents|sensory system agents|mesh-ancestor
20289606|NCT04637529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20289607|NCT04637529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289608|NCT04637529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20289609|NCT04637529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20289610|NCT04637529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20289611|NCT04637529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289612|NCT04637529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289613|NCT04635605|Methylene Blue|methylene blue|mesh-list
20289614|NCT04635605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289615|NCT04635605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289616|NCT04629534|Cholecalciferol|cholecalciferol|mesh-list
20289617|NCT04629534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20289618|NCT04629534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289619|NCT04629534|Vitamins|vitamins|mesh-ancestor
20289620|NCT04629534|Micronutrients|micronutrients|mesh-ancestor
20289621|NCT04629534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20289622|NCT04627142|Irinotecan|irinotecan|mesh-list
20289623|NCT04627142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20289624|NCT04627142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20289625|NCT04627142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289626|NCT04627142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289627|NCT04627142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289628|NCT04622904|Lidocaine|lidocaine|mesh-list
20289629|NCT04622904|Ketamine|ketamine|mesh-list
20289630|NCT04622904|Anesthetics, Local|anesthetics, local|mesh-ancestor
20289631|NCT04622904|Anesthetics|anesthetics|mesh-ancestor
20289632|NCT04622904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20289633|NCT04622904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289634|NCT04622904|Sensory System Agents|sensory system agents|mesh-ancestor
20289635|NCT04622904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20289636|NCT04622904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20289637|NCT04622904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20289638|NCT04622904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20289639|NCT04622904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20289640|NCT04622904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289641|NCT04622904|Analgesics|analgesics|mesh-ancestor
20289642|NCT04622904|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20289643|NCT04622904|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20289644|NCT04622904|Anesthetics, General|anesthetics, general|mesh-ancestor
20289645|NCT04622904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20289646|NCT04622904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20289647|NCT04622904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20289648|NCT04608331|Dexmedetomidine|dexmedetomidine|mesh-list
20289649|NCT04608331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20289650|NCT04608331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20289651|NCT04608331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289652|NCT04608331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20289653|NCT04608331|Analgesics|analgesics|mesh-ancestor
20289654|NCT04608331|Sensory System Agents|sensory system agents|mesh-ancestor
19996952|NCT02130635|Nemiralisib|nemiralisib|mesh-list
19996953|NCT02130635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19996954|NCT02130635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996955|NCT02130635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996956|NCT02131064|Carboplatin|carboplatin|mesh-list
19996957|NCT02131064|Docetaxel|docetaxel|mesh-list
19996958|NCT02131064|Trastuzumab|trastuzumab|mesh-list
19996959|NCT02131064|Pertuzumab|pertuzumab|mesh-list
19996960|NCT02131064|Maytansine|maytansine|mesh-list
19996961|NCT02131064|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19996962|NCT02131064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996963|NCT02131064|Tubulin Modulators|tubulin modulators|mesh-ancestor
19996964|NCT02131064|Antimitotic Agents|antimitotic agents|mesh-ancestor
19996965|NCT02131064|Mitosis Modulators|mitosis modulators|mesh-ancestor
19996966|NCT02131064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996967|NCT02131064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19996968|NCT02131064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19996969|NCT02131233|Raltegravir Potassium|raltegravir potassium|mesh-list
19996970|NCT02131233|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
19996971|NCT02131233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19996972|NCT02131233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19996973|NCT02131233|Antiviral Agents|antiviral agents|mesh-ancestor
19996974|NCT02131233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19996975|NCT02131233|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19996976|NCT02131233|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19996977|NCT02131233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996978|NCT02131233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996979|NCT02131233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19996980|NCT02131233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19996981|NCT02131259|Afatinib|afatinib|mesh-list
19996982|NCT02131259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19996983|NCT02131259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19996984|NCT02131259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19996985|NCT02131259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19996986|NCT02131272|Insulin|insulin|mesh-list
19996987|NCT02131272|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19996988|NCT02131272|Insulin Detemir|insulin detemir|mesh-list
19996989|NCT02131272|Isophane Insulin, Human|isophane insulin, human|mesh-list
19996990|NCT02131272|Insulin, Isophane|insulin, isophane|mesh-list
19996991|NCT02131272|Isophane insulin, beef|isophane insulin, beef|mesh-list
19996992|NCT02131272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19996993|NCT02131272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19996994|NCT02131324|Clobetasol|clobetasol|mesh-list
19996995|NCT02131324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19996996|NCT02131324|Glucocorticoids|glucocorticoids|mesh-ancestor
19996997|NCT02131324|Hormones|hormones|mesh-ancestor
19996998|NCT02131324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19996999|NCT02131324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997000|NCT02132117|Phenylephrine|phenylephrine|mesh-list
19997001|NCT02132117|Oxymetazoline|oxymetazoline|mesh-list
19997002|NCT02132117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19997003|NCT02132117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19997004|NCT02132117|Adrenergic Agents|adrenergic agents|mesh-ancestor
19997005|NCT02132117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19997006|NCT02132117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997007|NCT02132117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997008|NCT02132117|Sympathomimetics|sympathomimetics|mesh-ancestor
19997009|NCT02132117|Autonomic Agents|autonomic agents|mesh-ancestor
19997010|NCT02132117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997011|NCT02132117|Nasal Decongestants|nasal decongestants|mesh-ancestor
19997012|NCT02132117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19997013|NCT02132117|Respiratory System Agents|respiratory system agents|mesh-ancestor
19997014|NCT02132117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19997015|NCT02132117|Mydriatics|mydriatics|mesh-ancestor
19997016|NCT02132117|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19997017|NCT02132117|Protective Agents|protective agents|mesh-ancestor
19997018|NCT02132169|Cetirizine|cetirizine|mesh-list
19997019|NCT02132169|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19997020|NCT02132169|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19997021|NCT02132169|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19997022|NCT02132169|Histamine Antagonists|histamine antagonists|mesh-ancestor
19997023|NCT02132169|Histamine Agents|histamine agents|mesh-ancestor
19997024|NCT02132169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19997025|NCT02132169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997026|NCT02132169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997027|NCT02132195|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19997028|NCT02132195|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19997029|NCT02132195|beta-Endorphin|beta-endorphin|mesh-list
19997030|NCT02132195|Hormones|hormones|mesh-ancestor
19997031|NCT02132195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19997032|NCT02132195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997033|NCT02132195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19997034|NCT02132195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997035|NCT02132247|Diclofenac|diclofenac|mesh-list
19997036|NCT02132247|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
19997037|NCT02132247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19997038|NCT02132247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19997039|NCT02132247|Analgesics|analgesics|mesh-ancestor
19997040|NCT02132247|Sensory System Agents|sensory system agents|mesh-ancestor
19997041|NCT02132247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997042|NCT02132247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997043|NCT02132247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19997044|NCT02132247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19997045|NCT02132247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19997046|NCT02132247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19997047|NCT02132247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997048|NCT02132312|Phenylephrine|phenylephrine|mesh-list
19997049|NCT02132312|Oxymetazoline|oxymetazoline|mesh-list
19997050|NCT02132312|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19997051|NCT02132312|Mydriatics|mydriatics|mesh-ancestor
19997052|NCT02132312|Autonomic Agents|autonomic agents|mesh-ancestor
19997053|NCT02132312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997054|NCT02132312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997055|NCT02132312|Sympathomimetics|sympathomimetics|mesh-ancestor
19997056|NCT02132312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19997057|NCT02132312|Nasal Decongestants|nasal decongestants|mesh-ancestor
19997058|NCT02132312|Respiratory System Agents|respiratory system agents|mesh-ancestor
19997059|NCT02132312|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19997060|NCT02132312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19997061|NCT02132312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19997062|NCT02132312|Adrenergic Agents|adrenergic agents|mesh-ancestor
19997063|NCT02132312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19997064|NCT02132312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997065|NCT02132312|Protective Agents|protective agents|mesh-ancestor
19997066|NCT02132468|Fosbretabulin|fosbretabulin|mesh-list
19997067|NCT02132468|Combretastatin|combretastatin|mesh-list
19997068|NCT02132468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19997069|NCT02132468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997070|NCT02132468|Tubulin Modulators|tubulin modulators|mesh-ancestor
19997071|NCT02132468|Antimitotic Agents|antimitotic agents|mesh-ancestor
19997072|NCT02132468|Mitosis Modulators|mitosis modulators|mesh-ancestor
19997073|NCT02132468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997074|NCT02132533|Nifedipine|nifedipine|mesh-list
19997075|NCT02132533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19997076|NCT02132533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19997077|NCT02132533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997078|NCT02132533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19997079|NCT02132533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997080|NCT02132533|Vasodilator Agents|vasodilator agents|mesh-ancestor
19997081|NCT02132533|Tocolytic Agents|tocolytic agents|mesh-ancestor
19997082|NCT02132533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19997083|NCT02132637|Insulin|insulin|mesh-list
19997084|NCT02132637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19997085|NCT02132637|Insulin Glargine|insulin glargine|mesh-list
19997086|NCT02132637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19997087|NCT02132637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997088|NCT02132754|Pembrolizumab|pembrolizumab|mesh-list
19997089|NCT02132754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19997090|NCT02132754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997091|NCT02132767|Digoxin|digoxin|mesh-list
19997092|NCT02132767|Amiodarone|amiodarone|mesh-list
19997093|NCT02132767|Calcium Channel Blockers|calcium channel blockers|mesh-list
19997094|NCT02132767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19997095|NCT02132767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997096|NCT02132767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19997097|NCT02132767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19997098|NCT02132767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19997099|NCT02132767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997100|NCT02132767|Protective Agents|protective agents|mesh-ancestor
19997101|NCT02132767|Vasodilator Agents|vasodilator agents|mesh-ancestor
19997102|NCT02132767|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19997103|NCT02132767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19997104|NCT02132767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19997105|NCT02132767|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19997106|NCT02132767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19997107|NCT02132767|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19997108|NCT02132767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19997109|NCT02132767|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19997110|NCT02132832|Buspirone|buspirone|mesh-list
19997111|NCT02132832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19997112|NCT02132832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19997113|NCT02132832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19997114|NCT02132832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997115|NCT02132832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19997116|NCT02132832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19997117|NCT02132832|Serotonin Agents|serotonin agents|mesh-ancestor
19997118|NCT02132832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19997119|NCT02132832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997120|NCT02132936|Calcipotriene|calcipotriene|mesh-list
19997121|NCT02132936|Dermatologic Agents|dermatologic agents|mesh-ancestor
19997122|NCT02132949|Paclitaxel|paclitaxel|mesh-list
19997123|NCT02132949|Docetaxel|docetaxel|mesh-list
19997124|NCT02132949|Cyclophosphamide|cyclophosphamide|mesh-list
19997125|NCT02132949|Doxorubicin|doxorubicin|mesh-list
19997126|NCT02132949|Fluorouracil|fluorouracil|mesh-list
19997127|NCT02132949|Trastuzumab|trastuzumab|mesh-list
19997128|NCT02132949|Epirubicin|epirubicin|mesh-list
19997129|NCT02132949|Pertuzumab|pertuzumab|mesh-list
19997130|NCT02132949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19997131|NCT02132949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997132|NCT02132949|Tubulin Modulators|tubulin modulators|mesh-ancestor
19997133|NCT02132949|Antimitotic Agents|antimitotic agents|mesh-ancestor
19997134|NCT02132949|Mitosis Modulators|mitosis modulators|mesh-ancestor
19997135|NCT02132949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997136|NCT02132949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19997137|NCT02132949|Immunologic Factors|immunologic factors|mesh-ancestor
19997138|NCT02132949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997139|NCT02132949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19997140|NCT02132949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19997141|NCT02132949|Alkylating Agents|alkylating agents|mesh-ancestor
19997142|NCT02132949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19997143|NCT02132949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19997144|NCT02132949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19997145|NCT02132949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19997146|NCT02132949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19997147|NCT02132949|Antimetabolites|antimetabolites|mesh-ancestor
19997148|NCT02132949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19997149|NCT02132949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19997150|NCT02133001|Esketamine|esketamine|mesh-list
19997151|NCT02133001|Antidepressive Agents|antidepressive agents|mesh-ancestor
19997152|NCT02133001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19997153|NCT02133131|Sofosbuvir|sofosbuvir|mesh-list
19997154|NCT02133131|Grazoprevir|grazoprevir|mesh-list
19997155|NCT02133131|Antiviral Agents|antiviral agents|mesh-ancestor
19997156|NCT02133131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19997157|NCT02133352|Ranolazine|ranolazine|mesh-list
19997158|NCT02133352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19997159|NCT02133352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19997160|NCT02133352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997161|NCT02133664|Thioctic Acid|thioctic acid|mesh-list
19997162|NCT02133664|Antioxidants|antioxidants|mesh-ancestor
19997163|NCT02133664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997164|NCT02133664|Protective Agents|protective agents|mesh-ancestor
19997165|NCT02133664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997166|NCT02133664|Vitamin B Complex|vitamin b complex|mesh-ancestor
19997167|NCT02133664|Vitamins|vitamins|mesh-ancestor
19997168|NCT02133664|Micronutrients|micronutrients|mesh-ancestor
19997169|NCT02133742|Pembrolizumab|pembrolizumab|mesh-list
19997170|NCT02133742|Axitinib|axitinib|mesh-list
19997171|NCT02133742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19997172|NCT02133742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997173|NCT02133742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19997174|NCT02133742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19997175|NCT02133742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997176|NCT02133781|Vaccines|vaccines|mesh-list
19997177|NCT02133781|Immunologic Factors|immunologic factors|mesh-ancestor
19997178|NCT02133781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997179|NCT02134015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19997180|NCT02134015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997181|NCT02134015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19997182|NCT02134015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19997183|NCT02134015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997184|NCT02134184|Vaccines|vaccines|mesh-list
19997185|NCT02134184|Immunologic Factors|immunologic factors|mesh-ancestor
19997186|NCT02134184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997187|NCT02134210|Etanercept|etanercept|mesh-list
19997188|NCT02134210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19997189|NCT02134210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19997190|NCT02134210|Analgesics|analgesics|mesh-ancestor
19997191|NCT02134210|Sensory System Agents|sensory system agents|mesh-ancestor
19997192|NCT02134210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997193|NCT02134210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997194|NCT02134210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19997195|NCT02134210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19997196|NCT02134210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19997197|NCT02134210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19997198|NCT02134210|Immunologic Factors|immunologic factors|mesh-ancestor
19997199|NCT02134314|Complement C1s|complement c1s|mesh-list
19997200|NCT02134314|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
19997201|NCT02134314|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
19997202|NCT02134314|Immunologic Factors|immunologic factors|mesh-ancestor
19997203|NCT02134314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997204|NCT02134314|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19997205|NCT02134314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19997206|NCT02134353|Mannitol|mannitol|mesh-list
19997207|NCT02134353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
19997208|NCT02134353|Diuretics|diuretics|mesh-ancestor
19997209|NCT02134353|Natriuretic Agents|natriuretic agents|mesh-ancestor
19997210|NCT02134353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997211|NCT02134951|Ketamine|ketamine|mesh-list
19997212|NCT02134951|Analgesics|analgesics|mesh-ancestor
19997213|NCT02134951|Sensory System Agents|sensory system agents|mesh-ancestor
19997214|NCT02134951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997215|NCT02134951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997216|NCT02134951|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19997217|NCT02134951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19997218|NCT02134951|Anesthetics, General|anesthetics, general|mesh-ancestor
19997219|NCT02134951|Anesthetics|anesthetics|mesh-ancestor
19997220|NCT02134951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19997221|NCT02134951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19997222|NCT02134951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19997223|NCT02134951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19997224|NCT02134951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997225|NCT02134977|Leuprolide|leuprolide|mesh-list
19997226|NCT02134977|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19997227|NCT02134977|Fertility Agents|fertility agents|mesh-ancestor
19997228|NCT02134977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19997229|NCT02134977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997230|NCT02134977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19997231|NCT02134977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997232|NCT02135016|Lidocaine|lidocaine|mesh-list
19997233|NCT02135016|Anesthetics, Local|anesthetics, local|mesh-ancestor
19997234|NCT02135016|Anesthetics|anesthetics|mesh-ancestor
19997235|NCT02135016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19997236|NCT02135016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997237|NCT02135016|Sensory System Agents|sensory system agents|mesh-ancestor
19997238|NCT02135016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997239|NCT02135016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19997240|NCT02135016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19997241|NCT02135016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19997242|NCT02135016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19997243|NCT02135016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997244|NCT02135094|Oxymetazoline|oxymetazoline|mesh-list
19997245|NCT02135094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19997246|NCT02135094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19997247|NCT02135094|Adrenergic Agents|adrenergic agents|mesh-ancestor
19997248|NCT02135094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19997249|NCT02135094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997250|NCT02135094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997251|NCT02135094|Sympathomimetics|sympathomimetics|mesh-ancestor
19997252|NCT02135094|Autonomic Agents|autonomic agents|mesh-ancestor
19997253|NCT02135094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997254|NCT02135094|Nasal Decongestants|nasal decongestants|mesh-ancestor
19997255|NCT02135094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19997256|NCT02135094|Respiratory System Agents|respiratory system agents|mesh-ancestor
19997257|NCT02135107|Rabeprazole|rabeprazole|mesh-list
19997258|NCT02135107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19997259|NCT02135107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19997260|NCT02135107|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19997261|NCT02135107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19997262|NCT02135107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997263|NCT02135146|Plasma-lyte 148|plasma-lyte 148|mesh-list
19997264|NCT02135146|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19997265|NCT02135146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19997266|NCT02135432|Ivacaftor|ivacaftor|mesh-list
19997267|NCT02135432|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19997268|NCT02135432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19997269|NCT02135432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997270|NCT02135445|Relugolix|relugolix|mesh-list
19997271|NCT02135445|Androgen Antagonists|androgen antagonists|mesh-ancestor
19997272|NCT02135445|Hormone Antagonists|hormone antagonists|mesh-ancestor
19997273|NCT02135445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19997274|NCT02135445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997275|NCT02136420|Promethazine|promethazine|mesh-list
19997276|NCT02136420|Diphenhydramine|diphenhydramine|mesh-list
19997277|NCT02136420|Antipruritics|antipruritics|mesh-ancestor
19997278|NCT02136420|Dermatologic Agents|dermatologic agents|mesh-ancestor
19997279|NCT02136420|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19997280|NCT02136420|Histamine Antagonists|histamine antagonists|mesh-ancestor
19997281|NCT02136420|Histamine Agents|histamine agents|mesh-ancestor
19997282|NCT02136420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19997283|NCT02136420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997284|NCT02136420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997285|NCT02136420|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19997286|NCT02136420|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19997287|NCT02136420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19997288|NCT02136420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19997289|NCT02136420|Anesthetics, Local|anesthetics, local|mesh-ancestor
19997290|NCT02136420|Anesthetics|anesthetics|mesh-ancestor
19997291|NCT02136420|Sensory System Agents|sensory system agents|mesh-ancestor
19997292|NCT02136420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997293|NCT02136420|Antiemetics|antiemetics|mesh-ancestor
19997294|NCT02136420|Autonomic Agents|autonomic agents|mesh-ancestor
19997295|NCT02136420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19997296|NCT02136498|Varenicline|varenicline|mesh-list
19997297|NCT02136498|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19997298|NCT02136498|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19997299|NCT02136498|Cholinergic Agents|cholinergic agents|mesh-ancestor
19997300|NCT02136498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19997301|NCT02136498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997302|NCT02136498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997303|NCT02136576|Listerine|listerine|mesh-list
19997304|NCT02136576|Sodium Fluoride|sodium fluoride|mesh-list
19997305|NCT02136576|Cariostatic Agents|cariostatic agents|mesh-ancestor
19997306|NCT02136576|Protective Agents|protective agents|mesh-ancestor
19997307|NCT02136576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997308|NCT02136576|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19997309|NCT02136576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19997310|NCT02136914|Amantadine|amantadine|mesh-list
19997311|NCT02136914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19997312|NCT02136914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19997313|NCT02136914|Antiviral Agents|antiviral agents|mesh-ancestor
19997314|NCT02136914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19997315|NCT02136914|Dopamine Agents|dopamine agents|mesh-ancestor
19997316|NCT02136914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19997317|NCT02136914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997318|NCT02136914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997319|NCT02136914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19997320|NCT02136914|Analgesics|analgesics|mesh-ancestor
19997321|NCT02136914|Sensory System Agents|sensory system agents|mesh-ancestor
19997322|NCT02136914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997323|NCT02137226|Adalimumab|adalimumab|mesh-list
19997324|NCT02137226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19997325|NCT02137226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19997326|NCT02137369|Dexetimide|dexetimide|mesh-list
19997327|NCT02137369|Citalopram|citalopram|mesh-list
19997328|NCT02137369|Sertraline|sertraline|mesh-list
19997329|NCT02137369|Antidepressive Agents|antidepressive agents|mesh-list
19997330|NCT02137369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
19997331|NCT02137369|Serotonin|serotonin|mesh-list
19997332|NCT02137369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19997333|NCT02137369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19997334|NCT02137369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997335|NCT02137369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19997336|NCT02137369|Serotonin Agents|serotonin agents|mesh-ancestor
19997337|NCT02137369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997338|NCT02137369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19997339|NCT02137369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19997340|NCT02137369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19997341|NCT02137369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19997342|NCT02137369|Parasympatholytics|parasympatholytics|mesh-ancestor
19997343|NCT02137369|Autonomic Agents|autonomic agents|mesh-ancestor
19997344|NCT02137369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997345|NCT02137369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19997346|NCT02137369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19997347|NCT02137369|Cholinergic Agents|cholinergic agents|mesh-ancestor
19997348|NCT02137369|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19997349|NCT02137382|Pancrelipase|pancrelipase|mesh-list
19997350|NCT02137382|Pancreatin|pancreatin|mesh-list
19997351|NCT02137382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19997352|NCT02137538|Letrozole|letrozole|mesh-list
19997353|NCT02137538|Anastrozole|anastrozole|mesh-list
19997354|NCT02137538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997355|NCT02137538|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19997356|NCT02137538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19997357|NCT02137538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19997358|NCT02137538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997359|NCT02137538|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19997360|NCT02137538|Hormone Antagonists|hormone antagonists|mesh-ancestor
19997361|NCT02137538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19997362|NCT02137538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997363|NCT02137538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19997364|NCT02137772|Letermovir|letermovir|mesh-list
20556683|NCT01948336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556684|NCT01948336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20556685|NCT01948336|Anesthetics, General|anesthetics, general|mesh-ancestor
20556686|NCT01948336|Anesthetics|anesthetics|mesh-ancestor
20556687|NCT01948336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20556688|NCT01948336|Analgesics|analgesics|mesh-ancestor
20556689|NCT01948336|Sensory System Agents|sensory system agents|mesh-ancestor
20556690|NCT01948336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556691|NCT01948336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20556692|NCT01948336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20556693|NCT01948336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20556694|NCT01948336|Adrenergic Agents|adrenergic agents|mesh-ancestor
20556695|NCT01948336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20556696|NCT01948336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556697|NCT01948336|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20556698|NCT01948336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20556699|NCT01948336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20556700|NCT01948362|Sulforaphane|sulforaphane|mesh-list
20556701|NCT01948362|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20556702|NCT01948362|Protective Agents|protective agents|mesh-ancestor
20556703|NCT01948362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556704|NCT01948362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556705|NCT01948401|Prednisolone|prednisolone|mesh-list
20556706|NCT01948401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20556707|NCT01948401|Glucocorticoids|glucocorticoids|mesh-ancestor
20556708|NCT01948401|Hormones|hormones|mesh-ancestor
20556709|NCT01948401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20556710|NCT01948401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556711|NCT01948401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20556712|NCT01948401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556713|NCT01948505|Acetaminophen|acetaminophen|mesh-list
20556714|NCT01948505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20556715|NCT01948505|Analgesics|analgesics|mesh-ancestor
20556716|NCT01948505|Sensory System Agents|sensory system agents|mesh-ancestor
20556717|NCT01948505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997365|NCT02137772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19997366|NCT02137772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19997367|NCT02137772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997368|NCT02137772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997369|NCT02137772|Antiviral Agents|antiviral agents|mesh-ancestor
19997370|NCT02137772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19997371|NCT02137785|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19997372|NCT02137785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19997373|NCT02137785|Dermatologic Agents|dermatologic agents|mesh-ancestor
19997374|NCT02137837|Everolimus|everolimus|mesh-list
19997375|NCT02137837|Fulvestrant|fulvestrant|mesh-list
19997376|NCT02137837|Anastrozole|anastrozole|mesh-list
19997377|NCT02137837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997378|NCT02137837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19997379|NCT02137837|Immunologic Factors|immunologic factors|mesh-ancestor
19997380|NCT02137837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997381|NCT02137837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19997382|NCT02137837|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19997383|NCT02137837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19997384|NCT02137837|Hormone Antagonists|hormone antagonists|mesh-ancestor
19997385|NCT02137837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19997386|NCT02137837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19997387|NCT02137837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19997388|NCT02137837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19997389|NCT02137837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997390|NCT02138006|Insulin|insulin|mesh-list
19997391|NCT02138006|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19997392|NCT02138006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19997393|NCT02138006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997394|NCT02138136|Lubiprostone|lubiprostone|mesh-list
19997395|NCT02138136|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
19997396|NCT02138136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19997397|NCT02138136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997398|NCT02138747|Mirabegron|mirabegron|mesh-list
19997399|NCT02138747|Tolterodine Tartrate|tolterodine tartrate|mesh-list
19997400|NCT02138747|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
19997401|NCT02138747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19997402|NCT02138747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19997403|NCT02138747|Adrenergic Agents|adrenergic agents|mesh-ancestor
19997404|NCT02138747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19997405|NCT02138747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997406|NCT02138747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997407|NCT02138747|Urological Agents|urological agents|mesh-ancestor
19997408|NCT02138747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19997409|NCT02138747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19997410|NCT02138747|Cholinergic Agents|cholinergic agents|mesh-ancestor
20289655|NCT04608331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20289656|NCT04608331|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20289657|NCT04608331|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20289658|NCT04608331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20289659|NCT04608331|Adrenergic Agents|adrenergic agents|mesh-ancestor
20289660|NCT04608331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20289661|NCT04608331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289662|NCT04605861|Liraglutide|liraglutide|mesh-list
20289663|NCT04605861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20289664|NCT04605861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289665|NCT04605861|Incretins|incretins|mesh-ancestor
20289666|NCT04605861|Hormones|hormones|mesh-ancestor
20289667|NCT04605861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20289668|NCT04600336|Oxybutynin|oxybutynin|mesh-list
20289669|NCT04600336|Parasympatholytics|parasympatholytics|mesh-ancestor
20289670|NCT04600336|Autonomic Agents|autonomic agents|mesh-ancestor
20289671|NCT04600336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20289672|NCT04600336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289673|NCT04600336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20289674|NCT04600336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20289675|NCT04600336|Cholinergic Agents|cholinergic agents|mesh-ancestor
20289676|NCT04600336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20289677|NCT04600336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289678|NCT04600336|Urological Agents|urological agents|mesh-ancestor
20289679|NCT04597333|Dinoprostone|dinoprostone|mesh-list
20289680|NCT04597333|Oxytocics|oxytocics|mesh-ancestor
20289681|NCT04597333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20289682|NCT04597333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289683|NCT04596579|Antibodies|antibodies|mesh-list
19997411|NCT02138825|Riociguat|riociguat|mesh-list
19997412|NCT02138825|Enzyme Activators|enzyme activators|mesh-ancestor
19997413|NCT02138825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997414|NCT02138838|Cinacalcet|cinacalcet|mesh-list
19997415|NCT02138838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19997416|NCT02138838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997417|NCT02138838|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
19997418|NCT02138838|Hormone Antagonists|hormone antagonists|mesh-ancestor
19997419|NCT02138838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19997420|NCT02138916|Benralizumab|benralizumab|mesh-list
19997421|NCT02138916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19997422|NCT02138916|Respiratory System Agents|respiratory system agents|mesh-ancestor
19997423|NCT02139007|Alendronate|alendronate|mesh-list
19997424|NCT02139007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19997425|NCT02139007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997426|NCT02139046|Naproxen|naproxen|mesh-list
19997427|NCT02139046|Colchicine|colchicine|mesh-list
19997428|NCT02139046|Febuxostat|febuxostat|mesh-list
19997429|NCT02139046|Lansoprazole|lansoprazole|mesh-list
19997430|NCT02139046|Dexlansoprazole|dexlansoprazole|mesh-list
19997431|NCT02139046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19997432|NCT02139046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19997433|NCT02139046|Analgesics|analgesics|mesh-ancestor
19997434|NCT02139046|Sensory System Agents|sensory system agents|mesh-ancestor
19997435|NCT02139046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997436|NCT02139046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997437|NCT02139046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19997438|NCT02139046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19997439|NCT02139046|Gout Suppressants|gout suppressants|mesh-ancestor
19997440|NCT02139046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19997441|NCT02139046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19997442|NCT02139046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997443|NCT02139046|Tubulin Modulators|tubulin modulators|mesh-ancestor
19997444|NCT02139046|Antimitotic Agents|antimitotic agents|mesh-ancestor
19997445|NCT02139046|Mitosis Modulators|mitosis modulators|mesh-ancestor
19997446|NCT02139046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997447|NCT02139046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19997448|NCT02139046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19997449|NCT02139046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19997450|NCT02139280|Cyclophosphamide|cyclophosphamide|mesh-list
19997451|NCT02139280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19997452|NCT02139280|Immunologic Factors|immunologic factors|mesh-ancestor
19997453|NCT02139280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997454|NCT02139280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19997455|NCT02139280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19997456|NCT02139280|Alkylating Agents|alkylating agents|mesh-ancestor
19997457|NCT02139280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997458|NCT02139280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997459|NCT02139280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19997460|NCT02139358|Gemcitabine|gemcitabine|mesh-list
19997461|NCT02139358|Trastuzumab|trastuzumab|mesh-list
19997462|NCT02139358|Pertuzumab|pertuzumab|mesh-list
19997463|NCT02139358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19997464|NCT02139358|Antimetabolites|antimetabolites|mesh-ancestor
19997465|NCT02139358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997466|NCT02139358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997467|NCT02139358|Antiviral Agents|antiviral agents|mesh-ancestor
19997468|NCT02139358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19997469|NCT02139358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19997470|NCT02139358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19997471|NCT02139358|Immunologic Factors|immunologic factors|mesh-ancestor
19997472|NCT02139358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997473|NCT02139358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19997474|NCT02139592|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19997475|NCT02139592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19997476|NCT02139592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997477|NCT02139644|Fluticasone|fluticasone|mesh-list
19997478|NCT02139644|Xhance|xhance|mesh-list
19997479|NCT02139644|Beclomethasone|beclomethasone|mesh-list
19997480|NCT02139644|Albuterol|albuterol|mesh-list
19997481|NCT02139644|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19997482|NCT02139644|Adrenergic Agonists|adrenergic agonists|mesh-list
19997483|NCT02139644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19997484|NCT02139644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19997485|NCT02139644|Autonomic Agents|autonomic agents|mesh-ancestor
19997486|NCT02139644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997487|NCT02139644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997488|NCT02139644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19997489|NCT02139644|Respiratory System Agents|respiratory system agents|mesh-ancestor
19997490|NCT02139644|Dermatologic Agents|dermatologic agents|mesh-ancestor
19997491|NCT02139644|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19997492|NCT02139644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19997493|NCT02139644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19997494|NCT02139644|Adrenergic Agents|adrenergic agents|mesh-ancestor
19997495|NCT02139644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19997496|NCT02139644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997497|NCT02139644|Tocolytic Agents|tocolytic agents|mesh-ancestor
19997498|NCT02139644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19997499|NCT02139644|Glucocorticoids|glucocorticoids|mesh-ancestor
19997500|NCT02139644|Hormones|hormones|mesh-ancestor
19997501|NCT02139644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19997502|NCT02139943|Canagliflozin|canagliflozin|mesh-list
19997503|NCT02139943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19997504|NCT02139943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997505|NCT02139943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19997506|NCT02139943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997507|NCT02139982|Ropivacaine|ropivacaine|mesh-list
19997508|NCT02139982|Anesthetics, Local|anesthetics, local|mesh-ancestor
19997509|NCT02139982|Anesthetics|anesthetics|mesh-ancestor
19997510|NCT02139982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19997511|NCT02139982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997512|NCT02139982|Sensory System Agents|sensory system agents|mesh-ancestor
19997513|NCT02139982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997514|NCT02140060|Travoprost|travoprost|mesh-list
19997515|NCT02140060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19997516|NCT02140060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19997517|NCT02140060|Brinzolamide|brinzolamide|mesh-list
19997518|NCT02140060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19997519|NCT02140060|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
19997520|NCT02140060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19997521|NCT02140060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997522|NCT02140164|Minocycline|minocycline|mesh-list
19997523|NCT02140164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19997524|NCT02140164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19997525|NCT02140372|Colchicine|colchicine|mesh-list
19997526|NCT02140372|Gout Suppressants|gout suppressants|mesh-ancestor
19997527|NCT02140372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19997528|NCT02140372|Tubulin Modulators|tubulin modulators|mesh-ancestor
19997529|NCT02140372|Antimitotic Agents|antimitotic agents|mesh-ancestor
19997530|NCT02140372|Mitosis Modulators|mitosis modulators|mesh-ancestor
19997531|NCT02140372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997532|NCT02140372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997533|NCT02140411|Ranibizumab|ranibizumab|mesh-list
19997534|NCT02140411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19997535|NCT02140411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19997536|NCT02140411|Growth Substances|growth substances|mesh-ancestor
19997537|NCT02140411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997538|NCT02140411|Growth Inhibitors|growth inhibitors|mesh-ancestor
19997539|NCT02140411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997540|NCT02140593|Rocuronium|rocuronium|mesh-list
19997541|NCT02140593|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19997542|NCT02140593|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19997543|NCT02140593|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19997544|NCT02140593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997545|NCT02140593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997546|NCT02140645|Linagliptin|linagliptin|mesh-list
19997547|NCT02140645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19997548|NCT02140645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997549|NCT02140645|Incretins|incretins|mesh-ancestor
19997550|NCT02140645|Hormones|hormones|mesh-ancestor
19997551|NCT02140645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19997552|NCT02140645|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19997553|NCT02140645|Protease Inhibitors|protease inhibitors|mesh-ancestor
19997554|NCT02140645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19997555|NCT02140645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997556|NCT02140970|Ibuprofen|ibuprofen|mesh-list
19997557|NCT02140970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19997558|NCT02140970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19997559|NCT02140970|Analgesics|analgesics|mesh-ancestor
19997560|NCT02140970|Sensory System Agents|sensory system agents|mesh-ancestor
19997561|NCT02140970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997562|NCT02140970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997563|NCT02140970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19997564|NCT02140970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19997565|NCT02140970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19997566|NCT02140970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19997567|NCT02140970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997568|NCT02141217|Amoxicillin|amoxicillin|mesh-list
19997569|NCT02141217|Clindamycin|clindamycin|mesh-list
19997570|NCT02141217|Clindamycin palmitate|clindamycin palmitate|mesh-list
19997571|NCT02141217|Clindamycin phosphate|clindamycin phosphate|mesh-list
19997572|NCT02141217|Clavulanic Acid|clavulanic acid|mesh-list
19997573|NCT02141217|Clavulanic Acids|clavulanic acids|mesh-list
19997574|NCT02141217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19997575|NCT02141217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19997576|NCT02141217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19997577|NCT02141217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19997578|NCT02141217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19997579|NCT02141217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997580|NCT02141217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19997581|NCT02141295|Leucovorin|leucovorin|mesh-list
19997582|NCT02141295|Folic Acid|folic acid|mesh-list
19997583|NCT02141295|Bevacizumab|bevacizumab|mesh-list
19997584|NCT02141295|Oxaliplatin|oxaliplatin|mesh-list
19997585|NCT02141295|Levoleucovorin|levoleucovorin|mesh-list
19997586|NCT02141295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19997587|NCT02141295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997588|NCT02141295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19997589|NCT02141295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19997590|NCT02141295|Growth Substances|growth substances|mesh-ancestor
19997591|NCT02141295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997592|NCT02141295|Growth Inhibitors|growth inhibitors|mesh-ancestor
19997593|NCT02141295|Antidotes|antidotes|mesh-ancestor
19997594|NCT02141295|Protective Agents|protective agents|mesh-ancestor
19997595|NCT02141295|Vitamin B Complex|vitamin b complex|mesh-ancestor
19997596|NCT02141295|Vitamins|vitamins|mesh-ancestor
19997597|NCT02141295|Micronutrients|micronutrients|mesh-ancestor
19997598|NCT02141295|Hematinics|hematinics|mesh-ancestor
19997599|NCT02141451|Rituximab|rituximab|mesh-list
19997600|NCT02141451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19997601|NCT02141451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997602|NCT02141451|Immunologic Factors|immunologic factors|mesh-ancestor
19997603|NCT02141451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997604|NCT02141451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19997605|NCT02141490|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19997606|NCT02141490|Hematinics|hematinics|mesh-ancestor
19997607|NCT02141490|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19997608|NCT02141490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19997609|NCT02141555|Misoprostol|misoprostol|mesh-list
19997610|NCT02141555|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19997611|NCT02141555|Abortifacient Agents|abortifacient agents|mesh-ancestor
19997612|NCT02141555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19997613|NCT02141555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997614|NCT02141555|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19997615|NCT02141555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19997616|NCT02141555|Oxytocics|oxytocics|mesh-ancestor
19997617|NCT02141581|Vaccines|vaccines|mesh-list
19997618|NCT02141581|Immunologic Factors|immunologic factors|mesh-ancestor
19997619|NCT02141581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997620|NCT02141620|Acetylcysteine|acetylcysteine|mesh-list
19997621|NCT02141620|Cocaine|cocaine|mesh-list
19997622|NCT02141620|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19997623|NCT02141620|Antiviral Agents|antiviral agents|mesh-ancestor
19997624|NCT02141620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19997625|NCT02141620|Expectorants|expectorants|mesh-ancestor
19997626|NCT02141620|Respiratory System Agents|respiratory system agents|mesh-ancestor
19997627|NCT02141620|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19997628|NCT02141620|Antioxidants|antioxidants|mesh-ancestor
19997629|NCT02141620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997630|NCT02141620|Protective Agents|protective agents|mesh-ancestor
19997631|NCT02141620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997632|NCT02141620|Antidotes|antidotes|mesh-ancestor
19997633|NCT02141620|Anesthetics, Local|anesthetics, local|mesh-ancestor
19997634|NCT02141620|Anesthetics|anesthetics|mesh-ancestor
19997635|NCT02141620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19997636|NCT02141620|Sensory System Agents|sensory system agents|mesh-ancestor
20556718|NCT01948505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997637|NCT02141620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997638|NCT02141620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19997639|NCT02141620|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19997640|NCT02141620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19997641|NCT02141620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19997642|NCT02141620|Dopamine Agents|dopamine agents|mesh-ancestor
19997643|NCT02141620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19997644|NCT02141633|Fluticasone|fluticasone|mesh-list
19997645|NCT02141633|Xhance|xhance|mesh-list
19997646|NCT02141633|Albuterol|albuterol|mesh-list
19997647|NCT02141633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19997648|NCT02141633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19997649|NCT02141633|Autonomic Agents|autonomic agents|mesh-ancestor
19997650|NCT02141633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997651|NCT02141633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997652|NCT02141633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19997653|NCT02141633|Respiratory System Agents|respiratory system agents|mesh-ancestor
19997654|NCT02141633|Dermatologic Agents|dermatologic agents|mesh-ancestor
19997655|NCT02141633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19997656|NCT02141633|Tocolytic Agents|tocolytic agents|mesh-ancestor
19997657|NCT02141633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19997658|NCT02141633|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19997659|NCT02141633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19997660|NCT02141633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19997661|NCT02141633|Adrenergic Agents|adrenergic agents|mesh-ancestor
19997662|NCT02141633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19997663|NCT02141633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997664|NCT02141659|Relugolix|relugolix|mesh-list
19997665|NCT02141659|Androgen Antagonists|androgen antagonists|mesh-ancestor
19997666|NCT02141659|Hormone Antagonists|hormone antagonists|mesh-ancestor
19997667|NCT02141659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19997668|NCT02141659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997669|NCT02141672|Cyclosporine|cyclosporine|mesh-list
19997670|NCT02141672|Antifungal Agents|antifungal agents|mesh-ancestor
19997671|NCT02141672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19997672|NCT02141672|Dermatologic Agents|dermatologic agents|mesh-ancestor
19997673|NCT02141672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19997674|NCT02141672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997675|NCT02141672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19997676|NCT02141672|Immunologic Factors|immunologic factors|mesh-ancestor
19997677|NCT02141672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997678|NCT02141672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19997679|NCT02141672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19997680|NCT02141854|Fluticasone|fluticasone|mesh-list
19997681|NCT02141854|Xhance|xhance|mesh-list
19997682|NCT02141854|Albuterol|albuterol|mesh-list
19997683|NCT02141854|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
19997684|NCT02141854|Adrenergic Agonists|adrenergic agonists|mesh-list
19997685|NCT02141854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19997686|NCT02141854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19997687|NCT02141854|Autonomic Agents|autonomic agents|mesh-ancestor
19997688|NCT02141854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997689|NCT02141854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997690|NCT02141854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19997691|NCT02141854|Respiratory System Agents|respiratory system agents|mesh-ancestor
19997692|NCT02141854|Dermatologic Agents|dermatologic agents|mesh-ancestor
19997693|NCT02141854|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19997694|NCT02141854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19997695|NCT02141854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19997696|NCT02141854|Adrenergic Agents|adrenergic agents|mesh-ancestor
19997697|NCT02141854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19997698|NCT02141854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997699|NCT02141854|Tocolytic Agents|tocolytic agents|mesh-ancestor
19997700|NCT02141854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19997701|NCT02141997|Adalimumab|adalimumab|mesh-list
19997702|NCT02141997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19997703|NCT02141997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19997704|NCT02142049|Lenalidomide|lenalidomide|mesh-list
19997705|NCT02142049|Immunologic Factors|immunologic factors|mesh-ancestor
19997706|NCT02142049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997707|NCT02142049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19997708|NCT02142049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19997709|NCT02142049|Growth Substances|growth substances|mesh-ancestor
19997710|NCT02142049|Growth Inhibitors|growth inhibitors|mesh-ancestor
19997711|NCT02142049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997712|NCT02142153|Olorofim|olorofim|mesh-list
19997713|NCT02142153|Antifungal Agents|antifungal agents|mesh-ancestor
19997714|NCT02142153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19997715|NCT02142712|Diphenhydramine|diphenhydramine|mesh-list
19997716|NCT02142712|Promethazine|promethazine|mesh-list
19997717|NCT02142712|Dextromethorphan|dextromethorphan|mesh-list
19997718|NCT02142712|Pantoprazole|pantoprazole|mesh-list
19997719|NCT02142712|Famotidine|famotidine|mesh-list
19997720|NCT02142712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19997721|NCT02142712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19997722|NCT02142712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19997723|NCT02142712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19997724|NCT02142712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997725|NCT02142712|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19997726|NCT02142712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19997727|NCT02142712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19997728|NCT02142712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997729|NCT02142712|Anesthetics, Local|anesthetics, local|mesh-ancestor
19997730|NCT02142712|Anesthetics|anesthetics|mesh-ancestor
19997731|NCT02142712|Sensory System Agents|sensory system agents|mesh-ancestor
19997732|NCT02142712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997733|NCT02142712|Antiemetics|antiemetics|mesh-ancestor
19997734|NCT02142712|Autonomic Agents|autonomic agents|mesh-ancestor
19997735|NCT02142712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19997736|NCT02142712|Histamine Antagonists|histamine antagonists|mesh-ancestor
19997737|NCT02142712|Histamine Agents|histamine agents|mesh-ancestor
19997738|NCT02142712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19997739|NCT02142712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19997740|NCT02142712|Antipruritics|antipruritics|mesh-ancestor
19997741|NCT02142712|Dermatologic Agents|dermatologic agents|mesh-ancestor
19997742|NCT02142712|Antitussive Agents|antitussive agents|mesh-ancestor
19997743|NCT02142712|Respiratory System Agents|respiratory system agents|mesh-ancestor
19997744|NCT02142712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19997745|NCT02142712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19997746|NCT02142712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19997747|NCT02142738|Gemcitabine|gemcitabine|mesh-list
19997748|NCT02142738|Paclitaxel|paclitaxel|mesh-list
19997749|NCT02142738|Carboplatin|carboplatin|mesh-list
19997750|NCT02142738|Pembrolizumab|pembrolizumab|mesh-list
19997751|NCT02142738|Pemetrexed|pemetrexed|mesh-list
19997752|NCT02142738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19997753|NCT02142738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997754|NCT02142738|Tubulin Modulators|tubulin modulators|mesh-ancestor
19997755|NCT02142738|Antimitotic Agents|antimitotic agents|mesh-ancestor
19997756|NCT02142738|Mitosis Modulators|mitosis modulators|mesh-ancestor
19997757|NCT02142738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997758|NCT02142738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19997759|NCT02142738|Antimetabolites|antimetabolites|mesh-ancestor
19997760|NCT02142738|Antiviral Agents|antiviral agents|mesh-ancestor
19997761|NCT02142738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19997762|NCT02142738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19997763|NCT02142738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19997764|NCT02142738|Immunologic Factors|immunologic factors|mesh-ancestor
19997765|NCT02142738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997766|NCT02142738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19997767|NCT02142738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19997768|NCT02142738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19997769|NCT02143141|Morphine|morphine|mesh-list
19997770|NCT02143141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19997771|NCT02143141|Narcotics|narcotics|mesh-ancestor
19997772|NCT02143141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19997773|NCT02143141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997774|NCT02143141|Analgesics|analgesics|mesh-ancestor
19997775|NCT02143141|Sensory System Agents|sensory system agents|mesh-ancestor
19997776|NCT02143141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997777|NCT02143648|Nalbuphine|nalbuphine|mesh-list
19997778|NCT02143648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19997779|NCT02143648|Narcotics|narcotics|mesh-ancestor
19997780|NCT02143648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19997781|NCT02143648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997782|NCT02143648|Analgesics|analgesics|mesh-ancestor
19997783|NCT02143648|Sensory System Agents|sensory system agents|mesh-ancestor
19997784|NCT02143648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997785|NCT02143843|Bimatoprost|bimatoprost|mesh-list
19997786|NCT02143843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19997787|NCT02143973|Nalbuphine|nalbuphine|mesh-list
19997788|NCT02143973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19997789|NCT02143973|Narcotics|narcotics|mesh-ancestor
19997790|NCT02143973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19997791|NCT02143973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997792|NCT02143973|Analgesics|analgesics|mesh-ancestor
19997793|NCT02143973|Sensory System Agents|sensory system agents|mesh-ancestor
19997794|NCT02143973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997795|NCT02144012|Docetaxel|docetaxel|mesh-list
19997796|NCT02144012|Trastuzumab|trastuzumab|mesh-list
19997797|NCT02144012|Maytansine|maytansine|mesh-list
19997798|NCT02144012|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
19997799|NCT02144012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997800|NCT02144012|Tubulin Modulators|tubulin modulators|mesh-ancestor
19997801|NCT02144012|Antimitotic Agents|antimitotic agents|mesh-ancestor
19997802|NCT02144012|Mitosis Modulators|mitosis modulators|mesh-ancestor
19997803|NCT02144012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997804|NCT02144012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19997805|NCT02144012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19997806|NCT02144077|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19997807|NCT02144077|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
19997808|NCT02144077|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19997809|NCT02144077|Dermatologic Agents|dermatologic agents|mesh-ancestor
19997810|NCT02144233|Salicylic Acid|salicylic acid|mesh-list
19997811|NCT02144233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19997812|NCT02144233|Antifungal Agents|antifungal agents|mesh-ancestor
19997813|NCT02144233|Keratolytic Agents|keratolytic agents|mesh-ancestor
19997814|NCT02144233|Dermatologic Agents|dermatologic agents|mesh-ancestor
19997815|NCT02144259|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19997816|NCT02144259|Medroxyprogesterone|medroxyprogesterone|mesh-list
19997817|NCT02144259|Etonogestrel|etonogestrel|mesh-list
19997818|NCT02144259|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19997819|NCT02144259|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19997820|NCT02144259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19997821|NCT02144259|Contraceptive Agents|contraceptive agents|mesh-ancestor
19997822|NCT02144259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19997823|NCT02144259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997824|NCT02144259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19997825|NCT02144259|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19997826|NCT02144259|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19997827|NCT02144259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19997828|NCT02144259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997829|NCT02139540|Nitrous Oxide|nitrous oxide|mesh-list
19997830|NCT02139540|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19997831|NCT02139540|Anesthetics, General|anesthetics, general|mesh-ancestor
19997832|NCT02139540|Anesthetics|anesthetics|mesh-ancestor
19997833|NCT02139540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19997834|NCT02139540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997835|NCT02139540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19997836|NCT02139540|Analgesics|analgesics|mesh-ancestor
19997837|NCT02139540|Sensory System Agents|sensory system agents|mesh-ancestor
19997838|NCT02139540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997839|NCT02144675|Cytarabine|cytarabine|mesh-list
19997840|NCT02144675|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
19997841|NCT02144675|Salicylates|salicylates|mesh-list
19997842|NCT02144675|Idarubicin|idarubicin|mesh-list
19997843|NCT02144675|Choline|choline|mesh-list
19997844|NCT02144675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19997845|NCT02144675|Antimetabolites|antimetabolites|mesh-ancestor
19997846|NCT02144675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997847|NCT02144675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997848|NCT02144675|Antiviral Agents|antiviral agents|mesh-ancestor
19997849|NCT02144675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19997850|NCT02144675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19997851|NCT02144675|Immunologic Factors|immunologic factors|mesh-ancestor
19997852|NCT02144675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997853|NCT02144675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19997854|NCT02144675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19997855|NCT02144675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19997856|NCT02144675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19997857|NCT02144675|Lipotropic Agents|lipotropic agents|mesh-ancestor
19997858|NCT02144675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19997859|NCT02144675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19997860|NCT02144675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19997861|NCT02144675|Nootropic Agents|nootropic agents|mesh-ancestor
19997862|NCT02144675|Analgesics|analgesics|mesh-ancestor
19997863|NCT02144675|Sensory System Agents|sensory system agents|mesh-ancestor
19997864|NCT02144675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997865|NCT02144675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19997866|NCT02144675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19997867|NCT02144675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19997868|NCT02144675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19997869|NCT02144675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19997870|NCT02144714|Adalimumab|adalimumab|mesh-list
19997871|NCT02144714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19997872|NCT02144714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19997873|NCT02145026|Epoetin Alfa|epoetin alfa|mesh-list
19997874|NCT02145026|Hematinics|hematinics|mesh-ancestor
19997875|NCT02145039|Cyclophosphamide|cyclophosphamide|mesh-list
19997876|NCT02145039|Fludarabine|fludarabine|mesh-list
19997877|NCT02145039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19997878|NCT02145039|Immunologic Factors|immunologic factors|mesh-ancestor
19997879|NCT02145039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997880|NCT02145039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19997881|NCT02145039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19997882|NCT02145039|Alkylating Agents|alkylating agents|mesh-ancestor
19997883|NCT02145039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997884|NCT02145039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997885|NCT02145039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19997886|NCT02145078|Gemcitabine|gemcitabine|mesh-list
19997887|NCT02145078|Docetaxel|docetaxel|mesh-list
19997888|NCT02145078|Pemetrexed|pemetrexed|mesh-list
19997889|NCT02145078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19997890|NCT02145078|Antimetabolites|antimetabolites|mesh-ancestor
19997891|NCT02145078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997892|NCT02145078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997893|NCT02145078|Antiviral Agents|antiviral agents|mesh-ancestor
19997894|NCT02145078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19997895|NCT02145078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19997896|NCT02145078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19997897|NCT02145078|Immunologic Factors|immunologic factors|mesh-ancestor
19997898|NCT02145078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997899|NCT02145078|Tubulin Modulators|tubulin modulators|mesh-ancestor
19997900|NCT02145078|Antimitotic Agents|antimitotic agents|mesh-ancestor
19997901|NCT02145078|Mitosis Modulators|mitosis modulators|mesh-ancestor
19997902|NCT02145078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19997903|NCT02145078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19997904|NCT02145182|Eculizumab|eculizumab|mesh-list
19997905|NCT02145182|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
19997906|NCT02145182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19997907|NCT02145182|Immunologic Factors|immunologic factors|mesh-ancestor
19997908|NCT02145182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997909|NCT02145247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19997910|NCT02145247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19997911|NCT02145247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997912|NCT02145676|Botulinum Toxins|botulinum toxins|mesh-list
19997913|NCT02145676|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19997914|NCT02145676|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19997915|NCT02145676|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19997916|NCT02145676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19997917|NCT02145676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997918|NCT02145676|Cholinergic Agents|cholinergic agents|mesh-ancestor
19997919|NCT02145676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19997920|NCT02145676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997921|NCT02145676|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19997922|NCT02145676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997923|NCT02146248|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19997924|NCT02146248|Contraceptive Agents|contraceptive agents|mesh-list
19997925|NCT02146248|Medroxyprogesterone|medroxyprogesterone|mesh-list
19997926|NCT02146248|Contraceptives, Oral|contraceptives, oral|mesh-list
19997927|NCT02146248|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19997928|NCT02146248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19997929|NCT02146248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997930|NCT02146248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19997931|NCT02146248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19997932|NCT02146248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19997933|NCT02146248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19997934|NCT02146248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19997935|NCT02146248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19997936|NCT02146248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289684|NCT04596579|Immunologic Factors|immunologic factors|mesh-ancestor
20289685|NCT04596579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289686|NCT04595565|Carboplatin|carboplatin|mesh-list
20289687|NCT04595565|Capecitabine|capecitabine|mesh-list
20289688|NCT04595565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19997937|NCT02146430|Pregabalin|pregabalin|mesh-list
19997938|NCT02146430|Analgesics|analgesics|mesh-ancestor
19997939|NCT02146430|Sensory System Agents|sensory system agents|mesh-ancestor
19997940|NCT02146430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997941|NCT02146430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997942|NCT02146430|Anticonvulsants|anticonvulsants|mesh-ancestor
19997943|NCT02146430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19997944|NCT02146430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19997945|NCT02146430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997946|NCT02146430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19997947|NCT02146430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19997948|NCT02146430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19997949|NCT02146430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19997950|NCT02146430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19997951|NCT02147067|Ranolazine|ranolazine|mesh-list
19997952|NCT02147067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19997953|NCT02147067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19997954|NCT02147067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997955|NCT02147132|Nicotine|nicotine|mesh-list
19997956|NCT02147132|Varenicline|varenicline|mesh-list
19997957|NCT02147132|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19997958|NCT02147132|Autonomic Agents|autonomic agents|mesh-ancestor
19997959|NCT02147132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997960|NCT02147132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997961|NCT02147132|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19997962|NCT02147132|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19997963|NCT02147132|Cholinergic Agents|cholinergic agents|mesh-ancestor
19997964|NCT02147132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19997965|NCT02147132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997966|NCT02147158|Ulipristal acetate|ulipristal acetate|mesh-list
19997967|NCT02147158|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19997968|NCT02147158|Contraceptive Agents|contraceptive agents|mesh-ancestor
19997969|NCT02147158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19997970|NCT02147158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997971|NCT02147158|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19997972|NCT02147197|Ulipristal acetate|ulipristal acetate|mesh-list
19997973|NCT02147197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19997974|NCT02147197|Contraceptive Agents|contraceptive agents|mesh-ancestor
19997975|NCT02147197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19997976|NCT02147197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997977|NCT02147197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19997978|NCT02147561|Botulinum Toxins|botulinum toxins|mesh-list
19997979|NCT02147561|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19997980|NCT02147561|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19997981|NCT02147561|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19997982|NCT02147561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19997983|NCT02147561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997984|NCT02147561|Cholinergic Agents|cholinergic agents|mesh-ancestor
19997985|NCT02147561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19997986|NCT02147561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19997987|NCT02147561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19997988|NCT02147561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19997989|NCT02147587|Tofacitinib|tofacitinib|mesh-list
19997990|NCT02147587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19997991|NCT02147587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19997992|NCT02147587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19997993|NCT02147691|Azelaic acid|azelaic acid|mesh-list
19997994|NCT02147691|Brimonidine Tartrate|brimonidine tartrate|mesh-list
19997995|NCT02147691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19997996|NCT02147691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19997997|NCT02147691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19997998|NCT02147691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19997999|NCT02147691|Adrenergic Agents|adrenergic agents|mesh-ancestor
19998000|NCT02147691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19998001|NCT02147691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998002|NCT02147691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998003|NCT02147691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998004|NCT02147691|Dermatologic Agents|dermatologic agents|mesh-ancestor
19998005|NCT02147899|Secnidazole|secnidazole|mesh-list
19998006|NCT02147899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19998007|NCT02147899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19998008|NCT02147899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19998009|NCT02148250|Insulin|insulin|mesh-list
19998010|NCT02148250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19998011|NCT02148250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19998012|NCT02148250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998013|NCT02148445|Nicotine|nicotine|mesh-list
19998014|NCT02148445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19998015|NCT02148445|Autonomic Agents|autonomic agents|mesh-ancestor
19998016|NCT02148445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998017|NCT02148445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998018|NCT02148445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19998019|NCT02148445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19998020|NCT02148445|Cholinergic Agents|cholinergic agents|mesh-ancestor
19998021|NCT02148445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19998022|NCT02148445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998023|NCT02148588|Lidocaine|lidocaine|mesh-list
19998024|NCT02148588|Anesthetics, Local|anesthetics, local|mesh-ancestor
19998025|NCT02148588|Anesthetics|anesthetics|mesh-ancestor
19998026|NCT02148588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19998027|NCT02148588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998028|NCT02148588|Sensory System Agents|sensory system agents|mesh-ancestor
19998029|NCT02148588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998030|NCT02148588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19998031|NCT02148588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19998032|NCT02148588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19998033|NCT02148588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19998034|NCT02148588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998035|NCT02148718|Adalimumab|adalimumab|mesh-list
19998036|NCT02148718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19998037|NCT02148718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19998038|NCT02148874|Vaccines|vaccines|mesh-list
19998039|NCT02148874|Immunologic Factors|immunologic factors|mesh-ancestor
19998040|NCT02148874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998041|NCT02149108|Nintedanib|nintedanib|mesh-list
19998042|NCT02149108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998043|NCT02149108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19998044|NCT02149108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998045|NCT02149108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998046|NCT02149173|Deoxyglucose|deoxyglucose|mesh-list
19998047|NCT02149173|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19998048|NCT02149173|Fluorides|fluorides|mesh-list
19998049|NCT02149173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19998050|NCT02149173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998051|NCT02149173|Cariostatic Agents|cariostatic agents|mesh-ancestor
19998052|NCT02149173|Protective Agents|protective agents|mesh-ancestor
19998053|NCT02149173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998054|NCT02149173|Antimetabolites|antimetabolites|mesh-ancestor
19998055|NCT02149173|Antiviral Agents|antiviral agents|mesh-ancestor
19998056|NCT02149173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19998057|NCT02149199|Budesonide|budesonide|mesh-list
19998058|NCT02149199|Terbutaline|terbutaline|mesh-list
19998059|NCT02149199|Formoterol Fumarate|formoterol fumarate|mesh-list
19998060|NCT02149199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19998061|NCT02149199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19998062|NCT02149199|Autonomic Agents|autonomic agents|mesh-ancestor
19998063|NCT02149199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998064|NCT02149199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998065|NCT02149199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19998066|NCT02149199|Respiratory System Agents|respiratory system agents|mesh-ancestor
19998067|NCT02149199|Glucocorticoids|glucocorticoids|mesh-ancestor
19998068|NCT02149199|Hormones|hormones|mesh-ancestor
19998069|NCT02149199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19998070|NCT02149199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19998071|NCT02149199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19998072|NCT02149199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19998073|NCT02149199|Adrenergic Agents|adrenergic agents|mesh-ancestor
19998074|NCT02149199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19998075|NCT02149199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998076|NCT02149199|Sympathomimetics|sympathomimetics|mesh-ancestor
19998077|NCT02149199|Tocolytic Agents|tocolytic agents|mesh-ancestor
19998078|NCT02149199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19998079|NCT02149264|Testosterone|testosterone|mesh-list
19998080|NCT02149264|Androgens|androgens|mesh-ancestor
19998081|NCT02149264|Hormones|hormones|mesh-ancestor
19998082|NCT02149264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19998083|NCT02149264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998084|NCT02149303|Dabigatran|dabigatran|mesh-list
19998085|NCT02149303|Antithrombins|antithrombins|mesh-ancestor
19998086|NCT02149303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19998087|NCT02149303|Protease Inhibitors|protease inhibitors|mesh-ancestor
19998088|NCT02149303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998089|NCT02149303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998090|NCT02149303|Anticoagulants|anticoagulants|mesh-ancestor
19998091|NCT02149342|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
19998092|NCT02149342|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19998093|NCT02149342|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19998094|NCT02149342|Dermatologic Agents|dermatologic agents|mesh-ancestor
19998095|NCT02149524|Trastuzumab|trastuzumab|mesh-list
19998096|NCT02149524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19998097|NCT02149524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998098|NCT02149836|Ezogabine|ezogabine|mesh-list
19998099|NCT02149836|Anticonvulsants|anticonvulsants|mesh-ancestor
19998100|NCT02149836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19998101|NCT02149836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998102|NCT02149875|Cerebrolysin|cerebrolysin|mesh-list
19998103|NCT02149875|3-n-butylphthalide|3-n-butylphthalide|mesh-list
19998104|NCT02149875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19998105|NCT02149875|Protective Agents|protective agents|mesh-ancestor
19998106|NCT02149875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998107|NCT02149875|Nootropic Agents|nootropic agents|mesh-ancestor
19998108|NCT02149875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19998109|NCT02150213|Dexamethasone|dexamethasone|mesh-list
19998110|NCT02150213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19998111|NCT02150213|Antiemetics|antiemetics|mesh-ancestor
19998112|NCT02150213|Autonomic Agents|autonomic agents|mesh-ancestor
19998113|NCT02150213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998114|NCT02150213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998115|NCT02150213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19998116|NCT02150213|Glucocorticoids|glucocorticoids|mesh-ancestor
19998117|NCT02150213|Hormones|hormones|mesh-ancestor
19998118|NCT02150213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19998119|NCT02150213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19998120|NCT02150213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998121|NCT02150499|Albuterol|albuterol|mesh-list
19998122|NCT02150499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19998123|NCT02150499|Autonomic Agents|autonomic agents|mesh-ancestor
19998124|NCT02150499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998125|NCT02150499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998126|NCT02150499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19998127|NCT02150499|Respiratory System Agents|respiratory system agents|mesh-ancestor
19998128|NCT02150499|Tocolytic Agents|tocolytic agents|mesh-ancestor
19998129|NCT02150499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19998130|NCT02150499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19998131|NCT02150499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19998132|NCT02150499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19998133|NCT02150499|Adrenergic Agents|adrenergic agents|mesh-ancestor
19998134|NCT02150499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19998135|NCT02150499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998136|NCT02150759|Fentanyl|fentanyl|mesh-list
19998137|NCT02150759|Dexmedetomidine|dexmedetomidine|mesh-list
19998138|NCT02150759|Ketamine|ketamine|mesh-list
19998139|NCT02150759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19998140|NCT02150759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19998141|NCT02150759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998142|NCT02150759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19998143|NCT02150759|Analgesics|analgesics|mesh-ancestor
19998144|NCT02150759|Sensory System Agents|sensory system agents|mesh-ancestor
19998145|NCT02150759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998146|NCT02150759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19998147|NCT02150759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19998148|NCT02150759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19998149|NCT02150759|Adrenergic Agents|adrenergic agents|mesh-ancestor
19998150|NCT02150759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19998151|NCT02150759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998152|NCT02150759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19998153|NCT02150759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19998154|NCT02150759|Anesthetics, General|anesthetics, general|mesh-ancestor
19998155|NCT02150759|Anesthetics|anesthetics|mesh-ancestor
19998156|NCT02150759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19998157|NCT02150759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19998158|NCT02150759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19998159|NCT02150759|Narcotics|narcotics|mesh-ancestor
19998160|NCT02150759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19998161|NCT02150954|Oxytocin|oxytocin|mesh-list
19998162|NCT02150954|Oxytocics|oxytocics|mesh-ancestor
19998163|NCT02150954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19998164|NCT02150954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998165|NCT02151058|Listerine|listerine|mesh-list
19998166|NCT02151058|Sodium Fluoride|sodium fluoride|mesh-list
19998167|NCT02151058|Cariostatic Agents|cariostatic agents|mesh-ancestor
19998168|NCT02151058|Protective Agents|protective agents|mesh-ancestor
19998169|NCT02151058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998170|NCT02151058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19998171|NCT02151058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19998172|NCT02151149|Paclitaxel|paclitaxel|mesh-list
19998173|NCT02151149|Carboplatin|carboplatin|mesh-list
19998174|NCT02151149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19998175|NCT02151149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998176|NCT02151149|Tubulin Modulators|tubulin modulators|mesh-ancestor
19998177|NCT02151149|Antimitotic Agents|antimitotic agents|mesh-ancestor
19998178|NCT02151149|Mitosis Modulators|mitosis modulators|mesh-ancestor
19998179|NCT02151149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998180|NCT02151253|Modafinil|modafinil|mesh-list
19998181|NCT02151253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19998182|NCT02151253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998183|NCT02151253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19998184|NCT02151253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19998185|NCT02151253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19998186|NCT02151253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998187|NCT02151448|Interferons|interferons|mesh-list
19998188|NCT02151448|Interferon-alpha|interferon-alpha|mesh-list
19998189|NCT02151448|Interferon alpha-2|interferon alpha-2|mesh-list
19998190|NCT02151448|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
19998191|NCT02151448|Celecoxib|celecoxib|mesh-list
19998192|NCT02151448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998193|NCT02151448|Antiviral Agents|antiviral agents|mesh-ancestor
19998194|NCT02151448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19998195|NCT02151448|Immunologic Factors|immunologic factors|mesh-ancestor
19998196|NCT02151448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998197|NCT02151448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19998198|NCT02151448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19998199|NCT02151448|Analgesics|analgesics|mesh-ancestor
19998200|NCT02151448|Sensory System Agents|sensory system agents|mesh-ancestor
19998201|NCT02151448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998202|NCT02151448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19998203|NCT02151448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19998204|NCT02151448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19998205|NCT02151448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19998206|NCT02151448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998207|NCT02151448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998208|NCT02151461|Metformin|metformin|mesh-list
19998209|NCT02151461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19998210|NCT02151461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998211|NCT02151487|Dexamethasone|dexamethasone|mesh-list
19998212|NCT02151487|Dexamethasone acetate|dexamethasone acetate|mesh-list
19998213|NCT02151487|Clonidine|clonidine|mesh-list
19998214|NCT02151487|Ropivacaine|ropivacaine|mesh-list
19998215|NCT02151487|BB 1101|bb 1101|mesh-list
19998216|NCT02151487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19998217|NCT02151487|Antiemetics|antiemetics|mesh-ancestor
19998218|NCT02151487|Autonomic Agents|autonomic agents|mesh-ancestor
19998219|NCT02151487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998220|NCT02151487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998221|NCT02151487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19998222|NCT02151487|Glucocorticoids|glucocorticoids|mesh-ancestor
19998223|NCT02151487|Hormones|hormones|mesh-ancestor
19998224|NCT02151487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19998225|NCT02151487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19998226|NCT02151487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998227|NCT02151487|Protease Inhibitors|protease inhibitors|mesh-ancestor
19998228|NCT02151487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998229|NCT02151487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998230|NCT02151487|Anesthetics, Local|anesthetics, local|mesh-ancestor
19998231|NCT02151487|Anesthetics|anesthetics|mesh-ancestor
19998232|NCT02151487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19998233|NCT02151487|Sensory System Agents|sensory system agents|mesh-ancestor
19998234|NCT02151487|Analgesics|analgesics|mesh-ancestor
19998235|NCT02151487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19998236|NCT02151487|Sympatholytics|sympatholytics|mesh-ancestor
19998237|NCT02151487|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19998238|NCT02151487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19998239|NCT02151487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19998240|NCT02151487|Adrenergic Agents|adrenergic agents|mesh-ancestor
19998241|NCT02151487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19998242|NCT02151591|Varenicline|varenicline|mesh-list
19998243|NCT02151591|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19998244|NCT02151591|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19998245|NCT02151591|Cholinergic Agents|cholinergic agents|mesh-ancestor
19998246|NCT02151591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19998247|NCT02151591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998248|NCT02151591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998249|NCT02151643|Iron|iron|mesh-list
19998250|NCT02151643|Trace Elements|trace elements|mesh-ancestor
19998251|NCT02151643|Micronutrients|micronutrients|mesh-ancestor
19998252|NCT02151643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998253|NCT02151682|Morphine|morphine|mesh-list
19998254|NCT02151682|Tapentadol|tapentadol|mesh-list
19998255|NCT02151682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19998256|NCT02151682|Narcotics|narcotics|mesh-ancestor
19998257|NCT02151682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19998258|NCT02151682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998259|NCT02151682|Analgesics|analgesics|mesh-ancestor
19998260|NCT02151682|Sensory System Agents|sensory system agents|mesh-ancestor
19998261|NCT02151682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998262|NCT02151682|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19998263|NCT02151682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19998264|NCT02151682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19998265|NCT02151682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998266|NCT02151682|Adrenergic Agents|adrenergic agents|mesh-ancestor
19998267|NCT02151682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19998268|NCT02151773|Vaccines|vaccines|mesh-list
19998269|NCT02151773|Immunologic Factors|immunologic factors|mesh-ancestor
19998270|NCT02151773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998271|NCT02151786|Lansoprazole|lansoprazole|mesh-list
19998272|NCT02151786|Dexlansoprazole|dexlansoprazole|mesh-list
19998273|NCT02151786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19998274|NCT02151786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19998275|NCT02151786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19998276|NCT02151786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998277|NCT02151786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998278|NCT02151851|Methotrexate|methotrexate|mesh-list
19998279|NCT02151851|Certolizumab Pegol|certolizumab pegol|mesh-list
19998280|NCT02151851|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19998281|NCT02151851|Abortifacient Agents|abortifacient agents|mesh-ancestor
19998282|NCT02151851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19998283|NCT02151851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998284|NCT02151851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19998285|NCT02151851|Antimetabolites|antimetabolites|mesh-ancestor
19998286|NCT02151851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998287|NCT02151851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998288|NCT02151851|Dermatologic Agents|dermatologic agents|mesh-ancestor
19998289|NCT02151851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998290|NCT02151851|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19998291|NCT02151851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19998292|NCT02151851|Immunologic Factors|immunologic factors|mesh-ancestor
19998293|NCT02151851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19998294|NCT02151851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19998295|NCT02151877|Nitric Oxide|nitric oxide|mesh-list
19998296|NCT02151877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19998297|NCT02151877|Autonomic Agents|autonomic agents|mesh-ancestor
19998298|NCT02151877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998299|NCT02151877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998300|NCT02151877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19998301|NCT02151877|Respiratory System Agents|respiratory system agents|mesh-ancestor
19998302|NCT02151877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19998303|NCT02151877|Antioxidants|antioxidants|mesh-ancestor
19998304|NCT02151877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998305|NCT02151877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19998306|NCT02151877|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19998307|NCT02151877|Vasodilator Agents|vasodilator agents|mesh-ancestor
19998308|NCT02151877|Gasotransmitters|gasotransmitters|mesh-ancestor
19998309|NCT02151877|Protective Agents|protective agents|mesh-ancestor
19459744|NCT03359005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19998310|NCT02151994|Zamicastat|zamicastat|mesh-list
19998311|NCT02151994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998312|NCT02151994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998313|NCT02152007|Sirolimus|sirolimus|mesh-list
19998314|NCT02152007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19998315|NCT02152007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19998316|NCT02152007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19998317|NCT02152007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998318|NCT02152007|Antifungal Agents|antifungal agents|mesh-ancestor
19998319|NCT02152007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19998320|NCT02152007|Immunologic Factors|immunologic factors|mesh-ancestor
19998321|NCT02152007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998322|NCT02152137|Paclitaxel|paclitaxel|mesh-list
19998323|NCT02152137|Efatutazone|efatutazone|mesh-list
19998324|NCT02152137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19998325|NCT02152137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998326|NCT02152137|Tubulin Modulators|tubulin modulators|mesh-ancestor
19998327|NCT02152137|Antimitotic Agents|antimitotic agents|mesh-ancestor
19998328|NCT02152137|Mitosis Modulators|mitosis modulators|mesh-ancestor
19998329|NCT02152137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998330|NCT02152163|Ibuprofen|ibuprofen|mesh-list
19998331|NCT02152163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19998332|NCT02152163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19998333|NCT02152163|Analgesics|analgesics|mesh-ancestor
19998334|NCT02152163|Sensory System Agents|sensory system agents|mesh-ancestor
19998335|NCT02152163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998336|NCT02152163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998337|NCT02152163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19998338|NCT02152163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19998339|NCT02152163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19998340|NCT02152163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998341|NCT02152163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998342|NCT02152345|Methylprednisolone|methylprednisolone|mesh-list
19998343|NCT02152345|Abatacept|abatacept|mesh-list
19998344|NCT02152345|Tacrolimus|tacrolimus|mesh-list
19998345|NCT02152345|Antilymphocyte Serum|antilymphocyte serum|mesh-list
19998346|NCT02152345|Thymoglobulin|thymoglobulin|mesh-list
19998347|NCT02152345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19998348|NCT02152345|Immunologic Factors|immunologic factors|mesh-ancestor
19998349|NCT02152345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998350|NCT02152345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19998351|NCT02152345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998352|NCT02152345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998353|NCT02152345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998354|NCT02152345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19998355|NCT02152345|Antiemetics|antiemetics|mesh-ancestor
19998356|NCT02152345|Autonomic Agents|autonomic agents|mesh-ancestor
19998357|NCT02152345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998358|NCT02152345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19998359|NCT02152345|Glucocorticoids|glucocorticoids|mesh-ancestor
19998360|NCT02152345|Hormones|hormones|mesh-ancestor
19998361|NCT02152345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19998362|NCT02152345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19998363|NCT02152345|Protective Agents|protective agents|mesh-ancestor
19998364|NCT02152345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19998365|NCT02152345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19998366|NCT02152371|Metformin|metformin|mesh-list
19998367|NCT02152371|Insulin Glargine|insulin glargine|mesh-list
19998368|NCT02152371|Dulaglutide|dulaglutide|mesh-list
19998369|NCT02152371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19998370|NCT02152371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998371|NCT02152384|Insulin|insulin|mesh-list
19998372|NCT02152384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19998373|NCT02152384|Insulin Glargine|insulin glargine|mesh-list
19998374|NCT02152384|Insulin Lispro|insulin lispro|mesh-list
19998375|NCT02152384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19998376|NCT02152384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998377|NCT02152631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19998378|NCT02152631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998379|NCT02152631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19998380|NCT02152631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998381|NCT02152631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998382|NCT02152696|Methotrexate|methotrexate|mesh-list
19998383|NCT02152696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19998384|NCT02152696|Abortifacient Agents|abortifacient agents|mesh-ancestor
19998385|NCT02152696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19998386|NCT02152696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998387|NCT02152696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19998388|NCT02152696|Antimetabolites|antimetabolites|mesh-ancestor
19998389|NCT02152696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998390|NCT02152696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998391|NCT02152696|Dermatologic Agents|dermatologic agents|mesh-ancestor
19998392|NCT02152696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998393|NCT02152696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19998394|NCT02152696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19998395|NCT02152696|Immunologic Factors|immunologic factors|mesh-ancestor
19998396|NCT02152696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19998397|NCT02152696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19998398|NCT02153489|Bromides|bromides|mesh-list
19998399|NCT02153489|Anticonvulsants|anticonvulsants|mesh-ancestor
20289689|NCT04595565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20289690|NCT04595565|Antimetabolites|antimetabolites|mesh-ancestor
20289691|NCT04595565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289692|NCT04593927|Siponimod|siponimod|mesh-list
20289693|NCT04593927|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20289694|NCT04593927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289695|NCT04593927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20289696|NCT04593927|Immunologic Factors|immunologic factors|mesh-ancestor
20289697|NCT04593927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289698|NCT04587830|Temozolomide|temozolomide|mesh-list
20289699|NCT04587830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20289700|NCT04587830|Alkylating Agents|alkylating agents|mesh-ancestor
20289701|NCT04587830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289702|NCT04587830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556719|NCT01948505|Antipyretics|antipyretics|mesh-ancestor
20556720|NCT01948583|Hyaluronic Acid|hyaluronic acid|mesh-list
20556721|NCT01948583|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20556722|NCT01948583|Immunologic Factors|immunologic factors|mesh-ancestor
20556723|NCT01948583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556724|NCT01948583|Viscosupplements|viscosupplements|mesh-ancestor
20556725|NCT01948583|Protective Agents|protective agents|mesh-ancestor
20556726|NCT01948648|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
20556727|NCT01948648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20556728|NCT01948648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20556729|NCT01948648|Antimetabolites|antimetabolites|mesh-ancestor
20556730|NCT01948648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556731|NCT01948648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20556732|NCT01948765|Propofol|propofol|mesh-list
20556733|NCT01948765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20556734|NCT01948765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20556735|NCT01948765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556736|NCT01948765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20556737|NCT01948765|Anesthetics, General|anesthetics, general|mesh-ancestor
20556738|NCT01948765|Anesthetics|anesthetics|mesh-ancestor
20556739|NCT01948804|Letrozole|letrozole|mesh-list
19998400|NCT02153671|Vaccines|vaccines|mesh-list
19998401|NCT02153671|Immunologic Factors|immunologic factors|mesh-ancestor
19998402|NCT02153671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998403|NCT02153723|Glatiramer Acetate|glatiramer acetate|mesh-list
19998404|NCT02153723|(T,G)-A-L|(t,g)-a-l|mesh-list
19998405|NCT02153723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19998406|NCT02153723|Immunologic Factors|immunologic factors|mesh-ancestor
19998407|NCT02153723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998408|NCT02153723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19998409|NCT02153723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19998410|NCT02153788|Temazepam|temazepam|mesh-list
19998411|NCT02153788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19998412|NCT02153788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19998413|NCT02153788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998414|NCT02153788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19998415|NCT02153788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19998416|NCT02153788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19998417|NCT02153788|GABA Modulators|gaba modulators|mesh-ancestor
19998418|NCT02153788|GABA Agents|gaba agents|mesh-ancestor
19998419|NCT02153788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19998420|NCT02153788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998421|NCT02153905|Aldesleukin|aldesleukin|mesh-list
19998422|NCT02153905|Cyclophosphamide|cyclophosphamide|mesh-list
19998423|NCT02153905|Fludarabine|fludarabine|mesh-list
19998424|NCT02153905|Interleukin-2|interleukin-2|mesh-list
19998425|NCT02153905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19998426|NCT02153905|Immunologic Factors|immunologic factors|mesh-ancestor
19998427|NCT02153905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998428|NCT02153905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19998429|NCT02153905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19998430|NCT02153905|Alkylating Agents|alkylating agents|mesh-ancestor
19998431|NCT02153905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998432|NCT02153905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998433|NCT02153905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19998434|NCT02153905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19998435|NCT02153905|Analgesics|analgesics|mesh-ancestor
19998436|NCT02153905|Sensory System Agents|sensory system agents|mesh-ancestor
19998437|NCT02153905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998438|NCT02153905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19998439|NCT02153905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19998440|NCT02153905|Antiviral Agents|antiviral agents|mesh-ancestor
19998441|NCT02153905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19998442|NCT02153918|Metronidazole|metronidazole|mesh-list
19998443|NCT02153918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19998444|NCT02153918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19998445|NCT02153918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19998446|NCT02153918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19998447|NCT02153983|Colchicine|colchicine|mesh-list
19998448|NCT02153983|Gout Suppressants|gout suppressants|mesh-ancestor
19998449|NCT02153983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19998450|NCT02153983|Tubulin Modulators|tubulin modulators|mesh-ancestor
19998451|NCT02153983|Antimitotic Agents|antimitotic agents|mesh-ancestor
19998452|NCT02153983|Mitosis Modulators|mitosis modulators|mesh-ancestor
19998453|NCT02153983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998454|NCT02153983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998455|NCT02154048|Dexamethasone|dexamethasone|mesh-list
19998456|NCT02154048|Ropivacaine|ropivacaine|mesh-list
19998457|NCT02154048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19998458|NCT02154048|Antiemetics|antiemetics|mesh-ancestor
19998459|NCT02154048|Autonomic Agents|autonomic agents|mesh-ancestor
19998460|NCT02154048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998461|NCT02154048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998462|NCT02154048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19998463|NCT02154048|Glucocorticoids|glucocorticoids|mesh-ancestor
19998464|NCT02154048|Hormones|hormones|mesh-ancestor
19998465|NCT02154048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19998466|NCT02154048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19998467|NCT02154048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998468|NCT02154048|Anesthetics, Local|anesthetics, local|mesh-ancestor
19998469|NCT02154048|Anesthetics|anesthetics|mesh-ancestor
19998470|NCT02154048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19998471|NCT02154048|Sensory System Agents|sensory system agents|mesh-ancestor
19998472|NCT02154061|Metronidazole|metronidazole|mesh-list
19998473|NCT02154061|Vancomycin|vancomycin|mesh-list
19998474|NCT02154061|Neomycin|neomycin|mesh-list
19998475|NCT02154061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19998476|NCT02154061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19998477|NCT02154061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19998478|NCT02154061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19998479|NCT02154061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19998480|NCT02154061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998481|NCT02154061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998482|NCT02154139|Leuprolide|leuprolide|mesh-list
19998483|NCT02154139|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19998484|NCT02154139|Fertility Agents|fertility agents|mesh-ancestor
19998485|NCT02154139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19998486|NCT02154139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998487|NCT02154139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19998488|NCT02154139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998489|NCT02154243|Midodrine|midodrine|mesh-list
19998490|NCT02154243|Sympathomimetics|sympathomimetics|mesh-ancestor
19998491|NCT02154243|Autonomic Agents|autonomic agents|mesh-ancestor
19998492|NCT02154243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998493|NCT02154243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998494|NCT02154243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19998495|NCT02154243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19998496|NCT02154243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19998497|NCT02154243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19998498|NCT02154243|Adrenergic Agents|adrenergic agents|mesh-ancestor
19998499|NCT02154243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19998500|NCT02154243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998501|NCT02154347|Mitiglinide|mitiglinide|mesh-list
19998502|NCT02154347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19998503|NCT02154347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998504|NCT02154425|Certolizumab Pegol|certolizumab pegol|mesh-list
19998505|NCT02154425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19998506|NCT02154425|Immunologic Factors|immunologic factors|mesh-ancestor
19998507|NCT02154425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998508|NCT02154425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19998509|NCT02154477|Insulin|insulin|mesh-list
19998510|NCT02154477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19998511|NCT02154477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998512|NCT02154763|Ropivacaine|ropivacaine|mesh-list
19998513|NCT02154763|Anesthetics, Local|anesthetics, local|mesh-ancestor
19998514|NCT02154763|Anesthetics|anesthetics|mesh-ancestor
19998515|NCT02154763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19998516|NCT02154763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998517|NCT02154763|Sensory System Agents|sensory system agents|mesh-ancestor
19998518|NCT02154763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998519|NCT02155010|Dexmedetomidine|dexmedetomidine|mesh-list
19998520|NCT02155010|Bupivacaine|bupivacaine|mesh-list
19998521|NCT02155010|Anesthetics, Local|anesthetics, local|mesh-ancestor
19998522|NCT02155010|Anesthetics|anesthetics|mesh-ancestor
19998523|NCT02155010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19998524|NCT02155010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998525|NCT02155010|Sensory System Agents|sensory system agents|mesh-ancestor
19998526|NCT02155010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998527|NCT02155010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19998528|NCT02155010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19998529|NCT02155010|Analgesics|analgesics|mesh-ancestor
19998530|NCT02155010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19998531|NCT02155010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19998532|NCT02155010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19998533|NCT02155010|Adrenergic Agents|adrenergic agents|mesh-ancestor
19998534|NCT02155010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19998535|NCT02155010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998536|NCT02155101|Ritonavir|ritonavir|mesh-list
19998537|NCT02155101|Lopinavir|lopinavir|mesh-list
19998538|NCT02155101|Atazanavir Sulfate|atazanavir sulfate|mesh-list
19998539|NCT02155101|Darunavir|darunavir|mesh-list
19998540|NCT02155101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19998541|NCT02155101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19998542|NCT02155101|Protease Inhibitors|protease inhibitors|mesh-ancestor
19998543|NCT02155101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998544|NCT02155101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998545|NCT02155101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19998546|NCT02155101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19998547|NCT02155101|Antiviral Agents|antiviral agents|mesh-ancestor
19998548|NCT02155101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19998549|NCT02155101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19998550|NCT02155101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19998551|NCT02155257|Gabapentin|gabapentin|mesh-list
19998552|NCT02155257|Modafinil|modafinil|mesh-list
19998553|NCT02155257|Analgesics|analgesics|mesh-ancestor
19998554|NCT02155257|Sensory System Agents|sensory system agents|mesh-ancestor
19998555|NCT02155257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998556|NCT02155257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998557|NCT02155257|Anticonvulsants|anticonvulsants|mesh-ancestor
19998558|NCT02155257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19998559|NCT02155257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19998560|NCT02155257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19998561|NCT02155257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19998562|NCT02155257|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19998563|NCT02155257|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19998564|NCT02155257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19998565|NCT02155257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998566|NCT02155257|Antimanic Agents|antimanic agents|mesh-ancestor
19998567|NCT02155257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19998568|NCT02155257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
19998569|NCT02155257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19998570|NCT02155257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19998571|NCT02155309|Scopolamine|scopolamine|mesh-list
19998572|NCT02155309|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
19998573|NCT02155309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19998574|NCT02155309|Antiemetics|antiemetics|mesh-ancestor
19998575|NCT02155309|Autonomic Agents|autonomic agents|mesh-ancestor
19998576|NCT02155309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998577|NCT02155309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998578|NCT02155309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19998579|NCT02155309|Mydriatics|mydriatics|mesh-ancestor
19998580|NCT02155309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19998581|NCT02155309|Cholinergic Agents|cholinergic agents|mesh-ancestor
19998582|NCT02155309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19998583|NCT02155309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998584|NCT02155309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19998585|NCT02155309|Parasympatholytics|parasympatholytics|mesh-ancestor
19998586|NCT02155322|Interferons|interferons|mesh-list
19998587|NCT02155322|Interferon-alpha|interferon-alpha|mesh-list
19998588|NCT02155322|Interferon alpha-2|interferon alpha-2|mesh-list
19998589|NCT02155322|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19998590|NCT02155322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998591|NCT02155322|Antiviral Agents|antiviral agents|mesh-ancestor
19998592|NCT02155322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19998593|NCT02155322|Immunologic Factors|immunologic factors|mesh-ancestor
19998594|NCT02155322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998595|NCT02155335|Golimumab|golimumab|mesh-list
19998596|NCT02155335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19998597|NCT02155335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19998598|NCT02155335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19998599|NCT02155335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19998600|NCT02155335|Immunologic Factors|immunologic factors|mesh-ancestor
19998601|NCT02155335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998602|NCT02155465|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
19998603|NCT02155465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998604|NCT02155465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19998605|NCT02155465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998606|NCT02155465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998607|NCT02155660|Benralizumab|benralizumab|mesh-list
19998608|NCT02155660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19998609|NCT02155660|Respiratory System Agents|respiratory system agents|mesh-ancestor
19998610|NCT02155738|Acetaminophen|acetaminophen|mesh-list
19998611|NCT02155738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19998612|NCT02155738|Analgesics|analgesics|mesh-ancestor
19998613|NCT02155738|Sensory System Agents|sensory system agents|mesh-ancestor
19998614|NCT02155738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998615|NCT02155738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998616|NCT02155738|Antipyretics|antipyretics|mesh-ancestor
19998617|NCT02155829|Riluzole|riluzole|mesh-list
19459745|NCT03359005|Alkylating Agents|alkylating agents|mesh-ancestor
19459746|NCT03358953|Nicotine|nicotine|mesh-list
19998618|NCT02155829|Anticonvulsants|anticonvulsants|mesh-ancestor
19459747|NCT03358953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19459748|NCT03358953|Autonomic Agents|autonomic agents|mesh-ancestor
19459749|NCT03358953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19459750|NCT03358953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459751|NCT03358953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19459752|NCT03358953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19459753|NCT03358953|Cholinergic Agents|cholinergic agents|mesh-ancestor
19998619|NCT02155829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19998620|NCT02155829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19998621|NCT02155829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19998622|NCT02155829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998623|NCT02155829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998624|NCT02155829|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19998625|NCT02155829|Protective Agents|protective agents|mesh-ancestor
19998626|NCT02155881|Ciclesonide|ciclesonide|mesh-list
19998627|NCT02155881|Glucocorticoids|glucocorticoids|mesh-ancestor
19998628|NCT02155881|Hormones|hormones|mesh-ancestor
19998629|NCT02155881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19998630|NCT02155881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998631|NCT02155881|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19998632|NCT02155985|Aspirin|aspirin|mesh-list
19998633|NCT02155985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19998634|NCT02155985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19998635|NCT02155985|Analgesics|analgesics|mesh-ancestor
19998636|NCT02155985|Sensory System Agents|sensory system agents|mesh-ancestor
19998637|NCT02155985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998638|NCT02155985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998639|NCT02155985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19998640|NCT02155985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19998641|NCT02155985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19998642|NCT02155985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19998643|NCT02155985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998644|NCT02155985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19998645|NCT02155985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19998646|NCT02155985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998647|NCT02155985|Antipyretics|antipyretics|mesh-ancestor
19998648|NCT02156154|Acetaminophen|acetaminophen|mesh-list
19998649|NCT02156154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19998650|NCT02156154|Analgesics|analgesics|mesh-ancestor
19998651|NCT02156154|Sensory System Agents|sensory system agents|mesh-ancestor
19998652|NCT02156154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998653|NCT02156154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998654|NCT02156154|Antipyretics|antipyretics|mesh-ancestor
19998655|NCT02156492|Atorvastatin|atorvastatin|mesh-list
19998656|NCT02156492|Simvastatin|simvastatin|mesh-list
19998657|NCT02156492|Evacetrapib|evacetrapib|mesh-list
19998658|NCT02156492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19998659|NCT02156492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19998660|NCT02156492|Antimetabolites|antimetabolites|mesh-ancestor
19998661|NCT02156492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998662|NCT02156492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19998663|NCT02156492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19998664|NCT02156492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998665|NCT02156804|Nivolumab|nivolumab|mesh-list
19998666|NCT02156804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19998667|NCT02156804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998668|NCT02156804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19998669|NCT02156804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998670|NCT02157103|Bevacizumab|bevacizumab|mesh-list
19998671|NCT02157103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19998672|NCT02157103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998673|NCT02157103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19998674|NCT02157103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19998675|NCT02157103|Growth Substances|growth substances|mesh-ancestor
19998676|NCT02157103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998677|NCT02157103|Growth Inhibitors|growth inhibitors|mesh-ancestor
19998678|NCT02157298|Dapagliflozin|dapagliflozin|mesh-list
19998679|NCT02157298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19998680|NCT02157298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998681|NCT02157298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19998682|NCT02157298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998683|NCT02157376|Esomeprazole|esomeprazole|mesh-list
19998684|NCT02157376|Cimetidine|cimetidine|mesh-list
19998685|NCT02157376|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19998686|NCT02157376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19998687|NCT02157376|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19998688|NCT02157376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998689|NCT02157376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998690|NCT02157376|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19998691|NCT02157376|Histamine Antagonists|histamine antagonists|mesh-ancestor
19998692|NCT02157376|Histamine Agents|histamine agents|mesh-ancestor
19998693|NCT02157376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19998694|NCT02157376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998695|NCT02157376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19998696|NCT02157376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19998697|NCT02157623|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19998698|NCT02157623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19998699|NCT02157623|Dermatologic Agents|dermatologic agents|mesh-ancestor
19998700|NCT02157935|Formoterol Fumarate|formoterol fumarate|mesh-list
19998701|NCT02157935|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
19998702|NCT02157935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19998703|NCT02157935|Autonomic Agents|autonomic agents|mesh-ancestor
19998704|NCT02157935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998705|NCT02157935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998706|NCT02157935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19998707|NCT02157935|Respiratory System Agents|respiratory system agents|mesh-ancestor
19998708|NCT02157935|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19998709|NCT02157935|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19998710|NCT02157935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19998711|NCT02157935|Adrenergic Agents|adrenergic agents|mesh-ancestor
19998712|NCT02157935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19998713|NCT02157935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998714|NCT02157948|Denosumab|denosumab|mesh-list
19998715|NCT02157948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19998716|NCT02157948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998717|NCT02158039|Ethanol|ethanol|mesh-list
19998718|NCT02158039|Lidocaine|lidocaine|mesh-list
19998719|NCT02158039|Anesthetics, Local|anesthetics, local|mesh-ancestor
19998720|NCT02158039|Anesthetics|anesthetics|mesh-ancestor
19998721|NCT02158039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19998722|NCT02158039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998723|NCT02158039|Sensory System Agents|sensory system agents|mesh-ancestor
19998724|NCT02158039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998725|NCT02158039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19998726|NCT02158039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19998727|NCT02158039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19998728|NCT02158039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19998729|NCT02158039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998730|NCT02158039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19998731|NCT02158039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19998732|NCT02158273|Fenofibrate|fenofibrate|mesh-list
19998733|NCT02158273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19998734|NCT02158273|Antimetabolites|antimetabolites|mesh-ancestor
19998735|NCT02158273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998736|NCT02158273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19998737|NCT02158364|Vaccines|vaccines|mesh-list
19998738|NCT02158364|Immunologic Factors|immunologic factors|mesh-ancestor
19998739|NCT02158364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998740|NCT02158442|Clavulanic Acid|clavulanic acid|mesh-list
19998741|NCT02158442|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
19998742|NCT02158442|Ticarcillin|ticarcillin|mesh-list
19998743|NCT02158442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19998744|NCT02158442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998745|NCT02158442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998746|NCT02158442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19998747|NCT02158442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19998748|NCT02158520|Paclitaxel|paclitaxel|mesh-list
19998749|NCT02158520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19998750|NCT02158520|Bevacizumab|bevacizumab|mesh-list
19998751|NCT02158520|Ipilimumab|ipilimumab|mesh-list
19998752|NCT02158520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19998753|NCT02158520|Endothelial Growth Factors|endothelial growth factors|mesh-list
19998754|NCT02158520|Antibodies|antibodies|mesh-list
19998755|NCT02158520|Immunoglobulins|immunoglobulins|mesh-list
19998756|NCT02158520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19998757|NCT02158520|Immunoglobulin G|immunoglobulin g|mesh-list
19998758|NCT02158520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19998759|NCT02158520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998760|NCT02158520|Tubulin Modulators|tubulin modulators|mesh-ancestor
19998761|NCT02158520|Antimitotic Agents|antimitotic agents|mesh-ancestor
19998762|NCT02158520|Mitosis Modulators|mitosis modulators|mesh-ancestor
19998763|NCT02158520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998764|NCT02158520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19998765|NCT02158520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19998766|NCT02158520|Growth Substances|growth substances|mesh-ancestor
19998767|NCT02158520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998768|NCT02158520|Growth Inhibitors|growth inhibitors|mesh-ancestor
19998769|NCT02158520|Immunologic Factors|immunologic factors|mesh-ancestor
19998770|NCT02158520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19998771|NCT02158533|Naltrexone|naltrexone|mesh-list
19998772|NCT02158533|Buprenorphine|buprenorphine|mesh-list
19998773|NCT02158533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19998774|NCT02158533|Narcotics|narcotics|mesh-ancestor
19998775|NCT02158533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19998776|NCT02158533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998777|NCT02158533|Analgesics|analgesics|mesh-ancestor
19998778|NCT02158533|Sensory System Agents|sensory system agents|mesh-ancestor
19998779|NCT02158533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998780|NCT02158533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19998781|NCT02158533|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19998782|NCT02158572|Contraceptive Agents|contraceptive agents|mesh-list
19998783|NCT02158572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19998784|NCT02158572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998785|NCT02158806|Aspirin|aspirin|mesh-list
19998786|NCT02158806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19998787|NCT02158806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19998788|NCT02158806|Analgesics|analgesics|mesh-ancestor
19998789|NCT02158806|Sensory System Agents|sensory system agents|mesh-ancestor
19998790|NCT02158806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998791|NCT02158806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998792|NCT02158806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19998793|NCT02158806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19998794|NCT02158806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19998795|NCT02158806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19998796|NCT02158806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998797|NCT02158806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19998798|NCT02158806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19998799|NCT02158806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998800|NCT02158806|Antipyretics|antipyretics|mesh-ancestor
19998801|NCT02158936|Azacitidine|azacitidine|mesh-list
19998802|NCT02158936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19998803|NCT02158936|Antimetabolites|antimetabolites|mesh-ancestor
19998804|NCT02158936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998805|NCT02158936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998806|NCT02158936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998807|NCT02158975|Ixazomib|ixazomib|mesh-list
19998808|NCT02158975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998809|NCT02158975|Protease Inhibitors|protease inhibitors|mesh-ancestor
19998810|NCT02158975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998811|NCT02158975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998812|NCT02159053|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19998813|NCT02159053|Immunologic Factors|immunologic factors|mesh-ancestor
19998814|NCT02159053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998815|NCT02159352|Ritonavir|ritonavir|mesh-list
19998816|NCT02159352|Lopinavir|lopinavir|mesh-list
19998817|NCT02159352|Darunavir|darunavir|mesh-list
19998818|NCT02159352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19998819|NCT02159352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19998820|NCT02159352|Protease Inhibitors|protease inhibitors|mesh-ancestor
19998821|NCT02159352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998822|NCT02159352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998823|NCT02159352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19998824|NCT02159352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19998825|NCT02159352|Antiviral Agents|antiviral agents|mesh-ancestor
19998826|NCT02159352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19998827|NCT02159352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19998828|NCT02159352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19998829|NCT02159365|Dexamethasone|dexamethasone|mesh-list
19998830|NCT02159365|Lenalidomide|lenalidomide|mesh-list
19998831|NCT02159365|Elotuzumab|elotuzumab|mesh-list
19998832|NCT02159365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19998833|NCT02159365|Antiemetics|antiemetics|mesh-ancestor
19998834|NCT02159365|Autonomic Agents|autonomic agents|mesh-ancestor
19998835|NCT02159365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998836|NCT02159365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998837|NCT02159365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19998838|NCT02159365|Glucocorticoids|glucocorticoids|mesh-ancestor
19998839|NCT02159365|Hormones|hormones|mesh-ancestor
19998840|NCT02159365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19998841|NCT02159365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19998842|NCT02159365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998843|NCT02159365|Immunologic Factors|immunologic factors|mesh-ancestor
19998844|NCT02159365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19998845|NCT02159365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19998846|NCT02159365|Growth Substances|growth substances|mesh-ancestor
19998847|NCT02159365|Growth Inhibitors|growth inhibitors|mesh-ancestor
19998848|NCT02159469|Methyltestosterone|methyltestosterone|mesh-list
19998849|NCT02159469|Testosterone|testosterone|mesh-list
19998850|NCT02159469|Testosterone undecanoate|testosterone undecanoate|mesh-list
19998851|NCT02159469|Testosterone enanthate|testosterone enanthate|mesh-list
19998852|NCT02159469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19998853|NCT02159469|Androgens|androgens|mesh-ancestor
19998854|NCT02159469|Hormones|hormones|mesh-ancestor
19998855|NCT02159469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19998856|NCT02159469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998857|NCT02159469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19998858|NCT02159469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998859|NCT02159469|Anabolic Agents|anabolic agents|mesh-ancestor
19998860|NCT02159482|Interferons|interferons|mesh-list
19998861|NCT02159482|Interferon-alpha|interferon-alpha|mesh-list
19998862|NCT02159482|Interferon alpha-2|interferon alpha-2|mesh-list
19998863|NCT02159482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998864|NCT02159482|Antiviral Agents|antiviral agents|mesh-ancestor
19998865|NCT02159482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19998866|NCT02159482|Immunologic Factors|immunologic factors|mesh-ancestor
19998867|NCT02159482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998868|NCT02159521|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19998869|NCT02159521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19998870|NCT02159521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19998871|NCT02159521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998872|NCT02159547|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
19998873|NCT02159547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19998874|NCT02159547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19998875|NCT02159547|Analgesics|analgesics|mesh-ancestor
19998876|NCT02159547|Sensory System Agents|sensory system agents|mesh-ancestor
19998877|NCT02159547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998878|NCT02159547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998879|NCT02159547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19998880|NCT02159547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19998881|NCT02159807|Fentanyl|fentanyl|mesh-list
19998882|NCT02159807|Bupivacaine|bupivacaine|mesh-list
19998883|NCT02159807|Anesthetics, Local|anesthetics, local|mesh-ancestor
19998884|NCT02159807|Anesthetics|anesthetics|mesh-ancestor
19998885|NCT02159807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19998886|NCT02159807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998887|NCT02159807|Sensory System Agents|sensory system agents|mesh-ancestor
19998888|NCT02159807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998889|NCT02159807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19998890|NCT02159807|Narcotics|narcotics|mesh-ancestor
19998891|NCT02159807|Analgesics|analgesics|mesh-ancestor
19998892|NCT02159807|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19998893|NCT02159807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19998894|NCT02159807|Anesthetics, General|anesthetics, general|mesh-ancestor
19998895|NCT02159859|Ertapenem|ertapenem|mesh-list
19998896|NCT02159859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19998897|NCT02159859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19998898|NCT02159872|Homoharringtonine|homoharringtonine|mesh-list
19998899|NCT02159872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19998900|NCT02159872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998901|NCT02159872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19998902|NCT02159872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998903|NCT02159872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998904|NCT02159950|Vaccines|vaccines|mesh-list
19998905|NCT02159950|Immunologic Factors|immunologic factors|mesh-ancestor
19998906|NCT02159950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998907|NCT02159976|Amoxicillin|amoxicillin|mesh-list
19998908|NCT02159976|Metronidazole|metronidazole|mesh-list
19998909|NCT02159976|Clarithromycin|clarithromycin|mesh-list
19998910|NCT02159976|Tetracycline|tetracycline|mesh-list
19998911|NCT02159976|Pantoprazole|pantoprazole|mesh-list
19998912|NCT02159976|Bismuth|bismuth|mesh-list
19998913|NCT02159976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19998914|NCT02159976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19998915|NCT02159976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19998916|NCT02159976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19998917|NCT02159976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19998918|NCT02159976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998919|NCT02159976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998920|NCT02159976|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19998921|NCT02159976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19998922|NCT02159976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19998923|NCT02159976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19998924|NCT02159976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19998925|NCT02159976|Antacids|antacids|mesh-ancestor
19998926|NCT02160041|Infigratinib|infigratinib|mesh-list
19998927|NCT02160041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998928|NCT02160145|Tolvaptan|tolvaptan|mesh-list
19998929|NCT02160145|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
19998930|NCT02160145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998931|NCT02160145|Natriuretic Agents|natriuretic agents|mesh-ancestor
19998932|NCT02160145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998933|NCT02160288|Botulinum Toxins|botulinum toxins|mesh-list
19998934|NCT02160288|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19998935|NCT02160288|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19998936|NCT02160288|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19998937|NCT02160288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19998938|NCT02160288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998939|NCT02160288|Cholinergic Agents|cholinergic agents|mesh-ancestor
19998940|NCT02160288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19998941|NCT02160288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998942|NCT02160288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19998943|NCT02160288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20289703|NCT04575038|Brequinar|brequinar|mesh-list
20289704|NCT04575038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289705|NCT04575038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289706|NCT04575038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289707|NCT04575038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20289708|NCT04575038|Immunologic Factors|immunologic factors|mesh-ancestor
20289709|NCT04575038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289710|NCT04563520|Coagulants|coagulants|mesh-list
20289711|NCT04563520|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
20289712|NCT04558918|Eculizumab|eculizumab|mesh-list
20289713|NCT04558918|Ravulizumab|ravulizumab|mesh-list
20289714|NCT04558918|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20289715|NCT04558918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20289716|NCT04558918|Immunologic Factors|immunologic factors|mesh-ancestor
20289717|NCT04558918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289718|NCT04553536|Sufentanil|sufentanil|mesh-list
20289719|NCT04553536|Remifentanil|remifentanil|mesh-list
20289720|NCT04553536|Dsuvia|dsuvia|mesh-list
20289721|NCT04553536|Bromides|bromides|mesh-list
20289722|NCT04553536|Propofol|propofol|mesh-list
20289723|NCT04553536|Esketamine|esketamine|mesh-list
20289724|NCT04553536|Rocuronium|rocuronium|mesh-list
20289725|NCT04553536|Cisatracurium|cisatracurium|mesh-list
20289726|NCT04553536|Atracurium|atracurium|mesh-list
20289727|NCT04553536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20289728|NCT04553536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20289729|NCT04553536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289730|NCT04553536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20289731|NCT04553536|Anesthetics, General|anesthetics, general|mesh-ancestor
20289732|NCT04553536|Anesthetics|anesthetics|mesh-ancestor
20289733|NCT04553536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20289734|NCT04553536|Narcotics|narcotics|mesh-ancestor
20289735|NCT04553536|Analgesics|analgesics|mesh-ancestor
20289736|NCT04553536|Sensory System Agents|sensory system agents|mesh-ancestor
20289737|NCT04553536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20289738|NCT04553536|Anticonvulsants|anticonvulsants|mesh-ancestor
20289739|NCT04553536|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20289740|NCT04553536|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20289741|NCT04553536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20289742|NCT04553536|Antidepressive Agents|antidepressive agents|mesh-ancestor
20289743|NCT04553536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20289744|NCT04553536|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20289745|NCT04553536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20289746|NCT04553536|Cholinergic Agents|cholinergic agents|mesh-ancestor
20289747|NCT04553536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20289748|NCT04553536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289749|NCT04553536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20289750|NCT04551547|Vaccines|vaccines|mesh-list
20289751|NCT04551547|Immunologic Factors|immunologic factors|mesh-ancestor
20289752|NCT04551547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289753|NCT04549792|Ustekinumab|ustekinumab|mesh-list
20289754|NCT04549792|Dermatologic Agents|dermatologic agents|mesh-ancestor
20289755|NCT04547140|Protease Inhibitors|protease inhibitors|mesh-list
19998944|NCT02160535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19998945|NCT02160535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19998946|NCT02160535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19998947|NCT02160535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998948|NCT02160535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998949|NCT02160535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19998950|NCT02160535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19998951|NCT02160535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998952|NCT02160535|Cholinergic Agents|cholinergic agents|mesh-ancestor
19998953|NCT02160535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19998954|NCT02160626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19998955|NCT02160730|Roscovitine|roscovitine|mesh-list
19998956|NCT02160730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19998957|NCT02160730|Antiviral Agents|antiviral agents|mesh-ancestor
19998958|NCT02160730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19998959|NCT02160730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19998960|NCT02160730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19998961|NCT02160730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998962|NCT02160808|Secretin|secretin|mesh-list
19998963|NCT02160808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19998964|NCT02160808|Hormones|hormones|mesh-ancestor
19998965|NCT02160808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19998966|NCT02160808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998967|NCT02160990|Exenatide|exenatide|mesh-list
19998968|NCT02160990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19998969|NCT02160990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998970|NCT02160990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19998971|NCT02160990|Incretins|incretins|mesh-ancestor
19998972|NCT02160990|Hormones|hormones|mesh-ancestor
19998973|NCT02160990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19998974|NCT02161146|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
19998975|NCT02161146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19998976|NCT02161146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19998977|NCT02161146|Analgesics|analgesics|mesh-ancestor
19998978|NCT02161146|Sensory System Agents|sensory system agents|mesh-ancestor
19998979|NCT02161146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19998980|NCT02161146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998981|NCT02161146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19998982|NCT02161146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19998983|NCT02161146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19998984|NCT02161146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19998985|NCT02161146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19998986|NCT02161146|Histamine Antagonists|histamine antagonists|mesh-ancestor
19998987|NCT02161146|Histamine Agents|histamine agents|mesh-ancestor
19998988|NCT02161146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19998989|NCT02161146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19998990|NCT02161185|Midazolam|midazolam|mesh-list
19998991|NCT02161185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19998992|NCT02161185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19998993|NCT02161185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19998994|NCT02161185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19998995|NCT02161185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19998996|NCT02161185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19998997|NCT02161185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19998998|NCT02161185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19998999|NCT02161185|Anesthetics, General|anesthetics, general|mesh-ancestor
19999000|NCT02161185|Anesthetics|anesthetics|mesh-ancestor
19999001|NCT02161185|GABA Modulators|gaba modulators|mesh-ancestor
19999002|NCT02161185|GABA Agents|gaba agents|mesh-ancestor
19999003|NCT02161185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999004|NCT02161185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999005|NCT02161406|Abatacept|abatacept|mesh-list
19999006|NCT02161406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19999007|NCT02161406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999008|NCT02161406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19999009|NCT02161406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19999010|NCT02161406|Immunologic Factors|immunologic factors|mesh-ancestor
19999011|NCT02161406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999012|NCT02161406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19999013|NCT02161458|Dexetimide|dexetimide|mesh-list
19999014|NCT02161458|Citalopram|citalopram|mesh-list
19999015|NCT02161458|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19999016|NCT02161458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19999017|NCT02161458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19999018|NCT02161458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999019|NCT02161458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999020|NCT02161458|Serotonin Agents|serotonin agents|mesh-ancestor
19999021|NCT02161458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999022|NCT02161458|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19999023|NCT02161458|Antidepressive Agents|antidepressive agents|mesh-ancestor
19999024|NCT02161458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19999025|NCT02161458|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19999026|NCT02161458|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19999027|NCT02161458|Parasympatholytics|parasympatholytics|mesh-ancestor
19999028|NCT02161458|Autonomic Agents|autonomic agents|mesh-ancestor
19999029|NCT02161458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19999030|NCT02161458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19999031|NCT02161458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19999032|NCT02161458|Cholinergic Agents|cholinergic agents|mesh-ancestor
19999033|NCT02161484|Bupivacaine|bupivacaine|mesh-list
19999034|NCT02161484|Anesthetics, Local|anesthetics, local|mesh-ancestor
19999035|NCT02161484|Anesthetics|anesthetics|mesh-ancestor
19999036|NCT02161484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19999037|NCT02161484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999038|NCT02161484|Sensory System Agents|sensory system agents|mesh-ancestor
19999039|NCT02161484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19999040|NCT02161562|Omalizumab|omalizumab|mesh-list
19999041|NCT02161562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19999042|NCT02161562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19999043|NCT02161562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19999044|NCT02161562|Respiratory System Agents|respiratory system agents|mesh-ancestor
19999045|NCT02161562|Immunologic Factors|immunologic factors|mesh-ancestor
19999046|NCT02161562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999047|NCT02161575|Ranibizumab|ranibizumab|mesh-list
19999048|NCT02161575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19999049|NCT02161575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19999050|NCT02161575|Growth Substances|growth substances|mesh-ancestor
19999051|NCT02161575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999052|NCT02161575|Growth Inhibitors|growth inhibitors|mesh-ancestor
19999053|NCT02161575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19999054|NCT02161705|Ropivacaine|ropivacaine|mesh-list
19999055|NCT02161705|Anesthetics, Local|anesthetics, local|mesh-ancestor
19999056|NCT02161705|Anesthetics|anesthetics|mesh-ancestor
19999057|NCT02161705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19999058|NCT02161705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999059|NCT02161705|Sensory System Agents|sensory system agents|mesh-ancestor
19999060|NCT02161705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19999061|NCT02161718|Olanzapine|olanzapine|mesh-list
19999062|NCT02161718|Antiemetics|antiemetics|mesh-ancestor
19999063|NCT02161718|Autonomic Agents|autonomic agents|mesh-ancestor
19999064|NCT02161718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19999065|NCT02161718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999066|NCT02161718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19999067|NCT02161718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19999068|NCT02161718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19999069|NCT02161718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19999070|NCT02161718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19999071|NCT02161718|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19999072|NCT02161718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19999073|NCT02161718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19999074|NCT02161718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999075|NCT02161718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999076|NCT02161718|Serotonin Agents|serotonin agents|mesh-ancestor
19999077|NCT02161731|Warfarin|warfarin|mesh-list
19999078|NCT02161731|Evacetrapib|evacetrapib|mesh-list
19999079|NCT02161731|Anticoagulants|anticoagulants|mesh-ancestor
19999080|NCT02161731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19999081|NCT02161731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19999082|NCT02161731|Antimetabolites|antimetabolites|mesh-ancestor
19999083|NCT02161731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999084|NCT02161731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19999085|NCT02162433|Dexmedetomidine|dexmedetomidine|mesh-list
19999086|NCT02162433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19999087|NCT02162433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19999088|NCT02162433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999089|NCT02162433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19999090|NCT02162433|Analgesics|analgesics|mesh-ancestor
19999091|NCT02162433|Sensory System Agents|sensory system agents|mesh-ancestor
19999092|NCT02162433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19999093|NCT02162433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19999094|NCT02162433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19999095|NCT02162433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19999096|NCT02162433|Adrenergic Agents|adrenergic agents|mesh-ancestor
19999097|NCT02162433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999098|NCT02162433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999099|NCT02162667|Trastuzumab|trastuzumab|mesh-list
19999100|NCT02162667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19999101|NCT02162667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19999102|NCT02162680|Lidocaine|lidocaine|mesh-list
19999103|NCT02162680|Anesthetics, Local|anesthetics, local|mesh-ancestor
19999104|NCT02162680|Anesthetics|anesthetics|mesh-ancestor
19999105|NCT02162680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19999106|NCT02162680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999107|NCT02162680|Sensory System Agents|sensory system agents|mesh-ancestor
19999108|NCT02162680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19999109|NCT02162680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19999110|NCT02162680|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19999111|NCT02162680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19999112|NCT02162680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19999113|NCT02162680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999114|NCT02162719|Paclitaxel|paclitaxel|mesh-list
19999115|NCT02162719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19999116|NCT02162719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19999117|NCT02162719|Tubulin Modulators|tubulin modulators|mesh-ancestor
19999118|NCT02162719|Antimitotic Agents|antimitotic agents|mesh-ancestor
19999119|NCT02162719|Mitosis Modulators|mitosis modulators|mesh-ancestor
19999120|NCT02162719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999121|NCT02162758|Dexlansoprazole|dexlansoprazole|mesh-list
19999122|NCT02162758|Lansoprazole|lansoprazole|mesh-list
19999123|NCT02162758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19999124|NCT02162758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19999125|NCT02162758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19999126|NCT02162758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999127|NCT02162758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999128|NCT02162771|Prednisone|prednisone|mesh-list
19999129|NCT02162771|Prednisolone|prednisolone|mesh-list
19999130|NCT02162771|Cyclophosphamide|cyclophosphamide|mesh-list
19999131|NCT02162771|Rituximab|rituximab|mesh-list
19999132|NCT02162771|Vincristine|vincristine|mesh-list
19999133|NCT02162771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19999134|NCT02162771|Immunologic Factors|immunologic factors|mesh-ancestor
19999135|NCT02162771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999136|NCT02162771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19999137|NCT02162771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19999138|NCT02162771|Alkylating Agents|alkylating agents|mesh-ancestor
19999139|NCT02162771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999140|NCT02162771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19999141|NCT02162771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19999142|NCT02162771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19999143|NCT02162771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19999144|NCT02162771|Glucocorticoids|glucocorticoids|mesh-ancestor
19999145|NCT02162771|Hormones|hormones|mesh-ancestor
19999146|NCT02162771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19999147|NCT02162771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19999148|NCT02162771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19999149|NCT02162771|Tubulin Modulators|tubulin modulators|mesh-ancestor
19999150|NCT02162771|Antimitotic Agents|antimitotic agents|mesh-ancestor
19999151|NCT02162771|Mitosis Modulators|mitosis modulators|mesh-ancestor
19999152|NCT02162862|Bupropion|bupropion|mesh-list
19999153|NCT02162862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19999154|NCT02162862|Antidepressive Agents|antidepressive agents|mesh-ancestor
19999155|NCT02162862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19999156|NCT02162862|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19999157|NCT02162862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19999158|NCT02162862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19999159|NCT02162862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999160|NCT02162862|Dopamine Agents|dopamine agents|mesh-ancestor
19999161|NCT02162862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999162|NCT02162862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999163|NCT02162862|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19999164|NCT02162862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19999165|NCT02162862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999166|NCT02163421|Vedolizumab|vedolizumab|mesh-list
19999167|NCT02163421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19999168|NCT02163434|Gabapentin|gabapentin|mesh-list
19999169|NCT02163434|Metoclopramide|metoclopramide|mesh-list
19999170|NCT02163434|Analgesics|analgesics|mesh-ancestor
19999171|NCT02163434|Sensory System Agents|sensory system agents|mesh-ancestor
19999172|NCT02163434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19999173|NCT02163434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999174|NCT02163434|Anticonvulsants|anticonvulsants|mesh-ancestor
19999175|NCT02163434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19999176|NCT02163434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19999177|NCT02163434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19999178|NCT02163434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19999179|NCT02163434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19999180|NCT02163434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19999181|NCT02163434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999182|NCT02163434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999183|NCT02163434|Antimanic Agents|antimanic agents|mesh-ancestor
19999184|NCT02163434|Antiemetics|antiemetics|mesh-ancestor
19999185|NCT02163434|Autonomic Agents|autonomic agents|mesh-ancestor
19999186|NCT02163434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19999187|NCT02163434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19999188|NCT02163434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19999189|NCT02163434|Dopamine Agents|dopamine agents|mesh-ancestor
19999190|NCT02163447|Pyrimethamine|pyrimethamine|mesh-list
19999191|NCT02163447|Piperaquine|piperaquine|mesh-list
19999192|NCT02163447|Sulfadoxine|sulfadoxine|mesh-list
19999193|NCT02163447|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
19999194|NCT02163447|Artenimol|artenimol|mesh-list
19999195|NCT02163447|Artemisinins|artemisinins|mesh-list
19999196|NCT02163447|Antimalarials|antimalarials|mesh-ancestor
19999197|NCT02163447|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19999198|NCT02163447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19999199|NCT02163447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19999200|NCT02163447|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19999201|NCT02163447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999202|NCT02163447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999203|NCT02163447|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19999204|NCT02163447|Renal Agents|renal agents|mesh-ancestor
19999205|NCT02163759|Adalimumab|adalimumab|mesh-list
19999206|NCT02163759|Etrolizumab|etrolizumab|mesh-list
19999207|NCT02163759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19999208|NCT02163759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19999209|NCT02163759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19999210|NCT02163759|Immunologic Factors|immunologic factors|mesh-ancestor
19999211|NCT02163759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999212|NCT02163824|Loteprednol Etabonate|loteprednol etabonate|mesh-list
19999213|NCT02163824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19999214|NCT02163837|Rifaximin|rifaximin|mesh-list
19999215|NCT02163837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19999216|NCT02163837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19999217|NCT02163837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19999218|NCT02164240|Sunitinib|sunitinib|mesh-list
19999219|NCT02164240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19999220|NCT02164240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19999221|NCT02164240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19999222|NCT02164240|Growth Substances|growth substances|mesh-ancestor
19999223|NCT02164240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999224|NCT02164240|Growth Inhibitors|growth inhibitors|mesh-ancestor
19999225|NCT02164240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19999226|NCT02164240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999227|NCT02164240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999228|NCT02164318|Nitroglycerin|nitroglycerin|mesh-list
19999229|NCT02164318|Vasodilator Agents|vasodilator agents|mesh-ancestor
19999230|NCT02164383|Nicotine|nicotine|mesh-list
19999231|NCT02164383|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19999232|NCT02164383|Autonomic Agents|autonomic agents|mesh-ancestor
19999233|NCT02164383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19999234|NCT02164383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999235|NCT02164383|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19999236|NCT02164383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19999237|NCT02164383|Cholinergic Agents|cholinergic agents|mesh-ancestor
19999238|NCT02164383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999239|NCT02164383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999240|NCT02164422|Guanfacine|guanfacine|mesh-list
19999241|NCT02164422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19999242|NCT02164422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19999243|NCT02164422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19999244|NCT02164422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19999245|NCT02164422|Adrenergic Agents|adrenergic agents|mesh-ancestor
19999246|NCT02164422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999247|NCT02164422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999248|NCT02164422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999249|NCT02164513|Fluticasone|fluticasone|mesh-list
19999250|NCT02164513|Xhance|xhance|mesh-list
19999251|NCT02164513|Bromides|bromides|mesh-list
19999252|NCT02164513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19999253|NCT02164513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19999254|NCT02164513|Autonomic Agents|autonomic agents|mesh-ancestor
19999255|NCT02164513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19999256|NCT02164513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999257|NCT02164513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19999258|NCT02164513|Respiratory System Agents|respiratory system agents|mesh-ancestor
19999259|NCT02164513|Dermatologic Agents|dermatologic agents|mesh-ancestor
19999260|NCT02164513|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19999261|NCT02164513|Anticonvulsants|anticonvulsants|mesh-ancestor
19999262|NCT02164864|Aspirin|aspirin|mesh-list
19999263|NCT02164864|Warfarin|warfarin|mesh-list
19999264|NCT02164864|Dabigatran|dabigatran|mesh-list
19999265|NCT02164864|Clopidogrel|clopidogrel|mesh-list
19999266|NCT02164864|Ticagrelor|ticagrelor|mesh-list
19999267|NCT02164864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19999268|NCT02164864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19999269|NCT02164864|Analgesics|analgesics|mesh-ancestor
19999270|NCT02164864|Sensory System Agents|sensory system agents|mesh-ancestor
19999271|NCT02164864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19999272|NCT02164864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999273|NCT02164864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19999274|NCT02164864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19999275|NCT02164864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19999276|NCT02164864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19999277|NCT02164864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999278|NCT02164864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19999279|NCT02164864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19999280|NCT02164864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999281|NCT02164864|Antipyretics|antipyretics|mesh-ancestor
19999282|NCT02164864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19999283|NCT02164864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20556740|NCT01948804|Clomiphene|clomiphene|mesh-list
20556741|NCT01948804|Cetrorelix|cetrorelix|mesh-list
20556742|NCT01948804|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
20556743|NCT01948804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556744|NCT01948804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20556745|NCT01948804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20556746|NCT01948804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999284|NCT02164864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19999285|NCT02164864|Purinergic Agents|purinergic agents|mesh-ancestor
19999286|NCT02164864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999287|NCT02164864|Anticoagulants|anticoagulants|mesh-ancestor
19999288|NCT02164864|Antithrombins|antithrombins|mesh-ancestor
19999289|NCT02164864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19999290|NCT02164864|Protease Inhibitors|protease inhibitors|mesh-ancestor
19999291|NCT02164916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19999292|NCT02164916|Cetuximab|cetuximab|mesh-list
19999293|NCT02164916|Irinotecan|irinotecan|mesh-list
19999294|NCT02164916|Camptothecin|camptothecin|mesh-list
19999295|NCT02164916|Vemurafenib|vemurafenib|mesh-list
19999296|NCT02164916|Antibodies|antibodies|mesh-list
19999297|NCT02164916|Immunoglobulins|immunoglobulins|mesh-list
19999298|NCT02164916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19999299|NCT02164916|Immunoglobulin G|immunoglobulin g|mesh-list
19999300|NCT02164916|Mitogens|mitogens|mesh-list
19999301|NCT02164916|Immunologic Factors|immunologic factors|mesh-ancestor
19999302|NCT02164916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999303|NCT02164916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19999304|NCT02164916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19999305|NCT02164916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19999306|NCT02164916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999307|NCT02164916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999308|NCT02164916|Mitosis Modulators|mitosis modulators|mesh-ancestor
19999309|NCT02164916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19999310|NCT02164916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19999311|NCT02164929|Acetaminophen|acetaminophen|mesh-list
19999312|NCT02164929|Dexamethasone|dexamethasone|mesh-list
19999313|NCT02164929|Lidocaine|lidocaine|mesh-list
19999314|NCT02164929|Epinephrine|epinephrine|mesh-list
19999315|NCT02164929|Midazolam|midazolam|mesh-list
19999316|NCT02164929|Hydromorphone|hydromorphone|mesh-list
19999317|NCT02164929|Ropivacaine|ropivacaine|mesh-list
19999318|NCT02164929|Propofol|propofol|mesh-list
19999319|NCT02164929|Sevoflurane|sevoflurane|mesh-list
19999320|NCT02164929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19999321|NCT02164929|Antiemetics|antiemetics|mesh-ancestor
19999322|NCT02164929|Autonomic Agents|autonomic agents|mesh-ancestor
19999323|NCT02164929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19999324|NCT02164929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999325|NCT02164929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19999326|NCT02164929|Glucocorticoids|glucocorticoids|mesh-ancestor
19999327|NCT02164929|Hormones|hormones|mesh-ancestor
19999328|NCT02164929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19999329|NCT02164929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19999330|NCT02164929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19999331|NCT02164929|Anesthetics, Local|anesthetics, local|mesh-ancestor
19999332|NCT02164929|Anesthetics|anesthetics|mesh-ancestor
19999333|NCT02164929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19999334|NCT02164929|Sensory System Agents|sensory system agents|mesh-ancestor
19999335|NCT02164929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19999336|NCT02164929|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19999337|NCT02164929|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19999338|NCT02164929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19999339|NCT02164929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999340|NCT02164929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19999341|NCT02164929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19999342|NCT02164929|Anesthetics, General|anesthetics, general|mesh-ancestor
19999343|NCT02164929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19999344|NCT02164929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19999345|NCT02164929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19999346|NCT02164929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19999347|NCT02164929|GABA Modulators|gaba modulators|mesh-ancestor
19999348|NCT02164929|GABA Agents|gaba agents|mesh-ancestor
19999349|NCT02164929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999350|NCT02164929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19999351|NCT02164929|Analgesics|analgesics|mesh-ancestor
19999352|NCT02164929|Antipyretics|antipyretics|mesh-ancestor
19999353|NCT02164929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19999354|NCT02164929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19999355|NCT02164929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19999356|NCT02164929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19999357|NCT02164929|Adrenergic Agents|adrenergic agents|mesh-ancestor
19999358|NCT02164929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19999359|NCT02164929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19999360|NCT02164929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19999361|NCT02164929|Respiratory System Agents|respiratory system agents|mesh-ancestor
19999362|NCT02164929|Mydriatics|mydriatics|mesh-ancestor
19999363|NCT02164929|Sympathomimetics|sympathomimetics|mesh-ancestor
19999364|NCT02164929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19999365|NCT02164929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19999366|NCT02164929|Narcotics|narcotics|mesh-ancestor
19999367|NCT02164981|Nitroprusside|nitroprusside|mesh-list
19999368|NCT02164981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19999369|NCT02164981|Vasodilator Agents|vasodilator agents|mesh-ancestor
19999370|NCT02164981|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19999371|NCT02164981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999372|NCT02165111|Botulinum Toxins|botulinum toxins|mesh-list
19999373|NCT02165111|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19999374|NCT02165111|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19999375|NCT02165111|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19999376|NCT02165111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19999377|NCT02165111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999378|NCT02165111|Cholinergic Agents|cholinergic agents|mesh-ancestor
19999379|NCT02165111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999380|NCT02165111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999381|NCT02165111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19999382|NCT02165111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19999383|NCT02165202|Rilpivirine|rilpivirine|mesh-list
19999384|NCT02165202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19999385|NCT02165202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19999386|NCT02165202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999387|NCT02165202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999388|NCT02165202|Antiviral Agents|antiviral agents|mesh-ancestor
19999389|NCT02165202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19999390|NCT02165202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19999391|NCT02165202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19999392|NCT02165397|Rituximab|rituximab|mesh-list
19999393|NCT02165397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19999394|NCT02165397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19999395|NCT02165397|Immunologic Factors|immunologic factors|mesh-ancestor
19999396|NCT02165397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999397|NCT02165397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19999398|NCT02166047|Vesatolimod|vesatolimod|mesh-list
19999399|NCT02166047|Antiviral Agents|antiviral agents|mesh-ancestor
19999400|NCT02166047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19999401|NCT02166333|Vitamin D|vitamin d|mesh-list
19999402|NCT02166333|Ergocalciferols|ergocalciferols|mesh-list
19999403|NCT02166333|Cholecalciferol|cholecalciferol|mesh-list
19999404|NCT02166333|Vitamins|vitamins|mesh-list
19999405|NCT02166333|Micronutrients|micronutrients|mesh-ancestor
19999406|NCT02166333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999407|NCT02166333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19999408|NCT02166333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19999409|NCT02166346|4-Aminopyridine|4-aminopyridine|mesh-list
19999410|NCT02166346|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19999411|NCT02166346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19999412|NCT02166346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999413|NCT02166476|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19999414|NCT02166476|Levofloxacin|levofloxacin|mesh-list
19999415|NCT02166476|Ofloxacin|ofloxacin|mesh-list
19999416|NCT02166476|Meropenem|meropenem|mesh-list
19999417|NCT02166476|Tazobactam|tazobactam|mesh-list
19999418|NCT02166476|Piperacillin|piperacillin|mesh-list
19999419|NCT02166476|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19999420|NCT02166476|Vaborbactam|vaborbactam|mesh-list
19999421|NCT02166476|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
19999422|NCT02166476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19999423|NCT02166476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19999424|NCT02166476|Renal Agents|renal agents|mesh-ancestor
19999425|NCT02166476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19999426|NCT02166476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19999427|NCT02166476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999428|NCT02166476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999429|NCT02166476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19999430|NCT02166476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19999431|NCT02166476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19999432|NCT02166697|Candesartan|candesartan|mesh-list
19999433|NCT02166697|Candesartan cilexetil|candesartan cilexetil|mesh-list
19999434|NCT02166697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19999435|NCT02166697|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19999436|NCT02166697|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19999437|NCT02166697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999438|NCT02167035|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
19999439|NCT02167035|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19999440|NCT02167035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19999441|NCT02167035|Adrenergic Agents|adrenergic agents|mesh-ancestor
19999442|NCT02167035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999443|NCT02167035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999444|NCT02167035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999445|NCT02167035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19999446|NCT02167035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19999447|NCT02167035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19999448|NCT02167139|Adalimumab|adalimumab|mesh-list
19999449|NCT02167139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19999450|NCT02167139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19999451|NCT02167204|Alovudine|alovudine|mesh-list
19999452|NCT02167204|Antiviral Agents|antiviral agents|mesh-ancestor
19999453|NCT02167204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19999454|NCT02167217|Prednisolone|prednisolone|mesh-list
19999455|NCT02167217|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19999456|NCT02167217|Methylprednisolone|methylprednisolone|mesh-list
19999457|NCT02167217|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19999458|NCT02167217|Prednisolone acetate|prednisolone acetate|mesh-list
19999459|NCT02167217|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19999460|NCT02167217|Prednisolone phosphate|prednisolone phosphate|mesh-list
19999461|NCT02167217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19999462|NCT02167217|Glucocorticoids|glucocorticoids|mesh-ancestor
19999463|NCT02167217|Hormones|hormones|mesh-ancestor
19999464|NCT02167217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19999465|NCT02167217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999466|NCT02167217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19999467|NCT02167217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19999468|NCT02167217|Antiemetics|antiemetics|mesh-ancestor
19999469|NCT02167217|Autonomic Agents|autonomic agents|mesh-ancestor
19999470|NCT02167217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19999471|NCT02167217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19999472|NCT02167217|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19999473|NCT02167217|Protective Agents|protective agents|mesh-ancestor
19999474|NCT02167256|Saracatinib|saracatinib|mesh-list
19999475|NCT02167256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19999476|NCT02167256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999477|NCT02167256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999478|NCT02167451|Maraviroc|maraviroc|mesh-list
19999479|NCT02167451|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
19999480|NCT02167451|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
19999481|NCT02167451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999482|NCT02167451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19999483|NCT02167451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19999484|NCT02167451|Antiviral Agents|antiviral agents|mesh-ancestor
19999485|NCT02167451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19999486|NCT02167451|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
19999487|NCT02167893|Leuprolide|leuprolide|mesh-list
19999488|NCT02167893|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19999489|NCT02167893|Fertility Agents|fertility agents|mesh-ancestor
19999490|NCT02167893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19999491|NCT02167893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999492|NCT02167893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19999493|NCT02167893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19999494|NCT02168062|Leuprolide|leuprolide|mesh-list
19999495|NCT02168062|Goserelin|goserelin|mesh-list
19999496|NCT02168062|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19999497|NCT02168062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19999498|NCT02168062|Fertility Agents|fertility agents|mesh-ancestor
19999499|NCT02168062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19999500|NCT02168062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999501|NCT02168062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19999502|NCT02168062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19999503|NCT02168062|Luteolytic Agents|luteolytic agents|mesh-ancestor
19999504|NCT02168062|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19999505|NCT02168062|Contraceptive Agents|contraceptive agents|mesh-ancestor
19999506|NCT02168062|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19999507|NCT02168101|Ixazomib|ixazomib|mesh-list
19999508|NCT02168101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19999509|NCT02168101|Protease Inhibitors|protease inhibitors|mesh-ancestor
19999510|NCT02168101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289756|NCT04547140|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
19999511|NCT02168101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999512|NCT02168309|Labetalol|labetalol|mesh-list
19999513|NCT02168309|Nifedipine|nifedipine|mesh-list
19999514|NCT02168309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19999515|NCT02168309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19999516|NCT02168309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999517|NCT02168309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19999518|NCT02168309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999519|NCT02168309|Vasodilator Agents|vasodilator agents|mesh-ancestor
19999520|NCT02168309|Tocolytic Agents|tocolytic agents|mesh-ancestor
19999521|NCT02168309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19999522|NCT02168309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19999523|NCT02168309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19999524|NCT02168309|Adrenergic Agents|adrenergic agents|mesh-ancestor
19999525|NCT02168309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999526|NCT02168309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19999527|NCT02168309|Sympathomimetics|sympathomimetics|mesh-ancestor
19999528|NCT02168309|Autonomic Agents|autonomic agents|mesh-ancestor
19999529|NCT02168309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19999530|NCT02168309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19999531|NCT02168309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20289757|NCT04547140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289758|NCT04547140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289759|NCT04547140|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20289760|NCT04547140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20289761|NCT04533997|Furosemide|furosemide|mesh-list
20289762|NCT04533997|Diuretics|diuretics|mesh-ancestor
20289763|NCT04533997|Natriuretic Agents|natriuretic agents|mesh-ancestor
20289764|NCT04533997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289765|NCT04533997|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20289766|NCT04533997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20289767|NCT04533997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289768|NCT04533451|Carboplatin|carboplatin|mesh-list
20289769|NCT04533451|Pembrolizumab|pembrolizumab|mesh-list
20289770|NCT04533451|Pemetrexed|pemetrexed|mesh-list
20289771|NCT04533451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289772|NCT04533451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20289773|NCT04533451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289774|NCT04533451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289775|NCT04533451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20289776|NCT04533451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20289777|NCT04519476|Methylprednisolone|methylprednisolone|mesh-list
20289778|NCT04519476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20289779|NCT04519476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20289780|NCT04519476|Prednisolone|prednisolone|mesh-list
20289781|NCT04519476|Prednisolone acetate|prednisolone acetate|mesh-list
20289782|NCT04519476|Lenalidomide|lenalidomide|mesh-list
20289783|NCT04519476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20289784|NCT04519476|Prednisolone phosphate|prednisolone phosphate|mesh-list
20289785|NCT04519476|Immunologic Factors|immunologic factors|mesh-ancestor
20289786|NCT04519476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289787|NCT04519476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20289788|NCT04519476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20289789|NCT04519476|Growth Substances|growth substances|mesh-ancestor
20289790|NCT04519476|Growth Inhibitors|growth inhibitors|mesh-ancestor
20289791|NCT04519476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289792|NCT04519476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20289793|NCT04519476|Antiemetics|antiemetics|mesh-ancestor
20289794|NCT04519476|Autonomic Agents|autonomic agents|mesh-ancestor
20289795|NCT04519476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20289796|NCT04519476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20289797|NCT04519476|Glucocorticoids|glucocorticoids|mesh-ancestor
20289798|NCT04519476|Hormones|hormones|mesh-ancestor
20289799|NCT04519476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20289800|NCT04519476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20289801|NCT04519476|Protective Agents|protective agents|mesh-ancestor
20289802|NCT04519476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20289803|NCT04500158|Lidocaine|lidocaine|mesh-list
20289804|NCT04500158|Anesthetics, Local|anesthetics, local|mesh-ancestor
20289805|NCT04500158|Anesthetics|anesthetics|mesh-ancestor
20289806|NCT04500158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20289807|NCT04500158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289808|NCT04500158|Sensory System Agents|sensory system agents|mesh-ancestor
20289809|NCT04500158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19999532|NCT02168361|Interferons|interferons|mesh-list
19999533|NCT02168361|Ribavirin|ribavirin|mesh-list
19999534|NCT02168361|Interferon-alpha|interferon-alpha|mesh-list
19999535|NCT02168361|Interferon alpha-2|interferon alpha-2|mesh-list
19999536|NCT02168361|Sofosbuvir|sofosbuvir|mesh-list
19999537|NCT02168361|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19999538|NCT02168361|Simeprevir|simeprevir|mesh-list
19999539|NCT02168361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19999540|NCT02168361|Antiviral Agents|antiviral agents|mesh-ancestor
19999541|NCT02168361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19999542|NCT02168361|Antimetabolites|antimetabolites|mesh-ancestor
19999543|NCT02168361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999544|NCT02168361|Immunologic Factors|immunologic factors|mesh-ancestor
19999545|NCT02168361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999546|NCT02168361|Protease Inhibitors|protease inhibitors|mesh-ancestor
19999547|NCT02168361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999548|NCT02168387|Acetylcysteine|acetylcysteine|mesh-list
19999549|NCT02168387|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19999550|NCT02168387|Antiviral Agents|antiviral agents|mesh-ancestor
20556747|NCT01948804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556748|NCT01948804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20556749|NCT01948804|Hormone Antagonists|hormone antagonists|mesh-ancestor
20556750|NCT01948804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20556751|NCT01948804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556752|NCT01948804|Hormones|hormones|mesh-ancestor
20556753|NCT01948804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20556754|NCT01948804|Fertility Agents|fertility agents|mesh-ancestor
20556755|NCT01948804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20556756|NCT01948804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20556757|NCT01948804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20556758|NCT01948817|Deferasirox|deferasirox|mesh-list
20556759|NCT01948817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20556760|NCT01948817|Chelating Agents|chelating agents|mesh-ancestor
20556761|NCT01948817|Sequestering Agents|sequestering agents|mesh-ancestor
20556762|NCT01948817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556763|NCT01948895|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20556764|NCT01948895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20556765|NCT01948895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20556766|NCT01948895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20556767|NCT01948895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556768|NCT01948895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20556769|NCT01948895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556770|NCT01948895|Antidepressive Agents|antidepressive agents|mesh-ancestor
20556771|NCT01948895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20556772|NCT01948921|Meperidine|meperidine|mesh-list
20556773|NCT01948921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20556774|NCT01948921|Narcotics|narcotics|mesh-ancestor
20556775|NCT01948921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20556776|NCT01948921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556777|NCT01948921|Analgesics|analgesics|mesh-ancestor
20556778|NCT01948921|Sensory System Agents|sensory system agents|mesh-ancestor
20556779|NCT01948921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556780|NCT01948921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20556781|NCT01948960|Everolimus|everolimus|mesh-list
20556782|NCT01948960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556783|NCT01948960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20556784|NCT01948960|Immunologic Factors|immunologic factors|mesh-ancestor
20556785|NCT01948960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556786|NCT01948999|Anesthetics|anesthetics|mesh-list
20556787|NCT01948999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20556788|NCT01948999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556789|NCT01949038|Alprazolam|alprazolam|mesh-list
20556790|NCT01949038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20556791|NCT01949038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20556792|NCT01949038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556793|NCT01949038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20556794|NCT01949038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20556795|NCT01949038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20556796|NCT01949038|GABA Modulators|gaba modulators|mesh-ancestor
20556797|NCT01949038|GABA Agents|gaba agents|mesh-ancestor
20556798|NCT01949038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20556799|NCT01949038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999551|NCT02168387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19999552|NCT02168387|Expectorants|expectorants|mesh-ancestor
19999553|NCT02168387|Respiratory System Agents|respiratory system agents|mesh-ancestor
19999554|NCT02168387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19999555|NCT02168387|Antioxidants|antioxidants|mesh-ancestor
19999556|NCT02168387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999557|NCT02168387|Protective Agents|protective agents|mesh-ancestor
19999558|NCT02168387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999559|NCT02168387|Antidotes|antidotes|mesh-ancestor
19999560|NCT02168439|Midazolam|midazolam|mesh-list
19999561|NCT02168439|Dexmedetomidine|dexmedetomidine|mesh-list
19999562|NCT02168439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19999563|NCT02168439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19999564|NCT02168439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999565|NCT02168439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19999566|NCT02168439|Analgesics|analgesics|mesh-ancestor
19999567|NCT02168439|Sensory System Agents|sensory system agents|mesh-ancestor
19999568|NCT02168439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19999569|NCT02168439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19999570|NCT02168439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19999571|NCT02168439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19999572|NCT02168439|Adrenergic Agents|adrenergic agents|mesh-ancestor
19999573|NCT02168439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999574|NCT02168439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999575|NCT02168439|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19999576|NCT02168439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19999577|NCT02168439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19999578|NCT02168439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19999579|NCT02168439|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19999580|NCT02168439|Anesthetics, General|anesthetics, general|mesh-ancestor
19999581|NCT02168439|Anesthetics|anesthetics|mesh-ancestor
19999582|NCT02168439|GABA Modulators|gaba modulators|mesh-ancestor
19999583|NCT02168439|GABA Agents|gaba agents|mesh-ancestor
19999584|NCT02168478|Neomycin|neomycin|mesh-list
19999585|NCT02168478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19999586|NCT02168478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19999587|NCT02168478|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19999588|NCT02168478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999589|NCT02168478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999590|NCT02168491|Insulin Glargine|insulin glargine|mesh-list
19999591|NCT02168491|Lixisenatide|lixisenatide|mesh-list
19999592|NCT02168491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19999593|NCT02168491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999594|NCT02168660|Vitamin D|vitamin d|mesh-list
19999595|NCT02168660|Cholecalciferol|cholecalciferol|mesh-list
19999596|NCT02168660|Vitamins|vitamins|mesh-ancestor
19999597|NCT02168660|Micronutrients|micronutrients|mesh-ancestor
19999598|NCT02168660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999599|NCT02168660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19999600|NCT02168660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19999601|NCT02168803|Evacetrapib|evacetrapib|mesh-list
19999602|NCT02168803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19999603|NCT02168803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19999604|NCT02168803|Antimetabolites|antimetabolites|mesh-ancestor
19999605|NCT02168803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999606|NCT02168803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19999607|NCT02168816|Moxifloxacin|moxifloxacin|mesh-list
19999608|NCT02168816|Metronidazole|metronidazole|mesh-list
19999609|NCT02168816|Vancomycin|vancomycin|mesh-list
19999610|NCT02168816|Ciprofloxacin|ciprofloxacin|mesh-list
19999611|NCT02168816|Clindamycin|clindamycin|mesh-list
19999612|NCT02168816|Meropenem|meropenem|mesh-list
19999613|NCT02168816|Tazobactam|tazobactam|mesh-list
19999614|NCT02168816|Linezolid|linezolid|mesh-list
19999615|NCT02168816|Piperacillin|piperacillin|mesh-list
19999616|NCT02168816|Daptomycin|daptomycin|mesh-list
19999617|NCT02168816|Cefepime|cefepime|mesh-list
19999618|NCT02168816|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
19999619|NCT02168816|Aztreonam|aztreonam|mesh-list
19999620|NCT02168816|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19999621|NCT02168816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
19999622|NCT02168816|Trimethoprim|trimethoprim|mesh-list
19999623|NCT02168816|Sulfamethoxazole|sulfamethoxazole|mesh-list
19999624|NCT02168816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19999625|NCT02168816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19999626|NCT02168816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19999627|NCT02168816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999628|NCT02168816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556800|NCT01949064|Salicylic Acid|salicylic acid|mesh-list
19999629|NCT02168816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19999630|NCT02168816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19999631|NCT02168816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19999632|NCT02168816|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19999633|NCT02168816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19999634|NCT02168816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19999635|NCT02168816|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19999636|NCT02168816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19999637|NCT02168816|Renal Agents|renal agents|mesh-ancestor
19999638|NCT02168816|Antimalarials|antimalarials|mesh-ancestor
19999639|NCT02168816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19999640|NCT02168816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19999641|NCT02168816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19999642|NCT02168842|Isradipine|isradipine|mesh-list
19999643|NCT02168842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19999644|NCT02168842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19999645|NCT02168842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19999646|NCT02168842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999647|NCT02168842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19999648|NCT02168842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999649|NCT02168842|Vasodilator Agents|vasodilator agents|mesh-ancestor
19999650|NCT02168855|Nicotine|nicotine|mesh-list
19999651|NCT02168855|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19999652|NCT02168855|Autonomic Agents|autonomic agents|mesh-ancestor
19999653|NCT02168855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19999654|NCT02168855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999655|NCT02168855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19999656|NCT02168855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19999657|NCT02168855|Cholinergic Agents|cholinergic agents|mesh-ancestor
19999658|NCT02168855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999659|NCT02168855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999660|NCT02168946|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19999661|NCT02168946|Meropenem|meropenem|mesh-list
19999662|NCT02168946|Vaborbactam|vaborbactam|mesh-list
19999663|NCT02168946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19999664|NCT02168946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
19999665|NCT02168946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19999666|NCT02168946|Antitubercular Agents|antitubercular agents|mesh-ancestor
19999667|NCT02168946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999668|NCT02168946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999669|NCT02169115|Omalizumab|omalizumab|mesh-list
19999670|NCT02169115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19999671|NCT02169115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19999672|NCT02169115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19999673|NCT02169115|Respiratory System Agents|respiratory system agents|mesh-ancestor
19999674|NCT02169115|Immunologic Factors|immunologic factors|mesh-ancestor
19999675|NCT02169115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999676|NCT02169219|Prednisone|prednisone|mesh-list
19999677|NCT02169219|Rituximab|rituximab|mesh-list
19999678|NCT02169219|Glucocorticoids|glucocorticoids|mesh-list
19999679|NCT02169219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19999680|NCT02169219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19999681|NCT02169219|Immunologic Factors|immunologic factors|mesh-ancestor
19999682|NCT02169219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999683|NCT02169219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19999684|NCT02169219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19999685|NCT02169219|Hormones|hormones|mesh-ancestor
19999686|NCT02169219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19999687|NCT02169219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19999688|NCT02169271|Aspirin|aspirin|mesh-list
19999689|NCT02169271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19999690|NCT02169271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19999691|NCT02169271|Analgesics|analgesics|mesh-ancestor
19999692|NCT02169271|Sensory System Agents|sensory system agents|mesh-ancestor
19999693|NCT02169271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19999694|NCT02169271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999695|NCT02169271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19999696|NCT02169271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19999697|NCT02169271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19999698|NCT02169271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19999699|NCT02169271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999700|NCT02169271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19999701|NCT02169271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19999702|NCT02169271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999703|NCT02169271|Antipyretics|antipyretics|mesh-ancestor
19999704|NCT02169284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20556801|NCT01949064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19999705|NCT02169284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19999706|NCT02169284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19999707|NCT02169284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999708|NCT02169284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999709|NCT02169336|Dexmedetomidine|dexmedetomidine|mesh-list
19999710|NCT02169336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20556802|NCT01949064|Antifungal Agents|antifungal agents|mesh-ancestor
20556803|NCT01949064|Keratolytic Agents|keratolytic agents|mesh-ancestor
20556804|NCT01949064|Dermatologic Agents|dermatologic agents|mesh-ancestor
20556805|NCT01949129|Cyclophosphamide|cyclophosphamide|mesh-list
20556806|NCT01949129|Busulfan|busulfan|mesh-list
20556807|NCT01949129|Thiotepa|thiotepa|mesh-list
20556808|NCT01949129|Treosulfan|treosulfan|mesh-list
20556809|NCT01949129|Fludarabine|fludarabine|mesh-list
20556810|NCT01949129|Etoposide|etoposide|mesh-list
20556811|NCT01949129|Thymoglobulin|thymoglobulin|mesh-list
20556812|NCT01949129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20556813|NCT01949129|Immunoglobulins|immunoglobulins|mesh-list
20556814|NCT01949129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20556815|NCT01949129|Immunologic Factors|immunologic factors|mesh-ancestor
20556816|NCT01949129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556817|NCT01949129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20556818|NCT01949129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20556819|NCT01949129|Alkylating Agents|alkylating agents|mesh-ancestor
20556820|NCT01949129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556821|NCT01949129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556822|NCT01949129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20556823|NCT01949129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20556824|NCT01949129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20556825|NCT01949129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20556826|NCT01949129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556827|NCT01949168|Ribavirin|ribavirin|mesh-list
20556828|NCT01949168|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20556829|NCT01949168|Antimetabolites|antimetabolites|mesh-ancestor
20556830|NCT01949168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556831|NCT01949168|Antiviral Agents|antiviral agents|mesh-ancestor
20556832|NCT01949168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20556833|NCT01949233|Doxycycline|doxycycline|mesh-list
20556834|NCT01949233|Irbesartan|irbesartan|mesh-list
20556835|NCT01949233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20556836|NCT01949233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20556837|NCT01949233|Antimalarials|antimalarials|mesh-ancestor
20556838|NCT01949233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20556839|NCT01949233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20556840|NCT01949233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20556841|NCT01949233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20556842|NCT01949233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20556843|NCT01949233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556844|NCT01949363|Cefixime|cefixime|mesh-list
20556845|NCT01949363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20556846|NCT01949363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20556847|NCT01949454|Fluorometholone|fluorometholone|mesh-list
20556848|NCT01949454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20556849|NCT01949454|Lubricant Eye Drops|lubricant eye drops|mesh-list
20556850|NCT01949454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20556851|NCT01949454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20556852|NCT01949454|Glucocorticoids|glucocorticoids|mesh-ancestor
20556853|NCT01949454|Hormones|hormones|mesh-ancestor
20556854|NCT01949454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20556855|NCT01949454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556856|NCT01949454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20556857|NCT01949519|Lycopene|lycopene|mesh-list
20556858|NCT01949519|Docetaxel|docetaxel|mesh-list
20556859|NCT01949519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556860|NCT01949519|Tubulin Modulators|tubulin modulators|mesh-ancestor
20556861|NCT01949519|Antimitotic Agents|antimitotic agents|mesh-ancestor
20556862|NCT01949519|Mitosis Modulators|mitosis modulators|mesh-ancestor
20556863|NCT01949519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556864|NCT01949519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20556865|NCT01949519|Antioxidants|antioxidants|mesh-ancestor
20556866|NCT01949519|Protective Agents|protective agents|mesh-ancestor
20556867|NCT01949519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556868|NCT01949519|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20556869|NCT01949519|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20556870|NCT01949571|Mirtazapine|mirtazapine|mesh-list
20556871|NCT01949571|Antidepressive Agents|antidepressive agents|mesh-ancestor
20556872|NCT01949571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19999711|NCT02169336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19999712|NCT02169336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999713|NCT02169336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19999714|NCT02169336|Analgesics|analgesics|mesh-ancestor
19999715|NCT02169336|Sensory System Agents|sensory system agents|mesh-ancestor
19999716|NCT02169336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19999717|NCT02169336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19999718|NCT02169336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19999719|NCT02169336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19999720|NCT02169336|Adrenergic Agents|adrenergic agents|mesh-ancestor
19999721|NCT02169336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999722|NCT02169336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999723|NCT02169414|Levodopa|levodopa|mesh-list
19999724|NCT02169414|Carbidopa|carbidopa|mesh-list
19999725|NCT02169414|Opicapone|opicapone|mesh-list
19999726|NCT02169414|Benserazide|benserazide|mesh-list
19999727|NCT02169414|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19999728|NCT02169414|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19999729|NCT02169414|Dopamine Agents|dopamine agents|mesh-ancestor
19999730|NCT02169414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999731|NCT02169414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999732|NCT02169414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999733|NCT02169414|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19999734|NCT02169414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999735|NCT02169414|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19999736|NCT02169427|Opicapone|opicapone|mesh-list
19999737|NCT02169427|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19999738|NCT02169427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999739|NCT02169427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999740|NCT02169427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19999741|NCT02169427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19999742|NCT02169440|Opicapone|opicapone|mesh-list
19999743|NCT02169440|Warfarin|warfarin|mesh-list
19999744|NCT02169440|Anticoagulants|anticoagulants|mesh-ancestor
19999745|NCT02169440|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19999746|NCT02169440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999747|NCT02169440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999748|NCT02169440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19999749|NCT02169440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19999750|NCT02169453|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19999751|NCT02169453|Opicapone|opicapone|mesh-list
19999752|NCT02169453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19999753|NCT02169453|Immunologic Factors|immunologic factors|mesh-ancestor
19999754|NCT02169453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999755|NCT02169453|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19999756|NCT02169453|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19999757|NCT02169453|Dopamine Agonists|dopamine agonists|mesh-ancestor
19999758|NCT02169453|Dopamine Agents|dopamine agents|mesh-ancestor
19999759|NCT02169453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999760|NCT02169453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999761|NCT02169453|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19999762|NCT02169453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999763|NCT02169466|Opicapone|opicapone|mesh-list
19999764|NCT02169466|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
19999765|NCT02169466|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19999766|NCT02169466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999767|NCT02169466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999768|NCT02169466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19999769|NCT02169466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19999770|NCT02169466|Dopamine Agents|dopamine agents|mesh-ancestor
19999771|NCT02169466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999772|NCT02169466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999773|NCT02169479|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
19999774|NCT02169479|Opicapone|opicapone|mesh-list
19999775|NCT02169479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19999776|NCT02169479|Immunologic Factors|immunologic factors|mesh-ancestor
19999777|NCT02169479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999778|NCT02169479|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19999779|NCT02169479|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19999780|NCT02169479|Dopamine Agonists|dopamine agonists|mesh-ancestor
19999781|NCT02169479|Dopamine Agents|dopamine agents|mesh-ancestor
19999782|NCT02169479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999783|NCT02169479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999784|NCT02169479|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19999785|NCT02169479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999786|NCT02169505|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19999787|NCT02169505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19999788|NCT02169505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19999789|NCT02169791|Ixazomib|ixazomib|mesh-list
19999790|NCT02169791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19999791|NCT02169791|Protease Inhibitors|protease inhibitors|mesh-ancestor
19999792|NCT02169791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999793|NCT02169791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999794|NCT02169869|Levonorgestrel|levonorgestrel|mesh-list
19999795|NCT02169869|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19999796|NCT02169869|Contraceptive Agents|contraceptive agents|mesh-ancestor
19999797|NCT02169869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19999798|NCT02169869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999799|NCT02169869|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19999800|NCT02169869|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19999801|NCT02169869|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19999802|NCT02169895|Opicapone|opicapone|mesh-list
19999803|NCT02169895|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
19999804|NCT02169895|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19999805|NCT02169895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999806|NCT02169895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999807|NCT02169895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19999808|NCT02169895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19999809|NCT02169895|Dopamine Agents|dopamine agents|mesh-ancestor
19999810|NCT02169895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999811|NCT02169895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999812|NCT02170025|Riociguat|riociguat|mesh-list
19999813|NCT02170025|Enzyme Activators|enzyme activators|mesh-ancestor
19999814|NCT02170025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999815|NCT02170064|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19999816|NCT02170064|Anticonvulsants|anticonvulsants|mesh-ancestor
19999817|NCT02170064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19999818|NCT02170064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19999819|NCT02170064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19999820|NCT02170064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999821|NCT02170077|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19999822|NCT02170077|Anticonvulsants|anticonvulsants|mesh-ancestor
19999823|NCT02170077|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19999824|NCT02170077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19999825|NCT02170077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20556873|NCT01949571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20556874|NCT01949571|Histamine Antagonists|histamine antagonists|mesh-ancestor
20556875|NCT01949571|Histamine Agents|histamine agents|mesh-ancestor
20556876|NCT01949571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20556877|NCT01949571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556878|NCT01949571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556879|NCT01949571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20556880|NCT01949571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20556881|NCT01949571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20556882|NCT01949571|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20556883|NCT01949571|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20556884|NCT01949571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20556885|NCT01949571|Adrenergic Agents|adrenergic agents|mesh-ancestor
20556886|NCT01949571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20556887|NCT01949571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20556888|NCT01949571|Serotonin Agents|serotonin agents|mesh-ancestor
20556889|NCT01949571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20556890|NCT01949675|Vaccines|vaccines|mesh-list
20556891|NCT01949675|Immunologic Factors|immunologic factors|mesh-ancestor
20556892|NCT01949675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556893|NCT01949766|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
20556894|NCT01949766|Glycerol|glycerol|mesh-list
20556895|NCT01949766|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20556896|NCT01949766|Protective Agents|protective agents|mesh-ancestor
20556897|NCT01949766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556898|NCT01949766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556899|NCT01949805|Interferon alpha-2|interferon alpha-2|mesh-list
20556900|NCT01949805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20556901|NCT01949805|Hydroxyurea|hydroxyurea|mesh-list
20556902|NCT01949805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556903|NCT01949805|Antisickling Agents|antisickling agents|mesh-ancestor
19999826|NCT02170077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999827|NCT02170207|Lansoprazole|lansoprazole|mesh-list
19999828|NCT02170207|Dexlansoprazole|dexlansoprazole|mesh-list
19999829|NCT02170207|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19999830|NCT02170207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19999831|NCT02170207|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19999832|NCT02170207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999833|NCT02170207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999834|NCT02170220|Vortioxetine|vortioxetine|mesh-list
19999835|NCT02170220|Antidepressive Agents|antidepressive agents|mesh-ancestor
19999836|NCT02170220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19999837|NCT02170220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19999838|NCT02170220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19999839|NCT02170220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19999840|NCT02170220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999841|NCT02170220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19999842|NCT02170220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19999843|NCT02170220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19999844|NCT02170220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999845|NCT02170220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999846|NCT02170220|Serotonin Agents|serotonin agents|mesh-ancestor
19999847|NCT02170220|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
19999848|NCT02170220|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19999849|NCT02170220|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19999850|NCT02170220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19999851|NCT02170376|Levodopa|levodopa|mesh-list
19999852|NCT02170376|Carbidopa|carbidopa|mesh-list
19999853|NCT02170376|Opicapone|opicapone|mesh-list
19999854|NCT02170376|Entacapone|entacapone|mesh-list
19999855|NCT02170376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19999856|NCT02170376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19999857|NCT02170376|Dopamine Agents|dopamine agents|mesh-ancestor
19999858|NCT02170376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999859|NCT02170376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999860|NCT02170376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999861|NCT02170376|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
19999862|NCT02170376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999863|NCT02170376|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
19999864|NCT02170519|Iloprost|iloprost|mesh-list
19999865|NCT02170519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19999866|NCT02170519|Vasodilator Agents|vasodilator agents|mesh-ancestor
19999867|NCT02170532|Albuterol|albuterol|mesh-list
19999868|NCT02170532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19999869|NCT02170532|Autonomic Agents|autonomic agents|mesh-ancestor
19999870|NCT02170532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19999871|NCT02170532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999872|NCT02170532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19999873|NCT02170532|Respiratory System Agents|respiratory system agents|mesh-ancestor
19999874|NCT02170532|Tocolytic Agents|tocolytic agents|mesh-ancestor
19999875|NCT02170532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19999876|NCT02170532|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19999877|NCT02170532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19999878|NCT02170532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19999879|NCT02170532|Adrenergic Agents|adrenergic agents|mesh-ancestor
19999880|NCT02170532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999881|NCT02170532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999882|NCT02170649|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19999883|NCT02170649|Anticonvulsants|anticonvulsants|mesh-ancestor
19999884|NCT02170649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19999885|NCT02170649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19999886|NCT02170649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19999887|NCT02170649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999888|NCT02170662|Bimatoprost|bimatoprost|mesh-list
19999889|NCT02170662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19999890|NCT02171130|Glucagon|glucagon|mesh-list
19999891|NCT02171130|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
19999892|NCT02171130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19999893|NCT02171130|Hormones|hormones|mesh-ancestor
19999894|NCT02171130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19999895|NCT02171130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999896|NCT02171130|Incretins|incretins|mesh-ancestor
19999897|NCT02171195|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19999898|NCT02171195|Anticonvulsants|anticonvulsants|mesh-ancestor
19999899|NCT02171195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19999900|NCT02171195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19999901|NCT02171195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19999902|NCT02171195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999903|NCT02171234|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19999904|NCT02171234|Anticonvulsants|anticonvulsants|mesh-ancestor
19999905|NCT02171234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19999906|NCT02171234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19999907|NCT02171234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19999908|NCT02171234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999909|NCT02171429|Adalimumab|adalimumab|mesh-list
19999910|NCT02171429|Etrolizumab|etrolizumab|mesh-list
19999911|NCT02171429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19999912|NCT02171429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19999913|NCT02171429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19999914|NCT02171429|Immunologic Factors|immunologic factors|mesh-ancestor
19999915|NCT02171429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999916|NCT02171611|Dabigatran|dabigatran|mesh-list
19999917|NCT02171611|Antithrombins|antithrombins|mesh-ancestor
19999918|NCT02171611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19999919|NCT02171611|Protease Inhibitors|protease inhibitors|mesh-ancestor
19999920|NCT02171611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999921|NCT02171611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999922|NCT02171611|Anticoagulants|anticoagulants|mesh-ancestor
19999923|NCT02172040|Celecoxib|celecoxib|mesh-list
19999924|NCT02172040|Amlodipine|amlodipine|mesh-list
19999925|NCT02172040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19999926|NCT02172040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19999927|NCT02172040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19999928|NCT02172040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999929|NCT02172040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19999930|NCT02172040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999931|NCT02172040|Vasodilator Agents|vasodilator agents|mesh-ancestor
19999932|NCT02172040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19999933|NCT02172040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19999934|NCT02172040|Analgesics|analgesics|mesh-ancestor
19999935|NCT02172040|Sensory System Agents|sensory system agents|mesh-ancestor
19999936|NCT02172040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19999937|NCT02172040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19999938|NCT02172040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19999939|NCT02172040|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19999940|NCT02172040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19999941|NCT02172040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999942|NCT02172742|Digoxin|digoxin|mesh-list
19999943|NCT02172742|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19999944|NCT02172742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19999945|NCT02172742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19999946|NCT02172742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999947|NCT02172742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999948|NCT02172742|Protective Agents|protective agents|mesh-ancestor
19999949|NCT02172742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999950|NCT02172742|Anticonvulsants|anticonvulsants|mesh-ancestor
19999951|NCT02172742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19999952|NCT02172742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19999953|NCT02172742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19999954|NCT02172755|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
19999955|NCT02172755|Anticonvulsants|anticonvulsants|mesh-ancestor
19999956|NCT02172755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19999957|NCT02172755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19999958|NCT02172755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19999959|NCT02172755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999960|NCT02173054|Adapalene|adapalene|mesh-list
19999961|NCT02173054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19999962|NCT02173054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19999963|NCT02173054|Analgesics|analgesics|mesh-ancestor
19999964|NCT02173054|Sensory System Agents|sensory system agents|mesh-ancestor
19999965|NCT02173054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19999966|NCT02173054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999967|NCT02173054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19999968|NCT02173054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19999969|NCT02173054|Dermatologic Agents|dermatologic agents|mesh-ancestor
19999970|NCT02173392|Brodalumab|brodalumab|mesh-list
19999971|NCT02173392|Dermatologic Agents|dermatologic agents|mesh-ancestor
19999972|NCT02173548|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19999973|NCT02173548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19999974|NCT02173769|Tiotropium Bromide|tiotropium bromide|mesh-list
19999975|NCT02173769|Olodaterol|olodaterol|mesh-list
19999976|NCT02173769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19999977|NCT02173769|Autonomic Agents|autonomic agents|mesh-ancestor
19999978|NCT02173769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19999979|NCT02173769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19999980|NCT02173769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19999981|NCT02173769|Respiratory System Agents|respiratory system agents|mesh-ancestor
19999982|NCT02173769|Parasympatholytics|parasympatholytics|mesh-ancestor
19999983|NCT02173769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19999984|NCT02173769|Cholinergic Agents|cholinergic agents|mesh-ancestor
19999985|NCT02173769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19999986|NCT02173769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999987|NCT02174276|Tenofovir|tenofovir|mesh-list
19999988|NCT02174276|Antiviral Agents|antiviral agents|mesh-ancestor
19999989|NCT02174276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19999990|NCT02174276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19999991|NCT02174276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19999992|NCT02174276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19999993|NCT02174276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19999994|NCT02174276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19999995|NCT02174276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19999996|NCT02174419|Nalbuphine|nalbuphine|mesh-list
19999997|NCT02174419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19999998|NCT02174419|Narcotics|narcotics|mesh-ancestor
19999999|NCT02174419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20000000|NCT02174419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000001|NCT02174419|Analgesics|analgesics|mesh-ancestor
20000002|NCT02174419|Sensory System Agents|sensory system agents|mesh-ancestor
20000003|NCT02174419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000004|NCT02174432|Nalbuphine|nalbuphine|mesh-list
20000005|NCT02174432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20000006|NCT02174432|Narcotics|narcotics|mesh-ancestor
20000007|NCT02174432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20000008|NCT02174432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000009|NCT02174432|Analgesics|analgesics|mesh-ancestor
20000010|NCT02174432|Sensory System Agents|sensory system agents|mesh-ancestor
20000011|NCT02174432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000012|NCT02174510|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20000013|NCT02174510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20000014|NCT02174510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20000015|NCT02174510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20000016|NCT02174510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000017|NCT02174510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20000018|NCT02174510|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20000019|NCT02174510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20000020|NCT02174510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20000021|NCT02174510|Adrenergic Agents|adrenergic agents|mesh-ancestor
20000022|NCT02174510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20000023|NCT02174510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000024|NCT02174510|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20000025|NCT02174510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20000026|NCT02174510|Serotonin Agents|serotonin agents|mesh-ancestor
20000027|NCT02174510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20000028|NCT02174510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20000029|NCT02174510|Dopamine Agents|dopamine agents|mesh-ancestor
20000030|NCT02174523|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20000031|NCT02174523|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20000032|NCT02174523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20000033|NCT02174523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20000034|NCT02174523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000035|NCT02174523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20000036|NCT02174523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20000037|NCT02174523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20000038|NCT02174523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20000039|NCT02174523|Adrenergic Agents|adrenergic agents|mesh-ancestor
20000040|NCT02174523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20000041|NCT02174523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000042|NCT02174523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20000043|NCT02174523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20000044|NCT02174523|Serotonin Agents|serotonin agents|mesh-ancestor
20000045|NCT02174523|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20000046|NCT02174523|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20000047|NCT02174523|Dopamine Agents|dopamine agents|mesh-ancestor
20000048|NCT02174731|Epoetin Alfa|epoetin alfa|mesh-list
20000049|NCT02174731|Hematinics|hematinics|mesh-ancestor
20000050|NCT02174848|Deferiprone|deferiprone|mesh-list
20000051|NCT02174848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20000052|NCT02174848|Chelating Agents|chelating agents|mesh-ancestor
20000053|NCT02174848|Sequestering Agents|sequestering agents|mesh-ancestor
20000054|NCT02174848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000055|NCT02174913|Fentanyl|fentanyl|mesh-list
20000056|NCT02174913|Propofol|propofol|mesh-list
20000057|NCT02174913|Atracurium|atracurium|mesh-list
20000058|NCT02174913|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20000059|NCT02174913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20000060|NCT02174913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000061|NCT02174913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20000062|NCT02174913|Anesthetics, General|anesthetics, general|mesh-ancestor
20000063|NCT02174913|Anesthetics|anesthetics|mesh-ancestor
20000064|NCT02174913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20000065|NCT02174913|Narcotics|narcotics|mesh-ancestor
20000066|NCT02174913|Analgesics|analgesics|mesh-ancestor
20000067|NCT02174913|Sensory System Agents|sensory system agents|mesh-ancestor
20000068|NCT02174913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000069|NCT02174913|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20000070|NCT02174913|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20000071|NCT02174913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20000072|NCT02174913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20000073|NCT02174913|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20000074|NCT02174913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20000075|NCT02174913|Cholinergic Agents|cholinergic agents|mesh-ancestor
20000076|NCT02174913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20000077|NCT02174913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000078|NCT02175212|Ascorbic Acid|ascorbic acid|mesh-list
20000079|NCT02175212|Methyltestosterone|methyltestosterone|mesh-list
20000080|NCT02175212|Androgens|androgens|mesh-list
20000081|NCT02175212|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20000082|NCT02175212|Hormones|hormones|mesh-ancestor
20000083|NCT02175212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20000084|NCT02175212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000085|NCT02175212|Antioxidants|antioxidants|mesh-ancestor
20000086|NCT02175212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000087|NCT02175212|Protective Agents|protective agents|mesh-ancestor
20000088|NCT02175212|Vitamins|vitamins|mesh-ancestor
20000089|NCT02175212|Micronutrients|micronutrients|mesh-ancestor
20000090|NCT02175212|Estrogens|estrogens|mesh-ancestor
20000091|NCT02175212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20000092|NCT02175212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20000093|NCT02175212|Anabolic Agents|anabolic agents|mesh-ancestor
20000094|NCT02175225|Deferoxamine|deferoxamine|mesh-list
20000095|NCT02175225|Siderophores|siderophores|mesh-ancestor
20000096|NCT02175225|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20000097|NCT02175225|Chelating Agents|chelating agents|mesh-ancestor
20000098|NCT02175225|Sequestering Agents|sequestering agents|mesh-ancestor
20000099|NCT02175225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556904|NCT01949805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556905|NCT01949805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556906|NCT01949805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20556907|NCT01949805|Antiviral Agents|antiviral agents|mesh-ancestor
20556908|NCT01949805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20556909|NCT01949818|Prednisone|prednisone|mesh-list
20556910|NCT01949818|Prednisolone|prednisolone|mesh-list
20556911|NCT01949818|Cyclophosphamide|cyclophosphamide|mesh-list
20000100|NCT02175277|Darbepoetin alfa|darbepoetin alfa|mesh-list
20000101|NCT02175277|Hematinics|hematinics|mesh-ancestor
20000102|NCT02175745|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
20000103|NCT02175745|Dopamine Agents|dopamine agents|mesh-ancestor
20556912|NCT01949818|Doxorubicin|doxorubicin|mesh-list
20000104|NCT02175745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20000105|NCT02175745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000106|NCT02175745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000107|NCT02175758|Ribavirin|ribavirin|mesh-list
20000108|NCT02175758|Sofosbuvir|sofosbuvir|mesh-list
20000109|NCT02175758|Antimetabolites|antimetabolites|mesh-ancestor
20000110|NCT02175758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000111|NCT02175758|Antiviral Agents|antiviral agents|mesh-ancestor
20000112|NCT02175758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20000113|NCT02175771|Fluticasone|fluticasone|mesh-list
20000114|NCT02175771|Xhance|xhance|mesh-list
20000115|NCT02175771|Albuterol|albuterol|mesh-list
20000116|NCT02175771|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20000117|NCT02175771|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20000118|NCT02175771|Adrenergic Agonists|adrenergic agonists|mesh-list
20000119|NCT02175771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20000120|NCT02175771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20000121|NCT02175771|Autonomic Agents|autonomic agents|mesh-ancestor
20000122|NCT02175771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000123|NCT02175771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000124|NCT02175771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20000125|NCT02175771|Respiratory System Agents|respiratory system agents|mesh-ancestor
20000126|NCT02175771|Dermatologic Agents|dermatologic agents|mesh-ancestor
20000127|NCT02175771|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20000128|NCT02175771|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20000129|NCT02175771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20000130|NCT02175771|Adrenergic Agents|adrenergic agents|mesh-ancestor
20000131|NCT02175771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20000132|NCT02175771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000133|NCT02175771|Tocolytic Agents|tocolytic agents|mesh-ancestor
20000134|NCT02175771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20000135|NCT02175771|Glucocorticoids|glucocorticoids|mesh-ancestor
20000136|NCT02175771|Hormones|hormones|mesh-ancestor
20000137|NCT02175771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20000138|NCT02175771|Sympathomimetics|sympathomimetics|mesh-ancestor
20000139|NCT02175966|Ribavirin|ribavirin|mesh-list
20000140|NCT02175966|Sofosbuvir|sofosbuvir|mesh-list
20000141|NCT02175966|Antimetabolites|antimetabolites|mesh-ancestor
20000142|NCT02175966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000143|NCT02175966|Antiviral Agents|antiviral agents|mesh-ancestor
20000144|NCT02175966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20000145|NCT02176005|Moxifloxacin|moxifloxacin|mesh-list
20000146|NCT02176005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20000147|NCT02176005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20000148|NCT02176005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20000149|NCT02176005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20000150|NCT02176005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000151|NCT02176005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000152|NCT02176005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20000153|NCT02176018|Quinidine|quinidine|mesh-list
20000154|NCT02176018|Dextromethorphan|dextromethorphan|mesh-list
20000155|NCT02176018|Antitussive Agents|antitussive agents|mesh-ancestor
20000156|NCT02176018|Respiratory System Agents|respiratory system agents|mesh-ancestor
20000157|NCT02176018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20000158|NCT02176018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20000159|NCT02176018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20000160|NCT02176018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000161|NCT02176018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000162|NCT02176018|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20000163|NCT02176018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20000164|NCT02176018|Adrenergic Agents|adrenergic agents|mesh-ancestor
20000165|NCT02176018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20000166|NCT02176018|Antimalarials|antimalarials|mesh-ancestor
20000167|NCT02176018|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20000168|NCT02176018|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20000169|NCT02176018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20000170|NCT02176018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000171|NCT02176018|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20000172|NCT02176018|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20000173|NCT02176018|Cholinergic Agents|cholinergic agents|mesh-ancestor
20000174|NCT02176018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20000175|NCT02176018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20000176|NCT02176018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20000177|NCT02176018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20556913|NCT01949818|Vincristine|vincristine|mesh-list
20000178|NCT02176018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20000179|NCT02176031|Methylprednisolone|methylprednisolone|mesh-list
20000180|NCT02176031|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20000181|NCT02176031|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20000182|NCT02176031|Prednisolone|prednisolone|mesh-list
20000183|NCT02176031|Prednisolone acetate|prednisolone acetate|mesh-list
20000184|NCT02176031|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20000185|NCT02176031|Prednisolone phosphate|prednisolone phosphate|mesh-list
20000186|NCT02176031|Natalizumab|natalizumab|mesh-list
20000187|NCT02176031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20000188|NCT02176031|Antiemetics|antiemetics|mesh-ancestor
20000189|NCT02176031|Autonomic Agents|autonomic agents|mesh-ancestor
20000190|NCT02176031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000191|NCT02176031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000192|NCT02176031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20000193|NCT02176031|Glucocorticoids|glucocorticoids|mesh-ancestor
20000194|NCT02176031|Hormones|hormones|mesh-ancestor
20000195|NCT02176031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20000196|NCT02176031|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20000197|NCT02176031|Protective Agents|protective agents|mesh-ancestor
20000198|NCT02176031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20000199|NCT02176031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20000200|NCT02176031|Immunologic Factors|immunologic factors|mesh-ancestor
20289810|NCT04500158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20289811|NCT04500158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20289812|NCT04500158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20289813|NCT04500158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20289814|NCT04500158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289815|NCT04494412|Zanamivir|zanamivir|mesh-list
20289816|NCT04494412|Antiviral Agents|antiviral agents|mesh-ancestor
20289817|NCT04494412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20289818|NCT04494412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289819|NCT04494412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289820|NCT04493203|Nivolumab|nivolumab|mesh-list
20289821|NCT04493203|Axitinib|axitinib|mesh-list
20289822|NCT04493203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20289823|NCT04493203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289824|NCT04493203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20289825|NCT04493203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289826|NCT04493203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20289827|NCT04493203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289828|NCT04480190|Gemcitabine|gemcitabine|mesh-list
20289829|NCT04480190|Fluorouracil|fluorouracil|mesh-list
20289830|NCT04480190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289831|NCT04480190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20289832|NCT04480190|Antimetabolites|antimetabolites|mesh-ancestor
20289833|NCT04480190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289834|NCT04480190|Antiviral Agents|antiviral agents|mesh-ancestor
20289835|NCT04480190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20289836|NCT04480190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289837|NCT04480190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20289838|NCT04480190|Immunologic Factors|immunologic factors|mesh-ancestor
20289839|NCT04480190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289840|NCT04480125|Azacitidine|azacitidine|mesh-list
20289841|NCT04480125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20289842|NCT04480125|Antimetabolites|antimetabolites|mesh-ancestor
20289843|NCT04480125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289844|NCT04480125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289845|NCT04480125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289846|NCT04472143|Granisetron|granisetron|mesh-list
20289847|NCT04472143|Antiemetics|antiemetics|mesh-ancestor
20289848|NCT04472143|Autonomic Agents|autonomic agents|mesh-ancestor
20289849|NCT04472143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20289850|NCT04472143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289851|NCT04472143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20289852|NCT04472143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20289853|NCT04472143|Serotonin Agents|serotonin agents|mesh-ancestor
20289854|NCT04472143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20289855|NCT04472143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289856|NCT04464980|Naltrexone|naltrexone|mesh-list
20289857|NCT04464980|Buprenorphine|buprenorphine|mesh-list
20289858|NCT04464980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20289859|NCT04464980|Narcotics|narcotics|mesh-ancestor
20289860|NCT04464980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20556914|NCT01949818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20000201|NCT02176291|Buprenorphine|buprenorphine|mesh-list
20000202|NCT02176291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20000203|NCT02176291|Narcotics|narcotics|mesh-ancestor
20000204|NCT02176291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20000205|NCT02176291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000206|NCT02176291|Analgesics|analgesics|mesh-ancestor
20000207|NCT02176291|Sensory System Agents|sensory system agents|mesh-ancestor
20000208|NCT02176291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000209|NCT02176291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20000210|NCT02176356|Bimatoprost|bimatoprost|mesh-list
20000211|NCT02176356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20000212|NCT02176356|Botulinum Toxins|botulinum toxins|mesh-list
20000213|NCT02176356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20000214|NCT02176356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20000215|NCT02176356|Hyaluronic Acid|hyaluronic acid|mesh-list
20000216|NCT02176356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20000217|NCT02176356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20000218|NCT02176356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20000219|NCT02176356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000220|NCT02176356|Cholinergic Agents|cholinergic agents|mesh-ancestor
20000221|NCT02176356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20000222|NCT02176356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000223|NCT02176356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20000224|NCT02176356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000225|NCT02176356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20556915|NCT01949818|Immunologic Factors|immunologic factors|mesh-ancestor
20556916|NCT01949818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556917|NCT01949818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20556918|NCT01949818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20556919|NCT01949818|Alkylating Agents|alkylating agents|mesh-ancestor
20556920|NCT01949818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556921|NCT01949818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556922|NCT01949818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20556923|NCT01949818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20556924|NCT01949818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20556925|NCT01949818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20556926|NCT01949818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556927|NCT01949818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20556928|NCT01949818|Glucocorticoids|glucocorticoids|mesh-ancestor
20556929|NCT01949818|Hormones|hormones|mesh-ancestor
20556930|NCT01949818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20556931|NCT01949818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20556932|NCT01949818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20556933|NCT01949818|Tubulin Modulators|tubulin modulators|mesh-ancestor
20556934|NCT01949818|Antimitotic Agents|antimitotic agents|mesh-ancestor
20556935|NCT01949818|Mitosis Modulators|mitosis modulators|mesh-ancestor
20556936|NCT01949857|Vaccines|vaccines|mesh-list
20556937|NCT01949857|Immunologic Factors|immunologic factors|mesh-ancestor
20556938|NCT01949857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000226|NCT02176356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20000227|NCT02176356|Immunologic Factors|immunologic factors|mesh-ancestor
20000228|NCT02176356|Viscosupplements|viscosupplements|mesh-ancestor
20000229|NCT02176356|Protective Agents|protective agents|mesh-ancestor
20000230|NCT02176382|Zoledronic Acid|zoledronic acid|mesh-list
20000231|NCT02176382|Denosumab|denosumab|mesh-list
20000232|NCT02176382|Teriparatide|teriparatide|mesh-list
20000233|NCT02176382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20000234|NCT02176382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000235|NCT02176382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20000236|NCT02176421|Lidocaine|lidocaine|mesh-list
20000237|NCT02176421|Anesthetics, Local|anesthetics, local|mesh-ancestor
20000238|NCT02176421|Anesthetics|anesthetics|mesh-ancestor
20000239|NCT02176421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20000240|NCT02176421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000241|NCT02176421|Sensory System Agents|sensory system agents|mesh-ancestor
20000242|NCT02176421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000243|NCT02176421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20000244|NCT02176421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20000245|NCT02176421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20000246|NCT02176421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20000247|NCT02176421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000248|NCT02176486|Ixazomib|ixazomib|mesh-list
20000249|NCT02176486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20000250|NCT02176486|Protease Inhibitors|protease inhibitors|mesh-ancestor
20000251|NCT02176486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000252|NCT02176486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000253|NCT02176642|Oxybutynin|oxybutynin|mesh-list
20000254|NCT02176642|Parasympatholytics|parasympatholytics|mesh-ancestor
20000255|NCT02176642|Autonomic Agents|autonomic agents|mesh-ancestor
20000256|NCT02176642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000257|NCT02176642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000258|NCT02176642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20000259|NCT02176642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20000260|NCT02176642|Cholinergic Agents|cholinergic agents|mesh-ancestor
20000261|NCT02176642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20000262|NCT02176642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000263|NCT02176642|Urological Agents|urological agents|mesh-ancestor
20000264|NCT02176655|Aspirin|aspirin|mesh-list
20000265|NCT02176655|Sumatriptan|sumatriptan|mesh-list
20000266|NCT02176655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20000267|NCT02176655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20000268|NCT02176655|Analgesics|analgesics|mesh-ancestor
20000269|NCT02176655|Sensory System Agents|sensory system agents|mesh-ancestor
20000270|NCT02176655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000271|NCT02176655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000272|NCT02176655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20000273|NCT02176655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20000274|NCT02176655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20000275|NCT02176655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20000276|NCT02176655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000277|NCT02176655|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20000278|NCT02176655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20000279|NCT02176655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000280|NCT02176655|Antipyretics|antipyretics|mesh-ancestor
20000281|NCT02176655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20000282|NCT02176655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20000283|NCT02176655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20000284|NCT02176655|Serotonin Agents|serotonin agents|mesh-ancestor
20000285|NCT02176655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20000286|NCT02177032|Vaccines|vaccines|mesh-list
20000287|NCT02177032|Immunoglobulins|immunoglobulins|mesh-list
20000288|NCT02177032|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20000289|NCT02177032|Antibodies|antibodies|mesh-list
20000290|NCT02177032|Immunologic Factors|immunologic factors|mesh-ancestor
20000291|NCT02177032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000292|NCT02177786|Selonsertib|selonsertib|mesh-list
20000293|NCT02177786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20000294|NCT02177786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000295|NCT02177786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000296|NCT02177838|Cetuximab|cetuximab|mesh-list
20000297|NCT02177838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20000298|NCT02177838|Antibodies|antibodies|mesh-list
20000299|NCT02177838|Immunoglobulins|immunoglobulins|mesh-list
20000300|NCT02177838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20000301|NCT02177838|Immunologic Factors|immunologic factors|mesh-ancestor
20000302|NCT02177838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000303|NCT02177838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20000304|NCT02177942|Micronutrients|micronutrients|mesh-list
20000305|NCT02177942|Trace Elements|trace elements|mesh-list
20000306|NCT02177942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000307|NCT02178059|Terbutaline|terbutaline|mesh-list
20000308|NCT02178059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20000309|NCT02178059|Autonomic Agents|autonomic agents|mesh-ancestor
20000310|NCT02178059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000311|NCT02178059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000312|NCT02178059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20000313|NCT02178059|Respiratory System Agents|respiratory system agents|mesh-ancestor
20000314|NCT02178059|Sympathomimetics|sympathomimetics|mesh-ancestor
20000315|NCT02178059|Tocolytic Agents|tocolytic agents|mesh-ancestor
20000316|NCT02178059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20000317|NCT02178059|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20000318|NCT02178059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20000319|NCT02178059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20000320|NCT02178059|Adrenergic Agents|adrenergic agents|mesh-ancestor
20000321|NCT02178059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20000322|NCT02178059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000323|NCT02178241|Gemcitabine|gemcitabine|mesh-list
20000324|NCT02178241|Halichondrin B|halichondrin b|mesh-list
20000325|NCT02178241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20000326|NCT02178241|Antimetabolites|antimetabolites|mesh-ancestor
20000327|NCT02178241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000328|NCT02178241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20000329|NCT02178241|Antiviral Agents|antiviral agents|mesh-ancestor
20000330|NCT02178241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20000331|NCT02178241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000332|NCT02178241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20000333|NCT02178241|Immunologic Factors|immunologic factors|mesh-ancestor
20000334|NCT02178241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000335|NCT02178241|Tubulin Modulators|tubulin modulators|mesh-ancestor
20000336|NCT02178241|Antimitotic Agents|antimitotic agents|mesh-ancestor
20000337|NCT02178241|Mitosis Modulators|mitosis modulators|mesh-ancestor
20000338|NCT02178540|Tobramycin|tobramycin|mesh-list
20000339|NCT02178540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20000340|NCT02178540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20000341|NCT02178553|Bupivacaine|bupivacaine|mesh-list
20000342|NCT02178553|Anesthetics, Local|anesthetics, local|mesh-ancestor
20000343|NCT02178553|Anesthetics|anesthetics|mesh-ancestor
20000344|NCT02178553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20000345|NCT02178553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000346|NCT02178553|Sensory System Agents|sensory system agents|mesh-ancestor
20000347|NCT02178553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000348|NCT02178696|Citalopram|citalopram|mesh-list
20000349|NCT02178696|Antidepressive Agents|antidepressive agents|mesh-list
20000350|NCT02178696|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20000351|NCT02178696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20000352|NCT02178696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20000353|NCT02178696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000354|NCT02178696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20000355|NCT02178696|Serotonin Agents|serotonin agents|mesh-ancestor
20000356|NCT02178696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000357|NCT02178696|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20000358|NCT02178696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20000359|NCT02178800|Cabotegravir|cabotegravir|mesh-list
20000360|NCT02178800|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20000361|NCT02178800|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20000362|NCT02178800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000363|NCT02178800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000364|NCT02178800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20000365|NCT02178800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20000366|NCT02178800|Antiviral Agents|antiviral agents|mesh-ancestor
20000367|NCT02178800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20000368|NCT02178995|Methylphenidate|methylphenidate|mesh-list
20000369|NCT02178995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20000370|NCT02178995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000371|NCT02178995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20000372|NCT02178995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20000373|NCT02178995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20556939|NCT01949909|Aluminum sulfate|aluminum sulfate|mesh-list
20000374|NCT02178995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000375|NCT02178995|Dopamine Agents|dopamine agents|mesh-ancestor
20000376|NCT02178995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20000377|NCT02179177|Apixaban|apixaban|mesh-list
20000378|NCT02179177|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20000379|NCT02179177|Antithrombins|antithrombins|mesh-ancestor
20000380|NCT02179177|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20000381|NCT02179177|Protease Inhibitors|protease inhibitors|mesh-ancestor
20000382|NCT02179177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000383|NCT02179177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000384|NCT02179177|Anticoagulants|anticoagulants|mesh-ancestor
20000385|NCT02179671|Docetaxel|docetaxel|mesh-list
20000386|NCT02179671|Gefitinib|gefitinib|mesh-list
20000387|NCT02179671|Tremelimumab|tremelimumab|mesh-list
20000388|NCT02179671|Osimertinib|osimertinib|mesh-list
20000389|NCT02179671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20000390|NCT02179671|Tubulin Modulators|tubulin modulators|mesh-ancestor
20000391|NCT02179671|Antimitotic Agents|antimitotic agents|mesh-ancestor
20000392|NCT02179671|Mitosis Modulators|mitosis modulators|mesh-ancestor
20000393|NCT02179671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000394|NCT02179671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20000395|NCT02179671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000396|NCT02179788|Metformin|metformin|mesh-list
20000397|NCT02179788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20000398|NCT02179788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000399|NCT02179892|Acetaminophen|acetaminophen|mesh-list
20000400|NCT02179892|Dexamethasone|dexamethasone|mesh-list
20000401|NCT02179892|Dexamethasone acetate|dexamethasone acetate|mesh-list
20000402|NCT02179892|Bupivacaine|bupivacaine|mesh-list
20000403|NCT02179892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20000404|NCT02179892|Antiemetics|antiemetics|mesh-ancestor
20000405|NCT02179892|Autonomic Agents|autonomic agents|mesh-ancestor
20000406|NCT02179892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000407|NCT02179892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000408|NCT02179892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20000409|NCT02179892|Glucocorticoids|glucocorticoids|mesh-ancestor
20000410|NCT02179892|Hormones|hormones|mesh-ancestor
20000411|NCT02179892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20000412|NCT02179892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20000413|NCT02179892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20000414|NCT02179892|Anesthetics, Local|anesthetics, local|mesh-ancestor
20000415|NCT02179892|Anesthetics|anesthetics|mesh-ancestor
20000416|NCT02179892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20000417|NCT02179892|Sensory System Agents|sensory system agents|mesh-ancestor
20000418|NCT02179892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20000419|NCT02179892|Analgesics|analgesics|mesh-ancestor
20000420|NCT02179892|Antipyretics|antipyretics|mesh-ancestor
20000421|NCT02179918|Pembrolizumab|pembrolizumab|mesh-list
20000422|NCT02179918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20000423|NCT02179918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20000424|NCT02180061|Pembrolizumab|pembrolizumab|mesh-list
20000425|NCT02180061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20000426|NCT02180061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20000427|NCT02180100|Fluconazole|fluconazole|mesh-list
20000428|NCT02180100|Terconazole|terconazole|mesh-list
20000429|NCT02180100|Antifungal Agents|antifungal agents|mesh-ancestor
20000430|NCT02180100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20000431|NCT02180100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20000432|NCT02180100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20000433|NCT02180100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000434|NCT02180100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000435|NCT02180100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20000436|NCT02180100|Hormone Antagonists|hormone antagonists|mesh-ancestor
20000437|NCT02180100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20000438|NCT02180100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000439|NCT02180100|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20000440|NCT02180100|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20000441|NCT02180165|Voriconazole|voriconazole|mesh-list
20000442|NCT02180165|Posaconazole|posaconazole|mesh-list
20000443|NCT02180165|Antifungal Agents|antifungal agents|mesh-ancestor
20000444|NCT02180165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20000445|NCT02180165|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20000446|NCT02180165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20000447|NCT02180165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000448|NCT02180165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000449|NCT02180165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20000450|NCT02180165|Hormone Antagonists|hormone antagonists|mesh-ancestor
20000451|NCT02180165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20000452|NCT02180165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000453|NCT02180165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20000454|NCT02180165|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20000455|NCT02180165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20000456|NCT02180165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20000457|NCT02180438|Tenofovir|tenofovir|mesh-list
20000458|NCT02180438|Emtricitabine|emtricitabine|mesh-list
20000459|NCT02180438|Cobicistat|cobicistat|mesh-list
20000460|NCT02180438|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20000461|NCT02180438|Elvitegravir|elvitegravir|mesh-list
20000462|NCT02180438|Antiviral Agents|antiviral agents|mesh-ancestor
20000463|NCT02180438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20000464|NCT02180438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20000465|NCT02180438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20000466|NCT02180438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000467|NCT02180438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000468|NCT02180438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20000469|NCT02180438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20000470|NCT02180438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20000471|NCT02180438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20000472|NCT02180438|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20000473|NCT02180659|Buprenorphine|buprenorphine|mesh-list
20000474|NCT02180659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20000475|NCT02180659|Narcotics|narcotics|mesh-ancestor
20000476|NCT02180659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20000477|NCT02180659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000478|NCT02180659|Analgesics|analgesics|mesh-ancestor
20000479|NCT02180659|Sensory System Agents|sensory system agents|mesh-ancestor
20000480|NCT02180659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000481|NCT02180659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20000482|NCT02180672|Fluticasone|fluticasone|mesh-list
20000483|NCT02180672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20556940|NCT01949909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20556941|NCT01949909|Immunologic Factors|immunologic factors|mesh-ancestor
20556942|NCT01949909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556943|NCT01949935|Mupirocin|mupirocin|mesh-list
20556944|NCT01949935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20556945|NCT01949935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20556946|NCT01949935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20556947|NCT01949935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20556948|NCT01949935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556949|NCT01949948|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20556950|NCT01949948|Tenecteplase|tenecteplase|mesh-list
20556951|NCT01949948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20556952|NCT01949948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20556953|NCT01949948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556954|NCT01950000|Fentanyl|fentanyl|mesh-list
20556955|NCT01950000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20556956|NCT01950000|Narcotics|narcotics|mesh-ancestor
20556957|NCT01950000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20556958|NCT01950000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556959|NCT01950000|Analgesics|analgesics|mesh-ancestor
20556960|NCT01950000|Sensory System Agents|sensory system agents|mesh-ancestor
20556961|NCT01950000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20556962|NCT01950000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20556963|NCT01950000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20556964|NCT01950000|Anesthetics, General|anesthetics, general|mesh-ancestor
20556965|NCT01950000|Anesthetics|anesthetics|mesh-ancestor
20556966|NCT01950182|Tamoxifen|tamoxifen|mesh-list
20556967|NCT01950182|Gemcitabine|gemcitabine|mesh-list
20556968|NCT01950182|Capecitabine|capecitabine|mesh-list
20556969|NCT01950182|Trastuzumab|trastuzumab|mesh-list
20556970|NCT01950182|Vinorelbine|vinorelbine|mesh-list
20556971|NCT01950182|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20556972|NCT01950182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20556973|NCT01950182|Antimetabolites|antimetabolites|mesh-ancestor
20556974|NCT01950182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20556975|NCT01950182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556976|NCT01950182|Antiviral Agents|antiviral agents|mesh-ancestor
20556977|NCT01950182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20556978|NCT01950182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000484|NCT02180672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20000485|NCT02180672|Autonomic Agents|autonomic agents|mesh-ancestor
20000486|NCT02180672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000487|NCT02180672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000488|NCT02180672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20000489|NCT02180672|Respiratory System Agents|respiratory system agents|mesh-ancestor
20000490|NCT02180672|Dermatologic Agents|dermatologic agents|mesh-ancestor
20000491|NCT02180672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20000492|NCT02180828|Fluconazole|fluconazole|mesh-list
20000493|NCT02180828|Clotrimazole|clotrimazole|mesh-list
20000494|NCT02180828|Miconazole|miconazole|mesh-list
20000495|NCT02180828|Antifungal Agents|antifungal agents|mesh-ancestor
20000496|NCT02180828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20000497|NCT02180828|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20000498|NCT02180828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20000499|NCT02180828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000500|NCT02180828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000501|NCT02180828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20000502|NCT02180828|Hormone Antagonists|hormone antagonists|mesh-ancestor
20000503|NCT02180828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20000504|NCT02180828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000505|NCT02180828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20000506|NCT02180828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20000507|NCT02180828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20000508|NCT02180828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20000509|NCT02181075|Doxorubicin|doxorubicin|mesh-list
20000510|NCT02181075|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20000511|NCT02181075|Liver Extracts|liver extracts|mesh-list
20000512|NCT02181075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20000513|NCT02181075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20000514|NCT02181075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20000515|NCT02181075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20000516|NCT02181075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000517|NCT02181075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000518|NCT02181075|Hematinics|hematinics|mesh-ancestor
20000519|NCT02181127|Glucagon|glucagon|mesh-list
20000520|NCT02181127|Pancrelipase|pancrelipase|mesh-list
20000521|NCT02181127|Pancreatin|pancreatin|mesh-list
20000522|NCT02181127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20000523|NCT02181127|Hormones|hormones|mesh-ancestor
20000524|NCT02181127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20000525|NCT02181127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000526|NCT02181231|Buprenorphine|buprenorphine|mesh-list
20000527|NCT02181231|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20000528|NCT02181231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20000529|NCT02181231|Narcotics|narcotics|mesh-ancestor
20000530|NCT02181231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20000531|NCT02181231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000532|NCT02181231|Analgesics|analgesics|mesh-ancestor
20000533|NCT02181231|Sensory System Agents|sensory system agents|mesh-ancestor
20000534|NCT02181231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000535|NCT02181231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20000536|NCT02181231|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20000537|NCT02181231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20000538|NCT02181231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20000539|NCT02181231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000540|NCT02181231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20000541|NCT02181231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20000542|NCT02181231|Antidepressive Agents|antidepressive agents|mesh-ancestor
20000543|NCT02181231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20000544|NCT02181296|Ropivacaine|ropivacaine|mesh-list
20000545|NCT02181296|Anesthetics, Local|anesthetics, local|mesh-ancestor
20000546|NCT02181296|Anesthetics|anesthetics|mesh-ancestor
20000547|NCT02181296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20000548|NCT02181296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000549|NCT02181296|Sensory System Agents|sensory system agents|mesh-ancestor
20000550|NCT02181296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000551|NCT02181387|Acetaminophen|acetaminophen|mesh-list
20000552|NCT02181387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20000553|NCT02181387|Analgesics|analgesics|mesh-ancestor
20000554|NCT02181387|Sensory System Agents|sensory system agents|mesh-ancestor
20000555|NCT02181387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000556|NCT02181387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000557|NCT02181387|Antipyretics|antipyretics|mesh-ancestor
20000558|NCT02181426|Ketorolac|ketorolac|mesh-list
20000559|NCT02181426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20000560|NCT02181426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20000561|NCT02181426|Analgesics|analgesics|mesh-ancestor
20000562|NCT02181426|Sensory System Agents|sensory system agents|mesh-ancestor
20000563|NCT02181426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000564|NCT02181426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000565|NCT02181426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20000566|NCT02181426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20000567|NCT02181426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20000568|NCT02181426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000569|NCT02181426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000570|NCT02181504|Ranibizumab|ranibizumab|mesh-list
20000571|NCT02181504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20000572|NCT02181504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20000573|NCT02181504|Growth Substances|growth substances|mesh-ancestor
20000574|NCT02181504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000575|NCT02181504|Growth Inhibitors|growth inhibitors|mesh-ancestor
20000576|NCT02181504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20000577|NCT02181517|Ranibizumab|ranibizumab|mesh-list
20000578|NCT02181517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20000579|NCT02181517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20000580|NCT02181517|Growth Substances|growth substances|mesh-ancestor
20000581|NCT02181517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000582|NCT02181517|Growth Inhibitors|growth inhibitors|mesh-ancestor
20000583|NCT02181517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20000584|NCT02181556|Aflibercept|aflibercept|mesh-list
20000585|NCT02181556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20000586|NCT02181556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20000587|NCT02181556|Growth Substances|growth substances|mesh-ancestor
20000588|NCT02181556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000589|NCT02181556|Growth Inhibitors|growth inhibitors|mesh-ancestor
20000590|NCT02181556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20000591|NCT02181634|Gemcitabine|gemcitabine|mesh-list
20000592|NCT02181634|Paclitaxel|paclitaxel|mesh-list
20000593|NCT02181634|Antimetabolites|antimetabolites|mesh-list
20000594|NCT02181634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20000595|NCT02181634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20000596|NCT02181634|Tubulin Modulators|tubulin modulators|mesh-ancestor
20000597|NCT02181634|Antimitotic Agents|antimitotic agents|mesh-ancestor
20000598|NCT02181634|Mitosis Modulators|mitosis modulators|mesh-ancestor
20000599|NCT02181634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000600|NCT02181634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20000601|NCT02181634|Antiviral Agents|antiviral agents|mesh-ancestor
20000602|NCT02181634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20000603|NCT02181634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000604|NCT02181634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20000605|NCT02181634|Immunologic Factors|immunologic factors|mesh-ancestor
20000606|NCT02181634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000607|NCT02181673|Golimumab|golimumab|mesh-list
20000608|NCT02181673|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20000609|NCT02181673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20000610|NCT02181673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20000611|NCT02181673|Immunologic Factors|immunologic factors|mesh-ancestor
20000612|NCT02181673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000613|NCT02181738|Doxorubicin|doxorubicin|mesh-list
20000614|NCT02181738|Nivolumab|nivolumab|mesh-list
20000615|NCT02181738|Dacarbazine|dacarbazine|mesh-list
20000616|NCT02181738|Vinblastine|vinblastine|mesh-list
20000617|NCT02181738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20000618|NCT02181738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20000619|NCT02181738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20000620|NCT02181738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20000621|NCT02181738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000622|NCT02181738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000623|NCT02181738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20000624|NCT02181738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20000625|NCT02181738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20000626|NCT02181738|Alkylating Agents|alkylating agents|mesh-ancestor
20000627|NCT02181738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20000628|NCT02181738|Tubulin Modulators|tubulin modulators|mesh-ancestor
20000629|NCT02181738|Antimitotic Agents|antimitotic agents|mesh-ancestor
20000630|NCT02181738|Mitosis Modulators|mitosis modulators|mesh-ancestor
20000631|NCT02181816|Amlodipine|amlodipine|mesh-list
20000632|NCT02181816|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20000633|NCT02181816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20000634|NCT02181816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20000635|NCT02181816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20000636|NCT02181816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000637|NCT02181816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20000638|NCT02181816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000639|NCT02181816|Vasodilator Agents|vasodilator agents|mesh-ancestor
20000640|NCT02181816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20000641|NCT02181816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20000642|NCT02181842|Pioglitazone|pioglitazone|mesh-list
20000643|NCT02181842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20000644|NCT02181842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000645|NCT02182115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
20000646|NCT02182115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20000647|NCT02182492|Clarithromycin|clarithromycin|mesh-list
20000648|NCT02182492|Glucocorticoids|glucocorticoids|mesh-list
20000649|NCT02182492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20000650|NCT02182492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20000651|NCT02182492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20000652|NCT02182492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000653|NCT02182492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000654|NCT02182492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20000655|NCT02182492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20000656|NCT02182492|Hormones|hormones|mesh-ancestor
20000657|NCT02182492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20000658|NCT02182492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000659|NCT02182830|Empagliflozin|empagliflozin|mesh-list
20000660|NCT02182830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20000661|NCT02182830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000662|NCT02182830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20000663|NCT02182830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000664|NCT02182895|Saxagliptin|saxagliptin|mesh-list
20000665|NCT02182895|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20000666|NCT02182895|Incretins|incretins|mesh-ancestor
20000667|NCT02182895|Hormones|hormones|mesh-ancestor
20000668|NCT02182895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20000669|NCT02182895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000670|NCT02182895|Protease Inhibitors|protease inhibitors|mesh-ancestor
20000671|NCT02182895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000672|NCT02182895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000673|NCT02182895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20000674|NCT02182999|Ropivacaine|ropivacaine|mesh-list
20000675|NCT02182999|Anesthetics, Local|anesthetics, local|mesh-ancestor
20000676|NCT02182999|Anesthetics|anesthetics|mesh-ancestor
20000677|NCT02182999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20000678|NCT02182999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000679|NCT02182999|Sensory System Agents|sensory system agents|mesh-ancestor
20000680|NCT02182999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000681|NCT02183519|Capsaicin|capsaicin|mesh-list
20000682|NCT02183519|Antipruritics|antipruritics|mesh-ancestor
20000683|NCT02183519|Dermatologic Agents|dermatologic agents|mesh-ancestor
20000684|NCT02183519|Sensory System Agents|sensory system agents|mesh-ancestor
20000685|NCT02183519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000686|NCT02183519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000687|NCT02183675|Amlodipine|amlodipine|mesh-list
20000688|NCT02183675|Telmisartan|telmisartan|mesh-list
20000689|NCT02183675|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20000690|NCT02183675|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
20000691|NCT02183675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20000692|NCT02183675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20000693|NCT02183675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20000694|NCT02183675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000695|NCT02183675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20000696|NCT02183675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000697|NCT02183675|Vasodilator Agents|vasodilator agents|mesh-ancestor
20000698|NCT02183675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20000699|NCT02183675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20000700|NCT02183675|Diuretics|diuretics|mesh-ancestor
20000701|NCT02183675|Natriuretic Agents|natriuretic agents|mesh-ancestor
20000702|NCT02183675|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20000703|NCT02183792|Furosemide|furosemide|mesh-list
20000704|NCT02183792|Tolvaptan|tolvaptan|mesh-list
20000705|NCT02183792|Diuretics|diuretics|mesh-ancestor
20000706|NCT02183792|Natriuretic Agents|natriuretic agents|mesh-ancestor
20000707|NCT02183792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000708|NCT02183792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20000709|NCT02183792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20000710|NCT02183792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000711|NCT02183792|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20000712|NCT02184572|Vaccines|vaccines|mesh-list
20556979|NCT01950182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20556980|NCT01950182|Immunologic Factors|immunologic factors|mesh-ancestor
20556981|NCT01950182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20556982|NCT01950182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20556983|NCT01950182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20556984|NCT01950182|Tubulin Modulators|tubulin modulators|mesh-ancestor
20556985|NCT01950182|Antimitotic Agents|antimitotic agents|mesh-ancestor
20556986|NCT01950182|Mitosis Modulators|mitosis modulators|mesh-ancestor
20556987|NCT01950182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20556988|NCT01950182|Hormone Antagonists|hormone antagonists|mesh-ancestor
20556989|NCT01950182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20556990|NCT01950182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20556991|NCT01950182|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20556992|NCT01950182|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20556993|NCT01950182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20556994|NCT01950182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20556995|NCT01950195|Ipilimumab|ipilimumab|mesh-list
20556996|NCT01950195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20556997|NCT01950195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20556998|NCT01950195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20556999|NCT01950195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557000|NCT01950403|Linaclotide|linaclotide|mesh-list
20557001|NCT01950403|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20557002|NCT01950403|Enzyme Activators|enzyme activators|mesh-ancestor
20557003|NCT01950403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557004|NCT01950403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20557005|NCT01950416|Clopidogrel|clopidogrel|mesh-list
20557006|NCT01950416|Ticagrelor|ticagrelor|mesh-list
20557007|NCT01950416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20557008|NCT01950416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20557009|NCT01950416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20557010|NCT01950416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20557011|NCT01950416|Purinergic Agents|purinergic agents|mesh-ancestor
20557012|NCT01950416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20557013|NCT01950416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557014|NCT01950416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557015|NCT01950481|Ceritinib|ceritinib|mesh-list
20557016|NCT01950481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557017|NCT01950481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20557018|NCT01950481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557019|NCT01950481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557020|NCT01950494|Hand Sanitizers|hand sanitizers|mesh-list
20557021|NCT01950494|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20557022|NCT01950494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20557023|NCT01950494|Disinfectants|disinfectants|mesh-ancestor
20557024|NCT01950507|Fluconazole|fluconazole|mesh-list
20557025|NCT01950507|Voriconazole|voriconazole|mesh-list
20557026|NCT01950507|Micafungin|micafungin|mesh-list
20557027|NCT01950507|Budesonide|budesonide|mesh-list
20557028|NCT01950507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20557029|NCT01950507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20557030|NCT01950507|Autonomic Agents|autonomic agents|mesh-ancestor
20557031|NCT01950507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20557032|NCT01950507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557033|NCT01950507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20557034|NCT01950507|Respiratory System Agents|respiratory system agents|mesh-ancestor
20557035|NCT01950507|Glucocorticoids|glucocorticoids|mesh-ancestor
20557036|NCT01950507|Hormones|hormones|mesh-ancestor
20557037|NCT01950507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20557038|NCT01950507|Antifungal Agents|antifungal agents|mesh-ancestor
20557039|NCT01950507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20557040|NCT01950507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20000713|NCT02184572|Immunologic Factors|immunologic factors|mesh-ancestor
20000714|NCT02184572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000715|NCT02184611|Bromides|bromides|mesh-list
20000716|NCT02184611|Anticonvulsants|anticonvulsants|mesh-ancestor
20000717|NCT02185014|Adalimumab|adalimumab|mesh-list
20000718|NCT02185014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20000719|NCT02185014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20000720|NCT02185131|Mirtazapine|mirtazapine|mesh-list
20000721|NCT02185131|Antidepressive Agents|antidepressive agents|mesh-ancestor
20000722|NCT02185131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20000723|NCT02185131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20000724|NCT02185131|Histamine Antagonists|histamine antagonists|mesh-ancestor
20000725|NCT02185131|Histamine Agents|histamine agents|mesh-ancestor
20000726|NCT02185131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20000727|NCT02185131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000728|NCT02185131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000729|NCT02185131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20000730|NCT02185131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20000731|NCT02185131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20000732|NCT02185131|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20000733|NCT02185131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20000734|NCT02185131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20000735|NCT02185131|Adrenergic Agents|adrenergic agents|mesh-ancestor
20000736|NCT02185131|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20000737|NCT02185131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20000738|NCT02185131|Serotonin Agents|serotonin agents|mesh-ancestor
20000739|NCT02185131|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20000740|NCT02185339|Rocuronium|rocuronium|mesh-list
20000741|NCT02185339|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20000742|NCT02185339|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20000743|NCT02185339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20000744|NCT02185339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000745|NCT02185339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289861|NCT04464980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289862|NCT04464980|Analgesics|analgesics|mesh-ancestor
20289863|NCT04464980|Sensory System Agents|sensory system agents|mesh-ancestor
20289864|NCT04464980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20289865|NCT04464980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20289866|NCT04464980|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20289867|NCT04460248|Rituximab|rituximab|mesh-list
20289868|NCT04460248|Lenalidomide|lenalidomide|mesh-list
20289869|NCT04460248|Zanubrutinib|zanubrutinib|mesh-list
20289870|NCT04460248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20289871|NCT04460248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289872|NCT04460248|Immunologic Factors|immunologic factors|mesh-ancestor
20289873|NCT04460248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289874|NCT04460248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20289875|NCT04460248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20289876|NCT04460248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20289877|NCT04460248|Growth Substances|growth substances|mesh-ancestor
20289878|NCT04460248|Growth Inhibitors|growth inhibitors|mesh-ancestor
20289879|NCT04460248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20289880|NCT04460248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289881|NCT04460248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289882|NCT04456439|Diphenhydramine|diphenhydramine|mesh-list
20289883|NCT04456439|Promethazine|promethazine|mesh-list
20289884|NCT04456439|Remestemcel-l|remestemcel-l|mesh-list
20289885|NCT04456439|Hydrocortisone|hydrocortisone|mesh-list
20289886|NCT04456439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20289887|NCT04456439|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20289888|NCT04456439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20289889|NCT04456439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20289890|NCT04456439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289891|NCT04456439|Anesthetics, Local|anesthetics, local|mesh-ancestor
20289892|NCT04456439|Anesthetics|anesthetics|mesh-ancestor
20289893|NCT04456439|Sensory System Agents|sensory system agents|mesh-ancestor
20289894|NCT04456439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20289895|NCT04456439|Antiemetics|antiemetics|mesh-ancestor
20289896|NCT04456439|Autonomic Agents|autonomic agents|mesh-ancestor
20289897|NCT04456439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20289898|NCT04456439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20289899|NCT04456439|Histamine Antagonists|histamine antagonists|mesh-ancestor
20289900|NCT04456439|Histamine Agents|histamine agents|mesh-ancestor
20289901|NCT04456439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20289902|NCT04456439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000746|NCT02185534|Clopidogrel|clopidogrel|mesh-list
20000747|NCT02185534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20000748|NCT02185534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20000749|NCT02185534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20000750|NCT02185534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20000751|NCT02185534|Purinergic Agents|purinergic agents|mesh-ancestor
20000752|NCT02185534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20000753|NCT02185534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000754|NCT02185534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000755|NCT02185729|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20000756|NCT02185729|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20000757|NCT02185729|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20000758|NCT02185729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20000759|NCT02186015|Vitamin D|vitamin d|mesh-list
20000760|NCT02186015|Ergocalciferols|ergocalciferols|mesh-list
20000761|NCT02186015|Cholecalciferol|cholecalciferol|mesh-list
20000762|NCT02186015|Vitamins|vitamins|mesh-list
20000763|NCT02186015|Micronutrients|micronutrients|mesh-ancestor
20000764|NCT02186015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000765|NCT02186015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20000766|NCT02186015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20000767|NCT02186301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20000768|NCT02186301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20000769|NCT02186301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20000770|NCT02186301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000771|NCT02186301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000772|NCT02186652|Pantoprazole|pantoprazole|mesh-list
20000773|NCT02186652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20000774|NCT02186652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20000775|NCT02186652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20000776|NCT02186652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000777|NCT02186652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000778|NCT02186665|Calcitriol|calcitriol|mesh-list
20000779|NCT02186665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20000780|NCT02186665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000781|NCT02186665|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20000782|NCT02186665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20000783|NCT02186665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000784|NCT02186665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20000785|NCT02186665|Vitamins|vitamins|mesh-ancestor
20000786|NCT02186665|Micronutrients|micronutrients|mesh-ancestor
20000787|NCT02186665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20000788|NCT02186821|Ceritinib|ceritinib|mesh-list
20000789|NCT02186821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20000790|NCT02186821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20000791|NCT02186821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000792|NCT02186821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000793|NCT02186873|Golimumab|golimumab|mesh-list
20000794|NCT02186873|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20000795|NCT02186873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20000796|NCT02186873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20000797|NCT02186873|Immunologic Factors|immunologic factors|mesh-ancestor
20000798|NCT02186873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000799|NCT02187016|Listerine|listerine|mesh-list
20000800|NCT02187016|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20000801|NCT02187016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20000802|NCT02187055|Adalimumab|adalimumab|mesh-list
20000803|NCT02187055|Methotrexate|methotrexate|mesh-list
20000804|NCT02187055|Tofacitinib|tofacitinib|mesh-list
20000805|NCT02187055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20000806|NCT02187055|Abortifacient Agents|abortifacient agents|mesh-ancestor
20000807|NCT02187055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20000808|NCT02187055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000809|NCT02187055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20000810|NCT02187055|Antimetabolites|antimetabolites|mesh-ancestor
20000811|NCT02187055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000812|NCT02187055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20000813|NCT02187055|Dermatologic Agents|dermatologic agents|mesh-ancestor
20000814|NCT02187055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000815|NCT02187055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20000816|NCT02187055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20000817|NCT02187055|Immunologic Factors|immunologic factors|mesh-ancestor
20000818|NCT02187055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20289903|NCT04456439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20000819|NCT02187055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20000820|NCT02187055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20000821|NCT02187055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20000822|NCT02187159|Pregabalin|pregabalin|mesh-list
20000823|NCT02187159|Analgesics|analgesics|mesh-ancestor
20000824|NCT02187159|Sensory System Agents|sensory system agents|mesh-ancestor
20000825|NCT02187159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000826|NCT02187159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000827|NCT02187159|Anticonvulsants|anticonvulsants|mesh-ancestor
20000828|NCT02187159|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20000829|NCT02187159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20000830|NCT02187159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000831|NCT02187159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20000832|NCT02187159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20000833|NCT02187159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20000834|NCT02187159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20000835|NCT02187159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20000836|NCT02187172|Ustekinumab|ustekinumab|mesh-list
20000837|NCT02187172|Dermatologic Agents|dermatologic agents|mesh-ancestor
20000838|NCT02187471|Pregabalin|pregabalin|mesh-list
20000839|NCT02187471|Analgesics|analgesics|mesh-ancestor
20000840|NCT02187471|Sensory System Agents|sensory system agents|mesh-ancestor
20000841|NCT02187471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000842|NCT02187471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000843|NCT02187471|Anticonvulsants|anticonvulsants|mesh-ancestor
20000844|NCT02187471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20000845|NCT02187471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20000846|NCT02187471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000847|NCT02187471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20000848|NCT02187471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20000849|NCT02187471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20000850|NCT02187471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20000851|NCT02187471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20000852|NCT02187744|Carboplatin|carboplatin|mesh-list
20000853|NCT02187744|Docetaxel|docetaxel|mesh-list
20000854|NCT02187744|Trastuzumab|trastuzumab|mesh-list
20557041|NCT01950507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20557042|NCT01950507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557043|NCT01950507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557044|NCT01950507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20557045|NCT01950507|Hormone Antagonists|hormone antagonists|mesh-ancestor
20557046|NCT01950507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20557047|NCT01950507|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20557048|NCT01950507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20557049|NCT01950546|Fluorides|fluorides|mesh-list
20557050|NCT01950546|Cariostatic Agents|cariostatic agents|mesh-ancestor
20557051|NCT01950546|Protective Agents|protective agents|mesh-ancestor
20557052|NCT01950546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557053|NCT01950585|Hydroxyurea|hydroxyurea|mesh-list
20557054|NCT01950585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557055|NCT01950585|Antisickling Agents|antisickling agents|mesh-ancestor
20557056|NCT01950585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557057|NCT01950585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557058|NCT01950585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20557059|NCT01950611|Bortezomib|bortezomib|mesh-list
20557060|NCT01950611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557061|NCT01950689|Nimorazole|nimorazole|mesh-list
20557062|NCT01950689|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
20557063|NCT01950689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20557064|NCT01950689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20557065|NCT01950689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20557066|NCT01950793|Triamcinolone|triamcinolone|mesh-list
20557067|NCT01950793|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20557068|NCT01950793|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20557069|NCT01950793|Hyaluronic Acid|hyaluronic acid|mesh-list
20557070|NCT01950793|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20557071|NCT01950793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20557072|NCT01950793|Glucocorticoids|glucocorticoids|mesh-ancestor
20557073|NCT01950793|Hormones|hormones|mesh-ancestor
20557074|NCT01950793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20557075|NCT01950793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557076|NCT01950793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20557077|NCT01950793|Immunologic Factors|immunologic factors|mesh-ancestor
20557078|NCT01950793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000855|NCT02187744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20000856|NCT02187744|Tubulin Modulators|tubulin modulators|mesh-ancestor
20000857|NCT02187744|Antimitotic Agents|antimitotic agents|mesh-ancestor
20000858|NCT02187744|Mitosis Modulators|mitosis modulators|mesh-ancestor
20000859|NCT02187744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000860|NCT02187744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20000861|NCT02187809|Clobazam|clobazam|mesh-list
20000862|NCT02187809|Anticonvulsants|anticonvulsants|mesh-ancestor
20000863|NCT02187809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20000864|NCT02187809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20000865|NCT02187809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20000866|NCT02187809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000867|NCT02187809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20000868|NCT02187809|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20000869|NCT02187809|GABA Agonists|gaba agonists|mesh-ancestor
20000870|NCT02187809|GABA Agents|gaba agents|mesh-ancestor
20000871|NCT02187809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20000872|NCT02187809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000873|NCT02187861|Rituximab|rituximab|mesh-list
20000874|NCT02187861|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20000875|NCT02187861|Venetoclax|venetoclax|mesh-list
20000876|NCT02187861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20000877|NCT02187861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20000878|NCT02187861|Immunologic Factors|immunologic factors|mesh-ancestor
20000879|NCT02187861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000880|NCT02187861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20000881|NCT02187861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20000882|NCT02187861|Alkylating Agents|alkylating agents|mesh-ancestor
20000883|NCT02187861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000884|NCT02188160|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20000885|NCT02188160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20000886|NCT02188459|Bupropion|bupropion|mesh-list
20000887|NCT02188459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20000888|NCT02188459|Antidepressive Agents|antidepressive agents|mesh-ancestor
20000889|NCT02188459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20000890|NCT02188459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20000891|NCT02188459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20000892|NCT02188459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20000893|NCT02188459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000894|NCT02188459|Dopamine Agents|dopamine agents|mesh-ancestor
20000895|NCT02188459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20000896|NCT02188459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000897|NCT02188459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20000898|NCT02188459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20000899|NCT02188459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000900|NCT02188576|Tranexamic Acid|tranexamic acid|mesh-list
20000901|NCT02188576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20000902|NCT02188576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20000903|NCT02188576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000904|NCT02188576|Hemostatics|hemostatics|mesh-ancestor
20000905|NCT02188576|Coagulants|coagulants|mesh-ancestor
20000906|NCT02188719|Acetaminophen|acetaminophen|mesh-list
20000907|NCT02188719|Diphenhydramine|diphenhydramine|mesh-list
20000908|NCT02188719|Promethazine|promethazine|mesh-list
20000909|NCT02188719|Mycophenolic Acid|mycophenolic acid|mesh-list
20000910|NCT02188719|Valganciclovir|valganciclovir|mesh-list
20000911|NCT02188719|Ganciclovir|ganciclovir|mesh-list
20000912|NCT02188719|Anti-Infective Agents|anti-infective agents|mesh-list
20000913|NCT02188719|Prednisone|prednisone|mesh-list
20000914|NCT02188719|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20000915|NCT02188719|Everolimus|everolimus|mesh-list
20000916|NCT02188719|Liver Extracts|liver extracts|mesh-list
20000917|NCT02188719|Tacrolimus|tacrolimus|mesh-list
20000918|NCT02188719|Thymoglobulin|thymoglobulin|mesh-list
20000919|NCT02188719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20000920|NCT02188719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20000921|NCT02188719|Glucocorticoids|glucocorticoids|mesh-ancestor
20000922|NCT02188719|Hormones|hormones|mesh-ancestor
20000923|NCT02188719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20000924|NCT02188719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000925|NCT02188719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20000926|NCT02188719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20000927|NCT02188719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20000928|NCT02188719|Immunologic Factors|immunologic factors|mesh-ancestor
20000929|NCT02188719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20000930|NCT02188719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000931|NCT02188719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000932|NCT02188719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20000933|NCT02188719|Analgesics|analgesics|mesh-ancestor
20000934|NCT02188719|Sensory System Agents|sensory system agents|mesh-ancestor
20000935|NCT02188719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000936|NCT02188719|Antipyretics|antipyretics|mesh-ancestor
20000937|NCT02188719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20000938|NCT02188719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20000939|NCT02188719|Antitubercular Agents|antitubercular agents|mesh-ancestor
20000940|NCT02188719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20000941|NCT02188719|Hematinics|hematinics|mesh-ancestor
20000942|NCT02188719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20000943|NCT02188719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20000944|NCT02188719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20000945|NCT02188719|Anesthetics, Local|anesthetics, local|mesh-ancestor
20000946|NCT02188719|Anesthetics|anesthetics|mesh-ancestor
20000947|NCT02188719|Antiemetics|antiemetics|mesh-ancestor
20000948|NCT02188719|Autonomic Agents|autonomic agents|mesh-ancestor
20000949|NCT02188719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20000950|NCT02188719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20000951|NCT02188719|Histamine Antagonists|histamine antagonists|mesh-ancestor
20000952|NCT02188719|Histamine Agents|histamine agents|mesh-ancestor
20000953|NCT02188719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20000954|NCT02188719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20000955|NCT02188719|Antipruritics|antipruritics|mesh-ancestor
20000956|NCT02188719|Dermatologic Agents|dermatologic agents|mesh-ancestor
20000957|NCT02188719|Antiviral Agents|antiviral agents|mesh-ancestor
20000958|NCT02188719|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20000959|NCT02188719|Protective Agents|protective agents|mesh-ancestor
20000960|NCT02188784|Iron|iron|mesh-list
20000961|NCT02188784|Trace Elements|trace elements|mesh-ancestor
20000962|NCT02188784|Micronutrients|micronutrients|mesh-ancestor
20000963|NCT02188784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000964|NCT02189122|Aspirin|aspirin|mesh-list
20000965|NCT02189122|Bradykinin|bradykinin|mesh-list
20000966|NCT02189122|Kininogens|kininogens|mesh-list
20000967|NCT02189122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20000968|NCT02189122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20000969|NCT02189122|Analgesics|analgesics|mesh-ancestor
20000970|NCT02189122|Sensory System Agents|sensory system agents|mesh-ancestor
20000971|NCT02189122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20000972|NCT02189122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000973|NCT02189122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20000974|NCT02189122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20000975|NCT02189122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20000976|NCT02189122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20000977|NCT02189122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000978|NCT02189122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20000979|NCT02189122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20000980|NCT02189122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20000981|NCT02189122|Antipyretics|antipyretics|mesh-ancestor
20000982|NCT02189122|Vasodilator Agents|vasodilator agents|mesh-ancestor
20000983|NCT02189122|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
20000984|NCT02189122|Protease Inhibitors|protease inhibitors|mesh-ancestor
20000985|NCT02189213|Sertraline|sertraline|mesh-list
20000986|NCT02189213|Antidepressive Agents|antidepressive agents|mesh-ancestor
20000987|NCT02189213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20000988|NCT02189213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20000989|NCT02189213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20000990|NCT02189213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20000991|NCT02189213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20000992|NCT02189213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20000993|NCT02189213|Serotonin Agents|serotonin agents|mesh-ancestor
20000994|NCT02189213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20000995|NCT02189317|Bupivacaine|bupivacaine|mesh-list
20000996|NCT02189317|Anesthetics, Local|anesthetics, local|mesh-ancestor
20000997|NCT02189317|Anesthetics|anesthetics|mesh-ancestor
20000998|NCT02189317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20000999|NCT02189317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001000|NCT02189317|Sensory System Agents|sensory system agents|mesh-ancestor
20557079|NCT01950793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557080|NCT01950793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20557081|NCT01950793|Viscosupplements|viscosupplements|mesh-ancestor
20001001|NCT02189317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001002|NCT02189629|Trifarotene|trifarotene|mesh-list
20001003|NCT02189629|Dermatologic Agents|dermatologic agents|mesh-ancestor
20001004|NCT02189668|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20001005|NCT02189668|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20001006|NCT02189668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20001007|NCT02189668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20001008|NCT02189668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001009|NCT02189668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001010|NCT02189837|Atorvastatin|atorvastatin|mesh-list
20001011|NCT02189837|Evolocumab|evolocumab|mesh-list
20001012|NCT02189837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20001013|NCT02189837|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20001014|NCT02189837|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20001015|NCT02189837|Antimetabolites|antimetabolites|mesh-ancestor
20001016|NCT02189837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001017|NCT02189837|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20001018|NCT02189837|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20001019|NCT02189837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001020|NCT02189837|Immunologic Factors|immunologic factors|mesh-ancestor
20001021|NCT02189837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001022|NCT02189889|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20001023|NCT02189889|Hematinics|hematinics|mesh-ancestor
20001024|NCT02189889|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20001025|NCT02189889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20001026|NCT02189941|Deferiprone|deferiprone|mesh-list
20001027|NCT02189941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20001028|NCT02189941|Chelating Agents|chelating agents|mesh-ancestor
20001029|NCT02189941|Sequestering Agents|sequestering agents|mesh-ancestor
20001030|NCT02189941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001031|NCT02190903|Anesthetics|anesthetics|mesh-list
20001032|NCT02190903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20001033|NCT02190903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001034|NCT02191033|Nicotine|nicotine|mesh-list
20001035|NCT02191033|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20001036|NCT02191033|Autonomic Agents|autonomic agents|mesh-ancestor
20001037|NCT02191033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001038|NCT02191033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001039|NCT02191033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20001040|NCT02191033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20001041|NCT02191033|Cholinergic Agents|cholinergic agents|mesh-ancestor
20001042|NCT02191033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20001043|NCT02191033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001044|NCT02191137|Riociguat|riociguat|mesh-list
20001045|NCT02191137|Enzyme Activators|enzyme activators|mesh-ancestor
20001046|NCT02191137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001047|NCT02191397|Dexetimide|dexetimide|mesh-list
20001048|NCT02191397|Citalopram|citalopram|mesh-list
20001049|NCT02191397|Bupropion|bupropion|mesh-list
20001050|NCT02191397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20001051|NCT02191397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20001052|NCT02191397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20001053|NCT02191397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001054|NCT02191397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20001055|NCT02191397|Serotonin Agents|serotonin agents|mesh-ancestor
20001056|NCT02191397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001057|NCT02191397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20001058|NCT02191397|Antidepressive Agents|antidepressive agents|mesh-ancestor
20001059|NCT02191397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20001060|NCT02191397|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20001061|NCT02191397|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20001062|NCT02191397|Parasympatholytics|parasympatholytics|mesh-ancestor
20001063|NCT02191397|Autonomic Agents|autonomic agents|mesh-ancestor
20001064|NCT02191397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001065|NCT02191397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20001066|NCT02191397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20001067|NCT02191397|Cholinergic Agents|cholinergic agents|mesh-ancestor
20001068|NCT02191397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20001069|NCT02191397|Dopamine Agents|dopamine agents|mesh-ancestor
20001070|NCT02191397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20001071|NCT02191397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20001072|NCT02191397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001073|NCT02191579|Topiramate|topiramate|mesh-list
20001074|NCT02191579|Botulinum Toxins|botulinum toxins|mesh-list
20001075|NCT02191579|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20001076|NCT02191579|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20001077|NCT02191579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20001078|NCT02191579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20001079|NCT02191579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001080|NCT02191579|Cholinergic Agents|cholinergic agents|mesh-ancestor
20001081|NCT02191579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20001082|NCT02191579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001083|NCT02191579|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20001084|NCT02191579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001085|NCT02191579|Anticonvulsants|anticonvulsants|mesh-ancestor
20001086|NCT02191579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20001087|NCT02191865|Nintedanib|nintedanib|mesh-list
20001088|NCT02191865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20001089|NCT02191865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20001090|NCT02191865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001091|NCT02191865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001092|NCT02192190|Celecoxib|celecoxib|mesh-list
20001093|NCT02192190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20001094|NCT02192190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20001095|NCT02192190|Analgesics|analgesics|mesh-ancestor
20001096|NCT02192190|Sensory System Agents|sensory system agents|mesh-ancestor
20001097|NCT02192190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001098|NCT02192190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001099|NCT02192190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20001100|NCT02192190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20001101|NCT02192190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20001102|NCT02192190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20001103|NCT02192190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001104|NCT02192190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001105|NCT02192541|Aflibercept|aflibercept|mesh-list
20001106|NCT02192541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20001107|NCT02192541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20001108|NCT02192541|Growth Substances|growth substances|mesh-ancestor
20001109|NCT02192541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001110|NCT02192541|Growth Inhibitors|growth inhibitors|mesh-ancestor
20001111|NCT02192541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20001112|NCT02192684|Pioglitazone|pioglitazone|mesh-list
20001113|NCT02192684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20557082|NCT01950793|Protective Agents|protective agents|mesh-ancestor
20557083|NCT01950884|Ezetimibe|ezetimibe|mesh-list
20557084|NCT01950884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20557085|NCT01950884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20557086|NCT01950884|Antimetabolites|antimetabolites|mesh-ancestor
20557087|NCT01950884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557088|NCT01950884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20557089|NCT01950923|Sildenafil Citrate|sildenafil citrate|mesh-list
20557090|NCT01950923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557091|NCT01950923|Vasodilator Agents|vasodilator agents|mesh-ancestor
20557092|NCT01950923|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20557093|NCT01950923|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20557094|NCT01950923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557095|NCT01950923|Urological Agents|urological agents|mesh-ancestor
20557096|NCT01950949|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20557097|NCT01950949|Plasma Substitutes|plasma substitutes|mesh-ancestor
20557098|NCT01950949|Blood Substitutes|blood substitutes|mesh-ancestor
20557099|NCT01951001|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20557100|NCT01951001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20557101|NCT01951027|Lenograstim|lenograstim|mesh-list
20557102|NCT01951027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20557103|NCT01951027|Immunologic Factors|immunologic factors|mesh-ancestor
20557104|NCT01951027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557105|NCT01951053|Citalopram|citalopram|mesh-list
20557106|NCT01951053|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20557107|NCT01951053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20557108|NCT01951053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20557109|NCT01951053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557110|NCT01951053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20557111|NCT01951053|Serotonin Agents|serotonin agents|mesh-ancestor
20557112|NCT01951053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557113|NCT01951053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20557114|NCT01951053|Antidepressive Agents|antidepressive agents|mesh-ancestor
20557115|NCT01951053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20001114|NCT02192684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001115|NCT02192814|Lacosamide|lacosamide|mesh-list
20001116|NCT02192814|Anticonvulsants|anticonvulsants|mesh-ancestor
20001117|NCT02192814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20001118|NCT02192814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20001119|NCT02192814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20001120|NCT02192814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001121|NCT02192970|Bevacizumab|bevacizumab|mesh-list
20001122|NCT02192970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20001123|NCT02192970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20001124|NCT02192970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20001125|NCT02192970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20001126|NCT02192970|Growth Substances|growth substances|mesh-ancestor
20001127|NCT02192970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001128|NCT02192970|Growth Inhibitors|growth inhibitors|mesh-ancestor
20001129|NCT02193165|Triclosan|triclosan|mesh-list
20001130|NCT02193165|Cetylpyridinium|cetylpyridinium|mesh-list
20001131|NCT02193165|Fluorides|fluorides|mesh-list
20001132|NCT02193165|Tin Fluorides|tin fluorides|mesh-list
20001133|NCT02193165|Cariostatic Agents|cariostatic agents|mesh-ancestor
20001134|NCT02193165|Protective Agents|protective agents|mesh-ancestor
20001135|NCT02193165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001136|NCT02193165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20001137|NCT02193165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20001138|NCT02193165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20001139|NCT02193165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20001140|NCT02193165|Antimetabolites|antimetabolites|mesh-ancestor
20001141|NCT02193165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001142|NCT02193165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20001143|NCT02193347|Temozolomide|temozolomide|mesh-list
20001144|NCT02193347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20001145|NCT02193347|Alkylating Agents|alkylating agents|mesh-ancestor
20001146|NCT02193347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001147|NCT02193347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20001148|NCT02193776|Moxifloxacin|moxifloxacin|mesh-list
20001149|NCT02193776|Rifampin|rifampin|mesh-list
20001150|NCT02193776|Isoniazid|isoniazid|mesh-list
20001151|NCT02193776|Pyrazinamide|pyrazinamide|mesh-list
20001152|NCT02193776|Ethambutol|ethambutol|mesh-list
20001153|NCT02193776|Bedaquiline|bedaquiline|mesh-list
20001154|NCT02193776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20001155|NCT02193776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20001156|NCT02193776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20001157|NCT02193776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20001158|NCT02193776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001159|NCT02193776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001160|NCT02193776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20001161|NCT02193776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20001162|NCT02193776|Antitubercular Agents|antitubercular agents|mesh-ancestor
20001163|NCT02193776|Leprostatic Agents|leprostatic agents|mesh-ancestor
20001164|NCT02193776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20001165|NCT02193776|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20001166|NCT02193776|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20001167|NCT02193776|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20001168|NCT02193776|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20001169|NCT02193776|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20001170|NCT02193776|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20001171|NCT02193776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20001172|NCT02193776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20001173|NCT02193776|Antimetabolites|antimetabolites|mesh-ancestor
20001174|NCT02193776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20001175|NCT02193815|Calcitriol|calcitriol|mesh-list
20001176|NCT02193815|Calcipotriene|calcipotriene|mesh-list
20001177|NCT02193815|Tofacitinib|tofacitinib|mesh-list
20001178|NCT02193815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20001179|NCT02193815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001180|NCT02193815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001181|NCT02193815|Dermatologic Agents|dermatologic agents|mesh-ancestor
20001182|NCT02193815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20001183|NCT02193815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001184|NCT02193815|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20001185|NCT02193815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20001186|NCT02193815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20001187|NCT02193815|Vitamins|vitamins|mesh-ancestor
20001188|NCT02193815|Micronutrients|micronutrients|mesh-ancestor
20001189|NCT02193815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20001190|NCT02193880|Cyclophosphamide|cyclophosphamide|mesh-list
20001191|NCT02193880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20001192|NCT02193880|Immunologic Factors|immunologic factors|mesh-ancestor
20001193|NCT02193880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001194|NCT02193880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20001195|NCT02193880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20001196|NCT02193880|Alkylating Agents|alkylating agents|mesh-ancestor
20001197|NCT02193880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001198|NCT02193880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20001199|NCT02193880|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20001200|NCT02194062|Fluticasone|fluticasone|mesh-list
20001201|NCT02194062|Xhance|xhance|mesh-list
20001202|NCT02194062|Budesonide|budesonide|mesh-list
20001203|NCT02194062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20001204|NCT02194062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20001205|NCT02194062|Autonomic Agents|autonomic agents|mesh-ancestor
20001206|NCT02194062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001207|NCT02194062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001208|NCT02194062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20001209|NCT02194062|Respiratory System Agents|respiratory system agents|mesh-ancestor
20001210|NCT02194062|Dermatologic Agents|dermatologic agents|mesh-ancestor
20001211|NCT02194062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20001212|NCT02194062|Glucocorticoids|glucocorticoids|mesh-ancestor
20001213|NCT02194062|Hormones|hormones|mesh-ancestor
20001214|NCT02194062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20001215|NCT02194088|Diclofenac|diclofenac|mesh-list
20001216|NCT02194088|Atropine|atropine|mesh-list
20001217|NCT02194088|Analgesics|analgesics|mesh-list
20001218|NCT02194088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20001219|NCT02194088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20001220|NCT02194088|Sensory System Agents|sensory system agents|mesh-ancestor
20001221|NCT02194088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001222|NCT02194088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001223|NCT02194088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20001224|NCT02194088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20001225|NCT02194088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20001226|NCT02194088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001227|NCT02194088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001228|NCT02194088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20001229|NCT02194088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20001230|NCT02194088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20001231|NCT02194088|Autonomic Agents|autonomic agents|mesh-ancestor
20001232|NCT02194088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20001233|NCT02194088|Respiratory System Agents|respiratory system agents|mesh-ancestor
20001234|NCT02194088|Mydriatics|mydriatics|mesh-ancestor
20001235|NCT02194088|Parasympatholytics|parasympatholytics|mesh-ancestor
20001236|NCT02194088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20001237|NCT02194088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20001238|NCT02194088|Cholinergic Agents|cholinergic agents|mesh-ancestor
20001239|NCT02194088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20289904|NCT04456439|Antipruritics|antipruritics|mesh-ancestor
20289905|NCT04456439|Dermatologic Agents|dermatologic agents|mesh-ancestor
20289906|NCT04456439|Antiviral Agents|antiviral agents|mesh-ancestor
20289907|NCT04456439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20289908|NCT04455750|Leuprolide|leuprolide|mesh-list
20289909|NCT04455750|Goserelin|goserelin|mesh-list
20289910|NCT04455750|Rucaparib|rucaparib|mesh-list
20289911|NCT04455750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20289912|NCT04455750|Fertility Agents|fertility agents|mesh-ancestor
20289913|NCT04455750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20289914|NCT04455750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289915|NCT04455750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20289916|NCT04455750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289917|NCT04455750|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20289918|NCT04455750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557116|NCT01951079|Digoxin|digoxin|mesh-list
20557117|NCT01951079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20557118|NCT01951079|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20557119|NCT01951079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557120|NCT01951079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557121|NCT01951079|Protective Agents|protective agents|mesh-ancestor
20557122|NCT01951079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557123|NCT01951144|Lorazepam|lorazepam|mesh-list
20557124|NCT01951144|PF-06372865|pf-06372865|mesh-list
20289919|NCT04455750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289920|NCT04451772|Upadacitinib|upadacitinib|mesh-list
20289921|NCT04451772|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
20001240|NCT02194465|Spironolactone|spironolactone|mesh-list
20001241|NCT02194465|Tadalafil|tadalafil|mesh-list
20001242|NCT02194465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
20001243|NCT02194465|Mineralocorticoids|mineralocorticoids|mesh-list
20001244|NCT02194465|Vasodilator Agents|vasodilator agents|mesh-ancestor
20001245|NCT02194465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20001246|NCT02194465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20001247|NCT02194465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001248|NCT02194465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001249|NCT02194465|Urological Agents|urological agents|mesh-ancestor
20001250|NCT02194465|Hormone Antagonists|hormone antagonists|mesh-ancestor
20001251|NCT02194465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20001252|NCT02194465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001253|NCT02194465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20001254|NCT02194465|Diuretics|diuretics|mesh-ancestor
20001255|NCT02194465|Natriuretic Agents|natriuretic agents|mesh-ancestor
20001256|NCT02194465|Hormones|hormones|mesh-ancestor
20001257|NCT02194933|Brexpiprazole|brexpiprazole|mesh-list
20001258|NCT02194933|Serotonin Agents|serotonin agents|mesh-ancestor
20001259|NCT02194933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20001260|NCT02194933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001261|NCT02194933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001262|NCT02194933|Dopamine Agonists|dopamine agonists|mesh-ancestor
20001263|NCT02194933|Dopamine Agents|dopamine agents|mesh-ancestor
20001264|NCT02194998|Ritonavir|ritonavir|mesh-list
20001265|NCT02194998|Ribavirin|ribavirin|mesh-list
20001266|NCT02194998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20001267|NCT02194998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20001268|NCT02194998|Protease Inhibitors|protease inhibitors|mesh-ancestor
20001269|NCT02194998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001270|NCT02194998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001271|NCT02194998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20001272|NCT02194998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20001273|NCT02194998|Antiviral Agents|antiviral agents|mesh-ancestor
20001274|NCT02194998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20001275|NCT02194998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20001276|NCT02194998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20001277|NCT02194998|Antimetabolites|antimetabolites|mesh-ancestor
20001278|NCT02195232|Quercetin|quercetin|mesh-list
20001279|NCT02195232|Antioxidants|antioxidants|mesh-ancestor
20001280|NCT02195232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001281|NCT02195232|Protective Agents|protective agents|mesh-ancestor
20001282|NCT02195232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001283|NCT02195518|Tenofovir|tenofovir|mesh-list
20001284|NCT02195518|Antiviral Agents|antiviral agents|mesh-ancestor
20001285|NCT02195518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20001286|NCT02195518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20001287|NCT02195518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20001288|NCT02195518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001289|NCT02195518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001290|NCT02195518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20001291|NCT02195518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20001292|NCT02195583|Zinc|zinc|mesh-list
20001293|NCT02195583|Listerine|listerine|mesh-list
20001294|NCT02195583|Fluorides|fluorides|mesh-list
20001295|NCT02195583|Sodium Fluoride|sodium fluoride|mesh-list
20001296|NCT02195583|Cariostatic Agents|cariostatic agents|mesh-ancestor
20001297|NCT02195583|Protective Agents|protective agents|mesh-ancestor
20001298|NCT02195583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001299|NCT02195583|Trace Elements|trace elements|mesh-ancestor
20001300|NCT02195583|Micronutrients|micronutrients|mesh-ancestor
20001301|NCT02195583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20001302|NCT02195583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20001303|NCT02195687|Botulinum Toxins|botulinum toxins|mesh-list
20001304|NCT02195687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20001305|NCT02195687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20001306|NCT02195687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20001307|NCT02195687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20001308|NCT02195687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001309|NCT02195687|Cholinergic Agents|cholinergic agents|mesh-ancestor
20001310|NCT02195687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20001311|NCT02195687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001312|NCT02195687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20001313|NCT02195687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001314|NCT02195895|Calcium, Dietary|calcium, dietary|mesh-list
20001315|NCT02195895|Vitamin D|vitamin d|mesh-list
20001316|NCT02195895|Ergocalciferols|ergocalciferols|mesh-list
20001317|NCT02195895|Cholecalciferol|cholecalciferol|mesh-list
20001318|NCT02195895|Alendronate|alendronate|mesh-list
20001319|NCT02195895|Vitamins|vitamins|mesh-list
20001320|NCT02195895|Calcium Carbonate|calcium carbonate|mesh-list
20001321|NCT02195895|Antacids|antacids|mesh-list
20001322|NCT02195895|Calcium|calcium|mesh-list
20001323|NCT02195895|Micronutrients|micronutrients|mesh-ancestor
20001324|NCT02195895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001325|NCT02195895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20001326|NCT02195895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20001327|NCT02195895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001328|NCT02195895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20001329|NCT02195921|Antiemetics|antiemetics|mesh-list
20001330|NCT02195921|Autonomic Agents|autonomic agents|mesh-ancestor
20001331|NCT02195921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001332|NCT02195921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001333|NCT02195921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20001334|NCT02196168|Cisplatin|cisplatin|mesh-list
20001335|NCT02196168|Adavosertib|adavosertib|mesh-list
20001336|NCT02196168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20001337|NCT02196168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001338|NCT02196168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001339|NCT02196259|Ketamine|ketamine|mesh-list
20001340|NCT02196259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-list
20001341|NCT02196259|Anesthetics|anesthetics|mesh-list
20001342|NCT02196259|Analgesics|analgesics|mesh-ancestor
20001343|NCT02196259|Sensory System Agents|sensory system agents|mesh-ancestor
20001344|NCT02196259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001345|NCT02196259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001346|NCT02196259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20001347|NCT02196259|Anesthetics, General|anesthetics, general|mesh-ancestor
20001348|NCT02196259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20001349|NCT02196259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20001350|NCT02196259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20001351|NCT02196259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20001352|NCT02196259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001353|NCT02196324|Serlopitant|serlopitant|mesh-list
20001354|NCT02196324|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20001355|NCT02196324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20001356|NCT02196324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001357|NCT02196324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001358|NCT02196506|Brexpiprazole|brexpiprazole|mesh-list
20001359|NCT02196506|Serotonin Agents|serotonin agents|mesh-ancestor
20001360|NCT02196506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20001361|NCT02196506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001362|NCT02196506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001363|NCT02196506|Dopamine Agonists|dopamine agonists|mesh-ancestor
20001364|NCT02196506|Dopamine Agents|dopamine agents|mesh-ancestor
20001365|NCT02196558|Quetmolimab|quetmolimab|mesh-list
20001366|NCT02196558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20001367|NCT02196701|Adalimumab|adalimumab|mesh-list
20001368|NCT02196701|Methotrexate|methotrexate|mesh-list
20001369|NCT02196701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20001370|NCT02196701|Abortifacient Agents|abortifacient agents|mesh-ancestor
20001371|NCT02196701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20001372|NCT02196701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001373|NCT02196701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20001374|NCT02196701|Antimetabolites|antimetabolites|mesh-ancestor
20001375|NCT02196701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001376|NCT02196701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20001377|NCT02196701|Dermatologic Agents|dermatologic agents|mesh-ancestor
20001378|NCT02196701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001379|NCT02196701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20001380|NCT02196701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20001381|NCT02196701|Immunologic Factors|immunologic factors|mesh-ancestor
20001382|NCT02196701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20001383|NCT02196701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20001384|NCT02196701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20001385|NCT02196714|Glycopyrrolate|glycopyrrolate|mesh-list
20001386|NCT02196714|Formoterol Fumarate|formoterol fumarate|mesh-list
20001387|NCT02196714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20001388|NCT02196714|Autonomic Agents|autonomic agents|mesh-ancestor
20001389|NCT02196714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001390|NCT02196714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001391|NCT02196714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20001392|NCT02196714|Respiratory System Agents|respiratory system agents|mesh-ancestor
20001393|NCT02196714|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20001394|NCT02196714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20001395|NCT02196714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20001396|NCT02196714|Adrenergic Agents|adrenergic agents|mesh-ancestor
20001397|NCT02196714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20001398|NCT02196714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001399|NCT02196714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20001400|NCT02196714|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20001401|NCT02196714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20001402|NCT02196714|Cholinergic Agents|cholinergic agents|mesh-ancestor
20001403|NCT02196831|Tesamorelin|tesamorelin|mesh-list
20001404|NCT02196831|Growth Substances|growth substances|mesh-ancestor
20001405|NCT02196831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001406|NCT02196857|Azacitidine|azacitidine|mesh-list
20001407|NCT02196857|Sorafenib|sorafenib|mesh-list
20001408|NCT02196857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20001409|NCT02196857|Antimetabolites|antimetabolites|mesh-ancestor
20001410|NCT02196857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001411|NCT02196857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20001412|NCT02196857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001413|NCT02196857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20001414|NCT02197065|Atorvastatin|atorvastatin|mesh-list
20001415|NCT02197065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20001416|NCT02197065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20001417|NCT02197065|Antimetabolites|antimetabolites|mesh-ancestor
20001418|NCT02197065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001419|NCT02197065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20001420|NCT02197065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20001421|NCT02197065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001422|NCT02197247|Rifampin|rifampin|mesh-list
20001423|NCT02197247|Osimertinib|osimertinib|mesh-list
20001424|NCT02197247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20001425|NCT02197247|Antitubercular Agents|antitubercular agents|mesh-ancestor
20001426|NCT02197247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20001427|NCT02197247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20001428|NCT02197247|Leprostatic Agents|leprostatic agents|mesh-ancestor
20001429|NCT02197247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20001430|NCT02197247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001431|NCT02197247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001432|NCT02197247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20001433|NCT02197247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20001434|NCT02197247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20001435|NCT02197247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20001436|NCT02197247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20001437|NCT02197247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20001438|NCT02197247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20001439|NCT02197247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20001440|NCT02197273|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20001441|NCT02197273|Epinephrine|epinephrine|mesh-list
20001442|NCT02197273|Fentanyl|fentanyl|mesh-list
20001443|NCT02197273|Morphine|morphine|mesh-list
20001444|NCT02197273|Bupivacaine|bupivacaine|mesh-list
20001445|NCT02197273|Ropivacaine|ropivacaine|mesh-list
20001446|NCT02197273|Anesthetics, Local|anesthetics, local|mesh-ancestor
20001447|NCT02197273|Anesthetics|anesthetics|mesh-ancestor
20001448|NCT02197273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20001449|NCT02197273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001450|NCT02197273|Sensory System Agents|sensory system agents|mesh-ancestor
20001451|NCT02197273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001452|NCT02197273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20001453|NCT02197273|Narcotics|narcotics|mesh-ancestor
20001454|NCT02197273|Analgesics|analgesics|mesh-ancestor
20001455|NCT02197273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20001456|NCT02197273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20001457|NCT02197273|Anesthetics, General|anesthetics, general|mesh-ancestor
20001458|NCT02197273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20001459|NCT02197273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20001460|NCT02197273|Adrenergic Agents|adrenergic agents|mesh-ancestor
20001461|NCT02197273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20001462|NCT02197273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001463|NCT02197273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20001464|NCT02197273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20001465|NCT02197273|Autonomic Agents|autonomic agents|mesh-ancestor
20001466|NCT02197273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20001467|NCT02197273|Respiratory System Agents|respiratory system agents|mesh-ancestor
20001468|NCT02197273|Mydriatics|mydriatics|mesh-ancestor
20001469|NCT02197273|Sympathomimetics|sympathomimetics|mesh-ancestor
20001470|NCT02197273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20001471|NCT02197273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20001472|NCT02197273|Glucocorticoids|glucocorticoids|mesh-ancestor
20001473|NCT02197273|Hormones|hormones|mesh-ancestor
20001474|NCT02197273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20001475|NCT02197273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20001476|NCT02197273|Protective Agents|protective agents|mesh-ancestor
20001477|NCT02197273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20001478|NCT02197273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20001479|NCT02197377|Chlorhexidine|chlorhexidine|mesh-list
20001480|NCT02197377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20001481|NCT02197377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20001482|NCT02197377|Disinfectants|disinfectants|mesh-ancestor
20001483|NCT02197416|Dabigatran|dabigatran|mesh-list
20001484|NCT02197416|Antithrombins|antithrombins|mesh-ancestor
20001485|NCT02197416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20001486|NCT02197416|Protease Inhibitors|protease inhibitors|mesh-ancestor
20001487|NCT02197416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001488|NCT02197416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001489|NCT02197416|Anticoagulants|anticoagulants|mesh-ancestor
20001490|NCT02197455|Tofacitinib|tofacitinib|mesh-list
20001491|NCT02197455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20001492|NCT02197455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001493|NCT02197455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001494|NCT02197520|Insulin|insulin|mesh-list
20001495|NCT02197520|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20001496|NCT02197520|Insulin Glargine|insulin glargine|mesh-list
20001497|NCT02197520|Insulin Lispro|insulin lispro|mesh-list
20557125|NCT01951144|Anticonvulsants|anticonvulsants|mesh-ancestor
20557126|NCT01951144|Antiemetics|antiemetics|mesh-ancestor
20557127|NCT01951144|Autonomic Agents|autonomic agents|mesh-ancestor
20557128|NCT01951144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20557129|NCT01951144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557130|NCT01951144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20557131|NCT01951144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20557132|NCT01951144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20557133|NCT01951144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20557134|NCT01951144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20557135|NCT01951144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20557136|NCT01951144|GABA Modulators|gaba modulators|mesh-ancestor
20557137|NCT01951144|GABA Agents|gaba agents|mesh-ancestor
20557138|NCT01951144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20557139|NCT01951144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557140|NCT01951209|Rifaximin|rifaximin|mesh-list
20557141|NCT01951209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20557142|NCT01951209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20557143|NCT01951209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20557144|NCT01951404|Allopurinol|allopurinol|mesh-list
20557145|NCT01951404|Antimetabolites|antimetabolites|mesh-ancestor
20557146|NCT01951404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557147|NCT01951404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557148|NCT01951404|Gout Suppressants|gout suppressants|mesh-ancestor
20557149|NCT01951404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20557150|NCT01951404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20557151|NCT01951404|Antioxidants|antioxidants|mesh-ancestor
20557152|NCT01951404|Protective Agents|protective agents|mesh-ancestor
20557153|NCT01951404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557154|NCT01951430|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20557155|NCT01951430|Cephalosporins|cephalosporins|mesh-list
20557156|NCT01951430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
20557157|NCT01951430|Itraconazole|itraconazole|mesh-list
20557158|NCT01951430|Fluconazole|fluconazole|mesh-list
20557159|NCT01951430|Posaconazole|posaconazole|mesh-list
20557160|NCT01951430|Antifungal Agents|antifungal agents|mesh-list
20557161|NCT01951430|Clotrimazole|clotrimazole|mesh-list
20557162|NCT01951430|Miconazole|miconazole|mesh-list
20557163|NCT01951430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20557164|NCT01951430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20557165|NCT01951430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20557166|NCT01951430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557167|NCT01951430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557168|NCT01951430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20557169|NCT01951430|Hormone Antagonists|hormone antagonists|mesh-ancestor
20557170|NCT01951430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20557171|NCT01951430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001498|NCT02197520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20557172|NCT01951430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20001499|NCT02197520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001500|NCT02197767|Rituximab|rituximab|mesh-list
20001501|NCT02197767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20001502|NCT02197767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20001503|NCT02197767|Immunologic Factors|immunologic factors|mesh-ancestor
20001504|NCT02197767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001505|NCT02197767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20001506|NCT02197897|Tamoxifen|tamoxifen|mesh-list
20001507|NCT02197897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20001508|NCT02197897|Hormone Antagonists|hormone antagonists|mesh-ancestor
20001509|NCT02197897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20001510|NCT02197897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001511|NCT02197897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20001512|NCT02197897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20001513|NCT02197897|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20001514|NCT02197897|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20001515|NCT02197897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20001516|NCT02198235|Dexamethasone|dexamethasone|mesh-list
20001517|NCT02198235|Buprenorphine|buprenorphine|mesh-list
20001518|NCT02198235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20001519|NCT02198235|Antiemetics|antiemetics|mesh-ancestor
20001520|NCT02198235|Autonomic Agents|autonomic agents|mesh-ancestor
20001521|NCT02198235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001522|NCT02198235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001523|NCT02198235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20001524|NCT02198235|Glucocorticoids|glucocorticoids|mesh-ancestor
20001525|NCT02198235|Hormones|hormones|mesh-ancestor
20001526|NCT02198235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20001527|NCT02198235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20001528|NCT02198235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20001529|NCT02198235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20001530|NCT02198235|Narcotics|narcotics|mesh-ancestor
20001531|NCT02198235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20001532|NCT02198235|Analgesics|analgesics|mesh-ancestor
20001533|NCT02198235|Sensory System Agents|sensory system agents|mesh-ancestor
20001534|NCT02198235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20001535|NCT02198651|Adalimumab|adalimumab|mesh-list
20001536|NCT02198651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20001537|NCT02198651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20001538|NCT02199041|Mycophenolic Acid|mycophenolic acid|mesh-list
20001539|NCT02199041|Methylprednisolone|methylprednisolone|mesh-list
20001540|NCT02199041|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20001541|NCT02199041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20001542|NCT02199041|Prednisolone|prednisolone|mesh-list
20001543|NCT02199041|Prednisolone acetate|prednisolone acetate|mesh-list
20001544|NCT02199041|Cyclophosphamide|cyclophosphamide|mesh-list
20001545|NCT02199041|Melphalan|melphalan|mesh-list
20001546|NCT02199041|Mechlorethamine|mechlorethamine|mesh-list
20001547|NCT02199041|Thiotepa|thiotepa|mesh-list
20001548|NCT02199041|Fludarabine|fludarabine|mesh-list
20001549|NCT02199041|Tacrolimus|tacrolimus|mesh-list
20001550|NCT02199041|Lenograstim|lenograstim|mesh-list
20001551|NCT02199041|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20001552|NCT02199041|Prednisolone phosphate|prednisolone phosphate|mesh-list
20001553|NCT02199041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20001554|NCT02199041|Immunologic Factors|immunologic factors|mesh-ancestor
20001555|NCT02199041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001556|NCT02199041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20001557|NCT02199041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20001558|NCT02199041|Alkylating Agents|alkylating agents|mesh-ancestor
20001559|NCT02199041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001560|NCT02199041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20001561|NCT02199041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20001562|NCT02199041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20001563|NCT02199041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001564|NCT02199041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20001565|NCT02199041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20001566|NCT02199041|Antitubercular Agents|antitubercular agents|mesh-ancestor
20001567|NCT02199041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20001568|NCT02199041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20001569|NCT02199041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20001570|NCT02199041|Antiemetics|antiemetics|mesh-ancestor
20001571|NCT02199041|Autonomic Agents|autonomic agents|mesh-ancestor
20001572|NCT02199041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001573|NCT02199041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20001574|NCT02199041|Glucocorticoids|glucocorticoids|mesh-ancestor
20001575|NCT02199041|Hormones|hormones|mesh-ancestor
20001576|NCT02199041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20001577|NCT02199041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20001578|NCT02199041|Protective Agents|protective agents|mesh-ancestor
20001579|NCT02199041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20001580|NCT02199041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20001581|NCT02199080|Fibrin fragment D|fibrin fragment d|mesh-list
20001582|NCT02199080|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20001583|NCT02199080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20001584|NCT02199080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001585|NCT02199080|Hemostatics|hemostatics|mesh-ancestor
20001586|NCT02199080|Coagulants|coagulants|mesh-ancestor
20001587|NCT02199197|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20001588|NCT02199197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20001589|NCT02199314|Desflurane|desflurane|mesh-list
20001590|NCT02199314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20001591|NCT02199314|Anesthetics, General|anesthetics, general|mesh-ancestor
20001592|NCT02199314|Anesthetics|anesthetics|mesh-ancestor
20001593|NCT02199314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20001594|NCT02199314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001595|NCT02199496|Ustekinumab|ustekinumab|mesh-list
20001596|NCT02199496|Dermatologic Agents|dermatologic agents|mesh-ancestor
20001597|NCT02199509|Levetiracetam|levetiracetam|mesh-list
20001598|NCT02199509|Anticonvulsants|anticonvulsants|mesh-ancestor
20001599|NCT02199509|Nootropic Agents|nootropic agents|mesh-ancestor
20001600|NCT02199574|Bupivacaine|bupivacaine|mesh-list
20001601|NCT02199574|Anesthetics, Local|anesthetics, local|mesh-ancestor
20001602|NCT02199574|Anesthetics|anesthetics|mesh-ancestor
20001603|NCT02199574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20001604|NCT02199574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001605|NCT02199574|Sensory System Agents|sensory system agents|mesh-ancestor
20001606|NCT02199574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001607|NCT02199652|Prazosin|prazosin|mesh-list
20001608|NCT02199652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20001609|NCT02199652|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20001610|NCT02199652|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20001611|NCT02199652|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20001612|NCT02199652|Adrenergic Agents|adrenergic agents|mesh-ancestor
20001613|NCT02199652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20001614|NCT02199652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001615|NCT02199652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001616|NCT02199743|Haloperidol|haloperidol|mesh-list
20001617|NCT02199743|Haloperidol decanoate|haloperidol decanoate|mesh-list
20001618|NCT02199743|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20001619|NCT02199743|Perphenazine|perphenazine|mesh-list
20001620|NCT02199743|Antiemetics|antiemetics|mesh-ancestor
20001621|NCT02199743|Autonomic Agents|autonomic agents|mesh-ancestor
20001622|NCT02199743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001623|NCT02199743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001624|NCT02199743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20001625|NCT02199743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20001626|NCT02199743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20001627|NCT02199743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20001628|NCT02199743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20001629|NCT02199743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20557173|NCT01951430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20557174|NCT01951430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20557175|NCT01951430|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20557176|NCT01951430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20557177|NCT01951430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20557178|NCT01951430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20557179|NCT01951430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20557180|NCT01951430|Renal Agents|renal agents|mesh-ancestor
20557181|NCT01951430|Antimalarials|antimalarials|mesh-ancestor
20557182|NCT01951482|Bevacizumab|bevacizumab|mesh-list
20557183|NCT01951482|Cisplatin|cisplatin|mesh-list
20557184|NCT01951482|Pemetrexed|pemetrexed|mesh-list
20557185|NCT01951482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20557186|NCT01951482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557187|NCT01951482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20557188|NCT01951482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20557189|NCT01951482|Growth Substances|growth substances|mesh-ancestor
20557190|NCT01951482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557191|NCT01951482|Growth Inhibitors|growth inhibitors|mesh-ancestor
20557192|NCT01951482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557193|NCT01951482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557194|NCT01951482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20557195|NCT01951482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20557196|NCT01951508|Methylphenidate|methylphenidate|mesh-list
20557197|NCT01951508|Modafinil|modafinil|mesh-list
20557198|NCT01951508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20557199|NCT01951508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557200|NCT01951508|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20557201|NCT01951508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20557202|NCT01951508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20557203|NCT01951508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557204|NCT01951508|Dopamine Agents|dopamine agents|mesh-ancestor
20557205|NCT01951508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20557206|NCT01951508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20557207|NCT01951508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20557208|NCT01951508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20557209|NCT01951560|Valproic Acid|valproic acid|mesh-list
20557210|NCT01951560|Anticonvulsants|anticonvulsants|mesh-ancestor
20557211|NCT01951560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557212|NCT01951560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557213|NCT01951560|GABA Agents|gaba agents|mesh-ancestor
20557214|NCT01951560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20557215|NCT01951560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557216|NCT01951560|Antimanic Agents|antimanic agents|mesh-ancestor
20557217|NCT01951560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20001630|NCT02199743|Dopamine Agents|dopamine agents|mesh-ancestor
20001631|NCT02199743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20001632|NCT02199743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001633|NCT02199743|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20001634|NCT02199743|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20001635|NCT02199743|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20001636|NCT02199743|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20001637|NCT02199743|Adrenergic Agents|adrenergic agents|mesh-ancestor
20001638|NCT02199743|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20001639|NCT02199743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20001640|NCT02199743|Serotonin Agents|serotonin agents|mesh-ancestor
20001641|NCT02199743|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20001642|NCT02199964|Cyclosporine|cyclosporine|mesh-list
20001643|NCT02199964|Lubricant Eye Drops|lubricant eye drops|mesh-list
20001644|NCT02199964|Cyclosporins|cyclosporins|mesh-list
20001645|NCT02199964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001646|NCT02199964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001647|NCT02199964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20001648|NCT02199964|Immunologic Factors|immunologic factors|mesh-ancestor
20001649|NCT02199964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001650|NCT02199964|Antifungal Agents|antifungal agents|mesh-ancestor
20001651|NCT02199964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20001652|NCT02199964|Dermatologic Agents|dermatologic agents|mesh-ancestor
20001653|NCT02199964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20001654|NCT02199964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20001655|NCT02199964|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20001656|NCT02199964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20001657|NCT02200445|Aldesleukin|aldesleukin|mesh-list
20001658|NCT02200445|Interleukin-2|interleukin-2|mesh-list
20001659|NCT02200445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20001660|NCT02200445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20001661|NCT02200445|Analgesics|analgesics|mesh-ancestor
20001662|NCT02200445|Sensory System Agents|sensory system agents|mesh-ancestor
20001663|NCT02200445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001664|NCT02200445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001665|NCT02200445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20001666|NCT02200445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20001667|NCT02200445|Antiviral Agents|antiviral agents|mesh-ancestor
20001668|NCT02200445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20001669|NCT02201108|Teriflunomide|teriflunomide|mesh-list
20001670|NCT02201108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20001671|NCT02201108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20001672|NCT02201108|Analgesics|analgesics|mesh-ancestor
20001673|NCT02201108|Sensory System Agents|sensory system agents|mesh-ancestor
20001674|NCT02201108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001675|NCT02201108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001676|NCT02201108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20001677|NCT02201108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20001678|NCT02201108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20001679|NCT02201108|Immunologic Factors|immunologic factors|mesh-ancestor
20001680|NCT02201212|Everolimus|everolimus|mesh-list
20001681|NCT02201212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20001682|NCT02201212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20001683|NCT02201212|Immunologic Factors|immunologic factors|mesh-ancestor
20001684|NCT02201212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001685|NCT02201329|Azacitidine|azacitidine|mesh-list
20001686|NCT02201329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20001687|NCT02201329|Antimetabolites|antimetabolites|mesh-ancestor
20001688|NCT02201329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001689|NCT02201329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20001690|NCT02201329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001691|NCT02201394|Aspirin|aspirin|mesh-list
20001692|NCT02201394|Ticagrelor|ticagrelor|mesh-list
20001693|NCT02201394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20001694|NCT02201394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20001695|NCT02201394|Analgesics|analgesics|mesh-ancestor
20001696|NCT02201394|Sensory System Agents|sensory system agents|mesh-ancestor
20001697|NCT02201394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001698|NCT02201394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001699|NCT02201394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20001700|NCT02201394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20001701|NCT02201394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20001702|NCT02201394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20001703|NCT02201394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001704|NCT02201394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20001705|NCT02201394|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20001706|NCT02201394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001707|NCT02201394|Antipyretics|antipyretics|mesh-ancestor
20001708|NCT02201394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20001709|NCT02201394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20001710|NCT02201394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20001711|NCT02201394|Purinergic Agents|purinergic agents|mesh-ancestor
20001712|NCT02201394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20001713|NCT02201524|Abrocitinib|abrocitinib|mesh-list
20001714|NCT02201524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20001715|NCT02201524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001716|NCT02201524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001717|NCT02201771|Aspirin|aspirin|mesh-list
20001718|NCT02201771|Ticagrelor|ticagrelor|mesh-list
20001719|NCT02201771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20001720|NCT02201771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20001721|NCT02201771|Analgesics|analgesics|mesh-ancestor
20001722|NCT02201771|Sensory System Agents|sensory system agents|mesh-ancestor
20001723|NCT02201771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001724|NCT02201771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001725|NCT02201771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20001726|NCT02201771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20001727|NCT02201771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20001728|NCT02201771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20001729|NCT02201771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001730|NCT02201771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20001731|NCT02201771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20001732|NCT02201771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001733|NCT02201771|Antipyretics|antipyretics|mesh-ancestor
20001734|NCT02201771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20001735|NCT02201771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20001736|NCT02201771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20001737|NCT02201771|Purinergic Agents|purinergic agents|mesh-ancestor
20001738|NCT02201771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20001739|NCT02201784|Ropivacaine|ropivacaine|mesh-list
20001740|NCT02201784|Levobupivacaine|levobupivacaine|mesh-list
20001741|NCT02201784|Anesthetics, Local|anesthetics, local|mesh-ancestor
20001742|NCT02201784|Anesthetics|anesthetics|mesh-ancestor
20001743|NCT02201784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20001744|NCT02201784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001745|NCT02201784|Sensory System Agents|sensory system agents|mesh-ancestor
20001746|NCT02201784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001747|NCT02201901|Sofosbuvir|sofosbuvir|mesh-list
20001748|NCT02201901|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20001749|NCT02201901|Velpatasvir|velpatasvir|mesh-list
20001750|NCT02201901|Antiviral Agents|antiviral agents|mesh-ancestor
20001751|NCT02201901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20001752|NCT02201940|Sofosbuvir|sofosbuvir|mesh-list
20001753|NCT02201940|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20001754|NCT02201940|Velpatasvir|velpatasvir|mesh-list
20001755|NCT02201940|Antiviral Agents|antiviral agents|mesh-ancestor
20001756|NCT02201940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20001757|NCT02201953|Sofosbuvir|sofosbuvir|mesh-list
20001758|NCT02201953|Antiviral Agents|antiviral agents|mesh-ancestor
20001759|NCT02201953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20001760|NCT02202135|Vancomycin|vancomycin|mesh-list
20001761|NCT02202135|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
20001762|NCT02202135|Aztreonam|aztreonam|mesh-list
20001763|NCT02202135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20001764|NCT02202135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20001765|NCT02202161|Metformin|metformin|mesh-list
20001766|NCT02202161|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20001767|NCT02202161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20001768|NCT02202161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001769|NCT02202161|Incretins|incretins|mesh-ancestor
20001770|NCT02202161|Hormones|hormones|mesh-ancestor
20001771|NCT02202161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20001772|NCT02202161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20001773|NCT02202161|Protease Inhibitors|protease inhibitors|mesh-ancestor
20001774|NCT02202161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001775|NCT02202161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001776|NCT02202499|Varenicline|varenicline|mesh-list
20001777|NCT02202499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20001778|NCT02202499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20001779|NCT02202499|Cholinergic Agents|cholinergic agents|mesh-ancestor
20001780|NCT02202499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20001781|NCT02202499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001782|NCT02202499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289922|NCT04451772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20289923|NCT04451772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289924|NCT04451772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289925|NCT04451772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20289926|NCT04432935|Lactoferrin|lactoferrin|mesh-list
20289927|NCT04432935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20289928|NCT04425538|Infliximab|infliximab|mesh-list
20289929|NCT04425538|Dermatologic Agents|dermatologic agents|mesh-ancestor
20289930|NCT04425538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20289931|NCT04425538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20289932|NCT04412096|Timolol|timolol|mesh-list
20289933|NCT04412096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20289934|NCT04412096|Latanoprost|latanoprost|mesh-list
20289935|NCT04412096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20289936|NCT04412096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20289937|NCT04412096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20289938|NCT04412096|Adrenergic Agents|adrenergic agents|mesh-ancestor
20289939|NCT04412096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20289940|NCT04412096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289941|NCT04412096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289942|NCT04412096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20289943|NCT04412096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20289944|NCT04392011|Midazolam|midazolam|mesh-list
20289945|NCT04392011|Dextromethorphan|dextromethorphan|mesh-list
20001783|NCT02202551|Amantadine|amantadine|mesh-list
20001784|NCT02202551|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20001785|NCT02202551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20001786|NCT02202551|Antiviral Agents|antiviral agents|mesh-ancestor
20001787|NCT02202551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20001788|NCT02202551|Dopamine Agents|dopamine agents|mesh-ancestor
20001789|NCT02202551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20001790|NCT02202551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001791|NCT02202551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001792|NCT02202551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20001793|NCT02202551|Analgesics|analgesics|mesh-ancestor
20001794|NCT02202551|Sensory System Agents|sensory system agents|mesh-ancestor
20001795|NCT02202551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001796|NCT02202616|Glycopyrrolate|glycopyrrolate|mesh-list
20001797|NCT02202616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001798|NCT02202616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20001799|NCT02202616|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20001800|NCT02202616|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20001801|NCT02202616|Cholinergic Agents|cholinergic agents|mesh-ancestor
20001802|NCT02202616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20001803|NCT02202616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557218|NCT01951560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20557219|NCT01951560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20557220|NCT01951599|Osimertinib|osimertinib|mesh-list
20557221|NCT01951599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557222|NCT01951599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20557223|NCT01951599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557224|NCT01951599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557225|NCT01951677|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20557226|NCT01951677|Immunologic Factors|immunologic factors|mesh-ancestor
20557227|NCT01951677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557228|NCT01951677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20557229|NCT01951677|Antacids|antacids|mesh-ancestor
20557230|NCT01951677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557231|NCT01951677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20557232|NCT01951729|Atropine|atropine|mesh-list
20557233|NCT01951729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20557234|NCT01951729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20557235|NCT01951729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20557236|NCT01951729|Autonomic Agents|autonomic agents|mesh-ancestor
20557237|NCT01951729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20557238|NCT01951729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557239|NCT01951729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20557240|NCT01951729|Respiratory System Agents|respiratory system agents|mesh-ancestor
20557241|NCT01951729|Mydriatics|mydriatics|mesh-ancestor
20557242|NCT01951729|Parasympatholytics|parasympatholytics|mesh-ancestor
20557243|NCT01951729|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20557244|NCT01951729|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20557245|NCT01951729|Cholinergic Agents|cholinergic agents|mesh-ancestor
20557246|NCT01951729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20557247|NCT01951729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001804|NCT02202837|Etanercept|etanercept|mesh-list
20001805|NCT02202837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20001806|NCT02202837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20001807|NCT02202837|Analgesics|analgesics|mesh-ancestor
20001808|NCT02202837|Sensory System Agents|sensory system agents|mesh-ancestor
20001809|NCT02202837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001810|NCT02202837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001811|NCT02202837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20001812|NCT02202837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20001813|NCT02202837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20001814|NCT02202837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20001815|NCT02202837|Immunologic Factors|immunologic factors|mesh-ancestor
20001816|NCT02202850|Etanercept|etanercept|mesh-list
20001817|NCT02202850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20001818|NCT02202850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20001819|NCT02202850|Analgesics|analgesics|mesh-ancestor
20001820|NCT02202850|Sensory System Agents|sensory system agents|mesh-ancestor
20001821|NCT02202850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001822|NCT02202850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001823|NCT02202850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20001824|NCT02202850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20001825|NCT02202850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20001826|NCT02202850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20001827|NCT02202850|Immunologic Factors|immunologic factors|mesh-ancestor
20001828|NCT02202980|Sofosbuvir|sofosbuvir|mesh-list
20001829|NCT02202980|Antiviral Agents|antiviral agents|mesh-ancestor
20001830|NCT02202980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20001831|NCT02203019|Fentanyl|fentanyl|mesh-list
20001832|NCT02203019|Dexmedetomidine|dexmedetomidine|mesh-list
20001833|NCT02203019|Propofol|propofol|mesh-list
20001834|NCT02203019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20001835|NCT02203019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20001836|NCT02203019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001837|NCT02203019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20001838|NCT02203019|Anesthetics, General|anesthetics, general|mesh-ancestor
20001839|NCT02203019|Anesthetics|anesthetics|mesh-ancestor
20001840|NCT02203019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20001841|NCT02203019|Analgesics|analgesics|mesh-ancestor
20001842|NCT02203019|Sensory System Agents|sensory system agents|mesh-ancestor
20001843|NCT02203019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001844|NCT02203019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20001845|NCT02203019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20001846|NCT02203019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20001847|NCT02203019|Adrenergic Agents|adrenergic agents|mesh-ancestor
20001848|NCT02203019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20001849|NCT02203019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001850|NCT02203019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20001851|NCT02203019|Narcotics|narcotics|mesh-ancestor
20001852|NCT02203019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20001853|NCT02203032|Ustekinumab|ustekinumab|mesh-list
20001854|NCT02203032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20001855|NCT02203032|Dermatologic Agents|dermatologic agents|mesh-ancestor
20001856|NCT02203032|Immunologic Factors|immunologic factors|mesh-ancestor
20001857|NCT02203032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001858|NCT02203149|Grazoprevir|grazoprevir|mesh-list
20001859|NCT02203149|Antiviral Agents|antiviral agents|mesh-ancestor
20001860|NCT02203149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20001861|NCT02203331|Anastrozole|anastrozole|mesh-list
20001862|NCT02203331|Leuprolide|leuprolide|mesh-list
20001863|NCT02203331|Levonorgestrel|levonorgestrel|mesh-list
20001864|NCT02203331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20001865|NCT02203331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20001866|NCT02203331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20001867|NCT02203331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20001868|NCT02203331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20001869|NCT02203331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001870|NCT02203331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20001871|NCT02203331|Hormone Antagonists|hormone antagonists|mesh-ancestor
20001872|NCT02203331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20001873|NCT02203331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001874|NCT02203331|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20001875|NCT02203331|Fertility Agents|fertility agents|mesh-ancestor
20001876|NCT02203331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20001877|NCT02203331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20001878|NCT02203331|Contraceptive Agents|contraceptive agents|mesh-ancestor
20001879|NCT02203331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20001880|NCT02203331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20001881|NCT02203331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20001882|NCT02203565|Sodium Hypochlorite|sodium hypochlorite|mesh-list
20001883|NCT02203565|Eusol|eusol|mesh-list
20001884|NCT02203565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20001885|NCT02203565|Disinfectants|disinfectants|mesh-ancestor
20001886|NCT02203565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20001887|NCT02203578|Romidepsin|romidepsin|mesh-list
20001888|NCT02203578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20001889|NCT02203578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20001890|NCT02203591|Ethanol|ethanol|mesh-list
20001891|NCT02203591|Chlorhexidine|chlorhexidine|mesh-list
20001892|NCT02203591|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20001893|NCT02203591|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20001894|NCT02203591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20001895|NCT02203591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20001896|NCT02203591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001897|NCT02203591|Disinfectants|disinfectants|mesh-ancestor
20001898|NCT02203591|Dermatologic Agents|dermatologic agents|mesh-ancestor
20001899|NCT02203630|Phenylephrine|phenylephrine|mesh-list
20001900|NCT02203630|Oxymetazoline|oxymetazoline|mesh-list
20001901|NCT02203630|Norepinephrine|norepinephrine|mesh-list
20001902|NCT02203630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20001903|NCT02203630|Mydriatics|mydriatics|mesh-ancestor
20001904|NCT02203630|Autonomic Agents|autonomic agents|mesh-ancestor
20001905|NCT02203630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001906|NCT02203630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001907|NCT02203630|Sympathomimetics|sympathomimetics|mesh-ancestor
20001908|NCT02203630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20001909|NCT02203630|Nasal Decongestants|nasal decongestants|mesh-ancestor
20001910|NCT02203630|Respiratory System Agents|respiratory system agents|mesh-ancestor
20001911|NCT02203630|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20001912|NCT02203630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20001913|NCT02203630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20001914|NCT02203630|Adrenergic Agents|adrenergic agents|mesh-ancestor
20001915|NCT02203630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20001916|NCT02203630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001917|NCT02203630|Protective Agents|protective agents|mesh-ancestor
20001918|NCT02203786|Haloperidol|haloperidol|mesh-list
20001919|NCT02203786|Haloperidol decanoate|haloperidol decanoate|mesh-list
20001920|NCT02203786|Fluphenazine|fluphenazine|mesh-list
20001921|NCT02203786|Fluphenazine depot|fluphenazine depot|mesh-list
20001922|NCT02203786|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
20001923|NCT02203786|Amphetamine|amphetamine|mesh-list
20001924|NCT02203786|Dextroamphetamine|dextroamphetamine|mesh-list
20001925|NCT02203786|Antiemetics|antiemetics|mesh-ancestor
20001926|NCT02203786|Autonomic Agents|autonomic agents|mesh-ancestor
20001927|NCT02203786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001928|NCT02203786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001929|NCT02203786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20001930|NCT02203786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20001931|NCT02203786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20001932|NCT02203786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20001933|NCT02203786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20001934|NCT02203786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20001935|NCT02203786|Dopamine Agents|dopamine agents|mesh-ancestor
20001936|NCT02203786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20001937|NCT02203786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001938|NCT02203786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20001939|NCT02203786|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20001940|NCT02203786|Sympathomimetics|sympathomimetics|mesh-ancestor
20001941|NCT02203786|Adrenergic Agents|adrenergic agents|mesh-ancestor
20001942|NCT02203786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20001943|NCT02203786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20001944|NCT02203786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20001945|NCT02203786|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20001946|NCT02203838|Risperidone|risperidone|mesh-list
20001947|NCT02203838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20001948|NCT02203838|Serotonin Agents|serotonin agents|mesh-ancestor
20001949|NCT02203838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20001950|NCT02203838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001951|NCT02203838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001952|NCT02203838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20001953|NCT02203838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20001954|NCT02203838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20001955|NCT02203838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20001956|NCT02203838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20001957|NCT02203838|Dopamine Agents|dopamine agents|mesh-ancestor
20001958|NCT02203916|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20001959|NCT02203916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20001960|NCT02203916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20001961|NCT02203916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001962|NCT02204410|Methylphenidate|methylphenidate|mesh-list
20001963|NCT02204410|Amphetamine|amphetamine|mesh-list
20001964|NCT02204410|Adderall|adderall|mesh-list
20001965|NCT02204410|Dextroamphetamine|dextroamphetamine|mesh-list
20001966|NCT02204410|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20001967|NCT02204410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001968|NCT02204410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20001969|NCT02204410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20001970|NCT02204410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20001971|NCT02204410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20001972|NCT02204410|Dopamine Agents|dopamine agents|mesh-ancestor
20001973|NCT02204410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20001974|NCT02204410|Sympathomimetics|sympathomimetics|mesh-ancestor
20001975|NCT02204410|Autonomic Agents|autonomic agents|mesh-ancestor
20001976|NCT02204410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20001977|NCT02204410|Adrenergic Agents|adrenergic agents|mesh-ancestor
20001978|NCT02204410|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20001979|NCT02204982|Rituximab|rituximab|mesh-list
20001980|NCT02204982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20001981|NCT02204982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20001982|NCT02204982|Immunologic Factors|immunologic factors|mesh-ancestor
20001983|NCT02204982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001984|NCT02204982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20001985|NCT02205333|Rituximab|rituximab|mesh-list
20001986|NCT02205333|Durvalumab|durvalumab|mesh-list
20001987|NCT02205333|Tremelimumab|tremelimumab|mesh-list
20001988|NCT02205333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20001989|NCT02205333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20001990|NCT02205333|Immunologic Factors|immunologic factors|mesh-ancestor
20001991|NCT02205333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20001992|NCT02205333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20001993|NCT02205801|Bupivacaine|bupivacaine|mesh-list
20001994|NCT02205801|Anesthetics, Local|anesthetics, local|mesh-ancestor
20001995|NCT02205801|Anesthetics|anesthetics|mesh-ancestor
20001996|NCT02205801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20001997|NCT02205801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557248|NCT01951846|Nintedanib|nintedanib|mesh-list
20557249|NCT01951846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557250|NCT01951846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20557251|NCT01951846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557252|NCT01951846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557253|NCT01951872|Caffeine|caffeine|mesh-list
20557254|NCT01951872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20557255|NCT01951872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557256|NCT01951872|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20557257|NCT01951872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557258|NCT01951872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557259|NCT01951872|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20557260|NCT01951872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20557261|NCT01951872|Purinergic Agents|purinergic agents|mesh-ancestor
20557262|NCT01951872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20557263|NCT01951885|Mycophenolic Acid|mycophenolic acid|mesh-list
20557264|NCT01951885|Methotrexate|methotrexate|mesh-list
20557265|NCT01951885|Tacrolimus|tacrolimus|mesh-list
20557266|NCT01951885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20557267|NCT01951885|Abortifacient Agents|abortifacient agents|mesh-ancestor
20557268|NCT01951885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20557269|NCT01951885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557270|NCT01951885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20557271|NCT01951885|Antimetabolites|antimetabolites|mesh-ancestor
20001998|NCT02205801|Sensory System Agents|sensory system agents|mesh-ancestor
20001999|NCT02205801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002000|NCT02205814|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
20002001|NCT02205814|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
20002002|NCT02205814|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
20002003|NCT02205814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002004|NCT02205814|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20002005|NCT02205814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20002006|NCT02205814|Immunologic Factors|immunologic factors|mesh-ancestor
20002007|NCT02205814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002008|NCT02205983|Acetaminophen|acetaminophen|mesh-list
20002009|NCT02205983|Hydromorphone|hydromorphone|mesh-list
20002010|NCT02205983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20002011|NCT02205983|Analgesics|analgesics|mesh-ancestor
20002012|NCT02205983|Sensory System Agents|sensory system agents|mesh-ancestor
20002013|NCT02205983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002014|NCT02205983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002015|NCT02205983|Antipyretics|antipyretics|mesh-ancestor
20002016|NCT02205983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20002017|NCT02205983|Narcotics|narcotics|mesh-ancestor
20002018|NCT02205983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20002019|NCT02206152|Acetylcysteine|acetylcysteine|mesh-list
20002020|NCT02206152|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20002021|NCT02206152|Antiviral Agents|antiviral agents|mesh-ancestor
20002022|NCT02206152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002023|NCT02206152|Expectorants|expectorants|mesh-ancestor
20002024|NCT02206152|Respiratory System Agents|respiratory system agents|mesh-ancestor
20002025|NCT02206152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20002026|NCT02206152|Antioxidants|antioxidants|mesh-ancestor
20002027|NCT02206152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002028|NCT02206152|Protective Agents|protective agents|mesh-ancestor
20002029|NCT02206152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002030|NCT02206152|Antidotes|antidotes|mesh-ancestor
20002031|NCT02206620|Donepezil|donepezil|mesh-list
20002032|NCT02206620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20002033|NCT02206620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002034|NCT02206620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002035|NCT02206620|Cholinergic Agents|cholinergic agents|mesh-ancestor
20002036|NCT02206620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20002037|NCT02206620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002038|NCT02206620|Nootropic Agents|nootropic agents|mesh-ancestor
20002039|NCT02206685|Methadone|methadone|mesh-list
20002040|NCT02206685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20002041|NCT02206685|Narcotics|narcotics|mesh-ancestor
20002042|NCT02206685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20002043|NCT02206685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002044|NCT02206685|Analgesics|analgesics|mesh-ancestor
20002045|NCT02206685|Sensory System Agents|sensory system agents|mesh-ancestor
20002046|NCT02206685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002047|NCT02206685|Antitussive Agents|antitussive agents|mesh-ancestor
20002048|NCT02206685|Respiratory System Agents|respiratory system agents|mesh-ancestor
20002049|NCT02206776|Midazolam|midazolam|mesh-list
20002050|NCT02206776|Ketamine|ketamine|mesh-list
20002051|NCT02206776|Analgesics|analgesics|mesh-ancestor
20002052|NCT02206776|Sensory System Agents|sensory system agents|mesh-ancestor
20002053|NCT02206776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002054|NCT02206776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002055|NCT02206776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20002056|NCT02206776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20002057|NCT02206776|Anesthetics, General|anesthetics, general|mesh-ancestor
20002058|NCT02206776|Anesthetics|anesthetics|mesh-ancestor
20002059|NCT02206776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20002060|NCT02206776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20002061|NCT02206776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20002062|NCT02206776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20002063|NCT02206776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002064|NCT02206776|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20002065|NCT02206776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20002066|NCT02206776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20002067|NCT02206776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20002068|NCT02206776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20002069|NCT02206776|GABA Modulators|gaba modulators|mesh-ancestor
20002070|NCT02206776|GABA Agents|gaba agents|mesh-ancestor
20002071|NCT02207088|Ritonavir|ritonavir|mesh-list
20002072|NCT02207088|Ribavirin|ribavirin|mesh-list
20002073|NCT02207088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20002074|NCT02207088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20002075|NCT02207088|Protease Inhibitors|protease inhibitors|mesh-ancestor
20002076|NCT02207088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002077|NCT02207088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002078|NCT02207088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20002079|NCT02207088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20002080|NCT02207088|Antiviral Agents|antiviral agents|mesh-ancestor
20002081|NCT02207088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002082|NCT02207088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20002083|NCT02207088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20002084|NCT02207088|Antimetabolites|antimetabolites|mesh-ancestor
20002085|NCT02207231|Adalimumab|adalimumab|mesh-list
20002086|NCT02207231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20002087|NCT02207231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20002088|NCT02207231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20002089|NCT02207231|Immunologic Factors|immunologic factors|mesh-ancestor
20002090|NCT02207231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002091|NCT02207244|Adalimumab|adalimumab|mesh-list
20002092|NCT02207244|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20002093|NCT02207244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20002094|NCT02207244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20002095|NCT02207244|Immunologic Factors|immunologic factors|mesh-ancestor
20002096|NCT02207244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002097|NCT02207374|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
20002098|NCT02207374|Protease Inhibitors|protease inhibitors|mesh-ancestor
20002099|NCT02207374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002100|NCT02207374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557272|NCT01951885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557273|NCT01951885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557274|NCT01951885|Dermatologic Agents|dermatologic agents|mesh-ancestor
20557275|NCT01951885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557276|NCT01951885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20557277|NCT01951885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20557278|NCT01951885|Immunologic Factors|immunologic factors|mesh-ancestor
20557279|NCT01951885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20557280|NCT01951885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20557281|NCT01951885|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20557282|NCT01951885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20557283|NCT01951885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20557284|NCT01951885|Antitubercular Agents|antitubercular agents|mesh-ancestor
20002101|NCT02207374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20557285|NCT01951885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20002102|NCT02207374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002103|NCT02207400|Listerine|listerine|mesh-list
20002104|NCT02207400|Fluorides|fluorides|mesh-list
20002105|NCT02207400|Sodium Fluoride|sodium fluoride|mesh-list
20002106|NCT02207400|Cariostatic Agents|cariostatic agents|mesh-ancestor
20002107|NCT02207400|Protective Agents|protective agents|mesh-ancestor
20002108|NCT02207400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002109|NCT02207400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20002110|NCT02207400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002111|NCT02207413|Vaccines|vaccines|mesh-list
20002112|NCT02207413|Immunologic Factors|immunologic factors|mesh-ancestor
20002113|NCT02207413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002114|NCT02207491|Timolol|timolol|mesh-list
20002115|NCT02207491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20002116|NCT02207491|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20002117|NCT02207491|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20002118|NCT02207491|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20002119|NCT02207491|Adrenergic Agents|adrenergic agents|mesh-ancestor
20002120|NCT02207491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20002121|NCT02207491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002122|NCT02207491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002123|NCT02207491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20002124|NCT02207491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20002125|NCT02207530|Durvalumab|durvalumab|mesh-list
20002126|NCT02207530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20002127|NCT02207530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20002128|NCT02207556|Doxycycline|doxycycline|mesh-list
20002129|NCT02207556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20002130|NCT02207556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002131|NCT02207556|Antimalarials|antimalarials|mesh-ancestor
20002132|NCT02207556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20002133|NCT02207556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20002134|NCT02207608|Hyaluronic Acid|hyaluronic acid|mesh-list
20002135|NCT02207608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20002136|NCT02207608|Immunologic Factors|immunologic factors|mesh-ancestor
20002137|NCT02207608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002138|NCT02207608|Viscosupplements|viscosupplements|mesh-ancestor
20002139|NCT02207608|Protective Agents|protective agents|mesh-ancestor
20002140|NCT02207621|Timolol|timolol|mesh-list
20002141|NCT02207621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20002142|NCT02207621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20002143|NCT02207621|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20002144|NCT02207621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20002145|NCT02207621|Adrenergic Agents|adrenergic agents|mesh-ancestor
20002146|NCT02207621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20002147|NCT02207621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002148|NCT02207621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002149|NCT02207621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20002150|NCT02207621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20002151|NCT02207634|Evolocumab|evolocumab|mesh-list
20002152|NCT02207634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20002153|NCT02207634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20002154|NCT02207634|Antimetabolites|antimetabolites|mesh-ancestor
20002155|NCT02207634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002156|NCT02207634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20002157|NCT02207816|Vaccines|vaccines|mesh-list
20002158|NCT02207816|Immunologic Factors|immunologic factors|mesh-ancestor
20002159|NCT02207816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002160|NCT02207829|Tiotropium Bromide|tiotropium bromide|mesh-list
20002161|NCT02207829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20002162|NCT02207829|Autonomic Agents|autonomic agents|mesh-ancestor
20002163|NCT02207829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002164|NCT02207829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002165|NCT02207829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20002166|NCT02207829|Respiratory System Agents|respiratory system agents|mesh-ancestor
20002167|NCT02207829|Parasympatholytics|parasympatholytics|mesh-ancestor
20002168|NCT02207829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20002169|NCT02207829|Cholinergic Agents|cholinergic agents|mesh-ancestor
20002170|NCT02207829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20002171|NCT02207829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002172|NCT02207907|Listerine|listerine|mesh-list
20002173|NCT02207907|Fluorides|fluorides|mesh-list
20002174|NCT02207907|Sodium Fluoride|sodium fluoride|mesh-list
20002175|NCT02207907|Cariostatic Agents|cariostatic agents|mesh-ancestor
20002176|NCT02207907|Protective Agents|protective agents|mesh-ancestor
20002177|NCT02207907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002178|NCT02207907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20002179|NCT02207907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002180|NCT02207946|Botulinum Toxins|botulinum toxins|mesh-list
20002181|NCT02207946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20002182|NCT02207946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20002183|NCT02207946|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20002184|NCT02207946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20002185|NCT02207946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20002186|NCT02207946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002187|NCT02207946|Cholinergic Agents|cholinergic agents|mesh-ancestor
20002188|NCT02207946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20002189|NCT02207946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002190|NCT02207946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20002191|NCT02207946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002192|NCT02208037|Mycophenolic Acid|mycophenolic acid|mesh-list
20002193|NCT02208037|Maraviroc|maraviroc|mesh-list
20002194|NCT02208037|Cyclophosphamide|cyclophosphamide|mesh-list
20002195|NCT02208037|Methotrexate|methotrexate|mesh-list
20002196|NCT02208037|Bortezomib|bortezomib|mesh-list
20002197|NCT02208037|Tacrolimus|tacrolimus|mesh-list
20002198|NCT02208037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20002199|NCT02208037|Immunologic Factors|immunologic factors|mesh-ancestor
20002200|NCT02208037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002201|NCT02208037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20002202|NCT02208037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20002203|NCT02208037|Alkylating Agents|alkylating agents|mesh-ancestor
20002204|NCT02208037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002205|NCT02208037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20002206|NCT02208037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20002207|NCT02208037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20002208|NCT02208037|Abortifacient Agents|abortifacient agents|mesh-ancestor
20002209|NCT02208037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20002210|NCT02208037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20002211|NCT02208037|Antimetabolites|antimetabolites|mesh-ancestor
20002212|NCT02208037|Dermatologic Agents|dermatologic agents|mesh-ancestor
20002213|NCT02208037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002214|NCT02208037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20002215|NCT02208037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20002216|NCT02208037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20002217|NCT02208037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20002218|NCT02208037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20002219|NCT02208037|Antitubercular Agents|antitubercular agents|mesh-ancestor
20002220|NCT02208037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20002221|NCT02208037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002222|NCT02208037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20002223|NCT02208037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20002224|NCT02208037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20002225|NCT02208037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20002226|NCT02208037|Antiviral Agents|antiviral agents|mesh-ancestor
20002227|NCT02208037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20002228|NCT02208050|4-Aminopyridine|4-aminopyridine|mesh-list
20002229|NCT02208050|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20002230|NCT02208050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20002231|NCT02208050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002232|NCT02208063|Vancomycin|vancomycin|mesh-list
20002233|NCT02208063|Cefazolin|cefazolin|mesh-list
20002234|NCT02208063|Daptomycin|daptomycin|mesh-list
20002235|NCT02208063|Penicillins|penicillins|mesh-list
20002236|NCT02208063|Cloxacillin|cloxacillin|mesh-list
20002237|NCT02208063|Oxacillin|oxacillin|mesh-list
20002238|NCT02208063|Telavancin|telavancin|mesh-list
20002239|NCT02208063|Nafcillin|nafcillin|mesh-list
20002240|NCT02208063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20002241|NCT02208063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002242|NCT02208297|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20002243|NCT02208297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20002244|NCT02208310|Vitamin D|vitamin d|mesh-list
20002245|NCT02208310|Ergocalciferols|ergocalciferols|mesh-list
20002246|NCT02208310|Cholecalciferol|cholecalciferol|mesh-list
20002247|NCT02208310|Vitamins|vitamins|mesh-list
20002248|NCT02208310|Micronutrients|micronutrients|mesh-ancestor
20002249|NCT02208310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002250|NCT02208310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20002251|NCT02208310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20002252|NCT02208466|Fluoxetine|fluoxetine|mesh-list
20002253|NCT02208466|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20002254|NCT02208466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20002255|NCT02208466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20002256|NCT02208466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002257|NCT02208466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20002258|NCT02208466|Serotonin Agents|serotonin agents|mesh-ancestor
20002259|NCT02208466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002260|NCT02208466|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20002261|NCT02208466|Antidepressive Agents|antidepressive agents|mesh-ancestor
20002262|NCT02208466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20002263|NCT02208466|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20002264|NCT02208466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20002265|NCT02208466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002266|NCT02208843|Afatinib|afatinib|mesh-list
20002267|NCT02208843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20002268|NCT02208843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20002269|NCT02208843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002270|NCT02208843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002271|NCT02209181|Acetaminophen|acetaminophen|mesh-list
20002272|NCT02209181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20002273|NCT02209181|Analgesics|analgesics|mesh-ancestor
20002274|NCT02209181|Sensory System Agents|sensory system agents|mesh-ancestor
20002275|NCT02209181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002276|NCT02209181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002277|NCT02209181|Antipyretics|antipyretics|mesh-ancestor
20002278|NCT02209272|Lidocaine|lidocaine|mesh-list
20002279|NCT02209272|Benzyl Alcohol|benzyl alcohol|mesh-list
20002280|NCT02209272|Anesthetics, Local|anesthetics, local|mesh-ancestor
20002281|NCT02209272|Anesthetics|anesthetics|mesh-ancestor
20002282|NCT02209272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20002283|NCT02209272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002284|NCT02209272|Sensory System Agents|sensory system agents|mesh-ancestor
20002285|NCT02209272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002286|NCT02209272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20002287|NCT02209272|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20002288|NCT02209272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20002289|NCT02209272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20002290|NCT02209272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002291|NCT02209454|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
20002292|NCT02209454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20002293|NCT02209454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20002294|NCT02209454|Analgesics|analgesics|mesh-ancestor
20002295|NCT02209454|Sensory System Agents|sensory system agents|mesh-ancestor
20002296|NCT02209454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002297|NCT02209454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002298|NCT02209454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20002299|NCT02209454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20002300|NCT02209519|Metronidazole|metronidazole|mesh-list
20002301|NCT02209519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002302|NCT02209519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20002303|NCT02209519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20002304|NCT02209519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20002305|NCT02209597|Bupropion|bupropion|mesh-list
20002306|NCT02209597|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20002307|NCT02209597|Antidepressive Agents|antidepressive agents|mesh-ancestor
20002308|NCT02209597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20557286|NCT01951885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20557287|NCT01951898|Montelukast|montelukast|mesh-list
20557288|NCT01951898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20557289|NCT01951898|Respiratory System Agents|respiratory system agents|mesh-ancestor
20557290|NCT01951898|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20557291|NCT01951898|Hormone Antagonists|hormone antagonists|mesh-ancestor
20557292|NCT01951898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20557293|NCT01951898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557294|NCT01951898|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20557295|NCT01951898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20557296|NCT01951898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557297|NCT01951911|Ketamine|ketamine|mesh-list
20557298|NCT01951911|Analgesics|analgesics|mesh-ancestor
20557299|NCT01951911|Sensory System Agents|sensory system agents|mesh-ancestor
20557300|NCT01951911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20557301|NCT01951911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557302|NCT01951911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20557303|NCT01951911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20557304|NCT01951911|Anesthetics, General|anesthetics, general|mesh-ancestor
20557305|NCT01951911|Anesthetics|anesthetics|mesh-ancestor
20557306|NCT01951911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20557307|NCT01951911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20557308|NCT01951911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20557309|NCT01951911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20557310|NCT01951911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557311|NCT01951924|Immunoglobulins|immunoglobulins|mesh-list
20557312|NCT01951924|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20557313|NCT01951924|Antibodies|antibodies|mesh-list
20557314|NCT01951924|Immunoglobulin G|immunoglobulin g|mesh-list
20557315|NCT01951924|Immunologic Factors|immunologic factors|mesh-ancestor
20557316|NCT01951924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557317|NCT01952314|Naftopidil|naftopidil|mesh-list
20557318|NCT01952314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20557319|NCT01952314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20557320|NCT01952314|Adrenergic Agents|adrenergic agents|mesh-ancestor
20557321|NCT01952314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20557322|NCT01952314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557323|NCT01952314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557324|NCT01952314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20002309|NCT02209597|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20002310|NCT02209597|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20002311|NCT02209597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20002312|NCT02209597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002313|NCT02209597|Dopamine Agents|dopamine agents|mesh-ancestor
20002314|NCT02209597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20002315|NCT02209597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002316|NCT02209597|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20002317|NCT02209597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20002318|NCT02209597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002319|NCT02209610|Fentanyl|fentanyl|mesh-list
20002320|NCT02209610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20002321|NCT02209610|Narcotics|narcotics|mesh-ancestor
20002322|NCT02209610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20002323|NCT02209610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002324|NCT02209610|Analgesics|analgesics|mesh-ancestor
20002325|NCT02209610|Sensory System Agents|sensory system agents|mesh-ancestor
20002326|NCT02209610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002327|NCT02209610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20002328|NCT02209610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20002329|NCT02209610|Anesthetics, General|anesthetics, general|mesh-ancestor
20002330|NCT02209610|Anesthetics|anesthetics|mesh-ancestor
20289946|NCT04392011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20289947|NCT04392011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20289948|NCT04392011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20289949|NCT04392011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289950|NCT04392011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20289951|NCT04392011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20289952|NCT04392011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20289953|NCT04392011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20289954|NCT04392011|Anesthetics, General|anesthetics, general|mesh-ancestor
20289955|NCT04392011|Anesthetics|anesthetics|mesh-ancestor
20289956|NCT04392011|GABA Modulators|gaba modulators|mesh-ancestor
20289957|NCT04392011|GABA Agents|gaba agents|mesh-ancestor
20289958|NCT04392011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20289959|NCT04392011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289960|NCT04392011|Antitussive Agents|antitussive agents|mesh-ancestor
20289961|NCT04392011|Respiratory System Agents|respiratory system agents|mesh-ancestor
20289962|NCT04392011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20289963|NCT04392011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20289964|NCT04390763|Gemcitabine|gemcitabine|mesh-list
20289965|NCT04390763|Paclitaxel|paclitaxel|mesh-list
20289966|NCT04390763|Spartalizumab|spartalizumab|mesh-list
20289967|NCT04390763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20289968|NCT04390763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20289969|NCT04390763|Tubulin Modulators|tubulin modulators|mesh-ancestor
20289970|NCT04390763|Antimitotic Agents|antimitotic agents|mesh-ancestor
20289971|NCT04390763|Mitosis Modulators|mitosis modulators|mesh-ancestor
20289972|NCT04390763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289973|NCT04390763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20289974|NCT04390763|Antimetabolites|antimetabolites|mesh-ancestor
20289975|NCT04390763|Antiviral Agents|antiviral agents|mesh-ancestor
20289976|NCT04390763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20289977|NCT04390763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20289978|NCT04390763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20289979|NCT04390763|Immunologic Factors|immunologic factors|mesh-ancestor
20289980|NCT04390763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289981|NCT04390763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20289982|NCT04388683|Nitric Oxide|nitric oxide|mesh-list
20289983|NCT04388683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20289984|NCT04388683|Autonomic Agents|autonomic agents|mesh-ancestor
20289985|NCT04388683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20289986|NCT04388683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20289987|NCT04388683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20289988|NCT04388683|Respiratory System Agents|respiratory system agents|mesh-ancestor
20289989|NCT04388683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20289990|NCT04388683|Antioxidants|antioxidants|mesh-ancestor
20289991|NCT04388683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20289992|NCT04388683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20289993|NCT04388683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20289994|NCT04388683|Vasodilator Agents|vasodilator agents|mesh-ancestor
20289995|NCT04388683|Gasotransmitters|gasotransmitters|mesh-ancestor
20289996|NCT04388683|Protective Agents|protective agents|mesh-ancestor
20289997|NCT04385680|Chlorhexidine|chlorhexidine|mesh-list
20289998|NCT04385680|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20002331|NCT02209948|Temozolomide|temozolomide|mesh-list
20002332|NCT02209948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20002333|NCT02209948|Alkylating Agents|alkylating agents|mesh-ancestor
20002334|NCT02209948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002335|NCT02209948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20002336|NCT02210091|Factor VIII|factor viii|mesh-list
20002337|NCT02210091|BAX 855|bax 855|mesh-list
20002338|NCT02210091|Coagulants|coagulants|mesh-ancestor
20002339|NCT02210195|Aprepitant|aprepitant|mesh-list
20002340|NCT02210195|Antiemetics|antiemetics|mesh-ancestor
20002341|NCT02210195|Autonomic Agents|autonomic agents|mesh-ancestor
20002342|NCT02210195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002343|NCT02210195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002344|NCT02210195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20002345|NCT02210195|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20002346|NCT02210195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20002347|NCT02210195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002348|NCT02210247|Bupivacaine|bupivacaine|mesh-list
20002349|NCT02210247|Anesthetics, Local|anesthetics, local|mesh-ancestor
20002350|NCT02210247|Anesthetics|anesthetics|mesh-ancestor
20002351|NCT02210247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20002352|NCT02210247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002353|NCT02210247|Sensory System Agents|sensory system agents|mesh-ancestor
20002354|NCT02210247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002355|NCT02210689|Clindamycin|clindamycin|mesh-list
20002356|NCT02210689|Clindamycin palmitate|clindamycin palmitate|mesh-list
20002357|NCT02210689|Clindamycin phosphate|clindamycin phosphate|mesh-list
20002358|NCT02210689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20002359|NCT02210689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002360|NCT02210689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20002361|NCT02210689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002362|NCT02210689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002363|NCT02211014|Acalabrutinib|acalabrutinib|mesh-list
20002364|NCT02211014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20002365|NCT02211638|Candesartan|candesartan|mesh-list
20002366|NCT02211638|Candesartan cilexetil|candesartan cilexetil|mesh-list
20002367|NCT02211638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20002368|NCT02211638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20002369|NCT02211638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20002370|NCT02211638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002371|NCT02212028|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20002372|NCT02212028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20002373|NCT02212106|Vaccines|vaccines|mesh-list
20002374|NCT02212106|Immunologic Factors|immunologic factors|mesh-ancestor
20002375|NCT02212106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002376|NCT02212197|Leuprolide|leuprolide|mesh-list
20002377|NCT02212197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20002378|NCT02212197|Fertility Agents|fertility agents|mesh-ancestor
20002379|NCT02212197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20002380|NCT02212197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002381|NCT02212197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20002382|NCT02212197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20002383|NCT02212379|Raltegravir Potassium|raltegravir potassium|mesh-list
20002384|NCT02212379|Etravirine|etravirine|mesh-list
20002385|NCT02212379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20002386|NCT02212379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20002387|NCT02212379|Antiviral Agents|antiviral agents|mesh-ancestor
20002388|NCT02212379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002389|NCT02212379|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20002390|NCT02212379|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20002391|NCT02212379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002392|NCT02212379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002393|NCT02212379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20002394|NCT02212379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20002395|NCT02212678|Acetylcysteine|acetylcysteine|mesh-list
20002396|NCT02212678|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20002397|NCT02212678|Antiviral Agents|antiviral agents|mesh-ancestor
20002398|NCT02212678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002399|NCT02212678|Expectorants|expectorants|mesh-ancestor
20002400|NCT02212678|Respiratory System Agents|respiratory system agents|mesh-ancestor
20002401|NCT02212678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20002402|NCT02212678|Antioxidants|antioxidants|mesh-ancestor
20002403|NCT02212678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002404|NCT02212678|Protective Agents|protective agents|mesh-ancestor
20002405|NCT02212678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002406|NCT02212678|Antidotes|antidotes|mesh-ancestor
20002407|NCT02212730|Pembrolizumab|pembrolizumab|mesh-list
20002408|NCT02212730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20002409|NCT02212730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20002410|NCT02213042|Trastuzumab|trastuzumab|mesh-list
20002411|NCT02213042|Lapatinib|lapatinib|mesh-list
20002412|NCT02213042|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20002413|NCT02213042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20002414|NCT02213042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20002415|NCT02213042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20002416|NCT02213042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002417|NCT02213042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002418|NCT02213042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20002419|NCT02213042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20002420|NCT02213042|Hormone Antagonists|hormone antagonists|mesh-ancestor
20002421|NCT02213042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20002422|NCT02213042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002423|NCT02213055|Permethrin|permethrin|mesh-list
20002424|NCT02213055|Malathion|malathion|mesh-list
20002425|NCT02213055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002426|NCT02213055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002427|NCT02213055|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20002428|NCT02213055|Cholinergic Agents|cholinergic agents|mesh-ancestor
20002429|NCT02213055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20002430|NCT02213055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002431|NCT02213068|Mycophenolic Acid|mycophenolic acid|mesh-list
20002432|NCT02213068|Abatacept|abatacept|mesh-list
20002433|NCT02213068|Tacrolimus|tacrolimus|mesh-list
20002434|NCT02213068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20002435|NCT02213068|Immunologic Factors|immunologic factors|mesh-ancestor
20002436|NCT02213068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002437|NCT02213068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20002438|NCT02213068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002439|NCT02213068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002440|NCT02213068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20002441|NCT02213068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20002442|NCT02213068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20002443|NCT02213068|Antitubercular Agents|antitubercular agents|mesh-ancestor
20002444|NCT02213068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20002445|NCT02213068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002446|NCT02213068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20002447|NCT02213068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20002448|NCT02213094|Vitamins|vitamins|mesh-list
20002449|NCT02213094|Niacinamide|niacinamide|mesh-list
20002450|NCT02213094|Niacin|niacin|mesh-list
20002451|NCT02213094|Nicotinic Acids|nicotinic acids|mesh-list
20002452|NCT02213094|Vitamin B Complex|vitamin b complex|mesh-list
20002453|NCT02213094|Micronutrients|micronutrients|mesh-ancestor
20002454|NCT02213094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002455|NCT02213094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20002456|NCT02213094|Antimetabolites|antimetabolites|mesh-ancestor
20002457|NCT02213094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002458|NCT02213094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20002459|NCT02213094|Vasodilator Agents|vasodilator agents|mesh-ancestor
20002460|NCT02213263|Rituximab|rituximab|mesh-list
20002461|NCT02213263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20002462|NCT02213263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20002463|NCT02213263|Immunologic Factors|immunologic factors|mesh-ancestor
20002464|NCT02213263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002465|NCT02213263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20002466|NCT02213289|Nivolumab|nivolumab|mesh-list
20002467|NCT02213289|Trastuzumab|trastuzumab|mesh-list
20002468|NCT02213289|Bemarituzumab|bemarituzumab|mesh-list
20002469|NCT02213289|Ramucirumab|ramucirumab|mesh-list
20002470|NCT02213289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20002471|NCT02213289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20002472|NCT02213289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20002473|NCT02213289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002474|NCT02213900|Haloperidol|haloperidol|mesh-list
20002475|NCT02213900|Haloperidol decanoate|haloperidol decanoate|mesh-list
20002476|NCT02213900|Antiemetics|antiemetics|mesh-ancestor
20002477|NCT02213900|Autonomic Agents|autonomic agents|mesh-ancestor
20002478|NCT02213900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002479|NCT02213900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002480|NCT02213900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20002481|NCT02213900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20002482|NCT02213900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20002483|NCT02213900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20002484|NCT02213900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20002485|NCT02213900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20002486|NCT02213900|Dopamine Agents|dopamine agents|mesh-ancestor
20002487|NCT02213900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20002488|NCT02213900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002489|NCT02213900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20557325|NCT01952314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20557326|NCT01952314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20557327|NCT01952314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20557328|NCT01952314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20557329|NCT01952561|Dapivirine|dapivirine|mesh-list
20557330|NCT01952561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20557331|NCT01952561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20557332|NCT01952561|Antiviral Agents|antiviral agents|mesh-ancestor
20557333|NCT01952561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20557334|NCT01952626|Ondansetron|ondansetron|mesh-list
20557335|NCT01952626|Palonosetron|palonosetron|mesh-list
20557336|NCT01952626|Antiemetics|antiemetics|mesh-ancestor
20557337|NCT01952626|Autonomic Agents|autonomic agents|mesh-ancestor
20557338|NCT01952626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20557339|NCT01952626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557340|NCT01952626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20557341|NCT01952626|Antipruritics|antipruritics|mesh-ancestor
20557342|NCT01952626|Dermatologic Agents|dermatologic agents|mesh-ancestor
20557343|NCT01952626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20557344|NCT01952626|Serotonin Agents|serotonin agents|mesh-ancestor
20557345|NCT01952626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20557346|NCT01952626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557347|NCT01952626|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20557348|NCT01952626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20557349|NCT01952626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20557350|NCT01952626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20557351|NCT01952626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20557352|NCT01952626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20557353|NCT01952652|Naproxen|naproxen|mesh-list
20557354|NCT01952652|Codeine|codeine|mesh-list
20557355|NCT01952652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20557356|NCT01952652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20557357|NCT01952652|Analgesics|analgesics|mesh-ancestor
20557358|NCT01952652|Sensory System Agents|sensory system agents|mesh-ancestor
20557359|NCT01952652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20557360|NCT01952652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557361|NCT01952652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20557362|NCT01952652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20557363|NCT01952652|Gout Suppressants|gout suppressants|mesh-ancestor
20557364|NCT01952652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20557365|NCT01952652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557366|NCT01952652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557367|NCT01952652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20557368|NCT01952652|Narcotics|narcotics|mesh-ancestor
20557369|NCT01952652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20557370|NCT01952652|Antitussive Agents|antitussive agents|mesh-ancestor
20557371|NCT01952652|Respiratory System Agents|respiratory system agents|mesh-ancestor
20557372|NCT01952756|Cilostazol|cilostazol|mesh-list
20557373|NCT01952756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20557374|NCT01952756|Autonomic Agents|autonomic agents|mesh-ancestor
20557375|NCT01952756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20557376|NCT01952756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557377|NCT01952756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20557378|NCT01952756|Respiratory System Agents|respiratory system agents|mesh-ancestor
20557379|NCT01952756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20002490|NCT02214121|Ticagrelor|ticagrelor|mesh-list
20002491|NCT02214121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20002492|NCT02214121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20002493|NCT02214121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20002494|NCT02214121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20002495|NCT02214121|Purinergic Agents|purinergic agents|mesh-ancestor
20002496|NCT02214121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20002497|NCT02214121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002498|NCT02214121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002499|NCT02214225|Vaccines|vaccines|mesh-list
20002500|NCT02214225|Immunologic Factors|immunologic factors|mesh-ancestor
20002501|NCT02214225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002502|NCT02214290|Caffeine|caffeine|mesh-list
20002503|NCT02214290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20002504|NCT02214290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002505|NCT02214290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20002506|NCT02214290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002507|NCT02214290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002508|NCT02214290|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20002509|NCT02214290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20002510|NCT02214290|Purinergic Agents|purinergic agents|mesh-ancestor
20002511|NCT02214290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20002512|NCT02214420|Ribavirin|ribavirin|mesh-list
20002513|NCT02214420|Sofosbuvir|sofosbuvir|mesh-list
20002514|NCT02214420|Simeprevir|simeprevir|mesh-list
20002515|NCT02214420|Antimetabolites|antimetabolites|mesh-ancestor
20002516|NCT02214420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002517|NCT02214420|Antiviral Agents|antiviral agents|mesh-ancestor
20002518|NCT02214420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002519|NCT02214420|Protease Inhibitors|protease inhibitors|mesh-ancestor
20002520|NCT02214420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002521|NCT02214615|Carbamazepine|carbamazepine|mesh-list
20002522|NCT02214615|Anticonvulsants|anticonvulsants|mesh-ancestor
20002523|NCT02214615|Antimanic Agents|antimanic agents|mesh-ancestor
20002524|NCT02214615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20002525|NCT02214615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20002526|NCT02214615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002527|NCT02214615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20002528|NCT02214615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20002529|NCT02214615|Analgesics|analgesics|mesh-ancestor
20002530|NCT02214615|Sensory System Agents|sensory system agents|mesh-ancestor
20002531|NCT02214615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002532|NCT02214615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20002533|NCT02214615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20002534|NCT02214615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002535|NCT02214615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20002536|NCT02214615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20002537|NCT02214628|Bevacizumab|bevacizumab|mesh-list
20002538|NCT02214628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20002539|NCT02214628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20002540|NCT02214628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20002541|NCT02214628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20002542|NCT02214628|Growth Substances|growth substances|mesh-ancestor
20002543|NCT02214628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002544|NCT02214628|Growth Inhibitors|growth inhibitors|mesh-ancestor
20002545|NCT02215070|Pasireotide|pasireotide|mesh-list
20002546|NCT02215070|Hormones|hormones|mesh-ancestor
20002547|NCT02215070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20002548|NCT02215070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002549|NCT02215200|Sargramostim|sargramostim|mesh-list
20002550|NCT02215200|Lenograstim|lenograstim|mesh-list
20002551|NCT02215200|Thymoglobulin|thymoglobulin|mesh-list
20002552|NCT02215200|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20002553|NCT02215200|Immunologic Factors|immunologic factors|mesh-ancestor
20002554|NCT02215200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002555|NCT02215200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20002556|NCT02215200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20002557|NCT02215252|Pregabalin|pregabalin|mesh-list
20002558|NCT02215252|Analgesics|analgesics|mesh-ancestor
20002559|NCT02215252|Sensory System Agents|sensory system agents|mesh-ancestor
20002560|NCT02215252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002561|NCT02215252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002562|NCT02215252|Anticonvulsants|anticonvulsants|mesh-ancestor
20002563|NCT02215252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20002564|NCT02215252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20002565|NCT02215252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002566|NCT02215252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20002567|NCT02215252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20002568|NCT02215252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20002569|NCT02215252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20002570|NCT02215252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20002571|NCT02215967|Cyclophosphamide|cyclophosphamide|mesh-list
20002572|NCT02215967|Fludarabine|fludarabine|mesh-list
20002573|NCT02215967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20002574|NCT02215967|Immunologic Factors|immunologic factors|mesh-ancestor
20002575|NCT02215967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002576|NCT02215967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20002577|NCT02215967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20002578|NCT02215967|Alkylating Agents|alkylating agents|mesh-ancestor
20002579|NCT02215967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002580|NCT02215967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20002581|NCT02215967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20002582|NCT02216071|Ciprofloxacin|ciprofloxacin|mesh-list
20002583|NCT02216071|Dexamethasone|dexamethasone|mesh-list
20002584|NCT02216071|Dexamethasone acetate|dexamethasone acetate|mesh-list
20002585|NCT02216071|BB 1101|bb 1101|mesh-list
20002586|NCT02216071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20002587|NCT02216071|Antiemetics|antiemetics|mesh-ancestor
20002588|NCT02216071|Autonomic Agents|autonomic agents|mesh-ancestor
20002589|NCT02216071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002590|NCT02216071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002591|NCT02216071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20002592|NCT02216071|Glucocorticoids|glucocorticoids|mesh-ancestor
20002593|NCT02216071|Hormones|hormones|mesh-ancestor
20002594|NCT02216071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20002595|NCT02216071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20002596|NCT02216071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20002597|NCT02216071|Protease Inhibitors|protease inhibitors|mesh-ancestor
20002598|NCT02216071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002599|NCT02216071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002600|NCT02216071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20002601|NCT02216071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002602|NCT02216071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20002603|NCT02216071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20002604|NCT02216071|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20002605|NCT02216071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20002606|NCT02216123|Chloroquine|chloroquine|mesh-list
20002607|NCT02216123|Primaquine|primaquine|mesh-list
20002608|NCT02216123|Tafenoquine|tafenoquine|mesh-list
20002609|NCT02216123|Amebicides|amebicides|mesh-ancestor
20002610|NCT02216123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20002611|NCT02216123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20002612|NCT02216123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002613|NCT02216123|Antimalarials|antimalarials|mesh-ancestor
20002614|NCT02216123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20002615|NCT02216214|Mirabegron|mirabegron|mesh-list
20002616|NCT02216214|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20002617|NCT02216214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20002618|NCT02216214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20002619|NCT02216214|Adrenergic Agents|adrenergic agents|mesh-ancestor
20002620|NCT02216214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20002621|NCT02216214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002622|NCT02216214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002623|NCT02216214|Urological Agents|urological agents|mesh-ancestor
20002624|NCT02216357|Ifetroban|ifetroban|mesh-list
20002625|NCT02216357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20002626|NCT02216422|Ritonavir|ritonavir|mesh-list
20002627|NCT02216422|Ribavirin|ribavirin|mesh-list
20002628|NCT02216422|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20002629|NCT02216422|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20002630|NCT02216422|Protease Inhibitors|protease inhibitors|mesh-ancestor
20002631|NCT02216422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002632|NCT02216422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002633|NCT02216422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20002634|NCT02216422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20002635|NCT02216422|Antiviral Agents|antiviral agents|mesh-ancestor
20002636|NCT02216422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002637|NCT02216422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20002638|NCT02216422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20002639|NCT02216422|Antimetabolites|antimetabolites|mesh-ancestor
20002640|NCT02216812|Ascorbic Acid|ascorbic acid|mesh-list
20002641|NCT02216812|Vitamins|vitamins|mesh-ancestor
20002642|NCT02216812|Micronutrients|micronutrients|mesh-ancestor
20002643|NCT02216812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002644|NCT02216812|Antioxidants|antioxidants|mesh-ancestor
20002645|NCT02216812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002646|NCT02216812|Protective Agents|protective agents|mesh-ancestor
20002647|NCT02217332|Pramipexole|pramipexole|mesh-list
20002648|NCT02217332|Antioxidants|antioxidants|mesh-ancestor
20002649|NCT02217332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002650|NCT02217332|Protective Agents|protective agents|mesh-ancestor
20002651|NCT02217332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002652|NCT02217332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20002653|NCT02217332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20002654|NCT02217332|Dopamine Agonists|dopamine agonists|mesh-ancestor
20002655|NCT02217332|Dopamine Agents|dopamine agents|mesh-ancestor
20002656|NCT02217332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20002657|NCT02217410|Mycophenolic Acid|mycophenolic acid|mesh-list
20002658|NCT02217410|Tacrolimus|tacrolimus|mesh-list
20002659|NCT02217410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20002660|NCT02217410|Immunologic Factors|immunologic factors|mesh-ancestor
20002661|NCT02217410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002662|NCT02217410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20002663|NCT02217410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002664|NCT02217410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002665|NCT02217410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20002666|NCT02217410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20002667|NCT02217410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20002668|NCT02217410|Antitubercular Agents|antitubercular agents|mesh-ancestor
20002669|NCT02217410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20002670|NCT02217410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002671|NCT02217475|Cenicriviroc|cenicriviroc|mesh-list
20002672|NCT02217475|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20002673|NCT02217475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002674|NCT02217475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20002675|NCT02217475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20002676|NCT02217475|Antiviral Agents|antiviral agents|mesh-ancestor
20002677|NCT02217475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002678|NCT02217501|Aspirin|aspirin|mesh-list
20002679|NCT02217501|Clopidogrel|clopidogrel|mesh-list
20002680|NCT02217501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20002681|NCT02217501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20002682|NCT02217501|Analgesics|analgesics|mesh-ancestor
20002683|NCT02217501|Sensory System Agents|sensory system agents|mesh-ancestor
20002684|NCT02217501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002685|NCT02217501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002686|NCT02217501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20002687|NCT02217501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20002688|NCT02217501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20002689|NCT02217501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20002690|NCT02217501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002691|NCT02217501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20002692|NCT02217501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20002693|NCT02217501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002694|NCT02217501|Antipyretics|antipyretics|mesh-ancestor
20002695|NCT02217501|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20002696|NCT02217501|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20002697|NCT02217501|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20002698|NCT02217501|Purinergic Agents|purinergic agents|mesh-ancestor
20002699|NCT02217501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20002700|NCT02217566|Prednisone|prednisone|mesh-list
20002701|NCT02217566|Abiraterone Acetate|abiraterone acetate|mesh-list
20002702|NCT02217566|Androgens|androgens|mesh-list
20002703|NCT02217566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20002704|NCT02217566|Glucocorticoids|glucocorticoids|mesh-ancestor
20002705|NCT02217566|Hormones|hormones|mesh-ancestor
20002706|NCT02217566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20002707|NCT02217566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002708|NCT02217566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20002709|NCT02217566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20002710|NCT02217566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20002711|NCT02217566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002712|NCT02217566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002713|NCT02217566|Hormone Antagonists|hormone antagonists|mesh-ancestor
20002714|NCT02217566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20002715|NCT02217800|Octreotide|octreotide|mesh-list
20002716|NCT02217800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20002717|NCT02217800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20002718|NCT02217800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20002719|NCT02217878|Morphine|morphine|mesh-list
20002720|NCT02217878|Ticagrelor|ticagrelor|mesh-list
20002721|NCT02217878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20002722|NCT02217878|Narcotics|narcotics|mesh-ancestor
20002723|NCT02217878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20002724|NCT02217878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002725|NCT02217878|Analgesics|analgesics|mesh-ancestor
20002726|NCT02217878|Sensory System Agents|sensory system agents|mesh-ancestor
20002727|NCT02217878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002728|NCT02217878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20002729|NCT02217878|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20002730|NCT02217878|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20002731|NCT02217878|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20002732|NCT02217878|Purinergic Agents|purinergic agents|mesh-ancestor
20002733|NCT02217878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20002734|NCT02217878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002735|NCT02217904|Islatravir|islatravir|mesh-list
20002736|NCT02217904|Antiviral Agents|antiviral agents|mesh-ancestor
20002737|NCT02217904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002738|NCT02217904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002739|NCT02217904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557380|NCT01952756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20557381|NCT01952756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557382|NCT01952756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20557383|NCT01952756|Vasodilator Agents|vasodilator agents|mesh-ancestor
20557384|NCT01952756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20557385|NCT01952756|Protective Agents|protective agents|mesh-ancestor
20557386|NCT01952756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20557387|NCT01952756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20557388|NCT01952756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557389|NCT01952769|Pidilizumab|pidilizumab|mesh-list
20557390|NCT01952769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20557391|NCT01952769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557392|NCT01952782|Naloxone|naloxone|mesh-list
20557393|NCT01952782|Hormones|hormones|mesh-list
20557394|NCT01952782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20557395|NCT01952782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557396|NCT01952782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20557397|NCT01952782|Sensory System Agents|sensory system agents|mesh-ancestor
20557398|NCT01952782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20557399|NCT01952886|Ondansetron|ondansetron|mesh-list
20557400|NCT01952886|Granisetron|granisetron|mesh-list
20557401|NCT01952886|Antiemetics|antiemetics|mesh-ancestor
20557402|NCT01952886|Autonomic Agents|autonomic agents|mesh-ancestor
20557403|NCT01952886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20557404|NCT01952886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557405|NCT01952886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20557406|NCT01952886|Antipruritics|antipruritics|mesh-ancestor
20557407|NCT01952886|Dermatologic Agents|dermatologic agents|mesh-ancestor
20002740|NCT02217904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20002741|NCT02217904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20002742|NCT02217904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20002743|NCT02217982|Simethicone|simethicone|mesh-list
20002744|NCT02217982|Loperamide|loperamide|mesh-list
20002745|NCT02217982|Antidiarrheals|antidiarrheals|mesh-list
20002746|NCT02217982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20002747|NCT02217982|Antifoaming Agents|antifoaming agents|mesh-ancestor
20002748|NCT02217982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002749|NCT02217982|Emollients|emollients|mesh-ancestor
20002750|NCT02217982|Dermatologic Agents|dermatologic agents|mesh-ancestor
20002751|NCT02218190|Alvimopan|alvimopan|mesh-list
20002752|NCT02218190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20002753|NCT02218203|Lidocaine|lidocaine|mesh-list
20002754|NCT02218203|Dextromethorphan|dextromethorphan|mesh-list
20002755|NCT02218203|Anesthetics, Local|anesthetics, local|mesh-ancestor
20002756|NCT02218203|Anesthetics|anesthetics|mesh-ancestor
20002757|NCT02218203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20002758|NCT02218203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002759|NCT02218203|Sensory System Agents|sensory system agents|mesh-ancestor
20002760|NCT02218203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002761|NCT02218203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20002762|NCT02218203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20002763|NCT02218203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20002764|NCT02218203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20002765|NCT02218203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002766|NCT02218203|Antitussive Agents|antitussive agents|mesh-ancestor
20002767|NCT02218203|Respiratory System Agents|respiratory system agents|mesh-ancestor
20002768|NCT02218203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20002769|NCT02218203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20002770|NCT02218203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20002771|NCT02218307|Mupirocin|mupirocin|mesh-list
20002772|NCT02218307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20002773|NCT02218307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002774|NCT02218307|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20002775|NCT02218307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002776|NCT02218307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002777|NCT02218320|Raltegravir Potassium|raltegravir potassium|mesh-list
20002778|NCT02218320|Dolutegravir|dolutegravir|mesh-list
20002779|NCT02218320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20002780|NCT02218320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20002781|NCT02218320|Antiviral Agents|antiviral agents|mesh-ancestor
20002782|NCT02218320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002783|NCT02218320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20002784|NCT02218320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20002785|NCT02218320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002786|NCT02218320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002787|NCT02218372|Vancomycin|vancomycin|mesh-list
20002788|NCT02218372|Fidaxomicin|fidaxomicin|mesh-list
20002789|NCT02218372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20002790|NCT02218372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20289999|NCT04385680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20290000|NCT04385680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20290001|NCT04385680|Disinfectants|disinfectants|mesh-ancestor
20290002|NCT04385680|Dermatologic Agents|dermatologic agents|mesh-ancestor
20290003|NCT04385667|Levonorgestrel|levonorgestrel|mesh-list
20290004|NCT04385667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20290005|NCT04385667|Contraceptive Agents|contraceptive agents|mesh-ancestor
20290006|NCT04385667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20290007|NCT04385667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290008|NCT04385667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20290009|NCT04385667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20290010|NCT04385667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20290011|NCT04383574|Vaccines|vaccines|mesh-list
20290012|NCT04383574|Immunologic Factors|immunologic factors|mesh-ancestor
20290013|NCT04383574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290014|NCT04382326|Vaccines|vaccines|mesh-list
20290015|NCT04382326|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20290016|NCT04382326|Immunologic Factors|immunologic factors|mesh-ancestor
20290017|NCT04382326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290018|NCT04377932|Cyclophosphamide|cyclophosphamide|mesh-list
20290019|NCT04377932|Fludarabine|fludarabine|mesh-list
20290020|NCT04377932|Fludarabine phosphate|fludarabine phosphate|mesh-list
20290021|NCT04377932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20290022|NCT04377932|Immunologic Factors|immunologic factors|mesh-ancestor
20290023|NCT04377932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002791|NCT02218463|Estradiol|estradiol|mesh-list
20002792|NCT02218463|Estrogens|estrogens|mesh-ancestor
20002793|NCT02218463|Hormones|hormones|mesh-ancestor
20002794|NCT02218463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20002795|NCT02218463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002796|NCT02218489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20002797|NCT02218489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20002798|NCT02218736|Aticaprant|aticaprant|mesh-list
20002799|NCT02218736|Narcotic Antagonists|narcotic antagonists|mesh-list
20002800|NCT02218736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002801|NCT02218736|Sensory System Agents|sensory system agents|mesh-ancestor
20002802|NCT02218736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002803|NCT02219009|Aripiprazole|aripiprazole|mesh-list
20002804|NCT02219009|Antidepressive Agents|antidepressive agents|mesh-ancestor
20002805|NCT02219009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20002806|NCT02219009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20002807|NCT02219009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20002808|NCT02219009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20002809|NCT02219009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002810|NCT02219009|Dopamine Agonists|dopamine agonists|mesh-ancestor
20002811|NCT02219009|Dopamine Agents|dopamine agents|mesh-ancestor
20002812|NCT02219009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20002813|NCT02219009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002814|NCT02219009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20002815|NCT02219009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20002816|NCT02219009|Serotonin Agents|serotonin agents|mesh-ancestor
20002817|NCT02219009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20002818|NCT02219009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20002819|NCT02219009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20002820|NCT02219009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20002821|NCT02219087|Bupivacaine|bupivacaine|mesh-list
20002822|NCT02219087|Anesthetics, Local|anesthetics, local|mesh-ancestor
20002823|NCT02219087|Anesthetics|anesthetics|mesh-ancestor
20002824|NCT02219087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20002825|NCT02219087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002826|NCT02219087|Sensory System Agents|sensory system agents|mesh-ancestor
20002827|NCT02219087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002828|NCT02219321|Lidocaine|lidocaine|mesh-list
20002829|NCT02219321|Anesthetics, Local|anesthetics, local|mesh-ancestor
20002830|NCT02219321|Anesthetics|anesthetics|mesh-ancestor
20002831|NCT02219321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20002832|NCT02219321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002833|NCT02219321|Sensory System Agents|sensory system agents|mesh-ancestor
20002834|NCT02219321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002835|NCT02219321|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20002836|NCT02219321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20002837|NCT02219321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20002838|NCT02219321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20002839|NCT02219321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002840|NCT02219477|Ritonavir|ritonavir|mesh-list
20002841|NCT02219477|Ribavirin|ribavirin|mesh-list
20002842|NCT02219477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20002843|NCT02219477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20002844|NCT02219477|Protease Inhibitors|protease inhibitors|mesh-ancestor
20002845|NCT02219477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002846|NCT02219477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002847|NCT02219477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20002848|NCT02219477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20002849|NCT02219477|Antiviral Agents|antiviral agents|mesh-ancestor
20002850|NCT02219477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002851|NCT02219477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20002852|NCT02219477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20002853|NCT02219477|Antimetabolites|antimetabolites|mesh-ancestor
20002854|NCT02219503|Ritonavir|ritonavir|mesh-list
20002855|NCT02219503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20002856|NCT02219503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20002857|NCT02219503|Protease Inhibitors|protease inhibitors|mesh-ancestor
20002858|NCT02219503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002859|NCT02219503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002860|NCT02219503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20002861|NCT02219503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20002862|NCT02219503|Antiviral Agents|antiviral agents|mesh-ancestor
20002863|NCT02219503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002864|NCT02219503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20002865|NCT02219503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20002866|NCT02219516|Verinurad|verinurad|mesh-list
20002867|NCT02219516|Gout Suppressants|gout suppressants|mesh-ancestor
20002868|NCT02219516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20002869|NCT02219685|Sofosbuvir|sofosbuvir|mesh-list
20002870|NCT02219685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
20002871|NCT02219685|Ledipasvir|ledipasvir|mesh-list
20002872|NCT02219685|Antiviral Agents|antiviral agents|mesh-ancestor
20002873|NCT02219685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002874|NCT02219932|4-Aminopyridine|4-aminopyridine|mesh-list
20002875|NCT02219932|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20002876|NCT02219932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20557408|NCT01952886|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20557409|NCT01952886|Serotonin Agents|serotonin agents|mesh-ancestor
20557410|NCT01952886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20557411|NCT01952886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557412|NCT01952886|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20557413|NCT01952886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20557414|NCT01952886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20557415|NCT01952886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20557416|NCT01952886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20557417|NCT01952951|Fluorouracil|fluorouracil|mesh-list
20557418|NCT01952951|Capecitabine|capecitabine|mesh-list
20557419|NCT01952951|Oxaliplatin|oxaliplatin|mesh-list
20557420|NCT01952951|Antimetabolites|antimetabolites|mesh-ancestor
20557421|NCT01952951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557422|NCT01952951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20557423|NCT01952951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557424|NCT01952951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20557425|NCT01952951|Immunologic Factors|immunologic factors|mesh-ancestor
20557426|NCT01952951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557427|NCT01953107|Ferrous fumarate|ferrous fumarate|mesh-list
20557428|NCT01953107|Trace Elements|trace elements|mesh-ancestor
20557429|NCT01953107|Micronutrients|micronutrients|mesh-ancestor
20557430|NCT01953107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557431|NCT01953120|Abatacept|abatacept|mesh-list
20557432|NCT01953120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20557433|NCT01953120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557434|NCT01953120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557435|NCT01953120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20557436|NCT01953120|Immunologic Factors|immunologic factors|mesh-ancestor
20557437|NCT01953120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557438|NCT01953120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20557439|NCT01953172|Tocotrienols|tocotrienols|mesh-list
20557440|NCT01953172|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
20557441|NCT01953172|Antioxidants|antioxidants|mesh-ancestor
20557442|NCT01953172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557443|NCT01953172|Protective Agents|protective agents|mesh-ancestor
20557444|NCT01953172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557445|NCT01953172|Vitamins|vitamins|mesh-ancestor
20557446|NCT01953172|Micronutrients|micronutrients|mesh-ancestor
20557447|NCT01953367|Tobramycin|tobramycin|mesh-list
20557448|NCT01953367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20557449|NCT01953367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20557450|NCT01953406|Fluorouracil|fluorouracil|mesh-list
20557451|NCT01953406|Mitomycins|mitomycins|mesh-list
20557452|NCT01953406|Mitomycin|mitomycin|mesh-list
20557453|NCT01953406|Antimetabolites|antimetabolites|mesh-ancestor
20557454|NCT01953406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002877|NCT02219932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002878|NCT02219997|Methamphetamine|methamphetamine|mesh-list
20557455|NCT01953406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20557456|NCT01953406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20002879|NCT02219997|beta-Endorphin|beta-endorphin|mesh-list
20002880|NCT02219997|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20002881|NCT02219997|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
20002882|NCT02219997|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20002883|NCT02219997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002884|NCT02219997|Sympathomimetics|sympathomimetics|mesh-ancestor
20002885|NCT02219997|Autonomic Agents|autonomic agents|mesh-ancestor
20002886|NCT02219997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002887|NCT02219997|Dopamine Agents|dopamine agents|mesh-ancestor
20002888|NCT02219997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20002889|NCT02219997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002890|NCT02219997|Adrenergic Agents|adrenergic agents|mesh-ancestor
20002891|NCT02219997|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20002892|NCT02219997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20002893|NCT02219997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20002894|NCT02219997|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20002895|NCT02219997|Hormones|hormones|mesh-ancestor
20002896|NCT02219997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20002897|NCT02220712|Aripiprazole|aripiprazole|mesh-list
20002898|NCT02220712|Antidepressive Agents|antidepressive agents|mesh-ancestor
20002899|NCT02220712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20002900|NCT02220712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20002901|NCT02220712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20002902|NCT02220712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20002903|NCT02220712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002904|NCT02220712|Dopamine Agonists|dopamine agonists|mesh-ancestor
20002905|NCT02220712|Dopamine Agents|dopamine agents|mesh-ancestor
20002906|NCT02220712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20002907|NCT02220712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002908|NCT02220712|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20290024|NCT04377932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19459754|NCT03358953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19459755|NCT03358953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459756|NCT03358888|Analgesics, Opioid|analgesics, opioid|mesh-list
19459757|NCT03358888|Narcotics|narcotics|mesh-ancestor
19459758|NCT03358888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19459759|NCT03358888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459760|NCT03358888|Analgesics|analgesics|mesh-ancestor
19459761|NCT03358888|Sensory System Agents|sensory system agents|mesh-ancestor
19459762|NCT03358888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19459763|NCT03358875|Docetaxel|docetaxel|mesh-list
19459764|NCT03358875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459765|NCT03358875|Tubulin Modulators|tubulin modulators|mesh-ancestor
19459766|NCT03358875|Antimitotic Agents|antimitotic agents|mesh-ancestor
19459767|NCT03358875|Mitosis Modulators|mitosis modulators|mesh-ancestor
19459768|NCT03358875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459769|NCT03358719|Poly I-C|poly i-c|mesh-list
19459770|NCT03358719|Nivolumab|nivolumab|mesh-list
19459771|NCT03358719|Decitabine|decitabine|mesh-list
19459772|NCT03358719|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
19459773|NCT03358719|Poly ICLC|poly iclc|mesh-list
19459774|NCT03358719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19459775|NCT03358719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459776|NCT03358719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19459777|NCT03358719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459778|NCT03358719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19459779|NCT03358719|Antimetabolites|antimetabolites|mesh-ancestor
19459780|NCT03358719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002909|NCT02220712|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20002910|NCT02220712|Serotonin Agents|serotonin agents|mesh-ancestor
20002911|NCT02220712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20002912|NCT02220712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20002913|NCT02220712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20002914|NCT02220712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20002915|NCT02220907|Canagliflozin|canagliflozin|mesh-list
20002916|NCT02220907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20002917|NCT02220907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002918|NCT02220907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20002919|NCT02220907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002920|NCT02220920|Canagliflozin|canagliflozin|mesh-list
20002921|NCT02220920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20002922|NCT02220920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002923|NCT02220920|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20002924|NCT02220920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002925|NCT02220998|Sofosbuvir|sofosbuvir|mesh-list
20002926|NCT02220998|Antiviral Agents|antiviral agents|mesh-ancestor
20002927|NCT02220998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002928|NCT02221219|Indomethacin|indomethacin|mesh-list
20002929|NCT02221219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20002930|NCT02221219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20002931|NCT02221219|Analgesics|analgesics|mesh-ancestor
20002932|NCT02221219|Sensory System Agents|sensory system agents|mesh-ancestor
20002933|NCT02221219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002934|NCT02221219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002935|NCT02221219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20002936|NCT02221219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20002937|NCT02221219|Gout Suppressants|gout suppressants|mesh-ancestor
20002938|NCT02221219|Tocolytic Agents|tocolytic agents|mesh-ancestor
20002939|NCT02221219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20002940|NCT02221219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20002941|NCT02221219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002942|NCT02221219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002943|NCT02221284|Alogliptin|alogliptin|mesh-list
20002944|NCT02221284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20002945|NCT02221284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002946|NCT02221284|Incretins|incretins|mesh-ancestor
20002947|NCT02221284|Hormones|hormones|mesh-ancestor
20002948|NCT02221284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20002949|NCT02221284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20002950|NCT02221284|Protease Inhibitors|protease inhibitors|mesh-ancestor
20002951|NCT02221284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20002952|NCT02221284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002953|NCT02221349|Listerine|listerine|mesh-list
20002954|NCT02221349|Fluorides|fluorides|mesh-list
20002955|NCT02221349|Sodium Fluoride|sodium fluoride|mesh-list
20002956|NCT02221349|Tin Fluorides|tin fluorides|mesh-list
20002957|NCT02221349|Cariostatic Agents|cariostatic agents|mesh-ancestor
20002958|NCT02221349|Protective Agents|protective agents|mesh-ancestor
20002959|NCT02221349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002960|NCT02221349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20002961|NCT02221349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20002962|NCT02221648|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20002963|NCT02221648|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20002964|NCT02221648|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20002965|NCT02221648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20002966|NCT02221648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002967|NCT02221648|Cholinergic Agents|cholinergic agents|mesh-ancestor
20002968|NCT02221648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20002969|NCT02221648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002970|NCT02221648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20002971|NCT02221648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002972|NCT02221674|Tapentadol|tapentadol|mesh-list
20002973|NCT02221674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20002974|NCT02221674|Narcotics|narcotics|mesh-ancestor
20002975|NCT02221674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20002976|NCT02221674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002977|NCT02221674|Analgesics|analgesics|mesh-ancestor
20002978|NCT02221674|Sensory System Agents|sensory system agents|mesh-ancestor
20002979|NCT02221674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20002980|NCT02221674|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20557457|NCT01953406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20557458|NCT01953406|Immunologic Factors|immunologic factors|mesh-ancestor
20002981|NCT02221674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20002982|NCT02221674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20002983|NCT02221674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002984|NCT02221674|Adrenergic Agents|adrenergic agents|mesh-ancestor
20002985|NCT02221674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20002986|NCT02221739|Ipilimumab|ipilimumab|mesh-list
20002987|NCT02221739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20002988|NCT02221739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20002989|NCT02221739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20002990|NCT02221739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20002991|NCT02221947|Bryostatin 1|bryostatin 1|mesh-list
20002992|NCT02221947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20002993|NCT02221947|Immunologic Factors|immunologic factors|mesh-ancestor
20002994|NCT02221947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20002995|NCT02221947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20002996|NCT02222129|Bupivacaine|bupivacaine|mesh-list
20002997|NCT02222129|Anesthetics, Local|anesthetics, local|mesh-ancestor
20002998|NCT02222129|Anesthetics|anesthetics|mesh-ancestor
20002999|NCT02222129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20003000|NCT02222129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003001|NCT02222129|Sensory System Agents|sensory system agents|mesh-ancestor
20003002|NCT02222129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003003|NCT02222207|Ranibizumab|ranibizumab|mesh-list
20003004|NCT02222207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20003005|NCT02222207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20003006|NCT02222207|Growth Substances|growth substances|mesh-ancestor
20003007|NCT02222207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003008|NCT02222207|Growth Inhibitors|growth inhibitors|mesh-ancestor
20003009|NCT02222207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20003010|NCT02222246|Morphine|morphine|mesh-list
20003011|NCT02222246|Hydromorphone|hydromorphone|mesh-list
20003012|NCT02222246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20003013|NCT02222246|Narcotics|narcotics|mesh-ancestor
20003014|NCT02222246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20003015|NCT02222246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003016|NCT02222246|Analgesics|analgesics|mesh-ancestor
20003017|NCT02222246|Sensory System Agents|sensory system agents|mesh-ancestor
20003018|NCT02222246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003019|NCT02222493|Infliximab|infliximab|mesh-list
20003020|NCT02222493|Dermatologic Agents|dermatologic agents|mesh-ancestor
20003021|NCT02222493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20003022|NCT02222493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20003023|NCT02222558|Testosterone|testosterone|mesh-list
20003024|NCT02222558|Androgens|androgens|mesh-ancestor
20003025|NCT02222558|Hormones|hormones|mesh-ancestor
20003026|NCT02222558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20557459|NCT01953406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557460|NCT01953406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20557461|NCT01953406|Alkylating Agents|alkylating agents|mesh-ancestor
20557462|NCT01953406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20557463|NCT01953406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557464|NCT01953419|Pemetrexed|pemetrexed|mesh-list
20557465|NCT01953419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557466|NCT01953419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557467|NCT01953419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557468|NCT01953419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20557469|NCT01953419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20557470|NCT01953445|Paclitaxel|paclitaxel|mesh-list
20557471|NCT01953445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20557472|NCT01953445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557473|NCT01953445|Tubulin Modulators|tubulin modulators|mesh-ancestor
20557474|NCT01953445|Antimitotic Agents|antimitotic agents|mesh-ancestor
20557475|NCT01953445|Mitosis Modulators|mitosis modulators|mesh-ancestor
20557476|NCT01953445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557477|NCT01953510|Vaccines|vaccines|mesh-list
20557478|NCT01953510|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20557479|NCT01953510|Immunologic Factors|immunologic factors|mesh-ancestor
20557480|NCT01953510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557481|NCT01953536|Folic Acid|folic acid|mesh-list
20557482|NCT01953536|Paclitaxel|paclitaxel|mesh-list
20557483|NCT01953536|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20557484|NCT01953536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20557485|NCT01953536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20003027|NCT02222558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003028|NCT02222610|Ranibizumab|ranibizumab|mesh-list
20003029|NCT02222610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20003030|NCT02222610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20003031|NCT02222610|Growth Substances|growth substances|mesh-ancestor
20003032|NCT02222610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003033|NCT02222610|Growth Inhibitors|growth inhibitors|mesh-ancestor
20003034|NCT02222610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20003035|NCT02222714|Protein C|protein c|mesh-list
20003036|NCT02222714|Anticoagulants|anticoagulants|mesh-ancestor
20003037|NCT02222714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20003038|NCT02222714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20003039|NCT02222714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003040|NCT02222870|Vaccines|vaccines|mesh-list
20003041|NCT02222870|Immunologic Factors|immunologic factors|mesh-ancestor
20003042|NCT02222870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003043|NCT02222896|Chlorhexidine|chlorhexidine|mesh-list
20003044|NCT02222896|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20003045|NCT02222896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20003046|NCT02222896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20003047|NCT02222896|Disinfectants|disinfectants|mesh-ancestor
20003048|NCT02222896|Dermatologic Agents|dermatologic agents|mesh-ancestor
20003049|NCT02222922|Fluconazole|fluconazole|mesh-list
20003050|NCT02222922|Avelumab|avelumab|mesh-list
20003051|NCT02222922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20003052|NCT02222922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20003053|NCT02222922|Antifungal Agents|antifungal agents|mesh-ancestor
20003054|NCT02222922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20003055|NCT02222922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20003056|NCT02222922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20003057|NCT02222922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003058|NCT02222922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003059|NCT02222922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20003060|NCT02222922|Hormone Antagonists|hormone antagonists|mesh-ancestor
20003061|NCT02222922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20003062|NCT02222922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003063|NCT02222922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20003064|NCT02222922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20003065|NCT02223065|Dapagliflozin|dapagliflozin|mesh-list
20003066|NCT02223065|Saxagliptin|saxagliptin|mesh-list
20003067|NCT02223065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20003068|NCT02223065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003069|NCT02223065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20003070|NCT02223065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003071|NCT02223065|Incretins|incretins|mesh-ancestor
20003072|NCT02223065|Hormones|hormones|mesh-ancestor
20003073|NCT02223065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20003074|NCT02223065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20003075|NCT02223065|Protease Inhibitors|protease inhibitors|mesh-ancestor
20003076|NCT02223065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003077|NCT02223260|Dabigatran|dabigatran|mesh-list
20003078|NCT02223260|Antithrombins|antithrombins|mesh-ancestor
20003079|NCT02223260|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20003080|NCT02223260|Protease Inhibitors|protease inhibitors|mesh-ancestor
20003081|NCT02223260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003082|NCT02223260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003083|NCT02223260|Anticoagulants|anticoagulants|mesh-ancestor
20003084|NCT02223338|Ciprofloxacin|ciprofloxacin|mesh-list
20003085|NCT02223338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20003086|NCT02223338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20003087|NCT02223338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20003088|NCT02223338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20003089|NCT02223338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003090|NCT02223338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003091|NCT02223338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20003092|NCT02223338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20003093|NCT02223338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20003094|NCT02223351|Ritonavir|ritonavir|mesh-list
20003095|NCT02223351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20003096|NCT02223351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20003097|NCT02223351|Protease Inhibitors|protease inhibitors|mesh-ancestor
20003098|NCT02223351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003099|NCT02223351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003100|NCT02223351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20003101|NCT02223351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20003102|NCT02223351|Antiviral Agents|antiviral agents|mesh-ancestor
20003103|NCT02223351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20003104|NCT02223351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20003105|NCT02223351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20003106|NCT02223364|Bupivacaine|bupivacaine|mesh-list
20003107|NCT02223364|Ropivacaine|ropivacaine|mesh-list
20003108|NCT02223364|Anesthetics, Local|anesthetics, local|mesh-ancestor
20003109|NCT02223364|Anesthetics|anesthetics|mesh-ancestor
20003110|NCT02223364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20003111|NCT02223364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003112|NCT02223364|Sensory System Agents|sensory system agents|mesh-ancestor
20003113|NCT02223364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003114|NCT02223429|Vasopressins|vasopressins|mesh-list
20003115|NCT02223429|Arginine Vasopressin|arginine vasopressin|mesh-list
20003116|NCT02223429|Oxytocin|oxytocin|mesh-list
20003117|NCT02223429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003118|NCT02223429|Oxytocics|oxytocics|mesh-ancestor
20003119|NCT02223429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20003120|NCT02223429|Hemostatics|hemostatics|mesh-ancestor
20003121|NCT02223429|Coagulants|coagulants|mesh-ancestor
20003122|NCT02223429|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20003123|NCT02223429|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20003124|NCT02223429|Natriuretic Agents|natriuretic agents|mesh-ancestor
20003125|NCT02223702|Amoxicillin|amoxicillin|mesh-list
20003126|NCT02223702|Moxifloxacin|moxifloxacin|mesh-list
20003127|NCT02223702|Metronidazole|metronidazole|mesh-list
20003128|NCT02223702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20003129|NCT02223702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20003130|NCT02223702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20003131|NCT02223702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20003132|NCT02223702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003133|NCT02223702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003134|NCT02223702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20003135|NCT02223702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20003136|NCT02223702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20003137|NCT02223871|Lumefantrine|lumefantrine|mesh-list
20003138|NCT02223871|Artemether|artemether|mesh-list
20003139|NCT02223871|Primaquine|primaquine|mesh-list
20003140|NCT02223871|Antimalarials|antimalarials|mesh-ancestor
20003141|NCT02223871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20003142|NCT02223871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20003143|NCT02223871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20003144|NCT02224053|Osimertinib|osimertinib|mesh-list
20003145|NCT02224053|Omeprazole|omeprazole|mesh-list
20003146|NCT02224053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20003147|NCT02224053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20003148|NCT02224053|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20003149|NCT02224053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003150|NCT02224053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557486|NCT01953536|Tubulin Modulators|tubulin modulators|mesh-ancestor
20003151|NCT02224053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20003152|NCT02224053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20003153|NCT02224157|Budesonide|budesonide|mesh-list
20003154|NCT02224157|Terbutaline|terbutaline|mesh-list
20003155|NCT02224157|Formoterol Fumarate|formoterol fumarate|mesh-list
20003156|NCT02224157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20003157|NCT02224157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20003158|NCT02224157|Autonomic Agents|autonomic agents|mesh-ancestor
20003159|NCT02224157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003160|NCT02224157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003161|NCT02224157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20003162|NCT02224157|Respiratory System Agents|respiratory system agents|mesh-ancestor
20003163|NCT02224157|Glucocorticoids|glucocorticoids|mesh-ancestor
20003164|NCT02224157|Hormones|hormones|mesh-ancestor
20003165|NCT02224157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20003166|NCT02224157|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20003167|NCT02224157|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20003168|NCT02224157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20003169|NCT02224157|Adrenergic Agents|adrenergic agents|mesh-ancestor
20003170|NCT02224157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003171|NCT02224157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003172|NCT02224157|Sympathomimetics|sympathomimetics|mesh-ancestor
20003173|NCT02224157|Tocolytic Agents|tocolytic agents|mesh-ancestor
20003174|NCT02224157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20003175|NCT02224274|Clopidogrel|clopidogrel|mesh-list
20003176|NCT02224274|Ticagrelor|ticagrelor|mesh-list
20003177|NCT02224274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20003178|NCT02224274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20003179|NCT02224274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20003180|NCT02224274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20003181|NCT02224274|Purinergic Agents|purinergic agents|mesh-ancestor
20003182|NCT02224274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003183|NCT02224274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003184|NCT02224274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003185|NCT02224313|Estradiol|estradiol|mesh-list
20003186|NCT02224313|Progesterone|progesterone|mesh-list
20003187|NCT02224313|Estrogens|estrogens|mesh-ancestor
20003188|NCT02224313|Hormones|hormones|mesh-ancestor
20003189|NCT02224313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20003190|NCT02224313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003191|NCT02224313|Progestins|progestins|mesh-ancestor
20003192|NCT02224560|Cannabidiol|cannabidiol|mesh-list
20557487|NCT01953536|Antimitotic Agents|antimitotic agents|mesh-ancestor
20557488|NCT01953536|Mitosis Modulators|mitosis modulators|mesh-ancestor
20557489|NCT01953536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557490|NCT01953536|Hematinics|hematinics|mesh-ancestor
20557491|NCT01953536|Vitamin B Complex|vitamin b complex|mesh-ancestor
20557492|NCT01953536|Vitamins|vitamins|mesh-ancestor
20557493|NCT01953536|Micronutrients|micronutrients|mesh-ancestor
20557494|NCT01953536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557495|NCT01953588|Fulvestrant|fulvestrant|mesh-list
20557496|NCT01953588|Anastrozole|anastrozole|mesh-list
20557497|NCT01953588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20557498|NCT01953588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557499|NCT01953588|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20557500|NCT01953588|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20557501|NCT01953588|Hormone Antagonists|hormone antagonists|mesh-ancestor
20557502|NCT01953588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20557503|NCT01953588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557504|NCT01953588|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20557505|NCT01953588|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20557506|NCT01953588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557507|NCT01953588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003193|NCT02224560|Anticonvulsants|anticonvulsants|mesh-ancestor
20003194|NCT02224625|Chlorhexidine|chlorhexidine|mesh-list
20003195|NCT02224625|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20003196|NCT02224625|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20003197|NCT02224625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20003198|NCT02224625|Disinfectants|disinfectants|mesh-ancestor
20003199|NCT02224625|Dermatologic Agents|dermatologic agents|mesh-ancestor
20003200|NCT02224690|Cannabidiol|cannabidiol|mesh-list
20003201|NCT02224690|Anticonvulsants|anticonvulsants|mesh-ancestor
20003202|NCT02224703|Cannabidiol|cannabidiol|mesh-list
20003203|NCT02224703|Anticonvulsants|anticonvulsants|mesh-ancestor
20003204|NCT02224729|Dexamethasone|dexamethasone|mesh-list
20003205|NCT02224729|Bortezomib|bortezomib|mesh-list
20003206|NCT02224729|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20003207|NCT02224729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20003208|NCT02224729|Antiemetics|antiemetics|mesh-ancestor
20003209|NCT02224729|Autonomic Agents|autonomic agents|mesh-ancestor
20003210|NCT02224729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003211|NCT02224729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003212|NCT02224729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20003213|NCT02224729|Glucocorticoids|glucocorticoids|mesh-ancestor
20003214|NCT02224729|Hormones|hormones|mesh-ancestor
20003215|NCT02224729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20003216|NCT02224729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20003217|NCT02224729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20003218|NCT02224729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20003219|NCT02224729|Alkylating Agents|alkylating agents|mesh-ancestor
20003220|NCT02224729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003221|NCT02224846|Tadalafil|tadalafil|mesh-list
20003222|NCT02224846|Vasodilator Agents|vasodilator agents|mesh-ancestor
20003223|NCT02224846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20003224|NCT02224846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20003225|NCT02224846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003226|NCT02224846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003227|NCT02224846|Urological Agents|urological agents|mesh-ancestor
20003228|NCT02225106|Methylphenidate|methylphenidate|mesh-list
20003229|NCT02225106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20003230|NCT02225106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003231|NCT02225106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20003232|NCT02225106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20003233|NCT02225106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20003234|NCT02225106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003235|NCT02225106|Dopamine Agents|dopamine agents|mesh-ancestor
20003236|NCT02225106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003237|NCT02225132|Hydroxyurea|hydroxyurea|mesh-list
20003238|NCT02225132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20003239|NCT02225132|Antisickling Agents|antisickling agents|mesh-ancestor
20003240|NCT02225132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003241|NCT02225132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003242|NCT02225132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20003243|NCT02225353|Progesterone|progesterone|mesh-list
20003244|NCT02225353|Progestins|progestins|mesh-ancestor
20003245|NCT02225353|Hormones|hormones|mesh-ancestor
20003246|NCT02225353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20003247|NCT02225353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003248|NCT02225587|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20003249|NCT02225587|Immunologic Factors|immunologic factors|mesh-ancestor
20003250|NCT02225587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003251|NCT02225665|Cyclophosphamide|cyclophosphamide|mesh-list
20003252|NCT02225665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20003253|NCT02225665|Immunologic Factors|immunologic factors|mesh-ancestor
20003254|NCT02225665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003255|NCT02225665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20003256|NCT02225665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20003257|NCT02225665|Alkylating Agents|alkylating agents|mesh-ancestor
20003258|NCT02225665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003259|NCT02225665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20003260|NCT02225665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20003261|NCT02226003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20003262|NCT02226003|Glimepiride|glimepiride|mesh-list
20003263|NCT02226003|Ertugliflozin|ertugliflozin|mesh-list
20003264|NCT02226003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20003265|NCT02226003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003266|NCT02226003|Incretins|incretins|mesh-ancestor
20003267|NCT02226003|Hormones|hormones|mesh-ancestor
20003268|NCT02226003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20003269|NCT02226003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20003270|NCT02226003|Protease Inhibitors|protease inhibitors|mesh-ancestor
20003271|NCT02226003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003272|NCT02226003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003273|NCT02226003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20003274|NCT02226003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20003275|NCT02226003|Immunologic Factors|immunologic factors|mesh-ancestor
20003276|NCT02226003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20003277|NCT02226120|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
20003278|NCT02226120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20003279|NCT02226120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290025|NCT04377932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20290026|NCT04377932|Alkylating Agents|alkylating agents|mesh-ancestor
20290027|NCT04377932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290028|NCT04377932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290029|NCT04377932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20290030|NCT04377932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20290031|NCT04377932|Antimetabolites|antimetabolites|mesh-ancestor
20290032|NCT04372706|Pembrolizumab|pembrolizumab|mesh-list
20290033|NCT04372706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20290034|NCT04372706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290035|NCT04371952|Doxycycline|doxycycline|mesh-list
20290036|NCT04371952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20290037|NCT04371952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20290038|NCT04371952|Antimalarials|antimalarials|mesh-ancestor
20290039|NCT04371952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20290040|NCT04371952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20290041|NCT04365257|Prazosin|prazosin|mesh-list
20290042|NCT04365257|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-list
20290043|NCT04365257|Adrenergic Antagonists|adrenergic antagonists|mesh-list
20003280|NCT02226159|Dexamethasone|dexamethasone|mesh-list
20003281|NCT02226159|Dexamethasone acetate|dexamethasone acetate|mesh-list
20003282|NCT02226159|Lidocaine|lidocaine|mesh-list
20003283|NCT02226159|BB 1101|bb 1101|mesh-list
20003284|NCT02226159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20003285|NCT02226159|Antiemetics|antiemetics|mesh-ancestor
20003286|NCT02226159|Autonomic Agents|autonomic agents|mesh-ancestor
20003287|NCT02226159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003288|NCT02226159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003289|NCT02226159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20003290|NCT02226159|Glucocorticoids|glucocorticoids|mesh-ancestor
20003291|NCT02226159|Hormones|hormones|mesh-ancestor
20003292|NCT02226159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20003293|NCT02226159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20003294|NCT02226159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20003295|NCT02226159|Protease Inhibitors|protease inhibitors|mesh-ancestor
20003296|NCT02226159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003297|NCT02226159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003298|NCT02226159|Anesthetics, Local|anesthetics, local|mesh-ancestor
20003299|NCT02226159|Anesthetics|anesthetics|mesh-ancestor
20003300|NCT02226159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20003301|NCT02226159|Sensory System Agents|sensory system agents|mesh-ancestor
20003302|NCT02226159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20003303|NCT02226159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20003304|NCT02226159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20003305|NCT02226159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20003306|NCT02226198|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20003307|NCT02226198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20003308|NCT02226198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20003309|NCT02226198|Antimetabolites|antimetabolites|mesh-ancestor
20003310|NCT02226198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003311|NCT02226198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20003312|NCT02226198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20003313|NCT02226198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003314|NCT02226549|Sofosbuvir|sofosbuvir|mesh-list
20003315|NCT02226549|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
20003316|NCT02226549|Ledipasvir|ledipasvir|mesh-list
20003317|NCT02226549|Antiviral Agents|antiviral agents|mesh-ancestor
20003318|NCT02226549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20003319|NCT02226562|Listerine|listerine|mesh-list
20003320|NCT02226562|Fluorides|fluorides|mesh-list
20003321|NCT02226562|Sodium Fluoride|sodium fluoride|mesh-list
20003322|NCT02226562|Cariostatic Agents|cariostatic agents|mesh-ancestor
20003323|NCT02226562|Protective Agents|protective agents|mesh-ancestor
20003324|NCT02226562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003325|NCT02226562|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20003326|NCT02226562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20003327|NCT02226653|Evacetrapib|evacetrapib|mesh-list
20003328|NCT02226653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20003329|NCT02226653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20003330|NCT02226653|Antimetabolites|antimetabolites|mesh-ancestor
20003331|NCT02226653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003332|NCT02226653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20003333|NCT02227108|Immunotoxin HA22|immunotoxin ha22|mesh-list
20003334|NCT02227108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20003335|NCT02227316|Acetaminophen|acetaminophen|mesh-list
20003336|NCT02227316|Ibuprofen|ibuprofen|mesh-list
20003337|NCT02227316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20003338|NCT02227316|Analgesics|analgesics|mesh-ancestor
20003339|NCT02227316|Sensory System Agents|sensory system agents|mesh-ancestor
20003340|NCT02227316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003341|NCT02227316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003342|NCT02227316|Antipyretics|antipyretics|mesh-ancestor
20003343|NCT02227316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20003344|NCT02227316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20003345|NCT02227316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20003346|NCT02227316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20003347|NCT02227316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003348|NCT02227316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003349|NCT02227329|Ethanol|ethanol|mesh-list
20003350|NCT02227329|Heparin|heparin|mesh-list
20557508|NCT01953679|Ulipristal acetate|ulipristal acetate|mesh-list
20557509|NCT01953679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20003351|NCT02227329|Calcium heparin|calcium heparin|mesh-list
20003352|NCT02227329|Anticoagulants|anticoagulants|mesh-ancestor
20003353|NCT02227329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20557510|NCT01953679|Contraceptive Agents|contraceptive agents|mesh-ancestor
20003354|NCT02227329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20003355|NCT02227329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003356|NCT02227329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20003357|NCT02227329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20003358|NCT02227329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20003359|NCT02227329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003360|NCT02227368|Aspirin|aspirin|mesh-list
20003361|NCT02227368|Ticagrelor|ticagrelor|mesh-list
20003362|NCT02227368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20003363|NCT02227368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20003364|NCT02227368|Analgesics|analgesics|mesh-ancestor
20003365|NCT02227368|Sensory System Agents|sensory system agents|mesh-ancestor
20003366|NCT02227368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003367|NCT02227368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003368|NCT02227368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20003369|NCT02227368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20003370|NCT02227368|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20003371|NCT02227368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20003372|NCT02227368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003373|NCT02227368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20003374|NCT02227368|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20003375|NCT02227368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003376|NCT02227368|Antipyretics|antipyretics|mesh-ancestor
20003377|NCT02227368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20003378|NCT02227368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20003379|NCT02227368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20003380|NCT02227368|Purinergic Agents|purinergic agents|mesh-ancestor
20003381|NCT02227368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003382|NCT02227446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20003383|NCT02227446|Vancomycin|vancomycin|mesh-list
20003384|NCT02227446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20003385|NCT02227485|Chlorhexidine|chlorhexidine|mesh-list
20003386|NCT02227485|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20003387|NCT02227485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20003388|NCT02227485|Disinfectants|disinfectants|mesh-ancestor
20003389|NCT02227667|Durvalumab|durvalumab|mesh-list
20003390|NCT02227667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20003391|NCT02227667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20003392|NCT02227706|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20003393|NCT02227706|Hemostatics|hemostatics|mesh-ancestor
20003394|NCT02227706|Coagulants|coagulants|mesh-ancestor
20003395|NCT02227784|Atorvastatin|atorvastatin|mesh-list
20003396|NCT02227784|Ezetimibe|ezetimibe|mesh-list
20003397|NCT02227784|Evacetrapib|evacetrapib|mesh-list
20003398|NCT02227784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20003399|NCT02227784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20003400|NCT02227784|Antimetabolites|antimetabolites|mesh-ancestor
20003401|NCT02227784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003402|NCT02227784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20003403|NCT02227784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20003404|NCT02227784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003405|NCT02227849|Canagliflozin|canagliflozin|mesh-list
20003406|NCT02227849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20003407|NCT02227849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003408|NCT02227849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20003409|NCT02227849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003410|NCT02228408|Hydralazine|hydralazine|mesh-list
20003411|NCT02228408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20003412|NCT02228408|Vasodilator Agents|vasodilator agents|mesh-ancestor
20003413|NCT02228590|Apomorphine|apomorphine|mesh-list
20003414|NCT02228590|Emetics|emetics|mesh-ancestor
20003415|NCT02228590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003416|NCT02228590|Autonomic Agents|autonomic agents|mesh-ancestor
20003417|NCT02228590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003418|NCT02228590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20003419|NCT02228590|Dopamine Agonists|dopamine agonists|mesh-ancestor
20003420|NCT02228590|Dopamine Agents|dopamine agents|mesh-ancestor
20003421|NCT02228590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003422|NCT02228590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459781|NCT03358719|Interferon Inducers|interferon inducers|mesh-ancestor
19459782|NCT03358719|Immunologic Factors|immunologic factors|mesh-ancestor
19459783|NCT03358719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459784|NCT03358719|Laxatives|laxatives|mesh-ancestor
19459785|NCT03358719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19459786|NCT03358719|Antiviral Agents|antiviral agents|mesh-ancestor
20003423|NCT02228681|Tamoxifen|tamoxifen|mesh-list
20003424|NCT02228681|Everolimus|everolimus|mesh-list
20003425|NCT02228681|Letrozole|letrozole|mesh-list
20003426|NCT02228681|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20003427|NCT02228681|Medroxyprogesterone|medroxyprogesterone|mesh-list
20003428|NCT02228681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20003429|NCT02228681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20003430|NCT02228681|Immunologic Factors|immunologic factors|mesh-ancestor
20003431|NCT02228681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003432|NCT02228681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20003433|NCT02228681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20003434|NCT02228681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003435|NCT02228681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003436|NCT02228681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20003437|NCT02228681|Hormone Antagonists|hormone antagonists|mesh-ancestor
20003438|NCT02228681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20003439|NCT02228681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20003440|NCT02228681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20003441|NCT02228681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20003442|NCT02228681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20003443|NCT02228681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20003444|NCT02228681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20003445|NCT02228681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20003446|NCT02228681|Contraceptive Agents|contraceptive agents|mesh-ancestor
20003447|NCT02228681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20003448|NCT02228681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20003449|NCT02228681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20003450|NCT02228681|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20003451|NCT02228720|Mometasone Furoate|mometasone furoate|mesh-list
20003452|NCT02228720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20003453|NCT02228720|Dermatologic Agents|dermatologic agents|mesh-ancestor
20003454|NCT02228720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20003455|NCT02228824|Nicotine|nicotine|mesh-list
20003456|NCT02228824|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20003457|NCT02228824|Autonomic Agents|autonomic agents|mesh-ancestor
20003458|NCT02228824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003459|NCT02228824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003460|NCT02228824|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20003461|NCT02228824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20003462|NCT02228824|Cholinergic Agents|cholinergic agents|mesh-ancestor
20003463|NCT02228824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003464|NCT02228824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003465|NCT02228980|Vaccines|vaccines|mesh-list
20003466|NCT02228980|Immunologic Factors|immunologic factors|mesh-ancestor
20003467|NCT02228980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003468|NCT02229214|Topiramate|topiramate|mesh-list
20003469|NCT02229214|Phentermine|phentermine|mesh-list
20003470|NCT02229214|Anticonvulsants|anticonvulsants|mesh-ancestor
20003471|NCT02229214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20003472|NCT02229214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003473|NCT02229214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20003474|NCT02229214|Appetite Depressants|appetite depressants|mesh-ancestor
20003475|NCT02229214|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20003476|NCT02229214|Sympathomimetics|sympathomimetics|mesh-ancestor
20003477|NCT02229214|Autonomic Agents|autonomic agents|mesh-ancestor
20003478|NCT02229214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003479|NCT02229214|Adrenergic Agents|adrenergic agents|mesh-ancestor
20003480|NCT02229214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003481|NCT02229214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003482|NCT02229227|Insulin|insulin|mesh-list
20003483|NCT02229227|Insulin Glargine|insulin glargine|mesh-list
20003484|NCT02229227|Insulin Lispro|insulin lispro|mesh-list
20003485|NCT02229227|rGLP-1 protein|rglp-1 protein|mesh-list
20003486|NCT02229227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20003487|NCT02229227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003488|NCT02229227|Incretins|incretins|mesh-ancestor
20003489|NCT02229227|Hormones|hormones|mesh-ancestor
20003490|NCT02229227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20003491|NCT02229383|Exenatide|exenatide|mesh-list
20003492|NCT02229383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20003493|NCT02229383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003494|NCT02229383|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20003495|NCT02229383|Incretins|incretins|mesh-ancestor
20003496|NCT02229383|Hormones|hormones|mesh-ancestor
20003497|NCT02229383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20003498|NCT02229396|Dapagliflozin|dapagliflozin|mesh-list
20003499|NCT02229396|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20003500|NCT02229396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003501|NCT02229396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20557511|NCT01953679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20557512|NCT01953679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557513|NCT01953679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20557514|NCT01953731|Rifampin|rifampin|mesh-list
20557515|NCT01953731|Palbociclib|palbociclib|mesh-list
20557516|NCT01953731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557517|NCT01953731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20557518|NCT01953731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557519|NCT01953731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557520|NCT01953731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20557521|NCT01953731|Antitubercular Agents|antitubercular agents|mesh-ancestor
20557522|NCT01953731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20557523|NCT01953731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20557524|NCT01953731|Leprostatic Agents|leprostatic agents|mesh-ancestor
20557525|NCT01953731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20557526|NCT01953731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20557527|NCT01953731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20557528|NCT01953731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20557529|NCT01953731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20557530|NCT01953731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20557531|NCT01953731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20557532|NCT01953744|Fluconazole|fluconazole|mesh-list
20557533|NCT01953744|Meglumine Antimoniate|meglumine antimoniate|mesh-list
20557534|NCT01953744|Antifungal Agents|antifungal agents|mesh-ancestor
20557535|NCT01953744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20557536|NCT01953744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20557537|NCT01953744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20557538|NCT01953744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557539|NCT01953744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557540|NCT01953744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20557541|NCT01953744|Hormone Antagonists|hormone antagonists|mesh-ancestor
20557542|NCT01953744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20557543|NCT01953744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557544|NCT01953744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20557545|NCT01953744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20557546|NCT01953744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20557547|NCT01953744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20557548|NCT01953757|Vitamins|vitamins|mesh-list
20557549|NCT01953757|Hydroxocobalamin|hydroxocobalamin|mesh-list
20557550|NCT01953757|Vitamin B 12|vitamin b 12|mesh-list
20557551|NCT01953757|Vitamin B Complex|vitamin b complex|mesh-list
20557552|NCT01953757|Micronutrients|micronutrients|mesh-ancestor
20557553|NCT01953757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557554|NCT01953757|Hematinics|hematinics|mesh-ancestor
20557555|NCT01953770|Cytarabine|cytarabine|mesh-list
20557556|NCT01953770|Prednisone|prednisone|mesh-list
20557557|NCT01953770|Methotrexate|methotrexate|mesh-list
20557558|NCT01953770|Daunorubicin|daunorubicin|mesh-list
20557559|NCT01953770|Asparaginase|asparaginase|mesh-list
20557560|NCT01953770|Pegaspargase|pegaspargase|mesh-list
20557561|NCT01953770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20557562|NCT01953770|Glucocorticoids|glucocorticoids|mesh-ancestor
20557563|NCT01953770|Hormones|hormones|mesh-ancestor
20557564|NCT01953770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20003502|NCT02229396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003503|NCT02229461|Aspirin|aspirin|mesh-list
20003504|NCT02229461|Naproxen|naproxen|mesh-list
20003505|NCT02229461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20003506|NCT02229461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20003507|NCT02229461|Analgesics|analgesics|mesh-ancestor
20003508|NCT02229461|Sensory System Agents|sensory system agents|mesh-ancestor
20003509|NCT02229461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003510|NCT02229461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003511|NCT02229461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20003512|NCT02229461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20003513|NCT02229461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20003514|NCT02229461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20003515|NCT02229461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003516|NCT02229461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20003517|NCT02229461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20003518|NCT02229461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003519|NCT02229461|Antipyretics|antipyretics|mesh-ancestor
20003520|NCT02229461|Gout Suppressants|gout suppressants|mesh-ancestor
20003521|NCT02229539|Diphenhydramine|diphenhydramine|mesh-list
20003522|NCT02229539|Promethazine|promethazine|mesh-list
20003523|NCT02229539|Lidocaine|lidocaine|mesh-list
20003524|NCT02229539|Doxepin|doxepin|mesh-list
20003525|NCT02229539|Antacids|antacids|mesh-list
20003526|NCT02229539|Anesthetics, Local|anesthetics, local|mesh-ancestor
20003527|NCT02229539|Anesthetics|anesthetics|mesh-ancestor
20003528|NCT02229539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20003529|NCT02229539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003530|NCT02229539|Sensory System Agents|sensory system agents|mesh-ancestor
20003531|NCT02229539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003532|NCT02229539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20003533|NCT02229539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20003534|NCT02229539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20003535|NCT02229539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20003536|NCT02229539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003537|NCT02229539|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20003538|NCT02229539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20003539|NCT02229539|Antiemetics|antiemetics|mesh-ancestor
20003540|NCT02229539|Autonomic Agents|autonomic agents|mesh-ancestor
20003541|NCT02229539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20003542|NCT02229539|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20003543|NCT02229539|Histamine Antagonists|histamine antagonists|mesh-ancestor
20003544|NCT02229539|Histamine Agents|histamine agents|mesh-ancestor
20003545|NCT02229539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003546|NCT02229539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20003547|NCT02229539|Antipruritics|antipruritics|mesh-ancestor
20003548|NCT02229539|Dermatologic Agents|dermatologic agents|mesh-ancestor
20003549|NCT02229539|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20003550|NCT02229539|Antidepressive Agents|antidepressive agents|mesh-ancestor
20003551|NCT02229539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20003552|NCT02230306|Vemurafenib|vemurafenib|mesh-list
20003553|NCT02230306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20003554|NCT02230306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20003555|NCT02230306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003556|NCT02230306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003557|NCT02230332|Alendronate|alendronate|mesh-list
20003558|NCT02230332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20003559|NCT02230332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003560|NCT02230527|Clopidogrel|clopidogrel|mesh-list
20003561|NCT02230527|Ticagrelor|ticagrelor|mesh-list
20003562|NCT02230527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20003563|NCT02230527|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20003564|NCT02230527|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20003565|NCT02230527|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20003566|NCT02230527|Purinergic Agents|purinergic agents|mesh-ancestor
20003567|NCT02230527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003568|NCT02230527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003569|NCT02230527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003570|NCT02230696|Fluticasone|fluticasone|mesh-list
20003571|NCT02230696|Xhance|xhance|mesh-list
20003572|NCT02230696|Azelastine|azelastine|mesh-list
20003573|NCT02230696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20003574|NCT02230696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20003575|NCT02230696|Autonomic Agents|autonomic agents|mesh-ancestor
20003576|NCT02230696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003577|NCT02230696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003578|NCT02230696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20003579|NCT02230696|Respiratory System Agents|respiratory system agents|mesh-ancestor
20003580|NCT02230696|Dermatologic Agents|dermatologic agents|mesh-ancestor
20003581|NCT02230696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20003582|NCT02230696|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20003583|NCT02230696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003584|NCT02230696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003585|NCT02230696|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20003586|NCT02230696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20003587|NCT02230696|Histamine Antagonists|histamine antagonists|mesh-ancestor
20003588|NCT02230696|Histamine Agents|histamine agents|mesh-ancestor
20003589|NCT02230696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003590|NCT02230904|Rotigotine|rotigotine|mesh-list
20003591|NCT02230904|Dopamine Agonists|dopamine agonists|mesh-ancestor
20003592|NCT02230904|Dopamine Agents|dopamine agents|mesh-ancestor
20003593|NCT02230904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003594|NCT02230904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003595|NCT02230904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003596|NCT02230956|Botulinum Toxins|botulinum toxins|mesh-list
20003597|NCT02230956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20003598|NCT02230956|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20003599|NCT02230956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20003600|NCT02230956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20003601|NCT02230956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003602|NCT02230956|Cholinergic Agents|cholinergic agents|mesh-ancestor
20003603|NCT02230956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003604|NCT02230956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003605|NCT02230956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20003606|NCT02230956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003607|NCT02230995|Metformin|metformin|mesh-list
20003608|NCT02230995|Empagliflozin|empagliflozin|mesh-list
20003609|NCT02230995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20003610|NCT02230995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003611|NCT02230995|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20003612|NCT02230995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003613|NCT02231086|Leucovorin|leucovorin|mesh-list
20003614|NCT02231086|Fluorouracil|fluorouracil|mesh-list
20003615|NCT02231086|Capecitabine|capecitabine|mesh-list
20003616|NCT02231086|Oxaliplatin|oxaliplatin|mesh-list
20003617|NCT02231086|Antimetabolites|antimetabolites|mesh-ancestor
20003618|NCT02231086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003619|NCT02231086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20003620|NCT02231086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20003621|NCT02231086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20003622|NCT02231086|Immunologic Factors|immunologic factors|mesh-ancestor
20003623|NCT02231086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003624|NCT02231086|Antidotes|antidotes|mesh-ancestor
20003625|NCT02231086|Protective Agents|protective agents|mesh-ancestor
20003626|NCT02231086|Vitamin B Complex|vitamin b complex|mesh-ancestor
20003627|NCT02231086|Vitamins|vitamins|mesh-ancestor
20003628|NCT02231086|Micronutrients|micronutrients|mesh-ancestor
20003629|NCT02231164|Docetaxel|docetaxel|mesh-list
20003630|NCT02231164|Nintedanib|nintedanib|mesh-list
20003631|NCT02231164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20003632|NCT02231164|Tubulin Modulators|tubulin modulators|mesh-ancestor
20003633|NCT02231164|Antimitotic Agents|antimitotic agents|mesh-ancestor
20003634|NCT02231164|Mitosis Modulators|mitosis modulators|mesh-ancestor
20003635|NCT02231164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003636|NCT02231164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20003637|NCT02231164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003638|NCT02231177|Tiotropium Bromide|tiotropium bromide|mesh-list
20003639|NCT02231177|Olodaterol|olodaterol|mesh-list
20003640|NCT02231177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20003641|NCT02231177|Autonomic Agents|autonomic agents|mesh-ancestor
20003642|NCT02231177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003643|NCT02231177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003644|NCT02231177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20003645|NCT02231177|Respiratory System Agents|respiratory system agents|mesh-ancestor
20003646|NCT02231177|Parasympatholytics|parasympatholytics|mesh-ancestor
20003647|NCT02231177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20003648|NCT02231177|Cholinergic Agents|cholinergic agents|mesh-ancestor
20003649|NCT02231177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003650|NCT02231177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003651|NCT02231918|Pramipexole|pramipexole|mesh-list
20003652|NCT02231918|Antioxidants|antioxidants|mesh-ancestor
20003653|NCT02231918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003654|NCT02231918|Protective Agents|protective agents|mesh-ancestor
20003655|NCT02231918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003656|NCT02231918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20003657|NCT02231918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20003658|NCT02231918|Dopamine Agonists|dopamine agonists|mesh-ancestor
20003659|NCT02231918|Dopamine Agents|dopamine agents|mesh-ancestor
20003660|NCT02231918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003661|NCT02232061|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20003662|NCT02232061|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20003663|NCT02232061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003664|NCT02232061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20003665|NCT02232061|Immunologic Factors|immunologic factors|mesh-ancestor
20003666|NCT02232061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003667|NCT02232087|Fluticasone|fluticasone|mesh-list
20003668|NCT02232087|Xhance|xhance|mesh-list
20003669|NCT02232087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20003670|NCT02232087|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20003671|NCT02232087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20003672|NCT02232087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20003673|NCT02232087|Autonomic Agents|autonomic agents|mesh-ancestor
20003674|NCT02232087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003675|NCT02232087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003676|NCT02232087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20003677|NCT02232087|Respiratory System Agents|respiratory system agents|mesh-ancestor
20003678|NCT02232087|Dermatologic Agents|dermatologic agents|mesh-ancestor
20003679|NCT02232087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20003680|NCT02232087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20003681|NCT02232087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20003682|NCT02232087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20003683|NCT02232087|Adrenergic Agents|adrenergic agents|mesh-ancestor
20003684|NCT02232087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003685|NCT02232087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003686|NCT02232087|Glucocorticoids|glucocorticoids|mesh-ancestor
20003687|NCT02232087|Hormones|hormones|mesh-ancestor
20003688|NCT02232087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20003689|NCT02232087|Sympathomimetics|sympathomimetics|mesh-ancestor
20003690|NCT02232178|Bupivacaine|bupivacaine|mesh-list
20003691|NCT02232178|Anesthetics, Local|anesthetics, local|mesh-ancestor
20003692|NCT02232178|Anesthetics|anesthetics|mesh-ancestor
20003693|NCT02232178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20003694|NCT02232178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003695|NCT02232178|Sensory System Agents|sensory system agents|mesh-ancestor
20003696|NCT02232178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003697|NCT02232243|Hydroxychloroquine|hydroxychloroquine|mesh-list
20003698|NCT02232243|Antimalarials|antimalarials|mesh-ancestor
20003699|NCT02232243|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20003700|NCT02232243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20003701|NCT02232243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20003702|NCT02232243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003703|NCT02232243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003704|NCT02232243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20003705|NCT02232802|Enoxaparin|enoxaparin|mesh-list
20003706|NCT02232802|Enoxaparin sodium|enoxaparin sodium|mesh-list
20003707|NCT02232802|Anticoagulants|anticoagulants|mesh-ancestor
20003708|NCT02232802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20003709|NCT02232802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20003710|NCT02232802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003711|NCT02233101|Tranexamic Acid|tranexamic acid|mesh-list
20003712|NCT02233101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20557565|NCT01953770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557566|NCT01953770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20557567|NCT01953770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557568|NCT01953770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20557569|NCT01953770|Abortifacient Agents|abortifacient agents|mesh-ancestor
20557570|NCT01953770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20557571|NCT01953770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20557572|NCT01953770|Antimetabolites|antimetabolites|mesh-ancestor
20557573|NCT01953770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557574|NCT01953770|Dermatologic Agents|dermatologic agents|mesh-ancestor
20557575|NCT01953770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557576|NCT01953770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20003713|NCT02233101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20003714|NCT02233101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003715|NCT02233101|Hemostatics|hemostatics|mesh-ancestor
20003716|NCT02233101|Coagulants|coagulants|mesh-ancestor
20003717|NCT02233296|Lasmiditan|lasmiditan|mesh-list
20003718|NCT02233296|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20003719|NCT02233296|Serotonin Agents|serotonin agents|mesh-ancestor
20003720|NCT02233296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003721|NCT02233296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003722|NCT02233296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003723|NCT02233309|Anesthetics|anesthetics|mesh-list
20003724|NCT02233309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20003725|NCT02233309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003726|NCT02233543|Glycopyrrolate|glycopyrrolate|mesh-list
20003727|NCT02233543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20003728|NCT02233543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20003729|NCT02233543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20003730|NCT02233543|Cholinergic Agents|cholinergic agents|mesh-ancestor
20003731|NCT02233543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003732|NCT02233543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003733|NCT02233543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003734|NCT02233647|Cocaine|cocaine|mesh-list
20003735|NCT02233647|Anesthetics, Local|anesthetics, local|mesh-ancestor
20003736|NCT02233647|Anesthetics|anesthetics|mesh-ancestor
20003737|NCT02233647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20003738|NCT02233647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003739|NCT02233647|Sensory System Agents|sensory system agents|mesh-ancestor
20003740|NCT02233647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003741|NCT02233647|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20003742|NCT02233647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20003743|NCT02233647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20003744|NCT02233647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20003745|NCT02233647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003746|NCT02233647|Dopamine Agents|dopamine agents|mesh-ancestor
20003747|NCT02233647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003748|NCT02233751|Methyltestosterone|methyltestosterone|mesh-list
20003749|NCT02233751|Testosterone|testosterone|mesh-list
20003750|NCT02233751|Testosterone undecanoate|testosterone undecanoate|mesh-list
20003751|NCT02233751|Testosterone enanthate|testosterone enanthate|mesh-list
20003752|NCT02233751|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20003753|NCT02233751|Androgens|androgens|mesh-ancestor
20003754|NCT02233751|Hormones|hormones|mesh-ancestor
20003755|NCT02233751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20003756|NCT02233751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003757|NCT02233751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20003758|NCT02233751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20003759|NCT02233751|Anabolic Agents|anabolic agents|mesh-ancestor
20003760|NCT02233803|Budesonide|budesonide|mesh-list
20003761|NCT02233803|Albuterol|albuterol|mesh-list
20003762|NCT02233803|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20003763|NCT02233803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20003764|NCT02233803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20003765|NCT02233803|Autonomic Agents|autonomic agents|mesh-ancestor
20003766|NCT02233803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003767|NCT02233803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003768|NCT02233803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20003769|NCT02233803|Respiratory System Agents|respiratory system agents|mesh-ancestor
20003770|NCT02233803|Glucocorticoids|glucocorticoids|mesh-ancestor
20003771|NCT02233803|Hormones|hormones|mesh-ancestor
20003772|NCT02233803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20003773|NCT02233803|Tocolytic Agents|tocolytic agents|mesh-ancestor
20003774|NCT02233803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20003775|NCT02233803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20003776|NCT02233803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20003777|NCT02233803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20003778|NCT02233803|Adrenergic Agents|adrenergic agents|mesh-ancestor
20003779|NCT02233803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003780|NCT02233803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003781|NCT02233998|Listerine|listerine|mesh-list
20003782|NCT02233998|Sodium Fluoride|sodium fluoride|mesh-list
20003783|NCT02233998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20003784|NCT02233998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20003785|NCT02233998|Cariostatic Agents|cariostatic agents|mesh-ancestor
20003786|NCT02233998|Protective Agents|protective agents|mesh-ancestor
20003787|NCT02233998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003788|NCT02234115|Leuprolide|leuprolide|mesh-list
20003789|NCT02234115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20003790|NCT02234115|Fertility Agents|fertility agents|mesh-ancestor
20003791|NCT02234115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20003792|NCT02234115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003793|NCT02234115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20003794|NCT02234115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290044|NCT04365257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20290045|NCT04365257|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20290046|NCT04365257|Adrenergic Agents|adrenergic agents|mesh-ancestor
20290047|NCT04365257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20290048|NCT04365257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290049|NCT04365257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290050|NCT04350593|Dapagliflozin|dapagliflozin|mesh-list
20290051|NCT04350593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20290052|NCT04350593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290053|NCT04350593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20290054|NCT04350593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557577|NCT01953770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20557578|NCT01953770|Immunologic Factors|immunologic factors|mesh-ancestor
20557579|NCT01953770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20557580|NCT01953770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20557581|NCT01953770|Antiviral Agents|antiviral agents|mesh-ancestor
20557582|NCT01953770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20557583|NCT01953770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20557584|NCT01953770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20557585|NCT01953770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20557586|NCT01953796|Clomiphene|clomiphene|mesh-list
20557587|NCT01953796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20557588|NCT01953796|Hormone Antagonists|hormone antagonists|mesh-ancestor
20557589|NCT01953796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20557590|NCT01953796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557591|NCT01953796|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20557592|NCT01953796|Fertility Agents|fertility agents|mesh-ancestor
20003795|NCT02234141|Selonsertib|selonsertib|mesh-list
20003796|NCT02234141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20003797|NCT02234141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003798|NCT02234141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003799|NCT02234362|Vortioxetine|vortioxetine|mesh-list
20003800|NCT02234362|Antidepressive Agents|antidepressive agents|mesh-ancestor
20003801|NCT02234362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20003802|NCT02234362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20003803|NCT02234362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20003804|NCT02234362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20003805|NCT02234362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003806|NCT02234362|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20003807|NCT02234362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20003808|NCT02234362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20003809|NCT02234362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003810|NCT02234362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003811|NCT02234362|Serotonin Agents|serotonin agents|mesh-ancestor
20003812|NCT02234362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20003813|NCT02234362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20003814|NCT02234362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20003815|NCT02234362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20003816|NCT02234427|Aspirin|aspirin|mesh-list
20003817|NCT02234427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20003818|NCT02234427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20003819|NCT02234427|Analgesics|analgesics|mesh-ancestor
20003820|NCT02234427|Sensory System Agents|sensory system agents|mesh-ancestor
20003821|NCT02234427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003822|NCT02234427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003823|NCT02234427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20003824|NCT02234427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20003825|NCT02234427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20003826|NCT02234427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20003827|NCT02234427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003828|NCT02234427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20003829|NCT02234427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20003830|NCT02234427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003831|NCT02234427|Antipyretics|antipyretics|mesh-ancestor
20003832|NCT02234570|Oxfendazole|oxfendazole|mesh-list
20003833|NCT02234570|Anthelmintics|anthelmintics|mesh-ancestor
20003834|NCT02234570|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20003835|NCT02234570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20003836|NCT02234570|Antinematodal Agents|antinematodal agents|mesh-ancestor
20003837|NCT02234596|Nintedanib|nintedanib|mesh-list
20003838|NCT02234596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20003839|NCT02234596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20003840|NCT02234596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003841|NCT02234596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003842|NCT02234752|Memantine|memantine|mesh-list
20003843|NCT02234752|Galantamine|galantamine|mesh-list
20003844|NCT02234752|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20003845|NCT02234752|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20003846|NCT02234752|Dopamine Agents|dopamine agents|mesh-ancestor
20003847|NCT02234752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003848|NCT02234752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003849|NCT02234752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003850|NCT02234752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20003851|NCT02234752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20003852|NCT02234752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20003853|NCT02234752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003854|NCT02234752|Cholinergic Agents|cholinergic agents|mesh-ancestor
20003855|NCT02234752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20003856|NCT02234752|Autonomic Agents|autonomic agents|mesh-ancestor
20003857|NCT02234752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003858|NCT02234752|Nootropic Agents|nootropic agents|mesh-ancestor
20003859|NCT02235064|Sertraline|sertraline|mesh-list
20003860|NCT02235064|Antidepressive Agents|antidepressive agents|mesh-ancestor
20003861|NCT02235064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20003862|NCT02235064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20003863|NCT02235064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20003864|NCT02235064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20003865|NCT02235064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003866|NCT02235064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003867|NCT02235064|Serotonin Agents|serotonin agents|mesh-ancestor
20003868|NCT02235064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003869|NCT02235077|Spironolactone|spironolactone|mesh-list
20003870|NCT02235077|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20003871|NCT02235077|Hormone Antagonists|hormone antagonists|mesh-ancestor
20003872|NCT02235077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20003873|NCT02235077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003874|NCT02235077|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20003875|NCT02235077|Diuretics|diuretics|mesh-ancestor
20003876|NCT02235077|Natriuretic Agents|natriuretic agents|mesh-ancestor
20003877|NCT02235298|Metformin|metformin|mesh-list
20003878|NCT02235298|Dapagliflozin|dapagliflozin|mesh-list
20003879|NCT02235298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20003880|NCT02235298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003881|NCT02235298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20003882|NCT02235298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003883|NCT02235311|Pantoprazole|pantoprazole|mesh-list
20003884|NCT02235311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20003885|NCT02235311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20003886|NCT02235311|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20003887|NCT02235311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003888|NCT02235311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003889|NCT02235987|Octreotide|octreotide|mesh-list
20003890|NCT02235987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20003891|NCT02235987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20003892|NCT02235987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20003893|NCT02236130|Acetaminophen|acetaminophen|mesh-list
20003894|NCT02236130|Morphine|morphine|mesh-list
20003895|NCT02236130|Hydrocodone|hydrocodone|mesh-list
20003896|NCT02236130|Analgesics|analgesics|mesh-list
20003897|NCT02236130|Anesthetics|anesthetics|mesh-list
20003898|NCT02236130|Ropivacaine|ropivacaine|mesh-list
20003899|NCT02236130|Anesthetics, Local|anesthetics, local|mesh-list
20003900|NCT02236130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20003901|NCT02236130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003902|NCT02236130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20003903|NCT02236130|Narcotics|narcotics|mesh-ancestor
20003904|NCT02236130|Sensory System Agents|sensory system agents|mesh-ancestor
20003905|NCT02236130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003906|NCT02236130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20003907|NCT02236130|Antipyretics|antipyretics|mesh-ancestor
20003908|NCT02236130|Antitussive Agents|antitussive agents|mesh-ancestor
20003909|NCT02236130|Respiratory System Agents|respiratory system agents|mesh-ancestor
20003910|NCT02236520|Chlorthalidone|chlorthalidone|mesh-list
20003911|NCT02236520|Spironolactone|spironolactone|mesh-list
20003912|NCT02236520|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20003913|NCT02236520|Hormone Antagonists|hormone antagonists|mesh-ancestor
20003914|NCT02236520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20003915|NCT02236520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003916|NCT02236520|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20003917|NCT02236520|Diuretics|diuretics|mesh-ancestor
20003918|NCT02236520|Natriuretic Agents|natriuretic agents|mesh-ancestor
20003919|NCT02236520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20003920|NCT02236520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20003921|NCT02236520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20003922|NCT02236520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003923|NCT02236611|Glycopyrrolate|glycopyrrolate|mesh-list
20003924|NCT02236611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20003925|NCT02236611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20003926|NCT02236611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20003927|NCT02236611|Cholinergic Agents|cholinergic agents|mesh-ancestor
20003928|NCT02236611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003929|NCT02236611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557593|NCT01953796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20557594|NCT01953796|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20557595|NCT01953796|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20557596|NCT01953835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20557597|NCT01953835|Simvastatin|simvastatin|mesh-list
20557598|NCT01953835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20557599|NCT01953835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20557600|NCT01953835|Antimetabolites|antimetabolites|mesh-ancestor
20557601|NCT01953835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557602|NCT01953835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20557603|NCT01953835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20557604|NCT01953835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557605|NCT01953848|Tamsulosin|tamsulosin|mesh-list
20557606|NCT01953848|Solifenacin Succinate|solifenacin succinate|mesh-list
20557607|NCT01953848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20557608|NCT01953848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20557609|NCT01953848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20557610|NCT01953848|Adrenergic Agents|adrenergic agents|mesh-ancestor
20557611|NCT01953848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20557612|NCT01953848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557613|NCT01953848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557614|NCT01953848|Urological Agents|urological agents|mesh-ancestor
20557615|NCT01953848|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20557616|NCT01953848|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20557617|NCT01953848|Cholinergic Agents|cholinergic agents|mesh-ancestor
20557618|NCT01953887|Tamsulosin|tamsulosin|mesh-list
20557619|NCT01953887|Solifenacin Succinate|solifenacin succinate|mesh-list
20557620|NCT01953887|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20557621|NCT01953887|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20557622|NCT01953887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20557623|NCT01953887|Adrenergic Agents|adrenergic agents|mesh-ancestor
20557624|NCT01953887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20557625|NCT01953887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557626|NCT01953887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557627|NCT01953887|Urological Agents|urological agents|mesh-ancestor
20557628|NCT01953887|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20557629|NCT01953887|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20557630|NCT01953887|Cholinergic Agents|cholinergic agents|mesh-ancestor
20557631|NCT01953952|Cisplatin|cisplatin|mesh-list
20557632|NCT01953952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557633|NCT01953978|Acetaminophen|acetaminophen|mesh-list
20557634|NCT01953978|Dexamethasone|dexamethasone|mesh-list
20557635|NCT01953978|Ibuprofen|ibuprofen|mesh-list
20557636|NCT01953978|Morphine|morphine|mesh-list
20557637|NCT01953978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20557638|NCT01953978|Antiemetics|antiemetics|mesh-ancestor
20557639|NCT01953978|Autonomic Agents|autonomic agents|mesh-ancestor
20557640|NCT01953978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20557641|NCT01953978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557642|NCT01953978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20557643|NCT01953978|Glucocorticoids|glucocorticoids|mesh-ancestor
20557644|NCT01953978|Hormones|hormones|mesh-ancestor
20557645|NCT01953978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20557646|NCT01953978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20557647|NCT01953978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557648|NCT01953978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20557649|NCT01953978|Narcotics|narcotics|mesh-ancestor
20557650|NCT01953978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20557651|NCT01953978|Analgesics|analgesics|mesh-ancestor
20557652|NCT01953978|Sensory System Agents|sensory system agents|mesh-ancestor
20557653|NCT01953978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20557654|NCT01953978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20557655|NCT01953978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20557656|NCT01953978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20557657|NCT01953978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557658|NCT01953978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557659|NCT01953978|Antipyretics|antipyretics|mesh-ancestor
20557660|NCT01954030|Bevacizumab|bevacizumab|mesh-list
20557661|NCT01954030|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
20557662|NCT01954030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20557663|NCT01954030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557664|NCT01954030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20557665|NCT01954030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20003930|NCT02236611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003931|NCT02236988|Thalidomide|thalidomide|mesh-list
20003932|NCT02236988|Apremilast|apremilast|mesh-list
20003933|NCT02236988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20003934|NCT02236988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20003935|NCT02236988|Analgesics|analgesics|mesh-ancestor
20003936|NCT02236988|Sensory System Agents|sensory system agents|mesh-ancestor
20003937|NCT02236988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20003938|NCT02236988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003939|NCT02236988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20003940|NCT02236988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20003941|NCT02236988|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20003942|NCT02236988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20003943|NCT02236988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003944|NCT02236988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003945|NCT02236988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20003946|NCT02236988|Immunologic Factors|immunologic factors|mesh-ancestor
20003947|NCT02236988|Leprostatic Agents|leprostatic agents|mesh-ancestor
20003948|NCT02236988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20003949|NCT02236988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20003950|NCT02236988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20003951|NCT02236988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20003952|NCT02236988|Growth Substances|growth substances|mesh-ancestor
20003953|NCT02236988|Growth Inhibitors|growth inhibitors|mesh-ancestor
20003954|NCT02236988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20003955|NCT02237157|Gemcitabine|gemcitabine|mesh-list
20003956|NCT02237157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20003957|NCT02237157|Antimetabolites|antimetabolites|mesh-ancestor
20003958|NCT02237157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003959|NCT02237157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20003960|NCT02237157|Antiviral Agents|antiviral agents|mesh-ancestor
20003961|NCT02237157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20003962|NCT02237157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20003963|NCT02237157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20003964|NCT02237157|Immunologic Factors|immunologic factors|mesh-ancestor
20003965|NCT02237157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003966|NCT02237196|Immunologic Factors|immunologic factors|mesh-list
20003967|NCT02237196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003968|NCT02237417|Aripiprazole|aripiprazole|mesh-list
20003969|NCT02237417|Antipsychotic Agents|antipsychotic agents|mesh-list
20003970|NCT02237417|Antidepressive Agents|antidepressive agents|mesh-ancestor
20003971|NCT02237417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20003972|NCT02237417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20003973|NCT02237417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20003974|NCT02237417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003975|NCT02237417|Dopamine Agonists|dopamine agonists|mesh-ancestor
20003976|NCT02237417|Dopamine Agents|dopamine agents|mesh-ancestor
20003977|NCT02237417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003978|NCT02237417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003979|NCT02237417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20003980|NCT02237417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20003981|NCT02237417|Serotonin Agents|serotonin agents|mesh-ancestor
20003982|NCT02237417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20003983|NCT02237417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20003984|NCT02237417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20003985|NCT02237417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20003986|NCT02237898|Carbon Monoxide|carbon monoxide|mesh-list
20003987|NCT02237898|Antimetabolites|antimetabolites|mesh-ancestor
20003988|NCT02237898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20003989|NCT02237898|Gasotransmitters|gasotransmitters|mesh-ancestor
20003990|NCT02237898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20003991|NCT02237898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20003992|NCT02237950|Metronidazole|metronidazole|mesh-list
20003993|NCT02237950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20003994|NCT02237950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20003995|NCT02237950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20003996|NCT02237950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20003997|NCT02237989|Acetaminophen|acetaminophen|mesh-list
20003998|NCT02237989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20003999|NCT02237989|Analgesics|analgesics|mesh-ancestor
20004000|NCT02237989|Sensory System Agents|sensory system agents|mesh-ancestor
20004001|NCT02237989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004002|NCT02237989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004003|NCT02237989|Antipyretics|antipyretics|mesh-ancestor
20004004|NCT02238080|Epoetin Alfa|epoetin alfa|mesh-list
20004005|NCT02238080|Hematinics|hematinics|mesh-ancestor
20004006|NCT02238379|Oxytocin|oxytocin|mesh-list
20004007|NCT02238379|Oxytocics|oxytocics|mesh-ancestor
20004008|NCT02238379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20004009|NCT02238379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004010|NCT02238483|AZD7624|azd7624|mesh-list
20004011|NCT02238483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20004012|NCT02238483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004013|NCT02238483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004014|NCT02238626|Ibudilast|ibudilast|mesh-list
20004015|NCT02238626|Riluzole|riluzole|mesh-list
20004016|NCT02238626|Anticonvulsants|anticonvulsants|mesh-ancestor
20004017|NCT02238626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20004018|NCT02238626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20004019|NCT02238626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004020|NCT02238626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004021|NCT02238626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004022|NCT02238626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20004023|NCT02238626|Protective Agents|protective agents|mesh-ancestor
20004024|NCT02238626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20004025|NCT02238626|Autonomic Agents|autonomic agents|mesh-ancestor
20004026|NCT02238626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004027|NCT02238626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20004028|NCT02238626|Respiratory System Agents|respiratory system agents|mesh-ancestor
20004029|NCT02238626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20004030|NCT02238626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004031|NCT02238626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20004032|NCT02238626|Vasodilator Agents|vasodilator agents|mesh-ancestor
20004033|NCT02238977|Bupropion|bupropion|mesh-list
20004034|NCT02238977|Fluoxetine|fluoxetine|mesh-list
20004035|NCT02238977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20004036|NCT02238977|Antidepressive Agents|antidepressive agents|mesh-ancestor
20004037|NCT02238977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20004038|NCT02238977|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20004039|NCT02238977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20004040|NCT02238977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20004041|NCT02238977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004042|NCT02238977|Dopamine Agents|dopamine agents|mesh-ancestor
20004043|NCT02238977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004044|NCT02238977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004045|NCT02238977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20004046|NCT02238977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20004047|NCT02238977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004048|NCT02238977|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20004049|NCT02238977|Serotonin Agents|serotonin agents|mesh-ancestor
20004050|NCT02239094|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20004051|NCT02239094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20004052|NCT02239094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20004053|NCT02239094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20004054|NCT02239094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004055|NCT02239094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20290055|NCT04340882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20004056|NCT02239094|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20004057|NCT02239094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20004058|NCT02239094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20004059|NCT02239094|Adrenergic Agents|adrenergic agents|mesh-ancestor
20004060|NCT02239094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004061|NCT02239094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004062|NCT02239094|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20004063|NCT02239094|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20004064|NCT02239094|Serotonin Agents|serotonin agents|mesh-ancestor
20004065|NCT02239094|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20004066|NCT02239094|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20004067|NCT02239094|Dopamine Agents|dopamine agents|mesh-ancestor
20004068|NCT02239120|Dabigatran|dabigatran|mesh-list
20004069|NCT02239120|Antithrombins|antithrombins|mesh-ancestor
20004070|NCT02239120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20004071|NCT02239120|Protease Inhibitors|protease inhibitors|mesh-ancestor
20004072|NCT02239120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004073|NCT02239120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004074|NCT02239120|Anticoagulants|anticoagulants|mesh-ancestor
20004075|NCT02239380|Lorazepam|lorazepam|mesh-list
20004076|NCT02239380|Anticonvulsants|anticonvulsants|mesh-ancestor
20004077|NCT02239380|Antiemetics|antiemetics|mesh-ancestor
20004078|NCT02239380|Autonomic Agents|autonomic agents|mesh-ancestor
20004079|NCT02239380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004080|NCT02239380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004081|NCT02239380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20004082|NCT02239380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20004083|NCT02239380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20004084|NCT02239380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20004085|NCT02239380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20004086|NCT02239380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20004087|NCT02239380|GABA Modulators|gaba modulators|mesh-ancestor
20004088|NCT02239380|GABA Agents|gaba agents|mesh-ancestor
20004089|NCT02239380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004090|NCT02239380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004091|NCT02239510|Linaclotide|linaclotide|mesh-list
20004092|NCT02239510|Sennosides|sennosides|mesh-list
20004093|NCT02239510|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20004094|NCT02239510|Enzyme Activators|enzyme activators|mesh-ancestor
20004095|NCT02239510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004096|NCT02239510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20004097|NCT02239510|Laxatives|laxatives|mesh-ancestor
20004098|NCT02239679|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20004099|NCT02239679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20004100|NCT02239679|Dermatologic Agents|dermatologic agents|mesh-ancestor
20004101|NCT02239692|Picosulfate sodium|picosulfate sodium|mesh-list
20004102|NCT02239692|Cathartics|cathartics|mesh-ancestor
20004103|NCT02239692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20004104|NCT02239770|Nicotine|nicotine|mesh-list
20004105|NCT02239770|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20004106|NCT02239770|Autonomic Agents|autonomic agents|mesh-ancestor
20004107|NCT02239770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004108|NCT02239770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004109|NCT02239770|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20004110|NCT02239770|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20004111|NCT02239770|Cholinergic Agents|cholinergic agents|mesh-ancestor
20004112|NCT02239770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004113|NCT02239770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004114|NCT02240030|Levodopa|levodopa|mesh-list
20004115|NCT02240030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20004116|NCT02240030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20004117|NCT02240030|Dopamine Agents|dopamine agents|mesh-ancestor
20004118|NCT02240030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004119|NCT02240030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004120|NCT02240030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004121|NCT02240108|Rifaximin|rifaximin|mesh-list
20004122|NCT02240108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20004123|NCT02240108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20004124|NCT02240108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20557666|NCT01954030|Growth Substances|growth substances|mesh-ancestor
20557667|NCT01954030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557668|NCT01954030|Growth Inhibitors|growth inhibitors|mesh-ancestor
20557669|NCT01954030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20557670|NCT01954030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20557671|NCT01954030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004125|NCT02240121|Rifaximin|rifaximin|mesh-list
20004126|NCT02240121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20004127|NCT02240121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20004128|NCT02240121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20004129|NCT02240329|Capsaicin|capsaicin|mesh-list
20004130|NCT02240329|Antipruritics|antipruritics|mesh-ancestor
20004131|NCT02240329|Dermatologic Agents|dermatologic agents|mesh-ancestor
20004132|NCT02240329|Sensory System Agents|sensory system agents|mesh-ancestor
20004133|NCT02240329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004134|NCT02240329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004135|NCT02240589|Memantine|memantine|mesh-list
20004136|NCT02240589|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20004137|NCT02240589|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20004138|NCT02240589|Dopamine Agents|dopamine agents|mesh-ancestor
20004139|NCT02240589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004140|NCT02240589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459787|NCT03358719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19459788|NCT03358524|Vitamins|vitamins|mesh-list
19459789|NCT03358524|Vitamin E|vitamin e|mesh-list
19459790|NCT03358524|Tocopherols|tocopherols|mesh-list
19459791|NCT03358524|Tocotrienols|tocotrienols|mesh-list
19459792|NCT03358524|alpha-Tocopherol|alpha-tocopherol|mesh-list
19459793|NCT03358524|Micronutrients|micronutrients|mesh-ancestor
19459794|NCT03358524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459795|NCT03358524|Antioxidants|antioxidants|mesh-ancestor
19459796|NCT03358524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459797|NCT03358524|Protective Agents|protective agents|mesh-ancestor
19459798|NCT03358433|Antidepressive Agents|antidepressive agents|mesh-list
19459799|NCT03358433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20004141|NCT02240589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004142|NCT02240589|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19459800|NCT03358277|Methylphenidate|methylphenidate|mesh-list
20004143|NCT02240589|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20004144|NCT02240628|Lidocaine|lidocaine|mesh-list
20004145|NCT02240628|Tetracaine|tetracaine|mesh-list
20004146|NCT02240628|Anesthetics, Local|anesthetics, local|mesh-ancestor
20004147|NCT02240628|Anesthetics|anesthetics|mesh-ancestor
20004148|NCT02240628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20004149|NCT02240628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004150|NCT02240628|Sensory System Agents|sensory system agents|mesh-ancestor
20004151|NCT02240628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004152|NCT02240628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20004153|NCT02240628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20004154|NCT02240628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20004155|NCT02240628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20004156|NCT02240628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004157|NCT02240667|Vitamin K|vitamin k|mesh-list
20004158|NCT02240667|Dabigatran|dabigatran|mesh-list
20004159|NCT02240667|Phenprocoumon|phenprocoumon|mesh-list
20004160|NCT02240667|Vitamins|vitamins|mesh-ancestor
20004161|NCT02240667|Micronutrients|micronutrients|mesh-ancestor
20004162|NCT02240667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004163|NCT02240667|Antithrombins|antithrombins|mesh-ancestor
20004164|NCT02240667|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20004165|NCT02240667|Protease Inhibitors|protease inhibitors|mesh-ancestor
20004166|NCT02240667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004167|NCT02240667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004168|NCT02240667|Anticoagulants|anticoagulants|mesh-ancestor
20004169|NCT02240667|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20004170|NCT02240667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20004171|NCT02240667|Hemostatics|hemostatics|mesh-ancestor
20004172|NCT02240667|Coagulants|coagulants|mesh-ancestor
20004173|NCT02240680|Linagliptin|linagliptin|mesh-list
20004174|NCT02240680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20004175|NCT02240680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004176|NCT02240680|Incretins|incretins|mesh-ancestor
20004177|NCT02240680|Hormones|hormones|mesh-ancestor
20004178|NCT02240680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20004179|NCT02240680|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20004180|NCT02240680|Protease Inhibitors|protease inhibitors|mesh-ancestor
20004181|NCT02240680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004182|NCT02240680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004183|NCT02240693|BI 409306|bi 409306|mesh-list
20004184|NCT02240693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20004185|NCT02240693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004186|NCT02240693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004187|NCT02241486|Fentanyl|fentanyl|mesh-list
20004188|NCT02241486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20004189|NCT02241486|Narcotics|narcotics|mesh-ancestor
20004190|NCT02241486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20004191|NCT02241486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004192|NCT02241486|Analgesics|analgesics|mesh-ancestor
20004193|NCT02241486|Sensory System Agents|sensory system agents|mesh-ancestor
20004194|NCT02241486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004195|NCT02241486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20004196|NCT02241486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20004197|NCT02241486|Anesthetics, General|anesthetics, general|mesh-ancestor
20004198|NCT02241486|Anesthetics|anesthetics|mesh-ancestor
20004199|NCT02241512|Ibuprofen|ibuprofen|mesh-list
20004200|NCT02241512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20004201|NCT02241512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20004202|NCT02241512|Analgesics|analgesics|mesh-ancestor
20004203|NCT02241512|Sensory System Agents|sensory system agents|mesh-ancestor
20004204|NCT02241512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004205|NCT02241512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004206|NCT02241512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20004207|NCT02241512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20004208|NCT02241512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20004209|NCT02241512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004210|NCT02241512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004211|NCT02241655|Anesthetics|anesthetics|mesh-list
20004212|NCT02241655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20004213|NCT02241655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004214|NCT02241785|Natalizumab|natalizumab|mesh-list
20004215|NCT02241785|Immunologic Factors|immunologic factors|mesh-ancestor
20004216|NCT02241785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004217|NCT02241889|Pancrelipase|pancrelipase|mesh-list
20004218|NCT02241889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20004219|NCT02242045|Idelalisib|idelalisib|mesh-list
20004220|NCT02242045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20004221|NCT02242045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004222|NCT02242045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004223|NCT02242201|Ketorolac|ketorolac|mesh-list
20004224|NCT02242201|Epinephrine|epinephrine|mesh-list
20004225|NCT02242201|Bupivacaine|bupivacaine|mesh-list
20004226|NCT02242201|Ropivacaine|ropivacaine|mesh-list
20004227|NCT02242201|Anesthetics, Local|anesthetics, local|mesh-ancestor
20004228|NCT02242201|Anesthetics|anesthetics|mesh-ancestor
20004229|NCT02242201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20004230|NCT02242201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004231|NCT02242201|Sensory System Agents|sensory system agents|mesh-ancestor
20004232|NCT02242201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004233|NCT02242201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20004234|NCT02242201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20004235|NCT02242201|Adrenergic Agents|adrenergic agents|mesh-ancestor
20004236|NCT02242201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004237|NCT02242201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004238|NCT02242201|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20004239|NCT02242201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20004240|NCT02242201|Autonomic Agents|autonomic agents|mesh-ancestor
20004241|NCT02242201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20004242|NCT02242201|Respiratory System Agents|respiratory system agents|mesh-ancestor
20004243|NCT02242201|Mydriatics|mydriatics|mesh-ancestor
20004244|NCT02242201|Sympathomimetics|sympathomimetics|mesh-ancestor
20004245|NCT02242201|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20004246|NCT02242201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20004247|NCT02242201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20004248|NCT02242201|Analgesics|analgesics|mesh-ancestor
20004249|NCT02242201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20004250|NCT02242201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20004251|NCT02242201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20004252|NCT02242201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004253|NCT02242305|Scopolamine|scopolamine|mesh-list
20004254|NCT02242305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20004255|NCT02242305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20004256|NCT02242305|Antiemetics|antiemetics|mesh-ancestor
20004257|NCT02242305|Autonomic Agents|autonomic agents|mesh-ancestor
20004258|NCT02242305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004259|NCT02242305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004260|NCT02242305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20004261|NCT02242305|Mydriatics|mydriatics|mesh-ancestor
20004262|NCT02242305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20004263|NCT02242305|Cholinergic Agents|cholinergic agents|mesh-ancestor
20004264|NCT02242305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004265|NCT02242305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004266|NCT02242305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20004267|NCT02242305|Parasympatholytics|parasympatholytics|mesh-ancestor
20004268|NCT02242487|Levodopa|levodopa|mesh-list
20004269|NCT02242487|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20004270|NCT02242487|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20004271|NCT02242487|Dopamine Agents|dopamine agents|mesh-ancestor
20004272|NCT02242487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004273|NCT02242487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004274|NCT02242487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004275|NCT02242630|Methylprednisolone|methylprednisolone|mesh-list
20004276|NCT02242630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20004277|NCT02242630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20004278|NCT02242630|Prednisolone|prednisolone|mesh-list
20004279|NCT02242630|Prednisolone acetate|prednisolone acetate|mesh-list
20004280|NCT02242630|Triamcinolone|triamcinolone|mesh-list
20004281|NCT02242630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20004282|NCT02242630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20004283|NCT02242630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20004284|NCT02242630|Prednisolone phosphate|prednisolone phosphate|mesh-list
20004285|NCT02242630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20004286|NCT02242630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20004287|NCT02242630|Antiemetics|antiemetics|mesh-ancestor
20004288|NCT02242630|Autonomic Agents|autonomic agents|mesh-ancestor
20004289|NCT02242630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004290|NCT02242630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004291|NCT02242630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20004292|NCT02242630|Glucocorticoids|glucocorticoids|mesh-ancestor
20004293|NCT02242630|Hormones|hormones|mesh-ancestor
20004294|NCT02242630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20004295|NCT02242630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20004296|NCT02242630|Protective Agents|protective agents|mesh-ancestor
20004297|NCT02242630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20004298|NCT02242630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20004299|NCT02242630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20004300|NCT02242630|Immunologic Factors|immunologic factors|mesh-ancestor
20004301|NCT02242630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004302|NCT02242630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290056|NCT04340882|Pembrolizumab|pembrolizumab|mesh-list
20290057|NCT04340882|Docetaxel|docetaxel|mesh-list
20290058|NCT04340882|Ramucirumab|ramucirumab|mesh-list
20290059|NCT04340882|Antibodies|antibodies|mesh-list
20290060|NCT04340882|Immunoglobulins|immunoglobulins|mesh-list
20290061|NCT04340882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20290062|NCT04340882|Lexatumumab|lexatumumab|mesh-list
20290063|NCT04340882|Immunologic Factors|immunologic factors|mesh-ancestor
20290064|NCT04340882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290065|NCT04340882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290066|NCT04340882|Tubulin Modulators|tubulin modulators|mesh-ancestor
20290067|NCT04340882|Antimitotic Agents|antimitotic agents|mesh-ancestor
20290068|NCT04340882|Mitosis Modulators|mitosis modulators|mesh-ancestor
20290069|NCT04340882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290070|NCT04338984|Fentanyl|fentanyl|mesh-list
20290071|NCT04338984|Anesthetics|anesthetics|mesh-list
20290072|NCT04338984|Ropivacaine|ropivacaine|mesh-list
20290073|NCT04338984|Anesthetics, General|anesthetics, general|mesh-list
20290074|NCT04338984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20290075|NCT04338984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290076|NCT04338984|Anesthetics, Local|anesthetics, local|mesh-ancestor
20290077|NCT04338984|Sensory System Agents|sensory system agents|mesh-ancestor
20290078|NCT04338984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20290079|NCT04338984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20557672|NCT01954030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20557673|NCT01954043|Rifampin|rifampin|mesh-list
20557674|NCT01954043|Dabrafenib|dabrafenib|mesh-list
20557675|NCT01954043|Rabeprazole|rabeprazole|mesh-list
20557676|NCT01954043|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20557677|NCT01954043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20557678|NCT01954043|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20557679|NCT01954043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557680|NCT01954043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557681|NCT01954043|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20557682|NCT01954043|Antitubercular Agents|antitubercular agents|mesh-ancestor
20557683|NCT01954043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20557684|NCT01954043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20557685|NCT01954043|Leprostatic Agents|leprostatic agents|mesh-ancestor
20557686|NCT01954043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20557687|NCT01954043|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20557688|NCT01954043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20557689|NCT01954043|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20004303|NCT02243007|Gemcitabine|gemcitabine|mesh-list
20004304|NCT02243007|Paclitaxel|paclitaxel|mesh-list
20004305|NCT02243007|Capecitabine|capecitabine|mesh-list
20004306|NCT02243007|Folfirinox|folfirinox|mesh-list
20004307|NCT02243007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20004308|NCT02243007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20004309|NCT02243007|Tubulin Modulators|tubulin modulators|mesh-ancestor
20004310|NCT02243007|Antimitotic Agents|antimitotic agents|mesh-ancestor
20004311|NCT02243007|Mitosis Modulators|mitosis modulators|mesh-ancestor
20004312|NCT02243007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004313|NCT02243007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20004314|NCT02243007|Antimetabolites|antimetabolites|mesh-ancestor
20004315|NCT02243007|Antiviral Agents|antiviral agents|mesh-ancestor
20004316|NCT02243007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20004317|NCT02243007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004318|NCT02243007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20004319|NCT02243007|Immunologic Factors|immunologic factors|mesh-ancestor
20004320|NCT02243007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004321|NCT02243176|Saxagliptin|saxagliptin|mesh-list
20004322|NCT02243176|Acarbose|acarbose|mesh-list
20004323|NCT02243176|Incretins|incretins|mesh-ancestor
20004324|NCT02243176|Hormones|hormones|mesh-ancestor
20004325|NCT02243176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20004326|NCT02243176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004327|NCT02243176|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20004328|NCT02243176|Protease Inhibitors|protease inhibitors|mesh-ancestor
20004329|NCT02243176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004330|NCT02243176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004331|NCT02243176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20004332|NCT02243176|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20004333|NCT02243202|Canagliflozin|canagliflozin|mesh-list
20004334|NCT02243202|Phentermine|phentermine|mesh-list
20004335|NCT02243202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20004336|NCT02243202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004337|NCT02243202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20004338|NCT02243202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004339|NCT02243202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20004340|NCT02243202|Appetite Depressants|appetite depressants|mesh-ancestor
20004341|NCT02243202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20004342|NCT02243202|Sympathomimetics|sympathomimetics|mesh-ancestor
20004343|NCT02243202|Autonomic Agents|autonomic agents|mesh-ancestor
20004344|NCT02243202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004345|NCT02243202|Adrenergic Agents|adrenergic agents|mesh-ancestor
20004346|NCT02243202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004347|NCT02243293|Ribavirin|ribavirin|mesh-list
20004348|NCT02243293|Antimetabolites|antimetabolites|mesh-ancestor
20004349|NCT02243293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004350|NCT02243293|Antiviral Agents|antiviral agents|mesh-ancestor
20004351|NCT02243293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20004352|NCT02243371|Cyclophosphamide|cyclophosphamide|mesh-list
20004353|NCT02243371|Nivolumab|nivolumab|mesh-list
20004354|NCT02243371|Immunologic Factors|immunologic factors|mesh-ancestor
20004355|NCT02243371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004356|NCT02243371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20004357|NCT02243371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20004358|NCT02243371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20004359|NCT02243371|Alkylating Agents|alkylating agents|mesh-ancestor
20004360|NCT02243371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004361|NCT02243371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20004362|NCT02243371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20004363|NCT02243371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20004364|NCT02243371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20004365|NCT02243579|Pembrolizumab|pembrolizumab|mesh-list
20004366|NCT02243579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20004367|NCT02243579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20004368|NCT02243943|Neostigmine|neostigmine|mesh-list
20004369|NCT02243943|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20004370|NCT02243943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004371|NCT02243943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004372|NCT02243943|Cholinergic Agents|cholinergic agents|mesh-ancestor
20004373|NCT02243943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004374|NCT02243943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004375|NCT02243943|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20004376|NCT02243943|Autonomic Agents|autonomic agents|mesh-ancestor
20004377|NCT02243943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004378|NCT02244619|Acetaminophen|acetaminophen|mesh-list
20004379|NCT02244619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20004380|NCT02244619|Analgesics|analgesics|mesh-ancestor
20004381|NCT02244619|Sensory System Agents|sensory system agents|mesh-ancestor
20004382|NCT02244619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004383|NCT02244619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004384|NCT02244619|Antipyretics|antipyretics|mesh-ancestor
20004385|NCT02244918|Nicotine|nicotine|mesh-list
20004386|NCT02244918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20004387|NCT02244918|Autonomic Agents|autonomic agents|mesh-ancestor
20004388|NCT02244918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004389|NCT02244918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004390|NCT02244918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20004391|NCT02244918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20004392|NCT02244918|Cholinergic Agents|cholinergic agents|mesh-ancestor
20004393|NCT02244918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004394|NCT02244918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004395|NCT02245516|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20004396|NCT02245516|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20004397|NCT02246218|Glycerol|glycerol|mesh-list
20004398|NCT02246218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20004399|NCT02246218|Protective Agents|protective agents|mesh-ancestor
20004400|NCT02246218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004401|NCT02246582|Insulin|insulin|mesh-list
20004402|NCT02246582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20004403|NCT02246582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004404|NCT02246647|Mannitol|mannitol|mesh-list
20004405|NCT02246647|Lactulose|lactulose|mesh-list
20004406|NCT02246647|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20004407|NCT02246647|Diuretics|diuretics|mesh-ancestor
20004408|NCT02246647|Natriuretic Agents|natriuretic agents|mesh-ancestor
20004409|NCT02246647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004410|NCT02246647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20004411|NCT02246660|Resveratrol|resveratrol|mesh-list
20004412|NCT02246660|Antioxidants|antioxidants|mesh-ancestor
20004413|NCT02246660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004414|NCT02246660|Protective Agents|protective agents|mesh-ancestor
20004415|NCT02246660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004416|NCT02246660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004417|NCT02246660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20004418|NCT02246673|Febuxostat|febuxostat|mesh-list
20004419|NCT02246673|Verinurad|verinurad|mesh-list
20004420|NCT02246673|Gout Suppressants|gout suppressants|mesh-ancestor
20004421|NCT02246673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20004422|NCT02246764|Timolol|timolol|mesh-list
20004423|NCT02246764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20004424|NCT02246764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20004425|NCT02246764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20004426|NCT02246764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20004427|NCT02246764|Adrenergic Agents|adrenergic agents|mesh-ancestor
20004428|NCT02246764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004429|NCT02246764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004430|NCT02246764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004431|NCT02246764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20004432|NCT02246764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20004433|NCT02246998|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20004434|NCT02246998|Antiviral Agents|antiviral agents|mesh-ancestor
20004435|NCT02246998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20004436|NCT02246998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20004437|NCT02246998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20004438|NCT02247193|Botulinum Toxins|botulinum toxins|mesh-list
20004439|NCT02247193|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20004440|NCT02247193|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20004441|NCT02247193|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20004442|NCT02247193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20004443|NCT02247193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004444|NCT02247193|Cholinergic Agents|cholinergic agents|mesh-ancestor
20004445|NCT02247193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004446|NCT02247193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004447|NCT02247193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20004448|NCT02247193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004449|NCT02247440|Interferons|interferons|mesh-list
20004450|NCT02247440|Ribavirin|ribavirin|mesh-list
20004451|NCT02247440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20004452|NCT02247440|Antiviral Agents|antiviral agents|mesh-ancestor
20004453|NCT02247440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20004454|NCT02247440|Antimetabolites|antimetabolites|mesh-ancestor
20004455|NCT02247440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004456|NCT02247466|Rocuronium|rocuronium|mesh-list
20004457|NCT02247466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20004458|NCT02247466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20004459|NCT02247466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20004460|NCT02247466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004461|NCT02247466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004462|NCT02247739|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
20004463|NCT02247739|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20004464|NCT02247739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20004465|NCT02247739|Immunologic Factors|immunologic factors|mesh-ancestor
20004466|NCT02247739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004467|NCT02247804|Timolol|timolol|mesh-list
20004468|NCT02247804|Bimatoprost|bimatoprost|mesh-list
20004469|NCT02247804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20004470|NCT02247804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20004471|NCT02247804|Adrenergic Agents|adrenergic agents|mesh-ancestor
20004472|NCT02247804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004473|NCT02247804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004474|NCT02247804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004475|NCT02247804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20004476|NCT02247804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20004477|NCT02247960|Ciprofloxacin|ciprofloxacin|mesh-list
20004478|NCT02247960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20004479|NCT02247960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20004480|NCT02247960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20004481|NCT02247960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20004482|NCT02247960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004483|NCT02247960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004484|NCT02247960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20004485|NCT02247960|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20004486|NCT02247960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20004487|NCT02248480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20004488|NCT02248480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20004489|NCT02248480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20004490|NCT02248480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20004491|NCT02248480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004492|NCT02248480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004493|NCT02248480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004494|NCT02248480|Analgesics|analgesics|mesh-ancestor
20004495|NCT02248480|Sensory System Agents|sensory system agents|mesh-ancestor
20004496|NCT02248480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004497|NCT02248480|Antidepressive Agents|antidepressive agents|mesh-ancestor
20004498|NCT02248480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20004499|NCT02248480|Dopamine Agents|dopamine agents|mesh-ancestor
20004500|NCT02248636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
20004501|NCT02248636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004502|NCT02248636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004503|NCT02248636|Cholinergic Agents|cholinergic agents|mesh-ancestor
20004504|NCT02248636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004505|NCT02248636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004506|NCT02248961|Losartan|losartan|mesh-list
20004507|NCT02248961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20004508|NCT02248961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20004509|NCT02248961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20004510|NCT02248961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20004511|NCT02248961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004512|NCT02249065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20004513|NCT02249065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20004514|NCT02249065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20004515|NCT02249065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20004516|NCT02249065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20004517|NCT02249065|Adrenergic Agents|adrenergic agents|mesh-ancestor
20004518|NCT02249065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004519|NCT02249065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004520|NCT02249065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004521|NCT02249091|Cytarabine|cytarabine|mesh-list
20004522|NCT02249091|Idarubicin|idarubicin|mesh-list
20004523|NCT02249091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20004524|NCT02249091|Antimetabolites|antimetabolites|mesh-ancestor
20004525|NCT02249091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004526|NCT02249091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20004527|NCT02249091|Antiviral Agents|antiviral agents|mesh-ancestor
20004528|NCT02249091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20004529|NCT02249091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20004530|NCT02249091|Immunologic Factors|immunologic factors|mesh-ancestor
20004531|NCT02249091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004532|NCT02249091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20557690|NCT01954043|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20557691|NCT01954043|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20557692|NCT01954043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20557693|NCT01954043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557694|NCT01954043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20557695|NCT01954108|Hyaluronic Acid|hyaluronic acid|mesh-list
20557696|NCT01954108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20557697|NCT01954108|Immunologic Factors|immunologic factors|mesh-ancestor
20557698|NCT01954108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557699|NCT01954108|Viscosupplements|viscosupplements|mesh-ancestor
20557700|NCT01954108|Protective Agents|protective agents|mesh-ancestor
20557701|NCT01954186|Oxytocin|oxytocin|mesh-list
20557702|NCT01954186|Oxytocics|oxytocics|mesh-ancestor
20557703|NCT01954186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20557704|NCT01954186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557705|NCT01954238|Rivaroxaban|rivaroxaban|mesh-list
20557706|NCT01954238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20557707|NCT01954238|Antithrombins|antithrombins|mesh-ancestor
20557708|NCT01954238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20557709|NCT01954238|Protease Inhibitors|protease inhibitors|mesh-ancestor
20557710|NCT01954238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557711|NCT01954238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557712|NCT01954238|Anticoagulants|anticoagulants|mesh-ancestor
20557713|NCT01954290|Mannitol|mannitol|mesh-list
20557714|NCT01954290|Conivaptan|conivaptan|mesh-list
20557715|NCT01954290|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20557716|NCT01954290|Diuretics|diuretics|mesh-ancestor
20557717|NCT01954290|Natriuretic Agents|natriuretic agents|mesh-ancestor
20557718|NCT01954290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557719|NCT01954290|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20557720|NCT01954290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557721|NCT01954355|Paclitaxel|paclitaxel|mesh-list
20557722|NCT01954355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20557723|NCT01954355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557724|NCT01954355|Tubulin Modulators|tubulin modulators|mesh-ancestor
20557725|NCT01954355|Antimitotic Agents|antimitotic agents|mesh-ancestor
20557726|NCT01954355|Mitosis Modulators|mitosis modulators|mesh-ancestor
20557727|NCT01954355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557728|NCT01954368|Sufentanil|sufentanil|mesh-list
20557729|NCT01954368|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20004533|NCT02249091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20004534|NCT02249091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20004535|NCT02249091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004536|NCT02249104|Adapalene|adapalene|mesh-list
20004537|NCT02249104|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
20004538|NCT02249104|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20004539|NCT02249104|Dermatologic Agents|dermatologic agents|mesh-ancestor
20004540|NCT02249104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20004541|NCT02249104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20004542|NCT02249104|Analgesics|analgesics|mesh-ancestor
20004543|NCT02249104|Sensory System Agents|sensory system agents|mesh-ancestor
20004544|NCT02249104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004545|NCT02249104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004546|NCT02249104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20004547|NCT02249104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20004548|NCT02249182|Ribavirin|ribavirin|mesh-list
20004549|NCT02249182|Sofosbuvir|sofosbuvir|mesh-list
20004550|NCT02249182|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
20004551|NCT02249182|Ledipasvir|ledipasvir|mesh-list
20004552|NCT02249182|Antimetabolites|antimetabolites|mesh-ancestor
20004553|NCT02249182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004554|NCT02249182|Antiviral Agents|antiviral agents|mesh-ancestor
20004555|NCT02249182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20004556|NCT02249585|Iodine|iodine|mesh-list
20004557|NCT02249585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20004558|NCT02249585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20004559|NCT02249585|Trace Elements|trace elements|mesh-ancestor
20004560|NCT02249585|Micronutrients|micronutrients|mesh-ancestor
20290080|NCT04338984|Narcotics|narcotics|mesh-ancestor
20004561|NCT02249585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004562|NCT02249767|Tretinoin|tretinoin|mesh-list
20004563|NCT02249767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20004564|NCT02249767|Keratolytic Agents|keratolytic agents|mesh-ancestor
20004565|NCT02249767|Dermatologic Agents|dermatologic agents|mesh-ancestor
20004566|NCT02249949|Efatutazone|efatutazone|mesh-list
20004567|NCT02249949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20004568|NCT02250612|Timolol|timolol|mesh-list
20004569|NCT02250612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20004570|NCT02250612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20004571|NCT02250612|Adrenergic Agents|adrenergic agents|mesh-ancestor
20004572|NCT02250612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004573|NCT02250612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004574|NCT02250612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004575|NCT02250612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20004576|NCT02250612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20004577|NCT02250651|Timolol|timolol|mesh-list
20004578|NCT02250651|Bimatoprost|bimatoprost|mesh-list
20004579|NCT02250651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20004580|NCT02250651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20004581|NCT02250651|Adrenergic Agents|adrenergic agents|mesh-ancestor
20004582|NCT02250651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004583|NCT02250651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004584|NCT02250651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004585|NCT02250651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20004586|NCT02250651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20004587|NCT02250703|Midazolam|midazolam|mesh-list
20004588|NCT02250703|Dexmedetomidine|dexmedetomidine|mesh-list
20004589|NCT02250703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20004590|NCT02250703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20004591|NCT02250703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004592|NCT02250703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20004593|NCT02250703|Analgesics|analgesics|mesh-ancestor
20004594|NCT02250703|Sensory System Agents|sensory system agents|mesh-ancestor
20004595|NCT02250703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004596|NCT02250703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20004597|NCT02250703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20004598|NCT02250703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20004599|NCT02250703|Adrenergic Agents|adrenergic agents|mesh-ancestor
20004600|NCT02250703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004601|NCT02250703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004602|NCT02250703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20004603|NCT02250703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20004604|NCT02250703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20004605|NCT02250703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20004606|NCT02250703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20004607|NCT02250703|Anesthetics, General|anesthetics, general|mesh-ancestor
20004608|NCT02250703|Anesthetics|anesthetics|mesh-ancestor
20004609|NCT02250703|GABA Modulators|gaba modulators|mesh-ancestor
20004610|NCT02250703|GABA Agents|gaba agents|mesh-ancestor
20004611|NCT02250807|Sofosbuvir|sofosbuvir|mesh-list
20004612|NCT02250807|Simeprevir|simeprevir|mesh-list
20004613|NCT02250807|Antiviral Agents|antiviral agents|mesh-ancestor
20004614|NCT02250807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20004615|NCT02250807|Protease Inhibitors|protease inhibitors|mesh-ancestor
20004616|NCT02250807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004617|NCT02250807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004618|NCT02251236|Tenofovir|tenofovir|mesh-list
20004619|NCT02251236|Emtricitabine|emtricitabine|mesh-list
20004620|NCT02251236|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20004621|NCT02251236|Cobicistat|cobicistat|mesh-list
20004622|NCT02251236|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
20004623|NCT02251236|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20004624|NCT02251236|Elvitegravir|elvitegravir|mesh-list
20004625|NCT02251236|Antiviral Agents|antiviral agents|mesh-ancestor
20004626|NCT02251236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20004627|NCT02251236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20004628|NCT02251236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20004629|NCT02251236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004630|NCT02251236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004631|NCT02251236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20004632|NCT02251236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20004633|NCT02251236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20004634|NCT02251236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20004635|NCT02251236|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20004636|NCT02251275|Tolvaptan|tolvaptan|mesh-list
20004637|NCT02251275|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20004638|NCT02251275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004639|NCT02251275|Natriuretic Agents|natriuretic agents|mesh-ancestor
20004640|NCT02251275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290081|NCT04338984|Analgesics|analgesics|mesh-ancestor
20290082|NCT04338984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20290083|NCT04338984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20290084|NCT04329832|Azithromycin|azithromycin|mesh-list
20290085|NCT04329832|Hydroxychloroquine|hydroxychloroquine|mesh-list
20290086|NCT04329832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20290087|NCT04329832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20290088|NCT04329832|Antimalarials|antimalarials|mesh-ancestor
20290089|NCT04329832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20290090|NCT04329832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20290091|NCT04329832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290092|NCT04329832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290093|NCT04329832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20290094|NCT04323046|Nivolumab|nivolumab|mesh-list
20290095|NCT04323046|Ipilimumab|ipilimumab|mesh-list
20290096|NCT04323046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20290097|NCT04323046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290098|NCT04323046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20290099|NCT04323046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290100|NCT04321395|Vigabatrin|vigabatrin|mesh-list
20290101|NCT04321395|Anticonvulsants|anticonvulsants|mesh-ancestor
20290102|NCT04321395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290103|NCT04321395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290104|NCT04321395|GABA Agents|gaba agents|mesh-ancestor
20290105|NCT04321395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20290106|NCT04321395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290107|NCT04318548|Vaccines|vaccines|mesh-list
20290108|NCT04318548|Immunologic Factors|immunologic factors|mesh-ancestor
20290109|NCT04318548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290110|NCT04311411|Liraglutide|liraglutide|mesh-list
20290111|NCT04311411|Tirzepatide|tirzepatide|mesh-list
20290112|NCT04311411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20290113|NCT04311411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290114|NCT04311411|Incretins|incretins|mesh-ancestor
20290115|NCT04311411|Hormones|hormones|mesh-ancestor
20290116|NCT04311411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20290117|NCT04305496|Fulvestrant|fulvestrant|mesh-list
20290118|NCT04305496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20290119|NCT04305496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290120|NCT04305496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20290121|NCT04305496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20290122|NCT04305496|Hormone Antagonists|hormone antagonists|mesh-ancestor
20557730|NCT01954368|Narcotics|narcotics|mesh-ancestor
20557731|NCT01954368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20557732|NCT01954368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557733|NCT01954368|Analgesics|analgesics|mesh-ancestor
20557734|NCT01954368|Sensory System Agents|sensory system agents|mesh-ancestor
20557735|NCT01954368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20557736|NCT01954368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20557737|NCT01954368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20557738|NCT01954368|Anesthetics, General|anesthetics, general|mesh-ancestor
20557739|NCT01954368|Anesthetics|anesthetics|mesh-ancestor
20557740|NCT01954524|Sildenafil Citrate|sildenafil citrate|mesh-list
20557741|NCT01954524|Vasodilator Agents|vasodilator agents|mesh-ancestor
20557742|NCT01954524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20557743|NCT01954524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20557744|NCT01954524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557745|NCT01954524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557746|NCT01954524|Urological Agents|urological agents|mesh-ancestor
20557747|NCT01954693|Everolimus|everolimus|mesh-list
20004641|NCT02251379|Fluticasone|fluticasone|mesh-list
20004642|NCT02251379|Xhance|xhance|mesh-list
20004643|NCT02251379|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20004644|NCT02251379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20004645|NCT02251379|Autonomic Agents|autonomic agents|mesh-ancestor
20004646|NCT02251379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004647|NCT02251379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004648|NCT02251379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20004649|NCT02251379|Respiratory System Agents|respiratory system agents|mesh-ancestor
20004650|NCT02251379|Glucocorticoids|glucocorticoids|mesh-ancestor
20004651|NCT02251379|Hormones|hormones|mesh-ancestor
20004652|NCT02251379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20004653|NCT02251379|Sympathomimetics|sympathomimetics|mesh-ancestor
20004654|NCT02251379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20004655|NCT02251379|Dermatologic Agents|dermatologic agents|mesh-ancestor
20004656|NCT02251379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20004657|NCT02251613|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
20004658|NCT02251613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20004659|NCT02251613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20004660|NCT02251613|Epinastine|epinastine|mesh-list
20004661|NCT02251613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20004662|NCT02251613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20004663|NCT02251613|Analgesics|analgesics|mesh-ancestor
20004664|NCT02251613|Sensory System Agents|sensory system agents|mesh-ancestor
20004665|NCT02251613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004666|NCT02251613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004667|NCT02251613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20004668|NCT02251613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20004669|NCT02251613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20004670|NCT02251613|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20004671|NCT02251613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20004672|NCT02251613|Histamine Antagonists|histamine antagonists|mesh-ancestor
20004673|NCT02251613|Histamine Agents|histamine agents|mesh-ancestor
20004674|NCT02251613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004675|NCT02251613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004676|NCT02251717|Sofosbuvir|sofosbuvir|mesh-list
20004677|NCT02251717|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
20004678|NCT02251717|Ledipasvir|ledipasvir|mesh-list
20004679|NCT02251717|Antiviral Agents|antiviral agents|mesh-ancestor
20004680|NCT02251717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20004681|NCT02251912|Oxytocin|oxytocin|mesh-list
20004682|NCT02251912|Oxytocics|oxytocics|mesh-ancestor
20004683|NCT02251912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20004684|NCT02251912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004685|NCT02251938|Sirolimus|sirolimus|mesh-list
20004686|NCT02251938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20004687|NCT02251938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20004688|NCT02251938|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20004689|NCT02251938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20004690|NCT02251938|Antifungal Agents|antifungal agents|mesh-ancestor
20004691|NCT02251938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20004692|NCT02251938|Immunologic Factors|immunologic factors|mesh-ancestor
20004693|NCT02251938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004694|NCT02251990|Grazoprevir|grazoprevir|mesh-list
20004695|NCT02251990|Antiviral Agents|antiviral agents|mesh-ancestor
20004696|NCT02251990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20004697|NCT02252016|Grazoprevir|grazoprevir|mesh-list
20004698|NCT02252016|Antiviral Agents|antiviral agents|mesh-ancestor
20004699|NCT02252016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20004700|NCT02252042|Docetaxel|docetaxel|mesh-list
20004701|NCT02252042|Pembrolizumab|pembrolizumab|mesh-list
20004702|NCT02252042|Methotrexate|methotrexate|mesh-list
20004703|NCT02252042|Cetuximab|cetuximab|mesh-list
20004704|NCT02252042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20004705|NCT02252042|Tubulin Modulators|tubulin modulators|mesh-ancestor
20004706|NCT02252042|Antimitotic Agents|antimitotic agents|mesh-ancestor
20004707|NCT02252042|Mitosis Modulators|mitosis modulators|mesh-ancestor
20004708|NCT02252042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004709|NCT02252042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20004710|NCT02252042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20004711|NCT02252042|Abortifacient Agents|abortifacient agents|mesh-ancestor
20004712|NCT02252042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20004713|NCT02252042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004714|NCT02252042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20004715|NCT02252042|Antimetabolites|antimetabolites|mesh-ancestor
20004716|NCT02252042|Dermatologic Agents|dermatologic agents|mesh-ancestor
20004717|NCT02252042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004718|NCT02252042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20004719|NCT02252042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20004720|NCT02252042|Immunologic Factors|immunologic factors|mesh-ancestor
20004721|NCT02252042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20004722|NCT02252042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20004723|NCT02252081|Metformin|metformin|mesh-list
20004724|NCT02252081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20004725|NCT02252081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004726|NCT02252354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20004727|NCT02252354|Relugolix|relugolix|mesh-list
20004728|NCT02252354|Androgen Antagonists|androgen antagonists|mesh-ancestor
20004729|NCT02252354|Hormone Antagonists|hormone antagonists|mesh-ancestor
20004730|NCT02252354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20004731|NCT02252354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004732|NCT02252406|Ranolazine|ranolazine|mesh-list
20004733|NCT02252406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20004734|NCT02252406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20004735|NCT02252406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004736|NCT02252445|Propofol|propofol|mesh-list
20004737|NCT02252445|Sevoflurane|sevoflurane|mesh-list
20004738|NCT02252445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20004739|NCT02252445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20004740|NCT02252445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004741|NCT02252445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20004742|NCT02252445|Anesthetics, General|anesthetics, general|mesh-ancestor
20004743|NCT02252445|Anesthetics|anesthetics|mesh-ancestor
20004744|NCT02252445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20004745|NCT02252445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20004746|NCT02252536|Gabapentin|gabapentin|mesh-list
20004747|NCT02252536|Analgesics|analgesics|mesh-ancestor
20004748|NCT02252536|Sensory System Agents|sensory system agents|mesh-ancestor
20004749|NCT02252536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004750|NCT02252536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004751|NCT02252536|Anticonvulsants|anticonvulsants|mesh-ancestor
20004752|NCT02252536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20004753|NCT02252536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20004754|NCT02252536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20004755|NCT02252536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20004756|NCT02252536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20004757|NCT02252536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20004758|NCT02252536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20557748|NCT01954693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459801|NCT03358277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459802|NCT03358277|Dopamine Agents|dopamine agents|mesh-ancestor
19459803|NCT03358277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19459804|NCT03358277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459805|NCT03358277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19459806|NCT03358277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19459807|NCT03358277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19459808|NCT03358277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19459809|NCT03358212|Denosumab|denosumab|mesh-list
20004759|NCT02252536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004760|NCT02252536|Antimanic Agents|antimanic agents|mesh-ancestor
20004761|NCT02252588|Chlorhexidine|chlorhexidine|mesh-list
20004762|NCT02252588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20004763|NCT02252588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20004764|NCT02252588|Disinfectants|disinfectants|mesh-ancestor
20004765|NCT02252965|Metformin|metformin|mesh-list
20004766|NCT02252965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20004767|NCT02252965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004768|NCT02253160|Sargramostim|sargramostim|mesh-list
20004769|NCT02253160|Lenograstim|lenograstim|mesh-list
20004770|NCT02253160|Immunologic Factors|immunologic factors|mesh-ancestor
20004771|NCT02253160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004772|NCT02253160|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20004773|NCT02253173|Estradiol|estradiol|mesh-list
20004774|NCT02253173|Estrogens|estrogens|mesh-ancestor
20004775|NCT02253173|Hormones|hormones|mesh-ancestor
20004776|NCT02253173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20004777|NCT02253173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004778|NCT02253654|Epoetin Alfa|epoetin alfa|mesh-list
20004779|NCT02253654|Hematinics|hematinics|mesh-ancestor
20004780|NCT02253992|Nivolumab|nivolumab|mesh-list
20004781|NCT02253992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20004782|NCT02253992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20004783|NCT02253992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20004784|NCT02253992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004785|NCT02254252|Nicorandil|nicorandil|mesh-list
20004786|NCT02254252|Nitroglycerin|nitroglycerin|mesh-list
20004787|NCT02254252|Vasodilator Agents|vasodilator agents|mesh-ancestor
20004788|NCT02254252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20004789|NCT02254252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20004790|NCT02254252|Vitamin B Complex|vitamin b complex|mesh-ancestor
20004791|NCT02254252|Vitamins|vitamins|mesh-ancestor
20004792|NCT02254252|Micronutrients|micronutrients|mesh-ancestor
20004793|NCT02254252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004794|NCT02254291|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20004795|NCT02254291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20004796|NCT02254291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004797|NCT02254291|Incretins|incretins|mesh-ancestor
20004798|NCT02254291|Hormones|hormones|mesh-ancestor
20004799|NCT02254291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20004800|NCT02254291|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20004801|NCT02254291|Protease Inhibitors|protease inhibitors|mesh-ancestor
20004802|NCT02254291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004803|NCT02254291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004804|NCT02254304|Interferons|interferons|mesh-list
20004805|NCT02254304|Interferon-beta|interferon-beta|mesh-list
20004806|NCT02254304|Interferon beta-1a|interferon beta-1a|mesh-list
20004807|NCT02254304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20004808|NCT02254304|Antiviral Agents|antiviral agents|mesh-ancestor
20004809|NCT02254304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20004810|NCT02254304|Immunologic Factors|immunologic factors|mesh-ancestor
20004811|NCT02254304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004812|NCT02254304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20004813|NCT02254551|Bortezomib|bortezomib|mesh-list
20004814|NCT02254551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20004815|NCT02254681|Gemcitabine|gemcitabine|mesh-list
20004816|NCT02254681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20004817|NCT02254681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20004818|NCT02254681|Antimetabolites|antimetabolites|mesh-ancestor
20004819|NCT02254681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004820|NCT02254681|Antiviral Agents|antiviral agents|mesh-ancestor
20004821|NCT02254681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20004822|NCT02254681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004823|NCT02254681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20004824|NCT02254681|Immunologic Factors|immunologic factors|mesh-ancestor
20004825|NCT02254681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004826|NCT02254772|Ipilimumab|ipilimumab|mesh-list
20004827|NCT02254772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20004828|NCT02254772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20004829|NCT02254772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20004830|NCT02254772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004831|NCT02255097|Pembrolizumab|pembrolizumab|mesh-list
20004832|NCT02255097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20004833|NCT02255097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20004834|NCT02255110|Doxorubicin|doxorubicin|mesh-list
20004835|NCT02255110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20004836|NCT02255110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20004837|NCT02255110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20004838|NCT02255110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20004839|NCT02255110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004840|NCT02255110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004841|NCT02255175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20004842|NCT02255175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20004843|NCT02255175|Estradiol|estradiol|mesh-list
20004844|NCT02255175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20004845|NCT02255175|Progesterone|progesterone|mesh-list
20004846|NCT02255175|Estrogens|estrogens|mesh-ancestor
20004847|NCT02255175|Hormones|hormones|mesh-ancestor
20004848|NCT02255175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20004849|NCT02255175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557749|NCT01954693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20557750|NCT01954693|Immunologic Factors|immunologic factors|mesh-ancestor
20557751|NCT01954693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557752|NCT01954732|Metformin|metformin|mesh-list
20557753|NCT01954732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20557754|NCT01954732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557755|NCT01954784|Cyclosporine|cyclosporine|mesh-list
20557756|NCT01954784|Mycophenolic Acid|mycophenolic acid|mesh-list
20557757|NCT01954784|Fludarabine|fludarabine|mesh-list
20557758|NCT01954784|Fludarabine phosphate|fludarabine phosphate|mesh-list
20557759|NCT01954784|Lenalidomide|lenalidomide|mesh-list
20557760|NCT01954784|Bortezomib|bortezomib|mesh-list
20557761|NCT01954784|Cyclosporins|cyclosporins|mesh-list
20557762|NCT01954784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557763|NCT01954784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20557764|NCT01954784|Antimetabolites|antimetabolites|mesh-ancestor
20557765|NCT01954784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557766|NCT01954784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20557767|NCT01954784|Immunologic Factors|immunologic factors|mesh-ancestor
20557768|NCT01954784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557769|NCT01954784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557770|NCT01954784|Antifungal Agents|antifungal agents|mesh-ancestor
20557771|NCT01954784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20004850|NCT02255175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20004851|NCT02255175|Contraceptive Agents|contraceptive agents|mesh-ancestor
20004852|NCT02255175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20004853|NCT02255175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20004854|NCT02255175|Progestins|progestins|mesh-ancestor
20004855|NCT02255279|Vaccines|vaccines|mesh-list
20004856|NCT02255279|Immunologic Factors|immunologic factors|mesh-ancestor
20004857|NCT02255279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004858|NCT02255357|Oxytocin|oxytocin|mesh-list
20004859|NCT02255357|Oxytocics|oxytocics|mesh-ancestor
20004860|NCT02255357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20004861|NCT02255357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004862|NCT02255461|Palbociclib|palbociclib|mesh-list
20004863|NCT02255461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20004864|NCT02255461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20004865|NCT02255461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004866|NCT02255461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004867|NCT02255500|Bupivacaine|bupivacaine|mesh-list
20004868|NCT02255500|Anesthetics, Local|anesthetics, local|mesh-ancestor
20004869|NCT02255500|Anesthetics|anesthetics|mesh-ancestor
20004870|NCT02255500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20004871|NCT02255500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004872|NCT02255500|Sensory System Agents|sensory system agents|mesh-ancestor
20004873|NCT02255500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004874|NCT02255513|Methylphenidate|methylphenidate|mesh-list
20004875|NCT02255513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20004876|NCT02255513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004877|NCT02255513|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20004878|NCT02255513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20004879|NCT02255513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20004880|NCT02255513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004881|NCT02255513|Dopamine Agents|dopamine agents|mesh-ancestor
20004882|NCT02255513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004883|NCT02255565|Methylphenidate|methylphenidate|mesh-list
20004884|NCT02255565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20004885|NCT02255565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004886|NCT02255565|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20004887|NCT02255565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20004888|NCT02255565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20004889|NCT02255565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004890|NCT02255565|Dopamine Agents|dopamine agents|mesh-ancestor
20004891|NCT02255565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004892|NCT02255760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20004893|NCT02255760|Immunologic Factors|immunologic factors|mesh-ancestor
20004894|NCT02255760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004895|NCT02256111|Androgens|androgens|mesh-list
20004896|NCT02256111|Hormones|hormones|mesh-ancestor
20004897|NCT02256111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20004898|NCT02256111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004899|NCT02256189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20004900|NCT02256189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20004901|NCT02256189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004902|NCT02256189|Incretins|incretins|mesh-ancestor
20004903|NCT02256189|Hormones|hormones|mesh-ancestor
20004904|NCT02256189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20004905|NCT02256189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20004906|NCT02256189|Protease Inhibitors|protease inhibitors|mesh-ancestor
20004907|NCT02256189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004908|NCT02256189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004909|NCT02256267|Rifampin|rifampin|mesh-list
20004910|NCT02256267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20004911|NCT02256267|Antitubercular Agents|antitubercular agents|mesh-ancestor
20004912|NCT02256267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20004913|NCT02256267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20004914|NCT02256267|Leprostatic Agents|leprostatic agents|mesh-ancestor
20004915|NCT02256267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20004916|NCT02256267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004917|NCT02256267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004918|NCT02256267|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20004919|NCT02256267|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20004920|NCT02256267|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20004921|NCT02256267|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20004922|NCT02256267|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20004923|NCT02256267|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20004924|NCT02256358|Midazolam|midazolam|mesh-list
20004925|NCT02256358|Ketamine|ketamine|mesh-list
20004926|NCT02256358|Analgesics|analgesics|mesh-ancestor
20004927|NCT02256358|Sensory System Agents|sensory system agents|mesh-ancestor
20004928|NCT02256358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004929|NCT02256358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004930|NCT02256358|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20004931|NCT02256358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20004932|NCT02256358|Anesthetics, General|anesthetics, general|mesh-ancestor
20004933|NCT02256358|Anesthetics|anesthetics|mesh-ancestor
20004934|NCT02256358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20004935|NCT02256358|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20004936|NCT02256358|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20004937|NCT02256358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20004938|NCT02256358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004939|NCT02256358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20004940|NCT02256358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20004941|NCT02256358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20004942|NCT02256358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20004943|NCT02256358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20004944|NCT02256358|GABA Modulators|gaba modulators|mesh-ancestor
20004945|NCT02256358|GABA Agents|gaba agents|mesh-ancestor
20004946|NCT02256436|Paclitaxel|paclitaxel|mesh-list
20004947|NCT02256436|Docetaxel|docetaxel|mesh-list
20004948|NCT02256436|Pembrolizumab|pembrolizumab|mesh-list
20004949|NCT02256436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20004950|NCT02256436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20004951|NCT02256436|Tubulin Modulators|tubulin modulators|mesh-ancestor
20004952|NCT02256436|Antimitotic Agents|antimitotic agents|mesh-ancestor
20004953|NCT02256436|Mitosis Modulators|mitosis modulators|mesh-ancestor
20004954|NCT02256436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004955|NCT02256436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20004956|NCT02256540|Resveratrol|resveratrol|mesh-list
20004957|NCT02256540|Estradiol|estradiol|mesh-list
20004958|NCT02256540|Estrogens|estrogens|mesh-ancestor
20004959|NCT02256540|Hormones|hormones|mesh-ancestor
20004960|NCT02256540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20004961|NCT02256540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004962|NCT02256540|Antioxidants|antioxidants|mesh-ancestor
20004963|NCT02256540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20004964|NCT02256540|Protective Agents|protective agents|mesh-ancestor
20004965|NCT02256540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20004966|NCT02256540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20004967|NCT02256969|Sulfacetamide|sulfacetamide|mesh-list
20004968|NCT02256969|Prednisolone|prednisolone|mesh-list
20004969|NCT02256969|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20004970|NCT02256969|Methylprednisolone|methylprednisolone|mesh-list
20004971|NCT02256969|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20004972|NCT02256969|Prednisolone acetate|prednisolone acetate|mesh-list
20004973|NCT02256969|Mineral Oil|mineral oil|mesh-list
20004974|NCT02256969|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20004975|NCT02256969|Prednisolone phosphate|prednisolone phosphate|mesh-list
20004976|NCT02256969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20004977|NCT02256969|Glucocorticoids|glucocorticoids|mesh-ancestor
20004978|NCT02256969|Hormones|hormones|mesh-ancestor
20004979|NCT02256969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20004980|NCT02256969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20004981|NCT02256969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20004982|NCT02256969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20004983|NCT02256969|Antiemetics|antiemetics|mesh-ancestor
20004984|NCT02256969|Autonomic Agents|autonomic agents|mesh-ancestor
20004985|NCT02256969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20004986|NCT02256969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20004987|NCT02256969|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20004988|NCT02256969|Protective Agents|protective agents|mesh-ancestor
20004989|NCT02256969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20004990|NCT02256969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20004991|NCT02256969|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20004992|NCT02256969|Renal Agents|renal agents|mesh-ancestor
20004993|NCT02256969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20004994|NCT02256969|Emollients|emollients|mesh-ancestor
20004995|NCT02256969|Dermatologic Agents|dermatologic agents|mesh-ancestor
20004996|NCT02256982|Gemcitabine|gemcitabine|mesh-list
20004997|NCT02256982|Cisplatin|cisplatin|mesh-list
20004998|NCT02256982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20004999|NCT02256982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20005000|NCT02256982|Antimetabolites|antimetabolites|mesh-ancestor
20005001|NCT02256982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005002|NCT02256982|Antiviral Agents|antiviral agents|mesh-ancestor
20005003|NCT02256982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20005004|NCT02256982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005005|NCT02256982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20005006|NCT02256982|Immunologic Factors|immunologic factors|mesh-ancestor
20005007|NCT02256982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005008|NCT02257372|Albuterol|albuterol|mesh-list
20005009|NCT02257372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20005010|NCT02257372|Autonomic Agents|autonomic agents|mesh-ancestor
20005011|NCT02257372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005012|NCT02257372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005013|NCT02257372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20005014|NCT02257372|Respiratory System Agents|respiratory system agents|mesh-ancestor
20005015|NCT02257372|Tocolytic Agents|tocolytic agents|mesh-ancestor
20005016|NCT02257372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20005017|NCT02257372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20005018|NCT02257372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20005019|NCT02257372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20005020|NCT02257372|Adrenergic Agents|adrenergic agents|mesh-ancestor
20005021|NCT02257372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20005022|NCT02257372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005023|NCT02257385|Albuterol|albuterol|mesh-list
20005024|NCT02257385|Tiotropium Bromide|tiotropium bromide|mesh-list
20005025|NCT02257385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20005026|NCT02257385|Autonomic Agents|autonomic agents|mesh-ancestor
20005027|NCT02257385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005028|NCT02257385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005029|NCT02257385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20005030|NCT02257385|Respiratory System Agents|respiratory system agents|mesh-ancestor
20005031|NCT02257385|Parasympatholytics|parasympatholytics|mesh-ancestor
20005032|NCT02257385|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20005033|NCT02257385|Cholinergic Agents|cholinergic agents|mesh-ancestor
20005034|NCT02257385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20005035|NCT02257385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005036|NCT02257385|Tocolytic Agents|tocolytic agents|mesh-ancestor
20005037|NCT02257385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20005038|NCT02257385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20005039|NCT02257385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20005040|NCT02257385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20005041|NCT02257385|Adrenergic Agents|adrenergic agents|mesh-ancestor
20005042|NCT02257541|Imatinib Mesylate|imatinib mesylate|mesh-list
20005043|NCT02257541|Infigratinib|infigratinib|mesh-list
20005044|NCT02257541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005045|NCT02257541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20005046|NCT02257541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005047|NCT02257541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005048|NCT02257632|Ranibizumab|ranibizumab|mesh-list
20005049|NCT02257632|Aflibercept|aflibercept|mesh-list
20005050|NCT02257632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20005051|NCT02257632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20005052|NCT02257632|Growth Substances|growth substances|mesh-ancestor
20005053|NCT02257632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005054|NCT02257632|Growth Inhibitors|growth inhibitors|mesh-ancestor
20005055|NCT02257632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005056|NCT02257957|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20005057|NCT02257957|Hyaluronic Acid|hyaluronic acid|mesh-list
20005058|NCT02257957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20005059|NCT02257957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20005060|NCT02257957|Immunologic Factors|immunologic factors|mesh-ancestor
20005061|NCT02257957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005062|NCT02257957|Viscosupplements|viscosupplements|mesh-ancestor
20005063|NCT02257957|Protective Agents|protective agents|mesh-ancestor
20005064|NCT02257970|Ketoprofen|ketoprofen|mesh-list
20005065|NCT02257970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20005066|NCT02257970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20005067|NCT02257970|Analgesics|analgesics|mesh-ancestor
20005068|NCT02257970|Sensory System Agents|sensory system agents|mesh-ancestor
20005069|NCT02257970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005070|NCT02257970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005071|NCT02257970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20005072|NCT02257970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20005073|NCT02257970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20005074|NCT02257970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005075|NCT02257970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005076|NCT02258074|Niacinamide|niacinamide|mesh-list
20005077|NCT02258074|Niacin|niacin|mesh-list
20005078|NCT02258074|Nicotinic Acids|nicotinic acids|mesh-list
20005079|NCT02258074|Vitamin B Complex|vitamin b complex|mesh-ancestor
20005080|NCT02258074|Vitamins|vitamins|mesh-ancestor
20005081|NCT02258074|Micronutrients|micronutrients|mesh-ancestor
20005082|NCT02258074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005083|NCT02258074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20005084|NCT02258074|Antimetabolites|antimetabolites|mesh-ancestor
20005085|NCT02258074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005086|NCT02258074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20005087|NCT02258074|Vasodilator Agents|vasodilator agents|mesh-ancestor
20005088|NCT02258217|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20005089|NCT02258217|Hormones|hormones|mesh-ancestor
20005090|NCT02258217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20005091|NCT02258217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005092|NCT02258334|Vaccines|vaccines|mesh-list
20005093|NCT02258334|Immunologic Factors|immunologic factors|mesh-ancestor
20005094|NCT02258334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005095|NCT02258412|Ethanol|ethanol|mesh-list
20005096|NCT02258412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
20005097|NCT02258412|Hand Sanitizers|hand sanitizers|mesh-list
20005098|NCT02258412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20005099|NCT02258412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20005100|NCT02258412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005101|NCT02258412|Disinfectants|disinfectants|mesh-ancestor
20005102|NCT02258464|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20005103|NCT02258464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290123|NCT04305496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20290124|NCT04305496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290125|NCT04305470|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20290126|NCT04305470|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20290127|NCT04305470|Dermatologic Agents|dermatologic agents|mesh-ancestor
20290128|NCT04276233|Prednisone|prednisone|mesh-list
20290129|NCT04276233|Prednisolone|prednisolone|mesh-list
20290130|NCT04276233|Albuterol|albuterol|mesh-list
20290131|NCT04276233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20290132|NCT04276233|Glucocorticoids|glucocorticoids|mesh-ancestor
20290133|NCT04276233|Hormones|hormones|mesh-ancestor
20290134|NCT04276233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20290135|NCT04276233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290136|NCT04276233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20290137|NCT04276233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290138|NCT04276233|Autonomic Agents|autonomic agents|mesh-ancestor
20290139|NCT04276233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20290140|NCT04276233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20290141|NCT04276233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20290142|NCT04276233|Respiratory System Agents|respiratory system agents|mesh-ancestor
20290143|NCT04276233|Tocolytic Agents|tocolytic agents|mesh-ancestor
20290144|NCT04276233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20290145|NCT04276233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20290146|NCT04276233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20290147|NCT04276233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20290148|NCT04276233|Adrenergic Agents|adrenergic agents|mesh-ancestor
20290149|NCT04276233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20290150|NCT04276233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290151|NCT04275661|Magnesium Sulfate|magnesium sulfate|mesh-list
20290152|NCT04275661|Ketamine|ketamine|mesh-list
20290153|NCT04275661|Levobupivacaine|levobupivacaine|mesh-list
20290154|NCT04275661|Analgesics|analgesics|mesh-ancestor
20557772|NCT01954784|Dermatologic Agents|dermatologic agents|mesh-ancestor
20557773|NCT01954784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20557774|NCT01954784|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20557775|NCT01954784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20557776|NCT01954784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20557777|NCT01954784|Growth Substances|growth substances|mesh-ancestor
20557778|NCT01954784|Growth Inhibitors|growth inhibitors|mesh-ancestor
20557779|NCT01954784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20557780|NCT01954784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20557781|NCT01954784|Antitubercular Agents|antitubercular agents|mesh-ancestor
20557782|NCT01954784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20557783|NCT01954914|Plerixafor|plerixafor|mesh-list
20557784|NCT01954914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20557785|NCT01954914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20557786|NCT01954914|Antiviral Agents|antiviral agents|mesh-ancestor
20557787|NCT01954914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20557788|NCT01954966|Progesterone|progesterone|mesh-list
20557789|NCT01954966|Progestins|progestins|mesh-ancestor
20557790|NCT01954966|Hormones|hormones|mesh-ancestor
20557791|NCT01954966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20557792|NCT01954966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557793|NCT01954992|Fluorouracil|fluorouracil|mesh-list
20557794|NCT01954992|Antimetabolites|antimetabolites|mesh-ancestor
20557795|NCT01954992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557796|NCT01954992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20557797|NCT01954992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557798|NCT01954992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20557799|NCT01954992|Immunologic Factors|immunologic factors|mesh-ancestor
20557800|NCT01954992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557801|NCT01955057|Carbon Monoxide|carbon monoxide|mesh-list
20557802|NCT01955057|Antimetabolites|antimetabolites|mesh-ancestor
20557803|NCT01955057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557804|NCT01955057|Gasotransmitters|gasotransmitters|mesh-ancestor
20557805|NCT01955057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20557806|NCT01955057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557807|NCT01955070|Ketamine|ketamine|mesh-list
20557808|NCT01955070|Analgesics|analgesics|mesh-ancestor
20557809|NCT01955070|Sensory System Agents|sensory system agents|mesh-ancestor
20557810|NCT01955070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20557811|NCT01955070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290155|NCT04275661|Sensory System Agents|sensory system agents|mesh-ancestor
20005104|NCT02258529|Rituximab|rituximab|mesh-list
20005105|NCT02258529|Idelalisib|idelalisib|mesh-list
20005106|NCT02258529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20005107|NCT02258529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005108|NCT02258529|Immunologic Factors|immunologic factors|mesh-ancestor
20005109|NCT02258529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005110|NCT02258529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20005111|NCT02258529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005112|NCT02258529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005113|NCT02259010|Itraconazole|itraconazole|mesh-list
20005114|NCT02259010|Antifungal Agents|antifungal agents|mesh-ancestor
20005115|NCT02259010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20005116|NCT02259010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20005117|NCT02259010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20005118|NCT02259010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005119|NCT02259010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005120|NCT02259010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20005121|NCT02259010|Hormone Antagonists|hormone antagonists|mesh-ancestor
20005122|NCT02259010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20005123|NCT02259010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005124|NCT02259010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20005125|NCT02259088|Ranibizumab|ranibizumab|mesh-list
20005126|NCT02259088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20005127|NCT02259088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20005128|NCT02259088|Growth Substances|growth substances|mesh-ancestor
20005129|NCT02259088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005130|NCT02259088|Growth Inhibitors|growth inhibitors|mesh-ancestor
20005131|NCT02259088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005132|NCT02259231|Nivolumab|nivolumab|mesh-list
20005133|NCT02259231|Ipilimumab|ipilimumab|mesh-list
20005134|NCT02259231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20005135|NCT02259231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005136|NCT02259231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20005137|NCT02259231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005138|NCT02259348|Aldesleukin|aldesleukin|mesh-list
20005139|NCT02259348|Cyclophosphamide|cyclophosphamide|mesh-list
20005140|NCT02259348|Melphalan|melphalan|mesh-list
20005141|NCT02259348|Mechlorethamine|mechlorethamine|mesh-list
20005142|NCT02259348|Thiotepa|thiotepa|mesh-list
20005143|NCT02259348|Rituximab|rituximab|mesh-list
20005144|NCT02259348|Fludarabine|fludarabine|mesh-list
20005145|NCT02259348|Fludarabine phosphate|fludarabine phosphate|mesh-list
20005146|NCT02259348|Interleukin-2|interleukin-2|mesh-list
20005147|NCT02259348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20005148|NCT02259348|Immunologic Factors|immunologic factors|mesh-ancestor
20005149|NCT02259348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005150|NCT02259348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20005151|NCT02259348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20005152|NCT02259348|Alkylating Agents|alkylating agents|mesh-ancestor
20005153|NCT02259348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005154|NCT02259348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005155|NCT02259348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20005156|NCT02259348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20005157|NCT02259348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20005158|NCT02259348|Antimetabolites|antimetabolites|mesh-ancestor
20005159|NCT02259348|Antiviral Agents|antiviral agents|mesh-ancestor
20005160|NCT02259348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20005161|NCT02259348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20005162|NCT02259348|Analgesics|analgesics|mesh-ancestor
20005163|NCT02259348|Sensory System Agents|sensory system agents|mesh-ancestor
20005164|NCT02259348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005165|NCT02259348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20005166|NCT02259348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20005167|NCT02259582|Carboplatin|carboplatin|mesh-list
20005168|NCT02259582|Pemetrexed|pemetrexed|mesh-list
20005169|NCT02259582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005170|NCT02259582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005171|NCT02259582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005172|NCT02259582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20005173|NCT02259582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20005174|NCT02259608|BCG Vaccine|bcg vaccine|mesh-list
20005175|NCT02259608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20005176|NCT02259608|Immunologic Factors|immunologic factors|mesh-ancestor
20005177|NCT02259608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005178|NCT02260154|Mebeverine|mebeverine|mesh-list
20005179|NCT02260154|Alverine|alverine|mesh-list
20005180|NCT02260154|Anticonvulsants|anticonvulsants|mesh-ancestor
20005181|NCT02260154|Parasympatholytics|parasympatholytics|mesh-ancestor
20005182|NCT02260154|Autonomic Agents|autonomic agents|mesh-ancestor
20005183|NCT02260154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005184|NCT02260154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005185|NCT02260258|Rocuronium|rocuronium|mesh-list
20005186|NCT02260258|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20005187|NCT02260258|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20005188|NCT02260258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20005189|NCT02260258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005190|NCT02260258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005191|NCT02260388|Mexiletine|mexiletine|mesh-list
20005192|NCT02260388|Pregabalin|pregabalin|mesh-list
20005193|NCT02260388|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20005194|NCT02260388|Nortriptyline|nortriptyline|mesh-list
20005195|NCT02260388|Analgesics|analgesics|mesh-ancestor
20005196|NCT02260388|Sensory System Agents|sensory system agents|mesh-ancestor
20005197|NCT02260388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005198|NCT02260388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005199|NCT02260388|Anticonvulsants|anticonvulsants|mesh-ancestor
20005200|NCT02260388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20005201|NCT02260388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20005202|NCT02260388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005203|NCT02260388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20005204|NCT02260388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20005205|NCT02260388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20005206|NCT02260388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20005207|NCT02260388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20005208|NCT02260388|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20005209|NCT02260388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20005210|NCT02260388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20005211|NCT02260388|Antidepressive Agents|antidepressive agents|mesh-ancestor
20005212|NCT02260388|Dopamine Agents|dopamine agents|mesh-ancestor
20005213|NCT02260388|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20005214|NCT02260388|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20005215|NCT02260388|Adrenergic Agents|adrenergic agents|mesh-ancestor
20005216|NCT02260388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20005217|NCT02260388|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20005218|NCT02260388|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20005219|NCT02260440|Pembrolizumab|pembrolizumab|mesh-list
20005220|NCT02260440|Azacitidine|azacitidine|mesh-list
20005221|NCT02260440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20005222|NCT02260440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005223|NCT02260440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20005224|NCT02260440|Antimetabolites|antimetabolites|mesh-ancestor
20005225|NCT02260440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005226|NCT02260440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005227|NCT02260492|Fluticasone|fluticasone|mesh-list
20005228|NCT02260492|Xhance|xhance|mesh-list
20005229|NCT02260492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20005230|NCT02260492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20005231|NCT02260492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20005232|NCT02260492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20005233|NCT02260492|Autonomic Agents|autonomic agents|mesh-ancestor
20005234|NCT02260492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005235|NCT02260492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005236|NCT02260492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20005237|NCT02260492|Respiratory System Agents|respiratory system agents|mesh-ancestor
20005238|NCT02260492|Dermatologic Agents|dermatologic agents|mesh-ancestor
20005239|NCT02260492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20005240|NCT02260492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20005241|NCT02260492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20005242|NCT02260492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20005243|NCT02260492|Adrenergic Agents|adrenergic agents|mesh-ancestor
20005244|NCT02260492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20005245|NCT02260492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005246|NCT02260492|Glucocorticoids|glucocorticoids|mesh-ancestor
20005247|NCT02260492|Hormones|hormones|mesh-ancestor
20005248|NCT02260492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20005249|NCT02260492|Sympathomimetics|sympathomimetics|mesh-ancestor
20005250|NCT02260531|Trastuzumab|trastuzumab|mesh-list
20005251|NCT02260531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20005252|NCT02260531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005253|NCT02260622|Aspirin|aspirin|mesh-list
20005254|NCT02260622|Rivaroxaban|rivaroxaban|mesh-list
20005255|NCT02260622|Clopidogrel|clopidogrel|mesh-list
20005256|NCT02260622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20005257|NCT02260622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20005258|NCT02260622|Analgesics|analgesics|mesh-ancestor
20005259|NCT02260622|Sensory System Agents|sensory system agents|mesh-ancestor
20005260|NCT02260622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005261|NCT02260622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005262|NCT02260622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20005263|NCT02260622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20005264|NCT02260622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20005265|NCT02260622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20005266|NCT02260622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005267|NCT02260622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20005268|NCT02260622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20005269|NCT02260622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005270|NCT02260622|Antipyretics|antipyretics|mesh-ancestor
20005271|NCT02260622|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20005272|NCT02260622|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20005273|NCT02260622|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20005274|NCT02260622|Purinergic Agents|purinergic agents|mesh-ancestor
20005275|NCT02260622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20005276|NCT02260622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20005277|NCT02260622|Antithrombins|antithrombins|mesh-ancestor
20005278|NCT02260622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20005279|NCT02260622|Protease Inhibitors|protease inhibitors|mesh-ancestor
20005280|NCT02260622|Anticoagulants|anticoagulants|mesh-ancestor
20005281|NCT02260635|Evacetrapib|evacetrapib|mesh-list
20005282|NCT02260635|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20005283|NCT02260635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20005284|NCT02260635|Antimetabolites|antimetabolites|mesh-ancestor
20005285|NCT02260635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005286|NCT02260635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20005287|NCT02260648|Atorvastatin|atorvastatin|mesh-list
20005288|NCT02260648|Ezetimibe|ezetimibe|mesh-list
20005289|NCT02260648|Evacetrapib|evacetrapib|mesh-list
20005290|NCT02260648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20005291|NCT02260648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20005292|NCT02260648|Antimetabolites|antimetabolites|mesh-ancestor
20005293|NCT02260648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005294|NCT02260648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20005295|NCT02260648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20005296|NCT02260648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005297|NCT02260791|Adalimumab|adalimumab|mesh-list
20005298|NCT02260791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20005299|NCT02260791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20005300|NCT02260804|Rituximab|rituximab|mesh-list
20005301|NCT02260804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20005302|NCT02260804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005303|NCT02260804|Immunologic Factors|immunologic factors|mesh-ancestor
20005304|NCT02260804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005305|NCT02260804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20005306|NCT02260817|Choline|choline|mesh-list
20005307|NCT02260817|Lipotropic Agents|lipotropic agents|mesh-ancestor
20005308|NCT02260817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20005309|NCT02260817|Antimetabolites|antimetabolites|mesh-ancestor
20005310|NCT02260817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005311|NCT02260817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20005312|NCT02260817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20005313|NCT02260817|Nootropic Agents|nootropic agents|mesh-ancestor
20005314|NCT02260882|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20005315|NCT02260882|Immunologic Factors|immunologic factors|mesh-ancestor
20005316|NCT02260882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005317|NCT02260934|Acetaminophen|acetaminophen|mesh-list
20005318|NCT02260934|Diphenhydramine|diphenhydramine|mesh-list
20005319|NCT02260934|Promethazine|promethazine|mesh-list
20005320|NCT02260934|Prednisone|prednisone|mesh-list
20005321|NCT02260934|Methylprednisolone|methylprednisolone|mesh-list
20005322|NCT02260934|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20005323|NCT02260934|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20005324|NCT02260934|Prednisolone|prednisolone|mesh-list
20005325|NCT02260934|Prednisolone acetate|prednisolone acetate|mesh-list
20005326|NCT02260934|Cyclophosphamide|cyclophosphamide|mesh-list
20005327|NCT02260934|Rituximab|rituximab|mesh-list
20005328|NCT02260934|Belimumab|belimumab|mesh-list
20005329|NCT02260934|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20005330|NCT02260934|Prednisolone phosphate|prednisolone phosphate|mesh-list
20005331|NCT02260934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20005332|NCT02260934|Immunologic Factors|immunologic factors|mesh-ancestor
20005333|NCT02260934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005334|NCT02260934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20005335|NCT02260934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20005336|NCT02260934|Alkylating Agents|alkylating agents|mesh-ancestor
20005337|NCT02260934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005338|NCT02260934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005339|NCT02260934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20005340|NCT02260934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20005341|NCT02260934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20005342|NCT02260934|Glucocorticoids|glucocorticoids|mesh-ancestor
20005343|NCT02260934|Hormones|hormones|mesh-ancestor
20005344|NCT02260934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20005345|NCT02260934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20005346|NCT02260934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20005347|NCT02260934|Analgesics|analgesics|mesh-ancestor
20005348|NCT02260934|Sensory System Agents|sensory system agents|mesh-ancestor
20005349|NCT02260934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005350|NCT02260934|Antipyretics|antipyretics|mesh-ancestor
20005351|NCT02260934|Antiemetics|antiemetics|mesh-ancestor
20005352|NCT02260934|Autonomic Agents|autonomic agents|mesh-ancestor
20005353|NCT02260934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20005354|NCT02260934|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20005355|NCT02260934|Protective Agents|protective agents|mesh-ancestor
20005356|NCT02260934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20005357|NCT02260934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20005358|NCT02260934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20005359|NCT02260934|Anesthetics, Local|anesthetics, local|mesh-ancestor
20005360|NCT02260934|Anesthetics|anesthetics|mesh-ancestor
20005361|NCT02260934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20005362|NCT02260934|Histamine Antagonists|histamine antagonists|mesh-ancestor
20005363|NCT02260934|Histamine Agents|histamine agents|mesh-ancestor
20005364|NCT02260934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20005365|NCT02260934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20005366|NCT02260934|Antipruritics|antipruritics|mesh-ancestor
20005367|NCT02260934|Dermatologic Agents|dermatologic agents|mesh-ancestor
20005368|NCT02260986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20005369|NCT02260986|Immunologic Factors|immunologic factors|mesh-ancestor
20005370|NCT02260986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005371|NCT02261467|Botulinum Toxins|botulinum toxins|mesh-list
20005372|NCT02261467|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20005373|NCT02261467|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20005374|NCT02261467|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20005375|NCT02261467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20005376|NCT02261467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557812|NCT01955070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20557813|NCT01955070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20557814|NCT01955070|Anesthetics, General|anesthetics, general|mesh-ancestor
20557815|NCT01955070|Anesthetics|anesthetics|mesh-ancestor
20557816|NCT01955070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20557817|NCT01955070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20557818|NCT01955070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20557819|NCT01955070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20557820|NCT01955070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557821|NCT01955135|Ketamine|ketamine|mesh-list
20557822|NCT01955135|Propofol|propofol|mesh-list
20557823|NCT01955135|Sevoflurane|sevoflurane|mesh-list
20557824|NCT01955135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20557825|NCT01955135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20557826|NCT01955135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557827|NCT01955135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20557828|NCT01955135|Anesthetics, General|anesthetics, general|mesh-ancestor
20557829|NCT01955135|Anesthetics|anesthetics|mesh-ancestor
20557830|NCT01955135|Analgesics|analgesics|mesh-ancestor
20557831|NCT01955135|Sensory System Agents|sensory system agents|mesh-ancestor
20005377|NCT02261467|Cholinergic Agents|cholinergic agents|mesh-ancestor
20005378|NCT02261467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20005379|NCT02261467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005380|NCT02261467|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20005381|NCT02261467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005382|NCT02261493|Botulinum Toxins|botulinum toxins|mesh-list
20005383|NCT02261493|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20005384|NCT02261493|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20005385|NCT02261493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20005386|NCT02261493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20005387|NCT02261493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005388|NCT02261493|Cholinergic Agents|cholinergic agents|mesh-ancestor
20005389|NCT02261493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20005390|NCT02261493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005391|NCT02261493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20005392|NCT02261493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005393|NCT02261727|Prednisone|prednisone|mesh-list
20005394|NCT02261727|Cortisone|cortisone|mesh-list
20005395|NCT02261727|Theophylline|theophylline|mesh-list
20005396|NCT02261727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20005397|NCT02261727|Glucocorticoids|glucocorticoids|mesh-ancestor
20005398|NCT02261727|Hormones|hormones|mesh-ancestor
20005399|NCT02261727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20005400|NCT02261727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005401|NCT02261727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20005402|NCT02261727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005403|NCT02261727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20005404|NCT02261727|Autonomic Agents|autonomic agents|mesh-ancestor
20005405|NCT02261727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005406|NCT02261727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20005407|NCT02261727|Respiratory System Agents|respiratory system agents|mesh-ancestor
20005408|NCT02261727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20005409|NCT02261727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005410|NCT02261727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005411|NCT02261727|Vasodilator Agents|vasodilator agents|mesh-ancestor
20005412|NCT02261727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20005413|NCT02261727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20005414|NCT02261727|Purinergic Agents|purinergic agents|mesh-ancestor
20005415|NCT02261727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20005416|NCT02261805|Doxorubicin|doxorubicin|mesh-list
20005417|NCT02261805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20005418|NCT02261805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005419|NCT02261805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20005420|NCT02261805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20005421|NCT02261805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005422|NCT02261805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005423|NCT02261948|Simendan|simendan|mesh-list
20005424|NCT02261948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20005425|NCT02261948|Vasodilator Agents|vasodilator agents|mesh-ancestor
20005426|NCT02261948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20005427|NCT02261948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20005428|NCT02261948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005429|NCT02261948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005430|NCT02261948|Protective Agents|protective agents|mesh-ancestor
20005431|NCT02261948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005432|NCT02261961|Vaccines|vaccines|mesh-list
20005433|NCT02261961|Immunologic Factors|immunologic factors|mesh-ancestor
20005434|NCT02261961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005435|NCT02262130|Omalizumab|omalizumab|mesh-list
20005436|NCT02262130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20005437|NCT02262130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20005438|NCT02262130|Respiratory System Agents|respiratory system agents|mesh-ancestor
20005439|NCT02262728|Sofosbuvir|sofosbuvir|mesh-list
20005440|NCT02262728|Simeprevir|simeprevir|mesh-list
20005441|NCT02262728|Antiviral Agents|antiviral agents|mesh-ancestor
20005442|NCT02262728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20005443|NCT02262728|Protease Inhibitors|protease inhibitors|mesh-ancestor
20005444|NCT02262728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005445|NCT02262728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005446|NCT02262754|Naproxen|naproxen|mesh-list
20005447|NCT02262754|PF-06372865|pf-06372865|mesh-list
20005448|NCT02262754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20005449|NCT02262754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20005450|NCT02262754|Analgesics|analgesics|mesh-ancestor
20005451|NCT02262754|Sensory System Agents|sensory system agents|mesh-ancestor
20005452|NCT02262754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005453|NCT02262754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005454|NCT02262754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20005455|NCT02262754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20005456|NCT02262754|Gout Suppressants|gout suppressants|mesh-ancestor
20005457|NCT02262754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20005458|NCT02262754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005459|NCT02262754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005460|NCT02262754|GABA Modulators|gaba modulators|mesh-ancestor
20005461|NCT02262754|GABA Agents|gaba agents|mesh-ancestor
20005462|NCT02262754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20005463|NCT02263079|Interferons|interferons|mesh-list
20005464|NCT02263079|Interferon-alpha|interferon-alpha|mesh-list
20005465|NCT02263079|Lamivudine|lamivudine|mesh-list
20005466|NCT02263079|Interferon alpha-2|interferon alpha-2|mesh-list
20005467|NCT02263079|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20005468|NCT02263079|Entecavir|entecavir|mesh-list
20005469|NCT02263079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005470|NCT02263079|Antiviral Agents|antiviral agents|mesh-ancestor
20005471|NCT02263079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20005472|NCT02263079|Immunologic Factors|immunologic factors|mesh-ancestor
20005473|NCT02263079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005474|NCT02263079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20005475|NCT02263079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20005476|NCT02263079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005477|NCT02263079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005478|NCT02263079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20005479|NCT02263079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20005480|NCT02263326|Lamivudine|lamivudine|mesh-list
20005481|NCT02263326|Dolutegravir|dolutegravir|mesh-list
20005482|NCT02263326|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20005483|NCT02263326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20005484|NCT02263326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20005485|NCT02263326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005486|NCT02263326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005487|NCT02263326|Antiviral Agents|antiviral agents|mesh-ancestor
20005488|NCT02263326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20005489|NCT02263326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20005490|NCT02263326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20005491|NCT02263326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20005492|NCT02263547|Teriflunomide|teriflunomide|mesh-list
20005493|NCT02263547|Colestipol|colestipol|mesh-list
20005494|NCT02263547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20005495|NCT02263547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20005496|NCT02263547|Analgesics|analgesics|mesh-ancestor
20005497|NCT02263547|Sensory System Agents|sensory system agents|mesh-ancestor
20005498|NCT02263547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005499|NCT02263547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005500|NCT02263547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20005501|NCT02263547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20005502|NCT02263547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20005503|NCT02263547|Immunologic Factors|immunologic factors|mesh-ancestor
20005504|NCT02263547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20005505|NCT02263547|Antimetabolites|antimetabolites|mesh-ancestor
20005506|NCT02263547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005507|NCT02263547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20005508|NCT02263547|Sequestering Agents|sequestering agents|mesh-ancestor
20005509|NCT02264353|Donepezil|donepezil|mesh-list
20005510|NCT02264353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20005511|NCT02264353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005512|NCT02264353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005513|NCT02264353|Cholinergic Agents|cholinergic agents|mesh-ancestor
20005514|NCT02264353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20005515|NCT02264353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005516|NCT02264353|Nootropic Agents|nootropic agents|mesh-ancestor
20005517|NCT02264574|Obinutuzumab|obinutuzumab|mesh-list
20005518|NCT02264574|Chlorambucil|chlorambucil|mesh-list
20005519|NCT02264574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20005520|NCT02264574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005521|NCT02264574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20005522|NCT02264574|Alkylating Agents|alkylating agents|mesh-ancestor
20005523|NCT02264574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005524|NCT02264821|Morphine|morphine|mesh-list
20005525|NCT02264821|Ropivacaine|ropivacaine|mesh-list
20005526|NCT02264821|Anesthetics, Local|anesthetics, local|mesh-list
20005527|NCT02264821|Anesthetics|anesthetics|mesh-list
20005528|NCT02264821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20005529|NCT02264821|Narcotics|narcotics|mesh-ancestor
20005530|NCT02264821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20005531|NCT02264821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005532|NCT02264821|Analgesics|analgesics|mesh-ancestor
20005533|NCT02264821|Sensory System Agents|sensory system agents|mesh-ancestor
20005534|NCT02264821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005535|NCT02264990|Paclitaxel|paclitaxel|mesh-list
20005536|NCT02264990|Carboplatin|carboplatin|mesh-list
20005537|NCT02264990|Pemetrexed|pemetrexed|mesh-list
20005538|NCT02264990|Veliparib|veliparib|mesh-list
20005539|NCT02264990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20005540|NCT02264990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005541|NCT02264990|Tubulin Modulators|tubulin modulators|mesh-ancestor
20005542|NCT02264990|Antimitotic Agents|antimitotic agents|mesh-ancestor
20005543|NCT02264990|Mitosis Modulators|mitosis modulators|mesh-ancestor
20005544|NCT02264990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005545|NCT02264990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005546|NCT02264990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20005547|NCT02264990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20005548|NCT02264990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20005549|NCT02265224|Acetylcysteine|acetylcysteine|mesh-list
20005550|NCT02265224|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20005551|NCT02265224|Antiviral Agents|antiviral agents|mesh-ancestor
20005552|NCT02265224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20005553|NCT02265224|Expectorants|expectorants|mesh-ancestor
20005554|NCT02265224|Respiratory System Agents|respiratory system agents|mesh-ancestor
20005555|NCT02265224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20005556|NCT02265224|Antioxidants|antioxidants|mesh-ancestor
20005557|NCT02265224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005558|NCT02265224|Protective Agents|protective agents|mesh-ancestor
20005559|NCT02265224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005560|NCT02265224|Antidotes|antidotes|mesh-ancestor
20005561|NCT02265237|Ritonavir|ritonavir|mesh-list
20005562|NCT02265237|Ribavirin|ribavirin|mesh-list
20005563|NCT02265237|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20005564|NCT02265237|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20005565|NCT02265237|Protease Inhibitors|protease inhibitors|mesh-ancestor
20005566|NCT02265237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005567|NCT02265237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005568|NCT02265237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20005569|NCT02265237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20005570|NCT02265237|Antiviral Agents|antiviral agents|mesh-ancestor
20005571|NCT02265237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20005572|NCT02265237|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20005573|NCT02265237|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20005574|NCT02265237|Antimetabolites|antimetabolites|mesh-ancestor
20005575|NCT02265341|Ponatinib|ponatinib|mesh-list
20005576|NCT02265341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005577|NCT02265341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20005578|NCT02265341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005579|NCT02265341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005580|NCT02265510|Gemcitabine|gemcitabine|mesh-list
20005581|NCT02265510|Dexamethasone|dexamethasone|mesh-list
20005582|NCT02265510|Paclitaxel|paclitaxel|mesh-list
20005583|NCT02265510|Lenalidomide|lenalidomide|mesh-list
20005584|NCT02265510|Bortezomib|bortezomib|mesh-list
20005585|NCT02265510|Azacitidine|azacitidine|mesh-list
20005586|NCT02265510|Pomalidomide|pomalidomide|mesh-list
20005587|NCT02265510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20005588|NCT02265510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005589|NCT02265510|Tubulin Modulators|tubulin modulators|mesh-ancestor
20005590|NCT02265510|Antimitotic Agents|antimitotic agents|mesh-ancestor
20005591|NCT02265510|Mitosis Modulators|mitosis modulators|mesh-ancestor
20005592|NCT02265510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005593|NCT02265510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20005594|NCT02265510|Antiemetics|antiemetics|mesh-ancestor
20005595|NCT02265510|Autonomic Agents|autonomic agents|mesh-ancestor
20005596|NCT02265510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005597|NCT02265510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005598|NCT02265510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20005599|NCT02265510|Glucocorticoids|glucocorticoids|mesh-ancestor
20005600|NCT02265510|Hormones|hormones|mesh-ancestor
20005601|NCT02265510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20005602|NCT02265510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20005603|NCT02265510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20005604|NCT02265510|Antimetabolites|antimetabolites|mesh-ancestor
20005605|NCT02265510|Antiviral Agents|antiviral agents|mesh-ancestor
20005606|NCT02265510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20005607|NCT02265510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005608|NCT02265510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20005609|NCT02265510|Immunologic Factors|immunologic factors|mesh-ancestor
20005610|NCT02265510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20005611|NCT02265510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20005612|NCT02265510|Growth Substances|growth substances|mesh-ancestor
20005613|NCT02265510|Growth Inhibitors|growth inhibitors|mesh-ancestor
20005614|NCT02265744|Antibodies|antibodies|mesh-list
20005615|NCT02265744|Immunologic Factors|immunologic factors|mesh-ancestor
20005616|NCT02265744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005617|NCT02265796|Ranolazine|ranolazine|mesh-list
20005618|NCT02265796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20005619|NCT02265796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20005620|NCT02265796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005621|NCT02265913|Acyclovir|acyclovir|mesh-list
20005622|NCT02265913|Antiviral Agents|antiviral agents|mesh-ancestor
20005623|NCT02265913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20005624|NCT02265965|Nitroglycerin|nitroglycerin|mesh-list
20005625|NCT02265965|Vasodilator Agents|vasodilator agents|mesh-ancestor
20005626|NCT02266433|Dexamethasone|dexamethasone|mesh-list
20005627|NCT02266433|Ketorolac|ketorolac|mesh-list
20005628|NCT02266433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20005629|NCT02266433|Antiemetics|antiemetics|mesh-ancestor
20005630|NCT02266433|Autonomic Agents|autonomic agents|mesh-ancestor
20005631|NCT02266433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005632|NCT02266433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005633|NCT02266433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20005634|NCT02266433|Glucocorticoids|glucocorticoids|mesh-ancestor
20005635|NCT02266433|Hormones|hormones|mesh-ancestor
20005636|NCT02266433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20005637|NCT02266433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20005638|NCT02266433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005639|NCT02266433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20005640|NCT02266433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20005641|NCT02266433|Analgesics|analgesics|mesh-ancestor
20005642|NCT02266433|Sensory System Agents|sensory system agents|mesh-ancestor
20005643|NCT02266433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20005644|NCT02266433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20005645|NCT02266433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005646|NCT02266433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005647|NCT02266472|Metformin|metformin|mesh-list
20005648|NCT02266472|Empagliflozin|empagliflozin|mesh-list
20005649|NCT02266472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20005650|NCT02266472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005651|NCT02266472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20005652|NCT02266472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005653|NCT02266706|Tazobactam|tazobactam|mesh-list
20005654|NCT02266706|Ceftolozane|ceftolozane|mesh-list
20005655|NCT02266706|Cephalosporins|cephalosporins|mesh-list
20005656|NCT02266706|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
20005657|NCT02266706|Penicillanic Acid|penicillanic acid|mesh-list
20005658|NCT02266706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20005659|NCT02266706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20005660|NCT02266706|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20005661|NCT02266706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005662|NCT02266706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005663|NCT02266706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20005664|NCT02266706|Renal Agents|renal agents|mesh-ancestor
20005665|NCT02266810|Mometasone Furoate|mometasone furoate|mesh-list
20005666|NCT02266810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20005667|NCT02266810|Dermatologic Agents|dermatologic agents|mesh-ancestor
20005668|NCT02266810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20005669|NCT02266888|Rituximab|rituximab|mesh-list
20005670|NCT02266888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20005671|NCT02266888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005672|NCT02266888|Immunologic Factors|immunologic factors|mesh-ancestor
20005673|NCT02266888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557832|NCT01955135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20557833|NCT01955135|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20557834|NCT01955135|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20557835|NCT01955135|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20557836|NCT01955135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20557837|NCT01955135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557838|NCT01955135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20557839|NCT01955135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20557840|NCT01955174|Botulinum Toxins|botulinum toxins|mesh-list
20005674|NCT02266888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20005675|NCT02267083|Doxorubicin|doxorubicin|mesh-list
20005676|NCT02267083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20005677|NCT02267083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005678|NCT02267083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20005679|NCT02267083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20005680|NCT02267083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005681|NCT02267083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005682|NCT02267187|Anesthetics|anesthetics|mesh-list
20005683|NCT02267187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20005684|NCT02267187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005685|NCT02267538|Dexmedetomidine|dexmedetomidine|mesh-list
20005686|NCT02267538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20005687|NCT02267538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20005688|NCT02267538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005689|NCT02267538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20005690|NCT02267538|Analgesics|analgesics|mesh-ancestor
20005691|NCT02267538|Sensory System Agents|sensory system agents|mesh-ancestor
20005692|NCT02267538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005693|NCT02267538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20005694|NCT02267538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20005695|NCT02267538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20005696|NCT02267538|Adrenergic Agents|adrenergic agents|mesh-ancestor
20005697|NCT02267538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20005698|NCT02267538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290156|NCT04275661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20290157|NCT04275661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290158|NCT04275661|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20290159|NCT04275661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20290160|NCT04275661|Anesthetics, General|anesthetics, general|mesh-ancestor
20290161|NCT04275661|Anesthetics|anesthetics|mesh-ancestor
20290162|NCT04275661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20290163|NCT04275661|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20290164|NCT04275661|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20290165|NCT04275661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20290166|NCT04275661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290167|NCT04275661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20557841|NCT01955174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19459810|NCT03358212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19459811|NCT03358212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290168|NCT04275661|Anticonvulsants|anticonvulsants|mesh-ancestor
20290169|NCT04275661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20290170|NCT04275661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20290171|NCT04275661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20290172|NCT04275661|Tocolytic Agents|tocolytic agents|mesh-ancestor
20290173|NCT04275661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20290174|NCT04275661|Anesthetics, Local|anesthetics, local|mesh-ancestor
20290175|NCT04256317|Azacitidine|azacitidine|mesh-list
20290176|NCT04256317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20290177|NCT04256317|Antimetabolites|antimetabolites|mesh-ancestor
20290178|NCT04256317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005699|NCT02267746|Nicotinic Acids|nicotinic acids|mesh-list
20005700|NCT02267746|Tazarotene|tazarotene|mesh-list
20005701|NCT02267746|Dermatologic Agents|dermatologic agents|mesh-ancestor
20005702|NCT02267746|Keratolytic Agents|keratolytic agents|mesh-ancestor
20005703|NCT02267746|Vitamin B Complex|vitamin b complex|mesh-ancestor
20005704|NCT02267746|Vitamins|vitamins|mesh-ancestor
20005705|NCT02267746|Micronutrients|micronutrients|mesh-ancestor
20005706|NCT02267746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005707|NCT02267772|Acetaminophen|acetaminophen|mesh-list
20005708|NCT02267772|Morphine|morphine|mesh-list
20005709|NCT02267772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20005710|NCT02267772|Narcotics|narcotics|mesh-ancestor
20005711|NCT02267772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20005712|NCT02267772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005713|NCT02267772|Analgesics|analgesics|mesh-ancestor
20005714|NCT02267772|Sensory System Agents|sensory system agents|mesh-ancestor
20005715|NCT02267772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005716|NCT02267772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20005717|NCT02267772|Antipyretics|antipyretics|mesh-ancestor
20005718|NCT02268045|Rituximab|rituximab|mesh-list
20005719|NCT02268045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20005720|NCT02268045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005721|NCT02268045|Immunologic Factors|immunologic factors|mesh-ancestor
20005722|NCT02268045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005723|NCT02268045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20005724|NCT02268058|Acetaminophen|acetaminophen|mesh-list
20005725|NCT02268058|Ibuprofen|ibuprofen|mesh-list
20005726|NCT02268058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20005727|NCT02268058|Analgesics|analgesics|mesh-ancestor
20005728|NCT02268058|Sensory System Agents|sensory system agents|mesh-ancestor
20005729|NCT02268058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005730|NCT02268058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005731|NCT02268058|Antipyretics|antipyretics|mesh-ancestor
20005732|NCT02268058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20005733|NCT02268058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20005734|NCT02268058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20005735|NCT02268058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20005736|NCT02268058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005737|NCT02268058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005738|NCT02268214|Dapagliflozin|dapagliflozin|mesh-list
20005739|NCT02268214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20005740|NCT02268214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005741|NCT02268214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20005742|NCT02268214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005743|NCT02268396|Glycopyrrolate|glycopyrrolate|mesh-list
20005744|NCT02268396|Formoterol Fumarate|formoterol fumarate|mesh-list
20005745|NCT02268396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20005746|NCT02268396|Autonomic Agents|autonomic agents|mesh-ancestor
20005747|NCT02268396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005748|NCT02268396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005749|NCT02268396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20005750|NCT02268396|Respiratory System Agents|respiratory system agents|mesh-ancestor
20005751|NCT02268396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20005752|NCT02268396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20005753|NCT02268396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20005754|NCT02268396|Adrenergic Agents|adrenergic agents|mesh-ancestor
20005755|NCT02268396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20005756|NCT02268396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005757|NCT02268396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20005758|NCT02268396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20005759|NCT02268396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20005760|NCT02268396|Cholinergic Agents|cholinergic agents|mesh-ancestor
20005761|NCT02268864|Simeprevir|simeprevir|mesh-list
20005762|NCT02268864|Antiviral Agents|antiviral agents|mesh-ancestor
20005763|NCT02268864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20005764|NCT02268864|Protease Inhibitors|protease inhibitors|mesh-ancestor
20005765|NCT02268864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005766|NCT02268864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005767|NCT02268955|Ibuprofen|ibuprofen|mesh-list
20005768|NCT02268955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20005769|NCT02268955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20005770|NCT02268955|Analgesics|analgesics|mesh-ancestor
20005771|NCT02268955|Sensory System Agents|sensory system agents|mesh-ancestor
20005772|NCT02268955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005773|NCT02268955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005774|NCT02268955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20005775|NCT02268955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20005776|NCT02268955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20005777|NCT02268955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005778|NCT02268955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005779|NCT02269163|Immunoglobulins|immunoglobulins|mesh-list
20005780|NCT02269163|Antibodies|antibodies|mesh-list
20005781|NCT02269163|gamma-Globulins|gamma-globulins|mesh-list
20005782|NCT02269163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20557842|NCT01955174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20557843|NCT01955174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557844|NCT01955174|Cholinergic Agents|cholinergic agents|mesh-ancestor
20557845|NCT01955174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20557846|NCT01955174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557847|NCT01955187|Methylprednisolone|methylprednisolone|mesh-list
20557848|NCT01955187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20557849|NCT01955187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20557850|NCT01955187|Prednisolone|prednisolone|mesh-list
20557851|NCT01955187|Prednisolone acetate|prednisolone acetate|mesh-list
20557852|NCT01955187|Cyclophosphamide|cyclophosphamide|mesh-list
20557853|NCT01955187|Rituximab|rituximab|mesh-list
20557854|NCT01955187|Tacrolimus|tacrolimus|mesh-list
20557855|NCT01955187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20557856|NCT01955187|Prednisolone phosphate|prednisolone phosphate|mesh-list
20557857|NCT01955187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20557858|NCT01955187|Immunologic Factors|immunologic factors|mesh-ancestor
20557859|NCT01955187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557860|NCT01955187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20557861|NCT01955187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20557862|NCT01955187|Alkylating Agents|alkylating agents|mesh-ancestor
20557863|NCT01955187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005783|NCT02269163|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20005784|NCT02269163|Immunoglobulin G|immunoglobulin g|mesh-list
20005785|NCT02269163|Immunologic Factors|immunologic factors|mesh-ancestor
20005786|NCT02269163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005787|NCT02269241|Drospirenone|drospirenone|mesh-list
20005788|NCT02269241|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20005789|NCT02269241|Hormone Antagonists|hormone antagonists|mesh-ancestor
20005790|NCT02269241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20005791|NCT02269241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005792|NCT02269241|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20005793|NCT02269241|Diuretics|diuretics|mesh-ancestor
20005794|NCT02269241|Natriuretic Agents|natriuretic agents|mesh-ancestor
20005795|NCT02269943|Azacitidine|azacitidine|mesh-list
20005796|NCT02269943|Cc-486|cc-486|mesh-list
20005797|NCT02269943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20005798|NCT02269943|Antimetabolites|antimetabolites|mesh-ancestor
20005799|NCT02269943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005800|NCT02269943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005801|NCT02269943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005802|NCT02270242|Aspirin|aspirin|mesh-list
20005803|NCT02270242|Ticagrelor|ticagrelor|mesh-list
20005804|NCT02270242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20005805|NCT02270242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20005806|NCT02270242|Analgesics|analgesics|mesh-ancestor
20005807|NCT02270242|Sensory System Agents|sensory system agents|mesh-ancestor
20005808|NCT02270242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005809|NCT02270242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005810|NCT02270242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20005811|NCT02270242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20005812|NCT02270242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20005813|NCT02270242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20005814|NCT02270242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005815|NCT02270242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20005816|NCT02270242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20005817|NCT02270242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005818|NCT02270242|Antipyretics|antipyretics|mesh-ancestor
20005819|NCT02270242|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20005820|NCT02270242|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20005821|NCT02270242|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20005822|NCT02270242|Purinergic Agents|purinergic agents|mesh-ancestor
20005823|NCT02270242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20005824|NCT02270255|Lidocaine|lidocaine|mesh-list
20005825|NCT02270255|Ropivacaine|ropivacaine|mesh-list
20005826|NCT02270255|Anesthetics, Local|anesthetics, local|mesh-ancestor
20005827|NCT02270255|Anesthetics|anesthetics|mesh-ancestor
20005828|NCT02270255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20005829|NCT02270255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005830|NCT02270255|Sensory System Agents|sensory system agents|mesh-ancestor
20005831|NCT02270255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005832|NCT02270255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20005833|NCT02270255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20005834|NCT02270255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20005835|NCT02270255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20005836|NCT02270255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005837|NCT02270736|Botulinum Toxins|botulinum toxins|mesh-list
20005838|NCT02270736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20005839|NCT02270736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20005840|NCT02270736|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20005841|NCT02270736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20005842|NCT02270736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20005843|NCT02270736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005844|NCT02270736|Cholinergic Agents|cholinergic agents|mesh-ancestor
20005845|NCT02270736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20005846|NCT02270736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005847|NCT02270736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20005848|NCT02270736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005849|NCT02270944|Vaccines|vaccines|mesh-list
20005850|NCT02270944|Immunologic Factors|immunologic factors|mesh-ancestor
20005851|NCT02270944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005852|NCT02270983|Linaclotide|linaclotide|mesh-list
20005853|NCT02270983|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20005854|NCT02270983|Enzyme Activators|enzyme activators|mesh-ancestor
20005855|NCT02270983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005856|NCT02270983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20005857|NCT02271217|4-Aminopyridine|4-aminopyridine|mesh-list
20005858|NCT02271217|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20005859|NCT02271217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20005860|NCT02271217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005861|NCT02271425|Evacetrapib|evacetrapib|mesh-list
20005862|NCT02271425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20005863|NCT02271425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20005864|NCT02271425|Antimetabolites|antimetabolites|mesh-ancestor
20005865|NCT02271425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005866|NCT02271425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20005867|NCT02271698|Dexamethasone|dexamethasone|mesh-list
20005868|NCT02271698|Dexamethasone acetate|dexamethasone acetate|mesh-list
20005869|NCT02271698|BB 1101|bb 1101|mesh-list
20005870|NCT02271698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20005871|NCT02271698|Antiemetics|antiemetics|mesh-ancestor
20005872|NCT02271698|Autonomic Agents|autonomic agents|mesh-ancestor
20005873|NCT02271698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005874|NCT02271698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005875|NCT02271698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20005876|NCT02271698|Glucocorticoids|glucocorticoids|mesh-ancestor
20005877|NCT02271698|Hormones|hormones|mesh-ancestor
20005878|NCT02271698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20005879|NCT02271698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20005880|NCT02271698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005881|NCT02271698|Protease Inhibitors|protease inhibitors|mesh-ancestor
20005882|NCT02271698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005883|NCT02271698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005884|NCT02271854|Diclofenac|diclofenac|mesh-list
20005885|NCT02271854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20005886|NCT02271854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20005887|NCT02271854|Analgesics|analgesics|mesh-ancestor
20005888|NCT02271854|Sensory System Agents|sensory system agents|mesh-ancestor
20005889|NCT02271854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005890|NCT02271854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005891|NCT02271854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20005892|NCT02271854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20005893|NCT02271854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20005894|NCT02271854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005895|NCT02271854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005896|NCT02271906|Afatinib|afatinib|mesh-list
20005897|NCT02271906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005898|NCT02271906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20005899|NCT02271906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005900|NCT02271906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005901|NCT02271984|Praziquantel|praziquantel|mesh-list
20005902|NCT02271984|Anthelmintics|anthelmintics|mesh-ancestor
20005903|NCT02271984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20005904|NCT02271984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20005905|NCT02272413|Bevacizumab|bevacizumab|mesh-list
20005906|NCT02272413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20005907|NCT02272413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005908|NCT02272413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20005909|NCT02272413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20005910|NCT02272413|Growth Substances|growth substances|mesh-ancestor
20005911|NCT02272413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005912|NCT02272413|Growth Inhibitors|growth inhibitors|mesh-ancestor
20005913|NCT02272725|Ibuprofen|ibuprofen|mesh-list
20005914|NCT02272725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20005915|NCT02272725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20005916|NCT02272725|Analgesics|analgesics|mesh-ancestor
20005917|NCT02272725|Sensory System Agents|sensory system agents|mesh-ancestor
20005918|NCT02272725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20005919|NCT02272725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005920|NCT02272725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20005921|NCT02272725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20005922|NCT02272725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20005923|NCT02272725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005924|NCT02272725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005925|NCT02272777|Imatinib Mesylate|imatinib mesylate|mesh-list
20005926|NCT02272777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005927|NCT02272777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20557864|NCT01955187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557865|NCT01955187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20005928|NCT02272777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005929|NCT02272777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459812|NCT03358082|Hydrocortisone|hydrocortisone|mesh-list
20005930|NCT02272816|Carboplatin|carboplatin|mesh-list
20005931|NCT02272816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005932|NCT02272842|Vitamin B 12|vitamin b 12|mesh-list
20005933|NCT02272842|Hydroxocobalamin|hydroxocobalamin|mesh-list
20005934|NCT02272842|Vitamins|vitamins|mesh-ancestor
20005935|NCT02272842|Micronutrients|micronutrients|mesh-ancestor
20005936|NCT02272842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005937|NCT02272842|Vitamin B Complex|vitamin b complex|mesh-ancestor
20005938|NCT02272842|Hematinics|hematinics|mesh-ancestor
20005939|NCT02273050|Metformin|metformin|mesh-list
20005940|NCT02273050|Saxagliptin|saxagliptin|mesh-list
20005941|NCT02273050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20005942|NCT02273050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005943|NCT02273050|Incretins|incretins|mesh-ancestor
20005944|NCT02273050|Hormones|hormones|mesh-ancestor
20005945|NCT02273050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20005946|NCT02273050|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20005947|NCT02273050|Protease Inhibitors|protease inhibitors|mesh-ancestor
20005948|NCT02273050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005949|NCT02273050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005950|NCT02273115|Oxytocin|oxytocin|mesh-list
20005951|NCT02273115|Oxytocics|oxytocics|mesh-ancestor
20005952|NCT02273115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20005953|NCT02273115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005954|NCT02273180|Insulin|insulin|mesh-list
20005955|NCT02273180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20005956|NCT02273180|Insulin Glargine|insulin glargine|mesh-list
20005957|NCT02273180|Insulin Lispro|insulin lispro|mesh-list
20005958|NCT02273180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20005959|NCT02273180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005960|NCT02273726|Epoetin Alfa|epoetin alfa|mesh-list
20005961|NCT02273726|Hematinics|hematinics|mesh-ancestor
20005962|NCT02273973|Letrozole|letrozole|mesh-list
20005963|NCT02273973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005964|NCT02273973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20005965|NCT02273973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20005966|NCT02273973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005967|NCT02273973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005968|NCT02273973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20005969|NCT02273973|Hormone Antagonists|hormone antagonists|mesh-ancestor
20005970|NCT02273973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20005971|NCT02273973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005972|NCT02274038|Pemetrexed|pemetrexed|mesh-list
20005973|NCT02274038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20005974|NCT02274038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20005975|NCT02274038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005976|NCT02274038|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20005977|NCT02274038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20005978|NCT02274311|Clomiphene|clomiphene|mesh-list
20005979|NCT02274311|Enclomiphene|enclomiphene|mesh-list
20005980|NCT02274311|Zuclomiphene|zuclomiphene|mesh-list
20005981|NCT02274311|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20005982|NCT02274311|Hormone Antagonists|hormone antagonists|mesh-ancestor
20005983|NCT02274311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20005984|NCT02274311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005985|NCT02274311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20005986|NCT02274311|Fertility Agents|fertility agents|mesh-ancestor
20005987|NCT02274311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20005988|NCT02274311|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20005989|NCT02274311|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20005990|NCT02274766|Amantadine|amantadine|mesh-list
20005991|NCT02274766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20005992|NCT02274766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20005993|NCT02274766|Antiviral Agents|antiviral agents|mesh-ancestor
20005994|NCT02274766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20005995|NCT02274766|Dopamine Agents|dopamine agents|mesh-ancestor
20005996|NCT02274766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20005997|NCT02274766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20005998|NCT02274766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20005999|NCT02274766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20006000|NCT02274766|Analgesics|analgesics|mesh-ancestor
20006001|NCT02274766|Sensory System Agents|sensory system agents|mesh-ancestor
20006002|NCT02274766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006003|NCT02274792|Etanercept|etanercept|mesh-list
20006004|NCT02274792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20006005|NCT02274792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20006006|NCT02274792|Analgesics|analgesics|mesh-ancestor
20006007|NCT02274792|Sensory System Agents|sensory system agents|mesh-ancestor
20006008|NCT02274792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006009|NCT02274792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006010|NCT02274792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20006011|NCT02274792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20006012|NCT02274792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20006013|NCT02274792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20006014|NCT02274792|Immunologic Factors|immunologic factors|mesh-ancestor
20557866|NCT01955187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20557867|NCT01955187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20557868|NCT01955187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557869|NCT01955187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20557870|NCT01955187|Antiemetics|antiemetics|mesh-ancestor
20557871|NCT01955187|Autonomic Agents|autonomic agents|mesh-ancestor
20557872|NCT01955187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20557873|NCT01955187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20557874|NCT01955187|Glucocorticoids|glucocorticoids|mesh-ancestor
20557875|NCT01955187|Hormones|hormones|mesh-ancestor
20557876|NCT01955187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20557877|NCT01955187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20557878|NCT01955187|Protective Agents|protective agents|mesh-ancestor
20557879|NCT01955187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20557880|NCT01955200|Cilostazol|cilostazol|mesh-list
20557881|NCT01955200|Clopidogrel|clopidogrel|mesh-list
20557882|NCT01955200|Ticagrelor|ticagrelor|mesh-list
20557883|NCT01955200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20557884|NCT01955200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20557885|NCT01955200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20557886|NCT01955200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20557887|NCT01955200|Purinergic Agents|purinergic agents|mesh-ancestor
20557888|NCT01955200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20557889|NCT01955200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557890|NCT01955200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557891|NCT01955200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20557892|NCT01955200|Autonomic Agents|autonomic agents|mesh-ancestor
20557893|NCT01955200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20557894|NCT01955200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20557895|NCT01955200|Respiratory System Agents|respiratory system agents|mesh-ancestor
20557896|NCT01955200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20006015|NCT02274870|Bupivacaine|bupivacaine|mesh-list
20006016|NCT02274870|Anesthetics, Local|anesthetics, local|mesh-ancestor
20006017|NCT02274870|Anesthetics|anesthetics|mesh-ancestor
20006018|NCT02274870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20006019|NCT02274870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006020|NCT02274870|Sensory System Agents|sensory system agents|mesh-ancestor
20006021|NCT02274870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006022|NCT02274948|Metformin|metformin|mesh-list
20006023|NCT02274948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20006024|NCT02274948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006025|NCT02275052|Albuterol|albuterol|mesh-list
20006026|NCT02275052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20006027|NCT02275052|Autonomic Agents|autonomic agents|mesh-ancestor
20006028|NCT02275052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006029|NCT02275052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006030|NCT02275052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20006031|NCT02275052|Respiratory System Agents|respiratory system agents|mesh-ancestor
20006032|NCT02275052|Tocolytic Agents|tocolytic agents|mesh-ancestor
20006033|NCT02275052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20006034|NCT02275052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20006035|NCT02275052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20006036|NCT02275052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20006037|NCT02275052|Adrenergic Agents|adrenergic agents|mesh-ancestor
20006038|NCT02275052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20006039|NCT02275052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006040|NCT02275156|Evolocumab|evolocumab|mesh-list
20006041|NCT02275156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20006042|NCT02275156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20006043|NCT02275156|Antimetabolites|antimetabolites|mesh-ancestor
20006044|NCT02275156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006045|NCT02275156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20006046|NCT02275338|Lanreotide|lanreotide|mesh-list
20006047|NCT02275338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290179|NCT04256317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290180|NCT04256317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290181|NCT04228042|Infigratinib|infigratinib|mesh-list
20290182|NCT04228042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290183|NCT04224987|Azithromycin|azithromycin|mesh-list
20290184|NCT04224987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20290185|NCT04224987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20290186|NCT04223752|Tazobactam|tazobactam|mesh-list
20290187|NCT04223752|Ceftolozane|ceftolozane|mesh-list
19459813|NCT03358082|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19459814|NCT03358082|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19459815|NCT03358082|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19459816|NCT03358082|Tacrolimus|tacrolimus|mesh-list
19459817|NCT03358082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19459818|NCT03358082|Immunologic Factors|immunologic factors|mesh-ancestor
20290188|NCT04223752|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
20290189|NCT04223752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20290190|NCT04223752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20290191|NCT04223752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20290192|NCT04223752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290193|NCT04223752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290194|NCT04223752|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20290195|NCT04223752|Renal Agents|renal agents|mesh-ancestor
20290196|NCT04207619|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20290197|NCT04207619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290198|NCT04207177|Mycophenolic Acid|mycophenolic acid|mesh-list
20290199|NCT04207177|Tacrolimus|tacrolimus|mesh-list
20290200|NCT04207177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20290201|NCT04207177|Immunologic Factors|immunologic factors|mesh-ancestor
20290202|NCT04207177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290203|NCT04207177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20290204|NCT04207177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290205|NCT04207177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290206|NCT04207177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20290207|NCT04207177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290208|NCT04207177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20290209|NCT04207177|Antitubercular Agents|antitubercular agents|mesh-ancestor
20290210|NCT04207177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20290211|NCT04207177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20290212|NCT04205136|Spironolactone|spironolactone|mesh-list
20290213|NCT04205136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20290214|NCT04205136|Hormone Antagonists|hormone antagonists|mesh-ancestor
20006048|NCT02275611|Oxytocin|oxytocin|mesh-list
20006049|NCT02275611|Oxytocics|oxytocics|mesh-ancestor
20006050|NCT02275611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20006051|NCT02275611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006052|NCT02275780|Ritonavir|ritonavir|mesh-list
20006053|NCT02275780|Darunavir|darunavir|mesh-list
20006054|NCT02275780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20006055|NCT02275780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20006056|NCT02275780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20006057|NCT02275780|Protease Inhibitors|protease inhibitors|mesh-ancestor
20006058|NCT02275780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006059|NCT02275780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006060|NCT02275780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20006061|NCT02275780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20006062|NCT02275780|Antiviral Agents|antiviral agents|mesh-ancestor
20006063|NCT02275780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20006064|NCT02275780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20006065|NCT02275780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20006066|NCT02275780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20006067|NCT02275780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20006068|NCT02276027|Ceritinib|ceritinib|mesh-list
20006069|NCT02276027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006070|NCT02276027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20006071|NCT02276027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006072|NCT02276027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006073|NCT02276040|Bupivacaine|bupivacaine|mesh-list
20006074|NCT02276040|Anesthetics, Local|anesthetics, local|mesh-ancestor
20006075|NCT02276040|Anesthetics|anesthetics|mesh-ancestor
20006076|NCT02276040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20006077|NCT02276040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006078|NCT02276040|Sensory System Agents|sensory system agents|mesh-ancestor
20006079|NCT02276040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006080|NCT02276222|Glycopyrrolate|glycopyrrolate|mesh-list
20006081|NCT02276222|Tiotropium Bromide|tiotropium bromide|mesh-list
20006082|NCT02276222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20006083|NCT02276222|Autonomic Agents|autonomic agents|mesh-ancestor
20006084|NCT02276222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006085|NCT02276222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006086|NCT02276222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20006087|NCT02276222|Respiratory System Agents|respiratory system agents|mesh-ancestor
20006088|NCT02276222|Parasympatholytics|parasympatholytics|mesh-ancestor
20006089|NCT02276222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20006090|NCT02276222|Cholinergic Agents|cholinergic agents|mesh-ancestor
20006091|NCT02276222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20006092|NCT02276222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006093|NCT02276222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20006094|NCT02276222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20006095|NCT02276274|Alogliptin|alogliptin|mesh-list
20006096|NCT02276274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20006097|NCT02276274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006098|NCT02276274|Incretins|incretins|mesh-ancestor
20006099|NCT02276274|Hormones|hormones|mesh-ancestor
20006100|NCT02276274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20006101|NCT02276274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19459819|NCT03358082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459820|NCT03358082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19459821|NCT03358082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459822|NCT03358082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459823|NCT03358082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19459824|NCT03358017|Zoledronic Acid|zoledronic acid|mesh-list
19459825|NCT03358017|Atorvastatin|atorvastatin|mesh-list
19459826|NCT03358017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19459827|NCT03358017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19459828|NCT03358017|Antimetabolites|antimetabolites|mesh-ancestor
19459829|NCT03358017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459830|NCT03358017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20006102|NCT02276274|Protease Inhibitors|protease inhibitors|mesh-ancestor
20006103|NCT02276274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006104|NCT02276274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006105|NCT02276482|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20006106|NCT02276482|Metronidazole|metronidazole|mesh-list
20006107|NCT02276482|Vancomycin|vancomycin|mesh-list
20006108|NCT02276482|Clindamycin|clindamycin|mesh-list
20006109|NCT02276482|Cefazolin|cefazolin|mesh-list
20006110|NCT02276482|Linezolid|linezolid|mesh-list
20006111|NCT02276482|Cephalexin|cephalexin|mesh-list
20006112|NCT02276482|Aztreonam|aztreonam|mesh-list
20006113|NCT02276482|Tedizolid|tedizolid|mesh-list
20006114|NCT02276482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20006115|NCT02276482|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20006116|NCT02276482|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20006117|NCT02276482|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20006118|NCT02276482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006119|NCT02276482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006120|NCT02276612|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20006121|NCT02276612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20006122|NCT02276612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20006123|NCT02276612|Antiviral Agents|antiviral agents|mesh-ancestor
20006124|NCT02276612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20006125|NCT02276872|Treprostinil|treprostinil|mesh-list
20006126|NCT02276872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20006127|NCT02277249|Digoxin|digoxin|mesh-list
20006128|NCT02277249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20006129|NCT02277249|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20006130|NCT02277249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006131|NCT02277249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006132|NCT02277249|Protective Agents|protective agents|mesh-ancestor
20006133|NCT02277249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006134|NCT02277548|Pregabalin|pregabalin|mesh-list
20006135|NCT02277548|Analgesics|analgesics|mesh-ancestor
20006136|NCT02277548|Sensory System Agents|sensory system agents|mesh-ancestor
20006137|NCT02277548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006138|NCT02277548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006139|NCT02277548|Anticonvulsants|anticonvulsants|mesh-ancestor
20006140|NCT02277548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20006141|NCT02277548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006142|NCT02277548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006143|NCT02277548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20006144|NCT02277548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20006145|NCT02277548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20006146|NCT02277548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20006147|NCT02277548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20006148|NCT02277691|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20006149|NCT02277691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20006150|NCT02277691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20006151|NCT02277691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006152|NCT02277743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20006153|NCT02277743|Immunologic Factors|immunologic factors|mesh-ancestor
20006154|NCT02277743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006155|NCT02277769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20006156|NCT02277769|Immunologic Factors|immunologic factors|mesh-ancestor
20006157|NCT02277769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006158|NCT02277990|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20006159|NCT02277990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20006160|NCT02278003|Propofol|propofol|mesh-list
20006161|NCT02278003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20006162|NCT02278003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20006163|NCT02278003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006164|NCT02278003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20006165|NCT02278003|Anesthetics, General|anesthetics, general|mesh-ancestor
20006166|NCT02278003|Anesthetics|anesthetics|mesh-ancestor
20006167|NCT02278263|Tranexamic Acid|tranexamic acid|mesh-list
20006168|NCT02278263|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20006169|NCT02278263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20006170|NCT02278263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006171|NCT02278263|Hemostatics|hemostatics|mesh-ancestor
20006172|NCT02278263|Coagulants|coagulants|mesh-ancestor
20006173|NCT02278341|Epoetin Alfa|epoetin alfa|mesh-list
20006174|NCT02278341|Darbepoetin alfa|darbepoetin alfa|mesh-list
20006175|NCT02278341|Hematinics|hematinics|mesh-ancestor
20006176|NCT02278471|Losartan|losartan|mesh-list
20006177|NCT02278471|Amlodipine|amlodipine|mesh-list
20006178|NCT02278471|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20006179|NCT02278471|Atorvastatin|atorvastatin|mesh-list
20006180|NCT02278471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20006181|NCT02278471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20006182|NCT02278471|Antimetabolites|antimetabolites|mesh-ancestor
20006183|NCT02278471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006184|NCT02278471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20006185|NCT02278471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20006186|NCT02278471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006187|NCT02278471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20006188|NCT02278471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20006189|NCT02278471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006190|NCT02278471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20006191|NCT02278471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006192|NCT02278471|Vasodilator Agents|vasodilator agents|mesh-ancestor
20006193|NCT02278471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20006194|NCT02278471|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20006195|NCT02278471|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20006196|NCT02278471|Diuretics|diuretics|mesh-ancestor
20006197|NCT02278471|Natriuretic Agents|natriuretic agents|mesh-ancestor
20006198|NCT02278471|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20006199|NCT02278562|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20006200|NCT02278562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20006201|NCT02278614|Timolol|timolol|mesh-list
20006202|NCT02278614|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20006203|NCT02278614|Latanoprost|latanoprost|mesh-list
20006204|NCT02278614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20006205|NCT02278614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20006206|NCT02278614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20006207|NCT02278614|Adrenergic Agents|adrenergic agents|mesh-ancestor
20006208|NCT02278614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20006209|NCT02278614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006210|NCT02278614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006211|NCT02278614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20006212|NCT02278614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20006213|NCT02279407|Dapagliflozin|dapagliflozin|mesh-list
20006214|NCT02279407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20006215|NCT02279407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006216|NCT02279407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20006217|NCT02279407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006218|NCT02279641|Allopurinol|allopurinol|mesh-list
20006219|NCT02279641|Verinurad|verinurad|mesh-list
20006220|NCT02279641|Antimetabolites|antimetabolites|mesh-ancestor
20006221|NCT02279641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006222|NCT02279641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006223|NCT02279641|Gout Suppressants|gout suppressants|mesh-ancestor
20557897|NCT01955200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20557898|NCT01955200|Vasodilator Agents|vasodilator agents|mesh-ancestor
20557899|NCT01955200|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20557900|NCT01955200|Protective Agents|protective agents|mesh-ancestor
20557901|NCT01955200|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20557902|NCT01955200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20557903|NCT01955200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557904|NCT01955213|Methylnaltrexone|methylnaltrexone|mesh-list
20557905|NCT01955213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20557906|NCT01955213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557907|NCT01955213|Sensory System Agents|sensory system agents|mesh-ancestor
20557908|NCT01955213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20557909|NCT01955252|Azithromycin|azithromycin|mesh-list
20006224|NCT02279641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20006225|NCT02279641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20006226|NCT02279641|Antioxidants|antioxidants|mesh-ancestor
20006227|NCT02279641|Protective Agents|protective agents|mesh-ancestor
20006228|NCT02279641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006229|NCT02279667|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
20006230|NCT02279667|Anticonvulsants|anticonvulsants|mesh-ancestor
20006231|NCT02279667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20006232|NCT02279667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20006233|NCT02279667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006234|NCT02279667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006235|NCT02279732|Paclitaxel|paclitaxel|mesh-list
20006236|NCT02279732|Carboplatin|carboplatin|mesh-list
20006237|NCT02279732|Ipilimumab|ipilimumab|mesh-list
20006238|NCT02279732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20006239|NCT02279732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006240|NCT02279732|Tubulin Modulators|tubulin modulators|mesh-ancestor
20006241|NCT02279732|Antimitotic Agents|antimitotic agents|mesh-ancestor
20006242|NCT02279732|Mitosis Modulators|mitosis modulators|mesh-ancestor
20006243|NCT02279732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006244|NCT02279732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20006245|NCT02279732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20006246|NCT02279862|Ipilimumab|ipilimumab|mesh-list
20006247|NCT02279862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20006248|NCT02279862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006249|NCT02279862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20006250|NCT02279862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006251|NCT02280044|Rifaximin|rifaximin|mesh-list
20006252|NCT02280044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20006253|NCT02280044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20006254|NCT02280044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20006255|NCT02280096|4-Aminopyridine|4-aminopyridine|mesh-list
20006256|NCT02280096|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20006257|NCT02280096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006258|NCT02280096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006259|NCT02280421|Cyclosporine|cyclosporine|mesh-list
20006260|NCT02280421|Cyclosporins|cyclosporins|mesh-list
20006261|NCT02280421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006262|NCT02280421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557910|NCT01955252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20557911|NCT01955252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20557912|NCT01955317|Chlorhexidine|chlorhexidine|mesh-list
20557913|NCT01955317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20557914|NCT01955317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20557915|NCT01955317|Disinfectants|disinfectants|mesh-ancestor
20006263|NCT02280421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20006264|NCT02280421|Immunologic Factors|immunologic factors|mesh-ancestor
20006265|NCT02280421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006266|NCT02280421|Antifungal Agents|antifungal agents|mesh-ancestor
20006267|NCT02280421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20006268|NCT02280421|Dermatologic Agents|dermatologic agents|mesh-ancestor
20006269|NCT02280421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20006270|NCT02280421|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20006271|NCT02280473|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20006272|NCT02280473|Laxatives|laxatives|mesh-ancestor
20006273|NCT02280473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20006274|NCT02280811|Aldesleukin|aldesleukin|mesh-list
20006275|NCT02280811|Cyclophosphamide|cyclophosphamide|mesh-list
20006276|NCT02280811|Fludarabine|fludarabine|mesh-list
20006277|NCT02280811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20006278|NCT02280811|Immunologic Factors|immunologic factors|mesh-ancestor
20006279|NCT02280811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006280|NCT02280811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20006281|NCT02280811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20557916|NCT01955408|Cholinergic Antagonists|cholinergic antagonists|mesh-list
20557917|NCT01955408|Cholinergic Agents|cholinergic agents|mesh-ancestor
20557918|NCT01955408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20557919|NCT01955408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557920|NCT01955408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557921|NCT01955421|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20557922|NCT01955421|Gefitinib|gefitinib|mesh-list
20557923|NCT01955421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557924|NCT01955421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20557925|NCT01955421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20557926|NCT01955421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557927|NCT01955460|Aldesleukin|aldesleukin|mesh-list
20557928|NCT01955460|Cyclophosphamide|cyclophosphamide|mesh-list
20557929|NCT01955460|Fludarabine|fludarabine|mesh-list
20557930|NCT01955460|Fludarabine phosphate|fludarabine phosphate|mesh-list
20557931|NCT01955460|Interleukin-2|interleukin-2|mesh-list
20557932|NCT01955460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20557933|NCT01955460|Immunologic Factors|immunologic factors|mesh-ancestor
20557934|NCT01955460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557935|NCT01955460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20557936|NCT01955460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20557937|NCT01955460|Alkylating Agents|alkylating agents|mesh-ancestor
20557938|NCT01955460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557939|NCT01955460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20557940|NCT01955460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20557941|NCT01955460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20557942|NCT01955460|Antimetabolites|antimetabolites|mesh-ancestor
20557943|NCT01955460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20557944|NCT01955460|Analgesics|analgesics|mesh-ancestor
20557945|NCT01955460|Sensory System Agents|sensory system agents|mesh-ancestor
20557946|NCT01955460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20557947|NCT01955460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20557948|NCT01955460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20557949|NCT01955460|Antiviral Agents|antiviral agents|mesh-ancestor
20557950|NCT01955460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20557951|NCT01955512|Clopidogrel|clopidogrel|mesh-list
20557952|NCT01955512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20557953|NCT01955512|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20557954|NCT01955512|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20557955|NCT01955512|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20557956|NCT01955512|Purinergic Agents|purinergic agents|mesh-ancestor
20557957|NCT01955512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20557958|NCT01955512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557959|NCT01955512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557960|NCT01955577|Vitamin D|vitamin d|mesh-list
20557961|NCT01955577|Cholecalciferol|cholecalciferol|mesh-list
20557962|NCT01955577|Vitamins|vitamins|mesh-ancestor
20557963|NCT01955577|Micronutrients|micronutrients|mesh-ancestor
20557964|NCT01955577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557965|NCT01955577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20557966|NCT01955577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20557967|NCT01955642|Clopidogrel|clopidogrel|mesh-list
20557968|NCT01955642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20557969|NCT01955642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20006282|NCT02280811|Alkylating Agents|alkylating agents|mesh-ancestor
20006283|NCT02280811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006284|NCT02280811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006285|NCT02280811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20006286|NCT02280811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20006287|NCT02280811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20006288|NCT02280811|Antiviral Agents|antiviral agents|mesh-ancestor
19459831|NCT03358017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19459832|NCT03358017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459833|NCT03358017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19459834|NCT03358017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459835|NCT03358004|Capecitabine|capecitabine|mesh-list
19459836|NCT03358004|Vinorelbine|vinorelbine|mesh-list
19459837|NCT03358004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19459838|NCT03358004|Antimetabolites|antimetabolites|mesh-ancestor
19459839|NCT03358004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459840|NCT03358004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459841|NCT03358004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19459842|NCT03358004|Tubulin Modulators|tubulin modulators|mesh-ancestor
19459843|NCT03358004|Antimitotic Agents|antimitotic agents|mesh-ancestor
19459844|NCT03358004|Mitosis Modulators|mitosis modulators|mesh-ancestor
19459845|NCT03357900|Remifentanil|remifentanil|mesh-list
19459846|NCT03357900|Propofol|propofol|mesh-list
19459847|NCT03357900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19459848|NCT03357900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19459849|NCT03357900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459850|NCT03357900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19459851|NCT03357900|Anesthetics, General|anesthetics, general|mesh-ancestor
19459852|NCT03357900|Anesthetics|anesthetics|mesh-ancestor
19459853|NCT03357900|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19459854|NCT03357900|Narcotics|narcotics|mesh-ancestor
19459855|NCT03357900|Analgesics|analgesics|mesh-ancestor
19459856|NCT03357900|Sensory System Agents|sensory system agents|mesh-ancestor
19459857|NCT03357900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19459858|NCT03357874|Clopidogrel|clopidogrel|mesh-list
19459859|NCT03357874|Ticagrelor|ticagrelor|mesh-list
19459860|NCT03357874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19459861|NCT03357874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19459862|NCT03357874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19459863|NCT03357874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19459864|NCT03357874|Purinergic Agents|purinergic agents|mesh-ancestor
19459865|NCT03357874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19459866|NCT03357874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459867|NCT03357874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459868|NCT03357822|Interferons|interferons|mesh-list
19459869|NCT03357822|Tenofovir|tenofovir|mesh-list
19459870|NCT03357822|Entecavir|entecavir|mesh-list
19459871|NCT03357822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459872|NCT03357822|Antiviral Agents|antiviral agents|mesh-ancestor
19459873|NCT03357822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19459874|NCT03357822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19459875|NCT03357822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19459876|NCT03357822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459877|NCT03357822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459878|NCT03357822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19459879|NCT03357822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19459880|NCT03357796|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
19459881|NCT03357796|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20006289|NCT02280811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20006290|NCT02281136|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20006291|NCT02281136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20006292|NCT02281136|Dermatologic Agents|dermatologic agents|mesh-ancestor
20006293|NCT02281409|Mogamulizumab|mogamulizumab|mesh-list
20006294|NCT02281409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006295|NCT02281422|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
20557970|NCT01955642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20557971|NCT01955642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20557972|NCT01955642|Purinergic Agents|purinergic agents|mesh-ancestor
20557973|NCT01955642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20557974|NCT01955642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557975|NCT01955642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557976|NCT01955655|Baclofen|baclofen|mesh-list
20557977|NCT01955655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20557978|NCT01955655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557979|NCT01955655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20557980|NCT01955655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20557981|NCT01955655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20557982|NCT01955655|GABA Agonists|gaba agonists|mesh-ancestor
20557983|NCT01955655|GABA Agents|gaba agents|mesh-ancestor
20557984|NCT01955655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20557985|NCT01955655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20557986|NCT01955694|Eplerenone|eplerenone|mesh-list
20557987|NCT01955694|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20557988|NCT01955694|Hormone Antagonists|hormone antagonists|mesh-ancestor
20557989|NCT01955694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19459882|NCT03357796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19459883|NCT03357796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19459884|NCT03357796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459885|NCT03357796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19459886|NCT03357796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459887|NCT03357796|Antidepressive Agents|antidepressive agents|mesh-ancestor
19459888|NCT03357796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19459889|NCT03357757|Avelumab|avelumab|mesh-list
19459890|NCT03357757|Valproic Acid|valproic acid|mesh-list
20006296|NCT02281422|Anticonvulsants|anticonvulsants|mesh-ancestor
20557990|NCT01955694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20557991|NCT01955694|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20557992|NCT01955694|Diuretics|diuretics|mesh-ancestor
20557993|NCT01955694|Natriuretic Agents|natriuretic agents|mesh-ancestor
20557994|NCT01955694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20557995|NCT01955759|Amiodarone|amiodarone|mesh-list
20557996|NCT01955759|Bisoprolol|bisoprolol|mesh-list
20557997|NCT01955759|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20557998|NCT01955759|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
20557999|NCT01955759|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20558000|NCT01955759|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20558001|NCT01955759|Antimetabolites|antimetabolites|mesh-ancestor
20558002|NCT01955759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558003|NCT01955759|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20558004|NCT01955759|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20558005|NCT01955759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558006|NCT01955759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20558007|NCT01955759|Vasodilator Agents|vasodilator agents|mesh-ancestor
20558008|NCT01955759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20558009|NCT01955759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006297|NCT02281422|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20006298|NCT02281422|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20006299|NCT02281422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006300|NCT02281422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006301|NCT02281448|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
20006302|NCT02281448|Contraceptive Agents|contraceptive agents|mesh-list
20006303|NCT02281448|Contraceptives, Oral|contraceptives, oral|mesh-list
20006304|NCT02281448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
20006305|NCT02281448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20006306|NCT02281448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006307|NCT02281448|Anticonvulsants|anticonvulsants|mesh-ancestor
20006308|NCT02281448|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20006309|NCT02281448|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20006310|NCT02281448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006311|NCT02281448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006312|NCT02281448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20006313|NCT02281526|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
20006314|NCT02281526|Anticonvulsants|anticonvulsants|mesh-ancestor
20006315|NCT02281526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20006316|NCT02281526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20558010|NCT01955759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20558011|NCT01955759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20558012|NCT01955759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20558013|NCT01955759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20558014|NCT01955759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20558015|NCT01955759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20558016|NCT01955759|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20558017|NCT01955759|Adrenergic Agents|adrenergic agents|mesh-ancestor
20558018|NCT01955759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558019|NCT01955759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558020|NCT01955759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20558021|NCT01955759|Sympatholytics|sympatholytics|mesh-ancestor
20558022|NCT01955759|Autonomic Agents|autonomic agents|mesh-ancestor
20558023|NCT01955759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558024|NCT01955759|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20558025|NCT01955824|Lidocaine|lidocaine|mesh-list
20558026|NCT01955824|Anesthetics, Local|anesthetics, local|mesh-ancestor
20558027|NCT01955824|Anesthetics|anesthetics|mesh-ancestor
20006317|NCT02281526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006318|NCT02281526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006319|NCT02281552|Tofacitinib|tofacitinib|mesh-list
20558028|NCT01955824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20558029|NCT01955824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558030|NCT01955824|Sensory System Agents|sensory system agents|mesh-ancestor
20558031|NCT01955824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558032|NCT01955824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20558033|NCT01955824|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20558034|NCT01955824|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20558035|NCT01955824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20558036|NCT01955824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558037|NCT01955967|Lidocaine|lidocaine|mesh-list
20558038|NCT01955967|Anesthetics, Local|anesthetics, local|mesh-ancestor
20558039|NCT01955967|Anesthetics|anesthetics|mesh-ancestor
20558040|NCT01955967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20558041|NCT01955967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558042|NCT01955967|Sensory System Agents|sensory system agents|mesh-ancestor
20558043|NCT01955967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558044|NCT01955967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20558045|NCT01955967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20558046|NCT01955967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20558047|NCT01955967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20558048|NCT01955967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558049|NCT01956006|Milrinone|milrinone|mesh-list
20558050|NCT01956006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20558051|NCT01956006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20558052|NCT01956006|Vasodilator Agents|vasodilator agents|mesh-ancestor
20558053|NCT01956006|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20558054|NCT01956006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20558055|NCT01956006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558056|NCT01956006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558057|NCT01956006|Protective Agents|protective agents|mesh-ancestor
20558058|NCT01956006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558059|NCT01956201|Atorvastatin|atorvastatin|mesh-list
20558060|NCT01956201|Fenofibrate|fenofibrate|mesh-list
20558061|NCT01956201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20558062|NCT01956201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20558063|NCT01956201|Antimetabolites|antimetabolites|mesh-ancestor
20558064|NCT01956201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558065|NCT01956201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20558066|NCT01956201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20558067|NCT01956201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558068|NCT01956305|Metformin|metformin|mesh-list
20558069|NCT01956305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20558070|NCT01956305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558071|NCT01956474|Riboflavin|riboflavin|mesh-list
20558072|NCT01956474|Vitamin B Complex|vitamin b complex|mesh-ancestor
20558073|NCT01956474|Vitamins|vitamins|mesh-ancestor
20558074|NCT01956474|Micronutrients|micronutrients|mesh-ancestor
20558075|NCT01956474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558076|NCT01956474|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20558077|NCT01956474|Dermatologic Agents|dermatologic agents|mesh-ancestor
20558078|NCT01956487|Propafenone|propafenone|mesh-list
20558079|NCT01956487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20558080|NCT01956487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20558081|NCT01956487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20558082|NCT01956487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20558083|NCT01956487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558084|NCT01956591|Oxybutynin|oxybutynin|mesh-list
20558085|NCT01956591|Parasympatholytics|parasympatholytics|mesh-ancestor
20558086|NCT01956591|Autonomic Agents|autonomic agents|mesh-ancestor
20558087|NCT01956591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558088|NCT01956591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558089|NCT01956591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20558090|NCT01956591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20558091|NCT01956591|Cholinergic Agents|cholinergic agents|mesh-ancestor
20558092|NCT01956591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558093|NCT01956591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558094|NCT01956591|Urological Agents|urological agents|mesh-ancestor
20558095|NCT01956604|Clonidine|clonidine|mesh-list
20558096|NCT01956604|Analgesics|analgesics|mesh-ancestor
20558097|NCT01956604|Sensory System Agents|sensory system agents|mesh-ancestor
20006320|NCT02281552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20006321|NCT02281552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006322|NCT02281552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006323|NCT02281591|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
20006324|NCT02281591|Anticonvulsants|anticonvulsants|mesh-ancestor
20006325|NCT02281591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20006326|NCT02281591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20558098|NCT01956604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558099|NCT01956604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558100|NCT01956604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20558101|NCT01956604|Sympatholytics|sympatholytics|mesh-ancestor
20558102|NCT01956604|Autonomic Agents|autonomic agents|mesh-ancestor
20558103|NCT01956604|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20558104|NCT01956604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20558105|NCT01956604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20558106|NCT01956604|Adrenergic Agents|adrenergic agents|mesh-ancestor
20558107|NCT01956604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558108|NCT01956604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558109|NCT01956695|Rituximab|rituximab|mesh-list
20558110|NCT01956695|Lenalidomide|lenalidomide|mesh-list
20558111|NCT01956695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20558112|NCT01956695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558113|NCT01956695|Immunologic Factors|immunologic factors|mesh-ancestor
20558114|NCT01956695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558115|NCT01956695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20558116|NCT01956695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20558117|NCT01956695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20558118|NCT01956695|Growth Substances|growth substances|mesh-ancestor
20558119|NCT01956695|Growth Inhibitors|growth inhibitors|mesh-ancestor
20558120|NCT01956734|Temozolomide|temozolomide|mesh-list
20558121|NCT01956734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20558122|NCT01956734|Alkylating Agents|alkylating agents|mesh-ancestor
20558123|NCT01956734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558124|NCT01956734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558125|NCT01956786|Amlodipine|amlodipine|mesh-list
20558126|NCT01956786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20558127|NCT01956786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20558128|NCT01956786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20558129|NCT01956786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558130|NCT01956786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20558131|NCT01956786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558132|NCT01956786|Vasodilator Agents|vasodilator agents|mesh-ancestor
20558133|NCT01956864|Vitamin D|vitamin d|mesh-list
20558134|NCT01956864|Vitamins|vitamins|mesh-ancestor
20558135|NCT01956864|Micronutrients|micronutrients|mesh-ancestor
20558136|NCT01956864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558137|NCT01956864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20006327|NCT02281591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006328|NCT02281591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006329|NCT02281760|Trametinib|trametinib|mesh-list
20006330|NCT02281760|Dabrafenib|dabrafenib|mesh-list
20006331|NCT02281760|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
20006332|NCT02281760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006333|NCT02281760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20006334|NCT02281760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006335|NCT02281760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006336|NCT02281760|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20006337|NCT02281760|Protective Agents|protective agents|mesh-ancestor
20006338|NCT02281760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006339|NCT02281760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20006340|NCT02281760|Antioxidants|antioxidants|mesh-ancestor
20006341|NCT02281773|BI 409306|bi 409306|mesh-list
20006342|NCT02281773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20006343|NCT02281773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006344|NCT02281773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006345|NCT02282293|Piperaquine|piperaquine|mesh-list
20006346|NCT02282293|Trimethoprim|trimethoprim|mesh-list
20006347|NCT02282293|Artenimol|artenimol|mesh-list
20006348|NCT02282293|Sulfamethoxazole|sulfamethoxazole|mesh-list
20006349|NCT02282293|Antimalarials|antimalarials|mesh-ancestor
20006350|NCT02282293|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20558138|NCT01956929|Metformin|metformin|mesh-list
20558139|NCT01956929|Lactulose|lactulose|mesh-list
20558140|NCT01956929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20558141|NCT01956929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558142|NCT01956929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20558143|NCT01956955|Heparin|heparin|mesh-list
20558144|NCT01956955|Enoxaparin|enoxaparin|mesh-list
20558145|NCT01956955|Calcium heparin|calcium heparin|mesh-list
20558146|NCT01956955|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20558147|NCT01956955|Anticoagulants|anticoagulants|mesh-ancestor
20558148|NCT01956955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20558149|NCT01956955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20558150|NCT01956955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558151|NCT01956981|Magnesium Sulfate|magnesium sulfate|mesh-list
20558152|NCT01956981|Dexmedetomidine|dexmedetomidine|mesh-list
20558153|NCT01956981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20558154|NCT01956981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20558155|NCT01956981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558156|NCT01956981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20558157|NCT01956981|Analgesics|analgesics|mesh-ancestor
20558158|NCT01956981|Sensory System Agents|sensory system agents|mesh-ancestor
20558159|NCT01956981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558160|NCT01956981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20558161|NCT01956981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20558162|NCT01956981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20558163|NCT01956981|Adrenergic Agents|adrenergic agents|mesh-ancestor
20558164|NCT01956981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558165|NCT01956981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558166|NCT01956981|Anesthetics|anesthetics|mesh-ancestor
20558167|NCT01956981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20558168|NCT01956981|Anticonvulsants|anticonvulsants|mesh-ancestor
20558169|NCT01956981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20558170|NCT01956981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20558171|NCT01956981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20558172|NCT01956981|Tocolytic Agents|tocolytic agents|mesh-ancestor
20558173|NCT01956981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20558174|NCT01957007|Docetaxel|docetaxel|mesh-list
20558175|NCT01957007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558176|NCT01957007|Tubulin Modulators|tubulin modulators|mesh-ancestor
20558177|NCT01957007|Antimitotic Agents|antimitotic agents|mesh-ancestor
20558178|NCT01957007|Mitosis Modulators|mitosis modulators|mesh-ancestor
20558179|NCT01957007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459891|NCT03357757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19459892|NCT03357757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459893|NCT03357757|Anticonvulsants|anticonvulsants|mesh-ancestor
20006351|NCT02282293|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19459894|NCT03357757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459895|NCT03357757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459896|NCT03357757|GABA Agents|gaba agents|mesh-ancestor
19459897|NCT03357757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19459898|NCT03357757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459899|NCT03357757|Antimanic Agents|antimanic agents|mesh-ancestor
19459900|NCT03357757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19459901|NCT03357757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19459902|NCT03357757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19459903|NCT03357718|Midazolam|midazolam|mesh-list
19459904|NCT03357718|Dexmedetomidine|dexmedetomidine|mesh-list
19459905|NCT03357718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19459906|NCT03357718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19459907|NCT03357718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459908|NCT03357718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19459909|NCT03357718|Analgesics|analgesics|mesh-ancestor
19459910|NCT03357718|Sensory System Agents|sensory system agents|mesh-ancestor
19459911|NCT03357718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006352|NCT02282293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20006353|NCT02282293|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20006354|NCT02282293|Renal Agents|renal agents|mesh-ancestor
20006355|NCT02282293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20006356|NCT02282293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006357|NCT02282293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006358|NCT02282293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20006359|NCT02282293|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20006360|NCT02282293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20006361|NCT02282514|Methylprednisolone|methylprednisolone|mesh-list
20006362|NCT02282514|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20006363|NCT02282514|Cyclophosphamide|cyclophosphamide|mesh-list
20006364|NCT02282514|Rituximab|rituximab|mesh-list
20006365|NCT02282514|Thymoglobulin|thymoglobulin|mesh-list
20006366|NCT02282514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20006367|NCT02282514|Immunologic Factors|immunologic factors|mesh-ancestor
20006368|NCT02282514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006369|NCT02282514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20558180|NCT01957046|Laxatives|laxatives|mesh-list
20558181|NCT01957046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20558182|NCT01957189|Tamsulosin|tamsulosin|mesh-list
20558183|NCT01957189|Dutasteride|dutasteride|mesh-list
20558184|NCT01957189|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20558185|NCT01957189|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20558186|NCT01957189|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20558187|NCT01957189|Adrenergic Agents|adrenergic agents|mesh-ancestor
20558188|NCT01957189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558189|NCT01957189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558190|NCT01957189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558191|NCT01957189|Urological Agents|urological agents|mesh-ancestor
20558192|NCT01957189|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
20558193|NCT01957189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20558194|NCT01957189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558195|NCT01957189|Hormone Antagonists|hormone antagonists|mesh-ancestor
20558196|NCT01957189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20558197|NCT01957293|Albuterol|albuterol|mesh-list
20558198|NCT01957293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20558199|NCT01957293|Autonomic Agents|autonomic agents|mesh-ancestor
20558200|NCT01957293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558201|NCT01957293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558202|NCT01957293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20558203|NCT01957293|Respiratory System Agents|respiratory system agents|mesh-ancestor
20558204|NCT01957293|Tocolytic Agents|tocolytic agents|mesh-ancestor
20558205|NCT01957293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20558206|NCT01957293|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20558207|NCT01957293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20558208|NCT01957293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20558209|NCT01957293|Adrenergic Agents|adrenergic agents|mesh-ancestor
20558210|NCT01957293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558211|NCT01957293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558212|NCT01957319|Vitamin E|vitamin e|mesh-list
20558213|NCT01957319|Silybin|silybin|mesh-list
20558214|NCT01957319|Vitamins|vitamins|mesh-ancestor
20558215|NCT01957319|Micronutrients|micronutrients|mesh-ancestor
20558216|NCT01957319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558217|NCT01957319|Antioxidants|antioxidants|mesh-ancestor
20558218|NCT01957319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006370|NCT02282514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20006371|NCT02282514|Alkylating Agents|alkylating agents|mesh-ancestor
20006372|NCT02282514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006373|NCT02282514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006374|NCT02282514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20006375|NCT02282514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20006376|NCT02282514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20006377|NCT02282514|Antiemetics|antiemetics|mesh-ancestor
20006378|NCT02282514|Autonomic Agents|autonomic agents|mesh-ancestor
20006379|NCT02282514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006380|NCT02282514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20006381|NCT02282514|Glucocorticoids|glucocorticoids|mesh-ancestor
20006382|NCT02282514|Hormones|hormones|mesh-ancestor
20006383|NCT02282514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20006384|NCT02282514|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20006385|NCT02282514|Protective Agents|protective agents|mesh-ancestor
20006386|NCT02282514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20006387|NCT02282527|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
20006388|NCT02282527|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20006389|NCT02282527|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20006390|NCT02282527|Protease Inhibitors|protease inhibitors|mesh-ancestor
20006391|NCT02282527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006392|NCT02282527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006393|NCT02282605|Chlorhexidine|chlorhexidine|mesh-list
20006394|NCT02282605|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20006395|NCT02282605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20006396|NCT02282605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20006397|NCT02282605|Disinfectants|disinfectants|mesh-ancestor
20006398|NCT02282605|Dermatologic Agents|dermatologic agents|mesh-ancestor
20006399|NCT02282813|Calcitriol|calcitriol|mesh-list
20006400|NCT02282813|Calcifediol|calcifediol|mesh-list
20006401|NCT02282813|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
20006402|NCT02282813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20006403|NCT02282813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558219|NCT01957319|Protective Agents|protective agents|mesh-ancestor
20558220|NCT01957319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20558221|NCT01957319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558222|NCT01957436|Docetaxel|docetaxel|mesh-list
20558223|NCT01957436|Abiraterone Acetate|abiraterone acetate|mesh-list
20558224|NCT01957436|Androgens|androgens|mesh-list
20558225|NCT01957436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558226|NCT01957436|Tubulin Modulators|tubulin modulators|mesh-ancestor
20558227|NCT01957436|Antimitotic Agents|antimitotic agents|mesh-ancestor
20558228|NCT01957436|Mitosis Modulators|mitosis modulators|mesh-ancestor
20558229|NCT01957436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558230|NCT01957436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20558231|NCT01957436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558232|NCT01957436|Hormone Antagonists|hormone antagonists|mesh-ancestor
20006404|NCT02282813|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20006405|NCT02282813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006406|NCT02282813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006407|NCT02282813|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20006408|NCT02282813|Vitamins|vitamins|mesh-ancestor
20006409|NCT02282813|Micronutrients|micronutrients|mesh-ancestor
20006410|NCT02282813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20006411|NCT02282904|Sirolimus|sirolimus|mesh-list
20006412|NCT02282904|Cyclophosphamide|cyclophosphamide|mesh-list
20006413|NCT02282904|Busulfan|busulfan|mesh-list
20006414|NCT02282904|Fludarabine|fludarabine|mesh-list
20006415|NCT02282904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20006416|NCT02282904|Immunologic Factors|immunologic factors|mesh-ancestor
20006417|NCT02282904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006418|NCT02282904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20006419|NCT02282904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20558233|NCT01957436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20558234|NCT01957436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558235|NCT01957436|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20558236|NCT01957436|Hormones|hormones|mesh-ancestor
20558237|NCT01957449|Propranolol|propranolol|mesh-list
20558238|NCT01957449|Metoprolol|metoprolol|mesh-list
20558239|NCT01957449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20558240|NCT01957449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20558241|NCT01957449|Adrenergic Agents|adrenergic agents|mesh-ancestor
20558242|NCT01957449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558243|NCT01957449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558244|NCT01957449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558245|NCT01957449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20558246|NCT01957449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20558247|NCT01957449|Vasodilator Agents|vasodilator agents|mesh-ancestor
20558248|NCT01957449|Sympatholytics|sympatholytics|mesh-ancestor
20558249|NCT01957449|Autonomic Agents|autonomic agents|mesh-ancestor
20558250|NCT01957449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558251|NCT01957449|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20558252|NCT01957540|Ticagrelor|ticagrelor|mesh-list
20558253|NCT01957540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20558254|NCT01957540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20558255|NCT01957540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20558256|NCT01957540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20558257|NCT01957540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20558258|NCT01957540|Purinergic Agents|purinergic agents|mesh-ancestor
20558259|NCT01957540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558260|NCT01957540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558261|NCT01957540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558262|NCT01957631|Methylprednisolone|methylprednisolone|mesh-list
20558263|NCT01957631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20558264|NCT01957631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20558265|NCT01957631|Prednisolone|prednisolone|mesh-list
20558266|NCT01957631|Prednisolone acetate|prednisolone acetate|mesh-list
20558267|NCT01957631|Bupivacaine|bupivacaine|mesh-list
20558268|NCT01957631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20558269|NCT01957631|Prednisolone phosphate|prednisolone phosphate|mesh-list
20558270|NCT01957631|Anesthetics, Local|anesthetics, local|mesh-ancestor
20558271|NCT01957631|Anesthetics|anesthetics|mesh-ancestor
20558272|NCT01957631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20558273|NCT01957631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558274|NCT01957631|Sensory System Agents|sensory system agents|mesh-ancestor
20558275|NCT01957631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558276|NCT01957631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20558277|NCT01957631|Antiemetics|antiemetics|mesh-ancestor
20558278|NCT01957631|Autonomic Agents|autonomic agents|mesh-ancestor
20558279|NCT01957631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20558280|NCT01957631|Glucocorticoids|glucocorticoids|mesh-ancestor
20558281|NCT01957631|Hormones|hormones|mesh-ancestor
20558282|NCT01957631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20558283|NCT01957631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20558284|NCT01957631|Protective Agents|protective agents|mesh-ancestor
20558285|NCT01957631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20558286|NCT01957631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558287|NCT01957839|Cabergoline|cabergoline|mesh-list
20558288|NCT01957839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20558289|NCT01957839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20558290|NCT01957839|Dopamine Agonists|dopamine agonists|mesh-ancestor
20006420|NCT02282904|Alkylating Agents|alkylating agents|mesh-ancestor
20006421|NCT02282904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006422|NCT02282904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006423|NCT02282904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20006424|NCT02282904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20006425|NCT02282904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20006426|NCT02282904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20006427|NCT02282904|Antifungal Agents|antifungal agents|mesh-ancestor
20290215|NCT04205136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20290216|NCT04205136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290217|NCT04205136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20290218|NCT04205136|Diuretics|diuretics|mesh-ancestor
20290219|NCT04205136|Natriuretic Agents|natriuretic agents|mesh-ancestor
20290220|NCT04194944|Carboplatin|carboplatin|mesh-list
20290221|NCT04194944|Pembrolizumab|pembrolizumab|mesh-list
20290222|NCT04194944|Pemetrexed|pemetrexed|mesh-list
20290223|NCT04194944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290224|NCT04194944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20290225|NCT04194944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290226|NCT04194944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290227|NCT04194944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20290228|NCT04194944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20290229|NCT04192903|Cisplatin|cisplatin|mesh-list
20290230|NCT04192903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558291|NCT01957839|Dopamine Agents|dopamine agents|mesh-ancestor
20558292|NCT01957839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558293|NCT01957839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558294|NCT01957839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558295|NCT01957852|Thrombin|thrombin|mesh-list
20558296|NCT01957852|Hemostatics|hemostatics|mesh-ancestor
20558297|NCT01957852|Coagulants|coagulants|mesh-ancestor
20558298|NCT01957943|SMOFlipid|smoflipid|mesh-list
20558299|NCT01957943|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20558300|NCT01957943|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20558301|NCT01957943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20558302|NCT01957956|Temozolomide|temozolomide|mesh-list
20558303|NCT01957956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20558304|NCT01957956|Alkylating Agents|alkylating agents|mesh-ancestor
20558305|NCT01957956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558306|NCT01957956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290231|NCT04190550|Cytarabine|cytarabine|mesh-list
20290232|NCT04190550|Idarubicin|idarubicin|mesh-list
20290233|NCT04190550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20290234|NCT04190550|Antimetabolites|antimetabolites|mesh-ancestor
20290235|NCT04190550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558307|NCT01957995|Docetaxel|docetaxel|mesh-list
20558308|NCT01957995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558309|NCT01957995|Tubulin Modulators|tubulin modulators|mesh-ancestor
20558310|NCT01957995|Antimitotic Agents|antimitotic agents|mesh-ancestor
20558311|NCT01957995|Mitosis Modulators|mitosis modulators|mesh-ancestor
20558312|NCT01957995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558313|NCT01958138|Propofol|propofol|mesh-list
20558314|NCT01958138|Isoflurane|isoflurane|mesh-list
20558315|NCT01958138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20558316|NCT01958138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20558317|NCT01958138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558318|NCT01958138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20558319|NCT01958138|Anesthetics, General|anesthetics, general|mesh-ancestor
20558320|NCT01958138|Anesthetics|anesthetics|mesh-ancestor
20558321|NCT01958138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20558322|NCT01958216|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20558323|NCT01958216|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20558324|NCT01958216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20558325|NCT01958216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20558326|NCT01958372|Etoposide|etoposide|mesh-list
20558327|NCT01958372|Pemetrexed|pemetrexed|mesh-list
20558328|NCT01958372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558329|NCT01958372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20558330|NCT01958372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20558331|NCT01958372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20558332|NCT01958372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558333|NCT01958372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558334|NCT01958372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20558335|NCT01958372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20558336|NCT01958580|Gemcitabine|gemcitabine|mesh-list
20558337|NCT01958580|Docetaxel|docetaxel|mesh-list
20006428|NCT02283294|Warfarin|warfarin|mesh-list
20006429|NCT02283294|Apixaban|apixaban|mesh-list
20006430|NCT02283294|Anticoagulants|anticoagulants|mesh-ancestor
20006431|NCT02283294|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20006432|NCT02283294|Antithrombins|antithrombins|mesh-ancestor
20006433|NCT02283294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20006434|NCT02283294|Protease Inhibitors|protease inhibitors|mesh-ancestor
20006435|NCT02283294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006436|NCT02283294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006437|NCT02283658|Everolimus|everolimus|mesh-list
20006438|NCT02283658|Letrozole|letrozole|mesh-list
20006439|NCT02283658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006440|NCT02283658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20006441|NCT02283658|Immunologic Factors|immunologic factors|mesh-ancestor
20006442|NCT02283658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006443|NCT02283658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20006444|NCT02283658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20006445|NCT02283658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459912|NCT03357718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19459913|NCT03357718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19459914|NCT03357718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19459915|NCT03357718|Adrenergic Agents|adrenergic agents|mesh-ancestor
19459916|NCT03357718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19459917|NCT03357718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459918|NCT03357718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19459919|NCT03357718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19459920|NCT03357718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19459921|NCT03357718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19459922|NCT03357718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19459923|NCT03357718|Anesthetics, General|anesthetics, general|mesh-ancestor
19459924|NCT03357718|Anesthetics|anesthetics|mesh-ancestor
19459925|NCT03357718|GABA Modulators|gaba modulators|mesh-ancestor
19459926|NCT03357718|GABA Agents|gaba agents|mesh-ancestor
19459927|NCT03357653|Losartan|losartan|mesh-list
19459928|NCT03357653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19459929|NCT03357653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19459930|NCT03357653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19459931|NCT03357653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19459932|NCT03357653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459933|NCT03357640|Contraceptive Agents|contraceptive agents|mesh-list
19459934|NCT03357640|Contraceptives, Oral|contraceptives, oral|mesh-list
19459935|NCT03357640|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
19459936|NCT03357640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19459937|NCT03357640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459938|NCT03357640|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19459939|NCT03357627|Venetoclax|venetoclax|mesh-list
19459940|NCT03357627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459941|NCT03357575|Hyaluronic Acid|hyaluronic acid|mesh-list
20006446|NCT02283658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006447|NCT02283658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20006448|NCT02283658|Hormone Antagonists|hormone antagonists|mesh-ancestor
20006449|NCT02283658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20558338|NCT01958580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20558339|NCT01958580|Antimetabolites|antimetabolites|mesh-ancestor
20558340|NCT01958580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558341|NCT01958580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558342|NCT01958580|Antiviral Agents|antiviral agents|mesh-ancestor
20558343|NCT01958580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20558344|NCT01958580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558345|NCT01958580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20558346|NCT01958580|Immunologic Factors|immunologic factors|mesh-ancestor
20558347|NCT01958580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558348|NCT01958580|Tubulin Modulators|tubulin modulators|mesh-ancestor
20558349|NCT01958580|Antimitotic Agents|antimitotic agents|mesh-ancestor
20558350|NCT01958580|Mitosis Modulators|mitosis modulators|mesh-ancestor
20558351|NCT01958684|Copper|copper|mesh-list
20558352|NCT01958684|Levonorgestrel|levonorgestrel|mesh-list
20558353|NCT01958684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20558354|NCT01958684|Contraceptive Agents|contraceptive agents|mesh-ancestor
20558355|NCT01958684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20558356|NCT01958684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558357|NCT01958684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20558358|NCT01958684|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20558359|NCT01958684|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20558360|NCT01958684|Trace Elements|trace elements|mesh-ancestor
20558361|NCT01958684|Micronutrients|micronutrients|mesh-ancestor
20558362|NCT01958775|Glucagon|glucagon|mesh-list
20558363|NCT01958775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20558364|NCT01958775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20558365|NCT01958775|Hormones|hormones|mesh-ancestor
20558366|NCT01958775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20558367|NCT01958775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558368|NCT01958775|Incretins|incretins|mesh-ancestor
20558369|NCT01958814|Albuterol|albuterol|mesh-list
20558370|NCT01958814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20558371|NCT01958814|Autonomic Agents|autonomic agents|mesh-ancestor
20558372|NCT01958814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558373|NCT01958814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558374|NCT01958814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20558375|NCT01958814|Respiratory System Agents|respiratory system agents|mesh-ancestor
20558376|NCT01958814|Tocolytic Agents|tocolytic agents|mesh-ancestor
20558377|NCT01958814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20558378|NCT01958814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20558379|NCT01958814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20558380|NCT01958814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20558381|NCT01958814|Adrenergic Agents|adrenergic agents|mesh-ancestor
20558382|NCT01958814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558383|NCT01958814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558384|NCT01958866|Acetaminophen|acetaminophen|mesh-list
20558385|NCT01958866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20558386|NCT01958866|Analgesics|analgesics|mesh-ancestor
20558387|NCT01958866|Sensory System Agents|sensory system agents|mesh-ancestor
20558388|NCT01958866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558389|NCT01958866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558390|NCT01958866|Antipyretics|antipyretics|mesh-ancestor
20558391|NCT01958905|Lumefantrine|lumefantrine|mesh-list
20558392|NCT01958905|Artemether|artemether|mesh-list
20558393|NCT01958905|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20558394|NCT01958905|Antimalarials|antimalarials|mesh-ancestor
20558395|NCT01958905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20558396|NCT01958905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20558397|NCT01958905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20558398|NCT01958944|Nitric Oxide|nitric oxide|mesh-list
20558399|NCT01958944|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20558400|NCT01958944|Autonomic Agents|autonomic agents|mesh-ancestor
20558401|NCT01958944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558402|NCT01958944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558403|NCT01958944|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20558404|NCT01958944|Respiratory System Agents|respiratory system agents|mesh-ancestor
20558405|NCT01958944|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20558406|NCT01958944|Antioxidants|antioxidants|mesh-ancestor
20558407|NCT01958944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558408|NCT01958944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558409|NCT01958944|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20006450|NCT02283749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20006451|NCT02283749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006452|NCT02283762|Riociguat|riociguat|mesh-list
20006453|NCT02283762|Enzyme Activators|enzyme activators|mesh-ancestor
20006454|NCT02283762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006455|NCT02283788|Moxifloxacin|moxifloxacin|mesh-list
20006456|NCT02283788|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
20006457|NCT02283788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20006458|NCT02283788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20558410|NCT01958944|Vasodilator Agents|vasodilator agents|mesh-ancestor
20558411|NCT01958944|Gasotransmitters|gasotransmitters|mesh-ancestor
20558412|NCT01958944|Protective Agents|protective agents|mesh-ancestor
20558413|NCT01958996|Idarubicin|idarubicin|mesh-list
20558414|NCT01958996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20558415|NCT01958996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558416|NCT01958996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20558417|NCT01958996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20558418|NCT01958996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558419|NCT01958996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006459|NCT02283788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20006460|NCT02283788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20006461|NCT02283788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006462|NCT02283788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006463|NCT02283788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006464|NCT02283788|Anticonvulsants|anticonvulsants|mesh-ancestor
20006465|NCT02283788|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20006466|NCT02283788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20006467|NCT02283788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006468|NCT02283814|Topiramate|topiramate|mesh-list
20006469|NCT02283814|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
20006470|NCT02283814|Anticonvulsants|anticonvulsants|mesh-ancestor
20006471|NCT02283814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20006472|NCT02283814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006473|NCT02283814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19459942|NCT03357575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19459943|NCT03357575|Immunologic Factors|immunologic factors|mesh-ancestor
19459944|NCT03357575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459945|NCT03357575|Viscosupplements|viscosupplements|mesh-ancestor
19459946|NCT03357575|Protective Agents|protective agents|mesh-ancestor
19459947|NCT03357224|Atezolizumab|atezolizumab|mesh-list
19459948|NCT03357224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006474|NCT02283814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20006475|NCT02283814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006476|NCT02283814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006477|NCT02283827|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
20006478|NCT02283827|Phenytoin|phenytoin|mesh-list
20006479|NCT02283827|Anticonvulsants|anticonvulsants|mesh-ancestor
20006480|NCT02283827|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20558420|NCT01959022|Doxazosin|doxazosin|mesh-list
20558421|NCT01959022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20558422|NCT01959022|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20558423|NCT01959022|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20558424|NCT01959022|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20558425|NCT01959022|Adrenergic Agents|adrenergic agents|mesh-ancestor
20558426|NCT01959022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558427|NCT01959022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558428|NCT01959022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558429|NCT01959061|Oxaliplatin|oxaliplatin|mesh-list
20558430|NCT01959061|Raltitrexed|raltitrexed|mesh-list
20558431|NCT01959061|Ethiodized Oil|ethiodized oil|mesh-list
19459949|NCT03357133|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20006481|NCT02283827|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20006482|NCT02283827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006483|NCT02283827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006484|NCT02283827|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20006485|NCT02283827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20006486|NCT02283840|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
20006487|NCT02283840|Anticonvulsants|anticonvulsants|mesh-ancestor
20006488|NCT02283840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20006489|NCT02283840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20006490|NCT02283840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006491|NCT02283840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006492|NCT02284009|rGLP-1 protein|rglp-1 protein|mesh-list
20006493|NCT02284009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006494|NCT02284009|Incretins|incretins|mesh-ancestor
20006495|NCT02284009|Hormones|hormones|mesh-ancestor
20006496|NCT02284009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20006497|NCT02284126|Vancomycin|vancomycin|mesh-list
20006498|NCT02284126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20006499|NCT02284126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20006500|NCT02284243|Dexmedetomidine|dexmedetomidine|mesh-list
20006501|NCT02284243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20006502|NCT02284243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20006503|NCT02284243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006504|NCT02284243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20558432|NCT01959061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558433|NCT01959061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20558434|NCT01959061|Antimetabolites|antimetabolites|mesh-ancestor
20558435|NCT01959061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558436|NCT01959061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20558437|NCT01959061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558438|NCT01959074|Aceclofenac|aceclofenac|mesh-list
20558439|NCT01959074|Naftopidil|naftopidil|mesh-list
20558440|NCT01959074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20558441|NCT01959074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20558442|NCT01959074|Analgesics|analgesics|mesh-ancestor
20558443|NCT01959074|Sensory System Agents|sensory system agents|mesh-ancestor
20558444|NCT01959074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558445|NCT01959074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558446|NCT01959074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20558447|NCT01959074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20558448|NCT01959074|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20558449|NCT01959074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20558450|NCT01959074|Adrenergic Agents|adrenergic agents|mesh-ancestor
20558451|NCT01959074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558452|NCT01959074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558453|NCT01959074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20558454|NCT01959074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20558455|NCT01959074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20558456|NCT01959074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20558457|NCT01959074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20558458|NCT01959100|Azithromycin|azithromycin|mesh-list
20558459|NCT01959100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20558460|NCT01959100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20558461|NCT01959152|Imidacloprid|imidacloprid|mesh-list
20558462|NCT01959152|Cholinergic Agents|cholinergic agents|mesh-ancestor
20558463|NCT01959152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558464|NCT01959152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558465|NCT01959152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558466|NCT01959191|Aspirin|aspirin|mesh-list
20558467|NCT01959191|Clopidogrel|clopidogrel|mesh-list
20558468|NCT01959191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20558469|NCT01959191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20558470|NCT01959191|Analgesics|analgesics|mesh-ancestor
20558471|NCT01959191|Sensory System Agents|sensory system agents|mesh-ancestor
20558472|NCT01959191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558473|NCT01959191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558474|NCT01959191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20558475|NCT01959191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20558476|NCT01959191|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20558477|NCT01959191|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20558478|NCT01959191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558479|NCT01959191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20558480|NCT01959191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20558481|NCT01959191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558482|NCT01959191|Antipyretics|antipyretics|mesh-ancestor
20558483|NCT01959191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20558484|NCT01959191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20558485|NCT01959191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20558486|NCT01959191|Purinergic Agents|purinergic agents|mesh-ancestor
20558487|NCT01959191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558488|NCT01959204|Oxycodone|oxycodone|mesh-list
20558489|NCT01959204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20558490|NCT01959204|Narcotics|narcotics|mesh-ancestor
20558491|NCT01959204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20558492|NCT01959204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558493|NCT01959204|Analgesics|analgesics|mesh-ancestor
20558494|NCT01959204|Sensory System Agents|sensory system agents|mesh-ancestor
20558495|NCT01959204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006505|NCT02284243|Analgesics|analgesics|mesh-ancestor
20006506|NCT02284243|Sensory System Agents|sensory system agents|mesh-ancestor
20006507|NCT02284243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006508|NCT02284243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20006509|NCT02284243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20006510|NCT02284243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20006511|NCT02284243|Adrenergic Agents|adrenergic agents|mesh-ancestor
20006512|NCT02284243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20006513|NCT02284243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006514|NCT02284386|Bupivacaine|bupivacaine|mesh-list
20006515|NCT02284386|Anesthetics, Local|anesthetics, local|mesh-ancestor
20006516|NCT02284386|Anesthetics|anesthetics|mesh-ancestor
20006517|NCT02284386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20006518|NCT02284386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006519|NCT02284386|Sensory System Agents|sensory system agents|mesh-ancestor
20006520|NCT02284386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006521|NCT02284464|Prednisone|prednisone|mesh-list
20006522|NCT02284464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20006523|NCT02284464|Glucocorticoids|glucocorticoids|mesh-ancestor
20006524|NCT02284464|Hormones|hormones|mesh-ancestor
20006525|NCT02284464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20006526|NCT02284464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006527|NCT02284464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20006528|NCT02284464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006529|NCT02284516|Lifitegrast|lifitegrast|mesh-list
20006530|NCT02284516|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20558496|NCT01959386|Trastuzumab|trastuzumab|mesh-list
20558497|NCT01959386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20558498|NCT01959386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558499|NCT01959399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20558500|NCT01959399|Peficitinib|peficitinib|mesh-list
20558501|NCT01959399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20558502|NCT01959399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20558503|NCT01959399|Antimetabolites|antimetabolites|mesh-ancestor
20558504|NCT01959399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558505|NCT01959399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20558506|NCT01959399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20558507|NCT01959399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558508|NCT01959399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20558509|NCT01959399|Immunologic Factors|immunologic factors|mesh-ancestor
20558510|NCT01959399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558511|NCT01959438|Selenious Acid|selenious acid|mesh-list
20558512|NCT01959438|Sodium Selenite|sodium selenite|mesh-list
20558513|NCT01959438|Trace Elements|trace elements|mesh-ancestor
20558514|NCT01959438|Micronutrients|micronutrients|mesh-ancestor
20558515|NCT01959438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558516|NCT01959451|Clopidogrel|clopidogrel|mesh-list
20558517|NCT01959451|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20558518|NCT01959451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20558519|NCT01959451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20558520|NCT01959451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20558521|NCT01959451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20558522|NCT01959451|Purinergic Agents|purinergic agents|mesh-ancestor
20558523|NCT01959451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558524|NCT01959451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558525|NCT01959451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558526|NCT01959477|Cyclophosphamide|cyclophosphamide|mesh-list
20558527|NCT01959477|Busulfan|busulfan|mesh-list
20558528|NCT01959477|Etoposide|etoposide|mesh-list
20558529|NCT01959477|Etoposide phosphate|etoposide phosphate|mesh-list
20558530|NCT01959477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20558531|NCT01959477|Immunologic Factors|immunologic factors|mesh-ancestor
20558532|NCT01959477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558533|NCT01959477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20558534|NCT01959477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20558535|NCT01959477|Alkylating Agents|alkylating agents|mesh-ancestor
20558536|NCT01959477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558537|NCT01959477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558538|NCT01959477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20558539|NCT01959477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19459950|NCT03357133|Tirofiban|tirofiban|mesh-list
20006531|NCT02284516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20006532|NCT02284555|Mupirocin|mupirocin|mesh-list
20006533|NCT02284555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20006534|NCT02284555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20006535|NCT02284555|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20006536|NCT02284555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006537|NCT02284555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006538|NCT02284828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
20006539|NCT02284828|Anticonvulsants|anticonvulsants|mesh-ancestor
20006540|NCT02284828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20006541|NCT02284828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20006542|NCT02284828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006543|NCT02284828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006544|NCT02284854|Carbamazepine|carbamazepine|mesh-list
20006545|NCT02284854|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
20006546|NCT02284854|Anticonvulsants|anticonvulsants|mesh-ancestor
20006547|NCT02284854|Antimanic Agents|antimanic agents|mesh-ancestor
20006548|NCT02284854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20006549|NCT02284854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20006550|NCT02284854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006551|NCT02284854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20006552|NCT02284854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20006553|NCT02284854|Analgesics|analgesics|mesh-ancestor
20006554|NCT02284854|Sensory System Agents|sensory system agents|mesh-ancestor
20006555|NCT02284854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006556|NCT02284854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20006557|NCT02284854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006558|NCT02284854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006559|NCT02284854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20006560|NCT02284854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20006561|NCT02284854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20006562|NCT02284880|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
20006563|NCT02284880|Anticonvulsants|anticonvulsants|mesh-ancestor
20006564|NCT02284880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20006565|NCT02284880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20006566|NCT02284880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006567|NCT02284880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006568|NCT02284893|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20006569|NCT02284893|Dapagliflozin|dapagliflozin|mesh-list
20006570|NCT02284893|Saxagliptin|saxagliptin|mesh-list
20006571|NCT02284893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20006572|NCT02284893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006573|NCT02284893|Incretins|incretins|mesh-ancestor
20006574|NCT02284893|Hormones|hormones|mesh-ancestor
20006575|NCT02284893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20006576|NCT02284893|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20006577|NCT02284893|Protease Inhibitors|protease inhibitors|mesh-ancestor
20006578|NCT02284893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19459951|NCT03357133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20006579|NCT02284893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006580|NCT02284893|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20006581|NCT02285010|Pregabalin|pregabalin|mesh-list
20006582|NCT02285010|Analgesics|analgesics|mesh-ancestor
20006583|NCT02285010|Sensory System Agents|sensory system agents|mesh-ancestor
20006584|NCT02285010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006585|NCT02285010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006586|NCT02285010|Anticonvulsants|anticonvulsants|mesh-ancestor
20006587|NCT02285010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20006588|NCT02285010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006589|NCT02285010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006590|NCT02285010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20006591|NCT02285010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20006592|NCT02285010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20006593|NCT02285010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20006594|NCT02285010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20006595|NCT02285153|Aspirin|aspirin|mesh-list
20006596|NCT02285153|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
20006597|NCT02285153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20006598|NCT02285153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20006599|NCT02285153|Analgesics|analgesics|mesh-ancestor
20006600|NCT02285153|Sensory System Agents|sensory system agents|mesh-ancestor
20006601|NCT02285153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006602|NCT02285153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006603|NCT02285153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20006604|NCT02285153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20006605|NCT02285153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20006606|NCT02285153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20006607|NCT02285153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006608|NCT02285153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20006609|NCT02285153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20006610|NCT02285153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006611|NCT02285153|Antipyretics|antipyretics|mesh-ancestor
20006612|NCT02285283|Itraconazole|itraconazole|mesh-list
20006613|NCT02285283|Antifungal Agents|antifungal agents|mesh-ancestor
20006614|NCT02285283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20006615|NCT02285283|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20006616|NCT02285283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20006617|NCT02285283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006618|NCT02285283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006619|NCT02285283|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20006620|NCT02285283|Hormone Antagonists|hormone antagonists|mesh-ancestor
20006621|NCT02285283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20006622|NCT02285283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558540|NCT01959477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20558541|NCT01959477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20558542|NCT01959477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558543|NCT01959828|Nitric Oxide|nitric oxide|mesh-list
20558544|NCT01959828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20558545|NCT01959828|Autonomic Agents|autonomic agents|mesh-ancestor
20558546|NCT01959828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558547|NCT01959828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558548|NCT01959828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20558549|NCT01959828|Respiratory System Agents|respiratory system agents|mesh-ancestor
20558550|NCT01959828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20558551|NCT01959828|Antioxidants|antioxidants|mesh-ancestor
20558552|NCT01959828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558553|NCT01959828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558554|NCT01959828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
20558555|NCT01959828|Vasodilator Agents|vasodilator agents|mesh-ancestor
20558556|NCT01959828|Gasotransmitters|gasotransmitters|mesh-ancestor
20558557|NCT01959828|Protective Agents|protective agents|mesh-ancestor
20558558|NCT01959854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20558559|NCT01959854|Laxatives|laxatives|mesh-ancestor
20558560|NCT01959854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20558561|NCT01960023|Cetuximab|cetuximab|mesh-list
20558562|NCT01960023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20558563|NCT01960023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558564|NCT01960049|Ropivacaine|ropivacaine|mesh-list
20558565|NCT01960049|Anesthetics, Local|anesthetics, local|mesh-ancestor
20558566|NCT01960049|Anesthetics|anesthetics|mesh-ancestor
20558567|NCT01960049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20006623|NCT02285283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20006624|NCT02285634|Lidocaine|lidocaine|mesh-list
20006625|NCT02285634|Phenylephrine|phenylephrine|mesh-list
20006626|NCT02285634|Epinephrine|epinephrine|mesh-list
20006627|NCT02285634|Oxymetazoline|oxymetazoline|mesh-list
20006628|NCT02285634|Anesthetics, Local|anesthetics, local|mesh-ancestor
20006629|NCT02285634|Anesthetics|anesthetics|mesh-ancestor
20006630|NCT02285634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20006631|NCT02285634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006632|NCT02285634|Sensory System Agents|sensory system agents|mesh-ancestor
20006633|NCT02285634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006634|NCT02285634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20006635|NCT02285634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20006636|NCT02285634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20006637|NCT02285634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006638|NCT02285634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006639|NCT02285634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20006640|NCT02285634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20006641|NCT02285634|Adrenergic Agents|adrenergic agents|mesh-ancestor
20006642|NCT02285634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20006643|NCT02285634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20006644|NCT02285634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20006645|NCT02285634|Autonomic Agents|autonomic agents|mesh-ancestor
20006646|NCT02285634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20006647|NCT02285634|Respiratory System Agents|respiratory system agents|mesh-ancestor
20006648|NCT02285634|Mydriatics|mydriatics|mesh-ancestor
20006649|NCT02285634|Sympathomimetics|sympathomimetics|mesh-ancestor
20006650|NCT02285634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20006651|NCT02285634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20006652|NCT02285634|Nasal Decongestants|nasal decongestants|mesh-ancestor
20006653|NCT02285634|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20006654|NCT02285634|Protective Agents|protective agents|mesh-ancestor
20006655|NCT02285855|Metformin|metformin|mesh-list
20006656|NCT02285855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20006657|NCT02285855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006658|NCT02285920|Spironolactone|spironolactone|mesh-list
20006659|NCT02285920|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20006660|NCT02285920|Hormone Antagonists|hormone antagonists|mesh-ancestor
20006661|NCT02285920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20006662|NCT02285920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006663|NCT02285920|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20006664|NCT02285920|Diuretics|diuretics|mesh-ancestor
20006665|NCT02285920|Natriuretic Agents|natriuretic agents|mesh-ancestor
20006666|NCT02285998|Vaccines|vaccines|mesh-list
20006667|NCT02285998|Immunologic Factors|immunologic factors|mesh-ancestor
20006668|NCT02285998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459952|NCT03357133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20006669|NCT02286726|Cytarabine|cytarabine|mesh-list
20006670|NCT02286726|Daunorubicin|daunorubicin|mesh-list
20006671|NCT02286726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20006672|NCT02286726|Antimetabolites|antimetabolites|mesh-ancestor
20006673|NCT02286726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006674|NCT02286726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006675|NCT02286726|Antiviral Agents|antiviral agents|mesh-ancestor
20006676|NCT02286726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20006677|NCT02286726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20006678|NCT02286726|Immunologic Factors|immunologic factors|mesh-ancestor
20006679|NCT02286726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006680|NCT02286726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20006681|NCT02286726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20006682|NCT02286726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20006683|NCT02286726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006684|NCT02286843|Trastuzumab|trastuzumab|mesh-list
20006685|NCT02286843|Pertuzumab|pertuzumab|mesh-list
20006686|NCT02286843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20006687|NCT02286843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006688|NCT02286895|Vaccines|vaccines|mesh-list
20006689|NCT02286895|Immunologic Factors|immunologic factors|mesh-ancestor
20006690|NCT02286895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006691|NCT02286921|Methyltestosterone|methyltestosterone|mesh-list
20006692|NCT02286921|Testosterone|testosterone|mesh-list
20006693|NCT02286921|Testosterone undecanoate|testosterone undecanoate|mesh-list
20006694|NCT02286921|Testosterone enanthate|testosterone enanthate|mesh-list
20006695|NCT02286921|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20006696|NCT02286921|Androgens|androgens|mesh-ancestor
20006697|NCT02286921|Hormones|hormones|mesh-ancestor
20006698|NCT02286921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20006699|NCT02286921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006700|NCT02286921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20006701|NCT02286921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006702|NCT02286921|Anabolic Agents|anabolic agents|mesh-ancestor
20006703|NCT02287038|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
20006704|NCT02287038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20006705|NCT02287038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20558568|NCT01960049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558569|NCT01960049|Sensory System Agents|sensory system agents|mesh-ancestor
20558570|NCT01960049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558571|NCT01960153|Tadalafil|tadalafil|mesh-list
20558572|NCT01960153|Vasodilator Agents|vasodilator agents|mesh-ancestor
20558573|NCT01960153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20558574|NCT01960153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20558575|NCT01960153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558576|NCT01960153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558577|NCT01960153|Urological Agents|urological agents|mesh-ancestor
20558578|NCT01960179|Lixisenatide|lixisenatide|mesh-list
20558579|NCT01960179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20558580|NCT01960179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558581|NCT01960205|Metformin|metformin|mesh-list
20558582|NCT01960205|Saxagliptin|saxagliptin|mesh-list
20558583|NCT01960205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20558584|NCT01960205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558585|NCT01960205|Incretins|incretins|mesh-ancestor
20558586|NCT01960205|Hormones|hormones|mesh-ancestor
20558587|NCT01960205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20558588|NCT01960205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20558589|NCT01960205|Protease Inhibitors|protease inhibitors|mesh-ancestor
20558590|NCT01960205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558591|NCT01960205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558592|NCT01960283|Methotrexate|methotrexate|mesh-list
20558593|NCT01960283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20558594|NCT01960283|Abortifacient Agents|abortifacient agents|mesh-ancestor
20558595|NCT01960283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20558596|NCT01960283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558597|NCT01960283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20558598|NCT01960283|Antimetabolites|antimetabolites|mesh-ancestor
20558599|NCT01960283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558600|NCT01960283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558601|NCT01960283|Dermatologic Agents|dermatologic agents|mesh-ancestor
20558602|NCT01960283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558603|NCT01960283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20558604|NCT01960283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20558605|NCT01960283|Immunologic Factors|immunologic factors|mesh-ancestor
20006706|NCT02287038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006707|NCT02287038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006708|NCT02287038|Adrenergic Agents|adrenergic agents|mesh-ancestor
20006709|NCT02287038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20006710|NCT02287038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006711|NCT02287350|Diclofenac|diclofenac|mesh-list
20006712|NCT02287350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20006713|NCT02287350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20006714|NCT02287350|Analgesics|analgesics|mesh-ancestor
20006715|NCT02287350|Sensory System Agents|sensory system agents|mesh-ancestor
20006716|NCT02287350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19459953|NCT03357133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459954|NCT03357133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19459955|NCT03357055|Ketamine|ketamine|mesh-list
19459956|NCT03357055|Analgesics|analgesics|mesh-ancestor
19459957|NCT03357055|Sensory System Agents|sensory system agents|mesh-ancestor
19459958|NCT03357055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19459959|NCT03357055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459960|NCT03357055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19459961|NCT03357055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19459962|NCT03357055|Anesthetics, General|anesthetics, general|mesh-ancestor
19459963|NCT03357055|Anesthetics|anesthetics|mesh-ancestor
19459964|NCT03357055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19459965|NCT03357055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19459966|NCT03357055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19459967|NCT03357055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19459968|NCT03357055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19459969|NCT03356964|Hormones|hormones|mesh-list
19459970|NCT03356964|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
19459971|NCT03356964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19459972|NCT03356964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459973|NCT03356912|Prednisone|prednisone|mesh-list
19459974|NCT03356912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19459975|NCT03356912|Glucocorticoids|glucocorticoids|mesh-ancestor
19459976|NCT03356912|Hormones|hormones|mesh-ancestor
19459977|NCT03356912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19459978|NCT03356912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459979|NCT03356912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19459980|NCT03356912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19459981|NCT03356899|Bupivacaine|bupivacaine|mesh-list
19459982|NCT03356899|Anesthetics|anesthetics|mesh-list
19459983|NCT03356899|Anesthetics, Local|anesthetics, local|mesh-ancestor
19459984|NCT03356899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19459985|NCT03356899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459986|NCT03356899|Sensory System Agents|sensory system agents|mesh-ancestor
19459987|NCT03356899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19459988|NCT03356873|Vitamin D|vitamin d|mesh-list
19459989|NCT03356873|Ergocalciferols|ergocalciferols|mesh-list
19459990|NCT03356873|Vitamins|vitamins|mesh-list
19459991|NCT03356873|Micronutrients|micronutrients|mesh-ancestor
19459992|NCT03356873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459993|NCT03356873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19459994|NCT03356873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19459995|NCT03356834|Tenofovir|tenofovir|mesh-list
19459996|NCT03356834|Antiviral Agents|antiviral agents|mesh-ancestor
19459997|NCT03356834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19459998|NCT03356834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20006717|NCT02287350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006718|NCT02287350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20006719|NCT02287350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20006720|NCT02287350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20006721|NCT02287350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006722|NCT02287350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006723|NCT02287376|Diclofenac|diclofenac|mesh-list
20006724|NCT02287376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20006725|NCT02287376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20006726|NCT02287376|Analgesics|analgesics|mesh-ancestor
20006727|NCT02287376|Sensory System Agents|sensory system agents|mesh-ancestor
20006728|NCT02287376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006729|NCT02287376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006730|NCT02287376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20006731|NCT02287376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20006732|NCT02287376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20006733|NCT02287376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006734|NCT02287376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006735|NCT02287402|Voglibose|voglibose|mesh-list
20006736|NCT02287402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20006737|NCT02287402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006738|NCT02287402|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20006739|NCT02287402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006740|NCT02287402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006741|NCT02287415|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
20006742|NCT02287415|Warfarin|warfarin|mesh-list
20006743|NCT02287415|Anticoagulants|anticoagulants|mesh-ancestor
20006744|NCT02287415|Anticonvulsants|anticonvulsants|mesh-ancestor
20006745|NCT02287415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20006746|NCT02287415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20006747|NCT02287415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006748|NCT02287415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006749|NCT02287467|Immunoglobulins|immunoglobulins|mesh-list
20006750|NCT02287467|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20006751|NCT02287467|Antibodies|antibodies|mesh-list
20006752|NCT02287467|gamma-Globulins|gamma-globulins|mesh-list
20006753|NCT02287467|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20006754|NCT02287467|Immunologic Factors|immunologic factors|mesh-ancestor
20006755|NCT02287467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558606|NCT01960283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20558607|NCT01960283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20558608|NCT01960426|Adalimumab|adalimumab|mesh-list
20558609|NCT01960426|Infliximab|infliximab|mesh-list
20558610|NCT01960426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20558611|NCT01960426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20558612|NCT01960426|Dermatologic Agents|dermatologic agents|mesh-ancestor
20558613|NCT01960426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20558614|NCT01960543|Fentanyl|fentanyl|mesh-list
20558615|NCT01960543|Bupivacaine|bupivacaine|mesh-list
20558616|NCT01960543|Levobupivacaine|levobupivacaine|mesh-list
20558617|NCT01960543|Anesthetics, Local|anesthetics, local|mesh-ancestor
20558618|NCT01960543|Anesthetics|anesthetics|mesh-ancestor
20558619|NCT01960543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20558620|NCT01960543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558621|NCT01960543|Sensory System Agents|sensory system agents|mesh-ancestor
20558622|NCT01960543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558623|NCT01960543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20558624|NCT01960543|Narcotics|narcotics|mesh-ancestor
20558625|NCT01960543|Analgesics|analgesics|mesh-ancestor
20558626|NCT01960543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20558627|NCT01960543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20558628|NCT01960543|Anesthetics, General|anesthetics, general|mesh-ancestor
20558629|NCT01960569|Hirudins|hirudins|mesh-list
20558630|NCT01960569|Antithrombins|antithrombins|mesh-ancestor
20558631|NCT01960569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20558632|NCT01960569|Protease Inhibitors|protease inhibitors|mesh-ancestor
20558633|NCT01960569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558634|NCT01960569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558635|NCT01960569|Anticoagulants|anticoagulants|mesh-ancestor
20558636|NCT01960569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20558637|NCT01960569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20558638|NCT01960595|Fentanyl|fentanyl|mesh-list
20558639|NCT01960595|Bupivacaine|bupivacaine|mesh-list
20558640|NCT01960595|Anesthetics, Local|anesthetics, local|mesh-ancestor
20558641|NCT01960595|Anesthetics|anesthetics|mesh-ancestor
20558642|NCT01960595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20006756|NCT02287610|Prednisone|prednisone|mesh-list
20006757|NCT02287610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20006758|NCT02287610|Glucocorticoids|glucocorticoids|mesh-ancestor
20006759|NCT02287610|Hormones|hormones|mesh-ancestor
20006760|NCT02287610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20006761|NCT02287610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006762|NCT02287610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20006763|NCT02287610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006764|NCT02287623|Bupivacaine|bupivacaine|mesh-list
20006765|NCT02287623|Anesthetics, Local|anesthetics, local|mesh-ancestor
20006766|NCT02287623|Anesthetics|anesthetics|mesh-ancestor
20006767|NCT02287623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20006768|NCT02287623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006769|NCT02287623|Sensory System Agents|sensory system agents|mesh-ancestor
20006770|NCT02287623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006771|NCT02287779|Volixibat|volixibat|mesh-list
20006772|NCT02287779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20006773|NCT02287818|Febuxostat|febuxostat|mesh-list
20006774|NCT02287818|Gout Suppressants|gout suppressants|mesh-ancestor
20006775|NCT02287818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20006776|NCT02287909|Clopidogrel|clopidogrel|mesh-list
20006777|NCT02287909|Ticagrelor|ticagrelor|mesh-list
20006778|NCT02287909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20006779|NCT02287909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20006780|NCT02287909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20006781|NCT02287909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20006782|NCT02287909|Purinergic Agents|purinergic agents|mesh-ancestor
20006783|NCT02287909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20006784|NCT02287909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006785|NCT02287909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006786|NCT02288156|Capsaicin|capsaicin|mesh-list
20006787|NCT02288156|Antipruritics|antipruritics|mesh-ancestor
20006788|NCT02288156|Dermatologic Agents|dermatologic agents|mesh-ancestor
20006789|NCT02288156|Sensory System Agents|sensory system agents|mesh-ancestor
20006790|NCT02288156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006791|NCT02288156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006792|NCT02288273|Exenatide|exenatide|mesh-list
20006793|NCT02288273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20006794|NCT02288273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006795|NCT02288273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20006796|NCT02288273|Incretins|incretins|mesh-ancestor
20558643|NCT01960595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558644|NCT01960595|Sensory System Agents|sensory system agents|mesh-ancestor
20558645|NCT01960595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558646|NCT01960595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20558647|NCT01960595|Narcotics|narcotics|mesh-ancestor
20558648|NCT01960595|Analgesics|analgesics|mesh-ancestor
20558649|NCT01960595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20558650|NCT01960595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20558651|NCT01960595|Anesthetics, General|anesthetics, general|mesh-ancestor
20558652|NCT01960647|Paclitaxel|paclitaxel|mesh-list
20558653|NCT01960647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20558654|NCT01960647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558655|NCT01960647|Tubulin Modulators|tubulin modulators|mesh-ancestor
20558656|NCT01960647|Antimitotic Agents|antimitotic agents|mesh-ancestor
20558657|NCT01960647|Mitosis Modulators|mitosis modulators|mesh-ancestor
20558658|NCT01960647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558659|NCT01960764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20558660|NCT01960764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20558661|NCT01960829|Everolimus|everolimus|mesh-list
20558662|NCT01960829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558663|NCT01960829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20558664|NCT01960829|Immunologic Factors|immunologic factors|mesh-ancestor
20558665|NCT01960829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006797|NCT02288273|Hormones|hormones|mesh-ancestor
20006798|NCT02288273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20006799|NCT02288312|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
20006800|NCT02288312|Anticonvulsants|anticonvulsants|mesh-ancestor
20558666|NCT01961154|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20558667|NCT01961154|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20558668|NCT01961154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20558669|NCT01961154|Respiratory System Agents|respiratory system agents|mesh-ancestor
20558670|NCT01961154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20558671|NCT01961154|Autonomic Agents|autonomic agents|mesh-ancestor
20558672|NCT01961154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558673|NCT01961154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558674|NCT01961154|Glucocorticoids|glucocorticoids|mesh-ancestor
20558675|NCT01961154|Hormones|hormones|mesh-ancestor
20558676|NCT01961154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20558677|NCT01961154|Sympathomimetics|sympathomimetics|mesh-ancestor
20558678|NCT01961180|Citalopram|citalopram|mesh-list
20558679|NCT01961180|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20558680|NCT01961180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20558681|NCT01961180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20558682|NCT01961180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558683|NCT01961180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558684|NCT01961180|Serotonin Agents|serotonin agents|mesh-ancestor
20558685|NCT01961180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558686|NCT01961180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20558687|NCT01961180|Antidepressive Agents|antidepressive agents|mesh-ancestor
20006801|NCT02288312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20006802|NCT02288312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20006803|NCT02288312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006804|NCT02288312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006805|NCT02288325|Milnacipran|milnacipran|mesh-list
20006806|NCT02288325|Levomilnacipran|levomilnacipran|mesh-list
20006807|NCT02288325|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20006808|NCT02288325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20006809|NCT02288325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006810|NCT02288325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006811|NCT02288325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20006812|NCT02288325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006813|NCT02288325|Antidepressive Agents|antidepressive agents|mesh-ancestor
20006814|NCT02288325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20006815|NCT02288325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20006816|NCT02288325|Analgesics|analgesics|mesh-ancestor
20006817|NCT02288325|Sensory System Agents|sensory system agents|mesh-ancestor
20006818|NCT02288325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006819|NCT02288364|Lidocaine|lidocaine|mesh-list
20006820|NCT02288364|Anesthetics, Local|anesthetics, local|mesh-ancestor
20006821|NCT02288364|Anesthetics|anesthetics|mesh-ancestor
20006822|NCT02288364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20006823|NCT02288364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006824|NCT02288364|Sensory System Agents|sensory system agents|mesh-ancestor
20006825|NCT02288364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006826|NCT02288364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20006827|NCT02288364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20006828|NCT02288364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20006829|NCT02288364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006830|NCT02288364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006831|NCT02288377|Lanreotide|lanreotide|mesh-list
20006832|NCT02288377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006833|NCT02288819|Diuretics|diuretics|mesh-list
20006834|NCT02288819|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
20006835|NCT02288819|Natriuretic Agents|natriuretic agents|mesh-ancestor
20006836|NCT02288819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006837|NCT02288819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20006838|NCT02288819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006839|NCT02289079|Bupivacaine|bupivacaine|mesh-list
20006840|NCT02289079|Anesthetics, Local|anesthetics, local|mesh-ancestor
20006841|NCT02289079|Anesthetics|anesthetics|mesh-ancestor
20006842|NCT02289079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20006843|NCT02289079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006844|NCT02289079|Sensory System Agents|sensory system agents|mesh-ancestor
20006845|NCT02289079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006846|NCT02289222|Dexamethasone|dexamethasone|mesh-list
20006847|NCT02289222|Pembrolizumab|pembrolizumab|mesh-list
20006848|NCT02289222|Pomalidomide|pomalidomide|mesh-list
20006849|NCT02289222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20006850|NCT02289222|Antiemetics|antiemetics|mesh-ancestor
20006851|NCT02289222|Autonomic Agents|autonomic agents|mesh-ancestor
20006852|NCT02289222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006853|NCT02289222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006854|NCT02289222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20006855|NCT02289222|Glucocorticoids|glucocorticoids|mesh-ancestor
20006856|NCT02289222|Hormones|hormones|mesh-ancestor
20006857|NCT02289222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20006858|NCT02289222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20006859|NCT02289222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006860|NCT02289222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20006861|NCT02289222|Immunologic Factors|immunologic factors|mesh-ancestor
20006862|NCT02289222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20006863|NCT02289222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20006864|NCT02289222|Growth Substances|growth substances|mesh-ancestor
20006865|NCT02289222|Growth Inhibitors|growth inhibitors|mesh-ancestor
20006866|NCT02289352|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20006867|NCT02289352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20006868|NCT02289352|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20006869|NCT02289352|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20006870|NCT02289352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20006871|NCT02289352|Adrenergic Agents|adrenergic agents|mesh-ancestor
20006872|NCT02289352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20006873|NCT02289352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006874|NCT02289352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006875|NCT02289417|Apremilast|apremilast|mesh-list
20006876|NCT02289417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20006877|NCT02289417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20006878|NCT02289417|Analgesics|analgesics|mesh-ancestor
20006879|NCT02289417|Sensory System Agents|sensory system agents|mesh-ancestor
20006880|NCT02289417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006881|NCT02289417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006882|NCT02289417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20006883|NCT02289417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20006884|NCT02289417|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20006885|NCT02289417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20006886|NCT02289417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006887|NCT02289417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006888|NCT02289456|Paclitaxel|paclitaxel|mesh-list
20006889|NCT02289456|Carboplatin|carboplatin|mesh-list
20558688|NCT01961180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20558689|NCT01961193|Silicon|silicon|mesh-list
20558690|NCT01961193|Trace Elements|trace elements|mesh-ancestor
20558691|NCT01961193|Micronutrients|micronutrients|mesh-ancestor
20558692|NCT01961193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558693|NCT01961219|Anesthetics|anesthetics|mesh-list
20558694|NCT01961219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20558695|NCT01961219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558696|NCT01961336|Testosterone|testosterone|mesh-list
20006890|NCT02289456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20006891|NCT02289456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006892|NCT02289456|Tubulin Modulators|tubulin modulators|mesh-ancestor
20006893|NCT02289456|Antimitotic Agents|antimitotic agents|mesh-ancestor
20006894|NCT02289456|Mitosis Modulators|mitosis modulators|mesh-ancestor
20006895|NCT02289456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006896|NCT02289690|Carboplatin|carboplatin|mesh-list
20006897|NCT02289690|Etoposide|etoposide|mesh-list
20006898|NCT02289690|Veliparib|veliparib|mesh-list
20006899|NCT02289690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006900|NCT02289690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20006901|NCT02289690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20006902|NCT02289690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20006903|NCT02289690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006904|NCT02289690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006905|NCT02289690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20006906|NCT02289833|Trastuzumab|trastuzumab|mesh-list
20006907|NCT02289833|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
20006908|NCT02289833|Maytansine|maytansine|mesh-list
20006909|NCT02289833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20006910|NCT02289833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006911|NCT02289833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20006912|NCT02289833|Tubulin Modulators|tubulin modulators|mesh-ancestor
20006913|NCT02289833|Antimitotic Agents|antimitotic agents|mesh-ancestor
20006914|NCT02289833|Mitosis Modulators|mitosis modulators|mesh-ancestor
20006915|NCT02289833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006916|NCT02289898|Gemcitabine|gemcitabine|mesh-list
20006917|NCT02289898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20006918|NCT02289898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20006919|NCT02289898|Antimetabolites|antimetabolites|mesh-ancestor
20006920|NCT02289898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006921|NCT02289898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006922|NCT02289898|Antiviral Agents|antiviral agents|mesh-ancestor
20006923|NCT02289898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20006924|NCT02289898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006925|NCT02289898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20006926|NCT02289898|Immunologic Factors|immunologic factors|mesh-ancestor
20006927|NCT02289898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006928|NCT02289950|Farletuzumab|farletuzumab|mesh-list
20006929|NCT02289950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006930|NCT02289963|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20006931|NCT02289963|Immunologic Factors|immunologic factors|mesh-ancestor
20006932|NCT02289963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006933|NCT02289989|Hydrocortisone|hydrocortisone|mesh-list
20006934|NCT02289989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20006935|NCT02290106|Pitavastatin|pitavastatin|mesh-list
20006936|NCT02290106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20006937|NCT02290106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20006938|NCT02290106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20006939|NCT02290106|Antimetabolites|antimetabolites|mesh-ancestor
20006940|NCT02290106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006941|NCT02290106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20006942|NCT02290106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20006943|NCT02290444|Hormones|hormones|mesh-list
20006944|NCT02290444|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20006945|NCT02290444|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
20006946|NCT02290444|beta-Endorphin|beta-endorphin|mesh-list
20006947|NCT02290444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20006948|NCT02290444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006949|NCT02290444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20006950|NCT02290444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290236|NCT04190550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290237|NCT04190550|Antiviral Agents|antiviral agents|mesh-ancestor
20290238|NCT04190550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20290239|NCT04190550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20290240|NCT04190550|Immunologic Factors|immunologic factors|mesh-ancestor
20290241|NCT04190550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290242|NCT04190550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20290243|NCT04190550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20290244|NCT04190550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20290245|NCT04190550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290246|NCT04170283|Zanubrutinib|zanubrutinib|mesh-list
20290247|NCT04170283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006951|NCT02290613|Ambrisentan|ambrisentan|mesh-list
20006952|NCT02290613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20006953|NCT02290873|Midazolam|midazolam|mesh-list
20006954|NCT02290873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20006955|NCT02290873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20006956|NCT02290873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20006957|NCT02290873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006958|NCT02290873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20006959|NCT02290873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20006960|NCT02290873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20006961|NCT02290873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20006962|NCT02290873|Anesthetics, General|anesthetics, general|mesh-ancestor
20006963|NCT02290873|Anesthetics|anesthetics|mesh-ancestor
20006964|NCT02290873|GABA Modulators|gaba modulators|mesh-ancestor
20006965|NCT02290873|GABA Agents|gaba agents|mesh-ancestor
20006966|NCT02290873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20006967|NCT02290873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006968|NCT02291016|Formoterol Fumarate|formoterol fumarate|mesh-list
20006969|NCT02291016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20006970|NCT02291016|Autonomic Agents|autonomic agents|mesh-ancestor
20006971|NCT02291016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20006972|NCT02291016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006973|NCT02291016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20006974|NCT02291016|Respiratory System Agents|respiratory system agents|mesh-ancestor
20006975|NCT02291016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20006976|NCT02291016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20006977|NCT02291016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20006978|NCT02291016|Adrenergic Agents|adrenergic agents|mesh-ancestor
20006979|NCT02291016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20006980|NCT02291016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20006981|NCT02291029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20006982|NCT02291029|Immunologic Factors|immunologic factors|mesh-ancestor
20006983|NCT02291029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20006984|NCT02291133|Bleomycin|bleomycin|mesh-list
20006985|NCT02291133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20006986|NCT02291133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006987|NCT02291289|Bevacizumab|bevacizumab|mesh-list
20006988|NCT02291289|Trastuzumab|trastuzumab|mesh-list
20006989|NCT02291289|Cetuximab|cetuximab|mesh-list
20006990|NCT02291289|Pertuzumab|pertuzumab|mesh-list
20006991|NCT02291289|Capecitabine|capecitabine|mesh-list
20006992|NCT02291289|Fluorouracil|fluorouracil|mesh-list
20006993|NCT02291289|Atezolizumab|atezolizumab|mesh-list
20006994|NCT02291289|Vemurafenib|vemurafenib|mesh-list
20006995|NCT02291289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20006996|NCT02291289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20006997|NCT02291289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20006998|NCT02291289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20006999|NCT02291289|Growth Substances|growth substances|mesh-ancestor
20007000|NCT02291289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19459999|NCT03356834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19460000|NCT03356834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19460001|NCT03356834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460002|NCT03356834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19460003|NCT03356834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19460004|NCT03356769|Aspirin|aspirin|mesh-list
19460005|NCT03356769|Anticonvulsants|anticonvulsants|mesh-list
19460006|NCT03356769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19460007|NCT03356769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19460008|NCT03356769|Analgesics|analgesics|mesh-ancestor
19460009|NCT03356769|Sensory System Agents|sensory system agents|mesh-ancestor
19460010|NCT03356769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460011|NCT03356769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007001|NCT02291289|Growth Inhibitors|growth inhibitors|mesh-ancestor
20007002|NCT02291289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20007003|NCT02291289|Antimetabolites|antimetabolites|mesh-ancestor
20007004|NCT02291289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007005|NCT02291289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20007006|NCT02291289|Immunologic Factors|immunologic factors|mesh-ancestor
20007007|NCT02291289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20007008|NCT02291289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007009|NCT02291419|Aspirin|aspirin|mesh-list
20007010|NCT02291419|Ticagrelor|ticagrelor|mesh-list
20007011|NCT02291419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20007012|NCT02291419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20007013|NCT02291419|Analgesics|analgesics|mesh-ancestor
20007014|NCT02291419|Sensory System Agents|sensory system agents|mesh-ancestor
20007015|NCT02291419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007016|NCT02291419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007017|NCT02291419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20007018|NCT02291419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20007019|NCT02291419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20007020|NCT02291419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20007021|NCT02291419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007022|NCT02291419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20007023|NCT02291419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20007024|NCT02291419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007025|NCT02291419|Antipyretics|antipyretics|mesh-ancestor
20007026|NCT02291419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20007027|NCT02291419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20007028|NCT02291419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20007029|NCT02291419|Purinergic Agents|purinergic agents|mesh-ancestor
20007030|NCT02291419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20007031|NCT02291549|Mometasone Furoate|mometasone furoate|mesh-list
20007032|NCT02291549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20007033|NCT02291549|Dermatologic Agents|dermatologic agents|mesh-ancestor
20007034|NCT02291549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20007035|NCT02291601|Chlorhexidine|chlorhexidine|mesh-list
20007036|NCT02291601|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20007037|NCT02291601|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20007038|NCT02291601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20007039|NCT02291601|Disinfectants|disinfectants|mesh-ancestor
20007040|NCT02291601|Dermatologic Agents|dermatologic agents|mesh-ancestor
20007041|NCT02291679|Linaclotide|linaclotide|mesh-list
20007042|NCT02291679|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20007043|NCT02291679|Enzyme Activators|enzyme activators|mesh-ancestor
20007044|NCT02291679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007045|NCT02291679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20007046|NCT02291913|Tamoxifen|tamoxifen|mesh-list
20007047|NCT02291913|Everolimus|everolimus|mesh-list
20007048|NCT02291913|Letrozole|letrozole|mesh-list
20007049|NCT02291913|Fulvestrant|fulvestrant|mesh-list
20007050|NCT02291913|Anastrozole|anastrozole|mesh-list
20007051|NCT02291913|Exemestane|exemestane|mesh-list
20007052|NCT02291913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007053|NCT02291913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20007054|NCT02291913|Immunologic Factors|immunologic factors|mesh-ancestor
20007055|NCT02291913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007056|NCT02291913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20007057|NCT02291913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20007058|NCT02291913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007059|NCT02291913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007060|NCT02291913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20558697|NCT01961336|Androgens|androgens|mesh-ancestor
20558698|NCT01961336|Hormones|hormones|mesh-ancestor
20558699|NCT01961336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20558700|NCT01961336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558701|NCT01961388|Metformin|metformin|mesh-list
20558702|NCT01961388|Acarbose|acarbose|mesh-list
20558703|NCT01961388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20558704|NCT01961388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558705|NCT01961388|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20558706|NCT01961388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558707|NCT01961388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558708|NCT01961414|Aflibercept|aflibercept|mesh-list
20558709|NCT01961414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20558710|NCT01961414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20558711|NCT01961414|Growth Substances|growth substances|mesh-ancestor
20558712|NCT01961414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558713|NCT01961414|Growth Inhibitors|growth inhibitors|mesh-ancestor
20558714|NCT01961414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558715|NCT01961453|Isosorbide|isosorbide|mesh-list
20558716|NCT01961453|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20558717|NCT01961453|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20558718|NCT01961453|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20558719|NCT01961453|Diuretics|diuretics|mesh-ancestor
20558720|NCT01961453|Natriuretic Agents|natriuretic agents|mesh-ancestor
20558721|NCT01961453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558722|NCT01961453|Vasodilator Agents|vasodilator agents|mesh-ancestor
20558723|NCT01961453|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20558724|NCT01961453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558725|NCT01961635|Cimetidine|cimetidine|mesh-list
20558726|NCT01961635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20558727|NCT01961635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20558728|NCT01961635|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20558729|NCT01961635|Histamine Antagonists|histamine antagonists|mesh-ancestor
20558730|NCT01961635|Histamine Agents|histamine agents|mesh-ancestor
20558731|NCT01961635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558732|NCT01961635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558733|NCT01961635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558734|NCT01961635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20558735|NCT01961635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20558736|NCT01961635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558737|NCT01961739|Lidocaine|lidocaine|mesh-list
20558738|NCT01961739|Anesthetics, Local|anesthetics, local|mesh-ancestor
20558739|NCT01961739|Anesthetics|anesthetics|mesh-ancestor
20007061|NCT02291913|Hormone Antagonists|hormone antagonists|mesh-ancestor
20007062|NCT02291913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20007063|NCT02291913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20007064|NCT02291913|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20007065|NCT02291913|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20007066|NCT02291913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20007067|NCT02291913|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20007068|NCT02292082|Cefazolin|cefazolin|mesh-list
20007069|NCT02292082|Dexamethasone|dexamethasone|mesh-list
20007070|NCT02292082|Methylprednisolone|methylprednisolone|mesh-list
20007071|NCT02292082|Midazolam|midazolam|mesh-list
20007072|NCT02292082|Morphine|morphine|mesh-list
20007073|NCT02292082|Bupivacaine|bupivacaine|mesh-list
20007074|NCT02292082|Propofol|propofol|mesh-list
20007075|NCT02292082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20007076|NCT02292082|Antiemetics|antiemetics|mesh-ancestor
20007077|NCT02292082|Autonomic Agents|autonomic agents|mesh-ancestor
20007078|NCT02292082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007079|NCT02292082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007080|NCT02292082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20007081|NCT02292082|Glucocorticoids|glucocorticoids|mesh-ancestor
20007082|NCT02292082|Hormones|hormones|mesh-ancestor
20007083|NCT02292082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20007084|NCT02292082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20007085|NCT02292082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007086|NCT02292082|Anesthetics, Local|anesthetics, local|mesh-ancestor
20007087|NCT02292082|Anesthetics|anesthetics|mesh-ancestor
20007088|NCT02292082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20007089|NCT02292082|Sensory System Agents|sensory system agents|mesh-ancestor
20007090|NCT02292082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20007091|NCT02292082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20007092|NCT02292082|Anesthetics, General|anesthetics, general|mesh-ancestor
20007093|NCT02292082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20007094|NCT02292082|Narcotics|narcotics|mesh-ancestor
20007095|NCT02292082|Analgesics|analgesics|mesh-ancestor
20007096|NCT02292082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20007097|NCT02292082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20007098|NCT02292082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20007099|NCT02292082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20007100|NCT02292082|GABA Modulators|gaba modulators|mesh-ancestor
20007101|NCT02292082|GABA Agents|gaba agents|mesh-ancestor
20007102|NCT02292082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20007103|NCT02292082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007104|NCT02292082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20007105|NCT02292082|Protective Agents|protective agents|mesh-ancestor
20007106|NCT02292082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20007107|NCT02292082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20007108|NCT02292719|Ritonavir|ritonavir|mesh-list
20007109|NCT02292719|Ribavirin|ribavirin|mesh-list
20007110|NCT02292719|Sofosbuvir|sofosbuvir|mesh-list
20007111|NCT02292719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20007112|NCT02292719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20007113|NCT02292719|Protease Inhibitors|protease inhibitors|mesh-ancestor
20007114|NCT02292719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007115|NCT02292719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007116|NCT02292719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20007117|NCT02292719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20007118|NCT02292719|Antiviral Agents|antiviral agents|mesh-ancestor
20007119|NCT02292719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20007120|NCT02292719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20007121|NCT02292719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20007122|NCT02292719|Antimetabolites|antimetabolites|mesh-ancestor
20007123|NCT02292771|Vasotocin|vasotocin|mesh-list
20007124|NCT02292771|Atosiban|atosiban|mesh-list
20007125|NCT02292771|Hormone Antagonists|hormone antagonists|mesh-ancestor
20007126|NCT02292771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20007127|NCT02292771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007128|NCT02292771|Tocolytic Agents|tocolytic agents|mesh-ancestor
20007129|NCT02292771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20007130|NCT02292771|Oxytocics|oxytocics|mesh-ancestor
20007131|NCT02292771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20007132|NCT02292784|Atosiban|atosiban|mesh-list
20007133|NCT02292784|Hormone Antagonists|hormone antagonists|mesh-ancestor
20007134|NCT02292784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20007135|NCT02292784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007136|NCT02292784|Tocolytic Agents|tocolytic agents|mesh-ancestor
20007137|NCT02292784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20007138|NCT02293096|Metoprolol|metoprolol|mesh-list
20007139|NCT02293096|Dextromethorphan|dextromethorphan|mesh-list
20007140|NCT02293096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20007141|NCT02293096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20007142|NCT02293096|Sympatholytics|sympatholytics|mesh-ancestor
19460012|NCT03356769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19460013|NCT03356769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19460014|NCT03356769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19460015|NCT03356769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19460016|NCT03356769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460017|NCT03356769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19460018|NCT03356769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19460019|NCT03356769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19460020|NCT03356769|Antipyretics|antipyretics|mesh-ancestor
20007143|NCT02293096|Autonomic Agents|autonomic agents|mesh-ancestor
20007144|NCT02293096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007145|NCT02293096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460024|NCT03356600|Apatinib|apatinib|mesh-list
19460025|NCT03356600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460026|NCT03356600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19460027|NCT03356600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007146|NCT02293096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20007147|NCT02293096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20007148|NCT02293096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20007149|NCT02293096|Adrenergic Agents|adrenergic agents|mesh-ancestor
20007150|NCT02293096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20007151|NCT02293096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007152|NCT02293096|Antitussive Agents|antitussive agents|mesh-ancestor
20007153|NCT02293096|Respiratory System Agents|respiratory system agents|mesh-ancestor
20007154|NCT02293096|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20007155|NCT02293096|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20007156|NCT02293395|Aspirin|aspirin|mesh-list
20007157|NCT02293395|Rivaroxaban|rivaroxaban|mesh-list
20007158|NCT02293395|Clopidogrel|clopidogrel|mesh-list
20007159|NCT02293395|Ticagrelor|ticagrelor|mesh-list
20007160|NCT02293395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20007161|NCT02293395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20007162|NCT02293395|Analgesics|analgesics|mesh-ancestor
20007163|NCT02293395|Sensory System Agents|sensory system agents|mesh-ancestor
20007164|NCT02293395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007165|NCT02293395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007166|NCT02293395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20007167|NCT02293395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20007168|NCT02293395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20007169|NCT02293395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20007170|NCT02293395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007171|NCT02293395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20007172|NCT02293395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20007173|NCT02293395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007174|NCT02293395|Antipyretics|antipyretics|mesh-ancestor
20007175|NCT02293395|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20007176|NCT02293395|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20007177|NCT02293395|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20007178|NCT02293395|Purinergic Agents|purinergic agents|mesh-ancestor
20007179|NCT02293395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20007180|NCT02293395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20007181|NCT02293395|Antithrombins|antithrombins|mesh-ancestor
20007182|NCT02293395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20007183|NCT02293395|Protease Inhibitors|protease inhibitors|mesh-ancestor
20007184|NCT02293395|Anticoagulants|anticoagulants|mesh-ancestor
20007185|NCT02293538|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20007186|NCT02293538|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20007187|NCT02293863|Oseltamivir|oseltamivir|mesh-list
20007188|NCT02293863|Antiviral Agents|antiviral agents|mesh-ancestor
20007189|NCT02293863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20007190|NCT02293863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007191|NCT02293863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007192|NCT02293902|Folic Acid|folic acid|mesh-list
20007193|NCT02293902|Methotrexate|methotrexate|mesh-list
20007194|NCT02293902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20007195|NCT02293902|Abortifacient Agents|abortifacient agents|mesh-ancestor
20007196|NCT02293902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20007197|NCT02293902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007198|NCT02293902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20007199|NCT02293902|Antimetabolites|antimetabolites|mesh-ancestor
20007200|NCT02293902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007201|NCT02293902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007202|NCT02293902|Dermatologic Agents|dermatologic agents|mesh-ancestor
20007203|NCT02293902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007204|NCT02293902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20007205|NCT02293902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20007206|NCT02293902|Immunologic Factors|immunologic factors|mesh-ancestor
20007207|NCT02293902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20007208|NCT02293902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20007209|NCT02293902|Hematinics|hematinics|mesh-ancestor
20007210|NCT02293902|Vitamin B Complex|vitamin b complex|mesh-ancestor
20007211|NCT02293902|Vitamins|vitamins|mesh-ancestor
20007212|NCT02293902|Micronutrients|micronutrients|mesh-ancestor
20007213|NCT02293993|Guadecitabine|guadecitabine|mesh-list
20007214|NCT02293993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007215|NCT02294019|Ibuprofen|ibuprofen|mesh-list
20007216|NCT02294019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20007217|NCT02294019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20007218|NCT02294019|Analgesics|analgesics|mesh-ancestor
20007219|NCT02294019|Sensory System Agents|sensory system agents|mesh-ancestor
20007220|NCT02294019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007221|NCT02294019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007222|NCT02294019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20007223|NCT02294019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20007224|NCT02294019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20007225|NCT02294019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007226|NCT02294019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007227|NCT02294058|Interferons|interferons|mesh-list
20007228|NCT02294058|Interferon-beta|interferon-beta|mesh-list
20007229|NCT02294058|Interferon beta-1a|interferon beta-1a|mesh-list
20007230|NCT02294058|Ozanimod|ozanimod|mesh-list
20007231|NCT02294058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007232|NCT02294058|Antiviral Agents|antiviral agents|mesh-ancestor
20007233|NCT02294058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20007234|NCT02294058|Immunologic Factors|immunologic factors|mesh-ancestor
20007235|NCT02294058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007236|NCT02294058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20007237|NCT02294058|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20007238|NCT02294058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007239|NCT02294058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20007240|NCT02294253|Buprenorphine|buprenorphine|mesh-list
20007241|NCT02294253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20007242|NCT02294253|Naloxone|naloxone|mesh-list
20007243|NCT02294253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20007244|NCT02294253|Narcotics|narcotics|mesh-ancestor
20007245|NCT02294253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20007246|NCT02294253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007247|NCT02294253|Analgesics|analgesics|mesh-ancestor
20007248|NCT02294253|Sensory System Agents|sensory system agents|mesh-ancestor
20007249|NCT02294253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007250|NCT02294253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20007251|NCT02294396|Solifenacin Succinate|solifenacin succinate|mesh-list
20007252|NCT02294396|Mirabegron|mirabegron|mesh-list
20007253|NCT02294396|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20007254|NCT02294396|Propiverine|propiverine|mesh-list
20007255|NCT02294396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20007256|NCT02294396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20007257|NCT02294396|Cholinergic Agents|cholinergic agents|mesh-ancestor
20007258|NCT02294396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20007259|NCT02294396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007260|NCT02294396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007261|NCT02294396|Urological Agents|urological agents|mesh-ancestor
20007262|NCT02294396|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20007263|NCT02294396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20007264|NCT02294396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20007265|NCT02294396|Adrenergic Agents|adrenergic agents|mesh-ancestor
20007266|NCT02294396|Parasympatholytics|parasympatholytics|mesh-ancestor
20007267|NCT02294396|Autonomic Agents|autonomic agents|mesh-ancestor
20007268|NCT02294396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007269|NCT02294474|Insulin|insulin|mesh-list
20007270|NCT02294474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20007271|NCT02294474|Insulin Glargine|insulin glargine|mesh-list
20007272|NCT02294474|Insulin Lispro|insulin lispro|mesh-list
20007273|NCT02294474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20007274|NCT02294474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007275|NCT02294604|Chlorhexidine|chlorhexidine|mesh-list
20007276|NCT02294604|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20007277|NCT02294604|Povidone-Iodine|povidone-iodine|mesh-list
20007278|NCT02294604|Povidone|povidone|mesh-list
20007279|NCT02294604|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20007280|NCT02294604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20007281|NCT02294604|Disinfectants|disinfectants|mesh-ancestor
20007282|NCT02294604|Dermatologic Agents|dermatologic agents|mesh-ancestor
20007283|NCT02294604|Plasma Substitutes|plasma substitutes|mesh-ancestor
20007284|NCT02294604|Blood Substitutes|blood substitutes|mesh-ancestor
20007285|NCT02294630|Pulmonary Surfactants|pulmonary surfactants|mesh-list
20007286|NCT02294630|Respiratory System Agents|respiratory system agents|mesh-ancestor
20007287|NCT02294734|Nemiralisib|nemiralisib|mesh-list
20007288|NCT02294734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20007289|NCT02294734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007290|NCT02294734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007291|NCT02294773|Letrozole|letrozole|mesh-list
20007292|NCT02294773|Clomiphene|clomiphene|mesh-list
20007293|NCT02294773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007294|NCT02294773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20007295|NCT02294773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20007296|NCT02294773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007297|NCT02294773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007298|NCT02294773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20007299|NCT02294773|Hormone Antagonists|hormone antagonists|mesh-ancestor
20007300|NCT02294773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20007301|NCT02294773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007302|NCT02294773|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20007303|NCT02294773|Fertility Agents|fertility agents|mesh-ancestor
20558740|NCT01961739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20558741|NCT01961739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558742|NCT01961739|Sensory System Agents|sensory system agents|mesh-ancestor
20558743|NCT01961739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558744|NCT01961739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20558745|NCT01961739|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20558746|NCT01961739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20558747|NCT01961739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20558748|NCT01961739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558749|NCT01961752|Triamcinolone|triamcinolone|mesh-list
20558750|NCT01961752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20558751|NCT01961752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20558752|NCT01961752|Bupivacaine|bupivacaine|mesh-list
20558753|NCT01961752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20558754|NCT01961752|Anesthetics, Local|anesthetics, local|mesh-ancestor
20558755|NCT01961752|Anesthetics|anesthetics|mesh-ancestor
20558756|NCT01961752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20558757|NCT01961752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558758|NCT01961752|Sensory System Agents|sensory system agents|mesh-ancestor
20558759|NCT01961752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558760|NCT01961752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20558761|NCT01961752|Glucocorticoids|glucocorticoids|mesh-ancestor
20558762|NCT01961752|Hormones|hormones|mesh-ancestor
20558763|NCT01961752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20558764|NCT01961752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20558765|NCT01961752|Immunologic Factors|immunologic factors|mesh-ancestor
20558766|NCT01961752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558767|NCT01961752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558768|NCT01961830|Arbekacin|arbekacin|mesh-list
20558769|NCT01961830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20558770|NCT01961843|Prednisone|prednisone|mesh-list
20558771|NCT01961843|Abiraterone Acetate|abiraterone acetate|mesh-list
20558772|NCT01961843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20558773|NCT01961843|Glucocorticoids|glucocorticoids|mesh-ancestor
20558774|NCT01961843|Hormones|hormones|mesh-ancestor
20558775|NCT01961843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20558776|NCT01961843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558777|NCT01961843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20558778|NCT01961843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558779|NCT01961843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20558780|NCT01961843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558781|NCT01961843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558782|NCT01961843|Hormone Antagonists|hormone antagonists|mesh-ancestor
20558783|NCT01961843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20558784|NCT01961856|Clopidogrel|clopidogrel|mesh-list
20558785|NCT01961856|Ticagrelor|ticagrelor|mesh-list
20558786|NCT01961856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20558787|NCT01961856|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20558788|NCT01961856|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20558789|NCT01961856|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20558790|NCT01961856|Purinergic Agents|purinergic agents|mesh-ancestor
20558791|NCT01961856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20007304|NCT02294773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20007305|NCT02294773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20007306|NCT02294773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20007307|NCT02294786|Capecitabine|capecitabine|mesh-list
20007308|NCT02294786|Lapatinib|lapatinib|mesh-list
20007309|NCT02294786|Octreotide|octreotide|mesh-list
20007310|NCT02294786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20007311|NCT02294786|Antimetabolites|antimetabolites|mesh-ancestor
20007312|NCT02294786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007313|NCT02294786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007314|NCT02294786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20007315|NCT02294786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007316|NCT02294786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20007317|NCT02294786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20007318|NCT02295280|Diphenhydramine|diphenhydramine|mesh-list
20007319|NCT02295280|Promethazine|promethazine|mesh-list
20007320|NCT02295280|Codeine|codeine|mesh-list
20007321|NCT02295280|Metoclopramide|metoclopramide|mesh-list
20007322|NCT02295280|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20007323|NCT02295280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20007324|NCT02295280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20007325|NCT02295280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007326|NCT02295280|Anesthetics, Local|anesthetics, local|mesh-ancestor
20007327|NCT02295280|Anesthetics|anesthetics|mesh-ancestor
20007328|NCT02295280|Sensory System Agents|sensory system agents|mesh-ancestor
20007329|NCT02295280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007330|NCT02295280|Antiemetics|antiemetics|mesh-ancestor
20007331|NCT02295280|Autonomic Agents|autonomic agents|mesh-ancestor
20007332|NCT02295280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20007333|NCT02295280|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20007334|NCT02295280|Histamine Antagonists|histamine antagonists|mesh-ancestor
20007335|NCT02295280|Histamine Agents|histamine agents|mesh-ancestor
20007336|NCT02295280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20007337|NCT02295280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007338|NCT02295280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20007339|NCT02295280|Antipruritics|antipruritics|mesh-ancestor
20007340|NCT02295280|Dermatologic Agents|dermatologic agents|mesh-ancestor
20007341|NCT02295280|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20007342|NCT02295280|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20007343|NCT02295280|Dopamine Agents|dopamine agents|mesh-ancestor
20007344|NCT02295280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20007345|NCT02295280|Narcotics|narcotics|mesh-ancestor
20007346|NCT02295280|Analgesics|analgesics|mesh-ancestor
20007347|NCT02295280|Antitussive Agents|antitussive agents|mesh-ancestor
20007348|NCT02295280|Respiratory System Agents|respiratory system agents|mesh-ancestor
20007349|NCT02295553|Ketamine|ketamine|mesh-list
20007350|NCT02295553|Propofol|propofol|mesh-list
20007351|NCT02295553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20007352|NCT02295553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20007353|NCT02295553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007354|NCT02295553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20007355|NCT02295553|Anesthetics, General|anesthetics, general|mesh-ancestor
20007356|NCT02295553|Anesthetics|anesthetics|mesh-ancestor
20007357|NCT02295553|Analgesics|analgesics|mesh-ancestor
20007358|NCT02295553|Sensory System Agents|sensory system agents|mesh-ancestor
20007359|NCT02295553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007360|NCT02295553|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20007361|NCT02295553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20007362|NCT02295553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20007363|NCT02295553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20007364|NCT02295553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007365|NCT02295774|Methylene Blue|methylene blue|mesh-list
20007366|NCT02295774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007367|NCT02295774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007368|NCT02296099|Bupivacaine|bupivacaine|mesh-list
20007369|NCT02296099|Anesthetics, Local|anesthetics, local|mesh-ancestor
20007370|NCT02296099|Anesthetics|anesthetics|mesh-ancestor
20007371|NCT02296099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20007372|NCT02296099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007373|NCT02296099|Sensory System Agents|sensory system agents|mesh-ancestor
20007374|NCT02296099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007375|NCT02296112|Trametinib|trametinib|mesh-list
20007376|NCT02296112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007377|NCT02296112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20007378|NCT02296112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007379|NCT02296112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007380|NCT02296138|Tiotropium Bromide|tiotropium bromide|mesh-list
20007381|NCT02296138|Olodaterol|olodaterol|mesh-list
20007382|NCT02296138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20007383|NCT02296138|Autonomic Agents|autonomic agents|mesh-ancestor
20007384|NCT02296138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007385|NCT02296138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007386|NCT02296138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20007387|NCT02296138|Respiratory System Agents|respiratory system agents|mesh-ancestor
20007388|NCT02296138|Parasympatholytics|parasympatholytics|mesh-ancestor
20007389|NCT02296138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20007390|NCT02296138|Cholinergic Agents|cholinergic agents|mesh-ancestor
20007391|NCT02296138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20007392|NCT02296138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007393|NCT02296164|Mechlorethamine|mechlorethamine|mesh-list
20007394|NCT02296164|Alkylating Agents|alkylating agents|mesh-ancestor
20007395|NCT02296164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007396|NCT02296164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20007397|NCT02296164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007398|NCT02296190|Etripamil|etripamil|mesh-list
20007399|NCT02296190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20007400|NCT02296190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20007401|NCT02296190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007402|NCT02296190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20007403|NCT02296190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007404|NCT02296346|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20007405|NCT02296346|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20007406|NCT02296346|Methylprednisolone|methylprednisolone|mesh-list
20007407|NCT02296346|Prednisolone|prednisolone|mesh-list
20007408|NCT02296346|Prednisolone acetate|prednisolone acetate|mesh-list
20007409|NCT02296346|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20007410|NCT02296346|Prednisolone phosphate|prednisolone phosphate|mesh-list
20007411|NCT02296346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20007412|NCT02296346|Glucocorticoids|glucocorticoids|mesh-ancestor
20007413|NCT02296346|Hormones|hormones|mesh-ancestor
20007414|NCT02296346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20007415|NCT02296346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007416|NCT02296346|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20007417|NCT02296346|Protective Agents|protective agents|mesh-ancestor
19460028|NCT03356600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007418|NCT02296346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20007419|NCT02296346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007420|NCT02296346|Antiemetics|antiemetics|mesh-ancestor
20007421|NCT02296346|Autonomic Agents|autonomic agents|mesh-ancestor
20007422|NCT02296346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007423|NCT02296346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20007424|NCT02296424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20007425|NCT02296424|Immunologic Factors|immunologic factors|mesh-ancestor
20007426|NCT02296424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007427|NCT02296775|Rituximab|rituximab|mesh-list
20007428|NCT02296775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20007429|NCT02296775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007430|NCT02296775|Immunologic Factors|immunologic factors|mesh-ancestor
20007431|NCT02296775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007432|NCT02296775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20007433|NCT02296840|Acetaminophen|acetaminophen|mesh-list
20007434|NCT02296840|Ibuprofen|ibuprofen|mesh-list
20007435|NCT02296840|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20007436|NCT02296840|Hydrocodone|hydrocodone|mesh-list
20007437|NCT02296840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20007438|NCT02296840|Analgesics|analgesics|mesh-ancestor
19460029|NCT03356730|Vitamin D|vitamin d|mesh-list
19460030|NCT03356730|Vitamins|vitamins|mesh-ancestor
19460031|NCT03356730|Micronutrients|micronutrients|mesh-ancestor
19460032|NCT03356730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460033|NCT03356730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19460034|NCT03356444|Docetaxel|docetaxel|mesh-list
19460035|NCT03356444|Abiraterone Acetate|abiraterone acetate|mesh-list
19460036|NCT03356444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460037|NCT03356444|Tubulin Modulators|tubulin modulators|mesh-ancestor
19460038|NCT03356444|Antimitotic Agents|antimitotic agents|mesh-ancestor
19460039|NCT03356444|Mitosis Modulators|mitosis modulators|mesh-ancestor
19460040|NCT03356444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007439|NCT02296840|Sensory System Agents|sensory system agents|mesh-ancestor
20007440|NCT02296840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007441|NCT02296840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007442|NCT02296840|Antipyretics|antipyretics|mesh-ancestor
20007443|NCT02296840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20007444|NCT02296840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20007445|NCT02296840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20007446|NCT02296840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20007447|NCT02296840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007448|NCT02296840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007449|NCT02296840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20007450|NCT02296840|Narcotics|narcotics|mesh-ancestor
20007451|NCT02296840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20007452|NCT02296840|Antitussive Agents|antitussive agents|mesh-ancestor
20007453|NCT02296840|Respiratory System Agents|respiratory system agents|mesh-ancestor
20007454|NCT02296892|Midazolam|midazolam|mesh-list
20007455|NCT02296892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20007456|NCT02296892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20007457|NCT02296892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20007458|NCT02296892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007459|NCT02296892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20007460|NCT02296892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20007461|NCT02296892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20007462|NCT02296892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20007463|NCT02296892|Anesthetics, General|anesthetics, general|mesh-ancestor
20007464|NCT02296892|Anesthetics|anesthetics|mesh-ancestor
20007465|NCT02296892|GABA Modulators|gaba modulators|mesh-ancestor
20007466|NCT02296892|GABA Agents|gaba agents|mesh-ancestor
20007467|NCT02296892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20007468|NCT02296892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007469|NCT02296931|Magnesium Sulfate|magnesium sulfate|mesh-list
20007470|NCT02296931|Analgesics|analgesics|mesh-ancestor
20007471|NCT02296931|Sensory System Agents|sensory system agents|mesh-ancestor
20007472|NCT02296931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007473|NCT02296931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007474|NCT02296931|Anesthetics|anesthetics|mesh-ancestor
20007475|NCT02296931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20007476|NCT02296931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20007477|NCT02296931|Anticonvulsants|anticonvulsants|mesh-ancestor
20007478|NCT02296931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20007479|NCT02296931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20007480|NCT02296931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007481|NCT02296931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20007482|NCT02296931|Tocolytic Agents|tocolytic agents|mesh-ancestor
20007483|NCT02296931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20007484|NCT02297100|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20007485|NCT02297100|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20007486|NCT02297100|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20007487|NCT02297100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007488|NCT02297100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007489|NCT02297100|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20007490|NCT02297100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20007491|NCT02297100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007492|NCT02297100|Cholinergic Agents|cholinergic agents|mesh-ancestor
20007493|NCT02297100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20007494|NCT02297503|Botulinum Toxins|botulinum toxins|mesh-list
20007495|NCT02297503|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20007496|NCT02297503|Hyaluronic Acid|hyaluronic acid|mesh-list
20007497|NCT02297503|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20007498|NCT02297503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20007499|NCT02297503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007500|NCT02297503|Cholinergic Agents|cholinergic agents|mesh-ancestor
20007501|NCT02297503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20007502|NCT02297503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007503|NCT02297503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20007504|NCT02297503|Immunologic Factors|immunologic factors|mesh-ancestor
20007505|NCT02297503|Viscosupplements|viscosupplements|mesh-ancestor
20007506|NCT02297503|Protective Agents|protective agents|mesh-ancestor
20007507|NCT02297516|Botulinum Toxins|botulinum toxins|mesh-list
20007508|NCT02297516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20007509|NCT02297516|Hyaluronic Acid|hyaluronic acid|mesh-list
20007510|NCT02297516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20007511|NCT02297516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20007512|NCT02297516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007513|NCT02297516|Cholinergic Agents|cholinergic agents|mesh-ancestor
20007514|NCT02297516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20007515|NCT02297516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007516|NCT02297516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20007517|NCT02297516|Immunologic Factors|immunologic factors|mesh-ancestor
20007518|NCT02297516|Viscosupplements|viscosupplements|mesh-ancestor
20007519|NCT02297516|Protective Agents|protective agents|mesh-ancestor
20558792|NCT01961856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558793|NCT01961856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558794|NCT01961947|Vaccines|vaccines|mesh-list
20558795|NCT01961947|Immunologic Factors|immunologic factors|mesh-ancestor
20558796|NCT01961947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558797|NCT01962116|Heparin|heparin|mesh-list
20558798|NCT01962116|Calcium heparin|calcium heparin|mesh-list
20558799|NCT01962116|Anticoagulants|anticoagulants|mesh-ancestor
20558800|NCT01962116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558801|NCT01962116|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20558802|NCT01962116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20558803|NCT01962181|Methylphenidate|methylphenidate|mesh-list
20558804|NCT01962181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20558805|NCT01962181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558806|NCT01962181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20558807|NCT01962181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20007520|NCT02297815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20007521|NCT02297815|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20007522|NCT02297815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20007523|NCT02297815|Antitubercular Agents|antitubercular agents|mesh-ancestor
20007524|NCT02298023|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20007525|NCT02298023|Hemostatics|hemostatics|mesh-ancestor
20007526|NCT02298023|Coagulants|coagulants|mesh-ancestor
20007527|NCT02298179|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20007528|NCT02298179|MF59 oil emulsion|mf59 oil emulsion|mesh-list
20007529|NCT02298179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20007530|NCT02298179|Immunologic Factors|immunologic factors|mesh-ancestor
20558808|NCT01962181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20558809|NCT01962181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558810|NCT01962181|Dopamine Agents|dopamine agents|mesh-ancestor
20558811|NCT01962181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558812|NCT01962285|Propofol|propofol|mesh-list
20558813|NCT01962285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20558814|NCT01962285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20558815|NCT01962285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558816|NCT01962285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20558817|NCT01962285|Anesthetics, General|anesthetics, general|mesh-ancestor
20558818|NCT01962285|Anesthetics|anesthetics|mesh-ancestor
20558819|NCT01962363|Tocotrienols|tocotrienols|mesh-list
20558820|NCT01962363|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
20558821|NCT01962363|Antioxidants|antioxidants|mesh-ancestor
20558822|NCT01962363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558823|NCT01962363|Protective Agents|protective agents|mesh-ancestor
20558824|NCT01962363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558825|NCT01962363|Vitamins|vitamins|mesh-ancestor
20007531|NCT02298179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007532|NCT02298179|Antacids|antacids|mesh-ancestor
20007533|NCT02298179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007534|NCT02298179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20007535|NCT02298192|Liraglutide|liraglutide|mesh-list
20007536|NCT02298192|Xultophy|xultophy|mesh-list
20007537|NCT02298192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20007538|NCT02298192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007539|NCT02298192|Incretins|incretins|mesh-ancestor
20007540|NCT02298192|Hormones|hormones|mesh-ancestor
20007541|NCT02298192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20007542|NCT02298868|Baclofen|baclofen|mesh-list
20007543|NCT02298868|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20007544|NCT02298868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007545|NCT02298868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20007546|NCT02298868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007547|NCT02298868|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20007548|NCT02298868|GABA Agonists|gaba agonists|mesh-ancestor
20007549|NCT02298868|GABA Agents|gaba agents|mesh-ancestor
20007550|NCT02298868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20007551|NCT02298868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290248|NCT04170283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20290249|NCT04170283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290250|NCT04170283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290251|NCT04158440|Paclitaxel|paclitaxel|mesh-list
20290252|NCT04158440|Docetaxel|docetaxel|mesh-list
20290253|NCT04158440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20290254|NCT04158440|Cisplatin|cisplatin|mesh-list
20290255|NCT04158440|Carboplatin|carboplatin|mesh-list
20290256|NCT04158440|Pemetrexed|pemetrexed|mesh-list
20290257|NCT04158440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20290258|NCT04158440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290259|NCT04158440|Tubulin Modulators|tubulin modulators|mesh-ancestor
20290260|NCT04158440|Antimitotic Agents|antimitotic agents|mesh-ancestor
20290261|NCT04158440|Mitosis Modulators|mitosis modulators|mesh-ancestor
20290262|NCT04158440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290263|NCT04158440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290264|NCT04158440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20290265|NCT04158440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20290266|NCT04157348|Benralizumab|benralizumab|mesh-list
20290267|NCT04157348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20290268|NCT04157348|Respiratory System Agents|respiratory system agents|mesh-ancestor
20290269|NCT04123262|Tamoxifen|tamoxifen|mesh-list
20290270|NCT04123262|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20290271|NCT04123262|Hormone Antagonists|hormone antagonists|mesh-ancestor
20290272|NCT04123262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20290273|NCT04123262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290274|NCT04123262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20290275|NCT04123262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290276|NCT04123262|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20290277|NCT04123262|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20290278|NCT04123262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20290279|NCT04112303|Sofosbuvir|sofosbuvir|mesh-list
20290280|NCT04112303|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20290281|NCT04112303|Antiviral Agents|antiviral agents|mesh-ancestor
20290282|NCT04112303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20290283|NCT04111926|Dexmedetomidine|dexmedetomidine|mesh-list
20290284|NCT04111926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20290285|NCT04111926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20290286|NCT04111926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290287|NCT04111926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20290288|NCT04111926|Analgesics|analgesics|mesh-ancestor
20290289|NCT04111926|Sensory System Agents|sensory system agents|mesh-ancestor
20290290|NCT04111926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20290291|NCT04111926|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20290292|NCT04111926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20290293|NCT04111926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20290294|NCT04111926|Adrenergic Agents|adrenergic agents|mesh-ancestor
20290295|NCT04111926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20290296|NCT04111926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290297|NCT04106115|Durvalumab|durvalumab|mesh-list
20290298|NCT04106115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20290299|NCT04106115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558826|NCT01962363|Micronutrients|micronutrients|mesh-ancestor
20007552|NCT02298933|Eculizumab|eculizumab|mesh-list
20007553|NCT02298933|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20007554|NCT02298933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20007555|NCT02298933|Immunologic Factors|immunologic factors|mesh-ancestor
20007556|NCT02298933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007557|NCT02298946|Cyclophosphamide|cyclophosphamide|mesh-list
20007558|NCT02298946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20007559|NCT02298946|Immunologic Factors|immunologic factors|mesh-ancestor
20007560|NCT02298946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007561|NCT02298946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20007562|NCT02298946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20007563|NCT02298946|Alkylating Agents|alkylating agents|mesh-ancestor
20007564|NCT02298946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007565|NCT02298946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007566|NCT02298946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20007567|NCT02299050|Bromocriptine|bromocriptine|mesh-list
20007568|NCT02299050|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20007569|NCT02299050|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20007570|NCT02299050|Hormone Antagonists|hormone antagonists|mesh-ancestor
20007571|NCT02299050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20007572|NCT02299050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007573|NCT02299050|Dopamine Agonists|dopamine agonists|mesh-ancestor
20007574|NCT02299050|Dopamine Agents|dopamine agents|mesh-ancestor
20007575|NCT02299050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20007576|NCT02299050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007577|NCT02299089|Octreotide|octreotide|mesh-list
20007578|NCT02299089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20007579|NCT02299089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20007580|NCT02299089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007581|NCT02299141|Nintedanib|nintedanib|mesh-list
20007582|NCT02299141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007583|NCT02299141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20007584|NCT02299141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007585|NCT02299141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007586|NCT02299297|Tofacitinib|tofacitinib|mesh-list
20007587|NCT02299297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20007588|NCT02299297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007589|NCT02299297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007590|NCT02299336|Aflibercept|aflibercept|mesh-list
20007591|NCT02299336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20007592|NCT02299336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20007593|NCT02299336|Growth Substances|growth substances|mesh-ancestor
20007594|NCT02299336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007595|NCT02299336|Growth Inhibitors|growth inhibitors|mesh-ancestor
20007596|NCT02299336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007597|NCT02299349|Epinephrine|epinephrine|mesh-list
20007598|NCT02299349|Racepinephrine|racepinephrine|mesh-list
20007599|NCT02299349|Morphine|morphine|mesh-list
20007600|NCT02299349|Bupivacaine|bupivacaine|mesh-list
20007601|NCT02299349|Epinephryl borate|epinephryl borate|mesh-list
20007602|NCT02299349|Anesthetics, Local|anesthetics, local|mesh-ancestor
20007603|NCT02299349|Anesthetics|anesthetics|mesh-ancestor
20007604|NCT02299349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20007605|NCT02299349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007606|NCT02299349|Sensory System Agents|sensory system agents|mesh-ancestor
20007607|NCT02299349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007608|NCT02299349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20007609|NCT02299349|Narcotics|narcotics|mesh-ancestor
20007610|NCT02299349|Analgesics|analgesics|mesh-ancestor
20007611|NCT02299349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20007612|NCT02299349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20007613|NCT02299349|Adrenergic Agents|adrenergic agents|mesh-ancestor
20007614|NCT02299349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20007615|NCT02299349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007616|NCT02299349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20007617|NCT02299349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20007618|NCT02299349|Autonomic Agents|autonomic agents|mesh-ancestor
20007619|NCT02299349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20007620|NCT02299349|Respiratory System Agents|respiratory system agents|mesh-ancestor
20007621|NCT02299349|Mydriatics|mydriatics|mesh-ancestor
20007622|NCT02299349|Sympathomimetics|sympathomimetics|mesh-ancestor
20007623|NCT02299349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20007624|NCT02299375|Albuterol|albuterol|mesh-list
20007625|NCT02299375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20007626|NCT02299375|Autonomic Agents|autonomic agents|mesh-ancestor
20007627|NCT02299375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007628|NCT02299375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007629|NCT02299375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20007630|NCT02299375|Respiratory System Agents|respiratory system agents|mesh-ancestor
20007631|NCT02299375|Tocolytic Agents|tocolytic agents|mesh-ancestor
20007632|NCT02299375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20007633|NCT02299375|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20007634|NCT02299375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20007635|NCT02299375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20007636|NCT02299375|Adrenergic Agents|adrenergic agents|mesh-ancestor
20007637|NCT02299375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20007638|NCT02299375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007639|NCT02299388|Liraglutide|liraglutide|mesh-list
20007640|NCT02299388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20007641|NCT02299388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007642|NCT02299388|Incretins|incretins|mesh-ancestor
20007643|NCT02299388|Hormones|hormones|mesh-ancestor
20007644|NCT02299388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20007645|NCT02300077|Fentanyl|fentanyl|mesh-list
20007646|NCT02300077|Morphine|morphine|mesh-list
20007647|NCT02300077|Methadone|methadone|mesh-list
20007648|NCT02300077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20007649|NCT02300077|Narcotics|narcotics|mesh-ancestor
20007650|NCT02300077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20007651|NCT02300077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007652|NCT02300077|Analgesics|analgesics|mesh-ancestor
20007653|NCT02300077|Sensory System Agents|sensory system agents|mesh-ancestor
20007654|NCT02300077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007655|NCT02300077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20007656|NCT02300077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20007657|NCT02300077|Anesthetics, General|anesthetics, general|mesh-ancestor
20007658|NCT02300077|Anesthetics|anesthetics|mesh-ancestor
20007659|NCT02300077|Antitussive Agents|antitussive agents|mesh-ancestor
20007660|NCT02300077|Respiratory System Agents|respiratory system agents|mesh-ancestor
20007661|NCT02300103|Sofosbuvir|sofosbuvir|mesh-list
20007662|NCT02300103|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20007663|NCT02300103|Velpatasvir|velpatasvir|mesh-list
20007664|NCT02300103|Antiviral Agents|antiviral agents|mesh-ancestor
20007665|NCT02300103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20007666|NCT02300220|Ciprofloxacin|ciprofloxacin|mesh-list
20007667|NCT02300220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20007668|NCT02300220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20007669|NCT02300220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20007670|NCT02300220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20007671|NCT02300220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007672|NCT02300220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007673|NCT02300220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007674|NCT02300220|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20007675|NCT02300220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20007676|NCT02300259|Itraconazole|itraconazole|mesh-list
20007677|NCT02300259|Diltiazem|diltiazem|mesh-list
20007678|NCT02300259|Tadalafil|tadalafil|mesh-list
20007679|NCT02300259|Simvastatin|simvastatin|mesh-list
20007680|NCT02300259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20007681|NCT02300259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20007682|NCT02300259|Antimetabolites|antimetabolites|mesh-ancestor
20007683|NCT02300259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007684|NCT02300259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20007685|NCT02300259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20007686|NCT02300259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007687|NCT02300259|Antifungal Agents|antifungal agents|mesh-ancestor
20007688|NCT02300259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20007689|NCT02300259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20007690|NCT02300259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20007691|NCT02300259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20007692|NCT02300259|Hormone Antagonists|hormone antagonists|mesh-ancestor
20007693|NCT02300259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20007694|NCT02300259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007695|NCT02300259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20007696|NCT02300259|Vasodilator Agents|vasodilator agents|mesh-ancestor
20007697|NCT02300259|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20007698|NCT02300259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20007699|NCT02300259|Urological Agents|urological agents|mesh-ancestor
20007700|NCT02300259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20007701|NCT02300259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20007702|NCT02300259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20007703|NCT02300259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20007704|NCT02300298|Docetaxel|docetaxel|mesh-list
20007705|NCT02300298|Nintedanib|nintedanib|mesh-list
20007706|NCT02300298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007707|NCT02300298|Tubulin Modulators|tubulin modulators|mesh-ancestor
20007708|NCT02300298|Antimitotic Agents|antimitotic agents|mesh-ancestor
20007709|NCT02300298|Mitosis Modulators|mitosis modulators|mesh-ancestor
20007710|NCT02300298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007711|NCT02300298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20007712|NCT02300298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007713|NCT02300311|Nicotinic Acids|nicotinic acids|mesh-list
20007714|NCT02300311|Capsaicin|capsaicin|mesh-list
20007715|NCT02300311|Nonivamide|nonivamide|mesh-list
20007716|NCT02300311|Vitamin B Complex|vitamin b complex|mesh-ancestor
20007717|NCT02300311|Vitamins|vitamins|mesh-ancestor
20007718|NCT02300311|Micronutrients|micronutrients|mesh-ancestor
20007719|NCT02300311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007720|NCT02300311|Sensory System Agents|sensory system agents|mesh-ancestor
20007721|NCT02300311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007722|NCT02300311|Antipruritics|antipruritics|mesh-ancestor
20007723|NCT02300311|Dermatologic Agents|dermatologic agents|mesh-ancestor
20007724|NCT02300610|Gemcitabine|gemcitabine|mesh-list
20007725|NCT02300610|Cisplatin|cisplatin|mesh-list
20007726|NCT02300610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007727|NCT02300610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20007728|NCT02300610|Antimetabolites|antimetabolites|mesh-ancestor
20007729|NCT02300610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007730|NCT02300610|Antiviral Agents|antiviral agents|mesh-ancestor
20007731|NCT02300610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20007732|NCT02300610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007733|NCT02300610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20007734|NCT02300610|Immunologic Factors|immunologic factors|mesh-ancestor
20007735|NCT02300610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007736|NCT02300727|Curcumin|curcumin|mesh-list
20007737|NCT02300727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20007738|NCT02300727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20007739|NCT02300727|Analgesics|analgesics|mesh-ancestor
20007740|NCT02300727|Sensory System Agents|sensory system agents|mesh-ancestor
20007741|NCT02300727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007742|NCT02300727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007743|NCT02300727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20007744|NCT02300727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20007745|NCT02300727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007746|NCT02300727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007747|NCT02300727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007748|NCT02301039|Pembrolizumab|pembrolizumab|mesh-list
20007749|NCT02301039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20007750|NCT02301039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007751|NCT02301143|Gemcitabine|gemcitabine|mesh-list
20007752|NCT02301143|Paclitaxel|paclitaxel|mesh-list
20007753|NCT02301143|Capecitabine|capecitabine|mesh-list
20007754|NCT02301143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20007755|NCT02301143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007756|NCT02301143|Tubulin Modulators|tubulin modulators|mesh-ancestor
20007757|NCT02301143|Antimitotic Agents|antimitotic agents|mesh-ancestor
20007758|NCT02301143|Mitosis Modulators|mitosis modulators|mesh-ancestor
20007759|NCT02301143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007760|NCT02301143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20558827|NCT01962376|Bevacizumab|bevacizumab|mesh-list
20558828|NCT01962376|Capecitabine|capecitabine|mesh-list
20558829|NCT01962376|Oxaliplatin|oxaliplatin|mesh-list
20007761|NCT02301143|Antimetabolites|antimetabolites|mesh-ancestor
20007762|NCT02301143|Antiviral Agents|antiviral agents|mesh-ancestor
20007763|NCT02301143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20007764|NCT02301143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007765|NCT02301143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20007766|NCT02301143|Immunologic Factors|immunologic factors|mesh-ancestor
20007767|NCT02301143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007768|NCT02301390|Amiodarone|amiodarone|mesh-list
20558830|NCT01962376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20558831|NCT01962376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558832|NCT01962376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20558833|NCT01962376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20558834|NCT01962376|Growth Substances|growth substances|mesh-ancestor
20558835|NCT01962376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558836|NCT01962376|Growth Inhibitors|growth inhibitors|mesh-ancestor
20558837|NCT01962376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20558838|NCT01962376|Antimetabolites|antimetabolites|mesh-ancestor
20558839|NCT01962376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558840|NCT01962454|Methyltestosterone|methyltestosterone|mesh-list
20558841|NCT01962454|Testosterone|testosterone|mesh-list
20558842|NCT01962454|Testosterone undecanoate|testosterone undecanoate|mesh-list
20558843|NCT01962454|Testosterone enanthate|testosterone enanthate|mesh-list
20558844|NCT01962454|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20558845|NCT01962454|Androgens|androgens|mesh-ancestor
20558846|NCT01962454|Hormones|hormones|mesh-ancestor
20558847|NCT01962454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20558848|NCT01962454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558849|NCT01962454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20558850|NCT01962454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558851|NCT01962454|Anabolic Agents|anabolic agents|mesh-ancestor
20007769|NCT02301390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20007770|NCT02301390|Vasodilator Agents|vasodilator agents|mesh-ancestor
20007771|NCT02301390|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20007772|NCT02301390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20007773|NCT02301390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007774|NCT02301390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20007775|NCT02301390|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20007776|NCT02301390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20007777|NCT02301390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007778|NCT02301390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20007779|NCT02301390|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20007780|NCT02301390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20007781|NCT02301403|Nicotine|nicotine|mesh-list
20007782|NCT02301403|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20007783|NCT02301403|Autonomic Agents|autonomic agents|mesh-ancestor
20007784|NCT02301403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007785|NCT02301403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007786|NCT02301403|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20007787|NCT02301403|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20007788|NCT02301403|Cholinergic Agents|cholinergic agents|mesh-ancestor
20007789|NCT02301403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20007790|NCT02301403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007791|NCT02301416|Topiramate|topiramate|mesh-list
20007792|NCT02301416|Phentermine|phentermine|mesh-list
20007793|NCT02301416|Anticonvulsants|anticonvulsants|mesh-ancestor
20007794|NCT02301416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20007795|NCT02301416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007796|NCT02301416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20007797|NCT02301416|Appetite Depressants|appetite depressants|mesh-ancestor
20007798|NCT02301416|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20007799|NCT02301416|Sympathomimetics|sympathomimetics|mesh-ancestor
20007800|NCT02301416|Autonomic Agents|autonomic agents|mesh-ancestor
20007801|NCT02301416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007802|NCT02301416|Adrenergic Agents|adrenergic agents|mesh-ancestor
20007803|NCT02301416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20007804|NCT02301416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007805|NCT02301624|Eculizumab|eculizumab|mesh-list
20007806|NCT02301624|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20007807|NCT02301624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20007808|NCT02301624|Immunologic Factors|immunologic factors|mesh-ancestor
20007809|NCT02301624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007810|NCT02301936|Sofosbuvir|sofosbuvir|mesh-list
20007811|NCT02301936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
20007812|NCT02301936|Ledipasvir|ledipasvir|mesh-list
20007813|NCT02301936|Antiviral Agents|antiviral agents|mesh-ancestor
20007814|NCT02301936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20007815|NCT02301975|Fluticasone|fluticasone|mesh-list
20007816|NCT02301975|Xhance|xhance|mesh-list
20007817|NCT02301975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20007818|NCT02301975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20007819|NCT02301975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20007820|NCT02301975|Autonomic Agents|autonomic agents|mesh-ancestor
20007821|NCT02301975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007822|NCT02301975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007823|NCT02301975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20007824|NCT02301975|Respiratory System Agents|respiratory system agents|mesh-ancestor
20007825|NCT02301975|Dermatologic Agents|dermatologic agents|mesh-ancestor
20007826|NCT02301975|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20007827|NCT02301975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20007828|NCT02301975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20007829|NCT02301975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20007830|NCT02301975|Adrenergic Agents|adrenergic agents|mesh-ancestor
20007831|NCT02301975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20007832|NCT02301975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007833|NCT02301988|Paclitaxel|paclitaxel|mesh-list
20007834|NCT02301988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20007835|NCT02301988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007836|NCT02301988|Tubulin Modulators|tubulin modulators|mesh-ancestor
20007837|NCT02301988|Antimitotic Agents|antimitotic agents|mesh-ancestor
20007838|NCT02301988|Mitosis Modulators|mitosis modulators|mesh-ancestor
20007839|NCT02301988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007840|NCT02302092|Cefepime|cefepime|mesh-list
20007841|NCT02302092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20007842|NCT02302092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20007843|NCT02302339|Pembrolizumab|pembrolizumab|mesh-list
20007844|NCT02302339|Nivolumab|nivolumab|mesh-list
20007845|NCT02302339|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
20007846|NCT02302339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20007847|NCT02302339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20007848|NCT02302339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007849|NCT02302339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20007850|NCT02302339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007851|NCT02302339|Immunologic Factors|immunologic factors|mesh-ancestor
20007852|NCT02302339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007853|NCT02302716|Hypoglycemic Agents|hypoglycemic agents|mesh-list
20007854|NCT02302716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007855|NCT02302807|Paclitaxel|paclitaxel|mesh-list
20007856|NCT02302807|Docetaxel|docetaxel|mesh-list
20007857|NCT02302807|Atezolizumab|atezolizumab|mesh-list
20007858|NCT02302807|Antibodies|antibodies|mesh-list
20007859|NCT02302807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20007860|NCT02302807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007861|NCT02302807|Tubulin Modulators|tubulin modulators|mesh-ancestor
20007862|NCT02302807|Antimitotic Agents|antimitotic agents|mesh-ancestor
20007863|NCT02302807|Mitosis Modulators|mitosis modulators|mesh-ancestor
20290300|NCT04094688|Vitamin D|vitamin d|mesh-list
20007864|NCT02302807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007865|NCT02302807|Immunologic Factors|immunologic factors|mesh-ancestor
20007866|NCT02302807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007867|NCT02302846|Ixazomib|ixazomib|mesh-list
20007868|NCT02302846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007869|NCT02302846|Protease Inhibitors|protease inhibitors|mesh-ancestor
20007870|NCT02302846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007871|NCT02302846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007872|NCT02303093|gamma-Globulins|gamma-globulins|mesh-list
20007873|NCT02303093|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20007874|NCT02303093|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20007875|NCT02303093|Immunologic Factors|immunologic factors|mesh-ancestor
20007876|NCT02303093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007877|NCT02303184|Aflibercept|aflibercept|mesh-list
20007878|NCT02303184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20007879|NCT02303184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20007880|NCT02303184|Growth Substances|growth substances|mesh-ancestor
20007881|NCT02303184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007882|NCT02303184|Growth Inhibitors|growth inhibitors|mesh-ancestor
20007883|NCT02303184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007884|NCT02303262|Gemcitabine|gemcitabine|mesh-list
20007885|NCT02303262|Mocetinostat|mocetinostat|mesh-list
20007886|NCT02303262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20007887|NCT02303262|Antimetabolites|antimetabolites|mesh-ancestor
20007888|NCT02303262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007889|NCT02303262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007890|NCT02303262|Antiviral Agents|antiviral agents|mesh-ancestor
20007891|NCT02303262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20007892|NCT02303262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007893|NCT02303262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20007894|NCT02303262|Immunologic Factors|immunologic factors|mesh-ancestor
20007895|NCT02303262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007896|NCT02303262|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20007897|NCT02303574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20007898|NCT02303977|Gemcitabine|gemcitabine|mesh-list
20007899|NCT02303977|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20007900|NCT02303977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20007901|NCT02303977|Antimetabolites|antimetabolites|mesh-ancestor
20007902|NCT02303977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007903|NCT02303977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007904|NCT02303977|Antiviral Agents|antiviral agents|mesh-ancestor
20007905|NCT02303977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20007906|NCT02303977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007907|NCT02303977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20007908|NCT02303977|Immunologic Factors|immunologic factors|mesh-ancestor
20007909|NCT02303977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007910|NCT02303990|Pembrolizumab|pembrolizumab|mesh-list
20007911|NCT02303990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20007912|NCT02303990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007913|NCT02304159|Ribavirin|ribavirin|mesh-list
20007914|NCT02304159|Sofosbuvir|sofosbuvir|mesh-list
20007915|NCT02304159|Antimetabolites|antimetabolites|mesh-ancestor
20007916|NCT02304159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007917|NCT02304159|Antiviral Agents|antiviral agents|mesh-ancestor
20007918|NCT02304159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20007919|NCT02304432|Cycloserine|cycloserine|mesh-list
20007920|NCT02304432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20007921|NCT02304432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20007922|NCT02304432|Renal Agents|renal agents|mesh-ancestor
20007923|NCT02304432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20007924|NCT02304432|Antitubercular Agents|antitubercular agents|mesh-ancestor
20007925|NCT02304432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20007926|NCT02304432|Antimetabolites|antimetabolites|mesh-ancestor
20007927|NCT02304432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007928|NCT02304484|Evolocumab|evolocumab|mesh-list
20007929|NCT02304484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20007930|NCT02304484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20007931|NCT02304484|Antimetabolites|antimetabolites|mesh-ancestor
20007932|NCT02304484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007933|NCT02304484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20007934|NCT02304705|Sildenafil Citrate|sildenafil citrate|mesh-list
20007935|NCT02304705|Vasodilator Agents|vasodilator agents|mesh-ancestor
20007936|NCT02304705|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20007937|NCT02304705|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20007938|NCT02304705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007939|NCT02304705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007940|NCT02304705|Urological Agents|urological agents|mesh-ancestor
20007941|NCT02304757|Alendronate|alendronate|mesh-list
20007942|NCT02304757|Methylene diphosphonate|methylene diphosphonate|mesh-list
20007943|NCT02304757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20007944|NCT02304757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007945|NCT02304926|Simvastatin|simvastatin|mesh-list
20007946|NCT02304926|Ezetimibe|ezetimibe|mesh-list
20007947|NCT02304926|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
20007948|NCT02304926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20007949|NCT02304926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20007950|NCT02304926|Antimetabolites|antimetabolites|mesh-ancestor
20007951|NCT02304926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007952|NCT02304926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20007953|NCT02304926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20007954|NCT02304926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007955|NCT02305017|Acetaminophen|acetaminophen|mesh-list
20007956|NCT02305017|Opicapone|opicapone|mesh-list
20007957|NCT02305017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20007958|NCT02305017|Analgesics|analgesics|mesh-ancestor
20007959|NCT02305017|Sensory System Agents|sensory system agents|mesh-ancestor
20007960|NCT02305017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20007961|NCT02305017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007962|NCT02305017|Antipyretics|antipyretics|mesh-ancestor
20007963|NCT02305017|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20007964|NCT02305017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007965|NCT02305017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007966|NCT02305017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20007967|NCT02305017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20558852|NCT01962571|Epoetin Alfa|epoetin alfa|mesh-list
20558853|NCT01962571|Hematinics|hematinics|mesh-ancestor
20558854|NCT01962636|Cyclosporine|cyclosporine|mesh-list
20558855|NCT01962636|Cyclophosphamide|cyclophosphamide|mesh-list
20558856|NCT01962636|Fludarabine|fludarabine|mesh-list
20558857|NCT01962636|Cyclosporins|cyclosporins|mesh-list
20558858|NCT01962636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20558859|NCT01962636|Immunologic Factors|immunologic factors|mesh-ancestor
20558860|NCT01962636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558861|NCT01962636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20558862|NCT01962636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20558863|NCT01962636|Alkylating Agents|alkylating agents|mesh-ancestor
20558864|NCT01962636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558865|NCT01962636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558866|NCT01962636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20558867|NCT01962636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558868|NCT01962636|Antifungal Agents|antifungal agents|mesh-ancestor
20558869|NCT01962636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20558870|NCT01962636|Dermatologic Agents|dermatologic agents|mesh-ancestor
20558871|NCT01962636|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20007968|NCT02305238|Aflibercept|aflibercept|mesh-list
20007969|NCT02305238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20007970|NCT02305238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20007971|NCT02305238|Growth Substances|growth substances|mesh-ancestor
20007972|NCT02305238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20007973|NCT02305238|Growth Inhibitors|growth inhibitors|mesh-ancestor
20007974|NCT02305238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007975|NCT02305277|Opicapone|opicapone|mesh-list
20007976|NCT02305277|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20007977|NCT02305277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007978|NCT02305277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007979|NCT02305277|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20007980|NCT02305277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20007981|NCT02305316|Opicapone|opicapone|mesh-list
20007982|NCT02305316|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20007983|NCT02305316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007984|NCT02305316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007985|NCT02305316|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20007986|NCT02305316|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20007987|NCT02305329|Opicapone|opicapone|mesh-list
20007988|NCT02305329|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20007989|NCT02305329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20007990|NCT02305329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007991|NCT02305329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20007992|NCT02305329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20007993|NCT02305563|Cytarabine|cytarabine|mesh-list
20007994|NCT02305563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20007995|NCT02305563|Antimetabolites|antimetabolites|mesh-ancestor
20007996|NCT02305563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20007997|NCT02305563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20007998|NCT02305563|Antiviral Agents|antiviral agents|mesh-ancestor
20007999|NCT02305563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20008000|NCT02305563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20008001|NCT02305563|Immunologic Factors|immunologic factors|mesh-ancestor
20008002|NCT02305563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008003|NCT02305758|Bevacizumab|bevacizumab|mesh-list
20008004|NCT02305758|Fluorouracil|fluorouracil|mesh-list
20008005|NCT02305758|Veliparib|veliparib|mesh-list
20008006|NCT02305758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20008007|NCT02305758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008008|NCT02305758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20008009|NCT02305758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20008010|NCT02305758|Growth Substances|growth substances|mesh-ancestor
20008011|NCT02305758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008012|NCT02305758|Growth Inhibitors|growth inhibitors|mesh-ancestor
20008013|NCT02305758|Antimetabolites|antimetabolites|mesh-ancestor
20008014|NCT02305758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008015|NCT02305758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20008016|NCT02305758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20008017|NCT02305758|Immunologic Factors|immunologic factors|mesh-ancestor
20008018|NCT02305758|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20008019|NCT02305758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008020|NCT02305797|Lorazepam|lorazepam|mesh-list
20008021|NCT02305797|Anticonvulsants|anticonvulsants|mesh-ancestor
20008022|NCT02305797|Antiemetics|antiemetics|mesh-ancestor
20008023|NCT02305797|Autonomic Agents|autonomic agents|mesh-ancestor
20008024|NCT02305797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008025|NCT02305797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008026|NCT02305797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20008027|NCT02305797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20008028|NCT02305797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20008029|NCT02305797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20008030|NCT02305797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20008031|NCT02305797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20008032|NCT02305797|GABA Modulators|gaba modulators|mesh-ancestor
20008033|NCT02305797|GABA Agents|gaba agents|mesh-ancestor
20008034|NCT02305797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20008035|NCT02305797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008036|NCT02305849|Methotrexate|methotrexate|mesh-list
20008037|NCT02305849|Peficitinib|peficitinib|mesh-list
20008038|NCT02305849|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20008039|NCT02305849|Abortifacient Agents|abortifacient agents|mesh-ancestor
20008040|NCT02305849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20008041|NCT02305849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008042|NCT02305849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20008043|NCT02305849|Antimetabolites|antimetabolites|mesh-ancestor
20008044|NCT02305849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008045|NCT02305849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008046|NCT02305849|Dermatologic Agents|dermatologic agents|mesh-ancestor
20008047|NCT02305849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008048|NCT02305849|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20008049|NCT02305849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20008050|NCT02305849|Immunologic Factors|immunologic factors|mesh-ancestor
20008051|NCT02305849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20008052|NCT02305849|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20008053|NCT02306694|Factor VIII|factor viii|mesh-list
20008054|NCT02306694|Coagulants|coagulants|mesh-ancestor
20008055|NCT02306759|Ketamine|ketamine|mesh-list
20008056|NCT02306759|Analgesics|analgesics|mesh-ancestor
20008057|NCT02306759|Sensory System Agents|sensory system agents|mesh-ancestor
20008058|NCT02306759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008059|NCT02306759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008060|NCT02306759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20008061|NCT02306759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20008062|NCT02306759|Anesthetics, General|anesthetics, general|mesh-ancestor
20008063|NCT02306759|Anesthetics|anesthetics|mesh-ancestor
20008064|NCT02306759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20008065|NCT02306759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20008066|NCT02306759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20008067|NCT02306759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20008068|NCT02306759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008069|NCT02306850|Pembrolizumab|pembrolizumab|mesh-list
20008070|NCT02306850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20008071|NCT02306850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008072|NCT02307318|Hemostatics|hemostatics|mesh-list
20008073|NCT02307318|Coagulants|coagulants|mesh-ancestor
20008074|NCT02307513|Apremilast|apremilast|mesh-list
20008075|NCT02307513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20008076|NCT02307513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20008077|NCT02307513|Analgesics|analgesics|mesh-ancestor
20008078|NCT02307513|Sensory System Agents|sensory system agents|mesh-ancestor
20008079|NCT02307513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008080|NCT02307513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008081|NCT02307513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20008082|NCT02307513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20008083|NCT02307513|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20008084|NCT02307513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20008085|NCT02307513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008086|NCT02307513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008087|NCT02307526|Bromides|bromides|mesh-list
20008088|NCT02307526|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
20008089|NCT02307526|Anticonvulsants|anticonvulsants|mesh-ancestor
20008090|NCT02307526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20008091|NCT02307526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008092|NCT02307526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008093|NCT02307526|Cholinergic Agents|cholinergic agents|mesh-ancestor
20008094|NCT02307526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20008095|NCT02307526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290301|NCT04094688|Cholecalciferol|cholecalciferol|mesh-list
20290302|NCT04094688|Leucovorin|leucovorin|mesh-list
20290303|NCT04094688|Bevacizumab|bevacizumab|mesh-list
20290304|NCT04094688|Fluorouracil|fluorouracil|mesh-list
20290305|NCT04094688|Oxaliplatin|oxaliplatin|mesh-list
20290306|NCT04094688|Irinotecan|irinotecan|mesh-list
20290307|NCT04094688|Levoleucovorin|levoleucovorin|mesh-list
20290308|NCT04094688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20290309|NCT04094688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290310|NCT04094688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20290311|NCT04094688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20290312|NCT04094688|Growth Substances|growth substances|mesh-ancestor
20290313|NCT04094688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290314|NCT04094688|Growth Inhibitors|growth inhibitors|mesh-ancestor
20290315|NCT04094688|Vitamins|vitamins|mesh-ancestor
20290316|NCT04094688|Micronutrients|micronutrients|mesh-ancestor
20290317|NCT04094688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20290318|NCT04094688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20290319|NCT04094688|Antimetabolites|antimetabolites|mesh-ancestor
20290320|NCT04094688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558872|NCT01962831|Dinoprostone|dinoprostone|mesh-list
20008096|NCT02307682|Aflibercept|aflibercept|mesh-list
20008097|NCT02307682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20008098|NCT02307682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19460041|NCT03356444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19460042|NCT03356444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19460043|NCT03356444|Hormone Antagonists|hormone antagonists|mesh-ancestor
19460044|NCT03356444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19460045|NCT03356444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460046|NCT03356444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19460047|NCT03356353|Sildenafil Citrate|sildenafil citrate|mesh-list
19460048|NCT03356353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460049|NCT03356353|Vasodilator Agents|vasodilator agents|mesh-ancestor
19460050|NCT03356353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19460051|NCT03356353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19460052|NCT03356353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19460053|NCT03356353|Urological Agents|urological agents|mesh-ancestor
19460054|NCT03356158|Cetuximab|cetuximab|mesh-list
19460055|NCT03356158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19460056|NCT03356158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460057|NCT03356080|Cytarabine|cytarabine|mesh-list
19460058|NCT03356080|Decitabine|decitabine|mesh-list
19460059|NCT03356080|Tretinoin|tretinoin|mesh-list
19460060|NCT03356080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19460061|NCT03356080|Antimetabolites|antimetabolites|mesh-ancestor
19460062|NCT03356080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460063|NCT03356080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460064|NCT03356080|Antiviral Agents|antiviral agents|mesh-ancestor
19460065|NCT03356080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19460066|NCT03356080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19460067|NCT03356080|Immunologic Factors|immunologic factors|mesh-ancestor
19460068|NCT03356080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460069|NCT03356080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008099|NCT02307682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20008100|NCT02307682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20008101|NCT02307682|Growth Substances|growth substances|mesh-ancestor
20008102|NCT02307682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008103|NCT02307682|Growth Inhibitors|growth inhibitors|mesh-ancestor
20008104|NCT02307682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008105|NCT02307916|Mitogens|mitogens|mesh-list
20008106|NCT02307916|Mitosis Modulators|mitosis modulators|mesh-ancestor
20008107|NCT02307916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008108|NCT02308007|Metronidazole|metronidazole|mesh-list
20008109|NCT02308007|Terconazole|terconazole|mesh-list
20008110|NCT02308007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20008111|NCT02308007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20008112|NCT02308007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20008113|NCT02308007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20008114|NCT02308007|Antifungal Agents|antifungal agents|mesh-ancestor
20008115|NCT02308033|Metronidazole|metronidazole|mesh-list
20008116|NCT02308033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20008117|NCT02308033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20008118|NCT02308033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20008119|NCT02308033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20008120|NCT02308046|Terconazole|terconazole|mesh-list
20008121|NCT02308046|Antifungal Agents|antifungal agents|mesh-ancestor
20008122|NCT02308046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20008123|NCT02308124|Midodrine|midodrine|mesh-list
20008124|NCT02308124|Bromides|bromides|mesh-list
20008125|NCT02308124|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
20008126|NCT02308124|Anticonvulsants|anticonvulsants|mesh-ancestor
20008127|NCT02308124|Sympathomimetics|sympathomimetics|mesh-ancestor
20008128|NCT02308124|Autonomic Agents|autonomic agents|mesh-ancestor
20008129|NCT02308124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008130|NCT02308124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008131|NCT02308124|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20008132|NCT02308124|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20008133|NCT02308124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20008134|NCT02308124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20008135|NCT02308124|Adrenergic Agents|adrenergic agents|mesh-ancestor
20008136|NCT02308124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20008137|NCT02308124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008138|NCT02308124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20008139|NCT02308124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008140|NCT02308124|Cholinergic Agents|cholinergic agents|mesh-ancestor
20008141|NCT02308163|Etanercept|etanercept|mesh-list
20008142|NCT02308163|Peficitinib|peficitinib|mesh-list
20008143|NCT02308163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20008144|NCT02308163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20008145|NCT02308163|Analgesics|analgesics|mesh-ancestor
20008146|NCT02308163|Sensory System Agents|sensory system agents|mesh-ancestor
20008147|NCT02308163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008148|NCT02308163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008149|NCT02308163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20008150|NCT02308163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20008151|NCT02308163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20008152|NCT02308163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20008153|NCT02308163|Immunologic Factors|immunologic factors|mesh-ancestor
20008154|NCT02308163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008155|NCT02308163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008156|NCT02308228|Metformin|metformin|mesh-list
20008157|NCT02308228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20008158|NCT02308228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008159|NCT02308501|Alcaftadine|alcaftadine|mesh-list
20008160|NCT02308501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20008161|NCT02308501|Histamine Antagonists|histamine antagonists|mesh-ancestor
20008162|NCT02308501|Histamine Agents|histamine agents|mesh-ancestor
20008163|NCT02308501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20008164|NCT02308501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008165|NCT02308501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008166|NCT02308540|Vaccines|vaccines|mesh-list
20008167|NCT02308540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20008168|NCT02308540|Immunologic Factors|immunologic factors|mesh-ancestor
20008169|NCT02308540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008170|NCT02308748|Moxifloxacin|moxifloxacin|mesh-list
20008171|NCT02308748|Lidocaine|lidocaine|mesh-list
20008172|NCT02308748|Mexiletine|mexiletine|mesh-list
20008173|NCT02308748|Dofetilide|dofetilide|mesh-list
20008174|NCT02308748|Diltiazem|diltiazem|mesh-list
20008175|NCT02308748|Anesthetics, Local|anesthetics, local|mesh-ancestor
20008176|NCT02308748|Anesthetics|anesthetics|mesh-ancestor
20008177|NCT02308748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20008178|NCT02308748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008179|NCT02308748|Sensory System Agents|sensory system agents|mesh-ancestor
20008180|NCT02308748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008181|NCT02308748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20558873|NCT01962831|Oxytocics|oxytocics|mesh-ancestor
20008182|NCT02308748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20008183|NCT02308748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20008184|NCT02308748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20008185|NCT02308748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008186|NCT02308748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20008187|NCT02308748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20008188|NCT02308748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20008189|NCT02308748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20008190|NCT02308748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008191|NCT02308748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008192|NCT02308748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20008193|NCT02308748|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20008194|NCT02308748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20008195|NCT02308748|Vasodilator Agents|vasodilator agents|mesh-ancestor
20008196|NCT02308748|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20008197|NCT02309359|Methotrexate|methotrexate|mesh-list
20008198|NCT02309359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20008199|NCT02309359|Abortifacient Agents|abortifacient agents|mesh-ancestor
20008200|NCT02309359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20008201|NCT02309359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008202|NCT02309359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20008203|NCT02309359|Antimetabolites|antimetabolites|mesh-ancestor
20008204|NCT02309359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008205|NCT02309359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008206|NCT02309359|Dermatologic Agents|dermatologic agents|mesh-ancestor
20008207|NCT02309359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008208|NCT02309359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20008209|NCT02309359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20008210|NCT02309359|Immunologic Factors|immunologic factors|mesh-ancestor
20008211|NCT02309359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20008212|NCT02309359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20008213|NCT02309411|Rivaroxaban|rivaroxaban|mesh-list
20008214|NCT02309411|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20008215|NCT02309411|Antithrombins|antithrombins|mesh-ancestor
20008216|NCT02309411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20008217|NCT02309411|Protease Inhibitors|protease inhibitors|mesh-ancestor
20008218|NCT02309411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008219|NCT02309411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008220|NCT02309411|Anticoagulants|anticoagulants|mesh-ancestor
20008221|NCT02309515|Lenalidomide|lenalidomide|mesh-list
20008222|NCT02309515|Vaccines|vaccines|mesh-list
20008223|NCT02309515|Immunologic Factors|immunologic factors|mesh-ancestor
20008224|NCT02309515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008225|NCT02309515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20008226|NCT02309515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20008227|NCT02309515|Growth Substances|growth substances|mesh-ancestor
20008228|NCT02309515|Growth Inhibitors|growth inhibitors|mesh-ancestor
20008229|NCT02309515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008230|NCT02310568|PF-06372865|pf-06372865|mesh-list
20008231|NCT02310568|GABA Modulators|gaba modulators|mesh-ancestor
20008232|NCT02310568|GABA Agents|gaba agents|mesh-ancestor
20008233|NCT02310568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20008234|NCT02310568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008235|NCT02310568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008236|NCT02310581|Buprenorphine|buprenorphine|mesh-list
20008237|NCT02310581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20008238|NCT02310581|Narcotics|narcotics|mesh-ancestor
20008239|NCT02310581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20008240|NCT02310581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008241|NCT02310581|Analgesics|analgesics|mesh-ancestor
20008242|NCT02310581|Sensory System Agents|sensory system agents|mesh-ancestor
20008243|NCT02310581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008244|NCT02310581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20008245|NCT02310672|Macitentan|macitentan|mesh-list
20008246|NCT02310672|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20008247|NCT02310672|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20008248|NCT02310672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008249|NCT02310672|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
20008250|NCT02310750|PF-06700841|pf-06700841|mesh-list
20008251|NCT02310750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20008252|NCT02310750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008253|NCT02310750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008254|NCT02310789|Ivacaftor|ivacaftor|mesh-list
20008255|NCT02310789|Pilocarpine|pilocarpine|mesh-list
20008256|NCT02310789|Adrenergic Agents|adrenergic agents|mesh-list
20008257|NCT02310789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20008258|NCT02310789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20008259|NCT02310789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008260|NCT02310789|Miotics|miotics|mesh-ancestor
20008261|NCT02310789|Autonomic Agents|autonomic agents|mesh-ancestor
20008262|NCT02310789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008263|NCT02310789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008264|NCT02310789|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20008265|NCT02310789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20008266|NCT02310789|Cholinergic Agents|cholinergic agents|mesh-ancestor
20008267|NCT02310789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20008268|NCT02311361|Durvalumab|durvalumab|mesh-list
20008269|NCT02311361|Tremelimumab|tremelimumab|mesh-list
20008270|NCT02311361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20008271|NCT02311361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008272|NCT02311478|Copper|copper|mesh-list
20008273|NCT02311478|Contraceptive Agents|contraceptive agents|mesh-list
20008274|NCT02311478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20008275|NCT02311478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008276|NCT02311478|Trace Elements|trace elements|mesh-ancestor
20008277|NCT02311478|Micronutrients|micronutrients|mesh-ancestor
20008278|NCT02311881|Acetaminophen|acetaminophen|mesh-list
20008279|NCT02311881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20008280|NCT02311881|Analgesics|analgesics|mesh-ancestor
20008281|NCT02311881|Sensory System Agents|sensory system agents|mesh-ancestor
20008282|NCT02311881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008283|NCT02311881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008284|NCT02311881|Antipyretics|antipyretics|mesh-ancestor
20008285|NCT02311907|Paclitaxel|paclitaxel|mesh-list
20008286|NCT02311907|Carboplatin|carboplatin|mesh-list
20008287|NCT02311907|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20008288|NCT02311907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20008289|NCT02311907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008290|NCT02311907|Tubulin Modulators|tubulin modulators|mesh-ancestor
20008291|NCT02311907|Antimitotic Agents|antimitotic agents|mesh-ancestor
20008292|NCT02311907|Mitosis Modulators|mitosis modulators|mesh-ancestor
20008293|NCT02311907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008294|NCT02311933|Tamoxifen|tamoxifen|mesh-list
20008295|NCT02311933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20008296|NCT02311933|Hormone Antagonists|hormone antagonists|mesh-ancestor
20008297|NCT02311933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20008298|NCT02311933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008299|NCT02311933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20008300|NCT02311933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008301|NCT02311933|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20558874|NCT01962831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20558875|NCT01962831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558876|NCT01962948|Paclitaxel|paclitaxel|mesh-list
20558877|NCT01962948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20558878|NCT01962948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558879|NCT01962948|Tubulin Modulators|tubulin modulators|mesh-ancestor
20558880|NCT01962948|Antimitotic Agents|antimitotic agents|mesh-ancestor
20008302|NCT02311933|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20008303|NCT02311933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20008304|NCT02312063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20008305|NCT02312063|Glimepiride|glimepiride|mesh-list
20008306|NCT02312063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20008307|NCT02312063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008308|NCT02312063|Incretins|incretins|mesh-ancestor
20008309|NCT02312063|Hormones|hormones|mesh-ancestor
20008310|NCT02312063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20008311|NCT02312063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20008312|NCT02312063|Protease Inhibitors|protease inhibitors|mesh-ancestor
20008313|NCT02312063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008314|NCT02312063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008315|NCT02312063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20008316|NCT02312063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20008317|NCT02312063|Immunologic Factors|immunologic factors|mesh-ancestor
20008318|NCT02312219|Folic Acid|folic acid|mesh-list
20008319|NCT02312219|Methotrexate|methotrexate|mesh-list
20008320|NCT02312219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20008321|NCT02312219|Abortifacient Agents|abortifacient agents|mesh-ancestor
20008322|NCT02312219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20008323|NCT02312219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008324|NCT02312219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20008325|NCT02312219|Antimetabolites|antimetabolites|mesh-ancestor
20008326|NCT02312219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008327|NCT02312219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008328|NCT02312219|Dermatologic Agents|dermatologic agents|mesh-ancestor
20008329|NCT02312219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008330|NCT02312219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20008331|NCT02312219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20008332|NCT02312219|Immunologic Factors|immunologic factors|mesh-ancestor
20008333|NCT02312219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20008334|NCT02312219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20008335|NCT02312219|Hematinics|hematinics|mesh-ancestor
20008336|NCT02312219|Vitamin B Complex|vitamin b complex|mesh-ancestor
20008337|NCT02312219|Vitamins|vitamins|mesh-ancestor
20008338|NCT02312219|Micronutrients|micronutrients|mesh-ancestor
20008339|NCT02312622|Irinotecan|irinotecan|mesh-list
20008340|NCT02312622|Etirinotecan pegol|etirinotecan pegol|mesh-list
20008341|NCT02312622|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20008342|NCT02312622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20008343|NCT02312622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008344|NCT02312622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008345|NCT02312622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008346|NCT02312622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20008347|NCT02312739|Ketorolac|ketorolac|mesh-list
20008348|NCT02312739|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20008349|NCT02312739|Nitrous Oxide|nitrous oxide|mesh-list
20008350|NCT02312739|Analgesics|analgesics|mesh-list
20008351|NCT02312739|Lorazepam|lorazepam|mesh-list
20008352|NCT02312739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20008353|NCT02312739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20008354|NCT02312739|Sensory System Agents|sensory system agents|mesh-ancestor
20008355|NCT02312739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008356|NCT02312739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008357|NCT02312739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20008358|NCT02312739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20008359|NCT02312739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20008360|NCT02312739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008361|NCT02312739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008362|NCT02312739|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20008363|NCT02312739|Anesthetics, General|anesthetics, general|mesh-ancestor
20008364|NCT02312739|Anesthetics|anesthetics|mesh-ancestor
20008365|NCT02312739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20008366|NCT02312739|Anticonvulsants|anticonvulsants|mesh-ancestor
20008367|NCT02312739|Antiemetics|antiemetics|mesh-ancestor
20008368|NCT02312739|Autonomic Agents|autonomic agents|mesh-ancestor
20008369|NCT02312739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20008370|NCT02312739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20008371|NCT02312739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20008372|NCT02312739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20008373|NCT02312739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20008374|NCT02312739|GABA Modulators|gaba modulators|mesh-ancestor
20008375|NCT02312739|GABA Agents|gaba agents|mesh-ancestor
20008376|NCT02312739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20008377|NCT02312882|Tofacitinib|tofacitinib|mesh-list
20008378|NCT02312882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20008379|NCT02312882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008380|NCT02312882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008381|NCT02312934|Nicotine|nicotine|mesh-list
20008382|NCT02312934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20008383|NCT02312934|Autonomic Agents|autonomic agents|mesh-ancestor
20008384|NCT02312934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008385|NCT02312934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008386|NCT02312934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20008387|NCT02312934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20008388|NCT02312934|Cholinergic Agents|cholinergic agents|mesh-ancestor
20008389|NCT02312934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20008390|NCT02312934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008391|NCT02313675|Acetaminophen|acetaminophen|mesh-list
20008392|NCT02313675|Ketorolac|ketorolac|mesh-list
20008393|NCT02313675|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20008394|NCT02313675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20008395|NCT02313675|Analgesics|analgesics|mesh-ancestor
20008396|NCT02313675|Sensory System Agents|sensory system agents|mesh-ancestor
20008397|NCT02313675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008398|NCT02313675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008399|NCT02313675|Antipyretics|antipyretics|mesh-ancestor
20008400|NCT02313675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20008401|NCT02313675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20008402|NCT02313675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20008403|NCT02313675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20008404|NCT02313675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008405|NCT02313675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008406|NCT02313909|Aspirin|aspirin|mesh-list
20008407|NCT02313909|Rivaroxaban|rivaroxaban|mesh-list
20008408|NCT02313909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20008409|NCT02313909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20008410|NCT02313909|Analgesics|analgesics|mesh-ancestor
20008411|NCT02313909|Sensory System Agents|sensory system agents|mesh-ancestor
20008412|NCT02313909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008413|NCT02313909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008414|NCT02313909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20008415|NCT02313909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20008416|NCT02313909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20008417|NCT02313909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20008418|NCT02313909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008419|NCT02313909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20008420|NCT02313909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20008421|NCT02313909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008422|NCT02313909|Antipyretics|antipyretics|mesh-ancestor
20008423|NCT02313909|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20008424|NCT02313909|Antithrombins|antithrombins|mesh-ancestor
20008425|NCT02313909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20008426|NCT02313909|Protease Inhibitors|protease inhibitors|mesh-ancestor
20008427|NCT02313909|Anticoagulants|anticoagulants|mesh-ancestor
20008428|NCT02314104|Ropivacaine|ropivacaine|mesh-list
20008429|NCT02314104|Anesthetics, Local|anesthetics, local|mesh-ancestor
20008430|NCT02314104|Anesthetics|anesthetics|mesh-ancestor
20008431|NCT02314104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20008432|NCT02314104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008433|NCT02314104|Sensory System Agents|sensory system agents|mesh-ancestor
20008434|NCT02314104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008435|NCT02314117|Fluorouracil|fluorouracil|mesh-list
20008436|NCT02314117|Capecitabine|capecitabine|mesh-list
20008437|NCT02314117|Ramucirumab|ramucirumab|mesh-list
20008438|NCT02314117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008439|NCT02314117|Antimetabolites|antimetabolites|mesh-ancestor
20008440|NCT02314117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008441|NCT02314117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20008442|NCT02314117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20008443|NCT02314117|Immunologic Factors|immunologic factors|mesh-ancestor
20008444|NCT02314117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008445|NCT02314143|Trametinib|trametinib|mesh-list
20008446|NCT02314143|Dabrafenib|dabrafenib|mesh-list
20008447|NCT02314143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008448|NCT02314143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20008449|NCT02314143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008450|NCT02314143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008451|NCT02314403|Rituximab|rituximab|mesh-list
20008452|NCT02314403|Abatacept|abatacept|mesh-list
20008453|NCT02314403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20008454|NCT02314403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008455|NCT02314403|Immunologic Factors|immunologic factors|mesh-ancestor
20008456|NCT02314403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008457|NCT02314403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20008458|NCT02314403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20008459|NCT02314403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008460|NCT02314403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20008461|NCT02314546|Lidocaine|lidocaine|mesh-list
20008462|NCT02314546|Midazolam|midazolam|mesh-list
20008463|NCT02314546|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20008464|NCT02314546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20008465|NCT02314546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20008466|NCT02314546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008467|NCT02314546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20008468|NCT02314546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20008469|NCT02314546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20008470|NCT02314546|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20008471|NCT02314546|Anesthetics, General|anesthetics, general|mesh-ancestor
20008472|NCT02314546|Anesthetics|anesthetics|mesh-ancestor
20008473|NCT02314546|GABA Modulators|gaba modulators|mesh-ancestor
20008474|NCT02314546|GABA Agents|gaba agents|mesh-ancestor
20008475|NCT02314546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20008476|NCT02314546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008477|NCT02314546|Anesthetics, Local|anesthetics, local|mesh-ancestor
20008478|NCT02314546|Sensory System Agents|sensory system agents|mesh-ancestor
20008479|NCT02314546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008480|NCT02314546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20008481|NCT02314546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20008482|NCT02314546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20008483|NCT02314546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20008484|NCT02314728|Misoprostol|misoprostol|mesh-list
20008485|NCT02314728|Oxytocin|oxytocin|mesh-list
20008486|NCT02314728|Oxytocics|oxytocics|mesh-ancestor
20008487|NCT02314728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20008488|NCT02314728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008489|NCT02314728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20008490|NCT02314728|Abortifacient Agents|abortifacient agents|mesh-ancestor
20008491|NCT02314728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20008492|NCT02314728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20008493|NCT02315625|Everolimus|everolimus|mesh-list
20008494|NCT02315625|Sunitinib|sunitinib|mesh-list
20008495|NCT02315625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008496|NCT02315625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20008497|NCT02315625|Immunologic Factors|immunologic factors|mesh-ancestor
20008498|NCT02315625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008499|NCT02315625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20008500|NCT02315625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20008501|NCT02315625|Growth Substances|growth substances|mesh-ancestor
20008502|NCT02315625|Growth Inhibitors|growth inhibitors|mesh-ancestor
20008503|NCT02315625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20008504|NCT02315625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008505|NCT02315625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008506|NCT02315872|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20008507|NCT02315872|Hormones|hormones|mesh-ancestor
20008508|NCT02315872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20008509|NCT02315872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290321|NCT04094688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20290322|NCT04094688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20290323|NCT04094688|Immunologic Factors|immunologic factors|mesh-ancestor
20290324|NCT04094688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20290325|NCT04094688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20290326|NCT04094688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290327|NCT04094688|Antidotes|antidotes|mesh-ancestor
20290328|NCT04094688|Protective Agents|protective agents|mesh-ancestor
20290329|NCT04094688|Vitamin B Complex|vitamin b complex|mesh-ancestor
20290330|NCT04088409|Adalimumab|adalimumab|mesh-list
20008510|NCT02316171|Mitomycins|mitomycins|mesh-list
20008511|NCT02316171|Mitomycin|mitomycin|mesh-list
20008512|NCT02316171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20008513|NCT02316171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008514|NCT02316171|Alkylating Agents|alkylating agents|mesh-ancestor
20008515|NCT02316171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460070|NCT03356080|Keratolytic Agents|keratolytic agents|mesh-ancestor
19460071|NCT03356080|Dermatologic Agents|dermatologic agents|mesh-ancestor
19460072|NCT03356054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
19460073|NCT03356054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19460074|NCT03356054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460075|NCT03355963|Botulinum Toxins|botulinum toxins|mesh-list
19460076|NCT03355963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19460077|NCT03355963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19460078|NCT03355963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19460079|NCT03355963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19460080|NCT03355963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460081|NCT03355963|Cholinergic Agents|cholinergic agents|mesh-ancestor
19460082|NCT03355963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19460083|NCT03355963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460084|NCT03355963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19460085|NCT03355963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460086|NCT03355794|Everolimus|everolimus|mesh-list
19460087|NCT03355794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460088|NCT03355794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19460089|NCT03355794|Immunologic Factors|immunologic factors|mesh-ancestor
19460090|NCT03355794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460091|NCT03355768|Romidepsin|romidepsin|mesh-list
19460092|NCT03355768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19460093|NCT03355768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460094|NCT03355716|Fentanyl|fentanyl|mesh-list
19460095|NCT03355716|Ketamine|ketamine|mesh-list
19460096|NCT03355716|Morphine|morphine|mesh-list
19460097|NCT03355716|Bupivacaine|bupivacaine|mesh-list
19460098|NCT03355716|Anesthetics, Local|anesthetics, local|mesh-ancestor
19460099|NCT03355716|Anesthetics|anesthetics|mesh-ancestor
19460100|NCT03355716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19460101|NCT03355716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460102|NCT03355716|Sensory System Agents|sensory system agents|mesh-ancestor
19460103|NCT03355716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460104|NCT03355716|Analgesics|analgesics|mesh-ancestor
19460105|NCT03355716|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19460106|NCT03355716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19460107|NCT03355716|Anesthetics, General|anesthetics, general|mesh-ancestor
19460108|NCT03355716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19460109|NCT03355716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19460110|NCT03355716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19460111|NCT03355716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460112|NCT03355716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19460113|NCT03355716|Narcotics|narcotics|mesh-ancestor
19460114|NCT03355716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19460115|NCT03355638|Pyranoprofen|pyranoprofen|mesh-list
19460116|NCT03355638|Aflibercept|aflibercept|mesh-list
19460117|NCT03355638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19460118|NCT03355638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19460119|NCT03355638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19460120|NCT03355638|Growth Substances|growth substances|mesh-ancestor
19460121|NCT03355638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460122|NCT03355638|Growth Inhibitors|growth inhibitors|mesh-ancestor
19460123|NCT03355638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460124|NCT03355638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19460125|NCT03355638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19460126|NCT03355638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19460127|NCT03355638|Analgesics|analgesics|mesh-ancestor
19460128|NCT03355638|Sensory System Agents|sensory system agents|mesh-ancestor
20008516|NCT02316171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20008517|NCT02316171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008518|NCT02316353|Complement C1s|complement c1s|mesh-list
20008519|NCT02316353|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
20558881|NCT01962948|Mitosis Modulators|mitosis modulators|mesh-ancestor
20558882|NCT01962948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558883|NCT01963039|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
20558884|NCT01963039|Vasodilator Agents|vasodilator agents|mesh-ancestor
20558885|NCT01963039|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20558886|NCT01963039|Protective Agents|protective agents|mesh-ancestor
20558887|NCT01963039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558888|NCT01963182|Irinotecan|irinotecan|mesh-list
20558889|NCT01963182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20558890|NCT01963182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20558891|NCT01963182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558892|NCT01963182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558893|NCT01963182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558894|NCT01963221|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20558895|NCT01963221|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20558896|NCT01963221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008520|NCT02316353|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
20008521|NCT02316353|Immunologic Factors|immunologic factors|mesh-ancestor
20008522|NCT02316353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008523|NCT02316353|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20008524|NCT02316353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20008525|NCT02316613|Rituximab|rituximab|mesh-list
20008526|NCT02316613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20008527|NCT02316613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008528|NCT02316613|Immunologic Factors|immunologic factors|mesh-ancestor
20008529|NCT02316613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008530|NCT02316613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20008531|NCT02316847|Diazepam|diazepam|mesh-list
20008532|NCT02316847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20008533|NCT02316847|Anticonvulsants|anticonvulsants|mesh-ancestor
20008534|NCT02316847|Antiemetics|antiemetics|mesh-ancestor
20008535|NCT02316847|Autonomic Agents|autonomic agents|mesh-ancestor
20008536|NCT02316847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008537|NCT02316847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008538|NCT02316847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20008539|NCT02316847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20008540|NCT02316847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20008541|NCT02316847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20008542|NCT02316847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20008543|NCT02316847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20008544|NCT02316847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20008545|NCT02316847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20008546|NCT02316847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20008547|NCT02316847|Anesthetics, General|anesthetics, general|mesh-ancestor
20008548|NCT02316847|Anesthetics|anesthetics|mesh-ancestor
20008549|NCT02316847|GABA Modulators|gaba modulators|mesh-ancestor
20008550|NCT02316847|GABA Agents|gaba agents|mesh-ancestor
20008551|NCT02316847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20008552|NCT02316847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008553|NCT02317016|Osimertinib|osimertinib|mesh-list
20008554|NCT02317016|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20008555|NCT02317016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20008556|NCT02317016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20008557|NCT02317016|Antimetabolites|antimetabolites|mesh-ancestor
20008558|NCT02317016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008559|NCT02317016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20008560|NCT02317016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20008561|NCT02317016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008562|NCT02317016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008563|NCT02317016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20008564|NCT02317510|Anesthetics|anesthetics|mesh-list
20008565|NCT02317510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20008566|NCT02317510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008567|NCT02317549|Tranexamic Acid|tranexamic acid|mesh-list
20008568|NCT02317549|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20008569|NCT02317549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20008570|NCT02317549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008571|NCT02317549|Hemostatics|hemostatics|mesh-ancestor
20008572|NCT02317549|Coagulants|coagulants|mesh-ancestor
20008573|NCT02317575|Insulin Lispro|insulin lispro|mesh-list
20008574|NCT02317575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20008575|NCT02317575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008576|NCT02317744|Naltrexone|naltrexone|mesh-list
20008577|NCT02317744|Bupropion|bupropion|mesh-list
20008578|NCT02317744|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20008579|NCT02317744|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20008580|NCT02317744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008581|NCT02317744|Sensory System Agents|sensory system agents|mesh-ancestor
20008582|NCT02317744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008583|NCT02317744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20008584|NCT02317744|Antidepressive Agents|antidepressive agents|mesh-ancestor
20008585|NCT02317744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20008586|NCT02317744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20008587|NCT02317744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20008588|NCT02317744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20008589|NCT02317744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008590|NCT02317744|Dopamine Agents|dopamine agents|mesh-ancestor
20008591|NCT02317744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20008592|NCT02317744|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20008593|NCT02317744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20008594|NCT02317744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008595|NCT02317809|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20008596|NCT02317809|Hormones|hormones|mesh-ancestor
20008597|NCT02317809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20008598|NCT02317809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008599|NCT02318303|Mometasone Furoate|mometasone furoate|mesh-list
20008600|NCT02318303|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
20008601|NCT02318303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20008602|NCT02318303|Dermatologic Agents|dermatologic agents|mesh-ancestor
20008603|NCT02318303|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20008604|NCT02318303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20008605|NCT02318303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20008606|NCT02318303|Analgesics|analgesics|mesh-ancestor
20008607|NCT02318303|Sensory System Agents|sensory system agents|mesh-ancestor
20008608|NCT02318303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008609|NCT02318303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008610|NCT02318303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20008611|NCT02318303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20008612|NCT02318303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20008613|NCT02318303|Histamine Antagonists|histamine antagonists|mesh-ancestor
20008614|NCT02318303|Histamine Agents|histamine agents|mesh-ancestor
20008615|NCT02318303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20008616|NCT02318303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008617|NCT02318368|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20008618|NCT02318368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008619|NCT02318368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20008620|NCT02318368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008621|NCT02318368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008622|NCT02318602|Cannabidiol|cannabidiol|mesh-list
20008623|NCT02318602|Anticonvulsants|anticonvulsants|mesh-ancestor
20008624|NCT02318667|Golimumab|golimumab|mesh-list
20008625|NCT02318667|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20008626|NCT02318667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20008627|NCT02318667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20008628|NCT02318667|Immunologic Factors|immunologic factors|mesh-ancestor
20008629|NCT02318667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008630|NCT02318693|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20008631|NCT02318693|Glyburide|glyburide|mesh-list
20008632|NCT02318693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20008633|NCT02318693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008634|NCT02318693|Incretins|incretins|mesh-ancestor
20008635|NCT02318693|Hormones|hormones|mesh-ancestor
20008636|NCT02318693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20008637|NCT02318693|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20008638|NCT02318693|Protease Inhibitors|protease inhibitors|mesh-ancestor
20008639|NCT02318693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008640|NCT02318693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008641|NCT02319031|Ribavirin|ribavirin|mesh-list
20008642|NCT02319031|Sofosbuvir|sofosbuvir|mesh-list
20008643|NCT02319031|Antimetabolites|antimetabolites|mesh-ancestor
20008644|NCT02319031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008645|NCT02319031|Antiviral Agents|antiviral agents|mesh-ancestor
20008646|NCT02319031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20008647|NCT02319044|Durvalumab|durvalumab|mesh-list
20008648|NCT02319044|Tremelimumab|tremelimumab|mesh-list
20008649|NCT02319044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20008650|NCT02319044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20008651|NCT02319044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008652|NCT02319044|Immunologic Factors|immunologic factors|mesh-ancestor
20008653|NCT02319044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008654|NCT02319148|Itraconazole|itraconazole|mesh-list
20008655|NCT02319148|Verapamil|verapamil|mesh-list
20008656|NCT02319148|Diltiazem|diltiazem|mesh-list
20008657|NCT02319148|Antifungal Agents|antifungal agents|mesh-ancestor
20008658|NCT02319148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20008659|NCT02319148|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20008660|NCT02319148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20008661|NCT02319148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008662|NCT02319148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008663|NCT02319148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20008664|NCT02319148|Hormone Antagonists|hormone antagonists|mesh-ancestor
20008665|NCT02319148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20008666|NCT02319148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008667|NCT02319148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20008668|NCT02319148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20008669|NCT02319148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20008670|NCT02319148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20008671|NCT02319148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20008672|NCT02319148|Vasodilator Agents|vasodilator agents|mesh-ancestor
20008673|NCT02319148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20008674|NCT02319304|Leucovorin|leucovorin|mesh-list
20558897|NCT01963299|Clonidine|clonidine|mesh-list
20558898|NCT01963299|Ropivacaine|ropivacaine|mesh-list
20558899|NCT01963299|Anesthetics, Local|anesthetics, local|mesh-ancestor
20558900|NCT01963299|Anesthetics|anesthetics|mesh-ancestor
20558901|NCT01963299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20558902|NCT01963299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558903|NCT01963299|Sensory System Agents|sensory system agents|mesh-ancestor
20558904|NCT01963299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558905|NCT01963299|Analgesics|analgesics|mesh-ancestor
20558906|NCT01963299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20558907|NCT01963299|Sympatholytics|sympatholytics|mesh-ancestor
20558908|NCT01963299|Autonomic Agents|autonomic agents|mesh-ancestor
20558909|NCT01963299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20558910|NCT01963299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20558911|NCT01963299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20558912|NCT01963299|Adrenergic Agents|adrenergic agents|mesh-ancestor
20558913|NCT01963299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558914|NCT01963299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558915|NCT01963325|Paclitaxel|paclitaxel|mesh-list
20558916|NCT01963325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20558917|NCT01963325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20558918|NCT01963325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558919|NCT01963325|Tubulin Modulators|tubulin modulators|mesh-ancestor
20558920|NCT01963325|Antimitotic Agents|antimitotic agents|mesh-ancestor
20558921|NCT01963325|Mitosis Modulators|mitosis modulators|mesh-ancestor
20558922|NCT01963325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558923|NCT01963390|Testosterone|testosterone|mesh-list
20558924|NCT01963390|Androgens|androgens|mesh-ancestor
20558925|NCT01963390|Hormones|hormones|mesh-ancestor
20558926|NCT01963390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20558927|NCT01963390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558928|NCT01963416|Micronutrients|micronutrients|mesh-list
20558929|NCT01963416|Trace Elements|trace elements|mesh-list
20558930|NCT01963416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558931|NCT01963442|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20558932|NCT01963442|Lactams|lactams|mesh-list
20558933|NCT01963442|beta-Lactams|beta-lactams|mesh-list
20558934|NCT01963442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20558935|NCT01963442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20558936|NCT01963442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20558937|NCT01963442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558938|NCT01963442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558939|NCT01963546|Dexmedetomidine|dexmedetomidine|mesh-list
20558940|NCT01963546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20558941|NCT01963546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558942|NCT01963546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20558943|NCT01963546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20008675|NCT02319304|Fluorouracil|fluorouracil|mesh-list
20008676|NCT02319304|Oxaliplatin|oxaliplatin|mesh-list
20008677|NCT02319304|Antimetabolites|antimetabolites|mesh-ancestor
20008678|NCT02319304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008679|NCT02319304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20008680|NCT02319304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008681|NCT02319304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20008682|NCT02319304|Immunologic Factors|immunologic factors|mesh-ancestor
20008683|NCT02319304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008684|NCT02319304|Antidotes|antidotes|mesh-ancestor
20008685|NCT02319304|Protective Agents|protective agents|mesh-ancestor
20008686|NCT02319304|Vitamin B Complex|vitamin b complex|mesh-ancestor
20008687|NCT02319304|Vitamins|vitamins|mesh-ancestor
20008688|NCT02319304|Micronutrients|micronutrients|mesh-ancestor
20008689|NCT02319369|Azacitidine|azacitidine|mesh-list
20008690|NCT02319369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20008691|NCT02319369|Antimetabolites|antimetabolites|mesh-ancestor
20008692|NCT02319369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008693|NCT02319369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008694|NCT02319369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008695|NCT02319486|Carboplatin|carboplatin|mesh-list
20008696|NCT02319486|Etoposide|etoposide|mesh-list
20008697|NCT02319486|Vincristine|vincristine|mesh-list
20008698|NCT02319486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008699|NCT02319486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20008700|NCT02319486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20008701|NCT02319486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20008702|NCT02319486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008703|NCT02319486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008704|NCT02319486|Tubulin Modulators|tubulin modulators|mesh-ancestor
20008705|NCT02319486|Antimitotic Agents|antimitotic agents|mesh-ancestor
20008706|NCT02319486|Mitosis Modulators|mitosis modulators|mesh-ancestor
20008707|NCT02319642|Certolizumab Pegol|certolizumab pegol|mesh-list
20008708|NCT02319642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20008709|NCT02319642|Immunologic Factors|immunologic factors|mesh-ancestor
20008710|NCT02319642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008711|NCT02319642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20008712|NCT02319668|Chlorhexidine|chlorhexidine|mesh-list
20008713|NCT02319668|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20008714|NCT02319668|Listerine|listerine|mesh-list
20008715|NCT02319668|Fluorides|fluorides|mesh-list
20008716|NCT02319668|Sodium Fluoride|sodium fluoride|mesh-list
20008717|NCT02319668|Cariostatic Agents|cariostatic agents|mesh-ancestor
20008718|NCT02319668|Protective Agents|protective agents|mesh-ancestor
20008719|NCT02319668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008720|NCT02319668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20008721|NCT02319668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20008722|NCT02319668|Disinfectants|disinfectants|mesh-ancestor
20008723|NCT02319668|Dermatologic Agents|dermatologic agents|mesh-ancestor
20008724|NCT02319759|Ustekinumab|ustekinumab|mesh-list
20008725|NCT02319759|Dermatologic Agents|dermatologic agents|mesh-ancestor
20008726|NCT02320058|Nivolumab|nivolumab|mesh-list
20008727|NCT02320058|Ipilimumab|ipilimumab|mesh-list
20008728|NCT02320058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20008729|NCT02320058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008730|NCT02320058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20008731|NCT02320058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008732|NCT02320149|Sarecycline|sarecycline|mesh-list
20008733|NCT02320149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20008734|NCT02320149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20008735|NCT02320149|Dermatologic Agents|dermatologic agents|mesh-ancestor
20008736|NCT02320487|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20008737|NCT02320487|Obinutuzumab|obinutuzumab|mesh-list
20008738|NCT02320487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20008739|NCT02320487|Alkylating Agents|alkylating agents|mesh-ancestor
20008740|NCT02320487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008741|NCT02320487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008742|NCT02320487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20008743|NCT02320695|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20008744|NCT02320695|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
20008745|NCT02320695|Bacitracin|bacitracin|mesh-list
20008746|NCT02320695|Neomycin|neomycin|mesh-list
20008747|NCT02320695|Polymyxin B|polymyxin b|mesh-list
20008748|NCT02320695|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20008749|NCT02320695|Ethanol|ethanol|mesh-list
20008750|NCT02320695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20008751|NCT02320695|Antitubercular Agents|antitubercular agents|mesh-ancestor
20558944|NCT01963546|Analgesics|analgesics|mesh-ancestor
20008752|NCT02320695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20008753|NCT02320695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20008754|NCT02320695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008755|NCT02320695|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20008756|NCT02320695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008757|NCT02320695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008758|NCT02320721|Insulin|insulin|mesh-list
20008759|NCT02320721|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20008760|NCT02320721|Insulin Glargine|insulin glargine|mesh-list
20008761|NCT02320721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20008762|NCT02320721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008763|NCT02321098|Amorolfine|amorolfine|mesh-list
20008764|NCT02321098|Antifungal Agents|antifungal agents|mesh-ancestor
20008765|NCT02321098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20008766|NCT02321319|Hydromorphone|hydromorphone|mesh-list
20008767|NCT02321319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20008768|NCT02321319|Narcotics|narcotics|mesh-ancestor
20008769|NCT02321319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20008770|NCT02321319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008771|NCT02321319|Analgesics|analgesics|mesh-ancestor
20008772|NCT02321319|Sensory System Agents|sensory system agents|mesh-ancestor
20008773|NCT02321319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008774|NCT02321436|Botulinum Toxins|botulinum toxins|mesh-list
20008775|NCT02321436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20008776|NCT02321436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20008777|NCT02321436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20008778|NCT02321436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20008779|NCT02321436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008780|NCT02321436|Cholinergic Agents|cholinergic agents|mesh-ancestor
20008781|NCT02321436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20008782|NCT02321436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008783|NCT02321436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20008784|NCT02321436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008785|NCT02321748|Montelukast|montelukast|mesh-list
20008786|NCT02321748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20008787|NCT02321748|Respiratory System Agents|respiratory system agents|mesh-ancestor
20008788|NCT02321748|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20008789|NCT02321748|Hormone Antagonists|hormone antagonists|mesh-ancestor
20008790|NCT02321748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20008791|NCT02321748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008792|NCT02321748|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20008793|NCT02321748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20008794|NCT02321748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008795|NCT02321800|Imipenem|imipenem|mesh-list
20008796|NCT02321800|Cilastatin|cilastatin|mesh-list
20008797|NCT02321800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20008798|NCT02321800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20008799|NCT02321800|Protease Inhibitors|protease inhibitors|mesh-ancestor
20008800|NCT02321800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008801|NCT02321800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008802|NCT02321930|Tofacitinib|tofacitinib|mesh-list
20008803|NCT02321930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20008804|NCT02321930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008805|NCT02321930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008806|NCT02322047|Prazosin|prazosin|mesh-list
20008807|NCT02322047|Naltrexone|naltrexone|mesh-list
20008808|NCT02322047|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20008809|NCT02322047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20008810|NCT02322047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008811|NCT02322047|Sensory System Agents|sensory system agents|mesh-ancestor
20008812|NCT02322047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008813|NCT02322047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20008814|NCT02322047|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20008815|NCT02322047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20008816|NCT02322047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20008817|NCT02322047|Adrenergic Agents|adrenergic agents|mesh-ancestor
20008818|NCT02322047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20008819|NCT02322047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008820|NCT02322190|Methoxsalen|methoxsalen|mesh-list
20008821|NCT02322190|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20008822|NCT02322190|Dermatologic Agents|dermatologic agents|mesh-ancestor
20008823|NCT02322216|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
20008824|NCT02322216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20008825|NCT02322216|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20008826|NCT02322216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20008827|NCT02322216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20008828|NCT02322216|Analgesics|analgesics|mesh-ancestor
20008829|NCT02322216|Sensory System Agents|sensory system agents|mesh-ancestor
20008830|NCT02322216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008831|NCT02322216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008832|NCT02322216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20008833|NCT02322216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20008834|NCT02322216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20008835|NCT02322216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20008836|NCT02322216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20008837|NCT02322216|Histamine Antagonists|histamine antagonists|mesh-ancestor
20008838|NCT02322216|Histamine Agents|histamine agents|mesh-ancestor
20008839|NCT02322216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20008840|NCT02322216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008841|NCT02322242|Dexamethasone|dexamethasone|mesh-list
20008842|NCT02322242|Dexamethasone acetate|dexamethasone acetate|mesh-list
20008843|NCT02322242|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20008844|NCT02322242|BB 1101|bb 1101|mesh-list
20008845|NCT02322242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20008846|NCT02322242|Antiemetics|antiemetics|mesh-ancestor
20008847|NCT02322242|Autonomic Agents|autonomic agents|mesh-ancestor
20008848|NCT02322242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008849|NCT02322242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008850|NCT02322242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20008851|NCT02322242|Glucocorticoids|glucocorticoids|mesh-ancestor
20008852|NCT02322242|Hormones|hormones|mesh-ancestor
20008853|NCT02322242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20008854|NCT02322242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20008855|NCT02322242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008856|NCT02322242|Protease Inhibitors|protease inhibitors|mesh-ancestor
20008857|NCT02322242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20558945|NCT01963546|Sensory System Agents|sensory system agents|mesh-ancestor
20558946|NCT01963546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558947|NCT01963546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20558948|NCT01963546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20558949|NCT01963546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20558950|NCT01963546|Adrenergic Agents|adrenergic agents|mesh-ancestor
20558951|NCT01963546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558952|NCT01963546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558953|NCT01963559|Lidocaine|lidocaine|mesh-list
20558954|NCT01963559|Prilocaine|prilocaine|mesh-list
20558955|NCT01963559|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20558956|NCT01963559|Anesthetics, Local|anesthetics, local|mesh-ancestor
20558957|NCT01963559|Anesthetics|anesthetics|mesh-ancestor
20008858|NCT02322242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008859|NCT02322281|Gemcitabine|gemcitabine|mesh-list
20008860|NCT02322281|Paclitaxel|paclitaxel|mesh-list
20008861|NCT02322281|Docetaxel|docetaxel|mesh-list
20008862|NCT02322281|Pemetrexed|pemetrexed|mesh-list
20008863|NCT02322281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20008864|NCT02322281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008865|NCT02322281|Tubulin Modulators|tubulin modulators|mesh-ancestor
20008866|NCT02322281|Antimitotic Agents|antimitotic agents|mesh-ancestor
20008867|NCT02322281|Mitosis Modulators|mitosis modulators|mesh-ancestor
20008868|NCT02322281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008869|NCT02322281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20008870|NCT02322281|Antimetabolites|antimetabolites|mesh-ancestor
20008871|NCT02322281|Antiviral Agents|antiviral agents|mesh-ancestor
20008872|NCT02322281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20008873|NCT02322281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008874|NCT02322281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20008875|NCT02322281|Immunologic Factors|immunologic factors|mesh-ancestor
20008876|NCT02322281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008877|NCT02322281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20008878|NCT02322281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20008879|NCT02322320|Lenalidomide|lenalidomide|mesh-list
20008880|NCT02322320|Immunologic Factors|immunologic factors|mesh-ancestor
20008881|NCT02322320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008882|NCT02322320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20008883|NCT02322320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20008884|NCT02322320|Growth Substances|growth substances|mesh-ancestor
20008885|NCT02322320|Growth Inhibitors|growth inhibitors|mesh-ancestor
20008886|NCT02322320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008887|NCT02322528|Loteprednol Etabonate|loteprednol etabonate|mesh-list
20008888|NCT02322528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20008889|NCT02322775|Benralizumab|benralizumab|mesh-list
20008890|NCT02322775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20008891|NCT02322775|Respiratory System Agents|respiratory system agents|mesh-ancestor
20008892|NCT02322788|Terbutaline|terbutaline|mesh-list
20008893|NCT02322788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20008894|NCT02322788|Autonomic Agents|autonomic agents|mesh-ancestor
20008895|NCT02322788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008896|NCT02322788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008897|NCT02322788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20008898|NCT02322788|Respiratory System Agents|respiratory system agents|mesh-ancestor
20008899|NCT02322788|Sympathomimetics|sympathomimetics|mesh-ancestor
20008900|NCT02322788|Tocolytic Agents|tocolytic agents|mesh-ancestor
20008901|NCT02322788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20008902|NCT02322788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20008903|NCT02322788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20008904|NCT02322788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20008905|NCT02322788|Adrenergic Agents|adrenergic agents|mesh-ancestor
20008906|NCT02322788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20008907|NCT02322788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008908|NCT02322814|Paclitaxel|paclitaxel|mesh-list
20008909|NCT02322814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20008910|NCT02322814|Atezolizumab|atezolizumab|mesh-list
20008911|NCT02322814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20008912|NCT02322814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008913|NCT02322814|Tubulin Modulators|tubulin modulators|mesh-ancestor
20008914|NCT02322814|Antimitotic Agents|antimitotic agents|mesh-ancestor
20008915|NCT02322814|Mitosis Modulators|mitosis modulators|mesh-ancestor
20008916|NCT02322814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008917|NCT02322866|Sarecycline|sarecycline|mesh-list
20008918|NCT02322866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20008919|NCT02322866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20008920|NCT02322866|Dermatologic Agents|dermatologic agents|mesh-ancestor
20008921|NCT02322892|Thiamine|thiamine|mesh-list
20008922|NCT02322892|Vitamins|vitamins|mesh-ancestor
20008923|NCT02322892|Micronutrients|micronutrients|mesh-ancestor
20008924|NCT02322892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008925|NCT02322892|Vitamin B Complex|vitamin b complex|mesh-ancestor
20008926|NCT02323048|Methamphetamine|methamphetamine|mesh-list
20008927|NCT02323048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20008928|NCT02323048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008929|NCT02323048|Sympathomimetics|sympathomimetics|mesh-ancestor
20008930|NCT02323048|Autonomic Agents|autonomic agents|mesh-ancestor
20008931|NCT02323048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008932|NCT02323048|Dopamine Agents|dopamine agents|mesh-ancestor
20008933|NCT02323048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20008934|NCT02323048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008935|NCT02323048|Adrenergic Agents|adrenergic agents|mesh-ancestor
20008936|NCT02323048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20008937|NCT02323048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20008938|NCT02323048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20008939|NCT02323048|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20008940|NCT02323217|Isocarboxazid|isocarboxazid|mesh-list
20008941|NCT02323217|Idazoxan|idazoxan|mesh-list
20008942|NCT02323217|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20008943|NCT02323217|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20008944|NCT02323217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20008945|NCT02323217|Adrenergic Agents|adrenergic agents|mesh-ancestor
20008946|NCT02323217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20008947|NCT02323217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008948|NCT02323217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008949|NCT02323217|Antidepressive Agents|antidepressive agents|mesh-ancestor
20008950|NCT02323217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20008951|NCT02323217|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20008952|NCT02323217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008953|NCT02323334|Itraconazole|itraconazole|mesh-list
20008954|NCT02323334|Antifungal Agents|antifungal agents|mesh-ancestor
20008955|NCT02323334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20008956|NCT02323334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20008957|NCT02323334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20008958|NCT02323334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008959|NCT02323334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008960|NCT02323334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20008961|NCT02323334|Hormone Antagonists|hormone antagonists|mesh-ancestor
20008962|NCT02323334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20008963|NCT02323334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008964|NCT02323334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20290331|NCT04088409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20290332|NCT04088409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20290333|NCT04086745|Adalimumab|adalimumab|mesh-list
20290334|NCT04086745|Etanercept|etanercept|mesh-list
20290335|NCT04086745|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
20290336|NCT04086745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20290337|NCT04086745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20290338|NCT04086745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20290339|NCT04086745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20290340|NCT04086745|Analgesics|analgesics|mesh-ancestor
20290341|NCT04086745|Sensory System Agents|sensory system agents|mesh-ancestor
20290342|NCT04086745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20290343|NCT04086745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290344|NCT04086745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20290345|NCT04086745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20290346|NCT04086745|Immunologic Factors|immunologic factors|mesh-ancestor
20290347|NCT04081831|Aspirin|aspirin|mesh-list
20290348|NCT04081831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20290349|NCT04081831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20290350|NCT04081831|Analgesics|analgesics|mesh-ancestor
20290351|NCT04081831|Sensory System Agents|sensory system agents|mesh-ancestor
20290352|NCT04081831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20290353|NCT04081831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290354|NCT04081831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20290355|NCT04081831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20290356|NCT04081831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20290357|NCT04081831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20290358|NCT04081831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290359|NCT04081831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20290360|NCT04081831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20290361|NCT04081831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290362|NCT04081831|Antipyretics|antipyretics|mesh-ancestor
20290363|NCT04070352|Fidaxomicin|fidaxomicin|mesh-list
20290364|NCT04070352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20290365|NCT04070352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20290366|NCT04047251|Topotecan|topotecan|mesh-list
20290367|NCT04047251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20290368|NCT04047251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20290369|NCT04047251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290370|NCT04047251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290371|NCT04047251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290372|NCT04032964|Doxorubicin|doxorubicin|mesh-list
20008965|NCT02324153|Riboflavin|riboflavin|mesh-list
20008966|NCT02324153|Vitamin B Complex|vitamin b complex|mesh-ancestor
20008967|NCT02324153|Vitamins|vitamins|mesh-ancestor
20008968|NCT02324153|Micronutrients|micronutrients|mesh-ancestor
20008969|NCT02324153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008970|NCT02324153|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20008971|NCT02324153|Dermatologic Agents|dermatologic agents|mesh-ancestor
20008972|NCT02324270|Diclofenac|diclofenac|mesh-list
20008973|NCT02324270|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
20008974|NCT02324270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20008975|NCT02324270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20008976|NCT02324270|Analgesics|analgesics|mesh-ancestor
20008977|NCT02324270|Sensory System Agents|sensory system agents|mesh-ancestor
20008978|NCT02324270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20008979|NCT02324270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008980|NCT02324270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20008981|NCT02324270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20008982|NCT02324270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20008983|NCT02324270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008984|NCT02324270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008985|NCT02324543|Gemcitabine|gemcitabine|mesh-list
20008986|NCT02324543|Docetaxel|docetaxel|mesh-list
20558958|NCT01963559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20008987|NCT02324543|Capecitabine|capecitabine|mesh-list
20558959|NCT01963559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558960|NCT01963559|Sensory System Agents|sensory system agents|mesh-ancestor
20558961|NCT01963559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20558962|NCT01963559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20558963|NCT01963559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20558964|NCT01963559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20558965|NCT01963559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20558966|NCT01963559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008988|NCT02324543|Irinotecan|irinotecan|mesh-list
20008989|NCT02324543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20008990|NCT02324543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20008991|NCT02324543|Antimetabolites|antimetabolites|mesh-ancestor
20008992|NCT02324543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20008993|NCT02324543|Antiviral Agents|antiviral agents|mesh-ancestor
20008994|NCT02324543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20008995|NCT02324543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20008996|NCT02324543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20008997|NCT02324543|Immunologic Factors|immunologic factors|mesh-ancestor
20008998|NCT02324543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20008999|NCT02324543|Tubulin Modulators|tubulin modulators|mesh-ancestor
20009000|NCT02324543|Antimitotic Agents|antimitotic agents|mesh-ancestor
20009001|NCT02324543|Mitosis Modulators|mitosis modulators|mesh-ancestor
20009002|NCT02324543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20009003|NCT02324543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20009004|NCT02324673|Cannabidiol|cannabidiol|mesh-list
20009005|NCT02324673|Anticonvulsants|anticonvulsants|mesh-ancestor
20009006|NCT02324699|Prednisone|prednisone|mesh-list
20009007|NCT02324699|Vedolizumab|vedolizumab|mesh-list
20009008|NCT02324699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20009009|NCT02324699|Glucocorticoids|glucocorticoids|mesh-ancestor
20009010|NCT02324699|Hormones|hormones|mesh-ancestor
20009011|NCT02324699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20009012|NCT02324699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009013|NCT02324699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20009014|NCT02324699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009015|NCT02324699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20009016|NCT02324842|Liraglutide|liraglutide|mesh-list
20009017|NCT02324842|Canagliflozin|canagliflozin|mesh-list
20009018|NCT02324842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20009019|NCT02324842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009020|NCT02324842|Incretins|incretins|mesh-ancestor
20009021|NCT02324842|Hormones|hormones|mesh-ancestor
20009022|NCT02324842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20009023|NCT02324842|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20009024|NCT02324842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009025|NCT02325219|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20009026|NCT02325219|Immunologic Factors|immunologic factors|mesh-ancestor
20009027|NCT02325219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009028|NCT02325401|Metformin|metformin|mesh-list
20009029|NCT02325401|Cisplatin|cisplatin|mesh-list
20009030|NCT02325401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009031|NCT02325401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20009032|NCT02325401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009033|NCT02325414|Zoledronic Acid|zoledronic acid|mesh-list
20009034|NCT02325414|Diphosphonates|diphosphonates|mesh-list
20009035|NCT02325414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20009036|NCT02325414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009037|NCT02325518|Timolol|timolol|mesh-list
20009038|NCT02325518|Dorzolamide|dorzolamide|mesh-list
20009039|NCT02325518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20009040|NCT02325518|Maleic acid|maleic acid|mesh-list
20009041|NCT02325518|Brinzolamide|brinzolamide|mesh-list
20009042|NCT02325518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20009043|NCT02325518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20009044|NCT02325518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20009045|NCT02325518|Adrenergic Agents|adrenergic agents|mesh-ancestor
20009046|NCT02325518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20009047|NCT02325518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009048|NCT02325518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009049|NCT02325518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20009050|NCT02325518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20009051|NCT02325518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009052|NCT02325518|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20009053|NCT02325713|Praziquantel|praziquantel|mesh-list
20009054|NCT02325713|Anthelmintics|anthelmintics|mesh-ancestor
20009055|NCT02325713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20009056|NCT02325713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20009057|NCT02325739|Spartalizumab|spartalizumab|mesh-list
20009058|NCT02325739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20009059|NCT02325739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009060|NCT02325739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009061|NCT02326025|Doxorubicin|doxorubicin|mesh-list
20009062|NCT02326025|Olaratumab|olaratumab|mesh-list
20009063|NCT02326025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20009064|NCT02326025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009065|NCT02326025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20009066|NCT02326025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20009067|NCT02326025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009068|NCT02326025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009069|NCT02326272|Certolizumab Pegol|certolizumab pegol|mesh-list
20009070|NCT02326272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20009071|NCT02326272|Immunologic Factors|immunologic factors|mesh-ancestor
20009072|NCT02326272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009073|NCT02326272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20009074|NCT02326298|Certolizumab Pegol|certolizumab pegol|mesh-list
20009075|NCT02326298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20009076|NCT02326298|Immunologic Factors|immunologic factors|mesh-ancestor
20009077|NCT02326298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009078|NCT02326298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20009079|NCT02326467|Chlorhexidine|chlorhexidine|mesh-list
20009080|NCT02326467|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20009081|NCT02326467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20009082|NCT02326467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20009083|NCT02326467|Disinfectants|disinfectants|mesh-ancestor
20009084|NCT02326467|Dermatologic Agents|dermatologic agents|mesh-ancestor
20009085|NCT02326805|Metronidazole|metronidazole|mesh-list
20009086|NCT02326805|Vaccines|vaccines|mesh-list
20009087|NCT02326805|Immunologic Factors|immunologic factors|mesh-ancestor
20009088|NCT02326805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009089|NCT02326805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20009090|NCT02326805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20009091|NCT02326805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20009092|NCT02326805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20009093|NCT02326844|Talazoparib|talazoparib|mesh-list
20009094|NCT02326844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20009095|NCT02326844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009096|NCT02326844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009097|NCT02326844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009098|NCT02327013|Vortioxetine|vortioxetine|mesh-list
20009099|NCT02327013|Antidepressive Agents|antidepressive agents|mesh-ancestor
20009100|NCT02327013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20009101|NCT02327013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20009102|NCT02327013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20009103|NCT02327013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20009104|NCT02327013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009105|NCT02327013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20009106|NCT02327013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20009107|NCT02327013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20558967|NCT01963559|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20558968|NCT01963663|Metformin|metformin|mesh-list
20558969|NCT01963663|Pioglitazone|pioglitazone|mesh-list
20558970|NCT01963663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20558971|NCT01963663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558972|NCT01963702|Capecitabine|capecitabine|mesh-list
20558973|NCT01963702|Oxaliplatin|oxaliplatin|mesh-list
20558974|NCT01963702|Docetaxel|docetaxel|mesh-list
20558975|NCT01963702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20558976|NCT01963702|Antimetabolites|antimetabolites|mesh-ancestor
20558977|NCT01963702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558978|NCT01963702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20558979|NCT01963702|Tubulin Modulators|tubulin modulators|mesh-ancestor
20558980|NCT01963702|Antimitotic Agents|antimitotic agents|mesh-ancestor
20558981|NCT01963702|Mitosis Modulators|mitosis modulators|mesh-ancestor
20558982|NCT01963741|Histamine|histamine|mesh-list
20558983|NCT01963741|Histamine Agonists|histamine agonists|mesh-ancestor
20558984|NCT01963741|Histamine Agents|histamine agents|mesh-ancestor
20558985|NCT01963741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558986|NCT01963741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20558987|NCT01963741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558988|NCT01963754|Epinephrine|epinephrine|mesh-list
20558989|NCT01963754|Racepinephrine|racepinephrine|mesh-list
20558990|NCT01963754|Anesthetics|anesthetics|mesh-list
20558991|NCT01963754|Carticaine|carticaine|mesh-list
20558992|NCT01963754|Epinephryl borate|epinephryl borate|mesh-list
20558993|NCT01963754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20558994|NCT01963754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20558995|NCT01963754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20558996|NCT01963754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20558997|NCT01963754|Adrenergic Agents|adrenergic agents|mesh-ancestor
20558998|NCT01963754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20558999|NCT01963754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559000|NCT01963754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20559001|NCT01963754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20559002|NCT01963754|Autonomic Agents|autonomic agents|mesh-ancestor
20559003|NCT01963754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559004|NCT01963754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20559005|NCT01963754|Respiratory System Agents|respiratory system agents|mesh-ancestor
20009108|NCT02327013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009109|NCT02327013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20009110|NCT02327013|Serotonin Agents|serotonin agents|mesh-ancestor
20009111|NCT02327013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20009112|NCT02327013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20009113|NCT02327013|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20009114|NCT02327013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20009115|NCT02327117|Tranexamic Acid|tranexamic acid|mesh-list
20009116|NCT02327117|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20009117|NCT02327117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20009118|NCT02327117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009119|NCT02327117|Hemostatics|hemostatics|mesh-ancestor
20009120|NCT02327117|Coagulants|coagulants|mesh-ancestor
20009121|NCT02327169|Paclitaxel|paclitaxel|mesh-list
20009122|NCT02327169|Irinotecan|irinotecan|mesh-list
20009123|NCT02327169|Cetuximab|cetuximab|mesh-list
20009124|NCT02327169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20009125|NCT02327169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009126|NCT02327169|Tubulin Modulators|tubulin modulators|mesh-ancestor
20009127|NCT02327169|Antimitotic Agents|antimitotic agents|mesh-ancestor
20009128|NCT02327169|Mitosis Modulators|mitosis modulators|mesh-ancestor
20009129|NCT02327169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009130|NCT02327169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20009131|NCT02327169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20009132|NCT02327169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009133|NCT02327169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20009134|NCT02327741|Clopidogrel|clopidogrel|mesh-list
20009135|NCT02327741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20009136|NCT02327741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20009137|NCT02327741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20009138|NCT02327741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20009139|NCT02327741|Purinergic Agents|purinergic agents|mesh-ancestor
20009140|NCT02327741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20009141|NCT02327741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009142|NCT02327741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009143|NCT02328040|Insulin|insulin|mesh-list
20009144|NCT02328040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20009145|NCT02328040|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20009146|NCT02328040|Insulin Aspart|insulin aspart|mesh-list
20009147|NCT02328040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20009148|NCT02328040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009149|NCT02328040|Incretins|incretins|mesh-ancestor
20009150|NCT02328040|Hormones|hormones|mesh-ancestor
20009151|NCT02328040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20009152|NCT02328040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20009153|NCT02328040|Protease Inhibitors|protease inhibitors|mesh-ancestor
20009154|NCT02328040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009155|NCT02328040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009156|NCT02328404|Vitamin D|vitamin d|mesh-list
20009157|NCT02328404|Cholecalciferol|cholecalciferol|mesh-list
20009158|NCT02328404|Vitamins|vitamins|mesh-ancestor
20009159|NCT02328404|Micronutrients|micronutrients|mesh-ancestor
20009160|NCT02328404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009161|NCT02328404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20009162|NCT02328404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20009163|NCT02328755|Methotrexate|methotrexate|mesh-list
20009164|NCT02328755|Tacrolimus|tacrolimus|mesh-list
20009165|NCT02328755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20009166|NCT02328755|Abortifacient Agents|abortifacient agents|mesh-ancestor
20009167|NCT02328755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20009168|NCT02328755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009169|NCT02328755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20009170|NCT02328755|Antimetabolites|antimetabolites|mesh-ancestor
20009171|NCT02328755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009172|NCT02328755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009173|NCT02328755|Dermatologic Agents|dermatologic agents|mesh-ancestor
20009174|NCT02328755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009175|NCT02328755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20009176|NCT02328755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20009177|NCT02328755|Immunologic Factors|immunologic factors|mesh-ancestor
20009178|NCT02328755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20009179|NCT02328755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20009180|NCT02328755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20009181|NCT02329223|Omalizumab|omalizumab|mesh-list
20009182|NCT02329223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20009183|NCT02329223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20009184|NCT02329223|Respiratory System Agents|respiratory system agents|mesh-ancestor
20009185|NCT02329600|Triamcinolone|triamcinolone|mesh-list
20009186|NCT02329600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20009187|NCT02329600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20009188|NCT02329600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20009189|NCT02329600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20009190|NCT02329600|Glucocorticoids|glucocorticoids|mesh-ancestor
20009191|NCT02329600|Hormones|hormones|mesh-ancestor
20009192|NCT02329600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20009193|NCT02329600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009194|NCT02329600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20009195|NCT02329600|Immunologic Factors|immunologic factors|mesh-ancestor
20009196|NCT02329600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009197|NCT02329600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009198|NCT02329964|Neostigmine|neostigmine|mesh-list
20009199|NCT02329964|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
20009200|NCT02329964|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20009201|NCT02329964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009202|NCT02329964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009203|NCT02329964|Cholinergic Agents|cholinergic agents|mesh-ancestor
20009204|NCT02329964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20009205|NCT02329964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009206|NCT02329964|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20009207|NCT02329964|Autonomic Agents|autonomic agents|mesh-ancestor
20009208|NCT02329964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20009209|NCT02330094|Gabapentin|gabapentin|mesh-list
20009210|NCT02330094|Analgesics|analgesics|mesh-ancestor
20009211|NCT02330094|Sensory System Agents|sensory system agents|mesh-ancestor
20009212|NCT02330094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20009213|NCT02330094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009214|NCT02330094|Anticonvulsants|anticonvulsants|mesh-ancestor
20009215|NCT02330094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20009216|NCT02330094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20009217|NCT02330094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20009218|NCT02330094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20009219|NCT02330094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20009220|NCT02330094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20009221|NCT02330094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20009222|NCT02330094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009223|NCT02330094|Antimanic Agents|antimanic agents|mesh-ancestor
20009224|NCT02330172|Neostigmine|neostigmine|mesh-list
20009225|NCT02330172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20009226|NCT02330172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009227|NCT02330172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009228|NCT02330172|Cholinergic Agents|cholinergic agents|mesh-ancestor
20009229|NCT02330172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20009230|NCT02330172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009231|NCT02330172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20009232|NCT02330172|Autonomic Agents|autonomic agents|mesh-ancestor
20009233|NCT02330172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20009234|NCT02330549|Cenicriviroc|cenicriviroc|mesh-list
20009235|NCT02330549|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20009236|NCT02330549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009237|NCT02330549|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20009238|NCT02330549|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20009239|NCT02330549|Antiviral Agents|antiviral agents|mesh-ancestor
20009240|NCT02330549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20009241|NCT02331095|Warfarin|warfarin|mesh-list
20009242|NCT02331095|Rivaroxaban|rivaroxaban|mesh-list
20009243|NCT02331095|Atorvastatin|atorvastatin|mesh-list
20009244|NCT02331095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20009245|NCT02331095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20009246|NCT02331095|Antimetabolites|antimetabolites|mesh-ancestor
20009247|NCT02331095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009248|NCT02331095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20009249|NCT02331095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20009250|NCT02331095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009251|NCT02331095|Anticoagulants|anticoagulants|mesh-ancestor
20009252|NCT02331095|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20009253|NCT02331095|Antithrombins|antithrombins|mesh-ancestor
20009254|NCT02331095|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20009255|NCT02331095|Protease Inhibitors|protease inhibitors|mesh-ancestor
20009256|NCT02331108|Anesthetics|anesthetics|mesh-list
20009257|NCT02331108|Propofol|propofol|mesh-list
20009258|NCT02331108|Sevoflurane|sevoflurane|mesh-list
20009259|NCT02331108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20009260|NCT02331108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009261|NCT02331108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20009262|NCT02331108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20009263|NCT02331108|Anesthetics, General|anesthetics, general|mesh-ancestor
20009264|NCT02331108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20009265|NCT02331108|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20009266|NCT02331368|Pembrolizumab|pembrolizumab|mesh-list
20009267|NCT02331368|Lenalidomide|lenalidomide|mesh-list
20009268|NCT02331368|Melphalan|melphalan|mesh-list
20009269|NCT02331368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20009270|NCT02331368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009271|NCT02331368|Immunologic Factors|immunologic factors|mesh-ancestor
20009272|NCT02331368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009273|NCT02331368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20009274|NCT02331368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20009275|NCT02331368|Growth Substances|growth substances|mesh-ancestor
20009276|NCT02331368|Growth Inhibitors|growth inhibitors|mesh-ancestor
20009277|NCT02331368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20009278|NCT02331368|Alkylating Agents|alkylating agents|mesh-ancestor
20009279|NCT02331368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009280|NCT02331368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20009281|NCT02331368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20009282|NCT02331680|Tolvaptan|tolvaptan|mesh-list
20009283|NCT02331680|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20009284|NCT02331680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009285|NCT02331680|Natriuretic Agents|natriuretic agents|mesh-ancestor
20009286|NCT02331680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009287|NCT02331940|Tiotropium Bromide|tiotropium bromide|mesh-list
20009288|NCT02331940|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20009289|NCT02331940|Autonomic Agents|autonomic agents|mesh-ancestor
20009290|NCT02331940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20009291|NCT02331940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009292|NCT02331940|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20009293|NCT02331940|Respiratory System Agents|respiratory system agents|mesh-ancestor
20009294|NCT02331940|Parasympatholytics|parasympatholytics|mesh-ancestor
20009295|NCT02331940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20009296|NCT02331940|Cholinergic Agents|cholinergic agents|mesh-ancestor
20009297|NCT02331940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20009298|NCT02331940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009299|NCT02332291|Citalopram|citalopram|mesh-list
20009300|NCT02332291|Bupropion|bupropion|mesh-list
20009301|NCT02332291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20009302|NCT02332291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20009303|NCT02332291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20009304|NCT02332291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009305|NCT02332291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20009306|NCT02332291|Serotonin Agents|serotonin agents|mesh-ancestor
20009307|NCT02332291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009308|NCT02332291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20009309|NCT02332291|Antidepressive Agents|antidepressive agents|mesh-ancestor
20009310|NCT02332291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20009311|NCT02332291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20009312|NCT02332291|Dopamine Agents|dopamine agents|mesh-ancestor
20009313|NCT02332291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20009314|NCT02332291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20009315|NCT02332291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009316|NCT02332707|Ribavirin|ribavirin|mesh-list
20009317|NCT02332707|Grazoprevir|grazoprevir|mesh-list
20009318|NCT02332707|Uprifosbuvir|uprifosbuvir|mesh-list
20009319|NCT02332707|Ruzasvir|ruzasvir|mesh-list
20009320|NCT02332707|Antimetabolites|antimetabolites|mesh-ancestor
20009321|NCT02332707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009322|NCT02332707|Antiviral Agents|antiviral agents|mesh-ancestor
20009323|NCT02332707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20009324|NCT02332720|Ribavirin|ribavirin|mesh-list
20009325|NCT02332720|Grazoprevir|grazoprevir|mesh-list
20009326|NCT02332720|Uprifosbuvir|uprifosbuvir|mesh-list
20009327|NCT02332720|Ruzasvir|ruzasvir|mesh-list
20009328|NCT02332720|Antimetabolites|antimetabolites|mesh-ancestor
20009329|NCT02332720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009330|NCT02332720|Antiviral Agents|antiviral agents|mesh-ancestor
20009331|NCT02332720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20009332|NCT02332824|Candesartan|candesartan|mesh-list
20009333|NCT02332824|Candesartan cilexetil|candesartan cilexetil|mesh-list
20009334|NCT02332824|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
20009335|NCT02332824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20009336|NCT02332824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20009337|NCT02332824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20009338|NCT02332824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009339|NCT02332824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009340|NCT02332889|Decitabine|decitabine|mesh-list
20009341|NCT02332889|Poly ICLC|poly iclc|mesh-list
20009342|NCT02332889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20009343|NCT02332889|Antimetabolites|antimetabolites|mesh-ancestor
20009344|NCT02332889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009345|NCT02332889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009346|NCT02332889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009347|NCT02332889|Interferon Inducers|interferon inducers|mesh-ancestor
20009348|NCT02332889|Immunologic Factors|immunologic factors|mesh-ancestor
20009349|NCT02332889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009350|NCT02332902|Everolimus|everolimus|mesh-list
20009351|NCT02332902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009352|NCT02332902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20009353|NCT02332902|Immunologic Factors|immunologic factors|mesh-ancestor
20009354|NCT02332902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009355|NCT02333045|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20009356|NCT02333045|Maraviroc|maraviroc|mesh-list
20009357|NCT02333045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20009358|NCT02333045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20009359|NCT02333045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009360|NCT02333045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009361|NCT02333045|Antiviral Agents|antiviral agents|mesh-ancestor
20009362|NCT02333045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20009363|NCT02333045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20009364|NCT02333045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20009365|NCT02333045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20009366|NCT02333045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20009367|NCT02333045|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20009368|NCT02333383|Adalimumab|adalimumab|mesh-list
20009369|NCT02333383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20009370|NCT02333383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20290373|NCT04032964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20290374|NCT04032964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290375|NCT04032964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20290376|NCT04032964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20290377|NCT04032964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290378|NCT04032964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290379|NCT04029454|Vaccines|vaccines|mesh-list
20290380|NCT04029454|Immunologic Factors|immunologic factors|mesh-ancestor
20009371|NCT02334059|Ketamine|ketamine|mesh-list
20009372|NCT02334059|Analgesics|analgesics|mesh-ancestor
20009373|NCT02334059|Sensory System Agents|sensory system agents|mesh-ancestor
20009374|NCT02334059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20009375|NCT02334059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009376|NCT02334059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20009377|NCT02334059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20009378|NCT02334059|Anesthetics, General|anesthetics, general|mesh-ancestor
20559006|NCT01963754|Mydriatics|mydriatics|mesh-ancestor
20559007|NCT01963754|Sympathomimetics|sympathomimetics|mesh-ancestor
20559008|NCT01963754|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19460129|NCT03355638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460130|NCT03355638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19460131|NCT03355638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19460132|NCT03355638|Gout Suppressants|gout suppressants|mesh-ancestor
19460133|NCT03355612|Capecitabine|capecitabine|mesh-list
19460134|NCT03355612|Oxaliplatin|oxaliplatin|mesh-list
19460135|NCT03355612|Apatinib|apatinib|mesh-list
19460136|NCT03355612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19460137|NCT03355612|Antimetabolites|antimetabolites|mesh-ancestor
19460138|NCT03355612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460139|NCT03355612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460140|NCT03355612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19460141|NCT03355612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19460142|NCT03355560|Nivolumab|nivolumab|mesh-list
19460143|NCT03355560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19460144|NCT03355560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460145|NCT03355560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19460146|NCT03355560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009379|NCT02334059|Anesthetics|anesthetics|mesh-ancestor
20009380|NCT02334059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20009381|NCT02334059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20009382|NCT02334059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20009383|NCT02334059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20009384|NCT02334059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009385|NCT02334215|Methadone|methadone|mesh-list
20009386|NCT02334215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20009387|NCT02334215|Narcotics|narcotics|mesh-ancestor
20009388|NCT02334215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20009389|NCT02334215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009390|NCT02334215|Analgesics|analgesics|mesh-ancestor
20009391|NCT02334215|Sensory System Agents|sensory system agents|mesh-ancestor
20009392|NCT02334215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460161|NCT03355482|Methylprednisolone|methylprednisolone|mesh-list
19460162|NCT03355482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19460163|NCT03355482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19460164|NCT03355482|Prednisolone|prednisolone|mesh-list
19460165|NCT03355482|Prednisolone acetate|prednisolone acetate|mesh-list
19460166|NCT03355482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19460167|NCT03355482|Prednisolone phosphate|prednisolone phosphate|mesh-list
19460168|NCT03355482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19460169|NCT03355482|Antiemetics|antiemetics|mesh-ancestor
19460170|NCT03355482|Autonomic Agents|autonomic agents|mesh-ancestor
19460171|NCT03355482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460172|NCT03355482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460173|NCT03355482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19460174|NCT03355482|Glucocorticoids|glucocorticoids|mesh-ancestor
19460175|NCT03355482|Hormones|hormones|mesh-ancestor
19460176|NCT03355482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19460177|NCT03355482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19460178|NCT03355482|Protective Agents|protective agents|mesh-ancestor
20009393|NCT02334215|Antitussive Agents|antitussive agents|mesh-ancestor
20559009|NCT01963754|Anesthetics, Local|anesthetics, local|mesh-ancestor
20559010|NCT01963754|Sensory System Agents|sensory system agents|mesh-ancestor
20559011|NCT01963832|Fluoxetine|fluoxetine|mesh-list
20559012|NCT01963832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20559013|NCT01963832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20559014|NCT01963832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20009394|NCT02334215|Respiratory System Agents|respiratory system agents|mesh-ancestor
20009395|NCT02334384|Anti-Infective Agents|anti-infective agents|mesh-list
20009396|NCT02334384|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20009397|NCT02334423|Botulinum Toxins|botulinum toxins|mesh-list
20009398|NCT02334423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20009399|NCT02334423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20009400|NCT02334423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20009401|NCT02334423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20009402|NCT02334423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009403|NCT02334423|Cholinergic Agents|cholinergic agents|mesh-ancestor
20009404|NCT02334423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20009405|NCT02334423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009406|NCT02334423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20009407|NCT02334423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20009408|NCT02334436|Botulinum Toxins|botulinum toxins|mesh-list
20009409|NCT02334436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20009410|NCT02334436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20009411|NCT02334436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20009412|NCT02334436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20009413|NCT02334436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009414|NCT02334436|Cholinergic Agents|cholinergic agents|mesh-ancestor
20009415|NCT02334436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20009416|NCT02334436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009417|NCT02334436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20009418|NCT02334436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20009419|NCT02334527|Palbociclib|palbociclib|mesh-list
20009420|NCT02334527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009421|NCT02334527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20009422|NCT02334527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009423|NCT02334527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009424|NCT02334800|Palbociclib|palbociclib|mesh-list
20009425|NCT02334800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009426|NCT02334800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20009427|NCT02334800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009428|NCT02334800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009429|NCT02334813|Dexamethasone|dexamethasone|mesh-list
20009430|NCT02334813|Prednisone|prednisone|mesh-list
20009431|NCT02334813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20009432|NCT02334813|Antiemetics|antiemetics|mesh-ancestor
20009433|NCT02334813|Autonomic Agents|autonomic agents|mesh-ancestor
20009434|NCT02334813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20009435|NCT02334813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009436|NCT02334813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20009437|NCT02334813|Glucocorticoids|glucocorticoids|mesh-ancestor
20009438|NCT02334813|Hormones|hormones|mesh-ancestor
20009439|NCT02334813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20009440|NCT02334813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20009441|NCT02334813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009442|NCT02335125|Psychotropic Drugs|psychotropic drugs|mesh-list
20009443|NCT02335294|Morphine|morphine|mesh-list
20009444|NCT02335294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20009445|NCT02335294|Narcotics|narcotics|mesh-ancestor
20009446|NCT02335294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20009447|NCT02335294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009448|NCT02335294|Analgesics|analgesics|mesh-ancestor
20009449|NCT02335294|Sensory System Agents|sensory system agents|mesh-ancestor
20009450|NCT02335294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20009451|NCT02335346|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20559015|NCT01963832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559016|NCT01963832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20559017|NCT01963832|Serotonin Agents|serotonin agents|mesh-ancestor
20559018|NCT01963832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559019|NCT01963832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20559020|NCT01963832|Antidepressive Agents|antidepressive agents|mesh-ancestor
20559021|NCT01963832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20009452|NCT02335346|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20009453|NCT02335346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20009454|NCT02335346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20009455|NCT02335346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009456|NCT02335346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20009457|NCT02335346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009458|NCT02335346|Analgesics|analgesics|mesh-ancestor
20009459|NCT02335346|Sensory System Agents|sensory system agents|mesh-ancestor
20009460|NCT02335346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20009461|NCT02335346|Antidepressive Agents|antidepressive agents|mesh-ancestor
20009462|NCT02335346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19460179|NCT03355482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19460180|NCT03355482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460181|NCT03355469|Metformin|metformin|mesh-list
19460182|NCT03355469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19460183|NCT03355469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009463|NCT02335346|Dopamine Agents|dopamine agents|mesh-ancestor
20009464|NCT02335905|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
20009465|NCT02335905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20009466|NCT02335905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20009467|NCT02335983|Dexamethasone|dexamethasone|mesh-list
20009468|NCT02335983|Lenalidomide|lenalidomide|mesh-list
20009469|NCT02335983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20009470|NCT02335983|Antiemetics|antiemetics|mesh-ancestor
20009471|NCT02335983|Autonomic Agents|autonomic agents|mesh-ancestor
20009472|NCT02335983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20009473|NCT02335983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009474|NCT02335983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20009475|NCT02335983|Glucocorticoids|glucocorticoids|mesh-ancestor
20009476|NCT02335983|Hormones|hormones|mesh-ancestor
20009477|NCT02335983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20009478|NCT02335983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20009479|NCT02335983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009480|NCT02335983|Immunologic Factors|immunologic factors|mesh-ancestor
20009481|NCT02335983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20009482|NCT02335983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20009483|NCT02335983|Growth Substances|growth substances|mesh-ancestor
20009484|NCT02335983|Growth Inhibitors|growth inhibitors|mesh-ancestor
20009485|NCT02336074|Raltegravir Potassium|raltegravir potassium|mesh-list
20009486|NCT02336074|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
20009487|NCT02336074|Vorinostat|vorinostat|mesh-list
20009488|NCT02336074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009489|NCT02336074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20009490|NCT02336074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009491|NCT02336074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009492|NCT02336074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20009493|NCT02336074|Antiviral Agents|antiviral agents|mesh-ancestor
20009494|NCT02336074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20009495|NCT02336074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20009496|NCT02336074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20009497|NCT02336165|Bevacizumab|bevacizumab|mesh-list
20009498|NCT02336165|Durvalumab|durvalumab|mesh-list
20009499|NCT02336165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20009500|NCT02336165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009501|NCT02336165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20009502|NCT02336165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20009503|NCT02336165|Growth Substances|growth substances|mesh-ancestor
20009504|NCT02336165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009505|NCT02336165|Growth Inhibitors|growth inhibitors|mesh-ancestor
20009506|NCT02336373|Hydroxyurea|hydroxyurea|mesh-list
20009507|NCT02336373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009508|NCT02336373|Antisickling Agents|antisickling agents|mesh-ancestor
20009509|NCT02336373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009510|NCT02336373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009511|NCT02336373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20009512|NCT02336438|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
20009513|NCT02336438|Cathartics|cathartics|mesh-ancestor
20009514|NCT02336438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20009515|NCT02336451|Ceritinib|ceritinib|mesh-list
20009516|NCT02336451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009517|NCT02336451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20009518|NCT02336451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009519|NCT02336451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009520|NCT02336594|Verinurad|verinurad|mesh-list
20009521|NCT02336594|Gout Suppressants|gout suppressants|mesh-ancestor
20009522|NCT02336594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20009523|NCT02336607|Metoprolol|metoprolol|mesh-list
20009524|NCT02336607|Felodipine|felodipine|mesh-list
20009525|NCT02336607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20009526|NCT02336607|Lisinopril|lisinopril|mesh-list
20009527|NCT02336607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20009528|NCT02336607|Diuretics|diuretics|mesh-ancestor
20009529|NCT02336607|Natriuretic Agents|natriuretic agents|mesh-ancestor
20009530|NCT02336607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009531|NCT02336607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20009532|NCT02336607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20009533|NCT02336607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009534|NCT02336607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20009535|NCT02336607|Sympatholytics|sympatholytics|mesh-ancestor
20009536|NCT02336607|Autonomic Agents|autonomic agents|mesh-ancestor
20009537|NCT02336607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20009538|NCT02336607|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20009539|NCT02336607|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20009540|NCT02336607|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20009541|NCT02336607|Adrenergic Agents|adrenergic agents|mesh-ancestor
20009542|NCT02336607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20009543|NCT02336607|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20009544|NCT02336607|Protease Inhibitors|protease inhibitors|mesh-ancestor
20009545|NCT02336607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009546|NCT02336607|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20009547|NCT02336607|Protective Agents|protective agents|mesh-ancestor
20009548|NCT02336607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20009549|NCT02336607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20009550|NCT02336607|Vasodilator Agents|vasodilator agents|mesh-ancestor
20009551|NCT02336737|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
20009552|NCT02336737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20009553|NCT02336737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009554|NCT02336815|Dexamethasone|dexamethasone|mesh-list
20009555|NCT02336815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20009556|NCT02336815|Antiemetics|antiemetics|mesh-ancestor
20009557|NCT02336815|Autonomic Agents|autonomic agents|mesh-ancestor
20009558|NCT02336815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20009559|NCT02336815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009560|NCT02336815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20009561|NCT02336815|Glucocorticoids|glucocorticoids|mesh-ancestor
20009562|NCT02336815|Hormones|hormones|mesh-ancestor
20009563|NCT02336815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20009564|NCT02336815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20009565|NCT02336815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009566|NCT02336958|Ropivacaine|ropivacaine|mesh-list
20009567|NCT02336958|Prilocaine|prilocaine|mesh-list
20009568|NCT02336958|Anesthetics, Local|anesthetics, local|mesh-ancestor
20009569|NCT02336958|Anesthetics|anesthetics|mesh-ancestor
20009570|NCT02336958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20009571|NCT02336958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009572|NCT02336958|Sensory System Agents|sensory system agents|mesh-ancestor
20009573|NCT02336958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20009574|NCT02337478|Vincristine|vincristine|mesh-list
20009575|NCT02337478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20009576|NCT02337478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009577|NCT02337478|Tubulin Modulators|tubulin modulators|mesh-ancestor
20009578|NCT02337478|Antimitotic Agents|antimitotic agents|mesh-ancestor
20009579|NCT02337478|Mitosis Modulators|mitosis modulators|mesh-ancestor
20009580|NCT02337478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009581|NCT02337491|Bevacizumab|bevacizumab|mesh-list
20009582|NCT02337491|Pembrolizumab|pembrolizumab|mesh-list
20009583|NCT02337491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20009584|NCT02337491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009585|NCT02337491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20009586|NCT02337491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20009587|NCT02337491|Growth Substances|growth substances|mesh-ancestor
20009588|NCT02337491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009589|NCT02337491|Growth Inhibitors|growth inhibitors|mesh-ancestor
20009590|NCT02337530|Carboplatin|carboplatin|mesh-list
20009591|NCT02337530|Pemetrexed|pemetrexed|mesh-list
20009592|NCT02337530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009593|NCT02337530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009594|NCT02337530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009595|NCT02337530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20009596|NCT02337530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20009597|NCT02337907|Donepezil|donepezil|mesh-list
20009598|NCT02337907|BI 409306|bi 409306|mesh-list
20009599|NCT02337907|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20009600|NCT02337907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009601|NCT02337907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009602|NCT02337907|Cholinergic Agents|cholinergic agents|mesh-ancestor
20009603|NCT02337907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20009604|NCT02337907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009605|NCT02337907|Nootropic Agents|nootropic agents|mesh-ancestor
20009606|NCT02337907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20009607|NCT02337933|Ursolic acid|ursolic acid|mesh-list
20009608|NCT02337933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009609|NCT02337933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20009610|NCT02337933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20009611|NCT02337933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009612|NCT02337933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20009613|NCT02337933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009614|NCT02337933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20009615|NCT02337933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20009616|NCT02337933|Analgesics|analgesics|mesh-ancestor
20009617|NCT02337933|Sensory System Agents|sensory system agents|mesh-ancestor
20009618|NCT02337933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20009619|NCT02337933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009620|NCT02337933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20009621|NCT02337933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20009622|NCT02337946|Calcium, Dietary|calcium, dietary|mesh-list
20009623|NCT02337946|Leucovorin|leucovorin|mesh-list
20009624|NCT02337946|Oxaliplatin|oxaliplatin|mesh-list
20009625|NCT02337946|Fluorouracil|fluorouracil|mesh-list
20009626|NCT02337946|Panitumumab|panitumumab|mesh-list
20009627|NCT02337946|Calcium|calcium|mesh-list
20009628|NCT02337946|Levoleucovorin|levoleucovorin|mesh-list
20009629|NCT02337946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20009630|NCT02337946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009631|NCT02337946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20009632|NCT02337946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009633|NCT02337946|Antimetabolites|antimetabolites|mesh-ancestor
20009634|NCT02337946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009635|NCT02337946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20009636|NCT02337946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20009637|NCT02337946|Immunologic Factors|immunologic factors|mesh-ancestor
20009638|NCT02337946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20009639|NCT02337946|Antidotes|antidotes|mesh-ancestor
20009640|NCT02337946|Protective Agents|protective agents|mesh-ancestor
20009641|NCT02337946|Vitamin B Complex|vitamin b complex|mesh-ancestor
20009642|NCT02337946|Vitamins|vitamins|mesh-ancestor
20009643|NCT02337946|Micronutrients|micronutrients|mesh-ancestor
20009644|NCT02338076|Petrolatum|petrolatum|mesh-list
20009645|NCT02338076|Emollients|emollients|mesh-ancestor
20009646|NCT02338076|Dermatologic Agents|dermatologic agents|mesh-ancestor
20009647|NCT02338193|Metformin|metformin|mesh-list
20009648|NCT02338193|Dapagliflozin|dapagliflozin|mesh-list
20009649|NCT02338193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20009650|NCT02338193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009651|NCT02338193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20009652|NCT02338193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009653|NCT02338362|Fluticasone|fluticasone|mesh-list
20009654|NCT02338362|Xhance|xhance|mesh-list
20009655|NCT02338362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20009656|NCT02338362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20009657|NCT02338362|Autonomic Agents|autonomic agents|mesh-ancestor
20009658|NCT02338362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20009659|NCT02338362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009660|NCT02338362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20009661|NCT02338362|Respiratory System Agents|respiratory system agents|mesh-ancestor
20009662|NCT02338362|Dermatologic Agents|dermatologic agents|mesh-ancestor
20009663|NCT02338362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20009664|NCT02338713|Calcium Carbonate|calcium carbonate|mesh-list
20009665|NCT02338713|Antacids|antacids|mesh-ancestor
20009666|NCT02338713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009667|NCT02338713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20009668|NCT02338843|Angiotensin II|angiotensin ii|mesh-list
20009669|NCT02338843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20009670|NCT02338973|Interferons|interferons|mesh-list
20009671|NCT02338973|Interferon-gamma|interferon-gamma|mesh-list
20009672|NCT02338973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009673|NCT02338973|Antiviral Agents|antiviral agents|mesh-ancestor
20009674|NCT02338973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20009675|NCT02338999|Pioglitazone|pioglitazone|mesh-list
20009676|NCT02338999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20009677|NCT02338999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009678|NCT02339038|Sofosbuvir|sofosbuvir|mesh-list
20009679|NCT02339038|Ledipasvir|ledipasvir|mesh-list
20009680|NCT02339038|Antiviral Agents|antiviral agents|mesh-ancestor
20009681|NCT02339038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20009682|NCT02339155|Diphenhydramine|diphenhydramine|mesh-list
20009683|NCT02339155|Promethazine|promethazine|mesh-list
20009684|NCT02339155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20009685|NCT02339155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20009686|NCT02339155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20009687|NCT02339155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009688|NCT02339155|Anesthetics, Local|anesthetics, local|mesh-ancestor
20009689|NCT02339155|Anesthetics|anesthetics|mesh-ancestor
20009690|NCT02339155|Sensory System Agents|sensory system agents|mesh-ancestor
20009691|NCT02339155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20009692|NCT02339155|Antiemetics|antiemetics|mesh-ancestor
20009693|NCT02339155|Autonomic Agents|autonomic agents|mesh-ancestor
20009694|NCT02339155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20009695|NCT02339155|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20009696|NCT02339155|Histamine Antagonists|histamine antagonists|mesh-ancestor
20009697|NCT02339155|Histamine Agents|histamine agents|mesh-ancestor
20009698|NCT02339155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20009699|NCT02339155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009700|NCT02339155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20009701|NCT02339155|Antipruritics|antipruritics|mesh-ancestor
20009702|NCT02339155|Dermatologic Agents|dermatologic agents|mesh-ancestor
20009703|NCT02339246|Tacrolimus|tacrolimus|mesh-list
20009704|NCT02339246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20009705|NCT02339246|Immunologic Factors|immunologic factors|mesh-ancestor
20009706|NCT02339246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009707|NCT02339246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20009708|NCT02339246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009709|NCT02339246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009710|NCT02339415|Edoxaban|edoxaban|mesh-list
20009711|NCT02339415|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20009712|NCT02339415|Antithrombins|antithrombins|mesh-ancestor
20009713|NCT02339415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20009714|NCT02339415|Protease Inhibitors|protease inhibitors|mesh-ancestor
20009715|NCT02339415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009716|NCT02339415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009717|NCT02339415|Anticoagulants|anticoagulants|mesh-ancestor
20009718|NCT02339506|Cosyntropin|cosyntropin|mesh-list
20009719|NCT02339506|Hormones|hormones|mesh-ancestor
20009720|NCT02339506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20009721|NCT02339506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009722|NCT02339558|Nivolumab|nivolumab|mesh-list
20009723|NCT02339558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20009724|NCT02339558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009725|NCT02339558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20009726|NCT02339558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009727|NCT02339584|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20009728|NCT02339584|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20009729|NCT02339584|Brinzolamide|brinzolamide|mesh-list
20559022|NCT01963832|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20559023|NCT01963832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20559024|NCT01963832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559025|NCT01963910|Mannitol|mannitol|mesh-list
20559026|NCT01963910|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20559027|NCT01963910|Diuretics|diuretics|mesh-ancestor
20559028|NCT01963910|Natriuretic Agents|natriuretic agents|mesh-ancestor
20559029|NCT01963910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559030|NCT01963962|Copper|copper|mesh-list
20559031|NCT01963962|Levonorgestrel|levonorgestrel|mesh-list
20559032|NCT01963962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20559033|NCT01963962|Contraceptive Agents|contraceptive agents|mesh-ancestor
20559034|NCT01963962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20559035|NCT01963962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559036|NCT01963962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20559037|NCT01963962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20559038|NCT01963962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20559039|NCT01963962|Trace Elements|trace elements|mesh-ancestor
20559040|NCT01963962|Micronutrients|micronutrients|mesh-ancestor
20559041|NCT01964001|Vitamins|vitamins|mesh-list
20559042|NCT01964001|Coenzyme Q10|coenzyme q10|mesh-list
20009730|NCT02339584|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20009731|NCT02339584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20009732|NCT02339584|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20009733|NCT02339584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20009734|NCT02339584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20009735|NCT02339584|Adrenergic Agents|adrenergic agents|mesh-ancestor
20009736|NCT02339584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20009737|NCT02339584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009738|NCT02339584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009739|NCT02339584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20009740|NCT02339584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009741|NCT02340000|Amoxicillin|amoxicillin|mesh-list
20009742|NCT02340000|Clavulanic Acid|clavulanic acid|mesh-list
20009743|NCT02340000|Clavulanic Acids|clavulanic acids|mesh-list
20009744|NCT02340000|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20009745|NCT02340000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20009746|NCT02340000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20009747|NCT02340000|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20009748|NCT02340000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009749|NCT02340000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009750|NCT02340156|Temozolomide|temozolomide|mesh-list
20009751|NCT02340156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20009752|NCT02340156|Alkylating Agents|alkylating agents|mesh-ancestor
20009753|NCT02340156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009754|NCT02340156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009755|NCT02340520|Theophylline|theophylline|mesh-list
20009756|NCT02340520|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20009757|NCT02340520|Autonomic Agents|autonomic agents|mesh-ancestor
20009758|NCT02340520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20009759|NCT02340520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009760|NCT02340520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20009761|NCT02340520|Respiratory System Agents|respiratory system agents|mesh-ancestor
20009762|NCT02340520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20009763|NCT02340520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009764|NCT02340520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009765|NCT02340520|Vasodilator Agents|vasodilator agents|mesh-ancestor
20009766|NCT02340520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20009767|NCT02340520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20009768|NCT02340520|Purinergic Agents|purinergic agents|mesh-ancestor
20009769|NCT02340520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20009770|NCT02340819|Teduglutide|teduglutide|mesh-list
20009771|NCT02340819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20009772|NCT02340819|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20009773|NCT02340819|Protective Agents|protective agents|mesh-ancestor
20009774|NCT02340819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009775|NCT02340949|Leucovorin|leucovorin|mesh-list
20009776|NCT02340949|Oxaliplatin|oxaliplatin|mesh-list
20009777|NCT02340949|Aflibercept|aflibercept|mesh-list
20009778|NCT02340949|Fluorouracil|fluorouracil|mesh-list
20009779|NCT02340949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009780|NCT02340949|Antidotes|antidotes|mesh-ancestor
20009781|NCT02340949|Protective Agents|protective agents|mesh-ancestor
20009782|NCT02340949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009783|NCT02340949|Vitamin B Complex|vitamin b complex|mesh-ancestor
20009784|NCT02340949|Vitamins|vitamins|mesh-ancestor
20009785|NCT02340949|Micronutrients|micronutrients|mesh-ancestor
20009786|NCT02340949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20009787|NCT02340949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20009788|NCT02340949|Growth Substances|growth substances|mesh-ancestor
20009789|NCT02340949|Growth Inhibitors|growth inhibitors|mesh-ancestor
20009790|NCT02340949|Antimetabolites|antimetabolites|mesh-ancestor
20009791|NCT02340949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009792|NCT02340949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20009793|NCT02340949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20009794|NCT02340949|Immunologic Factors|immunologic factors|mesh-ancestor
20009795|NCT02340962|Interferons|interferons|mesh-list
20009796|NCT02340962|Ribavirin|ribavirin|mesh-list
20009797|NCT02340962|Interferon-alpha|interferon-alpha|mesh-list
20009798|NCT02340962|Interferon alpha-2|interferon alpha-2|mesh-list
20009799|NCT02340962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009800|NCT02340962|Antiviral Agents|antiviral agents|mesh-ancestor
20009801|NCT02340962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20009802|NCT02340962|Antimetabolites|antimetabolites|mesh-ancestor
20009803|NCT02340962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009804|NCT02340962|Immunologic Factors|immunologic factors|mesh-ancestor
20009805|NCT02340962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009806|NCT02340975|Durvalumab|durvalumab|mesh-list
20009807|NCT02340975|Tremelimumab|tremelimumab|mesh-list
20009808|NCT02340975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20009809|NCT02340975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20009810|NCT02340975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009811|NCT02340975|Immunologic Factors|immunologic factors|mesh-ancestor
20009812|NCT02340975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009813|NCT02341144|Ropivacaine|ropivacaine|mesh-list
20009814|NCT02341144|Anesthetics, Local|anesthetics, local|mesh-ancestor
20009815|NCT02341144|Anesthetics|anesthetics|mesh-ancestor
20009816|NCT02341144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20009817|NCT02341144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009818|NCT02341144|Sensory System Agents|sensory system agents|mesh-ancestor
20009819|NCT02341144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20009820|NCT02341417|Cinacalcet|cinacalcet|mesh-list
20009821|NCT02341417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20009822|NCT02341417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009823|NCT02341417|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
20009824|NCT02341417|Hormone Antagonists|hormone antagonists|mesh-ancestor
20009825|NCT02341417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20009826|NCT02341456|Paclitaxel|paclitaxel|mesh-list
20009827|NCT02341456|Carboplatin|carboplatin|mesh-list
20009828|NCT02341456|Adavosertib|adavosertib|mesh-list
20009829|NCT02341456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20009830|NCT02341456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009831|NCT02341456|Tubulin Modulators|tubulin modulators|mesh-ancestor
20009832|NCT02341456|Antimitotic Agents|antimitotic agents|mesh-ancestor
20009833|NCT02341456|Mitosis Modulators|mitosis modulators|mesh-ancestor
20009834|NCT02341456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009835|NCT02341456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009836|NCT02341482|Itraconazole|itraconazole|mesh-list
20009837|NCT02341482|Antifungal Agents|antifungal agents|mesh-ancestor
20009838|NCT02341482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20009839|NCT02341482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20009840|NCT02341482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20009841|NCT02341482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009842|NCT02341482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009843|NCT02341482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20009844|NCT02341482|Hormone Antagonists|hormone antagonists|mesh-ancestor
20290381|NCT04029454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009845|NCT02341482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20009846|NCT02341482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009847|NCT02341482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20290382|NCT04025359|Dronabinol|dronabinol|mesh-list
20290383|NCT04025359|Hallucinogens|hallucinogens|mesh-ancestor
20290384|NCT04025359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290385|NCT04025359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20290386|NCT04025359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20290387|NCT04025359|Analgesics|analgesics|mesh-ancestor
20290388|NCT04025359|Sensory System Agents|sensory system agents|mesh-ancestor
20290389|NCT04025359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20290390|NCT04025359|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20290391|NCT04025359|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20290392|NCT04025359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20290393|NCT04025359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290394|NCT04025359|Hormones|hormones|mesh-ancestor
20290395|NCT04025359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20290396|NCT04020913|Hormones|hormones|mesh-list
20559043|NCT01964001|Vitamin B 6|vitamin b 6|mesh-list
20559044|NCT01964001|Pyridoxal|pyridoxal|mesh-list
20559045|NCT01964001|Pyridoxine|pyridoxine|mesh-list
20559046|NCT01964001|Vitamin B Complex|vitamin b complex|mesh-list
20559047|NCT01964001|Ubiquinone|ubiquinone|mesh-list
20559048|NCT01964001|Micronutrients|micronutrients|mesh-ancestor
20559049|NCT01964001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559050|NCT01964027|Irinotecan|irinotecan|mesh-list
20559051|NCT01964027|Epirubicin|epirubicin|mesh-list
20559052|NCT01964027|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20559053|NCT01964027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20559054|NCT01964027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559055|NCT01964027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559056|NCT01964027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559057|NCT01964027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20559058|NCT01964027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20559059|NCT01964040|Dexmedetomidine|dexmedetomidine|mesh-list
20559060|NCT01964040|Bupivacaine|bupivacaine|mesh-list
20559061|NCT01964040|Anesthetics, Local|anesthetics, local|mesh-ancestor
20559062|NCT01964040|Anesthetics|anesthetics|mesh-ancestor
20559063|NCT01964040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20559064|NCT01964040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559065|NCT01964040|Sensory System Agents|sensory system agents|mesh-ancestor
20559066|NCT01964040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559067|NCT01964040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20559068|NCT01964040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20559069|NCT01964040|Analgesics|analgesics|mesh-ancestor
20559070|NCT01964040|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20559071|NCT01964040|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20559072|NCT01964040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20559073|NCT01964040|Adrenergic Agents|adrenergic agents|mesh-ancestor
20009848|NCT02342015|Atorvastatin|atorvastatin|mesh-list
20009849|NCT02342015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20009850|NCT02342015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20009851|NCT02342015|Antimetabolites|antimetabolites|mesh-ancestor
20009852|NCT02342015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009853|NCT02342015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20009854|NCT02342015|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20009855|NCT02342015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009856|NCT02342197|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20009857|NCT02342197|Luteolytic Agents|luteolytic agents|mesh-ancestor
20009858|NCT02342197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20009859|NCT02342197|Contraceptive Agents|contraceptive agents|mesh-ancestor
20009860|NCT02342197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20009861|NCT02342197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009862|NCT02342197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20009863|NCT02342197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20009864|NCT02342197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009865|NCT02342223|Hyaluronic Acid|hyaluronic acid|mesh-list
20009866|NCT02342223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20009867|NCT02342223|Immunologic Factors|immunologic factors|mesh-ancestor
20009868|NCT02342223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009869|NCT02342223|Viscosupplements|viscosupplements|mesh-ancestor
20009870|NCT02342223|Protective Agents|protective agents|mesh-ancestor
20009871|NCT02342327|Menthol|menthol|mesh-list
20009872|NCT02342327|Antipruritics|antipruritics|mesh-ancestor
20009873|NCT02342327|Dermatologic Agents|dermatologic agents|mesh-ancestor
20009874|NCT02342379|Bevacizumab|bevacizumab|mesh-list
20009875|NCT02342379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20009876|NCT02342379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009877|NCT02342379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20009878|NCT02342379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20009879|NCT02342379|Growth Substances|growth substances|mesh-ancestor
20009880|NCT02342379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009881|NCT02342379|Growth Inhibitors|growth inhibitors|mesh-ancestor
20009882|NCT02342418|Tedizolid|tedizolid|mesh-list
20009883|NCT02342418|Tedizolid phosphate|tedizolid phosphate|mesh-list
20009884|NCT02342418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20009885|NCT02342418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20009886|NCT02342561|Anti-Infective Agents|anti-infective agents|mesh-list
20009887|NCT02342561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20009888|NCT02342639|Rifaximin|rifaximin|mesh-list
20009889|NCT02342639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20009890|NCT02342639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20009891|NCT02342639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20009892|NCT02342704|Natalizumab|natalizumab|mesh-list
20009893|NCT02342704|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20009894|NCT02342704|Immunologic Factors|immunologic factors|mesh-ancestor
20009895|NCT02342704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009896|NCT02342704|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20009897|NCT02342704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009898|NCT02342704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20009899|NCT02342886|Moxifloxacin|moxifloxacin|mesh-list
20009900|NCT02342886|Rifampin|rifampin|mesh-list
20009901|NCT02342886|Isoniazid|isoniazid|mesh-list
20009902|NCT02342886|Pyrazinamide|pyrazinamide|mesh-list
20009903|NCT02342886|Ethambutol|ethambutol|mesh-list
20009904|NCT02342886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20009905|NCT02342886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20009906|NCT02342886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20009907|NCT02342886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20009908|NCT02342886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009909|NCT02342886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009910|NCT02342886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009911|NCT02342886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20009912|NCT02342886|Antitubercular Agents|antitubercular agents|mesh-ancestor
20009913|NCT02342886|Leprostatic Agents|leprostatic agents|mesh-ancestor
20009914|NCT02342886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20009915|NCT02342886|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20009916|NCT02342886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20009917|NCT02342886|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20009918|NCT02342886|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20009919|NCT02342886|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20009920|NCT02342886|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20009921|NCT02342886|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20009922|NCT02342886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20009923|NCT02342886|Antimetabolites|antimetabolites|mesh-ancestor
20009924|NCT02342886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20009925|NCT02343081|Temozolomide|temozolomide|mesh-list
20009926|NCT02343081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20009927|NCT02343081|Alkylating Agents|alkylating agents|mesh-ancestor
20009928|NCT02343081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009929|NCT02343081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009930|NCT02343276|Nitroglycerin|nitroglycerin|mesh-list
20009931|NCT02343276|Vasodilator Agents|vasodilator agents|mesh-ancestor
20009932|NCT02343406|Temozolomide|temozolomide|mesh-list
20009933|NCT02343406|Lomustine|lomustine|mesh-list
20009934|NCT02343406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20009935|NCT02343406|Alkylating Agents|alkylating agents|mesh-ancestor
20009936|NCT02343406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009937|NCT02343406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009938|NCT02343458|Glycopyrrolate|glycopyrrolate|mesh-list
20009939|NCT02343458|Formoterol Fumarate|formoterol fumarate|mesh-list
20009940|NCT02343458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20009941|NCT02343458|Autonomic Agents|autonomic agents|mesh-ancestor
20009942|NCT02343458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20009943|NCT02343458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009944|NCT02343458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20009945|NCT02343458|Respiratory System Agents|respiratory system agents|mesh-ancestor
20009946|NCT02343458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20009947|NCT02343458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20009948|NCT02343458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20009949|NCT02343458|Adrenergic Agents|adrenergic agents|mesh-ancestor
20009950|NCT02343458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20009951|NCT02343458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009952|NCT02343458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20009953|NCT02343458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20009954|NCT02343458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20559074|NCT01964040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20559075|NCT01964040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559076|NCT01964079|Losartan|losartan|mesh-list
20559077|NCT01964079|Amlodipine|amlodipine|mesh-list
20559078|NCT01964079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20559079|NCT01964079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20559080|NCT01964079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20559081|NCT01964079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559082|NCT01964079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20559083|NCT01964079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559084|NCT01964079|Vasodilator Agents|vasodilator agents|mesh-ancestor
20559085|NCT01964079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20559086|NCT01964079|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20559087|NCT01964079|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20559088|NCT01964157|Ceritinib|ceritinib|mesh-list
20559089|NCT01964157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009955|NCT02343458|Cholinergic Agents|cholinergic agents|mesh-ancestor
20009956|NCT02343575|Valproic Acid|valproic acid|mesh-list
20009957|NCT02343575|Haloperidol|haloperidol|mesh-list
20009958|NCT02343575|Haloperidol decanoate|haloperidol decanoate|mesh-list
20009959|NCT02343575|Antiemetics|antiemetics|mesh-ancestor
20009960|NCT02343575|Autonomic Agents|autonomic agents|mesh-ancestor
20009961|NCT02343575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20009962|NCT02343575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009963|NCT02343575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20009964|NCT02343575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20009965|NCT02343575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20009966|NCT02343575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20009967|NCT02343575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20009968|NCT02343575|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20009969|NCT02343575|Dopamine Agents|dopamine agents|mesh-ancestor
20009970|NCT02343575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20009971|NCT02343575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009972|NCT02343575|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20009973|NCT02343575|Anticonvulsants|anticonvulsants|mesh-ancestor
20009974|NCT02343575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009975|NCT02343575|GABA Agents|gaba agents|mesh-ancestor
20009976|NCT02343575|Antimanic Agents|antimanic agents|mesh-ancestor
20009977|NCT02343939|Cytarabine|cytarabine|mesh-list
20009978|NCT02343939|Azacitidine|azacitidine|mesh-list
20009979|NCT02343939|Decitabine|decitabine|mesh-list
20009980|NCT02343939|Daunorubicin|daunorubicin|mesh-list
20009981|NCT02343939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20009982|NCT02343939|Antimetabolites|antimetabolites|mesh-ancestor
20009983|NCT02343939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20009984|NCT02343939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20009985|NCT02343939|Antiviral Agents|antiviral agents|mesh-ancestor
20009986|NCT02343939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20009987|NCT02343939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20009988|NCT02343939|Immunologic Factors|immunologic factors|mesh-ancestor
20009989|NCT02343939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20009990|NCT02343939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20009991|NCT02343939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20009992|NCT02343939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20009993|NCT02343939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20009994|NCT02344004|Amikacin|amikacin|mesh-list
20009995|NCT02344004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20009996|NCT02344004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20009997|NCT02344225|Ibuprofen|ibuprofen|mesh-list
20009998|NCT02344225|Ketorolac|ketorolac|mesh-list
20009999|NCT02344225|Caffeine|caffeine|mesh-list
20010000|NCT02344225|Caffeine citrate|caffeine citrate|mesh-list
20010001|NCT02344225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010002|NCT02344225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20010003|NCT02344225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20010004|NCT02344225|Analgesics|analgesics|mesh-ancestor
20010005|NCT02344225|Sensory System Agents|sensory system agents|mesh-ancestor
20010006|NCT02344225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010007|NCT02344225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010008|NCT02344225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20010009|NCT02344225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20010010|NCT02344225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20010011|NCT02344225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010012|NCT02344225|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20010013|NCT02344225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20010014|NCT02344225|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20010015|NCT02344225|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20010016|NCT02344225|Purinergic Agents|purinergic agents|mesh-ancestor
20010017|NCT02344225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010018|NCT02344238|Riboflavin|riboflavin|mesh-list
20010019|NCT02344238|Vitamin B Complex|vitamin b complex|mesh-ancestor
20010020|NCT02344238|Vitamins|vitamins|mesh-ancestor
20010021|NCT02344238|Micronutrients|micronutrients|mesh-ancestor
20010022|NCT02344238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010023|NCT02344238|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20010024|NCT02344238|Dermatologic Agents|dermatologic agents|mesh-ancestor
20010025|NCT02344316|Melatonin|melatonin|mesh-list
20010026|NCT02344316|Antioxidants|antioxidants|mesh-ancestor
20010027|NCT02344316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010028|NCT02344316|Protective Agents|protective agents|mesh-ancestor
20010029|NCT02344316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010030|NCT02344316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20010031|NCT02344342|Diuretics|diuretics|mesh-list
20010032|NCT02344342|Natriuretic Agents|natriuretic agents|mesh-ancestor
20010033|NCT02344342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010034|NCT02344628|Azithromycin|azithromycin|mesh-list
20010035|NCT02344628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20010036|NCT02344628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20010037|NCT02345161|Budesonide|budesonide|mesh-list
20010038|NCT02345161|Albuterol|albuterol|mesh-list
20010039|NCT02345161|Formoterol Fumarate|formoterol fumarate|mesh-list
20010040|NCT02345161|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20010041|NCT02345161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20010042|NCT02345161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20010043|NCT02345161|Autonomic Agents|autonomic agents|mesh-ancestor
20010044|NCT02345161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010045|NCT02345161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010046|NCT02345161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20010047|NCT02345161|Respiratory System Agents|respiratory system agents|mesh-ancestor
20010048|NCT02345161|Glucocorticoids|glucocorticoids|mesh-ancestor
20010049|NCT02345161|Hormones|hormones|mesh-ancestor
20010050|NCT02345161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20010051|NCT02345161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20010052|NCT02345161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20010053|NCT02345161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20010054|NCT02345161|Adrenergic Agents|adrenergic agents|mesh-ancestor
20010055|NCT02345161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010056|NCT02345161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010057|NCT02345161|Tocolytic Agents|tocolytic agents|mesh-ancestor
20010058|NCT02345161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20010059|NCT02345226|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20010060|NCT02345226|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20010061|NCT02345226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20010062|NCT02345226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20010063|NCT02345226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010064|NCT02345226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010065|NCT02345226|Antiviral Agents|antiviral agents|mesh-ancestor
20010066|NCT02345226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20010067|NCT02345226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20010068|NCT02345226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20010069|NCT02345252|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
20010070|NCT02345252|Antiviral Agents|antiviral agents|mesh-ancestor
20010071|NCT02345252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20010072|NCT02345252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20010073|NCT02345252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20010074|NCT02345252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010075|NCT02345252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010076|NCT02345252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20010077|NCT02345252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20010078|NCT02345330|Interleukin-12|interleukin-12|mesh-list
20010079|NCT02345330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20010080|NCT02345330|Immunologic Factors|immunologic factors|mesh-ancestor
20010081|NCT02345330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010082|NCT02345330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20010083|NCT02345330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20010084|NCT02345330|Growth Substances|growth substances|mesh-ancestor
20010085|NCT02345330|Growth Inhibitors|growth inhibitors|mesh-ancestor
20010086|NCT02345330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010087|NCT02345486|Plasma-lyte 148|plasma-lyte 148|mesh-list
20010088|NCT02345486|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20010089|NCT02345486|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20010090|NCT02346240|Etanercept|etanercept|mesh-list
20010091|NCT02346240|Certolizumab Pegol|certolizumab pegol|mesh-list
20010092|NCT02346240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20010093|NCT02346240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20010094|NCT02346240|Analgesics|analgesics|mesh-ancestor
20010095|NCT02346240|Sensory System Agents|sensory system agents|mesh-ancestor
20010096|NCT02346240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010097|NCT02346240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010098|NCT02346240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20010099|NCT02346240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20010100|NCT02346240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20010101|NCT02346240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20010102|NCT02346240|Immunologic Factors|immunologic factors|mesh-ancestor
20010103|NCT02346370|Docetaxel|docetaxel|mesh-list
20010104|NCT02346370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010105|NCT02346370|Tubulin Modulators|tubulin modulators|mesh-ancestor
20010106|NCT02346370|Antimitotic Agents|antimitotic agents|mesh-ancestor
20010107|NCT02346370|Mitosis Modulators|mitosis modulators|mesh-ancestor
20010108|NCT02346370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010109|NCT02346721|Sofosbuvir|sofosbuvir|mesh-list
20010110|NCT02346721|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20010111|NCT02346721|Velpatasvir|velpatasvir|mesh-list
20010112|NCT02346721|Antiviral Agents|antiviral agents|mesh-ancestor
20010113|NCT02346721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20010114|NCT02346903|Capsaicin|capsaicin|mesh-list
20010115|NCT02346903|Antipruritics|antipruritics|mesh-ancestor
20010116|NCT02346903|Dermatologic Agents|dermatologic agents|mesh-ancestor
20010117|NCT02346903|Sensory System Agents|sensory system agents|mesh-ancestor
20010118|NCT02346903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010119|NCT02346903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010120|NCT02346916|Capsaicin|capsaicin|mesh-list
20010121|NCT02346916|Antipruritics|antipruritics|mesh-ancestor
20010122|NCT02346916|Dermatologic Agents|dermatologic agents|mesh-ancestor
20010123|NCT02346916|Sensory System Agents|sensory system agents|mesh-ancestor
20010124|NCT02346916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010125|NCT02346916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010126|NCT02347072|Glycopyrrolate|glycopyrrolate|mesh-list
20010127|NCT02347072|Bromides|bromides|mesh-list
20010128|NCT02347072|Formoterol Fumarate|formoterol fumarate|mesh-list
20010129|NCT02347072|Tiotropium Bromide|tiotropium bromide|mesh-list
20010130|NCT02347072|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20010131|NCT02347072|Autonomic Agents|autonomic agents|mesh-ancestor
20010132|NCT02347072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010133|NCT02347072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010134|NCT02347072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20010135|NCT02347072|Respiratory System Agents|respiratory system agents|mesh-ancestor
19460184|NCT03355352|Sufentanil|sufentanil|mesh-list
19460185|NCT03355352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19460186|NCT03355352|Narcotics|narcotics|mesh-ancestor
20559090|NCT01964157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20559091|NCT01964157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559092|NCT01964157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559093|NCT01964170|Goserelin|goserelin|mesh-list
20559094|NCT01964170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20559095|NCT01964170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010136|NCT02347072|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20010137|NCT02347072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20559096|NCT01964183|Mirabegron|mirabegron|mesh-list
20559097|NCT01964183|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20559098|NCT01964183|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20559099|NCT01964183|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20559100|NCT01964183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20010138|NCT02347072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20010139|NCT02347072|Adrenergic Agents|adrenergic agents|mesh-ancestor
20010140|NCT02347072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010141|NCT02347072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010142|NCT02347072|Parasympatholytics|parasympatholytics|mesh-ancestor
20010143|NCT02347072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20010144|NCT02347072|Cholinergic Agents|cholinergic agents|mesh-ancestor
20010145|NCT02347072|Anticonvulsants|anticonvulsants|mesh-ancestor
20010146|NCT02347072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20010147|NCT02347072|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20010148|NCT02347085|Glycopyrrolate|glycopyrrolate|mesh-list
20010149|NCT02347085|Formoterol Fumarate|formoterol fumarate|mesh-list
20010150|NCT02347085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20010151|NCT02347085|Autonomic Agents|autonomic agents|mesh-ancestor
20010152|NCT02347085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010153|NCT02347085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010154|NCT02347085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20010155|NCT02347085|Respiratory System Agents|respiratory system agents|mesh-ancestor
20010156|NCT02347085|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20010157|NCT02347085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20010158|NCT02347085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20010159|NCT02347085|Adrenergic Agents|adrenergic agents|mesh-ancestor
20010160|NCT02347085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010161|NCT02347085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010162|NCT02347085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20010163|NCT02347085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20010164|NCT02347085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20010165|NCT02347085|Cholinergic Agents|cholinergic agents|mesh-ancestor
20010166|NCT02347098|Atorvastatin|atorvastatin|mesh-list
20010167|NCT02347098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
20010168|NCT02347098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20010169|NCT02347098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20010170|NCT02347098|Antimetabolites|antimetabolites|mesh-ancestor
20010171|NCT02347098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010172|NCT02347098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20010173|NCT02347098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010174|NCT02347176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20010175|NCT02347176|Immunologic Factors|immunologic factors|mesh-ancestor
20010176|NCT02347176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010177|NCT02347332|Methotrexate|methotrexate|mesh-list
20010178|NCT02347332|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20010179|NCT02347332|Abortifacient Agents|abortifacient agents|mesh-ancestor
20010180|NCT02347332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20010181|NCT02347332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010182|NCT02347332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20010183|NCT02347332|Antimetabolites|antimetabolites|mesh-ancestor
20010184|NCT02347332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010185|NCT02347332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010186|NCT02347332|Dermatologic Agents|dermatologic agents|mesh-ancestor
20010187|NCT02347332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010188|NCT02347332|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20010189|NCT02347332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20010190|NCT02347332|Immunologic Factors|immunologic factors|mesh-ancestor
20010191|NCT02347332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20010192|NCT02347332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20010193|NCT02347345|Sofosbuvir|sofosbuvir|mesh-list
20010194|NCT02347345|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
20010195|NCT02347345|Ledipasvir|ledipasvir|mesh-list
20010196|NCT02347345|Antiviral Agents|antiviral agents|mesh-ancestor
20010197|NCT02347345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20010198|NCT02347605|Nicotine|nicotine|mesh-list
20010199|NCT02347605|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20010200|NCT02347605|Autonomic Agents|autonomic agents|mesh-ancestor
20010201|NCT02347605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010202|NCT02347605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010203|NCT02347605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20010204|NCT02347605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20010205|NCT02347605|Cholinergic Agents|cholinergic agents|mesh-ancestor
20010206|NCT02347605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010207|NCT02347605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010208|NCT02347631|Dipivefrin|dipivefrin|mesh-list
20010209|NCT02347631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20010210|NCT02347631|Adrenergic Agents|adrenergic agents|mesh-ancestor
20010211|NCT02347631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20559101|NCT01964183|Adrenergic Agents|adrenergic agents|mesh-ancestor
20010212|NCT02347631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010213|NCT02347631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010214|NCT02347657|Ivacaftor|ivacaftor|mesh-list
20010215|NCT02347657|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20010216|NCT02347657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20559102|NCT01964183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20559103|NCT01964183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559104|NCT01964183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559105|NCT01964183|Urological Agents|urological agents|mesh-ancestor
20559106|NCT01964183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20559107|NCT01964183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20559108|NCT01964183|Cholinergic Agents|cholinergic agents|mesh-ancestor
20559109|NCT01964248|Lidocaine|lidocaine|mesh-list
20559110|NCT01964248|Prilocaine|prilocaine|mesh-list
20559111|NCT01964248|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20559112|NCT01964248|Anesthetics, Local|anesthetics, local|mesh-ancestor
20559113|NCT01964248|Anesthetics|anesthetics|mesh-ancestor
20559114|NCT01964248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20559115|NCT01964248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559116|NCT01964248|Sensory System Agents|sensory system agents|mesh-ancestor
20559117|NCT01964248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559118|NCT01964248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20559119|NCT01964248|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20559120|NCT01964248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20559121|NCT01964248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20559122|NCT01964248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559123|NCT01964248|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20559124|NCT01964287|Leucovorin|leucovorin|mesh-list
20559125|NCT01964287|Gemcitabine|gemcitabine|mesh-list
20559126|NCT01964287|Paclitaxel|paclitaxel|mesh-list
20559127|NCT01964287|Oxaliplatin|oxaliplatin|mesh-list
20559128|NCT01964287|Irinotecan|irinotecan|mesh-list
20559129|NCT01964287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20559130|NCT01964287|Folfirinox|folfirinox|mesh-list
20559131|NCT01964287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20559132|NCT01964287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559133|NCT01964287|Tubulin Modulators|tubulin modulators|mesh-ancestor
20559134|NCT01964287|Antimitotic Agents|antimitotic agents|mesh-ancestor
20559135|NCT01964287|Mitosis Modulators|mitosis modulators|mesh-ancestor
20559136|NCT01964287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559137|NCT01964287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20559138|NCT01964287|Antimetabolites|antimetabolites|mesh-ancestor
20559139|NCT01964287|Antiviral Agents|antiviral agents|mesh-ancestor
20559140|NCT01964287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20559141|NCT01964287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559142|NCT01964287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20559143|NCT01964287|Immunologic Factors|immunologic factors|mesh-ancestor
20559144|NCT01964287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559145|NCT01964287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20559146|NCT01964287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20559147|NCT01964287|Antidotes|antidotes|mesh-ancestor
20559148|NCT01964287|Protective Agents|protective agents|mesh-ancestor
20559149|NCT01964287|Vitamin B Complex|vitamin b complex|mesh-ancestor
20559150|NCT01964287|Vitamins|vitamins|mesh-ancestor
20559151|NCT01964287|Micronutrients|micronutrients|mesh-ancestor
20559152|NCT01964365|Fenofibric acid|fenofibric acid|mesh-list
20559153|NCT01964365|Fenofibrate|fenofibrate|mesh-list
20559154|NCT01964365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20559155|NCT01964365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20559156|NCT01964365|Antimetabolites|antimetabolites|mesh-ancestor
20559157|NCT01964365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559158|NCT01964365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20559159|NCT01964391|Paclitaxel|paclitaxel|mesh-list
20559160|NCT01964391|Docetaxel|docetaxel|mesh-list
20559161|NCT01964391|Cyclophosphamide|cyclophosphamide|mesh-list
20559162|NCT01964391|Carboplatin|carboplatin|mesh-list
20559163|NCT01964391|Doxorubicin|doxorubicin|mesh-list
20559164|NCT01964391|Trastuzumab|trastuzumab|mesh-list
20559165|NCT01964391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20559166|NCT01964391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559167|NCT01964391|Tubulin Modulators|tubulin modulators|mesh-ancestor
20559168|NCT01964391|Antimitotic Agents|antimitotic agents|mesh-ancestor
20559169|NCT01964391|Mitosis Modulators|mitosis modulators|mesh-ancestor
20559170|NCT01964391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559171|NCT01964391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20559172|NCT01964391|Immunologic Factors|immunologic factors|mesh-ancestor
20010217|NCT02347657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010218|NCT02347813|Pioglitazone|pioglitazone|mesh-list
20010219|NCT02347813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20010220|NCT02347813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010221|NCT02348008|Bevacizumab|bevacizumab|mesh-list
20010222|NCT02348008|Pembrolizumab|pembrolizumab|mesh-list
20010223|NCT02348008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20010224|NCT02348008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010225|NCT02348008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20010226|NCT02348008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20010227|NCT02348008|Growth Substances|growth substances|mesh-ancestor
20010228|NCT02348008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010229|NCT02348008|Growth Inhibitors|growth inhibitors|mesh-ancestor
20010230|NCT02348203|Aspirin|aspirin|mesh-list
20010231|NCT02348203|Zileuton|zileuton|mesh-list
20010232|NCT02348203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20010233|NCT02348203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20010234|NCT02348203|Analgesics|analgesics|mesh-ancestor
20010235|NCT02348203|Sensory System Agents|sensory system agents|mesh-ancestor
20010236|NCT02348203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010237|NCT02348203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010238|NCT02348203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20010239|NCT02348203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20010240|NCT02348203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20010241|NCT02348203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20010242|NCT02348203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010243|NCT02348203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20010244|NCT02348203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20010245|NCT02348203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010246|NCT02348203|Antipyretics|antipyretics|mesh-ancestor
20010247|NCT02348203|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20010248|NCT02348203|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20010249|NCT02348203|Hormone Antagonists|hormone antagonists|mesh-ancestor
20010250|NCT02348203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20010251|NCT02348385|Amphetamine|amphetamine|mesh-list
20010252|NCT02348385|Dextroamphetamine|dextroamphetamine|mesh-list
20010253|NCT02348385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20010254|NCT02348385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010255|NCT02348385|Sympathomimetics|sympathomimetics|mesh-ancestor
20559173|NCT01964391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559174|NCT01964391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20559175|NCT01964391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20559176|NCT01964391|Alkylating Agents|alkylating agents|mesh-ancestor
20559177|NCT01964391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20559178|NCT01964391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20559179|NCT01964391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20559180|NCT01964391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20559181|NCT01964391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010256|NCT02348385|Autonomic Agents|autonomic agents|mesh-ancestor
20010257|NCT02348385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010258|NCT02348385|Dopamine Agents|dopamine agents|mesh-ancestor
20010259|NCT02348385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010260|NCT02348385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010261|NCT02348385|Adrenergic Agents|adrenergic agents|mesh-ancestor
20010262|NCT02348385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20010263|NCT02348385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20010264|NCT02348385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20010265|NCT02348385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20010266|NCT02348489|Guadecitabine|guadecitabine|mesh-list
20010267|NCT02348489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010268|NCT02348658|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20010269|NCT02348658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20010270|NCT02348658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20010271|NCT02348658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010272|NCT02348723|Warfarin|warfarin|mesh-list
20010273|NCT02348723|Dabigatran|dabigatran|mesh-list
20010274|NCT02348723|Anticoagulants|anticoagulants|mesh-ancestor
20010275|NCT02348723|Antithrombins|antithrombins|mesh-ancestor
20010276|NCT02348723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20010277|NCT02348723|Protease Inhibitors|protease inhibitors|mesh-ancestor
20010278|NCT02348723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010279|NCT02348723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010280|NCT02348775|Acetylcysteine|acetylcysteine|mesh-list
20010281|NCT02348775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20010282|NCT02348775|Glycine|glycine|mesh-list
20010283|NCT02348775|Antiviral Agents|antiviral agents|mesh-ancestor
20010284|NCT02348775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20010285|NCT02348775|Expectorants|expectorants|mesh-ancestor
20010286|NCT02348775|Respiratory System Agents|respiratory system agents|mesh-ancestor
20010287|NCT02348775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20010288|NCT02348775|Antioxidants|antioxidants|mesh-ancestor
20010289|NCT02348775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010290|NCT02348775|Protective Agents|protective agents|mesh-ancestor
20010291|NCT02348775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010292|NCT02348775|Antidotes|antidotes|mesh-ancestor
20010293|NCT02348775|Glycine Agents|glycine agents|mesh-ancestor
20010294|NCT02348775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010295|NCT02348918|Bevacizumab|bevacizumab|mesh-list
20010296|NCT02348918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20010297|NCT02348918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010298|NCT02348918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20010299|NCT02348918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20010300|NCT02348918|Growth Substances|growth substances|mesh-ancestor
20010301|NCT02348918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010302|NCT02348918|Growth Inhibitors|growth inhibitors|mesh-ancestor
20010303|NCT02349048|Sofosbuvir|sofosbuvir|mesh-list
20010304|NCT02349048|Simeprevir|simeprevir|mesh-list
20010305|NCT02349048|Antiviral Agents|antiviral agents|mesh-ancestor
20010306|NCT02349048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20010307|NCT02349048|Protease Inhibitors|protease inhibitors|mesh-ancestor
20010308|NCT02349048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010309|NCT02349048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010310|NCT02349061|Ustekinumab|ustekinumab|mesh-list
20010311|NCT02349061|Dermatologic Agents|dermatologic agents|mesh-ancestor
20010312|NCT02349152|Fentanyl|fentanyl|mesh-list
20010313|NCT02349152|Remifentanil|remifentanil|mesh-list
20010314|NCT02349152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20010315|NCT02349152|Narcotics|narcotics|mesh-ancestor
20010316|NCT02349152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20010317|NCT02349152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010318|NCT02349152|Analgesics|analgesics|mesh-ancestor
20010319|NCT02349152|Sensory System Agents|sensory system agents|mesh-ancestor
20010320|NCT02349152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010321|NCT02349152|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20010322|NCT02349152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20010323|NCT02349152|Anesthetics, General|anesthetics, general|mesh-ancestor
20010324|NCT02349152|Anesthetics|anesthetics|mesh-ancestor
20010325|NCT02349178|Cyclophosphamide|cyclophosphamide|mesh-list
20010326|NCT02349178|Etoposide|etoposide|mesh-list
20010327|NCT02349178|Clofarabine|clofarabine|mesh-list
20010328|NCT02349178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20010329|NCT02349178|Immunologic Factors|immunologic factors|mesh-ancestor
20010330|NCT02349178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010331|NCT02349178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20010332|NCT02349178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20010333|NCT02349178|Alkylating Agents|alkylating agents|mesh-ancestor
20010334|NCT02349178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010335|NCT02349178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010336|NCT02349178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20010337|NCT02349178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20010338|NCT02349178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20010339|NCT02349178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20010340|NCT02349178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010341|NCT02349178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20010342|NCT02349178|Antimetabolites|antimetabolites|mesh-ancestor
20010343|NCT02349295|Ixekizumab|ixekizumab|mesh-list
20010344|NCT02349295|Dermatologic Agents|dermatologic agents|mesh-ancestor
20290397|NCT04020913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20290398|NCT04020913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290399|NCT04017247|Oxytocin|oxytocin|mesh-list
20290400|NCT04017247|Oxytocics|oxytocics|mesh-ancestor
20290401|NCT04017247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20290402|NCT04017247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290403|NCT04004819|Rituximab|rituximab|mesh-list
20290404|NCT04004819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20290405|NCT04004819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290406|NCT04004819|Immunologic Factors|immunologic factors|mesh-ancestor
20290407|NCT04004819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290408|NCT04004819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20290409|NCT04004078|Antifungal Agents|antifungal agents|mesh-list
20290410|NCT04004078|Clotrimazole|clotrimazole|mesh-list
20290411|NCT04004078|Miconazole|miconazole|mesh-list
20290412|NCT04004078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20290413|NCT04004078|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20290414|NCT04004078|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20290415|NCT04004078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20290416|NCT04004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290417|NCT04004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290418|NCT04004078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20290419|NCT04004078|Hormone Antagonists|hormone antagonists|mesh-ancestor
20290420|NCT04004078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20290421|NCT04004078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290422|NCT04004078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20290423|NCT04004078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20290424|NCT04001621|Capecitabine|capecitabine|mesh-list
20290425|NCT04001621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20290426|NCT04001621|Antimetabolites|antimetabolites|mesh-ancestor
20290427|NCT04001621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290428|NCT04001621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290429|NCT03994796|Entrectinib|entrectinib|mesh-list
20290430|NCT03994796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20290431|NCT03994796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290432|NCT03994796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290433|NCT03974594|Trifluridine|trifluridine|mesh-list
20290434|NCT03974594|Antimetabolites|antimetabolites|mesh-ancestor
20290435|NCT03974594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290436|NCT03974594|Antiviral Agents|antiviral agents|mesh-ancestor
20290437|NCT03974594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20290438|NCT03964688|Ascorbic Acid|ascorbic acid|mesh-list
20290439|NCT03964688|Vitamins|vitamins|mesh-ancestor
20290440|NCT03964688|Micronutrients|micronutrients|mesh-ancestor
20290441|NCT03964688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290442|NCT03964688|Antioxidants|antioxidants|mesh-ancestor
20290443|NCT03964688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290444|NCT03964688|Protective Agents|protective agents|mesh-ancestor
20290445|NCT03961165|Scopolamine|scopolamine|mesh-list
20290446|NCT03961165|Bromides|bromides|mesh-list
20290447|NCT03961165|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
20290448|NCT03961165|Anticonvulsants|anticonvulsants|mesh-ancestor
20290449|NCT03961165|Parasympatholytics|parasympatholytics|mesh-ancestor
20290450|NCT03961165|Autonomic Agents|autonomic agents|mesh-ancestor
20290451|NCT03961165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20290452|NCT03961165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290453|NCT03961165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20290454|NCT03961165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20290455|NCT03961165|Cholinergic Agents|cholinergic agents|mesh-ancestor
20290456|NCT03961165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20290457|NCT03961165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010345|NCT02349451|Adalimumab|adalimumab|mesh-list
20010346|NCT02349451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20010347|NCT02349451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20010348|NCT02349477|Gabapentin|gabapentin|mesh-list
20010349|NCT02349477|Analgesics|analgesics|mesh-ancestor
20010350|NCT02349477|Sensory System Agents|sensory system agents|mesh-ancestor
20010351|NCT02349477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010352|NCT02349477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010353|NCT02349477|Anticonvulsants|anticonvulsants|mesh-ancestor
20010354|NCT02349477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20010355|NCT02349477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20010356|NCT02349477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20010357|NCT02349477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20010358|NCT02349477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20010359|NCT02349477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20010360|NCT02349477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010361|NCT02349477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010362|NCT02349477|Antimanic Agents|antimanic agents|mesh-ancestor
20010363|NCT02349542|Bupivacaine|bupivacaine|mesh-list
20010364|NCT02349542|Anesthetics, Local|anesthetics, local|mesh-ancestor
20010365|NCT02349542|Anesthetics|anesthetics|mesh-ancestor
20010366|NCT02349542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20010367|NCT02349542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010368|NCT02349542|Sensory System Agents|sensory system agents|mesh-ancestor
20010369|NCT02349542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010370|NCT02349633|Palbociclib|palbociclib|mesh-list
20010371|NCT02349633|Avelumab|avelumab|mesh-list
20010372|NCT02349633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010373|NCT02349633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20010374|NCT02349633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010375|NCT02349633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010376|NCT02349633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20010377|NCT02349685|Anti-Infective Agents|anti-infective agents|mesh-list
20010378|NCT02349685|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20010379|NCT02350309|Lemborexant|lemborexant|mesh-list
20010380|NCT02350309|Flurazepam|flurazepam|mesh-list
20010381|NCT02350309|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20010382|NCT02350309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010383|NCT02350309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010384|NCT02350309|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20010385|NCT02350309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20010386|NCT02350309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20010387|NCT02350309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010388|NCT02350309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20010389|NCT02350309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20559182|NCT01964391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20559183|NCT01964404|Dronabinol|dronabinol|mesh-list
20559184|NCT01964404|Hallucinogens|hallucinogens|mesh-ancestor
20559185|NCT01964404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559186|NCT01964404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20559187|NCT01964404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20559188|NCT01964404|Analgesics|analgesics|mesh-ancestor
20559189|NCT01964404|Sensory System Agents|sensory system agents|mesh-ancestor
20559190|NCT01964404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559191|NCT01964404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20559192|NCT01964404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20559193|NCT01964404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20559194|NCT01964404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559195|NCT01964404|Hormones|hormones|mesh-ancestor
20559196|NCT01964404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20559197|NCT01964534|Gemcitabine|gemcitabine|mesh-list
20559198|NCT01964534|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20559199|NCT01964534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20559200|NCT01964534|Antimetabolites|antimetabolites|mesh-ancestor
20559201|NCT01964534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559202|NCT01964534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559203|NCT01964534|Antiviral Agents|antiviral agents|mesh-ancestor
20559204|NCT01964534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20559205|NCT01964534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010390|NCT02350309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20010391|NCT02350309|GABA Modulators|gaba modulators|mesh-ancestor
20010392|NCT02350309|GABA Agents|gaba agents|mesh-ancestor
20010393|NCT02350478|Linagliptin|linagliptin|mesh-list
20010394|NCT02350478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20010395|NCT02350478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010396|NCT02350478|Incretins|incretins|mesh-ancestor
20010397|NCT02350478|Hormones|hormones|mesh-ancestor
20010398|NCT02350478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20010399|NCT02350478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20010400|NCT02350478|Protease Inhibitors|protease inhibitors|mesh-ancestor
20010401|NCT02350478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010402|NCT02350478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010403|NCT02350569|Sofosbuvir|sofosbuvir|mesh-list
20010404|NCT02350569|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
20010405|NCT02350569|Ledipasvir|ledipasvir|mesh-list
20010406|NCT02350569|Antiviral Agents|antiviral agents|mesh-ancestor
20010407|NCT02350569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20010408|NCT02351037|Azacitidine|azacitidine|mesh-list
20010409|NCT02351037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20010410|NCT02351037|Antimetabolites|antimetabolites|mesh-ancestor
20010411|NCT02351037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010412|NCT02351037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010413|NCT02351037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010414|NCT02351115|Alprazolam|alprazolam|mesh-list
20010415|NCT02351115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20010416|NCT02351115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20010417|NCT02351115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010418|NCT02351115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20010419|NCT02351115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20010420|NCT02351115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20010421|NCT02351115|GABA Modulators|gaba modulators|mesh-ancestor
20010422|NCT02351115|GABA Agents|gaba agents|mesh-ancestor
20010423|NCT02351115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010424|NCT02351115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010425|NCT02351167|Nicotine|nicotine|mesh-list
20010426|NCT02351167|Varenicline|varenicline|mesh-list
20010427|NCT02351167|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20010428|NCT02351167|Autonomic Agents|autonomic agents|mesh-ancestor
20010429|NCT02351167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010430|NCT02351167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010431|NCT02351167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20010432|NCT02351167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20010433|NCT02351167|Cholinergic Agents|cholinergic agents|mesh-ancestor
20010434|NCT02351167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010435|NCT02351167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010436|NCT02351700|Ibuprofen|ibuprofen|mesh-list
20010437|NCT02351700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20010438|NCT02351700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20010439|NCT02351700|Analgesics|analgesics|mesh-ancestor
20010440|NCT02351700|Sensory System Agents|sensory system agents|mesh-ancestor
20010441|NCT02351700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010442|NCT02351700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010443|NCT02351700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20010444|NCT02351700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20010445|NCT02351700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20010446|NCT02351700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010447|NCT02351700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010448|NCT02351739|Pembrolizumab|pembrolizumab|mesh-list
20010449|NCT02351739|Acalabrutinib|acalabrutinib|mesh-list
20010450|NCT02351739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20010451|NCT02351739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010452|NCT02351934|Celecoxib|celecoxib|mesh-list
20010453|NCT02351934|Furosemide|furosemide|mesh-list
20010454|NCT02351934|Gabapentin|gabapentin|mesh-list
20010455|NCT02351934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20010456|NCT02351934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20010457|NCT02351934|Analgesics|analgesics|mesh-ancestor
20010458|NCT02351934|Sensory System Agents|sensory system agents|mesh-ancestor
20010459|NCT02351934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010460|NCT02351934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010461|NCT02351934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20010462|NCT02351934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20010463|NCT02351934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20010464|NCT02351934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20010465|NCT02351934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010466|NCT02351934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010467|NCT02351934|Anticonvulsants|anticonvulsants|mesh-ancestor
20010468|NCT02351934|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20010469|NCT02351934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20010470|NCT02351934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20010471|NCT02351934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20010472|NCT02351934|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20010473|NCT02351934|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20010474|NCT02351934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010475|NCT02351934|Antimanic Agents|antimanic agents|mesh-ancestor
20010476|NCT02351934|Diuretics|diuretics|mesh-ancestor
20010477|NCT02351934|Natriuretic Agents|natriuretic agents|mesh-ancestor
20010478|NCT02351934|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20010479|NCT02351934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20010480|NCT02351960|Dexlansoprazole|dexlansoprazole|mesh-list
20010481|NCT02351960|Lansoprazole|lansoprazole|mesh-list
20010482|NCT02351960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20010483|NCT02351960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20010484|NCT02351960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20010485|NCT02351960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010486|NCT02351960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010487|NCT02352259|Bleomycin|bleomycin|mesh-list
20010488|NCT02352259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20010489|NCT02352259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010490|NCT02352363|Levodopa|levodopa|mesh-list
20010491|NCT02352363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20010492|NCT02352363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20010493|NCT02352363|Dopamine Agents|dopamine agents|mesh-ancestor
20010494|NCT02352363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010495|NCT02352363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010496|NCT02352363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010497|NCT02352831|Capecitabine|capecitabine|mesh-list
20010498|NCT02352831|Tosedostat|tosedostat|mesh-list
20010499|NCT02352831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20010500|NCT02352831|Antimetabolites|antimetabolites|mesh-ancestor
20010501|NCT02352831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010502|NCT02352831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010503|NCT02352831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010504|NCT02352844|Everolimus|everolimus|mesh-list
20010505|NCT02352844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010506|NCT02352844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20010507|NCT02352844|Immunologic Factors|immunologic factors|mesh-ancestor
20010508|NCT02352844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010509|NCT02352922|Bupivacaine|bupivacaine|mesh-list
20010510|NCT02352922|Anesthetics, Local|anesthetics, local|mesh-ancestor
20010511|NCT02352922|Anesthetics|anesthetics|mesh-ancestor
20010512|NCT02352922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20010513|NCT02352922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010514|NCT02352922|Sensory System Agents|sensory system agents|mesh-ancestor
20010515|NCT02352922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010516|NCT02352974|Vitamin D|vitamin d|mesh-list
20010517|NCT02352974|Vitamins|vitamins|mesh-ancestor
20010518|NCT02352974|Micronutrients|micronutrients|mesh-ancestor
20010519|NCT02352974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010520|NCT02352974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20010521|NCT02353169|Dexmedetomidine|dexmedetomidine|mesh-list
20010522|NCT02353169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20010523|NCT02353169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20010524|NCT02353169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010525|NCT02353169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20010526|NCT02353169|Analgesics|analgesics|mesh-ancestor
20010527|NCT02353169|Sensory System Agents|sensory system agents|mesh-ancestor
20010528|NCT02353169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010529|NCT02353169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20010530|NCT02353169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20010531|NCT02353169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20010532|NCT02353169|Adrenergic Agents|adrenergic agents|mesh-ancestor
20010533|NCT02353169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010534|NCT02353169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010535|NCT02353299|Zolpidem|zolpidem|mesh-list
20010536|NCT02353299|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20010537|NCT02353299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20010538|NCT02353299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20010539|NCT02353299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010540|NCT02353299|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20010541|NCT02353299|GABA Agonists|gaba agonists|mesh-ancestor
20010542|NCT02353299|GABA Agents|gaba agents|mesh-ancestor
20010543|NCT02353299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010544|NCT02353299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010545|NCT02353754|Morphine|morphine|mesh-list
20010546|NCT02353754|Bupivacaine|bupivacaine|mesh-list
20010547|NCT02353754|Anesthetics, Local|anesthetics, local|mesh-ancestor
20010548|NCT02353754|Anesthetics|anesthetics|mesh-ancestor
20010549|NCT02353754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20010550|NCT02353754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010551|NCT02353754|Sensory System Agents|sensory system agents|mesh-ancestor
20010552|NCT02353754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010553|NCT02353754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20010554|NCT02353754|Narcotics|narcotics|mesh-ancestor
20010555|NCT02353754|Analgesics|analgesics|mesh-ancestor
20010556|NCT02353780|Etanercept|etanercept|mesh-list
20010557|NCT02353780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
20010558|NCT02353780|Abatacept|abatacept|mesh-list
20010559|NCT02353780|Infliximab|infliximab|mesh-list
20010560|NCT02353780|Certolizumab Pegol|certolizumab pegol|mesh-list
20010561|NCT02353780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20010562|NCT02353780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20010563|NCT02353780|Analgesics|analgesics|mesh-ancestor
20010564|NCT02353780|Sensory System Agents|sensory system agents|mesh-ancestor
20010565|NCT02353780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010566|NCT02353780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010567|NCT02353780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20010568|NCT02353780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20010569|NCT02353780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20010570|NCT02353780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20010571|NCT02353780|Immunologic Factors|immunologic factors|mesh-ancestor
20010572|NCT02353780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20010573|NCT02353780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010574|NCT02353780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010575|NCT02353780|Dermatologic Agents|dermatologic agents|mesh-ancestor
20010576|NCT02353806|Amlodipine|amlodipine|mesh-list
20010577|NCT02353806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20010578|NCT02353806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20010579|NCT02353806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20010580|NCT02353806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010581|NCT02353806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20010582|NCT02353806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010583|NCT02353806|Vasodilator Agents|vasodilator agents|mesh-ancestor
20010584|NCT02353871|Botulinum Toxins|botulinum toxins|mesh-list
20010585|NCT02353871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20010586|NCT02353871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20010587|NCT02353871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20010588|NCT02353871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20010589|NCT02353871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010590|NCT02353871|Cholinergic Agents|cholinergic agents|mesh-ancestor
20010591|NCT02353871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010592|NCT02353871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010593|NCT02353871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20010594|NCT02353871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010595|NCT02354092|Anesthetics|anesthetics|mesh-list
20559206|NCT01964534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20559207|NCT01964534|Immunologic Factors|immunologic factors|mesh-ancestor
20559208|NCT01964534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559209|NCT01964573|Rotigotine|rotigotine|mesh-list
20559210|NCT01964573|Dopamine Agonists|dopamine agonists|mesh-ancestor
20559211|NCT01964573|Dopamine Agents|dopamine agents|mesh-ancestor
20559212|NCT01964573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20559213|NCT01964573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559214|NCT01964573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010596|NCT02354092|Anesthetics, Local|anesthetics, local|mesh-list
20010597|NCT02354092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20010598|NCT02354092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010599|NCT02354092|Sensory System Agents|sensory system agents|mesh-ancestor
20010600|NCT02354092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010601|NCT02354222|Canagliflozin|canagliflozin|mesh-list
20010602|NCT02354222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20010603|NCT02354222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010604|NCT02354222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20010605|NCT02354222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010606|NCT02354235|Canagliflozin|canagliflozin|mesh-list
20010607|NCT02354235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20010608|NCT02354235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010609|NCT02354235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20010610|NCT02354235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010611|NCT02354339|Magnesium Oxide|magnesium oxide|mesh-list
20010612|NCT02354339|Antacids|antacids|mesh-ancestor
20010613|NCT02354339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010614|NCT02354339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20010615|NCT02354352|Eplerenone|eplerenone|mesh-list
20010616|NCT02354352|Spironolactone|spironolactone|mesh-list
20010617|NCT02354352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
20010618|NCT02354352|Hormone Antagonists|hormone antagonists|mesh-ancestor
20010619|NCT02354352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20010620|NCT02354352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010621|NCT02354352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20010622|NCT02354352|Diuretics|diuretics|mesh-ancestor
20010623|NCT02354352|Natriuretic Agents|natriuretic agents|mesh-ancestor
20010624|NCT02354352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20010625|NCT02354378|Dexmedetomidine|dexmedetomidine|mesh-list
20010626|NCT02354378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20010627|NCT02354378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20010628|NCT02354378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010629|NCT02354378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20010630|NCT02354378|Analgesics|analgesics|mesh-ancestor
20010631|NCT02354378|Sensory System Agents|sensory system agents|mesh-ancestor
20010632|NCT02354378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010633|NCT02354378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20010634|NCT02354378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20010635|NCT02354378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20010636|NCT02354378|Adrenergic Agents|adrenergic agents|mesh-ancestor
20010637|NCT02354378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010638|NCT02354378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010639|NCT02354508|Pasireotide|pasireotide|mesh-list
20010640|NCT02354508|Hormones|hormones|mesh-ancestor
20010641|NCT02354508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20010642|NCT02354508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010643|NCT02354534|Artesunate|artesunate|mesh-list
20010644|NCT02354534|Antimalarials|antimalarials|mesh-ancestor
20010645|NCT02354534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20010646|NCT02354534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20010647|NCT02354534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19460187|NCT03355352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19460188|NCT03355352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460189|NCT03355352|Analgesics|analgesics|mesh-ancestor
19460190|NCT03355352|Sensory System Agents|sensory system agents|mesh-ancestor
19460191|NCT03355352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460192|NCT03355352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19460193|NCT03355352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19460194|NCT03355352|Anesthetics, General|anesthetics, general|mesh-ancestor
19460195|NCT03355352|Anesthetics|anesthetics|mesh-ancestor
19460196|NCT03355300|Cannabidiol|cannabidiol|mesh-list
19460197|NCT03355300|Anticonvulsants|anticonvulsants|mesh-ancestor
19460198|NCT03355248|Acetaminophen|acetaminophen|mesh-list
19460199|NCT03355248|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
19460200|NCT03355248|Oxycodone|oxycodone|mesh-list
19460201|NCT03355248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19460202|NCT03355248|Analgesics|analgesics|mesh-ancestor
19460203|NCT03355248|Sensory System Agents|sensory system agents|mesh-ancestor
19460204|NCT03355248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460205|NCT03355248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460206|NCT03355248|Antipyretics|antipyretics|mesh-ancestor
19460207|NCT03355248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19460208|NCT03355248|Narcotics|narcotics|mesh-ancestor
19460209|NCT03355248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19460210|NCT03355248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20010648|NCT02354534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010649|NCT02354534|Antiviral Agents|antiviral agents|mesh-ancestor
20010650|NCT02354534|Schistosomicides|schistosomicides|mesh-ancestor
20010651|NCT02354534|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20010652|NCT02354534|Anthelmintics|anthelmintics|mesh-ancestor
20010653|NCT02354586|Niraparib|niraparib|mesh-list
20010654|NCT02354586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20010655|NCT02354586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010656|NCT02354586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010657|NCT02354586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010658|NCT02354599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20010659|NCT02354599|Immunologic Factors|immunologic factors|mesh-ancestor
20010660|NCT02354599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010661|NCT02354690|Cyclophosphamide|cyclophosphamide|mesh-list
20010662|NCT02354690|Fludarabine|fludarabine|mesh-list
20010663|NCT02354690|Interleukin-2|interleukin-2|mesh-list
20010664|NCT02354690|Vemurafenib|vemurafenib|mesh-list
20010665|NCT02354690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20010666|NCT02354690|Immunologic Factors|immunologic factors|mesh-ancestor
20010667|NCT02354690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010668|NCT02354690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20010669|NCT02354690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20010670|NCT02354690|Alkylating Agents|alkylating agents|mesh-ancestor
20010671|NCT02354690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010672|NCT02354690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010673|NCT02354690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20010674|NCT02354690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20010675|NCT02354690|Analgesics|analgesics|mesh-ancestor
20010676|NCT02354690|Sensory System Agents|sensory system agents|mesh-ancestor
20010677|NCT02354690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010678|NCT02354690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20010679|NCT02354690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010680|NCT02354833|Phenylephrine|phenylephrine|mesh-list
20010681|NCT02354833|Oxymetazoline|oxymetazoline|mesh-list
20010682|NCT02354833|Norepinephrine|norepinephrine|mesh-list
20010683|NCT02354833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20010684|NCT02354833|Mydriatics|mydriatics|mesh-ancestor
20010685|NCT02354833|Autonomic Agents|autonomic agents|mesh-ancestor
20010686|NCT02354833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010687|NCT02354833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010688|NCT02354833|Sympathomimetics|sympathomimetics|mesh-ancestor
20010689|NCT02354833|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20010690|NCT02354833|Nasal Decongestants|nasal decongestants|mesh-ancestor
20010691|NCT02354833|Respiratory System Agents|respiratory system agents|mesh-ancestor
20010692|NCT02354833|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20010693|NCT02354833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20010694|NCT02354833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20010695|NCT02354833|Adrenergic Agents|adrenergic agents|mesh-ancestor
20010696|NCT02354833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010697|NCT02354833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010698|NCT02354833|Protective Agents|protective agents|mesh-ancestor
20010699|NCT02354859|Gallium nitrate|gallium nitrate|mesh-list
20010700|NCT02354859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20010701|NCT02354859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010702|NCT02354859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010703|NCT02354976|Fenofibrate|fenofibrate|mesh-list
20010704|NCT02354976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20010705|NCT02354976|Antimetabolites|antimetabolites|mesh-ancestor
20010706|NCT02354976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010707|NCT02354976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20010708|NCT02355028|Ranibizumab|ranibizumab|mesh-list
20010709|NCT02355028|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20010710|NCT02355028|Acrizanib|acrizanib|mesh-list
20010711|NCT02355028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20010712|NCT02355028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20010713|NCT02355028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20010714|NCT02355028|Growth Substances|growth substances|mesh-ancestor
20010715|NCT02355028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010716|NCT02355028|Growth Inhibitors|growth inhibitors|mesh-ancestor
20010717|NCT02355028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010718|NCT02355028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20010719|NCT02355028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010720|NCT02355028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010721|NCT02355158|Clonidine|clonidine|mesh-list
20010722|NCT02355158|Analgesics|analgesics|mesh-ancestor
20010723|NCT02355158|Sensory System Agents|sensory system agents|mesh-ancestor
20010724|NCT02355158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010725|NCT02355158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010726|NCT02355158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20010727|NCT02355158|Sympatholytics|sympatholytics|mesh-ancestor
20010728|NCT02355158|Autonomic Agents|autonomic agents|mesh-ancestor
20010729|NCT02355158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20010730|NCT02355158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20010731|NCT02355158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20010732|NCT02355158|Adrenergic Agents|adrenergic agents|mesh-ancestor
20010733|NCT02355158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010734|NCT02355158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010735|NCT02355210|DEFB1 protein, human|defb1 protein, human|mesh-list
20010736|NCT02355210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20010737|NCT02355665|Nicotine|nicotine|mesh-list
20010738|NCT02355665|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20010739|NCT02355665|Autonomic Agents|autonomic agents|mesh-ancestor
20010740|NCT02355665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010741|NCT02355665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010742|NCT02355665|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20010743|NCT02355665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20010744|NCT02355665|Cholinergic Agents|cholinergic agents|mesh-ancestor
20010745|NCT02355665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010746|NCT02355665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010747|NCT02355821|Bisoprolol|bisoprolol|mesh-list
20010748|NCT02355821|Moxonidine|moxonidine|mesh-list
20010749|NCT02355821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20010750|NCT02355821|Sympatholytics|sympatholytics|mesh-ancestor
20010751|NCT02355821|Autonomic Agents|autonomic agents|mesh-ancestor
20010752|NCT02355821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010753|NCT02355821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010754|NCT02355821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20010755|NCT02355821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20010756|NCT02355821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20010757|NCT02355821|Adrenergic Agents|adrenergic agents|mesh-ancestor
20010758|NCT02355821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010759|NCT02355821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010760|NCT02355886|Gabapentin|gabapentin|mesh-list
20010761|NCT02355886|Analgesics|analgesics|mesh-ancestor
20010762|NCT02355886|Sensory System Agents|sensory system agents|mesh-ancestor
20010763|NCT02355886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010764|NCT02355886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010765|NCT02355886|Anticonvulsants|anticonvulsants|mesh-ancestor
20010766|NCT02355886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20010767|NCT02355886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20010768|NCT02355886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20010769|NCT02355886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20010770|NCT02355886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20010771|NCT02355886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20010772|NCT02355886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010773|NCT02355886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010774|NCT02355886|Antimanic Agents|antimanic agents|mesh-ancestor
20010775|NCT02355977|Minocycline|minocycline|mesh-list
20010776|NCT02355977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20010777|NCT02355977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20010778|NCT02356107|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
20010779|NCT02356107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20010780|NCT02356107|Antidepressive Agents|antidepressive agents|mesh-ancestor
20010781|NCT02356107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20010782|NCT02356198|Hydromorphone|hydromorphone|mesh-list
20010783|NCT02356198|Bupivacaine|bupivacaine|mesh-list
20010784|NCT02356198|Anesthetics, Local|anesthetics, local|mesh-ancestor
20010785|NCT02356198|Anesthetics|anesthetics|mesh-ancestor
20010786|NCT02356198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20010787|NCT02356198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010788|NCT02356198|Sensory System Agents|sensory system agents|mesh-ancestor
20010789|NCT02356198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010790|NCT02356198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20010791|NCT02356198|Narcotics|narcotics|mesh-ancestor
20010792|NCT02356198|Analgesics|analgesics|mesh-ancestor
20010793|NCT02356562|Ritonavir|ritonavir|mesh-list
20010794|NCT02356562|Ribavirin|ribavirin|mesh-list
20010795|NCT02356562|Sofosbuvir|sofosbuvir|mesh-list
20010796|NCT02356562|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20010797|NCT02356562|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20010798|NCT02356562|Protease Inhibitors|protease inhibitors|mesh-ancestor
20010799|NCT02356562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010800|NCT02356562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010801|NCT02356562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20010802|NCT02356562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20010803|NCT02356562|Antiviral Agents|antiviral agents|mesh-ancestor
20010804|NCT02356562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20010805|NCT02356562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20010806|NCT02356562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20010807|NCT02356562|Antimetabolites|antimetabolites|mesh-ancestor
20010808|NCT02356588|Sufentanil|sufentanil|mesh-list
20010809|NCT02356588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20010810|NCT02356588|Narcotics|narcotics|mesh-ancestor
20010811|NCT02356588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20010812|NCT02356588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010813|NCT02356588|Analgesics|analgesics|mesh-ancestor
20010814|NCT02356588|Sensory System Agents|sensory system agents|mesh-ancestor
20010815|NCT02356588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010816|NCT02356588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20010817|NCT02356588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20010818|NCT02356588|Anesthetics, General|anesthetics, general|mesh-ancestor
20010819|NCT02356588|Anesthetics|anesthetics|mesh-ancestor
20010820|NCT02357147|Pemetrexed|pemetrexed|mesh-list
20010821|NCT02357147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010822|NCT02357147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010823|NCT02357147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010824|NCT02357147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20010825|NCT02357147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20010826|NCT02357290|Acetylcysteine|acetylcysteine|mesh-list
20010827|NCT02357290|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20010828|NCT02357290|Antiviral Agents|antiviral agents|mesh-ancestor
20010829|NCT02357290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20010830|NCT02357290|Expectorants|expectorants|mesh-ancestor
20010831|NCT02357290|Respiratory System Agents|respiratory system agents|mesh-ancestor
20010832|NCT02357290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20010833|NCT02357290|Antioxidants|antioxidants|mesh-ancestor
20010834|NCT02357290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010835|NCT02357290|Protective Agents|protective agents|mesh-ancestor
20010836|NCT02357290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010837|NCT02357290|Antidotes|antidotes|mesh-ancestor
20010838|NCT02357342|Sirolimus|sirolimus|mesh-list
20010839|NCT02357342|Aflibercept|aflibercept|mesh-list
20010840|NCT02357342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010841|NCT02357342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20010842|NCT02357342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20010843|NCT02357342|Growth Substances|growth substances|mesh-ancestor
20010844|NCT02357342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010845|NCT02357342|Growth Inhibitors|growth inhibitors|mesh-ancestor
20010846|NCT02357342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20010847|NCT02357342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20010848|NCT02357342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20010849|NCT02357342|Antifungal Agents|antifungal agents|mesh-ancestor
20010850|NCT02357342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20010851|NCT02357342|Immunologic Factors|immunologic factors|mesh-ancestor
20010852|NCT02357368|Copper|copper|mesh-list
20010853|NCT02357368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20010854|NCT02357368|Contraceptive Agents|contraceptive agents|mesh-list
20010855|NCT02357368|Levonorgestrel|levonorgestrel|mesh-list
20010856|NCT02357368|Medroxyprogesterone|medroxyprogesterone|mesh-list
20010857|NCT02357368|Etonogestrel|etonogestrel|mesh-list
20010858|NCT02357368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20559215|NCT01964586|Lidocaine|lidocaine|mesh-list
20559216|NCT01964586|Epinephrine|epinephrine|mesh-list
20559217|NCT01964586|Racepinephrine|racepinephrine|mesh-list
20559218|NCT01964586|Dexmedetomidine|dexmedetomidine|mesh-list
20559219|NCT01964586|Epinephryl borate|epinephryl borate|mesh-list
20559220|NCT01964586|Anesthetics, Local|anesthetics, local|mesh-ancestor
20559221|NCT01964586|Anesthetics|anesthetics|mesh-ancestor
20559222|NCT01964586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20559223|NCT01964586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559224|NCT01964586|Sensory System Agents|sensory system agents|mesh-ancestor
20559225|NCT01964586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559226|NCT01964586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20559227|NCT01964586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20559228|NCT01964586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20559229|NCT01964586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20559230|NCT01964586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010859|NCT02357368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559231|NCT01964586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20010860|NCT02357368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20010861|NCT02357368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20010862|NCT02357368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20010863|NCT02357368|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20010864|NCT02357368|Trace Elements|trace elements|mesh-ancestor
20010865|NCT02357368|Micronutrients|micronutrients|mesh-ancestor
20010866|NCT02357368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20010867|NCT02357368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20010868|NCT02357368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20010869|NCT02357368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010870|NCT02357459|Triamcinolone|triamcinolone|mesh-list
20010871|NCT02357459|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20010872|NCT02357459|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20010873|NCT02357459|FX006|fx006|mesh-list
20010874|NCT02357459|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20010875|NCT02357459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20010876|NCT02357459|Glucocorticoids|glucocorticoids|mesh-ancestor
20010877|NCT02357459|Hormones|hormones|mesh-ancestor
20010878|NCT02357459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20010879|NCT02357459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010880|NCT02357459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20010881|NCT02357459|Immunologic Factors|immunologic factors|mesh-ancestor
20010882|NCT02357459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010883|NCT02357459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290458|NCT03961165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20290459|NCT03961165|Antiemetics|antiemetics|mesh-ancestor
20290460|NCT03961165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20290461|NCT03961165|Mydriatics|mydriatics|mesh-ancestor
20290462|NCT03958877|Interferons|interferons|mesh-list
20290463|NCT03958877|Interferon-beta|interferon-beta|mesh-list
20290464|NCT03958877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290465|NCT03958877|Antiviral Agents|antiviral agents|mesh-ancestor
20290466|NCT03958877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20290467|NCT03958877|Immunologic Factors|immunologic factors|mesh-ancestor
20290468|NCT03958877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290469|NCT03957876|Cytarabine|cytarabine|mesh-list
20290470|NCT03957876|Daunorubicin|daunorubicin|mesh-list
20290471|NCT03957876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20290472|NCT03957876|Antimetabolites|antimetabolites|mesh-ancestor
20290473|NCT03957876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290474|NCT03957876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290475|NCT03957876|Antiviral Agents|antiviral agents|mesh-ancestor
20290476|NCT03957876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20290477|NCT03957876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20290478|NCT03957876|Immunologic Factors|immunologic factors|mesh-ancestor
20290479|NCT03957876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290480|NCT03957876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20010884|NCT02357576|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20010885|NCT02357576|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20010886|NCT02357576|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20010887|NCT02357576|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20010888|NCT02357706|Acetaminophen|acetaminophen|mesh-list
20010889|NCT02357706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20010890|NCT02357706|Analgesics|analgesics|mesh-ancestor
20010891|NCT02357706|Sensory System Agents|sensory system agents|mesh-ancestor
20010892|NCT02357706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010893|NCT02357706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010894|NCT02357706|Antipyretics|antipyretics|mesh-ancestor
20010895|NCT02357758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20010896|NCT02357758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20010897|NCT02357836|Itraconazole|itraconazole|mesh-list
20010898|NCT02357836|Antifungal Agents|antifungal agents|mesh-ancestor
20010899|NCT02357836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20010900|NCT02357836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20010901|NCT02357836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20010902|NCT02357836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010903|NCT02357836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010904|NCT02357836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20010905|NCT02357836|Hormone Antagonists|hormone antagonists|mesh-ancestor
20010906|NCT02357836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20010907|NCT02357836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010908|NCT02357836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20010909|NCT02357901|Buprenorphine|buprenorphine|mesh-list
20010910|NCT02357901|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
20010911|NCT02357901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20010912|NCT02357901|Narcotics|narcotics|mesh-ancestor
20010913|NCT02357901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20010914|NCT02357901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010915|NCT02357901|Analgesics|analgesics|mesh-ancestor
20010916|NCT02357901|Sensory System Agents|sensory system agents|mesh-ancestor
20010917|NCT02357901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20010918|NCT02357901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20010919|NCT02357979|Fluorides|fluorides|mesh-list
20010920|NCT02357979|Cariostatic Agents|cariostatic agents|mesh-ancestor
20010921|NCT02357979|Protective Agents|protective agents|mesh-ancestor
20010922|NCT02357979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010923|NCT02358044|Ribavirin|ribavirin|mesh-list
20010924|NCT02358044|Sofosbuvir|sofosbuvir|mesh-list
20010925|NCT02358044|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20010926|NCT02358044|Grazoprevir|grazoprevir|mesh-list
20010927|NCT02358044|Antimetabolites|antimetabolites|mesh-ancestor
20010928|NCT02358044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010929|NCT02358044|Antiviral Agents|antiviral agents|mesh-ancestor
20010930|NCT02358044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20010931|NCT02358343|Sertraline|sertraline|mesh-list
20010932|NCT02358343|Antidepressive Agents|antidepressive agents|mesh-list
20010933|NCT02358343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20010934|NCT02358343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20010935|NCT02358343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20010936|NCT02358343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20010937|NCT02358343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010938|NCT02358343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010939|NCT02358343|Serotonin Agents|serotonin agents|mesh-ancestor
20010940|NCT02358343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010941|NCT02358369|Timolol|timolol|mesh-list
20010942|NCT02358369|Bimatoprost|bimatoprost|mesh-list
20010943|NCT02358369|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20010944|NCT02358369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20290481|NCT03957876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20290482|NCT03957876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20290483|NCT03957876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290484|NCT03940196|Paclitaxel|paclitaxel|mesh-list
20290485|NCT03940196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20290486|NCT03940196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20290487|NCT03940196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290488|NCT03940196|Tubulin Modulators|tubulin modulators|mesh-ancestor
20290489|NCT03940196|Antimitotic Agents|antimitotic agents|mesh-ancestor
20290490|NCT03940196|Mitosis Modulators|mitosis modulators|mesh-ancestor
20290491|NCT03940196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290492|NCT03932656|Psychotropic Drugs|psychotropic drugs|mesh-list
20290493|NCT03927378|Ketamine|ketamine|mesh-list
20290494|NCT03927378|Esketamine|esketamine|mesh-list
20290495|NCT03927378|Analgesics|analgesics|mesh-ancestor
20290496|NCT03927378|Sensory System Agents|sensory system agents|mesh-ancestor
20290497|NCT03927378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20290498|NCT03927378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290499|NCT03927378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20290500|NCT03927378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20290501|NCT03927378|Anesthetics, General|anesthetics, general|mesh-ancestor
20290502|NCT03927378|Anesthetics|anesthetics|mesh-ancestor
20010945|NCT02358369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19460211|NCT03355248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19460212|NCT03355248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20010946|NCT02358369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20010947|NCT02358369|Adrenergic Agents|adrenergic agents|mesh-ancestor
20010948|NCT02358369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010949|NCT02358369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010950|NCT02358369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010951|NCT02358369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20010952|NCT02358369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20010953|NCT02358473|Docetaxel|docetaxel|mesh-list
20010954|NCT02358473|Mogamulizumab|mogamulizumab|mesh-list
20010955|NCT02358473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010956|NCT02358473|Tubulin Modulators|tubulin modulators|mesh-ancestor
20010957|NCT02358473|Antimitotic Agents|antimitotic agents|mesh-ancestor
20290503|NCT03927378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20290504|NCT03927378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20290505|NCT03927378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20290506|NCT03927378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20290507|NCT03927378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290508|NCT03927378|Antidepressive Agents|antidepressive agents|mesh-ancestor
20290509|NCT03927378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20290510|NCT03925402|Ertapenem|ertapenem|mesh-list
20290511|NCT03925402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20290512|NCT03925402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20290513|NCT03896503|Topotecan|topotecan|mesh-list
20290514|NCT03896503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20290515|NCT03896503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20290516|NCT03896503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290517|NCT03896503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290518|NCT03896503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290519|NCT03896477|Vaccines|vaccines|mesh-list
20290520|NCT03896477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20290521|NCT03896477|Immunologic Factors|immunologic factors|mesh-ancestor
20290522|NCT03896477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290523|NCT03893175|Acetaminophen|acetaminophen|mesh-list
20290524|NCT03893175|Ibuprofen|ibuprofen|mesh-list
20290525|NCT03893175|Oxycodone|oxycodone|mesh-list
20290526|NCT03893175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20290527|NCT03893175|Analgesics|analgesics|mesh-ancestor
20290528|NCT03893175|Sensory System Agents|sensory system agents|mesh-ancestor
20290529|NCT03893175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20290530|NCT03893175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290531|NCT03893175|Antipyretics|antipyretics|mesh-ancestor
20290532|NCT03893175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20290533|NCT03893175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20290534|NCT03893175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20290535|NCT03893175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20290536|NCT03893175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290537|NCT03893175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290538|NCT03893175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20290539|NCT03893175|Narcotics|narcotics|mesh-ancestor
20290540|NCT03893175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20290541|NCT03875235|Durvalumab|durvalumab|mesh-list
20290542|NCT03875235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20290543|NCT03875235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290544|NCT03862157|Azacitidine|azacitidine|mesh-list
20290545|NCT03862157|Venetoclax|venetoclax|mesh-list
20290546|NCT03862157|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20290547|NCT03862157|Pevonedistat|pevonedistat|mesh-list
20290548|NCT03862157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20290549|NCT03862157|Antimetabolites|antimetabolites|mesh-ancestor
20290550|NCT03862157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290551|NCT03862157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559232|NCT01964586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20559233|NCT01964586|Analgesics|analgesics|mesh-ancestor
20559234|NCT01964586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20559235|NCT01964586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20559236|NCT01964586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20559237|NCT01964586|Adrenergic Agents|adrenergic agents|mesh-ancestor
20559238|NCT01964586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20559239|NCT01964586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20559240|NCT01964586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20559241|NCT01964586|Autonomic Agents|autonomic agents|mesh-ancestor
20010958|NCT02358473|Mitosis Modulators|mitosis modulators|mesh-ancestor
20559242|NCT01964586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20290552|NCT03854474|Pembrolizumab|pembrolizumab|mesh-list
20290553|NCT03854474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20290554|NCT03854474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290555|NCT03853044|Prednisone|prednisone|mesh-list
20290556|NCT03853044|Cyclophosphamide|cyclophosphamide|mesh-list
20290557|NCT03853044|Doxorubicin|doxorubicin|mesh-list
20290558|NCT03853044|Vincristine|vincristine|mesh-list
20290559|NCT03853044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20290560|NCT03853044|Immunologic Factors|immunologic factors|mesh-ancestor
20290561|NCT03853044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290562|NCT03853044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20290563|NCT03853044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20290564|NCT03853044|Alkylating Agents|alkylating agents|mesh-ancestor
20290565|NCT03853044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290566|NCT03853044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290567|NCT03853044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20290568|NCT03853044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20290569|NCT03853044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20290570|NCT03853044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20290571|NCT03853044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290572|NCT03853044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20290573|NCT03853044|Glucocorticoids|glucocorticoids|mesh-ancestor
20290574|NCT03853044|Hormones|hormones|mesh-ancestor
20290575|NCT03853044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20290576|NCT03853044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20290577|NCT03853044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20290578|NCT03853044|Tubulin Modulators|tubulin modulators|mesh-ancestor
20290579|NCT03853044|Antimitotic Agents|antimitotic agents|mesh-ancestor
20290580|NCT03853044|Mitosis Modulators|mitosis modulators|mesh-ancestor
20290581|NCT03847857|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20290582|NCT03847857|Hemostatics|hemostatics|mesh-ancestor
20290583|NCT03847857|Coagulants|coagulants|mesh-ancestor
20290584|NCT03843645|Anesthetics|anesthetics|mesh-list
20290585|NCT03843645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20290586|NCT03843645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290587|NCT03837899|Durvalumab|durvalumab|mesh-list
20290588|NCT03837899|Tremelimumab|tremelimumab|mesh-list
20290589|NCT03837899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20290590|NCT03837899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20290591|NCT03837899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290592|NCT03837899|Immunologic Factors|immunologic factors|mesh-ancestor
20290593|NCT03837899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290594|NCT03826303|Ethanol|ethanol|mesh-list
20290595|NCT03826303|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20290596|NCT03826303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20290597|NCT03826303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20290598|NCT03826303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290599|NCT03805594|Pembrolizumab|pembrolizumab|mesh-list
20290600|NCT03805594|177Lu-PSMA-617|177lu-psma-617|mesh-list
20290601|NCT03805594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20290602|NCT03805594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290603|NCT03805594|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20290604|NCT03805594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290605|NCT03803761|Fulvestrant|fulvestrant|mesh-list
20290606|NCT03803761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20290607|NCT03803761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290608|NCT03803761|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20290609|NCT03803761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20290610|NCT03803761|Hormone Antagonists|hormone antagonists|mesh-ancestor
20290611|NCT03803761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20290612|NCT03803761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290613|NCT03787251|Apatinib|apatinib|mesh-list
20290614|NCT03787251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290615|NCT03787251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20290616|NCT03787251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290617|NCT03787251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290618|NCT03761173|Anticoagulants|anticoagulants|mesh-list
20290619|NCT03760185|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20290620|NCT03760185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20290621|NCT03760185|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20290622|NCT03760185|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20290623|NCT03760185|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20290624|NCT03760185|Adrenergic Agents|adrenergic agents|mesh-ancestor
20290625|NCT03760185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20290626|NCT03760185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290627|NCT03760185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290628|NCT03753243|Pembrolizumab|pembrolizumab|mesh-list
20290629|NCT03753243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20290630|NCT03753243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290631|NCT03749070|Silymarin|silymarin|mesh-list
20290632|NCT03749070|Antioxidants|antioxidants|mesh-ancestor
20290633|NCT03749070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290634|NCT03749070|Protective Agents|protective agents|mesh-ancestor
20290635|NCT03749070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290636|NCT03747419|Avelumab|avelumab|mesh-list
20290637|NCT03747419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20290638|NCT03747419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290639|NCT03732677|Gemcitabine|gemcitabine|mesh-list
20290640|NCT03732677|Durvalumab|durvalumab|mesh-list
20290641|NCT03732677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290642|NCT03732677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20290643|NCT03732677|Antimetabolites|antimetabolites|mesh-ancestor
20290644|NCT03732677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290645|NCT03732677|Antiviral Agents|antiviral agents|mesh-ancestor
20290646|NCT03732677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20290647|NCT03732677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290648|NCT03732677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20290649|NCT03732677|Immunologic Factors|immunologic factors|mesh-ancestor
20290650|NCT03732677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290651|NCT03732677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20290652|NCT03673956|Vancomycin|vancomycin|mesh-list
20290653|NCT03673956|Levofloxacin|levofloxacin|mesh-list
20290654|NCT03673956|Ofloxacin|ofloxacin|mesh-list
20290655|NCT03673956|Tobramycin|tobramycin|mesh-list
20290656|NCT03673956|Mupirocin|mupirocin|mesh-list
20290657|NCT03673956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20290658|NCT03673956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20290659|NCT03673956|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20290660|NCT03673956|Renal Agents|renal agents|mesh-ancestor
20290661|NCT03673956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20290662|NCT03673956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20290663|NCT03673956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290664|NCT03673956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290665|NCT03673956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290666|NCT03673956|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20290667|NCT03673956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20290668|NCT03673956|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20290669|NCT03672630|Azithromycin|azithromycin|mesh-list
20290670|NCT03672630|Rifampin|rifampin|mesh-list
20290671|NCT03672630|Ethambutol|ethambutol|mesh-list
20290672|NCT03672630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20290673|NCT03672630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20290674|NCT03672630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19460213|NCT03355170|Domperidone|domperidone|mesh-list
19460214|NCT03355170|Lansoprazole|lansoprazole|mesh-list
19460215|NCT03355170|Dexlansoprazole|dexlansoprazole|mesh-list
19460216|NCT03355170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19460217|NCT03355170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19460218|NCT03355170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19460219|NCT03355170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290675|NCT03672630|Antitubercular Agents|antitubercular agents|mesh-ancestor
20290676|NCT03672630|Leprostatic Agents|leprostatic agents|mesh-ancestor
20290677|NCT03672630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20290678|NCT03672630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290679|NCT03672630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290680|NCT03672630|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20290681|NCT03672630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20290682|NCT03672630|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20290683|NCT03672630|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20290684|NCT03672630|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20290685|NCT03672630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20290686|NCT03669614|Gallium citrate|gallium citrate|mesh-list
20290687|NCT03669614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290688|NCT03669614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20290689|NCT03667482|Cetuximab|cetuximab|mesh-list
20290690|NCT03667482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20290691|NCT03667482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290692|NCT03661411|Aspirin|aspirin|mesh-list
20290693|NCT03661411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20290694|NCT03661411|Clopidogrel|clopidogrel|mesh-list
20290695|NCT03661411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20290696|NCT03661411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20290697|NCT03661411|Analgesics|analgesics|mesh-ancestor
20290698|NCT03661411|Sensory System Agents|sensory system agents|mesh-ancestor
20290699|NCT03661411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20290700|NCT03661411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290701|NCT03661411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20290702|NCT03661411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20290703|NCT03661411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20290704|NCT03661411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20290705|NCT03661411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460220|NCT03355170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460221|NCT03355170|Antiemetics|antiemetics|mesh-ancestor
19460222|NCT03355170|Autonomic Agents|autonomic agents|mesh-ancestor
19460223|NCT03355170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460224|NCT03355170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460225|NCT03355170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19460226|NCT03355170|Dopamine Agents|dopamine agents|mesh-ancestor
19460227|NCT03355170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19460228|NCT03355118|Anesthetics|anesthetics|mesh-list
19460229|NCT03355118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19460230|NCT03355118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460231|NCT03355053|Dexmedetomidine|dexmedetomidine|mesh-list
19460232|NCT03355053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19460233|NCT03355053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19460234|NCT03355053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460235|NCT03355053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19460236|NCT03355053|Analgesics|analgesics|mesh-ancestor
19460237|NCT03355053|Sensory System Agents|sensory system agents|mesh-ancestor
19460238|NCT03355053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460239|NCT03355053|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19460240|NCT03355053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19460241|NCT03355053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19460242|NCT03355053|Adrenergic Agents|adrenergic agents|mesh-ancestor
19460243|NCT03355053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19460244|NCT03355053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460245|NCT03355027|Atorvastatin|atorvastatin|mesh-list
19460246|NCT03355027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19460247|NCT03355027|Simvastatin|simvastatin|mesh-list
19460248|NCT03355027|Ezetimibe|ezetimibe|mesh-list
19460249|NCT03355027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19460250|NCT03355027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20290706|NCT03661411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20290707|NCT03661411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20290708|NCT03661411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290709|NCT03661411|Antipyretics|antipyretics|mesh-ancestor
20290710|NCT03661411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20010959|NCT02358473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010960|NCT02358668|PAZ320|paz320|mesh-list
20010961|NCT02358668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20010962|NCT02358668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290711|NCT03661411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20290712|NCT03661411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20290713|NCT03661411|Purinergic Agents|purinergic agents|mesh-ancestor
20290714|NCT03661411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20290715|NCT03651011|Aflibercept|aflibercept|mesh-list
20290716|NCT03651011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20290717|NCT03651011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20290718|NCT03651011|Growth Substances|growth substances|mesh-ancestor
20290719|NCT03651011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290720|NCT03651011|Growth Inhibitors|growth inhibitors|mesh-ancestor
20290721|NCT03651011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290722|NCT03646604|Upadacitinib|upadacitinib|mesh-list
20290723|NCT03646604|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
20290724|NCT03646604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20290725|NCT03646604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290726|NCT03646604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290727|NCT03646604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20290728|NCT03641326|Sunitinib|sunitinib|mesh-list
20290729|NCT03641326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290730|NCT03641326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20290731|NCT03641326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20290732|NCT03641326|Growth Substances|growth substances|mesh-ancestor
20290733|NCT03641326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290734|NCT03641326|Growth Inhibitors|growth inhibitors|mesh-ancestor
20290735|NCT03641326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20290736|NCT03641326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290737|NCT03641326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290738|NCT03637062|Progesterone|progesterone|mesh-list
20290739|NCT03637062|Progestins|progestins|mesh-ancestor
20290740|NCT03637062|Hormones|hormones|mesh-ancestor
20290741|NCT03637062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20290742|NCT03637062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290743|NCT03633110|Pembrolizumab|pembrolizumab|mesh-list
20290744|NCT03633110|Nivolumab|nivolumab|mesh-list
20290745|NCT03633110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20290746|NCT03633110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290747|NCT03633110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20290748|NCT03633110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290749|NCT03628066|Letrozole|letrozole|mesh-list
20290750|NCT03628066|Palbociclib|palbociclib|mesh-list
20290751|NCT03628066|Goserelin|goserelin|mesh-list
20290752|NCT03628066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290753|NCT03628066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20290754|NCT03628066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20290755|NCT03628066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290756|NCT03628066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290757|NCT03628066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20290758|NCT03628066|Hormone Antagonists|hormone antagonists|mesh-ancestor
20290759|NCT03628066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20290760|NCT03628066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290761|NCT03628066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20290762|NCT03628066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20290763|NCT03609216|Gemcitabine|gemcitabine|mesh-list
20290764|NCT03609216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290765|NCT03609216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20290766|NCT03609216|Antimetabolites|antimetabolites|mesh-ancestor
20290767|NCT03609216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290768|NCT03609216|Antiviral Agents|antiviral agents|mesh-ancestor
20290769|NCT03609216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20010963|NCT02358863|Leucovorin|leucovorin|mesh-list
20010964|NCT02358863|Cisplatin|cisplatin|mesh-list
20010965|NCT02358863|Docetaxel|docetaxel|mesh-list
20010966|NCT02358863|Capecitabine|capecitabine|mesh-list
20010967|NCT02358863|Oxaliplatin|oxaliplatin|mesh-list
20010968|NCT02358863|Irinotecan|irinotecan|mesh-list
20290770|NCT03609216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290771|NCT03609216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20290772|NCT03609216|Immunologic Factors|immunologic factors|mesh-ancestor
20290773|NCT03609216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290774|NCT03568097|Avelumab|avelumab|mesh-list
20290775|NCT03568097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20290776|NCT03568097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290777|NCT03567720|Paclitaxel|paclitaxel|mesh-list
20290778|NCT03567720|Pembrolizumab|pembrolizumab|mesh-list
20290779|NCT03567720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20290780|NCT03567720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290781|NCT03567720|Tubulin Modulators|tubulin modulators|mesh-ancestor
20290782|NCT03567720|Antimitotic Agents|antimitotic agents|mesh-ancestor
20290783|NCT03567720|Mitosis Modulators|mitosis modulators|mesh-ancestor
20290784|NCT03567720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290785|NCT03567720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20290786|NCT03557788|Rifaximin|rifaximin|mesh-list
20290787|NCT03557788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20290788|NCT03557788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20290789|NCT03557788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20290790|NCT03557385|Adenosine|adenosine|mesh-list
20290791|NCT03557385|Analgesics|analgesics|mesh-ancestor
20559243|NCT01964586|Respiratory System Agents|respiratory system agents|mesh-ancestor
20559244|NCT01964586|Mydriatics|mydriatics|mesh-ancestor
20559245|NCT01964586|Sympathomimetics|sympathomimetics|mesh-ancestor
20559246|NCT01964586|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20559247|NCT01964651|JNJ-42165279|jnj-42165279|mesh-list
20559248|NCT01964651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559249|NCT01964651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559250|NCT01964781|Epinephrine|epinephrine|mesh-list
20559251|NCT01964781|Racepinephrine|racepinephrine|mesh-list
20559252|NCT01964781|Bupivacaine|bupivacaine|mesh-list
20559253|NCT01964781|Tranexamic Acid|tranexamic acid|mesh-list
20559254|NCT01964781|Epinephryl borate|epinephryl borate|mesh-list
20559255|NCT01964781|Anesthetics, Local|anesthetics, local|mesh-ancestor
20559256|NCT01964781|Anesthetics|anesthetics|mesh-ancestor
20559257|NCT01964781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20559258|NCT01964781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559259|NCT01964781|Sensory System Agents|sensory system agents|mesh-ancestor
20559260|NCT01964781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559261|NCT01964781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20559262|NCT01964781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20559263|NCT01964781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559264|NCT01964781|Hemostatics|hemostatics|mesh-ancestor
20559265|NCT01964781|Coagulants|coagulants|mesh-ancestor
20559266|NCT01964781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20559267|NCT01964781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20559268|NCT01964781|Adrenergic Agents|adrenergic agents|mesh-ancestor
20559269|NCT01964781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20559270|NCT01964781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20559271|NCT01964781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20559272|NCT01964781|Autonomic Agents|autonomic agents|mesh-ancestor
20559273|NCT01964781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20559274|NCT01964781|Respiratory System Agents|respiratory system agents|mesh-ancestor
20559275|NCT01964781|Mydriatics|mydriatics|mesh-ancestor
20559276|NCT01964781|Sympathomimetics|sympathomimetics|mesh-ancestor
20559277|NCT01964781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20559278|NCT01964846|Curcumin|curcumin|mesh-list
20559279|NCT01964846|Resveratrol|resveratrol|mesh-list
20559280|NCT01964846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20559281|NCT01964846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20559282|NCT01964846|Analgesics|analgesics|mesh-ancestor
20559283|NCT01964846|Sensory System Agents|sensory system agents|mesh-ancestor
20559284|NCT01964846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559285|NCT01964846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559286|NCT01964846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20559287|NCT01964846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20559288|NCT01964846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559289|NCT01964846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559290|NCT01964846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559291|NCT01964846|Antioxidants|antioxidants|mesh-ancestor
20559292|NCT01964846|Protective Agents|protective agents|mesh-ancestor
20559293|NCT01964846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20559294|NCT01964911|Ropivacaine|ropivacaine|mesh-list
20559295|NCT01964911|Anesthetics, Local|anesthetics, local|mesh-ancestor
20559296|NCT01964911|Anesthetics|anesthetics|mesh-ancestor
20290792|NCT03557385|Sensory System Agents|sensory system agents|mesh-ancestor
20559297|NCT01964911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20290793|NCT03557385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20290794|NCT03557385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290795|NCT03557385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20290796|NCT03557385|Vasodilator Agents|vasodilator agents|mesh-ancestor
20290797|NCT03557385|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20290798|NCT03557385|Purinergic Agonists|purinergic agonists|mesh-ancestor
20290799|NCT03557385|Purinergic Agents|purinergic agents|mesh-ancestor
20290800|NCT03557385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20290801|NCT03557385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290802|NCT03557008|Metronidazole|metronidazole|mesh-list
20290803|NCT03557008|Vancomycin|vancomycin|mesh-list
20290804|NCT03557008|Neomycin|neomycin|mesh-list
20290805|NCT03557008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20290806|NCT03557008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20290807|NCT03557008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20290808|NCT03557008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20290809|NCT03557008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20290810|NCT03557008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290811|NCT03557008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559298|NCT01964911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559299|NCT01964911|Sensory System Agents|sensory system agents|mesh-ancestor
20559300|NCT01964911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559301|NCT01965041|Aflibercept|aflibercept|mesh-list
20559302|NCT01965041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20559303|NCT01965041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20559304|NCT01965041|Growth Substances|growth substances|mesh-ancestor
20559305|NCT01965041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559306|NCT01965041|Growth Inhibitors|growth inhibitors|mesh-ancestor
20559307|NCT01965041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559308|NCT01965080|Exemestane|exemestane|mesh-list
20559309|NCT01965080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559310|NCT01965080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20559311|NCT01965080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20559312|NCT01965080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559313|NCT01965080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559314|NCT01965080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20559315|NCT01965080|Hormone Antagonists|hormone antagonists|mesh-ancestor
20559316|NCT01965080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20559317|NCT01965080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559318|NCT01965275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20559319|NCT01965275|Gefitinib|gefitinib|mesh-list
20559320|NCT01965275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559321|NCT01965275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19460251|NCT03355027|Antimetabolites|antimetabolites|mesh-ancestor
20290812|NCT03491059|Nicotine|nicotine|mesh-list
20290813|NCT03491059|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20290814|NCT03491059|Autonomic Agents|autonomic agents|mesh-ancestor
20290815|NCT03491059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20290816|NCT03491059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290817|NCT03491059|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20290818|NCT03491059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20290819|NCT03491059|Cholinergic Agents|cholinergic agents|mesh-ancestor
20290820|NCT03491059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20290821|NCT03491059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290822|NCT03463993|Tranexamic Acid|tranexamic acid|mesh-list
20290823|NCT03463993|Oxytocin|oxytocin|mesh-list
20290824|NCT03463993|Oxytocics|oxytocics|mesh-ancestor
20290825|NCT03463993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20290826|NCT03463993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290827|NCT03463993|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20290828|NCT03463993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20290829|NCT03463993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290830|NCT03463993|Hemostatics|hemostatics|mesh-ancestor
20290831|NCT03463993|Coagulants|coagulants|mesh-ancestor
20290832|NCT03422822|Abrocitinib|abrocitinib|mesh-list
20290833|NCT03422822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20290834|NCT03422822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290835|NCT03422822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290836|NCT03421756|Sirolimus|sirolimus|mesh-list
20290837|NCT03421756|Alemtuzumab|alemtuzumab|mesh-list
20290838|NCT03421756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20290839|NCT03421756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20290840|NCT03421756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20290841|NCT03421756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290842|NCT03421756|Antifungal Agents|antifungal agents|mesh-ancestor
20290843|NCT03421756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20290844|NCT03421756|Immunologic Factors|immunologic factors|mesh-ancestor
20290845|NCT03421756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290846|NCT03421756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20290847|NCT03414229|Pembrolizumab|pembrolizumab|mesh-list
20290848|NCT03414229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20290849|NCT03414229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290850|NCT03412266|Cytarabine|cytarabine|mesh-list
20290851|NCT03412266|Cyclophosphamide|cyclophosphamide|mesh-list
20290852|NCT03412266|Busulfan|busulfan|mesh-list
20290853|NCT03412266|Semustine|semustine|mesh-list
20290854|NCT03412266|Fludarabine|fludarabine|mesh-list
20290855|NCT03412266|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20290856|NCT03412266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20290857|NCT03412266|Immunologic Factors|immunologic factors|mesh-ancestor
20290858|NCT03412266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290859|NCT03412266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20290860|NCT03412266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20290861|NCT03412266|Alkylating Agents|alkylating agents|mesh-ancestor
20290862|NCT03412266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290863|NCT03412266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290864|NCT03412266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20290865|NCT03412266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20290866|NCT03412266|Antimetabolites|antimetabolites|mesh-ancestor
20290867|NCT03412266|Antiviral Agents|antiviral agents|mesh-ancestor
20290868|NCT03412266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20290869|NCT03411031|Thalidomide|thalidomide|mesh-list
20290870|NCT03411031|Dexamethasone|dexamethasone|mesh-list
20290871|NCT03411031|Lenalidomide|lenalidomide|mesh-list
20290872|NCT03411031|Elotuzumab|elotuzumab|mesh-list
20290873|NCT03411031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20290874|NCT03411031|Antiemetics|antiemetics|mesh-ancestor
20290875|NCT03411031|Autonomic Agents|autonomic agents|mesh-ancestor
20290876|NCT03411031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20290877|NCT03411031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290878|NCT03411031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20290879|NCT03411031|Glucocorticoids|glucocorticoids|mesh-ancestor
20290880|NCT03411031|Hormones|hormones|mesh-ancestor
20290881|NCT03411031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20290882|NCT03411031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20290883|NCT03411031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290884|NCT03411031|Immunologic Factors|immunologic factors|mesh-ancestor
20290885|NCT03411031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20290886|NCT03411031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20290887|NCT03411031|Growth Substances|growth substances|mesh-ancestor
20290888|NCT03411031|Growth Inhibitors|growth inhibitors|mesh-ancestor
20290889|NCT03411031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20290890|NCT03411031|Leprostatic Agents|leprostatic agents|mesh-ancestor
20290891|NCT03411031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20290892|NCT03411031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20290893|NCT03404193|Decitabine|decitabine|mesh-list
20290894|NCT03404193|Venetoclax|venetoclax|mesh-list
20290895|NCT03404193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20290896|NCT03404193|Antimetabolites|antimetabolites|mesh-ancestor
20290897|NCT03404193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290898|NCT03404193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290899|NCT03404193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290900|NCT03366844|Pembrolizumab|pembrolizumab|mesh-list
20290901|NCT03366844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20290902|NCT03366844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290903|NCT03365752|Anesthetics|anesthetics|mesh-list
20290904|NCT03365752|Mepivacaine|mepivacaine|mesh-list
20290905|NCT03365752|Chloroprocaine|chloroprocaine|mesh-list
20290906|NCT03365752|Anesthetics, General|anesthetics, general|mesh-list
20290907|NCT03365752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20290908|NCT03365752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290909|NCT03365752|Anesthetics, Local|anesthetics, local|mesh-ancestor
20290910|NCT03365752|Sensory System Agents|sensory system agents|mesh-ancestor
20290911|NCT03365752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20290912|NCT03364036|Cladribine|cladribine|mesh-list
20290913|NCT03364036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290914|NCT03364036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20290915|NCT03364036|Immunologic Factors|immunologic factors|mesh-ancestor
20290916|NCT03364036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290917|NCT03289962|Atezolizumab|atezolizumab|mesh-list
20290918|NCT03289962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290919|NCT03260491|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
20290920|NCT03260491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20290921|NCT03260491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290922|NCT03254654|Apatinib|apatinib|mesh-list
20290923|NCT03254654|Vinorelbine|vinorelbine|mesh-list
20290924|NCT03254654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290925|NCT03254654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20290926|NCT03254654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290927|NCT03254654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290928|NCT03254654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20290929|NCT03254654|Tubulin Modulators|tubulin modulators|mesh-ancestor
20290930|NCT03254654|Antimitotic Agents|antimitotic agents|mesh-ancestor
20290931|NCT03254654|Mitosis Modulators|mitosis modulators|mesh-ancestor
20290932|NCT03253263|Mecasermin|mecasermin|mesh-list
20290933|NCT03253263|Growth Substances|growth substances|mesh-ancestor
20290934|NCT03253263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290935|NCT03205163|Factor VIII|factor viii|mesh-list
20290936|NCT03205163|Coagulants|coagulants|mesh-ancestor
20290937|NCT03145766|Immunoglobulins|immunoglobulins|mesh-list
20290938|NCT03145766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20290939|NCT03145766|Antibodies|antibodies|mesh-list
20290940|NCT03145766|Immunologic Factors|immunologic factors|mesh-ancestor
20290941|NCT03145766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290942|NCT03127592|Etodolac|etodolac|mesh-list
20290943|NCT03127592|Cyclobenzaprine|cyclobenzaprine|mesh-list
20290944|NCT03127592|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20290945|NCT03127592|Antidepressive Agents|antidepressive agents|mesh-ancestor
20290946|NCT03127592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20290947|NCT03127592|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20290948|NCT03127592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290949|NCT03127592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20290950|NCT03127592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20290951|NCT03127592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20290952|NCT03127592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20290953|NCT03127592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20290954|NCT03127592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20290955|NCT03127592|Analgesics|analgesics|mesh-ancestor
20290956|NCT03127592|Sensory System Agents|sensory system agents|mesh-ancestor
20290957|NCT03127592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20290958|NCT03127592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20290959|NCT03127592|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20290960|NCT03127592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20290961|NCT03127592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559322|NCT01965275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559323|NCT01965275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559324|NCT01965301|Diphenhydramine|diphenhydramine|mesh-list
20559325|NCT01965301|Promethazine|promethazine|mesh-list
20559326|NCT01965301|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20559327|NCT01965301|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20559328|NCT01965301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20559329|NCT01965301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559330|NCT01965301|Anesthetics, Local|anesthetics, local|mesh-ancestor
20559331|NCT01965301|Anesthetics|anesthetics|mesh-ancestor
20559332|NCT01965301|Sensory System Agents|sensory system agents|mesh-ancestor
20559333|NCT01965301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559334|NCT01965301|Antiemetics|antiemetics|mesh-ancestor
20559335|NCT01965301|Autonomic Agents|autonomic agents|mesh-ancestor
20559336|NCT01965301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20559337|NCT01965301|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20559338|NCT01965301|Histamine Antagonists|histamine antagonists|mesh-ancestor
20559339|NCT01965301|Histamine Agents|histamine agents|mesh-ancestor
20559340|NCT01965301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20559341|NCT01965301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559342|NCT01965301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20559343|NCT01965301|Antipruritics|antipruritics|mesh-ancestor
20559344|NCT01965301|Dermatologic Agents|dermatologic agents|mesh-ancestor
20559345|NCT01965353|Dexamethasone|dexamethasone|mesh-list
20559346|NCT01965353|Lenalidomide|lenalidomide|mesh-list
20559347|NCT01965353|Bortezomib|bortezomib|mesh-list
20559348|NCT01965353|Panobinostat|panobinostat|mesh-list
20559349|NCT01965353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20559350|NCT01965353|Antiemetics|antiemetics|mesh-ancestor
20559351|NCT01965353|Autonomic Agents|autonomic agents|mesh-ancestor
20559352|NCT01965353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559353|NCT01965353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559354|NCT01965353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20559355|NCT01965353|Glucocorticoids|glucocorticoids|mesh-ancestor
20559356|NCT01965353|Hormones|hormones|mesh-ancestor
20559357|NCT01965353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20559358|NCT01965353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20559359|NCT01965353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559360|NCT01965353|Immunologic Factors|immunologic factors|mesh-ancestor
20290962|NCT03127592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290963|NCT03116425|Pantothenic Acid|pantothenic acid|mesh-list
20290964|NCT03116425|Vitamin B Complex|vitamin b complex|mesh-ancestor
20290965|NCT03116425|Vitamins|vitamins|mesh-ancestor
20290966|NCT03116425|Micronutrients|micronutrients|mesh-ancestor
20290967|NCT03116425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290968|NCT03110822|Methylprednisolone|methylprednisolone|mesh-list
20290969|NCT03110822|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20290970|NCT03110822|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20290971|NCT03110822|Prednisolone|prednisolone|mesh-list
20290972|NCT03110822|Prednisolone acetate|prednisolone acetate|mesh-list
20290973|NCT03110822|Lenalidomide|lenalidomide|mesh-list
20290974|NCT03110822|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20290975|NCT03110822|Prednisolone phosphate|prednisolone phosphate|mesh-list
20290976|NCT03110822|Immunologic Factors|immunologic factors|mesh-ancestor
20290977|NCT03110822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20290978|NCT03110822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20290979|NCT03110822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20290980|NCT03110822|Growth Substances|growth substances|mesh-ancestor
20290981|NCT03110822|Growth Inhibitors|growth inhibitors|mesh-ancestor
20290982|NCT03110822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290983|NCT03110822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20290984|NCT03110822|Antiemetics|antiemetics|mesh-ancestor
20290985|NCT03110822|Autonomic Agents|autonomic agents|mesh-ancestor
20290986|NCT03110822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20290987|NCT03110822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20290988|NCT03110822|Glucocorticoids|glucocorticoids|mesh-ancestor
20290989|NCT03110822|Hormones|hormones|mesh-ancestor
20290990|NCT03110822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20290991|NCT03110822|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20290992|NCT03110822|Protective Agents|protective agents|mesh-ancestor
20290993|NCT03110822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20290994|NCT03106987|Olaparib|olaparib|mesh-list
20290995|NCT03106987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20290996|NCT03106987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20290997|NCT03106987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20290998|NCT03106987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20290999|NCT03105843|Methacholine Chloride|methacholine chloride|mesh-list
20291000|NCT03105843|Miotics|miotics|mesh-ancestor
20291001|NCT03105843|Autonomic Agents|autonomic agents|mesh-ancestor
20291002|NCT03105843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20291003|NCT03105843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291004|NCT03105843|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20291005|NCT03105843|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
20291006|NCT03105843|Respiratory System Agents|respiratory system agents|mesh-ancestor
20291007|NCT03105843|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
20291008|NCT03105843|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20291009|NCT03105843|Cholinergic Agents|cholinergic agents|mesh-ancestor
20291010|NCT03105843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20291011|NCT03105843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291012|NCT03103750|Calcitriol|calcitriol|mesh-list
20291013|NCT03103750|Amphetamine|amphetamine|mesh-list
20291014|NCT03103750|Dextroamphetamine|dextroamphetamine|mesh-list
20291015|NCT03103750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20291016|NCT03103750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291017|NCT03103750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20291018|NCT03103750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20291019|NCT03103750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291020|NCT03103750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20291021|NCT03103750|Vitamins|vitamins|mesh-ancestor
20291022|NCT03103750|Micronutrients|micronutrients|mesh-ancestor
20291023|NCT03103750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20291024|NCT03103750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20291025|NCT03103750|Sympathomimetics|sympathomimetics|mesh-ancestor
20291026|NCT03103750|Autonomic Agents|autonomic agents|mesh-ancestor
20291027|NCT03103750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20291028|NCT03103750|Dopamine Agents|dopamine agents|mesh-ancestor
20291029|NCT03103750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20291030|NCT03103750|Adrenergic Agents|adrenergic agents|mesh-ancestor
20291031|NCT03103750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20291032|NCT03103750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20291033|NCT03103750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20291034|NCT03103087|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20291035|NCT03103087|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20291036|NCT03103087|Norethindrone|norethindrone|mesh-list
20291037|NCT03103087|Norethindrone Acetate|norethindrone acetate|mesh-list
20291038|NCT03103087|Estradiol|estradiol|mesh-list
20291039|NCT03103087|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20291040|NCT03103087|Relugolix|relugolix|mesh-list
20291041|NCT03103087|Estrogens|estrogens|mesh-ancestor
20291042|NCT03103087|Hormones|hormones|mesh-ancestor
20291043|NCT03103087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20291044|NCT03103087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291045|NCT03103087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20291046|NCT03103087|Contraceptive Agents|contraceptive agents|mesh-ancestor
20291047|NCT03103087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20291048|NCT03103087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20291049|NCT03103087|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20291050|NCT03103087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20291051|NCT03103087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20291052|NCT03103087|Androgen Antagonists|androgen antagonists|mesh-ancestor
20291053|NCT03103087|Hormone Antagonists|hormone antagonists|mesh-ancestor
20291054|NCT03102047|Durvalumab|durvalumab|mesh-list
20291055|NCT03102047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20291056|NCT03102047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291057|NCT03097796|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
20291058|NCT03097796|Respiratory System Agents|respiratory system agents|mesh-ancestor
20291059|NCT03083678|Afatinib|afatinib|mesh-list
20291060|NCT03083678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291061|NCT03083678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20291062|NCT03083678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291063|NCT03083678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291064|NCT03071926|Doxorubicin|doxorubicin|mesh-list
20291065|NCT03071926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20291066|NCT03071926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20291067|NCT03071926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291068|NCT03071926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20291069|NCT03071926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20291070|NCT03071926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291071|NCT03071926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559361|NCT01965353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20559362|NCT01965353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20559363|NCT01965353|Growth Substances|growth substances|mesh-ancestor
20559364|NCT01965353|Growth Inhibitors|growth inhibitors|mesh-ancestor
20559365|NCT01965353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20559366|NCT01965353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559367|NCT01965353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559368|NCT01965405|Bupropion|bupropion|mesh-list
20559369|NCT01965405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20559370|NCT01965405|Antidepressive Agents|antidepressive agents|mesh-ancestor
20559371|NCT01965405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20559372|NCT01965405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20559373|NCT01965405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20559374|NCT01965405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20559375|NCT01965405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559376|NCT01965405|Dopamine Agents|dopamine agents|mesh-ancestor
20559377|NCT01965405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20559378|NCT01965405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559379|NCT01965405|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20559380|NCT01965405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20559381|NCT01965405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559382|NCT01965522|Vitamin D|vitamin d|mesh-list
20559383|NCT01965522|Ergocalciferols|ergocalciferols|mesh-list
20559384|NCT01965522|Vitamins|vitamins|mesh-list
20559385|NCT01965522|Melatonin|melatonin|mesh-list
20559386|NCT01965522|Micronutrients|micronutrients|mesh-ancestor
20559387|NCT01965522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559388|NCT01965522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20559389|NCT01965522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20559390|NCT01965522|Antioxidants|antioxidants|mesh-ancestor
20559391|NCT01965522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559392|NCT01965522|Protective Agents|protective agents|mesh-ancestor
20559393|NCT01965522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20559394|NCT01965587|Levonorgestrel|levonorgestrel|mesh-list
20559395|NCT01965587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20559396|NCT01965587|Contraceptive Agents|contraceptive agents|mesh-ancestor
20559397|NCT01965587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20559398|NCT01965587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559399|NCT01965587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20559400|NCT01965587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20559401|NCT01965587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20559402|NCT01965626|Oseltamivir|oseltamivir|mesh-list
20559403|NCT01965626|Dexamethasone|dexamethasone|mesh-list
20559404|NCT01965626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20559405|NCT01965626|Antiemetics|antiemetics|mesh-ancestor
20559406|NCT01965626|Autonomic Agents|autonomic agents|mesh-ancestor
20559407|NCT01965626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559408|NCT01965626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559409|NCT01965626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20559410|NCT01965626|Glucocorticoids|glucocorticoids|mesh-ancestor
20559411|NCT01965626|Hormones|hormones|mesh-ancestor
20559412|NCT01965626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20559413|NCT01965626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20291072|NCT03049735|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20291073|NCT03049735|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20291074|NCT03049735|Norethindrone|norethindrone|mesh-list
20291075|NCT03049735|Norethindrone Acetate|norethindrone acetate|mesh-list
20291076|NCT03049735|Estradiol|estradiol|mesh-list
20291077|NCT03049735|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20291078|NCT03049735|Relugolix|relugolix|mesh-list
20291079|NCT03049735|Estrogens|estrogens|mesh-ancestor
20291080|NCT03049735|Hormones|hormones|mesh-ancestor
20291081|NCT03049735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20291082|NCT03049735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291083|NCT03049735|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20291084|NCT03049735|Contraceptive Agents|contraceptive agents|mesh-ancestor
20291085|NCT03049735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20291086|NCT03049735|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20291087|NCT03049735|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20291088|NCT03049735|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20291089|NCT03049735|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20291090|NCT03049735|Androgen Antagonists|androgen antagonists|mesh-ancestor
20291091|NCT03049735|Hormone Antagonists|hormone antagonists|mesh-ancestor
20291092|NCT03044613|Paclitaxel|paclitaxel|mesh-list
20291093|NCT03044613|Carboplatin|carboplatin|mesh-list
20291094|NCT03044613|Nivolumab|nivolumab|mesh-list
20291095|NCT03044613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20291096|NCT03044613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291097|NCT03044613|Tubulin Modulators|tubulin modulators|mesh-ancestor
20291098|NCT03044613|Antimitotic Agents|antimitotic agents|mesh-ancestor
20291099|NCT03044613|Mitosis Modulators|mitosis modulators|mesh-ancestor
20291100|NCT03044613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291101|NCT03044613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20291102|NCT03044613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20291103|NCT03028519|Vitamin D|vitamin d|mesh-list
20291104|NCT03028519|Cholecalciferol|cholecalciferol|mesh-list
20291105|NCT03028519|Vitamins|vitamins|mesh-ancestor
20291106|NCT03028519|Micronutrients|micronutrients|mesh-ancestor
20291107|NCT03028519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291108|NCT03028519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20291109|NCT03028519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20291110|NCT03012971|Dexmedetomidine|dexmedetomidine|mesh-list
20291111|NCT03012971|Morphine|morphine|mesh-list
20291112|NCT03012971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20291113|NCT03012971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20291114|NCT03012971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291115|NCT03012971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20291116|NCT03012971|Analgesics|analgesics|mesh-ancestor
20291117|NCT03012971|Sensory System Agents|sensory system agents|mesh-ancestor
20291118|NCT03012971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20291119|NCT03012971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20291120|NCT03012971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20291121|NCT03012971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20291122|NCT03012971|Adrenergic Agents|adrenergic agents|mesh-ancestor
20291123|NCT03012971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20291124|NCT03012971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291125|NCT03012971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20291126|NCT03012971|Narcotics|narcotics|mesh-ancestor
20291127|NCT02992522|Lenalidomide|lenalidomide|mesh-list
20291128|NCT02992522|Venetoclax|venetoclax|mesh-list
20291129|NCT02992522|Obinutuzumab|obinutuzumab|mesh-list
20291130|NCT02992522|Immunologic Factors|immunologic factors|mesh-ancestor
20291131|NCT02992522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291132|NCT02992522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20291133|NCT02992522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20291134|NCT02992522|Growth Substances|growth substances|mesh-ancestor
20291135|NCT02992522|Growth Inhibitors|growth inhibitors|mesh-ancestor
20291136|NCT02992522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291137|NCT02992522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20291138|NCT02990338|Dexamethasone|dexamethasone|mesh-list
20291139|NCT02990338|Pomalidomide|pomalidomide|mesh-list
20291140|NCT02990338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20291141|NCT02990338|Antiemetics|antiemetics|mesh-ancestor
20559414|NCT01965626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559415|NCT01965626|Antiviral Agents|antiviral agents|mesh-ancestor
20559416|NCT01965626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20559417|NCT01965626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559418|NCT01965626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559419|NCT01965730|Aminocaproic Acid|aminocaproic acid|mesh-list
20559420|NCT01965730|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20559421|NCT01965730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20559422|NCT01965730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559423|NCT01965730|Hemostatics|hemostatics|mesh-ancestor
20559424|NCT01965730|Coagulants|coagulants|mesh-ancestor
20559425|NCT01965925|Modafinil|modafinil|mesh-list
20559426|NCT01965925|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20559427|NCT01965925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559428|NCT01965925|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20559429|NCT01965925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20559430|NCT01965925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20291142|NCT02990338|Autonomic Agents|autonomic agents|mesh-ancestor
20291143|NCT02990338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20291144|NCT02990338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291145|NCT02990338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20291146|NCT02990338|Glucocorticoids|glucocorticoids|mesh-ancestor
20291147|NCT02990338|Hormones|hormones|mesh-ancestor
20291148|NCT02990338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20291149|NCT02990338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20291150|NCT02990338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291151|NCT02990338|Immunologic Factors|immunologic factors|mesh-ancestor
20291152|NCT02990338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20291153|NCT02990338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20291154|NCT02990338|Growth Substances|growth substances|mesh-ancestor
20291155|NCT02990338|Growth Inhibitors|growth inhibitors|mesh-ancestor
20291156|NCT02978612|Capecitabine|capecitabine|mesh-list
20291157|NCT02978612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20291158|NCT02978612|Antimetabolites|antimetabolites|mesh-ancestor
20291159|NCT02978612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291160|NCT02978612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291161|NCT02975310|Anesthetics|anesthetics|mesh-list
20291162|NCT02975310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20291163|NCT02975310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291169|NCT02960230|Nivolumab|nivolumab|mesh-list
20291170|NCT02960230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20291171|NCT02960230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291172|NCT02960230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20291173|NCT02960230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291174|NCT02957032|Cytarabine|cytarabine|mesh-list
20291175|NCT02957032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20291176|NCT02957032|Antimetabolites|antimetabolites|mesh-ancestor
20291177|NCT02957032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291178|NCT02957032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291179|NCT02957032|Antiviral Agents|antiviral agents|mesh-ancestor
20291180|NCT02957032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20291181|NCT02957032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20291182|NCT02957032|Immunologic Factors|immunologic factors|mesh-ancestor
20291183|NCT02957032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291184|NCT02954991|Nivolumab|nivolumab|mesh-list
20291185|NCT02954991|Mocetinostat|mocetinostat|mesh-list
20291186|NCT02954991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20291187|NCT02954991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291188|NCT02954991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20291189|NCT02954991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291190|NCT02954991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20291191|NCT02954991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291192|NCT02947516|Liver Extracts|liver extracts|mesh-list
20291193|NCT02947516|Hematinics|hematinics|mesh-ancestor
20291194|NCT02932956|Cyclophosphamide|cyclophosphamide|mesh-list
20291195|NCT02932956|Fludarabine|fludarabine|mesh-list
20291196|NCT02932956|Fludarabine phosphate|fludarabine phosphate|mesh-list
20291197|NCT02932956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20291198|NCT02932956|Immunologic Factors|immunologic factors|mesh-ancestor
20291199|NCT02932956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291200|NCT02932956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20291201|NCT02932956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20291202|NCT02932956|Alkylating Agents|alkylating agents|mesh-ancestor
20291203|NCT02932956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291204|NCT02932956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291205|NCT02932956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20291206|NCT02932956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20291207|NCT02932956|Antimetabolites|antimetabolites|mesh-ancestor
20291208|NCT02909361|Fulvestrant|fulvestrant|mesh-list
20291209|NCT02909361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20291210|NCT02909361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291211|NCT02909361|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20291212|NCT02909361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20291213|NCT02909361|Hormone Antagonists|hormone antagonists|mesh-ancestor
20291214|NCT02909361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20291215|NCT02909361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291216|NCT02901717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20291217|NCT02901717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20291218|NCT02901717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20291219|NCT02901717|Antitubercular Agents|antitubercular agents|mesh-ancestor
20291220|NCT02897050|Cyclophosphamide|cyclophosphamide|mesh-list
20291221|NCT02897050|Docetaxel|docetaxel|mesh-list
20291222|NCT02897050|Fluorouracil|fluorouracil|mesh-list
20291223|NCT02897050|Capecitabine|capecitabine|mesh-list
20291224|NCT02897050|Epirubicin|epirubicin|mesh-list
20291225|NCT02897050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20291226|NCT02897050|Immunologic Factors|immunologic factors|mesh-ancestor
20291227|NCT02897050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291228|NCT02897050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20291229|NCT02897050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20291230|NCT02897050|Alkylating Agents|alkylating agents|mesh-ancestor
20291231|NCT02897050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291232|NCT02897050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291233|NCT02897050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20291234|NCT02897050|Tubulin Modulators|tubulin modulators|mesh-ancestor
20291235|NCT02897050|Antimitotic Agents|antimitotic agents|mesh-ancestor
20291236|NCT02897050|Mitosis Modulators|mitosis modulators|mesh-ancestor
20291237|NCT02897050|Antimetabolites|antimetabolites|mesh-ancestor
20291238|NCT02897050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20291239|NCT02897050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20291240|NCT02897050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20291241|NCT02897050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20291242|NCT02897050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291243|NCT02865551|Anesthetics|anesthetics|mesh-list
20291244|NCT02865551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20291245|NCT02865551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291246|NCT02864953|Glyburide|glyburide|mesh-list
20291247|NCT02864953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20291248|NCT02864953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291249|NCT02821507|Sirolimus|sirolimus|mesh-list
20291250|NCT02821507|Cyclophosphamide|cyclophosphamide|mesh-list
20291251|NCT02821507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20291252|NCT02821507|Immunologic Factors|immunologic factors|mesh-ancestor
20291253|NCT02821507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291254|NCT02821507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20291255|NCT02821507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20291256|NCT02821507|Alkylating Agents|alkylating agents|mesh-ancestor
20291257|NCT02821507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291258|NCT02821507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291259|NCT02821507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20291260|NCT02821507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20291261|NCT02821507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20291262|NCT02821507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20291263|NCT02821507|Antifungal Agents|antifungal agents|mesh-ancestor
20291264|NCT02607215|Vinorelbine|vinorelbine|mesh-list
20291265|NCT02607215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20291266|NCT02607215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291267|NCT02607215|Tubulin Modulators|tubulin modulators|mesh-ancestor
20291268|NCT02607215|Antimitotic Agents|antimitotic agents|mesh-ancestor
20291269|NCT02607215|Mitosis Modulators|mitosis modulators|mesh-ancestor
20291270|NCT02607215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291271|NCT02589353|Acarbose|acarbose|mesh-list
20291272|NCT02589353|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
20291273|NCT02589353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291274|NCT02589353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291275|NCT02589353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20291276|NCT02589353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291277|NCT02588248|Peppermint oil|peppermint oil|mesh-list
20291278|NCT02588248|Menthol|menthol|mesh-list
20291279|NCT02588248|Antipruritics|antipruritics|mesh-ancestor
20291280|NCT02588248|Dermatologic Agents|dermatologic agents|mesh-ancestor
20291281|NCT02588248|Antiemetics|antiemetics|mesh-ancestor
20291282|NCT02588248|Autonomic Agents|autonomic agents|mesh-ancestor
20291283|NCT02588248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20291284|NCT02588248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291285|NCT02588248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20291286|NCT02588248|Parasympatholytics|parasympatholytics|mesh-ancestor
20291287|NCT02584309|Doxorubicin|doxorubicin|mesh-list
20291288|NCT02584309|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20291289|NCT02584309|Dexrazoxane|dexrazoxane|mesh-list
20291290|NCT02584309|Razoxane|razoxane|mesh-list
20291291|NCT02584309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20291292|NCT02584309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291293|NCT02584309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20291294|NCT02584309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20291295|NCT02584309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291296|NCT02584309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291297|NCT02584309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20291298|NCT02584309|Protective Agents|protective agents|mesh-ancestor
20291299|NCT02584309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291300|NCT02584309|Antimitotic Agents|antimitotic agents|mesh-ancestor
20291301|NCT02584309|Mitosis Modulators|mitosis modulators|mesh-ancestor
20291302|NCT02512926|Cyclophosphamide|cyclophosphamide|mesh-list
20291303|NCT02512926|Etoposide|etoposide|mesh-list
20291304|NCT02512926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20291305|NCT02512926|Immunologic Factors|immunologic factors|mesh-ancestor
20291306|NCT02512926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291307|NCT02512926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20291308|NCT02512926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20291309|NCT02512926|Alkylating Agents|alkylating agents|mesh-ancestor
20291310|NCT02512926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291311|NCT02512926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291312|NCT02512926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20291313|NCT02512926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20291314|NCT02512926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20291315|NCT02512926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20291316|NCT02512926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291317|NCT02512497|Vidarabine|vidarabine|mesh-list
20291318|NCT02512497|Fludarabine|fludarabine|mesh-list
20291319|NCT02512497|Fludarabine phosphate|fludarabine phosphate|mesh-list
20291320|NCT02512497|Busulfan|busulfan|mesh-list
20291321|NCT02512497|Romidepsin|romidepsin|mesh-list
20291322|NCT02512497|Thymoglobulin|thymoglobulin|mesh-list
20291323|NCT02512497|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20291324|NCT02512497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291325|NCT02512497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20291326|NCT02512497|Antimetabolites|antimetabolites|mesh-ancestor
20291327|NCT02512497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291328|NCT02512497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20291329|NCT02512497|Immunologic Factors|immunologic factors|mesh-ancestor
20291330|NCT02512497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291331|NCT02512497|Antiviral Agents|antiviral agents|mesh-ancestor
20291332|NCT02512497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20291333|NCT02512497|Alkylating Agents|alkylating agents|mesh-ancestor
20291334|NCT02512497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20291335|NCT02512497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20291336|NCT02512497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20291337|NCT02451358|Vaccines|vaccines|mesh-list
20291338|NCT02451358|Immunologic Factors|immunologic factors|mesh-ancestor
20291339|NCT02451358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291340|NCT02414269|Cyclophosphamide|cyclophosphamide|mesh-list
20291341|NCT02414269|Pembrolizumab|pembrolizumab|mesh-list
20291342|NCT02414269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20291343|NCT02414269|Immunologic Factors|immunologic factors|mesh-ancestor
20291344|NCT02414269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291345|NCT02414269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20291346|NCT02414269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20291347|NCT02414269|Alkylating Agents|alkylating agents|mesh-ancestor
20291348|NCT02414269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291349|NCT02414269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291350|NCT02414269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20291351|NCT02414269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20291352|NCT02403310|Cytarabine|cytarabine|mesh-list
20291353|NCT02403310|Daunorubicin|daunorubicin|mesh-list
20291354|NCT02403310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20291355|NCT02403310|Antimetabolites|antimetabolites|mesh-ancestor
20291356|NCT02403310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291357|NCT02403310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291358|NCT02403310|Antiviral Agents|antiviral agents|mesh-ancestor
20291359|NCT02403310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20291360|NCT02403310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20291361|NCT02403310|Immunologic Factors|immunologic factors|mesh-ancestor
20291362|NCT02403310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291363|NCT02403310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20291364|NCT02403310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20291365|NCT02403310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20291366|NCT02403310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291367|NCT02389036|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20291368|NCT02389036|Ciprofloxacin|ciprofloxacin|mesh-list
20291369|NCT02389036|Ceftriaxone|ceftriaxone|mesh-list
20291370|NCT02389036|Tobramycin|tobramycin|mesh-list
20291371|NCT02389036|Colistin|colistin|mesh-list
20291372|NCT02389036|Nystatin|nystatin|mesh-list
20291373|NCT02389036|Cefotaxime|cefotaxime|mesh-list
20291374|NCT02389036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20291375|NCT02389036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20291376|NCT02389036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20291377|NCT02389036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291378|NCT02389036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291379|NCT02389036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291380|NCT02389036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20291381|NCT02389036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20291382|NCT02389036|Antifungal Agents|antifungal agents|mesh-ancestor
20291383|NCT02389036|Ionophores|ionophores|mesh-ancestor
20291384|NCT02389036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20291385|NCT02375204|Paclitaxel|paclitaxel|mesh-list
20291386|NCT02375204|Etoposide|etoposide|mesh-list
20291387|NCT02375204|Carboplatin|carboplatin|mesh-list
20291388|NCT02375204|Ifosfamide|ifosfamide|mesh-list
20291389|NCT02375204|Etoposide phosphate|etoposide phosphate|mesh-list
20291390|NCT02375204|Lenograstim|lenograstim|mesh-list
20291391|NCT02375204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20291392|NCT02375204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291393|NCT02375204|Tubulin Modulators|tubulin modulators|mesh-ancestor
20291394|NCT02375204|Antimitotic Agents|antimitotic agents|mesh-ancestor
20291395|NCT02375204|Mitosis Modulators|mitosis modulators|mesh-ancestor
20291396|NCT02375204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291397|NCT02375204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20291398|NCT02375204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20291399|NCT02375204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291400|NCT02375204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20291401|NCT02375204|Immunologic Factors|immunologic factors|mesh-ancestor
20291402|NCT02375204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291403|NCT02375204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20291404|NCT02375204|Alkylating Agents|alkylating agents|mesh-ancestor
20291405|NCT02349906|Treosulfan|treosulfan|mesh-list
20291406|NCT02349906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20010969|NCT02358863|Epirubicin|epirubicin|mesh-list
20010970|NCT02358863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010971|NCT02358863|Tubulin Modulators|tubulin modulators|mesh-ancestor
20010972|NCT02358863|Antimitotic Agents|antimitotic agents|mesh-ancestor
20010973|NCT02358863|Mitosis Modulators|mitosis modulators|mesh-ancestor
20010974|NCT02358863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20010975|NCT02358863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20010976|NCT02358863|Antimetabolites|antimetabolites|mesh-ancestor
20010977|NCT02358863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20010978|NCT02358863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20291407|NCT02349906|Alkylating Agents|alkylating agents|mesh-ancestor
20291408|NCT02349906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291409|NCT02349906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291410|NCT02341911|Gemcitabine|gemcitabine|mesh-list
20291411|NCT02341911|Carboplatin|carboplatin|mesh-list
20291412|NCT02341911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291413|NCT02341911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20291414|NCT02341911|Antimetabolites|antimetabolites|mesh-ancestor
20291415|NCT02341911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291416|NCT02341911|Antiviral Agents|antiviral agents|mesh-ancestor
20291417|NCT02341911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20291418|NCT02341911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291419|NCT02341911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20291420|NCT02341911|Immunologic Factors|immunologic factors|mesh-ancestor
20291421|NCT02341911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291422|NCT02336750|Aprepitant|aprepitant|mesh-list
20291423|NCT02336750|Fosaprepitant|fosaprepitant|mesh-list
20291424|NCT02336750|Mirtazapine|mirtazapine|mesh-list
20291425|NCT02336750|Antiemetics|antiemetics|mesh-ancestor
20291426|NCT02336750|Autonomic Agents|autonomic agents|mesh-ancestor
20291427|NCT02336750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20291428|NCT02336750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291429|NCT02336750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20291430|NCT02336750|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20291431|NCT02336750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20291432|NCT02336750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291433|NCT02336750|Antidepressive Agents|antidepressive agents|mesh-ancestor
20291434|NCT02336750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20291435|NCT02336750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20291436|NCT02336750|Histamine Antagonists|histamine antagonists|mesh-ancestor
20291437|NCT02336750|Histamine Agents|histamine agents|mesh-ancestor
20291438|NCT02336750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20291439|NCT02336750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20291440|NCT02336750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20291441|NCT02336750|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20291442|NCT02336750|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20291443|NCT02336750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20291444|NCT02336750|Adrenergic Agents|adrenergic agents|mesh-ancestor
20291445|NCT02336750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20291446|NCT02336750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20291447|NCT02336750|Serotonin Agents|serotonin agents|mesh-ancestor
20559431|NCT01965925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559432|NCT01965977|Bortezomib|bortezomib|mesh-list
20559433|NCT01965977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559434|NCT01966055|Solithromycin|solithromycin|mesh-list
20559435|NCT01966055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20559436|NCT01966055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20559437|NCT01966133|Doxorubicin|doxorubicin|mesh-list
20559438|NCT01966133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20559439|NCT01966133|Ethiodized Oil|ethiodized oil|mesh-list
20559440|NCT01966133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20559441|NCT01966133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559442|NCT01966133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20559443|NCT01966133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20559444|NCT01966133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291448|NCT02336750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20291449|NCT02268175|Prednisone|prednisone|mesh-list
20291450|NCT02268175|Leuprolide|leuprolide|mesh-list
20291451|NCT02268175|Abiraterone Acetate|abiraterone acetate|mesh-list
20291452|NCT02268175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20291453|NCT02268175|Glucocorticoids|glucocorticoids|mesh-ancestor
20291454|NCT02268175|Hormones|hormones|mesh-ancestor
20291455|NCT02268175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20291456|NCT02268175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291457|NCT02268175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20291458|NCT02268175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291459|NCT02268175|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20291460|NCT02268175|Fertility Agents|fertility agents|mesh-ancestor
20291461|NCT02268175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20291462|NCT02268175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20291463|NCT02268175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291464|NCT02268175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291465|NCT02268175|Hormone Antagonists|hormone antagonists|mesh-ancestor
20291466|NCT02268175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20291467|NCT02178709|Leucovorin|leucovorin|mesh-list
20291468|NCT02178709|Oxaliplatin|oxaliplatin|mesh-list
20291469|NCT02178709|Irinotecan|irinotecan|mesh-list
20291470|NCT02178709|Folfirinox|folfirinox|mesh-list
20291471|NCT02178709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291472|NCT02178709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20291473|NCT02178709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20291474|NCT02178709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291475|NCT02178709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291476|NCT02178709|Antidotes|antidotes|mesh-ancestor
20291477|NCT02178709|Protective Agents|protective agents|mesh-ancestor
20291478|NCT02178709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291479|NCT02178709|Vitamin B Complex|vitamin b complex|mesh-ancestor
20291480|NCT02178709|Vitamins|vitamins|mesh-ancestor
20291481|NCT02178709|Micronutrients|micronutrients|mesh-ancestor
20291482|NCT02117791|Riociguat|riociguat|mesh-list
20291483|NCT02117791|Enzyme Activators|enzyme activators|mesh-ancestor
20291484|NCT02117791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291485|NCT02066220|Cyclophosphamide|cyclophosphamide|mesh-list
20291486|NCT02066220|Lomustine|lomustine|mesh-list
20291487|NCT02066220|Cisplatin|cisplatin|mesh-list
20291488|NCT02066220|Carboplatin|carboplatin|mesh-list
20291489|NCT02066220|Vincristine|vincristine|mesh-list
20291490|NCT02066220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20291491|NCT02066220|Immunologic Factors|immunologic factors|mesh-ancestor
20291492|NCT02066220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291493|NCT02066220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20291494|NCT02066220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20291495|NCT02066220|Alkylating Agents|alkylating agents|mesh-ancestor
20291496|NCT02066220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291497|NCT02066220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291498|NCT02066220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20291499|NCT02066220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20291500|NCT02066220|Tubulin Modulators|tubulin modulators|mesh-ancestor
20291501|NCT02066220|Antimitotic Agents|antimitotic agents|mesh-ancestor
20291502|NCT02066220|Mitosis Modulators|mitosis modulators|mesh-ancestor
20559445|NCT01966133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559446|NCT01966172|Acetaminophen|acetaminophen|mesh-list
20559447|NCT01966172|Ibuprofen|ibuprofen|mesh-list
20559448|NCT01966172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20559449|NCT01966172|Morphine|morphine|mesh-list
20559450|NCT01966172|Gabapentin|gabapentin|mesh-list
20559451|NCT01966172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20559452|NCT01966172|Narcotics|narcotics|mesh-ancestor
20559453|NCT01966172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20559454|NCT01966172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559455|NCT01966172|Analgesics|analgesics|mesh-ancestor
20559456|NCT01966172|Sensory System Agents|sensory system agents|mesh-ancestor
20559457|NCT01966172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559458|NCT01966172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20559459|NCT01966172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20559460|NCT01966172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20559461|NCT01966172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20559462|NCT01966172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559463|NCT01966172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291503|NCT01991457|Fludarabine|fludarabine|mesh-list
20291504|NCT01991457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291505|NCT01905046|Metformin|metformin|mesh-list
20291506|NCT01905046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20291507|NCT01905046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291508|NCT01855867|Tenofovir|tenofovir|mesh-list
20291509|NCT01855867|Emtricitabine|emtricitabine|mesh-list
20291510|NCT01855867|Antiviral Agents|antiviral agents|mesh-ancestor
20291511|NCT01855867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20291512|NCT01855867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20291513|NCT01855867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20291514|NCT01855867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291515|NCT01855867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291516|NCT01855867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20291517|NCT01855867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20291518|NCT01754857|Rituximab|rituximab|mesh-list
20291519|NCT01754857|Lenalidomide|lenalidomide|mesh-list
20291520|NCT01754857|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20291521|NCT01754857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20291522|NCT01754857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291523|NCT01754857|Immunologic Factors|immunologic factors|mesh-ancestor
20291524|NCT01754857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291525|NCT01754857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20291526|NCT01754857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20291527|NCT01754857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20291528|NCT01754857|Growth Substances|growth substances|mesh-ancestor
20291529|NCT01754857|Growth Inhibitors|growth inhibitors|mesh-ancestor
20291530|NCT01754857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20291531|NCT01754857|Alkylating Agents|alkylating agents|mesh-ancestor
20291532|NCT01754857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291533|NCT01721746|Paclitaxel|paclitaxel|mesh-list
20291534|NCT01721746|Carboplatin|carboplatin|mesh-list
20291535|NCT01721746|Nivolumab|nivolumab|mesh-list
20291536|NCT01721746|Dacarbazine|dacarbazine|mesh-list
20291537|NCT01721746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20291538|NCT01721746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291539|NCT01721746|Tubulin Modulators|tubulin modulators|mesh-ancestor
20291540|NCT01721746|Antimitotic Agents|antimitotic agents|mesh-ancestor
20291541|NCT01721746|Mitosis Modulators|mitosis modulators|mesh-ancestor
20291542|NCT01721746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291543|NCT01721746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20291544|NCT01721746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20291545|NCT01721746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20291546|NCT01721746|Alkylating Agents|alkylating agents|mesh-ancestor
20291547|NCT01716312|Omalizumab|omalizumab|mesh-list
20291548|NCT01716312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20291549|NCT01716312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20291550|NCT01716312|Respiratory System Agents|respiratory system agents|mesh-ancestor
20291551|NCT01705977|Belimumab|belimumab|mesh-list
20291552|NCT01705977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20291553|NCT01705977|Immunologic Factors|immunologic factors|mesh-ancestor
20291554|NCT01705977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291555|NCT01661400|Thalidomide|thalidomide|mesh-list
20291556|NCT01661400|Cyclophosphamide|cyclophosphamide|mesh-list
20291557|NCT01661400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20291558|NCT01661400|Immunologic Factors|immunologic factors|mesh-ancestor
20291559|NCT01661400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291560|NCT01661400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20291561|NCT01661400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20291562|NCT01661400|Alkylating Agents|alkylating agents|mesh-ancestor
20291563|NCT01661400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291564|NCT01661400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291565|NCT01661400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20291566|NCT01661400|Leprostatic Agents|leprostatic agents|mesh-ancestor
20291567|NCT01661400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20291568|NCT01661400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20291569|NCT01661400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20291570|NCT01661400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20291571|NCT01661400|Growth Substances|growth substances|mesh-ancestor
20291572|NCT01661400|Growth Inhibitors|growth inhibitors|mesh-ancestor
20291573|NCT01503606|Clarithromycin|clarithromycin|mesh-list
20291574|NCT01503606|Cefazolin|cefazolin|mesh-list
20291575|NCT01503606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20291576|NCT01503606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20291577|NCT01503606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20291578|NCT01503606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291579|NCT01503606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291580|NCT01503606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20291581|NCT01503606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20291582|NCT01293682|Calcitriol|calcitriol|mesh-list
20291583|NCT01293682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20291584|NCT01293682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291585|NCT01293682|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20291586|NCT01293682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20291587|NCT01293682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291588|NCT01293682|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20291589|NCT01293682|Vitamins|vitamins|mesh-ancestor
20291590|NCT01293682|Micronutrients|micronutrients|mesh-ancestor
20291591|NCT01293682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20291592|NCT01253161|Pasireotide|pasireotide|mesh-list
20291593|NCT01253161|Hormones|hormones|mesh-ancestor
20291594|NCT01253161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20291595|NCT01253161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291596|NCT01084252|Dexamethasone|dexamethasone|mesh-list
20291597|NCT01084252|Dexamethasone acetate|dexamethasone acetate|mesh-list
20291598|NCT01084252|BB 1101|bb 1101|mesh-list
20010979|NCT02358863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20010980|NCT02358863|Antidotes|antidotes|mesh-ancestor
20010981|NCT02358863|Protective Agents|protective agents|mesh-ancestor
20010982|NCT02358863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010983|NCT02358863|Vitamin B Complex|vitamin b complex|mesh-ancestor
20291599|NCT01084252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20291600|NCT01084252|Antiemetics|antiemetics|mesh-ancestor
20291601|NCT01084252|Autonomic Agents|autonomic agents|mesh-ancestor
20291602|NCT01084252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20291603|NCT01084252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291604|NCT01084252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20291605|NCT01084252|Glucocorticoids|glucocorticoids|mesh-ancestor
20291606|NCT01084252|Hormones|hormones|mesh-ancestor
20291607|NCT01084252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20291608|NCT01084252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20291609|NCT01084252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291610|NCT01084252|Protease Inhibitors|protease inhibitors|mesh-ancestor
20291611|NCT01084252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291612|NCT01084252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291613|NCT00887536|Cyclophosphamide|cyclophosphamide|mesh-list
20291614|NCT00887536|Bevacizumab|bevacizumab|mesh-list
20291615|NCT00887536|Docetaxel|docetaxel|mesh-list
20291616|NCT00887536|Doxorubicin|doxorubicin|mesh-list
20291617|NCT00887536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20291618|NCT00887536|Immunologic Factors|immunologic factors|mesh-ancestor
20291619|NCT00887536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291620|NCT00887536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20291621|NCT00887536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20291622|NCT00887536|Alkylating Agents|alkylating agents|mesh-ancestor
20291623|NCT00887536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291624|NCT00887536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291625|NCT00887536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20010984|NCT02358863|Vitamins|vitamins|mesh-ancestor
20010985|NCT02358863|Micronutrients|micronutrients|mesh-ancestor
20010986|NCT02358863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20010987|NCT02358863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20010988|NCT02358889|Ranibizumab|ranibizumab|mesh-list
20010989|NCT02358889|Immunoconjugates|immunoconjugates|mesh-list
20010990|NCT02358889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20010991|NCT02358889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20010992|NCT02358889|Growth Substances|growth substances|mesh-ancestor
20010993|NCT02358889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20010994|NCT02358889|Growth Inhibitors|growth inhibitors|mesh-ancestor
20010995|NCT02358889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20010996|NCT02358889|Immunologic Factors|immunologic factors|mesh-ancestor
20291626|NCT00887536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20291627|NCT00887536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20291628|NCT00887536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20291629|NCT00887536|Growth Substances|growth substances|mesh-ancestor
20291630|NCT00887536|Growth Inhibitors|growth inhibitors|mesh-ancestor
20291631|NCT00887536|Tubulin Modulators|tubulin modulators|mesh-ancestor
20291632|NCT00887536|Antimitotic Agents|antimitotic agents|mesh-ancestor
20291633|NCT00887536|Mitosis Modulators|mitosis modulators|mesh-ancestor
20291634|NCT00887536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20291635|NCT00887536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20291636|NCT00887536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20291637|NCT00887536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291638|NCT00867321|Bevacizumab|bevacizumab|mesh-list
20291639|NCT00867321|Sorafenib|sorafenib|mesh-list
20559464|NCT01966172|Antipyretics|antipyretics|mesh-ancestor
20559465|NCT01966172|Anticonvulsants|anticonvulsants|mesh-ancestor
20559466|NCT01966172|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20559467|NCT01966172|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20559468|NCT01966172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20559469|NCT01966172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20559470|NCT01966172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20559471|NCT01966172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20010997|NCT02359006|Minocycline|minocycline|mesh-list
20010998|NCT02359006|Tetracycline|tetracycline|mesh-list
20010999|NCT02359006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20011000|NCT02359006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20559472|NCT01966172|Antimanic Agents|antimanic agents|mesh-ancestor
20559473|NCT01966263|Epinephrine|epinephrine|mesh-list
20559474|NCT01966263|Racepinephrine|racepinephrine|mesh-list
20559475|NCT01966263|Ropivacaine|ropivacaine|mesh-list
20559476|NCT01966263|Epinephryl borate|epinephryl borate|mesh-list
20559477|NCT01966263|Anesthetics, Local|anesthetics, local|mesh-ancestor
20559478|NCT01966263|Anesthetics|anesthetics|mesh-ancestor
20559479|NCT01966263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20559480|NCT01966263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559481|NCT01966263|Sensory System Agents|sensory system agents|mesh-ancestor
20559482|NCT01966263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559483|NCT01966263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20559484|NCT01966263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20559485|NCT01966263|Adrenergic Agents|adrenergic agents|mesh-ancestor
20559486|NCT01966263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20559487|NCT01966263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559488|NCT01966263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20559489|NCT01966263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20559490|NCT01966263|Autonomic Agents|autonomic agents|mesh-ancestor
20559491|NCT01966263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20559492|NCT01966263|Respiratory System Agents|respiratory system agents|mesh-ancestor
20559493|NCT01966263|Mydriatics|mydriatics|mesh-ancestor
20559494|NCT01966263|Sympathomimetics|sympathomimetics|mesh-ancestor
20559495|NCT01966263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20559496|NCT01966276|Methylphenidate|methylphenidate|mesh-list
20559497|NCT01966276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20559498|NCT01966276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559499|NCT01966276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20559500|NCT01966276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20559501|NCT01966276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20559502|NCT01966276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559503|NCT01966276|Dopamine Agents|dopamine agents|mesh-ancestor
20559504|NCT01966276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20559505|NCT01966289|Cyclophosphamide|cyclophosphamide|mesh-list
20559506|NCT01966289|Guadecitabine|guadecitabine|mesh-list
20559507|NCT01966289|Immunologic Factors|immunologic factors|mesh-ancestor
20559508|NCT01966289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559509|NCT01966289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20559510|NCT01966289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20559511|NCT01966289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20559512|NCT01966289|Alkylating Agents|alkylating agents|mesh-ancestor
20559513|NCT01966289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011001|NCT02359006|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20011002|NCT02359006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011003|NCT02359006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011004|NCT02359019|Pembrolizumab|pembrolizumab|mesh-list
20011005|NCT02359019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20011006|NCT02359019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011007|NCT02359058|Capecitabine|capecitabine|mesh-list
20291640|NCT00867321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20291641|NCT00867321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291642|NCT00867321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20291643|NCT00867321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20291644|NCT00867321|Growth Substances|growth substances|mesh-ancestor
20291645|NCT00867321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291646|NCT00867321|Growth Inhibitors|growth inhibitors|mesh-ancestor
20291647|NCT00867321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20291648|NCT00867321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291649|NCT00867321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291650|NCT00728754|Ethanol|ethanol|mesh-list
20291651|NCT00728754|Povidone-Iodine|povidone-iodine|mesh-list
20291652|NCT00728754|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20291653|NCT00728754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20291654|NCT00728754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20291655|NCT00728754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291656|NCT00723944|Ethanol|ethanol|mesh-list
20291657|NCT00723944|Povidone-Iodine|povidone-iodine|mesh-list
20291658|NCT00723944|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20291659|NCT00723944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20291660|NCT00723944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20291661|NCT00723944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291662|NCT00467142|Leucovorin|leucovorin|mesh-list
20291663|NCT00467142|Bevacizumab|bevacizumab|mesh-list
20291664|NCT00467142|Fluorouracil|fluorouracil|mesh-list
20291665|NCT00467142|Irinotecan|irinotecan|mesh-list
20291666|NCT00467142|Calcium|calcium|mesh-list
20291667|NCT00467142|Levoleucovorin|levoleucovorin|mesh-list
20291668|NCT00467142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20291669|NCT00467142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291670|NCT00467142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20291671|NCT00467142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20291672|NCT00467142|Growth Substances|growth substances|mesh-ancestor
20291673|NCT00467142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291674|NCT00467142|Growth Inhibitors|growth inhibitors|mesh-ancestor
20559514|NCT01966289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559515|NCT01966289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20559516|NCT01966302|Beraprost|beraprost|mesh-list
20559517|NCT01966302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20559518|NCT01966302|Vasodilator Agents|vasodilator agents|mesh-ancestor
20559519|NCT01966341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20559520|NCT01966341|Laxatives|laxatives|mesh-list
20559521|NCT01966341|Parasympatholytics|parasympatholytics|mesh-list
20559522|NCT01966341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20559523|NCT01966341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20559524|NCT01966341|Autonomic Agents|autonomic agents|mesh-ancestor
20559525|NCT01966341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20291675|NCT00467142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20291676|NCT00467142|Antimetabolites|antimetabolites|mesh-ancestor
20291677|NCT00467142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291678|NCT00467142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20291679|NCT00467142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20291680|NCT00467142|Immunologic Factors|immunologic factors|mesh-ancestor
20291681|NCT00467142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20291682|NCT00467142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20291683|NCT00467142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291684|NCT00467142|Antidotes|antidotes|mesh-ancestor
20291685|NCT00467142|Protective Agents|protective agents|mesh-ancestor
20291686|NCT00467142|Vitamin B Complex|vitamin b complex|mesh-ancestor
20291687|NCT00467142|Vitamins|vitamins|mesh-ancestor
20291688|NCT00467142|Micronutrients|micronutrients|mesh-ancestor
20291689|NCT05342597|Edaravone|edaravone|mesh-list
20291690|NCT05342597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20291691|NCT05342597|Antioxidants|antioxidants|mesh-ancestor
20291692|NCT05342597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291693|NCT05342597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20291694|NCT05342597|Protective Agents|protective agents|mesh-ancestor
20291695|NCT05342597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291696|NCT05342558|Fluticasone|fluticasone|mesh-list
20291697|NCT05342558|Xhance|xhance|mesh-list
20291698|NCT05342558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20291699|NCT05342558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20291700|NCT05342558|Autonomic Agents|autonomic agents|mesh-ancestor
20291701|NCT05342558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20291702|NCT05342558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291703|NCT05342558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20291704|NCT05342558|Respiratory System Agents|respiratory system agents|mesh-ancestor
20291705|NCT05342558|Dermatologic Agents|dermatologic agents|mesh-ancestor
20291706|NCT05342558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20291707|NCT05342532|Amoxicillin|amoxicillin|mesh-list
20291708|NCT05342532|Clarithromycin|clarithromycin|mesh-list
20291709|NCT05342532|Omeprazole|omeprazole|mesh-list
20291710|NCT05342532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20291711|NCT05342532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20291712|NCT05342532|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20291713|NCT05342532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20291714|NCT05342532|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20291715|NCT05342532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291716|NCT05342532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291717|NCT05342532|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20291718|NCT05342532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20291719|NCT05342532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20291720|NCT05342519|Sirolimus|sirolimus|mesh-list
20291721|NCT05342519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20291722|NCT05342519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20291723|NCT05342519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20291724|NCT05342519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291725|NCT05342519|Antifungal Agents|antifungal agents|mesh-ancestor
20291726|NCT05342519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20291727|NCT05342519|Immunologic Factors|immunologic factors|mesh-ancestor
20291728|NCT05342519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291729|NCT05342389|Apatinib|apatinib|mesh-list
20291730|NCT05342389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291731|NCT05342389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20291732|NCT05342389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291733|NCT05342389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291734|NCT05342272|Lactoferrin|lactoferrin|mesh-list
20291735|NCT05342272|Betaine|betaine|mesh-list
20291736|NCT05342272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20291737|NCT05342272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20291738|NCT05342272|Lipotropic Agents|lipotropic agents|mesh-ancestor
20291739|NCT05342272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20291740|NCT05342272|Antimetabolites|antimetabolites|mesh-ancestor
20291741|NCT05342272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291742|NCT05342272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20291743|NCT05342194|Gemcitabine|gemcitabine|mesh-list
20291744|NCT05342194|Oxaliplatin|oxaliplatin|mesh-list
20291745|NCT05342194|Lenvatinib|lenvatinib|mesh-list
20291746|NCT05342194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291747|NCT05342194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20291748|NCT05342194|Antimetabolites|antimetabolites|mesh-ancestor
20291749|NCT05342194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291750|NCT05342194|Antiviral Agents|antiviral agents|mesh-ancestor
20291751|NCT05342194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20291752|NCT05342194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291753|NCT05342194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20291754|NCT05342194|Immunologic Factors|immunologic factors|mesh-ancestor
20291755|NCT05342194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291756|NCT05342194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20291757|NCT05341999|Ibuprofen|ibuprofen|mesh-list
20291758|NCT05341999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20291759|NCT05341999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20291760|NCT05341999|Analgesics|analgesics|mesh-ancestor
20291761|NCT05341999|Sensory System Agents|sensory system agents|mesh-ancestor
20291762|NCT05341999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20291763|NCT05341999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291764|NCT05341999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20291765|NCT05341999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20291766|NCT05341999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20291767|NCT05341999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291768|NCT05341999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559526|NCT01966341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559527|NCT01966484|Succinylcholine|succinylcholine|mesh-list
20559528|NCT01966484|Mivacurium|mivacurium|mesh-list
20559529|NCT01966484|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
20559530|NCT01966484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20559531|NCT01966484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20559532|NCT01966484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559533|NCT01966484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559534|NCT01966484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20291769|NCT05341856|Isosorbide|isosorbide|mesh-list
20291770|NCT05341856|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20291771|NCT05341856|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20291772|NCT05341856|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20291773|NCT05341856|Diuretics|diuretics|mesh-ancestor
20291774|NCT05341856|Natriuretic Agents|natriuretic agents|mesh-ancestor
20291775|NCT05341856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291776|NCT05341856|Vasodilator Agents|vasodilator agents|mesh-ancestor
20291777|NCT05341856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20291778|NCT05341856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291779|NCT05341843|Sertraline|sertraline|mesh-list
20291780|NCT05341843|Antidepressive Agents|antidepressive agents|mesh-ancestor
20291781|NCT05341843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20291782|NCT05341843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20291783|NCT05341843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20291784|NCT05341843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20291785|NCT05341843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291786|NCT05341843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20291787|NCT05341843|Serotonin Agents|serotonin agents|mesh-ancestor
20291788|NCT05341843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291789|NCT05341817|Letrozole|letrozole|mesh-list
20291790|NCT05341817|Mifepristone|mifepristone|mesh-list
20291791|NCT05341817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291792|NCT05341817|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20291793|NCT05341817|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20291794|NCT05341817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291795|NCT05341817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291796|NCT05341817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20291797|NCT05341817|Hormone Antagonists|hormone antagonists|mesh-ancestor
20291798|NCT05341817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20291799|NCT05341817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291800|NCT05341817|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20291801|NCT05341817|Abortifacient Agents|abortifacient agents|mesh-ancestor
20291802|NCT05341817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20291803|NCT05341817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20291804|NCT05341817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20291805|NCT05341817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20291806|NCT05341817|Contraceptive Agents|contraceptive agents|mesh-ancestor
20291807|NCT05341817|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20291808|NCT05341817|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20291809|NCT05341817|Luteolytic Agents|luteolytic agents|mesh-ancestor
20291810|NCT05341817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20291811|NCT05341817|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20291812|NCT05341583|Ensartinib|ensartinib|mesh-list
20291813|NCT05341583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291814|NCT05341583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20291815|NCT05341583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291816|NCT05341583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291817|NCT05341401|Prednisolone|prednisolone|mesh-list
20291818|NCT05341401|Budesonide|budesonide|mesh-list
20291819|NCT05341401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20291820|NCT05341401|Glucocorticoids|glucocorticoids|mesh-ancestor
20291821|NCT05341401|Hormones|hormones|mesh-ancestor
20291822|NCT05341401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20291823|NCT05341401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291824|NCT05341401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20291825|NCT05341401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291826|NCT05341401|Autonomic Agents|autonomic agents|mesh-ancestor
20291827|NCT05341401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20291828|NCT05341401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20291829|NCT05341401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20291830|NCT05341401|Respiratory System Agents|respiratory system agents|mesh-ancestor
20291831|NCT05341349|Pembrolizumab|pembrolizumab|mesh-list
20291832|NCT05341349|Nivolumab|nivolumab|mesh-list
20291833|NCT05341349|Ipilimumab|ipilimumab|mesh-list
20291834|NCT05341349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20291835|NCT05341349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291836|NCT05341349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20291837|NCT05341349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291838|NCT05341323|Ketamine|ketamine|mesh-list
20291839|NCT05341323|Bupivacaine|bupivacaine|mesh-list
20291840|NCT05341323|Anesthetics, Local|anesthetics, local|mesh-ancestor
20291841|NCT05341323|Anesthetics|anesthetics|mesh-ancestor
20291842|NCT05341323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20291843|NCT05341323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291844|NCT05341323|Sensory System Agents|sensory system agents|mesh-ancestor
20291845|NCT05341323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20291846|NCT05341323|Analgesics|analgesics|mesh-ancestor
20291847|NCT05341323|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20291848|NCT05341323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20291849|NCT05341323|Anesthetics, General|anesthetics, general|mesh-ancestor
20291850|NCT05341323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20291851|NCT05341323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20291852|NCT05341323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20291853|NCT05341323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291854|NCT05341193|Gemcitabine|gemcitabine|mesh-list
20291855|NCT05341193|Bevacizumab|bevacizumab|mesh-list
20291856|NCT05341193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20291857|NCT05341193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20291858|NCT05341193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20291859|NCT05341193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20291860|NCT05341193|Growth Substances|growth substances|mesh-ancestor
20291861|NCT05341193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291862|NCT05341193|Growth Inhibitors|growth inhibitors|mesh-ancestor
20291863|NCT05341193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20291864|NCT05341193|Antimetabolites|antimetabolites|mesh-ancestor
20291865|NCT05341193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291866|NCT05341193|Antiviral Agents|antiviral agents|mesh-ancestor
20291867|NCT05341193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20291868|NCT05341193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20291869|NCT05341193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20291870|NCT05341193|Immunologic Factors|immunologic factors|mesh-ancestor
20291871|NCT05341167|Phenylephrine|phenylephrine|mesh-list
20291872|NCT05341167|Oxymetazoline|oxymetazoline|mesh-list
20291873|NCT05341167|Norepinephrine|norepinephrine|mesh-list
20291874|NCT05341167|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20291875|NCT05341167|Mydriatics|mydriatics|mesh-ancestor
20291876|NCT05341167|Autonomic Agents|autonomic agents|mesh-ancestor
20291877|NCT05341167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20291878|NCT05341167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291879|NCT05341167|Sympathomimetics|sympathomimetics|mesh-ancestor
20291880|NCT05341167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20291881|NCT05341167|Nasal Decongestants|nasal decongestants|mesh-ancestor
20291882|NCT05341167|Respiratory System Agents|respiratory system agents|mesh-ancestor
20291883|NCT05341167|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20291884|NCT05341167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20291885|NCT05341167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20291886|NCT05341167|Adrenergic Agents|adrenergic agents|mesh-ancestor
20291887|NCT05341167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20291888|NCT05341167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291889|NCT05341167|Protective Agents|protective agents|mesh-ancestor
20291890|NCT05341154|Dexmedetomidine|dexmedetomidine|mesh-list
20291891|NCT05341154|Ketamine|ketamine|mesh-list
20291892|NCT05341154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20291893|NCT05341154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20291894|NCT05341154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291895|NCT05341154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20291896|NCT05341154|Analgesics|analgesics|mesh-ancestor
20291897|NCT05341154|Sensory System Agents|sensory system agents|mesh-ancestor
20291898|NCT05341154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20291899|NCT05341154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20291900|NCT05341154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20291901|NCT05341154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20291902|NCT05341154|Adrenergic Agents|adrenergic agents|mesh-ancestor
20291903|NCT05341154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20291904|NCT05341154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291905|NCT05341154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20291906|NCT05341154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20291907|NCT05341154|Anesthetics, General|anesthetics, general|mesh-ancestor
20291908|NCT05341154|Anesthetics|anesthetics|mesh-ancestor
20291909|NCT05341154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20291910|NCT05341154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20291911|NCT05341076|Oxytocin|oxytocin|mesh-list
20291912|NCT05341076|Oxytocics|oxytocics|mesh-ancestor
20291913|NCT05341076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20291914|NCT05341076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291915|NCT05340985|Vitamin D|vitamin d|mesh-list
20291916|NCT05340985|Ergocalciferols|ergocalciferols|mesh-list
20291917|NCT05340985|Cholecalciferol|cholecalciferol|mesh-list
20291918|NCT05340985|Calcifediol|calcifediol|mesh-list
20291919|NCT05340985|Vitamins|vitamins|mesh-list
20291920|NCT05340985|Dehydrocholesterols|dehydrocholesterols|mesh-list
20291921|NCT05340985|7-dehydrocholesterol|7-dehydrocholesterol|mesh-list
20291922|NCT05340985|Micronutrients|micronutrients|mesh-ancestor
20291923|NCT05340985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291924|NCT05340985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20291925|NCT05340985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20291926|NCT05340985|Provitamins|provitamins|mesh-ancestor
20291927|NCT05340946|Anesthetics|anesthetics|mesh-list
20291928|NCT05340946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20291929|NCT05340946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291930|NCT05340803|Magnesium Sulfate|magnesium sulfate|mesh-list
20291931|NCT05340803|Midazolam|midazolam|mesh-list
20291932|NCT05340803|Dexmedetomidine|dexmedetomidine|mesh-list
20291933|NCT05340803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20291934|NCT05340803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20291935|NCT05340803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291936|NCT05340803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20291937|NCT05340803|Analgesics|analgesics|mesh-ancestor
20291938|NCT05340803|Sensory System Agents|sensory system agents|mesh-ancestor
20291939|NCT05340803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20291940|NCT05340803|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20291941|NCT05340803|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20291942|NCT05340803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20291943|NCT05340803|Adrenergic Agents|adrenergic agents|mesh-ancestor
20291944|NCT05340803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20291945|NCT05340803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291946|NCT05340803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20291947|NCT05340803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20291948|NCT05340803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20291949|NCT05340803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20291950|NCT05340803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20291951|NCT05340803|Anesthetics, General|anesthetics, general|mesh-ancestor
20291952|NCT05340803|Anesthetics|anesthetics|mesh-ancestor
20291953|NCT05340803|GABA Modulators|gaba modulators|mesh-ancestor
20291954|NCT05340803|GABA Agents|gaba agents|mesh-ancestor
20291955|NCT05340803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20291956|NCT05340803|Anticonvulsants|anticonvulsants|mesh-ancestor
20291957|NCT05340803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20291958|NCT05340803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20291959|NCT05340803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20291960|NCT05340803|Tocolytic Agents|tocolytic agents|mesh-ancestor
20291961|NCT05340803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20291962|NCT05340790|Anti-Infective Agents|anti-infective agents|mesh-list
20291963|NCT05340790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20291964|NCT05340764|Infliximab|infliximab|mesh-list
20291965|NCT05340764|Dermatologic Agents|dermatologic agents|mesh-ancestor
20291966|NCT05340764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20291967|NCT05340764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20291968|NCT05340725|Dexmedetomidine|dexmedetomidine|mesh-list
20291969|NCT05340725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20291970|NCT05340725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20291971|NCT05340725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291972|NCT05340725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20291973|NCT05340725|Analgesics|analgesics|mesh-ancestor
20291974|NCT05340725|Sensory System Agents|sensory system agents|mesh-ancestor
20291975|NCT05340725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20291976|NCT05340725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20291977|NCT05340725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20291978|NCT05340725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20291979|NCT05340725|Adrenergic Agents|adrenergic agents|mesh-ancestor
20291980|NCT05340725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20291981|NCT05340725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20291982|NCT05340673|Petrolatum|petrolatum|mesh-list
20291983|NCT05340673|Mineral Oil|mineral oil|mesh-list
20291984|NCT05340673|Emollients|emollients|mesh-ancestor
20291985|NCT05340673|Dermatologic Agents|dermatologic agents|mesh-ancestor
20291986|NCT05340634|Contraceptive Agents|contraceptive agents|mesh-list
20291987|NCT05340634|Contraceptives, Oral|contraceptives, oral|mesh-list
20291988|NCT05340634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20291989|NCT05340634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291990|NCT05340634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20291991|NCT05340582|Acetaminophen|acetaminophen|mesh-list
20291992|NCT05340582|Ibuprofen|ibuprofen|mesh-list
20291993|NCT05340582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20291994|NCT05340582|Analgesics|analgesics|mesh-ancestor
20291995|NCT05340582|Sensory System Agents|sensory system agents|mesh-ancestor
20291996|NCT05340582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20291997|NCT05340582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20291998|NCT05340582|Antipyretics|antipyretics|mesh-ancestor
20291999|NCT05340582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20292000|NCT05340582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20292001|NCT05340582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20292002|NCT05340582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20292003|NCT05340582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292004|NCT05340582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20292005|NCT05340530|Meropenem|meropenem|mesh-list
20292006|NCT05340530|Avibactam|avibactam|mesh-list
20292007|NCT05340530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20292008|NCT05340530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20292009|NCT05340530|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20292010|NCT05340530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20292011|NCT05340530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559535|NCT01966575|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20559536|NCT01966575|Medroxyprogesterone|medroxyprogesterone|mesh-list
20559537|NCT01966575|Progestins|progestins|mesh-list
20559538|NCT01966575|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20559539|NCT01966575|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20559540|NCT01966575|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20559541|NCT01966575|Contraceptive Agents|contraceptive agents|mesh-ancestor
20559542|NCT01966575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20559543|NCT01966575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559544|NCT01966575|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20559545|NCT01966575|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20559546|NCT01966575|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20559547|NCT01966575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20559548|NCT01966575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559549|NCT01966575|Hormones|hormones|mesh-ancestor
20559550|NCT01966575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20559551|NCT01966627|Liver Extracts|liver extracts|mesh-list
20559552|NCT01966627|Hematinics|hematinics|mesh-ancestor
20559553|NCT01966653|Fosfomycin|fosfomycin|mesh-list
20559554|NCT01966653|Nitrofurantoin|nitrofurantoin|mesh-list
20559555|NCT01966653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20559556|NCT01966653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20559557|NCT01966653|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20559558|NCT01966653|Renal Agents|renal agents|mesh-ancestor
20559559|NCT01966692|Fluticasone|fluticasone|mesh-list
20559560|NCT01966692|Xhance|xhance|mesh-list
20559561|NCT01966692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20559562|NCT01966692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20559563|NCT01966692|Autonomic Agents|autonomic agents|mesh-ancestor
20559564|NCT01966692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559565|NCT01966692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559566|NCT01966692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20559567|NCT01966692|Respiratory System Agents|respiratory system agents|mesh-ancestor
20559568|NCT01966692|Dermatologic Agents|dermatologic agents|mesh-ancestor
20559569|NCT01966692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20559570|NCT01966783|Budesonide|budesonide|mesh-list
20559571|NCT01966783|Mesalamine|mesalamine|mesh-list
20559572|NCT01966783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20559573|NCT01966783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20559574|NCT01966783|Autonomic Agents|autonomic agents|mesh-ancestor
20559575|NCT01966783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559576|NCT01966783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559577|NCT01966783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20559578|NCT01966783|Respiratory System Agents|respiratory system agents|mesh-ancestor
20559579|NCT01966783|Glucocorticoids|glucocorticoids|mesh-ancestor
20559580|NCT01966783|Hormones|hormones|mesh-ancestor
20559581|NCT01966783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20559582|NCT01966783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20559583|NCT01966783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20559584|NCT01966783|Analgesics|analgesics|mesh-ancestor
20559585|NCT01966783|Sensory System Agents|sensory system agents|mesh-ancestor
20559586|NCT01966783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20559587|NCT01966822|Ritonavir|ritonavir|mesh-list
20559588|NCT01966822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
20559589|NCT01966822|Dolutegravir|dolutegravir|mesh-list
20559590|NCT01966822|Protease Inhibitors|protease inhibitors|mesh-list
20559591|NCT01966822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20559592|NCT01966822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559593|NCT01966822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559594|NCT01966822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20559595|NCT01966822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20559596|NCT01966822|Antiviral Agents|antiviral agents|mesh-ancestor
20559597|NCT01966822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20559598|NCT01966822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20559599|NCT01966822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20559600|NCT01966822|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20559601|NCT01966822|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20559602|NCT01966913|Bevacizumab|bevacizumab|mesh-list
20559603|NCT01966913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20559604|NCT01966913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559605|NCT01966913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20559606|NCT01966913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20559607|NCT01966913|Growth Substances|growth substances|mesh-ancestor
20559608|NCT01966913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559609|NCT01966913|Growth Inhibitors|growth inhibitors|mesh-ancestor
20559610|NCT01967017|Lidocaine|lidocaine|mesh-list
20559611|NCT01967017|Anesthetics, Local|anesthetics, local|mesh-ancestor
20559612|NCT01967017|Anesthetics|anesthetics|mesh-ancestor
20559613|NCT01967017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20559614|NCT01967017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559615|NCT01967017|Sensory System Agents|sensory system agents|mesh-ancestor
20559616|NCT01967017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559617|NCT01967017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20559618|NCT01967017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20559619|NCT01967017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20559620|NCT01967017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20559621|NCT01967017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559622|NCT01967095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20559623|NCT01967095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559624|NCT01967095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20559625|NCT01967095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559626|NCT01967095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559627|NCT01967199|Paclitaxel|paclitaxel|mesh-list
20559628|NCT01967199|Everolimus|everolimus|mesh-list
20559629|NCT01967199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20559630|NCT01967199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559631|NCT01967199|Tubulin Modulators|tubulin modulators|mesh-ancestor
20559632|NCT01967199|Antimitotic Agents|antimitotic agents|mesh-ancestor
20559633|NCT01967199|Mitosis Modulators|mitosis modulators|mesh-ancestor
20559634|NCT01967199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559635|NCT01967199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20559636|NCT01967199|Immunologic Factors|immunologic factors|mesh-ancestor
20559637|NCT01967199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559638|NCT01967238|Vaccines|vaccines|mesh-list
20559639|NCT01967238|Immunologic Factors|immunologic factors|mesh-ancestor
20559640|NCT01967238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559641|NCT01967251|Udenafil|udenafil|mesh-list
20559642|NCT01967251|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20559643|NCT01967251|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20559644|NCT01967251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559645|NCT01967251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559646|NCT01967264|Udenafil|udenafil|mesh-list
20559647|NCT01967264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20559648|NCT01967264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20559649|NCT01967264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559650|NCT01967264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559651|NCT01967368|Vaccines|vaccines|mesh-list
20559652|NCT01967368|Immunologic Factors|immunologic factors|mesh-ancestor
20559653|NCT01967368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559654|NCT01967381|Methamphetamine|methamphetamine|mesh-list
20559655|NCT01967381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20559656|NCT01967381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559657|NCT01967381|Sympathomimetics|sympathomimetics|mesh-ancestor
20559658|NCT01967381|Autonomic Agents|autonomic agents|mesh-ancestor
20559659|NCT01967381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559660|NCT01967381|Dopamine Agents|dopamine agents|mesh-ancestor
20559661|NCT01967381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20559662|NCT01967381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559663|NCT01967381|Adrenergic Agents|adrenergic agents|mesh-ancestor
20559664|NCT01967381|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20559665|NCT01967381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20559666|NCT01967381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20559667|NCT01967381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20559668|NCT01967459|Cholecalciferol|cholecalciferol|mesh-list
20559669|NCT01967459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20559670|NCT01967459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559671|NCT01967459|Vitamins|vitamins|mesh-ancestor
20559672|NCT01967459|Micronutrients|micronutrients|mesh-ancestor
20559673|NCT01967459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20559674|NCT01967472|Artesunate|artesunate|mesh-list
20559675|NCT01967472|Lumefantrine|lumefantrine|mesh-list
20559676|NCT01967472|Artemether|artemether|mesh-list
20559677|NCT01967472|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20559678|NCT01967472|Amodiaquine|amodiaquine|mesh-list
20559679|NCT01967472|Antimalarials|antimalarials|mesh-ancestor
20559680|NCT01967472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20559681|NCT01967472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20559682|NCT01967472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20559683|NCT01967472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559684|NCT01967472|Antiviral Agents|antiviral agents|mesh-ancestor
20559685|NCT01967472|Schistosomicides|schistosomicides|mesh-ancestor
20559686|NCT01967472|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20559687|NCT01967472|Anthelmintics|anthelmintics|mesh-ancestor
20559688|NCT01967498|Montelukast|montelukast|mesh-list
20559689|NCT01967498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20559690|NCT01967498|Respiratory System Agents|respiratory system agents|mesh-ancestor
20559691|NCT01967498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20559692|NCT01967498|Hormone Antagonists|hormone antagonists|mesh-ancestor
20559693|NCT01967498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20559694|NCT01967498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559695|NCT01967498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20559696|NCT01967498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20559697|NCT01967498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559698|NCT01967524|Ropivacaine|ropivacaine|mesh-list
20559699|NCT01967524|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20559700|NCT01967524|Botulinum Toxins|botulinum toxins|mesh-list
20559701|NCT01967524|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20559702|NCT01967524|Anesthetics, Local|anesthetics, local|mesh-ancestor
20559703|NCT01967524|Anesthetics|anesthetics|mesh-ancestor
20559704|NCT01967524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20559705|NCT01967524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559706|NCT01967524|Sensory System Agents|sensory system agents|mesh-ancestor
20559707|NCT01967524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559708|NCT01967524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20559709|NCT01967524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20559710|NCT01967524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559711|NCT01967524|Cholinergic Agents|cholinergic agents|mesh-ancestor
20559712|NCT01967524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20559713|NCT01967524|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20559714|NCT01967758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20559715|NCT01967758|Amoxicillin|amoxicillin|mesh-list
20559716|NCT01967758|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
20559717|NCT01967758|Trimethoprim|trimethoprim|mesh-list
20559718|NCT01967758|Sulfamethoxazole|sulfamethoxazole|mesh-list
20559719|NCT01967758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20559720|NCT01967758|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20559721|NCT01967758|Renal Agents|renal agents|mesh-ancestor
20559722|NCT01967758|Antimalarials|antimalarials|mesh-ancestor
20559723|NCT01967758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20559724|NCT01967758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20559725|NCT01967758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20559726|NCT01967758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559727|NCT01967758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559728|NCT01967758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20559729|NCT01967758|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
20559730|NCT01967758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20559731|NCT01967758|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20559732|NCT01967823|Aldesleukin|aldesleukin|mesh-list
20559733|NCT01967823|Cyclophosphamide|cyclophosphamide|mesh-list
20559734|NCT01967823|Fludarabine|fludarabine|mesh-list
20559735|NCT01967823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20559736|NCT01967823|Immunologic Factors|immunologic factors|mesh-ancestor
20559737|NCT01967823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559738|NCT01967823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20559739|NCT01967823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20559740|NCT01967823|Alkylating Agents|alkylating agents|mesh-ancestor
20559741|NCT01967823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559742|NCT01967823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559743|NCT01967823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20559744|NCT01967823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20559745|NCT01967823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20559746|NCT01967823|Antiviral Agents|antiviral agents|mesh-ancestor
20559747|NCT01967823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20559748|NCT01967875|Docetaxel|docetaxel|mesh-list
20559749|NCT01967875|Capecitabine|capecitabine|mesh-list
20559750|NCT01967875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559751|NCT01967875|Tubulin Modulators|tubulin modulators|mesh-ancestor
20559752|NCT01967875|Antimitotic Agents|antimitotic agents|mesh-ancestor
20559753|NCT01967875|Mitosis Modulators|mitosis modulators|mesh-ancestor
20559754|NCT01967875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559755|NCT01967875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20559756|NCT01967875|Antimetabolites|antimetabolites|mesh-ancestor
20559757|NCT01967927|Imidazole|imidazole|mesh-list
20559758|NCT01967927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559759|NCT01967927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559760|NCT01967979|Itraconazole|itraconazole|mesh-list
20559761|NCT01967979|Fluoxetine|fluoxetine|mesh-list
20559762|NCT01967979|Antifungal Agents|antifungal agents|mesh-ancestor
20559763|NCT01967979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20559764|NCT01967979|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20559765|NCT01967979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20559766|NCT01967979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559767|NCT01967979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559768|NCT01967979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20559769|NCT01967979|Hormone Antagonists|hormone antagonists|mesh-ancestor
20559770|NCT01967979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20559771|NCT01967979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559772|NCT01967979|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20559773|NCT01967979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20559774|NCT01967979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20559775|NCT01967979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20559776|NCT01967979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20559777|NCT01967979|Serotonin Agents|serotonin agents|mesh-ancestor
20559778|NCT01967979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20559779|NCT01967979|Antidepressive Agents|antidepressive agents|mesh-ancestor
20559780|NCT01967979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20559781|NCT01967979|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20559782|NCT01968005|Etodolac|etodolac|mesh-list
20559783|NCT01968005|Lidocaine|lidocaine|mesh-list
20559784|NCT01968005|Anesthetics, Local|anesthetics, local|mesh-ancestor
20559785|NCT01968005|Anesthetics|anesthetics|mesh-ancestor
20559786|NCT01968005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20559787|NCT01968005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559788|NCT01968005|Sensory System Agents|sensory system agents|mesh-ancestor
20559789|NCT01968005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559790|NCT01968005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20559791|NCT01968005|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20559792|NCT01968005|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20559793|NCT01968005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20559794|NCT01968005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559795|NCT01968005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20559796|NCT01968005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20559797|NCT01968005|Analgesics|analgesics|mesh-ancestor
20559798|NCT01968005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20559799|NCT01968005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20559800|NCT01968005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20559801|NCT01968005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20559802|NCT01968005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559803|NCT01968018|Acetaminophen|acetaminophen|mesh-list
20559804|NCT01968018|Tramadol|tramadol|mesh-list
20559805|NCT01968018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20559806|NCT01968018|Analgesics|analgesics|mesh-ancestor
20559807|NCT01968018|Sensory System Agents|sensory system agents|mesh-ancestor
20559808|NCT01968018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559809|NCT01968018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559810|NCT01968018|Antipyretics|antipyretics|mesh-ancestor
20559811|NCT01968018|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20559812|NCT01968018|Narcotics|narcotics|mesh-ancestor
20559813|NCT01968018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20559814|NCT01968044|Linagliptin|linagliptin|mesh-list
20559815|NCT01968044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20559816|NCT01968044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559817|NCT01968044|Incretins|incretins|mesh-ancestor
20559818|NCT01968044|Hormones|hormones|mesh-ancestor
20559819|NCT01968044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20559820|NCT01968044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20559821|NCT01968044|Protease Inhibitors|protease inhibitors|mesh-ancestor
20559822|NCT01968044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559823|NCT01968044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559824|NCT01968083|Vaccines|vaccines|mesh-list
20559825|NCT01968083|Immunologic Factors|immunologic factors|mesh-ancestor
20559826|NCT01968083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559827|NCT01968161|Asenapine|asenapine|mesh-list
20559828|NCT01968161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20559829|NCT01968161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20559830|NCT01968161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20559831|NCT01968161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559832|NCT01968161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20559833|NCT01968200|Enalapril|enalapril|mesh-list
20559834|NCT01968200|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20559835|NCT01968200|Protease Inhibitors|protease inhibitors|mesh-ancestor
20559836|NCT01968200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559837|NCT01968200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559838|NCT01968200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20559839|NCT01968239|Ranibizumab|ranibizumab|mesh-list
20559840|NCT01968239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20559841|NCT01968239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20559842|NCT01968239|Growth Substances|growth substances|mesh-ancestor
20559843|NCT01968239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559844|NCT01968239|Growth Inhibitors|growth inhibitors|mesh-ancestor
20559845|NCT01968239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559846|NCT01968395|Caspofungin|caspofungin|mesh-list
20559847|NCT01968395|Antifungal Agents|antifungal agents|mesh-ancestor
20559848|NCT01968395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20559849|NCT01968395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559850|NCT01968395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559851|NCT01968460|Pramipexole|pramipexole|mesh-list
20559852|NCT01968460|Rasagiline|rasagiline|mesh-list
20559853|NCT01968460|Antioxidants|antioxidants|mesh-ancestor
20559854|NCT01968460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559855|NCT01968460|Protective Agents|protective agents|mesh-ancestor
20559856|NCT01968460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559857|NCT01968460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20559858|NCT01968460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20559859|NCT01968460|Dopamine Agonists|dopamine agonists|mesh-ancestor
20559860|NCT01968460|Dopamine Agents|dopamine agents|mesh-ancestor
20559861|NCT01968460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20559862|NCT01968460|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20559863|NCT01968460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559864|NCT01968460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20559865|NCT01968486|Ranibizumab|ranibizumab|mesh-list
20559866|NCT01968486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20559867|NCT01968486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20559868|NCT01968486|Growth Substances|growth substances|mesh-ancestor
20559869|NCT01968486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559870|NCT01968486|Growth Inhibitors|growth inhibitors|mesh-ancestor
20559871|NCT01968486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559872|NCT01968564|Curcumin|curcumin|mesh-list
20559873|NCT01968564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20559874|NCT01968564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20559875|NCT01968564|Analgesics|analgesics|mesh-ancestor
20559876|NCT01968564|Sensory System Agents|sensory system agents|mesh-ancestor
20559877|NCT01968564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559878|NCT01968564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559879|NCT01968564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20559880|NCT01968564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20559881|NCT01968564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559882|NCT01968564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559883|NCT01968564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559884|NCT01968577|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20559885|NCT01968577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20559886|NCT01968577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20559887|NCT01968577|Antimetabolites|antimetabolites|mesh-ancestor
20559888|NCT01968577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559889|NCT01968577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20559890|NCT01968577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20559891|NCT01968577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559892|NCT01968616|Ranibizumab|ranibizumab|mesh-list
20559893|NCT01968616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20559894|NCT01968616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20559895|NCT01968616|Growth Substances|growth substances|mesh-ancestor
20559896|NCT01968616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559897|NCT01968616|Growth Inhibitors|growth inhibitors|mesh-ancestor
20559898|NCT01968616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559899|NCT01968655|Factor VIII|factor viii|mesh-list
20559900|NCT01968655|Coagulants|coagulants|mesh-ancestor
20559901|NCT01968759|Ramipril|ramipril|mesh-list
20559902|NCT01968759|Irbesartan|irbesartan|mesh-list
20559903|NCT01968759|Sevelamer|sevelamer|mesh-list
20559904|NCT01968759|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20559905|NCT01968759|Protease Inhibitors|protease inhibitors|mesh-ancestor
20559906|NCT01968759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559907|NCT01968759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559908|NCT01968759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20559909|NCT01968759|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20559910|NCT01968759|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20559911|NCT01968759|Chelating Agents|chelating agents|mesh-ancestor
20559912|NCT01968759|Sequestering Agents|sequestering agents|mesh-ancestor
20559913|NCT01968798|Aspirin|aspirin|mesh-list
20559914|NCT01968798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20559915|NCT01968798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20559916|NCT01968798|Analgesics|analgesics|mesh-ancestor
20559917|NCT01968798|Sensory System Agents|sensory system agents|mesh-ancestor
20559918|NCT01968798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559919|NCT01968798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559920|NCT01968798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20559921|NCT01968798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20559922|NCT01968798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20559923|NCT01968798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20559924|NCT01968798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559925|NCT01968798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20559926|NCT01968798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20559927|NCT01968798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559928|NCT01968798|Antipyretics|antipyretics|mesh-ancestor
20559929|NCT01968850|Vitamin D|vitamin d|mesh-list
20559930|NCT01968850|Alendronate|alendronate|mesh-list
20559931|NCT01968850|Vitamins|vitamins|mesh-ancestor
20559932|NCT01968850|Micronutrients|micronutrients|mesh-ancestor
20559933|NCT01968850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559934|NCT01968850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20559935|NCT01968915|Paclitaxel|paclitaxel|mesh-list
20559936|NCT01968915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20559937|NCT01968915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559938|NCT01968915|Tubulin Modulators|tubulin modulators|mesh-ancestor
20559939|NCT01968915|Antimitotic Agents|antimitotic agents|mesh-ancestor
20559940|NCT01968915|Mitosis Modulators|mitosis modulators|mesh-ancestor
20559941|NCT01968915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559942|NCT01969006|Bupivacaine|bupivacaine|mesh-list
20559943|NCT01969006|Anesthetics, Local|anesthetics, local|mesh-ancestor
20559944|NCT01969006|Anesthetics|anesthetics|mesh-ancestor
20559945|NCT01969006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20559946|NCT01969006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559947|NCT01969006|Sensory System Agents|sensory system agents|mesh-ancestor
20559948|NCT01969006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559949|NCT01969019|Prednisone|prednisone|mesh-list
20559950|NCT01969019|Methylprednisolone|methylprednisolone|mesh-list
20559951|NCT01969019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20559952|NCT01969019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20559953|NCT01969019|Prednisolone|prednisolone|mesh-list
20559954|NCT01969019|Prednisolone acetate|prednisolone acetate|mesh-list
20559955|NCT01969019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20559956|NCT01969019|Prednisolone phosphate|prednisolone phosphate|mesh-list
20559957|NCT01969019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20559958|NCT01969019|Glucocorticoids|glucocorticoids|mesh-ancestor
20559959|NCT01969019|Hormones|hormones|mesh-ancestor
20559960|NCT01969019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20559961|NCT01969019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559962|NCT01969019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20559963|NCT01969019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559964|NCT01969019|Antiemetics|antiemetics|mesh-ancestor
20559965|NCT01969019|Autonomic Agents|autonomic agents|mesh-ancestor
20559966|NCT01969019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20559967|NCT01969019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20559968|NCT01969019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20559969|NCT01969019|Protective Agents|protective agents|mesh-ancestor
20559970|NCT01969032|Paclitaxel|paclitaxel|mesh-list
20559971|NCT01969032|Doxorubicin|doxorubicin|mesh-list
20559972|NCT01969032|Capecitabine|capecitabine|mesh-list
20559973|NCT01969032|Cyclophosphamide|cyclophosphamide|mesh-list
20559974|NCT01969032|Carboplatin|carboplatin|mesh-list
20559975|NCT01969032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20559976|NCT01969032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20559977|NCT01969032|Tubulin Modulators|tubulin modulators|mesh-ancestor
20559978|NCT01969032|Antimitotic Agents|antimitotic agents|mesh-ancestor
20559979|NCT01969032|Mitosis Modulators|mitosis modulators|mesh-ancestor
20559980|NCT01969032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20559981|NCT01969032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20559982|NCT01969032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20559983|NCT01969032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20559984|NCT01969032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20559985|NCT01969032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20559986|NCT01969032|Antimetabolites|antimetabolites|mesh-ancestor
20559987|NCT01969032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20559988|NCT01969032|Immunologic Factors|immunologic factors|mesh-ancestor
20559989|NCT01969032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20559990|NCT01969032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20559991|NCT01969032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20559992|NCT01969032|Alkylating Agents|alkylating agents|mesh-ancestor
20559993|NCT01969032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20559994|NCT01969071|Simendan|simendan|mesh-list
20559995|NCT01969071|Dobutamine|dobutamine|mesh-list
20559996|NCT01969071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20559997|NCT01969071|Vasodilator Agents|vasodilator agents|mesh-ancestor
20559998|NCT01969071|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20559999|NCT01969071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20560000|NCT01969071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560001|NCT01969071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560002|NCT01969071|Protective Agents|protective agents|mesh-ancestor
20560003|NCT01969071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560004|NCT01969071|Sympathomimetics|sympathomimetics|mesh-ancestor
20560005|NCT01969071|Autonomic Agents|autonomic agents|mesh-ancestor
20560006|NCT01969071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20560007|NCT01969071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20560008|NCT01969071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20560009|NCT01969071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20560010|NCT01969071|Adrenergic Agents|adrenergic agents|mesh-ancestor
20560011|NCT01969071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20560012|NCT01969149|Insulin|insulin|mesh-list
20560013|NCT01969149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20560014|NCT01969149|Exenatide|exenatide|mesh-list
20560015|NCT01969149|Insulin Lispro|insulin lispro|mesh-list
20560016|NCT01969149|Incretins|incretins|mesh-list
20560017|NCT01969149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20560018|NCT01969149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560019|NCT01969149|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20560020|NCT01969149|Hormones|hormones|mesh-ancestor
20560021|NCT01969149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20560022|NCT01969227|Ketamine|ketamine|mesh-list
20560023|NCT01969227|Analgesics|analgesics|mesh-ancestor
20560024|NCT01969227|Sensory System Agents|sensory system agents|mesh-ancestor
20560025|NCT01969227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20560026|NCT01969227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560027|NCT01969227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20560028|NCT01969227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20560029|NCT01969227|Anesthetics, General|anesthetics, general|mesh-ancestor
20560030|NCT01969227|Anesthetics|anesthetics|mesh-ancestor
20560031|NCT01969227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20560032|NCT01969227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20560033|NCT01969227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20560034|NCT01969227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20560035|NCT01969227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560036|NCT01969318|Metformin|metformin|mesh-list
20560037|NCT01969318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20560038|NCT01969318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560039|NCT01969357|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20560040|NCT01969357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20560041|NCT01969357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560042|NCT01969357|Incretins|incretins|mesh-ancestor
20560043|NCT01969357|Hormones|hormones|mesh-ancestor
20560044|NCT01969357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20560045|NCT01969357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20560046|NCT01969357|Protease Inhibitors|protease inhibitors|mesh-ancestor
20560047|NCT01969357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560048|NCT01969357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560049|NCT01969578|Paclitaxel|paclitaxel|mesh-list
20560050|NCT01969578|Carboplatin|carboplatin|mesh-list
20560051|NCT01969578|Doxorubicin|doxorubicin|mesh-list
20560052|NCT01969578|Bicalutamide|bicalutamide|mesh-list
20560053|NCT01969578|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20560054|NCT01969578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20560055|NCT01969578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560056|NCT01969578|Tubulin Modulators|tubulin modulators|mesh-ancestor
20560057|NCT01969578|Antimitotic Agents|antimitotic agents|mesh-ancestor
20560058|NCT01969578|Mitosis Modulators|mitosis modulators|mesh-ancestor
20560059|NCT01969578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560060|NCT01969578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20560061|NCT01969578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20560062|NCT01969578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20560063|NCT01969578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560064|NCT01969578|Androgen Antagonists|androgen antagonists|mesh-ancestor
20560065|NCT01969578|Hormone Antagonists|hormone antagonists|mesh-ancestor
20560066|NCT01969578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20560067|NCT01969578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560068|NCT01969578|Luteolytic Agents|luteolytic agents|mesh-ancestor
20560069|NCT01969578|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20560070|NCT01969578|Contraceptive Agents|contraceptive agents|mesh-ancestor
20560071|NCT01969578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20560072|NCT01969578|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20560073|NCT01969578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20560074|NCT01969617|Naltrexone|naltrexone|mesh-list
20560075|NCT01969617|Nalmefene|nalmefene|mesh-list
20560076|NCT01969617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20560077|NCT01969617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560078|NCT01969617|Sensory System Agents|sensory system agents|mesh-ancestor
20560079|NCT01969617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20560080|NCT01969617|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20560081|NCT01969656|Calcitriol|calcitriol|mesh-list
20560082|NCT01969656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20560083|NCT01969656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560084|NCT01969656|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20560085|NCT01969656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20560086|NCT01969656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560087|NCT01969656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20560088|NCT01969656|Vitamins|vitamins|mesh-ancestor
20560089|NCT01969656|Micronutrients|micronutrients|mesh-ancestor
20560090|NCT01969656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20560091|NCT01969669|Ketoconazole|ketoconazole|mesh-list
20560092|NCT01969669|Venetoclax|venetoclax|mesh-list
20560093|NCT01969669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560094|NCT01969669|Antifungal Agents|antifungal agents|mesh-ancestor
20560095|NCT01969669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20560096|NCT01969669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20560097|NCT01969669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20560098|NCT01969669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560099|NCT01969669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560100|NCT01969669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20560101|NCT01969669|Hormone Antagonists|hormone antagonists|mesh-ancestor
20560102|NCT01969669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20560103|NCT01969669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560104|NCT01969669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20560105|NCT01969682|Rifampin|rifampin|mesh-list
20560106|NCT01969682|Venetoclax|venetoclax|mesh-list
20560107|NCT01969682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560108|NCT01969682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20560109|NCT01969682|Antitubercular Agents|antitubercular agents|mesh-ancestor
20560110|NCT01969682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20560111|NCT01969682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20560112|NCT01969682|Leprostatic Agents|leprostatic agents|mesh-ancestor
20560113|NCT01969682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20560114|NCT01969682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560115|NCT01969682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560116|NCT01969682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20560117|NCT01969682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20560118|NCT01969682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20560119|NCT01969682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20560120|NCT01969682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20560121|NCT01969682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20560122|NCT01969695|Venetoclax|venetoclax|mesh-list
20560123|NCT01969695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560124|NCT01969773|Botulinum Toxins|botulinum toxins|mesh-list
20560125|NCT01969773|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20560126|NCT01969773|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20560127|NCT01969773|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20560128|NCT01969773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20560129|NCT01969773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560130|NCT01969773|Cholinergic Agents|cholinergic agents|mesh-ancestor
20560131|NCT01969773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20560132|NCT01969773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560133|NCT01969773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20560134|NCT01969773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20560135|NCT01969877|Cetuximab|cetuximab|mesh-list
20560136|NCT01969877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560137|NCT01969877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20560138|NCT01969903|Dexmedetomidine|dexmedetomidine|mesh-list
20560139|NCT01969903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20560140|NCT01969903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20560141|NCT01969903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560142|NCT01969903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20560143|NCT01969903|Analgesics|analgesics|mesh-ancestor
20560144|NCT01969903|Sensory System Agents|sensory system agents|mesh-ancestor
20560145|NCT01969903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20560146|NCT01969903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20560147|NCT01969903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20560148|NCT01969903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20560149|NCT01969903|Adrenergic Agents|adrenergic agents|mesh-ancestor
20560150|NCT01969903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20560151|NCT01969903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560152|NCT01969942|Melphalan|melphalan|mesh-list
20560153|NCT01969942|Busulfan|busulfan|mesh-list
20560154|NCT01969942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20560155|NCT01969942|Alkylating Agents|alkylating agents|mesh-ancestor
20560156|NCT01969942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560157|NCT01969942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560158|NCT01969942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20560159|NCT01969942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20560160|NCT01969942|Immunologic Factors|immunologic factors|mesh-ancestor
20560161|NCT01969942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560162|NCT01969955|Paclitaxel|paclitaxel|mesh-list
20560163|NCT01969955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20560164|NCT01969955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20560165|NCT01969955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560166|NCT01969955|Tubulin Modulators|tubulin modulators|mesh-ancestor
20560167|NCT01969955|Antimitotic Agents|antimitotic agents|mesh-ancestor
20560168|NCT01969955|Mitosis Modulators|mitosis modulators|mesh-ancestor
20560169|NCT01969955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560170|NCT01970046|Metformin|metformin|mesh-list
20560171|NCT01970046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20560172|NCT01970046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560173|NCT01970059|Metoprolol|metoprolol|mesh-list
20560174|NCT01970059|Carvedilol|carvedilol|mesh-list
20560175|NCT01970059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20560176|NCT01970059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20560177|NCT01970059|Sympatholytics|sympatholytics|mesh-ancestor
20560178|NCT01970059|Autonomic Agents|autonomic agents|mesh-ancestor
20560179|NCT01970059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20560180|NCT01970059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560181|NCT01970059|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20560182|NCT01970059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20560183|NCT01970059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20560184|NCT01970059|Adrenergic Agents|adrenergic agents|mesh-ancestor
20560185|NCT01970059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20560186|NCT01970059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560187|NCT01970059|Antioxidants|antioxidants|mesh-ancestor
20560188|NCT01970059|Protective Agents|protective agents|mesh-ancestor
20560189|NCT01970059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20560190|NCT01970059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20560191|NCT01970059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20560192|NCT01970059|Vasodilator Agents|vasodilator agents|mesh-ancestor
20560193|NCT01970059|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20560194|NCT01970059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20560195|NCT01970072|Midazolam|midazolam|mesh-list
20560196|NCT01970072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20560197|NCT01970072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20560198|NCT01970072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20560199|NCT01970072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560200|NCT01970072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20560201|NCT01970072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20560202|NCT01970072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20560203|NCT01970072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20560204|NCT01970072|Anesthetics, General|anesthetics, general|mesh-ancestor
20560205|NCT01970072|Anesthetics|anesthetics|mesh-ancestor
20560206|NCT01970072|GABA Modulators|gaba modulators|mesh-ancestor
20560207|NCT01970072|GABA Agents|gaba agents|mesh-ancestor
20560208|NCT01970072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20560209|NCT01970072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560210|NCT01970202|Enoxaparin|enoxaparin|mesh-list
20560211|NCT01970202|Enoxaparin sodium|enoxaparin sodium|mesh-list
20560212|NCT01970202|Anticoagulants|anticoagulants|mesh-ancestor
20560213|NCT01970202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20560214|NCT01970202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20560215|NCT01970202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560216|NCT01970215|Atorvastatin|atorvastatin|mesh-list
20560217|NCT01970215|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20560218|NCT01970215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20560219|NCT01970215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20560220|NCT01970215|Antimetabolites|antimetabolites|mesh-ancestor
20560221|NCT01970215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560222|NCT01970215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20560223|NCT01970215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20560224|NCT01970215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560225|NCT01970280|Enoxaparin|enoxaparin|mesh-list
20560226|NCT01970280|Anticoagulants|anticoagulants|mesh-ancestor
20560227|NCT01970280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20560228|NCT01970280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20560229|NCT01970280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560230|NCT01970345|Mecasermin|mecasermin|mesh-list
19460252|NCT03355027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460253|NCT03355027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19460254|NCT03355027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19460255|NCT03355027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19460256|NCT03355014|Metformin|metformin|mesh-list
19460257|NCT03355014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19460258|NCT03355014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011008|NCT02359058|Oxaliplatin|oxaliplatin|mesh-list
20011009|NCT02359058|Ramucirumab|ramucirumab|mesh-list
20011010|NCT02359058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011011|NCT02359058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20011012|NCT02359058|Antimetabolites|antimetabolites|mesh-ancestor
20011013|NCT02359058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011014|NCT02359110|Gabapentin|gabapentin|mesh-list
20011015|NCT02359110|Analgesics|analgesics|mesh-ancestor
20011016|NCT02359110|Sensory System Agents|sensory system agents|mesh-ancestor
20011017|NCT02359110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20011018|NCT02359110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011019|NCT02359110|Anticonvulsants|anticonvulsants|mesh-ancestor
20011020|NCT02359110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20011021|NCT02359110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20011022|NCT02359110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20011023|NCT02359110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20011024|NCT02359110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20011025|NCT02359110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20011026|NCT02359110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011027|NCT02359110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011028|NCT02359110|Antimanic Agents|antimanic agents|mesh-ancestor
20011029|NCT02359305|Acetaminophen|acetaminophen|mesh-list
20011030|NCT02359305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20011031|NCT02359305|Analgesics|analgesics|mesh-ancestor
20011032|NCT02359305|Sensory System Agents|sensory system agents|mesh-ancestor
20011033|NCT02359305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20011034|NCT02359305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011035|NCT02359305|Antipyretics|antipyretics|mesh-ancestor
20011036|NCT02359435|Amoxicillin|amoxicillin|mesh-list
20011037|NCT02359435|Metronidazole|metronidazole|mesh-list
20011038|NCT02359435|Clarithromycin|clarithromycin|mesh-list
20011039|NCT02359435|Pantoprazole|pantoprazole|mesh-list
20011040|NCT02359435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20011041|NCT02359435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20011042|NCT02359435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20011043|NCT02359435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20011044|NCT02359435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20011045|NCT02359435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011046|NCT02359435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011047|NCT02359435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20011048|NCT02359435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20011049|NCT02359435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20011050|NCT02359435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20011051|NCT02359435|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20011052|NCT02359552|Rasagiline|rasagiline|mesh-list
20011053|NCT02359552|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
20011054|NCT02359552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011055|NCT02359552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011056|NCT02359552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20011057|NCT02359552|Protective Agents|protective agents|mesh-ancestor
20011058|NCT02359552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011059|NCT02359851|Pembrolizumab|pembrolizumab|mesh-list
20011060|NCT02359851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20011061|NCT02359851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011062|NCT02359877|Interferons|interferons|mesh-list
20011063|NCT02359877|Interferon-beta|interferon-beta|mesh-list
20560231|NCT01970345|Growth Substances|growth substances|mesh-ancestor
20560232|NCT01970345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560233|NCT01970358|Poly ICLC|poly iclc|mesh-list
20560234|NCT01970358|Interferon Inducers|interferon inducers|mesh-ancestor
20560235|NCT01970358|Immunologic Factors|immunologic factors|mesh-ancestor
20560236|NCT01970358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560237|NCT01970449|Vaccines|vaccines|mesh-list
20560238|NCT01970449|Immunologic Factors|immunologic factors|mesh-ancestor
20560239|NCT01970449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560240|NCT01970553|Gemcitabine|gemcitabine|mesh-list
20560241|NCT01970553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20560242|NCT01970553|Antimetabolites|antimetabolites|mesh-ancestor
20560243|NCT01970553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560244|NCT01970553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560245|NCT01970553|Antiviral Agents|antiviral agents|mesh-ancestor
20560246|NCT01970553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20560247|NCT01970553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560248|NCT01970553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20560249|NCT01970553|Immunologic Factors|immunologic factors|mesh-ancestor
20560250|NCT01970553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560251|NCT01970579|Paclitaxel|paclitaxel|mesh-list
20560252|NCT01970579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20560253|NCT01970579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560254|NCT01970579|Tubulin Modulators|tubulin modulators|mesh-ancestor
20560255|NCT01970579|Antimitotic Agents|antimitotic agents|mesh-ancestor
20560256|NCT01970579|Mitosis Modulators|mitosis modulators|mesh-ancestor
20560257|NCT01970579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560258|NCT01970722|Gemcitabine|gemcitabine|mesh-list
20560259|NCT01970722|Paclitaxel|paclitaxel|mesh-list
20560260|NCT01970722|Cisplatin|cisplatin|mesh-list
20560261|NCT01970722|Carboplatin|carboplatin|mesh-list
20560262|NCT01970722|Doxorubicin|doxorubicin|mesh-list
20560263|NCT01970722|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20560264|NCT01970722|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20560265|NCT01970722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20560266|NCT01970722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560267|NCT01970722|Tubulin Modulators|tubulin modulators|mesh-ancestor
20560268|NCT01970722|Antimitotic Agents|antimitotic agents|mesh-ancestor
20560269|NCT01970722|Mitosis Modulators|mitosis modulators|mesh-ancestor
20560270|NCT01970722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560271|NCT01970722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20560272|NCT01970722|Antimetabolites|antimetabolites|mesh-ancestor
20560273|NCT01970722|Antiviral Agents|antiviral agents|mesh-ancestor
20560274|NCT01970722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20560275|NCT01970722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560276|NCT01970722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20560277|NCT01970722|Immunologic Factors|immunologic factors|mesh-ancestor
20560278|NCT01970722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560279|NCT01970722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20560280|NCT01970722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20560281|NCT01970722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20560282|NCT01970748|Propranolol|propranolol|mesh-list
20560283|NCT01970748|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20560284|NCT01970748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20560285|NCT01970748|Adrenergic Agents|adrenergic agents|mesh-ancestor
20560286|NCT01970748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20560287|NCT01970748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560288|NCT01970748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560289|NCT01970748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20560290|NCT01970748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20560291|NCT01970748|Vasodilator Agents|vasodilator agents|mesh-ancestor
20560292|NCT01970800|Hormones|hormones|mesh-list
20560293|NCT01970800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20560294|NCT01970800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560295|NCT01970904|Ribavirin|ribavirin|mesh-list
20560296|NCT01970904|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20560297|NCT01970904|Antimetabolites|antimetabolites|mesh-ancestor
20560298|NCT01970904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560299|NCT01970904|Antiviral Agents|antiviral agents|mesh-ancestor
20560300|NCT01970904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20560301|NCT01970917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20560302|NCT01970917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20560303|NCT01971034|Metformin|metformin|mesh-list
20560304|NCT01971034|Paclitaxel|paclitaxel|mesh-list
20560305|NCT01971034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20560306|NCT01971034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560307|NCT01971034|Tubulin Modulators|tubulin modulators|mesh-ancestor
20560308|NCT01971034|Antimitotic Agents|antimitotic agents|mesh-ancestor
20560309|NCT01971034|Mitosis Modulators|mitosis modulators|mesh-ancestor
20560310|NCT01971034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560311|NCT01971034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20560312|NCT01971034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560313|NCT01971047|Insulin|insulin|mesh-list
20560314|NCT01971047|Insulin Lispro|insulin lispro|mesh-list
20560315|NCT01971047|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20560316|NCT01971047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20560317|NCT01971047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560318|NCT01971190|Aflibercept|aflibercept|mesh-list
20560319|NCT01971190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20560320|NCT01971190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20560321|NCT01971190|Growth Substances|growth substances|mesh-ancestor
20560322|NCT01971190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560323|NCT01971190|Growth Inhibitors|growth inhibitors|mesh-ancestor
20560324|NCT01971190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560325|NCT01971242|Exenatide|exenatide|mesh-list
20560326|NCT01971242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20560327|NCT01971242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560328|NCT01971242|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20560329|NCT01971242|Incretins|incretins|mesh-ancestor
20560330|NCT01971242|Hormones|hormones|mesh-ancestor
20560331|NCT01971242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20560332|NCT01971268|Cimetidine|cimetidine|mesh-list
20560333|NCT01971268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20560334|NCT01971268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20560335|NCT01971268|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20560336|NCT01971268|Histamine Antagonists|histamine antagonists|mesh-ancestor
20560337|NCT01971268|Histamine Agents|histamine agents|mesh-ancestor
20560338|NCT01971268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20560339|NCT01971268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560340|NCT01971268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560341|NCT01971268|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20560342|NCT01971268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20560343|NCT01971268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560344|NCT01971281|Gemcitabine|gemcitabine|mesh-list
20560345|NCT01971281|Paclitaxel|paclitaxel|mesh-list
20560346|NCT01971281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20560347|NCT01971281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560348|NCT01971281|Tubulin Modulators|tubulin modulators|mesh-ancestor
20560349|NCT01971281|Antimitotic Agents|antimitotic agents|mesh-ancestor
20560350|NCT01971281|Mitosis Modulators|mitosis modulators|mesh-ancestor
20560351|NCT01971281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560352|NCT01971281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20560353|NCT01971281|Antimetabolites|antimetabolites|mesh-ancestor
20560354|NCT01971281|Antiviral Agents|antiviral agents|mesh-ancestor
20560355|NCT01971281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20560356|NCT01971281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560357|NCT01971281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20560358|NCT01971281|Immunologic Factors|immunologic factors|mesh-ancestor
20560359|NCT01971281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560360|NCT01971411|Calcium, Dietary|calcium, dietary|mesh-list
20560361|NCT01971411|Vitamin D|vitamin d|mesh-list
20560362|NCT01971411|Ergocalciferols|ergocalciferols|mesh-list
20560363|NCT01971411|Vitamins|vitamins|mesh-list
20560364|NCT01971411|Calcium|calcium|mesh-list
20560365|NCT01971411|Micronutrients|micronutrients|mesh-ancestor
20560366|NCT01971411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560367|NCT01971411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20560368|NCT01971411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20560369|NCT01971424|Magnesium Oxide|magnesium oxide|mesh-list
20560370|NCT01971424|Antacids|antacids|mesh-ancestor
20560371|NCT01971424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560372|NCT01971424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20560373|NCT01971450|Iloprost|iloprost|mesh-list
20560374|NCT01971450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20560375|NCT01971450|Vasodilator Agents|vasodilator agents|mesh-ancestor
20560376|NCT01971489|Gemcitabine|gemcitabine|mesh-list
20560377|NCT01971489|Cisplatin|cisplatin|mesh-list
20560378|NCT01971489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560379|NCT01971489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20560380|NCT01971489|Antimetabolites|antimetabolites|mesh-ancestor
20560381|NCT01971489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560382|NCT01971489|Antiviral Agents|antiviral agents|mesh-ancestor
20560383|NCT01971489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20560384|NCT01971489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560385|NCT01971489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20560386|NCT01971489|Immunologic Factors|immunologic factors|mesh-ancestor
20560387|NCT01971489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560388|NCT01971515|Tamoxifen|tamoxifen|mesh-list
20560389|NCT01971515|Trastuzumab|trastuzumab|mesh-list
20560390|NCT01971515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20560391|NCT01971515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560392|NCT01971515|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20560393|NCT01971515|Hormone Antagonists|hormone antagonists|mesh-ancestor
20560394|NCT01971515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20560395|NCT01971515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560396|NCT01971515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20560397|NCT01971515|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20560398|NCT01971515|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20560399|NCT01971515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20560400|NCT01971606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20560401|NCT01971606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20560402|NCT01971606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20560403|NCT01971606|Antimetabolites|antimetabolites|mesh-ancestor
20560404|NCT01971606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560405|NCT01971606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20560406|NCT01971606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20560407|NCT01971606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560408|NCT01971632|Oxycodone|oxycodone|mesh-list
20560409|NCT01971632|Naloxone|naloxone|mesh-list
20560410|NCT01971632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20560411|NCT01971632|Narcotics|narcotics|mesh-ancestor
20560412|NCT01971632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20560413|NCT01971632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560414|NCT01971632|Analgesics|analgesics|mesh-ancestor
20560415|NCT01971632|Sensory System Agents|sensory system agents|mesh-ancestor
20560416|NCT01971632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20560417|NCT01971632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20560418|NCT01971658|Thalidomide|thalidomide|mesh-list
20560419|NCT01971658|Dexamethasone|dexamethasone|mesh-list
20560420|NCT01971658|Cyclophosphamide|cyclophosphamide|mesh-list
20560421|NCT01971658|Bortezomib|bortezomib|mesh-list
20560422|NCT01971658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20560423|NCT01971658|Immunologic Factors|immunologic factors|mesh-ancestor
20560424|NCT01971658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560425|NCT01971658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20560426|NCT01971658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20560427|NCT01971658|Alkylating Agents|alkylating agents|mesh-ancestor
20560428|NCT01971658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560429|NCT01971658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560430|NCT01971658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20560431|NCT01971658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20560432|NCT01971658|Antiemetics|antiemetics|mesh-ancestor
20560433|NCT01971658|Autonomic Agents|autonomic agents|mesh-ancestor
20560434|NCT01971658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20560435|NCT01971658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20560436|NCT01971658|Glucocorticoids|glucocorticoids|mesh-ancestor
20560437|NCT01971658|Hormones|hormones|mesh-ancestor
20560438|NCT01971658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20560439|NCT01971658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20560440|NCT01971658|Leprostatic Agents|leprostatic agents|mesh-ancestor
20560441|NCT01971658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20560442|NCT01971658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20560443|NCT01971658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20560444|NCT01971658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20560445|NCT01971658|Growth Substances|growth substances|mesh-ancestor
20560446|NCT01971658|Growth Inhibitors|growth inhibitors|mesh-ancestor
20560447|NCT01971684|Mycophenolic Acid|mycophenolic acid|mesh-list
20560448|NCT01971684|Sirolimus|sirolimus|mesh-list
20560449|NCT01971684|Mercaptopurine|mercaptopurine|mesh-list
20560450|NCT01971684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560451|NCT01971684|Immunologic Factors|immunologic factors|mesh-ancestor
20560452|NCT01971684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560453|NCT01971684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20560454|NCT01971684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20560455|NCT01971684|Antitubercular Agents|antitubercular agents|mesh-ancestor
20560456|NCT01971684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20560457|NCT01971684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20560458|NCT01971684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560459|NCT01971684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560460|NCT01971684|Antifungal Agents|antifungal agents|mesh-ancestor
20560461|NCT01971684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20560462|NCT01971684|Antimetabolites|antimetabolites|mesh-ancestor
20560463|NCT01971684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20560464|NCT01971684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20560465|NCT01971801|Vitamin D|vitamin d|mesh-list
20560466|NCT01971801|Cholecalciferol|cholecalciferol|mesh-list
20560467|NCT01971801|Vitamins|vitamins|mesh-ancestor
20560468|NCT01971801|Micronutrients|micronutrients|mesh-ancestor
20560469|NCT01971801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560470|NCT01971801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20560471|NCT01971801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20560472|NCT01971814|Infliximab|infliximab|mesh-list
20560473|NCT01971814|Dermatologic Agents|dermatologic agents|mesh-ancestor
20560474|NCT01971814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20560475|NCT01971814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20560476|NCT01971918|Antibodies|antibodies|mesh-list
20560477|NCT01971918|Immunologic Factors|immunologic factors|mesh-ancestor
20560478|NCT01971918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560479|NCT01972113|Vitamins|vitamins|mesh-list
20560480|NCT01972113|Vitamin K|vitamin k|mesh-list
20560481|NCT01972113|Vitamin K 2|vitamin k 2|mesh-list
20560482|NCT01972113|Vitamin MK 7|vitamin mk 7|mesh-list
20560483|NCT01972113|Micronutrients|micronutrients|mesh-ancestor
20560484|NCT01972113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560485|NCT01972113|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20560486|NCT01972113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20560487|NCT01972113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560488|NCT01972113|Hemostatics|hemostatics|mesh-ancestor
20560489|NCT01972113|Coagulants|coagulants|mesh-ancestor
20560490|NCT01972230|Remifentanil|remifentanil|mesh-list
20560491|NCT01972230|Sevoflurane|sevoflurane|mesh-list
20560492|NCT01972230|Propofol|propofol|mesh-list
20560493|NCT01972230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20560494|NCT01972230|Narcotics|narcotics|mesh-ancestor
20560495|NCT01972230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20560496|NCT01972230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560497|NCT01972230|Analgesics|analgesics|mesh-ancestor
20560498|NCT01972230|Sensory System Agents|sensory system agents|mesh-ancestor
20560499|NCT01972230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20560500|NCT01972230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20560501|NCT01972230|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20560502|NCT01972230|Anesthetics, General|anesthetics, general|mesh-ancestor
20560503|NCT01972230|Anesthetics|anesthetics|mesh-ancestor
20560504|NCT01972230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20560505|NCT01972230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20560506|NCT01972269|Lidocaine|lidocaine|mesh-list
20560507|NCT01972269|Fentanyl|fentanyl|mesh-list
20560508|NCT01972269|Bupivacaine|bupivacaine|mesh-list
20560509|NCT01972269|Anesthetics, Local|anesthetics, local|mesh-ancestor
20560510|NCT01972269|Anesthetics|anesthetics|mesh-ancestor
20560511|NCT01972269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20560512|NCT01972269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560513|NCT01972269|Sensory System Agents|sensory system agents|mesh-ancestor
20560514|NCT01972269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20560515|NCT01972269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20560516|NCT01972269|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20560517|NCT01972269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20560518|NCT01972269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20560519|NCT01972269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560520|NCT01972269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20560521|NCT01972269|Narcotics|narcotics|mesh-ancestor
20560522|NCT01972269|Analgesics|analgesics|mesh-ancestor
20560523|NCT01972269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20560524|NCT01972269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20560525|NCT01972269|Anesthetics, General|anesthetics, general|mesh-ancestor
20560526|NCT01972347|Trametinib|trametinib|mesh-list
20560527|NCT01972347|Dabrafenib|dabrafenib|mesh-list
20560528|NCT01972347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560529|NCT01972347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20560530|NCT01972347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560531|NCT01972347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560532|NCT01972373|Bevacizumab|bevacizumab|mesh-list
20560533|NCT01972373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20560534|NCT01972373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560535|NCT01972373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20560536|NCT01972373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20560537|NCT01972373|Growth Substances|growth substances|mesh-ancestor
20560538|NCT01972373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560539|NCT01972373|Growth Inhibitors|growth inhibitors|mesh-ancestor
20560540|NCT01972490|Bevacizumab|bevacizumab|mesh-list
20560541|NCT01972490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20560542|NCT01972490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560543|NCT01972490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20560544|NCT01972490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20560545|NCT01972490|Growth Substances|growth substances|mesh-ancestor
20560546|NCT01972490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560547|NCT01972490|Growth Inhibitors|growth inhibitors|mesh-ancestor
20560548|NCT01972503|Oxaliplatin|oxaliplatin|mesh-list
20560549|NCT01972503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560550|NCT01972620|Bupivacaine|bupivacaine|mesh-list
20560551|NCT01972620|Anesthetics, Local|anesthetics, local|mesh-ancestor
20560552|NCT01972620|Anesthetics|anesthetics|mesh-ancestor
20560553|NCT01972620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20560554|NCT01972620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560555|NCT01972620|Sensory System Agents|sensory system agents|mesh-ancestor
20560556|NCT01972620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20560557|NCT01972711|Amisulpride|amisulpride|mesh-list
20560558|NCT01972711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20560559|NCT01972711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20560560|NCT01972711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20560561|NCT01972711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560562|NCT01972711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20560563|NCT01972711|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20560564|NCT01972711|Dopamine Agents|dopamine agents|mesh-ancestor
20560565|NCT01972711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20560566|NCT01972711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560567|NCT01972711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20560568|NCT01972711|Antidepressive Agents|antidepressive agents|mesh-ancestor
20560569|NCT01972763|Ranibizumab|ranibizumab|mesh-list
20560570|NCT01972763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20560571|NCT01972763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20560572|NCT01972763|Growth Substances|growth substances|mesh-ancestor
20560573|NCT01972763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560574|NCT01972763|Growth Inhibitors|growth inhibitors|mesh-ancestor
20560575|NCT01972763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560576|NCT01972828|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
20560577|NCT01972828|Plasma Substitutes|plasma substitutes|mesh-ancestor
20560578|NCT01972828|Blood Substitutes|blood substitutes|mesh-ancestor
20560579|NCT01972880|Ipragliflozin|ipragliflozin|mesh-list
20560580|NCT01972880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20560581|NCT01972880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560582|NCT01972880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20560583|NCT01972880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560584|NCT01972906|Ibuprofen|ibuprofen|mesh-list
20560585|NCT01972906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20560586|NCT01972906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20560587|NCT01972906|Analgesics|analgesics|mesh-ancestor
20560588|NCT01972906|Sensory System Agents|sensory system agents|mesh-ancestor
20560589|NCT01972906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20560590|NCT01972906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560591|NCT01972906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20560592|NCT01972906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20560593|NCT01972906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20560594|NCT01972906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560595|NCT01972906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560596|NCT01972984|Anastrozole|anastrozole|mesh-list
20560597|NCT01972984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20560598|NCT01972984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560599|NCT01972984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20560600|NCT01972984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20560601|NCT01972984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560602|NCT01972984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560603|NCT01972984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20560604|NCT01972984|Hormone Antagonists|hormone antagonists|mesh-ancestor
20560605|NCT01972984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20560606|NCT01972984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560607|NCT01973010|Ibuprofen|ibuprofen|mesh-list
20560608|NCT01973010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20560609|NCT01973010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20560610|NCT01973010|Analgesics|analgesics|mesh-ancestor
20560611|NCT01973010|Sensory System Agents|sensory system agents|mesh-ancestor
20560612|NCT01973010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20560613|NCT01973010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560614|NCT01973010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20560615|NCT01973010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20560616|NCT01973010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20560617|NCT01973010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560618|NCT01973010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560619|NCT01973101|Gemcitabine|gemcitabine|mesh-list
20560620|NCT01973101|Cisplatin|cisplatin|mesh-list
20560621|NCT01973101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560622|NCT01973101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20560623|NCT01973101|Antimetabolites|antimetabolites|mesh-ancestor
20560624|NCT01973101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560625|NCT01973101|Antiviral Agents|antiviral agents|mesh-ancestor
20560626|NCT01973101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20560627|NCT01973101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560628|NCT01973101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20560629|NCT01973101|Immunologic Factors|immunologic factors|mesh-ancestor
20560630|NCT01973101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560631|NCT01973114|Latanoprost|latanoprost|mesh-list
20560632|NCT01973114|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20560633|NCT01973114|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20560634|NCT01973140|Tolvaptan|tolvaptan|mesh-list
20560635|NCT01973140|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20560636|NCT01973140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560637|NCT01973140|Natriuretic Agents|natriuretic agents|mesh-ancestor
20560638|NCT01973140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560639|NCT01973309|Paclitaxel|paclitaxel|mesh-list
20560640|NCT01973309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20560641|NCT01973309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560642|NCT01973309|Tubulin Modulators|tubulin modulators|mesh-ancestor
20560643|NCT01973309|Antimitotic Agents|antimitotic agents|mesh-ancestor
20560644|NCT01973309|Mitosis Modulators|mitosis modulators|mesh-ancestor
20560645|NCT01973309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560646|NCT01973322|Vaccines|vaccines|mesh-list
20560647|NCT01973322|Complement Factor H|complement factor h|mesh-list
20560648|NCT01973322|Immunologic Factors|immunologic factors|mesh-ancestor
20560649|NCT01973322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560650|NCT01973322|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
20560651|NCT01973322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20560652|NCT01973400|Tocotrienols|tocotrienols|mesh-list
20560653|NCT01973400|Vitamin E|vitamin e|mesh-list
20560654|NCT01973400|Tocopherols|tocopherols|mesh-list
20560655|NCT01973400|Antioxidants|antioxidants|mesh-ancestor
20560656|NCT01973400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560657|NCT01973400|Protective Agents|protective agents|mesh-ancestor
20560658|NCT01973400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560659|NCT01973400|Vitamins|vitamins|mesh-ancestor
20560660|NCT01973400|Micronutrients|micronutrients|mesh-ancestor
20560661|NCT01973517|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20560662|NCT01973517|Hematinics|hematinics|mesh-ancestor
20560663|NCT01973517|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20560664|NCT01973517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20560665|NCT01973660|Tamoxifen|tamoxifen|mesh-list
20560666|NCT01973660|Paclitaxel|paclitaxel|mesh-list
20560667|NCT01973660|Trastuzumab|trastuzumab|mesh-list
20560668|NCT01973660|Letrozole|letrozole|mesh-list
20560669|NCT01973660|Lapatinib|lapatinib|mesh-list
20560670|NCT01973660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20560671|NCT01973660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560672|NCT01973660|Tubulin Modulators|tubulin modulators|mesh-ancestor
20560673|NCT01973660|Antimitotic Agents|antimitotic agents|mesh-ancestor
20560674|NCT01973660|Mitosis Modulators|mitosis modulators|mesh-ancestor
20560675|NCT01973660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560676|NCT01973660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20560677|NCT01973660|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20560678|NCT01973660|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20560679|NCT01973660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560680|NCT01973660|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20560681|NCT01973660|Hormone Antagonists|hormone antagonists|mesh-ancestor
20560682|NCT01973660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20560683|NCT01973660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560684|NCT01973660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20560685|NCT01973660|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20560686|NCT01973660|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20560687|NCT01973660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20560688|NCT01973660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20560689|NCT01973751|Budesonide|budesonide|mesh-list
20560690|NCT01973751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20560691|NCT01973751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20560692|NCT01973751|Autonomic Agents|autonomic agents|mesh-ancestor
20560693|NCT01973751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20560694|NCT01973751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560695|NCT01973751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20560696|NCT01973751|Respiratory System Agents|respiratory system agents|mesh-ancestor
20560697|NCT01973751|Glucocorticoids|glucocorticoids|mesh-ancestor
20560698|NCT01973751|Hormones|hormones|mesh-ancestor
20560699|NCT01973751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20560700|NCT01973790|Z 338|z 338|mesh-list
20560701|NCT01973790|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20560702|NCT01973790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560703|NCT01973790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560704|NCT01973790|Cholinergic Agents|cholinergic agents|mesh-ancestor
20560705|NCT01973790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20560706|NCT01973790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560707|NCT01973790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20560708|NCT01973816|Cyproterone Acetate|cyproterone acetate|mesh-list
20560709|NCT01973816|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20560710|NCT01973816|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20560711|NCT01973816|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20560712|NCT01973816|Estradiol|estradiol|mesh-list
20560713|NCT01973816|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20560714|NCT01973816|Cyproterone|cyproterone|mesh-list
20560715|NCT01973816|Estrogens|estrogens|mesh-ancestor
20560716|NCT01973816|Hormones|hormones|mesh-ancestor
20560717|NCT01973816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20560718|NCT01973816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560719|NCT01973816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20560720|NCT01973816|Contraceptive Agents|contraceptive agents|mesh-ancestor
20560721|NCT01973816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20560722|NCT01973816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20560723|NCT01973816|Androgen Antagonists|androgen antagonists|mesh-ancestor
20560724|NCT01973816|Hormone Antagonists|hormone antagonists|mesh-ancestor
20560725|NCT01973816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560726|NCT01973816|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20560727|NCT01973816|Luteolytic Agents|luteolytic agents|mesh-ancestor
20560728|NCT01973816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20560729|NCT01973842|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20560730|NCT01973842|Luteolytic Agents|luteolytic agents|mesh-ancestor
20560731|NCT01973842|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20560732|NCT01973842|Contraceptive Agents|contraceptive agents|mesh-ancestor
20560733|NCT01973842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20560734|NCT01973842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560735|NCT01973842|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20560736|NCT01973842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20560737|NCT01973842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560738|NCT01973855|Ribavirin|ribavirin|mesh-list
20560739|NCT01973855|Antimetabolites|antimetabolites|mesh-ancestor
20560740|NCT01973855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560741|NCT01973855|Antiviral Agents|antiviral agents|mesh-ancestor
20560742|NCT01973855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20560743|NCT01973868|Cetuximab|cetuximab|mesh-list
20560744|NCT01973868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20560745|NCT01973868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560746|NCT01973920|Insulin|insulin|mesh-list
20560747|NCT01973920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20560748|NCT01973920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560749|NCT01973933|Metformin|metformin|mesh-list
20560750|NCT01973933|Pyrimethamine|pyrimethamine|mesh-list
20560751|NCT01973933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20560752|NCT01973933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560753|NCT01973933|Antimalarials|antimalarials|mesh-ancestor
20560754|NCT01973933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20560755|NCT01973933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20560756|NCT01973933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20560757|NCT01973933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20560758|NCT01973933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560759|NCT01973933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560760|NCT01974024|Methylprednisolone|methylprednisolone|mesh-list
20560761|NCT01974024|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20560762|NCT01974024|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20560763|NCT01974024|Prednisolone|prednisolone|mesh-list
20560764|NCT01974024|Prednisolone acetate|prednisolone acetate|mesh-list
20560765|NCT01974024|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20560766|NCT01974024|Prednisolone phosphate|prednisolone phosphate|mesh-list
20560767|NCT01974024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20560768|NCT01974024|Antiemetics|antiemetics|mesh-ancestor
20560769|NCT01974024|Autonomic Agents|autonomic agents|mesh-ancestor
20560770|NCT01974024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20560771|NCT01974024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560772|NCT01974024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20560773|NCT01974024|Glucocorticoids|glucocorticoids|mesh-ancestor
20560774|NCT01974024|Hormones|hormones|mesh-ancestor
20560775|NCT01974024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20560776|NCT01974024|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20560777|NCT01974024|Protective Agents|protective agents|mesh-ancestor
20560778|NCT01974024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20560779|NCT01974024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560780|NCT01974037|Capsaicin|capsaicin|mesh-list
20560781|NCT01974037|Antipruritics|antipruritics|mesh-ancestor
20560782|NCT01974037|Dermatologic Agents|dermatologic agents|mesh-ancestor
20560783|NCT01974037|Sensory System Agents|sensory system agents|mesh-ancestor
20560784|NCT01974037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20560785|NCT01974037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560786|NCT01974167|Alfacalcidol|alfacalcidol|mesh-list
20560787|NCT01974167|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
20560788|NCT01974167|Eldecalcitol|eldecalcitol|mesh-list
20560789|NCT01974167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20560790|NCT01974167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560791|NCT01974167|Vitamins|vitamins|mesh-ancestor
20560792|NCT01974167|Micronutrients|micronutrients|mesh-ancestor
20560793|NCT01974258|Vemurafenib|vemurafenib|mesh-list
20560794|NCT01974258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560795|NCT01974258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20560796|NCT01974258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560797|NCT01974258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560798|NCT01974297|Atorvastatin|atorvastatin|mesh-list
20560799|NCT01974297|Fenofibric acid|fenofibric acid|mesh-list
20560800|NCT01974297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20560801|NCT01974297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20560802|NCT01974297|Antimetabolites|antimetabolites|mesh-ancestor
20560803|NCT01974297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560804|NCT01974297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20560805|NCT01974297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20560806|NCT01974297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560807|NCT01974336|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
20560808|NCT01974336|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20560809|NCT01974336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20560810|NCT01974375|Fluconazole|fluconazole|mesh-list
20560811|NCT01974375|Micafungin|micafungin|mesh-list
20560812|NCT01974375|Antifungal Agents|antifungal agents|mesh-ancestor
20560813|NCT01974375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20560814|NCT01974375|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20560815|NCT01974375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20560816|NCT01974375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560817|NCT01974375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560818|NCT01974375|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20560819|NCT01974375|Hormone Antagonists|hormone antagonists|mesh-ancestor
20560820|NCT01974375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20560821|NCT01974375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560822|NCT01974375|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20560823|NCT01974375|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20560824|NCT01974401|Chlorhexidine|chlorhexidine|mesh-list
20560825|NCT01974401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20560826|NCT01974401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20560827|NCT01974401|Disinfectants|disinfectants|mesh-ancestor
20560828|NCT01974518|Cyclophosphamide|cyclophosphamide|mesh-list
20560829|NCT01974518|Rituximab|rituximab|mesh-list
20560830|NCT01974518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20560831|NCT01974518|Immunologic Factors|immunologic factors|mesh-ancestor
20560832|NCT01974518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560833|NCT01974518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20560834|NCT01974518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20560835|NCT01974518|Alkylating Agents|alkylating agents|mesh-ancestor
20560836|NCT01974518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560837|NCT01974518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560838|NCT01974518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20560839|NCT01974518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20560840|NCT01974622|Verteporfin|verteporfin|mesh-list
20560841|NCT01974622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20560842|NCT01974622|Dermatologic Agents|dermatologic agents|mesh-ancestor
20560843|NCT01974648|Remifentanil|remifentanil|mesh-list
20560844|NCT01974648|Propofol|propofol|mesh-list
20560845|NCT01974648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20560846|NCT01974648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20560847|NCT01974648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560848|NCT01974648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20560849|NCT01974648|Anesthetics, General|anesthetics, general|mesh-ancestor
20560850|NCT01974648|Anesthetics|anesthetics|mesh-ancestor
20560851|NCT01974648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20560852|NCT01974648|Narcotics|narcotics|mesh-ancestor
20560853|NCT01974648|Analgesics|analgesics|mesh-ancestor
20560854|NCT01974648|Sensory System Agents|sensory system agents|mesh-ancestor
20560855|NCT01974648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20560856|NCT01974843|Bupivacaine|bupivacaine|mesh-list
20560857|NCT01974843|Levobupivacaine|levobupivacaine|mesh-list
20560858|NCT01974843|Anesthetics, Local|anesthetics, local|mesh-ancestor
20560859|NCT01974843|Anesthetics|anesthetics|mesh-ancestor
20560860|NCT01974843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20560861|NCT01974843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560862|NCT01974843|Sensory System Agents|sensory system agents|mesh-ancestor
20560863|NCT01974843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20560864|NCT01974934|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20560865|NCT01974934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20560866|NCT01974934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20560867|NCT01974934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20560868|NCT01974934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560869|NCT01974934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20560870|NCT01974934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560871|NCT01974934|Antidepressive Agents|antidepressive agents|mesh-ancestor
20560872|NCT01974934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20560873|NCT01975012|Rilpivirine|rilpivirine|mesh-list
20560874|NCT01975012|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20560875|NCT01975012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20560876|NCT01975012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560877|NCT01975012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560878|NCT01975012|Antiviral Agents|antiviral agents|mesh-ancestor
20560879|NCT01975012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20560880|NCT01975012|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20560881|NCT01975012|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20560882|NCT01975051|Miltefosine|miltefosine|mesh-list
20560883|NCT01975051|Antifungal Agents|antifungal agents|mesh-ancestor
20560884|NCT01975051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20560885|NCT01975051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560886|NCT01975051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20560887|NCT01975051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20560888|NCT01975064|Propofol|propofol|mesh-list
20560889|NCT01975064|Sevoflurane|sevoflurane|mesh-list
20560890|NCT01975064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20560891|NCT01975064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20560892|NCT01975064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560893|NCT01975064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20560894|NCT01975064|Anesthetics, General|anesthetics, general|mesh-ancestor
20560895|NCT01975064|Anesthetics|anesthetics|mesh-ancestor
20560896|NCT01975064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20560897|NCT01975064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20560898|NCT01975129|Oxytocin|oxytocin|mesh-list
20560899|NCT01975129|Oxytocics|oxytocics|mesh-ancestor
20560900|NCT01975129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20560901|NCT01975129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560902|NCT01975142|Trastuzumab|trastuzumab|mesh-list
20560903|NCT01975142|Maytansine|maytansine|mesh-list
20560904|NCT01975142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20560905|NCT01975142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560906|NCT01975142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20560907|NCT01975142|Tubulin Modulators|tubulin modulators|mesh-ancestor
20560908|NCT01975142|Antimitotic Agents|antimitotic agents|mesh-ancestor
20560909|NCT01975142|Mitosis Modulators|mitosis modulators|mesh-ancestor
20560910|NCT01975142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560911|NCT01975194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20560912|NCT01975194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20560913|NCT01975194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20560914|NCT01975194|Antimetabolites|antimetabolites|mesh-ancestor
20560915|NCT01975194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560916|NCT01975194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20560917|NCT01975194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20560918|NCT01975194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560919|NCT01975259|Glucagon|glucagon|mesh-list
20560920|NCT01975259|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
20560921|NCT01975259|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20560922|NCT01975259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20560923|NCT01975259|Hormones|hormones|mesh-ancestor
20560924|NCT01975259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20560925|NCT01975259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560926|NCT01975259|Incretins|incretins|mesh-ancestor
20560927|NCT01975272|Iron|iron|mesh-list
20560928|NCT01975272|Ferrous fumarate|ferrous fumarate|mesh-list
20560929|NCT01975272|Ferric Compounds|ferric compounds|mesh-list
20560930|NCT01975272|Trace Elements|trace elements|mesh-ancestor
20560931|NCT01975272|Micronutrients|micronutrients|mesh-ancestor
20560932|NCT01975272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560933|NCT01975272|Hematinics|hematinics|mesh-ancestor
20560934|NCT01975324|4-Aminopyridine|4-aminopyridine|mesh-list
20560935|NCT01975324|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20560936|NCT01975324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20560937|NCT01975324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560938|NCT01975363|Curcumin|curcumin|mesh-list
20560939|NCT01975363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20560940|NCT01975363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20560941|NCT01975363|Analgesics|analgesics|mesh-ancestor
20560942|NCT01975363|Sensory System Agents|sensory system agents|mesh-ancestor
20560943|NCT01975363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20560944|NCT01975363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560945|NCT01975363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20560946|NCT01975363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20560947|NCT01975363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560948|NCT01975363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560949|NCT01975363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560950|NCT01975441|Ivermectin|ivermectin|mesh-list
20560951|NCT01975441|Albendazole|albendazole|mesh-list
20560952|NCT01975441|Diethylcarbamazine|diethylcarbamazine|mesh-list
20560953|NCT01975441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20560954|NCT01975441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20560955|NCT01975441|Anthelmintics|anthelmintics|mesh-ancestor
20560956|NCT01975441|Anticestodal Agents|anticestodal agents|mesh-ancestor
20560957|NCT01975441|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20560958|NCT01975441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20560959|NCT01975441|Tubulin Modulators|tubulin modulators|mesh-ancestor
20560960|NCT01975441|Antimitotic Agents|antimitotic agents|mesh-ancestor
20560961|NCT01975441|Mitosis Modulators|mitosis modulators|mesh-ancestor
20560962|NCT01975441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560963|NCT01975441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560964|NCT01975441|Filaricides|filaricides|mesh-ancestor
20560965|NCT01975441|Antinematodal Agents|antinematodal agents|mesh-ancestor
20560966|NCT01975441|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20560967|NCT01975441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20560968|NCT01975454|Capecitabine|capecitabine|mesh-list
20560969|NCT01975454|Oxaliplatin|oxaliplatin|mesh-list
20560970|NCT01975454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20560971|NCT01975454|Antimetabolites|antimetabolites|mesh-ancestor
20560972|NCT01975454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560973|NCT01975454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20560974|NCT01975480|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20560975|NCT01975480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20560976|NCT01975480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20560977|NCT01975480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20560978|NCT01975480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20560979|NCT01975480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20560980|NCT01975480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560981|NCT01975480|Antidepressive Agents|antidepressive agents|mesh-ancestor
20560982|NCT01975480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19460259|NCT03354962|Nivolumab|nivolumab|mesh-list
19460260|NCT03354962|Ipilimumab|ipilimumab|mesh-list
19460261|NCT03354962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20560983|NCT01975662|Vancomycin|vancomycin|mesh-list
20560984|NCT01975662|Daptomycin|daptomycin|mesh-list
20560985|NCT01975662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20560986|NCT01975662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20560987|NCT01975688|Nabiximols|nabiximols|mesh-list
20560988|NCT01975688|Analgesics|analgesics|mesh-ancestor
20560989|NCT01975688|Sensory System Agents|sensory system agents|mesh-ancestor
20560990|NCT01975688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20560991|NCT01975688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20560992|NCT01975714|Bimatoprost|bimatoprost|mesh-list
20560993|NCT01975714|Latanoprost|latanoprost|mesh-list
20560994|NCT01975714|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20560995|NCT01975714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20560996|NCT01975714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20560997|NCT01975727|Dexamethasone|dexamethasone|mesh-list
20560998|NCT01975727|Dexamethasone acetate|dexamethasone acetate|mesh-list
20560999|NCT01975727|BB 1101|bb 1101|mesh-list
20561000|NCT01975727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20561001|NCT01975727|Antiemetics|antiemetics|mesh-ancestor
20561002|NCT01975727|Autonomic Agents|autonomic agents|mesh-ancestor
20561003|NCT01975727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561004|NCT01975727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561005|NCT01975727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20561006|NCT01975727|Glucocorticoids|glucocorticoids|mesh-ancestor
20561007|NCT01975727|Hormones|hormones|mesh-ancestor
20561008|NCT01975727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20561009|NCT01975727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20561010|NCT01975727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20561011|NCT01975727|Protease Inhibitors|protease inhibitors|mesh-ancestor
20561012|NCT01975727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561013|NCT01975727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561014|NCT01975753|Fentanyl|fentanyl|mesh-list
20561015|NCT01975753|Morphine|morphine|mesh-list
20561016|NCT01975753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20561017|NCT01975753|Narcotics|narcotics|mesh-ancestor
20561018|NCT01975753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20561019|NCT01975753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561020|NCT01975753|Analgesics|analgesics|mesh-ancestor
20561021|NCT01975753|Sensory System Agents|sensory system agents|mesh-ancestor
20561022|NCT01975753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561023|NCT01975753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20561024|NCT01975753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20561025|NCT01975753|Anesthetics, General|anesthetics, general|mesh-ancestor
20561026|NCT01975753|Anesthetics|anesthetics|mesh-ancestor
20561027|NCT01975805|Chlorhexidine|chlorhexidine|mesh-list
20561028|NCT01975805|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20561029|NCT01975805|Povidone-Iodine|povidone-iodine|mesh-list
20561030|NCT01975805|Povidone|povidone|mesh-list
20561031|NCT01975805|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20561032|NCT01975805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20561033|NCT01975805|Disinfectants|disinfectants|mesh-ancestor
20561034|NCT01975805|Dermatologic Agents|dermatologic agents|mesh-ancestor
20561035|NCT01975805|Plasma Substitutes|plasma substitutes|mesh-ancestor
20561036|NCT01975805|Blood Substitutes|blood substitutes|mesh-ancestor
20561037|NCT01975961|Telmisartan|telmisartan|mesh-list
20561038|NCT01975961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20561039|NCT01975961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20561040|NCT01975961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20561041|NCT01975961|Antimetabolites|antimetabolites|mesh-ancestor
20561042|NCT01975961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561043|NCT01975961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20561044|NCT01975961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20561045|NCT01975961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561046|NCT01975961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20561047|NCT01975961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20561048|NCT01975961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20561049|NCT01976078|Midazolam|midazolam|mesh-list
20561050|NCT01976078|Esomeprazole|esomeprazole|mesh-list
20561051|NCT01976078|Ranitidine|ranitidine|mesh-list
20561052|NCT01976078|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20561053|NCT01976078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20561054|NCT01976078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20561055|NCT01976078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20561056|NCT01976078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561057|NCT01976078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20561058|NCT01976078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20561059|NCT01976078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20561060|NCT01976078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20561061|NCT01976078|Anesthetics, General|anesthetics, general|mesh-ancestor
20561062|NCT01976078|Anesthetics|anesthetics|mesh-ancestor
20561063|NCT01976078|GABA Modulators|gaba modulators|mesh-ancestor
20561064|NCT01976078|GABA Agents|gaba agents|mesh-ancestor
20561065|NCT01976078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20561066|NCT01976078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561067|NCT01976078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20561068|NCT01976078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20561069|NCT01976078|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20561070|NCT01976078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561071|NCT01976078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20561072|NCT01976078|Histamine Antagonists|histamine antagonists|mesh-ancestor
20561073|NCT01976078|Histamine Agents|histamine agents|mesh-ancestor
20561074|NCT01976143|Etirinotecan pegol|etirinotecan pegol|mesh-list
20561075|NCT01976143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20561076|NCT01976143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20561077|NCT01976143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20561078|NCT01976143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561079|NCT01976143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561080|NCT01976182|Cyclophosphamide|cyclophosphamide|mesh-list
20561081|NCT01976182|Methotrexate|methotrexate|mesh-list
20561082|NCT01976182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20561083|NCT01976182|Immunologic Factors|immunologic factors|mesh-ancestor
20561084|NCT01976182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561085|NCT01976182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20561086|NCT01976182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20561087|NCT01976182|Alkylating Agents|alkylating agents|mesh-ancestor
20561088|NCT01976182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561089|NCT01976182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20561090|NCT01976182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20561091|NCT01976182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20561092|NCT01976182|Abortifacient Agents|abortifacient agents|mesh-ancestor
20561093|NCT01976182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20561094|NCT01976182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20561095|NCT01976182|Antimetabolites|antimetabolites|mesh-ancestor
20561096|NCT01976182|Dermatologic Agents|dermatologic agents|mesh-ancestor
20561097|NCT01976182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561098|NCT01976182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20561099|NCT01976182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20561100|NCT01976195|Thalidomide|thalidomide|mesh-list
20561101|NCT01976195|Dexamethasone|dexamethasone|mesh-list
20561102|NCT01976195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20561103|NCT01976195|Antiemetics|antiemetics|mesh-ancestor
20561104|NCT01976195|Autonomic Agents|autonomic agents|mesh-ancestor
20561105|NCT01976195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561106|NCT01976195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561107|NCT01976195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20561108|NCT01976195|Glucocorticoids|glucocorticoids|mesh-ancestor
20561109|NCT01976195|Hormones|hormones|mesh-ancestor
20561110|NCT01976195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20561111|NCT01976195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20561112|NCT01976195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20561113|NCT01976195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20561114|NCT01976195|Immunologic Factors|immunologic factors|mesh-ancestor
20561115|NCT01976195|Leprostatic Agents|leprostatic agents|mesh-ancestor
20561116|NCT01976195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20561117|NCT01976195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20561118|NCT01976195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20561119|NCT01976195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20561120|NCT01976195|Growth Substances|growth substances|mesh-ancestor
20561121|NCT01976195|Growth Inhibitors|growth inhibitors|mesh-ancestor
20561122|NCT01976208|Omalizumab|omalizumab|mesh-list
20561123|NCT01976208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20561124|NCT01976208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20561125|NCT01976208|Respiratory System Agents|respiratory system agents|mesh-ancestor
20561126|NCT01976520|Vaccines|vaccines|mesh-list
20561127|NCT01976520|Immunologic Factors|immunologic factors|mesh-ancestor
20561128|NCT01976520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561129|NCT01976585|Poly ICLC|poly iclc|mesh-list
20561130|NCT01976585|Interferon Inducers|interferon inducers|mesh-ancestor
20561131|NCT01976585|Immunologic Factors|immunologic factors|mesh-ancestor
20561132|NCT01976585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561133|NCT01976611|Botulinum Toxins|botulinum toxins|mesh-list
20561134|NCT01976611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20561135|NCT01976611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20561136|NCT01976611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20561137|NCT01976611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20561138|NCT01976611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561139|NCT01976611|Cholinergic Agents|cholinergic agents|mesh-ancestor
20561140|NCT01976611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20561141|NCT01976611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561142|NCT01976611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20561143|NCT01976611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561144|NCT01976676|Folic Acid|folic acid|mesh-list
20561145|NCT01976676|Hematinics|hematinics|mesh-ancestor
20561146|NCT01976676|Vitamin B Complex|vitamin b complex|mesh-ancestor
20561147|NCT01976676|Vitamins|vitamins|mesh-ancestor
20561148|NCT01976676|Micronutrients|micronutrients|mesh-ancestor
20561149|NCT01976676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561150|NCT01976780|Artesunate|artesunate|mesh-list
20561151|NCT01976780|Lumefantrine|lumefantrine|mesh-list
20561152|NCT01976780|Artemether|artemether|mesh-list
20561153|NCT01976780|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20561154|NCT01976780|Mefloquine|mefloquine|mesh-list
20561155|NCT01976780|Antimalarials|antimalarials|mesh-ancestor
20561156|NCT01976780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20561157|NCT01976780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20561158|NCT01976780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20561159|NCT01976780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20561160|NCT01976780|Antiviral Agents|antiviral agents|mesh-ancestor
20561161|NCT01976780|Schistosomicides|schistosomicides|mesh-ancestor
20561162|NCT01976780|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20561163|NCT01976780|Anthelmintics|anthelmintics|mesh-ancestor
20561164|NCT01976923|Bevacizumab|bevacizumab|mesh-list
20561165|NCT01976923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20561166|NCT01976923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20561167|NCT01976923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20561168|NCT01976923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20561169|NCT01976923|Growth Substances|growth substances|mesh-ancestor
20561170|NCT01976923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561171|NCT01976923|Growth Inhibitors|growth inhibitors|mesh-ancestor
20561172|NCT01976936|Lovastatin|lovastatin|mesh-list
20561173|NCT01976936|L 647318|l 647318|mesh-list
20561174|NCT01976936|Dihydromevinolin|dihydromevinolin|mesh-list
20561175|NCT01976936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20561176|NCT01976936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20561177|NCT01976936|Antimetabolites|antimetabolites|mesh-ancestor
20561178|NCT01976936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561179|NCT01976936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20561180|NCT01976936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20561181|NCT01976936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561182|NCT01977118|Streptokinase|streptokinase|mesh-list
20561183|NCT01977118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20561184|NCT01977118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20561185|NCT01977118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561186|NCT01977209|Gossypol|gossypol|mesh-list
20561187|NCT01977209|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20561188|NCT01977209|Contraceptive Agents|contraceptive agents|mesh-ancestor
20561189|NCT01977209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20561190|NCT01977209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561191|NCT01977235|Irinotecan|irinotecan|mesh-list
20561192|NCT01977235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20561193|NCT01977235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20561194|NCT01977235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20561195|NCT01977235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561196|NCT01977235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561197|NCT01977300|Valproic Acid|valproic acid|mesh-list
20561198|NCT01977300|Olanzapine|olanzapine|mesh-list
20561199|NCT01977300|Risperidone|risperidone|mesh-list
20561200|NCT01977300|Lithium Carbonate|lithium carbonate|mesh-list
20561201|NCT01977300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20561202|NCT01977300|Serotonin Agents|serotonin agents|mesh-ancestor
20561203|NCT01977300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20561204|NCT01977300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561205|NCT01977300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561206|NCT01977300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20561207|NCT01977300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20561208|NCT01977300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20561209|NCT01977300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20561210|NCT01977300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20561211|NCT01977300|Dopamine Agents|dopamine agents|mesh-ancestor
20561212|NCT01977300|Antiemetics|antiemetics|mesh-ancestor
20561213|NCT01977300|Autonomic Agents|autonomic agents|mesh-ancestor
20561214|NCT01977300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561215|NCT01977300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20561216|NCT01977300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20561217|NCT01977300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20561218|NCT01977300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20561219|NCT01977300|Antidepressive Agents|antidepressive agents|mesh-ancestor
20561220|NCT01977300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561221|NCT01977300|Antimanic Agents|antimanic agents|mesh-ancestor
20561222|NCT01977300|Anticonvulsants|anticonvulsants|mesh-ancestor
20561223|NCT01977300|GABA Agents|gaba agents|mesh-ancestor
20561224|NCT01977339|Bupivacaine|bupivacaine|mesh-list
20561225|NCT01977339|Anesthetics, Local|anesthetics, local|mesh-ancestor
20561226|NCT01977339|Anesthetics|anesthetics|mesh-ancestor
20561227|NCT01977339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20561228|NCT01977339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561229|NCT01977339|Sensory System Agents|sensory system agents|mesh-ancestor
20561230|NCT01977339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561231|NCT01977378|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20561232|NCT01977378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
20561233|NCT01977378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20561234|NCT01977378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20561235|NCT01977378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20561236|NCT01977378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561237|NCT01977378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20561238|NCT01977378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561239|NCT01977378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20561240|NCT01977378|Antidepressive Agents|antidepressive agents|mesh-ancestor
20561241|NCT01977378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20561242|NCT01977417|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
20561243|NCT01977417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20561244|NCT01977417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20561245|NCT01977417|Analgesics|analgesics|mesh-ancestor
20561246|NCT01977417|Sensory System Agents|sensory system agents|mesh-ancestor
20561247|NCT01977417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561248|NCT01977417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561249|NCT01977417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20561250|NCT01977417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20561251|NCT01977430|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20561252|NCT01977430|Furosemide|furosemide|mesh-list
20561253|NCT01977430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20561254|NCT01977430|Diuretics|diuretics|mesh-ancestor
20561255|NCT01977430|Natriuretic Agents|natriuretic agents|mesh-ancestor
20561256|NCT01977430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561257|NCT01977430|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20561258|NCT01977430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20561259|NCT01977430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561260|NCT01977430|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20561261|NCT01977443|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20561262|NCT01977443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20561263|NCT01977859|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
20561264|NCT01977859|Natriuretic Agents|natriuretic agents|mesh-ancestor
20561265|NCT01977859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561266|NCT01977989|Vancomycin|vancomycin|mesh-list
20561267|NCT01977989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20561268|NCT01977989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20561269|NCT01978015|Timolol|timolol|mesh-list
20561270|NCT01978015|Bimatoprost|bimatoprost|mesh-list
20561271|NCT01978015|Travoprost|travoprost|mesh-list
20561272|NCT01978015|Dextrans|dextrans|mesh-list
20561273|NCT01978015|Latanoprost|latanoprost|mesh-list
20561274|NCT01978015|Maleic acid|maleic acid|mesh-list
20561275|NCT01978015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20561276|NCT01978015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20561277|NCT01978015|Adrenergic Agents|adrenergic agents|mesh-ancestor
20561278|NCT01978015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20561279|NCT01978015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561280|NCT01978015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561281|NCT01978015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20561282|NCT01978015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20561283|NCT01978015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561284|NCT01978015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20561285|NCT01978015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20561286|NCT01978015|Anticoagulants|anticoagulants|mesh-ancestor
20561287|NCT01978015|Plasma Substitutes|plasma substitutes|mesh-ancestor
20561288|NCT01978015|Blood Substitutes|blood substitutes|mesh-ancestor
20561289|NCT01978041|Fluorides|fluorides|mesh-list
20561290|NCT01978041|Cariostatic Agents|cariostatic agents|mesh-ancestor
20561291|NCT01978041|Protective Agents|protective agents|mesh-ancestor
20561292|NCT01978041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561293|NCT01978301|Triamcinolone|triamcinolone|mesh-list
20561294|NCT01978301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20561295|NCT01978301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20561296|NCT01978301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20561297|NCT01978301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20561298|NCT01978301|Glucocorticoids|glucocorticoids|mesh-ancestor
20561299|NCT01978301|Hormones|hormones|mesh-ancestor
20561300|NCT01978301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20561301|NCT01978301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561302|NCT01978301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20561303|NCT01978301|Immunologic Factors|immunologic factors|mesh-ancestor
20561304|NCT01978301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561305|NCT01978301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561306|NCT01978405|Thioctic Acid|thioctic acid|mesh-list
20561307|NCT01978405|Antioxidants|antioxidants|mesh-ancestor
20561308|NCT01978405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561309|NCT01978405|Protective Agents|protective agents|mesh-ancestor
20561310|NCT01978405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561311|NCT01978405|Vitamin B Complex|vitamin b complex|mesh-ancestor
20561312|NCT01978405|Vitamins|vitamins|mesh-ancestor
20561313|NCT01978405|Micronutrients|micronutrients|mesh-ancestor
20561314|NCT01978418|Albuterol|albuterol|mesh-list
20561315|NCT01978418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20561316|NCT01978418|Autonomic Agents|autonomic agents|mesh-ancestor
20561317|NCT01978418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561318|NCT01978418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561319|NCT01978418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20561320|NCT01978418|Respiratory System Agents|respiratory system agents|mesh-ancestor
20561321|NCT01978418|Tocolytic Agents|tocolytic agents|mesh-ancestor
20561322|NCT01978418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20561323|NCT01978418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20561324|NCT01978418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20561325|NCT01978418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20561326|NCT01978418|Adrenergic Agents|adrenergic agents|mesh-ancestor
20561327|NCT01978418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20561328|NCT01978418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561329|NCT01978431|Cocaine|cocaine|mesh-list
20561330|NCT01978431|Methylphenidate|methylphenidate|mesh-list
20561331|NCT01978431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20561332|NCT01978431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561333|NCT01978431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20561334|NCT01978431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20561335|NCT01978431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20561336|NCT01978431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561337|NCT01978431|Dopamine Agents|dopamine agents|mesh-ancestor
20561338|NCT01978431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20561339|NCT01978431|Anesthetics, Local|anesthetics, local|mesh-ancestor
20561340|NCT01978431|Anesthetics|anesthetics|mesh-ancestor
20561341|NCT01978431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20561342|NCT01978431|Sensory System Agents|sensory system agents|mesh-ancestor
20561343|NCT01978431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561344|NCT01978431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20561345|NCT01978457|Propranolol|propranolol|mesh-list
20561346|NCT01978457|Cocaine|cocaine|mesh-list
20561347|NCT01978457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20561348|NCT01978457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20561349|NCT01978457|Adrenergic Agents|adrenergic agents|mesh-ancestor
20561350|NCT01978457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20561351|NCT01978457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561352|NCT01978457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561353|NCT01978457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20561354|NCT01978457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20561355|NCT01978457|Vasodilator Agents|vasodilator agents|mesh-ancestor
20561356|NCT01978457|Anesthetics, Local|anesthetics, local|mesh-ancestor
20561357|NCT01978457|Anesthetics|anesthetics|mesh-ancestor
20561358|NCT01978457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20561359|NCT01978457|Sensory System Agents|sensory system agents|mesh-ancestor
20561360|NCT01978457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561361|NCT01978457|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20561362|NCT01978457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20561363|NCT01978457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20561364|NCT01978457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20561365|NCT01978457|Dopamine Agents|dopamine agents|mesh-ancestor
20561366|NCT01978483|Denosumab|denosumab|mesh-list
20561367|NCT01978483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20561368|NCT01978483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561369|NCT01978496|Eletriptan|eletriptan|mesh-list
20561370|NCT01978496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20561371|NCT01978496|Serotonin Agents|serotonin agents|mesh-ancestor
20561372|NCT01978496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20561373|NCT01978496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561374|NCT01978496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561375|NCT01978665|Prednisone|prednisone|mesh-list
20561376|NCT01978665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20561377|NCT01978665|Glucocorticoids|glucocorticoids|mesh-ancestor
20561378|NCT01978665|Hormones|hormones|mesh-ancestor
20561379|NCT01978665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20561380|NCT01978665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561381|NCT01978665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20561382|NCT01978665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20561383|NCT01978678|Budesonide|budesonide|mesh-list
20561384|NCT01978678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20561385|NCT01978678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20561386|NCT01978678|Autonomic Agents|autonomic agents|mesh-ancestor
20561387|NCT01978678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561388|NCT01978678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561389|NCT01978678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20561390|NCT01978678|Respiratory System Agents|respiratory system agents|mesh-ancestor
20561391|NCT01978678|Glucocorticoids|glucocorticoids|mesh-ancestor
20561392|NCT01978678|Hormones|hormones|mesh-ancestor
20561393|NCT01978678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20561394|NCT01978704|Insulin|insulin|mesh-list
20561395|NCT01978704|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20561396|NCT01978704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20561397|NCT01978704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561398|NCT01978717|Anesthetics|anesthetics|mesh-list
20561399|NCT01978717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20561400|NCT01978717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561401|NCT01978782|Raltegravir Potassium|raltegravir potassium|mesh-list
20561402|NCT01978782|Citalopram|citalopram|mesh-list
20561403|NCT01978782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20561404|NCT01978782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20561405|NCT01978782|Antiviral Agents|antiviral agents|mesh-ancestor
20561406|NCT01978782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20561407|NCT01978782|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20561408|NCT01978782|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20561409|NCT01978782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561410|NCT01978782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561411|NCT01978782|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20561412|NCT01978782|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20561413|NCT01978782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20561414|NCT01978782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20561415|NCT01978782|Serotonin Agents|serotonin agents|mesh-ancestor
20561416|NCT01978782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561417|NCT01978782|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20561418|NCT01978782|Antidepressive Agents|antidepressive agents|mesh-ancestor
20561419|NCT01978782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20561420|NCT01978873|Ascorbic Acid|ascorbic acid|mesh-list
20561421|NCT01978873|Methyltestosterone|methyltestosterone|mesh-list
20561422|NCT01978873|Androgens|androgens|mesh-list
20561423|NCT01978873|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
20561424|NCT01978873|Hormones|hormones|mesh-ancestor
20561425|NCT01978873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20561426|NCT01978873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561427|NCT01978873|Antioxidants|antioxidants|mesh-ancestor
20561428|NCT01978873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561429|NCT01978873|Protective Agents|protective agents|mesh-ancestor
20561430|NCT01978873|Vitamins|vitamins|mesh-ancestor
20561431|NCT01978873|Micronutrients|micronutrients|mesh-ancestor
20561432|NCT01978873|Estrogens|estrogens|mesh-ancestor
20561433|NCT01978873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20561434|NCT01978873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20561435|NCT01978873|Anabolic Agents|anabolic agents|mesh-ancestor
20561436|NCT01979341|Triptorelin Pamoate|triptorelin pamoate|mesh-list
20561437|NCT01979341|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20561438|NCT01979341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561439|NCT01979341|Luteolytic Agents|luteolytic agents|mesh-ancestor
20561440|NCT01979341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20561441|NCT01979341|Contraceptive Agents|contraceptive agents|mesh-ancestor
20561442|NCT01979341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20561443|NCT01979341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20561444|NCT01979341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20561445|NCT01979341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20561446|NCT01979354|Morphine|morphine|mesh-list
20561447|NCT01979354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20561448|NCT01979354|Narcotics|narcotics|mesh-ancestor
20561449|NCT01979354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20561450|NCT01979354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561451|NCT01979354|Analgesics|analgesics|mesh-ancestor
20561452|NCT01979354|Sensory System Agents|sensory system agents|mesh-ancestor
20561453|NCT01979354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561454|NCT01979406|Vaccines|vaccines|mesh-list
20561455|NCT01979406|Immunologic Factors|immunologic factors|mesh-ancestor
20561456|NCT01979406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561457|NCT01979510|Acetaminophen|acetaminophen|mesh-list
20561458|NCT01979510|Etoricoxib|etoricoxib|mesh-list
20561459|NCT01979510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20561460|NCT01979510|Analgesics|analgesics|mesh-ancestor
20561461|NCT01979510|Sensory System Agents|sensory system agents|mesh-ancestor
20561462|NCT01979510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561463|NCT01979510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561464|NCT01979510|Antipyretics|antipyretics|mesh-ancestor
20561465|NCT01979510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20561466|NCT01979510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20561467|NCT01979510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20561468|NCT01979510|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20561469|NCT01979510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20561470|NCT01979510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561471|NCT01979510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561472|NCT01979653|Midazolam|midazolam|mesh-list
20561473|NCT01979653|Dexmedetomidine|dexmedetomidine|mesh-list
20561474|NCT01979653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20561475|NCT01979653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20561476|NCT01979653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561477|NCT01979653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20561478|NCT01979653|Analgesics|analgesics|mesh-ancestor
20561479|NCT01979653|Sensory System Agents|sensory system agents|mesh-ancestor
20561480|NCT01979653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561481|NCT01979653|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20561482|NCT01979653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20561483|NCT01979653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20561484|NCT01979653|Adrenergic Agents|adrenergic agents|mesh-ancestor
20561485|NCT01979653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20561486|NCT01979653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561487|NCT01979653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20561488|NCT01979653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20561489|NCT01979653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20561490|NCT01979653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20561491|NCT01979653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20561492|NCT01979653|Anesthetics, General|anesthetics, general|mesh-ancestor
20561493|NCT01979653|Anesthetics|anesthetics|mesh-ancestor
20561494|NCT01979653|GABA Modulators|gaba modulators|mesh-ancestor
20561495|NCT01979653|GABA Agents|gaba agents|mesh-ancestor
20561496|NCT01979679|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
20561497|NCT01979679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20561498|NCT01979679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20561499|NCT01979679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20561500|NCT01979679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561501|NCT01979679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20561502|NCT01979679|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
20561503|NCT01979679|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20561504|NCT01979679|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20561505|NCT01979679|Adrenergic Agents|adrenergic agents|mesh-ancestor
20561506|NCT01979679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20561507|NCT01979679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561508|NCT01979679|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20561509|NCT01979679|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20561510|NCT01979679|Serotonin Agents|serotonin agents|mesh-ancestor
20561511|NCT01979679|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20561512|NCT01979679|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20561513|NCT01979679|Dopamine Agents|dopamine agents|mesh-ancestor
20561514|NCT01979965|Ranolazine|ranolazine|mesh-list
20561515|NCT01979965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20561516|NCT01979965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20561517|NCT01979965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561518|NCT01980004|Potassium Citrate|potassium citrate|mesh-list
20561519|NCT01980004|Diuretics|diuretics|mesh-ancestor
20561520|NCT01980004|Natriuretic Agents|natriuretic agents|mesh-ancestor
20561521|NCT01980004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561522|NCT01980004|Expectorants|expectorants|mesh-ancestor
20561523|NCT01980004|Respiratory System Agents|respiratory system agents|mesh-ancestor
20561524|NCT01980069|Neostigmine|neostigmine|mesh-list
20561525|NCT01980069|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20561526|NCT01980069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561527|NCT01980069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561528|NCT01980069|Cholinergic Agents|cholinergic agents|mesh-ancestor
20561529|NCT01980069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20561530|NCT01980069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561531|NCT01980069|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20561532|NCT01980069|Autonomic Agents|autonomic agents|mesh-ancestor
20561533|NCT01980069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561534|NCT01980082|Cefazolin|cefazolin|mesh-list
20561535|NCT01980082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20561536|NCT01980082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20561537|NCT01980277|Paclitaxel|paclitaxel|mesh-list
20561538|NCT01980277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20561539|NCT01980277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20561540|NCT01980277|Tubulin Modulators|tubulin modulators|mesh-ancestor
20561541|NCT01980277|Antimitotic Agents|antimitotic agents|mesh-ancestor
20561542|NCT01980277|Mitosis Modulators|mitosis modulators|mesh-ancestor
20561543|NCT01980277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561544|NCT01980303|Esketamine|esketamine|mesh-list
20561545|NCT01980303|Antidepressive Agents|antidepressive agents|mesh-ancestor
20561546|NCT01980303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20561547|NCT01980316|Heparin|heparin|mesh-list
20561548|NCT01980316|Calcium heparin|calcium heparin|mesh-list
20561549|NCT01980316|Argatroban|argatroban|mesh-list
20561550|NCT01980316|Anticoagulants|anticoagulants|mesh-ancestor
20561551|NCT01980316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20561552|NCT01980316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20561553|NCT01980316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561554|NCT01980316|Antithrombins|antithrombins|mesh-ancestor
20561555|NCT01980316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20561556|NCT01980316|Protease Inhibitors|protease inhibitors|mesh-ancestor
20561557|NCT01980316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561558|NCT01980316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20561559|NCT01980329|Maraviroc|maraviroc|mesh-list
20561560|NCT01980329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
20561561|NCT01980329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
20561562|NCT01980329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561563|NCT01980329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20561564|NCT01980329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20561565|NCT01980329|Antiviral Agents|antiviral agents|mesh-ancestor
20561566|NCT01980329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20561567|NCT01980329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
20561568|NCT01980407|Leucovorin|leucovorin|mesh-list
20561569|NCT01980407|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
20561570|NCT01980407|Oxaliplatin|oxaliplatin|mesh-list
20561571|NCT01980407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20561572|NCT01980407|Antidotes|antidotes|mesh-ancestor
20561573|NCT01980407|Protective Agents|protective agents|mesh-ancestor
20561574|NCT01980407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561575|NCT01980407|Vitamin B Complex|vitamin b complex|mesh-ancestor
20561576|NCT01980407|Vitamins|vitamins|mesh-ancestor
20561577|NCT01980407|Micronutrients|micronutrients|mesh-ancestor
20561578|NCT01980472|Paclitaxel|paclitaxel|mesh-list
20561579|NCT01980472|Bevacizumab|bevacizumab|mesh-list
20561580|NCT01980472|Carboplatin|carboplatin|mesh-list
20561581|NCT01980472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20561582|NCT01980472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20561583|NCT01980472|Tubulin Modulators|tubulin modulators|mesh-ancestor
20561584|NCT01980472|Antimitotic Agents|antimitotic agents|mesh-ancestor
20561585|NCT01980472|Mitosis Modulators|mitosis modulators|mesh-ancestor
20561586|NCT01980472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561587|NCT01980472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20561588|NCT01980472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20561589|NCT01980472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20561590|NCT01980472|Growth Substances|growth substances|mesh-ancestor
20561591|NCT01980472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561592|NCT01980472|Growth Inhibitors|growth inhibitors|mesh-ancestor
20561593|NCT01980498|Fentanyl|fentanyl|mesh-list
20561594|NCT01980498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20561595|NCT01980498|Narcotics|narcotics|mesh-ancestor
20561596|NCT01980498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20561597|NCT01980498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561598|NCT01980498|Analgesics|analgesics|mesh-ancestor
20561599|NCT01980498|Sensory System Agents|sensory system agents|mesh-ancestor
20561600|NCT01980498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561601|NCT01980498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20561602|NCT01980498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20561603|NCT01980498|Anesthetics, General|anesthetics, general|mesh-ancestor
20561604|NCT01980498|Anesthetics|anesthetics|mesh-ancestor
20561605|NCT01980550|Nicotine|nicotine|mesh-list
20561606|NCT01980550|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20561607|NCT01980550|Autonomic Agents|autonomic agents|mesh-ancestor
20561608|NCT01980550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561609|NCT01980550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561610|NCT01980550|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20561611|NCT01980550|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20561612|NCT01980550|Cholinergic Agents|cholinergic agents|mesh-ancestor
20561613|NCT01980550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20561614|NCT01980550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561615|NCT01980615|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20561616|NCT01980615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20561617|NCT01980615|Respiratory System Agents|respiratory system agents|mesh-ancestor
20561618|NCT01980667|Cisplatin|cisplatin|mesh-list
20561619|NCT01980667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20561620|NCT01980680|Estradiol|estradiol|mesh-list
20561621|NCT01980680|Progesterone|progesterone|mesh-list
20561622|NCT01980680|Estrogens|estrogens|mesh-ancestor
20561623|NCT01980680|Hormones|hormones|mesh-ancestor
20561624|NCT01980680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20561625|NCT01980680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561626|NCT01980680|Progestins|progestins|mesh-ancestor
20561627|NCT01980745|Chloroquine|chloroquine|mesh-list
20561628|NCT01980745|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20561629|NCT01980745|Amebicides|amebicides|mesh-ancestor
20561630|NCT01980745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20561631|NCT01980745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20561632|NCT01980745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20561633|NCT01980745|Antimalarials|antimalarials|mesh-ancestor
20561634|NCT01980745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20561635|NCT01980745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20561636|NCT01980745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20561637|NCT01980745|Analgesics|analgesics|mesh-ancestor
20561638|NCT01980745|Sensory System Agents|sensory system agents|mesh-ancestor
20561639|NCT01980745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20011064|NCT02359877|Interferon beta-1a|interferon beta-1a|mesh-list
20011065|NCT02359877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011066|NCT02359877|Antiviral Agents|antiviral agents|mesh-ancestor
20011067|NCT02359877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20011068|NCT02359877|Immunologic Factors|immunologic factors|mesh-ancestor
20011069|NCT02359877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011070|NCT02359877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20011071|NCT02359903|Infliximab|infliximab|mesh-list
20011072|NCT02359903|Dermatologic Agents|dermatologic agents|mesh-ancestor
20011073|NCT02359903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20011074|NCT02359903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20011075|NCT02360098|Anesthetics|anesthetics|mesh-list
20011076|NCT02360098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20011077|NCT02360098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011078|NCT02360124|Fluorides|fluorides|mesh-list
20011079|NCT02360124|Cariostatic Agents|cariostatic agents|mesh-ancestor
20011080|NCT02360124|Protective Agents|protective agents|mesh-ancestor
20011081|NCT02360124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011082|NCT02360215|Memantine|memantine|mesh-list
20561640|NCT01980745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561641|NCT01980745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20561642|NCT01980745|Filaricides|filaricides|mesh-ancestor
20011083|NCT02360215|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20561643|NCT01980745|Antinematodal Agents|antinematodal agents|mesh-ancestor
20561644|NCT01980745|Anthelmintics|anthelmintics|mesh-ancestor
20561645|NCT01980810|Paclitaxel|paclitaxel|mesh-list
20561646|NCT01980810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20561647|NCT01980810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20561648|NCT01980810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20561649|NCT01980810|Tubulin Modulators|tubulin modulators|mesh-ancestor
20561650|NCT01980810|Antimitotic Agents|antimitotic agents|mesh-ancestor
20561651|NCT01980810|Mitosis Modulators|mitosis modulators|mesh-ancestor
20561652|NCT01980810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561653|NCT01980823|Metformin|metformin|mesh-list
20561654|NCT01980823|Atorvastatin|atorvastatin|mesh-list
20561655|NCT01980823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20561656|NCT01980823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561657|NCT01980823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20561658|NCT01980823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20561659|NCT01980823|Antimetabolites|antimetabolites|mesh-ancestor
20561660|NCT01980823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561661|NCT01980823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20561662|NCT01980823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20561663|NCT01980823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561664|NCT01980849|Nadroparin|nadroparin|mesh-list
20561665|NCT01980849|Anticoagulants|anticoagulants|mesh-ancestor
20561666|NCT01980849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20561667|NCT01980849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20561668|NCT01980849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561669|NCT01980966|Oseltamivir|oseltamivir|mesh-list
20561670|NCT01980966|Antiviral Agents|antiviral agents|mesh-ancestor
20561671|NCT01980966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20561672|NCT01980966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561673|NCT01980966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561674|NCT01980979|Treprostinil|treprostinil|mesh-list
20561675|NCT01980979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20561676|NCT01981031|Insulin Lispro|insulin lispro|mesh-list
20561677|NCT01981031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20561678|NCT01981031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561679|NCT01981278|Tapentadol|tapentadol|mesh-list
20561680|NCT01981278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20561681|NCT01981278|Narcotics|narcotics|mesh-ancestor
20561682|NCT01981278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20561683|NCT01981278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561684|NCT01981278|Analgesics|analgesics|mesh-ancestor
20561685|NCT01981278|Sensory System Agents|sensory system agents|mesh-ancestor
20561686|NCT01981278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561687|NCT01981278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20561688|NCT01981278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20561689|NCT01981278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20561690|NCT01981278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561691|NCT01981278|Adrenergic Agents|adrenergic agents|mesh-ancestor
20561692|NCT01981278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20561693|NCT01981291|Anesthetics|anesthetics|mesh-list
20561694|NCT01981291|Mepivacaine|mepivacaine|mesh-list
20561695|NCT01981291|Anesthetics, Local|anesthetics, local|mesh-list
20561696|NCT01981291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20561697|NCT01981291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561698|NCT01981291|Sensory System Agents|sensory system agents|mesh-ancestor
20561699|NCT01981291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561700|NCT01981330|Hyaluronic Acid|hyaluronic acid|mesh-list
20561701|NCT01981330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20561702|NCT01981330|Immunologic Factors|immunologic factors|mesh-ancestor
20561703|NCT01981330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561704|NCT01981330|Viscosupplements|viscosupplements|mesh-ancestor
20561705|NCT01981330|Protective Agents|protective agents|mesh-ancestor
20561706|NCT01981369|Dexmedetomidine|dexmedetomidine|mesh-list
20561707|NCT01981369|Propofol|propofol|mesh-list
20561708|NCT01981369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20561709|NCT01981369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20561710|NCT01981369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561711|NCT01981369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20561712|NCT01981369|Anesthetics, General|anesthetics, general|mesh-ancestor
20561713|NCT01981369|Anesthetics|anesthetics|mesh-ancestor
20561714|NCT01981369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20561715|NCT01981369|Analgesics|analgesics|mesh-ancestor
20561716|NCT01981369|Sensory System Agents|sensory system agents|mesh-ancestor
20561717|NCT01981369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561718|NCT01981369|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20561719|NCT01981369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20561720|NCT01981369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20561721|NCT01981369|Adrenergic Agents|adrenergic agents|mesh-ancestor
20561722|NCT01981369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20561723|NCT01981369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561724|NCT01981447|Lacosamide|lacosamide|mesh-list
20561725|NCT01981447|Anticonvulsants|anticonvulsants|mesh-ancestor
20561726|NCT01981447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20561727|NCT01981447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20561728|NCT01981447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20561729|NCT01981447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561730|NCT01981460|Methylene Blue|methylene blue|mesh-list
20561731|NCT01981460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561732|NCT01981460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561733|NCT01981499|Cetirizine|cetirizine|mesh-list
20561734|NCT01981499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20561735|NCT01981499|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20561736|NCT01981499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20561737|NCT01981499|Histamine Antagonists|histamine antagonists|mesh-ancestor
20561738|NCT01981499|Histamine Agents|histamine agents|mesh-ancestor
20561739|NCT01981499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20561740|NCT01981499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561741|NCT01981499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561742|NCT01981525|Metformin|metformin|mesh-list
20561743|NCT01981525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20561744|NCT01981525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561745|NCT01981707|Choline|choline|mesh-list
20561746|NCT01981707|Lipotropic Agents|lipotropic agents|mesh-ancestor
20561747|NCT01981707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20561748|NCT01981707|Antimetabolites|antimetabolites|mesh-ancestor
20561749|NCT01981707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561750|NCT01981707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20561751|NCT01981707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20561752|NCT01981707|Nootropic Agents|nootropic agents|mesh-ancestor
20561753|NCT01981746|Ropivacaine|ropivacaine|mesh-list
20561754|NCT01981746|Anesthetics, Local|anesthetics, local|mesh-ancestor
20561755|NCT01981746|Anesthetics|anesthetics|mesh-ancestor
20561756|NCT01981746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20561757|NCT01981746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561758|NCT01981746|Sensory System Agents|sensory system agents|mesh-ancestor
20561759|NCT01981746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561760|NCT01981811|Aripiprazole|aripiprazole|mesh-list
20561761|NCT01981811|Antidepressive Agents|antidepressive agents|mesh-ancestor
20561762|NCT01981811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20561763|NCT01981811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20561764|NCT01981811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20561765|NCT01981811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20561766|NCT01981811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561767|NCT01981811|Dopamine Agonists|dopamine agonists|mesh-ancestor
20561768|NCT01981811|Dopamine Agents|dopamine agents|mesh-ancestor
20561769|NCT01981811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20561770|NCT01981811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561771|NCT01981811|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20561772|NCT01981811|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20561773|NCT01981811|Serotonin Agents|serotonin agents|mesh-ancestor
20561774|NCT01981811|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20561775|NCT01981811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20561776|NCT01981811|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20561777|NCT01981811|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20561778|NCT01981889|Prednisone|prednisone|mesh-list
20561779|NCT01981889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20561780|NCT01981889|Glucocorticoids|glucocorticoids|mesh-ancestor
19460262|NCT03354962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460263|NCT03354962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20561781|NCT01981889|Hormones|hormones|mesh-ancestor
20561782|NCT01981889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20561783|NCT01981889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561784|NCT01981889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20561785|NCT01981889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20561786|NCT01981941|Gabapentin|gabapentin|mesh-list
20561787|NCT01981941|Analgesics|analgesics|mesh-ancestor
20561788|NCT01981941|Sensory System Agents|sensory system agents|mesh-ancestor
20561789|NCT01981941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561790|NCT01981941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561791|NCT01981941|Anticonvulsants|anticonvulsants|mesh-ancestor
20561792|NCT01981941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20561793|NCT01981941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20561794|NCT01981941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20561795|NCT01981941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20561796|NCT01981941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20561797|NCT01981941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20561798|NCT01981941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20561799|NCT01981941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561800|NCT01981941|Antimanic Agents|antimanic agents|mesh-ancestor
20561801|NCT01982019|Hormones|hormones|mesh-list
20561802|NCT01982019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20561803|NCT01982019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561804|NCT01982071|Micafungin|micafungin|mesh-list
20561805|NCT01982071|Antifungal Agents|antifungal agents|mesh-ancestor
20561806|NCT01982071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20561807|NCT01982097|Sorafenib|sorafenib|mesh-list
20561808|NCT01982097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20561809|NCT01982097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20561810|NCT01982097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561811|NCT01982097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561812|NCT01982175|Alemtuzumab|alemtuzumab|mesh-list
20561813|NCT01982175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20561814|NCT01982175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20561815|NCT01982201|Lesinurad|lesinurad|mesh-list
20561816|NCT01982201|Gout Suppressants|gout suppressants|mesh-ancestor
20561817|NCT01982201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20561818|NCT01982201|Uricosuric Agents|uricosuric agents|mesh-ancestor
20561819|NCT01982201|Renal Agents|renal agents|mesh-ancestor
20561820|NCT01982396|Lamivudine|lamivudine|mesh-list
20561821|NCT01982396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20561822|NCT01982396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20561823|NCT01982396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561824|NCT01982396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561825|NCT01982396|Antiviral Agents|antiviral agents|mesh-ancestor
20561826|NCT01982396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20561827|NCT01982396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20561828|NCT01982396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20561829|NCT01982461|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20561830|NCT01982461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20561831|NCT01982461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20561832|NCT01982461|Antimetabolites|antimetabolites|mesh-ancestor
20561833|NCT01982461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561834|NCT01982461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20561835|NCT01982461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20561836|NCT01982461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561837|NCT01982578|Genistein|genistein|mesh-list
20561838|NCT01982578|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
20561839|NCT01982578|Protective Agents|protective agents|mesh-ancestor
20561840|NCT01982578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561841|NCT01982578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20561842|NCT01982578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20561843|NCT01982578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561844|NCT01982578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561845|NCT01982578|Phytoestrogens|phytoestrogens|mesh-ancestor
20561846|NCT01982578|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
20561847|NCT01982578|Estrogens|estrogens|mesh-ancestor
20561848|NCT01982578|Hormones|hormones|mesh-ancestor
20561849|NCT01982578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20561850|NCT01982734|Curcumin|curcumin|mesh-list
20561851|NCT01982734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20561852|NCT01982734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20561853|NCT01982734|Analgesics|analgesics|mesh-ancestor
20561854|NCT01982734|Sensory System Agents|sensory system agents|mesh-ancestor
20561855|NCT01982734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561856|NCT01982734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561857|NCT01982734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20561858|NCT01982734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20561859|NCT01982734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20561860|NCT01982734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561861|NCT01982734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561862|NCT01982760|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20561863|NCT01982760|Hemostatics|hemostatics|mesh-ancestor
20561864|NCT01982760|Coagulants|coagulants|mesh-ancestor
20561865|NCT01982760|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20561866|NCT01982760|Natriuretic Agents|natriuretic agents|mesh-ancestor
20561867|NCT01982760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561868|NCT01982799|Acetaminophen|acetaminophen|mesh-list
20561869|NCT01982799|Ibuprofen|ibuprofen|mesh-list
20561870|NCT01982799|Naproxen|naproxen|mesh-list
20561871|NCT01982799|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20561872|NCT01982799|Hydrocodone|hydrocodone|mesh-list
20561873|NCT01982799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20561874|NCT01982799|Analgesics|analgesics|mesh-ancestor
20561875|NCT01982799|Sensory System Agents|sensory system agents|mesh-ancestor
20561876|NCT01982799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561877|NCT01982799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561878|NCT01982799|Antipyretics|antipyretics|mesh-ancestor
20561879|NCT01982799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20561880|NCT01982799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20561881|NCT01982799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20561882|NCT01982799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20561883|NCT01982799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561884|NCT01982799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561885|NCT01982799|Gout Suppressants|gout suppressants|mesh-ancestor
20561886|NCT01982799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20561887|NCT01982799|Narcotics|narcotics|mesh-ancestor
20561888|NCT01982799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20561889|NCT01982799|Antitussive Agents|antitussive agents|mesh-ancestor
20561890|NCT01982799|Respiratory System Agents|respiratory system agents|mesh-ancestor
20561891|NCT01982864|Gentamicins|gentamicins|mesh-list
20561892|NCT01982864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20561893|NCT01982864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19460264|NCT03354962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460265|NCT03354897|Torsemide|torsemide|mesh-list
19460266|NCT03354897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19460267|NCT03354897|Diuretics|diuretics|mesh-ancestor
19460268|NCT03354897|Natriuretic Agents|natriuretic agents|mesh-ancestor
19460269|NCT03354897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460270|NCT03354897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
19460271|NCT03354897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19460272|NCT03354897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460273|NCT03354806|Analgesics|analgesics|mesh-list
19460274|NCT03354806|Sensory System Agents|sensory system agents|mesh-ancestor
20561894|NCT01982864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20561895|NCT01982864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561896|NCT01982864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561897|NCT01982929|Epinephrine|epinephrine|mesh-list
20561898|NCT01982929|Bupivacaine|bupivacaine|mesh-list
20561899|NCT01982929|Anesthetics, Local|anesthetics, local|mesh-ancestor
20561900|NCT01982929|Anesthetics|anesthetics|mesh-ancestor
20561901|NCT01982929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20561902|NCT01982929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561903|NCT01982929|Sensory System Agents|sensory system agents|mesh-ancestor
20561904|NCT01982929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561905|NCT01982929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20561906|NCT01982929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20561907|NCT01982929|Adrenergic Agents|adrenergic agents|mesh-ancestor
20561908|NCT01982929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20561909|NCT01982929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561910|NCT01982929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20561911|NCT01982929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20561912|NCT01982929|Autonomic Agents|autonomic agents|mesh-ancestor
20561913|NCT01982929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20561914|NCT01982929|Respiratory System Agents|respiratory system agents|mesh-ancestor
20561915|NCT01982929|Mydriatics|mydriatics|mesh-ancestor
20561916|NCT01982929|Sympathomimetics|sympathomimetics|mesh-ancestor
20561917|NCT01982929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20561918|NCT01983124|Vemurafenib|vemurafenib|mesh-list
20561919|NCT01983124|Fotemustine|fotemustine|mesh-list
20561920|NCT01983124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20561921|NCT01983124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20561922|NCT01983124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561923|NCT01983124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561924|NCT01983137|Oxycodone|oxycodone|mesh-list
20561925|NCT01983137|Naloxone|naloxone|mesh-list
20561926|NCT01983137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20561927|NCT01983137|Narcotics|narcotics|mesh-ancestor
20561928|NCT01983137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20561929|NCT01983137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561930|NCT01983137|Analgesics|analgesics|mesh-ancestor
20561931|NCT01983137|Sensory System Agents|sensory system agents|mesh-ancestor
20561932|NCT01983137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561933|NCT01983137|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20561934|NCT01983371|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20561935|NCT01983371|Hematinics|hematinics|mesh-ancestor
20561936|NCT01983371|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20561937|NCT01983371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20561938|NCT01983384|Anesthetics|anesthetics|mesh-list
20561939|NCT01983384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20561940|NCT01983384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561941|NCT01983449|Dexamethasone|dexamethasone|mesh-list
20561942|NCT01983449|Dexamethasone acetate|dexamethasone acetate|mesh-list
20561943|NCT01983449|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20561944|NCT01983449|BB 1101|bb 1101|mesh-list
20561945|NCT01983449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20561946|NCT01983449|Antiemetics|antiemetics|mesh-ancestor
20561947|NCT01983449|Autonomic Agents|autonomic agents|mesh-ancestor
20561948|NCT01983449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561949|NCT01983449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561950|NCT01983449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20561951|NCT01983449|Glucocorticoids|glucocorticoids|mesh-ancestor
20561952|NCT01983449|Hormones|hormones|mesh-ancestor
20561953|NCT01983449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20561954|NCT01983449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20561955|NCT01983449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20561956|NCT01983449|Protease Inhibitors|protease inhibitors|mesh-ancestor
20561957|NCT01983449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561958|NCT01983449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561959|NCT01983462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20561960|NCT01983462|Clonidine|clonidine|mesh-list
20561961|NCT01983462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20561962|NCT01983462|Diuretics|diuretics|mesh-ancestor
20561963|NCT01983462|Natriuretic Agents|natriuretic agents|mesh-ancestor
20561964|NCT01983462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561965|NCT01983462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20561966|NCT01983462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20561967|NCT01983462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561968|NCT01983462|Analgesics|analgesics|mesh-ancestor
20561969|NCT01983462|Sensory System Agents|sensory system agents|mesh-ancestor
20561970|NCT01983462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20561971|NCT01983462|Sympatholytics|sympatholytics|mesh-ancestor
20561972|NCT01983462|Autonomic Agents|autonomic agents|mesh-ancestor
20561973|NCT01983462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20561974|NCT01983462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20561975|NCT01983462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20561976|NCT01983462|Adrenergic Agents|adrenergic agents|mesh-ancestor
20561977|NCT01983462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20561978|NCT01983475|Denosumab|denosumab|mesh-list
20561979|NCT01983475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20561980|NCT01983475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561981|NCT01983501|Tucatinib|tucatinib|mesh-list
20561982|NCT01983501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20561983|NCT01983501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20561984|NCT01983501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20561985|NCT01983501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20561986|NCT01983514|Oxytocin|oxytocin|mesh-list
20561987|NCT01983514|Oxytocics|oxytocics|mesh-ancestor
20561988|NCT01983514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20561989|NCT01983514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20561990|NCT01983527|Methylprednisolone|methylprednisolone|mesh-list
20561991|NCT01983527|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20561992|NCT01983527|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20561993|NCT01983527|Prednisolone|prednisolone|mesh-list
20561994|NCT01983527|Prednisolone acetate|prednisolone acetate|mesh-list
20561995|NCT01983527|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20561996|NCT01983527|Prednisolone phosphate|prednisolone phosphate|mesh-list
20561997|NCT01983527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20561998|NCT01983527|Antiemetics|antiemetics|mesh-ancestor
20561999|NCT01983527|Autonomic Agents|autonomic agents|mesh-ancestor
20562000|NCT01983527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20562001|NCT01983527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562002|NCT01983527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20562003|NCT01983527|Glucocorticoids|glucocorticoids|mesh-ancestor
20562004|NCT01983527|Hormones|hormones|mesh-ancestor
20562005|NCT01983527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20562006|NCT01983527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20562007|NCT01983527|Protective Agents|protective agents|mesh-ancestor
20562008|NCT01983527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20562009|NCT01983527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562010|NCT01983540|Vaccines|vaccines|mesh-list
20562011|NCT01983540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20562012|NCT01983540|Immunologic Factors|immunologic factors|mesh-ancestor
20562013|NCT01983540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562014|NCT01983579|Bevacizumab|bevacizumab|mesh-list
20562015|NCT01983579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20562016|NCT01983579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562017|NCT01983579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20562018|NCT01983579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20562019|NCT01983579|Growth Substances|growth substances|mesh-ancestor
20562020|NCT01983579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562021|NCT01983579|Growth Inhibitors|growth inhibitors|mesh-ancestor
20562022|NCT01983657|Molgramostim|molgramostim|mesh-list
20562023|NCT01983657|Sargramostim|sargramostim|mesh-list
20562024|NCT01983657|Immunologic Factors|immunologic factors|mesh-ancestor
20562025|NCT01983657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562026|NCT01983657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562027|NCT01983722|Stiripentol|stiripentol|mesh-list
20562028|NCT01983722|Anticonvulsants|anticonvulsants|mesh-ancestor
20562029|NCT01983735|Niacin|niacin|mesh-list
20562030|NCT01983735|Amlodipine|amlodipine|mesh-list
20562031|NCT01983735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20562032|NCT01983735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20562033|NCT01983735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20562034|NCT01983735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562035|NCT01983735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20562036|NCT01983735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562037|NCT01983735|Vasodilator Agents|vasodilator agents|mesh-ancestor
20562038|NCT01983735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20562039|NCT01983735|Antimetabolites|antimetabolites|mesh-ancestor
20562040|NCT01983735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20562041|NCT01983735|Vitamin B Complex|vitamin b complex|mesh-ancestor
20562042|NCT01983735|Vitamins|vitamins|mesh-ancestor
20562043|NCT01983735|Micronutrients|micronutrients|mesh-ancestor
20562044|NCT01983761|Vidarabine|vidarabine|mesh-list
20562045|NCT01983761|Mycophenolic Acid|mycophenolic acid|mesh-list
20562046|NCT01983761|Fludarabine|fludarabine|mesh-list
20562047|NCT01983761|Fludarabine phosphate|fludarabine phosphate|mesh-list
20562048|NCT01983761|Melphalan|melphalan|mesh-list
20562049|NCT01983761|Busulfan|busulfan|mesh-list
20562050|NCT01983761|Clofarabine|clofarabine|mesh-list
20562051|NCT01983761|Tacrolimus|tacrolimus|mesh-list
20562052|NCT01983761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562053|NCT01983761|Immunologic Factors|immunologic factors|mesh-ancestor
20562054|NCT01983761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562055|NCT01983761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20562056|NCT01983761|Antimetabolites|antimetabolites|mesh-ancestor
20562057|NCT01983761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562058|NCT01983761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20562059|NCT01983761|Antiviral Agents|antiviral agents|mesh-ancestor
20562060|NCT01983761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20562061|NCT01983761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20562062|NCT01983761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20562063|NCT01983761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20562064|NCT01983761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20562065|NCT01983761|Antitubercular Agents|antitubercular agents|mesh-ancestor
20562066|NCT01983761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20562067|NCT01983761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20562068|NCT01983761|Alkylating Agents|alkylating agents|mesh-ancestor
20562069|NCT01983761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20562070|NCT01983800|Midazolam|midazolam|mesh-list
20562071|NCT01983800|Propofol|propofol|mesh-list
20562072|NCT01983800|Isoflurane|isoflurane|mesh-list
20562073|NCT01983800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20562074|NCT01983800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20562075|NCT01983800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562076|NCT01983800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20562077|NCT01983800|Anesthetics, General|anesthetics, general|mesh-ancestor
20562078|NCT01983800|Anesthetics|anesthetics|mesh-ancestor
20562079|NCT01983800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20562080|NCT01983800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20562081|NCT01983800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20562082|NCT01983800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20562083|NCT01983800|GABA Modulators|gaba modulators|mesh-ancestor
20562084|NCT01983800|GABA Agents|gaba agents|mesh-ancestor
20562085|NCT01983800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20562086|NCT01983800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562087|NCT01983800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20562088|NCT01983943|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
20562089|NCT01983943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20562090|NCT01983943|Antioxidants|antioxidants|mesh-ancestor
20562091|NCT01983943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562092|NCT01983943|Protective Agents|protective agents|mesh-ancestor
20562093|NCT01983943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562094|NCT01983943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20562095|NCT01984008|Picosulfate sodium|picosulfate sodium|mesh-list
20562096|NCT01984008|Magnesium Oxide|magnesium oxide|mesh-list
20562097|NCT01984008|Citric Acid|citric acid|mesh-list
20562098|NCT01984008|Sodium Citrate|sodium citrate|mesh-list
20562099|NCT01984008|Cathartics|cathartics|mesh-ancestor
20562100|NCT01984008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20562101|NCT01984008|Anticoagulants|anticoagulants|mesh-ancestor
20562102|NCT01984008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20562103|NCT01984008|Chelating Agents|chelating agents|mesh-ancestor
20562104|NCT01984008|Sequestering Agents|sequestering agents|mesh-ancestor
20562105|NCT01984008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562106|NCT01984008|Antacids|antacids|mesh-ancestor
20562107|NCT01984073|Niacin|niacin|mesh-list
20562108|NCT01984073|Niacinamide|niacinamide|mesh-list
20562109|NCT01984073|Nicotinic Acids|nicotinic acids|mesh-list
20562110|NCT01984073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20562111|NCT01984073|Antimetabolites|antimetabolites|mesh-ancestor
20562112|NCT01984073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562113|NCT01984073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20562114|NCT01984073|Vasodilator Agents|vasodilator agents|mesh-ancestor
20562115|NCT01984073|Vitamin B Complex|vitamin b complex|mesh-ancestor
20562116|NCT01984073|Vitamins|vitamins|mesh-ancestor
20562117|NCT01984073|Micronutrients|micronutrients|mesh-ancestor
20562118|NCT01984073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562119|NCT01984086|Albuterol|albuterol|mesh-list
20562120|NCT01984086|Charcoal|charcoal|mesh-list
20562121|NCT01984086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20562122|NCT01984086|Autonomic Agents|autonomic agents|mesh-ancestor
20562123|NCT01984086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20562124|NCT01984086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562125|NCT01984086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20562126|NCT01984086|Respiratory System Agents|respiratory system agents|mesh-ancestor
20562127|NCT01984086|Tocolytic Agents|tocolytic agents|mesh-ancestor
20562128|NCT01984086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20562129|NCT01984086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20562130|NCT01984086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20562131|NCT01984086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20562132|NCT01984086|Adrenergic Agents|adrenergic agents|mesh-ancestor
20562133|NCT01984086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20562134|NCT01984086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562135|NCT01984086|Antidotes|antidotes|mesh-ancestor
20562136|NCT01984086|Protective Agents|protective agents|mesh-ancestor
20562137|NCT01984099|Folic Acid|folic acid|mesh-list
20562138|NCT01984099|Vitamin B Complex|vitamin b complex|mesh-list
20562139|NCT01984099|Methotrexate|methotrexate|mesh-list
20562140|NCT01984099|Vitamins|vitamins|mesh-ancestor
20562141|NCT01984099|Micronutrients|micronutrients|mesh-ancestor
20562142|NCT01984099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562143|NCT01984099|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20562144|NCT01984099|Abortifacient Agents|abortifacient agents|mesh-ancestor
20562145|NCT01984099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20562146|NCT01984099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20562147|NCT01984099|Antimetabolites|antimetabolites|mesh-ancestor
20562148|NCT01984099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562149|NCT01984099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562150|NCT01984099|Dermatologic Agents|dermatologic agents|mesh-ancestor
20562151|NCT01984099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20562152|NCT01984099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20562153|NCT01984099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20562154|NCT01984099|Immunologic Factors|immunologic factors|mesh-ancestor
20562155|NCT01984099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20562156|NCT01984099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20562157|NCT01984099|Hematinics|hematinics|mesh-ancestor
20562158|NCT01984138|Estradiol|estradiol|mesh-list
20562159|NCT01984138|Estrogens|estrogens|mesh-ancestor
20562160|NCT01984138|Hormones|hormones|mesh-ancestor
20562161|NCT01984138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20562162|NCT01984138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562163|NCT01984177|Hormones|hormones|mesh-list
20562164|NCT01984177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20562165|NCT01984177|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
20562166|NCT01984177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20562167|NCT01984177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562168|NCT01984255|Ipilimumab|ipilimumab|mesh-list
20562169|NCT01984255|Bavituximab|bavituximab|mesh-list
20562170|NCT01984255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20562171|NCT01984255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562172|NCT01984255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20562173|NCT01984255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562174|NCT01984372|Insulin|insulin|mesh-list
20562175|NCT01984372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20562176|NCT01984372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562177|NCT01984463|Fentanyl|fentanyl|mesh-list
20562178|NCT01984463|Morphine|morphine|mesh-list
20562179|NCT01984463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20562180|NCT01984463|Narcotics|narcotics|mesh-ancestor
20562181|NCT01984463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20562182|NCT01984463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562183|NCT01984463|Analgesics|analgesics|mesh-ancestor
20562184|NCT01984463|Sensory System Agents|sensory system agents|mesh-ancestor
20562185|NCT01984463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20562186|NCT01984463|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20562187|NCT01984463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20562188|NCT01984463|Anesthetics, General|anesthetics, general|mesh-ancestor
20562189|NCT01984463|Anesthetics|anesthetics|mesh-ancestor
20562190|NCT01984567|Vitamin E|vitamin e|mesh-list
20562191|NCT01984567|Thioctic Acid|thioctic acid|mesh-list
20562192|NCT01984567|Vitamins|vitamins|mesh-ancestor
20011084|NCT02360215|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20011085|NCT02360215|Dopamine Agents|dopamine agents|mesh-ancestor
20011086|NCT02360215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011087|NCT02360215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011088|NCT02360215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011089|NCT02360215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20011090|NCT02360215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20011091|NCT02360280|Midazolam|midazolam|mesh-list
20011092|NCT02360280|Ketamine|ketamine|mesh-list
20011093|NCT02360280|Analgesics|analgesics|mesh-ancestor
20011094|NCT02360280|Sensory System Agents|sensory system agents|mesh-ancestor
20011095|NCT02360280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20011096|NCT02360280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011097|NCT02360280|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20011098|NCT02360280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20011099|NCT02360280|Anesthetics, General|anesthetics, general|mesh-ancestor
20011100|NCT02360280|Anesthetics|anesthetics|mesh-ancestor
20011101|NCT02360280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20011102|NCT02360280|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20011103|NCT02360280|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20011104|NCT02360280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011105|NCT02360280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011106|NCT02360280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20011107|NCT02360280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20562193|NCT01984567|Micronutrients|micronutrients|mesh-ancestor
20562194|NCT01984567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562195|NCT01984567|Antioxidants|antioxidants|mesh-ancestor
20562196|NCT01984567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562197|NCT01984567|Protective Agents|protective agents|mesh-ancestor
20562198|NCT01984567|Vitamin B Complex|vitamin b complex|mesh-ancestor
20562199|NCT01984606|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20562200|NCT01984606|Empagliflozin|empagliflozin|mesh-list
20562201|NCT01984606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20562202|NCT01984606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562203|NCT01984606|Incretins|incretins|mesh-ancestor
20562204|NCT01984606|Hormones|hormones|mesh-ancestor
20562205|NCT01984606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20562206|NCT01984606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20562207|NCT01984606|Protease Inhibitors|protease inhibitors|mesh-ancestor
20562208|NCT01984606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20562209|NCT01984606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562210|NCT01984606|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20562211|NCT01984749|Febuxostat|febuxostat|mesh-list
20562212|NCT01984749|Gout Suppressants|gout suppressants|mesh-ancestor
20562213|NCT01984749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20562214|NCT01984827|Moxifloxacin|moxifloxacin|mesh-list
20562215|NCT01984827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20562216|NCT01984827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20562217|NCT01984827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20562218|NCT01984827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20011108|NCT02360280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20011109|NCT02360280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20011110|NCT02360280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20011111|NCT02360280|GABA Modulators|gaba modulators|mesh-ancestor
20011112|NCT02360280|GABA Agents|gaba agents|mesh-ancestor
20011113|NCT02360319|Aripiprazole|aripiprazole|mesh-list
20011114|NCT02360319|Antipsychotic Agents|antipsychotic agents|mesh-list
20011115|NCT02360319|Antidepressive Agents|antidepressive agents|mesh-ancestor
20011116|NCT02360319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20011117|NCT02360319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20011118|NCT02360319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20011119|NCT02360319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011120|NCT02360319|Dopamine Agonists|dopamine agonists|mesh-ancestor
20011121|NCT02360319|Dopamine Agents|dopamine agents|mesh-ancestor
20011122|NCT02360319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011123|NCT02360319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011124|NCT02360319|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20011125|NCT02360319|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20011126|NCT02360319|Serotonin Agents|serotonin agents|mesh-ancestor
20011127|NCT02360319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20011128|NCT02360319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20562219|NCT01984827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20562220|NCT01984827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562221|NCT01984827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562222|NCT01984931|Medazepam|medazepam|mesh-list
20562223|NCT01984931|Metoclopramide|metoclopramide|mesh-list
20562224|NCT01984931|Bromazepam|bromazepam|mesh-list
20562225|NCT01984931|Simethicone|simethicone|mesh-list
20562226|NCT01984931|Trimebutine|trimebutine|mesh-list
20562227|NCT01984931|Mosapride|mosapride|mesh-list
20562228|NCT01984931|Maleic acid|maleic acid|mesh-list
20562229|NCT01984931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20562230|NCT01984931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562231|NCT01984931|Antiemetics|antiemetics|mesh-ancestor
20562232|NCT01984931|Autonomic Agents|autonomic agents|mesh-ancestor
20562233|NCT01984931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20562234|NCT01984931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562235|NCT01984931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20562236|NCT01984931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20562237|NCT01984931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20562238|NCT01984931|Dopamine Agents|dopamine agents|mesh-ancestor
20562239|NCT01984931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20562240|NCT01984931|Parasympatholytics|parasympatholytics|mesh-ancestor
20562241|NCT01984931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20562242|NCT01984931|Serotonin Agents|serotonin agents|mesh-ancestor
20562243|NCT01984931|Antifoaming Agents|antifoaming agents|mesh-ancestor
20562244|NCT01984931|Emollients|emollients|mesh-ancestor
20562245|NCT01984931|Dermatologic Agents|dermatologic agents|mesh-ancestor
20562246|NCT01984931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20562247|NCT01984931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20562248|NCT01984931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20562249|NCT01984931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20562250|NCT01984931|GABA Modulators|gaba modulators|mesh-ancestor
20562251|NCT01984931|GABA Agents|gaba agents|mesh-ancestor
20562252|NCT01984931|Anticonvulsants|anticonvulsants|mesh-ancestor
20562253|NCT01984931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20562254|NCT01984931|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20562255|NCT01984931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20562256|NCT01985061|Busulfan|busulfan|mesh-list
20562257|NCT01985061|Alkylating Agents|alkylating agents|mesh-ancestor
20562258|NCT01985061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562259|NCT01985061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20562260|NCT01985061|Immunologic Factors|immunologic factors|mesh-ancestor
20562261|NCT01985061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562262|NCT01985061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20562263|NCT01985061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562264|NCT01985061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20562265|NCT01985087|Temozolomide|temozolomide|mesh-list
20562266|NCT01985087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20562267|NCT01985087|Alkylating Agents|alkylating agents|mesh-ancestor
20562268|NCT01985087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562269|NCT01985087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562270|NCT01985152|Choline|choline|mesh-list
20562271|NCT01985152|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20562272|NCT01985152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20562273|NCT01985152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20562274|NCT01985152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562275|NCT01985152|Lipotropic Agents|lipotropic agents|mesh-ancestor
20562276|NCT01985152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20562277|NCT01985152|Antimetabolites|antimetabolites|mesh-ancestor
20562278|NCT01985152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20562279|NCT01985152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20562280|NCT01985152|Nootropic Agents|nootropic agents|mesh-ancestor
20562281|NCT01985256|Flucytosine|flucytosine|mesh-list
20562282|NCT01985256|Antifungal Agents|antifungal agents|mesh-ancestor
20562283|NCT01985256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20562284|NCT01985256|Antimetabolites|antimetabolites|mesh-ancestor
20562285|NCT01985256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562286|NCT01985373|Immunoglobulins|immunoglobulins|mesh-list
20562287|NCT01985373|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20562288|NCT01985373|Antibodies|antibodies|mesh-list
20562289|NCT01985373|gamma-Globulins|gamma-globulins|mesh-list
20562290|NCT01985373|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20562291|NCT01985373|Immunologic Factors|immunologic factors|mesh-ancestor
20562292|NCT01985373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562293|NCT01985451|Temozolomide|temozolomide|mesh-list
20562294|NCT01985451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20562295|NCT01985451|Alkylating Agents|alkylating agents|mesh-ancestor
20562296|NCT01985451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562297|NCT01985451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562298|NCT01985477|Dexamethasone|dexamethasone|mesh-list
20562299|NCT01985477|Lenalidomide|lenalidomide|mesh-list
20562300|NCT01985477|Tretinoin|tretinoin|mesh-list
20562301|NCT01985477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20562302|NCT01985477|Antiemetics|antiemetics|mesh-ancestor
20562303|NCT01985477|Autonomic Agents|autonomic agents|mesh-ancestor
20562304|NCT01985477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20562305|NCT01985477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562306|NCT01985477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20562307|NCT01985477|Glucocorticoids|glucocorticoids|mesh-ancestor
20562308|NCT01985477|Hormones|hormones|mesh-ancestor
20562309|NCT01985477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20562310|NCT01985477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20562311|NCT01985477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562312|NCT01985477|Immunologic Factors|immunologic factors|mesh-ancestor
20562313|NCT01985477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20562314|NCT01985477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20562315|NCT01985477|Growth Substances|growth substances|mesh-ancestor
20562316|NCT01985477|Growth Inhibitors|growth inhibitors|mesh-ancestor
20562317|NCT01985477|Keratolytic Agents|keratolytic agents|mesh-ancestor
20562318|NCT01985477|Dermatologic Agents|dermatologic agents|mesh-ancestor
20562319|NCT01985594|Nifedipine|nifedipine|mesh-list
20562320|NCT01985594|Progesterone|progesterone|mesh-list
20562321|NCT01985594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20562322|NCT01985594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20562323|NCT01985594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562324|NCT01985594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20562325|NCT01985594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562326|NCT01985594|Vasodilator Agents|vasodilator agents|mesh-ancestor
20562327|NCT01985594|Tocolytic Agents|tocolytic agents|mesh-ancestor
20562328|NCT01985594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20562329|NCT01985594|Progestins|progestins|mesh-ancestor
20562330|NCT01985594|Hormones|hormones|mesh-ancestor
20562331|NCT01985594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20562332|NCT01985724|Cyclophosphamide|cyclophosphamide|mesh-list
20562333|NCT01985724|Docetaxel|docetaxel|mesh-list
20562334|NCT01985724|Epirubicin|epirubicin|mesh-list
20562335|NCT01985724|Fluorouracil|fluorouracil|mesh-list
20562336|NCT01985724|Mitogens|mitogens|mesh-list
20562337|NCT01985724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20562338|NCT01985724|Immunologic Factors|immunologic factors|mesh-ancestor
20562339|NCT01985724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562340|NCT01985724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20562341|NCT01985724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20562342|NCT01985724|Alkylating Agents|alkylating agents|mesh-ancestor
20562343|NCT01985724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562344|NCT01985724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562345|NCT01985724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20562346|NCT01985724|Tubulin Modulators|tubulin modulators|mesh-ancestor
20562347|NCT01985724|Antimitotic Agents|antimitotic agents|mesh-ancestor
20562348|NCT01985724|Mitosis Modulators|mitosis modulators|mesh-ancestor
20562349|NCT01985724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20562350|NCT01985724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20562351|NCT01985724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20562352|NCT01985724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20562353|NCT01985724|Antimetabolites|antimetabolites|mesh-ancestor
20562354|NCT01985724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20562355|NCT01985750|Cycloserine|cycloserine|mesh-list
20562356|NCT01985750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20562357|NCT01985750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20562358|NCT01985750|Renal Agents|renal agents|mesh-ancestor
20562359|NCT01985750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20562360|NCT01985750|Antitubercular Agents|antitubercular agents|mesh-ancestor
20562361|NCT01985750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20562362|NCT01985750|Antimetabolites|antimetabolites|mesh-ancestor
20562363|NCT01985750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562364|NCT01985789|Diphenhydramine|diphenhydramine|mesh-list
20562365|NCT01985789|Promethazine|promethazine|mesh-list
20562366|NCT01985789|Cetirizine|cetirizine|mesh-list
20562367|NCT01985789|Desloratadine|desloratadine|mesh-list
20562368|NCT01985789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20562369|NCT01985789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20562370|NCT01985789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20562371|NCT01985789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562372|NCT01985789|Anesthetics, Local|anesthetics, local|mesh-ancestor
20562373|NCT01985789|Anesthetics|anesthetics|mesh-ancestor
20562374|NCT01985789|Sensory System Agents|sensory system agents|mesh-ancestor
20562375|NCT01985789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20562376|NCT01985789|Antiemetics|antiemetics|mesh-ancestor
20562377|NCT01985789|Autonomic Agents|autonomic agents|mesh-ancestor
20562378|NCT01985789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20562379|NCT01985789|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20562380|NCT01985789|Histamine Antagonists|histamine antagonists|mesh-ancestor
20562381|NCT01985789|Histamine Agents|histamine agents|mesh-ancestor
20562382|NCT01985789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20562383|NCT01985789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562384|NCT01985789|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20562385|NCT01985789|Antipruritics|antipruritics|mesh-ancestor
20562386|NCT01985789|Dermatologic Agents|dermatologic agents|mesh-ancestor
20562387|NCT01985789|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20562388|NCT01985789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20562389|NCT01985789|Cholinergic Agents|cholinergic agents|mesh-ancestor
20562390|NCT01985828|Androgens|androgens|mesh-list
20562391|NCT01985828|Hormones|hormones|mesh-ancestor
20562392|NCT01985828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20562393|NCT01985828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562394|NCT01985841|Cyclophosphamide|cyclophosphamide|mesh-list
20562395|NCT01985841|Docetaxel|docetaxel|mesh-list
20562396|NCT01985841|Fluorouracil|fluorouracil|mesh-list
20562397|NCT01985841|Epirubicin|epirubicin|mesh-list
20562398|NCT01985841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20562399|NCT01985841|Immunologic Factors|immunologic factors|mesh-ancestor
20562400|NCT01985841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562401|NCT01985841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20562402|NCT01985841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20562403|NCT01985841|Alkylating Agents|alkylating agents|mesh-ancestor
20562404|NCT01985841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562405|NCT01985841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562406|NCT01985841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20562407|NCT01985841|Tubulin Modulators|tubulin modulators|mesh-ancestor
20562408|NCT01985841|Antimitotic Agents|antimitotic agents|mesh-ancestor
20562409|NCT01985841|Mitosis Modulators|mitosis modulators|mesh-ancestor
20562410|NCT01985841|Antimetabolites|antimetabolites|mesh-ancestor
20562411|NCT01985841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20562412|NCT01985841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20562413|NCT01985841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20562414|NCT01985841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20562415|NCT01985841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20562416|NCT01985854|Propofol|propofol|mesh-list
20562417|NCT01985854|Desflurane|desflurane|mesh-list
20562418|NCT01985854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20562419|NCT01985854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20562420|NCT01985854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562421|NCT01985854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20562422|NCT01985854|Anesthetics, General|anesthetics, general|mesh-ancestor
20562423|NCT01985854|Anesthetics|anesthetics|mesh-ancestor
20562424|NCT01985854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20562425|NCT01985893|Trastuzumab|trastuzumab|mesh-list
20562426|NCT01985893|Lapatinib|lapatinib|mesh-list
20562427|NCT01985893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20562428|NCT01985893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562429|NCT01985893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20562430|NCT01985893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20562431|NCT01985893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562432|NCT01986036|Calcium|calcium|mesh-list
20562433|NCT01986036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20562434|NCT01986036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562435|NCT01986049|Bupivacaine|bupivacaine|mesh-list
20562436|NCT01986049|Anesthetics, Local|anesthetics, local|mesh-ancestor
20562437|NCT01986049|Anesthetics|anesthetics|mesh-ancestor
20562438|NCT01986049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20562439|NCT01986049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562440|NCT01986049|Sensory System Agents|sensory system agents|mesh-ancestor
20562441|NCT01986049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20562442|NCT01986088|Sumatriptan|sumatriptan|mesh-list
20562443|NCT01986088|Eletriptan|eletriptan|mesh-list
20562444|NCT01986088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20562445|NCT01986088|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20562446|NCT01986088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20562447|NCT01986088|Serotonin Agents|serotonin agents|mesh-ancestor
20562448|NCT01986088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20562449|NCT01986088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562450|NCT01986088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562451|NCT01986127|Adalimumab|adalimumab|mesh-list
20562452|NCT01986127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20562453|NCT01986127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20562454|NCT01986192|Warfarin|warfarin|mesh-list
20562455|NCT01986192|Rivaroxaban|rivaroxaban|mesh-list
20562456|NCT01986192|Anticoagulants|anticoagulants|mesh-ancestor
20562457|NCT01986192|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20562458|NCT01986192|Antithrombins|antithrombins|mesh-ancestor
20562459|NCT01986192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20562460|NCT01986192|Protease Inhibitors|protease inhibitors|mesh-ancestor
20562461|NCT01986192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20562462|NCT01986192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562463|NCT01986270|Sumatriptan|sumatriptan|mesh-list
20562464|NCT01986270|Eletriptan|eletriptan|mesh-list
20562465|NCT01986270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20562466|NCT01986270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20562467|NCT01986270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20562468|NCT01986270|Serotonin Agents|serotonin agents|mesh-ancestor
20562469|NCT01986270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20562470|NCT01986270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562471|NCT01986270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562472|NCT01986283|Oxycodone|oxycodone|mesh-list
20562473|NCT01986283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20562474|NCT01986283|Narcotics|narcotics|mesh-ancestor
20562475|NCT01986283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20562476|NCT01986283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562477|NCT01986283|Analgesics|analgesics|mesh-ancestor
20562478|NCT01986283|Sensory System Agents|sensory system agents|mesh-ancestor
20562479|NCT01986283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20562480|NCT01986309|Lidocaine|lidocaine|mesh-list
20562481|NCT01986309|Anesthetics, Local|anesthetics, local|mesh-ancestor
20562482|NCT01986309|Anesthetics|anesthetics|mesh-ancestor
20562483|NCT01986309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20562484|NCT01986309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562485|NCT01986309|Sensory System Agents|sensory system agents|mesh-ancestor
20562486|NCT01986309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20562487|NCT01986309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20562488|NCT01986309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20562489|NCT01986309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20562490|NCT01986309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20562491|NCT01986309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562492|NCT01986322|Vaccines|vaccines|mesh-list
20562493|NCT01986322|Immunologic Factors|immunologic factors|mesh-ancestor
20562494|NCT01986322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562495|NCT01986426|Pembrolizumab|pembrolizumab|mesh-list
20562496|NCT01986426|Ipilimumab|ipilimumab|mesh-list
20562497|NCT01986426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20562498|NCT01986426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562499|NCT01986426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20562500|NCT01986426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562501|NCT01986465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20562502|NCT01986465|Methylprednisolone|methylprednisolone|mesh-list
20562503|NCT01986465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20562504|NCT01986465|Prednisolone|prednisolone|mesh-list
20562505|NCT01986465|Prednisolone acetate|prednisolone acetate|mesh-list
20562506|NCT01986465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20562507|NCT01986465|Prednisolone phosphate|prednisolone phosphate|mesh-list
20562508|NCT01986465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20562509|NCT01986465|Antiemetics|antiemetics|mesh-ancestor
20562510|NCT01986465|Autonomic Agents|autonomic agents|mesh-ancestor
20562511|NCT01986465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20562512|NCT01986465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562513|NCT01986465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20562514|NCT01986465|Glucocorticoids|glucocorticoids|mesh-ancestor
20562515|NCT01986465|Hormones|hormones|mesh-ancestor
20562516|NCT01986465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20562517|NCT01986465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20562518|NCT01986465|Protective Agents|protective agents|mesh-ancestor
20562519|NCT01986465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20562520|NCT01986465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562521|NCT01986556|Lesinurad|lesinurad|mesh-list
20562522|NCT01986556|Gout Suppressants|gout suppressants|mesh-ancestor
20562523|NCT01986556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20562524|NCT01986556|Uricosuric Agents|uricosuric agents|mesh-ancestor
20562525|NCT01986556|Renal Agents|renal agents|mesh-ancestor
20562526|NCT01986582|Phenylephrine|phenylephrine|mesh-list
20562527|NCT01986582|Oxymetazoline|oxymetazoline|mesh-list
20562528|NCT01986582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20562529|NCT01986582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20562530|NCT01986582|Adrenergic Agents|adrenergic agents|mesh-ancestor
20562531|NCT01986582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20562532|NCT01986582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562533|NCT01986582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562534|NCT01986582|Sympathomimetics|sympathomimetics|mesh-ancestor
20562535|NCT01986582|Autonomic Agents|autonomic agents|mesh-ancestor
20562536|NCT01986582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20562537|NCT01986582|Nasal Decongestants|nasal decongestants|mesh-ancestor
20562538|NCT01986582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20562539|NCT01986582|Respiratory System Agents|respiratory system agents|mesh-ancestor
20562540|NCT01986582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20562541|NCT01986582|Mydriatics|mydriatics|mesh-ancestor
20562542|NCT01986582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20562543|NCT01986582|Protective Agents|protective agents|mesh-ancestor
20562544|NCT01986608|Lacosamide|lacosamide|mesh-list
20562545|NCT01986608|Anticonvulsants|anticonvulsants|mesh-ancestor
20562546|NCT01986608|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20562547|NCT01986608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20562548|NCT01986608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20562549|NCT01986608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562550|NCT01986660|Ibuprofen|ibuprofen|mesh-list
20011129|NCT02360319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20011130|NCT02360319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20011131|NCT02360397|Ranolazine|ranolazine|mesh-list
20011132|NCT02360397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20011133|NCT02360397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20011134|NCT02360397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011135|NCT02360475|Vaccines|vaccines|mesh-list
20011136|NCT02360475|Immunologic Factors|immunologic factors|mesh-ancestor
20011137|NCT02360475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011138|NCT02360631|Varenicline|varenicline|mesh-list
20011139|NCT02360631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20011140|NCT02360631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20011141|NCT02360631|Cholinergic Agents|cholinergic agents|mesh-ancestor
20562551|NCT01986660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20562552|NCT01986660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20562553|NCT01986660|Analgesics|analgesics|mesh-ancestor
20562554|NCT01986660|Sensory System Agents|sensory system agents|mesh-ancestor
20562555|NCT01986660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20562556|NCT01986660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562557|NCT01986660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20562558|NCT01986660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20562559|NCT01986660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20562560|NCT01986660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20562561|NCT01986660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562562|NCT01986673|Sildenafil Citrate|sildenafil citrate|mesh-list
20562563|NCT01986673|Vasodilator Agents|vasodilator agents|mesh-ancestor
20562564|NCT01986673|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20562565|NCT01986673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20562566|NCT01986673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20562567|NCT01986673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562568|NCT01986673|Urological Agents|urological agents|mesh-ancestor
20562569|NCT01986764|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20562570|NCT01986764|Estradiol|estradiol|mesh-list
20562571|NCT01986764|Estrogens|estrogens|mesh-list
20562572|NCT01986764|Hormones|hormones|mesh-ancestor
20562573|NCT01986764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20562574|NCT01986764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562575|NCT01986764|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20562576|NCT01986764|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20562577|NCT01986764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20562578|NCT01986764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20562579|NCT01986764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562580|NCT01986764|Dopamine Agents|dopamine agents|mesh-ancestor
20562581|NCT01986764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20562582|NCT01986777|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20562583|NCT01986777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20562584|NCT01986777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562585|NCT01986777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20562586|NCT01986777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20562587|NCT01986777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20562588|NCT01986777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562589|NCT01986777|Dopamine Agents|dopamine agents|mesh-ancestor
20562590|NCT01986777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20562591|NCT01986894|Moxifloxacin|moxifloxacin|mesh-list
20562592|NCT01986894|Thalidomide|thalidomide|mesh-list
20562593|NCT01986894|Pomalidomide|pomalidomide|mesh-list
20562594|NCT01986894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20562595|NCT01986894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20562596|NCT01986894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20562597|NCT01986894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20562598|NCT01986894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20562599|NCT01986894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562600|NCT01986894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562601|NCT01986894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562602|NCT01986894|Immunologic Factors|immunologic factors|mesh-ancestor
20562603|NCT01986894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20562604|NCT01986894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20562605|NCT01986894|Growth Substances|growth substances|mesh-ancestor
20562606|NCT01986894|Growth Inhibitors|growth inhibitors|mesh-ancestor
20562607|NCT01986894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20562608|NCT01986894|Leprostatic Agents|leprostatic agents|mesh-ancestor
20562609|NCT01986998|Methylprednisolone|methylprednisolone|mesh-list
20562610|NCT01986998|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20562611|NCT01986998|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20562612|NCT01986998|Prednisolone|prednisolone|mesh-list
20562613|NCT01986998|Prednisolone acetate|prednisolone acetate|mesh-list
20562614|NCT01986998|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20562615|NCT01986998|Prednisolone phosphate|prednisolone phosphate|mesh-list
20562616|NCT01986998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20562617|NCT01986998|Antiemetics|antiemetics|mesh-ancestor
20562618|NCT01986998|Autonomic Agents|autonomic agents|mesh-ancestor
20562619|NCT01986998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20562620|NCT01986998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562621|NCT01986998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20562622|NCT01986998|Glucocorticoids|glucocorticoids|mesh-ancestor
20562623|NCT01986998|Hormones|hormones|mesh-ancestor
20562624|NCT01986998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20562625|NCT01986998|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20562626|NCT01986998|Protective Agents|protective agents|mesh-ancestor
20562627|NCT01986998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20562628|NCT01986998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562629|NCT01987076|Prednisone|prednisone|mesh-list
20562630|NCT01987076|Clobetasol|clobetasol|mesh-list
20562631|NCT01987076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20562632|NCT01987076|Glucocorticoids|glucocorticoids|mesh-ancestor
20562633|NCT01987076|Hormones|hormones|mesh-ancestor
20562634|NCT01987076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20562635|NCT01987076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562636|NCT01987076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20562637|NCT01987076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562638|NCT01987128|Ropivacaine|ropivacaine|mesh-list
20562639|NCT01987128|Anesthetics, Local|anesthetics, local|mesh-ancestor
20562640|NCT01987128|Anesthetics|anesthetics|mesh-ancestor
20562641|NCT01987128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20562642|NCT01987128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562643|NCT01987128|Sensory System Agents|sensory system agents|mesh-ancestor
20562644|NCT01987128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20562645|NCT01987154|Caseins|caseins|mesh-list
20562646|NCT01987154|Chelating Agents|chelating agents|mesh-ancestor
20562647|NCT01987154|Sequestering Agents|sequestering agents|mesh-ancestor
20562648|NCT01987154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562649|NCT01987167|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20562650|NCT01987167|Hormones|hormones|mesh-ancestor
20562651|NCT01987167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20562652|NCT01987167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562653|NCT01987297|Cytarabine|cytarabine|mesh-list
20562654|NCT01987297|Daunorubicin|daunorubicin|mesh-list
20562655|NCT01987297|Idarubicin|idarubicin|mesh-list
20562656|NCT01987297|Tretinoin|tretinoin|mesh-list
20562657|NCT01987297|Arsenic Trioxide|arsenic trioxide|mesh-list
20562658|NCT01987297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20562659|NCT01987297|Antimetabolites|antimetabolites|mesh-ancestor
20562660|NCT01987297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562661|NCT01987297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562662|NCT01987297|Antiviral Agents|antiviral agents|mesh-ancestor
20562663|NCT01987297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20562664|NCT01987297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20562665|NCT01987297|Immunologic Factors|immunologic factors|mesh-ancestor
20562666|NCT01987297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562667|NCT01987297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20562668|NCT01987297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20562669|NCT01987297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20562670|NCT01987297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20562671|NCT01987297|Keratolytic Agents|keratolytic agents|mesh-ancestor
20562672|NCT01987297|Dermatologic Agents|dermatologic agents|mesh-ancestor
20562673|NCT01987310|Atorvastatin|atorvastatin|mesh-list
20562674|NCT01987310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20562675|NCT01987310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20562676|NCT01987310|Antimetabolites|antimetabolites|mesh-ancestor
20562677|NCT01987310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562678|NCT01987310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20562679|NCT01987310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20562680|NCT01987310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20562681|NCT01987323|Latanoprost|latanoprost|mesh-list
20562682|NCT01987323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20562683|NCT01987323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20562684|NCT01987375|Cetuximab|cetuximab|mesh-list
20562685|NCT01987375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20562686|NCT01987375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562687|NCT01987570|Allopurinol|allopurinol|mesh-list
20562688|NCT01987570|Antimetabolites|antimetabolites|mesh-ancestor
20562689|NCT01987570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562690|NCT01987570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20562691|NCT01987570|Gout Suppressants|gout suppressants|mesh-ancestor
20562692|NCT01987570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20562693|NCT01987570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20562694|NCT01987570|Antioxidants|antioxidants|mesh-ancestor
20562695|NCT01987570|Protective Agents|protective agents|mesh-ancestor
20562696|NCT01987570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562697|NCT01987739|Zolpidem|zolpidem|mesh-list
20562698|NCT01987739|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20562699|NCT01987739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20562700|NCT01987739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20562701|NCT01987739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562702|NCT01987739|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
20562703|NCT01987739|GABA Agonists|gaba agonists|mesh-ancestor
20562704|NCT01987739|GABA Agents|gaba agents|mesh-ancestor
20562705|NCT01987739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20562706|NCT01987739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562707|NCT01987804|Oxytocin|oxytocin|mesh-list
20562708|NCT01987804|Oxytocics|oxytocics|mesh-ancestor
20562709|NCT01987804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20562710|NCT01987804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562711|NCT01988077|Ipilimumab|ipilimumab|mesh-list
20562712|NCT01988077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20562713|NCT01988077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562714|NCT01988077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20562715|NCT01988077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562716|NCT01988116|Calcitriol|calcitriol|mesh-list
20562717|NCT01988116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20562718|NCT01988116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562719|NCT01988116|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
20562720|NCT01988116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20562721|NCT01988116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562722|NCT01988116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20562723|NCT01988116|Vitamins|vitamins|mesh-ancestor
20562724|NCT01988116|Micronutrients|micronutrients|mesh-ancestor
20562725|NCT01988116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20562726|NCT01988298|Acetaminophen|acetaminophen|mesh-list
20562727|NCT01988298|Ibuprofen|ibuprofen|mesh-list
20562728|NCT01988298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20562729|NCT01988298|Analgesics|analgesics|mesh-ancestor
20562730|NCT01988298|Sensory System Agents|sensory system agents|mesh-ancestor
20562731|NCT01988298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20562732|NCT01988298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562733|NCT01988298|Antipyretics|antipyretics|mesh-ancestor
20562734|NCT01988298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20562735|NCT01988298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19460275|NCT03354806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460276|NCT03354806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460277|NCT03354624|Mitogens|mitogens|mesh-list
19460278|NCT03354624|Mitosis Modulators|mitosis modulators|mesh-ancestor
19460279|NCT03354624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460280|NCT03354572|Acetylcysteine|acetylcysteine|mesh-list
19460281|NCT03354572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19460282|NCT03354572|Antiviral Agents|antiviral agents|mesh-ancestor
19460283|NCT03354572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19460284|NCT03354572|Expectorants|expectorants|mesh-ancestor
19460285|NCT03354572|Respiratory System Agents|respiratory system agents|mesh-ancestor
19460286|NCT03354572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19460287|NCT03354572|Antioxidants|antioxidants|mesh-ancestor
19460288|NCT03354572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460289|NCT03354572|Protective Agents|protective agents|mesh-ancestor
19460290|NCT03354572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460291|NCT03354572|Antidotes|antidotes|mesh-ancestor
19460292|NCT03354494|Desogestrel|desogestrel|mesh-list
19460293|NCT03354494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19460294|NCT03354494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19460295|NCT03354494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19460296|NCT03354494|Contraceptive Agents|contraceptive agents|mesh-ancestor
19460297|NCT03354494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19460298|NCT03354494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460299|NCT03354494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19460300|NCT03354494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19460301|NCT03354494|Progestins|progestins|mesh-ancestor
19460302|NCT03354494|Hormones|hormones|mesh-ancestor
19460303|NCT03354494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19460304|NCT03354338|Amoxicillin|amoxicillin|mesh-list
19460305|NCT03354338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19460306|NCT03354338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19460307|NCT03354312|Lidocaine|lidocaine|mesh-list
19460308|NCT03354312|Epinephrine|epinephrine|mesh-list
19460309|NCT03354312|Racepinephrine|racepinephrine|mesh-list
19460310|NCT03354312|Carticaine|carticaine|mesh-list
19460311|NCT03354312|Epinephryl borate|epinephryl borate|mesh-list
19460312|NCT03354312|Anesthetics, Local|anesthetics, local|mesh-ancestor
19460313|NCT03354312|Anesthetics|anesthetics|mesh-ancestor
19460314|NCT03354312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20562736|NCT01988298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20562737|NCT01988298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20562738|NCT01988298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20562739|NCT01988298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562740|NCT01988311|Psilocybin|psilocybin|mesh-list
20562741|NCT01988311|Hallucinogens|hallucinogens|mesh-ancestor
20562742|NCT01988311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562743|NCT01988311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20562744|NCT01988428|Ceftriaxone|ceftriaxone|mesh-list
20562745|NCT01988428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20562746|NCT01988428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20562747|NCT01988506|Interleukin-2|interleukin-2|mesh-list
20562748|NCT01988506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562749|NCT01988506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20562750|NCT01988506|Analgesics|analgesics|mesh-ancestor
20562751|NCT01988506|Sensory System Agents|sensory system agents|mesh-ancestor
20562752|NCT01988506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20562753|NCT01988506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562754|NCT01988545|Exenatide|exenatide|mesh-list
20562755|NCT01988545|Glucagon|glucagon|mesh-list
20562756|NCT01988545|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20562757|NCT01988545|Incretins|incretins|mesh-ancestor
20562758|NCT01988545|Hormones|hormones|mesh-ancestor
20562759|NCT01988545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20562760|NCT01988545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562761|NCT01988545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20562762|NCT01988545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20562763|NCT01988545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20562764|NCT01988610|Mifepristone|mifepristone|mesh-list
20562765|NCT01988610|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20562766|NCT01988610|Abortifacient Agents|abortifacient agents|mesh-ancestor
20562767|NCT01988610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20562768|NCT01988610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562769|NCT01988610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20562770|NCT01988610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20562771|NCT01988610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20562772|NCT01988610|Contraceptive Agents|contraceptive agents|mesh-ancestor
20562773|NCT01988610|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20562774|NCT01988610|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20562775|NCT01988610|Hormone Antagonists|hormone antagonists|mesh-ancestor
20562776|NCT01988610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20562777|NCT01988610|Luteolytic Agents|luteolytic agents|mesh-ancestor
20562778|NCT01988610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20562779|NCT01988610|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20562780|NCT01988649|Oxytocin|oxytocin|mesh-list
20562781|NCT01988649|Oxytocics|oxytocics|mesh-ancestor
20562782|NCT01988649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20562783|NCT01988649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562784|NCT01988831|Propranolol|propranolol|mesh-list
20562785|NCT01988831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20562786|NCT01988831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20562787|NCT01988831|Adrenergic Agents|adrenergic agents|mesh-ancestor
20562788|NCT01988831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20562789|NCT01988831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562790|NCT01988831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562791|NCT01988831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20562792|NCT01988831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20562793|NCT01988831|Vasodilator Agents|vasodilator agents|mesh-ancestor
20562794|NCT01988896|Atezolizumab|atezolizumab|mesh-list
20562795|NCT01988896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562796|NCT01988961|Golimumab|golimumab|mesh-list
20562797|NCT01988961|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20562798|NCT01988961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20562799|NCT01988961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20562800|NCT01988961|Immunologic Factors|immunologic factors|mesh-ancestor
20562801|NCT01988961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562802|NCT01989000|Gemcitabine|gemcitabine|mesh-list
20562803|NCT01989000|Imidazole|imidazole|mesh-list
20562804|NCT01989000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20562805|NCT01989000|Antimetabolites|antimetabolites|mesh-ancestor
20562806|NCT01989000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562807|NCT01989000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562808|NCT01989000|Antiviral Agents|antiviral agents|mesh-ancestor
20562809|NCT01989000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20562810|NCT01989000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20562811|NCT01989000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20562812|NCT01989000|Immunologic Factors|immunologic factors|mesh-ancestor
20562813|NCT01989000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562814|NCT01989052|Lomustine|lomustine|mesh-list
20562815|NCT01989052|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
20562816|NCT01989052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20562817|NCT01989052|Alkylating Agents|alkylating agents|mesh-ancestor
20562818|NCT01989052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562819|NCT01989052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562820|NCT01989052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20562821|NCT01989052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20562822|NCT01989052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20562823|NCT01989052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562824|NCT01989078|Losartan|losartan|mesh-list
20562825|NCT01989078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20562826|NCT01989078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20562827|NCT01989078|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20562828|NCT01989078|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20562829|NCT01989078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562830|NCT01989091|Heparin|heparin|mesh-list
20562831|NCT01989091|Anticoagulants|anticoagulants|mesh-ancestor
20562832|NCT01989091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20562833|NCT01989091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20562834|NCT01989091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562835|NCT01989312|Lidocaine|lidocaine|mesh-list
20562836|NCT01989312|Epinephrine|epinephrine|mesh-list
20562837|NCT01989312|Midazolam|midazolam|mesh-list
20562838|NCT01989312|Levobupivacaine|levobupivacaine|mesh-list
20562839|NCT01989312|Anesthetics, Local|anesthetics, local|mesh-ancestor
20562840|NCT01989312|Anesthetics|anesthetics|mesh-ancestor
20562841|NCT01989312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20562842|NCT01989312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562843|NCT01989312|Sensory System Agents|sensory system agents|mesh-ancestor
20562844|NCT01989312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20562845|NCT01989312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20562846|NCT01989312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20562847|NCT01989312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20562848|NCT01989312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20562849|NCT01989312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562850|NCT01989312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20562851|NCT01989312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20562852|NCT01989312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20562853|NCT01989312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20562854|NCT01989312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20562855|NCT01989312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20562856|NCT01989312|Anesthetics, General|anesthetics, general|mesh-ancestor
20562857|NCT01989312|GABA Modulators|gaba modulators|mesh-ancestor
20562858|NCT01989312|GABA Agents|gaba agents|mesh-ancestor
20562859|NCT01989312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20562860|NCT01989312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20562861|NCT01989312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20562862|NCT01989312|Adrenergic Agents|adrenergic agents|mesh-ancestor
20562863|NCT01989312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20562864|NCT01989312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20562865|NCT01989312|Autonomic Agents|autonomic agents|mesh-ancestor
20562866|NCT01989312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20562867|NCT01989312|Respiratory System Agents|respiratory system agents|mesh-ancestor
20562868|NCT01989312|Mydriatics|mydriatics|mesh-ancestor
20562869|NCT01989312|Sympathomimetics|sympathomimetics|mesh-ancestor
20562870|NCT01989312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20562871|NCT01989416|Chlorhexidine|chlorhexidine|mesh-list
20562872|NCT01989416|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20562873|NCT01989416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20562874|NCT01989416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20562875|NCT01989416|Disinfectants|disinfectants|mesh-ancestor
20562876|NCT01989416|Dermatologic Agents|dermatologic agents|mesh-ancestor
20562877|NCT01989507|Nicotine|nicotine|mesh-list
20562878|NCT01989507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20562879|NCT01989507|Autonomic Agents|autonomic agents|mesh-ancestor
20562880|NCT01989507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20562881|NCT01989507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562882|NCT01989507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20562883|NCT01989507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20562884|NCT01989507|Cholinergic Agents|cholinergic agents|mesh-ancestor
20562885|NCT01989507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20562886|NCT01989507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562887|NCT01989559|Vaccines|vaccines|mesh-list
20562888|NCT01989559|Immunologic Factors|immunologic factors|mesh-ancestor
20562889|NCT01989559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562890|NCT01989611|Tenofovir|tenofovir|mesh-list
20562891|NCT01989611|Emtricitabine|emtricitabine|mesh-list
20562892|NCT01989611|Antiviral Agents|antiviral agents|mesh-ancestor
20562893|NCT01989611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20562894|NCT01989611|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20562895|NCT01989611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20562896|NCT01989611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20562897|NCT01989611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562898|NCT01989611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20562899|NCT01989611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20562900|NCT01989663|Tenofovir|tenofovir|mesh-list
20011142|NCT02360631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011143|NCT02360631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011144|NCT02360631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011145|NCT02360774|Canagliflozin|canagliflozin|mesh-list
20562901|NCT01989663|Antiviral Agents|antiviral agents|mesh-ancestor
20562902|NCT01989663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20562903|NCT01989663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20562904|NCT01989663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20562905|NCT01989663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20562906|NCT01989663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562907|NCT01989663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20562908|NCT01989663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20562909|NCT01989676|Paclitaxel|paclitaxel|mesh-list
20562910|NCT01989676|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20562911|NCT01989676|Trastuzumab|trastuzumab|mesh-list
20562912|NCT01989676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20562913|NCT01989676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562914|NCT01989676|Tubulin Modulators|tubulin modulators|mesh-ancestor
20562915|NCT01989676|Antimitotic Agents|antimitotic agents|mesh-ancestor
20562916|NCT01989676|Mitosis Modulators|mitosis modulators|mesh-ancestor
20562917|NCT01989676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562918|NCT01989676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20562919|NCT01989780|Paclitaxel|paclitaxel|mesh-list
20562920|NCT01989780|Bevacizumab|bevacizumab|mesh-list
20562921|NCT01989780|Letrozole|letrozole|mesh-list
20562922|NCT01989780|Fulvestrant|fulvestrant|mesh-list
20562923|NCT01989780|Anastrozole|anastrozole|mesh-list
20562924|NCT01989780|Exemestane|exemestane|mesh-list
20562925|NCT01989780|Goserelin|goserelin|mesh-list
20562926|NCT01989780|Leuprolide|leuprolide|mesh-list
20562927|NCT01989780|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20562928|NCT01989780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20562929|NCT01989780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562930|NCT01989780|Tubulin Modulators|tubulin modulators|mesh-ancestor
20562931|NCT01989780|Antimitotic Agents|antimitotic agents|mesh-ancestor
20562932|NCT01989780|Mitosis Modulators|mitosis modulators|mesh-ancestor
20562933|NCT01989780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562934|NCT01989780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20562935|NCT01989780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20562936|NCT01989780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20562937|NCT01989780|Growth Substances|growth substances|mesh-ancestor
20562938|NCT01989780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562939|NCT01989780|Growth Inhibitors|growth inhibitors|mesh-ancestor
20562940|NCT01989780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20562941|NCT01989780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20562942|NCT01989780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20562943|NCT01989780|Hormone Antagonists|hormone antagonists|mesh-ancestor
20562944|NCT01989780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20562945|NCT01989780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20562946|NCT01989780|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20562947|NCT01989780|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20562948|NCT01989780|Fertility Agents|fertility agents|mesh-ancestor
20011146|NCT02360774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20011147|NCT02360774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011148|NCT02360774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20011149|NCT02360774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011150|NCT02360995|Triclosan|triclosan|mesh-list
20562949|NCT01989780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19460315|NCT03354312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460316|NCT03354312|Sensory System Agents|sensory system agents|mesh-ancestor
19460317|NCT03354312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460318|NCT03354312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19460319|NCT03354312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19460320|NCT03354312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19460321|NCT03354312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19460322|NCT03354312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460323|NCT03354312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19460324|NCT03354312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19460325|NCT03354312|Adrenergic Agents|adrenergic agents|mesh-ancestor
19460326|NCT03354312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19460327|NCT03354312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19460328|NCT03354312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19460329|NCT03354312|Autonomic Agents|autonomic agents|mesh-ancestor
19460330|NCT03354312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19460331|NCT03354312|Respiratory System Agents|respiratory system agents|mesh-ancestor
19460332|NCT03354312|Mydriatics|mydriatics|mesh-ancestor
19460333|NCT03354312|Sympathomimetics|sympathomimetics|mesh-ancestor
19460334|NCT03354312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19460335|NCT03354117|Meloxicam|meloxicam|mesh-list
19460336|NCT03354117|Ulipristal acetate|ulipristal acetate|mesh-list
20011151|NCT02360995|Cetylpyridinium|cetylpyridinium|mesh-list
20011152|NCT02360995|Fluorides|fluorides|mesh-list
20011153|NCT02360995|Tin Fluorides|tin fluorides|mesh-list
20011154|NCT02360995|Cariostatic Agents|cariostatic agents|mesh-ancestor
20011155|NCT02360995|Protective Agents|protective agents|mesh-ancestor
20011156|NCT02360995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011157|NCT02360995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20011158|NCT02360995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20011159|NCT02360995|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
20011160|NCT02360995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20011161|NCT02360995|Antimetabolites|antimetabolites|mesh-ancestor
20011162|NCT02360995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562950|NCT01989845|Rivaroxaban|rivaroxaban|mesh-list
20562951|NCT01989845|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20562952|NCT01989845|Antithrombins|antithrombins|mesh-ancestor
20562953|NCT01989845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20562954|NCT01989845|Protease Inhibitors|protease inhibitors|mesh-ancestor
20562955|NCT01989845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20562956|NCT01989845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562957|NCT01989845|Anticoagulants|anticoagulants|mesh-ancestor
20562958|NCT01989884|IDN 5109|idn 5109|mesh-list
20562959|NCT01989884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20562960|NCT01989897|Phenol|phenol|mesh-list
20562961|NCT01989897|Histamine|histamine|mesh-list
20562962|NCT01989897|Histamine Agonists|histamine agonists|mesh-ancestor
20562963|NCT01989897|Histamine Agents|histamine agents|mesh-ancestor
20562964|NCT01989897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20562965|NCT01989897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562966|NCT01989897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562967|NCT01989897|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20562968|NCT01989897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20562969|NCT01989897|Disinfectants|disinfectants|mesh-ancestor
20562970|NCT01989897|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
20562971|NCT01989897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20562972|NCT01989923|Nicotine|nicotine|mesh-list
20562973|NCT01989923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20562974|NCT01989923|Autonomic Agents|autonomic agents|mesh-ancestor
20562975|NCT01989923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20562976|NCT01989923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562977|NCT01989923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20562978|NCT01989923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20562979|NCT01989923|Cholinergic Agents|cholinergic agents|mesh-ancestor
20562980|NCT01989923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20562981|NCT01989923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562982|NCT01989936|Eletriptan|eletriptan|mesh-list
20562983|NCT01989936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20562984|NCT01989936|Serotonin Agents|serotonin agents|mesh-ancestor
20562985|NCT01989936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20562986|NCT01989936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562987|NCT01989936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562988|NCT01990079|Bupropion|bupropion|mesh-list
20562989|NCT01990079|Nicotine|nicotine|mesh-list
20562990|NCT01990079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20562991|NCT01990079|Autonomic Agents|autonomic agents|mesh-ancestor
20562992|NCT01990079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20562993|NCT01990079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20562994|NCT01990079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20562995|NCT01990079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20562996|NCT01990079|Cholinergic Agents|cholinergic agents|mesh-ancestor
20562997|NCT01990079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20562998|NCT01990079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20562999|NCT01990079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20563000|NCT01990079|Antidepressive Agents|antidepressive agents|mesh-ancestor
20563001|NCT01990079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20563002|NCT01990079|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20563003|NCT01990079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20563004|NCT01990079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20563005|NCT01990079|Dopamine Agents|dopamine agents|mesh-ancestor
20563006|NCT01990079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20563007|NCT01990079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20563008|NCT01990079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563009|NCT01990118|Cyclosporine|cyclosporine|mesh-list
20563010|NCT01990118|Cyclosporins|cyclosporins|mesh-list
20563011|NCT01990118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563012|NCT01990118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563013|NCT01990118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20563014|NCT01990118|Immunologic Factors|immunologic factors|mesh-ancestor
20563015|NCT01990118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563016|NCT01990118|Antifungal Agents|antifungal agents|mesh-ancestor
20563017|NCT01990118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20563018|NCT01990118|Dermatologic Agents|dermatologic agents|mesh-ancestor
20563019|NCT01990118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20563020|NCT01990118|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20563021|NCT01990144|Rituximab|rituximab|mesh-list
20563022|NCT01990144|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20563023|NCT01990144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20563024|NCT01990144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563025|NCT01990144|Immunologic Factors|immunologic factors|mesh-ancestor
20563026|NCT01990144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563027|NCT01990144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20563028|NCT01990144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20563029|NCT01990144|Alkylating Agents|alkylating agents|mesh-ancestor
20563030|NCT01990144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563031|NCT01990196|Dasatinib|dasatinib|mesh-list
20563032|NCT01990196|Trametinib|trametinib|mesh-list
20563033|NCT01990196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563034|NCT01990196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20563035|NCT01990196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563036|NCT01990196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563037|NCT01990352|Doxorubicin|doxorubicin|mesh-list
20563038|NCT01990352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20563039|NCT01990352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20563040|NCT01990352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563041|NCT01990352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20563042|NCT01990352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20563043|NCT01990352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563044|NCT01990352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563045|NCT01990378|Rabeprazole|rabeprazole|mesh-list
20563046|NCT01990378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20563047|NCT01990378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20563048|NCT01990378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20563049|NCT01990378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563050|NCT01990378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563051|NCT01990404|Nitrous Oxide|nitrous oxide|mesh-list
20563052|NCT01990404|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20563053|NCT01990404|Anesthetics, General|anesthetics, general|mesh-ancestor
20563054|NCT01990404|Anesthetics|anesthetics|mesh-ancestor
20563055|NCT01990404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20563056|NCT01990404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563057|NCT01990404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20563058|NCT01990404|Analgesics|analgesics|mesh-ancestor
20563059|NCT01990404|Sensory System Agents|sensory system agents|mesh-ancestor
20563060|NCT01990404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20563061|NCT01990443|Reslizumab|reslizumab|mesh-list
20563062|NCT01990443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20563063|NCT01990443|Respiratory System Agents|respiratory system agents|mesh-ancestor
20563064|NCT01990586|Rabeprazole|rabeprazole|mesh-list
20563065|NCT01990586|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20563066|NCT01990586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20563067|NCT01990586|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20563068|NCT01990586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563069|NCT01990586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563070|NCT01990690|Antioxidants|antioxidants|mesh-list
20563071|NCT01990690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563072|NCT01990690|Protective Agents|protective agents|mesh-ancestor
20563073|NCT01990690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563074|NCT01990755|Chlordesmethyldiazepam|chlordesmethyldiazepam|mesh-list
20011163|NCT02360995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20011164|NCT02361476|Clonidine|clonidine|mesh-list
20011165|NCT02361476|Analgesics|analgesics|mesh-ancestor
20011166|NCT02361476|Sensory System Agents|sensory system agents|mesh-ancestor
20011167|NCT02361476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20011168|NCT02361476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011169|NCT02361476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20011170|NCT02361476|Sympatholytics|sympatholytics|mesh-ancestor
20011171|NCT02361476|Autonomic Agents|autonomic agents|mesh-ancestor
20011172|NCT02361476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20563075|NCT01990755|Olanzapine|olanzapine|mesh-list
20563076|NCT01990755|Antiemetics|antiemetics|mesh-ancestor
20563077|NCT01990755|Autonomic Agents|autonomic agents|mesh-ancestor
20563078|NCT01990755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20563079|NCT01990755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563080|NCT01990755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20563081|NCT01990755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20563082|NCT01990755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20563083|NCT01990755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20563084|NCT01990755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20563085|NCT01990755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20563086|NCT01990755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20563087|NCT01990755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20563088|NCT01990755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563089|NCT01990755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20563090|NCT01990755|Serotonin Agents|serotonin agents|mesh-ancestor
20563091|NCT01990755|Anticonvulsants|anticonvulsants|mesh-ancestor
20563092|NCT01990781|Dexamethasone|dexamethasone|mesh-list
20563093|NCT01990781|Dexamethasone acetate|dexamethasone acetate|mesh-list
20563094|NCT01990781|Lidocaine|lidocaine|mesh-list
20563095|NCT01990781|BB 1101|bb 1101|mesh-list
20563096|NCT01990781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20563097|NCT01990781|Antiemetics|antiemetics|mesh-ancestor
20563098|NCT01990781|Autonomic Agents|autonomic agents|mesh-ancestor
20563099|NCT01990781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20563100|NCT01990781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563101|NCT01990781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20563102|NCT01990781|Glucocorticoids|glucocorticoids|mesh-ancestor
20563103|NCT01990781|Hormones|hormones|mesh-ancestor
20563104|NCT01990781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20563105|NCT01990781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20563106|NCT01990781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563107|NCT01990781|Protease Inhibitors|protease inhibitors|mesh-ancestor
20563108|NCT01990781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563109|NCT01990781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563110|NCT01990781|Anesthetics, Local|anesthetics, local|mesh-ancestor
20563111|NCT01990781|Anesthetics|anesthetics|mesh-ancestor
20563112|NCT01990781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20563113|NCT01990781|Sensory System Agents|sensory system agents|mesh-ancestor
20563114|NCT01990781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20563115|NCT01990781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20563116|NCT01990781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20563117|NCT01990781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20563118|NCT01990807|Idarubicin|idarubicin|mesh-list
20563119|NCT01990807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20563120|NCT01990807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563121|NCT01990807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20563122|NCT01990807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20563123|NCT01990807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563124|NCT01990807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563125|NCT01990872|Vitamin D|vitamin d|mesh-list
20563126|NCT01990872|Cholecalciferol|cholecalciferol|mesh-list
20563127|NCT01990872|Vitamins|vitamins|mesh-ancestor
20563128|NCT01990872|Micronutrients|micronutrients|mesh-ancestor
20563129|NCT01990872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563130|NCT01990872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20563131|NCT01990872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20563132|NCT01990911|Diuretics|diuretics|mesh-list
20563133|NCT01990911|Natriuretic Agents|natriuretic agents|mesh-ancestor
20563134|NCT01990911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563135|NCT01990937|Midazolam|midazolam|mesh-list
20563136|NCT01990937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20563137|NCT01990937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20563138|NCT01990937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20563139|NCT01990937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563140|NCT01990937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20563141|NCT01990937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20563142|NCT01990937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20563143|NCT01990937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20563144|NCT01990937|Anesthetics, General|anesthetics, general|mesh-ancestor
20563145|NCT01990937|Anesthetics|anesthetics|mesh-ancestor
20563146|NCT01990937|GABA Modulators|gaba modulators|mesh-ancestor
20563147|NCT01990937|GABA Agents|gaba agents|mesh-ancestor
20563148|NCT01990937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20563149|NCT01990937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563150|NCT01991028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20563151|NCT01991054|Vitamin D|vitamin d|mesh-list
20563152|NCT01991054|Cholecalciferol|cholecalciferol|mesh-list
20563153|NCT01991054|Vitamins|vitamins|mesh-ancestor
20563154|NCT01991054|Micronutrients|micronutrients|mesh-ancestor
20563155|NCT01991054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563156|NCT01991054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20563157|NCT01991054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20563158|NCT01991119|Dronedarone|dronedarone|mesh-list
20563159|NCT01991119|Propafenone|propafenone|mesh-list
20563160|NCT01991119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20563161|NCT01991119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20563162|NCT01991119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20563163|NCT01991119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20563164|NCT01991119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563165|NCT01991145|Epoetin Alfa|epoetin alfa|mesh-list
20563166|NCT01991145|Hematinics|hematinics|mesh-ancestor
20563167|NCT01991158|Gemcitabine|gemcitabine|mesh-list
20563168|NCT01991158|Dexamethasone|dexamethasone|mesh-list
20563169|NCT01991158|Methotrexate|methotrexate|mesh-list
20563170|NCT01991158|Pegaspargase|pegaspargase|mesh-list
20563171|NCT01991158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20563172|NCT01991158|Antiemetics|antiemetics|mesh-ancestor
20563173|NCT01991158|Autonomic Agents|autonomic agents|mesh-ancestor
20563174|NCT01991158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20563175|NCT01991158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563176|NCT01991158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20563177|NCT01991158|Glucocorticoids|glucocorticoids|mesh-ancestor
20563178|NCT01991158|Hormones|hormones|mesh-ancestor
20563179|NCT01991158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20563180|NCT01991158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20563181|NCT01991158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563182|NCT01991158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20563183|NCT01991158|Antimetabolites|antimetabolites|mesh-ancestor
20563184|NCT01991158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563185|NCT01991158|Antiviral Agents|antiviral agents|mesh-ancestor
20563186|NCT01991158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20563187|NCT01991158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563188|NCT01991158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20563189|NCT01991158|Immunologic Factors|immunologic factors|mesh-ancestor
20563190|NCT01991158|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20563191|NCT01991158|Abortifacient Agents|abortifacient agents|mesh-ancestor
20563192|NCT01991158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20563193|NCT01991158|Dermatologic Agents|dermatologic agents|mesh-ancestor
20563194|NCT01991158|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20563195|NCT01991158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20563196|NCT01991158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20563197|NCT01991275|Morphine|morphine|mesh-list
20563198|NCT01991275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20563199|NCT01991275|Narcotics|narcotics|mesh-ancestor
20563200|NCT01991275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20563201|NCT01991275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563202|NCT01991275|Analgesics|analgesics|mesh-ancestor
20563203|NCT01991275|Sensory System Agents|sensory system agents|mesh-ancestor
20563204|NCT01991275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20563205|NCT01991288|Epinephrine|epinephrine|mesh-list
20563206|NCT01991288|Racepinephrine|racepinephrine|mesh-list
20563207|NCT01991288|Bupivacaine|bupivacaine|mesh-list
20563208|NCT01991288|Levobupivacaine|levobupivacaine|mesh-list
20563209|NCT01991288|Epinephryl borate|epinephryl borate|mesh-list
20563210|NCT01991288|Anesthetics, Local|anesthetics, local|mesh-ancestor
20563211|NCT01991288|Anesthetics|anesthetics|mesh-ancestor
20563212|NCT01991288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20563213|NCT01991288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563214|NCT01991288|Sensory System Agents|sensory system agents|mesh-ancestor
20563215|NCT01991288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20563216|NCT01991288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20563217|NCT01991288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20563218|NCT01991288|Adrenergic Agents|adrenergic agents|mesh-ancestor
20563219|NCT01991288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20563220|NCT01991288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563221|NCT01991288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20563222|NCT01991288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20563223|NCT01991288|Autonomic Agents|autonomic agents|mesh-ancestor
20563224|NCT01991288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20563225|NCT01991288|Respiratory System Agents|respiratory system agents|mesh-ancestor
20563226|NCT01991288|Mydriatics|mydriatics|mesh-ancestor
20563227|NCT01991288|Sympathomimetics|sympathomimetics|mesh-ancestor
20563228|NCT01991288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20563229|NCT01991327|Enclomiphene|enclomiphene|mesh-list
20563230|NCT01991327|Clomiphene|clomiphene|mesh-list
20563231|NCT01991327|Zuclomiphene|zuclomiphene|mesh-list
20563232|NCT01991327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20563233|NCT01991327|Hormone Antagonists|hormone antagonists|mesh-ancestor
20563234|NCT01991327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20563235|NCT01991327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563236|NCT01991327|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20563237|NCT01991327|Fertility Agents|fertility agents|mesh-ancestor
20563238|NCT01991327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20563239|NCT01991327|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20563240|NCT01991327|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20563241|NCT01991379|Imatinib Mesylate|imatinib mesylate|mesh-list
20563242|NCT01991379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563243|NCT01991379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20563244|NCT01991379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563245|NCT01991379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563246|NCT01991561|Aluminum Hydroxide|aluminum hydroxide|mesh-list
20563247|NCT01991561|Vaccines|vaccines|mesh-list
20563248|NCT01991561|Immunologic Factors|immunologic factors|mesh-ancestor
20563249|NCT01991561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563250|NCT01991561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20563251|NCT01991561|Antacids|antacids|mesh-ancestor
20563252|NCT01991561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563253|NCT01991561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20563254|NCT01991574|Calcium|calcium|mesh-list
20563255|NCT01991574|Calcium acetate|calcium acetate|mesh-list
20563256|NCT01991574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20563257|NCT01991574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563258|NCT01991574|Chelating Agents|chelating agents|mesh-ancestor
20563259|NCT01991574|Sequestering Agents|sequestering agents|mesh-ancestor
20563260|NCT01991574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563261|NCT01991587|Vaccines|vaccines|mesh-list
20563262|NCT01991587|Immunologic Factors|immunologic factors|mesh-ancestor
20563263|NCT01991587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563264|NCT01991626|Iron|iron|mesh-list
20563265|NCT01991626|Trace Elements|trace elements|mesh-list
20563266|NCT01991626|Micronutrients|micronutrients|mesh-list
20563267|NCT01991626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563268|NCT01991678|Etirinotecan pegol|etirinotecan pegol|mesh-list
20563269|NCT01991678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563270|NCT01991678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20563271|NCT01991678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20563272|NCT01991678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563273|NCT01991678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563274|NCT01991834|Cefazolin|cefazolin|mesh-list
20563275|NCT01991834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20563276|NCT01991834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20563277|NCT01991873|Leucovorin|leucovorin|mesh-list
20563278|NCT01991873|Folic Acid|folic acid|mesh-list
20563279|NCT01991873|Fluorouracil|fluorouracil|mesh-list
20563280|NCT01991873|Oxaliplatin|oxaliplatin|mesh-list
20563281|NCT01991873|Panitumumab|panitumumab|mesh-list
20563282|NCT01991873|Levoleucovorin|levoleucovorin|mesh-list
20563283|NCT01991873|Antimetabolites|antimetabolites|mesh-ancestor
20563284|NCT01991873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563285|NCT01991873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20563286|NCT01991873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563287|NCT01991873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20563288|NCT01991873|Immunologic Factors|immunologic factors|mesh-ancestor
20563289|NCT01991873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563290|NCT01991873|Antidotes|antidotes|mesh-ancestor
20563291|NCT01991873|Protective Agents|protective agents|mesh-ancestor
20563292|NCT01991873|Vitamin B Complex|vitamin b complex|mesh-ancestor
20563293|NCT01991873|Vitamins|vitamins|mesh-ancestor
20563294|NCT01991873|Micronutrients|micronutrients|mesh-ancestor
20563295|NCT01991873|Hematinics|hematinics|mesh-ancestor
20563296|NCT01991873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20563297|NCT01991951|Warfarin|warfarin|mesh-list
20563298|NCT01991951|Anticoagulants|anticoagulants|mesh-ancestor
20563299|NCT01992133|Vitamin D|vitamin d|mesh-list
20563300|NCT01992133|Cholecalciferol|cholecalciferol|mesh-list
20563301|NCT01992133|Vitamins|vitamins|mesh-ancestor
20563302|NCT01992133|Micronutrients|micronutrients|mesh-ancestor
20563303|NCT01992133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563304|NCT01992133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20563305|NCT01992133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20563306|NCT01992146|Naloxone|naloxone|mesh-list
20563307|NCT01992146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20563308|NCT01992146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563309|NCT01992146|Sensory System Agents|sensory system agents|mesh-ancestor
20563310|NCT01992146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20563311|NCT01992198|Chlorhexidine|chlorhexidine|mesh-list
20563312|NCT01992198|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19460337|NCT03354117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19460338|NCT03354117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19460339|NCT03354117|Analgesics|analgesics|mesh-ancestor
19460340|NCT03354117|Sensory System Agents|sensory system agents|mesh-ancestor
19460341|NCT03354117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460342|NCT03354117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460343|NCT03354117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19460344|NCT03354117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19460345|NCT03354117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19460346|NCT03354117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20563313|NCT01992198|Metronidazole|metronidazole|mesh-list
20563314|NCT01992198|Meropenem|meropenem|mesh-list
20563315|NCT01992198|Cefoperazone|cefoperazone|mesh-list
20563316|NCT01992198|Sulperazone|sulperazone|mesh-list
20563317|NCT01992198|Somatostatin|somatostatin|mesh-list
20563318|NCT01992198|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20563319|NCT01992198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20563320|NCT01992198|Disinfectants|disinfectants|mesh-ancestor
20563321|NCT01992198|Dermatologic Agents|dermatologic agents|mesh-ancestor
20563322|NCT01992198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19460347|NCT03354117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19460348|NCT03354117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460349|NCT03354117|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19460350|NCT03354117|Contraceptive Agents|contraceptive agents|mesh-ancestor
19460351|NCT03354117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19460352|NCT03354117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19460353|NCT03354013|Calcium|calcium|mesh-list
19460354|NCT03354013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19460355|NCT03354013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460356|NCT03353948|Metformin|metformin|mesh-list
19460357|NCT03353948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19460358|NCT03353948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460359|NCT03353909|Hyaluronic Acid|hyaluronic acid|mesh-list
19460360|NCT03353909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19460361|NCT03353909|Immunologic Factors|immunologic factors|mesh-ancestor
19460362|NCT03353909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460363|NCT03353909|Viscosupplements|viscosupplements|mesh-ancestor
19460364|NCT03353909|Protective Agents|protective agents|mesh-ancestor
19460365|NCT03353883|Triptorelin Pamoate|triptorelin pamoate|mesh-list
19460366|NCT03353883|Luteolytic Agents|luteolytic agents|mesh-ancestor
19460367|NCT03353883|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19460368|NCT03353883|Contraceptive Agents|contraceptive agents|mesh-ancestor
19460369|NCT03353883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19460370|NCT03353883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460371|NCT03353883|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19460372|NCT03353883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19460373|NCT03353883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563323|NCT01992198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20563324|NCT01992198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20563325|NCT01992198|Hormones|hormones|mesh-ancestor
19460374|NCT03353857|Rifampin|rifampin|mesh-list
19460375|NCT03353857|Dienogest|dienogest|mesh-list
19460376|NCT03353857|Drospirenone|drospirenone|mesh-list
19460377|NCT03353857|Midazolam|midazolam|mesh-list
19460378|NCT03353857|Levonorgestrel|levonorgestrel|mesh-list
20563326|NCT01992198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19460379|NCT03353857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20563327|NCT01992198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563328|NCT01992198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20563329|NCT01992198|Renal Agents|renal agents|mesh-ancestor
20563330|NCT01992211|Metformin|metformin|mesh-list
20563331|NCT01992211|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20563332|NCT01992211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20563333|NCT01992211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563334|NCT01992211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20563335|NCT01992211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20563336|NCT01992211|Antimetabolites|antimetabolites|mesh-ancestor
20563337|NCT01992211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563338|NCT01992211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20563339|NCT01992211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20563340|NCT01992211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563341|NCT01992263|Vitamin D|vitamin d|mesh-list
20563342|NCT01992263|Ergocalciferols|ergocalciferols|mesh-list
20563343|NCT01992263|Vitamins|vitamins|mesh-list
20563344|NCT01992263|Micronutrients|micronutrients|mesh-ancestor
20563345|NCT01992263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563346|NCT01992263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20563347|NCT01992263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20563348|NCT01992328|Immunoglobulins|immunoglobulins|mesh-list
20563349|NCT01992328|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20563350|NCT01992328|Antibodies|antibodies|mesh-list
20563351|NCT01992328|Immunoglobulin G|immunoglobulin g|mesh-list
20563352|NCT01992328|gamma-Globulins|gamma-globulins|mesh-list
20563353|NCT01992328|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
20563354|NCT01992328|Immunologic Factors|immunologic factors|mesh-ancestor
20563355|NCT01992328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563356|NCT01992341|Paclitaxel|paclitaxel|mesh-list
20563357|NCT01992341|Trebananib|trebananib|mesh-list
20563358|NCT01992341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20563359|NCT01992341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563360|NCT01992341|Tubulin Modulators|tubulin modulators|mesh-ancestor
20563361|NCT01992341|Antimitotic Agents|antimitotic agents|mesh-ancestor
20563362|NCT01992341|Mitosis Modulators|mitosis modulators|mesh-ancestor
20563363|NCT01992341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563364|NCT01992341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20563365|NCT01992341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20563366|NCT01992341|Growth Substances|growth substances|mesh-ancestor
20563367|NCT01992341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563368|NCT01992341|Growth Inhibitors|growth inhibitors|mesh-ancestor
20563369|NCT01992562|Ziconotide|ziconotide|mesh-list
20563370|NCT01992562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20563371|NCT01992562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20563372|NCT01992562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563373|NCT01992562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20563374|NCT01992562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563375|NCT01992562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20563376|NCT01992562|Protective Agents|protective agents|mesh-ancestor
20563377|NCT01992562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20563378|NCT01992562|Analgesics|analgesics|mesh-ancestor
20563379|NCT01992562|Sensory System Agents|sensory system agents|mesh-ancestor
20563380|NCT01992562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20563381|NCT01992588|Insulin|insulin|mesh-list
20563382|NCT01992588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20563383|NCT01992588|Insulin Aspart|insulin aspart|mesh-list
20563384|NCT01992588|Insulin, Long-Acting|insulin, long-acting|mesh-list
20563385|NCT01992588|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20563386|NCT01992588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20563387|NCT01992588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563388|NCT01992601|Telmisartan|telmisartan|mesh-list
20563389|NCT01992601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20563390|NCT01992601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20563391|NCT01992601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20563392|NCT01992601|Antimetabolites|antimetabolites|mesh-ancestor
20563393|NCT01992601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563394|NCT01992601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20563395|NCT01992601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20563396|NCT01992601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563397|NCT01992601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20563398|NCT01992601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20563399|NCT01992601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20563400|NCT01992653|Prednisone|prednisone|mesh-list
20563401|NCT01992653|Prednisolone|prednisolone|mesh-list
20563402|NCT01992653|Cyclophosphamide|cyclophosphamide|mesh-list
20563403|NCT01992653|Rituximab|rituximab|mesh-list
20563404|NCT01992653|Doxorubicin|doxorubicin|mesh-list
20563405|NCT01992653|Obinutuzumab|obinutuzumab|mesh-list
20563406|NCT01992653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20563407|NCT01992653|Immunologic Factors|immunologic factors|mesh-ancestor
20563408|NCT01992653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563409|NCT01992653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20563410|NCT01992653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20563411|NCT01992653|Alkylating Agents|alkylating agents|mesh-ancestor
20563412|NCT01992653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563413|NCT01992653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563414|NCT01992653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20563415|NCT01992653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20563416|NCT01992653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20563417|NCT01992653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20563418|NCT01992653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20563419|NCT01992653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563420|NCT01992653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20563421|NCT01992653|Glucocorticoids|glucocorticoids|mesh-ancestor
20563422|NCT01992653|Hormones|hormones|mesh-ancestor
20563423|NCT01992653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20563424|NCT01992653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20563425|NCT01992705|Fluorouracil|fluorouracil|mesh-list
20563426|NCT01992705|Oxaliplatin|oxaliplatin|mesh-list
20563427|NCT01992705|Irinotecan|irinotecan|mesh-list
20563428|NCT01992705|Folfirinox|folfirinox|mesh-list
20563429|NCT01992705|Antimetabolites|antimetabolites|mesh-ancestor
20563430|NCT01992705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563431|NCT01992705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20563432|NCT01992705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563433|NCT01992705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20563434|NCT01992705|Immunologic Factors|immunologic factors|mesh-ancestor
20563435|NCT01992705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563436|NCT01992705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20563437|NCT01992705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20563438|NCT01992705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563439|NCT01992796|Telmisartan|telmisartan|mesh-list
20563440|NCT01992796|Candesartan|candesartan|mesh-list
20563441|NCT01992796|Olmesartan|olmesartan|mesh-list
20563442|NCT01992796|Irbesartan|irbesartan|mesh-list
20563443|NCT01992796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20563444|NCT01992796|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20563445|NCT01992796|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20563446|NCT01992796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563447|NCT01992900|Piperaquine|piperaquine|mesh-list
20563448|NCT01992900|Artenimol|artenimol|mesh-list
20563449|NCT01992900|Artemisinins|artemisinins|mesh-list
20563450|NCT01992900|Antimalarials|antimalarials|mesh-ancestor
20563451|NCT01992900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20563452|NCT01992900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20563453|NCT01992900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20563454|NCT01992952|Fulvestrant|fulvestrant|mesh-list
20563455|NCT01992952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20563456|NCT01992952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563457|NCT01992952|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20563458|NCT01992952|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20563459|NCT01992952|Hormone Antagonists|hormone antagonists|mesh-ancestor
20563460|NCT01992952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20563461|NCT01992952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563462|NCT01993134|Cefazolin|cefazolin|mesh-list
20563463|NCT01993134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20563464|NCT01993134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20563465|NCT01993173|Vaccines|vaccines|mesh-list
20563466|NCT01993173|Immunologic Factors|immunologic factors|mesh-ancestor
20563467|NCT01993173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563468|NCT01993212|Enclomiphene|enclomiphene|mesh-list
20563469|NCT01993212|Testosterone|testosterone|mesh-list
20563470|NCT01993212|Androgens|androgens|mesh-ancestor
20563471|NCT01993212|Hormones|hormones|mesh-ancestor
20563472|NCT01993212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20563473|NCT01993212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563474|NCT01993212|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20563475|NCT01993212|Hormone Antagonists|hormone antagonists|mesh-ancestor
20563476|NCT01993212|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20563477|NCT01993212|Fertility Agents|fertility agents|mesh-ancestor
20563478|NCT01993212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20563479|NCT01993212|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20563480|NCT01993212|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20563481|NCT01993225|Enclomiphene|enclomiphene|mesh-list
20563482|NCT01993225|Testosterone|testosterone|mesh-list
20563483|NCT01993225|Androgens|androgens|mesh-ancestor
20563484|NCT01993225|Hormones|hormones|mesh-ancestor
20563485|NCT01993225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20563486|NCT01993225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563487|NCT01993225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20563488|NCT01993225|Hormone Antagonists|hormone antagonists|mesh-ancestor
20563489|NCT01993225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20563490|NCT01993225|Fertility Agents|fertility agents|mesh-ancestor
20563491|NCT01993225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20563492|NCT01993225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20563493|NCT01993225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20563494|NCT01993251|Melatonin|melatonin|mesh-list
20563495|NCT01993251|Antioxidants|antioxidants|mesh-ancestor
20563496|NCT01993251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563497|NCT01993251|Protective Agents|protective agents|mesh-ancestor
20563498|NCT01993251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563499|NCT01993251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20563500|NCT01993290|Ropivacaine|ropivacaine|mesh-list
20563501|NCT01993290|Anesthetics, Local|anesthetics, local|mesh-ancestor
20563502|NCT01993290|Anesthetics|anesthetics|mesh-ancestor
20563503|NCT01993290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20563504|NCT01993290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563505|NCT01993290|Sensory System Agents|sensory system agents|mesh-ancestor
20563506|NCT01993290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20563507|NCT01993459|Midazolam|midazolam|mesh-list
20563508|NCT01993459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20563509|NCT01993459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20563510|NCT01993459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20563511|NCT01993459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20563512|NCT01993459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563513|NCT01993459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20563514|NCT01993459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20563515|NCT01993459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20563516|NCT01993459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20563517|NCT01993459|Anesthetics, General|anesthetics, general|mesh-ancestor
20563518|NCT01993459|Anesthetics|anesthetics|mesh-ancestor
20563519|NCT01993459|GABA Modulators|gaba modulators|mesh-ancestor
20563520|NCT01993459|GABA Agents|gaba agents|mesh-ancestor
20563521|NCT01993459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20563522|NCT01993459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563523|NCT01993472|Andrographolide|andrographolide|mesh-list
20563524|NCT01993472|Capecitabine|capecitabine|mesh-list
20563525|NCT01993472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20563526|NCT01993472|Antimetabolites|antimetabolites|mesh-ancestor
20563527|NCT01993472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563528|NCT01993472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563529|NCT01993472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20563530|NCT01993472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20563531|NCT01993472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20563532|NCT01993472|Analgesics|analgesics|mesh-ancestor
20563533|NCT01993472|Sensory System Agents|sensory system agents|mesh-ancestor
20563534|NCT01993472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20563535|NCT01993472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563536|NCT01993472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20563537|NCT01993472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20563538|NCT01993472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20563539|NCT01993472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20563540|NCT01993472|Antiviral Agents|antiviral agents|mesh-ancestor
20563541|NCT01993472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20563542|NCT01993537|Vitamin D|vitamin d|mesh-list
20563543|NCT01993537|Vitamins|vitamins|mesh-ancestor
20563544|NCT01993537|Micronutrients|micronutrients|mesh-ancestor
20563545|NCT01993537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563546|NCT01993537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20563547|NCT01993589|Acetaminophen|acetaminophen|mesh-list
20563548|NCT01993589|Analgesics|analgesics|mesh-list
20563549|NCT01993589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20563550|NCT01993589|Sensory System Agents|sensory system agents|mesh-ancestor
20563551|NCT01993589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20563552|NCT01993589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563553|NCT01993589|Antipyretics|antipyretics|mesh-ancestor
20563554|NCT01993680|Fludrocortisone|fludrocortisone|mesh-list
20563555|NCT01993680|Bromides|bromides|mesh-list
20563556|NCT01993680|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
20563557|NCT01993680|Anticonvulsants|anticonvulsants|mesh-ancestor
20011173|NCT02361476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20011174|NCT02361476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20011175|NCT02361476|Adrenergic Agents|adrenergic agents|mesh-ancestor
20011176|NCT02361476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011177|NCT02361476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011178|NCT02362048|Pembrolizumab|pembrolizumab|mesh-list
20011179|NCT02362048|Acalabrutinib|acalabrutinib|mesh-list
20011180|NCT02362048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20011181|NCT02362048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011182|NCT02362269|Vitamin D|vitamin d|mesh-list
20011183|NCT02362269|Vitamins|vitamins|mesh-ancestor
20011184|NCT02362269|Micronutrients|micronutrients|mesh-ancestor
20011185|NCT02362269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011186|NCT02362269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20011187|NCT02362321|Dexamethasone|dexamethasone|mesh-list
20563558|NCT01993680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20563559|NCT01993680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563560|NCT01993680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563561|NCT01993680|Cholinergic Agents|cholinergic agents|mesh-ancestor
20563562|NCT01993680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20563563|NCT01993680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563564|NCT01993680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20563565|NCT01993771|Anesthetics|anesthetics|mesh-list
20563566|NCT01993771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20563567|NCT01993771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563568|NCT01993784|Nimotuzumab|nimotuzumab|mesh-list
20563569|NCT01993784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20563570|NCT01993784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563571|NCT01993810|Paclitaxel|paclitaxel|mesh-list
20563572|NCT01993810|Etoposide|etoposide|mesh-list
20563573|NCT01993810|Podophyllotoxin|podophyllotoxin|mesh-list
20563574|NCT01993810|Cisplatin|cisplatin|mesh-list
20563575|NCT01993810|Carboplatin|carboplatin|mesh-list
20563576|NCT01993810|Pemetrexed|pemetrexed|mesh-list
19460380|NCT03353857|Norethindrone|norethindrone|mesh-list
19460381|NCT03353857|Norethindrone Acetate|norethindrone acetate|mesh-list
19460382|NCT03353857|Desogestrel|desogestrel|mesh-list
19460383|NCT03353857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19460384|NCT03353857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19460385|NCT03353857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19460386|NCT03353857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460387|NCT03353857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19460388|NCT03353857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19460389|NCT03353857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19460390|NCT03353857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19460391|NCT03353857|Anesthetics, General|anesthetics, general|mesh-ancestor
19460392|NCT03353857|Anesthetics|anesthetics|mesh-ancestor
19460393|NCT03353857|GABA Modulators|gaba modulators|mesh-ancestor
19460394|NCT03353857|GABA Agents|gaba agents|mesh-ancestor
19460395|NCT03353857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19460396|NCT03353857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460397|NCT03353857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19460398|NCT03353857|Contraceptive Agents|contraceptive agents|mesh-ancestor
19460399|NCT03353857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19460400|NCT03353857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19460401|NCT03353857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19460402|NCT03353857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19460403|NCT03353857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19460404|NCT03353857|Antitubercular Agents|antitubercular agents|mesh-ancestor
19460405|NCT03353857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19460406|NCT03353857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20011188|NCT02362321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20011189|NCT02362321|Antiemetics|antiemetics|mesh-ancestor
20011190|NCT02362321|Autonomic Agents|autonomic agents|mesh-ancestor
20011191|NCT02362321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20011192|NCT02362321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011193|NCT02362321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20011194|NCT02362321|Glucocorticoids|glucocorticoids|mesh-ancestor
20011195|NCT02362321|Hormones|hormones|mesh-ancestor
20011196|NCT02362321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20011197|NCT02362321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20011198|NCT02362321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011199|NCT02362373|Levonorgestrel|levonorgestrel|mesh-list
20011200|NCT02362373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20011201|NCT02362373|Contraceptive Agents|contraceptive agents|mesh-ancestor
20011202|NCT02362373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20011203|NCT02362373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563577|NCT01993810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20563578|NCT01993810|Etoposide phosphate|etoposide phosphate|mesh-list
20563579|NCT01993810|Durvalumab|durvalumab|mesh-list
20563580|NCT01993810|Immunoglobulins|immunoglobulins|mesh-list
20563581|NCT01993810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20563582|NCT01993810|Immunoglobulin G|immunoglobulin g|mesh-list
20563583|NCT01993810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20563584|NCT01993810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563585|NCT01993810|Tubulin Modulators|tubulin modulators|mesh-ancestor
20563586|NCT01993810|Antimitotic Agents|antimitotic agents|mesh-ancestor
20563587|NCT01993810|Mitosis Modulators|mitosis modulators|mesh-ancestor
20563588|NCT01993810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563589|NCT01993810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20563590|NCT01993810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20563591|NCT01993810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563592|NCT01993810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20563593|NCT01993810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20563594|NCT01993810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20563595|NCT01993810|Immunologic Factors|immunologic factors|mesh-ancestor
20563596|NCT01993810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563597|NCT01993810|Keratolytic Agents|keratolytic agents|mesh-ancestor
20563598|NCT01993810|Dermatologic Agents|dermatologic agents|mesh-ancestor
20563599|NCT01993979|Gemcitabine|gemcitabine|mesh-list
20563600|NCT01993979|Cisplatin|cisplatin|mesh-list
20563601|NCT01993979|Carboplatin|carboplatin|mesh-list
20563602|NCT01993979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563603|NCT01993979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20563604|NCT01993979|Antimetabolites|antimetabolites|mesh-ancestor
20563605|NCT01993979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563606|NCT01993979|Antiviral Agents|antiviral agents|mesh-ancestor
20563607|NCT01993979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20563608|NCT01993979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563609|NCT01993979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20563610|NCT01993979|Immunologic Factors|immunologic factors|mesh-ancestor
20563611|NCT01993979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563612|NCT01994031|Paclitaxel|paclitaxel|mesh-list
20563613|NCT01994031|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20563614|NCT01994031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20563615|NCT01994031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563616|NCT01994031|Tubulin Modulators|tubulin modulators|mesh-ancestor
20563617|NCT01994031|Antimitotic Agents|antimitotic agents|mesh-ancestor
20563618|NCT01994031|Mitosis Modulators|mitosis modulators|mesh-ancestor
20563619|NCT01994031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563620|NCT01994070|Procainamide|procainamide|mesh-list
20563621|NCT01994070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20563622|NCT01994070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20563623|NCT01994070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20563624|NCT01994070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20563625|NCT01994070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563626|NCT01994096|Caspofungin|caspofungin|mesh-list
20563627|NCT01994096|Antifungal Agents|antifungal agents|mesh-ancestor
20563628|NCT01994096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20563629|NCT01994096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563630|NCT01994096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563631|NCT01994265|Warfarin|warfarin|mesh-list
20563632|NCT01994265|Dabigatran|dabigatran|mesh-list
20563633|NCT01994265|Anticoagulants|anticoagulants|mesh-ancestor
20563634|NCT01994265|Antithrombins|antithrombins|mesh-ancestor
20563635|NCT01994265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20563636|NCT01994265|Protease Inhibitors|protease inhibitors|mesh-ancestor
20563637|NCT01994265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563638|NCT01994265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563639|NCT01994330|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
20563640|NCT01994330|Hemostatics|hemostatics|mesh-ancestor
20563641|NCT01994330|Coagulants|coagulants|mesh-ancestor
20563642|NCT01994330|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
20563643|NCT01994330|Natriuretic Agents|natriuretic agents|mesh-ancestor
20563644|NCT01994330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563645|NCT01994356|Contraceptive Agents|contraceptive agents|mesh-list
20563646|NCT01994356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20563647|NCT01994356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563648|NCT01994460|Linezolid|linezolid|mesh-list
20563649|NCT01994460|Ethambutol|ethambutol|mesh-list
20563650|NCT01994460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20563651|NCT01994460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20563652|NCT01994460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20563653|NCT01994460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563654|NCT01994460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563655|NCT01994460|Antitubercular Agents|antitubercular agents|mesh-ancestor
20563656|NCT01994525|Vaccines|vaccines|mesh-list
20563657|NCT01994525|Immunologic Factors|immunologic factors|mesh-ancestor
20563658|NCT01994525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563659|NCT01994642|Ciprofloxacin|ciprofloxacin|mesh-list
20563660|NCT01994642|Dexamethasone|dexamethasone|mesh-list
20563661|NCT01994642|Dexamethasone acetate|dexamethasone acetate|mesh-list
20563662|NCT01994642|BB 1101|bb 1101|mesh-list
20563663|NCT01994642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20563664|NCT01994642|Antiemetics|antiemetics|mesh-ancestor
20563665|NCT01994642|Autonomic Agents|autonomic agents|mesh-ancestor
20563666|NCT01994642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20563667|NCT01994642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563668|NCT01994642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20563669|NCT01994642|Glucocorticoids|glucocorticoids|mesh-ancestor
20563670|NCT01994642|Hormones|hormones|mesh-ancestor
20563671|NCT01994642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20563672|NCT01994642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20563673|NCT01994642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563674|NCT01994642|Protease Inhibitors|protease inhibitors|mesh-ancestor
20563675|NCT01994642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563676|NCT01994642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563677|NCT01994642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20563678|NCT01994642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20563679|NCT01994642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20563680|NCT01994642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20563681|NCT01994642|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20563682|NCT01994642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20563683|NCT01994668|Lorazepam|lorazepam|mesh-list
20563684|NCT01994668|Anticonvulsants|anticonvulsants|mesh-ancestor
20563685|NCT01994668|Antiemetics|antiemetics|mesh-ancestor
20563686|NCT01994668|Autonomic Agents|autonomic agents|mesh-ancestor
20563687|NCT01994668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20563688|NCT01994668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563689|NCT01994668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20563690|NCT01994668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20563691|NCT01994668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20563692|NCT01994668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20563693|NCT01994668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20563694|NCT01994668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20563695|NCT01994668|GABA Modulators|gaba modulators|mesh-ancestor
20563696|NCT01994668|GABA Agents|gaba agents|mesh-ancestor
20563697|NCT01994668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20563698|NCT01994668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563699|NCT01994733|Calcium, Dietary|calcium, dietary|mesh-list
20563700|NCT01994733|Calcium Carbonate|calcium carbonate|mesh-list
20563701|NCT01994733|Calcium|calcium|mesh-list
20563702|NCT01994733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20563703|NCT01994733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563704|NCT01994733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20563705|NCT01994733|Antacids|antacids|mesh-ancestor
20563706|NCT01994733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563707|NCT01994733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20563708|NCT01994759|Methylprednisolone|methylprednisolone|mesh-list
20563709|NCT01994759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20563710|NCT01994759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20563711|NCT01994759|Antiemetics|antiemetics|mesh-ancestor
20563712|NCT01994759|Autonomic Agents|autonomic agents|mesh-ancestor
20563713|NCT01994759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20563714|NCT01994759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563715|NCT01994759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20563716|NCT01994759|Glucocorticoids|glucocorticoids|mesh-ancestor
20563717|NCT01994759|Hormones|hormones|mesh-ancestor
20563718|NCT01994759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20563719|NCT01994759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20563720|NCT01994759|Protective Agents|protective agents|mesh-ancestor
20563721|NCT01994824|Thymoglobulin|thymoglobulin|mesh-list
20563722|NCT01994824|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20563723|NCT01994824|Immunologic Factors|immunologic factors|mesh-ancestor
20563724|NCT01994824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563725|NCT01994824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20563726|NCT01994941|Clopidogrel|clopidogrel|mesh-list
20563727|NCT01994941|Ticagrelor|ticagrelor|mesh-list
19460407|NCT03353857|Leprostatic Agents|leprostatic agents|mesh-ancestor
20563728|NCT01994941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20563729|NCT01994941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20563730|NCT01994941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20563731|NCT01994941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20563732|NCT01994941|Purinergic Agents|purinergic agents|mesh-ancestor
20563733|NCT01994941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20563734|NCT01994941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563735|NCT01994941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563736|NCT01994967|Bupivacaine|bupivacaine|mesh-list
20563737|NCT01994967|Levobupivacaine|levobupivacaine|mesh-list
20563738|NCT01994967|Anesthetics, Local|anesthetics, local|mesh-ancestor
20563739|NCT01994967|Anesthetics|anesthetics|mesh-ancestor
19460408|NCT03353857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20563740|NCT01994967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20563741|NCT01994967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563742|NCT01994967|Sensory System Agents|sensory system agents|mesh-ancestor
20563743|NCT01994967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20563744|NCT01994980|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20563745|NCT01994980|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20563746|NCT01994980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20563747|NCT01994980|Antitubercular Agents|antitubercular agents|mesh-ancestor
20563748|NCT01995006|Dipyrone|dipyrone|mesh-list
20563749|NCT01995006|Naproxen|naproxen|mesh-list
20563750|NCT01995006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20563751|NCT01995006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20563752|NCT01995006|Analgesics|analgesics|mesh-ancestor
20563753|NCT01995006|Sensory System Agents|sensory system agents|mesh-ancestor
20563754|NCT01995006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20563755|NCT01995006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563756|NCT01995006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20563757|NCT01995006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20563758|NCT01995006|Gout Suppressants|gout suppressants|mesh-ancestor
20563759|NCT01995006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20563760|NCT01995006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563761|NCT01995006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563762|NCT01995006|Antipyretics|antipyretics|mesh-ancestor
20563763|NCT01995019|Methylprednisolone|methylprednisolone|mesh-list
20563764|NCT01995019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20563765|NCT01995019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20563766|NCT01995019|Prednisolone|prednisolone|mesh-list
20563767|NCT01995019|Prednisolone acetate|prednisolone acetate|mesh-list
20563768|NCT01995019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20563769|NCT01995019|Prednisolone phosphate|prednisolone phosphate|mesh-list
20563770|NCT01995019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20563771|NCT01995019|Antiemetics|antiemetics|mesh-ancestor
20563772|NCT01995019|Autonomic Agents|autonomic agents|mesh-ancestor
20563773|NCT01995019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20563774|NCT01995019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563775|NCT01995019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20563776|NCT01995019|Glucocorticoids|glucocorticoids|mesh-ancestor
20563777|NCT01995019|Hormones|hormones|mesh-ancestor
20563778|NCT01995019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20563779|NCT01995019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20563780|NCT01995019|Protective Agents|protective agents|mesh-ancestor
20563781|NCT01995019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20563782|NCT01995019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563783|NCT01995032|Metformin|metformin|mesh-list
20563784|NCT01995032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20563785|NCT01995032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563786|NCT01995058|Prednisone|prednisone|mesh-list
20563787|NCT01995058|Abiraterone Acetate|abiraterone acetate|mesh-list
20563788|NCT01995058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20563789|NCT01995058|Glucocorticoids|glucocorticoids|mesh-ancestor
20563790|NCT01995058|Hormones|hormones|mesh-ancestor
20563791|NCT01995058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20563792|NCT01995058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563793|NCT01995058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20563794|NCT01995058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563795|NCT01995058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20563796|NCT01995058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563797|NCT01995058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563798|NCT01995058|Hormone Antagonists|hormone antagonists|mesh-ancestor
20563799|NCT01995058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20563800|NCT01995084|Imidazole|imidazole|mesh-list
20563801|NCT01995084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563802|NCT01995084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563803|NCT01995188|Bevacizumab|bevacizumab|mesh-list
20563804|NCT01995188|Carboplatin|carboplatin|mesh-list
20563805|NCT01995188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20563806|NCT01995188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563807|NCT01995188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20563808|NCT01995188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20563809|NCT01995188|Growth Substances|growth substances|mesh-ancestor
20563810|NCT01995188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563811|NCT01995188|Growth Inhibitors|growth inhibitors|mesh-ancestor
20563812|NCT01995214|Propofol|propofol|mesh-list
20563813|NCT01995214|Sevoflurane|sevoflurane|mesh-list
20563814|NCT01995214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20563815|NCT01995214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20563816|NCT01995214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563817|NCT01995214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20563818|NCT01995214|Anesthetics, General|anesthetics, general|mesh-ancestor
20563819|NCT01995214|Anesthetics|anesthetics|mesh-ancestor
20563820|NCT01995214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20563821|NCT01995214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20563822|NCT01995292|Anesthetics|anesthetics|mesh-list
20563823|NCT01995292|Anesthetics, Local|anesthetics, local|mesh-list
20563824|NCT01995292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20563825|NCT01995292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563826|NCT01995292|Sensory System Agents|sensory system agents|mesh-ancestor
20563827|NCT01995292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20563828|NCT01995331|Cyclosporine|cyclosporine|mesh-list
20563829|NCT01995331|Cyclophosphamide|cyclophosphamide|mesh-list
20563830|NCT01995331|Cyclosporins|cyclosporins|mesh-list
20563831|NCT01995331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20563832|NCT01995331|Immunologic Factors|immunologic factors|mesh-ancestor
20563833|NCT01995331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563834|NCT01995331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20563835|NCT01995331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20563836|NCT01995331|Alkylating Agents|alkylating agents|mesh-ancestor
20563837|NCT01995331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563838|NCT01995331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563839|NCT01995331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20563840|NCT01995331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563841|NCT01995331|Antifungal Agents|antifungal agents|mesh-ancestor
20563842|NCT01995331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20563843|NCT01995331|Dermatologic Agents|dermatologic agents|mesh-ancestor
20563844|NCT01995331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20563845|NCT01995344|Cyclophosphamide|cyclophosphamide|mesh-list
20563846|NCT01995344|Fludarabine|fludarabine|mesh-list
20563847|NCT01995344|Interleukin-2|interleukin-2|mesh-list
20563848|NCT01995344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20563849|NCT01995344|Immunologic Factors|immunologic factors|mesh-ancestor
20563850|NCT01995344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563851|NCT01995344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20563852|NCT01995344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20563853|NCT01995344|Alkylating Agents|alkylating agents|mesh-ancestor
20563854|NCT01995344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563855|NCT01995344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563856|NCT01995344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20563857|NCT01995344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20563858|NCT01995344|Analgesics|analgesics|mesh-ancestor
20563859|NCT01995344|Sensory System Agents|sensory system agents|mesh-ancestor
20563860|NCT01995344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20563861|NCT01995370|Aspirin|aspirin|mesh-list
20563862|NCT01995370|Cilostazol|cilostazol|mesh-list
20563863|NCT01995370|Clopidogrel|clopidogrel|mesh-list
20563864|NCT01995370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20563865|NCT01995370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20563866|NCT01995370|Analgesics|analgesics|mesh-ancestor
20563867|NCT01995370|Sensory System Agents|sensory system agents|mesh-ancestor
20563868|NCT01995370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20563869|NCT01995370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563870|NCT01995370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20563871|NCT01995370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20563872|NCT01995370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20563873|NCT01995370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20563874|NCT01995370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563875|NCT01995370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20563876|NCT01995370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20563877|NCT01995370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563878|NCT01995370|Antipyretics|antipyretics|mesh-ancestor
20563879|NCT01995370|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20563880|NCT01995370|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20563881|NCT01995370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20563882|NCT01995370|Purinergic Agents|purinergic agents|mesh-ancestor
20563883|NCT01995370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20563884|NCT01995370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20563885|NCT01995370|Autonomic Agents|autonomic agents|mesh-ancestor
20563886|NCT01995370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20563887|NCT01995370|Respiratory System Agents|respiratory system agents|mesh-ancestor
20563888|NCT01995370|Vasodilator Agents|vasodilator agents|mesh-ancestor
20563889|NCT01995370|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20563890|NCT01995370|Protective Agents|protective agents|mesh-ancestor
20563891|NCT01995370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20563892|NCT01995370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20563893|NCT01995656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20563894|NCT01995695|Vaccines|vaccines|mesh-list
20563895|NCT01995695|Immunologic Factors|immunologic factors|mesh-ancestor
20563896|NCT01995695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563897|NCT01995734|Pasireotide|pasireotide|mesh-list
20563898|NCT01995734|Hormones|hormones|mesh-ancestor
20563899|NCT01995734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20563900|NCT01995734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563901|NCT01995799|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
20563902|NCT01995799|Hematinics|hematinics|mesh-ancestor
20563903|NCT01995799|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20563904|NCT01995799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20563905|NCT01995890|Nepafenac|nepafenac|mesh-list
20563906|NCT01995890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20563907|NCT01995890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20563908|NCT01995890|Analgesics|analgesics|mesh-ancestor
20563909|NCT01995890|Sensory System Agents|sensory system agents|mesh-ancestor
20563910|NCT01995890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20563911|NCT01995890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563912|NCT01995890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20563913|NCT01995890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20563914|NCT01996085|Amlodipine|amlodipine|mesh-list
20563915|NCT01996085|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20563916|NCT01996085|Telmisartan|telmisartan|mesh-list
20563917|NCT01996085|Lisinopril|lisinopril|mesh-list
20563918|NCT01996085|Nebivolol|nebivolol|mesh-list
20563919|NCT01996085|Indapamide|indapamide|mesh-list
20563920|NCT01996085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20011204|NCT02362373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20011205|NCT02362373|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20011206|NCT02362373|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20011207|NCT02362412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20011208|NCT02362412|Antidepressive Agents|antidepressive agents|mesh-ancestor
20011209|NCT02362412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20011210|NCT02362412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20011211|NCT02362412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20011212|NCT02362412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20011213|NCT02362412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011214|NCT02362425|Acetylcysteine|acetylcysteine|mesh-list
20011215|NCT02362425|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20011216|NCT02362425|Antiviral Agents|antiviral agents|mesh-ancestor
20011217|NCT02362425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20011218|NCT02362425|Expectorants|expectorants|mesh-ancestor
20011219|NCT02362425|Respiratory System Agents|respiratory system agents|mesh-ancestor
20011220|NCT02362425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20011221|NCT02362425|Antioxidants|antioxidants|mesh-ancestor
20011222|NCT02362425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011223|NCT02362425|Protective Agents|protective agents|mesh-ancestor
20011224|NCT02362425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011225|NCT02362425|Antidotes|antidotes|mesh-ancestor
20011226|NCT02362594|Pembrolizumab|pembrolizumab|mesh-list
20011227|NCT02362594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20011228|NCT02362594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563921|NCT01996085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20563922|NCT01996085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20563923|NCT01996085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563924|NCT01996085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20563925|NCT01996085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563926|NCT01996085|Vasodilator Agents|vasodilator agents|mesh-ancestor
20563927|NCT01996085|Diuretics|diuretics|mesh-ancestor
20563928|NCT01996085|Natriuretic Agents|natriuretic agents|mesh-ancestor
20563929|NCT01996085|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20563930|NCT01996085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20563931|NCT01996085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20563932|NCT01996085|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20563933|NCT01996085|Protease Inhibitors|protease inhibitors|mesh-ancestor
20563934|NCT01996085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563935|NCT01996085|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20563936|NCT01996085|Protective Agents|protective agents|mesh-ancestor
20563937|NCT01996085|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
20563938|NCT01996085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20563939|NCT01996085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20563940|NCT01996085|Adrenergic Agents|adrenergic agents|mesh-ancestor
20563941|NCT01996085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20563942|NCT01996150|Sodium Hypochlorite|sodium hypochlorite|mesh-list
20563943|NCT01996150|Eusol|eusol|mesh-list
20563944|NCT01996150|Disinfectants|disinfectants|mesh-ancestor
20563945|NCT01996150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20563946|NCT01996189|Insulin|insulin|mesh-list
20563947|NCT01996189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20563948|NCT01996189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563949|NCT01996293|Lamotrigine|lamotrigine|mesh-list
20563950|NCT01996293|Anticonvulsants|anticonvulsants|mesh-ancestor
20563951|NCT01996293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20563952|NCT01996293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20563953|NCT01996293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563954|NCT01996293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20563955|NCT01996293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563956|NCT01996293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20563957|NCT01996293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20563958|NCT01996293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20563959|NCT01996293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20563960|NCT01996293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20563961|NCT01996306|Leucovorin|leucovorin|mesh-list
20563962|NCT01996306|Bevacizumab|bevacizumab|mesh-list
20563963|NCT01996306|Fluorouracil|fluorouracil|mesh-list
20563964|NCT01996306|Capecitabine|capecitabine|mesh-list
20563965|NCT01996306|Irinotecan|irinotecan|mesh-list
20563966|NCT01996306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20563967|NCT01996306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20563968|NCT01996306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20563969|NCT01996306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20563970|NCT01996306|Growth Substances|growth substances|mesh-ancestor
20563971|NCT01996306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563972|NCT01996306|Growth Inhibitors|growth inhibitors|mesh-ancestor
20563973|NCT01996306|Antimetabolites|antimetabolites|mesh-ancestor
20563974|NCT01996306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20563975|NCT01996306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20563976|NCT01996306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20563977|NCT01996306|Immunologic Factors|immunologic factors|mesh-ancestor
20563978|NCT01996306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20563979|NCT01996306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20563980|NCT01996306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20563981|NCT01996306|Antidotes|antidotes|mesh-ancestor
20563982|NCT01996306|Protective Agents|protective agents|mesh-ancestor
20563983|NCT01996306|Vitamin B Complex|vitamin b complex|mesh-ancestor
20563984|NCT01996306|Vitamins|vitamins|mesh-ancestor
20563985|NCT01996306|Micronutrients|micronutrients|mesh-ancestor
20563986|NCT01996358|Rocuronium|rocuronium|mesh-list
20563987|NCT01996358|Succinylcholine|succinylcholine|mesh-list
20563988|NCT01996358|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20563989|NCT01996358|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20563990|NCT01996358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20563991|NCT01996358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20563992|NCT01996358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563993|NCT01996358|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
20563994|NCT01996384|Lidocaine|lidocaine|mesh-list
20563995|NCT01996384|Anesthetics, Local|anesthetics, local|mesh-ancestor
20563996|NCT01996384|Anesthetics|anesthetics|mesh-ancestor
20563997|NCT01996384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20563998|NCT01996384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20563999|NCT01996384|Sensory System Agents|sensory system agents|mesh-ancestor
20564000|NCT01996384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564001|NCT01996384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20564002|NCT01996384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20564003|NCT01996384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20564004|NCT01996384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20564005|NCT01996384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564006|NCT01996423|Vitamin D|vitamin d|mesh-list
20564007|NCT01996423|Cholecalciferol|cholecalciferol|mesh-list
20564008|NCT01996423|Vitamins|vitamins|mesh-ancestor
20564009|NCT01996423|Micronutrients|micronutrients|mesh-ancestor
20564010|NCT01996423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564011|NCT01996423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20564012|NCT01996423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20564013|NCT01996462|Dexetimide|dexetimide|mesh-list
20564014|NCT01996462|Citalopram|citalopram|mesh-list
20564015|NCT01996462|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20564016|NCT01996462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20564017|NCT01996462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20564018|NCT01996462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564019|NCT01996462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011229|NCT02363270|Ketamine|ketamine|mesh-list
20011230|NCT02363270|Analgesics|analgesics|mesh-ancestor
20011231|NCT02363270|Sensory System Agents|sensory system agents|mesh-ancestor
20011232|NCT02363270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20011233|NCT02363270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011234|NCT02363270|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20011235|NCT02363270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20011236|NCT02363270|Anesthetics, General|anesthetics, general|mesh-ancestor
20011237|NCT02363270|Anesthetics|anesthetics|mesh-ancestor
20011238|NCT02363270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20011239|NCT02363270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20564020|NCT01996462|Serotonin Agents|serotonin agents|mesh-ancestor
20564021|NCT01996462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564022|NCT01996462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20564023|NCT01996462|Antidepressive Agents|antidepressive agents|mesh-ancestor
20564024|NCT01996462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20564025|NCT01996462|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20564026|NCT01996462|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20564027|NCT01996462|Parasympatholytics|parasympatholytics|mesh-ancestor
20564028|NCT01996462|Autonomic Agents|autonomic agents|mesh-ancestor
20564029|NCT01996462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564030|NCT01996462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20564031|NCT01996462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20564032|NCT01996462|Cholinergic Agents|cholinergic agents|mesh-ancestor
20564033|NCT01996475|Dexetimide|dexetimide|mesh-list
20564034|NCT01996475|Citalopram|citalopram|mesh-list
20564035|NCT01996475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20564036|NCT01996475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20564037|NCT01996475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20564038|NCT01996475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564039|NCT01996475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20564040|NCT01996475|Serotonin Agents|serotonin agents|mesh-ancestor
20564041|NCT01996475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564042|NCT01996475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20564043|NCT01996475|Antidepressive Agents|antidepressive agents|mesh-ancestor
20564044|NCT01996475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20564045|NCT01996475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20564046|NCT01996475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20564047|NCT01996475|Parasympatholytics|parasympatholytics|mesh-ancestor
20564048|NCT01996475|Autonomic Agents|autonomic agents|mesh-ancestor
20564049|NCT01996475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564050|NCT01996475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20564051|NCT01996475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20564052|NCT01996475|Cholinergic Agents|cholinergic agents|mesh-ancestor
20564053|NCT01996488|Olanzapine|olanzapine|mesh-list
20564054|NCT01996488|Antiemetics|antiemetics|mesh-ancestor
20564055|NCT01996488|Autonomic Agents|autonomic agents|mesh-ancestor
20564056|NCT01996488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564057|NCT01996488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564058|NCT01996488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20564059|NCT01996488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20564060|NCT01996488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20564061|NCT01996488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20564062|NCT01996488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20564063|NCT01996488|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20564064|NCT01996488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20564065|NCT01996488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20564066|NCT01996488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564067|NCT01996488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20564068|NCT01996488|Serotonin Agents|serotonin agents|mesh-ancestor
20564069|NCT01996501|Olanzapine|olanzapine|mesh-list
20564070|NCT01996501|Antiemetics|antiemetics|mesh-ancestor
20564071|NCT01996501|Autonomic Agents|autonomic agents|mesh-ancestor
20564072|NCT01996501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564073|NCT01996501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564074|NCT01996501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20564075|NCT01996501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20564076|NCT01996501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20564077|NCT01996501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20564078|NCT01996501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20564079|NCT01996501|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20564080|NCT01996501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20564081|NCT01996501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20564082|NCT01996501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564083|NCT01996501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20564084|NCT01996501|Serotonin Agents|serotonin agents|mesh-ancestor
20564085|NCT01996579|Lactoferrin|lactoferrin|mesh-list
20564086|NCT01996579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20564087|NCT01996618|Ranolazine|ranolazine|mesh-list
20564088|NCT01996618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20564089|NCT01996618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20564090|NCT01996618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564091|NCT01996683|Deferiprone|deferiprone|mesh-list
20564092|NCT01996683|Deferoxamine|deferoxamine|mesh-list
20564093|NCT01996683|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20564094|NCT01996683|Chelating Agents|chelating agents|mesh-ancestor
20564095|NCT01996683|Sequestering Agents|sequestering agents|mesh-ancestor
20564096|NCT01996683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564097|NCT01996683|Siderophores|siderophores|mesh-ancestor
20564098|NCT01996696|Metformin|metformin|mesh-list
20564099|NCT01996696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20564100|NCT01996696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564101|NCT01996735|Ticagrelor|ticagrelor|mesh-list
20564102|NCT01996735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20564103|NCT01996735|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20564104|NCT01996735|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20564105|NCT01996735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20564106|NCT01996735|Purinergic Agents|purinergic agents|mesh-ancestor
20564107|NCT01996735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20564108|NCT01996735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564109|NCT01996735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564110|NCT01996761|Cerebrolysin|cerebrolysin|mesh-list
20564111|NCT01996761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20564112|NCT01996761|Protective Agents|protective agents|mesh-ancestor
20564113|NCT01996761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564114|NCT01996761|Nootropic Agents|nootropic agents|mesh-ancestor
20564115|NCT01996891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
20564116|NCT01996930|Silver Nitrate|silver nitrate|mesh-list
20564117|NCT01996930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20564118|NCT01996930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20564119|NCT01997099|Diazepam|diazepam|mesh-list
20564120|NCT01997099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19460409|NCT03353857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19460410|NCT03353857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19460411|NCT03353857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19460412|NCT03353857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19460413|NCT03353857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19460414|NCT03353857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19460415|NCT03353857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19460416|NCT03353857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19460417|NCT03353857|Estrogens|estrogens|mesh-ancestor
19460418|NCT03353857|Hormones|hormones|mesh-ancestor
19460419|NCT03353857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19460420|NCT03353857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19460421|NCT03353857|Hormone Antagonists|hormone antagonists|mesh-ancestor
19460422|NCT03353857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
20011240|NCT02363270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20011241|NCT02363270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011242|NCT02363270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011243|NCT02363283|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
20011244|NCT02363283|Immunoconjugates|immunoconjugates|mesh-list
20011245|NCT02363283|Immunotoxins|immunotoxins|mesh-list
20011246|NCT02363283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20011247|NCT02363283|Immunologic Factors|immunologic factors|mesh-ancestor
20011248|NCT02363283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011249|NCT02363283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20011250|NCT02363283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011251|NCT02363478|Buspirone|buspirone|mesh-list
20011252|NCT02363478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20011253|NCT02363478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20011254|NCT02363478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20011255|NCT02363478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011256|NCT02363478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20011257|NCT02363478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20011258|NCT02363478|Serotonin Agents|serotonin agents|mesh-ancestor
20011259|NCT02363478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011260|NCT02363478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011261|NCT02363621|Ranibizumab|ranibizumab|mesh-list
20011262|NCT02363621|Aflibercept|aflibercept|mesh-list
20011263|NCT02363621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20011264|NCT02363621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20011265|NCT02363621|Growth Substances|growth substances|mesh-ancestor
20011266|NCT02363621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011267|NCT02363621|Growth Inhibitors|growth inhibitors|mesh-ancestor
20011268|NCT02363621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011269|NCT02363738|Infliximab|infliximab|mesh-list
20011270|NCT02363738|Dermatologic Agents|dermatologic agents|mesh-ancestor
20011271|NCT02363738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20011272|NCT02363738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20011273|NCT02363803|Lidocaine|lidocaine|mesh-list
20564121|NCT01997099|Anticonvulsants|anticonvulsants|mesh-ancestor
20011274|NCT02363803|Anesthetics, Local|anesthetics, local|mesh-ancestor
20564122|NCT01997099|Antiemetics|antiemetics|mesh-ancestor
20564123|NCT01997099|Autonomic Agents|autonomic agents|mesh-ancestor
20564124|NCT01997099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564125|NCT01997099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564126|NCT01997099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20564127|NCT01997099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20564128|NCT01997099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20564129|NCT01997099|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20564130|NCT01997099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20564131|NCT01997099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20564132|NCT01997099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20564133|NCT01997099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20564134|NCT01997099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20564135|NCT01997099|Anesthetics, General|anesthetics, general|mesh-ancestor
20564136|NCT01997099|Anesthetics|anesthetics|mesh-ancestor
20564137|NCT01997099|GABA Modulators|gaba modulators|mesh-ancestor
20564138|NCT01997099|GABA Agents|gaba agents|mesh-ancestor
20564139|NCT01997099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20564140|NCT01997099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564141|NCT01997112|Acetaminophen|acetaminophen|mesh-list
20564142|NCT01997112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20564143|NCT01997112|Analgesics|analgesics|mesh-ancestor
20564144|NCT01997112|Sensory System Agents|sensory system agents|mesh-ancestor
20564145|NCT01997112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564146|NCT01997112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564147|NCT01997112|Antipyretics|antipyretics|mesh-ancestor
20564148|NCT01997138|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20564149|NCT01997138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20564150|NCT01997164|Aflibercept|aflibercept|mesh-list
20564151|NCT01997164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20564152|NCT01997164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20564153|NCT01997164|Growth Substances|growth substances|mesh-ancestor
20564154|NCT01997164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564155|NCT01997164|Growth Inhibitors|growth inhibitors|mesh-ancestor
20564156|NCT01997164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564157|NCT01997190|Valacyclovir|valacyclovir|mesh-list
20564158|NCT01997190|Antiviral Agents|antiviral agents|mesh-ancestor
20564159|NCT01997190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20564160|NCT01997203|Vitamin D|vitamin d|mesh-list
20564161|NCT01997203|Interferons|interferons|mesh-list
20564162|NCT01997203|Ribavirin|ribavirin|mesh-list
20564163|NCT01997203|Vitamins|vitamins|mesh-ancestor
20564164|NCT01997203|Micronutrients|micronutrients|mesh-ancestor
20564165|NCT01997203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564166|NCT01997203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20564167|NCT01997203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564168|NCT01997203|Antiviral Agents|antiviral agents|mesh-ancestor
20564169|NCT01997203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20564170|NCT01997203|Antimetabolites|antimetabolites|mesh-ancestor
20564171|NCT01997203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564172|NCT01997255|Everolimus|everolimus|mesh-list
20564173|NCT01997255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564174|NCT01997255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20564175|NCT01997255|Immunologic Factors|immunologic factors|mesh-ancestor
20564176|NCT01997255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564177|NCT01997294|Atorvastatin|atorvastatin|mesh-list
20564178|NCT01997294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20564179|NCT01997294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20564180|NCT01997294|Antimetabolites|antimetabolites|mesh-ancestor
20564181|NCT01997294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564182|NCT01997294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20564183|NCT01997294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20564184|NCT01997294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20564185|NCT01997580|Citalopram|citalopram|mesh-list
20564186|NCT01997580|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20564187|NCT01997580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20564188|NCT01997580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20564189|NCT01997580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564190|NCT01997580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20564191|NCT01997580|Serotonin Agents|serotonin agents|mesh-ancestor
20564192|NCT01997580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564193|NCT01997580|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20564194|NCT01997580|Antidepressive Agents|antidepressive agents|mesh-ancestor
20564195|NCT01997580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20564196|NCT01997593|Ropivacaine|ropivacaine|mesh-list
20564197|NCT01997593|Anesthetics, Local|anesthetics, local|mesh-ancestor
20564198|NCT01997593|Anesthetics|anesthetics|mesh-ancestor
20564199|NCT01997593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20564200|NCT01997593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564201|NCT01997593|Sensory System Agents|sensory system agents|mesh-ancestor
20564202|NCT01997593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564203|NCT01997632|Vaccines|vaccines|mesh-list
20564204|NCT01997632|Immunologic Factors|immunologic factors|mesh-ancestor
20564205|NCT01997632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564206|NCT01997658|Methylprednisolone|methylprednisolone|mesh-list
20564207|NCT01997658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20564208|NCT01997658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20564209|NCT01997658|Prednisolone|prednisolone|mesh-list
20564210|NCT01997658|Prednisolone acetate|prednisolone acetate|mesh-list
20564211|NCT01997658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20564212|NCT01997658|Prednisolone phosphate|prednisolone phosphate|mesh-list
20564213|NCT01997658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20564214|NCT01997658|Antiemetics|antiemetics|mesh-ancestor
20564215|NCT01997658|Autonomic Agents|autonomic agents|mesh-ancestor
20564216|NCT01997658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564217|NCT01997658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564218|NCT01997658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20564219|NCT01997658|Glucocorticoids|glucocorticoids|mesh-ancestor
20564220|NCT01997658|Hormones|hormones|mesh-ancestor
20564221|NCT01997658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20564222|NCT01997658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20564223|NCT01997658|Protective Agents|protective agents|mesh-ancestor
20564224|NCT01997658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20564225|NCT01997658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564226|NCT01997762|Resveratrol|resveratrol|mesh-list
20564227|NCT01997762|Antioxidants|antioxidants|mesh-ancestor
20564228|NCT01997762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564229|NCT01997762|Protective Agents|protective agents|mesh-ancestor
20564230|NCT01997762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564231|NCT01997762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20564232|NCT01997762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20564233|NCT01997775|Metformin|metformin|mesh-list
20564234|NCT01997775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20564235|NCT01997775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564236|NCT01997788|Morphine|morphine|mesh-list
20564237|NCT01997788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20564238|NCT01997788|Narcotics|narcotics|mesh-ancestor
20564239|NCT01997788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20564240|NCT01997788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564241|NCT01997788|Analgesics|analgesics|mesh-ancestor
20564242|NCT01997788|Sensory System Agents|sensory system agents|mesh-ancestor
20564243|NCT01997788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564244|NCT01997801|Ketamine|ketamine|mesh-list
20564245|NCT01997801|Analgesics|analgesics|mesh-ancestor
20564246|NCT01997801|Sensory System Agents|sensory system agents|mesh-ancestor
20564247|NCT01997801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564248|NCT01997801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564249|NCT01997801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20564250|NCT01997801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20564251|NCT01997801|Anesthetics, General|anesthetics, general|mesh-ancestor
20564252|NCT01997801|Anesthetics|anesthetics|mesh-ancestor
20564253|NCT01997801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20564254|NCT01997801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20564255|NCT01997801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20564256|NCT01997801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011275|NCT02363803|Anesthetics|anesthetics|mesh-ancestor
20011276|NCT02363803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20011277|NCT02363803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011278|NCT02363803|Sensory System Agents|sensory system agents|mesh-ancestor
20011279|NCT02363803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20011280|NCT02363803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20011281|NCT02363803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20011282|NCT02363803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20011283|NCT02363803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20011284|NCT02363803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564257|NCT01997801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564258|NCT01997814|Immunologic Factors|immunologic factors|mesh-list
20564259|NCT01997814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
20564260|NCT01997814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564261|NCT01997879|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20564262|NCT01997879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20564263|NCT01997944|Interferons|interferons|mesh-list
20564264|NCT01997944|Interferon-alpha|interferon-alpha|mesh-list
20564265|NCT01997944|Interferon alpha-2|interferon alpha-2|mesh-list
20564266|NCT01997944|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20564267|NCT01997944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564268|NCT01997944|Antiviral Agents|antiviral agents|mesh-ancestor
20564269|NCT01997944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20564270|NCT01997944|Immunologic Factors|immunologic factors|mesh-ancestor
20564271|NCT01997944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564272|NCT01997983|Botulinum Toxins|botulinum toxins|mesh-list
20564273|NCT01997983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20564274|NCT01997983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20564275|NCT01997983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564276|NCT01997983|Cholinergic Agents|cholinergic agents|mesh-ancestor
20564277|NCT01997983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20564278|NCT01997983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564279|NCT01998113|Insulin|insulin|mesh-list
20564280|NCT01998113|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20564281|NCT01998113|Metformin|metformin|mesh-list
20564282|NCT01998113|Glyburide|glyburide|mesh-list
20564283|NCT01998113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20564284|NCT01998113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564285|NCT01998126|Nivolumab|nivolumab|mesh-list
20564286|NCT01998126|Ipilimumab|ipilimumab|mesh-list
20564287|NCT01998126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20564288|NCT01998126|Crizotinib|crizotinib|mesh-list
20564289|NCT01998126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20564290|NCT01998126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564291|NCT01998126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20564292|NCT01998126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564293|NCT01998126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20564294|NCT01998126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20564295|NCT01998165|Remifentanil|remifentanil|mesh-list
20564296|NCT01998165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20564297|NCT01998165|Narcotics|narcotics|mesh-ancestor
20564298|NCT01998165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20564299|NCT01998165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564300|NCT01998165|Analgesics|analgesics|mesh-ancestor
20564301|NCT01998165|Sensory System Agents|sensory system agents|mesh-ancestor
20564302|NCT01998165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564303|NCT01998217|Flurbiprofen|flurbiprofen|mesh-list
20564304|NCT01998217|Remifentanil|remifentanil|mesh-list
20564305|NCT01998217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20564306|NCT01998217|Narcotics|narcotics|mesh-ancestor
20564307|NCT01998217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20564308|NCT01998217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564309|NCT01998217|Analgesics|analgesics|mesh-ancestor
20564310|NCT01998217|Sensory System Agents|sensory system agents|mesh-ancestor
20564311|NCT01998217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564312|NCT01998217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20564313|NCT01998217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20564314|NCT01998217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20564315|NCT01998217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20564316|NCT01998217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20564317|NCT01998217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20564318|NCT01998217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564319|NCT01998295|Lumefantrine|lumefantrine|mesh-list
20564320|NCT01998295|Artemether|artemether|mesh-list
20564321|NCT01998295|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20564322|NCT01998295|Antimalarials|antimalarials|mesh-ancestor
20564323|NCT01998295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20564324|NCT01998295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20564325|NCT01998295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20564326|NCT01998308|Hyaluronic Acid|hyaluronic acid|mesh-list
20564327|NCT01998308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20564328|NCT01998308|Immunologic Factors|immunologic factors|mesh-ancestor
20564329|NCT01998308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564330|NCT01998308|Viscosupplements|viscosupplements|mesh-ancestor
20564331|NCT01998308|Protective Agents|protective agents|mesh-ancestor
20564332|NCT01998347|Paclitaxel|paclitaxel|mesh-list
20564333|NCT01998347|Fluorouracil|fluorouracil|mesh-list
20564334|NCT01998347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20564335|NCT01998347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564336|NCT01998347|Tubulin Modulators|tubulin modulators|mesh-ancestor
20564337|NCT01998347|Antimitotic Agents|antimitotic agents|mesh-ancestor
20564338|NCT01998347|Mitosis Modulators|mitosis modulators|mesh-ancestor
20564339|NCT01998347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564340|NCT01998347|Antimetabolites|antimetabolites|mesh-ancestor
20564341|NCT01998347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20564342|NCT01998347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20564343|NCT01998347|Immunologic Factors|immunologic factors|mesh-ancestor
20564344|NCT01998347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564345|NCT01998386|Hydrogen Peroxide|hydrogen peroxide|mesh-list
20564346|NCT01998386|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20564347|NCT01998386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20564348|NCT01998451|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
20564349|NCT01998451|Antiviral Agents|antiviral agents|mesh-ancestor
20564350|NCT01998451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20564351|NCT01998451|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20564352|NCT01998451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20564353|NCT01998503|Dexamethasone|dexamethasone|mesh-list
20564354|NCT01998503|Bortezomib|bortezomib|mesh-list
20564355|NCT01998503|Melphalan|melphalan|mesh-list
20564356|NCT01998503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20564357|NCT01998503|Antiemetics|antiemetics|mesh-ancestor
20564358|NCT01998503|Autonomic Agents|autonomic agents|mesh-ancestor
20564359|NCT01998503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564360|NCT01998503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564361|NCT01998503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20564362|NCT01998503|Glucocorticoids|glucocorticoids|mesh-ancestor
20564363|NCT01998503|Hormones|hormones|mesh-ancestor
20564364|NCT01998503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20564365|NCT01998503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20564366|NCT01998503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564367|NCT01998503|Immunologic Factors|immunologic factors|mesh-ancestor
20564368|NCT01998503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20564369|NCT01998503|Alkylating Agents|alkylating agents|mesh-ancestor
20564370|NCT01998503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564371|NCT01998503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20564372|NCT01998503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20564373|NCT01998529|Cisplatin|cisplatin|mesh-list
20564374|NCT01998529|Amifostine|amifostine|mesh-list
20564375|NCT01998529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564376|NCT01998529|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20564377|NCT01998529|Protective Agents|protective agents|mesh-ancestor
20564378|NCT01998529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564379|NCT01998685|Fentanyl|fentanyl|mesh-list
20564380|NCT01998685|Midazolam|midazolam|mesh-list
20564381|NCT01998685|Remifentanil|remifentanil|mesh-list
20564382|NCT01998685|Propofol|propofol|mesh-list
20564383|NCT01998685|Sevoflurane|sevoflurane|mesh-list
20564384|NCT01998685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20564385|NCT01998685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20564386|NCT01998685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564387|NCT01998685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20564388|NCT01998685|Anesthetics, General|anesthetics, general|mesh-ancestor
20564389|NCT01998685|Anesthetics|anesthetics|mesh-ancestor
20564390|NCT01998685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20564391|NCT01998685|Narcotics|narcotics|mesh-ancestor
20564392|NCT01998685|Analgesics|analgesics|mesh-ancestor
20564393|NCT01998685|Sensory System Agents|sensory system agents|mesh-ancestor
20564394|NCT01998685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564395|NCT01998685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20564396|NCT01998685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20564397|NCT01998685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20564398|NCT01998685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20564399|NCT01998685|GABA Modulators|gaba modulators|mesh-ancestor
20564400|NCT01998685|GABA Agents|gaba agents|mesh-ancestor
20564401|NCT01998685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20564402|NCT01998685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564403|NCT01998685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20564404|NCT01998685|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20564405|NCT01998698|Lidocaine|lidocaine|mesh-list
20564406|NCT01998698|Dipivefrin|dipivefrin|mesh-list
20564407|NCT01998698|Hyaluronic Acid|hyaluronic acid|mesh-list
20011285|NCT02363946|Diphenhydramine|diphenhydramine|mesh-list
20011286|NCT02363946|Promethazine|promethazine|mesh-list
20011287|NCT02363946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20011288|NCT02363946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20011289|NCT02363946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20011290|NCT02363946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011291|NCT02363946|Anesthetics, Local|anesthetics, local|mesh-ancestor
20011292|NCT02363946|Anesthetics|anesthetics|mesh-ancestor
20564408|NCT01998698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20564409|NCT01998698|Adrenergic Agents|adrenergic agents|mesh-ancestor
20564410|NCT01998698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20564411|NCT01998698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564412|NCT01998698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564413|NCT01998698|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20564414|NCT01998698|Immunologic Factors|immunologic factors|mesh-ancestor
20564415|NCT01998698|Viscosupplements|viscosupplements|mesh-ancestor
20564416|NCT01998698|Protective Agents|protective agents|mesh-ancestor
20564417|NCT01998698|Anesthetics, Local|anesthetics, local|mesh-ancestor
20564418|NCT01998698|Anesthetics|anesthetics|mesh-ancestor
20564419|NCT01998698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20564420|NCT01998698|Sensory System Agents|sensory system agents|mesh-ancestor
20564421|NCT01998698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564422|NCT01998698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20564423|NCT01998698|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20564424|NCT01998698|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20564425|NCT01998698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20564426|NCT01998763|Vitamin D|vitamin d|mesh-list
20564427|NCT01998763|Cholecalciferol|cholecalciferol|mesh-list
20564428|NCT01998763|Vitamins|vitamins|mesh-ancestor
20564429|NCT01998763|Micronutrients|micronutrients|mesh-ancestor
20564430|NCT01998763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564431|NCT01998763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20564432|NCT01998763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20564433|NCT01998776|Misoprostol|misoprostol|mesh-list
20564434|NCT01998776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20564435|NCT01998776|Abortifacient Agents|abortifacient agents|mesh-ancestor
20564436|NCT01998776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20564437|NCT01998776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564438|NCT01998776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20564439|NCT01998776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20564440|NCT01998776|Oxytocics|oxytocics|mesh-ancestor
20564441|NCT01998789|Everolimus|everolimus|mesh-list
20564442|NCT01998789|Tacrolimus|tacrolimus|mesh-list
20564443|NCT01998789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20564444|NCT01998789|Immunologic Factors|immunologic factors|mesh-ancestor
19460423|NCT03353857|Diuretics|diuretics|mesh-ancestor
20564445|NCT01998789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564446|NCT01998789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20564447|NCT01998789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20564448|NCT01998789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564449|NCT01998789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564450|NCT01999153|Ropivacaine|ropivacaine|mesh-list
20564451|NCT01999153|Anesthetics, Local|anesthetics, local|mesh-ancestor
20564452|NCT01999153|Anesthetics|anesthetics|mesh-ancestor
20564453|NCT01999153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20564454|NCT01999153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564455|NCT01999153|Sensory System Agents|sensory system agents|mesh-ancestor
20564456|NCT01999153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564457|NCT01999270|Bevacizumab|bevacizumab|mesh-list
20564458|NCT01999270|Irinotecan|irinotecan|mesh-list
20564459|NCT01999270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20564460|NCT01999270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564461|NCT01999270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20564462|NCT01999270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20564463|NCT01999270|Growth Substances|growth substances|mesh-ancestor
20564464|NCT01999270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564465|NCT01999270|Growth Inhibitors|growth inhibitors|mesh-ancestor
20564466|NCT01999270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20564467|NCT01999270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20564468|NCT01999270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20564469|NCT01999270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564470|NCT01999309|Simvastatin|simvastatin|mesh-list
20564471|NCT01999309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20564472|NCT01999309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20564473|NCT01999309|Antimetabolites|antimetabolites|mesh-ancestor
20564474|NCT01999309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564475|NCT01999309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20564476|NCT01999309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20564477|NCT01999309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20564478|NCT01999413|Cytarabine|cytarabine|mesh-list
20564479|NCT01999413|Daunorubicin|daunorubicin|mesh-list
20564480|NCT01999413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20564481|NCT01999413|Antimetabolites|antimetabolites|mesh-ancestor
20564482|NCT01999413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564483|NCT01999413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564484|NCT01999413|Antiviral Agents|antiviral agents|mesh-ancestor
20564485|NCT01999413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20564486|NCT01999413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20564487|NCT01999413|Immunologic Factors|immunologic factors|mesh-ancestor
20564488|NCT01999413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564489|NCT01999413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20564490|NCT01999413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20564491|NCT01999413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20564492|NCT01999413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20564493|NCT01999647|Ropivacaine|ropivacaine|mesh-list
20564494|NCT01999647|Anesthetics, Local|anesthetics, local|mesh-list
20564495|NCT01999647|Anesthetics|anesthetics|mesh-list
20564496|NCT01999647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20564497|NCT01999647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564498|NCT01999647|Sensory System Agents|sensory system agents|mesh-ancestor
20564499|NCT01999647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564500|NCT01999673|Docetaxel|docetaxel|mesh-list
20564501|NCT01999673|Bavituximab|bavituximab|mesh-list
20564502|NCT01999673|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20564503|NCT01999673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564504|NCT01999673|Tubulin Modulators|tubulin modulators|mesh-ancestor
20564505|NCT01999673|Antimitotic Agents|antimitotic agents|mesh-ancestor
20564506|NCT01999673|Mitosis Modulators|mitosis modulators|mesh-ancestor
20564507|NCT01999673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564508|NCT01999673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20564509|NCT01999673|Immunologic Factors|immunologic factors|mesh-ancestor
20564510|NCT01999673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564511|NCT01999686|Metformin|metformin|mesh-list
20564512|NCT01999686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20564513|NCT01999686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564514|NCT01999738|Folic Acid|folic acid|mesh-list
20564515|NCT01999738|Hematinics|hematinics|mesh-ancestor
20564516|NCT01999738|Vitamin B Complex|vitamin b complex|mesh-ancestor
19460424|NCT03353857|Natriuretic Agents|natriuretic agents|mesh-ancestor
19460425|NCT03353857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19460426|NCT03353857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19460427|NCT03353857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460428|NCT03353857|Progestins|progestins|mesh-ancestor
19460429|NCT03353831|Bevacizumab|bevacizumab|mesh-list
19460430|NCT03353831|Atezolizumab|atezolizumab|mesh-list
19460431|NCT03353831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19460432|NCT03353831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460433|NCT03353831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20564517|NCT01999738|Vitamins|vitamins|mesh-ancestor
20564518|NCT01999738|Micronutrients|micronutrients|mesh-ancestor
20564519|NCT01999738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564520|NCT01999829|Caffeine|caffeine|mesh-list
20564521|NCT01999829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564522|NCT01999829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20564523|NCT01999829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564524|NCT01999829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20564525|NCT01999829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20564526|NCT01999829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20564527|NCT01999829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20564528|NCT01999829|Purinergic Agents|purinergic agents|mesh-ancestor
20564529|NCT01999829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20564530|NCT01999842|Vaccines|vaccines|mesh-list
20564531|NCT01999842|Immunologic Factors|immunologic factors|mesh-ancestor
20564532|NCT01999842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564533|NCT01999907|Vitamin D|vitamin d|mesh-list
20564534|NCT01999907|Ergocalciferols|ergocalciferols|mesh-list
20564535|NCT01999907|Cholecalciferol|cholecalciferol|mesh-list
20564536|NCT01999907|Vitamins|vitamins|mesh-list
20564537|NCT01999907|Micronutrients|micronutrients|mesh-ancestor
20564538|NCT01999907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564539|NCT01999907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20564540|NCT01999907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20564541|NCT01999933|Cisplatin|cisplatin|mesh-list
20564542|NCT01999933|Docetaxel|docetaxel|mesh-list
19460434|NCT03353831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19460435|NCT03353831|Growth Substances|growth substances|mesh-ancestor
19460436|NCT03353831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564543|NCT01999933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564544|NCT01999933|Tubulin Modulators|tubulin modulators|mesh-ancestor
20564545|NCT01999933|Antimitotic Agents|antimitotic agents|mesh-ancestor
20564546|NCT01999933|Mitosis Modulators|mitosis modulators|mesh-ancestor
19460437|NCT03353831|Growth Inhibitors|growth inhibitors|mesh-ancestor
19460438|NCT03353480|Azithromycin|azithromycin|mesh-list
19460439|NCT03353480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19460440|NCT03353480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19460441|NCT03353441|Glycine|glycine|mesh-list
19460442|NCT03353441|Glycine Agents|glycine agents|mesh-ancestor
19460443|NCT03353441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19460444|NCT03353441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460445|NCT03353441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460446|NCT03353363|Bupivacaine|bupivacaine|mesh-list
19460447|NCT03353363|Anesthetics, Local|anesthetics, local|mesh-ancestor
19460448|NCT03353363|Anesthetics|anesthetics|mesh-ancestor
19460449|NCT03353363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19460450|NCT03353363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460451|NCT03353363|Sensory System Agents|sensory system agents|mesh-ancestor
19460452|NCT03353363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20011293|NCT02363946|Sensory System Agents|sensory system agents|mesh-ancestor
20011294|NCT02363946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20011295|NCT02363946|Antiemetics|antiemetics|mesh-ancestor
20011296|NCT02363946|Autonomic Agents|autonomic agents|mesh-ancestor
20564547|NCT01999933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564548|NCT02000102|Aflibercept|aflibercept|mesh-list
20564549|NCT02000102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20564550|NCT02000102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20564551|NCT02000102|Growth Substances|growth substances|mesh-ancestor
20564552|NCT02000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564553|NCT02000102|Growth Inhibitors|growth inhibitors|mesh-ancestor
20564554|NCT02000102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564555|NCT02000193|Fulvestrant|fulvestrant|mesh-list
20564556|NCT02000193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20564557|NCT02000193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564558|NCT02000193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20564559|NCT02000193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20011297|NCT02363946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20011298|NCT02363946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20011299|NCT02363946|Histamine Antagonists|histamine antagonists|mesh-ancestor
20011300|NCT02363946|Histamine Agents|histamine agents|mesh-ancestor
20011301|NCT02363946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011302|NCT02363946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011303|NCT02363946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20011304|NCT02363946|Antipruritics|antipruritics|mesh-ancestor
20011305|NCT02363946|Dermatologic Agents|dermatologic agents|mesh-ancestor
20011306|NCT02364037|Contraceptive Agents|contraceptive agents|mesh-list
20011307|NCT02364037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20011308|NCT02364037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011309|NCT02364076|Pembrolizumab|pembrolizumab|mesh-list
20011310|NCT02364076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20011311|NCT02364076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011312|NCT02364336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
20011313|NCT02364336|Antiviral Agents|antiviral agents|mesh-ancestor
20564560|NCT02000193|Hormone Antagonists|hormone antagonists|mesh-ancestor
20564561|NCT02000193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20564562|NCT02000193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564563|NCT02000206|Ketamine|ketamine|mesh-list
20564564|NCT02000206|Alfentanil|alfentanil|mesh-list
20564565|NCT02000206|Propofol|propofol|mesh-list
20564566|NCT02000206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20564567|NCT02000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20564568|NCT02000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564569|NCT02000206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20564570|NCT02000206|Anesthetics, General|anesthetics, general|mesh-ancestor
20564571|NCT02000206|Anesthetics|anesthetics|mesh-ancestor
20564572|NCT02000206|Analgesics|analgesics|mesh-ancestor
20564573|NCT02000206|Sensory System Agents|sensory system agents|mesh-ancestor
20564574|NCT02000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564575|NCT02000206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20564576|NCT02000206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20564577|NCT02000206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20564578|NCT02000206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20564579|NCT02000206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564580|NCT02000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20564581|NCT02000206|Narcotics|narcotics|mesh-ancestor
20564582|NCT02000336|Prednisolone|prednisolone|mesh-list
20564583|NCT02000336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20564584|NCT02000336|Glucocorticoids|glucocorticoids|mesh-ancestor
20564585|NCT02000336|Hormones|hormones|mesh-ancestor
20564586|NCT02000336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20564587|NCT02000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564588|NCT02000336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20564589|NCT02000336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564590|NCT02000375|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
20564591|NCT02000375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20564592|NCT02000375|Immunologic Factors|immunologic factors|mesh-ancestor
20564593|NCT02000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564594|NCT02000388|Ketorolac|ketorolac|mesh-list
20564595|NCT02000388|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20564596|NCT02000388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20564597|NCT02000388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20564598|NCT02000388|Analgesics|analgesics|mesh-ancestor
20564599|NCT02000388|Sensory System Agents|sensory system agents|mesh-ancestor
20564600|NCT02000388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460453|NCT03353324|Bevacizumab|bevacizumab|mesh-list
19460454|NCT03353324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19460455|NCT03353324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460456|NCT03353324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19460457|NCT03353324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20564601|NCT02000388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564602|NCT02000388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20564603|NCT02000388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20564604|NCT02000388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20564605|NCT02000388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20564606|NCT02000388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564607|NCT02000401|Ketorolac|ketorolac|mesh-list
20564608|NCT02000401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
20564609|NCT02000401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20564610|NCT02000401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20564611|NCT02000401|Analgesics|analgesics|mesh-ancestor
20564612|NCT02000401|Sensory System Agents|sensory system agents|mesh-ancestor
20564613|NCT02000401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564614|NCT02000401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460458|NCT03353324|Growth Substances|growth substances|mesh-ancestor
19460459|NCT03353324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460460|NCT03353324|Growth Inhibitors|growth inhibitors|mesh-ancestor
19460461|NCT03353298|Allopurinol|allopurinol|mesh-list
19460462|NCT03353298|Antimetabolites|antimetabolites|mesh-ancestor
19460463|NCT03353298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460464|NCT03353298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19460465|NCT03353298|Gout Suppressants|gout suppressants|mesh-ancestor
19460466|NCT03353298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19460467|NCT03353298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19460468|NCT03353298|Antioxidants|antioxidants|mesh-ancestor
19460469|NCT03353298|Protective Agents|protective agents|mesh-ancestor
19460470|NCT03353298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460471|NCT03353103|Listerine|listerine|mesh-list
19460472|NCT03353103|Fluorides|fluorides|mesh-list
19460473|NCT03353103|Sodium Fluoride|sodium fluoride|mesh-list
19460474|NCT03353103|Cariostatic Agents|cariostatic agents|mesh-ancestor
19460475|NCT03353103|Protective Agents|protective agents|mesh-ancestor
19460476|NCT03353103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460477|NCT03353103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19460478|NCT03353103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19460479|NCT03353025|Dopamine|dopamine|mesh-list
20564615|NCT02000401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20564616|NCT02000401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20564617|NCT02000401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20564618|NCT02000401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20564619|NCT02000401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564620|NCT02000414|Daptomycin|daptomycin|mesh-list
20564621|NCT02000414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20564622|NCT02000414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20564623|NCT02000674|Rocuronium|rocuronium|mesh-list
20564624|NCT02000674|Succinylcholine|succinylcholine|mesh-list
20564625|NCT02000674|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20564626|NCT02000674|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20564627|NCT02000674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20564628|NCT02000674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564629|NCT02000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564630|NCT02000674|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
20564631|NCT02000700|Canagliflozin|canagliflozin|mesh-list
20564632|NCT02000700|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20564633|NCT02000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564634|NCT02000700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20564635|NCT02000700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564636|NCT02000726|Citalopram|citalopram|mesh-list
20564637|NCT02000726|Antidepressive Agents|antidepressive agents|mesh-list
20564638|NCT02000726|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20564639|NCT02000726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20564640|NCT02000726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20564641|NCT02000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564642|NCT02000726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20564643|NCT02000726|Serotonin Agents|serotonin agents|mesh-ancestor
20564644|NCT02000726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460480|NCT03353025|Dopamine Agonists|dopamine agonists|mesh-list
19460481|NCT03353025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19460482|NCT03353025|Sympathomimetics|sympathomimetics|mesh-ancestor
19460483|NCT03353025|Autonomic Agents|autonomic agents|mesh-ancestor
19460484|NCT03353025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460485|NCT03353025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460486|NCT03353025|Dopamine Agents|dopamine agents|mesh-ancestor
19460487|NCT03353025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19460488|NCT03353025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460489|NCT03353025|Protective Agents|protective agents|mesh-ancestor
19460490|NCT03353012|Levonorgestrel|levonorgestrel|mesh-list
19460491|NCT03353012|Etonogestrel|etonogestrel|mesh-list
19460492|NCT03353012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19460493|NCT03353012|Contraceptive Agents|contraceptive agents|mesh-ancestor
19460494|NCT03353012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19460495|NCT03353012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460496|NCT03353012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19460497|NCT03353012|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19460498|NCT03353012|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19460499|NCT03352947|Trametinib|trametinib|mesh-list
19460500|NCT03352947|Dabrafenib|dabrafenib|mesh-list
19460501|NCT03352947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460502|NCT03352947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19460503|NCT03352947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19460504|NCT03352947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460505|NCT03352895|Grape Seed Extract|grape seed extract|mesh-list
19460506|NCT03352895|Resveratrol|resveratrol|mesh-list
19460507|NCT03352895|Antioxidants|antioxidants|mesh-ancestor
19460508|NCT03352895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460509|NCT03352895|Protective Agents|protective agents|mesh-ancestor
19460510|NCT03352895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011314|NCT02364336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20011315|NCT02364947|Nalmefene|nalmefene|mesh-list
20011316|NCT02364947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20011317|NCT02364947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011318|NCT02364947|Sensory System Agents|sensory system agents|mesh-ancestor
20011319|NCT02364947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20011320|NCT02364999|Paclitaxel|paclitaxel|mesh-list
20011321|NCT02364999|Bevacizumab|bevacizumab|mesh-list
20011322|NCT02364999|Carboplatin|carboplatin|mesh-list
20011323|NCT02364999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20011324|NCT02364999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011325|NCT02364999|Tubulin Modulators|tubulin modulators|mesh-ancestor
20011326|NCT02364999|Antimitotic Agents|antimitotic agents|mesh-ancestor
20011327|NCT02364999|Mitosis Modulators|mitosis modulators|mesh-ancestor
20011328|NCT02364999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564645|NCT02000726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20564646|NCT02000726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20564647|NCT02000804|Darapladib|darapladib|mesh-list
20564648|NCT02000804|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
20564649|NCT02000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20564650|NCT02000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564651|NCT02000830|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
20564652|NCT02000830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20564653|NCT02000830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564654|NCT02000947|Durvalumab|durvalumab|mesh-list
20564655|NCT02000947|Tremelimumab|tremelimumab|mesh-list
20564656|NCT02000947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20564657|NCT02000947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20564658|NCT02000947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564659|NCT02000947|Immunologic Factors|immunologic factors|mesh-ancestor
20564660|NCT02000947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564661|NCT02001012|Chloroquine|chloroquine|mesh-list
20564662|NCT02001012|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20564663|NCT02001012|Lumefantrine|lumefantrine|mesh-list
20564664|NCT02001012|Artemether|artemether|mesh-list
20564665|NCT02001012|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
20564666|NCT02001012|Amebicides|amebicides|mesh-ancestor
20564667|NCT02001012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20564668|NCT02001012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20564669|NCT02001012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20564670|NCT02001012|Antimalarials|antimalarials|mesh-ancestor
20564671|NCT02001012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20564672|NCT02001012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20564673|NCT02001012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20564674|NCT02001012|Analgesics|analgesics|mesh-ancestor
20564675|NCT02001012|Sensory System Agents|sensory system agents|mesh-ancestor
20564676|NCT02001012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564677|NCT02001012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564678|NCT02001012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20564679|NCT02001012|Filaricides|filaricides|mesh-ancestor
20564680|NCT02001012|Antinematodal Agents|antinematodal agents|mesh-ancestor
20564681|NCT02001012|Anthelmintics|anthelmintics|mesh-ancestor
20564682|NCT02001103|Memantine|memantine|mesh-list
20564683|NCT02001103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20564684|NCT02001103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20564685|NCT02001103|Dopamine Agents|dopamine agents|mesh-ancestor
20564686|NCT02001103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20564687|NCT02001103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564688|NCT02001103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564689|NCT02001103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20564690|NCT02001103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20564691|NCT02001168|Docetaxel|docetaxel|mesh-list
20564692|NCT02001168|Pemetrexed|pemetrexed|mesh-list
20564693|NCT02001168|Cisplatin|cisplatin|mesh-list
20564694|NCT02001168|Endostatins|endostatins|mesh-list
20011329|NCT02364999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20011330|NCT02364999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20011331|NCT02364999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20011332|NCT02364999|Growth Substances|growth substances|mesh-ancestor
20011333|NCT02364999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011334|NCT02364999|Growth Inhibitors|growth inhibitors|mesh-ancestor
20011335|NCT02365285|Heparin|heparin|mesh-list
20011336|NCT02365285|Galantamine|galantamine|mesh-list
20011337|NCT02365285|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20011338|NCT02365285|Anticoagulants|anticoagulants|mesh-ancestor
20011339|NCT02365285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20011340|NCT02365285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20011341|NCT02365285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011342|NCT02365285|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20011343|NCT02365285|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20011344|NCT02365285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20011345|NCT02365285|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20011346|NCT02365285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011347|NCT02365285|Cholinergic Agents|cholinergic agents|mesh-ancestor
20011348|NCT02365285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20564695|NCT02001168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564696|NCT02001168|Tubulin Modulators|tubulin modulators|mesh-ancestor
20564697|NCT02001168|Antimitotic Agents|antimitotic agents|mesh-ancestor
20564698|NCT02001168|Mitosis Modulators|mitosis modulators|mesh-ancestor
20564699|NCT02001168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564700|NCT02001168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20564701|NCT02001168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20564702|NCT02001168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20564703|NCT02001168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20564704|NCT02001168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20564705|NCT02001168|Growth Substances|growth substances|mesh-ancestor
20564706|NCT02001168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564707|NCT02001168|Growth Inhibitors|growth inhibitors|mesh-ancestor
20564708|NCT02001207|Hydrocortisone|hydrocortisone|mesh-list
20564709|NCT02001207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20564710|NCT02001259|Lidocaine|lidocaine|mesh-list
20564711|NCT02001259|Anesthetics, Local|anesthetics, local|mesh-ancestor
19460511|NCT03352895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19460512|NCT03352895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19460513|NCT03352895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19460514|NCT03352895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460515|NCT03352869|Metformin|metformin|mesh-list
19460516|NCT03352869|Exenatide|exenatide|mesh-list
19460517|NCT03352869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19460518|NCT03352869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460519|NCT03352869|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19460520|NCT03352869|Incretins|incretins|mesh-ancestor
19460521|NCT03352869|Hormones|hormones|mesh-ancestor
19460522|NCT03352869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19460523|NCT03352843|Primaquine|primaquine|mesh-list
19460524|NCT03352843|Antimalarials|antimalarials|mesh-ancestor
19460525|NCT03352843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19460526|NCT03352843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19460527|NCT03352843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20564712|NCT02001259|Anesthetics|anesthetics|mesh-ancestor
20564713|NCT02001259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20564714|NCT02001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564715|NCT02001259|Sensory System Agents|sensory system agents|mesh-ancestor
20564716|NCT02001259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564717|NCT02001259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20564718|NCT02001259|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20564719|NCT02001259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20564720|NCT02001259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20564721|NCT02001259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564722|NCT02001272|Paclitaxel|paclitaxel|mesh-list
20564723|NCT02001272|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20564724|NCT02001272|Carboplatin|carboplatin|mesh-list
20564725|NCT02001272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20564726|NCT02001272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564727|NCT02001272|Tubulin Modulators|tubulin modulators|mesh-ancestor
19460528|NCT03352700|Dyclonine|dyclonine|mesh-list
19460529|NCT03352700|Anesthetics, Local|anesthetics, local|mesh-ancestor
19460530|NCT03352700|Anesthetics|anesthetics|mesh-ancestor
19460531|NCT03352700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19460532|NCT03352700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460533|NCT03352700|Sensory System Agents|sensory system agents|mesh-ancestor
19460534|NCT03352700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460535|NCT03352674|Insulin|insulin|mesh-list
19460536|NCT03352674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19460537|NCT03352674|Insulin Glargine|insulin glargine|mesh-list
19460538|NCT03352674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19460539|NCT03352674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460540|NCT03352479|Analgesics, Opioid|analgesics, opioid|mesh-list
19460541|NCT03352479|Narcotics|narcotics|mesh-ancestor
19460542|NCT03352479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19460543|NCT03352479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460544|NCT03352479|Analgesics|analgesics|mesh-ancestor
19460545|NCT03352479|Sensory System Agents|sensory system agents|mesh-ancestor
19460546|NCT03352479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460547|NCT03352362|Acetaminophen|acetaminophen|mesh-list
19460548|NCT03352362|Ibuprofen|ibuprofen|mesh-list
19460549|NCT03352362|Propacetamol|propacetamol|mesh-list
19460550|NCT03352362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20564728|NCT02001272|Antimitotic Agents|antimitotic agents|mesh-ancestor
20564729|NCT02001272|Mitosis Modulators|mitosis modulators|mesh-ancestor
20564730|NCT02001272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564731|NCT02001285|Remifentanil|remifentanil|mesh-list
20564732|NCT02001285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20564733|NCT02001285|Narcotics|narcotics|mesh-ancestor
20564734|NCT02001285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20564735|NCT02001285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564736|NCT02001285|Analgesics|analgesics|mesh-ancestor
20564737|NCT02001285|Sensory System Agents|sensory system agents|mesh-ancestor
20564738|NCT02001285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564739|NCT02001298|Nitroprusside|nitroprusside|mesh-list
20564740|NCT02001298|Remifentanil|remifentanil|mesh-list
20564741|NCT02001298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20564742|NCT02001298|Narcotics|narcotics|mesh-ancestor
20564743|NCT02001298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20564744|NCT02001298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564745|NCT02001298|Analgesics|analgesics|mesh-ancestor
20564746|NCT02001298|Sensory System Agents|sensory system agents|mesh-ancestor
20564747|NCT02001298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564748|NCT02001298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20564749|NCT02001298|Vasodilator Agents|vasodilator agents|mesh-ancestor
20564750|NCT02001298|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20564751|NCT02001298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564752|NCT02001311|Chlorhexidine|chlorhexidine|mesh-list
20564753|NCT02001311|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20564754|NCT02001311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20564755|NCT02001311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20564756|NCT02001311|Disinfectants|disinfectants|mesh-ancestor
20564757|NCT02001311|Dermatologic Agents|dermatologic agents|mesh-ancestor
20564758|NCT02001363|Liraglutide|liraglutide|mesh-list
20564759|NCT02001363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20564760|NCT02001363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564761|NCT02001363|Incretins|incretins|mesh-ancestor
20564762|NCT02001363|Hormones|hormones|mesh-ancestor
20564763|NCT02001363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20564764|NCT02001428|Piperaquine|piperaquine|mesh-list
20564765|NCT02001428|Artenimol|artenimol|mesh-list
20564766|NCT02001428|Antimalarials|antimalarials|mesh-ancestor
20564767|NCT02001428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20564768|NCT02001428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20564769|NCT02001428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20564770|NCT02001506|Docetaxel|docetaxel|mesh-list
20564771|NCT02001506|Epirubicin|epirubicin|mesh-list
20564772|NCT02001506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564773|NCT02001506|Tubulin Modulators|tubulin modulators|mesh-ancestor
20564774|NCT02001506|Antimitotic Agents|antimitotic agents|mesh-ancestor
20564775|NCT02001506|Mitosis Modulators|mitosis modulators|mesh-ancestor
20564776|NCT02001506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564777|NCT02001506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20564778|NCT02001506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20564779|NCT02001506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20564780|NCT02001506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20564781|NCT02001571|Abiraterone Acetate|abiraterone acetate|mesh-list
20564782|NCT02001571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564783|NCT02001571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20564784|NCT02001571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20564785|NCT02001571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564786|NCT02001571|Hormone Antagonists|hormone antagonists|mesh-ancestor
20564787|NCT02001571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20564788|NCT02001571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564789|NCT02001571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20564790|NCT02001584|Memantine|memantine|mesh-list
20564791|NCT02001584|Baclofen|baclofen|mesh-list
20564792|NCT02001584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20564793|NCT02001584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20564794|NCT02001584|Dopamine Agents|dopamine agents|mesh-ancestor
20564795|NCT02001584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20564796|NCT02001584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564797|NCT02001584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564798|NCT02001584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20564799|NCT02001584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20564800|NCT02001584|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20564801|NCT02001584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20564802|NCT02001584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564803|NCT02001584|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20564804|NCT02001584|GABA Agonists|gaba agonists|mesh-ancestor
20564805|NCT02001584|GABA Agents|gaba agents|mesh-ancestor
20564806|NCT02001740|Lidocaine|lidocaine|mesh-list
20564807|NCT02001740|Anesthetics, Local|anesthetics, local|mesh-ancestor
20564808|NCT02001740|Anesthetics|anesthetics|mesh-ancestor
20564809|NCT02001740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20564810|NCT02001740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564811|NCT02001740|Sensory System Agents|sensory system agents|mesh-ancestor
20564812|NCT02001740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564813|NCT02001740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20564814|NCT02001740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20564815|NCT02001740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20564816|NCT02001740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20564817|NCT02001740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564818|NCT02001818|Interferons|interferons|mesh-list
20564819|NCT02001818|Interferon-alpha|interferon-alpha|mesh-list
20564820|NCT02001818|Interferon alpha-2|interferon alpha-2|mesh-list
20564821|NCT02001818|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20564822|NCT02001818|Imatinib Mesylate|imatinib mesylate|mesh-list
20564823|NCT02001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564824|NCT02001818|Antiviral Agents|antiviral agents|mesh-ancestor
20564825|NCT02001818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20564826|NCT02001818|Immunologic Factors|immunologic factors|mesh-ancestor
20564827|NCT02001818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564828|NCT02001818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20564829|NCT02001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20564830|NCT02001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564831|NCT02001857|Hemostatics|hemostatics|mesh-list
20564832|NCT02001857|Coagulants|coagulants|mesh-ancestor
20564833|NCT02001883|Policosanol|policosanol|mesh-list
20564834|NCT02001883|Atorvastatin|atorvastatin|mesh-list
20564835|NCT02001883|Simvastatin|simvastatin|mesh-list
20564836|NCT02001883|Red yeast rice|red yeast rice|mesh-list
20564837|NCT02001883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20564838|NCT02001883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20564839|NCT02001883|Antimetabolites|antimetabolites|mesh-ancestor
20564840|NCT02001883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460551|NCT03352362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19460552|NCT03352362|Analgesics|analgesics|mesh-ancestor
19460553|NCT03352362|Sensory System Agents|sensory system agents|mesh-ancestor
19460554|NCT03352362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460555|NCT03352362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460556|NCT03352362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19460557|NCT03352362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20564841|NCT02001883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20564842|NCT02001883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19460558|NCT03352362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19460559|NCT03352362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19460560|NCT03352362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011349|NCT02365285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011350|NCT02365285|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20011351|NCT02365285|Autonomic Agents|autonomic agents|mesh-ancestor
20011352|NCT02365285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20011353|NCT02365285|Nootropic Agents|nootropic agents|mesh-ancestor
20011354|NCT02365519|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20011355|NCT02365519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19460561|NCT03352362|Antipyretics|antipyretics|mesh-ancestor
19460562|NCT03352349|Terlipressin|terlipressin|mesh-list
19460563|NCT03352349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19460564|NCT03352349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19460565|NCT03352128|Calcium|calcium|mesh-list
19460566|NCT03352128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19460567|NCT03352128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460568|NCT03352115|Prednisolone|prednisolone|mesh-list
19460569|NCT03352115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19460570|NCT03352115|Glucocorticoids|glucocorticoids|mesh-ancestor
19460571|NCT03352115|Hormones|hormones|mesh-ancestor
19460572|NCT03352115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19460573|NCT03352115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460574|NCT03352115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20564843|NCT02001883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20564844|NCT02001883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19460575|NCT03352115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011356|NCT02365558|Omeprazole|omeprazole|mesh-list
20011357|NCT02365558|Evacetrapib|evacetrapib|mesh-list
20011358|NCT02365558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20011359|NCT02365558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20011360|NCT02365558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20011361|NCT02365558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011362|NCT02365558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011363|NCT02365558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20011364|NCT02365558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20564845|NCT02001896|Gemcitabine|gemcitabine|mesh-list
20564846|NCT02001896|Carboplatin|carboplatin|mesh-list
20564847|NCT02001896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20564848|NCT02001896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564849|NCT02001896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20564850|NCT02001896|Antimetabolites|antimetabolites|mesh-ancestor
20564851|NCT02001896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564852|NCT02001896|Antiviral Agents|antiviral agents|mesh-ancestor
20564853|NCT02001896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20564854|NCT02001896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20564855|NCT02001896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20564856|NCT02001896|Immunologic Factors|immunologic factors|mesh-ancestor
20564857|NCT02001896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564858|NCT02001896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20564859|NCT02001909|Neomycin|neomycin|mesh-list
20564860|NCT02001909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20564861|NCT02001909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20564862|NCT02001909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20564863|NCT02001909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20564864|NCT02001909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564865|NCT02001935|Theophylline|theophylline|mesh-list
19460576|NCT03352076|Danazol|danazol|mesh-list
20564866|NCT02001935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20564867|NCT02001935|Autonomic Agents|autonomic agents|mesh-ancestor
20564868|NCT02001935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564869|NCT02001935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564870|NCT02001935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20564871|NCT02001935|Respiratory System Agents|respiratory system agents|mesh-ancestor
20564872|NCT02001935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20564873|NCT02001935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20564874|NCT02001935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564875|NCT02001935|Vasodilator Agents|vasodilator agents|mesh-ancestor
20564876|NCT02001935|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20564877|NCT02001935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20564878|NCT02001935|Purinergic Agents|purinergic agents|mesh-ancestor
20564879|NCT02001935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20564880|NCT02001948|Morphine|morphine|mesh-list
20564881|NCT02001948|Bupivacaine|bupivacaine|mesh-list
20564882|NCT02001948|Anesthetics, Local|anesthetics, local|mesh-ancestor
20564883|NCT02001948|Anesthetics|anesthetics|mesh-ancestor
20564884|NCT02001948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20564885|NCT02001948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564886|NCT02001948|Sensory System Agents|sensory system agents|mesh-ancestor
20564887|NCT02001948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564888|NCT02001948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20564889|NCT02001948|Narcotics|narcotics|mesh-ancestor
20564890|NCT02001948|Analgesics|analgesics|mesh-ancestor
20564891|NCT02001974|Paclitaxel|paclitaxel|mesh-list
20564892|NCT02001974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19460577|NCT03352076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19460578|NCT03352076|Hormone Antagonists|hormone antagonists|mesh-ancestor
19460579|NCT03352076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19460580|NCT03352076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564893|NCT02001974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564894|NCT02001974|Tubulin Modulators|tubulin modulators|mesh-ancestor
20564895|NCT02001974|Antimitotic Agents|antimitotic agents|mesh-ancestor
20564896|NCT02001974|Mitosis Modulators|mitosis modulators|mesh-ancestor
20564897|NCT02001974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564898|NCT02002000|Vitamin D|vitamin d|mesh-list
20564899|NCT02002000|Cholecalciferol|cholecalciferol|mesh-list
20564900|NCT02002000|Vitamins|vitamins|mesh-ancestor
20564901|NCT02002000|Micronutrients|micronutrients|mesh-ancestor
20564902|NCT02002000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564903|NCT02002000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20564904|NCT02002000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20564905|NCT02002039|Epoetin Alfa|epoetin alfa|mesh-list
20564906|NCT02002039|Hematinics|hematinics|mesh-ancestor
20564907|NCT02002065|Vaccines|vaccines|mesh-list
20564908|NCT02002065|Immunologic Factors|immunologic factors|mesh-ancestor
20564909|NCT02002065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564910|NCT02002078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20564911|NCT02002078|Methylprednisolone|methylprednisolone|mesh-list
20564912|NCT02002078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20564913|NCT02002078|Prednisolone|prednisolone|mesh-list
20564914|NCT02002078|Prednisolone acetate|prednisolone acetate|mesh-list
20564915|NCT02002078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20564916|NCT02002078|Prednisolone phosphate|prednisolone phosphate|mesh-list
20564917|NCT02002078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20564918|NCT02002078|Antiemetics|antiemetics|mesh-ancestor
20564919|NCT02002078|Autonomic Agents|autonomic agents|mesh-ancestor
20564920|NCT02002078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20564921|NCT02002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564922|NCT02002078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20564923|NCT02002078|Glucocorticoids|glucocorticoids|mesh-ancestor
20564924|NCT02002078|Hormones|hormones|mesh-ancestor
20564925|NCT02002078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20564926|NCT02002078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20564927|NCT02002078|Protective Agents|protective agents|mesh-ancestor
20564928|NCT02002078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20564929|NCT02002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460581|NCT03351842|Cisplatin|cisplatin|mesh-list
19460582|NCT03351842|Carboplatin|carboplatin|mesh-list
19460583|NCT03351842|Pemetrexed|pemetrexed|mesh-list
19460584|NCT03351842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460585|NCT03351842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011365|NCT02365558|Antimetabolites|antimetabolites|mesh-ancestor
20011366|NCT02365558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20011367|NCT02365584|Lanreotide|lanreotide|mesh-list
20011368|NCT02365584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564930|NCT02002156|Vaccines|vaccines|mesh-list
20564931|NCT02002156|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20564932|NCT02002156|BCG Vaccine|bcg vaccine|mesh-list
20564933|NCT02002156|Immunologic Factors|immunologic factors|mesh-ancestor
20564934|NCT02002156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460586|NCT03351842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460587|NCT03351842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19460588|NCT03351842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20011369|NCT02365870|Rotigotine|rotigotine|mesh-list
20011370|NCT02365870|Dopamine Agonists|dopamine agonists|mesh-ancestor
20011371|NCT02365870|Dopamine Agents|dopamine agents|mesh-ancestor
20011372|NCT02365870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011373|NCT02365870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564935|NCT02002156|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20564936|NCT02002195|Leucovorin|leucovorin|mesh-list
20564937|NCT02002195|Fluorouracil|fluorouracil|mesh-list
20564938|NCT02002195|Capecitabine|capecitabine|mesh-list
20564939|NCT02002195|Oxaliplatin|oxaliplatin|mesh-list
20564940|NCT02002195|Antimetabolites|antimetabolites|mesh-ancestor
20564941|NCT02002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564942|NCT02002195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20564943|NCT02002195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564944|NCT02002195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20011374|NCT02365870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011375|NCT02365961|Clonidine|clonidine|mesh-list
20011376|NCT02365961|Epinephrine|epinephrine|mesh-list
20011377|NCT02365961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20011378|NCT02365961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20011379|NCT02365961|Adrenergic Agents|adrenergic agents|mesh-ancestor
20011380|NCT02365961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011381|NCT02365961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011382|NCT02365961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011383|NCT02365961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20011384|NCT02365961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20011385|NCT02365961|Autonomic Agents|autonomic agents|mesh-ancestor
20011386|NCT02365961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20011387|NCT02365961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20011388|NCT02365961|Respiratory System Agents|respiratory system agents|mesh-ancestor
20011389|NCT02365961|Mydriatics|mydriatics|mesh-ancestor
20011390|NCT02365961|Sympathomimetics|sympathomimetics|mesh-ancestor
20011391|NCT02365961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20011392|NCT02365961|Analgesics|analgesics|mesh-ancestor
20011393|NCT02365961|Sensory System Agents|sensory system agents|mesh-ancestor
20011394|NCT02365961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20011395|NCT02365961|Sympatholytics|sympatholytics|mesh-ancestor
20011396|NCT02365961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20011397|NCT02366091|Methotrexate|methotrexate|mesh-list
20011398|NCT02366091|Colchicine|colchicine|mesh-list
20011399|NCT02366091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20011400|NCT02366091|Abortifacient Agents|abortifacient agents|mesh-ancestor
20011401|NCT02366091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20011402|NCT02366091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011403|NCT02366091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20011404|NCT02366091|Antimetabolites|antimetabolites|mesh-ancestor
20011405|NCT02366091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011406|NCT02366091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011407|NCT02366091|Dermatologic Agents|dermatologic agents|mesh-ancestor
20011408|NCT02366091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011409|NCT02366091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20011410|NCT02366091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20011411|NCT02366091|Immunologic Factors|immunologic factors|mesh-ancestor
20011412|NCT02366091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20011413|NCT02366091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20011414|NCT02366091|Gout Suppressants|gout suppressants|mesh-ancestor
20011415|NCT02366091|Tubulin Modulators|tubulin modulators|mesh-ancestor
20011416|NCT02366091|Antimitotic Agents|antimitotic agents|mesh-ancestor
20011417|NCT02366091|Mitosis Modulators|mitosis modulators|mesh-ancestor
20011418|NCT02366130|Denosumab|denosumab|mesh-list
20011419|NCT02366130|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
20011420|NCT02366130|Hormones|hormones|mesh-list
20011421|NCT02366130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20011422|NCT02366130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011423|NCT02366130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20011424|NCT02366130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011425|NCT02366143|Paclitaxel|paclitaxel|mesh-list
20011426|NCT02366143|Bevacizumab|bevacizumab|mesh-list
19460589|NCT03351751|PF-06372865|pf-06372865|mesh-list
19460590|NCT03351751|GABA Modulators|gaba modulators|mesh-ancestor
19460591|NCT03351751|GABA Agents|gaba agents|mesh-ancestor
19460592|NCT03351751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19460593|NCT03351751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460594|NCT03351751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460595|NCT03351686|Tranexamic Acid|tranexamic acid|mesh-list
20564945|NCT02002195|Immunologic Factors|immunologic factors|mesh-ancestor
20564946|NCT02002195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564947|NCT02002195|Antidotes|antidotes|mesh-ancestor
20564948|NCT02002195|Protective Agents|protective agents|mesh-ancestor
20564949|NCT02002195|Vitamin B Complex|vitamin b complex|mesh-ancestor
20564950|NCT02002195|Vitamins|vitamins|mesh-ancestor
20564951|NCT02002195|Micronutrients|micronutrients|mesh-ancestor
20564952|NCT02002247|Selenium|selenium|mesh-list
20564953|NCT02002247|Selenious Acid|selenious acid|mesh-list
20564954|NCT02002247|Sodium Selenite|sodium selenite|mesh-list
20564955|NCT02002247|Antioxidants|antioxidants|mesh-ancestor
20564956|NCT02002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460596|NCT03351686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19460597|NCT03351686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19460598|NCT03351686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460599|NCT03351686|Hemostatics|hemostatics|mesh-ancestor
19460600|NCT03351686|Coagulants|coagulants|mesh-ancestor
19460601|NCT03351647|Ustekinumab|ustekinumab|mesh-list
19460602|NCT03351647|Dermatologic Agents|dermatologic agents|mesh-ancestor
19460603|NCT03351569|Immunoglobulins|immunoglobulins|mesh-list
19460604|NCT03351569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
19460605|NCT03351569|Antibodies|antibodies|mesh-list
19460606|NCT03351569|gamma-Globulins|gamma-globulins|mesh-list
20564957|NCT02002247|Protective Agents|protective agents|mesh-ancestor
20564958|NCT02002247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564959|NCT02002247|Trace Elements|trace elements|mesh-ancestor
20564960|NCT02002247|Micronutrients|micronutrients|mesh-ancestor
20564961|NCT02002260|Levonorgestrel|levonorgestrel|mesh-list
20564962|NCT02002260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
20564963|NCT02002260|Contraceptive Agents|contraceptive agents|mesh-list
20564964|NCT02002260|Contraceptives, Oral|contraceptives, oral|mesh-list
20564965|NCT02002260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
20564966|NCT02002260|Estradiol|estradiol|mesh-list
20564967|NCT02002260|Estrogens|estrogens|mesh-ancestor
20564968|NCT02002260|Hormones|hormones|mesh-ancestor
20564969|NCT02002260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20564970|NCT02002260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564971|NCT02002260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20564972|NCT02002260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20564973|NCT02002260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20564974|NCT02002260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20564975|NCT02002260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20564976|NCT02002286|Triptolide|triptolide|mesh-list
20564977|NCT02002286|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
20564978|NCT02002286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20564979|NCT02002286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20564980|NCT02002286|Contraceptive Agents|contraceptive agents|mesh-ancestor
20564981|NCT02002286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20564982|NCT02002286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20564983|NCT02002286|Immunologic Factors|immunologic factors|mesh-ancestor
20564984|NCT02002286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20564985|NCT02002286|Alkylating Agents|alkylating agents|mesh-ancestor
20564986|NCT02002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564987|NCT02002286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564988|NCT02002312|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
19460607|NCT03351569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
19460608|NCT03351569|Immunologic Factors|immunologic factors|mesh-ancestor
19460609|NCT03351569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460610|NCT03351517|Tapentadol|tapentadol|mesh-list
19460611|NCT03351517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19460612|NCT03351517|Narcotics|narcotics|mesh-ancestor
19460613|NCT03351517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19460614|NCT03351517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460615|NCT03351517|Analgesics|analgesics|mesh-ancestor
19460616|NCT03351517|Sensory System Agents|sensory system agents|mesh-ancestor
19460617|NCT03351517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460618|NCT03351517|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20564989|NCT02002312|Chelating Agents|chelating agents|mesh-ancestor
20564990|NCT02002312|Sequestering Agents|sequestering agents|mesh-ancestor
19460619|NCT03351517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19460620|NCT03351517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19460621|NCT03351517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460622|NCT03351517|Adrenergic Agents|adrenergic agents|mesh-ancestor
19460623|NCT03351517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19460624|NCT03351361|Nivolumab|nivolumab|mesh-list
19460625|NCT03351361|Ipilimumab|ipilimumab|mesh-list
19460626|NCT03351361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19460627|NCT03351361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20564991|NCT02002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564992|NCT02002325|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20564993|NCT02002325|Plasminogen|plasminogen|mesh-list
20564994|NCT02002325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20564995|NCT02002325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20564996|NCT02002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20564997|NCT02002377|Aflibercept|aflibercept|mesh-list
20564998|NCT02002377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20564999|NCT02002377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20565000|NCT02002377|Growth Substances|growth substances|mesh-ancestor
20565001|NCT02002377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565002|NCT02002377|Growth Inhibitors|growth inhibitors|mesh-ancestor
20565003|NCT02002377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565004|NCT02002390|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20565005|NCT02002390|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20565006|NCT02002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565007|NCT02002390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20565008|NCT02002390|Immunologic Factors|immunologic factors|mesh-ancestor
20565009|NCT02002390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565010|NCT02002403|Danazol|danazol|mesh-list
20565011|NCT02002403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20565012|NCT02002403|Hormone Antagonists|hormone antagonists|mesh-ancestor
20565013|NCT02002403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20565014|NCT02002403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565015|NCT02002442|Chlorhexidine|chlorhexidine|mesh-list
20565016|NCT02002442|Cetylpyridinium|cetylpyridinium|mesh-list
20565017|NCT02002442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20565018|NCT02002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20565019|NCT02002442|Disinfectants|disinfectants|mesh-ancestor
20565020|NCT02002598|Dexamethasone|dexamethasone|mesh-list
20565021|NCT02002598|Dexamethasone acetate|dexamethasone acetate|mesh-list
20565022|NCT02002598|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20565023|NCT02002598|BB 1101|bb 1101|mesh-list
20565024|NCT02002598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20565025|NCT02002598|Antiemetics|antiemetics|mesh-ancestor
20565026|NCT02002598|Autonomic Agents|autonomic agents|mesh-ancestor
20565027|NCT02002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565028|NCT02002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565029|NCT02002598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20565030|NCT02002598|Glucocorticoids|glucocorticoids|mesh-ancestor
20565031|NCT02002598|Hormones|hormones|mesh-ancestor
20565032|NCT02002598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20565033|NCT02002598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20565034|NCT02002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565035|NCT02002598|Protease Inhibitors|protease inhibitors|mesh-ancestor
20565036|NCT02002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565037|NCT02002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565038|NCT02002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20565039|NCT02002598|Alkylating Agents|alkylating agents|mesh-ancestor
20565040|NCT02002611|Warfarin|warfarin|mesh-list
20565041|NCT02002611|Anticoagulants|anticoagulants|mesh-ancestor
20565042|NCT02002663|Methylprednisolone|methylprednisolone|mesh-list
20565043|NCT02002663|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20565044|NCT02002663|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20565045|NCT02002663|Prednisolone|prednisolone|mesh-list
20565046|NCT02002663|Prednisolone acetate|prednisolone acetate|mesh-list
20565047|NCT02002663|Morphine|morphine|mesh-list
19460628|NCT03351361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19460629|NCT03351361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460630|NCT03351322|Minoxidil|minoxidil|mesh-list
19460631|NCT03351322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19460632|NCT03351322|Vasodilator Agents|vasodilator agents|mesh-ancestor
19460633|NCT03351296|Bevacizumab|bevacizumab|mesh-list
19460634|NCT03351296|Capecitabine|capecitabine|mesh-list
19460635|NCT03351296|Temozolomide|temozolomide|mesh-list
19460636|NCT03351296|Streptozocin|streptozocin|mesh-list
19460637|NCT03351296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19460638|NCT03351296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460639|NCT03351296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19460640|NCT03351296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19460641|NCT03351296|Growth Substances|growth substances|mesh-ancestor
19460642|NCT03351296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460643|NCT03351296|Growth Inhibitors|growth inhibitors|mesh-ancestor
19460644|NCT03351296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19460645|NCT03351296|Antimetabolites|antimetabolites|mesh-ancestor
19460646|NCT03351296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460647|NCT03351296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19460648|NCT03351296|Alkylating Agents|alkylating agents|mesh-ancestor
19460649|NCT03351296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19460650|NCT03351205|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20565048|NCT02002663|Ropivacaine|ropivacaine|mesh-list
20565049|NCT02002663|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19460651|NCT03351205|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20565050|NCT02002663|Prednisolone phosphate|prednisolone phosphate|mesh-list
20011427|NCT02366143|Carboplatin|carboplatin|mesh-list
20011428|NCT02366143|Atezolizumab|atezolizumab|mesh-list
20011429|NCT02366143|Antibodies|antibodies|mesh-list
19460652|NCT03351205|Estradiol|estradiol|mesh-list
19460653|NCT03351205|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19460654|NCT03351205|Dydrogesterone|dydrogesterone|mesh-list
19460655|NCT03351205|Estrogens|estrogens|mesh-ancestor
19460656|NCT03351205|Hormones|hormones|mesh-ancestor
19460657|NCT03351205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19460658|NCT03351205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460659|NCT03351205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19460660|NCT03351205|Contraceptive Agents|contraceptive agents|mesh-ancestor
19460661|NCT03351205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19460662|NCT03351205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19460663|NCT03351205|Progestins|progestins|mesh-ancestor
19460664|NCT03351062|Tamoxifen|tamoxifen|mesh-list
19460665|NCT03351062|Toremifene|toremifene|mesh-list
19460666|NCT03351062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19460667|NCT03351062|Hormone Antagonists|hormone antagonists|mesh-ancestor
19460668|NCT03351062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19460669|NCT03351062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460670|NCT03351062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19460671|NCT03351062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460672|NCT03351062|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19460673|NCT03351062|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19460674|NCT03351062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19460675|NCT03350737|Heparin|heparin|mesh-list
19460676|NCT03350737|Anticoagulants|anticoagulants|mesh-ancestor
19460677|NCT03350737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19460678|NCT03350737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19460679|NCT03350737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460680|NCT03350659|Midodrine|midodrine|mesh-list
19460681|NCT03350659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
19460682|NCT03350659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19460683|NCT03350659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19460684|NCT03350659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19460685|NCT03350659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460686|NCT03350659|Adrenergic Agents|adrenergic agents|mesh-ancestor
19460687|NCT03350659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19460688|NCT03350659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460689|NCT03350659|Sympathomimetics|sympathomimetics|mesh-ancestor
19460690|NCT03350659|Autonomic Agents|autonomic agents|mesh-ancestor
19460691|NCT03350659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460692|NCT03350659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19460693|NCT03350659|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19460694|NCT03350659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19460695|NCT03350659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19460696|NCT03350633|Azathioprine|azathioprine|mesh-list
20011430|NCT02366143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20011431|NCT02366143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20011432|NCT02366143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011433|NCT02366143|Tubulin Modulators|tubulin modulators|mesh-ancestor
20011434|NCT02366143|Antimitotic Agents|antimitotic agents|mesh-ancestor
20011435|NCT02366143|Mitosis Modulators|mitosis modulators|mesh-ancestor
20011436|NCT02366143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011437|NCT02366143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20011438|NCT02366143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20011439|NCT02366143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20011440|NCT02366143|Growth Substances|growth substances|mesh-ancestor
20011441|NCT02366143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011442|NCT02366143|Growth Inhibitors|growth inhibitors|mesh-ancestor
20011443|NCT02366143|Immunologic Factors|immunologic factors|mesh-ancestor
20011444|NCT02366195|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
20011445|NCT02366195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20011446|NCT02366195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011447|NCT02366468|Ranibizumab|ranibizumab|mesh-list
20011448|NCT02366468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20011449|NCT02366468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20011450|NCT02366468|Growth Substances|growth substances|mesh-ancestor
20011451|NCT02366468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011452|NCT02366468|Growth Inhibitors|growth inhibitors|mesh-ancestor
20011453|NCT02366468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460697|NCT03350633|Antimetabolites|antimetabolites|mesh-ancestor
20011454|NCT02366663|Cytarabine|cytarabine|mesh-list
20011455|NCT02366663|Rituximab|rituximab|mesh-list
20011456|NCT02366663|Etoposide|etoposide|mesh-list
20011457|NCT02366663|Melphalan|melphalan|mesh-list
20011458|NCT02366663|Carmustine|carmustine|mesh-list
20011459|NCT02366663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20565051|NCT02002663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20565052|NCT02002663|Narcotics|narcotics|mesh-ancestor
20565053|NCT02002663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20565054|NCT02002663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565055|NCT02002663|Analgesics|analgesics|mesh-ancestor
20565056|NCT02002663|Sensory System Agents|sensory system agents|mesh-ancestor
20565057|NCT02002663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565058|NCT02002663|Anesthetics, Local|anesthetics, local|mesh-ancestor
20565059|NCT02002663|Anesthetics|anesthetics|mesh-ancestor
20565060|NCT02002663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20565061|NCT02002663|Antiemetics|antiemetics|mesh-ancestor
20565062|NCT02002663|Autonomic Agents|autonomic agents|mesh-ancestor
19460698|NCT03350633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460699|NCT03350633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19460700|NCT03350633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460701|NCT03350633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19460702|NCT03350633|Immunologic Factors|immunologic factors|mesh-ancestor
19460703|NCT03350633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460704|NCT03350633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19460705|NCT03350399|Mitogens|mitogens|mesh-list
19460706|NCT03350399|Mitosis Modulators|mitosis modulators|mesh-ancestor
19460707|NCT03350399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460708|NCT03350386|Oxaprozin|oxaprozin|mesh-list
19460709|NCT03350386|Dotinurad|dotinurad|mesh-list
19460710|NCT03350386|Uricosuric Agents|uricosuric agents|mesh-ancestor
19460711|NCT03350386|Gout Suppressants|gout suppressants|mesh-ancestor
19460712|NCT03350386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19460713|NCT03350386|Renal Agents|renal agents|mesh-ancestor
19460714|NCT03350386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19460715|NCT03350386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19460716|NCT03350386|Analgesics|analgesics|mesh-ancestor
19460717|NCT03350386|Sensory System Agents|sensory system agents|mesh-ancestor
19460718|NCT03350386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20011460|NCT02366663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011461|NCT02366663|Immunologic Factors|immunologic factors|mesh-ancestor
20011462|NCT02366663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011463|NCT02366663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20011464|NCT02366663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20011465|NCT02366663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20011466|NCT02366663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20011467|NCT02366663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011468|NCT02366663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011469|NCT02366663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20011470|NCT02366663|Antimetabolites|antimetabolites|mesh-ancestor
20011471|NCT02366663|Antiviral Agents|antiviral agents|mesh-ancestor
20011472|NCT02366663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20011473|NCT02366663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20011474|NCT02366663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20011475|NCT02366663|Alkylating Agents|alkylating agents|mesh-ancestor
20011476|NCT02366663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20011477|NCT02366689|Triclosan|triclosan|mesh-list
20011478|NCT02366689|Cetylpyridinium|cetylpyridinium|mesh-list
20011479|NCT02366689|Fluorides|fluorides|mesh-list
20011480|NCT02366689|Tin Fluorides|tin fluorides|mesh-list
20011481|NCT02366689|Cariostatic Agents|cariostatic agents|mesh-ancestor
20011482|NCT02366689|Protective Agents|protective agents|mesh-ancestor
20011483|NCT02366689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011484|NCT02366689|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20011485|NCT02366689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20011486|NCT02366689|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19460719|NCT03350386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460720|NCT03350386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19460721|NCT03350386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19460722|NCT03350386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19460723|NCT03350386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460724|NCT03350373|Dotinurad|dotinurad|mesh-list
19460725|NCT03350373|Uricosuric Agents|uricosuric agents|mesh-ancestor
19460726|NCT03350373|Gout Suppressants|gout suppressants|mesh-ancestor
19460727|NCT03350373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19460728|NCT03350373|Renal Agents|renal agents|mesh-ancestor
19460729|NCT03350347|Darbepoetin alfa|darbepoetin alfa|mesh-list
19460730|NCT03350347|Hematinics|hematinics|mesh-ancestor
20011487|NCT02366689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20011488|NCT02366689|Antimetabolites|antimetabolites|mesh-ancestor
20011489|NCT02366689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460731|NCT03350334|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19460732|NCT03350334|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19460733|NCT03350334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19460734|NCT03350334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19460735|NCT03350334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460736|NCT03350334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19460737|NCT03350334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460738|NCT03350334|Analgesics|analgesics|mesh-ancestor
19460739|NCT03350334|Sensory System Agents|sensory system agents|mesh-ancestor
19460740|NCT03350334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460741|NCT03350334|Antidepressive Agents|antidepressive agents|mesh-ancestor
19460742|NCT03350334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19460743|NCT03350334|Dopamine Agents|dopamine agents|mesh-ancestor
19460744|NCT03350321|Darbepoetin alfa|darbepoetin alfa|mesh-list
19460745|NCT03350321|Hematinics|hematinics|mesh-ancestor
19460746|NCT03350295|Nifurtimox|nifurtimox|mesh-list
20565063|NCT02002663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20565064|NCT02002663|Glucocorticoids|glucocorticoids|mesh-ancestor
20565065|NCT02002663|Hormones|hormones|mesh-ancestor
20565066|NCT02002663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20565067|NCT02002663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20565068|NCT02002663|Protective Agents|protective agents|mesh-ancestor
20565069|NCT02002663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20565070|NCT02002663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565071|NCT02002715|Budesonide|budesonide|mesh-list
20565072|NCT02002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20565073|NCT02002715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20565074|NCT02002715|Autonomic Agents|autonomic agents|mesh-ancestor
19460747|NCT03350295|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19460748|NCT03350295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19460749|NCT03350295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19460750|NCT03350295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19460751|NCT03350191|Exenatide|exenatide|mesh-list
19460752|NCT03350191|Glucagon|glucagon|mesh-list
19460753|NCT03350191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19460754|NCT03350191|Hormones|hormones|mesh-ancestor
19460755|NCT03350191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20011490|NCT02366689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20011491|NCT02366767|Insulin|insulin|mesh-list
20011492|NCT02366767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20011493|NCT02366767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011494|NCT02366871|Enoxaparin|enoxaparin|mesh-list
20011495|NCT02366871|Apixaban|apixaban|mesh-list
20011496|NCT02366871|Anticoagulants|anticoagulants|mesh-ancestor
19460756|NCT03350191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460757|NCT03350191|Incretins|incretins|mesh-ancestor
19460758|NCT03350191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19460759|NCT03350191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19460760|NCT03350126|Nivolumab|nivolumab|mesh-list
19460761|NCT03350126|Ipilimumab|ipilimumab|mesh-list
19460762|NCT03350126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19460763|NCT03350126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460764|NCT03350126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19460765|NCT03350126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011497|NCT02366871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20011498|NCT02366871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20011499|NCT02366871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011500|NCT02366871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20011501|NCT02366871|Antithrombins|antithrombins|mesh-ancestor
20011502|NCT02366871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20011503|NCT02366871|Protease Inhibitors|protease inhibitors|mesh-ancestor
20011504|NCT02366871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011505|NCT02367131|Empagliflozin|empagliflozin|mesh-list
20011506|NCT02367131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20011507|NCT02367131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565075|NCT02002715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565076|NCT02002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565077|NCT02002715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20565078|NCT02002715|Respiratory System Agents|respiratory system agents|mesh-ancestor
20565079|NCT02002715|Glucocorticoids|glucocorticoids|mesh-ancestor
20565080|NCT02002715|Hormones|hormones|mesh-ancestor
20565081|NCT02002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20565082|NCT02002741|Acetaminophen|acetaminophen|mesh-list
20565083|NCT02002741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20565084|NCT02002741|Analgesics|analgesics|mesh-ancestor
20565085|NCT02002741|Sensory System Agents|sensory system agents|mesh-ancestor
20011508|NCT02367131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20011509|NCT02367131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011510|NCT02367352|Paclitaxel|paclitaxel|mesh-list
20011511|NCT02367352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20011512|NCT02367352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011513|NCT02367352|Tubulin Modulators|tubulin modulators|mesh-ancestor
20011514|NCT02367352|Antimitotic Agents|antimitotic agents|mesh-ancestor
20011515|NCT02367352|Mitosis Modulators|mitosis modulators|mesh-ancestor
20011516|NCT02367352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011517|NCT02367599|Vitamin D|vitamin d|mesh-list
20011518|NCT02367599|Vitamins|vitamins|mesh-ancestor
20011519|NCT02367599|Micronutrients|micronutrients|mesh-ancestor
20011520|NCT02367599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011521|NCT02367599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20011522|NCT02367781|Paclitaxel|paclitaxel|mesh-list
20011523|NCT02367781|Carboplatin|carboplatin|mesh-list
20011524|NCT02367781|Pemetrexed|pemetrexed|mesh-list
20011525|NCT02367781|Atezolizumab|atezolizumab|mesh-list
20011526|NCT02367781|Antibodies|antibodies|mesh-list
20011527|NCT02367781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20011528|NCT02367781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20011529|NCT02367781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565086|NCT02002741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565087|NCT02002741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565088|NCT02002741|Antipyretics|antipyretics|mesh-ancestor
20565089|NCT02002754|Bambuterol|bambuterol|mesh-list
20565090|NCT02002754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20565091|NCT02002754|Autonomic Agents|autonomic agents|mesh-ancestor
20565092|NCT02002754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565093|NCT02002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565094|NCT02002754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20565095|NCT02002754|Respiratory System Agents|respiratory system agents|mesh-ancestor
20565096|NCT02002806|Ethanol|ethanol|mesh-list
20565097|NCT02002806|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20565098|NCT02002806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20565099|NCT02002806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20565100|NCT02002806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565101|NCT02002858|Nicotine|nicotine|mesh-list
20565102|NCT02002858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20565103|NCT02002858|Autonomic Agents|autonomic agents|mesh-ancestor
20565104|NCT02002858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565105|NCT02002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011530|NCT02367781|Tubulin Modulators|tubulin modulators|mesh-ancestor
20011531|NCT02367781|Antimitotic Agents|antimitotic agents|mesh-ancestor
20565106|NCT02002858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20565107|NCT02002858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20565108|NCT02002858|Cholinergic Agents|cholinergic agents|mesh-ancestor
20565109|NCT02002858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20565110|NCT02002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565111|NCT02002923|Botulinum Toxins|botulinum toxins|mesh-list
20565112|NCT02002923|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20565113|NCT02002923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20565114|NCT02002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565115|NCT02002923|Cholinergic Agents|cholinergic agents|mesh-ancestor
20565116|NCT02002923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20565117|NCT02002923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565118|NCT02002962|Botulinum Toxins|botulinum toxins|mesh-list
20565119|NCT02002962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20565120|NCT02002962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20565121|NCT02002962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20565122|NCT02002962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20565123|NCT02002962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565124|NCT02002962|Cholinergic Agents|cholinergic agents|mesh-ancestor
20565125|NCT02002962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20565126|NCT02002962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565127|NCT02002962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20565128|NCT02002962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565129|NCT02003001|Botulinum Toxins|botulinum toxins|mesh-list
20565130|NCT02003001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20565131|NCT02003001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20565132|NCT02003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565133|NCT02003001|Cholinergic Agents|cholinergic agents|mesh-ancestor
20565134|NCT02003001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20565135|NCT02003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565136|NCT02003209|Carboplatin|carboplatin|mesh-list
20565137|NCT02003209|Docetaxel|docetaxel|mesh-list
20565138|NCT02003209|Trastuzumab|trastuzumab|mesh-list
20565139|NCT02003209|Pertuzumab|pertuzumab|mesh-list
20565140|NCT02003209|Goserelin|goserelin|mesh-list
20565141|NCT02003209|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
20565142|NCT02003209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
20565143|NCT02003209|Antibodies|antibodies|mesh-list
20565144|NCT02003209|Immunoglobulins|immunoglobulins|mesh-list
20565145|NCT02003209|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20565146|NCT02003209|Aromatase Inhibitors|aromatase inhibitors|mesh-list
20565147|NCT02003209|Immunologic Factors|immunologic factors|mesh-ancestor
20565148|NCT02003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565149|NCT02003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565150|NCT02003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
20565151|NCT02003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
20565152|NCT02003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
20565153|NCT02003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565154|NCT02003209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20011532|NCT02367781|Mitosis Modulators|mitosis modulators|mesh-ancestor
20011533|NCT02367781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011534|NCT02367781|Immunologic Factors|immunologic factors|mesh-ancestor
20011535|NCT02367781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011536|NCT02367781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011537|NCT02367781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20011538|NCT02367781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20011539|NCT02367833|Contraceptive Agents|contraceptive agents|mesh-list
20011540|NCT02367833|NuvaRing|nuvaring|mesh-list
20011541|NCT02367833|Contraceptives, Oral|contraceptives, oral|mesh-list
20565155|NCT02003209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20565156|NCT02003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565157|NCT02003209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20565158|NCT02003209|Hormone Antagonists|hormone antagonists|mesh-ancestor
20565159|NCT02003209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20565160|NCT02003313|Vaccines|vaccines|mesh-list
20565161|NCT02003313|Immunologic Factors|immunologic factors|mesh-ancestor
20565162|NCT02003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565163|NCT02003456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
20565164|NCT02003456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20565165|NCT02003456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565166|NCT02003495|Vaccines|vaccines|mesh-list
20565167|NCT02003495|Immunologic Factors|immunologic factors|mesh-ancestor
20565168|NCT02003495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565169|NCT02003664|Baclofen|baclofen|mesh-list
20565170|NCT02003664|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20565171|NCT02003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565172|NCT02003664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20565173|NCT02003664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565174|NCT02003664|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
20565175|NCT02003664|GABA Agonists|gaba agonists|mesh-ancestor
20565176|NCT02003664|GABA Agents|gaba agents|mesh-ancestor
20565177|NCT02003664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20565178|NCT02003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565179|NCT02003677|Insulin|insulin|mesh-list
20565180|NCT02003677|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20565181|NCT02003677|Insulin Aspart|insulin aspart|mesh-list
20565182|NCT02003677|Insulin, Long-Acting|insulin, long-acting|mesh-list
20565183|NCT02003677|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20565184|NCT02003677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20565185|NCT02003677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565186|NCT02003768|Propofol|propofol|mesh-list
20565187|NCT02003768|Desflurane|desflurane|mesh-list
20011542|NCT02367833|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
20011543|NCT02367833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20011544|NCT02367833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011545|NCT02367833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20011546|NCT02367833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20011547|NCT02367859|Trametinib|trametinib|mesh-list
20011548|NCT02367859|Dabrafenib|dabrafenib|mesh-list
20011549|NCT02367859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011550|NCT02367859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20011551|NCT02367859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011552|NCT02367859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011553|NCT02367872|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
20011554|NCT02367872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011555|NCT02367872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011556|NCT02368093|Dextromethorphan|dextromethorphan|mesh-list
20011557|NCT02368093|Antitussive Agents|antitussive agents|mesh-ancestor
20011558|NCT02368093|Respiratory System Agents|respiratory system agents|mesh-ancestor
20011559|NCT02368093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20011560|NCT02368093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20011561|NCT02368093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011562|NCT02368093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011563|NCT02368093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011564|NCT02368314|Enoxaparin|enoxaparin|mesh-list
20011565|NCT02368314|Enoxaparin sodium|enoxaparin sodium|mesh-list
20011566|NCT02368314|Anticoagulants|anticoagulants|mesh-ancestor
20011567|NCT02368314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20011568|NCT02368314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20011569|NCT02368314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011570|NCT02368431|Zonisamide|zonisamide|mesh-list
20011571|NCT02368431|Anticonvulsants|anticonvulsants|mesh-ancestor
20011572|NCT02368431|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20011573|NCT02368431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20011574|NCT02368431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011575|NCT02368431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20011576|NCT02368431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011577|NCT02368457|Tocopherols|tocopherols|mesh-list
20011578|NCT02368457|Vitamin E|vitamin e|mesh-list
20011579|NCT02368457|Tocotrienols|tocotrienols|mesh-list
20011580|NCT02368457|alpha-Tocopherol|alpha-tocopherol|mesh-list
20011581|NCT02368457|Pentoxifylline|pentoxifylline|mesh-list
20011582|NCT02368457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20011583|NCT02368457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011584|NCT02368457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011585|NCT02368457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20011586|NCT02368457|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20011587|NCT02368457|Protective Agents|protective agents|mesh-ancestor
20011588|NCT02368457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011589|NCT02368457|Vasodilator Agents|vasodilator agents|mesh-ancestor
20011590|NCT02368457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20011591|NCT02368457|Antioxidants|antioxidants|mesh-ancestor
20011592|NCT02368457|Vitamins|vitamins|mesh-ancestor
20011593|NCT02368457|Micronutrients|micronutrients|mesh-ancestor
20011594|NCT02369068|Triamcinolone|triamcinolone|mesh-list
20565188|NCT02003768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20565189|NCT02003768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20565190|NCT02003768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565191|NCT02003768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20565192|NCT02003768|Anesthetics, General|anesthetics, general|mesh-ancestor
20565193|NCT02003768|Anesthetics|anesthetics|mesh-ancestor
20565194|NCT02003768|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19460766|NCT03349957|Idarubicin|idarubicin|mesh-list
19460767|NCT03349957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19460768|NCT03349957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460769|NCT03349957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19460770|NCT03349957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19460771|NCT03349957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19460772|NCT03349957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460773|NCT03349866|Capecitabine|capecitabine|mesh-list
19460774|NCT03349866|Oxaliplatin|oxaliplatin|mesh-list
19460775|NCT03349866|Apatinib|apatinib|mesh-list
19460776|NCT03349866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19460777|NCT03349866|Antimetabolites|antimetabolites|mesh-ancestor
19460778|NCT03349866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460779|NCT03349866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460780|NCT03349866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19460781|NCT03349866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19460782|NCT03349840|Insulin|insulin|mesh-list
20011595|NCT02369068|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20011596|NCT02369068|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20011597|NCT02369068|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20011598|NCT02369068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20011599|NCT02369068|Glucocorticoids|glucocorticoids|mesh-ancestor
20011600|NCT02369068|Hormones|hormones|mesh-ancestor
20011601|NCT02369068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20011602|NCT02369068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011603|NCT02369068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20011604|NCT02369068|Immunologic Factors|immunologic factors|mesh-ancestor
20011605|NCT02369068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011606|NCT02369068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20011607|NCT02369068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20011608|NCT02369068|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20011609|NCT02369068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20011610|NCT02369068|Cholinergic Agents|cholinergic agents|mesh-ancestor
20011611|NCT02369068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011612|NCT02369159|Oseltamivir|oseltamivir|mesh-list
20011613|NCT02369159|Peramivir|peramivir|mesh-list
20011614|NCT02369159|Antiviral Agents|antiviral agents|mesh-ancestor
20011615|NCT02369159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20011616|NCT02369159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011617|NCT02369159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011618|NCT02369172|Bupropion|bupropion|mesh-list
20011619|NCT02369172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20011620|NCT02369172|Antidepressive Agents|antidepressive agents|mesh-ancestor
20011621|NCT02369172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20011622|NCT02369172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20565195|NCT02003885|Desflurane|desflurane|mesh-list
20565196|NCT02003885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20565197|NCT02003885|Anesthetics, General|anesthetics, general|mesh-ancestor
19460783|NCT03349840|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19460784|NCT03349840|Insulin Glargine|insulin glargine|mesh-list
19460785|NCT03349840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19460786|NCT03349840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460787|NCT03349827|Apatinib|apatinib|mesh-list
20565198|NCT02003885|Anesthetics|anesthetics|mesh-ancestor
20565199|NCT02003885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20565200|NCT02003885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565201|NCT02004067|Cyclosporine|cyclosporine|mesh-list
20565202|NCT02004067|Castor Oil|castor oil|mesh-list
20565203|NCT02004067|Cyclosporins|cyclosporins|mesh-list
20565204|NCT02004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565205|NCT02004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565206|NCT02004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20565207|NCT02004067|Immunologic Factors|immunologic factors|mesh-ancestor
20565208|NCT02004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565209|NCT02004067|Antifungal Agents|antifungal agents|mesh-ancestor
20565210|NCT02004067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20565211|NCT02004067|Dermatologic Agents|dermatologic agents|mesh-ancestor
20011623|NCT02369172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20011624|NCT02369172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20565212|NCT02004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20565213|NCT02004067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20565214|NCT02004067|Cathartics|cathartics|mesh-ancestor
19460788|NCT03349827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460789|NCT03349827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19460790|NCT03349827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19460791|NCT03349827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460792|NCT03349684|Metformin|metformin|mesh-list
19460793|NCT03349684|Acarbose|acarbose|mesh-list
19460794|NCT03349684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19460795|NCT03349684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460796|NCT03349684|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
19460797|NCT03349684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565215|NCT02004067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20565216|NCT02004171|Nicotine|nicotine|mesh-list
20565217|NCT02004171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20565218|NCT02004171|Autonomic Agents|autonomic agents|mesh-ancestor
20565219|NCT02004171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565220|NCT02004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565221|NCT02004171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19460798|NCT03349684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565222|NCT02004171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20565223|NCT02004171|Cholinergic Agents|cholinergic agents|mesh-ancestor
20565224|NCT02004171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20565225|NCT02004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565226|NCT02004184|Pemetrexed|pemetrexed|mesh-list
19460799|NCT03349658|Anesthetics|anesthetics|mesh-list
19460800|NCT03349658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19460801|NCT03349658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460802|NCT03349619|Resveratrol|resveratrol|mesh-list
19460803|NCT03349619|Antioxidants|antioxidants|mesh-ancestor
19460804|NCT03349619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460805|NCT03349619|Protective Agents|protective agents|mesh-ancestor
19460806|NCT03349619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460807|NCT03349619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19460808|NCT03349619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19460809|NCT03349606|Amphetamine|amphetamine|mesh-list
19460810|NCT03349606|Dextroamphetamine|dextroamphetamine|mesh-list
19460811|NCT03349606|FLB 457|flb 457|mesh-list
19460812|NCT03349606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19460813|NCT03349606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460814|NCT03349606|Sympathomimetics|sympathomimetics|mesh-ancestor
19460815|NCT03349606|Autonomic Agents|autonomic agents|mesh-ancestor
19460816|NCT03349606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460817|NCT03349606|Dopamine Agents|dopamine agents|mesh-ancestor
19460818|NCT03349606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19460819|NCT03349606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460820|NCT03349606|Adrenergic Agents|adrenergic agents|mesh-ancestor
19460821|NCT03349606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19460822|NCT03349606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19460823|NCT03349606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19460824|NCT03349606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19460825|NCT03349606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19460826|NCT03349489|Insulin|insulin|mesh-list
19460827|NCT03349489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19460828|NCT03349489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19460829|NCT03349489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460830|NCT03349424|Somatostatin|somatostatin|mesh-list
19460831|NCT03349424|Hormones|hormones|mesh-ancestor
19460832|NCT03349424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19460833|NCT03349424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460834|NCT03349359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
19460835|NCT03349359|Antiviral Agents|antiviral agents|mesh-ancestor
19460836|NCT03349359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19460837|NCT03349346|Rituximab|rituximab|mesh-list
19460838|NCT03349346|Carboplatin|carboplatin|mesh-list
19460839|NCT03349346|Etoposide|etoposide|mesh-list
19460840|NCT03349346|Ifosfamide|ifosfamide|mesh-list
19460841|NCT03349346|Idelalisib|idelalisib|mesh-list
19460842|NCT03349346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19460843|NCT03349346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460844|NCT03349346|Immunologic Factors|immunologic factors|mesh-ancestor
19460845|NCT03349346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460846|NCT03349346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19460847|NCT03349346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19460848|NCT03349346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19460849|NCT03349346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19460850|NCT03349346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19460851|NCT03349346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460852|NCT03349346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19460853|NCT03349346|Alkylating Agents|alkylating agents|mesh-ancestor
19460854|NCT03349216|Anesthetics|anesthetics|mesh-list
19460855|NCT03349216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19460856|NCT03349216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460857|NCT03349190|Ulipristal acetate|ulipristal acetate|mesh-list
19460858|NCT03349190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19460859|NCT03349190|Contraceptive Agents|contraceptive agents|mesh-ancestor
19460860|NCT03349190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19460861|NCT03349190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460862|NCT03349190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19460863|NCT03349177|Cyclophosphamide|cyclophosphamide|mesh-list
19460864|NCT03349177|Docetaxel|docetaxel|mesh-list
20565227|NCT02004184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565228|NCT02004184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565229|NCT02004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565230|NCT02004184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20565231|NCT02004184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20565232|NCT02004197|Amoxicillin|amoxicillin|mesh-list
20565233|NCT02004197|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
20565234|NCT02004197|Bismuth|bismuth|mesh-list
20565235|NCT02004197|Ranitidine|ranitidine|mesh-list
20565236|NCT02004197|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
20565237|NCT02004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565238|NCT02004197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20565239|NCT02004197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20565240|NCT02004197|Antacids|antacids|mesh-ancestor
20565241|NCT02004197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20565242|NCT02004197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20565243|NCT02004197|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
20565244|NCT02004197|Histamine Antagonists|histamine antagonists|mesh-ancestor
20565245|NCT02004197|Histamine Agents|histamine agents|mesh-ancestor
20565246|NCT02004197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20565247|NCT02004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565248|NCT02004301|Diclofenac|diclofenac|mesh-list
20565249|NCT02004301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20565250|NCT02004301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20565251|NCT02004301|Analgesics|analgesics|mesh-ancestor
20565252|NCT02004301|Sensory System Agents|sensory system agents|mesh-ancestor
20565253|NCT02004301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565254|NCT02004301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565255|NCT02004301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20565256|NCT02004301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20565257|NCT02004301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20565258|NCT02004301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565259|NCT02004301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565260|NCT02004314|Chloroquine|chloroquine|mesh-list
20565261|NCT02004314|Amebicides|amebicides|mesh-ancestor
20565262|NCT02004314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20565263|NCT02004314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20565264|NCT02004314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20565265|NCT02004314|Antimalarials|antimalarials|mesh-ancestor
20565266|NCT02004314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20565267|NCT02004418|Choline|choline|mesh-list
20565268|NCT02004418|Lipotropic Agents|lipotropic agents|mesh-ancestor
20565269|NCT02004418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20565270|NCT02004418|Antimetabolites|antimetabolites|mesh-ancestor
20565271|NCT02004418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565272|NCT02004418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20565273|NCT02004418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20565274|NCT02004418|Nootropic Agents|nootropic agents|mesh-ancestor
20565275|NCT02004509|Anticoagulants|anticoagulants|mesh-list
19460865|NCT03349177|Fluorouracil|fluorouracil|mesh-list
19460866|NCT03349177|Epirubicin|epirubicin|mesh-list
19460867|NCT03349177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19460868|NCT03349177|Immunologic Factors|immunologic factors|mesh-ancestor
19460869|NCT03349177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460870|NCT03349177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19460871|NCT03349177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19460872|NCT03349177|Alkylating Agents|alkylating agents|mesh-ancestor
19460873|NCT03349177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460874|NCT03349177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460875|NCT03349177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19460876|NCT03349177|Tubulin Modulators|tubulin modulators|mesh-ancestor
20565276|NCT02004574|Betamethasone|betamethasone|mesh-list
20565277|NCT02004574|Betamethasone Valerate|betamethasone valerate|mesh-list
20565278|NCT02004574|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
20565279|NCT02004574|Betamethasone benzoate|betamethasone benzoate|mesh-list
20565280|NCT02004574|Calcipotriene|calcipotriene|mesh-list
20565281|NCT02004574|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
20565282|NCT02004574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20565283|NCT02004574|Glucocorticoids|glucocorticoids|mesh-ancestor
20565284|NCT02004574|Hormones|hormones|mesh-ancestor
20565285|NCT02004574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20565286|NCT02004574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565287|NCT02004574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20565288|NCT02004574|Respiratory System Agents|respiratory system agents|mesh-ancestor
20565289|NCT02004574|Dermatologic Agents|dermatologic agents|mesh-ancestor
20565290|NCT02004652|Prucalopride|prucalopride|mesh-list
20565291|NCT02004652|Laxatives|laxatives|mesh-ancestor
20565292|NCT02004652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20565293|NCT02004652|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
19460877|NCT03349177|Antimitotic Agents|antimitotic agents|mesh-ancestor
19460878|NCT03349177|Mitosis Modulators|mitosis modulators|mesh-ancestor
19460879|NCT03349177|Antimetabolites|antimetabolites|mesh-ancestor
19460880|NCT03349177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19460881|NCT03349177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19460882|NCT03349177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19460883|NCT03349177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19460884|NCT03349177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19460885|NCT03349112|Lidocaine|lidocaine|mesh-list
19460886|NCT03349112|Anesthetics, Local|anesthetics, local|mesh-ancestor
19460887|NCT03349112|Anesthetics|anesthetics|mesh-ancestor
19460888|NCT03349112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19460889|NCT03349112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565294|NCT02004652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20565295|NCT02004652|Serotonin Agents|serotonin agents|mesh-ancestor
20565296|NCT02004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20565297|NCT02004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565298|NCT02004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565299|NCT02004769|Docetaxel|docetaxel|mesh-list
20565300|NCT02004769|Capecitabine|capecitabine|mesh-list
20565301|NCT02004769|Trastuzumab|trastuzumab|mesh-list
20565302|NCT02004769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565303|NCT02004769|Tubulin Modulators|tubulin modulators|mesh-ancestor
20565304|NCT02004769|Antimitotic Agents|antimitotic agents|mesh-ancestor
20565305|NCT02004769|Mitosis Modulators|mitosis modulators|mesh-ancestor
20565306|NCT02004769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565307|NCT02004769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20565308|NCT02004769|Antimetabolites|antimetabolites|mesh-ancestor
20565309|NCT02004769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20565310|NCT02004782|Prednisolone|prednisolone|mesh-list
20565311|NCT02004782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20565312|NCT02004782|Glucocorticoids|glucocorticoids|mesh-ancestor
20565313|NCT02004782|Hormones|hormones|mesh-ancestor
20565314|NCT02004782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20565315|NCT02004782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565316|NCT02004782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20565317|NCT02004782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565318|NCT02004860|Ciclopirox|ciclopirox|mesh-list
20565319|NCT02004860|Tacrolimus|tacrolimus|mesh-list
20565320|NCT02004860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20565321|NCT02004860|Immunologic Factors|immunologic factors|mesh-ancestor
20565322|NCT02004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565323|NCT02004860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20565324|NCT02004860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565325|NCT02004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565326|NCT02004860|Antifungal Agents|antifungal agents|mesh-ancestor
20565327|NCT02004860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20565328|NCT02004899|Fentanyl|fentanyl|mesh-list
20565329|NCT02004899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20565330|NCT02004899|Narcotics|narcotics|mesh-ancestor
19460890|NCT03349112|Sensory System Agents|sensory system agents|mesh-ancestor
19460891|NCT03349112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460892|NCT03349112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19460893|NCT03349112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20565331|NCT02004899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20565332|NCT02004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565333|NCT02004899|Analgesics|analgesics|mesh-ancestor
20565334|NCT02004899|Sensory System Agents|sensory system agents|mesh-ancestor
20565335|NCT02004899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565336|NCT02004899|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20565337|NCT02004899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20565338|NCT02004899|Anesthetics, General|anesthetics, general|mesh-ancestor
20565339|NCT02004899|Anesthetics|anesthetics|mesh-ancestor
20565340|NCT02005068|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
20565341|NCT02005068|Cephalosporins|cephalosporins|mesh-list
20565342|NCT02005068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20565343|NCT02005068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20565344|NCT02005107|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20565345|NCT02005107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20565346|NCT02005107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20565347|NCT02005107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20565348|NCT02005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565349|NCT02005107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20565350|NCT02005107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565351|NCT02005107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20565352|NCT02005107|Antidepressive Agents|antidepressive agents|mesh-ancestor
20565353|NCT02005107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20565354|NCT02005120|Bevacizumab|bevacizumab|mesh-list
20565355|NCT02005120|Endostatins|endostatins|mesh-list
20565356|NCT02005120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20565357|NCT02005120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565358|NCT02005120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20565359|NCT02005120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20565360|NCT02005120|Growth Substances|growth substances|mesh-ancestor
20565361|NCT02005120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565362|NCT02005120|Growth Inhibitors|growth inhibitors|mesh-ancestor
20565363|NCT02005289|Lenalidomide|lenalidomide|mesh-list
20565364|NCT02005289|Immunologic Factors|immunologic factors|mesh-ancestor
20565365|NCT02005289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565366|NCT02005289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20565367|NCT02005289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20565368|NCT02005289|Growth Substances|growth substances|mesh-ancestor
20565369|NCT02005289|Growth Inhibitors|growth inhibitors|mesh-ancestor
20565370|NCT02005289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565371|NCT02005302|Vitamin D|vitamin d|mesh-list
20565372|NCT02005302|Ergocalciferols|ergocalciferols|mesh-list
20565373|NCT02005302|Cholecalciferol|cholecalciferol|mesh-list
20565374|NCT02005302|Vitamins|vitamins|mesh-list
19460894|NCT03349112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19460895|NCT03349112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19460896|NCT03349112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460897|NCT03349008|Entecavir|entecavir|mesh-list
19460898|NCT03349008|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
19460899|NCT03349008|Antiviral Agents|antiviral agents|mesh-ancestor
19460900|NCT03349008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19460901|NCT03349008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19460902|NCT03348969|Mitomycins|mitomycins|mesh-list
19460903|NCT03348969|Mitomycin|mitomycin|mesh-list
19460904|NCT03348969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19460905|NCT03348969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19460906|NCT03348969|Alkylating Agents|alkylating agents|mesh-ancestor
19460907|NCT03348969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565375|NCT02005302|Micronutrients|micronutrients|mesh-ancestor
20565376|NCT02005302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565377|NCT02005302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20565378|NCT02005302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20565379|NCT02005315|Gemcitabine|gemcitabine|mesh-list
20565380|NCT02005315|Paclitaxel|paclitaxel|mesh-list
20565381|NCT02005315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20565382|NCT02005315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565383|NCT02005315|Tubulin Modulators|tubulin modulators|mesh-ancestor
19460908|NCT03348969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19460909|NCT03348969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19460910|NCT03348917|Chlorhexidine|chlorhexidine|mesh-list
19460911|NCT03348917|Povidone-Iodine|povidone-iodine|mesh-list
19460912|NCT03348917|Povidone|povidone|mesh-list
19460913|NCT03348917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19460914|NCT03348917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20565384|NCT02005315|Antimitotic Agents|antimitotic agents|mesh-ancestor
20565385|NCT02005315|Mitosis Modulators|mitosis modulators|mesh-ancestor
20565386|NCT02005315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565387|NCT02005315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20565388|NCT02005315|Antimetabolites|antimetabolites|mesh-ancestor
20565389|NCT02005315|Antiviral Agents|antiviral agents|mesh-ancestor
20565390|NCT02005315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20565391|NCT02005315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565392|NCT02005315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20011625|NCT02369172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011626|NCT02369172|Dopamine Agents|dopamine agents|mesh-ancestor
20011627|NCT02369172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011628|NCT02369172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011629|NCT02369172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20565393|NCT02005315|Immunologic Factors|immunologic factors|mesh-ancestor
20565394|NCT02005315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565395|NCT02005419|Metformin|metformin|mesh-list
20565396|NCT02005419|Gemcitabine|gemcitabine|mesh-list
20565397|NCT02005419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20565398|NCT02005419|Antimetabolites|antimetabolites|mesh-ancestor
20565399|NCT02005419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565400|NCT02005419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565401|NCT02005419|Antiviral Agents|antiviral agents|mesh-ancestor
20565402|NCT02005419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20565403|NCT02005419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565404|NCT02005419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20565405|NCT02005419|Immunologic Factors|immunologic factors|mesh-ancestor
20565406|NCT02005419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565407|NCT02005419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20565408|NCT02005523|RNS60|rns60|mesh-list
20565409|NCT02005523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20565410|NCT02005523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20565411|NCT02005523|Analgesics|analgesics|mesh-ancestor
20565412|NCT02005523|Sensory System Agents|sensory system agents|mesh-ancestor
20565413|NCT02005523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20011630|NCT02369172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20011631|NCT02369172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011632|NCT02369211|Acetaminophen|acetaminophen|mesh-list
20011633|NCT02369211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20011634|NCT02369211|Analgesics|analgesics|mesh-ancestor
20011635|NCT02369211|Sensory System Agents|sensory system agents|mesh-ancestor
20565414|NCT02005523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565415|NCT02005523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19460915|NCT03348917|Disinfectants|disinfectants|mesh-ancestor
19460916|NCT03348917|Plasma Substitutes|plasma substitutes|mesh-ancestor
19460917|NCT03348917|Blood Substitutes|blood substitutes|mesh-ancestor
19460918|NCT03348826|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20565416|NCT02005523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20565417|NCT02005523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20565418|NCT02005575|Dexamethasone|dexamethasone|mesh-list
20565419|NCT02005575|Bupivacaine|bupivacaine|mesh-list
20565420|NCT02005575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20565421|NCT02005575|Antiemetics|antiemetics|mesh-ancestor
20565422|NCT02005575|Autonomic Agents|autonomic agents|mesh-ancestor
20565423|NCT02005575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565424|NCT02005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565425|NCT02005575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20565426|NCT02005575|Glucocorticoids|glucocorticoids|mesh-ancestor
20565427|NCT02005575|Hormones|hormones|mesh-ancestor
20565428|NCT02005575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20565429|NCT02005575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19460919|NCT03348826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19460920|NCT03348826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19460921|NCT03348826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19460922|NCT03348826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460923|NCT03348800|Anesthetics|anesthetics|mesh-list
19460924|NCT03348800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19460925|NCT03348800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460926|NCT03348735|Lidocaine|lidocaine|mesh-list
19460927|NCT03348735|Pregabalin|pregabalin|mesh-list
19460928|NCT03348735|Capsaicin|capsaicin|mesh-list
19460929|NCT03348735|Anesthetics, Local|anesthetics, local|mesh-ancestor
19460930|NCT03348735|Anesthetics|anesthetics|mesh-ancestor
19460931|NCT03348735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19460932|NCT03348735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460933|NCT03348735|Sensory System Agents|sensory system agents|mesh-ancestor
19460934|NCT03348735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460935|NCT03348735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19460936|NCT03348735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19460937|NCT03348735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19460938|NCT03348735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19460939|NCT03348735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460940|NCT03348735|Analgesics|analgesics|mesh-ancestor
19460941|NCT03348735|Anticonvulsants|anticonvulsants|mesh-ancestor
19460942|NCT03348735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19460943|NCT03348735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19460944|NCT03348735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19460945|NCT03348735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19460946|NCT03348735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19460947|NCT03348735|Antipruritics|antipruritics|mesh-ancestor
19460948|NCT03348735|Dermatologic Agents|dermatologic agents|mesh-ancestor
19460949|NCT03348696|Dexamethasone|dexamethasone|mesh-list
19460950|NCT03348696|Dexamethasone acetate|dexamethasone acetate|mesh-list
19460951|NCT03348696|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19460952|NCT03348696|BB 1101|bb 1101|mesh-list
19460953|NCT03348696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19460954|NCT03348696|Antiemetics|antiemetics|mesh-ancestor
19460955|NCT03348696|Autonomic Agents|autonomic agents|mesh-ancestor
19460956|NCT03348696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460957|NCT03348696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460958|NCT03348696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19460959|NCT03348696|Glucocorticoids|glucocorticoids|mesh-ancestor
19460960|NCT03348696|Hormones|hormones|mesh-ancestor
19460961|NCT03348696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19460962|NCT03348696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19460963|NCT03348696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565430|NCT02005575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565431|NCT02005575|Anesthetics, Local|anesthetics, local|mesh-ancestor
20565432|NCT02005575|Anesthetics|anesthetics|mesh-ancestor
20565433|NCT02005575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20565434|NCT02005575|Sensory System Agents|sensory system agents|mesh-ancestor
20565435|NCT02005588|Iron|iron|mesh-list
20565436|NCT02005588|Ferrous fumarate|ferrous fumarate|mesh-list
20565437|NCT02005588|Iron Chelating Agents|iron chelating agents|mesh-list
20565438|NCT02005588|Trace Elements|trace elements|mesh-ancestor
20565439|NCT02005588|Micronutrients|micronutrients|mesh-ancestor
20565440|NCT02005588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565441|NCT02005588|Chelating Agents|chelating agents|mesh-ancestor
20565442|NCT02005588|Sequestering Agents|sequestering agents|mesh-ancestor
20565443|NCT02005588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565444|NCT02005653|Doxycycline|doxycycline|mesh-list
20565445|NCT02005653|Albendazole|albendazole|mesh-list
20565446|NCT02005653|Diethylcarbamazine|diethylcarbamazine|mesh-list
20565447|NCT02005653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20565448|NCT02005653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20565449|NCT02005653|Antimalarials|antimalarials|mesh-ancestor
20565450|NCT02005653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20565451|NCT02005653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20565452|NCT02005653|Anthelmintics|anthelmintics|mesh-ancestor
20565453|NCT02005653|Anticestodal Agents|anticestodal agents|mesh-ancestor
20565454|NCT02005653|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
20565455|NCT02005653|Tubulin Modulators|tubulin modulators|mesh-ancestor
20565456|NCT02005653|Antimitotic Agents|antimitotic agents|mesh-ancestor
20565457|NCT02005653|Mitosis Modulators|mitosis modulators|mesh-ancestor
20565458|NCT02005653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565459|NCT02005653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565460|NCT02005653|Filaricides|filaricides|mesh-ancestor
20565461|NCT02005653|Antinematodal Agents|antinematodal agents|mesh-ancestor
20565462|NCT02005653|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
20565463|NCT02005653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565464|NCT02005718|Cholecalciferol|cholecalciferol|mesh-list
20565465|NCT02005718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20565466|NCT02005718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565467|NCT02005718|Vitamins|vitamins|mesh-ancestor
20565468|NCT02005718|Micronutrients|micronutrients|mesh-ancestor
20565469|NCT02005718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20565470|NCT02005757|Mizoribine|mizoribine|mesh-list
20565471|NCT02005757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19460964|NCT03348696|Protease Inhibitors|protease inhibitors|mesh-ancestor
19460965|NCT03348696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011636|NCT02369211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565472|NCT02005757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20565473|NCT02005757|Analgesics|analgesics|mesh-ancestor
20565474|NCT02005757|Sensory System Agents|sensory system agents|mesh-ancestor
20565475|NCT02005757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565476|NCT02005757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565477|NCT02005757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20565478|NCT02005757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20565479|NCT02005757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20565480|NCT02005757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20565481|NCT02005757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20565482|NCT02005757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565483|NCT02005757|Antimalarials|antimalarials|mesh-ancestor
20565484|NCT02005757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20565485|NCT02005757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20565486|NCT02005757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565487|NCT02005757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565488|NCT02005757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20565489|NCT02005757|Immunologic Factors|immunologic factors|mesh-ancestor
20565490|NCT02005770|Propofol|propofol|mesh-list
20565491|NCT02005770|Sevoflurane|sevoflurane|mesh-list
20565492|NCT02005770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20565493|NCT02005770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20565494|NCT02005770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565495|NCT02005770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20565496|NCT02005770|Anesthetics, General|anesthetics, general|mesh-ancestor
20565497|NCT02005770|Anesthetics|anesthetics|mesh-ancestor
20565498|NCT02005770|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20565499|NCT02005770|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20565500|NCT02005783|Cyclophosphamide|cyclophosphamide|mesh-list
20565501|NCT02005783|Docetaxel|docetaxel|mesh-list
20565502|NCT02005783|Epirubicin|epirubicin|mesh-list
20565503|NCT02005783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20565504|NCT02005783|Immunologic Factors|immunologic factors|mesh-ancestor
20565505|NCT02005783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565506|NCT02005783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20565507|NCT02005783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20565508|NCT02005783|Alkylating Agents|alkylating agents|mesh-ancestor
20565509|NCT02005783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565510|NCT02005783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565511|NCT02005783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20565512|NCT02005783|Tubulin Modulators|tubulin modulators|mesh-ancestor
20565513|NCT02005783|Antimitotic Agents|antimitotic agents|mesh-ancestor
20565514|NCT02005783|Mitosis Modulators|mitosis modulators|mesh-ancestor
20565515|NCT02005783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20565516|NCT02005783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20565517|NCT02005783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20565518|NCT02005783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565519|NCT02005822|Valganciclovir|valganciclovir|mesh-list
20565520|NCT02005822|Antiviral Agents|antiviral agents|mesh-ancestor
20565521|NCT02005822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20565522|NCT02005848|Protease Inhibitors|protease inhibitors|mesh-list
20565523|NCT02005848|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
20565524|NCT02005848|Protein C Inhibitor|protein c inhibitor|mesh-list
20565525|NCT02005848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565526|NCT02005848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565527|NCT02005848|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20011637|NCT02369211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011638|NCT02369211|Antipyretics|antipyretics|mesh-ancestor
20011639|NCT02369341|Vaccines|vaccines|mesh-list
20011640|NCT02369341|Immunologic Factors|immunologic factors|mesh-ancestor
20011641|NCT02369341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011642|NCT02369484|Afatinib|afatinib|mesh-list
20011643|NCT02369484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011644|NCT02369484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20011645|NCT02369484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565528|NCT02005848|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20565529|NCT02006043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20565530|NCT02006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565531|NCT02006043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20565532|NCT02006043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565533|NCT02006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565534|NCT02006173|Lidocaine|lidocaine|mesh-list
20565535|NCT02006173|Anesthetics, Local|anesthetics, local|mesh-ancestor
20565536|NCT02006173|Anesthetics|anesthetics|mesh-ancestor
20565537|NCT02006173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20565538|NCT02006173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565539|NCT02006173|Sensory System Agents|sensory system agents|mesh-ancestor
20565540|NCT02006173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565541|NCT02006173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20565542|NCT02006173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20565543|NCT02006173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20565544|NCT02006173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20565545|NCT02006173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565546|NCT02006225|Plerixafor|plerixafor|mesh-list
20565547|NCT02006225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20565548|NCT02006225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20565549|NCT02006225|Antiviral Agents|antiviral agents|mesh-ancestor
20565550|NCT02006225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20565551|NCT02006277|Crizotinib|crizotinib|mesh-list
20565552|NCT02006277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20565553|NCT02006277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565554|NCT02006277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20565555|NCT02006277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565556|NCT02006277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565557|NCT02006355|Ropivacaine|ropivacaine|mesh-list
20565558|NCT02006355|Anesthetics, Local|anesthetics, local|mesh-ancestor
20565559|NCT02006355|Anesthetics|anesthetics|mesh-ancestor
20565560|NCT02006355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20565561|NCT02006355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565562|NCT02006355|Sensory System Agents|sensory system agents|mesh-ancestor
20565563|NCT02006355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565564|NCT02006485|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20565565|NCT02006485|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20565566|NCT02006485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20565567|NCT02006485|Alkylating Agents|alkylating agents|mesh-ancestor
20565568|NCT02006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565569|NCT02006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565570|NCT02006485|Immunologic Factors|immunologic factors|mesh-ancestor
20565571|NCT02006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565572|NCT02006498|Silymarin|silymarin|mesh-list
20565573|NCT02006498|Antioxidants|antioxidants|mesh-ancestor
20565574|NCT02006498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565575|NCT02006498|Protective Agents|protective agents|mesh-ancestor
20565576|NCT02006498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565577|NCT02006589|Candesartan|candesartan|mesh-list
20565578|NCT02006589|Candesartan cilexetil|candesartan cilexetil|mesh-list
20565579|NCT02006589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20565580|NCT02006589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20565581|NCT02006589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20565582|NCT02006589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565583|NCT02006602|Candesartan|candesartan|mesh-list
20565584|NCT02006602|Candesartan cilexetil|candesartan cilexetil|mesh-list
20565585|NCT02006602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20565586|NCT02006602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20565587|NCT02006602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20565588|NCT02006602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565589|NCT02006745|Ribavirin|ribavirin|mesh-list
20565590|NCT02006745|Antimetabolites|antimetabolites|mesh-ancestor
20565591|NCT02006745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565592|NCT02006745|Antiviral Agents|antiviral agents|mesh-ancestor
20565593|NCT02006745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20565594|NCT02006849|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20565595|NCT02006849|Hormones|hormones|mesh-ancestor
20565596|NCT02006849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20565597|NCT02006849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565598|NCT02006914|Chromium|chromium|mesh-list
20565599|NCT02006914|Picolinic acid|picolinic acid|mesh-list
20565600|NCT02006914|Trace Elements|trace elements|mesh-ancestor
20565601|NCT02006914|Micronutrients|micronutrients|mesh-ancestor
20565602|NCT02006914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565603|NCT02006914|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20565604|NCT02006914|Chelating Agents|chelating agents|mesh-ancestor
20565605|NCT02006914|Sequestering Agents|sequestering agents|mesh-ancestor
20565606|NCT02006914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565607|NCT02006966|Lidocaine|lidocaine|mesh-list
20565608|NCT02006966|Anesthetics, Local|anesthetics, local|mesh-ancestor
20565609|NCT02006966|Anesthetics|anesthetics|mesh-ancestor
20565610|NCT02006966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20565611|NCT02006966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565612|NCT02006966|Sensory System Agents|sensory system agents|mesh-ancestor
20565613|NCT02006966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565614|NCT02006966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20565615|NCT02006966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20565616|NCT02006966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20565617|NCT02006966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20565618|NCT02006966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565619|NCT02007005|Viscum album peptide|viscum album peptide|mesh-list
20565620|NCT02007005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565621|NCT02007005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20565622|NCT02007005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20565623|NCT02007005|Antiviral Agents|antiviral agents|mesh-ancestor
20565624|NCT02007005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20565625|NCT02007148|Docetaxel|docetaxel|mesh-list
20565626|NCT02007148|Capecitabine|capecitabine|mesh-list
19460966|NCT03348696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460967|NCT03348527|Hydroxyflutamide|hydroxyflutamide|mesh-list
19460968|NCT03348527|Androgen Antagonists|androgen antagonists|mesh-ancestor
19460969|NCT03348527|Hormone Antagonists|hormone antagonists|mesh-ancestor
19460970|NCT03348527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19460971|NCT03348527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460972|NCT03348462|Anthralin|anthralin|mesh-list
19460973|NCT03348462|Dermatologic Agents|dermatologic agents|mesh-ancestor
19460974|NCT03348423|Fentanyl|fentanyl|mesh-list
19460975|NCT03348423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19460976|NCT03348423|Narcotics|narcotics|mesh-ancestor
19460977|NCT03348423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19460978|NCT03348423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460979|NCT03348423|Analgesics|analgesics|mesh-ancestor
19460980|NCT03348423|Sensory System Agents|sensory system agents|mesh-ancestor
19460981|NCT03348423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19460982|NCT03348423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19460983|NCT03348423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19460984|NCT03348423|Anesthetics, General|anesthetics, general|mesh-ancestor
19460985|NCT03348423|Anesthetics|anesthetics|mesh-ancestor
19460986|NCT03348371|Ethanol|ethanol|mesh-list
19460987|NCT03348371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19460988|NCT03348371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19460989|NCT03348371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19460990|NCT03348371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19460991|NCT03348267|Caseins|caseins|mesh-list
19460992|NCT03348267|Chelating Agents|chelating agents|mesh-ancestor
19460993|NCT03348267|Sequestering Agents|sequestering agents|mesh-ancestor
19460994|NCT03348267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19460995|NCT03348254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19460996|NCT03348254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
19460997|NCT03348254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19460998|NCT03348254|Antitubercular Agents|antitubercular agents|mesh-ancestor
20011646|NCT02369484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565627|NCT02007148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565628|NCT02007148|Tubulin Modulators|tubulin modulators|mesh-ancestor
20565629|NCT02007148|Antimitotic Agents|antimitotic agents|mesh-ancestor
20565630|NCT02007148|Mitosis Modulators|mitosis modulators|mesh-ancestor
20565631|NCT02007148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565632|NCT02007148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20565633|NCT02007148|Antimetabolites|antimetabolites|mesh-ancestor
20565634|NCT02007161|Diclofenac|diclofenac|mesh-list
20565635|NCT02007161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20565636|NCT02007161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20565637|NCT02007161|Analgesics|analgesics|mesh-ancestor
20565638|NCT02007161|Sensory System Agents|sensory system agents|mesh-ancestor
20565639|NCT02007161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565640|NCT02007161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565641|NCT02007161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20565642|NCT02007161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20565643|NCT02007161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20565644|NCT02007161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565645|NCT02007161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565646|NCT02007174|Bevacizumab|bevacizumab|mesh-list
20565647|NCT02007174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20565648|NCT02007174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565649|NCT02007174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20565650|NCT02007174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20565651|NCT02007174|Growth Substances|growth substances|mesh-ancestor
20565652|NCT02007174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565653|NCT02007174|Growth Inhibitors|growth inhibitors|mesh-ancestor
20565654|NCT02007330|Lidocaine|lidocaine|mesh-list
20565655|NCT02007330|Anesthetics, Local|anesthetics, local|mesh-ancestor
20565656|NCT02007330|Anesthetics|anesthetics|mesh-ancestor
20565657|NCT02007330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20565658|NCT02007330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565659|NCT02007330|Sensory System Agents|sensory system agents|mesh-ancestor
20565660|NCT02007330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565661|NCT02007330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20565662|NCT02007330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20565663|NCT02007330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20565664|NCT02007330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20565665|NCT02007330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565666|NCT02007408|Lidocaine|lidocaine|mesh-list
20565667|NCT02007408|Anesthetics, Local|anesthetics, local|mesh-ancestor
20565668|NCT02007408|Anesthetics|anesthetics|mesh-ancestor
20565669|NCT02007408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20565670|NCT02007408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565671|NCT02007408|Sensory System Agents|sensory system agents|mesh-ancestor
20565672|NCT02007408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565673|NCT02007408|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20565674|NCT02007408|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20565675|NCT02007408|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20565676|NCT02007408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20565677|NCT02007408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565678|NCT02007447|Oxytocin|oxytocin|mesh-list
20565679|NCT02007447|Oxytocics|oxytocics|mesh-ancestor
20565680|NCT02007447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20565681|NCT02007447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565682|NCT02007603|Amoxicillin|amoxicillin|mesh-list
20565683|NCT02007603|Clavulanic Acids|clavulanic acids|mesh-list
20565684|NCT02007603|Clavulanic Acid|clavulanic acid|mesh-list
20565685|NCT02007603|Ampicillin|ampicillin|mesh-list
20565686|NCT02007603|Sulbactam|sulbactam|mesh-list
20565687|NCT02007603|Sultamicillin|sultamicillin|mesh-list
20565688|NCT02007603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20565689|NCT02007603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20565690|NCT02007603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565691|NCT02007603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565692|NCT02007603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20565693|NCT02007629|Riociguat|riociguat|mesh-list
20565694|NCT02007629|Enzyme Activators|enzyme activators|mesh-ancestor
20565695|NCT02007629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565696|NCT02007655|Apixaban|apixaban|mesh-list
20565697|NCT02007655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20565698|NCT02007655|Antithrombins|antithrombins|mesh-ancestor
20565699|NCT02007655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20565700|NCT02007655|Protease Inhibitors|protease inhibitors|mesh-ancestor
20565701|NCT02007655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565702|NCT02007655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565703|NCT02007655|Anticoagulants|anticoagulants|mesh-ancestor
20565704|NCT02007746|Liver Extracts|liver extracts|mesh-list
20565705|NCT02007746|Hematinics|hematinics|mesh-ancestor
20565706|NCT02007798|Dexmedetomidine|dexmedetomidine|mesh-list
20565707|NCT02007798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20565708|NCT02007798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20565709|NCT02007798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565710|NCT02007798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20565711|NCT02007798|Analgesics|analgesics|mesh-ancestor
20565712|NCT02007798|Sensory System Agents|sensory system agents|mesh-ancestor
20565713|NCT02007798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565714|NCT02007798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20565715|NCT02007798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20565716|NCT02007798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20565717|NCT02007798|Adrenergic Agents|adrenergic agents|mesh-ancestor
20565718|NCT02007798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20565719|NCT02007798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565720|NCT02007837|Aspirin|aspirin|mesh-list
20565721|NCT02007837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20565722|NCT02007837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20565723|NCT02007837|Analgesics|analgesics|mesh-ancestor
20565724|NCT02007837|Sensory System Agents|sensory system agents|mesh-ancestor
20565725|NCT02007837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565726|NCT02007837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565727|NCT02007837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20565728|NCT02007837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20565729|NCT02007837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20565730|NCT02007837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20565731|NCT02007837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565732|NCT02007837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20565733|NCT02007837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20565734|NCT02007837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565735|NCT02007837|Antipyretics|antipyretics|mesh-ancestor
20565736|NCT02007850|Ropivacaine|ropivacaine|mesh-list
20565737|NCT02007850|Anesthetics, Local|anesthetics, local|mesh-ancestor
20565738|NCT02007850|Anesthetics|anesthetics|mesh-ancestor
20565739|NCT02007850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20565740|NCT02007850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565741|NCT02007850|Sensory System Agents|sensory system agents|mesh-ancestor
20565742|NCT02007850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565743|NCT02007915|Pamidronate|pamidronate|mesh-list
20565744|NCT02007915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20565745|NCT02007915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565746|NCT02007928|Olanzapine|olanzapine|mesh-list
20565747|NCT02007928|Risperidone|risperidone|mesh-list
20565748|NCT02007928|Aripiprazole|aripiprazole|mesh-list
20565749|NCT02007928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20565750|NCT02007928|Serotonin Agents|serotonin agents|mesh-ancestor
20565751|NCT02007928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20565752|NCT02007928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565753|NCT02007928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565754|NCT02007928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20565755|NCT02007928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20565756|NCT02007928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20565757|NCT02007928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20565758|NCT02007928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20565759|NCT02007928|Dopamine Agents|dopamine agents|mesh-ancestor
20565760|NCT02007928|Antiemetics|antiemetics|mesh-ancestor
20565761|NCT02007928|Autonomic Agents|autonomic agents|mesh-ancestor
20565762|NCT02007928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565763|NCT02007928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20565764|NCT02007928|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20565765|NCT02007928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20565766|NCT02007928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20565767|NCT02007928|Antidepressive Agents|antidepressive agents|mesh-ancestor
20565768|NCT02007928|Dopamine Agonists|dopamine agonists|mesh-ancestor
20565769|NCT02007928|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20565770|NCT02007928|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20565771|NCT02007928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20565772|NCT02007928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20565773|NCT02008006|Cytarabine|cytarabine|mesh-list
20565774|NCT02008006|Etoposide|etoposide|mesh-list
20565775|NCT02008006|Melphalan|melphalan|mesh-list
20565776|NCT02008006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20565777|NCT02008006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20565778|NCT02008006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565779|NCT02008006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20565780|NCT02008006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20565781|NCT02008006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565782|NCT02008006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565783|NCT02008006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20565784|NCT02008006|Antimetabolites|antimetabolites|mesh-ancestor
20565785|NCT02008006|Antiviral Agents|antiviral agents|mesh-ancestor
20565786|NCT02008006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20565787|NCT02008006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20565788|NCT02008006|Immunologic Factors|immunologic factors|mesh-ancestor
20565789|NCT02008006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565790|NCT02008006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20565791|NCT02008006|Alkylating Agents|alkylating agents|mesh-ancestor
20565792|NCT02008006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20565793|NCT02008019|Everolimus|everolimus|mesh-list
20565794|NCT02008019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565795|NCT02008019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20565796|NCT02008019|Immunologic Factors|immunologic factors|mesh-ancestor
20565797|NCT02008019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565798|NCT02008123|Primidone|primidone|mesh-list
20565799|NCT02008123|Anticonvulsants|anticonvulsants|mesh-ancestor
20565800|NCT02008123|GABA Modulators|gaba modulators|mesh-ancestor
20565801|NCT02008123|GABA Agents|gaba agents|mesh-ancestor
20565802|NCT02008123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20565803|NCT02008123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565804|NCT02008123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565805|NCT02008136|Botulinum Toxins|botulinum toxins|mesh-list
20565806|NCT02008136|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20565807|NCT02008136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20565808|NCT02008136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565809|NCT02008136|Cholinergic Agents|cholinergic agents|mesh-ancestor
20565810|NCT02008136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20565811|NCT02008136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565812|NCT02008162|Bromides|bromides|mesh-list
20565813|NCT02008162|Albuterol|albuterol|mesh-list
20565814|NCT02008162|Tiotropium Bromide|tiotropium bromide|mesh-list
20565815|NCT02008162|Bronchodilator Agents|bronchodilator agents|mesh-list
20565816|NCT02008162|Autonomic Agents|autonomic agents|mesh-ancestor
20565817|NCT02008162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565818|NCT02008162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565819|NCT02008162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20565820|NCT02008162|Respiratory System Agents|respiratory system agents|mesh-ancestor
20565821|NCT02008162|Parasympatholytics|parasympatholytics|mesh-ancestor
20565822|NCT02008162|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20565823|NCT02008162|Cholinergic Agents|cholinergic agents|mesh-ancestor
20565824|NCT02008162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20565825|NCT02008162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565826|NCT02008162|Anticonvulsants|anticonvulsants|mesh-ancestor
20565827|NCT02008162|Tocolytic Agents|tocolytic agents|mesh-ancestor
20565828|NCT02008162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20565829|NCT02008162|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20565830|NCT02008162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20565831|NCT02008162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20565832|NCT02008162|Adrenergic Agents|adrenergic agents|mesh-ancestor
20565833|NCT02008201|Vitamin D|vitamin d|mesh-list
20565834|NCT02008201|Vitamins|vitamins|mesh-ancestor
20565835|NCT02008201|Micronutrients|micronutrients|mesh-ancestor
20565836|NCT02008201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565837|NCT02008201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20565838|NCT02008214|Pentoxifylline|pentoxifylline|mesh-list
20565839|NCT02008214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20565840|NCT02008214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19460999|NCT03348098|Paclitaxel|paclitaxel|mesh-list
19461000|NCT03348098|Apatinib|apatinib|mesh-list
20565841|NCT02008214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565842|NCT02008214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20565843|NCT02008214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20565844|NCT02008214|Protective Agents|protective agents|mesh-ancestor
20565845|NCT02008214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565846|NCT02008214|Vasodilator Agents|vasodilator agents|mesh-ancestor
20565847|NCT02008214|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20565848|NCT02008214|Antioxidants|antioxidants|mesh-ancestor
20565849|NCT02008383|Panitumumab|panitumumab|mesh-list
20565850|NCT02008383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20565851|NCT02008383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565852|NCT02008422|Oxaliplatin|oxaliplatin|mesh-list
20011647|NCT02369510|Epinephrine|epinephrine|mesh-list
20011648|NCT02369510|Racepinephrine|racepinephrine|mesh-list
20011649|NCT02369510|Epinephryl borate|epinephryl borate|mesh-list
20011650|NCT02369510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20011651|NCT02369510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20011652|NCT02369510|Adrenergic Agents|adrenergic agents|mesh-ancestor
20011653|NCT02369510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20565853|NCT02008422|Tegafur|tegafur|mesh-list
20565854|NCT02008422|Endostar protein|endostar protein|mesh-list
20565855|NCT02008422|Endostatins|endostatins|mesh-list
20565856|NCT02008422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565857|NCT02008422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20565858|NCT02008422|Antimetabolites|antimetabolites|mesh-ancestor
20565859|NCT02008422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565860|NCT02008422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20565861|NCT02008422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20565862|NCT02008422|Growth Substances|growth substances|mesh-ancestor
20565863|NCT02008422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565864|NCT02008422|Growth Inhibitors|growth inhibitors|mesh-ancestor
20565865|NCT02008461|Botulinum Toxins|botulinum toxins|mesh-list
20565866|NCT02008461|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20565867|NCT02008461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20565868|NCT02008461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565869|NCT02008461|Cholinergic Agents|cholinergic agents|mesh-ancestor
20565870|NCT02008461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20565871|NCT02008461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565872|NCT02008578|Immunoglobulins|immunoglobulins|mesh-list
20565873|NCT02008578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
20565874|NCT02008578|Antibodies|antibodies|mesh-list
20565875|NCT02008578|Immunologic Factors|immunologic factors|mesh-ancestor
20565876|NCT02008578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565877|NCT02008721|Neuroprotective Agents|neuroprotective agents|mesh-list
20565878|NCT02008721|Protective Agents|protective agents|mesh-ancestor
20565879|NCT02008721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565880|NCT02008734|Palbociclib|palbociclib|mesh-list
20011654|NCT02369510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011655|NCT02369510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011656|NCT02369510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20565881|NCT02008734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565882|NCT02008734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20565883|NCT02008734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565884|NCT02008734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565885|NCT02008747|Magnesium Sulfate|magnesium sulfate|mesh-list
20565886|NCT02008747|Analgesics|analgesics|mesh-ancestor
20565887|NCT02008747|Sensory System Agents|sensory system agents|mesh-ancestor
20565888|NCT02008747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565889|NCT02008747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565890|NCT02008747|Anesthetics|anesthetics|mesh-ancestor
20565891|NCT02008747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20565892|NCT02008747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20565893|NCT02008747|Anticonvulsants|anticonvulsants|mesh-ancestor
20565894|NCT02008747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20565895|NCT02008747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20565896|NCT02008747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565897|NCT02008747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20565898|NCT02008747|Tocolytic Agents|tocolytic agents|mesh-ancestor
20565899|NCT02008747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20565900|NCT02008786|Ramipril|ramipril|mesh-list
20565901|NCT02008786|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20565902|NCT02008786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20565903|NCT02008786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20565904|NCT02008786|Antimetabolites|antimetabolites|mesh-ancestor
20565905|NCT02008786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565906|NCT02008786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20565907|NCT02008786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20565908|NCT02008786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011657|NCT02369510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20011658|NCT02369510|Autonomic Agents|autonomic agents|mesh-ancestor
20011659|NCT02369510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20011660|NCT02369510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20565909|NCT02008786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
20565910|NCT02008786|Protease Inhibitors|protease inhibitors|mesh-ancestor
20565911|NCT02008786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20565912|NCT02008968|Allopurinol|allopurinol|mesh-list
20565913|NCT02008968|Antimetabolites|antimetabolites|mesh-ancestor
20565914|NCT02008968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565915|NCT02008968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565916|NCT02008968|Gout Suppressants|gout suppressants|mesh-ancestor
20565917|NCT02008968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20565918|NCT02008968|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20565919|NCT02008968|Antioxidants|antioxidants|mesh-ancestor
20565920|NCT02008968|Protective Agents|protective agents|mesh-ancestor
20565921|NCT02008968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565922|NCT02008981|Aspirin|aspirin|mesh-list
20565923|NCT02008981|Turmeric extract|turmeric extract|mesh-list
20565924|NCT02008981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20565925|NCT02008981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20565926|NCT02008981|Analgesics|analgesics|mesh-ancestor
20565927|NCT02008981|Sensory System Agents|sensory system agents|mesh-ancestor
20565928|NCT02008981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565929|NCT02008981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565930|NCT02008981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20565931|NCT02008981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20565932|NCT02008981|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20565933|NCT02008981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20565934|NCT02008981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565935|NCT02008981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20565936|NCT02008981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20565937|NCT02008981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20565938|NCT02008981|Antipyretics|antipyretics|mesh-ancestor
20565939|NCT02008981|Antioxidants|antioxidants|mesh-ancestor
20565940|NCT02008981|Protective Agents|protective agents|mesh-ancestor
20565941|NCT02009007|Phenylephrine|phenylephrine|mesh-list
20565942|NCT02009007|Dopamine|dopamine|mesh-list
20565943|NCT02009007|Oxymetazoline|oxymetazoline|mesh-list
20565944|NCT02009007|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20565945|NCT02009007|Mydriatics|mydriatics|mesh-ancestor
20565946|NCT02009007|Autonomic Agents|autonomic agents|mesh-ancestor
20565947|NCT02009007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565948|NCT02009007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565949|NCT02009007|Sympathomimetics|sympathomimetics|mesh-ancestor
20565950|NCT02009007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20565951|NCT02009007|Nasal Decongestants|nasal decongestants|mesh-ancestor
20565952|NCT02009007|Respiratory System Agents|respiratory system agents|mesh-ancestor
20565953|NCT02009007|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20565954|NCT02009007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20565955|NCT02009007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20565956|NCT02009007|Adrenergic Agents|adrenergic agents|mesh-ancestor
20565957|NCT02009007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20565958|NCT02009007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20565959|NCT02009007|Protective Agents|protective agents|mesh-ancestor
20565960|NCT02009007|Dopamine Agents|dopamine agents|mesh-ancestor
20565961|NCT02009098|Cefuroxime|cefuroxime|mesh-list
20565962|NCT02009098|Cefuroxime axetil|cefuroxime axetil|mesh-list
20565963|NCT02009098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20565964|NCT02009098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20565965|NCT02009189|Taurolidine|taurolidine|mesh-list
20565966|NCT02009189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20565967|NCT02009189|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20565968|NCT02009189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20565969|NCT02009202|Picosulfate sodium|picosulfate sodium|mesh-list
20565970|NCT02009202|Cathartics|cathartics|mesh-ancestor
20565971|NCT02009202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20565972|NCT02009215|Piperaquine|piperaquine|mesh-list
20565973|NCT02009215|Artenimol|artenimol|mesh-list
20565974|NCT02009215|Antimalarials|antimalarials|mesh-ancestor
20565975|NCT02009215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20565976|NCT02009215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20565977|NCT02009215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20565978|NCT02009280|Anesthetics|anesthetics|mesh-list
20565979|NCT02009280|Propofol|propofol|mesh-list
20565980|NCT02009280|Sevoflurane|sevoflurane|mesh-list
20565981|NCT02009280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20565982|NCT02009280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565983|NCT02009280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20565984|NCT02009280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20565985|NCT02009280|Anesthetics, General|anesthetics, general|mesh-ancestor
20565986|NCT02009280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20565987|NCT02009280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20565988|NCT02009306|Fentanyl|fentanyl|mesh-list
20565989|NCT02009306|Midazolam|midazolam|mesh-list
20565990|NCT02009306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20565991|NCT02009306|Narcotics|narcotics|mesh-ancestor
20565992|NCT02009306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20565993|NCT02009306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20565994|NCT02009306|Analgesics|analgesics|mesh-ancestor
20565995|NCT02009306|Sensory System Agents|sensory system agents|mesh-ancestor
20565996|NCT02009306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20565997|NCT02009306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20565998|NCT02009306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20565999|NCT02009306|Anesthetics, General|anesthetics, general|mesh-ancestor
20566000|NCT02009306|Anesthetics|anesthetics|mesh-ancestor
20566001|NCT02009306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20566002|NCT02009306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20566003|NCT02009306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20566004|NCT02009306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20566005|NCT02009306|GABA Modulators|gaba modulators|mesh-ancestor
20566006|NCT02009306|GABA Agents|gaba agents|mesh-ancestor
20566007|NCT02009306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566008|NCT02009306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566009|NCT02009410|Pancrelipase|pancrelipase|mesh-list
20566010|NCT02009410|Pancreatin|pancreatin|mesh-list
20566011|NCT02009410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20566012|NCT02009436|Azacitidine|azacitidine|mesh-list
20566013|NCT02009436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20566014|NCT02009436|Antimetabolites|antimetabolites|mesh-ancestor
20566015|NCT02009436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566016|NCT02009436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566017|NCT02009436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20566018|NCT02009449|Leucovorin|leucovorin|mesh-list
20566019|NCT02009449|Gemcitabine|gemcitabine|mesh-list
20566020|NCT02009449|Paclitaxel|paclitaxel|mesh-list
19461001|NCT03348098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19461002|NCT03348098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461003|NCT03348098|Tubulin Modulators|tubulin modulators|mesh-ancestor
19461004|NCT03348098|Antimitotic Agents|antimitotic agents|mesh-ancestor
19461005|NCT03348098|Mitosis Modulators|mitosis modulators|mesh-ancestor
19461006|NCT03348098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566021|NCT02009449|Docetaxel|docetaxel|mesh-list
20566022|NCT02009449|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20566023|NCT02009449|Carboplatin|carboplatin|mesh-list
20566024|NCT02009449|Pembrolizumab|pembrolizumab|mesh-list
20566025|NCT02009449|Fluorouracil|fluorouracil|mesh-list
20566026|NCT02009449|Capecitabine|capecitabine|mesh-list
20566027|NCT02009449|Oxaliplatin|oxaliplatin|mesh-list
20566028|NCT02009449|Nivolumab|nivolumab|mesh-list
20566029|NCT02009449|Levoleucovorin|levoleucovorin|mesh-list
20566030|NCT02009449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20566031|NCT02009449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566032|NCT02009449|Tubulin Modulators|tubulin modulators|mesh-ancestor
20566033|NCT02009449|Antimitotic Agents|antimitotic agents|mesh-ancestor
20566034|NCT02009449|Mitosis Modulators|mitosis modulators|mesh-ancestor
20566035|NCT02009449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566036|NCT02009449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20566037|NCT02009449|Antimetabolites|antimetabolites|mesh-ancestor
20566038|NCT02009449|Antiviral Agents|antiviral agents|mesh-ancestor
20566039|NCT02009449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20566040|NCT02009449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20566041|NCT02009449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20566042|NCT02009449|Immunologic Factors|immunologic factors|mesh-ancestor
20566043|NCT02009449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566044|NCT02009449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20566045|NCT02009449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20566046|NCT02009449|Antidotes|antidotes|mesh-ancestor
20566047|NCT02009449|Protective Agents|protective agents|mesh-ancestor
20566048|NCT02009449|Vitamin B Complex|vitamin b complex|mesh-ancestor
20566049|NCT02009449|Vitamins|vitamins|mesh-ancestor
20566050|NCT02009449|Micronutrients|micronutrients|mesh-ancestor
20566051|NCT02009462|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
20566052|NCT02009462|Vasodilator Agents|vasodilator agents|mesh-ancestor
20566053|NCT02009462|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
20566054|NCT02009462|Protective Agents|protective agents|mesh-ancestor
20566055|NCT02009462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566056|NCT02009488|Canagliflozin|canagliflozin|mesh-list
20566057|NCT02009488|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20566058|NCT02009488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566059|NCT02009488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20566060|NCT02009488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566061|NCT02009514|Dialysis Solutions|dialysis solutions|mesh-list
20566062|NCT02009514|Hemodialysis Solutions|hemodialysis solutions|mesh-list
20566063|NCT02009514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20566064|NCT02009540|Botulinum Toxins|botulinum toxins|mesh-list
20566065|NCT02009540|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20566066|NCT02009540|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20566067|NCT02009540|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20566068|NCT02009540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20566069|NCT02009540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566070|NCT02009540|Cholinergic Agents|cholinergic agents|mesh-ancestor
20566071|NCT02009540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566072|NCT02009540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566073|NCT02009540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20566074|NCT02009540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20566075|NCT02009592|Rifaximin|rifaximin|mesh-list
20566076|NCT02009592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20566077|NCT02009592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20566078|NCT02009592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20566079|NCT02009618|Rifaximin|rifaximin|mesh-list
20566080|NCT02009618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20566081|NCT02009618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20566082|NCT02009618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20566083|NCT02009631|Veliparib|veliparib|mesh-list
20566084|NCT02009631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20566085|NCT02009631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20566086|NCT02009631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566087|NCT02009631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011661|NCT02369510|Respiratory System Agents|respiratory system agents|mesh-ancestor
20011662|NCT02369510|Mydriatics|mydriatics|mesh-ancestor
20011663|NCT02369510|Sympathomimetics|sympathomimetics|mesh-ancestor
20566088|NCT02009709|Riboflavin|riboflavin|mesh-list
20566089|NCT02009709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20566090|NCT02009709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20566091|NCT02009709|Vitamin B Complex|vitamin b complex|mesh-ancestor
20566092|NCT02009709|Vitamins|vitamins|mesh-ancestor
20566093|NCT02009709|Micronutrients|micronutrients|mesh-ancestor
20566094|NCT02009709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566095|NCT02009709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20566096|NCT02009709|Dermatologic Agents|dermatologic agents|mesh-ancestor
20566097|NCT02009748|Vitamin D|vitamin d|mesh-list
20566098|NCT02009748|Vitamins|vitamins|mesh-ancestor
20566099|NCT02009748|Micronutrients|micronutrients|mesh-ancestor
20566100|NCT02009748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566101|NCT02009748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20566102|NCT02009787|Vitamin D|vitamin d|mesh-list
20566103|NCT02009787|Cholecalciferol|cholecalciferol|mesh-list
20566104|NCT02009787|Vitamins|vitamins|mesh-ancestor
20566105|NCT02009787|Micronutrients|micronutrients|mesh-ancestor
20566106|NCT02009787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566107|NCT02009787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20566108|NCT02009787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20566109|NCT02009943|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
20566110|NCT02009943|Hematinics|hematinics|mesh-ancestor
20566111|NCT02010164|Ubiquinone|ubiquinone|mesh-list
20566112|NCT02010164|Coenzyme Q10|coenzyme q10|mesh-list
20566113|NCT02010164|Micronutrients|micronutrients|mesh-ancestor
20566114|NCT02010164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566115|NCT02010164|Vitamins|vitamins|mesh-ancestor
20566116|NCT02010372|Vaccines|vaccines|mesh-list
20566117|NCT02010372|Immunologic Factors|immunologic factors|mesh-ancestor
20566118|NCT02010372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566119|NCT02010411|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
20566120|NCT02010411|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
20566121|NCT02010411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20566122|NCT02010411|Protease Inhibitors|protease inhibitors|mesh-ancestor
20566123|NCT02010411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20566124|NCT02010411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566125|NCT02010437|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
20566126|NCT02010437|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
20566127|NCT02010437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20566128|NCT02010723|Polidocanol|polidocanol|mesh-list
20566129|NCT02010723|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
20566130|NCT02010723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20566131|NCT02010762|Vitamin D|vitamin d|mesh-list
20566132|NCT02010762|Vitamins|vitamins|mesh-ancestor
20566133|NCT02010762|Micronutrients|micronutrients|mesh-ancestor
20566134|NCT02010762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566135|NCT02010762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20566136|NCT02010788|Botulinum Toxins|botulinum toxins|mesh-list
20566137|NCT02010788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20566138|NCT02010788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20566139|NCT02010788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20566140|NCT02010788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20566141|NCT02010788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566142|NCT02010788|Cholinergic Agents|cholinergic agents|mesh-ancestor
20566143|NCT02010788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566144|NCT02010788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566145|NCT02010788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20566146|NCT02010788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20566147|NCT02010827|Glucagon|glucagon|mesh-list
20566148|NCT02010827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20566149|NCT02010827|Hormones|hormones|mesh-ancestor
20566150|NCT02010827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20566151|NCT02010827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566152|NCT02010905|Losartan|losartan|mesh-list
20566153|NCT02010905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20566154|NCT02010905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20566155|NCT02010905|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20566156|NCT02010905|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20566157|NCT02010905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566158|NCT02010944|Solifenacin Succinate|solifenacin succinate|mesh-list
20566159|NCT02010944|Mirabegron|mirabegron|mesh-list
20566160|NCT02010944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20566161|NCT02010944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20566162|NCT02010944|Cholinergic Agents|cholinergic agents|mesh-ancestor
20566163|NCT02010944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566164|NCT02010944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566165|NCT02010944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566166|NCT02010944|Urological Agents|urological agents|mesh-ancestor
20566167|NCT02010944|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20566168|NCT02010944|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20566169|NCT02010944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20566170|NCT02010944|Adrenergic Agents|adrenergic agents|mesh-ancestor
20566171|NCT02010957|Etomidate|etomidate|mesh-list
20566172|NCT02010957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20566173|NCT02010957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20566174|NCT02010957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566175|NCT02010957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20566176|NCT02010957|Anesthetics, General|anesthetics, general|mesh-ancestor
20566177|NCT02010957|Anesthetics|anesthetics|mesh-ancestor
20566178|NCT02010970|Itraconazole|itraconazole|mesh-list
20566179|NCT02010970|Diltiazem|diltiazem|mesh-list
20566180|NCT02010970|Calcium Channel Blockers|calcium channel blockers|mesh-list
20566181|NCT02010970|Midazolam|midazolam|mesh-list
20566182|NCT02010970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20566183|NCT02010970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566184|NCT02010970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20566185|NCT02010970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20566186|NCT02010970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20566187|NCT02010970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20566188|NCT02010970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20566189|NCT02010970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20566190|NCT02010970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20566191|NCT02010970|Anesthetics, General|anesthetics, general|mesh-ancestor
20566192|NCT02010970|Anesthetics|anesthetics|mesh-ancestor
20566193|NCT02010970|GABA Modulators|gaba modulators|mesh-ancestor
20566194|NCT02010970|GABA Agents|gaba agents|mesh-ancestor
20566195|NCT02010970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566196|NCT02010970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566197|NCT02010970|Antifungal Agents|antifungal agents|mesh-ancestor
20566198|NCT02010970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20566199|NCT02010970|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20566200|NCT02010970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20566201|NCT02010970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20566202|NCT02010970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20566203|NCT02010970|Hormone Antagonists|hormone antagonists|mesh-ancestor
20566204|NCT02010970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20566205|NCT02010970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20566206|NCT02010970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20566207|NCT02010970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20566208|NCT02010970|Vasodilator Agents|vasodilator agents|mesh-ancestor
20566209|NCT02011126|Imetelstat|imetelstat|mesh-list
20566210|NCT02011126|Motesanib diphosphate|motesanib diphosphate|mesh-list
20566211|NCT02011126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20566212|NCT02011126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566213|NCT02011126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20566214|NCT02011191|Biotin|biotin|mesh-list
20566215|NCT02011191|Vitamin B Complex|vitamin b complex|mesh-ancestor
20566216|NCT02011191|Vitamins|vitamins|mesh-ancestor
20566217|NCT02011191|Micronutrients|micronutrients|mesh-ancestor
20566218|NCT02011191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566219|NCT02011321|Clevidipine|clevidipine|mesh-list
20566220|NCT02011321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20566221|NCT02011321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20566222|NCT02011321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566223|NCT02011321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20566224|NCT02011321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566225|NCT02011347|Ketamine|ketamine|mesh-list
20566226|NCT02011347|Analgesics|analgesics|mesh-ancestor
20566227|NCT02011347|Sensory System Agents|sensory system agents|mesh-ancestor
20566228|NCT02011347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20566229|NCT02011347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566230|NCT02011347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20566231|NCT02011347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20566232|NCT02011347|Anesthetics, General|anesthetics, general|mesh-ancestor
20566233|NCT02011347|Anesthetics|anesthetics|mesh-ancestor
20566234|NCT02011347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20566235|NCT02011347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20566236|NCT02011347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20566237|NCT02011347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566238|NCT02011347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566239|NCT02011594|Nimotuzumab|nimotuzumab|mesh-list
20566240|NCT02011594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20566241|NCT02011594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566242|NCT02011620|Isosorbide|isosorbide|mesh-list
20566243|NCT02011620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
20566244|NCT02011620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
20566245|NCT02011620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
20566246|NCT02011620|Diuretics|diuretics|mesh-ancestor
20566247|NCT02011620|Natriuretic Agents|natriuretic agents|mesh-ancestor
20566248|NCT02011620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566249|NCT02011620|Vasodilator Agents|vasodilator agents|mesh-ancestor
20566250|NCT02011620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
20566251|NCT02011620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566252|NCT02011633|Metformin|metformin|mesh-list
20566253|NCT02011633|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20566254|NCT02011633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20566255|NCT02011633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566256|NCT02011633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20566257|NCT02011633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20566258|NCT02011633|Antimetabolites|antimetabolites|mesh-ancestor
20566259|NCT02011633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566260|NCT02011633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20566261|NCT02011633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20566262|NCT02011633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20566263|NCT02011659|Ramosetron|ramosetron|mesh-list
20566264|NCT02011659|Antiemetics|antiemetics|mesh-ancestor
20566265|NCT02011659|Autonomic Agents|autonomic agents|mesh-ancestor
20566266|NCT02011659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20566267|NCT02011659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566268|NCT02011659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20566269|NCT02011659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20566270|NCT02011659|Serotonin Agents|serotonin agents|mesh-ancestor
20566271|NCT02011659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566272|NCT02011659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566273|NCT02011737|Naftopidil|naftopidil|mesh-list
20566274|NCT02011737|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20566275|NCT02011737|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20566276|NCT02011737|Adrenergic Agents|adrenergic agents|mesh-ancestor
20566277|NCT02011737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566278|NCT02011737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566279|NCT02011737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566280|NCT02011737|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20566281|NCT02011737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20566282|NCT02011737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20566283|NCT02011737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20566284|NCT02011737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20566285|NCT02011750|Valproic Acid|valproic acid|mesh-list
20566286|NCT02011750|Anticonvulsants|anticonvulsants|mesh-ancestor
20566287|NCT02011750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20566288|NCT02011750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566289|NCT02011750|GABA Agents|gaba agents|mesh-ancestor
20566290|NCT02011750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566291|NCT02011750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566292|NCT02011750|Antimanic Agents|antimanic agents|mesh-ancestor
20566293|NCT02011750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20566294|NCT02011750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20566295|NCT02011750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20566296|NCT02011828|Ergocalciferols|ergocalciferols|mesh-list
20566297|NCT02011828|Vitamin D|vitamin d|mesh-list
20566298|NCT02011828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20566299|NCT02011828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566300|NCT02011828|Vitamins|vitamins|mesh-ancestor
20566301|NCT02011828|Micronutrients|micronutrients|mesh-ancestor
20566302|NCT02011828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20566303|NCT02011841|Ciprofloxacin|ciprofloxacin|mesh-list
20566304|NCT02011841|Rifaximin|rifaximin|mesh-list
20566305|NCT02011841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20566306|NCT02011841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20566307|NCT02011841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20566308|NCT02011841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20566309|NCT02011841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20566310|NCT02011841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566311|NCT02011841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566312|NCT02011841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20566313|NCT02011841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20566314|NCT02011841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20566315|NCT02011880|Corylifolin|corylifolin|mesh-list
20566316|NCT02011880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20566317|NCT02011880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011664|NCT02369510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20011665|NCT02369835|Sodium Hypochlorite|sodium hypochlorite|mesh-list
20011666|NCT02369835|Eusol|eusol|mesh-list
20011667|NCT02369835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20011668|NCT02369835|Disinfectants|disinfectants|mesh-ancestor
20011669|NCT02369835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20011670|NCT02369874|Durvalumab|durvalumab|mesh-list
20011671|NCT02369874|Tremelimumab|tremelimumab|mesh-list
20011672|NCT02369874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20566318|NCT02011880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566319|NCT02011880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20566320|NCT02011880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20566321|NCT02011880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566322|NCT02011906|Vitamins|vitamins|mesh-list
20566323|NCT02011906|Vitamin E|vitamin e|mesh-list
20566324|NCT02011906|Tocopherols|tocopherols|mesh-list
20566325|NCT02011906|Tocotrienols|tocotrienols|mesh-list
20011673|NCT02369874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20566326|NCT02011906|alpha-Tocopherol|alpha-tocopherol|mesh-list
20566327|NCT02011906|Micronutrients|micronutrients|mesh-ancestor
20566328|NCT02011906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566329|NCT02011906|Antioxidants|antioxidants|mesh-ancestor
20566330|NCT02011906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566331|NCT02011906|Protective Agents|protective agents|mesh-ancestor
20566332|NCT02011958|Amphotericin B|amphotericin b|mesh-list
20566333|NCT02011958|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
20566334|NCT02011958|Miltefosine|miltefosine|mesh-list
20566335|NCT02011958|Amebicides|amebicides|mesh-ancestor
20566336|NCT02011958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20566337|NCT02011958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20566338|NCT02011958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20566339|NCT02011958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20566340|NCT02011958|Antifungal Agents|antifungal agents|mesh-ancestor
20566341|NCT02011958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566342|NCT02011971|Vinpocetine|vinpocetine|mesh-list
20566343|NCT02011971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20566344|NCT02011971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20566345|NCT02011971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566346|NCT02011971|Vasodilator Agents|vasodilator agents|mesh-ancestor
20566347|NCT02011971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20566348|NCT02011971|Protective Agents|protective agents|mesh-ancestor
20566349|NCT02011971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566350|NCT02011971|Nootropic Agents|nootropic agents|mesh-ancestor
20566351|NCT02012036|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20566352|NCT02012036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20566353|NCT02012036|Dermatologic Agents|dermatologic agents|mesh-ancestor
20566354|NCT02012049|Risperidone|risperidone|mesh-list
20566355|NCT02012049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20566356|NCT02012049|Serotonin Agents|serotonin agents|mesh-ancestor
20566357|NCT02012049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566358|NCT02012049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566359|NCT02012049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566360|NCT02012049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20566361|NCT02012049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20566362|NCT02012049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20566363|NCT02012049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20566364|NCT02012049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20566365|NCT02012049|Dopamine Agents|dopamine agents|mesh-ancestor
20566366|NCT02012062|Nimotuzumab|nimotuzumab|mesh-list
20566367|NCT02012062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566368|NCT02012062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20566369|NCT02012075|Metoprolol|metoprolol|mesh-list
20566370|NCT02012075|Carvedilol|carvedilol|mesh-list
20566371|NCT02012075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20566372|NCT02012075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20566373|NCT02012075|Sympatholytics|sympatholytics|mesh-ancestor
20566374|NCT02012075|Autonomic Agents|autonomic agents|mesh-ancestor
20566375|NCT02012075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20566376|NCT02012075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566377|NCT02012075|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20566378|NCT02012075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20566379|NCT02012075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20566380|NCT02012075|Adrenergic Agents|adrenergic agents|mesh-ancestor
20566381|NCT02012075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566382|NCT02012075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566383|NCT02012075|Antioxidants|antioxidants|mesh-ancestor
20566384|NCT02012075|Protective Agents|protective agents|mesh-ancestor
20566385|NCT02012075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20566386|NCT02012075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20566387|NCT02012075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20566388|NCT02012075|Vasodilator Agents|vasodilator agents|mesh-ancestor
20566389|NCT02012075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20566390|NCT02012075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20566391|NCT02012088|Prednisone|prednisone|mesh-list
20566392|NCT02012088|Cyclophosphamide|cyclophosphamide|mesh-list
20566393|NCT02012088|Rituximab|rituximab|mesh-list
20566394|NCT02012088|Doxorubicin|doxorubicin|mesh-list
20566395|NCT02012088|Vincristine|vincristine|mesh-list
20566396|NCT02012088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20566397|NCT02012088|Immunologic Factors|immunologic factors|mesh-ancestor
20566398|NCT02012088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566399|NCT02012088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20566400|NCT02012088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20566401|NCT02012088|Alkylating Agents|alkylating agents|mesh-ancestor
20566402|NCT02012088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566403|NCT02012088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566404|NCT02012088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19461007|NCT03348098|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19461008|NCT03348098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19461009|NCT03348059|Antiviral Agents|antiviral agents|mesh-list
19461010|NCT03348059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19461011|NCT03348046|Infliximab|infliximab|mesh-list
19461012|NCT03348046|Dermatologic Agents|dermatologic agents|mesh-ancestor
19461013|NCT03348046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19461014|NCT03348046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19461015|NCT03347994|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
19461016|NCT03347994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19461017|NCT03347994|Alkylating Agents|alkylating agents|mesh-ancestor
19461018|NCT03347994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461019|NCT03347994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461020|NCT03347968|Warfarin|warfarin|mesh-list
19461021|NCT03347968|Esmolol|esmolol|mesh-list
19461022|NCT03347968|Anticoagulants|anticoagulants|mesh-ancestor
19461023|NCT03347968|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
19461024|NCT03347968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19461025|NCT03347968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19461026|NCT03347968|Adrenergic Agents|adrenergic agents|mesh-ancestor
19461027|NCT03347968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19461028|NCT03347968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461029|NCT03347968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461030|NCT03347916|Gabapentin|gabapentin|mesh-list
19461031|NCT03347916|Analgesics|analgesics|mesh-ancestor
19461032|NCT03347916|Sensory System Agents|sensory system agents|mesh-ancestor
19461033|NCT03347916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19461034|NCT03347916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461035|NCT03347916|Anticonvulsants|anticonvulsants|mesh-ancestor
19461036|NCT03347916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19461037|NCT03347916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19461038|NCT03347916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19461039|NCT03347916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19461040|NCT03347916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19461041|NCT03347916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19461042|NCT03347916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19461043|NCT03347916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461044|NCT03347916|Antimanic Agents|antimanic agents|mesh-ancestor
19461045|NCT03347890|Liraglutide|liraglutide|mesh-list
19461046|NCT03347890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19461047|NCT03347890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461048|NCT03347890|Incretins|incretins|mesh-ancestor
19461049|NCT03347890|Hormones|hormones|mesh-ancestor
19461050|NCT03347890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19461051|NCT03347864|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
19461052|NCT03347864|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19461053|NCT03347864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461054|NCT03347786|Verapamil|verapamil|mesh-list
19461055|NCT03347786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19461056|NCT03347786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19461057|NCT03347786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19461058|NCT03347786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461059|NCT03347786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19461060|NCT03347786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461061|NCT03347786|Vasodilator Agents|vasodilator agents|mesh-ancestor
19461062|NCT03347760|Octreotide|octreotide|mesh-list
19461063|NCT03347760|Edotreotide|edotreotide|mesh-list
19461064|NCT03347760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19461065|NCT03347760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461066|NCT03347760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19461067|NCT03347760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20566405|NCT02012088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20566406|NCT02012088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20566407|NCT02012088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20566408|NCT02012088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20566409|NCT02012088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20566410|NCT02012088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20566411|NCT02012088|Glucocorticoids|glucocorticoids|mesh-ancestor
20566412|NCT02012088|Hormones|hormones|mesh-ancestor
20566413|NCT02012088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20566414|NCT02012088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20566415|NCT02012088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20566416|NCT02012088|Tubulin Modulators|tubulin modulators|mesh-ancestor
20566417|NCT02012088|Antimitotic Agents|antimitotic agents|mesh-ancestor
20566418|NCT02012088|Mitosis Modulators|mitosis modulators|mesh-ancestor
20566419|NCT02012140|Ticagrelor|ticagrelor|mesh-list
20566420|NCT02012140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20566421|NCT02012140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20566422|NCT02012140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20566423|NCT02012140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20566424|NCT02012140|Purinergic Agents|purinergic agents|mesh-ancestor
20566425|NCT02012140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566426|NCT02012140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566427|NCT02012140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566428|NCT02012166|Insulin|insulin|mesh-list
20566429|NCT02012166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20566430|NCT02012166|Octreotide|octreotide|mesh-list
20566431|NCT02012166|Glucagon|glucagon|mesh-list
20566432|NCT02012166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20566433|NCT02012166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566434|NCT02012166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20566435|NCT02012166|Hormones|hormones|mesh-ancestor
20566436|NCT02012166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20566437|NCT02012166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20566438|NCT02012166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20566439|NCT02012244|Fentanyl|fentanyl|mesh-list
20566440|NCT02012244|Anesthetics|anesthetics|mesh-list
20566441|NCT02012244|Anesthetics, Local|anesthetics, local|mesh-list
20566442|NCT02012244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20566443|NCT02012244|Narcotics|narcotics|mesh-ancestor
20566444|NCT02012244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20566445|NCT02012244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566446|NCT02012244|Analgesics|analgesics|mesh-ancestor
20566447|NCT02012244|Sensory System Agents|sensory system agents|mesh-ancestor
20566448|NCT02012244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20566449|NCT02012244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20566450|NCT02012244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20566451|NCT02012244|Anesthetics, General|anesthetics, general|mesh-ancestor
20566452|NCT02012296|Mifepristone|mifepristone|mesh-list
20566453|NCT02012296|Androgens|androgens|mesh-list
20566454|NCT02012296|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
20566455|NCT02012296|Abortifacient Agents|abortifacient agents|mesh-ancestor
20566456|NCT02012296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20566457|NCT02012296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566458|NCT02012296|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20566459|NCT02012296|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20566460|NCT02012296|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20566461|NCT02012296|Contraceptive Agents|contraceptive agents|mesh-ancestor
20566462|NCT02012296|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
20566463|NCT02012296|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
20566464|NCT02012296|Hormone Antagonists|hormone antagonists|mesh-ancestor
20566465|NCT02012296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20566466|NCT02012296|Luteolytic Agents|luteolytic agents|mesh-ancestor
20566467|NCT02012296|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20566468|NCT02012296|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20566469|NCT02012296|Hormones|hormones|mesh-ancestor
20566470|NCT02012309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20566471|NCT02012309|Immunologic Factors|immunologic factors|mesh-ancestor
20566472|NCT02012309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566473|NCT02012322|Ubiquinone|ubiquinone|mesh-list
20566474|NCT02012322|Coenzyme Q10|coenzyme q10|mesh-list
20566475|NCT02012322|Micronutrients|micronutrients|mesh-ancestor
20566476|NCT02012322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566477|NCT02012322|Vitamins|vitamins|mesh-ancestor
20566478|NCT02012335|Ketamine|ketamine|mesh-list
20566479|NCT02012335|Analgesics|analgesics|mesh-ancestor
20566480|NCT02012335|Sensory System Agents|sensory system agents|mesh-ancestor
20566481|NCT02012335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20566482|NCT02012335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566483|NCT02012335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20566484|NCT02012335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20566485|NCT02012335|Anesthetics, General|anesthetics, general|mesh-ancestor
20566486|NCT02012335|Anesthetics|anesthetics|mesh-ancestor
20566487|NCT02012335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20566488|NCT02012335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20566489|NCT02012335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20566490|NCT02012335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20566491|NCT02012335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20566492|NCT02012387|Omalizumab|omalizumab|mesh-list
20566493|NCT02012387|Vaccines|vaccines|mesh-list
20566494|NCT02012387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20566495|NCT02012387|Immunologic Factors|immunologic factors|mesh-ancestor
20566496|NCT02012387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566497|NCT02012387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20566498|NCT02012387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20566499|NCT02012387|Respiratory System Agents|respiratory system agents|mesh-ancestor
20011674|NCT02369874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011675|NCT02369874|Immunologic Factors|immunologic factors|mesh-ancestor
20011676|NCT02369874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011677|NCT02369900|Esmolol|esmolol|mesh-list
20011678|NCT02369900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20011679|NCT02369900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20011680|NCT02369900|Adrenergic Agents|adrenergic agents|mesh-ancestor
20566500|NCT02012465|Insulin|insulin|mesh-list
20566501|NCT02012465|Insulin Glargine|insulin glargine|mesh-list
20566502|NCT02012465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20566503|NCT02012465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20566504|NCT02012517|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
20566505|NCT02012517|Cefazolin|cefazolin|mesh-list
20566506|NCT02012517|Cephalexin|cephalexin|mesh-list
20566507|NCT02012517|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
20566508|NCT02012517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20566509|NCT02012517|Antitubercular Agents|antitubercular agents|mesh-ancestor
20011681|NCT02369900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011682|NCT02369900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011683|NCT02369900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011684|NCT02369900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20011685|NCT02370095|Treprostinil|treprostinil|mesh-list
20011686|NCT02370095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20011687|NCT02370095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20011688|NCT02370238|Paclitaxel|paclitaxel|mesh-list
20011689|NCT02370238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20011690|NCT02370238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011691|NCT02370238|Tubulin Modulators|tubulin modulators|mesh-ancestor
20011692|NCT02370238|Antimitotic Agents|antimitotic agents|mesh-ancestor
20011693|NCT02370238|Mitosis Modulators|mitosis modulators|mesh-ancestor
20011694|NCT02370238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011695|NCT02370498|Paclitaxel|paclitaxel|mesh-list
20011696|NCT02370498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20011697|NCT02370498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011698|NCT02370498|Tubulin Modulators|tubulin modulators|mesh-ancestor
20011699|NCT02370498|Antimitotic Agents|antimitotic agents|mesh-ancestor
19461068|NCT03347760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461069|NCT03347721|Lidocaine|lidocaine|mesh-list
19461070|NCT03347721|Anesthetics, Local|anesthetics, local|mesh-ancestor
19461071|NCT03347721|Anesthetics|anesthetics|mesh-ancestor
19461072|NCT03347721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19461073|NCT03347721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461074|NCT03347721|Sensory System Agents|sensory system agents|mesh-ancestor
19461075|NCT03347721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19461076|NCT03347721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19461077|NCT03347721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19461078|NCT03347721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19461079|NCT03347721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19461080|NCT03347721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461081|NCT03347708|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19461082|NCT03347708|Hyaluronic Acid|hyaluronic acid|mesh-list
19461083|NCT03347708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20011700|NCT02370498|Mitosis Modulators|mitosis modulators|mesh-ancestor
20011701|NCT02370498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011702|NCT02370615|Itraconazole|itraconazole|mesh-list
20011703|NCT02370615|Digoxin|digoxin|mesh-list
20011704|NCT02370615|Midazolam|midazolam|mesh-list
20011705|NCT02370615|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
20011706|NCT02370615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20011707|NCT02370615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20011708|NCT02370615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20011709|NCT02370615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011710|NCT02370615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20011711|NCT02370615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19461084|NCT03347708|Immunologic Factors|immunologic factors|mesh-ancestor
19461085|NCT03347708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461086|NCT03347708|Viscosupplements|viscosupplements|mesh-ancestor
19461087|NCT03347708|Protective Agents|protective agents|mesh-ancestor
19461088|NCT03347591|polysaccharide-K|polysaccharide-k|mesh-list
19461089|NCT03347591|Hemostatics|hemostatics|mesh-list
19461090|NCT03347591|Coagulants|coagulants|mesh-ancestor
19461091|NCT03347591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19461092|NCT03347591|Immunologic Factors|immunologic factors|mesh-ancestor
19461093|NCT03347591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461094|NCT03347591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19461095|NCT03347591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461096|NCT03347591|Antiviral Agents|antiviral agents|mesh-ancestor
19461097|NCT03347591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19461098|NCT03347591|Interferon Inducers|interferon inducers|mesh-ancestor
19461099|NCT03347591|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19461100|NCT03347591|Protective Agents|protective agents|mesh-ancestor
19461101|NCT03347526|Vigabatrin|vigabatrin|mesh-list
19461102|NCT03347526|Cosyntropin|cosyntropin|mesh-list
19461103|NCT03347526|Anticonvulsants|anticonvulsants|mesh-ancestor
19461104|NCT03347526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19461105|NCT03347526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461106|NCT03347526|GABA Agents|gaba agents|mesh-ancestor
19461107|NCT03347526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19461108|NCT03347526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461109|NCT03347526|Hormones|hormones|mesh-ancestor
19461110|NCT03347526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19461111|NCT03347513|Glycine|glycine|mesh-list
19461112|NCT03347513|Glycine Agents|glycine agents|mesh-ancestor
20011712|NCT02370615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20011713|NCT02370615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20011714|NCT02370615|Anesthetics, General|anesthetics, general|mesh-ancestor
20011715|NCT02370615|Anesthetics|anesthetics|mesh-ancestor
19461113|NCT03347513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19461114|NCT03347513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461115|NCT03347513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461116|NCT03347461|Ciprofloxacin|ciprofloxacin|mesh-list
19461117|NCT03347461|Dexamethasone|dexamethasone|mesh-list
19461118|NCT03347461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19461119|NCT03347461|Antiemetics|antiemetics|mesh-ancestor
19461120|NCT03347461|Autonomic Agents|autonomic agents|mesh-ancestor
19461121|NCT03347461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19461122|NCT03347461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461123|NCT03347461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19461124|NCT03347461|Glucocorticoids|glucocorticoids|mesh-ancestor
19461125|NCT03347461|Hormones|hormones|mesh-ancestor
19461126|NCT03347461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19461127|NCT03347461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20011716|NCT02370615|GABA Modulators|gaba modulators|mesh-ancestor
20011717|NCT02370615|GABA Agents|gaba agents|mesh-ancestor
19461128|NCT03347461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461129|NCT03347461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19461130|NCT03347461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461131|NCT03347461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19461132|NCT03347461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19461133|NCT03347461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19461134|NCT03347461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19461135|NCT03347461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19461136|NCT03347461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19461137|NCT03347370|Interferons|interferons|mesh-list
19461138|NCT03347370|Interferon-beta|interferon-beta|mesh-list
19461139|NCT03347370|Interferon beta-1a|interferon beta-1a|mesh-list
19461140|NCT03347370|Interferon beta-1b|interferon beta-1b|mesh-list
19461141|NCT03347370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461142|NCT03347370|Antiviral Agents|antiviral agents|mesh-ancestor
19461143|NCT03347370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19461144|NCT03347370|Immunologic Factors|immunologic factors|mesh-ancestor
19461145|NCT03347370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461146|NCT03347370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19461147|NCT03347357|Tacrolimus|tacrolimus|mesh-list
19461148|NCT03347357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19461149|NCT03347357|Immunologic Factors|immunologic factors|mesh-ancestor
19461150|NCT03347357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461151|NCT03347357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19461152|NCT03347357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19461153|NCT03347357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461154|NCT03347344|Riluzole|riluzole|mesh-list
19461155|NCT03347344|Anticonvulsants|anticonvulsants|mesh-ancestor
19461156|NCT03347344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19461157|NCT03347344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19461158|NCT03347344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19461159|NCT03347344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461160|NCT03347344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461161|NCT03347344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19461162|NCT03347344|Protective Agents|protective agents|mesh-ancestor
19461163|NCT03347240|Baclofen|baclofen|mesh-list
19461164|NCT03347240|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19461165|NCT03347240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461166|NCT03347240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19461167|NCT03347240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19461168|NCT03347240|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
19461169|NCT03347240|GABA Agonists|gaba agonists|mesh-ancestor
19461170|NCT03347240|GABA Agents|gaba agents|mesh-ancestor
19461171|NCT03347240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19461172|NCT03347240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461173|NCT03346993|Bupivacaine|bupivacaine|mesh-list
19461174|NCT03346993|Anesthetics, Local|anesthetics, local|mesh-ancestor
19461175|NCT03346993|Anesthetics|anesthetics|mesh-ancestor
19461176|NCT03346993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19461177|NCT03346993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461178|NCT03346993|Sensory System Agents|sensory system agents|mesh-ancestor
19461179|NCT03346993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19461180|NCT03346837|Itraconazole|itraconazole|mesh-list
19461181|NCT03346837|Rifampin|rifampin|mesh-list
19461182|NCT03346837|Linrodostat|linrodostat|mesh-list
19461183|NCT03346837|Antifungal Agents|antifungal agents|mesh-ancestor
19461184|NCT03346837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19461185|NCT03346837|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19461186|NCT03346837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19461187|NCT03346837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19461188|NCT03346837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461189|NCT03346837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19461190|NCT03346837|Hormone Antagonists|hormone antagonists|mesh-ancestor
19461191|NCT03346837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19461192|NCT03346837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461193|NCT03346837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19461194|NCT03346837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19461195|NCT03346837|Antitubercular Agents|antitubercular agents|mesh-ancestor
19461196|NCT03346837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19461197|NCT03346837|Leprostatic Agents|leprostatic agents|mesh-ancestor
19461198|NCT03346837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19461199|NCT03346837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19461200|NCT03346837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19461201|NCT03346837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19461202|NCT03346837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19461203|NCT03346837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19461204|NCT03346837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19461205|NCT03346772|Vaccines|vaccines|mesh-list
19461206|NCT03346772|Immunologic Factors|immunologic factors|mesh-ancestor
19461207|NCT03346772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461208|NCT03346733|Psyllium|psyllium|mesh-list
19461209|NCT03346733|Cathartics|cathartics|mesh-ancestor
19461210|NCT03346733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19461211|NCT03346681|Acetylcysteine|acetylcysteine|mesh-list
19461212|NCT03346681|N-monoacetylcystine|n-monoacetylcystine|mesh-list
19461213|NCT03346681|Antiviral Agents|antiviral agents|mesh-ancestor
19461214|NCT03346681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19461215|NCT03346681|Expectorants|expectorants|mesh-ancestor
19461216|NCT03346681|Respiratory System Agents|respiratory system agents|mesh-ancestor
19461217|NCT03346681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19461218|NCT03346681|Antioxidants|antioxidants|mesh-ancestor
19461219|NCT03346681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461220|NCT03346681|Protective Agents|protective agents|mesh-ancestor
19461221|NCT03346681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461222|NCT03346681|Antidotes|antidotes|mesh-ancestor
19461223|NCT03346642|Decitabine|decitabine|mesh-list
19461224|NCT03346642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19461225|NCT03346642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19461226|NCT03346642|Antimetabolites|antimetabolites|mesh-ancestor
19461227|NCT03346642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461228|NCT03346642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461229|NCT03346642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19461230|NCT03346629|Misoprostol|misoprostol|mesh-list
19461231|NCT03346629|Mifepristone|mifepristone|mesh-list
19461232|NCT03346629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19461233|NCT03346629|Abortifacient Agents|abortifacient agents|mesh-ancestor
19461234|NCT03346629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19461235|NCT03346629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461236|NCT03346629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19461237|NCT03346629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19461238|NCT03346629|Oxytocics|oxytocics|mesh-ancestor
19461239|NCT03346629|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
19461240|NCT03346629|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19461241|NCT03346629|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19461242|NCT03346629|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19461243|NCT03346629|Contraceptive Agents|contraceptive agents|mesh-ancestor
19461244|NCT03346629|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
19461245|NCT03346629|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
19461246|NCT03346629|Hormone Antagonists|hormone antagonists|mesh-ancestor
19461247|NCT03346629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19461248|NCT03346629|Luteolytic Agents|luteolytic agents|mesh-ancestor
19461249|NCT03346629|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19461250|NCT03346629|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
20011718|NCT02370615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011719|NCT02370615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011720|NCT02370615|Antifungal Agents|antifungal agents|mesh-ancestor
20011721|NCT02370615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19461251|NCT03346538|Edaravone|edaravone|mesh-list
19461252|NCT03346538|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19461253|NCT03346538|Antioxidants|antioxidants|mesh-ancestor
19461254|NCT03346538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461255|NCT03346538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19461256|NCT03346538|Protective Agents|protective agents|mesh-ancestor
19461257|NCT03346538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461258|NCT03346525|Penicillins|penicillins|mesh-list
19461259|NCT03346525|Penicillin G|penicillin g|mesh-list
19461260|NCT03346525|Penicillin G Benzathine|penicillin g benzathine|mesh-list
19461261|NCT03346525|Penicillin G Procaine|penicillin g procaine|mesh-list
19461262|NCT03346525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19461263|NCT03346525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19461264|NCT03346317|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19461265|NCT03346317|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19461266|NCT03346317|Estradiol|estradiol|mesh-list
19461267|NCT03346317|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19461268|NCT03346317|Dydrogesterone|dydrogesterone|mesh-list
19461269|NCT03346317|Estrogens|estrogens|mesh-ancestor
19461270|NCT03346317|Hormones|hormones|mesh-ancestor
19461271|NCT03346317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19461272|NCT03346317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461273|NCT03346317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19461274|NCT03346317|Contraceptive Agents|contraceptive agents|mesh-ancestor
19461275|NCT03346317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19461276|NCT03346317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19461277|NCT03346317|Progestins|progestins|mesh-ancestor
19461278|NCT03346252|Botulinum Toxins|botulinum toxins|mesh-list
19461279|NCT03346252|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19461280|NCT03346252|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19461281|NCT03346252|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19461282|NCT03346252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19461283|NCT03346252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461284|NCT03346252|Cholinergic Agents|cholinergic agents|mesh-ancestor
19461285|NCT03346252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19461286|NCT03346252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461287|NCT03346252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19461288|NCT03346252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19461289|NCT03346226|Dexmedetomidine|dexmedetomidine|mesh-list
19461290|NCT03346226|Propofol|propofol|mesh-list
19461291|NCT03346226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19461292|NCT03346226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19461293|NCT03346226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461294|NCT03346226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19461295|NCT03346226|Anesthetics, General|anesthetics, general|mesh-ancestor
19461296|NCT03346226|Anesthetics|anesthetics|mesh-ancestor
19461297|NCT03346226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19461298|NCT03346226|Analgesics|analgesics|mesh-ancestor
19461299|NCT03346226|Sensory System Agents|sensory system agents|mesh-ancestor
19461300|NCT03346226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19461301|NCT03346226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19461302|NCT03346226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19461303|NCT03346226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19461304|NCT03346226|Adrenergic Agents|adrenergic agents|mesh-ancestor
19461305|NCT03346226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19461306|NCT03346226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461307|NCT03346200|Tamoxifen|tamoxifen|mesh-list
19461308|NCT03346200|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19461309|NCT03346200|Hormone Antagonists|hormone antagonists|mesh-ancestor
19461310|NCT03346200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19461311|NCT03346200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461312|NCT03346200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19461313|NCT03346200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461314|NCT03346200|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19461315|NCT03346200|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19461316|NCT03346200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19461317|NCT03346187|Atorvastatin|atorvastatin|mesh-list
19461318|NCT03346187|Fenofibrate|fenofibrate|mesh-list
19461319|NCT03346187|Calcium|calcium|mesh-list
19461320|NCT03346187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19461321|NCT03346187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461322|NCT03346187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19461323|NCT03346187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19461324|NCT03346187|Antimetabolites|antimetabolites|mesh-ancestor
19461325|NCT03346187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461326|NCT03346187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19461327|NCT03346187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19461328|NCT03346187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19461329|NCT03346096|Thiotepa|thiotepa|mesh-list
19461330|NCT03346096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19461331|NCT03346096|Alkylating Agents|alkylating agents|mesh-ancestor
19461332|NCT03346096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461333|NCT03346096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461334|NCT03346096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19461335|NCT03346096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19461336|NCT03346096|Immunologic Factors|immunologic factors|mesh-ancestor
19461337|NCT03346096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461338|NCT03346083|Betrixaban|betrixaban|mesh-list
19461339|NCT03346083|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19461340|NCT03346083|Antithrombins|antithrombins|mesh-ancestor
19461341|NCT03346083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19461342|NCT03346083|Protease Inhibitors|protease inhibitors|mesh-ancestor
19461343|NCT03346083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19461344|NCT03346083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461345|NCT03346083|Anticoagulants|anticoagulants|mesh-ancestor
19461346|NCT03345992|Clarithromycin|clarithromycin|mesh-list
19461347|NCT03345992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19461348|NCT03345992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19461349|NCT03345992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19461350|NCT03345992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19461351|NCT03345992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461352|NCT03345992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19461353|NCT03345992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19461354|NCT03345966|Antibodies|antibodies|mesh-list
19461355|NCT03345966|Immunologic Factors|immunologic factors|mesh-ancestor
19461356|NCT03345966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461357|NCT03345940|Dimethyl Fumarate|dimethyl fumarate|mesh-list
19461358|NCT03345940|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
19461359|NCT03345940|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
19461360|NCT03345940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461361|NCT03345940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19461362|NCT03345940|Immunologic Factors|immunologic factors|mesh-ancestor
19461363|NCT03345940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461364|NCT03345940|Dermatologic Agents|dermatologic agents|mesh-ancestor
19461365|NCT03345836|Upadacitinib|upadacitinib|mesh-list
19461366|NCT03345836|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
19461367|NCT03345836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19461368|NCT03345836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19461369|NCT03345836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461370|NCT03345836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19461371|NCT03345797|Testosterone|testosterone|mesh-list
19461372|NCT03345797|Androgens|androgens|mesh-ancestor
19461373|NCT03345797|Hormones|hormones|mesh-ancestor
19461374|NCT03345797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19461375|NCT03345797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461376|NCT03345667|Ranibizumab|ranibizumab|mesh-list
19461377|NCT03345667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19461378|NCT03345667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19461379|NCT03345667|Growth Substances|growth substances|mesh-ancestor
19461380|NCT03345667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461381|NCT03345667|Growth Inhibitors|growth inhibitors|mesh-ancestor
19461382|NCT03345667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461383|NCT03345628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
19461384|NCT03345628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19461385|NCT03345628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461386|NCT03345498|Entecavir|entecavir|mesh-list
19461387|NCT03345498|Antiviral Agents|antiviral agents|mesh-ancestor
19461388|NCT03345498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19461389|NCT03345303|Bortezomib|bortezomib|mesh-list
19461390|NCT03345303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461391|NCT03345147|Vitamins|vitamins|mesh-list
19461392|NCT03345147|Vitamin A|vitamin a|mesh-list
19461393|NCT03345147|Retinol palmitate|retinol palmitate|mesh-list
19461394|NCT03345147|Micronutrients|micronutrients|mesh-ancestor
19461395|NCT03345147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461396|NCT03345147|Antioxidants|antioxidants|mesh-ancestor
19461397|NCT03345147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461398|NCT03345147|Protective Agents|protective agents|mesh-ancestor
19461399|NCT03345147|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19461400|NCT03345147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461401|NCT03345134|Pembrolizumab|pembrolizumab|mesh-list
19461402|NCT03345134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19461403|NCT03345134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461404|NCT03345095|Temozolomide|temozolomide|mesh-list
19461405|NCT03345095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19461406|NCT03345095|Alkylating Agents|alkylating agents|mesh-ancestor
19461407|NCT03345095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461408|NCT03345095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461409|NCT03345004|Vitamin D|vitamin d|mesh-list
19461410|NCT03345004|Ergocalciferols|ergocalciferols|mesh-list
19461411|NCT03345004|Vitamins|vitamins|mesh-list
19461412|NCT03345004|Aluminum sulfate|aluminum sulfate|mesh-list
19461413|NCT03345004|Micronutrients|micronutrients|mesh-ancestor
19461414|NCT03345004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461415|NCT03345004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19461416|NCT03345004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19461417|NCT03345004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19461418|NCT03345004|Immunologic Factors|immunologic factors|mesh-ancestor
19461419|NCT03344952|Botulinum Toxins|botulinum toxins|mesh-list
19461420|NCT03344952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19461421|NCT03344952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19461422|NCT03344952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19461423|NCT03344952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19461424|NCT03344952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461425|NCT03344952|Cholinergic Agents|cholinergic agents|mesh-ancestor
19461426|NCT03344952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19461427|NCT03344952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461428|NCT03344952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19461429|NCT03344952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20011722|NCT02370615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19461430|NCT03344822|Choline|choline|mesh-list
19461431|NCT03344822|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19461432|NCT03344822|Lipotropic Agents|lipotropic agents|mesh-ancestor
19461433|NCT03344822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19461434|NCT03344822|Antimetabolites|antimetabolites|mesh-ancestor
19461435|NCT03344822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461436|NCT03344822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19461437|NCT03344822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19461438|NCT03344822|Nootropic Agents|nootropic agents|mesh-ancestor
19461439|NCT03344822|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19461440|NCT03344705|Cyclophosphamide|cyclophosphamide|mesh-list
19461441|NCT03344705|Fludarabine|fludarabine|mesh-list
19461442|NCT03344705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19461443|NCT03344705|Immunologic Factors|immunologic factors|mesh-ancestor
19461444|NCT03344705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461445|NCT03344705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19461446|NCT03344705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19461447|NCT03344705|Alkylating Agents|alkylating agents|mesh-ancestor
19461448|NCT03344705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461449|NCT03344705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461450|NCT03344705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19461451|NCT03344679|Magnesium Sulfate|magnesium sulfate|mesh-list
19461452|NCT03344679|Adenosine|adenosine|mesh-list
19461453|NCT03344679|Bupivacaine|bupivacaine|mesh-list
19461454|NCT03344679|Anesthetics, Local|anesthetics, local|mesh-ancestor
19461455|NCT03344679|Anesthetics|anesthetics|mesh-ancestor
19461456|NCT03344679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19461457|NCT03344679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461458|NCT03344679|Sensory System Agents|sensory system agents|mesh-ancestor
19461459|NCT03344679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19461460|NCT03344679|Analgesics|analgesics|mesh-ancestor
19461461|NCT03344679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19461462|NCT03344679|Anticonvulsants|anticonvulsants|mesh-ancestor
19461463|NCT03344679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19461464|NCT03344679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19461465|NCT03344679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461466|NCT03344679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19461467|NCT03344679|Tocolytic Agents|tocolytic agents|mesh-ancestor
19461468|NCT03344679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19461469|NCT03344679|Vasodilator Agents|vasodilator agents|mesh-ancestor
19461470|NCT03344679|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19461471|NCT03344679|Purinergic Agonists|purinergic agonists|mesh-ancestor
19461472|NCT03344679|Purinergic Agents|purinergic agents|mesh-ancestor
19461473|NCT03344679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19461474|NCT03344627|Meropenem|meropenem|mesh-list
19461475|NCT03344627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19461476|NCT03344627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19461477|NCT03344614|Apatinib|apatinib|mesh-list
19461478|NCT03344614|Raltitrexed|raltitrexed|mesh-list
19461479|NCT03344614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461480|NCT03344614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19461481|NCT03344614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19461482|NCT03344614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461483|NCT03344614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19461484|NCT03344614|Antimetabolites|antimetabolites|mesh-ancestor
19461485|NCT03344614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19461486|NCT03344536|Fulvestrant|fulvestrant|mesh-list
19461487|NCT03344536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19461488|NCT03344536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461489|NCT03344536|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19461490|NCT03344536|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19461491|NCT03344536|Hormone Antagonists|hormone antagonists|mesh-ancestor
19461492|NCT03344536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19461493|NCT03344536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461494|NCT03344523|Iron protein succinylate|iron protein succinylate|mesh-list
19461495|NCT03344523|Hematinics|hematinics|mesh-ancestor
19461496|NCT03344445|Anesthetics|anesthetics|mesh-list
19461497|NCT03344445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19461498|NCT03344445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461499|NCT03344393|Ketamine|ketamine|mesh-list
19461500|NCT03344393|Analgesics|analgesics|mesh-ancestor
19461501|NCT03344393|Sensory System Agents|sensory system agents|mesh-ancestor
19461502|NCT03344393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19461503|NCT03344393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461504|NCT03344393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19461505|NCT03344393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19461506|NCT03344393|Anesthetics, General|anesthetics, general|mesh-ancestor
19461507|NCT03344393|Anesthetics|anesthetics|mesh-ancestor
19461508|NCT03344393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19461509|NCT03344393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19461510|NCT03344393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19461511|NCT03344393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011723|NCT02370615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20011724|NCT02370615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011725|NCT02370615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20011726|NCT02370615|Hormone Antagonists|hormone antagonists|mesh-ancestor
20011727|NCT02370615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20011728|NCT02370615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20011729|NCT02370615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20011730|NCT02370615|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20011731|NCT02370615|Protective Agents|protective agents|mesh-ancestor
20011732|NCT02370693|Mycophenolic Acid|mycophenolic acid|mesh-list
19461512|NCT03344393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461513|NCT03344328|Bortezomib|bortezomib|mesh-list
19461514|NCT03344328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461515|NCT03344302|Oxytocin|oxytocin|mesh-list
19461516|NCT03344302|Oxytocics|oxytocics|mesh-ancestor
19461517|NCT03344302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19461518|NCT03344302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461519|NCT03344211|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19461520|NCT03344211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461521|NCT03344094|Interferons|interferons|mesh-list
19461522|NCT03344094|Interferon-beta|interferon-beta|mesh-list
19461523|NCT03344094|Ocrelizumab|ocrelizumab|mesh-list
19461524|NCT03344094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461525|NCT03344094|Antiviral Agents|antiviral agents|mesh-ancestor
19461526|NCT03344094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19461527|NCT03344094|Immunologic Factors|immunologic factors|mesh-ancestor
19461528|NCT03344094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461529|NCT03344042|Fentanyl|fentanyl|mesh-list
19461530|NCT03344042|Sufentanil|sufentanil|mesh-list
19461531|NCT03344042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19461532|NCT03344042|Narcotics|narcotics|mesh-ancestor
19461533|NCT03344042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20011733|NCT02370693|Bortezomib|bortezomib|mesh-list
19461534|NCT03344042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461535|NCT03344042|Analgesics|analgesics|mesh-ancestor
19461536|NCT03344042|Sensory System Agents|sensory system agents|mesh-ancestor
19461537|NCT03344042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19461538|NCT03344042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19461539|NCT03344042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19461540|NCT03344042|Anesthetics, General|anesthetics, general|mesh-ancestor
19461541|NCT03344042|Anesthetics|anesthetics|mesh-ancestor
19461542|NCT03344029|Vaccines|vaccines|mesh-list
19461543|NCT03344029|Immunologic Factors|immunologic factors|mesh-ancestor
19461544|NCT03344029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461545|NCT03344003|Factor VIII|factor viii|mesh-list
19461546|NCT03344003|Coagulants|coagulants|mesh-ancestor
19461547|NCT03343977|Docetaxel|docetaxel|mesh-list
19461548|NCT03343977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461549|NCT03343977|Tubulin Modulators|tubulin modulators|mesh-ancestor
19461550|NCT03343977|Antimitotic Agents|antimitotic agents|mesh-ancestor
19461551|NCT03343977|Mitosis Modulators|mitosis modulators|mesh-ancestor
19461552|NCT03343977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461553|NCT03343873|Midazolam|midazolam|mesh-list
19461554|NCT03343873|Dexmedetomidine|dexmedetomidine|mesh-list
19461555|NCT03343873|Propofol|propofol|mesh-list
19461556|NCT03343873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19461557|NCT03343873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19461558|NCT03343873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461559|NCT03343873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19461560|NCT03343873|Anesthetics, General|anesthetics, general|mesh-ancestor
19461561|NCT03343873|Anesthetics|anesthetics|mesh-ancestor
19461562|NCT03343873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19461563|NCT03343873|Analgesics|analgesics|mesh-ancestor
19461564|NCT03343873|Sensory System Agents|sensory system agents|mesh-ancestor
19461565|NCT03343873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19461566|NCT03343873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19461567|NCT03343873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19461568|NCT03343873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19461569|NCT03343873|Adrenergic Agents|adrenergic agents|mesh-ancestor
19461570|NCT03343873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19461571|NCT03343873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461572|NCT03343873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19461573|NCT03343873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19461574|NCT03343873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19461575|NCT03343873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19461576|NCT03343873|GABA Modulators|gaba modulators|mesh-ancestor
19461577|NCT03343873|GABA Agents|gaba agents|mesh-ancestor
19461578|NCT03343795|Progesterone|progesterone|mesh-list
19461579|NCT03343795|Progestins|progestins|mesh-ancestor
19461580|NCT03343795|Hormones|hormones|mesh-ancestor
19461581|NCT03343795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19461582|NCT03343795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461583|NCT03343678|Venetoclax|venetoclax|mesh-list
19461584|NCT03343678|BI 836826|bi 836826|mesh-list
19461585|NCT03343678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461586|NCT03343678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19461587|NCT03343665|Nivolumab|nivolumab|mesh-list
19461588|NCT03343665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19461589|NCT03343665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461590|NCT03343665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19461591|NCT03343665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461592|NCT03343652|Nivolumab|nivolumab|mesh-list
19461593|NCT03343652|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19461594|NCT03343652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19461595|NCT03343652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461596|NCT03343652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19461597|NCT03343652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461598|NCT03343652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19461599|NCT03343652|Alkylating Agents|alkylating agents|mesh-ancestor
19461600|NCT03343600|Imatinib Mesylate|imatinib mesylate|mesh-list
19461601|NCT03343600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461602|NCT03343600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19461603|NCT03343600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19461604|NCT03343600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461605|NCT03343548|Magnesium Sulfate|magnesium sulfate|mesh-list
19461606|NCT03343548|Analgesics|analgesics|mesh-ancestor
19461607|NCT03343548|Sensory System Agents|sensory system agents|mesh-ancestor
19461608|NCT03343548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19461609|NCT03343548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461610|NCT03343548|Anesthetics|anesthetics|mesh-ancestor
19461611|NCT03343548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19461612|NCT03343548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19461613|NCT03343548|Anticonvulsants|anticonvulsants|mesh-ancestor
19461614|NCT03343548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19461615|NCT03343548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19461616|NCT03343548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461617|NCT03343548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19461618|NCT03343548|Tocolytic Agents|tocolytic agents|mesh-ancestor
19461619|NCT03343548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19461620|NCT03343509|Metronidazole|metronidazole|mesh-list
19461621|NCT03343509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19461622|NCT03343509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19461623|NCT03343509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19461624|NCT03343509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19461625|NCT03343444|Sofosbuvir|sofosbuvir|mesh-list
19461626|NCT03343444|Ledipasvir|ledipasvir|mesh-list
19461627|NCT03343444|Antiviral Agents|antiviral agents|mesh-ancestor
19461628|NCT03343444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19461629|NCT03343418|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
19461630|NCT03343418|Hemostatics|hemostatics|mesh-ancestor
19461631|NCT03343418|Coagulants|coagulants|mesh-ancestor
19461632|NCT03343418|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19461633|NCT03343418|Natriuretic Agents|natriuretic agents|mesh-ancestor
19461634|NCT03343418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461635|NCT03343366|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19461636|NCT03343366|Metronidazole|metronidazole|mesh-list
19461637|NCT03343366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19461638|NCT03343366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19461639|NCT03343366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20011734|NCT02370693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20011735|NCT02370693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011736|NCT02370693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20011737|NCT02370693|Antitubercular Agents|antitubercular agents|mesh-ancestor
20011738|NCT02370693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20011739|NCT02370693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20011740|NCT02370693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011741|NCT02370693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011742|NCT02370784|Atorvastatin|atorvastatin|mesh-list
20011743|NCT02370784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20011744|NCT02370784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20011745|NCT02370784|Antimetabolites|antimetabolites|mesh-ancestor
20011746|NCT02370784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011747|NCT02370784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20011748|NCT02370784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20011749|NCT02370784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011750|NCT02371187|Dapagliflozin|dapagliflozin|mesh-list
20011751|NCT02371187|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20011752|NCT02371187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011753|NCT02371187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20011754|NCT02371187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011755|NCT02371252|Alendronate|alendronate|mesh-list
20011756|NCT02371252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20011757|NCT02371252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011758|NCT02371616|Listerine|listerine|mesh-list
20011759|NCT02371616|Calcium|calcium|mesh-list
20011760|NCT02371616|Fluorides|fluorides|mesh-list
20011761|NCT02371616|Sodium Fluoride|sodium fluoride|mesh-list
20011762|NCT02371616|Fluorophosphate|fluorophosphate|mesh-list
20011763|NCT02371616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20011764|NCT02371616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011765|NCT02371616|Cariostatic Agents|cariostatic agents|mesh-ancestor
20011766|NCT02371616|Protective Agents|protective agents|mesh-ancestor
20011767|NCT02371616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20011768|NCT02371616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20011769|NCT02371629|Glycopyrrolate|glycopyrrolate|mesh-list
20011770|NCT02371629|Bromides|bromides|mesh-list
20011771|NCT02371629|Albuterol|albuterol|mesh-list
20011772|NCT02371629|Anticonvulsants|anticonvulsants|mesh-ancestor
20011773|NCT02371629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20011774|NCT02371629|Autonomic Agents|autonomic agents|mesh-ancestor
20011775|NCT02371629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20011776|NCT02371629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011777|NCT02371629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20011778|NCT02371629|Respiratory System Agents|respiratory system agents|mesh-ancestor
20011779|NCT02371629|Tocolytic Agents|tocolytic agents|mesh-ancestor
20011780|NCT02371629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19461640|NCT03343002|Fentanyl|fentanyl|mesh-list
19461641|NCT03343002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19461642|NCT03343002|Narcotics|narcotics|mesh-ancestor
19461643|NCT03343002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19461644|NCT03343002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461645|NCT03343002|Analgesics|analgesics|mesh-ancestor
19461646|NCT03343002|Sensory System Agents|sensory system agents|mesh-ancestor
19461647|NCT03343002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19461648|NCT03343002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19461649|NCT03343002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20011781|NCT02371629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20011782|NCT02371629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20011783|NCT02371629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20011784|NCT02371629|Adrenergic Agents|adrenergic agents|mesh-ancestor
20011785|NCT02371629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011786|NCT02371629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011787|NCT02371629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20011788|NCT02371629|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20011789|NCT02371629|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19461650|NCT03343002|Anesthetics, General|anesthetics, general|mesh-ancestor
19461651|NCT03343002|Anesthetics|anesthetics|mesh-ancestor
19461652|NCT03342911|Paclitaxel|paclitaxel|mesh-list
19461653|NCT03342911|Carboplatin|carboplatin|mesh-list
19461654|NCT03342911|Nivolumab|nivolumab|mesh-list
19461655|NCT03342911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19461656|NCT03342911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461657|NCT03342911|Tubulin Modulators|tubulin modulators|mesh-ancestor
19461658|NCT03342911|Antimitotic Agents|antimitotic agents|mesh-ancestor
19461659|NCT03342911|Mitosis Modulators|mitosis modulators|mesh-ancestor
19461660|NCT03342911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461661|NCT03342911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19461662|NCT03342911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19461663|NCT03342859|Ulipristal acetate|ulipristal acetate|mesh-list
19461664|NCT03342859|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19461665|NCT03342859|Contraceptive Agents|contraceptive agents|mesh-ancestor
19461666|NCT03342859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19461667|NCT03342859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461668|NCT03342859|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19461669|NCT03342807|Insulin|insulin|mesh-list
19461670|NCT03342807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19461671|NCT03342807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461672|NCT03342651|Vitamin D|vitamin d|mesh-list
19461673|NCT03342651|Vitamins|vitamins|mesh-ancestor
19461674|NCT03342651|Micronutrients|micronutrients|mesh-ancestor
19461675|NCT03342651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461676|NCT03342651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19461677|NCT03342599|Thioctic Acid|thioctic acid|mesh-list
19461678|NCT03342599|Antioxidants|antioxidants|mesh-ancestor
19461679|NCT03342599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461680|NCT03342599|Protective Agents|protective agents|mesh-ancestor
19461681|NCT03342599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461682|NCT03342599|Vitamin B Complex|vitamin b complex|mesh-ancestor
19461683|NCT03342599|Vitamins|vitamins|mesh-ancestor
19461684|NCT03342599|Micronutrients|micronutrients|mesh-ancestor
19461685|NCT03342443|Memantine|memantine|mesh-list
19461686|NCT03342443|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19461687|NCT03342443|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19461688|NCT03342443|Dopamine Agents|dopamine agents|mesh-ancestor
19461689|NCT03342443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19461690|NCT03342443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461691|NCT03342443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461692|NCT03342443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19461693|NCT03342443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19461694|NCT03342352|Carboplatin|carboplatin|mesh-list
19461695|NCT03342352|Fluorouracil|fluorouracil|mesh-list
19461696|NCT03342352|Nivolumab|nivolumab|mesh-list
19461697|NCT03342352|Cetuximab|cetuximab|mesh-list
19461698|NCT03342352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461699|NCT03342352|Antimetabolites|antimetabolites|mesh-ancestor
19461700|NCT03342352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461701|NCT03342352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19461702|NCT03342352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19461703|NCT03342352|Immunologic Factors|immunologic factors|mesh-ancestor
19461704|NCT03342352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461705|NCT03342352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19461706|NCT03342352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19461707|NCT03342300|Doxorubicin|doxorubicin|mesh-list
19461708|NCT03342300|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19461709|NCT03342300|Pirarubicin|pirarubicin|mesh-list
19461710|NCT03342300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19461711|NCT03342300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461712|NCT03342300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19461713|NCT03342300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19461714|NCT03342300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19461715|NCT03342300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461716|NCT03342261|Antiviral Agents|antiviral agents|mesh-list
19461717|NCT03342261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19461718|NCT03342170|Thrombin|thrombin|mesh-list
19461719|NCT03342170|Hemostatics|hemostatics|mesh-ancestor
19461720|NCT03342170|Coagulants|coagulants|mesh-ancestor
19461721|NCT03342079|Nitrous Oxide|nitrous oxide|mesh-list
19461722|NCT03342079|Anesthetics|anesthetics|mesh-list
19461723|NCT03342079|Anesthetics, Local|anesthetics, local|mesh-list
19461724|NCT03342079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19461725|NCT03342079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461726|NCT03342079|Sensory System Agents|sensory system agents|mesh-ancestor
19461727|NCT03342079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19461728|NCT03342079|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19461729|NCT03342079|Anesthetics, General|anesthetics, general|mesh-ancestor
19461730|NCT03342079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19461731|NCT03342079|Analgesics|analgesics|mesh-ancestor
19461732|NCT03342040|Bupivacaine|bupivacaine|mesh-list
19461733|NCT03342040|Ropivacaine|ropivacaine|mesh-list
19461734|NCT03342040|Anesthetics, Local|anesthetics, local|mesh-ancestor
19461735|NCT03342040|Anesthetics|anesthetics|mesh-ancestor
19461736|NCT03342040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19461737|NCT03342040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461738|NCT03342040|Sensory System Agents|sensory system agents|mesh-ancestor
19461739|NCT03342040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19461740|NCT03341988|Ritonavir|ritonavir|mesh-list
19461741|NCT03341988|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19461742|NCT03341988|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19461743|NCT03341988|Protease Inhibitors|protease inhibitors|mesh-ancestor
19461744|NCT03341988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19461745|NCT03341988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461746|NCT03341988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19461747|NCT03341988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19461748|NCT03341988|Antiviral Agents|antiviral agents|mesh-ancestor
19461749|NCT03341988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19461750|NCT03341988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19461751|NCT03341988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19461752|NCT03341936|Nivolumab|nivolumab|mesh-list
19461753|NCT03341936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19461754|NCT03341936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461755|NCT03341936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19461756|NCT03341936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461757|NCT03341845|Avelumab|avelumab|mesh-list
19461758|NCT03341845|Axitinib|axitinib|mesh-list
19461759|NCT03341845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20011790|NCT02371629|Cholinergic Agents|cholinergic agents|mesh-ancestor
19461760|NCT03341845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461761|NCT03341845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19461762|NCT03341845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19461763|NCT03341845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461764|NCT03341767|Clofazimine|clofazimine|mesh-list
19461765|NCT03341767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19461766|NCT03341767|Leprostatic Agents|leprostatic agents|mesh-ancestor
19461767|NCT03341767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19461768|NCT03341767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19461769|NCT03341741|Tobramycin|tobramycin|mesh-list
19461770|NCT03341741|Colistin|colistin|mesh-list
19461771|NCT03341741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19461772|NCT03341741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19461773|NCT03341676|Dexamethasone|dexamethasone|mesh-list
19461774|NCT03341676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19461775|NCT03341676|Antiemetics|antiemetics|mesh-ancestor
19461776|NCT03341676|Autonomic Agents|autonomic agents|mesh-ancestor
19461777|NCT03341676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19461778|NCT03341676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461779|NCT03341676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19461780|NCT03341676|Glucocorticoids|glucocorticoids|mesh-ancestor
19461781|NCT03341676|Hormones|hormones|mesh-ancestor
19461782|NCT03341676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19461783|NCT03341676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19461784|NCT03341676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461785|NCT03341520|Obinutuzumab|obinutuzumab|mesh-list
19461786|NCT03341520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19461787|NCT03341520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461788|NCT03341494|Thalidomide|thalidomide|mesh-list
19461789|NCT03341494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19461790|NCT03341494|Immunologic Factors|immunologic factors|mesh-ancestor
19461791|NCT03341494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461792|NCT03341494|Leprostatic Agents|leprostatic agents|mesh-ancestor
19461793|NCT03341494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19461794|NCT03341494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19461795|NCT03341494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19461796|NCT03341494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19461797|NCT03341494|Growth Substances|growth substances|mesh-ancestor
19461798|NCT03341494|Growth Inhibitors|growth inhibitors|mesh-ancestor
19461799|NCT03341494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461800|NCT03341429|Liraglutide|liraglutide|mesh-list
19461801|NCT03341429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19461802|NCT03341429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461803|NCT03341429|Incretins|incretins|mesh-ancestor
19461804|NCT03341429|Hormones|hormones|mesh-ancestor
19461805|NCT03341429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20011791|NCT02371746|Travoprost|travoprost|mesh-list
20011792|NCT02371746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20011793|NCT02371759|Anesthetics|anesthetics|mesh-list
19461806|NCT03341390|Aspirin|aspirin|mesh-list
19461807|NCT03341390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19461808|NCT03341390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19461809|NCT03341390|Analgesics|analgesics|mesh-ancestor
19461810|NCT03341390|Sensory System Agents|sensory system agents|mesh-ancestor
19461811|NCT03341390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19461812|NCT03341390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461813|NCT03341390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19461814|NCT03341390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19461815|NCT03341390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19461816|NCT03341390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19461817|NCT03341390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461818|NCT03341390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19461819|NCT03341390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19461820|NCT03341390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19461821|NCT03341390|Antipyretics|antipyretics|mesh-ancestor
19461822|NCT03341260|Diclofenac|diclofenac|mesh-list
19461823|NCT03341260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19461824|NCT03341260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19461825|NCT03341260|Analgesics|analgesics|mesh-ancestor
19461826|NCT03341260|Sensory System Agents|sensory system agents|mesh-ancestor
19461827|NCT03341260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19461828|NCT03341260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461829|NCT03341260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19461830|NCT03341260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19461831|NCT03341260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19461832|NCT03341260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19461833|NCT03341260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461834|NCT03341234|Bupivacaine|bupivacaine|mesh-list
19461835|NCT03341234|Anesthetics, Local|anesthetics, local|mesh-ancestor
19461836|NCT03341234|Anesthetics|anesthetics|mesh-ancestor
19461837|NCT03341234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19461838|NCT03341234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461839|NCT03341234|Sensory System Agents|sensory system agents|mesh-ancestor
19461840|NCT03341234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19461841|NCT03341117|Aspirin|aspirin|mesh-list
19461842|NCT03341117|Magnesium Oxide|magnesium oxide|mesh-list
19461843|NCT03341117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19461844|NCT03341117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19461845|NCT03341117|Analgesics|analgesics|mesh-ancestor
19461846|NCT03341117|Sensory System Agents|sensory system agents|mesh-ancestor
19461847|NCT03341117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19461848|NCT03341117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461849|NCT03341117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19461850|NCT03341117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19461851|NCT03341117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19461852|NCT03341117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19461853|NCT03341117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461854|NCT03341117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19461855|NCT03341117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19461856|NCT03341117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19461857|NCT03341117|Antipyretics|antipyretics|mesh-ancestor
19461858|NCT03341117|Antacids|antacids|mesh-ancestor
19461859|NCT03341117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19461860|NCT03341104|Bupivacaine|bupivacaine|mesh-list
19461861|NCT03341104|Anesthetics, Local|anesthetics, local|mesh-ancestor
19461862|NCT03341104|Anesthetics|anesthetics|mesh-ancestor
19461863|NCT03341104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19461864|NCT03341104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461865|NCT03341104|Sensory System Agents|sensory system agents|mesh-ancestor
19461866|NCT03341104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19461867|NCT03340922|Long-Acting Thyroid Stimulator|long-acting thyroid stimulator|mesh-list
19461868|NCT03340922|Immunologic Factors|immunologic factors|mesh-ancestor
19461869|NCT03340922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461870|NCT03340909|Prednisolone|prednisolone|mesh-list
19461871|NCT03340909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19461872|NCT03340909|Glucocorticoids|glucocorticoids|mesh-ancestor
19461873|NCT03340909|Hormones|hormones|mesh-ancestor
19461874|NCT03340909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19461875|NCT03340909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461876|NCT03340909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19461877|NCT03340909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461878|NCT03340779|Dobutamine|dobutamine|mesh-list
19461879|NCT03340779|Norepinephrine|norepinephrine|mesh-list
19461880|NCT03340779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19461881|NCT03340779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19461882|NCT03340779|Adrenergic Agents|adrenergic agents|mesh-ancestor
19461883|NCT03340779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19461884|NCT03340779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461885|NCT03340779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461886|NCT03340779|Sympathomimetics|sympathomimetics|mesh-ancestor
19461887|NCT03340779|Autonomic Agents|autonomic agents|mesh-ancestor
19461888|NCT03340779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19461889|NCT03340779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19461890|NCT03340779|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19461891|NCT03340779|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19461892|NCT03340779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19461893|NCT03340779|Protective Agents|protective agents|mesh-ancestor
19461894|NCT03340753|Mineralocorticoids|mineralocorticoids|mesh-list
19461895|NCT03340753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
19461896|NCT03340753|Hormones|hormones|mesh-ancestor
19461897|NCT03340753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19461898|NCT03340753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461899|NCT03340753|Hormone Antagonists|hormone antagonists|mesh-ancestor
19461900|NCT03340753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19461901|NCT03340753|Diuretics|diuretics|mesh-ancestor
19461902|NCT03340753|Natriuretic Agents|natriuretic agents|mesh-ancestor
19461903|NCT03340740|Cetirizine|cetirizine|mesh-list
19461904|NCT03340740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19461905|NCT03340740|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
19461906|NCT03340740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19461907|NCT03340740|Histamine Antagonists|histamine antagonists|mesh-ancestor
19461908|NCT03340740|Histamine Agents|histamine agents|mesh-ancestor
19461909|NCT03340740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19461910|NCT03340740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461911|NCT03340740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461912|NCT03340701|Progesterone|progesterone|mesh-list
19461913|NCT03340701|Progestins|progestins|mesh-ancestor
19461914|NCT03340701|Hormones|hormones|mesh-ancestor
19461915|NCT03340701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19461916|NCT03340701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461917|NCT03340662|Itraconazole|itraconazole|mesh-list
19461918|NCT03340662|Rifampin|rifampin|mesh-list
19461919|NCT03340662|Fluvoxamine|fluvoxamine|mesh-list
19461920|NCT03340662|Antifungal Agents|antifungal agents|mesh-ancestor
19461921|NCT03340662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19461922|NCT03340662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19461923|NCT03340662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19461924|NCT03340662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19461925|NCT03340662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461926|NCT03340662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19461927|NCT03340662|Hormone Antagonists|hormone antagonists|mesh-ancestor
19461928|NCT03340662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19461929|NCT03340662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461930|NCT03340662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19461931|NCT03340662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19461932|NCT03340662|Antitubercular Agents|antitubercular agents|mesh-ancestor
19461933|NCT03340662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19461934|NCT03340662|Leprostatic Agents|leprostatic agents|mesh-ancestor
19461935|NCT03340662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19461936|NCT03340662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19461937|NCT03340662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19461938|NCT03340662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19461939|NCT03340662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19461940|NCT03340662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19461941|NCT03340662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19461942|NCT03340662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19461943|NCT03340662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19461944|NCT03340662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19461945|NCT03340662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19461946|NCT03340662|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19461947|NCT03340662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19461948|NCT03340662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19461949|NCT03340662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19461950|NCT03340662|Serotonin Agents|serotonin agents|mesh-ancestor
19461951|NCT03340662|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19461952|NCT03340662|Antidepressive Agents|antidepressive agents|mesh-ancestor
19461953|NCT03340662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19461954|NCT03340662|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19461955|NCT03340597|Olorofim|olorofim|mesh-list
19461956|NCT03340597|Antifungal Agents|antifungal agents|mesh-ancestor
19461957|NCT03340597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19461958|NCT03340558|Atezolizumab|atezolizumab|mesh-list
19461959|NCT03340558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461960|NCT03340493|Tenecteplase|tenecteplase|mesh-list
19461961|NCT03340493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19461962|NCT03340493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19461963|NCT03340493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461964|NCT03340376|Doxorubicin|doxorubicin|mesh-list
19461965|NCT03340376|Atezolizumab|atezolizumab|mesh-list
19461966|NCT03340376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19461967|NCT03340376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461968|NCT03340376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19461969|NCT03340376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19461970|NCT03340376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19461971|NCT03340376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461972|NCT03340168|Bisphenol A|bisphenol a|mesh-list
19461973|NCT03340168|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
19461974|NCT03340168|Estrogens|estrogens|mesh-ancestor
19461975|NCT03340168|Hormones|hormones|mesh-ancestor
19461976|NCT03340168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19461977|NCT03340168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461978|NCT03340168|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19461979|NCT03340168|Antioxidants|antioxidants|mesh-ancestor
19461980|NCT03340168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461981|NCT03340168|Protective Agents|protective agents|mesh-ancestor
19461982|NCT03340129|Nivolumab|nivolumab|mesh-list
19461983|NCT03340129|Ipilimumab|ipilimumab|mesh-list
19461984|NCT03340129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19461985|NCT03340129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19461986|NCT03340129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19461987|NCT03340129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461988|NCT03339921|Botulinum Toxins|botulinum toxins|mesh-list
19461989|NCT03339921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19461990|NCT03339921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19461991|NCT03339921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19461992|NCT03339921|Cholinergic Agents|cholinergic agents|mesh-ancestor
19461993|NCT03339921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19461994|NCT03339921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19461995|NCT03339804|Cyclophosphamide|cyclophosphamide|mesh-list
19461996|NCT03339804|Doxorubicin|doxorubicin|mesh-list
19461997|NCT03339804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19461998|NCT03339804|Immunologic Factors|immunologic factors|mesh-ancestor
19461999|NCT03339804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462000|NCT03339804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19462001|NCT03339804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19462002|NCT03339804|Alkylating Agents|alkylating agents|mesh-ancestor
19462003|NCT03339804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462004|NCT03339804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462005|NCT03339804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19462006|NCT03339804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19462007|NCT03339804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19462008|NCT03339804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19462009|NCT03339804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462010|NCT03339752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19462011|NCT03339752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19462012|NCT03339752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19462013|NCT03339752|Antimetabolites|antimetabolites|mesh-ancestor
19462014|NCT03339752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462015|NCT03339752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19462016|NCT03339752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19462017|NCT03339752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462018|NCT03339700|Gemcitabine|gemcitabine|mesh-list
19462019|NCT03339700|Cyclophosphamide|cyclophosphamide|mesh-list
19462020|NCT03339700|Busulfan|busulfan|mesh-list
19462021|NCT03339700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19462022|NCT03339700|Immunologic Factors|immunologic factors|mesh-ancestor
19462023|NCT03339700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462024|NCT03339700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19462025|NCT03339700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19462026|NCT03339700|Alkylating Agents|alkylating agents|mesh-ancestor
19462027|NCT03339700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462028|NCT03339700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462029|NCT03339700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19462030|NCT03339700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19462031|NCT03339700|Antimetabolites|antimetabolites|mesh-ancestor
19462032|NCT03339700|Antiviral Agents|antiviral agents|mesh-ancestor
19462033|NCT03339700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19462034|NCT03339700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011794|NCT02371759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20011795|NCT02371759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011796|NCT02371850|Nicotine|nicotine|mesh-list
20011797|NCT02371850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20011798|NCT02371850|Autonomic Agents|autonomic agents|mesh-ancestor
20011799|NCT02371850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20011800|NCT02371850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462035|NCT03339635|Methyltestosterone|methyltestosterone|mesh-list
19462036|NCT03339635|Testosterone|testosterone|mesh-list
19462037|NCT03339635|Testosterone undecanoate|testosterone undecanoate|mesh-list
19462038|NCT03339635|Testosterone enanthate|testosterone enanthate|mesh-list
19462039|NCT03339635|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19462040|NCT03339635|Androgens|androgens|mesh-ancestor
19462041|NCT03339635|Hormones|hormones|mesh-ancestor
19462042|NCT03339635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19462043|NCT03339635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462044|NCT03339635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19462045|NCT03339635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462046|NCT03339635|Anabolic Agents|anabolic agents|mesh-ancestor
19462047|NCT03339596|Epoetin Alfa|epoetin alfa|mesh-list
19462048|NCT03339596|Hematinics|hematinics|mesh-ancestor
19462049|NCT03339544|Celecoxib|celecoxib|mesh-list
19462050|NCT03339544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19462051|NCT03339544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19462052|NCT03339544|Analgesics|analgesics|mesh-ancestor
19462053|NCT03339544|Sensory System Agents|sensory system agents|mesh-ancestor
19462054|NCT03339544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462055|NCT03339544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011801|NCT02371850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20011802|NCT02371850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20011803|NCT02371850|Cholinergic Agents|cholinergic agents|mesh-ancestor
20011804|NCT02371850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011805|NCT02371850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011806|NCT02371980|Vortioxetine|vortioxetine|mesh-list
20011807|NCT02371980|Antidepressive Agents|antidepressive agents|mesh-ancestor
20011808|NCT02371980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20011809|NCT02371980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20011810|NCT02371980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20011811|NCT02371980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20011812|NCT02371980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011813|NCT02371980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20011814|NCT02371980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20011815|NCT02371980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20011816|NCT02371980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011817|NCT02371980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011818|NCT02371980|Serotonin Agents|serotonin agents|mesh-ancestor
20011819|NCT02371980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20011820|NCT02371980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20011821|NCT02371980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20011822|NCT02371980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20011823|NCT02372006|Afatinib|afatinib|mesh-list
20011824|NCT02372006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011825|NCT02372006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20011826|NCT02372006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011827|NCT02372006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011828|NCT02372253|Verapamil|verapamil|mesh-list
20011829|NCT02372253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20011830|NCT02372253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20011831|NCT02372253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19462056|NCT03339544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19462057|NCT03339544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19462058|NCT03339544|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19462059|NCT03339544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19462060|NCT03339544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462061|NCT03339544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462062|NCT03339427|Vitamin D|vitamin d|mesh-list
19462063|NCT03339427|Vitamins|vitamins|mesh-ancestor
19462064|NCT03339427|Micronutrients|micronutrients|mesh-ancestor
19462065|NCT03339427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462066|NCT03339427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19462067|NCT03339362|Methylprednisolone|methylprednisolone|mesh-list
19462068|NCT03339362|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19462069|NCT03339362|Bupivacaine|bupivacaine|mesh-list
19462070|NCT03339362|Anesthetics, Local|anesthetics, local|mesh-ancestor
19462071|NCT03339362|Anesthetics|anesthetics|mesh-ancestor
19462072|NCT03339362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19462073|NCT03339362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462074|NCT03339362|Sensory System Agents|sensory system agents|mesh-ancestor
19462075|NCT03339362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462076|NCT03339362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19462077|NCT03339362|Antiemetics|antiemetics|mesh-ancestor
19462078|NCT03339362|Autonomic Agents|autonomic agents|mesh-ancestor
19462079|NCT03339362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19462080|NCT03339362|Glucocorticoids|glucocorticoids|mesh-ancestor
19462081|NCT03339362|Hormones|hormones|mesh-ancestor
19462082|NCT03339362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19462083|NCT03339362|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19462084|NCT03339362|Protective Agents|protective agents|mesh-ancestor
19462085|NCT03339349|Enoxaparin|enoxaparin|mesh-list
19462086|NCT03339349|Anticoagulants|anticoagulants|mesh-ancestor
19462087|NCT03339349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19462088|NCT03339349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19462089|NCT03339349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462090|NCT03339258|Doxazosin|doxazosin|mesh-list
19462091|NCT03339258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19462092|NCT03339258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19462093|NCT03339258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19462094|NCT03339258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19462095|NCT03339258|Adrenergic Agents|adrenergic agents|mesh-ancestor
19462096|NCT03339258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19462097|NCT03339258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462098|NCT03339258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462099|NCT03339024|Oxytocin|oxytocin|mesh-list
19462100|NCT03339024|Oxytocics|oxytocics|mesh-ancestor
19462101|NCT03339024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19462102|NCT03339024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462103|NCT03338621|Moxifloxacin|moxifloxacin|mesh-list
19462104|NCT03338621|Rifampin|rifampin|mesh-list
19462105|NCT03338621|Isoniazid|isoniazid|mesh-list
19462106|NCT03338621|Pyrazinamide|pyrazinamide|mesh-list
19462107|NCT03338621|Ethambutol|ethambutol|mesh-list
19462108|NCT03338621|Bedaquiline|bedaquiline|mesh-list
19462109|NCT03338621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19462110|NCT03338621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19462111|NCT03338621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19462112|NCT03338621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19462113|NCT03338621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462114|NCT03338621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462115|NCT03338621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462116|NCT03338621|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19462117|NCT03338621|Antitubercular Agents|antitubercular agents|mesh-ancestor
19462118|NCT03338621|Leprostatic Agents|leprostatic agents|mesh-ancestor
19462119|NCT03338621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19462120|NCT03338621|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19462121|NCT03338621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19462122|NCT03338621|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19462123|NCT03338621|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19462124|NCT03338621|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19462125|NCT03338621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19462126|NCT03338621|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19462127|NCT03338621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19462128|NCT03338621|Antimetabolites|antimetabolites|mesh-ancestor
19462129|NCT03338621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19462130|NCT03338426|Atorvastatin|atorvastatin|mesh-list
19462131|NCT03338426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19462132|NCT03338426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19462133|NCT03338426|Antimetabolites|antimetabolites|mesh-ancestor
19462134|NCT03338426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462135|NCT03338426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19462136|NCT03338426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19462137|NCT03338426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462138|NCT03338387|Acipimox|acipimox|mesh-list
19462139|NCT03338387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19462140|NCT03338387|Antimetabolites|antimetabolites|mesh-ancestor
19462141|NCT03338387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462142|NCT03338387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19462143|NCT03338348|Azacitidine|azacitidine|mesh-list
19462144|NCT03338348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19462145|NCT03338348|Antimetabolites|antimetabolites|mesh-ancestor
19462146|NCT03338348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462147|NCT03338348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462148|NCT03338348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462149|NCT03338244|Azithromycin|azithromycin|mesh-list
19462150|NCT03338244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19462151|NCT03338244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19462152|NCT03338205|Ketamine|ketamine|mesh-list
19462153|NCT03338205|Analgesics|analgesics|mesh-ancestor
19462154|NCT03338205|Sensory System Agents|sensory system agents|mesh-ancestor
19462155|NCT03338205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462156|NCT03338205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462157|NCT03338205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19462158|NCT03338205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19462159|NCT03338205|Anesthetics, General|anesthetics, general|mesh-ancestor
19462160|NCT03338205|Anesthetics|anesthetics|mesh-ancestor
19462161|NCT03338205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19462162|NCT03338205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19462163|NCT03338205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19462164|NCT03338205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19462165|NCT03338205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462166|NCT03337932|Doxycycline|doxycycline|mesh-list
19462167|NCT03337932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19462168|NCT03337932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19462169|NCT03337932|Antimalarials|antimalarials|mesh-ancestor
19462170|NCT03337932|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19462171|NCT03337932|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19462172|NCT03337841|Pembrolizumab|pembrolizumab|mesh-list
19462173|NCT03337841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19462174|NCT03337841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462175|NCT03337828|Ethanol|ethanol|mesh-list
19462176|NCT03337828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19462177|NCT03337828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19462178|NCT03337828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19462179|NCT03337828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011832|NCT02372253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011833|NCT02372253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20011834|NCT02372253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011835|NCT02372253|Vasodilator Agents|vasodilator agents|mesh-ancestor
19462180|NCT03337672|Midazolam|midazolam|mesh-list
19462181|NCT03337672|Dexmedetomidine|dexmedetomidine|mesh-list
19462182|NCT03337672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19462183|NCT03337672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19462184|NCT03337672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462185|NCT03337672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19462186|NCT03337672|Analgesics|analgesics|mesh-ancestor
19462187|NCT03337672|Sensory System Agents|sensory system agents|mesh-ancestor
19462188|NCT03337672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462189|NCT03337672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19462190|NCT03337672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19462191|NCT03337672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19462192|NCT03337672|Adrenergic Agents|adrenergic agents|mesh-ancestor
19462193|NCT03337672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19462194|NCT03337672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462195|NCT03337672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19462196|NCT03337672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19462197|NCT03337672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19462198|NCT03337672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19462199|NCT03337672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19462200|NCT03337672|Anesthetics, General|anesthetics, general|mesh-ancestor
19462201|NCT03337672|Anesthetics|anesthetics|mesh-ancestor
19462202|NCT03337672|GABA Modulators|gaba modulators|mesh-ancestor
19462203|NCT03337672|GABA Agents|gaba agents|mesh-ancestor
19462204|NCT03337607|Celecoxib|celecoxib|mesh-list
19462205|NCT03337607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
19462206|NCT03337607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
19462207|NCT03337607|Eperisone|eperisone|mesh-list
19462208|NCT03337607|Parasympatholytics|parasympatholytics|mesh-list
19462209|NCT03337607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19462210|NCT03337607|Analgesics|analgesics|mesh-ancestor
19462211|NCT03337607|Sensory System Agents|sensory system agents|mesh-ancestor
19462212|NCT03337607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462213|NCT03337607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462214|NCT03337607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19462215|NCT03337607|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19462216|NCT03337607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19462217|NCT03337607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462218|NCT03337607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462219|NCT03337607|Anticonvulsants|anticonvulsants|mesh-ancestor
19462220|NCT03337607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20011836|NCT02372383|Azithromycin|azithromycin|mesh-list
19462221|NCT03337607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19462222|NCT03337607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19462223|NCT03337607|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
19462224|NCT03337607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19462225|NCT03337607|Autonomic Agents|autonomic agents|mesh-ancestor
19462226|NCT03337607|Vasodilator Agents|vasodilator agents|mesh-ancestor
19462227|NCT03337581|Dexmedetomidine|dexmedetomidine|mesh-list
19462228|NCT03337581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19462229|NCT03337581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19462230|NCT03337581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462231|NCT03337581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19462232|NCT03337581|Analgesics|analgesics|mesh-ancestor
19462233|NCT03337581|Sensory System Agents|sensory system agents|mesh-ancestor
19462234|NCT03337581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462235|NCT03337581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20011837|NCT02372383|Rifampin|rifampin|mesh-list
19462236|NCT03337581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19462237|NCT03337581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19462238|NCT03337581|Adrenergic Agents|adrenergic agents|mesh-ancestor
19462239|NCT03337581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19462240|NCT03337581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462241|NCT03337529|Ascorbic Acid|ascorbic acid|mesh-list
19462242|NCT03337529|Vitamins|vitamins|mesh-ancestor
19462243|NCT03337529|Micronutrients|micronutrients|mesh-ancestor
19462244|NCT03337529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462245|NCT03337529|Antioxidants|antioxidants|mesh-ancestor
19462246|NCT03337529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462247|NCT03337529|Protective Agents|protective agents|mesh-ancestor
19462248|NCT03337503|Dronabinol|dronabinol|mesh-list
19462249|NCT03337503|Hallucinogens|hallucinogens|mesh-ancestor
19462250|NCT03337503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462251|NCT03337503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19462252|NCT03337503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19462253|NCT03337503|Analgesics|analgesics|mesh-ancestor
19462254|NCT03337503|Sensory System Agents|sensory system agents|mesh-ancestor
19462255|NCT03337503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462256|NCT03337503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
19462257|NCT03337503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
19462258|NCT03337503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19462259|NCT03337503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462260|NCT03337503|Hormones|hormones|mesh-ancestor
19462261|NCT03337503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19462262|NCT03337373|Cisatracurium|cisatracurium|mesh-list
19462263|NCT03337373|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19462264|NCT03337373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19462265|NCT03337373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462266|NCT03337373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462267|NCT03337282|Anesthetics|anesthetics|mesh-list
19462268|NCT03337282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19462269|NCT03337282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462270|NCT03337191|Morphine|morphine|mesh-list
19462271|NCT03337191|Levobupivacaine|levobupivacaine|mesh-list
19462272|NCT03337191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19462273|NCT03337191|Narcotics|narcotics|mesh-ancestor
19462274|NCT03337191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19462275|NCT03337191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462276|NCT03337191|Analgesics|analgesics|mesh-ancestor
19462277|NCT03337191|Sensory System Agents|sensory system agents|mesh-ancestor
19462278|NCT03337191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462279|NCT03337191|Anesthetics, Local|anesthetics, local|mesh-ancestor
19462280|NCT03337191|Anesthetics|anesthetics|mesh-ancestor
19462281|NCT03337126|Metronidazole|metronidazole|mesh-list
19462282|NCT03337126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19462283|NCT03337126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19462284|NCT03337126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19462285|NCT03337126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19462286|NCT03337035|Oxytocin|oxytocin|mesh-list
19462287|NCT03337035|Oxytocics|oxytocics|mesh-ancestor
19462288|NCT03337035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20011838|NCT02372383|Ethambutol|ethambutol|mesh-list
19462289|NCT03337035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462290|NCT03337009|Naloxone|naloxone|mesh-list
19462291|NCT03337009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19462292|NCT03337009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462293|NCT03337009|Sensory System Agents|sensory system agents|mesh-ancestor
19462294|NCT03337009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462295|NCT03336970|Calcium|calcium|mesh-list
19462296|NCT03336970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19462297|NCT03336970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462298|NCT03336918|Lithium Carbonate|lithium carbonate|mesh-list
19462299|NCT03336918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462300|NCT03336918|Antidepressive Agents|antidepressive agents|mesh-ancestor
19462301|NCT03336918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19462302|NCT03336918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462303|NCT03336918|Antimanic Agents|antimanic agents|mesh-ancestor
19462304|NCT03336918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19462305|NCT03336918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19462306|NCT03336918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462307|NCT03336840|Metformin|metformin|mesh-list
19462308|NCT03336840|Promethazine|promethazine|mesh-list
19462309|NCT03336840|Diphenhydramine|diphenhydramine|mesh-list
19462310|NCT03336840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19462311|NCT03336840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462312|NCT03336840|Antipruritics|antipruritics|mesh-ancestor
19462313|NCT03336840|Dermatologic Agents|dermatologic agents|mesh-ancestor
19462314|NCT03336840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19462315|NCT03336840|Histamine Antagonists|histamine antagonists|mesh-ancestor
19462316|NCT03336840|Histamine Agents|histamine agents|mesh-ancestor
19462317|NCT03336840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19462318|NCT03336840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462319|NCT03336840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19462320|NCT03336840|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19462321|NCT03336840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19462322|NCT03336840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19462323|NCT03336840|Anesthetics, Local|anesthetics, local|mesh-ancestor
19462324|NCT03336840|Anesthetics|anesthetics|mesh-ancestor
19462325|NCT03336840|Sensory System Agents|sensory system agents|mesh-ancestor
19462326|NCT03336840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462327|NCT03336840|Antiemetics|antiemetics|mesh-ancestor
19462328|NCT03336840|Autonomic Agents|autonomic agents|mesh-ancestor
19462329|NCT03336840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19462330|NCT03336814|Terlipressin|terlipressin|mesh-list
19462331|NCT03336814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19462332|NCT03336814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19462333|NCT03336801|Propofol|propofol|mesh-list
19462334|NCT03336801|Sevoflurane|sevoflurane|mesh-list
19462335|NCT03336801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19462336|NCT03336801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19462337|NCT03336801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462338|NCT03336801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19462339|NCT03336801|Anesthetics, General|anesthetics, general|mesh-ancestor
19462340|NCT03336801|Anesthetics|anesthetics|mesh-ancestor
19462341|NCT03336801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19462342|NCT03336801|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19462343|NCT03336632|Cyclosporine|cyclosporine|mesh-list
19462344|NCT03336632|Cyclophosphamide|cyclophosphamide|mesh-list
19462345|NCT03336632|Cyclosporins|cyclosporins|mesh-list
19462346|NCT03336632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19462347|NCT03336632|Immunologic Factors|immunologic factors|mesh-ancestor
19462348|NCT03336632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462349|NCT03336632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19462350|NCT03336632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19462351|NCT03336632|Alkylating Agents|alkylating agents|mesh-ancestor
19462352|NCT03336632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462353|NCT03336632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462354|NCT03336632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19462355|NCT03336632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462356|NCT03336632|Antifungal Agents|antifungal agents|mesh-ancestor
19462357|NCT03336632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19462358|NCT03336632|Dermatologic Agents|dermatologic agents|mesh-ancestor
19462359|NCT03336632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19462360|NCT03336593|Vaccines|vaccines|mesh-list
19462361|NCT03336593|Immunologic Factors|immunologic factors|mesh-ancestor
19462362|NCT03336593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462363|NCT03336437|Estradiol|estradiol|mesh-list
19462364|NCT03336437|Estrogens|estrogens|mesh-ancestor
19462365|NCT03336437|Hormones|hormones|mesh-ancestor
19462366|NCT03336437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19462367|NCT03336437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462368|NCT03336398|Ketamine|ketamine|mesh-list
19462369|NCT03336398|Analgesics|analgesics|mesh-ancestor
19462370|NCT03336398|Sensory System Agents|sensory system agents|mesh-ancestor
20011839|NCT02372383|Pancrelipase|pancrelipase|mesh-list
19462371|NCT03336398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462372|NCT03336398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462373|NCT03336398|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19462374|NCT03336398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19462375|NCT03336398|Anesthetics, General|anesthetics, general|mesh-ancestor
19462376|NCT03336398|Anesthetics|anesthetics|mesh-ancestor
19462377|NCT03336398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19462378|NCT03336398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19462379|NCT03336398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19462380|NCT03336398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19462381|NCT03336398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462382|NCT03336346|Efavirenz|efavirenz|mesh-list
19462383|NCT03336346|Dolutegravir|dolutegravir|mesh-list
19462384|NCT03336346|Etonogestrel|etonogestrel|mesh-list
19462385|NCT03336346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19462386|NCT03336346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19462387|NCT03336346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462388|NCT03336346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462389|NCT03336346|Antiviral Agents|antiviral agents|mesh-ancestor
19462390|NCT03336346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19462391|NCT03336346|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19462392|NCT03336346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19462393|NCT03336346|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19462394|NCT03336346|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19462395|NCT03336346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19462396|NCT03336346|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19462397|NCT03336346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19462398|NCT03336346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19462399|NCT03336346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19462400|NCT03336346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19462401|NCT03336346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19462402|NCT03336346|Contraceptive Agents|contraceptive agents|mesh-ancestor
19462403|NCT03336346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19462404|NCT03336346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462405|NCT03336346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19462406|NCT03336281|Ustekinumab|ustekinumab|mesh-list
19462407|NCT03336281|Dermatologic Agents|dermatologic agents|mesh-ancestor
19462408|NCT03336242|Cannabidiol|cannabidiol|mesh-list
19462409|NCT03336242|Anticonvulsants|anticonvulsants|mesh-ancestor
19462410|NCT03336125|Vitamin D|vitamin d|mesh-list
19462411|NCT03336125|Vitamins|vitamins|mesh-ancestor
19462412|NCT03336125|Micronutrients|micronutrients|mesh-ancestor
19462413|NCT03336125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462414|NCT03336125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19462415|NCT03336073|Dexamethasone|dexamethasone|mesh-list
19462416|NCT03336073|Cyclophosphamide|cyclophosphamide|mesh-list
19462417|NCT03336073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19462418|NCT03336073|Immunologic Factors|immunologic factors|mesh-ancestor
19462419|NCT03336073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462420|NCT03336073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19462421|NCT03336073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19462422|NCT03336073|Alkylating Agents|alkylating agents|mesh-ancestor
19462423|NCT03336073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462424|NCT03336073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462425|NCT03336073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19462426|NCT03336073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19462427|NCT03336073|Antiemetics|antiemetics|mesh-ancestor
19462428|NCT03336073|Autonomic Agents|autonomic agents|mesh-ancestor
19462429|NCT03336073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462430|NCT03336073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19462431|NCT03336073|Glucocorticoids|glucocorticoids|mesh-ancestor
19462432|NCT03336073|Hormones|hormones|mesh-ancestor
19462433|NCT03336073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19462434|NCT03336073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20011840|NCT02372383|Pancreatin|pancreatin|mesh-list
20011841|NCT02372383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20011842|NCT02372383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20011843|NCT02372383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20011844|NCT02372383|Antitubercular Agents|antitubercular agents|mesh-ancestor
20011845|NCT02372383|Leprostatic Agents|leprostatic agents|mesh-ancestor
20011846|NCT02372383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20011847|NCT02372383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462435|NCT03335956|Pioglitazone|pioglitazone|mesh-list
19462436|NCT03335956|Prednisone|prednisone|mesh-list
19462437|NCT03335956|Cortisone|cortisone|mesh-list
19462438|NCT03335956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19462439|NCT03335956|Glucocorticoids|glucocorticoids|mesh-ancestor
19462440|NCT03335956|Hormones|hormones|mesh-ancestor
19462441|NCT03335956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19462442|NCT03335956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462443|NCT03335956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19462444|NCT03335956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462445|NCT03335956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19462446|NCT03335904|Losartan|losartan|mesh-list
19462447|NCT03335904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19462448|NCT03335904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19462449|NCT03335904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19462450|NCT03335904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19462451|NCT03335904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462452|NCT03335839|Plasminogen|plasminogen|mesh-list
19462453|NCT03335839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19462454|NCT03335839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19462455|NCT03335839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19462456|NCT03335839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462457|NCT03335826|Anesthetics|anesthetics|mesh-list
19462458|NCT03335826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19462459|NCT03335826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462460|NCT03335774|Hydrocortisone|hydrocortisone|mesh-list
19462461|NCT03335774|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
19462462|NCT03335774|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
19462463|NCT03335774|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19462464|NCT03335774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19462465|NCT03335579|Sufentanil|sufentanil|mesh-list
19462466|NCT03335579|Remifentanil|remifentanil|mesh-list
19462467|NCT03335579|Propofol|propofol|mesh-list
19462468|NCT03335579|Anesthetics|anesthetics|mesh-ancestor
19462469|NCT03335579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19462470|NCT03335579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462471|NCT03335579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19462472|NCT03335579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19462473|NCT03335579|Anesthetics, General|anesthetics, general|mesh-ancestor
19462474|NCT03335579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19462475|NCT03335579|Narcotics|narcotics|mesh-ancestor
19462476|NCT03335579|Analgesics|analgesics|mesh-ancestor
19462477|NCT03335579|Sensory System Agents|sensory system agents|mesh-ancestor
19462478|NCT03335579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462479|NCT03335579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19462480|NCT03335527|Dexmedetomidine|dexmedetomidine|mesh-list
19462481|NCT03335527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19462482|NCT03335527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19462483|NCT03335527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462484|NCT03335527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19462485|NCT03335527|Analgesics|analgesics|mesh-ancestor
19462486|NCT03335527|Sensory System Agents|sensory system agents|mesh-ancestor
19462487|NCT03335527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462488|NCT03335527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19462489|NCT03335527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19462490|NCT03335527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19462491|NCT03335527|Adrenergic Agents|adrenergic agents|mesh-ancestor
19462492|NCT03335527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19462493|NCT03335527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462494|NCT03335501|Pancrelipase|pancrelipase|mesh-list
19462495|NCT03335501|Hormones|hormones|mesh-list
19462496|NCT03335501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462497|NCT03335501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19462498|NCT03335501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19462499|NCT03335436|Gabapentin|gabapentin|mesh-list
19462500|NCT03335436|Analgesics|analgesics|mesh-ancestor
19462501|NCT03335436|Sensory System Agents|sensory system agents|mesh-ancestor
19462502|NCT03335436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462503|NCT03335436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462504|NCT03335436|Anticonvulsants|anticonvulsants|mesh-ancestor
19462505|NCT03335436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19462506|NCT03335436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19462507|NCT03335436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19462508|NCT03335436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19462509|NCT03335436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19462510|NCT03335436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19462511|NCT03335436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19462512|NCT03335436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462513|NCT03335436|Antimanic Agents|antimanic agents|mesh-ancestor
19462514|NCT03335423|Metformin|metformin|mesh-list
19462515|NCT03335423|Codeine|codeine|mesh-list
19462516|NCT03335423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19462517|NCT03335423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462518|NCT03335423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19462519|NCT03335423|Narcotics|narcotics|mesh-ancestor
19462520|NCT03335423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19462521|NCT03335423|Analgesics|analgesics|mesh-ancestor
19462522|NCT03335423|Sensory System Agents|sensory system agents|mesh-ancestor
19462523|NCT03335423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462524|NCT03335423|Antitussive Agents|antitussive agents|mesh-ancestor
19462525|NCT03335423|Respiratory System Agents|respiratory system agents|mesh-ancestor
19462526|NCT03335293|Epinephrine|epinephrine|mesh-list
19462527|NCT03335293|Racepinephrine|racepinephrine|mesh-list
19462528|NCT03335293|Epinephryl borate|epinephryl borate|mesh-list
19462529|NCT03335293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19462530|NCT03335293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19462531|NCT03335293|Adrenergic Agents|adrenergic agents|mesh-ancestor
19462532|NCT03335293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19462533|NCT03335293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462534|NCT03335293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462535|NCT03335293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19462536|NCT03335293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19462537|NCT03335293|Autonomic Agents|autonomic agents|mesh-ancestor
19462538|NCT03335293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462539|NCT03335293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19462540|NCT03335293|Respiratory System Agents|respiratory system agents|mesh-ancestor
19462541|NCT03335293|Mydriatics|mydriatics|mesh-ancestor
19462542|NCT03335293|Sympathomimetics|sympathomimetics|mesh-ancestor
19462543|NCT03335293|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19462544|NCT03335241|Doxorubicin|doxorubicin|mesh-list
19462545|NCT03335241|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
19462546|NCT03335241|Fludarabine|fludarabine|mesh-list
19462547|NCT03335241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19462548|NCT03335241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462549|NCT03335241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19462550|NCT03335241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19462551|NCT03335241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462552|NCT03335241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462553|NCT03335124|Vitamins|vitamins|mesh-list
19462554|NCT03335124|Ascorbic Acid|ascorbic acid|mesh-list
19462555|NCT03335124|Thiamine|thiamine|mesh-list
19462556|NCT03335124|Hydrocortisone|hydrocortisone|mesh-list
19462557|NCT03335124|Micronutrients|micronutrients|mesh-ancestor
19462558|NCT03335124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462559|NCT03335124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19462560|NCT03335124|Antioxidants|antioxidants|mesh-ancestor
19462561|NCT03335124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462562|NCT03335124|Protective Agents|protective agents|mesh-ancestor
19462563|NCT03335124|Vitamin B Complex|vitamin b complex|mesh-ancestor
19462564|NCT03335098|Thalidomide|thalidomide|mesh-list
19462565|NCT03335098|Dexamethasone|dexamethasone|mesh-list
19462566|NCT03335098|Bortezomib|bortezomib|mesh-list
19462567|NCT03335098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19462568|NCT03335098|Antiemetics|antiemetics|mesh-ancestor
19462569|NCT03335098|Autonomic Agents|autonomic agents|mesh-ancestor
19462570|NCT03335098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462571|NCT03335098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462572|NCT03335098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19462573|NCT03335098|Glucocorticoids|glucocorticoids|mesh-ancestor
19462574|NCT03335098|Hormones|hormones|mesh-ancestor
19462575|NCT03335098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19462576|NCT03335098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19462577|NCT03335098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462578|NCT03335098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19462579|NCT03335098|Immunologic Factors|immunologic factors|mesh-ancestor
19462580|NCT03335098|Leprostatic Agents|leprostatic agents|mesh-ancestor
19462581|NCT03335098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19462582|NCT03335098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19462583|NCT03335098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19462584|NCT03335098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19462585|NCT03335098|Growth Substances|growth substances|mesh-ancestor
19462586|NCT03335098|Growth Inhibitors|growth inhibitors|mesh-ancestor
19462587|NCT03335085|Oxytocin|oxytocin|mesh-list
19462588|NCT03335085|Oxytocics|oxytocics|mesh-ancestor
19462589|NCT03335085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19462590|NCT03335085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462591|NCT03335072|Azithromycin|azithromycin|mesh-list
19462592|NCT03335072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19462593|NCT03335072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19462594|NCT03335059|Mitomycins|mitomycins|mesh-list
19462595|NCT03335059|Mitomycin|mitomycin|mesh-list
19462596|NCT03335059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19462597|NCT03335059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462598|NCT03335059|Alkylating Agents|alkylating agents|mesh-ancestor
19462599|NCT03335059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462600|NCT03335059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19462601|NCT03335059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462602|NCT03335007|Aceclofenac|aceclofenac|mesh-list
19462603|NCT03335007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19462604|NCT03335007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19462605|NCT03335007|Analgesics|analgesics|mesh-ancestor
19462606|NCT03335007|Sensory System Agents|sensory system agents|mesh-ancestor
19462607|NCT03335007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462608|NCT03335007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462609|NCT03335007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19462610|NCT03335007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19462611|NCT03334981|Buprenorphine|buprenorphine|mesh-list
19462612|NCT03334981|Methadone|methadone|mesh-list
19462613|NCT03334981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19462614|NCT03334981|Narcotics|narcotics|mesh-ancestor
19462615|NCT03334981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19462616|NCT03334981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462617|NCT03334981|Analgesics|analgesics|mesh-ancestor
19462618|NCT03334981|Sensory System Agents|sensory system agents|mesh-ancestor
19462619|NCT03334981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462620|NCT03334981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
19462621|NCT03334981|Antitussive Agents|antitussive agents|mesh-ancestor
19462622|NCT03334981|Respiratory System Agents|respiratory system agents|mesh-ancestor
19462623|NCT03334877|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19462624|NCT03334877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19462625|NCT03334877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462626|NCT03334838|Nifurtimox|nifurtimox|mesh-list
19462627|NCT03334838|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19462628|NCT03334838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19462629|NCT03334838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19462630|NCT03334838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19462631|NCT03334682|Doxycycline|doxycycline|mesh-list
19462632|NCT03334682|Spironolactone|spironolactone|mesh-list
19462633|NCT03334682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19462634|NCT03334682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19462635|NCT03334682|Antimalarials|antimalarials|mesh-ancestor
19462636|NCT03334682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19462637|NCT03334682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19462638|NCT03334682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19462639|NCT03334682|Hormone Antagonists|hormone antagonists|mesh-ancestor
19462640|NCT03334682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19462641|NCT03334682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462642|NCT03334682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19462643|NCT03334682|Diuretics|diuretics|mesh-ancestor
19462644|NCT03334682|Natriuretic Agents|natriuretic agents|mesh-ancestor
19462645|NCT03334591|Apatinib|apatinib|mesh-list
19462646|NCT03334591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462647|NCT03334591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19462648|NCT03334591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462649|NCT03334591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462650|NCT03334513|Bevacizumab|bevacizumab|mesh-list
19462651|NCT03334513|Ranibizumab|ranibizumab|mesh-list
19462652|NCT03334513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19462653|NCT03334513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462654|NCT03334513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19462655|NCT03334513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19462656|NCT03334513|Growth Substances|growth substances|mesh-ancestor
19462657|NCT03334513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462658|NCT03334513|Growth Inhibitors|growth inhibitors|mesh-ancestor
19462659|NCT03334487|Dexamethasone|dexamethasone|mesh-list
19462660|NCT03334487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19462661|NCT03334487|Antiemetics|antiemetics|mesh-ancestor
19462662|NCT03334487|Autonomic Agents|autonomic agents|mesh-ancestor
19462663|NCT03334487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462664|NCT03334487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462665|NCT03334487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19462666|NCT03334487|Glucocorticoids|glucocorticoids|mesh-ancestor
19462667|NCT03334487|Hormones|hormones|mesh-ancestor
19462668|NCT03334487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19462669|NCT03334487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19462670|NCT03334487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011848|NCT02372383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011849|NCT02372383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19462673|NCT03334136|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
19462674|NCT03334136|Calcifediol|calcifediol|mesh-list
19462675|NCT03334136|Vitamins|vitamins|mesh-ancestor
19462676|NCT03334136|Micronutrients|micronutrients|mesh-ancestor
19462677|NCT03334136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462678|NCT03334136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20011850|NCT02372383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19462679|NCT03333824|Midazolam|midazolam|mesh-list
19462680|NCT03333824|Granisetron|granisetron|mesh-list
19462681|NCT03333824|Caffeine|caffeine|mesh-list
19462682|NCT03333824|Omeprazole|omeprazole|mesh-list
19462683|NCT03333824|Adavosertib|adavosertib|mesh-list
19462684|NCT03333824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19462685|NCT03333824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19462686|NCT03333824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19462687|NCT03333824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462688|NCT03333824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19462689|NCT03333824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19462690|NCT03333824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19462691|NCT03333824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19462692|NCT03333824|Anesthetics, General|anesthetics, general|mesh-ancestor
19462693|NCT03333824|Anesthetics|anesthetics|mesh-ancestor
19462694|NCT03333824|GABA Modulators|gaba modulators|mesh-ancestor
19462695|NCT03333824|GABA Agents|gaba agents|mesh-ancestor
19462696|NCT03333824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19462697|NCT03333824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462698|NCT03333824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19462699|NCT03333824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19462700|NCT03333824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19462701|NCT03333824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462702|NCT03333824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19462703|NCT03333824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19462704|NCT03333824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19462705|NCT03333824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19462706|NCT03333824|Purinergic Agents|purinergic agents|mesh-ancestor
19462707|NCT03333824|Antiemetics|antiemetics|mesh-ancestor
19462708|NCT03333824|Autonomic Agents|autonomic agents|mesh-ancestor
19462709|NCT03333824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462710|NCT03333824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19462711|NCT03333824|Serotonin Agents|serotonin agents|mesh-ancestor
19462712|NCT03333668|Guanfacine|guanfacine|mesh-list
19462713|NCT03333668|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
19462714|NCT03333668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19462715|NCT03333668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462716|NCT03333668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19462717|NCT03333668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19462718|NCT03333668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19462719|NCT03333668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462720|NCT03333668|Dopamine Agents|dopamine agents|mesh-ancestor
19462721|NCT03333668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19462722|NCT03333668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19462723|NCT03333668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19462724|NCT03333668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19462725|NCT03333668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19462726|NCT03333668|Adrenergic Agents|adrenergic agents|mesh-ancestor
19462727|NCT03333616|Nivolumab|nivolumab|mesh-list
19462728|NCT03333616|Ipilimumab|ipilimumab|mesh-list
19462729|NCT03333616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19462730|NCT03333616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462731|NCT03333616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19462732|NCT03333616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462733|NCT03333603|Esomeprazole|esomeprazole|mesh-list
19462734|NCT03333603|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19462735|NCT03333603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19462736|NCT03333603|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19462737|NCT03333603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462738|NCT03333603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462739|NCT03333525|Insulin|insulin|mesh-list
19462740|NCT03333525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19462741|NCT03333525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462742|NCT03333499|Trimetazidine|trimetazidine|mesh-list
19462743|NCT03333499|Vasodilator Agents|vasodilator agents|mesh-ancestor
19462744|NCT03333395|Heparin|heparin|mesh-list
19462745|NCT03333395|Albuterol|albuterol|mesh-list
19462746|NCT03333395|Anticoagulants|anticoagulants|mesh-ancestor
19462747|NCT03333395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19462748|NCT03333395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19462749|NCT03333395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462750|NCT03333395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19462751|NCT03333395|Autonomic Agents|autonomic agents|mesh-ancestor
19462752|NCT03333395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462753|NCT03333395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462754|NCT03333395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19462755|NCT03333395|Respiratory System Agents|respiratory system agents|mesh-ancestor
19462756|NCT03333395|Tocolytic Agents|tocolytic agents|mesh-ancestor
19462757|NCT03333395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19462758|NCT03333395|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19462759|NCT03333395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19462760|NCT03333395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19462761|NCT03333395|Adrenergic Agents|adrenergic agents|mesh-ancestor
19462762|NCT03333395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011851|NCT02372383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20011852|NCT02372383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20011853|NCT02372383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20011854|NCT02372383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20011855|NCT02372383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20011856|NCT02372799|Fluoxetine|fluoxetine|mesh-list
20011857|NCT02372799|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
20011858|NCT02372799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20011859|NCT02372799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20011860|NCT02372799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20011861|NCT02372799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011862|NCT02372799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011863|NCT02372799|Serotonin Agents|serotonin agents|mesh-ancestor
20011864|NCT02372799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011865|NCT02372799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20011866|NCT02372799|Antidepressive Agents|antidepressive agents|mesh-ancestor
20011867|NCT02372799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20011868|NCT02372799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20011869|NCT02372799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20011870|NCT02372799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011871|NCT02372799|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20011872|NCT02372799|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20011873|NCT02373098|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
20011874|NCT02373098|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20011875|NCT02373098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011876|NCT02373098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20011877|NCT02373098|Immunologic Factors|immunologic factors|mesh-ancestor
20011878|NCT02373098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011879|NCT02373124|N-Methylaspartate|n-methylaspartate|mesh-list
20011880|NCT02373124|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
19462763|NCT03333369|Levodopa|levodopa|mesh-list
19462764|NCT03333369|Benserazide|benserazide|mesh-list
19462765|NCT03333369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19462766|NCT03333369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19462767|NCT03333369|Dopamine Agents|dopamine agents|mesh-ancestor
19462768|NCT03333369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19462769|NCT03333369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462770|NCT03333369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462771|NCT03333369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462772|NCT03333343|Gefitinib|gefitinib|mesh-list
19462773|NCT03333343|Trametinib|trametinib|mesh-list
19462774|NCT03333343|Nazartinib|nazartinib|mesh-list
19462775|NCT03333343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462776|NCT03333343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19462777|NCT03333343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462778|NCT03333343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462779|NCT03333278|Vitamins|vitamins|mesh-list
19462780|NCT03333278|Ascorbic Acid|ascorbic acid|mesh-list
19462781|NCT03333278|Thiamine|thiamine|mesh-list
19462782|NCT03333278|Hydrocortisone|hydrocortisone|mesh-list
19462783|NCT03333278|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
19462784|NCT03333278|Micronutrients|micronutrients|mesh-ancestor
19462785|NCT03333278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462786|NCT03333278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19462787|NCT03333278|Antioxidants|antioxidants|mesh-ancestor
19462788|NCT03333278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462789|NCT03333278|Protective Agents|protective agents|mesh-ancestor
19462790|NCT03333278|Vitamin B Complex|vitamin b complex|mesh-ancestor
19462791|NCT03333083|Lamivudine|lamivudine|mesh-list
19462792|NCT03333083|Raltegravir Potassium|raltegravir potassium|mesh-list
19462793|NCT03333083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19462794|NCT03333083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19462795|NCT03333083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462796|NCT03333083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462797|NCT03333083|Antiviral Agents|antiviral agents|mesh-ancestor
19462798|NCT03333083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19462799|NCT03333083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19462800|NCT03333083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19462801|NCT03333083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19462802|NCT03333083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19462803|NCT03333018|Bromides|bromides|mesh-list
19462804|NCT03333018|Formoterol Fumarate|formoterol fumarate|mesh-list
19462805|NCT03333018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19462806|NCT03333018|Autonomic Agents|autonomic agents|mesh-ancestor
19462807|NCT03333018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462808|NCT03333018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462809|NCT03333018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19462810|NCT03333018|Respiratory System Agents|respiratory system agents|mesh-ancestor
19462811|NCT03333018|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19462812|NCT03333018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19462813|NCT03333018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19462814|NCT03333018|Adrenergic Agents|adrenergic agents|mesh-ancestor
19462815|NCT03333018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19462816|NCT03333018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462817|NCT03333018|Anticonvulsants|anticonvulsants|mesh-ancestor
19462818|NCT03333005|Antifungal Agents|antifungal agents|mesh-list
19462819|NCT03333005|Clotrimazole|clotrimazole|mesh-list
19462820|NCT03333005|Miconazole|miconazole|mesh-list
19462821|NCT03333005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19462822|NCT03333005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19462823|NCT03333005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19462824|NCT03333005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19462825|NCT03333005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462826|NCT03333005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462827|NCT03333005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19462828|NCT03333005|Hormone Antagonists|hormone antagonists|mesh-ancestor
19462829|NCT03333005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19462830|NCT03333005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462831|NCT03333005|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19462832|NCT03333005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19462833|NCT03332953|Nicotine|nicotine|mesh-list
19462834|NCT03332953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19462835|NCT03332953|Autonomic Agents|autonomic agents|mesh-ancestor
19462836|NCT03332953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462837|NCT03332953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462838|NCT03332953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19462839|NCT03332953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19462840|NCT03332953|Cholinergic Agents|cholinergic agents|mesh-ancestor
19462841|NCT03332953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19462842|NCT03332953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462843|NCT03332940|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
19462844|NCT03332940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19462845|NCT03332940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462846|NCT03332888|Rituximab|rituximab|mesh-list
19462847|NCT03332888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19462848|NCT03332888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462849|NCT03332888|Immunologic Factors|immunologic factors|mesh-ancestor
19462850|NCT03332888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462851|NCT03332888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19462852|NCT03332732|Metronidazole|metronidazole|mesh-list
19462853|NCT03332732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19462854|NCT03332732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19462855|NCT03332732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19462856|NCT03332732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19462857|NCT03332719|Etanercept|etanercept|mesh-list
19462858|NCT03332719|Methotrexate|methotrexate|mesh-list
19462859|NCT03332719|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19462860|NCT03332719|Abortifacient Agents|abortifacient agents|mesh-ancestor
19462861|NCT03332719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19462862|NCT03332719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462863|NCT03332719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19462864|NCT03332719|Antimetabolites|antimetabolites|mesh-ancestor
19462865|NCT03332719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462866|NCT03332719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462867|NCT03332719|Dermatologic Agents|dermatologic agents|mesh-ancestor
19462868|NCT03332719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462869|NCT03332719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19462870|NCT03332719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19462871|NCT03332719|Immunologic Factors|immunologic factors|mesh-ancestor
19462872|NCT03332719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19462873|NCT03332719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19462874|NCT03332719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19462875|NCT03332719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19462876|NCT03332719|Analgesics|analgesics|mesh-ancestor
19462877|NCT03332719|Sensory System Agents|sensory system agents|mesh-ancestor
19462878|NCT03332719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462879|NCT03332719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19462880|NCT03332719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19462881|NCT03332602|Vitamins|vitamins|mesh-list
19462882|NCT03332602|Folic Acid|folic acid|mesh-list
19462883|NCT03332602|Vitamin A|vitamin a|mesh-list
19462884|NCT03332602|Retinol palmitate|retinol palmitate|mesh-list
19462885|NCT03332602|Fesoterodine|fesoterodine|mesh-list
19462886|NCT03332602|Hyaluronic Acid|hyaluronic acid|mesh-list
19462887|NCT03332602|Micronutrients|micronutrients|mesh-ancestor
19462888|NCT03332602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462889|NCT03332602|Hematinics|hematinics|mesh-ancestor
19462890|NCT03332602|Vitamin B Complex|vitamin b complex|mesh-ancestor
19462891|NCT03332602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19462892|NCT03332602|Immunologic Factors|immunologic factors|mesh-ancestor
19462893|NCT03332602|Viscosupplements|viscosupplements|mesh-ancestor
19462894|NCT03332602|Protective Agents|protective agents|mesh-ancestor
19462895|NCT03332602|Antioxidants|antioxidants|mesh-ancestor
19462896|NCT03332602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462897|NCT03332602|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
19462898|NCT03332602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462899|NCT03332602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19462900|NCT03332602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19462901|NCT03332602|Cholinergic Agents|cholinergic agents|mesh-ancestor
19462902|NCT03332602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19462903|NCT03332602|Urological Agents|urological agents|mesh-ancestor
19462904|NCT03332576|Cyclophosphamide|cyclophosphamide|mesh-list
19462905|NCT03332576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19462906|NCT03332576|Immunologic Factors|immunologic factors|mesh-ancestor
19462907|NCT03332576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462908|NCT03332576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19462909|NCT03332576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19462910|NCT03332576|Alkylating Agents|alkylating agents|mesh-ancestor
19462911|NCT03332576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462912|NCT03332576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462913|NCT03332576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20011881|NCT02373124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20011882|NCT02373124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011883|NCT02373124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011884|NCT02373124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011885|NCT02373137|Ofloxacin|ofloxacin|mesh-list
20011886|NCT02373137|Prednisolone|prednisolone|mesh-list
20011887|NCT02373137|Phenylephrine|phenylephrine|mesh-list
20011888|NCT02373137|Oxymetazoline|oxymetazoline|mesh-list
20011889|NCT02373137|Tropicamide|tropicamide|mesh-list
20011890|NCT02373137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20011891|NCT02373137|Glucocorticoids|glucocorticoids|mesh-ancestor
20011892|NCT02373137|Hormones|hormones|mesh-ancestor
20011893|NCT02373137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20011894|NCT02373137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011895|NCT02373137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20011896|NCT02373137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011897|NCT02373137|Autonomic Agents|autonomic agents|mesh-ancestor
20011898|NCT02373137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20011899|NCT02373137|Protective Agents|protective agents|mesh-ancestor
20011900|NCT02373137|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20011901|NCT02373137|Mydriatics|mydriatics|mesh-ancestor
20011902|NCT02373137|Sympathomimetics|sympathomimetics|mesh-ancestor
20011903|NCT02373137|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20011904|NCT02373137|Nasal Decongestants|nasal decongestants|mesh-ancestor
19462914|NCT03332524|Chlorpheniramine|chlorpheniramine|mesh-list
19462915|NCT03332524|Ibuprofen|ibuprofen|mesh-list
19462916|NCT03332524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19462917|NCT03332524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19462918|NCT03332524|Analgesics|analgesics|mesh-ancestor
19462919|NCT03332524|Sensory System Agents|sensory system agents|mesh-ancestor
19462920|NCT03332524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462921|NCT03332524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462922|NCT03332524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19462923|NCT03332524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19462924|NCT03332524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19462925|NCT03332524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462926|NCT03332524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462927|NCT03332524|Antipruritics|antipruritics|mesh-ancestor
19462928|NCT03332524|Dermatologic Agents|dermatologic agents|mesh-ancestor
19462929|NCT03332524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19462930|NCT03332524|Histamine Antagonists|histamine antagonists|mesh-ancestor
19462931|NCT03332524|Histamine Agents|histamine agents|mesh-ancestor
19462932|NCT03332524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19462933|NCT03332524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20011905|NCT02373137|Respiratory System Agents|respiratory system agents|mesh-ancestor
20011906|NCT02373137|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20011907|NCT02373137|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20011908|NCT02373137|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20011909|NCT02373137|Adrenergic Agents|adrenergic agents|mesh-ancestor
20011910|NCT02373137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20011911|NCT02373137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011912|NCT02373137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20011913|NCT02373137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20011914|NCT02373137|Cholinergic Agents|cholinergic agents|mesh-ancestor
20011915|NCT02373137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20011916|NCT02373137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20011917|NCT02373137|Renal Agents|renal agents|mesh-ancestor
20011918|NCT02373137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20011919|NCT02373137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20011920|NCT02373137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20011921|NCT02373137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011922|NCT02373137|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20011923|NCT02373137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20011924|NCT02373202|Sulfasalazine|sulfasalazine|mesh-list
20011925|NCT02373202|Mizoribine|mizoribine|mesh-list
20011926|NCT02373202|Bucillamine|bucillamine|mesh-list
20011927|NCT02373202|Tacrolimus|tacrolimus|mesh-list
20011928|NCT02373202|Leflunomide|leflunomide|mesh-list
20011929|NCT02373202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20011930|NCT02373202|Immunologic Factors|immunologic factors|mesh-ancestor
20011931|NCT02373202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011932|NCT02373202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20011933|NCT02373202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011934|NCT02373202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011935|NCT02373202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20011936|NCT02373202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20011937|NCT02373202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20011938|NCT02373202|Analgesics|analgesics|mesh-ancestor
20011939|NCT02373202|Sensory System Agents|sensory system agents|mesh-ancestor
20011940|NCT02373202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462934|NCT03332329|Entecavir|entecavir|mesh-list
19462935|NCT03332329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
19462936|NCT03332329|Molgramostim|molgramostim|mesh-list
19462937|NCT03332329|Vaccines|vaccines|mesh-list
19462938|NCT03332329|Sargramostim|sargramostim|mesh-list
19462939|NCT03332329|Immunologic Factors|immunologic factors|mesh-ancestor
19462940|NCT03332329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462941|NCT03332329|Antiviral Agents|antiviral agents|mesh-ancestor
19462942|NCT03332329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19462943|NCT03332329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462944|NCT03332316|Dexamethasone|dexamethasone|mesh-list
19462945|NCT03332316|Dexamethasone acetate|dexamethasone acetate|mesh-list
19462946|NCT03332316|Ropivacaine|ropivacaine|mesh-list
19462947|NCT03332316|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19462948|NCT03332316|BB 1101|bb 1101|mesh-list
19462949|NCT03332316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19462950|NCT03332316|Antiemetics|antiemetics|mesh-ancestor
19462951|NCT03332316|Autonomic Agents|autonomic agents|mesh-ancestor
19462952|NCT03332316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462953|NCT03332316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462954|NCT03332316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19462955|NCT03332316|Glucocorticoids|glucocorticoids|mesh-ancestor
19462956|NCT03332316|Hormones|hormones|mesh-ancestor
19462957|NCT03332316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19462958|NCT03332316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19462959|NCT03332316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462960|NCT03332316|Anesthetics, Local|anesthetics, local|mesh-ancestor
19462961|NCT03332316|Anesthetics|anesthetics|mesh-ancestor
19462962|NCT03332316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19462963|NCT03332316|Sensory System Agents|sensory system agents|mesh-ancestor
19462964|NCT03332316|Protease Inhibitors|protease inhibitors|mesh-ancestor
19462965|NCT03332316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462966|NCT03332316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462967|NCT03332225|Interferons|interferons|mesh-list
19462968|NCT03332225|Interferon-gamma|interferon-gamma|mesh-list
19462969|NCT03332225|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
19462970|NCT03332225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462971|NCT03332225|Antiviral Agents|antiviral agents|mesh-ancestor
19462972|NCT03332225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19462973|NCT03332225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19462974|NCT03332069|Cisplatin|cisplatin|mesh-list
19462975|NCT03332069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462976|NCT03332017|Obinutuzumab|obinutuzumab|mesh-list
19462977|NCT03332017|Zanubrutinib|zanubrutinib|mesh-list
19462978|NCT03332017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19462979|NCT03332017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19462980|NCT03332017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19462981|NCT03332017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19462982|NCT03332017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462983|NCT03331913|Botulinum Toxins|botulinum toxins|mesh-list
19462984|NCT03331913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19462985|NCT03331913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19462986|NCT03331913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19462987|NCT03331913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19462988|NCT03331913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19462989|NCT03331913|Cholinergic Agents|cholinergic agents|mesh-ancestor
19462990|NCT03331913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19462991|NCT03331913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462992|NCT03331913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19462993|NCT03331913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19462994|NCT03331861|Metformin|metformin|mesh-list
19462995|NCT03331861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19462996|NCT03331861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19462997|NCT03331770|Latanoprost|latanoprost|mesh-list
19462998|NCT03331770|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19462999|NCT03331770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19463000|NCT03331692|Anesthetics|anesthetics|mesh-list
19463001|NCT03331692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19463002|NCT03331692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463003|NCT03331562|Ergocalciferols|ergocalciferols|mesh-list
19463004|NCT03331562|Pembrolizumab|pembrolizumab|mesh-list
19463005|NCT03331562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19463006|NCT03331562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463007|NCT03331562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19463008|NCT03331562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463009|NCT03331562|Vitamins|vitamins|mesh-ancestor
19463010|NCT03331562|Micronutrients|micronutrients|mesh-ancestor
19463011|NCT03331562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19463012|NCT03331523|Betamethasone|betamethasone|mesh-list
19463013|NCT03331523|Betamethasone Valerate|betamethasone valerate|mesh-list
19463014|NCT03331523|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
19463015|NCT03331523|Betamethasone benzoate|betamethasone benzoate|mesh-list
19463016|NCT03331523|Calcipotriene|calcipotriene|mesh-list
19463017|NCT03331523|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
19463018|NCT03331523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19463019|NCT03331523|Glucocorticoids|glucocorticoids|mesh-ancestor
19463020|NCT03331523|Hormones|hormones|mesh-ancestor
19463021|NCT03331523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19463022|NCT03331523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463023|NCT03331523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19463024|NCT03331523|Respiratory System Agents|respiratory system agents|mesh-ancestor
19463025|NCT03331523|Dermatologic Agents|dermatologic agents|mesh-ancestor
19463026|NCT03331484|Rivaroxaban|rivaroxaban|mesh-list
19463027|NCT03331484|Ticagrelor|ticagrelor|mesh-list
19463028|NCT03331484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19463029|NCT03331484|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19463030|NCT03331484|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19463031|NCT03331484|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19463032|NCT03331484|Purinergic Agents|purinergic agents|mesh-ancestor
19463033|NCT03331484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19463034|NCT03331484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463035|NCT03331484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463036|NCT03331484|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19463037|NCT03331484|Antithrombins|antithrombins|mesh-ancestor
19463038|NCT03331484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19463039|NCT03331484|Protease Inhibitors|protease inhibitors|mesh-ancestor
19463040|NCT03331484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19463041|NCT03331484|Anticoagulants|anticoagulants|mesh-ancestor
19463042|NCT03331445|Nitric Oxide|nitric oxide|mesh-list
19463043|NCT03331445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19463044|NCT03331445|Autonomic Agents|autonomic agents|mesh-ancestor
19463045|NCT03331445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463046|NCT03331445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463047|NCT03331445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19463048|NCT03331445|Respiratory System Agents|respiratory system agents|mesh-ancestor
19463049|NCT03331445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
19463050|NCT03331445|Antioxidants|antioxidants|mesh-ancestor
19463051|NCT03331445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463052|NCT03331445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19463053|NCT03331445|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
19463054|NCT03331445|Vasodilator Agents|vasodilator agents|mesh-ancestor
19463055|NCT03331445|Gasotransmitters|gasotransmitters|mesh-ancestor
19463056|NCT03331445|Protective Agents|protective agents|mesh-ancestor
19463057|NCT03331432|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
19463058|NCT03331432|Antiviral Agents|antiviral agents|mesh-ancestor
19463059|NCT03331432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19463060|NCT03331432|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
19463061|NCT03331432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19463062|NCT03331302|Xenon|xenon|mesh-list
19463063|NCT03331302|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19463064|NCT03331302|Anesthetics, General|anesthetics, general|mesh-ancestor
19463065|NCT03331302|Anesthetics|anesthetics|mesh-ancestor
19463066|NCT03331302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19463067|NCT03331302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463068|NCT03331263|Chlorhexidine|chlorhexidine|mesh-list
19463069|NCT03331263|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
19463070|NCT03331263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19463071|NCT03331263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19463072|NCT03331263|Disinfectants|disinfectants|mesh-ancestor
19463073|NCT03331263|Dermatologic Agents|dermatologic agents|mesh-ancestor
19463074|NCT03331211|Dasatinib|dasatinib|mesh-list
19463075|NCT03331211|Ponatinib|ponatinib|mesh-list
19463076|NCT03331211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463077|NCT03331211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19463078|NCT03331211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19463079|NCT03331211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463080|NCT03330990|Midazolam|midazolam|mesh-list
19463081|NCT03330990|Entrectinib|entrectinib|mesh-list
19463082|NCT03330990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19463083|NCT03330990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19463084|NCT03330990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19463085|NCT03330990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463086|NCT03330990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19463087|NCT03330990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19463088|NCT03330990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19463089|NCT03330990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19463090|NCT03330990|Anesthetics, General|anesthetics, general|mesh-ancestor
19463091|NCT03330990|Anesthetics|anesthetics|mesh-ancestor
19463092|NCT03330990|GABA Modulators|gaba modulators|mesh-ancestor
19463093|NCT03330990|GABA Agents|gaba agents|mesh-ancestor
19463094|NCT03330990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19463095|NCT03330990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463096|NCT03330990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19463097|NCT03330990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19463098|NCT03330886|Atezolizumab|atezolizumab|mesh-list
19463099|NCT03330886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463100|NCT03330860|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
19463101|NCT03330860|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
19463102|NCT03330860|beta-Endorphin|beta-endorphin|mesh-list
19463103|NCT03330860|Hormones|hormones|mesh-ancestor
19463104|NCT03330860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19463105|NCT03330860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463106|NCT03330860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19463107|NCT03330860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463108|NCT03330808|Anesthetics|anesthetics|mesh-list
19463109|NCT03330808|Ropivacaine|ropivacaine|mesh-list
19463110|NCT03330808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19463111|NCT03330808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463112|NCT03330808|Anesthetics, Local|anesthetics, local|mesh-ancestor
19463113|NCT03330808|Sensory System Agents|sensory system agents|mesh-ancestor
19463114|NCT03330808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463115|NCT03330782|Remifentanil|remifentanil|mesh-list
19463116|NCT03330782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19463117|NCT03330782|Narcotics|narcotics|mesh-ancestor
19463118|NCT03330782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19463119|NCT03330782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463120|NCT03330782|Analgesics|analgesics|mesh-ancestor
20011941|NCT02373202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20011942|NCT02373202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20011943|NCT02373202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20011944|NCT02373202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20011945|NCT02373202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20011946|NCT02373202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011947|NCT02373202|Antimalarials|antimalarials|mesh-ancestor
20011948|NCT02373202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20011949|NCT02373202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20011950|NCT02373202|Antioxidants|antioxidants|mesh-ancestor
20011951|NCT02373202|Protective Agents|protective agents|mesh-ancestor
20011952|NCT02373371|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
20011953|NCT02373371|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20011954|NCT02373371|Dermatologic Agents|dermatologic agents|mesh-ancestor
20011955|NCT02373813|Folic Acid|folic acid|mesh-list
20011956|NCT02373813|Etanercept|etanercept|mesh-list
20011957|NCT02373813|Methotrexate|methotrexate|mesh-list
20011958|NCT02373813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20011959|NCT02373813|Abortifacient Agents|abortifacient agents|mesh-ancestor
20011960|NCT02373813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20011961|NCT02373813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011962|NCT02373813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20011963|NCT02373813|Antimetabolites|antimetabolites|mesh-ancestor
20011964|NCT02373813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20011965|NCT02373813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20011966|NCT02373813|Dermatologic Agents|dermatologic agents|mesh-ancestor
20011967|NCT02373813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20011968|NCT02373813|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20011969|NCT02373813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20011970|NCT02373813|Immunologic Factors|immunologic factors|mesh-ancestor
19463121|NCT03330782|Sensory System Agents|sensory system agents|mesh-ancestor
20011971|NCT02373813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20011972|NCT02373813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19463122|NCT03330782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463123|NCT03330769|Antirheumatic Agents|antirheumatic agents|mesh-list
19463124|NCT03330717|Anesthetics|anesthetics|mesh-list
19463125|NCT03330717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19463126|NCT03330717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011973|NCT02373813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20011974|NCT02373813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20011975|NCT02373813|Analgesics|analgesics|mesh-ancestor
20011976|NCT02373813|Sensory System Agents|sensory system agents|mesh-ancestor
20011977|NCT02373813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20011978|NCT02373813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20011979|NCT02373813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20011980|NCT02373813|Hematinics|hematinics|mesh-ancestor
20011981|NCT02373813|Vitamin B Complex|vitamin b complex|mesh-ancestor
20011982|NCT02373813|Vitamins|vitamins|mesh-ancestor
20011983|NCT02373813|Micronutrients|micronutrients|mesh-ancestor
20011984|NCT02374060|Dexamethasone|dexamethasone|mesh-list
20011985|NCT02374060|Triamcinolone|triamcinolone|mesh-list
20011986|NCT02374060|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
20011987|NCT02374060|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
20011988|NCT02374060|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
20011989|NCT02374060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20011990|NCT02374060|Antiemetics|antiemetics|mesh-ancestor
20011991|NCT02374060|Autonomic Agents|autonomic agents|mesh-ancestor
20011992|NCT02374060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20011993|NCT02374060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20011994|NCT02374060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20011995|NCT02374060|Glucocorticoids|glucocorticoids|mesh-ancestor
20011996|NCT02374060|Hormones|hormones|mesh-ancestor
20011997|NCT02374060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20011998|NCT02374060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20011999|NCT02374060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012000|NCT02374060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20012001|NCT02374060|Immunologic Factors|immunologic factors|mesh-ancestor
20012002|NCT02374060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012003|NCT02374060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012004|NCT02374099|Azacitidine|azacitidine|mesh-list
20012005|NCT02374099|Fulvestrant|fulvestrant|mesh-list
20012006|NCT02374099|Cc-486|cc-486|mesh-list
20012007|NCT02374099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20012008|NCT02374099|Antimetabolites|antimetabolites|mesh-ancestor
20012009|NCT02374099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012010|NCT02374099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012011|NCT02374099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012012|NCT02374099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20012013|NCT02374099|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20012014|NCT02374099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20012015|NCT02374099|Hormone Antagonists|hormone antagonists|mesh-ancestor
20012016|NCT02374099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20012017|NCT02374099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012018|NCT02374164|Febuxostat|febuxostat|mesh-list
20012019|NCT02374164|Gout Suppressants|gout suppressants|mesh-ancestor
20012020|NCT02374164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20012021|NCT02374398|Tranexamic Acid|tranexamic acid|mesh-list
20012022|NCT02374398|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20012023|NCT02374398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20012024|NCT02374398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012025|NCT02374398|Hemostatics|hemostatics|mesh-ancestor
20012026|NCT02374398|Coagulants|coagulants|mesh-ancestor
20012027|NCT02374957|Cilostazol|cilostazol|mesh-list
20012028|NCT02374957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20012029|NCT02374957|Autonomic Agents|autonomic agents|mesh-ancestor
20012030|NCT02374957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012031|NCT02374957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012032|NCT02374957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20012033|NCT02374957|Respiratory System Agents|respiratory system agents|mesh-ancestor
20012034|NCT02374957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20012035|NCT02374957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20012036|NCT02374957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012037|NCT02374957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20012038|NCT02374957|Vasodilator Agents|vasodilator agents|mesh-ancestor
20012039|NCT02374957|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20012040|NCT02374957|Protective Agents|protective agents|mesh-ancestor
20012041|NCT02374957|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
20012042|NCT02374957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19463127|NCT03330639|Capsaicin|capsaicin|mesh-list
19463128|NCT03330639|Antipruritics|antipruritics|mesh-ancestor
19463129|NCT03330639|Dermatologic Agents|dermatologic agents|mesh-ancestor
19463130|NCT03330639|Sensory System Agents|sensory system agents|mesh-ancestor
19463131|NCT03330639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463132|NCT03330639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463133|NCT03330613|Anesthetics|anesthetics|mesh-list
19463134|NCT03330613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19463135|NCT03330613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463136|NCT03330223|Clopidogrel|clopidogrel|mesh-list
19463137|NCT03330223|Ticagrelor|ticagrelor|mesh-list
19463138|NCT03330223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19463139|NCT03330223|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19463140|NCT03330223|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19463141|NCT03330223|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19463142|NCT03330223|Purinergic Agents|purinergic agents|mesh-ancestor
19463143|NCT03330223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19463144|NCT03330223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463145|NCT03330223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463146|NCT03330171|Vaccines|vaccines|mesh-list
19463147|NCT03330171|Immunologic Factors|immunologic factors|mesh-ancestor
19463148|NCT03330171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463149|NCT03330132|Vaccines|vaccines|mesh-list
19463150|NCT03330132|Hemagglutinins|hemagglutinins|mesh-list
19463151|NCT03330132|Immunologic Factors|immunologic factors|mesh-ancestor
19463152|NCT03330132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463153|NCT03330132|Agglutinins|agglutinins|mesh-ancestor
19463154|NCT03330106|Paclitaxel|paclitaxel|mesh-list
19463155|NCT03330106|Docetaxel|docetaxel|mesh-list
19463156|NCT03330106|Carboplatin|carboplatin|mesh-list
19463157|NCT03330106|Pevonedistat|pevonedistat|mesh-list
19463158|NCT03330106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19463159|NCT03330106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463160|NCT03330106|Tubulin Modulators|tubulin modulators|mesh-ancestor
19463161|NCT03330106|Antimitotic Agents|antimitotic agents|mesh-ancestor
19463162|NCT03330106|Mitosis Modulators|mitosis modulators|mesh-ancestor
19463163|NCT03330106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463164|NCT03330106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19463165|NCT03329898|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19463166|NCT03329898|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19463167|NCT03329898|Estradiol|estradiol|mesh-list
19463168|NCT03329898|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19463169|NCT03329898|Dydrogesterone|dydrogesterone|mesh-list
19463170|NCT03329898|Estrogens|estrogens|mesh-ancestor
19463171|NCT03329898|Hormones|hormones|mesh-ancestor
19463172|NCT03329898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19463173|NCT03329898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463174|NCT03329898|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19463175|NCT03329898|Contraceptive Agents|contraceptive agents|mesh-ancestor
19463176|NCT03329898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19463177|NCT03329898|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19463178|NCT03329898|Progestins|progestins|mesh-ancestor
19463179|NCT03329781|Curcumin|curcumin|mesh-list
19463180|NCT03329781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19463181|NCT03329781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19463182|NCT03329781|Analgesics|analgesics|mesh-ancestor
19463183|NCT03329781|Sensory System Agents|sensory system agents|mesh-ancestor
19463184|NCT03329781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463185|NCT03329781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463186|NCT03329781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19463187|NCT03329781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19463188|NCT03329781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463189|NCT03329781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19463190|NCT03329781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463191|NCT03329729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
19463192|NCT03329729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19463193|NCT03329729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19463194|NCT03329729|Antimetabolites|antimetabolites|mesh-ancestor
19463195|NCT03329729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463196|NCT03329729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19463197|NCT03329729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19463198|NCT03329729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19463199|NCT03329651|Metformin|metformin|mesh-list
19463200|NCT03329651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19463201|NCT03329651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463202|NCT03329638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19463203|NCT03329638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19463204|NCT03329547|Cefixime|cefixime|mesh-list
19463205|NCT03329547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19463206|NCT03329547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19463207|NCT03329508|Pramipexole|pramipexole|mesh-list
19463208|NCT03329508|Rasagiline|rasagiline|mesh-list
19463209|NCT03329508|Antioxidants|antioxidants|mesh-ancestor
19463210|NCT03329508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463211|NCT03329508|Protective Agents|protective agents|mesh-ancestor
19463212|NCT03329508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463213|NCT03329508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19463214|NCT03329508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19463215|NCT03329508|Dopamine Agonists|dopamine agonists|mesh-ancestor
19463216|NCT03329508|Dopamine Agents|dopamine agents|mesh-ancestor
19463217|NCT03329508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19463218|NCT03329508|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
19463219|NCT03329508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19463220|NCT03329508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19463221|NCT03329456|Ropivacaine|ropivacaine|mesh-list
19463222|NCT03329456|Anesthetics, Local|anesthetics, local|mesh-ancestor
19463223|NCT03329456|Anesthetics|anesthetics|mesh-ancestor
19463224|NCT03329456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19463225|NCT03329456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463226|NCT03329456|Sensory System Agents|sensory system agents|mesh-ancestor
19463227|NCT03329456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463228|NCT03329443|Spironolactone|spironolactone|mesh-list
19463229|NCT03329443|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19463230|NCT03329443|Hormone Antagonists|hormone antagonists|mesh-ancestor
19463231|NCT03329443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19463232|NCT03329443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463233|NCT03329443|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19463234|NCT03329443|Diuretics|diuretics|mesh-ancestor
19463235|NCT03329443|Natriuretic Agents|natriuretic agents|mesh-ancestor
19463236|NCT03329339|Ascorbic Acid|ascorbic acid|mesh-list
19463237|NCT03329339|Antioxidants|antioxidants|mesh-ancestor
19463238|NCT03329339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463239|NCT03329339|Protective Agents|protective agents|mesh-ancestor
19463240|NCT03329339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463241|NCT03329339|Vitamins|vitamins|mesh-ancestor
19463242|NCT03329339|Micronutrients|micronutrients|mesh-ancestor
19463243|NCT03329261|Clopidogrel|clopidogrel|mesh-list
19463244|NCT03329261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19463245|NCT03329261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19463246|NCT03329261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19463247|NCT03329261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19463248|NCT03329261|Purinergic Agents|purinergic agents|mesh-ancestor
19463249|NCT03329261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19463250|NCT03329261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463251|NCT03329261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463252|NCT03329248|Leucovorin|leucovorin|mesh-list
19463253|NCT03329248|Paclitaxel|paclitaxel|mesh-list
19463254|NCT03329248|Cyclophosphamide|cyclophosphamide|mesh-list
19463255|NCT03329248|Bevacizumab|bevacizumab|mesh-list
19463256|NCT03329248|Fluorouracil|fluorouracil|mesh-list
19463257|NCT03329248|Capecitabine|capecitabine|mesh-list
19463258|NCT03329248|Oxaliplatin|oxaliplatin|mesh-list
19463259|NCT03329248|Avelumab|avelumab|mesh-list
19463260|NCT03329248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19463261|NCT03329248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463262|NCT03329248|Tubulin Modulators|tubulin modulators|mesh-ancestor
19463263|NCT03329248|Antimitotic Agents|antimitotic agents|mesh-ancestor
19463264|NCT03329248|Mitosis Modulators|mitosis modulators|mesh-ancestor
19463265|NCT03329248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463266|NCT03329248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19463267|NCT03329248|Immunologic Factors|immunologic factors|mesh-ancestor
19463268|NCT03329248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463269|NCT03329248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19463270|NCT03329248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19463271|NCT03329248|Alkylating Agents|alkylating agents|mesh-ancestor
19463272|NCT03329248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19463273|NCT03329248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19463274|NCT03329248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19463275|NCT03329248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19463276|NCT03329248|Growth Substances|growth substances|mesh-ancestor
19463277|NCT03329248|Growth Inhibitors|growth inhibitors|mesh-ancestor
19463278|NCT03329248|Antimetabolites|antimetabolites|mesh-ancestor
19463279|NCT03329248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19463280|NCT03329248|Antidotes|antidotes|mesh-ancestor
19463281|NCT03329248|Protective Agents|protective agents|mesh-ancestor
19463282|NCT03329248|Vitamin B Complex|vitamin b complex|mesh-ancestor
19463283|NCT03329248|Vitamins|vitamins|mesh-ancestor
19463284|NCT03329248|Micronutrients|micronutrients|mesh-ancestor
19463285|NCT03329183|Irinotecan|irinotecan|mesh-list
19463286|NCT03329183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19463287|NCT03329183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19463288|NCT03329183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19463289|NCT03329183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463290|NCT03329183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463291|NCT03329118|Simvastatin|simvastatin|mesh-list
19463292|NCT03329118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19463293|NCT03329118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19463294|NCT03329118|Antimetabolites|antimetabolites|mesh-ancestor
19463295|NCT03329118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463296|NCT03329118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19463297|NCT03329118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19463298|NCT03329118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19463299|NCT03328975|Dexamethasone|dexamethasone|mesh-list
19463300|NCT03328975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19463301|NCT03328975|Antiemetics|antiemetics|mesh-ancestor
19463302|NCT03328975|Autonomic Agents|autonomic agents|mesh-ancestor
19463303|NCT03328975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463304|NCT03328975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463305|NCT03328975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19463306|NCT03328975|Glucocorticoids|glucocorticoids|mesh-ancestor
19463307|NCT03328975|Hormones|hormones|mesh-ancestor
19463308|NCT03328975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19463309|NCT03328975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19463310|NCT03328975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463311|NCT03328936|Melphalan|melphalan|mesh-list
19463312|NCT03328936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19463313|NCT03328936|Alkylating Agents|alkylating agents|mesh-ancestor
19463314|NCT03328936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463315|NCT03328936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463316|NCT03328936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19463317|NCT03328936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19463318|NCT03328936|Immunologic Factors|immunologic factors|mesh-ancestor
19463319|NCT03328936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012043|NCT02374957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012044|NCT02375724|Bromides|bromides|mesh-list
20012045|NCT02375724|Anticonvulsants|anticonvulsants|mesh-ancestor
20012046|NCT02375971|Ranibizumab|ranibizumab|mesh-list
20012047|NCT02375971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20012048|NCT02375971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20012049|NCT02375971|Growth Substances|growth substances|mesh-ancestor
20012050|NCT02375971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012051|NCT02375971|Growth Inhibitors|growth inhibitors|mesh-ancestor
20012052|NCT02375971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012053|NCT02376010|Warfarin|warfarin|mesh-list
20012054|NCT02376010|Rivaroxaban|rivaroxaban|mesh-list
20012055|NCT02376010|Anticoagulants|anticoagulants|mesh-ancestor
20012056|NCT02376010|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20012057|NCT02376010|Antithrombins|antithrombins|mesh-ancestor
20012058|NCT02376010|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20012059|NCT02376010|Protease Inhibitors|protease inhibitors|mesh-ancestor
20012060|NCT02376010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012061|NCT02376010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012062|NCT02376166|Metformin|metformin|mesh-list
20012063|NCT02376166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20012064|NCT02376166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012065|NCT02376257|Cycloserine|cycloserine|mesh-list
20012066|NCT02376257|Modafinil|modafinil|mesh-list
20012067|NCT02376257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20012068|NCT02376257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012069|NCT02376257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20012070|NCT02376257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20012071|NCT02376257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20012072|NCT02376257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012073|NCT02376257|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20012074|NCT02376257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20012075|NCT02376257|Renal Agents|renal agents|mesh-ancestor
20012076|NCT02376257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19463320|NCT03328728|Hylan|hylan|mesh-list
19463321|NCT03328728|Viscosupplements|viscosupplements|mesh-ancestor
19463322|NCT03328728|Protective Agents|protective agents|mesh-ancestor
19463323|NCT03328728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463324|NCT03328533|Phenylephrine|phenylephrine|mesh-list
19463325|NCT03328533|Oxymetazoline|oxymetazoline|mesh-list
19463326|NCT03328533|Norepinephrine|norepinephrine|mesh-list
19463327|NCT03328533|Bupivacaine|bupivacaine|mesh-list
19463328|NCT03328533|Anesthetics, Local|anesthetics, local|mesh-ancestor
19463329|NCT03328533|Anesthetics|anesthetics|mesh-ancestor
19463330|NCT03328533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19463331|NCT03328533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463332|NCT03328533|Sensory System Agents|sensory system agents|mesh-ancestor
19463333|NCT03328533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463334|NCT03328533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19463335|NCT03328533|Mydriatics|mydriatics|mesh-ancestor
19463336|NCT03328533|Autonomic Agents|autonomic agents|mesh-ancestor
19463337|NCT03328533|Sympathomimetics|sympathomimetics|mesh-ancestor
19463338|NCT03328533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19463339|NCT03328533|Nasal Decongestants|nasal decongestants|mesh-ancestor
19463340|NCT03328533|Respiratory System Agents|respiratory system agents|mesh-ancestor
19463341|NCT03328533|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19463342|NCT03328533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19463343|NCT03328533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19463344|NCT03328533|Adrenergic Agents|adrenergic agents|mesh-ancestor
19463345|NCT03328533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19463346|NCT03328533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463347|NCT03328533|Protective Agents|protective agents|mesh-ancestor
19463348|NCT03328494|Paclitaxel|paclitaxel|mesh-list
19463349|NCT03328494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19463350|NCT03328494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463351|NCT03328494|Tubulin Modulators|tubulin modulators|mesh-ancestor
19463352|NCT03328494|Antimitotic Agents|antimitotic agents|mesh-ancestor
19463353|NCT03328494|Mitosis Modulators|mitosis modulators|mesh-ancestor
19463354|NCT03328494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463355|NCT03328481|Anesthetics|anesthetics|mesh-list
19463356|NCT03328481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19463357|NCT03328481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463358|NCT03328364|Docetaxel|docetaxel|mesh-list
19463359|NCT03328364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463360|NCT03328364|Tubulin Modulators|tubulin modulators|mesh-ancestor
19463361|NCT03328364|Antimitotic Agents|antimitotic agents|mesh-ancestor
19463362|NCT03328364|Mitosis Modulators|mitosis modulators|mesh-ancestor
19463363|NCT03328364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463364|NCT03328312|Atropine|atropine|mesh-list
19463365|NCT03328312|Neostigmine|neostigmine|mesh-list
19463366|NCT03328312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19463367|NCT03328312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19463368|NCT03328312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19463369|NCT03328312|Autonomic Agents|autonomic agents|mesh-ancestor
19463370|NCT03328312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463371|NCT03328312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463372|NCT03328312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19463373|NCT03328312|Respiratory System Agents|respiratory system agents|mesh-ancestor
20012077|NCT02376257|Antitubercular Agents|antitubercular agents|mesh-ancestor
20012078|NCT02376257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20012079|NCT02376257|Antimetabolites|antimetabolites|mesh-ancestor
20012080|NCT02376283|Clopidogrel|clopidogrel|mesh-list
20012081|NCT02376283|Ticagrelor|ticagrelor|mesh-list
20012082|NCT02376283|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
20012083|NCT02376283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20012084|NCT02376283|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20012085|NCT02376283|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20012086|NCT02376283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20012087|NCT02376283|Purinergic Agents|purinergic agents|mesh-ancestor
20012088|NCT02376283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20012089|NCT02376283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012090|NCT02376283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012091|NCT02376790|Etanercept|etanercept|mesh-list
20012092|NCT02376790|Methotrexate|methotrexate|mesh-list
20012093|NCT02376790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20012094|NCT02376790|Abortifacient Agents|abortifacient agents|mesh-ancestor
20012095|NCT02376790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19463374|NCT03328312|Mydriatics|mydriatics|mesh-ancestor
19463375|NCT03328312|Parasympatholytics|parasympatholytics|mesh-ancestor
19463376|NCT03328312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19463377|NCT03328312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19463378|NCT03328312|Cholinergic Agents|cholinergic agents|mesh-ancestor
19463379|NCT03328312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19463380|NCT03328312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463381|NCT03328312|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19463382|NCT03328312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19463383|NCT03328312|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19463384|NCT03328299|Dexmedetomidine|dexmedetomidine|mesh-list
19463385|NCT03328299|Bupivacaine|bupivacaine|mesh-list
19463386|NCT03328299|Anesthetics, Local|anesthetics, local|mesh-ancestor
19463387|NCT03328299|Anesthetics|anesthetics|mesh-ancestor
19463388|NCT03328299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19463389|NCT03328299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463390|NCT03328299|Sensory System Agents|sensory system agents|mesh-ancestor
19463391|NCT03328299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463392|NCT03328299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19463393|NCT03328299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19463394|NCT03328299|Analgesics|analgesics|mesh-ancestor
19463395|NCT03328299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19463396|NCT03328299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19463397|NCT03328299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19463398|NCT03328299|Adrenergic Agents|adrenergic agents|mesh-ancestor
19463399|NCT03328299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19463400|NCT03328299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463401|NCT03328234|Paclitaxel|paclitaxel|mesh-list
19463402|NCT03328234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19463403|NCT03328234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19463404|NCT03328234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463405|NCT03328234|Tubulin Modulators|tubulin modulators|mesh-ancestor
19463406|NCT03328234|Antimitotic Agents|antimitotic agents|mesh-ancestor
19463407|NCT03328234|Mitosis Modulators|mitosis modulators|mesh-ancestor
19463408|NCT03328234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463409|NCT03328117|Imatinib Mesylate|imatinib mesylate|mesh-list
19463410|NCT03328117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463411|NCT03328117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19463412|NCT03328117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19463413|NCT03328117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463414|NCT03328104|Cyclophosphamide|cyclophosphamide|mesh-list
19463415|NCT03328104|Etoposide|etoposide|mesh-list
19463416|NCT03328104|Everolimus|everolimus|mesh-list
19463417|NCT03328104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19463418|NCT03328104|Immunologic Factors|immunologic factors|mesh-ancestor
19463419|NCT03328104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463420|NCT03328104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19463421|NCT03328104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19463422|NCT03328104|Alkylating Agents|alkylating agents|mesh-ancestor
19463423|NCT03328104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463424|NCT03328104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463425|NCT03328104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19463426|NCT03328104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19463427|NCT03328104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19463428|NCT03328104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19463429|NCT03328104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19463430|NCT03328052|Antidepressive Agents|antidepressive agents|mesh-list
19463431|NCT03328052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19463432|NCT03327987|Vaccines|vaccines|mesh-list
19463433|NCT03327987|Immunologic Factors|immunologic factors|mesh-ancestor
19463434|NCT03327987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463435|NCT03327831|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19463436|NCT03327831|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19463437|NCT03327831|Dermatologic Agents|dermatologic agents|mesh-ancestor
19463438|NCT03327766|Calcifediol|calcifediol|mesh-list
19463439|NCT03327766|Vitamins|vitamins|mesh-ancestor
19463440|NCT03327766|Micronutrients|micronutrients|mesh-ancestor
19463441|NCT03327766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463442|NCT03327766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19463443|NCT03327727|Voriconazole|voriconazole|mesh-list
19463444|NCT03327727|Amphotericin B|amphotericin b|mesh-list
19463445|NCT03327727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19463446|NCT03327727|Isavuconazole|isavuconazole|mesh-list
19463447|NCT03327727|VL-2397|vl-2397|mesh-list
19463448|NCT03327727|Antifungal Agents|antifungal agents|mesh-ancestor
19463449|NCT03327727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19463450|NCT03327727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19463451|NCT03327727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19463452|NCT03327727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19463453|NCT03327727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463454|NCT03327727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19463455|NCT03327727|Hormone Antagonists|hormone antagonists|mesh-ancestor
19463456|NCT03327727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19463457|NCT03327727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463458|NCT03327727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19463459|NCT03327727|Amebicides|amebicides|mesh-ancestor
19463460|NCT03327727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19463461|NCT03327727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19463462|NCT03327727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19463463|NCT03327701|Benralizumab|benralizumab|mesh-list
19463464|NCT03327701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19463465|NCT03327701|Respiratory System Agents|respiratory system agents|mesh-ancestor
19463466|NCT03327675|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
19463467|NCT03327675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19463468|NCT03327675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463469|NCT03327558|Mesalamine|mesalamine|mesh-list
19463470|NCT03327558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19463471|NCT03327558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19463472|NCT03327558|Analgesics|analgesics|mesh-ancestor
19463473|NCT03327558|Sensory System Agents|sensory system agents|mesh-ancestor
19463474|NCT03327558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463475|NCT03327558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463476|NCT03327558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19463477|NCT03327558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19463478|NCT03327506|Alprazolam|alprazolam|mesh-list
19463479|NCT03327506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19463480|NCT03327506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19463481|NCT03327506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463482|NCT03327506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19463483|NCT03327506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19463484|NCT03327506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19463485|NCT03327506|GABA Modulators|gaba modulators|mesh-ancestor
19463486|NCT03327506|GABA Agents|gaba agents|mesh-ancestor
19463487|NCT03327506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19463488|NCT03327506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463489|NCT03327454|Etanercept|etanercept|mesh-list
19463490|NCT03327454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19463491|NCT03327454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19463492|NCT03327454|Analgesics|analgesics|mesh-ancestor
19463493|NCT03327454|Sensory System Agents|sensory system agents|mesh-ancestor
19463494|NCT03327454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463495|NCT03327454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463496|NCT03327454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19463497|NCT03327454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19463498|NCT03327454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19463499|NCT03327454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19463500|NCT03327454|Immunologic Factors|immunologic factors|mesh-ancestor
19463501|NCT03327389|Dexmedetomidine|dexmedetomidine|mesh-list
19463502|NCT03327389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19463503|NCT03327389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19463504|NCT03327389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463505|NCT03327389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19463506|NCT03327389|Analgesics|analgesics|mesh-ancestor
19463507|NCT03327389|Sensory System Agents|sensory system agents|mesh-ancestor
19463508|NCT03327389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463509|NCT03327389|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19463510|NCT03327389|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19463511|NCT03327389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19463512|NCT03327389|Adrenergic Agents|adrenergic agents|mesh-ancestor
19463513|NCT03327389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19463514|NCT03327389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463515|NCT03327350|Anticoagulants|anticoagulants|mesh-list
19463516|NCT03327272|Methylprednisolone|methylprednisolone|mesh-list
19463517|NCT03327272|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19463518|NCT03327272|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19463519|NCT03327272|Prednisolone|prednisolone|mesh-list
19463520|NCT03327272|Prednisolone acetate|prednisolone acetate|mesh-list
19463521|NCT03327272|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19463522|NCT03327272|Prednisolone phosphate|prednisolone phosphate|mesh-list
19463523|NCT03327272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19463524|NCT03327272|Antiemetics|antiemetics|mesh-ancestor
19463525|NCT03327272|Autonomic Agents|autonomic agents|mesh-ancestor
19463526|NCT03327272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463527|NCT03327272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463528|NCT03327272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19463529|NCT03327272|Glucocorticoids|glucocorticoids|mesh-ancestor
19463530|NCT03327272|Hormones|hormones|mesh-ancestor
19463531|NCT03327272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19463532|NCT03327272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19463533|NCT03327272|Protective Agents|protective agents|mesh-ancestor
19463534|NCT03327272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19463535|NCT03327272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463536|NCT03327168|Adenosine|adenosine|mesh-list
19463537|NCT03327168|Analgesics|analgesics|mesh-ancestor
19463538|NCT03327168|Sensory System Agents|sensory system agents|mesh-ancestor
19463539|NCT03327168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463540|NCT03327168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463541|NCT03327168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19463542|NCT03327168|Vasodilator Agents|vasodilator agents|mesh-ancestor
19463543|NCT03327168|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
19463544|NCT03327168|Purinergic Agonists|purinergic agonists|mesh-ancestor
19463545|NCT03327168|Purinergic Agents|purinergic agents|mesh-ancestor
19463546|NCT03327168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19463547|NCT03327168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463548|NCT03327155|Tenofovir|tenofovir|mesh-list
19463549|NCT03327155|Emtricitabine|emtricitabine|mesh-list
19463550|NCT03327155|Antiviral Agents|antiviral agents|mesh-ancestor
19463551|NCT03327155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19463552|NCT03327155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19463553|NCT03327155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19463554|NCT03327155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19463555|NCT03327155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463556|NCT03327155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19463557|NCT03327155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19463558|NCT03327116|Methotrexate|methotrexate|mesh-list
19463559|NCT03327116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19463560|NCT03327116|Abortifacient Agents|abortifacient agents|mesh-ancestor
19463561|NCT03327116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19463562|NCT03327116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463563|NCT03327116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19463564|NCT03327116|Antimetabolites|antimetabolites|mesh-ancestor
19463565|NCT03327116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463566|NCT03327116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463567|NCT03327116|Dermatologic Agents|dermatologic agents|mesh-ancestor
19463568|NCT03327116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19463569|NCT03327116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19463570|NCT03327116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19463571|NCT03327116|Immunologic Factors|immunologic factors|mesh-ancestor
19463572|NCT03327116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19463573|NCT03327116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20012096|NCT02376790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012097|NCT02376790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20012098|NCT02376790|Antimetabolites|antimetabolites|mesh-ancestor
20012099|NCT02376790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012100|NCT02376790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012101|NCT02376790|Dermatologic Agents|dermatologic agents|mesh-ancestor
20012102|NCT02376790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012103|NCT02376790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20012104|NCT02376790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20012105|NCT02376790|Immunologic Factors|immunologic factors|mesh-ancestor
20012106|NCT02376790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20012107|NCT02376790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20012108|NCT02376790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20012109|NCT02376790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20012110|NCT02376790|Analgesics|analgesics|mesh-ancestor
20012111|NCT02376790|Sensory System Agents|sensory system agents|mesh-ancestor
20012112|NCT02376790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012113|NCT02376790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20012114|NCT02376790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20012115|NCT02377752|Doxorubicin|doxorubicin|mesh-list
20012116|NCT02377752|Olaratumab|olaratumab|mesh-list
20012117|NCT02377752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20012118|NCT02377752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012119|NCT02377752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20012120|NCT02377752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20012121|NCT02377752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19463574|NCT03326960|Propofol|propofol|mesh-list
19463575|NCT03326960|Sevoflurane|sevoflurane|mesh-list
19463576|NCT03326960|Desflurane|desflurane|mesh-list
19463577|NCT03326960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19463578|NCT03326960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19463579|NCT03326960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463580|NCT03326960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20012122|NCT02377752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012123|NCT02378480|Linezolid|linezolid|mesh-list
20012124|NCT02378480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20012125|NCT02378480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19463581|NCT03326960|Anesthetics, General|anesthetics, general|mesh-ancestor
19463582|NCT03326960|Anesthetics|anesthetics|mesh-ancestor
19463583|NCT03326960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19463584|NCT03326960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19463585|NCT03326947|Docetaxel|docetaxel|mesh-list
19463586|NCT03326947|Fluorouracil|fluorouracil|mesh-list
19463587|NCT03326947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463588|NCT03326947|Tubulin Modulators|tubulin modulators|mesh-ancestor
19463589|NCT03326947|Antimitotic Agents|antimitotic agents|mesh-ancestor
19463590|NCT03326947|Mitosis Modulators|mitosis modulators|mesh-ancestor
19463591|NCT03326947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463592|NCT03326947|Antimetabolites|antimetabolites|mesh-ancestor
19463593|NCT03326947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19463594|NCT03326947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19463595|NCT03326947|Immunologic Factors|immunologic factors|mesh-ancestor
19463596|NCT03326947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463597|NCT03326752|Nivolumab|nivolumab|mesh-list
19463598|NCT03326752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19463599|NCT03326752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20012126|NCT02378480|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20012127|NCT02378480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012128|NCT02378480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012129|NCT02378506|Etanercept|etanercept|mesh-list
20012130|NCT02378506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20012131|NCT02378506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19463600|NCT03326752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463601|NCT03326752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463602|NCT03326674|Capecitabine|capecitabine|mesh-list
19463603|NCT03326674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19463604|NCT03326674|Antimetabolites|antimetabolites|mesh-ancestor
19463605|NCT03326674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463606|NCT03326674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463607|NCT03326661|Clindamycin|clindamycin|mesh-list
19463608|NCT03326661|Clindamycin palmitate|clindamycin palmitate|mesh-list
19463609|NCT03326661|Clindamycin phosphate|clindamycin phosphate|mesh-list
19463610|NCT03326661|Penicillins|penicillins|mesh-list
19463611|NCT03326661|Metronidazole|metronidazole|mesh-list
19463612|NCT03326661|Penicillin V|penicillin v|mesh-list
19463613|NCT03326661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19463614|NCT03326661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19463615|NCT03326661|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19463616|NCT03326661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19463617|NCT03326661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463618|NCT03326661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19463619|NCT03326661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19463620|NCT03326609|Ropivacaine|ropivacaine|mesh-list
19463621|NCT03326609|Anesthetics, Local|anesthetics, local|mesh-ancestor
19463622|NCT03326609|Anesthetics|anesthetics|mesh-ancestor
19463623|NCT03326609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19463624|NCT03326609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463625|NCT03326609|Sensory System Agents|sensory system agents|mesh-ancestor
19463626|NCT03326609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463627|NCT03326596|Tranexamic Acid|tranexamic acid|mesh-list
19463628|NCT03326596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19463629|NCT03326596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19463630|NCT03326596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463631|NCT03326596|Hemostatics|hemostatics|mesh-ancestor
19463632|NCT03326596|Coagulants|coagulants|mesh-ancestor
19463633|NCT03326258|Nivolumab|nivolumab|mesh-list
19463634|NCT03326258|Ipilimumab|ipilimumab|mesh-list
19463635|NCT03326258|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
19463636|NCT03326258|Antibodies|antibodies|mesh-list
19463637|NCT03326258|Immunoglobulins|immunoglobulins|mesh-list
19463638|NCT03326258|Immunoconjugates|immunoconjugates|mesh-list
19463639|NCT03326258|Immunotoxins|immunotoxins|mesh-list
19463640|NCT03326258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19463641|NCT03326258|Immunologic Factors|immunologic factors|mesh-ancestor
19463642|NCT03326258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463643|NCT03326258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19463644|NCT03326258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012132|NCT02378506|Analgesics|analgesics|mesh-ancestor
20012133|NCT02378506|Sensory System Agents|sensory system agents|mesh-ancestor
20012134|NCT02378506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012135|NCT02378506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012136|NCT02378506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20012137|NCT02378506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20012138|NCT02378506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20012139|NCT02378506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20012140|NCT02378506|Immunologic Factors|immunologic factors|mesh-ancestor
20012141|NCT02378714|Varenicline|varenicline|mesh-list
20012142|NCT02378714|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20012143|NCT02378714|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20012144|NCT02378714|Cholinergic Agents|cholinergic agents|mesh-ancestor
20012145|NCT02378714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20012146|NCT02378714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012147|NCT02378714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012148|NCT02378935|Sofosbuvir|sofosbuvir|mesh-list
20012149|NCT02378935|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20012150|NCT02378935|Velpatasvir|velpatasvir|mesh-list
20012151|NCT02378935|Antiviral Agents|antiviral agents|mesh-ancestor
20012152|NCT02378935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20012153|NCT02378961|Sofosbuvir|sofosbuvir|mesh-list
20012154|NCT02378961|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20012155|NCT02378961|Velpatasvir|velpatasvir|mesh-list
20012156|NCT02378961|Antiviral Agents|antiviral agents|mesh-ancestor
20012157|NCT02378961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20012158|NCT02379091|Leucovorin|leucovorin|mesh-list
20012159|NCT02379091|Folic Acid|folic acid|mesh-list
20012160|NCT02379091|Methotrexate|methotrexate|mesh-list
20012161|NCT02379091|Levoleucovorin|levoleucovorin|mesh-list
20012162|NCT02379091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20012163|NCT02379091|Abortifacient Agents|abortifacient agents|mesh-ancestor
20012164|NCT02379091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20012165|NCT02379091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012166|NCT02379091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20012167|NCT02379091|Antimetabolites|antimetabolites|mesh-ancestor
20012168|NCT02379091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012169|NCT02379091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012170|NCT02379091|Dermatologic Agents|dermatologic agents|mesh-ancestor
20012171|NCT02379091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012172|NCT02379091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20012173|NCT02379091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20012174|NCT02379091|Immunologic Factors|immunologic factors|mesh-ancestor
20012175|NCT02379091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20012176|NCT02379091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20012177|NCT02379091|Antidotes|antidotes|mesh-ancestor
20012178|NCT02379091|Protective Agents|protective agents|mesh-ancestor
20012179|NCT02379091|Vitamin B Complex|vitamin b complex|mesh-ancestor
20012180|NCT02379091|Vitamins|vitamins|mesh-ancestor
20012181|NCT02379091|Micronutrients|micronutrients|mesh-ancestor
20012182|NCT02379091|Hematinics|hematinics|mesh-ancestor
20012183|NCT02379195|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
20012184|NCT02379195|Cyclophosphamide|cyclophosphamide|mesh-list
19463645|NCT03326258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19463646|NCT03326258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463647|NCT03326180|Bupivacaine|bupivacaine|mesh-list
19463648|NCT03326180|Anesthetics, Local|anesthetics, local|mesh-ancestor
19463649|NCT03326180|Anesthetics|anesthetics|mesh-ancestor
19463650|NCT03326180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20012185|NCT02379195|Fludarabine|fludarabine|mesh-list
20012186|NCT02379195|Interleukin-2|interleukin-2|mesh-list
20012187|NCT02379195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20012188|NCT02379195|Immunologic Factors|immunologic factors|mesh-ancestor
20012189|NCT02379195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012190|NCT02379195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20012191|NCT02379195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20012192|NCT02379195|Alkylating Agents|alkylating agents|mesh-ancestor
20012193|NCT02379195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012194|NCT02379195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012195|NCT02379195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19463651|NCT03326180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463652|NCT03326180|Sensory System Agents|sensory system agents|mesh-ancestor
19463653|NCT03326180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463654|NCT03326128|Bupropion|bupropion|mesh-list
19463655|NCT03326128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19463656|NCT03326128|Antidepressive Agents|antidepressive agents|mesh-ancestor
19463657|NCT03326128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19463658|NCT03326128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19463659|NCT03326128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19463660|NCT03326128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19463661|NCT03326128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463662|NCT03326128|Dopamine Agents|dopamine agents|mesh-ancestor
19463663|NCT03326128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19463664|NCT03326128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463665|NCT03326128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19463666|NCT03326128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19463667|NCT03326128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19463668|NCT03326102|Paclitaxel|paclitaxel|mesh-list
19463669|NCT03326102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19463670|NCT03326102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19463671|NCT03326102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463672|NCT03326102|Tubulin Modulators|tubulin modulators|mesh-ancestor
19463673|NCT03326102|Antimitotic Agents|antimitotic agents|mesh-ancestor
19463674|NCT03326102|Mitosis Modulators|mitosis modulators|mesh-ancestor
19463675|NCT03326102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463676|NCT03326063|Ifetroban|ifetroban|mesh-list
19463677|NCT03326063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19463678|NCT03326050|Ciprofloxacin|ciprofloxacin|mesh-list
19463679|NCT03326050|Rifampin|rifampin|mesh-list
19463680|NCT03326050|Gemifloxacin|gemifloxacin|mesh-list
19463681|NCT03326050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19463682|NCT03326050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19463683|NCT03326050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19463684|NCT03326050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19463685|NCT03326050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19463686|NCT03326050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463687|NCT03326050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463688|NCT03326050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19463689|NCT03326050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19463690|NCT03326050|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19463691|NCT03326050|Antitubercular Agents|antitubercular agents|mesh-ancestor
19463692|NCT03326050|Leprostatic Agents|leprostatic agents|mesh-ancestor
19463693|NCT03326050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19463694|NCT03326050|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19463695|NCT03326050|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19463696|NCT03326050|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19463697|NCT03326050|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19463698|NCT03326050|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19463699|NCT03326050|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19463700|NCT03325972|Dexmedetomidine|dexmedetomidine|mesh-list
19463701|NCT03325972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19463702|NCT03325972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19463703|NCT03325972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463704|NCT03325972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19463705|NCT03325972|Analgesics|analgesics|mesh-ancestor
19463706|NCT03325972|Sensory System Agents|sensory system agents|mesh-ancestor
19463707|NCT03325972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463708|NCT03325972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19463709|NCT03325972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19463710|NCT03325972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19463711|NCT03325972|Adrenergic Agents|adrenergic agents|mesh-ancestor
19463712|NCT03325972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19463713|NCT03325972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463714|NCT03325959|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19463715|NCT03325959|Analgesics|analgesics|mesh-ancestor
19463716|NCT03325959|Sensory System Agents|sensory system agents|mesh-ancestor
19463717|NCT03325959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463718|NCT03325959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463719|NCT03325959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19463720|NCT03325959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463721|NCT03325959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19463722|NCT03325959|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19463723|NCT03325959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19463724|NCT03325959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19463725|NCT03325959|Antidepressive Agents|antidepressive agents|mesh-ancestor
19463726|NCT03325959|Dopamine Agents|dopamine agents|mesh-ancestor
19463727|NCT03325868|Ulipristal acetate|ulipristal acetate|mesh-list
19463728|NCT03325868|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19463729|NCT03325868|Contraceptive Agents|contraceptive agents|mesh-ancestor
19463730|NCT03325868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19463731|NCT03325868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463732|NCT03325868|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19463733|NCT03325803|Lidocaine|lidocaine|mesh-list
19463734|NCT03325803|Prilocaine|prilocaine|mesh-list
19463735|NCT03325803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19463736|NCT03325803|Anesthetics, Local|anesthetics, local|mesh-ancestor
19463737|NCT03325803|Anesthetics|anesthetics|mesh-ancestor
19463738|NCT03325803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19463739|NCT03325803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463740|NCT03325803|Sensory System Agents|sensory system agents|mesh-ancestor
19463741|NCT03325803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463742|NCT03325803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19463743|NCT03325803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19463744|NCT03325803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19463745|NCT03325803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19463746|NCT03325803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463747|NCT03325803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19463748|NCT03325790|Ebselen|ebselen|mesh-list
19463749|NCT03325790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19463750|NCT03325790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19463751|NCT03325790|Analgesics|analgesics|mesh-ancestor
19463752|NCT03325790|Sensory System Agents|sensory system agents|mesh-ancestor
19463753|NCT03325790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463754|NCT03325790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463755|NCT03325790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19463756|NCT03325790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19463757|NCT03325790|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19463758|NCT03325790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19463759|NCT03325790|Antioxidants|antioxidants|mesh-ancestor
19463760|NCT03325790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463761|NCT03325790|Protective Agents|protective agents|mesh-ancestor
19463762|NCT03325790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19463763|NCT03325790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19463764|NCT03325790|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19463765|NCT03325686|Vitamin D|vitamin d|mesh-list
19463766|NCT03325686|Vitamins|vitamins|mesh-ancestor
19463767|NCT03325686|Micronutrients|micronutrients|mesh-ancestor
19463768|NCT03325686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463769|NCT03325686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19463770|NCT03325491|Acipimox|acipimox|mesh-list
19463771|NCT03325491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19463772|NCT03325491|Antimetabolites|antimetabolites|mesh-ancestor
19463773|NCT03325491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463774|NCT03325491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19463775|NCT03325465|Pembrolizumab|pembrolizumab|mesh-list
19463776|NCT03325465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19463777|NCT03325465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463778|NCT03325413|Anesthetics|anesthetics|mesh-list
19463779|NCT03325413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19463780|NCT03325413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463781|NCT03325400|Fluorides|fluorides|mesh-list
19463782|NCT03325400|Cariostatic Agents|cariostatic agents|mesh-ancestor
19463783|NCT03325400|Protective Agents|protective agents|mesh-ancestor
19463784|NCT03325400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463785|NCT03325348|Labetalol|labetalol|mesh-list
19463786|NCT03325348|Nifedipine|nifedipine|mesh-list
19463787|NCT03325348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19463788|NCT03325348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19463789|NCT03325348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463790|NCT03325348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19463791|NCT03325348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463792|NCT03325348|Vasodilator Agents|vasodilator agents|mesh-ancestor
19463793|NCT03325348|Tocolytic Agents|tocolytic agents|mesh-ancestor
19463794|NCT03325348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19463795|NCT03325348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19463796|NCT03325348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19463797|NCT03325348|Adrenergic Agents|adrenergic agents|mesh-ancestor
19463798|NCT03325348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19463799|NCT03325348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19463800|NCT03325348|Sympathomimetics|sympathomimetics|mesh-ancestor
19463801|NCT03325348|Autonomic Agents|autonomic agents|mesh-ancestor
19463802|NCT03325348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463803|NCT03325348|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19463804|NCT03325348|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19463805|NCT03325335|Midazolam|midazolam|mesh-list
19463806|NCT03325335|Remifentanil|remifentanil|mesh-list
19463807|NCT03325335|Propofol|propofol|mesh-list
19463808|NCT03325335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19463809|NCT03325335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19463810|NCT03325335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463811|NCT03325335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19463812|NCT03325335|Anesthetics, General|anesthetics, general|mesh-ancestor
19463813|NCT03325335|Anesthetics|anesthetics|mesh-ancestor
19463814|NCT03325335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19463815|NCT03325335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19463816|NCT03325335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19463817|NCT03325335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19463818|NCT03325335|GABA Modulators|gaba modulators|mesh-ancestor
19463819|NCT03325335|GABA Agents|gaba agents|mesh-ancestor
19463820|NCT03325335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19463821|NCT03325335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463822|NCT03325335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19463823|NCT03325335|Narcotics|narcotics|mesh-ancestor
19463824|NCT03325335|Analgesics|analgesics|mesh-ancestor
19463825|NCT03325335|Sensory System Agents|sensory system agents|mesh-ancestor
19463826|NCT03325335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012196|NCT02379195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20012197|NCT02379195|Analgesics|analgesics|mesh-ancestor
20012198|NCT02379195|Sensory System Agents|sensory system agents|mesh-ancestor
20012199|NCT02379195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012200|NCT02379195|Antiviral Agents|antiviral agents|mesh-ancestor
20012201|NCT02379195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20012202|NCT02379221|Lidocaine|lidocaine|mesh-list
20012203|NCT02379221|Epinephrine|epinephrine|mesh-list
20012204|NCT02379221|Benzocaine|benzocaine|mesh-list
20012205|NCT02379221|Anesthetics, Local|anesthetics, local|mesh-ancestor
20012206|NCT02379221|Anesthetics|anesthetics|mesh-ancestor
20012207|NCT02379221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20012208|NCT02379221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012209|NCT02379221|Sensory System Agents|sensory system agents|mesh-ancestor
20012210|NCT02379221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012211|NCT02379221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20012212|NCT02379221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20012213|NCT02379221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20012214|NCT02379221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20012215|NCT02379221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012216|NCT02379221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20012217|NCT02379221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20012218|NCT02379221|Adrenergic Agents|adrenergic agents|mesh-ancestor
20012219|NCT02379221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20012220|NCT02379221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20012221|NCT02379221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20012222|NCT02379221|Autonomic Agents|autonomic agents|mesh-ancestor
19463827|NCT03325270|Ferrous fumarate|ferrous fumarate|mesh-list
19463828|NCT03325270|Trace Elements|trace elements|mesh-ancestor
19463829|NCT03325270|Micronutrients|micronutrients|mesh-ancestor
19463830|NCT03325270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463831|NCT03325166|Pembrolizumab|pembrolizumab|mesh-list
19463832|NCT03325166|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
19463833|NCT03325166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19463834|NCT03325166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463835|NCT03325166|Hematinics|hematinics|mesh-ancestor
19463836|NCT03325166|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
19463837|NCT03325166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19463838|NCT03325127|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19463839|NCT03325127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463840|NCT03324867|Insulin|insulin|mesh-list
19463841|NCT03324867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19463842|NCT03324867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19463843|NCT03324867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463844|NCT03324828|Hydroxyzine|hydroxyzine|mesh-list
19463845|NCT03324828|Antipruritics|antipruritics|mesh-ancestor
19463846|NCT03324828|Dermatologic Agents|dermatologic agents|mesh-ancestor
19463847|NCT03324828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19463848|NCT03324828|Histamine Antagonists|histamine antagonists|mesh-ancestor
19463849|NCT03324828|Histamine Agents|histamine agents|mesh-ancestor
19463850|NCT03324828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19463851|NCT03324828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463852|NCT03324828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463853|NCT03324815|Morphine|morphine|mesh-list
19463854|NCT03324815|Methadone|methadone|mesh-list
19463855|NCT03324815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19463856|NCT03324815|Narcotics|narcotics|mesh-ancestor
19463857|NCT03324815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19463858|NCT03324815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463859|NCT03324815|Analgesics|analgesics|mesh-ancestor
19463860|NCT03324815|Sensory System Agents|sensory system agents|mesh-ancestor
19463861|NCT03324815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463862|NCT03324815|Antitussive Agents|antitussive agents|mesh-ancestor
19463863|NCT03324815|Respiratory System Agents|respiratory system agents|mesh-ancestor
19463864|NCT03324776|Insulin|insulin|mesh-list
19463865|NCT03324776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19463866|NCT03324776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19463867|NCT03324776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463868|NCT03324685|Levonorgestrel|levonorgestrel|mesh-list
19463869|NCT03324685|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19463870|NCT03324685|Estradiol|estradiol|mesh-list
19463871|NCT03324685|Estrogens|estrogens|mesh-ancestor
19463872|NCT03324685|Hormones|hormones|mesh-ancestor
19463873|NCT03324685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19463874|NCT03324685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463875|NCT03324685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19463876|NCT03324685|Contraceptive Agents|contraceptive agents|mesh-ancestor
19463877|NCT03324685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19463878|NCT03324685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19463879|NCT03324685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19463880|NCT03324685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19463881|NCT03324685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19463882|NCT03324542|Ranibizumab|ranibizumab|mesh-list
19463883|NCT03324542|Aflibercept|aflibercept|mesh-list
19463884|NCT03324542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463885|NCT03324542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19463886|NCT03324542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19463887|NCT03324542|Growth Substances|growth substances|mesh-ancestor
19463888|NCT03324542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463889|NCT03324542|Growth Inhibitors|growth inhibitors|mesh-ancestor
19463890|NCT03324503|Prednisone|prednisone|mesh-list
19463891|NCT03324503|Prednisolone|prednisolone|mesh-list
19463892|NCT03324503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19463893|NCT03324503|Methylprednisolone|methylprednisolone|mesh-list
19463894|NCT03324503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19463895|NCT03324503|Prednisolone acetate|prednisolone acetate|mesh-list
19463896|NCT03324503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19463897|NCT03324503|Prednisolone phosphate|prednisolone phosphate|mesh-list
19463898|NCT03324503|Glucocorticoids|glucocorticoids|mesh-list
19463899|NCT03324503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19463900|NCT03324503|Hormones|hormones|mesh-ancestor
19463901|NCT03324503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19463902|NCT03324503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463903|NCT03324503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19463904|NCT03324503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463905|NCT03324503|Antiemetics|antiemetics|mesh-ancestor
19463906|NCT03324503|Autonomic Agents|autonomic agents|mesh-ancestor
19463907|NCT03324503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463908|NCT03324503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19463909|NCT03324503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19463910|NCT03324503|Protective Agents|protective agents|mesh-ancestor
19463911|NCT03324490|Fentanyl|fentanyl|mesh-list
19463912|NCT03324490|Dexmedetomidine|dexmedetomidine|mesh-list
19463913|NCT03324490|Bupivacaine|bupivacaine|mesh-list
19463914|NCT03324490|Anesthetics|anesthetics|mesh-list
19463915|NCT03324490|Anesthetics, Local|anesthetics, local|mesh-ancestor
19463916|NCT03324490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19463917|NCT03324490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463918|NCT03324490|Sensory System Agents|sensory system agents|mesh-ancestor
19463919|NCT03324490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463920|NCT03324490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19463921|NCT03324490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19463922|NCT03324490|Analgesics|analgesics|mesh-ancestor
19463923|NCT03324490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19463924|NCT03324490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19463925|NCT03324490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19463926|NCT03324490|Adrenergic Agents|adrenergic agents|mesh-ancestor
19463927|NCT03324490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19463928|NCT03324490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463929|NCT03324490|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19463930|NCT03324490|Narcotics|narcotics|mesh-ancestor
19463931|NCT03324490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19463932|NCT03324490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19463933|NCT03324490|Anesthetics, General|anesthetics, general|mesh-ancestor
19463934|NCT03324425|Simvastatin|simvastatin|mesh-list
19463935|NCT03324425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19463936|NCT03324425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19463937|NCT03324425|Antimetabolites|antimetabolites|mesh-ancestor
19463938|NCT03324425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463939|NCT03324425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19463940|NCT03324425|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
19463941|NCT03324425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19463942|NCT03324334|Antibodies|antibodies|mesh-list
19463943|NCT03324334|Immunologic Factors|immunologic factors|mesh-ancestor
19463944|NCT03324334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463945|NCT03324243|Cytarabine|cytarabine|mesh-list
19463946|NCT03324243|Fludarabine|fludarabine|mesh-list
19463947|NCT03324243|Crenolanib|crenolanib|mesh-list
19463948|NCT03324243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463949|NCT03324243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19463950|NCT03324243|Antimetabolites|antimetabolites|mesh-ancestor
19463951|NCT03324243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463952|NCT03324243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19463953|NCT03324243|Immunologic Factors|immunologic factors|mesh-ancestor
19463954|NCT03324243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463955|NCT03324243|Antiviral Agents|antiviral agents|mesh-ancestor
19463956|NCT03324243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19463957|NCT03324139|Heparin|heparin|mesh-list
19463958|NCT03324139|Calcium heparin|calcium heparin|mesh-list
19463959|NCT03324139|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19463960|NCT03324139|Tinzaparin|tinzaparin|mesh-list
19463961|NCT03324139|Dalteparin|dalteparin|mesh-list
19463962|NCT03324139|Anticoagulants|anticoagulants|mesh-ancestor
19463963|NCT03324139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19463964|NCT03324139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19463965|NCT03324139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463966|NCT03324061|Fulvestrant|fulvestrant|mesh-list
19463967|NCT03324061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19463968|NCT03324061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463969|NCT03324061|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19463970|NCT03324061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19463971|NCT03324061|Hormone Antagonists|hormone antagonists|mesh-ancestor
19463972|NCT03324061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19463973|NCT03324061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463974|NCT03323866|Mometasone Furoate|mometasone furoate|mesh-list
19463975|NCT03323866|Budesonide|budesonide|mesh-list
19463976|NCT03323866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19463977|NCT03323866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19463978|NCT03323866|Autonomic Agents|autonomic agents|mesh-ancestor
19463979|NCT03323866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19463980|NCT03323866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463981|NCT03323866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19463982|NCT03323866|Respiratory System Agents|respiratory system agents|mesh-ancestor
19463983|NCT03323866|Glucocorticoids|glucocorticoids|mesh-ancestor
19463984|NCT03323866|Hormones|hormones|mesh-ancestor
19463985|NCT03323866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19463986|NCT03323866|Dermatologic Agents|dermatologic agents|mesh-ancestor
19463987|NCT03323866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19463988|NCT03323710|Sunitinib|sunitinib|mesh-list
19463989|NCT03323710|Propranolol|propranolol|mesh-list
19463990|NCT03323710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19463991|NCT03323710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19463992|NCT03323710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19463993|NCT03323710|Growth Substances|growth substances|mesh-ancestor
19463994|NCT03323710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19463995|NCT03323710|Growth Inhibitors|growth inhibitors|mesh-ancestor
19463996|NCT03323710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19463997|NCT03323710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19463998|NCT03323710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19463999|NCT03323710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
19464000|NCT03323710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19464001|NCT03323710|Adrenergic Agents|adrenergic agents|mesh-ancestor
19464002|NCT03323710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19464003|NCT03323710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19464004|NCT03323710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19464005|NCT03323710|Vasodilator Agents|vasodilator agents|mesh-ancestor
19464006|NCT03323697|Citalopram|citalopram|mesh-list
19464007|NCT03323697|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19464008|NCT03323697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19464009|NCT03323697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19464010|NCT03323697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464011|NCT03323697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19464012|NCT03323697|Serotonin Agents|serotonin agents|mesh-ancestor
19464013|NCT03323697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464014|NCT03323697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19464015|NCT03323697|Antidepressive Agents|antidepressive agents|mesh-ancestor
19464016|NCT03323697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19464017|NCT03323684|Acetaminophen|acetaminophen|mesh-list
19464018|NCT03323684|Ketorolac|ketorolac|mesh-list
19464019|NCT03323684|Fentanyl|fentanyl|mesh-list
19464020|NCT03323684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19464021|NCT03323684|Narcotics|narcotics|mesh-ancestor
19464022|NCT03323684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19464023|NCT03323684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464024|NCT03323684|Analgesics|analgesics|mesh-ancestor
19464025|NCT03323684|Sensory System Agents|sensory system agents|mesh-ancestor
19464026|NCT03323684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464027|NCT03323684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19464028|NCT03323684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19464029|NCT03323684|Anesthetics, General|anesthetics, general|mesh-ancestor
19464030|NCT03323684|Anesthetics|anesthetics|mesh-ancestor
19464031|NCT03323684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19464032|NCT03323684|Antipyretics|antipyretics|mesh-ancestor
19464033|NCT03323684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19464034|NCT03323684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19464035|NCT03323684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19464036|NCT03323684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19464037|NCT03323684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464038|NCT03323684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464039|NCT03323671|Mefenamic Acid|mefenamic acid|mesh-list
19464040|NCT03323671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19464041|NCT03323671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19464042|NCT03323671|Analgesics|analgesics|mesh-ancestor
19464043|NCT03323671|Sensory System Agents|sensory system agents|mesh-ancestor
19464044|NCT03323671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464045|NCT03323671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464046|NCT03323671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19464047|NCT03323671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19464048|NCT03323671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19464049|NCT03323671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464050|NCT03323671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464051|NCT03323619|Anesthetics|anesthetics|mesh-list
19464052|NCT03323619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19464053|NCT03323619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012223|NCT02379221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19464054|NCT03323593|Dexmedetomidine|dexmedetomidine|mesh-list
19464055|NCT03323593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19464056|NCT03323593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19464057|NCT03323593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464058|NCT03323593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19464059|NCT03323593|Analgesics|analgesics|mesh-ancestor
19464060|NCT03323593|Sensory System Agents|sensory system agents|mesh-ancestor
19464061|NCT03323593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464062|NCT03323593|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19464063|NCT03323593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19464064|NCT03323593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19464065|NCT03323593|Adrenergic Agents|adrenergic agents|mesh-ancestor
19464066|NCT03323593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19464067|NCT03323593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464068|NCT03323567|Lidocaine|lidocaine|mesh-list
19464069|NCT03323567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19464070|NCT03323567|Anesthetics, Local|anesthetics, local|mesh-ancestor
19464071|NCT03323567|Anesthetics|anesthetics|mesh-ancestor
19464072|NCT03323567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19464073|NCT03323567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464074|NCT03323567|Sensory System Agents|sensory system agents|mesh-ancestor
19464075|NCT03323567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464076|NCT03323567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19464077|NCT03323567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19464078|NCT03323567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19464079|NCT03323567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19464080|NCT03323567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464081|NCT03323541|Lenograstim|lenograstim|mesh-list
19464082|NCT03323541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19464083|NCT03323541|Immunologic Factors|immunologic factors|mesh-ancestor
19464084|NCT03323541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464085|NCT03323528|Benzalkonium Compounds|benzalkonium compounds|mesh-list
19464086|NCT03323528|Benzocaine|benzocaine|mesh-list
19464087|NCT03323528|Anesthetics, Local|anesthetics, local|mesh-ancestor
19464088|NCT03323528|Anesthetics|anesthetics|mesh-ancestor
19464089|NCT03323528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19464090|NCT03323528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464091|NCT03323528|Sensory System Agents|sensory system agents|mesh-ancestor
20012224|NCT02379221|Respiratory System Agents|respiratory system agents|mesh-ancestor
20012225|NCT02379221|Mydriatics|mydriatics|mesh-ancestor
20012226|NCT02379221|Sympathomimetics|sympathomimetics|mesh-ancestor
20012227|NCT02379221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20012228|NCT02379247|Paclitaxel|paclitaxel|mesh-list
20012229|NCT02379247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20012230|NCT02379247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012231|NCT02379247|Tubulin Modulators|tubulin modulators|mesh-ancestor
20012232|NCT02379247|Antimitotic Agents|antimitotic agents|mesh-ancestor
20012233|NCT02379247|Mitosis Modulators|mitosis modulators|mesh-ancestor
20012234|NCT02379247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012235|NCT02379637|Acetylcysteine|acetylcysteine|mesh-list
20012236|NCT02379637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
20012237|NCT02379637|Antiviral Agents|antiviral agents|mesh-ancestor
20012238|NCT02379637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20012239|NCT02379637|Expectorants|expectorants|mesh-ancestor
20012240|NCT02379637|Respiratory System Agents|respiratory system agents|mesh-ancestor
20012241|NCT02379637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20012242|NCT02379637|Antioxidants|antioxidants|mesh-ancestor
20012243|NCT02379637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012244|NCT02379637|Protective Agents|protective agents|mesh-ancestor
20012245|NCT02379637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012246|NCT02379637|Antidotes|antidotes|mesh-ancestor
20012247|NCT02379858|Alvimopan|alvimopan|mesh-list
20012248|NCT02379858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20012249|NCT02380248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20012250|NCT02380248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20012251|NCT02380287|Antibodies|antibodies|mesh-list
20012252|NCT02380287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20012253|NCT02380287|Immunologic Factors|immunologic factors|mesh-ancestor
20012254|NCT02380287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012255|NCT02380742|Lidocaine|lidocaine|mesh-list
20012256|NCT02380742|Prilocaine|prilocaine|mesh-list
20012257|NCT02380742|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
20012258|NCT02380742|Anesthetics, Local|anesthetics, local|mesh-ancestor
20012259|NCT02380742|Anesthetics|anesthetics|mesh-ancestor
20012260|NCT02380742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20012261|NCT02380742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464092|NCT03323528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464093|NCT03323528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19464094|NCT03323528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19464095|NCT03323437|Risperidone|risperidone|mesh-list
19464096|NCT03323437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19464097|NCT03323437|Serotonin Agents|serotonin agents|mesh-ancestor
19464098|NCT03323437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19464099|NCT03323437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464100|NCT03323437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464101|NCT03323437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19464102|NCT03323437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19464103|NCT03323437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19464104|NCT03323437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19464105|NCT03323437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19464106|NCT03323437|Dopamine Agents|dopamine agents|mesh-ancestor
19464107|NCT03323385|Meloxicam|meloxicam|mesh-list
19464108|NCT03323385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19464109|NCT03323385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19464110|NCT03323385|Analgesics|analgesics|mesh-ancestor
19464111|NCT03323385|Sensory System Agents|sensory system agents|mesh-ancestor
19464112|NCT03323385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464113|NCT03323385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464114|NCT03323385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19464115|NCT03323385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19464116|NCT03323385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19464117|NCT03323385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19464118|NCT03323385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464119|NCT03323385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464120|NCT03323372|Listerine|listerine|mesh-list
19464121|NCT03323372|Fluorides|fluorides|mesh-list
19464122|NCT03323372|Sodium Fluoride|sodium fluoride|mesh-list
19464123|NCT03323372|Cariostatic Agents|cariostatic agents|mesh-ancestor
19464124|NCT03323372|Protective Agents|protective agents|mesh-ancestor
19464125|NCT03323372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464126|NCT03323372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19464127|NCT03323372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19464128|NCT03323346|Disulfiram|disulfiram|mesh-list
19464129|NCT03323346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
19464130|NCT03323346|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
19464131|NCT03323346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464132|NCT03323346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464133|NCT03323047|Acetaminophen|acetaminophen|mesh-list
19464134|NCT03323047|Dexamethasone|dexamethasone|mesh-list
19464135|NCT03323047|Dexamethasone acetate|dexamethasone acetate|mesh-list
19464136|NCT03323047|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19464137|NCT03323047|BB 1101|bb 1101|mesh-list
19464138|NCT03323047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19464139|NCT03323047|Antiemetics|antiemetics|mesh-ancestor
19464140|NCT03323047|Autonomic Agents|autonomic agents|mesh-ancestor
19464141|NCT03323047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464142|NCT03323047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464143|NCT03323047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19464144|NCT03323047|Glucocorticoids|glucocorticoids|mesh-ancestor
19464145|NCT03323047|Hormones|hormones|mesh-ancestor
19464146|NCT03323047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19464147|NCT03323047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19464148|NCT03323047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19464149|NCT03323047|Protease Inhibitors|protease inhibitors|mesh-ancestor
19464150|NCT03323047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464151|NCT03323047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464152|NCT03323047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19464153|NCT03323047|Analgesics|analgesics|mesh-ancestor
19464154|NCT03323047|Sensory System Agents|sensory system agents|mesh-ancestor
19464155|NCT03323047|Antipyretics|antipyretics|mesh-ancestor
19464156|NCT03322995|Fluorouracil|fluorouracil|mesh-list
19464157|NCT03322995|Antimetabolites|antimetabolites|mesh-ancestor
19464158|NCT03322995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464159|NCT03322995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19464160|NCT03322995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19464161|NCT03322995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19464162|NCT03322995|Immunologic Factors|immunologic factors|mesh-ancestor
19464163|NCT03322995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464164|NCT03322969|Paclitaxel|paclitaxel|mesh-list
19464165|NCT03322969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19464166|NCT03322969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19464167|NCT03322969|Tubulin Modulators|tubulin modulators|mesh-ancestor
19464168|NCT03322969|Antimitotic Agents|antimitotic agents|mesh-ancestor
19464169|NCT03322969|Mitosis Modulators|mitosis modulators|mesh-ancestor
19464170|NCT03322969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012262|NCT02380742|Sensory System Agents|sensory system agents|mesh-ancestor
20012263|NCT02380742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012264|NCT02380742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20012265|NCT02380742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20012266|NCT02380742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20012267|NCT02380742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19464171|NCT03322878|Magnesium Sulfate|magnesium sulfate|mesh-list
19464172|NCT03322878|Anesthetics|anesthetics|mesh-ancestor
19464173|NCT03322878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19464174|NCT03322878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464175|NCT03322878|Analgesics|analgesics|mesh-ancestor
19464176|NCT03322878|Sensory System Agents|sensory system agents|mesh-ancestor
19464177|NCT03322878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464178|NCT03322878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19464179|NCT03322878|Anticonvulsants|anticonvulsants|mesh-ancestor
19464180|NCT03322878|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19464181|NCT03322878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19464182|NCT03322878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464183|NCT03322878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19464184|NCT03322878|Tocolytic Agents|tocolytic agents|mesh-ancestor
19464185|NCT03322878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19464186|NCT03322800|Ziresovir|ziresovir|mesh-list
19464187|NCT03322800|Antiviral Agents|antiviral agents|mesh-ancestor
19464188|NCT03322800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19464189|NCT03322735|Cyclophosphamide|cyclophosphamide|mesh-list
19464190|NCT03322735|Fludarabine|fludarabine|mesh-list
19464191|NCT03322735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19464192|NCT03322735|Immunologic Factors|immunologic factors|mesh-ancestor
19464193|NCT03322735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464194|NCT03322735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19464195|NCT03322735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19464196|NCT03322735|Alkylating Agents|alkylating agents|mesh-ancestor
19464197|NCT03322735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464198|NCT03322735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19464199|NCT03322735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19464200|NCT03322631|Tirzepatide|tirzepatide|mesh-list
19464201|NCT03322631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19464202|NCT03322631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464203|NCT03322631|Incretins|incretins|mesh-ancestor
19464204|NCT03322631|Hormones|hormones|mesh-ancestor
19464205|NCT03322631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19464206|NCT03322488|Metronidazole|metronidazole|mesh-list
19464207|NCT03322488|Doxycycline|doxycycline|mesh-list
19464208|NCT03322488|Ciprofloxacin|ciprofloxacin|mesh-list
19464209|NCT03322488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19464210|NCT03322488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19464211|NCT03322488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19464212|NCT03322488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19464213|NCT03322488|Antimalarials|antimalarials|mesh-ancestor
19464214|NCT03322488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19464215|NCT03322488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19464216|NCT03322488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464217|NCT03322488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464218|NCT03322488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19464219|NCT03322488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19464220|NCT03322488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19464221|NCT03322358|Diphenhydramine|diphenhydramine|mesh-list
19464222|NCT03322358|Promethazine|promethazine|mesh-list
19464223|NCT03322358|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19464224|NCT03322358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19464225|NCT03322358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19464226|NCT03322358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464227|NCT03322358|Anesthetics, Local|anesthetics, local|mesh-ancestor
19464228|NCT03322358|Anesthetics|anesthetics|mesh-ancestor
19464229|NCT03322358|Sensory System Agents|sensory system agents|mesh-ancestor
19464230|NCT03322358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464231|NCT03322358|Antiemetics|antiemetics|mesh-ancestor
19464232|NCT03322358|Autonomic Agents|autonomic agents|mesh-ancestor
19464233|NCT03322358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19464234|NCT03322358|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19464235|NCT03322358|Histamine Antagonists|histamine antagonists|mesh-ancestor
19464236|NCT03322358|Histamine Agents|histamine agents|mesh-ancestor
19464237|NCT03322358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19464238|NCT03322358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464239|NCT03322358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19464240|NCT03322358|Antipruritics|antipruritics|mesh-ancestor
19464241|NCT03322358|Dermatologic Agents|dermatologic agents|mesh-ancestor
19464242|NCT03322267|Cisplatin|cisplatin|mesh-list
19464243|NCT03322267|Pembrolizumab|pembrolizumab|mesh-list
19464244|NCT03322267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19464245|NCT03322267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19464246|NCT03322150|Atropine|atropine|mesh-list
19464247|NCT03322150|Glycopyrrolate|glycopyrrolate|mesh-list
19464248|NCT03322150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19464249|NCT03322150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19464250|NCT03322150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19464251|NCT03322150|Autonomic Agents|autonomic agents|mesh-ancestor
19464252|NCT03322150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464253|NCT03322150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464254|NCT03322150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19464255|NCT03322150|Respiratory System Agents|respiratory system agents|mesh-ancestor
19464256|NCT03322150|Mydriatics|mydriatics|mesh-ancestor
19464257|NCT03322150|Parasympatholytics|parasympatholytics|mesh-ancestor
19464258|NCT03322150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19464259|NCT03322150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19464260|NCT03322150|Cholinergic Agents|cholinergic agents|mesh-ancestor
19464261|NCT03322150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19464262|NCT03322150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464263|NCT03322124|Octenidine|octenidine|mesh-list
19464264|NCT03322124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19464265|NCT03322124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19464266|NCT03322098|Atropine|atropine|mesh-list
19464267|NCT03322098|Glycopyrrolate|glycopyrrolate|mesh-list
19464268|NCT03322098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19464269|NCT03322098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19464270|NCT03322098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19464271|NCT03322098|Autonomic Agents|autonomic agents|mesh-ancestor
19464272|NCT03322098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464273|NCT03322098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464274|NCT03322098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19464275|NCT03322098|Respiratory System Agents|respiratory system agents|mesh-ancestor
19464276|NCT03322098|Mydriatics|mydriatics|mesh-ancestor
19464277|NCT03322098|Parasympatholytics|parasympatholytics|mesh-ancestor
19464278|NCT03322098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19464279|NCT03322098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19464280|NCT03322098|Cholinergic Agents|cholinergic agents|mesh-ancestor
19464281|NCT03322098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19464282|NCT03322098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464283|NCT03321981|Trastuzumab|trastuzumab|mesh-list
19464284|NCT03321981|Letrozole|letrozole|mesh-list
19464285|NCT03321981|Vinorelbine|vinorelbine|mesh-list
19464286|NCT03321981|Fulvestrant|fulvestrant|mesh-list
19464287|NCT03321981|Exemestane|exemestane|mesh-list
19464288|NCT03321981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19464289|NCT03321981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19464290|NCT03321981|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19464291|NCT03321981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19464292|NCT03321981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464293|NCT03321981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464294|NCT03321981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19464295|NCT03321981|Hormone Antagonists|hormone antagonists|mesh-ancestor
19464296|NCT03321981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19464297|NCT03321981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464298|NCT03321981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19464299|NCT03321981|Tubulin Modulators|tubulin modulators|mesh-ancestor
19464300|NCT03321981|Antimitotic Agents|antimitotic agents|mesh-ancestor
19464301|NCT03321981|Mitosis Modulators|mitosis modulators|mesh-ancestor
19464302|NCT03321981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19464303|NCT03321981|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19464304|NCT03321955|Ziconotide|ziconotide|mesh-list
19464305|NCT03321955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19464306|NCT03321955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19464307|NCT03321955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464308|NCT03321955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19464309|NCT03321955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464310|NCT03321955|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19464311|NCT03321955|Protective Agents|protective agents|mesh-ancestor
19464312|NCT03321955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19464313|NCT03321955|Analgesics|analgesics|mesh-ancestor
19464314|NCT03321955|Sensory System Agents|sensory system agents|mesh-ancestor
19464315|NCT03321955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012268|NCT02380742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012269|NCT02380742|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
20012270|NCT02382016|Macitentan|macitentan|mesh-list
20012271|NCT02382016|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
20012272|NCT02382016|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
20012273|NCT02382016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012274|NCT02382016|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
20012275|NCT02382276|Nalmefene|nalmefene|mesh-list
20012276|NCT02382276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20012277|NCT02382276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012278|NCT02382276|Sensory System Agents|sensory system agents|mesh-ancestor
20012279|NCT02382276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012280|NCT02382640|Febuxostat|febuxostat|mesh-list
20012281|NCT02382640|Gout Suppressants|gout suppressants|mesh-ancestor
20012282|NCT02382640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19464316|NCT03321903|Charcoal|charcoal|mesh-list
19464317|NCT03321903|Antidotes|antidotes|mesh-ancestor
19464318|NCT03321903|Protective Agents|protective agents|mesh-ancestor
19464319|NCT03321903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464320|NCT03321890|Prednisone|prednisone|mesh-list
19464321|NCT03321890|Cyclophosphamide|cyclophosphamide|mesh-list
19464322|NCT03321890|Methotrexate|methotrexate|mesh-list
19464323|NCT03321890|Etoposide|etoposide|mesh-list
19464324|NCT03321890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19464325|NCT03321890|Immunologic Factors|immunologic factors|mesh-ancestor
19464326|NCT03321890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464327|NCT03321890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19464328|NCT03321890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19464329|NCT03321890|Alkylating Agents|alkylating agents|mesh-ancestor
19464330|NCT03321890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464331|NCT03321890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19464332|NCT03321890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19464333|NCT03321890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19464334|NCT03321890|Glucocorticoids|glucocorticoids|mesh-ancestor
19464335|NCT03321890|Hormones|hormones|mesh-ancestor
19464336|NCT03321890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19464337|NCT03321890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19464338|NCT03321890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19464339|NCT03321890|Abortifacient Agents|abortifacient agents|mesh-ancestor
19464340|NCT03321890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19464341|NCT03321890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19464342|NCT03321890|Antimetabolites|antimetabolites|mesh-ancestor
19464343|NCT03321890|Dermatologic Agents|dermatologic agents|mesh-ancestor
19464344|NCT03321890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464345|NCT03321890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19464346|NCT03321890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19464347|NCT03321890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19464348|NCT03321890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19464349|NCT03321890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19464350|NCT03321825|Lidocaine|lidocaine|mesh-list
20012283|NCT02382848|Prazosin|prazosin|mesh-list
20012284|NCT02382848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20012285|NCT02382848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20012286|NCT02382848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20012287|NCT02382848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20012288|NCT02382848|Adrenergic Agents|adrenergic agents|mesh-ancestor
20012289|NCT02382848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20012290|NCT02382848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012291|NCT02382848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012292|NCT02383043|Cocaine|cocaine|mesh-list
20012293|NCT02383043|Amphetamine|amphetamine|mesh-list
20012294|NCT02383043|Dextroamphetamine|dextroamphetamine|mesh-list
20012295|NCT02383043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20012296|NCT02383043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012297|NCT02383043|Sympathomimetics|sympathomimetics|mesh-ancestor
20012298|NCT02383043|Autonomic Agents|autonomic agents|mesh-ancestor
20012299|NCT02383043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012300|NCT02383043|Dopamine Agents|dopamine agents|mesh-ancestor
20012301|NCT02383043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20012302|NCT02383043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012303|NCT02383043|Adrenergic Agents|adrenergic agents|mesh-ancestor
20012304|NCT02383043|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20012305|NCT02383043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20012306|NCT02383043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20012307|NCT02383043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20012308|NCT02383043|Anesthetics, Local|anesthetics, local|mesh-ancestor
20012309|NCT02383043|Anesthetics|anesthetics|mesh-ancestor
20012310|NCT02383043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20012311|NCT02383043|Sensory System Agents|sensory system agents|mesh-ancestor
20012312|NCT02383043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20012313|NCT02383355|Raltegravir Potassium|raltegravir potassium|mesh-list
20012314|NCT02383355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20012315|NCT02383355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20012316|NCT02383355|Antiviral Agents|antiviral agents|mesh-ancestor
20012317|NCT02383355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20012318|NCT02383355|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20012319|NCT02383355|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20012320|NCT02383355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012321|NCT02383355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012322|NCT02383589|Mycophenolic Acid|mycophenolic acid|mesh-list
19464351|NCT03321825|Hyaluronic Acid|hyaluronic acid|mesh-list
19464352|NCT03321825|Anesthetics, Local|anesthetics, local|mesh-ancestor
19464353|NCT03321825|Anesthetics|anesthetics|mesh-ancestor
19464354|NCT03321825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19464355|NCT03321825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464356|NCT03321825|Sensory System Agents|sensory system agents|mesh-ancestor
19464357|NCT03321825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464358|NCT03321825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19464359|NCT03321825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19464360|NCT03321825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19464361|NCT03321825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19464362|NCT03321825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464363|NCT03321825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19464364|NCT03321825|Immunologic Factors|immunologic factors|mesh-ancestor
19464365|NCT03321825|Viscosupplements|viscosupplements|mesh-ancestor
19464366|NCT03321825|Protective Agents|protective agents|mesh-ancestor
19464367|NCT03321799|Anti-Infective Agents|anti-infective agents|mesh-list
19464368|NCT03321799|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19464369|NCT03321773|Amoxicillin|amoxicillin|mesh-list
19464370|NCT03321773|Metronidazole|metronidazole|mesh-list
19464371|NCT03321773|Clarithromycin|clarithromycin|mesh-list
19464372|NCT03321773|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
19464373|NCT03321773|Pantoprazole|pantoprazole|mesh-list
19464374|NCT03321773|Bismuth|bismuth|mesh-list
19464375|NCT03321773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19464376|NCT03321773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19464377|NCT03321773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19464378|NCT03321773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19464379|NCT03321773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19464380|NCT03321773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464381|NCT03321773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464382|NCT03321773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19464383|NCT03321773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19464384|NCT03321773|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19464385|NCT03321773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19464386|NCT03321773|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19464387|NCT03321773|Antacids|antacids|mesh-ancestor
19464388|NCT03321734|Caffeine|caffeine|mesh-list
19464389|NCT03321734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19464390|NCT03321734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464391|NCT03321734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19464392|NCT03321734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464393|NCT03321734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464394|NCT03321734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19464395|NCT03321734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19464396|NCT03321734|Purinergic Agents|purinergic agents|mesh-ancestor
19464397|NCT03321734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19464398|NCT03321318|Cholecalciferol|cholecalciferol|mesh-list
19464399|NCT03321318|Bazedoxifene|bazedoxifene|mesh-list
19464400|NCT03321318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19464401|NCT03321318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464402|NCT03321318|Vitamins|vitamins|mesh-ancestor
19464403|NCT03321318|Micronutrients|micronutrients|mesh-ancestor
19464404|NCT03321318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19464405|NCT03321318|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19464406|NCT03321318|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19464407|NCT03321318|Hormone Antagonists|hormone antagonists|mesh-ancestor
19464408|NCT03321318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19464409|NCT03321292|Aspirin|aspirin|mesh-list
19464410|NCT03321292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19464411|NCT03321292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19464412|NCT03321292|Analgesics|analgesics|mesh-ancestor
19464413|NCT03321292|Sensory System Agents|sensory system agents|mesh-ancestor
19464414|NCT03321292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464415|NCT03321292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464416|NCT03321292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19464417|NCT03321292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19464418|NCT03321292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19464419|NCT03321292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19464420|NCT03321292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464421|NCT03321292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19464422|NCT03321292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19464423|NCT03321292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464424|NCT03321292|Antipyretics|antipyretics|mesh-ancestor
19464425|NCT03321201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19464426|NCT03321201|Hemostatics|hemostatics|mesh-ancestor
19464427|NCT03321201|Coagulants|coagulants|mesh-ancestor
19464428|NCT03321136|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
19464429|NCT03321136|Hallucinogens|hallucinogens|mesh-ancestor
19464430|NCT03321136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464431|NCT03321136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19464432|NCT03321136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19464433|NCT03321136|Serotonin Agents|serotonin agents|mesh-ancestor
19464434|NCT03321136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19464435|NCT03321136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464436|NCT03321136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19464437|NCT03321110|Ubiquinone|ubiquinone|mesh-list
19464438|NCT03321110|Coenzyme Q10|coenzyme q10|mesh-list
19464439|NCT03321110|Micronutrients|micronutrients|mesh-ancestor
19464440|NCT03321110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464441|NCT03321110|Vitamins|vitamins|mesh-ancestor
19464442|NCT03320967|Arginine Vasopressin|arginine vasopressin|mesh-list
19464443|NCT03320967|Hemostatics|hemostatics|mesh-ancestor
19464444|NCT03320967|Coagulants|coagulants|mesh-ancestor
19464445|NCT03320967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19464446|NCT03320967|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19464447|NCT03320967|Natriuretic Agents|natriuretic agents|mesh-ancestor
19464448|NCT03320967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464449|NCT03320928|Methotrexate|methotrexate|mesh-list
19464450|NCT03320928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
19464451|NCT03320928|Abortifacient Agents|abortifacient agents|mesh-ancestor
19464452|NCT03320928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19464453|NCT03320928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464454|NCT03320928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19464455|NCT03320928|Antimetabolites|antimetabolites|mesh-ancestor
19464456|NCT03320928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464457|NCT03320928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19464458|NCT03320928|Dermatologic Agents|dermatologic agents|mesh-ancestor
19464459|NCT03320928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464460|NCT03320928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19464461|NCT03320928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19464462|NCT03320928|Immunologic Factors|immunologic factors|mesh-ancestor
19464463|NCT03320928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19464464|NCT03320928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19464465|NCT03320915|Cholecalciferol|cholecalciferol|mesh-list
19464466|NCT03320915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19464467|NCT03320915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464468|NCT03320915|Vitamins|vitamins|mesh-ancestor
19464469|NCT03320915|Micronutrients|micronutrients|mesh-ancestor
19464470|NCT03320915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19464471|NCT03320707|Daratumumab|daratumumab|mesh-list
19464472|NCT03320707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19464473|NCT03320694|Insulin|insulin|mesh-list
19464474|NCT03320694|Metformin|metformin|mesh-list
19464475|NCT03320694|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19464476|NCT03320694|Isophane Insulin, Human|isophane insulin, human|mesh-list
19464477|NCT03320694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19464478|NCT03320694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464479|NCT03320629|Apatinib|apatinib|mesh-list
19464480|NCT03320629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19464481|NCT03320629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19464482|NCT03320629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012323|NCT02383589|Rituximab|rituximab|mesh-list
19464483|NCT03320629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464484|NCT03320603|Thrombin|thrombin|mesh-list
19464485|NCT03320603|Hemostatics|hemostatics|mesh-ancestor
19464486|NCT03320603|Coagulants|coagulants|mesh-ancestor
19464487|NCT03320538|Rabeprazole|rabeprazole|mesh-list
19464488|NCT03320538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19464489|NCT03320538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19464490|NCT03320538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19464491|NCT03320538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464492|NCT03320538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464493|NCT03320486|Ketoconazole|ketoconazole|mesh-list
19464494|NCT03320486|Antifungal Agents|antifungal agents|mesh-ancestor
19464495|NCT03320486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19464496|NCT03320486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19464497|NCT03320486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19464498|NCT03320486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464499|NCT03320486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464500|NCT03320486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19464501|NCT03320486|Hormone Antagonists|hormone antagonists|mesh-ancestor
19464502|NCT03320486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19464503|NCT03320486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464504|NCT03320486|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19464505|NCT03320460|Clobetasol|clobetasol|mesh-list
19464506|NCT03320460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19464507|NCT03320460|Glucocorticoids|glucocorticoids|mesh-ancestor
19464508|NCT03320460|Hormones|hormones|mesh-ancestor
19464509|NCT03320460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19464510|NCT03320460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464511|NCT03320447|Lidocaine|lidocaine|mesh-list
19464512|NCT03320447|Prilocaine|prilocaine|mesh-list
19464513|NCT03320447|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19464514|NCT03320447|Aminolevulinic Acid|aminolevulinic acid|mesh-list
19464515|NCT03320447|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
19464516|NCT03320447|Anesthetics, Local|anesthetics, local|mesh-ancestor
19464517|NCT03320447|Anesthetics|anesthetics|mesh-ancestor
19464518|NCT03320447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19464519|NCT03320447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464520|NCT03320447|Sensory System Agents|sensory system agents|mesh-ancestor
19464521|NCT03320447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464522|NCT03320447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19464523|NCT03320447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19464524|NCT03320447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19464525|NCT03320447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19464526|NCT03320447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464527|NCT03320447|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
19464528|NCT03320447|Dermatologic Agents|dermatologic agents|mesh-ancestor
19464529|NCT03320447|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19464530|NCT03320187|Nitroglycerin|nitroglycerin|mesh-list
19464531|NCT03320187|Dinoprostone|dinoprostone|mesh-list
19464532|NCT03320187|Vasodilator Agents|vasodilator agents|mesh-ancestor
19464533|NCT03320187|Oxytocics|oxytocics|mesh-ancestor
19464534|NCT03320187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19464535|NCT03320187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464536|NCT03320174|Tafenoquine|tafenoquine|mesh-list
19464537|NCT03320174|Antimalarials|antimalarials|mesh-ancestor
19464538|NCT03320174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19464539|NCT03320174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19464540|NCT03320174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20012324|NCT02383589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20012325|NCT02383589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012326|NCT02383589|Immunologic Factors|immunologic factors|mesh-ancestor
20012327|NCT02383589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012328|NCT02383589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20012329|NCT02383589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20012330|NCT02383589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20012331|NCT02383589|Antitubercular Agents|antitubercular agents|mesh-ancestor
20012332|NCT02383589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20012333|NCT02383589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20012334|NCT02383589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012335|NCT02383589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012336|NCT02383758|Bisacodyl|bisacodyl|mesh-list
20012337|NCT02383758|Glycerol|glycerol|mesh-list
20012338|NCT02383758|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20012339|NCT02383758|Protective Agents|protective agents|mesh-ancestor
19464541|NCT03320109|Vitamin D|vitamin d|mesh-list
19464542|NCT03320109|Ergocalciferols|ergocalciferols|mesh-list
19464543|NCT03320109|Vitamins|vitamins|mesh-list
19464544|NCT03320109|Micronutrients|micronutrients|mesh-ancestor
19464545|NCT03320109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464546|NCT03320109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19464547|NCT03320109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19464548|NCT03320031|Insulin Lispro|insulin lispro|mesh-list
19464549|NCT03320031|Linagliptin|linagliptin|mesh-list
19464550|NCT03320031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19464551|NCT03320031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464552|NCT03320031|Incretins|incretins|mesh-ancestor
19464553|NCT03320031|Hormones|hormones|mesh-ancestor
19464554|NCT03320031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19464555|NCT03320031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
19464556|NCT03320031|Protease Inhibitors|protease inhibitors|mesh-ancestor
19464557|NCT03320031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464558|NCT03320031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464559|NCT03319901|Venetoclax|venetoclax|mesh-list
19464560|NCT03319901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19464561|NCT03319823|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
19464562|NCT03319823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19464563|NCT03319823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464564|NCT03319823|Diuretics|diuretics|mesh-ancestor
19464565|NCT03319823|Natriuretic Agents|natriuretic agents|mesh-ancestor
19464566|NCT03319823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464567|NCT03319784|Triamcinolone|triamcinolone|mesh-list
19464568|NCT03319784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19464569|NCT03319784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19464570|NCT03319784|Ketorolac|ketorolac|mesh-list
19464571|NCT03319784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19464572|NCT03319784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19464573|NCT03319784|Glucocorticoids|glucocorticoids|mesh-ancestor
19464574|NCT03319784|Hormones|hormones|mesh-ancestor
19464575|NCT03319784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19464576|NCT03319784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464577|NCT03319784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19464578|NCT03319784|Immunologic Factors|immunologic factors|mesh-ancestor
19464579|NCT03319784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464580|NCT03319784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464581|NCT03319784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19464582|NCT03319784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19464583|NCT03319784|Analgesics|analgesics|mesh-ancestor
19464584|NCT03319784|Sensory System Agents|sensory system agents|mesh-ancestor
19464585|NCT03319784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464586|NCT03319784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19464587|NCT03319784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19464588|NCT03319706|Olmesartan|olmesartan|mesh-list
19464589|NCT03319706|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19464590|NCT03319706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19464591|NCT03319706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19464592|NCT03319706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19464593|NCT03319706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464594|NCT03319680|Dialysis Solutions|dialysis solutions|mesh-list
19464595|NCT03319680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19464596|NCT03319563|Epinephrine|epinephrine|mesh-list
19464597|NCT03319563|Anesthetics|anesthetics|mesh-list
19464598|NCT03319563|Anesthetics, Local|anesthetics, local|mesh-list
19464599|NCT03319563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19464600|NCT03319563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464601|NCT03319563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19464602|NCT03319563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19464603|NCT03319563|Adrenergic Agents|adrenergic agents|mesh-ancestor
19464604|NCT03319563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19464605|NCT03319563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464606|NCT03319563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19464607|NCT03319563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19464608|NCT03319563|Autonomic Agents|autonomic agents|mesh-ancestor
19464609|NCT03319563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464610|NCT03319563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19464611|NCT03319563|Respiratory System Agents|respiratory system agents|mesh-ancestor
19464612|NCT03319563|Mydriatics|mydriatics|mesh-ancestor
19464613|NCT03319563|Sympathomimetics|sympathomimetics|mesh-ancestor
19464614|NCT03319563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19464615|NCT03319563|Sensory System Agents|sensory system agents|mesh-ancestor
19464616|NCT03319550|Caseins|caseins|mesh-list
19464617|NCT03319550|Chelating Agents|chelating agents|mesh-ancestor
19464618|NCT03319550|Sequestering Agents|sequestering agents|mesh-ancestor
19464619|NCT03319550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464620|NCT03319537|Pemetrexed|pemetrexed|mesh-list
19464621|NCT03319537|Pevonedistat|pevonedistat|mesh-list
19464622|NCT03319537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19464623|NCT03319537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464624|NCT03319537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464625|NCT03319537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19464626|NCT03319537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19464627|NCT03319498|Peppermint oil|peppermint oil|mesh-list
19464628|NCT03319498|Mineral Oil|mineral oil|mesh-list
19464629|NCT03319498|Antiemetics|antiemetics|mesh-ancestor
19464630|NCT03319498|Autonomic Agents|autonomic agents|mesh-ancestor
19464631|NCT03319498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464632|NCT03319498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464633|NCT03319498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19464634|NCT03319498|Parasympatholytics|parasympatholytics|mesh-ancestor
19464635|NCT03319498|Emollients|emollients|mesh-ancestor
19464636|NCT03319498|Dermatologic Agents|dermatologic agents|mesh-ancestor
19464637|NCT03319420|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19464638|NCT03319420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19464639|NCT03319238|Ketamine|ketamine|mesh-list
19464640|NCT03319238|Analgesics|analgesics|mesh-ancestor
19464641|NCT03319238|Sensory System Agents|sensory system agents|mesh-ancestor
19464642|NCT03319238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464643|NCT03319238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464644|NCT03319238|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19464645|NCT03319238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19464646|NCT03319238|Anesthetics, General|anesthetics, general|mesh-ancestor
19464647|NCT03319238|Anesthetics|anesthetics|mesh-ancestor
19464648|NCT03319238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19464649|NCT03319238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19464650|NCT03319238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19464651|NCT03319238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19464652|NCT03319238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464653|NCT03319121|Theophylline|theophylline|mesh-list
19464654|NCT03319121|Dexlansoprazole|dexlansoprazole|mesh-list
19464655|NCT03319121|Lansoprazole|lansoprazole|mesh-list
19464656|NCT03319121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19464657|NCT03319121|Autonomic Agents|autonomic agents|mesh-ancestor
19464658|NCT03319121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464659|NCT03319121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464660|NCT03319121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19464661|NCT03319121|Respiratory System Agents|respiratory system agents|mesh-ancestor
19464662|NCT03319121|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19464663|NCT03319121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464664|NCT03319121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464665|NCT03319121|Vasodilator Agents|vasodilator agents|mesh-ancestor
19464666|NCT03319121|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19464667|NCT03319121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19464668|NCT03319121|Purinergic Agents|purinergic agents|mesh-ancestor
19464669|NCT03319121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19464670|NCT03319121|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19464671|NCT03319121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19464672|NCT03319121|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19464673|NCT03319043|Budesonide|budesonide|mesh-list
19464674|NCT03319043|Formoterol Fumarate|formoterol fumarate|mesh-list
19464675|NCT03319043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19464676|NCT03319043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19464677|NCT03319043|Autonomic Agents|autonomic agents|mesh-ancestor
19464678|NCT03319043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464679|NCT03319043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464680|NCT03319043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19464681|NCT03319043|Respiratory System Agents|respiratory system agents|mesh-ancestor
19464682|NCT03319043|Glucocorticoids|glucocorticoids|mesh-ancestor
19464683|NCT03319043|Hormones|hormones|mesh-ancestor
19464684|NCT03319043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19464685|NCT03319043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19464686|NCT03319043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19464687|NCT03319043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19464688|NCT03319043|Adrenergic Agents|adrenergic agents|mesh-ancestor
19464689|NCT03319043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19464690|NCT03319043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464691|NCT03318887|Ribavirin|ribavirin|mesh-list
19464692|NCT03318887|Sofosbuvir|sofosbuvir|mesh-list
19464693|NCT03318887|Antimetabolites|antimetabolites|mesh-ancestor
19464694|NCT03318887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464695|NCT03318887|Antiviral Agents|antiviral agents|mesh-ancestor
19464696|NCT03318887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19464697|NCT03318835|Thalidomide|thalidomide|mesh-list
19464698|NCT03318835|Prednisone|prednisone|mesh-list
19464699|NCT03318835|Cyclophosphamide|cyclophosphamide|mesh-list
20012340|NCT02383758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012341|NCT02383758|Cathartics|cathartics|mesh-ancestor
20012342|NCT02383758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20012343|NCT02383758|Laxatives|laxatives|mesh-ancestor
20012344|NCT02383940|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20012345|NCT02383940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20012346|NCT02383940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012347|NCT02383940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20012348|NCT02383940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012349|NCT02384044|Listerine|listerine|mesh-list
20012350|NCT02384044|Sodium Fluoride|sodium fluoride|mesh-list
20012351|NCT02384044|Cariostatic Agents|cariostatic agents|mesh-ancestor
20012352|NCT02384044|Protective Agents|protective agents|mesh-ancestor
20012353|NCT02384044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012354|NCT02384044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20012355|NCT02384044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20012356|NCT02384070|Aspirin|aspirin|mesh-list
20012357|NCT02384070|Bivalirudin|bivalirudin|mesh-list
20012358|NCT02384070|Clopidogrel|clopidogrel|mesh-list
20012359|NCT02384070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20012360|NCT02384070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20012361|NCT02384070|Analgesics|analgesics|mesh-ancestor
20012362|NCT02384070|Sensory System Agents|sensory system agents|mesh-ancestor
20012363|NCT02384070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012364|NCT02384070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012365|NCT02384070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20012366|NCT02384070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20012367|NCT02384070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20012368|NCT02384070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20012369|NCT02384070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012370|NCT02384070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20012371|NCT02384070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20012372|NCT02384070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012373|NCT02384070|Antipyretics|antipyretics|mesh-ancestor
20012374|NCT02384070|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20012375|NCT02384070|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20012376|NCT02384070|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20012377|NCT02384070|Purinergic Agents|purinergic agents|mesh-ancestor
20012378|NCT02384070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20012379|NCT02384070|Antithrombins|antithrombins|mesh-ancestor
20012380|NCT02384070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20012381|NCT02384070|Protease Inhibitors|protease inhibitors|mesh-ancestor
20012382|NCT02384070|Anticoagulants|anticoagulants|mesh-ancestor
20012383|NCT02384200|Vancomycin|vancomycin|mesh-list
20012384|NCT02384200|Gentamicins|gentamicins|mesh-list
20012385|NCT02384200|Ceftriaxone|ceftriaxone|mesh-list
20012386|NCT02384200|Ampicillin|ampicillin|mesh-list
20012387|NCT02384200|Nitrofurantoin|nitrofurantoin|mesh-list
20012388|NCT02384200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20012389|NCT02384200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20012390|NCT02384200|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20012391|NCT02384200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012392|NCT02384200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012393|NCT02384200|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20012394|NCT02384200|Renal Agents|renal agents|mesh-ancestor
20012395|NCT02384395|Lamivudine|lamivudine|mesh-list
20012396|NCT02384395|Abacavir|abacavir|mesh-list
20012397|NCT02384395|Dolutegravir|dolutegravir|mesh-list
20012398|NCT02384395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20012399|NCT02384395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20012400|NCT02384395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012401|NCT02384395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012402|NCT02384395|Antiviral Agents|antiviral agents|mesh-ancestor
20012403|NCT02384395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20012404|NCT02384395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19464700|NCT03318835|Vincristine|vincristine|mesh-list
19464701|NCT03318835|Rituximab|rituximab|mesh-list
19464702|NCT03318835|Doxorubicin|doxorubicin|mesh-list
19464703|NCT03318835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19464704|NCT03318835|Immunologic Factors|immunologic factors|mesh-ancestor
19464705|NCT03318835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464706|NCT03318835|Leprostatic Agents|leprostatic agents|mesh-ancestor
19464707|NCT03318835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19464708|NCT03318835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19464709|NCT03318835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19464710|NCT03318835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19464711|NCT03318835|Growth Substances|growth substances|mesh-ancestor
19464712|NCT03318835|Growth Inhibitors|growth inhibitors|mesh-ancestor
19464713|NCT03318835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19464714|NCT03318835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19464715|NCT03318835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19464716|NCT03318835|Alkylating Agents|alkylating agents|mesh-ancestor
19464717|NCT03318835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464718|NCT03318835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19464719|NCT03318835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19464720|NCT03318835|Glucocorticoids|glucocorticoids|mesh-ancestor
19464721|NCT03318835|Hormones|hormones|mesh-ancestor
19464722|NCT03318835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19464723|NCT03318835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19464724|NCT03318835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19464725|NCT03318835|Tubulin Modulators|tubulin modulators|mesh-ancestor
19464726|NCT03318835|Antimitotic Agents|antimitotic agents|mesh-ancestor
19464727|NCT03318835|Mitosis Modulators|mitosis modulators|mesh-ancestor
19464728|NCT03318835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19464729|NCT03318835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19464730|NCT03318835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19464731|NCT03318835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19464732|NCT03318835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464733|NCT03318770|Dasatinib|dasatinib|mesh-list
19464734|NCT03318770|Blinatumomab|blinatumomab|mesh-list
19464735|NCT03318770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19464736|NCT03318770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19464737|NCT03318770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464738|NCT03318770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464739|NCT03318757|Bupivacaine|bupivacaine|mesh-list
19464740|NCT03318757|Anesthetics, Local|anesthetics, local|mesh-ancestor
19464741|NCT03318757|Anesthetics|anesthetics|mesh-ancestor
19464742|NCT03318757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19464743|NCT03318757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464744|NCT03318757|Sensory System Agents|sensory system agents|mesh-ancestor
19464745|NCT03318757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464746|NCT03318744|Aspirin|aspirin|mesh-list
19464747|NCT03318744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19464748|NCT03318744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19464749|NCT03318744|Analgesics|analgesics|mesh-ancestor
19464750|NCT03318744|Sensory System Agents|sensory system agents|mesh-ancestor
19464751|NCT03318744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464752|NCT03318744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464753|NCT03318744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19464754|NCT03318744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19464755|NCT03318744|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19464756|NCT03318744|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19464757|NCT03318744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464758|NCT03318744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19464759|NCT03318744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19464760|NCT03318744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464761|NCT03318744|Antipyretics|antipyretics|mesh-ancestor
19464762|NCT03318731|Fenugreek seed meal|fenugreek seed meal|mesh-list
19464763|NCT03318731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19464764|NCT03318731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464765|NCT03318718|Rocuronium|rocuronium|mesh-list
19464766|NCT03318718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464767|NCT03318718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19464768|NCT03318718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19464769|NCT03318718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19464770|NCT03318718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464771|NCT03318536|Granisetron|granisetron|mesh-list
19464772|NCT03318536|Serotonin|serotonin|mesh-list
19464773|NCT03318536|Antiemetics|antiemetics|mesh-ancestor
19464774|NCT03318536|Autonomic Agents|autonomic agents|mesh-ancestor
19464775|NCT03318536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464776|NCT03318536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464777|NCT03318536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19464778|NCT03318536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19464779|NCT03318536|Serotonin Agents|serotonin agents|mesh-ancestor
19464780|NCT03318536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19464781|NCT03318536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464782|NCT03318536|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
19464783|NCT03318471|Magnesium Sulfate|magnesium sulfate|mesh-list
19464784|NCT03318471|Analgesics|analgesics|mesh-ancestor
19464785|NCT03318471|Sensory System Agents|sensory system agents|mesh-ancestor
19464786|NCT03318471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464787|NCT03318471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464788|NCT03318471|Anesthetics|anesthetics|mesh-ancestor
19464789|NCT03318471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19464790|NCT03318471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19464791|NCT03318471|Anticonvulsants|anticonvulsants|mesh-ancestor
19464792|NCT03318471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19464793|NCT03318471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19464794|NCT03318471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464795|NCT03318471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19464796|NCT03318471|Tocolytic Agents|tocolytic agents|mesh-ancestor
19464797|NCT03318471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19464798|NCT03318445|Irinotecan|irinotecan|mesh-list
19464799|NCT03318445|Rucaparib|rucaparib|mesh-list
19464800|NCT03318445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19464801|NCT03318445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19464802|NCT03318445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464803|NCT03318445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464804|NCT03318445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19464805|NCT03318445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19464806|NCT03318419|Cytarabine|cytarabine|mesh-list
19464807|NCT03318419|Pegaspargase|pegaspargase|mesh-list
19464808|NCT03318419|Asparaginase|asparaginase|mesh-list
19464809|NCT03318419|Cladribine|cladribine|mesh-list
19464810|NCT03318419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19464811|NCT03318419|Antimetabolites|antimetabolites|mesh-ancestor
19464812|NCT03318419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464813|NCT03318419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19464814|NCT03318419|Antiviral Agents|antiviral agents|mesh-ancestor
19464815|NCT03318419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19464816|NCT03318419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19464817|NCT03318419|Immunologic Factors|immunologic factors|mesh-ancestor
19464818|NCT03318419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464819|NCT03318354|Olmesartan|olmesartan|mesh-list
19464820|NCT03318354|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
19464821|NCT03318354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19464822|NCT03318354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19464823|NCT03318354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19464824|NCT03318354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012405|NCT02384395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20012406|NCT02384395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20012407|NCT02384395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20012408|NCT02384941|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20012409|NCT02384941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20012410|NCT02384941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012411|NCT02384941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20012412|NCT02384941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012413|NCT02385097|Ropivacaine|ropivacaine|mesh-list
20012414|NCT02385097|Chloroprocaine|chloroprocaine|mesh-list
20012415|NCT02385097|Anesthetics, Local|anesthetics, local|mesh-ancestor
20012416|NCT02385097|Anesthetics|anesthetics|mesh-ancestor
20012417|NCT02385097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20012418|NCT02385097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012419|NCT02385097|Sensory System Agents|sensory system agents|mesh-ancestor
20012420|NCT02385097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012421|NCT02385240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20012422|NCT02385240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20012423|NCT02385240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20012424|NCT02385240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20012425|NCT02385240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20012426|NCT02385240|Adrenergic Agents|adrenergic agents|mesh-ancestor
20012427|NCT02385240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19464825|NCT03318211|Magnesium Sulfate|magnesium sulfate|mesh-list
19464826|NCT03318211|Analgesics|analgesics|mesh-ancestor
19464827|NCT03318211|Sensory System Agents|sensory system agents|mesh-ancestor
19464828|NCT03318211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464829|NCT03318211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464830|NCT03318211|Anesthetics|anesthetics|mesh-ancestor
19464831|NCT03318211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19464832|NCT03318211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19464833|NCT03318211|Anticonvulsants|anticonvulsants|mesh-ancestor
19464834|NCT03318211|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19464835|NCT03318211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19464836|NCT03318211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464837|NCT03318211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19464838|NCT03318211|Tocolytic Agents|tocolytic agents|mesh-ancestor
19464839|NCT03318211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19464840|NCT03318159|Posaconazole|posaconazole|mesh-list
19464841|NCT03318159|Antifungal Agents|antifungal agents|mesh-ancestor
19464842|NCT03318159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19464843|NCT03318159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
19464844|NCT03318159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19464845|NCT03318159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19464846|NCT03318159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19464847|NCT03318159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19464848|NCT03318159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464849|NCT03318159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464850|NCT03318159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19464851|NCT03318159|Hormone Antagonists|hormone antagonists|mesh-ancestor
19464852|NCT03318159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19464853|NCT03318159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464854|NCT03318146|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19464855|NCT03318146|Latanoprost|latanoprost|mesh-list
19464856|NCT03318146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19464857|NCT03318133|Anesthetics|anesthetics|mesh-list
19464858|NCT03318133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19464859|NCT03318133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464860|NCT03318029|Vitamin D|vitamin d|mesh-list
19464861|NCT03318029|Vitamins|vitamins|mesh-ancestor
19464862|NCT03318029|Micronutrients|micronutrients|mesh-ancestor
19464863|NCT03318029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464864|NCT03318029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19464865|NCT03318016|Cyclophosphamide|cyclophosphamide|mesh-list
19464866|NCT03318016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19464867|NCT03318016|Immunologic Factors|immunologic factors|mesh-ancestor
19464868|NCT03318016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464869|NCT03318016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19464870|NCT03318016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19464871|NCT03318016|Alkylating Agents|alkylating agents|mesh-ancestor
19464872|NCT03318016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464873|NCT03318016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19464874|NCT03318016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19464875|NCT03317912|Lidocaine|lidocaine|mesh-list
19464876|NCT03317912|Anesthetics, Local|anesthetics, local|mesh-ancestor
19464877|NCT03317912|Anesthetics|anesthetics|mesh-ancestor
19464878|NCT03317912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19464879|NCT03317912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464880|NCT03317912|Sensory System Agents|sensory system agents|mesh-ancestor
19464881|NCT03317912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464882|NCT03317912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19464883|NCT03317912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19464884|NCT03317912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19464885|NCT03317912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19464886|NCT03317912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464887|NCT03317899|Lenograstim|lenograstim|mesh-list
19464888|NCT03317899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19464889|NCT03317899|Immunologic Factors|immunologic factors|mesh-ancestor
19464890|NCT03317899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464891|NCT03317847|Dexamethasone|dexamethasone|mesh-list
19464892|NCT03317847|Bromfenac|bromfenac|mesh-list
19464893|NCT03317847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19464894|NCT03317847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19464895|NCT03317847|Antiemetics|antiemetics|mesh-ancestor
19464896|NCT03317847|Autonomic Agents|autonomic agents|mesh-ancestor
19464897|NCT03317847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464898|NCT03317847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464899|NCT03317847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19464900|NCT03317847|Glucocorticoids|glucocorticoids|mesh-ancestor
19464901|NCT03317847|Hormones|hormones|mesh-ancestor
19464902|NCT03317847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19464903|NCT03317847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19464904|NCT03317847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19464905|NCT03317847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19464906|NCT03317847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19464907|NCT03317847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19464908|NCT03317847|Analgesics|analgesics|mesh-ancestor
19464909|NCT03317847|Sensory System Agents|sensory system agents|mesh-ancestor
19464910|NCT03317847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19464911|NCT03317730|Oxycodone|oxycodone|mesh-list
19464912|NCT03317730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19464913|NCT03317730|Narcotics|narcotics|mesh-ancestor
19464914|NCT03317730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19464915|NCT03317730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464916|NCT03317730|Analgesics|analgesics|mesh-ancestor
19464917|NCT03317730|Sensory System Agents|sensory system agents|mesh-ancestor
19464918|NCT03317730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464919|NCT03317717|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19464920|NCT03317717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19464921|NCT03317717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464922|NCT03317717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464923|NCT03317717|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19464924|NCT03317717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19464925|NCT03317717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464926|NCT03317717|Cholinergic Agents|cholinergic agents|mesh-ancestor
19464927|NCT03317717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19464928|NCT03317652|Nitroprusside|nitroprusside|mesh-list
19464929|NCT03317652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19464930|NCT03317652|Vasodilator Agents|vasodilator agents|mesh-ancestor
19464931|NCT03317652|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
19464932|NCT03317652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464933|NCT03317600|Lidocaine|lidocaine|mesh-list
19464934|NCT03317600|Anesthetics, Local|anesthetics, local|mesh-ancestor
19464935|NCT03317600|Anesthetics|anesthetics|mesh-ancestor
19464936|NCT03317600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19464937|NCT03317600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464938|NCT03317600|Sensory System Agents|sensory system agents|mesh-ancestor
19464939|NCT03317600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464940|NCT03317600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19464941|NCT03317600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19464942|NCT03317600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19464943|NCT03317600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19464944|NCT03317600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464945|NCT03317574|Botulinum Toxins|botulinum toxins|mesh-list
19464946|NCT03317574|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19464947|NCT03317574|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19464948|NCT03317574|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19464949|NCT03317574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19464950|NCT03317574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464951|NCT03317574|Cholinergic Agents|cholinergic agents|mesh-ancestor
19464952|NCT03317574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19464953|NCT03317574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464954|NCT03317574|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19464955|NCT03317574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19464956|NCT03317548|Progesterone|progesterone|mesh-list
19464957|NCT03317548|Progestins|progestins|mesh-ancestor
19464958|NCT03317548|Hormones|hormones|mesh-ancestor
19464959|NCT03317548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19464960|NCT03317548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464961|NCT03317535|Anesthetics|anesthetics|mesh-list
19464962|NCT03317535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19464963|NCT03317535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464964|NCT03317457|Doxorubicin|doxorubicin|mesh-list
19464965|NCT03317457|Durvalumab|durvalumab|mesh-list
19464966|NCT03317457|Tremelimumab|tremelimumab|mesh-list
19464967|NCT03317457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19464968|NCT03317457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19464969|NCT03317457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19464970|NCT03317457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19464971|NCT03317457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19464972|NCT03317457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464973|NCT03317457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19464974|NCT03317327|Nivolumab|nivolumab|mesh-list
19464975|NCT03317327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19464976|NCT03317327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19464977|NCT03317327|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19464978|NCT03317327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19464979|NCT03317275|Fluorides|fluorides|mesh-list
19464980|NCT03317275|Cariostatic Agents|cariostatic agents|mesh-ancestor
19464981|NCT03317275|Protective Agents|protective agents|mesh-ancestor
19464982|NCT03317275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464983|NCT03317236|Quetiapine Fumarate|quetiapine fumarate|mesh-list
19464984|NCT03317236|Antidepressive Agents|antidepressive agents|mesh-ancestor
19464985|NCT03317236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19464986|NCT03317236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19464987|NCT03317236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19464988|NCT03317236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19464989|NCT03317236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19464990|NCT03317210|Epoetin Alfa|epoetin alfa|mesh-list
19464991|NCT03317210|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
19464992|NCT03317210|Hematinics|hematinics|mesh-ancestor
19464993|NCT03317197|Vasopressins|vasopressins|mesh-list
19464994|NCT03317197|Arginine Vasopressin|arginine vasopressin|mesh-list
19464995|NCT03317197|Epinephrine|epinephrine|mesh-list
19464996|NCT03317197|Racepinephrine|racepinephrine|mesh-list
19464997|NCT03317197|Epinephryl borate|epinephryl borate|mesh-list
19464998|NCT03317197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19464999|NCT03317197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19465000|NCT03317197|Adrenergic Agents|adrenergic agents|mesh-ancestor
19465001|NCT03317197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19465002|NCT03317197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465003|NCT03317197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465004|NCT03317197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19465005|NCT03317197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19465006|NCT03317197|Autonomic Agents|autonomic agents|mesh-ancestor
19465007|NCT03317197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465008|NCT03317197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19465009|NCT03317197|Respiratory System Agents|respiratory system agents|mesh-ancestor
19465010|NCT03317197|Mydriatics|mydriatics|mesh-ancestor
19465011|NCT03317197|Sympathomimetics|sympathomimetics|mesh-ancestor
19465012|NCT03317197|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19465013|NCT03317197|Hemostatics|hemostatics|mesh-ancestor
19465014|NCT03317197|Coagulants|coagulants|mesh-ancestor
19465015|NCT03317197|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
19465016|NCT03317197|Natriuretic Agents|natriuretic agents|mesh-ancestor
19465017|NCT03317158|Durvalumab|durvalumab|mesh-list
19465018|NCT03317158|BCG Vaccine|bcg vaccine|mesh-list
19465019|NCT03317158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19465020|NCT03317158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465021|NCT03317158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19465022|NCT03317158|Immunologic Factors|immunologic factors|mesh-ancestor
19465023|NCT03317158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465024|NCT03317093|Ceftobiprole|ceftobiprole|mesh-list
19465025|NCT03317093|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
19465026|NCT03317093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19465027|NCT03317093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19465028|NCT03317067|Dexmedetomidine|dexmedetomidine|mesh-list
19465029|NCT03317067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19465030|NCT03317067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19465031|NCT03317067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465032|NCT03317067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19465033|NCT03317067|Analgesics|analgesics|mesh-ancestor
19465034|NCT03317067|Sensory System Agents|sensory system agents|mesh-ancestor
19465035|NCT03317067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465036|NCT03317067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19465037|NCT03317067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19465038|NCT03317067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19465039|NCT03317067|Adrenergic Agents|adrenergic agents|mesh-ancestor
19465040|NCT03317067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19465041|NCT03317067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465042|NCT03317015|Fluticasone|fluticasone|mesh-list
19465043|NCT03317015|Triamcinolone|triamcinolone|mesh-list
19465044|NCT03317015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19465045|NCT03317015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19465046|NCT03317015|Autonomic Agents|autonomic agents|mesh-ancestor
19465047|NCT03317015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465048|NCT03317015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465049|NCT03317015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19465050|NCT03317015|Respiratory System Agents|respiratory system agents|mesh-ancestor
19465051|NCT03317015|Dermatologic Agents|dermatologic agents|mesh-ancestor
19465052|NCT03317015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19465053|NCT03317015|Glucocorticoids|glucocorticoids|mesh-ancestor
19465054|NCT03317015|Hormones|hormones|mesh-ancestor
19465055|NCT03317015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19465056|NCT03316963|Neostigmine|neostigmine|mesh-list
19465057|NCT03316963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19465058|NCT03316963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19465059|NCT03316963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012428|NCT02385240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012429|NCT02385240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012430|NCT02385669|Ipilimumab|ipilimumab|mesh-list
20012431|NCT02385669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20012432|NCT02385669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012433|NCT02385669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20012434|NCT02385669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012435|NCT02385708|Chlorhexidine|chlorhexidine|mesh-list
20012436|NCT02385708|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20012437|NCT02385708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20012438|NCT02385708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20012439|NCT02385708|Disinfectants|disinfectants|mesh-ancestor
20012440|NCT02385708|Dermatologic Agents|dermatologic agents|mesh-ancestor
20012441|NCT02385799|Sertraline|sertraline|mesh-list
20012442|NCT02385799|Antidepressive Agents|antidepressive agents|mesh-ancestor
20012443|NCT02385799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20012444|NCT02385799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20012445|NCT02385799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20012446|NCT02385799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20012447|NCT02385799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012448|NCT02385799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20012449|NCT02385799|Serotonin Agents|serotonin agents|mesh-ancestor
20012450|NCT02385799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012451|NCT02386098|Ritonavir|ritonavir|mesh-list
20012452|NCT02386098|Atazanavir Sulfate|atazanavir sulfate|mesh-list
20012453|NCT02386098|Tenofovir|tenofovir|mesh-list
20012454|NCT02386098|Dolutegravir|dolutegravir|mesh-list
20012455|NCT02386098|BMS-955176|bms-955176|mesh-list
20012456|NCT02386098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20012457|NCT02386098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20012458|NCT02386098|Protease Inhibitors|protease inhibitors|mesh-ancestor
20012459|NCT02386098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012460|NCT02386098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012461|NCT02386098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20012462|NCT02386098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20012463|NCT02386098|Antiviral Agents|antiviral agents|mesh-ancestor
20012464|NCT02386098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20012465|NCT02386098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20012466|NCT02386098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20012467|NCT02386098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20012468|NCT02386098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20012469|NCT02386098|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19465060|NCT03316963|Cholinergic Agents|cholinergic agents|mesh-ancestor
19465061|NCT03316963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19465062|NCT03316963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465063|NCT03316963|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19465064|NCT03316963|Autonomic Agents|autonomic agents|mesh-ancestor
19465065|NCT03316963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465066|NCT03316898|Memantine|memantine|mesh-list
19465067|NCT03316898|Donepezil|donepezil|mesh-list
19465068|NCT03316898|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19465069|NCT03316898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19465070|NCT03316898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465071|NCT03316898|Cholinergic Agents|cholinergic agents|mesh-ancestor
19465072|NCT03316898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19465073|NCT03316898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465074|NCT03316898|Nootropic Agents|nootropic agents|mesh-ancestor
19465075|NCT03316898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19465076|NCT03316898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19465077|NCT03316898|Dopamine Agents|dopamine agents|mesh-ancestor
19465078|NCT03316898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19465079|NCT03316898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19465080|NCT03316690|Metformin|metformin|mesh-list
19465081|NCT03316690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19465082|NCT03316690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465083|NCT03316599|Gemcitabine|gemcitabine|mesh-list
19465084|NCT03316599|Paclitaxel|paclitaxel|mesh-list
19465085|NCT03316599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19465086|NCT03316599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465087|NCT03316599|Tubulin Modulators|tubulin modulators|mesh-ancestor
19465088|NCT03316599|Antimitotic Agents|antimitotic agents|mesh-ancestor
19465089|NCT03316599|Mitosis Modulators|mitosis modulators|mesh-ancestor
19465090|NCT03316599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465091|NCT03316599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19465092|NCT03316599|Antimetabolites|antimetabolites|mesh-ancestor
19465093|NCT03316599|Antiviral Agents|antiviral agents|mesh-ancestor
19465094|NCT03316599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19465095|NCT03316599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19465096|NCT03316599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19465097|NCT03316599|Immunologic Factors|immunologic factors|mesh-ancestor
19465098|NCT03316599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465099|NCT03316573|Pembrolizumab|pembrolizumab|mesh-list
19465100|NCT03316573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19465101|NCT03316573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012470|NCT02386098|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20012471|NCT02386319|Melatonin|melatonin|mesh-list
20012472|NCT02386319|Antioxidants|antioxidants|mesh-ancestor
20012473|NCT02386319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012474|NCT02386319|Protective Agents|protective agents|mesh-ancestor
20012475|NCT02386319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012476|NCT02386319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20012477|NCT02387164|Vitamin D|vitamin d|mesh-list
20012478|NCT02387164|Cholecalciferol|cholecalciferol|mesh-list
20012479|NCT02387164|Vitamins|vitamins|mesh-ancestor
20012480|NCT02387164|Micronutrients|micronutrients|mesh-ancestor
20012481|NCT02387164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012482|NCT02387164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20012483|NCT02387164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20012484|NCT02387216|Docetaxel|docetaxel|mesh-list
20012485|NCT02387216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012486|NCT02387216|Tubulin Modulators|tubulin modulators|mesh-ancestor
20012487|NCT02387216|Antimitotic Agents|antimitotic agents|mesh-ancestor
20012488|NCT02387216|Mitosis Modulators|mitosis modulators|mesh-ancestor
20012489|NCT02387216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012490|NCT02387294|Vaccines|vaccines|mesh-list
20012491|NCT02387294|Immunologic Factors|immunologic factors|mesh-ancestor
20012492|NCT02387294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012493|NCT02387359|Plecanatide|plecanatide|mesh-list
20012494|NCT02387359|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20012495|NCT02387359|Enzyme Activators|enzyme activators|mesh-ancestor
20012496|NCT02387359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012497|NCT02387359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20012498|NCT02387372|Tazobactam|tazobactam|mesh-list
20012499|NCT02387372|Ceftolozane|ceftolozane|mesh-list
20012500|NCT02387372|Cephalosporins|cephalosporins|mesh-list
20012501|NCT02387372|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
20012502|NCT02387372|Penicillanic Acid|penicillanic acid|mesh-list
20012503|NCT02387372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20012504|NCT02387372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20012505|NCT02387372|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20012506|NCT02387372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012507|NCT02387372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012508|NCT02387372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20012509|NCT02387372|Renal Agents|renal agents|mesh-ancestor
20012510|NCT02387554|Losartan|losartan|mesh-list
20012511|NCT02387554|Amlodipine|amlodipine|mesh-list
20012512|NCT02387554|Chlorthalidone|chlorthalidone|mesh-list
20012513|NCT02387554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19465102|NCT03316534|Aspirin|aspirin|mesh-list
19465103|NCT03316534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19465104|NCT03316534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19465105|NCT03316534|Analgesics|analgesics|mesh-ancestor
19465106|NCT03316534|Sensory System Agents|sensory system agents|mesh-ancestor
19465107|NCT03316534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465108|NCT03316534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465109|NCT03316534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19465110|NCT03316534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19465111|NCT03316534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19465112|NCT03316534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19465113|NCT03316534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465114|NCT03316534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19465115|NCT03316534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19465116|NCT03316534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19465117|NCT03316534|Antipyretics|antipyretics|mesh-ancestor
19465118|NCT03316482|Leuprolide|leuprolide|mesh-list
19465119|NCT03316482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19465120|NCT03316482|Fertility Agents|fertility agents|mesh-ancestor
19465121|NCT03316482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19465122|NCT03316482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465123|NCT03316482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19465124|NCT03316482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465125|NCT03316469|Clomiphene|clomiphene|mesh-list
19465126|NCT03316469|Enclomiphene|enclomiphene|mesh-list
19465127|NCT03316469|Zuclomiphene|zuclomiphene|mesh-list
19465128|NCT03316469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19465129|NCT03316469|Hormone Antagonists|hormone antagonists|mesh-ancestor
19465130|NCT03316469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19465131|NCT03316469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465132|NCT03316469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19465133|NCT03316469|Fertility Agents|fertility agents|mesh-ancestor
19465134|NCT03316469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19465135|NCT03316469|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19465136|NCT03316469|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19465137|NCT03316352|Bupivacaine|bupivacaine|mesh-list
19465138|NCT03316352|Anesthetics|anesthetics|mesh-list
19465139|NCT03316352|Anesthetics, Local|anesthetics, local|mesh-ancestor
19465140|NCT03316352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19465141|NCT03316352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465142|NCT03316352|Sensory System Agents|sensory system agents|mesh-ancestor
19465143|NCT03316352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465144|NCT03316339|Dexmedetomidine|dexmedetomidine|mesh-list
19465145|NCT03316339|Remifentanil|remifentanil|mesh-list
19465146|NCT03316339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19465147|NCT03316339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19465148|NCT03316339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465149|NCT03316339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19465150|NCT03316339|Analgesics|analgesics|mesh-ancestor
19465151|NCT03316339|Sensory System Agents|sensory system agents|mesh-ancestor
19465152|NCT03316339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465153|NCT03316339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19465154|NCT03316339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19465155|NCT03316339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19465156|NCT03316339|Adrenergic Agents|adrenergic agents|mesh-ancestor
19465157|NCT03316339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19465158|NCT03316339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465159|NCT03316339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19465160|NCT03316339|Narcotics|narcotics|mesh-ancestor
19465161|NCT03316326|Oxaliplatin|oxaliplatin|mesh-list
19465162|NCT03316326|Irinotecan|irinotecan|mesh-list
19465163|NCT03316326|Tegafur|tegafur|mesh-list
19465164|NCT03316326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465165|NCT03316326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19465166|NCT03316326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19465167|NCT03316326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19465168|NCT03316326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465169|NCT03316326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19465170|NCT03316326|Antimetabolites|antimetabolites|mesh-ancestor
19465171|NCT03316313|Antibodies|antibodies|mesh-list
19465172|NCT03316313|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
19465173|NCT03316313|Immunologic Factors|immunologic factors|mesh-ancestor
19465174|NCT03316313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465175|NCT03316118|Bupivacaine|bupivacaine|mesh-list
19465176|NCT03316118|Anesthetics, Local|anesthetics, local|mesh-ancestor
19465177|NCT03316118|Anesthetics|anesthetics|mesh-ancestor
19465178|NCT03316118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19465179|NCT03316118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465180|NCT03316118|Sensory System Agents|sensory system agents|mesh-ancestor
19465181|NCT03316118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465182|NCT03316066|Ropivacaine|ropivacaine|mesh-list
19465183|NCT03316066|Anesthetics, Local|anesthetics, local|mesh-ancestor
19465184|NCT03316066|Anesthetics|anesthetics|mesh-ancestor
19465185|NCT03316066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19465186|NCT03316066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465187|NCT03316066|Sensory System Agents|sensory system agents|mesh-ancestor
19465188|NCT03316066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465189|NCT03315923|Rituximab|rituximab|mesh-list
19465190|NCT03315923|Glatiramer Acetate|glatiramer acetate|mesh-list
19465191|NCT03315923|(T,G)-A-L|(t,g)-a-l|mesh-list
19465192|NCT03315923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19465193|NCT03315923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465194|NCT03315923|Immunologic Factors|immunologic factors|mesh-ancestor
19465195|NCT03315923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465196|NCT03315923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19465197|NCT03315923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19465198|NCT03315923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19465199|NCT03315845|Anesthetics|anesthetics|mesh-list
19465200|NCT03315845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19465201|NCT03315845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465202|NCT03315741|Pirfenidone|pirfenidone|mesh-list
19465203|NCT03315741|Analgesics|analgesics|mesh-ancestor
19465204|NCT03315741|Sensory System Agents|sensory system agents|mesh-ancestor
19465205|NCT03315741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465206|NCT03315741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465207|NCT03315741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19465208|NCT03315741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19465209|NCT03315741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19465210|NCT03315741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19465211|NCT03315741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465212|NCT03315676|Esomeprazole|esomeprazole|mesh-list
19465213|NCT03315676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19465214|NCT03315676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19465215|NCT03315676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19465216|NCT03315676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19465217|NCT03315676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465218|NCT03315533|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19465219|NCT03315533|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19465220|NCT03315533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19465221|NCT03315533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19465222|NCT03315533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465223|NCT03315533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19465224|NCT03315533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465225|NCT03315533|Analgesics|analgesics|mesh-ancestor
19465226|NCT03315533|Sensory System Agents|sensory system agents|mesh-ancestor
19465227|NCT03315533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465228|NCT03315533|Antidepressive Agents|antidepressive agents|mesh-ancestor
19465229|NCT03315533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19465230|NCT03315533|Dopamine Agents|dopamine agents|mesh-ancestor
19465231|NCT03315520|Cytarabine|cytarabine|mesh-list
19465232|NCT03315520|Cyclophosphamide|cyclophosphamide|mesh-list
19465233|NCT03315520|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
19465234|NCT03315520|Etoposide|etoposide|mesh-list
19465235|NCT03315520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19465236|NCT03315520|Immunologic Factors|immunologic factors|mesh-ancestor
19465237|NCT03315520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465238|NCT03315520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19465239|NCT03315520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19465240|NCT03315520|Alkylating Agents|alkylating agents|mesh-ancestor
19465241|NCT03315520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465242|NCT03315520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465243|NCT03315520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19465244|NCT03315520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19465245|NCT03315520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19465246|NCT03315520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19465247|NCT03315520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19465248|NCT03315520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19465249|NCT03315520|Antimetabolites|antimetabolites|mesh-ancestor
19465250|NCT03315520|Antiviral Agents|antiviral agents|mesh-ancestor
19465251|NCT03315520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19465252|NCT03315507|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
19465253|NCT03315507|Vasodilator Agents|vasodilator agents|mesh-ancestor
19465254|NCT03315442|Caffeine|caffeine|mesh-list
19465255|NCT03315442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19465256|NCT03315442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465257|NCT03315442|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19465258|NCT03315442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19465259|NCT03315442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465260|NCT03315442|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19465261|NCT03315442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19465262|NCT03315442|Purinergic Agents|purinergic agents|mesh-ancestor
19465263|NCT03315442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19465264|NCT03315364|Paclitaxel|paclitaxel|mesh-list
19465265|NCT03315364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19465266|NCT03315364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19465267|NCT03315364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465268|NCT03315364|Tubulin Modulators|tubulin modulators|mesh-ancestor
19465269|NCT03315364|Antimitotic Agents|antimitotic agents|mesh-ancestor
19465270|NCT03315364|Mitosis Modulators|mitosis modulators|mesh-ancestor
19465271|NCT03315364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465272|NCT03315338|Prednisone|prednisone|mesh-list
19465273|NCT03315338|Cortisone|cortisone|mesh-list
19465274|NCT03315338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19465275|NCT03315338|Glucocorticoids|glucocorticoids|mesh-ancestor
19465276|NCT03315338|Hormones|hormones|mesh-ancestor
19465277|NCT03315338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19465278|NCT03315338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465279|NCT03315338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19465280|NCT03315338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465281|NCT03315312|Fluorides|fluorides|mesh-list
19465282|NCT03315312|Fluorides, Topical|fluorides, topical|mesh-list
19465283|NCT03315312|Cariostatic Agents|cariostatic agents|mesh-ancestor
19465284|NCT03315312|Protective Agents|protective agents|mesh-ancestor
19465285|NCT03315312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465286|NCT03315091|Adavosertib|adavosertib|mesh-list
19465287|NCT03315091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19465288|NCT03315091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465289|NCT03315078|Busulfan|busulfan|mesh-list
19465290|NCT03315078|Alkylating Agents|alkylating agents|mesh-ancestor
19465291|NCT03315078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465292|NCT03315078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19465293|NCT03315078|Immunologic Factors|immunologic factors|mesh-ancestor
19465294|NCT03315078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465295|NCT03315078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19465296|NCT03315078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465297|NCT03315078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19465298|NCT03315052|Mycophenolic Acid|mycophenolic acid|mesh-list
19465299|NCT03315052|Prednisone|prednisone|mesh-list
19465300|NCT03315052|Budesonide|budesonide|mesh-list
19465301|NCT03315052|Tacrolimus|tacrolimus|mesh-list
19465302|NCT03315052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19465303|NCT03315052|Glucocorticoids|glucocorticoids|mesh-ancestor
19465304|NCT03315052|Hormones|hormones|mesh-ancestor
19465305|NCT03315052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19465306|NCT03315052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465307|NCT03315052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19465308|NCT03315052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465309|NCT03315052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19465310|NCT03315052|Immunologic Factors|immunologic factors|mesh-ancestor
19465311|NCT03315052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19465312|NCT03315052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19465313|NCT03315052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465314|NCT03315052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19465315|NCT03315052|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19465316|NCT03315052|Antitubercular Agents|antitubercular agents|mesh-ancestor
19465317|NCT03315052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19465318|NCT03315052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19465319|NCT03315052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19465320|NCT03315052|Autonomic Agents|autonomic agents|mesh-ancestor
19465321|NCT03315052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465322|NCT03315052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19465323|NCT03315052|Respiratory System Agents|respiratory system agents|mesh-ancestor
19465324|NCT03315000|Fluticasone|fluticasone|mesh-list
19465325|NCT03315000|Xhance|xhance|mesh-list
19465326|NCT03315000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19465327|NCT03315000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19465328|NCT03315000|Autonomic Agents|autonomic agents|mesh-ancestor
19465329|NCT03315000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465330|NCT03315000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465331|NCT03315000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19465332|NCT03315000|Respiratory System Agents|respiratory system agents|mesh-ancestor
19465333|NCT03315000|Dermatologic Agents|dermatologic agents|mesh-ancestor
19465334|NCT03315000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19465335|NCT03314792|Oxycodone|oxycodone|mesh-list
19465336|NCT03314792|Tapentadol|tapentadol|mesh-list
19465337|NCT03314792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19465338|NCT03314792|Narcotics|narcotics|mesh-ancestor
19465339|NCT03314792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19465340|NCT03314792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465341|NCT03314792|Analgesics|analgesics|mesh-ancestor
19465342|NCT03314792|Sensory System Agents|sensory system agents|mesh-ancestor
19465343|NCT03314792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465344|NCT03314792|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19465345|NCT03314792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19465346|NCT03314792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19465347|NCT03314792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465348|NCT03314792|Adrenergic Agents|adrenergic agents|mesh-ancestor
19465349|NCT03314792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19465350|NCT03314740|Paclitaxel|paclitaxel|mesh-list
19465351|NCT03314740|Olaparib|olaparib|mesh-list
19465352|NCT03314740|Cediranib|cediranib|mesh-list
19465353|NCT03314740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19465354|NCT03314740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465355|NCT03314740|Tubulin Modulators|tubulin modulators|mesh-ancestor
19465356|NCT03314740|Antimitotic Agents|antimitotic agents|mesh-ancestor
19465357|NCT03314740|Mitosis Modulators|mitosis modulators|mesh-ancestor
19465358|NCT03314740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465359|NCT03314740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
19465360|NCT03314740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19465361|NCT03314740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19465362|NCT03314636|Dexamethasone|dexamethasone|mesh-list
19465363|NCT03314636|Lenalidomide|lenalidomide|mesh-list
19465364|NCT03314636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19465365|NCT03314636|Antiemetics|antiemetics|mesh-ancestor
19465366|NCT03314636|Autonomic Agents|autonomic agents|mesh-ancestor
19465367|NCT03314636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465368|NCT03314636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465369|NCT03314636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19465370|NCT03314636|Glucocorticoids|glucocorticoids|mesh-ancestor
19465371|NCT03314636|Hormones|hormones|mesh-ancestor
19465372|NCT03314636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19465373|NCT03314636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19465374|NCT03314636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465375|NCT03314636|Immunologic Factors|immunologic factors|mesh-ancestor
19465376|NCT03314636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19465377|NCT03314636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19465378|NCT03314636|Growth Substances|growth substances|mesh-ancestor
19465379|NCT03314636|Growth Inhibitors|growth inhibitors|mesh-ancestor
20012514|NCT02387554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20012515|NCT02387554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20012516|NCT02387554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012517|NCT02387554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20012518|NCT02387554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012519|NCT02387554|Vasodilator Agents|vasodilator agents|mesh-ancestor
20012520|NCT02387554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20012521|NCT02387554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20012522|NCT02387554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20012523|NCT02387554|Diuretics|diuretics|mesh-ancestor
20012524|NCT02387554|Natriuretic Agents|natriuretic agents|mesh-ancestor
20012525|NCT02387554|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
20012526|NCT02387580|Artefenomel|artefenomel|mesh-list
20012527|NCT02387580|Antimalarials|antimalarials|mesh-ancestor
20012528|NCT02387580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20012529|NCT02387580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20012530|NCT02387580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20012531|NCT02387710|Tiagabine|tiagabine|mesh-list
20012532|NCT02387710|Anticonvulsants|anticonvulsants|mesh-ancestor
20012533|NCT02387710|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
20012534|NCT02387710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19465380|NCT03314493|Spironolactone|spironolactone|mesh-list
19465381|NCT03314493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
19465382|NCT03314493|Hormone Antagonists|hormone antagonists|mesh-ancestor
19465383|NCT03314493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19465384|NCT03314493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465385|NCT03314493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
19465386|NCT03314493|Diuretics|diuretics|mesh-ancestor
19465387|NCT03314493|Natriuretic Agents|natriuretic agents|mesh-ancestor
19465388|NCT03314298|Methyltestosterone|methyltestosterone|mesh-list
19465389|NCT03314298|Anastrozole|anastrozole|mesh-list
19465390|NCT03314298|Testosterone|testosterone|mesh-list
19465391|NCT03314298|Testosterone undecanoate|testosterone undecanoate|mesh-list
19465392|NCT03314298|Testosterone enanthate|testosterone enanthate|mesh-list
19465393|NCT03314298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
19465394|NCT03314298|Androgens|androgens|mesh-ancestor
19465395|NCT03314298|Hormones|hormones|mesh-ancestor
19465396|NCT03314298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19465397|NCT03314298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465398|NCT03314298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19465399|NCT03314298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465400|NCT03314298|Anabolic Agents|anabolic agents|mesh-ancestor
19465401|NCT03314298|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19465402|NCT03314298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19465403|NCT03314298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19465404|NCT03314298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465405|NCT03314298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19465406|NCT03314298|Hormone Antagonists|hormone antagonists|mesh-ancestor
19465407|NCT03314259|Tamsulosin|tamsulosin|mesh-list
19465408|NCT03314259|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19465409|NCT03314259|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19465410|NCT03314259|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19465411|NCT03314259|Adrenergic Agents|adrenergic agents|mesh-ancestor
19465412|NCT03314259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19465413|NCT03314259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465414|NCT03314259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465415|NCT03314259|Urological Agents|urological agents|mesh-ancestor
19465416|NCT03314064|Dolutegravir|dolutegravir|mesh-list
19465417|NCT03314064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19465418|NCT03314064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19465419|NCT03314064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19465420|NCT03314064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465421|NCT03314064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19465422|NCT03314064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19465423|NCT03314064|Antiviral Agents|antiviral agents|mesh-ancestor
19465424|NCT03314064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19465425|NCT03314025|Tamsulosin|tamsulosin|mesh-list
19465426|NCT03314025|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
19465427|NCT03314025|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19465428|NCT03314025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19465429|NCT03314025|Adrenergic Agents|adrenergic agents|mesh-ancestor
19465430|NCT03314025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19465431|NCT03314025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465432|NCT03314025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465433|NCT03314025|Urological Agents|urological agents|mesh-ancestor
19465434|NCT03313960|Insulin|insulin|mesh-list
19465435|NCT03313960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19465436|NCT03313960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465437|NCT03313934|Hyaluronic Acid|hyaluronic acid|mesh-list
19465438|NCT03313934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19465439|NCT03313934|Immunologic Factors|immunologic factors|mesh-ancestor
19465440|NCT03313934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465441|NCT03313934|Viscosupplements|viscosupplements|mesh-ancestor
19465442|NCT03313934|Protective Agents|protective agents|mesh-ancestor
19465443|NCT03313869|Vitamin E|vitamin e|mesh-list
19465444|NCT03313869|Selenium|selenium|mesh-list
19465445|NCT03313869|Vitamins|vitamins|mesh-ancestor
19465446|NCT03313869|Micronutrients|micronutrients|mesh-ancestor
19465447|NCT03313869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465448|NCT03313869|Antioxidants|antioxidants|mesh-ancestor
19465449|NCT03313869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465450|NCT03313869|Protective Agents|protective agents|mesh-ancestor
19465451|NCT03313869|Trace Elements|trace elements|mesh-ancestor
19465452|NCT03313856|Magnesium Oxide|magnesium oxide|mesh-list
19465453|NCT03313856|Antacids|antacids|mesh-ancestor
19465454|NCT03313856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465455|NCT03313856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19465456|NCT03313804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19465457|NCT03313804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465458|NCT03313804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465459|NCT03313791|Caseins|caseins|mesh-list
19465460|NCT03313791|Chelating Agents|chelating agents|mesh-ancestor
19465461|NCT03313791|Sequestering Agents|sequestering agents|mesh-ancestor
19465462|NCT03313791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465463|NCT03313752|Dapagliflozin|dapagliflozin|mesh-list
19465464|NCT03313752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19465465|NCT03313752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465466|NCT03313752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19465467|NCT03313752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465468|NCT03313726|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
19465469|NCT03313726|Hormones|hormones|mesh-ancestor
19465470|NCT03313726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19465471|NCT03313726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465472|NCT03313661|Gliclazide|gliclazide|mesh-list
19465473|NCT03313661|Cabergoline|cabergoline|mesh-list
19465474|NCT03313661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
19465475|NCT03313661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19465476|NCT03313661|Dopamine Agonists|dopamine agonists|mesh-ancestor
19465477|NCT03313661|Dopamine Agents|dopamine agents|mesh-ancestor
19465478|NCT03313661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19465479|NCT03313661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465480|NCT03313661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465481|NCT03313661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19465482|NCT03313557|Adavosertib|adavosertib|mesh-list
19465483|NCT03313557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19465484|NCT03313557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465485|NCT03313544|Nivolumab|nivolumab|mesh-list
19465486|NCT03313544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19465487|NCT03313544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465488|NCT03313544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19465489|NCT03313544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465490|NCT03313531|Thrombin|thrombin|mesh-list
19465491|NCT03313531|Hemostatics|hemostatics|mesh-ancestor
19465492|NCT03313531|Coagulants|coagulants|mesh-ancestor
19465493|NCT03313479|Dexmedetomidine|dexmedetomidine|mesh-list
19465494|NCT03313479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19465495|NCT03313479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19465496|NCT03313479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465497|NCT03313479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19465498|NCT03313479|Analgesics|analgesics|mesh-ancestor
19465499|NCT03313479|Sensory System Agents|sensory system agents|mesh-ancestor
19465500|NCT03313479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465501|NCT03313479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19465502|NCT03313479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19465503|NCT03313479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19465504|NCT03313479|Adrenergic Agents|adrenergic agents|mesh-ancestor
19465505|NCT03313479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19465506|NCT03313479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465507|NCT03313414|Sofosbuvir|sofosbuvir|mesh-list
19465508|NCT03313414|Velpatasvir|velpatasvir|mesh-list
19465509|NCT03313414|Antiviral Agents|antiviral agents|mesh-ancestor
19465510|NCT03313414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19465511|NCT03313401|Aflibercept|aflibercept|mesh-list
19465512|NCT03313401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19465513|NCT03313401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19465514|NCT03313401|Growth Substances|growth substances|mesh-ancestor
19465515|NCT03313401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465516|NCT03313401|Growth Inhibitors|growth inhibitors|mesh-ancestor
19465517|NCT03313401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465518|NCT03313336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
19465519|NCT03313336|Anesthetics, Local|anesthetics, local|mesh-ancestor
19465520|NCT03313336|Anesthetics|anesthetics|mesh-ancestor
19465521|NCT03313336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19465522|NCT03313336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465523|NCT03313336|Sensory System Agents|sensory system agents|mesh-ancestor
19465524|NCT03313336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465525|NCT03313336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
19465526|NCT03313323|Ipilimumab|ipilimumab|mesh-list
19465527|NCT03313323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19465528|NCT03313323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465529|NCT03313323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19465530|NCT03313323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465531|NCT03313206|Pembrolizumab|pembrolizumab|mesh-list
19465532|NCT03313206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19465533|NCT03313206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012535|NCT02387710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20012536|NCT02387710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012537|NCT02387710|GABA Agents|gaba agents|mesh-ancestor
20012538|NCT02387710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20012539|NCT02387710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012540|NCT02387762|Methotrexate|methotrexate|mesh-list
20012541|NCT02387762|Acalabrutinib|acalabrutinib|mesh-list
20012542|NCT02387762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20012543|NCT02387762|Abortifacient Agents|abortifacient agents|mesh-ancestor
20012544|NCT02387762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20012545|NCT02387762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012546|NCT02387762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20012547|NCT02387762|Antimetabolites|antimetabolites|mesh-ancestor
20012548|NCT02387762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012549|NCT02387762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012550|NCT02387762|Dermatologic Agents|dermatologic agents|mesh-ancestor
20012551|NCT02387762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012552|NCT02387762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20012553|NCT02387762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20012554|NCT02387762|Immunologic Factors|immunologic factors|mesh-ancestor
20012555|NCT02387762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20012556|NCT02387762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20012557|NCT02387801|Ixekizumab|ixekizumab|mesh-list
20012558|NCT02387801|Dermatologic Agents|dermatologic agents|mesh-ancestor
20012559|NCT02387957|Bevacizumab|bevacizumab|mesh-list
20012560|NCT02387957|Ranibizumab|ranibizumab|mesh-list
20012561|NCT02387957|Aflibercept|aflibercept|mesh-list
20012562|NCT02387957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20012563|NCT02387957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012564|NCT02387957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20012565|NCT02387957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20012566|NCT02387957|Growth Substances|growth substances|mesh-ancestor
20012567|NCT02387957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012568|NCT02387957|Growth Inhibitors|growth inhibitors|mesh-ancestor
20012569|NCT02387983|Posaconazole|posaconazole|mesh-list
20012570|NCT02387983|Antifungal Agents|antifungal agents|mesh-ancestor
20012571|NCT02387983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20012572|NCT02387983|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20012573|NCT02387983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20012574|NCT02387983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20012575|NCT02387983|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20012576|NCT02387983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20012577|NCT02387983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012578|NCT02387983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012579|NCT02387983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20012580|NCT02387983|Hormone Antagonists|hormone antagonists|mesh-ancestor
20012581|NCT02387983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20012582|NCT02387983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012583|NCT02388165|Vaccines|vaccines|mesh-list
20012584|NCT02388165|Immunologic Factors|immunologic factors|mesh-ancestor
20012585|NCT02388165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012586|NCT02388191|Naproxen|naproxen|mesh-list
20012587|NCT02388191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20012588|NCT02388191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20012589|NCT02388191|Analgesics|analgesics|mesh-ancestor
20012590|NCT02388191|Sensory System Agents|sensory system agents|mesh-ancestor
20012591|NCT02388191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012592|NCT02388191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012593|NCT02388191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20012594|NCT02388191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20012595|NCT02388191|Gout Suppressants|gout suppressants|mesh-ancestor
20012596|NCT02388191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20012597|NCT02388191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012598|NCT02388191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012599|NCT02388321|Fentanyl|fentanyl|mesh-list
20012600|NCT02388321|Ketamine|ketamine|mesh-list
20012601|NCT02388321|Analgesics|analgesics|mesh-ancestor
20012602|NCT02388321|Sensory System Agents|sensory system agents|mesh-ancestor
19465534|NCT03312855|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
19465535|NCT03312855|Immunologic Factors|immunologic factors|mesh-ancestor
19465536|NCT03312855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465537|NCT03312777|Tramadol|tramadol|mesh-list
19465538|NCT03312777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19465539|NCT03312777|Narcotics|narcotics|mesh-ancestor
19465540|NCT03312777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19465541|NCT03312777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465542|NCT03312777|Analgesics|analgesics|mesh-ancestor
19465543|NCT03312777|Sensory System Agents|sensory system agents|mesh-ancestor
19465544|NCT03312777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465545|NCT03312699|Vaccines|vaccines|mesh-list
19465546|NCT03312699|Immunologic Factors|immunologic factors|mesh-ancestor
19465547|NCT03312699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465548|NCT03312582|Metformin|metformin|mesh-list
19465549|NCT03312582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19465550|NCT03312582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465551|NCT03312530|Atezolizumab|atezolizumab|mesh-list
19465552|NCT03312530|Venetoclax|venetoclax|mesh-list
19465553|NCT03312530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465554|NCT03312478|Antibodies|antibodies|mesh-list
19465555|NCT03312478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465556|NCT03312478|Immunologic Factors|immunologic factors|mesh-ancestor
19465557|NCT03312426|Linrodostat|linrodostat|mesh-list
19465558|NCT03312426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19465559|NCT03312426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465560|NCT03312413|Dexmedetomidine|dexmedetomidine|mesh-list
19465561|NCT03312413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19465562|NCT03312413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19465563|NCT03312413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465564|NCT03312413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19465565|NCT03312413|Analgesics|analgesics|mesh-ancestor
19465566|NCT03312413|Sensory System Agents|sensory system agents|mesh-ancestor
19465567|NCT03312413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465568|NCT03312413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19465569|NCT03312413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19465570|NCT03312413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19465571|NCT03312413|Adrenergic Agents|adrenergic agents|mesh-ancestor
19465572|NCT03312413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19465573|NCT03312413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465574|NCT03312335|Aldesleukin|aldesleukin|mesh-list
19465575|NCT03312335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465576|NCT03312335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19465577|NCT03312335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19465578|NCT03312335|Antiviral Agents|antiviral agents|mesh-ancestor
19465579|NCT03312335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19465580|NCT03312283|Ranibizumab|ranibizumab|mesh-list
19465581|NCT03312283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19465582|NCT03312283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19465583|NCT03312283|Growth Substances|growth substances|mesh-ancestor
19465584|NCT03312283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465585|NCT03312283|Growth Inhibitors|growth inhibitors|mesh-ancestor
19465586|NCT03312283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465587|NCT03312257|Atropine|atropine|mesh-list
19465588|NCT03312257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19465589|NCT03312257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19465590|NCT03312257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19465591|NCT03312257|Autonomic Agents|autonomic agents|mesh-ancestor
19465592|NCT03312257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465593|NCT03312257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465594|NCT03312257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19465595|NCT03312257|Respiratory System Agents|respiratory system agents|mesh-ancestor
19465596|NCT03312257|Mydriatics|mydriatics|mesh-ancestor
19465597|NCT03312257|Parasympatholytics|parasympatholytics|mesh-ancestor
19465598|NCT03312257|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
19465599|NCT03312257|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19465600|NCT03312257|Cholinergic Agents|cholinergic agents|mesh-ancestor
19465601|NCT03312257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19465602|NCT03312257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465603|NCT03312244|Bromides|bromides|mesh-list
19465604|NCT03312244|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
19465605|NCT03312244|Anticonvulsants|anticonvulsants|mesh-ancestor
19465606|NCT03312244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19465607|NCT03312244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19465608|NCT03312244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465609|NCT03312244|Cholinergic Agents|cholinergic agents|mesh-ancestor
19465610|NCT03312244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19465611|NCT03312244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465612|NCT03312179|Incretins|incretins|mesh-list
19465613|NCT03312179|Hormones|hormones|mesh-ancestor
19465614|NCT03312179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19465615|NCT03312179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465616|NCT03312153|Sodium Hypochlorite|sodium hypochlorite|mesh-list
19465617|NCT03312153|Eusol|eusol|mesh-list
19465618|NCT03312153|Disinfectants|disinfectants|mesh-ancestor
19465619|NCT03312153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19465620|NCT03312140|Choline|choline|mesh-list
19465621|NCT03312140|Lipotropic Agents|lipotropic agents|mesh-ancestor
19465622|NCT03312140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19465623|NCT03312140|Antimetabolites|antimetabolites|mesh-ancestor
19465624|NCT03312140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465625|NCT03312140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19465626|NCT03312140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19465627|NCT03312140|Nootropic Agents|nootropic agents|mesh-ancestor
19465628|NCT03311984|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19465629|NCT03311984|Dalteparin|dalteparin|mesh-list
19465630|NCT03311984|Anticoagulants|anticoagulants|mesh-ancestor
19465631|NCT03311984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19465632|NCT03311984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19465633|NCT03311984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465634|NCT03311971|Methamphetamine|methamphetamine|mesh-list
19465635|NCT03311971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19465636|NCT03311971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465637|NCT03311971|Sympathomimetics|sympathomimetics|mesh-ancestor
19465638|NCT03311971|Autonomic Agents|autonomic agents|mesh-ancestor
19465639|NCT03311971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465640|NCT03311971|Dopamine Agents|dopamine agents|mesh-ancestor
19465641|NCT03311971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19465642|NCT03311971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465643|NCT03311971|Adrenergic Agents|adrenergic agents|mesh-ancestor
19465644|NCT03311971|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
19465645|NCT03311971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19465646|NCT03311971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19465647|NCT03311971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19465648|NCT03311945|Lamivudine|lamivudine|mesh-list
19465649|NCT03311945|Raltegravir Potassium|raltegravir potassium|mesh-list
19465650|NCT03311945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19465651|NCT03311945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19465652|NCT03311945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19465653|NCT03311945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465654|NCT03311945|Antiviral Agents|antiviral agents|mesh-ancestor
19465655|NCT03311945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19465656|NCT03311945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19465657|NCT03311945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19465658|NCT03311945|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
19465659|NCT03311945|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
19465660|NCT03311906|Hyaluronic Acid|hyaluronic acid|mesh-list
19465661|NCT03311906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19465662|NCT03311906|Immunologic Factors|immunologic factors|mesh-ancestor
19465663|NCT03311906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465664|NCT03311906|Viscosupplements|viscosupplements|mesh-ancestor
19465665|NCT03311906|Protective Agents|protective agents|mesh-ancestor
19465666|NCT03311828|Daratumumab|daratumumab|mesh-list
19465667|NCT03311828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465668|NCT03311789|Gemcitabine|gemcitabine|mesh-list
19465669|NCT03311789|Nivolumab|nivolumab|mesh-list
19465670|NCT03311789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
19465671|NCT03311789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465672|NCT03311789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19465673|NCT03311789|Antimetabolites|antimetabolites|mesh-ancestor
19465674|NCT03311789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465675|NCT03311789|Antiviral Agents|antiviral agents|mesh-ancestor
19465676|NCT03311789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19465677|NCT03311789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19465678|NCT03311789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19465679|NCT03311789|Immunologic Factors|immunologic factors|mesh-ancestor
19465680|NCT03311789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465681|NCT03311789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19465682|NCT03311750|Panitumumab|panitumumab|mesh-list
19465683|NCT03311750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20012603|NCT02388321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465684|NCT03311750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465685|NCT03311737|Anesthetics|anesthetics|mesh-list
19465686|NCT03311737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19465687|NCT03311737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465688|NCT03311672|Pembrolizumab|pembrolizumab|mesh-list
19465689|NCT03311672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19465690|NCT03311672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465691|NCT03311607|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
19465692|NCT03311607|Antifungal Agents|antifungal agents|mesh-ancestor
19465693|NCT03311607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19465694|NCT03311607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19465695|NCT03311607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19465696|NCT03311594|Ethanol|ethanol|mesh-list
19465697|NCT03311594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19465698|NCT03311594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19465699|NCT03311594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19465700|NCT03311594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465701|NCT03311581|Propofol|propofol|mesh-list
19465702|NCT03311581|Sevoflurane|sevoflurane|mesh-list
19465703|NCT03311581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19465704|NCT03311581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19465705|NCT03311581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465706|NCT03311581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19465707|NCT03311581|Anesthetics, General|anesthetics, general|mesh-ancestor
19465708|NCT03311581|Anesthetics|anesthetics|mesh-ancestor
19465709|NCT03311581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19465710|NCT03311581|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
19465711|NCT03311542|Pembrolizumab|pembrolizumab|mesh-list
19465712|NCT03311542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19465713|NCT03311542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465714|NCT03311516|Insulin|insulin|mesh-list
19465715|NCT03311516|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19465716|NCT03311516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19465717|NCT03311516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465718|NCT03311464|Adalimumab|adalimumab|mesh-list
19465719|NCT03311464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19465720|NCT03311464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19465721|NCT03311425|Dexamethasone|dexamethasone|mesh-list
19465722|NCT03311425|Methylprednisolone|methylprednisolone|mesh-list
19465723|NCT03311425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19465724|NCT03311425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19465725|NCT03311425|Prednisolone|prednisolone|mesh-list
19465726|NCT03311425|Prednisolone acetate|prednisolone acetate|mesh-list
19465727|NCT03311425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19465728|NCT03311425|Prednisolone phosphate|prednisolone phosphate|mesh-list
19465729|NCT03311425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19465730|NCT03311425|Antiemetics|antiemetics|mesh-ancestor
19465731|NCT03311425|Autonomic Agents|autonomic agents|mesh-ancestor
20012604|NCT02388321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012605|NCT02388321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20012606|NCT02388321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20012607|NCT02388321|Anesthetics, General|anesthetics, general|mesh-ancestor
20012608|NCT02388321|Anesthetics|anesthetics|mesh-ancestor
20012609|NCT02388321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20012610|NCT02388321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20012611|NCT02388321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20012612|NCT02388321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19465732|NCT03311425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465733|NCT03311425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465734|NCT03311425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19465735|NCT03311425|Glucocorticoids|glucocorticoids|mesh-ancestor
19465736|NCT03311425|Hormones|hormones|mesh-ancestor
19465737|NCT03311425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19465738|NCT03311425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19465739|NCT03311425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465740|NCT03311425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19465741|NCT03311425|Protective Agents|protective agents|mesh-ancestor
19465742|NCT03311386|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
19465743|NCT03311386|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19465744|NCT03311386|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19465745|NCT03311386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465746|NCT03311321|Vitamin K|vitamin k|mesh-list
19465747|NCT03311321|Vitamin K 2|vitamin k 2|mesh-list
19465748|NCT03311321|Vitamin MK 7|vitamin mk 7|mesh-list
19465749|NCT03311321|Vitamins|vitamins|mesh-ancestor
19465750|NCT03311321|Micronutrients|micronutrients|mesh-ancestor
19465751|NCT03311321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465752|NCT03311321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19465753|NCT03311321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19465754|NCT03311321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465755|NCT03311321|Hemostatics|hemostatics|mesh-ancestor
19465756|NCT03311321|Coagulants|coagulants|mesh-ancestor
20012613|NCT02388321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012614|NCT02388321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20012615|NCT02388321|Narcotics|narcotics|mesh-ancestor
20012616|NCT02388321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20012617|NCT02388724|Lansoprazole|lansoprazole|mesh-list
20012618|NCT02388724|Dexlansoprazole|dexlansoprazole|mesh-list
20012619|NCT02388724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20012620|NCT02388724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20012621|NCT02388724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20012622|NCT02388724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012623|NCT02388724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012624|NCT02388737|Lansoprazole|lansoprazole|mesh-list
20012625|NCT02388737|Dexlansoprazole|dexlansoprazole|mesh-list
20012626|NCT02388737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20012627|NCT02388737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20012628|NCT02388737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20012629|NCT02388737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012630|NCT02388737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012631|NCT02388997|Omalizumab|omalizumab|mesh-list
20012632|NCT02388997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20012633|NCT02388997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20012634|NCT02388997|Respiratory System Agents|respiratory system agents|mesh-ancestor
20012635|NCT02389088|Letrozole|letrozole|mesh-list
20012636|NCT02389088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012637|NCT02389088|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20012638|NCT02389088|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20012639|NCT02389088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012640|NCT02389088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012641|NCT02389088|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20012642|NCT02389088|Hormone Antagonists|hormone antagonists|mesh-ancestor
20012643|NCT02389088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20012644|NCT02389088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012645|NCT02389361|Acetaminophen|acetaminophen|mesh-list
20012646|NCT02389361|Tramadol|tramadol|mesh-list
20012647|NCT02389361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20012648|NCT02389361|Analgesics|analgesics|mesh-ancestor
20012649|NCT02389361|Sensory System Agents|sensory system agents|mesh-ancestor
20012650|NCT02389361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012651|NCT02389361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012652|NCT02389361|Antipyretics|antipyretics|mesh-ancestor
20012653|NCT02389361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20012654|NCT02389361|Narcotics|narcotics|mesh-ancestor
20012655|NCT02389361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20012656|NCT02389452|Hylan|hylan|mesh-list
20012657|NCT02389452|Viscosupplements|viscosupplements|mesh-ancestor
20012658|NCT02389452|Protective Agents|protective agents|mesh-ancestor
20012659|NCT02389452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012660|NCT02389738|Temozolomide|temozolomide|mesh-list
20012661|NCT02389738|Regadenoson|regadenoson|mesh-list
20012662|NCT02389738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20012663|NCT02389738|Alkylating Agents|alkylating agents|mesh-ancestor
20012664|NCT02389738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012665|NCT02389738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012666|NCT02389738|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
20012667|NCT02389738|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
20012668|NCT02389738|Purinergic Agonists|purinergic agonists|mesh-ancestor
20012669|NCT02389738|Purinergic Agents|purinergic agents|mesh-ancestor
20012670|NCT02389738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20012671|NCT02389738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012672|NCT02389764|Nintedanib|nintedanib|mesh-list
20012673|NCT02389764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012674|NCT02389764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20012675|NCT02389764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012676|NCT02389764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012677|NCT02389816|Vortioxetine|vortioxetine|mesh-list
20012678|NCT02389816|Antidepressive Agents|antidepressive agents|mesh-ancestor
20012679|NCT02389816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20012680|NCT02389816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20012681|NCT02389816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19465757|NCT03311178|Dobutamine|dobutamine|mesh-list
19465758|NCT03311178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19465759|NCT03311178|Sympathomimetics|sympathomimetics|mesh-ancestor
19465760|NCT03311178|Autonomic Agents|autonomic agents|mesh-ancestor
19465761|NCT03311178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465762|NCT03311178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465763|NCT03311178|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
19465764|NCT03311178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19465765|NCT03311178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19465766|NCT03311178|Adrenergic Agents|adrenergic agents|mesh-ancestor
19465767|NCT03311178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19465768|NCT03311178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465769|NCT03311178|Protective Agents|protective agents|mesh-ancestor
19465770|NCT03311139|Fibrinolytic Agents|fibrinolytic agents|mesh-list
19465771|NCT03311139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19465772|NCT03311139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465773|NCT03311022|Nefopam|nefopam|mesh-list
19465774|NCT03311022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19465775|NCT03311022|Analgesics|analgesics|mesh-ancestor
19465776|NCT03311022|Sensory System Agents|sensory system agents|mesh-ancestor
19465777|NCT03311022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465778|NCT03311022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465779|NCT03310762|Silicon|silicon|mesh-list
19465780|NCT03310762|Trace Elements|trace elements|mesh-ancestor
19465781|NCT03310762|Micronutrients|micronutrients|mesh-ancestor
19465782|NCT03310762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465783|NCT03310749|Metformin|metformin|mesh-list
19465784|NCT03310749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19465785|NCT03310749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465786|NCT03310736|Hepcidins|hepcidins|mesh-list
19465787|NCT03310736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19465788|NCT03310606|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19465789|NCT03310606|Lactams|lactams|mesh-list
19465790|NCT03310606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19465791|NCT03310593|Cannabidiol|cannabidiol|mesh-list
19465792|NCT03310593|Anticonvulsants|anticonvulsants|mesh-ancestor
19465793|NCT03310567|Pembrolizumab|pembrolizumab|mesh-list
19465794|NCT03310567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19465795|NCT03310567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465796|NCT03310541|Fulvestrant|fulvestrant|mesh-list
19465797|NCT03310541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19465798|NCT03310541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465799|NCT03310541|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19465800|NCT03310541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19465801|NCT03310541|Hormone Antagonists|hormone antagonists|mesh-ancestor
19465802|NCT03310541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19465803|NCT03310541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465804|NCT03310372|Temozolomide|temozolomide|mesh-list
19465805|NCT03310372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19465806|NCT03310372|Alkylating Agents|alkylating agents|mesh-ancestor
19465807|NCT03310372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465808|NCT03310372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465809|NCT03310333|Dinoprostone|dinoprostone|mesh-list
19465810|NCT03310333|Oxytocics|oxytocics|mesh-ancestor
19465811|NCT03310333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19465812|NCT03310333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465813|NCT03310242|Vitamin D|vitamin d|mesh-list
19465814|NCT03310242|Vitamins|vitamins|mesh-ancestor
19465815|NCT03310242|Micronutrients|micronutrients|mesh-ancestor
19465816|NCT03310242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465817|NCT03310242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19465818|NCT03310125|Colchicine|colchicine|mesh-list
19465819|NCT03310125|Gout Suppressants|gout suppressants|mesh-ancestor
19465820|NCT03310125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19465821|NCT03310125|Tubulin Modulators|tubulin modulators|mesh-ancestor
19465822|NCT03310125|Antimitotic Agents|antimitotic agents|mesh-ancestor
19465823|NCT03310125|Mitosis Modulators|mitosis modulators|mesh-ancestor
19465824|NCT03310125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465825|NCT03310125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465826|NCT03310073|Vaccines|vaccines|mesh-list
19465827|NCT03310073|Immunologic Factors|immunologic factors|mesh-ancestor
19465828|NCT03310073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465829|NCT03310060|Tranexamic Acid|tranexamic acid|mesh-list
19465830|NCT03310060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19465831|NCT03310060|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19465832|NCT03310060|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20012682|NCT02389816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19465833|NCT03310060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465834|NCT03310060|Hemostatics|hemostatics|mesh-ancestor
19465835|NCT03310060|Coagulants|coagulants|mesh-ancestor
19465836|NCT03310047|Lidocaine|lidocaine|mesh-list
19465837|NCT03310047|Anesthetics, Local|anesthetics, local|mesh-ancestor
19465838|NCT03310047|Anesthetics|anesthetics|mesh-ancestor
19465839|NCT03310047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19465840|NCT03310047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465841|NCT03310047|Sensory System Agents|sensory system agents|mesh-ancestor
19465842|NCT03310047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465843|NCT03310047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19465844|NCT03310047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19465845|NCT03310047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19465846|NCT03310047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19465847|NCT03310047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465848|NCT03309865|Vedolizumab|vedolizumab|mesh-list
19465849|NCT03309865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19465850|NCT03309748|Anti-Infective Agents|anti-infective agents|mesh-list
19465851|NCT03309748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19465852|NCT03309735|Progesterone|progesterone|mesh-list
19465853|NCT03309735|Dydrogesterone|dydrogesterone|mesh-list
19465854|NCT03309735|Progestins|progestins|mesh-ancestor
19465855|NCT03309735|Hormones|hormones|mesh-ancestor
19465856|NCT03309735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19465857|NCT03309735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465858|NCT03309709|Progesterone|progesterone|mesh-list
19465859|NCT03309709|Progestins|progestins|mesh-ancestor
19465860|NCT03309709|Hormones|hormones|mesh-ancestor
19465861|NCT03309709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19465862|NCT03309709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465863|NCT03309644|Iodine|iodine|mesh-list
19465864|NCT03309644|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19465865|NCT03309644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19465866|NCT03309644|Trace Elements|trace elements|mesh-ancestor
19465867|NCT03309644|Micronutrients|micronutrients|mesh-ancestor
19465868|NCT03309644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465869|NCT03309618|Valsartan|valsartan|mesh-list
19465870|NCT03309618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19465871|NCT03309618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
19465872|NCT03309618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
19465873|NCT03309618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465874|NCT03309592|Ambrisentan|ambrisentan|mesh-list
19465875|NCT03309592|Tadalafil|tadalafil|mesh-list
19465876|NCT03309592|Vasodilator Agents|vasodilator agents|mesh-ancestor
19465877|NCT03309592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19465878|NCT03309592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19465879|NCT03309592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19465880|NCT03309592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465881|NCT03309592|Urological Agents|urological agents|mesh-ancestor
19465882|NCT03309592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20012683|NCT02389816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012684|NCT02389816|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20012685|NCT02389816|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20012686|NCT02389816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20012687|NCT02389816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012688|NCT02389816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20012689|NCT02389816|Serotonin Agents|serotonin agents|mesh-ancestor
20012690|NCT02389816|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20012691|NCT02389816|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20012692|NCT02389816|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20012693|NCT02389816|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20012694|NCT02389829|Diphenhydramine|diphenhydramine|mesh-list
20012695|NCT02389829|Promethazine|promethazine|mesh-list
20012696|NCT02389829|Hydromorphone|hydromorphone|mesh-list
20012697|NCT02389829|Prochlorperazine|prochlorperazine|mesh-list
20012698|NCT02389829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20012699|NCT02389829|Narcotics|narcotics|mesh-ancestor
20012700|NCT02389829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20012701|NCT02389829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012702|NCT02389829|Analgesics|analgesics|mesh-ancestor
20012703|NCT02389829|Sensory System Agents|sensory system agents|mesh-ancestor
20012704|NCT02389829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012705|NCT02389829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20012706|NCT02389829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19465883|NCT03309566|Tenofovir|tenofovir|mesh-list
19465884|NCT03309566|Emtricitabine|emtricitabine|mesh-list
19465885|NCT03309566|Efavirenz|efavirenz|mesh-list
19465886|NCT03309566|Antiviral Agents|antiviral agents|mesh-ancestor
19465887|NCT03309566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19465888|NCT03309566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
19465889|NCT03309566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19465890|NCT03309566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19465891|NCT03309566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465892|NCT03309566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19465893|NCT03309566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19465894|NCT03309566|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19465895|NCT03309566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19465896|NCT03309566|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19465897|NCT03309566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19465898|NCT03309566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19465899|NCT03309566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19465900|NCT03309527|Diphenhydramine|diphenhydramine|mesh-list
19465901|NCT03309527|Promethazine|promethazine|mesh-list
19465902|NCT03309527|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
19465903|NCT03309527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19465904|NCT03309527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19465905|NCT03309527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465906|NCT03309527|Anesthetics, Local|anesthetics, local|mesh-ancestor
19465907|NCT03309527|Anesthetics|anesthetics|mesh-ancestor
19465908|NCT03309527|Sensory System Agents|sensory system agents|mesh-ancestor
19465909|NCT03309527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465910|NCT03309527|Antiemetics|antiemetics|mesh-ancestor
19465911|NCT03309527|Autonomic Agents|autonomic agents|mesh-ancestor
19465912|NCT03309527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19465913|NCT03309527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19465914|NCT03309527|Histamine Antagonists|histamine antagonists|mesh-ancestor
19465915|NCT03309527|Histamine Agents|histamine agents|mesh-ancestor
19465916|NCT03309527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19465917|NCT03309527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19465918|NCT03309527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
19465919|NCT03309527|Antipruritics|antipruritics|mesh-ancestor
19465920|NCT03309527|Dermatologic Agents|dermatologic agents|mesh-ancestor
19465921|NCT03309475|Psychotropic Drugs|psychotropic drugs|mesh-list
19465922|NCT03309436|Clomiphene|clomiphene|mesh-list
19465923|NCT03309436|Enclomiphene|enclomiphene|mesh-list
19465924|NCT03309436|Zuclomiphene|zuclomiphene|mesh-list
19465925|NCT03309436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19465926|NCT03309436|Hormone Antagonists|hormone antagonists|mesh-ancestor
19465927|NCT03309436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19465928|NCT03309436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465929|NCT03309436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
19465930|NCT03309436|Fertility Agents|fertility agents|mesh-ancestor
19465931|NCT03309436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19465932|NCT03309436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
19465933|NCT03309436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
19465934|NCT03309319|Rosiglitazone|rosiglitazone|mesh-list
19465935|NCT03309319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19465936|NCT03309319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465937|NCT03309215|Nickel|nickel|mesh-list
19465938|NCT03309215|Trace Elements|trace elements|mesh-ancestor
19465939|NCT03309215|Micronutrients|micronutrients|mesh-ancestor
19465940|NCT03309215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465941|NCT03309176|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19465942|NCT03309176|Medroxyprogesterone|medroxyprogesterone|mesh-list
19465943|NCT03309176|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19465944|NCT03309176|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19465945|NCT03309176|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19465946|NCT03309176|Contraceptive Agents|contraceptive agents|mesh-ancestor
19465947|NCT03309176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19465948|NCT03309176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465949|NCT03309176|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19465950|NCT03309176|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19465951|NCT03309176|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19465952|NCT03309176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19465953|NCT03309176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465954|NCT03309163|Tramadol|tramadol|mesh-list
19465955|NCT03309163|Hydromorphone|hydromorphone|mesh-list
19465956|NCT03309163|Ropivacaine|ropivacaine|mesh-list
19465957|NCT03309163|Anesthetics, Local|anesthetics, local|mesh-ancestor
19465958|NCT03309163|Anesthetics|anesthetics|mesh-ancestor
19465959|NCT03309163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19465960|NCT03309163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465961|NCT03309163|Sensory System Agents|sensory system agents|mesh-ancestor
19465962|NCT03309163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465963|NCT03309163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19465964|NCT03309163|Narcotics|narcotics|mesh-ancestor
19465965|NCT03309163|Analgesics|analgesics|mesh-ancestor
19465966|NCT03309059|Zinc Oxide|zinc oxide|mesh-list
19465967|NCT03309059|Dermatologic Agents|dermatologic agents|mesh-ancestor
19465968|NCT03309059|Sunscreening Agents|sunscreening agents|mesh-ancestor
19465969|NCT03309059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
19465970|NCT03309059|Protective Agents|protective agents|mesh-ancestor
19465971|NCT03309059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465972|NCT03308955|Tramadol|tramadol|mesh-list
19465973|NCT03308955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19465974|NCT03308955|Narcotics|narcotics|mesh-ancestor
19465975|NCT03308955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19465976|NCT03308955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465977|NCT03308955|Analgesics|analgesics|mesh-ancestor
19465978|NCT03308955|Sensory System Agents|sensory system agents|mesh-ancestor
19465979|NCT03308955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465980|NCT03308916|Liver Extracts|liver extracts|mesh-list
19465981|NCT03308916|Hematinics|hematinics|mesh-ancestor
19465982|NCT03308890|Entecavir|entecavir|mesh-list
19465983|NCT03308890|Antiviral Agents|antiviral agents|mesh-ancestor
19465984|NCT03308890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19465985|NCT03308786|Aldesleukin|aldesleukin|mesh-list
19465986|NCT03308786|Interleukin-2|interleukin-2|mesh-list
19465987|NCT03308786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19465988|NCT03308786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19465989|NCT03308786|Analgesics|analgesics|mesh-ancestor
19465990|NCT03308786|Sensory System Agents|sensory system agents|mesh-ancestor
19465991|NCT03308786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19465992|NCT03308786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19465993|NCT03308786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19465994|NCT03308786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19465995|NCT03308786|Antiviral Agents|antiviral agents|mesh-ancestor
19465996|NCT03308786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19465997|NCT03308708|Norepinephrine|norepinephrine|mesh-list
19465998|NCT03308708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19465999|NCT03308708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19466000|NCT03308708|Adrenergic Agents|adrenergic agents|mesh-ancestor
19466001|NCT03308708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19466002|NCT03308708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466003|NCT03308708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466004|NCT03308708|Sympathomimetics|sympathomimetics|mesh-ancestor
19466005|NCT03308708|Autonomic Agents|autonomic agents|mesh-ancestor
19466006|NCT03308708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466007|NCT03308708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19466008|NCT03308682|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
19466009|NCT03308682|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19466010|NCT03308682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466011|NCT03308643|Oxytocin|oxytocin|mesh-list
19466012|NCT03308643|Oxytocics|oxytocics|mesh-ancestor
19466013|NCT03308643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19466014|NCT03308643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466015|NCT03308604|Cisplatin|cisplatin|mesh-list
19466016|NCT03308604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466017|NCT03308552|Paclitaxel|paclitaxel|mesh-list
19466018|NCT03308552|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19466019|NCT03308552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19466020|NCT03308552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466021|NCT03308552|Tubulin Modulators|tubulin modulators|mesh-ancestor
19466022|NCT03308552|Antimitotic Agents|antimitotic agents|mesh-ancestor
19466023|NCT03308552|Mitosis Modulators|mitosis modulators|mesh-ancestor
19466024|NCT03308552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466025|NCT03308487|Vitamin D|vitamin d|mesh-list
19466026|NCT03308487|Ergocalciferols|ergocalciferols|mesh-list
19466027|NCT03308487|Cholecalciferol|cholecalciferol|mesh-list
19466028|NCT03308487|Vitamins|vitamins|mesh-list
19466029|NCT03308487|Micronutrients|micronutrients|mesh-ancestor
19466030|NCT03308487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466031|NCT03308487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19466032|NCT03308487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19466033|NCT03308357|Infliximab|infliximab|mesh-list
19466034|NCT03308357|Dermatologic Agents|dermatologic agents|mesh-ancestor
19466035|NCT03308357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19466036|NCT03308357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19466037|NCT03308331|Nicotine|nicotine|mesh-list
19466038|NCT03308331|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
19466039|NCT03308331|Autonomic Agents|autonomic agents|mesh-ancestor
19466040|NCT03308331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466041|NCT03308331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466042|NCT03308331|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
19466043|NCT03308331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19466044|NCT03308331|Cholinergic Agents|cholinergic agents|mesh-ancestor
19466045|NCT03308331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19466046|NCT03308331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466047|NCT03308253|Vancomycin|vancomycin|mesh-list
19466048|NCT03308253|Tobramycin|tobramycin|mesh-list
19466049|NCT03308253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19466050|NCT03308253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19466051|NCT03308214|Imipenem|imipenem|mesh-list
19466052|NCT03308214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19466053|NCT03308214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19466054|NCT03308201|Letrozole|letrozole|mesh-list
19466055|NCT03308201|Fulvestrant|fulvestrant|mesh-list
19466056|NCT03308201|Exemestane|exemestane|mesh-list
19466057|NCT03308201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466058|NCT03308201|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19466059|NCT03308201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19466060|NCT03308201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19466061|NCT03308201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466062|NCT03308201|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19466063|NCT03308201|Hormone Antagonists|hormone antagonists|mesh-ancestor
19466064|NCT03308201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19466065|NCT03308201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466066|NCT03308201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19466067|NCT03308201|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
19466068|NCT03308149|Triamcinolone|triamcinolone|mesh-list
19466069|NCT03308149|Bupivacaine|bupivacaine|mesh-list
19466070|NCT03308149|Anesthetics, Local|anesthetics, local|mesh-ancestor
19466071|NCT03308149|Anesthetics|anesthetics|mesh-ancestor
19466072|NCT03308149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466073|NCT03308149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466074|NCT03308149|Sensory System Agents|sensory system agents|mesh-ancestor
19466075|NCT03308149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466076|NCT03308149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19466077|NCT03308149|Glucocorticoids|glucocorticoids|mesh-ancestor
19466078|NCT03308149|Hormones|hormones|mesh-ancestor
19466079|NCT03308149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19466080|NCT03308136|Lidocaine|lidocaine|mesh-list
19466081|NCT03308136|Anesthetics, Local|anesthetics, local|mesh-list
19466082|NCT03308136|Anesthetics|anesthetics|mesh-list
19466083|NCT03308136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466084|NCT03308136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466085|NCT03308136|Sensory System Agents|sensory system agents|mesh-ancestor
19466086|NCT03308136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466087|NCT03308136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19466088|NCT03308136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19466089|NCT03308136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19466090|NCT03308136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20012707|NCT02389829|Anesthetics, Local|anesthetics, local|mesh-ancestor
20012708|NCT02389829|Anesthetics|anesthetics|mesh-ancestor
20012709|NCT02389829|Antiemetics|antiemetics|mesh-ancestor
20012710|NCT02389829|Autonomic Agents|autonomic agents|mesh-ancestor
20012711|NCT02389829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20012712|NCT02389829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20012713|NCT02389829|Histamine Antagonists|histamine antagonists|mesh-ancestor
20012714|NCT02389829|Histamine Agents|histamine agents|mesh-ancestor
20012715|NCT02389829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20012716|NCT02389829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012717|NCT02389829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20012718|NCT02389829|Antipruritics|antipruritics|mesh-ancestor
20012719|NCT02389829|Dermatologic Agents|dermatologic agents|mesh-ancestor
20012720|NCT02389829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20012721|NCT02389829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20012722|NCT02389829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20012723|NCT02389829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20012724|NCT02389829|Dopamine Agents|dopamine agents|mesh-ancestor
20012725|NCT02389959|Bevacizumab|bevacizumab|mesh-list
20012726|NCT02389959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20012727|NCT02389959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012728|NCT02389959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19466091|NCT03308136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466092|NCT03308084|Dexamethasone|dexamethasone|mesh-list
19466093|NCT03308084|Methylprednisolone|methylprednisolone|mesh-list
19466094|NCT03308084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
19466095|NCT03308084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
19466096|NCT03308084|Prednisolone|prednisolone|mesh-list
19466097|NCT03308084|Prednisolone acetate|prednisolone acetate|mesh-list
19466098|NCT03308084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
19466099|NCT03308084|Prednisolone phosphate|prednisolone phosphate|mesh-list
19466100|NCT03308084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19466101|NCT03308084|Antiemetics|antiemetics|mesh-ancestor
19466102|NCT03308084|Autonomic Agents|autonomic agents|mesh-ancestor
19466103|NCT03308084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466104|NCT03308084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466105|NCT03308084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19466106|NCT03308084|Glucocorticoids|glucocorticoids|mesh-ancestor
19466107|NCT03308084|Hormones|hormones|mesh-ancestor
19466108|NCT03308084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19466109|NCT03308084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19466110|NCT03308084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466111|NCT03308084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
19466112|NCT03308084|Protective Agents|protective agents|mesh-ancestor
19466113|NCT03307941|Fluorouracil|fluorouracil|mesh-list
19466114|NCT03307941|Oxaliplatin|oxaliplatin|mesh-list
19466115|NCT03307941|Antimetabolites|antimetabolites|mesh-ancestor
19466116|NCT03307941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466117|NCT03307941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19466118|NCT03307941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466119|NCT03307941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19466120|NCT03307941|Immunologic Factors|immunologic factors|mesh-ancestor
19466121|NCT03307941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466122|NCT03307902|Imiquimod|imiquimod|mesh-list
19466123|NCT03307902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
19466124|NCT03307902|Immunologic Factors|immunologic factors|mesh-ancestor
19466125|NCT03307902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466126|NCT03307902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466127|NCT03307902|Interferon Inducers|interferon inducers|mesh-ancestor
19466128|NCT03307863|Topiramate|topiramate|mesh-list
19466129|NCT03307863|Carbamazepine|carbamazepine|mesh-list
19466130|NCT03307863|Anticonvulsants|anticonvulsants|mesh-ancestor
19466131|NCT03307863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19466132|NCT03307863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466133|NCT03307863|Antimanic Agents|antimanic agents|mesh-ancestor
19466134|NCT03307863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19466135|NCT03307863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466136|NCT03307863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19466137|NCT03307863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19466138|NCT03307863|Analgesics|analgesics|mesh-ancestor
19466139|NCT03307863|Sensory System Agents|sensory system agents|mesh-ancestor
19466140|NCT03307863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466141|NCT03307863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19466142|NCT03307863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19466143|NCT03307863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466144|NCT03307863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19466145|NCT03307863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20012729|NCT02389959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20012730|NCT02389959|Growth Substances|growth substances|mesh-ancestor
20012731|NCT02389959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012732|NCT02389959|Growth Inhibitors|growth inhibitors|mesh-ancestor
20012733|NCT02389998|Hyoscyamine|hyoscyamine|mesh-list
20012734|NCT02389998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20012735|NCT02389998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20012736|NCT02389998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20012737|NCT02389998|Autonomic Agents|autonomic agents|mesh-ancestor
20012738|NCT02389998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012739|NCT02389998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012740|NCT02389998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20012741|NCT02389998|Respiratory System Agents|respiratory system agents|mesh-ancestor
20012742|NCT02389998|Mydriatics|mydriatics|mesh-ancestor
20012743|NCT02389998|Parasympatholytics|parasympatholytics|mesh-ancestor
20012744|NCT02389998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20012745|NCT02389998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20012746|NCT02389998|Cholinergic Agents|cholinergic agents|mesh-ancestor
20012747|NCT02389998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20012748|NCT02389998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466146|NCT03307746|Rituximab|rituximab|mesh-list
19466147|NCT03307746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19466148|NCT03307746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466149|NCT03307746|Immunologic Factors|immunologic factors|mesh-ancestor
19466150|NCT03307746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466151|NCT03307746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19466152|NCT03307720|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
19466153|NCT03307720|Hormones|hormones|mesh-list
19466154|NCT03307720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19466155|NCT03307720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466156|NCT03307720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19466157|NCT03307603|Nivolumab|nivolumab|mesh-list
19466158|NCT03307603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19466159|NCT03307603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466160|NCT03307603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19466161|NCT03307603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466162|NCT03307590|Dexmedetomidine|dexmedetomidine|mesh-list
19466163|NCT03307590|Bupivacaine|bupivacaine|mesh-list
19466164|NCT03307590|Anesthetics, Local|anesthetics, local|mesh-ancestor
19466165|NCT03307590|Anesthetics|anesthetics|mesh-ancestor
19466166|NCT03307590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466167|NCT03307590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466168|NCT03307590|Sensory System Agents|sensory system agents|mesh-ancestor
19466169|NCT03307590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466170|NCT03307590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19466171|NCT03307590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19466172|NCT03307590|Analgesics|analgesics|mesh-ancestor
19466173|NCT03307590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19466174|NCT03307590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19466175|NCT03307590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19466176|NCT03307590|Adrenergic Agents|adrenergic agents|mesh-ancestor
19466177|NCT03307590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19466178|NCT03307590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466179|NCT03307551|Propofol|propofol|mesh-list
19466180|NCT03307551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19466181|NCT03307551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466182|NCT03307551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466183|NCT03307551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19466184|NCT03307551|Anesthetics, General|anesthetics, general|mesh-ancestor
19466185|NCT03307551|Anesthetics|anesthetics|mesh-ancestor
19466186|NCT03307512|Insulin|insulin|mesh-list
19466187|NCT03307512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
19466188|NCT03307512|Insulin Lispro|insulin lispro|mesh-list
19466189|NCT03307512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19466190|NCT03307512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466191|NCT03307213|Sirolimus|sirolimus|mesh-list
19466192|NCT03307213|Umirolimus|umirolimus|mesh-list
19466193|NCT03307213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19466194|NCT03307213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19466195|NCT03307213|Immunologic Factors|immunologic factors|mesh-ancestor
19466196|NCT03307213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466197|NCT03307213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19466198|NCT03307213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19466199|NCT03307213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19466200|NCT03307213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466201|NCT03307213|Antifungal Agents|antifungal agents|mesh-ancestor
19466202|NCT03307148|Gemcitabine|gemcitabine|mesh-list
19466203|NCT03307148|Paclitaxel|paclitaxel|mesh-list
19466204|NCT03307148|Tretinoin|tretinoin|mesh-list
19466205|NCT03307148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19466206|NCT03307148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466207|NCT03307148|Tubulin Modulators|tubulin modulators|mesh-ancestor
19466208|NCT03307148|Antimitotic Agents|antimitotic agents|mesh-ancestor
19466209|NCT03307148|Mitosis Modulators|mitosis modulators|mesh-ancestor
19466210|NCT03307148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466211|NCT03307148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19466212|NCT03307148|Antimetabolites|antimetabolites|mesh-ancestor
19466213|NCT03307148|Antiviral Agents|antiviral agents|mesh-ancestor
19466214|NCT03307148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19466215|NCT03307148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19466216|NCT03307148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19466217|NCT03307148|Immunologic Factors|immunologic factors|mesh-ancestor
19466218|NCT03307148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466219|NCT03307148|Keratolytic Agents|keratolytic agents|mesh-ancestor
19466220|NCT03307148|Dermatologic Agents|dermatologic agents|mesh-ancestor
19466221|NCT03306940|Botulinum Toxins|botulinum toxins|mesh-list
19466222|NCT03306940|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19466223|NCT03306940|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19466224|NCT03306940|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19466225|NCT03306940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19466226|NCT03306940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466227|NCT03306940|Cholinergic Agents|cholinergic agents|mesh-ancestor
19466228|NCT03306940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19466229|NCT03306940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466230|NCT03306940|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19466231|NCT03306940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466232|NCT03306914|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
19466233|NCT03306914|Plasma Substitutes|plasma substitutes|mesh-ancestor
19466234|NCT03306914|Blood Substitutes|blood substitutes|mesh-ancestor
19466235|NCT03306836|Heparin|heparin|mesh-list
19466236|NCT03306836|Calcium heparin|calcium heparin|mesh-list
19466237|NCT03306836|Anticoagulants|anticoagulants|mesh-ancestor
19466238|NCT03306836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19466239|NCT03306836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19466240|NCT03306836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466241|NCT03306745|Folic Acid|folic acid|mesh-list
19466242|NCT03306745|Hematinics|hematinics|mesh-ancestor
19466243|NCT03306745|Vitamin B Complex|vitamin b complex|mesh-ancestor
19466244|NCT03306745|Vitamins|vitamins|mesh-ancestor
19466245|NCT03306745|Micronutrients|micronutrients|mesh-ancestor
19466246|NCT03306745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466247|NCT03306732|Thiamine|thiamine|mesh-list
19466248|NCT03306732|Vitamin B Complex|vitamin b complex|mesh-ancestor
19466249|NCT03306732|Vitamins|vitamins|mesh-ancestor
19466250|NCT03306732|Micronutrients|micronutrients|mesh-ancestor
19466251|NCT03306732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466252|NCT03306667|Dotinurad|dotinurad|mesh-list
19466253|NCT03306667|Uricosuric Agents|uricosuric agents|mesh-ancestor
19466254|NCT03306667|Gout Suppressants|gout suppressants|mesh-ancestor
19466255|NCT03306667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19466256|NCT03306667|Renal Agents|renal agents|mesh-ancestor
19466257|NCT03306602|Z 350|z 350|mesh-list
19466258|NCT03306602|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
19466259|NCT03306602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19466260|NCT03306602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19466261|NCT03306602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466262|NCT03306602|Hormone Antagonists|hormone antagonists|mesh-ancestor
19466263|NCT03306602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19466264|NCT03306602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466265|NCT03306550|Aspirin|aspirin|mesh-list
19466266|NCT03306550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19466267|NCT03306550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19466268|NCT03306550|Analgesics|analgesics|mesh-ancestor
19466269|NCT03306550|Sensory System Agents|sensory system agents|mesh-ancestor
19466270|NCT03306550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466271|NCT03306550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466272|NCT03306550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19466273|NCT03306550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19466274|NCT03306550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19466275|NCT03306550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19466276|NCT03306550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466277|NCT03306550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19466278|NCT03306550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19466279|NCT03306550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19466280|NCT03306550|Antipyretics|antipyretics|mesh-ancestor
19466281|NCT03306472|Letrozole|letrozole|mesh-list
19466282|NCT03306472|Megestrol|megestrol|mesh-list
19466283|NCT03306472|Megestrol Acetate|megestrol acetate|mesh-list
19466284|NCT03306472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466285|NCT03306472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19466286|NCT03306472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19466287|NCT03306472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19466288|NCT03306472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466289|NCT03306472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19466290|NCT03306472|Hormone Antagonists|hormone antagonists|mesh-ancestor
19466291|NCT03306472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19466292|NCT03306472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466293|NCT03306472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19466294|NCT03306472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19466295|NCT03306472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19466296|NCT03306472|Contraceptive Agents|contraceptive agents|mesh-ancestor
20012749|NCT02390050|Bexagliflozin|bexagliflozin|mesh-list
19466297|NCT03306472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19466298|NCT03306472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19466299|NCT03306472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19466300|NCT03306472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19466301|NCT03306472|Appetite Stimulants|appetite stimulants|mesh-ancestor
19466302|NCT03306472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19466303|NCT03306446|Adalimumab|adalimumab|mesh-list
19466304|NCT03306446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19466305|NCT03306446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19466306|NCT03306368|Analgesics, Opioid|analgesics, opioid|mesh-list
19466307|NCT03306368|Narcotics|narcotics|mesh-ancestor
19466308|NCT03306368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466309|NCT03306368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466310|NCT03306368|Analgesics|analgesics|mesh-ancestor
19466311|NCT03306368|Sensory System Agents|sensory system agents|mesh-ancestor
19466312|NCT03306368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466313|NCT03306290|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19466314|NCT03306290|Cefoxitin|cefoxitin|mesh-list
19466315|NCT03306290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19466316|NCT03306264|Decitabine|decitabine|mesh-list
19466317|NCT03306264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19466318|NCT03306264|Antimetabolites|antimetabolites|mesh-ancestor
19466319|NCT03306264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466320|NCT03306264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466321|NCT03306264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19466322|NCT03306212|Botulinum Toxins|botulinum toxins|mesh-list
19466323|NCT03306212|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19466324|NCT03306212|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19466325|NCT03306212|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19466326|NCT03306212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19466327|NCT03306212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466328|NCT03306212|Cholinergic Agents|cholinergic agents|mesh-ancestor
19466329|NCT03306212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19466330|NCT03306212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466331|NCT03306212|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19466332|NCT03306212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012750|NCT02390050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20012751|NCT02390050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466333|NCT03305978|Ivermectin|ivermectin|mesh-list
19466334|NCT03305978|Selamectin|selamectin|mesh-list
19466335|NCT03305978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19466336|NCT03305978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19466337|NCT03305536|Vitamin D|vitamin d|mesh-list
19466338|NCT03305536|Vitamins|vitamins|mesh-list
19466339|NCT03305536|Vitamin K|vitamin k|mesh-list
19466340|NCT03305536|Vitamin K 2|vitamin k 2|mesh-list
19466341|NCT03305536|Vitamin MK 7|vitamin mk 7|mesh-list
19466342|NCT03305536|Micronutrients|micronutrients|mesh-ancestor
19466343|NCT03305536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466344|NCT03305536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19466345|NCT03305536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
19466346|NCT03305536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20012752|NCT02390219|Ivacaftor|ivacaftor|mesh-list
20012753|NCT02390219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20012754|NCT02390219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20012755|NCT02390219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012756|NCT02391337|Digoxin|digoxin|mesh-list
20012757|NCT02391337|Bisoprolol|bisoprolol|mesh-list
20012758|NCT02391337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20012759|NCT02391337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20012760|NCT02391337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19466347|NCT03305536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466348|NCT03305536|Hemostatics|hemostatics|mesh-ancestor
19466349|NCT03305536|Coagulants|coagulants|mesh-ancestor
19466350|NCT03305510|Vitamin D|vitamin d|mesh-list
19466351|NCT03305510|Vitamins|vitamins|mesh-ancestor
19466352|NCT03305510|Micronutrients|micronutrients|mesh-ancestor
19466353|NCT03305510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466354|NCT03305510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19466355|NCT03305471|Sevelamer|sevelamer|mesh-list
19466356|NCT03305471|Chelating Agents|chelating agents|mesh-ancestor
19466357|NCT03305471|Sequestering Agents|sequestering agents|mesh-ancestor
19466358|NCT03305471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466359|NCT03305445|Nivolumab|nivolumab|mesh-list
20012761|NCT02391337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012762|NCT02391337|Protective Agents|protective agents|mesh-ancestor
20012763|NCT02391337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012764|NCT02391337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20012765|NCT02391337|Sympatholytics|sympatholytics|mesh-ancestor
20012766|NCT02391337|Autonomic Agents|autonomic agents|mesh-ancestor
20012767|NCT02391337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012768|NCT02391337|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20012769|NCT02391337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20012770|NCT02391337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20012771|NCT02391337|Adrenergic Agents|adrenergic agents|mesh-ancestor
20012772|NCT02391337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20012773|NCT02391545|Rituximab|rituximab|mesh-list
20012774|NCT02391545|Obinutuzumab|obinutuzumab|mesh-list
20012775|NCT02391545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20012776|NCT02391545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012777|NCT02391545|Immunologic Factors|immunologic factors|mesh-ancestor
20012778|NCT02391545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012779|NCT02391545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20012780|NCT02391714|Chlorhexidine|chlorhexidine|mesh-list
20012781|NCT02391714|Povidone-Iodine|povidone-iodine|mesh-list
20012782|NCT02391714|Nitrous Oxide|nitrous oxide|mesh-list
20012783|NCT02391714|Povidone|povidone|mesh-list
20012784|NCT02391714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20012785|NCT02391714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20012786|NCT02391714|Disinfectants|disinfectants|mesh-ancestor
20012787|NCT02391714|Plasma Substitutes|plasma substitutes|mesh-ancestor
20012788|NCT02391714|Blood Substitutes|blood substitutes|mesh-ancestor
20012789|NCT02391714|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20012790|NCT02391714|Anesthetics, General|anesthetics, general|mesh-ancestor
20012791|NCT02391714|Anesthetics|anesthetics|mesh-ancestor
20012792|NCT02391714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20012793|NCT02391714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012794|NCT02391714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20012795|NCT02391714|Analgesics|analgesics|mesh-ancestor
20012796|NCT02391714|Sensory System Agents|sensory system agents|mesh-ancestor
20012797|NCT02391714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012798|NCT02391961|4-Aminopyridine|4-aminopyridine|mesh-list
20012799|NCT02391961|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19466360|NCT03305445|Ipilimumab|ipilimumab|mesh-list
19466361|NCT03305445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19466362|NCT03305445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466363|NCT03305445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19466364|NCT03305445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466365|NCT03305263|Hydroxychloroquine|hydroxychloroquine|mesh-list
19466366|NCT03305263|Antimalarials|antimalarials|mesh-ancestor
19466367|NCT03305263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19466368|NCT03305263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19466369|NCT03305263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19466370|NCT03305263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19466371|NCT03305263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466372|NCT03305263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19466373|NCT03305068|Celecoxib|celecoxib|mesh-list
19466374|NCT03305068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19466375|NCT03305068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19466376|NCT03305068|Analgesics|analgesics|mesh-ancestor
19466377|NCT03305068|Sensory System Agents|sensory system agents|mesh-ancestor
19466378|NCT03305068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466379|NCT03305068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466380|NCT03305068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19466381|NCT03305068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19466382|NCT03305068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
19466383|NCT03305068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19466384|NCT03305068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19466385|NCT03305068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466386|NCT03304652|Zaleplon|zaleplon|mesh-list
19466387|NCT03304652|Anticonvulsants|anticonvulsants|mesh-ancestor
19466388|NCT03304652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19466389|NCT03304652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466390|NCT03304652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466391|NCT03304652|GABA Modulators|gaba modulators|mesh-ancestor
19466392|NCT03304652|GABA Agents|gaba agents|mesh-ancestor
19466393|NCT03304652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19466394|NCT03304652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466395|NCT03304496|Nitroglycerin|nitroglycerin|mesh-list
19466396|NCT03304496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19466397|NCT03304496|Vasodilator Agents|vasodilator agents|mesh-ancestor
19466398|NCT03304457|Olanzapine|olanzapine|mesh-list
19466399|NCT03304457|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
19466400|NCT03304457|Antiemetics|antiemetics|mesh-ancestor
19466401|NCT03304457|Autonomic Agents|autonomic agents|mesh-ancestor
19466402|NCT03304457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466403|NCT03304457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466404|NCT03304457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19466405|NCT03304457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19466406|NCT03304457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19466407|NCT03304457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466408|NCT03304457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19466409|NCT03304457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19466410|NCT03304457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19466411|NCT03304457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19466412|NCT03304457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466413|NCT03304457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19466414|NCT03304457|Serotonin Agents|serotonin agents|mesh-ancestor
19466415|NCT03304457|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19466416|NCT03304457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19466417|NCT03304457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19466418|NCT03304457|Adrenergic Agents|adrenergic agents|mesh-ancestor
19466419|NCT03304457|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19466420|NCT03304457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19466421|NCT03304457|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
19466422|NCT03304457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
19466423|NCT03304457|Dopamine Agents|dopamine agents|mesh-ancestor
19466424|NCT03304444|Bupivacaine|bupivacaine|mesh-list
19466425|NCT03304444|Anesthetics, Local|anesthetics, local|mesh-ancestor
19466426|NCT03304444|Anesthetics|anesthetics|mesh-ancestor
19466427|NCT03304444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466428|NCT03304444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466429|NCT03304444|Sensory System Agents|sensory system agents|mesh-ancestor
19466430|NCT03304444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466431|NCT03304431|Lidocaine|lidocaine|mesh-list
19466432|NCT03304431|Anesthetics, Local|anesthetics, local|mesh-ancestor
19466433|NCT03304431|Anesthetics|anesthetics|mesh-ancestor
19466434|NCT03304431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466435|NCT03304431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466436|NCT03304431|Sensory System Agents|sensory system agents|mesh-ancestor
19466437|NCT03304431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466438|NCT03304431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19466439|NCT03304431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19466440|NCT03304431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19466441|NCT03304431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19466442|NCT03304431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466443|NCT03304418|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
19466444|NCT03304418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012800|NCT02391961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20012801|NCT02391961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012802|NCT02392104|Warfarin|warfarin|mesh-list
20012803|NCT02392104|Anticoagulants|anticoagulants|mesh-ancestor
20012804|NCT02392208|Telavancin|telavancin|mesh-list
20012805|NCT02392208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20012806|NCT02392208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20012807|NCT02392234|Ivacaftor|ivacaftor|mesh-list
20012808|NCT02392234|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20012809|NCT02392234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20012810|NCT02392234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012811|NCT02392286|Prednisone|prednisone|mesh-list
20012812|NCT02392286|Methylprednisolone|methylprednisolone|mesh-list
20012813|NCT02392286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20012814|NCT02392286|Glucocorticoids|glucocorticoids|mesh-ancestor
20012815|NCT02392286|Hormones|hormones|mesh-ancestor
20012816|NCT02392286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20012817|NCT02392286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012818|NCT02392286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20012819|NCT02392286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012820|NCT02392286|Antiemetics|antiemetics|mesh-ancestor
20012821|NCT02392286|Autonomic Agents|autonomic agents|mesh-ancestor
20012822|NCT02392286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012823|NCT02392286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20012824|NCT02392286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20012825|NCT02392286|Protective Agents|protective agents|mesh-ancestor
20012826|NCT02392507|Paclitaxel|paclitaxel|mesh-list
20012827|NCT02392507|Carboplatin|carboplatin|mesh-list
20012828|NCT02392507|Necitumumab|necitumumab|mesh-list
20012829|NCT02392507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20012830|NCT02392507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012831|NCT02392507|Tubulin Modulators|tubulin modulators|mesh-ancestor
20012832|NCT02392507|Antimitotic Agents|antimitotic agents|mesh-ancestor
20012833|NCT02392507|Mitosis Modulators|mitosis modulators|mesh-ancestor
20012834|NCT02392507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012835|NCT02392507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20012836|NCT02392559|Evolocumab|evolocumab|mesh-list
20012837|NCT02392559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20012838|NCT02392559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20012839|NCT02392559|Antimetabolites|antimetabolites|mesh-ancestor
20012840|NCT02392559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012841|NCT02392559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20012842|NCT02392611|Fulvestrant|fulvestrant|mesh-list
20012843|NCT02392611|Exemestane|exemestane|mesh-list
20012844|NCT02392611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20012845|NCT02392611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012846|NCT02392611|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20012847|NCT02392611|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20012848|NCT02392611|Hormone Antagonists|hormone antagonists|mesh-ancestor
20012849|NCT02392611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20012850|NCT02392611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012851|NCT02392611|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20012852|NCT02392611|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20012853|NCT02392611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012854|NCT02392611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012855|NCT02392624|Omalizumab|omalizumab|mesh-list
20012856|NCT02392624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20012857|NCT02392624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20012858|NCT02392624|Respiratory System Agents|respiratory system agents|mesh-ancestor
20012859|NCT02393209|Docetaxel|docetaxel|mesh-list
20012860|NCT02393209|Serabelisib|serabelisib|mesh-list
20012861|NCT02393209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012862|NCT02393209|Tubulin Modulators|tubulin modulators|mesh-ancestor
20012863|NCT02393209|Antimitotic Agents|antimitotic agents|mesh-ancestor
20012864|NCT02393209|Mitosis Modulators|mitosis modulators|mesh-ancestor
20012865|NCT02393209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012866|NCT02393209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012867|NCT02393339|Acetaminophen|acetaminophen|mesh-list
19466445|NCT03304288|Rituximab|rituximab|mesh-list
19466446|NCT03304288|Tretinoin|tretinoin|mesh-list
19466447|NCT03304288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19466448|NCT03304288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466449|NCT03304288|Immunologic Factors|immunologic factors|mesh-ancestor
19466450|NCT03304288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466451|NCT03304288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19466452|NCT03304288|Keratolytic Agents|keratolytic agents|mesh-ancestor
19466453|NCT03304288|Dermatologic Agents|dermatologic agents|mesh-ancestor
19466454|NCT03304210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
19466455|NCT03304210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466456|NCT03304093|Nivolumab|nivolumab|mesh-list
19466457|NCT03304093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19466458|NCT03304093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466459|NCT03304093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19466460|NCT03304093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466461|NCT03304080|Trastuzumab|trastuzumab|mesh-list
19466462|NCT03304080|Pertuzumab|pertuzumab|mesh-list
19466463|NCT03304080|Palbociclib|palbociclib|mesh-list
19466464|NCT03304080|Anastrozole|anastrozole|mesh-list
19466465|NCT03304080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19466466|NCT03304080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466467|NCT03304080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19466468|NCT03304080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19466469|NCT03304080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466470|NCT03304080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19466471|NCT03304080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
19466472|NCT03304080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19466473|NCT03304080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
19466474|NCT03304080|Hormone Antagonists|hormone antagonists|mesh-ancestor
19466475|NCT03304080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19466476|NCT03304080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466477|NCT03303976|Vaccines|vaccines|mesh-list
19466478|NCT03303976|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
19466479|NCT03303976|Immunologic Factors|immunologic factors|mesh-ancestor
19466480|NCT03303976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466481|NCT03303924|Sulbactam|sulbactam|mesh-list
19466482|NCT03303924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19466483|NCT03303924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19466484|NCT03303924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19466485|NCT03303924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19466486|NCT03303924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466487|NCT03303677|Vancomycin|vancomycin|mesh-list
19466488|NCT03303677|Ciprofloxacin|ciprofloxacin|mesh-list
19466489|NCT03303677|Gentamicins|gentamicins|mesh-list
19466490|NCT03303677|Mupirocin|mupirocin|mesh-list
19466491|NCT03303677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
19466492|NCT03303677|Trimethoprim|trimethoprim|mesh-list
19466493|NCT03303677|Sulfamethoxazole|sulfamethoxazole|mesh-list
19466494|NCT03303677|Budesonide|budesonide|mesh-list
19466495|NCT03303677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19466496|NCT03303677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19466497|NCT03303677|Autonomic Agents|autonomic agents|mesh-ancestor
19466498|NCT03303677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466499|NCT03303677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466500|NCT03303677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19466501|NCT03303677|Respiratory System Agents|respiratory system agents|mesh-ancestor
19466502|NCT03303677|Glucocorticoids|glucocorticoids|mesh-ancestor
19466503|NCT03303677|Hormones|hormones|mesh-ancestor
19466504|NCT03303677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19466505|NCT03303677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19466506|NCT03303677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19466507|NCT03303677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19466508|NCT03303677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19466509|NCT03303677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466510|NCT03303677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466511|NCT03303677|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19466512|NCT03303677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19466513|NCT03303677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19466514|NCT03303677|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19466515|NCT03303677|Renal Agents|renal agents|mesh-ancestor
19466516|NCT03303677|Antimalarials|antimalarials|mesh-ancestor
19466517|NCT03303677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19466518|NCT03303677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19466519|NCT03303677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
19466520|NCT03303677|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
19466521|NCT03303677|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
19466522|NCT03303651|Analgesics, Opioid|analgesics, opioid|mesh-list
19466523|NCT03303651|Narcotics|narcotics|mesh-ancestor
19466524|NCT03303651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466525|NCT03303651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466526|NCT03303651|Analgesics|analgesics|mesh-ancestor
19466527|NCT03303651|Sensory System Agents|sensory system agents|mesh-ancestor
19466528|NCT03303651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466529|NCT03303573|Epoetin Alfa|epoetin alfa|mesh-list
19466530|NCT03303573|Hematinics|hematinics|mesh-ancestor
19466531|NCT03303495|Leucovorin|leucovorin|mesh-list
19466532|NCT03303495|Bevacizumab|bevacizumab|mesh-list
19466533|NCT03303495|Fluorouracil|fluorouracil|mesh-list
19466534|NCT03303495|Irinotecan|irinotecan|mesh-list
19466535|NCT03303495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19466536|NCT03303495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466537|NCT03303495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
19466538|NCT03303495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
19466539|NCT03303495|Growth Substances|growth substances|mesh-ancestor
19466540|NCT03303495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466541|NCT03303495|Growth Inhibitors|growth inhibitors|mesh-ancestor
19466542|NCT03303495|Antimetabolites|antimetabolites|mesh-ancestor
19466543|NCT03303495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466544|NCT03303495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19466545|NCT03303495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19466546|NCT03303495|Immunologic Factors|immunologic factors|mesh-ancestor
19466547|NCT03303495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19466548|NCT03303495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19466549|NCT03303495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19466550|NCT03303495|Antidotes|antidotes|mesh-ancestor
19466551|NCT03303495|Protective Agents|protective agents|mesh-ancestor
19466552|NCT03303495|Vitamin B Complex|vitamin b complex|mesh-ancestor
19466553|NCT03303495|Vitamins|vitamins|mesh-ancestor
19466554|NCT03303495|Micronutrients|micronutrients|mesh-ancestor
19466555|NCT03303378|Melatonin|melatonin|mesh-list
19466556|NCT03303378|Antioxidants|antioxidants|mesh-ancestor
19466557|NCT03303378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466558|NCT03303378|Protective Agents|protective agents|mesh-ancestor
19466559|NCT03303378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466560|NCT03303378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466561|NCT03303235|Methylergonovine|methylergonovine|mesh-list
19466562|NCT03303235|Oxytocics|oxytocics|mesh-ancestor
19466563|NCT03303235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19466564|NCT03303235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466565|NCT03303209|Analgesics, Opioid|analgesics, opioid|mesh-list
19466566|NCT03303209|Narcotics|narcotics|mesh-ancestor
19466567|NCT03303209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466568|NCT03303209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466569|NCT03303209|Analgesics|analgesics|mesh-ancestor
19466570|NCT03303209|Sensory System Agents|sensory system agents|mesh-ancestor
19466571|NCT03303209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466572|NCT03303053|Prednisolone|prednisolone|mesh-list
19466573|NCT03303053|Cholestyramine Resin|cholestyramine resin|mesh-list
19466574|NCT03303053|Carbimazole|carbimazole|mesh-list
19466575|NCT03303053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19466576|NCT03303053|Glucocorticoids|glucocorticoids|mesh-ancestor
19466577|NCT03303053|Hormones|hormones|mesh-ancestor
19466578|NCT03303053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19466579|NCT03303053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466580|NCT03303053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19466581|NCT03303053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466582|NCT03303053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
19466583|NCT03303053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19466584|NCT03303053|Antimetabolites|antimetabolites|mesh-ancestor
19466585|NCT03303053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466586|NCT03303053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19466587|NCT03303053|Antithyroid Agents|antithyroid agents|mesh-ancestor
19466588|NCT03303053|Hormone Antagonists|hormone antagonists|mesh-ancestor
19466589|NCT03302871|Botulinum Toxins|botulinum toxins|mesh-list
19466590|NCT03302871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19466591|NCT03302871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19466592|NCT03302871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19466593|NCT03302871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19466594|NCT03302871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466595|NCT03302871|Cholinergic Agents|cholinergic agents|mesh-ancestor
19466596|NCT03302871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19466597|NCT03302871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466598|NCT03302871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19466599|NCT03302871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466600|NCT03302845|Omeprazole|omeprazole|mesh-list
19466601|NCT03302845|Famotidine|famotidine|mesh-list
19466602|NCT03302845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
19466603|NCT03302845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19466604|NCT03302845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
19466605|NCT03302845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19466606|NCT03302845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466607|NCT03302845|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
19466608|NCT03302845|Histamine Antagonists|histamine antagonists|mesh-ancestor
19466609|NCT03302845|Histamine Agents|histamine agents|mesh-ancestor
19466610|NCT03302845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19466611|NCT03302845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466612|NCT03302754|Alemtuzumab|alemtuzumab|mesh-list
19466613|NCT03302754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19466614|NCT03302754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466615|NCT03302689|Ropivacaine|ropivacaine|mesh-list
19466616|NCT03302689|Levobupivacaine|levobupivacaine|mesh-list
19466617|NCT03302689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19466618|NCT03302689|Anesthetics, Local|anesthetics, local|mesh-ancestor
19466619|NCT03302689|Anesthetics|anesthetics|mesh-ancestor
19466620|NCT03302689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466621|NCT03302689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466622|NCT03302689|Sensory System Agents|sensory system agents|mesh-ancestor
19466623|NCT03302689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466624|NCT03302650|Norepinephrine|norepinephrine|mesh-list
19466625|NCT03302650|Angiotensin II|angiotensin ii|mesh-list
19466626|NCT03302650|Giapreza|giapreza|mesh-list
19466627|NCT03302650|Angiotensinogen|angiotensinogen|mesh-list
19466628|NCT03302650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19466629|NCT03302650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19466630|NCT03302650|Adrenergic Agents|adrenergic agents|mesh-ancestor
19466631|NCT03302650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19466632|NCT03302650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466633|NCT03302650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466634|NCT03302650|Sympathomimetics|sympathomimetics|mesh-ancestor
19466635|NCT03302650|Autonomic Agents|autonomic agents|mesh-ancestor
19466636|NCT03302650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466637|NCT03302650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19466638|NCT03302650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19466639|NCT03302650|Protease Inhibitors|protease inhibitors|mesh-ancestor
19466640|NCT03302650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012868|NCT02393339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20012869|NCT02393339|Analgesics|analgesics|mesh-ancestor
20012870|NCT02393339|Sensory System Agents|sensory system agents|mesh-ancestor
20012871|NCT02393339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012872|NCT02393339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012873|NCT02393339|Antipyretics|antipyretics|mesh-ancestor
20012874|NCT02393378|Folic Acid|folic acid|mesh-list
20012875|NCT02393378|Adalimumab|adalimumab|mesh-list
20012876|NCT02393378|Methotrexate|methotrexate|mesh-list
20012877|NCT02393378|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20012878|NCT02393378|Abortifacient Agents|abortifacient agents|mesh-ancestor
20012879|NCT02393378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20012880|NCT02393378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012881|NCT02393378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20012882|NCT02393378|Antimetabolites|antimetabolites|mesh-ancestor
20012883|NCT02393378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012884|NCT02393378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012885|NCT02393378|Dermatologic Agents|dermatologic agents|mesh-ancestor
20012886|NCT02393378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012887|NCT02393378|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20012888|NCT02393378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20012889|NCT02393378|Immunologic Factors|immunologic factors|mesh-ancestor
20012890|NCT02393378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20012891|NCT02393378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20012892|NCT02393378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20012893|NCT02393378|Hematinics|hematinics|mesh-ancestor
20012894|NCT02393378|Vitamin B Complex|vitamin b complex|mesh-ancestor
20012895|NCT02393378|Vitamins|vitamins|mesh-ancestor
20012896|NCT02393378|Micronutrients|micronutrients|mesh-ancestor
20012897|NCT02393547|Varenicline|varenicline|mesh-list
20012898|NCT02393547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20012899|NCT02393547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
19466641|NCT03302585|Vitamin D|vitamin d|mesh-list
19466642|NCT03302585|Ergocalciferols|ergocalciferols|mesh-list
19466643|NCT03302585|Cholecalciferol|cholecalciferol|mesh-list
19466644|NCT03302585|Vitamins|vitamins|mesh-list
19466645|NCT03302585|Micronutrients|micronutrients|mesh-ancestor
19466646|NCT03302585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466647|NCT03302585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19466648|NCT03302585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19466649|NCT03302403|Cyclophosphamide|cyclophosphamide|mesh-list
19466650|NCT03302403|Fludarabine|fludarabine|mesh-list
19466651|NCT03302403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19466652|NCT03302403|Immunologic Factors|immunologic factors|mesh-ancestor
19466653|NCT03302403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466654|NCT03302403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19466655|NCT03302403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19466656|NCT03302403|Alkylating Agents|alkylating agents|mesh-ancestor
19466657|NCT03302403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466658|NCT03302403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466659|NCT03302403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19466660|NCT03302390|Lidocaine|lidocaine|mesh-list
19466661|NCT03302390|Epinephrine|epinephrine|mesh-list
19466662|NCT03302390|Anesthetics, Local|anesthetics, local|mesh-ancestor
19466663|NCT03302390|Anesthetics|anesthetics|mesh-ancestor
19466664|NCT03302390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466665|NCT03302390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466666|NCT03302390|Sensory System Agents|sensory system agents|mesh-ancestor
19466667|NCT03302390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466668|NCT03302390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19466669|NCT03302390|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19466670|NCT03302390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19466671|NCT03302390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19466672|NCT03302390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466673|NCT03302390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19466674|NCT03302390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19466675|NCT03302390|Adrenergic Agents|adrenergic agents|mesh-ancestor
19466676|NCT03302390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19466677|NCT03302390|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19466678|NCT03302390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19466679|NCT03302390|Autonomic Agents|autonomic agents|mesh-ancestor
19466680|NCT03302390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19466681|NCT03302390|Respiratory System Agents|respiratory system agents|mesh-ancestor
19466682|NCT03302390|Mydriatics|mydriatics|mesh-ancestor
19466683|NCT03302390|Sympathomimetics|sympathomimetics|mesh-ancestor
19466684|NCT03302390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19466685|NCT03302364|Risperidone|risperidone|mesh-list
19466686|NCT03302364|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19466687|NCT03302364|Serotonin Agents|serotonin agents|mesh-ancestor
19466688|NCT03302364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19466689|NCT03302364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466690|NCT03302364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466691|NCT03302364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
19466692|NCT03302364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19466693|NCT03302364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466694|NCT03302364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19466695|NCT03302364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20012900|NCT02393547|Cholinergic Agents|cholinergic agents|mesh-ancestor
20012901|NCT02393547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20012902|NCT02393547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012903|NCT02393547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012904|NCT02393677|Dexmedetomidine|dexmedetomidine|mesh-list
20012905|NCT02393677|Ropivacaine|ropivacaine|mesh-list
20012906|NCT02393677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20012907|NCT02393677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20012908|NCT02393677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012909|NCT02393677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20012910|NCT02393677|Analgesics|analgesics|mesh-ancestor
20012911|NCT02393677|Sensory System Agents|sensory system agents|mesh-ancestor
20012912|NCT02393677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012913|NCT02393677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20012914|NCT02393677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20012915|NCT02393677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20012916|NCT02393677|Adrenergic Agents|adrenergic agents|mesh-ancestor
20012917|NCT02393677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20012918|NCT02393677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466696|NCT03302364|Dopamine Agents|dopamine agents|mesh-ancestor
19466697|NCT03302351|Dexmedetomidine|dexmedetomidine|mesh-list
19466698|NCT03302351|Ketamine|ketamine|mesh-list
19466699|NCT03302351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19466700|NCT03302351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466701|NCT03302351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466702|NCT03302351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19466703|NCT03302351|Analgesics|analgesics|mesh-ancestor
19466704|NCT03302351|Sensory System Agents|sensory system agents|mesh-ancestor
19466705|NCT03302351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466706|NCT03302351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19466707|NCT03302351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19466708|NCT03302351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19466709|NCT03302351|Adrenergic Agents|adrenergic agents|mesh-ancestor
19466710|NCT03302351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19466711|NCT03302351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466712|NCT03302351|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
19466713|NCT03302351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19466714|NCT03302351|Anesthetics, General|anesthetics, general|mesh-ancestor
19466715|NCT03302351|Anesthetics|anesthetics|mesh-ancestor
19466716|NCT03302351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
19466717|NCT03302351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
19466718|NCT03302299|Pyridoxine|pyridoxine|mesh-list
19466719|NCT03302299|Vitamin B 6|vitamin b 6|mesh-list
19466720|NCT03302299|Isoniazid|isoniazid|mesh-list
19466721|NCT03302299|Vitamins|vitamins|mesh-ancestor
19466722|NCT03302299|Micronutrients|micronutrients|mesh-ancestor
19466723|NCT03302299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466724|NCT03302299|Vitamin B Complex|vitamin b complex|mesh-ancestor
19466725|NCT03302299|Antitubercular Agents|antitubercular agents|mesh-ancestor
19466726|NCT03302299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19466727|NCT03302299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19466728|NCT03302299|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
19466729|NCT03302299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
19466730|NCT03302299|Antimetabolites|antimetabolites|mesh-ancestor
19466731|NCT03302299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466732|NCT03302299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
19466733|NCT03302221|Ropivacaine|ropivacaine|mesh-list
19466734|NCT03302221|Anesthetics|anesthetics|mesh-ancestor
19466735|NCT03302221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466736|NCT03302221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466737|NCT03302221|Anesthetics, Local|anesthetics, local|mesh-ancestor
19466738|NCT03302221|Sensory System Agents|sensory system agents|mesh-ancestor
19466739|NCT03302221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466740|NCT03302208|Pregabalin|pregabalin|mesh-list
19466741|NCT03302208|Analgesics|analgesics|mesh-ancestor
19466742|NCT03302208|Sensory System Agents|sensory system agents|mesh-ancestor
19466743|NCT03302208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466744|NCT03302208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466745|NCT03302208|Anticonvulsants|anticonvulsants|mesh-ancestor
19466746|NCT03302208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19466747|NCT03302208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19466748|NCT03302208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466749|NCT03302208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19466750|NCT03302208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19466751|NCT03302208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19466752|NCT03302208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466753|NCT03302208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19466754|NCT03302195|Heparin|heparin|mesh-list
19466755|NCT03302195|Anticoagulants|anticoagulants|mesh-ancestor
19466756|NCT03302195|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19466757|NCT03302195|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19466758|NCT03302195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466759|NCT03302182|Ritonavir|ritonavir|mesh-list
19466760|NCT03302182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19466761|NCT03302182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19466762|NCT03302182|Protease Inhibitors|protease inhibitors|mesh-ancestor
19466763|NCT03302182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19466764|NCT03302182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466765|NCT03302182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19466766|NCT03302182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19466767|NCT03302182|Antiviral Agents|antiviral agents|mesh-ancestor
19466768|NCT03302182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19466769|NCT03302182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19466770|NCT03302182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19466771|NCT03302065|Tiotropium Bromide|tiotropium bromide|mesh-list
19466772|NCT03302065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19466773|NCT03302065|Autonomic Agents|autonomic agents|mesh-ancestor
19466774|NCT03302065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466775|NCT03302065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466776|NCT03302065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19466777|NCT03302065|Respiratory System Agents|respiratory system agents|mesh-ancestor
19466778|NCT03302065|Parasympatholytics|parasympatholytics|mesh-ancestor
19466779|NCT03302065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19466780|NCT03302065|Cholinergic Agents|cholinergic agents|mesh-ancestor
19466781|NCT03302065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19466782|NCT03302065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466783|NCT03302039|Phenylephrine|phenylephrine|mesh-list
19466784|NCT03302039|Oxymetazoline|oxymetazoline|mesh-list
19466785|NCT03302039|Bupivacaine|bupivacaine|mesh-list
19466786|NCT03302039|Anesthetics, Local|anesthetics, local|mesh-ancestor
19466787|NCT03302039|Anesthetics|anesthetics|mesh-ancestor
19466788|NCT03302039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466789|NCT03302039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466790|NCT03302039|Sensory System Agents|sensory system agents|mesh-ancestor
19466791|NCT03302039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466792|NCT03302039|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19466793|NCT03302039|Mydriatics|mydriatics|mesh-ancestor
19466794|NCT03302039|Autonomic Agents|autonomic agents|mesh-ancestor
20012919|NCT02393677|Anesthetics, Local|anesthetics, local|mesh-ancestor
20012920|NCT02393677|Anesthetics|anesthetics|mesh-ancestor
20012921|NCT02393755|Capecitabine|capecitabine|mesh-list
20012922|NCT02393755|Nintedanib|nintedanib|mesh-list
20012923|NCT02393755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20012924|NCT02393755|Antimetabolites|antimetabolites|mesh-ancestor
20012925|NCT02393755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012926|NCT02393755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012927|NCT02393755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20012928|NCT02393755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012929|NCT02394340|Luliconazole|luliconazole|mesh-list
20012930|NCT02394340|Omeprazole|omeprazole|mesh-list
20012931|NCT02394340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20012932|NCT02394340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20012933|NCT02394340|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20012934|NCT02394340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012935|NCT02394340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012936|NCT02394340|Antifungal Agents|antifungal agents|mesh-ancestor
20012937|NCT02394340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20012938|NCT02394457|Cosyntropin|cosyntropin|mesh-list
20012939|NCT02394457|Hormones|hormones|mesh-ancestor
20012940|NCT02394457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20012941|NCT02394457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012942|NCT02394730|Vorapaxar|vorapaxar|mesh-list
20012943|NCT02394730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20012944|NCT02394769|Aspirin|aspirin|mesh-list
20012945|NCT02394769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20012946|NCT02394769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20012947|NCT02394769|Analgesics|analgesics|mesh-ancestor
20012948|NCT02394769|Sensory System Agents|sensory system agents|mesh-ancestor
20012949|NCT02394769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012950|NCT02394769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012951|NCT02394769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20012952|NCT02394769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20012953|NCT02394769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20012954|NCT02394769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20012955|NCT02394769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012956|NCT02394769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20012957|NCT02394769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20012958|NCT02394769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20012959|NCT02394769|Antipyretics|antipyretics|mesh-ancestor
20012960|NCT02394951|Pregabalin|pregabalin|mesh-list
20012961|NCT02394951|Analgesics|analgesics|mesh-ancestor
20012962|NCT02394951|Sensory System Agents|sensory system agents|mesh-ancestor
20012963|NCT02394951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20012964|NCT02394951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012965|NCT02394951|Anticonvulsants|anticonvulsants|mesh-ancestor
20012966|NCT02394951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20012967|NCT02394951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20012968|NCT02394951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012969|NCT02394951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20012970|NCT02394951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20012971|NCT02394951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20012972|NCT02394951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20012973|NCT02394951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20012974|NCT02395055|Adalimumab|adalimumab|mesh-list
20012975|NCT02395055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20012976|NCT02395055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20012977|NCT02395081|Vitamin D|vitamin d|mesh-list
20012978|NCT02395081|Ergocalciferols|ergocalciferols|mesh-list
20012979|NCT02395081|Cholecalciferol|cholecalciferol|mesh-list
20012980|NCT02395081|Vitamins|vitamins|mesh-list
20012981|NCT02395081|Micronutrients|micronutrients|mesh-ancestor
20012982|NCT02395081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20012983|NCT02395081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20012984|NCT02395081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20012985|NCT02395172|Docetaxel|docetaxel|mesh-list
20012986|NCT02395172|Avelumab|avelumab|mesh-list
20012987|NCT02395172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012988|NCT02395172|Tubulin Modulators|tubulin modulators|mesh-ancestor
20012989|NCT02395172|Antimitotic Agents|antimitotic agents|mesh-ancestor
20012990|NCT02395172|Mitosis Modulators|mitosis modulators|mesh-ancestor
20012991|NCT02395172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20012992|NCT02395172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20012993|NCT02395627|Tamoxifen|tamoxifen|mesh-list
20012994|NCT02395627|Pembrolizumab|pembrolizumab|mesh-list
20012995|NCT02395627|Vorinostat|vorinostat|mesh-list
20012996|NCT02395627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20012997|NCT02395627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20012998|NCT02395627|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20012999|NCT02395627|Hormone Antagonists|hormone antagonists|mesh-ancestor
20013000|NCT02395627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20013001|NCT02395627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013002|NCT02395627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20013003|NCT02395627|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20013004|NCT02395627|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20013005|NCT02395627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20013006|NCT02395627|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20013007|NCT02395627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20013008|NCT02395627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013009|NCT02395653|Fentanyl|fentanyl|mesh-list
20013010|NCT02395653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20013011|NCT02395653|Narcotics|narcotics|mesh-ancestor
20013012|NCT02395653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20013013|NCT02395653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013014|NCT02395653|Analgesics|analgesics|mesh-ancestor
20013015|NCT02395653|Sensory System Agents|sensory system agents|mesh-ancestor
20013016|NCT02395653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20013017|NCT02395653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20013018|NCT02395653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20013019|NCT02395653|Anesthetics, General|anesthetics, general|mesh-ancestor
20013020|NCT02395653|Anesthetics|anesthetics|mesh-ancestor
20013021|NCT02395692|Temozolomide|temozolomide|mesh-list
20013022|NCT02395692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20013023|NCT02395692|Alkylating Agents|alkylating agents|mesh-ancestor
20013024|NCT02395692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013025|NCT02395692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013026|NCT02396147|Relugolix|relugolix|mesh-list
20013027|NCT02396147|Androgen Antagonists|androgen antagonists|mesh-ancestor
20013028|NCT02396147|Hormone Antagonists|hormone antagonists|mesh-ancestor
20013029|NCT02396147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20013030|NCT02396147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013031|NCT02396316|Aflibercept|aflibercept|mesh-list
20013032|NCT02396316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20013033|NCT02396316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20013034|NCT02396316|Growth Substances|growth substances|mesh-ancestor
20013035|NCT02396316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013036|NCT02396316|Growth Inhibitors|growth inhibitors|mesh-ancestor
20013037|NCT02396316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013038|NCT02396511|Bevacizumab|bevacizumab|mesh-list
20013039|NCT02396511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20013040|NCT02396511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013041|NCT02396511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20013042|NCT02396511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20013043|NCT02396511|Growth Substances|growth substances|mesh-ancestor
20013044|NCT02396511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013045|NCT02396511|Growth Inhibitors|growth inhibitors|mesh-ancestor
20013046|NCT02396537|Lidocaine|lidocaine|mesh-list
20013047|NCT02396537|Midazolam|midazolam|mesh-list
20013048|NCT02396537|Anesthetics, Local|anesthetics, local|mesh-ancestor
20013049|NCT02396537|Anesthetics|anesthetics|mesh-ancestor
20013050|NCT02396537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20013051|NCT02396537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013052|NCT02396537|Sensory System Agents|sensory system agents|mesh-ancestor
20013053|NCT02396537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20013054|NCT02396537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20013055|NCT02396537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20013056|NCT02396537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20013057|NCT02396537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20013058|NCT02396537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013059|NCT02396537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19466795|NCT03302039|Sympathomimetics|sympathomimetics|mesh-ancestor
19466796|NCT03302039|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19466797|NCT03302039|Nasal Decongestants|nasal decongestants|mesh-ancestor
19466798|NCT03302039|Respiratory System Agents|respiratory system agents|mesh-ancestor
19466799|NCT03302039|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
19466800|NCT03302039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19466801|NCT03302039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20013060|NCT02396537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20013061|NCT02396537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20013062|NCT02396537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20013063|NCT02396537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20013064|NCT02396537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19466802|NCT03302039|Adrenergic Agents|adrenergic agents|mesh-ancestor
19466803|NCT03302039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19466804|NCT03302039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466805|NCT03302039|Protective Agents|protective agents|mesh-ancestor
19466806|NCT03301974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
19466807|NCT03301974|Hemostatics|hemostatics|mesh-ancestor
19466808|NCT03301974|Coagulants|coagulants|mesh-ancestor
19466809|NCT03301766|Lidocaine|lidocaine|mesh-list
19466810|NCT03301766|Anesthetics, Local|anesthetics, local|mesh-ancestor
19466811|NCT03301766|Anesthetics|anesthetics|mesh-ancestor
20013065|NCT02396537|Anesthetics, General|anesthetics, general|mesh-ancestor
20013066|NCT02396537|GABA Modulators|gaba modulators|mesh-ancestor
20013067|NCT02396537|GABA Agents|gaba agents|mesh-ancestor
20013068|NCT02396537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20013069|NCT02396732|Aspirin|aspirin|mesh-list
20013070|NCT02396732|Enoxaparin|enoxaparin|mesh-list
20013071|NCT02396732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20013072|NCT02396732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20013073|NCT02396732|Analgesics|analgesics|mesh-ancestor
20013074|NCT02396732|Sensory System Agents|sensory system agents|mesh-ancestor
20013075|NCT02396732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20013076|NCT02396732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013077|NCT02396732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20013078|NCT02396732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20013079|NCT02396732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20013080|NCT02396732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20013081|NCT02396732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013082|NCT02396732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20013083|NCT02396732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20013084|NCT02396732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20013085|NCT02396732|Antipyretics|antipyretics|mesh-ancestor
20013086|NCT02396732|Anticoagulants|anticoagulants|mesh-ancestor
20013087|NCT02396758|Plasminogen|plasminogen|mesh-list
20013088|NCT02396758|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
20013089|NCT02396758|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20013090|NCT02396758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20013091|NCT02396758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013092|NCT02396953|Lanreotide|lanreotide|mesh-list
20013093|NCT02396953|Somatostatin|somatostatin|mesh-list
20013094|NCT02396953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013095|NCT02396953|Hormones|hormones|mesh-ancestor
20013096|NCT02396953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20013097|NCT02396953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013098|NCT02397096|Ritonavir|ritonavir|mesh-list
20013099|NCT02397096|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
20013100|NCT02397096|Tenofovir|tenofovir|mesh-list
20013101|NCT02397096|Lamivudine|lamivudine|mesh-list
20013102|NCT02397096|Cobicistat|cobicistat|mesh-list
20013103|NCT02397096|Elvitegravir|elvitegravir|mesh-list
20013104|NCT02397096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
20013105|NCT02397096|Protease Inhibitors|protease inhibitors|mesh-list
20013106|NCT02397096|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20013107|NCT02397096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20013108|NCT02397096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013109|NCT02397096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20013110|NCT02397096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20013111|NCT02397096|Antiviral Agents|antiviral agents|mesh-ancestor
20013112|NCT02397096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20013113|NCT02397096|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20013114|NCT02397096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20013115|NCT02397096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20013116|NCT02397096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20013117|NCT02397265|Insulin|insulin|mesh-list
20013118|NCT02397265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20013119|NCT02397265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013120|NCT02397291|Inositol|inositol|mesh-list
20013121|NCT02397291|Vitamin B Complex|vitamin b complex|mesh-ancestor
20013122|NCT02397291|Vitamins|vitamins|mesh-ancestor
20013123|NCT02397291|Micronutrients|micronutrients|mesh-ancestor
20013124|NCT02397291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013125|NCT02397408|Choline|choline|mesh-list
20013126|NCT02397408|Lipotropic Agents|lipotropic agents|mesh-ancestor
20013127|NCT02397408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20013128|NCT02397408|Antimetabolites|antimetabolites|mesh-ancestor
20013129|NCT02397408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013130|NCT02397408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20013131|NCT02397408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20013132|NCT02397408|Nootropic Agents|nootropic agents|mesh-ancestor
20013133|NCT02397694|Dolutegravir|dolutegravir|mesh-list
20013134|NCT02397694|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20013135|NCT02397694|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20013136|NCT02397694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20013137|NCT02397694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013138|NCT02397694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20013139|NCT02397694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20013140|NCT02397694|Antiviral Agents|antiviral agents|mesh-ancestor
20013141|NCT02397694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20013142|NCT02397837|Pramipexole|pramipexole|mesh-list
20013143|NCT02397837|Antioxidants|antioxidants|mesh-ancestor
20013144|NCT02397837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013145|NCT02397837|Protective Agents|protective agents|mesh-ancestor
20013146|NCT02397837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013147|NCT02397837|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20013148|NCT02397837|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20013149|NCT02397837|Dopamine Agonists|dopamine agonists|mesh-ancestor
20013150|NCT02397837|Dopamine Agents|dopamine agents|mesh-ancestor
20013151|NCT02397837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20013152|NCT02397889|Midazolam|midazolam|mesh-list
20013153|NCT02397889|Ketamine|ketamine|mesh-list
20013154|NCT02397889|Analgesics|analgesics|mesh-ancestor
20013155|NCT02397889|Sensory System Agents|sensory system agents|mesh-ancestor
20013156|NCT02397889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20013157|NCT02397889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013158|NCT02397889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20013159|NCT02397889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20013160|NCT02397889|Anesthetics, General|anesthetics, general|mesh-ancestor
20013161|NCT02397889|Anesthetics|anesthetics|mesh-ancestor
20013162|NCT02397889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20013163|NCT02397889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20013164|NCT02397889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20013165|NCT02397889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20013166|NCT02397889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013167|NCT02397889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20013168|NCT02397889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20013169|NCT02397889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20013170|NCT02397889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20013171|NCT02397889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20013172|NCT02397889|GABA Modulators|gaba modulators|mesh-ancestor
20013173|NCT02397889|GABA Agents|gaba agents|mesh-ancestor
20013174|NCT02397954|Ranibizumab|ranibizumab|mesh-list
20013175|NCT02397954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20013176|NCT02397954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20013177|NCT02397954|Growth Substances|growth substances|mesh-ancestor
20013178|NCT02397954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013179|NCT02397954|Growth Inhibitors|growth inhibitors|mesh-ancestor
20013180|NCT02397954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013181|NCT02398188|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20013182|NCT02398188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20013183|NCT02398188|Autonomic Agents|autonomic agents|mesh-ancestor
20013184|NCT02398188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20013185|NCT02398188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013186|NCT02398188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20013187|NCT02398188|Respiratory System Agents|respiratory system agents|mesh-ancestor
20013188|NCT02398188|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20013189|NCT02398188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20013190|NCT02398188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20013191|NCT02398188|Adrenergic Agents|adrenergic agents|mesh-ancestor
20013192|NCT02398188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20013193|NCT02398188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013194|NCT02399085|Lenalidomide|lenalidomide|mesh-list
20013195|NCT02399085|Immunologic Factors|immunologic factors|mesh-ancestor
20013196|NCT02399085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013197|NCT02399085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20013198|NCT02399085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20013199|NCT02399085|Growth Substances|growth substances|mesh-ancestor
20013200|NCT02399085|Growth Inhibitors|growth inhibitors|mesh-ancestor
20013201|NCT02399085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013202|NCT02399163|Fluorides|fluorides|mesh-list
20013203|NCT02399163|Cariostatic Agents|cariostatic agents|mesh-ancestor
20013204|NCT02399163|Protective Agents|protective agents|mesh-ancestor
20013205|NCT02399163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013206|NCT02399345|Ritonavir|ritonavir|mesh-list
20013207|NCT02399345|Ribavirin|ribavirin|mesh-list
20013208|NCT02399345|Sofosbuvir|sofosbuvir|mesh-list
20013209|NCT02399345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20013210|NCT02399345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20013211|NCT02399345|Protease Inhibitors|protease inhibitors|mesh-ancestor
20013212|NCT02399345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20013213|NCT02399345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013214|NCT02399345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20013215|NCT02399345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20013216|NCT02399345|Antiviral Agents|antiviral agents|mesh-ancestor
20013217|NCT02399345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20013218|NCT02399345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20013219|NCT02399345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20013220|NCT02399345|Antimetabolites|antimetabolites|mesh-ancestor
20013221|NCT02399475|Hormones|hormones|mesh-list
20013222|NCT02399475|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
20013223|NCT02399475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20013224|NCT02399475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013225|NCT02399917|Azacitidine|azacitidine|mesh-list
20013226|NCT02399917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20013227|NCT02399917|Antimetabolites|antimetabolites|mesh-ancestor
20013228|NCT02399917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013229|NCT02399917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013230|NCT02399917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20013231|NCT02400333|Ticagrelor|ticagrelor|mesh-list
20013232|NCT02400333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20013233|NCT02400333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20013234|NCT02400333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20013235|NCT02400333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20013236|NCT02400333|Purinergic Agents|purinergic agents|mesh-ancestor
20013237|NCT02400333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20013238|NCT02400333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013239|NCT02400333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013240|NCT02400346|Brexpiprazole|brexpiprazole|mesh-list
20013241|NCT02400346|Serotonin Agents|serotonin agents|mesh-ancestor
20013242|NCT02400346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20013243|NCT02400346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013244|NCT02400346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013245|NCT02400346|Dopamine Agonists|dopamine agonists|mesh-ancestor
20013246|NCT02400346|Dopamine Agents|dopamine agents|mesh-ancestor
20013247|NCT02400437|Dexamethasone|dexamethasone|mesh-list
20013248|NCT02400437|Rituximab|rituximab|mesh-list
20013249|NCT02400437|Ixazomib|ixazomib|mesh-list
20013250|NCT02400437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20013251|NCT02400437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013252|NCT02400437|Immunologic Factors|immunologic factors|mesh-ancestor
20013253|NCT02400437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013254|NCT02400437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20013255|NCT02400437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20013256|NCT02400437|Antiemetics|antiemetics|mesh-ancestor
20013257|NCT02400437|Autonomic Agents|autonomic agents|mesh-ancestor
20013258|NCT02400437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20013259|NCT02400437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20013260|NCT02400437|Glucocorticoids|glucocorticoids|mesh-ancestor
20013261|NCT02400437|Hormones|hormones|mesh-ancestor
20013262|NCT02400437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20013263|NCT02400437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20013264|NCT02400437|Protease Inhibitors|protease inhibitors|mesh-ancestor
20013265|NCT02400437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20013266|NCT02400437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013267|NCT02400580|Acetaminophen|acetaminophen|mesh-list
20013268|NCT02400580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20013269|NCT02400580|Analgesics|analgesics|mesh-ancestor
20013270|NCT02400580|Sensory System Agents|sensory system agents|mesh-ancestor
20013271|NCT02400580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20013272|NCT02400580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013273|NCT02400580|Antipyretics|antipyretics|mesh-ancestor
20013274|NCT02400749|Apremilast|apremilast|mesh-list
20013275|NCT02400749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20013276|NCT02400749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20013277|NCT02400749|Analgesics|analgesics|mesh-ancestor
20013278|NCT02400749|Sensory System Agents|sensory system agents|mesh-ancestor
20013279|NCT02400749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20013280|NCT02400749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013281|NCT02400749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20013282|NCT02400749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20013283|NCT02400749|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20013284|NCT02400749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20013285|NCT02400749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20013286|NCT02400749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013287|NCT02401048|Durvalumab|durvalumab|mesh-list
20013288|NCT02401048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20013289|NCT02401048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013290|NCT02401230|Tenofovir|tenofovir|mesh-list
20013291|NCT02401230|Emtricitabine|emtricitabine|mesh-list
20013292|NCT02401230|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20013293|NCT02401230|Antiviral Agents|antiviral agents|mesh-ancestor
20013294|NCT02401230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20013295|NCT02401230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20013296|NCT02401230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20013297|NCT02401230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20013298|NCT02401230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013299|NCT02401230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20013300|NCT02401230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20013301|NCT02401256|Efavirenz|efavirenz|mesh-list
20013302|NCT02401256|Bupropion|bupropion|mesh-list
20013303|NCT02401256|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20013304|NCT02401256|Montelukast|montelukast|mesh-list
20013305|NCT02401256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20013306|NCT02401256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20013307|NCT02401256|Antimetabolites|antimetabolites|mesh-ancestor
20013308|NCT02401256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013309|NCT02401256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20013310|NCT02401256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20013311|NCT02401256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20013312|NCT02401256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20013313|NCT02401256|Antidepressive Agents|antidepressive agents|mesh-ancestor
20013314|NCT02401256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20013315|NCT02401256|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20013316|NCT02401256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20013317|NCT02401256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20013318|NCT02401256|Dopamine Agents|dopamine agents|mesh-ancestor
20013319|NCT02401256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20013320|NCT02401256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013321|NCT02401256|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20013322|NCT02401256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20013323|NCT02401256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20013324|NCT02401256|Respiratory System Agents|respiratory system agents|mesh-ancestor
20013325|NCT02401256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20013326|NCT02401256|Hormone Antagonists|hormone antagonists|mesh-ancestor
20013327|NCT02401256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20013328|NCT02401256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20013329|NCT02401256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20013330|NCT02401256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20013331|NCT02401256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20013332|NCT02401256|Antiviral Agents|antiviral agents|mesh-ancestor
20013333|NCT02401256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20013334|NCT02401256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
20013335|NCT02401256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
20013336|NCT02401256|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20013337|NCT02401256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20013338|NCT02401464|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20013339|NCT02401464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20013340|NCT02401464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20013341|NCT02401464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013342|NCT02401529|Acetaminophen|acetaminophen|mesh-list
20013343|NCT02401529|Dexamethasone|dexamethasone|mesh-list
20013344|NCT02401529|Prednisolone|prednisolone|mesh-list
20013345|NCT02401529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20013346|NCT02401529|Antiemetics|antiemetics|mesh-ancestor
20013347|NCT02401529|Autonomic Agents|autonomic agents|mesh-ancestor
20013348|NCT02401529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20013349|NCT02401529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013350|NCT02401529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20013351|NCT02401529|Glucocorticoids|glucocorticoids|mesh-ancestor
20013352|NCT02401529|Hormones|hormones|mesh-ancestor
20013353|NCT02401529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20013354|NCT02401529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20013355|NCT02401529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013356|NCT02401529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20013357|NCT02401529|Analgesics|analgesics|mesh-ancestor
20013358|NCT02401529|Sensory System Agents|sensory system agents|mesh-ancestor
20013359|NCT02401529|Antipyretics|antipyretics|mesh-ancestor
20013360|NCT02401542|Docetaxel|docetaxel|mesh-list
20013361|NCT02401542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013362|NCT02401542|Tubulin Modulators|tubulin modulators|mesh-ancestor
20013363|NCT02401542|Antimitotic Agents|antimitotic agents|mesh-ancestor
20013364|NCT02401542|Mitosis Modulators|mitosis modulators|mesh-ancestor
20013365|NCT02401542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013366|NCT02402062|Sunitinib|sunitinib|mesh-list
20013367|NCT02402062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013368|NCT02402062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20013369|NCT02402062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20013370|NCT02402062|Growth Substances|growth substances|mesh-ancestor
20013371|NCT02402062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013372|NCT02402062|Growth Inhibitors|growth inhibitors|mesh-ancestor
20013373|NCT02402062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20013374|NCT02402062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19466812|NCT03301766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466813|NCT03301766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466814|NCT03301766|Sensory System Agents|sensory system agents|mesh-ancestor
19466815|NCT03301766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466816|NCT03301766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19466817|NCT03301766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19466818|NCT03301766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19466819|NCT03301766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20013375|NCT02402062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013376|NCT02402907|Chlorhexidine|chlorhexidine|mesh-list
20013377|NCT02402907|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20013378|NCT02402907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20013379|NCT02402907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20013380|NCT02402907|Disinfectants|disinfectants|mesh-ancestor
20013381|NCT02402907|Dermatologic Agents|dermatologic agents|mesh-ancestor
20013382|NCT02402933|Glucagon|glucagon|mesh-list
20013383|NCT02402933|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20013384|NCT02402933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20013385|NCT02402933|Hormones|hormones|mesh-ancestor
20013386|NCT02402933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20013387|NCT02402933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013388|NCT02402933|Incretins|incretins|mesh-ancestor
20013389|NCT02403271|Durvalumab|durvalumab|mesh-list
20013390|NCT02403271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20013391|NCT02403271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013392|NCT02403635|Midazolam|midazolam|mesh-list
20013393|NCT02403635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20013394|NCT02403635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20013395|NCT02403635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20013396|NCT02403635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013397|NCT02403635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20013398|NCT02403635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20013399|NCT02403635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20013400|NCT02403635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20013401|NCT02403635|Anesthetics, General|anesthetics, general|mesh-ancestor
20013402|NCT02403635|Anesthetics|anesthetics|mesh-ancestor
20013403|NCT02403635|GABA Modulators|gaba modulators|mesh-ancestor
20013404|NCT02403635|GABA Agents|gaba agents|mesh-ancestor
20013405|NCT02403635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20013406|NCT02403635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013407|NCT02403674|Tenofovir|tenofovir|mesh-list
20013408|NCT02403674|Lamivudine|lamivudine|mesh-list
20013409|NCT02403674|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20013410|NCT02403674|Antiviral Agents|antiviral agents|mesh-ancestor
20013411|NCT02403674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20013412|NCT02403674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20013413|NCT02403674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20013414|NCT02403674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20013415|NCT02403674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013416|NCT02403674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20013417|NCT02403674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20013418|NCT02403778|Ipilimumab|ipilimumab|mesh-list
20013419|NCT02403778|Tretinoin|tretinoin|mesh-list
20013420|NCT02403778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20013421|NCT02403778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013422|NCT02403778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20013423|NCT02403778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013424|NCT02403778|Keratolytic Agents|keratolytic agents|mesh-ancestor
20013425|NCT02403778|Dermatologic Agents|dermatologic agents|mesh-ancestor
20013426|NCT02403830|Morphine|morphine|mesh-list
20013427|NCT02403830|Methylnaltrexone|methylnaltrexone|mesh-list
20013428|NCT02403830|Ticagrelor|ticagrelor|mesh-list
20013429|NCT02403830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20013430|NCT02403830|Narcotics|narcotics|mesh-ancestor
20013431|NCT02403830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20013432|NCT02403830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013433|NCT02403830|Analgesics|analgesics|mesh-ancestor
20013434|NCT02403830|Sensory System Agents|sensory system agents|mesh-ancestor
20013435|NCT02403830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20013436|NCT02403830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20013437|NCT02403830|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20013438|NCT02403830|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20013439|NCT02403830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20013440|NCT02403830|Purinergic Agents|purinergic agents|mesh-ancestor
20013441|NCT02403830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20013442|NCT02403830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013443|NCT02403830|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20013444|NCT02403895|Paclitaxel|paclitaxel|mesh-list
20013445|NCT02403895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20013446|NCT02403895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013447|NCT02403895|Tubulin Modulators|tubulin modulators|mesh-ancestor
20013448|NCT02403895|Antimitotic Agents|antimitotic agents|mesh-ancestor
20013449|NCT02403895|Mitosis Modulators|mitosis modulators|mesh-ancestor
20013450|NCT02403895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013451|NCT02403986|Lidocaine|lidocaine|mesh-list
20013452|NCT02403986|Anesthetics, Local|anesthetics, local|mesh-ancestor
20013453|NCT02403986|Anesthetics|anesthetics|mesh-ancestor
20013454|NCT02403986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20013455|NCT02403986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013456|NCT02403986|Sensory System Agents|sensory system agents|mesh-ancestor
20013457|NCT02403986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20013458|NCT02403986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20013459|NCT02403986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20013460|NCT02403986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20013461|NCT02403986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20013462|NCT02403986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013463|NCT02404025|Thymoglobulin|thymoglobulin|mesh-list
20013464|NCT02404025|Immunologic Factors|immunologic factors|mesh-ancestor
20013465|NCT02404025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013466|NCT02404025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20013467|NCT02404103|Flunisolide|flunisolide|mesh-list
20013468|NCT02404103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20013469|NCT02404103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20013470|NCT02404103|Respiratory System Agents|respiratory system agents|mesh-ancestor
20013471|NCT02404168|Lamotrigine|lamotrigine|mesh-list
20013472|NCT02404168|Anticonvulsants|anticonvulsants|mesh-list
20013473|NCT02404168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20013474|NCT02404168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20013475|NCT02404168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013476|NCT02404168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20013477|NCT02404168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013478|NCT02404168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20013479|NCT02404168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20013480|NCT02404168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20013481|NCT02404168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20013482|NCT02404168|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20013483|NCT02404220|Dexamethasone|dexamethasone|mesh-list
20013484|NCT02404220|Vincristine|vincristine|mesh-list
20013485|NCT02404220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20013486|NCT02404220|Antiemetics|antiemetics|mesh-ancestor
20013487|NCT02404220|Autonomic Agents|autonomic agents|mesh-ancestor
20013488|NCT02404220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20013489|NCT02404220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013490|NCT02404220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20013491|NCT02404220|Glucocorticoids|glucocorticoids|mesh-ancestor
20013492|NCT02404220|Hormones|hormones|mesh-ancestor
20013493|NCT02404220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20013494|NCT02404220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20013495|NCT02404220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013496|NCT02404220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20013497|NCT02404220|Tubulin Modulators|tubulin modulators|mesh-ancestor
20013498|NCT02404220|Antimitotic Agents|antimitotic agents|mesh-ancestor
20013499|NCT02404220|Mitosis Modulators|mitosis modulators|mesh-ancestor
20013500|NCT02404220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013501|NCT02404311|MF59 oil emulsion|mf59 oil emulsion|mesh-list
20013502|NCT02404311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20013503|NCT02404311|Immunologic Factors|immunologic factors|mesh-ancestor
20013504|NCT02404311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013505|NCT02404441|Spartalizumab|spartalizumab|mesh-list
20013506|NCT02404441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20013507|NCT02404441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013508|NCT02404441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013509|NCT02404493|Decanoic acid|decanoic acid|mesh-list
20013510|NCT02404493|Antifungal Agents|antifungal agents|mesh-ancestor
20013511|NCT02404493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20013512|NCT02404610|Propofol|propofol|mesh-list
20013513|NCT02404610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
20013514|NCT02404610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20013515|NCT02404610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013516|NCT02404610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20013517|NCT02404610|Anesthetics, General|anesthetics, general|mesh-ancestor
20013518|NCT02404610|Anesthetics|anesthetics|mesh-ancestor
20013519|NCT02404805|Dolutegravir|dolutegravir|mesh-list
20013520|NCT02404805|Simeprevir|simeprevir|mesh-list
20013521|NCT02404805|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20013522|NCT02404805|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20013523|NCT02404805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20013524|NCT02404805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013525|NCT02404805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20013526|NCT02404805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20013527|NCT02404805|Antiviral Agents|antiviral agents|mesh-ancestor
20013528|NCT02404805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20013529|NCT02404805|Protease Inhibitors|protease inhibitors|mesh-ancestor
20013530|NCT02405780|Adalimumab|adalimumab|mesh-list
20013531|NCT02405780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20013532|NCT02405780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20013533|NCT02406248|Ticagrelor|ticagrelor|mesh-list
20013534|NCT02406248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20013535|NCT02406248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20013536|NCT02406248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20013537|NCT02406248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20013538|NCT02406248|Purinergic Agents|purinergic agents|mesh-ancestor
20013539|NCT02406248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20013540|NCT02406248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013541|NCT02406248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013542|NCT02406261|Midazolam|midazolam|mesh-list
20013543|NCT02406261|Donepezil|donepezil|mesh-list
20013544|NCT02406261|Simvastatin|simvastatin|mesh-list
20013545|NCT02406261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20013546|NCT02406261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20013547|NCT02406261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20013548|NCT02406261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013549|NCT02406261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20013550|NCT02406261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20013551|NCT02406261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20013552|NCT02406261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20013553|NCT02406261|Anesthetics, General|anesthetics, general|mesh-ancestor
20013554|NCT02406261|Anesthetics|anesthetics|mesh-ancestor
20013555|NCT02406261|GABA Modulators|gaba modulators|mesh-ancestor
20013556|NCT02406261|GABA Agents|gaba agents|mesh-ancestor
20013557|NCT02406261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20013558|NCT02406261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013559|NCT02406261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20013560|NCT02406261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20013561|NCT02406261|Antimetabolites|antimetabolites|mesh-ancestor
20013562|NCT02406261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20013563|NCT02406261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20013564|NCT02406261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20013565|NCT02406261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20013566|NCT02406261|Cholinergic Agents|cholinergic agents|mesh-ancestor
20013567|NCT02406261|Nootropic Agents|nootropic agents|mesh-ancestor
20013568|NCT02406443|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20013569|NCT02406443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20013570|NCT02406443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013571|NCT02406443|Incretins|incretins|mesh-ancestor
20013572|NCT02406443|Hormones|hormones|mesh-ancestor
20013573|NCT02406443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20013574|NCT02406443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20013575|NCT02406443|Protease Inhibitors|protease inhibitors|mesh-ancestor
20013576|NCT02406443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20013577|NCT02406443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013578|NCT02406586|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
20013579|NCT02406586|Carvedilol|carvedilol|mesh-list
20013580|NCT02406586|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
20013581|NCT02406586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20013582|NCT02406586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20013583|NCT02406586|Adrenergic Agents|adrenergic agents|mesh-ancestor
20013584|NCT02406586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20013585|NCT02406586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013586|NCT02406586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013587|NCT02406586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20013588|NCT02406586|Antioxidants|antioxidants|mesh-ancestor
20013589|NCT02406586|Protective Agents|protective agents|mesh-ancestor
20013590|NCT02406586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20013591|NCT02406586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20013592|NCT02406586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20013593|NCT02406586|Vasodilator Agents|vasodilator agents|mesh-ancestor
20013594|NCT02406586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20013595|NCT02406586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20013596|NCT02406586|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
20013597|NCT02406586|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
20013598|NCT02406586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20013599|NCT02406586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20013600|NCT02406586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20013601|NCT02406586|Analgesics|analgesics|mesh-ancestor
20013602|NCT02406586|Sensory System Agents|sensory system agents|mesh-ancestor
20013603|NCT02406586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20013604|NCT02406586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20013605|NCT02406586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20013606|NCT02406742|Obinutuzumab|obinutuzumab|mesh-list
19466820|NCT03301766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466821|NCT03301636|Pembrolizumab|pembrolizumab|mesh-list
19466822|NCT03301636|Nivolumab|nivolumab|mesh-list
19466823|NCT03301636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19466824|NCT03301636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466825|NCT03301636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19466826|NCT03301636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466827|NCT03301454|Paclitaxel|paclitaxel|mesh-list
19466828|NCT03301454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19466829|NCT03301454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466830|NCT03301454|Tubulin Modulators|tubulin modulators|mesh-ancestor
19466831|NCT03301454|Antimitotic Agents|antimitotic agents|mesh-ancestor
19466832|NCT03301454|Mitosis Modulators|mitosis modulators|mesh-ancestor
19466833|NCT03301454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466834|NCT03301350|Paclitaxel|paclitaxel|mesh-list
19466835|NCT03301350|Cyclophosphamide|cyclophosphamide|mesh-list
19466836|NCT03301350|Carboplatin|carboplatin|mesh-list
19466837|NCT03301350|Doxorubicin|doxorubicin|mesh-list
19466838|NCT03301350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19466839|NCT03301350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466840|NCT03301350|Tubulin Modulators|tubulin modulators|mesh-ancestor
20013607|NCT02406742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20013608|NCT02406742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013609|NCT02406885|Apixaban|apixaban|mesh-list
20013610|NCT02406885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20013611|NCT02406885|Antithrombins|antithrombins|mesh-ancestor
20013612|NCT02406885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20013613|NCT02406885|Protease Inhibitors|protease inhibitors|mesh-ancestor
20013614|NCT02406885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20013615|NCT02406885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013616|NCT02406885|Anticoagulants|anticoagulants|mesh-ancestor
20013617|NCT02407223|Ustekinumab|ustekinumab|mesh-list
20013618|NCT02407223|Dermatologic Agents|dermatologic agents|mesh-ancestor
20013619|NCT02407704|Lorazepam|lorazepam|mesh-list
20013620|NCT02407704|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20013621|NCT02407704|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20013622|NCT02407704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20013623|NCT02407704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20013624|NCT02407704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013625|NCT02407704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20013626|NCT02407704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013627|NCT02407704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20013628|NCT02407704|Antidepressive Agents|antidepressive agents|mesh-ancestor
20013629|NCT02407704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20013630|NCT02407704|Anticonvulsants|anticonvulsants|mesh-ancestor
20013631|NCT02407704|Antiemetics|antiemetics|mesh-ancestor
20013632|NCT02407704|Autonomic Agents|autonomic agents|mesh-ancestor
20013633|NCT02407704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20013634|NCT02407704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20013635|NCT02407704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20013636|NCT02407704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20013637|NCT02407704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20013638|NCT02407704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20013639|NCT02407704|GABA Modulators|gaba modulators|mesh-ancestor
20013640|NCT02407704|GABA Agents|gaba agents|mesh-ancestor
20013641|NCT02408016|Aldesleukin|aldesleukin|mesh-list
20013642|NCT02408016|Cyclophosphamide|cyclophosphamide|mesh-list
20013643|NCT02408016|Interleukin-2|interleukin-2|mesh-list
20013644|NCT02408016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20013645|NCT02408016|Immunologic Factors|immunologic factors|mesh-ancestor
20013646|NCT02408016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013647|NCT02408016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20013648|NCT02408016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20013649|NCT02408016|Alkylating Agents|alkylating agents|mesh-ancestor
20013650|NCT02408016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013651|NCT02408016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013652|NCT02408016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20013653|NCT02408016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20013654|NCT02408016|Analgesics|analgesics|mesh-ancestor
20013655|NCT02408016|Sensory System Agents|sensory system agents|mesh-ancestor
20013656|NCT02408016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20013657|NCT02408016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20013658|NCT02408016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20013659|NCT02408016|Antiviral Agents|antiviral agents|mesh-ancestor
20013660|NCT02408016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20013661|NCT02408120|Insulin|insulin|mesh-list
20013662|NCT02408120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20013663|NCT02408120|Insulin Glargine|insulin glargine|mesh-list
20013664|NCT02408120|Insulin Aspart|insulin aspart|mesh-list
20013665|NCT02408120|Insulin, Long-Acting|insulin, long-acting|mesh-list
20013666|NCT02408120|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20013667|NCT02408120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20013668|NCT02408120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013669|NCT02408445|Methyltestosterone|methyltestosterone|mesh-list
20013670|NCT02408445|Testosterone|testosterone|mesh-list
20013671|NCT02408445|Testosterone undecanoate|testosterone undecanoate|mesh-list
20013672|NCT02408445|Testosterone enanthate|testosterone enanthate|mesh-list
20013673|NCT02408445|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
20013674|NCT02408445|Androgens|androgens|mesh-ancestor
20013675|NCT02408445|Hormones|hormones|mesh-ancestor
20013676|NCT02408445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20013677|NCT02408445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013678|NCT02408445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20013679|NCT02408445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013680|NCT02408445|Anabolic Agents|anabolic agents|mesh-ancestor
20013681|NCT02408523|Lacosamide|lacosamide|mesh-list
20013682|NCT02408523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20013683|NCT02408523|Anticonvulsants|anticonvulsants|mesh-ancestor
20013684|NCT02408523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20013685|NCT02408523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20013686|NCT02408523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20013687|NCT02408523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013688|NCT02408965|Methylergonovine|methylergonovine|mesh-list
20013689|NCT02408965|Oxytocics|oxytocics|mesh-ancestor
20013690|NCT02408965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20013691|NCT02408965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013692|NCT02409680|Aspirin|aspirin|mesh-list
20013693|NCT02409680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20013694|NCT02409680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20013695|NCT02409680|Analgesics|analgesics|mesh-ancestor
20013696|NCT02409680|Sensory System Agents|sensory system agents|mesh-ancestor
20013697|NCT02409680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20013698|NCT02409680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013699|NCT02409680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20013700|NCT02409680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20013701|NCT02409680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20013702|NCT02409680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20013703|NCT02409680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013704|NCT02409680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20013705|NCT02409680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20013706|NCT02409680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20013707|NCT02409680|Antipyretics|antipyretics|mesh-ancestor
20013708|NCT02409732|Aminolevulinic Acid|aminolevulinic acid|mesh-list
20013709|NCT02409732|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
20013710|NCT02409732|Dermatologic Agents|dermatologic agents|mesh-ancestor
20013711|NCT02410200|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20013712|NCT02410200|Dermatologic Agents|dermatologic agents|mesh-ancestor
20013713|NCT02410200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20013714|NCT02410200|Immunologic Factors|immunologic factors|mesh-ancestor
20013715|NCT02410200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013716|NCT02410278|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20013717|NCT02410278|Montelukast|montelukast|mesh-list
20013718|NCT02410278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20013719|NCT02410278|Respiratory System Agents|respiratory system agents|mesh-ancestor
20013720|NCT02410278|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20013721|NCT02410278|Hormone Antagonists|hormone antagonists|mesh-ancestor
20013722|NCT02410278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20013723|NCT02410278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013724|NCT02410278|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20013725|NCT02410278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20013726|NCT02410278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013727|NCT02410278|Dermatologic Agents|dermatologic agents|mesh-ancestor
20013728|NCT02410278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20013729|NCT02410278|Immunologic Factors|immunologic factors|mesh-ancestor
20013730|NCT02410382|Dexamethasone|dexamethasone|mesh-list
20013731|NCT02410382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20013732|NCT02410382|Antiemetics|antiemetics|mesh-ancestor
20013733|NCT02410382|Autonomic Agents|autonomic agents|mesh-ancestor
20013734|NCT02410382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20013735|NCT02410382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013736|NCT02410382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20013737|NCT02410382|Glucocorticoids|glucocorticoids|mesh-ancestor
20013738|NCT02410382|Hormones|hormones|mesh-ancestor
20013739|NCT02410382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20013740|NCT02410382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20013741|NCT02410382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013742|NCT02410707|Nitrous Oxide|nitrous oxide|mesh-list
20013743|NCT02410707|Propofol|propofol|mesh-list
20013744|NCT02410707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20013745|NCT02410707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20013746|NCT02410707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013747|NCT02410707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20013748|NCT02410707|Anesthetics, General|anesthetics, general|mesh-ancestor
20013749|NCT02410707|Anesthetics|anesthetics|mesh-ancestor
20013750|NCT02410707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20013751|NCT02410707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20013752|NCT02410707|Analgesics|analgesics|mesh-ancestor
20013753|NCT02410707|Sensory System Agents|sensory system agents|mesh-ancestor
20013754|NCT02410707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20013755|NCT02410772|Moxifloxacin|moxifloxacin|mesh-list
20013756|NCT02410772|Rifapentine|rifapentine|mesh-list
20013757|NCT02410772|Rifampin|rifampin|mesh-list
20013758|NCT02410772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20013759|NCT02410772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20013760|NCT02410772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20013761|NCT02410772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20013762|NCT02410772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20013763|NCT02410772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013764|NCT02410772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013765|NCT02410772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20013766|NCT02410772|Antitubercular Agents|antitubercular agents|mesh-ancestor
20013767|NCT02410772|Leprostatic Agents|leprostatic agents|mesh-ancestor
20013768|NCT02410772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20013769|NCT02410772|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
20013770|NCT02410772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20013771|NCT02410772|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
20013772|NCT02410772|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
20013773|NCT02410772|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
20013774|NCT02410772|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20013775|NCT02411201|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
20013776|NCT02411201|Chelating Agents|chelating agents|mesh-ancestor
20013777|NCT02411201|Sequestering Agents|sequestering agents|mesh-ancestor
20013778|NCT02411201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013779|NCT02411292|Enoxaparin|enoxaparin|mesh-list
20013780|NCT02411292|Anticoagulants|anticoagulants|mesh-ancestor
20013781|NCT02411292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20013782|NCT02411292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20013783|NCT02411292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013784|NCT02411578|Glucagon|glucagon|mesh-list
20013785|NCT02411578|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20013786|NCT02411578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20013787|NCT02411578|Hormones|hormones|mesh-ancestor
20013788|NCT02411578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20013789|NCT02411578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013790|NCT02411578|Incretins|incretins|mesh-ancestor
20013791|NCT02411591|Necitumumab|necitumumab|mesh-list
20013792|NCT02411591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20013793|NCT02411591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013794|NCT02411916|Misoprostol|misoprostol|mesh-list
20013795|NCT02411916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20013796|NCT02411916|Abortifacient Agents|abortifacient agents|mesh-ancestor
20013797|NCT02411916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20013798|NCT02411916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466841|NCT03301350|Antimitotic Agents|antimitotic agents|mesh-ancestor
19466842|NCT03301350|Mitosis Modulators|mitosis modulators|mesh-ancestor
19466843|NCT03301350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466844|NCT03301350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19466845|NCT03301350|Immunologic Factors|immunologic factors|mesh-ancestor
19466846|NCT03301350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466847|NCT03301350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19466848|NCT03301350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19466849|NCT03301350|Alkylating Agents|alkylating agents|mesh-ancestor
19466850|NCT03301350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19466851|NCT03301350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19466852|NCT03301350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19466853|NCT03301350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19466854|NCT03301350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19466855|NCT03301285|Zoledronic Acid|zoledronic acid|mesh-list
19466856|NCT03301285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20013799|NCT02411916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20013800|NCT02411916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20013801|NCT02411916|Oxytocics|oxytocics|mesh-ancestor
20013802|NCT02411929|Ertugliflozin|ertugliflozin|mesh-list
20013803|NCT02411929|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20013804|NCT02411929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013805|NCT02411929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20013806|NCT02411929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013807|NCT02412111|Ivacaftor|ivacaftor|mesh-list
20013808|NCT02412111|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20013809|NCT02412111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20013810|NCT02412111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013811|NCT02412228|Dexamethasone|dexamethasone|mesh-list
20013812|NCT02412228|Cyclophosphamide|cyclophosphamide|mesh-list
20013813|NCT02412228|Ixazomib|ixazomib|mesh-list
20013814|NCT02412228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20013815|NCT02412228|Immunologic Factors|immunologic factors|mesh-ancestor
20013816|NCT02412228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013817|NCT02412228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20013818|NCT02412228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20013819|NCT02412228|Alkylating Agents|alkylating agents|mesh-ancestor
20013820|NCT02412228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013821|NCT02412228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013822|NCT02412228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20013823|NCT02412228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20013824|NCT02412228|Antiemetics|antiemetics|mesh-ancestor
20013825|NCT02412228|Autonomic Agents|autonomic agents|mesh-ancestor
20013826|NCT02412228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20013827|NCT02412228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20013828|NCT02412228|Glucocorticoids|glucocorticoids|mesh-ancestor
20013829|NCT02412228|Hormones|hormones|mesh-ancestor
20013830|NCT02412228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20013831|NCT02412228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20013832|NCT02412228|Protease Inhibitors|protease inhibitors|mesh-ancestor
20013833|NCT02412228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20013834|NCT02412306|Blinatumomab|blinatumomab|mesh-list
20013835|NCT02412306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013836|NCT02412371|Paclitaxel|paclitaxel|mesh-list
20013837|NCT02412371|Carboplatin|carboplatin|mesh-list
20013838|NCT02412371|Veliparib|veliparib|mesh-list
20013839|NCT02412371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20013840|NCT02412371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013841|NCT02412371|Tubulin Modulators|tubulin modulators|mesh-ancestor
20013842|NCT02412371|Antimitotic Agents|antimitotic agents|mesh-ancestor
20013843|NCT02412371|Mitosis Modulators|mitosis modulators|mesh-ancestor
20013844|NCT02412371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013845|NCT02412371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20013846|NCT02412371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20013847|NCT02412436|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
20013848|NCT02412436|Medroxyprogesterone|medroxyprogesterone|mesh-list
20013849|NCT02412436|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
20013850|NCT02412436|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20013851|NCT02412436|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20013852|NCT02412436|Contraceptive Agents|contraceptive agents|mesh-ancestor
20013853|NCT02412436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20013854|NCT02412436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013855|NCT02412436|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20013856|NCT02412436|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20013857|NCT02412436|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
20013858|NCT02412436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20013859|NCT02412436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013860|NCT02412631|Varenicline|varenicline|mesh-list
20013861|NCT02412631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20013862|NCT02412631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20013863|NCT02412631|Cholinergic Agents|cholinergic agents|mesh-ancestor
20013864|NCT02412631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20013865|NCT02412631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013866|NCT02412631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013867|NCT02412644|Apremilast|apremilast|mesh-list
20013868|NCT02412644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20013869|NCT02412644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20013870|NCT02412644|Analgesics|analgesics|mesh-ancestor
20013871|NCT02412644|Sensory System Agents|sensory system agents|mesh-ancestor
20013872|NCT02412644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20013873|NCT02412644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013874|NCT02412644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20013875|NCT02412644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20013876|NCT02412644|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
20013877|NCT02412644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20013878|NCT02412644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20013879|NCT02412644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013880|NCT02412657|Dexamethasone|dexamethasone|mesh-list
20013881|NCT02412657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20013882|NCT02412657|Antiemetics|antiemetics|mesh-ancestor
20013883|NCT02412657|Autonomic Agents|autonomic agents|mesh-ancestor
20013884|NCT02412657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20013885|NCT02412657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013886|NCT02412657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20013887|NCT02412657|Glucocorticoids|glucocorticoids|mesh-ancestor
20013888|NCT02412657|Hormones|hormones|mesh-ancestor
20013889|NCT02412657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20013890|NCT02412657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20013891|NCT02412657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013892|NCT02412722|Paclitaxel|paclitaxel|mesh-list
20013893|NCT02412722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20013894|NCT02412722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013895|NCT02412722|Tubulin Modulators|tubulin modulators|mesh-ancestor
20013896|NCT02412722|Antimitotic Agents|antimitotic agents|mesh-ancestor
20013897|NCT02412722|Mitosis Modulators|mitosis modulators|mesh-ancestor
20013898|NCT02412722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013899|NCT02412761|Amlodipine|amlodipine|mesh-list
20013900|NCT02412761|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
20013901|NCT02412761|Lisinopril|lisinopril|mesh-list
20013902|NCT02412761|Calcium Channel Blockers|calcium channel blockers|mesh-list
20013903|NCT02412761|Diuretics|diuretics|mesh-list
20013904|NCT02412761|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
20013905|NCT02412761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
20013906|NCT02412761|Enzyme Inhibitors|enzyme inhibitors|mesh-list
20013907|NCT02412761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20013908|NCT02412761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013909|NCT02412761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20013910|NCT02412761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20013911|NCT02412761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013912|NCT02412761|Vasodilator Agents|vasodilator agents|mesh-ancestor
20013913|NCT02412761|Natriuretic Agents|natriuretic agents|mesh-ancestor
20013914|NCT02412761|Protease Inhibitors|protease inhibitors|mesh-ancestor
20013915|NCT02412761|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20013916|NCT02412761|Protective Agents|protective agents|mesh-ancestor
20013917|NCT02412878|Dexamethasone|dexamethasone|mesh-list
20013918|NCT02412878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20013919|NCT02412878|Antiemetics|antiemetics|mesh-ancestor
20013920|NCT02412878|Autonomic Agents|autonomic agents|mesh-ancestor
20013921|NCT02412878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20013922|NCT02412878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013923|NCT02412878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20013924|NCT02412878|Glucocorticoids|glucocorticoids|mesh-ancestor
20013925|NCT02412878|Hormones|hormones|mesh-ancestor
20013926|NCT02412878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20013927|NCT02412878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20013928|NCT02412878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013929|NCT02412982|Enoxaparin|enoxaparin|mesh-list
20013930|NCT02412982|Enoxaparin sodium|enoxaparin sodium|mesh-list
20013931|NCT02412982|Anticoagulants|anticoagulants|mesh-ancestor
20013932|NCT02412982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20013933|NCT02412982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20013934|NCT02412982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013935|NCT02413034|Vancomycin|vancomycin|mesh-list
20013936|NCT02413034|Cefazolin|cefazolin|mesh-list
20013937|NCT02413034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20013938|NCT02413034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20013939|NCT02413203|Celecoxib|celecoxib|mesh-list
20013940|NCT02413203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20013941|NCT02413203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20013942|NCT02413203|Analgesics|analgesics|mesh-ancestor
20013943|NCT02413203|Sensory System Agents|sensory system agents|mesh-ancestor
20013944|NCT02413203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20013945|NCT02413203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013946|NCT02413203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20013947|NCT02413203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20013948|NCT02413203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20013949|NCT02413203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20013950|NCT02413203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20013951|NCT02413203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013952|NCT02413320|Paclitaxel|paclitaxel|mesh-list
20013953|NCT02413320|Docetaxel|docetaxel|mesh-list
20013954|NCT02413320|Cyclophosphamide|cyclophosphamide|mesh-list
20013955|NCT02413320|Carboplatin|carboplatin|mesh-list
20013956|NCT02413320|Doxorubicin|doxorubicin|mesh-list
20013957|NCT02413320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20013958|NCT02413320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013959|NCT02413320|Tubulin Modulators|tubulin modulators|mesh-ancestor
20013960|NCT02413320|Antimitotic Agents|antimitotic agents|mesh-ancestor
20013961|NCT02413320|Mitosis Modulators|mitosis modulators|mesh-ancestor
20013962|NCT02413320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013963|NCT02413320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20013964|NCT02413320|Immunologic Factors|immunologic factors|mesh-ancestor
20013965|NCT02413320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013966|NCT02413320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20013967|NCT02413320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20013968|NCT02413320|Alkylating Agents|alkylating agents|mesh-ancestor
20013969|NCT02413320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20013970|NCT02413320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20013971|NCT02413320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20013972|NCT02413320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20013973|NCT02413320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20013974|NCT02413333|Contact Lens Solutions|contact lens solutions|mesh-list
20013975|NCT02413333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20013976|NCT02413333|Disinfectants|disinfectants|mesh-ancestor
20013977|NCT02413333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20013978|NCT02413346|Sarecycline|sarecycline|mesh-list
20013979|NCT02413346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20013980|NCT02413346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20013981|NCT02413346|Dermatologic Agents|dermatologic agents|mesh-ancestor
20013982|NCT02413398|Dapagliflozin|dapagliflozin|mesh-list
20013983|NCT02413398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20013984|NCT02413398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20013985|NCT02413398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20013986|NCT02413398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013987|NCT02413489|Daratumumab|daratumumab|mesh-list
20013988|NCT02413489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20013989|NCT02413593|Sofosbuvir|sofosbuvir|mesh-list
20013990|NCT02413593|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
20013991|NCT02413593|Ledipasvir|ledipasvir|mesh-list
20013992|NCT02413593|Antiviral Agents|antiviral agents|mesh-ancestor
20013993|NCT02413593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20013994|NCT02413918|Iloperidone|iloperidone|mesh-list
20013995|NCT02413918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20013996|NCT02413918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20013997|NCT02413918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20013998|NCT02413918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20013999|NCT02413918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20014000|NCT02414204|Sildenafil Citrate|sildenafil citrate|mesh-list
20014001|NCT02414204|Vasodilator Agents|vasodilator agents|mesh-ancestor
20014002|NCT02414204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20014003|NCT02414204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20014004|NCT02414204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014005|NCT02414204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014006|NCT02414204|Urological Agents|urological agents|mesh-ancestor
20014007|NCT02414854|Albuterol|albuterol|mesh-list
20014008|NCT02414854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20014009|NCT02414854|Autonomic Agents|autonomic agents|mesh-ancestor
20014010|NCT02414854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014011|NCT02414854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014012|NCT02414854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20014013|NCT02414854|Respiratory System Agents|respiratory system agents|mesh-ancestor
20014014|NCT02414854|Tocolytic Agents|tocolytic agents|mesh-ancestor
20014015|NCT02414854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20014016|NCT02414854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20014017|NCT02414854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20014018|NCT02414854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20014019|NCT02414854|Adrenergic Agents|adrenergic agents|mesh-ancestor
20014020|NCT02414854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014021|NCT02414854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014022|NCT02414932|Midazolam|midazolam|mesh-list
20014023|NCT02414932|Ketamine|ketamine|mesh-list
20014024|NCT02414932|Analgesics|analgesics|mesh-ancestor
20014025|NCT02414932|Sensory System Agents|sensory system agents|mesh-ancestor
20014026|NCT02414932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014027|NCT02414932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014028|NCT02414932|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20014029|NCT02414932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20014030|NCT02414932|Anesthetics, General|anesthetics, general|mesh-ancestor
20014031|NCT02414932|Anesthetics|anesthetics|mesh-ancestor
20014032|NCT02414932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20014033|NCT02414932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20014034|NCT02414932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20014035|NCT02414932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014036|NCT02414932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014037|NCT02414932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20014038|NCT02414932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20014039|NCT02414932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20014040|NCT02414932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20014041|NCT02414932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20014042|NCT02414932|GABA Modulators|gaba modulators|mesh-ancestor
20014043|NCT02414932|GABA Agents|gaba agents|mesh-ancestor
20014044|NCT02414958|Empagliflozin|empagliflozin|mesh-list
20014045|NCT02414958|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20014046|NCT02414958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014047|NCT02414958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20014048|NCT02414958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014049|NCT02415127|Interferons|interferons|mesh-list
20014050|NCT02415127|Interferon-gamma|interferon-gamma|mesh-list
20014051|NCT02415127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014052|NCT02415127|Antiviral Agents|antiviral agents|mesh-ancestor
20014053|NCT02415127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20014054|NCT02415400|Aspirin|aspirin|mesh-list
20014055|NCT02415400|Vitamin K|vitamin k|mesh-list
20014056|NCT02415400|Apixaban|apixaban|mesh-list
20014057|NCT02415400|Vitamins|vitamins|mesh-ancestor
20014058|NCT02415400|Micronutrients|micronutrients|mesh-ancestor
20014059|NCT02415400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014060|NCT02415400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20014061|NCT02415400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20014062|NCT02415400|Analgesics|analgesics|mesh-ancestor
20014063|NCT02415400|Sensory System Agents|sensory system agents|mesh-ancestor
20014064|NCT02415400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014065|NCT02415400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20014066|NCT02415400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20014067|NCT02415400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
20014068|NCT02415400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
20014069|NCT02415400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014070|NCT02415400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20014071|NCT02415400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20014072|NCT02415400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014073|NCT02415400|Antipyretics|antipyretics|mesh-ancestor
20014074|NCT02415400|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
20014075|NCT02415400|Antithrombins|antithrombins|mesh-ancestor
20014076|NCT02415400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20014077|NCT02415400|Protease Inhibitors|protease inhibitors|mesh-ancestor
20014078|NCT02415400|Anticoagulants|anticoagulants|mesh-ancestor
20014079|NCT02415400|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
20014080|NCT02415400|Hemostatics|hemostatics|mesh-ancestor
20014081|NCT02415400|Coagulants|coagulants|mesh-ancestor
20014082|NCT02415595|BMS-955176|bms-955176|mesh-list
20014083|NCT02415595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20014084|NCT02415595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20014085|NCT02415595|Antiviral Agents|antiviral agents|mesh-ancestor
20014086|NCT02415595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20014087|NCT02415855|Dabigatran|dabigatran|mesh-list
20014088|NCT02415855|Antithrombins|antithrombins|mesh-ancestor
20014089|NCT02415855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
20014090|NCT02415855|Protease Inhibitors|protease inhibitors|mesh-ancestor
20014091|NCT02415855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014092|NCT02415855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014093|NCT02415855|Anticoagulants|anticoagulants|mesh-ancestor
20014094|NCT02415959|Pancrelipase|pancrelipase|mesh-list
20014095|NCT02415959|Pancreatin|pancreatin|mesh-list
20014096|NCT02415959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20014097|NCT02416102|Losartan|losartan|mesh-list
20014098|NCT02416102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20014099|NCT02416102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20014100|NCT02416102|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20014101|NCT02416102|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20014102|NCT02416102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014103|NCT02416180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20014104|NCT02416180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20014105|NCT02416180|Autonomic Agents|autonomic agents|mesh-ancestor
20014106|NCT02416180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014107|NCT02416180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014108|NCT02416180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20014109|NCT02416180|Respiratory System Agents|respiratory system agents|mesh-ancestor
20014110|NCT02416180|Glucocorticoids|glucocorticoids|mesh-ancestor
20014111|NCT02416180|Hormones|hormones|mesh-ancestor
20014112|NCT02416180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20014113|NCT02416180|Sympathomimetics|sympathomimetics|mesh-ancestor
20014114|NCT02416193|Vitamin D|vitamin d|mesh-list
20014115|NCT02416193|Ergocalciferols|ergocalciferols|mesh-list
20014116|NCT02416193|Cholecalciferol|cholecalciferol|mesh-list
20014117|NCT02416193|Vitamins|vitamins|mesh-list
20014118|NCT02416193|Micronutrients|micronutrients|mesh-ancestor
20014119|NCT02416193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014120|NCT02416193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20014121|NCT02416193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20014122|NCT02416908|Cytarabine|cytarabine|mesh-list
20014123|NCT02416908|Plerixafor|plerixafor|mesh-list
20014124|NCT02416908|2'-deoxyadenosine|2'-deoxyadenosine|mesh-list
20014125|NCT02416908|Cladribine|cladribine|mesh-list
20014126|NCT02416908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20014127|NCT02416908|Antimetabolites|antimetabolites|mesh-ancestor
20014128|NCT02416908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014129|NCT02416908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014130|NCT02416908|Antiviral Agents|antiviral agents|mesh-ancestor
20014131|NCT02416908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20014132|NCT02416908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20014133|NCT02416908|Immunologic Factors|immunologic factors|mesh-ancestor
20014134|NCT02416908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014135|NCT02416908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20014136|NCT02416908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20014137|NCT02416934|Dexamethasone|dexamethasone|mesh-list
20014138|NCT02416934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20014139|NCT02416934|Antiemetics|antiemetics|mesh-ancestor
20014140|NCT02416934|Autonomic Agents|autonomic agents|mesh-ancestor
20014141|NCT02416934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014142|NCT02416934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014143|NCT02416934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20014144|NCT02416934|Glucocorticoids|glucocorticoids|mesh-ancestor
20014145|NCT02416934|Hormones|hormones|mesh-ancestor
20014146|NCT02416934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20014147|NCT02416934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20014148|NCT02416934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014149|NCT02417064|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20014150|NCT02417064|Citalopram|citalopram|mesh-list
20014151|NCT02417064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20014152|NCT02417064|Sertraline|sertraline|mesh-list
20014153|NCT02417064|Antidepressive Agents|antidepressive agents|mesh-list
20014154|NCT02417064|Esketamine|esketamine|mesh-list
20014155|NCT02417064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20014156|NCT02417064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20014157|NCT02417064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19466857|NCT03301285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466858|NCT03301233|Sildenafil Citrate|sildenafil citrate|mesh-list
19466859|NCT03301233|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
19466860|NCT03301233|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
19466861|NCT03301233|Estradiol|estradiol|mesh-list
19466862|NCT03301233|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
19466863|NCT03301233|Estrogens|estrogens|mesh-ancestor
19466864|NCT03301233|Hormones|hormones|mesh-ancestor
19466865|NCT03301233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19466866|NCT03301233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466867|NCT03301233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19466868|NCT03301233|Contraceptive Agents|contraceptive agents|mesh-ancestor
20014158|NCT02417064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014159|NCT02417064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014160|NCT02417064|Serotonin Agents|serotonin agents|mesh-ancestor
20014161|NCT02417064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014162|NCT02417064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20014163|NCT02417064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20014164|NCT02417064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014165|NCT02417064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20014166|NCT02417064|Analgesics|analgesics|mesh-ancestor
20014167|NCT02417064|Sensory System Agents|sensory system agents|mesh-ancestor
20014168|NCT02417064|Dopamine Agents|dopamine agents|mesh-ancestor
20014169|NCT02417129|Rituximab|rituximab|mesh-list
20014170|NCT02417129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20014171|NCT02417129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014172|NCT02417129|Immunologic Factors|immunologic factors|mesh-ancestor
20014173|NCT02417129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014174|NCT02417129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20014175|NCT02417246|Metoprolol|metoprolol|mesh-list
20014176|NCT02417246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20014177|NCT02417246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20014178|NCT02417246|Sympatholytics|sympatholytics|mesh-ancestor
20014179|NCT02417246|Autonomic Agents|autonomic agents|mesh-ancestor
20014180|NCT02417246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014181|NCT02417246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014182|NCT02417246|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20014183|NCT02417246|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20014184|NCT02417246|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20014185|NCT02417246|Adrenergic Agents|adrenergic agents|mesh-ancestor
20014186|NCT02417246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014187|NCT02417246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014188|NCT02417831|Tamsulosin|tamsulosin|mesh-list
20014189|NCT02417831|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20014190|NCT02417831|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20014191|NCT02417831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20014192|NCT02417831|Adrenergic Agents|adrenergic agents|mesh-ancestor
20014193|NCT02417831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014194|NCT02417831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014195|NCT02417831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014196|NCT02417831|Urological Agents|urological agents|mesh-ancestor
20014197|NCT02417844|Tamsulosin|tamsulosin|mesh-list
20014198|NCT02417844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20014199|NCT02417844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20014200|NCT02417844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20014201|NCT02417844|Adrenergic Agents|adrenergic agents|mesh-ancestor
20014202|NCT02417844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014203|NCT02417844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014204|NCT02417844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014205|NCT02417844|Urological Agents|urological agents|mesh-ancestor
20014206|NCT02417935|Pregabalin|pregabalin|mesh-list
20014207|NCT02417935|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20014208|NCT02417935|Analgesics|analgesics|mesh-ancestor
20014209|NCT02417935|Sensory System Agents|sensory system agents|mesh-ancestor
20014210|NCT02417935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014211|NCT02417935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014212|NCT02417935|Anticonvulsants|anticonvulsants|mesh-ancestor
20014213|NCT02417935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20014214|NCT02417935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20014215|NCT02417935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014216|NCT02417935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20014217|NCT02417935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20014218|NCT02417935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20014219|NCT02417935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20014220|NCT02417935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20014221|NCT02417935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20014222|NCT02417935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20014223|NCT02417935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014224|NCT02417935|Antidepressive Agents|antidepressive agents|mesh-ancestor
20014225|NCT02417935|Dopamine Agents|dopamine agents|mesh-ancestor
20014226|NCT02417961|Benralizumab|benralizumab|mesh-list
20014227|NCT02417961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20014228|NCT02417961|Respiratory System Agents|respiratory system agents|mesh-ancestor
20014229|NCT02418182|Acetaminophen|acetaminophen|mesh-list
20014230|NCT02418182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20014231|NCT02418182|Analgesics|analgesics|mesh-ancestor
20014232|NCT02418182|Sensory System Agents|sensory system agents|mesh-ancestor
20014233|NCT02418182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014234|NCT02418182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014235|NCT02418182|Antipyretics|antipyretics|mesh-ancestor
20014236|NCT02418312|Famotidine|famotidine|mesh-list
20014237|NCT02418312|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
20014238|NCT02418312|Histamine|histamine|mesh-list
20014239|NCT02418312|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20014240|NCT02418312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20014241|NCT02418312|Histamine Antagonists|histamine antagonists|mesh-ancestor
20014242|NCT02418312|Histamine Agents|histamine agents|mesh-ancestor
20014243|NCT02418312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014244|NCT02418312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014245|NCT02418312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014246|NCT02418312|Histamine Agonists|histamine agonists|mesh-ancestor
20014247|NCT02418585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20014248|NCT02418585|Citalopram|citalopram|mesh-list
20014249|NCT02418585|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20014250|NCT02418585|Sertraline|sertraline|mesh-list
20014251|NCT02418585|Antidepressive Agents|antidepressive agents|mesh-list
20014252|NCT02418585|Esketamine|esketamine|mesh-list
20014253|NCT02418585|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20014254|NCT02418585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20014255|NCT02418585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20014256|NCT02418585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014257|NCT02418585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014258|NCT02418585|Serotonin Agents|serotonin agents|mesh-ancestor
20014259|NCT02418585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014260|NCT02418585|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20014261|NCT02418585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20014262|NCT02418585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014263|NCT02418585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20014264|NCT02418585|Analgesics|analgesics|mesh-ancestor
20014265|NCT02418585|Sensory System Agents|sensory system agents|mesh-ancestor
20014266|NCT02418585|Dopamine Agents|dopamine agents|mesh-ancestor
20014267|NCT02418676|Insulin|insulin|mesh-list
20014268|NCT02418676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20014269|NCT02418676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014270|NCT02418754|Aflibercept|aflibercept|mesh-list
20014271|NCT02418754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20014272|NCT02418754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20014273|NCT02418754|Growth Substances|growth substances|mesh-ancestor
20014274|NCT02418754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014275|NCT02418754|Growth Inhibitors|growth inhibitors|mesh-ancestor
20014276|NCT02418754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014277|NCT02418949|Cyproheptadine|cyproheptadine|mesh-list
20014278|NCT02418949|Antipruritics|antipruritics|mesh-ancestor
20014279|NCT02418949|Dermatologic Agents|dermatologic agents|mesh-ancestor
20014280|NCT02418949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20014281|NCT02418949|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20014282|NCT02418949|Histamine Antagonists|histamine antagonists|mesh-ancestor
20014283|NCT02418949|Histamine Agents|histamine agents|mesh-ancestor
20014284|NCT02418949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014285|NCT02418949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014286|NCT02418949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014287|NCT02418949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20014288|NCT02418949|Serotonin Agents|serotonin agents|mesh-ancestor
20014289|NCT02418949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20014290|NCT02419313|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20014291|NCT02419313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20014292|NCT02419313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014293|NCT02419313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014294|NCT02419313|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20014295|NCT02419313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20014296|NCT02419313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014297|NCT02419313|Cholinergic Agents|cholinergic agents|mesh-ancestor
20014298|NCT02419313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014299|NCT02419469|Cytarabine|cytarabine|mesh-list
20014300|NCT02419469|Dexamethasone|dexamethasone|mesh-list
20014301|NCT02419469|Prednisone|prednisone|mesh-list
20014302|NCT02419469|Dexamethasone acetate|dexamethasone acetate|mesh-list
20014303|NCT02419469|Cyclophosphamide|cyclophosphamide|mesh-list
20014304|NCT02419469|Rituximab|rituximab|mesh-list
20014305|NCT02419469|Doxorubicin|doxorubicin|mesh-list
20014306|NCT02419469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20014307|NCT02419469|Methotrexate|methotrexate|mesh-list
20014308|NCT02419469|Vincristine|vincristine|mesh-list
20014309|NCT02419469|Daunorubicin|daunorubicin|mesh-list
20014310|NCT02419469|Asparaginase|asparaginase|mesh-list
20014311|NCT02419469|Mercaptopurine|mercaptopurine|mesh-list
20014312|NCT02419469|Ofatumumab|ofatumumab|mesh-list
20014313|NCT02419469|Pegaspargase|pegaspargase|mesh-list
20014314|NCT02419469|Thioguanine|thioguanine|mesh-list
20014315|NCT02419469|BB 1101|bb 1101|mesh-list
20014316|NCT02419469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20014317|NCT02419469|Immunologic Factors|immunologic factors|mesh-ancestor
20014318|NCT02419469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014319|NCT02419469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20014320|NCT02419469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20014321|NCT02419469|Alkylating Agents|alkylating agents|mesh-ancestor
20014322|NCT02419469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014323|NCT02419469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014324|NCT02419469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20014325|NCT02419469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20014326|NCT02419469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20014327|NCT02419469|Antiemetics|antiemetics|mesh-ancestor
20014328|NCT02419469|Autonomic Agents|autonomic agents|mesh-ancestor
20014329|NCT02419469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014330|NCT02419469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20014331|NCT02419469|Glucocorticoids|glucocorticoids|mesh-ancestor
20014332|NCT02419469|Hormones|hormones|mesh-ancestor
20014333|NCT02419469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20014334|NCT02419469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20014335|NCT02419469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20014336|NCT02419469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20014337|NCT02419469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20014338|NCT02419469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014339|NCT02419469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20014340|NCT02419469|Abortifacient Agents|abortifacient agents|mesh-ancestor
20014341|NCT02419469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20014342|NCT02419469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20014343|NCT02419469|Antimetabolites|antimetabolites|mesh-ancestor
20014344|NCT02419469|Dermatologic Agents|dermatologic agents|mesh-ancestor
20014345|NCT02419469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20014346|NCT02419469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20014347|NCT02419469|Antiviral Agents|antiviral agents|mesh-ancestor
20014348|NCT02419469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20014349|NCT02419469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20014350|NCT02419469|Tubulin Modulators|tubulin modulators|mesh-ancestor
20014351|NCT02419469|Antimitotic Agents|antimitotic agents|mesh-ancestor
20014352|NCT02419469|Mitosis Modulators|mitosis modulators|mesh-ancestor
20014353|NCT02419469|Protease Inhibitors|protease inhibitors|mesh-ancestor
20014354|NCT02419508|Brimonidine Tartrate|brimonidine tartrate|mesh-list
20014355|NCT02419508|Bimatoprost|bimatoprost|mesh-list
20014356|NCT02419508|Travoprost|travoprost|mesh-list
20014357|NCT02419508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20014358|NCT02419508|Latanoprost|latanoprost|mesh-list
20014359|NCT02419508|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20014360|NCT02419508|Brinzolamide|brinzolamide|mesh-list
20014361|NCT02419508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20014362|NCT02419508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20014363|NCT02419508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20014364|NCT02419508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20014365|NCT02419508|Adrenergic Agents|adrenergic agents|mesh-ancestor
20014366|NCT02419508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014367|NCT02419508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014368|NCT02419508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466869|NCT03301233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19466870|NCT03301233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19466871|NCT03301233|Vasodilator Agents|vasodilator agents|mesh-ancestor
19466872|NCT03301233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
19466873|NCT03301233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19466874|NCT03301233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19466875|NCT03301233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466876|NCT03301233|Urological Agents|urological agents|mesh-ancestor
19466877|NCT03301207|Midazolam|midazolam|mesh-list
19466878|NCT03301207|Bupropion|bupropion|mesh-list
20014369|NCT02419508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20014370|NCT02419508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014371|NCT02419547|Fentanyl|fentanyl|mesh-list
20014372|NCT02419547|Midazolam|midazolam|mesh-list
20014373|NCT02419547|Propofol|propofol|mesh-list
20014374|NCT02419547|Sevoflurane|sevoflurane|mesh-list
20014375|NCT02419547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20014376|NCT02419547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20014377|NCT02419547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014378|NCT02419547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20014379|NCT02419547|Anesthetics, General|anesthetics, general|mesh-ancestor
20014380|NCT02419547|Anesthetics|anesthetics|mesh-ancestor
20014381|NCT02419547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20014382|NCT02419547|Narcotics|narcotics|mesh-ancestor
20014383|NCT02419547|Analgesics|analgesics|mesh-ancestor
20014384|NCT02419547|Sensory System Agents|sensory system agents|mesh-ancestor
20014385|NCT02419547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014386|NCT02419547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20014387|NCT02419547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20014388|NCT02419547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20014389|NCT02419547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20014390|NCT02419547|GABA Modulators|gaba modulators|mesh-ancestor
20014391|NCT02419547|GABA Agents|gaba agents|mesh-ancestor
20014392|NCT02419547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014393|NCT02419547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014394|NCT02419547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20014395|NCT02419547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20014396|NCT02419612|Dapagliflozin|dapagliflozin|mesh-list
20014397|NCT02419612|Glimepiride|glimepiride|mesh-list
20014398|NCT02419612|Saxagliptin|saxagliptin|mesh-list
20014399|NCT02419612|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20014400|NCT02419612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014401|NCT02419612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20014402|NCT02419612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014403|NCT02419612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20014404|NCT02419612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20014405|NCT02419612|Immunologic Factors|immunologic factors|mesh-ancestor
20014406|NCT02419612|Incretins|incretins|mesh-ancestor
20014407|NCT02419612|Hormones|hormones|mesh-ancestor
20014408|NCT02419612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20014409|NCT02419612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20014410|NCT02419612|Protease Inhibitors|protease inhibitors|mesh-ancestor
20014411|NCT02419612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014412|NCT02419755|Cytarabine|cytarabine|mesh-list
19466879|NCT03301207|Levonorgestrel|levonorgestrel|mesh-list
19466880|NCT03301207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
19466881|NCT03301207|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
19466882|NCT03301207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19466883|NCT03301207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19466884|NCT03301207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466885|NCT03301207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466886|NCT03301207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19466887|NCT03301207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19466888|NCT03301207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19466889|NCT03301207|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19466890|NCT03301207|Anesthetics, General|anesthetics, general|mesh-ancestor
19466891|NCT03301207|Anesthetics|anesthetics|mesh-ancestor
19466892|NCT03301207|GABA Modulators|gaba modulators|mesh-ancestor
19466893|NCT03301207|GABA Agents|gaba agents|mesh-ancestor
19466894|NCT03301207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19466895|NCT03301207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466896|NCT03301207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19466897|NCT03301207|Antidepressive Agents|antidepressive agents|mesh-ancestor
19466898|NCT03301207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
19466899|NCT03301207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19466900|NCT03301207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19466901|NCT03301207|Dopamine Agents|dopamine agents|mesh-ancestor
19466902|NCT03301207|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19466903|NCT03301207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19466904|NCT03301207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19466905|NCT03301207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19466906|NCT03301207|Contraceptive Agents|contraceptive agents|mesh-ancestor
19466907|NCT03301207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19466908|NCT03301207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19466909|NCT03301207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
19466910|NCT03301207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
19466911|NCT03301207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
19466912|NCT03301207|Estrogens|estrogens|mesh-ancestor
19466913|NCT03301207|Hormones|hormones|mesh-ancestor
19466914|NCT03301207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19466915|NCT03301207|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
19466916|NCT03301181|Itraconazole|itraconazole|mesh-list
19466917|NCT03301181|Rifampin|rifampin|mesh-list
19466918|NCT03301181|Zanubrutinib|zanubrutinib|mesh-list
19466919|NCT03301181|Antifungal Agents|antifungal agents|mesh-ancestor
19466920|NCT03301181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19466921|NCT03301181|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
19466922|NCT03301181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19466923|NCT03301181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19466924|NCT03301181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466925|NCT03301181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
19466926|NCT03301181|Hormone Antagonists|hormone antagonists|mesh-ancestor
19466927|NCT03301181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19466928|NCT03301181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466929|NCT03301181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19466930|NCT03301181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
19466931|NCT03301181|Antitubercular Agents|antitubercular agents|mesh-ancestor
19466932|NCT03301181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19466933|NCT03301181|Leprostatic Agents|leprostatic agents|mesh-ancestor
20014413|NCT02419755|Dexamethasone|dexamethasone|mesh-list
20014414|NCT02419755|Hydrocortisone|hydrocortisone|mesh-list
20014415|NCT02419755|Doxorubicin|doxorubicin|mesh-list
20014416|NCT02419755|Methotrexate|methotrexate|mesh-list
20014417|NCT02419755|Bortezomib|bortezomib|mesh-list
20014418|NCT02419755|Asparaginase|asparaginase|mesh-list
20014419|NCT02419755|Mercaptopurine|mercaptopurine|mesh-list
20014420|NCT02419755|Mitoxantrone|mitoxantrone|mesh-list
20014421|NCT02419755|Vorinostat|vorinostat|mesh-list
20014422|NCT02419755|Pegaspargase|pegaspargase|mesh-list
20014423|NCT02419755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20014424|NCT02419755|Antiemetics|antiemetics|mesh-ancestor
19466934|NCT03301181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19466935|NCT03301181|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
19466936|NCT03301181|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
19466937|NCT03301181|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
19466938|NCT03301181|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
19466939|NCT03301181|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
19466940|NCT03301181|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
19466941|NCT03301181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466942|NCT03301181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19466943|NCT03301025|Pregabalin|pregabalin|mesh-list
19466944|NCT03301025|Analgesics|analgesics|mesh-ancestor
19466945|NCT03301025|Sensory System Agents|sensory system agents|mesh-ancestor
19466946|NCT03301025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466947|NCT03301025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466948|NCT03301025|Anticonvulsants|anticonvulsants|mesh-ancestor
19466949|NCT03301025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19466950|NCT03301025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19466951|NCT03301025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466952|NCT03301025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19466953|NCT03301025|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19466954|NCT03301025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19466955|NCT03301025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466956|NCT03301025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19466957|NCT03300960|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
19466958|NCT03300960|Ganirelix|ganirelix|mesh-list
19466959|NCT03300960|Hormone Antagonists|hormone antagonists|mesh-ancestor
20014425|NCT02419755|Autonomic Agents|autonomic agents|mesh-ancestor
20014426|NCT02419755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014427|NCT02419755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014428|NCT02419755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20014429|NCT02419755|Glucocorticoids|glucocorticoids|mesh-ancestor
20014430|NCT02419755|Hormones|hormones|mesh-ancestor
20014431|NCT02419755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20014432|NCT02419755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20014433|NCT02419755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014434|NCT02419755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20014435|NCT02419755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20014436|NCT02419755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20014437|NCT02419755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014438|NCT02419755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014439|NCT02419755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20014440|NCT02419755|Abortifacient Agents|abortifacient agents|mesh-ancestor
20014441|NCT02419755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20014442|NCT02419755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20014443|NCT02419755|Antimetabolites|antimetabolites|mesh-ancestor
20014444|NCT02419755|Dermatologic Agents|dermatologic agents|mesh-ancestor
20014445|NCT02419755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20014446|NCT02419755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20014447|NCT02419755|Immunologic Factors|immunologic factors|mesh-ancestor
20014448|NCT02419755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20014449|NCT02419755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20014450|NCT02419755|Antiviral Agents|antiviral agents|mesh-ancestor
20014451|NCT02419755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20014452|NCT02419755|Analgesics|analgesics|mesh-ancestor
20014453|NCT02419755|Sensory System Agents|sensory system agents|mesh-ancestor
20014454|NCT02419755|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
20014455|NCT02419807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20014456|NCT02419807|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
20014457|NCT02419807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19466960|NCT03300960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19466961|NCT03300960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466962|NCT03300960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19466963|NCT03300960|Contraceptive Agents|contraceptive agents|mesh-ancestor
19466964|NCT03300960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19466965|NCT03300960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19466966|NCT03300960|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
19466967|NCT03300960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19466968|NCT03300960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466969|NCT03300947|Lorazepam|lorazepam|mesh-list
19466970|NCT03300947|Psilocybin|psilocybin|mesh-list
19466971|NCT03300947|Anticonvulsants|anticonvulsants|mesh-ancestor
19466972|NCT03300947|Antiemetics|antiemetics|mesh-ancestor
19466973|NCT03300947|Autonomic Agents|autonomic agents|mesh-ancestor
19466974|NCT03300947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19466975|NCT03300947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466976|NCT03300947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19466977|NCT03300947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19466978|NCT03300947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19466979|NCT03300947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19466980|NCT03300947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19466981|NCT03300947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19466982|NCT03300947|GABA Modulators|gaba modulators|mesh-ancestor
19466983|NCT03300947|GABA Agents|gaba agents|mesh-ancestor
19466984|NCT03300947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19466985|NCT03300947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19466986|NCT03300947|Hallucinogens|hallucinogens|mesh-ancestor
19466987|NCT03300765|Apatinib|apatinib|mesh-list
19466988|NCT03300765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19466989|NCT03300765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19466990|NCT03300765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19466991|NCT03300765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014458|NCT02419807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014459|NCT02420015|Bupropion|bupropion|mesh-list
20014460|NCT02420015|Nicotine|nicotine|mesh-list
20014461|NCT02420015|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20014462|NCT02420015|Autonomic Agents|autonomic agents|mesh-ancestor
20014463|NCT02420015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014464|NCT02420015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014465|NCT02420015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20014466|NCT02420015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20014467|NCT02420015|Cholinergic Agents|cholinergic agents|mesh-ancestor
20014468|NCT02420015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014469|NCT02420015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014470|NCT02420015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20014471|NCT02420015|Antidepressive Agents|antidepressive agents|mesh-ancestor
20014472|NCT02420015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20014473|NCT02420015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20014474|NCT02420015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20014475|NCT02420015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20014476|NCT02420015|Dopamine Agents|dopamine agents|mesh-ancestor
20014477|NCT02420015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20014478|NCT02420015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20014479|NCT02420015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014480|NCT02420041|Triamcinolone|triamcinolone|mesh-list
20014481|NCT02420041|Lidocaine|lidocaine|mesh-list
20014482|NCT02420041|Anesthetics, Local|anesthetics, local|mesh-ancestor
20014483|NCT02420041|Anesthetics|anesthetics|mesh-ancestor
20014484|NCT02420041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20014485|NCT02420041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19466992|NCT03300609|Calcium, Dietary|calcium, dietary|mesh-list
19466993|NCT03300609|Leucovorin|leucovorin|mesh-list
19466994|NCT03300609|Folic Acid|folic acid|mesh-list
19466995|NCT03300609|Tetrahydrofolates|tetrahydrofolates|mesh-list
19466996|NCT03300609|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
19466997|NCT03300609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
19466998|NCT03300609|Panitumumab|panitumumab|mesh-list
19466999|NCT03300609|Fluorouracil|fluorouracil|mesh-list
19467000|NCT03300609|Capecitabine|capecitabine|mesh-list
19467001|NCT03300609|Oxaliplatin|oxaliplatin|mesh-list
19467002|NCT03300609|Antibodies|antibodies|mesh-list
19467003|NCT03300609|Immunoglobulins|immunoglobulins|mesh-list
19467004|NCT03300609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
19467005|NCT03300609|Calcium|calcium|mesh-list
19467006|NCT03300609|Levoleucovorin|levoleucovorin|mesh-list
19467007|NCT03300609|Immunologic Factors|immunologic factors|mesh-ancestor
19467008|NCT03300609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467009|NCT03300609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467010|NCT03300609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19467011|NCT03300609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19467012|NCT03300609|Antimetabolites|antimetabolites|mesh-ancestor
19467013|NCT03300609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467014|NCT03300609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19467015|NCT03300609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19467016|NCT03300609|Antidotes|antidotes|mesh-ancestor
19467017|NCT03300609|Protective Agents|protective agents|mesh-ancestor
19467018|NCT03300609|Vitamin B Complex|vitamin b complex|mesh-ancestor
19467019|NCT03300609|Vitamins|vitamins|mesh-ancestor
19467020|NCT03300609|Micronutrients|micronutrients|mesh-ancestor
19467021|NCT03300609|Hematinics|hematinics|mesh-ancestor
19467022|NCT03300531|Betamethasone|betamethasone|mesh-list
19467023|NCT03300531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19467024|NCT03300531|Glucocorticoids|glucocorticoids|mesh-ancestor
19467025|NCT03300531|Hormones|hormones|mesh-ancestor
19467026|NCT03300531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19467027|NCT03300531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467028|NCT03300531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19467029|NCT03300531|Respiratory System Agents|respiratory system agents|mesh-ancestor
19467030|NCT03300440|Vitamins|vitamins|mesh-list
19467031|NCT03300440|Biotin|biotin|mesh-list
19467032|NCT03300440|Vitamin B Complex|vitamin b complex|mesh-list
19467033|NCT03300440|Micronutrients|micronutrients|mesh-ancestor
19467034|NCT03300440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467035|NCT03300362|Vaccines|vaccines|mesh-list
19467036|NCT03300362|Immunologic Factors|immunologic factors|mesh-ancestor
19467037|NCT03300362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467038|NCT03300115|Abivertinib|abivertinib|mesh-list
19467039|NCT03300115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19467040|NCT03300115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467041|NCT03300115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467042|NCT03300089|Anesthetics|anesthetics|mesh-list
20014486|NCT02420041|Sensory System Agents|sensory system agents|mesh-ancestor
20014487|NCT02420041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014488|NCT02420041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20014489|NCT02420041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20014490|NCT02420041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20014491|NCT02420041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19467043|NCT03300089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19467044|NCT03300089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467045|NCT03299998|Anesthetics|anesthetics|mesh-list
20014492|NCT02420041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467046|NCT03299998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19467047|NCT03299998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467048|NCT03299946|Nivolumab|nivolumab|mesh-list
19467049|NCT03299946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19467050|NCT03299946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467051|NCT03299946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19467052|NCT03299946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467053|NCT03299842|Fenfluramine|fenfluramine|mesh-list
19467054|NCT03299842|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19467055|NCT03299842|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19467056|NCT03299842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19467057|NCT03299842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467058|NCT03299842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19467059|NCT03299842|Serotonin Agents|serotonin agents|mesh-ancestor
19467060|NCT03299842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467061|NCT03299829|Trientine|trientine|mesh-list
19467062|NCT03299829|Chelating Agents|chelating agents|mesh-ancestor
19467063|NCT03299829|Sequestering Agents|sequestering agents|mesh-ancestor
19467064|NCT03299829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467065|NCT03299725|Bismuth|bismuth|mesh-list
19467066|NCT03299725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467067|NCT03299725|Antacids|antacids|mesh-ancestor
19467068|NCT03299725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19467069|NCT03299712|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
19467070|NCT03299712|Vasodilator Agents|vasodilator agents|mesh-ancestor
19467071|NCT03299712|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
19467072|NCT03299712|Protective Agents|protective agents|mesh-ancestor
19467073|NCT03299712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467074|NCT03299621|Rocuronium|rocuronium|mesh-list
19467075|NCT03299621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
19467076|NCT03299621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
19467077|NCT03299621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19467078|NCT03299621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19467079|NCT03299621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467080|NCT03299517|Lidocaine|lidocaine|mesh-list
19467081|NCT03299517|Amiodarone|amiodarone|mesh-list
19467082|NCT03299517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
19467083|NCT03299517|Anesthetics, Local|anesthetics, local|mesh-ancestor
19467084|NCT03299517|Anesthetics|anesthetics|mesh-ancestor
19467085|NCT03299517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19467086|NCT03299517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467087|NCT03299517|Sensory System Agents|sensory system agents|mesh-ancestor
19467088|NCT03299517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19467089|NCT03299517|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19467090|NCT03299517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19467091|NCT03299517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19467092|NCT03299517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467093|NCT03299517|Vasodilator Agents|vasodilator agents|mesh-ancestor
19467094|NCT03299517|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
19467095|NCT03299517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
19467096|NCT03299517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19467097|NCT03299517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467098|NCT03299517|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
19467099|NCT03299517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
19467100|NCT03299517|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19467101|NCT03299426|Vaccines|vaccines|mesh-list
19467102|NCT03299426|Immunologic Factors|immunologic factors|mesh-ancestor
19467103|NCT03299426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467104|NCT03299387|Gentamicins|gentamicins|mesh-list
19467105|NCT03299387|Nitrofurantoin|nitrofurantoin|mesh-list
19467106|NCT03299387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19467107|NCT03299387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19467108|NCT03299387|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19467109|NCT03299387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467110|NCT03299387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467111|NCT03299387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
19467112|NCT03299387|Renal Agents|renal agents|mesh-ancestor
19467113|NCT03299296|Enoxaparin|enoxaparin|mesh-list
19467114|NCT03299296|Rivaroxaban|rivaroxaban|mesh-list
19467115|NCT03299296|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19467116|NCT03299296|Antithrombins|antithrombins|mesh-ancestor
19467117|NCT03299296|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19467118|NCT03299296|Protease Inhibitors|protease inhibitors|mesh-ancestor
20014493|NCT02420041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20014494|NCT02420041|Glucocorticoids|glucocorticoids|mesh-ancestor
20014495|NCT02420041|Hormones|hormones|mesh-ancestor
20014496|NCT02420041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20014497|NCT02420210|Dexamethasone|dexamethasone|mesh-list
19467119|NCT03299296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014498|NCT02420210|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20014499|NCT02420210|Obinutuzumab|obinutuzumab|mesh-list
20014500|NCT02420210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20014501|NCT02420210|Antiemetics|antiemetics|mesh-ancestor
20014502|NCT02420210|Autonomic Agents|autonomic agents|mesh-ancestor
20014503|NCT02420210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014504|NCT02420210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014505|NCT02420210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19467120|NCT03299296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467121|NCT03299296|Anticoagulants|anticoagulants|mesh-ancestor
19467122|NCT03299296|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19467123|NCT03299296|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19467124|NCT03299257|Donepezil|donepezil|mesh-list
19467125|NCT03299257|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19467126|NCT03299257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467127|NCT03299257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467128|NCT03299257|Cholinergic Agents|cholinergic agents|mesh-ancestor
19467129|NCT03299257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19467130|NCT03299257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467131|NCT03299257|Nootropic Agents|nootropic agents|mesh-ancestor
19467132|NCT03299036|Doxorubicin|doxorubicin|mesh-list
19467133|NCT03299036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19467134|NCT03299036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467135|NCT03299036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19467136|NCT03299036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19467137|NCT03299036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467138|NCT03299036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014506|NCT02420210|Glucocorticoids|glucocorticoids|mesh-ancestor
20014507|NCT02420210|Hormones|hormones|mesh-ancestor
20014508|NCT02420210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20014509|NCT02420210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20014510|NCT02420210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014511|NCT02420210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20014512|NCT02420210|Alkylating Agents|alkylating agents|mesh-ancestor
20014513|NCT02420210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014514|NCT02420210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20014515|NCT02420223|Propranolol|propranolol|mesh-list
20014516|NCT02420223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20014517|NCT02420223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20014518|NCT02420223|Adrenergic Agents|adrenergic agents|mesh-ancestor
20014519|NCT02420223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014520|NCT02420223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014521|NCT02420223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467139|NCT03298958|Sirolimus|sirolimus|mesh-list
19467140|NCT03298958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19467141|NCT03298958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19467142|NCT03298958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19467143|NCT03298958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467144|NCT03298958|Antifungal Agents|antifungal agents|mesh-ancestor
19467145|NCT03298958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19467146|NCT03298958|Immunologic Factors|immunologic factors|mesh-ancestor
19467147|NCT03298958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467148|NCT03298906|Ticlopidine|ticlopidine|mesh-list
19467149|NCT03298906|Esketamine|esketamine|mesh-list
19467150|NCT03298906|Antidepressive Agents|antidepressive agents|mesh-ancestor
19467151|NCT03298906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19467152|NCT03298906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19467153|NCT03298906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19467154|NCT03298906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467155|NCT03298906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19467156|NCT03298906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
19467157|NCT03298906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
19467158|NCT03298906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19467159|NCT03298906|Purinergic Agents|purinergic agents|mesh-ancestor
19467160|NCT03298906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19467161|NCT03298906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467162|NCT03298906|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
19467163|NCT03298906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19467164|NCT03298906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467165|NCT03298854|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
19467166|NCT03298854|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19467167|NCT03298854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467168|NCT03298815|Ophthalmic Solutions|ophthalmic solutions|mesh-list
19467169|NCT03298815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
19467170|NCT03298698|Prednisone|prednisone|mesh-list
19467171|NCT03298698|Prednisolone|prednisolone|mesh-list
19467172|NCT03298698|Rituximab|rituximab|mesh-list
19467173|NCT03298698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19467174|NCT03298698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467175|NCT03298698|Immunologic Factors|immunologic factors|mesh-ancestor
19467176|NCT03298698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467177|NCT03298698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19467178|NCT03298698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19467179|NCT03298698|Glucocorticoids|glucocorticoids|mesh-ancestor
19467180|NCT03298698|Hormones|hormones|mesh-ancestor
19467181|NCT03298698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19467182|NCT03298698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19467183|NCT03298646|Diclofenac|diclofenac|mesh-list
19467184|NCT03298646|Lidocaine|lidocaine|mesh-list
19467185|NCT03298646|Anesthetics, Local|anesthetics, local|mesh-ancestor
19467186|NCT03298646|Anesthetics|anesthetics|mesh-ancestor
19467187|NCT03298646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19467188|NCT03298646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467189|NCT03298646|Sensory System Agents|sensory system agents|mesh-ancestor
19467190|NCT03298646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19467191|NCT03298646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19467192|NCT03298646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
19467193|NCT03298646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
19467194|NCT03298646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19467195|NCT03298646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467196|NCT03298646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19467197|NCT03298646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19467198|NCT03298646|Analgesics|analgesics|mesh-ancestor
19467199|NCT03298646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19467200|NCT03298646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19467201|NCT03298646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19467202|NCT03298646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467203|NCT03298581|Clobetasol|clobetasol|mesh-list
19467204|NCT03298581|Halobetasol|halobetasol|mesh-list
19467205|NCT03298581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
19467206|NCT03298581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19467207|NCT03298581|Glucocorticoids|glucocorticoids|mesh-ancestor
19467208|NCT03298581|Hormones|hormones|mesh-ancestor
19467209|NCT03298581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19467210|NCT03298581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467211|NCT03298542|Golimumab|golimumab|mesh-list
19467212|NCT03298542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
19467213|NCT03298542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19467214|NCT03298542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19467215|NCT03298542|Immunologic Factors|immunologic factors|mesh-ancestor
19467216|NCT03298542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467217|NCT03298516|Azacitidine|azacitidine|mesh-list
19467218|NCT03298516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19467219|NCT03298516|Antimetabolites|antimetabolites|mesh-ancestor
19467220|NCT03298516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467221|NCT03298516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467222|NCT03298516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467223|NCT03298464|Pioglitazone|pioglitazone|mesh-list
19467224|NCT03298464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19467225|NCT03298464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467226|NCT03298373|Nandrolone Decanoate|nandrolone decanoate|mesh-list
19467227|NCT03298373|Nandrolone|nandrolone|mesh-list
19467228|NCT03298373|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
19467229|NCT03298373|Androgens|androgens|mesh-ancestor
19467230|NCT03298373|Hormones|hormones|mesh-ancestor
19467231|NCT03298373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19467232|NCT03298373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467233|NCT03298373|Anabolic Agents|anabolic agents|mesh-ancestor
19467234|NCT03298373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19467235|NCT03298347|Caffeine|caffeine|mesh-list
20014522|NCT02420223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20014523|NCT02420223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20014524|NCT02420223|Vasodilator Agents|vasodilator agents|mesh-ancestor
19467236|NCT03298347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19467237|NCT03298347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014525|NCT02420262|Insulin|insulin|mesh-list
20014526|NCT02420262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20014527|NCT02420262|Insulin Glargine|insulin glargine|mesh-list
20014528|NCT02420262|Insulin Aspart|insulin aspart|mesh-list
20014529|NCT02420262|Liraglutide|liraglutide|mesh-list
20014530|NCT02420262|Xultophy|xultophy|mesh-list
20014531|NCT02420262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19467238|NCT03298347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19467239|NCT03298347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467240|NCT03298347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467241|NCT03298347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19467242|NCT03298347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19467243|NCT03298347|Purinergic Agents|purinergic agents|mesh-ancestor
19467244|NCT03298347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19467245|NCT03298321|Azacitidine|azacitidine|mesh-list
19467246|NCT03298321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19467247|NCT03298321|Antimetabolites|antimetabolites|mesh-ancestor
19467248|NCT03298321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467249|NCT03298321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467250|NCT03298321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467251|NCT03298295|Insulin|insulin|mesh-list
19467252|NCT03298295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19467253|NCT03298295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467254|NCT03298191|Magnesium Sulfate|magnesium sulfate|mesh-list
19467255|NCT03298191|Calcium Channel Blockers|calcium channel blockers|mesh-list
19467256|NCT03298191|Ritodrine|ritodrine|mesh-list
19467257|NCT03298191|Calcium|calcium|mesh-list
19467258|NCT03298191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19467259|NCT03298191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467260|NCT03298191|Analgesics|analgesics|mesh-ancestor
19467261|NCT03298191|Sensory System Agents|sensory system agents|mesh-ancestor
19467262|NCT03298191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19467263|NCT03298191|Anesthetics|anesthetics|mesh-ancestor
19467264|NCT03298191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19467265|NCT03298191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19467266|NCT03298191|Anticonvulsants|anticonvulsants|mesh-ancestor
19467267|NCT03298191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19467268|NCT03298191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467269|NCT03298191|Tocolytic Agents|tocolytic agents|mesh-ancestor
19467270|NCT03298191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19467271|NCT03298191|Sympathomimetics|sympathomimetics|mesh-ancestor
19467272|NCT03298191|Autonomic Agents|autonomic agents|mesh-ancestor
19467273|NCT03298191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19467274|NCT03298191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19467275|NCT03298191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19467276|NCT03298191|Adrenergic Agents|adrenergic agents|mesh-ancestor
19467277|NCT03298191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19467278|NCT03298074|Etoposide|etoposide|mesh-list
19467279|NCT03298074|Apatinib|apatinib|mesh-list
19467280|NCT03298074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
19467281|NCT03298074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467282|NCT03298074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19467283|NCT03298074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19467284|NCT03298074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467285|NCT03298074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467286|NCT03298074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
19467287|NCT03298009|Canagliflozin|canagliflozin|mesh-list
19467288|NCT03298009|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
19467289|NCT03298009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467290|NCT03298009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19467291|NCT03298009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467292|NCT03297931|Iproplatin|iproplatin|mesh-list
19467293|NCT03297931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467294|NCT03297879|Metformin|metformin|mesh-list
19467295|NCT03297879|Exenatide|exenatide|mesh-list
19467296|NCT03297879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
19467297|NCT03297879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467298|NCT03297879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
19467299|NCT03297879|Incretins|incretins|mesh-ancestor
19467300|NCT03297879|Hormones|hormones|mesh-ancestor
19467301|NCT03297879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19467302|NCT03297593|Nivolumab|nivolumab|mesh-list
19467303|NCT03297593|Ipilimumab|ipilimumab|mesh-list
19467304|NCT03297593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19467305|NCT03297593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467306|NCT03297593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19467307|NCT03297593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467308|NCT03297502|Pimecrolimus|pimecrolimus|mesh-list
19467309|NCT03297502|Tacrolimus|tacrolimus|mesh-list
19467310|NCT03297502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19467311|NCT03297502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19467312|NCT03297502|Analgesics|analgesics|mesh-ancestor
19467313|NCT03297502|Sensory System Agents|sensory system agents|mesh-ancestor
19467314|NCT03297502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19467315|NCT03297502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467316|NCT03297502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19467317|NCT03297502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19467318|NCT03297502|Dermatologic Agents|dermatologic agents|mesh-ancestor
19467319|NCT03297502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19467320|NCT03297502|Immunologic Factors|immunologic factors|mesh-ancestor
19467321|NCT03297502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
19467322|NCT03297502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467323|NCT03297502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467324|NCT03297463|Ipilimumab|ipilimumab|mesh-list
19467325|NCT03297463|Interleukin-2|interleukin-2|mesh-list
19467326|NCT03297463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19467327|NCT03297463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467328|NCT03297463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19467329|NCT03297463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467330|NCT03297463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19467331|NCT03297463|Analgesics|analgesics|mesh-ancestor
19467332|NCT03297463|Sensory System Agents|sensory system agents|mesh-ancestor
19467333|NCT03297463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19467334|NCT03297463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467335|NCT03297359|Dalteparin|dalteparin|mesh-list
19467336|NCT03297359|Tinzaparin|tinzaparin|mesh-list
19467337|NCT03297359|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
19467338|NCT03297359|Anticoagulants|anticoagulants|mesh-ancestor
19467339|NCT03297359|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19467340|NCT03297359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19467341|NCT03297359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014532|NCT02420262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014533|NCT02420262|Incretins|incretins|mesh-ancestor
20014534|NCT02420262|Hormones|hormones|mesh-ancestor
20014535|NCT02420262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20014536|NCT02420327|Galantamine|galantamine|mesh-list
20014537|NCT02420327|Nicotine|nicotine|mesh-list
20014538|NCT02420327|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
20014539|NCT02420327|Autonomic Agents|autonomic agents|mesh-ancestor
20014540|NCT02420327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014541|NCT02420327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014542|NCT02420327|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
20014543|NCT02420327|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
20014544|NCT02420327|Cholinergic Agents|cholinergic agents|mesh-ancestor
20014545|NCT02420327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014546|NCT02420327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467342|NCT03297073|Acetaminophen|acetaminophen|mesh-list
19467343|NCT03297073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19467344|NCT03297073|Analgesics|analgesics|mesh-ancestor
19467345|NCT03297073|Sensory System Agents|sensory system agents|mesh-ancestor
19467346|NCT03297073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19467347|NCT03297073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467348|NCT03297073|Antipyretics|antipyretics|mesh-ancestor
19467349|NCT03296982|Enoxaparin|enoxaparin|mesh-list
19467350|NCT03296982|Edoxaban|edoxaban|mesh-list
19467351|NCT03296982|Anticoagulants|anticoagulants|mesh-ancestor
19467352|NCT03296982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19467353|NCT03296982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19467354|NCT03296982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467355|NCT03296982|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
19467356|NCT03296982|Antithrombins|antithrombins|mesh-ancestor
19467357|NCT03296982|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
19467358|NCT03296982|Protease Inhibitors|protease inhibitors|mesh-ancestor
19467359|NCT03296982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467360|NCT03296930|Ritonavir|ritonavir|mesh-list
19467361|NCT03296930|Ribavirin|ribavirin|mesh-list
19467362|NCT03296930|Sofosbuvir|sofosbuvir|mesh-list
19467363|NCT03296930|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
19467364|NCT03296930|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
19467365|NCT03296930|Protease Inhibitors|protease inhibitors|mesh-ancestor
19467366|NCT03296930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467367|NCT03296930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467368|NCT03296930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19467369|NCT03296930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19467370|NCT03296930|Antiviral Agents|antiviral agents|mesh-ancestor
19467371|NCT03296930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19467372|NCT03296930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
19467373|NCT03296930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
19467374|NCT03296930|Antimetabolites|antimetabolites|mesh-ancestor
19467375|NCT03296670|Nitroglycerin|nitroglycerin|mesh-list
19467376|NCT03296670|Alprostadil|alprostadil|mesh-list
19467377|NCT03296670|Vasodilator Agents|vasodilator agents|mesh-ancestor
19467378|NCT03296670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19467379|NCT03296670|Urological Agents|urological agents|mesh-ancestor
19467380|NCT03296657|Fluorides|fluorides|mesh-list
19467381|NCT03296657|Tin Fluorides|tin fluorides|mesh-list
19467382|NCT03296657|Cariostatic Agents|cariostatic agents|mesh-ancestor
19467383|NCT03296657|Protective Agents|protective agents|mesh-ancestor
19467384|NCT03296657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014547|NCT02420327|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
20014548|NCT02420327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467385|NCT03296579|Magnesium Sulfate|magnesium sulfate|mesh-list
19467386|NCT03296579|Aminophylline|aminophylline|mesh-list
19467387|NCT03296579|Albuterol|albuterol|mesh-list
19467388|NCT03296579|Ipratropium|ipratropium|mesh-list
19467389|NCT03296579|Analgesics|analgesics|mesh-ancestor
19467390|NCT03296579|Sensory System Agents|sensory system agents|mesh-ancestor
19467391|NCT03296579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19467392|NCT03296579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467393|NCT03296579|Anesthetics|anesthetics|mesh-ancestor
19467394|NCT03296579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19467395|NCT03296579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
19467396|NCT03296579|Anticonvulsants|anticonvulsants|mesh-ancestor
19467397|NCT03296579|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19467398|NCT03296579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19467399|NCT03296579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467400|NCT03296579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19467401|NCT03296579|Tocolytic Agents|tocolytic agents|mesh-ancestor
19467402|NCT03296579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19467403|NCT03296579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
19467404|NCT03296579|Autonomic Agents|autonomic agents|mesh-ancestor
19467405|NCT03296579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
19467406|NCT03296579|Respiratory System Agents|respiratory system agents|mesh-ancestor
19467407|NCT03296579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
19467408|NCT03296579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
19467409|NCT03296579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19467410|NCT03296579|Adrenergic Agents|adrenergic agents|mesh-ancestor
19467411|NCT03296579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19467412|NCT03296579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
19467413|NCT03296579|Cholinergic Agents|cholinergic agents|mesh-ancestor
19467414|NCT03296579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19467415|NCT03296579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19467416|NCT03296579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014549|NCT02420327|Parasympathomimetics|parasympathomimetics|mesh-ancestor
20014550|NCT02420327|Nootropic Agents|nootropic agents|mesh-ancestor
20014551|NCT02420873|Maytansine|maytansine|mesh-list
20014552|NCT02420873|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
20014553|NCT02420873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20014554|NCT02420873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014555|NCT02420873|Tubulin Modulators|tubulin modulators|mesh-ancestor
20014556|NCT02420873|Antimitotic Agents|antimitotic agents|mesh-ancestor
19467417|NCT03296579|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19467418|NCT03296579|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19467419|NCT03296579|Purinergic Agents|purinergic agents|mesh-ancestor
19467420|NCT03296579|Protective Agents|protective agents|mesh-ancestor
19467421|NCT03296540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
19467422|NCT03296540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19467423|NCT03296488|Fentanyl|fentanyl|mesh-list
19467424|NCT03296488|Nalbuphine|nalbuphine|mesh-list
19467425|NCT03296488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19467426|NCT03296488|Narcotics|narcotics|mesh-ancestor
19467427|NCT03296488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19467428|NCT03296488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467429|NCT03296488|Analgesics|analgesics|mesh-ancestor
19467430|NCT03296488|Sensory System Agents|sensory system agents|mesh-ancestor
19467431|NCT03296488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19467432|NCT03296488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19467433|NCT03296488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19467434|NCT03296488|Anesthetics, General|anesthetics, general|mesh-ancestor
19467435|NCT03296488|Anesthetics|anesthetics|mesh-ancestor
19467436|NCT03296423|Vaccines|vaccines|mesh-list
19467437|NCT03296423|Immunologic Factors|immunologic factors|mesh-ancestor
19467438|NCT03296423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467439|NCT03296410|Vaccines|vaccines|mesh-list
19467440|NCT03296410|Immunoglobulins|immunoglobulins|mesh-list
19467441|NCT03296410|Immunologic Factors|immunologic factors|mesh-ancestor
19467442|NCT03296410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467443|NCT03296397|Vaccines|vaccines|mesh-list
19467444|NCT03296397|Immunologic Factors|immunologic factors|mesh-ancestor
19467445|NCT03296397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467446|NCT03296358|Dexamethasone|dexamethasone|mesh-list
19467447|NCT03296358|Prednisolone|prednisolone|mesh-list
19467448|NCT03296358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19467449|NCT03296358|Antiemetics|antiemetics|mesh-ancestor
19467450|NCT03296358|Autonomic Agents|autonomic agents|mesh-ancestor
19467451|NCT03296358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19467452|NCT03296358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467453|NCT03296358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19467454|NCT03296358|Glucocorticoids|glucocorticoids|mesh-ancestor
19467455|NCT03296358|Hormones|hormones|mesh-ancestor
19467456|NCT03296358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19467457|NCT03296358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19467458|NCT03296358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467459|NCT03296306|Cisplatin|cisplatin|mesh-list
19467460|NCT03296306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467461|NCT03296189|Dexamethasone|dexamethasone|mesh-list
19467462|NCT03296189|Dexamethasone acetate|dexamethasone acetate|mesh-list
19467463|NCT03296189|Levobupivacaine|levobupivacaine|mesh-list
19467464|NCT03296189|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
19467465|NCT03296189|BB 1101|bb 1101|mesh-list
19467466|NCT03296189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19467467|NCT03296189|Antiemetics|antiemetics|mesh-ancestor
19467468|NCT03296189|Autonomic Agents|autonomic agents|mesh-ancestor
19467469|NCT03296189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19467470|NCT03296189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467471|NCT03296189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
19467472|NCT03296189|Glucocorticoids|glucocorticoids|mesh-ancestor
19467473|NCT03296189|Hormones|hormones|mesh-ancestor
19467474|NCT03296189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19467475|NCT03296189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
19467476|NCT03296189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467477|NCT03296189|Anesthetics, Local|anesthetics, local|mesh-ancestor
19467478|NCT03296189|Anesthetics|anesthetics|mesh-ancestor
20014557|NCT02420873|Mitosis Modulators|mitosis modulators|mesh-ancestor
20014558|NCT02420873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014559|NCT02420873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20014560|NCT02420951|Bupivacaine|bupivacaine|mesh-list
20014561|NCT02420951|Anesthetics, Local|anesthetics, local|mesh-ancestor
20014562|NCT02420951|Anesthetics|anesthetics|mesh-ancestor
20014563|NCT02420951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19467479|NCT03296189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19467480|NCT03296189|Sensory System Agents|sensory system agents|mesh-ancestor
19467481|NCT03296189|Protease Inhibitors|protease inhibitors|mesh-ancestor
19467482|NCT03296189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467483|NCT03296189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467484|NCT03296137|Aldesleukin|aldesleukin|mesh-list
19467485|NCT03296137|Cyclophosphamide|cyclophosphamide|mesh-list
19467486|NCT03296137|Nivolumab|nivolumab|mesh-list
19467487|NCT03296137|Ipilimumab|ipilimumab|mesh-list
19467488|NCT03296137|Fludarabine phosphate|fludarabine phosphate|mesh-list
19467489|NCT03296137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19467490|NCT03296137|Immunologic Factors|immunologic factors|mesh-ancestor
19467491|NCT03296137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467492|NCT03296137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19467493|NCT03296137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19467494|NCT03296137|Alkylating Agents|alkylating agents|mesh-ancestor
19467495|NCT03296137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467496|NCT03296137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467497|NCT03296137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19467498|NCT03296137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19467499|NCT03296137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
19467500|NCT03296137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19467501|NCT03296137|Antimetabolites|antimetabolites|mesh-ancestor
19467502|NCT03296137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
19467503|NCT03296137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
19467504|NCT03296137|Antiviral Agents|antiviral agents|mesh-ancestor
19467505|NCT03296137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19467506|NCT03296098|Ulipristal acetate|ulipristal acetate|mesh-list
19467507|NCT03296098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
19467508|NCT03296098|Contraceptive Agents|contraceptive agents|mesh-ancestor
19467509|NCT03296098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19467510|NCT03296098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467511|NCT03296098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
19467512|NCT03295968|Ibuprofen|ibuprofen|mesh-list
19467513|NCT03295968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
19467514|NCT03295968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19467515|NCT03295968|Analgesics|analgesics|mesh-ancestor
19467516|NCT03295968|Sensory System Agents|sensory system agents|mesh-ancestor
19467517|NCT03295968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19467518|NCT03295968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467519|NCT03295968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19467520|NCT03295968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19467521|NCT03295968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
19467522|NCT03295968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467523|NCT03295968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467524|NCT03295955|Amoxicillin|amoxicillin|mesh-list
19467525|NCT03295955|Clavulanic Acid|clavulanic acid|mesh-list
19467526|NCT03295955|Clavulanic Acids|clavulanic acids|mesh-list
19467527|NCT03295955|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
19467528|NCT03295955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19467529|NCT03295955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19467530|NCT03295955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
19467531|NCT03295955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467532|NCT03295955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467533|NCT03295903|Cannabidiol|cannabidiol|mesh-list
19467534|NCT03295903|Anticonvulsants|anticonvulsants|mesh-ancestor
19467535|NCT03295851|Iron|iron|mesh-list
19467536|NCT03295851|Ferrous fumarate|ferrous fumarate|mesh-list
19467537|NCT03295851|Trace Elements|trace elements|mesh-ancestor
19467538|NCT03295851|Micronutrients|micronutrients|mesh-ancestor
19467539|NCT03295851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467540|NCT03295825|Heparin|heparin|mesh-list
19467541|NCT03295825|Anticoagulants|anticoagulants|mesh-ancestor
19467542|NCT03295825|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
19467543|NCT03295825|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
19467544|NCT03295825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467545|NCT03295786|Dopamine|dopamine|mesh-list
19467546|NCT03295786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
19467547|NCT03295786|Sympathomimetics|sympathomimetics|mesh-ancestor
19467548|NCT03295786|Autonomic Agents|autonomic agents|mesh-ancestor
19467549|NCT03295786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19467550|NCT03295786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467551|NCT03295786|Dopamine Agents|dopamine agents|mesh-ancestor
19467552|NCT03295786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19467553|NCT03295786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467554|NCT03295786|Protective Agents|protective agents|mesh-ancestor
19467555|NCT03295760|Ubiquinone|ubiquinone|mesh-list
19467556|NCT03295760|Coenzyme Q10|coenzyme q10|mesh-list
19467557|NCT03295760|Micronutrients|micronutrients|mesh-ancestor
19467558|NCT03295760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467559|NCT03295760|Vitamins|vitamins|mesh-ancestor
19467560|NCT03295695|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
19467561|NCT03295695|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
19467562|NCT03295695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014564|NCT02420951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014565|NCT02420951|Sensory System Agents|sensory system agents|mesh-ancestor
20014566|NCT02420951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014567|NCT02421120|Tazobactam|tazobactam|mesh-list
20014568|NCT02421120|Ceftolozane|ceftolozane|mesh-list
20014569|NCT02421120|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
20014570|NCT02421120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20014571|NCT02421120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20014572|NCT02421120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20014573|NCT02421120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014574|NCT02421120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467563|NCT03295487|Estrogens|estrogens|mesh-list
19467564|NCT03295487|Hormones|hormones|mesh-ancestor
19467565|NCT03295487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19467566|NCT03295487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467567|NCT03295461|Chlorhexidine|chlorhexidine|mesh-list
19467568|NCT03295461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19467569|NCT03295461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19467570|NCT03295461|Disinfectants|disinfectants|mesh-ancestor
19467571|NCT03295383|Cyclophosphamide|cyclophosphamide|mesh-list
19467572|NCT03295383|Rituximab|rituximab|mesh-list
19467573|NCT03295383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19467574|NCT03295383|Immunologic Factors|immunologic factors|mesh-ancestor
19467575|NCT03295383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467576|NCT03295383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19467577|NCT03295383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19467578|NCT03295383|Alkylating Agents|alkylating agents|mesh-ancestor
19467579|NCT03295383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467580|NCT03295383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467581|NCT03295383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19467582|NCT03295383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19467583|NCT03295227|Pembrolizumab|pembrolizumab|mesh-list
19467584|NCT03295227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19467585|NCT03295227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467586|NCT03295214|Acetaminophen|acetaminophen|mesh-list
19467587|NCT03295214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19467588|NCT03295214|Analgesics|analgesics|mesh-ancestor
19467589|NCT03295214|Sensory System Agents|sensory system agents|mesh-ancestor
19467590|NCT03295214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19467591|NCT03295214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467592|NCT03295214|Antipyretics|antipyretics|mesh-ancestor
19467593|NCT03295162|Melatonin|melatonin|mesh-list
19467594|NCT03295162|Antioxidants|antioxidants|mesh-ancestor
19467595|NCT03295162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467596|NCT03295162|Protective Agents|protective agents|mesh-ancestor
19467597|NCT03295162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467598|NCT03295162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19467599|NCT03295110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
19467600|NCT03295084|Capecitabine|capecitabine|mesh-list
19467601|NCT03295084|Irinotecan|irinotecan|mesh-list
19467602|NCT03295084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19467603|NCT03295084|Antimetabolites|antimetabolites|mesh-ancestor
19467604|NCT03295084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467605|NCT03295084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467606|NCT03295084|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
19467607|NCT03295084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19467608|NCT03295084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467609|NCT03294967|Vitamin E|vitamin e|mesh-list
19467610|NCT03294967|Caffeine|caffeine|mesh-list
19467611|NCT03294967|Vitamins|vitamins|mesh-ancestor
19467612|NCT03294967|Micronutrients|micronutrients|mesh-ancestor
19467613|NCT03294967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467614|NCT03294967|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
19467615|NCT03294967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
19467616|NCT03294967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014575|NCT02421120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20014576|NCT02421120|Renal Agents|renal agents|mesh-ancestor
20014577|NCT02421211|Sofosbuvir|sofosbuvir|mesh-list
20014578|NCT02421211|Ledipasvir|ledipasvir|mesh-list
20014579|NCT02421211|Simeprevir|simeprevir|mesh-list
19467617|NCT03294967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467618|NCT03294967|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
19467619|NCT03294967|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
19467620|NCT03294967|Purinergic Agents|purinergic agents|mesh-ancestor
20014580|NCT02421211|Antiviral Agents|antiviral agents|mesh-ancestor
20014581|NCT02421211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20014582|NCT02421211|Protease Inhibitors|protease inhibitors|mesh-ancestor
20014583|NCT02421211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014584|NCT02421211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014585|NCT02421354|Nivolumab|nivolumab|mesh-list
20014586|NCT02421354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20014587|NCT02421354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014588|NCT02421354|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20014589|NCT02421354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014590|NCT02421419|Dexamethasone|dexamethasone|mesh-list
20014591|NCT02421419|Dexamethasone acetate|dexamethasone acetate|mesh-list
20014592|NCT02421419|Lidocaine|lidocaine|mesh-list
19467621|NCT03294967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19467622|NCT03294967|Antioxidants|antioxidants|mesh-ancestor
19467623|NCT03294967|Protective Agents|protective agents|mesh-ancestor
19467624|NCT03294798|Interferons|interferons|mesh-list
19467625|NCT03294798|Interferon-alpha|interferon-alpha|mesh-list
19467626|NCT03294798|Interferon alpha-2|interferon alpha-2|mesh-list
19467627|NCT03294798|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
19467628|NCT03294798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467629|NCT03294798|Antiviral Agents|antiviral agents|mesh-ancestor
19467630|NCT03294798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19467631|NCT03294798|Immunologic Factors|immunologic factors|mesh-ancestor
19467632|NCT03294798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467633|NCT03294772|Hand Sanitizers|hand sanitizers|mesh-list
19467634|NCT03294772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
19467635|NCT03294772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19467636|NCT03294772|Disinfectants|disinfectants|mesh-ancestor
19467637|NCT03294707|Coal Tar|coal tar|mesh-list
19467638|NCT03294707|Keratolytic Agents|keratolytic agents|mesh-ancestor
19467639|NCT03294707|Dermatologic Agents|dermatologic agents|mesh-ancestor
19467640|NCT03294577|Cyclophosphamide|cyclophosphamide|mesh-list
19467641|NCT03294577|Docetaxel|docetaxel|mesh-list
19467642|NCT03294577|Doxorubicin|doxorubicin|mesh-list
19467643|NCT03294577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19467644|NCT03294577|Immunologic Factors|immunologic factors|mesh-ancestor
19467645|NCT03294577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467646|NCT03294577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
19467647|NCT03294577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
19467648|NCT03294577|Alkylating Agents|alkylating agents|mesh-ancestor
19467649|NCT03294577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467650|NCT03294577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467651|NCT03294577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
19467652|NCT03294577|Tubulin Modulators|tubulin modulators|mesh-ancestor
19467653|NCT03294577|Antimitotic Agents|antimitotic agents|mesh-ancestor
19467654|NCT03294577|Mitosis Modulators|mitosis modulators|mesh-ancestor
19467655|NCT03294577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19467656|NCT03294577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
19467657|NCT03294577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
19467658|NCT03294577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467659|NCT03294551|Vaccines|vaccines|mesh-list
19467660|NCT03294551|Immunologic Factors|immunologic factors|mesh-ancestor
19467661|NCT03294551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467662|NCT03294525|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
19467663|NCT03294525|Mirtazapine|mirtazapine|mesh-list
19467664|NCT03294525|Citalopram|citalopram|mesh-list
19467665|NCT03294525|Antidepressive Agents|antidepressive agents|mesh-list
19467666|NCT03294525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
19467667|NCT03294525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
19467668|NCT03294525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19467669|NCT03294525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467670|NCT03294525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19467671|NCT03294525|Serotonin Agents|serotonin agents|mesh-ancestor
19467672|NCT03294525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467673|NCT03294525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
19467674|NCT03294525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
19467675|NCT03294525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19467676|NCT03294525|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
19467677|NCT03294525|Analgesics|analgesics|mesh-ancestor
19467678|NCT03294525|Sensory System Agents|sensory system agents|mesh-ancestor
19467679|NCT03294525|Dopamine Agents|dopamine agents|mesh-ancestor
19467680|NCT03294525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
19467681|NCT03294525|Histamine Antagonists|histamine antagonists|mesh-ancestor
19467682|NCT03294525|Histamine Agents|histamine agents|mesh-ancestor
19467683|NCT03294525|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
19467684|NCT03294525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
19467685|NCT03294525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19467686|NCT03294525|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
19467687|NCT03294525|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
19467688|NCT03294525|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
19467689|NCT03294525|Adrenergic Agents|adrenergic agents|mesh-ancestor
19467690|NCT03294525|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
19467691|NCT03294525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
19467692|NCT03294525|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
19467693|NCT03294486|Flucytosine|flucytosine|mesh-list
19467694|NCT03294486|Antifungal Agents|antifungal agents|mesh-ancestor
19467695|NCT03294486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19467696|NCT03294486|Antimetabolites|antimetabolites|mesh-ancestor
19467697|NCT03294486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467698|NCT03294395|Gentamicins|gentamicins|mesh-list
19467699|NCT03294395|Ceftriaxone|ceftriaxone|mesh-list
19467700|NCT03294395|Fosfomycin|fosfomycin|mesh-list
19467701|NCT03294395|Ertapenem|ertapenem|mesh-list
19467702|NCT03294395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19467703|NCT03294395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19467704|NCT03294395|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
19467705|NCT03294395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467706|NCT03294395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467707|NCT03294382|Botulinum Toxins|botulinum toxins|mesh-list
19467708|NCT03294382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
19467709|NCT03294382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
19467710|NCT03294382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
19467711|NCT03294382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19467712|NCT03294382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467713|NCT03294382|Cholinergic Agents|cholinergic agents|mesh-ancestor
19467714|NCT03294382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19467715|NCT03294382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467716|NCT03294382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
19467717|NCT03294382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19467718|NCT03294252|Leucovorin|leucovorin|mesh-list
19467719|NCT03294252|Folic Acid|folic acid|mesh-list
19467720|NCT03294252|Fluorouracil|fluorouracil|mesh-list
19467721|NCT03294252|Oxaliplatin|oxaliplatin|mesh-list
19467722|NCT03294252|Levoleucovorin|levoleucovorin|mesh-list
19467723|NCT03294252|Antimetabolites|antimetabolites|mesh-ancestor
19467724|NCT03294252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467725|NCT03294252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
19467726|NCT03294252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467727|NCT03294252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19467728|NCT03294252|Immunologic Factors|immunologic factors|mesh-ancestor
19467729|NCT03294252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467730|NCT03294252|Antidotes|antidotes|mesh-ancestor
19467731|NCT03294252|Protective Agents|protective agents|mesh-ancestor
19467732|NCT03294252|Vitamin B Complex|vitamin b complex|mesh-ancestor
19467733|NCT03294252|Vitamins|vitamins|mesh-ancestor
19467734|NCT03294252|Micronutrients|micronutrients|mesh-ancestor
19467735|NCT03294252|Hematinics|hematinics|mesh-ancestor
19467736|NCT03294174|Ropivacaine|ropivacaine|mesh-list
19467737|NCT03294174|Anesthetics, Local|anesthetics, local|mesh-ancestor
19467738|NCT03294174|Anesthetics|anesthetics|mesh-ancestor
19467739|NCT03294174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19467740|NCT03294174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467741|NCT03294174|Sensory System Agents|sensory system agents|mesh-ancestor
19467742|NCT03294174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19467743|NCT03294161|Meglumine Antimoniate|meglumine antimoniate|mesh-list
19467744|NCT03294161|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19467745|NCT03294161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19467746|NCT03294161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19467747|NCT03294083|Cemiplimab|cemiplimab|mesh-list
19467748|NCT03294083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
19467749|NCT03294083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467750|NCT03294070|Amlodipine|amlodipine|mesh-list
19467751|NCT03294070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
19467752|NCT03294070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
19467753|NCT03294070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
19467754|NCT03294070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467755|NCT03294070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19467756|NCT03294070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467757|NCT03294070|Vasodilator Agents|vasodilator agents|mesh-ancestor
19467758|NCT03293992|Latanoprost|latanoprost|mesh-list
19467759|NCT03293992|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
19467760|NCT03293992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20014593|NCT02421419|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20014594|NCT02421419|BB 1101|bb 1101|mesh-list
20014595|NCT02421419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20014596|NCT02421419|Antiemetics|antiemetics|mesh-ancestor
20014597|NCT02421419|Autonomic Agents|autonomic agents|mesh-ancestor
20014598|NCT02421419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014599|NCT02421419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014600|NCT02421419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20014601|NCT02421419|Glucocorticoids|glucocorticoids|mesh-ancestor
20014602|NCT02421419|Hormones|hormones|mesh-ancestor
20014603|NCT02421419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20014604|NCT02421419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20014605|NCT02421419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014606|NCT02421419|Anesthetics, Local|anesthetics, local|mesh-ancestor
20014607|NCT02421419|Anesthetics|anesthetics|mesh-ancestor
20014608|NCT02421419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20014609|NCT02421419|Sensory System Agents|sensory system agents|mesh-ancestor
20014610|NCT02421419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20014611|NCT02421419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20014612|NCT02421419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20014613|NCT02421419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20014614|NCT02421419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014615|NCT02421419|Protease Inhibitors|protease inhibitors|mesh-ancestor
20014616|NCT02421419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014617|NCT02421510|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20014618|NCT02421510|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20014619|NCT02421510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014620|NCT02421510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20014621|NCT02421510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014622|NCT02421588|Doxorubicin|doxorubicin|mesh-list
20014623|NCT02421588|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20014624|NCT02421588|Topotecan|topotecan|mesh-list
19467761|NCT03293927|Fentanyl|fentanyl|mesh-list
19467762|NCT03293927|Dexmedetomidine|dexmedetomidine|mesh-list
19467763|NCT03293927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19467764|NCT03293927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19467765|NCT03293927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467766|NCT03293927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19467767|NCT03293927|Analgesics|analgesics|mesh-ancestor
19467768|NCT03293927|Sensory System Agents|sensory system agents|mesh-ancestor
19467769|NCT03293927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19467770|NCT03293927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19467771|NCT03293927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19467772|NCT03293927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19467773|NCT03293927|Adrenergic Agents|adrenergic agents|mesh-ancestor
19467774|NCT03293927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19467775|NCT03293927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467776|NCT03293927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
19467777|NCT03293927|Narcotics|narcotics|mesh-ancestor
19467778|NCT03293927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
19467779|NCT03293927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
19467780|NCT03293927|Anesthetics, General|anesthetics, general|mesh-ancestor
19467781|NCT03293927|Anesthetics|anesthetics|mesh-ancestor
19467782|NCT03293641|Folic Acid|folic acid|mesh-list
19467783|NCT03293641|Penicillins|penicillins|mesh-list
19467784|NCT03293641|Penicillin V|penicillin v|mesh-list
19467785|NCT03293641|Proguanil|proguanil|mesh-list
19467786|NCT03293641|Hydroxyurea|hydroxyurea|mesh-list
19467787|NCT03293641|Zinc Sulfate|zinc sulfate|mesh-list
19467788|NCT03293641|Hematinics|hematinics|mesh-ancestor
19467789|NCT03293641|Vitamin B Complex|vitamin b complex|mesh-ancestor
19467790|NCT03293641|Vitamins|vitamins|mesh-ancestor
19467791|NCT03293641|Micronutrients|micronutrients|mesh-ancestor
19467792|NCT03293641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467793|NCT03293641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
19467794|NCT03293641|Antisickling Agents|antisickling agents|mesh-ancestor
19467795|NCT03293641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467796|NCT03293641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467797|NCT03293641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
19467798|NCT03293641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
19467799|NCT03293641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
19467800|NCT03293641|Astringents|astringents|mesh-ancestor
19467801|NCT03293641|Dermatologic Agents|dermatologic agents|mesh-ancestor
19467802|NCT03293641|Antimalarials|antimalarials|mesh-ancestor
19467803|NCT03293641|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
19467804|NCT03293641|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
19467805|NCT03293641|Antimetabolites|antimetabolites|mesh-ancestor
19467806|NCT03293511|Oxytocin|oxytocin|mesh-list
19467807|NCT03293511|Oxytocics|oxytocics|mesh-ancestor
19467808|NCT03293511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
19467809|NCT03293511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467810|NCT03293472|Bupivacaine|bupivacaine|mesh-list
19467811|NCT03293472|Ropivacaine|ropivacaine|mesh-list
19467812|NCT03293472|Anesthetics, Local|anesthetics, local|mesh-ancestor
19467813|NCT03293472|Anesthetics|anesthetics|mesh-ancestor
19467814|NCT03293472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19467815|NCT03293472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467816|NCT03293472|Sensory System Agents|sensory system agents|mesh-ancestor
19467817|NCT03293472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19467818|NCT03293407|Iloprost|iloprost|mesh-list
19467819|NCT03293407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
19467820|NCT03293407|Vasodilator Agents|vasodilator agents|mesh-ancestor
19467821|NCT03293368|Triamcinolone|triamcinolone|mesh-list
19467822|NCT03293368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
19467823|NCT03293368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
19467824|NCT03293368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
19467825|NCT03293368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
19467826|NCT03293368|Glucocorticoids|glucocorticoids|mesh-ancestor
19467827|NCT03293368|Hormones|hormones|mesh-ancestor
19467828|NCT03293368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
19467829|NCT03293368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467830|NCT03293368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
19467831|NCT03293368|Immunologic Factors|immunologic factors|mesh-ancestor
19467832|NCT03293368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467833|NCT03293368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467834|NCT03293277|Dexmedetomidine|dexmedetomidine|mesh-list
19467835|NCT03293277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
19467836|NCT03293277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
19467837|NCT03293277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467838|NCT03293277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
19467839|NCT03293277|Analgesics|analgesics|mesh-ancestor
19467840|NCT03293277|Sensory System Agents|sensory system agents|mesh-ancestor
19467841|NCT03293277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19467842|NCT03293277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
19467843|NCT03293277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
19467844|NCT03293277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
19467845|NCT03293277|Adrenergic Agents|adrenergic agents|mesh-ancestor
19467846|NCT03293277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19467847|NCT03293277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467848|NCT03293108|Vitamin D|vitamin d|mesh-list
19467849|NCT03293108|Denosumab|denosumab|mesh-list
19467850|NCT03293108|Calcium|calcium|mesh-list
19467851|NCT03293108|Vitamins|vitamins|mesh-ancestor
19467852|NCT03293108|Micronutrients|micronutrients|mesh-ancestor
19467853|NCT03293108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467854|NCT03293108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
19467855|NCT03293108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
19467856|NCT03293069|Deferiprone|deferiprone|mesh-list
19467857|NCT03293069|Iron Chelating Agents|iron chelating agents|mesh-ancestor
19467858|NCT03293069|Chelating Agents|chelating agents|mesh-ancestor
19467859|NCT03293069|Sequestering Agents|sequestering agents|mesh-ancestor
19467860|NCT03293069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467861|NCT03293004|Vitamins|vitamins|mesh-list
19467862|NCT03293004|Ascorbic Acid|ascorbic acid|mesh-list
19467863|NCT03293004|Micronutrients|micronutrients|mesh-ancestor
19467864|NCT03293004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467865|NCT03293004|Antioxidants|antioxidants|mesh-ancestor
20014625|NCT02421588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
19467866|NCT03293004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467867|NCT03293004|Protective Agents|protective agents|mesh-ancestor
19467868|NCT03292965|Neostigmine|neostigmine|mesh-list
19467869|NCT03292965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
19467870|NCT03292965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
19467871|NCT03292965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467872|NCT03292965|Cholinergic Agents|cholinergic agents|mesh-ancestor
19467873|NCT03292965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19467874|NCT03292965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467875|NCT03292965|Parasympathomimetics|parasympathomimetics|mesh-ancestor
19467876|NCT03292965|Autonomic Agents|autonomic agents|mesh-ancestor
19467877|NCT03292965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
19467878|NCT03292848|Brexpiprazole|brexpiprazole|mesh-list
19467879|NCT03292848|Serotonin Agents|serotonin agents|mesh-ancestor
19467880|NCT03292848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
19467881|NCT03292848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
19467882|NCT03292848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
19467883|NCT03292848|Dopamine Agonists|dopamine agonists|mesh-ancestor
19467884|NCT03292848|Dopamine Agents|dopamine agents|mesh-ancestor
20014626|NCT02421588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014627|NCT02421588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20014628|NCT02421588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20014629|NCT02421588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014630|NCT02421588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014631|NCT02421588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20014632|NCT02421887|Antioxidants|antioxidants|mesh-list
20014633|NCT02421887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014634|NCT02421887|Protective Agents|protective agents|mesh-ancestor
20014635|NCT02421887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014636|NCT02422186|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20014637|NCT02422186|Citalopram|citalopram|mesh-list
20014638|NCT02422186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20014639|NCT02422186|Sertraline|sertraline|mesh-list
20014640|NCT02422186|Antidepressive Agents|antidepressive agents|mesh-list
20014641|NCT02422186|Esketamine|esketamine|mesh-list
20014642|NCT02422186|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20014643|NCT02422186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20014644|NCT02422186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20014645|NCT02422186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014646|NCT02422186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014647|NCT02422186|Serotonin Agents|serotonin agents|mesh-ancestor
20014648|NCT02422186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014649|NCT02422186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20014650|NCT02422186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20014651|NCT02422186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014652|NCT02422186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20014653|NCT02422186|Analgesics|analgesics|mesh-ancestor
20014654|NCT02422186|Sensory System Agents|sensory system agents|mesh-ancestor
20014655|NCT02422186|Dopamine Agents|dopamine agents|mesh-ancestor
20014656|NCT02422264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20014657|NCT02422264|Immunologic Factors|immunologic factors|mesh-ancestor
20014658|NCT02422264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014659|NCT02422290|Ketamine|ketamine|mesh-list
20014660|NCT02422290|Analgesics|analgesics|mesh-ancestor
20014661|NCT02422290|Sensory System Agents|sensory system agents|mesh-ancestor
20014662|NCT02422290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014663|NCT02422290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014664|NCT02422290|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20014665|NCT02422290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20014666|NCT02422290|Anesthetics, General|anesthetics, general|mesh-ancestor
20014667|NCT02422290|Anesthetics|anesthetics|mesh-ancestor
20014668|NCT02422290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20014669|NCT02422290|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20014670|NCT02422290|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20014671|NCT02422290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014672|NCT02422290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014673|NCT02422940|4-Aminopyridine|4-aminopyridine|mesh-list
20014674|NCT02422940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
20014675|NCT02422940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20014676|NCT02422940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014677|NCT02423291|Brentuximab Vedotin|brentuximab vedotin|mesh-list
20014678|NCT02423291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20014679|NCT02423291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014680|NCT02423343|Nivolumab|nivolumab|mesh-list
20014681|NCT02423343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20014682|NCT02423343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014683|NCT02423343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20014684|NCT02423343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014685|NCT02423980|Glucagon|glucagon|mesh-list
20014686|NCT02423980|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20014687|NCT02423980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20014688|NCT02423980|Hormones|hormones|mesh-ancestor
20014689|NCT02423980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20014690|NCT02423980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014691|NCT02423980|Incretins|incretins|mesh-ancestor
20014692|NCT02424097|Listerine|listerine|mesh-list
20014693|NCT02424097|Fluorides|fluorides|mesh-list
20014694|NCT02424097|Sodium Fluoride|sodium fluoride|mesh-list
20014695|NCT02424097|Fluorides, Topical|fluorides, topical|mesh-list
20014696|NCT02424097|Cariostatic Agents|cariostatic agents|mesh-ancestor
20014697|NCT02424097|Protective Agents|protective agents|mesh-ancestor
20014698|NCT02424097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014699|NCT02424097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20014700|NCT02424097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20014701|NCT02424344|Formoterol Fumarate|formoterol fumarate|mesh-list
20014702|NCT02424344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20014703|NCT02424344|Autonomic Agents|autonomic agents|mesh-ancestor
20014704|NCT02424344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014705|NCT02424344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014706|NCT02424344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20014707|NCT02424344|Respiratory System Agents|respiratory system agents|mesh-ancestor
20014708|NCT02424344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20014709|NCT02424344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20014710|NCT02424344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20014711|NCT02424344|Adrenergic Agents|adrenergic agents|mesh-ancestor
20014712|NCT02424344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014713|NCT02424344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014714|NCT02424357|Povidone-Iodine|povidone-iodine|mesh-list
20014715|NCT02424357|Povidone|povidone|mesh-list
20014716|NCT02424357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20014717|NCT02424357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20014718|NCT02424357|Plasma Substitutes|plasma substitutes|mesh-ancestor
20014719|NCT02424357|Blood Substitutes|blood substitutes|mesh-ancestor
20014720|NCT02424357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20014721|NCT02424357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20014722|NCT02424578|Diclofenac|diclofenac|mesh-list
20014723|NCT02424578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20014724|NCT02424578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20014725|NCT02424578|Analgesics|analgesics|mesh-ancestor
20014726|NCT02424578|Sensory System Agents|sensory system agents|mesh-ancestor
20014727|NCT02424578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014728|NCT02424578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014729|NCT02424578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20014730|NCT02424578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20014731|NCT02424578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20014732|NCT02424578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014733|NCT02424578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014734|NCT02424591|Ketamine|ketamine|mesh-list
20014735|NCT02424591|Analgesics|analgesics|mesh-ancestor
20014736|NCT02424591|Sensory System Agents|sensory system agents|mesh-ancestor
20014737|NCT02424591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014738|NCT02424591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014739|NCT02424591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20014740|NCT02424591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20014741|NCT02424591|Anesthetics, General|anesthetics, general|mesh-ancestor
20014742|NCT02424591|Anesthetics|anesthetics|mesh-ancestor
20014743|NCT02424591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20014744|NCT02424591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20014745|NCT02424591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20014746|NCT02424591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014747|NCT02424591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014748|NCT02424630|Ropivacaine|ropivacaine|mesh-list
20014749|NCT02424630|Anesthetics, Local|anesthetics, local|mesh-ancestor
20014750|NCT02424630|Anesthetics|anesthetics|mesh-ancestor
20014751|NCT02424630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20014752|NCT02424630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014753|NCT02424630|Sensory System Agents|sensory system agents|mesh-ancestor
20014754|NCT02424630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014755|NCT02424734|Ampicillin|ampicillin|mesh-list
20014756|NCT02424734|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
20014757|NCT02424734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20014758|NCT02424734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20014759|NCT02424799|GSK2646264|gsk2646264|mesh-list
20014760|NCT02424799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20014761|NCT02424799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014762|NCT02424799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014763|NCT02424968|Cyclosporine|cyclosporine|mesh-list
20014764|NCT02424968|Mycophenolic Acid|mycophenolic acid|mesh-list
20014765|NCT02424968|Cyclosporins|cyclosporins|mesh-list
20014766|NCT02424968|Thymoglobulin|thymoglobulin|mesh-list
20014767|NCT02424968|Antilymphocyte Serum|antilymphocyte serum|mesh-list
20014768|NCT02424968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014769|NCT02424968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014770|NCT02424968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20014771|NCT02424968|Immunologic Factors|immunologic factors|mesh-ancestor
20014772|NCT02424968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014773|NCT02424968|Antifungal Agents|antifungal agents|mesh-ancestor
20014774|NCT02424968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20014775|NCT02424968|Dermatologic Agents|dermatologic agents|mesh-ancestor
20014776|NCT02424968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20014777|NCT02424968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20014778|NCT02424968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20014779|NCT02424968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014780|NCT02424968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20014781|NCT02424968|Antitubercular Agents|antitubercular agents|mesh-ancestor
20014782|NCT02424968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20014783|NCT02425098|Vaccines|vaccines|mesh-list
20014784|NCT02425098|Immunologic Factors|immunologic factors|mesh-ancestor
20014785|NCT02425098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014786|NCT02425111|Vedolizumab|vedolizumab|mesh-list
20014787|NCT02425111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20014788|NCT02425449|Succinylcholine|succinylcholine|mesh-list
20014789|NCT02425449|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
20014790|NCT02425449|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20014791|NCT02425449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20014792|NCT02425449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014793|NCT02425449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014794|NCT02425891|Paclitaxel|paclitaxel|mesh-list
20014795|NCT02425891|Atezolizumab|atezolizumab|mesh-list
20014796|NCT02425891|Antibodies|antibodies|mesh-list
20014797|NCT02425891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20014798|NCT02425891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20014799|NCT02425891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014800|NCT02425891|Tubulin Modulators|tubulin modulators|mesh-ancestor
20014801|NCT02425891|Antimitotic Agents|antimitotic agents|mesh-ancestor
20014802|NCT02425891|Mitosis Modulators|mitosis modulators|mesh-ancestor
20014803|NCT02425891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014804|NCT02425891|Immunologic Factors|immunologic factors|mesh-ancestor
20014805|NCT02425891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014806|NCT02426086|Niacinamide|niacinamide|mesh-list
20014807|NCT02426086|Imetelstat|imetelstat|mesh-list
20014808|NCT02426086|Motesanib diphosphate|motesanib diphosphate|mesh-list
20014809|NCT02426086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014810|NCT02426086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014811|NCT02426086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20014812|NCT02426086|Vitamin B Complex|vitamin b complex|mesh-ancestor
20014813|NCT02426086|Vitamins|vitamins|mesh-ancestor
20014814|NCT02426086|Micronutrients|micronutrients|mesh-ancestor
20014815|NCT02426086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014816|NCT02426541|Dapagliflozin|dapagliflozin|mesh-list
20014817|NCT02426541|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20014818|NCT02426541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014819|NCT02426541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20014820|NCT02426541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014821|NCT02426658|Pemetrexed|pemetrexed|mesh-list
20014822|NCT02426658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014823|NCT02426658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014824|NCT02426658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014825|NCT02426658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20014826|NCT02426658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20014827|NCT02426918|Vancomycin|vancomycin|mesh-list
20014828|NCT02426918|Linezolid|linezolid|mesh-list
20014829|NCT02426918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20014830|NCT02426918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20014831|NCT02426918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20014832|NCT02426918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014833|NCT02426918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014834|NCT02427646|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
20014835|NCT02427646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20014836|NCT02427646|Botulinum Toxins|botulinum toxins|mesh-list
20014837|NCT02427646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20014838|NCT02427646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20014839|NCT02427646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014840|NCT02427646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014841|NCT02427646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20014842|NCT02427646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20014843|NCT02427646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014844|NCT02427646|Cholinergic Agents|cholinergic agents|mesh-ancestor
20014845|NCT02427646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014846|NCT02427737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
20014847|NCT02427737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20014848|NCT02427737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014849|NCT02427802|Gentamicins|gentamicins|mesh-list
20014850|NCT02427802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20014851|NCT02427802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20014852|NCT02427802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20014853|NCT02427802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014854|NCT02427802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014855|NCT02427841|Gemcitabine|gemcitabine|mesh-list
20014856|NCT02427841|Paclitaxel|paclitaxel|mesh-list
20014857|NCT02427841|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
20014858|NCT02427841|Fluorouracil|fluorouracil|mesh-list
20014859|NCT02427841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20014860|NCT02427841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014861|NCT02427841|Tubulin Modulators|tubulin modulators|mesh-ancestor
20014862|NCT02427841|Antimitotic Agents|antimitotic agents|mesh-ancestor
20014863|NCT02427841|Mitosis Modulators|mitosis modulators|mesh-ancestor
20014864|NCT02427841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014865|NCT02427841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20014866|NCT02427841|Antimetabolites|antimetabolites|mesh-ancestor
20014867|NCT02427841|Antiviral Agents|antiviral agents|mesh-ancestor
20014868|NCT02427841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20014869|NCT02427841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014870|NCT02427841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20014871|NCT02427841|Immunologic Factors|immunologic factors|mesh-ancestor
20014872|NCT02427841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014873|NCT02428296|Sirolimus|sirolimus|mesh-list
20014874|NCT02428296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20014875|NCT02428296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20014876|NCT02428296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20014877|NCT02428296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014878|NCT02428296|Antifungal Agents|antifungal agents|mesh-ancestor
20014879|NCT02428296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20014880|NCT02428296|Immunologic Factors|immunologic factors|mesh-ancestor
20014881|NCT02428296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014882|NCT02428478|Desipramine|desipramine|mesh-list
20014883|NCT02428478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20014884|NCT02428478|Antidepressive Agents|antidepressive agents|mesh-ancestor
20014885|NCT02428478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20014886|NCT02428478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014887|NCT02428478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014888|NCT02428478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20014889|NCT02428478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20014890|NCT02428478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20014891|NCT02428478|Adrenergic Agents|adrenergic agents|mesh-ancestor
20014892|NCT02428478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014893|NCT02428478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014894|NCT02428608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20014895|NCT02428608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20014896|NCT02428608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014897|NCT02428608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014898|NCT02428608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20014899|NCT02428608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20014900|NCT02428608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014901|NCT02428608|Cholinergic Agents|cholinergic agents|mesh-ancestor
20014902|NCT02428608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014903|NCT02428699|Cod Liver Oil|cod liver oil|mesh-list
20014904|NCT02428699|Liver Extracts|liver extracts|mesh-list
20014905|NCT02428699|Hematinics|hematinics|mesh-ancestor
20014906|NCT02428699|Vitamins|vitamins|mesh-ancestor
20014907|NCT02428699|Micronutrients|micronutrients|mesh-ancestor
20014908|NCT02428699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014909|NCT02428855|Dasatinib|dasatinib|mesh-list
20014910|NCT02428855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014911|NCT02428855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20014912|NCT02428855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014913|NCT02428855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014914|NCT02429258|Metformin|metformin|mesh-list
20014915|NCT02429258|Dapagliflozin|dapagliflozin|mesh-list
20014916|NCT02429258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20014917|NCT02429258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014918|NCT02429258|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20014919|NCT02429258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014920|NCT02429427|Celecoxib|celecoxib|mesh-list
20014921|NCT02429427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20014922|NCT02429427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20014923|NCT02429427|Analgesics|analgesics|mesh-ancestor
20014924|NCT02429427|Sensory System Agents|sensory system agents|mesh-ancestor
20014925|NCT02429427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014926|NCT02429427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014927|NCT02429427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20014928|NCT02429427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20014929|NCT02429427|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
20014930|NCT02429427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20014931|NCT02429427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014932|NCT02429427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014933|NCT02429869|Everolimus|everolimus|mesh-list
20014934|NCT02429869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014935|NCT02429869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20014936|NCT02429869|Immunologic Factors|immunologic factors|mesh-ancestor
20014937|NCT02429869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014938|NCT02429934|Abatacept|abatacept|mesh-list
20014939|NCT02429934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20014940|NCT02429934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014941|NCT02429934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014942|NCT02429934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20014943|NCT02429934|Immunologic Factors|immunologic factors|mesh-ancestor
20014944|NCT02429934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014945|NCT02429934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20014946|NCT02430090|Fentanyl|fentanyl|mesh-list
20014947|NCT02430090|Sufentanil|sufentanil|mesh-list
20014948|NCT02430090|Levobupivacaine|levobupivacaine|mesh-list
20014949|NCT02430090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20014950|NCT02430090|Narcotics|narcotics|mesh-ancestor
20014951|NCT02430090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20014952|NCT02430090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014953|NCT02430090|Analgesics|analgesics|mesh-ancestor
20014954|NCT02430090|Sensory System Agents|sensory system agents|mesh-ancestor
20014955|NCT02430090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014956|NCT02430090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20014957|NCT02430090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20014958|NCT02430090|Anesthetics, General|anesthetics, general|mesh-ancestor
20014959|NCT02430090|Anesthetics|anesthetics|mesh-ancestor
20014960|NCT02430090|Anesthetics, Local|anesthetics, local|mesh-ancestor
20014961|NCT02430311|Paclitaxel|paclitaxel|mesh-list
20014962|NCT02430311|Olaparib|olaparib|mesh-list
20014963|NCT02430311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20014964|NCT02430311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014965|NCT02430311|Tubulin Modulators|tubulin modulators|mesh-ancestor
20014966|NCT02430311|Antimitotic Agents|antimitotic agents|mesh-ancestor
20014967|NCT02430311|Mitosis Modulators|mitosis modulators|mesh-ancestor
20014968|NCT02430311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014969|NCT02430311|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20014970|NCT02430311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20014971|NCT02430389|Remifentanil|remifentanil|mesh-list
20014972|NCT02430389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20014973|NCT02430389|Narcotics|narcotics|mesh-ancestor
20014974|NCT02430389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20014975|NCT02430389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014976|NCT02430389|Analgesics|analgesics|mesh-ancestor
20014977|NCT02430389|Sensory System Agents|sensory system agents|mesh-ancestor
20014978|NCT02430389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014979|NCT02430480|Goserelin|goserelin|mesh-list
20014980|NCT02430480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20014981|NCT02430480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20014982|NCT02430818|Ketamine|ketamine|mesh-list
20014983|NCT02430818|Morphine|morphine|mesh-list
20014984|NCT02430818|Analgesics|analgesics|mesh-ancestor
20014985|NCT02430818|Sensory System Agents|sensory system agents|mesh-ancestor
20014986|NCT02430818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20014987|NCT02430818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20014988|NCT02430818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20014989|NCT02430818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20014990|NCT02430818|Anesthetics, General|anesthetics, general|mesh-ancestor
20014991|NCT02430818|Anesthetics|anesthetics|mesh-ancestor
20014992|NCT02430818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20014993|NCT02430818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20014994|NCT02430818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20014995|NCT02430818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20014996|NCT02430818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20014997|NCT02430818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20014998|NCT02430818|Narcotics|narcotics|mesh-ancestor
20014999|NCT02431260|INCB054329|incb054329|mesh-list
20015000|NCT02431260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015001|NCT02431468|Bryostatin 1|bryostatin 1|mesh-list
20015002|NCT02431468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20015003|NCT02431468|Immunologic Factors|immunologic factors|mesh-ancestor
20015004|NCT02431468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015005|NCT02431468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015006|NCT02431533|Calcium|calcium|mesh-list
20015007|NCT02431533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20015008|NCT02431533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015009|NCT02431559|Doxorubicin|doxorubicin|mesh-list
20015010|NCT02431559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20015011|NCT02431559|Durvalumab|durvalumab|mesh-list
20015012|NCT02431559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20015013|NCT02431559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015014|NCT02431559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20015015|NCT02431559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20015016|NCT02431559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015017|NCT02431559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015018|NCT02431559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20015019|NCT02431572|Vaccines|vaccines|mesh-list
20015020|NCT02431572|Immunologic Factors|immunologic factors|mesh-ancestor
20015021|NCT02431572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015022|NCT02431598|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
20015023|NCT02431598|Chelating Agents|chelating agents|mesh-ancestor
20015024|NCT02431598|Sequestering Agents|sequestering agents|mesh-ancestor
20015025|NCT02431598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015026|NCT02431637|Piperaquine|piperaquine|mesh-list
20015027|NCT02431637|Antimalarials|antimalarials|mesh-ancestor
20015028|NCT02431637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20015029|NCT02431637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20015030|NCT02431637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20015031|NCT02431650|Primaquine|primaquine|mesh-list
20015032|NCT02431650|Antimalarials|antimalarials|mesh-ancestor
20015033|NCT02431650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20015034|NCT02431650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20015035|NCT02431650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20015036|NCT02431676|Metformin|metformin|mesh-list
20015037|NCT02431676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20015038|NCT02431676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015039|NCT02431754|Tadalafil|tadalafil|mesh-list
20015040|NCT02431754|Vasodilator Agents|vasodilator agents|mesh-ancestor
20015041|NCT02431754|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
20015042|NCT02431754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20015043|NCT02431754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015044|NCT02431754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015045|NCT02431754|Urological Agents|urological agents|mesh-ancestor
20015046|NCT02431806|Milnacipran|milnacipran|mesh-list
20015047|NCT02431806|Fluoxetine|fluoxetine|mesh-list
20015048|NCT02431806|Levomilnacipran|levomilnacipran|mesh-list
20015049|NCT02431806|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20015050|NCT02431806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20015051|NCT02431806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20015052|NCT02431806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015053|NCT02431806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20015054|NCT02431806|Serotonin Agents|serotonin agents|mesh-ancestor
20015055|NCT02431806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015056|NCT02431806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20015057|NCT02431806|Antidepressive Agents|antidepressive agents|mesh-ancestor
20015058|NCT02431806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20015059|NCT02431806|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20015060|NCT02431806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20015061|NCT02431806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015062|NCT02431806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20015063|NCT02431806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20015064|NCT02431806|Analgesics|analgesics|mesh-ancestor
20015065|NCT02431806|Sensory System Agents|sensory system agents|mesh-ancestor
20015066|NCT02431806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20015067|NCT02432040|Atorvastatin|atorvastatin|mesh-list
20015068|NCT02432040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20015069|NCT02432040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20015070|NCT02432040|Antimetabolites|antimetabolites|mesh-ancestor
20015071|NCT02432040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015072|NCT02432040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20015073|NCT02432040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20015074|NCT02432040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015075|NCT02432274|Etoposide|etoposide|mesh-list
20015076|NCT02432274|Etoposide phosphate|etoposide phosphate|mesh-list
20015077|NCT02432274|Ifosfamide|ifosfamide|mesh-list
20015078|NCT02432274|Isophosphamide mustard|isophosphamide mustard|mesh-list
20015079|NCT02432274|Lenvatinib|lenvatinib|mesh-list
20015080|NCT02432274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20015081|NCT02432274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015082|NCT02432274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20015083|NCT02432274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20015084|NCT02432274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015085|NCT02432274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015086|NCT02432274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20015087|NCT02432274|Alkylating Agents|alkylating agents|mesh-ancestor
20015088|NCT02432274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20015089|NCT02432287|Metformin|metformin|mesh-list
20015090|NCT02432287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20015091|NCT02432287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015092|NCT02432456|Acetaminophen|acetaminophen|mesh-list
20015093|NCT02432456|Ibuprofen|ibuprofen|mesh-list
20015094|NCT02432456|Ketamine|ketamine|mesh-list
20015095|NCT02432456|Narcotics|narcotics|mesh-list
20015096|NCT02432456|Methocarbamol|methocarbamol|mesh-list
20015097|NCT02432456|Pantoprazole|pantoprazole|mesh-list
20015098|NCT02432456|Analgesics|analgesics|mesh-ancestor
20015099|NCT02432456|Sensory System Agents|sensory system agents|mesh-ancestor
20015100|NCT02432456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20015101|NCT02432456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015102|NCT02432456|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20015103|NCT02432456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20015104|NCT02432456|Anesthetics, General|anesthetics, general|mesh-ancestor
20015105|NCT02432456|Anesthetics|anesthetics|mesh-ancestor
20015106|NCT02432456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20015107|NCT02432456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20015108|NCT02432456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20015109|NCT02432456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20015110|NCT02432456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015111|NCT02432456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20015112|NCT02432456|Antipyretics|antipyretics|mesh-ancestor
20015113|NCT02432456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20015114|NCT02432456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20015115|NCT02432456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20015116|NCT02432456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20015117|NCT02432456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015118|NCT02432456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20015119|NCT02432456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20015120|NCT02432456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20015121|NCT02432456|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20015122|NCT02432456|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20015123|NCT02432703|JNJ-42165279|jnj-42165279|mesh-list
20015124|NCT02432703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015125|NCT02432703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015126|NCT02432716|Insulin|insulin|mesh-list
20015127|NCT02432716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20015128|NCT02432716|Insulin glulisine|insulin glulisine|mesh-list
20015129|NCT02432716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20015130|NCT02432716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015131|NCT02432742|Hyaluronic Acid|hyaluronic acid|mesh-list
20015132|NCT02432742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20015133|NCT02432742|Immunologic Factors|immunologic factors|mesh-ancestor
20015134|NCT02432742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015135|NCT02432742|Viscosupplements|viscosupplements|mesh-ancestor
20015136|NCT02432742|Protective Agents|protective agents|mesh-ancestor
20015137|NCT02433483|Cytarabine|cytarabine|mesh-list
20015138|NCT02433483|Hydrocortisone|hydrocortisone|mesh-list
20015139|NCT02433483|Methotrexate|methotrexate|mesh-list
20015140|NCT02433483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
20015141|NCT02433483|Abortifacient Agents|abortifacient agents|mesh-ancestor
20015142|NCT02433483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20015143|NCT02433483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015144|NCT02433483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20015145|NCT02433483|Antimetabolites|antimetabolites|mesh-ancestor
20015146|NCT02433483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015147|NCT02433483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015148|NCT02433483|Dermatologic Agents|dermatologic agents|mesh-ancestor
20015149|NCT02433483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015150|NCT02433483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20015151|NCT02433483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20015152|NCT02433483|Immunologic Factors|immunologic factors|mesh-ancestor
20015153|NCT02433483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20015154|NCT02433483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20015155|NCT02433483|Antiviral Agents|antiviral agents|mesh-ancestor
20015156|NCT02433483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20015157|NCT02433483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20015158|NCT02433678|Dapagliflozin|dapagliflozin|mesh-list
20015159|NCT02433678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20015160|NCT02433678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015161|NCT02433678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20015162|NCT02433678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015163|NCT02433834|Glycopyrrolate|glycopyrrolate|mesh-list
20015164|NCT02433834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20015165|NCT02433834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20015166|NCT02433834|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20015167|NCT02433834|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20015168|NCT02433834|Cholinergic Agents|cholinergic agents|mesh-ancestor
20015169|NCT02433834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20015170|NCT02433834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015171|NCT02433834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015172|NCT02433834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20015173|NCT02433834|Autonomic Agents|autonomic agents|mesh-ancestor
20015174|NCT02433834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20015175|NCT02433834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20015176|NCT02433834|Respiratory System Agents|respiratory system agents|mesh-ancestor
20015177|NCT02433834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20015178|NCT02433834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20015179|NCT02433834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20015180|NCT02433834|Adrenergic Agents|adrenergic agents|mesh-ancestor
20015181|NCT02434081|Nivolumab|nivolumab|mesh-list
20015182|NCT02434081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20015183|NCT02434081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015184|NCT02434081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20015185|NCT02434081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015186|NCT02434328|Aflibercept|aflibercept|mesh-list
20015187|NCT02434328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20015188|NCT02434328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20015189|NCT02434328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20015190|NCT02434328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20015191|NCT02434328|Growth Substances|growth substances|mesh-ancestor
20015192|NCT02434328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015193|NCT02434328|Growth Inhibitors|growth inhibitors|mesh-ancestor
20015194|NCT02434328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015195|NCT02434497|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
20015196|NCT02434497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20015197|NCT02434497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20015198|NCT02434497|Antimetabolites|antimetabolites|mesh-ancestor
20015199|NCT02434497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015200|NCT02434497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20015201|NCT02434497|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20015202|NCT02434497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015203|NCT02434523|Amitriptyline|amitriptyline|mesh-list
20015204|NCT02434523|Amitriptyline, perphenazine drug combination|amitriptyline, perphenazine drug combination|mesh-list
20015205|NCT02434523|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20015206|NCT02434523|Antidepressive Agents|antidepressive agents|mesh-ancestor
20015207|NCT02434523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20015208|NCT02434523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20015209|NCT02434523|Analgesics|analgesics|mesh-ancestor
20015210|NCT02434523|Sensory System Agents|sensory system agents|mesh-ancestor
20015211|NCT02434523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20015212|NCT02434523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015213|NCT02434523|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20015214|NCT02434523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20015215|NCT02434523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20015216|NCT02434523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015217|NCT02434523|Adrenergic Agents|adrenergic agents|mesh-ancestor
20015218|NCT02434523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20015219|NCT02434523|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20015220|NCT02434523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20015221|NCT02434523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20015222|NCT02434770|Vaccines|vaccines|mesh-list
20015223|NCT02434770|Immunologic Factors|immunologic factors|mesh-ancestor
20015224|NCT02434770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015225|NCT02434939|Ketamine|ketamine|mesh-list
20015226|NCT02434939|Morphine|morphine|mesh-list
20015227|NCT02434939|Analgesics|analgesics|mesh-ancestor
20015228|NCT02434939|Sensory System Agents|sensory system agents|mesh-ancestor
20015229|NCT02434939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20015230|NCT02434939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015231|NCT02434939|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20015232|NCT02434939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20015233|NCT02434939|Anesthetics, General|anesthetics, general|mesh-ancestor
20015234|NCT02434939|Anesthetics|anesthetics|mesh-ancestor
20015235|NCT02434939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20015236|NCT02434939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20015237|NCT02434939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20015238|NCT02434939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20015239|NCT02434939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015240|NCT02434939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20015241|NCT02434939|Narcotics|narcotics|mesh-ancestor
20015242|NCT02435069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20015243|NCT02435069|Glycerol|glycerol|mesh-list
20015244|NCT02435069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20015245|NCT02435069|Protective Agents|protective agents|mesh-ancestor
20015246|NCT02435069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015247|NCT02435147|Denosumab|denosumab|mesh-list
20015248|NCT02435147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20015249|NCT02435147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015250|NCT02435277|Metformin|metformin|mesh-list
20015251|NCT02435277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20015252|NCT02435277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015253|NCT02435680|Gemcitabine|gemcitabine|mesh-list
20015254|NCT02435680|Carboplatin|carboplatin|mesh-list
20015255|NCT02435680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015256|NCT02435680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20015257|NCT02435680|Antimetabolites|antimetabolites|mesh-ancestor
20015258|NCT02435680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015259|NCT02435680|Antiviral Agents|antiviral agents|mesh-ancestor
20015260|NCT02435680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20015261|NCT02435680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015262|NCT02435680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20015263|NCT02435680|Immunologic Factors|immunologic factors|mesh-ancestor
20015264|NCT02435680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015265|NCT02435836|Aripiprazole|aripiprazole|mesh-list
20015266|NCT02435836|Antidepressive Agents|antidepressive agents|mesh-ancestor
20015267|NCT02435836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20015268|NCT02435836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20015269|NCT02435836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20015270|NCT02435836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20015271|NCT02435836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015272|NCT02435836|Dopamine Agonists|dopamine agonists|mesh-ancestor
20015273|NCT02435836|Dopamine Agents|dopamine agents|mesh-ancestor
20015274|NCT02435836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20015275|NCT02435836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015276|NCT02435836|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20015277|NCT02435836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20015278|NCT02435836|Serotonin Agents|serotonin agents|mesh-ancestor
20015279|NCT02435836|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20015280|NCT02435836|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20015281|NCT02435836|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20015282|NCT02435836|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20015283|NCT02435901|Cyclosporine|cyclosporine|mesh-list
20015284|NCT02435901|Mycophenolic Acid|mycophenolic acid|mesh-list
20015285|NCT02435901|Fludarabine|fludarabine|mesh-list
20015286|NCT02435901|Melphalan|melphalan|mesh-list
20015287|NCT02435901|Alemtuzumab|alemtuzumab|mesh-list
20015288|NCT02435901|Tacrolimus|tacrolimus|mesh-list
20015289|NCT02435901|Cyclosporins|cyclosporins|mesh-list
20015290|NCT02435901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015291|NCT02435901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015292|NCT02435901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20015293|NCT02435901|Immunologic Factors|immunologic factors|mesh-ancestor
20015294|NCT02435901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015295|NCT02435901|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20015296|NCT02435901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015297|NCT02435901|Antifungal Agents|antifungal agents|mesh-ancestor
20015298|NCT02435901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20015299|NCT02435901|Dermatologic Agents|dermatologic agents|mesh-ancestor
20015300|NCT02435901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20015301|NCT02435901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20015302|NCT02435901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
20015303|NCT02435901|Antitubercular Agents|antitubercular agents|mesh-ancestor
20015304|NCT02435901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20015305|NCT02435901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20015306|NCT02435901|Alkylating Agents|alkylating agents|mesh-ancestor
20015307|NCT02435901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20015308|NCT02435901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20015309|NCT02435914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20015310|NCT02435914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20015311|NCT02435992|Ozanimod|ozanimod|mesh-list
20015312|NCT02435992|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20015313|NCT02435992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015314|NCT02435992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20015315|NCT02435992|Immunologic Factors|immunologic factors|mesh-ancestor
20015316|NCT02435992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015317|NCT02436031|Desipramine|desipramine|mesh-list
20015318|NCT02436031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
20015319|NCT02436031|Antidepressive Agents|antidepressive agents|mesh-ancestor
20015320|NCT02436031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20015321|NCT02436031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015322|NCT02436031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015323|NCT02436031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20015324|NCT02436031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20015325|NCT02436031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20015326|NCT02436031|Adrenergic Agents|adrenergic agents|mesh-ancestor
20015327|NCT02436031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20015328|NCT02436031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015329|NCT02436135|Idelalisib|idelalisib|mesh-list
20015330|NCT02436135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015331|NCT02436135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015332|NCT02436135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015333|NCT02436239|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
20015334|NCT02436239|Antidepressive Agents|antidepressive agents|mesh-ancestor
20015335|NCT02436239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20015336|NCT02436239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20015337|NCT02436239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20015338|NCT02436239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20015339|NCT02436239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015340|NCT02436239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20015341|NCT02436239|Serotonin Agents|serotonin agents|mesh-ancestor
20015342|NCT02436239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015343|NCT02436239|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20015344|NCT02436239|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20015345|NCT02436577|Ticagrelor|ticagrelor|mesh-list
20015346|NCT02436577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20015347|NCT02436577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20015348|NCT02436577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20015349|NCT02436577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20015350|NCT02436577|Purinergic Agents|purinergic agents|mesh-ancestor
20015351|NCT02436577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20015352|NCT02436577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015353|NCT02436577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015354|NCT02436668|Gemcitabine|gemcitabine|mesh-list
20015355|NCT02436668|Paclitaxel|paclitaxel|mesh-list
20015356|NCT02436668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20015357|NCT02436668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015358|NCT02436668|Tubulin Modulators|tubulin modulators|mesh-ancestor
20015359|NCT02436668|Antimitotic Agents|antimitotic agents|mesh-ancestor
20015360|NCT02436668|Mitosis Modulators|mitosis modulators|mesh-ancestor
20015361|NCT02436668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015362|NCT02436668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20015363|NCT02436668|Antimetabolites|antimetabolites|mesh-ancestor
20015364|NCT02436668|Antiviral Agents|antiviral agents|mesh-ancestor
20015365|NCT02436668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20015366|NCT02436668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015367|NCT02436668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20015368|NCT02436668|Immunologic Factors|immunologic factors|mesh-ancestor
20015369|NCT02436668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015370|NCT02436759|Phenylephrine|phenylephrine|mesh-list
20015371|NCT02436759|Oxymetazoline|oxymetazoline|mesh-list
20015372|NCT02436759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20015373|NCT02436759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20015374|NCT02436759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20015375|NCT02436759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20015376|NCT02436759|Adrenergic Agents|adrenergic agents|mesh-ancestor
20015377|NCT02436759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20015378|NCT02436759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015379|NCT02436759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015380|NCT02436759|Sympathomimetics|sympathomimetics|mesh-ancestor
20015381|NCT02436759|Autonomic Agents|autonomic agents|mesh-ancestor
20015382|NCT02436759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20015383|NCT02436759|Nasal Decongestants|nasal decongestants|mesh-ancestor
20015384|NCT02436759|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20015385|NCT02436759|Respiratory System Agents|respiratory system agents|mesh-ancestor
20015386|NCT02436759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20015387|NCT02436759|Mydriatics|mydriatics|mesh-ancestor
20015388|NCT02436759|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20015389|NCT02436759|Protective Agents|protective agents|mesh-ancestor
20015390|NCT02436889|Mirabegron|mirabegron|mesh-list
20015391|NCT02436889|Tolterodine Tartrate|tolterodine tartrate|mesh-list
20015392|NCT02436889|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20015393|NCT02436889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20015394|NCT02436889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20015395|NCT02436889|Adrenergic Agents|adrenergic agents|mesh-ancestor
20015396|NCT02436889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20015397|NCT02436889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015398|NCT02436889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015399|NCT02436889|Urological Agents|urological agents|mesh-ancestor
20015400|NCT02436889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20015401|NCT02436889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20015402|NCT02436889|Cholinergic Agents|cholinergic agents|mesh-ancestor
20015403|NCT02437084|Atorvastatin|atorvastatin|mesh-list
20015404|NCT02437084|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20015405|NCT02437084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20015406|NCT02437084|Antimetabolites|antimetabolites|mesh-ancestor
20015407|NCT02437084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015408|NCT02437084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20015409|NCT02437084|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20015410|NCT02437084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015411|NCT02437162|Golimumab|golimumab|mesh-list
20015412|NCT02437162|Ustekinumab|ustekinumab|mesh-list
20015413|NCT02437162|Dermatologic Agents|dermatologic agents|mesh-ancestor
20015414|NCT02437162|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20015415|NCT02437162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20015416|NCT02437162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20015417|NCT02437162|Immunologic Factors|immunologic factors|mesh-ancestor
20015418|NCT02437162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015419|NCT02437253|Adalimumab|adalimumab|mesh-list
20015420|NCT02437253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20015421|NCT02437253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20015422|NCT02437344|Naltrexone|naltrexone|mesh-list
20015423|NCT02437344|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20015424|NCT02437344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20015425|NCT02437344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015426|NCT02437344|Sensory System Agents|sensory system agents|mesh-ancestor
20015427|NCT02437344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20015428|NCT02437383|Propranolol|propranolol|mesh-list
20015429|NCT02437383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20015430|NCT02437383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20015431|NCT02437383|Adrenergic Agents|adrenergic agents|mesh-ancestor
20015432|NCT02437383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20015433|NCT02437383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015434|NCT02437383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015435|NCT02437383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20015436|NCT02437383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20015437|NCT02437383|Vasodilator Agents|vasodilator agents|mesh-ancestor
20015438|NCT02437669|Hydromorphone|hydromorphone|mesh-list
20015439|NCT02437669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20015440|NCT02437669|Narcotics|narcotics|mesh-ancestor
20015441|NCT02437669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20015442|NCT02437669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015443|NCT02437669|Analgesics|analgesics|mesh-ancestor
20015444|NCT02437669|Sensory System Agents|sensory system agents|mesh-ancestor
20015445|NCT02437669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20015446|NCT02438137|Dimethyl Fumarate|dimethyl fumarate|mesh-list
20015447|NCT02438137|Dermatologic Agents|dermatologic agents|mesh-ancestor
20015448|NCT02438137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20015449|NCT02438137|Immunologic Factors|immunologic factors|mesh-ancestor
20015450|NCT02438137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015451|NCT02438371|Indomethacin|indomethacin|mesh-list
20015452|NCT02438371|Nifedipine|nifedipine|mesh-list
20015453|NCT02438371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20015454|NCT02438371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20015455|NCT02438371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015456|NCT02438371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20015457|NCT02438371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015458|NCT02438371|Vasodilator Agents|vasodilator agents|mesh-ancestor
20015459|NCT02438371|Tocolytic Agents|tocolytic agents|mesh-ancestor
20015460|NCT02438371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20015461|NCT02438371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20015462|NCT02438371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20015463|NCT02438371|Analgesics|analgesics|mesh-ancestor
20015464|NCT02438371|Sensory System Agents|sensory system agents|mesh-ancestor
20015465|NCT02438371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20015466|NCT02438371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20015467|NCT02438371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20015468|NCT02438371|Gout Suppressants|gout suppressants|mesh-ancestor
20015469|NCT02438371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20015470|NCT02438371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015471|NCT02438540|Metformin|metformin|mesh-list
20015472|NCT02438540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20015473|NCT02438540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015474|NCT02438787|Golimumab|golimumab|mesh-list
20015475|NCT02438787|Ustekinumab|ustekinumab|mesh-list
20015476|NCT02438787|Dermatologic Agents|dermatologic agents|mesh-ancestor
20015477|NCT02438787|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
20015478|NCT02438787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20015479|NCT02438787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20015480|NCT02438787|Immunologic Factors|immunologic factors|mesh-ancestor
20015481|NCT02438787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015482|NCT02438813|Deoxycholic Acid|deoxycholic acid|mesh-list
20015483|NCT02438813|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
20015484|NCT02438813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20015485|NCT02439138|Idelalisib|idelalisib|mesh-list
20015486|NCT02439138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015487|NCT02439138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015488|NCT02439138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015489|NCT02439164|Midazolam|midazolam|mesh-list
20015490|NCT02439164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20015491|NCT02439164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20015492|NCT02439164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20015493|NCT02439164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015494|NCT02439164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20015495|NCT02439164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20015496|NCT02439164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20015497|NCT02439164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20015498|NCT02439164|Anesthetics, General|anesthetics, general|mesh-ancestor
20015499|NCT02439164|Anesthetics|anesthetics|mesh-ancestor
20015500|NCT02439164|GABA Modulators|gaba modulators|mesh-ancestor
20015501|NCT02439164|GABA Agents|gaba agents|mesh-ancestor
20015502|NCT02439164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20015503|NCT02439164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015504|NCT02439281|Clonidine|clonidine|mesh-list
20015505|NCT02439281|Ropivacaine|ropivacaine|mesh-list
20015506|NCT02439281|Anesthetics, Local|anesthetics, local|mesh-ancestor
20015507|NCT02439281|Anesthetics|anesthetics|mesh-ancestor
20015508|NCT02439281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20015509|NCT02439281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015510|NCT02439281|Sensory System Agents|sensory system agents|mesh-ancestor
20015511|NCT02439281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20015512|NCT02439281|Analgesics|analgesics|mesh-ancestor
20015513|NCT02439281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20015514|NCT02439281|Sympatholytics|sympatholytics|mesh-ancestor
20015515|NCT02439281|Autonomic Agents|autonomic agents|mesh-ancestor
20015516|NCT02439281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20015517|NCT02439281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20015518|NCT02439281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20015519|NCT02439281|Adrenergic Agents|adrenergic agents|mesh-ancestor
20015520|NCT02439281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20015521|NCT02439281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015522|NCT02439320|Lasmiditan|lasmiditan|mesh-list
20015523|NCT02439320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20015524|NCT02439320|Serotonin Agents|serotonin agents|mesh-ancestor
20015525|NCT02439320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20015526|NCT02439320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015527|NCT02439320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015528|NCT02439879|Thioctic Acid|thioctic acid|mesh-list
20015529|NCT02439879|Antioxidants|antioxidants|mesh-ancestor
20015530|NCT02439879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015531|NCT02439879|Protective Agents|protective agents|mesh-ancestor
20015532|NCT02439879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015533|NCT02439879|Vitamin B Complex|vitamin b complex|mesh-ancestor
20015534|NCT02439879|Vitamins|vitamins|mesh-ancestor
20015535|NCT02439879|Micronutrients|micronutrients|mesh-ancestor
20015536|NCT02440178|Micafungin|micafungin|mesh-list
20015537|NCT02440178|Antifungal Agents|antifungal agents|mesh-ancestor
20015538|NCT02440178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20015539|NCT02440204|Remifentanil|remifentanil|mesh-list
20015540|NCT02440204|Sevoflurane|sevoflurane|mesh-list
20015541|NCT02440204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20015542|NCT02440204|Narcotics|narcotics|mesh-ancestor
20015543|NCT02440204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20015544|NCT02440204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015545|NCT02440204|Analgesics|analgesics|mesh-ancestor
20015546|NCT02440204|Sensory System Agents|sensory system agents|mesh-ancestor
20015547|NCT02440204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20015548|NCT02440204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20015549|NCT02440204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20015550|NCT02440204|Anesthetics, General|anesthetics, general|mesh-ancestor
20015551|NCT02440204|Anesthetics|anesthetics|mesh-ancestor
20015552|NCT02440308|Bombesin|bombesin|mesh-list
20015553|NCT02440308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015554|NCT02440308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20015555|NCT02440308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015556|NCT02440568|Cytarabine|cytarabine|mesh-list
20015557|NCT02440568|Idarubicin|idarubicin|mesh-list
20015558|NCT02440568|Homoharringtonine|homoharringtonine|mesh-list
20015559|NCT02440568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20015560|NCT02440568|Antimetabolites|antimetabolites|mesh-ancestor
20015561|NCT02440568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015562|NCT02440568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015563|NCT02440568|Antiviral Agents|antiviral agents|mesh-ancestor
20015564|NCT02440568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20015565|NCT02440568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20015566|NCT02440568|Immunologic Factors|immunologic factors|mesh-ancestor
20015567|NCT02440568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015568|NCT02440568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20015569|NCT02440568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20015570|NCT02440568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20015571|NCT02440568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015572|NCT02440568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20015573|NCT02440568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20015574|NCT02440789|Sirolimus|sirolimus|mesh-list
20015575|NCT02440789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20015576|NCT02440789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20015577|NCT02440789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20015578|NCT02440789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015579|NCT02440789|Antifungal Agents|antifungal agents|mesh-ancestor
20015580|NCT02440789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20015581|NCT02440789|Immunologic Factors|immunologic factors|mesh-ancestor
20015582|NCT02440789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015583|NCT02441062|Edotreotide|edotreotide|mesh-list
20015584|NCT02441062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
20015585|NCT02441062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015586|NCT02441114|Fluticasone|fluticasone|mesh-list
20015587|NCT02441114|Tiotropium Bromide|tiotropium bromide|mesh-list
20015588|NCT02441114|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20015589|NCT02441114|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
20015590|NCT02441114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20015591|NCT02441114|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20015592|NCT02441114|Autonomic Agents|autonomic agents|mesh-ancestor
20015593|NCT02441114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20015594|NCT02441114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015595|NCT02441114|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20015596|NCT02441114|Respiratory System Agents|respiratory system agents|mesh-ancestor
20015597|NCT02441114|Dermatologic Agents|dermatologic agents|mesh-ancestor
20015598|NCT02441114|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20015599|NCT02441114|Parasympatholytics|parasympatholytics|mesh-ancestor
20015600|NCT02441114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20015601|NCT02441114|Cholinergic Agents|cholinergic agents|mesh-ancestor
20015602|NCT02441114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20015603|NCT02441114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015604|NCT02441114|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20015605|NCT02441114|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20015606|NCT02441114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20015607|NCT02441114|Adrenergic Agents|adrenergic agents|mesh-ancestor
20015608|NCT02441114|Glucocorticoids|glucocorticoids|mesh-ancestor
20015609|NCT02441114|Hormones|hormones|mesh-ancestor
20015610|NCT02441114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20015611|NCT02441114|Sympathomimetics|sympathomimetics|mesh-ancestor
20015612|NCT02441309|Ifosfamide|ifosfamide|mesh-list
20015613|NCT02441309|Mifamurtide|mifamurtide|mesh-list
20015614|NCT02441309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20015615|NCT02441309|Alkylating Agents|alkylating agents|mesh-ancestor
20015616|NCT02441309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015617|NCT02441309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015618|NCT02441309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20015619|NCT02441309|Immunologic Factors|immunologic factors|mesh-ancestor
20015620|NCT02441309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015621|NCT02441946|Anastrozole|anastrozole|mesh-list
20015622|NCT02441946|Loperamide|loperamide|mesh-list
20015623|NCT02441946|Antidiarrheals|antidiarrheals|mesh-list
20015624|NCT02441946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20015625|NCT02441946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015626|NCT02441946|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20015627|NCT02441946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20015628|NCT02441946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015629|NCT02441946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015630|NCT02441946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20015631|NCT02441946|Hormone Antagonists|hormone antagonists|mesh-ancestor
20015632|NCT02441946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20015633|NCT02441946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015634|NCT02441946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20015635|NCT02442271|Ritonavir|ritonavir|mesh-list
20015636|NCT02442271|Ribavirin|ribavirin|mesh-list
20015637|NCT02442271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20015638|NCT02442271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20015639|NCT02442271|Protease Inhibitors|protease inhibitors|mesh-ancestor
20015640|NCT02442271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015641|NCT02442271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015642|NCT02442271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20015643|NCT02442271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20015644|NCT02442271|Antiviral Agents|antiviral agents|mesh-ancestor
20015645|NCT02442271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20015646|NCT02442271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20015647|NCT02442271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20015648|NCT02442271|Antimetabolites|antimetabolites|mesh-ancestor
20015649|NCT02442284|Ritonavir|ritonavir|mesh-list
20015650|NCT02442284|Ribavirin|ribavirin|mesh-list
20015651|NCT02442284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20015652|NCT02442284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20015653|NCT02442284|Protease Inhibitors|protease inhibitors|mesh-ancestor
20015654|NCT02442284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015655|NCT02442284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015656|NCT02442284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20015657|NCT02442284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20015658|NCT02442284|Antiviral Agents|antiviral agents|mesh-ancestor
20015659|NCT02442284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20015660|NCT02442284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20015661|NCT02442284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20015662|NCT02442284|Antimetabolites|antimetabolites|mesh-ancestor
20015663|NCT02442310|Deferiprone|deferiprone|mesh-list
20015664|NCT02442310|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20015665|NCT02442310|Chelating Agents|chelating agents|mesh-ancestor
20015666|NCT02442310|Sequestering Agents|sequestering agents|mesh-ancestor
20015667|NCT02442310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015668|NCT02442700|Pitavastatin|pitavastatin|mesh-list
20015669|NCT02442700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
20015670|NCT02442700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20015671|NCT02442700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20015672|NCT02442700|Antimetabolites|antimetabolites|mesh-ancestor
20015673|NCT02442700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015674|NCT02442700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015675|NCT02442700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20015676|NCT02443103|Guanabenz|guanabenz|mesh-list
20015677|NCT02443103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20015678|NCT02443103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20015679|NCT02443103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20015680|NCT02443103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20015681|NCT02443103|Adrenergic Agents|adrenergic agents|mesh-ancestor
20015682|NCT02443103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20015683|NCT02443103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015684|NCT02443103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015685|NCT02443155|Liraglutide|liraglutide|mesh-list
20015686|NCT02443155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20015687|NCT02443155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015688|NCT02443155|Incretins|incretins|mesh-ancestor
20015689|NCT02443155|Hormones|hormones|mesh-ancestor
20015690|NCT02443155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20015691|NCT02443337|Necitumumab|necitumumab|mesh-list
20015692|NCT02443337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20015693|NCT02443337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015694|NCT02443402|Insulin|insulin|mesh-list
20015695|NCT02443402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20015696|NCT02443402|Insulin Glargine|insulin glargine|mesh-list
20015697|NCT02443402|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
20015698|NCT02443402|Insulin Aspart|insulin aspart|mesh-list
20015699|NCT02443402|Insulin Lispro|insulin lispro|mesh-list
20015700|NCT02443402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20015701|NCT02443402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015702|NCT02443402|Incretins|incretins|mesh-ancestor
20015703|NCT02443402|Hormones|hormones|mesh-ancestor
20015704|NCT02443402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20015705|NCT02443402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20015706|NCT02443402|Protease Inhibitors|protease inhibitors|mesh-ancestor
20015707|NCT02443402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015708|NCT02443402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015709|NCT02443883|Ramucirumab|ramucirumab|mesh-list
20015710|NCT02443883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015711|NCT02444143|Tacrolimus|tacrolimus|mesh-list
20015712|NCT02444143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20015713|NCT02444143|Immunologic Factors|immunologic factors|mesh-ancestor
20015714|NCT02444143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015715|NCT02444143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
20015716|NCT02444143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015717|NCT02444143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015718|NCT02444234|Tedizolid|tedizolid|mesh-list
20015719|NCT02444234|Oxazolidinones|oxazolidinones|mesh-list
20015720|NCT02444234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20015721|NCT02444234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20015722|NCT02444234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20015723|NCT02444234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015724|NCT02444234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015725|NCT02444533|Bupivacaine|bupivacaine|mesh-list
20015726|NCT02444533|Anesthetics, Local|anesthetics, local|mesh-ancestor
20015727|NCT02444533|Anesthetics|anesthetics|mesh-ancestor
20015728|NCT02444533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20015729|NCT02444533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015730|NCT02444533|Sensory System Agents|sensory system agents|mesh-ancestor
20015731|NCT02444533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20015732|NCT02444793|Mogamulizumab|mogamulizumab|mesh-list
20015733|NCT02444793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015734|NCT02444936|Vaccines|vaccines|mesh-list
20015735|NCT02444936|Immunologic Factors|immunologic factors|mesh-ancestor
20015736|NCT02444936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015737|NCT02444988|Plasma-lyte 148|plasma-lyte 148|mesh-list
20015738|NCT02444988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20015739|NCT02444988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20015740|NCT02445326|Dexamethasone|dexamethasone|mesh-list
20015741|NCT02445326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20015742|NCT02445326|Antiemetics|antiemetics|mesh-ancestor
20015743|NCT02445326|Autonomic Agents|autonomic agents|mesh-ancestor
20015744|NCT02445326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20015745|NCT02445326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015746|NCT02445326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20015747|NCT02445326|Glucocorticoids|glucocorticoids|mesh-ancestor
20015748|NCT02445326|Hormones|hormones|mesh-ancestor
20015749|NCT02445326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20015750|NCT02445326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20015751|NCT02445326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015752|NCT02445586|Docetaxel|docetaxel|mesh-list
20015753|NCT02445586|Trastuzumab|trastuzumab|mesh-list
20015754|NCT02445586|Pertuzumab|pertuzumab|mesh-list
20015755|NCT02445586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015756|NCT02445586|Tubulin Modulators|tubulin modulators|mesh-ancestor
20015757|NCT02445586|Antimitotic Agents|antimitotic agents|mesh-ancestor
20015758|NCT02445586|Mitosis Modulators|mitosis modulators|mesh-ancestor
20015759|NCT02445586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015760|NCT02445586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20015761|NCT02445807|Clobetasol|clobetasol|mesh-list
20015762|NCT02445807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20015763|NCT02445807|Glucocorticoids|glucocorticoids|mesh-ancestor
20015764|NCT02445807|Hormones|hormones|mesh-ancestor
20015765|NCT02445807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20015766|NCT02445807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015767|NCT02445859|Cefuroxime|cefuroxime|mesh-list
20015768|NCT02445859|Cefuroxime axetil|cefuroxime axetil|mesh-list
20015769|NCT02445859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20015770|NCT02445859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20015771|NCT02446015|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20015772|NCT02446015|Lubricant Eye Drops|lubricant eye drops|mesh-list
20015773|NCT02446015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20015774|NCT02446171|Naloxegol|naloxegol|mesh-list
20015775|NCT02446171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20015776|NCT02446171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015777|NCT02446171|Sensory System Agents|sensory system agents|mesh-ancestor
20015778|NCT02446171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20015779|NCT02446418|Fluticasone|fluticasone|mesh-list
20015780|NCT02446418|Xhance|xhance|mesh-list
20015781|NCT02446418|Budesonide|budesonide|mesh-list
20015782|NCT02446418|Formoterol Fumarate|formoterol fumarate|mesh-list
20015783|NCT02446418|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
20015784|NCT02446418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20015785|NCT02446418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20015786|NCT02446418|Autonomic Agents|autonomic agents|mesh-ancestor
20015787|NCT02446418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20015788|NCT02446418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015789|NCT02446418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20015790|NCT02446418|Respiratory System Agents|respiratory system agents|mesh-ancestor
20015791|NCT02446418|Dermatologic Agents|dermatologic agents|mesh-ancestor
20015792|NCT02446418|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20015793|NCT02446418|Glucocorticoids|glucocorticoids|mesh-ancestor
20015794|NCT02446418|Hormones|hormones|mesh-ancestor
20015795|NCT02446418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20015796|NCT02446418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20015797|NCT02446418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20015798|NCT02446418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20015799|NCT02446418|Adrenergic Agents|adrenergic agents|mesh-ancestor
20015800|NCT02446418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20015801|NCT02446418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015802|NCT02446483|Rabeprazole|rabeprazole|mesh-list
20015803|NCT02446483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20015804|NCT02446483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20015805|NCT02446483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20015806|NCT02446483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015807|NCT02446483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015808|NCT02446496|Cefadroxil|cefadroxil|mesh-list
20015809|NCT02446496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20015810|NCT02446496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20015811|NCT02446717|Ribavirin|ribavirin|mesh-list
20015812|NCT02446717|Antimetabolites|antimetabolites|mesh-ancestor
20015813|NCT02446717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015814|NCT02446717|Antiviral Agents|antiviral agents|mesh-ancestor
20015815|NCT02446717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20015816|NCT02446886|Hormones|hormones|mesh-list
20015817|NCT02446886|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
20015818|NCT02446886|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
20015819|NCT02446886|beta-Endorphin|beta-endorphin|mesh-list
20015820|NCT02446886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20015821|NCT02446886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015822|NCT02446886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20015823|NCT02446886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015824|NCT02447003|Pembrolizumab|pembrolizumab|mesh-list
20015825|NCT02447003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20015826|NCT02447003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015827|NCT02447029|Lidocaine|lidocaine|mesh-list
20015828|NCT02447029|Anesthetics, Local|anesthetics, local|mesh-ancestor
20015829|NCT02447029|Anesthetics|anesthetics|mesh-ancestor
20015830|NCT02447029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20015831|NCT02447029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015832|NCT02447029|Sensory System Agents|sensory system agents|mesh-ancestor
20015833|NCT02447029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20015834|NCT02447029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20015835|NCT02447029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20015836|NCT02447029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20015837|NCT02447029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20015838|NCT02447029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015839|NCT02447172|Gentamicins|gentamicins|mesh-list
20015840|NCT02447172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20015841|NCT02447172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20015842|NCT02447172|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20015843|NCT02447172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015844|NCT02447172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015845|NCT02447250|Albuterol|albuterol|mesh-list
20015846|NCT02447250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20015847|NCT02447250|Autonomic Agents|autonomic agents|mesh-ancestor
20015848|NCT02447250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20015849|NCT02447250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015850|NCT02447250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20015851|NCT02447250|Respiratory System Agents|respiratory system agents|mesh-ancestor
20015852|NCT02447250|Tocolytic Agents|tocolytic agents|mesh-ancestor
20015853|NCT02447250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20015854|NCT02447250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20015855|NCT02447250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20015856|NCT02447250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20015857|NCT02447250|Adrenergic Agents|adrenergic agents|mesh-ancestor
20015858|NCT02447250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20015859|NCT02447250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015860|NCT02447328|Fulvestrant|fulvestrant|mesh-list
20015861|NCT02447328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20015862|NCT02447328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015863|NCT02447328|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
20015864|NCT02447328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20015865|NCT02447328|Hormone Antagonists|hormone antagonists|mesh-ancestor
20015866|NCT02447328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20015867|NCT02447328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015868|NCT02447432|Vaccines|vaccines|mesh-list
20015869|NCT02447432|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20015870|NCT02447432|Immunologic Factors|immunologic factors|mesh-ancestor
20015871|NCT02447432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015872|NCT02447718|Vaccines|vaccines|mesh-list
20015873|NCT02447718|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20015874|NCT02447718|Immunologic Factors|immunologic factors|mesh-ancestor
20015875|NCT02447718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015876|NCT02447848|Sufentanil|sufentanil|mesh-list
20015877|NCT02447848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20015878|NCT02447848|Narcotics|narcotics|mesh-ancestor
20015879|NCT02447848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20015880|NCT02447848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015881|NCT02447848|Analgesics|analgesics|mesh-ancestor
20015882|NCT02447848|Sensory System Agents|sensory system agents|mesh-ancestor
20015883|NCT02447848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20015884|NCT02447848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20015885|NCT02447848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20015886|NCT02447848|Anesthetics, General|anesthetics, general|mesh-ancestor
20015887|NCT02447848|Anesthetics|anesthetics|mesh-ancestor
20015888|NCT02447991|Rizatriptan|rizatriptan|mesh-list
20015889|NCT02447991|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20015890|NCT02447991|Serotonin Agents|serotonin agents|mesh-ancestor
20015891|NCT02447991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20015892|NCT02447991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015893|NCT02447991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015894|NCT02448043|Bimatoprost|bimatoprost|mesh-list
20015895|NCT02448043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20015896|NCT02448303|Pembrolizumab|pembrolizumab|mesh-list
20015897|NCT02448303|Acalabrutinib|acalabrutinib|mesh-list
20015898|NCT02448303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20015899|NCT02448303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015900|NCT02448368|Verinurad|verinurad|mesh-list
20015901|NCT02448368|Gout Suppressants|gout suppressants|mesh-ancestor
20015902|NCT02448368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20015903|NCT02448446|Ranibizumab|ranibizumab|mesh-list
20015904|NCT02448446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20015905|NCT02448446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20015906|NCT02448446|Growth Substances|growth substances|mesh-ancestor
20015907|NCT02448446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015908|NCT02448446|Growth Inhibitors|growth inhibitors|mesh-ancestor
20015909|NCT02448446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015910|NCT02448537|Gemcitabine|gemcitabine|mesh-list
20015911|NCT02448537|Doxorubicin|doxorubicin|mesh-list
20015912|NCT02448537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20015913|NCT02448537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20015914|NCT02448537|Antimetabolites|antimetabolites|mesh-ancestor
20015915|NCT02448537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015916|NCT02448537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015917|NCT02448537|Antiviral Agents|antiviral agents|mesh-ancestor
20015918|NCT02448537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20015919|NCT02448537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015920|NCT02448537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20015921|NCT02448537|Immunologic Factors|immunologic factors|mesh-ancestor
20015922|NCT02448537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015923|NCT02448537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20015924|NCT02448537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20015925|NCT02448537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20015926|NCT02448654|Tolcapone|tolcapone|mesh-list
20015927|NCT02448654|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20015928|NCT02448654|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20015929|NCT02448654|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
20015930|NCT02448654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015931|NCT02448654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015932|NCT02448771|Bazedoxifene|bazedoxifene|mesh-list
20015933|NCT02448771|Palbociclib|palbociclib|mesh-list
20015934|NCT02448771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015935|NCT02448771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20015936|NCT02448771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20015937|NCT02448771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015938|NCT02448771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
20015939|NCT02448771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
20015940|NCT02448771|Hormone Antagonists|hormone antagonists|mesh-ancestor
20015941|NCT02448771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20015942|NCT02448771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015943|NCT02448771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20015944|NCT02448810|Fluorouracil|fluorouracil|mesh-list
20015945|NCT02448810|Panitumumab|panitumumab|mesh-list
20015946|NCT02448810|Antimetabolites|antimetabolites|mesh-ancestor
20015947|NCT02448810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015948|NCT02448810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20015949|NCT02448810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20015950|NCT02448810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20015951|NCT02448810|Immunologic Factors|immunologic factors|mesh-ancestor
20015952|NCT02448810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015953|NCT02448810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20015954|NCT02448862|Fentanyl|fentanyl|mesh-list
20015955|NCT02448862|Analgesics|analgesics|mesh-list
20015956|NCT02448862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20015957|NCT02448862|Narcotics|narcotics|mesh-ancestor
20015958|NCT02448862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20015959|NCT02448862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015960|NCT02448862|Sensory System Agents|sensory system agents|mesh-ancestor
20015961|NCT02448862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20015962|NCT02448862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20015963|NCT02448862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20015964|NCT02448862|Anesthetics, General|anesthetics, general|mesh-ancestor
20015965|NCT02448862|Anesthetics|anesthetics|mesh-ancestor
20015966|NCT02448914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
20015967|NCT02448914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20015968|NCT02448914|Immunologic Factors|immunologic factors|mesh-ancestor
20015969|NCT02448914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015970|NCT02448914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20015971|NCT02448914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20015972|NCT02448914|Dopamine Agonists|dopamine agonists|mesh-ancestor
20015973|NCT02448914|Dopamine Agents|dopamine agents|mesh-ancestor
20015974|NCT02448914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20015975|NCT02448914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015976|NCT02449044|Tolvaptan|tolvaptan|mesh-list
20015977|NCT02449044|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
20015978|NCT02449044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20015979|NCT02449044|Natriuretic Agents|natriuretic agents|mesh-ancestor
20015980|NCT02449044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015981|NCT02449889|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
20015982|NCT02449889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20015983|NCT02449889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015984|NCT02449902|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
20015985|NCT02449902|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
20015986|NCT02449902|Estradiol|estradiol|mesh-list
20015987|NCT02449902|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
20015988|NCT02449902|Estrogens|estrogens|mesh-ancestor
20015989|NCT02449902|Hormones|hormones|mesh-ancestor
20015990|NCT02449902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20015991|NCT02449902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20015992|NCT02449902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20015993|NCT02449902|Contraceptive Agents|contraceptive agents|mesh-ancestor
20015994|NCT02449902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20015995|NCT02449902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20015996|NCT02449915|Bupivacaine|bupivacaine|mesh-list
20015997|NCT02449915|Anesthetics, Local|anesthetics, local|mesh-ancestor
20015998|NCT02449915|Anesthetics|anesthetics|mesh-ancestor
20015999|NCT02449915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20016000|NCT02449915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016001|NCT02449915|Sensory System Agents|sensory system agents|mesh-ancestor
20016002|NCT02449915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016003|NCT02450487|Piroxicam|piroxicam|mesh-list
20016004|NCT02450487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20016005|NCT02450487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20016006|NCT02450487|Analgesics|analgesics|mesh-ancestor
20016007|NCT02450487|Sensory System Agents|sensory system agents|mesh-ancestor
20016008|NCT02450487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016009|NCT02450487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016010|NCT02450487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20016011|NCT02450487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20016012|NCT02450487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20016013|NCT02450487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016014|NCT02450487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016015|NCT02450526|Botulinum Toxins|botulinum toxins|mesh-list
20016016|NCT02450526|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20016017|NCT02450526|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20016018|NCT02450526|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20016019|NCT02450526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20016020|NCT02450526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016021|NCT02450526|Cholinergic Agents|cholinergic agents|mesh-ancestor
20016022|NCT02450526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20016023|NCT02450526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016024|NCT02450526|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20016025|NCT02450526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016026|NCT02450539|Docetaxel|docetaxel|mesh-list
20016027|NCT02450539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016028|NCT02450539|Tubulin Modulators|tubulin modulators|mesh-ancestor
20016029|NCT02450539|Antimitotic Agents|antimitotic agents|mesh-ancestor
20016030|NCT02450539|Mitosis Modulators|mitosis modulators|mesh-ancestor
20016031|NCT02450539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016032|NCT02450552|Ezogabine|ezogabine|mesh-list
20016033|NCT02450552|Anticonvulsants|anticonvulsants|mesh-ancestor
20016034|NCT02450552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20016035|NCT02450552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016036|NCT02450578|Atovaquone|atovaquone|mesh-list
20016037|NCT02450578|Proguanil|proguanil|mesh-list
20016038|NCT02450578|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
20016039|NCT02450578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20016040|NCT02450578|Antimalarials|antimalarials|mesh-ancestor
20016041|NCT02450578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20016042|NCT02450578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20016043|NCT02450578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016044|NCT02450578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016045|NCT02450578|Antimetabolites|antimetabolites|mesh-ancestor
20016046|NCT02450903|Ceritinib|ceritinib|mesh-list
20016047|NCT02450903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016048|NCT02450903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20016049|NCT02450903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016050|NCT02450903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016051|NCT02451137|Insulin|insulin|mesh-list
20016052|NCT02451137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20016053|NCT02451137|Insulin Glargine|insulin glargine|mesh-list
20016054|NCT02451137|Insulin Detemir|insulin detemir|mesh-list
20016055|NCT02451137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20016056|NCT02451137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016057|NCT02451150|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20016058|NCT02451150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20016059|NCT02451150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20016060|NCT02451150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016061|NCT02451202|Rocuronium|rocuronium|mesh-list
20016062|NCT02451202|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20016063|NCT02451202|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20016064|NCT02451202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20016065|NCT02451202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016066|NCT02451202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016067|NCT02451488|Sargramostim|sargramostim|mesh-list
20016068|NCT02451488|Immunologic Factors|immunologic factors|mesh-ancestor
20016069|NCT02451488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016070|NCT02451696|Everolimus|everolimus|mesh-list
20016071|NCT02451696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016072|NCT02451696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20016073|NCT02451696|Immunologic Factors|immunologic factors|mesh-ancestor
20016074|NCT02451696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016075|NCT02451917|Insulin|insulin|mesh-list
20016076|NCT02451917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20016077|NCT02451917|Insulin Glargine|insulin glargine|mesh-list
20016078|NCT02451917|Insulin, Isophane|insulin, isophane|mesh-list
20016079|NCT02451917|Isophane Insulin, Human|isophane insulin, human|mesh-list
20016080|NCT02451917|Isophane insulin, beef|isophane insulin, beef|mesh-list
20016081|NCT02451917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20016082|NCT02451917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016083|NCT02451930|Pembrolizumab|pembrolizumab|mesh-list
20016084|NCT02451930|Necitumumab|necitumumab|mesh-list
20016085|NCT02451930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20016086|NCT02451930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016087|NCT02452034|Posaconazole|posaconazole|mesh-list
20016088|NCT02452034|Antifungal Agents|antifungal agents|mesh-ancestor
20016089|NCT02452034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20016090|NCT02452034|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20016091|NCT02452034|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20016092|NCT02452034|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20016093|NCT02452034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20016094|NCT02452034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20016095|NCT02452034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016096|NCT02452034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016097|NCT02452034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20016098|NCT02452034|Hormone Antagonists|hormone antagonists|mesh-ancestor
20016099|NCT02452034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20016100|NCT02452034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016101|NCT02452047|Imipenem|imipenem|mesh-list
20016102|NCT02452047|Relebactam|relebactam|mesh-list
20016103|NCT02452047|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
20016104|NCT02452047|Cilastatin|cilastatin|mesh-list
20016105|NCT02452047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20016106|NCT02452047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20016107|NCT02452047|Protease Inhibitors|protease inhibitors|mesh-ancestor
20016108|NCT02452047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016109|NCT02452047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016110|NCT02452047|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20016111|NCT02452060|Ketamine|ketamine|mesh-list
20016112|NCT02452060|Analgesics|analgesics|mesh-ancestor
20016113|NCT02452060|Sensory System Agents|sensory system agents|mesh-ancestor
20016114|NCT02452060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016115|NCT02452060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016116|NCT02452060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20016117|NCT02452060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20016118|NCT02452060|Anesthetics, General|anesthetics, general|mesh-ancestor
20016119|NCT02452060|Anesthetics|anesthetics|mesh-ancestor
20016120|NCT02452060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20016121|NCT02452060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20016122|NCT02452060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20016123|NCT02452060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20016124|NCT02452060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016125|NCT02452190|Reslizumab|reslizumab|mesh-list
20016126|NCT02452190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20016127|NCT02452190|Respiratory System Agents|respiratory system agents|mesh-ancestor
20016128|NCT02452320|Acetaminophen|acetaminophen|mesh-list
20016129|NCT02452320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20016130|NCT02452320|Analgesics|analgesics|mesh-ancestor
20016131|NCT02452320|Sensory System Agents|sensory system agents|mesh-ancestor
20016132|NCT02452320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016133|NCT02452320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016134|NCT02452320|Antipyretics|antipyretics|mesh-ancestor
20016135|NCT02452346|Tosedostat|tosedostat|mesh-list
20016136|NCT02452346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016137|NCT02452346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016138|NCT02452424|Pembrolizumab|pembrolizumab|mesh-list
20016139|NCT02452424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20016140|NCT02452424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016141|NCT02452463|Durvalumab|durvalumab|mesh-list
20016142|NCT02452463|Nintedanib|nintedanib|mesh-list
20016143|NCT02452463|Immunoglobulins|immunoglobulins|mesh-list
20016144|NCT02452463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20016145|NCT02452463|Immunoglobulin G|immunoglobulin g|mesh-list
20016146|NCT02452463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20016147|NCT02452463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016148|NCT02452463|Immunologic Factors|immunologic factors|mesh-ancestor
20016149|NCT02452463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016150|NCT02452463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20016151|NCT02452463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016152|NCT02452463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016153|NCT02452476|Poractant alfa|poractant alfa|mesh-list
20016154|NCT02452476|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
20016155|NCT02452476|Respiratory System Agents|respiratory system agents|mesh-ancestor
20016156|NCT02452528|Diphenhydramine|diphenhydramine|mesh-list
20016157|NCT02452528|Promethazine|promethazine|mesh-list
20016158|NCT02452528|Tenofovir|tenofovir|mesh-list
20016159|NCT02452528|Entecavir|entecavir|mesh-list
20016160|NCT02452528|Antiviral Agents|antiviral agents|mesh-ancestor
20016161|NCT02452528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20016162|NCT02452528|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20016163|NCT02452528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20016164|NCT02452528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016165|NCT02452528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016166|NCT02452528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20016167|NCT02452528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20016168|NCT02452528|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20016169|NCT02452528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20016170|NCT02452528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20016171|NCT02452528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016172|NCT02452528|Anesthetics, Local|anesthetics, local|mesh-ancestor
20016173|NCT02452528|Anesthetics|anesthetics|mesh-ancestor
20016174|NCT02452528|Sensory System Agents|sensory system agents|mesh-ancestor
20016175|NCT02452528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016176|NCT02452528|Antiemetics|antiemetics|mesh-ancestor
20016177|NCT02452528|Autonomic Agents|autonomic agents|mesh-ancestor
20016178|NCT02452528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20016179|NCT02452528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20016180|NCT02452528|Histamine Antagonists|histamine antagonists|mesh-ancestor
20016181|NCT02452528|Histamine Agents|histamine agents|mesh-ancestor
20016182|NCT02452528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20016183|NCT02452528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20016184|NCT02452528|Antipruritics|antipruritics|mesh-ancestor
20016185|NCT02452528|Dermatologic Agents|dermatologic agents|mesh-ancestor
20016186|NCT02452762|Vitamin D|vitamin d|mesh-list
20016187|NCT02452762|Cholecalciferol|cholecalciferol|mesh-list
20016188|NCT02452762|Vitamins|vitamins|mesh-ancestor
20016189|NCT02452762|Micronutrients|micronutrients|mesh-ancestor
20016190|NCT02452762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016191|NCT02452762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20016192|NCT02452762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20016193|NCT02452866|Secnidazole|secnidazole|mesh-list
20016194|NCT02452866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20016195|NCT02452866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20016196|NCT02452866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20016197|NCT02452931|Leuprolide|leuprolide|mesh-list
20016198|NCT02452931|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20016199|NCT02452931|Fertility Agents|fertility agents|mesh-ancestor
20016200|NCT02452931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20016201|NCT02452931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016202|NCT02452931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20016203|NCT02452931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016204|NCT02453191|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
20016205|NCT02453191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20016206|NCT02453191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016207|NCT02453282|Gemcitabine|gemcitabine|mesh-list
20016208|NCT02453282|Paclitaxel|paclitaxel|mesh-list
20016209|NCT02453282|Cisplatin|cisplatin|mesh-list
20016210|NCT02453282|Carboplatin|carboplatin|mesh-list
20016211|NCT02453282|Pemetrexed|pemetrexed|mesh-list
20016212|NCT02453282|Durvalumab|durvalumab|mesh-list
20016213|NCT02453282|Tremelimumab|tremelimumab|mesh-list
20016214|NCT02453282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
20016215|NCT02453282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20016216|NCT02453282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016217|NCT02453282|Tubulin Modulators|tubulin modulators|mesh-ancestor
20016218|NCT02453282|Antimitotic Agents|antimitotic agents|mesh-ancestor
20016219|NCT02453282|Mitosis Modulators|mitosis modulators|mesh-ancestor
20016220|NCT02453282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016221|NCT02453282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20016222|NCT02453282|Antimetabolites|antimetabolites|mesh-ancestor
20016223|NCT02453282|Antiviral Agents|antiviral agents|mesh-ancestor
20016224|NCT02453282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20016225|NCT02453282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016226|NCT02453282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20016227|NCT02453282|Immunologic Factors|immunologic factors|mesh-ancestor
20016228|NCT02453282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016229|NCT02453282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
20016230|NCT02453282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20016231|NCT02453282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20016232|NCT02453321|Bupivacaine|bupivacaine|mesh-list
20016233|NCT02453321|Anesthetics, Local|anesthetics, local|mesh-ancestor
20016234|NCT02453321|Anesthetics|anesthetics|mesh-ancestor
20016235|NCT02453321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20016236|NCT02453321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016237|NCT02453321|Sensory System Agents|sensory system agents|mesh-ancestor
20016238|NCT02453321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016239|NCT02453360|Bupivacaine|bupivacaine|mesh-list
20016240|NCT02453360|Anesthetics, Local|anesthetics, local|mesh-ancestor
20016241|NCT02453360|Anesthetics|anesthetics|mesh-ancestor
20016242|NCT02453360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20016243|NCT02453360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016244|NCT02453360|Sensory System Agents|sensory system agents|mesh-ancestor
20016245|NCT02453360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016246|NCT02453555|Empagliflozin|empagliflozin|mesh-list
20016247|NCT02453555|Linagliptin|linagliptin|mesh-list
20016248|NCT02453555|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20016249|NCT02453555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016250|NCT02453555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20016251|NCT02453555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016252|NCT02453555|Incretins|incretins|mesh-ancestor
20016253|NCT02453555|Hormones|hormones|mesh-ancestor
20016254|NCT02453555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20016255|NCT02453555|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20016256|NCT02453555|Protease Inhibitors|protease inhibitors|mesh-ancestor
20016257|NCT02453555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016258|NCT02453581|Artefenomel|artefenomel|mesh-list
20016259|NCT02453581|Antimalarials|antimalarials|mesh-ancestor
20016260|NCT02453581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20016261|NCT02453581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20016262|NCT02453581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20016263|NCT02453672|Bevacizumab|bevacizumab|mesh-list
20016264|NCT02453672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20016265|NCT02453672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016266|NCT02453672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20016267|NCT02453672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20016268|NCT02453672|Growth Substances|growth substances|mesh-ancestor
20016269|NCT02453672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016270|NCT02453672|Growth Inhibitors|growth inhibitors|mesh-ancestor
20016271|NCT02453685|Insulin|insulin|mesh-list
20016272|NCT02453685|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
20016273|NCT02453685|Insulin Glargine|insulin glargine|mesh-list
20016274|NCT02453685|Insulin Aspart|insulin aspart|mesh-list
20016275|NCT02453685|Insulin, Long-Acting|insulin, long-acting|mesh-list
20016276|NCT02453685|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
20016277|NCT02453685|Biphasic Insulins|biphasic insulins|mesh-list
20016278|NCT02453685|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
20016279|NCT02453685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20016280|NCT02453685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016281|NCT02453711|Liraglutide|liraglutide|mesh-list
20016282|NCT02453711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20016283|NCT02453711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016284|NCT02453711|Incretins|incretins|mesh-ancestor
20016285|NCT02453711|Hormones|hormones|mesh-ancestor
20016286|NCT02453711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20016287|NCT02453750|Bronchodilator Agents|bronchodilator agents|mesh-list
20016288|NCT02453750|Autonomic Agents|autonomic agents|mesh-ancestor
20016289|NCT02453750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016290|NCT02453750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016291|NCT02453750|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20016292|NCT02453750|Respiratory System Agents|respiratory system agents|mesh-ancestor
20016293|NCT02453841|Phenylephrine|phenylephrine|mesh-list
20016294|NCT02453841|Oxymetazoline|oxymetazoline|mesh-list
20016295|NCT02453841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20016296|NCT02453841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20016297|NCT02453841|Adrenergic Agents|adrenergic agents|mesh-ancestor
20016298|NCT02453841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20016299|NCT02453841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016300|NCT02453841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016301|NCT02453841|Sympathomimetics|sympathomimetics|mesh-ancestor
20016302|NCT02453841|Autonomic Agents|autonomic agents|mesh-ancestor
20016303|NCT02453841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016304|NCT02453841|Nasal Decongestants|nasal decongestants|mesh-ancestor
20016305|NCT02453841|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20016306|NCT02453841|Respiratory System Agents|respiratory system agents|mesh-ancestor
20016307|NCT02453841|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20016308|NCT02453841|Mydriatics|mydriatics|mesh-ancestor
20016309|NCT02453841|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
20016310|NCT02453841|Protective Agents|protective agents|mesh-ancestor
20016311|NCT02454179|Pembrolizumab|pembrolizumab|mesh-list
20016312|NCT02454179|Acalabrutinib|acalabrutinib|mesh-list
20016313|NCT02454179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20016314|NCT02454179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016315|NCT02454283|Vanoxerine|vanoxerine|mesh-list
20016316|NCT02454283|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20016317|NCT02454283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20016318|NCT02454283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20016319|NCT02454283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016320|NCT02454283|Dopamine Agents|dopamine agents|mesh-ancestor
20016321|NCT02454283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20016322|NCT02454283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016323|NCT02454296|Lidocaine|lidocaine|mesh-list
20016324|NCT02454296|Anesthetics, Local|anesthetics, local|mesh-ancestor
20016325|NCT02454296|Anesthetics|anesthetics|mesh-ancestor
20016326|NCT02454296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20016327|NCT02454296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016328|NCT02454296|Sensory System Agents|sensory system agents|mesh-ancestor
20016329|NCT02454296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016330|NCT02454296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20016331|NCT02454296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20016332|NCT02454296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20016333|NCT02454296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20016334|NCT02454296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016335|NCT02454478|Everolimus|everolimus|mesh-list
20016336|NCT02454478|Lenvatinib|lenvatinib|mesh-list
20016337|NCT02454478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016338|NCT02454478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20016339|NCT02454478|Immunologic Factors|immunologic factors|mesh-ancestor
20016340|NCT02454478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016341|NCT02454478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20016342|NCT02454478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016343|NCT02454478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016344|NCT02454608|Verapamil|verapamil|mesh-list
20016345|NCT02454608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20016346|NCT02454608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20016347|NCT02454608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20016348|NCT02454608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016349|NCT02454608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20016350|NCT02454608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016351|NCT02454608|Vasodilator Agents|vasodilator agents|mesh-ancestor
20016352|NCT02455050|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
20016353|NCT02455050|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20016354|NCT02455050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20016355|NCT02455050|Laxatives|laxatives|mesh-ancestor
20016356|NCT02455050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20016357|NCT02455076|Exenatide|exenatide|mesh-list
20016358|NCT02455076|Insulin, Short-Acting|insulin, short-acting|mesh-list
20016359|NCT02455076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20016360|NCT02455076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016361|NCT02455076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
20016362|NCT02455076|Incretins|incretins|mesh-ancestor
20016363|NCT02455076|Hormones|hormones|mesh-ancestor
20016364|NCT02455076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20016365|NCT02455167|Ribavirin|ribavirin|mesh-list
20016366|NCT02455167|Sofosbuvir|sofosbuvir|mesh-list
20016367|NCT02455167|Antimetabolites|antimetabolites|mesh-ancestor
20016368|NCT02455167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016369|NCT02455167|Antiviral Agents|antiviral agents|mesh-ancestor
20016370|NCT02455167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20016371|NCT02455336|Fenofibrate|fenofibrate|mesh-list
20016372|NCT02455336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20016373|NCT02455336|Antimetabolites|antimetabolites|mesh-ancestor
20016374|NCT02455336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016375|NCT02455336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20016376|NCT02455453|Estradiol|estradiol|mesh-list
20016377|NCT02455453|Estrogens|estrogens|mesh-ancestor
20016378|NCT02455453|Hormones|hormones|mesh-ancestor
20016379|NCT02455453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20016380|NCT02455453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016381|NCT02455518|Acetaminophen|acetaminophen|mesh-list
20016382|NCT02455518|Ibuprofen|ibuprofen|mesh-list
20016383|NCT02455518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20016384|NCT02455518|Oxycodone|oxycodone|mesh-list
20016385|NCT02455518|Hydrocodone|hydrocodone|mesh-list
20016386|NCT02455518|Codeine|codeine|mesh-list
20016387|NCT02455518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20016388|NCT02455518|Analgesics|analgesics|mesh-ancestor
20016389|NCT02455518|Sensory System Agents|sensory system agents|mesh-ancestor
20016390|NCT02455518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016391|NCT02455518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016392|NCT02455518|Antipyretics|antipyretics|mesh-ancestor
20016393|NCT02455518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20016394|NCT02455518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20016395|NCT02455518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20016396|NCT02455518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20016397|NCT02455518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016398|NCT02455518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016399|NCT02455518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20016400|NCT02455518|Narcotics|narcotics|mesh-ancestor
20016401|NCT02455518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20016402|NCT02455518|Antitussive Agents|antitussive agents|mesh-ancestor
20016403|NCT02455518|Respiratory System Agents|respiratory system agents|mesh-ancestor
20016404|NCT02456662|Ondansetron|ondansetron|mesh-list
20016405|NCT02456662|Antiemetics|antiemetics|mesh-ancestor
20016406|NCT02456662|Autonomic Agents|autonomic agents|mesh-ancestor
20016407|NCT02456662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016408|NCT02456662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016409|NCT02456662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20016410|NCT02456662|Antipruritics|antipruritics|mesh-ancestor
20016411|NCT02456662|Dermatologic Agents|dermatologic agents|mesh-ancestor
20016412|NCT02456662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20016413|NCT02456662|Serotonin Agents|serotonin agents|mesh-ancestor
20016414|NCT02456662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20016415|NCT02456662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016416|NCT02456662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20016417|NCT02456662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20016418|NCT02456662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20016419|NCT02456662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20016420|NCT02456662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20016421|NCT02456896|Oxcarbazepine|oxcarbazepine|mesh-list
20016422|NCT02456896|Anticonvulsants|anticonvulsants|mesh-ancestor
20016423|NCT02456896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20016424|NCT02456896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20016425|NCT02456896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20016426|NCT02456896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016427|NCT02456896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20016428|NCT02456896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20016429|NCT02456909|Morphine|morphine|mesh-list
20016430|NCT02456909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20016431|NCT02456909|Narcotics|narcotics|mesh-ancestor
20016432|NCT02456909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20016433|NCT02456909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016434|NCT02456909|Analgesics|analgesics|mesh-ancestor
20016435|NCT02456909|Sensory System Agents|sensory system agents|mesh-ancestor
20016436|NCT02456909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016437|NCT02457195|Granisetron|granisetron|mesh-list
20016438|NCT02457195|Antiemetics|antiemetics|mesh-ancestor
20016439|NCT02457195|Autonomic Agents|autonomic agents|mesh-ancestor
20016440|NCT02457195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016441|NCT02457195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016442|NCT02457195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20016443|NCT02457195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20016444|NCT02457195|Serotonin Agents|serotonin agents|mesh-ancestor
20016445|NCT02457195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20016446|NCT02457195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016447|NCT02457247|Calcium Carbonate|calcium carbonate|mesh-list
20016448|NCT02457247|Antacids|antacids|mesh-ancestor
20016449|NCT02457247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016450|NCT02457247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20016451|NCT02457325|Carticaine|carticaine|mesh-list
20016452|NCT02457325|Anesthetics, Local|anesthetics, local|mesh-ancestor
20016453|NCT02457325|Anesthetics|anesthetics|mesh-ancestor
20016454|NCT02457325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20016455|NCT02457325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016456|NCT02457325|Sensory System Agents|sensory system agents|mesh-ancestor
20016457|NCT02457325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016458|NCT02457520|Isotretinoin|isotretinoin|mesh-list
20016459|NCT02457520|Dermatologic Agents|dermatologic agents|mesh-ancestor
20016460|NCT02457546|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
20016461|NCT02457546|Hemostatics|hemostatics|mesh-ancestor
20016462|NCT02457546|Coagulants|coagulants|mesh-ancestor
20016463|NCT02457611|Sofosbuvir|sofosbuvir|mesh-list
20016464|NCT02457611|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
20016465|NCT02457611|Ledipasvir|ledipasvir|mesh-list
20016466|NCT02457611|Antiviral Agents|antiviral agents|mesh-ancestor
20016467|NCT02457611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20016468|NCT02457793|Ravoxertinib|ravoxertinib|mesh-list
20016469|NCT02457793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016470|NCT02457793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20016471|NCT02457793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016472|NCT02457793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016473|NCT02458235|Azacitidine|azacitidine|mesh-list
20016474|NCT02458235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20016475|NCT02458235|Antimetabolites|antimetabolites|mesh-ancestor
20016476|NCT02458235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016477|NCT02458235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016478|NCT02458235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016479|NCT02458287|Bococizumab|bococizumab|mesh-list
20016480|NCT02458287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
20016481|NCT02458287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
20016482|NCT02458287|Antimetabolites|antimetabolites|mesh-ancestor
20016483|NCT02458287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016484|NCT02458287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
20016485|NCT02458469|Buspirone|buspirone|mesh-list
20016486|NCT02458469|Trazodone|trazodone|mesh-list
20016487|NCT02458469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20016488|NCT02458469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20016489|NCT02458469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20016490|NCT02458469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016491|NCT02458469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20016492|NCT02458469|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20016493|NCT02458469|Serotonin Agents|serotonin agents|mesh-ancestor
20016494|NCT02458469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20016495|NCT02458469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016496|NCT02458469|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20016497|NCT02458469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20016498|NCT02458469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20016499|NCT02458469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20016500|NCT02458469|Antidepressive Agents|antidepressive agents|mesh-ancestor
20016501|NCT02458638|Atezolizumab|atezolizumab|mesh-list
20016502|NCT02458638|Antibodies|antibodies|mesh-list
20016503|NCT02458638|Immunologic Factors|immunologic factors|mesh-ancestor
20016504|NCT02458638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016505|NCT02458638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016506|NCT02458690|Dopamine|dopamine|mesh-list
20016507|NCT02458690|Norepinephrine|norepinephrine|mesh-list
20016508|NCT02458690|Antidepressive Agents|antidepressive agents|mesh-list
20016509|NCT02458690|Serotonin|serotonin|mesh-list
20016510|NCT02458690|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
20016511|NCT02458690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-list
20016512|NCT02458690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20016513|NCT02458690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20016514|NCT02458690|Adrenergic Agents|adrenergic agents|mesh-ancestor
20016515|NCT02458690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20016516|NCT02458690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016517|NCT02458690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016518|NCT02458690|Sympathomimetics|sympathomimetics|mesh-ancestor
20016519|NCT02458690|Autonomic Agents|autonomic agents|mesh-ancestor
20016520|NCT02458690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016521|NCT02458690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20016522|NCT02458690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20016523|NCT02458690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
20016524|NCT02458690|Dopamine Agents|dopamine agents|mesh-ancestor
20016525|NCT02458690|Protective Agents|protective agents|mesh-ancestor
20016526|NCT02458690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20016527|NCT02458690|Serotonin Agents|serotonin agents|mesh-ancestor
20016528|NCT02458690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20016529|NCT02458690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20016530|NCT02458768|Menotropins|menotropins|mesh-list
20016531|NCT02458768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
20016532|NCT02458768|Fertility Agents|fertility agents|mesh-ancestor
20016533|NCT02458768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20016534|NCT02458768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016535|NCT02459275|Metoclopramide|metoclopramide|mesh-list
20016536|NCT02459275|Antiemetics|antiemetics|mesh-ancestor
20016537|NCT02459275|Autonomic Agents|autonomic agents|mesh-ancestor
20016538|NCT02459275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016539|NCT02459275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016540|NCT02459275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20016541|NCT02459275|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20016542|NCT02459275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20016543|NCT02459275|Dopamine Agents|dopamine agents|mesh-ancestor
20016544|NCT02459275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20016545|NCT02459275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016546|NCT02459418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
20016547|NCT02459418|Hormones|hormones|mesh-ancestor
20016548|NCT02459418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20016549|NCT02459418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016550|NCT02459665|Metronidazole|metronidazole|mesh-list
20016551|NCT02459665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20016552|NCT02459665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20016553|NCT02459665|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20016554|NCT02459665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20016555|NCT02459899|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
20016556|NCT02459899|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20016557|NCT02459899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016558|NCT02459899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20016559|NCT02459899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016560|NCT02459964|Fentanyl|fentanyl|mesh-list
20016561|NCT02459964|Hydromorphone|hydromorphone|mesh-list
20016562|NCT02459964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20016563|NCT02459964|Narcotics|narcotics|mesh-ancestor
20016564|NCT02459964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20016565|NCT02459964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016566|NCT02459964|Analgesics|analgesics|mesh-ancestor
20016567|NCT02459964|Sensory System Agents|sensory system agents|mesh-ancestor
20016568|NCT02459964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016569|NCT02459964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20016570|NCT02459964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20016571|NCT02459964|Anesthetics, General|anesthetics, general|mesh-ancestor
20016572|NCT02459964|Anesthetics|anesthetics|mesh-ancestor
20016573|NCT02460380|Vitamin D|vitamin d|mesh-list
20016574|NCT02460380|Cholecalciferol|cholecalciferol|mesh-list
20016575|NCT02460380|Vitamins|vitamins|mesh-ancestor
20016576|NCT02460380|Micronutrients|micronutrients|mesh-ancestor
20016577|NCT02460380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016578|NCT02460380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20016579|NCT02460380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20016580|NCT02460978|Dapagliflozin|dapagliflozin|mesh-list
20016581|NCT02460978|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20016582|NCT02460978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016583|NCT02460978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20016584|NCT02460978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016585|NCT02460991|Sorafenib|sorafenib|mesh-list
20016586|NCT02460991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016587|NCT02460991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20016588|NCT02460991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016589|NCT02460991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016590|NCT02461134|Ponesimod|ponesimod|mesh-list
20016591|NCT02461134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
20016592|NCT02461134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016593|NCT02461134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20016594|NCT02461134|Immunologic Factors|immunologic factors|mesh-ancestor
20016595|NCT02461134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016596|NCT02461160|Midazolam|midazolam|mesh-list
20016597|NCT02461160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20016598|NCT02461160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20016599|NCT02461160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20016600|NCT02461160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016601|NCT02461160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20016602|NCT02461160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20016603|NCT02461160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20016604|NCT02461160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20016605|NCT02461160|Anesthetics, General|anesthetics, general|mesh-ancestor
20016606|NCT02461160|Anesthetics|anesthetics|mesh-ancestor
20016607|NCT02461160|GABA Modulators|gaba modulators|mesh-ancestor
20016608|NCT02461160|GABA Agents|gaba agents|mesh-ancestor
20016609|NCT02461160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20016610|NCT02461160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016611|NCT02461290|Rituximab|rituximab|mesh-list
20016612|NCT02461290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20016613|NCT02461290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016614|NCT02461290|Immunologic Factors|immunologic factors|mesh-ancestor
20016615|NCT02461290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016616|NCT02461290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20016617|NCT02461589|Liraglutide|liraglutide|mesh-list
20016618|NCT02461589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20016619|NCT02461589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016620|NCT02461589|Incretins|incretins|mesh-ancestor
20016621|NCT02461589|Hormones|hormones|mesh-ancestor
20016622|NCT02461589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20016623|NCT02461693|Caffeine|caffeine|mesh-list
20016624|NCT02461693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20016625|NCT02461693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016626|NCT02461693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20016627|NCT02461693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016628|NCT02461693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016629|NCT02461693|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20016630|NCT02461693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20016631|NCT02461693|Purinergic Agents|purinergic agents|mesh-ancestor
20016632|NCT02461693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20016633|NCT02461745|Ribavirin|ribavirin|mesh-list
20016634|NCT02461745|Ritonavir|ritonavir|mesh-list
20016635|NCT02461745|Antimetabolites|antimetabolites|mesh-ancestor
20016636|NCT02461745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016637|NCT02461745|Antiviral Agents|antiviral agents|mesh-ancestor
20016638|NCT02461745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20016639|NCT02461745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20016640|NCT02461745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20016641|NCT02461745|Protease Inhibitors|protease inhibitors|mesh-ancestor
20016642|NCT02461745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016643|NCT02461745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20016644|NCT02461745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20016645|NCT02461745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20016646|NCT02461745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20016647|NCT02461758|Vaccines|vaccines|mesh-list
20016648|NCT02461758|Immunologic Factors|immunologic factors|mesh-ancestor
20016649|NCT02461758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016650|NCT02462148|Dexamethasone|dexamethasone|mesh-list
20016651|NCT02462148|Dexamethasone acetate|dexamethasone acetate|mesh-list
20016652|NCT02462148|Epinephrine|epinephrine|mesh-list
20016653|NCT02462148|Bupivacaine|bupivacaine|mesh-list
20016654|NCT02462148|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20016655|NCT02462148|BB 1101|bb 1101|mesh-list
20016656|NCT02462148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20016657|NCT02462148|Antiemetics|antiemetics|mesh-ancestor
20016658|NCT02462148|Autonomic Agents|autonomic agents|mesh-ancestor
20016659|NCT02462148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016660|NCT02462148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016661|NCT02462148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20016662|NCT02462148|Glucocorticoids|glucocorticoids|mesh-ancestor
20016663|NCT02462148|Hormones|hormones|mesh-ancestor
20016664|NCT02462148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20016665|NCT02462148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20016666|NCT02462148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016667|NCT02462148|Protease Inhibitors|protease inhibitors|mesh-ancestor
20016668|NCT02462148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016669|NCT02462148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016670|NCT02462148|Anesthetics, Local|anesthetics, local|mesh-ancestor
20016671|NCT02462148|Anesthetics|anesthetics|mesh-ancestor
20016672|NCT02462148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20016673|NCT02462148|Sensory System Agents|sensory system agents|mesh-ancestor
20016674|NCT02462148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20016675|NCT02462148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20016676|NCT02462148|Adrenergic Agents|adrenergic agents|mesh-ancestor
20016677|NCT02462148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20016678|NCT02462148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20016679|NCT02462148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20016680|NCT02462148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20016681|NCT02462148|Respiratory System Agents|respiratory system agents|mesh-ancestor
20016682|NCT02462148|Mydriatics|mydriatics|mesh-ancestor
20016683|NCT02462148|Sympathomimetics|sympathomimetics|mesh-ancestor
20016684|NCT02462148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20016685|NCT02462382|Ropivacaine|ropivacaine|mesh-list
20016686|NCT02462382|Anesthetics, Local|anesthetics, local|mesh-ancestor
20016687|NCT02462382|Anesthetics|anesthetics|mesh-ancestor
20016688|NCT02462382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20016689|NCT02462382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016690|NCT02462382|Sensory System Agents|sensory system agents|mesh-ancestor
20016691|NCT02462382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016692|NCT02462473|Olanzapine|olanzapine|mesh-list
20016693|NCT02462473|Risperidone|risperidone|mesh-list
20016694|NCT02462473|Aripiprazole|aripiprazole|mesh-list
20016695|NCT02462473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
20016696|NCT02462473|Paliperidone Palmitate|paliperidone palmitate|mesh-list
20016697|NCT02462473|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20016698|NCT02462473|Serotonin Agents|serotonin agents|mesh-ancestor
20016699|NCT02462473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20016700|NCT02462473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016701|NCT02462473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016702|NCT02462473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20016703|NCT02462473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20016704|NCT02462473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20016705|NCT02462473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20016706|NCT02462473|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20016707|NCT02462473|Dopamine Agents|dopamine agents|mesh-ancestor
20016708|NCT02462473|Antiemetics|antiemetics|mesh-ancestor
20016709|NCT02462473|Autonomic Agents|autonomic agents|mesh-ancestor
20016710|NCT02462473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016711|NCT02462473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20016712|NCT02462473|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20016713|NCT02462473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20016714|NCT02462473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20016715|NCT02462473|Antidepressive Agents|antidepressive agents|mesh-ancestor
20016716|NCT02462473|Dopamine Agonists|dopamine agonists|mesh-ancestor
20016717|NCT02462473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20016718|NCT02462473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20016719|NCT02462473|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20016720|NCT02462473|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20016721|NCT02462486|Ranibizumab|ranibizumab|mesh-list
20016722|NCT02462486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20016723|NCT02462486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20016724|NCT02462486|Growth Substances|growth substances|mesh-ancestor
20016725|NCT02462486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016726|NCT02462486|Growth Inhibitors|growth inhibitors|mesh-ancestor
20016727|NCT02462486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016728|NCT02462720|Polidocanol|polidocanol|mesh-list
20016729|NCT02462720|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
20016730|NCT02462720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20016731|NCT02462928|Ranibizumab|ranibizumab|mesh-list
20016732|NCT02462928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20016733|NCT02462928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20016734|NCT02462928|Growth Substances|growth substances|mesh-ancestor
20016735|NCT02462928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016736|NCT02462928|Growth Inhibitors|growth inhibitors|mesh-ancestor
20016737|NCT02462928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016738|NCT02463097|Insulin|insulin|mesh-list
20016739|NCT02463097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20016740|NCT02463097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016741|NCT02463331|Chloroquine|chloroquine|mesh-list
20016742|NCT02463331|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
20016743|NCT02463331|Prednisone|prednisone|mesh-list
20016744|NCT02463331|Azathioprine|azathioprine|mesh-list
20016745|NCT02463331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20016746|NCT02463331|Glucocorticoids|glucocorticoids|mesh-ancestor
20016747|NCT02463331|Hormones|hormones|mesh-ancestor
20016748|NCT02463331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20016749|NCT02463331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016750|NCT02463331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20016751|NCT02463331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016752|NCT02463331|Amebicides|amebicides|mesh-ancestor
20016753|NCT02463331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20016754|NCT02463331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20016755|NCT02463331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20016756|NCT02463331|Antimalarials|antimalarials|mesh-ancestor
20016757|NCT02463331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20016758|NCT02463331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20016759|NCT02463331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20016760|NCT02463331|Analgesics|analgesics|mesh-ancestor
20016761|NCT02463331|Sensory System Agents|sensory system agents|mesh-ancestor
20016762|NCT02463331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016763|NCT02463331|Filaricides|filaricides|mesh-ancestor
20016764|NCT02463331|Antinematodal Agents|antinematodal agents|mesh-ancestor
20016765|NCT02463331|Anthelmintics|anthelmintics|mesh-ancestor
20016766|NCT02463331|Antimetabolites|antimetabolites|mesh-ancestor
20016767|NCT02463331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016768|NCT02463331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20016769|NCT02463331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20016770|NCT02463331|Immunologic Factors|immunologic factors|mesh-ancestor
20016771|NCT02463357|Metformin|metformin|mesh-list
20016772|NCT02463357|Nifedipine|nifedipine|mesh-list
20016773|NCT02463357|Methazolamide|methazolamide|mesh-list
20016774|NCT02463357|Quercetin|quercetin|mesh-list
20016775|NCT02463357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20016776|NCT02463357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016777|NCT02463357|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20016778|NCT02463357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20016779|NCT02463357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016780|NCT02463357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20016781|NCT02463357|Vasodilator Agents|vasodilator agents|mesh-ancestor
20016782|NCT02463357|Tocolytic Agents|tocolytic agents|mesh-ancestor
20016783|NCT02463357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20016784|NCT02463357|Antioxidants|antioxidants|mesh-ancestor
20016785|NCT02463357|Protective Agents|protective agents|mesh-ancestor
20016786|NCT02463357|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
20016787|NCT02463357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016788|NCT02463357|Diuretics|diuretics|mesh-ancestor
20016789|NCT02463357|Natriuretic Agents|natriuretic agents|mesh-ancestor
20016790|NCT02463409|Theophylline|theophylline|mesh-list
20016791|NCT02463409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20016792|NCT02463409|Autonomic Agents|autonomic agents|mesh-ancestor
20016793|NCT02463409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016794|NCT02463409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016795|NCT02463409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20016796|NCT02463409|Respiratory System Agents|respiratory system agents|mesh-ancestor
20016797|NCT02463409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20016798|NCT02463409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016799|NCT02463409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016800|NCT02463409|Vasodilator Agents|vasodilator agents|mesh-ancestor
20016801|NCT02463409|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
20016802|NCT02463409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20016803|NCT02463409|Purinergic Agents|purinergic agents|mesh-ancestor
20016804|NCT02463409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20016805|NCT02464033|Vitamin D|vitamin d|mesh-list
20016806|NCT02464033|Cholecalciferol|cholecalciferol|mesh-list
20016807|NCT02464033|Etanercept|etanercept|mesh-list
20016808|NCT02464033|Vitamins|vitamins|mesh-ancestor
20016809|NCT02464033|Micronutrients|micronutrients|mesh-ancestor
20016810|NCT02464033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016811|NCT02464033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20016812|NCT02464033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20016813|NCT02464033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20016814|NCT02464033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20016815|NCT02464033|Analgesics|analgesics|mesh-ancestor
20016816|NCT02464033|Sensory System Agents|sensory system agents|mesh-ancestor
20016817|NCT02464033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016818|NCT02464033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20016819|NCT02464033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20016820|NCT02464033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20016821|NCT02464033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20016822|NCT02464033|Immunologic Factors|immunologic factors|mesh-ancestor
20016823|NCT02464059|Vitamin D|vitamin d|mesh-list
20016824|NCT02464059|Cholecalciferol|cholecalciferol|mesh-list
20016825|NCT02464059|Vitamins|vitamins|mesh-ancestor
20016826|NCT02464059|Micronutrients|micronutrients|mesh-ancestor
20016827|NCT02464059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016828|NCT02464059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20016829|NCT02464059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20016830|NCT02464163|Hemagglutinins|hemagglutinins|mesh-list
20016831|NCT02464163|Agglutinins|agglutinins|mesh-ancestor
20016832|NCT02464163|Immunologic Factors|immunologic factors|mesh-ancestor
20016833|NCT02464163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016834|NCT02464176|Dexamethasone|dexamethasone|mesh-list
20016835|NCT02464176|Dexamethasone acetate|dexamethasone acetate|mesh-list
20016836|NCT02464176|Epinephrine|epinephrine|mesh-list
20016837|NCT02464176|Bupivacaine|bupivacaine|mesh-list
20016838|NCT02464176|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
20016839|NCT02464176|BB 1101|bb 1101|mesh-list
20016840|NCT02464176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20016841|NCT02464176|Antiemetics|antiemetics|mesh-ancestor
20016842|NCT02464176|Autonomic Agents|autonomic agents|mesh-ancestor
20016843|NCT02464176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016844|NCT02464176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016845|NCT02464176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20016846|NCT02464176|Glucocorticoids|glucocorticoids|mesh-ancestor
20016847|NCT02464176|Hormones|hormones|mesh-ancestor
20016848|NCT02464176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20016849|NCT02464176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20016850|NCT02464176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016851|NCT02464176|Protease Inhibitors|protease inhibitors|mesh-ancestor
20016852|NCT02464176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016853|NCT02464176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016854|NCT02464176|Anesthetics, Local|anesthetics, local|mesh-ancestor
20016855|NCT02464176|Anesthetics|anesthetics|mesh-ancestor
20016856|NCT02464176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20016857|NCT02464176|Sensory System Agents|sensory system agents|mesh-ancestor
20016858|NCT02464176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20016859|NCT02464176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20016860|NCT02464176|Adrenergic Agents|adrenergic agents|mesh-ancestor
20016861|NCT02464176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20016862|NCT02464176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20016863|NCT02464176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20016864|NCT02464176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20016865|NCT02464176|Respiratory System Agents|respiratory system agents|mesh-ancestor
20016866|NCT02464176|Mydriatics|mydriatics|mesh-ancestor
20016867|NCT02464176|Sympathomimetics|sympathomimetics|mesh-ancestor
20016868|NCT02464176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20016869|NCT02464657|Cytarabine|cytarabine|mesh-list
20016870|NCT02464657|Dexamethasone|dexamethasone|mesh-list
20016871|NCT02464657|Methylprednisolone|methylprednisolone|mesh-list
20016872|NCT02464657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
20016873|NCT02464657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
20016874|NCT02464657|Prednisolone|prednisolone|mesh-list
20016875|NCT02464657|Prednisolone acetate|prednisolone acetate|mesh-list
20016876|NCT02464657|Nivolumab|nivolumab|mesh-list
20016877|NCT02464657|Idarubicin|idarubicin|mesh-list
20016878|NCT02464657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
20016879|NCT02464657|Prednisolone phosphate|prednisolone phosphate|mesh-list
20016880|NCT02464657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20016881|NCT02464657|Antiemetics|antiemetics|mesh-ancestor
20016882|NCT02464657|Autonomic Agents|autonomic agents|mesh-ancestor
20016883|NCT02464657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016884|NCT02464657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016885|NCT02464657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20016886|NCT02464657|Glucocorticoids|glucocorticoids|mesh-ancestor
20016887|NCT02464657|Hormones|hormones|mesh-ancestor
20016888|NCT02464657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20016889|NCT02464657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20016890|NCT02464657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016891|NCT02464657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20016892|NCT02464657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20016893|NCT02464657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016894|NCT02464657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20016895|NCT02464657|Antimetabolites|antimetabolites|mesh-ancestor
20016896|NCT02464657|Antiviral Agents|antiviral agents|mesh-ancestor
20016897|NCT02464657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20016898|NCT02464657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20016899|NCT02464657|Immunologic Factors|immunologic factors|mesh-ancestor
20016900|NCT02464657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
20016901|NCT02464657|Protective Agents|protective agents|mesh-ancestor
20016902|NCT02464657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20016903|NCT02464657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20016904|NCT02464657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20016905|NCT02464657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016906|NCT02465489|Deferiprone|deferiprone|mesh-list
20016907|NCT02465489|Iron Chelating Agents|iron chelating agents|mesh-ancestor
20016908|NCT02465489|Chelating Agents|chelating agents|mesh-ancestor
20016909|NCT02465489|Sequestering Agents|sequestering agents|mesh-ancestor
20016910|NCT02465489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016911|NCT02465515|rGLP-1 protein|rglp-1 protein|mesh-list
20016912|NCT02465515|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
20016913|NCT02465515|Incretins|incretins|mesh-ancestor
20016914|NCT02465515|Hormones|hormones|mesh-ancestor
20016915|NCT02465515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20016916|NCT02465515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016917|NCT02465528|Ceritinib|ceritinib|mesh-list
20016918|NCT02465528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016919|NCT02465528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20016920|NCT02465528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016921|NCT02465528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016922|NCT02465632|Clindamycin|clindamycin|mesh-list
20016923|NCT02465632|Clindamycin palmitate|clindamycin palmitate|mesh-list
20016924|NCT02465632|Clindamycin phosphate|clindamycin phosphate|mesh-list
20016925|NCT02465632|Benzoyl Peroxide|benzoyl peroxide|mesh-list
20016926|NCT02465632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20016927|NCT02465632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20016928|NCT02465632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20016929|NCT02465632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016930|NCT02465632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016931|NCT02465632|Dermatologic Agents|dermatologic agents|mesh-ancestor
20016932|NCT02465866|Promethazine|promethazine|mesh-list
20016933|NCT02465866|Antipruritics|antipruritics|mesh-ancestor
20016934|NCT02465866|Dermatologic Agents|dermatologic agents|mesh-ancestor
20016935|NCT02465866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20016936|NCT02465866|Histamine Antagonists|histamine antagonists|mesh-ancestor
20016937|NCT02465866|Histamine Agents|histamine agents|mesh-ancestor
20016938|NCT02465866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20016939|NCT02465866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016940|NCT02465866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016941|NCT02465866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20016942|NCT02466386|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
20016943|NCT02466386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20016944|NCT02466386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016945|NCT02466386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20016946|NCT02466386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20016947|NCT02466386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20016948|NCT02466386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016949|NCT02466386|Dopamine Agents|dopamine agents|mesh-ancestor
20016950|NCT02466386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20016951|NCT02466399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20016952|NCT02466399|Latanoprost|latanoprost|mesh-list
20016953|NCT02466399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20016954|NCT02466958|Milnacipran|milnacipran|mesh-list
20016955|NCT02466958|Levomilnacipran|levomilnacipran|mesh-list
20016956|NCT02466958|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20016957|NCT02466958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20016958|NCT02466958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20016959|NCT02466958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016960|NCT02466958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20016961|NCT02466958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016962|NCT02466958|Antidepressive Agents|antidepressive agents|mesh-ancestor
20016963|NCT02466958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20016964|NCT02466958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20016965|NCT02466958|Analgesics|analgesics|mesh-ancestor
20016966|NCT02466958|Sensory System Agents|sensory system agents|mesh-ancestor
20016967|NCT02466958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016968|NCT02467504|Folic Acid|folic acid|mesh-list
20016969|NCT02467504|Loxoprofen|loxoprofen|mesh-list
20016970|NCT02467504|Hematinics|hematinics|mesh-ancestor
20016971|NCT02467504|Vitamin B Complex|vitamin b complex|mesh-ancestor
20016972|NCT02467504|Vitamins|vitamins|mesh-ancestor
20016973|NCT02467504|Micronutrients|micronutrients|mesh-ancestor
20016974|NCT02467504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20016975|NCT02467504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20016976|NCT02467504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20016977|NCT02467504|Analgesics|analgesics|mesh-ancestor
20016978|NCT02467504|Sensory System Agents|sensory system agents|mesh-ancestor
20016979|NCT02467504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20016980|NCT02467504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20016981|NCT02467504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20016982|NCT02467621|Pantoprazole|pantoprazole|mesh-list
20016983|NCT02467621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20016984|NCT02467621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20016985|NCT02467621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20016986|NCT02467621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016987|NCT02467621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016988|NCT02468557|Paclitaxel|paclitaxel|mesh-list
20016989|NCT02468557|Idelalisib|idelalisib|mesh-list
20016990|NCT02468557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20016991|NCT02468557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20016992|NCT02468557|Tubulin Modulators|tubulin modulators|mesh-ancestor
20016993|NCT02468557|Antimitotic Agents|antimitotic agents|mesh-ancestor
20016994|NCT02468557|Mitosis Modulators|mitosis modulators|mesh-ancestor
20016995|NCT02468557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20016996|NCT02468557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20016997|NCT02468648|Sofosbuvir|sofosbuvir|mesh-list
20016998|NCT02468648|Velpatasvir|velpatasvir|mesh-list
20016999|NCT02468648|Antiviral Agents|antiviral agents|mesh-ancestor
20017000|NCT02468648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20017001|NCT02468700|Dexamethasone|dexamethasone|mesh-list
20017002|NCT02468700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20017003|NCT02468700|Antiemetics|antiemetics|mesh-ancestor
20017004|NCT02468700|Autonomic Agents|autonomic agents|mesh-ancestor
20017005|NCT02468700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017006|NCT02468700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017007|NCT02468700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20017008|NCT02468700|Glucocorticoids|glucocorticoids|mesh-ancestor
20017009|NCT02468700|Hormones|hormones|mesh-ancestor
20017010|NCT02468700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20017011|NCT02468700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20017012|NCT02468700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20017013|NCT02468830|Mirabegron|mirabegron|mesh-list
20017014|NCT02468830|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20017015|NCT02468830|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20017016|NCT02468830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20017017|NCT02468830|Adrenergic Agents|adrenergic agents|mesh-ancestor
20017018|NCT02468830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20017019|NCT02468830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017020|NCT02468830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017021|NCT02468830|Urological Agents|urological agents|mesh-ancestor
20017022|NCT02469077|Morphine|morphine|mesh-list
20017023|NCT02469077|Naloxone|naloxone|mesh-list
20017024|NCT02469077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20017025|NCT02469077|Narcotics|narcotics|mesh-ancestor
20017026|NCT02469077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20017027|NCT02469077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017028|NCT02469077|Analgesics|analgesics|mesh-ancestor
20017029|NCT02469077|Sensory System Agents|sensory system agents|mesh-ancestor
20017030|NCT02469077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017031|NCT02469077|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20017032|NCT02469090|Apomorphine|apomorphine|mesh-list
20017033|NCT02469090|Emetics|emetics|mesh-ancestor
20017034|NCT02469090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017035|NCT02469090|Autonomic Agents|autonomic agents|mesh-ancestor
20017036|NCT02469090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017037|NCT02469090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20017038|NCT02469090|Dopamine Agonists|dopamine agonists|mesh-ancestor
20017039|NCT02469090|Dopamine Agents|dopamine agents|mesh-ancestor
20017040|NCT02469090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20017041|NCT02469090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017042|NCT02469116|Carboplatin|carboplatin|mesh-list
20017043|NCT02469116|Docetaxel|docetaxel|mesh-list
20017044|NCT02469116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20017045|NCT02469116|Tubulin Modulators|tubulin modulators|mesh-ancestor
20017046|NCT02469116|Antimitotic Agents|antimitotic agents|mesh-ancestor
20017047|NCT02469116|Mitosis Modulators|mitosis modulators|mesh-ancestor
20017048|NCT02469116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017049|NCT02469246|Lamivudine|lamivudine|mesh-list
20017050|NCT02469246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20017051|NCT02469246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20017052|NCT02469246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017053|NCT02469246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017054|NCT02469246|Antiviral Agents|antiviral agents|mesh-ancestor
20017055|NCT02469246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20017056|NCT02469246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20017057|NCT02469246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20017058|NCT02469298|Oseltamivir|oseltamivir|mesh-list
20017059|NCT02469298|Antiviral Agents|antiviral agents|mesh-ancestor
20017060|NCT02469298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20017061|NCT02469298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017062|NCT02469298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017063|NCT02469597|Furosemide|furosemide|mesh-list
20017064|NCT02469597|Diuretics|diuretics|mesh-ancestor
20017065|NCT02469597|Natriuretic Agents|natriuretic agents|mesh-ancestor
20017066|NCT02469597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017067|NCT02469597|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
20017068|NCT02469597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20017069|NCT02469597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017070|NCT02469610|Bupivacaine|bupivacaine|mesh-list
20017071|NCT02469610|Anesthetics, Local|anesthetics, local|mesh-ancestor
20017072|NCT02469610|Anesthetics|anesthetics|mesh-ancestor
20017073|NCT02469610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20017074|NCT02469610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017075|NCT02469610|Sensory System Agents|sensory system agents|mesh-ancestor
20017076|NCT02469610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017077|NCT02469701|Nivolumab|nivolumab|mesh-list
20017078|NCT02469701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20017079|NCT02469701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20017080|NCT02469701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20017081|NCT02469701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017082|NCT02469961|Dexmedetomidine|dexmedetomidine|mesh-list
20017083|NCT02469961|Propofol|propofol|mesh-list
20017084|NCT02469961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20017085|NCT02469961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20017086|NCT02469961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017087|NCT02469961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20017088|NCT02469961|Anesthetics, General|anesthetics, general|mesh-ancestor
20017089|NCT02469961|Anesthetics|anesthetics|mesh-ancestor
20017090|NCT02469961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20017091|NCT02469961|Analgesics|analgesics|mesh-ancestor
20017092|NCT02469961|Sensory System Agents|sensory system agents|mesh-ancestor
20017093|NCT02469961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017094|NCT02469961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20017095|NCT02469961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20017096|NCT02469961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20017097|NCT02469961|Adrenergic Agents|adrenergic agents|mesh-ancestor
20017098|NCT02469961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20017099|NCT02469961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017100|NCT02470234|Methylphenidate|methylphenidate|mesh-list
20017101|NCT02470234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20017102|NCT02470234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017103|NCT02470234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20017104|NCT02470234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20017105|NCT02470234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20017106|NCT02470234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017107|NCT02470234|Dopamine Agents|dopamine agents|mesh-ancestor
20017108|NCT02470234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20017109|NCT02470390|Fentanyl|fentanyl|mesh-list
20017110|NCT02470390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20017111|NCT02470390|Narcotics|narcotics|mesh-ancestor
20017112|NCT02470390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20017113|NCT02470390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017114|NCT02470390|Analgesics|analgesics|mesh-ancestor
20017115|NCT02470390|Sensory System Agents|sensory system agents|mesh-ancestor
20017116|NCT02470390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017117|NCT02470390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20017118|NCT02470390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20017119|NCT02470390|Anesthetics, General|anesthetics, general|mesh-ancestor
20017120|NCT02470390|Anesthetics|anesthetics|mesh-ancestor
20017121|NCT02470403|Licogliflozin|licogliflozin|mesh-list
20017122|NCT02470403|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20017123|NCT02470403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017124|NCT02470403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20017125|NCT02470403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017126|NCT02470429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20017127|NCT02470429|Lubricant Eye Drops|lubricant eye drops|mesh-list
20017128|NCT02470429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20017129|NCT02470585|Paclitaxel|paclitaxel|mesh-list
20017130|NCT02470585|Carboplatin|carboplatin|mesh-list
20017131|NCT02470585|Veliparib|veliparib|mesh-list
20017132|NCT02470585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20017133|NCT02470585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20017134|NCT02470585|Tubulin Modulators|tubulin modulators|mesh-ancestor
20017135|NCT02470585|Antimitotic Agents|antimitotic agents|mesh-ancestor
20017136|NCT02470585|Mitosis Modulators|mitosis modulators|mesh-ancestor
20017137|NCT02470585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017138|NCT02470585|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
20017139|NCT02470585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017140|NCT02470741|Letrozole|letrozole|mesh-list
20017141|NCT02470741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20017142|NCT02470741|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
20017143|NCT02470741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20017144|NCT02470741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017145|NCT02470741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017146|NCT02470741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
20017147|NCT02470741|Hormone Antagonists|hormone antagonists|mesh-ancestor
20017148|NCT02470741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20017149|NCT02470741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017150|NCT02471014|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
20017151|NCT02471014|Immunologic Factors|immunologic factors|mesh-ancestor
20017152|NCT02471014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017153|NCT02471183|Selexipag|selexipag|mesh-list
20017154|NCT02471183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20017155|NCT02471404|Dapagliflozin|dapagliflozin|mesh-list
20017156|NCT02471404|Glimepiride|glimepiride|mesh-list
20017157|NCT02471404|Saxagliptin|saxagliptin|mesh-list
20017158|NCT02471404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20017159|NCT02471404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017160|NCT02471404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20017161|NCT02471404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017162|NCT02471404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20017163|NCT02471404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20017164|NCT02471404|Immunologic Factors|immunologic factors|mesh-ancestor
20017165|NCT02471404|Incretins|incretins|mesh-ancestor
20017166|NCT02471404|Hormones|hormones|mesh-ancestor
20017167|NCT02471404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20017168|NCT02471404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20017169|NCT02471404|Protease Inhibitors|protease inhibitors|mesh-ancestor
20017170|NCT02471404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017171|NCT02471521|Rocuronium|rocuronium|mesh-list
20017172|NCT02471521|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20017173|NCT02471521|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20017174|NCT02471521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20017175|NCT02471521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017176|NCT02471521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017177|NCT02471651|Dexamethasone|dexamethasone|mesh-list
20017178|NCT02471651|Ranibizumab|ranibizumab|mesh-list
20017179|NCT02471651|Aflibercept|aflibercept|mesh-list
20017180|NCT02471651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20017181|NCT02471651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20017182|NCT02471651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20017183|NCT02471651|Growth Substances|growth substances|mesh-ancestor
20017184|NCT02471651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017185|NCT02471651|Growth Inhibitors|growth inhibitors|mesh-ancestor
20017186|NCT02471651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20017187|NCT02471651|Antiemetics|antiemetics|mesh-ancestor
20017188|NCT02471651|Autonomic Agents|autonomic agents|mesh-ancestor
20017189|NCT02471651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017190|NCT02471651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20017191|NCT02471651|Glucocorticoids|glucocorticoids|mesh-ancestor
20017192|NCT02471651|Hormones|hormones|mesh-ancestor
20017193|NCT02471651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20017194|NCT02471651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20017195|NCT02472145|Decitabine|decitabine|mesh-list
20017196|NCT02472145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20017197|NCT02472145|Antimetabolites|antimetabolites|mesh-ancestor
20017198|NCT02472145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017199|NCT02472145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20017200|NCT02472145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017201|NCT02472223|Povidone-Iodine|povidone-iodine|mesh-list
20017202|NCT02472223|Povidone|povidone|mesh-list
20017203|NCT02472223|Lubricant Eye Drops|lubricant eye drops|mesh-list
20017204|NCT02472223|Plasma Substitutes|plasma substitutes|mesh-ancestor
20017205|NCT02472223|Blood Substitutes|blood substitutes|mesh-ancestor
20017206|NCT02472223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20017207|NCT02472223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20017208|NCT02472223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
20017209|NCT02472223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
20017210|NCT02472314|Bupivacaine|bupivacaine|mesh-list
20017211|NCT02472314|Anesthetics, Local|anesthetics, local|mesh-ancestor
20017212|NCT02472314|Anesthetics|anesthetics|mesh-ancestor
20017213|NCT02472314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20017214|NCT02472314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017215|NCT02472314|Sensory System Agents|sensory system agents|mesh-ancestor
20017216|NCT02472314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017217|NCT02472353|Metformin|metformin|mesh-list
20017218|NCT02472353|Doxorubicin|doxorubicin|mesh-list
20017219|NCT02472353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20017220|NCT02472353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017221|NCT02472353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20017222|NCT02472353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20017223|NCT02472353|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20017224|NCT02472353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20017225|NCT02472353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017226|NCT02472353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017227|NCT02472366|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
20017228|NCT02472366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20017229|NCT02472366|Glucocorticoids|glucocorticoids|mesh-ancestor
20017230|NCT02472366|Hormones|hormones|mesh-ancestor
20017231|NCT02472366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20017232|NCT02472366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017233|NCT02472522|Dexmedetomidine|dexmedetomidine|mesh-list
20017234|NCT02472522|Ropivacaine|ropivacaine|mesh-list
20017235|NCT02472522|Adrenergic Agonists|adrenergic agonists|mesh-list
20017236|NCT02472522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20017237|NCT02472522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20017238|NCT02472522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017239|NCT02472522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20017240|NCT02472522|Analgesics|analgesics|mesh-ancestor
20017241|NCT02472522|Sensory System Agents|sensory system agents|mesh-ancestor
20017242|NCT02472522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017243|NCT02472522|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
20017244|NCT02472522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20017245|NCT02472522|Adrenergic Agents|adrenergic agents|mesh-ancestor
20017246|NCT02472522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20017247|NCT02472522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017248|NCT02472522|Anesthetics, Local|anesthetics, local|mesh-ancestor
20017249|NCT02472522|Anesthetics|anesthetics|mesh-ancestor
20017250|NCT02472652|Aripiprazole|aripiprazole|mesh-list
20017251|NCT02472652|Antidepressive Agents|antidepressive agents|mesh-ancestor
20017252|NCT02472652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20017253|NCT02472652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20017254|NCT02472652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20017255|NCT02472652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20017256|NCT02472652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017257|NCT02472652|Dopamine Agonists|dopamine agonists|mesh-ancestor
20017258|NCT02472652|Dopamine Agents|dopamine agents|mesh-ancestor
20017259|NCT02472652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20017260|NCT02472652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017261|NCT02472652|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
20017262|NCT02472652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
20017263|NCT02472652|Serotonin Agents|serotonin agents|mesh-ancestor
20017264|NCT02472652|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
20017265|NCT02472652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20017266|NCT02472652|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20017267|NCT02472652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20017268|NCT02472756|Rituximab|rituximab|mesh-list
20017269|NCT02472756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20017270|NCT02472756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20017271|NCT02472756|Immunologic Factors|immunologic factors|mesh-ancestor
20017272|NCT02472756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017273|NCT02472756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20017274|NCT02472847|Dronabinol|dronabinol|mesh-list
20017275|NCT02472847|Hallucinogens|hallucinogens|mesh-ancestor
20017276|NCT02472847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017277|NCT02472847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20017278|NCT02472847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20017279|NCT02472847|Analgesics|analgesics|mesh-ancestor
20017280|NCT02472847|Sensory System Agents|sensory system agents|mesh-ancestor
20017281|NCT02472847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017282|NCT02472847|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20017283|NCT02472847|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20017284|NCT02472847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20017285|NCT02472847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017286|NCT02472847|Hormones|hormones|mesh-ancestor
20017287|NCT02472847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20017288|NCT02472886|Sofosbuvir|sofosbuvir|mesh-list
20017289|NCT02472886|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
20017290|NCT02472886|Ledipasvir|ledipasvir|mesh-list
20017291|NCT02472886|Antiviral Agents|antiviral agents|mesh-ancestor
20017292|NCT02472886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20017293|NCT02472977|Nivolumab|nivolumab|mesh-list
20017294|NCT02472977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20017295|NCT02472977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20017296|NCT02472977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
20017297|NCT02472977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017298|NCT02473250|Fluoxetine|fluoxetine|mesh-list
20017299|NCT02473250|Citalopram|citalopram|mesh-list
20017300|NCT02473250|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20017301|NCT02473250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20017302|NCT02473250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20017303|NCT02473250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017304|NCT02473250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20017305|NCT02473250|Serotonin Agents|serotonin agents|mesh-ancestor
20017306|NCT02473250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017307|NCT02473250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20017308|NCT02473250|Antidepressive Agents|antidepressive agents|mesh-ancestor
20017309|NCT02473250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20017310|NCT02473250|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
20017311|NCT02473250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20017312|NCT02473250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017313|NCT02473367|Raltegravir Potassium|raltegravir potassium|mesh-list
20017314|NCT02473367|Antacids|antacids|mesh-list
20017315|NCT02473367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20017316|NCT02473367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20017317|NCT02473367|Antiviral Agents|antiviral agents|mesh-ancestor
20017318|NCT02473367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20017319|NCT02473367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20017320|NCT02473367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20017321|NCT02473367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017322|NCT02473367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017323|NCT02473367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20017324|NCT02473640|Ceftriaxone|ceftriaxone|mesh-list
20017325|NCT02473640|Esomeprazole|esomeprazole|mesh-list
20017326|NCT02473640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
20017327|NCT02473640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20017328|NCT02473640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
20017329|NCT02473640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017330|NCT02473640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017331|NCT02473640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20017332|NCT02473640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20017333|NCT02473783|Sertraline|sertraline|mesh-list
20017334|NCT02473783|Antidepressive Agents|antidepressive agents|mesh-ancestor
20017335|NCT02473783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20017336|NCT02473783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20017337|NCT02473783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20017338|NCT02473783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20017339|NCT02473783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017340|NCT02473783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20017341|NCT02473783|Serotonin Agents|serotonin agents|mesh-ancestor
20017342|NCT02473783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017343|NCT02473913|Silymarin|silymarin|mesh-list
20017344|NCT02473913|Antioxidants|antioxidants|mesh-ancestor
20017345|NCT02473913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017346|NCT02473913|Protective Agents|protective agents|mesh-ancestor
20017347|NCT02473913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017348|NCT02474199|Acetaminophen|acetaminophen|mesh-list
20017349|NCT02474199|Diphenhydramine|diphenhydramine|mesh-list
20017350|NCT02474199|Promethazine|promethazine|mesh-list
20017351|NCT02474199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20017352|NCT02474199|Analgesics|analgesics|mesh-ancestor
20017353|NCT02474199|Sensory System Agents|sensory system agents|mesh-ancestor
20017354|NCT02474199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017355|NCT02474199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017356|NCT02474199|Antipyretics|antipyretics|mesh-ancestor
20017357|NCT02474199|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20017358|NCT02474199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20017359|NCT02474199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20017360|NCT02474199|Anesthetics, Local|anesthetics, local|mesh-ancestor
20017361|NCT02474199|Anesthetics|anesthetics|mesh-ancestor
20017362|NCT02474199|Antiemetics|antiemetics|mesh-ancestor
20017363|NCT02474199|Autonomic Agents|autonomic agents|mesh-ancestor
20017364|NCT02474199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20017365|NCT02474199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20017366|NCT02474199|Histamine Antagonists|histamine antagonists|mesh-ancestor
20017367|NCT02474199|Histamine Agents|histamine agents|mesh-ancestor
20017368|NCT02474199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20017369|NCT02474199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017370|NCT02474199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20017371|NCT02474199|Antipruritics|antipruritics|mesh-ancestor
20017372|NCT02474199|Dermatologic Agents|dermatologic agents|mesh-ancestor
20017373|NCT02474355|Osimertinib|osimertinib|mesh-list
20017374|NCT02474355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20017375|NCT02474355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20017376|NCT02474355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017377|NCT02474355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017378|NCT02474407|Diazepam|diazepam|mesh-list
20017379|NCT02474407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20017380|NCT02474407|Anticonvulsants|anticonvulsants|mesh-ancestor
20017381|NCT02474407|Antiemetics|antiemetics|mesh-ancestor
20017382|NCT02474407|Autonomic Agents|autonomic agents|mesh-ancestor
20017383|NCT02474407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017384|NCT02474407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017385|NCT02474407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20017386|NCT02474407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20017387|NCT02474407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20017388|NCT02474407|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20017389|NCT02474407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20017390|NCT02474407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20017391|NCT02474407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20017392|NCT02474407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20017393|NCT02474407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20017394|NCT02474407|Anesthetics, General|anesthetics, general|mesh-ancestor
20017395|NCT02474407|Anesthetics|anesthetics|mesh-ancestor
20017396|NCT02474407|GABA Modulators|gaba modulators|mesh-ancestor
20017397|NCT02474407|GABA Agents|gaba agents|mesh-ancestor
20017398|NCT02474407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20017399|NCT02474407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017400|NCT02475070|Dapagliflozin|dapagliflozin|mesh-list
20017401|NCT02475070|Vildagliptin|vildagliptin|mesh-list
20017402|NCT02475070|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20017403|NCT02475070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017404|NCT02475070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20017405|NCT02475070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017406|NCT02475070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20017407|NCT02475070|Protease Inhibitors|protease inhibitors|mesh-ancestor
20017408|NCT02475070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017409|NCT02475265|Levonorgestrel|levonorgestrel|mesh-list
20017410|NCT02475265|Estradiol|estradiol|mesh-list
20017411|NCT02475265|Estrogens|estrogens|mesh-ancestor
20017412|NCT02475265|Hormones|hormones|mesh-ancestor
20017413|NCT02475265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20017414|NCT02475265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017415|NCT02475265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
20017416|NCT02475265|Contraceptive Agents|contraceptive agents|mesh-ancestor
20017417|NCT02475265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20017418|NCT02475265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
20017419|NCT02475265|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
20017420|NCT02475265|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
20017421|NCT02475369|Pancrelipase|pancrelipase|mesh-list
20017422|NCT02475369|Pancreatin|pancreatin|mesh-list
20017423|NCT02475369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20017424|NCT02475564|Resveratrol|resveratrol|mesh-list
20017425|NCT02475564|Antioxidants|antioxidants|mesh-ancestor
20017426|NCT02475564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017427|NCT02475564|Protective Agents|protective agents|mesh-ancestor
20017428|NCT02475564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017429|NCT02475564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017430|NCT02475564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20017431|NCT02475629|Ibalizumab|ibalizumab|mesh-list
20017432|NCT02475629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20017433|NCT02475629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20017434|NCT02475629|Antiviral Agents|antiviral agents|mesh-ancestor
20017435|NCT02475629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20017436|NCT02475733|Metronidazole|metronidazole|mesh-list
20017437|NCT02475733|Meropenem|meropenem|mesh-list
20017438|NCT02475733|Ceftazidime|ceftazidime|mesh-list
20017439|NCT02475733|Avibactam|avibactam|mesh-list
20017440|NCT02475733|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
20017441|NCT02475733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20017442|NCT02475733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20017443|NCT02475733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20017444|NCT02475733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20017445|NCT02475733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20017446|NCT02475733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017447|NCT02475733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017448|NCT02475837|Vorapaxar|vorapaxar|mesh-list
20017449|NCT02475837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20017450|NCT02476175|Mirabegron|mirabegron|mesh-list
20017451|NCT02476175|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20017452|NCT02476175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20017453|NCT02476175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20017454|NCT02476175|Adrenergic Agents|adrenergic agents|mesh-ancestor
20017455|NCT02476175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20017456|NCT02476175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017457|NCT02476175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017458|NCT02476175|Urological Agents|urological agents|mesh-ancestor
20017459|NCT02476422|Ibuprofen|ibuprofen|mesh-list
20017460|NCT02476422|Diclofenac|diclofenac|mesh-list
20017461|NCT02476422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20017462|NCT02476422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20017463|NCT02476422|Analgesics|analgesics|mesh-ancestor
20017464|NCT02476422|Sensory System Agents|sensory system agents|mesh-ancestor
20017465|NCT02476422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017466|NCT02476422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017467|NCT02476422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20017468|NCT02476422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20017469|NCT02476422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20017470|NCT02476422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017471|NCT02476422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017472|NCT02476617|Ritonavir|ritonavir|mesh-list
20017473|NCT02476617|Ribavirin|ribavirin|mesh-list
20017474|NCT02476617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20017475|NCT02476617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20017476|NCT02476617|Protease Inhibitors|protease inhibitors|mesh-ancestor
20017477|NCT02476617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017478|NCT02476617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017479|NCT02476617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20017480|NCT02476617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20017481|NCT02476617|Antiviral Agents|antiviral agents|mesh-ancestor
20017482|NCT02476617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20017483|NCT02476617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20017484|NCT02476617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20017485|NCT02476617|Antimetabolites|antimetabolites|mesh-ancestor
20017486|NCT02477215|Dexamethasone|dexamethasone|mesh-list
20017487|NCT02477215|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
20017488|NCT02477215|Ixazomib|ixazomib|mesh-list
20017489|NCT02477215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20017490|NCT02477215|Antiemetics|antiemetics|mesh-ancestor
20017491|NCT02477215|Autonomic Agents|autonomic agents|mesh-ancestor
20017492|NCT02477215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017493|NCT02477215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017494|NCT02477215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20017495|NCT02477215|Glucocorticoids|glucocorticoids|mesh-ancestor
20017496|NCT02477215|Hormones|hormones|mesh-ancestor
20017497|NCT02477215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20017498|NCT02477215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20017499|NCT02477215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20017500|NCT02477215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20017501|NCT02477215|Alkylating Agents|alkylating agents|mesh-ancestor
20017502|NCT02477215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017503|NCT02477215|Protease Inhibitors|protease inhibitors|mesh-ancestor
20017504|NCT02477215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017505|NCT02477332|Omalizumab|omalizumab|mesh-list
20017506|NCT02477332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20017507|NCT02477332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20017508|NCT02477332|Respiratory System Agents|respiratory system agents|mesh-ancestor
20017509|NCT02477423|Gentamicins|gentamicins|mesh-list
20017510|NCT02477423|Ampicillin|ampicillin|mesh-list
20017511|NCT02477423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20017512|NCT02477423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20017513|NCT02477423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20017514|NCT02477423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017515|NCT02477423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017516|NCT02477527|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
20017517|NCT02477527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20017518|NCT02477527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20017519|NCT02477527|Antiviral Agents|antiviral agents|mesh-ancestor
20017520|NCT02477527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20017521|NCT02477839|Lacosamide|lacosamide|mesh-list
20017522|NCT02477839|Anticonvulsants|anticonvulsants|mesh-ancestor
20017523|NCT02477839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20017524|NCT02477839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20017525|NCT02477839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20017526|NCT02477839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017527|NCT02478164|Ponatinib|ponatinib|mesh-list
20017528|NCT02478164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20017529|NCT02478164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20017530|NCT02478164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017531|NCT02478164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017532|NCT02478372|Bupivacaine|bupivacaine|mesh-list
20017533|NCT02478372|Ropivacaine|ropivacaine|mesh-list
20017534|NCT02478372|Levobupivacaine|levobupivacaine|mesh-list
20017535|NCT02478372|Anesthetics, Local|anesthetics, local|mesh-ancestor
20017536|NCT02478372|Anesthetics|anesthetics|mesh-ancestor
20017537|NCT02478372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20017538|NCT02478372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017539|NCT02478372|Sensory System Agents|sensory system agents|mesh-ancestor
20017540|NCT02478372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017541|NCT02478398|Mometasone Furoate|mometasone furoate|mesh-list
20017542|NCT02478398|Loratadine|loratadine|mesh-list
20017543|NCT02478398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
20017544|NCT02478398|Epinephrine|epinephrine|mesh-list
20017545|NCT02478398|Albuterol|albuterol|mesh-list
20017546|NCT02478398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
20017547|NCT02478398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20017548|NCT02478398|Adrenergic Agents|adrenergic agents|mesh-ancestor
20017549|NCT02478398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20017550|NCT02478398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017551|NCT02478398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017552|NCT02478398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20017553|NCT02478398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20017554|NCT02478398|Autonomic Agents|autonomic agents|mesh-ancestor
20017555|NCT02478398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017556|NCT02478398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20017557|NCT02478398|Respiratory System Agents|respiratory system agents|mesh-ancestor
20017558|NCT02478398|Mydriatics|mydriatics|mesh-ancestor
20017559|NCT02478398|Sympathomimetics|sympathomimetics|mesh-ancestor
20017560|NCT02478398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
20017561|NCT02478398|Tocolytic Agents|tocolytic agents|mesh-ancestor
20017562|NCT02478398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20017563|NCT02478398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20017564|NCT02478398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20017565|NCT02478398|Dermatologic Agents|dermatologic agents|mesh-ancestor
20017566|NCT02478398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
20017567|NCT02478398|Antipruritics|antipruritics|mesh-ancestor
20017568|NCT02478398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
20017569|NCT02478398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
20017570|NCT02478398|Histamine Antagonists|histamine antagonists|mesh-ancestor
20017571|NCT02478398|Histamine Agents|histamine agents|mesh-ancestor
20017572|NCT02478398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20017573|NCT02478398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20017574|NCT02478398|Analgesics|analgesics|mesh-ancestor
20017575|NCT02478398|Sensory System Agents|sensory system agents|mesh-ancestor
20017576|NCT02478398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20017577|NCT02478463|Cabotegravir|cabotegravir|mesh-list
20017578|NCT02478463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
20017579|NCT02478463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
20017580|NCT02478463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017581|NCT02478463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017582|NCT02478463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20017583|NCT02478463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20017584|NCT02478463|Antiviral Agents|antiviral agents|mesh-ancestor
20017585|NCT02478463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20017586|NCT02478489|Naltrexone|naltrexone|mesh-list
20017587|NCT02478489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
20017588|NCT02478489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
20017589|NCT02478489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017590|NCT02478489|Sensory System Agents|sensory system agents|mesh-ancestor
20017591|NCT02478489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017592|NCT02478580|Modafinil|modafinil|mesh-list
20017593|NCT02478580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20017594|NCT02478580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017595|NCT02478580|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20017596|NCT02478580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20017597|NCT02478580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20017598|NCT02478580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017599|NCT02479412|Albuterol|albuterol|mesh-list
20017600|NCT02479412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20017601|NCT02479412|Autonomic Agents|autonomic agents|mesh-ancestor
20017602|NCT02479412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017603|NCT02479412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017604|NCT02479412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20017605|NCT02479412|Respiratory System Agents|respiratory system agents|mesh-ancestor
20017606|NCT02479412|Tocolytic Agents|tocolytic agents|mesh-ancestor
20017607|NCT02479412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20017608|NCT02479412|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20017609|NCT02479412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20017610|NCT02479412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20017611|NCT02479412|Adrenergic Agents|adrenergic agents|mesh-ancestor
20017612|NCT02479412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20017613|NCT02479412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017614|NCT02479880|Tenofovir|tenofovir|mesh-list
20017615|NCT02479880|Antiviral Agents|antiviral agents|mesh-ancestor
20017616|NCT02479880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20017617|NCT02479880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20017618|NCT02479880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20017619|NCT02479880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017620|NCT02479880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017621|NCT02479880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20017622|NCT02479880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20017623|NCT02480010|Pertuzumab|pertuzumab|mesh-list
20017624|NCT02480010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20017625|NCT02480010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20017626|NCT02480114|Acetaminophen|acetaminophen|mesh-list
20017627|NCT02480114|Ibuprofen|ibuprofen|mesh-list
20017628|NCT02480114|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
20017629|NCT02480114|Fentanyl|fentanyl|mesh-list
20017630|NCT02480114|Oxycodone|oxycodone|mesh-list
20017631|NCT02480114|Hydrocodone|hydrocodone|mesh-list
20017632|NCT02480114|Gabapentin|gabapentin|mesh-list
20017633|NCT02480114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20017634|NCT02480114|Narcotics|narcotics|mesh-ancestor
20017635|NCT02480114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20017636|NCT02480114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017637|NCT02480114|Analgesics|analgesics|mesh-ancestor
20017638|NCT02480114|Sensory System Agents|sensory system agents|mesh-ancestor
20017639|NCT02480114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017640|NCT02480114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20017641|NCT02480114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20017642|NCT02480114|Anesthetics, General|anesthetics, general|mesh-ancestor
20017643|NCT02480114|Anesthetics|anesthetics|mesh-ancestor
20017644|NCT02480114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20017645|NCT02480114|Antipyretics|antipyretics|mesh-ancestor
20017646|NCT02480114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20017647|NCT02480114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20017648|NCT02480114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20017649|NCT02480114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20017650|NCT02480114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017651|NCT02480114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017652|NCT02480114|Anticonvulsants|anticonvulsants|mesh-ancestor
20017653|NCT02480114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20017654|NCT02480114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20017655|NCT02480114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20017656|NCT02480114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20017657|NCT02480114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20017658|NCT02480114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20017659|NCT02480114|Antimanic Agents|antimanic agents|mesh-ancestor
20017660|NCT02480114|Antitussive Agents|antitussive agents|mesh-ancestor
20017661|NCT02480114|Respiratory System Agents|respiratory system agents|mesh-ancestor
20017662|NCT02480153|Adalimumab|adalimumab|mesh-list
20017663|NCT02480153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20017664|NCT02480153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20017665|NCT02480166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
20017666|NCT02480166|Antiviral Agents|antiviral agents|mesh-ancestor
20017667|NCT02480166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20017668|NCT02480621|Bupivacaine|bupivacaine|mesh-list
20017669|NCT02480621|Anesthetics, Local|anesthetics, local|mesh-ancestor
20017670|NCT02480621|Anesthetics|anesthetics|mesh-ancestor
20017671|NCT02480621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20017672|NCT02480621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017673|NCT02480621|Sensory System Agents|sensory system agents|mesh-ancestor
20017674|NCT02480621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017675|NCT02480712|Sofosbuvir|sofosbuvir|mesh-list
20017676|NCT02480712|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
20017677|NCT02480712|Velpatasvir|velpatasvir|mesh-list
20017678|NCT02480712|Antiviral Agents|antiviral agents|mesh-ancestor
20017679|NCT02480712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20017680|NCT02480764|Valsartan|valsartan|mesh-list
20017681|NCT02480764|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
20017682|NCT02480764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20017683|NCT02480764|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
20017684|NCT02480764|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
20017685|NCT02480764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017686|NCT02480998|Vaccines|vaccines|mesh-list
20017687|NCT02480998|Immunologic Factors|immunologic factors|mesh-ancestor
20017688|NCT02480998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017689|NCT02481219|Erythromycin|erythromycin|mesh-list
20017690|NCT02481219|Erythromycin Estolate|erythromycin estolate|mesh-list
20017691|NCT02481219|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
20017692|NCT02481219|Erythromycin stearate|erythromycin stearate|mesh-list
20017693|NCT02481219|Metoclopramide|metoclopramide|mesh-list
20017694|NCT02481219|Bisacodyl|bisacodyl|mesh-list
20017695|NCT02481219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20017696|NCT02481219|Antiemetics|antiemetics|mesh-ancestor
20017697|NCT02481219|Autonomic Agents|autonomic agents|mesh-ancestor
20017698|NCT02481219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017699|NCT02481219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017700|NCT02481219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20017701|NCT02481219|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
20017702|NCT02481219|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
20017703|NCT02481219|Dopamine Agents|dopamine agents|mesh-ancestor
20017704|NCT02481219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20017705|NCT02481219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017706|NCT02481219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20017707|NCT02481219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20017708|NCT02481219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20017709|NCT02481219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017710|NCT02481219|Cathartics|cathartics|mesh-ancestor
20017711|NCT02481219|Laxatives|laxatives|mesh-ancestor
20017712|NCT02481258|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
20017713|NCT02481258|Enzyme Activators|enzyme activators|mesh-ancestor
20017714|NCT02481258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017715|NCT02481297|Rituximab|rituximab|mesh-list
20017716|NCT02481297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20017717|NCT02481297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20017718|NCT02481297|Immunologic Factors|immunologic factors|mesh-ancestor
20017719|NCT02481297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017720|NCT02481297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20017721|NCT02481375|Iron|iron|mesh-list
20017722|NCT02481375|Trace Elements|trace elements|mesh-list
20017723|NCT02481375|Micronutrients|micronutrients|mesh-list
20017724|NCT02481375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017725|NCT02481505|Chloroprocaine|chloroprocaine|mesh-list
20017726|NCT02481505|Anesthetics, Local|anesthetics, local|mesh-ancestor
20017727|NCT02481505|Anesthetics|anesthetics|mesh-ancestor
20017728|NCT02481505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20017729|NCT02481505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017730|NCT02481505|Sensory System Agents|sensory system agents|mesh-ancestor
20017731|NCT02481505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017732|NCT02481934|Lenalidomide|lenalidomide|mesh-list
20017733|NCT02481934|Bortezomib|bortezomib|mesh-list
20017734|NCT02481934|Immunologic Factors|immunologic factors|mesh-ancestor
20017735|NCT02481934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017736|NCT02481934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20017737|NCT02481934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20017738|NCT02481934|Growth Substances|growth substances|mesh-ancestor
20017739|NCT02481934|Growth Inhibitors|growth inhibitors|mesh-ancestor
20017740|NCT02481934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20017741|NCT02481947|Laxatives|laxatives|mesh-list
20017742|NCT02481947|Lubiprostone|lubiprostone|mesh-list
20017743|NCT02481947|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
20017744|NCT02481947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20017745|NCT02481947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017746|NCT02481947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20017747|NCT02482129|Dexamethasone|dexamethasone|mesh-list
20017748|NCT02482129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
20017749|NCT02482129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
20017750|NCT02482129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20017751|NCT02482129|Antiemetics|antiemetics|mesh-ancestor
20017752|NCT02482129|Autonomic Agents|autonomic agents|mesh-ancestor
20017753|NCT02482129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017754|NCT02482129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017755|NCT02482129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20017756|NCT02482129|Glucocorticoids|glucocorticoids|mesh-ancestor
20017757|NCT02482129|Hormones|hormones|mesh-ancestor
20017758|NCT02482129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20017759|NCT02482129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20017760|NCT02482129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20017761|NCT02482298|Ticagrelor|ticagrelor|mesh-list
20017762|NCT02482298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20017763|NCT02482298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
20017764|NCT02482298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
20017765|NCT02482298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
20017766|NCT02482298|Purinergic Agents|purinergic agents|mesh-ancestor
20017767|NCT02482298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20017768|NCT02482298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017769|NCT02482298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017770|NCT02482428|Imiquimod|imiquimod|mesh-list
20017771|NCT02482428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20017772|NCT02482428|Immunologic Factors|immunologic factors|mesh-ancestor
20017773|NCT02482428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017774|NCT02482428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20017775|NCT02482428|Interferon Inducers|interferon inducers|mesh-ancestor
20017776|NCT02482675|Caseins|caseins|mesh-list
20017777|NCT02482675|Chelating Agents|chelating agents|mesh-ancestor
20017778|NCT02482675|Sequestering Agents|sequestering agents|mesh-ancestor
20017779|NCT02482675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017780|NCT02483000|Biotin|biotin|mesh-list
20017781|NCT02483000|Cytarabine|cytarabine|mesh-list
20017782|NCT02483000|Etoposide|etoposide|mesh-list
20017783|NCT02483000|Podophyllotoxin|podophyllotoxin|mesh-list
20017784|NCT02483000|Etoposide phosphate|etoposide phosphate|mesh-list
20017785|NCT02483000|Melphalan|melphalan|mesh-list
20017786|NCT02483000|Mechlorethamine|mechlorethamine|mesh-list
20017787|NCT02483000|Carmustine|carmustine|mesh-list
20017788|NCT02483000|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
20017789|NCT02483000|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
20017790|NCT02483000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20017791|NCT02483000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20017792|NCT02483000|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20017793|NCT02483000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20017794|NCT02483000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017795|NCT02483000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017796|NCT02483000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20017797|NCT02483000|Antimetabolites|antimetabolites|mesh-ancestor
20017798|NCT02483000|Antiviral Agents|antiviral agents|mesh-ancestor
20017799|NCT02483000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20017800|NCT02483000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20017801|NCT02483000|Immunologic Factors|immunologic factors|mesh-ancestor
20017802|NCT02483000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017803|NCT02483000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20017804|NCT02483000|Alkylating Agents|alkylating agents|mesh-ancestor
20017805|NCT02483000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20017806|NCT02483000|Chelating Agents|chelating agents|mesh-ancestor
20017807|NCT02483000|Sequestering Agents|sequestering agents|mesh-ancestor
20017808|NCT02483000|Keratolytic Agents|keratolytic agents|mesh-ancestor
20017809|NCT02483000|Dermatologic Agents|dermatologic agents|mesh-ancestor
20017810|NCT02483000|Tubulin Modulators|tubulin modulators|mesh-ancestor
20017811|NCT02483000|Antimitotic Agents|antimitotic agents|mesh-ancestor
20017812|NCT02483000|Mitosis Modulators|mitosis modulators|mesh-ancestor
20017813|NCT02483000|Vitamin B Complex|vitamin b complex|mesh-ancestor
20017814|NCT02483000|Vitamins|vitamins|mesh-ancestor
20017815|NCT02483000|Micronutrients|micronutrients|mesh-ancestor
20017816|NCT02483611|Lidocaine|lidocaine|mesh-list
20017817|NCT02483611|Magnesium Sulfate|magnesium sulfate|mesh-list
20017818|NCT02483611|Cisatracurium|cisatracurium|mesh-list
20017819|NCT02483611|Anesthetics, Local|anesthetics, local|mesh-ancestor
20017820|NCT02483611|Anesthetics|anesthetics|mesh-ancestor
20017821|NCT02483611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20017822|NCT02483611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017823|NCT02483611|Sensory System Agents|sensory system agents|mesh-ancestor
20017824|NCT02483611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017825|NCT02483611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20017826|NCT02483611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
20017827|NCT02483611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
20017828|NCT02483611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20017829|NCT02483611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017830|NCT02483611|Analgesics|analgesics|mesh-ancestor
20017831|NCT02483611|Anticonvulsants|anticonvulsants|mesh-ancestor
20017832|NCT02483611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
20017833|NCT02483611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20017834|NCT02483611|Tocolytic Agents|tocolytic agents|mesh-ancestor
20017835|NCT02483611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20017836|NCT02483611|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20017837|NCT02483611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20017838|NCT02483975|Albuterol|albuterol|mesh-list
20017839|NCT02483975|Montelukast|montelukast|mesh-list
20017840|NCT02483975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20017841|NCT02483975|Respiratory System Agents|respiratory system agents|mesh-ancestor
20017842|NCT02483975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
20017843|NCT02483975|Hormone Antagonists|hormone antagonists|mesh-ancestor
20017844|NCT02483975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20017845|NCT02483975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017846|NCT02483975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
20017847|NCT02483975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20017848|NCT02483975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017849|NCT02483975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20017850|NCT02483975|Autonomic Agents|autonomic agents|mesh-ancestor
20017851|NCT02483975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017852|NCT02483975|Tocolytic Agents|tocolytic agents|mesh-ancestor
20017853|NCT02483975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
20017854|NCT02483975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20017855|NCT02483975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20017856|NCT02483975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20017857|NCT02483975|Adrenergic Agents|adrenergic agents|mesh-ancestor
20017858|NCT02483975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20017859|NCT02484222|Fentanyl|fentanyl|mesh-list
20017860|NCT02484222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20017861|NCT02484222|Narcotics|narcotics|mesh-ancestor
20017862|NCT02484222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20017863|NCT02484222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017864|NCT02484222|Analgesics|analgesics|mesh-ancestor
20017865|NCT02484222|Sensory System Agents|sensory system agents|mesh-ancestor
20017866|NCT02484222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017867|NCT02484222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20017868|NCT02484222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20017869|NCT02484222|Anesthetics, General|anesthetics, general|mesh-ancestor
20017870|NCT02484222|Anesthetics|anesthetics|mesh-ancestor
20017871|NCT02484651|Rocuronium|rocuronium|mesh-list
20017872|NCT02484651|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20017873|NCT02484651|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20017874|NCT02484651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20017875|NCT02484651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017876|NCT02484651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017877|NCT02484690|Ranibizumab|ranibizumab|mesh-list
20017878|NCT02484690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20017879|NCT02484690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20017880|NCT02484690|Growth Substances|growth substances|mesh-ancestor
20017881|NCT02484690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017882|NCT02484690|Growth Inhibitors|growth inhibitors|mesh-ancestor
20017883|NCT02484690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20017884|NCT02484859|Metoprolol|metoprolol|mesh-list
20017885|NCT02484859|Remifentanil|remifentanil|mesh-list
20017886|NCT02484859|Tramadol|tramadol|mesh-list
20017887|NCT02484859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20017888|NCT02484859|Narcotics|narcotics|mesh-ancestor
20017889|NCT02484859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20017890|NCT02484859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017891|NCT02484859|Analgesics|analgesics|mesh-ancestor
20017892|NCT02484859|Sensory System Agents|sensory system agents|mesh-ancestor
20017893|NCT02484859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017894|NCT02484859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
20017895|NCT02484859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
20017896|NCT02484859|Sympatholytics|sympatholytics|mesh-ancestor
20017897|NCT02484859|Autonomic Agents|autonomic agents|mesh-ancestor
20017898|NCT02484859|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
20017899|NCT02484859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
20017900|NCT02484859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20017901|NCT02484859|Adrenergic Agents|adrenergic agents|mesh-ancestor
20017902|NCT02484859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20017903|NCT02484859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017904|NCT02484911|Dexamethasone|dexamethasone|mesh-list
20017905|NCT02484911|Olanzapine|olanzapine|mesh-list
20017906|NCT02484911|Aprepitant|aprepitant|mesh-list
20017907|NCT02484911|Palonosetron|palonosetron|mesh-list
20017908|NCT02484911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20017909|NCT02484911|Antiemetics|antiemetics|mesh-ancestor
20017910|NCT02484911|Autonomic Agents|autonomic agents|mesh-ancestor
20017911|NCT02484911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017912|NCT02484911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017913|NCT02484911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20017914|NCT02484911|Glucocorticoids|glucocorticoids|mesh-ancestor
20017915|NCT02484911|Hormones|hormones|mesh-ancestor
20017916|NCT02484911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20017917|NCT02484911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20017918|NCT02484911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20017919|NCT02484911|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
20017920|NCT02484911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20017921|NCT02484911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20017922|NCT02484911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20017923|NCT02484911|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20017924|NCT02484911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20017925|NCT02484911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20017926|NCT02484911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017927|NCT02484911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20017928|NCT02484911|Serotonin Agents|serotonin agents|mesh-ancestor
20017929|NCT02484911|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
20017930|NCT02484911|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
20017931|NCT02484911|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
20017932|NCT02485158|Dronabinol|dronabinol|mesh-list
20017933|NCT02485158|Amphetamine|amphetamine|mesh-list
20017934|NCT02485158|Dextroamphetamine|dextroamphetamine|mesh-list
20017935|NCT02485158|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20017936|NCT02485158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017937|NCT02485158|Sympathomimetics|sympathomimetics|mesh-ancestor
20017938|NCT02485158|Autonomic Agents|autonomic agents|mesh-ancestor
20017939|NCT02485158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017940|NCT02485158|Dopamine Agents|dopamine agents|mesh-ancestor
20017941|NCT02485158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20017942|NCT02485158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017943|NCT02485158|Adrenergic Agents|adrenergic agents|mesh-ancestor
20017944|NCT02485158|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
20017945|NCT02485158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20017946|NCT02485158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20017947|NCT02485158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20017948|NCT02485158|Hallucinogens|hallucinogens|mesh-ancestor
20017949|NCT02485158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20017950|NCT02485158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20017951|NCT02485158|Analgesics|analgesics|mesh-ancestor
20017952|NCT02485158|Sensory System Agents|sensory system agents|mesh-ancestor
20017953|NCT02485158|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
20017954|NCT02485158|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
20017955|NCT02485158|Hormones|hormones|mesh-ancestor
20017956|NCT02485158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20017957|NCT02485353|Cytarabine|cytarabine|mesh-list
20017958|NCT02485353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20017959|NCT02485353|Antimetabolites|antimetabolites|mesh-ancestor
20017960|NCT02485353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017961|NCT02485353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20017962|NCT02485353|Antiviral Agents|antiviral agents|mesh-ancestor
20017963|NCT02485353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20017964|NCT02485353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20017965|NCT02485353|Immunologic Factors|immunologic factors|mesh-ancestor
20017966|NCT02485353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017967|NCT02485834|Docetaxel|docetaxel|mesh-list
20017968|NCT02485834|Capecitabine|capecitabine|mesh-list
20017969|NCT02485834|Irinotecan|irinotecan|mesh-list
20017970|NCT02485834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20017971|NCT02485834|Tubulin Modulators|tubulin modulators|mesh-ancestor
20017972|NCT02485834|Antimitotic Agents|antimitotic agents|mesh-ancestor
20017973|NCT02485834|Mitosis Modulators|mitosis modulators|mesh-ancestor
20017974|NCT02485834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20017975|NCT02485834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20017976|NCT02485834|Antimetabolites|antimetabolites|mesh-ancestor
20017977|NCT02485834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
20017978|NCT02485834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20017979|NCT02485834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20017980|NCT02486016|Fentanyl|fentanyl|mesh-list
20017981|NCT02486016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20017982|NCT02486016|Narcotics|narcotics|mesh-ancestor
20017983|NCT02486016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20017984|NCT02486016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20017985|NCT02486016|Analgesics|analgesics|mesh-ancestor
20017986|NCT02486016|Sensory System Agents|sensory system agents|mesh-ancestor
20017987|NCT02486016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20017988|NCT02486016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20017989|NCT02486016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20017990|NCT02486016|Anesthetics, General|anesthetics, general|mesh-ancestor
20017991|NCT02486016|Anesthetics|anesthetics|mesh-ancestor
20017992|NCT02486211|Amantadine|amantadine|mesh-list
20017993|NCT02486211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
20017994|NCT02486211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
20017995|NCT02486211|Antiviral Agents|antiviral agents|mesh-ancestor
20017996|NCT02486211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20017997|NCT02486211|Dopamine Agents|dopamine agents|mesh-ancestor
20017998|NCT02486211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20017999|NCT02486211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018000|NCT02486211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018001|NCT02486211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20018002|NCT02486211|Analgesics|analgesics|mesh-ancestor
20018003|NCT02486211|Sensory System Agents|sensory system agents|mesh-ancestor
20018004|NCT02486211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018005|NCT02486302|Etanercept|etanercept|mesh-list
20018006|NCT02486302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20018007|NCT02486302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20018008|NCT02486302|Analgesics|analgesics|mesh-ancestor
20018009|NCT02486302|Sensory System Agents|sensory system agents|mesh-ancestor
20018010|NCT02486302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018011|NCT02486302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018012|NCT02486302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20018013|NCT02486302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20018014|NCT02486302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20018015|NCT02486302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20018016|NCT02486302|Immunologic Factors|immunologic factors|mesh-ancestor
20018017|NCT02486328|Midazolam|midazolam|mesh-list
20018018|NCT02486328|Meperidine|meperidine|mesh-list
20018019|NCT02486328|Remifentanil|remifentanil|mesh-list
20018020|NCT02486328|Propofol|propofol|mesh-list
20018021|NCT02486328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20018022|NCT02486328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20018023|NCT02486328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018024|NCT02486328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20018025|NCT02486328|Anesthetics, General|anesthetics, general|mesh-ancestor
20018026|NCT02486328|Anesthetics|anesthetics|mesh-ancestor
20018027|NCT02486328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20018028|NCT02486328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20018029|NCT02486328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20018030|NCT02486328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20018031|NCT02486328|GABA Modulators|gaba modulators|mesh-ancestor
20018032|NCT02486328|GABA Agents|gaba agents|mesh-ancestor
20018033|NCT02486328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20018034|NCT02486328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018035|NCT02486328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20018036|NCT02486328|Narcotics|narcotics|mesh-ancestor
20018037|NCT02486328|Analgesics|analgesics|mesh-ancestor
20018038|NCT02486328|Sensory System Agents|sensory system agents|mesh-ancestor
20018039|NCT02486328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018040|NCT02486406|Ritonavir|ritonavir|mesh-list
20018041|NCT02486406|Ribavirin|ribavirin|mesh-list
20018042|NCT02486406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20018043|NCT02486406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20018044|NCT02486406|Protease Inhibitors|protease inhibitors|mesh-ancestor
20018045|NCT02486406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018046|NCT02486406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018047|NCT02486406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20018048|NCT02486406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20018049|NCT02486406|Antiviral Agents|antiviral agents|mesh-ancestor
20018050|NCT02486406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20018051|NCT02486406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20018052|NCT02486406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20018053|NCT02486406|Antimetabolites|antimetabolites|mesh-ancestor
20018054|NCT02486627|Levofloxacin|levofloxacin|mesh-list
20018055|NCT02486627|Ofloxacin|ofloxacin|mesh-list
20018056|NCT02486627|Meropenem|meropenem|mesh-list
20018057|NCT02486627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
20018058|NCT02486627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20018059|NCT02486627|Renal Agents|renal agents|mesh-ancestor
20018060|NCT02486627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20018061|NCT02486627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20018062|NCT02486627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20018063|NCT02486627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018064|NCT02486627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018065|NCT02486627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018066|NCT02486627|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
20018067|NCT02486627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20018068|NCT02486653|Tamsulosin|tamsulosin|mesh-list
20018069|NCT02486653|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
20018070|NCT02486653|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
20018071|NCT02486653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
20018072|NCT02486653|Adrenergic Agents|adrenergic agents|mesh-ancestor
20018073|NCT02486653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20018074|NCT02486653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018075|NCT02486653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018076|NCT02486653|Urological Agents|urological agents|mesh-ancestor
20018077|NCT02486757|Estradiol|estradiol|mesh-list
20018078|NCT02486757|Progesterone|progesterone|mesh-list
20018079|NCT02486757|Estrogens|estrogens|mesh-ancestor
20018080|NCT02486757|Hormones|hormones|mesh-ancestor
20018081|NCT02486757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20018082|NCT02486757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018083|NCT02486757|Progestins|progestins|mesh-ancestor
20018084|NCT02486796|Ubiquinone|ubiquinone|mesh-list
20018085|NCT02486796|Coenzyme Q10|coenzyme q10|mesh-list
20018086|NCT02486796|Melatonin|melatonin|mesh-list
20018087|NCT02486796|Antioxidants|antioxidants|mesh-ancestor
20018088|NCT02486796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018089|NCT02486796|Protective Agents|protective agents|mesh-ancestor
20018090|NCT02486796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018091|NCT02486796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20018092|NCT02486796|Micronutrients|micronutrients|mesh-ancestor
20018093|NCT02486796|Vitamins|vitamins|mesh-ancestor
20018094|NCT02486952|Prednisone|prednisone|mesh-list
20018095|NCT02486952|Cyclophosphamide|cyclophosphamide|mesh-list
20018096|NCT02486952|Rituximab|rituximab|mesh-list
20018097|NCT02486952|Vincristine|vincristine|mesh-list
20018098|NCT02486952|Doxorubicin|doxorubicin|mesh-list
20018099|NCT02486952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
20018100|NCT02486952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20018101|NCT02486952|Immunologic Factors|immunologic factors|mesh-ancestor
20018102|NCT02486952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018103|NCT02486952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20018104|NCT02486952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20018105|NCT02486952|Alkylating Agents|alkylating agents|mesh-ancestor
20018106|NCT02486952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018107|NCT02486952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018108|NCT02486952|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20018109|NCT02486952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20018110|NCT02486952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20018111|NCT02486952|Glucocorticoids|glucocorticoids|mesh-ancestor
20018112|NCT02486952|Hormones|hormones|mesh-ancestor
20018113|NCT02486952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20018114|NCT02486952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20018115|NCT02486952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
20018116|NCT02486952|Tubulin Modulators|tubulin modulators|mesh-ancestor
20018117|NCT02486952|Antimitotic Agents|antimitotic agents|mesh-ancestor
20018118|NCT02486952|Mitosis Modulators|mitosis modulators|mesh-ancestor
20018119|NCT02486952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20018120|NCT02486952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20018121|NCT02486952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20018122|NCT02486952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018123|NCT02487030|Sofosbuvir|sofosbuvir|mesh-list
20018124|NCT02487030|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
20018125|NCT02487030|Ledipasvir|ledipasvir|mesh-list
20018126|NCT02487030|Antiviral Agents|antiviral agents|mesh-ancestor
20018127|NCT02487030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20018128|NCT02487199|Ritonavir|ritonavir|mesh-list
20018129|NCT02487199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20018130|NCT02487199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20018131|NCT02487199|Protease Inhibitors|protease inhibitors|mesh-ancestor
20018132|NCT02487199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018133|NCT02487199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018134|NCT02487199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20018135|NCT02487199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20018136|NCT02487199|Antiviral Agents|antiviral agents|mesh-ancestor
20018137|NCT02487199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20018138|NCT02487199|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20018139|NCT02487199|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20018140|NCT02487225|Pentoxifylline|pentoxifylline|mesh-list
20018141|NCT02487225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
20018142|NCT02487225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018143|NCT02487225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018144|NCT02487225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20018145|NCT02487225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
20018146|NCT02487225|Protective Agents|protective agents|mesh-ancestor
20018147|NCT02487225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018148|NCT02487225|Vasodilator Agents|vasodilator agents|mesh-ancestor
20018149|NCT02487225|Free Radical Scavengers|free radical scavengers|mesh-ancestor
20018150|NCT02487225|Antioxidants|antioxidants|mesh-ancestor
20018151|NCT02487303|Acetaminophen|acetaminophen|mesh-list
20018152|NCT02487303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20018153|NCT02487303|Analgesics|analgesics|mesh-ancestor
20018154|NCT02487303|Sensory System Agents|sensory system agents|mesh-ancestor
20018155|NCT02487303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018156|NCT02487303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018157|NCT02487303|Antipyretics|antipyretics|mesh-ancestor
20018158|NCT02487446|Glycopyrrolate|glycopyrrolate|mesh-list
20018159|NCT02487446|Bromides|bromides|mesh-list
20018160|NCT02487446|Anticonvulsants|anticonvulsants|mesh-ancestor
20018161|NCT02487446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018162|NCT02487446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20018163|NCT02487446|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20018164|NCT02487446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20018165|NCT02487446|Cholinergic Agents|cholinergic agents|mesh-ancestor
20018166|NCT02487446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20018167|NCT02487446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018168|NCT02487485|Sirolimus|sirolimus|mesh-list
20018169|NCT02487485|Ketamine|ketamine|mesh-list
20018170|NCT02487485|Analgesics|analgesics|mesh-ancestor
20018171|NCT02487485|Sensory System Agents|sensory system agents|mesh-ancestor
20018172|NCT02487485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018173|NCT02487485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018174|NCT02487485|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20018175|NCT02487485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20018176|NCT02487485|Anesthetics, General|anesthetics, general|mesh-ancestor
20018177|NCT02487485|Anesthetics|anesthetics|mesh-ancestor
20018178|NCT02487485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20018179|NCT02487485|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20018180|NCT02487485|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20018181|NCT02487485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20018182|NCT02487485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018183|NCT02487485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20018184|NCT02487485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20018185|NCT02487485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20018186|NCT02487485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018187|NCT02487485|Antifungal Agents|antifungal agents|mesh-ancestor
20018188|NCT02487485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20018189|NCT02487485|Immunologic Factors|immunologic factors|mesh-ancestor
20018190|NCT02487498|Glycopyrrolate|glycopyrrolate|mesh-list
20018191|NCT02487498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20018192|NCT02487498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
20018193|NCT02487498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20018194|NCT02487498|Cholinergic Agents|cholinergic agents|mesh-ancestor
20018195|NCT02487498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20018196|NCT02487498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018197|NCT02487498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018198|NCT02487563|Decitabine|decitabine|mesh-list
20018199|NCT02487563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20018200|NCT02487563|Antimetabolites|antimetabolites|mesh-ancestor
20018201|NCT02487563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018202|NCT02487563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018203|NCT02487563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018204|NCT02488070|Edetic Acid|edetic acid|mesh-list
20018205|NCT02488070|Chelating Agents|chelating agents|mesh-ancestor
20018206|NCT02488070|Sequestering Agents|sequestering agents|mesh-ancestor
20018207|NCT02488070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018208|NCT02488070|Anticoagulants|anticoagulants|mesh-ancestor
20018209|NCT02488070|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
20018210|NCT02488330|Bevacizumab|bevacizumab|mesh-list
20018211|NCT02488330|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20018212|NCT02488330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20018213|NCT02488330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018214|NCT02488330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20018215|NCT02488330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20018216|NCT02488330|Growth Substances|growth substances|mesh-ancestor
20018217|NCT02488330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018218|NCT02488330|Growth Inhibitors|growth inhibitors|mesh-ancestor
20018219|NCT02488330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20018220|NCT02488330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018221|NCT02488330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018222|NCT02488980|Mefloquine|mefloquine|mesh-list
20018223|NCT02488980|Tafenoquine|tafenoquine|mesh-list
20018224|NCT02488980|Antimalarials|antimalarials|mesh-ancestor
20018225|NCT02488980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20018226|NCT02488980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20018227|NCT02488980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20018228|NCT02489227|Adalimumab|adalimumab|mesh-list
20018229|NCT02489227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20018230|NCT02489227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20018231|NCT02489357|Pembrolizumab|pembrolizumab|mesh-list
20018232|NCT02489357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20018233|NCT02489357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018234|NCT02489500|Bortezomib|bortezomib|mesh-list
20018235|NCT02489500|Melphalan|melphalan|mesh-list
20018236|NCT02489500|Sargramostim|sargramostim|mesh-list
20018237|NCT02489500|Lenograstim|lenograstim|mesh-list
20018238|NCT02489500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018239|NCT02489500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20018240|NCT02489500|Alkylating Agents|alkylating agents|mesh-ancestor
20018241|NCT02489500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018242|NCT02489500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
20018243|NCT02489500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
20018244|NCT02489500|Immunologic Factors|immunologic factors|mesh-ancestor
20018245|NCT02489500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018246|NCT02489500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20018247|NCT02489630|Ketamine|ketamine|mesh-list
20018248|NCT02489630|Analgesics|analgesics|mesh-list
20018249|NCT02489630|Sensory System Agents|sensory system agents|mesh-ancestor
20018250|NCT02489630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018251|NCT02489630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018252|NCT02489630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
20018253|NCT02489630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20018254|NCT02489630|Anesthetics, General|anesthetics, general|mesh-ancestor
20018255|NCT02489630|Anesthetics|anesthetics|mesh-ancestor
20018256|NCT02489630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20018257|NCT02489630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
20018258|NCT02489630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
20018259|NCT02489630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20018260|NCT02489630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018261|NCT02489734|Sevoflurane|sevoflurane|mesh-list
20018262|NCT02489734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
20018263|NCT02489734|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
20018264|NCT02489734|Anesthetics, General|anesthetics, general|mesh-ancestor
20018265|NCT02489734|Anesthetics|anesthetics|mesh-ancestor
20018266|NCT02489734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20018267|NCT02489734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018268|NCT02489968|Empagliflozin|empagliflozin|mesh-list
20018269|NCT02489968|Linagliptin|linagliptin|mesh-list
20018270|NCT02489968|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
20018271|NCT02489968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018272|NCT02489968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20018273|NCT02489968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018274|NCT02489968|Incretins|incretins|mesh-ancestor
20018275|NCT02489968|Hormones|hormones|mesh-ancestor
20018276|NCT02489968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20018277|NCT02489968|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
20018278|NCT02489968|Protease Inhibitors|protease inhibitors|mesh-ancestor
20018279|NCT02489968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018280|NCT02489981|Tiotropium Bromide|tiotropium bromide|mesh-list
20018281|NCT02489981|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20018282|NCT02489981|Autonomic Agents|autonomic agents|mesh-ancestor
20018283|NCT02489981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018284|NCT02489981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018285|NCT02489981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20018286|NCT02489981|Respiratory System Agents|respiratory system agents|mesh-ancestor
20018287|NCT02489981|Parasympatholytics|parasympatholytics|mesh-ancestor
20018288|NCT02489981|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20018289|NCT02489981|Cholinergic Agents|cholinergic agents|mesh-ancestor
20018290|NCT02489981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20018291|NCT02489981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018292|NCT02490293|Cephalosporins|cephalosporins|mesh-list
20018293|NCT02490293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20018294|NCT02490293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20018295|NCT02490475|Docetaxel|docetaxel|mesh-list
20018296|NCT02490475|Pertuzumab|pertuzumab|mesh-list
20018297|NCT02490475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018298|NCT02490475|Tubulin Modulators|tubulin modulators|mesh-ancestor
20018299|NCT02490475|Antimitotic Agents|antimitotic agents|mesh-ancestor
20018300|NCT02490475|Mitosis Modulators|mitosis modulators|mesh-ancestor
20018301|NCT02490475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018302|NCT02490475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20018303|NCT02490631|Chlorhexidine|chlorhexidine|mesh-list
20018304|NCT02490631|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
20018305|NCT02490631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20018306|NCT02490631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20018307|NCT02490631|Disinfectants|disinfectants|mesh-ancestor
20018308|NCT02490631|Dermatologic Agents|dermatologic agents|mesh-ancestor
20018309|NCT02490670|Cephalexin|cephalexin|mesh-list
20018310|NCT02490670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20018311|NCT02490670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20018312|NCT02490878|Bevacizumab|bevacizumab|mesh-list
20018313|NCT02490878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20018314|NCT02490878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018315|NCT02490878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20018316|NCT02490878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20018317|NCT02490878|Growth Substances|growth substances|mesh-ancestor
20018318|NCT02490878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018319|NCT02490878|Growth Inhibitors|growth inhibitors|mesh-ancestor
20018320|NCT02491437|Progesterone|progesterone|mesh-list
20018321|NCT02491437|Dydrogesterone|dydrogesterone|mesh-list
20018322|NCT02491437|Progestins|progestins|mesh-ancestor
20018323|NCT02491437|Hormones|hormones|mesh-ancestor
20018324|NCT02491437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20018325|NCT02491437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018326|NCT02491463|Vaccines|vaccines|mesh-list
20018327|NCT02491463|Immunologic Factors|immunologic factors|mesh-ancestor
20018328|NCT02491463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018329|NCT02491684|Interferons|interferons|mesh-list
20018330|NCT02491684|Interferon-beta|interferon-beta|mesh-list
20018331|NCT02491684|Interferon beta-1a|interferon beta-1a|mesh-list
20018332|NCT02491684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018333|NCT02491684|Antiviral Agents|antiviral agents|mesh-ancestor
20018334|NCT02491684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20018335|NCT02491684|Immunologic Factors|immunologic factors|mesh-ancestor
20018336|NCT02491684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018337|NCT02491684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
20018338|NCT02491788|Suvorexant|suvorexant|mesh-list
20018339|NCT02491788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
20018340|NCT02491788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20018341|NCT02491788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20018342|NCT02491788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018343|NCT02491788|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
20018344|NCT02491788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20018345|NCT02491788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018346|NCT02491892|Pertuzumab|pertuzumab|mesh-list
20018347|NCT02491892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20018348|NCT02491892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018349|NCT02491944|Osimertinib|osimertinib|mesh-list
20018350|NCT02491944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018351|NCT02491944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20018352|NCT02491944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018353|NCT02491944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018354|NCT02492451|Progesterone|progesterone|mesh-list
20018355|NCT02492451|Progestins|progestins|mesh-ancestor
20018356|NCT02492451|Hormones|hormones|mesh-ancestor
20018357|NCT02492451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20018358|NCT02492451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018359|NCT02492750|Dexamethasone|dexamethasone|mesh-list
20018360|NCT02492750|Dexamethasone acetate|dexamethasone acetate|mesh-list
20018361|NCT02492750|Lenalidomide|lenalidomide|mesh-list
20018362|NCT02492750|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
20018363|NCT02492750|Ichthammol|ichthammol|mesh-list
20018364|NCT02492750|BB 1101|bb 1101|mesh-list
20018365|NCT02492750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20018366|NCT02492750|Antiemetics|antiemetics|mesh-ancestor
20018367|NCT02492750|Autonomic Agents|autonomic agents|mesh-ancestor
20018368|NCT02492750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018369|NCT02492750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018370|NCT02492750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20018371|NCT02492750|Glucocorticoids|glucocorticoids|mesh-ancestor
20018372|NCT02492750|Hormones|hormones|mesh-ancestor
20018373|NCT02492750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20018374|NCT02492750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20018375|NCT02492750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018376|NCT02492750|Immunologic Factors|immunologic factors|mesh-ancestor
20018377|NCT02492750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
20018378|NCT02492750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
20018379|NCT02492750|Growth Substances|growth substances|mesh-ancestor
20018380|NCT02492750|Growth Inhibitors|growth inhibitors|mesh-ancestor
20018381|NCT02492750|Protease Inhibitors|protease inhibitors|mesh-ancestor
20018382|NCT02492750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018383|NCT02492750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018384|NCT02492750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20018385|NCT02492750|Dermatologic Agents|dermatologic agents|mesh-ancestor
20018386|NCT02492763|Metformin|metformin|mesh-list
20018387|NCT02492763|Liraglutide|liraglutide|mesh-list
20018388|NCT02492763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20018389|NCT02492763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018390|NCT02492763|Incretins|incretins|mesh-ancestor
20018391|NCT02492763|Hormones|hormones|mesh-ancestor
20018392|NCT02492763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20018393|NCT02492802|Posaconazole|posaconazole|mesh-list
20018394|NCT02492802|Antifungal Agents|antifungal agents|mesh-ancestor
20018395|NCT02492802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20018396|NCT02492802|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
20018397|NCT02492802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
20018398|NCT02492802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
20018399|NCT02492802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20018400|NCT02492802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20018401|NCT02492802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018402|NCT02492802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018403|NCT02492802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20018404|NCT02492802|Hormone Antagonists|hormone antagonists|mesh-ancestor
20018405|NCT02492802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20018406|NCT02492802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018407|NCT02492841|Calcium, Dietary|calcium, dietary|mesh-list
20018408|NCT02492841|Calcium|calcium|mesh-list
20018409|NCT02492841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
20018410|NCT02492841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018411|NCT02492841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
20018412|NCT02492984|Factor VIII|factor viii|mesh-list
20018413|NCT02492984|Coagulants|coagulants|mesh-ancestor
20018414|NCT02492997|Glycerol|glycerol|mesh-list
20018415|NCT02492997|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
20018416|NCT02492997|Protective Agents|protective agents|mesh-ancestor
20018417|NCT02492997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018418|NCT02493257|Ethanol|ethanol|mesh-list
20018419|NCT02493257|Capsaicin|capsaicin|mesh-list
20018420|NCT02493257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
20018421|NCT02493257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20018422|NCT02493257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20018423|NCT02493257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018424|NCT02493257|Antipruritics|antipruritics|mesh-ancestor
20018425|NCT02493257|Dermatologic Agents|dermatologic agents|mesh-ancestor
20018426|NCT02493257|Sensory System Agents|sensory system agents|mesh-ancestor
20018427|NCT02493257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018428|NCT02493361|Pembrolizumab|pembrolizumab|mesh-list
20018429|NCT02493361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20018430|NCT02493361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018431|NCT02493452|Plecanatide|plecanatide|mesh-list
20018432|NCT02493452|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
20018433|NCT02493452|Enzyme Activators|enzyme activators|mesh-ancestor
20018434|NCT02493452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018435|NCT02493452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20018436|NCT02493517|Lanreotide|lanreotide|mesh-list
20018437|NCT02493517|Somatostatin|somatostatin|mesh-list
20018438|NCT02493517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018439|NCT02493517|Hormones|hormones|mesh-ancestor
20018440|NCT02493517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20018441|NCT02493517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018442|NCT02493712|Mesalamine|mesalamine|mesh-list
20018443|NCT02493712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20018444|NCT02493712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20018445|NCT02493712|Analgesics|analgesics|mesh-ancestor
20018446|NCT02493712|Sensory System Agents|sensory system agents|mesh-ancestor
20018447|NCT02493712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018448|NCT02493712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018449|NCT02493712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20018450|NCT02493712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20018451|NCT02493764|Tazobactam|tazobactam|mesh-list
20018452|NCT02493764|Linezolid|linezolid|mesh-list
20018453|NCT02493764|Piperacillin|piperacillin|mesh-list
20018454|NCT02493764|Imipenem|imipenem|mesh-list
20018455|NCT02493764|Relebactam|relebactam|mesh-list
20018456|NCT02493764|Cilastatin|cilastatin|mesh-list
20018457|NCT02493764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
20018458|NCT02493764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20018459|NCT02493764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
20018460|NCT02493764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018461|NCT02493764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018462|NCT02493764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
20018463|NCT02493764|Protease Inhibitors|protease inhibitors|mesh-ancestor
20018464|NCT02493777|Methylphenidate|methylphenidate|mesh-list
20018465|NCT02493777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20018466|NCT02493777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018467|NCT02493777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
20018468|NCT02493777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20018469|NCT02493777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20018470|NCT02493777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018471|NCT02493777|Dopamine Agents|dopamine agents|mesh-ancestor
20018472|NCT02493777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20018473|NCT02493855|Ritonavir|ritonavir|mesh-list
20018474|NCT02493855|Ribavirin|ribavirin|mesh-list
20018475|NCT02493855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
20018476|NCT02493855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
20018477|NCT02493855|Protease Inhibitors|protease inhibitors|mesh-ancestor
20018478|NCT02493855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018479|NCT02493855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018480|NCT02493855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20018481|NCT02493855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20018482|NCT02493855|Antiviral Agents|antiviral agents|mesh-ancestor
20018483|NCT02493855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20018484|NCT02493855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20018485|NCT02493855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20018486|NCT02493855|Antimetabolites|antimetabolites|mesh-ancestor
20018487|NCT02493868|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
20018488|NCT02493868|Citalopram|citalopram|mesh-list
20018489|NCT02493868|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
20018490|NCT02493868|Sertraline|sertraline|mesh-list
20018491|NCT02493868|Antidepressive Agents|antidepressive agents|mesh-list
20018492|NCT02493868|Esketamine|esketamine|mesh-list
20018493|NCT02493868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
20018494|NCT02493868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
20018495|NCT02493868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20018496|NCT02493868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018497|NCT02493868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20018498|NCT02493868|Serotonin Agents|serotonin agents|mesh-ancestor
20018499|NCT02493868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018500|NCT02493868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
20018501|NCT02493868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20018502|NCT02493868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018503|NCT02493868|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
20018504|NCT02493868|Analgesics|analgesics|mesh-ancestor
20018505|NCT02493868|Sensory System Agents|sensory system agents|mesh-ancestor
20018506|NCT02493868|Dopamine Agents|dopamine agents|mesh-ancestor
20018507|NCT02493946|Botulinum Toxins|botulinum toxins|mesh-list
20018508|NCT02493946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
20018509|NCT02493946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
20018510|NCT02493946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
20018511|NCT02493946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
20018512|NCT02493946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018513|NCT02493946|Cholinergic Agents|cholinergic agents|mesh-ancestor
20018514|NCT02493946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20018515|NCT02493946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018516|NCT02493946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20018517|NCT02493946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018518|NCT02494102|Modafinil|modafinil|mesh-list
20018519|NCT02494102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
20018520|NCT02494102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018521|NCT02494102|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
20018522|NCT02494102|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
20018523|NCT02494102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
20018524|NCT02494102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018525|NCT02494180|Fentanyl|fentanyl|mesh-list
20018526|NCT02494180|Midazolam|midazolam|mesh-list
20018527|NCT02494180|Diazepam|diazepam|mesh-list
20018528|NCT02494180|Meperidine|meperidine|mesh-list
20018529|NCT02494180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
20018530|NCT02494180|Narcotics|narcotics|mesh-ancestor
20018531|NCT02494180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20018532|NCT02494180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018533|NCT02494180|Analgesics|analgesics|mesh-ancestor
20018534|NCT02494180|Sensory System Agents|sensory system agents|mesh-ancestor
20018535|NCT02494180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018536|NCT02494180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
20018537|NCT02494180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
20018538|NCT02494180|Anesthetics, General|anesthetics, general|mesh-ancestor
20018539|NCT02494180|Anesthetics|anesthetics|mesh-ancestor
20018540|NCT02494180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
20018541|NCT02494180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
20018542|NCT02494180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
20018543|NCT02494180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
20018544|NCT02494180|GABA Modulators|gaba modulators|mesh-ancestor
20018545|NCT02494180|GABA Agents|gaba agents|mesh-ancestor
20018546|NCT02494180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20018547|NCT02494180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018548|NCT02494180|Anticonvulsants|anticonvulsants|mesh-ancestor
20018549|NCT02494180|Antiemetics|antiemetics|mesh-ancestor
20018550|NCT02494180|Autonomic Agents|autonomic agents|mesh-ancestor
20018551|NCT02494180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
20018552|NCT02494180|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
20018553|NCT02494180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20018554|NCT02494336|Ropivacaine|ropivacaine|mesh-list
20018555|NCT02494336|Anesthetics, Local|anesthetics, local|mesh-ancestor
20018556|NCT02494336|Anesthetics|anesthetics|mesh-ancestor
20018557|NCT02494336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
20018558|NCT02494336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018559|NCT02494336|Sensory System Agents|sensory system agents|mesh-ancestor
20018560|NCT02494336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018561|NCT02494583|Pembrolizumab|pembrolizumab|mesh-list
20018562|NCT02494583|Capecitabine|capecitabine|mesh-list
20018563|NCT02494583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018564|NCT02494583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20018565|NCT02494583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20018566|NCT02494583|Antimetabolites|antimetabolites|mesh-ancestor
20018567|NCT02494583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018568|NCT02494596|Capecitabine|capecitabine|mesh-list
20018569|NCT02494596|Pertuzumab|pertuzumab|mesh-list
20018570|NCT02494596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
20018571|NCT02494596|Antimetabolites|antimetabolites|mesh-ancestor
20018572|NCT02494596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018573|NCT02494596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018574|NCT02494596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20018575|NCT02494713|Ketoconazole|ketoconazole|mesh-list
20018576|NCT02494713|Docetaxel|docetaxel|mesh-list
20018577|NCT02494713|Doxorubicin|doxorubicin|mesh-list
20018578|NCT02494713|Estramustine|estramustine|mesh-list
20018579|NCT02494713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018580|NCT02494713|Tubulin Modulators|tubulin modulators|mesh-ancestor
20018581|NCT02494713|Antimitotic Agents|antimitotic agents|mesh-ancestor
20018582|NCT02494713|Mitosis Modulators|mitosis modulators|mesh-ancestor
20018583|NCT02494713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018584|NCT02494713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
20018585|NCT02494713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
20018586|NCT02494713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
20018587|NCT02494713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018588|NCT02494713|Antifungal Agents|antifungal agents|mesh-ancestor
20018589|NCT02494713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20018590|NCT02494713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
20018591|NCT02494713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
20018592|NCT02494713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
20018593|NCT02494713|Hormone Antagonists|hormone antagonists|mesh-ancestor
20018594|NCT02494713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20018595|NCT02494713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018596|NCT02494713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
20018597|NCT02494713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
20018598|NCT02494713|Alkylating Agents|alkylating agents|mesh-ancestor
20018599|NCT02494713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
20018600|NCT02495038|Rocuronium|rocuronium|mesh-list
20018601|NCT02495038|Atracurium|atracurium|mesh-list
20018602|NCT02495038|Cisatracurium|cisatracurium|mesh-list
20018603|NCT02495038|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
20018604|NCT02495038|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
20018605|NCT02495038|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
20018606|NCT02495038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018607|NCT02495038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018608|NCT02495038|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
20018609|NCT02495038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
20018610|NCT02495038|Cholinergic Agents|cholinergic agents|mesh-ancestor
20018611|NCT02495038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20018612|NCT02495038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018613|NCT02495103|Metformin|metformin|mesh-list
20018614|NCT02495103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
20018615|NCT02495103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018616|NCT02495168|Budesonide|budesonide|mesh-list
20018617|NCT02495168|Formoterol Fumarate|formoterol fumarate|mesh-list
20018618|NCT02495168|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
20018619|NCT02495168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20018620|NCT02495168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
20018621|NCT02495168|Autonomic Agents|autonomic agents|mesh-ancestor
20018622|NCT02495168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018623|NCT02495168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018624|NCT02495168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
20018625|NCT02495168|Respiratory System Agents|respiratory system agents|mesh-ancestor
20018626|NCT02495168|Glucocorticoids|glucocorticoids|mesh-ancestor
20018627|NCT02495168|Hormones|hormones|mesh-ancestor
20018628|NCT02495168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
20018629|NCT02495168|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
20018630|NCT02495168|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20018631|NCT02495168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20018632|NCT02495168|Adrenergic Agents|adrenergic agents|mesh-ancestor
20018633|NCT02495168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20018634|NCT02495168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018635|NCT02495233|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
20018636|NCT02495233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018637|NCT02495233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
20018638|NCT02495233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018639|NCT02495233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018640|NCT02495389|Mirabegron|mirabegron|mesh-list
20018641|NCT02495389|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
20018642|NCT02495389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
20018643|NCT02495389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
20018644|NCT02495389|Adrenergic Agents|adrenergic agents|mesh-ancestor
20018645|NCT02495389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
20018646|NCT02495389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018647|NCT02495389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018648|NCT02495389|Urological Agents|urological agents|mesh-ancestor
20018649|NCT02495454|Obinutuzumab|obinutuzumab|mesh-list
20018650|NCT02495454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
20018651|NCT02495454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
20018652|NCT02495467|Nitroglycerin|nitroglycerin|mesh-list
20018653|NCT02495467|Vasodilator Agents|vasodilator agents|mesh-ancestor
20018654|NCT02495779|Tenofovir|tenofovir|mesh-list
20018655|NCT02495779|Emtricitabine|emtricitabine|mesh-list
20018656|NCT02495779|Antiviral Agents|antiviral agents|mesh-ancestor
20018657|NCT02495779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
20018658|NCT02495779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
20018659|NCT02495779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
20018660|NCT02495779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018661|NCT02495779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
20018662|NCT02495779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
20018663|NCT02495779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
20018664|NCT02495831|Diclofenac|diclofenac|mesh-list
20018665|NCT02495831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
20018666|NCT02495831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
20018667|NCT02495831|Analgesics|analgesics|mesh-ancestor
20018668|NCT02495831|Sensory System Agents|sensory system agents|mesh-ancestor
20018669|NCT02495831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
20018670|NCT02495831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
20018671|NCT02495831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
20018672|NCT02495831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
20018673|NCT02495831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
20018674|NCT02495831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
20018675|NCT02495831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
